,category,over_represented_pvalue,under_represented_pvalue,numDEInCat,numInCat,term,ontology,foreground_genes
1252,GO:0003008,2.07734942315461e-07,1,130,800,system process,BP,TGFBI;POSTN;SERPINE2;SREBF1;ACTA2;APOE;GAMT;EGFR;ESPN;ALDH1A3;SLITRK6;OBSL1;MTHFR;EPS8L2;EPHB2;EYS;SULF2;TENM4;KCNAB2;REEP2;OR2A4;STAT1;MYL9;ITGB5;NOS1;PRKACB;CRY1;GAA;HSF4;TBC1D8;ITPR3;MDM2;CRTC1;NDN;MYH11;NLGN4Y;RGS2;F2R;BLOC1S4;SLC24A1;TRPV4;NLGN2;ADORA2B;ANK3;PER2;PTGS1;UNC119;SNTA1;GSTM2;ITGA2;NMU;KCNJ5;JARID2;NISCH;INSR;GSN;TANC1;TTN;SCNN1A;AHNAK2;TRIOBP;SCN4B;PGAP1;MDK;BMP6;B4GALT2;VEGFB;ALDH7A1;SYNGAP1;HEXB;METTL23;PLA2G6;HOMER2;BBS2;DNM1;TNFRSF21;SHANK3;CYBA;RRM2B;SPRY2;RAB11FIP3;KCNMA1;ATXN1;THRA;ADARB1;GPR155;RNPEP;BRINP1;DGCR2;MYO3B;WNK1;BBS1;PDE2A;PRX;DDHD2;OLFM2;BBS5;SCN2A;KLHL3;MYO9A;VDR;CACNB3;BBS10;TPRN;RASL10B;SHROOM4;DLG4;TNNI2;ALOXE3;SHANK2;LMNA;ANO1;PBLD;TAS1R3;TUB;RDH12;CACNB1;PLCB3;AKAP6;TH;PPARG;PRKACA;SERPING1;LAMB2;NFASC;FOXP2;NPNT;EML2;CTNNBIP1;GCLC
12650,GO:0050877,2.16482760701511e-07,1,76,406,nervous system process,BP,TGFBI;SERPINE2;APOE;EGFR;ESPN;ALDH1A3;SLITRK6;EPS8L2;EPHB2;EYS;TENM4;KCNAB2;REEP2;OR2A4;GAA;HSF4;ITPR3;CRTC1;NDN;NLGN4Y;F2R;BLOC1S4;SLC24A1;NLGN2;ANK3;UNC119;ITGA2;NMU;INSR;TANC1;SCNN1A;AHNAK2;TRIOBP;PGAP1;MDK;B4GALT2;ALDH7A1;SYNGAP1;HEXB;METTL23;PLA2G6;HOMER2;BBS2;DNM1;TNFRSF21;SHANK3;SPRY2;ATXN1;THRA;ADARB1;GPR155;BRINP1;DGCR2;MYO3B;BBS1;PRX;DDHD2;OLFM2;BBS5;SCN2A;MYO9A;BBS10;TPRN;SHROOM4;DLG4;ALOXE3;SHANK2;ANO1;TAS1R3;TUB;RDH12;TH;LAMB2;NFASC;FOXP2;EML2
7918,GO:0032501,2.10933134988161e-06,0.999998660140299,509,4159,multicellular organismal process,BP,TNFAIP3;TGFBI;POSTN;TAGLN;ITGB6;SERPINE2;ULK2;GPNMB;SIK1;MAP6;PTHLH;SREBF1;ACTA2;APOE;GPSM1;INPP5D;APCDD1;GAMT;OAS2;ADAM19;MN1;LMF1;DDX60;HSPA2;FBXW4;EGFR;ESPN;PTPRS;FAM20C;PKD2;CAPRIN2;MNT;ASH2L;DIXDC1;ALDH1A3;SRSF5;LRIG3;PLCD3;SLITRK6;SFRP1;OBSL1;MTHFR;KCTD11;KIF26B;PCDH1;EPS8L2;EPHB2;GLUD1;DGKQ;PIK3R1;ADAMTS7;BRSK1;TXNRD3;MARVELD1;KDM3A;CXCL14;DOCK9;TSC22D3;EYS;EVC;RNF135;POU3F1;SULF2;WNT3;DHTKD1;HERC5;VAV3;UNK;CSPG4;ISG15;HTRA1;TFCP2L1;TENM4;UNC119B;RGMA;KCNAB2;ZFPM1;KITLG;HOXC5;SDK2;CUL7;REEP2;PRICKLE2;MC1R;OR2A4;STAT1;IMPACT;CRY2;MYL9;KRT15;UNC5B;ITGB5;COL10A1;NOS1;PRKACB;HOXA3;CRY1;ZFP41;SCMH1;KLF13;CRTAP;PLEKHG5;NFATC4;HMGCL;BTBD2;FERMT1;CYP26B1;GAA;HSF4;MICALL1;TBC1D8;PLXNB1;SPEG;NDRG1;COL7A1;SPOCK1;ITPR3;NAGLU;MDM2;CRTC1;LZTS2;PLCD1;NDN;IFITM1;MLH3;CSMD3;LTBP4;OBSCN;TNFSF10;MYH11;NEO1;RAPGEF3;TCF25;NINJ1;FAM210B;CTSV;NLGN4Y;SPATA20;FLRT3;KCTD15;KIF26A;RGS2;IL20RB;ADGRB2;F2R;PPL;HPS4;PDCD4;BLOC1S4;SPTB;SERPINB5;NYAP1;SLC24A1;ZNF160;CAPN7;DNAH1;RTN4RL1;ZFP36L2;TRPV4;FLOT1;GLI2;NLGN2;ADORA2B;ANK3;KLF7;RNF165;ADAMTS13;SOX12;CLMN;SPG11;GJC2;ZCCHC11;ARHGEF19;PER2;TMEM204;MICALCL;PTGS1;UNC119;C5;SNTA1;PSKH1;ADGRL1;MINK1;PHF2;GSTM2;AMIGO2;THBS3;TNFRSF14;WWTR1;LHFPL2;ITGA2;SEMA4G;ULK1;GLI3;FHOD3;TPGS1;IRX4;SMARCA1;BHLHE40;NAIP;LTBP1;NMU;NEK8;MAP2K5;GAS8;BOC;ITGA6;LTBP3;KCNJ5;CES3;BSN;IGFBP4;TCFL5;TRAK1;JARID2;NUPR1;PRR9;GPC2;NISCH;INSR;HSF2BP;CELSR1;GSN;BAIAP2;TANC1;TTN;SCNN1A;DDT;PLXNB3;SUN1;AHNAK2;TRIOBP;ZNF287;CD109;PMS2P3;SCN4B;SEPT6;RAB11FIP4;DOCK8;DHX58;ENDOG;SLC27A1;PGAP1;RTF1;BLOC1S3;MDK;CASP14;RICTOR;BMP6;NLRX1;B4GALT2;ETNK2;S100A4;MICALL2;VEGFB;ALDH7A1;CABYR;PTK6;FZD7;ETV5;LOXL1;SYNGAP1;FAM213A;FAT2;DLX3;EPB41L3;SHARPIN;HEXB;KDM4C;HYAL1;METTL23;SH2D2A;PLA2G6;CST3;HOMER2;MMRN2;PEX7;BBS2;TXNIP;CTF1;TCF4;COL6A1;NPHP3;PLAG1;IDH2;WRN;PODXL;MALL;DNM1;MCM9;TNFRSF21;IQCB1;TREX1;CDK5R1;ATRX;REC8;CA2;EFNB3;MAPK10;SHANK3;HFE;HMG20B;CYBA;NID1;AGO4;ERCC6;RRM2B;SLIT3;KRT14;EDA2R;SPRY2;MRC2;MEF2D;IFT140;CREBRF;RAB11FIP3;LRP11;CTSB;KLK5;FBXW7;KCNMA1;CDK5RAP3;ATXN1;LMO2;NOTCH2NL;TFPI2;THRA;APC2;ADARB1;RAI1;ELF1;SLC2A1;ACACB;NLRP1;ERMAP;GPR155;TNS2;DBP;NAB2;GNG2;SRR;LRP1;LRRN3;NPHP4;CCDC136;ACP5;PLA2G7;RNPEP;RFX2;MTURN;BRINP1;DGCR2;MYO3B;SALL2;WNK1;BBS1;ATXN10;JPH2;ZBTB20;PDE2A;SDHA;MAF;LTB4R2;RET;ZMYND8;PRX;DAB2IP;CASZ1;TEAD2;MYSM1;DDHD2;SHROOM2;RNF213;OLFM2;RAPGEFL1;TSHZ2;IFI16;SYT7;FGFR4;BBS5;IL20RA;SCN2A;TEF;AREG;TMEM203;KLHL3;MYO9A;RPS6KA5;DLG5;BTG1;BST2;VDR;CACNB3;TNRC6C;DPY19L2P2;PLXND1;BBS10;ZMYM3;SIX5;PCSK6;DMTN;TPRN;ARFGEF2;RASL10B;WWC3;TMEM231;TFDP2;PMP22;UCN2;NRARP;ACVR1B;SHROOM4;TACC1;KREMEN1;CCDC88B;DLG4;TNNI2;TSSK1B;ALOXE3;PALB2;ENDOU;NHSL1;MATN2;NBEAL2;DUOX1;WEE1;GTF2IRD2;PTK7;TCF7;SHANK2;RSAD2;TNFRSF25;ZFP36L1;LMNA;MXRA8;CLSTN3;IL11;KAT2B;MARK4;APOLD1;IRS2;ANO1;ALOX15B;GPR21;TKFC;MTR;S100A6;TRERF1;ZSWIM8;APBB2;PBLD;RAPGEF5;TNFSF12;TAS1R3;STAT6;PCSK1N;SOX13;PHC2;TUB;GSTM3;RDH12;SRPX2;CD9;RANBP9;CACNB1;HDAC11;PTPN3;GJB5;COL13A1;ERBB2;PLCB3;GPR68;PAQR7;AKAP6;TH;RORA;SSH3;PPARG;PRKACA;DOCK6;LDLRAP1;NPAP1;POLM;FMNL3;GCNT4;SYNE2;ACKR3;PLTP;SERPING1;PARN;UFL1;LAMB2;RIPK3;NFASC;CIT;MAP1A;PER3;FOXP2;PTBP2;HIVEP1;ECM2;SMURF1;NPNT;HERPUD2;TTLL1;EML2;CTNNBIP1;GCLC;ECM1
2591,GO:0005886,1.13418257155084e-05,0.999991799876219,360,2819,plasma membrane,CC,TGFBI;ITGB6;SERPINE2;GPNMB;MUC19;IFI6;AMACR;APOE;GPSM1;NT5E;INPP5D;APCDD1;ADAM19;PSD4;HSPA2;EGFR;PTPRS;FLNC;PKD2;CAPRIN2;XPC;SYT8;CXCR1;ALDH1A3;LRIG3;PLCD3;SLITRK6;SFRP1;PCDH1;EPS8L2;EPHB2;SYNC;DGKQ;PIK3R1;MARVELD1;EVC;SULF2;WNT3;VAV3;CSPG4;MVB12B;CYBRD1;HTRA1;TENM4;RGMA;PI4KAP2;KCNAB2;KITLG;SDK2;VAMP3;REEP2;KCNJ15;MC1R;OR2A4;CSMD2;CAMK2N1;GRIP2;MARCKSL1;NSG1;UNC5B;SLC16A5;ITGB5;GJD3;RAB40B;NOS1;PRKACB;SDC3;BCAM;PLEKHG5;FERMT1;GAA;PIK3C2G;PLXNB1;NDRG1;KCNC4;SLC29A4;ITPR3;MDM2;CRTC1;LZTS2;PLCD1;IFITM1;ST6GALNAC6;FCGRT;CSMD3;PIK3IP1;OBSCN;GPRC5C;HLA-B;TNFSF10;HGSNAT;PARVB;SYTL1;RHOBTB2;NEO1;RAPGEF3;CTSV;NLGN4Y;BLVRB;FLRT3;RASA4;RGS2;IL20RB;ADGRB2;F2R;PPL;C2CD4C;SPTB;SLC24A1;RTN4RL1;TRPV4;TMC6;FLOT1;NLGN2;ADORA2B;ANK3;LAMP3;PLCH2;SLC13A5;RIMS3;SPG11;GJC2;TSPAN18;TMEM204;FNDC4;FRS3;C5;SNTA1;PSKH1;ADGRL1;MINK1;AMIGO2;TNFRSF14;ASAP2;ARHGEF4;LHFPL2;ITGA2;SEMA4G;SYT15;SPPL2B;LRSAM1;VAMP2;NAIP;BOC;ITGA6;KCNJ5;LZTS1;PRR9;GPC2;NISCH;INSR;CELSR1;GSN;CDK14;ST3GAL5;BAIAP2;TANC1;CBLC;SCNN1A;PLXNB3;LPAR5;AHNAK2;CNTNAP3;PLEKHH2;RIN1;CD109;SCN4B;ARHGEF1;SEPT6;RAB11FIP4;MGST2;DOCK8;PILRB;SLC27A1;TM7SF3;NRSN2;SIRPB2;NLRX1;SLC2A3;TCIRG1;MICALL2;MAP2K2;PTK6;SLC12A7;TMEM8B;FZD7;ETV5;SYNGAP1;FAT2;TMEM117;EPB41L3;CLCA2;ARHGAP33;ARRDC1;KIAA0319L;CENPC;HOMER2;CAPNS2;BBS2;ATP6V0A2;COL6A1;PSD3;CERCAM;MAP3K12;PODXL;SEPT5;MALL;OSCP1;DNM1;TNFRSF21;CDK5R1;NET1;ANO9;CA2;EFNB3;PI4KAP1;MAPK10;NKTR;SHANK3;HFE;SCART1;CYBA;SHC2;EDA2R;SPRY2;MRC2;GABBR1;XRN1;RAB11FIP3;LRP11;KCNMA1;GPR87;PAQR6;APC2;ARAP1;RPH3AL;SLC2A1;ERMAP;TNS2;SLC38A4;TP53I13;GNG2;PRR7;SRR;LRP1;HLA-A;RGS12;RNPEP;KCNG1;SLC48A1;CD99L2;PMEL;BBS1;ATXN10;JPH2;PDE2A;SDHA;LTB4R2;RET;PRX;DAB2IP;MYSM1;SHROOM2;OLFM2;SYT7;FGFR4;BBS5;EXOC2;IL20RA;SCN2A;ABTB1;DEF6;DLG5;BST2;CACNB3;PHF7;VIPR1;EFS;PLXND1;EHBP1;PCSK6;LPAR6;DMTN;STAT2;RASL10B;SLC36A4;TMEM231;PMP22;CA11;ACVR1B;SHROOM4;KREMEN1;CADM4;DLG4;ESYT2;ENDOU;NBEAL2;CD68;DUOX1;SLC22A15;SLC35G2;PTK7;SHANK2;TNFRSF25;CLSTN3;ACSL1;APOLD1;IRS2;ANO1;ALOX15B;GPR21;ZMAT3;S100A6;TNFSF12;TAS1R3;GPR132;SMPDL3B;TUB;SLC43A1;CPT1C;RDH12;TRAF5;SRPX2;CD9;PLIN4;RANBP9;CACNB1;HDAC11;PTPN3;GJB5;COL13A1;ERBB2;SYNGR1;GPR68;PAQR7;ABCA2;AKAP6;SLC2A11;TH;MPP7;PRKACA;LDLRAP1;FMNL3;SYNE2;PARD6G;ACKR3;SUCLG2;RIPK3;NFASC;KLF9;PI4K2B;AIP;KCNS3;CIT;CALHM2;SMURF1;NPNT;PEMT;TM4SF1;SERINC3
15520,GO:0071944,1.15533041912342e-05,0.999991629051171,368,2890,cell periphery,CC,TGFBI;ITGB6;SERPINE2;GPNMB;MUC19;IFI6;AMACR;APOE;GPSM1;NT5E;INPP5D;APCDD1;ADAM19;PSD4;HSPA2;EGFR;PTPRS;FLNC;PKD2;CAPRIN2;XPC;SYT8;CXCR1;ALDH1A3;LRIG3;PLCD3;SLITRK6;SFRP1;PCDH1;EPS8L2;EPHB2;SYNC;DGKQ;PIK3R1;MARVELD1;EVC;SULF2;WNT3;VAV3;CSPG4;MVB12B;CYBRD1;HTRA1;TENM4;RGMA;PI4KAP2;KCNAB2;KITLG;SDK2;VAMP3;REEP2;KCNJ15;MC1R;OR2A4;CSMD2;CAMK2N1;GRIP2;MARCKSL1;NSG1;UNC5B;SLC16A5;ITGB5;COL10A1;GJD3;RAB40B;NOS1;PRKACB;SDC3;BCAM;PLEKHG5;FERMT1;GAA;PIK3C2G;PLXNB1;NDRG1;KCNC4;SLC29A4;ITPR3;MDM2;CRTC1;LZTS2;PLCD1;IFITM1;ST6GALNAC6;FCGRT;CSMD3;PIK3IP1;OBSCN;GPRC5C;HLA-B;TNFSF10;HGSNAT;PARVB;SYTL1;RHOBTB2;NEO1;RAPGEF3;CTSV;NLGN4Y;BLVRB;FLRT3;RASA4;RGS2;IL20RB;ADGRB2;F2R;PPL;C2CD4C;SPTB;SLC24A1;RTN4RL1;TRPV4;TMC6;FLOT1;NLGN2;ADORA2B;ANK3;LAMP3;PLCH2;SLC13A5;RIMS3;SPG11;GJC2;TSPAN18;TMEM204;FNDC4;FRS3;C5;WIPF1;SNTA1;PSKH1;ADGRL1;MINK1;AMIGO2;TNFRSF14;ASAP2;ARHGEF4;LHFPL2;ITGA2;SEMA4G;FAM110C;SYT15;SPPL2B;LRSAM1;VAMP2;NAIP;BOC;ITGA6;KCNJ5;BSN;LZTS1;PRR9;GPC2;NISCH;INSR;CELSR1;GSN;CDK14;ST3GAL5;BAIAP2;TANC1;CBLC;SCNN1A;PLXNB3;LPAR5;AHNAK2;CNTNAP3;PLEKHH2;TRIOBP;RIN1;CD109;SCN4B;ARHGEF1;SEPT6;RAB11FIP4;MGST2;DOCK8;PILRB;SLC27A1;TM7SF3;NRSN2;SIRPB2;NLRX1;SLC2A3;TCIRG1;MICALL2;MAP2K2;PTK6;SLC12A7;TMEM8B;FZD7;ETV5;SYNGAP1;FAT2;TMEM117;EPB41L3;CLCA2;ARHGAP33;ARRDC1;KIAA0319L;CENPC;HOMER2;CAPNS2;BBS2;ATP6V0A2;COL6A1;PSD3;CERCAM;MAP3K12;PODXL;SEPT5;MALL;OSCP1;DNM1;TNFRSF21;CDK5R1;NET1;ANO9;CA2;EFNB3;PI4KAP1;MAPK10;NKTR;SHANK3;HFE;SCART1;CYBA;NID1;KRT14;SHC2;EDA2R;SPRY2;MRC2;GABBR1;XRN1;RAB11FIP3;LRP11;KCNMA1;GPR87;PAQR6;APC2;ARAP1;ASTN2;RPH3AL;SLC2A1;ERMAP;TNS2;SLC38A4;TP53I13;GNG2;PRR7;SRR;LRP1;HLA-A;RGS12;RNPEP;KCNG1;SLC48A1;CD99L2;PMEL;BBS1;ATXN10;JPH2;PDE2A;SDHA;LTB4R2;RET;PRX;DAB2IP;MYSM1;SHROOM2;OLFM2;SYT7;FGFR4;BBS5;EXOC2;IL20RA;SCN2A;ABTB1;DEF6;DLG5;BST2;CACNB3;PHF7;VIPR1;EFS;PLXND1;EHBP1;PCSK6;LPAR6;DMTN;STAT2;RASL10B;SLC36A4;TMEM231;PMP22;CA11;ACVR1B;SHROOM4;KREMEN1;CADM4;DLG4;ESYT2;ENDOU;NBEAL2;CD68;DUOX1;SLC22A15;SLC35G2;PTK7;SHANK2;TNFRSF25;CLSTN3;ACSL1;APOLD1;IRS2;ANO1;ALOX15B;GPR21;ZMAT3;S100A6;TNFSF12;TAS1R3;GPR132;SMPDL3B;TUB;SLC43A1;CPT1C;RDH12;TRAF5;SRPX2;CD9;PLIN4;RANBP9;CACNB1;HDAC11;PTPN3;GJB5;COL13A1;ERBB2;SYNGR1;GPR68;PAQR7;ABCA2;AKAP6;SLC2A11;TH;MPP7;PRKACA;LDLRAP1;FMNL3;SYNE2;PARD6G;ACKR3;SUCLG2;RIPK3;NFASC;KLF9;PI4K2B;AIP;KCNS3;CIT;CALHM2;SMURF1;NPNT;PEMT;TM4SF1;SERINC3
7145,GO:0031012,1.92670601998056e-05,0.999991304062638,47,236,extracellular matrix,CC,TGFBI;POSTN;SERPINE2;APOE;SLITRK6;SFRP1;ADAMTS7;COL22A1;WNT3;SMOC2;CSPG4;HTRA1;COL10A1;CRTAP;SDC3;BCAM;COL7A1;SPOCK1;LTBP4;TNXB;FLRT3;ADAMTS13;THBS3;LTBP1;ITGA6;LTBP3;MMP1;GPC2;MMP28;LOXL1;MXRA7;CST3;MMRN2;THSD4;COL6A1;NID1;SLIT3;TFPI2;LRRN3;PCSK6;MATN2;EFEMP2;CTSD;LAMB2;ECM2;NPNT;ECM1
3404,GO:0007186,2.98757703164905e-05,0.99998447288528,65,380,G-protein coupled receptor signaling pathway,BP,PTHLH;APOE;CXCR1;SFRP1;DGKQ;PIK3R1;VAV3;MC1R;OR2A4;NSG1;NOS1;PRKACB;CRY1;PLEKHG5;PLXNB1;ITPR3;OBSCN;GPRC5C;RGS2;ADGRB2;F2R;ADGRF4;ADORA2B;ARHGEF19;C5;ADGRL1;ARHGEF4;NMU;INSR;CELSR1;HEBP1;LPAR5;ARHGEF1;FZD7;NXPH4;HOMER2;CDK5R1;NET1;CA2;GABBR1;KLK5;GPR87;RPH3AL;GNG2;LRP1;RGS12;PDE2A;LTB4R2;RAPGEFL1;AREG;ARHGEF17;VIPR1;LPAR6;UCN2;ANO1;GPR21;SCG5;ARHGEF9;TAS1R3;PCSK1N;GPR132;PLCB3;GPR68;PPARG;ACKR3
3559,GO:0007600,5.17413808334288e-05,0.999976819623233,41,210,sensory perception,BP,TGFBI;SERPINE2;ESPN;SLITRK6;EPS8L2;EYS;REEP2;OR2A4;HSF4;ITPR3;NDN;F2R;SLC24A1;NLGN2;UNC119;ITGA2;NMU;SCNN1A;TRIOBP;PGAP1;ALDH7A1;HEXB;HOMER2;BBS2;DNM1;SPRY2;MYO3B;BBS1;OLFM2;BBS5;MYO9A;BBS10;TPRN;ALOXE3;ANO1;TAS1R3;TUB;RDH12;TH;LAMB2;EML2
15360,GO:0071625,6.01178187361446e-05,0.999996162687966,7,11,vocalization behavior,BP,NLGN4Y;SHANK3;BRINP1;DLG4;SHANK2;SRPX2;FOXP2
11240,GO:0045494,6.28664558522109e-05,0.999992654716092,9,19,photoreceptor cell maintenance,BP,BBS2;NPHP3;IQCB1;ERCC6;NPHP4;BBS1;BBS10;TUB;RDH12
5317,GO:0016042,6.76378183324227e-05,0.999969875158683,39,203,lipid catabolic process,BP,AMACR;APOE;CES2;CPT2;PLCD3;SRD5A3;CYP26B1;PLCD1;TYSND1;CRAT;MLYCD;PHYH;PLCH2;SULT1E1;CES3;MGST2;HEXB;PLA2G6;PEX7;PLD3;LPIN3;HADH;THRA;ACADS;ACACB;PLA2G7;ACOX3;DDHD2;ETFB;IRS2;HSD17B14;ECI1;TRERF1;FAAH;SMPDL3B;CPT1C;PLCB3;LONP2;EHHADH
2377,GO:0005509,6.89140820140122e-05,0.999963046415043,64,364,calcium ion binding,MF,FAM20C;PKD2;SYT8;PCDH1;EYS;SULF2;SMOC2;VWCE;MYL9;PITPNM3;SPOCK1;ITPR3;PLCD1;LTBP4;SYTL1;FKBP9;CALML3;C2CD4C;CGREF1;SLC24A1;ADAMTS13;PLCH2;PITPNM2;NINL;THBS3;SYT15;LTBP1;LTBP3;CELSR1;GSN;TTN;CBLC;RAB11FIP4;S100A4;CABYR;FAT2;CAPNS2;MCTP1;CDK5R1;NID1;SLIT3;RAB11FIP3;NOTCH2NL;ASTN2;RPH3AL;SRR;LRP1;DLK2;RET;SYT7;SNCB;NECAB3;PPP2R3B;ESYT2;MATN2;DUOX1;CLSTN3;CAPS;ALOX15B;MAN1B1;S100A6;EFEMP2;PLCB3;NPNT
3454,GO:0007267,7.0563497575099e-05,0.999954023299489,131,906,cell-cell signaling,BP,SERPINE2;GPNMB;PTHLH;SREBF1;APOE;APCDD1;FBXW4;EGFR;CAPRIN2;SYT8;SYN1;DIXDC1;SFRP1;PCDH1;EPHB2;GLUD1;BRSK1;CXCL14;SULF2;WNT3;PRICKLE2;NSG1;NOS1;CRY1;NFATC4;FERMT1;KCNC4;ITPR3;CRTC1;LZTS2;LTBP4;TNFSF10;SYTL1;RAPGEF3;NLGN4Y;GAL3ST4;F2R;C2CD4C;SLC24A1;TRPV4;FLOT1;GLI2;NLGN2;RIMS3;SPG11;GJC2;ARHGEF19;PER2;UNC119;MINK1;WWTR1;SYT15;GLI3;PCSK1;TPGS1;VAMP2;NAIP;NMU;KCNJ5;BSN;IGFBP4;NISCH;CELSR1;CDK14;BAIAP2;SCN4B;TM7SF3;RTF1;BMP6;SQSTM1;SLC12A7;FZD7;ETV5;SYNGAP1;PLA2G6;GDF15;CTF1;NPHP3;SEPT5;DNM1;MCTP1;CA2;EFNB3;SHANK3;HFE;AGO4;HADH;RAB11FIP3;PFKFB2;APC2;ADARB1;SLC2A1;FRAT1;GLUL;GNG2;LRP1;NPHP4;WNK1;ZMYND8;DAB2IP;CALCOCO1;RNF213;SYT7;AREG;SNCB;BST2;CACNB3;TNRC6C;RASL10B;PMP22;NRARP;KREMEN1;DLG4;IGFBP6;PTK7;TCF7;SHANK2;CLSTN3;IL11;IRS2;ANO1;SCG5;PHPT1;CACNB1;SYNGR1;PLCB3;GPR68;TH;KCNS3;SMURF1;CTNNBIP1
17034,GO:0099537,7.32368483004543e-05,0.9999626899592,54,298,trans-synaptic signaling,BP,SERPINE2;APOE;EGFR;SYT8;SYN1;EPHB2;BRSK1;NSG1;NOS1;NFATC4;KCNC4;ITPR3;CRTC1;SYTL1;NLGN4Y;F2R;C2CD4C;SLC24A1;FLOT1;NLGN2;RIMS3;SPG11;UNC119;MINK1;SYT15;TPGS1;VAMP2;NMU;BSN;NISCH;BAIAP2;SQSTM1;SLC12A7;ETV5;SYNGAP1;PLA2G6;SEPT5;DNM1;MCTP1;CA2;SHANK3;ADARB1;GLUL;ZMYND8;SYT7;SNCB;CACNB3;PMP22;DLG4;SHANK2;CLSTN3;CACNB1;SYNGR1;TH
17033,GO:0099536,8.12344223226176e-05,0.999958431054611,54,299,synaptic signaling,BP,SERPINE2;APOE;EGFR;SYT8;SYN1;EPHB2;BRSK1;NSG1;NOS1;NFATC4;KCNC4;ITPR3;CRTC1;SYTL1;NLGN4Y;F2R;C2CD4C;SLC24A1;FLOT1;NLGN2;RIMS3;SPG11;UNC119;MINK1;SYT15;TPGS1;VAMP2;NMU;BSN;NISCH;BAIAP2;SQSTM1;SLC12A7;ETV5;SYNGAP1;PLA2G6;SEPT5;DNM1;MCTP1;CA2;SHANK3;ADARB1;GLUL;ZMYND8;SYT7;SNCB;CACNB3;PMP22;DLG4;SHANK2;CLSTN3;CACNB1;SYNGR1;TH
3455,GO:0007268,0.000116630306741111,0.999939769064086,53,296,chemical synaptic transmission,BP,SERPINE2;APOE;EGFR;SYT8;SYN1;EPHB2;BRSK1;NSG1;NFATC4;KCNC4;ITPR3;CRTC1;SYTL1;NLGN4Y;F2R;C2CD4C;SLC24A1;FLOT1;NLGN2;RIMS3;SPG11;UNC119;MINK1;SYT15;TPGS1;VAMP2;NMU;BSN;NISCH;BAIAP2;SQSTM1;SLC12A7;ETV5;SYNGAP1;PLA2G6;SEPT5;DNM1;MCTP1;CA2;SHANK3;ADARB1;GLUL;ZMYND8;SYT7;SNCB;CACNB3;PMP22;DLG4;SHANK2;CLSTN3;CACNB1;SYNGR1;TH
16916,GO:0098916,0.000116630306741111,0.999939769064086,53,296,anterograde trans-synaptic signaling,BP,SERPINE2;APOE;EGFR;SYT8;SYN1;EPHB2;BRSK1;NSG1;NFATC4;KCNC4;ITPR3;CRTC1;SYTL1;NLGN4Y;F2R;C2CD4C;SLC24A1;FLOT1;NLGN2;RIMS3;SPG11;UNC119;MINK1;SYT15;TPGS1;VAMP2;NMU;BSN;NISCH;BAIAP2;SQSTM1;SLC12A7;ETV5;SYNGAP1;PLA2G6;SEPT5;DNM1;MCTP1;CA2;SHANK3;ADARB1;GLUL;ZMYND8;SYT7;SNCB;CACNB3;PMP22;DLG4;SHANK2;CLSTN3;CACNB1;SYNGR1;TH
11137,GO:0045202,0.000131063273059502,0.99992212385136,82,511,synapse,CC,POSTN;SERPINE2;EGFR;PTPRS;SYT8;SYN1;MTHFR;EPHB2;SYNC;BRSK1;KCNAB2;SDK2;VAMP3;CAMK2N1;NSG1;RAB40B;NOS1;KCNC4;SPOCK1;MDM2;CRTC1;SYTL1;NLGN4Y;BLVRB;FLRT3;F2R;C2CD4C;NLGN2;ANK3;RIMS3;SPG11;DTNB;SNTA1;ADGRL1;MINK1;ITGA2;SYT15;VAMP2;NMU;BSN;LZTS1;BAIAP2;TANC1;SEPT6;SYNGAP1;EPB41L3;SHARPIN;HOMER2;PSD3;SEPT5;DNM1;MCTP1;CDK5R1;SHANK3;FBXO2;GABBR1;XRN1;KCNMA1;GLUL;PRR7;NPHP4;RGS12;PDE2A;ZMYND8;OLFM2;SYT7;SNCB;DLG5;DMTN;ARFGEF2;DLG4;SHANK2;CLSTN3;DMXL2;APBB2;CPT1C;SRPX2;COL13A1;SYNGR1;TH;LAMB2;MAP1A
2210,GO:0005102,0.000157403874016866,0.999896000019432,124,882,signaling receptor binding,MF,TGFBI;ITGB6;SERPINE2;GPNMB;PTHLH;AMACR;APOE;EGFR;PKD2;CAPRIN2;SFRP1;EPHB2;PIK3R1;KDM3A;CXCL14;WNT3;VAV3;RGMA;KITLG;REEP2;STAT1;NSG1;CRY1;NFATC4;PITPNM3;HMGCL;THNSL2;PLXNB1;MDM2;LTBP4;IDUA;HLA-B;TNFSF10;SYTL1;TNXB;NLGN4Y;FLRT3;CRAT;F2R;MLYCD;FLOT1;NLGN2;ADAMTS13;PIDD1;PITPNM2;FRS3;C5;GSTM2;ITGA2;SEMA4G;THRAP3;NMU;ITGA6;IGFBP4;TRAK1;NISCH;INSR;CBLC;DDT;ARHGEF1;PILRB;MDK;BMP6;S100A4;VEGFB;SQSTM1;PTK6;FZD7;NXPH4;KDM4C;HOMER2;GDF15;CTF1;DNM1;CDK5R1;EFNB3;SHANK3;HFE;SLIT3;SHC2;NUDT6;ARAP1;ERMAP;LRP1;HLA-A;BBS1;DAB2IP;ACOX3;PIK3R2;AREG;VDR;DMTN;ARFGEF2;SNX1;UCN2;CADM4;DLG4;IGFL2;ENDOU;IGFBP6;SHANK2;IL11;IRS2;ERN1;DHRS4;TNFSF12;PCSK1N;PRDX5;TRAF5;SRPX2;CD9;ERBB2;PPARG;LDLRAP1;ACOT2;LAMB2;AIP;LONP2;EHHADH;FOXP2;ECM2;NPNT;EML2;ECM1
12602,GO:0050806,0.00017318826881152,0.99994227863622,21,84,positive regulation of synaptic transmission,BP,SERPINE2;APOE;EGFR;EPHB2;NSG1;ITPR3;CRTC1;SLC24A1;FLOT1;NLGN2;RIMS3;VAMP2;NMU;BAIAP2;SQSTM1;CA2;SHANK3;GLUL;DLG4;SHANK2;CLSTN3
4259,GO:0009605,0.000205991911863347,0.999853966728459,177,1332,response to external stimulus,BP,TNFAIP3;POSTN;SERPINE2;ULK2;GPNMB;SIK1;SREBF1;ACTA2;APOE;NT5E;OAS2;DDX60;EGFR;PTPRS;PKD2;XPC;APOBEC3C;CXCR1;TRIM22;ALDH1A3;SLITRK6;SFRP1;MTHFR;IFI44L;EPHB2;MAP3K14;DGKQ;PIK3R1;CXCL14;EYS;WNT3;HERC5;VAV3;VWCE;ISG15;HTRA1;RGMA;STAT1;IMPACT;CRY2;UNC5B;NOS1;CRY1;PLEKHG5;HMGCL;CMPK2;PIK3C2G;PLXNB1;MDM2;CRTC1;IFITM1;NEO1;CTSV;OAS1;FLRT3;KIF26A;IL20RB;F2R;PPL;PDCD4;SPTB;RTN4RL1;TRPV4;GLI2;ADORA2B;KLF7;RNF165;ADAMTS13;PER2;CLCN6;UNC119;FNDC4;C5;WIPF1;TNFRSF14;ITGA2;SEMA4G;ULK1;GLI3;BHLHE40;LRSAM1;BOC;ITGA6;SESN3;IFI44;MMP28;GSN;BAIAP2;TTN;DDT;PLXNB3;SUN1;CD109;MGST2;DHX58;ENDOG;BLOC1S3;IRF9;RICTOR;BMP6;NLRX1;VEGFB;LOXL1;SHARPIN;HYAL1;PLA2G6;CST3;BBS2;TXNIP;WRN;TNFRSF21;CDK5R1;EFNB3;SESN1;SHANK3;HFE;CYBA;SLIT3;HLCS;LRP11;KLK5;ADARB1;MX2;SLC2A1;ACACB;NLRP1;GLUL;SRR;ACP5;PLA2G7;C12ORF66;PDE2A;LTB4R2;RET;DAB2IP;SHROOM2;PIK3C3;IFI16;RPS6KA5;BST2;VDR;FAM3A;PLXND1;DMTN;STAT2;UCN2;CCDC88B;MATN2;RSAD2;TNFRSF25;ACSL1;IRS2;ANO1;IVNS1ABP;TKFC;ZSWIM8;APBB2;PCSK1N;SMPDL3B;CD9;RANBP9;ERBB2;TH;ATG14;RORA;PPARG;ACKR3;SERPING1;UFL1;LAMB2;NFASC;PER3;FOXP2;NPNT;PEMT;SERINC3;GCLC
4562,GO:0010646,0.000236671170398521,0.99982053017431,289,2308,regulation of cell communication,BP,TNFAIP3;POSTN;SERPINE2;GPNMB;EPM2A;TP53INP1;IFI6;PTHLH;SREBF1;APOE;INPP5D;APCDD1;PSD4;DDX60;EGFR;PTPRS;FAM20C;PKD2;CAPRIN2;MNT;SYN1;DIXDC1;TRIM22;SFRP1;KCTD11;EPS8L2;EPHB2;MAP3K14;GLUD1;DGKQ;PIK3R1;RBCK1;CXCL14;EVC;SULF2;WNT3;VAV3;CSPG4;MVB12B;HTRA1;KITLG;MC1R;ASAP3;STAT1;CAMK2N1;CRY2;NSG1;UNC5B;NOS1;PRKACB;CRY1;MAML3;PLEKHG5;NFATC4;IQSEC2;FERMT1;CYP26B1;THNSL2;PLXNB1;PLEKHG3;KCNC4;ITPR3;MDM2;CRTC1;LZTS2;CHN2;LTBP4;PIK3IP1;OBSCN;TNFSF10;RHOBTB2;NEO1;RAPGEF3;NLGN4Y;FLRT3;RASA4;KIF26A;RGS2;ACAP3;F2R;PDCD4;SLC24A1;RTN4RL1;TRPV4;FLOT1;GLI2;AGAP4;NLGN2;ADORA2B;ANK3;RNF165;RALGAPA1;MAPK8IP3;PIDD1;RIMS3;ARHGEF19;RHBDF1;RASGEF1A;PER2;TMEM204;C5;MINK1;GSTM2;WWTR1;ASAP2;ARHGEF4;ITGA2;FAM110C;GLI3;SPPL2B;AKAP7;VAMP2;NAIP;LTBP1;NMU;NEK8;MAP2K5;ITGA6;SRGAP3;SESN3;IGFBP4;GPC2;NISCH;INSR;GSN;CHD3;CDK14;BAIAP2;CBLC;DDT;CD109;RMI2;ARHGEF1;DHX58;TM7SF3;MDK;RICTOR;BMP6;NLRX1;S100A4;MAP2K2;VEGFB;SQSTM1;PTK6;FZD7;SYNGAP1;FAM13A;SHARPIN;ARHGAP33;SH2D2A;ARRDC1;PLA2G6;HOMER2;MMRN2;GDF15;CTF1;NPHP3;PSD3;MAP3K12;WRN;SEPT5;DNM1;KLHL24;MCTP1;CDK5R1;AGAP6;NET1;CA2;SESN1;MAPK10;SHANK3;HFE;CYBA;TRIM38;ERCC6;HADH;RRM2B;SLIT3;SHC2;EDA2R;SPRY2;IFT140;CREBRF;AGAP7P;RAB11FIP3;KLK5;FBXW7;NUDT6;CDK5RAP3;PAK6;PFKFB2;THRA;APC2;ARAP1;ELF1;RPH3AL;SLC2A1;NLRP1;GLUL;LRP1;NPHP4;RGS12;C12ORF66;DLK2;MAP3K6;APPL2;WNK1;JPH2;PDE2A;RET;ZMYND8;DAB2IP;RWDD3;RNF213;SYT7;FGFR4;IL20RA;PIK3R2;AREG;MYO9A;DLG5;BST2;RGL2;ARHGEF17;PCSK6;LPAR6;PPP1R2;DMTN;STAT2;ARFGEF2;RASL10B;WWC3;TFDP2;UCN2;NRARP;ACVR1B;KREMEN1;DLG4;IQSEC1;ENDOU;IGFBP6;SHANK2;RSAD2;TNFRSF25;LMNA;CLSTN3;IL11;KAT2B;IRS2;ANO1;ERN1;IVNS1ABP;ALOX15B;RAD50;GPR21;TKFC;SCG5;ARHGEF9;PBLD;TNFSF12;PHPT1;SMPDL3B;KIF7;TRAF5;RANBP9;PTPN3;ERBB2;SYNGR1;GPR68;ARHGAP23;AKAP6;MPP7;RORA;PPARG;PRKACA;LDLRAP1;CXXC5;ACKR3;UFL1;RIPK3;AIP;KCNS3;CCDC3;SMURF1;NPNT;CTNNBIP1;SERINC3;GCLC;ECM1
10774,GO:0044255,0.00023821179822925,0.999845181994665,108,753,cellular lipid metabolic process,BP,SIK1;SREBF1;AMACR;APOE;CES2;INPP5D;LMF1;EGFR;CPT2;ALDH1A3;DGKQ;PIK3R1;VAV3;PI4KAP2;KITLG;MVD;SRD5A3;KDSR;SDC3;PITPNM3;CYP26B1;THNSL2;PIK3C2G;PLCD1;ST6GALNAC6;TYSND1;PIK3IP1;UGT1A3;CERS4;CYP3A5;ACOT1;GAL3ST4;CRAT;B4GALT6;MLYCD;PHYH;SLC27A3;ARSI;PLCH2;PER2;PITPNM2;PTGS1;HEXA;ARSD;GSTM2;MBOAT2;GPC2;ST3GAL5;CYP2D7;MGST2;SLC27A1;PGAP1;ETNK2;PDK1;HEXB;PLA2G6;PEX7;LPIN3;PIGZ;OSBPL10;PI4KAP1;HADH;MLXIPL;FBXW7;ACADS;ACACB;LRP1;PLA2G7;DAB2IP;ACOX3;DDHD2;PIK3C3;FGFR4;PIK3R2;RETSAT;OSBPL5;ETFB;MPPE1;KDELC2;ESYT2;ALOXE3;ACSL1;IRS2;IMPA2;ALOX15B;DHRS4;ECI1;FAAH;CBR4;ISYNA1;CERS5;SMPDL3B;GLB1;CPT1C;RDH12;ACSS2;ERBB2;PQLC3;TH;ATG14;PPARG;ACOT2;IP6K2;PI4K2B;LONP2;EHHADH;PEMT;SERINC3
12604,GO:0050808,0.000245909233031278,0.999886962027816,36,179,synapse organization,BP,APOE;CAPRIN2;SLITRK6;EPHB2;SDK2;NFATC4;NLGN4Y;FLRT3;ADGRB2;F2R;NLGN2;ANK3;ADGRL1;AMIGO2;BSN;INSR;BAIAP2;TANC1;ETV5;CDK5R1;SHANK3;LRRN3;ZMYND8;DAB2IP;SNCB;DLG5;CACNB3;PLXND1;DLG4;SHANK2;CLSTN3;SRPX2;CACNB1;ERBB2;LAMB2;NFASC
3068,GO:0006635,0.000247537298086044,0.999929638029785,16,61,fatty acid beta-oxidation,BP,AMACR;CPT2;TYSND1;CRAT;MLYCD;PEX7;HADH;ACADS;ACACB;ACOX3;ETFB;IRS2;ECI1;CPT1C;LONP2;EHHADH
4350,GO:0009925,0.000253502183226622,0.999962286054389,9,21,basal plasma membrane,CC,EGFR;PKD2;ANK3;ITGA6;CLCA2;OSCP1;SHROOM4;ERBB2;LDLRAP1
3498,GO:0007399,0.000259619141173872,0.999811834928333,198,1469,nervous system development,BP,POSTN;SERPINE2;ULK2;MAP6;APOE;GPSM1;APCDD1;EGFR;PTPRS;PKD2;CAPRIN2;DIXDC1;ALDH1A3;SLITRK6;SFRP1;OBSL1;KCTD11;PCDH1;EPHB2;GLUD1;PIK3R1;BRSK1;MARVELD1;POU3F1;SULF2;WNT3;UNK;CSPG4;TENM4;UNC119B;RGMA;SDK2;CUL7;IMPACT;UNC5B;NOS1;PRKACB;HOXA3;NFATC4;BTBD2;MICALL1;PLXNB1;NDRG1;SPOCK1;NAGLU;MDM2;CRTC1;NDN;CSMD3;NEO1;NINJ1;CTSV;NLGN4Y;FLRT3;KIF26A;ADGRB2;BLOC1S4;SPTB;NYAP1;RTN4RL1;TRPV4;FLOT1;GLI2;NLGN2;ANK3;KLF7;RNF165;SOX12;CLMN;SPG11;GJC2;PER2;UNC119;ADGRL1;MINK1;AMIGO2;SEMA4G;ULK1;GLI3;SMARCA1;NAIP;GAS8;BOC;BSN;TRAK1;JARID2;GPC2;CELSR1;GSN;BAIAP2;PLXNB3;SUN1;AHNAK2;TRIOBP;PGAP1;BLOC1S3;MDK;BMP6;B4GALT2;MICALL2;PTK6;FZD7;ETV5;SYNGAP1;EPB41L3;SHARPIN;HEXB;KDM4C;CST3;PEX7;BBS2;CTF1;TCF4;NPHP3;PLAG1;IDH2;WRN;MALL;TNFRSF21;CDK5R1;ATRX;EFNB3;MAPK10;SHANK3;HMG20B;SLIT3;MEF2D;IFT140;CDK5RAP3;ATXN1;THRA;ADARB1;SLC2A1;NAB2;SRR;LRP1;LRRN3;NPHP4;BRINP1;SALL2;WNK1;ATXN10;SDHA;RET;ZMYND8;PRX;DAB2IP;CASZ1;TEAD2;SHROOM2;RAPGEFL1;FGFR4;SCN2A;AREG;RPS6KA5;DLG5;PLXND1;PMP22;ACVR1B;SHROOM4;TACC1;DLG4;NHSL1;MATN2;WEE1;PTK7;TCF7;SHANK2;ZFP36L1;MXRA8;CLSTN3;MARK4;IRS2;MTR;S100A6;ZSWIM8;APBB2;RAPGEF5;GSTM3;SRPX2;CD9;RANBP9;HDAC11;ERBB2;TH;RORA;SSH3;PPARG;SYNE2;UFL1;LAMB2;NFASC;CIT;MAP1A;FOXP2;PTBP2;ECM2;SMURF1
8756,GO:0034440,0.000271086061198919,0.999911635241159,19,79,lipid oxidation,BP,AMACR;CPT2;TYSND1;CRAT;MLYCD;PHYH;PEX7;HADH;ACADS;ACACB;PLA2G7;ACOX3;ETFB;IRS2;ECI1;CPT1C;PPARG;LONP2;EHHADH
7613,GO:0032011,0.000278312297597076,0.999934571423803,13,40,ARF protein signal transduction,BP,PSD4;ASAP3;IQSEC2;ACAP3;AGAP4;ASAP2;PSD3;AGAP6;AGAP7P;ARAP1;APPL2;ARFGEF2;IQSEC1
7614,GO:0032012,0.000278312297597076,0.999934571423803,13,40,regulation of ARF protein signal transduction,BP,PSD4;ASAP3;IQSEC2;ACAP3;AGAP4;ASAP2;PSD3;AGAP6;AGAP7P;ARAP1;APPL2;ARFGEF2;IQSEC1
3376,GO:0007154,0.000285202331296093,0.999774351353471,468,3947,cell communication,BP,TNFAIP3;POSTN;ITGB6;SERPINE2;ULK2;GPNMB;SIK1;EPM2A;MUC19;TP53INP1;IFI6;PTHLH;SREBF1;APOE;INPP5D;APCDD1;OAS2;PSD4;DDX60;FBXW4;EGFR;GIGYF1;PTPRS;FAM20C;PKD2;CAPRIN2;MNT;SYT8;CXCR1;SYN1;DIXDC1;TRIM22;PLCD3;SFRP1;KCTD11;PCDH1;EPS8L2;EPHB2;RALGDS;MAP3K14;GLUD1;DGKQ;PIK3R1;BRSK1;RBCK1;KDM3A;CXCL14;DOCK9;EVC;SULF2;WNT3;CAMKK1;VAV3;SMOC2;CSPG4;ISG15;MVB12B;HTRA1;TENM4;RGMA;PI4KAP2;KITLG;CUL7;PRICKLE2;MC1R;ASAP3;OR2A4;STAT1;IMPACT;CAMK2N1;CRY2;NSG1;UNC5B;ITGB5;GJD3;RAB43;RAB40B;NOS1;PRKACB;CRY1;MAML3;BCAM;PLEKHG5;NFATC4;IQSEC2;FERMT1;CYP26B1;THNSL2;PIK3C2G;PLXNB1;PLEKHG3;NDRG1;KCNC4;SPOCK1;ITPR3;MDM2;CRTC1;LZTS2;PLCD1;NDN;IFITM1;FCGRT;CHN2;LTBP4;PIK3IP1;OBSCN;GPRC5C;HLA-B;TNFSF10;PRODH;SYTL1;RHOBTB2;NEO1;RAPGEF3;PCBP4;CTSV;NLGN4Y;OAS1;FLRT3;RASA4;GAL3ST4;KIF26A;RGL4;RGS2;ACAP3;IL20RB;ADGRB2;F2R;C2CD4C;PDCD4;SPTB;NYAP1;SLC24A1;RTN4RL1;ZFP36L2;ADGRF4;CLTCL1;TRPV4;FLOT1;GLI2;AGAP4;TOM1L2;RHPN1;NLGN2;ADORA2B;ANK3;RNF165;ADAMTS13;PLCH2;RALGAPA1;MAPK8IP3;PIDD1;RIMS3;SPG11;GJC2;ARHGEF19;RHBDF1;TSPAN18;RASGEF1A;PER2;TMEM204;PITPNM2;CLCN6;UNC119;FRS3;C5;WIPF1;PSKH1;ADGRL1;MINK1;GSTM2;TNFRSF14;WWTR1;ASAP2;ARHGEF4;ITGA2;SEMA4G;FAM110C;SYT15;ULK1;GLI3;SPPL2B;PCSK1;TPGS1;THRAP3;AKAP7;LRSAM1;VAMP2;NAIP;LTBP1;NMU;NEK8;MAP2K5;BOC;ITGA6;KCNJ5;SRGAP3;BSN;SESN3;IGFBP4;MMP1;NUPR1;GPC2;NISCH;INSR;CELSR1;GSN;HEBP1;CHD3;CDK14;BAIAP2;TTN;CBLC;DDT;PLXNB3;LPAR5;AHNAK2;RIN1;CD109;RMI2;SCN4B;ARHGEF1;DOCK8;DHX58;PILRB;SLC27A1;TM7SF3;RTF1;MDK;CASP14;IRF9;RICTOR;BMP6;NLRX1;TCIRG1;S100A4;MAP2K2;PDK1;VEGFB;SQSTM1;PTK6;SLC12A7;FZD7;ETV5;SYNGAP1;NXPH4;FAM13A;TMEM117;SHARPIN;ARHGAP33;SH2D2A;ARRDC1;PLA2G6;HOMER2;MMRN2;GDF15;BBS2;TXNIP;CTF1;ATP6V0A2;PEX11B;NPHP3;PSD3;MAP3K12;WRN;SEPT5;IFI27;DNM1;TNFRSF21;KLHL24;MCTP1;CDK5R1;ATRX;ARHGAP27;AGAP6;NET1;CA2;EFNB3;PI4KAP1;SESN1;MAPK10;SHANK3;HFE;CYBA;TRIM38;DTX3;AGO4;ERCC6;HADH;RRM2B;SLIT3;SHC2;EDA2R;SPRY2;MRC2;IFT140;GABBR1;CREBRF;AGAP7P;RAB11FIP3;MLXIPL;CTSB;KLK5;FBXW7;GPR87;ING4;NUDT6;CDK5RAP3;NOTCH2NL;PAK6;PFKFB2;PAQR6;THRA;APC2;ARAP1;ADARB1;ELF1;MX2;RPH3AL;SLC2A1;NLRP1;FRAT1;ERMAP;GPR155;GLUL;TNS2;GNG2;LRP1;HLA-A;NPHP4;RGS12;C12ORF66;DLK2;MAP3K6;APPL2;SALL2;WNK1;JPH2;PDE2A;LTB4R2;RET;ZMYND8;PRX;DAB2IP;RWDD3;CALCOCO1;TEAD2;RNF213;RAPGEFL1;PIK3C3;IFI16;SYT7;FGFR4;IL20RA;PIK3R2;SCN2A;AREG;SNCB;MYO9A;RPS6KA5;DLG5;BST2;VDR;RGL2;ARHGEF17;CACNB3;TNRC6C;VIPR1;EFS;PLXND1;PCSK6;LPAR6;PPP1R2;DMTN;STAT2;ARFGEF2;RASL10B;WWC3;TMEM231;TFDP2;PMP22;UCN2;NRARP;ACVR1B;KREMEN1;DLG4;TSSK1B;IQSEC1;ALOXE3;ENDOU;IGFBP6;DUOX1;PTK7;TCF7;SHANK2;RSAD2;TNFRSF25;ZFP36L1;LMNA;CLSTN3;GLMP;ACSL1;IL11;KAT2B;IRS2;IMPA2;ANO1;CAPS;ERN1;IVNS1ABP;ALOX15B;RAD50;GPR21;TKFC;ZMAT3;S100A6;SCG5;APBB2;ARHGEF9;PBLD;RAPGEF5;TNFSF12;TAS1R3;STAT6;PCSK1N;PHPT1;GPR132;SMPDL3B;KIF7;TRAF5;CD9;RANBP9;CACNB1;PTPN3;GJB5;ERBB2;SYNGR1;PLCB3;GPR68;PAQR7;ARHGAP23;AKAP6;TH;ATG14;MPP7;RORA;PPARG;PRKACA;DOCK6;LDLRAP1;CXXC5;ACKR3;DOCK3;UFL1;IP6K2;RIPK3;NFASC;AIP;KCNS3;CIT;CCDC3;HIVEP1;SMURF1;NPNT;CTNNBIP1;SERINC3;GCLC;ECM1
12130,GO:0048251,0.000299257603120762,0.999987793705649,5,7,elastic fiber assembly,BP,MYH11;TNXB;LOXL1;THSD4;EFEMP2
8876,GO:0034703,0.000319439132032658,0.999894926987846,19,76,cation channel complex,CC,HSPA2;KCNAB2;NOS1;KCNC4;VAMP2;KCNJ5;SCNN1A;SCN4B;KCNMA1;KCNG1;OLFM2;SCN2A;CACNB3;DLG4;CPT1C;CACNB1;AKAP6;PRKACA;KCNS3
2406,GO:0005578,0.000336912791198129,0.999842164851068,36,182,proteinaceous extracellular matrix,CC,TGFBI;POSTN;SLITRK6;SFRP1;ADAMTS7;COL22A1;WNT3;SMOC2;COL10A1;CRTAP;COL7A1;SPOCK1;LTBP4;TNXB;FLRT3;ADAMTS13;LTBP1;ITGA6;MMP1;GPC2;MMP28;LOXL1;CST3;MMRN2;THSD4;COL6A1;NID1;SLIT3;TFPI2;LRRN3;MATN2;EFEMP2;LAMB2;ECM2;NPNT;ECM1
6641,GO:0023052,0.000338329530035479,0.999731673280563,465,3923,signaling,BP,TNFAIP3;POSTN;ITGB6;SERPINE2;ULK2;GPNMB;SIK1;EPM2A;MUC19;TP53INP1;IFI6;PTHLH;SREBF1;APOE;INPP5D;APCDD1;OAS2;PSD4;DDX60;FBXW4;EGFR;GIGYF1;PTPRS;FAM20C;PKD2;CAPRIN2;MNT;SYT8;CXCR1;SYN1;DIXDC1;TRIM22;PLCD3;SFRP1;KCTD11;PCDH1;EPS8L2;EPHB2;RALGDS;MAP3K14;GLUD1;DGKQ;PIK3R1;BRSK1;RBCK1;KDM3A;CXCL14;DOCK9;EVC;SULF2;WNT3;CAMKK1;VAV3;SMOC2;CSPG4;ISG15;MVB12B;HTRA1;TENM4;RGMA;PI4KAP2;KITLG;CUL7;VAMP3;PRICKLE2;MC1R;ASAP3;OR2A4;STAT1;CAMK2N1;CRY2;NSG1;UNC5B;ITGB5;RAB43;RAB40B;NOS1;PRKACB;CRY1;MAML3;BCAM;PLEKHG5;NFATC4;IQSEC2;FERMT1;CYP26B1;THNSL2;PIK3C2G;PLXNB1;PLEKHG3;NDRG1;KCNC4;SPOCK1;ITPR3;MDM2;CRTC1;LZTS2;PLCD1;NDN;IFITM1;FCGRT;CHN2;LTBP4;PIK3IP1;OBSCN;GPRC5C;HLA-B;TNFSF10;PRODH;SYTL1;RHOBTB2;NEO1;RAPGEF3;PCBP4;NLGN4Y;OAS1;FLRT3;RASA4;GAL3ST4;KIF26A;RGL4;RGS2;ACAP3;IL20RB;ADGRB2;F2R;C2CD4C;PDCD4;SPTB;NYAP1;SLC24A1;RTN4RL1;ZFP36L2;ADGRF4;CLTCL1;TRPV4;FLOT1;GLI2;AGAP4;TOM1L2;RHPN1;NLGN2;ADORA2B;ANK3;RNF165;ADAMTS13;PLCH2;RALGAPA1;MAPK8IP3;PIDD1;RIMS3;SPG11;GJC2;ARHGEF19;RHBDF1;TSPAN18;RASGEF1A;PER2;TMEM204;PITPNM2;CLCN6;UNC119;FRS3;C5;WIPF1;PSKH1;ADGRL1;MINK1;GSTM2;TNFRSF14;WWTR1;ASAP2;ARHGEF4;ITGA2;SEMA4G;FAM110C;SYT15;ULK1;GLI3;SPPL2B;PCSK1;TPGS1;THRAP3;AKAP7;LRSAM1;VAMP2;NAIP;LTBP1;NMU;NEK8;MAP2K5;BOC;ITGA6;KCNJ5;SRGAP3;BSN;SESN3;IGFBP4;MMP1;NUPR1;GPC2;NISCH;INSR;CELSR1;GSN;HEBP1;CHD3;CDK14;BAIAP2;TTN;CBLC;DDT;PLXNB3;LPAR5;AHNAK2;RIN1;CD109;RMI2;SCN4B;ARHGEF1;DOCK8;DHX58;PILRB;SLC27A1;TM7SF3;RTF1;MDK;CASP14;IRF9;RICTOR;BMP6;NLRX1;TCIRG1;S100A4;MAP2K2;PDK1;VEGFB;SQSTM1;PTK6;SLC12A7;FZD7;ETV5;SYNGAP1;NXPH4;FAM13A;TMEM117;SHARPIN;ARHGAP33;SH2D2A;ARRDC1;PLA2G6;HOMER2;MMRN2;GDF15;BBS2;TXNIP;CTF1;ATP6V0A2;PEX11B;NPHP3;PSD3;MAP3K12;WRN;SEPT5;IFI27;DNM1;TNFRSF21;KLHL24;MCTP1;CDK5R1;ATRX;ARHGAP27;AGAP6;NET1;CA2;EFNB3;PI4KAP1;SESN1;MAPK10;SHANK3;HFE;CYBA;TRIM38;DTX3;AGO4;ERCC6;HADH;RRM2B;SLIT3;SHC2;EDA2R;SPRY2;MRC2;IFT140;GABBR1;CREBRF;AGAP7P;RAB11FIP3;MLXIPL;CTSB;KLK5;FBXW7;GPR87;ING4;NUDT6;CDK5RAP3;NOTCH2NL;PAK6;PFKFB2;PAQR6;THRA;APC2;ARAP1;ADARB1;ELF1;MX2;RPH3AL;SLC2A1;NLRP1;FRAT1;ERMAP;GPR155;GLUL;TNS2;GNG2;LRP1;HLA-A;NPHP4;RGS12;C12ORF66;DLK2;MAP3K6;APPL2;SALL2;WNK1;JPH2;PDE2A;LTB4R2;RET;ZMYND8;PRX;DAB2IP;RWDD3;CALCOCO1;TEAD2;RNF213;RAPGEFL1;PIK3C3;IFI16;SYT7;FGFR4;IL20RA;PIK3R2;SCN2A;AREG;SNCB;MYO9A;RPS6KA5;DLG5;BST2;VDR;RGL2;ARHGEF17;CACNB3;TNRC6C;VIPR1;EFS;PLXND1;PCSK6;TBC1D16;LPAR6;PPP1R2;DMTN;STAT2;ARFGEF2;RASL10B;WWC3;TMEM231;TFDP2;PMP22;UCN2;NRARP;ACVR1B;KREMEN1;DLG4;TSSK1B;IQSEC1;ALOXE3;ENDOU;IGFBP6;DUOX1;PTK7;TCF7;SHANK2;RSAD2;TNFRSF25;ZFP36L1;LMNA;CLSTN3;GLMP;ACSL1;IL11;KAT2B;IRS2;IMPA2;ANO1;CAPS;ERN1;IVNS1ABP;ALOX15B;RAD50;GPR21;TKFC;ZMAT3;S100A6;SCG5;APBB2;ARHGEF9;PBLD;RAPGEF5;TNFSF12;TAS1R3;STAT6;PCSK1N;PHPT1;GPR132;SMPDL3B;KIF7;TRAF5;CD9;RANBP9;CACNB1;PTPN3;ERBB2;SYNGR1;PLCB3;GPR68;PAQR7;ARHGAP23;AKAP6;TH;MPP7;RORA;PPARG;PRKACA;DOCK6;LDLRAP1;CXXC5;ACKR3;DOCK3;UFL1;IP6K2;RIPK3;NFASC;AIP;KCNS3;CIT;CCDC3;HIVEP1;SMURF1;NPNT;CTNNBIP1;SERINC3;GCLC;ECM1
11120,GO:0045178,0.00035209147125456,0.999921119347196,12,36,basal part of cell,CC,EGFR;PKD2;ANK3;ITGA2;ITGA6;CLCA2;OSCP1;HFE;KRT14;SHROOM4;ERBB2;LDLRAP1
16846,GO:0098797,0.000361520270233114,0.999808059311645,49,281,plasma membrane protein complex,CC,ITGB6;HSPA2;EGFR;EVC;KCNAB2;ITGB5;GJD3;NOS1;KCNC4;HLA-B;NEO1;FLOT1;GJC2;C5;SNTA1;ITGA2;VAMP2;ITGA6;KCNJ5;INSR;SCN4B;SHANK3;HFE;CYBA;GABBR1;KCNMA1;APC2;GNG2;LRP1;HLA-A;KCNG1;SDHA;RET;OLFM2;SCN2A;CACNB3;ACVR1B;DLG4;SHANK2;CPT1C;TRAF5;CACNB1;GJB5;COL13A1;ABCA2;MPP7;LDLRAP1;KCNS3;NPNT
6611,GO:0022839,0.000386306376739455,0.999850371439708,24,108,ion gated channel activity,MF,PKD2;KCNAB2;KCNJ15;KCNC4;ITPR3;TMEM63C;TRPV4;CLCN6;KCNJ5;SCNN1A;SCN4B;CLCA2;ANO9;KCNMA1;KCNG1;JPH2;SHROOM2;SCN2A;CACNB3;DLG4;ANO1;CACNB1;KCNS3;CLCN7
2295,GO:0005261,0.000386859935679182,0.999850416670335,24,106,cation channel activity,MF,PKD2;ORAI3;KCNAB2;KCNJ15;KCNC4;ITPR3;TMEM63C;SLC24A1;TRPV4;KCNJ5;SCNN1A;SCN4B;KCNMA1;KCNG1;JPH2;PDE2A;SHROOM2;SCN2A;CACNB3;ORAI2;ANO1;CACNB1;KCNS3;CALHM2
3782,GO:0008347,0.000410316063393717,0.999913413745612,11,33,glial cell migration,BP,APCDD1;CSPG4;NDN;GLI3;SUN1;HEXB;IDH2;CDK5R1;DAB2IP;MATN2;SYNE2
6609,GO:0022836,0.000442650835789302,0.999826664811076,24,109,gated channel activity,MF,PKD2;KCNAB2;KCNJ15;KCNC4;ITPR3;TMEM63C;TRPV4;CLCN6;KCNJ5;SCNN1A;SCN4B;CLCA2;ANO9;KCNMA1;KCNG1;JPH2;SHROOM2;SCN2A;CACNB3;DLG4;ANO1;CACNB1;KCNS3;CLCN7
6640,GO:0023051,0.000453883972226692,0.999651132514354,290,2339,regulation of signaling,BP,TNFAIP3;POSTN;SERPINE2;GPNMB;EPM2A;TP53INP1;IFI6;PTHLH;SREBF1;APOE;INPP5D;APCDD1;PSD4;DDX60;EGFR;PTPRS;FAM20C;PKD2;CAPRIN2;MNT;SYN1;DIXDC1;TRIM22;SFRP1;KCTD11;EPS8L2;EPHB2;MAP3K14;GLUD1;DGKQ;PIK3R1;RBCK1;CXCL14;EVC;SULF2;WNT3;VAV3;CSPG4;MVB12B;HTRA1;KITLG;VAMP3;MC1R;ASAP3;STAT1;CAMK2N1;CRY2;NSG1;UNC5B;NOS1;PRKACB;CRY1;MAML3;PLEKHG5;NFATC4;IQSEC2;FERMT1;CYP26B1;THNSL2;PLXNB1;PLEKHG3;KCNC4;ITPR3;MDM2;CRTC1;LZTS2;CHN2;LTBP4;PIK3IP1;OBSCN;TNFSF10;RHOBTB2;NEO1;RAPGEF3;NLGN4Y;FLRT3;RASA4;KIF26A;RGS2;ACAP3;F2R;PDCD4;SLC24A1;RTN4RL1;TRPV4;FLOT1;GLI2;AGAP4;NLGN2;ADORA2B;RNF165;RALGAPA1;MAPK8IP3;PIDD1;RIMS3;ARHGEF19;RHBDF1;RASGEF1A;PER2;TMEM204;C5;MINK1;GSTM2;WWTR1;ASAP2;ARHGEF4;ITGA2;FAM110C;GLI3;SPPL2B;AKAP7;VAMP2;NAIP;LTBP1;NMU;NEK8;MAP2K5;ITGA6;SRGAP3;SESN3;IGFBP4;GPC2;NISCH;INSR;GSN;CHD3;CDK14;BAIAP2;CBLC;DDT;CD109;RMI2;ARHGEF1;DHX58;TM7SF3;MDK;RICTOR;BMP6;NLRX1;S100A4;MAP2K2;VEGFB;SQSTM1;PTK6;FZD7;SYNGAP1;FAM13A;SHARPIN;ARHGAP33;SH2D2A;ARRDC1;PLA2G6;HOMER2;MMRN2;GDF15;CTF1;NPHP3;PSD3;MAP3K12;WRN;SEPT5;DNM1;KLHL24;MCTP1;CDK5R1;AGAP6;NET1;CA2;SESN1;MAPK10;SHANK3;HFE;CYBA;TRIM38;ERCC6;HADH;RRM2B;SLIT3;SHC2;EDA2R;SPRY2;IFT140;CREBRF;AGAP7P;RAB11FIP3;KLK5;FBXW7;NUDT6;CDK5RAP3;PAK6;PFKFB2;THRA;APC2;ARAP1;ELF1;RPH3AL;SLC2A1;NLRP1;GLUL;LRP1;NPHP4;RGS12;C12ORF66;DLK2;MAP3K6;APPL2;WNK1;JPH2;PDE2A;RET;ZMYND8;DAB2IP;RWDD3;RNF213;SYT7;FGFR4;IL20RA;PIK3R2;AREG;MYO9A;DLG5;BST2;RGL2;ARHGEF17;PCSK6;TBC1D16;LPAR6;PPP1R2;DMTN;STAT2;ARFGEF2;RASL10B;WWC3;TFDP2;UCN2;NRARP;ACVR1B;KREMEN1;DLG4;IQSEC1;ENDOU;IGFBP6;SHANK2;RSAD2;TNFRSF25;LMNA;CLSTN3;IL11;KAT2B;IRS2;ANO1;ERN1;IVNS1ABP;ALOX15B;RAD50;GPR21;TKFC;SCG5;ARHGEF9;PBLD;TNFSF12;PHPT1;SMPDL3B;KIF7;TRAF5;RANBP9;PTPN3;ERBB2;SYNGR1;GPR68;ARHGAP23;AKAP6;MPP7;RORA;PPARG;PRKACA;LDLRAP1;CXXC5;ACKR3;UFL1;RIPK3;AIP;KCNS3;CCDC3;SMURF1;NPNT;CTNNBIP1;SERINC3;GCLC;ECM1
11725,GO:0046578,0.000456898409861324,0.999779648051064,37,189,regulation of Ras protein signal transduction,BP,APOE;PSD4;EPS8L2;EPHB2;VAV3;KITLG;ASAP3;PLEKHG5;IQSEC2;PLEKHG3;OBSCN;RASA4;ACAP3;F2R;FLOT1;AGAP4;ARHGEF19;RASGEF1A;ASAP2;ARHGEF4;ARHGEF1;SQSTM1;SYNGAP1;PSD3;AGAP6;NET1;SPRY2;AGAP7P;ARAP1;APPL2;DAB2IP;RGL2;ARHGEF17;LPAR6;ARFGEF2;IQSEC1;ARHGEF9
17724,GO:1901681,0.000485504414156435,0.999791655197683,28,141,sulfur compound binding,MF,POSTN;SERPINE2;GPNMB;APOE;PTPRS;SFRP1;DHTKD1;SMOC2;HMGCL;TNXB;GAL3ST4;RTN4RL1;NAT6;GSTM2;THBS3;ITGA2;GPC2;MDK;VEGFB;HLCS;ACACB;OGDHL;LRP1;FGFR4;PCSK6;GSTM3;COL13A1;ECM2
6800,GO:0030258,0.000556490430551092,0.999730521473526,36,194,lipid modification,BP,AMACR;APOE;INPP5D;EGFR;CPT2;DGKQ;PIK3R1;PI4KAP2;KITLG;PIK3C2G;TYSND1;CYP3A5;CRAT;MLYCD;PHYH;PEX7;PI4KAP1;HADH;ACADS;ACACB;PLA2G7;ACOX3;PIK3C3;FGFR4;PIK3R2;ETFB;IRS2;IMPA2;ECI1;CPT1C;ERBB2;PPARG;IP6K2;PI4K2B;LONP2;EHHADH
20262,GO:2001257,0.000587148994699818,0.999795537432912,19,79,regulation of cation channel activity,BP,PKD2;EPHB2;NOS1;NLGN2;ANK3;MINK1;GSTM2;VAMP2;PLA2G6;KLHL24;SHANK3;KCNG1;JPH2;CACNB3;DLG4;SHANK2;CACNB1;AKAP6;PRKACA
4666,GO:0010817,0.000607539278248162,0.999673110419571,47,280,regulation of hormone levels,BP,SREBF1;EGFR;ALDH1A3;SFRP1;GLUD1;DGKQ;SRD5A3;CRY1;CYP26B1;ITPR3;LTBP4;UGT1A3;RAPGEF3;TRPV4;NLGN2;SULT1E1;PER2;PCSK1;NMU;TM7SF3;BMP6;PLA2G6;HFE;HADH;RAB11FIP3;PFKFB2;SLC2A1;GLUL;SYT7;RETSAT;VDR;PCSK6;RASL10B;DUOX1;IL11;IRS2;ANO1;HSD17B14;DHRS4;TRERF1;SCG5;PCSK1N;PHPT1;RDH12;GPR68;GCNT4;KCNS3
13256,GO:0051965,0.000607652002450574,0.999865280741405,11,33,positive regulation of synapse assembly,BP,SLITRK6;EPHB2;FLRT3;ADGRB2;NLGN2;ADGRL1;AMIGO2;LRRN3;DLG5;CLSTN3;SRPX2
6766,GO:0030207,0.000651083554578129,0.999961266932594,5,8,chondroitin sulfate catabolic process,BP,CSPG4;IDUA;HEXA;HEXB;HYAL1
6130,GO:0019395,0.000670140810930044,0.999770385436508,18,78,fatty acid oxidation,BP,AMACR;CPT2;TYSND1;CRAT;MLYCD;PHYH;PEX7;HADH;ACADS;ACACB;ACOX3;ETFB;IRS2;ECI1;CPT1C;PPARG;LONP2;EHHADH
9824,GO:0042063,0.000674567914674118,0.999681289460799,33,174,gliogenesis,BP,SERPINE2;APCDD1;EGFR;POU3F1;CSPG4;TENM4;NDRG1;NDN;GJC2;GLI3;GSN;SUN1;AHNAK2;ETV5;HEXB;PLAG1;IDH2;TNFRSF21;CDK5R1;NAB2;LRP1;PRX;DAB2IP;AREG;MATN2;MXRA8;CD9;HDAC11;ERBB2;PPARG;SYNE2;UFL1;LAMB2
2272,GO:0005216,0.000706061063932004,0.9996795977306,30,151,ion channel activity,MF,PKD2;ORAI3;KCNAB2;KCNJ15;GJD3;KCNC4;ITPR3;TMEM63C;SLC24A1;TRPV4;CLCN6;KCNJ5;SCNN1A;SCN4B;CLCA2;ANO9;KCNMA1;KCNG1;JPH2;PDE2A;SHROOM2;SCN2A;CACNB3;ORAI2;DLG4;ANO1;CACNB1;KCNS3;CLCN7;CALHM2
16207,GO:0090277,0.000712714328836078,0.999795785361346,14,53,positive regulation of peptide hormone secretion,BP,EGFR;GLUD1;NLGN2;NMU;TM7SF3;PLA2G6;HFE;PFKFB2;GLUL;RASL10B;IRS2;ANO1;PHPT1;GPR68
6556,GO:0022008,0.000827225347032813,0.999413458041633,141,1016,neurogenesis,BP,POSTN;SERPINE2;ULK2;MAP6;APOE;APCDD1;EGFR;PTPRS;CAPRIN2;DIXDC1;SLITRK6;SFRP1;OBSL1;KCTD11;EPHB2;PIK3R1;BRSK1;POU3F1;WNT3;UNK;CSPG4;TENM4;UNC119B;RGMA;SDK2;CUL7;IMPACT;UNC5B;NOS1;NFATC4;BTBD2;MICALL1;PLXNB1;NDRG1;SPOCK1;NAGLU;MDM2;CRTC1;NDN;CSMD3;NEO1;FLRT3;BLOC1S4;SPTB;NYAP1;RTN4RL1;TRPV4;FLOT1;GLI2;ANK3;KLF7;RNF165;CLMN;SPG11;GJC2;PER2;UNC119;MINK1;SEMA4G;ULK1;GLI3;SMARCA1;BOC;TRAK1;GPC2;CELSR1;GSN;BAIAP2;PLXNB3;SUN1;AHNAK2;TRIOBP;BLOC1S3;BMP6;MICALL2;PTK6;FZD7;ETV5;SYNGAP1;EPB41L3;HEXB;KDM4C;PEX7;CTF1;TCF4;PLAG1;IDH2;TNFRSF21;CDK5R1;EFNB3;MAPK10;SHANK3;HMG20B;SLIT3;IFT140;CDK5RAP3;ADARB1;NAB2;LRP1;NPHP4;BRINP1;WNK1;ATXN10;RET;ZMYND8;PRX;DAB2IP;CASZ1;AREG;RPS6KA5;DLG5;PLXND1;PMP22;DLG4;NHSL1;MATN2;WEE1;PTK7;SHANK2;MXRA8;IRS2;MTR;S100A6;ZSWIM8;APBB2;CD9;RANBP9;HDAC11;ERBB2;TH;RORA;SSH3;PPARG;SYNE2;UFL1;LAMB2;NFASC;CIT;MAP1A;ECM2;SMURF1
4279,GO:0009648,0.000844305801387842,0.999861988643268,8,21,photoperiodism,BP,SIK1;CRY2;CRY1;CRTC1;PER2;BHLHE40;NMU;PER3
12600,GO:0050804,0.000845938617121314,0.99958928949537,34,183,modulation of chemical synaptic transmission,BP,SERPINE2;APOE;EGFR;SYN1;EPHB2;NSG1;NFATC4;KCNC4;ITPR3;CRTC1;NLGN4Y;F2R;SLC24A1;FLOT1;NLGN2;RIMS3;VAMP2;NMU;NISCH;BAIAP2;SQSTM1;SYNGAP1;PLA2G6;SEPT5;MCTP1;CA2;SHANK3;GLUL;ZMYND8;SYT7;DLG4;SHANK2;CLSTN3;SYNGR1
17003,GO:0099177,0.000845938617121314,0.99958928949537,34,183,regulation of trans-synaptic signaling,BP,SERPINE2;APOE;EGFR;SYN1;EPHB2;NSG1;NFATC4;KCNC4;ITPR3;CRTC1;NLGN4Y;F2R;SLC24A1;FLOT1;NLGN2;RIMS3;VAMP2;NMU;NISCH;BAIAP2;SQSTM1;SYNGAP1;PLA2G6;SEPT5;MCTP1;CA2;SHANK3;GLUL;ZMYND8;SYT7;DLG4;SHANK2;CLSTN3;SYNGR1
11859,GO:0046883,0.000847263978220714,0.999621740864507,28,144,regulation of hormone secretion,BP,SREBF1;EGFR;SFRP1;GLUD1;CRY1;ITPR3;RAPGEF3;NLGN2;PER2;NMU;TM7SF3;BMP6;PLA2G6;HFE;HADH;RAB11FIP3;PFKFB2;SLC2A1;GLUL;SYT7;RASL10B;IL11;IRS2;ANO1;SCG5;PHPT1;GPR68;KCNS3
15723,GO:0072329,0.000849717634328076,0.99967230563381,21,100,monocarboxylic acid catabolic process,BP,AMACR;CPT2;CYP26B1;TYSND1;IDUA;CRAT;MLYCD;PHYH;PEX7;LPIN3;HADH;ACADS;ACACB;ACOX3;ETFB;IRS2;ECI1;FAAH;CPT1C;LONP2;EHHADH
12698,GO:0050954,0.000935834940977134,0.99968145374212,17,72,sensory perception of mechanical stimulus,BP,SERPINE2;ESPN;SLITRK6;EPS8L2;ITGA2;TRIOBP;PGAP1;ALDH7A1;HEXB;HOMER2;DNM1;SPRY2;MYO3B;TPRN;TUB;TH;EML2
17107,GO:0102148,0.000947528431177114,1,3,3,N-acetyl-beta-D-galactosaminidase activity,MF,HEXA;HEXB;HEXDC
6610,GO:0022838,0.000948769726189963,0.999560311697805,30,154,substrate-specific channel activity,MF,PKD2;ORAI3;KCNAB2;KCNJ15;GJD3;KCNC4;ITPR3;TMEM63C;SLC24A1;TRPV4;CLCN6;KCNJ5;SCNN1A;SCN4B;CLCA2;ANO9;KCNMA1;KCNG1;JPH2;PDE2A;SHROOM2;SCN2A;CACNB3;ORAI2;DLG4;ANO1;CACNB1;KCNS3;CLCN7;CALHM2
10286,GO:0043062,0.00100147287711594,0.999468433254322,42,237,extracellular structure organization,BP,TGFBI;POSTN;ITGB6;APOE;ADAM19;SULF2;SMOC2;HTRA1;ITGB5;COL10A1;PRKACB;FERMT1;COL7A1;MYH11;TNXB;CTSV;SERPINB5;FLOT1;THBS3;ITGA2;ITGA6;MMP1;LOXL1;HYAL1;CST3;CAPNS2;THSD4;COL6A1;NPHP3;NID1;KLK5;LRP1;PLA2G7;FGFR4;EFEMP2;APBB2;COL13A1;PRKACA;PLTP;LAMB2;ECM2;NPNT
8875,GO:0034702,0.00108523290709184,0.999563549899117,22,102,ion channel complex,CC,HSPA2;KCNAB2;NOS1;KCNC4;VAMP2;KCNJ5;SCNN1A;SCN4B;SHANK3;KCNMA1;KCNG1;OLFM2;SCN2A;CACNB3;DLG4;SHANK2;ANO1;CPT1C;CACNB1;AKAP6;PRKACA;KCNS3
8912,GO:0034765,0.00116720846724881,0.999401891698933,37,209,regulation of ion transmembrane transport,BP,HSPA2;PKD2;EPHB2;KCNAB2;KCNJ15;NOS1;KCNC4;F2R;NLGN2;ANK3;GJC2;PER2;SNTA1;MINK1;GSTM2;VAMP2;KCNJ5;SCN4B;PLA2G6;KLHL24;ANO9;SHANK3;CYBA;KCNMA1;KCNG1;WNK1;JPH2;SCN2A;CACNB3;DLG4;SHANK2;IRS2;CACNB1;PTPN3;AKAP6;PRKACA;KCNS3
4028,GO:0009062,0.00120343941665207,0.999547814630103,19,89,fatty acid catabolic process,BP,AMACR;CPT2;TYSND1;CRAT;MLYCD;PHYH;PEX7;LPIN3;HADH;ACADS;ACACB;ACOX3;ETFB;IRS2;ECI1;FAAH;CPT1C;LONP2;EHHADH
10804,GO:0044306,0.00123230353497683,0.999552845379874,18,79,neuron projection terminus,CC,SYN1;KCNAB2;KCNC4;BLVRB;FLRT3;ITGA2;VAMP2;NMU;BSN;BAIAP2;TANC1;SEPT6;SEPT5;GLUL;SYT7;DLG4;SYNGR1;TH
17228,GO:0120025,0.00123852310167114,0.9990884459168,167,1258,plasma membrane bounded cell projection,CC,MAP6;ACTA2;APOE;PSD4;ESPN;PTPRS;PKD2;RBM3;SYN1;EPS8L2;EPHB2;EVC;CSPG4;CYBRD1;TENM4;UNC119B;KCNAB2;KITLG;VAMP3;ASAP3;STAT1;CAMK2N1;NSG1;NOS1;PRKACB;PLEKHG5;FERMT1;CNTRL;KCNC4;SPOCK1;CRTC1;PARVB;SYTL1;RAPGEF3;CTSV;BLVRB;FLRT3;RGS2;ARPIN;BLOC1S4;DNAH1;TRPV4;FLOT1;GLI2;ANK3;SPG11;GJC2;ANKS6;PTGS1;UNC119;FRMD4B;WIPF1;ADGRL1;MINK1;ARHGEF4;ITGA2;ULK1;GLI3;TPGS1;VAMP2;NAIP;NMU;NEK8;GAS8;BOC;ITGA6;BSN;LZTS1;TRAK1;INSR;GSN;BAIAP2;TANC1;SCNN1A;CEP126;PLEKHH2;TRIOBP;SEPT6;DOCK8;BLOC1S3;S100A4;MICALL2;SQSTM1;CABYR;PTK6;SYNGAP1;EPB41L3;SHARPIN;CST3;HOMER2;BBS2;NPHP3;PSD3;MAP3K12;WRN;PODXL;SEPT5;DNM1;TNFRSF21;IQCB1;KLHL24;CDK5R1;CA2;MAPK10;SHANK3;CYBA;SPRY2;FBXO2;WASH3P;IFT140;GABBR1;XRN1;DZIP1L;APC2;GLUL;PRR7;LRP1;NPHP4;RGS12;BRINP1;MYO3B;BBS1;ATXN10;RET;ZMYND8;DAB2IP;PIK3C3;SYT7;BBS5;SCN2A;DEF6;DLG5;PLXND1;BBS10;TMEM80;DMTN;TPRN;ORAI2;ARFGEF2;LMTK3;ALMS1;TMEM231;SNX1;DLG4;TSSK1B;SHANK2;MARK4;CEP250;S100A6;SCYL3;APBB2;TUB;KIF7;CPT1C;GSTM3;SYNGR1;TH;ATG14;PRKACA;LDLRAP1;SYNE2;UFL1;NFASC;MAP1A;PTBP2;SMURF1;PEMT
12678,GO:0050916,0.00123937637771067,1,3,3,sensory perception of sweet taste,BP,REEP2;ITPR3;TAS1R3
12599,GO:0050803,0.00125125491377546,0.999490874243971,22,102,regulation of synapse structure or activity,BP,APOE;CAPRIN2;SLITRK6;EPHB2;NFATC4;FLRT3;ADGRB2;NLGN2;ADGRL1;AMIGO2;BAIAP2;ETV5;SYNGAP1;DNM1;CDK5R1;SHANK3;LRRN3;ZMYND8;DAB2IP;DLG5;CLSTN3;SRPX2
3182,GO:0006805,0.00125786732325006,0.999590668285717,15,66,xenobiotic metabolic process,BP,CES2;BPHL;CYP26B1;UGT1A3;CYP3A5;PTGS1;GSTM2;CES3;CYP2D7;MGST2;AKR7A2;ACSL1;GSTM3;RORA;AIP
2199,GO:0005085,0.00129009410414703,0.999311236480665,41,230,guanyl-nucleotide exchange factor activity,MF,ALS2CL;PSD4;EGFR;EPS8L2;RALGDS;DOCK9;VAV3;KITLG;PLEKHG5;IQSEC2;PLEKHG3;OBSCN;RAPGEF3;RGL4;HPS4;SPTB;ARHGEF19;RASGEF1A;FRS3;ARHGEF4;RIN1;ARHGEF1;DOCK8;PSD3;NET1;SHC2;RET;RAPGEFL1;FGFR4;RGL2;ARHGEF17;ARFGEF2;DLG4;IQSEC1;IRS2;ARHGEF9;RAPGEF5;RANBP9;ERBB2;DOCK6;DOCK3
10900,GO:0044463,0.00129927695073081,0.999086936103539,123,889,cell projection part,CC,MAP6;APOE;PSD4;ESPN;PKD2;RBM3;SYN1;EPS8L2;EPHB2;EVC;CSPG4;CYBRD1;UNC119B;KCNAB2;STAT1;CAMK2N1;NSG1;NOS1;PRKACB;FERMT1;CNTRL;KCNC4;SPOCK1;CRTC1;SYTL1;BLVRB;FLRT3;BLOC1S4;DNAH1;TRPV4;GLI2;ANK3;SPG11;GJC2;PTGS1;UNC119;ADGRL1;MINK1;ARHGEF4;ITGA2;GLI3;TPGS1;VAMP2;NMU;NEK8;GAS8;BOC;BSN;LZTS1;TRAK1;INSR;BAIAP2;TANC1;SCNN1A;CEP126;TRIOBP;SEPT6;DOCK8;BLOC1S3;SQSTM1;CABYR;SYNGAP1;EPB41L3;SHARPIN;HOMER2;BBS2;NPHP3;PSD3;MAP3K12;PODXL;SEPT5;DNM1;IQCB1;CDK5R1;SHANK3;CYBA;SPRY2;FBXO2;IFT140;GABBR1;XRN1;DZIP1L;APC2;GLUL;PRR7;LRP1;NPHP4;RGS12;BRINP1;MYO3B;BBS1;ATXN10;RET;ZMYND8;DAB2IP;PIK3C3;SYT7;BBS5;SCN2A;DLG5;PLXND1;TMEM80;DMTN;ORAI2;ARFGEF2;LMTK3;TMEM231;DLG4;SHANK2;MARK4;APBB2;KIF7;CPT1C;GSTM3;SYNGR1;TH;ATG14;PRKACA;SYNE2;NFASC;MAP1A;PTBP2;PEMT
17235,GO:0120038,0.00129927695073081,0.999086936103539,123,889,plasma membrane bounded cell projection part,CC,MAP6;APOE;PSD4;ESPN;PKD2;RBM3;SYN1;EPS8L2;EPHB2;EVC;CSPG4;CYBRD1;UNC119B;KCNAB2;STAT1;CAMK2N1;NSG1;NOS1;PRKACB;FERMT1;CNTRL;KCNC4;SPOCK1;CRTC1;SYTL1;BLVRB;FLRT3;BLOC1S4;DNAH1;TRPV4;GLI2;ANK3;SPG11;GJC2;PTGS1;UNC119;ADGRL1;MINK1;ARHGEF4;ITGA2;GLI3;TPGS1;VAMP2;NMU;NEK8;GAS8;BOC;BSN;LZTS1;TRAK1;INSR;BAIAP2;TANC1;SCNN1A;CEP126;TRIOBP;SEPT6;DOCK8;BLOC1S3;SQSTM1;CABYR;SYNGAP1;EPB41L3;SHARPIN;HOMER2;BBS2;NPHP3;PSD3;MAP3K12;PODXL;SEPT5;DNM1;IQCB1;CDK5R1;SHANK3;CYBA;SPRY2;FBXO2;IFT140;GABBR1;XRN1;DZIP1L;APC2;GLUL;PRR7;LRP1;NPHP4;RGS12;BRINP1;MYO3B;BBS1;ATXN10;RET;ZMYND8;DAB2IP;PIK3C3;SYT7;BBS5;SCN2A;DLG5;PLXND1;TMEM80;DMTN;ORAI2;ARFGEF2;LMTK3;TMEM231;DLG4;SHANK2;MARK4;APBB2;KIF7;CPT1C;GSTM3;SYNGR1;TH;ATG14;PRKACA;SYNE2;NFASC;MAP1A;PTBP2;PEMT
3065,GO:0006629,0.00130150918137801,0.999077204975621,129,971,lipid metabolic process,BP,SIK1;SREBF1;AMACR;APOE;CES2;INPP5D;LMF1;EGFR;CPT2;ALDH1A3;PLCD3;SEC14L2;DGKQ;PIK3R1;VAV3;TFCP2L1;PI4KAP2;KITLG;MVD;SRD5A3;KDSR;SDC3;PITPNM3;HMGCL;CYP26B1;THNSL2;PIK3C2G;PLCD1;ST6GALNAC6;TYSND1;PIK3IP1;UGT1A3;CERS4;CYP3A5;ACOT1;GAL3ST4;CRAT;B4GALT6;MLYCD;PHYH;SLC27A3;ARSI;PLCH2;SULT1E1;PER2;PITPNM2;PTGS1;HEXA;ARSD;GSTM2;MBOAT2;CES3;GPC2;ST3GAL5;CYP2D7;MGST2;SLC27A1;PGAP1;BMP6;ETNK2;PDK1;HEXB;PLA2G6;PEX7;NPHP3;TNFRSF21;PLD3;LPIN3;PIGZ;OSBPL10;PI4KAP1;HADH;MLXIPL;FBXW7;THRA;ACADS;ACACB;LRP1;PLA2G7;DAB2IP;ACOX3;DDHD2;PIK3C3;FGFR4;PIK3R2;RETSAT;OSBPL5;ETFB;VDR;MPPE1;OSBPL1A;KDELC2;ESYT2;ALOXE3;ACSL1;IRS2;IMPA2;HSD17B14;ALOX15B;DHRS4;ECI1;TRERF1;FAAH;CBR4;ISYNA1;CERS5;SMPDL3B;GLB1;CPT1C;RDH12;ACSS2;ERBB2;PLCB3;PQLC3;ABCA2;TH;ATG14;RORA;PPARG;LDLRAP1;ACOT2;PLTP;IP6K2;PI4K2B;LONP2;EHHADH;CCDC3;PEMT;SERINC3
5056,GO:0015267,0.00141825024025204,0.999313786617485,31,166,channel activity,MF,PKD2;ORAI3;KCNAB2;KCNJ15;GJD3;KCNC4;ITPR3;TMEM63C;SLC24A1;TRPV4;GJC2;CLCN6;KCNJ5;SCNN1A;SCN4B;CLCA2;ANO9;KCNMA1;KCNG1;JPH2;PDE2A;SHROOM2;SCN2A;CACNB3;ORAI2;DLG4;ANO1;CACNB1;KCNS3;CLCN7;CALHM2
6601,GO:0022803,0.00141825024025204,0.999313786617485,31,166,passive transmembrane transporter activity,MF,PKD2;ORAI3;KCNAB2;KCNJ15;GJD3;KCNC4;ITPR3;TMEM63C;SLC24A1;TRPV4;GJC2;CLCN6;KCNJ5;SCNN1A;SCN4B;CLCA2;ANO9;KCNMA1;KCNG1;JPH2;PDE2A;SHROOM2;SCN2A;CACNB3;ORAI2;DLG4;ANO1;CACNB1;KCNS3;CLCN7;CALHM2
12761,GO:0051056,0.00143189319670447,0.999201207499321,46,265,regulation of small GTPase mediated signal transduction,BP,APOE;PSD4;EPS8L2;EPHB2;VAV3;KITLG;ASAP3;PLEKHG5;IQSEC2;PLEKHG3;CHN2;OBSCN;RHOBTB2;RASA4;ACAP3;F2R;FLOT1;AGAP4;RALGAPA1;ARHGEF19;RASGEF1A;ASAP2;ARHGEF4;SRGAP3;ARHGEF1;SQSTM1;SYNGAP1;FAM13A;ARHGAP33;PSD3;AGAP6;NET1;SPRY2;AGAP7P;ARAP1;APPL2;DAB2IP;PIK3R2;MYO9A;RGL2;ARHGEF17;LPAR6;ARFGEF2;IQSEC1;ARHGEF9;ARHGAP23
7450,GO:0031594,0.00149008918487541,0.999619983337079,11,37,neuromuscular junction,CC,POSTN;SERPINE2;SYNC;KCNC4;SPOCK1;F2R;ANK3;SNTA1;CDK5R1;DLG4;SYNGR1
6736,GO:0030160,0.00149504665925734,1,3,3,GKAP/Homer scaffold activity,MF,HOMER2;SHANK3;SHANK2
6645,GO:0023061,0.00156606894667044,0.999152422078329,41,242,signal release,BP,SREBF1;EGFR;SYT8;SYN1;SFRP1;GLUD1;BRSK1;CRY1;KCNC4;ITPR3;LTBP4;SYTL1;RAPGEF3;C2CD4C;TRPV4;NLGN2;RIMS3;PER2;SYT15;VAMP2;NMU;TM7SF3;BMP6;PLA2G6;SEPT5;MCTP1;HFE;HADH;RAB11FIP3;PFKFB2;SLC2A1;GLUL;SYT7;RASL10B;IL11;IRS2;ANO1;SCG5;PHPT1;GPR68;KCNS3
10243,GO:0042995,0.0015662771798854,0.998835129017851,172,1307,cell projection,CC,MAP6;ACTA2;APOE;PSD4;ESPN;PTPRS;PKD2;RBM3;SYN1;EPS8L2;EPHB2;EVC;CSPG4;CYBRD1;TENM4;UNC119B;KCNAB2;KITLG;VAMP3;ASAP3;STAT1;CAMK2N1;NSG1;NOS1;PRKACB;PLEKHG5;PITPNM3;FERMT1;CNTRL;KCNC4;SPOCK1;CRTC1;NDN;PARVB;SYTL1;RAPGEF3;CTSV;BLVRB;FLRT3;RGS2;ARPIN;BLOC1S4;DNAH1;RTN4RL1;TRPV4;FLOT1;GLI2;ANK3;SPG11;GJC2;ANKS6;PTGS1;UNC119;FRMD4B;WIPF1;ADGRL1;MINK1;ARHGEF4;ITGA2;RSPH3;ULK1;GLI3;TPGS1;VAMP2;NAIP;NMU;NEK8;GAS8;BOC;ITGA6;BSN;LZTS1;TRAK1;INSR;GSN;BAIAP2;TANC1;SCNN1A;CEP126;PLEKHH2;TRIOBP;SEPT6;DOCK8;BLOC1S3;MDK;S100A4;MICALL2;SQSTM1;CABYR;PTK6;SYNGAP1;EPB41L3;SHARPIN;CST3;HOMER2;BBS2;NPHP3;PSD3;MAP3K12;WRN;PODXL;SEPT5;DNM1;TNFRSF21;IQCB1;KLHL24;CDK5R1;CA2;MAPK10;SHANK3;CYBA;SPRY2;FBXO2;WASH3P;IFT140;GABBR1;XRN1;DZIP1L;APC2;GLUL;PRR7;LRP1;NPHP4;RGS12;BRINP1;MYO3B;BBS1;ATXN10;RET;ZMYND8;DAB2IP;PIK3C3;SYT7;BBS5;SCN2A;DEF6;DLG5;PLXND1;BBS10;TMEM80;DMTN;TPRN;ORAI2;ARFGEF2;LMTK3;ALMS1;TMEM231;SNX1;DLG4;TSSK1B;SHANK2;MARK4;CEP250;S100A6;SCYL3;APBB2;TUB;KIF7;CPT1C;GSTM3;SYNGR1;TH;ATG14;PRKACA;LDLRAP1;SYNE2;UFL1;NFASC;MAP1A;PTBP2;SMURF1;PEMT
10899,GO:0044459,0.00156930690945313,0.998819190380021,188,1443,plasma membrane part,CC,ITGB6;SERPINE2;GPNMB;APCDD1;PSD4;HSPA2;EGFR;PTPRS;PKD2;PLCD3;SLITRK6;PCDH1;EPS8L2;EPHB2;EVC;CSPG4;CYBRD1;TENM4;KCNAB2;VAMP3;REEP2;KCNJ15;MC1R;OR2A4;CAMK2N1;NSG1;SLC16A5;ITGB5;GJD3;NOS1;BCAM;FERMT1;PLXNB1;KCNC4;SLC29A4;ITPR3;GPRC5C;HLA-B;TNFSF10;SYTL1;NEO1;CTSV;NLGN4Y;FLRT3;RASA4;RGS2;F2R;SPTB;SLC24A1;RTN4RL1;TRPV4;FLOT1;NLGN2;ADORA2B;ANK3;SLC13A5;RIMS3;GJC2;TSPAN18;C5;SNTA1;ADGRL1;MINK1;TNFRSF14;ARHGEF4;ITGA2;VAMP2;NAIP;BOC;ITGA6;KCNJ5;LZTS1;GPC2;INSR;CELSR1;ST3GAL5;BAIAP2;TANC1;SCNN1A;PLXNB3;AHNAK2;SCN4B;SEPT6;RAB11FIP4;DOCK8;PILRB;SLC2A3;TCIRG1;MAP2K2;PTK6;SLC12A7;SYNGAP1;EPB41L3;CLCA2;CENPC;HOMER2;BBS2;PSD3;PODXL;OSCP1;DNM1;TNFRSF21;CA2;EFNB3;SHANK3;HFE;SCART1;CYBA;EDA2R;SPRY2;MRC2;GABBR1;RAB11FIP3;KCNMA1;GPR87;APC2;SLC2A1;ERMAP;SLC38A4;GNG2;PRR7;LRP1;HLA-A;KCNG1;PMEL;BBS1;PDE2A;SDHA;LTB4R2;RET;PRX;DAB2IP;SHROOM2;OLFM2;SYT7;FGFR4;BBS5;SCN2A;DLG5;BST2;CACNB3;VIPR1;PLXND1;LPAR6;DMTN;TMEM231;CA11;ACVR1B;SHROOM4;CADM4;DLG4;ESYT2;DUOX1;SLC22A15;SLC35G2;PTK7;SHANK2;TNFRSF25;CLSTN3;ANO1;S100A6;TNFSF12;TAS1R3;SLC43A1;CPT1C;RDH12;TRAF5;SRPX2;CD9;CACNB1;PTPN3;GJB5;COL13A1;ERBB2;GPR68;ABCA2;AKAP6;TH;MPP7;PRKACA;LDLRAP1;SYNE2;KCNS3;CIT;CALHM2;NPNT;PEMT;TM4SF1
5326,GO:0016054,0.00157034754518705,0.999212594174902,33,192,organic acid catabolic process,BP,AMACR;CPT2;GLUD1;NOS1;HMGCL;CYP26B1;THNSL2;TYSND1;IDUA;PRODH;CRAT;MLYCD;PHYH;HEXA;ALDH4A1;ALDH7A1;HEXB;HYAL1;PEX7;LPIN3;HADH;ACADS;ACACB;GLUL;ACOX3;ETFB;AMT;IRS2;ECI1;FAAH;CPT1C;LONP2;EHHADH
11640,GO:0046395,0.00157034754518705,0.999212594174902,33,192,carboxylic acid catabolic process,BP,AMACR;CPT2;GLUD1;NOS1;HMGCL;CYP26B1;THNSL2;TYSND1;IDUA;PRODH;CRAT;MLYCD;PHYH;HEXA;ALDH4A1;ALDH7A1;HEXB;HYAL1;PEX7;LPIN3;HADH;ACADS;ACACB;GLUL;ACOX3;ETFB;AMT;IRS2;ECI1;FAAH;CPT1C;LONP2;EHHADH
12394,GO:0048856,0.00158697360315453,0.998712716222796,425,3600,anatomical structure development,BP,TNFAIP3;TGFBI;POSTN;TAGLN;SERPINE2;ULK2;GPNMB;SIK1;MAP6;PTHLH;SREBF1;ACTA2;APOE;GPSM1;INPP5D;APCDD1;GAMT;OAS2;ADAM19;MN1;HSPA2;FBXW4;EGFR;PTPRS;FLNC;FAM20C;PKD2;CAPRIN2;MNT;ASH2L;DIXDC1;ALDH1A3;SRSF5;LRIG3;PLCD3;SLITRK6;SFRP1;OBSL1;KCTD11;KIF26B;PCDH1;EPHB2;GLUD1;PIK3R1;ADAMTS7;BRSK1;TXNRD3;MARVELD1;KDM3A;CXCL14;TSC22D3;EYS;EVC;POU3F1;SULF2;WNT3;DHTKD1;VAV3;UNK;CSPG4;ISG15;HTRA1;TFCP2L1;TENM4;UNC119B;RGMA;KCNAB2;ZFPM1;KITLG;HOXC5;SDK2;CUL7;VAMP3;PRICKLE2;MC1R;STAT1;IMPACT;MYL9;KRT15;UNC5B;ITGB5;COL10A1;NOS1;PRKACB;HOXA3;ZFP41;SCMH1;KLF13;NFATC4;HMGCL;BTBD2;FERMT1;CYP26B1;GAA;HSF4;MICALL1;LIG1;PLXNB1;SPEG;NDRG1;COL7A1;SPOCK1;NAGLU;MDM2;CRTC1;LZTS2;PLCD1;NDN;CSMD3;LTBP4;OBSCN;TNFSF10;MYH11;PARVB;RHOBTB2;NEO1;RAPGEF3;TCF25;NINJ1;FAM210B;CTSV;NLGN4Y;SPATA20;FLRT3;KCTD15;KIF26A;ARPIN;ADGRB2;F2R;PPL;PDCD4;BLOC1S4;SPTB;SERPINB5;NYAP1;ZNF160;DNAH1;RTN4RL1;ZFP36L2;CLTCL1;TRPV4;FLOT1;GLI2;NLGN2;ANK3;KLF7;RNF165;SOX12;CLMN;SPG11;GJC2;ARHGEF19;PER2;TMEM204;MICALCL;UNC119;C5;WIPF1;PSKH1;ADGRL1;MINK1;PHF2;AMIGO2;THBS3;TNFRSF14;WWTR1;LHFPL2;ITGA2;SEMA4G;ULK1;GLI3;FHOD3;TPGS1;IRX4;SMARCA1;NAIP;LTBP1;NEK8;MAP2K5;GAS8;BOC;ITGA6;BSN;IGFBP4;TCFL5;TRAK1;JARID2;NUPR1;PRR9;GPC2;INSR;TST;CELSR1;GSN;BAIAP2;TANC1;TTN;PLXNB3;SUN1;AHNAK2;TRIOBP;CD109;PMS2P3;RAB11FIP4;ENDOG;PGAP1;RTF1;BLOC1S3;MDK;CASP14;RICTOR;BMP6;B4GALT2;ETNK2;S100A4;MICALL2;VEGFB;CABYR;PTK6;FZD7;ETV5;LOXL1;SYNGAP1;FAM213A;DLX3;EPB41L3;SHARPIN;HEXB;KDM4C;HYAL1;SH2D2A;CST3;MMRN2;GDF15;PEX7;BBS2;TXNIP;CTF1;TCF4;COL6A1;NPHP3;PLAG1;IDH2;WRN;PODXL;MALL;TNFRSF21;IQCB1;CDK5R1;ATRX;REC8;NET1;CA2;EFNB3;MAPK10;SHANK3;HFE;HMG20B;NID1;AGO4;RRM2B;SLIT3;KRT14;EDA2R;SPRY2;MEF2D;IFT140;MLXIPL;CTSB;KLK5;FBXW7;CDK5RAP3;ATXN1;LMO2;NOTCH2NL;THRA;APC2;ARAP1;ASTN2;ADARB1;RAI1;FMNL2;SLC2A1;ACACB;TNS2;DBP;NAB2;SRR;LRP1;LRRN3;NPHP4;CCDC136;ACP5;RFX2;MTURN;BRINP1;DGCR2;MYO3B;SALL2;WNK1;ATXN10;JPH2;PDE2A;SDHA;MAF;RET;ZMYND8;PRX;DAB2IP;CASZ1;TEAD2;MYSM1;DDHD2;SHROOM2;RNF213;OLFM2;RAPGEFL1;TSHZ2;IFI16;FGFR4;BBS5;SCN2A;TEF;AREG;KLHL3;MYO9A;RPS6KA5;DLG5;BTG1;BST2;VDR;MAMSTR;TNRC6C;DPY19L2P2;PLXND1;ZMYM3;SIX5;PCSK6;DMTN;STAT2;TMEM231;TFDP2;SNX1;PMP22;NRARP;ACVR1B;SHROOM4;TACC1;KREMEN1;DLG4;TSSK1B;ALOXE3;PALB2;NHSL1;MATN2;NBEAL2;DUOX1;WEE1;GTF2IRD2;PTK7;TCF7;SHANK2;RSAD2;TNFRSF25;ZFP36L1;LMNA;MXRA8;CLSTN3;IL11;KAT2B;MARK4;APOLD1;IRS2;ANO1;ALOX15B;MTR;S100A6;TRERF1;ZSWIM8;APBB2;PBLD;RAPGEF5;TNFSF12;STAT6;SOX13;PHC2;TUB;GSTM3;SRPX2;CD9;RANBP9;HDAC11;PTPN3;GJB5;COL13A1;ERBB2;GPR68;PAQR7;AKAP6;TH;RORA;SSH3;PPARG;PRKACA;NPAP1;POLM;FMNL3;GCNT4;SYNE2;ACKR3;UFL1;LAMB2;RIPK3;NFASC;CIT;MAP1A;FOXP2;PTBP2;HIVEP1;ECM2;SMURF1;NPNT;TTLL1;CTNNBIP1;ECM1
12663,GO:0050896,0.00160106970233282,0.998684315459343,621,5518,response to stimulus,BP,TNFAIP3;TGFBI;POSTN;ITGB6;SERPINE2;ULK2;GPNMB;SIK1;EPM2A;MUC19;DDB2;TP53INP1;IFI6;PTHLH;SREBF1;PYGB;MXRA5;ACTA2;APOE;CES2;NT5E;INPP5D;APCDD1;OAS2;PSD4;DDX60;HSPA2;FBXW4;EGFR;GIGYF1;PTPRS;CIRBP;FAM20C;PKD2;CAPRIN2;MNT;XPC;APOBEC3C;CXCR1;ASH2L;DIXDC1;TRIM22;ALDH1A3;SRSF5;PLCD3;SLITRK6;SFRP1;MTHFR;PERM1;KCTD11;IFI44L;EPS8L2;EPHB2;RALGDS;GPX3;MAP3K14;BPHL;DGKQ;TMEM129;PIK3R1;ADAMTS7;BRSK1;TXNRD3;RBCK1;KDM3A;CXCL14;DOCK9;TSC22D3;EYS;EVC;RNF135;SULF2;WNT3;CAMKK1;HERC5;UBXN4;VAV3;SMOC2;VWCE;CSPG4;ISG15;MVB12B;CYBRD1;HTRA1;SPATA18;TENM4;RGMA;PI4KAP2;KCNAB2;ZFPM1;KITLG;CUL7;VAMP3;CITED4;SNN;NAPRT;PRICKLE2;MC1R;ASAP3;OR2A4;STAT1;IMPACT;CAMK2N1;CRY2;MYL9;NSG1;UNC5B;UROS;ITGB5;GJD3;RAB43;RAB40B;NOS1;PRKACB;CRY1;MAML3;BCAM;MAGEF1;PLEKHG5;NFATC4;IQSEC2;HMGCL;D2HGDH;BTBD2;SCARA3;FERMT1;CYP26B1;GAA;AP5Z1;CMPK2;THNSL2;HSF4;MICALL1;PIK3C2G;LIG1;PLXNB1;PLEKHG3;NDRG1;SPOCK1;ITPR3;MDM2;CRTC1;LZTS2;PLCD1;NDN;IFITM1;MLH3;FCGRT;CHN2;LTBP4;PIK3IP1;OBSCN;GPRC5C;HLA-B;TNFSF10;PRODH;HGSNAT;ACTR1B;RHOBTB2;UGT1A3;CYP3A5;NEO1;RAPGEF3;PCBP4;NINJ1;FAM210B;CTSV;POLH;OAS1;FLRT3;RASA4;KIF26A;RGL4;RGS2;ACAP3;IL20RB;ADGRB2;F2R;MLYCD;PPL;HPS4;MT1X;PDCD4;BLOC1S4;SPTB;NYAP1;SLC24A1;RTN4RL1;ZFP36L2;ADGRF4;CLTCL1;TRPV4;TMC6;FLOT1;GLI2;AGAP4;TOM1L2;RHPN1;NLGN2;ADORA2B;ANK3;KLF7;RNF165;ADAMTS13;LAMP3;PLCH2;RALGAPA1;MAPK8IP3;SLC13A5;PIDD1;SLX1A;SLX1B;GJC2;ZCCHC11;ARHGEF19;RHBDF1;TSPAN18;RASGEF1A;PER2;TMEM204;PITPNM2;CLCN6;PTGS1;UNC119;FNDC4;FRS3;C5;ZNF658;WIPF1;PSKH1;ADGRL1;MINK1;GSTM2;TNFRSF14;WWTR1;ASAP2;ARHGEF4;ITGA2;SEMA4G;FAM110C;ULK1;GLI3;SPPL2B;THRAP3;AKAP7;BHLHE40;LRSAM1;VAMP2;NAIP;LTBP1;NMU;NEK8;MAP2K5;BOC;ITGA6;SRGAP3;CES3;BSN;SESN3;IGFBP4;MMP1;JARID2;NUPR1;GPC2;NISCH;INSR;IFI44;CELSR1;MMP28;GSN;HEBP1;CHD3;CDK14;BAIAP2;TANC1;TTN;CBLC;SCNN1A;DDT;PLXNB3;SUN1;LPAR5;POLD4;RIN1;CD109;CYP2D7;PNMA1;PMS2P3;ETAA1;RMI2;ARHGEF1;MGST2;DOCK8;DHX58;PILRB;ENDOG;SLC27A1;TM7SF3;RTF1;BLOC1S3;MDK;CASP14;IRF9;RICTOR;BMP6;NLRX1;B4GALT2;SLC2A3;TCIRG1;S100A4;MAP2K2;PDK1;VEGFB;SQSTM1;PTK6;FZD7;ETV5;AKR7A2;LOXL1;SYNGAP1;NXPH4;FAM13A;FAM213A;TMEM117;SHARPIN;HEXB;HYAL1;ARHGAP33;SH2D2A;NSMCE4A;ARRDC1;PLA2G6;CST3;HOMER2;MMRN2;GDF15;BBS2;TXNIP;CTF1;ATP6V0A2;COL6A1;PEX11B;NPHP3;PSD3;MAP3K12;WRN;IFI27;DNM1;MCM9;TNFRSF21;MACROD1;KLHL24;TREX1;MCTP1;CDK5R1;ATRX;REC8;ARHGAP27;AGAP6;NET1;CA2;EFNB3;PI4KAP1;SESN1;MAPK10;SHANK3;HFE;SCART1;ADIRF;HMG20B;CYBA;TRIM38;DTX3;AGO4;ERCC6;HADH;HCP5;RRM2B;SLIT3;KRT14;HLCS;SHC2;EDA2R;SPRY2;MRC2;FBXO2;IFT140;GABBR1;CREBRF;XRN1;AGAP7P;LRP11;MLXIPL;CTSB;KLK5;FBXW7;KCNMA1;GPR87;ING4;NUDT6;CDK5RAP3;LMO2;NOTCH2NL;PAK6;TFPI2;CARF;PGM1;PFKFB2;PAQR6;THRA;APC2;ARAP1;ADARB1;ELF1;MX2;RPH3AL;SLC2A1;ACACB;NLRP1;C1RL;FRAT1;ERMAP;GPR155;GLUL;TNS2;EPM2AIP1;TP53I13;GNG2;PRR7;SRR;LRP1;HLA-A;NPHP4;RGS12;ACP5;MPG;PLA2G7;C12ORF66;RFX2;DLK2;BRINP1;MAP3K6;MYO3B;APPL2;SALL2;WNK1;BBS1;JPH2;PDE2A;STK16;LTB4R2;RET;ZMYND8;DAB2IP;RWDD3;CALCOCO1;TEAD2;DDHD2;SHROOM2;FBXO4;RNF213;RAPGEFL1;PIK3C3;IFI16;SYT7;FGFR4;ERCC5;BBS5;IL20RA;PIK3R2;SCN2A;AREG;ABTB1;SNCB;MYO9A;RPS6KA5;DLG5;BTG1;BST2;VDR;RGL2;ARHGEF17;CACNB3;TNRC6C;VIPR1;FAM3A;EFS;PLXND1;BBS10;MARCH8;PCSK6;LPAR6;PPP1R2;DMTN;STAT2;ARFGEF2;RASL10B;WWC3;PHF1;SLC36A4;TMEM231;TFDP2;UCN2;NRARP;ACVR1B;TMX4;KREMEN1;PRIMPOL;CCDC88B;DLG4;TSSK1B;IQSEC1;ALOXE3;PALB2;ENDOU;IGFBP6;MATN2;NBEAL2;CD68;DUOX1;PTK7;TCF7;SHANK2;RSAD2;TNFRSF25;ZFP36L1;LMNA;GLMP;ACSL1;IL11;KAT2B;APOLD1;IRS2;IMPA2;ANO1;CAPS;METTL7A;ERN1;IVNS1ABP;ALOX15B;RAD50;GPR21;TKFC;ZMAT3;MTR;MAN1B1;S100A6;SCG5;ZSWIM8;APBB2;ARHGEF9;PBLD;RAPGEF5;TNFSF12;TAS1R3;STAT6;PCSK1N;PRDX5;PHPT1;GPR132;SMPDL3B;TUB;KIF7;GLB1;DNAJC4;GSTM3;RDH12;CHD6;TRAF5;DPP7;CD9;RANBP9;CACNB1;PTPN3;CTSD;ERBB2;SYNGR1;PLCB3;GPR68;UVSSA;PAQR7;ARHGAP23;ABCA2;AKAP6;TH;ATG14;MPP7;RORA;PPARG;PRKACA;DOCK6;LDLRAP1;CXXC5;C6ORF120;POLM;ACKR3;SERPING1;DOCK3;UFL1;LAMB2;IP6K2;RIPK3;NFASC;KLF9;AIP;LONP2;CIT;MSH5;CLCN7;CCDC3;PER3;FOXP2;HIVEP1;SMURF1;NPNT;HERPUD2;CTNNBIP1;PEMT;SERINC3;GCLC;ECM1
10367,GO:0043202,0.0016285935902571,0.999433632718839,16,70,lysosomal lumen,CC,CSPG4;NSG1;SDC3;GAA;NAGLU;IDUA;CTSV;HEXA;GPC2;CTSF;HEXB;HYAL1;CTSB;SGSH;GLB1;CTSD
4234,GO:0009416,0.0017430191594836,0.999074657282807,38,223,response to light stimulus,BP,SIK1;DDB2;TP53INP1;EGFR;CIRBP;XPC;PIK3R1;BRSK1;EYS;MC1R;IMPACT;CRY2;CRY1;NFATC4;SCARA3;MDM2;CRTC1;POLH;SLC24A1;PER2;UNC119;BHLHE40;NMU;TANC1;B4GALT2;SYNGAP1;HYAL1;WRN;MAPK10;ERCC6;TP53I13;NPHP4;DDHD2;ERCC5;PRIMPOL;UVSSA;TH;PER3
4635,GO:0010760,0.00176617841240444,0.999963636088704,3,4,negative regulation of macrophage chemotaxis,BP,C5;MMP28;DDT
19266,GO:1905522,0.00176617841240444,0.999963636088704,3,4,negative regulation of macrophage migration,BP,C5;MMP28;DDT
3590,GO:0008015,0.00179798047071921,0.999004915795872,43,250,blood circulation,BP,POSTN;SREBF1;APOE;EGFR;MTHFR;STAT1;NOS1;GAA;TBC1D8;ITPR3;MDM2;RGS2;F2R;TRPV4;ADORA2B;PER2;PTGS1;SNTA1;GSTM2;NMU;KCNJ5;NISCH;TTN;SCN4B;VEGFB;PLA2G6;BBS2;CYBA;THRA;RNPEP;WNK1;PDE2A;CACNB3;RASL10B;TNNI2;CACNB1;PLCB3;TH;PPARG;PRKACA;SERPING1;CTNNBIP1;GCLC
6409,GO:0021675,0.00184246196082233,0.999477965763813,12,43,nerve development,BP,SERPINE2;SLITRK6;EPHB2;SULF2;HOXA3;CTSV;RNF165;GLI3;AHNAK2;ADARB1;RET;PRX
12202,GO:0048468,0.00184926498488205,0.998618744818963,172,1292,cell development,BP,POSTN;SERPINE2;ULK2;MAP6;PTHLH;ACTA2;APOE;HSPA2;EGFR;PTPRS;FLNC;FAM20C;CAPRIN2;DIXDC1;SLITRK6;SFRP1;OBSL1;KCTD11;EPHB2;PIK3R1;BRSK1;KDM3A;POU3F1;SULF2;WNT3;UNK;TFCP2L1;TENM4;RGMA;ZFPM1;KITLG;CUL7;VAMP3;IMPACT;UNC5B;NOS1;NFATC4;HSF4;MICALL1;PLXNB1;NDRG1;SPOCK1;NAGLU;MDM2;CRTC1;NDN;CSMD3;OBSCN;MYH11;PARVB;NEO1;RAPGEF3;FAM210B;FLRT3;PDCD4;BLOC1S4;SPTB;NYAP1;DNAH1;RTN4RL1;TRPV4;FLOT1;GLI2;ANK3;KLF7;RNF165;CLMN;SPG11;GJC2;PER2;MINK1;SEMA4G;ULK1;GLI3;FHOD3;TPGS1;BOC;TRAK1;GSN;BAIAP2;TTN;PLXNB3;AHNAK2;TRIOBP;BLOC1S3;BMP6;MICALL2;CABYR;PTK6;FZD7;ETV5;SYNGAP1;EPB41L3;HEXB;KDM4C;CST3;GDF15;BBS2;CTF1;TCF4;PLAG1;IDH2;PODXL;TNFRSF21;CDK5R1;ATRX;REC8;NET1;EFNB3;MAPK10;SHANK3;HMG20B;SLIT3;IFT140;FBXW7;CDK5RAP3;ADARB1;LRP1;NPHP4;CCDC136;RFX2;BRINP1;WNK1;ATXN10;PDE2A;MAF;RET;ZMYND8;PRX;DAB2IP;CASZ1;AREG;RPS6KA5;DLG5;DPY19L2P2;PLXND1;SIX5;DMTN;PMP22;DLG4;TSSK1B;MATN2;NBEAL2;WEE1;PTK7;SHANK2;LMNA;MXRA8;IRS2;MTR;S100A6;ZSWIM8;APBB2;GSTM3;CD9;RANBP9;HDAC11;ERBB2;GPR68;PAQR7;AKAP6;TH;SSH3;PPARG;PRKACA;UFL1;LAMB2;NFASC;MAP1A;ECM2;SMURF1;TTLL1
3461,GO:0007275,0.00190944414193899,0.998453368742922,391,3290,multicellular organism development,BP,TNFAIP3;TGFBI;POSTN;TAGLN;SERPINE2;ULK2;GPNMB;SIK1;MAP6;PTHLH;SREBF1;ACTA2;APOE;GPSM1;INPP5D;APCDD1;GAMT;OAS2;ADAM19;MN1;FBXW4;EGFR;PTPRS;FAM20C;PKD2;CAPRIN2;MNT;ASH2L;DIXDC1;ALDH1A3;SRSF5;LRIG3;PLCD3;SLITRK6;SFRP1;OBSL1;KCTD11;KIF26B;PCDH1;EPHB2;GLUD1;PIK3R1;ADAMTS7;BRSK1;TXNRD3;MARVELD1;CXCL14;TSC22D3;EVC;POU3F1;SULF2;WNT3;DHTKD1;VAV3;UNK;CSPG4;ISG15;HTRA1;TFCP2L1;TENM4;UNC119B;RGMA;KCNAB2;ZFPM1;KITLG;HOXC5;SDK2;CUL7;PRICKLE2;MC1R;STAT1;IMPACT;MYL9;KRT15;UNC5B;ITGB5;COL10A1;NOS1;PRKACB;HOXA3;ZFP41;SCMH1;KLF13;NFATC4;HMGCL;BTBD2;FERMT1;CYP26B1;GAA;HSF4;MICALL1;PLXNB1;SPEG;NDRG1;COL7A1;SPOCK1;NAGLU;MDM2;CRTC1;LZTS2;PLCD1;NDN;CSMD3;LTBP4;OBSCN;TNFSF10;MYH11;NEO1;RAPGEF3;TCF25;NINJ1;FAM210B;CTSV;NLGN4Y;SPATA20;FLRT3;KCTD15;KIF26A;ADGRB2;PPL;PDCD4;BLOC1S4;SPTB;SERPINB5;NYAP1;ZNF160;RTN4RL1;ZFP36L2;TRPV4;FLOT1;GLI2;NLGN2;ANK3;KLF7;RNF165;SOX12;CLMN;SPG11;GJC2;ARHGEF19;PER2;TMEM204;MICALCL;UNC119;C5;PSKH1;ADGRL1;MINK1;PHF2;AMIGO2;THBS3;TNFRSF14;WWTR1;LHFPL2;ITGA2;SEMA4G;ULK1;GLI3;FHOD3;TPGS1;IRX4;SMARCA1;NAIP;LTBP1;NEK8;MAP2K5;GAS8;BOC;ITGA6;BSN;IGFBP4;TCFL5;TRAK1;JARID2;NUPR1;PRR9;GPC2;INSR;CELSR1;GSN;BAIAP2;TTN;PLXNB3;SUN1;AHNAK2;TRIOBP;CD109;PMS2P3;RAB11FIP4;ENDOG;PGAP1;RTF1;BLOC1S3;MDK;CASP14;RICTOR;BMP6;B4GALT2;ETNK2;S100A4;MICALL2;VEGFB;PTK6;FZD7;ETV5;LOXL1;SYNGAP1;FAM213A;DLX3;EPB41L3;SHARPIN;HEXB;KDM4C;HYAL1;SH2D2A;CST3;MMRN2;PEX7;BBS2;TXNIP;CTF1;TCF4;COL6A1;NPHP3;PLAG1;IDH2;WRN;PODXL;MALL;TNFRSF21;IQCB1;CDK5R1;ATRX;REC8;CA2;EFNB3;MAPK10;SHANK3;HFE;HMG20B;NID1;AGO4;RRM2B;SLIT3;KRT14;EDA2R;SPRY2;MEF2D;IFT140;CTSB;KLK5;FBXW7;CDK5RAP3;ATXN1;LMO2;NOTCH2NL;THRA;APC2;ADARB1;RAI1;SLC2A1;ACACB;TNS2;DBP;NAB2;SRR;LRP1;LRRN3;NPHP4;ACP5;MTURN;BRINP1;DGCR2;MYO3B;SALL2;WNK1;ATXN10;JPH2;SDHA;MAF;RET;ZMYND8;PRX;DAB2IP;CASZ1;TEAD2;MYSM1;SHROOM2;RNF213;RAPGEFL1;TSHZ2;IFI16;FGFR4;BBS5;SCN2A;TEF;AREG;KLHL3;RPS6KA5;DLG5;BTG1;BST2;VDR;TNRC6C;PLXND1;ZMYM3;SIX5;PCSK6;DMTN;TMEM231;TFDP2;PMP22;NRARP;ACVR1B;SHROOM4;TACC1;KREMEN1;DLG4;TSSK1B;ALOXE3;PALB2;NHSL1;MATN2;NBEAL2;DUOX1;WEE1;GTF2IRD2;PTK7;TCF7;SHANK2;RSAD2;TNFRSF25;ZFP36L1;LMNA;MXRA8;CLSTN3;IL11;KAT2B;MARK4;APOLD1;IRS2;ANO1;ALOX15B;MTR;S100A6;TRERF1;ZSWIM8;APBB2;PBLD;RAPGEF5;TNFSF12;STAT6;SOX13;PHC2;TUB;GSTM3;SRPX2;CD9;RANBP9;HDAC11;PTPN3;GJB5;COL13A1;ERBB2;GPR68;PAQR7;AKAP6;TH;RORA;SSH3;PPARG;NPAP1;POLM;FMNL3;GCNT4;SYNE2;ACKR3;UFL1;LAMB2;RIPK3;NFASC;CIT;MAP1A;FOXP2;PTBP2;HIVEP1;ECM2;SMURF1;NPNT;CTNNBIP1;ECM1
16402,GO:0097060,0.00199764301365324,0.99902461123951,30,157,synaptic membrane,CC,PTPRS;CAMK2N1;NSG1;NLGN4Y;FLRT3;F2R;NLGN2;ANK3;RIMS3;ADGRL1;MINK1;LZTS1;BAIAP2;TANC1;HOMER2;PSD3;DNM1;SHANK3;GABBR1;KCNMA1;PRR7;PDE2A;OLFM2;SYT7;DLG5;DLG4;SHANK2;CLSTN3;SRPX2;COL13A1
13739,GO:0060337,0.00200090064574742,0.999313752640725,15,68,type I interferon signaling pathway,BP,IFI6;OAS2;ISG15;STAT1;IFITM1;HLA-B;OAS1;IRF9;IFI27;MX2;HLA-A;BST2;STAT2;RSAD2;IP6K2
15189,GO:0071357,0.00200090064574742,0.999313752640725,15,68,cellular response to type I interferon,BP,IFI6;OAS2;ISG15;STAT1;IFITM1;HLA-B;OAS1;IRF9;IFI27;MX2;HLA-A;BST2;STAT2;RSAD2;IP6K2
16206,GO:0090276,0.00210895876718214,0.999077809961716,23,117,regulation of peptide hormone secretion,BP,SREBF1;EGFR;SFRP1;GLUD1;ITPR3;RAPGEF3;NLGN2;PER2;NMU;TM7SF3;PLA2G6;HFE;HADH;PFKFB2;SLC2A1;GLUL;SYT7;RASL10B;IRS2;ANO1;PHPT1;GPR68;KCNS3
10226,GO:0042953,0.0021156079641665,0.999894219533812,4,6,lipoprotein transport,BP,UNC119B;UNC119;LRP1;PPARG
11013,GO:0044872,0.0021156079641665,0.999894219533812,4,6,lipoprotein localization,BP,UNC119B;UNC119;LRP1;PPARG
13701,GO:0060291,0.00213643391056722,0.999423051848108,11,39,long-term synaptic potentiation,BP,SERPINE2;APOE;EPHB2;NSG1;ITPR3;CRTC1;SLC24A1;VAMP2;SQSTM1;SHANK3;SHANK2
1257,GO:0003013,0.00216360830542697,0.998789511432592,43,252,circulatory system process,BP,POSTN;SREBF1;APOE;EGFR;MTHFR;STAT1;NOS1;GAA;TBC1D8;ITPR3;MDM2;RGS2;F2R;TRPV4;ADORA2B;PER2;PTGS1;SNTA1;GSTM2;NMU;KCNJ5;NISCH;TTN;SCN4B;VEGFB;PLA2G6;BBS2;CYBA;THRA;RNPEP;WNK1;PDE2A;CACNB3;RASL10B;TNNI2;CACNB1;PLCB3;TH;PPARG;PRKACA;SERPING1;CTNNBIP1;GCLC
2525,GO:0005782,0.00227417971597936,0.99947736636795,9,31,peroxisomal matrix,CC,AMACR;CRAT;MLYCD;PHYH;PEX7;ACOX3;PRDX5;LONP2;EHHADH
7557,GO:0031907,0.00227417971597936,0.99947736636795,9,31,microbody lumen,CC,AMACR;CRAT;MLYCD;PHYH;PEX7;ACOX3;PRDX5;LONP2;EHHADH
16758,GO:0098590,0.00231728764372299,0.998431509689743,90,619,plasma membrane region,CC,PSD4;EGFR;PTPRS;PKD2;PLCD3;EPS8L2;EVC;CSPG4;CYBRD1;VAMP3;OR2A4;CAMK2N1;NSG1;NOS1;FERMT1;KCNC4;SLC29A4;SYTL1;NLGN4Y;FLRT3;F2R;TRPV4;FLOT1;NLGN2;ANK3;RIMS3;ADGRL1;MINK1;ARHGEF4;NAIP;ITGA6;LZTS1;INSR;BAIAP2;TANC1;SCNN1A;SEPT6;RAB11FIP4;DOCK8;TCIRG1;EPB41L3;CLCA2;CENPC;HOMER2;BBS2;PSD3;PODXL;OSCP1;DNM1;CA2;SHANK3;CYBA;SPRY2;GABBR1;RAB11FIP3;KCNMA1;APC2;SLC2A1;PRR7;LRP1;BBS1;PDE2A;SHROOM2;OLFM2;SYT7;BBS5;DLG5;BST2;CACNB3;PLXND1;DMTN;TMEM231;CA11;SHROOM4;DLG4;DUOX1;SHANK2;CLSTN3;ANO1;RDH12;SRPX2;CD9;COL13A1;ERBB2;AKAP6;PRKACA;LDLRAP1;SYNE2;CIT;PEMT
10881,GO:0044438,0.00239816746510849,0.999126965592369,16,74,microbody part,CC,AMACR;CRAT;MLYCD;PHYH;PEX10;MAP2K2;PEX7;PEX11B;ACOX3;SYT7;ACSL1;DHRS4;PEX1;PRDX5;LONP2;EHHADH
10882,GO:0044439,0.00239816746510849,0.999126965592369,16,74,peroxisomal part,CC,AMACR;CRAT;MLYCD;PHYH;PEX10;MAP2K2;PEX7;PEX11B;ACOX3;SYT7;ACSL1;DHRS4;PEX1;PRDX5;LONP2;EHHADH
10334,GO:0043153,0.00244477835186374,0.99957991041586,7,19,entrainment of circadian clock by photoperiod,BP,SIK1;CRY2;CRY1;CRTC1;PER2;BHLHE40;PER3
12603,GO:0050807,0.00244954560817838,0.998991560830539,20,94,regulation of synapse organization,BP,APOE;CAPRIN2;SLITRK6;EPHB2;NFATC4;FLRT3;ADGRB2;NLGN2;ADGRL1;AMIGO2;BAIAP2;ETV5;CDK5R1;SHANK3;LRRN3;ZMYND8;DAB2IP;DLG5;CLSTN3;SRPX2
2674,GO:0006027,0.00245534143598518,0.999321576288461,11,40,glycosaminoglycan catabolic process,BP,CSPG4;SDC3;NAGLU;IDUA;HGSNAT;HEXA;GPC2;HEXB;HYAL1;SGSH;GLB1
4283,GO:0009653,0.002491486582671,0.998071967043028,216,1690,anatomical structure morphogenesis,BP,TNFAIP3;TGFBI;POSTN;SERPINE2;ULK2;GPNMB;MAP6;ACTA2;APOE;GAMT;FBXW4;EGFR;PTPRS;FAM20C;PKD2;CAPRIN2;ALDH1A3;LRIG3;PLCD3;SLITRK6;SFRP1;OBSL1;KIF26B;EPHB2;PIK3R1;BRSK1;SULF2;WNT3;VAV3;UNK;CSPG4;HTRA1;TFCP2L1;TENM4;ZFPM1;SDK2;CUL7;VAMP3;PRICKLE2;STAT1;IMPACT;UNC5B;ITGB5;NOS1;PRKACB;HOXA3;NFATC4;CYP26B1;GAA;LIG1;PLXNB1;COL7A1;NAGLU;MDM2;PLCD1;NDN;OBSCN;MYH11;PARVB;RHOBTB2;NEO1;RAPGEF3;NINJ1;CTSV;FLRT3;ARPIN;ADGRB2;F2R;PDCD4;SPTB;SERPINB5;NYAP1;CLTCL1;TRPV4;FLOT1;GLI2;ANK3;KLF7;RNF165;SPG11;ARHGEF19;C5;WIPF1;MINK1;THBS3;WWTR1;ITGA2;SEMA4G;ULK1;GLI3;FHOD3;IRX4;NEK8;MAP2K5;BOC;ITGA6;TRAK1;INSR;CELSR1;BAIAP2;TANC1;TTN;PLXNB3;AHNAK2;TRIOBP;CD109;RTF1;BMP6;MICALL2;VEGFB;FZD7;ETV5;SYNGAP1;DLX3;EPB41L3;HEXB;KDM4C;HYAL1;SH2D2A;CST3;MMRN2;GDF15;PEX7;BBS2;COL6A1;NPHP3;PLAG1;PODXL;CDK5R1;ATRX;NET1;CA2;EFNB3;SHANK3;AGO4;SLIT3;SPRY2;MEF2D;IFT140;MLXIPL;KLK5;FBXW7;THRA;ARAP1;ASTN2;ADARB1;FMNL2;NAB2;LRP1;CCDC136;ACP5;RFX2;DGCR2;MYO3B;RET;PRX;DAB2IP;TEAD2;DDHD2;SHROOM2;RNF213;FGFR4;BBS5;AREG;KLHL3;MYO9A;RPS6KA5;DLG5;BTG1;VDR;PLXND1;ZMYM3;DMTN;STAT2;TMEM231;SNX1;NRARP;DLG4;PALB2;MATN2;NBEAL2;WEE1;PTK7;TCF7;SHANK2;ZFP36L1;APOLD1;IRS2;S100A6;ZSWIM8;APBB2;TNFSF12;STAT6;SOX13;SRPX2;CD9;RANBP9;GJB5;COL13A1;ERBB2;TH;RORA;SSH3;PPARG;FMNL3;GCNT4;ACKR3;LAMB2;NFASC;MAP1A;FOXP2;ECM2;SMURF1;NPNT;CTNNBIP1;ECM1
12339,GO:0048731,0.00249402320640824,0.997983956159932,350,2928,system development,BP,TNFAIP3;TGFBI;POSTN;TAGLN;SERPINE2;ULK2;GPNMB;SIK1;MAP6;PTHLH;SREBF1;ACTA2;APOE;GPSM1;INPP5D;APCDD1;GAMT;OAS2;ADAM19;FBXW4;EGFR;PTPRS;FAM20C;PKD2;CAPRIN2;ASH2L;DIXDC1;ALDH1A3;SRSF5;LRIG3;PLCD3;SLITRK6;SFRP1;OBSL1;KCTD11;KIF26B;PCDH1;EPHB2;GLUD1;PIK3R1;ADAMTS7;BRSK1;MARVELD1;CXCL14;TSC22D3;EVC;POU3F1;SULF2;WNT3;DHTKD1;VAV3;UNK;CSPG4;ISG15;HTRA1;TFCP2L1;TENM4;UNC119B;RGMA;KCNAB2;ZFPM1;KITLG;SDK2;CUL7;PRICKLE2;STAT1;IMPACT;MYL9;KRT15;UNC5B;COL10A1;NOS1;PRKACB;HOXA3;KLF13;NFATC4;HMGCL;BTBD2;FERMT1;CYP26B1;GAA;HSF4;MICALL1;PLXNB1;SPEG;NDRG1;SPOCK1;NAGLU;MDM2;CRTC1;LZTS2;PLCD1;NDN;CSMD3;TNFSF10;MYH11;NEO1;RAPGEF3;TCF25;NINJ1;FAM210B;CTSV;NLGN4Y;FLRT3;KIF26A;ADGRB2;PPL;PDCD4;BLOC1S4;SPTB;SERPINB5;NYAP1;ZNF160;RTN4RL1;ZFP36L2;TRPV4;FLOT1;GLI2;NLGN2;ANK3;KLF7;RNF165;SOX12;CLMN;SPG11;GJC2;ARHGEF19;PER2;TMEM204;UNC119;C5;PSKH1;ADGRL1;MINK1;PHF2;AMIGO2;THBS3;WWTR1;ITGA2;SEMA4G;ULK1;GLI3;FHOD3;IRX4;SMARCA1;NAIP;LTBP1;NEK8;MAP2K5;GAS8;BOC;ITGA6;BSN;IGFBP4;TRAK1;JARID2;NUPR1;PRR9;GPC2;INSR;CELSR1;GSN;BAIAP2;TTN;PLXNB3;SUN1;AHNAK2;TRIOBP;CD109;PMS2P3;RAB11FIP4;PGAP1;BLOC1S3;MDK;CASP14;BMP6;B4GALT2;ETNK2;S100A4;MICALL2;VEGFB;PTK6;FZD7;ETV5;LOXL1;SYNGAP1;FAM213A;DLX3;EPB41L3;SHARPIN;HEXB;KDM4C;HYAL1;SH2D2A;CST3;MMRN2;PEX7;BBS2;TXNIP;CTF1;TCF4;NPHP3;PLAG1;IDH2;WRN;PODXL;MALL;TNFRSF21;IQCB1;CDK5R1;ATRX;REC8;CA2;EFNB3;MAPK10;SHANK3;HFE;HMG20B;NID1;AGO4;RRM2B;SLIT3;KRT14;SPRY2;MEF2D;IFT140;CTSB;KLK5;FBXW7;CDK5RAP3;ATXN1;LMO2;THRA;ADARB1;RAI1;SLC2A1;ACACB;TNS2;DBP;NAB2;SRR;LRP1;LRRN3;NPHP4;ACP5;BRINP1;DGCR2;MYO3B;SALL2;WNK1;ATXN10;JPH2;SDHA;MAF;RET;ZMYND8;PRX;DAB2IP;CASZ1;TEAD2;MYSM1;SHROOM2;RNF213;RAPGEFL1;IFI16;FGFR4;BBS5;SCN2A;AREG;KLHL3;RPS6KA5;DLG5;BTG1;VDR;TNRC6C;PLXND1;SIX5;PCSK6;DMTN;TMEM231;TFDP2;PMP22;NRARP;ACVR1B;SHROOM4;TACC1;DLG4;ALOXE3;PALB2;NHSL1;MATN2;NBEAL2;WEE1;PTK7;TCF7;SHANK2;RSAD2;ZFP36L1;LMNA;MXRA8;CLSTN3;IL11;KAT2B;MARK4;APOLD1;IRS2;ALOX15B;MTR;S100A6;ZSWIM8;APBB2;PBLD;RAPGEF5;TNFSF12;STAT6;SOX13;TUB;GSTM3;SRPX2;CD9;RANBP9;HDAC11;PTPN3;GJB5;COL13A1;ERBB2;GPR68;AKAP6;TH;RORA;SSH3;PPARG;POLM;FMNL3;GCNT4;SYNE2;ACKR3;UFL1;LAMB2;RIPK3;NFASC;CIT;MAP1A;FOXP2;PTBP2;ECM2;SMURF1;NPNT;CTNNBIP1;ECM1
17991,GO:1902495,0.0025017079558264,0.998891970910519,23,115,transmembrane transporter complex,CC,HSPA2;KCNAB2;NOS1;KCNC4;VAMP2;KCNJ5;SCNN1A;SCN4B;SHANK3;KCNMA1;KCNG1;OLFM2;SCN2A;CACNB3;DLG4;SHANK2;ANO1;CPT1C;CACNB1;ABCA2;AKAP6;PRKACA;KCNS3
9973,GO:0042383,0.0025438250272073,0.999040564525502,17,75,sarcolemma,CC,FLNC;SYNC;NOS1;OBSCN;FLOT1;ANK3;SNTA1;KCNJ5;AHNAK2;COL6A1;SLC2A1;PRX;SCN2A;CACNB3;CACNB1;AKAP6;PEMT
1480,GO:0003779,0.00259221139493443,0.998477225458381,49,291,actin binding,MF,TAGLN;EGFR;ESPN;FLNC;SYN1;DIXDC1;OBSL1;EPS8L2;TNS1;IMPACT;MARCKSL1;MYH11;PARVB;PHACTR3;SPTB;TRPV4;CORO6;CLMN;WIPF1;SNTA1;FHOD3;GSN;TTN;PLEKHH2;TRIOBP;S100A4;MICALL2;EPB41L3;HOMER2;CDK5R1;SHANK3;WASH3P;KCNMA1;FMNL2;CAPG;SYNPO2;MYO3B;SHROOM2;KLHL3;MYO9A;TNS4;DMTN;SHROOM4;TNNI2;MPRIP;SSH3;FMNL3;SYNE2;MAP1A
10789,GO:0044282,0.0027797993226419,0.998382757592732,46,303,small molecule catabolic process,BP,AMACR;APOE;NT5E;APOBEC3C;CPT2;GLUD1;SRD5A3;NOS1;HMGCL;CYP26B1;THNSL2;TYSND1;IDUA;PRODH;CRAT;MLYCD;PHYH;SULT1E1;HEXA;ALDH4A1;ALDH7A1;HEXB;HYAL1;PEX7;LPIN3;HADH;PGM1;PFKFB2;ACADS;ACACB;GLUL;BDH1;ACOX3;ETFB;GALE;AMT;IRS2;IMPA2;TKFC;ECI1;TRERF1;FAAH;GLB1;CPT1C;LONP2;EHHADH
7844,GO:0032412,0.0028276196188843,0.998707772364288,24,124,regulation of ion transmembrane transporter activity,BP,HSPA2;PKD2;EPHB2;NOS1;NLGN2;ANK3;MINK1;GSTM2;VAMP2;SCN4B;PLA2G6;KLHL24;ANO9;SHANK3;KCNG1;WNK1;JPH2;CACNB3;DLG4;SHANK2;CACNB1;PTPN3;AKAP6;PRKACA
2101,GO:0004871,0.0028866177761543,0.998011455312528,94,674,signal transducer activity,MF,SREBF1;EGFR;PKD2;CXCR1;PLCD3;SFRP1;EPHB2;MAP3K14;DGKQ;PIK3R1;CSPG4;RGMA;MC1R;OR2A4;STAT1;CRY2;UNC5B;CRY1;BCAM;PLEKHG5;PLXNB1;ITPR3;PLCD1;IFITM1;FCGRT;LTBP4;GPRC5C;RHOBTB2;FLRT3;IL20RB;ADGRB2;F2R;ADGRF4;CLTCL1;TRPV4;ADORA2B;PLCH2;ADGRL1;MINK1;TNFRSF14;ITGA2;LTBP1;INSR;CELSR1;CBLC;PLXNB3;LPAR5;MAP2K2;FZD7;MAP3K12;TNFRSF21;EFNB3;MAPK10;TRIM38;EDA2R;MRC2;GABBR1;GPR87;PAQR6;THRA;GNG2;RGS12;MAP3K6;JPH2;LTB4R2;RET;FGFR4;IL20RA;BST2;VDR;VIPR1;PLXND1;LPAR6;STAT2;ACVR1B;PTK7;TNFRSF25;GLMP;IRS2;GPR21;TAS1R3;STAT6;GPR132;ERBB2;PLCB3;GPR68;PAQR7;RORA;PPARG;CXXC5;ACKR3;RIPK3;AIP;ECM1
16645,GO:0097546,0.00290987232360041,0.999387581361099,8,25,ciliary base,CC,PRKACB;GLI2;GLI3;NEK8;CEP126;NPHP3;NPHP4;PRKACA
4264,GO:0009612,0.00292611903819963,0.998614912437894,26,132,response to mechanical stimulus,BP,POSTN;SERPINE2;EGFR;PKD2;XPC;SLITRK6;MAP3K14;STAT1;PPL;TRPV4;GLI2;CLCN6;ITGA2;TTN;SUN1;ENDOG;BMP6;TXNIP;SHANK3;CYBA;LRP11;SLC2A1;PDE2A;PPARG;FOXP2;GCLC
8909,GO:0034762,0.00295800328411549,0.998311508979522,43,264,regulation of transmembrane transport,BP,HSPA2;PKD2;EPHB2;PIK3R1;KCNAB2;KCNJ15;NOS1;KCNC4;F2R;CLTCL1;NLGN2;ANK3;GJC2;PER2;SNTA1;MINK1;GSTM2;VAMP2;KCNJ5;INSR;SCN4B;PLA2G6;KLHL24;ANO9;CA2;SHANK3;CYBA;KCNMA1;SLC2A1;KCNG1;WNK1;JPH2;PIK3R2;SCN2A;CACNB3;DLG4;SHANK2;IRS2;CACNB1;PTPN3;AKAP6;PRKACA;KCNS3
2285,GO:0005244,0.0029699785964928,0.998941892924879,15,65,voltage-gated ion channel activity,MF,PKD2;KCNAB2;KCNJ15;KCNC4;CLCN6;KCNJ5;SCN4B;KCNMA1;KCNG1;SCN2A;CACNB3;ANO1;CACNB1;KCNS3;CLCN7
6606,GO:0022832,0.0029699785964928,0.998941892924879,15,65,voltage-gated channel activity,MF,PKD2;KCNAB2;KCNJ15;KCNC4;CLCN6;KCNJ5;SCN4B;KCNMA1;KCNG1;SCN2A;CACNB3;ANO1;CACNB1;KCNS3;CLCN7
6735,GO:0030159,0.00301893331720516,0.99946043233079,7,19,receptor signaling complex scaffold activity,MF,GRIP2;MAPK8IP3;HOMER2;SHANK3;DLG5;SHANK2;LDLRAP1
6730,GO:0030154,0.0030698200058464,0.997534343968923,303,2514,cell differentiation,BP,TGFBI;POSTN;TAGLN;SERPINE2;ULK2;GPNMB;SIK1;SLFN5;TP53INP1;MAP6;PTHLH;SREBF1;ACTA2;APOE;GPSM1;INPP5D;APCDD1;HSPA2;EGFR;PTPRS;FLNC;FAM20C;CAPRIN2;ASH2L;DIXDC1;SLITRK6;SFRP1;OBSL1;KCTD11;EPHB2;PIK3R1;ADAMTS7;BRSK1;TXNRD3;KDM3A;CXCL14;POU3F1;SULF2;WNT3;DHTKD1;UNK;CSPG4;HTRA1;TFCP2L1;TENM4;UNC119B;RGMA;KCNAB2;ZFPM1;KITLG;SDK2;CUL7;VAMP3;STAT1;IMPACT;MYL9;KRT15;UNC5B;ITGB5;NOS1;ZFP41;KLF13;NFATC4;BTBD2;CYP26B1;HSF4;MICALL1;PLXNB1;SPEG;NDRG1;COL7A1;SPOCK1;NAGLU;MDM2;CRTC1;NDN;IFITM1;CSMD3;LTBP4;OBSCN;MYH11;PARVB;NEO1;RAPGEF3;FAM210B;CTSV;SPATA20;FLRT3;RGS2;PPL;HPS4;PDCD4;BLOC1S4;SPTB;NYAP1;DNAH1;RTN4RL1;ZFP36L2;TRPV4;FLOT1;GLI2;ANK3;KLF7;RNF165;SOX12;CLMN;SPG11;GJC2;SULT1E1;PER2;TMEM204;MICALCL;UNC119;MINK1;WWTR1;ITGA2;SEMA4G;ULK1;GLI3;FHOD3;TPGS1;SMARCA1;BOC;ITGA6;LTBP3;TCFL5;TRAK1;JARID2;NUPR1;PRR9;GPC2;INSR;TST;CCDC85B;CELSR1;GSN;BAIAP2;TANC1;TTN;PLXNB3;SUN1;AHNAK2;TRIOBP;CD109;SEPT6;RTF1;BLOC1S3;MDK;CASP14;BMP6;S100A4;MICALL2;SQSTM1;CABYR;PTK6;FZD7;ETV5;SYNGAP1;FAM213A;DLX3;EPB41L3;SHARPIN;HEXB;KDM4C;SH2D2A;CST3;GDF15;PEX7;BBS2;TXNIP;CTF1;TCF4;COL6A1;NPHP3;PLAG1;IDH2;PODXL;TNFRSF21;IQCB1;CDK5R1;ATRX;REC8;NET1;CA2;EFNB3;MAPK10;SHANK3;ADIRF;HMG20B;AGO4;SLIT3;KRT14;EDA2R;SPRY2;MRC2;MEF2D;IFT140;CTSB;KLK5;FBXW7;CDK5RAP3;LMO2;NOTCH2NL;THRA;APC2;ADARB1;ELF1;NAB2;LRP1;NPHP4;CCDC136;RFX2;DLK2;BRINP1;WNK1;ATXN10;PDE2A;MAF;RET;ZMYND8;PRX;DAB2IP;CASZ1;TEAD2;OLFM2;IFI16;FGFR4;AREG;MYO9A;RPS6KA5;DLG5;BTG1;VDR;MAMSTR;TNRC6C;DPY19L2P2;PLXND1;SIX5;PCSK6;DMTN;TMEM231;PMP22;NRARP;ACVR1B;DLG4;TSSK1B;ALOXE3;NHSL1;MATN2;NBEAL2;WEE1;PTK7;TCF7;SHANK2;RSAD2;ZFP36L1;LMNA;MXRA8;IL11;KAT2B;APOLD1;IRS2;ALOX15B;MTR;S100A6;ZSWIM8;APBB2;PBLD;TNFSF12;STAT6;SOX13;GSTM3;CD9;RANBP9;HDAC11;GJB5;COL13A1;ERBB2;GPR68;PAQR7;AKAP6;TH;RORA;SSH3;PPARG;PRKACA;NPAP1;POLM;SYNE2;ACKR3;UFL1;LAMB2;RIPK3;NFASC;CIT;MAP1A;CCDC3;FOXP2;ECM2;SMURF1;NPNT;TTLL1;CTNNBIP1
16596,GO:0097458,0.00311891380171321,0.997735752520229,126,937,neuron part,CC,MAP6;APOE;ESPN;PTPRS;SYT8;RBM3;SYN1;EPS8L2;EPHB2;BRSK1;TENM4;KCNAB2;VAMP3;STAT1;CAMK2N1;NSG1;RAB40B;NOS1;KCNC4;SPOCK1;ITPR3;CRTC1;NDN;SYTL1;CTSV;NLGN4Y;BLVRB;FLRT3;RGS2;C2CD4C;BLOC1S4;RTN4RL1;TRPV4;NLGN2;ANK3;RIMS3;SPG11;GJC2;PTGS1;ADGRL1;MINK1;ITGA2;SYT15;ULK1;TPGS1;VAMP2;NAIP;NMU;BOC;BSN;LZTS1;TRAK1;INSR;BAIAP2;TANC1;TRIOBP;SEPT6;ENDOG;NRSN2;BLOC1S3;S100A4;MICALL2;SQSTM1;SYNGAP1;EPB41L3;SHARPIN;CST3;HOMER2;BBS2;PSD3;MAP3K12;WRN;SEPT5;DNM1;TNFRSF21;IQCB1;KLHL24;MCTP1;CDK5R1;CA2;MAPK10;SHANK3;CYBA;FBXO2;IFT140;GABBR1;XRN1;ASTN2;GLUL;PRR7;SRR;LRP1;NPHP4;RGS12;BRINP1;MYO3B;ATXN10;PDE2A;RET;ZMYND8;DAB2IP;SYT7;SCN2A;DLG5;DMTN;TPRN;ORAI2;ARFGEF2;LMTK3;DLG4;SHANK2;CLSTN3;MARK4;DMXL2;APBB2;CPT1C;RDH12;SYNGR1;TH;LDLRAP1;UFL1;NFASC;CIT;MAP1A;PTBP2;SMURF1
10769,GO:0044242,0.00316217653545893,0.998483347307182,26,147,cellular lipid catabolic process,BP,AMACR;APOE;CPT2;SRD5A3;CYP26B1;TYSND1;CRAT;MLYCD;PHYH;MGST2;HEXB;PEX7;LPIN3;HADH;ACADS;ACACB;ACOX3;DDHD2;ETFB;IRS2;ECI1;FAAH;SMPDL3B;CPT1C;LONP2;EHHADH
7919,GO:0032502,0.00329581947803443,0.997280683636577,451,3883,developmental process,BP,TNFAIP3;TGFBI;POSTN;TAGLN;SERPINE2;ULK2;GPNMB;SIK1;SLFN5;TP53INP1;MAP6;PTHLH;SREBF1;ACTA2;APOE;GPSM1;INPP5D;APCDD1;GAMT;OAS2;ADAM19;MN1;HSPA2;FBXW4;EGFR;PTPRS;FLNC;FAM20C;PKD2;CAPRIN2;MNT;ASH2L;DIXDC1;ALDH1A3;SRSF5;LRIG3;PLCD3;SLITRK6;SFRP1;OBSL1;KCTD11;KIF26B;PCDH1;EPHB2;GLUD1;PIK3R1;ADAMTS7;BRSK1;TXNRD3;MARVELD1;KDM3A;CXCL14;TSC22D3;EYS;EVC;POU3F1;SULF2;WNT3;DHTKD1;VAV3;UNK;CSPG4;ISG15;HTRA1;TFCP2L1;TENM4;UNC119B;RGMA;KCNAB2;ZFPM1;KITLG;HOXC5;SDK2;CUL7;VAMP3;CITED4;IRF2BPL;PRICKLE2;MC1R;STAT1;IMPACT;MYL9;KRT15;UNC5B;ITGB5;COL10A1;NOS1;PRKACB;HOXA3;ZFP41;SCMH1;KLF13;NFATC4;HMGCL;BTBD2;FERMT1;CYP26B1;GAA;HSF4;MICALL1;LIG1;PLXNB1;SPEG;NDRG1;COL7A1;SPOCK1;NAGLU;MDM2;CRTC1;LZTS2;PLCD1;NDN;IFITM1;PPP2R2C;CSMD3;LTBP4;OBSCN;TNFSF10;MYH11;PARVB;RHOBTB2;NEO1;RAPGEF3;TCF25;NINJ1;FAM210B;CTSV;NLGN4Y;SPATA20;FLRT3;NUDCD3;KCTD15;KIF26A;RGS2;ARPIN;ADGRB2;F2R;PPL;HPS4;PDCD4;BLOC1S4;SPTB;SERPINB5;NYAP1;ZNF160;DNAH1;RTN4RL1;ZFP36L2;CLTCL1;TRPV4;FLOT1;GLI2;NLGN2;ANK3;KLF7;RNF165;SOX12;CLMN;SPG11;GJC2;ZCCHC11;ARHGEF19;SULT1E1;PER2;TMEM204;MICALCL;UNC119;C5;WIPF1;PSKH1;ADGRL1;MINK1;PHF2;AMIGO2;THBS3;TNFRSF14;WWTR1;LHFPL2;ITGA2;SEMA4G;ULK1;GLI3;FHOD3;TPGS1;IRX4;SMARCA1;NAIP;LTBP1;NEK8;MAP2K5;GAS8;BOC;ITGA6;LTBP3;BSN;IGFBP4;TCFL5;TRAK1;JARID2;NUPR1;PRR9;GPC2;INSR;TST;CCDC85B;CELSR1;GSN;BAIAP2;TANC1;TTN;PLXNB3;SUN1;AHNAK2;TRIOBP;CD109;PMS2P3;SEPT6;RAB11FIP4;ENDOG;PGAP1;RTF1;BLOC1S3;MDK;CASP14;RICTOR;BMP6;B4GALT2;ETNK2;S100A4;MICALL2;VEGFB;SQSTM1;CABYR;PTK6;FZD7;ETV5;LOXL1;SYNGAP1;FAM213A;DLX3;EPB41L3;SHARPIN;HEXB;KDM4C;HYAL1;SH2D2A;CST3;MMRN2;GDF15;PEX7;BBS2;TXNIP;CTF1;TCF4;COL6A1;NPHP3;PLAG1;IDH2;WRN;PODXL;MALL;TNFRSF21;IQCB1;CDK5R1;ATRX;REC8;NET1;CA2;EFNB3;MAPK10;SHANK3;HFE;ADIRF;HMG20B;NID1;AGO4;ERCC6;RRM2B;SLIT3;KRT14;EDA2R;SPRY2;MRC2;MEF2D;IFT140;MLXIPL;CTSB;KLK5;FBXW7;CDK5RAP3;ATXN1;LMO2;NOTCH2NL;THRA;APC2;ARAP1;ASTN2;ADARB1;RAI1;FMNL2;ELF1;SLC2A1;ACACB;TNS2;DBP;NAB2;SRR;LRP1;LRRN3;NPHP4;CCDC136;ACP5;RFX2;MTURN;DLK2;BRINP1;DGCR2;MYO3B;SALL2;WNK1;ATXN10;JPH2;PDE2A;SDHA;MAF;RET;ZMYND8;PRX;DAB2IP;CASZ1;TEAD2;MYSM1;DDHD2;SHROOM2;FBXO4;RNF213;OLFM2;RAPGEFL1;TSHZ2;IFI16;FGFR4;BBS5;SCN2A;TEF;AREG;KLHL3;MYO9A;RPS6KA5;DLG5;BTG1;BST2;VDR;MAMSTR;TNRC6C;DPY19L2P2;PLXND1;ZMYM3;SIX5;PCSK6;DMTN;STAT2;WWC3;TMEM231;TFDP2;SNX1;PMP22;NRARP;ACVR1B;SHROOM4;TACC1;KREMEN1;DLG4;TSSK1B;ALOXE3;PALB2;NHSL1;MATN2;NBEAL2;DUOX1;WEE1;GTF2IRD2;PTK7;TCF7;SHANK2;RSAD2;TNFRSF25;ZFP36L1;LMNA;MXRA8;CLSTN3;IL11;KAT2B;MARK4;APOLD1;IRS2;ANO1;ALOX15B;GPR21;MTR;S100A6;TRERF1;ZSWIM8;APBB2;PBLD;RAPGEF5;TNFSF12;STAT6;SOX13;PHC2;TUB;GSTM3;SRPX2;CD9;RANBP9;HDAC11;PTPN3;GJB5;COL13A1;ERBB2;GPR68;PAQR7;AKAP6;TH;RORA;SSH3;PPARG;PRKACA;NPAP1;POLM;FMNL3;GCNT4;SYNE2;ACKR3;SERPING1;UFL1;LAMB2;RIPK3;NFASC;CIT;MAP1A;CCDC3;FOXP2;PTBP2;HIVEP1;ECM2;SMURF1;NPNT;TTLL1;CTNNBIP1;GCLC;ECM1
7857,GO:0032426,0.00335109524011644,0.999770341265765,4,7,stereocilium tip,CC,ESPN;EPS8L2;HOMER2;MYO3B
9653,GO:0038023,0.0033587168235571,0.99790208157707,58,384,signaling receptor activity,MF,EGFR;CXCR1;SFRP1;EPHB2;RGMA;MC1R;OR2A4;CRY2;UNC5B;CRY1;BCAM;PLXNB1;FCGRT;LTBP4;GPRC5C;IL20RB;ADGRB2;F2R;ADGRF4;TRPV4;ADORA2B;ADGRL1;TNFRSF14;ITGA2;LTBP1;INSR;CELSR1;PLXNB3;LPAR5;FZD7;TNFRSF21;EFNB3;EDA2R;MRC2;GABBR1;GPR87;PAQR6;THRA;LTB4R2;RET;FGFR4;IL20RA;VDR;VIPR1;PLXND1;LPAR6;ACVR1B;PTK7;TNFRSF25;GPR21;TAS1R3;GPR132;ERBB2;GPR68;PAQR7;RORA;PPARG;ACKR3
13595,GO:0060089,0.0033587168235571,0.99790208157707,58,384,molecular transducer activity,MF,EGFR;CXCR1;SFRP1;EPHB2;RGMA;MC1R;OR2A4;CRY2;UNC5B;CRY1;BCAM;PLXNB1;FCGRT;LTBP4;GPRC5C;IL20RB;ADGRB2;F2R;ADGRF4;TRPV4;ADORA2B;ADGRL1;TNFRSF14;ITGA2;LTBP1;INSR;CELSR1;PLXNB3;LPAR5;FZD7;TNFRSF21;EFNB3;EDA2R;MRC2;GABBR1;GPR87;PAQR6;THRA;LTB4R2;RET;FGFR4;IL20RA;VDR;VIPR1;PLXND1;LPAR6;ACVR1B;PTK7;TNFRSF25;GPR21;TAS1R3;GPR132;ERBB2;GPR68;PAQR7;RORA;PPARG;ACKR3
2290,GO:0005249,0.00337288840670929,0.999272093348073,8,25,voltage-gated potassium channel activity,MF,PKD2;KCNAB2;KCNJ15;KCNC4;KCNJ5;KCNMA1;KCNG1;KCNS3
10897,GO:0044456,0.00344700297336427,0.997801449713291,63,419,synapse part,CC,PTPRS;SYT8;SYN1;EPHB2;BRSK1;KCNAB2;CAMK2N1;NSG1;RAB40B;NOS1;KCNC4;SPOCK1;SYTL1;NLGN4Y;BLVRB;FLRT3;F2R;C2CD4C;NLGN2;ANK3;RIMS3;ADGRL1;MINK1;ITGA2;SYT15;VAMP2;NMU;BSN;LZTS1;BAIAP2;TANC1;SEPT6;SYNGAP1;EPB41L3;SHARPIN;HOMER2;PSD3;SEPT5;DNM1;MCTP1;CDK5R1;SHANK3;FBXO2;GABBR1;KCNMA1;GLUL;PRR7;PDE2A;ZMYND8;OLFM2;SYT7;DLG5;DMTN;ARFGEF2;DLG4;SHANK2;CLSTN3;DMXL2;SRPX2;COL13A1;SYNGR1;TH;LAMB2
2522,GO:0005777,0.00351706565826249,0.998489693006795,20,105,peroxisome,CC,AMACR;HMGCL;TYSND1;CRAT;MLYCD;PHYH;PEX10;MAP2K2;PEX7;PEX11B;IDH2;ACOX3;PIK3C3;SYT7;ACSL1;DHRS4;PEX1;PRDX5;LONP2;EHHADH
10066,GO:0042579,0.00351706565826249,0.998489693006795,20,105,microbody,CC,AMACR;HMGCL;TYSND1;CRAT;MLYCD;PHYH;PEX10;MAP2K2;PEX7;PEX11B;IDH2;ACOX3;PIK3C3;SYT7;ACSL1;DHRS4;PEX1;PRDX5;LONP2;EHHADH
3563,GO:0007605,0.0036178436233253,0.998676197394855,15,68,sensory perception of sound,BP,ESPN;SLITRK6;EPS8L2;TRIOBP;PGAP1;ALDH7A1;HEXB;HOMER2;DNM1;SPRY2;MYO3B;TPRN;TUB;TH;EML2
684,GO:0001895,0.00365150437795561,0.999091472122865,9,32,retina homeostasis,BP,BBS2;NPHP3;IQCB1;ERCC6;NPHP4;BBS1;BBS10;TUB;RDH12
2673,GO:0006026,0.00369894085224458,0.998911191744306,11,42,aminoglycan catabolic process,BP,CSPG4;SDC3;NAGLU;IDUA;HGSNAT;HEXA;GPC2;HEXB;HYAL1;SGSH;GLB1
3535,GO:0007528,0.00370068688401854,0.999094802895029,9,29,neuromuscular junction development,BP,F2R;ANK3;ETV5;SHANK3;CACNB3;SHANK2;CACNB1;ERBB2;LAMB2
11855,GO:0046879,0.00373953724002671,0.99808009616597,30,172,hormone secretion,BP,SREBF1;EGFR;SFRP1;GLUD1;CRY1;ITPR3;LTBP4;RAPGEF3;TRPV4;NLGN2;PER2;NMU;TM7SF3;BMP6;PLA2G6;HFE;HADH;RAB11FIP3;PFKFB2;SLC2A1;GLUL;SYT7;RASL10B;IL11;IRS2;ANO1;SCG5;PHPT1;GPR68;KCNS3
6625,GO:0022898,0.00375929415830893,0.998238243562026,24,127,regulation of transmembrane transporter activity,BP,HSPA2;PKD2;EPHB2;NOS1;NLGN2;ANK3;MINK1;GSTM2;VAMP2;SCN4B;PLA2G6;KLHL24;ANO9;SHANK3;KCNG1;WNK1;JPH2;CACNB3;DLG4;SHANK2;CACNB1;PTPN3;AKAP6;PRKACA
6757,GO:0030198,0.00381852975028209,0.99790990720061,36,208,extracellular matrix organization,BP,TGFBI;POSTN;ITGB6;ADAM19;SULF2;SMOC2;HTRA1;ITGB5;COL10A1;FERMT1;COL7A1;MYH11;TNXB;CTSV;SERPINB5;FLOT1;THBS3;ITGA2;ITGA6;MMP1;LOXL1;CST3;CAPNS2;THSD4;COL6A1;NPHP3;NID1;KLK5;LRP1;FGFR4;EFEMP2;APBB2;COL13A1;LAMB2;ECM2;NPNT
16167,GO:0090209,0.00384203194052192,0.999894872359179,3,4,negative regulation of triglyceride metabolic process,BP,SIK1;APOE;FBXW7
5621,GO:0016684,0.00386031700992619,0.999110816569061,8,31,oxidoreductase activity, acting on peroxide as acceptor,MF,GPX3;PTGS1;GSTM2;SESN3;MGST2;SESN1;DUOX1;PRDX5
13775,GO:0060384,0.00399818573867379,0.999378641295681,6,15,innervation,BP,SERPINE2;SLITRK6;SULF2;RNF165;ADARB1;RET
15282,GO:0071494,0.00402503389997035,0.999887945571257,3,4,cellular response to UV-C,BP,IMPACT;MDM2;POLH
3380,GO:0007158,0.00429091879568259,0.999683907937381,4,7,neuron cell-cell adhesion,BP,NLGN4Y;NLGN2;CDK5R1;RET
17471,GO:1900449,0.00430612742609143,0.999164402907476,7,20,regulation of glutamate receptor signaling pathway,BP,EPHB2;NLGN2;MINK1;KLHL24;SHANK3;DLG4;SHANK2
9190,GO:0035584,0.00431372483218908,0.999620583169759,4,9,calcium-mediated signaling using intracellular calcium source,BP,ADGRL1;HOMER2;DMTN;PRKACA
12098,GO:0048167,0.00434527940180388,0.998152414555438,19,93,regulation of synaptic plasticity,BP,SERPINE2;APOE;EPHB2;NSG1;NFATC4;ITPR3;CRTC1;SLC24A1;RIMS3;VAMP2;BAIAP2;SQSTM1;SYNGAP1;MCTP1;SHANK3;SYT7;DLG4;SHANK2;SYNGR1
8691,GO:0034340,0.00438371960321457,0.998349722788943,15,73,response to type I interferon,BP,IFI6;OAS2;ISG15;STAT1;IFITM1;HLA-B;OAS1;IRF9;IFI27;MX2;HLA-A;BST2;STAT2;RSAD2;IP6K2
2127,GO:0004930,0.00441833181344443,0.997891920505892,24,136,G-protein coupled receptor activity,MF,CXCR1;SFRP1;MC1R;OR2A4;GPRC5C;ADGRB2;F2R;ADGRF4;ADORA2B;ADGRL1;CELSR1;LPAR5;FZD7;GABBR1;GPR87;LTB4R2;VIPR1;LPAR6;GPR21;TAS1R3;GPR132;GPR68;PPARG;ACKR3
715,GO:0001941,0.0044317654315996,0.999123916303654,7,21,postsynaptic membrane organization,BP,APOE;NLGN4Y;NLGN2;ETV5;SHANK3;ZMYND8;DLG4
7251,GO:0031226,0.0045831734137732,0.996724020629597,105,770,intrinsic component of plasma membrane,CC,ITGB6;GPNMB;APCDD1;EGFR;PTPRS;PKD2;SLITRK6;PCDH1;EPHB2;CSPG4;TENM4;KCNAB2;REEP2;KCNJ15;MC1R;SLC16A5;ITGB5;GJD3;BCAM;PLXNB1;KCNC4;ITPR3;GPRC5C;TNFSF10;NEO1;NLGN4Y;FLRT3;RASA4;F2R;SPTB;SLC24A1;RTN4RL1;TRPV4;NLGN2;ADORA2B;SLC13A5;TSPAN18;C5;TNFRSF14;ITGA2;VAMP2;BOC;ITGA6;KCNJ5;GPC2;INSR;CELSR1;ST3GAL5;SCNN1A;PLXNB3;SCN4B;PILRB;SLC2A3;TCIRG1;SLC12A7;SYNGAP1;CLCA2;PODXL;TNFRSF21;EFNB3;SHANK3;HFE;CYBA;EDA2R;MRC2;GABBR1;KCNMA1;GPR87;SLC2A1;SLC38A4;LRP1;KCNG1;PMEL;LTB4R2;RET;DAB2IP;OLFM2;FGFR4;SCN2A;BST2;VIPR1;PLXND1;LPAR6;ACVR1B;CADM4;DLG4;ESYT2;SLC22A15;SLC35G2;PTK7;SHANK2;TNFRSF25;TNFSF12;TAS1R3;SLC43A1;CPT1C;TRAF5;CD9;COL13A1;ERBB2;GPR68;KCNS3;CALHM2;NPNT;TM4SF1
5383,GO:0016209,0.00459777700523873,0.998566919131651,11,52,antioxidant activity,MF,TP53INP1;APOE;GPX3;TXNRD3;PTGS1;GSTM2;MGST2;FAM213A;SESN1;DUOX1;PRDX5
8363,GO:0033270,0.00463127162605715,0.999651084259347,4,7,paranode region of axon,CC,GJC2;EPB41L3;SCN2A;NFASC
16423,GO:0097106,0.00469733536895707,0.99964462547783,4,7,postsynaptic density organization,BP,NLGN2;SHANK3;ZMYND8;SHANK2
16979,GO:0099084,0.00469733536895707,0.99964462547783,4,7,postsynaptic specialization organization,BP,NLGN2;SHANK3;ZMYND8;SHANK2
5276,GO:0015929,0.00476003501205625,0.999392286043224,5,12,hexosaminidase activity,MF,NAGLU;HEXA;HEXB;HYAL1;HEXDC
3507,GO:0007416,0.00490222652685587,0.99801657440634,17,77,synapse assembly,BP,SLITRK6;EPHB2;SDK2;NLGN4Y;FLRT3;ADGRB2;NLGN2;ADGRL1;AMIGO2;BSN;SHANK3;LRRN3;DLG5;PLXND1;SHANK2;CLSTN3;SRPX2
4347,GO:0009914,0.00492720340919791,0.99741619965442,30,175,hormone transport,BP,SREBF1;EGFR;SFRP1;GLUD1;CRY1;ITPR3;LTBP4;RAPGEF3;TRPV4;NLGN2;PER2;NMU;TM7SF3;BMP6;PLA2G6;HFE;HADH;RAB11FIP3;PFKFB2;SLC2A1;GLUL;SYT7;RASL10B;IL11;IRS2;ANO1;SCG5;PHPT1;GPR68;KCNS3
11863,GO:0046887,0.00516748611699599,0.998023305427296,15,71,positive regulation of hormone secretion,BP,EGFR;GLUD1;NLGN2;NMU;TM7SF3;BMP6;PLA2G6;HFE;PFKFB2;GLUL;RASL10B;IRS2;ANO1;PHPT1;GPR68
13720,GO:0060314,0.00517553741433894,0.999113704421272,6,17,regulation of ryanodine-sensitive calcium-release channel activity,BP,PKD2;NOS1;GSTM2;JPH2;AKAP6;PRKACA
19480,GO:1990351,0.00518402693981686,0.997545038022061,23,123,transporter complex,CC,HSPA2;KCNAB2;NOS1;KCNC4;VAMP2;KCNJ5;SCNN1A;SCN4B;SHANK3;KCNMA1;KCNG1;OLFM2;SCN2A;CACNB3;DLG4;SHANK2;ANO1;CPT1C;CACNB1;ABCA2;AKAP6;PRKACA;KCNS3
3131,GO:0006720,0.0052442845596977,0.997987910032696,15,72,isoprenoid metabolic process,BP,APOE;EGFR;ALDH1A3;MVD;SRD5A3;SDC3;CYP26B1;UGT1A3;PHYH;GPC2;LRP1;RETSAT;DHRS4;RDH12;TH
12406,GO:0048871,0.00531326622725797,0.997102846552495,33,198,multicellular organismal homeostasis,BP,TNFAIP3;INPP5D;EGFR;PRKACB;CYP26B1;CRTC1;NDN;IL20RB;F2R;TRPV4;NMU;SCNN1A;SLC27A1;BMP6;HOMER2;BBS2;NPHP3;IQCB1;CA2;HFE;ERCC6;ACACB;TNS2;NPHP4;ACP5;BBS1;IL20RA;BBS10;ALOXE3;PBLD;TUB;RDH12;PRKACA
7604,GO:0031998,0.00533225557930544,0.999327751263936,5,11,regulation of fatty acid beta-oxidation,BP,TYSND1;MLYCD;ACACB;IRS2;LONP2
17236,GO:0120039,0.00535426816545856,0.996475834722268,66,441,plasma membrane bounded cell projection morphogenesis,BP,POSTN;ULK2;MAP6;APOE;EGFR;PTPRS;CAPRIN2;SLITRK6;OBSL1;EPHB2;PIK3R1;BRSK1;WNT3;CUL7;IMPACT;UNC5B;NFATC4;PLXNB1;NDN;NEO1;FLRT3;ARPIN;SPTB;NYAP1;FLOT1;GLI2;ANK3;KLF7;RNF165;SPG11;MINK1;SEMA4G;ULK1;GLI3;BOC;TRAK1;BAIAP2;PLXNB3;SYNGAP1;EPB41L3;CDK5R1;EFNB3;SHANK3;SLIT3;ADARB1;RET;DAB2IP;RPS6KA5;PLXND1;SNX1;DLG4;MATN2;WEE1;SHANK2;IRS2;S100A6;ZSWIM8;APBB2;RANBP9;ERBB2;SSH3;LAMB2;NFASC;MAP1A;ECM2;SMURF1
7841,GO:0032409,0.0055863832884206,0.997241893467813,25,138,regulation of transporter activity,BP,HSPA2;PKD2;EPHB2;NOS1;NLGN2;ANK3;MINK1;GSTM2;VAMP2;SCN4B;PLA2G6;KLHL24;ANO9;SHANK3;KCNG1;WNK1;JPH2;CACNB3;DLG4;SHANK2;CACNB1;PTPN3;AKAP6;PPARG;PRKACA
3694,GO:0008201,0.00561001781343093,0.997752459666014,16,78,heparin binding,MF,POSTN;SERPINE2;GPNMB;APOE;PTPRS;SFRP1;SMOC2;TNXB;RTN4RL1;THBS3;MDK;VEGFB;FGFR4;PCSK6;COL13A1;ECM2
12396,GO:0048858,0.0056107792296746,0.996298452945873,66,442,cell projection morphogenesis,BP,POSTN;ULK2;MAP6;APOE;EGFR;PTPRS;CAPRIN2;SLITRK6;OBSL1;EPHB2;PIK3R1;BRSK1;WNT3;CUL7;IMPACT;UNC5B;NFATC4;PLXNB1;NDN;NEO1;FLRT3;ARPIN;SPTB;NYAP1;FLOT1;GLI2;ANK3;KLF7;RNF165;SPG11;MINK1;SEMA4G;ULK1;GLI3;BOC;TRAK1;BAIAP2;PLXNB3;SYNGAP1;EPB41L3;CDK5R1;EFNB3;SHANK3;SLIT3;ADARB1;RET;DAB2IP;RPS6KA5;PLXND1;SNX1;DLG4;MATN2;WEE1;SHANK2;IRS2;S100A6;ZSWIM8;APBB2;RANBP9;ERBB2;SSH3;LAMB2;NFASC;MAP1A;ECM2;SMURF1
2108,GO:0004888,0.00571682019580991,0.996477813943873,49,323,transmembrane signaling receptor activity,MF,EGFR;CXCR1;SFRP1;EPHB2;MC1R;OR2A4;UNC5B;BCAM;PLXNB1;FCGRT;LTBP4;GPRC5C;IL20RB;ADGRB2;F2R;ADGRF4;TRPV4;ADORA2B;ADGRL1;TNFRSF14;ITGA2;LTBP1;INSR;CELSR1;PLXNB3;LPAR5;FZD7;TNFRSF21;EFNB3;EDA2R;MRC2;GABBR1;GPR87;LTB4R2;RET;FGFR4;IL20RA;VIPR1;PLXND1;LPAR6;ACVR1B;TNFRSF25;GPR21;TAS1R3;GPR132;ERBB2;GPR68;PPARG;ACKR3
3517,GO:0007442,0.00574120946494793,0.999817440116256,3,4,hindgut morphogenesis,BP,GLI2;GLI3;TCF7
12050,GO:0048015,0.00583370522021518,0.997378389902303,20,102,phosphatidylinositol-mediated signaling,BP,SERPINE2;EGFR;PIK3R1;PI4KAP2;UNC5B;PIK3C2G;PLXNB1;PIK3IP1;F2R;NYAP1;PITPNM2;GSN;PI4KAP1;DAB2IP;PIK3C3;PIK3R2;RGL2;ZFP36L1;IRS2;ERBB2
6028,GO:0019098,0.00591640456044816,0.998957230461579,6,17,reproductive behavior,BP,SERPINE2;HEXB;CREBRF;THRA;BRINP1;TH
10411,GO:0043269,0.00594117797097238,0.996411991413894,45,295,regulation of ion transport,BP,SERPINE2;SIK1;APOE;HSPA2;PKD2;EPHB2;KCNAB2;KCNJ15;CRY2;NOS1;KCNC4;F2R;NLGN2;ANK3;GJC2;PER2;SNTA1;MINK1;GSTM2;VAMP2;KCNJ5;SCN4B;PLA2G6;HOMER2;KLHL24;ANO9;CA2;SHANK3;HFE;CYBA;KCNMA1;KCNG1;WNK1;JPH2;SYT7;SCN2A;CACNB3;DLG4;SHANK2;IRS2;CACNB1;PTPN3;AKAP6;PRKACA;KCNS3
11601,GO:0046320,0.00599683062139785,0.998959803386439,6,16,regulation of fatty acid oxidation,BP,TYSND1;MLYCD;ACACB;IRS2;PPARG;LONP2
6689,GO:0030072,0.00616667925810627,0.996926102630406,25,141,peptide hormone secretion,BP,SREBF1;EGFR;SFRP1;GLUD1;ITPR3;LTBP4;RAPGEF3;TRPV4;NLGN2;PER2;NMU;TM7SF3;PLA2G6;HFE;HADH;PFKFB2;SLC2A1;GLUL;SYT7;RASL10B;IRS2;ANO1;PHPT1;GPR68;KCNS3
7756,GO:0032280,0.00619070437892083,0.999797458556801,3,4,symmetric synapse,CC,NLGN4Y;NLGN2;ARFGEF2
10186,GO:0042805,0.00640021157595298,0.998791990605036,7,15,actinin binding,MF,PKD2;OBSL1;TTN;MICALL2;SYNPO2;ALMS1;PPARG
12372,GO:0048812,0.00647611797079945,0.995725374274556,64,429,neuron projection morphogenesis,BP,POSTN;ULK2;MAP6;APOE;EGFR;PTPRS;CAPRIN2;SLITRK6;OBSL1;EPHB2;PIK3R1;BRSK1;WNT3;CUL7;IMPACT;UNC5B;NFATC4;PLXNB1;NDN;NEO1;FLRT3;SPTB;NYAP1;FLOT1;GLI2;ANK3;KLF7;RNF165;SPG11;MINK1;SEMA4G;ULK1;GLI3;BOC;TRAK1;BAIAP2;PLXNB3;SYNGAP1;EPB41L3;CDK5R1;EFNB3;SHANK3;SLIT3;ADARB1;RET;DAB2IP;RPS6KA5;PLXND1;DLG4;MATN2;WEE1;SHANK2;IRS2;S100A6;ZSWIM8;APBB2;RANBP9;ERBB2;SSH3;LAMB2;NFASC;MAP1A;ECM2;SMURF1
16424,GO:0097107,0.00649223383985675,0.99978373014528,3,4,postsynaptic density assembly,BP,NLGN2;SHANK3;SHANK2
16799,GO:0098698,0.00649223383985675,0.99978373014528,3,4,postsynaptic specialization assembly,BP,NLGN2;SHANK3;SHANK2
3560,GO:0007601,0.00661837403291897,0.997216690197749,17,83,visual perception,BP,TGFBI;SLITRK6;EYS;HSF4;SLC24A1;UNC119;BBS2;MYO3B;BBS1;OLFM2;BBS5;MYO9A;BBS10;RDH12;TH;LAMB2;EML2
12697,GO:0050953,0.00661837403291897,0.997216690197749,17,83,sensory perception of light stimulus,BP,TGFBI;SLITRK6;EYS;HSF4;SLC24A1;UNC119;BBS2;MYO3B;BBS1;OLFM2;BBS5;MYO9A;BBS10;RDH12;TH;LAMB2;EML2
6885,GO:0030424,0.00664979923056517,0.995769041965904,54,358,axon,CC,MAP6;PTPRS;SYN1;EPHB2;KCNAB2;STAT1;KCNC4;SPOCK1;BLVRB;FLRT3;BLOC1S4;TRPV4;ANK3;SPG11;GJC2;ADGRL1;MINK1;ITGA2;ULK1;TPGS1;NMU;BOC;BSN;TRAK1;INSR;TANC1;SEPT6;BLOC1S3;EPB41L3;CST3;MAP3K12;SEPT5;DNM1;TNFRSF21;KLHL24;CDK5R1;CA2;GLUL;RET;DAB2IP;SYT7;SCN2A;ORAI2;LMTK3;DLG4;SHANK2;APBB2;CPT1C;SYNGR1;TH;LDLRAP1;NFASC;PTBP2;SMURF1
5577,GO:0016597,0.00666918919043273,0.998154134270765,9,34,amino acid binding,MF,GLUD1;NOS1;THNSL2;SESN3;SESN1;GLUL;SRR;TH;GCLC
12322,GO:0048699,0.0067552458211291,0.994965337126458,126,945,generation of neurons,BP,POSTN;SERPINE2;ULK2;MAP6;APOE;EGFR;PTPRS;CAPRIN2;DIXDC1;SLITRK6;SFRP1;OBSL1;KCTD11;EPHB2;PIK3R1;BRSK1;WNT3;UNK;TENM4;UNC119B;RGMA;SDK2;CUL7;IMPACT;UNC5B;NOS1;NFATC4;MICALL1;PLXNB1;SPOCK1;NAGLU;MDM2;CRTC1;NDN;CSMD3;NEO1;FLRT3;BLOC1S4;SPTB;NYAP1;RTN4RL1;TRPV4;FLOT1;GLI2;ANK3;KLF7;RNF165;CLMN;SPG11;GJC2;PER2;UNC119;MINK1;SEMA4G;ULK1;GLI3;SMARCA1;BOC;TRAK1;GPC2;CELSR1;BAIAP2;PLXNB3;TRIOBP;BLOC1S3;BMP6;MICALL2;PTK6;FZD7;ETV5;SYNGAP1;EPB41L3;KDM4C;PEX7;CTF1;TCF4;PLAG1;IDH2;TNFRSF21;CDK5R1;EFNB3;MAPK10;SHANK3;HMG20B;SLIT3;IFT140;CDK5RAP3;ADARB1;LRP1;NPHP4;BRINP1;WNK1;ATXN10;RET;ZMYND8;DAB2IP;CASZ1;AREG;RPS6KA5;DLG5;PLXND1;PMP22;DLG4;NHSL1;MATN2;WEE1;PTK7;SHANK2;IRS2;MTR;S100A6;ZSWIM8;APBB2;RANBP9;ERBB2;TH;RORA;SSH3;PPARG;UFL1;LAMB2;NFASC;CIT;MAP1A;ECM2;SMURF1
11142,GO:0045211,0.00681977741978803,0.996757092136566,22,114,postsynaptic membrane,CC,PTPRS;CAMK2N1;NSG1;NLGN4Y;F2R;NLGN2;ANK3;MINK1;LZTS1;TANC1;HOMER2;PSD3;DNM1;SHANK3;GABBR1;KCNMA1;PRR7;DLG5;DLG4;SHANK2;CLSTN3;COL13A1
6664,GO:0030030,0.00686322669956242,0.994822465531275,137,1046,cell projection organization,BP,POSTN;ULK2;MAP6;APOE;EGFR;ESPN;PTPRS;CAPRIN2;SLITRK6;SFRP1;OBSL1;EPS8L2;EPHB2;PIK3R1;EVI5L;BRSK1;WNT3;VAV3;UNC119B;RGMA;CUL7;IMPACT;UNC5B;NFATC4;CNTRL;MICALL1;PLXNB1;SPOCK1;MDM2;CRTC1;NDN;CSMD3;PARVB;NEO1;FLRT3;NUDCD3;ARPIN;BLOC1S4;SPTB;NYAP1;DNAH1;RTN4RL1;TRPV4;FLOT1;GLI2;ANK3;KLF7;RNF165;CLMN;SPG11;UNC119;MINK1;NINL;WWTR1;ARHGEF4;ITGA2;SEMA4G;FAM110C;ULK1;GLI3;TPGS1;GAS8;BOC;ITGA6;TRAK1;INSR;GSN;BAIAP2;TANC1;PLXNB3;CEP126;TRIOBP;SEPT6;BLOC1S3;MICALL2;CEP192;PTK6;SYNGAP1;EPB41L3;BBS2;NPHP3;PODXL;SEPT5;IQCB1;CDK5R1;EFNB3;SHANK3;SLIT3;SPRY2;IFT140;DZIP1L;ARAP1;ADARB1;LRP1;NPHP4;RFX2;BBS1;ATXN10;RET;ZMYND8;DAB2IP;BBS5;AREG;RPS6KA5;DLG5;PLXND1;BBS10;TMEM80;DMTN;ALMS1;TMEM231;SNX1;PMP22;DLG4;CCDC113;MATN2;WEE1;PTK7;SHANK2;MARK4;IRS2;CEP250;MTR;S100A6;ZSWIM8;APBB2;RANBP9;ERBB2;SSH3;PRKACA;SYNE2;LAMB2;NFASC;MAP1A;ECM2;SMURF1;TTLL1
3387,GO:0007165,0.00689295531413827,0.994245433380782,421,3660,signal transduction,BP,TNFAIP3;POSTN;ITGB6;SERPINE2;ULK2;GPNMB;SIK1;EPM2A;MUC19;TP53INP1;IFI6;PTHLH;SREBF1;APOE;INPP5D;APCDD1;OAS2;PSD4;DDX60;FBXW4;EGFR;GIGYF1;PTPRS;FAM20C;PKD2;CAPRIN2;MNT;CXCR1;DIXDC1;TRIM22;PLCD3;SFRP1;KCTD11;EPS8L2;EPHB2;RALGDS;MAP3K14;DGKQ;PIK3R1;BRSK1;RBCK1;KDM3A;CXCL14;DOCK9;EVC;SULF2;WNT3;CAMKK1;VAV3;SMOC2;CSPG4;ISG15;MVB12B;HTRA1;TENM4;RGMA;PI4KAP2;KITLG;CUL7;PRICKLE2;MC1R;ASAP3;OR2A4;STAT1;CAMK2N1;CRY2;NSG1;UNC5B;ITGB5;RAB43;RAB40B;NOS1;PRKACB;CRY1;MAML3;BCAM;PLEKHG5;NFATC4;IQSEC2;FERMT1;CYP26B1;THNSL2;PIK3C2G;PLXNB1;PLEKHG3;NDRG1;SPOCK1;ITPR3;MDM2;LZTS2;PLCD1;NDN;IFITM1;FCGRT;CHN2;LTBP4;PIK3IP1;OBSCN;GPRC5C;HLA-B;TNFSF10;PRODH;RHOBTB2;NEO1;RAPGEF3;PCBP4;OAS1;FLRT3;RASA4;KIF26A;RGL4;RGS2;ACAP3;IL20RB;ADGRB2;F2R;PDCD4;SPTB;NYAP1;RTN4RL1;ZFP36L2;ADGRF4;CLTCL1;TRPV4;FLOT1;GLI2;AGAP4;TOM1L2;RHPN1;NLGN2;ADORA2B;ANK3;RNF165;ADAMTS13;PLCH2;RALGAPA1;MAPK8IP3;PIDD1;ARHGEF19;RHBDF1;TSPAN18;RASGEF1A;TMEM204;PITPNM2;CLCN6;UNC119;FRS3;C5;WIPF1;PSKH1;ADGRL1;MINK1;GSTM2;TNFRSF14;WWTR1;ASAP2;ARHGEF4;ITGA2;SEMA4G;FAM110C;ULK1;GLI3;SPPL2B;THRAP3;AKAP7;LRSAM1;NAIP;LTBP1;NMU;NEK8;MAP2K5;BOC;ITGA6;SRGAP3;BSN;SESN3;IGFBP4;MMP1;NUPR1;GPC2;NISCH;INSR;CELSR1;GSN;HEBP1;CHD3;CDK14;BAIAP2;TTN;CBLC;DDT;PLXNB3;LPAR5;RIN1;CD109;RMI2;ARHGEF1;DOCK8;DHX58;PILRB;SLC27A1;RTF1;MDK;CASP14;IRF9;RICTOR;BMP6;NLRX1;TCIRG1;S100A4;MAP2K2;PDK1;VEGFB;SQSTM1;PTK6;FZD7;SYNGAP1;NXPH4;FAM13A;TMEM117;SHARPIN;ARHGAP33;SH2D2A;ARRDC1;PLA2G6;HOMER2;MMRN2;GDF15;BBS2;TXNIP;CTF1;ATP6V0A2;PEX11B;NPHP3;PSD3;MAP3K12;WRN;IFI27;DNM1;TNFRSF21;KLHL24;MCTP1;CDK5R1;ATRX;ARHGAP27;AGAP6;NET1;CA2;EFNB3;PI4KAP1;SESN1;MAPK10;SHANK3;HFE;CYBA;TRIM38;DTX3;AGO4;ERCC6;RRM2B;SLIT3;SHC2;EDA2R;SPRY2;MRC2;IFT140;GABBR1;CREBRF;AGAP7P;MLXIPL;CTSB;KLK5;FBXW7;GPR87;ING4;NUDT6;CDK5RAP3;NOTCH2NL;PAK6;PAQR6;THRA;APC2;ARAP1;ELF1;MX2;RPH3AL;NLRP1;FRAT1;ERMAP;GPR155;TNS2;GNG2;LRP1;HLA-A;NPHP4;RGS12;C12ORF66;DLK2;MAP3K6;APPL2;SALL2;WNK1;JPH2;PDE2A;LTB4R2;RET;ZMYND8;DAB2IP;RWDD3;CALCOCO1;TEAD2;RNF213;RAPGEFL1;PIK3C3;IFI16;FGFR4;IL20RA;PIK3R2;SCN2A;AREG;MYO9A;RPS6KA5;DLG5;BST2;VDR;RGL2;ARHGEF17;CACNB3;TNRC6C;VIPR1;EFS;PLXND1;PCSK6;LPAR6;PPP1R2;DMTN;STAT2;ARFGEF2;RASL10B;WWC3;TMEM231;TFDP2;UCN2;NRARP;ACVR1B;KREMEN1;DLG4;TSSK1B;IQSEC1;ALOXE3;ENDOU;IGFBP6;DUOX1;PTK7;TCF7;SHANK2;RSAD2;TNFRSF25;ZFP36L1;LMNA;GLMP;ACSL1;IL11;KAT2B;IRS2;IMPA2;ANO1;CAPS;ERN1;IVNS1ABP;ALOX15B;RAD50;GPR21;TKFC;ZMAT3;S100A6;SCG5;APBB2;ARHGEF9;PBLD;RAPGEF5;TNFSF12;TAS1R3;STAT6;PCSK1N;PHPT1;GPR132;SMPDL3B;KIF7;TRAF5;CD9;RANBP9;PTPN3;ERBB2;PLCB3;GPR68;PAQR7;ARHGAP23;AKAP6;MPP7;RORA;PPARG;PRKACA;DOCK6;LDLRAP1;CXXC5;ACKR3;DOCK3;UFL1;IP6K2;RIPK3;AIP;CIT;CCDC3;HIVEP1;SMURF1;NPNT;CTNNBIP1;SERINC3;GCLC;ECM1
18680,GO:1904062,0.00696887219312344,0.996383752225256,27,157,regulation of cation transmembrane transport,BP,HSPA2;PKD2;EPHB2;KCNAB2;NOS1;F2R;NLGN2;ANK3;GJC2;SNTA1;MINK1;GSTM2;VAMP2;SCN4B;PLA2G6;KLHL24;SHANK3;CYBA;KCNG1;JPH2;CACNB3;DLG4;SHANK2;CACNB1;PTPN3;AKAP6;PRKACA
3503,GO:0007409,0.00725254193818089,0.995499013335283,48,306,axonogenesis,BP,ULK2;APOE;PTPRS;SLITRK6;EPHB2;PIK3R1;BRSK1;WNT3;UNC5B;PLXNB1;NDN;NEO1;FLRT3;SPTB;FLOT1;GLI2;ANK3;KLF7;RNF165;SPG11;SEMA4G;ULK1;GLI3;BOC;TRAK1;BAIAP2;PLXNB3;SYNGAP1;CDK5R1;EFNB3;SHANK3;SLIT3;ADARB1;RET;RPS6KA5;PLXND1;MATN2;IRS2;S100A6;ZSWIM8;APBB2;RANBP9;ERBB2;SSH3;LAMB2;NFASC;MAP1A;ECM2
12300,GO:0048667,0.00726481807090761,0.995280388786168,58,383,cell morphogenesis involved in neuron differentiation,BP,ULK2;MAP6;APOE;PTPRS;CAPRIN2;SLITRK6;OBSL1;EPHB2;PIK3R1;BRSK1;WNT3;UNK;CUL7;UNC5B;NFATC4;PLXNB1;NDN;NEO1;FLRT3;SPTB;FLOT1;GLI2;ANK3;KLF7;RNF165;SPG11;MINK1;SEMA4G;ULK1;GLI3;BOC;TRAK1;BAIAP2;PLXNB3;TRIOBP;SYNGAP1;CDK5R1;EFNB3;SHANK3;SLIT3;ADARB1;RET;RPS6KA5;PLXND1;DLG4;MATN2;SHANK2;IRS2;S100A6;ZSWIM8;APBB2;RANBP9;ERBB2;SSH3;LAMB2;NFASC;MAP1A;ECM2
14327,GO:0061564,0.00732800859823458,0.995378597997848,51,331,axon development,BP,ULK2;APOE;PTPRS;SLITRK6;EPHB2;PIK3R1;BRSK1;WNT3;RGMA;UNC5B;PLXNB1;NDN;NEO1;FLRT3;SPTB;RTN4RL1;FLOT1;GLI2;ANK3;KLF7;RNF165;SPG11;SEMA4G;ULK1;GLI3;BOC;TRAK1;BAIAP2;PLXNB3;SYNGAP1;CDK5R1;EFNB3;SHANK3;SLIT3;ADARB1;RET;RPS6KA5;PLXND1;MATN2;IRS2;MTR;S100A6;ZSWIM8;APBB2;RANBP9;ERBB2;SSH3;LAMB2;NFASC;MAP1A;ECM2
20108,GO:2000821,0.00743603166224515,1,2,2,regulation of grooming behavior,BP,NMU;DLG4
2592,GO:0005887,0.00764826298433534,0.994476044426864,99,732,integral component of plasma membrane,CC,ITGB6;GPNMB;APCDD1;EGFR;PTPRS;PKD2;SLITRK6;PCDH1;EPHB2;CSPG4;TENM4;KCNAB2;REEP2;KCNJ15;MC1R;SLC16A5;ITGB5;GJD3;BCAM;PLXNB1;KCNC4;ITPR3;GPRC5C;TNFSF10;NEO1;NLGN4Y;FLRT3;F2R;SLC24A1;TRPV4;NLGN2;ADORA2B;SLC13A5;TSPAN18;C5;TNFRSF14;ITGA2;VAMP2;BOC;ITGA6;KCNJ5;INSR;CELSR1;ST3GAL5;SCNN1A;PLXNB3;SCN4B;PILRB;SLC2A3;TCIRG1;SLC12A7;CLCA2;PODXL;TNFRSF21;EFNB3;SHANK3;HFE;CYBA;EDA2R;MRC2;GABBR1;KCNMA1;GPR87;SLC2A1;SLC38A4;LRP1;KCNG1;PMEL;LTB4R2;RET;OLFM2;FGFR4;SCN2A;BST2;VIPR1;PLXND1;LPAR6;ACVR1B;CADM4;DLG4;ESYT2;SLC22A15;SLC35G2;PTK7;SHANK2;TNFRSF25;TNFSF12;TAS1R3;SLC43A1;CPT1C;TRAF5;CD9;COL13A1;ERBB2;GPR68;KCNS3;CALHM2;NPNT;TM4SF1
5347,GO:0016101,0.0077881939418696,0.997416408890264,11,47,diterpenoid metabolic process,BP,APOE;EGFR;ALDH1A3;SDC3;CYP26B1;UGT1A3;GPC2;LRP1;RETSAT;DHRS4;RDH12
4280,GO:0009649,0.0077920158861987,0.998245166920754,7,23,entrainment of circadian clock,BP,SIK1;CRY2;CRY1;CRTC1;PER2;BHLHE40;PER3
10634,GO:0043679,0.00780378146980648,0.996982728074446,14,66,axon terminus,CC,SYN1;KCNAB2;KCNC4;BLVRB;FLRT3;ITGA2;NMU;TANC1;SEPT6;SEPT5;GLUL;SYT7;SYNGR1;TH
3066,GO:0006631,0.00790070441885485,0.995325113980766,39,259,fatty acid metabolic process,BP,SREBF1;AMACR;CES2;CPT2;THNSL2;TYSND1;ACOT1;CRAT;MLYCD;PHYH;SLC27A3;PER2;PTGS1;GSTM2;CYP2D7;SLC27A1;PDK1;PEX7;LPIN3;HADH;MLXIPL;ACADS;ACACB;ACOX3;ETFB;ALOXE3;ACSL1;IRS2;ALOX15B;ECI1;FAAH;CBR4;CPT1C;ACSS2;TH;PPARG;ACOT2;LONP2;EHHADH
13254,GO:0051963,0.00790996819589763,0.997392147212746,11,44,regulation of synapse assembly,BP,SLITRK6;EPHB2;FLRT3;ADGRB2;NLGN2;ADGRL1;AMIGO2;LRRN3;DLG5;CLSTN3;SRPX2
12969,GO:0051393,0.00795635391886527,0.998774743565921,6,11,alpha-actinin binding,MF,PKD2;OBSL1;TTN;SYNPO2;ALMS1;PPARG
17234,GO:0120036,0.00811442061804351,0.99386123803164,134,1025,plasma membrane bounded cell projection organization,BP,POSTN;ULK2;MAP6;APOE;EGFR;ESPN;PTPRS;CAPRIN2;SLITRK6;SFRP1;OBSL1;EPS8L2;EPHB2;PIK3R1;EVI5L;BRSK1;WNT3;VAV3;UNC119B;RGMA;CUL7;IMPACT;UNC5B;NFATC4;CNTRL;MICALL1;PLXNB1;SPOCK1;MDM2;CRTC1;NDN;CSMD3;PARVB;NEO1;FLRT3;NUDCD3;ARPIN;BLOC1S4;SPTB;NYAP1;DNAH1;RTN4RL1;TRPV4;FLOT1;GLI2;ANK3;KLF7;RNF165;CLMN;SPG11;UNC119;MINK1;NINL;WWTR1;ARHGEF4;SEMA4G;ULK1;GLI3;TPGS1;GAS8;BOC;ITGA6;TRAK1;INSR;GSN;BAIAP2;TANC1;PLXNB3;CEP126;TRIOBP;SEPT6;BLOC1S3;MICALL2;CEP192;PTK6;SYNGAP1;EPB41L3;BBS2;NPHP3;PODXL;SEPT5;IQCB1;CDK5R1;EFNB3;SHANK3;SLIT3;IFT140;DZIP1L;ARAP1;ADARB1;LRP1;NPHP4;RFX2;BBS1;ATXN10;RET;ZMYND8;DAB2IP;BBS5;AREG;RPS6KA5;DLG5;PLXND1;BBS10;TMEM80;DMTN;ALMS1;TMEM231;SNX1;PMP22;DLG4;CCDC113;MATN2;WEE1;PTK7;SHANK2;MARK4;IRS2;CEP250;MTR;S100A6;ZSWIM8;APBB2;RANBP9;ERBB2;SSH3;PRKACA;SYNE2;LAMB2;NFASC;MAP1A;ECM2;SMURF1;TTLL1
4360,GO:0009966,0.00812144301987524,0.993416492895246,255,2137,regulation of signal transduction,BP,TNFAIP3;POSTN;SERPINE2;GPNMB;EPM2A;TP53INP1;IFI6;PTHLH;APOE;INPP5D;APCDD1;PSD4;DDX60;EGFR;PTPRS;FAM20C;PKD2;CAPRIN2;MNT;DIXDC1;TRIM22;SFRP1;KCTD11;EPS8L2;EPHB2;MAP3K14;DGKQ;PIK3R1;RBCK1;CXCL14;EVC;SULF2;WNT3;VAV3;CSPG4;MVB12B;HTRA1;KITLG;MC1R;ASAP3;STAT1;CAMK2N1;CRY2;UNC5B;NOS1;PRKACB;CRY1;MAML3;PLEKHG5;NFATC4;IQSEC2;FERMT1;CYP26B1;THNSL2;PLXNB1;PLEKHG3;MDM2;LZTS2;CHN2;LTBP4;PIK3IP1;OBSCN;TNFSF10;RHOBTB2;NEO1;FLRT3;RASA4;KIF26A;RGS2;ACAP3;F2R;PDCD4;RTN4RL1;TRPV4;FLOT1;GLI2;AGAP4;NLGN2;ADORA2B;RNF165;RALGAPA1;MAPK8IP3;PIDD1;ARHGEF19;RHBDF1;RASGEF1A;TMEM204;C5;MINK1;GSTM2;WWTR1;ASAP2;ARHGEF4;FAM110C;GLI3;SPPL2B;AKAP7;NAIP;LTBP1;NEK8;MAP2K5;ITGA6;SRGAP3;SESN3;IGFBP4;GPC2;INSR;GSN;CHD3;CDK14;BAIAP2;CBLC;DDT;CD109;RMI2;ARHGEF1;DHX58;MDK;RICTOR;BMP6;NLRX1;S100A4;MAP2K2;VEGFB;SQSTM1;PTK6;FZD7;SYNGAP1;FAM13A;SHARPIN;ARHGAP33;SH2D2A;ARRDC1;PLA2G6;HOMER2;MMRN2;GDF15;CTF1;NPHP3;PSD3;MAP3K12;WRN;DNM1;KLHL24;CDK5R1;AGAP6;NET1;SESN1;MAPK10;SHANK3;HFE;CYBA;TRIM38;ERCC6;RRM2B;SLIT3;SHC2;EDA2R;SPRY2;IFT140;CREBRF;AGAP7P;KLK5;FBXW7;NUDT6;CDK5RAP3;PAK6;THRA;APC2;ARAP1;ELF1;RPH3AL;NLRP1;LRP1;NPHP4;RGS12;C12ORF66;DLK2;MAP3K6;APPL2;WNK1;JPH2;PDE2A;RET;ZMYND8;DAB2IP;RWDD3;RNF213;FGFR4;IL20RA;PIK3R2;AREG;MYO9A;DLG5;BST2;RGL2;ARHGEF17;PCSK6;LPAR6;PPP1R2;DMTN;STAT2;ARFGEF2;WWC3;TFDP2;UCN2;NRARP;ACVR1B;KREMEN1;DLG4;IQSEC1;ENDOU;IGFBP6;SHANK2;RSAD2;TNFRSF25;LMNA;IL11;KAT2B;IRS2;ERN1;IVNS1ABP;ALOX15B;RAD50;GPR21;TKFC;ARHGEF9;PBLD;TNFSF12;PHPT1;SMPDL3B;KIF7;TRAF5;RANBP9;PTPN3;ERBB2;ARHGAP23;AKAP6;MPP7;RORA;PPARG;PRKACA;LDLRAP1;CXXC5;ACKR3;UFL1;RIPK3;AIP;CCDC3;SMURF1;NPNT;CTNNBIP1;SERINC3;GCLC;ECM1
12052,GO:0048017,0.00812946904638107,0.996219040481257,20,105,inositol lipid-mediated signaling,BP,SERPINE2;EGFR;PIK3R1;PI4KAP2;UNC5B;PIK3C2G;PLXNB1;PIK3IP1;F2R;NYAP1;PITPNM2;GSN;PI4KAP1;DAB2IP;PIK3C3;PIK3R2;RGL2;ZFP36L1;IRS2;ERBB2
4419,GO:0010225,0.00815247256331958,0.998772073958913,5,13,response to UV-C,BP,IMPACT;MDM2;POLH;WRN;ERCC5
3504,GO:0007411,0.00828404903168499,0.99548711159624,30,171,axon guidance,BP,EPHB2;PIK3R1;WNT3;UNC5B;PLXNB1;NEO1;FLRT3;SPTB;GLI2;KLF7;RNF165;SEMA4G;GLI3;BOC;PLXNB3;CDK5R1;EFNB3;SHANK3;SLIT3;RET;RPS6KA5;PLXND1;MATN2;IRS2;ZSWIM8;APBB2;RANBP9;ERBB2;LAMB2;NFASC
6615,GO:0022843,0.00840569050355378,0.997374503606944,10,40,voltage-gated cation channel activity,MF,PKD2;KCNAB2;KCNJ15;KCNC4;KCNJ5;KCNMA1;KCNG1;CACNB3;CACNB1;KCNS3
16948,GO:0098984,0.0085596394097091,0.995492741006748,27,151,neuron to neuron synapse,CC,PTPRS;SYN1;KCNAB2;CAMK2N1;NOS1;SPOCK1;NLGN4Y;NLGN2;MINK1;BSN;LZTS1;BAIAP2;TANC1;SYNGAP1;EPB41L3;SHARPIN;HOMER2;PSD3;DNM1;CDK5R1;SHANK3;DLG5;DMTN;ARFGEF2;DLG4;SHANK2;CLSTN3
6251,GO:0019838,0.00861689237230846,0.996260466128002,17,86,growth factor binding,MF,EGFR;HTRA1;LTBP4;RHBDF1;LTBP1;ITGA6;LTBP3;IGFBP4;INSR;CD109;COL6A1;FGFR4;PCSK6;ACVR1B;IGFBP6;SRPX2;ERBB2
5536,GO:0016528,0.00870696256015566,0.997265617376837,10,40,sarcoplasm,CC,FLNC;NOS1;SPOCK1;ITPR3;ANK3;GSTM2;GSN;JPH2;AKAP6;SYNE2
9777,GO:0040007,0.00883045684352266,0.993706385077728,88,648,growth,BP,POSTN;SERPINE2;ULK2;APOE;GAMT;EGFR;PTPRS;CAPRIN2;SLITRK6;SFRP1;KCTD11;KIF26B;EYS;EVC;WNT3;HTRA1;TFCP2L1;TENM4;IMPACT;PLXNB1;SPOCK1;NDN;LTBP4;NINJ1;FLRT3;KIF26A;MT1X;GLI2;SPG11;THBS3;WWTR1;SEMA4G;ULK1;GLI3;MAP2K5;IGFBP4;JARID2;INSR;CCDC85B;GSN;PLXNB3;RTF1;ETNK2;SQSTM1;PTK6;TMEM8B;FZD7;EPB41L3;HYAL1;BBS2;PLAG1;WRN;CDK5R1;ATRX;NET1;SHANK3;CYBA;ERCC6;SLIT3;SPRY2;ING4;ADARB1;RAI1;ACACB;TNS2;DAB2IP;AREG;BTG1;BST2;WWC3;ACVR1B;PALB2;IGFBP6;PTK7;SHANK2;ZFP36L1;CLSTN3;ALOX15B;GPR21;ZMAT3;APBB2;ERBB2;AKAP6;PPARG;LAMB2;IP6K2;FOXP2;SMURF1
16607,GO:0097485,0.00891868587255975,0.995111960194752,30,172,neuron projection guidance,BP,EPHB2;PIK3R1;WNT3;UNC5B;PLXNB1;NEO1;FLRT3;SPTB;GLI2;KLF7;RNF165;SEMA4G;GLI3;BOC;PLXNB3;CDK5R1;EFNB3;SHANK3;SLIT3;RET;RPS6KA5;PLXND1;MATN2;IRS2;ZSWIM8;APBB2;RANBP9;ERBB2;LAMB2;NFASC
12948,GO:0051350,0.0090990052479261,0.999002800711578,4,9,negative regulation of lyase activity,BP,GABBR1;GPR87;LTB4R2;PHPT1
9856,GO:0042127,0.00927382247867719,0.992981423781868,129,1026,regulation of cell proliferation,BP,TNFAIP3;SERPINE2;GPNMB;TP53INP1;PTHLH;APOE;INPP5D;FBXW4;EGFR;PKD2;MNT;ASH2L;PLCD3;SFRP1;KCTD11;SULF2;WNT3;VAV3;HTRA1;KITLG;TP53I11;MVD;STAT1;CAMK2N1;MARCKSL1;HOXA3;KLF13;RNF187;FERMT1;HSF4;TBC1D8;PLXNB1;SPEG;NDRG1;EAPP;MDM2;LZTS2;PLCD1;NDN;IFITM1;CTSV;IL20RB;F2R;PDCD4;CGREF1;SERPINB5;GLI2;CLMN;GJC2;PER2;PTGS1;TNFRSF14;WWTR1;ITGA2;GLI3;MAP2K5;GAS8;LTBP3;TCFL5;JARID2;NUPR1;INSR;PLXNB3;MXD4;CD109;RICTOR;BMP6;TCIRG1;VEGFB;PTK6;FZD7;ETV5;KDM4C;HYAL1;CST3;TXNIP;CTF1;PLAG1;IDH2;TNFRSF21;CYBA;SLIT3;SPRY2;FBXO2;MEF2D;MLXIPL;FBXW7;ING4;MXI1;ADARB1;GLUL;TNS2;DAB2IP;FBXO4;FGFR4;AREG;DLG5;BTG1;VDR;VIPR1;SIX5;PMP22;NRARP;CCDC88B;IGFBP6;TCF7;TNFRSF25;ZFP36L1;LMNA;IL11;KAT2B;IRS2;ERN1;ALOX15B;S100A6;PBLD;TNFSF12;STAT6;CD9;ERBB2;PPARG;UFL1;RIPK3;KLF9;FOXP2;PTBP2;CTNNBIP1;PEMT;ECM1
5578,GO:0016598,0.00942866566693932,1,2,2,protein arginylation,BP,C17ORF97;ATE1
3426,GO:0007215,0.00946701647137676,0.997224271590784,9,34,glutamate receptor signaling pathway,BP,EPHB2;NLGN2;MINK1;HOMER2;KLHL24;CDK5R1;SHANK3;DLG4;SHANK2
413,GO:0001101,0.00947897758359577,0.994500653335089,35,224,response to acid chemical,BP,SREBF1;EGFR;PKD2;SFRP1;MTHFR;WNT3;NFATC4;HMGCL;CYP26B1;ITGA2;NAIP;SESN3;GSN;BAIAP2;BMP6;PTK6;FZD7;COL6A1;SESN1;CYBA;HLCS;LRP11;GNG2;BRINP1;RET;TEAD2;PIK3C3;PTK7;ACSL1;CD9;TH;PPARG;UFL1;PEMT;GCLC
18161,GO:1902952,0.00949510176952703,1,2,2,positive regulation of dendritic spine maintenance,BP,APOE;ZMYND8
5801,GO:0017057,0.00949893776648713,1,2,2,6-phosphogluconolactonase activity,MF,H6PD;PGLS
7852,GO:0032420,0.00958572222618733,0.997731334735243,7,24,stereocilium,CC,ESPN;EPS8L2;TRIOBP;HOMER2;BBS2;MYO3B;TPRN
16842,GO:0098793,0.00970939372848132,0.994457815590772,33,208,presynapse,CC,PTPRS;SYT8;SYN1;BRSK1;KCNAB2;RAB40B;KCNC4;SYTL1;BLVRB;FLRT3;C2CD4C;NLGN2;RIMS3;ADGRL1;ITGA2;SYT15;VAMP2;NMU;BSN;BAIAP2;TANC1;SEPT6;SEPT5;DNM1;MCTP1;GABBR1;GLUL;PDE2A;SYT7;DLG4;DMXL2;SYNGR1;TH
1881,GO:0004563,0.00973984954603133,0.999451171400943,3,5,beta-N-acetylhexosaminidase activity,MF,HEXA;HEXB;HEXDC
16431,GO:0097114,0.0098340976107896,1,2,2,NMDA glutamate receptor clustering,BP,APOE;SHANK3
478,GO:0001523,0.00990468593427236,0.996806259987223,10,42,retinoid metabolic process,BP,APOE;ALDH1A3;SDC3;CYP26B1;UGT1A3;GPC2;LRP1;RETSAT;DHRS4;RDH12
5118,GO:0015467,0.0102059340519671,1,2,2,G-protein activated inward rectifier potassium channel activity,MF,KCNJ15;KCNJ5
16430,GO:0097113,0.010217386452135,0.999413657358983,3,5,AMPA glutamate receptor clustering,BP,APOE;SHANK3;DLG4
16687,GO:0097688,0.010217386452135,0.999413657358983,3,5,glutamate receptor clustering,BP,APOE;SHANK3;DLG4
1412,GO:0003351,0.0102626477198152,0.998775570411343,4,10,epithelial cilium movement,BP,GAS8;CABYR;NPHP3;TTLL1
16824,GO:0098754,0.0103216270713477,0.995972802462112,13,72,detoxification,BP,TP53INP1;APOE;GPX3;TXNRD3;MT1X;PTGS1;GSTM2;MGST2;FAM213A;SESN1;DUOX1;PRDX5;GSTM3
3016,GO:0006562,0.0103417593705273,1,2,2,proline catabolic process,BP,PRODH;ALDH4A1
4399,GO:0010133,0.0103417593705273,1,2,2,proline catabolic process to glutamate,BP,PRODH;ALDH4A1
12299,GO:0048666,0.0103689361911535,0.99245512199956,96,705,neuron development,BP,POSTN;ULK2;MAP6;APOE;EGFR;PTPRS;CAPRIN2;SLITRK6;SFRP1;OBSL1;EPHB2;PIK3R1;BRSK1;WNT3;UNK;TENM4;RGMA;CUL7;IMPACT;UNC5B;NFATC4;MICALL1;PLXNB1;SPOCK1;NAGLU;MDM2;CRTC1;NDN;CSMD3;NEO1;FLRT3;BLOC1S4;SPTB;NYAP1;RTN4RL1;TRPV4;FLOT1;GLI2;ANK3;KLF7;RNF165;CLMN;SPG11;MINK1;SEMA4G;ULK1;GLI3;BOC;TRAK1;BAIAP2;PLXNB3;TRIOBP;BLOC1S3;MICALL2;PTK6;SYNGAP1;EPB41L3;CTF1;CDK5R1;EFNB3;MAPK10;SHANK3;SLIT3;IFT140;ADARB1;LRP1;NPHP4;WNK1;ATXN10;RET;ZMYND8;DAB2IP;AREG;RPS6KA5;DLG5;PLXND1;PMP22;DLG4;MATN2;WEE1;PTK7;SHANK2;IRS2;MTR;S100A6;ZSWIM8;APBB2;RANBP9;ERBB2;TH;SSH3;LAMB2;NFASC;MAP1A;ECM2;SMURF1
13383,GO:0052742,0.0103771401171108,0.996924938675194,9,33,phosphatidylinositol kinase activity,MF,PIK3R1;PI4KAP2;PIK3C2G;PI4KAP1;PIK3C3;FGFR4;PIK3R2;IRS2;PI4K2B
7018,GO:0030799,0.0105839419338199,0.996551830624811,10,42,regulation of cyclic nucleotide metabolic process,BP,PTHLH;APOE;PKD2;NOS1;RAPGEF3;ADORA2B;NPHP3;GABBR1;GPR87;LTB4R2
8586,GO:0034103,0.0105880211288519,0.996550294292372,10,42,regulation of tissue remodeling,BP,TNFAIP3;GPNMB;INPP5D;EGFR;SFRP1;CST3;CA2;SYT7;IL20RA;VDR
3466,GO:0007286,0.010612313345993,0.995720274972577,14,69,spermatid development,BP,HSPA2;KDM3A;DNAH1;TPGS1;CABYR;BBS2;REC8;CCDC136;RFX2;DPY19L2P2;SIX5;TSSK1B;PRKACA;TTLL1
7600,GO:0031994,0.0107721706367541,0.998757743738284,4,9,insulin-like growth factor I binding,MF,ITGA6;IGFBP4;INSR;IGFBP6
11847,GO:0046854,0.0109806631184062,0.995576926077155,14,65,phosphatidylinositol phosphorylation,BP,EGFR;PIK3R1;PI4KAP2;KITLG;PIK3C2G;PI4KAP1;PIK3C3;FGFR4;PIK3R2;IRS2;IMPA2;ERBB2;IP6K2;PI4K2B
19588,GO:1990748,0.011091795514705,0.995832278001126,12,64,cellular detoxification,BP,TP53INP1;APOE;GPX3;TXNRD3;PTGS1;GSTM2;MGST2;FAM213A;SESN1;DUOX1;PRDX5;GSTM3
4580,GO:0010668,0.0112027584264108,0.999334053252305,3,5,ectodermal cell differentiation,BP,ITGA6;FZD7;EDA2R
8316,GO:0033169,0.0112872124681452,0.998153330451764,5,13,histone H3-K9 demethylation,BP,KDM3A;HR;HSF4;PHF2;KDM4C
10479,GO:0043394,0.0112930024090845,0.997262448031326,7,23,proteoglycan binding,MF,GPNMB;PTPRS;ITGA2;GPC2;NID1;CTSB;LRP1
13259,GO:0051968,0.0113219780514577,0.998146178739037,5,13,positive regulation of synaptic transmission, glutamatergic,BP,EGFR;NLGN2;SHANK3;GLUL;SHANK2
3566,GO:0007610,0.0113491712582534,0.992824294167049,46,310,behavior,BP,SERPINE2;APOE;EGFR;ESPN;ALDH1A3;SLITRK6;EPHB2;GAA;ITPR3;NAGLU;CRTC1;NLGN4Y;NLGN2;SPG11;TPGS1;NMU;INSR;CELSR1;TANC1;MDK;B4GALT2;ETV5;SYNGAP1;HEXB;PLA2G6;CST3;HOMER2;BBS2;DNM1;EFNB3;SHANK3;CREBRF;ATXN1;THRA;ADARB1;NPHP4;BRINP1;DDHD2;OLFM2;DLG4;SHANK2;SRPX2;TH;GCNT4;PER3;FOXP2
17444,GO:1900271,0.0115559458603744,0.997569572832011,6,19,regulation of long-term synaptic potentiation,BP,APOE;EPHB2;NSG1;CRTC1;SQSTM1;SHANK3
12367,GO:0048791,0.0115806822129873,0.997595730581614,6,18,calcium ion-regulated exocytosis of neurotransmitter,BP,SYT8;SYTL1;C2CD4C;RIMS3;SYT15;SYT7
10252,GO:0043005,0.0117473538695921,0.991349941765325,100,753,neuron projection,CC,MAP6;APOE;ESPN;PTPRS;RBM3;SYN1;EPS8L2;EPHB2;TENM4;KCNAB2;VAMP3;STAT1;CAMK2N1;NSG1;NOS1;KCNC4;SPOCK1;CRTC1;CTSV;BLVRB;FLRT3;RGS2;BLOC1S4;TRPV4;ANK3;SPG11;GJC2;PTGS1;ADGRL1;MINK1;ITGA2;ULK1;TPGS1;VAMP2;NAIP;NMU;BOC;BSN;LZTS1;TRAK1;INSR;BAIAP2;TANC1;TRIOBP;SEPT6;BLOC1S3;S100A4;MICALL2;SYNGAP1;EPB41L3;SHARPIN;CST3;HOMER2;BBS2;MAP3K12;WRN;SEPT5;DNM1;TNFRSF21;IQCB1;KLHL24;CDK5R1;CA2;MAPK10;SHANK3;CYBA;FBXO2;IFT140;GABBR1;XRN1;GLUL;PRR7;LRP1;NPHP4;RGS12;BRINP1;MYO3B;ATXN10;RET;ZMYND8;DAB2IP;SYT7;SCN2A;TPRN;ORAI2;ARFGEF2;LMTK3;DLG4;SHANK2;MARK4;APBB2;CPT1C;SYNGR1;TH;LDLRAP1;UFL1;NFASC;MAP1A;PTBP2;SMURF1
12732,GO:0051020,0.0118638998018922,0.991690862369492,74,522,GTPase binding,MF,ALS2CL;PSD4;EGFR;EPS8L2;RALGDS;EVI5L;DOCK9;VAV3;KITLG;ASAP3;PLEKHG5;IQSEC2;MICALL1;TBC1D8;PLEKHG3;NDRG1;OBSCN;SYTL1;RAPGEF3;RGL4;ACAP3;HPS4;SPTB;AGAP4;RIMS3;ARHGEF19;RASGEF1A;FRS3;ASAP2;ARHGEF4;ULK1;GAS8;SRGAP3;TRIOBP;RIN1;ARHGEF1;RAB11FIP4;DOCK8;MICALL2;WHAMMP3;PSD3;AGAP6;NET1;SHC2;AGAP7P;RAB11FIP3;PAK6;ARAP1;FMNL2;RPH3AL;TBC1D17;APPL2;RET;RAPGEFL1;FGFR4;EXOC2;RGL2;ARHGEF17;TBC1D16;SGSM2;ARFGEF2;DLG4;IQSEC1;IRS2;DMXL2;ARHGEF9;RAPGEF5;RANBP9;ERBB2;ATG14;DOCK6;FMNL3;DOCK3;CIT
3757,GO:0008300,0.0118719514631483,1,2,2,isoprenoid catabolic process,BP,SRD5A3;CYP26B1
600,GO:0001768,0.0119093182559905,0.999275216582191,3,5,establishment of T cell polarity,BP,CYP26B1;GSN;DOCK8
8218,GO:0032990,0.0119442621189639,0.99180929665638,66,460,cell part morphogenesis,BP,POSTN;ULK2;MAP6;APOE;EGFR;PTPRS;CAPRIN2;SLITRK6;OBSL1;EPHB2;PIK3R1;BRSK1;WNT3;CUL7;IMPACT;UNC5B;NFATC4;PLXNB1;NDN;NEO1;FLRT3;ARPIN;SPTB;NYAP1;FLOT1;GLI2;ANK3;KLF7;RNF165;SPG11;MINK1;SEMA4G;ULK1;GLI3;BOC;TRAK1;BAIAP2;PLXNB3;SYNGAP1;EPB41L3;CDK5R1;EFNB3;SHANK3;SLIT3;ADARB1;RET;DAB2IP;RPS6KA5;PLXND1;SNX1;DLG4;MATN2;WEE1;SHANK2;IRS2;S100A6;ZSWIM8;APBB2;RANBP9;ERBB2;SSH3;LAMB2;NFASC;MAP1A;ECM2;SMURF1
13257,GO:0051966,0.0119598637207505,0.997041580271112,7,24,regulation of synaptic transmission, glutamatergic,BP,SERPINE2;EGFR;NLGN2;PLA2G6;SHANK3;GLUL;SHANK2
17059,GO:0099601,0.0120210974810677,0.997023375112653,7,24,regulation of neurotransmitter receptor activity,BP,EPHB2;NLGN2;MINK1;KLHL24;SHANK3;DLG4;SHANK2
10049,GO:0042552,0.0120298038755109,0.994735240048473,16,80,myelination,BP,MARVELD1;POU3F1;TENM4;NDRG1;AHNAK2;EPB41L3;HEXB;MALL;TNFRSF21;NAB2;PRX;SCN2A;PMP22;CD9;ERBB2;NFASC
4274,GO:0009637,0.0120837171783565,1,2,2,response to blue light,BP,CRY2;CRY1
4306,GO:0009785,0.0120837171783565,1,2,2,blue light signaling pathway,BP,CRY2;CRY1
4331,GO:0009882,0.0120837171783565,1,2,2,blue light photoreceptor activity,MF,CRY2;CRY1
15276,GO:0071483,0.0120837171783565,1,2,2,cellular response to blue light,BP,CRY2;CRY1
10002,GO:0042445,0.0121399019288443,0.994085252114885,20,116,hormone metabolic process,BP,ALDH1A3;DGKQ;SRD5A3;CYP26B1;UGT1A3;SULT1E1;PCSK1;BMP6;HFE;RETSAT;VDR;PCSK6;DUOX1;HSD17B14;DHRS4;TRERF1;SCG5;PCSK1N;RDH12;GCNT4
6751,GO:0030182,0.0121434851333881,0.990888648947493,113,852,neuron differentiation,BP,POSTN;ULK2;MAP6;APOE;EGFR;PTPRS;CAPRIN2;DIXDC1;SLITRK6;SFRP1;OBSL1;KCTD11;EPHB2;PIK3R1;BRSK1;WNT3;UNK;TENM4;UNC119B;RGMA;SDK2;CUL7;IMPACT;UNC5B;NFATC4;MICALL1;PLXNB1;SPOCK1;NAGLU;MDM2;CRTC1;NDN;CSMD3;NEO1;FLRT3;BLOC1S4;SPTB;NYAP1;RTN4RL1;TRPV4;FLOT1;GLI2;ANK3;KLF7;RNF165;CLMN;SPG11;UNC119;MINK1;SEMA4G;ULK1;GLI3;SMARCA1;BOC;TRAK1;GPC2;BAIAP2;PLXNB3;TRIOBP;BLOC1S3;BMP6;MICALL2;PTK6;FZD7;ETV5;SYNGAP1;EPB41L3;KDM4C;CTF1;TCF4;CDK5R1;EFNB3;MAPK10;SHANK3;HMG20B;SLIT3;IFT140;CDK5RAP3;ADARB1;LRP1;NPHP4;BRINP1;WNK1;ATXN10;RET;ZMYND8;DAB2IP;CASZ1;AREG;RPS6KA5;DLG5;PLXND1;PMP22;DLG4;MATN2;WEE1;PTK7;SHANK2;IRS2;MTR;S100A6;ZSWIM8;APBB2;RANBP9;ERBB2;TH;RORA;SSH3;LAMB2;NFASC;MAP1A;ECM2;SMURF1
12404,GO:0048869,0.0121910721737529,0.989862797498408,313,2670,cellular developmental process,BP,TGFBI;POSTN;TAGLN;SERPINE2;ULK2;GPNMB;SIK1;SLFN5;TP53INP1;MAP6;PTHLH;SREBF1;ACTA2;APOE;GPSM1;INPP5D;APCDD1;HSPA2;EGFR;PTPRS;FLNC;FAM20C;CAPRIN2;MNT;ASH2L;DIXDC1;SLITRK6;SFRP1;OBSL1;KCTD11;EPHB2;PIK3R1;ADAMTS7;BRSK1;TXNRD3;KDM3A;CXCL14;POU3F1;SULF2;WNT3;DHTKD1;UNK;CSPG4;HTRA1;TFCP2L1;TENM4;UNC119B;RGMA;KCNAB2;ZFPM1;KITLG;SDK2;CUL7;VAMP3;STAT1;IMPACT;MYL9;KRT15;UNC5B;ITGB5;NOS1;ZFP41;KLF13;NFATC4;BTBD2;CYP26B1;HSF4;MICALL1;PLXNB1;SPEG;NDRG1;COL7A1;SPOCK1;NAGLU;MDM2;CRTC1;NDN;IFITM1;CSMD3;LTBP4;OBSCN;MYH11;PARVB;RHOBTB2;NEO1;RAPGEF3;FAM210B;CTSV;SPATA20;FLRT3;RGS2;ARPIN;PPL;HPS4;PDCD4;BLOC1S4;SPTB;NYAP1;DNAH1;RTN4RL1;ZFP36L2;TRPV4;FLOT1;GLI2;ANK3;KLF7;RNF165;SOX12;CLMN;SPG11;GJC2;SULT1E1;PER2;TMEM204;MICALCL;UNC119;WIPF1;MINK1;WWTR1;ITGA2;SEMA4G;ULK1;GLI3;FHOD3;TPGS1;SMARCA1;BOC;ITGA6;LTBP3;TCFL5;TRAK1;JARID2;NUPR1;PRR9;GPC2;INSR;TST;CCDC85B;CELSR1;GSN;BAIAP2;TANC1;TTN;PLXNB3;SUN1;AHNAK2;TRIOBP;CD109;SEPT6;RTF1;BLOC1S3;MDK;CASP14;BMP6;S100A4;MICALL2;SQSTM1;CABYR;PTK6;FZD7;ETV5;SYNGAP1;FAM213A;DLX3;EPB41L3;SHARPIN;HEXB;KDM4C;SH2D2A;CST3;GDF15;PEX7;BBS2;TXNIP;CTF1;TCF4;COL6A1;NPHP3;PLAG1;IDH2;WRN;PODXL;TNFRSF21;IQCB1;CDK5R1;ATRX;REC8;NET1;CA2;EFNB3;MAPK10;SHANK3;ADIRF;HMG20B;AGO4;SLIT3;KRT14;EDA2R;SPRY2;MRC2;MEF2D;IFT140;CTSB;KLK5;FBXW7;CDK5RAP3;LMO2;NOTCH2NL;THRA;APC2;ARAP1;ADARB1;FMNL2;ELF1;NAB2;LRP1;NPHP4;CCDC136;RFX2;DLK2;BRINP1;WNK1;ATXN10;PDE2A;MAF;RET;ZMYND8;PRX;DAB2IP;CASZ1;TEAD2;OLFM2;IFI16;FGFR4;AREG;MYO9A;RPS6KA5;DLG5;BTG1;VDR;MAMSTR;TNRC6C;DPY19L2P2;PLXND1;ZMYM3;SIX5;PCSK6;DMTN;TMEM231;SNX1;PMP22;NRARP;ACVR1B;DLG4;TSSK1B;ALOXE3;NHSL1;MATN2;NBEAL2;WEE1;PTK7;TCF7;SHANK2;RSAD2;ZFP36L1;LMNA;MXRA8;IL11;KAT2B;APOLD1;IRS2;ALOX15B;MTR;S100A6;ZSWIM8;APBB2;PBLD;TNFSF12;STAT6;SOX13;GSTM3;CD9;RANBP9;HDAC11;GJB5;COL13A1;ERBB2;GPR68;PAQR7;AKAP6;TH;RORA;SSH3;PPARG;PRKACA;NPAP1;POLM;FMNL3;SYNE2;ACKR3;UFL1;LAMB2;RIPK3;NFASC;CIT;MAP1A;CCDC3;FOXP2;ECM2;SMURF1;NPNT;TTLL1;CTNNBIP1
16644,GO:0097543,0.0122291078129782,1,2,2,ciliary inversin compartment,CC,NEK8;NPHP3
16666,GO:0097632,0.012230506855925,1,2,2,extrinsic component of phagophore assembly site membrane,CC,ULK1;ATG14
8379,GO:0033300,0.0124337418731865,1,2,2,dehydroascorbic acid transmembrane transporter activity,MF,SLC2A3;SLC2A1
14924,GO:0070837,0.0124337418731865,1,2,2,dehydroascorbic acid transport,BP,SLC2A3;SLC2A1
12679,GO:0050917,0.012554398510751,1,2,2,sensory perception of umami taste,BP,ITPR3;TAS1R3
10673,GO:0043954,0.0126811748471078,0.996825886116042,7,24,cellular component maintenance,BP,APOE;MTHFR;F2R;NLGN2;INSR;TANC1;ZMYND8
8412,GO:0033500,0.0127041227410886,0.993328979138648,24,145,carbohydrate homeostasis,BP,PIK3R1;CRY2;CRY1;OAS1;TRPV4;SESN3;INSR;ENDOG;PLA2G6;CYBA;MLXIPL;RPH3AL;FGFR4;PIK3R2;IRS2;ANO1;ERN1;GPR21;PHPT1;GPR68;TH;PPARG;PRKACA;GCLC
10078,GO:0042593,0.0127041227410886,0.993328979138648,24,145,glucose homeostasis,BP,PIK3R1;CRY2;CRY1;OAS1;TRPV4;SESN3;INSR;ENDOG;PLA2G6;CYBA;MLXIPL;RPH3AL;FGFR4;PIK3R2;IRS2;ANO1;ERN1;GPR21;PHPT1;GPR68;TH;PPARG;PRKACA;GCLC
19820,GO:2000311,0.0127367681571761,0.998454255328814,4,9,regulation of AMPA receptor activity,BP,NLGN2;MINK1;SHANK3;SHANK2
7067,GO:0030863,0.0128231212978658,0.99435174814635,16,79,cortical cytoskeleton,CC,RAPGEF3;SPTB;TRPV4;FLOT1;RIMS3;WIPF1;BSN;GSN;PLEKHH2;TRIOBP;HFE;SLC2A1;SHROOM2;DMTN;SHROOM4;DLG4
551,GO:0001673,0.0128543452676698,0.998358240693135,4,10,male germ cell nucleus,CC,HSPA2;MLH3;TCFL5;REC8
16303,GO:0090527,0.0129520783585156,0.998420029497208,4,9,actin filament reorganization,BP,GSN;ARAP1;EFS;DMTN
12937,GO:0051339,0.0131034404555826,0.997131945708917,6,20,regulation of lyase activity,BP,NOS1;ADORA2B;GABBR1;GPR87;LTB4R2;PHPT1
7755,GO:0032279,0.0131525771315253,0.992899008433969,26,149,asymmetric synapse,CC,PTPRS;SYN1;KCNAB2;CAMK2N1;NOS1;SPOCK1;NLGN4Y;MINK1;BSN;LZTS1;BAIAP2;TANC1;SYNGAP1;EPB41L3;SHARPIN;HOMER2;PSD3;DNM1;CDK5R1;SHANK3;DLG5;DMTN;ARFGEF2;DLG4;SHANK2;CLSTN3
4703,GO:0010868,0.0131565039043736,1,2,2,negative regulation of triglyceride biosynthetic process,BP,SIK1;FBXW7
18955,GO:1904761,0.0131680116841431,1,2,2,negative regulation of myofibroblast differentiation,BP,TP53INP1;PDCD4
12595,GO:0050796,0.0132383809328438,0.993640327698702,19,106,regulation of insulin secretion,BP,SREBF1;SFRP1;GLUD1;ITPR3;RAPGEF3;NLGN2;PER2;TM7SF3;PLA2G6;HADH;PFKFB2;SLC2A1;GLUL;SYT7;IRS2;ANO1;PHPT1;GPR68;KCNS3
14314,GO:0061525,0.0133544719938954,0.999150519006669,3,5,hindgut development,BP,GLI2;GLI3;TCF7
3621,GO:0008076,0.0135799322743043,0.996093005561873,8,31,voltage-gated potassium channel complex,CC,KCNAB2;KCNC4;VAMP2;KCNJ5;KCNMA1;KCNG1;DLG4;KCNS3
17000,GO:0099173,0.0136644275191415,0.994317565171972,14,68,postsynapse organization,BP,APOE;CAPRIN2;EPHB2;NLGN4Y;NLGN2;INSR;BAIAP2;TANC1;ETV5;CDK5R1;SHANK3;ZMYND8;DLG4;SHANK2
14603,GO:0070193,0.0137734011313837,0.998203389408685,4,10,synaptonemal complex organization,BP,HSPA2;MLH3;REC8;AGO4
598,GO:0001766,0.0138498184045713,0.998948116507676,3,6,membrane raft polarization,BP,MARVELD1;GSN;MALL
7438,GO:0031580,0.0138498184045713,0.998948116507676,3,6,membrane raft distribution,BP,MARVELD1;GSN;MALL
4232,GO:0009414,0.0141663209538672,0.998914699019476,3,6,response to water deprivation,BP,LRP11;CD9;TH
2595,GO:0005891,0.0141874347641648,0.99813252707514,4,10,voltage-gated calcium channel complex,CC,HSPA2;NOS1;CACNB3;CACNB1
16946,GO:0098982,0.0142039380769052,1,2,2,GABA-ergic synapse,CC,NLGN4Y;NLGN2
16947,GO:0098983,0.0142039380769052,1,2,2,symmetric, GABA-ergic, inhibitory synapse,CC,NLGN4Y;NLGN2
16928,GO:0098936,0.0143254897271463,1,2,2,intrinsic component of postsynaptic membrane,CC,PTPRS;NLGN2
16965,GO:0099055,0.0143254897271463,1,2,2,integral component of postsynaptic membrane,CC,PTPRS;NLGN2
17006,GO:0099240,0.0143254897271463,1,2,2,intrinsic component of synaptic membrane,CC,PTPRS;NLGN2
17083,GO:0099699,0.0143254897271463,1,2,2,integral component of synaptic membrane,CC,PTPRS;NLGN2
15505,GO:0071910,0.0143773697317479,1,2,2,determination of liver left/right asymmetry,BP,PKD2;NPHP3
7079,GO:0030881,0.0143856816256283,0.998891362119457,3,6,beta-2-microglobulin binding,MF,FCGRT;HFE;HLA-A
4233,GO:0009415,0.0144356238541391,0.998089728531989,4,10,response to water,BP,PKD2;LRP11;CD9;TH
6542,GO:0021965,0.0144619916890476,1,2,2,spinal cord ventral commissure morphogenesis,BP,GLI2;ADARB1
10148,GO:0042745,0.0145071783509486,0.998006802894703,4,11,circadian sleep/wake cycle,BP,NMU;CST3;TH;PER3
10388,GO:0043235,0.0145136720922921,0.991631527089675,31,186,receptor complex,CC,ITGB6;EGFR;CAPRIN2;EPHB2;ITGB5;PLXNB1;ITPR3;GPRC5C;ITGA2;ITGA6;INSR;PLXNB3;SHANK3;HFE;GABBR1;LRP1;RET;OLFM2;FGFR4;VDR;VIPR1;PLXND1;ACVR1B;DLG4;SHANK2;TAS1R3;CPT1C;TRAF5;ERBB2;AIP;NPNT
8361,GO:0033268,0.0147691831347871,0.998124049967845,4,9,node of Ranvier,CC,SPOCK1;ANK3;SCN2A;NFASC
7617,GO:0032024,0.014812155765002,0.994869435057105,10,45,positive regulation of insulin secretion,BP,GLUD1;NLGN2;TM7SF3;PLA2G6;PFKFB2;GLUL;IRS2;ANO1;PHPT1;GPR68
3467,GO:0007288,0.0148217550375957,0.998022671828647,4,10,sperm axoneme assembly,BP,DNAH1;TPGS1;BBS2;TTLL1
3459,GO:0007272,0.0149788517687161,0.993260403169578,16,82,ensheathment of neurons,BP,MARVELD1;POU3F1;TENM4;NDRG1;AHNAK2;EPB41L3;HEXB;MALL;TNFRSF21;NAB2;PRX;SCN2A;PMP22;CD9;ERBB2;NFASC
3793,GO:0008366,0.0149788517687161,0.993260403169578,16,82,axon ensheathment,BP,MARVELD1;POU3F1;TENM4;NDRG1;AHNAK2;EPB41L3;HEXB;MALL;TNFRSF21;NAB2;PRX;SCN2A;PMP22;CD9;ERBB2;NFASC
7760,GO:0032288,0.0151591416138716,0.996609989103473,6,19,myelin assembly,BP,TENM4;AHNAK2;EPB41L3;PRX;CD9;NFASC
6840,GO:0030315,0.0152915906304268,0.995525557246824,8,30,T-tubule,CC,NOS1;ANK3;KCNJ5;AHNAK2;PRX;SCN2A;CACNB3;AKAP6
19343,GO:1905793,0.0153884099345881,1,2,2,protein localization to pericentriolar material,BP,NUDCD3;GOLGB1
3429,GO:0007218,0.0156848348169684,0.996985687664918,5,17,neuropeptide signaling pathway,BP,NMU;NXPH4;LTB4R2;SCG5;PCSK1N
17507,GO:1901019,0.0157199814790249,0.994516888516886,10,44,regulation of calcium ion transmembrane transporter activity,BP,HSPA2;PKD2;NOS1;GSTM2;PLA2G6;JPH2;CACNB3;CACNB1;AKAP6;PRKACA
2383,GO:0005520,0.0158315610440925,0.997043385994435,5,15,insulin-like growth factor binding,MF,HTRA1;ITGA6;IGFBP4;INSR;IGFBP6
7601,GO:0031995,0.0158982912426019,0.998726614693408,3,6,insulin-like growth factor II binding,MF,IGFBP4;INSR;IGFBP6
16408,GO:0097067,0.0160100148953597,0.997812804173857,4,10,cellular response to thyroid hormone stimulus,BP,CTSB;LMO2;KLF9;GCLC
9236,GO:0035641,0.0162630712707303,0.998685907856036,3,6,locomotory exploration behavior,BP,APOE;NLGN2;DLG4
8878,GO:0034705,0.0163635123215845,0.995103016177845,8,32,potassium channel complex,CC,KCNAB2;KCNC4;VAMP2;KCNJ5;KCNMA1;KCNG1;DLG4;KCNS3
17910,GO:1902259,0.0163747754140699,0.997747344121035,4,10,regulation of delayed rectifier potassium channel activity,BP,ANK3;VAMP2;KCNG1;AKAP6
7021,GO:0030802,0.0163938290463623,0.995584935128222,7,27,regulation of cyclic nucleotide biosynthetic process,BP,PTHLH;APOE;NOS1;ADORA2B;GABBR1;GPR87;LTB4R2
19523,GO:1990459,0.0164691989210743,0.998662741543065,3,6,transferrin receptor binding,MF,RGMA;HFE;SNX1
16883,GO:0098858,0.0167321528759209,0.991431448831246,21,119,actin-based cell projection,CC,ACTA2;ESPN;EPS8L2;KITLG;SYTL1;RAPGEF3;CTSV;TRPV4;ITGA6;BAIAP2;TRIOBP;HOMER2;BBS2;PODXL;CA2;WASH3P;MYO3B;DEF6;TPRN;SYNE2;NFASC
13584,GO:0060076,0.016778178808648,0.996881669933513,5,14,excitatory synapse,CC,NLGN4Y;BSN;BAIAP2;DLG4;SRPX2
11836,GO:0046834,0.0168522126719216,0.992544214390613,15,75,lipid phosphorylation,BP,EGFR;DGKQ;PIK3R1;PI4KAP2;KITLG;PIK3C2G;PI4KAP1;PIK3C3;FGFR4;PIK3R2;IRS2;IMPA2;ERBB2;IP6K2;PI4K2B
12226,GO:0048515,0.0168957459371528,0.992736228389194,14,73,spermatid differentiation,BP,HSPA2;KDM3A;DNAH1;TPGS1;CABYR;BBS2;REC8;CCDC136;RFX2;DPY19L2P2;SIX5;TSSK1B;PRKACA;TTLL1
3746,GO:0008285,0.0170288452273777,0.988186986351766,63,466,negative regulation of cell proliferation,BP,TNFAIP3;SERPINE2;GPNMB;TP53INP1;PTHLH;APOE;INPP5D;PKD2;MNT;SFRP1;KCTD11;TP53I11;STAT1;CAMK2N1;KLF13;FERMT1;PLXNB1;SPEG;NDRG1;LZTS2;NDN;IFITM1;CTSV;IL20RB;F2R;PDCD4;CGREF1;CLMN;PER2;GLI3;GAS8;JARID2;NUPR1;MXD4;CD109;IDH2;TNFRSF21;SLIT3;SPRY2;FBXO2;FBXW7;ING4;MXI1;ADARB1;TNS2;DAB2IP;FBXO4;DLG5;BTG1;VDR;SIX5;PMP22;IGFBP6;LMNA;KAT2B;ALOX15B;PBLD;CD9;ERBB2;PPARG;KLF9;CTNNBIP1;PEMT
16886,GO:0098869,0.0171359733266557,0.993459618546156,11,60,cellular oxidant detoxification,BP,TP53INP1;APOE;GPX3;TXNRD3;PTGS1;GSTM2;MGST2;FAM213A;SESN1;DUOX1;PRDX5
9023,GO:0035249,0.0171415187928758,0.994849523547845,8,31,synaptic transmission, glutamatergic,BP,SERPINE2;EGFR;NLGN2;PLA2G6;SHANK3;GLUL;SHANK2;CLSTN3
5471,GO:0016406,0.0174889674479114,0.998546418803228,3,6,carnitine O-acyltransferase activity,MF,CPT2;CRAT;CPT1C
7236,GO:0031175,0.0180244212920893,0.986760811378543,87,645,neuron projection development,BP,POSTN;ULK2;MAP6;APOE;EGFR;PTPRS;CAPRIN2;SLITRK6;SFRP1;OBSL1;EPHB2;PIK3R1;BRSK1;WNT3;RGMA;CUL7;IMPACT;UNC5B;NFATC4;MICALL1;PLXNB1;SPOCK1;MDM2;CRTC1;NDN;CSMD3;NEO1;FLRT3;BLOC1S4;SPTB;NYAP1;RTN4RL1;TRPV4;FLOT1;GLI2;ANK3;KLF7;RNF165;CLMN;SPG11;MINK1;SEMA4G;ULK1;GLI3;BOC;TRAK1;BAIAP2;PLXNB3;TRIOBP;BLOC1S3;MICALL2;PTK6;SYNGAP1;EPB41L3;CDK5R1;EFNB3;SHANK3;SLIT3;ADARB1;LRP1;ATXN10;RET;ZMYND8;DAB2IP;AREG;RPS6KA5;DLG5;PLXND1;PMP22;DLG4;MATN2;WEE1;PTK7;SHANK2;IRS2;MTR;S100A6;ZSWIM8;APBB2;RANBP9;ERBB2;SSH3;LAMB2;NFASC;MAP1A;ECM2;SMURF1
10802,GO:0044304,0.0180249202949558,0.994030214514394,9,37,main axon,CC,KCNAB2;SPOCK1;ANK3;GJC2;EPB41L3;DNM1;SCN2A;DLG4;NFASC
3581,GO:0007626,0.0180278826020558,0.991245449939844,18,99,locomotory behavior,BP,APOE;ESPN;ALDH1A3;SLITRK6;GAA;NAGLU;NLGN2;SPG11;CELSR1;B4GALT2;ETV5;HEXB;DNM1;EFNB3;DDHD2;OLFM2;DLG4;TH
7200,GO:0031099,0.0180897592615977,0.990807455980935,20,118,regeneration,BP,POSTN;APOE;EGFR;PTPRS;SRSF5;EYS;SULF2;RGMA;NINJ1;RTN4RL1;ULK1;GLI3;GSN;FZD7;HFE;MATN2;MTR;PTPN3;PPARG;LAMB2
16403,GO:0097061,0.0182228511604306,0.993096983629197,11,50,dendritic spine organization,BP,APOE;CAPRIN2;EPHB2;INSR;BAIAP2;TANC1;CDK5R1;SHANK3;ZMYND8;DLG4;SHANK2
16107,GO:0090128,0.0183416364085146,0.998447014577531,3,6,regulation of synapse maturation,BP,NFATC4;ADGRL1;DAB2IP
1100,GO:0002689,0.0183799047841367,0.998290558156862,3,7,negative regulation of leukocyte chemotaxis,BP,C5;MMP28;DDT
3132,GO:0006721,0.0184646889954038,0.992950260332035,11,53,terpenoid metabolic process,BP,APOE;EGFR;ALDH1A3;SDC3;CYP26B1;UGT1A3;GPC2;LRP1;RETSAT;DHRS4;RDH12
9757,GO:0039533,0.0186273388993239,0.998413280036904,3,6,regulation of MDA-5 signaling pathway,BP,DDX60;DHX58;TKFC
13522,GO:0060004,0.0186818690194242,0.997322536878482,4,10,reflex,BP,ALDH1A3;SLITRK6;FOXP2;NPNT
11455,GO:0045926,0.0193519150873093,0.989132454230824,26,165,negative regulation of growth,BP,SERPINE2;ULK2;PTPRS;CAPRIN2;SFRP1;WNT3;MT1X;SEMA4G;JARID2;CCDC85B;SQSTM1;PTK6;HYAL1;BBS2;CDK5R1;SLIT3;ING4;RAI1;BTG1;BST2;WWC3;ACVR1B;ALOX15B;APBB2;PPARG;IP6K2
7665,GO:0032102,0.0194340595567315,0.988703552514539,29,189,negative regulation of response to external stimulus,BP,TNFAIP3;SERPINE2;APOE;NT5E;PTPRS;WNT3;HTRA1;RGMA;IL20RB;PDCD4;RTN4RL1;FNDC4;C5;SEMA4G;MMP28;DDT;CD109;DHX58;NLRX1;SHARPIN;BBS2;ACP5;FAM3A;TKFC;SMPDL3B;CD9;RORA;PPARG;SERPING1
12954,GO:0051371,0.019447948360288,0.998693699470687,4,5,muscle alpha-actinin binding,MF,PKD2;OBSL1;TTN;SYNPO2
15838,GO:0072578,0.0196211465309209,0.99829429730455,3,6,neurotransmitter-gated ion channel clustering,BP,APOE;SHANK3;DLG4
9602,GO:0036477,0.0196809476068418,0.986165505351277,65,474,somatodendritic compartment,CC,MAP6;APOE;PTPRS;RBM3;SYN1;EPHB2;STAT1;CAMK2N1;NSG1;NOS1;KCNC4;ITPR3;CRTC1;NDN;CTSV;RTN4RL1;ANK3;SPG11;GJC2;MINK1;TPGS1;NAIP;BSN;LZTS1;TRAK1;INSR;BAIAP2;TANC1;ENDOG;NRSN2;SYNGAP1;SHARPIN;CST3;HOMER2;DNM1;KLHL24;CDK5R1;SHANK3;CYBA;FBXO2;GABBR1;XRN1;ASTN2;GLUL;PRR7;SRR;LRP1;RGS12;BRINP1;ATXN10;RET;ZMYND8;DAB2IP;SYT7;ARFGEF2;LMTK3;DLG4;SHANK2;CPT1C;TH;NFASC;CIT;MAP1A;PTBP2;SMURF1
1794,GO:0004430,0.0197216412122065,0.998282125731963,3,6,1-phosphatidylinositol 4-kinase activity,MF,PI4KAP2;PI4KAP1;PI4K2B
8092,GO:0032787,0.0198153791662323,0.986440444388024,56,416,monocarboxylic acid metabolic process,BP,SREBF1;AMACR;CES2;CPT2;ALDH1A3;DHTKD1;CSPG4;D2HGDH;CYP26B1;THNSL2;TYSND1;IDUA;UGT1A3;ACOT1;CRAT;MLYCD;PHYH;SLC27A3;PER2;PTGS1;GSTM2;INSR;ALDH4A1;CYP2D7;SLC27A1;PDK1;PEX7;IDH2;LPIN3;HADH;HLCS;MLXIPL;PGM1;PFKFB2;ACADS;ACACB;OGDHL;SRR;ACOX3;FGFR4;ETFB;OSBPL1A;ALOXE3;ACSL1;IRS2;ALOX15B;ECI1;FAAH;CBR4;CPT1C;ACSS2;TH;PPARG;ACOT2;LONP2;EHHADH
5515,GO:0016480,0.0198275614476691,0.999415115621809,2,3,negative regulation of transcription by RNA polymerase III,BP,NAB2;PRDX5
8200,GO:0032963,0.0198787050504695,0.991269906407307,14,73,collagen metabolic process,BP,COL10A1;COL7A1;TNXB;F2R;ITGA2;MMP1;CST3;COL6A1;MRC2;CTSB;TNS2;CTSD;COL13A1;PPARG
13251,GO:0051960,0.0199946108924182,0.985584935726681,75,548,regulation of nervous system development,BP,SERPINE2;ULK2;APOE;PTPRS;CAPRIN2;DIXDC1;SLITRK6;SFRP1;OBSL1;KCTD11;EPHB2;WNT3;TENM4;RGMA;CUL7;IMPACT;NOS1;PRKACB;NFATC4;PLXNB1;SPOCK1;MDM2;CRTC1;CSMD3;FLRT3;ADGRB2;RTN4RL1;TRPV4;GLI2;NLGN2;GJC2;PER2;ADGRL1;AMIGO2;SEMA4G;GLI3;TRAK1;CELSR1;BAIAP2;PLXNB3;BMP6;PTK6;ETV5;SYNGAP1;KDM4C;TCF4;NPHP3;PLAG1;IDH2;TNFRSF21;CDK5R1;EFNB3;SHANK3;HMG20B;CDK5RAP3;LRP1;LRRN3;BRINP1;RET;ZMYND8;DAB2IP;CASZ1;DLG5;PLXND1;PMP22;DLG4;PTK7;SHANK2;CLSTN3;ZSWIM8;SRPX2;SSH3;PPARG;UFL1;SMURF1
4854,GO:0014069,0.0200100845263797,0.988907466780183,25,147,postsynaptic density,CC,PTPRS;SYN1;KCNAB2;CAMK2N1;NOS1;SPOCK1;NLGN4Y;MINK1;BSN;LZTS1;BAIAP2;TANC1;SYNGAP1;EPB41L3;SHARPIN;HOMER2;PSD3;DNM1;CDK5R1;SHANK3;DLG5;DMTN;DLG4;SHANK2;CLSTN3
2200,GO:0005086,0.0201440193070114,0.995992089517328,5,15,ARF guanyl-nucleotide exchange factor activity,MF,PSD4;IQSEC2;PSD3;ARFGEF2;IQSEC1
4427,GO:0010259,0.0201625847643976,0.995080631594038,6,21,multicellular organism aging,BP,INPP5D;TFCP2L1;CTSV;RNF165;WRN;TH
14884,GO:0070728,0.0201707169468537,0.998227425354969,3,6,leucine binding,MF,GLUD1;SESN3;SESN1
16415,GO:0097090,0.0203858302312376,0.998201044918734,3,6,presynaptic membrane organization,BP,APOE;NLGN4Y;NLGN2
3511,GO:0007422,0.0206028368127212,0.992030556953692,11,51,peripheral nervous system development,BP,POU3F1;NDRG1;ADGRB2;AHNAK2;NAB2;PRX;PMP22;GSTM3;ERBB2;LAMB2;NFASC
9235,GO:0035640,0.0209535844812459,0.996774753899011,4,11,exploration behavior,BP,APOE;NLGN2;BRINP1;DLG4
8587,GO:0034104,0.0210606101662698,0.996753107673842,4,11,negative regulation of tissue remodeling,BP,TNFAIP3;INPP5D;SFRP1;CST3
2298,GO:0005272,0.0211051324540044,0.995748531555178,5,15,sodium channel activity,MF,PKD2;SCNN1A;SCN4B;SHROOM2;SCN2A
10480,GO:0043395,0.0211610515743452,0.996846419575036,4,10,heparan sulfate proteoglycan binding,MF,PTPRS;ITGA2;GPC2;LRP1
10761,GO:0044224,0.0213174079957572,0.998085485735604,3,6,juxtaparanode region of axon,CC,KCNAB2;EPB41L3;DLG4
16968,GO:0099068,0.0214766891096102,0.996784416579763,4,10,postsynapse assembly,BP,NLGN4Y;NLGN2;SHANK3;SHANK2
11116,GO:0045171,0.0215091446119071,0.99203159558355,10,48,intercellular bridge,CC,PRKACB;UNC119;NINL;GSTM2;CENPC;IQCB1;RAB11FIP3;APC2;GSTM3;PRKACA
3572,GO:0007617,0.0215433482411273,0.996655022544739,4,11,mating behavior,BP,SERPINE2;HEXB;THRA;TH
9255,GO:0035686,0.0216787111025581,0.999328519472274,2,3,sperm fibrous sheath,CC,CABYR;GSTM3
7327,GO:0031345,0.0216893729051178,0.988566496438187,21,124,negative regulation of cell projection organization,BP,ULK2;APOE;PTPRS;EPHB2;EVI5L;WNT3;RGMA;NFATC4;SPOCK1;MDM2;ARPIN;RTN4RL1;TRPV4;SEMA4G;PLXNB3;SYNGAP1;CDK5R1;EFNB3;SPRY2;LRP1;PMP22
17053,GO:0099572,0.0216944699023391,0.987878261840235,25,148,postsynaptic specialization,CC,PTPRS;SYN1;KCNAB2;CAMK2N1;NOS1;SPOCK1;NLGN4Y;MINK1;BSN;LZTS1;BAIAP2;TANC1;SYNGAP1;EPB41L3;SHARPIN;HOMER2;PSD3;DNM1;CDK5R1;SHANK3;DLG5;DMTN;DLG4;SHANK2;CLSTN3
6465,GO:0021799,0.02177162194432,0.994592236972386,6,21,cerebral cortex radially oriented cell migration,BP,DIXDC1;GLI3;SUN1;CDK5R1;DAB2IP;SYNE2
12751,GO:0051046,0.0221255542170741,0.984666003501497,58,423,regulation of secretion,BP,POSTN;SREBF1;OAS2;EGFR;SYT8;SYN1;SFRP1;GLUD1;VAMP3;RAB40B;CRY1;FERMT1;KCNC4;ITPR3;SYTL1;RAPGEF3;F2R;C2CD4C;TRPV4;NLGN2;ADORA2B;RIMS3;RHBDF1;PER2;C5;SYT15;VAMP2;NMU;TTN;TM7SF3;BMP6;PLA2G6;IDH2;SEPT5;TNFRSF21;MCTP1;HFE;CYBA;HADH;RAB11FIP3;PFKFB2;RPH3AL;SLC2A1;NLRP1;GLUL;WNK1;PIK3C3;SYT7;RASL10B;RSAD2;IL11;IRS2;ANO1;ALOX15B;SCG5;PHPT1;GPR68;KCNS3
1993,GO:0004716,0.022193175982213,0.997974932232631,3,6,signal transducer, downstream of receptor, with protein tyrosine kinase activity,MF,EGFR;INSR;ERBB2
7853,GO:0032421,0.0222257673993393,0.993588732613713,7,28,stereocilium bundle,CC,ESPN;EPS8L2;TRIOBP;HOMER2;BBS2;MYO3B;TPRN
2707,GO:0006081,0.0225097984579905,0.991081349458097,11,57,cellular aldehyde metabolic process,BP,ALDH1A3;KDM3A;H6PD;ALDH4A1;PGLS;BMP6;ALDH7A1;AKR7A2;IDH2;TKFC;PNPO
5061,GO:0015276,0.0225697707045029,0.992171698239676,9,39,ligand-gated ion channel activity,MF,PKD2;KCNJ15;ITPR3;KCNJ5;SCNN1A;CLCA2;JPH2;SHROOM2;DLG4
6607,GO:0022834,0.0225697707045029,0.992171698239676,9,39,ligand-gated channel activity,MF,PKD2;KCNJ15;ITPR3;KCNJ5;SCNN1A;CLCA2;JPH2;SHROOM2;DLG4
1290,GO:0003105,0.0225961527500212,0.999284004157031,2,3,negative regulation of glomerular filtration,BP,F2R;CYBA
599,GO:0001767,0.0226450169658358,0.997917179551163,3,6,establishment of lymphocyte polarity,BP,CYP26B1;GSN;DOCK8
728,GO:0001958,0.0226907433983694,0.995262642799054,5,16,endochondral ossification,BP,BMP6;PEX7;MEF2D;NAB2;COL13A1
9455,GO:0036075,0.0226907433983694,0.995262642799054,5,16,replacement ossification,BP,BMP6;PEX7;MEF2D;NAB2;COL13A1
4563,GO:0010647,0.0227694649734738,0.982025083308208,139,1142,positive regulation of cell communication,BP,SERPINE2;GPNMB;TP53INP1;APOE;DDX60;EGFR;PKD2;CAPRIN2;DIXDC1;TRIM22;SFRP1;EPHB2;MAP3K14;GLUD1;PIK3R1;RBCK1;EVC;SULF2;WNT3;VAV3;CSPG4;KITLG;MC1R;NSG1;UNC5B;NOS1;MAML3;PLEKHG5;NFATC4;FERMT1;PLXNB1;ITPR3;CRTC1;CHN2;TNFSF10;NEO1;F2R;PDCD4;SLC24A1;TRPV4;FLOT1;NLGN2;ADORA2B;ANK3;RNF165;MAPK8IP3;PIDD1;RIMS3;RASGEF1A;C5;MINK1;GSTM2;ITGA2;FAM110C;VAMP2;NAIP;NMU;MAP2K5;IGFBP4;INSR;GSN;BAIAP2;DDT;DHX58;TM7SF3;RICTOR;BMP6;S100A4;MAP2K2;SQSTM1;PTK6;FZD7;SHARPIN;SH2D2A;PLA2G6;GDF15;CTF1;MAP3K12;CA2;MAPK10;SHANK3;HFE;CYBA;TRIM38;ERCC6;SHC2;EDA2R;SPRY2;CREBRF;KLK5;FBXW7;CDK5RAP3;PFKFB2;ARAP1;GLUL;MAP3K6;WNK1;JPH2;RET;DAB2IP;RWDD3;FGFR4;IL20RA;PIK3R2;DLG5;BST2;RGL2;LPAR6;DMTN;RASL10B;TFDP2;NRARP;ACVR1B;DLG4;SHANK2;RSAD2;TNFRSF25;CLSTN3;IL11;KAT2B;IRS2;ANO1;ERN1;ALOX15B;TNFSF12;PHPT1;KIF7;TRAF5;ERBB2;GPR68;AKAP6;MPP7;LDLRAP1;CXXC5;ACKR3;RIPK3;NPNT;SERINC3;ECM1
8911,GO:0034764,0.0228464366459548,0.988582221421576,18,102,positive regulation of transmembrane transport,BP,HSPA2;PKD2;EPHB2;PIK3R1;NOS1;F2R;CLTCL1;ANK3;GJC2;GSTM2;INSR;CA2;SHANK3;WNK1;JPH2;PIK3R2;IRS2;AKAP6
4126,GO:0009187,0.0230115655571486,0.990473575696861,12,59,cyclic nucleotide metabolic process,BP,PTHLH;APOE;PKD2;NOS1;RAPGEF3;ADORA2B;NPHP3;GABBR1;GPR87;PDE2A;LTB4R2;RORA
13103,GO:0051665,0.0230183120188295,0.997662922905516,3,7,membrane raft localization,BP,MARVELD1;GSN;MALL
7033,GO:0030814,0.0231071605228851,0.993279843494528,7,28,regulation of cAMP metabolic process,BP,PTHLH;PKD2;RAPGEF3;NPHP3;GABBR1;GPR87;LTB4R2
13722,GO:0060316,0.0231728842398744,0.997641039610773,3,7,positive regulation of ryanodine-sensitive calcium-release channel activity,BP,GSTM2;JPH2;AKAP6
14744,GO:0070458,0.02319169156012,0.999254551777953,2,3,cellular detoxification of nitrogen compound,BP,GSTM2;GSTM3
8716,GO:0034374,0.0233620679525154,0.9992460459867,2,3,low-density lipoprotein particle remodeling,BP,APOE;PLA2G7
6358,GO:0021544,0.023369333478153,0.995082421506109,5,16,subpallium development,BP,ALDH1A3;GLI3;BBS2;SHANK3;FOXP2
2202,GO:0005088,0.0233923914607807,0.986356820504555,28,172,Ras guanyl-nucleotide exchange factor activity,MF,ALS2CL;EGFR;EPS8L2;VAV3;KITLG;PLEKHG5;PLEKHG3;OBSCN;RAPGEF3;SPTB;ARHGEF19;RASGEF1A;FRS3;ARHGEF4;RIN1;ARHGEF1;NET1;SHC2;RET;FGFR4;RGL2;ARHGEF17;DLG4;IRS2;ARHGEF9;RAPGEF5;RANBP9;ERBB2
4868,GO:0014731,0.0234164832044741,0.997817467529595,3,6,spectrin-associated cytoskeleton,CC,SPTB;ANK3;DMTN
1909,GO:0004601,0.023471486839607,0.993819705034201,6,27,peroxidase activity,MF,GPX3;PTGS1;GSTM2;MGST2;DUOX1;PRDX5
1094,GO:0002683,0.0235241033721189,0.985134932129257,37,265,negative regulation of immune system process,BP,TNFAIP3;GPNMB;INPP5D;PTPRS;SFRP1;PIK3R1;TSC22D3;HTRA1;ZFPM1;KITLG;KLF13;IL20RB;C5;GLI3;MMP28;DDT;DHX58;NLRX1;TNFRSF21;HFE;FBXW7;ELF1;DAB2IP;IFI16;DLG5;BST2;FAM3A;NRARP;ZFP36L1;TKFC;STAT6;PHPT1;SMPDL3B;ERBB2;GPR68;PPARG;SERPING1
18423,GO:1903530,0.0235424705156394,0.983790254781036,55,398,regulation of secretion by cell,BP,POSTN;SREBF1;EGFR;SYT8;SYN1;SFRP1;GLUD1;VAMP3;RAB40B;CRY1;FERMT1;KCNC4;ITPR3;SYTL1;RAPGEF3;F2R;C2CD4C;TRPV4;NLGN2;ADORA2B;RIMS3;RHBDF1;PER2;C5;SYT15;VAMP2;NMU;TTN;TM7SF3;BMP6;PLA2G6;IDH2;SEPT5;TNFRSF21;MCTP1;HFE;HADH;RAB11FIP3;PFKFB2;RPH3AL;SLC2A1;NLRP1;GLUL;PIK3C3;SYT7;RASL10B;RSAD2;IL11;IRS2;ANO1;ALOX15B;SCG5;PHPT1;GPR68;KCNS3
12659,GO:0050890,0.0236003221692775,0.986678851549651,25,155,cognition,BP,APOE;EGFR;EPHB2;ITPR3;CRTC1;NLGN4Y;INSR;TANC1;MDK;B4GALT2;SYNGAP1;METTL23;PLA2G6;SHANK3;ATXN1;THRA;GPR155;BRINP1;DGCR2;DDHD2;SHROOM4;DLG4;SHANK2;TH;FOXP2
6842,GO:0030317,0.0237505469687015,0.993017203456102,7,29,flagellated sperm motility,BP,DNAH1;TPGS1;GAS8;BBS2;NPHP4;PLTP;TTLL1
66,GO:0000137,0.0239199135309403,0.996161672274178,4,11,Golgi cis cisterna,CC,GOLGA8A;GOLGA8B;GOLGA8N;NECAB3
487,GO:0001540,0.0240325505164634,0.991499785212658,9,42,amyloid-beta binding,MF,APOE;EPHB2;ITGA2;INSR;CST3;FBXO2;APBB3;APBB2;LDLRAP1
7249,GO:0031224,0.0241883576004868,0.979521136328902,314,2761,intrinsic component of membrane,CC,ITGB6;GPNMB;IFI6;SREBF1;NYNRIN;NT5E;APCDD1;LOC441081;ADAM19;LMF1;HSPA2;EGFR;PTPRS;PKD2;SYT8;CXCR1;SYN1;LRIG3;SLITRK6;SFRP1;PCDH1;EPHB2;TMEM129;MARVELD1;ORAI3;EVC;ST6GALNAC2;CSPG4;CYBRD1;ELFN2;TENM4;RGMA;KCNAB2;KITLG;TP53I11;SDK2;ZDHHC1;VAMP3;SNN;REEP2;KCNJ15;MC1R;SRD5A3;OR2A4;CSMD2;NSG1;UNC5B;SLC16A5;KDSR;ITGB5;GJD3;NOS1;B4GALNT4;SDC3;BCAM;SCARA3;TMEM200B;PLXNB1;KCNC4;SLC29A4;ITPR3;IFITM1;ST6GALNAC6;FCGRT;CSMD3;PIK3IP1;GPRC5C;HLA-B;TNFSF10;HGSNAT;UGT1A3;CERS4;NEO1;NINJ1;FAM210B;NLGN4Y;FLRT3;RASA4;GAL3ST4;B4GALT6;TMEM63C;IL20RB;ADGRB2;F2R;TMEM134;SPTB;SLC24A1;SLC27A3;RTN4RL1;ADGRF4;TRPV4;TMC6;TMEM128;FLOT1;NLGN2;ADORA2B;LAMP3;SLC13A5;CLMN;AVL9;G6PC3;GJC2;RHBDF1;TSPAN18;TMEM204;CLCN6;DIRC2;FNDC4;C5;ADGRL1;AMIGO2;TNFRSF14;MBOAT2;LHFPL2;ITGA2;SEMA4G;SYT15;SPPL2B;VAMP2;BOC;ITGA6;KCNJ5;GPC2;INSR;CELSR1;ST3GAL5;TMC7;SCNN1A;PLXNB3;SUN1;LPAR5;CNTNAP3;CD109;CYP2D7;FAM171A2;SCN4B;MGST2;PILRB;SLC27A1;PGAP1;TM7SF3;NRSN2;SIRPB2;TMEM9;B4GALT2;TMCC3;NIPAL2;PEX10;SLC2A3;TCIRG1;SLC12A7;TMEM8B;FZD7;SYNGAP1;FAT2;TMEM117;METTL23;CLCA2;KIAA0319L;B3GNT9;PAQR4;MXRA7;ATP6V0A2;PEX11B;PODXL;IFI27;MALL;TNFRSF21;PLD3;ZDHHC12;ABHD14A;MCTP1;ANO9;PIGZ;EFNB3;SHANK3;HFE;SCART1;CYBA;EDA2R;MRC2;GABBR1;LRP11;KCNMA1;GPR87;TMEM164;PAQR6;RNF170;ASTN2;SLC2A1;ERMAP;REEP4;GPR155;NDST2;SLC38A4;TP53I13;PRR7;LRP1;LRRN3;HLA-A;TSNARE1;CCDC136;ACP5;DLK2;KCNG1;SLC48A1;CD99L2;DGCR2;PMEL;JPH2;LTB4R2;RET;DAB2IP;SLC37A2;OLFM2;SYT7;FGFR4;IL20RA;SCN2A;OSBPL5;AREG;TMEM203;MYO9A;BST2;LETMD1;CACNB3;DPY19L2P2;VIPR1;PLXND1;MARCH8;TMEM80;MPPE1;TMCO6;LRRC37A3;LPAR6;ORAI2;SLC35E2B;LMTK3;SLC36A4;TMEM231;PMP22;ACVR1B;TMX4;APCDD1L;KREMEN1;CADM4;DLG4;ESYT2;ADCK5;NAT14;CD68;DUOX1;SLC22A15;TMEM143;SLC35G2;PTK7;SHANK2;TNFRSF25;NEMP2;XYLT1;MXRA8;CLSTN3;GLMP;ACSL1;APOLD1;ANO1;ERN1;GPR21;LAPTM4A;MAN1B1;FAAH;MFSD11;CCDC90B;TNFSF12;TAS1R3;CERS5;GPR132;SMPDL3B;SLC43A1;CPT1C;DNAJC4;TRAF5;GOLGB1;CD9;CACNB1;GJB5;COL13A1;ERBB2;SYNGR1;GPR68;XKR9;ZDHHC24;PAQR7;PQLC3;ABCA2;AKAP6;SLC2A11;PRKACA;DNAJC22;GCNT4;SYNE2;ACKR3;TMEM212;NFASC;KCNS3;CLCN7;CALHM2;NPNT;HERPUD2;PEMT;ABCA11P;GLIPR1L2;TM4SF1;SERINC3
9029,GO:0035255,0.0241942990445239,0.993839857248773,6,21,ionotropic glutamate receptor binding,MF,FLOT1;SQSTM1;CDK5R1;SHANK3;DLG4;SHANK2
17178,GO:0106027,0.0242788316598113,0.990347049913208,11,52,neuron projection organization,BP,APOE;CAPRIN2;EPHB2;INSR;BAIAP2;TANC1;CDK5R1;SHANK3;ZMYND8;DLG4;SHANK2
18071,GO:1902722,0.0243709890948069,0.99919495587329,2,3,positive regulation of prolactin secretion,BP,EGFR;NMU
4894,GO:0014823,0.0243826010419926,0.991376389459866,9,41,response to activity,BP,POSTN;PERM1;ITGA2;BMP6;CYBA;HADH;TNS2;TH;GCLC
16156,GO:0090197,0.0244015078143145,0.997464979997684,3,7,positive regulation of chemokine secretion,BP,POSTN;C5;ALOX15B
323,GO:0000904,0.0246166561122678,0.982394794749794,67,483,cell morphogenesis involved in differentiation,BP,POSTN;ULK2;MAP6;APOE;PTPRS;CAPRIN2;SLITRK6;OBSL1;EPHB2;PIK3R1;BRSK1;WNT3;UNK;ZFPM1;CUL7;VAMP3;UNC5B;NFATC4;PLXNB1;NDN;PARVB;NEO1;FLRT3;SPTB;FLOT1;GLI2;ANK3;KLF7;RNF165;SPG11;MINK1;SEMA4G;ULK1;GLI3;BOC;TRAK1;BAIAP2;PLXNB3;TRIOBP;MICALL2;FZD7;SYNGAP1;CDK5R1;NET1;EFNB3;SHANK3;SLIT3;ADARB1;RET;RPS6KA5;PLXND1;DMTN;DLG4;MATN2;NBEAL2;SHANK2;IRS2;S100A6;ZSWIM8;APBB2;RANBP9;ERBB2;SSH3;LAMB2;NFASC;MAP1A;ECM2
2262,GO:0005178,0.0246380743472349,0.988865490370881,14,73,integrin binding,MF,TGFBI;ITGB6;GPNMB;EGFR;LTBP4;TNXB;ADAMTS13;ITGA2;ITGA6;NISCH;CD9;LAMB2;ECM2;NPNT
11844,GO:0046850,0.0248486712049661,0.992702273140853,7,27,regulation of bone remodeling,BP,TNFAIP3;INPP5D;EGFR;SFRP1;CA2;SYT7;IL20RA
17446,GO:1900273,0.0248872166064906,0.995956044361609,4,11,positive regulation of long-term synaptic potentiation,BP,EPHB2;CRTC1;SQSTM1;SHANK3
7413,GO:0031514,0.0251800812623859,0.988542788834095,14,77,motile cilium,CC,PKD2;DNAH1;GLI2;TPGS1;GAS8;SCNN1A;SEPT6;SQSTM1;CABYR;BBS2;ALMS1;TSSK1B;GSTM3;PRKACA
3267,GO:0006939,0.0252543998107671,0.9898611421581,11,54,smooth muscle contraction,BP,SULF2;MYH11;RGS2;F2R;ADORA2B;ITGA2;NMU;PLA2G6;BBS2;KCNMA1;NPNT
9938,GO:0042311,0.0254190532157391,0.994386203535342,5,18,vasodilation,BP,APOE;NOS1;RGS2;ADORA2B;BBS2
9109,GO:0035418,0.0254863296016382,0.993373462221041,6,22,protein localization to synapse,BP,NSG1;NLGN2;BSN;BAIAP2;DLG4;CLSTN3
8877,GO:0034704,0.0256163668396655,0.993279892078833,6,23,calcium channel complex,CC,HSPA2;NOS1;CACNB3;CACNB1;AKAP6;PRKACA
2297,GO:0005267,0.0257946473343535,0.991480932750525,8,35,potassium channel activity,MF,PKD2;KCNAB2;KCNJ15;KCNC4;KCNJ5;KCNMA1;KCNG1;KCNS3
15261,GO:0071466,0.0258336015201014,0.987131084710804,17,104,cellular response to xenobiotic stimulus,BP,CES2;EGFR;BPHL;CYP26B1;UGT1A3;CYP3A5;PTGS1;GSTM2;CES3;CYP2D7;MGST2;AKR7A2;PDE2A;ACSL1;GSTM3;RORA;AIP
7248,GO:0031223,0.0258504617925782,0.997493963456568,3,6,auditory behavior,BP,SLITRK6;SHANK3;FOXP2
7045,GO:0030828,0.0263976177015214,0.997171097911432,3,7,positive regulation of cGMP biosynthetic process,BP,APOE;NOS1;ADORA2B
17314,GO:1900006,0.0265119179592438,0.989312040685661,11,52,positive regulation of dendrite development,BP,APOE;CAPRIN2;OBSL1;CUL7;CRTC1;BAIAP2;SHANK3;ZMYND8;DAB2IP;DLG5;SHANK2
6642,GO:0023056,0.026676563192122,0.978812035254593,139,1148,positive regulation of signaling,BP,SERPINE2;GPNMB;TP53INP1;APOE;DDX60;EGFR;PKD2;CAPRIN2;DIXDC1;TRIM22;SFRP1;EPHB2;MAP3K14;GLUD1;PIK3R1;RBCK1;EVC;SULF2;WNT3;VAV3;CSPG4;KITLG;VAMP3;MC1R;NSG1;UNC5B;NOS1;MAML3;PLEKHG5;NFATC4;FERMT1;PLXNB1;ITPR3;CRTC1;CHN2;TNFSF10;NEO1;F2R;PDCD4;SLC24A1;TRPV4;FLOT1;NLGN2;ADORA2B;RNF165;MAPK8IP3;PIDD1;RIMS3;RASGEF1A;C5;MINK1;GSTM2;ITGA2;FAM110C;VAMP2;NAIP;NMU;MAP2K5;IGFBP4;INSR;GSN;BAIAP2;DDT;DHX58;TM7SF3;RICTOR;BMP6;S100A4;MAP2K2;SQSTM1;PTK6;FZD7;SHARPIN;SH2D2A;PLA2G6;GDF15;CTF1;MAP3K12;CA2;MAPK10;SHANK3;HFE;CYBA;TRIM38;ERCC6;SHC2;EDA2R;SPRY2;CREBRF;KLK5;FBXW7;CDK5RAP3;PFKFB2;ARAP1;GLUL;MAP3K6;WNK1;JPH2;RET;DAB2IP;RWDD3;FGFR4;IL20RA;PIK3R2;DLG5;BST2;RGL2;LPAR6;DMTN;RASL10B;TFDP2;NRARP;ACVR1B;DLG4;SHANK2;RSAD2;TNFRSF25;CLSTN3;IL11;KAT2B;IRS2;ANO1;ERN1;ALOX15B;TNFSF12;PHPT1;KIF7;TRAF5;ERBB2;GPR68;AKAP6;MPP7;LDLRAP1;CXXC5;ACKR3;RIPK3;NPNT;SERINC3;ECM1
10292,GO:0043073,0.0268380840757387,0.995409935665213,4,12,germ cell nucleus,CC,HSPA2;MLH3;TCFL5;REC8
6941,GO:0030574,0.0269466839351899,0.990323893694593,9,40,collagen catabolic process,BP,COL10A1;COL7A1;MMP1;CST3;COL6A1;MRC2;CTSB;CTSD;COL13A1
2621,GO:0005942,0.0269916647917506,0.994095720044199,5,16,phosphatidylinositol 3-kinase complex,CC,PIK3R1;PIK3C2G;PIK3C3;PIK3R2;ATG14
7068,GO:0030864,0.027142809840728,0.988483816547536,12,59,cortical actin cytoskeleton,CC,RAPGEF3;SPTB;TRPV4;FLOT1;WIPF1;GSN;PLEKHH2;TRIOBP;HFE;SLC2A1;SHROOM2;SHROOM4
290,GO:0000795,0.0271686407959148,0.99396378021838,5,17,synaptonemal complex,CC,HSPA2;SYN1;MLH3;REC8;MSH5
16980,GO:0099086,0.0271686407959148,0.99396378021838,5,17,synaptonemal structure,CC,HSPA2;SYN1;MLH3;REC8;MSH5
9951,GO:0042340,0.0272709780078011,0.997039542973754,3,7,keratan sulfate catabolic process,BP,HEXA;HEXB;GLB1
6811,GO:0030276,0.0273737388318156,0.989465887614694,10,47,clathrin binding,MF,SYT8;NSG1;SYTL1;C2CD4C;CLTCL1;TOM1L2;SYT15;LRP1;SYT7;LDLRAP1
6725,GO:0030145,0.027574704193425,0.990003866016288,9,42,manganese ion binding,MF,NPEPL1;FAM20C;HMGCL;WRN;GLUL;MPPE1;PRIMPOL;ENDOU;PPM1M
10785,GO:0044273,0.0276225944221043,0.991575905940773,7,30,sulfur compound catabolic process,BP,CSPG4;IDUA;MLYCD;HEXA;HEXB;HYAL1;GLB1
2825,GO:0006290,0.0276294447594596,0.996985033601256,3,7,pyrimidine dimer repair,BP,DDB2;POLH;ERCC6
2520,GO:0005775,0.0278078531018997,0.985151479304892,20,126,vacuolar lumen,CC,PYGB;CSPG4;NAPRT;NSG1;SDC3;GAA;NAGLU;IDUA;CTSV;HEXA;GPC2;CTSF;HEXB;HYAL1;CTSB;SGSH;GLB1;DPP7;CTSD;C6ORF120
17043,GO:0099550,0.027942151544603,0.999004427166089,2,3,trans-synaptic signaling, modulating synaptic transmission,BP,EPHB2;F2R
7494,GO:0031674,0.0279682974437508,0.986810344496618,15,74,I band,CC,FLNC;OBSL1;SYNC;NOS1;OBSCN;PARVB;ANK3;FHOD3;TTN;AHNAK2;SLC2A1;SYNPO2;JPH2;KAT2B;SYNE2
3367,GO:0007130,0.0279921394718091,0.996929580192133,3,7,synaptonemal complex assembly,BP,MLH3;REC8;AGO4
4231,GO:0009411,0.0281177185986931,0.984985857369962,20,123,response to UV,BP,DDB2;TP53INP1;EGFR;CIRBP;XPC;PIK3R1;BRSK1;MC1R;IMPACT;NFATC4;SCARA3;MDM2;POLH;HYAL1;WRN;ERCC6;TP53I13;ERCC5;PRIMPOL;UVSSA
16471,GO:0097187,0.0284082022100158,0.998978472787057,2,3,dentinogenesis,BP,FAM20C;HTRA1
12100,GO:0048169,0.0284357581984523,0.993603927463804,5,17,regulation of long-term neuronal synaptic plasticity,BP,EPHB2;SYNGAP1;SHANK3;DLG4;SYNGR1
8427,GO:0033557,0.0286067194522438,0.998967342319084,2,3,Slx1-Slx4 complex,CC,SLX1A;SLX1B
13253,GO:0051962,0.0286323352554179,0.980664580527247,47,328,positive regulation of nervous system development,BP,SERPINE2;APOE;CAPRIN2;SLITRK6;OBSL1;KCTD11;EPHB2;WNT3;TENM4;CUL7;IMPACT;PLXNB1;CRTC1;FLRT3;ADGRB2;GLI2;NLGN2;GJC2;ADGRL1;AMIGO2;GLI3;TRAK1;BAIAP2;PLXNB3;BMP6;PTK6;ETV5;KDM4C;TCF4;PLAG1;SHANK3;HMG20B;LRRN3;BRINP1;RET;ZMYND8;DAB2IP;DLG5;PLXND1;DLG4;PTK7;SHANK2;CLSTN3;SRPX2;PPARG;UFL1;SMURF1
12091,GO:0048147,0.0286588290257474,0.992225949014547,6,24,negative regulation of fibroblast proliferation,BP,TP53INP1;SFRP1;NUPR1;DAB2IP;FBXO4;PPARG
2404,GO:0005576,0.0287869416632627,0.975564178750703,301,2778,extracellular region,CC,TNFAIP3;TGFBI;POSTN;ITGB6;SERPINE2;MUC19;PTHLH;PYGB;MXRA5;ACTA2;APOE;CES2;NT5E;GAMT;HSPA2;EGFR;PTPRS;FAM20C;PKD2;XPC;ALDH1A3;LRIG3;SLITRK6;CTSO;SFRP1;SEC14L2;EPS8L2;EPHB2;GPX3;BPHL;ADAMTS7;CXCL14;COL22A1;EYS;SULF2;WNT3;VAV3;SMOC2;VWCE;CSPG4;ISG15;MVB12B;CYBRD1;ELFN2;HTRA1;RGMA;KITLG;ZDHHC1;IRF2BPL;NAPRT;REEP2;C1QTNF6;CRY2;KRT15;LGALS7B;MARCKSL1;KDSR;ITGB5;COL10A1;RAB43;PRKACB;CRTAP;SDC3;BCAM;MAGEF1;FKBP5;GAA;THNSL2;PLXNB1;NDRG1;COL7A1;SPOCK1;NAGLU;PLCD1;LTBP4;PIK3IP1;IDUA;GPRC5C;TNFSF10;MYH11;SYTL1;CALML3;ACTR1B;TNXB;RAPGEF3;ENDOD1;CTSV;SPATA20;BLVRB;OAS1;FLRT3;GAL3ST4;F2R;PPL;CGREF1;SERPINB5;CAPN7;ARSI;RTN4RL1;CLTCL1;TMC6;FLOT1;TOM1L2;ADAMTS13;SPG11;ZCCHC11;PTGS1;UNC119;HEXA;FNDC4;C5;FRMD4B;ARSD;MINK1;NINL;ABHD14B;GSTM2;THBS3;SEMA4G;PCSK1;THRAP3;VAMP2;NAIP;LTBP1;NMU;ITGA6;LTBP3;CES3;IGFBP4;MMP1;C14ORF93;GPC2;INSR;TST;MMP28;GSN;HEBP1;BAIAP2;TTN;CBLC;SCNN1A;DDT;CNTNAP3;CTSF;CD109;PGLS;ZNF446;RAB11FIP4;TM7SF3;MDK;CASP14;H2AFJ;BMP6;SLC2A3;S100A4;MAP2K2;VEGFB;ALDH7A1;SQSTM1;AKR7A2;LOXL1;NXPH4;FAM213A;FAT2;HEXB;HYAL1;CLCA2;ARRDC1;KIAA0319L;CENPC;PLA2G6;MXRA7;CST3;MMRN2;GDF15;CTF1;THSD4;COL6A1;PEX11B;IDH2;PODXL;DNM1;IQCB1;PLD3;ABHD14A;CA2;HFE;ADIRF;NID1;RRM2B;SLIT3;KRT14;FBXO2;GABBR1;RAB11FIP3;CTSB;KLK5;KCNMA1;NOTCH2NL;TFPI2;PGM1;CHMP1B;HSD11B1L;APC2;SLC2A1;C1RL;GPR155;GLUL;GNG2;CAPG;LRRN3;ACP5;PLA2G7;RNPEP;DLK2;PPCS;APPL2;DHRS4L2;PMEL;ATXN10;DAB2IP;SLC37A2;SHROOM2;IGIP;OLFM2;SYT7;FGFR4;AREG;ETFB;BST2;FAM3A;PCSK6;UCN2;CA11;OSBPL1A;ACVR1B;CADM4;IGFL2;ENDOU;MPI;SNX29;IGFBP6;MATN2;GALE;TNFRSF25;XYLT1;MXRA8;CLSTN3;IL11;APOLD1;DMXL2;CEP250;ANO1;CAPS;MBLAC2;METTL7A;ALOX15B;TKFC;PNPO;MAN1B1;DHRS4;PEX1;ECI1;S100A6;EFEMP2;SCG5;SGSH;GAREM2;PBLD;TNFSF12;PCSK1N;PRDX5;PHPT1;SMPDL3B;TUB;GLB1;THEM6;GSTM3;SRPX2;DPP7;CD9;C22ORF46;HDAC11;CTSD;COL13A1;ARHGAP23;PRKACA;NPAP1;C6ORF120;ACOT2;SYNE2;PLTP;SERPING1;LAMB2;NFASC;CCDC3;ECM2;SMURF1;NPNT;GLIPR1L2;ECM1
3275,GO:0006954,0.0288462805759993,0.980390605124555,48,359,inflammatory response,BP,TNFAIP3;ITGB6;APOE;NT5E;EGFR;NFATC4;CYP26B1;IL20RB;F2R;PDCD4;TRPV4;ADORA2B;PTGS1;FNDC4;C5;TNFRSF14;ITGA2;NAIP;IGFBP4;NUPR1;DDT;PNMA1;MGST2;RICTOR;BMP6;NLRX1;SHARPIN;HYAL1;TNFRSF21;HFE;CYBA;NLRP1;ACP5;PLA2G7;PDE2A;LTB4R2;DAB2IP;IFI16;RPS6KA5;TNFRSF25;PRDX5;SMPDL3B;GPR68;RORA;PPARG;SERPING1;CTNNBIP1;ECM1
9802,GO:0042015,0.029525572323465,0.998915243803193,2,3,interleukin-20 binding,MF,IL20RB;IL20RA
4617,GO:0010738,0.0295339612875283,0.994792548723263,4,12,regulation of protein kinase A signaling,BP,MC1R;AKAP7;AKAP6;AIP
16701,GO:0097722,0.029646247887422,0.990821157137594,7,30,sperm motility,BP,DNAH1;TPGS1;GAS8;BBS2;NPHP4;PLTP;TTLL1
3411,GO:0007194,0.0297442766809079,0.996657485707675,3,7,negative regulation of adenylate cyclase activity,BP,GABBR1;GPR87;LTB4R2
7280,GO:0031280,0.0297442766809079,0.996657485707675,3,7,negative regulation of cyclase activity,BP,GABBR1;GPR87;LTB4R2
10014,GO:0042472,0.029881426777347,0.988328980911127,10,47,inner ear morphogenesis,BP,ALDH1A3;LRIG3;SLITRK6;EPHB2;GLI2;CELSR1;TRIOBP;SPRY2;MYO3B;PTK7
3308,GO:0007009,0.0299243539706494,0.987097072935816,12,60,plasma membrane organization,BP,MICALL1;NDRG1;FLOT1;ANK3;GSN;BAIAP2;AHNAK2;EPB41L3;ANO9;PRX;SYT7;SNX33
7032,GO:0030813,0.0299509867793913,0.99483682138144,4,11,positive regulation of nucleotide catabolic process,BP,RAPGEF3;INSR;MLXIPL;PFKFB2
3916,GO:0008589,0.0299635367772726,0.987660954766265,11,53,regulation of smoothened signaling pathway,BP,SERPINE2;SFRP1;KCTD11;EVC;PRKACB;GLI2;GLI3;IFT140;DLG5;KIF7;RORA
3775,GO:0008331,0.0300795812675452,0.998883373597775,2,3,high voltage-gated calcium channel activity,MF,CACNB3;CACNB1
4388,GO:0010043,0.0302069965870768,0.991604266184625,6,26,response to zinc ion,BP,D2HGDH;MT1X;ZNF658;CA2;KRT14;TH
7259,GO:0031235,0.0302232901296573,0.994774686573899,4,11,intrinsic component of the cytoplasmic side of the plasma membrane,CC,RASA4;SPTB;SYNGAP1;DAB2IP
11237,GO:0045472,0.0302853431043531,0.99657207463533,3,7,response to ether,BP,NFATC4;MDM2;TH
5730,GO:0016879,0.0303386096177039,0.988782801713834,9,43,ligase activity, forming carbon-nitrogen bonds,MF,NAPRT;TPGS1;HLCS;ACACB;GLUL;RIMKLB;PPCS;TTLL1;GCLC
19913,GO:2000463,0.0303885876434007,0.993040237469422,5,17,positive regulation of excitatory postsynaptic potential,BP,NLGN2;BAIAP2;SHANK3;DLG4;SHANK2
7423,GO:0031532,0.0304677188453004,0.985760004642204,14,78,actin cytoskeleton reorganization,BP,PARVB;RAPGEF3;CTSV;TRPV4;MINK1;GSN;BAIAP2;RICTOR;MICALL2;ARAP1;EFS;DMTN;PTK7;PHPT1
12099,GO:0048168,0.030508089452876,0.990539519022708,7,29,regulation of neuronal synaptic plasticity,BP,APOE;EPHB2;SYNGAP1;MCTP1;SHANK3;DLG4;SYNGR1
6549,GO:0021987,0.0305490239386517,0.985316382422444,15,82,cerebral cortex development,BP,EGFR;PTPRS;DIXDC1;GLI3;SUN1;MDK;BBS2;CDK5R1;SLC2A1;LRP1;DAB2IP;TACC1;TH;SYNE2;FOXP2
9870,GO:0042149,0.0307403579804848,0.989458405828232,8,36,cellular response to glucose starvation,BP,IMPACT;SESN3;SESN1;SLC2A1;C12ORF66;PIK3C3;IFI16;ATG14
6467,GO:0021801,0.0307486861231,0.992935117906461,5,17,cerebral cortex radial glia guided migration,BP,GLI3;SUN1;CDK5R1;DAB2IP;SYNE2
6565,GO:0022030,0.0307486861231,0.992935117906461,5,17,telencephalon glial cell migration,BP,GLI3;SUN1;CDK5R1;DAB2IP;SYNE2
1689,GO:0004165,0.0307726576189892,0.998843022005356,2,3,dodecenoyl-CoA delta-isomerase activity,MF,ECI1;EHHADH
1168,GO:0002791,0.0309579355440297,0.97980008651723,39,271,regulation of peptide secretion,BP,POSTN;SREBF1;EGFR;SFRP1;GLUD1;FERMT1;ITPR3;RAPGEF3;F2R;TRPV4;NLGN2;RHBDF1;PER2;C5;NMU;TTN;TM7SF3;BMP6;PLA2G6;IDH2;TNFRSF21;HFE;HADH;RAB11FIP3;PFKFB2;RPH3AL;SLC2A1;NLRP1;GLUL;PIK3C3;SYT7;RASL10B;RSAD2;IRS2;ANO1;ALOX15B;PHPT1;GPR68;KCNS3
6781,GO:0030224,0.0310313112122773,0.991421308481929,6,24,monocyte differentiation,BP,INPP5D;IFI16;ZFP36L1;GPR68;PPARG;CTNNBIP1
18246,GO:1903131,0.0310313112122773,0.991421308481929,6,24,mononuclear cell differentiation,BP,INPP5D;IFI16;ZFP36L1;GPR68;PPARG;CTNNBIP1
8822,GO:0034617,0.0312510179972258,0.99881486132001,2,3,tetrahydrobiopterin binding,MF,NOS1;TH
3574,GO:0007619,0.0313065757270079,0.998811574341182,2,3,courtship behavior,BP,HEXB;THRA
10575,GO:0043553,0.031383160479561,0.998807037771557,2,3,negative regulation of phosphatidylinositol 3-kinase activity,BP,PIK3IP1;DAB2IP
3230,GO:0006884,0.0314045183665663,0.992742745458601,5,17,cell volume homeostasis,BP,TRPV4;CLCN6;SLC12A7;SHANK3;KCNMA1
4369,GO:0009991,0.0316208640586882,0.978563489155524,46,338,response to extracellular stimulus,BP,POSTN;ULK2;SREBF1;APOE;EGFR;SFRP1;MTHFR;DGKQ;STAT1;IMPACT;HMGCL;MDM2;CTSV;KIF26A;TRPV4;ADORA2B;ITGA2;ULK1;ITGA6;SESN3;GSN;BAIAP2;CST3;BBS2;WRN;SESN1;HFE;CYBA;HLCS;LRP11;SLC2A1;ACACB;GLUL;C12ORF66;PIK3C3;IFI16;VDR;UCN2;ACSL1;PCSK1N;TH;ATG14;PPARG;UFL1;PEMT;GCLC
7356,GO:0031406,0.0316582673882833,0.983828492709423,17,105,carboxylic acid binding,MF,GLUD1;NOS1;HMGCL;CYP26B1;THNSL2;UGT1A3;PHYH;SESN3;SESN1;HLCS;ACACB;GLUL;SRR;VDR;TH;PPARG;GCLC
5947,GO:0018298,0.0316700268880765,0.998789987746922,2,3,protein-chromophore linkage,BP,CRY2;CRY1
4680,GO:0010831,0.0316768984614772,0.992575864403771,5,18,positive regulation of myotube differentiation,BP,CYP26B1;FLOT1;GDF15;THRA;MAMSTR
3366,GO:0007129,0.0317266694670411,0.992561016704634,5,18,synapsis,BP,MLH3;SUN1;REC8;AGO4;MSH5
2292,GO:0005251,0.0318687258687237,0.996318443445724,3,7,delayed rectifier potassium channel activity,MF,KCNC4;KCNG1;KCNS3
11845,GO:0046851,0.0319918557853389,0.996298492697946,3,7,negative regulation of bone remodeling,BP,TNFAIP3;INPP5D;SFRP1
1994,GO:0004719,0.0320262424717712,0.998768690515488,2,3,protein-L-isoaspartate (D-aspartate) O-methyltransferase activity,MF,PCMTD2;PCMTD1
18598,GO:1903903,0.0321332582149155,0.998762265245874,2,3,regulation of establishment of T cell polarity,BP,GSN;DOCK8
1626,GO:0004065,0.0325941786524971,0.996200430853537,3,7,arylsulfatase activity,MF,SULF2;ARSI;ARSD
7768,GO:0032300,0.0326415202603597,0.994056828821942,4,12,mismatch repair complex,CC,MLH3;PMS2P3;WRN;MSH5
19845,GO:2000345,0.0326845527198858,0.99618565070352,3,7,regulation of hepatocyte proliferation,BP,TNFAIP3;SULF2;FBXW7
7105,GO:0030913,0.0327901423144421,0.996168360182812,3,7,paranodal junction assembly,BP,EPB41L3;CD9;NFASC
13127,GO:0051716,0.0328658445626662,0.971378404580433,514,4655,cellular response to stimulus,BP,TNFAIP3;POSTN;ITGB6;SERPINE2;ULK2;GPNMB;SIK1;EPM2A;MUC19;DDB2;TP53INP1;IFI6;PTHLH;SREBF1;APOE;CES2;INPP5D;APCDD1;OAS2;PSD4;DDX60;HSPA2;FBXW4;EGFR;GIGYF1;PTPRS;FAM20C;PKD2;CAPRIN2;MNT;XPC;CXCR1;ASH2L;DIXDC1;TRIM22;SRSF5;PLCD3;SFRP1;KCTD11;EPS8L2;EPHB2;RALGDS;GPX3;MAP3K14;BPHL;DGKQ;TMEM129;PIK3R1;ADAMTS7;BRSK1;TXNRD3;RBCK1;KDM3A;CXCL14;DOCK9;EVC;SULF2;WNT3;CAMKK1;UBXN4;VAV3;SMOC2;CSPG4;ISG15;MVB12B;HTRA1;SPATA18;TENM4;RGMA;PI4KAP2;KITLG;CUL7;VAMP3;PRICKLE2;MC1R;ASAP3;OR2A4;STAT1;IMPACT;CAMK2N1;CRY2;NSG1;UNC5B;UROS;ITGB5;RAB43;RAB40B;NOS1;PRKACB;CRY1;MAML3;BCAM;MAGEF1;PLEKHG5;NFATC4;IQSEC2;FERMT1;CYP26B1;AP5Z1;CMPK2;THNSL2;HSF4;MICALL1;PIK3C2G;LIG1;PLXNB1;PLEKHG3;NDRG1;SPOCK1;ITPR3;MDM2;LZTS2;PLCD1;NDN;IFITM1;MLH3;FCGRT;CHN2;LTBP4;PIK3IP1;OBSCN;GPRC5C;HLA-B;TNFSF10;PRODH;RHOBTB2;UGT1A3;CYP3A5;NEO1;RAPGEF3;PCBP4;FAM210B;CTSV;POLH;OAS1;FLRT3;RASA4;KIF26A;RGL4;RGS2;ACAP3;IL20RB;ADGRB2;F2R;MT1X;PDCD4;SPTB;NYAP1;RTN4RL1;ZFP36L2;ADGRF4;CLTCL1;TRPV4;FLOT1;GLI2;AGAP4;TOM1L2;RHPN1;NLGN2;ADORA2B;ANK3;RNF165;ADAMTS13;PLCH2;RALGAPA1;MAPK8IP3;PIDD1;SLX1A;SLX1B;ZCCHC11;ARHGEF19;RHBDF1;TSPAN18;RASGEF1A;TMEM204;PITPNM2;CLCN6;PTGS1;UNC119;FRS3;C5;ZNF658;WIPF1;PSKH1;ADGRL1;MINK1;GSTM2;TNFRSF14;WWTR1;ASAP2;ARHGEF4;ITGA2;SEMA4G;FAM110C;ULK1;GLI3;SPPL2B;THRAP3;AKAP7;LRSAM1;VAMP2;NAIP;LTBP1;NMU;NEK8;MAP2K5;BOC;ITGA6;SRGAP3;CES3;BSN;SESN3;IGFBP4;MMP1;JARID2;NUPR1;GPC2;NISCH;INSR;CELSR1;MMP28;GSN;HEBP1;CHD3;CDK14;BAIAP2;TTN;CBLC;DDT;PLXNB3;LPAR5;POLD4;RIN1;CD109;CYP2D7;PMS2P3;ETAA1;RMI2;ARHGEF1;MGST2;DOCK8;DHX58;PILRB;ENDOG;SLC27A1;TM7SF3;RTF1;BLOC1S3;MDK;CASP14;IRF9;RICTOR;BMP6;NLRX1;TCIRG1;S100A4;MAP2K2;PDK1;VEGFB;SQSTM1;PTK6;FZD7;ETV5;AKR7A2;SYNGAP1;NXPH4;FAM13A;FAM213A;TMEM117;SHARPIN;HYAL1;ARHGAP33;SH2D2A;NSMCE4A;ARRDC1;PLA2G6;CST3;HOMER2;MMRN2;GDF15;BBS2;TXNIP;CTF1;ATP6V0A2;COL6A1;PEX11B;NPHP3;PSD3;MAP3K12;WRN;IFI27;DNM1;MCM9;TNFRSF21;MACROD1;KLHL24;TREX1;MCTP1;CDK5R1;ATRX;REC8;ARHGAP27;AGAP6;NET1;CA2;EFNB3;PI4KAP1;SESN1;MAPK10;SHANK3;HFE;ADIRF;CYBA;TRIM38;DTX3;AGO4;ERCC6;RRM2B;SLIT3;SHC2;EDA2R;SPRY2;MRC2;FBXO2;IFT140;GABBR1;CREBRF;XRN1;AGAP7P;MLXIPL;CTSB;KLK5;FBXW7;GPR87;ING4;NUDT6;CDK5RAP3;LMO2;NOTCH2NL;PAK6;TFPI2;CARF;PAQR6;THRA;APC2;ARAP1;ELF1;MX2;RPH3AL;SLC2A1;NLRP1;FRAT1;ERMAP;GPR155;GLUL;TNS2;GNG2;LRP1;HLA-A;NPHP4;RGS12;MPG;PLA2G7;C12ORF66;RFX2;DLK2;BRINP1;MAP3K6;APPL2;SALL2;WNK1;JPH2;PDE2A;STK16;LTB4R2;RET;ZMYND8;DAB2IP;RWDD3;CALCOCO1;TEAD2;SHROOM2;FBXO4;RNF213;RAPGEFL1;PIK3C3;IFI16;FGFR4;ERCC5;IL20RA;PIK3R2;SCN2A;AREG;MYO9A;RPS6KA5;DLG5;BST2;VDR;RGL2;ARHGEF17;CACNB3;TNRC6C;VIPR1;EFS;PLXND1;PCSK6;LPAR6;PPP1R2;DMTN;STAT2;ARFGEF2;RASL10B;WWC3;PHF1;TMEM231;TFDP2;UCN2;NRARP;ACVR1B;TMX4;KREMEN1;PRIMPOL;DLG4;TSSK1B;IQSEC1;ALOXE3;PALB2;ENDOU;IGFBP6;MATN2;CD68;DUOX1;PTK7;TCF7;SHANK2;RSAD2;TNFRSF25;ZFP36L1;LMNA;GLMP;ACSL1;IL11;KAT2B;IRS2;IMPA2;ANO1;CAPS;ERN1;IVNS1ABP;ALOX15B;RAD50;GPR21;TKFC;ZMAT3;MTR;MAN1B1;S100A6;SCG5;APBB2;ARHGEF9;PBLD;RAPGEF5;TNFSF12;TAS1R3;STAT6;PCSK1N;PRDX5;PHPT1;GPR132;SMPDL3B;KIF7;GSTM3;CHD6;TRAF5;CD9;RANBP9;CACNB1;PTPN3;ERBB2;SYNGR1;PLCB3;GPR68;UVSSA;PAQR7;ARHGAP23;AKAP6;TH;ATG14;MPP7;RORA;PPARG;PRKACA;DOCK6;LDLRAP1;CXXC5;POLM;ACKR3;DOCK3;UFL1;LAMB2;IP6K2;RIPK3;KLF9;AIP;CIT;MSH5;CCDC3;HIVEP1;SMURF1;NPNT;CTNNBIP1;SERINC3;GCLC;ECM1
2288,GO:0005247,0.0329991542770818,0.99613406437959,3,7,voltage-gated chloride channel activity,MF,CLCN6;ANO1;CLCN7
5729,GO:0016878,0.0329995476694801,0.992178999277996,5,18,acid-thiol ligase activity,MF,SLC27A3;SLC27A1;ACSL1;ACSS2;SUCLG2
2203,GO:0005089,0.0331155413601719,0.985540663804115,12,58,Rho guanyl-nucleotide exchange factor activity,MF,EPS8L2;VAV3;PLEKHG5;PLEKHG3;OBSCN;ARHGEF19;ARHGEF4;ARHGEF1;NET1;RGL2;ARHGEF17;ARHGEF9
8941,GO:0035004,0.0331921598906083,0.987619728273134,9,40,phosphatidylinositol 3-kinase activity,MF,EGFR;PIK3R1;KITLG;PIK3C2G;PIK3C3;FGFR4;PIK3R2;IRS2;ERBB2
2098,GO:0004866,0.0333338549895511,0.984647136042144,13,78,endopeptidase inhibitor activity,MF,SERPINE2;COL7A1;SPOCK1;SERPINB5;C5;NAIP;CD109;CST3;TFPI2;BST2;PCSK1N;PRDX5;SERPING1
6881,GO:0030414,0.0333338549895511,0.984647136042144,13,78,peptidase inhibitor activity,MF,SERPINE2;COL7A1;SPOCK1;SERPINB5;C5;NAIP;CD109;CST3;TFPI2;BST2;PCSK1N;PRDX5;SERPING1
2652,GO:0005996,0.0333651714647402,0.979634074096057,29,197,monosaccharide metabolic process,BP,SIK1;DGKQ;H6PD;CRY1;GAA;UGT1A3;OAS1;MLYCD;G6PC3;PER2;FGGY;IGFBP4;NISCH;INSR;SLC2A3;PDK1;PGM1;PFKFB2;SLC2A1;ACACB;EPM2AIP1;MPI;GALE;KAT2B;IRS2;TKFC;GLB1;RORA;GCLC
5064,GO:0015280,0.0333677724195051,0.998687245440691,2,3,ligand-gated sodium channel activity,MF,SCNN1A;SHROOM2
2647,GO:0005984,0.0335779431625108,0.996038612687106,3,7,disaccharide metabolic process,BP,GAA;IDUA;SLC2A1
8127,GO:0032836,0.0336060132092278,0.996033965583664,3,7,glomerular basement membrane development,BP,SULF2;NID1;LAMB2
4466,GO:0010464,0.0337773078937605,0.990534542683873,6,23,regulation of mesenchymal cell proliferation,BP,FBXW4;STAT1;LMNA;IRS2;FOXP2;CTNNBIP1
19551,GO:1990597,0.0337873998475803,0.998661370634358,2,3,AIP1-IRE1 complex,CC,DAB2IP;ERN1
2831,GO:0006298,0.0337875575160813,0.989194509606858,7,31,mismatch repair,BP,XPC;LIG1;MLH3;POLD4;PMS2P3;TREX1;MSH5
8421,GO:0033540,0.033796809864627,0.99364177408542,4,13,fatty acid beta-oxidation using acyl-CoA oxidase,BP,AMACR;CRAT;ACOX3;EHHADH
3827,GO:0008429,0.0338181071158059,0.995754162399753,3,8,phosphatidylethanolamine binding,MF,ESYT2;PLTP;PEMT
13369,GO:0052689,0.0339021227978043,0.98339260353099,15,89,carboxylic ester hydrolase activity,MF,CES2;BPHL;H6PD;ACOT1;NLGN4Y;NLGN2;CES3;PGLS;PGAP1;PLA2G6;CA2;PLA2G7;DDHD2;FAAH;ACOT2
2209,GO:0005096,0.0339555899498947,0.978414462347361,34,225,GTPase activator activity,MF,ALS2CL;EVI5L;VAV3;ASAP3;TBC1D8;PLXNB1;CHN2;RASA4;RGS2;ACAP3;AGAP4;RALGAPA1;ARHGEF19;TBC1D19;ASAP2;SRGAP3;RIN1;ARHGEF1;SYNGAP1;FAM13A;ARHGAP33;ARHGAP27;AGAP6;AGAP7P;ARAP1;TBC1D17;RGS12;APPL2;DAB2IP;PIK3R2;MYO9A;TBC1D16;SGSM2;ARHGAP23
2408,GO:0005581,0.033970252523229,0.988199349479661,8,34,collagen trimer,CC,COL22A1;C1QTNF6;COL10A1;SCARA3;COL7A1;TNXB;COL6A1;COL13A1
10423,GO:0043292,0.0340243557478411,0.980900342885263,22,130,contractile fiber,CC,FLNC;OBSL1;SYNC;MYL9;NOS1;OBSCN;MYH11;PARVB;ANK3;FHOD3;TTN;AHNAK2;SQSTM1;CST3;CDK5R1;SLC2A1;SYNPO2;JPH2;TNNI2;KAT2B;SYNE2;NPNT
4750,GO:0010927,0.0340310413936381,0.984584601792175,13,60,cellular component assembly involved in morphogenesis,BP,OBSL1;TENM4;OBSCN;MYH11;FHOD3;TTN;AHNAK2;EPB41L3;CCDC136;RFX2;PRX;CD9;NFASC
10265,GO:0043025,0.0340552198352389,0.977740449871503,38,266,neuronal cell body,CC,APOE;PTPRS;EPHB2;CAMK2N1;KCNC4;ITPR3;CRTC1;NDN;CTSV;RTN4RL1;GJC2;NAIP;INSR;BAIAP2;TANC1;ENDOG;NRSN2;CST3;HOMER2;KLHL24;CDK5R1;CYBA;XRN1;ASTN2;GLUL;SRR;LRP1;BRINP1;ATXN10;RET;DAB2IP;SYT7;SHANK2;TH;CIT;MAP1A;PTBP2;SMURF1
10369,GO:0043204,0.0342844988638296,0.985480809702648,11,57,perikaryon,CC,PTPRS;NDN;CTSV;RTN4RL1;GJC2;NAIP;ENDOG;KLHL24;ASTN2;GLUL;TH
187,GO:0000405,0.034294082081635,0.995919538603251,3,7,bubble DNA binding,MF,XPC;WRN;ERCC5
10349,GO:0043177,0.0345151586464998,0.982172024252205,17,106,organic acid binding,MF,GLUD1;NOS1;HMGCL;CYP26B1;THNSL2;UGT1A3;PHYH;SESN3;SESN1;HLCS;ACACB;GLUL;SRR;VDR;TH;PPARG;GCLC
12554,GO:0050728,0.0345263839415644,0.98465473252182,12,67,negative regulation of inflammatory response,BP,TNFAIP3;APOE;NT5E;IL20RB;PDCD4;FNDC4;NLRX1;SHARPIN;ACP5;SMPDL3B;RORA;PPARG
12512,GO:0050673,0.0346132813564524,0.977625321497815,36,251,epithelial cell proliferation,BP,TNFAIP3;APOE;EGFR;SFRP1;SULF2;HTRA1;STAT1;FERMT1;CTSV;SERPINB5;MAP2K5;IGFBP4;PLXNB3;CD109;RICTOR;BMP6;VEGFB;FZD7;HYAL1;CYBA;FBXW7;GLUL;DAB2IP;AREG;VDR;NRARP;ZFP36L1;ERN1;PBLD;TNFSF12;STAT6;ERBB2;PPARG;KLF9;FOXP2;ECM1
15149,GO:0071300,0.0346667283664134,0.986865881661459,9,43,cellular response to retinoic acid,BP,WNT3;CYP26B1;PTK6;FZD7;BRINP1;RET;TEAD2;PTK7;PPARG
8626,GO:0034163,0.0347301433944594,0.998602552477093,2,3,regulation of toll-like receptor 9 signaling pathway,BP,PTPRS;RSAD2
12672,GO:0050909,0.0349186386159761,0.993243494458622,4,14,sensory perception of taste,BP,REEP2;ITPR3;SCNN1A;TAS1R3
12218,GO:0048496,0.0349479702777862,0.998588827565066,2,3,maintenance of animal organ identity,BP,NPHP3;IQCB1
6658,GO:0030018,0.0351049946680768,0.983414698793664,14,69,Z disc,CC,FLNC;OBSL1;SYNC;NOS1;OBSCN;PARVB;ANK3;FHOD3;TTN;AHNAK2;SLC2A1;SYNPO2;JPH2;SYNE2
8113,GO:0032809,0.035128451301536,0.995779464603955,3,7,neuronal cell body membrane,CC,KCNC4;INSR;DAB2IP
10797,GO:0044298,0.035128451301536,0.995779464603955,3,7,cell body membrane,CC,KCNC4;INSR;DAB2IP
4901,GO:0014832,0.0354869841572671,0.998554649127417,2,3,urinary bladder smooth muscle contraction,BP,PLA2G6;KCNMA1
4910,GO:0014848,0.0354869841572671,0.998554649127417,2,3,urinary tract smooth muscle contraction,BP,PLA2G6;KCNMA1
3862,GO:0008484,0.0356000924098413,0.99333365693409,4,12,sulfuric ester hydrolase activity,MF,SULF2;ARSI;ARSD;SGSH
6469,GO:0021814,0.0358134499571698,0.995663398592068,3,7,cell motility involved in cerebral cortex radial glia guided migration,BP,SUN1;DAB2IP;SYNE2
12304,GO:0048671,0.0359017862110205,0.998528138060863,2,3,negative regulation of collateral sprouting,BP,ULK2;PTPRS
18515,GO:1903726,0.0359467027506188,0.995374990545639,3,8,negative regulation of phospholipid metabolic process,BP,PIK3IP1;SLC27A1;DAB2IP
6127,GO:0019388,0.036124906308774,0.995342805173506,3,8,galactose catabolic process,BP,PGM1;GALE;GLB1
3379,GO:0007157,0.0362345805565301,0.99109931748609,5,19,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,BP,TENM4;LGALS7B;ADGRL1;AMIGO2;CADM4
9582,GO:0036446,0.0362854638604374,0.998503455202504,2,3,myofibroblast differentiation,BP,TP53INP1;PDCD4
18954,GO:1904760,0.0362854638604374,0.998503455202504,2,3,regulation of myofibroblast differentiation,BP,TP53INP1;PDCD4
4229,GO:0009409,0.0363984127764199,0.98816953322798,7,31,response to cold,BP,HSPA2;CIRBP;SLC27A1;LRP11;THRA;PCSK1N;PPARG
19002,GO:1904861,0.0364521765783366,0.995554313210717,3,7,excitatory synapse assembly,BP,NLGN2;SHANK3;SHANK2
17436,GO:1900245,0.0365874268374436,0.998483920762672,2,3,positive regulation of MDA-5 signaling pathway,BP,DDX60;DHX58
16155,GO:0090196,0.0365879264132674,0.995258864053652,3,8,regulation of chemokine secretion,BP,POSTN;C5;ALOX15B
2394,GO:0005539,0.0368487555334635,0.980840881412015,17,103,glycosaminoglycan binding,MF,POSTN;SERPINE2;GPNMB;APOE;PTPRS;SFRP1;SMOC2;LTBP4;TNXB;RTN4RL1;THBS3;MDK;VEGFB;FGFR4;PCSK6;COL13A1;ECM2
5856,GO:0017158,0.036866880473833,0.985872486159914,9,43,regulation of calcium ion-dependent exocytosis,BP,SYT8;SYN1;SYTL1;C2CD4C;RIMS3;SYT15;SEPT5;RPH3AL;SYT7
16493,GO:0097223,0.0368737700665117,0.981720993459617,15,90,sperm part,CC,SYT8;DNAH1;GAS8;SUN1;SEPT6;SQSTM1;CABYR;LOXL1;HEXB;ATP6V0A2;CCDC136;TSSK1B;GOLGA1;GSTM3;PRKACA
12502,GO:0050662,0.0370022119958975,0.976777338257488,31,220,coenzyme binding,MF,PYGB;ALDH1A3;MTHFR;GLUD1;TXNRD3;H6PD;DHTKD1;CRY2;NOS1;HMGCL;D2HGDH;THNSL2;PRODH;PHYH;NAT6;IDH2;HADH;HLCS;NUDT6;ACADS;ACACB;ACCS;OGDHL;SRR;SDHA;ACOX3;DUOX1;PNPO;CBR4;TH;GCLC
5262,GO:0015909,0.0374478556592984,0.986603440876313,8,37,long-chain fatty acid transport,BP,APOE;CPT2;SLC27A1;PLA2G6;ACACB;ACSL1;IRS2;PPARG
20279,GO:2001293,0.0374735843018028,0.998426044788982,2,3,malonyl-CoA metabolic process,BP,MLYCD;ACACB
13075,GO:0051607,0.0375417055295966,0.97801752806586,24,161,defense response to virus,BP,TNFAIP3;OAS2;DDX60;APOBEC3C;TRIM22;IFI44L;MAP3K14;HERC5;ISG15;HTRA1;STAT1;IFITM1;OAS1;DHX58;IRF9;NLRX1;ADARB1;MX2;IFI16;BST2;STAT2;RSAD2;TKFC;SERINC3
4799,GO:0010996,0.0377619588481968,0.992791816626731,4,12,response to auditory stimulus,BP,XPC;SLITRK6;SHANK3;FOXP2
13198,GO:0051880,0.0378875545324607,0.995306179564572,3,7,G-quadruplex DNA binding,MF,WRN;XRN1;RAD50
4296,GO:0009743,0.0379352975960705,0.97835346264801,22,144,response to carbohydrate,BP,SREBF1;GJD3;CTSV;ITGA2;VAMP2;ENDOG;PLA2G6;CST3;TXNIP;CYBA;MLXIPL;PFKFB2;GLUL;ZFP36L1;IRS2;ANO1;ERN1;PHPT1;GPR68;TH;PRKACA;GCLC
8723,GO:0034382,0.0380065231819059,0.997757120131335,2,4,chylomicron remnant clearance,BP,APOE;LMF1
15461,GO:0071830,0.0380065231819059,0.997757120131335,2,4,triglyceride-rich lipoprotein particle clearance,BP,APOE;LMF1
16833,GO:0098772,0.0381319986725252,0.96936868446446,135,1133,molecular function regulator,MF,SERPINE2;GPNMB;PTHLH;APOE;GPSM1;ALS2CL;PSD4;EGFR;EPS8L2;RALGDS;DGKQ;PIK3R1;EVI5L;CXCL14;DOCK9;WNT3;VAV3;ELFN2;KCNAB2;KITLG;ASAP3;CAMK2N1;NOS1;PLEKHG5;IQSEC2;THNSL2;TBC1D8;PLXNB1;PLEKHG3;COL7A1;SPOCK1;PPP2R2C;CHN2;OBSCN;TNFSF10;RAPGEF3;PHACTR3;FLRT3;RASA4;RGL4;RGS2;ACAP3;HPS4;SPTB;SERPINB5;RTN4RL1;AGAP4;RALGAPA1;ARHGEF19;RASGEF1A;FRS3;C5;SNTA1;TBC1D19;ASAP2;ARHGEF4;SEMA4G;NAIP;SRGAP3;RIN1;CD109;ETAA1;SCN4B;ARHGEF1;MGST2;DOCK8;MDK;RICTOR;BMP6;MAP2K2;VEGFB;SYNGAP1;FAM13A;ARHGAP33;CST3;GDF15;TXNIP;CTF1;PSD3;CDK5R1;ARHGAP27;AGAP6;NET1;ERCC6;SHC2;SPRY2;AGAP7P;FBXW7;NUDT6;TFPI2;ARAP1;NLRP1;TBC1D17;RGS12;APPL2;WNK1;RET;DAB2IP;RAPGEFL1;FGFR4;PIK3R2;AREG;SNCB;MYO9A;BST2;RGL2;ARHGEF17;TBC1D16;PPP1R2;PPP1R35;SGSM2;ARFGEF2;UCN2;DLG4;PPP2R3B;IQSEC1;ENDOU;IL11;KAT2B;IRS2;SCG5;ARHGEF9;RAPGEF5;TNFSF12;PCSK1N;PRDX5;PHPT1;RANBP9;PTPN3;ERBB2;ARHGAP23;DOCK6;SERPING1;DOCK3;KCNS3
13511,GO:0055114,0.0381814158747673,0.970981172544245,84,716,oxidation-reduction process,BP,AMACR;PYGB;CPT2;ALDH1A3;MTHFR;GPX3;GLUD1;TXNRD3;KDM3A;H6PD;DHTKD1;HR;CYBRD1;KCNAB2;SRD5A3;KDSR;NOS1;NFATC4;D2HGDH;CYP26B1;GAA;TYSND1;PRODH;NDUFA4L2;CYP3A5;BLVRB;CRAT;MLYCD;PHYH;PPP1R3E;PER2;PTGS1;PHF2;SESN3;INSR;ALDH4A1;CYP2D7;ALDH7A1;AKR7A2;LOXL1;FAM213A;KDM4C;PEX7;IDH2;SESN1;CYBA;HADH;RRM2B;PGM1;HSD11B1L;ACADS;ACACB;OGDHL;EPM2AIP1;PLA2G7;BDH1;DHRS4L2;SDHA;ACOX3;RETSAT;DHRS12;ETFB;NDUFV3;PPP1R2;TMX4;ALOXE3;DUOX1;IRS2;HSD17B14;ALOX15B;PNPO;DHRS4;ECI1;CBR4;TTC19;PRDX5;CPT1C;RDH12;ACSS2;TH;PPARG;SUCLG2;LONP2;EHHADH
4859,GO:0014701,0.0382151421954615,0.998376986696702,2,3,junctional sarcoplasmic reticulum membrane,CC,JPH2;AKAP6
10799,GO:0044300,0.0382755684990313,0.998372964149609,2,3,cerebellar mossy fiber,CC,DAB2IP;DLG4
13750,GO:0060350,0.0383112439935787,0.987459439046283,7,30,endochondral bone morphogenesis,BP,TRPV4;THBS3;BMP6;PEX7;MEF2D;NAB2;COL13A1
14479,GO:0061971,0.0383112439935787,0.987459439046283,7,30,replacement bone morphogenesis,BP,TRPV4;THBS3;BMP6;PEX7;MEF2D;NAB2;COL13A1
20264,GO:2001259,0.0383633261758771,0.987438638247836,7,30,positive regulation of cation channel activity,BP,PKD2;EPHB2;ANK3;GSTM2;SHANK3;JPH2;AKAP6
10569,GO:0043547,0.0383836954102826,0.974012609367626,43,299,positive regulation of GTPase activity,BP,ALS2CL;SFRP1;EVI5L;DOCK9;VAV3;ASAP3;TBC1D8;PLXNB1;CHN2;RAPGEF3;RASA4;RGS2;ACAP3;F2R;AGAP4;RALGAPA1;ARHGEF19;TBC1D19;ASAP2;ITGA6;SRGAP3;RIN1;ARHGEF1;DOCK8;SYNGAP1;FAM13A;ARHGAP33;ARHGAP27;AGAP6;NET1;AGAP7P;APC2;ARAP1;TBC1D17;RGS12;DAB2IP;PIK3R2;MYO9A;TBC1D16;SGSM2;IQSEC1;ERBB2;ARHGAP23
11890,GO:0046935,0.0384401361735972,0.998361989901969,2,3,1-phosphatidylinositol-3-kinase regulator activity,MF,PIK3R1;PIK3R2
16859,GO:0098815,0.0384571681099969,0.988802619910573,6,24,modulation of excitatory postsynaptic potential,BP,NLGN2;BAIAP2;SHANK3;ZMYND8;DLG4;SHANK2
5774,GO:0016999,0.0384820518408685,0.980766967476905,15,94,antibiotic metabolic process,BP,EGFR;GPX3;KDM3A;DHTKD1;SULT1E1;AKR7A2;IDH2;CYBA;OGDHL;SDHA;DUOX1;CBR4;PRDX5;ACSS2;SUCLG2
16139,GO:0090179,0.0386297262760009,0.992571232432075,4,12,planar cell polarity pathway involved in neural tube closure,BP,SFRP1;CELSR1;NPHP3;PTK7
6472,GO:0021817,0.0387672005210523,0.998340096844838,2,3,nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration,BP,SUN1;SYNE2
2099,GO:0004867,0.0389436270256478,0.985810684784843,8,41,serine-type endopeptidase inhibitor activity,MF,SERPINE2;COL7A1;SPOCK1;SERPINB5;CD109;TFPI2;PCSK1N;SERPING1
16165,GO:0090207,0.0391093517386382,0.990188473297652,5,19,regulation of triglyceride metabolic process,BP,SIK1;SREBF1;APOE;LMF1;FBXW7
7488,GO:0031667,0.039165869540202,0.973402813275838,43,316,response to nutrient levels,BP,POSTN;ULK2;SREBF1;APOE;EGFR;SFRP1;MTHFR;DGKQ;STAT1;IMPACT;HMGCL;MDM2;CTSV;TRPV4;ITGA2;ULK1;SESN3;GSN;BAIAP2;CST3;BBS2;WRN;SESN1;HFE;CYBA;HLCS;LRP11;SLC2A1;ACACB;GLUL;C12ORF66;PIK3C3;IFI16;VDR;UCN2;ACSL1;PCSK1N;TH;ATG14;PPARG;UFL1;PEMT;GCLC
3759,GO:0008305,0.0394464841079906,0.990292018804779,5,17,integrin complex,CC,ITGB6;ITGB5;ITGA2;ITGA6;NPNT
16775,GO:0098636,0.0394464841079906,0.990292018804779,5,17,protein complex involved in cell adhesion,CC,ITGB6;ITGB5;ITGA2;ITGA6;NPNT
12879,GO:0051241,0.0395835082853678,0.969888558857832,84,675,negative regulation of multicellular organismal process,BP,TNFAIP3;SERPINE2;ULK2;GPNMB;PTHLH;APOE;INPP5D;EGFR;PTPRS;DIXDC1;SFRP1;KCTD11;EPHB2;PIK3R1;ADAMTS7;TSC22D3;RNF135;WNT3;HERC5;ISG15;RGMA;ZFPM1;MC1R;STAT1;PRKACB;CRY1;KLF13;NFATC4;FERMT1;SPOCK1;MDM2;RGS2;IL20RB;ADGRB2;F2R;PDCD4;RTN4RL1;TRPV4;GLI2;ADORA2B;SEMA4G;GLI3;NMU;MAP2K5;JARID2;DHX58;NLRX1;FZD7;SYNGAP1;CST3;MMRN2;BBS2;IDH2;TNFRSF21;CDK5R1;EFNB3;HFE;CYBA;SPRY2;RAB11FIP3;FBXW7;RAI1;LRP1;ACP5;BRINP1;WNK1;DAB2IP;AREG;RPS6KA5;BST2;WWC3;PMP22;NRARP;KREMEN1;ZFP36L1;LMNA;PBLD;CD9;ERBB2;GPR68;PPARG;SERPING1;SMURF1;ECM1
11315,GO:0045655,0.0397052436852296,0.99212980953738,4,13,regulation of monocyte differentiation,BP,INPP5D;ZFP36L1;GPR68;CTNNBIP1
4633,GO:0010758,0.0397421957192583,0.991981600912526,4,14,regulation of macrophage chemotaxis,BP,TRPV4;C5;MMP28;DDT
7197,GO:0031094,0.03984805660524,0.994960687831901,3,7,platelet dense tubular network,CC,ITPR3;F2R;DMTN
7330,GO:0031348,0.0401230744688662,0.97844036542038,18,114,negative regulation of defense response,BP,TNFAIP3;APOE;NT5E;HTRA1;IL20RB;PDCD4;FNDC4;DHX58;NLRX1;SHARPIN;ACP5;IFI16;FAM3A;TKFC;SMPDL3B;RORA;PPARG;SERPING1
10259,GO:0043015,0.0401502558867121,0.988114207222386,6,25,gamma-tubulin binding,MF,DIXDC1;BRSK1;NDRG1;NDN;TUBGCP5;MARK4
6401,GO:0021631,0.04025406834753,0.998239189452704,2,3,optic nerve morphogenesis,BP,EPHB2;GLI3
12539,GO:0050708,0.0403142475475086,0.973452294132553,37,259,regulation of protein secretion,BP,POSTN;SREBF1;EGFR;SFRP1;GLUD1;FERMT1;ITPR3;RAPGEF3;F2R;TRPV4;NLGN2;RHBDF1;PER2;C5;NMU;TTN;TM7SF3;BMP6;PLA2G6;IDH2;TNFRSF21;HADH;RAB11FIP3;PFKFB2;RPH3AL;SLC2A1;NLRP1;GLUL;PIK3C3;SYT7;RSAD2;IRS2;ANO1;ALOX15B;PHPT1;GPR68;KCNS3
6341,GO:0021521,0.0404324951750058,0.998226929214268,2,3,ventral spinal cord interneuron specification,BP,GLI2;GLI3
6450,GO:0021775,0.0404324951750058,0.998226929214268,2,3,smoothened signaling pathway involved in ventral spinal cord interneuron specification,BP,GLI2;GLI3
6451,GO:0021776,0.0404324951750058,0.998226929214268,2,3,smoothened signaling pathway involved in spinal cord motor neuron cell fate specification,BP,GLI2;GLI3
13894,GO:0060573,0.0404324951750058,0.998226929214268,2,3,cell fate specification involved in pattern specification,BP,GLI2;GLI3
13900,GO:0060579,0.0404324951750058,0.998226929214268,2,3,ventral spinal cord interneuron fate commitment,BP,GLI2;GLI3
13901,GO:0060581,0.0404324951750058,0.998226929214268,2,3,cell fate commitment involved in pattern specification,BP,GLI2;GLI3
1170,GO:0002793,0.0407104843373133,0.976013623915297,24,153,positive regulation of peptide secretion,BP,POSTN;EGFR;GLUD1;FERMT1;F2R;TRPV4;NLGN2;C5;NMU;TTN;TM7SF3;BMP6;PLA2G6;HFE;PFKFB2;RPH3AL;NLRP1;GLUL;RASL10B;IRS2;ANO1;ALOX15B;PHPT1;GPR68
2572,GO:0005859,0.040813659086662,0.993882342916282,4,7,muscle myosin complex,CC,OBSL1;MYL9;MYH11;TTN
7879,GO:0032454,0.040859892311995,0.991996403981024,4,12,histone demethylase activity (H3-K9 specific),MF,KDM3A;HR;PHF2;KDM4C
7044,GO:0030826,0.0411333814169665,0.994411181132655,3,8,regulation of cGMP biosynthetic process,BP,APOE;NOS1;ADORA2B
7274,GO:0031267,0.0412732329022467,0.970039689882414,61,445,small GTPase binding,MF,ALS2CL;EGFR;EPS8L2;EVI5L;VAV3;KITLG;ASAP3;PLEKHG5;MICALL1;TBC1D8;PLEKHG3;NDRG1;OBSCN;SYTL1;RAPGEF3;ACAP3;HPS4;SPTB;AGAP4;RIMS3;ARHGEF19;RASGEF1A;FRS3;ASAP2;ARHGEF4;ULK1;GAS8;SRGAP3;TRIOBP;RIN1;ARHGEF1;RAB11FIP4;MICALL2;WHAMMP3;AGAP6;NET1;SHC2;AGAP7P;RAB11FIP3;PAK6;ARAP1;FMNL2;RPH3AL;TBC1D17;APPL2;RET;FGFR4;EXOC2;RGL2;ARHGEF17;TBC1D16;SGSM2;DLG4;IRS2;DMXL2;ARHGEF9;RAPGEF5;RANBP9;ERBB2;FMNL3;CIT
7202,GO:0031102,0.0413342830347942,0.984872882995918,8,38,neuron projection regeneration,BP,APOE;PTPRS;RGMA;RTN4RL1;ULK1;MATN2;MTR;LAMB2
3126,GO:0006706,0.0414490026399823,0.991521873630352,4,14,steroid catabolic process,BP,APOE;SULT1E1;HSD17B14;TRERF1
3282,GO:0006970,0.0414594523572153,0.982706976636814,10,52,response to osmotic stress,BP,EGFR;PKD2;TSC22D3;TRPV4;ITGA2;KCNMA1;SLC2A1;SCN2A;ZFP36L1;TH
6461,GO:0021795,0.0414886549072036,0.986178281587544,7,30,cerebral cortex cell migration,BP,EGFR;DIXDC1;GLI3;SUN1;CDK5R1;DAB2IP;SYNE2
11466,GO:0045940,0.0416456913413429,0.991468465433953,4,14,positive regulation of steroid metabolic process,BP,SREBF1;APOE;BMP6;LDLRAP1
12513,GO:0050678,0.0417236907491466,0.973558570807,31,214,regulation of epithelial cell proliferation,BP,TNFAIP3;APOE;EGFR;SFRP1;SULF2;HTRA1;STAT1;CTSV;SERPINB5;MAP2K5;PLXNB3;CD109;RICTOR;BMP6;VEGFB;FZD7;HYAL1;CYBA;FBXW7;GLUL;DAB2IP;VDR;NRARP;ZFP36L1;PBLD;TNFSF12;ERBB2;PPARG;KLF9;FOXP2;ECM1
9884,GO:0042178,0.0417474345426178,0.994051997946456,3,9,xenobiotic catabolic process,BP,GSTM2;ACSL1;GSTM3
16604,GO:0097479,0.0420134889286801,0.979443667186907,14,79,synaptic vesicle localization,BP,SYT8;SYN1;SYTL1;C2CD4C;BLOC1S4;NLGN2;RIMS3;SPG11;SYT15;VAMP2;BLOC1S3;SEPT5;DNM1;SYT7
5984,GO:0018916,0.0420710812925786,0.997371851653467,2,4,nitrobenzene metabolic process,BP,GSTM2;GSTM3
7279,GO:0031279,0.0421575369203694,0.989200652493912,5,19,regulation of cyclase activity,BP,NOS1;ADORA2B;GABBR1;GPR87;LTB4R2
5721,GO:0016863,0.0421744022167495,0.993777382511375,3,10,intramolecular oxidoreductase activity, transposing C=C bonds,MF,DDT;ECI1;EHHADH
15399,GO:0071688,0.0422533579216803,1,3,3,striated muscle myosin thick filament assembly,BP,OBSL1;MYH11;TTN
7049,GO:0030835,0.042320487352064,0.987384824440784,6,24,negative regulation of actin filament depolymerization,BP,SPTB;GSN;PLEKHH2;TRIOBP;CAPG;DMTN
13593,GO:0060087,0.0424972456750776,0.99733014440114,2,4,relaxation of vascular smooth muscle,BP,RGS2;ADORA2B
9028,GO:0035254,0.0428806731176789,0.985609405547045,7,30,glutamate receptor binding,MF,FLOT1;SQSTM1;HOMER2;CDK5R1;SHANK3;DLG4;SHANK2
6577,GO:0022410,0.0429634288013018,0.993807109035032,3,9,circadian sleep/wake cycle process,BP,NMU;CST3;PER3
12598,GO:0050802,0.0429634288013018,0.993807109035032,3,9,circadian sleep/wake cycle, sleep,BP,NMU;CST3;PER3
8711,GO:0034368,0.0429641446339492,0.993806963988081,3,9,protein-lipid complex remodeling,BP,APOE;PLA2G7;PLTP
8712,GO:0034369,0.0429641446339492,0.993806963988081,3,9,plasma lipoprotein particle remodeling,BP,APOE;PLA2G7;PLTP
17684,GO:1901615,0.042984142268571,0.970465937845257,44,327,organic hydroxy compound metabolic process,BP,SREBF1;AMACR;APOE;INPP5D;LMF1;ALDH1A3;PLCD3;SEC14L2;DGKQ;MVD;SRD5A3;D2HGDH;CYP26B1;PLCD1;PLCH2;SULT1E1;PER2;DDT;BMP6;PFKFB2;ACACB;PMEL;FGFR4;RETSAT;OSBPL5;SNCB;VDR;OSBPL1A;DUOX1;IMPA2;TKFC;PNPO;DHRS4;TRERF1;ISYNA1;RDH12;ACSS2;PLCB3;NUDT10;TH;LDLRAP1;GCNT4;PLTP;IP6K2
3259,GO:0006928,0.0430008129028285,0.964860790228772,154,1260,movement of cell or subcellular component,BP,POSTN;SERPINE2;GPNMB;TP53INP1;APOE;INPP5D;APCDD1;EGFR;CXCR1;DIXDC1;SFRP1;KIF26B;EPHB2;TNS1;PIK3R1;CXCL14;WNT3;VAV3;UNK;CSPG4;KITLG;ASAP3;WDR63;UNC5B;SDC3;PLEKHG5;FERMT1;PIK3C2G;PLXNB1;SPOCK1;MDM2;NDN;IFITM1;MYH11;RHOBTB2;NEO1;FLRT3;KIF26A;ARPIN;F2R;BLOC1S4;SPTB;CAPN7;DNAH1;TRPV4;GLI2;KLF7;RNF165;AVL9;SPG11;RHBDF1;RASGEF1A;C5;WIPF1;SNTA1;MINK1;ITGA2;SEMA4G;FAM110C;GLI3;TPGS1;MAP2K5;GAS8;BOC;ITGA6;KCNJ5;SRGAP3;MMP1;TRAK1;NISCH;INSR;CELSR1;MMP28;TTN;DDT;PLXNB3;SUN1;SCN4B;DOCK8;BLOC1S3;MDK;VEGFB;CABYR;PTK6;FAT2;HEXB;HYAL1;MMRN2;PEX7;BBS2;NPHP3;IDH2;PODXL;MCTP1;CDK5R1;NET1;EFNB3;SHANK3;SLIT3;SPRY2;IFT140;PAK6;APC2;ARAP1;ADARB1;LRP1;NPHP4;PLA2G7;MYO3B;LTB4R2;RET;ZMYND8;DAB2IP;MYSM1;SHROOM2;FGFR4;PIK3R2;MYO9A;RPS6KA5;DLG5;BTG1;BST2;EFS;PLXND1;DMTN;ACVR1B;TNNI2;NHSL1;MATN2;PTK7;LMNA;IRS2;ALOX15B;SCYL3;ZSWIM8;APBB2;PBLD;TNFSF12;PHPT1;KIF7;SRPX2;CD9;RANBP9;ERBB2;PPARG;FMNL3;SYNE2;ACKR3;PLTP;LAMB2;RIPK3;NFASC;TTLL1;ECM1
3450,GO:0007263,0.0430213694830378,0.994046819627265,3,8,nitric oxide mediated signal transduction,BP,APOE;EGFR;NOS1
10890,GO:0044449,0.0430378088638151,0.975950703078426,20,117,contractile fiber part,CC,FLNC;OBSL1;SYNC;MYL9;NOS1;OBSCN;MYH11;PARVB;ANK3;FHOD3;TTN;AHNAK2;SQSTM1;SLC2A1;SYNPO2;JPH2;TNNI2;KAT2B;SYNE2;NPNT
10627,GO:0043651,0.0430718811995155,0.991078580551681,4,14,linoleic acid metabolic process,BP,GSTM2;ALOXE3;ACSL1;ALOX15B
14111,GO:0060999,0.043085444006915,0.985525340235927,7,30,positive regulation of dendritic spine development,BP,APOE;CAPRIN2;BAIAP2;SHANK3;ZMYND8;DLG5;SHANK2
8903,GO:0034754,0.0431246109651449,0.980895019170178,11,63,cellular hormone metabolic process,BP,ALDH1A3;DGKQ;SRD5A3;CYP26B1;UGT1A3;SULT1E1;BMP6;RETSAT;HSD17B14;DHRS4;RDH12
7022,GO:0030803,0.043244571889369,0.994003279728317,3,8,negative regulation of cyclic nucleotide biosynthetic process,BP,GABBR1;GPR87;LTB4R2
7037,GO:0030818,0.043244571889369,0.994003279728317,3,8,negative regulation of cAMP biosynthetic process,BP,GABBR1;GPR87;LTB4R2
1405,GO:0003341,0.0432937064878127,0.986872884495801,6,26,cilium movement,BP,DNAH1;GAS8;CABYR;BBS2;NPHP3;TTLL1
683,GO:0001894,0.0433494508325953,0.976063285562941,19,120,tissue homeostasis,BP,TNFAIP3;INPP5D;EGFR;IL20RB;F2R;HOMER2;BBS2;NPHP3;IQCB1;CA2;ERCC6;NPHP4;ACP5;BBS1;IL20RA;BBS10;PBLD;TUB;RDH12
7810,GO:0032371,0.0434193215579995,0.986825402582178,6,26,regulation of sterol transport,BP,APOE;LRP1;ABCA2;PPARG;LDLRAP1;PLTP
7813,GO:0032374,0.0434193215579995,0.986825402582178,6,26,regulation of cholesterol transport,BP,APOE;LRP1;ABCA2;PPARG;LDLRAP1;PLTP
3631,GO:0008092,0.0436402669520823,0.966505576687056,87,668,cytoskeletal protein binding,MF,TAGLN;MAP6;APOE;EGFR;ESPN;FLNC;PKD2;SYN1;DIXDC1;OBSL1;KIF26B;EPS8L2;TNS1;BRSK1;IMPACT;MARCKSL1;NDRG1;NDN;OBSCN;MYH11;PARVB;PHACTR3;KIF26A;RGS2;SPTB;TUBGCP5;TRPV4;CORO6;ANK3;MAPK8IP3;CLMN;WIPF1;SNTA1;FAM110C;FHOD3;TPGS1;GAS8;LZTS1;TRAK1;GSN;BAIAP2;TTN;PLEKHH2;TRIOBP;S100A4;MICALL2;EPB41L3;HOMER2;DNM1;CDK5R1;HOOK2;EPB41L4A;SHANK3;CLIP2;WASH3P;KCNMA1;APC2;FMNL2;MX2;RPH3AL;REEP4;CAPG;SYNPO2;MYO3B;SHROOM2;KLHL3;MYO9A;DLG5;TNS4;EML3;DMTN;ARFGEF2;ALMS1;SHROOM4;CCDC88B;TNNI2;MARK4;S100A6;KIF7;PTPN3;MPRIP;SSH3;PPARG;FMNL3;SYNE2;MAP1A;EML2
16427,GO:0097110,0.0440040153842009,0.982493895968359,9,45,scaffold protein binding,MF,KRT15;NOS1;MDM2;NLGN4Y;BAIAP2;MAP2K2;SHANK3;DLG4;CIT
8674,GO:0034284,0.0443750426072491,0.974989946851283,20,130,response to monosaccharide,BP,SREBF1;GJD3;CTSV;ITGA2;VAMP2;ENDOG;PLA2G6;TXNIP;CYBA;MLXIPL;PFKFB2;GLUL;IRS2;ANO1;ERN1;PHPT1;GPR68;TH;PRKACA;GCLC
13678,GO:0060252,0.0443798568734921,0.993780318719914,3,8,positive regulation of glial cell proliferation,BP,ETV5;PLAG1;UFL1
14485,GO:0062013,0.0444324106581713,0.976863202644959,16,96,positive regulation of small molecule metabolic process,BP,PTHLH;SREBF1;APOE;NOS1;RAPGEF3;MLYCD;ADORA2B;INSR;BMP6;MLXIPL;PFKFB2;EPM2AIP1;KAT2B;IRS2;PPARG;LDLRAP1
425,GO:0001133,0.0445464032318895,0.990830511374382,4,13,RNA polymerase II transcription factor activity, sequence-specific transcription regulatory region DNA binding,MF,THRA;VDR;RORA;PPARG
6437,GO:0021756,0.0445519457172505,0.990828994091157,4,13,striatum development,BP,ALDH1A3;BBS2;SHANK3;FOXP2
10868,GO:0044420,0.0447345472374172,0.977361681062354,15,82,extracellular matrix component,CC,TGFBI;SMOC2;COL7A1;TNXB;LTBP1;ITGA6;LOXL1;CST3;MMRN2;THSD4;NID1;MATN2;EFEMP2;LAMB2;NPNT
19398,GO:1990000,0.0447631900406316,0.990610326724613,4,14,amyloid fibril formation,BP,APOE;MDM2;GSN;RIPK3
6456,GO:0021782,0.0447648703285406,0.979307608140082,12,66,glial cell development,BP,EGFR;POU3F1;TENM4;NDRG1;GSN;AHNAK2;LRP1;PRX;MXRA8;CD9;HDAC11;LAMB2
16404,GO:0097062,0.0448902448119428,0.990736256828529,4,13,dendritic spine maintenance,BP,APOE;INSR;TANC1;ZMYND8
4333,GO:0009887,0.045790239709468,0.965033366945087,82,635,animal organ morphogenesis,BP,TNFAIP3;ACTA2;GAMT;EGFR;FAM20C;PKD2;ALDH1A3;LRIG3;SLITRK6;SFRP1;KIF26B;EPHB2;SULF2;HTRA1;ZFPM1;SDK2;PRICKLE2;STAT1;HOXA3;CYP26B1;GAA;NAGLU;MDM2;PDCD4;SERPINB5;TRPV4;GLI2;ARHGEF19;THBS3;WWTR1;ITGA2;GLI3;IRX4;NEK8;ITGA6;INSR;CELSR1;TTN;TRIOBP;BMP6;FZD7;ETV5;DLX3;HYAL1;PEX7;BBS2;NPHP3;PLAG1;CA2;SHANK3;SLIT3;SPRY2;MEF2D;IFT140;KLK5;FBXW7;THRA;ADARB1;NAB2;ACP5;DGCR2;MYO3B;TEAD2;SHROOM2;BBS5;AREG;KLHL3;DLG5;VDR;PLXND1;PALB2;PTK7;TCF7;SHANK2;STAT6;COL13A1;TH;GCNT4;FOXP2;SMURF1;NPNT;CTNNBIP1
6256,GO:0019852,0.0458697837270364,0.993209741904132,3,9,L-ascorbic acid metabolic process,BP,SLC2A3;SLC2A1;GCLC
10373,GO:0043217,0.0460252523808818,0.990622728457725,4,12,myelin maintenance,BP,NDRG1;AHNAK2;EPB41L3;PRX
5310,GO:0016021,0.0460271987686958,0.960396757406215,303,2695,integral component of membrane,CC,ITGB6;GPNMB;IFI6;SREBF1;NYNRIN;APCDD1;LOC441081;ADAM19;LMF1;HSPA2;EGFR;PTPRS;PKD2;SYT8;CXCR1;LRIG3;SLITRK6;SFRP1;PCDH1;EPHB2;TMEM129;MARVELD1;ORAI3;EVC;ST6GALNAC2;CSPG4;CYBRD1;ELFN2;TENM4;KCNAB2;KITLG;TP53I11;SDK2;ZDHHC1;VAMP3;SNN;REEP2;KCNJ15;MC1R;SRD5A3;OR2A4;CSMD2;NSG1;UNC5B;SLC16A5;KDSR;ITGB5;GJD3;NOS1;B4GALNT4;SDC3;BCAM;SCARA3;TMEM200B;PLXNB1;KCNC4;SLC29A4;ITPR3;IFITM1;ST6GALNAC6;FCGRT;CSMD3;PIK3IP1;GPRC5C;HLA-B;TNFSF10;HGSNAT;UGT1A3;CERS4;NEO1;NINJ1;FAM210B;NLGN4Y;FLRT3;GAL3ST4;B4GALT6;TMEM63C;IL20RB;ADGRB2;F2R;TMEM134;SLC24A1;SLC27A3;ADGRF4;TRPV4;TMC6;TMEM128;FLOT1;NLGN2;ADORA2B;LAMP3;SLC13A5;CLMN;AVL9;G6PC3;GJC2;RHBDF1;TSPAN18;TMEM204;CLCN6;DIRC2;FNDC4;C5;ADGRL1;AMIGO2;TNFRSF14;MBOAT2;LHFPL2;ITGA2;SEMA4G;SYT15;SPPL2B;VAMP2;BOC;ITGA6;KCNJ5;INSR;CELSR1;ST3GAL5;TMC7;SCNN1A;PLXNB3;SUN1;LPAR5;CNTNAP3;CYP2D7;FAM171A2;SCN4B;MGST2;PILRB;SLC27A1;PGAP1;TM7SF3;NRSN2;SIRPB2;TMEM9;B4GALT2;TMCC3;NIPAL2;PEX10;SLC2A3;TCIRG1;SLC12A7;TMEM8B;FZD7;FAT2;TMEM117;METTL23;CLCA2;KIAA0319L;B3GNT9;PAQR4;MXRA7;ATP6V0A2;PEX11B;PODXL;IFI27;MALL;TNFRSF21;PLD3;ZDHHC12;ABHD14A;MCTP1;ANO9;PIGZ;EFNB3;SHANK3;HFE;SCART1;CYBA;EDA2R;MRC2;GABBR1;LRP11;KCNMA1;GPR87;TMEM164;PAQR6;RNF170;ASTN2;SLC2A1;ERMAP;REEP4;GPR155;NDST2;SLC38A4;TP53I13;PRR7;LRP1;LRRN3;HLA-A;TSNARE1;CCDC136;ACP5;DLK2;KCNG1;SLC48A1;CD99L2;DGCR2;PMEL;JPH2;LTB4R2;RET;SLC37A2;OLFM2;SYT7;FGFR4;IL20RA;SCN2A;OSBPL5;AREG;TMEM203;MYO9A;BST2;LETMD1;CACNB3;DPY19L2P2;VIPR1;PLXND1;MARCH8;TMEM80;MPPE1;TMCO6;LRRC37A3;LPAR6;ORAI2;SLC35E2B;LMTK3;SLC36A4;TMEM231;PMP22;ACVR1B;TMX4;APCDD1L;KREMEN1;CADM4;DLG4;ESYT2;ADCK5;NAT14;CD68;DUOX1;SLC22A15;TMEM143;SLC35G2;PTK7;SHANK2;TNFRSF25;NEMP2;XYLT1;MXRA8;CLSTN3;GLMP;ACSL1;APOLD1;ANO1;ERN1;GPR21;LAPTM4A;MAN1B1;FAAH;MFSD11;CCDC90B;TNFSF12;TAS1R3;CERS5;GPR132;SLC43A1;CPT1C;DNAJC4;TRAF5;GOLGB1;CD9;CACNB1;GJB5;COL13A1;ERBB2;SYNGR1;GPR68;XKR9;ZDHHC24;PAQR7;PQLC3;ABCA2;AKAP6;SLC2A11;PRKACA;DNAJC22;GCNT4;SYNE2;ACKR3;TMEM212;NFASC;KCNS3;CLCN7;CALHM2;NPNT;HERPUD2;PEMT;ABCA11P;GLIPR1L2;TM4SF1;SERINC3
4230,GO:0009410,0.0463342723254225,0.972240894065765,24,166,response to xenobiotic stimulus,BP,CES2;EGFR;BPHL;PRKACB;CYP26B1;MDM2;UGT1A3;CYP3A5;PTGS1;GSTM2;CES3;CYP2D7;MGST2;AKR7A2;HOMER2;SRR;PDE2A;ACSL1;GSTM3;TH;RORA;PPARG;AIP;GCLC
16576,GO:0097421,0.046337238080934,0.985641747654206,6,27,liver regeneration,BP,EGFR;SRSF5;SULF2;GLI3;HFE;PTPN3
554,GO:0001676,0.0465321352561201,0.979146994743733,11,62,long-chain fatty acid metabolic process,BP,ACOT1;SLC27A3;PTGS1;GSTM2;CYP2D7;SLC27A1;ALOXE3;ACSL1;ALOX15B;FAAH;ACOT2
3567,GO:0007611,0.0465631515845007,0.973243243613969,21,133,learning or memory,BP,APOE;EGFR;EPHB2;ITPR3;CRTC1;NLGN4Y;INSR;TANC1;MDK;B4GALT2;SYNGAP1;PLA2G6;SHANK3;ATXN1;THRA;BRINP1;DDHD2;DLG4;SHANK2;TH;FOXP2
4911,GO:0014850,0.0466830264559689,0.990071209881535,4,14,response to muscle activity,BP,POSTN;PERM1;ITGA2;TNS2
12592,GO:0050793,0.0467075169615131,0.960966450469569,193,1645,regulation of developmental process,BP,TNFAIP3;POSTN;SERPINE2;ULK2;GPNMB;SIK1;TP53INP1;PTHLH;APOE;INPP5D;GAMT;OAS2;EGFR;PTPRS;FAM20C;CAPRIN2;ASH2L;DIXDC1;SLITRK6;SFRP1;OBSL1;KCTD11;EPHB2;PIK3R1;ADAMTS7;KDM3A;CXCL14;TSC22D3;SULF2;WNT3;ISG15;TENM4;RGMA;ZFPM1;KITLG;CUL7;PRICKLE2;STAT1;IMPACT;MYL9;NOS1;PRKACB;KLF13;NFATC4;FERMT1;CYP26B1;HSF4;PLXNB1;SPOCK1;MDM2;CRTC1;IFITM1;CSMD3;LTBP4;PARVB;RHOBTB2;RAPGEF3;FAM210B;CTSV;FLRT3;ARPIN;ADGRB2;PDCD4;RTN4RL1;ZFP36L2;TRPV4;FLOT1;GLI2;NLGN2;GJC2;ARHGEF19;SULT1E1;PER2;C5;WIPF1;ADGRL1;AMIGO2;WWTR1;SEMA4G;GLI3;MAP2K5;BOC;LTBP3;TCFL5;TRAK1;JARID2;NUPR1;INSR;CCDC85B;CELSR1;BAIAP2;PLXNB3;TRIOBP;CD109;BMP6;VEGFB;PTK6;FZD7;ETV5;SYNGAP1;FAM213A;EPB41L3;HEXB;KDM4C;HYAL1;CST3;MMRN2;GDF15;BBS2;TCF4;NPHP3;PLAG1;IDH2;TNFRSF21;IQCB1;CDK5R1;NET1;CA2;EFNB3;SHANK3;ADIRF;HMG20B;AGO4;SPRY2;FBXW7;CDK5RAP3;LMO2;THRA;APC2;ARAP1;RAI1;FMNL2;ACACB;NAB2;LRP1;LRRN3;DLK2;BRINP1;JPH2;MAF;RET;ZMYND8;DAB2IP;CASZ1;TEAD2;MYSM1;DDHD2;OLFM2;AREG;DLG5;BTG1;VDR;MAMSTR;TNRC6C;PLXND1;ZMYM3;DMTN;STAT2;WWC3;PMP22;NRARP;ACVR1B;DLG4;PTK7;SHANK2;ZFP36L1;LMNA;CLSTN3;KAT2B;APOLD1;ALOX15B;GPR21;ZSWIM8;PBLD;TNFSF12;STAT6;SOX13;SRPX2;ERBB2;GPR68;AKAP6;RORA;SSH3;PPARG;PRKACA;FMNL3;UFL1;CCDC3;FOXP2;SMURF1;NPNT;CTNNBIP1;ECM1
15115,GO:0071229,0.0469640497427,0.972977648731025,21,134,cellular response to acid chemical,BP,SREBF1;EGFR;PKD2;SFRP1;WNT3;NFATC4;CYP26B1;SESN3;BAIAP2;PTK6;FZD7;COL6A1;SESN1;CYBA;GNG2;BRINP1;RET;TEAD2;PTK7;PPARG;GCLC
3265,GO:0006936,0.0471735070461105,0.971141668171501,26,168,muscle contraction,BP,ACTA2;GAMT;OBSL1;SULF2;MYL9;ITGB5;NOS1;GAA;MYH11;RGS2;F2R;ADORA2B;SNTA1;GSTM2;ITGA2;NMU;KCNJ5;TTN;SCN4B;VEGFB;PLA2G6;BBS2;KCNMA1;TNNI2;PRKACA;NPNT
12877,GO:0051239,0.0473660329106265,0.960129524579425,211,1820,regulation of multicellular organismal process,BP,TNFAIP3;POSTN;SERPINE2;ULK2;GPNMB;PTHLH;SREBF1;APOE;INPP5D;GAMT;OAS2;DDX60;EGFR;PTPRS;FAM20C;CAPRIN2;ASH2L;DIXDC1;SLITRK6;SFRP1;OBSL1;KCTD11;EPHB2;PIK3R1;ADAMTS7;KDM3A;TSC22D3;RNF135;SULF2;WNT3;HERC5;ISG15;TENM4;RGMA;ZFPM1;KITLG;CUL7;PRICKLE2;MC1R;STAT1;IMPACT;MYL9;NOS1;PRKACB;CRY1;KLF13;NFATC4;FERMT1;CYP26B1;GAA;PLXNB1;SPOCK1;ITPR3;MDM2;CRTC1;IFITM1;CSMD3;RAPGEF3;FAM210B;CTSV;FLRT3;RGS2;IL20RB;ADGRB2;F2R;PDCD4;CAPN7;RTN4RL1;ZFP36L2;TRPV4;FLOT1;GLI2;NLGN2;ADORA2B;GJC2;ARHGEF19;PER2;C5;SNTA1;ADGRL1;GSTM2;AMIGO2;WWTR1;ITGA2;SEMA4G;GLI3;NMU;MAP2K5;KCNJ5;TRAK1;JARID2;NUPR1;INSR;CELSR1;BAIAP2;DDT;PLXNB3;ZNF287;CD109;SCN4B;DHX58;SLC27A1;BMP6;NLRX1;VEGFB;PTK6;FZD7;ETV5;SYNGAP1;FAM213A;KDM4C;HYAL1;CST3;MMRN2;BBS2;TCF4;NPHP3;PLAG1;IDH2;TNFRSF21;TREX1;CDK5R1;CA2;EFNB3;SHANK3;HFE;HMG20B;CYBA;AGO4;SPRY2;RAB11FIP3;FBXW7;CDK5RAP3;LMO2;THRA;RAI1;ELF1;ACACB;NLRP1;ERMAP;LRP1;LRRN3;ACP5;BRINP1;WNK1;JPH2;ZBTB20;MAF;RET;ZMYND8;DAB2IP;CASZ1;MYSM1;IFI16;SYT7;IL20RA;AREG;RPS6KA5;DLG5;BTG1;BST2;VDR;CACNB3;TNRC6C;PLXND1;DMTN;ARFGEF2;WWC3;PMP22;NRARP;ACVR1B;KREMEN1;CCDC88B;DLG4;TNNI2;PTK7;SHANK2;RSAD2;ZFP36L1;LMNA;CLSTN3;KAT2B;APOLD1;ALOX15B;GPR21;TKFC;ZSWIM8;PBLD;TNFSF12;STAT6;SOX13;SRPX2;CD9;CACNB1;ERBB2;GPR68;AKAP6;TH;RORA;SSH3;PPARG;PRKACA;SERPING1;UFL1;RIPK3;PER3;FOXP2;SMURF1;NPNT;CTNNBIP1;ECM1
4785,GO:0010977,0.0475085410162563,0.974491027519394,17,103,negative regulation of neuron projection development,BP,ULK2;APOE;PTPRS;EPHB2;WNT3;RGMA;NFATC4;SPOCK1;MDM2;RTN4RL1;TRPV4;SEMA4G;SYNGAP1;CDK5R1;EFNB3;LRP1;PMP22
3578,GO:0007623,0.0476603577909478,0.972522192953979,21,135,circadian rhythm,BP,SIK1;SREBF1;EGFR;CRY2;CRY1;NAGLU;CRTC1;PER2;THRAP3;BHLHE40;NMU;HEBP1;CST3;MAPK10;RAI1;DBP;TH;RORA;PPARG;KLF9;PER3
16503,GO:0097237,0.0478452930833355,0.971917667799374,22,155,cellular response to toxic substance,BP,TNFAIP3;TP53INP1;APOE;GPX3;TXNRD3;IMPACT;MDM2;PTGS1;GSTM2;MGST2;ENDOG;FAM213A;CST3;NET1;SESN1;ADIRF;XRN1;DUOX1;STAT6;PRDX5;GSTM3;TH
12668,GO:0050905,0.0481285703638572,0.98056501719104,9,44,neuromuscular process,BP,ALDH1A3;SLITRK6;KCNAB2;GAA;BLOC1S4;NLGN2;HEXB;ADARB1;DLG4
7268,GO:0031258,0.0481761699992107,0.987187177103828,5,19,lamellipodium membrane,CC,CSPG4;DOCK8;APC2;PLXND1;SYNE2
10050,GO:0042554,0.0482531093209575,0.989474684754521,4,15,superoxide anion generation,BP,EGFR;CYBA;ACP5;DUOX1
12669,GO:0050906,0.0486130100060013,0.984687821102995,6,28,detection of stimulus involved in sensory perception,BP,SERPINE2;EYS;OR2A4;ITGA2;ANO1;TAS1R3
14183,GO:0061135,0.0488977830491734,0.97608096147799,13,83,endopeptidase regulator activity,MF,SERPINE2;COL7A1;SPOCK1;SERPINB5;C5;NAIP;CD109;CST3;TFPI2;BST2;PCSK1N;PRDX5;SERPING1
7002,GO:0030695,0.0489284075465244,0.96746786985223,36,249,GTPase regulator activity,MF,GPSM1;ALS2CL;RALGDS;EVI5L;VAV3;ASAP3;TBC1D8;PLXNB1;CHN2;RASA4;RGS2;ACAP3;AGAP4;RALGAPA1;ARHGEF19;TBC1D19;ASAP2;SRGAP3;RIN1;ARHGEF1;SYNGAP1;FAM13A;ARHGAP33;ARHGAP27;AGAP6;AGAP7P;ARAP1;TBC1D17;RGS12;APPL2;DAB2IP;PIK3R2;MYO9A;TBC1D16;SGSM2;ARHGAP23
7762,GO:0032290,0.048974829862795,0.997602971286446,2,3,peripheral nervous system myelin formation,BP,AHNAK2;PRX
4687,GO:0010839,0.0489908752998638,0.98959274150846,4,13,negative regulation of keratinocyte proliferation,BP,CTSV;CD109;VDR;KLF9
5775,GO:0017000,0.0490090477618732,0.989407455107981,4,14,antibiotic biosynthetic process,BP,KDM3A;CYBA;DUOX1;ACSS2
545,GO:0001665,0.0492107844875218,0.996641155860485,2,4,alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity,MF,ST6GALNAC2;ST6GALNAC6
10013,GO:0042471,0.0492291397443799,0.977809273480788,11,59,ear morphogenesis,BP,ALDH1A3;LRIG3;SLITRK6;EPHB2;NAGLU;GLI2;CELSR1;TRIOBP;SPRY2;MYO3B;PTK7
7029,GO:0030810,0.0493228408210385,0.982726469106403,7,33,positive regulation of nucleotide biosynthetic process,BP,PTHLH;APOE;NOS1;ADORA2B;INSR;MLXIPL;PFKFB2
17458,GO:1900373,0.0493228408210385,0.982726469106403,7,33,positive regulation of purine nucleotide biosynthetic process,BP,PTHLH;APOE;NOS1;ADORA2B;INSR;MLXIPL;PFKFB2
14339,GO:0061577,0.0496602413886778,0.992711022143295,3,8,calcium ion transmembrane transport via high voltage-gated calcium channel,BP,NOS1;CACNB3;CACNB1
8547,GO:0033981,0.049774372646567,1,1,1,D-dopachrome decarboxylase activity,MF,DDT
4031,GO:0009065,0.0499381212544498,0.98646640057727,5,20,glutamine family amino acid catabolic process,BP,GLUD1;NOS1;PRODH;ALDH4A1;GLUL
4900,GO:0014831,0.0499473585972394,0.996561970392847,2,4,gastro-intestinal system smooth muscle contraction,BP,SULF2;NMU
6680,GO:0030054,0.0499697586328997,0.960383870646156,107,869,cell junction,CC,ITGB6;DDB2;EGFR;PTPRS;FLNC;PKD2;SYN1;DIXDC1;OBSL1;PCDH1;TNS1;PIK3R1;BRSK1;CSPG4;KCNAB2;HOXC5;SDK2;VAMP3;ASAP3;CAMK2N1;ITGB5;GJD3;PLEKHG5;FERMT1;NDRG1;PARVB;NLGN4Y;FLRT3;PPL;TRPV4;FLOT1;NLGN2;ANK3;RIMS3;GJC2;TMEM204;FRMD4B;SNTA1;ADGRL1;MINK1;ITGA2;VAMP2;ITGA6;BSN;LZTS1;GSN;CEP68;BAIAP2;TANC1;TRIOBP;SCN4B;NLRX1;MICALL2;MAP2K2;FAT2;EPB41L3;SHARPIN;CLCA2;UBOX5;HOMER2;PSD3;PODXL;KLHL24;MCTP1;SHANK3;CYBA;MRC2;GABBR1;PAK6;SLC2A1;TNS2;PRR7;LRP1;NPHP4;RGS12;SYNPO2;CD99L2;PRX;SHROOM2;OLFM2;SYT7;FGFR4;SCN2A;DLG5;TNS4;ARFGEF2;PMP22;SHROOM4;CADM4;DLG4;PTK7;SHANK2;DMXL2;CPT1C;SRPX2;CD9;GJB5;COL13A1;SYNGR1;MPRIP;AKAP6;SLC2A11;MPP7;SYNE2;PARD6G;IP6K2;NFASC
6302,GO:0019935,0.0500157629999745,0.976445160865447,12,67,cyclic-nucleotide-mediated signaling,BP,PTHLH;APOE;DGKQ;MC1R;NOS1;RAPGEF3;RGS2;ADORA2B;GNG2;PDE2A;UCN2;AKAP6
10708,GO:0044057,0.0500336699210226,0.966847723588305,35,248,regulation of system process,BP,SREBF1;EGFR;TENM4;MYL9;NOS1;CRY1;GAA;ITPR3;MDM2;RGS2;F2R;NLGN2;ADORA2B;PER2;SNTA1;GSTM2;ITGA2;NMU;KCNJ5;JARID2;SCN4B;BMP6;TNFRSF21;CYBA;RAB11FIP3;THRA;WNK1;CACNB3;TNNI2;LMNA;CACNB1;AKAP6;TH;PRKACA;NPNT
9758,GO:0039534,0.0502066331300341,0.996533930786134,2,4,negative regulation of MDA-5 signaling pathway,BP,DHX58;TKFC
1086,GO:0002674,0.0502136018282456,0.996533175954149,2,4,negative regulation of acute inflammatory response,BP,IL20RB;PPARG
16843,GO:0098794,0.0502841924105363,0.966290238716997,37,257,postsynapse,CC,PTPRS;SYN1;EPHB2;KCNAB2;CAMK2N1;NSG1;NOS1;SPOCK1;NLGN4Y;F2R;NLGN2;ANK3;MINK1;BSN;LZTS1;BAIAP2;TANC1;SYNGAP1;EPB41L3;SHARPIN;HOMER2;PSD3;DNM1;CDK5R1;SHANK3;FBXO2;GABBR1;KCNMA1;PRR7;ZMYND8;DLG5;DMTN;ARFGEF2;DLG4;SHANK2;CLSTN3;COL13A1
13232,GO:0051932,0.050311997344895,0.986453467410336,5,19,synaptic transmission, GABAergic,BP,NLGN2;NISCH;DNM1;CA2;CLSTN3
7782,GO:0032330,0.0503319201717968,0.98424218251289,6,25,regulation of chondrocyte differentiation,BP,PTHLH;ADAMTS7;GLI2;GLI3;BMP6;MAF
9001,GO:0035176,0.0503455237611442,0.982413431975763,7,31,social behavior,BP,NLGN4Y;SHANK3;ATXN1;BRINP1;DLG4;SHANK2;TH
13117,GO:0051703,0.0503455237611442,0.982413431975763,7,31,intraspecies interaction between organisms,BP,NLGN4Y;SHANK3;ATXN1;BRINP1;DLG4;SHANK2;TH
4321,GO:0009820,0.0504614743344267,0.996506286469437,2,4,alkaloid metabolic process,BP,CYP3A5;TH
18258,GO:1903169,0.0505892483285308,0.975273744726441,13,75,regulation of calcium ion transmembrane transport,BP,HSPA2;PKD2;NOS1;F2R;GJC2;GSTM2;PLA2G6;CYBA;JPH2;CACNB3;CACNB1;AKAP6;PRKACA
6299,GO:0019932,0.0510474250132781,0.969146973259091,24,160,second-messenger-mediated signaling,BP,PTHLH;APOE;EGFR;PKD2;DGKQ;MC1R;NOS1;NFATC4;ITPR3;RAPGEF3;RGS2;ADGRB2;ADORA2B;ADGRL1;GSTM2;HOMER2;MCTP1;GNG2;JPH2;PDE2A;DMTN;UCN2;AKAP6;PRKACA
9780,GO:0040011,0.0510554518262457,0.958555190822749,133,1093,locomotion,BP,POSTN;SERPINE2;GPNMB;TP53INP1;APOE;INPP5D;APCDD1;EGFR;CXCR1;DIXDC1;SFRP1;EPHB2;TNS1;PIK3R1;CXCL14;WNT3;VAV3;UNK;CSPG4;KITLG;ASAP3;UNC5B;SDC3;PLEKHG5;FERMT1;PIK3C2G;PLXNB1;SPOCK1;MDM2;NDN;IFITM1;RHOBTB2;NEO1;FLRT3;ARPIN;F2R;SPTB;CAPN7;DNAH1;TRPV4;GLI2;KLF7;RNF165;AVL9;RHBDF1;RASGEF1A;C5;MINK1;ITGA2;SEMA4G;FAM110C;GLI3;TPGS1;MAP2K5;GAS8;BOC;ITGA6;SRGAP3;MMP1;NISCH;INSR;CELSR1;MMP28;DDT;PLXNB3;SUN1;DOCK8;MDK;VEGFB;PTK6;FAT2;HEXB;HYAL1;PLA2G6;MMRN2;PEX7;BBS2;IDH2;PODXL;MCTP1;CDK5R1;NET1;EFNB3;SHANK3;SLIT3;SPRY2;PAK6;APC2;ADARB1;LRP1;NPHP4;PLA2G7;LTB4R2;RET;ZMYND8;DAB2IP;MYSM1;SHROOM2;FGFR4;PIK3R2;RPS6KA5;DLG5;BTG1;BST2;EFS;PLXND1;DMTN;ACVR1B;NHSL1;MATN2;PTK7;LMNA;IRS2;ALOX15B;SCYL3;ZSWIM8;APBB2;PBLD;TNFSF12;PHPT1;SRPX2;RANBP9;ERBB2;PPARG;FMNL3;SYNE2;ACKR3;PLTP;LAMB2;RIPK3;NFASC;TTLL1;ECM1
6049,GO:0019199,0.051105567341371,0.977949895134785,10,50,transmembrane receptor protein kinase activity,MF,EGFR;EPHB2;LTBP4;LTBP1;INSR;EFNB3;RET;FGFR4;ACVR1B;ERBB2
4299,GO:0009749,0.0511161019548841,0.971167017789326,19,124,response to glucose,BP,SREBF1;GJD3;CTSV;VAMP2;ENDOG;PLA2G6;TXNIP;CYBA;MLXIPL;PFKFB2;GLUL;IRS2;ANO1;ERN1;PHPT1;GPR68;TH;PRKACA;GCLC
8194,GO:0032956,0.0511464326649929,0.966259660971949,34,241,regulation of actin cytoskeleton organization,BP,DIXDC1;SFRP1;EPS8L2;PIK3R1;ASAP3;OR2A4;RHOBTB2;RAPGEF3;CTSV;ARPIN;SPTB;ARHGEF19;WIPF1;FHOD3;CELSR1;GSN;BAIAP2;PLEKHH2;TRIOBP;RICTOR;WHAMMP3;CDK5R1;SHANK3;WASH3P;ARAP1;CAPG;LRP1;SYNPO2;BST2;DMTN;ALMS1;PHPT1;SSH3;CIT
11268,GO:0045595,0.0513861971662829,0.958146510786107,137,1150,regulation of cell differentiation,BP,POSTN;SERPINE2;ULK2;SIK1;TP53INP1;PTHLH;APOE;INPP5D;EGFR;PTPRS;FAM20C;CAPRIN2;ASH2L;DIXDC1;SFRP1;OBSL1;KCTD11;EPHB2;PIK3R1;ADAMTS7;KDM3A;CXCL14;WNT3;TENM4;RGMA;ZFPM1;KITLG;CUL7;STAT1;IMPACT;MYL9;NOS1;KLF13;NFATC4;CYP26B1;HSF4;PLXNB1;SPOCK1;MDM2;CRTC1;IFITM1;CSMD3;LTBP4;FAM210B;CTSV;PDCD4;RTN4RL1;ZFP36L2;TRPV4;FLOT1;GLI2;GJC2;SULT1E1;PER2;WWTR1;SEMA4G;GLI3;BOC;LTBP3;TCFL5;TRAK1;CCDC85B;BAIAP2;PLXNB3;TRIOBP;CD109;BMP6;PTK6;FZD7;ETV5;SYNGAP1;FAM213A;KDM4C;GDF15;TCF4;NPHP3;PLAG1;IDH2;TNFRSF21;IQCB1;CDK5R1;NET1;CA2;EFNB3;SHANK3;ADIRF;HMG20B;AGO4;SPRY2;FBXW7;CDK5RAP3;LMO2;THRA;APC2;LRP1;DLK2;BRINP1;MAF;RET;ZMYND8;DAB2IP;CASZ1;TEAD2;OLFM2;AREG;DLG5;BTG1;VDR;MAMSTR;TNRC6C;PLXND1;DMTN;PMP22;NRARP;ACVR1B;DLG4;PTK7;SHANK2;ZFP36L1;KAT2B;APOLD1;ALOX15B;ZSWIM8;PBLD;SOX13;ERBB2;GPR68;AKAP6;RORA;SSH3;PPARG;PRKACA;UFL1;CCDC3;SMURF1;NPNT;CTNNBIP1
1608,GO:0004033,0.0514024057563099,0.988411481939788,4,16,aldo-keto reductase (NADP) activity,MF,KCNAB2;AKR7A2;DHRS4;RDH12
19265,GO:1905521,0.0514058039836248,0.988549597592738,4,15,regulation of macrophage migration,BP,TRPV4;C5;MMP28;DDT
16137,GO:0090177,0.0514598570088346,0.988887356991139,4,13,establishment of planar polarity involved in neural tube closure,BP,SFRP1;CELSR1;NPHP3;PTK7
16138,GO:0090178,0.0514598570088346,0.988887356991139,4,13,regulation of establishment of planar polarity involved in neural tube closure,BP,SFRP1;CELSR1;NPHP3;PTK7
5507,GO:0016460,0.051498869932238,0.987250567598649,5,13,myosin II complex,CC,OBSL1;MYL9;MYH11;TTN;SHROOM4
13163,GO:0051790,0.0519076636790746,0.996347834701716,2,4,short-chain fatty acid biosynthetic process,BP,THNSL2;ACSS2
5522,GO:0016494,0.051916551077254,0.996346852707222,2,4,C-X-C chemokine receptor activity,MF,CXCR1;ACKR3
1186,GO:0002833,0.0521518615962121,0.98335712978078,6,27,positive regulation of response to biotic stimulus,BP,DDX60;LRSAM1;DHX58;BMP6;CYBA;KLK5
13749,GO:0060349,0.0522495846801454,0.977292043735552,10,52,bone morphogenesis,BP,CYP26B1;TRPV4;THBS3;GLI3;BMP6;PEX7;MEF2D;NAB2;ACP5;COL13A1
763,GO:0002016,0.0522904982337613,1,1,1,regulation of blood volume by renin-angiotensin,BP,CYBA
765,GO:0002019,0.0522904982337613,1,1,1,regulation of renal output by angiotensin,BP,CYBA
1279,GO:0003083,0.0522904982337613,1,1,1,negative regulation of renal output by angiotensin,BP,CYBA
1291,GO:0003106,0.0522904982337613,1,1,1,negative regulation of glomerular filtration by angiotensin,BP,CYBA
4933,GO:0014895,0.0522904982337613,1,1,1,smooth muscle hypertrophy,BP,CYBA
3772,GO:0008328,0.0523691371751422,0.985737653889262,5,19,ionotropic glutamate receptor complex,CC,SHANK3;OLFM2;DLG4;SHANK2;CPT1C
16892,GO:0098878,0.0523691371751422,0.985737653889262,5,19,neurotransmitter receptor complex,CC,SHANK3;OLFM2;DLG4;SHANK2;CPT1C
12657,GO:0050885,0.0524649312150243,0.983402131605628,6,25,neuromuscular process controlling balance,BP,ALDH1A3;GAA;BLOC1S4;NLGN2;HEXB;DLG4
13636,GO:0060170,0.0525320453489503,0.978382930109966,9,45,ciliary membrane,CC,PKD2;EVC;SCNN1A;BBS2;SHANK3;BBS1;BBS5;TMEM231;SHANK2
13119,GO:0051705,0.0527106860855356,0.979722475205559,8,38,multi-organism behavior,BP,NLGN4Y;SHANK3;ATXN1;BRINP1;DLG4;SHANK2;TH;GCNT4
5470,GO:0016405,0.052834020549168,0.988291479039171,4,14,CoA-ligase activity,MF,SLC27A3;SLC27A1;ACSL1;ACSS2
16983,GO:0099094,0.0529699011510748,0.981212642680768,7,32,ligand-gated cation channel activity,MF,PKD2;KCNJ15;ITPR3;KCNJ5;SCNN1A;JPH2;SHROOM2
10889,GO:0044448,0.0529898434692136,0.969561305223563,20,125,cell cortex part,CC,PKD2;RAPGEF3;SPTB;TRPV4;FLOT1;RIMS3;WIPF1;BSN;GSN;PLEKHH2;TRIOBP;SEPT6;SEPT5;HFE;SLC2A1;SHROOM2;EXOC2;DMTN;SHROOM4;DLG4
4204,GO:0009314,0.0530081332158625,0.962835589162465,45,339,response to radiation,BP,SIK1;DDB2;TP53INP1;EGFR;CIRBP;XPC;SFRP1;PIK3R1;BRSK1;EYS;MC1R;IMPACT;CRY2;CRY1;NFATC4;SCARA3;MDM2;CRTC1;POLH;SLC24A1;PER2;UNC119;BHLHE40;NMU;TANC1;B4GALT2;SYNGAP1;HYAL1;WRN;NET1;MAPK10;ADIRF;CYBA;ERCC6;KRT14;TP53I13;NPHP4;DDHD2;FBXO4;IFI16;ERCC5;PRIMPOL;UVSSA;TH;PER3
8360,GO:0033267,0.0531067049444455,0.964859942597957,34,239,axon part,CC,SYN1;KCNAB2;KCNC4;SPOCK1;BLVRB;FLRT3;BLOC1S4;TRPV4;ANK3;GJC2;ADGRL1;ITGA2;NMU;BOC;TRAK1;TANC1;SEPT6;BLOC1S3;EPB41L3;MAP3K12;SEPT5;DNM1;CDK5R1;GLUL;SYT7;SCN2A;ORAI2;DLG4;SHANK2;APBB2;SYNGR1;TH;NFASC;PTBP2
12309,GO:0048678,0.0531560292889219,0.97791745448108,9,49,response to axon injury,BP,PTPRS;RGMA;FLRT3;RTN4RL1;NAIP;CST3;MATN2;MTR;LAMB2
7619,GO:0032026,0.0531702924483155,0.991971728473173,3,8,response to magnesium ion,BP,MDM2;ANK3;BMP6
6150,GO:0019470,0.0532863831163904,0.996194298159911,2,4,4-hydroxyproline catabolic process,BP,PRODH;ALDH4A1
17730,GO:1901700,0.0532975549534612,0.957045123300246,121,1015,response to oxygen-containing compound,BP,TNFAIP3;POSTN;TP53INP1;SREBF1;APOE;EGFR;PKD2;SRSF5;SFRP1;MTHFR;GPX3;DGKQ;PIK3R1;TXNRD3;WNT3;STAT1;IMPACT;GJD3;NOS1;PRKACB;CRY1;NFATC4;HMGCL;CYP26B1;CMPK2;MDM2;TNFSF10;RAPGEF3;FAM210B;CTSV;F2R;PDCD4;TRPV4;ADAMTS13;TNFRSF14;ITGA2;VAMP2;NAIP;SESN3;INSR;GSN;BAIAP2;MGST2;ENDOG;SLC27A1;BMP6;TCIRG1;PTK6;FZD7;LOXL1;HYAL1;PLA2G6;CST3;HOMER2;TXNIP;ATP6V0A2;COL6A1;TNFRSF21;CDK5R1;NET1;CA2;SESN1;CYBA;ERCC6;HADH;SLIT3;HLCS;XRN1;LRP11;MLXIPL;KCNMA1;PFKFB2;SLC2A1;NLRP1;GLUL;EPM2AIP1;GNG2;SRR;LRP1;ACP5;BRINP1;PDE2A;RET;DAB2IP;TEAD2;PIK3C3;PIK3R2;AREG;BTG1;VDR;DMTN;DUOX1;PTK7;TNFRSF25;ZFP36L1;ACSL1;KAT2B;IRS2;ANO1;ERN1;GPR21;MTR;MAN1B1;STAT6;PRDX5;PHPT1;GLB1;CD9;CACNB1;GPR68;ABCA2;AKAP6;TH;RORA;PPARG;PRKACA;UFL1;KLF9;FOXP2;PEMT;GCLC
14529,GO:0070070,0.0532996282404898,0.991944064045414,3,8,proton-transporting V-type ATPase complex assembly,BP,TCIRG1;ATP6V0A2;DMXL2
14531,GO:0070072,0.0532996282404898,0.991944064045414,3,8,vacuolar proton-transporting V-type ATPase complex assembly,BP,TCIRG1;ATP6V0A2;DMXL2
6309,GO:0019958,0.053348355416265,0.99618734034595,2,4,C-X-C chemokine binding,MF,CXCR1;ACKR3
12796,GO:0051121,0.0533538377511154,0.996186724594668,2,4,hepoxilin metabolic process,BP,ALOXE3;ALOX15B
12797,GO:0051122,0.0533538377511154,0.996186724594668,2,4,hepoxilin biosynthetic process,BP,ALOXE3;ALOX15B
3451,GO:0007264,0.0533576836419623,0.960612280293876,61,458,small GTPase mediated signal transduction,BP,APOE;PSD4;EPS8L2;EPHB2;RALGDS;DOCK9;VAV3;KITLG;ASAP3;RAB43;RAB40B;PLEKHG5;IQSEC2;PLEKHG3;CHN2;OBSCN;RHOBTB2;RAPGEF3;RASA4;RGL4;ACAP3;F2R;FLOT1;AGAP4;RALGAPA1;ARHGEF19;RASGEF1A;ASAP2;ARHGEF4;SRGAP3;NISCH;CELSR1;ARHGEF1;DOCK8;SQSTM1;SYNGAP1;FAM13A;ARHGAP33;PSD3;AGAP6;NET1;SHC2;SPRY2;AGAP7P;PAK6;ARAP1;APPL2;DAB2IP;RAPGEFL1;PIK3R2;MYO9A;RGL2;ARHGEF17;LPAR6;ARFGEF2;IQSEC1;ARHGEF9;RAPGEF5;ARHGAP23;DOCK6;DOCK3
11400,GO:0045824,0.0533641856612886,0.980914716885474,7,34,negative regulation of innate immune response,BP,TNFAIP3;DHX58;NLRX1;IFI16;FAM3A;PPARG;SERPING1
11104,GO:0045143,0.0534325939431933,0.98284424497268,6,27,homologous chromosome segregation,BP,MLH3;SUN1;CENPC;REC8;AGO4;MSH5
8217,GO:0032989,0.053519362564093,0.957977373095433,96,745,cellular component morphogenesis,BP,POSTN;ULK2;MAP6;APOE;EGFR;PTPRS;CAPRIN2;SLITRK6;OBSL1;EPHB2;PIK3R1;BRSK1;WNT3;UNK;TFCP2L1;TENM4;ZFPM1;CUL7;VAMP3;IMPACT;UNC5B;NFATC4;PLXNB1;NDN;OBSCN;MYH11;PARVB;RHOBTB2;NEO1;FLRT3;ARPIN;SPTB;NYAP1;FLOT1;GLI2;ANK3;KLF7;RNF165;SPG11;WIPF1;MINK1;SEMA4G;ULK1;GLI3;FHOD3;BOC;TRAK1;BAIAP2;TTN;PLXNB3;AHNAK2;TRIOBP;MICALL2;FZD7;SYNGAP1;EPB41L3;HEXB;CDK5R1;NET1;EFNB3;SHANK3;AGO4;SLIT3;ARAP1;ADARB1;FMNL2;CCDC136;RFX2;RET;PRX;DAB2IP;RPS6KA5;VDR;PLXND1;ZMYM3;DMTN;SNX1;DLG4;MATN2;NBEAL2;WEE1;SHANK2;IRS2;S100A6;ZSWIM8;APBB2;CD9;RANBP9;ERBB2;SSH3;FMNL3;LAMB2;NFASC;MAP1A;ECM2;SMURF1
15438,GO:0071797,0.0535216879078732,0.996167854072626,2,4,LUBAC complex,CC,RBCK1;SHARPIN
3145,GO:0006741,0.0535579548737393,0.996163772099997,2,4,NADP biosynthetic process,BP,IDH2;NADK
7807,GO:0032368,0.0535835538477406,0.976503639534805,10,55,regulation of lipid transport,BP,APOE;CRY1;BMP6;PLA2G6;LRP1;IRS2;ABCA2;PPARG;LDLRAP1;PLTP
510,GO:0001574,0.0537311694333866,0.996144253346842,2,4,ganglioside biosynthetic process,BP,ST6GALNAC6;ST3GAL5
8914,GO:0034767,0.0539911447601015,0.974208631699308,12,69,positive regulation of ion transmembrane transport,BP,HSPA2;PKD2;EPHB2;NOS1;F2R;ANK3;GJC2;GSTM2;SHANK3;WNK1;JPH2;AKAP6
4736,GO:0010906,0.054100547106597,0.974198145000483,12,67,regulation of glucose metabolic process,BP,SIK1;DGKQ;MLYCD;IGFBP4;INSR;PDK1;PFKFB2;ACACB;EPM2AIP1;KAT2B;IRS2;RORA
7020,GO:0030801,0.0542591744931441,0.984829600701779,5,21,positive regulation of cyclic nucleotide metabolic process,BP,PTHLH;APOE;NOS1;RAPGEF3;ADORA2B
5165,GO:0015712,0.054363973757388,0.996072624769045,2,4,hexose phosphate transport,BP,G6PC3;SLC37A2
5185,GO:0015760,0.054363973757388,0.996072624769045,2,4,glucose-6-phosphate transport,BP,G6PC3;SLC37A2
18817,GO:1904431,0.0544267992408814,0.996065485966928,2,4,positive regulation of t-circle formation,BP,SLX1A;SLX1B
2398,GO:0005544,0.0544967588364728,0.980478917639259,7,33,calcium-dependent phospholipid binding,MF,SYT8;SYTL1;C2CD4C;SYT15;RPH3AL;SYT7;ESYT2
8773,GO:0034464,0.0545929091182202,0.991318913696129,3,9,BBSome,CC,BBS2;BBS1;BBS5
11517,GO:0046058,0.0549548272542672,0.978619215533684,8,39,cAMP metabolic process,BP,PTHLH;PKD2;RAPGEF3;NPHP3;GABBR1;GPR87;PDE2A;LTB4R2
3568,GO:0007612,0.0552240744647575,0.972666525561026,13,74,learning,BP,EPHB2;NLGN4Y;INSR;TANC1;B4GALT2;SYNGAP1;SHANK3;ATXN1;DDHD2;DLG4;SHANK2;TH;FOXP2
577,GO:0001730,0.0553009853916119,0.995965640120726,2,4,2'-5'-oligoadenylate synthetase activity,MF,OAS2;OAS1
11602,GO:0046321,0.0555321989133591,0.991461857141753,3,8,positive regulation of fatty acid oxidation,BP,MLYCD;IRS2;PPARG
10152,GO:0042752,0.0556772500668847,0.973296235923301,12,68,regulation of circadian rhythm,BP,SIK1;CRY2;CRY1;CRTC1;PER2;THRAP3;BHLHE40;NMU;MAPK10;RORA;PPARG;PER3
10318,GO:0043125,0.0558437252192597,0.995903170426202,2,4,ErbB-3 class receptor binding,MF,PIK3R1;ERBB2
5863,GO:0017171,0.0559933863140497,0.970498912655657,15,96,serine hydrolase activity,MF,HTRA1;TYSND1;CTSV;RHBDF1;PCSK1;MMP1;PLA2G6;CTSB;KLK5;C1RL;PCSK6;ENDOU;DPP7;CTSD;LONP2
9891,GO:0042221,0.0559995157992997,0.951488050652205,308,2769,response to chemical,BP,TNFAIP3;POSTN;GPNMB;SIK1;TP53INP1;IFI6;SREBF1;MXRA5;APOE;CES2;INPP5D;OAS2;HSPA2;EGFR;FAM20C;PKD2;XPC;CXCR1;TRIM22;SRSF5;SFRP1;MTHFR;EPHB2;GPX3;MAP3K14;BPHL;DGKQ;TMEM129;PIK3R1;ADAMTS7;TXNRD3;RBCK1;KDM3A;CXCL14;SULF2;WNT3;UBXN4;VAV3;ISG15;CYBRD1;HTRA1;RGMA;CUL7;VAMP3;SNN;OR2A4;STAT1;IMPACT;CRY2;UNC5B;UROS;ITGB5;GJD3;RAB43;NOS1;PRKACB;CRY1;PLEKHG5;NFATC4;HMGCL;D2HGDH;FERMT1;CYP26B1;CMPK2;MICALL1;PIK3C2G;PLXNB1;NDRG1;ITPR3;MDM2;NDN;IFITM1;LTBP4;HLA-B;TNFSF10;PRODH;UGT1A3;CYP3A5;NEO1;RAPGEF3;FAM210B;CTSV;OAS1;FLRT3;RASA4;IL20RB;F2R;MT1X;PDCD4;SPTB;RTN4RL1;ZFP36L2;TRPV4;FLOT1;GLI2;ANK3;KLF7;RNF165;ADAMTS13;LAMP3;SLC13A5;GJC2;ZCCHC11;PER2;TMEM204;PTGS1;FNDC4;FRS3;C5;ZNF658;GSTM2;TNFRSF14;ITGA2;SEMA4G;GLI3;SPPL2B;THRAP3;VAMP2;NAIP;LTBP1;MAP2K5;BOC;ITGA6;CES3;SESN3;MMP1;JARID2;NUPR1;INSR;MMP28;GSN;BAIAP2;TTN;DDT;PLXNB3;CD109;CYP2D7;MGST2;DOCK8;ENDOG;SLC27A1;TM7SF3;MDK;IRF9;BMP6;TCIRG1;MAP2K2;PDK1;VEGFB;SQSTM1;PTK6;FZD7;ETV5;AKR7A2;LOXL1;FAM213A;SHARPIN;HYAL1;PLA2G6;CST3;HOMER2;MMRN2;GDF15;BBS2;TXNIP;CTF1;ATP6V0A2;COL6A1;IFI27;TNFRSF21;CDK5R1;ATRX;NET1;CA2;EFNB3;SESN1;MAPK10;SHANK3;HFE;ADIRF;CYBA;TRIM38;AGO4;ERCC6;HADH;RRM2B;SLIT3;KRT14;HLCS;EDA2R;SPRY2;FBXO2;CREBRF;XRN1;LRP11;MLXIPL;CTSB;FBXW7;KCNMA1;CDK5RAP3;LMO2;CARF;PFKFB2;PAQR6;THRA;ELF1;MX2;RPH3AL;SLC2A1;ACACB;NLRP1;GLUL;EPM2AIP1;TP53I13;GNG2;SRR;LRP1;HLA-A;ACP5;PLA2G7;RFX2;BRINP1;WNK1;PDE2A;STK16;LTB4R2;RET;DAB2IP;RWDD3;CALCOCO1;TEAD2;PIK3C3;SYT7;FGFR4;IL20RA;PIK3R2;AREG;SNCB;RPS6KA5;BTG1;BST2;VDR;PLXND1;PCSK6;DMTN;STAT2;SLC36A4;UCN2;MATN2;CD68;DUOX1;PTK7;TCF7;RSAD2;TNFRSF25;ZFP36L1;LMNA;ACSL1;IL11;KAT2B;IRS2;ANO1;ERN1;GPR21;MTR;MAN1B1;ZSWIM8;APBB2;PBLD;TNFSF12;TAS1R3;STAT6;PRDX5;PHPT1;TUB;GLB1;DNAJC4;GSTM3;CHD6;CD9;RANBP9;CACNB1;ERBB2;SYNGR1;GPR68;PAQR7;ABCA2;AKAP6;TH;RORA;PPARG;PRKACA;ACKR3;UFL1;LAMB2;IP6K2;NFASC;KLF9;AIP;LONP2;CCDC3;FOXP2;SMURF1;NPNT;HERPUD2;PEMT;GCLC;ECM1
10872,GO:0044425,0.0560503413661725,0.950853209442536,407,3690,membrane part,CC,ITGB6;SERPINE2;GPNMB;IFI6;SREBF1;NYNRIN;GPSM1;NT5E;INPP5D;APCDD1;LOC441081;ADAM19;LMF1;PSD4;HSPA2;EGFR;PTPRS;PKD2;SYT8;CXCR1;SYN1;LRIG3;PLCD3;SLITRK6;SFRP1;PCDH1;EPS8L2;EPHB2;TMEM129;PIK3R1;MARVELD1;ORAI3;EVC;UBXN4;ST6GALNAC2;CSPG4;MVB12B;CYBRD1;ELFN2;TENM4;RGMA;KCNAB2;KITLG;TP53I11;SDK2;ZDHHC1;VAMP3;SNN;REEP2;KCNJ15;MC1R;SRD5A3;OR2A4;CSMD2;CAMK2N1;NSG1;UNC5B;SLC16A5;KDSR;ITGB5;GJD3;NOS1;B4GALNT4;SDC3;BCAM;SCARA3;TMEM200B;FERMT1;CYP26B1;AP5Z1;MICALL1;PIK3C2G;PLXNB1;VPS11;KCNC4;SLC29A4;ITPR3;IFITM1;ST6GALNAC6;FCGRT;CSMD3;PIK3IP1;GPRC5C;HLA-B;TNFSF10;HGSNAT;SYTL1;NDUFA4L2;UGT1A3;CERS4;CYP3A5;NEO1;NINJ1;FAM210B;CTSV;NLGN4Y;FLRT3;RASA4;GAL3ST4;B4GALT6;AP1G2;RGS2;TMEM63C;IL20RB;ADGRB2;F2R;TMEM134;SPTB;SLC24A1;SLC27A3;RTN4RL1;ADGRF4;CLTCL1;TRPV4;TMC6;TMEM128;FLOT1;NLGN2;ADORA2B;ANK3;LAMP3;SLC13A5;CLMN;RIMS3;AVL9;G6PC3;GJC2;RHBDF1;TSPAN18;TMEM204;CLCN6;PTGS1;DIRC2;FNDC4;C5;SNTA1;PSKH1;ADGRL1;MINK1;AMIGO2;TNFRSF14;MBOAT2;ARHGEF4;LHFPL2;ITGA2;SEMA4G;SYT15;ULK1;SPPL2B;VAMP2;NAIP;BOC;ITGA6;KCNJ5;LZTS1;GPC2;INSR;CELSR1;ST3GAL5;BAIAP2;TANC1;CBLC;TMC7;SCNN1A;PLXNB3;SUN1;LPAR5;AHNAK2;CNTNAP3;CD109;CYP2D7;FAM171A2;SCN4B;SEPT6;RAB11FIP4;VPS39;MGST2;DOCK8;PILRB;SLC27A1;PGAP1;TM7SF3;NRSN2;SIRPB2;TMEM9;B4GALT2;TMCC3;NIPAL2;PEX10;SLC2A3;TCIRG1;MAP2K2;PTK6;SLC12A7;TMEM8B;FZD7;SYNGAP1;FAT2;TMEM117;EPB41L3;METTL23;CLCA2;KIAA0319L;B3GNT9;PAQR4;CENPC;MXRA7;HOMER2;BBS2;ATP6V0A2;PEX11B;PSD3;PODXL;IFI27;MALL;OSCP1;DNM1;TNFRSF21;PLD3;TREX1;LPIN3;ZDHHC12;ABHD14A;MCTP1;ANO9;PIGZ;CA2;EFNB3;HOOK2;SHANK3;HFE;SCART1;CYBA;EDA2R;SPRY2;MRC2;GABBR1;RAB11FIP3;LRP11;KCNMA1;GPR87;TMEM164;PAQR6;RNF170;CHMP1B;APC2;ASTN2;SLC2A1;ERMAP;REEP4;GPR155;NDST2;SLC38A4;TP53I13;GNG2;PRR7;LRP1;LRRN3;HLA-A;TSNARE1;CCDC136;ACP5;DLK2;KCNG1;SLC48A1;BDH1;CD99L2;DGCR2;PMEL;BBS1;JPH2;PDE2A;SDHA;LTB4R2;RET;PRX;DAB2IP;SLC37A2;SHROOM2;OLFM2;PIK3C3;SYT7;FGFR4;BBS5;IL20RA;PIK3R2;RETSAT;SCN2A;OSBPL5;AREG;TMEM203;MYO9A;DLG5;BST2;LETMD1;CACNB3;DPY19L2P2;VIPR1;PLXND1;MARCH8;TMEM80;MPPE1;NDUFV3;TMCO6;LRRC37A3;LPAR6;DMTN;ORAI2;SLC35E2B;LMTK3;SLC36A4;TMEM231;SNX1;PMP22;CA11;ACVR1B;TMX4;SHROOM4;APCDD1L;KREMEN1;CADM4;NECAB3;DLG4;ESYT2;ADCK5;NAT14;CD68;DUOX1;SLC22A15;TMEM143;SLC35G2;PTK7;SHANK2;RSAD2;TNFRSF25;NEMP2;XYLT1;MXRA8;CLSTN3;GLMP;ACSL1;APOLD1;ANO1;ERN1;ALOX15B;GPR21;LAPTM4A;MAN1B1;DHRS4;S100A6;FAAH;TTC19;MFSD11;CCDC90B;TNFSF12;TAS1R3;CERS5;STAT6;GPR132;SMPDL3B;SLC43A1;CPT1C;DNAJC4;RDH12;TRAF5;GOLGB1;SRPX2;CD9;CACNB1;PTPN3;CTSD;GJB5;COL13A1;ERBB2;SYNGR1;GPR68;XKR9;ZDHHC24;PAQR7;PQLC3;ABCA2;AKAP6;SLC2A11;TH;ATG14;MPP7;PRKACA;LDLRAP1;DNAJC22;GCNT4;SYNE2;ACKR3;TMEM212;UFL1;NFASC;KCNS3;SNX33;CIT;CLCN7;CALHM2;NPNT;HERPUD2;PEMT;ABCA11P;GLIPR1L2;TM4SF1;SERINC3
2669,GO:0006021,0.0560524789673429,0.995879045049366,2,4,inositol biosynthetic process,BP,IMPA2;ISYNA1
3744,GO:0008283,0.0562721669829635,0.953495927139761,154,1321,cell proliferation,BP,TNFAIP3;TGFBI;SERPINE2;GPNMB;TP53INP1;PTHLH;APOE;INPP5D;FBXW4;EGFR;PKD2;MNT;ASH2L;DIXDC1;PLCD3;SFRP1;KCTD11;SULF2;WNT3;VAV3;CSPG4;HTRA1;TENM4;KITLG;TP53I11;MVD;STAT1;CAMK2N1;MARCKSL1;HOXA3;KLF13;RNF187;FERMT1;HSF4;TBC1D8;PLXNB1;SPEG;NDRG1;EAPP;MDM2;LZTS2;PLCD1;NDN;IFITM1;RAPGEF3;CTSV;IL20RB;F2R;PDCD4;CGREF1;SERPINB5;ZFP36L2;GLI2;CLMN;GJC2;RHBDF1;PER2;PTGS1;TNFRSF14;WWTR1;ITGA2;GLI3;MAP2K5;GAS8;LTBP3;IGFBP4;TCFL5;JARID2;NUPR1;INSR;PLXNB3;MXD4;CD109;ARHGEF1;DOCK8;RICTOR;BMP6;TCIRG1;PDK1;VEGFB;PTK6;FZD7;ETV5;KDM4C;HYAL1;SH2D2A;CST3;TXNIP;CTF1;PLAG1;IDH2;TNFRSF21;CDK5R1;CYBA;SLIT3;HLCS;SPRY2;FBXO2;MEF2D;MLXIPL;FBXW7;ING4;CDK5RAP3;MXI1;APC2;ADARB1;GLUL;TNS2;NAB2;GNG2;LRP1;APPL2;DAB2IP;FBXO4;IFI16;FGFR4;AREG;DLG5;BTG1;BST2;VDR;VIPR1;SIX5;PMP22;NRARP;TACC1;CCDC88B;PALB2;IGFBP6;TCF7;TNFRSF25;ZFP36L1;LMNA;IL11;KAT2B;IRS2;ERN1;ALOX15B;S100A6;PBLD;TNFSF12;STAT6;CD9;ERBB2;RORA;PPARG;UFL1;RIPK3;KLF9;FOXP2;PTBP2;CTNNBIP1;PEMT;ECM1
377,GO:0001010,0.0563260655893859,0.987246891430801,4,14,transcription factor activity, sequence-specific DNA binding transcription factor recruiting,MF,THRA;VDR;RORA;PPARG
1646,GO:0004095,0.0564371798420157,0.995834443822506,2,4,carnitine O-palmitoyltransferase activity,MF,CPT2;CPT1C
5480,GO:0016416,0.0564371798420157,0.995834443822506,2,4,O-palmitoyltransferase activity,MF,CPT2;CPT1C
10312,GO:0043117,0.0566965389196964,0.995804270735835,2,4,positive regulation of vascular permeability,BP,TRPV4;PDE2A
11109,GO:0045159,0.0567018183455134,0.995803655676585,2,4,myosin II binding,MF,GSN;TRIOBP
7043,GO:0030825,0.0567544926982415,0.990828579453116,3,9,positive regulation of cGMP metabolic process,BP,APOE;NOS1;ADORA2B
4593,GO:0010711,0.0569184112306203,1,1,1,negative regulation of collagen catabolic process,BP,CST3
13715,GO:0060309,0.0569184112306203,1,1,1,elastin catabolic process,BP,CST3
13716,GO:0060310,0.0569184112306203,1,1,1,regulation of elastin catabolic process,BP,CST3
13717,GO:0060311,0.0569184112306203,1,1,1,negative regulation of elastin catabolic process,BP,CST3
12861,GO:0051216,0.0570975828050285,0.968584108917545,17,104,cartilage development,BP,TGFBI;PTHLH;FBXW4;ADAMTS7;EVC;SULF2;HOXA3;TRPV4;GLI2;THBS3;GLI3;BMP6;HYAL1;BBS2;MEF2D;THRA;MAF
5834,GO:0017124,0.0571240013409177,0.96921612043779,16,97,SH3 domain binding,MF,INPP5D;ADAM19;ESPN;WIPF1;CBLC;CABYR;SYNGAP1;SH2D2A;ARHGAP27;SHANK3;CYBA;DAB2IP;EFS;SHANK2;DOCK3;CIT
8364,GO:0033273,0.0571654700199243,0.973446052282662,11,63,response to vitamin,BP,POSTN;EGFR;SFRP1;MTHFR;MDM2;ITGA2;GSN;HLCS;VDR;PPARG;PEMT
12514,GO:0050679,0.0572219877827094,0.967839332939201,18,116,positive regulation of epithelial cell proliferation,BP,TNFAIP3;EGFR;SFRP1;HTRA1;MAP2K5;PLXNB3;RICTOR;BMP6;VEGFB;FZD7;HYAL1;CYBA;GLUL;NRARP;TNFSF12;ERBB2;FOXP2;ECM1
10884,GO:0044441,0.0572577862377428,0.961140415711329,37,270,ciliary part,CC,PKD2;EVC;UNC119B;PRKACB;CNTRL;DNAH1;GLI2;PTGS1;UNC119;GLI3;NEK8;GAS8;SCNN1A;CEP126;SEPT6;SQSTM1;CABYR;BBS2;NPHP3;IQCB1;SHANK3;IFT140;DZIP1L;NPHP4;BBS1;PIK3C3;BBS5;DLG5;TMEM80;ARFGEF2;TMEM231;SHANK2;MARK4;KIF7;GSTM3;ATG14;PRKACA
13062,GO:0051591,0.0574571187267799,0.973346568782106,11,61,response to cAMP,BP,SREBF1;PKD2;DGKQ;STAT1;RAPGEF3;PDE2A;AREG;DMTN;DUOX1;ZFP36L1;AKAP6
3594,GO:0008021,0.0576508270904058,0.968784767367518,16,104,synaptic vesicle,CC,PTPRS;SYT8;SYN1;BRSK1;RAB40B;C2CD4C;VAMP2;SEPT6;SEPT5;DNM1;MCTP1;SYT7;DLG4;DMXL2;SYNGR1;TH
16172,GO:0090219,0.0576552884046384,0.995692009791741,2,4,negative regulation of lipid kinase activity,BP,PIK3IP1;DAB2IP
9754,GO:0039530,0.0577507057736595,0.990599778089361,3,9,MDA-5 signaling pathway,BP,DDX60;DHX58;TKFC
4330,GO:0009881,0.0578333487866805,0.995671035534837,2,4,photoreceptor activity,MF,CRY2;CRY1
6981,GO:0030666,0.0580351164497681,0.967886126686905,17,112,endocytic vesicle membrane,CC,APOE;EGFR;WNT3;VAMP3;RAB43;MDM2;HLA-B;TCIRG1;ATP6V0A2;CYBA;LRP1;HLA-A;PIK3C3;SYT7;DLG4;CD9;LDLRAP1
16717,GO:0097755,0.0580720699395491,0.978764549753649,7,35,positive regulation of blood vessel diameter,BP,APOE;EGFR;NOS1;RGS2;ADORA2B;PLA2G6;BBS2
8721,GO:0034380,0.0581310417948483,0.990511960734389,3,9,high-density lipoprotein particle assembly,BP,APOE;PRKACB;PRKACA
2185,GO:0005044,0.0582665228528963,0.983373497216265,5,21,scavenger receptor activity,MF,SCARA3;SCART1;LRP1;ENDOU;ACKR3
2296,GO:0005262,0.0585259655490014,0.974035175150974,10,52,calcium channel activity,MF,PKD2;ORAI3;ITPR3;SLC24A1;TRPV4;JPH2;PDE2A;CACNB3;ORAI2;CACNB1
2974,GO:0006516,0.0585726366852188,0.986371435382491,4,15,glycoprotein catabolic process,BP,CST3;FBXO2;MAN1B1;SGSH
17537,GO:1901136,0.0585900398455323,0.966337742272907,19,129,carbohydrate derivative catabolic process,BP,NT5E;APOBEC3C;CSPG4;SDC3;NAGLU;IDUA;HGSNAT;RAPGEF3;HEXA;GPC2;HEXB;HYAL1;CST3;FBXO2;PDE2A;MAN1B1;SGSH;GLB1;NUDT10
3388,GO:0007166,0.058764063444785,0.950124770731277,213,1855,cell surface receptor signaling pathway,BP,TNFAIP3;POSTN;ITGB6;SERPINE2;MUC19;IFI6;SREBF1;APOE;INPP5D;APCDD1;OAS2;FBXW4;EGFR;GIGYF1;FAM20C;CAPRIN2;CXCR1;DIXDC1;TRIM22;SFRP1;KCTD11;EPHB2;MAP3K14;DGKQ;PIK3R1;RBCK1;EVC;SULF2;WNT3;VAV3;CSPG4;ISG15;MVB12B;HTRA1;RGMA;KITLG;PRICKLE2;STAT1;UNC5B;ITGB5;PRKACB;MAML3;NFATC4;FERMT1;PLXNB1;LZTS2;NDN;IFITM1;FCGRT;LTBP4;HLA-B;TNFSF10;NEO1;OAS1;FLRT3;IL20RB;ADGRB2;PDCD4;RTN4RL1;ADGRF4;GLI2;NLGN2;ADORA2B;RNF165;ADAMTS13;PIDD1;ARHGEF19;RHBDF1;TSPAN18;TMEM204;FRS3;C5;WIPF1;ADGRL1;MINK1;TNFRSF14;WWTR1;ITGA2;SEMA4G;GLI3;SPPL2B;NAIP;LTBP1;MAP2K5;BOC;ITGA6;SESN3;IGFBP4;MMP1;GPC2;INSR;CELSR1;CDK14;BAIAP2;CBLC;PLXNB3;CD109;PILRB;SLC27A1;RTF1;MDK;IRF9;BMP6;TCIRG1;VEGFB;SQSTM1;PTK6;FZD7;SHARPIN;SH2D2A;ARRDC1;PLA2G6;HOMER2;MMRN2;GDF15;BBS2;TXNIP;CTF1;ATP6V0A2;NPHP3;IFI27;DNM1;TNFRSF21;KLHL24;CDK5R1;EFNB3;MAPK10;SHANK3;HFE;CYBA;TRIM38;DTX3;AGO4;SLIT3;SHC2;EDA2R;SPRY2;IFT140;CREBRF;FBXW7;GPR87;NOTCH2NL;APC2;ARAP1;ELF1;MX2;FRAT1;ERMAP;GNG2;LRP1;HLA-A;NPHP4;DLK2;WNK1;RET;ZMYND8;DAB2IP;CALCOCO1;RNF213;FGFR4;IL20RA;PIK3R2;AREG;RPS6KA5;DLG5;BST2;CACNB3;TNRC6C;VIPR1;EFS;PLXND1;PCSK6;DMTN;STAT2;TMEM231;NRARP;ACVR1B;KREMEN1;DLG4;IGFBP6;DUOX1;PTK7;TCF7;SHANK2;RSAD2;TNFRSF25;LMNA;ACSL1;IL11;KAT2B;IRS2;GPR21;PBLD;TNFSF12;STAT6;PHPT1;KIF7;CD9;PTPN3;ERBB2;PLCB3;RORA;PPARG;PRKACA;ACKR3;IP6K2;AIP;CCDC3;SMURF1;NPNT;CTNNBIP1;GCLC;ECM1
8710,GO:0034367,0.0588651981375305,0.990045642620811,3,10,protein-containing complex remodeling,BP,APOE;PLA2G7;PLTP
6690,GO:0030073,0.0588701428414311,0.966213685020056,19,124,insulin secretion,BP,SREBF1;SFRP1;GLUD1;ITPR3;RAPGEF3;NLGN2;PER2;TM7SF3;PLA2G6;HADH;PFKFB2;SLC2A1;GLUL;SYT7;IRS2;ANO1;PHPT1;GPR68;KCNS3
4298,GO:0009746,0.0588730433899877,0.966188499308325,19,126,response to hexose,BP,SREBF1;GJD3;CTSV;VAMP2;ENDOG;PLA2G6;TXNIP;CYBA;MLXIPL;PFKFB2;GLUL;IRS2;ANO1;ERN1;PHPT1;GPR68;TH;PRKACA;GCLC
8879,GO:0034706,0.0589564150303904,0.990705373907527,3,8,sodium channel complex,CC,SCNN1A;SCN4B;SCN2A
10502,GO:0043425,0.0590232552639597,0.983221349614783,5,20,bHLH transcription factor binding,MF,TSC22D3;BHLHE40;TCF4;LMO2;IKZF4
4896,GO:0014825,0.0590888730462567,1,1,1,stomach fundus smooth muscle contraction,BP,NMU
4909,GO:0014847,0.0590888730462567,1,1,1,proximal stomach smooth muscle contraction,BP,NMU
7537,GO:0031839,0.0590888730462567,1,1,1,type 1 neuromedin U receptor binding,MF,NMU
7538,GO:0031840,0.0590888730462567,1,1,1,type 2 neuromedin U receptor binding,MF,NMU
9130,GO:0035483,0.0590888730462567,1,1,1,gastric emptying,BP,NMU
10217,GO:0042922,0.0590888730462567,1,1,1,neuromedin U receptor binding,MF,NMU
10902,GO:0044495,0.0590888730462567,1,1,1,modulation of blood pressure in other organism,BP,NMU
10903,GO:0044497,0.0590888730462567,1,1,1,positive regulation of blood pressure in other organism,BP,NMU
17241,GO:0120060,0.0590888730462567,1,1,1,regulation of gastric emptying,BP,NMU
17242,GO:0120061,0.0590888730462567,1,1,1,negative regulation of gastric emptying,BP,NMU
17243,GO:0120063,0.0590888730462567,1,1,1,stomach smooth muscle contraction,BP,NMU
17244,GO:0120068,0.0590888730462567,1,1,1,regulation of stomach fundus smooth muscle contraction,BP,NMU
17245,GO:0120069,0.0590888730462567,1,1,1,positive regulation of stomach fundus smooth muscle contraction,BP,NMU
13930,GO:0060633,0.059269951534744,0.995500387619894,2,4,negative regulation of transcription initiation from RNA polymerase II promoter,BP,THRA;CTNNBIP1
19732,GO:2000143,0.059269951534744,0.995500387619894,2,4,negative regulation of DNA-templated transcription, initiation,BP,THRA;CTNNBIP1
1903,GO:0004591,0.0592844790380965,0.995498649031739,2,4,oxoglutarate dehydrogenase (succinyl-transferring) activity,MF,DHTKD1;OGDHL
10503,GO:0043426,0.0594046211662292,0.995484261049453,2,4,MRF binding,MF,TSC22D3;BHLHE40
1795,GO:0004435,0.0594349059604954,0.986296911073204,4,14,phosphatidylinositol phospholipase C activity,MF,PLCD3;PLCD1;PLCH2;PLCB3
7869,GO:0032438,0.0598322307864585,0.982680664048173,5,22,melanosome organization,BP,HPS4;BLOC1S4;BLOC1S3;PMEL;SHROOM2
16572,GO:0097411,0.0599264387904876,0.995421564507545,2,4,hypoxia-inducible factor-1alpha signaling pathway,BP,PDK1;RWDD3
12215,GO:0048489,0.0603452805933833,0.969668696029043,13,76,synaptic vesicle transport,BP,SYT8;SYN1;SYTL1;C2CD4C;BLOC1S4;RIMS3;SPG11;SYT15;VAMP2;BLOC1S3;SEPT5;DNM1;SYT7
16605,GO:0097480,0.0603452805933833,0.969668696029043,13,76,establishment of synaptic vesicle localization,BP,SYT8;SYN1;SYTL1;C2CD4C;BLOC1S4;RIMS3;SPG11;SYT15;VAMP2;BLOC1S3;SEPT5;DNM1;SYT7
3587,GO:0007638,0.0606350167675099,0.990327197215595,3,8,mechanosensory behavior,BP,SLITRK6;SHANK3;FOXP2
6763,GO:0030204,0.0609298060657773,0.979871942009032,6,26,chondroitin sulfate metabolic process,BP,CSPG4;IDUA;HEXA;HEXB;HYAL1;XYLT1
3577,GO:0007622,0.0609927306387001,0.982246831809943,5,22,rhythmic behavior,BP,NAGLU;NMU;CST3;TH;PER3
12223,GO:0048512,0.0609927306387001,0.982246831809943,5,22,circadian behavior,BP,NAGLU;NMU;CST3;TH;PER3
15148,GO:0071295,0.0610269142203323,0.982483518886708,5,20,cellular response to vitamin,BP,POSTN;SFRP1;MDM2;VDR;PPARG
4465,GO:0010463,0.0610301139847477,0.979830318339797,6,26,mesenchymal cell proliferation,BP,FBXW4;STAT1;LMNA;IRS2;FOXP2;CTNNBIP1
10083,GO:0042602,0.0612682593987631,1,1,1,riboflavin reductase (NADPH) activity,MF,BLVRB
16953,GO:0099003,0.0614319034290256,0.967314541590941,15,90,vesicle-mediated transport in synapse,BP,SYT8;SYN1;SYTL1;NLGN4Y;C2CD4C;BLOC1S4;NLGN2;RIMS3;SPG11;SYT15;VAMP2;BLOC1S3;SEPT5;DNM1;SYT7
6300,GO:0019933,0.0618670480563929,0.970900165978184,11,62,cAMP-mediated signaling,BP,PTHLH;DGKQ;MC1R;NOS1;RAPGEF3;RGS2;ADORA2B;GNG2;PDE2A;UCN2;AKAP6
8616,GO:0034144,0.0618741059527987,0.995184624382175,2,4,negative regulation of toll-like receptor 4 signaling pathway,BP,TNFAIP3;DAB2IP
10154,GO:0042754,0.0619092427781766,0.989625810002529,3,9,negative regulation of circadian rhythm,BP,CRY2;CRY1;PER2
11484,GO:0045981,0.0619926134266894,0.975092858863338,8,42,positive regulation of nucleotide metabolic process,BP,PTHLH;APOE;NOS1;RAPGEF3;ADORA2B;INSR;MLXIPL;PFKFB2
17482,GO:1900544,0.0619926134266894,0.975092858863338,8,42,positive regulation of purine nucleotide metabolic process,BP,PTHLH;APOE;NOS1;RAPGEF3;ADORA2B;INSR;MLXIPL;PFKFB2
7846,GO:0032414,0.0620158626401941,0.973497878116218,9,48,positive regulation of ion transmembrane transporter activity,BP,HSPA2;PKD2;EPHB2;ANK3;GSTM2;SHANK3;WNK1;JPH2;AKAP6
17473,GO:1900451,0.0620625513346841,0.995161455373138,2,4,positive regulation of glutamate receptor signaling pathway,BP,EPHB2;SHANK3
1815,GO:0004467,0.0622570277997958,0.98954299362395,3,9,long-chain fatty acid-CoA ligase activity,MF,SLC27A3;SLC27A1;ACSL1
10573,GO:0043551,0.0624072032001429,0.979256949058781,6,26,regulation of phosphatidylinositol 3-kinase activity,BP,PIK3R1;VAV3;PIK3IP1;DAB2IP;PIK3R2;ATG14
12101,GO:0048170,0.0626927491170143,0.995083662290155,2,4,positive regulation of long-term neuronal synaptic plasticity,BP,EPHB2;SHANK3
19848,GO:2000348,0.0627134925746616,0.995081093528187,2,4,regulation of CD40 signaling pathway,BP,TNFAIP3;SHARPIN
16407,GO:0097066,0.0627160647200947,0.985066552703553,4,15,response to thyroid hormone,BP,CTSB;LMO2;KLF9;GCLC
4858,GO:0014075,0.0628025538363083,0.981687154647472,5,21,response to amine,BP,UROS;ADAMTS13;ITGA2;RRM2B;TH
16851,GO:0098802,0.0630621340547565,0.966320704499671,15,90,plasma membrane receptor complex,CC,ITGB6;ITGB5;ITGA2;ITGA6;INSR;SHANK3;HFE;GABBR1;OLFM2;ACVR1B;DLG4;SHANK2;CPT1C;TRAF5;NPNT
16435,GO:0097119,0.0633008322052518,0.995008145491716,2,4,postsynaptic density protein 95 clustering,BP,NLGN2;ZMYND8
6882,GO:0030421,0.0633008870329894,1,1,1,defecation,BP,MDK
1705,GO:0004252,0.0639293534446125,0.968475477772882,12,74,serine-type endopeptidase activity,MF,HTRA1;TYSND1;CTSV;RHBDF1;PCSK1;MMP1;CTSB;KLK5;C1RL;PCSK6;CTSD;LONP2
14441,GO:0061820,0.0640829195624625,0.9891048033556,3,9,telomeric D-loop disassembly,BP,SLX1A;SLX1B;WRN
14707,GO:0070382,0.0642199767202987,0.96396937608089,17,113,exocytic vesicle,CC,PTPRS;SYT8;SYN1;BRSK1;RAB40B;SYTL1;C2CD4C;VAMP2;SEPT6;SEPT5;DNM1;MCTP1;SYT7;DLG4;DMXL2;SYNGR1;TH
2424,GO:0005604,0.0643424121462858,0.968496328979057,12,65,basement membrane,CC,TGFBI;SMOC2;COL7A1;ITGA6;LOXL1;CST3;MMRN2;NID1;MATN2;EFEMP2;LAMB2;NPNT
4850,GO:0014065,0.0645716767387972,0.966232992521532,14,84,phosphatidylinositol 3-kinase signaling,BP,SERPINE2;EGFR;PIK3R1;UNC5B;PIK3C2G;PLXNB1;PIK3IP1;F2R;NYAP1;DAB2IP;PIK3R2;RGL2;ZFP36L1;ERBB2
8948,GO:0035023,0.064588398922319,0.964637941723614,16,95,regulation of Rho protein signal transduction,BP,APOE;EPS8L2;VAV3;PLEKHG5;PLEKHG3;OBSCN;F2R;FLOT1;ARHGEF19;ARHGEF4;ARHGEF1;NET1;ARAP1;ARHGEF17;LPAR6;ARHGEF9
8395,GO:0033363,0.064600794203134,0.981007761567848,5,21,secretory granule organization,BP,SERPINE2;F2R;BLOC1S3;CCDC136;RFX2
1167,GO:0002790,0.0646443308274167,0.953808296050614,46,347,peptide secretion,BP,POSTN;ITGB6;SREBF1;LMF1;EGFR;SFRP1;GLUD1;RAB40B;FERMT1;ITPR3;LTBP4;RAPGEF3;F2R;TRPV4;NLGN2;RHBDF1;PER2;C5;NMU;TTN;TM7SF3;BMP6;PLA2G6;IDH2;TNFRSF21;HFE;HADH;RAB11FIP3;PFKFB2;RPH3AL;SLC2A1;NLRP1;GLUL;OLFM2;PIK3C3;SYT7;DMTN;RASL10B;NECAB3;RSAD2;IRS2;ANO1;ALOX15B;PHPT1;GPR68;KCNS3
4852,GO:0014067,0.0647142467183303,0.988951972483882,3,9,negative regulation of phosphatidylinositol 3-kinase signaling,BP,SERPINE2;PIK3IP1;DAB2IP
12727,GO:0051015,0.065044124832767,0.961759503482754,20,121,actin filament binding,MF,TAGLN;EGFR;ESPN;FLNC;OBSL1;MYH11;SPTB;TRPV4;CORO6;WIPF1;GSN;TTN;TRIOBP;MICALL2;CDK5R1;CAPG;SHROOM2;DMTN;SHROOM4;SYNE2
953,GO:0002373,0.0653883723497354,1,1,1,plasmacytoid dendritic cell cytokine production,BP,BST2
1141,GO:0002736,0.0653883723497354,1,1,1,regulation of plasmacytoid dendritic cell cytokine production,BP,BST2
1142,GO:0002737,0.0653883723497354,1,1,1,negative regulation of plasmacytoid dendritic cell cytokine production,BP,BST2
17574,GO:1901253,0.0653883723497354,1,1,1,negative regulation of intracellular transport of viral material,BP,BST2
13582,GO:0060074,0.0654258884852504,0.98877889113185,3,9,synapse maturation,BP,NFATC4;ADGRL1;DAB2IP
18649,GO:1904016,0.0654466740964817,0.994738114261747,2,4,response to Thyroglobulin triiodothyronine,BP,SLC2A1;GLB1
19464,GO:1990253,0.0654790818680816,0.988765919452685,3,9,cellular response to leucine starvation,BP,IMPACT;SESN3;SESN1
2617,GO:0005929,0.0655528296682444,0.953283181024529,45,341,cilium,CC,PKD2;EVC;UNC119B;PRKACB;CNTRL;DNAH1;TRPV4;GLI2;ANKS6;PTGS1;UNC119;GLI3;TPGS1;NEK8;GAS8;SCNN1A;CEP126;SEPT6;SQSTM1;CABYR;BBS2;NPHP3;IQCB1;SHANK3;IFT140;DZIP1L;NPHP4;BBS1;PIK3C3;BBS5;DLG5;BBS10;TMEM80;ARFGEF2;ALMS1;TMEM231;TSSK1B;SHANK2;MARK4;CEP250;TUB;KIF7;GSTM3;ATG14;PRKACA
11426,GO:0045879,0.0656920896560642,0.980736037790089,5,20,negative regulation of smoothened signaling pathway,BP,SERPINE2;KCTD11;PRKACB;GLI3;KIF7
3658,GO:0008142,0.0657866643774459,0.994694825628739,2,4,oxysterol binding,MF,OSBPL5;RORA
18682,GO:1904064,0.0665904520088717,0.968208476060355,11,64,positive regulation of cation transmembrane transport,BP,HSPA2;PKD2;EPHB2;NOS1;F2R;ANK3;GJC2;GSTM2;SHANK3;JPH2;AKAP6
9901,GO:0042249,0.0665955474951276,0.98403977039916,4,14,establishment of planar polarity of embryonic epithelium,BP,SFRP1;CELSR1;NPHP3;PTK7
5537,GO:0016529,0.0666169090566794,0.974929583072708,7,34,sarcoplasmic reticulum,CC,NOS1;ITPR3;ANK3;GSTM2;JPH2;AKAP6;SYNE2
6968,GO:0030638,0.0666369694595815,0.993775978672228,2,5,polyketide metabolic process,BP,AKR7A2;CBR4
6972,GO:0030647,0.0666369694595815,0.993775978672228,2,5,aminoglycoside antibiotic metabolic process,BP,AKR7A2;CBR4
10925,GO:0044597,0.0666369694595815,0.993775978672228,2,5,daunorubicin metabolic process,BP,AKR7A2;CBR4
10926,GO:0044598,0.0666369694595815,0.993775978672228,2,5,doxorubicin metabolic process,BP,AKR7A2;CBR4
12981,GO:0051425,0.0666765862757751,0.994580867622961,2,4,PTB domain binding,MF,INPP5D;INSR
10059,GO:0042568,0.0667042470070908,1,1,1,insulin-like growth factor binary complex,CC,IGFBP6
10389,GO:0043236,0.0667188092752698,0.980199825728146,5,21,laminin binding,MF,BCAM;ITGA2;ITGA6;NID1;ECM1
7759,GO:0032287,0.0667465344211127,0.988910567948704,3,8,peripheral nervous system myelin maintenance,BP,NDRG1;AHNAK2;PRX
10151,GO:0042749,0.0669465083294335,0.993730352562071,2,5,regulation of circadian sleep/wake cycle,BP,NMU;PER3
11128,GO:0045187,0.0669465083294335,0.993730352562071,2,5,regulation of circadian sleep/wake cycle, sleep,BP,NMU;PER3
2618,GO:0005930,0.0669495192133258,0.968039895787227,11,63,axoneme,CC,DNAH1;GLI2;GLI3;GAS8;IFT140;BBS1;PIK3C3;BBS5;ARFGEF2;ATG14;PRKACA
4968,GO:0015079,0.0671136720105606,0.969333736604254,10,55,potassium ion transmembrane transporter activity,MF,PKD2;KCNAB2;KCNJ15;KCNC4;SLC24A1;KCNJ5;SLC12A7;KCNMA1;KCNG1;KCNS3
3692,GO:0008199,0.0671919618954229,0.993694081593458,2,5,ferric iron binding,MF,ACP5;TH
10788,GO:0044281,0.0672707380222821,0.943605676573456,167,1502,small molecule metabolic process,BP,SIK1;PTHLH;SREBF1;AMACR;APOE;CES2;NT5E;INPP5D;GAMT;LMF1;FAM20C;PKD2;APOBEC3C;CPT2;ALDH1A3;PLCD3;MTHFR;SEC14L2;GLUD1;BPHL;DGKQ;KDM3A;H6PD;DHTKD1;CSPG4;KCNAB2;MVD;NAPRT;SRD5A3;UROS;KDSR;NOS1;CRY1;CRTAP;HMGCL;D2HGDH;CYP26B1;GAA;CMPK2;THNSL2;PLCD1;NMRK1;TYSND1;IDUA;PRODH;UGT1A3;ACOT1;RAPGEF3;OAS1;CRAT;B4GALT6;MLYCD;PHYH;SLC27A3;ADORA2B;PLCH2;G6PC3;SULT1E1;PER2;PTGS1;HEXA;ABHD14B;GSTM2;FGGY;IGFBP4;NISCH;INSR;TST;ALDH4A1;CYP2D7;PGLS;MGST2;SLC27A1;BMP6;B4GALT2;SLC2A3;TCIRG1;PDK1;ALDH7A1;AKR7A2;HEXB;HYAL1;PEX7;ATP6V0A2;NPHP3;IDH2;MACROD1;LPIN3;OARD1;CA2;HADH;RRM2B;HLCS;GABBR1;MLXIPL;GPR87;PGM1;PFKFB2;ACADS;SLC2A1;ACACB;OGDHL;TK2;GLUL;NDST2;EPM2AIP1;SRR;ACP5;BDH1;RIMKLB;PPCS;PDE2A;SDHA;LTB4R2;ACOX3;DALRD3;FGFR4;RETSAT;OSBPL5;ETFB;VDR;NADK;NDUFV3;OSBPL1A;DLG4;ALOXE3;MPI;GALE;AMT;XYLT1;ACSL1;KAT2B;IRS2;IMPA2;ALOX15B;RAD50;TKFC;PNPO;MTR;DHRS4;ECI1;TRERF1;UAP1L1;FAAH;CBR4;ISYNA1;GLB1;CPT1C;RDH12;ACSS2;PLCB3;NUDT10;TH;RORA;PPARG;LDLRAP1;ACOT2;PLTP;SUCLG2;UCKL1;IP6K2;LONP2;HARS2;EHHADH;PEMT;SERINC3;GCLC
10003,GO:0042446,0.0673254752214176,0.972364636545819,8,44,hormone biosynthetic process,BP,DGKQ;SRD5A3;BMP6;HFE;VDR;DUOX1;HSD17B14;TRERF1
16740,GO:0098552,0.0674361194849675,0.954080131164798,35,259,side of membrane,CC,ITGB6;SERPINE2;PKD2;KCNAB2;BCAM;HLA-B;CTSV;RASA4;RGS2;SPTB;RTN4RL1;ITGA2;SPPL2B;ITGA6;KCNJ5;INSR;MAP2K2;PTK6;SYNGAP1;HFE;SCART1;ERMAP;GNG2;HLA-A;BDH1;DAB2IP;SHROOM4;DLG4;ESYT2;S100A6;TRAF5;CD9;PTPN3;TH;LDLRAP1
15460,GO:0071827,0.067632608824981,0.97971543648449,5,22,plasma lipoprotein particle organization,BP,APOE;PRKACB;PLA2G7;PRKACA;PLTP
8592,GO:0034112,0.0679682343069112,0.993578841750873,2,5,positive regulation of homotypic cell-cell adhesion,BP,ANK3;DMTN
270,GO:0000773,0.0680467294160825,1,1,1,phosphatidyl-N-methylethanolamine N-methyltransferase activity,MF,PEMT
1913,GO:0004608,0.0680467294160825,1,1,1,phosphatidylethanolamine N-methyltransferase activity,MF,PEMT
15951,GO:0080101,0.0680467294160825,1,1,1,phosphatidyl-N-dimethylethanolamine N-methyltransferase activity,MF,PEMT
18084,GO:1902744,0.0680822932781239,0.994398950566298,2,4,negative regulation of lamellipodium organization,BP,ARPIN;PLXNB3
3564,GO:0007606,0.0684129069279903,0.976324032100972,6,30,sensory perception of chemical stimulus,BP,REEP2;OR2A4;ITPR3;SCNN1A;BBS1;TAS1R3
7023,GO:0030804,0.0686208644461891,0.982952381726146,4,16,positive regulation of cyclic nucleotide biosynthetic process,BP,PTHLH;APOE;NOS1;ADORA2B
3046,GO:0006601,0.0686622283510302,1,1,1,creatine biosynthetic process,BP,GAMT
7012,GO:0030731,0.0686622283510302,1,1,1,guanidinoacetate N-methyltransferase activity,MF,GAMT
9667,GO:0038044,0.0687498408025626,0.99431174476398,2,4,transforming growth factor-beta secretion,BP,ITGB6;FERMT1
16416,GO:0097091,0.0687764736772639,0.994308254673459,2,4,synaptic vesicle clustering,BP,SYN1;NLGN2
15924,GO:0075044,0.0690587473064781,0.994271213048727,2,4,autophagy of host cells involved in interaction with symbiont,BP,ULK2;ULK1
15925,GO:0075071,0.0690587473064781,0.994271213048727,2,4,autophagy involved in symbiotic interaction,BP,ULK2;ULK1
847,GO:0002175,0.0691106416205906,0.994264392983994,2,4,protein localization to paranode region of axon,BP,EPB41L3;NFASC
11692,GO:0046500,0.0691203584499442,0.987499156875808,3,10,S-adenosylmethionine metabolic process,BP,GAMT;MTHFR;PEMT
12711,GO:0050994,0.0691818489104845,0.976170916535344,6,28,regulation of lipid catabolic process,BP,TYSND1;MLYCD;THRA;ACACB;IRS2;LONP2
6071,GO:0019226,0.0692420794667182,0.97624742948885,6,27,transmission of nerve impulse,BP,ANK3;ITGA2;AHNAK2;PRX;SCN2A;NFASC
10055,GO:0042562,0.069365120720684,0.971399365002817,8,43,hormone binding,MF,EGFR;ALDH1A3;PIK3R1;INSR;THRA;VDR;VIPR1;UCN2
4189,GO:0009268,0.0695559929008416,0.978966930013536,5,22,response to pH,BP,IMPACT;HYAL1;CA2;GPR68;CLCN7
6886,GO:0030425,0.069700663020151,0.94954611122289,48,362,dendrite,CC,MAP6;APOE;RBM3;SYN1;EPHB2;STAT1;CAMK2N1;NSG1;NOS1;KCNC4;CRTC1;ANK3;SPG11;MINK1;TPGS1;BSN;LZTS1;TRAK1;INSR;BAIAP2;TANC1;SYNGAP1;SHARPIN;HOMER2;DNM1;CDK5R1;SHANK3;CYBA;FBXO2;GABBR1;XRN1;PRR7;LRP1;RGS12;BRINP1;ATXN10;RET;ZMYND8;DAB2IP;SYT7;ARFGEF2;LMTK3;DLG4;SHANK2;CPT1C;TH;NFASC;MAP1A
16589,GO:0097447,0.069700663020151,0.94954611122289,48,362,dendritic tree,CC,MAP6;APOE;RBM3;SYN1;EPHB2;STAT1;CAMK2N1;NSG1;NOS1;KCNC4;CRTC1;ANK3;SPG11;MINK1;TPGS1;BSN;LZTS1;TRAK1;INSR;BAIAP2;TANC1;SYNGAP1;SHARPIN;HOMER2;DNM1;CDK5R1;SHANK3;CYBA;FBXO2;GABBR1;XRN1;PRR7;LRP1;RGS12;BRINP1;ATXN10;RET;ZMYND8;DAB2IP;SYT7;ARFGEF2;LMTK3;DLG4;SHANK2;CPT1C;TH;NFASC;MAP1A
13704,GO:0060294,0.069757655754935,0.98733495088999,3,10,cilium movement involved in cell motility,BP,GAS8;BBS2;TTLL1
16154,GO:0090195,0.0699740180125352,0.987279048119042,3,10,chemokine secretion,BP,POSTN;C5;ALOX15B
19392,GO:1905952,0.0701895363345917,0.964877365793435,12,73,regulation of lipid localization,BP,APOE;CRY1;BMP6;PLA2G6;FBXW7;ACACB;LRP1;IRS2;ABCA2;PPARG;LDLRAP1;PLTP
11358,GO:0045740,0.0703009253180056,0.970930129006758,8,43,positive regulation of DNA replication,BP,EGFR;KITLG;GLI2;INSR;BMP6;CST3;ATRX;AREG
13470,GO:0055037,0.0703505556202992,0.957457445282989,21,143,recycling endosome,CC,VAMP3;OR2A4;NSG1;MICALL1;NDRG1;HLA-B;AVL9;ULK1;NISCH;RAB11FIP4;MICALL2;FZD7;MCTP1;HFE;WASH3P;RAB11FIP3;TBC1D17;HLA-A;ARFGEF2;LDLRAP1;ACKR3
12494,GO:0050654,0.0703886884583803,0.975750907905582,6,27,chondroitin sulfate proteoglycan metabolic process,BP,CSPG4;IDUA;HEXA;HEXB;HYAL1;XYLT1
12545,GO:0050714,0.0707103380493789,0.956728336024265,22,145,positive regulation of protein secretion,BP,POSTN;EGFR;GLUD1;FERMT1;F2R;TRPV4;NLGN2;C5;NMU;TTN;TM7SF3;BMP6;PLA2G6;PFKFB2;RPH3AL;NLRP1;GLUL;IRS2;ANO1;ALOX15B;PHPT1;GPR68
767,GO:0002021,0.0707506860518381,0.987077731187577,3,10,response to dietary excess,BP,APOE;TRPV4;PCSK1N
6669,GO:0030036,0.0708368858225521,0.94659827896372,62,469,actin cytoskeleton organization,BP,ESPN;DIXDC1;SFRP1;OBSL1;EPS8L2;PIK3R1;PI4KAP2;ASAP3;OR2A4;ITGB5;IQSEC2;OBSCN;MYH11;PARVB;TNXB;RHOBTB2;RAPGEF3;CTSV;ARPIN;SPTB;TRPV4;CORO6;ARHGEF19;WIPF1;MINK1;FHOD3;NISCH;CELSR1;GSN;BAIAP2;TTN;PLEKHH2;TRIOBP;RICTOR;MICALL2;EPB41L3;WHAMMP3;CDK5R1;PI4KAP1;EPB41L4A;SHANK3;WASH3P;PAK6;ARAP1;FMNL2;CAPG;LRP1;NPHP4;SYNPO2;SHROOM2;BST2;ARHGEF17;EFS;DMTN;ALMS1;SHROOM4;IQSEC1;PTK7;PHPT1;SSH3;FMNL3;CIT
12944,GO:0051346,0.0708613099885212,0.951217765642814,36,276,negative regulation of hydrolase activity,BP,SERPINE2;IFI6;GPSM1;ELFN2;CRY2;NOS1;COL7A1;SPOCK1;MDM2;PHACTR3;RASA4;RGS2;SERPINB5;LAMP3;C5;NAIP;MAP2K5;PLXNB3;CD109;CEP192;CST3;SPRY2;TFPI2;WNK1;DAB2IP;IFI16;BST2;PPP1R2;PPP1R35;LMTK3;PCSK1N;PRDX5;SPOCD1;SERPING1;AIP;ECM1
12263,GO:0048589,0.0709152078943628,0.947784792336747,53,396,developmental growth,BP,POSTN;ULK2;APOE;GAMT;PTPRS;SLITRK6;SFRP1;KIF26B;EYS;EVC;WNT3;TENM4;IMPACT;PLXNB1;NDN;NINJ1;FLRT3;GLI2;SPG11;THBS3;WWTR1;SEMA4G;ULK1;GLI3;JARID2;INSR;GSN;PLXNB3;RTF1;ETNK2;FZD7;BBS2;PLAG1;CDK5R1;ATRX;SHANK3;ERCC6;SLIT3;SPRY2;ADARB1;RAI1;ACACB;TNS2;AREG;WWC3;PALB2;PTK7;SHANK2;ZFP36L1;GPR21;AKAP6;LAMB2;SMURF1
11057,GO:0045071,0.0709876655988772,0.970426936841112,8,46,negative regulation of viral genome replication,BP,OAS2;APOBEC3C;ISG15;IFITM1;OAS1;IFI16;BST2;RSAD2
12067,GO:0048037,0.0710196805793719,0.949206050415317,44,352,cofactor binding,MF,PYGB;ALDH1A3;MTHFR;GLUD1;TXNRD3;H6PD;DHTKD1;CRY2;UROS;NOS1;HMGCL;D2HGDH;CYP26B1;THNSL2;PRODH;CYP3A5;PHYH;NAT6;PTGS1;GSTM2;HEBP1;CYP2D7;IDH2;CYBA;HADH;HLCS;NUDT6;LMO2;ACADS;ACACB;ACCS;OGDHL;SRR;SLC48A1;SDHA;ACOX3;DUOX1;RSAD2;PNPO;MTR;CBR4;GSTM3;TH;GCLC
17156,GO:0102991,0.0711552274933445,0.993097344680815,2,5,myristoyl-CoA hydrolase activity,MF,ACOT1;ACOT2
11889,GO:0046934,0.0716130951046969,0.972673747871364,7,33,phosphatidylinositol-4,5-bisphosphate 3-kinase activity,MF,EGFR;PIK3R1;KITLG;FGFR4;PIK3R2;IRS2;ERBB2
15978,GO:0086009,0.0717771034080015,0.978237257746317,5,21,membrane repolarization,BP,SNTA1;KCNJ5;SCN4B;CACNB3;AKAP6
12405,GO:0048870,0.0717972162965771,0.941629821496852,115,949,cell motility,BP,POSTN;SERPINE2;GPNMB;TP53INP1;APOE;INPP5D;APCDD1;EGFR;CXCR1;DIXDC1;SFRP1;TNS1;PIK3R1;CXCL14;VAV3;UNK;CSPG4;KITLG;ASAP3;SDC3;PLEKHG5;FERMT1;PIK3C2G;PLXNB1;SPOCK1;MDM2;NDN;IFITM1;RHOBTB2;FLRT3;ARPIN;F2R;CAPN7;DNAH1;TRPV4;AVL9;RHBDF1;RASGEF1A;C5;MINK1;ITGA2;SEMA4G;FAM110C;GLI3;TPGS1;MAP2K5;GAS8;ITGA6;SRGAP3;MMP1;NISCH;INSR;CELSR1;MMP28;DDT;PLXNB3;SUN1;DOCK8;MDK;VEGFB;PTK6;FAT2;HEXB;HYAL1;MMRN2;PEX7;BBS2;IDH2;PODXL;MCTP1;CDK5R1;NET1;SPRY2;PAK6;APC2;ADARB1;LRP1;NPHP4;PLA2G7;LTB4R2;RET;ZMYND8;DAB2IP;MYSM1;SHROOM2;FGFR4;PIK3R2;DLG5;BTG1;BST2;EFS;PLXND1;DMTN;ACVR1B;NHSL1;MATN2;PTK7;LMNA;IRS2;ALOX15B;SCYL3;APBB2;PBLD;TNFSF12;PHPT1;SRPX2;ERBB2;PPARG;FMNL3;SYNE2;ACKR3;PLTP;RIPK3;TTLL1;ECM1
13107,GO:0051674,0.0717972162965771,0.941629821496852,115,949,localization of cell,BP,POSTN;SERPINE2;GPNMB;TP53INP1;APOE;INPP5D;APCDD1;EGFR;CXCR1;DIXDC1;SFRP1;TNS1;PIK3R1;CXCL14;VAV3;UNK;CSPG4;KITLG;ASAP3;SDC3;PLEKHG5;FERMT1;PIK3C2G;PLXNB1;SPOCK1;MDM2;NDN;IFITM1;RHOBTB2;FLRT3;ARPIN;F2R;CAPN7;DNAH1;TRPV4;AVL9;RHBDF1;RASGEF1A;C5;MINK1;ITGA2;SEMA4G;FAM110C;GLI3;TPGS1;MAP2K5;GAS8;ITGA6;SRGAP3;MMP1;NISCH;INSR;CELSR1;MMP28;DDT;PLXNB3;SUN1;DOCK8;MDK;VEGFB;PTK6;FAT2;HEXB;HYAL1;MMRN2;PEX7;BBS2;IDH2;PODXL;MCTP1;CDK5R1;NET1;SPRY2;PAK6;APC2;ADARB1;LRP1;NPHP4;PLA2G7;LTB4R2;RET;ZMYND8;DAB2IP;MYSM1;SHROOM2;FGFR4;PIK3R2;DLG5;BTG1;BST2;EFS;PLXND1;DMTN;ACVR1B;NHSL1;MATN2;PTK7;LMNA;IRS2;ALOX15B;SCYL3;APBB2;PBLD;TNFSF12;PHPT1;SRPX2;ERBB2;PPARG;FMNL3;SYNE2;ACKR3;PLTP;RIPK3;TTLL1;ECM1
6594,GO:0022617,0.0718244061519301,0.966720657296873,10,56,extracellular matrix disassembly,BP,HTRA1;CTSV;FLOT1;MMP1;CST3;CAPNS2;NID1;KLK5;LRP1;FGFR4
11387,GO:0045794,0.0718469893444379,0.993900312340614,2,4,negative regulation of cell volume,BP,SHANK3;KCNMA1
269,GO:0000768,0.0718855536279718,0.974992116059064,6,28,syncytium formation by plasma membrane fusion,BP,NOS1;RAPGEF3;FLOT1;TANC1;CD109;GDF15
4471,GO:0010469,0.071889897156494,0.953004027399378,28,214,regulation of signaling receptor activity,BP,GPNMB;PTHLH;EPHB2;CXCL14;WNT3;KITLG;THNSL2;TNFSF10;NLGN2;MINK1;CBLC;MDK;BMP6;VEGFB;GDF15;CTF1;KLHL24;SHANK3;HFE;FBXW7;NUDT6;AREG;UCN2;DLG4;ENDOU;SHANK2;IL11;TNFSF12
12352,GO:0048753,0.0718947029103962,0.977918612082842,5,23,pigment granule organization,BP,HPS4;BLOC1S4;BLOC1S3;PMEL;SHROOM2
13112,GO:0051693,0.0719421260648232,0.978172460507882,5,21,actin filament capping,BP,SPTB;GSN;TRIOBP;CAPG;DMTN
6859,GO:0030336,0.0720324184815085,0.954752163680899,24,165,negative regulation of cell migration,BP,TP53INP1;APOE;SFRP1;IFITM1;ARPIN;C5;MAP2K5;SRGAP3;NISCH;MMP28;DDT;PLXNB3;MMRN2;IDH2;MCTP1;ADARB1;LRP1;ZMYND8;DAB2IP;DLG5;BST2;ALOX15B;PBLD;PPARG
15124,GO:0071248,0.0721209684565751,0.960556668711759,15,98,cellular response to metal ion,BP,EGFR;PKD2;NFATC4;RASA4;MT1X;ANK3;ZNF658;GSN;ENDOG;BMP6;HFE;CARF;WNK1;DMTN;TH
1524,GO:0003905,0.0723376785810272,1,1,1,alkylbase DNA N-glycosylase activity,MF,MPG
3958,GO:0008725,0.0723376785810272,1,1,1,DNA-3-methyladenine glycosylase activity,MF,MPG
10641,GO:0043733,0.0723376785810272,1,1,1,DNA-3-methylbase glycosylase activity,MF,MPG
10660,GO:0043916,0.0723376785810272,1,1,1,DNA-7-methylguanine glycosylase activity,MF,MPG
13399,GO:0052821,0.0723376785810272,1,1,1,DNA-7-methyladenine glycosylase activity,MF,MPG
13400,GO:0052822,0.0723376785810272,1,1,1,DNA-3-methylguanine glycosylase activity,MF,MPG
14745,GO:0070459,0.072491183435591,0.99289152523674,2,5,prolactin secretion,BP,EGFR;NMU
3279,GO:0006958,0.0726992131748499,0.986568247519246,3,10,complement activation, classical pathway,BP,C5;C1RL;SERPING1
12084,GO:0048104,0.072953476225218,0.993750614236918,2,4,establishment of body hair or bristle planar orientation,BP,CELSR1;ASTN2
12085,GO:0048105,0.072953476225218,0.993750614236918,2,4,establishment of body hair planar orientation,BP,CELSR1;ASTN2
10796,GO:0044297,0.0731216742168913,0.948295104263681,41,310,cell body,CC,ACTA2;APOE;PTPRS;EPHB2;CAMK2N1;PITPNM3;KCNC4;ITPR3;CRTC1;NDN;CTSV;RTN4RL1;GJC2;PITPNM2;NAIP;INSR;BAIAP2;TANC1;ENDOG;NRSN2;CST3;HOMER2;KLHL24;CDK5R1;CYBA;XRN1;ASTN2;GLUL;SRR;LRP1;BRINP1;ATXN10;RET;DAB2IP;SYT7;SHANK2;TH;CIT;MAP1A;PTBP2;SMURF1
3497,GO:0007398,0.0732239303783458,0.981616009035496,4,15,ectoderm development,BP,ITGA6;FZD7;EDA2R;SMURF1
1928,GO:0004629,0.0732337522927829,0.981612692201826,4,15,phospholipase C activity,MF,PLCD3;PLCD1;PLCH2;PLCB3
2612,GO:0005922,0.0732664625659961,0.986418749243713,3,10,connexin complex,CC,GJD3;GJC2;GJB5
8126,GO:0032835,0.0733049385125049,0.971787028869066,7,34,glomerulus development,BP,ACTA2;SULF2;WWTR1;PODXL;NID1;RET;LAMB2
6589,GO:0022612,0.0734354591538269,0.960840858243385,14,84,gland morphogenesis,BP,TNFAIP3;EGFR;SFRP1;SULF2;SERPINB5;GLI2;GLI3;ETV5;PLAG1;FBXW7;AREG;VDR;PLXND1;STAT6
3569,GO:0007613,0.0735708646336385,0.964291244129002,11,63,memory,BP,APOE;ITPR3;CRTC1;INSR;MDK;B4GALT2;PLA2G6;SHANK3;ATXN1;BRINP1;TH
7265,GO:0031253,0.0736704375174351,0.951481429374471,29,201,cell projection membrane,CC,PSD4;PKD2;EPS8L2;EVC;CSPG4;CYBRD1;FERMT1;KCNC4;SYTL1;TRPV4;ARHGEF4;INSR;SCNN1A;DOCK8;EPB41L3;BBS2;PSD3;PODXL;SHANK3;SPRY2;APC2;BBS1;BBS5;PLXND1;DMTN;TMEM231;SHANK2;SYNE2;PEMT
16375,GO:0097014,0.0736877986686078,0.964188153220544,11,64,ciliary plasm,CC,DNAH1;GLI2;GLI3;GAS8;IFT140;BBS1;PIK3C3;BBS5;ARFGEF2;ATG14;PRKACA
6391,GO:0021602,0.073717663341918,0.981449070206848,4,15,cranial nerve morphogenesis,BP,EPHB2;HOXA3;GLI3;ADARB1
1088,GO:0002676,0.0738146518859843,0.992685328004394,2,5,regulation of chronic inflammatory response,BP,TNFAIP3;ADORA2B
8180,GO:0032928,0.0740648653759395,0.985887076943018,3,11,regulation of superoxide anion generation,BP,EGFR;CYBA;ACP5
12974,GO:0051410,0.0741446185616419,0.99263356351061,2,5,detoxification of nitrogen compound,BP,GSTM2;GSTM3
6336,GO:0021514,0.0741519981499577,0.993586865211099,2,4,ventral spinal cord interneuron differentiation,BP,GLI2;GLI3
15538,GO:0072006,0.0743275787095701,0.96029168948856,14,84,nephron development,BP,ACTA2;PKD2;KIF26B;SULF2;STAT1;WWTR1;GLI3;PODXL;NID1;RET;KLHL3;LAMB2;NPNT;CTNNBIP1
6564,GO:0022029,0.0743737054744612,0.971277695377839,7,34,telencephalon cell migration,BP,EGFR;DIXDC1;GLI3;SUN1;CDK5R1;DAB2IP;SYNE2
12127,GO:0048246,0.0743985137919517,0.980638607366155,4,18,macrophage chemotaxis,BP,TRPV4;C5;MMP28;DDT
11093,GO:0045124,0.0745872207907915,0.977127330613686,5,21,regulation of bone resorption,BP,TNFAIP3;INPP5D;EGFR;CA2;IL20RA
4263,GO:0009611,0.0746328633224402,0.94493507324315,52,414,response to wounding,BP,TNFAIP3;POSTN;SERPINE2;APOE;EGFR;PTPRS;DGKQ;PIK3R1;DOCK9;EYS;SULF2;VAV3;RGMA;ZFPM1;MYL9;PRKACB;ITPR3;NINJ1;FLRT3;F2R;HPS4;BLOC1S4;RTN4RL1;ZFP36L2;ADAMTS13;ARHGEF19;ITGA2;GLI3;NAIP;CELSR1;GSN;CD109;DOCK8;BLOC1S3;MDK;FZD7;CST3;HMG20B;TFPI2;GNG2;SYT7;DMTN;MATN2;PTK7;ZFP36L1;MTR;CD9;ERBB2;PRKACA;DOCK6;SERPING1;LAMB2
15495,GO:0071896,0.0747622284002644,0.993502855097008,2,4,protein localization to adherens junction,BP,DLG5;MPP7
19690,GO:2000051,0.0748585823952932,0.993489550883816,2,4,negative regulation of non-canonical Wnt signaling pathway,BP,SFRP1;RNF213
4468,GO:0010466,0.0750586511333988,0.955409954703699,19,137,negative regulation of peptidase activity,BP,SERPINE2;IFI6;COL7A1;SPOCK1;MDM2;SERPINB5;LAMP3;C5;NAIP;MAP2K5;CD109;CST3;TFPI2;IFI16;BST2;PCSK1N;PRDX5;SERPING1;ECM1
105,GO:0000220,0.0751586597813827,0.992473597638867,2,5,vacuolar proton-transporting V-type ATPase, V0 domain,CC,TCIRG1;ATP6V0A2
10919,GO:0044557,0.0753916830445885,0.992436649631387,2,5,relaxation of smooth muscle,BP,RGS2;ADORA2B
5437,GO:0016303,0.0755787468323006,0.973598038834861,6,26,1-phosphatidylinositol-3-kinase activity,MF,PIK3R1;PIK3C2G;PIK3C3;FGFR4;PIK3R2;IRS2
10518,GO:0043473,0.0756418334347431,0.96164229416106,12,74,pigmentation,BP,KITLG;MC1R;HPS4;BLOC1S4;GLI3;BLOC1S3;BBS2;PMEL;MYSM1;SHROOM2;BBS5;TH
4818,GO:0014015,0.0756490354500516,0.970504815016681,7,36,positive regulation of gliogenesis,BP,SERPINE2;TENM4;GJC2;ETV5;PLAG1;PPARG;UFL1
6663,GO:0030029,0.0756788055238421,0.942070967531702,67,513,actin filament-based process,BP,ESPN;DIXDC1;SFRP1;OBSL1;EPS8L2;PIK3R1;PI4KAP2;ASAP3;OR2A4;ITGB5;IQSEC2;OBSCN;MYH11;PARVB;TNXB;RHOBTB2;RAPGEF3;CTSV;ARPIN;SPTB;TRPV4;CORO6;ARHGEF19;WIPF1;SNTA1;MINK1;FHOD3;KCNJ5;NISCH;CELSR1;GSN;BAIAP2;TTN;PLEKHH2;TRIOBP;SCN4B;RICTOR;MICALL2;EPB41L3;WHAMMP3;CDK5R1;PI4KAP1;EPB41L4A;SHANK3;WASH3P;PAK6;ARAP1;FMNL2;CAPG;LRP1;NPHP4;SYNPO2;SHROOM2;BST2;ARHGEF17;EFS;DMTN;ALMS1;SHROOM4;TNNI2;IQSEC1;PTK7;PHPT1;SSH3;FMNL3;SYNE2;CIT
509,GO:0001573,0.0758146695055548,0.985740672789025,3,10,ganglioside metabolic process,BP,ST6GALNAC6;ST3GAL5;HEXB
5995,GO:0019005,0.0758369603532414,0.966066575216986,9,52,SCF ubiquitin ligase complex,CC,FBXW4;BTBD2;SPSB3;FBXO44;FBXO2;FBXW7;FBXW5;FBXO4;ABTB1
15097,GO:0071205,0.0758966168577607,0.993345546045444,2,4,protein localization to juxtaparanode region of axon,BP,EPB41L3;NFASC
11269,GO:0045596,0.075904661645435,0.943775799407345,53,417,negative regulation of cell differentiation,BP,POSTN;ULK2;TP53INP1;PTHLH;APOE;INPP5D;EGFR;PTPRS;DIXDC1;SFRP1;KCTD11;EPHB2;PIK3R1;ADAMTS7;CXCL14;WNT3;RGMA;ZFPM1;STAT1;KLF13;NFATC4;SPOCK1;MDM2;PDCD4;RTN4RL1;ZFP36L2;TRPV4;GLI2;WWTR1;SEMA4G;GLI3;CCDC85B;FZD7;SYNGAP1;NPHP3;IDH2;IQCB1;CDK5R1;EFNB3;FBXW7;LRP1;BRINP1;DAB2IP;AREG;DMTN;PMP22;NRARP;ZFP36L1;PBLD;ERBB2;GPR68;RORA;PPARG
12363,GO:0048771,0.0759610905770891,0.958201461085713,15,95,tissue remodeling,BP,TNFAIP3;GPNMB;INPP5D;EGFR;SFRP1;CSPG4;HOXA3;MDM2;F2R;CST3;CA2;ACP5;SYT7;IL20RA;VDR
10778,GO:0044262,0.0760338757560251,0.950534470683488,27,191,cellular carbohydrate metabolic process,BP,SIK1;PYGB;DGKQ;GAA;IDUA;MLYCD;PPP1R3E;PER2;FGGY;IGFBP4;INSR;PDK1;B3GNT9;IDH2;PGM1;PFKFB2;SLC2A1;ACACB;EPM2AIP1;PPP1R2;KAT2B;IRS2;IMPA2;TKFC;ISYNA1;GLB1;RORA
3264,GO:0006935,0.0761618025086965,0.944851495210628,46,356,chemotaxis,BP,GPNMB;CXCR1;EPHB2;PIK3R1;CXCL14;WNT3;VAV3;UNC5B;PLEKHG5;PIK3C2G;PLXNB1;NEO1;FLRT3;SPTB;TRPV4;GLI2;KLF7;RNF165;C5;ITGA2;SEMA4G;GLI3;BOC;MMP28;DDT;PLXNB3;VEGFB;PLA2G6;CDK5R1;EFNB3;SHANK3;SLIT3;PLA2G7;LTB4R2;RET;RPS6KA5;PLXND1;MATN2;IRS2;ZSWIM8;APBB2;RANBP9;ERBB2;ACKR3;LAMB2;NFASC
9948,GO:0042330,0.0761618025086965,0.944851495210628,46,356,taxis,BP,GPNMB;CXCR1;EPHB2;PIK3R1;CXCL14;WNT3;VAV3;UNC5B;PLEKHG5;PIK3C2G;PLXNB1;NEO1;FLRT3;SPTB;TRPV4;GLI2;KLF7;RNF165;C5;ITGA2;SEMA4G;GLI3;BOC;MMP28;DDT;PLXNB3;VEGFB;PLA2G6;CDK5R1;EFNB3;SHANK3;SLIT3;PLA2G7;LTB4R2;RET;RPS6KA5;PLXND1;MATN2;IRS2;ZSWIM8;APBB2;RANBP9;ERBB2;ACKR3;LAMB2;NFASC
17330,GO:1900039,0.076231214712038,1,1,1,positive regulation of cellular response to hypoxia,BP,RWDD3
17837,GO:1902071,0.076231214712038,1,1,1,regulation of hypoxia-inducible factor-1alpha signaling pathway,BP,RWDD3
17838,GO:1902073,0.076231214712038,1,1,1,positive regulation of hypoxia-inducible factor-1alpha signaling pathway,BP,RWDD3
8706,GO:0034363,0.0763147166441603,1,1,1,intermediate-density lipoprotein particle,CC,APOE
8708,GO:0034365,0.0763147166441603,1,1,1,discoidal high-density lipoprotein particle,CC,APOE
8714,GO:0034371,0.0763147166441603,1,1,1,chylomicron remodeling,BP,APOE
11875,GO:0046911,0.0763147166441603,1,1,1,metal chelating activity,MF,APOE
16361,GO:0090731,0.0763147166441603,1,1,1,cellular response to very-low-density lipoprotein particle stimulus,BP,APOE
17695,GO:1901630,0.0763147166441603,1,1,1,negative regulation of presynaptic membrane organization,BP,APOE
18189,GO:1903000,0.0763147166441603,1,1,1,regulation of lipid transport across blood brain barrier,BP,APOE
18190,GO:1903002,0.0763147166441603,1,1,1,positive regulation of lipid transport across blood brain barrier,BP,APOE
19355,GO:1905853,0.0763147166441603,1,1,1,regulation of heparan sulfate binding,BP,APOE
19356,GO:1905855,0.0763147166441603,1,1,1,positive regulation of heparan sulfate binding,BP,APOE
19357,GO:1905858,0.0763147166441603,1,1,1,regulation of heparan sulfate proteoglycan binding,BP,APOE
19358,GO:1905860,0.0763147166441603,1,1,1,positive regulation of heparan sulfate proteoglycan binding,BP,APOE
19366,GO:1905890,0.0763147166441603,1,1,1,regulation of cellular response to very-low-density lipoprotein particle stimulus,BP,APOE
9930,GO:0042297,0.0767258561057502,0.99322961896674,2,4,vocal learning,BP,SHANK3;FOXP2
16761,GO:0098596,0.0767258561057502,0.99322961896674,2,4,imitative learning,BP,SHANK3;FOXP2
16763,GO:0098598,0.0767258561057502,0.99322961896674,2,4,learned vocalization behavior or vocal learning,BP,SHANK3;FOXP2
19260,GO:1905502,0.0768542010038967,1,1,1,acetyl-CoA binding,MF,NAT6
5732,GO:0016881,0.0769466669190655,0.980116897116317,4,16,acid-amino acid ligase activity,MF,TPGS1;PPCS;TTLL1;GCLC
11118,GO:0045176,0.0772222026128881,0.98578833176825,3,9,apical protein localization,BP,CELSR1;SHROOM2;DLG5
4129,GO:0009190,0.0772672660479551,0.969722695358768,7,36,cyclic nucleotide biosynthetic process,BP,PTHLH;APOE;NOS1;ADORA2B;GABBR1;GPR87;LTB4R2
13361,GO:0052652,0.0772672660479551,0.969722695358768,7,36,cyclic purine nucleotide metabolic process,BP,PTHLH;APOE;NOS1;ADORA2B;GABBR1;GPR87;LTB4R2
10610,GO:0043621,0.0773317487901019,0.965785949799145,9,43,protein self-association,MF,TNFAIP3;VAMP2;TTN;SHANK3;ATXN1;SLC2A1;DMTN;RSAD2;PPARG
9381,GO:0035930,0.0777014803605438,0.992066617671624,2,5,corticosteroid hormone secretion,BP,CRY1;BMP6
20123,GO:2000846,0.0777014803605438,0.992066617671624,2,5,regulation of corticosteroid hormone secretion,BP,CRY1;BMP6
4679,GO:0010830,0.0777796186383849,0.972270316642787,6,29,regulation of myotube differentiation,BP,SIK1;CYP26B1;FLOT1;GDF15;THRA;MAMSTR
322,GO:0000902,0.0780211393531247,0.938175164459852,87,688,cell morphogenesis,BP,POSTN;ULK2;MAP6;APOE;EGFR;PTPRS;CAPRIN2;SLITRK6;OBSL1;EPHB2;PIK3R1;BRSK1;WNT3;UNK;TFCP2L1;TENM4;ZFPM1;CUL7;VAMP3;IMPACT;UNC5B;NFATC4;PLXNB1;NDN;PARVB;RHOBTB2;NEO1;FLRT3;ARPIN;SPTB;NYAP1;FLOT1;GLI2;ANK3;KLF7;RNF165;SPG11;WIPF1;MINK1;SEMA4G;ULK1;GLI3;BOC;TRAK1;BAIAP2;PLXNB3;TRIOBP;MICALL2;FZD7;SYNGAP1;EPB41L3;HEXB;CDK5R1;NET1;EFNB3;SHANK3;AGO4;SLIT3;ARAP1;ADARB1;FMNL2;RET;DAB2IP;RPS6KA5;VDR;PLXND1;ZMYM3;DMTN;SNX1;DLG4;MATN2;NBEAL2;WEE1;SHANK2;IRS2;S100A6;ZSWIM8;APBB2;RANBP9;ERBB2;SSH3;FMNL3;LAMB2;NFASC;MAP1A;ECM2;SMURF1
9399,GO:0035971,0.078036990127691,1,1,1,peptidyl-histidine dephosphorylation,BP,PHPT1
10354,GO:0043184,0.0781401619711211,0.991995564572258,2,5,vascular endothelial growth factor receptor 2 binding,MF,VEGFB;DAB2IP
16890,GO:0098876,0.0782012540263487,0.961553477681692,11,65,vesicle-mediated transport to the plasma membrane,BP,VAMP3;NSG1;MICALL1;ANK3;VAMP2;VPS39;BBS2;BBS1;EXOC2;OSBPL5;ARFGEF2
12259,GO:0048583,0.0783819361938542,0.931437658483958,303,2706,regulation of response to stimulus,BP,TNFAIP3;POSTN;SERPINE2;GPNMB;EPM2A;MUC19;TP53INP1;IFI6;PTHLH;APOE;NT5E;INPP5D;APCDD1;PSD4;DDX60;EGFR;PTPRS;FAM20C;PKD2;CAPRIN2;MNT;DIXDC1;TRIM22;SFRP1;KCTD11;EPS8L2;EPHB2;MAP3K14;DGKQ;PIK3R1;RBCK1;CXCL14;EVC;RNF135;SULF2;WNT3;HERC5;VAV3;CSPG4;MVB12B;HTRA1;RGMA;KITLG;MC1R;ASAP3;STAT1;IMPACT;CAMK2N1;CRY2;UNC5B;NOS1;PRKACB;CRY1;MAML3;MAGEF1;PLEKHG5;NFATC4;IQSEC2;FERMT1;CYP26B1;THNSL2;PLXNB1;PLEKHG3;MDM2;LZTS2;IFITM1;FCGRT;CHN2;LTBP4;PIK3IP1;OBSCN;HLA-B;TNFSF10;RHOBTB2;NEO1;POLH;FLRT3;RASA4;KIF26A;RGS2;ACAP3;IL20RB;F2R;PDCD4;RTN4RL1;TRPV4;FLOT1;GLI2;AGAP4;NLGN2;ADORA2B;RNF165;RALGAPA1;MAPK8IP3;PIDD1;ARHGEF19;RHBDF1;RASGEF1A;PER2;TMEM204;FNDC4;C5;WIPF1;MINK1;GSTM2;WWTR1;ASAP2;ARHGEF4;ITGA2;SEMA4G;FAM110C;GLI3;SPPL2B;AKAP7;LRSAM1;NAIP;LTBP1;NEK8;MAP2K5;ITGA6;SRGAP3;SESN3;IGFBP4;JARID2;GPC2;INSR;MMP28;GSN;CHD3;CDK14;BAIAP2;CBLC;DDT;CD109;ETAA1;RMI2;ARHGEF1;MGST2;DHX58;PILRB;ENDOG;MDK;RICTOR;BMP6;NLRX1;S100A4;MAP2K2;VEGFB;SQSTM1;PTK6;FZD7;SYNGAP1;FAM13A;SHARPIN;ARHGAP33;SH2D2A;NSMCE4A;ARRDC1;PLA2G6;HOMER2;MMRN2;GDF15;BBS2;CTF1;NPHP3;PSD3;MAP3K12;WRN;DNM1;TNFRSF21;KLHL24;MCTP1;CDK5R1;AGAP6;NET1;SESN1;MAPK10;SHANK3;HFE;ADIRF;CYBA;TRIM38;ERCC6;RRM2B;SLIT3;SHC2;EDA2R;SPRY2;IFT140;CREBRF;AGAP7P;CTSB;KLK5;FBXW7;NUDT6;CDK5RAP3;PAK6;THRA;APC2;ARAP1;ELF1;RPH3AL;NLRP1;C1RL;ERMAP;LRP1;HLA-A;NPHP4;RGS12;ACP5;PLA2G7;C12ORF66;DLK2;MAP3K6;APPL2;WNK1;JPH2;PDE2A;RET;ZMYND8;DAB2IP;RWDD3;FBXO4;RNF213;PIK3C3;IFI16;SYT7;FGFR4;IL20RA;PIK3R2;AREG;MYO9A;RPS6KA5;DLG5;BST2;RGL2;ARHGEF17;CACNB3;FAM3A;PCSK6;LPAR6;PPP1R2;DMTN;STAT2;ARFGEF2;WWC3;TFDP2;UCN2;NRARP;ACVR1B;KREMEN1;DLG4;IQSEC1;ENDOU;IGFBP6;SHANK2;RSAD2;TNFRSF25;LMNA;IL11;KAT2B;IRS2;ANO1;ERN1;IVNS1ABP;ALOX15B;RAD50;GPR21;TKFC;ZSWIM8;ARHGEF9;PBLD;TNFSF12;STAT6;PHPT1;SMPDL3B;KIF7;TRAF5;CD9;RANBP9;PTPN3;ERBB2;GPR68;ARHGAP23;AKAP6;MPP7;RORA;PPARG;PRKACA;LDLRAP1;CXXC5;ACKR3;SERPING1;UFL1;RIPK3;AIP;CCDC3;SMURF1;NPNT;CTNNBIP1;SERINC3;GCLC;ECM1
9421,GO:0036004,0.0785578254817237,1,1,1,GAF domain binding,MF,AIP
555,GO:0001678,0.0786535518876147,0.957438876595726,14,91,cellular glucose homeostasis,BP,PIK3R1;ENDOG;PLA2G6;CYBA;MLXIPL;PIK3R2;IRS2;ANO1;ERN1;PHPT1;GPR68;TH;PRKACA;GCLC
13912,GO:0060598,0.07867718555472,1,1,1,dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis,BP,AREG
11271,GO:0045598,0.0787297765142191,0.958603031218104,13,80,regulation of fat cell differentiation,BP,SFRP1;ZFPM1;ZFP36L2;TRPV4;SULT1E1;WWTR1;CCDC85B;ADIRF;DLK2;ZFP36L1;RORA;PPARG;CCDC3
2289,GO:0005248,0.0787302922564175,0.985389905887207,3,9,voltage-gated sodium channel activity,MF,PKD2;SCN4B;SCN2A
11935,GO:0047045,0.0788754219648739,1,1,1,testosterone 17-beta-dehydrogenase (NADP+) activity,MF,HSD17B14
17509,GO:1901021,0.0790792532114629,0.975164487954551,5,22,positive regulation of calcium ion transmembrane transporter activity,BP,HSPA2;PKD2;GSTM2;JPH2;AKAP6
8377,GO:0033293,0.0791573771863373,0.971364088365117,6,32,monocarboxylic acid binding,MF,CYP26B1;UGT1A3;HLCS;ACACB;VDR;PPARG
10869,GO:0044421,0.0793132084814449,0.931026561672653,266,2500,extracellular region part,CC,TNFAIP3;TGFBI;POSTN;ITGB6;SERPINE2;MUC19;PTHLH;PYGB;MXRA5;ACTA2;APOE;CES2;NT5E;GAMT;HSPA2;EGFR;PTPRS;FAM20C;PKD2;XPC;ALDH1A3;LRIG3;SLITRK6;CTSO;SFRP1;SEC14L2;EPS8L2;GPX3;BPHL;ADAMTS7;CXCL14;COL22A1;EYS;SULF2;WNT3;VAV3;SMOC2;CSPG4;MVB12B;CYBRD1;ELFN2;HTRA1;RGMA;KITLG;ZDHHC1;IRF2BPL;NAPRT;REEP2;C1QTNF6;KRT15;LGALS7B;MARCKSL1;KDSR;ITGB5;COL10A1;RAB43;PRKACB;CRTAP;SDC3;BCAM;MAGEF1;FKBP5;GAA;THNSL2;NDRG1;COL7A1;SPOCK1;NAGLU;PLCD1;LTBP4;PIK3IP1;IDUA;GPRC5C;TNFSF10;MYH11;SYTL1;CALML3;ACTR1B;TNXB;RAPGEF3;ENDOD1;CTSV;BLVRB;FLRT3;GAL3ST4;PPL;SERPINB5;CAPN7;RTN4RL1;CLTCL1;TMC6;FLOT1;TOM1L2;ADAMTS13;SPG11;ZCCHC11;PTGS1;UNC119;HEXA;FNDC4;C5;FRMD4B;ARSD;MINK1;NINL;ABHD14B;GSTM2;THBS3;SEMA4G;PCSK1;THRAP3;VAMP2;NAIP;LTBP1;ITGA6;LTBP3;CES3;IGFBP4;MMP1;GPC2;INSR;TST;MMP28;GSN;HEBP1;BAIAP2;TTN;CBLC;SCNN1A;DDT;CTSF;CD109;PGLS;ZNF446;RAB11FIP4;TM7SF3;CASP14;H2AFJ;BMP6;SLC2A3;S100A4;VEGFB;ALDH7A1;SQSTM1;AKR7A2;LOXL1;FAM213A;FAT2;HEXB;HYAL1;ARRDC1;KIAA0319L;CENPC;PLA2G6;MXRA7;CST3;MMRN2;GDF15;CTF1;THSD4;COL6A1;PEX11B;IDH2;PODXL;DNM1;IQCB1;PLD3;ABHD14A;CA2;HFE;ADIRF;NID1;RRM2B;SLIT3;KRT14;FBXO2;RAB11FIP3;CTSB;KLK5;KCNMA1;TFPI2;PGM1;CHMP1B;APC2;SLC2A1;C1RL;GPR155;GLUL;GNG2;CAPG;LRRN3;ACP5;PLA2G7;RNPEP;DLK2;PPCS;APPL2;ATXN10;DAB2IP;SLC37A2;SHROOM2;SYT7;AREG;ETFB;BST2;FAM3A;PCSK6;UCN2;OSBPL1A;ACVR1B;CADM4;IGFL2;ENDOU;MPI;SNX29;IGFBP6;MATN2;GALE;MXRA8;CLSTN3;IL11;DMXL2;CEP250;ANO1;CAPS;MBLAC2;METTL7A;ALOX15B;TKFC;PNPO;MAN1B1;DHRS4;PEX1;ECI1;S100A6;EFEMP2;SGSH;GAREM2;PBLD;TNFSF12;PCSK1N;PRDX5;PHPT1;SMPDL3B;GLB1;GSTM3;SRPX2;DPP7;CD9;HDAC11;CTSD;ARHGAP23;PRKACA;NPAP1;C6ORF120;ACOT2;SYNE2;PLTP;SERPING1;LAMB2;NFASC;ECM2;SMURF1;NPNT;GLIPR1L2;ECM1
9756,GO:0039532,0.0794406043718313,0.984757705334584,3,10,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway,BP,DHX58;NLRX1;TKFC
3716,GO:0008236,0.0795918773267546,0.956807414431875,14,93,serine-type peptidase activity,MF,HTRA1;TYSND1;CTSV;RHBDF1;PCSK1;MMP1;CTSB;KLK5;C1RL;PCSK6;ENDOU;DPP7;CTSD;LONP2
6473,GO:0021819,0.0796099743302765,0.984711275874597,3,10,layer formation in cerebral cortex,BP,GLI3;CDK5R1;DAB2IP
16519,GO:0097283,0.0796754893614703,0.99174494710065,2,5,keratinocyte apoptotic process,BP,GSN;ZFP36L1
17868,GO:1902172,0.0796754893614703,0.99174494710065,2,5,regulation of keratinocyte apoptotic process,BP,GSN;ZFP36L1
6985,GO:0030672,0.0797238619737219,0.963966136902628,9,52,synaptic vesicle membrane,CC,PTPRS;SYT8;SYN1;C2CD4C;VAMP2;MCTP1;SYT7;DMXL2;SYNGR1
17012,GO:0099501,0.0797238619737219,0.963966136902628,9,52,exocytic vesicle membrane,CC,PTPRS;SYT8;SYN1;C2CD4C;VAMP2;MCTP1;SYT7;DMXL2;SYNGR1
1931,GO:0004632,0.0797566331594279,1,1,1,phosphopantothenate--cysteine ligase activity,MF,PPCS
8656,GO:0034237,0.0798180067277714,0.9793521398914,4,15,protein kinase A regulatory subunit binding,MF,AKAP7;ARFGEF2;AKAP6;PRKACA
4771,GO:0010959,0.0798693232539567,0.948200495872023,26,186,regulation of metal ion transport,BP,SERPINE2;SIK1;HSPA2;PKD2;KCNAB2;NOS1;F2R;ANK3;GJC2;SNTA1;GSTM2;VAMP2;SCN4B;PLA2G6;HOMER2;KLHL24;HFE;CYBA;KCNG1;WNK1;JPH2;CACNB3;CACNB1;PTPN3;AKAP6;PRKACA
548,GO:0001669,0.0799002885128889,0.963870238695107,9,52,acrosomal vesicle,CC,SYT8;SUN1;LOXL1;HEXB;ATP6V0A2;CCDC136;TSSK1B;GOLGA1;PRKACA
10570,GO:0043548,0.0803160142967873,0.974822520289313,5,21,phosphatidylinositol 3-kinase binding,MF,PIK3R1;PIK3IP1;INSR;DAB2IP;IRS2
3127,GO:0006707,0.0803524560557755,0.991633486729323,2,5,cholesterol catabolic process,BP,APOE;TRERF1
5354,GO:0016127,0.0803524560557755,0.991633486729323,2,5,sterol catabolic process,BP,APOE;TRERF1
5972,GO:0018455,0.080353264674813,1,1,1,alcohol dehydrogenase [NAD(P)+] activity,MF,DHRS4
19486,GO:1990384,0.080353264674813,1,1,1,hyaloid vascular plexus regression,BP,NINJ1
7156,GO:0031034,0.080357448546263,0.992382024626798,3,4,myosin filament assembly,BP,OBSL1;MYH11;TTN
7812,GO:0032373,0.080538454912031,0.978856844098197,4,16,positive regulation of sterol transport,BP,APOE;LRP1;LDLRAP1;PLTP
7815,GO:0032376,0.080538454912031,0.978856844098197,4,16,positive regulation of cholesterol transport,BP,APOE;LRP1;LDLRAP1;PLTP
15285,GO:0071498,0.0805520554125678,0.978852031677047,4,16,cellular response to fluid shear stress,BP,PKD2;MAP2K5;CA2;TFPI2
2139,GO:0004953,0.0806065775560292,0.991591495731956,2,5,icosanoid receptor activity,MF,LTB4R2;PPARG
3370,GO:0007140,0.0806535004730554,0.97437295007834,5,23,male meiotic nuclear division,BP,HSPA2;CYP26B1;MLH3;REC8;AGO4
5135,GO:0015645,0.0806974915938243,0.984412069308214,3,10,fatty acid ligase activity,MF,SLC27A3;SLC27A1;ACSL1
11306,GO:0045646,0.0809155894986286,0.967943609476632,7,36,regulation of erythrocyte differentiation,BP,INPP5D;ZFPM1;STAT1;KLF13;FAM210B;ACVR1B;ZFP36L1
12553,GO:0050727,0.080926478570989,0.948376091935673,24,177,regulation of inflammatory response,BP,TNFAIP3;APOE;NT5E;EGFR;IL20RB;PDCD4;TRPV4;ADORA2B;FNDC4;C5;ITGA2;DDT;MGST2;RICTOR;NLRX1;SHARPIN;NLRP1;ACP5;PLA2G7;PDE2A;SMPDL3B;RORA;PPARG;SERPING1
2991,GO:0006536,0.0811642622046784,0.974162155344052,5,23,glutamate metabolic process,BP,GLUD1;PRODH;ALDH4A1;GLUL;GCLC
11994,GO:0047499,0.0811874930857702,0.991495196832037,2,5,calcium-independent phospholipase A2 activity,MF,PLA2G6;PLA2G7
10297,GO:0043087,0.0812497263655262,0.940501499295596,48,359,regulation of GTPase activity,BP,GPSM1;ALS2CL;SFRP1;EVI5L;DOCK9;VAV3;ASAP3;TBC1D8;PLXNB1;CHN2;RAPGEF3;RASA4;RGS2;ACAP3;F2R;AGAP4;RALGAPA1;ARHGEF19;TBC1D19;ASAP2;ITGA6;SRGAP3;PLXNB3;RIN1;ARHGEF1;DOCK8;RICTOR;SYNGAP1;FAM13A;ARHGAP33;ARHGAP27;AGAP6;NET1;SPRY2;AGAP7P;APC2;ARAP1;TBC1D17;RGS12;DAB2IP;PIK3R2;MYO9A;PLXND1;TBC1D16;SGSM2;IQSEC1;ERBB2;ARHGAP23
3377,GO:0007155,0.0813393727618518,0.934599359211377,97,788,cell adhesion,BP,TGFBI;POSTN;ITGB6;SERPINE2;GPNMB;NT5E;EGFR;PTPRS;SFRP1;KIF26B;PCDH1;MAP3K14;PIK3R1;VAV3;SMOC2;TENM4;KITLG;SDK2;VAMP3;MYL9;LGALS7B;ITGB5;BCAM;FERMT1;PLXNB1;COL7A1;SPOCK1;PARVB;TNXB;NEO1;NINJ1;NLGN4Y;FLRT3;IL20RB;BLOC1S4;CGREF1;TRPV4;FLOT1;GLI2;NLGN2;ANK3;ADAMTS13;ADGRL1;MINK1;AMIGO2;THBS3;TNFRSF14;ITGA2;GLI3;MAP2K5;BOC;ITGA6;CELSR1;GSN;BAIAP2;PLXNB3;CNTNAP3;TRIOBP;DOCK8;MICALL2;TMEM8B;FZD7;FAT2;HYAL1;CLCA2;COL6A1;CERCAM;PODXL;TNFRSF21;CDK5R1;NET1;EFNB3;HFE;NID1;NPHP4;CD99L2;DGCR2;RET;DLG5;EFS;PLXND1;DMTN;NRARP;CADM4;CCDC88B;PTK7;ZFP36L1;CLSTN3;SRPX2;CD9;COL13A1;ERBB2;ACKR3;LAMB2;NFASC;ECM2;NPNT
7019,GO:0030800,0.0814276340467144,0.984210136502214,3,10,negative regulation of cyclic nucleotide metabolic process,BP,GABBR1;GPR87;LTB4R2
7034,GO:0030815,0.0814276340467144,0.984210136502214,3,10,negative regulation of cAMP metabolic process,BP,GABBR1;GPR87;LTB4R2
6254,GO:0019842,0.0815228486798062,0.956756593634158,13,85,vitamin binding,MF,PYGB;SEC14L2;DHTKD1;THNSL2;PHYH;HLCS;ACACB;ACCS;OGDHL;SRR;VDR;PNPO;MTR
2661,GO:0006006,0.0815724756014561,0.950418370373341,20,137,glucose metabolic process,BP,SIK1;DGKQ;H6PD;CRY1;GAA;OAS1;MLYCD;G6PC3;PER2;IGFBP4;NISCH;INSR;PDK1;PGM1;PFKFB2;ACACB;EPM2AIP1;KAT2B;IRS2;RORA
12463,GO:0050431,0.0815893567768755,0.978731560301129,4,15,transforming growth factor beta binding,MF,LTBP4;LTBP1;LTBP3;CD109
11349,GO:0045725,0.0819155435422604,0.984536726426553,3,9,positive regulation of glycogen biosynthetic process,BP,INSR;EPM2AIP1;IRS2
3075,GO:0006643,0.0820057462450158,0.947609088978389,24,177,membrane lipid metabolic process,BP,KDSR;ST6GALNAC6;CERS4;GAL3ST4;B4GALT6;ARSI;HEXA;ARSD;ST3GAL5;MGST2;PGAP1;HEXB;PLA2G6;PIGZ;MPPE1;KDELC2;ESYT2;ALOXE3;CERS5;SMPDL3B;GLB1;TH;PEMT;SERINC3
1910,GO:0004602,0.0820733560723735,0.982907005927247,3,14,glutathione peroxidase activity,MF,GPX3;GSTM2;MGST2
16499,GO:0097229,0.0822552237907296,1,1,1,sperm end piece,CC,CABYR
10656,GO:0043901,0.0822845074800006,0.952150577797936,17,119,negative regulation of multi-organism process,BP,TNFAIP3;OAS2;APOBEC3C;ISG15;HTRA1;STAT1;IFITM1;OAS1;GSN;DHX58;NLRX1;SQSTM1;IFI16;BST2;FAM3A;RSAD2;TKFC
15834,GO:0072574,0.0823762163952273,0.98394653611029,3,10,hepatocyte proliferation,BP,TNFAIP3;SULF2;FBXW7
15835,GO:0072575,0.0823762163952273,0.98394653611029,3,10,epithelial cell proliferation involved in liver morphogenesis,BP,TNFAIP3;SULF2;FBXW7
15682,GO:0072243,0.0824780299453629,0.978418270259523,4,15,metanephric nephron epithelium development,BP,PKD2;STAT1;WWTR1;LAMB2
14602,GO:0070192,0.0827467019084332,0.967042568715724,7,36,chromosome organization involved in meiotic cell cycle,BP,MLH3;SUN1;ATRX;REC8;AGO4;RAD50;MSH5
15483,GO:0071877,0.0829393930943602,1,1,1,regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway,BP,RGS2
15487,GO:0071881,0.0829393930943602,1,1,1,adenylate cyclase-inhibiting adrenergic receptor signaling pathway,BP,RGS2
16033,GO:0086096,0.0829393930943602,1,1,1,adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process,BP,RGS2
17296,GO:0140193,0.0829393930943602,1,1,1,regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process,BP,RGS2
17297,GO:0140194,0.0829393930943602,1,1,1,negative regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process,BP,RGS2
12445,GO:0050291,0.0831082985104286,0.991173735601775,2,5,sphingosine N-acyltransferase activity,MF,CERS4;CERS5
2086,GO:0004852,0.0832587753862902,1,1,1,uroporphyrinogen-III synthase activity,MF,UROS
15229,GO:0071418,0.0832587753862902,1,1,1,cellular response to amine stimulus,BP,UROS
8341,GO:0033211,0.0834269671745848,0.991119952681911,2,5,adiponectin-activated signaling pathway,BP,SLC27A1;ACSL1
486,GO:0001539,0.0834599888669467,0.977816040128564,4,16,cilium or flagellum-dependent cell motility,BP,DNAH1;GAS8;BBS2;TTLL1
13698,GO:0060285,0.0834599888669467,0.977816040128564,4,16,cilium-dependent cell motility,BP,DNAH1;GAS8;BBS2;TTLL1
15494,GO:0071895,0.083469146937696,0.991112824239212,2,5,odontoblast differentiation,BP,FAM20C;DLX3
6034,GO:0019118,0.0834700077066255,1,1,1,phenanthrene-epoxide hydrolase activity,MF,AKR7A2
6035,GO:0019119,0.0834700077066255,1,1,1,phenanthrene-9,10-epoxide hydrolase activity,MF,AKR7A2
536,GO:0001655,0.0836338327278468,0.943767672044187,30,212,urogenital system development,BP,ACTA2;PKD2;SFRP1;KIF26B;EPHB2;SULF2;STAT1;LZTS2;SERPINB5;GLI2;WWTR1;GLI3;ITGA6;BMP6;NPHP3;PLAG1;PODXL;CA2;NID1;RRM2B;IFT140;TNS2;RET;KLHL3;DLG5;ALOX15B;GCNT4;LAMB2;NPNT;CTNNBIP1
1256,GO:0003012,0.0836810138003336,0.943340026992612,31,220,muscle system process,BP,ACTA2;GAMT;OBSL1;SULF2;MYL9;ITGB5;NOS1;GAA;MYH11;RGS2;F2R;ADORA2B;SNTA1;GSTM2;ITGA2;NMU;KCNJ5;JARID2;GSN;TTN;SCN4B;VEGFB;PLA2G6;BBS2;CYBA;KCNMA1;TNNI2;LMNA;AKAP6;PRKACA;NPNT
8600,GO:0034121,0.0836968947772678,0.966572899656549,7,36,regulation of toll-like receptor signaling pathway,BP,TNFAIP3;PTPRS;FLOT1;CYBA;DAB2IP;RSAD2;SMPDL3B
8968,GO:0035082,0.0838199337445354,0.973059158712972,5,23,axoneme assembly,BP,DNAH1;TPGS1;GAS8;BBS2;TTLL1
15102,GO:0071214,0.0839930644497181,0.943036764013815,31,230,cellular response to abiotic stimulus,BP,DDB2;TP53INP1;EGFR;PKD2;XPC;SFRP1;MAP3K14;PIK3R1;MC1R;IMPACT;CRY2;CRY1;NFATC4;MDM2;POLH;TRPV4;ITGA2;BMP6;HYAL1;WRN;NET1;ADIRF;CYBA;SLC2A1;PDE2A;FBXO4;IFI16;SCN2A;ZFP36L1;GPR68;GCLC
17165,GO:0104004,0.0839930644497181,0.943036764013815,31,230,cellular response to environmental stimulus,BP,DDB2;TP53INP1;EGFR;PKD2;XPC;SFRP1;MAP3K14;PIK3R1;MC1R;IMPACT;CRY2;CRY1;NFATC4;MDM2;POLH;TRPV4;ITGA2;BMP6;HYAL1;WRN;NET1;ADIRF;CYBA;SLC2A1;PDE2A;FBXO4;IFI16;SCN2A;ZFP36L1;GPR68;GCLC
1982,GO:0004704,0.084147490643603,0.990997875050233,2,5,NF-kappaB-inducing kinase activity,MF,MAP3K14;RIPK3
14628,GO:0070235,0.0842401993583348,0.990982120008195,2,5,regulation of activation-induced cell death of T cells,BP,TSC22D3;RIPK3
2517,GO:0005771,0.0844646502232685,0.972518998841247,5,25,multivesicular body,CC,EGFR;NSG1;CST3;PMEL;BST2
7282,GO:0031282,0.0850545635003419,0.99084326132182,2,5,regulation of guanylate cyclase activity,BP,NOS1;ADORA2B
7283,GO:0031284,0.0850545635003419,0.99084326132182,2,5,positive regulation of guanylate cyclase activity,BP,NOS1;ADORA2B
1154,GO:0002762,0.0851091961157114,0.96892731666504,6,29,negative regulation of myeloid leukocyte differentiation,BP,INPP5D;SFRP1;PIK3R1;ZFPM1;FBXW7;GPR68
20239,GO:2001225,0.0851136397417452,0.990833155704824,2,5,regulation of chloride transport,BP,ANO9;CA2
16108,GO:0090129,0.0851977907584415,0.990818753215704,2,5,positive regulation of synapse maturation,BP,ADGRL1;DAB2IP
12779,GO:0051093,0.0852117066450779,0.93395821504902,69,558,negative regulation of developmental process,BP,POSTN;ULK2;TP53INP1;PTHLH;APOE;INPP5D;EGFR;PTPRS;DIXDC1;SFRP1;KCTD11;EPHB2;PIK3R1;ADAMTS7;CXCL14;TSC22D3;WNT3;RGMA;ZFPM1;STAT1;PRKACB;KLF13;NFATC4;FERMT1;SPOCK1;MDM2;RAPGEF3;ARPIN;ADGRB2;PDCD4;RTN4RL1;ZFP36L2;TRPV4;GLI2;WWTR1;SEMA4G;GLI3;MAP2K5;JARID2;CCDC85B;FZD7;SYNGAP1;CST3;MMRN2;BBS2;NPHP3;IDH2;TNFRSF21;IQCB1;CDK5R1;EFNB3;SPRY2;FBXW7;RAI1;LRP1;BRINP1;DAB2IP;AREG;DMTN;WWC3;PMP22;NRARP;ZFP36L1;PBLD;ERBB2;GPR68;RORA;PPARG;ECM1
3268,GO:0006940,0.0853496677041525,0.96870512417914,6,30,regulation of smooth muscle contraction,BP,RGS2;F2R;ADORA2B;ITGA2;NMU;NPNT
10061,GO:0042573,0.0856938995845819,0.982623906523093,3,11,retinoic acid metabolic process,BP,ALDH1A3;CYP26B1;UGT1A3
4646,GO:0010771,0.0860508749453679,0.957001582377824,11,64,negative regulation of cell morphogenesis involved in differentiation,BP,POSTN;ULK2;PTPRS;EPHB2;WNT3;NFATC4;SEMA4G;SYNGAP1;CDK5R1;EFNB3;DMTN
6657,GO:0030017,0.0860639199439737,0.949931549607832,17,104,sarcomere,CC,FLNC;OBSL1;SYNC;NOS1;OBSCN;PARVB;ANK3;FHOD3;TTN;AHNAK2;SQSTM1;SLC2A1;SYNPO2;JPH2;TNNI2;KAT2B;SYNE2
6363,GO:0021549,0.0861405694558159,0.958637405367759,10,57,cerebellum development,BP,SERPINE2;PTPRS;NAGLU;GLI2;MDK;B4GALT2;CDK5R1;RORA;FOXP2;PTBP2
5513,GO:0016477,0.0863761883174771,0.929681447326927,106,876,cell migration,BP,POSTN;SERPINE2;GPNMB;TP53INP1;APOE;INPP5D;APCDD1;EGFR;CXCR1;DIXDC1;SFRP1;TNS1;PIK3R1;CXCL14;VAV3;UNK;CSPG4;KITLG;ASAP3;SDC3;PLEKHG5;FERMT1;PIK3C2G;PLXNB1;SPOCK1;MDM2;NDN;IFITM1;RHOBTB2;FLRT3;ARPIN;F2R;CAPN7;TRPV4;AVL9;RHBDF1;RASGEF1A;C5;MINK1;ITGA2;SEMA4G;FAM110C;GLI3;MAP2K5;ITGA6;SRGAP3;MMP1;NISCH;INSR;CELSR1;MMP28;DDT;PLXNB3;SUN1;DOCK8;MDK;VEGFB;PTK6;FAT2;HEXB;HYAL1;MMRN2;PEX7;IDH2;PODXL;MCTP1;CDK5R1;NET1;SPRY2;PAK6;APC2;ADARB1;LRP1;PLA2G7;LTB4R2;RET;ZMYND8;DAB2IP;MYSM1;SHROOM2;FGFR4;PIK3R2;DLG5;BTG1;BST2;EFS;PLXND1;DMTN;ACVR1B;NHSL1;MATN2;PTK7;LMNA;IRS2;ALOX15B;SCYL3;APBB2;PBLD;TNFSF12;SRPX2;PPARG;FMNL3;SYNE2;ACKR3;RIPK3;ECM1
5506,GO:0016459,0.0865724366752823,0.963252025828225,8,35,myosin complex,CC,OBSL1;MYL9;MYH11;TTN;MYO3B;MYO9A;SHROOM4;MYH16
14677,GO:0070324,0.0866305083794633,0.990572180600977,2,5,thyroid hormone binding,MF,ALDH1A3;THRA
6588,GO:0022610,0.0867735461165729,0.929980809130308,97,791,biological adhesion,BP,TGFBI;POSTN;ITGB6;SERPINE2;GPNMB;NT5E;EGFR;PTPRS;SFRP1;KIF26B;PCDH1;MAP3K14;PIK3R1;VAV3;SMOC2;TENM4;KITLG;SDK2;VAMP3;MYL9;LGALS7B;ITGB5;BCAM;FERMT1;PLXNB1;COL7A1;SPOCK1;PARVB;TNXB;NEO1;NINJ1;NLGN4Y;FLRT3;IL20RB;BLOC1S4;CGREF1;TRPV4;FLOT1;GLI2;NLGN2;ANK3;ADAMTS13;ADGRL1;MINK1;AMIGO2;THBS3;TNFRSF14;ITGA2;GLI3;MAP2K5;BOC;ITGA6;CELSR1;GSN;BAIAP2;PLXNB3;CNTNAP3;TRIOBP;DOCK8;MICALL2;TMEM8B;FZD7;FAT2;HYAL1;CLCA2;COL6A1;CERCAM;PODXL;TNFRSF21;CDK5R1;NET1;EFNB3;HFE;NID1;NPHP4;CD99L2;DGCR2;RET;DLG5;EFS;PLXND1;DMTN;NRARP;CADM4;CCDC88B;PTK7;ZFP36L1;CLSTN3;SRPX2;CD9;COL13A1;ERBB2;ACKR3;LAMB2;NFASC;ECM2;NPNT
10605,GO:0043615,0.0870918387676289,0.990492238306866,2,5,astrocyte cell migration,BP,APCDD1;HEXB
12986,GO:0051431,0.0873423667870576,1,1,1,corticotropin-releasing hormone receptor 2 binding,MF,UCN2
14109,GO:0060997,0.0873672143024551,0.964837557505464,7,35,dendritic spine morphogenesis,BP,CAPRIN2;EPHB2;BAIAP2;CDK5R1;SHANK3;DLG4;SHANK2
16884,GO:0098862,0.0873933115634493,0.953229565832008,13,81,cluster of actin-based cell projections,CC,ESPN;EPS8L2;RALGDS;CYBRD1;ITPR3;TRIOBP;HOMER2;BBS2;SCART1;MYO3B;TPRN;SHANK2;PEMT
15313,GO:0071556,0.0874067289294103,0.975949456123829,4,18,integral component of lumenal side of endoplasmic reticulum membrane,CC,PKD2;HLA-B;SPPL2B;HLA-A
16741,GO:0098553,0.0874067289294103,0.975949456123829,4,18,lumenal side of endoplasmic reticulum membrane,CC,PKD2;HLA-B;SPPL2B;HLA-A
2191,GO:0005053,0.0874639991333015,1,1,1,peroxisome matrix targeting signal-2 binding,MF,PEX7
12320,GO:0048696,0.0877652470411454,1,1,1,regulation of collateral sprouting in absence of injury,BP,WNT3
12321,GO:0048697,0.0877652470411454,1,1,1,positive regulation of collateral sprouting in absence of injury,BP,WNT3
13573,GO:0060064,0.0877652470411454,1,1,1,Spemann organizer formation at the anterior end of the primitive streak,BP,WNT3
19256,GO:1905474,0.0877652470411454,1,1,1,canonical Wnt signaling pathway involved in stem cell proliferation,BP,WNT3
1788,GO:0004419,0.0879885164976568,1,1,1,hydroxymethylglutaryl-CoA lyase activity,MF,HMGCL
16663,GO:0097629,0.0885063385910575,0.990245469476972,2,5,extrinsic component of omegasome membrane,CC,ULK1;ATG14
13914,GO:0060600,0.0886161717064588,0.982177608547284,3,10,dichotomous subdivision of an epithelial terminal unit,BP,CELSR1;AREG;PLXND1
18417,GO:1903522,0.0888552137709343,0.94618599213251,19,128,regulation of blood circulation,BP,SREBF1;EGFR;NOS1;GAA;ITPR3;MDM2;RGS2;F2R;PER2;SNTA1;GSTM2;NMU;KCNJ5;SCN4B;THRA;CACNB3;CACNB1;TH;PRKACA
2664,GO:0006012,0.0889582457746731,0.981669247031991,3,11,galactose metabolic process,BP,PGM1;GALE;GLB1
9814,GO:0042043,0.0890311604215782,0.982057840175157,3,10,neurexin family protein binding,MF,SYTL1;NLGN4Y;NLGN2
2625,GO:0005952,0.0892147321340643,0.99012094957743,2,5,cAMP-dependent protein kinase complex,CC,PRKACB;PRKACA
12210,GO:0048484,0.0893236536357627,0.990101748290796,2,5,enteric nervous system development,BP,KIF26A;RET
2278,GO:0005229,0.0894863333681091,0.981926172589653,3,10,intracellular calcium activated chloride channel activity,MF,CLCA2;ANO9;ANO1
14431,GO:0061778,0.0894863333681091,0.981926172589653,3,10,intracellular chloride channel activity,MF,CLCA2;ANO9;ANO1
7495,GO:0031681,0.0895212347214755,0.990066880016378,2,5,G-protein beta-subunit binding,MF,F2R;GNG2
3636,GO:0008106,0.089521757296592,0.98116685847606,3,12,alcohol dehydrogenase (NADP+) activity,MF,AKR7A2;DHRS4;RDH12
19169,GO:1905276,0.0899499992234132,0.975454157519985,4,16,regulation of epithelial tube formation,BP,SFRP1;CELSR1;NPHP3;PTK7
16903,GO:0098902,0.0901140825568497,0.989961966135716,2,5,regulation of membrane depolarization during action potential,BP,ANK3;PTPN3
2713,GO:0006089,0.0901623986611201,0.981312915682987,3,11,lactate metabolic process,BP,D2HGDH;PER2;PFKFB2
16110,GO:0090131,0.0901726388046254,1,1,1,mesenchyme migration,BP,ACTA2
15255,GO:0071458,0.0903041856704272,0.989928232131688,2,5,integral component of cytoplasmic side of endoplasmic reticulum membrane,CC,PKD2;SPPL2B
7615,GO:0032020,0.0905930814989372,0.989066200941435,2,6,ISG15-protein conjugation,BP,HERC5;ISG15
5518,GO:0016486,0.0908613010993178,0.974871867896003,4,17,peptide hormone processing,BP,PCSK1;PCSK6;SCG5;PCSK1N
5339,GO:0016079,0.0908727755915286,0.957930320168954,9,50,synaptic vesicle exocytosis,BP,SYT8;SYN1;SYTL1;C2CD4C;RIMS3;SYT15;VAMP2;SEPT5;SYT7
9755,GO:0039531,0.090900884090804,0.97510243944849,4,16,regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway,BP,DDX60;DHX58;NLRX1;TKFC
1565,GO:0003974,0.0909818545052827,1,1,1,UDP-N-acetylglucosamine 4-epimerase activity,MF,GALE
1569,GO:0003978,0.0909818545052827,1,1,1,UDP-glucose 4-epimerase activity,MF,GALE
9977,GO:0042398,0.0913636930729691,0.965575271774902,6,33,cellular modified amino acid biosynthetic process,BP,GAMT;MGST2;SLC27A1;OPLAH;ALDH7A1;GCLC
16393,GO:0097049,0.0913682932930656,0.989738579407081,2,5,motor neuron apoptotic process,BP,MAP3K12;ADARB1
1744,GO:0004346,0.091569600371619,1,1,1,glucose-6-phosphatase activity,MF,G6PC3
12448,GO:0050309,0.091569600371619,1,1,1,sugar-terminal-phosphatase activity,MF,G6PC3
12366,GO:0048788,0.091704166465025,0.991002073892196,2,4,cytoskeleton of presynaptic active zone,CC,RIMS3;BSN
17051,GO:0099569,0.091704166465025,0.991002073892196,2,4,presynaptic cytoskeleton,CC,RIMS3;BSN
8469,GO:0033627,0.0918007773338732,0.962418733992259,7,37,cell adhesion mediated by integrin,BP,ITGB6;FERMT1;ITGA2;ITGA6;PODXL;RET;NPNT
10147,GO:0042744,0.0922088646746075,0.980352742723991,3,12,hydrogen peroxide catabolic process,BP,GPX3;DUOX1;PRDX5
11079,GO:0045098,0.0922233606125024,1,1,1,type III intermediate filament,CC,VMAC
12125,GO:0048244,0.0922233606125024,1,1,1,phytanoyl-CoA dioxygenase activity,MF,PHYH
16414,GO:0097089,0.0922233606125024,1,1,1,methyl-branched fatty acid metabolic process,BP,PHYH
5141,GO:0015670,0.0922913464835627,1,1,1,carbon dioxide transport,BP,CA2
8132,GO:0032849,0.0922913464835627,1,1,1,positive regulation of cellular pH reduction,BP,CA2
1690,GO:0004167,0.0925027860453278,0.997757677961833,1,2,dopachrome isomerase activity,MF,DDT
5720,GO:0016862,0.0925027860453278,0.997757677961833,1,2,intramolecular oxidoreductase activity, interconverting keto- and enol-groups,MF,DDT
12433,GO:0050178,0.0925027860453278,0.997757677961833,1,2,phenylpyruvate tautomerase activity,MF,DDT
4414,GO:0010189,0.0925039864484624,1,1,1,vitamin E biosynthetic process,BP,PLTP
9960,GO:0042360,0.0925039864484624,1,1,1,vitamin E metabolic process,BP,PLTP
18690,GO:1904121,0.0925039864484624,1,1,1,phosphatidylethanolamine transporter activity,MF,PLTP
14974,GO:0070914,0.0926542032960697,0.980568465057121,3,11,UV-damage excision repair,BP,DDB2;XPC;MC1R
17014,GO:0099504,0.0926578877009453,0.949997535031179,13,79,synaptic vesicle cycle,BP,SYT8;SYN1;SYTL1;NLGN4Y;C2CD4C;NLGN2;RIMS3;SYT15;VAMP2;SEPT5;DNM1;SYT7;TH
8115,GO:0032813,0.0926951393860086,0.965036640720038,6,32,tumor necrosis factor receptor superfamily binding,MF,STAT1;TNFSF10;PIDD1;DAB2IP;TNFSF12;TRAF5
6053,GO:0019203,0.0926991359547952,0.989499419674356,2,5,carbohydrate phosphatase activity,MF,G6PC3;PFKFB2
12447,GO:0050308,0.0926991359547952,0.989499419674356,2,5,sugar-phosphatase activity,MF,G6PC3;PFKFB2
11572,GO:0046164,0.0927042861835699,0.965137476575096,6,31,alcohol catabolic process,BP,APOE;SRD5A3;SULT1E1;IMPA2;TKFC;TRERF1
3176,GO:0006790,0.0927249235076087,0.935226101469164,34,271,sulfur compound metabolic process,BP,GAMT;MTHFR;CSPG4;MVD;HMGCL;IDUA;ACOT1;GAL3ST4;B4GALT6;MLYCD;SULT1E1;HEXA;ABHD14B;GSTM2;MGST2;B4GALT2;OPLAH;PDK1;HEXB;HYAL1;HLCS;ACACB;NDST2;XYLT1;ACSL1;MTR;CBR4;GLB1;GSTM3;ACSS2;ACOT2;SUCLG2;PEMT;GCLC
13904,GO:0060586,0.092783187995331,0.989484241794529,2,5,multicellular organismal iron ion homeostasis,BP,BMP6;HFE
12008,GO:0047658,0.0929277754376802,1,1,1,alpha-amino-acid esterase activity,MF,BPHL
13397,GO:0052813,0.0932261825946775,0.961884154656597,7,35,phosphatidylinositol bisphosphate kinase activity,MF,EGFR;PIK3R1;KITLG;FGFR4;PIK3R2;IRS2;ERBB2
4322,GO:0009822,0.0932832066681908,1,1,1,alkaloid catabolic process,BP,CYP3A5
10623,GO:0043647,0.09336505292507,0.956533521514948,9,50,inositol phosphate metabolic process,BP,INPP5D;PLCD3;PLCD1;PLCH2;IMPA2;ISYNA1;PLCB3;NUDT10;IP6K2
14110,GO:0060998,0.0933930676457401,0.956517770520698,9,50,regulation of dendritic spine development,BP,APOE;PTPRS;CAPRIN2;BAIAP2;CDK5R1;SHANK3;ZMYND8;DLG5;SHANK2
6095,GO:0019318,0.0935129000339645,0.939394743973326,24,173,hexose metabolic process,BP,SIK1;DGKQ;H6PD;CRY1;GAA;OAS1;MLYCD;G6PC3;PER2;IGFBP4;NISCH;INSR;PDK1;PGM1;PFKFB2;ACACB;EPM2AIP1;MPI;GALE;KAT2B;IRS2;TKFC;GLB1;RORA
15458,GO:0071825,0.0935341383874532,0.968767496026603,5,24,protein-lipid complex subunit organization,BP,APOE;PRKACB;PLA2G7;PRKACA;PLTP
10831,GO:0044340,0.0936813771376199,0.989321506825557,2,5,canonical Wnt signaling pathway involved in regulation of cell proliferation,BP,SFRP1;WNT3
18828,GO:1904464,0.0937040536023474,1,1,1,regulation of matrix metallopeptidase secretion,BP,IDH2
18829,GO:1904465,0.0937040536023474,1,1,1,negative regulation of matrix metallopeptidase secretion,BP,IDH2
19599,GO:1990773,0.0937040536023474,1,1,1,matrix metallopeptidase secretion,BP,IDH2
3271,GO:0006949,0.0937633789895409,0.964746183735122,6,30,syncytium formation,BP,NOS1;RAPGEF3;FLOT1;TANC1;CD109;GDF15
12707,GO:0050974,0.093817255448755,0.989296801907778,2,5,detection of mechanical stimulus involved in sensory perception,BP,SERPINE2;ITGA2
13473,GO:0055056,0.0938466885870888,0.989291447490997,2,5,D-glucose transmembrane transporter activity,MF,SLC2A3;SLC2A1
16765,GO:0098609,0.0938619144423889,0.928989622874594,55,435,cell-cell adhesion,BP,SERPINE2;GPNMB;NT5E;EGFR;KIF26B;PCDH1;MAP3K14;PIK3R1;TENM4;SDK2;MYL9;LGALS7B;ITGB5;NLGN4Y;FLRT3;IL20RB;BLOC1S4;TRPV4;FLOT1;GLI2;NLGN2;ANK3;ADGRL1;MINK1;AMIGO2;TNFRSF14;GLI3;MAP2K5;ITGA6;CELSR1;BAIAP2;PLXNB3;DOCK8;FAT2;CERCAM;PODXL;TNFRSF21;CDK5R1;EFNB3;HFE;NPHP4;RET;DLG5;DMTN;NRARP;CADM4;CCDC88B;ZFP36L1;CLSTN3;SRPX2;CD9;COL13A1;ERBB2;NFASC;NPNT
6301,GO:0019934,0.093915954870785,0.989278842513344,2,5,cGMP-mediated signaling,BP,APOE;PDE2A
15528,GO:0071963,0.0939163956738203,1,1,1,establishment or maintenance of cell polarity regulating cell shape,BP,PARVB
2675,GO:0006029,0.0939241548084824,0.95413886428459,10,57,proteoglycan metabolic process,BP,SULF2;CSPG4;IDUA;GAL3ST4;HEXA;HEXB;HYAL1;NDST2;XYLT1;SGSH
3828,GO:0008430,0.0941785682881339,1,1,1,selenium binding,MF,GPX3
7133,GO:0030976,0.0942169423788229,0.989224000868063,2,5,thiamine pyrophosphate binding,MF,DHTKD1;OGDHL
969,GO:0002416,0.0942244414804131,1,1,1,IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor,BP,FCGRT
6219,GO:0019770,0.0942244414804131,1,1,1,IgG receptor activity,MF,FCGRT
6266,GO:0019864,0.0942244414804131,1,1,1,IgG binding,MF,FCGRT
2397,GO:0005543,0.094393174820566,0.932374079758487,39,295,phospholipid binding,MF,APOE;PSD4;SYT8;SEC14L2;HS1BP3;MICALL1;PIK3C2G;ITPR3;PLCD1;SYTL1;RASA4;C2CD4C;SYT15;VAMP2;NISCH;FZD7;ARHGAP33;MCTP1;OSBPL10;ARAP1;RPH3AL;PLA2G7;JPH2;DAB2IP;SYT7;BBS5;OSBPL5;SNX21;MPPE1;SNX1;OSBPL1A;ESYT2;SNX29;TUB;LDLRAP1;PLTP;SNX33;SMURF1;PEMT
17,GO:0000032,0.0944318251780068,1,1,1,cell wall mannoprotein biosynthetic process,BP,MPI
1821,GO:0004476,0.0944318251780068,1,1,1,mannose-6-phosphate isomerase activity,MF,MPI
2691,GO:0006056,0.0944318251780068,1,1,1,mannoprotein metabolic process,BP,MPI
2692,GO:0006057,0.0944318251780068,1,1,1,mannoprotein biosynthetic process,BP,MPI
7408,GO:0031506,0.0944318251780068,1,1,1,cell wall glycoprotein biosynthetic process,BP,MPI
10047,GO:0042546,0.0944318251780068,1,1,1,cell wall biogenesis,BP,MPI
10705,GO:0044038,0.0944318251780068,1,1,1,cell wall macromolecule biosynthetic process,BP,MPI
14352,GO:0061611,0.0944318251780068,1,1,1,mannose to fructose-6-phosphate metabolic process,BP,MPI
14824,GO:0070589,0.0944318251780068,1,1,1,cellular component macromolecule biosynthetic process,BP,MPI
9364,GO:0035902,0.0945241126374549,0.973491682298849,4,17,response to immobilization stress,BP,MDM2;LRP11;TH;PPARG
1710,GO:0004304,0.0945726091210399,1,1,1,estrone sulfotransferase activity,MF,SULT1E1
3129,GO:0006711,0.0945726091210399,1,1,1,estrogen catabolic process,BP,SULT1E1
17850,GO:1902106,0.0946262604330497,0.9557019161133,9,52,negative regulation of leukocyte differentiation,BP,INPP5D;SFRP1;PIK3R1;ZFPM1;GLI3;FBXW7;NRARP;ERBB2;GPR68
7171,GO:0031061,0.0947564791735599,0.973661741998649,4,16,negative regulation of histone methylation,BP,KDM3A;JARID2;KDM4C;PHF1
8757,GO:0034441,0.0948707892544958,1,1,1,plasma lipoprotein particle oxidation,BP,PLA2G7
1687,GO:0004163,0.0948791138743479,1,1,1,diphosphomevalonate decarboxylase activity,MF,MVD
2180,GO:0005031,0.0950029937832658,0.973082849318198,4,18,tumor necrosis factor-activated receptor activity,MF,TNFRSF14;TNFRSF21;EDA2R;TNFRSF25
2182,GO:0005035,0.0950029937832658,0.973082849318198,4,18,death receptor activity,MF,TNFRSF14;TNFRSF21;EDA2R;TNFRSF25
5462,GO:0016358,0.0950687658488727,0.938362611098049,24,165,dendrite development,BP,MAP6;APOE;PTPRS;CAPRIN2;OBSL1;EPHB2;CUL7;NFATC4;CRTC1;CSMD3;KLF7;MINK1;TRAK1;BAIAP2;SYNGAP1;CDK5R1;SHANK3;ZMYND8;DAB2IP;DLG5;DLG4;MATN2;SHANK2;MAP1A
4334,GO:0009888,0.0952252860371034,0.919989091986507,143,1221,tissue development,BP,TGFBI;POSTN;TAGLN;SERPINE2;GPNMB;SIK1;PTHLH;ACTA2;APCDD1;FBXW4;EGFR;PTPRS;FAM20C;PKD2;ALDH1A3;SLITRK6;SFRP1;OBSL1;KIF26B;ADAMTS7;TSC22D3;EYS;EVC;POU3F1;SULF2;WNT3;ISG15;TFCP2L1;TENM4;ZFPM1;KITLG;CUL7;PRICKLE2;STAT1;KRT15;ITGB5;PRKACB;HOXA3;NFATC4;FERMT1;CYP26B1;GAA;COL7A1;MDM2;MYH11;RAPGEF3;NINJ1;CTSV;FLRT3;PPL;PDCD4;SERPINB5;TRPV4;FLOT1;GLI2;ARHGEF19;THBS3;WWTR1;ITGA2;SEMA4G;GLI3;FHOD3;ITGA6;JARID2;NUPR1;PRR9;INSR;TST;CELSR1;GSN;TTN;TRIOBP;CD109;RTF1;CASP14;BMP6;S100A4;PTK6;FZD7;ETV5;DLX3;SHARPIN;HYAL1;CST3;BBS2;TXNIP;COL6A1;NPHP3;PODXL;ATRX;CA2;HMG20B;KRT14;EDA2R;SPRY2;MEF2D;IFT140;CTSB;KLK5;THRA;ASTN2;ADARB1;NAB2;SALL2;JPH2;PDE2A;MAF;RET;DAB2IP;TEAD2;MYSM1;BBS5;AREG;KLHL3;MYO9A;DLG5;BTG1;VDR;PLXND1;PCSK6;TMEM231;NRARP;ACVR1B;PALB2;PTK7;TCF7;ZFP36L1;LMNA;APOLD1;ALOX15B;PBLD;STAT6;GSTM3;GJB5;AKAP6;PPARG;GCNT4;LAMB2;FOXP2;SMURF1;NPNT;CTNNBIP1;ECM1
10366,GO:0043201,0.095235651118986,0.980236131752459,3,10,response to leucine,BP,SESN3;SESN1;PIK3C3
3324,GO:0007032,0.0952769978811853,0.951284350439031,11,69,endosome organization,BP,ALS2CL;VPS11;SQSTM1;DNM1;HOOK2;WASH3P;CHMP1B;PIK3C3;ARFGEF2;PI4K2B;SNX33
16702,GO:0097724,0.095351562767871,1,1,1,sperm flagellum movement,BP,TTLL1
19229,GO:1905419,0.095351562767871,1,1,1,sperm flagellum movement involved in flagellated sperm motility,BP,TTLL1
15119,GO:0071241,0.095427615905023,0.943364230799637,17,118,cellular response to inorganic substance,BP,EGFR;PKD2;NFATC4;RASA4;MT1X;ANK3;ZNF658;GSN;ENDOG;BMP6;ATRX;HFE;CARF;WNK1;DMTN;MTR;TH
11316,GO:0045656,0.0955951142637738,0.988971472121951,2,5,negative regulation of monocyte differentiation,BP,INPP5D;GPR68
3062,GO:0006625,0.0956529454552129,0.97306208796602,4,17,protein targeting to peroxisome,BP,PEX10;PEX7;PEX1;LONP2
15873,GO:0072662,0.0956529454552129,0.97306208796602,4,17,protein localization to peroxisome,BP,PEX10;PEX7;PEX1;LONP2
15874,GO:0072663,0.0956529454552129,0.97306208796602,4,17,establishment of protein localization to peroxisome,BP,PEX10;PEX7;PEX1;LONP2
13961,GO:0060694,0.0957669659417904,1,1,1,regulation of cholesterol transporter activity,BP,PPARG
15731,GO:0072343,0.0957669659417904,1,1,1,pancreatic stellate cell proliferation,BP,PPARG
17661,GO:1901558,0.0957669659417904,1,1,1,response to metformin,BP,PPARG
19279,GO:1905563,0.0957669659417904,1,1,1,negative regulation of vascular endothelial cell proliferation,BP,PPARG
19773,GO:2000229,0.0957669659417904,1,1,1,regulation of pancreatic stellate cell proliferation,BP,PPARG
19774,GO:2000230,0.0957669659417904,1,1,1,negative regulation of pancreatic stellate cell proliferation,BP,PPARG
16390,GO:0097039,0.0957818290788709,0.988937080738217,2,5,protein linear polyubiquitination,BP,RBCK1;SHARPIN
10143,GO:0042737,0.0958010534653842,0.950819161889435,11,73,drug catabolic process,BP,NT5E;GPX3;NOS1;IDUA;CYP3A5;SULT1E1;CYP2D7;BDH1;DUOX1;AMT;PRDX5
10041,GO:0042537,0.0958819761454685,0.979221867493924,3,12,benzene-containing compound metabolic process,BP,GSTM2;GSTM3;TH
13713,GO:0060306,0.0959307384815111,0.973218362530907,4,16,regulation of membrane repolarization,BP,SNTA1;SCN4B;CACNB3;AKAP6
8192,GO:0032947,0.0959976402645041,0.94936740519159,12,72,protein-containing complex scaffold activity,MF,GRIP2;MAPK8IP3;SEPT6;HOMER2;SEPT5;SHANK3;DLG5;WWC3;SHANK2;AKAP6;MPP7;LDLRAP1
13744,GO:0060342,0.096091834041598,1,1,1,photoreceptor inner segment membrane,CC,RDH12
1036,GO:0002545,0.0961051906770014,1,1,1,chronic inflammatory response to non-antigenic stimulus,BP,ADORA2B
1210,GO:0002880,0.0961051906770014,1,1,1,regulation of chronic inflammatory response to non-antigenic stimulus,BP,ADORA2B
1211,GO:0002882,0.0961051906770014,1,1,1,positive regulation of chronic inflammatory response to non-antigenic stimulus,BP,ADORA2B
5063,GO:0015279,0.0962254426543787,0.988855199822717,2,5,store-operated calcium channel activity,MF,ORAI3;ORAI2
664,GO:0001868,0.0962431760744425,1,1,1,regulation of complement activation, lectin pathway,BP,SERPING1
665,GO:0001869,0.0962431760744425,1,1,1,negative regulation of complement activation, lectin pathway,BP,SERPING1
1250,GO:0003006,0.0962621218056547,0.927624710958392,52,410,developmental process involved in reproduction,BP,SERPINE2;HSPA2;EGFR;PKD2;PLCD3;SFRP1;KDM3A;HTRA1;KITLG;CUL7;IRF2BPL;PLCD1;TNFSF10;CTSV;SERPINB5;DNAH1;GLI2;LHFPL2;GLI3;TPGS1;NUPR1;INSR;BMP6;ETNK2;CABYR;ETV5;DLX3;HEXB;CST3;BBS2;PLAG1;ATRX;REC8;AGO4;SLIT3;CTSB;CCDC136;RFX2;AREG;VDR;DPY19L2P2;SIX5;ACVR1B;TSSK1B;TCF7;ZFP36L1;ALOX15B;GJB5;PAQR7;PPARG;PRKACA;TTLL1
2103,GO:0004879,0.0963875087826912,0.963489113027088,6,30,nuclear receptor activity,MF,SREBF1;THRA;VDR;GLMP;RORA;PPARG
16731,GO:0098531,0.0963875087826912,0.963489113027088,6,30,transcription factor activity, direct ligand regulated sequence-specific DNA binding,MF,SREBF1;THRA;VDR;GLMP;RORA;PPARG
426,GO:0001134,0.096408055604566,0.967676209291787,5,23,transcription factor activity, transcription factor recruiting,MF,THRA;TEAD2;VDR;RORA;PPARG
1846,GO:0004511,0.096414609878297,1,1,1,tyrosine 3-monooxygenase activity,MF,TH
3035,GO:0006585,0.096414609878297,1,1,1,dopamine biosynthetic process from tyrosine,BP,TH
8262,GO:0033076,0.096414609878297,1,1,1,isoquinoline alkaloid metabolic process,BP,TH
9016,GO:0035240,0.096414609878297,1,1,1,dopamine binding,MF,TH
9888,GO:0042214,0.096414609878297,1,1,1,terpene metabolic process,BP,TH
9989,GO:0042418,0.096414609878297,1,1,1,epinephrine biosynthetic process,BP,TH
13316,GO:0052314,0.096414609878297,1,1,1,phytoalexin metabolic process,BP,TH
3609,GO:0008049,0.0964394442678358,1,1,1,male courtship behavior,BP,HEXB
1640,GO:0004085,0.0965973840142777,1,1,1,butyryl-CoA dehydrogenase activity,MF,ACADS
6182,GO:0019605,0.0965973840142777,1,1,1,butyrate metabolic process,BP,ACADS
11625,GO:0046359,0.0965973840142777,1,1,1,butyrate catabolic process,BP,ACADS
13426,GO:0052890,0.0965973840142777,1,1,1,oxidoreductase activity, acting on the CH-CH group of donors, with a flavin as acceptor,MF,ACADS
12906,GO:0051281,0.096605200875049,0.967424113202252,5,24,positive regulation of release of sequestered calcium ion into cytosol,BP,PKD2;F2R;GSTM2;JPH2;AKAP6
11182,GO:0045309,0.0966213242009016,0.960046285307502,7,36,protein phosphorylated amino acid binding,MF,PIK3R1;CBLC;RTF1;FBXW7;PIK3R2;PTPN3;LDLRAP1
11331,GO:0045671,0.0967410230863339,0.972911171850028,4,16,negative regulation of osteoclast differentiation,BP,INPP5D;SFRP1;PIK3R1;FBXW7
10309,GO:0043113,0.096855323493103,0.963263917867535,6,30,receptor clustering,BP,APOE;GSN;ETV5;SYNGAP1;SHANK3;DLG4
1066,GO:0002625,0.0968845447432832,1,1,1,regulation of T cell antigen processing and presentation,BP,HFE
1067,GO:0002626,0.0968845447432832,1,1,1,negative regulation of T cell antigen processing and presentation,BP,HFE
4395,GO:0010106,0.0968845447432832,1,1,1,cellular response to iron ion starvation,BP,HFE
18753,GO:1904282,0.0968845447432832,1,1,1,regulation of antigen processing and presentation of endogenous peptide antigen via MHC class I,BP,HFE
18754,GO:1904283,0.0968845447432832,1,1,1,negative regulation of antigen processing and presentation of endogenous peptide antigen via MHC class I,BP,HFE
20219,GO:2001186,0.0968845447432832,1,1,1,negative regulation of CD8-positive, alpha-beta T cell activation,BP,HFE
15491,GO:0071889,0.0969322162585664,0.967446683429686,5,23,14-3-3 protein binding,MF,SIK1;SYNPO2;DAB2IP;ZFP36L1;IRS2
3640,GO:0008111,0.0971863864033634,1,1,1,alpha-methylacyl-CoA racemase activity,MF,AMACR
3109,GO:0006687,0.0974029019922731,0.954068192330924,9,53,glycosphingolipid metabolic process,BP,ST6GALNAC6;B4GALT6;ARSI;HEXA;ARSD;ST3GAL5;HEXB;ESYT2;GLB1
3580,GO:0007625,0.0975026367642276,0.987710953054558,2,6,grooming behavior,BP,NMU;DLG4
624,GO:0001808,0.0978010764912429,1,1,1,negative regulation of type IV hypersensitivity,BP,IL20RB
1205,GO:0002865,0.0978010764912429,1,1,1,negative regulation of acute inflammatory response to antigenic stimulus,BP,IL20RB
1213,GO:0002884,0.0978010764912429,1,1,1,negative regulation of hypersensitivity,BP,IL20RB
12594,GO:0050795,0.0978602466280757,0.966870932928218,5,24,regulation of behavior,BP,APOE;NMU;MDK;DLG4;PER3
6040,GO:0019150,0.0979392139458203,1,1,1,D-ribulokinase activity,MF,FGGY
11397,GO:0045821,0.0980946788276101,0.979377336189561,3,10,positive regulation of glycolytic process,BP,INSR;MLXIPL;PFKFB2
12854,GO:0051197,0.0980946788276101,0.979377336189561,3,10,positive regulation of coenzyme metabolic process,BP,INSR;MLXIPL;PFKFB2
12312,GO:0048681,0.098112805626365,0.978904698407163,3,11,negative regulation of axon regeneration,BP,PTPRS;RGMA;RTN4RL1
12977,GO:0051414,0.0981792633242007,0.988491713155397,2,5,response to cortisol,BP,SLIT3;KLF9
7548,GO:0031883,0.0982351014095445,1,1,1,taste receptor binding,MF,REEP2
12120,GO:0048232,0.0982504089402904,0.929963178475706,37,287,male gamete generation,BP,GAMT;HSPA2;TXNRD3;KDM3A;ZFP41;SCMH1;CRTAP;CYP26B1;MLH3;CTSV;SPATA20;RGS2;DNAH1;MICALCL;TPGS1;TCFL5;HSF2BP;SUN1;SEPT6;CABYR;ETV5;BBS2;ATRX;REC8;AGO4;CCDC136;RFX2;TMEM203;BTG1;DPY19L2P2;SIX5;TSSK1B;PHC2;PRKACA;NPAP1;HERPUD2;TTLL1
5935,GO:0018230,0.0982606557058009,0.971825655783251,4,18,peptidyl-L-cysteine S-palmitoylation,BP,ZDHHC1;ZDHHC12;GOLGA7B;ZDHHC24
5936,GO:0018231,0.0982606557058009,0.971825655783251,4,18,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine,BP,ZDHHC1;ZDHHC12;GOLGA7B;ZDHHC24
5806,GO:0017064,0.0982613845339529,1,1,1,fatty acid amide hydrolase activity,MF,FAAH
17100,GO:0102077,0.0982613845339529,1,1,1,oleamide hydrolase activity,MF,FAAH
17164,GO:0103073,0.0982613845339529,1,1,1,anandamide amidohydrolase activity,MF,FAAH
4197,GO:0009306,0.0982815944218022,0.928141277556829,43,332,protein secretion,BP,POSTN;ITGB6;SREBF1;LMF1;EGFR;SFRP1;GLUD1;RAB40B;FERMT1;ITPR3;RAPGEF3;F2R;TRPV4;NLGN2;RHBDF1;PER2;C5;NMU;TTN;TM7SF3;BMP6;PLA2G6;IDH2;TNFRSF21;HADH;RAB11FIP3;PFKFB2;RPH3AL;SLC2A1;NLRP1;GLUL;OLFM2;PIK3C3;SYT7;DMTN;NECAB3;RSAD2;IRS2;ANO1;ALOX15B;PHPT1;GPR68;KCNS3
2046,GO:0004795,0.0983254533373309,1,1,1,threonine synthase activity,MF,THNSL2
4048,GO:0009088,0.0983254533373309,1,1,1,threonine biosynthetic process,BP,THNSL2
11626,GO:0046360,0.0983254533373309,1,1,1,2-oxobutyrate biosynthetic process,BP,THNSL2
11627,GO:0046361,0.0983254533373309,1,1,1,2-oxobutyrate metabolic process,BP,THNSL2
15284,GO:0071496,0.0983453544946035,0.932210323819978,31,234,cellular response to external stimulus,BP,POSTN;SREBF1;EGFR;SFRP1;MAP3K14;IMPACT;MDM2;CTSV;KIF26A;ADORA2B;ITGA2;ULK1;ITGA6;SESN3;BAIAP2;BMP6;WRN;SESN1;HFE;CYBA;SLC2A1;GLUL;C12ORF66;PDE2A;PIK3C3;IFI16;VDR;UCN2;ATG14;PPARG;GCLC
6713,GO:0030130,0.0984307036486089,0.978806424108335,3,11,clathrin coat of trans-Golgi network vesicle,CC,AP1G2;CLTCL1;LDLRAP1
5322,GO:0016050,0.0985320049156601,0.928496529965422,41,318,vesicle organization,BP,SERPINE2;ALS2CL;SYT8;EVI5L;VAV3;VAMP3;TBC1D8;VPS11;COL7A1;SYTL1;F2R;C2CD4C;HPS4;BLOC1S4;SPG11;SYT15;VAMP2;VPS39;BLOC1S3;SQSTM1;DNM1;HOOK2;WASH3P;ANKRD28;CHMP1B;TBC1D17;TSNARE1;CCDC136;RFX2;PMEL;SHROOM2;PIK3C3;SYT7;AREG;TBC1D16;SGSM2;ARFGEF2;SNX1;DLG4;PI4K2B;SNX33
4265,GO:0009615,0.0987005012271282,0.932811230422876,29,223,response to virus,BP,TNFAIP3;ACTA2;OAS2;DDX60;APOBEC3C;TRIM22;IFI44L;MAP3K14;HERC5;VWCE;ISG15;HTRA1;STAT1;IFITM1;OAS1;IFI44;DHX58;IRF9;NLRX1;HYAL1;ADARB1;MX2;IFI16;BST2;STAT2;RSAD2;IVNS1ABP;TKFC;SERINC3
12422,GO:0050080,0.0987514113308718,1,1,1,malonyl-CoA decarboxylase activity,MF,MLYCD
20280,GO:2001294,0.0987514113308718,1,1,1,malonyl-CoA catabolic process,BP,MLYCD
1543,GO:0003940,0.0987560963609073,1,1,1,L-iduronidase activity,MF,IDUA
6768,GO:0030209,0.0987560963609073,1,1,1,dermatan sulfate catabolic process,BP,IDUA
9589,GO:0036458,0.0987560963609073,1,1,1,hepatocyte growth factor binding,MF,SRPX2
11330,GO:0045670,0.0987928684604739,0.9588261702664,7,37,regulation of osteoclast differentiation,BP,INPP5D;SFRP1;PIK3R1;FAM213A;CA2;FBXW7;GPR68
4564,GO:0010648,0.0988167308514779,0.918735275792679,109,931,negative regulation of cell communication,BP,TNFAIP3;SERPINE2;EPM2A;IFI6;SREBF1;APOE;INPP5D;APCDD1;EGFR;PTPRS;PKD2;MNT;SFRP1;KCTD11;EPHB2;SULF2;HTRA1;STAT1;CAMK2N1;CRY2;UNC5B;PRKACB;CRY1;NFATC4;FERMT1;CYP26B1;MDM2;LZTS2;PIK3IP1;TNFSF10;FLRT3;RASA4;KIF26A;RGS2;PDCD4;SLC24A1;RTN4RL1;GSTM2;WWTR1;GLI3;LTBP1;MAP2K5;ITGA6;SESN3;IGFBP4;INSR;CBLC;CD109;DHX58;NLRX1;PTK6;SYNGAP1;ARRDC1;PLA2G6;MMRN2;NPHP3;DNM1;SESN1;SHANK3;HFE;HADH;RRM2B;SLIT3;SPRY2;CREBRF;RAB11FIP3;FBXW7;CDK5RAP3;APC2;ELF1;RPH3AL;NLRP1;LRP1;NPHP4;RGS12;C12ORF66;DLK2;PDE2A;RET;DAB2IP;RNF213;FGFR4;PIK3R2;DLG5;WWC3;NRARP;KREMEN1;IGFBP6;SHANK2;LMNA;IL11;IVNS1ABP;GPR21;TKFC;PBLD;PHPT1;SMPDL3B;KIF7;RANBP9;PTPN3;ERBB2;RORA;PPARG;ACKR3;CCDC3;SMURF1;CTNNBIP1;GCLC;ECM1
18746,GO:1904262,0.0988208495755762,0.978685609249952,3,11,negative regulation of TORC1 signaling,BP,SESN3;SESN1;C12ORF66
1621,GO:0004057,0.0988504242687106,1,1,1,arginyltransferase activity,MF,ATE1
1951,GO:0004657,0.0988675401923801,1,1,1,proline dehydrogenase activity,MF,PRODH
12251,GO:0048561,0.0988759993621504,1,1,1,establishment of animal organ orientation,BP,IRX4
15324,GO:0071569,0.0989879350945362,0.987411509189553,2,6,protein ufmylation,BP,CDK5RAP3;UFL1
10097,GO:0042628,0.0990339575095178,1,1,1,mating plug formation,BP,SERPINE2
11180,GO:0045297,0.0990339575095178,1,1,1,post-mating behavior,BP,SERPINE2
14175,GO:0061107,0.0990339575095178,1,1,1,seminal vesicle development,BP,SERPINE2
14176,GO:0061108,0.0990339575095178,1,1,1,seminal vesicle epithelium development,BP,SERPINE2
1847,GO:0004512,0.0990393482991836,1,1,1,inositol-3-phosphate synthase activity,MF,ISYNA1
5725,GO:0016872,0.0990393482991836,1,1,1,intramolecular lyase activity,MF,ISYNA1
3238,GO:0006893,0.099070670447331,0.955669835166653,8,45,Golgi to plasma membrane transport,BP,VAMP3;ANK3;VAMP2;BBS2;BBS1;EXOC2;OSBPL5;ARFGEF2
14051,GO:0060857,0.0990882055595536,1,1,1,establishment of glial blood-brain barrier,BP,MXRA8
1848,GO:0004513,0.0991937362913386,1,1,1,neolactotetraosylceramide alpha-2,3-sialyltransferase activity,MF,ST3GAL5
11967,GO:0047291,0.0991937362913386,1,1,1,lactosylceramide alpha-2,3-sialyltransferase activity,MF,ST3GAL5
4213,GO:0009374,0.0992194324955135,0.988296307133881,2,5,biotin binding,MF,HLCS;ACACB
2235,GO:0005142,0.0993165950635698,1,1,1,interleukin-11 receptor binding,MF,IL11
10128,GO:0042709,0.099321770110795,1,1,1,succinate-CoA ligase complex,CC,SUCLG2
11159,GO:0045244,0.099321770110795,1,1,1,succinate-CoA ligase complex (GDP-forming),CC,SUCLG2
5942,GO:0018277,0.0993396369493228,1,1,1,protein deamination,BP,LOXL1
4027,GO:0009061,0.099421599416389,1,1,1,anaerobic respiration,BP,SDHA
11169,GO:0045274,0.099421599416389,1,1,1,plasma membrane respiratory chain complex II,CC,SDHA
11173,GO:0045282,0.099421599416389,1,1,1,plasma membrane succinate dehydrogenase complex,CC,SDHA
839,GO:0002153,0.0994744798273322,1,1,1,steroid receptor RNA activator RNA binding,MF,THRA
11454,GO:0045925,0.0994744798273322,1,1,1,positive regulation of female receptivity,BP,THRA
18813,GO:1904427,0.0995101799781061,0.958359619522086,7,38,positive regulation of calcium ion transmembrane transport,BP,HSPA2;PKD2;F2R;GJC2;GSTM2;JPH2;AKAP6
13599,GO:0060099,0.0995244782454643,0.988238752302354,2,5,regulation of phagocytosis, engulfment,BP,ITGA2;PPARG
13600,GO:0060100,0.0995244782454643,0.988238752302354,2,5,positive regulation of phagocytosis, engulfment,BP,ITGA2;PPARG
19128,GO:1905155,0.0995244782454643,0.988238752302354,2,5,positive regulation of membrane invagination,BP,ITGA2;PPARG
5011,GO:0015173,0.0995777000186782,1,1,1,aromatic amino acid transmembrane transporter activity,MF,SLC36A4
5029,GO:0015196,0.0995777000186782,1,1,1,L-tryptophan transmembrane transporter activity,MF,SLC36A4
18751,GO:1904271,0.0995777000186782,1,1,1,L-proline import across plasma membrane,BP,SLC36A4
18858,GO:1904555,0.0995777000186782,1,1,1,L-proline transmembrane transport,BP,SLC36A4
18859,GO:1904556,0.0995777000186782,1,1,1,L-tryptophan transmembrane transport,BP,SLC36A4
19309,GO:1905647,0.0995777000186782,1,1,1,proline import across plasma membrane,BP,SLC36A4
3957,GO:0008721,0.0996005634463922,1,1,1,D-serine ammonia-lyase activity,MF,SRR
5715,GO:0016855,0.0996005634463922,1,1,1,racemase and epimerase activity, acting on amino acids and derivatives,MF,SRR
5900,GO:0018114,0.0996005634463922,1,1,1,threonine racemase activity,MF,SRR
6875,GO:0030378,0.0996005634463922,1,1,1,serine racemase activity,MF,SRR
9556,GO:0036361,0.0996005634463922,1,1,1,racemase activity, acting on amino acids and derivatives,MF,SRR
11645,GO:0046416,0.0996005634463922,1,1,1,D-amino acid metabolic process,BP,SRR
11650,GO:0046437,0.0996005634463922,1,1,1,D-amino acid biosynthetic process,BP,SRR
12009,GO:0047661,0.0996005634463922,1,1,1,amino-acid racemase activity,MF,SRR
14592,GO:0070178,0.0996005634463922,1,1,1,D-serine metabolic process,BP,SRR
14593,GO:0070179,0.0996005634463922,1,1,1,D-serine biosynthetic process,BP,SRR
2122,GO:0004918,0.0996026394069776,1,1,1,interleukin-8 receptor activity,MF,CXCR1
6310,GO:0019959,0.0996026394069776,1,1,1,interleukin-8 binding,MF,CXCR1
9696,GO:0038112,0.0996026394069776,1,1,1,interleukin-8-mediated signaling pathway,BP,CXCR1
12976,GO:0051413,0.0996651254839439,1,1,1,response to cortisone,BP,GLB1
580,GO:0001733,0.0997226280114782,1,1,1,galactosylceramide sulfotransferase activity,MF,GAL3ST4
12528,GO:0050694,0.0997226280114782,1,1,1,galactose 3-O-sulfotransferase activity,MF,GAL3ST4
12529,GO:0050698,0.0997226280114782,1,1,1,proteoglycan sulfotransferase activity,MF,GAL3ST4
516,GO:0001582,0.0997689928085854,1,1,1,detection of chemical stimulus involved in sensory perception of sweet taste,BP,TAS1R3
8250,GO:0033041,0.0997689928085854,1,1,1,sweet taste receptor activity,MF,TAS1R3
18532,GO:1903767,0.0997689928085854,1,1,1,sweet taste receptor complex,CC,TAS1R3
18533,GO:1903768,0.0997689928085854,1,1,1,taste receptor complex,CC,TAS1R3
4626,GO:0010750,0.0997757714543047,1,1,1,positive regulation of nitric oxide mediated signal transduction,BP,EGFR
7862,GO:0032431,0.0997757714543047,1,1,1,activation of phospholipase A2 activity,BP,EGFR
8446,GO:0033594,0.0997757714543047,1,1,1,response to hydroxyisoflavone,BP,EGFR
10253,GO:0043006,0.0997757714543047,1,1,1,activation of phospholipase A2 activity by calcium-mediated signaling,BP,EGFR
16610,GO:0097489,0.0997757714543047,1,1,1,multivesicular body, internal vesicle lumen,CC,EGFR
1807,GO:0004458,0.0998438052330526,1,1,1,D-lactate dehydrogenase (cytochrome) activity,MF,D2HGDH
5747,GO:0016898,0.0998438052330526,1,1,1,oxidoreductase activity, acting on the CH-OH group of donors, cytochrome as acceptor,MF,D2HGDH
6160,GO:0019516,0.0998438052330526,1,1,1,lactate oxidation,BP,D2HGDH
19455,GO:1990188,0.0999321636013764,1,1,1,euchromatin binding,MF,ASH2L
9573,GO:0036403,0.099936224424372,1,1,1,arachidonate 8(S)-lipoxygenase activity,MF,ALOX15B
5345,GO:0016095,0.100030993339017,1,1,1,polyprenol catabolic process,BP,SRD5A3
17123,GO:0102389,0.100030993339017,1,1,1,polyprenol reductase activity,MF,SRD5A3
13495,GO:0055088,0.100100206814848,0.948350539020309,11,69,lipid homeostasis,BP,APOE;MALL;MLXIPL;FBXW7;ACOX3;VDR;IRS2;ABCA2;RORA;PPARG;LDLRAP1
11006,GO:0044855,0.100296177277526,1,1,1,plasma membrane raft distribution,BP,GSN
11007,GO:0044856,0.100296177277526,1,1,1,plasma membrane raft localization,BP,GSN
11009,GO:0044858,0.100296177277526,1,1,1,plasma membrane raft polarization,BP,GSN
18600,GO:1903906,0.100296177277526,1,1,1,regulation of plasma membrane raft polarization,BP,GSN
13530,GO:0060013,0.100299771020884,0.988091965665585,2,5,righting reflex,BP,ALDH1A3;FOXP2
9502,GO:0036179,0.100382414875137,1,1,1,osteoclast maturation,BP,FAM20C
5407,GO:0016250,0.100440740460983,1,1,1,N-sulfoglucosamine sulfohydrolase activity,MF,SGSH
5697,GO:0016826,0.100440740460983,1,1,1,hydrolase activity, acting on acid sulfur-nitrogen bonds,MF,SGSH
1880,GO:0004561,0.10049722610094,1,1,1,alpha-N-acetylglucosaminidase activity,MF,NAGLU
4595,GO:0010713,0.100545357708164,0.987094464334429,2,6,negative regulation of collagen metabolic process,BP,CST3;PPARG
14278,GO:0061430,0.1005767721973,0.978622004014528,3,10,bone trabecula morphogenesis,BP,SFRP1;PLXNB1;THBS3
2163,GO:0004999,0.100581809472319,1,1,1,vasoactive intestinal polypeptide receptor activity,MF,VIPR1
19490,GO:1990393,0.100605632964419,0.98803385649216,2,5,3M complex,CC,OBSL1;CUL7
7757,GO:0032281,0.100611056887524,0.978128341114499,3,11,AMPA glutamate receptor complex,CC,OLFM2;DLG4;CPT1C
1645,GO:0004092,0.100716453147401,1,1,1,carnitine O-acetyltransferase activity,MF,CRAT
5434,GO:0016298,0.100726576395358,0.946266839033644,12,76,lipase activity,MF,CES2;PLCD3;PLCD1;PLCH2;CES3;PLA2G6;PLD3;PLA2G7;DDHD2;FAAH;SMPDL3B;PLCB3
12274,GO:0048619,0.10082104583919,1,1,1,embryonic hindgut morphogenesis,BP,TCF7
19175,GO:1905288,0.100826543881601,0.987991816365835,2,5,vascular associated smooth muscle cell apoptotic process,BP,PDCD4;PPARG
19249,GO:1905459,0.100826543881601,0.987991816365835,2,5,regulation of vascular associated smooth muscle cell apoptotic process,BP,PDCD4;PPARG
19250,GO:1905461,0.100826543881601,0.987991816365835,2,5,positive regulation of vascular associated smooth muscle cell apoptotic process,BP,PDCD4;PPARG
5467,GO:0016402,0.100884949499452,1,1,1,pristanoyl-CoA oxidase activity,MF,ACOX3
10556,GO:0043533,0.101100637367477,0.987939573407004,2,5,inositol 1,3,4,5 tetrakisphosphate binding,MF,ITPR3;ASTN2
1765,GO:0004371,0.101150756099094,1,1,1,glycerone kinase activity,MF,TKFC
1851,GO:0004516,0.101150756099094,1,1,1,nicotinate phosphoribosyltransferase activity,MF,NAPRT
5686,GO:0016807,0.101150756099094,1,1,1,cysteine-type carboxypeptidase activity,MF,CTSV
6109,GO:0019357,0.101150756099094,1,1,1,nicotinate nucleotide biosynthetic process,BP,NAPRT
6110,GO:0019358,0.101150756099094,1,1,1,nicotinate nucleotide salvage,BP,NAPRT
6115,GO:0019365,0.101150756099094,1,1,1,pyridine nucleotide salvage,BP,NAPRT
8257,GO:0033058,0.101150756099094,1,1,1,directional locomotion,BP,ARPIN
8458,GO:0033608,0.101150756099094,1,1,1,formyl-CoA transferase activity,MF,SUGCT
8550,GO:0034012,0.101150756099094,1,1,1,FAD-AMP lyase (cyclizing) activity,MF,TKFC
8701,GO:0034355,0.101150756099094,1,1,1,NAD salvage,BP,NAPRT
9191,GO:0035585,0.101150756099094,1,1,1,calcium-mediated signaling using extracellular calcium source,BP,DMTN
9710,GO:0038161,0.101150756099094,1,1,1,prolactin signaling pathway,BP,CREBRF
10927,GO:0044599,0.101150756099094,1,1,1,AP-5 adaptor complex,CC,AP5Z1
11689,GO:0046497,0.101150756099094,1,1,1,nicotinate nucleotide metabolic process,BP,NAPRT
11976,GO:0047369,0.101150756099094,1,1,1,succinate-hydroxymethylglutarate CoA-transferase activity,MF,SUGCT
12441,GO:0050262,0.101150756099094,1,1,1,ribosylnicotinamide kinase activity,MF,NMRK1
12456,GO:0050354,0.101150756099094,1,1,1,triokinase activity,MF,TKFC
13000,GO:0051455,0.101150756099094,1,1,1,attachment of spindle microtubules to kinetochore involved in homologous chromosome segregation,BP,CENPC
14065,GO:0060912,0.101150756099094,1,1,1,cardiac cell fate specification,BP,TENM4
14273,GO:0061400,0.101150756099094,1,1,1,positive regulation of transcription from RNA polymerase II promoter in response to calcium ion,BP,CARF
14427,GO:0061769,0.101150756099094,1,1,1,ribosylnicotinate kinase activity,MF,NMRK1
14498,GO:0070004,0.101150756099094,1,1,1,cysteine-type exopeptidase activity,MF,CTSV
14801,GO:0070560,0.101150756099094,1,1,1,protein secretion by platelet,BP,DMTN
17071,GO:0099627,0.101150756099094,1,1,1,neurotransmitter receptor cycle,BP,NSG1
17073,GO:0099630,0.101150756099094,1,1,1,postsynaptic neurotransmitter receptor cycle,BP,NSG1
17401,GO:1900170,0.101150756099094,1,1,1,negative regulation of glucocorticoid mediated signaling pathway,BP,CREBRF
17881,GO:1902211,0.101150756099094,1,1,1,regulation of prolactin signaling pathway,BP,CREBRF
17882,GO:1902213,0.101150756099094,1,1,1,positive regulation of prolactin signaling pathway,BP,CREBRF
19188,GO:1905319,0.101150756099094,1,1,1,mesenchymal stem cell migration,BP,ACKR3
19189,GO:1905320,0.101150756099094,1,1,1,regulation of mesenchymal stem cell migration,BP,ACKR3
19190,GO:1905322,0.101150756099094,1,1,1,positive regulation of mesenchymal stem cell migration,BP,ACKR3
19946,GO:2000543,0.101150756099094,1,1,1,positive regulation of gastrulation,BP,TENM4
18152,GO:1902939,0.101157697803507,1,1,1,negative regulation of intracellular calcium activated chloride channel activity,BP,ANO9
16030,GO:0086089,0.101171634782898,1,1,1,voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization,MF,KCNJ5
17920,GO:1902282,0.101171634782898,1,1,1,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization,MF,KCNJ5
10960,GO:0044753,0.101228093050518,1,1,1,amphisome,CC,SQSTM1
1262,GO:0003018,0.101271328706925,0.944359782851809,13,84,vascular process in circulatory system,BP,APOE;EGFR;NOS1;RGS2;F2R;TRPV4;ADORA2B;PER2;PLA2G6;BBS2;PDE2A;CTNNBIP1;GCLC
10624,GO:0043648,0.101306461821612,0.94579686680424,12,79,dicarboxylic acid metabolic process,BP,MTHFR;GLUD1;D2HGDH;PRODH;PHYH;ALDH4A1;IDH2;GLUL;SDHA;TH;SUCLG2;GCLC
14422,GO:0061760,0.101411721854899,1,1,1,antifungal innate immune response,BP,FAM3A
15114,GO:0071228,0.101411721854899,1,1,1,cellular response to tumor cell,BP,TXNIP
19082,GO:1905034,0.101411721854899,1,1,1,regulation of antifungal innate immune response,BP,FAM3A
19083,GO:1905035,0.101411721854899,1,1,1,negative regulation of antifungal innate immune response,BP,FAM3A
5519,GO:0016491,0.101448206777051,0.921913240602694,59,526,oxidoreductase activity,MF,ALDH1A3;MTHFR;GPX3;GLUD1;TXNRD3;KDM3A;H6PD;DHTKD1;HR;CYBRD1;KCNAB2;SRD5A3;KDSR;NOS1;D2HGDH;CYP26B1;PRODH;NDUFA4L2;CYP3A5;BLVRB;PHYH;PTGS1;PHF2;GSTM2;SESN3;ALDH4A1;CYP2D7;MGST2;ALDH7A1;AKR7A2;LOXL1;KDM4C;IDH2;SESN1;CYBA;HADH;RRM2B;HSD11B1L;ACADS;OGDHL;BDH1;DHRS4L2;SDHA;ACOX3;RETSAT;DHRS12;ETFB;NDUFV3;ALOXE3;DUOX1;HSD17B14;ALOX15B;PNPO;DHRS4;CBR4;PRDX5;RDH12;TH;EHHADH
11581,GO:0046184,0.101620873057294,0.977811904154098,3,11,aldehyde biosynthetic process,BP,KDM3A;BMP6;PNPO
5854,GO:0017156,0.101712198707125,0.947449663594315,11,67,calcium ion regulated exocytosis,BP,SYT8;SYN1;VAMP3;SYTL1;C2CD4C;RIMS3;SYT15;VAMP2;SEPT5;RPH3AL;SYT7
8526,GO:0033862,0.101886284992457,1,1,1,UMP kinase activity,MF,CMPK2
7483,GO:0031659,0.101888048892025,0.987788985908329,2,5,positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle,BP,EGFR;PKD2
8426,GO:0033555,0.101897486666796,0.960690273607092,6,31,multicellular organismal response to stress,BP,APOE;NOS1;MDK;LRP11;BRINP1;RET
3091,GO:0006665,0.101979580965594,0.937889359945429,18,127,sphingolipid metabolic process,BP,KDSR;ST6GALNAC6;CERS4;B4GALT6;ARSI;HEXA;ARSD;ST3GAL5;HEXB;PLA2G6;ESYT2;ALOXE3;CERS5;SMPDL3B;GLB1;TH;PEMT;SERINC3
7693,GO:0032173,0.102002582211042,1,1,1,septin collar,CC,SEPT6
1406,GO:0003342,0.102166376106343,1,1,1,proepicardium development,BP,ZFP36L1
1407,GO:0003343,0.102166376106343,1,1,1,septum transversum development,BP,ZFP36L1
16570,GO:0097403,0.102166376106343,1,1,1,cellular response to raffinose,BP,ZFP36L1
17656,GO:1901545,0.102166376106343,1,1,1,response to raffinose,BP,ZFP36L1
5588,GO:0016616,0.10226727423619,0.945032220007497,12,84,oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor,MF,H6PD;KCNAB2;KDSR;AKR7A2;IDH2;HADH;BDH1;HSD17B14;DHRS4;CBR4;RDH12;EHHADH
5058,GO:0015271,0.102303644244418,0.987709204302236,2,5,outward rectifier potassium channel activity,MF,PKD2;KCNMA1
3829,GO:0008431,0.102466030965932,1,1,1,vitamin E binding,MF,SEC14L2
4201,GO:0009311,0.102469301824678,0.951104454474428,9,54,oligosaccharide metabolic process,BP,ST6GALNAC2;GAA;ST6GALNAC6;IDUA;GAL3ST4;ST3GAL5;HEXB;SLC2A1;MAN1B1
17204,GO:0110008,0.102475484042615,1,1,1,ncRNA deadenylation,BP,PARN
2423,GO:0005600,0.102546813727953,1,1,1,collagen type XIII trimer,CC,COL13A1
7113,GO:0030936,0.102546813727953,1,1,1,transmembrane collagen trimer,CC,COL13A1
7783,GO:0032331,0.102783980468951,0.97744556823375,3,11,negative regulation of chondrocyte differentiation,BP,PTHLH;ADAMTS7;GLI2
2155,GO:0004980,0.102879460823536,1,1,1,melanocyte-stimulating hormone receptor activity,MF,MC1R
3077,GO:0006646,0.102883466135051,0.977414141544295,3,11,phosphatidylethanolamine biosynthetic process,BP,SLC27A1;ETNK2;LPIN3
10689,GO:0043990,0.102889468273892,1,1,1,histone H2A-S1 phosphorylation,BP,RPS6KA5
18396,GO:1903461,0.10300036690991,1,1,1,Okazaki fragment processing involved in mitotic DNA replication,BP,LIG1
7489,GO:0031668,0.103151706688135,0.93171215092111,25,184,cellular response to extracellular stimulus,BP,POSTN;SREBF1;SFRP1;IMPACT;MDM2;CTSV;KIF26A;ADORA2B;ULK1;ITGA6;SESN3;BAIAP2;WRN;SESN1;HFE;CYBA;SLC2A1;GLUL;C12ORF66;PIK3C3;IFI16;VDR;UCN2;ATG14;PPARG
2053,GO:0004806,0.103388983546454,0.977254228353574,3,11,triglyceride lipase activity,MF,CES2;CES3;DDHD2
2181,GO:0005034,0.103538579139656,1,1,1,osmosensor activity,MF,TRPV4
6697,GO:0030103,0.103538579139656,1,1,1,vasopressin secretion,BP,TRPV4
16615,GO:0097497,0.103538579139656,1,1,1,blood vessel endothelial cell delamination,BP,TRPV4
18392,GO:1903444,0.103538579139656,1,1,1,negative regulation of brown fat cell differentiation,BP,TRPV4
18527,GO:1903759,0.103538579139656,1,1,1,signal transduction involved in regulation of aerobic respiration,BP,TRPV4
15027,GO:0070995,0.103570849061822,1,1,1,NADPH oxidation,BP,KCNAB2
19407,GO:1990031,0.103570849061822,1,1,1,pinceau fiber,CC,KCNAB2
6975,GO:0030658,0.103602963857083,0.936780601916011,18,126,transport vesicle membrane,CC,MAP6;SREBF1;PTPRS;SYT8;SYN1;HLA-B;AP1G2;C2CD4C;CLTCL1;VAMP2;MCTP1;RPH3AL;HLA-A;SYT7;AREG;DMXL2;SYNGR1;LDLRAP1
4857,GO:0014074,0.103698519941922,0.941358827809587,14,92,response to purine-containing compound,BP,SREBF1;PKD2;DGKQ;STAT1;RAPGEF3;GSTM2;XRN1;PDE2A;AREG;DMTN;DUOX1;ZFP36L1;AKAP6;PPARG
12754,GO:0051049,0.103757287760637,0.91313422418067,130,1110,regulation of transport,BP,POSTN;SERPINE2;SIK1;SREBF1;APOE;OAS2;HSPA2;EGFR;PKD2;SYT8;SYN1;SFRP1;EPHB2;GLUD1;PIK3R1;EVI5L;KCNAB2;VAMP3;REEP2;KCNJ15;CRY2;RAB40B;NOS1;CRY1;FERMT1;TBC1D8;VPS11;KCNC4;ITPR3;MDM2;SYTL1;RAPGEF3;F2R;C2CD4C;HPS4;CLTCL1;TRPV4;FLOT1;NLGN2;ADORA2B;ANK3;RIMS3;GJC2;RHBDF1;PER2;UNC119;C5;SNTA1;MINK1;GSTM2;ITGA2;SYT15;GLI3;LRSAM1;VAMP2;NMU;KCNJ5;INSR;TTN;SCN4B;TM7SF3;BMP6;MICALL2;MAP2K2;PLA2G6;HOMER2;IDH2;SEPT5;IFI27;OSCP1;DNM1;TNFRSF21;KLHL24;MCTP1;CDK5R1;ANO9;CA2;SHANK3;HFE;CYBA;HADH;RAB11FIP3;FBXW7;KCNMA1;PFKFB2;MX2;RPH3AL;SLC2A1;NLRP1;GLUL;TBC1D17;LRP1;KCNG1;WNK1;JPH2;PDE2A;PIK3C3;SYT7;PIK3R2;SCN2A;BST2;CACNB3;TBC1D16;DMTN;SGSM2;RASL10B;TFDP2;DLG4;SHANK2;RSAD2;IL11;IRS2;ANO1;ALOX15B;SCG5;PHPT1;TUB;CACNB1;PTPN3;ERBB2;GPR68;ABCA2;AKAP6;PPARG;PRKACA;LDLRAP1;PLTP;KCNS3;SNX33;PEMT
1266,GO:0003050,0.103915368033661,1,1,1,regulation of systemic arterial blood pressure by atrial natriuretic peptide,BP,RASL10B
11523,GO:0046068,0.104145573855836,0.964245742768591,5,23,cGMP metabolic process,BP,APOE;NOS1;ADORA2B;PDE2A;RORA
5784,GO:0017016,0.104177140573893,0.921028256676866,53,405,Ras GTPase binding,MF,ALS2CL;EGFR;EPS8L2;EVI5L;VAV3;KITLG;PLEKHG5;MICALL1;TBC1D8;PLEKHG3;NDRG1;OBSCN;SYTL1;RAPGEF3;HPS4;SPTB;RIMS3;ARHGEF19;RASGEF1A;FRS3;ARHGEF4;ULK1;GAS8;SRGAP3;TRIOBP;RIN1;ARHGEF1;RAB11FIP4;MICALL2;WHAMMP3;NET1;SHC2;RAB11FIP3;PAK6;FMNL2;RPH3AL;TBC1D17;RET;FGFR4;EXOC2;RGL2;ARHGEF17;TBC1D16;SGSM2;DLG4;IRS2;DMXL2;ARHGEF9;RAPGEF5;RANBP9;ERBB2;FMNL3;CIT
19534,GO:1990523,0.104309623936411,1,1,1,bone regeneration,BP,POSTN
1335,GO:0003195,0.104516722574029,1,1,1,tricuspid valve formation,BP,ZFPM1
9839,GO:0042097,0.104516722574029,1,1,1,interleukin-4 biosynthetic process,BP,ZFPM1
11218,GO:0045402,0.104516722574029,1,1,1,regulation of interleukin-4 biosynthetic process,BP,ZFPM1
11219,GO:0045403,0.104516722574029,1,1,1,negative regulation of interleukin-4 biosynthetic process,BP,ZFPM1
13767,GO:0060375,0.104516722574029,1,1,1,regulation of mast cell differentiation,BP,ZFPM1
13768,GO:0060377,0.104516722574029,1,1,1,negative regulation of mast cell differentiation,BP,ZFPM1
1495,GO:0003842,0.104586372662445,1,1,1,1-pyrroline-5-carboxylate dehydrogenase activity,MF,ALDH4A1
12901,GO:0051271,0.104598093951509,0.929503064403148,27,197,negative regulation of cellular component movement,BP,TP53INP1;APOE;SFRP1;WNT3;IFITM1;ARPIN;C5;SEMA4G;MAP2K5;SRGAP3;NISCH;MMP28;DDT;PLXNB3;MMRN2;IDH2;MCTP1;ADARB1;LRP1;ZMYND8;DAB2IP;DLG5;BST2;ALOX15B;PBLD;CD9;PPARG
6396,GO:0021615,0.104621310204656,1,1,1,glossopharyngeal nerve morphogenesis,BP,HOXA3
14450,GO:0061845,0.104644643078351,1,1,1,neuron projection branch point,CC,BAIAP2
14451,GO:0061846,0.104644643078351,1,1,1,dendritic spine cytoplasm,CC,BAIAP2
9163,GO:0035538,0.104673855123183,1,1,1,carbohydrate response element binding,MF,MLXIPL
3570,GO:0007614,0.104685038019809,0.986236597932191,2,6,short-term memory,BP,MDK;BRINP1
3456,GO:0007269,0.104718742590143,0.943791654384608,12,75,neurotransmitter secretion,BP,SYT8;SYN1;BRSK1;KCNC4;SYTL1;C2CD4C;RIMS3;SYT15;VAMP2;SEPT5;MCTP1;SYT7
17082,GO:0099643,0.104718742590143,0.943791654384608,12,75,signal release from synapse,BP,SYT8;SYN1;BRSK1;KCNC4;SYTL1;C2CD4C;RIMS3;SYT15;VAMP2;SEPT5;MCTP1;SYT7
9120,GO:0035455,0.104822547360261,0.969017830451832,4,19,response to interferon-alpha,BP,IFITM1;LAMP3;MX2;BST2
6470,GO:0021815,0.105065262905952,0.987173778540444,2,5,modulation of microtubule cytoskeleton involved in cerebral cortex radial glia guided migration,BP,SUN1;SYNE2
6643,GO:0023057,0.105142199721084,0.91324476887809,109,934,negative regulation of signaling,BP,TNFAIP3;SERPINE2;EPM2A;IFI6;SREBF1;APOE;INPP5D;APCDD1;EGFR;PTPRS;PKD2;MNT;SFRP1;KCTD11;EPHB2;SULF2;HTRA1;STAT1;CAMK2N1;CRY2;UNC5B;PRKACB;CRY1;NFATC4;FERMT1;CYP26B1;MDM2;LZTS2;PIK3IP1;TNFSF10;FLRT3;RASA4;KIF26A;RGS2;PDCD4;SLC24A1;RTN4RL1;GSTM2;WWTR1;GLI3;LTBP1;MAP2K5;ITGA6;SESN3;IGFBP4;INSR;CBLC;CD109;DHX58;NLRX1;PTK6;SYNGAP1;ARRDC1;PLA2G6;MMRN2;NPHP3;DNM1;SESN1;SHANK3;HFE;HADH;RRM2B;SLIT3;SPRY2;CREBRF;RAB11FIP3;FBXW7;CDK5RAP3;APC2;ELF1;RPH3AL;NLRP1;LRP1;NPHP4;RGS12;C12ORF66;DLK2;PDE2A;RET;DAB2IP;RNF213;FGFR4;PIK3R2;DLG5;WWC3;NRARP;KREMEN1;IGFBP6;SHANK2;LMNA;IL11;IVNS1ABP;GPR21;TKFC;PBLD;PHPT1;SMPDL3B;KIF7;RANBP9;PTPN3;ERBB2;RORA;PPARG;ACKR3;CCDC3;SMURF1;CTNNBIP1;GCLC;ECM1
4597,GO:0010715,0.105240185298151,0.97666543389876,3,11,regulation of extracellular matrix disassembly,BP,CST3;LRP1;FGFR4
11324,GO:0045664,0.105307829403931,0.920078872331438,53,412,regulation of neuron differentiation,BP,ULK2;APOE;PTPRS;CAPRIN2;DIXDC1;SFRP1;OBSL1;KCTD11;EPHB2;WNT3;RGMA;CUL7;IMPACT;NFATC4;PLXNB1;SPOCK1;MDM2;CRTC1;CSMD3;RTN4RL1;TRPV4;GLI2;SEMA4G;GLI3;TRAK1;BAIAP2;PLXNB3;BMP6;PTK6;ETV5;SYNGAP1;KDM4C;TCF4;CDK5R1;EFNB3;SHANK3;HMG20B;CDK5RAP3;LRP1;BRINP1;RET;ZMYND8;DAB2IP;CASZ1;DLG5;PLXND1;PMP22;DLG4;PTK7;SHANK2;ZSWIM8;SSH3;SMURF1
11452,GO:0045923,0.105339207887066,0.969295485403622,4,17,positive regulation of fatty acid metabolic process,BP,MLYCD;MLXIPL;IRS2;PPARG
13160,GO:0051786,0.105358878066081,1,1,1,all-trans-retinol 13,14-reductase activity,MF,RETSAT
11460,GO:0045933,0.105371517082327,0.96334333549778,5,25,positive regulation of muscle contraction,BP,RGS2;F2R;ITGA2;NMU;NPNT
4919,GO:0014859,0.105504751838409,1,1,1,negative regulation of skeletal muscle cell proliferation,BP,SIX5
18072,GO:1902723,0.105504751838409,1,1,1,negative regulation of skeletal muscle satellite cell proliferation,BP,SIX5
16501,GO:0097232,0.105663798314501,1,1,1,lamellar body membrane,CC,LAMP3
16502,GO:0097233,0.105663798314501,1,1,1,alveolar lamellar body membrane,CC,LAMP3
14949,GO:0070875,0.105711791048036,0.977030903900073,3,10,positive regulation of glycogen metabolic process,BP,INSR;EPM2AIP1;IRS2
5791,GO:0017034,0.105775986571377,0.98703450144544,2,5,Rap guanyl-nucleotide exchange factor activity,MF,RAPGEF3;RAPGEF5
3432,GO:0007221,0.105868428193361,0.969381907525039,4,16,positive regulation of transcription of Notch receptor target,BP,STAT1;MAML3;PLXND1;KAT2B
4383,GO:0010038,0.105969616887698,0.927369886949406,29,217,response to metal ion,BP,EGFR;PKD2;CYBRD1;UROS;NFATC4;D2HGDH;NDRG1;ITPR3;MDM2;RASA4;MT1X;ANK3;ADAMTS13;ZNF658;GSN;TTN;ENDOG;BMP6;TXNIP;CA2;HFE;KRT14;KCNMA1;CARF;WNK1;SNCB;DMTN;TH;GCLC
1812,GO:0004464,0.106024512506462,0.997032584993326,1,2,leukotriene-C4 synthase activity,MF,MGST2
16422,GO:0097105,0.106222032565812,0.986946783043819,2,5,presynaptic membrane assembly,BP,NLGN4Y;NLGN2
12645,GO:0050869,0.106301070515184,0.96891372799183,4,17,negative regulation of B cell activation,BP,TNFAIP3;INPP5D;SFRP1;TNFRSF21
17066,GO:0099617,0.10633450951947,1,1,1,matrix side of mitochondrial inner membrane,CC,BDH1
15737,GO:0072350,0.106335404363441,0.958261596641696,6,33,tricarboxylic acid metabolic process,BP,GLUD1;DHTKD1;IDH2;OGDHL;SDHA;SUCLG2
11690,GO:0046498,0.106491918776215,0.985855291621269,2,6,S-adenosylhomocysteine metabolic process,BP,GAMT;PEMT
10060,GO:0042572,0.106528773049394,0.968561880111335,4,18,retinol metabolic process,BP,ALDH1A3;RETSAT;DHRS4;RDH12
16421,GO:0097104,0.106534485766111,0.986885194938443,2,5,postsynaptic membrane assembly,BP,NLGN4Y;NLGN2
11369,GO:0045761,0.106565892880688,0.976240708197243,3,11,regulation of adenylate cyclase activity,BP,GABBR1;GPR87;LTB4R2
3028,GO:0006575,0.106641825918248,0.934520688187416,18,134,cellular modified amino acid metabolic process,BP,GAMT;MTHFR;CRTAP;PRODH;GSTM2;ALDH4A1;MGST2;SLC27A1;OPLAH;ALDH7A1;OSBPL10;OSBPL5;DUOX1;GSTM3;GCNT4;PEMT;SERINC3;GCLC
11861,GO:0046885,0.106653356955355,0.968773563492653,4,17,regulation of hormone biosynthetic process,BP,DGKQ;BMP6;VDR;TRERF1
829,GO:0002118,0.106789187255137,1,1,1,aggressive behavior,BP,GCNT4
830,GO:0002121,0.106789187255137,1,1,1,inter-male aggressive behavior,BP,GCNT4
11682,GO:0046487,0.106849823535395,0.985779269926068,2,6,glyoxylate metabolic process,BP,ALDH4A1;IDH2
15743,GO:0072359,0.106893872037763,0.91402656356577,84,674,circulatory system development,BP,TNFAIP3;TGFBI;GPNMB;SIK1;ACTA2;APOE;ADAM19;EGFR;PKD2;PLCD3;SFRP1;OBSL1;EPHB2;VAV3;CSPG4;TENM4;ZFPM1;CUL7;STAT1;UNC5B;HOXA3;NFATC4;GAA;MDM2;PLCD1;MYH11;RAPGEF3;TCF25;FLRT3;ADGRB2;PDCD4;GLI2;TMEM204;C5;PSKH1;GLI3;FHOD3;IRX4;LTBP1;NEK8;MAP2K5;JARID2;INSR;TTN;VEGFB;FZD7;LOXL1;DLX3;HYAL1;SH2D2A;MMRN2;NPHP3;SPRY2;MEF2D;IFT140;FBXW7;ACACB;LRP1;JPH2;DAB2IP;TEAD2;RNF213;FGFR4;BBS5;BTG1;PLXND1;TMEM231;TFDP2;NRARP;PTK7;ZFP36L1;LMNA;KAT2B;APOLD1;TNFSF12;SRPX2;ERBB2;AKAP6;TH;RORA;PPARG;FMNL3;ACKR3;ECM1
3964,GO:0008753,0.107069386079038,1,1,1,NADPH dehydrogenase (quinone) activity,MF,CBR4
16040,GO:0089717,0.107220770401327,0.986749510743237,2,5,spanning component of membrane,CC,NLGN4Y;NLGN2
2006,GO:0004733,0.107235650862667,1,1,1,pyridoxamine-phosphate oxidase activity,MF,PNPO
6505,GO:0021885,0.107247862002892,0.954387652387757,7,37,forebrain cell migration,BP,EGFR;DIXDC1;GLI3;SUN1;CDK5R1;DAB2IP;SYNE2
7633,GO:0032051,0.107330110575888,0.986727841323127,2,5,clathrin light chain binding,MF,NSG1;CLTCL1
15162,GO:0071320,0.107337681478494,0.95813326009446,6,30,cellular response to cAMP,BP,PKD2;RAPGEF3;PDE2A;DMTN;ZFP36L1;AKAP6
1750,GO:0004352,0.107466583626212,1,1,1,glutamate dehydrogenase (NAD+) activity,MF,GLUD1
1751,GO:0004353,0.107466583626212,1,1,1,glutamate dehydrogenase [NAD(P)+] activity,MF,GLUD1
5598,GO:0016639,0.107466583626212,1,1,1,oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor,MF,GLUD1
16338,GO:0090657,0.107574591088914,0.975915836043191,3,11,telomeric loop disassembly,BP,SLX1A;SLX1B;WRN
15836,GO:0072576,0.107612587475525,0.97590356973032,3,11,liver morphogenesis,BP,TNFAIP3;SULF2;FBXW7
13677,GO:0060251,0.107620398478984,0.968387860195099,4,17,regulation of glial cell proliferation,BP,ETV5;PLAG1;IDH2;UFL1
6445,GO:0021768,0.107685329499448,1,1,1,nucleus accumbens development,BP,ALDH1A3
17437,GO:1900246,0.107766664889534,0.986641181231191,2,5,positive regulation of RIG-I signaling pathway,BP,DDX60;DHX58
8623,GO:0034155,0.107840042717639,1,1,1,regulation of toll-like receptor 7 signaling pathway,BP,RSAD2
8624,GO:0034157,0.107840042717639,1,1,1,positive regulation of toll-like receptor 7 signaling pathway,BP,RSAD2
9341,GO:0035864,0.107841481861532,0.98556778433458,2,6,response to potassium ion,BP,ADAMTS13;CARF
12904,GO:0051279,0.108046591128614,0.95061555268315,8,46,regulation of release of sequestered calcium ion into cytosol,BP,PKD2;NOS1;F2R;GSTM2;CYBA;JPH2;AKAP6;PRKACA
15445,GO:0071804,0.10805101993058,0.940017331215175,13,83,cellular potassium ion transport,BP,PKD2;KCNAB2;KCNJ15;KCNC4;ANK3;VAMP2;KCNJ5;SLC12A7;KLHL24;KCNMA1;KCNG1;AKAP6;KCNS3
15446,GO:0071805,0.10805101993058,0.940017331215175,13,83,potassium ion transmembrane transport,BP,PKD2;KCNAB2;KCNJ15;KCNC4;ANK3;VAMP2;KCNJ5;SLC12A7;KLHL24;KCNMA1;KCNG1;AKAP6;KCNS3
8602,GO:0034123,0.108097926542611,0.975314498150839,3,12,positive regulation of toll-like receptor signaling pathway,BP,FLOT1;CYBA;RSAD2
3573,GO:0007618,0.10823868490149,0.967874080505709,4,18,mating,BP,SERPINE2;HEXB;THRA;TH
4587,GO:0010694,0.108402328138745,0.986514589692217,2,5,positive regulation of alkaline phosphatase activity,BP,ITGA2;NPNT
828,GO:0002116,0.108453114078185,0.976165970708701,3,10,semaphorin receptor complex,CC,PLXNB1;PLXNB3;PLXND1
5853,GO:0017154,0.108453114078185,0.976165970708701,3,10,semaphorin receptor activity,MF,PLXNB1;PLXNB3;PLXND1
6894,GO:0030473,0.10845835992193,0.986503407934605,2,5,nuclear migration along microtubule,BP,SUN1;SYNE2
12575,GO:0050771,0.108466360402746,0.950541172306685,8,44,negative regulation of axonogenesis,BP,ULK2;PTPRS;EPHB2;WNT3;SEMA4G;SYNGAP1;CDK5R1;EFNB3
1612,GO:0004043,0.108499261393349,1,1,1,L-aminoadipate-semialdehyde dehydrogenase activity,MF,ALDH7A1
3976,GO:0008802,0.108499261393349,1,1,1,betaine-aldehyde dehydrogenase activity,MF,ALDH7A1
6090,GO:0019285,0.108499261393349,1,1,1,glycine betaine biosynthetic process from choline,BP,ALDH7A1
7387,GO:0031455,0.108499261393349,1,1,1,glycine betaine metabolic process,BP,ALDH7A1
7388,GO:0031456,0.108499261393349,1,1,1,glycine betaine biosynthetic process,BP,ALDH7A1
11810,GO:0046725,0.108602769962252,1,1,1,negative regulation by virus of viral protein levels in host cell,BP,STAT1
15643,GO:0072183,0.108602769962252,1,1,1,negative regulation of nephron tubule epithelial cell differentiation,BP,STAT1
15713,GO:0072308,0.108602769962252,1,1,1,negative regulation of metanephric nephron tubule epithelial cell differentiation,BP,STAT1
7809,GO:0032370,0.108857108180479,0.956997429786601,6,33,positive regulation of lipid transport,BP,APOE;BMP6;PLA2G6;LRP1;LDLRAP1;PLTP
11404,GO:0045834,0.108858631054952,0.941086420445666,12,77,positive regulation of lipid metabolic process,BP,SREBF1;APOE;VAV3;MLYCD;BMP6;PLA2G6;MLXIPL;IRS2;ATG14;PPARG;LDLRAP1;CCDC3
13558,GO:0060047,0.108936106907911,0.932239196000018,19,126,heart contraction,BP,SREBF1;NOS1;GAA;ITPR3;MDM2;RGS2;SNTA1;GSTM2;NMU;KCNJ5;TTN;SCN4B;VEGFB;THRA;CACNB3;TNNI2;CACNB1;TH;PRKACA
812,GO:0002086,0.10902949223125,1,1,1,diaphragm contraction,BP,GAA
1890,GO:0004574,0.10902949223125,1,1,1,oligo-1,6-glucosidase activity,MF,GAA
2648,GO:0005985,0.10902949223125,1,1,1,sucrose metabolic process,BP,GAA
10352,GO:0043181,0.10902949223125,1,1,1,vacuolar sequestering,BP,GAA
54,GO:0000111,0.109197343759118,1,1,1,nucleotide-excision repair factor 2 complex,CC,XPC
1280,GO:0003084,0.10931222966092,0.985251830399416,2,6,positive regulation of systemic arterial blood pressure,BP,CYBA;WNK1
20018,GO:2000663,0.109403610374805,1,1,1,negative regulation of interleukin-5 secretion,BP,TNFRSF21
4764,GO:0010951,0.109466632815769,0.932523431635463,18,135,negative regulation of endopeptidase activity,BP,SERPINE2;IFI6;COL7A1;SPOCK1;MDM2;SERPINB5;LAMP3;C5;NAIP;MAP2K5;CD109;CST3;TFPI2;IFI16;BST2;PCSK1N;PRDX5;SERPING1
6438,GO:0021757,0.10954516236445,1,1,1,caudate nucleus development,BP,FOXP2
6439,GO:0021758,0.10954516236445,1,1,1,putamen development,BP,FOXP2
14714,GO:0070403,0.109802884327714,0.974751624422278,3,12,NAD+ binding,MF,ALDH1A3;GLUD1;HADH
3591,GO:0008016,0.109913044597838,0.934626795257916,16,108,regulation of heart contraction,BP,SREBF1;NOS1;GAA;ITPR3;MDM2;RGS2;SNTA1;GSTM2;NMU;KCNJ5;SCN4B;THRA;CACNB3;CACNB1;TH;PRKACA
4616,GO:0010737,0.110106410284621,0.962887220230563,5,18,protein kinase A signaling,BP,MC1R;AKAP7;TTN;AKAP6;AIP
11230,GO:0045444,0.110381865110152,0.9301460979523,20,142,fat cell differentiation,BP,SREBF1;SFRP1;ZFPM1;RGS2;ZFP36L2;TRPV4;SULT1E1;PER2;WWTR1;ITGA6;CCDC85B;BBS2;ADIRF;DLK2;ALOXE3;ZFP36L1;IL11;RORA;PPARG;CCDC3
9304,GO:0035774,0.11056963130139,0.966688135451429,4,19,positive regulation of insulin secretion involved in cellular response to glucose stimulus,BP,PLA2G6;ANO1;PHPT1;GPR68
6064,GO:0019216,0.110673868145435,0.921427093532982,34,260,regulation of lipid metabolic process,BP,SIK1;SREBF1;APOE;LMF1;CPT2;SEC14L2;DGKQ;PIK3R1;VAV3;MVD;TYSND1;PIK3IP1;MLYCD;SLC27A1;BMP6;PDK1;PLA2G6;TNFRSF21;MLXIPL;FBXW7;THRA;ACACB;DAB2IP;FGFR4;PIK3R2;VDR;ACSL1;IRS2;ATG14;RORA;PPARG;LDLRAP1;LONP2;CCDC3
8607,GO:0034135,0.110952868197764,0.98489615235002,2,6,regulation of toll-like receptor 2 signaling pathway,BP,TNFAIP3;CYBA
4281,GO:0009650,0.110963240729062,0.974366129546122,3,12,UV protection,BP,MC1R;SCARA3;ERCC5
15922,GO:0072755,0.111028498439659,1,1,1,cellular response to benomyl,BP,IMPACT
17662,GO:1901561,0.111028498439659,1,1,1,response to benomyl,BP,IMPACT
8705,GO:0034362,0.111161833241903,0.984850606448405,2,6,low-density lipoprotein particle,CC,APOE;PLA2G7
11486,GO:0045987,0.11124693992936,0.966653541666581,4,18,positive regulation of smooth muscle contraction,BP,F2R;ITGA2;NMU;NPNT
13619,GO:0060143,0.111259815308567,0.974267288310189,3,12,positive regulation of syncytium formation by plasma membrane fusion,BP,RAPGEF3;FLOT1;GDF15
4812,GO:0014009,0.111317960657743,0.960790878952604,5,24,glial cell proliferation,BP,ETV5;PLAG1;IDH2;AREG;UFL1
13046,GO:0051570,0.111332957581891,0.966894314365959,4,17,regulation of histone H3-K9 methylation,BP,KDM3A;JARID2;KDM4C;ATRX
7195,GO:0031092,0.11149240780863,0.974640106125884,3,11,platelet alpha granule membrane,CC,LHFPL2;CD109;CD9
17045,GO:0099552,0.11157054137405,1,1,1,trans-synaptic signaling by lipid, modulating synaptic transmission,BP,F2R
17046,GO:0099553,0.11157054137405,1,1,1,trans-synaptic signaling by endocannabinoid, modulating synaptic transmission,BP,F2R
17381,GO:1900134,0.11157054137405,1,1,1,negative regulation of renin secretion into blood stream,BP,F2R
20116,GO:2000831,0.111622250559454,0.984750059972674,2,6,regulation of steroid hormone secretion,BP,CRY1;BMP6
3749,GO:0008289,0.111641348325779,0.914188655325811,56,453,lipid binding,MF,APOE;PSD4;HSPA2;SYT8;SEC14L2;MVB12B;UNC119B;HS1BP3;PITPNM3;CYP26B1;MICALL1;PIK3C2G;ITPR3;PLCD1;SYTL1;UGT1A3;RASA4;C2CD4C;SULT1E1;PITPNM2;UNC119;SYT15;VAMP2;NISCH;FZD7;ARHGAP33;MCTP1;OSBPL10;PAQR6;ARAP1;RPH3AL;PLA2G7;JPH2;DAB2IP;SYT7;BBS5;OSBPL5;VDR;SNX21;MPPE1;SNX1;OSBPL1A;ESYT2;IQSEC1;SNX29;APOLD1;ALOX15B;TUB;PAQR7;RORA;PPARG;LDLRAP1;PLTP;SNX33;SMURF1;PEMT
14105,GO:0060993,0.111667146139194,0.943457422476154,10,59,kidney morphogenesis,BP,PKD2;KIF26B;STAT1;WWTR1;GLI3;NPHP3;KLHL3;GCNT4;NPNT;CTNNBIP1
12504,GO:0050664,0.111682574237499,0.984736866633537,2,6,oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor,MF,CYBA;DUOX1
4892,GO:0014820,0.111915328240691,0.98468591826647,2,6,tonic smooth muscle contraction,BP,NMU;BBS2
572,GO:0001715,0.112064825907682,1,1,1,ectodermal cell fate specification,BP,FZD7
10116,GO:0042665,0.112064825907682,1,1,1,regulation of ectodermal cell fate specification,BP,FZD7
10117,GO:0042666,0.112064825907682,1,1,1,negative regulation of ectodermal cell fate specification,BP,FZD7
19872,GO:2000383,0.112064825907682,1,1,1,regulation of ectoderm development,BP,FZD7
19873,GO:2000384,0.112064825907682,1,1,1,negative regulation of ectoderm development,BP,FZD7
5542,GO:0016534,0.112100534075438,1,1,1,cyclin-dependent protein kinase 5 activator activity,MF,CDK5R1
6383,GO:0021586,0.112100534075438,1,1,1,pons maturation,BP,CDK5R1
6432,GO:0021718,0.112100534075438,1,1,1,superior olivary nucleus development,BP,CDK5R1
6433,GO:0021722,0.112100534075438,1,1,1,superior olivary nucleus maturation,BP,CDK5R1
10578,GO:0043559,0.112239482568599,0.985740218745067,2,5,insulin binding,MF,PIK3R1;INSR
12642,GO:0050866,0.112257437973761,0.934215832172243,15,103,negative regulation of cell activation,BP,TNFAIP3;SERPINE2;GPNMB;APOE;INPP5D;SFRP1;IL20RB;GLI3;TNFRSF21;HFE;DLG5;NRARP;CD9;ERBB2;GCLC
1409,GO:0003345,0.112366186625565,1,1,1,proepicardium cell migration involved in pericardium morphogenesis,BP,FLRT3
7570,GO:0031941,0.112366942597553,0.959961027934743,5,26,filamentous actin,CC,ESPN;PKD2;FERMT1;APC2;SHROOM4
7882,GO:0032458,0.112395460922154,1,1,1,slow endocytic recycling,BP,MICALL1
8420,GO:0033539,0.112403907971704,0.973884799021488,3,12,fatty acid beta-oxidation using acyl-CoA dehydrogenase,BP,ACADS;ACOX3;ETFB
13665,GO:0060228,0.112455162084498,0.996649974267734,1,2,phosphatidylcholine-sterol O-acyltransferase activator activity,MF,APOE
15164,GO:0071322,0.112519100939703,0.936901199162302,13,89,cellular response to carbohydrate stimulus,BP,ENDOG;PLA2G6;CYBA;MLXIPL;ZFP36L1;IRS2;ANO1;ERN1;PHPT1;GPR68;TH;PRKACA;GCLC
14662,GO:0070300,0.112598565001255,0.96610082427199,4,18,phosphatidic acid binding,MF,MICALL1;PLCD1;JPH2;PLTP
7533,GO:0031811,0.112656631266847,1,1,1,G-protein coupled nucleotide receptor binding,MF,DLG4
7534,GO:0031812,0.112656631266847,1,1,1,P2Y1 nucleotide receptor binding,MF,DLG4
12571,GO:0050767,0.112920431612749,0.911833593390702,63,500,regulation of neurogenesis,BP,SERPINE2;ULK2;APOE;PTPRS;CAPRIN2;DIXDC1;SFRP1;OBSL1;KCTD11;EPHB2;WNT3;TENM4;RGMA;CUL7;IMPACT;NOS1;NFATC4;PLXNB1;SPOCK1;MDM2;CRTC1;CSMD3;RTN4RL1;TRPV4;GLI2;GJC2;PER2;SEMA4G;GLI3;TRAK1;BAIAP2;PLXNB3;BMP6;PTK6;ETV5;SYNGAP1;KDM4C;TCF4;PLAG1;IDH2;TNFRSF21;CDK5R1;EFNB3;SHANK3;HMG20B;CDK5RAP3;LRP1;BRINP1;RET;ZMYND8;DAB2IP;CASZ1;DLG5;PLXND1;PMP22;DLG4;PTK7;SHANK2;ZSWIM8;SSH3;PPARG;UFL1;SMURF1
10146,GO:0042743,0.113011436616518,0.959367638757718,5,28,hydrogen peroxide metabolic process,BP,EGFR;GPX3;CYBA;DUOX1;PRDX5
11699,GO:0046513,0.113145523568205,0.950926659532008,7,40,ceramide biosynthetic process,BP,ST6GALNAC6;CERS4;B4GALT6;ST3GAL5;PLA2G6;ALOXE3;CERS5
3014,GO:0006560,0.113304138448782,0.984380500303197,2,6,proline metabolic process,BP,PRODH;ALDH4A1
11873,GO:0046906,0.113515080102064,0.94211085105797,10,63,tetrapyrrole binding,MF,NOS1;CYP26B1;CYP3A5;PTGS1;HEBP1;CYP2D7;CYBA;SLC48A1;DUOX1;MTR
12303,GO:0048670,0.113619714986742,0.973476267577172,3,12,regulation of collateral sprouting,BP,ULK2;PTPRS;WNT3
7930,GO:0032526,0.113647560342479,0.939861814259561,11,71,response to retinoic acid,BP,SREBF1;WNT3;CYP26B1;BMP6;PTK6;FZD7;BRINP1;RET;TEAD2;PTK7;PPARG
2221,GO:0005125,0.113748898866584,0.939521168246996,11,78,cytokine activity,MF,CXCL14;KITLG;THNSL2;TNFSF10;C5;BMP6;GDF15;CTF1;AREG;IL11;TNFSF12
16737,GO:0098542,0.113765739388928,0.919757515233321,32,264,defense response to other organism,BP,TNFAIP3;OAS2;DDX60;APOBEC3C;TRIM22;IFI44L;MAP3K14;HERC5;ISG15;HTRA1;STAT1;IFITM1;OAS1;LRSAM1;DHX58;IRF9;NLRX1;PLA2G6;CYBA;KLK5;ADARB1;MX2;NLRP1;ACP5;IFI16;BST2;FAM3A;STAT2;CCDC88B;RSAD2;TKFC;SERINC3
11899,GO:0046951,0.113977019944526,0.984231653383986,2,6,ketone body biosynthetic process,BP,HMGCL;BDH1
10587,GO:0043574,0.113999289509177,0.965525220283459,4,18,peroxisomal transport,BP,PEX10;PEX7;PEX1;LONP2
9527,GO:0036290,0.114015298282377,1,1,1,protein trans-autophosphorylation,BP,ERN1
19479,GO:1990332,0.114015298282377,1,1,1,Ire1 complex,CC,ERN1
19546,GO:1990579,0.114015298282377,1,1,1,peptidyl-serine trans-autophosphorylation,BP,ERN1
19559,GO:1990630,0.114015298282377,1,1,1,IRE1-RACK1-PP2A complex,CC,ERN1
18159,GO:1902950,0.114089154491917,0.984206793084126,2,6,regulation of dendritic spine maintenance,BP,APOE;ZMYND8
5861,GO:0017168,0.114127316188169,1,1,1,5-oxoprolinase (ATP-hydrolyzing) activity,MF,OPLAH
7155,GO:0031033,0.114202128140305,0.981958962471931,3,5,myosin filament organization,BP,OBSL1;MYH11;TTN
7437,GO:0031579,0.114230686217966,0.965178622747543,4,19,membrane raft organization,BP,MARVELD1;FLOT1;GSN;MALL
6066,GO:0019218,0.114321551076655,0.937469833502118,12,80,regulation of steroid metabolic process,BP,SREBF1;APOE;LMF1;SEC14L2;DGKQ;MVD;BMP6;ACACB;FGFR4;VDR;RORA;LDLRAP1
19574,GO:1990715,0.11439638343854,1,1,1,mRNA CDS binding,MF,UNK
14832,GO:0070615,0.114642923913353,1,1,1,nucleosome-dependent ATPase activity,MF,SMARCA1
16306,GO:0090537,0.114642923913353,1,1,1,CERF complex,CC,SMARCA1
7204,GO:0031104,0.114699876672985,1,1,1,dendrite regeneration,BP,MATN2
3602,GO:0008037,0.114943242061112,0.941288761493281,10,62,cell recognition,BP,EPHB2;NDN;ST6GALNAC6;CNTNAP3;DOCK8;CDK5R1;EFNB3;CADM4;TUB;GLIPR1L2
19262,GO:1905515,0.115073830822129,0.946558979262259,8,47,non-motile cilium assembly,BP,CEP126;BBS2;NPHP3;IFT140;BBS1;BBS10;TMEM80;CEP250
19724,GO:2000118,0.115150179645613,1,1,1,regulation of sodium-dependent phosphate transport,BP,CRY2
13541,GO:0060026,0.115199582826917,0.973412762100271,3,11,convergent extension,BP,SFRP1;NPHP3;PTK7
19735,GO:2000146,0.115321369188628,0.923358560293944,24,175,negative regulation of cell motility,BP,TP53INP1;APOE;SFRP1;IFITM1;ARPIN;C5;MAP2K5;SRGAP3;NISCH;MMP28;DDT;PLXNB3;MMRN2;IDH2;MCTP1;ADARB1;LRP1;ZMYND8;DAB2IP;DLG5;BST2;ALOX15B;PBLD;PPARG
13523,GO:0060005,0.115477327237296,1,1,1,vestibular reflex,BP,SLITRK6
13524,GO:0060007,0.115477327237296,1,1,1,linear vestibuloocular reflex,BP,SLITRK6
6076,GO:0019233,0.115558838166208,0.949614950526634,7,40,sensory perception of pain,BP,NDN;F2R;NLGN2;ITGA2;NMU;ALOXE3;ANO1
17070,GO:0099625,0.115627838579096,0.973269722433864,3,11,ventricular cardiac muscle cell membrane repolarization,BP,SNTA1;KCNJ5;SCN4B
1660,GO:0004118,0.115703726372199,1,1,1,cGMP-stimulated cyclic-nucleotide phosphodiesterase activity,MF,PDE2A
16269,GO:0090385,0.115922869303272,0.98379802250502,2,6,phagosome-lysosome fusion,BP,SPG11;SYT7
13471,GO:0055038,0.116011583444384,0.940527646967627,10,64,recycling endosome membrane,CC,VAMP3;NSG1;MICALL1;NDRG1;HLA-B;RAB11FIP4;FZD7;WASH3P;RAB11FIP3;HLA-A
4908,GO:0014846,0.116017540822096,1,1,1,esophagus smooth muscle contraction,BP,SULF2
2414,GO:0005589,0.116103280358919,1,1,1,collagen type VI trimer,CC,COL6A1
16783,GO:0098647,0.116103280358919,1,1,1,collagen beaded filament,CC,COL6A1
17726,GO:1901685,0.116198055915649,0.971347831632538,3,16,glutathione derivative metabolic process,BP,GSTM2;MGST2;GSTM3
17727,GO:1901687,0.116198055915649,0.971347831632538,3,16,glutathione derivative biosynthetic process,BP,GSTM2;MGST2;GSTM3
2603,GO:0005902,0.116416161328567,0.945790992230869,8,47,microvillus,CC,ESPN;SYTL1;RAPGEF3;CTSV;BBS2;PODXL;CA2;NFASC
9261,GO:0035695,0.116492473017504,1,1,1,mitophagy by induced vacuole formation,BP,SPATA18
12079,GO:0048075,0.116521326107883,1,1,1,positive regulation of eye pigmentation,BP,HPS4
18196,GO:1903010,0.116588435562802,0.972947936439589,3,11,regulation of bone development,BP,GLI3;FBXW7;GPR68
5474,GO:0016409,0.116804047605721,0.952954918081556,6,33,palmitoyltransferase activity,MF,CPT2;ZDHHC1;ZDHHC12;GOLGA7B;CPT1C;ZDHHC24
12825,GO:0051155,0.116890647824434,0.952910382880089,6,33,positive regulation of striated muscle cell differentiation,BP,CYP26B1;FLOT1;GDF15;THRA;MAMSTR;AKAP6
1752,GO:0004356,0.116896076142575,1,1,1,glutamate-ammonia ligase activity,MF,GLUL
2996,GO:0006542,0.116896076142575,1,1,1,glutamine biosynthetic process,BP,GLUL
5384,GO:0016211,0.116896076142575,1,1,1,ammonia ligase activity,MF,GLUL
6195,GO:0019676,0.116896076142575,1,1,1,ammonia assimilation cycle,BP,GLUL
9665,GO:0038039,0.116909435528182,1,1,1,G-protein coupled receptor heterodimeric complex,CC,GABBR1
4685,GO:0010837,0.117153005173916,0.958072770199649,5,24,regulation of keratinocyte proliferation,BP,CTSV;CD109;VDR;ZFP36L1;KLF9
8618,GO:0034146,0.117323997434221,1,1,1,toll-like receptor 5 signaling pathway,BP,TNFAIP3
8619,GO:0034147,0.117323997434221,1,1,1,regulation of toll-like receptor 5 signaling pathway,BP,TNFAIP3
8620,GO:0034148,0.117323997434221,1,1,1,negative regulation of toll-like receptor 5 signaling pathway,BP,TNFAIP3
14729,GO:0070425,0.117323997434221,1,1,1,negative regulation of nucleotide-binding oligomerization domain containing signaling pathway,BP,TNFAIP3
14732,GO:0070428,0.117323997434221,1,1,1,regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway,BP,TNFAIP3
14733,GO:0070429,0.117323997434221,1,1,1,negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway,BP,TNFAIP3
14736,GO:0070433,0.117323997434221,1,1,1,negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway,BP,TNFAIP3
15833,GO:0072573,0.117323997434221,1,1,1,tolerance induction to lipopolysaccharide,BP,TNFAIP3
16220,GO:0090291,0.117323997434221,1,1,1,negative regulation of osteoclast proliferation,BP,TNFAIP3
19849,GO:2000349,0.117323997434221,1,1,1,negative regulation of CD40 signaling pathway,BP,TNFAIP3
8472,GO:0033630,0.117446987367455,0.97217641962765,3,12,positive regulation of cell adhesion mediated by integrin,BP,FERMT1;PODXL;RET
3030,GO:0006577,0.117495681312261,0.972159747321035,3,12,amino-acid betaine metabolic process,BP,CRAT;ALDH7A1;CPT1C
10834,GO:0044343,0.117520273038618,1,1,1,canonical Wnt signaling pathway involved in regulation of type B pancreatic cell proliferation,BP,SFRP1
10836,GO:0044345,0.117520273038618,1,1,1,stromal-epithelial cell signaling involved in prostate gland development,BP,SFRP1
16190,GO:0090246,0.117520273038618,1,1,1,convergent extension involved in somitogenesis,BP,SFRP1
19682,GO:2000040,0.117520273038618,1,1,1,regulation of planar cell polarity pathway involved in axis elongation,BP,SFRP1
19683,GO:2000041,0.117520273038618,1,1,1,negative regulation of planar cell polarity pathway involved in axis elongation,BP,SFRP1
19693,GO:2000054,0.117520273038618,1,1,1,negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification,BP,SFRP1
19705,GO:2000079,0.117520273038618,1,1,1,regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation,BP,SFRP1
19706,GO:2000080,0.117520273038618,1,1,1,negative regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation,BP,SFRP1
11317,GO:0045657,0.117525417744975,0.983437341042206,2,6,positive regulation of monocyte differentiation,BP,ZFP36L1;CTNNBIP1
10800,GO:0044301,0.117637538117448,1,1,1,climbing fiber,CC,DAB2IP
19408,GO:1990032,0.117637538117448,1,1,1,parallel fiber,CC,DAB2IP
16536,GO:0097338,0.117640354245485,1,1,1,response to clozapine,BP,PRKACB
15661,GO:0072207,0.117812508435161,0.964239629229905,4,17,metanephric epithelium development,BP,PKD2;STAT1;WWTR1;LAMB2
5349,GO:0016103,0.117874841438703,1,1,1,diterpenoid catabolic process,BP,CYP26B1
5351,GO:0016115,0.117874841438703,1,1,1,terpenoid catabolic process,BP,CYP26B1
8846,GO:0034653,0.117874841438703,1,1,1,retinoic acid catabolic process,BP,CYP26B1
16106,GO:0090119,0.117895890572189,1,1,1,vesicle-mediated cholesterol transport,BP,SYT7
19645,GO:1990926,0.117895890572189,1,1,1,short-term synaptic potentiation,BP,SYT7
8938,GO:0034992,0.118006571163907,0.984543616459526,2,5,microtubule organizing center attachment site,CC,SUN1;SYNE2
8939,GO:0034993,0.118006571163907,0.984543616459526,2,5,meiotic nuclear membrane microtubule tethering complex,CC,SUN1;SYNE2
16215,GO:0090286,0.118006571163907,0.984543616459526,2,5,cytoskeletal anchoring at nuclear membrane,BP,SUN1;SYNE2
17198,GO:0106083,0.118006571163907,0.984543616459526,2,5,nuclear membrane protein complex,CC,SUN1;SYNE2
17201,GO:0106094,0.118006571163907,0.984543616459526,2,5,nuclear membrane microtubule tethering complex,CC,SUN1;SYNE2
16463,GO:0097168,0.118143479983284,1,1,1,mesenchymal stem cell proliferation,BP,LTBP3
17978,GO:1902460,0.118143479983284,1,1,1,regulation of mesenchymal stem cell proliferation,BP,LTBP3
17979,GO:1902462,0.118143479983284,1,1,1,positive regulation of mesenchymal stem cell proliferation,BP,LTBP3
9773,GO:0039706,0.118152698865492,0.983295288048399,2,6,co-receptor binding,MF,NEO1;HFE
20050,GO:2000721,0.118182132667687,1,1,1,positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation,BP,NPNT
3762,GO:0008308,0.118227184710172,0.971908883124949,3,12,voltage-gated anion channel activity,MF,CLCN6;ANO1;CLCN7
7843,GO:0032411,0.118241473900941,0.94177048033685,9,55,positive regulation of transporter activity,BP,HSPA2;PKD2;EPHB2;ANK3;GSTM2;SHANK3;WNK1;JPH2;AKAP6
1987,GO:0004709,0.118321621410222,0.942003775572859,9,51,MAP kinase kinase kinase activity,MF,EGFR;EPHB2;MAP3K14;INSR;MAP3K12;MAP3K6;RET;FGFR4;ERBB2
4647,GO:0010792,0.118373008836508,0.983245280713263,2,6,DNA double-strand break processing involved in repair via single-strand annealing,BP,SLX1A;SLX1B
16432,GO:0097116,0.118430467530497,1,1,1,gephyrin clustering involved in postsynaptic density assembly,BP,NLGN2
9067,GO:0035329,0.118527214180457,0.94831260449017,7,37,hippo signaling,BP,MAP3K14;WWTR1;NEK8;NPHP4;TEAD2;DLG5;WWC3
3831,GO:0008434,0.118734742657224,1,1,1,calcitriol receptor activity,MF,VDR
9719,GO:0038181,0.118734742657224,1,1,1,bile acid receptor activity,MF,VDR
9720,GO:0038183,0.118734742657224,1,1,1,bile acid signaling pathway,BP,VDR
9721,GO:0038186,0.118734742657224,1,1,1,lithocholic acid receptor activity,MF,VDR
17843,GO:1902098,0.118734742657224,1,1,1,calcitriol binding,MF,VDR
17858,GO:1902121,0.118734742657224,1,1,1,lithocholic acid binding,MF,VDR
17918,GO:1902271,0.118734742657224,1,1,1,D3 vitamins binding,MF,VDR
17237,GO:0120043,0.118846471945522,1,1,1,stereocilium shaft,CC,TRIOBP
17238,GO:0120044,0.118846471945522,1,1,1,stereocilium base,CC,TRIOBP
3469,GO:0007290,0.118949006160745,1,1,1,spermatid nucleus elongation,BP,KDM3A
11594,GO:0046293,0.118949006160745,1,1,1,formaldehyde biosynthetic process,BP,KDM3A
13225,GO:0051920,0.118962363503154,0.981660354895602,2,8,peroxiredoxin activity,MF,SESN1;PRDX5
508,GO:0001572,0.11908913521589,1,1,1,lactosylceramide biosynthetic process,BP,B4GALT6
11677,GO:0046478,0.11908913521589,1,1,1,lactosylceramide metabolic process,BP,B4GALT6
4829,GO:0014037,0.119142895449849,0.952167677336103,6,30,Schwann cell differentiation,BP,POU3F1;NDRG1;AHNAK2;NAB2;PRX;LAMB2
17040,GO:0099545,0.119274842623301,1,1,1,trans-synaptic signaling by trans-synaptic complex,BP,EPHB2
17047,GO:0099557,0.119274842623301,1,1,1,trans-synaptic signaling by trans-synaptic complex, modulating synaptic transmission,BP,EPHB2
17179,GO:0106028,0.119274842623301,1,1,1,neuron projection retraction,BP,EPHB2
17472,GO:1900450,0.119274842623301,1,1,1,negative regulation of glutamate receptor signaling pathway,BP,EPHB2
18966,GO:1904782,0.119274842623301,1,1,1,negative regulation of NMDA glutamate receptor activity,BP,EPHB2
3522,GO:0007497,0.119339932611958,1,1,1,posterior midgut development,BP,RET
6375,GO:0021566,0.119457685416016,1,1,1,hypoglossal nerve development,BP,ADARB1
6397,GO:0021618,0.119457685416016,1,1,1,hypoglossal nerve morphogenesis,BP,ADARB1
6670,GO:0030037,0.119531227480855,1,1,1,actin filament reorganization involved in cell cycle,BP,ARAP1
4835,GO:0014044,0.119550733215992,0.957154545043895,5,23,Schwann cell development,BP,POU3F1;NDRG1;AHNAK2;PRX;LAMB2
2184,GO:0005042,0.119611361442136,1,1,1,netrin receptor activity,MF,UNC5B
5586,GO:0016614,0.119677961517383,0.93201733910607,13,94,oxidoreductase activity, acting on CH-OH group of donors,MF,H6PD;KCNAB2;KDSR;D2HGDH;AKR7A2;IDH2;HADH;BDH1;HSD17B14;DHRS4;CBR4;RDH12;EHHADH
11539,GO:0046092,0.119700864457474,1,1,1,deoxycytidine metabolic process,BP,TK2
1292,GO:0003127,0.119725630026539,1,1,1,detection of nodal flow,BP,PKD2
12357,GO:0048763,0.119725630026539,1,1,1,calcium-induced calcium release activity,MF,PKD2
15260,GO:0071464,0.119725630026539,1,1,1,cellular response to hydrostatic pressure,BP,PKD2
15564,GO:0072055,0.119725630026539,1,1,1,renal cortex development,BP,PKD2
15565,GO:0072059,0.119725630026539,1,1,1,cortical collecting duct development,BP,PKD2
15651,GO:0072194,0.119725630026539,1,1,1,kidney smooth muscle tissue development,BP,PKD2
15662,GO:0072208,0.119725630026539,1,1,1,metanephric smooth muscle tissue development,BP,PKD2
15666,GO:0072214,0.119725630026539,1,1,1,metanephric cortex development,BP,PKD2
15671,GO:0072219,0.119725630026539,1,1,1,metanephric cortical collecting duct development,BP,PKD2
7147,GO:0031014,0.119755879997432,0.996185630236353,1,2,troponin T binding,MF,TNNI2
13204,GO:0051886,0.119892417943912,1,1,1,negative regulation of timing of anagen,BP,FERMT1
20229,GO:2001203,0.119892417943912,1,1,1,positive regulation of transforming growth factor-beta secretion,BP,FERMT1
3092,GO:0006666,0.1199550494837,1,1,1,3-keto-sphinganine metabolic process,BP,KDSR
11999,GO:0047560,0.1199550494837,1,1,1,3-dehydrosphinganine reductase activity,MF,KDSR
15210,GO:0071387,0.119956464387956,1,1,1,cellular response to cortisol stimulus,BP,KLF9
4953,GO:0015019,0.119988068371893,1,1,1,heparan-alpha-glucosaminide N-acetyltransferase activity,MF,HGSNAT
19809,GO:2000297,0.120082201752993,1,1,1,negative regulation of synapse maturation,BP,NFATC4
9126,GO:0035469,0.120169504765434,1,1,1,determination of pancreatic left/right asymmetry,BP,NPHP3
15503,GO:0071908,0.120169504765434,1,1,1,determination of intestine left/right asymmetry,BP,NPHP3
15504,GO:0071909,0.120169504765434,1,1,1,determination of stomach left/right asymmetry,BP,NPHP3
19741,GO:2000167,0.120169504765434,1,1,1,regulation of planar cell polarity pathway involved in neural tube closure,BP,NPHP3
8239,GO:0033026,0.120171701316841,1,1,1,negative regulation of mast cell apoptotic process,BP,KITLG
18968,GO:1904784,0.120247175501084,1,1,1,NLRP1 inflammasome complex assembly,BP,NLRP1
2407,GO:0005579,0.120252030232082,1,1,1,membrane attack complex,CC,C5
15897,GO:0072702,0.120333549354172,1,1,1,response to methyl methanesulfonate,BP,TP53INP1
15898,GO:0072703,0.120333549354172,1,1,1,cellular response to methyl methanesulfonate,BP,TP53INP1
14408,GO:0061736,0.120376544480117,1,1,1,engulfment of target by autophagosome,BP,SMURF1
14419,GO:0061753,0.120376544480117,1,1,1,substrate localization to autophagosome,BP,SMURF1
19438,GO:1990138,0.120401284608424,0.926248244897501,17,112,neuron projection extension,BP,POSTN;ULK2;APOE;PTPRS;WNT3;IMPACT;PLXNB1;NDN;FLRT3;SPG11;SEMA4G;ULK1;PLXNB3;CDK5R1;SLIT3;LAMB2;SMURF1
8860,GO:0034676,0.120405255527281,1,1,1,integrin alpha6-beta4 complex,CC,ITGA6
13877,GO:0060542,0.120410377649595,1,1,1,regulation of strand invasion,BP,WRN
14686,GO:0070337,0.120410377649595,1,1,1,3'-flap-structured DNA binding,MF,WRN
16730,GO:0098530,0.120410377649595,1,1,1,positive regulation of strand invasion,BP,WRN
19545,GO:1990578,0.120429543743868,1,1,1,perinuclear endoplasmic reticulum membrane,CC,PIK3R1
15847,GO:0072590,0.120441829534691,1,1,1,N-acetyl-L-aspartate-L-glutamate ligase activity,MF,RIMKLB
15848,GO:0072591,0.120441829534691,1,1,1,citrate-L-glutamate ligase activity,MF,RIMKLB
12308,GO:0048677,0.120442955552487,1,1,1,axon extension involved in regeneration,BP,LAMB2
15683,GO:0072244,0.120442955552487,1,1,1,metanephric glomerular epithelium development,BP,LAMB2
15684,GO:0072248,0.120442955552487,1,1,1,metanephric glomerular visceral epithelial cell differentiation,BP,LAMB2
15685,GO:0072249,0.120442955552487,1,1,1,metanephric glomerular visceral epithelial cell development,BP,LAMB2
15696,GO:0072274,0.120442955552487,1,1,1,metanephric glomerular basement membrane development,BP,LAMB2
15717,GO:0072312,0.120442955552487,1,1,1,metanephric glomerular epithelial cell differentiation,BP,LAMB2
15718,GO:0072313,0.120442955552487,1,1,1,metanephric glomerular epithelial cell development,BP,LAMB2
7026,GO:0030807,0.120543594205024,1,1,1,positive regulation of cyclic nucleotide catabolic process,BP,RAPGEF3
7041,GO:0030822,0.120543594205024,1,1,1,positive regulation of cAMP catabolic process,BP,RAPGEF3
8284,GO:0033123,0.120543594205024,1,1,1,positive regulation of purine nucleotide catabolic process,BP,RAPGEF3
1632,GO:0004077,0.120551784709869,1,1,1,biotin-[acetyl-CoA-carboxylase] ligase activity,MF,HLCS
1633,GO:0004078,0.120551784709869,1,1,1,biotin-[methylcrotonoyl-CoA-carboxylase] ligase activity,MF,HLCS
1634,GO:0004079,0.120551784709869,1,1,1,biotin-[methylmalonyl-CoA-carboxytransferase] ligase activity,MF,HLCS
1635,GO:0004080,0.120551784709869,1,1,1,biotin-[propionyl-CoA-carboxylase (ATP-hydrolyzing)] ligase activity,MF,HLCS
4196,GO:0009305,0.120551784709869,1,1,1,protein biotinylation,BP,HLCS
5940,GO:0018271,0.120551784709869,1,1,1,biotin-protein ligase activity,MF,HLCS
14907,GO:0070781,0.120551784709869,1,1,1,response to biotin,BP,HLCS
15076,GO:0071110,0.120551784709869,1,1,1,histone biotinylation,BP,HLCS
16762,GO:0098597,0.120609023433427,0.983990838812101,2,5,observational learning,BP,SHANK3;FOXP2
13580,GO:0060072,0.120727210574791,1,1,1,large conductance calcium-activated potassium channel activity,MF,KCNMA1
13233,GO:0051933,0.120791002385825,1,1,1,amino acid neurotransmitter reuptake,BP,PER2
13235,GO:0051935,0.120791002385825,1,1,1,glutamate reuptake,BP,PER2
13239,GO:0051941,0.120791002385825,1,1,1,regulation of amino acid uptake involved in synaptic transmission,BP,PER2
13242,GO:0051946,0.120791002385825,1,1,1,regulation of glutamate uptake involved in transmission of nerve impulse,BP,PER2
12369,GO:0048799,0.120981616810993,0.97145977238338,3,11,animal organ maturation,BP,PLXNB1;THBS3;RET
15968,GO:0085029,0.121006223495715,0.956251512802895,5,24,extracellular matrix assembly,BP,MYH11;TNXB;LOXL1;THSD4;EFEMP2
8627,GO:0034164,0.121029632246613,1,1,1,negative regulation of toll-like receptor 9 signaling pathway,BP,PTPRS
16932,GO:0098948,0.121029632246613,1,1,1,intrinsic component of postsynaptic specialization membrane,CC,PTPRS
16966,GO:0099060,0.121029632246613,1,1,1,integral component of postsynaptic specialization membrane,CC,PTPRS
16967,GO:0099061,0.121029632246613,1,1,1,integral component of postsynaptic density membrane,CC,PTPRS
16995,GO:0099146,0.121029632246613,1,1,1,intrinsic component of postsynaptic density membrane,CC,PTPRS
5966,GO:0018400,0.121030504563687,1,1,1,peptidyl-proline hydroxylation to 3-hydroxy-L-proline,BP,CRTAP
6331,GO:0021508,0.121141579754972,1,1,1,floor plate formation,BP,GLI2
8415,GO:0033505,0.121141579754972,1,1,1,floor plate morphogenesis,BP,GLI2
13546,GO:0060032,0.121141579754972,1,1,1,notochord regression,BP,GLI2
5825,GO:0017108,0.121185114045313,0.982601669487505,2,6,5'-flap endonuclease activity,MF,SLX1A;SLX1B
2249,GO:0005164,0.121228143299646,0.961999237864291,4,20,tumor necrosis factor receptor binding,MF,STAT1;TNFSF10;TNFSF12;TRAF5
13832,GO:0060457,0.1212343440645,0.982590314684749,2,6,negative regulation of digestive system process,BP,NMU;WNK1
18047,GO:1902630,0.121333365541538,1,1,1,regulation of membrane hyperpolarization,BP,CRTC1
18048,GO:1902631,0.121333365541538,1,1,1,negative regulation of membrane hyperpolarization,BP,CRTC1
7036,GO:0030817,0.121392166372605,0.962169723787344,4,19,regulation of cAMP biosynthetic process,BP,PTHLH;GABBR1;GPR87;LTB4R2
8952,GO:0035032,0.121397477385755,0.982552666845588,2,6,phosphatidylinositol 3-kinase complex, class III,CC,PIK3C3;ATG14
5359,GO:0016137,0.121462489338487,0.970371964059348,3,13,glycoside metabolic process,BP,AKR7A2;CBR4;TH
16921,GO:0098923,0.121511443434979,1,1,1,retrograde trans-synaptic signaling by soluble gas,BP,NOS1
16922,GO:0098924,0.121511443434979,1,1,1,retrograde trans-synaptic signaling by nitric oxide,BP,NOS1
16997,GO:0099163,0.121511443434979,1,1,1,synaptic signaling by nitric oxide,BP,NOS1
17039,GO:0099543,0.121511443434979,1,1,1,trans-synaptic signaling by soluble gas,BP,NOS1
17042,GO:0099548,0.121511443434979,1,1,1,trans-synaptic signaling by nitric oxide,BP,NOS1
17298,GO:0140196,0.121511443434979,1,1,1,positive regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process,BP,NOS1
1832,GO:0004489,0.121518863603479,1,1,1,methylenetetrahydrofolate reductase (NAD(P)H) activity,MF,MTHFR
8365,GO:0033274,0.121518863603479,1,1,1,response to vitamin B2,BP,MTHFR
16433,GO:0097117,0.121525238268982,1,1,1,guanylate kinase-associated protein clustering,BP,SHANK3
1153,GO:0002761,0.121656417120905,0.934833720845985,11,70,regulation of myeloid leukocyte differentiation,BP,INPP5D;SFRP1;PIK3R1;ZFPM1;KITLG;FAM213A;CA2;FBXW7;ZFP36L1;GPR68;CTNNBIP1
5549,GO:0016558,0.121705258185672,0.970705752473663,3,12,protein import into peroxisome matrix,BP,PEX10;PEX7;PEX1
14380,GO:0061663,0.121752222010552,1,1,1,NEDD8 ligase activity,MF,MDM2
15150,GO:0071301,0.121752222010552,1,1,1,cellular response to vitamin B1,BP,MDM2
18803,GO:1904404,0.121752222010552,1,1,1,response to formaldehyde,BP,MDM2
3613,GO:0008057,0.121845788146586,1,1,1,eye pigment granule organization,BP,SHROOM2
14301,GO:0061485,0.121898819824858,1,1,1,memory T cell proliferation,BP,DOCK8
11127,GO:0045186,0.121909516132263,1,1,1,zonula adherens assembly,BP,DLG5
12728,GO:0051016,0.122025004653791,0.970594291329005,3,12,barbed-end actin filament capping,BP,GSN;TRIOBP;CAPG
10010,GO:0042461,0.122078089813487,0.962150276233312,4,18,photoreceptor cell development,BP,NAGLU;IFT140;NPHP4;TH
16272,GO:0090389,0.122089085137606,1,1,1,phagosome-lysosome fusion involved in apoptotic cell clearance,BP,SPG11
16056,GO:0090037,0.122215159743424,0.982363465591169,2,6,positive regulation of protein kinase C signaling,BP,MC1R;PLA2G6
8392,GO:0033343,0.12240042180318,1,1,1,positive regulation of collagen binding,BP,ITGA2
5268,GO:0015918,0.122402109380532,0.939205126204049,9,56,sterol transport,BP,APOE;LRP1;SYT7;OSBPL5;OSBPL1A;ABCA2;PPARG;LDLRAP1;PLTP
11864,GO:0046888,0.122477276474743,0.950015801219291,6,33,negative regulation of hormone secretion,BP,SREBF1;SFRP1;CRY1;HADH;RAB11FIP3;IL11
18338,GO:1903349,0.122543006212423,0.982287373582319,2,6,omegasome membrane,CC,ULK1;ATG14
13525,GO:0060008,0.12268780523755,0.970362787506328,3,12,Sertoli cell differentiation,BP,CTSV;CST3;ATRX
12577,GO:0050773,0.122720443492777,0.927183857434581,15,99,regulation of dendrite development,BP,APOE;PTPRS;CAPRIN2;OBSL1;CUL7;NFATC4;CRTC1;CSMD3;BAIAP2;CDK5R1;SHANK3;ZMYND8;DAB2IP;DLG5;SHANK2
6560,GO:0022012,0.122859038871211,1,1,1,subpallium cell proliferation in forebrain,BP,GLI3
6561,GO:0022018,0.122859038871211,1,1,1,lateral ganglionic eminence cell proliferation,BP,GLI3
13758,GO:0060366,0.122859038871211,1,1,1,lambdoid suture morphogenesis,BP,GLI3
13759,GO:0060367,0.122859038871211,1,1,1,sagittal suture morphogenesis,BP,GLI3
14053,GO:0060873,0.122859038871211,1,1,1,anterior semicircular canal development,BP,GLI3
14054,GO:0060875,0.122859038871211,1,1,1,lateral semicircular canal development,BP,GLI3
378,GO:0001011,0.123034673462693,1,1,1,transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting,MF,TCF4
405,GO:0001087,0.123034673462693,1,1,1,transcription factor activity, TFIIB-class binding,MF,TCF4
15469,GO:0071855,0.123081404650725,0.981277180033747,2,7,neuropeptide receptor binding,MF,NMU;UCN2
9068,GO:0035330,0.123164750962159,0.970710236263849,3,11,regulation of hippo signaling,BP,NEK8;DLG5;WWC3
16510,GO:0097264,0.123292778573283,0.982112854272344,2,6,self proteolysis,BP,TENM4;CAPN7
6118,GO:0019369,0.123441424791712,0.954705283476218,5,26,arachidonic acid metabolic process,BP,PTGS1;CYP2D7;ALOXE3;ALOX15B;FAAH
18394,GO:1903450,0.12349070274135,1,1,1,regulation of G1 to G0 transition,BP,RAB11FIP4
18395,GO:1903452,0.12349070274135,1,1,1,positive regulation of G1 to G0 transition,BP,RAB11FIP4
1259,GO:0003015,0.12356245246571,0.921746707461453,19,128,heart process,BP,SREBF1;NOS1;GAA;ITPR3;MDM2;RGS2;SNTA1;GSTM2;NMU;KCNJ5;TTN;SCN4B;VEGFB;THRA;CACNB3;TNNI2;CACNB1;TH;PRKACA
15664,GO:0072210,0.123594285840999,0.954815463679253,5,25,metanephric nephron development,BP,PKD2;KIF26B;STAT1;RET;LAMB2
2482,GO:0005721,0.123869677028794,0.961389269998076,4,18,pericentric heterochromatin,CC,KDM4C;CENPC;ATRX;KMT5C
4366,GO:0009986,0.124101199177668,0.906414778814579,46,367,cell surface,CC,ITGB6;SERPINE2;NT5E;HSPA2;EGFR;SLITRK6;SFRP1;TNS1;ADAMTS7;SULF2;CSPG4;VAMP3;ITGB5;GJD3;SDC3;BCAM;HLA-B;CTSV;NLGN4Y;F2R;RTN4RL1;TRPV4;NLGN2;ANK3;ADAMTS13;ITGA2;ITGA6;KCNJ5;BSN;INSR;PLXNB3;CD109;TMEM8B;HFE;SCART1;ERMAP;HLA-A;AREG;BST2;PCSK6;ACVR1B;MXRA8;CLSTN3;SRPX2;CD9;ACKR3
2172,GO:0005009,0.124200879047034,1,1,1,insulin-activated receptor activity,MF,INSR
1742,GO:0004344,0.124298949435476,1,1,1,glucose dehydrogenase activity,MF,H6PD
12035,GO:0047936,0.124298949435476,1,1,1,glucose 1-dehydrogenase [NAD(P)] activity,MF,H6PD
6078,GO:0019237,0.124316690389446,0.981873403150158,2,6,centromeric DNA binding,MF,MLH3;CENPC
2415,GO:0005590,0.124604386631392,1,1,1,collagen type VII trimer,CC,COL7A1
16784,GO:0098648,0.124604386631392,1,1,1,collagen anchoring fibril,CC,COL7A1
16786,GO:0098652,0.124604386631392,1,1,1,collagen type VII anchoring fibril,CC,COL7A1
6424,GO:0021695,0.124645863744334,0.949017498453502,6,32,cerebellar cortex development,BP,SERPINE2;NAGLU;GLI2;MDK;B4GALT2;RORA
12053,GO:0048018,0.124646972973805,0.91861787430088,21,167,receptor ligand activity,MF,GPNMB;PTHLH;CXCL14;WNT3;KITLG;THNSL2;TNFSF10;FLRT3;C5;SEMA4G;MDK;BMP6;VEGFB;GDF15;CTF1;NUDT6;AREG;UCN2;ENDOU;IL11;TNFSF12
3076,GO:0006644,0.124691356107966,0.906869539344783,43,342,phospholipid metabolic process,BP,INPP5D;EGFR;DGKQ;PIK3R1;VAV3;PI4KAP2;KITLG;MVD;SRD5A3;PITPNM3;PIK3C2G;PLCD1;PIK3IP1;PLCH2;PITPNM2;MBOAT2;SLC27A1;PGAP1;ETNK2;HEXB;PLA2G6;LPIN3;PIGZ;OSBPL10;PI4KAP1;PLA2G7;DAB2IP;DDHD2;PIK3C3;FGFR4;PIK3R2;OSBPL5;MPPE1;IRS2;IMPA2;ISYNA1;SMPDL3B;ERBB2;ATG14;IP6K2;PI4K2B;PEMT;SERINC3
3090,GO:0006664,0.124731041772453,0.927045413172872,14,100,glycolipid metabolic process,BP,ST6GALNAC6;GAL3ST4;B4GALT6;ARSI;HEXA;ARSD;ST3GAL5;PGAP1;HEXB;PIGZ;MPPE1;KDELC2;ESYT2;GLB1
18407,GO:1903509,0.124731041772453,0.927045413172872,14,100,liposaccharide metabolic process,BP,ST6GALNAC6;GAL3ST4;B4GALT6;ARSI;HEXA;ARSD;ST3GAL5;PGAP1;HEXB;PIGZ;MPPE1;KDELC2;ESYT2;GLB1
7048,GO:0030834,0.124911485081836,0.9488783754897,6,32,regulation of actin filament depolymerization,BP,SPTB;GSN;PLEKHH2;TRIOBP;CAPG;DMTN
6836,GO:0030308,0.124916547122529,0.922815236652726,17,122,negative regulation of cell growth,BP,SERPINE2;ULK2;PTPRS;CAPRIN2;SFRP1;WNT3;SEMA4G;CCDC85B;HYAL1;CDK5R1;SLIT3;BTG1;BST2;ACVR1B;APBB2;PPARG;IP6K2
6831,GO:0030301,0.124946289096555,0.940694684914911,8,49,cholesterol transport,BP,APOE;LRP1;SYT7;OSBPL5;ABCA2;PPARG;LDLRAP1;PLTP
678,GO:0001889,0.124986102534377,0.925501186572921,15,103,liver development,BP,TNFAIP3;EGFR;PKD2;SRSF5;SULF2;HMGCL;PHF2;ITGA2;GLI3;JARID2;NPHP3;HFE;FBXW7;DBP;PTPN3
20145,GO:2000983,0.125840752786863,0.995773995774992,1,2,regulation of ATP citrate synthase activity,BP,PHPT1
20146,GO:2000984,0.125840752786863,0.995773995774992,1,2,negative regulation of ATP citrate synthase activity,BP,PHPT1
4566,GO:0010650,0.125907259643725,1,1,1,positive regulation of cell communication by electrical coupling,BP,ANK3
15870,GO:0072658,0.125907259643725,1,1,1,maintenance of protein location in membrane,BP,ANK3
15872,GO:0072660,0.125907259643725,1,1,1,maintenance of protein location in plasma membrane,BP,ANK3
17499,GO:1900827,0.125907259643725,1,1,1,positive regulation of membrane depolarization during cardiac muscle cell action potential,BP,ANK3
10129,GO:0042711,0.126040762030623,0.981467290311984,2,6,maternal behavior,BP,CREBRF;BRINP1
17692,GO:1901626,0.126152489516996,0.98144084602224,2,6,regulation of postsynaptic membrane organization,BP,APOE;ZMYND8
19344,GO:1905794,0.126241545175102,1,1,1,response to puromycin,BP,XRN1
19345,GO:1905795,0.126241545175102,1,1,1,cellular response to puromycin,BP,XRN1
5713,GO:0016853,0.126423158266838,0.922840994174324,16,122,isomerase activity,MF,AMACR;FKBP5;FKBP9;DDT;NKTR;PGM1;SRR;TMX4;ALOXE3;MPI;GALE;TOP3B;ECI1;ISYNA1;PBLD;EHHADH
10365,GO:0043200,0.12643846799532,0.929570903840461,12,80,response to amino acid,BP,EGFR;MTHFR;NAIP;SESN3;BAIAP2;COL6A1;SESN1;CYBA;PIK3C3;UFL1;PEMT;GCLC
9950,GO:0042339,0.126498759085316,0.953224243208256,5,26,keratan sulfate metabolic process,BP,B4GALT6;HEXA;B4GALT2;HEXB;GLB1
1991,GO:0004714,0.126516204153201,0.943785744331132,7,38,transmembrane receptor protein tyrosine kinase activity,MF,EGFR;EPHB2;INSR;EFNB3;RET;FGFR4;ERBB2
19264,GO:1905517,0.126718336026007,0.959404137521149,4,21,macrophage migration,BP,TRPV4;C5;MMP28;DDT
3955,GO:0008705,0.127299953340196,1,1,1,methionine synthase activity,MF,MTR
9830,GO:0042084,0.127299953340196,1,1,1,5-methyltetrahydrofolate-dependent methyltransferase activity,MF,MTR
3392,GO:0007171,0.127512525606142,0.981117713487907,2,6,activation of transmembrane receptor protein tyrosine kinase activity,BP,DGKQ;PILRB
4495,GO:0010523,0.1277168726492,0.96813905523025,3,13,negative regulation of calcium ion transport into cytosol,BP,PKD2;NOS1;GSTM2
2993,GO:0006538,0.128199620895307,0.980953601135902,2,6,glutamate catabolic process,BP,GLUD1;GLUL
6705,GO:0030121,0.128230116428849,0.980946303854523,2,6,AP-1 adaptor complex,CC,AP1G2;LDLRAP1
3464,GO:0007283,0.128287410296709,0.907038317172528,35,277,spermatogenesis,BP,GAMT;HSPA2;TXNRD3;KDM3A;ZFP41;SCMH1;CRTAP;CYP26B1;CTSV;SPATA20;RGS2;DNAH1;MICALCL;TPGS1;TCFL5;HSF2BP;SUN1;SEPT6;CABYR;ETV5;BBS2;ATRX;REC8;CCDC136;RFX2;TMEM203;BTG1;DPY19L2P2;SIX5;TSSK1B;PHC2;PRKACA;NPAP1;HERPUD2;TTLL1
2029,GO:0004771,0.128458242025497,0.980891679424121,2,6,sterol esterase activity,MF,CES2;CES3
16308,GO:0090543,0.128478841075684,0.952258231780918,5,26,Flemming body,CC,OR2A4;CNTRL;CENPC;CAPG;EXOC2
11380,GO:0045779,0.128545940655069,0.98087066308076,2,6,negative regulation of bone resorption,BP,TNFAIP3;INPP5D
12434,GO:0050185,0.12861369320503,1,1,1,phosphatidylinositol deacylase activity,MF,PGAP1
8988,GO:0035120,0.128662270315017,1,1,1,post-embryonic appendage morphogenesis,BP,ATRX
8989,GO:0035127,0.128662270315017,1,1,1,post-embryonic limb morphogenesis,BP,ATRX
8990,GO:0035128,0.128662270315017,1,1,1,post-embryonic forelimb morphogenesis,BP,ATRX
16565,GO:0097393,0.128662270315017,1,1,1,telomeric repeat-containing RNA transcription,BP,ATRX
16566,GO:0097394,0.128662270315017,1,1,1,telomeric repeat-containing RNA transcription by RNA polymerase II,BP,ATRX
17674,GO:1901580,0.128662270315017,1,1,1,regulation of telomeric RNA transcription from RNA pol II promoter,BP,ATRX
17675,GO:1901581,0.128662270315017,1,1,1,negative regulation of telomeric RNA transcription from RNA pol II promoter,BP,ATRX
17676,GO:1901582,0.128662270315017,1,1,1,positive regulation of telomeric RNA transcription from RNA pol II promoter,BP,ATRX
19506,GO:1990421,0.128662270315017,1,1,1,subtelomeric heterochromatin,CC,ATRX
19572,GO:1990707,0.128662270315017,1,1,1,nuclear subtelomeric heterochromatin,CC,ATRX
1630,GO:0004074,0.128882965451091,0.995559721305221,1,2,biliverdin reductase activity,MF,BLVRB
5597,GO:0016638,0.128981829043833,0.968133885283276,3,12,oxidoreductase activity, acting on the CH-NH2 group of donors,MF,GLUD1;LOXL1;PNPO
15264,GO:0071470,0.128998138934794,0.952004003391679,5,26,cellular response to osmotic stress,BP,PKD2;TRPV4;SLC2A1;SCN2A;ZFP36L1
20263,GO:2001258,0.129128182957498,0.958578178097208,4,20,negative regulation of cation channel activity,BP,PKD2;EPHB2;ANK3;GSTM2
15170,GO:0071333,0.129150550830312,0.927660049829934,12,83,cellular response to glucose stimulus,BP,ENDOG;PLA2G6;CYBA;MLXIPL;IRS2;ANO1;ERN1;PHPT1;GPR68;TH;PRKACA;GCLC
14889,GO:0070739,0.129318538007277,0.980685107932289,2,6,protein-glutamic acid ligase activity,MF,TPGS1;TTLL1
14890,GO:0070740,0.129318538007277,0.980685107932289,2,6,tubulin-glutamic acid ligase activity,MF,TPGS1;TTLL1
16193,GO:0090251,0.129336649309898,1,1,1,protein localization involved in establishment of planar polarity,BP,CELSR1
788,GO:0002053,0.12940455684102,0.959009886068468,4,18,positive regulation of mesenchymal cell proliferation,BP,FBXW4;STAT1;IRS2;FOXP2
6638,GO:0023035,0.129434740269963,0.980657136231701,2,6,CD40 signaling pathway,BP,TNFAIP3;SHARPIN
3143,GO:0006739,0.129849514653358,0.951243127458653,5,28,NADP metabolic process,BP,H6PD;KCNAB2;PGLS;IDH2;NADK
11660,GO:0046459,0.130048553393794,0.967292605044815,3,13,short-chain fatty acid metabolic process,BP,THNSL2;ACADS;ACSS2
10615,GO:0043627,0.130293293441009,0.937548020125793,8,49,response to estrogen,BP,ASH2L;SFRP1;CITED4;MDM2;GLI3;CA2;GSTM3;PPARG
772,GO:0002028,0.130542942704513,0.934318789019647,9,55,regulation of sodium ion transport,BP,SERPINE2;SIK1;NOS1;ANK3;SNTA1;SCN4B;KLHL24;WNK1;PTPN3
11683,GO:0046488,0.130687283033355,0.913479792448386,22,159,phosphatidylinositol metabolic process,BP,INPP5D;EGFR;PIK3R1;PI4KAP2;KITLG;PITPNM3;PIK3C2G;PLCH2;PITPNM2;SLC27A1;PGAP1;PIGZ;PI4KAP1;PIK3C3;FGFR4;PIK3R2;MPPE1;IRS2;IMPA2;ERBB2;IP6K2;PI4K2B
15147,GO:0071294,0.130805172459687,0.978649795672897,2,8,cellular response to zinc ion,BP,MT1X;ZNF658
6327,GO:0020037,0.1321392222108,0.933199420389151,9,57,heme binding,MF,NOS1;CYP26B1;CYP3A5;PTGS1;HEBP1;CYP2D7;CYBA;SLC48A1;DUOX1
4710,GO:0010875,0.132268416025729,0.966948241919104,3,12,positive regulation of cholesterol efflux,BP,APOE;LRP1;PLTP
16163,GO:0090205,0.132464604501244,0.979921964461048,2,6,positive regulation of cholesterol metabolic process,BP,SREBF1;LDLRAP1
6365,GO:0021554,0.132614143053877,0.979885389451236,2,6,optic nerve development,BP,EPHB2;GLI3
13559,GO:0060048,0.132806513412359,0.927998530815492,11,64,cardiac muscle contraction,BP,NOS1;GAA;RGS2;SNTA1;GSTM2;KCNJ5;TTN;SCN4B;VEGFB;TNNI2;PRKACA
19831,GO:2000323,0.132833638452603,0.979831654528707,2,6,negative regulation of glucocorticoid receptor signaling pathway,BP,CRY2;CRY1
15656,GO:0072201,0.132836056442341,0.979831062250199,2,6,negative regulation of mesenchymal cell proliferation,BP,LMNA;CTNNBIP1
2640,GO:0005977,0.132958702659678,0.93283413595643,9,55,glycogen metabolic process,BP,PYGB;GAA;PPP1R3E;PER2;INSR;PGM1;EPM2AIP1;PPP1R2;IRS2
6566,GO:0022037,0.132986341349241,0.930030350747854,10,62,metencephalon development,BP,SERPINE2;PTPRS;NAGLU;GLI2;MDK;B4GALT2;CDK5R1;RORA;FOXP2;PTBP2
6340,GO:0021520,0.133010026668538,0.979788430096169,2,6,spinal cord motor neuron cell fate specification,BP,GLI2;GLI3
16097,GO:0090103,0.133087972915262,0.966650277706469,3,12,cochlea morphogenesis,BP,GLI2;MYO3B;PTK7
11378,GO:0045777,0.133342437727767,0.966084014671835,3,13,positive regulation of blood pressure,BP,NMU;CYBA;WNK1
11146,GO:0045217,0.133609854577671,0.979641156439869,2,6,cell-cell junction maintenance,BP,F2R;NLGN2
13618,GO:0060142,0.133626300226977,0.965979159469647,3,13,regulation of syncytium formation by plasma membrane fusion,BP,RAPGEF3;FLOT1;GDF15
17924,GO:1902287,0.133688795664423,0.967005062197817,3,11,semaphorin-plexin signaling pathway involved in axon guidance,BP,PLXNB1;PLXNB3;PLXND1
13626,GO:0060155,0.133801601753855,0.978588902149689,2,7,platelet dense granule organization,BP,F2R;BLOC1S3
2720,GO:0006099,0.133811706209314,0.949274768628437,5,28,tricarboxylic acid cycle,BP,DHTKD1;IDH2;OGDHL;SDHA;SUCLG2
5575,GO:0016595,0.133830147635612,0.979586958444896,2,6,glutamate binding,MF,GLUL;GCLC
17470,GO:1900426,0.133855027437383,0.978575139043874,2,7,positive regulation of defense response to bacterium,BP,CYBA;KLK5
16868,GO:0098831,0.134142359652105,0.980989203191731,2,5,presynaptic active zone cytoplasmic component,CC,RIMS3;BSN
5601,GO:0016645,0.134507103573856,0.956199116199717,4,20,oxidoreductase activity, acting on the CH-NH group of donors,MF,MTHFR;PRODH;BLVRB;ALDH4A1
13547,GO:0060033,0.134563087510249,0.979406209660923,2,6,anatomical structure regression,BP,NINJ1;GLI2
14530,GO:0070071,0.134693111058494,0.966064044627177,3,12,proton-transporting two-sector ATPase complex assembly,BP,TCIRG1;ATP6V0A2;DMXL2
3247,GO:0006906,0.134907976281369,0.915725664095975,17,120,vesicle fusion,BP,SYT8;EVI5L;VAV3;VAMP3;TBC1D8;VPS11;SYTL1;C2CD4C;SPG11;SYT15;VAMP2;VPS39;TBC1D17;TSNARE1;SYT7;TBC1D16;SGSM2
8676,GO:0034308,0.134922603053574,0.943148043252795,6,35,primary alcohol metabolic process,BP,ALDH1A3;SULT1E1;RETSAT;DHRS4;RDH12;ACSS2
11272,GO:0045599,0.135019209827212,0.94336606616711,6,33,negative regulation of fat cell differentiation,BP,ZFPM1;ZFP36L2;TRPV4;WWTR1;CCDC85B;RORA
14108,GO:0060996,0.135299314772427,0.926077781260211,11,69,dendritic spine development,BP,APOE;PTPRS;CAPRIN2;EPHB2;BAIAP2;CDK5R1;SHANK3;ZMYND8;DLG5;DLG4;SHANK2
2431,GO:0005615,0.135452576890092,0.880263273487889,250,2391,extracellular space,CC,TNFAIP3;TGFBI;POSTN;ITGB6;SERPINE2;MUC19;PTHLH;PYGB;MXRA5;ACTA2;APOE;CES2;NT5E;GAMT;HSPA2;EGFR;PTPRS;FAM20C;PKD2;XPC;ALDH1A3;LRIG3;SLITRK6;CTSO;SFRP1;SEC14L2;EPS8L2;GPX3;BPHL;ADAMTS7;CXCL14;EYS;SULF2;WNT3;VAV3;CSPG4;MVB12B;CYBRD1;ELFN2;HTRA1;RGMA;KITLG;ZDHHC1;IRF2BPL;NAPRT;REEP2;C1QTNF6;KRT15;LGALS7B;MARCKSL1;KDSR;ITGB5;RAB43;PRKACB;CRTAP;BCAM;MAGEF1;FKBP5;GAA;THNSL2;NDRG1;COL7A1;SPOCK1;NAGLU;PLCD1;LTBP4;PIK3IP1;IDUA;GPRC5C;TNFSF10;MYH11;SYTL1;CALML3;ACTR1B;TNXB;RAPGEF3;ENDOD1;CTSV;BLVRB;FLRT3;GAL3ST4;PPL;SERPINB5;CAPN7;RTN4RL1;CLTCL1;TMC6;FLOT1;TOM1L2;ADAMTS13;SPG11;ZCCHC11;PTGS1;HEXA;FNDC4;C5;FRMD4B;ARSD;MINK1;ABHD14B;GSTM2;SEMA4G;PCSK1;THRAP3;VAMP2;NAIP;LTBP1;LTBP3;CES3;IGFBP4;GPC2;INSR;TST;GSN;HEBP1;BAIAP2;TTN;CBLC;SCNN1A;DDT;CTSF;CD109;PGLS;ZNF446;RAB11FIP4;TM7SF3;CASP14;H2AFJ;BMP6;SLC2A3;S100A4;VEGFB;ALDH7A1;SQSTM1;AKR7A2;LOXL1;FAM213A;FAT2;HEXB;HYAL1;ARRDC1;KIAA0319L;PLA2G6;CST3;MMRN2;GDF15;CTF1;THSD4;COL6A1;PEX11B;IDH2;PODXL;DNM1;IQCB1;PLD3;ABHD14A;CA2;HFE;ADIRF;NID1;RRM2B;SLIT3;KRT14;FBXO2;CTSB;KLK5;KCNMA1;PGM1;CHMP1B;SLC2A1;C1RL;GPR155;GLUL;GNG2;CAPG;LRRN3;ACP5;PLA2G7;RNPEP;DLK2;PPCS;APPL2;ATXN10;DAB2IP;SLC37A2;SHROOM2;SYT7;AREG;ETFB;BST2;FAM3A;PCSK6;UCN2;OSBPL1A;ACVR1B;CADM4;IGFL2;ENDOU;MPI;SNX29;IGFBP6;MATN2;GALE;MXRA8;CLSTN3;IL11;DMXL2;CEP250;ANO1;CAPS;MBLAC2;METTL7A;ALOX15B;TKFC;PNPO;DHRS4;PEX1;ECI1;S100A6;EFEMP2;SGSH;GAREM2;PBLD;TNFSF12;PCSK1N;PRDX5;PHPT1;SMPDL3B;GLB1;GSTM3;SRPX2;DPP7;CD9;HDAC11;CTSD;ARHGAP23;PRKACA;NPAP1;C6ORF120;ACOT2;SYNE2;PLTP;SERPING1;LAMB2;NFASC;ECM2;SMURF1;NPNT;GLIPR1L2;ECM1
10572,GO:0043550,0.13549264893381,0.943260914996604,6,32,regulation of lipid kinase activity,BP,PIK3R1;VAV3;PIK3IP1;DAB2IP;PIK3R2;ATG14
7860,GO:0032429,0.135628055074682,0.979142413811766,2,6,regulation of phospholipase A2 activity,BP,EGFR;LRP1
9093,GO:0035374,0.135832517682971,0.979091609779048,2,6,chondroitin sulfate binding,MF,PTPRS;RTN4RL1
3192,GO:0006817,0.136273195211587,0.965483535809351,3,12,phosphate ion transport,BP,CRY2;SLC37A2;IP6K2
12123,GO:0048240,0.136397769820878,0.977915927626647,2,7,sperm capacitation,BP,CABYR;PRKACA
2638,GO:0005975,0.136417014480168,0.89395857586779,54,447,carbohydrate metabolic process,BP,SIK1;PYGB;DGKQ;H6PD;DHTKD1;ST6GALNAC2;CRY1;GAA;ST6GALNAC6;IDUA;UGT1A3;OAS1;GAL3ST4;B4GALT6;MLYCD;PPP1R3E;G6PC3;PER2;HEXA;FGGY;IGFBP4;NISCH;INSR;ST3GAL5;PGLS;B4GALT2;SLC2A3;PDK1;AKR7A2;HEXB;HYAL1;B3GNT9;IDH2;MLXIPL;PGM1;PFKFB2;SLC2A1;ACACB;OGDHL;EPM2AIP1;HEXDC;PPP1R2;MPI;GALE;KAT2B;IRS2;IMPA2;TKFC;MAN1B1;ISYNA1;GLB1;RORA;GCNT4;GCLC
14781,GO:0070528,0.136560357196456,0.955558381493866,4,19,protein kinase C signaling,BP,DGKQ;MC1R;FLOT1;PLA2G6
15674,GO:0072224,0.136660014106118,0.978885477437365,2,6,metanephric glomerulus development,BP,RET;LAMB2
3891,GO:0008528,0.136757419361787,0.947797775120512,5,28,G-protein coupled peptide receptor activity,MF,CXCR1;MC1R;F2R;LTB4R2;ACKR3
15535,GO:0072001,0.136865518875255,0.905585510872499,26,190,renal system development,BP,ACTA2;PKD2;SFRP1;KIF26B;SULF2;STAT1;LZTS2;GLI2;WWTR1;GLI3;ITGA6;BMP6;NPHP3;PODXL;CA2;NID1;RRM2B;IFT140;TNS2;RET;KLHL3;DLG5;GCNT4;LAMB2;NPNT;CTNNBIP1
16140,GO:0090181,0.136905534743326,0.933608549584495,8,49,regulation of cholesterol metabolic process,BP,SREBF1;APOE;LMF1;SEC14L2;DGKQ;MVD;ACACB;LDLRAP1
17984,GO:1902474,0.137295121914263,0.978726705119724,2,6,positive regulation of protein localization to synapse,BP,NLGN2;CLSTN3
10079,GO:0042594,0.137389769131709,0.911451674322014,19,138,response to starvation,BP,ULK2;SREBF1;SFRP1;IMPACT;HMGCL;CTSV;ULK1;SESN3;WRN;SESN1;HFE;LRP11;SLC2A1;GLUL;C12ORF66;PIK3C3;IFI16;ATG14;PPARG
15730,GO:0072341,0.137444123480718,0.933121805230652,8,51,modified amino acid binding,MF,MTHFR;PLCD1;GSTM2;OSBPL10;JPH2;SYT7;OSBPL5;GSTM3
9526,GO:0036289,0.13752622356847,0.97866880977819,2,6,peptidyl-serine autophosphorylation,BP,MAP2K2;ERN1
15166,GO:0071326,0.137582370763362,0.921994766992787,12,84,cellular response to monosaccharide stimulus,BP,ENDOG;PLA2G6;CYBA;MLXIPL;IRS2;ANO1;ERN1;PHPT1;GPR68;TH;PRKACA;GCLC
15168,GO:0071331,0.137582370763362,0.921994766992787,12,84,cellular response to hexose stimulus,BP,ENDOG;PLA2G6;CYBA;MLXIPL;IRS2;ANO1;ERN1;PHPT1;GPR68;TH;PRKACA;GCLC
277,GO:0000780,0.137778936898185,0.954732598149417,4,20,condensed nuclear chromosome, centromeric region,CC,CENPC;ATRX;REC8;KMT5C
15414,GO:0071709,0.137806509696566,0.955001155800928,4,19,membrane assembly,BP,NLGN4Y;FLOT1;NLGN2;ANK3
15782,GO:0072497,0.137834972409892,0.978591361127829,2,6,mesenchymal stem cell differentiation,BP,WNT3;LTBP3
4807,GO:0012510,0.138003028798425,0.964348464477375,3,13,trans-Golgi network transport vesicle membrane,CC,AP1G2;CLTCL1;LDLRAP1
10360,GO:0043195,0.138418474270048,0.936700955639046,7,41,terminal bouton,CC,SYN1;BLVRB;NMU;SEPT5;SYT7;SYNGR1;TH
13359,GO:0052650,0.138493000513746,0.977366607434146,2,7,NADP-retinol dehydrogenase activity,MF,DHRS4;RDH12
13697,GO:0060284,0.13866792825826,0.888736333580648,70,570,regulation of cell development,BP,POSTN;SERPINE2;ULK2;APOE;PTPRS;CAPRIN2;DIXDC1;SFRP1;OBSL1;KCTD11;EPHB2;WNT3;TENM4;RGMA;CUL7;IMPACT;NOS1;NFATC4;PLXNB1;SPOCK1;MDM2;CRTC1;CSMD3;RTN4RL1;TRPV4;GLI2;GJC2;PER2;SEMA4G;GLI3;TRAK1;BAIAP2;PLXNB3;TRIOBP;BMP6;PTK6;ETV5;SYNGAP1;KDM4C;TCF4;PLAG1;IDH2;TNFRSF21;CDK5R1;NET1;EFNB3;SHANK3;HMG20B;FBXW7;CDK5RAP3;LRP1;BRINP1;RET;ZMYND8;DAB2IP;CASZ1;DLG5;PLXND1;DMTN;PMP22;DLG4;PTK7;SHANK2;ZSWIM8;GPR68;AKAP6;SSH3;PPARG;UFL1;SMURF1
3190,GO:0006814,0.138773716323026,0.912991795008847,17,118,sodium ion transport,BP,SERPINE2;SIK1;PKD2;NOS1;SLC24A1;ANK3;SLC13A5;SNTA1;SCNN1A;SCN4B;KLHL24;SLC38A4;WNK1;SHROOM2;SCN2A;KLHL3;PTPN3
1708,GO:0004301,0.138916882416066,0.977254803619352,2,7,epoxide hydrolase activity,MF,AKR7A2;RNPEP
17031,GO:0099531,0.138970526653555,0.921231183776025,12,80,presynaptic process involved in chemical synaptic transmission,BP,SYT8;SYN1;BRSK1;KCNC4;SYTL1;C2CD4C;RIMS3;SYT15;VAMP2;SEPT5;MCTP1;SYT7
8499,GO:0033689,0.139038786491078,0.97828828319379,2,6,negative regulation of osteoblast proliferation,BP,SFRP1;PLXNB1
12045,GO:0048010,0.139324535350292,0.923277061234888,11,72,vascular endothelial growth factor receptor signaling pathway,BP,PIK3R1;VAV3;TMEM204;BAIAP2;VEGFB;SH2D2A;MMRN2;CYBA;SHC2;DAB2IP;PIK3R2
14493,GO:0065008,0.139498009468504,0.876330704712524,261,2377,regulation of biological quality,BP,TNFAIP3;POSTN;SERPINE2;ULK2;IFI6;SREBF1;APOE;INPP5D;OAS2;EGFR;PTPRS;CIRBP;PKD2;CAPRIN2;SYT8;SYN1;ALDH1A3;SLITRK6;SFRP1;EPS8L2;EPHB2;GLUD1;DGKQ;PIK3R1;BRSK1;TXNRD3;DOCK9;TSC22D3;WNT3;VAV3;CYBRD1;ZFPM1;KITLG;SRD5A3;STAT1;CRY2;MYL9;NSG1;NOS1;PRKACB;CRY1;KLF13;CRTAP;NFATC4;CYP26B1;GAA;PLXNB1;VPS11;KCNC4;ITPR3;MDM2;CRTC1;NDN;LTBP4;PARVB;SYTL1;RHOBTB2;UGT1A3;NEO1;RAPGEF3;PCBP4;FAM210B;OAS1;FLRT3;RGS2;ARPIN;IL20RB;ADGRB2;F2R;C2CD4C;HPS4;MT1X;BLOC1S4;SPTB;SLC24A1;ZFP36L2;TRPV4;FLOT1;NLGN2;ADORA2B;ANK3;ADAMTS13;RIMS3;SLX1A;SLX1B;SULT1E1;PER2;CLCN6;PTGS1;WIPF1;SNTA1;ADGRL1;GSTM2;AMIGO2;ITGA2;SEMA4G;SYT15;FGGY;FHOD3;PCSK1;THRAP3;VAMP2;LTBP1;NMU;KCNJ5;SESN3;NISCH;INSR;GSN;BAIAP2;SCNN1A;PLXNB3;SUN1;PLEKHH2;TRIOBP;POLD4;SCN4B;DOCK8;ENDOG;SLC27A1;TM7SF3;BLOC1S3;RICTOR;BMP6;TCIRG1;ALDH7A1;SQSTM1;SLC12A7;ETV5;SYNGAP1;EPB41L3;HEXB;WHAMMP3;PLA2G6;HOMER2;BBS2;ATP6V0A2;PEX11B;NPHP3;WRN;SEPT5;MALL;DNM1;IQCB1;MCTP1;CDK5R1;ATRX;ANO9;CA2;SHANK3;HFE;HMG20B;CYBA;ERCC6;HADH;WASH3P;XRN1;RAB11FIP3;MLXIPL;FBXW7;KCNMA1;TFPI2;MXI1;PFKFB2;THRA;ARAP1;RPH3AL;SLC2A1;ACACB;GLUL;TNS2;GNG2;CAPG;LRRN3;NPHP4;ACP5;RNPEP;WNK1;BBS1;JPH2;PDE2A;RET;ZMYND8;DAB2IP;ACOX3;FBXO4;SYT7;FGFR4;IL20RA;PIK3R2;RETSAT;SCN2A;TMEM203;KLHL3;DLG5;VDR;LETMD1;CACNB3;PLXND1;BBS10;PCSK6;LPAR6;DMTN;RASL10B;TFDP2;ACVR1B;TMX4;DLG4;ALOXE3;PANO1;DUOX1;AMT;SHANK2;ZFP36L1;CLSTN3;IL11;TEP1;IRS2;DMXL2;ANO1;ERN1;HSD17B14;RAD50;GPR21;ANGEL2;DHRS4;TRERF1;SCG5;PBLD;PCSK1N;PRDX5;PHPT1;TUB;RDH12;SRPX2;CD9;PTPN3;SYNGR1;PLCB3;GPR68;ABCA2;AKAP6;TH;ATG14;RORA;SSH3;PPARG;PRKACA;DOCK6;LDLRAP1;FMNL3;GCNT4;SYNE2;SERPING1;PARN;RIPK3;KCNS3;CIT;PER3;CTNNBIP1;GCLC
12622,GO:0050840,0.139587592104199,0.940893211782482,6,33,extracellular matrix binding,MF,TGFBI;BCAM;ITGA2;ITGA6;NID1;ECM1
6567,GO:0022038,0.139667254700352,0.963721539622403,3,13,corpus callosum development,BP,PTPRS;EPHB2;RTN4RL1
6294,GO:0019911,0.139690862273245,0.977050074670273,2,7,structural constituent of myelin sheath,MF,MARVELD1;MALL
3686,GO:0008191,0.139810432301641,0.977018379537829,2,7,metalloendopeptidase inhibitor activity,MF,SPOCK1;BST2
4496,GO:0010524,0.140105004917656,0.946284978919941,5,27,positive regulation of calcium ion transport into cytosol,BP,PKD2;F2R;GSTM2;JPH2;AKAP6
5517,GO:0016485,0.140189556420684,0.908168242733692,20,152,protein processing,BP,SERPINE2;PRKACB;MDM2;TYSND1;CTSV;ADAMTS13;RHBDF1;C5;GLI3;SPPL2B;PCSK1;NAIP;GSN;PIK3C3;IFI16;PCSK6;SCG5;PCSK1N;SERPING1;LONP2
5766,GO:0016964,0.140610217362096,1,1,1,alpha-2 macroglobulin receptor activity,MF,LRP1
466,GO:0001505,0.140670386618203,0.90590185569787,22,163,regulation of neurotransmitter levels,BP,PKD2;SYT8;SYN1;BRSK1;NOS1;KCNC4;SYTL1;C2CD4C;RIMS3;PER2;SYT15;VAMP2;INSR;ALDH7A1;SEPT5;MCTP1;GLUL;ACP5;SYT7;AMT;TH;RORA
7390,GO:0031461,0.140851566366513,0.90669740845355,21,157,cullin-RING ubiquitin ligase complex,CC,DDB2;FBXW4;DCAF16;CUL9;CUL7;BTBD2;SPSB3;FBXO44;ZYG11B;KLHL24;FBXO2;FBXW7;DCAF10;FBXW5;KLHDC8B;FBXO4;ABTB1;KLHL3;ZSWIM8;DCAF8;KLHL29
7563,GO:0031932,0.141170628632317,0.963151975323972,3,13,TORC2 complex,CC,SESN3;RICTOR;SESN1
19126,GO:1905153,0.14132394131706,0.977708129442537,2,6,regulation of membrane invagination,BP,ITGA2;PPARG
4860,GO:0014704,0.141499311044265,0.940007767464151,6,32,intercalated disc,CC,OBSL1;ANK3;SCN4B;SLC2A1;SCN2A;AKAP6
14118,GO:0061008,0.141548830563175,0.913849190848532,15,105,hepaticobiliary system development,BP,TNFAIP3;EGFR;PKD2;SRSF5;SULF2;HMGCL;PHF2;ITGA2;GLI3;JARID2;NPHP3;HFE;FBXW7;DBP;PTPN3
7490,GO:0031669,0.14176767432576,0.905054094601182,22,164,cellular response to nutrient levels,BP,POSTN;SREBF1;SFRP1;IMPACT;MDM2;CTSV;ULK1;SESN3;BAIAP2;WRN;SESN1;HFE;CYBA;SLC2A1;GLUL;C12ORF66;PIK3C3;IFI16;VDR;UCN2;ATG14;PPARG
4382,GO:0010035,0.141953186406893,0.893050004920099,42,342,response to inorganic substance,BP,TNFAIP3;EGFR;PKD2;TXNRD3;CYBRD1;STAT1;IMPACT;UROS;NFATC4;D2HGDH;NDRG1;ITPR3;MDM2;RASA4;MT1X;ANK3;ADAMTS13;ZNF658;GSN;TTN;ENDOG;BMP6;CST3;TXNIP;ATRX;NET1;CA2;HFE;ERCC6;KRT14;LRP11;KCNMA1;CARF;WNK1;AREG;SNCB;DMTN;MTR;STAT6;CD9;TH;GCLC
14494,GO:0065009,0.142018825125064,0.874313644848026,248,2243,regulation of molecular function,BP,TNFAIP3;SERPINE2;GPNMB;SIK1;IFI6;PTHLH;APOE;GPSM1;ALS2CL;OAS2;LMF1;PSD4;HSPA2;EGFR;PKD2;CAPRIN2;TRIM22;SFRP1;EPS8L2;EPHB2;RALGDS;MAP3K14;DGKQ;PIK3R1;EVI5L;RBCK1;CXCL14;DOCK9;WNT3;CAMKK1;HERC5;VAV3;CSPG4;ELFN2;KCNAB2;ZFPM1;KITLG;ASAP3;CAMK2N1;CRY2;NOS1;PRKACB;PLEKHG5;NFATC4;IQSEC2;SPDYE6;THNSL2;TBC1D8;PLXNB1;PLEKHG3;COL7A1;SPOCK1;MDM2;CRTC1;PPP2R2C;CHN2;PIK3IP1;OBSCN;TNFSF10;RAPGEF3;PHACTR3;OAS1;FLRT3;RASA4;RGL4;RGS2;ACAP3;F2R;HPS4;PDCD4;SPTB;SERPINB5;RTN4RL1;FLOT1;AGAP4;NLGN2;ADORA2B;ANK3;LAMP3;RALGAPA1;MAPK8IP3;SPDYE5;PIDD1;ARHGEF19;RASGEF1A;PER2;UNC119;FRS3;C5;SNTA1;MINK1;TBC1D19;GSTM2;WWTR1;ASAP2;ARHGEF4;ITGA2;BHLHE40;VAMP2;NAIP;MAP2K5;GAS8;ITGA6;SRGAP3;INSR;GSN;TTN;CBLC;PLXNB3;RIN1;CD109;ETAA1;SCN4B;ARHGEF1;MGST2;DOCK8;PILRB;SLC27A1;MDK;RICTOR;BMP6;NLRX1;MAP2K2;VEGFB;CEP192;PTK6;SYNGAP1;FAM13A;ARHGAP33;PLA2G6;CST3;GDF15;TXNIP;CTF1;PSD3;MAP3K12;WRN;IFI27;ZYG11B;KLHL24;CDK5R1;ARHGAP27;AGAP6;NET1;ANO9;MAPK10;SHANK3;HFE;CYBA;TRIM38;ERCC6;SHC2;EDA2R;SPRY2;GABBR1;AGAP7P;CTSB;FBXW7;GPR87;NUDT6;CDK5RAP3;PAK6;TFPI2;MXI1;PFKFB2;THRA;APC2;ARAP1;ADARB1;ACACB;NLRP1;TBC1D17;NAB2;EPM2AIP1;LRP1;RGS12;KCNG1;MAP3K6;WNK1;JPH2;LTB4R2;RET;DAB2IP;RWDD3;RAPGEFL1;IFI16;FGFR4;PIK3R2;AREG;SNCB;MYO9A;RPS6KA5;BST2;VDR;RGL2;ARHGEF17;CACNB3;PLXND1;PCSK6;TBC1D16;PPP1R2;PPP1R35;SGSM2;ARFGEF2;LMTK3;UCN2;DLG4;PPP2R3B;IQSEC1;ENDOU;SHANK2;ACSL1;IL11;KAT2B;IRS2;ERN1;RAD50;SCG5;ARHGEF9;RAPGEF5;TNFSF12;PCSK1N;PRDX5;PHPT1;TRAF5;RANBP9;CACNB1;PTPN3;ERBB2;SPOCD1;ARHGAP23;AKAP6;ATG14;PPARG;PRKACA;DOCK6;LDLRAP1;SERPING1;PARN;DOCK3;UFL1;RIPK3;AIP;KCNS3;ZFP90;NPNT;CTNNBIP1;ECM1
10153,GO:0042753,0.142025832072488,0.977528664876823,2,6,positive regulation of circadian rhythm,BP,THRAP3;RORA
8943,GO:0035014,0.142253131919052,0.977470419490785,2,6,phosphatidylinositol 3-kinase regulator activity,MF,PIK3R1;PIK3R2
19756,GO:2000194,0.142276134576832,0.976360781718999,2,7,regulation of female gonad development,BP,NUPR1;INSR
10606,GO:0043616,0.142340003658232,0.939390548202871,6,33,keratinocyte proliferation,BP,FERMT1;CTSV;CD109;VDR;ZFP36L1;KLF9
10012,GO:0042470,0.14253183516488,0.916562208583363,13,93,melanosome,CC,GPNMB;MYH11;SYTL1;HPS4;FLOT1;CTSB;SLC2A1;CAPG;PMEL;SGSM2;CTSD;SYNGR1;TH
12362,GO:0048770,0.14253183516488,0.916562208583363,13,93,pigment granule,CC,GPNMB;MYH11;SYTL1;HPS4;FLOT1;CTSB;SLC2A1;CAPG;PMEL;SGSM2;CTSD;SYNGR1;TH
13887,GO:0060560,0.14256551827726,0.904590833108377,22,156,developmental growth involved in morphogenesis,BP,POSTN;ULK2;APOE;PTPRS;SFRP1;KIF26B;WNT3;IMPACT;PLXNB1;NDN;FLRT3;SPG11;SEMA4G;ULK1;PLXNB3;CDK5R1;SLIT3;SPRY2;AREG;PTK7;LAMB2;SMURF1
6359,GO:0021545,0.142758519592319,0.945136245526682,5,26,cranial nerve development,BP,SLITRK6;EPHB2;HOXA3;GLI3;ADARB1
5680,GO:0016798,0.142817698281167,0.918462991503776,12,84,hydrolase activity, acting on glycosyl bonds,MF,GAA;NAGLU;IDUA;HEXA;HEXB;HYAL1;MACROD1;MPG;HEXDC;MAN1B1;SMPDL3B;GLB1
4037,GO:0009071,0.142833241095969,0.976211147102233,2,7,serine family amino acid catabolic process,BP,THNSL2;AMT
3151,GO:0006750,0.142917710784852,0.962049220385866,3,14,glutathione biosynthetic process,BP,MGST2;OPLAH;GCLC
6890,GO:0030431,0.143038352160625,0.962002608813117,3,14,sleep,BP,NMU;CST3;PER3
17773,GO:1901879,0.143046359689071,0.926561371657186,9,55,regulation of protein depolymerization,BP,SPTB;TRPV4;GSN;PLEKHH2;TRIOBP;APC2;CAPG;DMTN;MAP1A
17310,GO:0150034,0.143502645169333,0.901980680008187,24,178,distal axon,CC,SYN1;KCNAB2;KCNC4;BLVRB;FLRT3;TRPV4;ADGRL1;ITGA2;NMU;BOC;TRAK1;TANC1;SEPT6;MAP3K12;SEPT5;CDK5R1;GLUL;SYT7;ORAI2;SHANK2;APBB2;SYNGR1;TH;PTBP2
8234,GO:0033017,0.143625373470773,0.952371500969626,4,19,sarcoplasmic reticulum membrane,CC,NOS1;JPH2;AKAP6;SYNE2
12291,GO:0048646,0.143740324627548,0.882188450302794,84,685,anatomical structure formation involved in morphogenesis,BP,TNFAIP3;TGFBI;GPNMB;FAM20C;ALDH1A3;PLCD3;SFRP1;OBSL1;KIF26B;EPHB2;WNT3;VAV3;CSPG4;HTRA1;TENM4;ZFPM1;SDK2;STAT1;UNC5B;ITGB5;NOS1;PRKACB;HOXA3;NFATC4;COL7A1;PLCD1;OBSCN;MYH11;RAPGEF3;ADGRB2;FLOT1;GLI2;C5;THBS3;ITGA2;GLI3;FHOD3;MAP2K5;ITGA6;CELSR1;TANC1;TTN;AHNAK2;CD109;RTF1;VEGFB;FZD7;EPB41L3;KDM4C;HYAL1;SH2D2A;MMRN2;GDF15;COL6A1;NPHP3;PODXL;CDK5R1;SPRY2;KLK5;CCDC136;RFX2;RET;PRX;DAB2IP;TEAD2;RNF213;FGFR4;BTG1;PLXND1;NRARP;PALB2;NBEAL2;PTK7;APOLD1;TNFSF12;SRPX2;CD9;ERBB2;RORA;PPARG;FMNL3;ACKR3;NFASC;ECM1
1973,GO:0004691,0.143780385495204,0.97707744321655,2,6,cAMP-dependent protein kinase activity,MF,PRKACB;PRKACA
14368,GO:0061635,0.1439533709853,0.975909112889867,2,7,regulation of protein complex stability,BP,SQSTM1;ATG14
6520,GO:0021910,0.14396750500532,0.977029101974006,2,6,smoothened signaling pathway involved in ventral spinal cord patterning,BP,GLI2;GLI3
15262,GO:0071467,0.144143801901837,0.962016566944192,3,13,cellular response to pH,BP,IMPACT;HYAL1;GPR68
15141,GO:0071281,0.144171020677047,0.975850243259636,2,7,cellular response to iron ion,BP,BMP6;HFE
12581,GO:0050777,0.144186898610853,0.91753463341686,12,84,negative regulation of immune response,BP,TNFAIP3;INPP5D;IL20RB;DHX58;NLRX1;HFE;IFI16;BST2;FAM3A;STAT6;PPARG;SERPING1
4701,GO:0010866,0.144375962234123,0.961927406919614,3,13,regulation of triglyceride biosynthetic process,BP,SIK1;SREBF1;FBXW7
17357,GO:1900103,0.14444054553781,0.961902591130726,3,13,positive regulation of endoplasmic reticulum unfolded protein response,BP,PIK3R1;DAB2IP;ERN1
17680,GO:1901606,0.144715658972515,0.925151769305426,9,60,alpha-amino acid catabolic process,BP,GLUD1;NOS1;HMGCL;THNSL2;PRODH;ALDH4A1;ALDH7A1;GLUL;AMT
8206,GO:0032970,0.144861671161277,0.894267359680625,34,265,regulation of actin filament-based process,BP,DIXDC1;SFRP1;EPS8L2;PIK3R1;ASAP3;OR2A4;RHOBTB2;RAPGEF3;CTSV;ARPIN;SPTB;ARHGEF19;WIPF1;FHOD3;CELSR1;GSN;BAIAP2;PLEKHH2;TRIOBP;RICTOR;WHAMMP3;CDK5R1;SHANK3;WASH3P;ARAP1;CAPG;LRP1;SYNPO2;BST2;DMTN;ALMS1;PHPT1;SSH3;CIT
11303,GO:0045639,0.144908451225603,0.925238010635878,9,57,positive regulation of myeloid cell differentiation,BP,INPP5D;KITLG;STAT1;FAM210B;CA2;ACVR1B;ZFP36L1;GPR68;CTNNBIP1
464,GO:0001503,0.145249905225686,0.8956470541605,31,237,ossification,BP,GPNMB;PTHLH;MN1;EGFR;FAM20C;SFRP1;WNT3;ISG15;PLXNB1;IFITM1;GLI2;THBS3;WWTR1;GLI3;SUN1;BMP6;PEX7;COL6A1;MRC2;MEF2D;THRA;NAB2;AREG;KREMEN1;COL13A1;PRKACA;UFL1;SMURF1;NPNT;CTNNBIP1;ECM1
4373,GO:0010001,0.145256320179883,0.906859543569052,18,130,glial cell differentiation,BP,SERPINE2;EGFR;POU3F1;TENM4;NDRG1;GLI3;GSN;AHNAK2;TNFRSF21;NAB2;LRP1;PRX;MXRA8;CD9;HDAC11;ERBB2;PPARG;LAMB2
448,GO:0001222,0.145262212078387,0.961586380679457,3,13,transcription corepressor binding,MF,PER2;RORA;PER3
2706,GO:0006073,0.145581943228661,0.924888167131427,9,56,cellular glucan metabolic process,BP,PYGB;GAA;PPP1R3E;PER2;INSR;PGM1;EPM2AIP1;PPP1R2;IRS2
10706,GO:0044042,0.145581943228661,0.924888167131427,9,56,glucan metabolic process,BP,PYGB;GAA;PPP1R3E;PER2;INSR;PGM1;EPM2AIP1;PPP1R2;IRS2
18995,GO:1904844,0.145720696589299,0.994270100504886,1,2,response to L-glutamine,BP,CYBA
18996,GO:1904845,0.145720696589299,0.994270100504886,1,2,cellular response to L-glutamine,BP,CYBA
9129,GO:0035482,0.145781246102027,0.994265142359426,1,2,gastric motility,BP,NMU
19195,GO:1905333,0.145781246102027,0.994265142359426,1,2,regulation of gastric motility,BP,NMU
6772,GO:0030214,0.145907670745774,0.961337346221293,3,13,hyaluronan catabolic process,BP,HEXA;HEXB;HYAL1
15205,GO:0071380,0.146085465007462,0.961803183270781,3,12,cellular response to prostaglandin E stimulus,BP,SFRP1;GNG2;PPARG
5368,GO:0016175,0.146369697464489,0.994216835662804,1,2,superoxide-generating NADPH oxidase activity,MF,CYBA
18923,GO:1904705,0.14653922589152,0.943000400344766,5,27,regulation of vascular smooth muscle cell proliferation,BP,MDM2;PDCD4;MEF2D;ERN1;PPARG
19629,GO:1990874,0.14653922589152,0.943000400344766,5,27,vascular smooth muscle cell proliferation,BP,MDM2;PDCD4;MEF2D;ERN1;PPARG
17065,GO:0099612,0.146554365531532,0.97635647461742,2,6,protein localization to axon,BP,EPB41L3;NFASC
16746,GO:0098562,0.14679646131636,0.904466804359522,19,139,cytoplasmic side of membrane,CC,PKD2;KCNAB2;RASA4;RGS2;SPTB;SPPL2B;MAP2K2;PTK6;SYNGAP1;GNG2;DAB2IP;SHROOM4;DLG4;ESYT2;S100A6;TRAF5;PTPN3;TH;LDLRAP1
3708,GO:0008217,0.146835502097874,0.915820595545239,12,82,regulation of blood pressure,BP,POSTN;NOS1;F2R;PTGS1;NMU;NISCH;CYBA;RNPEP;WNK1;RASL10B;PLCB3;PPARG
11157,GO:0045239,0.146973297124455,0.96092497783628,3,13,tricarboxylic acid cycle enzyme complex,CC,DHTKD1;OGDHL;SUCLG2
7135,GO:0030983,0.147387342718156,0.960764343262302,3,13,mismatched DNA binding,MF,XPC;MLH3;MSH5
6988,GO:0030676,0.147424750069744,0.961290857679681,3,12,Rac guanyl-nucleotide exchange factor activity,MF,EPS8L2;VAV3;ARHGEF4
12845,GO:0051186,0.147771754044417,0.885722077209124,49,427,cofactor metabolic process,BP,NT5E;GAMT;EGFR;MTHFR;GPX3;H6PD;DHTKD1;KCNAB2;MVD;NAPRT;UROS;HMGCL;D2HGDH;NMRK1;ACOT1;BLVRB;MLYCD;PHYH;GSTM2;INSR;PGLS;MGST2;SLC2A3;OPLAH;PDK1;AKR7A2;IDH2;CYBA;HLCS;MLXIPL;PGM1;PFKFB2;SLC2A1;ACACB;OGDHL;PPCS;NADK;DUOX1;ACSL1;PNPO;MTR;CBR4;PRDX5;GSTM3;ACSS2;ACOT2;SUCLG2;PEMT;GCLC
12804,GO:0051129,0.148169576337177,0.882795349692259,59,489,negative regulation of cellular component organization,BP,POSTN;ULK2;APOE;HSPA2;ESPN;PTPRS;EPHB2;EVI5L;KDM3A;WNT3;RGMA;IMPACT;NFATC4;SPOCK1;MDM2;RAPGEF3;ARPIN;SPTB;RTN4RL1;TRPV4;TOM1L2;SLX1A;SLX1B;UNC119;PHF2;SEMA4G;ULK1;FHOD3;LRSAM1;JARID2;GSN;PLXNB3;PLEKHH2;TRIOBP;SYNGAP1;KDM4C;CST3;MCTP1;CDK5R1;ATRX;EFNB3;SHANK3;SPRY2;XRN1;THRA;APC2;ARAP1;CAPG;LRP1;DMTN;PHF1;PMP22;DLG4;LMNA;KAT2B;RAD50;SNX33;EML2;CTNNBIP1
6834,GO:0030306,0.148177414736051,0.97593033973631,2,6,ADP-ribosylation factor binding,MF,RAB11FIP4;RAB11FIP3
3549,GO:0007584,0.148397745401513,0.903188720159931,19,143,response to nutrient,BP,POSTN;EGFR;SFRP1;MTHFR;DGKQ;STAT1;HMGCL;MDM2;ITGA2;GSN;BAIAP2;CYBA;HLCS;VDR;ACSL1;PPARG;UFL1;PEMT;GCLC
289,GO:0000794,0.148533212714946,0.917533537989821,11,66,condensed nuclear chromosome,CC,HSPA2;SYN1;MLH3;TTN;CENPC;ATRX;REC8;RGS12;RAD50;KMT5C;MSH5
9192,GO:0035586,0.148783678919534,0.974588709405565,2,7,purinergic receptor activity,MF,ADORA2B;GPR87
3434,GO:0007224,0.148801121205785,0.910478704817445,14,96,smoothened signaling pathway,BP,SERPINE2;SFRP1;KCTD11;EVC;PRKACB;GLI2;GLI3;BOC;GPC2;IFT140;DLG5;TMEM231;KIF7;RORA
3110,GO:0006688,0.149007341345938,0.960133640857744,3,13,glycosphingolipid biosynthetic process,BP,ST6GALNAC6;B4GALT6;ST3GAL5
14811,GO:0070571,0.149012267807048,0.960131717531075,3,13,negative regulation of neuron projection regeneration,BP,PTPRS;RGMA;RTN4RL1
18551,GO:1903800,0.149283654910086,0.974450376155309,2,7,positive regulation of production of miRNAs involved in gene silencing by miRNA,BP,EGFR;MAP2K2
4519,GO:0010575,0.149336284926848,0.949746715015186,4,19,positive regulation of vascular endothelial growth factor production,BP,SULF2;ADORA2B;C5;RORA
8026,GO:0032680,0.14934112535606,0.919124419775413,10,68,regulation of tumor necrosis factor production,BP,TNFAIP3;GPNMB;PIK3R1;MC1R;NFATC4;DDT;CYBA;ACP5;ZBTB20;ARFGEF2
1604,GO:0004029,0.149455831599177,0.959958414351686,3,13,aldehyde dehydrogenase (NAD) activity,MF,ALDH1A3;ALDH4A1;ALDH7A1
14117,GO:0061005,0.149681918871037,0.935335916254629,6,33,cell differentiation involved in kidney development,BP,ACTA2;STAT1;WWTR1;GLI3;PODXL;LAMB2
3806,GO:0008395,0.149741703274012,0.974323370454198,2,7,steroid hydroxylase activity,MF,CYP3A5;CYP2D7
14134,GO:0061037,0.149827240585224,0.959813100834587,3,13,negative regulation of cartilage development,BP,PTHLH;ADAMTS7;GLI2
13018,GO:0051494,0.14985447213544,0.909698276702191,14,97,negative regulation of cytoskeleton organization,BP,ESPN;ARPIN;SPTB;FHOD3;GSN;PLEKHH2;TRIOBP;SHANK3;APC2;ARAP1;CAPG;DMTN;KAT2B;EML2
3194,GO:0006821,0.150100500946028,0.929781219531114,7,42,chloride transport,BP,CLCN6;SLC12A7;CLCA2;ANO9;CA2;ANO1;CLCN7
7480,GO:0031652,0.150123703554778,0.974217251500464,2,7,positive regulation of heat generation,BP,NMU;SLC27A1
17686,GO:1901617,0.150216624012346,0.899566112985087,21,160,organic hydroxy compound biosynthetic process,BP,SREBF1;AMACR;APOE;SEC14L2;DGKQ;MVD;SRD5A3;PER2;DDT;BMP6;ACACB;PMEL;FGFR4;VDR;OSBPL1A;IMPA2;PNPO;ISYNA1;TH;PLTP;IP6K2
3323,GO:0007031,0.15026782429538,0.940877886594976,5,28,peroxisome organization,BP,PEX10;PEX7;PEX11B;PEX1;LONP2
6205,GO:0019722,0.150682564976719,0.911027060068593,13,90,calcium-mediated signaling,BP,EGFR;PKD2;NOS1;NFATC4;ADGRB2;ADGRL1;GSTM2;HOMER2;MCTP1;JPH2;DMTN;AKAP6;PRKACA
12708,GO:0050982,0.150826925007904,0.953022497174789,4,12,detection of mechanical stimulus,BP,SERPINE2;PKD2;ITGA2;TTN
12245,GO:0048546,0.150829089247099,0.941224555526236,5,25,digestive tract morphogenesis,BP,EGFR;SFRP1;GLI2;GLI3;TCF7
4344,GO:0009898,0.150834918299373,0.904157966202773,17,120,cytoplasmic side of plasma membrane,CC,KCNAB2;RASA4;RGS2;SPTB;MAP2K2;PTK6;SYNGAP1;GNG2;DAB2IP;SHROOM4;DLG4;ESYT2;S100A6;TRAF5;PTPN3;TH;LDLRAP1
527,GO:0001637,0.150968142023149,0.973982024425875,2,7,G-protein coupled chemoattractant receptor activity,MF,CXCR1;ACKR3
2137,GO:0004950,0.150968142023149,0.973982024425875,2,7,chemokine receptor activity,MF,CXCR1;ACKR3
5661,GO:0016773,0.151011002947939,0.877751524913887,72,579,phosphotransferase activity, alcohol group as acceptor,MF,ULK2;SIK1;EGFR;FAM20C;EPHB2;MAP3K14;DGKQ;PIK3R1;BRSK1;CAMKK1;PI4KAP2;KITLG;PRKACB;CNTRL;PIK3C2G;CDK18;SPEG;NMRK1;LTBP4;OBSCN;ALPK1;NEK9;PSKH1;MINK1;ULK1;FGGY;LTBP1;NEK8;MAP2K5;INSR;CDK14;TTN;ETNK2;MAP2K2;PDK1;SQSTM1;PTK6;PDIK1L;MAP3K12;CDK5R1;EFNB3;PI4KAP1;MAPK10;PAK6;PFKFB2;MAP3K6;MYO3B;WNK1;STK16;RET;PIK3C3;FGFR4;PIK3R2;RPS6KA5;NADK;STK19;LMTK3;ACVR1B;TSSK1B;ADCK5;WEE1;PTK7;MARK4;IRS2;ERN1;TKFC;ERBB2;PRKACA;IP6K2;RIPK3;PI4K2B;CIT
9332,GO:0035850,0.151155495628109,0.940823824499869,5,26,epithelial cell differentiation involved in kidney development,BP,ACTA2;STAT1;WWTR1;PODXL;LAMB2
517,GO:0001588,0.151269362129584,0.993806076927312,1,2,dopamine neurotransmitter receptor activity, coupled via Gs,MF,GPR21
2138,GO:0004952,0.151269362129584,0.993806076927312,1,2,dopamine neurotransmitter receptor activity,MF,GPR21
3533,GO:0007520,0.151711272901783,0.948326610057132,4,20,myoblast fusion,BP,NOS1;FLOT1;TANC1;GDF15
6065,GO:0019217,0.151740512026402,0.920902620623194,9,57,regulation of fatty acid metabolic process,BP,SREBF1;TYSND1;MLYCD;PDK1;MLXIPL;ACACB;IRS2;PPARG;LONP2
6984,GO:0030670,0.151754969552861,0.920542907906695,9,62,phagocytic vesicle membrane,CC,VAMP3;RAB43;HLA-B;TCIRG1;ATP6V0A2;CYBA;HLA-A;PIK3C3;SYT7
3452,GO:0007265,0.151833282238856,0.883466606452794,46,366,Ras protein signal transduction,BP,APOE;PSD4;EPS8L2;EPHB2;RALGDS;VAV3;KITLG;ASAP3;RAB43;RAB40B;PLEKHG5;IQSEC2;PLEKHG3;OBSCN;RHOBTB2;RAPGEF3;RASA4;ACAP3;F2R;FLOT1;AGAP4;ARHGEF19;RASGEF1A;ASAP2;ARHGEF4;NISCH;CELSR1;ARHGEF1;SQSTM1;SYNGAP1;PSD3;AGAP6;NET1;SHC2;SPRY2;AGAP7P;PAK6;ARAP1;APPL2;DAB2IP;RGL2;ARHGEF17;LPAR6;ARFGEF2;IQSEC1;ARHGEF9
12381,GO:0048839,0.152201869192776,0.908075014110348,14,96,inner ear development,BP,ALDH1A3;LRIG3;SLITRK6;EPHB2;CXCL14;NAGLU;GLI2;GLI3;CELSR1;TRIOBP;SPRY2;MYO3B;MAF;PTK7
16371,GO:0097009,0.152364148444681,0.958815631151315,3,13,energy homeostasis,BP,CRTC1;NMU;ACACB
3290,GO:0006982,0.152383416884417,0.993710545383263,1,2,response to lipid hydroperoxide,BP,GPX3
11898,GO:0046950,0.152440054312044,0.973569890665489,2,7,cellular ketone body metabolic process,BP,HMGCL;BDH1
17891,GO:1902224,0.152440054312044,0.973569890665489,2,7,ketone body metabolic process,BP,HMGCL;BDH1
827,GO:0002115,0.152642231154735,0.958705774124979,3,13,store-operated calcium entry,BP,ORAI3;HOMER2;ORAI2
2277,GO:0005227,0.152861105993791,0.958619235196927,3,13,calcium activated cation channel activity,MF,TMEM63C;KCNMA1;ANO1
11016,GO:0045002,0.152889958131182,0.973443381576641,2,7,double-strand break repair via single-strand annealing,BP,SLX1A;SLX1B
16370,GO:0097006,0.152920798688499,0.923584870821478,8,52,regulation of plasma lipoprotein particle levels,BP,APOE;LMF1;PRKACB;CES3;PLA2G7;PRKACA;LDLRAP1;PLTP
8713,GO:0034370,0.153126475740023,0.993646385509572,1,2,triglyceride-rich lipoprotein particle remodeling,BP,APOE
8715,GO:0034372,0.153126475740023,0.993646385509572,1,2,very-low-density lipoprotein particle remodeling,BP,APOE
3329,GO:0007040,0.153248521258112,0.923467252798597,8,51,lysosome organization,BP,GAA;VPS11;NAGLU;HPS4;SPG11;HEXB;HOOK2;SYT7
15964,GO:0080171,0.153248521258112,0.923467252798597,8,51,lytic vacuole organization,BP,GAA;VPS11;NAGLU;HPS4;SPG11;HEXB;HOOK2;SYT7
8182,GO:0032930,0.153353978212716,0.972414903634038,2,8,positive regulation of superoxide anion generation,BP,EGFR;CYBA
7899,GO:0032480,0.153354787977342,0.92763374270494,7,44,negative regulation of type I interferon production,BP,TNFAIP3;PTPRS;RNF135;HERC5;ISG15;DHX58;NLRX1
13497,GO:0055090,0.153566720085779,0.957859242617573,3,14,acylglycerol homeostasis,BP,APOE;MLXIPL;RORA
14681,GO:0070328,0.153566720085779,0.957859242617573,3,14,triglyceride homeostasis,BP,APOE;MLXIPL;RORA
12082,GO:0048102,0.153595053557906,0.973244609819253,2,7,autophagic cell death,BP,TP53INP1;CTSV
7198,GO:0031095,0.153731411758913,0.974448187784352,2,6,platelet dense tubular network membrane,CC,ITPR3;DMTN
534,GO:0001653,0.153956447762027,0.938762896162084,5,29,peptide receptor activity,MF,CXCR1;MC1R;F2R;LTB4R2;ACKR3
15271,GO:0071478,0.153962329572594,0.899043736844048,19,142,cellular response to radiation,BP,DDB2;TP53INP1;XPC;SFRP1;PIK3R1;MC1R;IMPACT;CRY2;CRY1;NFATC4;MDM2;POLH;HYAL1;WRN;NET1;ADIRF;CYBA;FBXO4;IFI16
5714,GO:0016854,0.153982213609343,0.957692683769491,3,14,racemase and epimerase activity,MF,AMACR;SRR;GALE
2283,GO:0005242,0.154017625570284,0.973125188207777,2,7,inward rectifier potassium channel activity,MF,KCNJ15;KCNJ5
4239,GO:0009439,0.154723351424261,0.993507303890238,1,2,cyanate metabolic process,BP,TST
4240,GO:0009440,0.154723351424261,0.993507303890238,1,2,cyanate catabolic process,BP,TST
12222,GO:0048511,0.154943164651973,0.892217064324737,25,189,rhythmic process,BP,SIK1;SREBF1;EGFR;CRY2;CRY1;NAGLU;CRTC1;PER2;THRAP3;BHLHE40;NMU;HEBP1;CST3;CDK5R1;MAPK10;SLIT3;RAI1;DBP;TEF;KAT2B;TH;RORA;PPARG;KLF9;PER3
2957,GO:0006489,0.154970559069145,0.972855071012686,2,7,dolichyl diphosphate biosynthetic process,BP,MVD;SRD5A3
11666,GO:0046465,0.154970559069145,0.972855071012686,2,7,dolichyl diphosphate metabolic process,BP,MVD;SRD5A3
14532,GO:0070076,0.155060194930494,0.939026723514715,5,25,histone lysine demethylation,BP,KDM3A;HR;HSF4;PHF2;KDM4C
15688,GO:0072257,0.155297099625356,0.974023685702046,2,6,metanephric nephron tubule epithelial cell differentiation,BP,STAT1;WWTR1
15712,GO:0072307,0.155297099625356,0.974023685702046,2,6,regulation of metanephric nephron tubule epithelial cell differentiation,BP,STAT1;WWTR1
8343,GO:0033218,0.155323770543123,0.891792721872249,25,198,amide binding,MF,APOE;EPHB2;PIK3R1;HLA-B;CTSV;GSTM2;ITGA2;INSR;RNPEPL1;CST3;PEX7;NKTR;HLCS;FBXO2;ACACB;HLA-A;RNPEP;APBB3;VIPR1;APBB2;GSTM3;PPARG;LDLRAP1;NPAP1;PLTP
12799,GO:0051124,0.155337753815891,0.974012624146351,2,6,synaptic growth at neuromuscular junction,BP,SHANK3;SHANK2
6306,GO:0019955,0.155568129044724,0.918299455969248,9,59,cytokine binding,MF,CXCR1;LTBP4;IL20RB;LTBP1;LTBP3;CD109;IL20RA;TNFRSF25;ACKR3
7816,GO:0032377,0.155572761364986,0.972683791774971,2,7,regulation of intracellular lipid transport,BP,ABCA2;LDLRAP1
7819,GO:0032380,0.155572761364986,0.972683791774971,2,7,regulation of intracellular sterol transport,BP,ABCA2;LDLRAP1
7822,GO:0032383,0.155572761364986,0.972683791774971,2,7,regulation of intracellular cholesterol transport,BP,ABCA2;LDLRAP1
4602,GO:0010720,0.155878613718696,0.881191047506322,43,341,positive regulation of cell development,BP,SERPINE2;APOE;CAPRIN2;OBSL1;KCTD11;EPHB2;WNT3;TENM4;CUL7;IMPACT;PLXNB1;CRTC1;GLI2;GJC2;GLI3;TRAK1;BAIAP2;PLXNB3;TRIOBP;BMP6;PTK6;ETV5;KDM4C;TCF4;PLAG1;NET1;SHANK3;HMG20B;BRINP1;RET;ZMYND8;DAB2IP;DLG5;PLXND1;DMTN;DLG4;PTK7;SHANK2;GPR68;AKAP6;PPARG;UFL1;SMURF1
3385,GO:0007163,0.156253845773907,0.894083616819348,22,159,establishment or maintenance of cell polarity,BP,KIF26B;BRSK1;FERMT1;CYP26B1;PARVB;RHOBTB2;FRMD4B;GSN;DOCK8;RICTOR;NPHP3;SPRY2;MYO9A;DLG5;DLG4;WEE1;PTK7;LMNA;MARK4;MPP7;SYNE2;PARD6G
4362,GO:0009968,0.156550355208853,0.868729675893847,101,882,negative regulation of signal transduction,BP,TNFAIP3;SERPINE2;EPM2A;IFI6;APOE;INPP5D;APCDD1;EGFR;PTPRS;PKD2;MNT;SFRP1;KCTD11;EPHB2;SULF2;HTRA1;STAT1;CAMK2N1;CRY2;UNC5B;PRKACB;CRY1;NFATC4;FERMT1;CYP26B1;MDM2;LZTS2;PIK3IP1;TNFSF10;FLRT3;RASA4;KIF26A;RGS2;PDCD4;RTN4RL1;GSTM2;WWTR1;GLI3;LTBP1;MAP2K5;ITGA6;SESN3;IGFBP4;INSR;CBLC;CD109;DHX58;NLRX1;PTK6;SYNGAP1;ARRDC1;MMRN2;NPHP3;DNM1;SESN1;HFE;RRM2B;SLIT3;SPRY2;CREBRF;FBXW7;CDK5RAP3;APC2;ELF1;RPH3AL;NLRP1;LRP1;NPHP4;RGS12;C12ORF66;DLK2;PDE2A;RET;DAB2IP;RNF213;FGFR4;PIK3R2;DLG5;WWC3;NRARP;KREMEN1;IGFBP6;LMNA;IVNS1ABP;GPR21;TKFC;PBLD;PHPT1;SMPDL3B;KIF7;RANBP9;PTPN3;ERBB2;RORA;PPARG;ACKR3;CCDC3;SMURF1;CTNNBIP1;GCLC;ECM1
18596,GO:1903901,0.156733735004121,0.917339562813906,9,62,negative regulation of viral life cycle,BP,OAS2;APOBEC3C;ISG15;IFITM1;OAS1;GSN;IFI16;BST2;RSAD2
12340,GO:0048732,0.157037764112651,0.882827052190447,37,293,gland development,BP,TNFAIP3;SERPINE2;OAS2;EGFR;PKD2;ALDH1A3;SRSF5;SFRP1;SULF2;WNT3;TFCP2L1;HOXA3;HMGCL;SERPINB5;GLI2;PHF2;ITGA2;GLI3;JARID2;INSR;MDK;ETV5;CST3;NPHP3;PLAG1;HFE;FBXW7;THRA;DBP;AREG;VDR;PLXND1;IRS2;ALOX15B;STAT6;PTPN3;RIPK3
5705,GO:0016838,0.157067646555592,0.993300153496198,1,2,carbon-oxygen lyase activity, acting on phosphates,MF,THNSL2
3189,GO:0006813,0.157338538482051,0.904384773875191,14,97,potassium ion transport,BP,PKD2;KCNAB2;KCNJ15;NOS1;KCNC4;ANK3;VAMP2;KCNJ5;SLC12A7;KLHL24;KCNMA1;KCNG1;AKAP6;KCNS3
15266,GO:0071472,0.15778060321991,0.972051996855226,2,7,cellular response to salt stress,BP,TRPV4;ZFP36L1
17463,GO:1900390,0.157999319207151,0.993216843089104,1,2,regulation of iron ion import,BP,HFE
18818,GO:1904432,0.157999319207151,0.993216843089104,1,2,regulation of ferrous iron binding,BP,HFE
18819,GO:1904434,0.157999319207151,0.993216843089104,1,2,positive regulation of ferrous iron binding,BP,HFE
18820,GO:1904435,0.157999319207151,0.993216843089104,1,2,regulation of transferrin receptor binding,BP,HFE
18821,GO:1904437,0.157999319207151,0.993216843089104,1,2,positive regulation of transferrin receptor binding,BP,HFE
14415,GO:0061744,0.158080099068038,0.993209593301236,1,2,motor behavior,BP,ADARB1
2286,GO:0005245,0.158125005831893,0.956518929757882,3,13,voltage-gated calcium channel activity,MF,PKD2;CACNB3;CACNB1
8004,GO:0032642,0.158271285384441,0.92458599652979,7,45,regulation of chemokine production,BP,POSTN;ZFPM1;TRPV4;ADORA2B;C5;MAP2K5;ALOX15B
1964,GO:0004675,0.158355801718002,0.95702080050582,3,12,transmembrane receptor protein serine/threonine kinase activity,MF,LTBP4;LTBP1;ACVR1B
17013,GO:0099503,0.158388301960678,0.871754343995063,69,609,secretory vesicle,CC,SERPINE2;PYGB;PTPRS;SYT8;CXCR1;SYN1;BRSK1;KCNAB2;VAMP3;NAPRT;RAB40B;GAA;ITPR3;HGSNAT;SYTL1;ACTR1B;CTSV;C2CD4C;HPS4;TMC6;LAMP3;HEXA;LHFPL2;PCSK1;VAMP2;GSN;BAIAP2;SUN1;CD109;SEPT6;SLC2A3;TCIRG1;VEGFB;LOXL1;HEXB;CST3;ATP6V0A2;SEPT5;DNM1;MCTP1;CYBA;CTSB;KLK5;PGM1;RPH3AL;CCDC136;RNPEP;SYT7;BST2;DLG4;TSSK1B;NBEAL2;CD68;DMXL2;METTL7A;SCG5;PCSK1N;GLB1;GOLGA1;DPP7;CD9;CTSD;SYNGR1;TH;PRKACA;C6ORF120;SERPING1;NFASC;ECM1
4441,GO:0010340,0.15844044818635,0.971862006601935,2,7,carboxyl-O-methyltransferase activity,MF,PCMTD2;PCMTD1
13274,GO:0051998,0.15844044818635,0.971862006601935,2,7,protein carboxyl O-methyltransferase activity,MF,PCMTD2;PCMTD1
13721,GO:0060315,0.158509166933352,0.970898268150354,2,8,negative regulation of ryanodine-sensitive calcium-release channel activity,BP,PKD2;GSTM2
474,GO:0001518,0.158697873675796,0.973091545924401,2,6,voltage-gated sodium channel complex,CC,SCN4B;SCN2A
1185,GO:0002832,0.158995415544536,0.929626978261951,6,36,negative regulation of response to biotic stimulus,BP,TNFAIP3;HTRA1;DHX58;NLRX1;FAM3A;TKFC
5295,GO:0015985,0.158997718305263,0.970752793371718,2,8,energy coupled proton transport, down electrochemical gradient,BP,TCIRG1;ATP6V0A2
5296,GO:0015986,0.158997718305263,0.970752793371718,2,8,ATP synthesis coupled proton transport,BP,TCIRG1;ATP6V0A2
13735,GO:0060333,0.159127546691881,0.915789817163535,9,62,interferon-gamma-mediated signaling pathway,BP,OAS2;TRIM22;STAT1;HLA-B;OAS1;IRF9;TRIM38;HLA-A;PPARG
19795,GO:2000273,0.159194674341379,0.944480630865924,4,21,positive regulation of signaling receptor activity,BP,EPHB2;SHANK3;HFE;FBXW7
8143,GO:0032879,0.159372369244101,0.860227649113297,190,1683,regulation of localization,BP,POSTN;SERPINE2;GPNMB;SIK1;TP53INP1;SREBF1;APOE;OAS2;HSPA2;EGFR;PKD2;SYT8;SYN1;TRIM22;SFRP1;EPHB2;GLUD1;PIK3R1;EVI5L;CXCL14;WNT3;KCNAB2;KITLG;VAMP3;REEP2;KCNJ15;CRY2;RAB40B;NOS1;CRY1;FERMT1;TBC1D8;PLXNB1;VPS11;KCNC4;ITPR3;MDM2;LZTS2;IFITM1;SYTL1;RHOBTB2;RAPGEF3;ARPIN;F2R;C2CD4C;HPS4;CAPN7;CLTCL1;TRPV4;FLOT1;NLGN2;ADORA2B;ANK3;RIMS3;GJC2;RHBDF1;PER2;UNC119;C5;SNTA1;MINK1;GSTM2;ITGA2;SEMA4G;FAM110C;SYT15;GLI3;LRSAM1;VAMP2;NMU;MAP2K5;ITGA6;KCNJ5;SRGAP3;NISCH;INSR;MMP28;GSN;TTN;DDT;PLXNB3;SCN4B;DOCK8;TM7SF3;BMP6;MICALL2;MAP2K2;VEGFB;SQSTM1;HYAL1;PLA2G6;HOMER2;MMRN2;BBS2;IDH2;PODXL;SEPT5;IFI27;OSCP1;DNM1;TNFRSF21;KLHL24;MCTP1;CDK5R1;ANO9;CA2;SHANK3;HFE;CYBA;HADH;SPRY2;RAB11FIP3;FBXW7;KCNMA1;CDK5RAP3;DZIP1L;PFKFB2;ARAP1;ASTN2;ADARB1;MX2;RPH3AL;SLC2A1;ACACB;NLRP1;GLUL;TBC1D17;LRP1;PLA2G7;KCNG1;WNK1;JPH2;PDE2A;RET;ZMYND8;DAB2IP;MYSM1;FBXO4;PIK3C3;SYT7;PIK3R2;SCN2A;DLG5;BST2;CACNB3;PLXND1;TBC1D16;DMTN;SGSM2;RASL10B;TMEM231;TFDP2;ACVR1B;DLG4;SHANK2;RSAD2;ZFP36L1;LMNA;CLSTN3;IL11;IRS2;CEP250;ANO1;ALOX15B;SCG5;ZSWIM8;PBLD;PHPT1;TUB;SRPX2;CD9;CACNB1;PTPN3;ERBB2;GPR68;ABCA2;AKAP6;PPARG;PRKACA;LDLRAP1;SYNE2;ACKR3;PLTP;PARN;UFL1;RIPK3;KCNS3;SNX33;PEMT;ECM1
10847,GO:0044375,0.159424092210985,0.993088353589832,1,2,regulation of peroxisome size,BP,PEX11B
11255,GO:0045577,0.159427773050428,0.944668492647412,4,20,regulation of B cell differentiation,BP,INPP5D;SFRP1;ZFP36L2;ZFP36L1
7581,GO:0031957,0.159791765040385,0.971471241979934,2,7,very long-chain fatty acid-CoA ligase activity,MF,SLC27A3;SLC27A1
14809,GO:0070569,0.159823586421674,0.971462012931879,2,7,uridylyltransferase activity,MF,ZCCHC11;UAP1L1
11715,GO:0046543,0.159827027400009,0.971461014881683,2,7,development of secondary female sexual characteristics,BP,IRF2BPL;AREG
3825,GO:0008427,0.159947926177484,0.993040782246254,1,2,calcium-dependent protein kinase inhibitor activity,MF,CAMK2N1
4697,GO:0010858,0.159947926177484,0.993040782246254,1,2,calcium-dependent protein kinase regulator activity,MF,CAMK2N1
5765,GO:0016942,0.15995202720272,0.993040409114336,1,2,insulin-like growth factor binding protein complex,CC,IGFBP6
9586,GO:0036454,0.15995202720272,0.993040409114336,1,2,growth factor complex,CC,IGFBP6
12862,GO:0051219,0.159983028991538,0.912355589448046,10,64,phosphoprotein binding,MF,PKD2;PIK3R1;THRAP3;CBLC;RTF1;LRP11;FBXW7;PIK3R2;PTPN3;LDLRAP1
1258,GO:0003014,0.160019209606978,0.915501039013065,9,58,renal system process,BP,SULF2;PRKACB;F2R;GSN;CYBA;RRM2B;KCNMA1;KLHL3;PRKACA
18390,GO:1903441,0.160214302663962,0.971348592993496,2,7,protein localization to ciliary membrane,BP,BBS2;TUB
17002,GO:0099175,0.160343073206488,0.929161912684212,6,34,regulation of postsynapse organization,BP,APOE;CAPRIN2;BAIAP2;CDK5R1;SHANK3;ZMYND8
910,GO:0002295,0.160661733583989,0.971218478261071,2,7,T-helper cell lineage commitment,BP,ZFPM1;STAT6
10466,GO:0043373,0.160661733583989,0.971218478261071,2,7,CD4-positive, alpha-beta T cell lineage commitment,BP,ZFPM1;STAT6
7828,GO:0032389,0.160734934554724,0.971197167625411,2,7,MutLalpha complex,CC,PMS2P3;WRN
12224,GO:0048513,0.160806120282122,0.857339126174191,235,2120,animal organ development,BP,TNFAIP3;TGFBI;TAGLN;SERPINE2;GPNMB;SIK1;PTHLH;SREBF1;ACTA2;INPP5D;APCDD1;GAMT;OAS2;ADAM19;FBXW4;EGFR;PTPRS;FAM20C;PKD2;ASH2L;DIXDC1;ALDH1A3;SRSF5;LRIG3;PLCD3;SLITRK6;SFRP1;OBSL1;KIF26B;EPHB2;GLUD1;PIK3R1;ADAMTS7;CXCL14;TSC22D3;EVC;POU3F1;SULF2;WNT3;DHTKD1;ISG15;HTRA1;TFCP2L1;TENM4;KCNAB2;ZFPM1;KITLG;SDK2;CUL7;PRICKLE2;STAT1;MYL9;KRT15;HOXA3;KLF13;NFATC4;HMGCL;FERMT1;CYP26B1;GAA;HSF4;PLXNB1;SPEG;NAGLU;MDM2;LZTS2;PLCD1;TNFSF10;MYH11;TCF25;NINJ1;FAM210B;CTSV;FLRT3;PPL;PDCD4;SERPINB5;ZNF160;RTN4RL1;ZFP36L2;TRPV4;FLOT1;GLI2;SOX12;GJC2;ARHGEF19;PSKH1;PHF2;AMIGO2;THBS3;WWTR1;ITGA2;SEMA4G;GLI3;FHOD3;IRX4;SMARCA1;LTBP1;NEK8;MAP2K5;GAS8;ITGA6;JARID2;NUPR1;PRR9;INSR;CELSR1;BAIAP2;TTN;SUN1;TRIOBP;CD109;RAB11FIP4;PGAP1;BLOC1S3;MDK;CASP14;BMP6;B4GALT2;ETNK2;S100A4;VEGFB;FZD7;ETV5;FAM213A;DLX3;SHARPIN;HYAL1;CST3;PEX7;BBS2;TXNIP;CTF1;NPHP3;PLAG1;WRN;PODXL;IQCB1;CDK5R1;ATRX;REC8;CA2;SHANK3;HFE;HMG20B;NID1;AGO4;RRM2B;SLIT3;KRT14;SPRY2;MEF2D;IFT140;CTSB;KLK5;FBXW7;CDK5RAP3;ATXN1;LMO2;THRA;ADARB1;SLC2A1;ACACB;TNS2;DBP;NAB2;SRR;LRP1;NPHP4;ACP5;DGCR2;MYO3B;SALL2;JPH2;MAF;RET;DAB2IP;TEAD2;MYSM1;SHROOM2;IFI16;BBS5;AREG;KLHL3;DLG5;VDR;TNRC6C;PLXND1;SIX5;PCSK6;DMTN;TMEM231;TFDP2;NRARP;ACVR1B;SHROOM4;TACC1;ALOXE3;PALB2;NBEAL2;PTK7;TCF7;SHANK2;RSAD2;ZFP36L1;LMNA;IL11;KAT2B;IRS2;ALOX15B;PBLD;STAT6;SOX13;TUB;CD9;PTPN3;GJB5;COL13A1;ERBB2;GPR68;AKAP6;TH;RORA;PPARG;POLM;GCNT4;SYNE2;LAMB2;RIPK3;FOXP2;PTBP2;SMURF1;NPNT;CTNNBIP1;ECM1
19525,GO:1990462,0.160922151466203,0.971142634041615,2,7,omegasome,CC,ULK1;ATG14
7836,GO:0032401,0.161200374385729,0.943513194666223,4,21,establishment of melanosome localization,BP,BLOC1S3;BBS2;SHROOM2;BBS5
13220,GO:0051905,0.161200374385729,0.943513194666223,4,21,establishment of pigment granule localization,BP,BLOC1S3;BBS2;SHROOM2;BBS5
12080,GO:0048087,0.161541894802299,0.970961803547471,2,7,positive regulation of developmental pigmentation,BP,KITLG;HPS4
14048,GO:0060850,0.161612312566122,0.970941226904734,2,7,regulation of transcription involved in cell fate commitment,BP,RORA;PPARG
7474,GO:0031646,0.161636621467235,0.955097536897625,3,13,positive regulation of neurological system process,BP,TENM4;ITGA2;NMU
1759,GO:0004364,0.161689582974607,0.953123020562189,3,18,glutathione transferase activity,MF,GSTM2;MGST2;GSTM3
698,GO:0001919,0.1617052623378,0.943574072,4,20,regulation of receptor recycling,BP,VAMP3;NSG1;ARAP1;TBC1D16
5920,GO:0018198,0.161799121755576,0.927747114958341,6,38,peptidyl-cysteine modification,BP,ZDHHC1;NOS1;SNTA1;ZDHHC12;GOLGA7B;ZDHHC24
5726,GO:0016874,0.161872938645519,0.894380912394727,18,135,ligase activity,MF,NAPRT;LIG1;MDM2;SLC27A3;TPGS1;SLC27A1;HLCS;ACACB;GLUL;RIMKLB;PPCS;DALRD3;ACSL1;ACSS2;SUCLG2;HARS2;TTLL1;GCLC
8258,GO:0033059,0.162178770139778,0.922224993398395,7,45,cellular pigmentation,BP,HPS4;BLOC1S4;BLOC1S3;BBS2;PMEL;SHROOM2;BBS5
5728,GO:0016877,0.162186836113399,0.934579435791659,5,28,ligase activity, forming carbon-sulfur bonds,MF,SLC27A3;SLC27A1;ACSL1;ACSS2;SUCLG2
18815,GO:1904429,0.162260544038624,0.970751521452054,2,7,regulation of t-circle formation,BP,SLX1A;SLX1B
8322,GO:0033179,0.162544918538808,0.969687514298429,2,8,proton-transporting V-type ATPase, V0 domain,CC,TCIRG1;ATP6V0A2
700,GO:0001921,0.162550265312719,0.954725078735112,3,13,positive regulation of receptor recycling,BP,VAMP3;NSG1;ARAP1
710,GO:0001936,0.162707478759669,0.907419219509023,11,75,regulation of endothelial cell proliferation,BP,APOE;STAT1;PLXNB3;RICTOR;BMP6;VEGFB;CYBA;NRARP;TNFSF12;PPARG;ECM1
10531,GO:0043495,0.162729815258575,0.970613865923433,2,7,protein membrane anchor,MF,SUN1;AKAP6
8717,GO:0034375,0.162864816752642,0.969590663785681,2,8,high-density lipoprotein particle remodeling,BP,APOE;PLTP
10961,GO:0044754,0.162888610195323,0.969583455070085,2,8,autolysosome,CC,SQSTM1;PIK3C3
7457,GO:0031623,0.162966157558901,0.91350928363661,9,59,receptor internalization,BP,CXCR1;FLOT1;DNM1;LRP1;SNX1;DLG4;CD9;LDLRAP1;ACKR3
8590,GO:0034110,0.163126528491276,0.942579247800531,4,21,regulation of homotypic cell-cell adhesion,BP,SERPINE2;ANK3;DMTN;CD9
616,GO:0001786,0.163172718747158,0.934264391154453,5,27,phosphatidylserine binding,MF,PLCD1;OSBPL10;JPH2;SYT7;OSBPL5
4282,GO:0009651,0.163289636537307,0.953901735929604,3,14,response to salt stress,BP,TRPV4;ZFP36L1;TH
2700,GO:0006066,0.16339354208365,0.88230399057727,29,231,alcohol metabolic process,BP,SREBF1;APOE;INPP5D;LMF1;ALDH1A3;PLCD3;SEC14L2;DGKQ;MVD;SRD5A3;PLCD1;PLCH2;SULT1E1;ACACB;RETSAT;OSBPL5;VDR;OSBPL1A;IMPA2;TKFC;DHRS4;TRERF1;ISYNA1;RDH12;ACSS2;PLCB3;NUDT10;LDLRAP1;IP6K2
13821,GO:0060443,0.163568708965641,0.927314229457923,6,34,mammary gland morphogenesis,BP,GLI2;GLI3;ETV5;AREG;VDR;STAT6
17923,GO:1902285,0.163587220029348,0.954921952086406,3,12,semaphorin-plexin signaling pathway involved in neuron projection guidance,BP,PLXNB1;PLXNB3;PLXND1
819,GO:0002093,0.163651063869586,0.970342839321078,2,7,auditory receptor cell morphogenesis,BP,SLITRK6;TRIOBP
9760,GO:0039536,0.163662293495364,0.970339529179451,2,7,negative regulation of RIG-I signaling pathway,BP,DHX58;NLRX1
3070,GO:0006637,0.163795988555563,0.906514753627398,11,78,acyl-CoA metabolic process,BP,MVD;HMGCL;ACOT1;MLYCD;PDK1;ACACB;ACSL1;CBR4;ACSS2;ACOT2;SUCLG2
9096,GO:0035383,0.163795988555563,0.906514753627398,11,78,thioester metabolic process,BP,MVD;HMGCL;ACOT1;MLYCD;PDK1;ACACB;ACSL1;CBR4;ACSS2;ACOT2;SUCLG2
12521,GO:0050687,0.164025087255179,0.942141927749687,4,21,negative regulation of defense response to virus,BP,HTRA1;DHX58;NLRX1;TKFC
447,GO:0001221,0.164056996150412,0.926871602528068,6,35,transcription cofactor binding,MF,PER2;BAIAP2;TEAD2;CHD6;RORA;PER3
12573,GO:0050769,0.164118155433316,0.876527005105078,38,298,positive regulation of neurogenesis,BP,SERPINE2;APOE;CAPRIN2;OBSL1;KCTD11;EPHB2;WNT3;TENM4;CUL7;IMPACT;PLXNB1;CRTC1;GLI2;GJC2;GLI3;TRAK1;BAIAP2;PLXNB3;BMP6;PTK6;ETV5;KDM4C;TCF4;PLAG1;SHANK3;HMG20B;BRINP1;RET;ZMYND8;DAB2IP;DLG5;PLXND1;DLG4;PTK7;SHANK2;PPARG;UFL1;SMURF1
2222,GO:0005126,0.164323412169802,0.893812961851719,17,134,cytokine receptor binding,MF,PIK3R1;CXCL14;KITLG;STAT1;TNFSF10;PIDD1;C5;DDT;BMP6;VEGFB;GDF15;CTF1;DAB2IP;IL11;TNFSF12;TRAF5;ECM1
11161,GO:0045252,0.164367720529679,0.970131280434346,2,7,oxoglutarate dehydrogenase complex,CC,DHTKD1;OGDHL
5430,GO:0016290,0.164479410316688,0.969099871799079,2,8,palmitoyl-CoA hydrolase activity,MF,ACOT1;ACOT2
12285,GO:0048640,0.165174383917878,0.908820302701371,10,65,negative regulation of developmental growth,BP,ULK2;PTPRS;SFRP1;WNT3;SEMA4G;JARID2;BBS2;CDK5R1;RAI1;WWC3
14182,GO:0061134,0.165613020844739,0.898024660978854,14,109,peptidase regulator activity,MF,SERPINE2;COL7A1;SPOCK1;SERPINB5;C5;NAIP;CD109;CST3;TFPI2;NLRP1;BST2;PCSK1N;PRDX5;SERPING1
4502,GO:0010544,0.165701583447799,0.952900757385582,3,14,negative regulation of platelet activation,BP,SERPINE2;APOE;CD9
11234,GO:0045453,0.165745810483755,0.925896503217658,6,35,bone resorption,BP,TNFAIP3;INPP5D;EGFR;CA2;ACP5;IL20RA
2192,GO:0005055,0.166015385060947,0.992476753735765,1,2,laminin receptor activity,MF,BCAM
14766,GO:0070493,0.166521179258928,0.969491774311997,2,7,thrombin-activated receptor signaling pathway,BP,DGKQ;F2R
12032,GO:0047894,0.166527954651051,0.992428002804083,1,2,flavonol 3-sulfotransferase activity,MF,SULT1E1
6662,GO:0030027,0.166528231981618,0.887185711917961,21,154,lamellipodium,CC,ACTA2;PKD2;CSPG4;KITLG;PLEKHG5;PARVB;RAPGEF3;ARPIN;TRPV4;FLOT1;GSN;PLEKHH2;DOCK8;PODXL;WASH3P;APC2;PLXND1;SNX1;SCYL3;APBB2;SYNE2
11607,GO:0046326,0.166743137851046,0.932582250084039,5,26,positive regulation of glucose import,BP,PIK3R1;CLTCL1;INSR;PIK3R2;IRS2
9919,GO:0042277,0.167391365939126,0.885223333547557,22,172,peptide binding,MF,APOE;EPHB2;PIK3R1;HLA-B;CTSV;GSTM2;ITGA2;INSR;RNPEPL1;CST3;PEX7;NKTR;FBXO2;HLA-A;RNPEP;APBB3;VIPR1;APBB2;GSTM3;PPARG;LDLRAP1;NPAP1
18765,GO:1904304,0.167448548860256,0.992340011010919,1,2,regulation of gastro-intestinal system smooth muscle contraction,BP,NMU
18766,GO:1904306,0.167448548860256,0.992340011010919,1,2,positive regulation of gastro-intestinal system smooth muscle contraction,BP,NMU
19483,GO:1990379,0.167520346535292,0.992333125059245,1,2,lipid transport across blood brain barrier,BP,APOE
14856,GO:0070664,0.167573300915322,0.919048971287882,7,44,negative regulation of leukocyte proliferation,BP,TNFAIP3;GPNMB;INPP5D;IL20RB;TNFRSF21;DLG5;ERBB2
15323,GO:0071568,0.167605273135857,0.992324975564255,1,2,UFM1 transferase activity,MF,UFL1
19929,GO:2000501,0.16778413124185,0.992307796948545,1,2,regulation of natural killer cell chemotaxis,BP,CXCL14
19930,GO:2000503,0.16778413124185,0.992307796948545,1,2,positive regulation of natural killer cell chemotaxis,BP,CXCL14
4712,GO:0010877,0.167808198433596,0.99230548378272,1,2,lipid transport involved in lipid storage,BP,APOE
11932,GO:0047025,0.167835911687957,0.992302819711246,1,2,3-oxoacyl-[acyl-carrier-protein] reductase (NADH) activity,MF,CBR4
3084,GO:0006658,0.167935262420414,0.940226859196962,4,21,phosphatidylserine metabolic process,BP,SLC27A1;OSBPL10;OSBPL5;SERINC3
15522,GO:0071949,0.167936884097724,0.940226060911394,4,21,FAD binding,MF,CRY2;D2HGDH;PRODH;ACOX3
2588,GO:0005883,0.168136283464797,0.969008403380823,2,7,neurofilament,CC,SHANK2;LDLRAP1
10851,GO:0044387,0.168158905734788,0.969001610214243,2,7,negative regulation of protein kinase activity by regulation of protein phosphorylation,BP,CDK5RAP3;ADARB1
6930,GO:0030545,0.168211038569598,0.884405408072282,22,183,receptor regulator activity,MF,GPNMB;PTHLH;DGKQ;CXCL14;WNT3;KITLG;THNSL2;TNFSF10;FLRT3;C5;SEMA4G;MDK;BMP6;VEGFB;GDF15;CTF1;NUDT6;AREG;UCN2;ENDOU;IL11;TNFSF12
19394,GO:1905954,0.168231253433899,0.918533461985541,7,45,positive regulation of lipid localization,BP,APOE;BMP6;PLA2G6;ACACB;LRP1;LDLRAP1;PLTP
2048,GO:0004798,0.168870069222655,0.992203044662483,1,2,thymidylate kinase activity,MF,CMPK2
2790,GO:0006227,0.168870069222655,0.992203044662483,1,2,dUDP biosynthetic process,BP,CMPK2
2793,GO:0006233,0.168870069222655,0.992203044662483,1,2,dTDP biosynthetic process,BP,CMPK2
4083,GO:0009139,0.168870069222655,0.992203044662483,1,2,pyrimidine nucleoside diphosphate biosynthetic process,BP,CMPK2
4134,GO:0009196,0.168870069222655,0.992203044662483,1,2,pyrimidine deoxyribonucleoside diphosphate metabolic process,BP,CMPK2
4135,GO:0009197,0.168870069222655,0.992203044662483,1,2,pyrimidine deoxyribonucleoside diphosphate biosynthetic process,BP,CMPK2
11526,GO:0046072,0.168870069222655,0.992203044662483,1,2,dTDP metabolic process,BP,CMPK2
11529,GO:0046077,0.168870069222655,0.992203044662483,1,2,dUDP metabolic process,BP,CMPK2
19830,GO:2000322,0.168890531000438,0.968781574371791,2,7,regulation of glucocorticoid receptor signaling pathway,BP,CRY2;CRY1
4418,GO:0010224,0.168952721588154,0.951539494309218,3,14,response to UV-B,BP,XPC;HYAL1;ERCC6
13830,GO:0060455,0.169032332546643,0.992187325594238,1,2,negative regulation of gastric acid secretion,BP,NMU
9437,GO:0036035,0.16907432290178,0.95203391205458,3,13,osteoclast development,BP,FAM20C;FBXW7;GPR68
7136,GO:0030984,0.169224034618882,0.992168732301631,1,2,kininogen binding,MF,CTSV
18440,GO:1903555,0.169391968105682,0.905654153721028,10,70,regulation of tumor necrosis factor superfamily cytokine production,BP,TNFAIP3;GPNMB;PIK3R1;MC1R;NFATC4;DDT;CYBA;ACP5;ZBTB20;ARFGEF2
14001,GO:0060746,0.169511664860468,0.968594253441657,2,7,parental behavior,BP,CREBRF;BRINP1
9759,GO:0039535,0.169724958271965,0.951762501800118,3,13,regulation of RIG-I signaling pathway,BP,DDX60;DHX58;NLRX1
12500,GO:0050660,0.169782638893212,0.908965871677314,9,60,flavin adenine dinucleotide binding,MF,MTHFR;TXNRD3;CRY2;NOS1;D2HGDH;PRODH;ACADS;SDHA;ACOX3
14035,GO:0060831,0.170001217991071,0.951647095732869,3,13,smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,PRKACB;GLI2;GLI3
12851,GO:0051194,0.170280515165277,0.951530320674507,3,13,positive regulation of cofactor metabolic process,BP,INSR;MLXIPL;PFKFB2
16787,GO:0098655,0.170287394672101,0.866744734912434,49,412,cation transmembrane transport,BP,HSPA2;PKD2;EPHB2;ORAI3;KCNAB2;KCNJ15;NOS1;KCNC4;ITPR3;NDUFA4L2;F2R;SLC24A1;TRPV4;NLGN2;ANK3;GJC2;SNTA1;MINK1;GSTM2;VAMP2;KCNJ5;SCNN1A;SCN4B;NIPAL2;TCIRG1;SLC12A7;PLA2G6;ATP6V0A2;KLHL24;SHANK3;HFE;CYBA;KCNMA1;KCNG1;JPH2;PDE2A;SHROOM2;SCN2A;CACNB3;ORAI2;SLC36A4;DLG4;SHANK2;CACNB1;PTPN3;AKAP6;PRKACA;KCNS3;CALHM2
9331,GO:0035845,0.170469164629135,0.968304565009476,2,7,photoreceptor cell outer segment organization,BP,IFT140;NPHP4
11681,GO:0046486,0.170544677286706,0.870635054342527,39,315,glycerolipid metabolic process,BP,SIK1;SREBF1;APOE;INPP5D;LMF1;EGFR;DGKQ;PIK3R1;PI4KAP2;KITLG;PITPNM3;PIK3C2G;PLCH2;PITPNM2;MBOAT2;SLC27A1;PGAP1;ETNK2;PLA2G6;LPIN3;PIGZ;OSBPL10;PI4KAP1;FBXW7;PLA2G7;DDHD2;PIK3C3;FGFR4;PIK3R2;OSBPL5;MPPE1;ACSL1;IRS2;IMPA2;ERBB2;IP6K2;PI4K2B;PEMT;SERINC3
4582,GO:0010675,0.170764838913354,0.899243578028977,12,82,regulation of cellular carbohydrate metabolic process,BP,SIK1;DGKQ;MLYCD;IGFBP4;INSR;PDK1;PFKFB2;ACACB;EPM2AIP1;KAT2B;IRS2;RORA
670,GO:0001881,0.170874523530845,0.929877271620467,5,28,receptor recycling,BP,VAMP3;NSG1;ARAP1;TBC1D16;ARFGEF2
1980,GO:0004702,0.17102266371143,0.896798915590679,13,87,signal transducer, downstream of receptor, with serine/threonine kinase activity,MF,EGFR;EPHB2;MAP3K14;MINK1;INSR;MAP3K12;MAPK10;MAP3K6;RET;FGFR4;ACVR1B;ERBB2;RIPK3
12298,GO:0048665,0.171743943493357,0.967917141273783,2,7,neuron fate specification,BP,GLI2;GLI3
18647,GO:1903999,0.171975771554734,0.991899163357221,1,2,negative regulation of eating behavior,BP,NMU
19783,GO:2000252,0.171975771554734,0.991899163357221,1,2,negative regulation of feeding behavior,BP,NMU
9172,GO:0035556,0.1722957808646,0.847157219282282,221,1981,intracellular signal transduction,BP,TNFAIP3;SERPINE2;GPNMB;SIK1;EPM2A;TP53INP1;PTHLH;APOE;INPP5D;PSD4;DDX60;EGFR;PKD2;TRIM22;PLCD3;SFRP1;EPS8L2;EPHB2;RALGDS;MAP3K14;DGKQ;PIK3R1;BRSK1;RBCK1;DOCK9;CAMKK1;VAV3;CSPG4;PI4KAP2;KITLG;MC1R;ASAP3;STAT1;CAMK2N1;UNC5B;RAB43;RAB40B;NOS1;PLEKHG5;NFATC4;IQSEC2;PIK3C2G;PLXNB1;PLEKHG3;NDRG1;ITPR3;MDM2;PLCD1;CHN2;PIK3IP1;OBSCN;TNFSF10;PRODH;RHOBTB2;RAPGEF3;PCBP4;FLRT3;RASA4;RGL4;RGS2;ACAP3;ADGRB2;F2R;PDCD4;SPTB;NYAP1;RTN4RL1;ZFP36L2;TRPV4;FLOT1;AGAP4;ADORA2B;PLCH2;RALGAPA1;MAPK8IP3;PIDD1;ARHGEF19;RASGEF1A;PITPNM2;FRS3;C5;PSKH1;ADGRL1;MINK1;GSTM2;WWTR1;ASAP2;ARHGEF4;FAM110C;AKAP7;NEK8;MAP2K5;SRGAP3;SESN3;IGFBP4;NUPR1;NISCH;INSR;CELSR1;GSN;CHD3;TTN;CBLC;DDT;RMI2;ARHGEF1;DOCK8;DHX58;CASP14;RICTOR;BMP6;NLRX1;S100A4;MAP2K2;PDK1;SQSTM1;PTK6;FZD7;SYNGAP1;FAM13A;TMEM117;SHARPIN;ARHGAP33;PLA2G6;HOMER2;GDF15;CTF1;PSD3;MAP3K12;WRN;MCTP1;CDK5R1;ATRX;AGAP6;NET1;PI4KAP1;SESN1;MAPK10;SHANK3;TRIM38;ERCC6;RRM2B;SHC2;EDA2R;SPRY2;AGAP7P;MLXIPL;FBXW7;ING4;CDK5RAP3;PAK6;ARAP1;NLRP1;GPR155;TNS2;GNG2;NPHP4;C12ORF66;MAP3K6;APPL2;WNK1;JPH2;PDE2A;RET;DAB2IP;TEAD2;RAPGEFL1;PIK3C3;IFI16;FGFR4;IL20RA;PIK3R2;SCN2A;MYO9A;RPS6KA5;DLG5;BST2;RGL2;ARHGEF17;EFS;LPAR6;DMTN;STAT2;ARFGEF2;WWC3;TFDP2;UCN2;DLG4;TSSK1B;IQSEC1;TNFRSF25;ZFP36L1;IL11;IRS2;CAPS;ERN1;IVNS1ABP;RAD50;TKFC;ZMAT3;APBB2;ARHGEF9;RAPGEF5;TRAF5;RANBP9;ERBB2;PLCB3;ARHGAP23;AKAP6;RORA;PRKACA;DOCK6;CXXC5;ACKR3;DOCK3;RIPK3;AIP;CIT;NPNT;SERINC3;ECM1
16134,GO:0090174,0.172566932977065,0.887862727282958,17,125,organelle membrane fusion,BP,SYT8;EVI5L;VAV3;VAMP3;TBC1D8;VPS11;SYTL1;C2CD4C;SPG11;SYT15;VAMP2;VPS39;TBC1D17;TSNARE1;SYT7;TBC1D16;SGSM2
6843,GO:0030318,0.172615872818365,0.950549965525642,3,13,melanocyte differentiation,BP,KITLG;HPS4;GLI3
6716,GO:0030133,0.17267870570576,0.873344854300159,31,253,transport vesicle,CC,MAP6;SREBF1;PTPRS;SYT8;SYN1;BRSK1;VAMP3;RAB40B;HLA-B;SYTL1;AP1G2;C2CD4C;CLTCL1;PCSK1;VAMP2;SEPT6;NRSN2;BLOC1S3;SEPT5;DNM1;MCTP1;RPH3AL;HLA-A;SYT7;FGFR4;AREG;DLG4;DMXL2;SYNGR1;TH;LDLRAP1
12555,GO:0050729,0.172815317166246,0.90667098950033,9,64,positive regulation of inflammatory response,BP,EGFR;PDCD4;TRPV4;ADORA2B;ITGA2;DDT;MGST2;PLA2G7;PDE2A
4594,GO:0010712,0.17285981049531,0.937489731961703,4,22,regulation of collagen metabolic process,BP,F2R;ITGA2;CST3;PPARG
12878,GO:0051240,0.172884052480004,0.852969005416212,112,972,positive regulation of multicellular organismal process,BP,TNFAIP3;POSTN;SERPINE2;APOE;INPP5D;DDX60;EGFR;FAM20C;CAPRIN2;SLITRK6;OBSL1;KCTD11;EPHB2;PIK3R1;RNF135;SULF2;WNT3;ISG15;TENM4;ZFPM1;KITLG;CUL7;STAT1;IMPACT;NOS1;NFATC4;FERMT1;CYP26B1;PLXNB1;CRTC1;IFITM1;RAPGEF3;FAM210B;FLRT3;RGS2;IL20RB;ADGRB2;F2R;CAPN7;TRPV4;FLOT1;GLI2;NLGN2;ADORA2B;GJC2;C5;ADGRL1;AMIGO2;WWTR1;ITGA2;GLI3;NMU;TRAK1;BAIAP2;DDT;PLXNB3;DHX58;SLC27A1;BMP6;NLRX1;VEGFB;PTK6;ETV5;KDM4C;HYAL1;BBS2;TCF4;PLAG1;CA2;SHANK3;HMG20B;CYBA;ACACB;NLRP1;LRP1;LRRN3;BRINP1;ZBTB20;RET;ZMYND8;DAB2IP;IFI16;DLG5;BTG1;VDR;PLXND1;DMTN;ARFGEF2;ACVR1B;CCDC88B;DLG4;PTK7;SHANK2;RSAD2;ZFP36L1;CLSTN3;ALOX15B;GPR21;TKFC;TNFSF12;STAT6;SRPX2;GPR68;AKAP6;RORA;PPARG;UFL1;FOXP2;SMURF1;NPNT;CTNNBIP1;ECM1
9778,GO:0040008,0.173178046810824,0.862985604634909,53,444,regulation of growth,BP,SERPINE2;ULK2;APOE;GAMT;EGFR;PTPRS;CAPRIN2;SFRP1;KCTD11;WNT3;HTRA1;TFCP2L1;SPOCK1;NDN;LTBP4;KIF26A;MT1X;SEMA4G;MAP2K5;IGFBP4;JARID2;INSR;CCDC85B;SQSTM1;PTK6;TMEM8B;EPB41L3;HYAL1;BBS2;WRN;CDK5R1;NET1;CYBA;SLIT3;ING4;RAI1;ACACB;DAB2IP;BTG1;BST2;WWC3;ACVR1B;IGFBP6;CLSTN3;ALOX15B;GPR21;ZMAT3;APBB2;ERBB2;AKAP6;PPARG;IP6K2;SMURF1
1707,GO:0004300,0.173253921392377,0.966375388967059,2,8,enoyl-CoA hydratase activity,MF,ECI1;EHHADH
2670,GO:0006022,0.173456426753458,0.88887112515611,16,116,aminoglycan metabolic process,BP,CSPG4;SDC3;NAGLU;IDUA;HGSNAT;B4GALT6;HEXA;GPC2;B4GALT2;HEXB;HYAL1;B3GNT9;NDST2;XYLT1;SGSH;GLB1
10710,GO:0044060,0.173477182062404,0.937479336972432,4,21,regulation of endocrine process,BP,CRY1;F2R;BMP6;RAB11FIP3
5436,GO:0016301,0.173537080793113,0.857124454925355,77,633,kinase activity,MF,ULK2;SIK1;EGFR;FAM20C;EPHB2;MAP3K14;DGKQ;PIK3R1;BRSK1;CAMKK1;PI4KAP2;KITLG;PRKACB;CMPK2;CNTRL;PIK3C2G;CDK18;SPEG;NMRK1;LTBP4;OBSCN;ALPK1;NEK9;PSKH1;MINK1;ULK1;FGGY;LTBP1;NEK8;MAP2K5;INSR;CDK14;TTN;ETNK2;MAP2K2;PDK1;SQSTM1;PTK6;PDIK1L;MAP3K12;CDK5R1;EFNB3;PI4KAP1;MAPK10;PAK6;PFKFB2;TK2;MAP3K6;MYO3B;WNK1;STK16;RET;PIK3C3;FGFR4;PIK3R2;RPS6KA5;NADK;STK19;LMTK3;ACVR1B;DLG4;TSSK1B;ADCK5;WEE1;PTK7;MARK4;IRS2;ERN1;RAD50;TKFC;ERBB2;PRKACA;UCKL1;IP6K2;RIPK3;PI4K2B;CIT
3168,GO:0006780,0.173686224952403,0.991729072741849,1,2,uroporphyrinogen III biosynthetic process,BP,UROS
11694,GO:0046502,0.173686224952403,0.991729072741849,1,2,uroporphyrinogen III metabolic process,BP,UROS
6841,GO:0030316,0.173734723851017,0.906516163337429,9,58,osteoclast differentiation,BP,INPP5D;FAM20C;SFRP1;PIK3R1;CD109;FAM213A;CA2;FBXW7;GPR68
10353,GO:0043183,0.173773307356848,0.991720361094941,1,2,vascular endothelial growth factor receptor 1 binding,MF,VEGFB
6673,GO:0030042,0.173939309058098,0.921118088853409,6,35,actin filament depolymerization,BP,SPTB;GSN;PLEKHH2;TRIOBP;CAPG;DMTN
10317,GO:0043124,0.173940344032122,0.921117480312388,6,35,negative regulation of I-kappaB kinase/NF-kappaB signaling,BP,TNFAIP3;STAT1;NLRX1;NLRP1;DAB2IP;RORA
623,GO:0001807,0.173956156340818,0.991702052623929,1,2,regulation of type IV hypersensitivity,BP,IL20RB
873,GO:0002225,0.174033741468551,0.991694277385499,1,2,positive regulation of antimicrobial peptide production,BP,KLK5
1152,GO:0002760,0.174033741468551,0.991694277385499,1,2,positive regulation of antimicrobial humoral response,BP,KLK5
1171,GO:0002803,0.174033741468551,0.991694277385499,1,2,positive regulation of antibacterial peptide production,BP,KLK5
12626,GO:0050850,0.174062420431671,0.936886832594264,4,22,positive regulation of calcium-mediated signaling,BP,PKD2;GSTM2;JPH2;AKAP6
4970,GO:0015085,0.17429173247824,0.902740685441415,10,64,calcium ion transmembrane transporter activity,MF,PKD2;ORAI3;ITPR3;SLC24A1;TRPV4;JPH2;PDE2A;CACNB3;ORAI2;CACNB1
13781,GO:0060392,0.174343254062941,0.991663219520862,1,2,negative regulation of SMAD protein signal transduction,BP,PBLD
5321,GO:0016049,0.174378426329312,0.866024431518315,42,344,cell growth,BP,POSTN;SERPINE2;ULK2;APOE;EGFR;PTPRS;CAPRIN2;SFRP1;WNT3;HTRA1;IMPACT;PLXNB1;SPOCK1;NDN;LTBP4;FLRT3;KIF26A;SPG11;SEMA4G;ULK1;MAP2K5;IGFBP4;CCDC85B;PLXNB3;EPB41L3;HYAL1;CDK5R1;NET1;CYBA;SLIT3;BTG1;BST2;ACVR1B;IGFBP6;CLSTN3;APBB2;ERBB2;AKAP6;PPARG;LAMB2;IP6K2;SMURF1
17573,GO:1901252,0.174708653202196,0.991626471626777,1,2,regulation of intracellular transport of viral material,BP,BST2
17983,GO:1902473,0.174780210119433,0.966986363301512,2,7,regulation of protein localization to synapse,BP,NLGN2;CLSTN3
19678,GO:2000026,0.174909342386028,0.848530983930718,143,1267,regulation of multicellular organismal development,BP,TNFAIP3;SERPINE2;ULK2;GPNMB;PTHLH;APOE;INPP5D;OAS2;EGFR;PTPRS;FAM20C;CAPRIN2;ASH2L;DIXDC1;SLITRK6;SFRP1;OBSL1;KCTD11;EPHB2;PIK3R1;ADAMTS7;TSC22D3;SULF2;WNT3;ISG15;TENM4;RGMA;ZFPM1;KITLG;CUL7;PRICKLE2;STAT1;IMPACT;MYL9;NOS1;PRKACB;KLF13;NFATC4;FERMT1;CYP26B1;PLXNB1;SPOCK1;MDM2;CRTC1;CSMD3;RAPGEF3;FAM210B;CTSV;FLRT3;ADGRB2;PDCD4;RTN4RL1;ZFP36L2;TRPV4;FLOT1;GLI2;NLGN2;GJC2;ARHGEF19;PER2;C5;ADGRL1;AMIGO2;WWTR1;SEMA4G;GLI3;MAP2K5;TRAK1;JARID2;NUPR1;INSR;CELSR1;BAIAP2;PLXNB3;CD109;BMP6;VEGFB;PTK6;FZD7;ETV5;SYNGAP1;FAM213A;KDM4C;HYAL1;MMRN2;TCF4;NPHP3;PLAG1;IDH2;TNFRSF21;CDK5R1;CA2;EFNB3;SHANK3;HMG20B;AGO4;SPRY2;FBXW7;CDK5RAP3;LMO2;ACACB;LRP1;LRRN3;BRINP1;JPH2;MAF;RET;ZMYND8;DAB2IP;CASZ1;MYSM1;DLG5;BTG1;VDR;TNRC6C;PLXND1;PMP22;NRARP;ACVR1B;DLG4;PTK7;SHANK2;ZFP36L1;CLSTN3;KAT2B;APOLD1;ALOX15B;ZSWIM8;PBLD;TNFSF12;STAT6;SOX13;SRPX2;ERBB2;GPR68;AKAP6;SSH3;PPARG;UFL1;FOXP2;SMURF1;CTNNBIP1;ECM1
632,GO:0001822,0.174998453357421,0.877342906550355,24,180,kidney development,BP,ACTA2;PKD2;SFRP1;KIF26B;SULF2;STAT1;LZTS2;GLI2;WWTR1;GLI3;BMP6;NPHP3;PODXL;CA2;NID1;RRM2B;TNS2;RET;KLHL3;DLG5;GCNT4;LAMB2;NPNT;CTNNBIP1
11270,GO:0045597,0.175738857142755,0.856281504633898,71,597,positive regulation of cell differentiation,BP,SERPINE2;APOE;INPP5D;FAM20C;CAPRIN2;SFRP1;OBSL1;KCTD11;EPHB2;WNT3;TENM4;KITLG;CUL7;STAT1;IMPACT;CYP26B1;HSF4;PLXNB1;CRTC1;IFITM1;FAM210B;FLOT1;GLI2;GJC2;SULT1E1;WWTR1;GLI3;BOC;LTBP3;TRAK1;BAIAP2;PLXNB3;TRIOBP;BMP6;PTK6;ETV5;KDM4C;GDF15;TCF4;PLAG1;NET1;CA2;SHANK3;ADIRF;HMG20B;THRA;BRINP1;RET;ZMYND8;DAB2IP;OLFM2;DLG5;BTG1;VDR;MAMSTR;PLXND1;DMTN;ACVR1B;DLG4;PTK7;SHANK2;ZFP36L1;ALOX15B;GPR68;AKAP6;PPARG;UFL1;CCDC3;SMURF1;NPNT;CTNNBIP1
12307,GO:0048675,0.175748498637535,0.893408502585305,13,87,axon extension,BP,ULK2;APOE;PTPRS;WNT3;PLXNB1;NDN;SPG11;SEMA4G;ULK1;PLXNB3;CDK5R1;SLIT3;LAMB2
1544,GO:0003941,0.175878543082203,0.991508217946134,1,2,L-serine ammonia-lyase activity,MF,SRR
9821,GO:0042058,0.175925819909218,0.901276049537994,10,69,regulation of epidermal growth factor receptor signaling pathway,BP,EGFR;MVB12B;RHBDF1;CBLC;PTK6;SPRY2;FBXW7;ARAP1;DAB2IP;PTPN3
16856,GO:0098810,0.176093113577775,0.96547316084059,2,8,neurotransmitter reuptake,BP,NOS1;PER2
3257,GO:0006924,0.176258367289869,0.965420336730001,2,8,activation-induced cell death of T cells,BP,TSC22D3;RIPK3
16535,GO:0097332,0.17641799928714,0.991453381342613,1,2,response to antipsychotic drug,BP,PRKACB
5761,GO:0016936,0.17653792778052,0.991441163988908,1,2,galactoside binding,MF,GLB1
8995,GO:0035150,0.176686611661911,0.900756316254648,10,69,regulation of tube size,BP,APOE;EGFR;NOS1;RGS2;F2R;ADORA2B;PER2;PLA2G6;BBS2;GCLC
12653,GO:0050880,0.176686611661911,0.900756316254648,10,69,regulation of blood vessel size,BP,APOE;EGFR;NOS1;RGS2;F2R;ADORA2B;PER2;PLA2G6;BBS2;GCLC
17774,GO:1901880,0.176814517876913,0.913602497003769,7,42,negative regulation of protein depolymerization,BP,SPTB;GSN;PLEKHH2;TRIOBP;APC2;CAPG;DMTN
12780,GO:0051094,0.177014134729706,0.851096329364447,96,823,positive regulation of developmental process,BP,TNFAIP3;SERPINE2;APOE;INPP5D;FAM20C;CAPRIN2;SLITRK6;SFRP1;OBSL1;KCTD11;EPHB2;WNT3;ISG15;TENM4;KITLG;CUL7;STAT1;IMPACT;CYP26B1;HSF4;PLXNB1;CRTC1;IFITM1;RAPGEF3;FAM210B;FLRT3;ADGRB2;FLOT1;GLI2;NLGN2;GJC2;SULT1E1;C5;ADGRL1;AMIGO2;WWTR1;GLI3;BOC;LTBP3;TRAK1;INSR;BAIAP2;PLXNB3;TRIOBP;BMP6;VEGFB;PTK6;ETV5;KDM4C;HYAL1;GDF15;BBS2;TCF4;PLAG1;NET1;CA2;SHANK3;ADIRF;HMG20B;THRA;ACACB;LRRN3;BRINP1;RET;ZMYND8;DAB2IP;DDHD2;OLFM2;DLG5;BTG1;VDR;MAMSTR;PLXND1;DMTN;ACVR1B;DLG4;PTK7;SHANK2;ZFP36L1;LMNA;CLSTN3;ALOX15B;GPR21;TNFSF12;STAT6;SRPX2;GPR68;AKAP6;PPARG;UFL1;CCDC3;FOXP2;SMURF1;NPNT;CTNNBIP1;ECM1
7055,GO:0030850,0.177138205064671,0.919231291455835,6,35,prostate gland development,BP,SFRP1;SERPINB5;GLI2;GLI3;PLAG1;ALOX15B
14915,GO:0070821,0.177159552304976,0.91313153963372,7,44,tertiary granule membrane,CC,KCNAB2;GAA;HGSNAT;TMC6;SLC2A3;CYBA;NBEAL2
11843,GO:0046849,0.177342334072664,0.908208628722115,8,51,bone remodeling,BP,TNFAIP3;INPP5D;EGFR;SFRP1;CA2;ACP5;SYT7;IL20RA
1090,GO:0002678,0.177390067318096,0.991354077773788,1,2,positive regulation of chronic inflammatory response,BP,ADORA2B
2034,GO:0004776,0.177410882011823,0.991351944490446,1,2,succinate-CoA ligase (GDP-forming) activity,MF,SUCLG2
1616,GO:0004047,0.177455423395636,0.991347378500402,1,2,aminomethyltransferase activity,MF,AMT
8109,GO:0032805,0.17748244436422,0.991344607901305,1,2,positive regulation of low-density lipoprotein particle receptor catabolic process,BP,APOE
8839,GO:0034644,0.177708817782567,0.900057095660203,10,69,cellular response to UV,BP,DDB2;TP53INP1;XPC;PIK3R1;MC1R;IMPACT;NFATC4;MDM2;POLH;HYAL1
12249,GO:0048557,0.177733744419869,0.96607013063992,2,7,embryonic digestive tract morphogenesis,BP,GLI3;TCF7
1139,GO:0002731,0.177751364000547,0.991317007527966,1,2,negative regulation of dendritic cell cytokine production,BP,BST2
10089,GO:0042612,0.177802380704853,0.964073254083719,2,9,MHC class I protein complex,CC,HLA-B;HLA-A
8686,GO:0034331,0.177918866437386,0.966012347974318,2,7,cell junction maintenance,BP,F2R;NLGN2
16873,GO:0098839,0.17793037227189,0.966008755243963,2,7,postsynaptic density membrane,CC,PTPRS;DLG4
17076,GO:0099634,0.17793037227189,0.966008755243963,2,7,postsynaptic specialization membrane,CC,PTPRS;DLG4
7051,GO:0030837,0.178023005176806,0.918385280987169,6,37,negative regulation of actin filament polymerization,BP,SPTB;FHOD3;GSN;TRIOBP;CAPG;DMTN
993,GO:0002455,0.178041710830449,0.947163162580212,3,15,humoral immune response mediated by circulating immunoglobulin,BP,C5;C1RL;SERPING1
13133,GO:0051725,0.178064921765254,0.991284764551682,1,2,protein de-ADP-ribosylation,BP,MACROD1
17781,GO:1901896,0.178124331158198,0.99127864808806,1,2,positive regulation of calcium-transporting ATPase activity,BP,HSPA2
10593,GO:0043586,0.178134586746327,0.947621042423519,3,14,tongue development,BP,EGFR;CYP26B1;GLI3
13905,GO:0060589,0.178153468252846,0.865887967740454,36,284,nucleoside-triphosphatase regulator activity,MF,GPSM1;ALS2CL;RALGDS;EVI5L;VAV3;ASAP3;TBC1D8;PLXNB1;CHN2;RASA4;RGS2;ACAP3;AGAP4;RALGAPA1;ARHGEF19;TBC1D19;ASAP2;SRGAP3;RIN1;ARHGEF1;SYNGAP1;FAM13A;ARHGAP33;ARHGAP27;AGAP6;AGAP7P;ARAP1;TBC1D17;RGS12;APPL2;DAB2IP;PIK3R2;MYO9A;TBC1D16;SGSM2;ARHGAP23
1121,GO:0002710,0.178410461650003,0.964729294859657,2,8,negative regulation of T cell mediated immunity,BP,IL20RB;HFE
1924,GO:0004620,0.178498567685986,0.903181949375973,9,60,phospholipase activity,MF,PLCD3;PLCD1;PLCH2;PLA2G6;PLD3;PLA2G7;DDHD2;SMPDL3B;PLCB3
3520,GO:0007494,0.178557289129621,0.96581275429375,2,7,midgut development,BP,EGFR;RET
15646,GO:0072189,0.178557600362539,0.965812656869909,2,7,ureter development,BP,NPHP3;RET
7727,GO:0032230,0.178666981896458,0.965778410334583,2,7,positive regulation of synaptic transmission, GABAergic,BP,NLGN2;CA2
5541,GO:0016533,0.178798917905502,0.991209030266879,1,2,cyclin-dependent protein kinase 5 holoenzyme complex,CC,CDK5R1
17392,GO:1900150,0.17900789287475,0.991187401933978,1,2,regulation of defense response to fungus,BP,FAM3A
4644,GO:0010769,0.179191774241891,0.872110583919277,26,197,regulation of cell morphogenesis involved in differentiation,BP,POSTN;ULK2;APOE;PTPRS;CAPRIN2;OBSL1;EPHB2;WNT3;CUL7;NFATC4;PLXNB1;SEMA4G;TRAK1;BAIAP2;PLXNB3;TRIOBP;SYNGAP1;CDK5R1;NET1;EFNB3;SHANK3;RET;PLXND1;DMTN;ZSWIM8;SSH3
16218,GO:0090289,0.179295784918201,0.991157557857974,1,2,regulation of osteoclast proliferation,BP,TNFAIP3
13542,GO:0060027,0.179458731239881,0.965530084158494,2,7,convergent extension involved in gastrulation,BP,SFRP1;NPHP3
8181,GO:0032929,0.179823085129348,0.991102751281808,1,2,negative regulation of superoxide anion generation,BP,ACP5
7961,GO:0032580,0.179848190339627,0.898657884406971,10,68,Golgi cisterna membrane,CC,NSG1;B4GALNT4;GOLGA8A;GAL3ST4;B4GALT6;GOLGA8B;ASAP2;B4GALT2;ARAP1;GOLGA8N
9828,GO:0042078,0.179948363738164,0.99108970257128,1,2,germ-line stem cell division,BP,ETV5
12086,GO:0048133,0.179948363738164,0.99108970257128,1,2,male germ-line stem cell asymmetric division,BP,ETV5
16811,GO:0098728,0.179948363738164,0.99108970257128,1,2,germline stem cell asymmetric division,BP,ETV5
15195,GO:0071364,0.180336567919189,0.917164710065386,6,36,cellular response to epidermal growth factor stimulus,BP,EGFR;ZFP36L2;BAIAP2;DAB2IP;ZFP36L1;ERBB2
627,GO:0001817,0.180495639163408,0.858345843677735,48,410,regulation of cytokine production,BP,TNFAIP3;POSTN;GPNMB;INPP5D;DDX60;PTPRS;PIK3R1;RNF135;SULF2;HERC5;ISG15;ZFPM1;MC1R;STAT1;NFATC4;FERMT1;IL20RB;F2R;PDCD4;TRPV4;FLOT1;ADORA2B;C5;MAP2K5;DDT;ZNF287;DHX58;NLRX1;TNFRSF21;TREX1;HFE;CYBA;ELF1;NLRP1;ERMAP;ACP5;ZBTB20;IFI16;RPS6KA5;BST2;ARFGEF2;CCDC88B;RSAD2;ALOX15B;TKFC;STAT6;RORA;RIPK3
8002,GO:0032640,0.181135634352604,0.897575859547633,10,71,tumor necrosis factor production,BP,TNFAIP3;GPNMB;PIK3R1;MC1R;NFATC4;DDT;CYBA;ACP5;ZBTB20;ARFGEF2
17999,GO:1902514,0.181158501196577,0.964994380595755,2,7,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel,BP,NOS1;CACNB1
11978,GO:0047374,0.18126851236619,0.990951556716493,1,2,methylumbelliferyl-acetate deacetylase activity,MF,CES2
3266,GO:0006937,0.18126870858767,0.894383395113202,11,78,regulation of muscle contraction,BP,MYL9;NOS1;RGS2;F2R;ADORA2B;GSTM2;ITGA2;NMU;TNNI2;PRKACA;NPNT
4538,GO:0010614,0.181319608412244,0.946236453420341,3,14,negative regulation of cardiac muscle hypertrophy,BP,RGS2;JARID2;LMNA
4877,GO:0014741,0.181319608412244,0.946236453420341,3,14,negative regulation of muscle hypertrophy,BP,RGS2;JARID2;LMNA
12676,GO:0050913,0.181498534326724,0.962848848302362,2,9,sensory perception of bitter taste,BP,REEP2;ITPR3
7042,GO:0030823,0.181507967447676,0.946154163384068,3,14,regulation of cGMP metabolic process,BP,APOE;NOS1;ADORA2B
20230,GO:2001204,0.181924301823375,0.964751877662765,2,7,regulation of osteoclast development,BP,FBXW7;GPR68
3794,GO:0008373,0.182010334747752,0.945934468027418,3,14,sialyltransferase activity,MF,ST6GALNAC2;ST6GALNAC6;ST3GAL5
16621,GO:0097503,0.182010334747752,0.945934468027418,3,14,sialylation,BP,ST6GALNAC2;ST6GALNAC6;ST3GAL5
4425,GO:0010256,0.182106054024863,0.85864528475347,44,358,endomembrane system organization,BP,SERPINE2;ALS2CL;OBSL1;CUL7;REEP2;RAB43;MICALL1;VPS11;NDRG1;GOLGA8A;F2R;NEK9;FLOT1;ANK3;GOLGA8B;GSN;BAIAP2;SUN1;AHNAK2;BLOC1S3;MAP2K2;SQSTM1;EPB41L3;DNM1;ANO9;HOOK2;WASH3P;CHMP1B;GOLGA8N;REEP4;CCDC136;RFX2;PRX;PIK3C3;SYT7;ARFGEF2;LMNA;GOLGB1;SYNGR1;SYNE2;PI4K2B;COG1;SNX33;CIT
9194,GO:0035588,0.182228537133672,0.963489079670642,2,8,G-protein coupled purinergic receptor signaling pathway,BP,ADORA2B;GPR87
11615,GO:0046337,0.182233416830182,0.945836806314016,3,14,phosphatidylethanolamine metabolic process,BP,SLC27A1;ETNK2;LPIN3
3073,GO:0006641,0.182328817876812,0.90477208553824,8,53,triglyceride metabolic process,BP,SIK1;SREBF1;APOE;LMF1;LPIN3;FBXW7;DDHD2;ACSL1
4783,GO:0010975,0.182456861971815,0.860200726698797,40,318,regulation of neuron projection development,BP,ULK2;APOE;PTPRS;CAPRIN2;SFRP1;OBSL1;EPHB2;WNT3;RGMA;CUL7;NFATC4;PLXNB1;SPOCK1;MDM2;CRTC1;CSMD3;RTN4RL1;TRPV4;SEMA4G;TRAK1;BAIAP2;PLXNB3;PTK6;SYNGAP1;CDK5R1;EFNB3;SHANK3;LRP1;RET;ZMYND8;DAB2IP;DLG5;PLXND1;PMP22;DLG4;PTK7;SHANK2;ZSWIM8;SSH3;SMURF1
709,GO:0001935,0.182565191164756,0.890708195707451,12,85,endothelial cell proliferation,BP,APOE;STAT1;PLXNB3;RICTOR;BMP6;VEGFB;CYBA;NRARP;ERN1;TNFSF12;PPARG;ECM1
771,GO:0002027,0.182701737993718,0.909663955989762,7,44,regulation of heart rate,BP,SREBF1;MDM2;SNTA1;NMU;KCNJ5;SCN4B;PRKACA
3384,GO:0007162,0.182711052432125,0.873277947982951,22,168,negative regulation of cell adhesion,BP,TGFBI;POSTN;SERPINE2;GPNMB;PIK3R1;PLXNB1;SPOCK1;IL20RB;TRPV4;GLI3;MAP2K5;PLXNB3;FZD7;PODXL;TNFRSF21;HFE;DLG5;PLXND1;DMTN;NRARP;CD9;ERBB2
1061,GO:0002589,0.182842393799337,0.990785322869485,1,2,regulation of antigen processing and presentation of peptide antigen via MHC class I,BP,HFE
1062,GO:0002590,0.182842393799337,0.990785322869485,1,2,negative regulation of antigen processing and presentation of peptide antigen via MHC class I,BP,HFE
615,GO:0001784,0.18289488236066,0.923463624829889,5,27,phosphotyrosine residue binding,MF,PIK3R1;CBLC;PIK3R2;PTPN3;LDLRAP1
9262,GO:0035697,0.183065439983324,0.990761629216859,1,2,CD8-positive, alpha-beta T cell extravasation,BP,RIPK3
9263,GO:0035698,0.183065439983324,0.990761629216859,1,2,CD8-positive, alpha-beta cytotoxic T cell extravasation,BP,RIPK3
15890,GO:0072683,0.183065439983324,0.990761629216859,1,2,T cell extravasation,BP,RIPK3
19890,GO:2000407,0.183065439983324,0.990761629216859,1,2,regulation of T cell extravasation,BP,RIPK3
19908,GO:2000449,0.183065439983324,0.990761629216859,1,2,regulation of CD8-positive, alpha-beta T cell extravasation,BP,RIPK3
19910,GO:2000452,0.183065439983324,0.990761629216859,1,2,regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation,BP,RIPK3
9117,GO:0035442,0.183084826261629,0.990759568269738,1,2,dipeptide transmembrane transport,BP,CA2
10220,GO:0042938,0.183084826261629,0.990759568269738,1,2,dipeptide transport,BP,CA2
16086,GO:0090088,0.183084826261629,0.990759568269738,1,2,regulation of oligopeptide transport,BP,CA2
16087,GO:0090089,0.183084826261629,0.990759568269738,1,2,regulation of dipeptide transport,BP,CA2
20134,GO:2000878,0.183084826261629,0.990759568269738,1,2,positive regulation of oligopeptide transport,BP,CA2
20135,GO:2000880,0.183084826261629,0.990759568269738,1,2,positive regulation of dipeptide transport,BP,CA2
20196,GO:2001148,0.183084826261629,0.990759568269738,1,2,regulation of dipeptide transmembrane transport,BP,CA2
20197,GO:2001150,0.183084826261629,0.990759568269738,1,2,positive regulation of dipeptide transmembrane transport,BP,CA2
6335,GO:0021513,0.18311345961271,0.964373894996266,2,7,spinal cord dorsal/ventral patterning,BP,GLI2;GLI3
9461,GO:0036092,0.183200878487452,0.916000319984113,6,33,phosphatidylinositol-3-phosphate biosynthetic process,BP,PIK3R1;PIK3C2G;PIK3C3;FGFR4;PIK3R2;IRS2
17216,GO:0110053,0.183231571395155,0.870666982396532,24,187,regulation of actin filament organization,BP,SFRP1;EPS8L2;PIK3R1;ASAP3;RAPGEF3;ARPIN;SPTB;WIPF1;FHOD3;GSN;BAIAP2;PLEKHH2;TRIOBP;RICTOR;WHAMMP3;SHANK3;WASH3P;ARAP1;CAPG;SYNPO2;DMTN;ALMS1;SSH3;CIT
7374,GO:0031434,0.183268734499193,0.909573253440483,7,42,mitogen-activated protein kinase kinase binding,MF,EGFR;EPHB2;INSR;RET;DAB2IP;FGFR4;ERBB2
9545,GO:0036324,0.183409404659444,0.99072502469222,1,2,vascular endothelial growth factor receptor-2 signaling pathway,BP,DAB2IP
5227,GO:0015842,0.183529018808117,0.990712276651371,1,2,aminergic neurotransmitter loading into synaptic vesicle,BP,TH
16800,GO:0098700,0.183529018808117,0.990712276651371,1,2,neurotransmitter loading into synaptic vesicle,BP,TH
1803,GO:0004450,0.183670040034915,0.990697234674872,1,2,isocitrate dehydrogenase (NADP+) activity,MF,IDH2
2718,GO:0006097,0.183670040034915,0.990697234674872,1,2,glyoxylate cycle,BP,IDH2
19299,GO:1905602,0.183775123370488,0.99068601724017,1,2,positive regulation of receptor-mediated endocytosis involved in cholesterol transport,BP,LDLRAP1
13064,GO:0051593,0.183837849204493,0.962960887404334,2,8,response to folic acid,BP,MTHFR;GSN
1238,GO:0002933,0.183860878521391,0.990676857505797,1,2,lipid hydroxylation,BP,CYP3A5
17092,GO:0101020,0.183860878521391,0.990676857505797,1,2,estrogen 16-alpha-hydroxylase activity,MF,CYP3A5
13633,GO:0060166,0.183873853216675,0.990675471210243,1,2,olfactory pit development,BP,ALDH1A3
8625,GO:0034162,0.1840393486269,0.945043859397373,3,14,toll-like receptor 9 signaling pathway,BP,PTPRS;PIK3C3;RSAD2
15213,GO:0071392,0.184291289434507,0.931685542930768,4,22,cellular response to estradiol stimulus,BP,EGFR;SFRP1;FAM210B;ITGA2
12794,GO:0051119,0.184560857254808,0.944814101717735,3,14,sugar transmembrane transporter activity,MF,SLC2A3;SLC2A1;SLC2A11
1283,GO:0003093,0.184592966308946,0.96271193865474,2,8,regulation of glomerular filtration,BP,F2R;CYBA
17393,GO:1900151,0.184653438457181,0.944773277589406,3,14,regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,BP,ZFP36L2;TNRC6C;ZFP36L1
17395,GO:1900153,0.184653438457181,0.944773277589406,3,14,positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,BP,ZFP36L2;TNRC6C;ZFP36L1
17870,GO:1902174,0.184713823090259,0.990585480808812,1,2,positive regulation of keratinocyte apoptotic process,BP,GSN
19051,GO:1904954,0.185131063379173,0.990540601675736,1,2,canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation,BP,WNT3
147,GO:0000302,0.185303669450635,0.873458230984708,20,163,response to reactive oxygen species,BP,TNFAIP3;APOE;EGFR;PKD2;TXNRD3;STAT1;IMPACT;MDM2;SESN3;ENDOG;HYAL1;CST3;TXNIP;NET1;SESN1;ERCC6;AREG;MTR;STAT6;PRDX5
12884,GO:0051250,0.185362390006099,0.891498806663751,11,78,negative regulation of lymphocyte activation,BP,TNFAIP3;GPNMB;INPP5D;SFRP1;IL20RB;GLI3;TNFRSF21;HFE;DLG5;NRARP;ERBB2
9254,GO:0035674,0.185483854129787,0.990502562589202,1,2,tricarboxylic acid transmembrane transport,BP,SLC13A5
10361,GO:0043196,0.185488859704877,0.990502022262651,1,2,varicosity,CC,DNM1
1972,GO:0004690,0.185580528211309,0.963584223908656,2,7,cyclic nucleotide-dependent protein kinase activity,MF,PRKACB;PRKACA
5261,GO:0015908,0.185617763455194,0.902719412649502,8,52,fatty acid transport,BP,APOE;CPT2;SLC27A1;PLA2G6;ACACB;ACSL1;IRS2;PPARG
19656,GO:1990967,0.185793521113215,0.990469103533643,1,2,multi-organism toxin transport,BP,RAB40B
3439,GO:0007231,0.185920626169107,0.990455351145338,1,2,osmosensory signaling pathway,BP,TRPV4
15979,GO:0086010,0.186157856820133,0.931409374048949,4,20,membrane depolarization during action potential,BP,ANK3;SCN4B;SCN2A;PTPN3
524,GO:0001631,0.186198324613947,0.990425266761287,1,2,cysteinyl leukotriene receptor activity,MF,LTB4R2
525,GO:0001632,0.186198324613947,0.990425266761287,1,2,leukotriene B4 receptor activity,MF,LTB4R2
2152,GO:0004974,0.186198324613947,0.990425266761287,1,2,leukotriene receptor activity,MF,LTB4R2
14409,GO:0061737,0.186198324613947,0.990425266761287,1,2,leukotriene signaling pathway,BP,LTB4R2
18874,GO:1904580,0.186425964624495,0.990400566296887,1,2,regulation of intracellular mRNA localization,BP,ZFP36L1
18875,GO:1904582,0.186425964624495,0.990400566296887,1,2,positive regulation of intracellular mRNA localization,BP,ZFP36L1
16036,GO:0086103,0.186594280313516,0.963257588829478,2,7,G-protein coupled receptor signaling pathway involved in heart process,BP,NOS1;RGS2
4982,GO:0015108,0.186661976385345,0.913369712959989,6,36,chloride transmembrane transporter activity,MF,CLCN6;SLC12A7;CLCA2;ANO9;ANO1;CLCN7
5463,GO:0016361,0.186677796019572,0.990373199795948,1,2,activin receptor activity, type I,MF,ACVR1B
12103,GO:0048179,0.186677796019572,0.990373199795948,1,2,activin receptor complex,CC,ACVR1B
2294,GO:0005254,0.18676926469006,0.920807402635991,5,29,chloride channel activity,MF,CLCN6;CLCA2;ANO9;ANO1;CLCN7
5988,GO:0018963,0.18683763581055,0.9903558076048,1,2,phthalate metabolic process,BP,TH
2066,GO:0004821,0.18711400983514,0.990325694227479,1,2,histidine-tRNA ligase activity,MF,HARS2
2916,GO:0006427,0.18711400983514,0.990325694227479,1,2,histidyl-tRNA aminoacylation,BP,HARS2
14508,GO:0070032,0.187155056282607,0.990321217415709,1,2,synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex,CC,VAMP2
14509,GO:0070033,0.187155056282607,0.990321217415709,1,2,synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex,CC,VAMP2
2257,GO:0005172,0.187161723742875,0.96185975151148,2,8,vascular endothelial growth factor receptor binding,MF,VEGFB;DAB2IP
16351,GO:0090677,0.187199484062825,0.990316370517622,1,2,reversible differentiation,BP,OLFM2
16352,GO:0090678,0.187199484062825,0.990316370517622,1,2,cell dedifferentiation involved in phenotypic switching,BP,OLFM2
19138,GO:1905174,0.187199484062825,0.990316370517622,1,2,regulation of vascular smooth muscle cell dedifferentiation,BP,OLFM2
19650,GO:1990936,0.187199484062825,0.990316370517622,1,2,vascular smooth muscle cell dedifferentiation,BP,OLFM2
9629,GO:0036509,0.187203672501917,0.990315913505788,1,2,trimming of terminal mannose on B branch,BP,MAN1B1
9631,GO:0036511,0.187203672501917,0.990315913505788,1,2,trimming of first mannose on A branch,BP,MAN1B1
9632,GO:0036512,0.187203672501917,0.990315913505788,1,2,trimming of second mannose on A branch,BP,MAN1B1
4709,GO:0010874,0.187230122234309,0.943632698963544,3,14,regulation of cholesterol efflux,BP,APOE;LRP1;PLTP
13746,GO:0060346,0.187234885363179,0.963050538288421,2,7,bone trabecula formation,BP,SFRP1;THBS3
9480,GO:0036128,0.187465323699498,0.990287340321474,1,2,CatSper complex,CC,HSPA2
9471,GO:0036117,0.187686606659111,0.990263139031528,1,2,hyaluranon cable,CC,HYAL1
12250,GO:0048560,0.187818467576337,0.990248701767917,1,2,establishment of anatomical structure orientation,BP,IRX4
12964,GO:0051387,0.187952542528541,0.990234009922359,1,2,negative regulation of neurotrophin TRK receptor signaling pathway,BP,SPRY2
5602,GO:0016646,0.188045923738485,0.942734768696651,3,15,oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor,MF,MTHFR;BLVRB;ALDH4A1
14972,GO:0070905,0.188100473627524,0.990217785486093,1,2,serine binding,MF,THNSL2
18184,GO:1902994,0.188288997628872,0.990197087335152,1,2,regulation of phospholipid efflux,BP,APOE
18185,GO:1902995,0.188288997628872,0.990197087335152,1,2,positive regulation of phospholipid efflux,BP,APOE
15829,GO:0072566,0.188357601586793,0.990189549243988,1,2,chemokine (C-X-C motif) ligand 1 production,BP,TRPV4
19839,GO:2000338,0.188357601586793,0.990189549243988,1,2,regulation of chemokine (C-X-C motif) ligand 1 production,BP,TRPV4
19840,GO:2000340,0.188357601586793,0.990189549243988,1,2,positive regulation of chemokine (C-X-C motif) ligand 1 production,BP,TRPV4
19793,GO:2000271,0.188362553565,0.962684850441419,2,7,positive regulation of fibroblast apoptotic process,BP,SFRP1;BTG1
6762,GO:0030203,0.188482255125706,0.879449126053933,15,109,glycosaminoglycan metabolic process,BP,CSPG4;SDC3;NAGLU;IDUA;HGSNAT;B4GALT6;HEXA;GPC2;B4GALT2;HEXB;HYAL1;NDST2;XYLT1;SGSH;GLB1
4073,GO:0009128,0.188674769845654,0.961353956488135,2,8,purine nucleoside monophosphate catabolic process,BP,NT5E;NUDT10
4102,GO:0009158,0.188674769845654,0.961353956488135,2,8,ribonucleoside monophosphate catabolic process,BP,NT5E;NUDT10
4112,GO:0009169,0.188674769845654,0.961353956488135,2,8,purine ribonucleoside monophosphate catabolic process,BP,NT5E;NUDT10
17946,GO:1902359,0.188681753171076,0.990153888489649,1,2,Notch signaling pathway involved in somitogenesis,BP,NRARP
17950,GO:1902366,0.188681753171076,0.990153888489649,1,2,regulation of Notch signaling pathway involved in somitogenesis,BP,NRARP
17951,GO:1902367,0.188681753171076,0.990153888489649,1,2,negative regulation of Notch signaling pathway involved in somitogenesis,BP,NRARP
5201,GO:0015801,0.188765373120039,0.990144677587142,1,2,aromatic amino acid transport,BP,SLC36A4
5222,GO:0015827,0.188765373120039,0.990144677587142,1,2,tryptophan transport,BP,SLC36A4
2153,GO:0004977,0.18889627674684,0.990130248691727,1,2,melanocortin receptor activity,MF,MC1R
12255,GO:0048566,0.189008602698327,0.942840526204646,3,14,embryonic digestive tract development,BP,GLI2;GLI3;TCF7
15966,GO:0080184,0.189071442606798,0.990110922640166,1,2,response to phenylpropanoid,BP,EGFR
10665,GO:0043931,0.189150661310879,0.962428359185271,2,7,ossification involved in bone maturation,BP,PLXNB1;THBS3
1505,GO:0003865,0.189167349376765,0.990100332350973,1,2,3-oxo-5-alpha-steroid 4-dehydrogenase activity,MF,SRD5A3
8516,GO:0033765,0.189167349376765,0.990100332350973,1,2,steroid dehydrogenase activity, acting on the CH-CH group of donors,MF,SRD5A3
9251,GO:0035671,0.189167349376765,0.990100332350973,1,2,enone reductase activity,MF,SRD5A3
12021,GO:0047751,0.189167349376765,0.990100332350973,1,2,cholestenone 5-alpha-reductase activity,MF,SRD5A3
9752,GO:0039528,0.189169351854149,0.929490935852809,4,21,cytoplasmic pattern recognition receptor signaling pathway in response to virus,BP,DDX60;DHX58;NLRX1;TKFC
14604,GO:0070194,0.189172917043024,0.990099717360635,1,2,synaptonemal complex disassembly,BP,HSPA2
13412,GO:0052836,0.189191080672439,0.990097710904576,1,2,inositol 5-diphosphate pentakisphosphate 5-kinase activity,MF,IP6K2
13413,GO:0052839,0.189191080672439,0.990097710904576,1,2,inositol diphosphate tetrakisphosphate kinase activity,MF,IP6K2
13272,GO:0051990,0.18920075529218,0.990096642099814,1,2,(R)-2-hydroxyglutarate dehydrogenase activity,MF,D2HGDH
7491,GO:0031670,0.189217043118919,0.905417303653123,7,45,cellular response to nutrient,BP,POSTN;SFRP1;MDM2;BAIAP2;CYBA;VDR;PPARG
5366,GO:0016165,0.189362280591834,0.990078788109394,1,2,linoleate 13S-lipoxygenase activity,MF,ALOX15B
12234,GO:0048525,0.189447625837583,0.891691358944562,10,73,negative regulation of viral process,BP,OAS2;APOBEC3C;ISG15;STAT1;IFITM1;OAS1;GSN;IFI16;BST2;RSAD2
11708,GO:0046530,0.189506728636407,0.919484885357039,5,28,photoreceptor cell differentiation,BP,SDK2;NAGLU;IFT140;NPHP4;TH
17694,GO:1901629,0.189530059508839,0.990060223970612,1,2,regulation of presynaptic membrane organization,BP,APOE
16377,GO:0097017,0.189965029650589,0.990012006286928,1,2,renal protein absorption,BP,GSN
13815,GO:0060437,0.190018742455733,0.990006043075869,1,2,lung growth,BP,SPRY2
2169,GO:0005006,0.19004876663224,0.990002708921518,1,2,epidermal growth factor-activated receptor activity,MF,EGFR
10408,GO:0043266,0.190134246539202,0.90496105041965,7,44,regulation of potassium ion transport,BP,KCNAB2;NOS1;ANK3;VAMP2;KLHL24;KCNG1;AKAP6
12933,GO:0051316,0.190150017973062,0.989991460506888,1,2,attachment of spindle microtubules to kinetochore involved in meiotic chromosome segregation,BP,CENPC
1458,GO:0003707,0.190176857956594,0.911241333453004,6,36,steroid hormone receptor activity,MF,PAQR6;THRA;VDR;PAQR7;RORA;PPARG
2452,GO:0005665,0.190344927971848,0.94082109393386,3,17,DNA-directed RNA polymerase II, core complex,CC,POLR2J2;POLR2J3;CHD6
20277,GO:2001287,0.190475679643775,0.98995523378789,1,2,negative regulation of caveolin-mediated endocytosis,BP,UNC119
4501,GO:0010543,0.190546223334843,0.928440942397681,4,22,regulation of platelet activation,BP,SERPINE2;APOE;DMTN;CD9
6085,GO:0019254,0.190563727725113,0.98994542679526,1,2,carnitine metabolic process, CoA-linked,BP,CRAT
15977,GO:0086008,0.190582525129636,0.989943332409237,1,2,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization,MF,KCNJ5
19842,GO:2000342,0.190708399917103,0.989929301331245,1,2,negative regulation of chemokine (C-X-C motif) ligand 2 production,BP,MAP2K5
18214,GO:1903044,0.191039461071291,0.960557767375413,2,8,protein localization to membrane raft,BP,REEP2;FLOT1
11273,GO:0045600,0.19104983657996,0.910542160563542,6,37,positive regulation of fat cell differentiation,BP,SFRP1;SULT1E1;ADIRF;ZFP36L1;PPARG;CCDC3
2710,GO:0006084,0.191050308491167,0.918369237059597,5,29,acetyl-CoA metabolic process,BP,MVD;MLYCD;PDK1;ACACB;ACSS2
17685,GO:1901616,0.191241729557337,0.910266393665323,6,38,organic hydroxy compound catabolic process,BP,APOE;SRD5A3;SULT1E1;IMPA2;TKFC;TRERF1
4516,GO:0010572,0.191254621836862,0.989868288761381,1,2,positive regulation of platelet activation,BP,DMTN
17740,GO:1901731,0.191254621836862,0.989868288761381,1,2,positive regulation of platelet aggregation,BP,DMTN
18151,GO:1902938,0.191299331750687,0.989863285625262,1,2,regulation of intracellular calcium activated chloride channel activity,BP,ANO9
14743,GO:0070447,0.191391897920406,0.989852922905045,1,2,positive regulation of oligodendrocyte progenitor proliferation,BP,GJC2
3277,GO:0006956,0.191462927907501,0.941192919620386,3,15,complement activation,BP,C5;C1RL;SERPING1
792,GO:0002062,0.191518648385721,0.894577344952057,9,58,chondrocyte differentiation,BP,TGFBI;PTHLH;ADAMTS7;SULF2;GLI2;GLI3;BMP6;MEF2D;MAF
19329,GO:1905719,0.191559592558816,0.989834134606539,1,2,protein localization to perinuclear region of cytoplasm,BP,SQSTM1
19508,GO:1990425,0.19156680071743,0.989833326580126,1,2,ryanodine receptor complex,CC,NOS1
9380,GO:0035929,0.191598675884356,0.960368464731899,2,8,steroid hormone secretion,BP,CRY1;BMP6
9961,GO:0042362,0.191681240520641,0.960340482456564,2,8,fat-soluble vitamin biosynthetic process,BP,VDR;PLTP
1006,GO:0002480,0.191713752367401,0.959374994170349,2,9,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent,BP,HLA-B;HLA-A
10296,GO:0043086,0.191768231770611,0.844457201589903,61,535,negative regulation of catalytic activity,BP,TNFAIP3;SERPINE2;IFI6;APOE;GPSM1;SFRP1;EPHB2;ELFN2;CAMK2N1;CRY2;NOS1;COL7A1;SPOCK1;MDM2;PIK3IP1;PHACTR3;FLRT3;RASA4;RGS2;PDCD4;SERPINB5;RTN4RL1;LAMP3;C5;WWTR1;NAIP;MAP2K5;CBLC;PLXNB3;CD109;CEP192;PTK6;CST3;TXNIP;SPRY2;GABBR1;GPR87;CDK5RAP3;TFPI2;ADARB1;ACACB;WNK1;LTB4R2;DAB2IP;IFI16;SNCB;BST2;PPP1R2;PPP1R35;LMTK3;KAT2B;IRS2;SCG5;PCSK1N;PRDX5;PHPT1;SPOCD1;PPARG;SERPING1;AIP;ECM1
3634,GO:0008097,0.191770645905588,0.95860651861355,2,10,5S rRNA binding,MF,MDM2;TST
5534,GO:0016524,0.192077490400041,0.989775987911418,1,2,latrotoxin receptor activity,MF,ADGRL1
6016,GO:0019075,0.192077490400041,0.989775987911418,1,2,virus maturation,BP,MVB12B
2141,GO:0004955,0.192119136401012,0.989771304114877,1,2,prostaglandin receptor activity,MF,PPARG
19597,GO:1990769,0.192145620774288,0.989768324878749,1,2,proximal neuron projection,CC,GJC2
6210,GO:0019732,0.192312076322618,0.989749589186276,1,2,antifungal humoral response,BP,FAM3A
1664,GO:0004127,0.192525101536115,0.989725583939839,1,2,cytidylate kinase activity,MF,CMPK2
16827,GO:0098758,0.19260203589517,0.989716906730425,1,2,response to interleukin-8,BP,CXCR1
16828,GO:0098759,0.19260203589517,0.989716906730425,1,2,cellular response to interleukin-8,BP,CXCR1
8070,GO:0032760,0.192619231820571,0.909424306020356,6,38,positive regulation of tumor necrosis factor production,BP,PIK3R1;NFATC4;DDT;CYBA;ZBTB20;ARFGEF2
9540,GO:0036313,0.192808569409885,0.989693592234472,1,2,phosphatidylinositol 3-kinase catalytic subunit binding,MF,PIK3IP1
6793,GO:0030241,0.192859031118541,1,2,2,skeletal muscle myosin thick filament assembly,BP,MYH11;TTN
9382,GO:0035931,0.192898693402508,0.989683409394916,1,2,mineralocorticoid secretion,BP,BMP6
9383,GO:0035932,0.192898693402508,0.989683409394916,1,2,aldosterone secretion,BP,BMP6
20129,GO:2000855,0.192898693402508,0.989683409394916,1,2,regulation of mineralocorticoid secretion,BP,BMP6
20130,GO:2000857,0.192898693402508,0.989683409394916,1,2,positive regulation of mineralocorticoid secretion,BP,BMP6
20131,GO:2000858,0.192898693402508,0.989683409394916,1,2,regulation of aldosterone secretion,BP,BMP6
20132,GO:2000860,0.192898693402508,0.989683409394916,1,2,positive regulation of aldosterone secretion,BP,BMP6
18400,GO:1903487,0.19295300709658,0.9896772699505,1,2,regulation of lactation,BP,OAS2
18717,GO:1904207,0.193025732773907,0.989669046091289,1,2,regulation of chemokine (C-C motif) ligand 2 secretion,BP,POSTN
18718,GO:1904209,0.193025732773907,0.989669046091289,1,2,positive regulation of chemokine (C-C motif) ligand 2 secretion,BP,POSTN
7631,GO:0032049,0.193037001344861,0.959879786159003,2,8,cardiolipin biosynthetic process,BP,SLC27A1;PLA2G6
7478,GO:0031650,0.193129112136558,0.95984840353737,2,8,regulation of heat generation,BP,NMU;SLC27A1
7215,GO:0031117,0.193222771471923,0.98964674652717,1,2,positive regulation of microtubule depolymerization,BP,TRPV4
2732,GO:0006112,0.193230907685192,0.893229887890464,9,60,energy reserve metabolic process,BP,PYGB;GAA;PPP1R3E;PER2;INSR;PGM1;EPM2AIP1;PPP1R2;IRS2
2721,GO:0006101,0.193250284390282,0.91668035283142,5,31,citrate metabolic process,BP,DHTKD1;IDH2;OGDHL;SDHA;SUCLG2
19441,GO:1990164,0.193278867954315,0.989640392995164,1,2,histone H2A phosphorylation,BP,RPS6KA5
15156,GO:0071313,0.193292219846504,0.989638880429542,1,2,cellular response to caffeine,BP,GSTM2
15227,GO:0071415,0.193292219846504,0.989638880429542,1,2,cellular response to purine-containing compound,BP,GSTM2
5592,GO:0016624,0.193483295649075,0.959727633292118,2,8,oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor,MF,DHTKD1;OGDHL
7958,GO:0032571,0.193578767758309,0.989606389287522,1,2,response to vitamin K,BP,POSTN
15153,GO:0071307,0.193578767758309,0.989606389287522,1,2,cellular response to vitamin K,BP,POSTN
4772,GO:0010960,0.193585437254992,0.960970972139131,2,7,magnesium ion homeostasis,BP,EGFR;ANK3
15657,GO:0072202,0.193710750242028,0.94072678835259,3,14,cell differentiation involved in metanephros development,BP,STAT1;WWTR1;LAMB2
9479,GO:0036126,0.193805454367941,0.908545452173635,6,39,sperm flagellum,CC,DNAH1;GAS8;SEPT6;SQSTM1;CABYR;GSTM3
16704,GO:0097729,0.193805454367941,0.908545452173635,6,39,9+2 motile cilium,CC,DNAH1;GAS8;SEPT6;SQSTM1;CABYR;GSTM3
2368,GO:0005496,0.193933433939041,0.897027126003509,8,54,steroid binding,MF,APOE;SULT1E1;OSBPL10;PAQR6;OSBPL5;VDR;PAQR7;RORA
3657,GO:0008140,0.193950428814787,0.959568111158968,2,8,cAMP response element binding protein binding,MF,SIK1;CRTC1
3294,GO:0006987,0.19399276656319,0.959553639782537,2,8,activation of signaling protein activity involved in unfolded protein response,BP,DAB2IP;ERN1
8130,GO:0032847,0.194015675182256,0.98955674009728,1,2,regulation of cellular pH reduction,BP,CA2
2708,GO:0006082,0.194071058287061,0.836400027604647,91,824,organic acid metabolic process,BP,SREBF1;AMACR;CES2;GAMT;CPT2;ALDH1A3;MTHFR;GLUD1;BPHL;DHTKD1;CSPG4;UROS;NOS1;CRTAP;HMGCL;D2HGDH;CYP26B1;THNSL2;TYSND1;IDUA;PRODH;UGT1A3;ACOT1;CRAT;B4GALT6;MLYCD;PHYH;SLC27A3;SULT1E1;PER2;PTGS1;HEXA;ABHD14B;GSTM2;INSR;TST;ALDH4A1;CYP2D7;MGST2;SLC27A1;B4GALT2;SLC2A3;PDK1;ALDH7A1;HEXB;HYAL1;PEX7;IDH2;LPIN3;HADH;HLCS;MLXIPL;PGM1;PFKFB2;ACADS;SLC2A1;ACACB;OGDHL;GLUL;NDST2;SRR;RIMKLB;SDHA;ACOX3;DALRD3;FGFR4;ETFB;OSBPL1A;ALOXE3;AMT;XYLT1;ACSL1;IRS2;ALOX15B;MTR;ECI1;FAAH;CBR4;GLB1;CPT1C;ACSS2;TH;PPARG;ACOT2;SUCLG2;LONP2;HARS2;EHHADH;PEMT;SERINC3;GCLC
8320,GO:0033177,0.194182399954214,0.95851572442026,2,9,proton-transporting two-sector ATPase complex, proton-transporting domain,CC,TCIRG1;ATP6V0A2
20240,GO:2001226,0.194206056195388,0.989535064392852,1,2,negative regulation of chloride transport,BP,ANO9
10829,GO:0044338,0.194285655250614,0.989525994272764,1,2,canonical Wnt signaling pathway involved in mesenchymal stem cell differentiation,BP,WNT3
12795,GO:0051120,0.194345022423706,0.989519226676797,1,2,hepoxilin A3 synthase activity,MF,ALOXE3
2176,GO:0005024,0.194348941615077,0.960717652552554,2,7,transforming growth factor beta-activated receptor activity,MF,LTBP4;LTBP1
8098,GO:0032794,0.1944664092452,0.940384493957944,3,14,GTPase activating protein binding,MF,PLXNB1;PLCD1;FMNL3
2237,GO:0005146,0.194588777968066,0.989491414088873,1,2,leukemia inhibitory factor receptor binding,MF,CTF1
7804,GO:0032365,0.194621742477616,0.916318754395938,5,29,intracellular lipid transport,BP,CPT2;ACACB;SYT7;ABCA2;LDLRAP1
1568,GO:0003977,0.194738823801459,0.989474273387148,1,2,UDP-N-acetylglucosamine diphosphorylase activity,MF,UAP1L1
14738,GO:0070435,0.194783317500064,0.989469187592971,1,2,Shc-EGFR complex,CC,EGFR
9083,GO:0035357,0.194892081475569,0.94019135808725,3,14,peroxisome proliferator activated receptor signaling pathway,BP,ALOXE3;ALOX15B;PPARG
20213,GO:2001180,0.19504943263518,0.989438741064473,1,2,negative regulation of interleukin-10 secretion,BP,TNFRSF21
3930,GO:0008614,0.195055351162142,0.989438063362321,1,2,pyridoxine metabolic process,BP,PNPO
3931,GO:0008615,0.195055351162142,0.989438063362321,1,2,pyridoxine biosynthetic process,BP,PNPO
14132,GO:0061035,0.195104850665523,0.908233918374092,6,36,regulation of cartilage development,BP,PTHLH;ADAMTS7;GLI2;GLI3;BMP6;MAF
9275,GO:0035725,0.195189586670198,0.884698698385917,11,75,sodium ion transmembrane transport,BP,PKD2;NOS1;SLC24A1;ANK3;SNTA1;SCNN1A;SCN4B;KLHL24;SHROOM2;SCN2A;PTPN3
8601,GO:0034122,0.195335898448255,0.926268518886492,4,21,negative regulation of toll-like receptor signaling pathway,BP,TNFAIP3;PTPRS;DAB2IP;SMPDL3B
15372,GO:0071642,0.195407355927934,0.989397713388179,1,2,positive regulation of macrophage inflammatory protein 1 alpha production,BP,TRPV4
6747,GO:0030175,0.195430399646377,0.887999758509677,10,66,filopodium,CC,ACTA2;KITLG;RAPGEF3;TRPV4;ITGA6;BAIAP2;PODXL;WASH3P;DEF6;SYNE2
11326,GO:0045666,0.195474807066054,0.855441892189531,30,234,positive regulation of neuron differentiation,BP,APOE;CAPRIN2;OBSL1;KCTD11;WNT3;CUL7;IMPACT;PLXNB1;CRTC1;GLI2;TRAK1;BAIAP2;PLXNB3;BMP6;PTK6;ETV5;KDM4C;TCF4;SHANK3;HMG20B;BRINP1;RET;ZMYND8;DAB2IP;DLG5;PLXND1;DLG4;PTK7;SHANK2;SMURF1
5799,GO:0017055,0.195568594719247,0.989379202093159,1,2,negative regulation of RNA polymerase II transcriptional preinitiation complex assembly,BP,THRA
5562,GO:0016577,0.195574979844792,0.916274012128041,5,27,histone demethylation,BP,KDM3A;HR;HSF4;PHF2;KDM4C
6216,GO:0019752,0.195643108928386,0.836264895121588,83,751,carboxylic acid metabolic process,BP,SREBF1;AMACR;CES2;GAMT;CPT2;ALDH1A3;MTHFR;GLUD1;BPHL;DHTKD1;CSPG4;UROS;NOS1;CRTAP;HMGCL;D2HGDH;CYP26B1;THNSL2;TYSND1;IDUA;PRODH;UGT1A3;ACOT1;CRAT;MLYCD;PHYH;SLC27A3;PER2;PTGS1;HEXA;GSTM2;INSR;ALDH4A1;CYP2D7;MGST2;SLC27A1;SLC2A3;PDK1;ALDH7A1;HEXB;HYAL1;PEX7;IDH2;LPIN3;HADH;HLCS;MLXIPL;PGM1;PFKFB2;ACADS;SLC2A1;ACACB;OGDHL;GLUL;SRR;RIMKLB;SDHA;ACOX3;DALRD3;FGFR4;ETFB;OSBPL1A;ALOXE3;AMT;ACSL1;IRS2;ALOX15B;MTR;ECI1;FAAH;CBR4;CPT1C;ACSS2;TH;PPARG;ACOT2;SUCLG2;LONP2;HARS2;EHHADH;PEMT;SERINC3;GCLC
4585,GO:0010692,0.195692302512939,0.960270226280882,2,7,regulation of alkaline phosphatase activity,BP,ITGA2;NPNT
5812,GO:0017080,0.195782368546359,0.925687855361206,4,22,sodium channel regulator activity,MF,NOS1;SNTA1;SCN4B;PTPN3
12133,GO:0048256,0.19601590571404,0.958859522640834,2,8,flap endonuclease activity,MF,SLX1A;SLX1B
20021,GO:2000666,0.196023218274276,0.98932691128718,1,2,negative regulation of interleukin-13 secretion,BP,TNFRSF21
6908,GO:0030506,0.196121712630033,0.940295226854865,3,13,ankyrin binding,MF,FLNC;OBSCN;SPTB
18006,GO:1902531,0.196214821957944,0.828738523123839,147,1307,regulation of intracellular signal transduction,BP,TNFAIP3;SERPINE2;GPNMB;EPM2A;TP53INP1;APOE;PSD4;DDX60;EGFR;PKD2;TRIM22;SFRP1;EPS8L2;EPHB2;MAP3K14;DGKQ;PIK3R1;RBCK1;VAV3;CSPG4;KITLG;MC1R;ASAP3;STAT1;CAMK2N1;UNC5B;NOS1;PLEKHG5;IQSEC2;PLXNB1;PLEKHG3;MDM2;CHN2;PIK3IP1;OBSCN;TNFSF10;RHOBTB2;FLRT3;RASA4;RGS2;ACAP3;F2R;PDCD4;RTN4RL1;TRPV4;FLOT1;AGAP4;ADORA2B;RALGAPA1;MAPK8IP3;ARHGEF19;RASGEF1A;C5;MINK1;GSTM2;ASAP2;ARHGEF4;FAM110C;AKAP7;NEK8;MAP2K5;SRGAP3;SESN3;IGFBP4;INSR;CHD3;CBLC;DDT;RMI2;ARHGEF1;DHX58;RICTOR;BMP6;NLRX1;S100A4;MAP2K2;SQSTM1;PTK6;FZD7;SYNGAP1;FAM13A;SHARPIN;ARHGAP33;PLA2G6;GDF15;CTF1;PSD3;MAP3K12;WRN;CDK5R1;AGAP6;NET1;SESN1;MAPK10;TRIM38;ERCC6;RRM2B;SHC2;EDA2R;SPRY2;AGAP7P;FBXW7;CDK5RAP3;PAK6;ARAP1;NLRP1;C12ORF66;MAP3K6;APPL2;JPH2;PDE2A;RET;DAB2IP;FGFR4;IL20RA;PIK3R2;MYO9A;DLG5;BST2;RGL2;ARHGEF17;LPAR6;ARFGEF2;WWC3;IQSEC1;TNFRSF25;IL11;IRS2;ERN1;IVNS1ABP;RAD50;TKFC;ARHGEF9;TRAF5;RANBP9;ERBB2;ARHGAP23;AKAP6;RORA;PRKACA;CXXC5;ACKR3;RIPK3;AIP;NPNT;SERINC3;ECM1
6742,GO:0030168,0.196353606467689,0.875600125768732,14,103,platelet activation,BP,SERPINE2;APOE;DGKQ;PIK3R1;VAV3;MYL9;ITPR3;F2R;BLOC1S4;ADAMTS13;BLOC1S3;GNG2;DMTN;CD9
9404,GO:0035981,0.196354212095873,0.989288750259525,1,2,tongue muscle cell differentiation,BP,CYP26B1
18104,GO:1902811,0.196354212095873,0.989288750259525,1,2,positive regulation of skeletal muscle fiber differentiation,BP,CYP26B1
20167,GO:2001035,0.196354212095873,0.989288750259525,1,2,regulation of tongue muscle cell differentiation,BP,CYP26B1
20168,GO:2001037,0.196354212095873,0.989288750259525,1,2,positive regulation of tongue muscle cell differentiation,BP,CYP26B1
11307,GO:0045647,0.1963605821113,0.958740761736713,2,8,negative regulation of erythrocyte differentiation,BP,KLF13;ZFP36L1
4372,GO:0009996,0.19636319420466,0.989287713633085,1,2,negative regulation of cell fate specification,BP,FZD7
6045,GO:0019184,0.196438077783614,0.938432740782625,3,16,nonribosomal peptide biosynthetic process,BP,MGST2;OPLAH;GCLC
13748,GO:0060348,0.196799588029567,0.871229928680751,16,116,bone development,BP,FAM20C;SULF2;ZFPM1;CYP26B1;PLXNB1;TRPV4;THBS3;GLI3;BMP6;PEX7;MEF2D;FBXW7;NAB2;ACP5;COL13A1;GPR68
19927,GO:2000490,0.196807129198585,0.989236409284337,1,2,negative regulation of hepatic stellate cell activation,BP,GCLC
13212,GO:0051897,0.196889028597417,0.880357221510627,12,85,positive regulation of protein kinase B signaling,BP,EGFR;PIK3R1;KITLG;MC1R;FAM110C;INSR;RICTOR;SPRY2;FGFR4;PIK3R2;IRS2;ERBB2
1502,GO:0003858,0.196943571168849,0.989220613580774,1,2,3-hydroxybutyrate dehydrogenase activity,MF,BDH1
1184,GO:0002831,0.196975348286275,0.877437225644659,13,97,regulation of response to biotic stimulus,BP,TNFAIP3;DDX60;HERC5;HTRA1;STAT1;LRSAM1;DHX58;BMP6;NLRX1;CYBA;KLK5;FAM3A;TKFC
4035,GO:0009069,0.197239855546357,0.914368672257526,5,31,serine family amino acid metabolic process,BP,THNSL2;SRR;AMT;SERINC3;GCLC
12522,GO:0050688,0.197385272061813,0.894724549906498,8,54,regulation of defense response to virus,BP,TNFAIP3;DDX60;HERC5;HTRA1;STAT1;DHX58;NLRX1;TKFC
15275,GO:0071482,0.197406301853905,0.879873408797093,12,87,cellular response to light stimulus,BP,DDB2;TP53INP1;XPC;PIK3R1;MC1R;IMPACT;CRY2;CRY1;NFATC4;MDM2;POLH;HYAL1
6898,GO:0030485,0.19748313519561,0.989158022315817,1,2,smooth muscle contractile fiber,CC,NPNT
10308,GO:0043112,0.197501561775979,0.868712374908392,17,129,receptor metabolic process,BP,APOE;CXCR1;VAMP3;NSG1;FLOT1;DNM1;ARAP1;LRP1;TBC1D16;ARFGEF2;SNX1;DLG4;CD9;PPARG;LDLRAP1;ACKR3;SMURF1
19841,GO:2000341,0.197680238703454,0.957285072832881,2,9,regulation of chemokine (C-X-C motif) ligand 2 production,BP,POSTN;MAP2K5
12157,GO:0048295,0.197764643249993,0.989125286109607,1,2,positive regulation of isotype switching to IgE isotypes,BP,STAT6
14082,GO:0060940,0.197818978659154,0.989118961171318,1,2,epithelial to mesenchymal transition involved in cardiac fibroblast development,BP,PDCD4
1089,GO:0002677,0.197987587045081,0.989099321161943,1,2,negative regulation of chronic inflammatory response,BP,TNFAIP3
12227,GO:0048518,0.198072750163591,0.819182671103785,418,3883,positive regulation of biological process,BP,TNFAIP3;POSTN;SERPINE2;GPNMB;SIK1;EPM2A;MUC19;DDB2;TP53INP1;PTHLH;SREBF1;ACTA2;APOE;GPSM1;INPP5D;DDX60;HSPA2;FBXW4;EGFR;ESPN;TRIM65;PTPRS;CIRBP;FAM20C;PKD2;CAPRIN2;RBM3;ASH2L;DIXDC1;TRIM22;ALDH1A3;SRSF5;SLITRK6;SFRP1;OBSL1;SEC14L2;KCTD11;KIF26B;EPS8L2;EPHB2;MAP3K14;GLUD1;DGKQ;PIK3R1;RBCK1;KDM3A;CXCL14;EVC;RNF135;POU3F1;SULF2;WNT3;CAMKK1;VAV3;SMOC2;CSPG4;ISG15;MVB12B;HTRA1;TFCP2L1;TENM4;RGMA;ZFPM1;KITLG;MVD;CUL7;VAMP3;CITED4;IRF2BPL;MC1R;OR2A4;STAT1;IMPACT;CAMK2N1;MARCKSL1;NSG1;UNC5B;NOS1;PRKACB;HOXA3;MAML3;KLF13;MAGEF1;PLEKHG5;NFATC4;RNF187;FERMT1;CYP26B1;HSF4;TBC1D8;PLXNB1;VPS11;NDRG1;ITPR3;EAPP;MDM2;CRTC1;NDN;IFITM1;CHN2;OBSCN;TNFSF10;PRODH;NEO1;RAPGEF3;PCBP4;NINJ1;FAM210B;FLRT3;RGS2;ARPIN;IL20RB;ADGRB2;F2R;MLYCD;HPS4;PDCD4;SLC24A1;CAPN7;ZFP36L2;CLTCL1;TRPV4;FLOT1;GLI2;NLGN2;ADORA2B;ANK3;KLF7;RNF165;LAMP3;TCEA2;MAPK8IP3;ZNF76;SOX12;PIDD1;RIMS3;SLX1A;SLX1B;GJC2;ARHGEF19;SULT1E1;RASGEF1A;UNC119;C5;WIPF1;ADGRL1;MINK1;PHF2;ABHD14B;GSTM2;AMIGO2;TNFRSF14;WWTR1;ARHGEF4;LHFPL2;ITGA2;SEMA4G;FAM110C;ULK1;GLI3;THRAP3;SMARCA1;LRSAM1;VAMP2;NAIP;NMU;MAP2K5;BOC;ITGA6;LTBP3;SESN3;ZNF318;IGFBP4;MMP1;TRAK1;JARID2;NUPR1;INSR;GSN;BAIAP2;TTN;DDT;PLXNB3;TRIOBP;ZNF287;PNMA1;ETAA1;SCN4B;ARHGEF1;RAB11FIP4;MGST2;DOCK8;DHX58;PILRB;ENDOG;SLC27A1;TM7SF3;RTF1;MDK;RICTOR;BMP6;NLRX1;TCIRG1;S100A4;MICALL2;MAP2K2;VEGFB;SQSTM1;PTK6;FZD7;ETV5;DLX3;SHARPIN;HEXB;KDM4C;HYAL1;METTL23;SH2D2A;NSMCE4A;WHAMMP3;PLA2G6;CST3;GDF15;BBS2;TXNIP;CTF1;TCF4;PLAG1;MAP3K12;WRN;PODXL;IFI27;OSCP1;DNM1;TNFRSF21;LPIN3;CDK5R1;ATRX;NET1;CA2;EFNB3;SESN1;MAPK10;SHANK3;HFE;ADIRF;HMG20B;CYBA;TRIM38;NID1;ERCC6;SHC2;EDA2R;SPRY2;WASH3P;MEF2D;CREBRF;MLXIPL;CTSB;KLK5;FBXW7;KCNMA1;ING4;CDK5RAP3;LMO2;NFIX;PAK6;CARF;PFKFB2;THRA;APC2;ARAP1;ADARB1;RAI1;ELF1;IKZF4;RPH3AL;ACACB;NLRP1;C1RL;ERMAP;GLUL;DBP;NAB2;EPM2AIP1;LRP1;LRRN3;PEG3;NPHP4;PLA2G7;SYNPO2;RFX2;BRINP1;MAP3K6;SALL2;WNK1;JPH2;ZBTB20;PDE2A;MAF;STK16;RET;ZMYND8;DAB2IP;CASZ1;RWDD3;CALCOCO1;TEAD2;MYSM1;DDHD2;FBXO4;OLFM2;PIK3C3;IFI16;SYT7;FGFR4;ERCC5;IL20RA;PIK3R2;TEF;AREG;RPS6KA5;DLG5;BTG1;BST2;VDR;RGL2;ARHGEF17;CACNB3;MAMSTR;TNRC6C;VIPR1;PLXND1;SIX5;HLTF;LPAR6;DMTN;ARFGEF2;RASL10B;PHF1;ZNF292;TFDP2;SNX1;NRARP;ACVR1B;CCDC88B;DLG4;TNNI2;NAT14;PANO1;PTK7;SHANK2;RSAD2;TNFRSF25;ZFP36L1;LMNA;CLSTN3;GLMP;ACSL1;IL11;KAT2B;MARK4;IRS2;CEP250;ANO1;ERN1;IVNS1ABP;ALOX15B;RAD50;GPR21;TKFC;ANGEL2;ZMAT3;S100A6;TRERF1;APBB2;ARHGEF9;TNFSF12;STAT6;PHPT1;NELFCD;SMPDL3B;TUB;KIF7;CHD6;TRAF5;SRPX2;ERBB2;GPR68;AKAP6;ATG14;MPP7;RORA;PPARG;PRKACA;LDLRAP1;CXXC5;SYNE2;ACKR3;PLTP;SERPING1;PARN;UFL1;IP6K2;RIPK3;SNX33;CIT;ZFP90;CCDC3;FOXP2;ECM2;SMURF1;NPNT;CTNNBIP1;PEMT;SERINC3;GCLC;ECM1
13879,GO:0060545,0.198100877953869,0.98908611358904,1,2,positive regulation of necroptotic process,BP,RIPK3
7093,GO:0030897,0.198106279222385,0.938725645421074,3,14,HOPS complex,CC,VPS11;VPS39;HOOK2
13572,GO:0060061,0.198108638737847,0.989085208501843,1,2,Spemann organizer formation,BP,WNT3
6580,GO:0022414,0.198137574795255,0.832351841660558,94,824,reproductive process,BP,SERPINE2;PTHLH;GAMT;HSPA2;EGFR;PKD2;SYT8;PLCD3;SFRP1;TXNRD3;KDM3A;WNT3;HTRA1;TFCP2L1;KITLG;CUL7;IRF2BPL;PRKACB;ZFP41;SCMH1;CRTAP;CYP26B1;PLCD1;MLH3;TNFSF10;CTSV;SPATA20;RGS2;SERPINB5;DNAH1;TUBGCP5;GLI2;MICALCL;LHFPL2;ITGA2;GLI3;TPGS1;ZNF318;TCFL5;NUPR1;INSR;HSF2BP;SUN1;SEPT6;BMP6;ETNK2;CABYR;ETV5;DLX3;HEXB;CENPC;PLA2G6;CST3;BBS2;PLAG1;MCM9;ATRX;REC8;HFE;AGO4;SLIT3;CREBRF;CTSB;THRA;SLC2A1;CCDC136;RFX2;BRINP1;AREG;TMEM203;BTG1;VDR;DPY19L2P2;SIX5;ACVR1B;TSSK1B;ENDOU;TCF7;ZFP36L1;ALOX15B;RAD50;PHC2;CD9;GJB5;PAQR7;TH;PPARG;PRKACA;NPAP1;PARN;MSH5;HERPUD2;TTLL1;GLIPR1L2
11325,GO:0045665,0.198347400081944,0.864892613841843,19,143,negative regulation of neuron differentiation,BP,ULK2;APOE;PTPRS;DIXDC1;EPHB2;WNT3;RGMA;NFATC4;SPOCK1;MDM2;RTN4RL1;TRPV4;SEMA4G;GLI3;SYNGAP1;CDK5R1;EFNB3;LRP1;PMP22
8114,GO:0032810,0.198411323634276,0.989049875731954,1,2,sterol response element binding,MF,SREBF1
6535,GO:0021952,0.198472141260858,0.938557984095591,3,14,central nervous system projection neuron axonogenesis,BP,EPHB2;GLI2;ADARB1
15541,GO:0072009,0.198663378231724,0.885650508013037,10,67,nephron epithelium development,BP,PKD2;KIF26B;STAT1;WWTR1;GLI3;PODXL;KLHL3;LAMB2;NPNT;CTNNBIP1
2606,GO:0005911,0.198818981487942,0.847399647100636,38,301,cell-cell junction,CC,PKD2;OBSL1;PCDH1;PIK3R1;GJD3;PLEKHG5;NDRG1;FLRT3;PPL;FLOT1;ANK3;GJC2;FRMD4B;ITGA6;BAIAP2;SCN4B;MICALL2;MAP2K2;FAT2;EPB41L3;PODXL;KLHL24;SLC2A1;NPHP4;SHROOM2;FGFR4;SCN2A;DLG5;PMP22;SHROOM4;CADM4;PTK7;GJB5;COL13A1;AKAP6;MPP7;PARD6G;NFASC
9232,GO:0035637,0.198822429764402,0.876353140324791,13,91,multicellular organismal signaling,BP,NOS1;ITPR3;ANK3;ITGA2;KCNJ5;AHNAK2;SCN4B;PRX;SCN2A;CACNB3;CACNB1;PRKACA;NFASC
16551,GO:0097362,0.198953117913153,0.988986472134012,1,2,MCM8-MCM9 complex,CC,MCM9
514,GO:0001579,0.198986996331149,0.988982500710237,1,2,medium-chain fatty acid transport,BP,SLC27A1
19099,GO:1905064,0.199246165517516,0.988952092929773,1,2,negative regulation of vascular smooth muscle cell differentiation,BP,PDCD4
3289,GO:0006979,0.199313400860182,0.847317074284305,37,319,response to oxidative stress,BP,TNFAIP3;TP53INP1;APOE;EGFR;PKD2;GPX3;TXNRD3;NAPRT;STAT1;IMPACT;SCARA3;MDM2;PRODH;PTGS1;SESN3;ENDOG;PDK1;ETV5;HYAL1;CST3;TXNIP;WRN;MCTP1;NET1;SESN1;CYBA;ERCC6;RRM2B;FBXW7;AREG;BTG1;DUOX1;MTR;STAT6;PRDX5;CHD6;GCLC
2047,GO:0004797,0.199442814578767,0.988928989252787,1,2,thymidine kinase activity,MF,TK2
6218,GO:0019763,0.199561546877014,0.988915026709617,1,2,immunoglobulin receptor activity,MF,FCGRT
3446,GO:0007257,0.199571234684797,0.913700560263756,5,28,activation of JUN kinase activity,BP,MAPK8IP3;ERCC6;MAP3K6;DAB2IP;ERN1
6202,GO:0019706,0.199639315753122,0.923318740296741,4,23,protein-cysteine S-palmitoyltransferase activity,MF,ZDHHC1;ZDHHC12;GOLGA7B;ZDHHC24
6203,GO:0019707,0.199639315753122,0.923318740296741,4,23,protein-cysteine S-acyltransferase activity,MF,ZDHHC1;ZDHHC12;GOLGA7B;ZDHHC24
19996,GO:2000638,0.199875492982373,0.988878060242775,1,2,regulation of SREBP signaling pathway,BP,FBXW7
19997,GO:2000639,0.199875492982373,0.988878060242775,1,2,negative regulation of SREBP signaling pathway,BP,FBXW7
1501,GO:0003857,0.199906892690042,0.956493641060587,2,9,3-hydroxyacyl-CoA dehydrogenase activity,MF,HADH;EHHADH
2723,GO:0006103,0.199960672611018,0.937294305519723,3,15,2-oxoglutarate metabolic process,BP,D2HGDH;PHYH;IDH2
4715,GO:0010880,0.199973981304777,0.937288128193929,3,15,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,BP,GSTM2;AKAP6;PRKACA
8651,GO:0034220,0.200226061713731,0.835506960655759,67,579,ion transmembrane transport,BP,HSPA2;PKD2;CPT2;EPHB2;ORAI3;TSC22D3;KCNAB2;KCNJ15;GJD3;NOS1;KCNC4;ITPR3;NDUFA4L2;TMEM63C;F2R;SLC24A1;TRPV4;NLGN2;ANK3;SLC13A5;GJC2;PER2;CLCN6;SNTA1;MINK1;GSTM2;VAMP2;KCNJ5;SCNN1A;SCN4B;NIPAL2;TCIRG1;SLC12A7;CLCA2;PLA2G6;ATP6V0A2;KLHL24;ANO9;SHANK3;HFE;CYBA;KCNMA1;ACACB;SLC38A4;KCNG1;WNK1;JPH2;PDE2A;SLC37A2;SHROOM2;SCN2A;CACNB3;ORAI2;SLC36A4;DLG4;SHANK2;IRS2;ANO1;S100A6;SLC43A1;CACNB1;PTPN3;AKAP6;PRKACA;KCNS3;CLCN7;CALHM2
10096,GO:0042627,0.200227911443286,0.985298422819599,1,3,chylomicron,CC,APOE
12188,GO:0048382,0.200273385710381,0.988831110366576,1,2,mesendoderm development,BP,ZFP36L1
4708,GO:0010873,0.200371790124639,0.985276181437117,1,3,positive regulation of cholesterol esterification,BP,APOE
6413,GO:0021681,0.200423311444327,0.957329817709795,2,8,cerebellar granular layer development,BP,SERPINE2;MDK
3158,GO:0006766,0.200437483436209,0.877455995067086,12,91,vitamin metabolic process,BP,MTHFR;CYP26B1;SLC2A3;HLCS;SLC2A1;ACACB;ACP5;VDR;PNPO;MTR;PLTP;GCLC
17037,GO:0099541,0.20064600580375,0.98878704226981,1,2,trans-synaptic signaling by lipid,BP,F2R
17038,GO:0099542,0.20064600580375,0.98878704226981,1,2,trans-synaptic signaling by endocannabinoid,BP,F2R
15204,GO:0071379,0.200689260409089,0.937538362917699,3,14,cellular response to prostaglandin stimulus,BP,SFRP1;GNG2;PPARG
11427,GO:0045880,0.200707666599091,0.923423649402101,4,21,positive regulation of smoothened signaling pathway,BP,SFRP1;EVC;DLG5;KIF7
18135,GO:1902903,0.200869727124053,0.850090911849612,31,251,regulation of supramolecular fiber organization,BP,APOE;SFRP1;EPS8L2;PIK3R1;ASAP3;RAPGEF3;RGS2;ARPIN;SPTB;TRPV4;WIPF1;FHOD3;GSN;BAIAP2;PLEKHH2;TRIOBP;RICTOR;WHAMMP3;CDK5R1;SHANK3;WASH3P;APC2;ARAP1;CAPG;SYNPO2;DMTN;ALMS1;SSH3;CIT;MAP1A;EML2
11536,GO:0046086,0.201100161670509,0.988733200032781,1,2,adenosine biosynthetic process,BP,NT5E
13725,GO:0060319,0.20118048821541,0.988723661938443,1,2,primitive erythrocyte differentiation,BP,ZFPM1
593,GO:0001758,0.201268635545256,0.988713189995547,1,2,retinal dehydrogenase activity,MF,ALDH1A3
16096,GO:0090102,0.201464014583674,0.92266272597715,4,22,cochlea development,BP,SLITRK6;GLI2;MYO3B;PTK7
2273,GO:0005217,0.201628242026138,0.937104679979103,3,14,intracellular ligand-gated ion channel activity,MF,PKD2;ITPR3;JPH2
5062,GO:0015278,0.201628242026138,0.937104679979103,3,14,calcium-release channel activity,MF,PKD2;ITPR3;JPH2
6559,GO:0022011,0.2016355012223,0.923326725678283,4,20,myelination in peripheral nervous system,BP,POU3F1;NDRG1;AHNAK2;PRX
7764,GO:0032292,0.2016355012223,0.923326725678283,4,20,peripheral nervous system axon ensheathment,BP,POU3F1;NDRG1;AHNAK2;PRX
2,GO:0000003,0.201678488087624,0.82915276553844,94,825,reproduction,BP,SERPINE2;PTHLH;GAMT;HSPA2;EGFR;PKD2;SYT8;PLCD3;SFRP1;TXNRD3;KDM3A;WNT3;HTRA1;TFCP2L1;KITLG;CUL7;IRF2BPL;PRKACB;ZFP41;SCMH1;CRTAP;CYP26B1;PLCD1;MLH3;TNFSF10;CTSV;SPATA20;RGS2;SERPINB5;DNAH1;TUBGCP5;GLI2;MICALCL;LHFPL2;ITGA2;GLI3;TPGS1;ZNF318;TCFL5;NUPR1;INSR;HSF2BP;SUN1;SEPT6;BMP6;ETNK2;CABYR;ETV5;DLX3;HEXB;CENPC;PLA2G6;CST3;BBS2;PLAG1;MCM9;ATRX;REC8;HFE;AGO4;SLIT3;CREBRF;CTSB;THRA;SLC2A1;CCDC136;RFX2;BRINP1;AREG;TMEM203;BTG1;VDR;DPY19L2P2;SIX5;ACVR1B;TSSK1B;ENDOU;TCF7;ZFP36L1;ALOX15B;RAD50;PHC2;CD9;GJB5;PAQR7;TH;PPARG;PRKACA;NPAP1;PARN;MSH5;HERPUD2;TTLL1;GLIPR1L2
8871,GO:0034695,0.201798537144771,0.937025908216879,3,14,response to prostaglandin E,BP,SFRP1;GNG2;PPARG
1753,GO:0004357,0.201942073802417,0.98863300565067,1,2,glutamate-cysteine ligase activity,MF,GCLC
5826,GO:0017109,0.201942073802417,0.98863300565067,1,2,glutamate-cysteine ligase complex,CC,GCLC
16410,GO:0097069,0.201942073802417,0.98863300565067,1,2,cellular response to thyroxine stimulus,BP,GCLC
18798,GO:1904387,0.201942073802417,0.98863300565067,1,2,cellular response to L-phenylalanine derivative,BP,GCLC
1610,GO:0004040,0.201954353592208,0.98863154058199,1,2,amidase activity,MF,FAAH
1874,GO:0004553,0.201968353514529,0.887049976675722,9,62,hydrolase activity, hydrolyzing O-glycosyl compounds,MF,GAA;NAGLU;IDUA;HEXA;HEXB;HYAL1;HEXDC;MAN1B1;GLB1
8270,GO:0033084,0.202187796938149,0.988603668978505,1,2,regulation of immature T cell proliferation in thymus,BP,ERBB2
8273,GO:0033088,0.202187796938149,0.988603668978505,1,2,negative regulation of immature T cell proliferation in thymus,BP,ERBB2
3405,GO:0007187,0.202368578940436,0.879348655812066,11,78,G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger,BP,PTHLH;MC1R;NOS1;PRKACB;RGS2;ADORA2B;GABBR1;GNG2;LTB4R2;VIPR1;UCN2
1809,GO:0004461,0.202555210208592,0.988559724838421,1,2,lactose synthase activity,MF,B4GALT2
7521,GO:0031749,0.202643697031731,0.988549127298949,1,2,D2 dopamine receptor binding,MF,DNM1
12075,GO:0048066,0.202762269203852,0.911355609886957,5,30,developmental pigmentation,BP,KITLG;HPS4;GLI3;BLOC1S3;PMEL
8525,GO:0033860,0.202797615010069,0.984898385663002,1,3,regulation of NAD(P)H oxidase activity,BP,CYBA
8527,GO:0033864,0.202797615010069,0.984898385663002,1,3,positive regulation of NAD(P)H oxidase activity,BP,CYBA
16380,GO:0097021,0.202800824218948,0.988530295569162,1,2,lymphocyte migration into lymphoid organs,BP,RET
7835,GO:0032400,0.202808168342572,0.921615468626213,4,23,melanosome localization,BP,BLOC1S3;BBS2;SHROOM2;BBS5
13195,GO:0051875,0.202808168342572,0.921615468626213,4,23,pigment granule localization,BP,BLOC1S3;BBS2;SHROOM2;BBS5
8937,GO:0034991,0.202833633440312,0.988526361189165,1,2,nuclear meiotic cohesin complex,CC,REC8
5143,GO:0015672,0.202834383466288,0.849121067964876,30,251,monovalent inorganic cation transport,BP,SERPINE2;SIK1;PKD2;KCNAB2;KCNJ15;NOS1;KCNC4;NDUFA4L2;SLC24A1;ANK3;SLC13A5;SNTA1;VAMP2;KCNJ5;SCNN1A;SCN4B;TCIRG1;SLC12A7;ATP6V0A2;KLHL24;KCNMA1;SLC38A4;KCNG1;WNK1;SHROOM2;SCN2A;KLHL3;PTPN3;AKAP6;KCNS3
8522,GO:0033842,0.202854515766316,0.988523856651895,1,2,N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase activity,MF,B4GALNT4
4518,GO:0010574,0.202936150176387,0.921872519715216,4,22,regulation of vascular endothelial growth factor production,BP,SULF2;ADORA2B;C5;RORA
8628,GO:0034165,0.203042120131169,0.988501342451137,1,2,positive regulation of toll-like receptor 9 signaling pathway,BP,RSAD2
19562,GO:1990641,0.203061040200864,0.988499070501621,1,2,response to iron ion starvation,BP,HFE
2096,GO:0004864,0.20325788967413,0.921372756397675,4,23,protein phosphatase inhibitor activity,MF,ELFN2;PHACTR3;PPP1R2;PPP1R35
10507,GO:0043436,0.203280937925015,0.828250713174598,90,817,oxoacid metabolic process,BP,SREBF1;AMACR;CES2;GAMT;CPT2;ALDH1A3;MTHFR;GLUD1;BPHL;DHTKD1;CSPG4;UROS;NOS1;CRTAP;HMGCL;D2HGDH;CYP26B1;THNSL2;TYSND1;IDUA;PRODH;UGT1A3;ACOT1;CRAT;B4GALT6;MLYCD;PHYH;SLC27A3;SULT1E1;PER2;PTGS1;HEXA;ABHD14B;GSTM2;INSR;ALDH4A1;CYP2D7;MGST2;SLC27A1;B4GALT2;SLC2A3;PDK1;ALDH7A1;HEXB;HYAL1;PEX7;IDH2;LPIN3;HADH;HLCS;MLXIPL;PGM1;PFKFB2;ACADS;SLC2A1;ACACB;OGDHL;GLUL;NDST2;SRR;RIMKLB;SDHA;ACOX3;DALRD3;FGFR4;ETFB;OSBPL1A;ALOXE3;AMT;XYLT1;ACSL1;IRS2;ALOX15B;MTR;ECI1;FAAH;CBR4;GLB1;CPT1C;ACSS2;TH;PPARG;ACOT2;SUCLG2;LONP2;HARS2;EHHADH;PEMT;SERINC3;GCLC
18133,GO:1902897,0.203307575270444,0.988469443225517,1,2,regulation of postsynaptic density protein 95 clustering,BP,ZMYND8
19361,GO:1905874,0.203307575270444,0.988469443225517,1,2,regulation of postsynaptic density organization,BP,ZMYND8
19520,GO:1990452,0.203498591037136,0.988446458600536,1,2,Parkin-FBXW7-Cul1 ubiquitin ligase complex,CC,FBXW7
4494,GO:0010522,0.203575759659498,0.890564806500328,8,54,regulation of calcium ion transport into cytosol,BP,PKD2;NOS1;F2R;GSTM2;CYBA;JPH2;AKAP6;PRKACA
1404,GO:0003340,0.203746119339437,0.988416635757389,1,2,negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,STAT1
20039,GO:2000697,0.203746119339437,0.988416635757389,1,2,negative regulation of epithelial cell differentiation involved in kidney development,BP,STAT1
4939,GO:0014902,0.203794440375226,0.890522281041921,8,53,myotube differentiation,BP,SIK1;NOS1;CYP26B1;FLOT1;TANC1;GDF15;THRA;MAMSTR
215,GO:0000451,0.20384547940675,0.988404652483644,1,2,rRNA 2'-O-methylation,BP,TARBP1
216,GO:0000453,0.20384547940675,0.988404652483644,1,2,enzyme-directed rRNA 2'-O-methylation,BP,TARBP1
14513,GO:0070039,0.20384547940675,0.988404652483644,1,2,rRNA (guanosine-2'-O-)-methyltransferase activity,MF,TARBP1
6926,GO:0030538,0.203994777518214,0.988386633398804,1,2,embryonic genitalia morphogenesis,BP,TCF7
1381,GO:0003283,0.204067539042184,0.935972893117259,3,14,atrial septum development,BP,ZFPM1;MDM2;NPHP3
7789,GO:0032346,0.204118344284371,0.988371708019561,1,2,positive regulation of aldosterone metabolic process,BP,BMP6
7792,GO:0032349,0.204118344284371,0.988371708019561,1,2,positive regulation of aldosterone biosynthetic process,BP,BMP6
3681,GO:0008184,0.204243013732158,0.988356638559772,1,2,glycogen phosphorylase activity,MF,PYGB
17112,GO:0102250,0.204243013732158,0.988356638559772,1,2,linear malto-oligosaccharide phosphorylase activity,MF,PYGB
17134,GO:0102499,0.204243013732158,0.988356638559772,1,2,SHG alpha-glucan phosphorylase activity,MF,PYGB
12961,GO:0051384,0.204282646694434,0.874728168895764,12,89,response to glucocorticoid,BP,EGFR;CTSV;ZFP36L2;MDK;BMP6;SLIT3;CREBRF;AREG;ZFP36L1;GLB1;TH;KLF9
11786,GO:0046684,0.204306907042128,0.988348911195044,1,2,response to pyrethroid,BP,TH
1749,GO:0004351,0.204647093272796,0.98830772010205,1,2,glutamate decarboxylase activity,MF,GLUL
5893,GO:0018095,0.204673590117908,0.955831852143097,2,8,protein polyglutamylation,BP,TPGS1;TTLL1
15152,GO:0071306,0.204756774525141,0.98829442208527,1,2,cellular response to vitamin E,BP,PPARG
17550,GO:1901184,0.204821686270518,0.877512137441281,11,79,regulation of ERBB signaling pathway,BP,EGFR;MVB12B;RHBDF1;CBLC;PTK6;SPRY2;FBXW7;ARAP1;DAB2IP;PTPN3;ERBB2
13690,GO:0060271,0.204906016434752,0.843917264315378,35,287,cilium assembly,BP,EVI5L;UNC119B;CNTRL;NUDCD3;DNAH1;UNC119;NINL;WWTR1;TPGS1;GAS8;GSN;CEP126;SEPT6;CEP192;BBS2;NPHP3;SEPT5;IQCB1;IFT140;DZIP1L;NPHP4;RFX2;BBS1;ATXN10;BBS5;BBS10;TMEM80;ALMS1;TMEM231;CCDC113;MARK4;CEP250;PRKACA;SYNE2;TTLL1
7188,GO:0031085,0.20494778095281,0.988271243775039,1,2,BLOC-3 complex,CC,HPS4
2370,GO:0005499,0.205043364931944,0.988259635165437,1,2,vitamin D binding,MF,VDR
16477,GO:0097195,0.205226912090831,0.988237325426456,1,2,pilomotor reflex,BP,NPNT
8833,GO:0034637,0.205243026298563,0.884777756375265,9,62,cellular carbohydrate biosynthetic process,BP,PER2;INSR;B3GNT9;PGM1;SLC2A1;EPM2AIP1;IRS2;IMPA2;ISYNA1
8044,GO:0032714,0.205339174148001,0.988223668519873,1,2,negative regulation of interleukin-5 production,BP,TNFRSF21
4380,GO:0010033,0.205372987141769,0.815927397471558,233,2157,response to organic substance,BP,TNFAIP3;POSTN;SIK1;TP53INP1;IFI6;SREBF1;MXRA5;APOE;INPP5D;OAS2;HSPA2;EGFR;FAM20C;PKD2;CXCR1;TRIM22;SRSF5;SFRP1;MTHFR;GPX3;MAP3K14;DGKQ;TMEM129;PIK3R1;ADAMTS7;RBCK1;KDM3A;SULF2;WNT3;UBXN4;ISG15;HTRA1;RGMA;CUL7;VAMP3;STAT1;IMPACT;CRY2;UROS;ITGB5;GJD3;RAB43;NOS1;PRKACB;CRY1;NFATC4;HMGCL;FERMT1;CYP26B1;CMPK2;MICALL1;MDM2;NDN;IFITM1;LTBP4;HLA-B;TNFSF10;NEO1;RAPGEF3;FAM210B;CTSV;OAS1;FLRT3;IL20RB;F2R;MT1X;PDCD4;RTN4RL1;ZFP36L2;TRPV4;FLOT1;GLI2;RNF165;ADAMTS13;LAMP3;ZCCHC11;TMEM204;FNDC4;FRS3;GSTM2;TNFRSF14;ITGA2;SPPL2B;THRAP3;VAMP2;NAIP;LTBP1;MAP2K5;ITGA6;SESN3;MMP1;JARID2;INSR;GSN;BAIAP2;CD109;MGST2;DOCK8;ENDOG;SLC27A1;TM7SF3;MDK;IRF9;BMP6;TCIRG1;MAP2K2;SQSTM1;PTK6;FZD7;LOXL1;SHARPIN;HYAL1;PLA2G6;CST3;HOMER2;MMRN2;GDF15;BBS2;TXNIP;CTF1;ATP6V0A2;COL6A1;IFI27;TNFRSF21;CDK5R1;ATRX;CA2;SESN1;MAPK10;HFE;CYBA;TRIM38;AGO4;HADH;RRM2B;SLIT3;HLCS;EDA2R;SPRY2;FBXO2;CREBRF;XRN1;MLXIPL;CTSB;KCNMA1;CDK5RAP3;LMO2;PFKFB2;PAQR6;THRA;ELF1;MX2;SLC2A1;ACACB;NLRP1;GLUL;EPM2AIP1;TP53I13;GNG2;SRR;LRP1;HLA-A;ACP5;RFX2;BRINP1;PDE2A;STK16;RET;DAB2IP;CALCOCO1;TEAD2;PIK3C3;FGFR4;IL20RA;PIK3R2;AREG;RPS6KA5;BTG1;BST2;VDR;PCSK6;DMTN;STAT2;UCN2;CD68;DUOX1;PTK7;TCF7;RSAD2;TNFRSF25;ZFP36L1;LMNA;ACSL1;IL11;KAT2B;IRS2;ANO1;ERN1;GPR21;MAN1B1;PBLD;TNFSF12;STAT6;PHPT1;TUB;GLB1;DNAJC4;CD9;CACNB1;ERBB2;SYNGR1;GPR68;PAQR7;ABCA2;AKAP6;TH;RORA;PPARG;PRKACA;ACKR3;UFL1;IP6K2;KLF9;AIP;LONP2;CCDC3;FOXP2;SMURF1;NPNT;HERPUD2;PEMT;GCLC;ECM1
12819,GO:0051149,0.205570020529156,0.889114719382201,8,55,positive regulation of muscle cell differentiation,BP,CYP26B1;FLOT1;BOC;GDF15;THRA;OLFM2;MAMSTR;AKAP6
4098,GO:0009154,0.205681861973002,0.920060345059363,4,23,purine ribonucleotide catabolic process,BP,NT5E;RAPGEF3;PDE2A;NUDT10
5060,GO:0015275,0.20569279388999,0.988180591848906,1,2,stretch-activated, cation-selective, calcium channel activity,MF,TRPV4
17292,GO:0140135,0.20569279388999,0.988180591848906,1,2,mechanosensitive cation channel activity,MF,TRPV4
18525,GO:1903756,0.205826229942633,0.988164314220283,1,2,regulation of transcription from RNA polymerase II promoter by histone modification,BP,ZMYND8
18526,GO:1903758,0.205826229942633,0.988164314220283,1,2,negative regulation of transcription from RNA polymerase II promoter by histone modification,BP,ZMYND8
12471,GO:0050473,0.205883769374661,0.988157291207494,1,2,arachidonate 15-lipoxygenase activity,MF,ALOX15B
8660,GO:0034242,0.205891032888265,0.988156404488461,1,2,negative regulation of syncytium formation by plasma membrane fusion,BP,RAPGEF3
13651,GO:0060199,0.205913764843488,0.988153629164064,1,2,clathrin-sculpted glutamate transport vesicle,CC,VAMP2
13654,GO:0060203,0.205913764843488,0.988153629164064,1,2,clathrin-sculpted glutamate transport vesicle membrane,CC,VAMP2
12044,GO:0048009,0.205964138619003,0.920606034938627,4,21,insulin-like growth factor receptor signaling pathway,BP,GIGYF1;PIK3R1;IGFBP4;IGFBP6
3269,GO:0006941,0.205977793614297,0.874064343558576,12,79,striated muscle contraction,BP,OBSL1;NOS1;GAA;RGS2;SNTA1;GSTM2;KCNJ5;TTN;SCN4B;VEGFB;TNNI2;PRKACA
3808,GO:0008401,0.206032395897201,0.988139139681774,1,2,retinoic acid 4-hydroxylase activity,MF,CYP26B1
9557,GO:0036363,0.206106433925463,0.988130091710989,1,2,transforming growth factor beta activation,BP,LTBP3
15188,GO:0071356,0.206115984804302,0.85298899737802,23,198,cellular response to tumor necrosis factor,BP,TNFAIP3;POSTN;SFRP1;MAP3K14;ADAMTS7;RBCK1;STAT1;ZFP36L2;ADAMTS13;TNFRSF14;SPPL2B;SHARPIN;HYAL1;TNFRSF21;CYBA;EDA2R;DAB2IP;TNFRSF25;ZFP36L1;TNFSF12;RORA;CCDC3;NPNT
19846,GO:2000346,0.206200847885405,0.988118548039644,1,2,negative regulation of hepatocyte proliferation,BP,FBXW7
5731,GO:0016880,0.206231178108287,0.988114838330689,1,2,acid-ammonia (or amide) ligase activity,MF,GLUL
6121,GO:0019372,0.206273809297921,0.954196207894111,2,9,lipoxygenase pathway,BP,ALOXE3;ALOX15B
16307,GO:0090541,0.206338077561863,0.988101758207275,1,2,MIT domain binding,MF,CAPN7
19473,GO:1990269,0.20642061014518,0.988091654068275,1,2,RNA polymerase II C-terminal domain phosphoserine binding,MF,RTF1
696,GO:0001917,0.206536481846376,0.919928928280659,4,22,photoreceptor inner segment,CC,NOS1;DNM1;SHANK2;RDH12
4786,GO:0010979,0.206537859497146,0.988077291413367,1,2,regulation of vitamin D 24-hydroxylase activity,BP,VDR
4787,GO:0010980,0.206537859497146,0.988077291413367,1,2,positive regulation of vitamin D 24-hydroxylase activity,BP,VDR
9337,GO:0035860,0.206739370034842,0.988052584336712,1,2,glial cell-derived neurotrophic factor receptor signaling pathway,BP,SULF2
15083,GO:0071149,0.206858811780039,0.98803792610592,1,2,TEAD-2-YAP complex,CC,TEAD2
8611,GO:0034139,0.206910032900184,0.955034660813361,2,8,regulation of toll-like receptor 3 signaling pathway,BP,TNFAIP3;FLOT1
15676,GO:0072234,0.207071074019661,0.934569091591457,3,14,metanephric nephron tubule development,BP,PKD2;STAT1;WWTR1
6137,GO:0019408,0.20718056881103,0.987998388949276,1,2,dolichol biosynthetic process,BP,SRD5A3
7861,GO:0032430,0.207361030809094,0.987976181899977,1,2,positive regulation of phospholipase A2 activity,BP,EGFR
18967,GO:1904783,0.207388571016579,0.987972790866333,1,2,positive regulation of NMDA glutamate receptor activity,BP,EPHB2
20137,GO:2000969,0.20741350552797,0.987969720209526,1,2,positive regulation of AMPA receptor activity,BP,SHANK3
14285,GO:0061441,0.207419125907612,0.987969028005319,1,2,renal artery morphogenesis,BP,PKD2
1575,GO:0003987,0.207561622896257,0.987951470647067,1,2,acetate-CoA ligase activity,MF,ACSS2
6138,GO:0019413,0.207561622896257,0.987951470647067,1,2,acetate biosynthetic process,BP,ACSS2
6141,GO:0019427,0.207561622896257,0.987951470647067,1,2,acetyl-CoA biosynthetic process from acetate,BP,ACSS2
6172,GO:0019542,0.207561622896257,0.987951470647067,1,2,propionate biosynthetic process,BP,ACSS2
15546,GO:0072017,0.207606257940645,0.956206269545066,2,7,distal tubule development,BP,PKD2;KLHL3
7597,GO:0031985,0.20761439777155,0.872375489857485,12,87,Golgi cisterna,CC,NSG1;B4GALNT4;GOLGA8A;GAL3ST4;B4GALT6;GOLGA8B;ASAP2;B4GALT2;ARAP1;GOLGA8N;NECAB3;CIT
1671,GO:0004137,0.207632430661217,0.987942740921999,1,2,deoxycytidine kinase activity,MF,TK2
5795,GO:0017048,0.207674547005328,0.857672028293516,19,138,Rho GTPase binding,MF,EPS8L2;VAV3;PLEKHG5;PLEKHG3;OBSCN;ARHGEF19;ARHGEF4;SRGAP3;TRIOBP;ARHGEF1;WHAMMP3;NET1;PAK6;FMNL2;RGL2;ARHGEF17;ARHGEF9;FMNL3;CIT
9985,GO:0042414,0.207821809505962,0.987919375388096,1,2,epinephrine metabolic process,BP,TH
12313,GO:0048682,0.207987755040463,0.987898880158599,1,2,sprouting of injured axon,BP,LAMB2
4654,GO:0010801,0.208156768352743,0.933447887229539,3,15,negative regulation of peptidyl-threonine phosphorylation,BP,DGKQ;SPRY2;DMTN
7748,GO:0032272,0.208256991041467,0.892844458469661,7,47,negative regulation of protein polymerization,BP,SPTB;FHOD3;GSN;TRIOBP;CAPG;DMTN;EML2
12705,GO:0050966,0.208474555787716,0.987838644805096,1,2,detection of mechanical stimulus involved in sensory perception of pain,BP,ITGA2
8158,GO:0032902,0.208637880439049,0.987818397808002,1,2,nerve growth factor production,BP,PCSK6
14961,GO:0070893,0.20865227649288,0.987816612252991,1,2,transposon integration,BP,ZNF91
14962,GO:0070894,0.20865227649288,0.987816612252991,1,2,regulation of transposon integration,BP,ZNF91
14963,GO:0070895,0.20865227649288,0.987816612252991,1,2,negative regulation of transposon integration,BP,ZNF91
8867,GO:0034685,0.208693333286635,0.987811519135356,1,2,integrin alphav-beta6 complex,CC,ITGB6
10249,GO:0043001,0.208867576826948,0.907750693270414,5,30,Golgi to plasma membrane protein transport,BP,VAMP3;ANK3;VAMP2;BBS2;BBS1
16050,GO:0090030,0.208881199520679,0.954326896319037,2,8,regulation of steroid hormone biosynthetic process,BP,DGKQ;BMP6
19880,GO:2000393,0.208922511430461,0.987783067476959,1,2,negative regulation of lamellipodium morphogenesis,BP,ARPIN
5305,GO:0016013,0.208979499535055,0.987775986814482,1,2,syntrophin complex,CC,SNTA1
1852,GO:0004517,0.208990635281626,0.987774602949933,1,2,nitric-oxide synthase activity,MF,NOS1
15628,GO:0072162,0.20908964591379,0.987762294800604,1,2,metanephric mesenchymal cell differentiation,BP,STAT1
7978,GO:0032602,0.209091839380466,0.891944248763137,7,50,chemokine production,BP,POSTN;ZFPM1;TRPV4;ADORA2B;C5;MAP2K5;ALOX15B
3617,GO:0008065,0.209111650183129,0.987759558473478,1,2,establishment of blood-nerve barrier,BP,GSTM3
3610,GO:0008050,0.209228463535535,0.987745026461647,1,2,female courtship behavior,BP,THRA
11453,GO:0045924,0.209228463535535,0.987745026461647,1,2,regulation of female receptivity,BP,THRA
18442,GO:1903557,0.209316311455715,0.898884882979241,6,39,positive regulation of tumor necrosis factor superfamily cytokine production,BP,PIK3R1;NFATC4;DDT;CYBA;ZBTB20;ARFGEF2
14685,GO:0070336,0.209390229920959,0.987724886114714,1,2,flap-structured DNA binding,MF,WRN
3506,GO:0007413,0.2094042294275,0.933470846950087,3,14,axonal fasciculation,BP,EPHB2;NDN;CDK5R1
17180,GO:0106030,0.2094042294275,0.933470846950087,3,14,neuron projection fasciculation,BP,EPHB2;NDN;CDK5R1
4293,GO:0009726,0.209410999503229,0.987722298898962,1,2,detection of endogenous stimulus,BP,PKD2
19752,GO:2000182,0.209521839633427,0.987708486631579,1,2,regulation of progesterone biosynthetic process,BP,DGKQ
1490,GO:0003831,0.20959908489441,0.954067939061233,2,8,beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity,MF,B4GALT6;B4GALT2
563,GO:0001705,0.20967283722068,0.987689656114382,1,2,ectoderm formation,BP,FZD7
570,GO:0001712,0.20967283722068,0.987689656114382,1,2,ectodermal cell fate commitment,BP,FZD7
13261,GO:0051971,0.209675529991836,0.987689320158764,1,2,positive regulation of transmission of nerve impulse,BP,ITGA2
18599,GO:1903905,0.209685866481274,0.987688030509219,1,2,positive regulation of establishment of T cell polarity,BP,DOCK8
2477,GO:0005712,0.209767955611534,0.987677785822412,1,2,chiasma,CC,MLH3
8390,GO:0033341,0.209901167573613,0.98766115082792,1,2,regulation of collagen binding,BP,ITGA2
17771,GO:1901873,0.209947670047301,0.987655340805974,1,2,regulation of post-translational protein modification,BP,CRTAP
17772,GO:1901874,0.209947670047301,0.987655340805974,1,2,negative regulation of post-translational protein modification,BP,CRTAP
17497,GO:1900756,0.21002612793162,0.987645534784747,1,2,protein processing in phagocytic vesicle,BP,GSN
18608,GO:1903921,0.21002612793162,0.987645534784747,1,2,regulation of protein processing in phagocytic vesicle,BP,GSN
18609,GO:1903923,0.21002612793162,0.987645534784747,1,2,positive regulation of protein processing in phagocytic vesicle,BP,GSN
15706,GO:0072300,0.210302186186964,0.987610996946303,1,2,positive regulation of metanephric glomerulus development,BP,RET
15616,GO:0072135,0.210344377350613,0.987605713601025,1,2,kidney mesenchymal cell proliferation,BP,STAT1
15617,GO:0072136,0.210344377350613,0.987605713601025,1,2,metanephric mesenchymal cell proliferation involved in metanephros development,BP,STAT1
3283,GO:0006971,0.210437062544097,0.953764855355901,2,8,hypotonic response,BP,TRPV4;ITGA2
14854,GO:0070662,0.210442054691597,0.987593477191327,1,2,mast cell proliferation,BP,KITLG
14858,GO:0070666,0.210442054691597,0.987593477191327,1,2,regulation of mast cell proliferation,BP,KITLG
14860,GO:0070668,0.210442054691597,0.987593477191327,1,2,positive regulation of mast cell proliferation,BP,KITLG
7131,GO:0030971,0.210480160940215,0.891643422346786,7,45,receptor tyrosine kinase binding,MF,PIK3R1;PITPNM3;PITPNM2;CBLC;SQSTM1;SHC2;PIK3R2
9899,GO:0042246,0.210490269073931,0.906558837457893,5,31,tissue regeneration,BP,POSTN;EYS;NINJ1;GSN;FZD7
10260,GO:0043020,0.21051420998498,0.983661235346789,1,3,NADPH oxidase complex,CC,CYBA
16792,GO:0098661,0.210538753998517,0.891604810725704,7,45,inorganic anion transmembrane transport,BP,CLCN6;SLC12A7;CLCA2;ANO9;SLC37A2;ANO1;CLCN7
18354,GO:1903378,0.210662873638282,0.987565789319328,1,2,positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,BP,FBXW7
11221,GO:0045409,0.211204020115969,0.987497789538977,1,2,negative regulation of interleukin-6 biosynthetic process,BP,INPP5D
1743,GO:0004345,0.211248046272098,0.98749224808292,1,2,glucose-6-phosphate dehydrogenase activity,MF,H6PD
8703,GO:0034358,0.211282221221517,0.930953307062628,3,17,plasma lipoprotein particle,CC,APOE;PLA2G7;PLTP
19602,GO:1990777,0.211282221221517,0.930953307062628,3,17,lipoprotein particle,CC,APOE;PLA2G7;PLTP
17405,GO:1900181,0.211402033416518,0.931901631469428,3,15,negative regulation of protein localization to nucleus,BP,LZTS2;PDE2A;FBXO4
11308,GO:0045648,0.211510917482756,0.917217903244686,4,22,positive regulation of erythrocyte differentiation,BP,INPP5D;STAT1;FAM210B;ACVR1B
14518,GO:0070052,0.211605635401654,0.987447188050593,1,2,collagen V binding,MF,ECM2
12935,GO:0051336,0.211666731989584,0.819230906748881,100,889,regulation of hydrolase activity,BP,SERPINE2;IFI6;GPSM1;ALS2CL;OAS2;LMF1;HSPA2;EGFR;SFRP1;EVI5L;DOCK9;VAV3;ELFN2;ASAP3;CRY2;NOS1;TBC1D8;PLXNB1;COL7A1;SPOCK1;MDM2;PPP2R2C;CHN2;TNFSF10;RAPGEF3;PHACTR3;OAS1;RASA4;RGS2;ACAP3;F2R;SERPINB5;AGAP4;LAMP3;RALGAPA1;PIDD1;ARHGEF19;C5;TBC1D19;ASAP2;ITGA2;NAIP;MAP2K5;ITGA6;SRGAP3;GSN;PLXNB3;RIN1;CD109;ARHGEF1;DOCK8;RICTOR;CEP192;SYNGAP1;FAM13A;ARHGAP33;CST3;WRN;IFI27;ARHGAP27;AGAP6;NET1;SPRY2;AGAP7P;CDK5RAP3;TFPI2;APC2;ARAP1;NLRP1;TBC1D17;LRP1;RGS12;WNK1;DAB2IP;IFI16;PIK3R2;MYO9A;BST2;PLXND1;PCSK6;TBC1D16;PPP1R2;PPP1R35;SGSM2;LMTK3;PPP2R3B;IQSEC1;ERN1;PCSK1N;PRDX5;ERBB2;SPOCD1;ARHGAP23;AKAP6;PPARG;SERPING1;RIPK3;AIP;NPNT;ECM1
9036,GO:0035264,0.211788977466836,0.863982262824548,14,102,multicellular organism growth,BP,GAMT;SLITRK6;WWTR1;ETNK2;BBS2;PLAG1;ATRX;ERCC6;ADARB1;RAI1;TNS2;PALB2;ZFP36L1;GPR21
1025,GO:0002528,0.211896654772696,0.987410449149004,1,2,regulation of vascular permeability involved in acute inflammatory response,BP,CTNNBIP1
740,GO:0001972,0.211904954965038,0.953231847582997,2,8,retinoic acid binding,MF,CYP26B1;UGT1A3
3639,GO:0008109,0.212042498810433,0.987392014738248,1,2,N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity,MF,GCNT4
16914,GO:0098914,0.212042635977197,0.987391997393511,1,2,membrane repolarization during atrial cardiac muscle cell action potential,BP,KCNJ5
17069,GO:0099624,0.212042635977197,0.987391997393511,1,2,atrial cardiac muscle cell membrane repolarization,BP,KCNJ5
7117,GO:0030948,0.212083312866479,0.953166902285623,2,8,negative regulation of vascular endothelial growth factor receptor signaling pathway,BP,MMRN2;DAB2IP
7688,GO:0032153,0.212158424898396,0.875827125944148,10,70,cell division site,CC,PLCD3;OR2A4;RHOBTB2;TUBGCP5;SEPT6;RAB11FIP4;CENPC;SEPT5;RAB11FIP3;CIT
7454,GO:0031618,0.212186301712312,0.953129383133158,2,8,nuclear pericentric heterochromatin,CC,CENPC;ATRX
8514,GO:0033762,0.212331420397909,0.905686484570644,5,30,response to glucagon,BP,SREBF1;PRKACB;CRY1;GNG2;PRKACA
18547,GO:1903796,0.212373348790781,0.987350139582738,1,2,negative regulation of inorganic anion transmembrane transport,BP,ANO9
13078,GO:0051611,0.212582217581687,0.987323663101859,1,2,regulation of serotonin uptake,BP,NOS1
13079,GO:0051612,0.212582217581687,0.987323663101859,1,2,negative regulation of serotonin uptake,BP,NOS1
10043,GO:0042539,0.212828337256002,0.987292424607637,1,2,hypotonic salinity response,BP,TRPV4
15270,GO:0071477,0.212828337256002,0.987292424607637,1,2,cellular hypotonic salinity response,BP,TRPV4
20117,GO:2000832,0.212852872531267,0.987289308116978,1,2,negative regulation of steroid hormone secretion,BP,CRY1
20124,GO:2000847,0.212852872531267,0.987289308116978,1,2,negative regulation of corticosteroid hormone secretion,BP,CRY1
20127,GO:2000850,0.212852872531267,0.987289308116978,1,2,negative regulation of glucocorticoid secretion,BP,CRY1
2649,GO:0005988,0.212886507101561,0.987285035126505,1,2,lactose metabolic process,BP,SLC2A1
2650,GO:0005989,0.212886507101561,0.987285035126505,1,2,lactose biosynthetic process,BP,SLC2A1
11622,GO:0046351,0.212886507101561,0.987285035126505,1,2,disaccharide biosynthetic process,BP,SLC2A1
7605,GO:0031999,0.213022038893457,0.987267808743899,1,2,negative regulation of fatty acid beta-oxidation,BP,ACACB
6839,GO:0030314,0.213116890907389,0.987255745028406,1,2,junctional membrane complex,CC,JPH2
16507,GO:0097242,0.213272977699722,0.931634847870908,3,14,amyloid-beta clearance,BP,APOE;INSR;LRP1
16242,GO:0090322,0.213291697215555,0.929977142256952,3,17,regulation of superoxide metabolic process,BP,EGFR;CYBA;ACP5
13779,GO:0060390,0.213490366992609,0.930899661609265,3,15,regulation of SMAD protein signal transduction,BP,WWTR1;BMP6;PBLD
12373,GO:0048813,0.213577066328024,0.862711533796063,14,100,dendrite morphogenesis,BP,MAP6;CAPRIN2;OBSL1;EPHB2;CUL7;NFATC4;KLF7;MINK1;TRAK1;BAIAP2;CDK5R1;SHANK3;DLG4;SHANK2
12231,GO:0048522,0.21365300445231,0.804937859526519,376,3472,positive regulation of cellular process,BP,TNFAIP3;POSTN;SERPINE2;GPNMB;SIK1;EPM2A;DDB2;TP53INP1;PTHLH;SREBF1;APOE;GPSM1;INPP5D;DDX60;HSPA2;FBXW4;EGFR;ESPN;TRIM65;CIRBP;FAM20C;PKD2;CAPRIN2;RBM3;ASH2L;DIXDC1;TRIM22;ALDH1A3;SRSF5;SLITRK6;SFRP1;OBSL1;SEC14L2;KCTD11;EPS8L2;EPHB2;MAP3K14;GLUD1;DGKQ;PIK3R1;RBCK1;KDM3A;CXCL14;EVC;POU3F1;SULF2;WNT3;CAMKK1;VAV3;CSPG4;HTRA1;TENM4;RGMA;ZFPM1;KITLG;MVD;CUL7;VAMP3;CITED4;IRF2BPL;MC1R;OR2A4;STAT1;IMPACT;MARCKSL1;NSG1;UNC5B;NOS1;PRKACB;HOXA3;MAML3;KLF13;MAGEF1;PLEKHG5;NFATC4;RNF187;FERMT1;CYP26B1;HSF4;TBC1D8;PLXNB1;VPS11;NDRG1;ITPR3;EAPP;MDM2;CRTC1;NDN;IFITM1;CHN2;OBSCN;TNFSF10;PRODH;NEO1;RAPGEF3;PCBP4;FAM210B;FLRT3;RGS2;ARPIN;ADGRB2;F2R;MLYCD;HPS4;PDCD4;SLC24A1;CAPN7;ZFP36L2;TRPV4;FLOT1;GLI2;NLGN2;ADORA2B;ANK3;KLF7;RNF165;TCEA2;MAPK8IP3;ZNF76;SOX12;PIDD1;RIMS3;SLX1A;SLX1B;GJC2;ARHGEF19;SULT1E1;RASGEF1A;UNC119;C5;WIPF1;ADGRL1;MINK1;PHF2;ABHD14B;GSTM2;AMIGO2;TNFRSF14;WWTR1;ARHGEF4;ITGA2;SEMA4G;FAM110C;ULK1;GLI3;THRAP3;SMARCA1;LRSAM1;VAMP2;NAIP;NMU;MAP2K5;BOC;ITGA6;LTBP3;SESN3;ZNF318;IGFBP4;MMP1;TRAK1;JARID2;NUPR1;INSR;GSN;BAIAP2;TTN;DDT;PLXNB3;TRIOBP;ZNF287;PNMA1;ETAA1;ARHGEF1;RAB11FIP4;DOCK8;DHX58;PILRB;ENDOG;SLC27A1;TM7SF3;RTF1;MDK;RICTOR;BMP6;TCIRG1;S100A4;MICALL2;MAP2K2;VEGFB;SQSTM1;PTK6;FZD7;ETV5;DLX3;SHARPIN;HEXB;KDM4C;HYAL1;METTL23;SH2D2A;NSMCE4A;WHAMMP3;PLA2G6;CST3;GDF15;TXNIP;CTF1;TCF4;PLAG1;MAP3K12;WRN;PODXL;IFI27;OSCP1;LPIN3;CDK5R1;ATRX;NET1;CA2;EFNB3;SESN1;MAPK10;SHANK3;HFE;ADIRF;HMG20B;CYBA;TRIM38;ERCC6;SHC2;EDA2R;SPRY2;WASH3P;MEF2D;CREBRF;MLXIPL;KLK5;FBXW7;KCNMA1;ING4;CDK5RAP3;LMO2;NFIX;PAK6;CARF;PFKFB2;THRA;ARAP1;RAI1;ELF1;IKZF4;RPH3AL;ACACB;NLRP1;GLUL;DBP;NAB2;EPM2AIP1;LRP1;LRRN3;PEG3;NPHP4;PLA2G7;SYNPO2;RFX2;BRINP1;MAP3K6;SALL2;WNK1;JPH2;MAF;STK16;RET;ZMYND8;DAB2IP;CASZ1;RWDD3;CALCOCO1;TEAD2;MYSM1;DDHD2;FBXO4;OLFM2;IFI16;SYT7;FGFR4;ERCC5;IL20RA;PIK3R2;TEF;AREG;RPS6KA5;DLG5;BTG1;BST2;VDR;RGL2;ARHGEF17;MAMSTR;TNRC6C;VIPR1;PLXND1;SIX5;HLTF;LPAR6;DMTN;RASL10B;PHF1;ZNF292;TFDP2;NRARP;ACVR1B;CCDC88B;DLG4;TNNI2;NAT14;PANO1;PTK7;SHANK2;RSAD2;TNFRSF25;ZFP36L1;LMNA;CLSTN3;GLMP;ACSL1;IL11;KAT2B;MARK4;IRS2;ANO1;ERN1;IVNS1ABP;ALOX15B;RAD50;ZMAT3;S100A6;TRERF1;APBB2;ARHGEF9;TNFSF12;STAT6;PHPT1;TUB;KIF7;CHD6;TRAF5;SRPX2;ERBB2;GPR68;AKAP6;ATG14;MPP7;RORA;PPARG;PRKACA;LDLRAP1;CXXC5;SYNE2;ACKR3;PARN;UFL1;IP6K2;RIPK3;SNX33;CIT;ZFP90;CCDC3;FOXP2;SMURF1;NPNT;CTNNBIP1;PEMT;SERINC3;GCLC;ECM1
9994,GO:0042426,0.213686547188773,0.987183157986424,1,2,choline catabolic process,BP,ALDH7A1
3889,GO:0008526,0.214256988029002,0.952372242348732,2,8,phosphatidylinositol transporter activity,MF,PITPNM3;PITPNM2
1489,GO:0003829,0.214262088408759,0.987109584892238,1,2,beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity,MF,GCNT4
3980,GO:0008821,0.214310459108547,0.951223563676689,2,9,crossover junction endodeoxyribonuclease activity,MF,SLX1A;SLX1B
749,GO:0001990,0.214507676589842,0.92986155520267,3,16,regulation of systemic arterial blood pressure by hormone,BP,F2R;CYBA;RASL10B
9998,GO:0042438,0.214552164012462,0.95226388022768,2,8,melanin biosynthetic process,BP,DDT;PMEL
8866,GO:0034684,0.214594101589364,0.98706703461612,1,2,integrin alphav-beta5 complex,CC,ITGB5
3536,GO:0007529,0.214817954896932,0.987038301273621,1,2,establishment of synaptic specificity at neuromuscular junction,BP,F2R
15226,GO:0071409,0.214879866470233,0.987030348080848,1,2,cellular response to cycloheximide,BP,XRN1
6575,GO:0022408,0.21505424407668,0.86386117838389,13,98,negative regulation of cell-cell adhesion,BP,SERPINE2;GPNMB;IL20RB;TRPV4;GLI3;MAP2K5;PODXL;TNFRSF21;HFE;DLG5;NRARP;CD9;ERBB2
17997,GO:1902512,0.215117016632756,0.982897455585775,1,3,positive regulation of apoptotic DNA fragmentation,BP,ENDOG
15412,GO:0071706,0.215148939744957,0.873389520773936,10,74,tumor necrosis factor superfamily cytokine production,BP,TNFAIP3;GPNMB;PIK3R1;MC1R;NFATC4;DDT;CYBA;ACP5;ZBTB20;ARFGEF2
11364,GO:0045746,0.215241912592142,0.90349294309445,5,32,negative regulation of Notch signaling pathway,BP,EGFR;ARRDC1;FBXW7;DLK2;NRARP
459,GO:0001325,0.215269845297196,0.930041590567351,3,15,formation of extrachromosomal circular DNA,BP,SLX1A;SLX1B;WRN
16337,GO:0090656,0.215269845297196,0.930041590567351,3,15,t-circle formation,BP,SLX1A;SLX1B;WRN
16364,GO:0090737,0.215269845297196,0.930041590567351,3,15,telomere maintenance via telomere trimming,BP,SLX1A;SLX1B;WRN
15259,GO:0071462,0.215386334613891,0.986965183505362,1,2,cellular response to water stimulus,BP,PKD2
11319,GO:0045659,0.215501759352861,0.986950306616333,1,2,negative regulation of neutrophil differentiation,BP,INPP5D
2218,GO:0005119,0.215516097174858,0.986948457971051,1,2,smoothened binding,MF,BBS1
8236,GO:0033023,0.215653044761093,0.986930793200644,1,2,mast cell homeostasis,BP,KITLG
8237,GO:0033024,0.215653044761093,0.986930793200644,1,2,mast cell apoptotic process,BP,KITLG
8238,GO:0033025,0.215653044761093,0.986930793200644,1,2,regulation of mast cell apoptotic process,BP,KITLG
1255,GO:0003011,0.215660449948441,0.986929837626398,1,2,involuntary skeletal muscle contraction,BP,GAA
480,GO:0001527,0.215751061112118,0.951822645290613,2,8,microfibril,CC,LTBP1;THSD4
10194,GO:0042823,0.215958295672147,0.986891370550536,1,2,pyridoxal phosphate biosynthetic process,BP,PNPO
19781,GO:2000249,0.216067615457537,0.914038124349818,4,24,regulation of actin cytoskeleton reorganization,BP,RAPGEF3;CTSV;BAIAP2;PHPT1
8862,GO:0034678,0.216131227309983,0.986869006957941,1,2,integrin alpha8-beta1 complex,CC,NPNT
1333,GO:0003192,0.21617483594528,0.986863364071489,1,2,mitral valve formation,BP,ZFPM1
8128,GO:0032838,0.216621934009626,0.855651724012097,16,123,plasma membrane bounded cell projection cytoplasm,CC,BLOC1S4;DNAH1;GLI2;GLI3;GAS8;TRAK1;BAIAP2;BLOC1S3;IFT140;BBS1;PIK3C3;BBS5;ARFGEF2;DLG4;ATG14;PRKACA
2156,GO:0004984,0.216733486925169,0.982624604172246,1,3,olfactory receptor activity,MF,OR2A4
12674,GO:0050911,0.216733486925169,0.982624604172246,1,3,detection of chemical stimulus involved in sensory perception of smell,BP,OR2A4
3273,GO:0006952,0.216754677136338,0.814682708541201,99,909,defense response,BP,TNFAIP3;ITGB6;MUC19;IFI6;APOE;NT5E;OAS2;DDX60;EGFR;PTPRS;APOBEC3C;TRIM22;IFI44L;MAP3K14;RNF135;HERC5;ISG15;HTRA1;VAMP3;STAT1;RAB43;PRKACB;NFATC4;CYP26B1;IFITM1;HLA-B;OAS1;IL20RB;F2R;PDCD4;TRPV4;FLOT1;ADORA2B;ADAMTS13;PTGS1;FNDC4;C5;TNFRSF14;ITGA2;LRSAM1;NAIP;IGFBP4;NUPR1;GSN;DDT;PNMA1;MGST2;DHX58;MDK;IRF9;RICTOR;BMP6;NLRX1;TCIRG1;PTK6;SHARPIN;HYAL1;PLA2G6;CST3;IFI27;TNFRSF21;HFE;CYBA;TRIM38;HCP5;CTSB;KLK5;ADARB1;MX2;NLRP1;C1RL;HLA-A;ACP5;PLA2G7;BRINP1;PDE2A;LTB4R2;DAB2IP;PIK3C3;IFI16;RPS6KA5;BST2;FAM3A;STAT2;CCDC88B;RSAD2;TNFRSF25;TKFC;PRDX5;SMPDL3B;GPR68;RORA;PPARG;PRKACA;SERPING1;IP6K2;CTNNBIP1;SERINC3;ECM1
16754,GO:0098582,0.216862364437792,0.986774217945899,1,2,innate vocalization behavior,BP,FOXP2
4827,GO:0014034,0.217213369482849,0.986728574639193,1,2,neural crest cell fate commitment,BP,SFRP1
6804,GO:0030262,0.217407330305964,0.913290724282097,4,24,apoptotic nuclear changes,BP,H1F0;ENDOG;SHARPIN;CDK5RAP3
4816,GO:0014013,0.217472814487619,0.876111362148077,9,63,regulation of gliogenesis,BP,SERPINE2;TENM4;GJC2;ETV5;PLAG1;IDH2;TNFRSF21;PPARG;UFL1
17743,GO:1901741,0.217528930478729,0.950010364459261,2,9,positive regulation of myoblast fusion,BP,FLOT1;GDF15
2622,GO:0005943,0.217666447810953,0.986669526690578,1,2,phosphatidylinositol 3-kinase complex, class IA,CC,PIK3R1
16679,GO:0097651,0.217666447810953,0.986669526690578,1,2,phosphatidylinositol 3-kinase complex, class I,CC,PIK3R1
17931,GO:1902305,0.217736005477188,0.893702901028076,6,38,regulation of sodium ion transmembrane transport,BP,NOS1;ANK3;SNTA1;SCN4B;KLHL24;PTPN3
7897,GO:0032474,0.217775468213013,0.986655296361126,1,2,otolith morphogenesis,BP,LRIG3
2773,GO:0006196,0.217794539383544,0.986652806137178,1,2,AMP catabolic process,BP,NT5E
8718,GO:0034377,0.217837745276626,0.928237290877801,3,16,plasma lipoprotein particle assembly,BP,APOE;PRKACB;PRKACA
1420,GO:0003373,0.217863493273057,0.951040873489336,2,8,dynamin family protein polymerization involved in membrane fission,BP,DNM1;MX2
1421,GO:0003374,0.217863493273057,0.951040873489336,2,8,dynamin family protein polymerization involved in mitochondrial fission,BP,DNM1;MX2
13990,GO:0060733,0.217966546169439,0.986630334427218,1,2,regulation of eIF2 alpha phosphorylation by amino acid starvation,BP,IMPACT
15130,GO:0071262,0.217966546169439,0.986630334427218,1,2,regulation of translational initiation in response to starvation,BP,IMPACT
15131,GO:0071264,0.217966546169439,0.986630334427218,1,2,positive regulation of translational initiation in response to starvation,BP,IMPACT
16426,GO:0097109,0.218330386926494,0.986582730253825,1,2,neuroligin family protein binding,MF,DLG4
6656,GO:0030016,0.218362284053133,0.852691690220571,17,121,myofibril,CC,FLNC;OBSL1;SYNC;NOS1;OBSCN;PARVB;ANK3;FHOD3;TTN;AHNAK2;SQSTM1;SLC2A1;SYNPO2;JPH2;TNNI2;KAT2B;SYNE2
6629,GO:0023016,0.218443070895092,0.986567967506259,1,2,signal transduction by trans-phosphorylation,BP,WNK1
3509,GO:0007418,0.218509872763558,0.986559211445575,1,2,ventral midline development,BP,GLI2
6529,GO:0021937,0.218509872763558,0.986559211445575,1,2,cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation,BP,GLI2
6530,GO:0021938,0.218509872763558,0.986559211445575,1,2,smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation,BP,GLI2
6531,GO:0021940,0.218509872763558,0.986559211445575,1,2,positive regulation of cerebellar granule cell precursor proliferation,BP,GLI2
16267,GO:0090382,0.218540389271395,0.901290713932238,5,33,phagosome maturation,BP,RAB43;SPG11;TCIRG1;ATP6V0A2;SYT7
3078,GO:0006650,0.218838046216354,0.833461324305087,33,270,glycerophospholipid metabolic process,BP,INPP5D;EGFR;DGKQ;PIK3R1;PI4KAP2;KITLG;PITPNM3;PIK3C2G;PLCH2;PITPNM2;MBOAT2;SLC27A1;PGAP1;ETNK2;PLA2G6;LPIN3;PIGZ;OSBPL10;PI4KAP1;PLA2G7;DDHD2;PIK3C3;FGFR4;PIK3R2;OSBPL5;MPPE1;IRS2;IMPA2;ERBB2;IP6K2;PI4K2B;PEMT;SERINC3
18514,GO:1903725,0.218842406024384,0.885956256109013,7,46,regulation of phospholipid metabolic process,BP,PIK3R1;VAV3;PIK3IP1;SLC27A1;DAB2IP;PIK3R2;ATG14
2146,GO:0004965,0.218993006668755,0.986495788512772,1,2,G-protein coupled GABA receptor activity,MF,GABBR1
6373,GO:0021563,0.219198546458437,0.986468755246598,1,2,glossopharyngeal nerve development,BP,HOXA3
152,GO:0000308,0.21921518611513,0.986466565405808,1,2,cytoplasmic cyclin-dependent protein kinase holoenzyme complex,CC,CDK14
12468,GO:0050436,0.219215649464522,0.98646650442443,1,2,microfibril binding,MF,LTBP1
8692,GO:0034341,0.219508594941161,0.855306359403829,15,121,response to interferon-gamma,BP,OAS2;TRIM22;VAMP3;STAT1;RAB43;IFITM1;HLA-B;OAS1;ADAMTS13;GSN;IRF9;TRIM38;HLA-A;BST2;PPARG
3407,GO:0007189,0.219727546400618,0.89242698375471,6,38,adenylate cyclase-activating G-protein coupled receptor signaling pathway,BP,PTHLH;MC1R;NOS1;ADORA2B;GNG2;UCN2
12078,GO:0048073,0.21975857952757,0.986394942565281,1,2,regulation of eye pigmentation,BP,HPS4
7104,GO:0030911,0.220132962350981,0.950194837029344,2,8,TPR domain binding,MF,TRAK1;PDE2A
14477,GO:0061951,0.220456881146402,0.891784362991161,6,39,establishment of protein localization to plasma membrane,BP,VAMP3;NSG1;ANK3;VAMP2;BBS2;BBS1
11276,GO:0045603,0.220511491095569,0.950053105437784,2,8,positive regulation of endothelial cell differentiation,BP,BMP6;BTG1
13702,GO:0060292,0.220582089075967,0.927456586093636,3,15,long term synaptic depression,BP,SLC24A1;SHANK3;SHANK2
9675,GO:0038064,0.220642725900342,0.986277948574102,1,2,collagen receptor activity,MF,ITGA2
7793,GO:0032350,0.220867185032633,0.911678194677386,4,23,regulation of hormone metabolic process,BP,DGKQ;BMP6;VDR;TRERF1
10714,GO:0044070,0.220998978353008,0.884377311017232,7,47,regulation of anion transport,BP,APOE;CRY2;PER2;PLA2G6;ANO9;CA2;IRS2
13623,GO:0060151,0.221127652684318,0.986213539981734,1,2,peroxisome localization,BP,PEX1
13624,GO:0060152,0.221127652684318,0.986213539981734,1,2,microtubule-based peroxisome localization,BP,PEX1
911,GO:0002296,0.221168931042722,0.98620804944482,1,2,T-helper 1 cell lineage commitment,BP,STAT6
12214,GO:0048488,0.22118495788747,0.900606195548805,5,29,synaptic vesicle endocytosis,BP,SYT8;NLGN4Y;C2CD4C;NLGN2;DNM1
4660,GO:0010811,0.221237590367741,0.865561529401058,11,78,positive regulation of cell-substrate adhesion,BP,SFRP1;SMOC2;FERMT1;NINJ1;ITGA6;TRIOBP;NET1;NID1;DMTN;ECM2;NPNT
745,GO:0001977,0.221302872670809,0.948571229469576,2,9,renal system process involved in regulation of blood volume,BP,F2R;CYBA
502,GO:0001560,0.221612120602785,0.986149021631527,1,2,regulation of cell growth by extracellular stimulus,BP,KIF26A
10258,GO:0043014,0.221682338504388,0.911220467915962,4,23,alpha-tubulin binding,MF,TRPV4;FAM110C;CDK5R1;WASH3P
530,GO:0001649,0.221691053208308,0.84793443927702,18,138,osteoblast differentiation,BP,GPNMB;PTHLH;FAM20C;SFRP1;WNT3;IFITM1;GLI2;WWTR1;GLI3;BMP6;COL6A1;MRC2;MEF2D;AREG;PRKACA;UFL1;NPNT;CTNNBIP1
12753,GO:0051048,0.221854257072728,0.85596989365354,14,109,negative regulation of secretion,BP,SREBF1;SFRP1;VAMP3;CRY1;F2R;RHBDF1;NMU;IDH2;TNFRSF21;HADH;RAB11FIP3;WNK1;RSAD2;IL11
13052,GO:0051580,0.221887981114959,0.948346507841247,2,9,regulation of neurotransmitter uptake,BP,NOS1;PER2
8133,GO:0032868,0.221895629495331,0.839154039796039,24,192,response to insulin,BP,SREBF1;SRSF5;PIK3R1;STAT1;CRY1;TNFSF10;TRPV4;VAMP2;SESN3;INSR;BAIAP2;SLC27A1;TCIRG1;ATP6V0A2;HADH;SLC2A1;EPM2AIP1;PIK3R2;ZFP36L1;KAT2B;IRS2;GPR21;PPARG;GCLC
9161,GO:0035526,0.221903444150896,0.986110142802436,1,2,retrograde transport, plasma membrane to Golgi,BP,RAB43
12864,GO:0051222,0.221957365599781,0.828731313086285,36,297,positive regulation of protein transport,BP,POSTN;EGFR;GLUD1;FERMT1;VPS11;MDM2;RAPGEF3;F2R;HPS4;TRPV4;NLGN2;ANK3;C5;GLI3;VAMP2;NMU;TTN;TM7SF3;BMP6;MICALL2;PLA2G6;OSCP1;CDK5R1;FBXW7;PFKFB2;RPH3AL;NLRP1;GLUL;LRP1;IRS2;ANO1;ALOX15B;PHPT1;ERBB2;GPR68;PEMT
13590,GO:0060083,0.221961823389965,0.98610234432142,1,2,smooth muscle contraction involved in micturition,BP,KCNMA1
3839,GO:0008449,0.221974417473051,0.986100661639063,1,2,N-acetylglucosamine-6-sulfatase activity,MF,SULF2
5794,GO:0017046,0.222033078304909,0.926744427284708,3,15,peptide hormone binding,MF,PIK3R1;INSR;VIPR1
2765,GO:0006182,0.222135579652852,0.926694020023211,3,15,cGMP biosynthetic process,BP,APOE;NOS1;ADORA2B
12375,GO:0048817,0.222299133838036,0.986057236738072,1,2,negative regulation of hair follicle maturation,BP,FERMT1
17400,GO:1900169,0.222384728322031,0.986045777242033,1,2,regulation of glucocorticoid mediated signaling pathway,BP,CREBRF
18889,GO:1904612,0.222459003590924,0.986035828850036,1,2,response to 2,3,7,8-tetrachlorodibenzodioxine,BP,PDE2A
18890,GO:1904613,0.222459003590924,0.986035828850036,1,2,cellular response to 2,3,7,8-tetrachlorodibenzodioxine,BP,PDE2A
4951,GO:0015016,0.222500836039444,0.986030224063012,1,2,[heparan sulfate]-glucosamine N-sulfotransferase activity,MF,NDST2
12425,GO:0050119,0.222500836039444,0.986030224063012,1,2,N-acetylglucosamine deacetylase activity,MF,NDST2
15975,GO:0086006,0.222742770519188,0.985997784221252,1,2,voltage-gated sodium channel activity involved in cardiac muscle cell action potential,MF,SCN4B
19661,GO:2000001,0.222786986056325,0.925797747516205,3,16,regulation of DNA damage checkpoint,BP,CRY1;ETAA1;FBXO4
12980,GO:0051418,0.222837244979751,0.949178390733494,2,8,microtubule nucleation by microtubule organizing center,BP,TUBGCP5;CEP192
11524,GO:0046069,0.222886318666332,0.985978516359282,1,2,cGMP catabolic process,BP,PDE2A
553,GO:0001675,0.222898117268522,0.949155406883086,2,8,acrosome assembly,BP,CCDC136;RFX2
4886,GO:0014808,0.222965692580568,0.925709091230267,3,16,release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,BP,GSTM2;AKAP6;PRKACA
18410,GO:1903514,0.222965692580568,0.925709091230267,3,16,release of sequestered calcium ion into cytosol by endoplasmic reticulum,BP,GSTM2;AKAP6;PRKACA
1958,GO:0004666,0.223307421716319,0.985921906737886,1,2,prostaglandin-endoperoxide synthase activity,MF,PTGS1
10590,GO:0043583,0.22348996794129,0.852541658104023,15,112,ear development,BP,ALDH1A3;LRIG3;SLITRK6;EPHB2;CXCL14;NAGLU;GLI2;GLI3;CELSR1;TRIOBP;SPRY2;MYO3B;MAF;SHROOM2;PTK7
13909,GO:0060594,0.223530621639293,0.985891849095742,1,2,mammary gland specification,BP,GLI3
3736,GO:0008273,0.223594343654616,0.985883261173599,1,2,calcium, potassium:sodium antiporter activity,MF,SLC24A1
19646,GO:1990927,0.223773015335323,0.985859165475195,1,2,calcium ion regulated lysosome exocytosis,BP,SYT7
6764,GO:0030205,0.223852829830442,0.948794331895836,2,8,dermatan sulfate metabolic process,BP,CSPG4;IDUA
17493,GO:1900747,0.223880295610735,0.985844686428873,1,2,negative regulation of vascular endothelial growth factor signaling pathway,BP,DAB2IP
18012,GO:1902548,0.223880295610735,0.985844686428873,1,2,negative regulation of cellular response to vascular endothelial growth factor stimulus,BP,DAB2IP
14416,GO:0061749,0.224166137247845,0.98580606684153,1,2,forked DNA-dependent helicase activity,MF,WRN
14453,GO:0061849,0.224166137247845,0.98580606684153,1,2,telomeric G-quadruplex DNA binding,MF,WRN
16667,GO:0097635,0.224288793068418,0.985789476700701,1,2,extrinsic component of autophagosome membrane,CC,ULK1
13645,GO:0060187,0.224473737947954,0.98576444068121,1,2,cell pole,CC,ASTN2
19003,GO:1904862,0.224620800903088,0.985744514882279,1,2,inhibitory synapse assembly,BP,NLGN2
16270,GO:0090386,0.224723432597503,0.985730599769528,1,2,phagosome maturation involved in apoptotic cell clearance,BP,SPG11
16271,GO:0090387,0.224723432597503,0.985730599769528,1,2,phagolysosome assembly involved in apoptotic cell clearance,BP,SPG11
10560,GO:0043537,0.224948089886518,0.909378787867615,4,23,negative regulation of blood vessel endothelial cell migration,BP,APOE;MAP2K5;MMRN2;PPARG
4517,GO:0010573,0.225155743639623,0.909261257773063,4,23,vascular endothelial growth factor production,BP,SULF2;ADORA2B;C5;RORA
5444,GO:0016314,0.225155898307467,0.985671880054788,1,2,phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity,MF,INPP5D
17422,GO:1900220,0.225175103081921,0.985669269275103,1,2,semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis,BP,PLXNB1
4128,GO:0009189,0.225315579368267,0.981135450491554,1,3,deoxyribonucleoside diphosphate biosynthetic process,BP,CMPK2
20101,GO:2000809,0.22533485236491,0.985647541796465,1,2,positive regulation of synaptic vesicle clustering,BP,NLGN2
12693,GO:0050931,0.225379396630314,0.909134615305928,4,23,pigment cell differentiation,BP,KITLG;HPS4;GLI3;BLOC1S3
3278,GO:0006957,0.225703170979356,0.985597375548348,1,2,complement activation, alternative pathway,BP,C5
8432,GO:0033564,0.225720531545751,0.985595008525365,1,2,anterior/posterior axon guidance,BP,UNC5B
14920,GO:0070829,0.225802497777795,0.985583829869954,1,2,heterochromatin maintenance,BP,MTHFR
4525,GO:0010593,0.225886258817644,0.985572401345033,1,2,negative regulation of lamellipodium assembly,BP,PLXNB3
2573,GO:0005861,0.225956659725459,0.981021455146925,1,3,troponin complex,CC,TNNI2
8788,GO:0034499,0.225958050132231,0.985562601896912,1,2,late endosome to Golgi transport,BP,SGSM2
1468,GO:0003726,0.225959236131535,0.985562439977372,1,2,double-stranded RNA adenosine deaminase activity,MF,ADARB1
17912,GO:1902261,0.226007922450005,0.985555792145513,1,2,positive regulation of delayed rectifier potassium channel activity,BP,AKAP6
12087,GO:0048143,0.226057854382357,0.947956077658172,2,8,astrocyte activation,BP,EGFR;LRP1
12606,GO:0050811,0.226132291768247,0.946703549076998,2,9,GABA receptor binding,MF,TRAK1;ARFGEF2
14207,GO:0061187,0.226255145379984,0.98552200845512,1,2,regulation of chromatin silencing at rDNA,BP,PHF2
14208,GO:0061188,0.226255145379984,0.98552200845512,1,2,negative regulation of chromatin silencing at rDNA,BP,PHF2
6061,GO:0019212,0.226368095184549,0.908236891193905,4,24,phosphatase inhibitor activity,MF,ELFN2;PHACTR3;PPP1R2;PPP1R35
4677,GO:0010828,0.226471456053665,0.897383572507559,5,29,positive regulation of glucose transmembrane transport,BP,PIK3R1;CLTCL1;INSR;PIK3R2;IRS2
7064,GO:0030859,0.226593165279488,0.92448932650827,3,15,polarized epithelial cell differentiation,BP,MYO9A;DLG5;PTK7
3463,GO:0007281,0.226689412623998,0.845713790246701,17,132,germ cell development,BP,HSPA2;KDM3A;DNAH1;TPGS1;CABYR;ETV5;HEXB;BBS2;REC8;CCDC136;RFX2;DPY19L2P2;SIX5;TSSK1B;PAQR7;PRKACA;TTLL1
11100,GO:0045136,0.226706847992514,0.946479404091669,2,9,development of secondary sexual characteristics,BP,IRF2BPL;AREG
3626,GO:0008083,0.226934677111719,0.868877832373016,9,69,growth factor activity,MF,KITLG;MDK;BMP6;VEGFB;GDF15;NUDT6;AREG;ENDOU;IL11
16075,GO:0090075,0.226972780129973,0.923710770506765,3,16,relaxation of muscle,BP,RGS2;ADORA2B;GSTM2
16945,GO:0098978,0.227150447594171,0.985399287288058,1,2,glutamatergic synapse,CC,NLGN4Y
16949,GO:0098985,0.227150447594171,0.985399287288058,1,2,asymmetric, glutamatergic, excitatory synapse,CC,NLGN4Y
465,GO:0001504,0.227156287286848,0.923618779487344,3,16,neurotransmitter uptake,BP,NOS1;PER2;GLUL
11733,GO:0046596,0.227169936230824,0.922645434199285,3,18,regulation of viral entry into host cell,BP,IFITM1;GSN;TRIM38
13252,GO:0051961,0.227194589653182,0.834827568833146,24,189,negative regulation of nervous system development,BP,ULK2;APOE;PTPRS;DIXDC1;KCTD11;EPHB2;WNT3;RGMA;PRKACB;NFATC4;SPOCK1;MDM2;RTN4RL1;TRPV4;SEMA4G;GLI3;SYNGAP1;IDH2;TNFRSF21;CDK5R1;EFNB3;LRP1;BRINP1;PMP22
16470,GO:0097186,0.227270621461242,0.924152110412968,3,15,amelogenesis,BP,FAM20C;ITGA6;KLK5
16791,GO:0098660,0.227332683147316,0.81810133460236,47,405,inorganic ion transmembrane transport,BP,HSPA2;PKD2;ORAI3;KCNAB2;KCNJ15;NOS1;KCNC4;ITPR3;NDUFA4L2;F2R;SLC24A1;TRPV4;ANK3;GJC2;CLCN6;SNTA1;GSTM2;VAMP2;KCNJ5;SCNN1A;SCN4B;NIPAL2;TCIRG1;SLC12A7;CLCA2;PLA2G6;ATP6V0A2;KLHL24;ANO9;HFE;CYBA;KCNMA1;KCNG1;JPH2;PDE2A;SLC37A2;SHROOM2;SCN2A;CACNB3;ORAI2;ANO1;CACNB1;PTPN3;AKAP6;PRKACA;KCNS3;CLCN7
4070,GO:0009125,0.22743917350069,0.946193110253777,2,9,nucleoside monophosphate catabolic process,BP,NT5E;NUDT10
6464,GO:0021798,0.22759130179684,0.985338641818247,1,2,forebrain dorsal/ventral pattern formation,BP,GLI3
17050,GO:0099568,0.227609062597257,0.820907133288919,41,338,cytoplasmic region,CC,GPSM1;PKD2;COL10A1;RHOBTB2;RAPGEF3;BLOC1S4;SPTB;DNAH1;TRPV4;FLOT1;GLI2;RIMS3;WIPF1;FAM110C;GLI3;GAS8;BSN;TRAK1;GSN;BAIAP2;PLEKHH2;TRIOBP;SEPT6;BLOC1S3;ARHGAP33;SEPT5;HFE;IFT140;ASTN2;SLC2A1;BBS1;SHROOM2;PIK3C3;BBS5;EXOC2;DMTN;ARFGEF2;SHROOM4;DLG4;ATG14;PRKACA
7121,GO:0030952,0.227628396220798,0.923381922487529,3,16,establishment or maintenance of cytoskeleton polarity,BP,RHOBTB2;RICTOR;LMNA
6333,GO:0021511,0.227869893917321,0.947262718357182,2,8,spinal cord patterning,BP,GLI2;GLI3
4182,GO:0009261,0.22797319680125,0.907321590017157,4,24,ribonucleotide catabolic process,BP,NT5E;RAPGEF3;PDE2A;NUDT10
8175,GO:0032922,0.228042247879864,0.879912268530926,7,45,circadian regulation of gene expression,BP,CRY2;CRY1;PER2;BHLHE40;RAI1;RORA;PER3
4059,GO:0009110,0.228129283340139,0.923130325748526,3,16,vitamin biosynthetic process,BP,VDR;PNPO;PLTP
20227,GO:2001201,0.228260790443038,0.985246270943445,1,2,regulation of transforming growth factor-beta secretion,BP,FERMT1
10592,GO:0043585,0.228454937852322,0.985219422208581,1,2,nose morphogenesis,BP,GLI3
654,GO:0001845,0.228455093075474,0.945794834991337,2,9,phagolysosome assembly,BP,SPG11;SYT7
12656,GO:0050884,0.228485568124869,0.947026212326259,2,8,neuromuscular process controlling posture,BP,GAA;ADARB1
8609,GO:0034137,0.228681053471876,0.980532707216739,1,3,positive regulation of toll-like receptor 2 signaling pathway,BP,CYBA
6069,GO:0019221,0.228777058007201,0.812830777082596,57,528,cytokine-mediated signaling pathway,BP,TNFAIP3;IFI6;INPP5D;OAS2;CXCR1;TRIM22;MAP3K14;PIK3R1;RBCK1;ISG15;STAT1;NDN;IFITM1;HLA-B;OAS1;FLRT3;IL20RB;PDCD4;RTN4RL1;TNFRSF14;SPPL2B;MMP1;SLC27A1;IRF9;SQSTM1;SHARPIN;BBS2;CTF1;IFI27;TNFRSF21;TRIM38;SLIT3;EDA2R;CREBRF;ELF1;MX2;HLA-A;IL20RA;RPS6KA5;BST2;STAT2;DUOX1;RSAD2;TNFRSF25;ACSL1;IL11;IRS2;TNFSF12;STAT6;RORA;PPARG;PRKACA;ACKR3;IP6K2;AIP;CCDC3;ECM1
16174,GO:0090222,0.22878706146569,0.985173428235517,1,2,centrosome-templated microtubule nucleation,BP,CEP192
19692,GO:2000053,0.228921199733227,0.985154829094261,1,2,regulation of Wnt signaling pathway involved in dorsal/ventral axis specification,BP,SFRP1
9559,GO:0036369,0.22903215644896,0.985139434190557,1,2,transcription factor catabolic process,BP,MDM2
9594,GO:0036465,0.229242024173647,0.886465352499549,6,37,synaptic vesicle recycling,BP,SYT8;NLGN4Y;C2CD4C;NLGN2;DNM1;SYT7
10341,GO:0043168,0.229278998287487,0.793897017018531,223,1999,anion binding,MF,POSTN;SERPINE2;ULK2;GPNMB;SIK1;SLFN5;PYGB;ACTA2;APOE;OAS2;PSD4;DDX60;HSPA2;EGFR;PTPRS;FAM20C;SYT8;SYN1;ALDH1A3;SFRP1;MTHFR;SEC14L2;IFI44L;KIF26B;EPHB2;MAP3K14;GLUD1;DGKQ;BRSK1;TXNRD3;CUL9;DHTKD1;CAMKK1;SMOC2;MVD;CRY2;HS1BP3;RAB43;RAB40B;NOS1;PRKACB;HMGCL;D2HGDH;CYP26B1;CMPK2;THNSL2;MICALL1;PIK3C2G;LIG1;CDK18;SPEG;ITPR3;PLCD1;MLH3;NMRK1;DDX59;OBSCN;PRODH;MYH11;SYTL1;ACTR1B;TNXB;RHOBTB2;UGT1A3;RAPGEF3;OAS1;RASA4;GAL3ST4;KIF26A;C2CD4C;PHYH;ALPK1;DNAH1;NEK9;RTN4RL1;TRPV4;NAT6;DHX32;CLCN6;PSKH1;MINK1;GSTM2;THBS3;ITGA2;SYT15;ULK1;THRAP3;SMARCA1;VAMP2;NAIP;NEK8;MAP2K5;SESN3;GPC2;NISCH;INSR;CHD3;CDK14;TTN;SLFNL1;SEPT6;DHX58;MDK;NLRX1;ETNK2;MAP2K2;OPLAH;PDK1;VEGFB;PTK6;FZD7;ARHGAP33;PDIK1L;MAP3K12;WRN;SEPT5;DNM1;MCM9;MCTP1;ATRX;OSBPL10;SESN1;MAPK10;ERCC6;HADH;HLCS;PAK6;PFKFB2;ACADS;ARAP1;ASTN2;MX2;RPH3AL;ACACB;ACCS;OGDHL;NLRP1;TK2;GLUL;SRR;LRP1;PLA2G7;MAP3K6;RIMKLB;MYO3B;WNK1;JPH2;ARL11;PDE2A;SDHA;STK16;RET;DAB2IP;ACOX3;PIK3C3;SYT7;DALRD3;FGFR4;BBS5;OSBPL5;MYO9A;RPS6KA5;VDR;SNX21;NADK;BBS10;HLTF;PCSK6;MPPE1;STK19;RASL10B;LMTK3;SNX1;OSBPL1A;ACVR1B;ESYT2;TSSK1B;SNX29;WEE1;PTK7;DQX1;ACSL1;MARK4;TEP1;ERN1;RAD50;TKFC;PNPO;PEX1;SCYL3;SCG5;CBR4;TUB;KIF7;GSTM3;CHD6;ACSS2;COL13A1;ERBB2;ABCA2;TH;PPARG;PRKACA;LDLRAP1;PLTP;SUCLG2;UCKL1;DDX12P;IP6K2;RIPK3;PI4K2B;LONP2;SNX33;HARS2;CIT;MSH5;CLCN7;ECM2;SMURF1;TTLL1;PEMT;ABCA11P;GCLC
5566,GO:0016581,0.22929744317118,0.92313983934967,3,15,NuRD complex,CC,CHD3;APPL2;SALL2
16309,GO:0090545,0.22929744317118,0.92313983934967,3,15,CHD-type complex,CC,CHD3;APPL2;SALL2
17966,GO:1902414,0.229397609366474,0.946674997723828,2,8,protein localization to cell junction,BP,DLG5;MPP7
15117,GO:0071233,0.229414657861968,0.946668422785336,2,8,cellular response to leucine,BP,SESN3;SESN1
17815,GO:1902001,0.229573477784814,0.923001585048214,3,15,fatty acid transmembrane transport,BP,CPT2;ACACB;IRS2
11403,GO:0045833,0.229763680595051,0.878193781647114,7,49,negative regulation of lipid metabolic process,BP,SIK1;APOE;PIK3IP1;SLC27A1;FBXW7;ACACB;DAB2IP
7152,GO:0031022,0.229819245984486,0.985029966931677,1,2,nuclear migration along microfilament,BP,SYNE2
14394,GO:0061700,0.230012781089423,0.945181653983536,2,9,GATOR2 complex,CC,SESN3;SESN1
9730,GO:0038201,0.23003685694276,0.922169304381345,3,16,TOR complex,CC,SESN3;RICTOR;SESN1
10792,GO:0044291,0.230078597865852,0.878531690434164,7,45,cell-cell contact zone,CC,OBSL1;FLOT1;ANK3;SCN4B;SLC2A1;SCN2A;AKAP6
15145,GO:0071286,0.230129959203689,0.984986627341607,1,2,cellular response to magnesium ion,BP,ANK3
17295,GO:0140192,0.230291684616003,0.984964040941167,1,2,regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process,BP,NOS1
9070,GO:0035332,0.230468322280113,0.984939349797327,1,2,positive regulation of hippo signaling,BP,DLG5
2428,GO:0005608,0.230528641497374,0.984930912837706,1,2,laminin-3 complex,CC,LAMB2
13966,GO:0060700,0.230642079516736,0.944933068728353,2,9,regulation of ribonuclease activity,BP,OAS2;OAS1
6579,GO:0022412,0.230822727190755,0.832957423698437,23,185,cellular process involved in reproduction in multicellular organism,BP,HSPA2;SFRP1;KDM3A;CYP26B1;MLH3;DNAH1;TPGS1;CABYR;ETV5;HEXB;BBS2;REC8;AGO4;SLIT3;CCDC136;RFX2;DPY19L2P2;SIX5;TSSK1B;CD9;PAQR7;PRKACA;TTLL1
18382,GO:1903432,0.230942947652085,0.905620102084188,4,24,regulation of TORC1 signaling,BP,DGKQ;SESN3;SESN1;C12ORF66
9069,GO:0035331,0.230950266484909,0.946074723873161,2,8,negative regulation of hippo signaling,BP,DLG5;WWC3
2193,GO:0005057,0.231078088307482,0.844461545405825,16,118,signal transducer activity, downstream of receptor,MF,EGFR;EPHB2;MAP3K14;IFITM1;FLRT3;MINK1;INSR;MAP3K12;MAPK10;RGS12;MAP3K6;RET;FGFR4;ACVR1B;ERBB2;RIPK3
3138,GO:0006732,0.231133518060294,0.822070513280929,34,294,coenzyme metabolic process,BP,NT5E;GAMT;MTHFR;H6PD;DHTKD1;KCNAB2;MVD;NAPRT;HMGCL;NMRK1;ACOT1;MLYCD;INSR;PGLS;SLC2A3;PDK1;IDH2;HLCS;MLXIPL;PGM1;PFKFB2;SLC2A1;ACACB;OGDHL;PPCS;NADK;ACSL1;PNPO;CBR4;ACSS2;ACOT2;SUCLG2;PEMT;GCLC
2430,GO:0005614,0.231233641559922,0.945964846221706,2,8,interstitial matrix,CC,SMOC2;ECM2
9053,GO:0035296,0.231405628502346,0.865982382395256,9,65,regulation of tube diameter,BP,APOE;EGFR;NOS1;RGS2;F2R;ADORA2B;PER2;PLA2G6;BBS2
16712,GO:0097746,0.231405628502346,0.865982382395256,9,65,regulation of blood vessel diameter,BP,APOE;EGFR;NOS1;RGS2;F2R;ADORA2B;PER2;PLA2G6;BBS2
9753,GO:0039529,0.231583056548409,0.921992238400625,3,15,RIG-I signaling pathway,BP,DDX60;DHX58;NLRX1
7920,GO:0032504,0.231610738710935,0.811520536951547,54,465,multicellular organism reproduction,BP,SERPINE2;GAMT;HSPA2;EGFR;SFRP1;TXNRD3;KDM3A;WNT3;ZFP41;SCMH1;CRTAP;CYP26B1;MLH3;CTSV;SPATA20;RGS2;DNAH1;MICALCL;TPGS1;TCFL5;HSF2BP;SUN1;SEPT6;CABYR;ETV5;HEXB;PLA2G6;BBS2;MCM9;ATRX;REC8;AGO4;SLIT3;CREBRF;CTSB;THRA;CCDC136;RFX2;BRINP1;TMEM203;BTG1;VDR;DPY19L2P2;SIX5;TSSK1B;PHC2;CD9;PAQR7;TH;PRKACA;NPAP1;PARN;HERPUD2;TTLL1
12446,GO:0050294,0.231813462358257,0.979962120723435,1,3,steroid sulfotransferase activity,MF,SULT1E1
15545,GO:0072015,0.231922183303785,0.945697452709976,2,8,glomerular visceral epithelial cell development,BP,PODXL;LAMB2
15715,GO:0072310,0.231922183303785,0.945697452709976,2,8,glomerular epithelial cell development,BP,PODXL;LAMB2
3691,GO:0008198,0.232114399431737,0.920588703894551,3,17,ferrous iron binding,MF,PHYH;ACP5;TH
9914,GO:0042272,0.232239742828236,0.984690454743232,1,2,nuclear RNA export factor complex,CC,ATXN1
2531,GO:0005788,0.232341631506453,0.831719672105783,23,184,endoplasmic reticulum lumen,CC,APOE;CES2;FAM20C;ADAMTS7;COL22A1;WNT3;H6PD;COL10A1;CRTAP;COL7A1;ARSI;ADAMTS13;ARSD;LTBP1;CES3;IGFBP4;CST3;COL6A1;CERCAM;KDELC2;MXRA8;COL13A1;LAMB2
2147,GO:0004966,0.232743736066085,0.979790878667439,1,3,galanin receptor activity,MF,LTB4R2
5228,GO:0015844,0.232756875258202,0.904575729613047,4,24,monoamine transport,BP,NOS1;SLC29A4;NISCH;SYT7
12966,GO:0051389,0.232830632771377,0.984606913180588,1,2,inactivation of MAPKK activity,BP,EPHB2
2953,GO:0006482,0.232869235700644,0.893441729658501,5,29,protein demethylation,BP,KDM3A;HR;HSF4;PHF2;KDM4C
3705,GO:0008214,0.232869235700644,0.893441729658501,5,29,protein dealkylation,BP,KDM3A;HR;HSF4;PHF2;KDM4C
12252,GO:0048562,0.232941234477131,0.834041130825994,21,163,embryonic organ morphogenesis,BP,PKD2;ALDH1A3;LRIG3;SLITRK6;EPHB2;HOXA3;NAGLU;GLI2;GLI3;CELSR1;TRIOBP;HYAL1;NPHP3;SPRY2;IFT140;MYO3B;TEAD2;BBS5;PTK7;TCF7;TH
7584,GO:0031960,0.233378996020511,0.849722783795567,13,101,response to corticosteroid,BP,EGFR;CTSV;ZFP36L2;MDK;BMP6;CYBA;SLIT3;CREBRF;AREG;ZFP36L1;GLB1;TH;KLF9
18136,GO:1902904,0.233415604939953,0.852907234621971,12,89,negative regulation of supramolecular fiber organization,BP,ARPIN;SPTB;FHOD3;GSN;PLEKHH2;TRIOBP;SHANK3;APC2;ARAP1;CAPG;DMTN;EML2
10158,GO:0042759,0.233443479372369,0.943820433009293,2,9,long-chain fatty acid biosynthetic process,BP,ALOXE3;ALOX15B
13849,GO:0060488,0.233938935533095,0.984449517959047,1,2,orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis,BP,CELSR1
13850,GO:0060489,0.233938935533095,0.984449517959047,1,2,planar dichotomous subdivision of terminal units involved in lung branching morphogenesis,BP,CELSR1
13851,GO:0060490,0.233938935533095,0.984449517959047,1,2,lateral sprouting involved in lung morphogenesis,BP,CELSR1
19432,GO:1990126,0.233992390434886,0.920162202440046,3,16,retrograde transport, endosome to plasma membrane,BP,NSG1;MICALL1;VPS39
16067,GO:0090066,0.234126840832547,0.816330227334921,39,326,regulation of anatomical structure size,BP,ULK2;APOE;EGFR;PTPRS;EPS8L2;WNT3;VAV3;NOS1;RGS2;ARPIN;F2R;SPTB;TRPV4;ADORA2B;PER2;CLCN6;WIPF1;SEMA4G;FHOD3;GSN;BAIAP2;PLEKHH2;TRIOBP;RICTOR;SLC12A7;WHAMMP3;PLA2G6;BBS2;PEX11B;CDK5R1;SHANK3;WASH3P;KCNMA1;CAPG;RET;DMTN;SSH3;CIT;GCLC
9782,GO:0040013,0.234195937105293,0.826675585461861,26,209,negative regulation of locomotion,BP,TP53INP1;APOE;SFRP1;WNT3;IFITM1;ARPIN;C5;SEMA4G;MAP2K5;SRGAP3;NISCH;MMP28;DDT;PLXNB3;MMRN2;IDH2;MCTP1;ADARB1;LRP1;ZMYND8;DAB2IP;DLG5;BST2;ALOX15B;PBLD;PPARG
14936,GO:0070851,0.234233757385503,0.855614398176173,11,82,growth factor receptor binding,MF,VAV3;FLRT3;FRS3;CBLC;VEGFB;DAB2IP;AREG;SNX1;IL11;ERN1;ECM1
15013,GO:0070977,0.234235361472437,0.944794839897741,2,8,bone maturation,BP,PLXNB1;THBS3
7267,GO:0031256,0.234287243438865,0.844124771527261,15,111,leading edge membrane,CC,PSD4;EPS8L2;CSPG4;FERMT1;KCNC4;TRPV4;ARHGEF4;INSR;DOCK8;EPB41L3;PSD3;SPRY2;APC2;PLXND1;SYNE2
8048,GO:0032722,0.234528294228533,0.891422093253023,5,33,positive regulation of chemokine production,BP,POSTN;TRPV4;ADORA2B;C5;ALOX15B
14935,GO:0070849,0.234540599681968,0.882618031542911,6,39,response to epidermal growth factor,BP,EGFR;ZFP36L2;BAIAP2;DAB2IP;ZFP36L1;ERBB2
1577,GO:0003989,0.234563090944994,0.984360475930457,1,2,acetyl-CoA carboxylase activity,MF,ACACB
20281,GO:2001295,0.234563090944994,0.984360475930457,1,2,malonyl-CoA biosynthetic process,BP,ACACB
7111,GO:0030934,0.234721026512557,0.984337898766829,1,2,anchoring collagen complex,CC,COL7A1
3555,GO:0007596,0.234754008241105,0.827115646754956,25,212,blood coagulation,BP,SERPINE2;APOE;DGKQ;PIK3R1;DOCK9;VAV3;ZFPM1;MYL9;PRKACB;ITPR3;F2R;HPS4;BLOC1S4;ADAMTS13;ITGA2;DOCK8;BLOC1S3;HMG20B;TFPI2;GNG2;DMTN;CD9;PRKACA;DOCK6;SERPING1
5269,GO:0015919,0.234824184471923,0.919737678405671,3,16,peroxisomal membrane transport,BP,PEX10;PEX7;PEX1
15824,GO:0072558,0.234923961749092,0.979386330471251,1,3,NLRP1 inflammasome complex,CC,NLRP1
16249,GO:0090330,0.235264627171092,0.919512543359995,3,16,regulation of platelet aggregation,BP,SERPINE2;DMTN;CD9
9346,GO:0035869,0.235514402855933,0.874260367166552,7,49,ciliary transition zone,CC,UNC119B;UNC119;IQCB1;IFT140;NPHP4;TMEM80;TMEM231
9428,GO:0036017,0.23559346740466,0.9768407243627,1,4,response to erythropoietin,BP,MT1X
9429,GO:0036018,0.23559346740466,0.9768407243627,1,4,cellular response to erythropoietin,BP,MT1X
4598,GO:0010716,0.235593621028966,0.979261165173272,1,3,negative regulation of extracellular matrix disassembly,BP,CST3
3527,GO:0007507,0.235813840409867,0.812249576886635,44,354,heart development,BP,SIK1;ADAM19;EGFR;PKD2;OBSL1;TENM4;ZFPM1;NFATC4;GAA;MDM2;MYH11;TCF25;FLRT3;PDCD4;GLI2;PSKH1;GLI3;FHOD3;IRX4;LTBP1;NEK8;MAP2K5;JARID2;INSR;TTN;VEGFB;FZD7;NPHP3;MEF2D;IFT140;ACACB;JPH2;TEAD2;BBS5;PLXND1;TFDP2;PTK7;ZFP36L1;LMNA;KAT2B;ERBB2;AKAP6;TH;PPARG
10144,GO:0042738,0.235973537621246,0.9428071052524,2,9,exogenous drug catabolic process,BP,NOS1;CYP2D7
8707,GO:0034364,0.236114760062653,0.940904203082345,2,11,high-density lipoprotein particle,CC,APOE;PLTP
7326,GO:0031344,0.236167878015986,0.808293938281588,52,436,regulation of cell projection organization,BP,ULK2;APOE;ESPN;PTPRS;CAPRIN2;SFRP1;OBSL1;EPS8L2;EPHB2;EVI5L;WNT3;RGMA;CUL7;NFATC4;PLXNB1;SPOCK1;MDM2;CRTC1;CSMD3;ARPIN;RTN4RL1;TRPV4;ITGA2;SEMA4G;FAM110C;TRAK1;BAIAP2;PLXNB3;PTK6;SYNGAP1;PODXL;CDK5R1;EFNB3;SHANK3;SPRY2;IFT140;ARAP1;LRP1;RET;ZMYND8;DAB2IP;DLG5;PLXND1;DMTN;PMP22;DLG4;PTK7;SHANK2;ZSWIM8;SSH3;SYNE2;SMURF1
15667,GO:0072215,0.23639950857453,0.918931339369828,3,16,regulation of metanephros development,BP,STAT1;WWTR1;RET
16969,GO:0099072,0.23641021843714,0.91892584699212,3,16,regulation of postsynaptic membrane neurotransmitter receptor levels,BP,NSG1;DNM1;DLG4
17622,GO:1901379,0.236595301599094,0.88126320820084,6,39,regulation of potassium ion transmembrane transport,BP,KCNAB2;ANK3;VAMP2;KLHL24;KCNG1;AKAP6
10583,GO:0043567,0.23663637563549,0.942540300543116,2,9,regulation of insulin-like growth factor receptor signaling pathway,BP,IGFBP4;IGFBP6
8263,GO:0033077,0.236917661263785,0.87342798832634,7,48,T cell differentiation in thymus,BP,ZFP36L2;GLI2;GLI3;FZD7;ZFP36L1;ERBB2;RIPK3
14683,GO:0070330,0.237050730592569,0.942373234861141,2,9,aromatase activity,MF,CYP3A5;CYP2D7
13059,GO:0051588,0.237166978559314,0.873256498697628,7,48,regulation of neurotransmitter transport,BP,SYN1;NOS1;KCNC4;RIMS3;PER2;SEPT5;MCTP1
7725,GO:0032228,0.237229901576647,0.919129389273594,3,15,regulation of synaptic transmission, GABAergic,BP,NLGN2;NISCH;CA2
626,GO:0001816,0.237400819236644,0.807466821782648,51,450,cytokine production,BP,TNFAIP3;POSTN;ITGB6;GPNMB;INPP5D;DDX60;PTPRS;PIK3R1;RNF135;SULF2;HERC5;ISG15;ZFPM1;MC1R;STAT1;NFATC4;FERMT1;IL20RB;F2R;PDCD4;TRPV4;FLOT1;ADORA2B;C5;MAP2K5;LTBP3;DDT;ZNF287;DHX58;NLRX1;TNFRSF21;TREX1;HFE;CYBA;ELF1;NLRP1;ERMAP;ACP5;ZBTB20;MAF;IFI16;RPS6KA5;BST2;ARFGEF2;CCDC88B;RSAD2;ALOX15B;TKFC;STAT6;RORA;RIPK3
15585,GO:0072092,0.237568986620144,0.983927577321845,1,2,ureteric bud invasion,BP,KIF26B
17009,GO:0099403,0.237804882649894,0.983893317910317,1,2,maintenance of mitotic sister chromatid cohesion, telomeric,BP,ATRX
17010,GO:0099404,0.237804882649894,0.983893317910317,1,2,mitotic sister chromatid cohesion, telomeric,BP,ATRX
19031,GO:1904907,0.237804882649894,0.983893317910317,1,2,regulation of maintenance of mitotic sister chromatid cohesion, telomeric,BP,ATRX
19032,GO:1904908,0.237804882649894,0.983893317910317,1,2,negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric,BP,ATRX
4361,GO:0009967,0.237834286694833,0.793065670213463,117,1058,positive regulation of signal transduction,BP,GPNMB;TP53INP1;DDX60;EGFR;PKD2;CAPRIN2;DIXDC1;TRIM22;SFRP1;EPHB2;MAP3K14;PIK3R1;RBCK1;EVC;SULF2;WNT3;VAV3;CSPG4;KITLG;MC1R;UNC5B;NOS1;MAML3;PLEKHG5;NFATC4;FERMT1;PLXNB1;CHN2;TNFSF10;NEO1;F2R;PDCD4;TRPV4;FLOT1;NLGN2;ADORA2B;RNF165;MAPK8IP3;PIDD1;RASGEF1A;C5;MINK1;GSTM2;FAM110C;NAIP;MAP2K5;IGFBP4;INSR;GSN;BAIAP2;DDT;DHX58;RICTOR;BMP6;S100A4;MAP2K2;PTK6;FZD7;SHARPIN;SH2D2A;PLA2G6;GDF15;CTF1;MAP3K12;MAPK10;SHANK3;HFE;CYBA;TRIM38;ERCC6;SHC2;EDA2R;SPRY2;CREBRF;KLK5;FBXW7;CDK5RAP3;ARAP1;MAP3K6;WNK1;JPH2;RET;DAB2IP;RWDD3;FGFR4;IL20RA;PIK3R2;DLG5;BST2;RGL2;LPAR6;DMTN;TFDP2;NRARP;ACVR1B;DLG4;SHANK2;RSAD2;TNFRSF25;IL11;KAT2B;IRS2;ERN1;ALOX15B;TNFSF12;KIF7;TRAF5;ERBB2;AKAP6;MPP7;LDLRAP1;CXXC5;ACKR3;RIPK3;NPNT;SERINC3;ECM1
15632,GO:0072170,0.238223960670102,0.918621360073956,3,15,metanephric tubule development,BP,PKD2;STAT1;WWTR1
6412,GO:0021680,0.238394413895577,0.918534125406567,3,15,cerebellar Purkinje cell layer development,BP,NAGLU;B4GALT2;RORA
9379,GO:0035928,0.238409883263008,0.978730095539005,1,3,rRNA import into mitochondrion,BP,TST
4513,GO:0010566,0.238515361973042,0.941780976486466,2,9,regulation of ketone biosynthetic process,BP,DGKQ;BMP6
10412,GO:0043270,0.238563625586701,0.840424299021137,15,119,positive regulation of ion transport,BP,APOE;HSPA2;PKD2;EPHB2;NOS1;F2R;ANK3;GJC2;GSTM2;SCN4B;PLA2G6;SHANK3;WNK1;JPH2;AKAP6
10720,GO:0044091,0.238669785605755,0.901144578763105,4,24,membrane biogenesis,BP,NLGN4Y;FLOT1;NLGN2;ANK3
16817,GO:0098742,0.238725141263635,0.843125563282467,14,103,cell-cell adhesion via plasma-membrane adhesion molecules,BP,PCDH1;TENM4;SDK2;LGALS7B;FLRT3;ADGRL1;AMIGO2;MAP2K5;CELSR1;PLXNB3;FAT2;RET;CADM4;CLSTN3
2043,GO:0004792,0.238878601182483,0.978640971726906,1,3,thiosulfate sulfurtransferase activity,MF,TST
20125,GO:2000848,0.239061174973678,0.978606199457379,1,3,positive regulation of corticosteroid hormone secretion,BP,BMP6
12905,GO:0051280,0.239417005602059,0.940370481979531,2,10,negative regulation of release of sequestered calcium ion into cytosol,BP,PKD2;GSTM2
12909,GO:0051284,0.239417005602059,0.940370481979531,2,10,positive regulation of sequestering of calcium ion,BP,PKD2;GSTM2
10779,GO:0044264,0.239684080429251,0.855566757883431,10,72,cellular polysaccharide metabolic process,BP,PYGB;GAA;PPP1R3E;PER2;INSR;B3GNT9;PGM1;EPM2AIP1;PPP1R2;IRS2
2513,GO:0005767,0.239734786337562,0.940239189290549,2,10,secondary lysosome,CC,SQSTM1;PIK3C3
16250,GO:0090331,0.239817849902235,0.941252022757171,2,9,negative regulation of platelet aggregation,BP,SERPINE2;CD9
10422,GO:0043291,0.239818961875388,0.983599107667631,1,2,RAVE complex,CC,DMXL2
3072,GO:0006639,0.240175718052773,0.859621334727693,9,65,acylglycerol metabolic process,BP,SIK1;SREBF1;APOE;LMF1;DGKQ;LPIN3;FBXW7;DDHD2;ACSL1
946,GO:0002363,0.240308097739083,0.941052376425412,2,9,alpha-beta T cell lineage commitment,BP,ZFPM1;STAT6
15177,GO:0071345,0.24034131650063,0.796403461588014,80,742,cellular response to cytokine stimulus,BP,TNFAIP3;POSTN;IFI6;INPP5D;OAS2;CXCR1;TRIM22;SFRP1;MAP3K14;PIK3R1;ADAMTS7;RBCK1;KDM3A;ISG15;VAMP3;STAT1;RAB43;NDN;IFITM1;HLA-B;OAS1;FLRT3;IL20RB;MT1X;PDCD4;RTN4RL1;ZFP36L2;ADAMTS13;TNFRSF14;SPPL2B;MMP1;JARID2;GSN;DOCK8;SLC27A1;IRF9;SQSTM1;SHARPIN;HYAL1;BBS2;CTF1;IFI27;TNFRSF21;CYBA;TRIM38;SLIT3;EDA2R;SPRY2;CREBRF;ELF1;MX2;HLA-A;RFX2;PDE2A;DAB2IP;IL20RA;RPS6KA5;BST2;STAT2;DUOX1;TCF7;RSAD2;TNFRSF25;ZFP36L1;ACSL1;IL11;IRS2;TNFSF12;STAT6;SYNGR1;AKAP6;RORA;PPARG;PRKACA;ACKR3;IP6K2;AIP;CCDC3;NPNT;ECM1
3603,GO:0008038,0.240401725932388,0.900892053862783,4,22,neuron recognition,BP,EPHB2;NDN;CDK5R1;EFNB3
4887,GO:0014809,0.240649159185029,0.978302409005203,1,3,regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion,BP,GSTM2
11884,GO:0046928,0.240720421202428,0.887996667857158,5,31,regulation of neurotransmitter secretion,BP,SYN1;KCNC4;RIMS3;SEPT5;MCTP1
3948,GO:0008652,0.240802323270579,0.864301972639074,8,58,cellular amino acid biosynthetic process,BP,GAMT;GLUD1;THNSL2;GLUL;SRR;RIMKLB;MTR;SERINC3
5776,GO:0017001,0.24096743130748,0.89888719895916,4,27,antibiotic catabolic process,BP,GPX3;SULT1E1;DUOX1;PRDX5
832,GO:0002133,0.240985976102473,0.983427235258211,1,2,polycystin complex,CC,PKD2
15548,GO:0072021,0.240985976102473,0.983427235258211,1,2,ascending thin limb development,BP,PKD2
15639,GO:0072177,0.240985976102473,0.983427235258211,1,2,mesonephric duct development,BP,PKD2
15670,GO:0072218,0.240985976102473,0.983427235258211,1,2,metanephric ascending thin limb development,BP,PKD2
13501,GO:0055094,0.241044072513799,0.916536196822047,3,16,response to lipoprotein particle,BP,APOE;CD9;PPARG
1155,GO:0002763,0.241201905694999,0.887447577462845,5,32,positive regulation of myeloid leukocyte differentiation,BP,KITLG;CA2;ZFP36L1;GPR68;CTNNBIP1
12947,GO:0051349,0.241353827942273,0.940625509642688,2,9,positive regulation of lyase activity,BP,NOS1;ADORA2B
13526,GO:0060009,0.241500264319254,0.940565624754821,2,9,Sertoli cell development,BP,CST3;ATRX
12293,GO:0048660,0.241730154254258,0.849958484430631,11,82,regulation of smooth muscle cell proliferation,BP,TNFAIP3;EGFR;STAT1;MDM2;PDCD4;ITGA2;CYBA;MEF2D;ERN1;PPARG;CTNNBIP1
9496,GO:0036156,0.241938972947587,0.983286119045658,1,2,inner dynein arm,CC,DNAH1
11021,GO:0045007,0.241984664599706,0.978045041984164,1,3,depurination,BP,MPG
5630,GO:0016714,0.242059949873858,0.97803048250264,1,3,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen,MF,TH
15625,GO:0072156,0.242238164807179,0.983241674067797,1,2,distal tubule morphogenesis,BP,KLHL3
7664,GO:0032101,0.242272883193448,0.803561536877006,50,439,regulation of response to external stimulus,BP,TNFAIP3;SERPINE2;APOE;NT5E;DDX60;EGFR;PTPRS;CXCL14;WNT3;HERC5;HTRA1;RGMA;STAT1;IL20RB;F2R;PDCD4;RTN4RL1;TRPV4;ADORA2B;FNDC4;C5;ITGA2;SEMA4G;LRSAM1;MMP28;DDT;CD109;MGST2;DHX58;RICTOR;BMP6;NLRX1;VEGFB;SHARPIN;BBS2;CYBA;KLK5;NLRP1;ACP5;PLA2G7;PDE2A;FAM3A;DMTN;TKFC;ZSWIM8;SMPDL3B;CD9;RORA;PPARG;SERPING1
3625,GO:0008081,0.242453256294393,0.863340029244534,8,56,phosphoric diester hydrolase activity,MF,PLCD3;PLCD1;PLCH2;PLD3;PDE2A;MPPE1;SMPDL3B;PLCB3
18319,GO:1903305,0.242649604452192,0.853280449291075,10,73,regulation of regulated secretory pathway,BP,SYT8;SYN1;SYTL1;C2CD4C;ADORA2B;RIMS3;SYT15;SEPT5;RPH3AL;SYT7
18209,GO:1903035,0.242939582334246,0.862881958964143,8,57,negative regulation of response to wounding,BP,SERPINE2;APOE;PTPRS;RGMA;RTN4RL1;CD109;CD9;SERPING1
17679,GO:1901605,0.243062648991488,0.83042098911886,18,148,alpha-amino acid metabolic process,BP,GAMT;MTHFR;GLUD1;NOS1;CRTAP;HMGCL;THNSL2;PRODH;ALDH4A1;ALDH7A1;GLUL;SRR;AMT;MTR;TH;PEMT;SERINC3;GCLC
14289,GO:0061448,0.243080356377218,0.830674423133625,18,139,connective tissue development,BP,TGFBI;PTHLH;ACTA2;FBXW4;ADAMTS7;EVC;SULF2;HOXA3;TRPV4;GLI2;THBS3;GLI3;BMP6;HYAL1;BBS2;MEF2D;THRA;MAF
18669,GO:1904044,0.243168123583686,0.977815539269216,1,3,response to aldosterone,BP,CYBA
17504,GO:1901016,0.243256512997088,0.886393203189816,5,31,regulation of potassium ion transmembrane transporter activity,BP,ANK3;VAMP2;KLHL24;KCNG1;AKAP6
4019,GO:0009051,0.24338658917117,0.977773025402578,1,3,pentose-phosphate shunt, oxidative branch,BP,PGLS
10972,GO:0044782,0.243458761157819,0.810813582701142,35,293,cilium organization,BP,EVI5L;UNC119B;CNTRL;NUDCD3;DNAH1;UNC119;NINL;WWTR1;TPGS1;GAS8;GSN;CEP126;SEPT6;CEP192;BBS2;NPHP3;SEPT5;IQCB1;IFT140;DZIP1L;NPHP4;RFX2;BBS1;ATXN10;BBS5;BBS10;TMEM80;ALMS1;TMEM231;CCDC113;MARK4;CEP250;PRKACA;SYNE2;TTLL1
12610,GO:0050817,0.243603658714319,0.819660351832947,25,213,coagulation,BP,SERPINE2;APOE;DGKQ;PIK3R1;DOCK9;VAV3;ZFPM1;MYL9;PRKACB;ITPR3;F2R;HPS4;BLOC1S4;ADAMTS13;ITGA2;DOCK8;BLOC1S3;HMG20B;TFPI2;GNG2;DMTN;CD9;PRKACA;DOCK6;SERPING1
17836,GO:1902065,0.243724618787444,0.939652667829021,2,9,response to L-glutamate,BP,BAIAP2;UFL1
9342,GO:0035865,0.243744206256801,0.977703332804921,1,3,cellular response to potassium ion,BP,CARF
19133,GO:1905167,0.243791290130553,0.983009866533839,1,2,positive regulation of lysosomal protein catabolic process,BP,LRP1
10672,GO:0043951,0.243806778603141,0.939618827412436,2,9,negative regulation of cAMP-mediated signaling,BP,RGS2;PDE2A
3159,GO:0006767,0.244015692728578,0.856637027306841,9,67,water-soluble vitamin metabolic process,BP,MTHFR;SLC2A3;HLCS;SLC2A1;ACACB;ACP5;PNPO;MTR;GCLC
12605,GO:0050810,0.244202063381325,0.856587395851655,9,66,regulation of steroid biosynthetic process,BP,SREBF1;APOE;SEC14L2;DGKQ;MVD;BMP6;ACACB;FGFR4;VDR
2443,GO:0005652,0.244399961124609,0.939374252666815,2,9,nuclear lamina,CC,HLCS;LMNA
8733,GO:0034393,0.244705452636461,0.939248123194528,2,9,positive regulation of smooth muscle cell apoptotic process,BP,PDCD4;PPARG
3312,GO:0007016,0.244830097198903,0.940576065369957,2,8,cytoskeletal anchoring at plasma membrane,BP,ANK3;EPB41L3
16609,GO:0097487,0.244944948331774,0.977468426419598,1,3,multivesicular body, internal vesicle,CC,EGFR
10670,GO:0043949,0.245008837527578,0.914470623888611,3,16,regulation of cAMP-mediated signaling,BP,NOS1;RGS2;PDE2A
7689,GO:0032154,0.245021049217055,0.867822493078314,7,48,cleavage furrow,CC,PLCD3;OR2A4;SEPT6;RAB11FIP4;CENPC;RAB11FIP3;CIT
12859,GO:0051209,0.245152303700467,0.856073963913139,9,64,release of sequestered calcium ion into cytosol,BP,PKD2;NOS1;ITPR3;F2R;GSTM2;CYBA;JPH2;AKAP6;PRKACA
12908,GO:0051283,0.245152303700467,0.856073963913139,9,64,negative regulation of sequestering of calcium ion,BP,PKD2;NOS1;ITPR3;F2R;GSTM2;CYBA;JPH2;AKAP6;PRKACA
11795,GO:0046697,0.245510770303545,0.914207748548437,3,16,decidualization,BP,CTSV;CTSB;VDR
8615,GO:0034143,0.245592935247489,0.938881039700901,2,9,regulation of toll-like receptor 4 signaling pathway,BP,TNFAIP3;DAB2IP
6267,GO:0019865,0.245593416080234,0.977340983027901,1,3,immunoglobulin binding,MF,FCGRT
15699,GO:0072283,0.245735881299054,0.938821821346117,2,9,metanephric renal vesicle morphogenesis,BP,KIF26B;STAT1
15908,GO:0072717,0.245822610837836,0.977295841820708,1,3,cellular response to actinomycin D,BP,MDM2
8818,GO:0034612,0.245910580226614,0.818782899509901,24,212,response to tumor necrosis factor,BP,TNFAIP3;POSTN;SFRP1;MAP3K14;ADAMTS7;RBCK1;STAT1;ZFP36L2;ADAMTS13;TNFRSF14;SPPL2B;ENDOG;SHARPIN;HYAL1;TNFRSF21;CYBA;EDA2R;DAB2IP;TNFRSF25;ZFP36L1;TNFSF12;RORA;CCDC3;NPNT
7203,GO:0031103,0.245979609280232,0.884413105007032,5,32,axon regeneration,BP,PTPRS;RGMA;RTN4RL1;MTR;LAMB2
4592,GO:0010710,0.24600862608949,0.977259167582449,1,3,regulation of collagen catabolic process,BP,CST3
15942,GO:0080008,0.246100146197115,0.884336223912644,5,32,Cul4-RING E3 ubiquitin ligase complex,CC,DDB2;DCAF16;DCAF10;FBXW5;DCAF8
17091,GO:0101006,0.246998809812289,0.977063380140085,1,3,protein histidine phosphatase activity,MF,PHPT1
6709,GO:0030125,0.247022194085113,0.896228282351931,4,24,clathrin vesicle coat,CC,EGFR;AP1G2;CLTCL1;LDLRAP1
3589,GO:0008013,0.248182999426588,0.854045990078778,9,62,beta-catenin binding,MF,ASH2L;GLI3;APC2;CALCOCO1;SHROOM2;DLG5;TCF7;RORA;CTNNBIP1
362,GO:0000981,0.248224131917297,0.788931034537514,82,711,RNA polymerase II transcription factor activity, sequence-specific DNA binding,MF,HES2;ZSCAN18;TSC22D1;SREBF1;MNT;TSC22D3;POU3F1;TFCP2L1;ZFPM1;HOXC5;STAT1;THAP8;HOXA3;KLF13;NFATC4;HSF4;NDN;ZNF160;ZFP36L2;GLI2;KLF7;ZNF76;SOX12;GLI3;IRX4;BHLHE40;TCFL5;JARID2;ZNF18;MXD4;ZNF446;IRF9;ETV5;DLX3;TCF4;PLAG1;RCOR2;MEF2D;CREBRF;MLXIPL;LMO2;NFIX;CARF;MXI1;THRA;ELF1;DBP;EPM2AIP1;PEG3;RFX2;SALL2;ZBTB20;MAF;STK16;TEAD2;MYSM1;TSHZ2;IFI16;TEF;ZNF25;VDR;ZMYM3;SIX5;HLTF;STAT2;ZNF292;TFDP2;ZNF91;GTF2IRD2;TCF7;ZFP36L1;GLMP;TRERF1;STAT6;SOX13;KLF8;RORA;PPARG;KLF9;ZFP90;FOXP2;HIVEP1
12648,GO:0050872,0.24822694558073,0.93778572346533,2,9,white fat cell differentiation,BP,PER2;PPARG
6357,GO:0021543,0.248866771542833,0.832430846278126,15,114,pallium development,BP,EGFR;PTPRS;DIXDC1;GLI3;SUN1;MDK;BBS2;CDK5R1;SLC2A1;LRP1;DAB2IP;TACC1;TH;SYNE2;FOXP2
4603,GO:0010721,0.248989647520521,0.815323250665915,25,201,negative regulation of cell development,BP,POSTN;ULK2;APOE;PTPRS;DIXDC1;KCTD11;EPHB2;WNT3;RGMA;NFATC4;SPOCK1;MDM2;RTN4RL1;TRPV4;SEMA4G;GLI3;SYNGAP1;IDH2;CDK5R1;EFNB3;FBXW7;LRP1;BRINP1;DMTN;PMP22
10751,GO:0044211,0.24901173603726,0.976662426043891,1,3,CTP salvage,BP,UCKL1
11807,GO:0046718,0.249133737220026,0.848196635028843,10,76,viral entry into host cell,BP,ITGB6;EGFR;ITGB5;IFITM1;TNFRSF14;ITGA2;GSN;EFNB3;TRIM38;CTSB
3352,GO:0007084,0.249181856820961,0.936277572609513,2,10,mitotic nuclear envelope reassembly,BP,REEP4;LMNA
3020,GO:0006566,0.249195325884252,0.976625660255339,1,3,threonine metabolic process,BP,THNSL2
4805,GO:0012506,0.249510122256093,0.793401953968373,60,524,vesicle membrane,CC,ULK2;MAP6;SREBF1;APOE;EGFR;PTPRS;PKD2;SYT8;CXCR1;SYN1;LRIG3;DGKQ;WNT3;KCNAB2;VAMP3;NSG1;RAB43;RAB40B;NOS1;GAA;ITPR3;MDM2;GPRC5C;HLA-B;HGSNAT;AP1G2;C2CD4C;CLTCL1;TMC6;LAMP3;LHFPL2;VAMP2;SUN1;AHNAK2;CD109;SLC2A3;TCIRG1;ATP6V0A2;MCTP1;CYBA;RPH3AL;LRP1;HLA-A;CCDC136;PIK3C3;SYT7;AREG;BST2;SNX21;MARCH8;DLG4;NBEAL2;CD68;DMXL2;CD9;SYNGR1;TH;LDLRAP1;NFASC;SNX33
12261,GO:0048585,0.249753404837145,0.781553253666543,121,1099,negative regulation of response to stimulus,BP,TNFAIP3;SERPINE2;EPM2A;IFI6;APOE;NT5E;INPP5D;APCDD1;EGFR;PTPRS;PKD2;MNT;SFRP1;KCTD11;EPHB2;SULF2;WNT3;HTRA1;RGMA;STAT1;CAMK2N1;CRY2;UNC5B;PRKACB;CRY1;MAGEF1;NFATC4;FERMT1;CYP26B1;MDM2;LZTS2;PIK3IP1;TNFSF10;FLRT3;RASA4;KIF26A;RGS2;IL20RB;PDCD4;RTN4RL1;FNDC4;C5;GSTM2;WWTR1;SEMA4G;GLI3;LTBP1;MAP2K5;ITGA6;SESN3;IGFBP4;INSR;MMP28;CBLC;DDT;CD109;DHX58;NLRX1;PTK6;SYNGAP1;SHARPIN;ARRDC1;MMRN2;BBS2;NPHP3;DNM1;MCTP1;SESN1;HFE;RRM2B;SLIT3;SPRY2;CREBRF;FBXW7;CDK5RAP3;APC2;ELF1;RPH3AL;NLRP1;LRP1;NPHP4;RGS12;ACP5;C12ORF66;DLK2;PDE2A;RET;DAB2IP;RNF213;IFI16;FGFR4;PIK3R2;DLG5;BST2;FAM3A;WWC3;NRARP;KREMEN1;IGFBP6;LMNA;IVNS1ABP;GPR21;TKFC;PBLD;STAT6;PHPT1;SMPDL3B;KIF7;CD9;RANBP9;PTPN3;ERBB2;RORA;PPARG;ACKR3;SERPING1;CCDC3;SMURF1;CTNNBIP1;GCLC;ECM1
6091,GO:0019287,0.249823825707984,0.976499547350984,1,3,isopentenyl diphosphate biosynthetic process, mevalonate pathway,BP,MVD
1097,GO:0002686,0.250117655455606,0.910686765473492,3,18,negative regulation of leukocyte migration,BP,C5;MMP28;DDT
15129,GO:0071260,0.250238932611118,0.857529170592065,8,58,cellular response to mechanical stimulus,BP,EGFR;MAP3K14;ITGA2;BMP6;CYBA;SLC2A1;PDE2A;GCLC
8564,GO:0034045,0.250762100662487,0.911438953729144,3,16,phagophore assembly site membrane,CC,ULK2;ULK1;ATG14
4172,GO:0009247,0.250847748543084,0.86310826679524,7,53,glycolipid biosynthetic process,BP,ST6GALNAC6;GAL3ST4;B4GALT6;ST3GAL5;PGAP1;PIGZ;MPPE1
9784,GO:0040015,0.250896408121929,0.936666765803591,2,9,negative regulation of multicellular organism growth,BP,BBS2;RAI1
717,GO:0001944,0.25099620886593,0.794282602940798,54,454,vasculature development,BP,TNFAIP3;TGFBI;GPNMB;ACTA2;APOE;PKD2;PLCD3;SFRP1;EPHB2;VAV3;CSPG4;CUL7;STAT1;UNC5B;HOXA3;NFATC4;MDM2;PLCD1;RAPGEF3;ADGRB2;PDCD4;TMEM204;C5;GLI3;LTBP1;MAP2K5;VEGFB;LOXL1;DLX3;HYAL1;SH2D2A;MMRN2;SPRY2;FBXW7;LRP1;DAB2IP;TEAD2;RNF213;FGFR4;BTG1;PLXND1;TMEM231;NRARP;PTK7;ZFP36L1;APOLD1;TNFSF12;SRPX2;ERBB2;RORA;PPARG;FMNL3;ACKR3;ECM1
3406,GO:0007188,0.251015087805378,0.847010043371796,10,73,adenylate cyclase-modulating G-protein coupled receptor signaling pathway,BP,PTHLH;MC1R;NOS1;PRKACB;RGS2;ADORA2B;GABBR1;GNG2;LTB4R2;UCN2
1426,GO:0003401,0.251131317766433,0.894160640637332,4,23,axis elongation,BP,SFRP1;SPRY2;AREG;PTK7
1056,GO:0002584,0.251289863624318,0.976203875056541,1,3,negative regulation of antigen processing and presentation of peptide antigen,BP,HFE
8473,GO:0033631,0.251434399765618,0.936440170922864,2,9,cell-cell adhesion mediated by integrin,BP,PODXL;NPNT
14679,GO:0070326,0.251476767307037,0.97616602882677,1,3,very-low-density lipoprotein particle receptor binding,MF,APOE
13073,GO:0051604,0.251594093326977,0.81405571893201,24,208,protein maturation,BP,SERPINE2;LMF1;PRKACB;MAGEF1;MDM2;TYSND1;CTSV;ADAMTS13;RHBDF1;C5;GLI3;SPPL2B;PCSK1;NAIP;GSN;PIK3C3;IFI16;PCSK6;KAT2B;SCG5;PCSK1N;SERPING1;AIP;LONP2
16085,GO:0090087,0.251704270431184,0.792808747533831,56,488,regulation of peptide transport,BP,POSTN;SREBF1;EGFR;SFRP1;GLUD1;FERMT1;VPS11;ITPR3;MDM2;RAPGEF3;F2R;HPS4;TRPV4;NLGN2;ANK3;RHBDF1;PER2;C5;GLI3;VAMP2;NMU;TTN;TM7SF3;BMP6;MICALL2;PLA2G6;IDH2;IFI27;OSCP1;TNFRSF21;CDK5R1;CA2;HFE;HADH;RAB11FIP3;FBXW7;PFKFB2;RPH3AL;SLC2A1;NLRP1;GLUL;LRP1;PDE2A;PIK3C3;SYT7;DMTN;RASL10B;RSAD2;IRS2;ANO1;ALOX15B;PHPT1;ERBB2;GPR68;KCNS3;PEMT
6744,GO:0030170,0.2518482006149,0.880411570888256,5,33,pyridoxal phosphate binding,MF,PYGB;THNSL2;ACCS;SRR;PNPO
14650,GO:0070279,0.2518482006149,0.880411570888256,5,33,vitamin B6 binding,MF,PYGB;THNSL2;ACCS;SRR;PNPO
17168,GO:0106003,0.251899897166046,0.936243815823074,2,9,amyloid-beta complex,CC,APOE;INSR
17067,GO:0099622,0.252470626677165,0.910530834412927,3,16,cardiac muscle cell membrane repolarization,BP,SNTA1;KCNJ5;SCN4B
7472,GO:0031644,0.25247888450052,0.880245031503683,5,32,regulation of neurological system process,BP,TENM4;F2R;ITGA2;NMU;TNFRSF21
393,GO:0001055,0.252546215658545,0.933929539443673,2,11,RNA polymerase II activity,MF,POLR2J2;POLR2J3
4748,GO:0010922,0.252585855902345,0.893291835438031,4,23,positive regulation of phosphatase activity,BP,ITGA2;AKAP6;RIPK3;NPNT
12479,GO:0050542,0.252596857851863,0.97314667468487,1,4,icosanoid binding,MF,PPARG
12480,GO:0050543,0.252596857851863,0.97314667468487,1,4,icosatetraenoic acid binding,MF,PPARG
12481,GO:0050544,0.252596857851863,0.97314667468487,1,4,arachidonic acid binding,MF,PPARG
7964,GO:0032585,0.25262575664218,0.934805200550217,2,10,multivesicular body membrane,CC,NSG1;PMEL
4017,GO:0009041,0.252753905663448,0.9759065032614,1,3,uridylate kinase activity,MF,CMPK2
6976,GO:0030659,0.252775160116591,0.791128747103346,58,507,cytoplasmic vesicle membrane,CC,ULK2;MAP6;SREBF1;APOE;EGFR;PTPRS;PKD2;SYT8;CXCR1;SYN1;LRIG3;WNT3;KCNAB2;VAMP3;NSG1;RAB43;RAB40B;GAA;ITPR3;MDM2;GPRC5C;HLA-B;HGSNAT;AP1G2;C2CD4C;CLTCL1;TMC6;LAMP3;LHFPL2;VAMP2;SUN1;AHNAK2;CD109;SLC2A3;TCIRG1;ATP6V0A2;MCTP1;CYBA;RPH3AL;LRP1;HLA-A;CCDC136;PIK3C3;SYT7;AREG;BST2;SNX21;MARCH8;DLG4;NBEAL2;CD68;DMXL2;CD9;SYNGR1;TH;LDLRAP1;NFASC;SNX33
5684,GO:0016803,0.25285492045617,0.934706691401938,2,10,ether hydrolase activity,MF,AKR7A2;RNPEP
4082,GO:0009138,0.253193725928742,0.9758167571608,1,3,pyrimidine nucleoside diphosphate metabolic process,BP,CMPK2
16975,GO:0099080,0.253255984505941,0.787142300449737,70,598,supramolecular complex,CC,MAP6;ESPN;FLNC;PKD2;OBSL1;KIF26B;SYNC;KCNAB2;REEP2;MYL9;KRT15;NOS1;FERMT1;NDRG1;COL7A1;LZTS2;OBSCN;MYH11;PARVB;TNXB;KIF26A;DNAH1;TUBGCP5;TRPV4;ANK3;WIPF1;NINL;FAM110C;FHOD3;TPGS1;LTBP1;GAS8;BAIAP2;TTN;AHNAK2;CASP14;MAP2K2;SQSTM1;CST3;THSD4;COL6A1;DNM1;CDK5R1;HOOK2;CLIP2;KRT14;SPRY2;CDK5RAP3;APC2;SLC2A1;REEP4;SYNPO2;JPH2;SHROOM2;EML3;DMTN;ARFGEF2;SHROOM4;TNNI2;SHANK2;LMNA;KAT2B;KIF7;LDLRAP1;VMAC;SYNE2;MAP1A;NPNT;TTLL1;EML2
3017,GO:0006563,0.253276123428143,0.934525457596478,2,10,L-serine metabolic process,BP,SRR;SERINC3
5782,GO:0017014,0.253367724889499,0.934486013780708,2,10,protein nitrosylation,BP,NOS1;SNTA1
5902,GO:0018119,0.253367724889499,0.934486013780708,2,10,peptidyl-cysteine S-nitrosylation,BP,NOS1;SNTA1
7818,GO:0032379,0.253498680208901,0.975754419040011,1,3,positive regulation of intracellular lipid transport,BP,LDLRAP1
7821,GO:0032382,0.253498680208901,0.975754419040011,1,3,positive regulation of intracellular sterol transport,BP,LDLRAP1
7824,GO:0032385,0.253498680208901,0.975754419040011,1,3,positive regulation of intracellular cholesterol transport,BP,LDLRAP1
12292,GO:0048659,0.253651413743579,0.840798844919344,11,83,smooth muscle cell proliferation,BP,TNFAIP3;EGFR;STAT1;MDM2;PDCD4;ITGA2;CYBA;MEF2D;ERN1;PPARG;CTNNBIP1
7185,GO:0031082,0.253893303742523,0.908656940386737,3,18,BLOC complex,CC,HPS4;BLOC1S4;BLOC1S3
189,GO:0000407,0.253901185418217,0.879326736634505,5,32,phagophore assembly site,CC,ULK2;ULK1;SQSTM1;PIK3C3;ATG14
3071,GO:0006638,0.254086371602457,0.849294735035551,9,66,neutral lipid metabolic process,BP,SIK1;SREBF1;APOE;LMF1;DGKQ;LPIN3;FBXW7;DDHD2;ACSL1
12330,GO:0048709,0.254183283955786,0.854673412686651,8,58,oligodendrocyte differentiation,BP,TENM4;GLI3;GSN;TNFRSF21;CD9;HDAC11;ERBB2;PPARG
10142,GO:0042734,0.254226452165767,0.869658691285683,6,38,presynaptic membrane,CC,NLGN2;RIMS3;ADGRL1;GABBR1;PDE2A;SYT7
12353,GO:0048754,0.254429595625237,0.830679380765897,14,104,branching morphogenesis of an epithelial tube,BP,PKD2;NFATC4;GLI2;GLI3;CELSR1;ETV5;SPRY2;AREG;DLG5;VDR;PLXND1;NRARP;NPNT;CTNNBIP1
4384,GO:0010039,0.254735586321709,0.891262979544178,4,25,response to iron ion,BP,CYBRD1;MDM2;BMP6;HFE
1277,GO:0003073,0.254774682346406,0.868711355462204,6,41,regulation of systemic arterial blood pressure,BP,POSTN;F2R;CYBA;WNK1;RASL10B;PLCB3
2334,GO:0005355,0.254790982546538,0.935018198600619,2,9,glucose transmembrane transporter activity,MF,SLC2A3;SLC2A1
17741,GO:1901739,0.25503147811784,0.933767741663733,2,10,regulation of myoblast fusion,BP,FLOT1;GDF15
2611,GO:0005921,0.255760382604303,0.908173157169452,3,17,gap junction,CC,GJD3;GJC2;GJB5
4737,GO:0010907,0.255793765066333,0.891367083214574,4,23,positive regulation of glucose metabolic process,BP,INSR;EPM2AIP1;KAT2B;IRS2
1278,GO:0003081,0.255944431582805,0.933372108108722,2,10,regulation of systemic arterial blood pressure by renin-angiotensin,BP,F2R;CYBA
6750,GO:0030178,0.255952637195281,0.819759314430573,18,152,negative regulation of Wnt signaling pathway,BP,APOE;APCDD1;SFRP1;NFATC4;FERMT1;LZTS2;WWTR1;GLI3;IGFBP4;NPHP3;APC2;LRP1;NPHP4;DAB2IP;RNF213;KREMEN1;IGFBP6;CTNNBIP1
19819,GO:2000310,0.255964634779824,0.934517649680565,2,9,regulation of NMDA receptor activity,BP,EPHB2;DLG4
1554,GO:0003955,0.256134369844725,0.975211818632757,1,3,NAD(P)H dehydrogenase (quinone) activity,MF,CBR4
10017,GO:0042475,0.256174953091432,0.853454530389794,8,56,odontogenesis of dentin-containing tooth,BP,FAM20C;HTRA1;GLI2;GLI3;ITGA6;DLX3;CA2;KLK5
13258,GO:0051967,0.256380566112987,0.975160784856959,1,3,negative regulation of synaptic transmission, glutamatergic,BP,PLA2G6
2620,GO:0005940,0.256635506372277,0.934230751610222,2,9,septin ring,CC,SEPT6;SEPT5
7205,GO:0031105,0.256635506372277,0.934230751610222,2,9,septin complex,CC,SEPT6;SEPT5
7692,GO:0032160,0.256635506372277,0.934230751610222,2,9,septin filament array,CC,SEPT6;SEPT5
3558,GO:0007599,0.256721092524814,0.808512868041334,25,215,hemostasis,BP,SERPINE2;APOE;DGKQ;PIK3R1;DOCK9;VAV3;ZFPM1;MYL9;PRKACB;ITPR3;F2R;HPS4;BLOC1S4;ADAMTS13;ITGA2;DOCK8;BLOC1S3;HMG20B;TFPI2;GNG2;DMTN;CD9;PRKACA;DOCK6;SERPING1
10033,GO:0042501,0.256757074970395,0.933019052986743,2,10,serine phosphorylation of STAT protein,BP,CDK5R1;RET
11583,GO:0046189,0.257075715221143,0.907462351305728,3,17,phenol-containing compound biosynthetic process,BP,DDT;PMEL;TH
19360,GO:1905867,0.257133284480131,0.97500438270423,1,3,epididymis development,BP,GJB5
4430,GO:0010266,0.257166147735233,0.974997541497396,1,3,response to vitamin B1,BP,MDM2
14661,GO:0070296,0.257191353492762,0.907399758972997,3,17,sarcoplasmic reticulum calcium ion transport,BP,GSTM2;AKAP6;PRKACA
12658,GO:0050886,0.257252946154966,0.867020824949598,6,41,endocrine process,BP,CRY1;F2R;BMP6;CYBA;RAB11FIP3;RASL10B
13753,GO:0060353,0.25752504630437,0.974922759255052,1,3,regulation of cell adhesion molecule production,BP,FLOT1
13754,GO:0060355,0.25752504630437,0.974922759255052,1,3,positive regulation of cell adhesion molecule production,BP,FLOT1
13688,GO:0060267,0.257534290059831,0.974920831485231,1,3,positive regulation of respiratory burst,BP,INSR
2701,GO:0006067,0.257782626951104,0.932572300403081,2,10,ethanol metabolic process,BP,SULT1E1;ACSS2
9384,GO:0035933,0.257874946655194,0.974849729044755,1,3,glucocorticoid secretion,BP,CRY1
20126,GO:2000849,0.257874946655194,0.974849729044755,1,3,regulation of glucocorticoid secretion,BP,CRY1
1697,GO:0004177,0.257890378455345,0.876493199817147,5,33,aminopeptidase activity,MF,NPEPL1;CTSV;RNPEPL1;RNPEP;DPP7
3033,GO:0006582,0.258138446243828,0.933585961875255,2,9,melanin metabolic process,BP,DDT;PMEL
17364,GO:1900112,0.258215054218802,0.933553019365413,2,9,regulation of histone H3-K9 trimethylation,BP,KDM4C;ATRX
9450,GO:0036064,0.258241124117607,0.833574149191957,12,92,ciliary basal body,CC,PKD2;EVC;GAS8;BBS2;IFT140;DZIP1L;NPHP4;BBS1;BBS5;DLG5;MARK4;KIF7
2032,GO:0004774,0.25855794400052,0.974706825917373,1,3,succinate-CoA ligase activity,MF,SUCLG2
622,GO:0001806,0.25873638762058,0.974669413977487,1,3,type IV hypersensitivity,BP,IL20RB
1625,GO:0004064,0.258874925019571,0.97464034684636,1,3,arylesterase activity,MF,CA2
10688,GO:0043988,0.259000273140165,0.974614030584774,1,3,histone H3-S28 phosphorylation,BP,RPS6KA5
17015,GO:0099512,0.259018973194781,0.782155147455306,69,591,supramolecular fiber,CC,MAP6;ESPN;FLNC;PKD2;OBSL1;KIF26B;SYNC;KCNAB2;REEP2;MYL9;KRT15;NOS1;FERMT1;NDRG1;LZTS2;OBSCN;MYH11;PARVB;TNXB;KIF26A;DNAH1;TUBGCP5;TRPV4;ANK3;WIPF1;NINL;FAM110C;FHOD3;TPGS1;LTBP1;GAS8;BAIAP2;TTN;AHNAK2;CASP14;MAP2K2;SQSTM1;CST3;THSD4;COL6A1;DNM1;CDK5R1;HOOK2;CLIP2;KRT14;SPRY2;CDK5RAP3;APC2;SLC2A1;REEP4;SYNPO2;JPH2;SHROOM2;EML3;DMTN;ARFGEF2;SHROOM4;TNNI2;SHANK2;LMNA;KAT2B;KIF7;LDLRAP1;VMAC;SYNE2;MAP1A;NPNT;TTLL1;EML2
10425,GO:0043295,0.25932171428648,0.930952938525493,2,11,glutathione binding,MF,GSTM2;GSTM3
17495,GO:1900750,0.25932171428648,0.930952938525493,2,11,oligopeptide binding,MF,GSTM2;GSTM3
13585,GO:0060077,0.25949861940703,0.93299996802823,2,9,inhibitory synapse,CC,NLGN4Y;NLGN2
10392,GO:0043242,0.259531947133541,0.85777442601209,7,47,negative regulation of protein complex disassembly,BP,SPTB;GSN;PLEKHH2;TRIOBP;APC2;CAPG;DMTN
12907,GO:0051282,0.25966030627817,0.845238912905224,9,65,regulation of sequestering of calcium ion,BP,PKD2;NOS1;ITPR3;F2R;GSTM2;CYBA;JPH2;AKAP6;PRKACA
663,GO:0001867,0.259674700831528,0.97447216951985,1,3,complement activation, lectin pathway,BP,SERPING1
1133,GO:0002725,0.259698897339836,0.974467071551155,1,3,negative regulation of T cell cytokine production,BP,HFE
12301,GO:0048668,0.259736817914141,0.906017808418754,3,17,collateral sprouting,BP,ULK2;PTPRS;WNT3
14831,GO:0070613,0.259741575249425,0.857189854722378,7,50,regulation of protein processing,BP,SERPINE2;PRKACB;MDM2;C5;NAIP;GSN;SERPING1
12574,GO:0050770,0.259828657504821,0.821263876091343,16,121,regulation of axonogenesis,BP,ULK2;APOE;PTPRS;EPHB2;WNT3;PLXNB1;SEMA4G;TRAK1;PLXNB3;SYNGAP1;CDK5R1;EFNB3;RET;PLXND1;ZSWIM8;SSH3
10313,GO:0043120,0.259992960578639,0.974405068726147,1,3,tumor necrosis factor binding,MF,TNFRSF25
10229,GO:0042975,0.260392838764716,0.932613447140547,2,9,peroxisome proliferator activated receptor binding,MF,NFATC4;MDM2
1522,GO:0003896,0.260551222384616,0.974287123139348,1,3,DNA primase activity,MF,PRIMPOL
10735,GO:0044130,0.260633700733084,0.974269671378179,1,3,negative regulation of growth of symbiont in host,BP,SQSTM1
10738,GO:0044146,0.260633700733084,0.974269671378179,1,3,negative regulation of growth of symbiont involved in interaction with host,BP,SQSTM1
15138,GO:0071277,0.260733904640291,0.86482129135607,6,40,cellular response to calcium ion,BP,PKD2;RASA4;ENDOG;CARF;WNK1;DMTN
17481,GO:1900543,0.26090173291201,0.887516610764446,4,25,negative regulation of purine nucleotide metabolic process,BP,GABBR1;MLXIPL;GPR87;LTB4R2
712,GO:0001938,0.260917880828745,0.849763896066679,8,58,positive regulation of endothelial cell proliferation,BP,PLXNB3;RICTOR;BMP6;VEGFB;CYBA;NRARP;TNFSF12;ECM1
11286,GO:0045620,0.260929352530809,0.88749973127249,4,25,negative regulation of lymphocyte differentiation,BP,SFRP1;GLI3;NRARP;ERBB2
3256,GO:0006921,0.260941747499689,0.887159516620577,4,26,cellular component disassembly involved in execution phase of apoptosis,BP,H1F0;ENDOG;SHARPIN;CDK5RAP3
842,GO:0002158,0.26096262904112,0.974200005329278,1,3,osteoclast proliferation,BP,TNFAIP3
17986,GO:1902476,0.261035481646454,0.874687336137884,5,32,chloride transmembrane transport,BP,CLCN6;SLC12A7;CLCA2;ANO1;CLCN7
16237,GO:0090313,0.261176973036937,0.887015374771553,4,26,regulation of protein targeting to membrane,BP,ANK3;CDK5R1;DMTN;ERBB2
5707,GO:0016841,0.261197541657494,0.974150185491685,1,3,ammonia-lyase activity,MF,SRR
6084,GO:0019249,0.261222093853962,0.974144975329627,1,3,lactate biosynthetic process,BP,PER2
12719,GO:0051004,0.261268202959082,0.931043905341742,2,10,regulation of lipoprotein lipase activity,BP,LMF1;PCSK6
6652,GO:0030010,0.261349488217155,0.825156953497321,14,104,establishment of cell polarity,BP,KIF26B;BRSK1;FERMT1;CYP26B1;FRMD4B;GSN;DOCK8;RICTOR;SPRY2;MYO9A;WEE1;PTK7;MARK4;MPP7
10880,GO:0044437,0.261424777932387,0.785998810835882,51,452,vacuolar part,CC,PYGB;CSPG4;CYBRD1;NAPRT;NSG1;SDC3;GAA;VPS11;NAGLU;IDUA;HGSNAT;CTSV;FLOT1;LAMP3;ATG16L2;SPG11;CLCN6;DIRC2;HEXA;ULK1;SPPL2B;GPC2;CTSF;VPS39;TMEM9;TCIRG1;HEXB;HYAL1;ATP6V0A2;COL6A1;CTSB;LRP1;C12ORF66;SLC48A1;SYT7;BST2;MARCH8;SLC36A4;CD68;GLMP;LAPTM4A;SGSH;GLB1;DPP7;CTSD;SYNGR1;ABCA2;ATG14;C6ORF120;PI4K2B;CLCN7
10704,GO:0044036,0.261478395942631,0.974090550173202,1,3,cell wall macromolecule metabolic process,BP,MPI
15312,GO:0071554,0.261478395942631,0.974090550173202,1,3,cell wall organization or biogenesis,BP,MPI
628,GO:0001818,0.261495212577516,0.813336743199821,19,160,negative regulation of cytokine production,BP,TNFAIP3;GPNMB;INPP5D;PTPRS;RNF135;HERC5;ISG15;ZFPM1;MC1R;IL20RB;PDCD4;MAP2K5;DHX58;NLRX1;TNFRSF21;HFE;ACP5;RPS6KA5;BST2
3202,GO:0006836,0.261613820784049,0.819612399718426,16,126,neurotransmitter transport,BP,SYT8;SYN1;BRSK1;NOS1;KCNC4;SYTL1;C2CD4C;RIMS3;PER2;SYT15;VAMP2;SEPT5;MCTP1;GLUL;SYT7;TH
16836,GO:0098780,0.261659124814563,0.904968915743238,3,17,response to mitochondrial depolarisation,BP,SQSTM1;ATG14;SMURF1
5140,GO:0015669,0.261721881852644,0.974038785772849,1,3,gas transport,BP,CA2
14957,GO:0070887,0.261734651623481,0.763097350958499,225,2111,cellular response to chemical stimulus,BP,TNFAIP3;POSTN;SIK1;TP53INP1;IFI6;SREBF1;APOE;CES2;INPP5D;OAS2;HSPA2;EGFR;FAM20C;PKD2;CXCR1;TRIM22;SRSF5;SFRP1;GPX3;MAP3K14;BPHL;PIK3R1;ADAMTS7;TXNRD3;RBCK1;KDM3A;CXCL14;SULF2;WNT3;VAV3;ISG15;HTRA1;RGMA;CUL7;VAMP3;STAT1;IMPACT;CRY2;UROS;ITGB5;RAB43;NOS1;PRKACB;CRY1;PLEKHG5;NFATC4;FERMT1;CYP26B1;CMPK2;MICALL1;NDRG1;MDM2;NDN;IFITM1;LTBP4;HLA-B;PRODH;UGT1A3;CYP3A5;NEO1;RAPGEF3;FAM210B;OAS1;FLRT3;RASA4;IL20RB;MT1X;PDCD4;RTN4RL1;ZFP36L2;TRPV4;FLOT1;GLI2;ANK3;RNF165;ADAMTS13;ZCCHC11;TMEM204;PTGS1;FRS3;C5;ZNF658;GSTM2;TNFRSF14;ITGA2;SPPL2B;THRAP3;VAMP2;LTBP1;MAP2K5;ITGA6;CES3;SESN3;MMP1;JARID2;INSR;MMP28;GSN;BAIAP2;DDT;PLXNB3;CD109;CYP2D7;MGST2;DOCK8;ENDOG;SLC27A1;TM7SF3;IRF9;BMP6;TCIRG1;MAP2K2;PDK1;VEGFB;SQSTM1;PTK6;FZD7;ETV5;AKR7A2;FAM213A;SHARPIN;HYAL1;PLA2G6;CST3;MMRN2;GDF15;BBS2;CTF1;ATP6V0A2;COL6A1;IFI27;TNFRSF21;CDK5R1;ATRX;NET1;CA2;SESN1;MAPK10;HFE;ADIRF;CYBA;TRIM38;AGO4;SLIT3;EDA2R;SPRY2;CREBRF;XRN1;MLXIPL;CTSB;FBXW7;CDK5RAP3;LMO2;CARF;PAQR6;THRA;ELF1;MX2;GNG2;LRP1;HLA-A;PLA2G7;RFX2;BRINP1;WNK1;PDE2A;STK16;RET;DAB2IP;RWDD3;CALCOCO1;TEAD2;FGFR4;IL20RA;PIK3R2;RPS6KA5;BST2;VDR;PCSK6;DMTN;STAT2;UCN2;CD68;DUOX1;PTK7;TCF7;RSAD2;TNFRSF25;ZFP36L1;LMNA;ACSL1;IL11;KAT2B;IRS2;ANO1;ERN1;GPR21;MTR;PBLD;TNFSF12;STAT6;PRDX5;PHPT1;GSTM3;CHD6;CACNB1;ERBB2;SYNGR1;GPR68;PAQR7;AKAP6;TH;RORA;PPARG;PRKACA;ACKR3;UFL1;IP6K2;KLF9;AIP;CCDC3;SMURF1;NPNT;GCLC;ECM1
8905,GO:0034756,0.261819126719613,0.974018095253746,1,3,regulation of iron ion transport,BP,HFE
6429,GO:0021700,0.261991216988619,0.815044097931929,18,143,developmental maturation,BP,FAM20C;TFCP2L1;NFATC4;FERMT1;PLXNB1;FAM210B;ADGRL1;THBS3;BLOC1S3;CABYR;CDK5R1;REC8;RET;DAB2IP;DLG4;PPARG;PRKACA;NFASC
7805,GO:0032366,0.262043027181248,0.904758900346802,3,17,intracellular sterol transport,BP,SYT7;ABCA2;LDLRAP1
7806,GO:0032367,0.262043027181248,0.904758900346802,3,17,intracellular cholesterol transport,BP,SYT7;ABCA2;LDLRAP1
6211,GO:0019740,0.262043180501457,0.973970388004725,1,3,nitrogen utilization,BP,GLUL
17061,GO:0099604,0.262130678639736,0.905329102023684,3,16,ligand-gated calcium channel activity,MF,PKD2;ITPR3;JPH2
13049,GO:0051573,0.262137397433423,0.931856469498615,2,9,negative regulation of histone H3-K9 methylation,BP,KDM3A;KDM4C
1644,GO:0004090,0.262162125614787,0.970932086187679,1,4,carbonyl reductase (NADPH) activity,MF,DHRS4
15573,GO:0072075,0.262261205120895,0.931802602476561,2,9,metanephric mesenchyme development,BP,PKD2;STAT1
11302,GO:0045638,0.26230156982828,0.847884755675118,8,67,negative regulation of myeloid cell differentiation,BP,INPP5D;SFRP1;PIK3R1;ZFPM1;KLF13;FBXW7;ZFP36L1;GPR68
9197,GO:0035591,0.262587031896635,0.848898726263877,8,55,signaling adaptor activity,MF,PIK3R1;VAV3;CHN2;MAPK8IP3;SH2D2A;DAB2IP;MPP7;LDLRAP1
3214,GO:0006858,0.262636705578097,0.973843767626504,1,3,extracellular transport,BP,ARRDC1
15584,GO:0072091,0.262767572165077,0.863423550660326,6,40,regulation of stem cell proliferation,BP,KCTD11;KITLG;FERMT1;GLI3;LTBP3;ZFP36L1
8570,GO:0034061,0.262837150511991,0.873020548513327,5,34,DNA polymerase activity,MF,POLH;POLD4;PRIMPOL;TEP1;POLM
8442,GO:0033590,0.262871123724814,0.973793660711692,1,3,response to cobalamin,BP,EGFR
2381,GO:0005518,0.262959993624547,0.863291080037618,6,40,collagen binding,MF,TGFBI;ITGA2;NID1;MRC2;CTSB;ECM2
19707,GO:2000095,0.262986109629979,0.93148681834401,2,9,regulation of Wnt signaling pathway, planar cell polarity pathway,BP,SFRP1;NPHP3
12505,GO:0050665,0.263140289100755,0.930216627501148,2,10,hydrogen peroxide biosynthetic process,BP,CYBA;DUOX1
12295,GO:0048662,0.263320978369379,0.885698631450827,4,26,negative regulation of smooth muscle cell proliferation,BP,TNFAIP3;PDCD4;PPARG;CTNNBIP1
1157,GO:0002765,0.263373241475732,0.97368614790652,1,3,immune response-inhibiting signal transduction,BP,IL20RB
3761,GO:0008307,0.263390080213863,0.876020939851999,5,24,structural constituent of muscle,MF,OBSL1;MYL9;OBSCN;MYH11;TTN
16917,GO:0098917,0.263423397689768,0.973675394655256,1,3,retrograde trans-synaptic signaling,BP,NOS1
8606,GO:0034134,0.263575423730929,0.930023701458093,2,10,toll-like receptor 2 signaling pathway,BP,TNFAIP3;CYBA
17423,GO:1900221,0.263706447647716,0.931172366562521,2,9,regulation of amyloid-beta clearance,BP,APOE;LRP1
12823,GO:0051153,0.264310176455419,0.847274950226324,8,58,regulation of striated muscle cell differentiation,BP,SIK1;CYP26B1;FLOT1;FZD7;GDF15;THRA;MAMSTR;AKAP6
2866,GO:0006359,0.264430304044515,0.885353045383183,4,25,regulation of transcription by RNA polymerase III,BP,ZNF76;NAB2;PRDX5;ERBB2
10242,GO:0042994,0.264481222882069,0.902871411221084,3,18,cytoplasmic sequestering of transcription factor,BP,PKD2;MXI1;THRA
3332,GO:0007043,0.264730262774408,0.83245693683586,11,80,cell-cell junction assembly,BP,GJD3;TRPV4;MICALL2;EPB41L3;NPHP4;DLG5;CD9;MPP7;PRKACA;PARD6G;NFASC
12593,GO:0050794,0.264732341455748,0.754984068785736,751,7110,regulation of cellular process,BP,TNFAIP3;TGFBI;POSTN;ITGB6;HES2;SERPINE2;ZSCAN18;ULK2;GPNMB;TSC22D1;SIK1;EPM2A;MUC19;DDB2;TP53INP1;IFI6;PTHLH;SREBF1;APOE;GPSM1;INPP5D;APCDD1;OAS2;MN1;LMF1;PSD4;DDX60;HSPA2;FBXW4;EGFR;ESPN;TRIM65;GIGYF1;PTPRS;CIRBP;FAM20C;PKD2;CAPRIN2;MNT;XPC;APOBEC3C;SYT8;CXCR1;RBM3;SYN1;ASH2L;DIXDC1;TRIM22;ALDH1A3;SRSF5;PLCD3;SLITRK6;SFRP1;OBSL1;MTHFR;PERM1;SEC14L2;KCTD11;EPS8L2;EPHB2;RALGDS;MAP3K14;GLUD1;DGKQ;PIK3R1;ADAMTS7;EVI5L;BRSK1;TXNRD3;RBCK1;KDM3A;CXCL14;DOCK9;TSC22D3;CUL9;EVC;POU3F1;SULF2;WNT3;CAMKK1;HERC5;VAV3;UNK;HR;SMOC2;CSPG4;ISG15;MVB12B;ELFN2;HTRA1;TFCP2L1;TENM4;RGMA;PI4KAP2;KCNAB2;ZFPM1;KITLG;TP53I11;HOXC5;MVD;ZNF362;CUL7;VAMP3;CITED4;IRF2BPL;PRICKLE2;MC1R;ASAP3;ZNF266;OR2A4;STAT1;IMPACT;CAMK2N1;CRY2;MYL9;HS1BP3;MARCKSL1;NSG1;UNC5B;ITGB5;RAB43;RAB40B;THAP8;NOS1;PRKACB;ZNF704;HOXA3;CRY1;ZNF699;MAML3;ZFP41;SCMH1;KLF13;CRTAP;BCAM;MAGEF1;PLEKHG5;NFATC4;ZNF783;IQSEC2;SPDYE6;RNF187;FERMT1;CYP26B1;THNSL2;HSF4;CNTRL;ZNF251;PIK3C2G;TBC1D8;PLXNB1;PLEKHG3;VPS11;SPEG;NDRG1;COL7A1;KCNC4;SPOCK1;ITPR3;EAPP;MDM2;CRTC1;LZTS2;PLCD1;NDN;IFITM1;PPP2R2C;FCGRT;CSMD3;CHN2;ZNF662;TYSND1;LTBP4;PIK3IP1;OBSCN;GPRC5C;HLA-B;TNFSF10;PRODH;PARVB;SYTL1;RHOBTB2;NEO1;RAPGEF3;PHACTR3;ZNF414;TCF25;PCBP4;FAM210B;CTSV;NLGN4Y;POLH;OAS1;FLRT3;RASA4;KIF26A;MLLT6;RGL4;RGS2;ARPIN;ACAP3;IL20RB;ADGRB2;F2R;MLYCD;C2CD4C;HPS4;MT1X;PDCD4;CGREF1;SPTB;SERPINB5;NYAP1;SLC24A1;ZNF160;CAPN7;RTN4RL1;ZFP36L2;ADGRF4;CLTCL1;TRPV4;FLOT1;GLI2;AGAP4;TOM1L2;RHPN1;NLGN2;ADORA2B;ANK3;KLF7;RNF165;ADAMTS13;LAMP3;TCEA2;PLCH2;RALGAPA1;MAPK8IP3;SPDYE5;ZNF76;SOX12;CLMN;PIDD1;RIMS3;SLX1A;SLX1B;ZNF747;GJC2;ZCCHC11;ARHGEF19;RHBDF1;TSPAN18;SULT1E1;RASGEF1A;PER2;TMEM204;PITPNM2;CLCN6;PTGS1;UNC119;FRS3;C5;ZNF658;WIPF1;SNTA1;PSKH1;ADGRL1;MINK1;PHF2;NINL;ABHD14B;GSTM2;TCEAL1;AMIGO2;TNFRSF14;WWTR1;ASAP2;ARHGEF4;ITGA2;SEMA4G;FAM110C;SYT15;ULK1;GLI3;SPPL2B;FHOD3;THRAP3;ZNF558;IRX4;SMARCA1;AKAP7;BHLHE40;LRSAM1;VAMP2;ZNF655;NAIP;LTBP1;NMU;ZNF333;NEK8;MAP2K5;GAS8;BOC;ITGA6;LTBP3;SRGAP3;BSN;SESN3;ZNF318;LZTS1;IGFBP4;MMP1;TCFL5;TRAK1;JARID2;NUPR1;GPC2;NISCH;INSR;CCDC85B;CELSR1;MMP28;GSN;HEBP1;CHD3;CDK14;BAIAP2;TTN;CBLC;DDT;ZNF18;PLXNB3;LPAR5;AHNAK2;PLEKHH2;TRIOBP;MXD4;RIN1;ZNF287;CD109;PNMA1;PMS2P3;ETAA1;RMI2;ZNF446;ARHGEF1;RAB11FIP4;ZNF581;DOCK8;TP53AIP1;DHX58;PILRB;ENDOG;SLC27A1;TM7SF3;RTF1;MDK;CASP14;IRF9;RICTOR;H2AFJ;BMP6;NLRX1;TCIRG1;S100A4;MICALL2;MAP2K2;PDK1;VEGFB;GLI4;SQSTM1;CEP192;PTK6;TMEM8B;FZD7;ETV5;SYNGAP1;NXPH4;FAM13A;FAM213A;DLX3;TMEM117;EPB41L3;SHARPIN;HEXB;KDM4C;HYAL1;METTL23;ARHGAP33;SH2D2A;NSMCE4A;ARRDC1;ZNF608;WHAMMP3;PLA2G6;CST3;HOMER2;MMRN2;GDF15;BBS2;TXNIP;CTF1;TCF4;ATP6V0A2;PEX11B;NPHP3;PSD3;PLAG1;IDH2;MAP3K12;RCOR2;WRN;PODXL;SEPT5;IFI27;OSCP1;DNM1;TNFRSF21;ZYG11B;IQCB1;KLHL24;LPIN3;MCTP1;CDK5R1;ATRX;ARHGAP27;AGAP6;NET1;CA2;EFNB3;PI4KAP1;SESN1;MAPK10;SHANK3;HFE;ADIRF;HMG20B;CYBA;TRIM38;DTX3;AGO4;ERCC6;HADH;RRM2B;SLIT3;SHC2;EDA2R;SPRY2;MRC2;FBXO2;WASH3P;MEF2D;IFT140;GABBR1;CREBRF;XRN1;AGAP7P;RAB11FIP3;MLXIPL;CTSB;KLK5;TARBP1;FBXW7;KCNMA1;GPR87;ING4;NUDT6;CDK5RAP3;ZNF862;ATXN1;LMO2;NOTCH2NL;NFIX;PAK6;TFPI2;CARF;MXI1;PFKFB2;PAQR6;CHMP1B;THRA;APC2;ARAP1;ADARB1;RAI1;FMNL2;ELF1;MX2;IKZF4;RPH3AL;SLC2A1;ACACB;NLRP1;FRAT1;ZBTB34;ERMAP;ZNF627;GPR155;BEX2;GLUL;TNS2;TBC1D17;MIF4GD;DBP;NAB2;EPM2AIP1;TP53I13;GNG2;FBXW5;CAPG;LRP1;LRRN3;HLA-A;PEG3;NPHP4;RGS12;ACP5;PLA2G7;SYNPO2;C12ORF66;RFX2;DLK2;KCNG1;ZNF554;BRINP1;MAP3K6;APPL2;SALL2;WNK1;ZNF107;ZNF532;JPH2;ZBTB20;PDE2A;ZNF334;MAF;STK16;LTB4R2;RET;ZMYND8;PRX;DAB2IP;CASZ1;RWDD3;CALCOCO1;TEAD2;MYSM1;DDHD2;FBXO4;RNF213;OLFM2;RAPGEFL1;TSHZ2;PIK3C3;ZNF276;IFI16;SYT7;FGFR4;ERCC5;IL20RA;PIK3R2;SCN2A;TEF;ZNF25;AREG;SNCB;MYO9A;RPS6KA5;APBB3;ZNF630;DLG5;BTG1;BST2;ZNF687;VDR;RGL2;ARHGEF17;CACNB3;MAMSTR;TNRC18;TNRC6C;ZFP28;VIPR1;EFS;PLXND1;BBS10;ZMYM3;SIX5;HLTF;PCSK6;ZNF789;ZNF563;ZNF517;TBC1D16;LPAR6;PPP1R2;DMTN;PPP1R35;STAT2;SGSM2;ARFGEF2;RASL10B;LMTK3;ALMS1;WWC3;PHF1;ZNF292;TMEM231;TFDP2;PMP22;UCN2;NRARP;ACVR1B;TMX4;ZNF737;KREMEN1;NECAB3;CCDC88B;DLG4;TNNI2;PPP2R3B;TSSK1B;IQSEC1;ZNF701;ALOXE3;NAT14;PANO1;PALB2;ENDOU;IGFBP6;TCEAL4;ZNF91;DUOX1;WEE1;DYDC1;CCNG2;GTF2IRD2;PTK7;TCF7;SHANK2;RSAD2;TNFRSF25;ZFP36L1;LMNA;CLSTN3;GLMP;ACSL1;IL11;KAT2B;MARK4;APOLD1;IRS2;IMPA2;CEP250;ANO1;CAPS;ERN1;RNF141;IVNS1ABP;ALOX15B;RAD50;GPR21;ZNF439;TKFC;ANGEL2;ZMAT3;S100A6;TRERF1;SCG5;ZSWIM8;APBB2;ARHGEF9;PBLD;RAPGEF5;TNFSF12;TAS1R3;STAT6;PCSK1N;SOX13;PRDX5;PHPT1;NELFCD;GPR132;SMPDL3B;TUB;KIF7;KLF8;CHD6;TRAF5;GOLGB1;SRPX2;TRIM2;CD9;RANBP9;HDAC11;PTPN3;ERBB2;SYNGR1;SPOCD1;PLCB3;GPR68;PAQR7;ARHGAP23;ABCA2;KMT5C;AKAP6;ATG14;MPP7;RORA;SSH3;PPARG;PRKACA;DOCK6;LDLRAP1;CXXC5;FMNL3;ZNF572;SYNE2;ACKR3;ZNF658B;SERPING1;PARN;DOCK3;ZNF529;UFL1;IP6K2;RIPK3;KLF9;AIP;KCNS3;SCAND1;LONP2;PRMT3;SNX33;CIT;ZFP90;MAP1A;CCDC3;PER3;ZFP30;FOXP2;PTBP2;ZC3H6;HIVEP1;SMURF1;NPNT;EML2;CTNNBIP1;PEMT;SERINC3;GCLC;ECM1
1161,GO:0002775,0.264760842983404,0.973387722660245,1,3,antimicrobial peptide production,BP,KLK5
1162,GO:0002778,0.264760842983404,0.973387722660245,1,3,antibacterial peptide production,BP,KLK5
1163,GO:0002784,0.264760842983404,0.973387722660245,1,3,regulation of antimicrobial peptide production,BP,KLK5
1165,GO:0002786,0.264760842983404,0.973387722660245,1,3,regulation of antibacterial peptide production,BP,KLK5
1253,GO:0003009,0.26508261078772,0.902538671357651,3,18,skeletal muscle contraction,BP,GAA;GSTM2;TNNI2
6721,GO:0030139,0.265186037430846,0.80137415425979,25,210,endocytic vesicle,CC,APOE;EGFR;WNT3;VAMP3;ITGB5;RAB43;PLEKHG5;VPS11;MDM2;HLA-B;CLTCL1;GSN;RAB11FIP4;TCIRG1;ATP6V0A2;CYBA;RAB11FIP3;LRP1;HLA-A;DAB2IP;PIK3C3;SYT7;DLG4;CD9;LDLRAP1
12540,GO:0050709,0.26533768359097,0.840613731885003,9,69,negative regulation of protein secretion,BP,SREBF1;SFRP1;F2R;RHBDF1;IDH2;TNFRSF21;HADH;RAB11FIP3;RSAD2
2059,GO:0004814,0.265398706586218,0.973249891878407,1,3,arginine-tRNA ligase activity,MF,DALRD3
2909,GO:0006420,0.265398706586218,0.973249891878407,1,3,arginyl-tRNA aminoacylation,BP,DALRD3
12983,GO:0051428,0.265458057518021,0.929186216403348,2,10,peptide hormone receptor binding,MF,PTHLH;UCN2
6872,GO:0030374,0.265503949653425,0.846512528649646,8,57,ligand-dependent nuclear receptor transcription coactivator activity,MF,THRAP3;THRA;CALCOCO1;VDR;GLMP;TRERF1;RORA;PPARG
17606,GO:1901338,0.26560844457329,0.973204481966894,1,3,catecholamine binding,MF,TH
9193,GO:0035587,0.265610045137821,0.929118408019528,2,10,purinergic receptor signaling pathway,BP,ADORA2B;GPR87
18638,GO:1903976,0.265618554120224,0.973202292053684,1,3,negative regulation of glial cell migration,BP,IDH2
7256,GO:0031232,0.265876028688541,0.97314648369513,1,3,extrinsic component of external side of plasma membrane,CC,SERPINE2
13890,GO:0060563,0.26588121957803,0.871250247821821,5,33,neuroepithelial cell differentiation,BP,FAM20C;SLITRK6;TRIOBP;DLX3;TMEM231
14429,GO:0061771,0.265978051116757,0.973124351589954,1,3,response to caloric restriction,BP,APOE
13972,GO:0060708,0.26599206193349,0.97312131135333,1,3,spongiotrophoblast differentiation,BP,GJB5
2375,GO:0005506,0.266213693478598,0.830886197214875,11,86,iron ion binding,MF,KDM3A;NOS1;CYP26B1;CYP3A5;PHYH;PHF2;CYP2D7;ACP5;ALOXE3;ALOX15B;TH
8221,GO:0032994,0.266502617230986,0.901259852188243,3,19,protein-lipid complex,CC,APOE;PLA2G7;PLTP
13568,GO:0060057,0.266568879585401,0.972995974946381,1,3,apoptotic process involved in mammary gland involution,BP,VDR
13569,GO:0060058,0.266568879585401,0.972995974946381,1,3,positive regulation of apoptotic process involved in mammary gland involution,BP,VDR
17943,GO:1902339,0.266568879585401,0.972995974946381,1,3,positive regulation of apoptotic process involved in morphogenesis,BP,VDR
18415,GO:1903519,0.266568879585401,0.972995974946381,1,3,regulation of mammary gland involution,BP,VDR
18416,GO:1903521,0.266568879585401,0.972995974946381,1,3,positive regulation of mammary gland involution,BP,VDR
18946,GO:1904747,0.266568879585401,0.972995974946381,1,3,positive regulation of apoptotic process involved in development,BP,VDR
10359,GO:0043194,0.266623963234814,0.929892072568704,2,9,axon initial segment,CC,ANK3;NFASC
6760,GO:0030201,0.266674884787788,0.884341737344519,4,24,heparan sulfate proteoglycan metabolic process,BP,SULF2;NDST2;XYLT1;SGSH
19482,GO:1990357,0.266695986393187,0.972968310920567,1,3,terminal web,CC,HFE
12219,GO:0048499,0.266797730187851,0.97294615527049,1,3,synaptic vesicle membrane organization,BP,SYNGR1
14914,GO:0070820,0.267066990523458,0.823031850260395,13,106,tertiary granule,CC,KCNAB2;GAA;HGSNAT;TMC6;SLC2A3;TCIRG1;CST3;CYBA;PGM1;NBEAL2;METTL7A;CTSD;NFASC
10655,GO:0043900,0.267114465059633,0.792364915150454,32,284,regulation of multi-organism process,BP,TNFAIP3;APOE;OAS2;DDX60;APOBEC3C;HERC5;ISG15;MVB12B;HTRA1;STAT1;IFITM1;OAS1;LAMP3;LHFPL2;LRSAM1;GSN;DHX58;BMP6;NLRX1;SQSTM1;CYBA;TRIM38;KLK5;ADARB1;IFI16;EXOC2;BST2;FAM3A;ACVR1B;RSAD2;TKFC;NELFCD
4601,GO:0010719,0.267140722828945,0.901396593902315,3,18,negative regulation of epithelial to mesenchymal transition,BP,SFRP1;DAB2IP;PBLD
2091,GO:0004857,0.267480852701517,0.798025438847958,26,230,enzyme inhibitor activity,MF,SERPINE2;ELFN2;CAMK2N1;COL7A1;SPOCK1;PHACTR3;FLRT3;SERPINB5;RTN4RL1;C5;NAIP;CD109;CST3;TXNIP;SPRY2;TFPI2;WNK1;SNCB;BST2;PPP1R2;PPP1R35;KAT2B;SCG5;PCSK1N;PRDX5;SERPING1
19689,GO:2000050,0.267574763096644,0.902347334680221,3,16,regulation of non-canonical Wnt signaling pathway,BP,SFRP1;NPHP3;RNF213
2759,GO:0006171,0.267624499689858,0.883382159922583,4,25,cAMP biosynthetic process,BP,PTHLH;GABBR1;GPR87;LTB4R2
11785,GO:0046683,0.267645991392114,0.829902446499942,11,84,response to organophosphorus,BP,SREBF1;PKD2;DGKQ;STAT1;RAPGEF3;PDE2A;AREG;DMTN;DUOX1;ZFP36L1;AKAP6
15582,GO:0072088,0.267744953992538,0.851758413592308,7,48,nephron epithelium morphogenesis,BP,PKD2;KIF26B;STAT1;GLI3;KLHL3;NPNT;CTNNBIP1
9290,GO:0035747,0.267831024792734,0.972720554525187,1,3,natural killer cell chemotaxis,BP,CXCL14
4809,GO:0014003,0.267937024879727,0.88284573903774,4,26,oligodendrocyte development,BP,TENM4;GSN;CD9;HDAC11
521,GO:0001609,0.267962119770511,0.972691855344818,1,3,G-protein coupled adenosine receptor activity,MF,ADORA2B
7927,GO:0032515,0.268087402391197,0.86955037642049,5,34,negative regulation of phosphoprotein phosphatase activity,BP,ELFN2;CRY2;PHACTR3;PPP1R2;PPP1R35
13447,GO:0055003,0.268115197906295,0.91127639179912,3,9,cardiac myofibril assembly,BP,OBSL1;FHOD3;TTN
12670,GO:0050907,0.26812690108834,0.926179691234009,2,12,detection of chemical stimulus involved in sensory perception,BP,OR2A4;TAS1R3
11593,GO:0046292,0.268166802426596,0.972647011717789,1,3,formaldehyde metabolic process,BP,KDM3A
12572,GO:0050768,0.268279334445577,0.80294659772694,22,177,negative regulation of neurogenesis,BP,ULK2;APOE;PTPRS;DIXDC1;KCTD11;EPHB2;WNT3;RGMA;NFATC4;SPOCK1;MDM2;RTN4RL1;TRPV4;SEMA4G;GLI3;SYNGAP1;IDH2;CDK5R1;EFNB3;LRP1;BRINP1;PMP22
11224,GO:0045415,0.26833287631906,0.972610595726148,1,3,negative regulation of interleukin-8 biosynthetic process,BP,MAP2K5
15519,GO:0071942,0.268480097823232,0.972578290301619,1,3,XPC complex,CC,XPC
11243,GO:0045503,0.268602173650223,0.90251285366509,3,15,dynein light chain binding,MF,WDR63;DNAH1;GLUL
8719,GO:0034378,0.268607242139635,0.972550372866049,1,3,chylomicron assembly,BP,APOE
2400,GO:0005546,0.26866395732257,0.858974237368829,6,42,phosphatidylinositol-4,5-bisphosphate binding,MF,PLCD1;FZD7;JPH2;SYT7;SNX21;LDLRAP1
2523,GO:0005778,0.268722729288554,0.8506250949095,7,51,peroxisomal membrane,CC,PEX10;MAP2K2;PEX11B;SYT7;ACSL1;DHRS4;PEX1
7553,GO:0031903,0.268722729288554,0.8506250949095,7,51,microbody membrane,CC,PEX10;MAP2K2;PEX11B;SYT7;ACSL1;DHRS4;PEX1
537,GO:0001656,0.268793139998854,0.844208759058626,8,56,metanephros development,BP,PKD2;KIF26B;STAT1;WWTR1;GLI3;RET;DLG5;LAMB2
12644,GO:0050868,0.268834904565988,0.843825560427356,8,59,negative regulation of T cell activation,BP,GPNMB;IL20RB;GLI3;TNFRSF21;HFE;DLG5;NRARP;ERBB2
6143,GO:0019432,0.269134993579164,0.882446073922544,4,25,triglyceride biosynthetic process,BP,SIK1;SREBF1;LPIN3;FBXW7
7028,GO:0030809,0.269283357277122,0.900764285921804,3,17,negative regulation of nucleotide biosynthetic process,BP,GABBR1;GPR87;LTB4R2
17457,GO:1900372,0.269283357277122,0.900764285921804,3,17,negative regulation of purine nucleotide biosynthetic process,BP,GABBR1;GPR87;LTB4R2
3000,GO:0006546,0.269450315025568,0.972364843273837,1,3,glycine catabolic process,BP,AMT
6149,GO:0019464,0.269450315025568,0.972364843273837,1,3,glycine decarboxylation via glycine cleavage system,BP,AMT
14274,GO:0061408,0.269770954156068,0.972294093427477,1,3,positive regulation of transcription from RNA polymerase II promoter in response to heat stress,BP,HSF4
8429,GO:0033559,0.27002120043814,0.842630754302165,8,62,unsaturated fatty acid metabolic process,BP,CES2;PTGS1;GSTM2;CYP2D7;ALOXE3;ACSL1;ALOX15B;FAAH
2656,GO:0006000,0.270039567648964,0.92712926176717,2,10,fructose metabolic process,BP,PFKFB2;TKFC
4432,GO:0010273,0.270099908338471,0.967123238175321,1,5,detoxification of copper ion,BP,MT1X
19446,GO:1990169,0.270099908338471,0.967123238175321,1,5,stress response to copper ion,BP,MT1X
9121,GO:0035456,0.270203635682568,0.898741266665517,3,20,response to interferon-beta,BP,STAT1;IFITM1;BST2
17693,GO:1901628,0.270208763611104,0.972197321407342,1,3,positive regulation of postsynaptic membrane organization,BP,APOE
1093,GO:0002682,0.270251176635377,0.765408099994275,99,923,regulation of immune system process,BP,TNFAIP3;GPNMB;MUC19;INPP5D;DDX60;PTPRS;ASH2L;SFRP1;MAP3K14;PIK3R1;RBCK1;CXCL14;TSC22D3;RNF135;HERC5;VAV3;HTRA1;ZFPM1;KITLG;STAT1;MYL9;PRKACB;KLF13;CYP26B1;IFITM1;FCGRT;HLA-B;FAM210B;IL20RB;ZFP36L2;TRPV4;FLOT1;GLI2;ADORA2B;C5;WIPF1;TNFRSF14;ITGA2;GLI3;SPPL2B;MMP28;GSN;BAIAP2;DDT;DOCK8;DHX58;PILRB;NLRX1;VEGFB;FAM213A;PLA2G6;TNFRSF21;CA2;EFNB3;MAPK10;HFE;CYBA;AGO4;CTSB;KLK5;FBXW7;LMO2;ELF1;C1RL;ERMAP;HLA-A;PLA2G7;DAB2IP;PIK3C3;IFI16;PIK3R2;RPS6KA5;DLG5;BST2;CACNB3;TNRC6C;FAM3A;STAT2;NRARP;ACVR1B;CCDC88B;RSAD2;ZFP36L1;KAT2B;IRS2;TKFC;STAT6;SOX13;PHPT1;SMPDL3B;ERBB2;GPR68;RORA;PPARG;PRKACA;SERPING1;RIPK3;CTNNBIP1;ECM1
8045,GO:0032715,0.270254353219781,0.900223697286961,3,17,negative regulation of interleukin-6 production,BP,TNFAIP3;INPP5D;NLRX1
6983,GO:0030669,0.270326779112393,0.881705651265991,4,25,clathrin-coated endocytic vesicle membrane,CC,APOE;EGFR;CD9;LDLRAP1
18678,GO:1904058,0.270467958698215,0.9721399381523,1,3,positive regulation of sensory perception of pain,BP,NMU
12401,GO:0048865,0.27052708184808,0.972126839319977,1,3,stem cell fate commitment,BP,SFRP1
2725,GO:0006105,0.270536844096851,0.926904388892293,2,10,succinate metabolic process,BP,SDHA;SUCLG2
2229,GO:0005134,0.270595465882515,0.972111684299489,1,3,interleukin-2 receptor binding,MF,ECM1
8900,GO:0034751,0.270615552565479,0.972107231860392,1,3,aryl hydrocarbon receptor complex,CC,AIP
10088,GO:0042611,0.270738438829334,0.924975361309594,2,12,MHC protein complex,CC,HLA-B;HLA-A
13719,GO:0060313,0.2707571394201,0.972075835926323,1,3,negative regulation of blood vessel remodeling,BP,CST3
20232,GO:2001206,0.271062784871882,0.972007991714639,1,3,positive regulation of osteoclast development,BP,GPR68
9692,GO:0038108,0.271217061577563,0.971973710838818,1,3,negative regulation of appetite by leptin-mediated signaling pathway,BP,BBS2
8476,GO:0033634,0.271334419363764,0.97194761729557,1,3,positive regulation of cell-cell adhesion mediated by integrin,BP,PODXL
13250,GO:0051959,0.271338870841366,0.881872073102996,4,23,dynein light intermediate chain binding,MF,DNAH1;HOOK2;RAB11FIP3;CCDC88B
13214,GO:0051899,0.271341303944835,0.848873693634723,7,50,membrane depolarization,BP,IFI6;ANK3;SCN4B;SCN2A;CACNB3;PTPN3;GCLC
18503,GO:1903707,0.271424050776548,0.82634114855086,11,94,negative regulation of hemopoiesis,BP,INPP5D;SFRP1;PIK3R1;ZFPM1;KLF13;GLI3;FBXW7;NRARP;ZFP36L1;ERBB2;GPR68
12609,GO:0050816,0.271524020367044,0.9719054314928,1,3,phosphothreonine residue binding,MF,FBXW7
8281,GO:0033120,0.271687855961873,0.880858060999099,4,25,positive regulation of RNA splicing,BP,SRSF5;PIK3R1;THRAP3;ERN1
18347,GO:1903365,0.271865442171368,0.971829373741651,1,3,regulation of fear response,BP,APOE
20109,GO:2000822,0.271865442171368,0.971829373741651,1,3,regulation of behavioral fear response,BP,APOE
8190,GO:0032945,0.272088060685051,0.856585871261285,6,42,negative regulation of mononuclear cell proliferation,BP,GPNMB;INPP5D;IL20RB;TNFRSF21;DLG5;ERBB2
12511,GO:0050672,0.272088060685051,0.856585871261285,6,42,negative regulation of lymphocyte proliferation,BP,GPNMB;INPP5D;IL20RB;TNFRSF21;DLG5;ERBB2
9664,GO:0038037,0.272110383006488,0.971774735795142,1,3,G-protein coupled receptor dimeric complex,CC,GABBR1
16678,GO:0097648,0.272110383006488,0.971774735795142,1,3,G-protein coupled receptor complex,CC,GABBR1
2140,GO:0004954,0.272162887796406,0.97176301582195,1,3,prostanoid receptor activity,MF,PPARG
9991,GO:0042421,0.272195530960798,0.971755727891256,1,3,norepinephrine biosynthetic process,BP,TH
5131,GO:0015629,0.272322454918724,0.780933022388127,42,347,actin cytoskeleton,CC,ESPN;PKD2;OBSL1;MYL9;FERMT1;H1F0;MYH11;PARVB;ACTR1B;RAPGEF3;SPTB;TRPV4;FLOT1;CORO6;WIPF1;SPPL2B;FHOD3;GSN;BAIAP2;TTN;PLEKHH2;TRIOBP;MICALL2;ARHGAP33;HFE;CYBA;PGM1;APC2;SLC2A1;CAPG;SYNPO2;MYO3B;SHROOM2;MYO9A;APBB3;DMTN;SHROOM4;TNNI2;KAT2B;IVNS1ABP;MYH16;MPRIP
12942,GO:0051344,0.272398889649737,0.971710301494104,1,3,negative regulation of cyclic-nucleotide phosphodiesterase activity,BP,AIP
12684,GO:0050922,0.272447685435323,0.86689022169883,5,33,negative regulation of chemotaxis,BP,WNT3;C5;SEMA4G;MMP28;DDT
5629,GO:0016712,0.272484857674998,0.926020438201974,2,10,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen,MF,CYP3A5;CYP2D7
3487,GO:0007354,0.272562092524657,0.971673814675027,1,3,zygotic determination of anterior/posterior axis, embryo,BP,PCSK6
6332,GO:0021510,0.27257448584277,0.848279557113507,7,48,spinal cord development,BP,PTPRS;PKD2;GLI2;SOX12;GLI3;ADARB1;PTBP2
20208,GO:2001171,0.272609286249109,0.898907836371077,3,17,positive regulation of ATP biosynthetic process,BP,INSR;MLXIPL;PFKFB2
11329,GO:0045669,0.272656360299651,0.856372482964677,6,41,positive regulation of osteoblast differentiation,BP,FAM20C;IFITM1;GLI3;BMP6;NPNT;CTNNBIP1
10077,GO:0042592,0.272663403936155,0.760514690111781,118,1089,homeostatic process,BP,TNFAIP3;IFI6;APOE;INPP5D;EGFR;PKD2;PIK3R1;TXNRD3;TSC22D3;CYBRD1;ZFPM1;KITLG;STAT1;CRY2;NOS1;PRKACB;CRY1;KLF13;CYP26B1;GAA;ITPR3;CRTC1;NDN;NEO1;FAM210B;OAS1;IL20RB;F2R;MT1X;SLC24A1;TRPV4;ANK3;SLX1A;SLX1B;CLCN6;GSTM2;FGGY;NMU;SESN3;INSR;SCNN1A;POLD4;ENDOG;SLC27A1;BMP6;TCIRG1;SLC12A7;HEXB;PLA2G6;HOMER2;BBS2;ATP6V0A2;NPHP3;WRN;MALL;IQCB1;ATRX;CA2;SHANK3;HFE;CYBA;ERCC6;XRN1;MLXIPL;FBXW7;KCNMA1;THRA;RPH3AL;ACACB;TNS2;NPHP4;ACP5;BBS1;JPH2;ACOX3;FBXO4;FGFR4;IL20RA;PIK3R2;TMEM203;KLHL3;VDR;LETMD1;CACNB3;BBS10;LPAR6;DMTN;ACVR1B;TMX4;DLG4;ALOXE3;ZFP36L1;TEP1;IRS2;DMXL2;ANO1;ERN1;RAD50;GPR21;TRERF1;PBLD;PRDX5;PHPT1;TUB;RDH12;PTPN3;GPR68;ABCA2;AKAP6;TH;RORA;PPARG;PRKACA;LDLRAP1;GCNT4;PARN;RIPK3;GCLC
12474,GO:0050501,0.272876197075936,0.971603514829856,1,3,hyaluronan synthase activity,MF,HYAL1
2774,GO:0006198,0.272901222589261,0.927100942897817,2,9,cAMP catabolic process,BP,RAPGEF3;PDE2A
1212,GO:0002883,0.272974932360905,0.97158139608643,1,3,regulation of hypersensitivity,BP,IL20RB
19297,GO:1905600,0.273181497479908,0.971535089092116,1,3,regulation of receptor-mediated endocytosis involved in cholesterol transport,BP,LDLRAP1
12984,GO:0051429,0.273306548519543,0.971507034478734,1,3,corticotropin-releasing hormone receptor binding,MF,UCN2
3695,GO:0008202,0.273712793404208,0.796603660989765,23,198,steroid metabolic process,BP,SREBF1;AMACR;APOE;LMF1;SEC14L2;DGKQ;TFCP2L1;MVD;SRD5A3;CYP26B1;CYP3A5;SULT1E1;BMP6;ACACB;FGFR4;OSBPL5;VDR;OSBPL1A;HSD17B14;DHRS4;TRERF1;RORA;LDLRAP1
15695,GO:0072273,0.273740852817187,0.898273143983284,3,17,metanephric nephron morphogenesis,BP,PKD2;KIF26B;STAT1
9539,GO:0036312,0.273808816507127,0.926693262668584,2,9,phosphatidylinositol 3-kinase regulatory subunit binding,MF,PIK3R1;DAB2IP
3460,GO:0007274,0.27384719894286,0.926675998745011,2,9,neuromuscular synaptic transmission,BP,ETV5;ADARB1
8047,GO:0032720,0.274433634908982,0.878465087784009,4,27,negative regulation of tumor necrosis factor production,BP,TNFAIP3;GPNMB;MC1R;ACP5
18646,GO:1903998,0.274435382970872,0.971253063570921,1,3,regulation of eating behavior,BP,NMU
544,GO:0001664,0.274448050982159,0.811329894124068,15,124,G-protein coupled receptor binding,MF,SFRP1;CXCL14;WNT3;REEP2;STAT1;C5;NMU;ARHGEF1;FZD7;HOMER2;DNM1;ARAP1;BBS1;UCN2;DLG4
2716,GO:0006094,0.274449573932759,0.846348788054882,7,52,gluconeogenesis,BP,SIK1;DGKQ;CRY1;G6PC3;PER2;PGM1;KAT2B
19592,GO:1990756,0.274557927333546,0.971225414607633,1,3,protein binding, bridging involved in substrate recognition for ubiquitination,MF,ARRDC1
15642,GO:0072182,0.274558946947835,0.92635552545979,2,9,regulation of nephron tubule epithelial cell differentiation,BP,STAT1;WWTR1
12089,GO:0048145,0.2748978376818,0.839104604782515,8,61,regulation of fibroblast proliferation,BP,TP53INP1;EGFR;SFRP1;NUPR1;DAB2IP;FBXO4;S100A6;PPARG
6741,GO:0030167,0.274974237617296,0.971131370293893,1,3,proteoglycan catabolic process,BP,SGSH
6759,GO:0030200,0.274974237617296,0.971131370293893,1,3,heparan sulfate proteoglycan catabolic process,BP,SGSH
14113,GO:0061001,0.275003529699899,0.879170252582475,4,24,regulation of dendritic spine morphogenesis,BP,CAPRIN2;BAIAP2;CDK5R1;SHANK3
3815,GO:0008410,0.275099803106778,0.971102970308034,1,3,CoA-transferase activity,MF,SUGCT
2657,GO:0006001,0.275113377045228,0.971099899233492,1,3,fructose catabolic process,BP,TKFC
14361,GO:0061624,0.275113377045228,0.971099899233492,1,3,fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate,BP,TKFC
4902,GO:0014834,0.275371697809985,0.971041418773498,1,3,skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration,BP,FZD7
357,GO:0000976,0.275407393077757,0.770679119646782,58,498,transcription regulatory region sequence-specific DNA binding,MF,HES2;SREBF1;MNT;KDM3A;HR;TFCP2L1;ZFPM1;STAT1;CRY2;ZNF704;CRY1;KLF13;NFATC4;HSF4;NDN;GLI2;KLF7;SOX12;PER2;ZNF658;GLI3;THRAP3;BHLHE40;TCFL5;JARID2;ETV5;TCF4;PLAG1;MEF2D;CREBRF;MLXIPL;LMO2;CARF;MXI1;THRA;ELF1;DBP;RFX2;SALL2;ZMYND8;IFI16;TEF;VDR;TNRC18;SIX5;HLTF;TFDP2;KAT2B;IVNS1ABP;STAT6;SOX13;KLF8;RORA;PPARG;PER3;FOXP2;ZC3H6;HIVEP1
13915,GO:0060601,0.275407591743015,0.925972573633489,2,9,lateral sprouting from an epithelium,BP,GLI2;CELSR1
2439,GO:0005640,0.27561565205944,0.897218133322035,3,17,nuclear outer membrane,CC,ITPR3;RETSAT;SYNE2
7690,GO:0032155,0.275869125184551,0.838714341907494,8,58,cell division site part,CC,PLCD3;OR2A4;TUBGCP5;SEPT6;RAB11FIP4;CENPC;RAB11FIP3;CIT
7761,GO:0032289,0.275984617545939,0.970902388326656,1,3,central nervous system myelin formation,BP,TENM4
9823,GO:0042060,0.276011161698887,0.779321888080274,39,341,wound healing,BP,TNFAIP3;POSTN;SERPINE2;APOE;EGFR;DGKQ;PIK3R1;DOCK9;EYS;VAV3;ZFPM1;MYL9;PRKACB;ITPR3;NINJ1;F2R;HPS4;BLOC1S4;ADAMTS13;ARHGEF19;ITGA2;GLI3;CELSR1;GSN;CD109;DOCK8;BLOC1S3;FZD7;HMG20B;TFPI2;GNG2;SYT7;DMTN;PTK7;CD9;ERBB2;PRKACA;DOCK6;SERPING1
15571,GO:0072073,0.276011923183471,0.81974284176921,12,89,kidney epithelium development,BP,PKD2;SFRP1;KIF26B;STAT1;WWTR1;GLI3;PODXL;RET;KLHL3;LAMB2;NPNT;CTNNBIP1
1367,GO:0003254,0.276281712060611,0.877626369491644,4,26,regulation of membrane depolarization,BP,IFI6;ANK3;PTPN3;GCLC
11483,GO:0045980,0.276448992985511,0.877520924800778,4,26,negative regulation of nucleotide metabolic process,BP,GABBR1;MLXIPL;GPR87;LTB4R2
1096,GO:0002685,0.276472659496283,0.818731185273053,12,100,regulation of leukocyte migration,BP,CXCL14;KITLG;TRPV4;C5;ITGA2;MMP28;DDT;DOCK8;VEGFB;PLA2G7;RIPK3;ECM1
13782,GO:0060393,0.276480350332043,0.863941344229487,5,34,regulation of pathway-restricted SMAD protein phosphorylation,BP,BMP6;GDF15;HFE;ACVR1B;PBLD
18897,GO:1904636,0.276496644259197,0.970785948602852,1,3,response to ionomycin,BP,NFATC4
18898,GO:1904637,0.276496644259197,0.970785948602852,1,3,cellular response to ionomycin,BP,NFATC4
16771,GO:0098631,0.276515583717884,0.863917638136253,5,34,cell adhesion mediator activity,MF,BCAM;ITGA2;BAIAP2;PLXNB3;NFASC
8272,GO:0033087,0.276590473491456,0.970764581796125,1,3,negative regulation of immature T cell proliferation,BP,ERBB2
1169,GO:0002792,0.276647922292508,0.831949616170141,9,70,negative regulation of peptide secretion,BP,SREBF1;SFRP1;F2R;RHBDF1;IDH2;TNFRSF21;HADH;RAB11FIP3;RSAD2
14731,GO:0070427,0.276811223263661,0.970714276997233,1,3,nucleotide-binding oligomerization domain containing 1 signaling pathway,BP,TNFAIP3
14613,GO:0070206,0.276867845079879,0.863447444145801,5,35,protein trimerization,BP,TRIM22;C1QTNF6;HSF4;COL6A1;ATXN10
967,GO:0002414,0.276918859400477,0.970689730569113,1,3,immunoglobulin transcytosis in epithelial cells,BP,FCGRT
9537,GO:0036309,0.276984559792845,0.977608040322405,1,2,protein localization to M-band,BP,OBSCN
17779,GO:1901894,0.277349003982211,0.970591517301403,1,3,regulation of calcium-transporting ATPase activity,BP,HSPA2
4767,GO:0010955,0.277374037051446,0.876937250225581,4,26,negative regulation of protein processing,BP,SERPINE2;MDM2;NAIP;SERPING1
18326,GO:1903318,0.277374037051446,0.876937250225581,4,26,negative regulation of protein maturation,BP,SERPINE2;MDM2;NAIP;SERPING1
13105,GO:0051668,0.277402298522646,0.822256995944919,11,84,localization within membrane,BP,APOE;MARVELD1;REEP2;NSG1;GSN;ETV5;SYNGAP1;MALL;DNM1;SHANK3;DLG4
3081,GO:0006655,0.277410079265459,0.923763885685883,2,10,phosphatidylglycerol biosynthetic process,BP,SLC27A1;PLA2G6
3779,GO:0008340,0.277455981094086,0.92504447383718,2,9,determination of adult lifespan,BP,INPP5D;TFCP2L1
13186,GO:0051835,0.277492881649899,0.970558623842551,1,3,positive regulation of synapse structural plasticity,BP,SHANK3
18103,GO:1902809,0.277607682436879,0.97053236271008,1,3,regulation of skeletal muscle fiber differentiation,BP,CYP26B1
19543,GO:1990573,0.277701684838794,0.970510849201974,1,3,potassium ion import across plasma membrane,BP,KCNJ5
11382,GO:0045785,0.277911752559178,0.786944439979875,28,236,positive regulation of cell adhesion,BP,SFRP1;KIF26B;MAP3K14;PIK3R1;VAV3;SMOC2;FERMT1;NINJ1;FLOT1;GLI2;ANK3;TNFRSF14;ITGA2;GLI3;ITGA6;TRIOBP;DOCK8;HYAL1;PODXL;NET1;EFNB3;NID1;RET;DMTN;CCDC88B;ERBB2;ECM2;NPNT
14491,GO:0065005,0.277912124344045,0.895334834593638,3,18,protein-lipid complex assembly,BP,APOE;PRKACB;PRKACA
19620,GO:1990834,0.278119604693587,0.970415093535071,1,3,response to odorant,BP,CTSV
1849,GO:0004514,0.278133412414176,0.970411926782362,1,3,nicotinate-nucleotide diphosphorylase (carboxylating) activity,MF,NAPRT
19951,GO:2000553,0.278168114995706,0.970403966999739,1,3,positive regulation of T-helper 2 cell cytokine production,BP,RSAD2
11301,GO:0045637,0.278177420449002,0.797277718749361,20,181,regulation of myeloid cell differentiation,BP,INPP5D;ASH2L;SFRP1;PIK3R1;ZFPM1;KITLG;STAT1;MYL9;KLF13;FAM210B;FAM213A;CA2;AGO4;FBXW7;TNRC6C;ACVR1B;ZFP36L1;KAT2B;GPR68;CTNNBIP1
16508,GO:0097252,0.278233353659437,0.970388999755923,1,3,oligodendrocyte apoptotic process,BP,TNFRSF21
3480,GO:0007341,0.278339377363973,0.970364666145826,1,3,penetration of zona pellucida,BP,HEXB
15830,GO:0072567,0.278347978821023,0.922279351194547,2,11,chemokine (C-X-C motif) ligand 2 production,BP,POSTN;MAP2K5
3616,GO:0008064,0.278415886407399,0.8056261417643,16,131,regulation of actin polymerization or depolymerization,BP,EPS8L2;ARPIN;SPTB;WIPF1;FHOD3;GSN;BAIAP2;PLEKHH2;TRIOBP;RICTOR;WHAMMP3;WASH3P;CAPG;DMTN;SSH3;CIT
14790,GO:0070541,0.278445154238707,0.970340377655452,1,3,response to platinum ion,BP,UROS
9768,GO:0039689,0.278565158891009,0.970312808234344,1,3,negative stranded viral RNA replication,BP,ATG16L2
16925,GO:0098928,0.278573848370044,0.977327411724829,1,2,presynaptic signal transduction,BP,BSN
17027,GO:0099526,0.278573848370044,0.977327411724829,1,2,presynapse to nucleus signaling pathway,BP,BSN
10473,GO:0043383,0.278674341175624,0.970287712219659,1,3,negative T cell selection,BP,GLI3
11048,GO:0045060,0.278674341175624,0.970287712219659,1,3,negative thymic T cell selection,BP,GLI3
10483,GO:0043398,0.278752594062717,0.970269717905694,1,3,HLH domain binding,MF,PKD2
10302,GO:0043097,0.278811471415661,0.922062245893455,2,11,pyrimidine nucleoside salvage,BP,TK2;UCKL1
18325,GO:1903317,0.278897356730629,0.843244361560749,7,51,regulation of protein maturation,BP,SERPINE2;PRKACB;MDM2;C5;NAIP;GSN;SERPING1
9971,GO:0042379,0.278900258923674,0.892994353204834,3,22,chemokine receptor binding,MF,CXCL14;STAT1;C5
19585,GO:1990743,0.278958592886372,0.970222318149327,1,3,protein sialylation,BP,ST6GALNAC2
4459,GO:0010454,0.27935050502338,0.9701320195023,1,3,negative regulation of cell fate commitment,BP,FZD7
629,GO:0001819,0.279411645515888,0.784481622673815,29,252,positive regulation of cytokine production,BP,POSTN;DDX60;PIK3R1;RNF135;SULF2;ZFPM1;STAT1;NFATC4;FERMT1;IL20RB;F2R;TRPV4;FLOT1;ADORA2B;C5;DDT;DHX58;NLRX1;CYBA;NLRP1;ZBTB20;IFI16;ARFGEF2;CCDC88B;RSAD2;ALOX15B;TKFC;STAT6;RORA
12894,GO:0051260,0.279468398277737,0.788980391172316,25,216,protein homooligomerization,BP,APOE;PKD2;ALDH1A3;KCTD11;GPX3;HSF4;KCNC4;ITPR3;CRTC1;KCTD18;TYSND1;KCTD15;FLOT1;SHARPIN;PEX11B;IKZF4;ACACB;GLUL;SRR;KCNG1;ATXN10;RNF213;CBR4;RIPK3;KCNS3
9812,GO:0042036,0.27958838734737,0.894378738272659,3,18,negative regulation of cytokine biosynthetic process,BP,INPP5D;ZFPM1;MAP2K5
11485,GO:0045986,0.279599458757262,0.922750828485329,2,10,negative regulation of smooth muscle contraction,BP,RGS2;ADORA2B
8345,GO:0033227,0.279676617689894,0.970056760669489,1,3,dsRNA transport,BP,FLOT1
19669,GO:2000009,0.279916075018661,0.922603817515175,2,10,negative regulation of protein localization to cell surface,BP,ASTN2;SNX33
19926,GO:2000489,0.280108552570492,0.969956911710185,1,3,regulation of hepatic stellate cell activation,BP,GCLC
15178,GO:0071346,0.280124296166143,0.812488395152945,13,107,cellular response to interferon-gamma,BP,OAS2;TRIM22;VAMP3;STAT1;RAB43;HLA-B;OAS1;ADAMTS13;GSN;IRF9;TRIM38;HLA-A;PPARG
14516,GO:0070050,0.280174537484747,0.969941641234229,1,3,neuron cellular homeostasis,BP,FGGY
8759,GO:0034447,0.28039940229513,0.966430439349549,1,4,very-low-density lipoprotein particle clearance,BP,APOE
9472,GO:0036118,0.280408400494898,0.969887483563805,1,3,hyaluranon cable assembly,BP,HYAL1
17358,GO:1900104,0.280408400494898,0.969887483563805,1,3,regulation of hyaluranon cable assembly,BP,HYAL1
17359,GO:1900106,0.280408400494898,0.969887483563805,1,3,positive regulation of hyaluranon cable assembly,BP,HYAL1
12756,GO:0051051,0.280432808124803,0.782589705442344,30,261,negative regulation of transport,BP,SERPINE2;SREBF1;PKD2;SFRP1;EPHB2;VAMP3;NOS1;CRY1;F2R;ANK3;RHBDF1;UNC119;GSTM2;LRSAM1;NMU;IDH2;TNFRSF21;MCTP1;ANO9;HADH;RAB11FIP3;WNK1;PDE2A;BST2;DMTN;DLG4;RSAD2;IL11;IRS2;SNX33
3453,GO:0007266,0.280470275818609,0.797764699818861,19,149,Rho protein signal transduction,BP,APOE;EPS8L2;VAV3;PLEKHG5;PLEKHG3;OBSCN;RHOBTB2;F2R;FLOT1;ARHGEF19;ARHGEF4;CELSR1;ARHGEF1;NET1;PAK6;ARAP1;ARHGEF17;LPAR6;ARHGEF9
3327,GO:0007035,0.280556555571191,0.893300500255585,3,19,vacuolar acidification,BP,TCIRG1;ATP6V0A2;DMXL2
10784,GO:0044272,0.280894923559202,0.80118051937958,17,142,sulfur compound biosynthetic process,BP,CSPG4;B4GALT6;MLYCD;GSTM2;MGST2;B4GALT2;OPLAH;PDK1;ACACB;NDST2;XYLT1;ACSL1;MTR;CBR4;GSTM3;ACSS2;GCLC
1085,GO:0002673,0.280942000278716,0.874343918232209,4,27,regulation of acute inflammatory response,BP,IL20RB;C5;PPARG;SERPING1
4963,GO:0015057,0.280951685100286,0.969761452294313,1,3,thrombin-activated receptor activity,MF,F2R
5751,GO:0016903,0.281118364828592,0.860809308191113,5,34,oxidoreductase activity, acting on the aldehyde or oxo group of donors,MF,ALDH1A3;DHTKD1;ALDH4A1;ALDH7A1;OGDHL
10959,GO:0044752,0.28115778255012,0.969713561909604,1,3,response to human chorionic gonadotropin,BP,GCLC
15742,GO:0072358,0.28115933577953,0.767014276395094,54,460,cardiovascular system development,BP,TNFAIP3;TGFBI;GPNMB;ACTA2;APOE;PKD2;PLCD3;SFRP1;EPHB2;VAV3;CSPG4;CUL7;STAT1;UNC5B;HOXA3;NFATC4;MDM2;PLCD1;RAPGEF3;ADGRB2;PDCD4;TMEM204;C5;GLI3;LTBP1;MAP2K5;VEGFB;LOXL1;DLX3;HYAL1;SH2D2A;MMRN2;SPRY2;FBXW7;LRP1;DAB2IP;TEAD2;RNF213;FGFR4;BTG1;PLXND1;TMEM231;NRARP;PTK7;ZFP36L1;APOLD1;TNFSF12;SRPX2;ERBB2;RORA;PPARG;FMNL3;ACKR3;ECM1
12310,GO:0048679,0.281450593600627,0.893312559094842,3,18,regulation of axon regeneration,BP,PTPRS;RGMA;RTN4RL1
18925,GO:1904707,0.281509966248084,0.893873261459336,3,17,positive regulation of vascular smooth muscle cell proliferation,BP,MDM2;MEF2D;ERN1
11900,GO:0046952,0.281821255647547,0.969559093638625,1,3,ketone body catabolic process,BP,BDH1
1035,GO:0002544,0.281867538156126,0.920623812224021,2,11,chronic inflammatory response,BP,TNFAIP3;ADORA2B
8883,GO:0034711,0.281897847239435,0.969541232410293,1,3,inhibin binding,MF,ACVR1B
6025,GO:0019087,0.282011629887727,0.969514686971528,1,3,transformation of host cell by virus,BP,INSR
11546,GO:0046104,0.282078998462162,0.969498963590775,1,3,thymidine metabolic process,BP,TK2
11556,GO:0046125,0.282078998462162,0.969498963590775,1,3,pyrimidine deoxyribonucleoside metabolic process,BP,TK2
4412,GO:0010181,0.282127488027985,0.921573433979048,2,10,FMN binding,MF,NOS1;PNPO
12164,GO:0048306,0.282148630923411,0.859438823353198,5,37,calcium-dependent protein binding,MF,SYT8;SYN1;VAMP2;S100A4;S100A6
501,GO:0001558,0.282274933551725,0.778284409282811,33,284,regulation of cell growth,BP,SERPINE2;ULK2;APOE;EGFR;PTPRS;CAPRIN2;SFRP1;WNT3;HTRA1;SPOCK1;LTBP4;KIF26A;SEMA4G;MAP2K5;IGFBP4;CCDC85B;EPB41L3;HYAL1;CDK5R1;NET1;CYBA;SLIT3;BTG1;BST2;ACVR1B;IGFBP6;CLSTN3;APBB2;ERBB2;AKAP6;PPARG;IP6K2;SMURF1
9220,GO:0035620,0.282352160958791,0.969435161052541,1,3,ceramide transporter activity,MF,PLTP
14536,GO:0070081,0.282478978897282,0.969405513899655,1,3,clathrin-sculpted monoamine transport vesicle,CC,VAMP2
14537,GO:0070083,0.282478978897282,0.969405513899655,1,3,clathrin-sculpted monoamine transport vesicle membrane,CC,VAMP2
8037,GO:0032696,0.282634859983738,0.969369049587556,1,3,negative regulation of interleukin-13 production,BP,TNFRSF21
16933,GO:0098953,0.282640284675609,0.969367780168575,1,3,receptor diffusion trapping,BP,DLG4
16939,GO:0098970,0.282640284675609,0.969367780168575,1,3,postsynaptic neurotransmitter receptor diffusion trapping,BP,DLG4
17072,GO:0099628,0.282640284675609,0.969367780168575,1,3,neurotransmitter receptor diffusion trapping,BP,DLG4
15797,GO:0072520,0.282656929405299,0.921325816361397,2,10,seminiferous tubule development,BP,ATRX;REC8
16389,GO:0097038,0.282869896164489,0.921226111262281,2,10,perinuclear endoplasmic reticulum,CC,PIK3R1;CYBA
16594,GO:0097454,0.282913858309553,0.969303722260735,1,3,Schwann cell microvillus,CC,NFASC
4997,GO:0015141,0.283056730177451,0.969270237597347,1,3,succinate transmembrane transporter activity,MF,SLC13A5
5180,GO:0015744,0.283056730177451,0.969270237597347,1,3,succinate transport,BP,SLC13A5
15232,GO:0071422,0.283056730177451,0.969270237597347,1,3,succinate transmembrane transport,BP,SLC13A5
1521,GO:0003887,0.283212341499307,0.873230902843533,4,26,DNA-directed DNA polymerase activity,MF,POLH;POLD4;PRIMPOL;POLM
543,GO:0001662,0.283233205612752,0.892287981643259,3,18,behavioral fear response,BP,APOE;MDK;BRINP1
867,GO:0002209,0.283233205612752,0.892287981643259,3,18,behavioral defense response,BP,APOE;MDK;BRINP1
10081,GO:0042596,0.283233205612752,0.892287981643259,3,18,fear response,BP,APOE;MDK;BRINP1
17407,GO:1900186,0.283298979980653,0.969213413436039,1,3,negative regulation of clathrin-dependent endocytosis,BP,UNC119
11719,GO:0046548,0.283439925008723,0.969180324126767,1,3,retinal rod cell development,BP,NAGLU
16051,GO:0090031,0.283450561087052,0.969177826283866,1,3,positive regulation of steroid hormone biosynthetic process,BP,BMP6
5528,GO:0016508,0.283472601126994,0.969172649889287,1,3,long-chain-enoyl-CoA hydratase activity,MF,EHHADH
12302,GO:0048669,0.283521644263946,0.969161129649365,1,3,collateral sprouting in absence of injury,BP,WNT3
1983,GO:0004705,0.283762096314617,0.969104611251179,1,3,JUN kinase activity,MF,MAPK10
5753,GO:0016909,0.283762096314617,0.969104611251179,1,3,SAP kinase activity,MF,MAPK10
11390,GO:0045806,0.283801154954181,0.8587477851047,5,35,negative regulation of endocytosis,BP,UNC119;LRSAM1;MCTP1;DLG4;SNX33
14139,GO:0061043,0.283936426315746,0.969063597289966,1,3,regulation of vascular wound healing,BP,TNFAIP3
13641,GO:0060179,0.283966309509764,0.969056563610361,1,3,male mating behavior,BP,HEXB
7129,GO:0030969,0.284099023841292,0.969025315094152,1,3,mRNA splicing via endonucleolytic cleavage and ligation involved in unfolded protein response,BP,ERN1
14520,GO:0070054,0.284099023841292,0.969025315094152,1,3,mRNA splicing, via endonucleolytic cleavage and ligation,BP,ERN1
14521,GO:0070055,0.284099023841292,0.969025315094152,1,3,mRNA endonucleolytic cleavage involved in unfolded protein response,BP,ERN1
15539,GO:0072007,0.284113505041763,0.969021904285643,1,3,mesangial cell differentiation,BP,ACTA2
15540,GO:0072008,0.284113505041763,0.969021904285643,1,3,glomerular mesangial cell differentiation,BP,ACTA2
15622,GO:0072143,0.284113505041763,0.969021904285643,1,3,mesangial cell development,BP,ACTA2
15623,GO:0072144,0.284113505041763,0.969021904285643,1,3,glomerular mesangial cell development,BP,ACTA2
18735,GO:1904238,0.284113505041763,0.969021904285643,1,3,pericyte cell differentiation,BP,ACTA2
17380,GO:1900133,0.284120624297287,0.969020227382153,1,3,regulation of renin secretion into blood stream,BP,F2R
6055,GO:0019206,0.284305904045934,0.91946747221354,2,11,nucleoside kinase activity,MF,TK2;UCKL1
9140,GO:0035502,0.284371201643253,0.968961171597052,1,3,metanephric part of ureteric bud development,BP,PKD2
14735,GO:0070432,0.284384683272387,0.968957992409443,1,3,regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway,BP,TNFAIP3
18008,GO:1902533,0.284384933590691,0.757701124685014,73,658,positive regulation of intracellular signal transduction,BP,GPNMB;DDX60;EGFR;PKD2;TRIM22;EPHB2;MAP3K14;PIK3R1;RBCK1;CSPG4;KITLG;MC1R;UNC5B;NOS1;PLEKHG5;PLXNB1;TNFSF10;F2R;PDCD4;TRPV4;ADORA2B;MAPK8IP3;RASGEF1A;C5;MINK1;GSTM2;FAM110C;MAP2K5;IGFBP4;INSR;DDT;DHX58;RICTOR;S100A4;MAP2K2;PTK6;FZD7;SHARPIN;PLA2G6;CTF1;MAP3K12;MAPK10;TRIM38;ERCC6;SHC2;EDA2R;SPRY2;FBXW7;CDK5RAP3;MAP3K6;JPH2;RET;DAB2IP;FGFR4;IL20RA;PIK3R2;DLG5;BST2;RGL2;LPAR6;TNFRSF25;IL11;IRS2;ERN1;TRAF5;ERBB2;AKAP6;CXXC5;ACKR3;RIPK3;NPNT;SERINC3;ECM1
7281,GO:0031281,0.284409166208526,0.920503737661189,2,10,positive regulation of cyclase activity,BP,NOS1;ADORA2B
6171,GO:0019541,0.2845328147001,0.968923048145639,1,3,propionate metabolic process,BP,ACSS2
1260,GO:0003016,0.28458316625895,0.892112485211132,3,17,respiratory system process,BP,GAA;NDN;NLGN2
4988,GO:0015119,0.284615668652052,0.968903492901444,1,3,hexose phosphate transmembrane transporter activity,MF,SLC37A2
5077,GO:0015315,0.284615668652052,0.968903492901444,1,3,organophosphate:inorganic phosphate antiporter activity,MF,SLC37A2
5124,GO:0015526,0.284615668652052,0.968903492901444,1,3,hexose-phosphate:inorganic phosphate antiporter activity,MF,SLC37A2
14309,GO:0061513,0.284615668652052,0.968903492901444,1,3,glucose 6-phosphate:inorganic phosphate antiporter activity,MF,SLC37A2
18625,GO:1903959,0.284847296230453,0.891960615429689,3,17,regulation of anion transmembrane transport,BP,PER2;ANO9;IRS2
19688,GO:2000049,0.284896105716494,0.968837250905264,1,3,positive regulation of cell-cell adhesion mediated by cadherin,BP,FLOT1
5232,GO:0015850,0.28501824457243,0.808724896675399,13,103,organic hydroxy compound transport,BP,APOE;NOS1;NISCH;PGAP1;BMP6;LRP1;SYT7;OSBPL5;OSBPL1A;ABCA2;PPARG;LDLRAP1;PLTP
9630,GO:0036510,0.285279735731066,0.968746500987183,1,3,trimming of terminal mannose on C branch,BP,MAN1B1
20004,GO:2000647,0.285511205893557,0.919984686498668,2,10,negative regulation of stem cell proliferation,BP,KCTD11;FERMT1
20026,GO:2000671,0.285586935991295,0.968673720335824,1,3,regulation of motor neuron apoptotic process,BP,MAP3K12
20027,GO:2000672,0.285586935991295,0.968673720335824,1,3,negative regulation of motor neuron apoptotic process,BP,MAP3K12
14189,GO:0061146,0.285594688226518,0.968671882433957,1,3,Peyer's patch morphogenesis,BP,RET
8581,GO:0034092,0.285640161494816,0.968661100357707,1,3,negative regulation of maintenance of sister chromatid cohesion,BP,ATRX
8631,GO:0034183,0.285640161494816,0.968661100357707,1,3,negative regulation of maintenance of mitotic sister chromatid cohesion,BP,ATRX
141,GO:0000293,0.285648265408914,0.968659178628259,1,3,ferric-chelate reductase activity,MF,CYBRD1
13809,GO:0060429,0.285675697297837,0.752890136442999,89,804,epithelium development,BP,TAGLN;SERPINE2;ACTA2;APCDD1;EGFR;PTPRS;FAM20C;PKD2;ALDH1A3;SLITRK6;SFRP1;KIF26B;POU3F1;WNT3;TFCP2L1;PRICKLE2;STAT1;KRT15;PRKACB;NFATC4;FERMT1;CYP26B1;RAPGEF3;CTSV;FLRT3;PPL;SERPINB5;GLI2;ARHGEF19;WWTR1;ITGA2;GLI3;PRR9;TST;CELSR1;TRIOBP;CD109;CASP14;BMP6;PTK6;FZD7;ETV5;DLX3;SHARPIN;CST3;TXNIP;NPHP3;PODXL;ATRX;CA2;KRT14;SPRY2;IFT140;CTSB;KLK5;THRA;ASTN2;SALL2;PDE2A;MAF;RET;TEAD2;MYSM1;BBS5;AREG;KLHL3;MYO9A;DLG5;BTG1;VDR;PLXND1;PCSK6;TMEM231;NRARP;ACVR1B;PALB2;PTK7;TCF7;ZFP36L1;APOLD1;ALOX15B;STAT6;GSTM3;PPARG;LAMB2;FOXP2;SMURF1;NPNT;CTNNBIP1
2576,GO:0005865,0.28568356721125,0.897806305966977,3,11,striated muscle thin filament,CC,FHOD3;TTN;TNNI2
4405,GO:0010159,0.285709121548841,0.968644745259361,1,3,specification of animal organ position,BP,HOXA3
1584,GO:0003997,0.285760178083111,0.968632633100665,1,3,acyl-CoA oxidase activity,MF,ACOX3
523,GO:0001618,0.285823824851887,0.846885627905379,6,42,virus receptor activity,MF,ITGB6;EGFR;ITGB5;TNFRSF14;ITGA2;EFNB3
17166,GO:0104005,0.285823824851887,0.846885627905379,6,42,hijacked molecular function,MF,ITGB6;EGFR;ITGB5;TNFRSF14;ITGA2;EFNB3
12815,GO:0051145,0.285914272661895,0.857546444338761,5,34,smooth muscle cell differentiation,BP,NFATC4;PDCD4;TMEM204;OLFM2;NPNT
3801,GO:0008381,0.286051750930606,0.968563411038409,1,3,mechanosensitive ion channel activity,MF,TRPV4
12526,GO:0050692,0.286184855158701,0.968531781367006,1,3,DBD domain binding,MF,PPARG
15550,GO:0072028,0.286264283515117,0.838136947010157,7,49,nephron morphogenesis,BP,PKD2;KIF26B;STAT1;GLI3;KLHL3;NPNT;CTNNBIP1
15426,GO:0071733,0.286387728567061,0.968483536788063,1,3,transcriptional activation by promoter-enhancer looping,BP,ZFPM1
16161,GO:0090202,0.286387728567061,0.968483536788063,1,3,gene looping,BP,ZFPM1
16320,GO:0090579,0.286387728567061,0.968483536788063,1,3,dsDNA loop formation,BP,ZFPM1
14659,GO:0070294,0.286393063422986,0.968482267545395,1,3,renal sodium ion absorption,BP,KLHL3
15116,GO:0071230,0.286413773987078,0.837874250902776,7,50,cellular response to amino acid stimulus,BP,EGFR;SESN3;BAIAP2;COL6A1;SESN1;CYBA;GCLC
9501,GO:0036166,0.28642185786743,0.968475416399366,1,3,phenotypic switching,BP,OLFM2
17431,GO:1900239,0.28642185786743,0.968475416399366,1,3,regulation of phenotypic switching,BP,OLFM2
96,GO:0000187,0.286575057388046,0.807459972898155,13,103,activation of MAPK activity,BP,CSPG4;ADORA2B;MAPK8IP3;C5;MAP2K5;INSR;MAP2K2;MAPK10;ERCC6;SHC2;MAP3K6;DAB2IP;ERN1
995,GO:0002457,0.286594075330174,0.968434422108585,1,3,T cell antigen processing and presentation,BP,HFE
11445,GO:0045916,0.286699695216754,0.968409265231823,1,3,negative regulation of complement activation,BP,SERPING1
19789,GO:2000258,0.286699695216754,0.968409265231823,1,3,negative regulation of protein activation cascade,BP,SERPING1
7564,GO:0031933,0.286704534047335,0.968408112424551,1,3,telomeric heterochromatin,CC,ATRX
841,GO:0002155,0.286786392336039,0.968388606723653,1,3,regulation of thyroid hormone mediated signaling pathway,BP,THRA
1202,GO:0002862,0.287206095395992,0.964654521836094,1,4,negative regulation of inflammatory response to antigenic stimulus,BP,IL20RB
4528,GO:0010596,0.28723506540502,0.856902096896397,5,33,negative regulation of endothelial cell migration,BP,APOE;MAP2K5;MMRN2;DAB2IP;PPARG
8033,GO:0032691,0.287351902538275,0.918012182428338,2,11,negative regulation of interleukin-1 beta production,BP,TNFAIP3;ACP5
4444,GO:0010360,0.287590071485833,0.968196728816287,1,3,negative regulation of anion channel activity,BP,ANO9
19524,GO:1990460,0.287618057500374,0.968190034991318,1,3,leptin receptor binding,MF,SNX1
264,GO:0000732,0.287684953654981,0.87073733553942,4,25,strand displacement,BP,RMI2;WRN;PALB2;RAD50
13,GO:0000026,0.287722152149865,0.968165129949624,1,3,alpha-1,2-mannosyltransferase activity,MF,PIGZ
12748,GO:0051043,0.287818138406334,0.889634907382012,3,18,regulation of membrane protein ectodomain proteolysis,BP,APOE;PTPN3;SNX33
14703,GO:0070375,0.287823465283288,0.968140879497015,1,3,ERK5 cascade,BP,MAP2K5
10100,GO:0042632,0.287881102385427,0.855958235468317,5,35,cholesterol homeostasis,BP,APOE;MALL;VDR;ABCA2;LDLRAP1
13499,GO:0055092,0.287881102385427,0.855958235468317,5,35,sterol homeostasis,BP,APOE;MALL;VDR;ABCA2;LDLRAP1
806,GO:0002080,0.287979983119629,0.918816251891942,2,10,acrosomal membrane,CC,SUN1;CCDC136
3481,GO:0007342,0.287994359577994,0.964445443796308,1,4,fusion of sperm to egg plasma membrane involved in single fertilization,BP,CD9
13565,GO:0060054,0.28802057212523,0.968093668914644,1,3,positive regulation of epithelial cell proliferation involved in wound healing,BP,FZD7
8669,GO:0034271,0.288031525044888,0.968091044302178,1,3,phosphatidylinositol 3-kinase complex, class III, type I,CC,PIK3C3
8670,GO:0034272,0.288031525044888,0.968091044302178,1,3,phosphatidylinositol 3-kinase complex, class III, type II,CC,PIK3C3
12232,GO:0048523,0.28806335449366,0.7343616834368,348,3279,negative regulation of cellular process,BP,TNFAIP3;TGFBI;POSTN;HES2;SERPINE2;ULK2;GPNMB;SIK1;EPM2A;TP53INP1;IFI6;PTHLH;SREBF1;APOE;INPP5D;APCDD1;HSPA2;EGFR;ESPN;PTPRS;CIRBP;PKD2;CAPRIN2;MNT;XPC;APOBEC3C;DIXDC1;TRIM22;SFRP1;KCTD11;EPHB2;MAP3K14;DGKQ;PIK3R1;ADAMTS7;EVI5L;BRSK1;RBCK1;KDM3A;CXCL14;TSC22D3;SULF2;WNT3;UNK;HR;ISG15;ELFN2;HTRA1;TFCP2L1;RGMA;ZFPM1;KITLG;TP53I11;VAMP3;IRF2BPL;STAT1;IMPACT;CAMK2N1;CRY2;UNC5B;NOS1;PRKACB;CRY1;SCMH1;KLF13;CRTAP;MAGEF1;NFATC4;FERMT1;CYP26B1;HSF4;PLXNB1;SPEG;NDRG1;COL7A1;SPOCK1;ITPR3;EAPP;MDM2;LZTS2;NDN;IFITM1;PIK3IP1;TNFSF10;RAPGEF3;PHACTR3;TCF25;PCBP4;CTSV;FLRT3;RASA4;KIF26A;RGS2;ARPIN;IL20RB;F2R;PDCD4;CGREF1;SPTB;SERPINB5;SLC24A1;RTN4RL1;ZFP36L2;TRPV4;GLI2;TOM1L2;ANK3;LAMP3;CLMN;PIDD1;SLX1A;SLX1B;GJC2;ZCCHC11;RHBDF1;PER2;UNC119;C5;ZNF658;SNTA1;PHF2;GSTM2;TCEAL1;AMIGO2;WWTR1;SEMA4G;ULK1;GLI3;FHOD3;THRAP3;BHLHE40;LRSAM1;ZNF655;NAIP;LTBP1;MAP2K5;GAS8;ITGA6;SRGAP3;SESN3;ZNF318;LZTS1;IGFBP4;TCFL5;JARID2;NUPR1;NISCH;INSR;CCDC85B;MMP28;GSN;CBLC;DDT;PLXNB3;PLEKHH2;TRIOBP;MXD4;CD109;ETAA1;DOCK8;DHX58;SLC27A1;TM7SF3;RTF1;MDK;H2AFJ;BMP6;NLRX1;MAP2K2;SQSTM1;CEP192;PTK6;FZD7;SYNGAP1;KDM4C;HYAL1;ARRDC1;ZNF608;WHAMMP3;PLA2G6;CST3;MMRN2;TXNIP;NPHP3;IDH2;MAP3K12;RCOR2;PODXL;IFI27;DNM1;TNFRSF21;IQCB1;MCTP1;CDK5R1;ATRX;EFNB3;SESN1;SHANK3;HFE;HMG20B;CYBA;AGO4;HADH;RRM2B;SLIT3;SPRY2;FBXO2;GABBR1;CREBRF;XRN1;RAB11FIP3;MLXIPL;FBXW7;GPR87;ING4;CDK5RAP3;ATXN1;NFIX;TFPI2;MXI1;THRA;APC2;ARAP1;ADARB1;ELF1;IKZF4;RPH3AL;ACACB;NLRP1;TNS2;NAB2;TP53I13;CAPG;LRP1;PEG3;NPHP4;RGS12;ACP5;C12ORF66;DLK2;BRINP1;SALL2;WNK1;JPH2;ZBTB20;PDE2A;MAF;LTB4R2;RET;ZMYND8;DAB2IP;TEAD2;FBXO4;RNF213;TSHZ2;IFI16;FGFR4;ERCC5;PIK3R2;AREG;SNCB;RPS6KA5;DLG5;BTG1;BST2;VDR;RGL2;TNRC18;TNRC6C;PLXND1;SIX5;PPP1R2;DMTN;PPP1R35;LMTK3;WWC3;PHF1;TFDP2;PMP22;NRARP;ACVR1B;KREMEN1;DLG4;PPP2R3B;PANO1;PALB2;IGFBP6;ZNF91;DYDC1;TCF7;SHANK2;RSAD2;ZFP36L1;LMNA;IL11;KAT2B;IRS2;ERN1;IVNS1ABP;ALOX15B;RAD50;GPR21;TKFC;ANGEL2;APBB2;PBLD;STAT6;PCSK1N;PRDX5;PHPT1;NELFCD;GPR132;SMPDL3B;KIF7;KLF8;CD9;RANBP9;PTPN3;ERBB2;SPOCD1;GPR68;AKAP6;ATG14;RORA;PPARG;PRKACA;CXXC5;ACKR3;SERPING1;PARN;UFL1;IP6K2;KLF9;PRMT3;SNX33;ZFP90;CCDC3;PER3;FOXP2;PTBP2;ZC3H6;HIVEP1;SMURF1;EML2;CTNNBIP1;PEMT;GCLC;ECM1
9962,GO:0042363,0.288149756777436,0.96806270481275,1,3,fat-soluble vitamin catabolic process,BP,CYP26B1
10,GO:0000019,0.288204244298495,0.968049639524048,1,3,regulation of mitotic recombination,BP,RAD50
14709,GO:0070384,0.28827117315288,0.968033586730618,1,3,Harderian gland development,BP,ALDH1A3
11282,GO:0045616,0.288318818833663,0.85590128403293,5,34,regulation of keratinocyte differentiation,BP,CTSV;CD109;VDR;ZFP36L1;ALOX15B
12570,GO:0050766,0.288345393156609,0.869940148962699,4,26,positive regulation of phagocytosis,BP,ITGA2;CYBA;TUB;PPARG
5599,GO:0016641,0.288514867045458,0.918562066992539,2,10,oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor,MF,LOXL1;PNPO
16618,GO:0097500,0.288552550509357,0.967966047370601,1,3,receptor localization to non-motile cilium,BP,TUB
2804,GO:0006264,0.288630064465061,0.918507275293586,2,10,mitochondrial DNA replication,BP,RRM2B;PRIMPOL
13642,GO:0060180,0.289229981785178,0.96780310189542,1,3,female mating behavior,BP,THRA
8583,GO:0034097,0.289631808574,0.749725421704454,86,809,response to cytokine,BP,TNFAIP3;POSTN;IFI6;INPP5D;OAS2;CXCR1;TRIM22;SFRP1;MTHFR;MAP3K14;PIK3R1;ADAMTS7;RBCK1;KDM3A;ISG15;VAMP3;STAT1;RAB43;NDN;IFITM1;HLA-B;OAS1;FLRT3;IL20RB;MT1X;PDCD4;RTN4RL1;ZFP36L2;ADAMTS13;LAMP3;TNFRSF14;SPPL2B;MAP2K5;MMP1;JARID2;GSN;DOCK8;ENDOG;SLC27A1;IRF9;SQSTM1;SHARPIN;HYAL1;BBS2;CTF1;IFI27;TNFRSF21;CYBA;TRIM38;SLIT3;EDA2R;SPRY2;CREBRF;ELF1;MX2;HLA-A;ACP5;RFX2;PDE2A;DAB2IP;IL20RA;RPS6KA5;BST2;STAT2;DUOX1;TCF7;RSAD2;TNFRSF25;ZFP36L1;ACSL1;IL11;IRS2;TNFSF12;STAT6;SYNGR1;AKAP6;RORA;PPARG;PRKACA;ACKR3;IP6K2;AIP;CCDC3;NPNT;GCLC;ECM1
8311,GO:0033159,0.289813917952781,0.967662258369755,1,3,negative regulation of protein import into nucleus, translocation,BP,PDE2A
10830,GO:0044339,0.29003211192902,0.967609538680478,1,3,canonical Wnt signaling pathway involved in osteoblast differentiation,BP,WNT3
13053,GO:0051581,0.290063499174763,0.967601950822852,1,3,negative regulation of neurotransmitter uptake,BP,NOS1
18924,GO:1904706,0.290267146016258,0.916608121881554,2,11,negative regulation of vascular smooth muscle cell proliferation,BP,PDCD4;PPARG
10462,GO:0043369,0.290365315986043,0.91767986703913,2,10,CD4-positive or CD8-positive, alpha-beta T cell lineage commitment,BP,ZFPM1;STAT6
3382,GO:0007160,0.29049969124366,0.789276431170322,19,149,cell-matrix adhesion,BP,POSTN;ITGB6;SFRP1;PIK3R1;ITGB5;BCAM;FERMT1;NINJ1;ADAMTS13;MINK1;THBS3;ITGA2;ITGA6;TMEM8B;NID1;DMTN;COL13A1;ECM2;NPNT
5344,GO:0016094,0.290568113319994,0.967479818174792,1,3,polyprenol biosynthetic process,BP,SRD5A3
6062,GO:0019213,0.290600827432048,0.834632036150087,7,51,deacetylase activity,MF,CES2;CHD3;MACROD1;OARD1;HMG20B;NDST2;HDAC11
4605,GO:0010724,0.290751070951904,0.967435470393873,1,3,regulation of definitive erythrocyte differentiation,BP,ZFPM1
11256,GO:0045578,0.290794253504679,0.967424998071077,1,3,negative regulation of B cell differentiation,BP,SFRP1
10752,GO:0044212,0.290808516944293,0.752670965709442,70,609,transcription regulatory region DNA binding,MF,HES2;SREBF1;MNT;ASH2L;KDM3A;HR;TFCP2L1;ZFPM1;STAT1;CRY2;ZNF704;CRY1;KLF13;NFATC4;HSF4;NDN;GLI2;KLF7;SOX12;PER2;ZNF658;GLI3;THRAP3;BHLHE40;TCFL5;JARID2;IRF9;ETV5;TCF4;PLAG1;RCOR2;MEF2D;CREBRF;MLXIPL;LMO2;CARF;MXI1;THRA;RAI1;ELF1;IKZF4;DBP;RFX2;SALL2;ZNF532;ZMYND8;CALCOCO1;TEAD2;IFI16;TEF;VDR;TNRC18;SIX5;HLTF;TFDP2;TCF7;GLMP;KAT2B;IVNS1ABP;TRERF1;STAT6;SOX13;PRDX5;KLF8;RORA;PPARG;PER3;FOXP2;ZC3H6;HIVEP1
16090,GO:0090092,0.290820078330153,0.793035883560657,17,137,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,BP,SFRP1;HTRA1;FERMT1;LTBP4;NEO1;RNF165;WWTR1;LTBP1;CD109;BMP6;GDF15;HFE;PCSK6;ACVR1B;PBLD;SMURF1;NPNT
15704,GO:0072298,0.290888655933124,0.967402097429563,1,3,regulation of metanephric glomerulus development,BP,RET
16409,GO:0097068,0.290953231995141,0.967386426817375,1,3,response to thyroxine,BP,GCLC
18797,GO:1904386,0.290953231995141,0.967386426817375,1,3,response to L-phenylalanine derivative,BP,GCLC
19884,GO:2000401,0.291008828689186,0.867874282752281,4,27,regulation of lymphocyte migration,BP,CXCL14;DOCK8;RIPK3;ECM1
13012,GO:0051482,0.291061454481806,0.916223653430827,2,11,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway,BP,F2R;LPAR6
4883,GO:0014805,0.291198391835106,0.963588270501959,1,4,smooth muscle adaptation,BP,CYBA
19046,GO:1904948,0.291306437066665,0.917229497852661,2,10,midbrain dopaminergic neuron differentiation,BP,SFRP1;WNT3
293,GO:0000798,0.29131734283424,0.967297986119928,1,3,nuclear cohesin complex,CC,REC8
14750,GO:0070470,0.291376620349291,0.963540242331244,1,4,plasma membrane respiratory chain,CC,SDHA
9391,GO:0035948,0.291547830039051,0.96724192967629,1,3,positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter,BP,KAT2B
16976,GO:0099081,0.291649789905064,0.752194310561283,69,597,supramolecular polymer,CC,MAP6;ESPN;FLNC;PKD2;OBSL1;KIF26B;SYNC;KCNAB2;REEP2;MYL9;KRT15;NOS1;FERMT1;NDRG1;LZTS2;OBSCN;MYH11;PARVB;TNXB;KIF26A;DNAH1;TUBGCP5;TRPV4;ANK3;WIPF1;NINL;FAM110C;FHOD3;TPGS1;LTBP1;GAS8;BAIAP2;TTN;AHNAK2;CASP14;MAP2K2;SQSTM1;CST3;THSD4;COL6A1;DNM1;CDK5R1;HOOK2;CLIP2;KRT14;SPRY2;CDK5RAP3;APC2;SLC2A1;REEP4;SYNPO2;JPH2;SHROOM2;EML3;DMTN;ARFGEF2;SHROOM4;TNNI2;SHANK2;LMNA;KAT2B;KIF7;LDLRAP1;VMAC;SYNE2;MAP1A;NPNT;TTLL1;EML2
10828,GO:0044336,0.291746172657931,0.96719364620163,1,3,canonical Wnt signaling pathway involved in negative regulation of apoptotic process,BP,TCF7
12088,GO:0048144,0.291801855196362,0.826252026441305,8,62,fibroblast proliferation,BP,TP53INP1;EGFR;SFRP1;NUPR1;DAB2IP;FBXO4;S100A6;PPARG
11318,GO:0045658,0.291893846903686,0.967157670202858,1,3,regulation of neutrophil differentiation,BP,INPP5D
17681,GO:1901607,0.291977415971254,0.833331300784641,7,53,alpha-amino acid biosynthetic process,BP,GAMT;GLUD1;THNSL2;GLUL;SRR;MTR;SERINC3
8266,GO:0033080,0.292132440955594,0.967099495916696,1,3,immature T cell proliferation in thymus,BP,ERBB2
18337,GO:1903348,0.292253863485379,0.967069867447185,1,3,positive regulation of bicellular tight junction assembly,BP,NPHP4
10193,GO:0042822,0.292379922478151,0.967039091149289,1,3,pyridoxal phosphate metabolic process,BP,PNPO
3116,GO:0006694,0.292477365490155,0.796372172338268,15,126,steroid biosynthetic process,BP,SREBF1;AMACR;APOE;SEC14L2;DGKQ;TFCP2L1;MVD;SRD5A3;BMP6;ACACB;FGFR4;VDR;OSBPL1A;HSD17B14;TRERF1
7880,GO:0032455,0.292515389131683,0.967005999327841,1,3,nerve growth factor processing,BP,PCSK6
5511,GO:0016471,0.292574974022497,0.915488802406714,2,11,vacuolar proton-transporting V-type ATPase complex,CC,TCIRG1;ATP6V0A2
9313,GO:0035799,0.292610811655497,0.966982677851336,1,3,ureter maturation,BP,RET
12624,GO:0050848,0.29281170238111,0.841690018426971,6,43,regulation of calcium-mediated signaling,BP,PKD2;NOS1;GSTM2;JPH2;AKAP6;PRKACA
13766,GO:0060374,0.293025016810517,0.966881333593345,1,3,mast cell differentiation,BP,ZFPM1
11867,GO:0046898,0.29306088451496,0.966872549245605,1,3,response to cycloheximide,BP,XRN1
10191,GO:0042819,0.293090800478993,0.966865221495561,1,3,vitamin B6 biosynthetic process,BP,PNPO
3588,GO:0008009,0.293347919063743,0.913399447951219,2,13,chemokine activity,MF,CXCL14;C5
19521,GO:1990454,0.293514355311599,0.96676137243954,1,3,L-type voltage-gated calcium channel complex,CC,CACNB3
5958,GO:0018345,0.29358641269506,0.866199192676113,4,27,protein palmitoylation,BP,ZDHHC1;ZDHHC12;GOLGA7B;ZDHHC24
5002,GO:0015149,0.293608621490463,0.916122989587956,2,10,hexose transmembrane transporter activity,MF,SLC2A3;SLC2A1
122,GO:0000253,0.293626775556864,0.962930727422804,1,4,3-keto sterol reductase activity,MF,DHRS4
6826,GO:0030295,0.293628475909077,0.832239547289219,7,52,protein kinase activator activity,MF,DGKQ;ETAA1;MAP2K2;CDK5R1;ERCC6;SPRY2;WNK1
4964,GO:0015074,0.293635427634833,0.916110065415674,2,10,DNA integration,BP,NYNRIN;ZNF91
10562,GO:0043539,0.293755440448791,0.866089082884316,4,27,protein serine/threonine kinase activator activity,MF,ETAA1;MAP2K2;CDK5R1;SPRY2
7140,GO:0030997,0.293777871192657,0.966696666590819,1,3,regulation of centriole-centriole cohesion,BP,CEP250
1181,GO:0002828,0.2938950942869,0.885522828863937,3,19,regulation of type 2 immune response,BP,RSAD2;STAT6;ECM1
15502,GO:0071907,0.293918326648532,0.966662147952261,1,3,determination of digestive tract left/right asymmetry,BP,NPHP3
16603,GO:0097475,0.294504477829204,0.966517868422355,1,3,motor neuron migration,BP,NHSL1
2017,GO:0004748,0.294558129034241,0.966504644120304,1,3,ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor,MF,RRM2B
2637,GO:0005971,0.294558129034241,0.966504644120304,1,3,ribonucleoside-diphosphate reductase complex,CC,RRM2B
5640,GO:0016728,0.294558129034241,0.966504644120304,1,3,oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor,MF,RRM2B
14404,GO:0061731,0.294558129034241,0.966504644120304,1,3,ribonucleoside-diphosphate reductase activity,MF,RRM2B
14078,GO:0060935,0.294774219426148,0.96645134981241,1,3,cardiac fibroblast cell differentiation,BP,PDCD4
14079,GO:0060936,0.294774219426148,0.96645134981241,1,3,cardiac fibroblast cell development,BP,PDCD4
14080,GO:0060938,0.294774219426148,0.96645134981241,1,3,epicardium-derived cardiac fibroblast cell differentiation,BP,PDCD4
14081,GO:0060939,0.294774219426148,0.96645134981241,1,3,epicardium-derived cardiac fibroblast cell development,BP,PDCD4
2389,GO:0005527,0.29479869231413,0.91346390679759,2,12,macrolide binding,MF,FKBP5;FKBP9
2390,GO:0005528,0.29479869231413,0.91346390679759,2,12,FK506 binding,MF,FKBP5;FKBP9
2243,GO:0005154,0.294909558710875,0.865688202296111,4,26,epidermal growth factor receptor binding,MF,VAV3;CBLC;AREG;SNX1
10832,GO:0044341,0.295005838941279,0.966394170524347,1,3,sodium-dependent phosphate transport,BP,CRY2
10911,GO:0044539,0.295063056521335,0.966380036599782,1,3,long-chain fatty acid import,BP,ACSL1
18441,GO:1903556,0.295150818050095,0.864854068859889,4,28,negative regulation of tumor necrosis factor superfamily cytokine production,BP,TNFAIP3;GPNMB;MC1R;ACP5
11119,GO:0045177,0.295213797438362,0.774205969719546,26,215,apical part of cell,CC,EGFR;CSPG4;VAMP3;SLC29A4;ITPR3;CTSV;TRPV4;SCNN1A;TCIRG1;HOMER2;PODXL;CA2;HFE;CYBA;KCNMA1;SLC2A1;SRR;SHROOM2;BST2;CACNB3;SHROOM4;DUOX1;SHANK2;ANO1;CD9;ERBB2
12584,GO:0050780,0.295355522893824,0.915278810417893,2,10,dopamine receptor binding,MF,DNM1;DLG4
1963,GO:0004674,0.295398895633547,0.756887546883489,48,396,protein serine/threonine kinase activity,MF,ULK2;SIK1;EGFR;FAM20C;EPHB2;MAP3K14;BRSK1;CAMKK1;PRKACB;CDK18;SPEG;LTBP4;OBSCN;ALPK1;NEK9;PSKH1;MINK1;ULK1;LTBP1;NEK8;MAP2K5;INSR;CDK14;TTN;MAP2K2;SQSTM1;PDIK1L;MAP3K12;MAPK10;PAK6;MAP3K6;MYO3B;WNK1;STK16;RET;FGFR4;RPS6KA5;STK19;LMTK3;ACVR1B;TSSK1B;ADCK5;MARK4;ERN1;ERBB2;PRKACA;RIPK3;CIT
14615,GO:0070208,0.295450779083352,0.915232665286354,2,10,protein heterotrimerization,BP,C1QTNF6;COL6A1
19821,GO:2000312,0.295696364656238,0.966223364093,1,3,regulation of kainate selective glutamate receptor activity,BP,KLHL24
4699,GO:0010862,0.295802473342817,0.865106028809218,4,26,positive regulation of pathway-restricted SMAD protein phosphorylation,BP,BMP6;GDF15;HFE;ACVR1B
12501,GO:0050661,0.295833360521121,0.850235198268869,5,36,NADP binding,MF,MTHFR;H6PD;NOS1;DUOX1;CBR4
3309,GO:0007010,0.295893568917246,0.739605903617778,112,980,cytoskeleton organization,BP,MAP6;APOE;ESPN;PKD2;DIXDC1;SFRP1;OBSL1;EPS8L2;PIK3R1;BRSK1;CUL9;PI4KAP2;CUL7;ASAP3;OR2A4;KRT15;ITGB5;IQSEC2;PLXNB1;OBSCN;GOLGA8A;MYH11;PARVB;TNXB;RHOBTB2;RAPGEF3;CTSV;RGS2;ARPIN;PPL;SPTB;DNAH1;TUBGCP5;TRPV4;CORO6;ANK3;GOLGA8B;ARHGEF19;WIPF1;MINK1;NINL;FHOD3;TPGS1;NAIP;GAS8;NISCH;CELSR1;GSN;CEP68;CHD3;BAIAP2;TTN;CEP126;SUN1;PLEKHH2;TRIOBP;SEPT6;RICTOR;MICALL2;CEP192;EPB41L3;WHAMMP3;BBS2;SEPT5;KLHL24;CDK5R1;ATRX;PI4KAP1;HOOK2;EPB41L4A;SHANK3;KRT14;SPRY2;WASH3P;PAK6;CHMP1B;APC2;ARAP1;GOLGA8N;FMNL2;FBXW5;CAPG;LRP1;NPHP4;SYNPO2;SHROOM2;BST2;ARHGEF17;EFS;ZMYM3;EML3;DMTN;ALMS1;SHROOM4;TACC1;CCDC88B;IQSEC1;WEE1;PTK7;LMNA;KAT2B;MARK4;CEP250;PHPT1;RANBP9;SSH3;FMNL3;SYNE2;CIT;MAP1A;TTLL1;EML2
9859,GO:0042130,0.295931322316419,0.850402109849738,5,35,negative regulation of T cell proliferation,BP,GPNMB;IL20RB;TNFRSF21;DLG5;ERBB2
3927,GO:0008610,0.295951886440785,0.752160102059799,57,512,lipid biosynthetic process,BP,SIK1;SREBF1;AMACR;APOE;INPP5D;ALDH1A3;SEC14L2;DGKQ;PIK3R1;TFCP2L1;MVD;SRD5A3;KDSR;PITPNM3;THNSL2;PIK3C2G;ST6GALNAC6;CERS4;GAL3ST4;B4GALT6;MLYCD;PITPNM2;PTGS1;MBOAT2;ST3GAL5;SLC27A1;PGAP1;BMP6;ETNK2;HEXB;PLA2G6;PEX7;LPIN3;PIGZ;MLXIPL;FBXW7;ACACB;DDHD2;PIK3C3;FGFR4;PIK3R2;VDR;MPPE1;OSBPL1A;ALOXE3;ACSL1;IRS2;HSD17B14;ALOX15B;TRERF1;CBR4;ISYNA1;CERS5;ACSS2;PI4K2B;CCDC3;PEMT
186,GO:0000404,0.295994206258629,0.966149534389802,1,3,heteroduplex DNA loop binding,MF,XPC
11323,GO:0045663,0.296025882690524,0.914953818039002,2,10,positive regulation of myoblast differentiation,BP,BOC;BTG1
395,GO:0001067,0.296431158320451,0.74746758947559,70,610,regulatory region nucleic acid binding,MF,HES2;SREBF1;MNT;ASH2L;KDM3A;HR;TFCP2L1;ZFPM1;STAT1;CRY2;ZNF704;CRY1;KLF13;NFATC4;HSF4;NDN;GLI2;KLF7;SOX12;PER2;ZNF658;GLI3;THRAP3;BHLHE40;TCFL5;JARID2;IRF9;ETV5;TCF4;PLAG1;RCOR2;MEF2D;CREBRF;MLXIPL;LMO2;CARF;MXI1;THRA;RAI1;ELF1;IKZF4;DBP;RFX2;SALL2;ZNF532;ZMYND8;CALCOCO1;TEAD2;IFI16;TEF;VDR;TNRC18;SIX5;HLTF;TFDP2;TCF7;GLMP;KAT2B;IVNS1ABP;TRERF1;STAT6;SOX13;PRDX5;KLF8;RORA;PPARG;PER3;FOXP2;ZC3H6;HIVEP1
6676,GO:0030047,0.296461934268887,0.966033402323655,1,3,actin modification,BP,TRIOBP
7898,GO:0032479,0.296886117234994,0.79882556862631,13,107,regulation of type I interferon production,BP,TNFAIP3;PTPRS;RNF135;HERC5;ISG15;STAT1;FLOT1;DHX58;NLRX1;TREX1;ZBTB20;IFI16;STAT6
9654,GO:0038024,0.297095294298009,0.838783843212275,6,42,cargo receptor activity,MF,SCARA3;SCART1;LRP1;ENDOU;LDLRAP1;ACKR3
14823,GO:0070588,0.297330835580464,0.783296567800646,19,154,calcium ion transmembrane transport,BP,HSPA2;PKD2;ORAI3;NOS1;ITPR3;F2R;SLC24A1;TRPV4;GJC2;GSTM2;PLA2G6;CYBA;JPH2;PDE2A;CACNB3;ORAI2;CACNB1;AKAP6;PRKACA
4716,GO:0010881,0.297353603698557,0.913149154579931,2,11,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion,BP,GSTM2;PRKACA
6675,GO:0030046,0.297464443577861,0.965783704508482,1,3,parallel actin filament bundle assembly,BP,ESPN
11661,GO:0046460,0.297495173065388,0.863999914300495,4,26,neutral lipid biosynthetic process,BP,SIK1;SREBF1;LPIN3;FBXW7
11664,GO:0046463,0.297495173065388,0.863999914300495,4,26,acylglycerol biosynthetic process,BP,SIK1;SREBF1;LPIN3;FBXW7
19554,GO:1990604,0.297608697181216,0.965747686659297,1,3,IRE1-TRAF2-ASK1 complex,CC,ERN1
8155,GO:0032898,0.297718980019233,0.965720135796172,1,3,neurotrophin production,BP,PCSK6
1024,GO:0002526,0.297808825537177,0.82871658909805,7,55,acute inflammatory response,BP,IL20RB;C5;NUPR1;HFE;PPARG;SERPING1;CTNNBIP1
16128,GO:0090162,0.297816687133482,0.86417649613909,4,25,establishment of epithelial cell polarity,BP,FERMT1;FRMD4B;MYO9A;PTK7
8612,GO:0034140,0.297849675873879,0.96568746854285,1,3,negative regulation of toll-like receptor 3 signaling pathway,BP,TNFAIP3
9097,GO:0035384,0.297879174968578,0.838024610383109,6,43,thioester biosynthetic process,BP,MLYCD;PDK1;ACACB;ACSL1;CBR4;ACSS2
15353,GO:0071616,0.297879174968578,0.838024610383109,6,43,acyl-CoA biosynthetic process,BP,MLYCD;PDK1;ACACB;ACSL1;CBR4;ACSS2
4343,GO:0009897,0.297933550226485,0.798068350212951,13,105,external side of plasma membrane,CC,ITGB6;SERPINE2;BCAM;CTSV;RTN4RL1;ITGA2;ITGA6;KCNJ5;INSR;HFE;SCART1;ERMAP;CD9
7868,GO:0032437,0.298123653699217,0.965618928960479,1,3,cuticular plate,CC,TRIOBP
2634,GO:0005967,0.298393608298314,0.965551317418802,1,3,mitochondrial pyruvate dehydrogenase complex,CC,PDK1
11134,GO:0045198,0.298422876308782,0.913787002273369,2,10,establishment of epithelial cell apical/basal polarity,BP,MYO9A;PTK7
6209,GO:0019731,0.29843310680073,0.908648747582627,2,17,antibacterial humoral response,BP,PLA2G6;KLK5
3902,GO:0008544,0.298500932681271,0.766570691281779,30,267,epidermis development,BP,PTHLH;APCDD1;EGFR;SLITRK6;POU3F1;KRT15;FERMT1;CYP26B1;COL7A1;CTSV;PPL;PRR9;INSR;CELSR1;TRIOBP;CD109;CASP14;SHARPIN;TXNIP;KRT14;EDA2R;KLK5;NAB2;MYSM1;VDR;PCSK6;ACVR1B;ZFP36L1;ALOX15B;GJB5
16915,GO:0098915,0.298564262694433,0.965508535952825,1,3,membrane repolarization during ventricular cardiac muscle cell action potential,BP,KCNJ5
1055,GO:0002583,0.2986197396057,0.961557284227446,1,4,regulation of antigen processing and presentation of peptide antigen,BP,HFE
5481,GO:0016417,0.298700054474089,0.862853641606946,4,27,S-acyltransferase activity,MF,ZDHHC1;ZDHHC12;GOLGA7B;ZDHHC24
6734,GO:0030158,0.298716176085829,0.96547042648732,1,3,protein xylosyltransferase activity,MF,XYLT1
18424,GO:1903531,0.298840456124017,0.800802699397845,12,98,negative regulation of secretion by cell,BP,SREBF1;SFRP1;VAMP3;CRY1;F2R;RHBDF1;IDH2;TNFRSF21;HADH;RAB11FIP3;RSAD2;IL11
16823,GO:0098751,0.298979901652225,0.863415782581815,4,25,bone cell development,BP,FAM20C;ZFPM1;FBXW7;GPR68
14678,GO:0070325,0.299035915828654,0.88303549474498,3,18,lipoprotein particle receptor binding,MF,APOE;LRP1;LDLRAP1
6186,GO:0019637,0.299136414281443,0.74005619829172,90,845,organophosphate metabolic process,BP,PTHLH;APOE;NT5E;INPP5D;EGFR;FAM20C;PKD2;PLCD3;DGKQ;PIK3R1;H6PD;DHTKD1;VAV3;PI4KAP2;KCNAB2;KITLG;MVD;NAPRT;SRD5A3;NOS1;PITPNM3;CMPK2;PIK3C2G;PLCD1;NMRK1;PIK3IP1;RAPGEF3;ADORA2B;PLCH2;G6PC3;SULT1E1;PITPNM2;ABHD14B;MBOAT2;INSR;PGLS;SLC27A1;PGAP1;ETNK2;TCIRG1;HEXB;PLA2G6;ATP6V0A2;NPHP3;IDH2;LPIN3;PIGZ;OSBPL10;PI4KAP1;RRM2B;GABBR1;MLXIPL;GPR87;PGM1;PFKFB2;OGDHL;TK2;PLA2G7;PPCS;PDE2A;SDHA;LTB4R2;DAB2IP;DDHD2;PIK3C3;FGFR4;PIK3R2;OSBPL5;NADK;MPPE1;NDUFV3;DLG4;MPI;IRS2;IMPA2;RAD50;TKFC;PNPO;ISYNA1;SMPDL3B;ERBB2;PLCB3;NUDT10;ATG14;RORA;UCKL1;IP6K2;PI4K2B;PEMT;SERINC3
7046,GO:0030832,0.299274562878561,0.788178401076071,16,132,regulation of actin filament length,BP,EPS8L2;ARPIN;SPTB;WIPF1;FHOD3;GSN;BAIAP2;PLEKHH2;TRIOBP;RICTOR;WHAMMP3;WASH3P;CAPG;DMTN;SSH3;CIT
5449,GO:0016323,0.29935947458954,0.788390673890626,16,125,basolateral plasma membrane,CC,EGFR;PKD2;FLOT1;ANK3;NAIP;ITGA6;CLCA2;OSCP1;CA2;SLC2A1;LRP1;CA11;SHROOM4;DLG4;ERBB2;LDLRAP1
12382,GO:0048840,0.299546299905793,0.965261742945902,1,3,otolith development,BP,LRIG3
7142,GO:0031005,0.299548565815536,0.913236474036388,2,10,filamin binding,MF,MICALL2;SYNPO2
15485,GO:0071879,0.29958977729246,0.965250792901258,1,3,positive regulation of adenylate cyclase-activating adrenergic receptor signaling pathway,BP,NOS1
14541,GO:0070091,0.299633484115412,0.965239783030679,1,3,glucagon secretion,BP,SYT7
14542,GO:0070092,0.299633484115412,0.965239783030679,1,3,regulation of glucagon secretion,BP,SYT7
1275,GO:0003071,0.299759851901513,0.911959809144966,2,11,renal system process involved in regulation of systemic arterial blood pressure,BP,F2R;CYBA
5754,GO:0016917,0.299851641477562,0.965184797978898,1,3,GABA receptor activity,MF,GABBR1
8855,GO:0034666,0.299928811949418,0.96516533548416,1,3,integrin alpha2-beta1 complex,CC,ITGA2
7291,GO:0031297,0.300053801797885,0.86232176886316,4,26,replication fork processing,BP,ETAA1;WRN;ATRX;PRIMPOL
703,GO:0001927,0.30015768279396,0.965107576411148,1,3,exocyst assembly,BP,EXOC2
7075,GO:0030877,0.300286886858267,0.912874501987548,2,10,beta-catenin destruction complex,CC,APC2;CTNNBIP1
11850,GO:0046870,0.300316606213145,0.965067436601514,1,3,cadmium ion binding,MF,NOS1
2100,GO:0004869,0.300380151553322,0.861110152275531,4,29,cysteine-type endopeptidase inhibitor activity,MF,SPOCK1;NAIP;CST3;PRDX5
8010,GO:0032651,0.300422264587849,0.84703383781804,5,36,regulation of interleukin-1 beta production,BP,TNFAIP3;F2R;NLRP1;ACP5;IFI16
1231,GO:0002920,0.300518158593344,0.881580134842814,3,19,regulation of humoral immune response,BP,C5;KLK5;SERPING1
13825,GO:0060448,0.300686255225101,0.964973968326735,1,3,dichotomous subdivision of terminal units involved in lung branching,BP,CELSR1
12495,GO:0050655,0.300688796376076,0.912677163930413,2,10,dermatan sulfate proteoglycan metabolic process,BP,CSPG4;IDUA
15222,GO:0071402,0.300709666167492,0.882037653566293,3,18,cellular response to lipoprotein particle stimulus,BP,APOE;CD9;PPARG
7845,GO:0032413,0.300847769565653,0.846974987474905,5,35,negative regulation of ion transmembrane transporter activity,BP,PKD2;EPHB2;ANK3;GSTM2;ANO9
16850,GO:0098801,0.300867804759272,0.911409644337342,2,11,regulation of renal system process,BP,F2R;CYBA
14104,GO:0060992,0.301057991884863,0.912495704318692,2,10,response to fungicide,BP,IMPACT;XRN1
16583,GO:0097435,0.301156737366986,0.748335772205929,55,468,supramolecular fiber organization,BP,APOE;ESPN;SFRP1;OBSL1;EPS8L2;PIK3R1;ASAP3;ITGB5;MDM2;OBSCN;MYH11;TNXB;RHOBTB2;RAPGEF3;RGS2;ARPIN;SPTB;TUBGCP5;TRPV4;WIPF1;FHOD3;GSN;BAIAP2;TTN;CEP126;PLEKHH2;TRIOBP;RICTOR;MICALL2;CEP192;LOXL1;WHAMMP3;CST3;KLHL24;CDK5R1;HOOK2;SHANK3;KRT14;WASH3P;APC2;ARAP1;CAPG;SYNPO2;SHROOM2;EFS;DMTN;ALMS1;SHROOM4;CCDC88B;RANBP9;SSH3;RIPK3;CIT;MAP1A;EML2
6828,GO:0030297,0.301465032897574,0.964776568915948,1,3,transmembrane receptor protein tyrosine kinase activator activity,MF,DGKQ
11841,GO:0046847,0.301484973515994,0.835797933480543,6,41,filopodium assembly,BP,ESPN;ARHGEF4;ITGA6;ARAP1;ZMYND8;DMTN
12262,GO:0048588,0.301616187971187,0.781810857796966,18,142,developmental cell growth,BP,POSTN;ULK2;APOE;PTPRS;WNT3;IMPACT;PLXNB1;NDN;FLRT3;SPG11;SEMA4G;ULK1;PLXNB3;CDK5R1;SLIT3;AKAP6;LAMB2;SMURF1
9649,GO:0038007,0.301724274198738,0.964710713545862,1,3,netrin-activated signaling pathway,BP,UNC5B
7691,GO:0032156,0.301811947085871,0.912124587326406,2,10,septin cytoskeleton,CC,SEPT6;SEPT5
16798,GO:0098693,0.301983751563588,0.846707644753141,5,33,regulation of synaptic vesicle cycle,BP,SYN1;NLGN2;RIMS3;SEPT5;DNM1
12244,GO:0048545,0.30203739685338,0.76257507333484,31,266,response to steroid hormone,BP,SREBF1;EGFR;SFRP1;KDM3A;CRY2;CRY1;MDM2;CTSV;ZFP36L2;THRAP3;MDK;BMP6;TXNIP;CA2;CYBA;SLIT3;CREBRF;PAQR6;THRA;CALCOCO1;AREG;VDR;ZFP36L1;GLB1;PAQR7;ABCA2;TH;RORA;PPARG;UFL1;KLF9
4077,GO:0009133,0.302113740766059,0.960578869219309,1,4,nucleoside diphosphate biosynthetic process,BP,CMPK2
16188,GO:0090244,0.302133422556843,0.964606630025351,1,3,Wnt signaling pathway involved in somitogenesis,BP,SFRP1
6197,GO:0019682,0.302133537894353,0.880097034820564,3,20,glyceraldehyde-3-phosphate metabolic process,BP,H6PD;PGLS;TKFC
407,GO:0001093,0.302191742905262,0.964591779203363,1,3,TFIIB-class transcription factor binding,MF,TCF4
2011,GO:0004740,0.302251874724777,0.964576463270292,1,3,pyruvate dehydrogenase (acetyl-transferring) kinase activity,MF,PDK1
7086,GO:0030889,0.302298350587362,0.911884775941973,2,10,negative regulation of B cell proliferation,BP,INPP5D;TNFRSF21
19668,GO:2000008,0.302337510705304,0.860455791662685,4,27,regulation of protein localization to cell surface,BP,KCNAB2;HFE;ASTN2;SNX33
9980,GO:0042403,0.302431429463721,0.911819110723911,2,10,thyroid hormone metabolic process,BP,DUOX1;GCNT4
2709,GO:0006083,0.302579330062342,0.964492990106465,1,3,acetate metabolic process,BP,ACSS2
16990,GO:0099122,0.302609968156059,0.964485174098587,1,3,RNA polymerase II C-terminal domain binding,MF,RTF1
7798,GO:0032355,0.302810687092365,0.806181555360083,10,81,response to estradiol,BP,POSTN;EGFR;SFRP1;FAM210B;ITGA2;ENDOG;CST3;TXNIP;AREG;TH
7089,GO:0030893,0.302886560275383,0.964414567585329,1,3,meiotic cohesin complex,CC,REC8
10315,GO:0043122,0.302994459834316,0.774498884199656,21,181,regulation of I-kappaB kinase/NF-kappaB signaling,BP,TNFAIP3;TRIM22;MAP3K14;RBCK1;STAT1;PLEKHG5;TNFSF10;F2R;NLRX1;S100A4;SQSTM1;SHARPIN;TRIM38;EDA2R;NLRP1;DAB2IP;BST2;TRAF5;RORA;CXXC5;ECM1
330,GO:0000921,0.303039629217809,0.911518714257084,2,10,septin ring assembly,BP,SEPT6;SEPT5
9949,GO:0042335,0.303060270981475,0.964370181765272,1,3,cuticle development,BP,DUOX1
17467,GO:1900409,0.303117188832348,0.910287773421869,2,11,positive regulation of cellular response to oxidative stress,BP,ENDOG;FBXW7
18125,GO:1902884,0.303117188832348,0.910287773421869,2,11,positive regulation of response to oxidative stress,BP,ENDOG;FBXW7
18281,GO:1903209,0.303117188832348,0.910287773421869,2,11,positive regulation of oxidative stress-induced cell death,BP,ENDOG;FBXW7
566,GO:0001708,0.303118065287312,0.845640343618732,5,34,cell fate specification,BP,TENM4;GLI2;GLI3;FZD7;APC2
8608,GO:0034136,0.303326530376287,0.964302085132316,1,3,negative regulation of toll-like receptor 2 signaling pathway,BP,TNFAIP3
14504,GO:0070016,0.303354327191089,0.91136309338639,2,10,armadillo repeat domain binding,MF,CALCOCO1;CTNNBIP1
19916,GO:2000467,0.303403758721448,0.964282319444912,1,3,positive regulation of glycogen (starch) synthase activity,BP,EPM2AIP1
3799,GO:0008379,0.303890883592778,0.95766613059477,1,5,thioredoxin peroxidase activity,MF,PRDX5
12858,GO:0051208,0.304138976012933,0.810829913352293,9,68,sequestering of calcium ion,BP,PKD2;NOS1;ITPR3;F2R;GSTM2;CYBA;JPH2;AKAP6;PRKACA
12442,GO:0050265,0.304288269028257,0.964055480229172,1,3,RNA uridylyltransferase activity,MF,ZCCHC11
10833,GO:0044342,0.304556835231423,0.90956629482746,2,11,type B pancreatic cell proliferation,BP,SFRP1;IGFBP4
8202,GO:0032965,0.30468366100109,0.87907295454068,3,19,regulation of collagen biosynthetic process,BP,F2R;ITGA2;PPARG
6449,GO:0021773,0.304931234606471,0.963890056250771,1,3,striatal medium spiny neuron differentiation,BP,SHANK3
9656,GO:0038026,0.304983531583422,0.96387658147104,1,3,reelin-mediated signaling pathway,BP,DAB2IP
6290,GO:0019904,0.305129024940803,0.741542306001005,63,562,protein domain specific binding,MF,INPP5D;ADAM19;HSPA2;ESPN;PKD2;DIXDC1;WNT3;HOXA3;VPS11;MDM2;RAPGEF3;CAPN7;TRPV4;WIPF1;SNTA1;TCEAL1;ARHGEF4;BHLHE40;TRAK1;INSR;CEP68;BAIAP2;CBLC;SCNN1A;PLXNB3;MAP2K2;SQSTM1;CABYR;FZD7;SYNGAP1;SH2D2A;HOMER2;ATRX;ARHGAP27;SHANK3;CYBA;CHMP1B;THRA;IKZF4;RPH3AL;NLRP1;SRR;CAPG;PDE2A;DAB2IP;CALCOCO1;TEAD2;EFS;PLXND1;TFDP2;DLG4;TCEAL4;SHANK2;IRS2;CEP250;TH;MPP7;PPARG;DOCK3;NFASC;AIP;CIT;CTNNBIP1
13077,GO:0051610,0.305465068625205,0.963752370033352,1,3,serotonin uptake,BP,NOS1
7024,GO:0030805,0.305558082927144,0.963728348255309,1,3,regulation of cyclic nucleotide catabolic process,BP,RAPGEF3
7039,GO:0030820,0.305558082927144,0.963728348255309,1,3,regulation of cAMP catabolic process,BP,RAPGEF3
8282,GO:0033121,0.305558082927144,0.963728348255309,1,3,regulation of purine nucleotide catabolic process,BP,RAPGEF3
14697,GO:0070369,0.305658805893563,0.963702325073485,1,3,beta-catenin-TCF7L2 complex,CC,TCF4
18284,GO:1903223,0.30576878747425,0.963673897242507,1,3,positive regulation of oxidative stress-induced neuron death,BP,FBXW7
2794,GO:0006235,0.305805227773704,0.95952956514596,1,4,dTTP biosynthetic process,BP,CMPK2
4148,GO:0009212,0.305805227773704,0.95952956514596,1,4,pyrimidine deoxyribonucleoside triphosphate biosynthetic process,BP,CMPK2
11528,GO:0046075,0.305805227773704,0.95952956514596,1,4,dTTP metabolic process,BP,CMPK2
4983,GO:0015111,0.306143859209612,0.963576850790207,1,3,iodide transmembrane transporter activity,MF,ANO1
17191,GO:0106071,0.306220652525664,0.963556962390612,1,3,positive regulation of adenylate cyclase-activating G-protein coupled receptor signaling pathway,BP,NOS1
4625,GO:0010749,0.306250032767998,0.963549351624826,1,3,regulation of nitric oxide mediated signal transduction,BP,EGFR
4273,GO:0009636,0.306284350703855,0.755014605061865,35,319,response to toxic substance,BP,TNFAIP3;TP53INP1;APOE;GPX3;BPHL;TXNRD3;SNN;STAT1;IMPACT;MDM2;MT1X;ADAMTS13;GJC2;PTGS1;GSTM2;NUPR1;GSN;MGST2;ENDOG;FAM213A;CST3;TXNIP;NET1;SESN1;ADIRF;ERCC6;XRN1;KCNMA1;AREG;DUOX1;STAT6;PRDX5;GSTM3;TH;PEMT
6214,GO:0019748,0.306305774967051,0.842667333062028,5,37,secondary metabolic process,BP,DDT;AKR7A2;PMEL;CBR4;TH
3211,GO:0006853,0.306321537135148,0.909889470180178,2,10,carnitine shuttle,BP,CPT2;ACACB
1624,GO:0004062,0.306324265732015,0.959380738551272,1,4,aryl sulfotransferase activity,MF,SULT1E1
2970,GO:0006509,0.306546429856978,0.842970539029001,5,35,membrane protein ectodomain proteolysis,BP,APOE;ADAM19;SPPL2B;PTPN3;SNX33
1510,GO:0003873,0.306688654972951,0.96343561793103,1,3,6-phosphofructo-2-kinase activity,MF,PFKFB2
7980,GO:0032606,0.306831425294279,0.790568878156596,13,108,type I interferon production,BP,TNFAIP3;PTPRS;RNF135;HERC5;ISG15;STAT1;FLOT1;DHX58;NLRX1;TREX1;ZBTB20;IFI16;STAT6
18626,GO:1903960,0.307057679240359,0.9095221070754,2,10,negative regulation of anion transmembrane transport,BP,ANO9;IRS2
16742,GO:0098554,0.307270889143667,0.906365100148263,2,13,cytoplasmic side of endoplasmic reticulum membrane,CC,PKD2;SPPL2B
14702,GO:0070374,0.307304925228472,0.787051284160098,14,114,positive regulation of ERK1 and ERK2 cascade,BP,GPNMB;EGFR;EPHB2;F2R;TRPV4;INSR;DDT;SPRY2;FBXW7;RET;FGFR4;ERBB2;ACKR3;NPNT
7903,GO:0032484,0.307728772911775,0.963165082422104,1,3,Ral protein signal transduction,BP,RGL2
7904,GO:0032485,0.307728772911775,0.963165082422104,1,3,regulation of Ral protein signal transduction,BP,RGL2
2711,GO:0006085,0.307729326533344,0.877815463980714,3,18,acetyl-CoA biosynthetic process,BP,MLYCD;PDK1;ACSS2
19621,GO:1990837,0.307936093106723,0.739710029479981,61,531,sequence-specific double-stranded DNA binding,MF,HES2;SREBF1;MNT;KDM3A;HR;TFCP2L1;ZFPM1;STAT1;CRY2;ZNF704;CRY1;KLF13;NFATC4;H1F0;HSF4;NDN;MLH3;GLI2;KLF7;SOX12;PER2;ZNF658;GLI3;THRAP3;BHLHE40;TCFL5;JARID2;ETV5;CENPC;TCF4;PLAG1;MEF2D;CREBRF;MLXIPL;LMO2;CARF;MXI1;THRA;ELF1;DBP;RFX2;SALL2;ZMYND8;IFI16;TEF;VDR;TNRC18;SIX5;HLTF;TFDP2;KAT2B;IVNS1ABP;STAT6;SOX13;KLF8;RORA;PPARG;PER3;FOXP2;ZC3H6;HIVEP1
14958,GO:0070888,0.308029359757522,0.877633658109611,3,18,E-box binding,MF,BHLHE40;TCF4;LMO2
5700,GO:0016831,0.308062130242751,0.85631078509798,4,28,carboxy-lyase activity,MF,MVD;MLYCD;DDT;GLUL
12271,GO:0048609,0.308217999390669,0.743043015551079,52,460,multicellular organismal reproductive process,BP,SERPINE2;GAMT;HSPA2;EGFR;TXNRD3;KDM3A;WNT3;ZFP41;SCMH1;CRTAP;CYP26B1;MLH3;CTSV;SPATA20;RGS2;DNAH1;MICALCL;TPGS1;TCFL5;HSF2BP;SUN1;SEPT6;CABYR;ETV5;HEXB;PLA2G6;BBS2;MCM9;ATRX;REC8;AGO4;SLIT3;CREBRF;CTSB;THRA;CCDC136;RFX2;BRINP1;TMEM203;BTG1;VDR;DPY19L2P2;SIX5;TSSK1B;PHC2;PAQR7;TH;PRKACA;NPAP1;PARN;HERPUD2;TTLL1
1873,GO:0004551,0.308241491721039,0.906703865623738,2,12,nucleotide diphosphatase activity,MF,NUDT6;NUDT10
12579,GO:0050775,0.30837619405928,0.857214505903023,4,25,positive regulation of dendrite morphogenesis,BP,CAPRIN2;OBSL1;CUL7;BAIAP2
6144,GO:0019433,0.308427987844175,0.907612851530755,2,11,triglyceride catabolic process,BP,APOE;DDHD2
13172,GO:0051799,0.308468207323734,0.962972039207158,1,3,negative regulation of hair follicle development,BP,FERMT1
14658,GO:0070293,0.308528791009768,0.90756172317058,2,11,renal absorption,BP,GSN;KLHL3
6382,GO:0021578,0.308622329387925,0.962931727752163,1,3,hindbrain maturation,BP,CDK5R1
6400,GO:0021626,0.308622329387925,0.962931727752163,1,3,central nervous system maturation,BP,CDK5R1
1106,GO:0002695,0.308758590356148,0.796873886736,11,88,negative regulation of leukocyte activation,BP,TNFAIP3;GPNMB;INPP5D;SFRP1;IL20RB;GLI3;TNFRSF21;HFE;DLG5;NRARP;ERBB2
12201,GO:0048408,0.308839452419702,0.958655021568571,1,4,epidermal growth factor binding,MF,EGFR
1499,GO:0003847,0.308913315591347,0.958633595959795,1,4,1-alkyl-2-acetylglycerophosphocholine esterase activity,MF,PLA2G7
7264,GO:0031252,0.308969442082111,0.752107811068291,36,300,cell leading edge,CC,ACTA2;PSD4;PKD2;EPS8L2;CSPG4;KITLG;ASAP3;PLEKHG5;FERMT1;KCNC4;PARVB;RAPGEF3;ARPIN;TRPV4;FLOT1;FRMD4B;WIPF1;ARHGEF4;INSR;GSN;BAIAP2;PLEKHH2;DOCK8;PTK6;EPB41L3;PSD3;PODXL;SPRY2;WASH3P;APC2;PLXND1;SNX1;S100A6;SCYL3;APBB2;SYNE2
11734,GO:0046597,0.309231292337022,0.906196759130394,2,12,negative regulation of viral entry into host cell,BP,IFITM1;GSN
310,GO:0000822,0.309375633084571,0.962734324450704,1,3,inositol hexakisphosphate binding,MF,ITPR3
12,GO:0000023,0.309410018698467,0.962725298922314,1,3,maltose metabolic process,BP,GAA
1877,GO:0004558,0.309410018698467,0.962725298922314,1,3,alpha-1,4-glucosidase activity,MF,GAA
7875,GO:0032450,0.309410018698467,0.962725298922314,1,3,maltose alpha-glucosidase activity,MF,GAA
19606,GO:1990785,0.309454404439722,0.962713646654237,1,3,response to water-immersion restraint stress,BP,MDM2
7543,GO:0031860,0.309570327667811,0.962683204022315,1,3,telomeric 3' overhang formation,BP,RAD50
13917,GO:0060603,0.309666787031745,0.856354926549066,4,25,mammary gland duct morphogenesis,BP,GLI2;ETV5;AREG;VDR
2402,GO:0005548,0.309697660324358,0.829575071840239,6,42,phospholipid transporter activity,MF,PITPNM3;PITPNM2;ANO9;OSBPL10;OSBPL5;PLTP
6938,GO:0030553,0.309747382925343,0.96263667916847,1,3,cGMP binding,MF,PDE2A
5340,GO:0016080,0.309772951634219,0.962629957643279,1,3,synaptic vesicle targeting,BP,SEPT5
3150,GO:0006749,0.309908133001612,0.83913117852567,5,42,glutathione metabolic process,BP,GSTM2;MGST2;OPLAH;GSTM3;GCLC
19387,GO:1905939,0.310473834291907,0.906572575951802,2,11,regulation of gonad development,BP,NUPR1;INSR
6982,GO:0030667,0.310526544393408,0.764770519594599,23,196,secretory granule membrane,CC,CXCR1;KCNAB2;RAB40B;GAA;ITPR3;HGSNAT;TMC6;LAMP3;LHFPL2;VAMP2;SUN1;CD109;SLC2A3;TCIRG1;CYBA;RPH3AL;CCDC136;BST2;NBEAL2;CD68;CD9;SYNGR1;NFASC
15073,GO:0071107,0.310665295019548,0.962394929986307,1,3,response to parathyroid hormone,BP,ITGA2
6528,GO:0021936,0.310694003079982,0.962387354325889,1,3,regulation of cerebellar granule cell precursor proliferation,BP,GLI2
7492,GO:0031672,0.310848051435575,0.85985944334373,4,18,A band,CC,OBSL1;OBSCN;TTN;KAT2B
1631,GO:0004075,0.310925076768325,0.962326344323865,1,3,biotin carboxylase activity,MF,ACACB
8223,GO:0033002,0.311003209727795,0.784004956075296,14,113,muscle cell proliferation,BP,TNFAIP3;EGFR;TENM4;STAT1;MDM2;PDCD4;ITGA2;JARID2;CYBA;MEF2D;SIX5;ERN1;PPARG;CTNNBIP1
14791,GO:0070542,0.311334067323686,0.818904610023073,7,52,response to fatty acid,BP,SREBF1;SFRP1;NFATC4;HMGCL;GNG2;ACSL1;PPARG
4237,GO:0009437,0.311409550708083,0.90609495589818,2,11,carnitine metabolic process,BP,CRAT;CPT1C
3316,GO:0007020,0.311446497017622,0.854759356773795,4,26,microtubule nucleation,BP,TUBGCP5;CEP192;RANBP9;EML2
3119,GO:0006699,0.311485160387662,0.874933583007184,3,19,bile acid biosynthetic process,BP,AMACR;FGFR4;OSBPL1A
14169,GO:0061098,0.311803569747167,0.854145297062969,4,27,positive regulation of protein tyrosine kinase activity,BP,UNC119;ERCC6;FBXW7;DLG4
15155,GO:0071312,0.31182708374872,0.874723995562253,3,19,cellular response to alkaloid,BP,MDM2;GSTM2;TH
701,GO:0001922,0.311959554399728,0.962052495892532,1,3,B-1 B cell homeostasis,BP,TNFAIP3
414,GO:0001102,0.311979101822325,0.839121000617432,5,35,RNA polymerase II activating transcription factor binding,MF,ZFPM1;BHLHE40;IFI27;MEF2D;LMO2
13714,GO:0060307,0.312889374363241,0.906586976055382,2,10,regulation of ventricular cardiac muscle cell membrane repolarization,BP,SNTA1;SCN4B
1332,GO:0003190,0.313167747160605,0.961731174967941,1,3,atrioventricular valve formation,BP,ZFPM1
19337,GO:1905773,0.313196807809491,0.961723426486129,1,3,8-hydroxy-2'-deoxyguanosine DNA binding,MF,WRN
8568,GO:0034058,0.313242754418809,0.906407695111691,2,10,endosomal vesicle fusion,BP,VPS11;VPS39
9015,GO:0035239,0.313361351119464,0.734358556322697,62,534,tube morphogenesis,BP,TNFAIP3;TGFBI;GPNMB;APOE;EGFR;PKD2;PLCD3;SFRP1;KIF26B;EPHB2;VAV3;CSPG4;CUL7;STAT1;UNC5B;PRKACB;HOXA3;NFATC4;PLCD1;RAPGEF3;ADGRB2;GLI2;C5;GLI3;MAP2K5;CELSR1;VEGFB;ETV5;HYAL1;SH2D2A;MMRN2;NPHP3;PODXL;SPRY2;LRP1;RET;DAB2IP;TEAD2;RNF213;FGFR4;BBS5;AREG;KLHL3;DLG5;BTG1;VDR;PLXND1;NRARP;PTK7;TCF7;ZFP36L1;APOLD1;TNFSF12;SRPX2;ERBB2;RORA;PPARG;FMNL3;ACKR3;NPNT;CTNNBIP1;ECM1
7060,GO:0030855,0.313438977938204,0.740147727826346,48,431,epithelial cell differentiation,BP,TAGLN;ACTA2;PTPRS;FAM20C;SLITRK6;POU3F1;TFCP2L1;STAT1;KRT15;CYP26B1;RAPGEF3;CTSV;PPL;WWTR1;ITGA2;PRR9;TST;TRIOBP;CD109;CASP14;BMP6;PTK6;FZD7;DLX3;SHARPIN;CST3;TXNIP;PODXL;ATRX;KRT14;CTSB;KLK5;THRA;PDE2A;MAF;MYO9A;DLG5;BTG1;VDR;PCSK6;TMEM231;PTK7;ZFP36L1;APOLD1;ALOX15B;GSTM3;PPARG;LAMB2
1047,GO:0002573,0.313625284569202,0.778798293937912,15,122,myeloid leukocyte differentiation,BP,INPP5D;FAM20C;SFRP1;PIK3R1;ZFPM1;KITLG;CD109;FAM213A;CA2;FBXW7;IFI16;ZFP36L1;GPR68;PPARG;CTNNBIP1
14439,GO:0061817,0.313651329246059,0.961602115911007,1,3,endoplasmic reticulum-plasma membrane tethering,BP,ESYT2
2668,GO:0006020,0.313833060825733,0.906107850866502,2,10,inositol metabolic process,BP,IMPA2;ISYNA1
11300,GO:0045636,0.313886062202246,0.961539377281458,1,3,positive regulation of melanocyte differentiation,BP,KITLG
6519,GO:0021904,0.313892026450336,0.874059076904305,3,18,dorsal/ventral neural tube patterning,BP,PRKACB;GLI2;GLI3
3950,GO:0008655,0.313907463946684,0.903783587046166,2,12,pyrimidine-containing compound salvage,BP,TK2;UCKL1
8186,GO:0032940,0.313934231831881,0.724198107186443,101,930,secretion by cell,BP,POSTN;ITGB6;SERPINE2;SREBF1;PYGB;LMF1;EGFR;SYT8;CXCR1;SYN1;SFRP1;GLUD1;BRSK1;KCNAB2;VAMP3;NAPRT;RAB40B;CRY1;FERMT1;GAA;VPS11;KCNC4;ITPR3;LTBP4;HGSNAT;SYTL1;ACTR1B;RAPGEF3;ENDOD1;F2R;C2CD4C;TRPV4;TMC6;NLGN2;ADORA2B;RIMS3;RHBDF1;PER2;C5;LHFPL2;SYT15;VAMP2;NMU;NISCH;GSN;TTN;CD109;TM7SF3;BMP6;SLC2A3;TCIRG1;VEGFB;HEXB;PLA2G6;CST3;IDH2;SEPT5;TNFRSF21;MCTP1;HFE;CYBA;HADH;RAB11FIP3;CTSB;PGM1;PFKFB2;RPH3AL;SLC2A1;NLRP1;GLUL;OLFM2;PIK3C3;SYT7;EXOC2;BST2;PCSK6;DMTN;ARFGEF2;RASL10B;NECAB3;NBEAL2;CD68;RSAD2;IL11;IRS2;ANO1;METTL7A;ALOX15B;SCG5;PHPT1;GLB1;DPP7;CD9;CTSD;SYNGR1;GPR68;C6ORF120;SERPING1;NFASC;KCNS3;ECM1
11263,GO:0045586,0.313950035035397,0.961522268319834,1,3,regulation of gamma-delta T cell differentiation,BP,SOX13
3311,GO:0007015,0.313952004412851,0.7492864648406,34,282,actin filament organization,BP,ESPN;SFRP1;OBSL1;EPS8L2;PIK3R1;ASAP3;ITGB5;RHOBTB2;RAPGEF3;ARPIN;SPTB;TRPV4;WIPF1;FHOD3;GSN;BAIAP2;TTN;PLEKHH2;TRIOBP;RICTOR;MICALL2;WHAMMP3;SHANK3;WASH3P;ARAP1;CAPG;SYNPO2;SHROOM2;EFS;DMTN;ALMS1;SHROOM4;SSH3;CIT
20248,GO:2001238,0.314090788821989,0.825579635203556,6,46,positive regulation of extrinsic apoptotic signaling pathway,BP,SFRP1;RBCK1;TNFSF10;PIDD1;RET;TNFSF12
13587,GO:0060079,0.314157885348399,0.826076659971045,6,43,excitatory postsynaptic potential,BP,NLGN2;BAIAP2;SHANK3;ZMYND8;DLG4;SHANK2
11362,GO:0045744,0.314225667853841,0.852165766092764,4,28,negative regulation of G-protein coupled receptor protein signaling pathway,BP,CRY1;RGS2;DNM1;RPH3AL
18408,GO:1903510,0.31438816907789,0.79720856019017,10,77,mucopolysaccharide metabolic process,BP,CSPG4;IDUA;B4GALT6;HEXA;B4GALT2;HEXB;HYAL1;NDST2;XYLT1;GLB1
4188,GO:0009267,0.314511693385138,0.781010394429026,14,114,cellular response to starvation,BP,SREBF1;SFRP1;IMPACT;CTSV;SESN3;WRN;SESN1;HFE;SLC2A1;GLUL;C12ORF66;PIK3C3;IFI16;ATG14
14667,GO:0070305,0.314556777177764,0.96135977640868,1,3,response to cGMP,BP,PDE2A
15163,GO:0071321,0.314556777177764,0.96135977640868,1,3,cellular response to cGMP,BP,PDE2A
3024,GO:0006570,0.314567038477219,0.956974284616398,1,4,tyrosine metabolic process,BP,TH
19887,GO:2000404,0.314682664827776,0.872427969143457,3,20,regulation of T cell migration,BP,DOCK8;RIPK3;ECM1
20063,GO:2000741,0.314788641462766,0.961297573555355,1,3,positive regulation of mesenchymal stem cell differentiation,BP,LTBP3
6849,GO:0030325,0.314804038667942,0.904352670240948,2,11,adrenal gland development,BP,INSR;MDK
2739,GO:0006121,0.314863330270453,0.956886269891626,1,4,mitochondrial electron transport, succinate to ubiquinone,BP,SDHA
14846,GO:0070644,0.314873401169294,0.961274820041837,1,3,vitamin D response element binding,MF,VDR
2211,GO:0005104,0.315010025478374,0.905508659353686,2,10,fibroblast growth factor receptor binding,MF,FLRT3;FRS3
6495,GO:0021869,0.315038733381251,0.961230414248099,1,3,forebrain ventricular zone progenitor cell division,BP,DIXDC1
6857,GO:0030334,0.315304226622227,0.732860190014205,61,536,regulation of cell migration,BP,POSTN;SERPINE2;GPNMB;TP53INP1;APOE;EGFR;SFRP1;PIK3R1;CXCL14;KITLG;PLXNB1;MDM2;IFITM1;RHOBTB2;ARPIN;F2R;CAPN7;TRPV4;C5;MINK1;ITGA2;SEMA4G;FAM110C;MAP2K5;ITGA6;SRGAP3;NISCH;INSR;MMP28;DDT;PLXNB3;DOCK8;VEGFB;HYAL1;MMRN2;IDH2;PODXL;MCTP1;SPRY2;ADARB1;LRP1;PLA2G7;RET;ZMYND8;DAB2IP;MYSM1;DLG5;BST2;PLXND1;DMTN;ACVR1B;LMNA;IRS2;ALOX15B;PBLD;SRPX2;PPARG;SYNE2;ACKR3;RIPK3;ECM1
71,GO:0000147,0.31534920949023,0.961146943422026,1,3,actin cortical patch assembly,BP,WIPF1
10858,GO:0044396,0.31534920949023,0.961146943422026,1,3,actin cortical patch organization,BP,WIPF1
13104,GO:0051666,0.31534920949023,0.961146943422026,1,3,actin cortical patch localization,BP,WIPF1
18425,GO:1903532,0.315371123205297,0.756385072982474,26,218,positive regulation of secretion by cell,BP,POSTN;EGFR;GLUD1;FERMT1;F2R;TRPV4;NLGN2;ADORA2B;C5;NMU;TTN;TM7SF3;BMP6;PLA2G6;HFE;PFKFB2;RPH3AL;NLRP1;GLUL;SYT7;RASL10B;IRS2;ANO1;ALOX15B;PHPT1;GPR68
12749,GO:0051044,0.315707502764814,0.903886403798158,2,11,positive regulation of membrane protein ectodomain proteolysis,BP,APOE;SNX33
10579,GO:0043560,0.315744051468086,0.905134052469408,2,10,insulin receptor substrate binding,MF,PIK3R1;INSR
8588,GO:0034105,0.315942230516588,0.87219032619596,3,19,positive regulation of tissue remodeling,BP,EGFR;CA2;VDR
18475,GO:1903626,0.316029702174512,0.956538767849376,1,4,positive regulation of DNA catabolic process,BP,ENDOG
679,GO:0001890,0.316171212967871,0.779614116241185,14,114,placenta development,BP,EGFR;PKD2;PLCD3;HTRA1;CUL7;PLCD1;CTSV;ETNK2;DLX3;CTSB;VDR;ZFP36L1;GJB5;PPARG
6097,GO:0019320,0.31643380334156,0.83545186798784,5,37,hexose catabolic process,BP,PGM1;PFKFB2;GALE;TKFC;GLB1
4777,GO:0010966,0.31645973615253,0.960847509003944,1,3,regulation of phosphate transport,BP,CRY2
10486,GO:0043402,0.316494022907109,0.960838242466369,1,3,glucocorticoid mediated signaling pathway,BP,CREBRF
2436,GO:0005637,0.316547569434769,0.824107764373076,6,44,nuclear inner membrane,CC,SUN1;IFI27;DPY19L2P2;NEMP2;ERN1;NPAP1
1867,GO:0004534,0.316648249854176,0.9607965441055,1,3,5'-3' exoribonuclease activity,MF,XRN1
15521,GO:0071947,0.316711070508849,0.96077955172964,1,3,protein deubiquitination involved in ubiquitin-dependent protein catabolic process,BP,TNFAIP3
4396,GO:0010107,0.316715483588177,0.872322563661203,3,18,potassium ion import,BP,KCNJ15;KCNJ5;SLC12A7
3221,GO:0006869,0.316853490850046,0.757800649733086,24,201,lipid transport,BP,APOE;CPT2;CRY1;PITPNM3;PITPNM2;SLC27A1;BMP6;PLA2G6;ANO9;OSBPL10;ACACB;LRP1;SYT7;OSBPL5;OSBPL1A;ESYT2;ACSL1;APOLD1;IRS2;ABCA2;PPARG;LDLRAP1;PLTP;ABCA11P
8870,GO:0034694,0.316890833367366,0.872214396439426,3,18,response to prostaglandin,BP,SFRP1;GNG2;PPARG
2480,GO:0005719,0.316965129794318,0.870523495063294,3,21,nuclear euchromatin,CC,ASH2L;H1F0;TCF7
2258,GO:0005173,0.316997028607669,0.960702147624458,1,3,stem cell factor receptor binding,MF,KITLG
10198,GO:0042827,0.31703465475609,0.903199533958051,2,11,platelet dense granule,CC,HPS4;ECM1
4867,GO:0014722,0.31734961223328,0.956143543900612,1,4,regulation of skeletal muscle contraction by calcium ion signaling,BP,GSTM2
18197,GO:1903011,0.317617648819486,0.960533844329801,1,3,negative regulation of bone development,BP,FBXW7
20231,GO:2001205,0.317617648819486,0.960533844329801,1,3,negative regulation of osteoclast development,BP,FBXW7
16381,GO:0097025,0.317621955956035,0.960532674804088,1,3,MPP7-DLG1-LIN7 complex,CC,MPP7
13449,GO:0055006,0.31773346074879,0.81569058709138,7,43,cardiac cell development,BP,OBSL1;MYH11;PDCD4;FHOD3;TTN;LMNA;AKAP6
13215,GO:0051900,0.317913663308054,0.901693248390549,2,12,regulation of mitochondrial depolarization,BP,IFI6;GCLC
4191,GO:0009298,0.318170699883692,0.955896622047145,1,4,GDP-mannose biosynthetic process,BP,MPI
1961,GO:0004672,0.31827052691727,0.732169342358674,56,473,protein kinase activity,MF,ULK2;SIK1;EGFR;FAM20C;EPHB2;MAP3K14;BRSK1;CAMKK1;PRKACB;CNTRL;CDK18;SPEG;LTBP4;OBSCN;ALPK1;NEK9;PSKH1;MINK1;ULK1;LTBP1;NEK8;MAP2K5;INSR;CDK14;TTN;MAP2K2;PDK1;SQSTM1;PTK6;PDIK1L;MAP3K12;CDK5R1;EFNB3;MAPK10;PAK6;MAP3K6;MYO3B;WNK1;STK16;RET;PIK3C3;FGFR4;RPS6KA5;STK19;LMTK3;ACVR1B;TSSK1B;ADCK5;WEE1;PTK7;MARK4;ERN1;ERBB2;PRKACA;RIPK3;CIT
8642,GO:0034199,0.318326799513409,0.903810365369028,2,10,activation of protein kinase A activity,BP,PRKACB;PRKACA
12729,GO:0051017,0.318528773550644,0.777780036065709,14,111,actin filament bundle assembly,BP,ESPN;SFRP1;PIK3R1;ASAP3;ITGB5;RHOBTB2;RAPGEF3;BAIAP2;TRIOBP;SHANK3;ARAP1;SYNPO2;DMTN;ALMS1
20099,GO:2000807,0.318534014368321,0.96028455790533,1,3,regulation of synaptic vesicle clustering,BP,NLGN2
16814,GO:0098735,0.318712905629352,0.960235783848749,1,3,positive regulation of the force of heart contraction,BP,NOS1
14261,GO:0061364,0.318722417820242,0.960233189388438,1,3,apoptotic process involved in luteolysis,BP,SLIT3
15578,GO:0072080,0.318757319315972,0.805758235528446,8,59,nephron tubule development,BP,PKD2;KIF26B;STAT1;WWTR1;GLI3;KLHL3;NPNT;CTNNBIP1
20118,GO:2000833,0.31889411100384,0.955678398131087,1,4,positive regulation of steroid hormone secretion,BP,BMP6
5738,GO:0016888,0.319113726545657,0.902118853612575,2,11,endodeoxyribonuclease activity, producing 5'-phosphomonoesters,MF,SLX1A;SLX1B
9565,GO:0036379,0.319145363075271,0.877003753464811,3,12,myofilament,CC,FHOD3;TTN;TNNI2
8414,GO:0033504,0.319245678779662,0.960090314401987,1,3,floor plate development,BP,GLI2
10582,GO:0043565,0.319285081419613,0.722327906857799,85,754,sequence-specific DNA binding,MF,HES2;SREBF1;MNT;KDM3A;POU3F1;HR;TFCP2L1;ZFPM1;HOXC5;ZNF266;STAT1;CRY2;ZNF704;HOXA3;CRY1;KLF13;NFATC4;H1F0;HSF4;NDN;MLH3;GLI2;KLF7;ZNF76;SOX12;PER2;ZNF658;GLI3;THRAP3;ZNF558;IRX4;BHLHE40;TCFL5;JARID2;ETV5;DLX3;CENPC;TCF4;PLAG1;WRN;MEF2D;CREBRF;MLXIPL;LMO2;CARF;MXI1;THRA;ELF1;IKZF4;DBP;RFX2;ZNF554;SALL2;ZNF532;MAF;ZMYND8;CALCOCO1;TEAD2;IFI16;TEF;ZNF25;VDR;TNRC18;SIX5;HLTF;PHF1;TFDP2;TCF7;KAT2B;IVNS1ABP;RAD50;ZNF439;STAT6;SOX13;KLF8;GOLGB1;RORA;PPARG;CXXC5;ZNF529;ZFP90;PER3;FOXP2;ZC3H6;HIVEP1
9378,GO:0035927,0.31929572345343,0.955556974238706,1,4,RNA import into mitochondrion,BP,TST
3325,GO:0007033,0.31929601420806,0.768632750754393,17,142,vacuole organization,BP,ULK2;TP53INP1;GAA;VPS11;NAGLU;HPS4;ATG16L2;SPG11;ULK1;LRSAM1;HEXB;HOOK2;SYNPO2;PIK3C3;SYT7;ATG14;SMURF1
589,GO:0001754,0.320199273800761,0.870166479853184,3,18,eye photoreceptor cell differentiation,BP,SDK2;NAGLU;TH
13227,GO:0051924,0.320285837293346,0.776094530786009,14,115,regulation of calcium ion transport,BP,HSPA2;PKD2;NOS1;F2R;GJC2;GSTM2;PLA2G6;HOMER2;CYBA;JPH2;CACNB3;CACNB1;AKAP6;PRKACA
9929,GO:0042296,0.320330689779022,0.955243159880938,1,4,ISG15 transferase activity,MF,HERC5
1204,GO:0002864,0.320347338836882,0.955238101057272,1,4,regulation of acute inflammatory response to antigenic stimulus,BP,IL20RB
4400,GO:0010138,0.320416292237066,0.95521714595082,1,4,pyrimidine ribonucleotide salvage,BP,UCKL1
10746,GO:0044206,0.320416292237066,0.95521714595082,1,4,UMP salvage,BP,UCKL1
6244,GO:0019825,0.320922937915599,0.901173816816078,2,11,oxygen binding,MF,CYP3A5;TH
3584,GO:0007632,0.321181342197614,0.83252925268691,5,35,visual behavior,BP,TANC1;B4GALT2;SYNGAP1;NPHP4;DDHD2
15626,GO:0072160,0.321187853450176,0.902333860681904,2,10,nephron tubule epithelial cell differentiation,BP,STAT1;WWTR1
10120,GO:0042692,0.321365131603741,0.752558937507552,25,202,muscle cell differentiation,BP,SIK1;FLNC;OBSL1;NOS1;NFATC4;CYP26B1;SPEG;OBSCN;MYH11;PDCD4;FLOT1;TMEM204;FHOD3;BOC;TANC1;TTN;FZD7;GDF15;THRA;OLFM2;MAMSTR;LMNA;AKAP6;RORA;NPNT
16845,GO:0098796,0.321376447621074,0.722121230327484,77,730,membrane protein complex,CC,ITGB6;HSPA2;EGFR;PIK3R1;EVC;MVB12B;KCNAB2;VAMP3;ITGB5;GJD3;NOS1;AP5Z1;PIK3C2G;VPS11;KCNC4;HLA-B;NDUFA4L2;NEO1;AP1G2;CLTCL1;FLOT1;GJC2;C5;SNTA1;ITGA2;VAMP2;ITGA6;KCNJ5;INSR;SCNN1A;SUN1;SCN4B;VPS39;TCIRG1;ATP6V0A2;DNM1;HOOK2;SHANK3;HFE;CYBA;GABBR1;KCNMA1;CHMP1B;APC2;GNG2;LRP1;HLA-A;TSNARE1;KCNG1;SDHA;RET;OLFM2;PIK3C3;PIK3R2;SCN2A;CACNB3;NDUFV3;SNX1;ACVR1B;DLG4;SHANK2;ANO1;ERN1;CPT1C;TRAF5;CACNB1;GJB5;COL13A1;ABCA2;AKAP6;ATG14;MPP7;PRKACA;LDLRAP1;SYNE2;KCNS3;NPNT
10273,GO:0043034,0.321409248031639,0.870116691144603,3,17,costamere,CC,FLNC;ANK3;AHNAK2
12002,GO:0047617,0.321862230130388,0.899612241727197,2,12,acyl-CoA hydrolase activity,MF,ACOT1;ACOT2
15586,GO:0072093,0.322047371371188,0.959320129453984,1,3,metanephric renal vesicle formation,BP,KIF26B
15907,GO:0072716,0.32212490743244,0.954696046844202,1,4,response to actinomycin D,BP,MDM2
13791,GO:0060402,0.322366579472138,0.790653658319411,10,78,calcium ion transport into cytosol,BP,PKD2;NOS1;ITPR3;F2R;GSTM2;CYBA;JPH2;CACNB3;AKAP6;PRKACA
10310,GO:0043114,0.322500106027515,0.868734368758509,3,18,regulation of vascular permeability,BP,TRPV4;PDE2A;CTNNBIP1
10082,GO:0042599,0.322648086296002,0.89919561233188,2,12,lamellar body,CC,LAMP3;KLK5
12105,GO:0048185,0.322950762617298,0.900109463657345,2,11,activin binding,MF,ACVR1B;SMURF1
5495,GO:0016435,0.322994415102214,0.954429496220097,1,4,rRNA (guanine) methyltransferase activity,MF,TARBP1
2371,GO:0005501,0.323073819080147,0.898969564361241,2,12,retinoid binding,MF,CYP26B1;UGT1A3
4560,GO:0010644,0.323335318611049,0.867586353236102,3,19,cell communication by electrical coupling,BP,ANK3;GJC2;PRKACA
5660,GO:0016772,0.32341415917632,0.717800689025996,88,778,transferase activity, transferring phosphorus-containing groups,MF,ULK2;SIK1;OAS2;EGFR;FAM20C;EPHB2;MAP3K14;DGKQ;PIK3R1;BRSK1;CAMKK1;PI4KAP2;KITLG;PRKACB;CMPK2;CNTRL;PIK3C2G;CDK18;SPEG;NMRK1;LTBP4;OBSCN;POLH;POLR2J2;OAS1;ALPK1;NEK9;ZCCHC11;PSKH1;MINK1;ULK1;FGGY;LTBP1;NEK8;MAP2K5;INSR;CDK14;TTN;POLD4;ETNK2;MAP2K2;PDK1;SQSTM1;PTK6;PDIK1L;MAP3K12;CDK5R1;EFNB3;PI4KAP1;POLR2J3;MAPK10;PAK6;PFKFB2;TK2;MAP3K6;MYO3B;WNK1;STK16;RET;PIK3C3;FGFR4;PIK3R2;RPS6KA5;NADK;STK19;LMTK3;ACVR1B;PRIMPOL;DLG4;TSSK1B;ADCK5;WEE1;PTK7;MARK4;TEP1;IRS2;ERN1;RAD50;TKFC;UAP1L1;ERBB2;PRKACA;POLM;UCKL1;IP6K2;RIPK3;PI4K2B;CIT
18555,GO:1903818,0.323677288329896,0.958868027822261,1,3,positive regulation of voltage-gated potassium channel activity,BP,AKAP6
8097,GO:0032793,0.323758421869077,0.899684034339017,2,11,positive regulation of CREB transcription factor activity,BP,CRTC1;RPS6KA5
8591,GO:0034111,0.32382163861602,0.899650699008241,2,11,negative regulation of homotypic cell-cell adhesion,BP,SERPINE2;CD9
7141,GO:0031000,0.32389675545767,0.899611081687065,2,11,response to caffeine,BP,GSTM2;PPARG
9524,GO:0036270,0.32389675545767,0.899611081687065,2,11,response to diuretic,BP,GSTM2;PPARG
7170,GO:0031060,0.324317589770861,0.809096299545459,7,51,regulation of histone methylation,BP,MTHFR;KDM3A;JARID2;RTF1;KDM4C;ATRX;PHF1
6096,GO:0019319,0.324342532089597,0.808484999009082,7,55,hexose biosynthetic process,BP,SIK1;DGKQ;CRY1;G6PC3;PER2;PGM1;KAT2B
4727,GO:0010893,0.324437607928437,0.899325611227317,2,11,positive regulation of steroid biosynthetic process,BP,SREBF1;BMP6
10613,GO:0043625,0.324451122921128,0.953980868368639,1,4,delta DNA polymerase complex,CC,POLD4
7443,GO:0031587,0.324727316716891,0.958575195325524,1,3,positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity,BP,PKD2
2600,GO:0005899,0.325027539201547,0.958491241250033,1,3,insulin receptor complex,CC,INSR
11865,GO:0046889,0.325069182345983,0.817534833918235,6,45,positive regulation of lipid biosynthetic process,BP,SREBF1;APOE;BMP6;PLA2G6;MLXIPL;CCDC3
5846,GO:0017145,0.325107170213376,0.84549746392911,4,26,stem cell division,BP,ZFP36L2;WWTR1;FZD7;ETV5
4851,GO:0014066,0.325144239205548,0.800472029696823,8,61,regulation of phosphatidylinositol 3-kinase signaling,BP,SERPINE2;EGFR;UNC5B;PLXNB1;PIK3IP1;F2R;DAB2IP;RGL2
12912,GO:0051289,0.325412967078347,0.807520952275637,7,56,protein homotetramerization,BP,PKD2;ALDH1A3;GPX3;CRTC1;ACACB;SRR;CBR4
891,GO:0002265,0.325419830768356,0.95838138813884,1,3,astrocyte activation involved in immune response,BP,LRP1
12640,GO:0050864,0.326070568046826,0.793064426265109,9,71,regulation of B cell activation,BP,TNFAIP3;INPP5D;SFRP1;VAV3;ZFP36L2;TNFRSF21;ZFP36L1;IRS2;STAT6
16459,GO:0097164,0.326218654349318,0.767746065977326,15,130,ammonium ion metabolic process,BP,KDSR;CRAT;MBOAT2;SLC27A1;ALDH7A1;AKR7A2;PLA2G6;LPIN3;PLA2G7;SNCB;CBR4;SMPDL3B;CPT1C;TH;PEMT
1806,GO:0004457,0.32622778343567,0.953430187141544,1,4,lactate dehydrogenase activity,MF,D2HGDH
10342,GO:0043169,0.326231036582023,0.698137005442336,322,2974,cation binding,MF,TNFAIP3;POSTN;ZSCAN18;SIK1;NPEPL1;APOE;NT5E;OAS2;ADAM19;TRIM65;FAM20C;PKD2;CAPRIN2;APOBEC3C;SYT8;ASH2L;TRIM22;PLCD3;PCDH1;GLUD1;DGKQ;TMEM129;ADAMTS7;BRSK1;RBCK1;KDM3A;CUL9;EYS;RNF135;SULF2;DHTKD1;VAV3;UNK;HR;SMOC2;VWCE;CYBRD1;ZFPM1;ZNF362;SNN;IRF2BPL;PRICKLE2;ASAP3;ZNF266;MYL9;COL10A1;THAP8;NOS1;PRKACB;ZNF704;ZNF699;ZFP41;KLF13;PITPNM3;HMGCL;RNF187;CYP26B1;THNSL2;ZNF251;MICALL1;LIG1;VPS11;SPOCK1;ITPR3;CYHR1;MDM2;PLCD1;NMRK1;DDX59;CHN2;ZNF662;LTBP4;OBSCN;TNFSF10;LENG9;SYTL1;FKBP9;CALML3;CYP3A5;ZNF414;ENDOD1;HAGHL;POLH;OAS1;RASA4;TRIM66;B4GALT6;MLLT6;ACAP3;C2CD4C;PHYH;MT1X;CGREF1;SLC24A1;ZNF160;ARSI;NEK9;ZFP36L2;GLI2;AGAP4;KLF7;RNF165;ADAMTS13;TCEA2;PLCH2;ZNF76;SLX1A;SLX1B;ZCCHC11;PITPNM2;PTGS1;DTNB;ZNF658;ARSD;PHF2;NINL;THBS3;ASAP2;ITGA2;SYT15;GLI3;ZNF558;LRSAM1;ZNF655;NAIP;LTBP1;ZNF333;NEK8;MAP2K5;ITGA6;LTBP3;BSN;SESN3;ZNF318;MMP1;CELSR1;MMP28;GSN;CHD3;TTN;CBLC;ZNF18;RNPEPL1;ZNF287;CYP2D7;ZNF446;RAB11FIP4;ZNF581;DHX58;ENDOG;B4GALT2;PEX10;S100A4;MICALL2;MAP2K2;GLI4;SQSTM1;CABYR;LOXL1;FAT2;SHARPIN;KDM4C;CLCA2;UBOX5;ZNF608;ZCCHC24;CAPNS2;PLAG1;IDH2;WRN;TREX1;MCTP1;CDK5R1;ATRX;AGAP6;CA2;SESN1;SHANK3;CYBA;TRIM38;NID1;DTX3;RRM2B;SLIT3;AGAP7P;RAB11FIP3;KCNMA1;ING4;ZNF862;LMO2;NOTCH2NL;DZIP1L;PGM1;RNF170;THRA;ARAP1;ASTN2;ADARB1;RAI1;IKZF4;RPH3AL;ACACB;OGDHL;ZBTB34;ZNF627;LACTB2;GLUL;TNS2;SRR;LRP1;PEG3;ACP5;RNPEP;DLK2;ZNF554;MAP3K6;RIMKLB;SALL2;WNK1;ZNF107;ZNF532;ZBTB20;PDE2A;ZNF334;RET;ZMYND8;CASZ1;MYSM1;DDHD2;RNF213;TSHZ2;ZNF276;SYT7;ERCC5;ZNF25;SNCB;MYO9A;RPS6KA5;ZNF630;ZNF687;VDR;PHF7;ZFP28;NADK;ZMYM3;NUDT8;HLTF;MARCH8;ZNF789;MPPE1;ZNF563;ZNF517;FAHD2B;LMTK3;PHF1;ZNF292;ACVR1B;ZNF737;PRIMPOL;NECAB3;PPP2R3B;ESYT2;TSSK1B;ZNF701;ALOXE3;ENDOU;MPI;MATN2;ZNF91;DUOX1;WEE1;RSAD2;ZFP36L1;CLSTN3;IMPA2;CAPS;MBLAC2;ERN1;RNF141;ALOX15B;RAD50;ZNF439;TKFC;ZMAT3;MTR;MAN1B1;S100A6;TRERF1;EFEMP2;ZSWIM8;SGSH;PHC2;ANKMY1;SMPDL3B;KLF8;TRAF5;ACSS2;TRIM2;PLCB3;NUDT10;PPM1M;TH;RORA;PPARG;CXXC5;POLM;ZNF572;PLTP;ZNF658B;SUCLG2;PARN;ZNF529;KLF9;PRMT3;CIT;ZFP90;ZFP30;FOXP2;ZC3H6;HIVEP1;NPNT;GCLC
6305,GO:0019953,0.326256694225657,0.727839817178349,49,439,sexual reproduction,BP,SERPINE2;GAMT;HSPA2;SYT8;TXNRD3;KDM3A;WNT3;ZFP41;SCMH1;CRTAP;CYP26B1;MLH3;CTSV;SPATA20;RGS2;DNAH1;MICALCL;LHFPL2;TPGS1;TCFL5;HSF2BP;SUN1;SEPT6;CABYR;ETV5;HEXB;BBS2;MCM9;ATRX;REC8;AGO4;THRA;CCDC136;RFX2;TMEM203;BTG1;DPY19L2P2;SIX5;TSSK1B;PHC2;CD9;PAQR7;TH;PRKACA;NPAP1;PARN;HERPUD2;TTLL1;GLIPR1L2
15677,GO:0072235,0.326277799177089,0.958140527624264,1,3,metanephric distal tubule development,BP,PKD2
15678,GO:0072236,0.326629036001228,0.958041684158103,1,3,metanephric loop of Henle development,BP,PKD2
11158,GO:0045240,0.326702038003155,0.898126214948468,2,11,dihydrolipoyl dehydrogenase complex,CC,DHTKD1;OGDHL
15219,GO:0071398,0.326770627452274,0.828481937629542,5,35,cellular response to fatty acid,BP,SREBF1;SFRP1;NFATC4;GNG2;PPARG
7149,GO:0031017,0.326971990370143,0.953198366808995,1,4,exocrine pancreas development,BP,INSR
18212,GO:1903038,0.327016076565253,0.798751029931309,8,63,negative regulation of leukocyte cell-cell adhesion,BP,GPNMB;IL20RB;GLI3;TNFRSF21;HFE;DLG5;NRARP;ERBB2
4808,GO:0014002,0.327053776409558,0.865245397149391,3,19,astrocyte development,BP,EGFR;LRP1;LAMB2
3607,GO:0008047,0.327213479015288,0.72921609684936,45,394,enzyme activator activity,MF,APOE;ALS2CL;DGKQ;EVI5L;VAV3;ASAP3;TBC1D8;PLXNB1;CHN2;RASA4;RGS2;ACAP3;AGAP4;RALGAPA1;ARHGEF19;TBC1D19;ASAP2;SRGAP3;RIN1;ETAA1;ARHGEF1;MGST2;RICTOR;MAP2K2;SYNGAP1;FAM13A;ARHGAP33;CDK5R1;ARHGAP27;AGAP6;ERCC6;SPRY2;AGAP7P;ARAP1;NLRP1;TBC1D17;RGS12;APPL2;WNK1;DAB2IP;PIK3R2;MYO9A;TBC1D16;SGSM2;ARHGAP23
10149,GO:0042747,0.327420744241571,0.95305825095392,1,4,circadian sleep/wake cycle, REM sleep,BP,CST3
12752,GO:0051047,0.327623621345292,0.744137067781354,27,230,positive regulation of secretion,BP,POSTN;EGFR;GLUD1;FERMT1;F2R;TRPV4;NLGN2;ADORA2B;C5;NMU;TTN;TM7SF3;BMP6;PLA2G6;HFE;CYBA;PFKFB2;RPH3AL;NLRP1;GLUL;SYT7;RASL10B;IRS2;ANO1;ALOX15B;PHPT1;GPR68
13017,GO:0051493,0.327699597177709,0.728760418273067,45,395,regulation of cytoskeleton organization,BP,ESPN;DIXDC1;SFRP1;EPS8L2;PIK3R1;ASAP3;OR2A4;PLXNB1;RHOBTB2;RAPGEF3;CTSV;RGS2;ARPIN;SPTB;TRPV4;ARHGEF19;WIPF1;FHOD3;CELSR1;GSN;BAIAP2;PLEKHH2;TRIOBP;RICTOR;WHAMMP3;CDK5R1;SHANK3;WASH3P;CHMP1B;APC2;ARAP1;FBXW5;CAPG;LRP1;SYNPO2;BST2;DMTN;ALMS1;KAT2B;CEP250;PHPT1;SSH3;CIT;MAP1A;EML2
159,GO:0000323,0.327752519414593,0.722744026877038,57,519,lytic vacuole,CC,TNFAIP3;PYGB;CTSO;CSPG4;CYBRD1;NAPRT;NSG1;SDC3;GAA;VPS11;NAGLU;IDUA;HGSNAT;CTSV;HPS4;FLOT1;ANK3;LAMP3;SPG11;CLCN6;DIRC2;HEXA;ARSD;SPPL2B;GPC2;CTSF;VPS39;TMEM9;TCIRG1;SQSTM1;HEXB;HYAL1;CST3;ATP6V0A2;COL6A1;CTSB;LRP1;ACP5;C12ORF66;SLC48A1;PIK3C3;SYT7;BST2;MARCH8;SNX1;CD68;GLMP;LAPTM4A;SGSH;GLB1;DPP7;CTSD;SYNGR1;ABCA2;C6ORF120;PI4K2B;CLCN7
2510,GO:0005764,0.327752519414593,0.722744026877038,57,519,lysosome,CC,TNFAIP3;PYGB;CTSO;CSPG4;CYBRD1;NAPRT;NSG1;SDC3;GAA;VPS11;NAGLU;IDUA;HGSNAT;CTSV;HPS4;FLOT1;ANK3;LAMP3;SPG11;CLCN6;DIRC2;HEXA;ARSD;SPPL2B;GPC2;CTSF;VPS39;TMEM9;TCIRG1;SQSTM1;HEXB;HYAL1;CST3;ATP6V0A2;COL6A1;CTSB;LRP1;ACP5;C12ORF66;SLC48A1;PIK3C3;SYT7;BST2;MARCH8;SNX1;CD68;GLMP;LAPTM4A;SGSH;GLB1;DPP7;CTSD;SYNGR1;ABCA2;C6ORF120;PI4K2B;CLCN7
13192,GO:0051865,0.327755903494593,0.806121120368741,7,53,protein autoubiquitination,BP,DDB2;RNF187;MDM2;LRSAM1;KLHL24;RNF213;RNF141
6296,GO:0019915,0.327979349884552,0.815336365301939,6,45,lipid storage,BP,APOE;CRY1;HEXB;FBXW7;ACACB;PPARG
10406,GO:0043260,0.328142990996664,0.957614038570056,1,3,laminin-11 complex,CC,LAMB2
13043,GO:0051567,0.328162811004941,0.843396813050889,4,26,histone H3-K9 methylation,BP,KDM3A;JARID2;KDM4C;ATRX
5718,GO:0016860,0.328218614242868,0.826260849862294,5,40,intramolecular oxidoreductase activity,MF,DDT;TMX4;MPI;ECI1;EHHADH
7642,GO:0032069,0.328249436644616,0.842235856572712,4,29,regulation of nuclease activity,BP,OAS2;OAS1;DAB2IP;ERN1
5000,GO:0015144,0.328472600075059,0.864347705110315,3,19,carbohydrate transmembrane transporter activity,MF,SLC2A3;SLC2A1;SLC2A11
17535,GO:1901099,0.32885312298343,0.863024488565476,3,21,negative regulation of signal transduction in absence of ligand,BP,IFI6;UNC5B;MAP2K5
20250,GO:2001240,0.32885312298343,0.863024488565476,3,21,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand,BP,IFI6;UNC5B;MAP2K5
6037,GO:0019136,0.329074657725979,0.952539702630266,1,4,deoxynucleoside kinase activity,MF,TK2
7445,GO:0031589,0.329075551656823,0.742929830017606,27,225,cell-substrate adhesion,BP,POSTN;ITGB6;SFRP1;PIK3R1;SMOC2;VAMP3;ITGB5;BCAM;FERMT1;SPOCK1;PARVB;NINJ1;ADAMTS13;MINK1;THBS3;ITGA2;ITGA6;TRIOBP;MICALL2;TMEM8B;FZD7;NET1;NID1;DMTN;COL13A1;ECM2;NPNT
19721,GO:2000114,0.329132070858037,0.864570121052657,3,18,regulation of establishment of cell polarity,BP,GSN;DOCK8;RICTOR
16564,GO:0097386,0.329362138285071,0.896708584712455,2,11,glial cell projection,CC,GLUL;NFASC
6352,GO:0021537,0.329541541493176,0.755322832432716,19,158,telencephalon development,BP,EGFR;PTPRS;DIXDC1;ALDH1A3;EPHB2;RTN4RL1;GLI3;SUN1;MDK;BBS2;CDK5R1;SHANK3;SLC2A1;LRP1;DAB2IP;TACC1;TH;SYNE2;FOXP2
201,GO:0000423,0.329577330523729,0.863647029370615,3,19,mitophagy,BP,SQSTM1;ATG14;SMURF1
10490,GO:0043407,0.329651578620723,0.796542518518552,8,64,negative regulation of MAP kinase activity,BP,APOE;SFRP1;RGS2;PDCD4;CBLC;SPRY2;CDK5RAP3;DAB2IP
4920,GO:0014866,0.329799007779816,0.924098035219916,2,4,skeletal myofibril assembly,BP,MYH11;TTN
13496,GO:0055089,0.329800887573156,0.896473864949249,2,11,fatty acid homeostasis,BP,APOE;MLXIPL
14335,GO:0061572,0.329949026223321,0.768050314627524,14,112,actin filament bundle organization,BP,ESPN;SFRP1;PIK3R1;ASAP3;ITGB5;RHOBTB2;RAPGEF3;BAIAP2;TRIOBP;SHANK3;ARAP1;SYNPO2;DMTN;ALMS1
15753,GO:0072376,0.330010477085612,0.862799038131124,3,20,protein activation cascade,BP,C5;C1RL;SERPING1
13859,GO:0060512,0.33031555625037,0.863821331575211,3,18,prostate gland morphogenesis,BP,SFRP1;SERPINB5;GLI2
7837,GO:0032402,0.330684815908914,0.862368797537967,3,20,melanosome transport,BP,BLOC1S3;BBS2;BBS5
13219,GO:0051904,0.330684815908914,0.862368797537967,3,20,pigment granule transport,BP,BLOC1S3;BBS2;BBS5
2956,GO:0006488,0.330792000957026,0.862300360043966,3,20,dolichol-linked oligosaccharide biosynthetic process,BP,MVD;SRD5A3;PQLC3
15980,GO:0086011,0.33079559914345,0.895940774790005,2,11,membrane repolarization during action potential,BP,KCNJ5;CACNB3
3160,GO:0006768,0.330850363505839,0.895911387144734,2,11,biotin metabolic process,BP,HLCS;ACACB
3371,GO:0007141,0.330875471437829,0.894784601277454,2,12,male meiosis I,BP,HSPA2;REC8
14539,GO:0070086,0.33119697475119,0.951869348180278,1,4,ubiquitin-dependent endocytosis,BP,LRSAM1
11321,GO:0045661,0.331356765925404,0.840419009928135,4,28,regulation of myoblast differentiation,BP,CXCL14;BOC;BTG1;ZFP36L1
12625,GO:0050849,0.331452688256601,0.894471756024124,2,12,negative regulation of calcium-mediated signaling,BP,PKD2;GSTM2
479,GO:0001525,0.331489383808079,0.730778573420654,37,317,angiogenesis,BP,TNFAIP3;TGFBI;GPNMB;PLCD3;SFRP1;EPHB2;VAV3;CSPG4;STAT1;UNC5B;HOXA3;NFATC4;PLCD1;RAPGEF3;ADGRB2;C5;MAP2K5;VEGFB;HYAL1;SH2D2A;MMRN2;SPRY2;DAB2IP;RNF213;FGFR4;BTG1;PLXND1;NRARP;APOLD1;TNFSF12;SRPX2;ERBB2;RORA;PPARG;FMNL3;ACKR3;ECM1
11113,GO:0045165,0.332080144914124,0.76311460423856,15,121,cell fate commitment,BP,SFRP1;WNT3;TENM4;ZFPM1;CYP26B1;GLI2;SOX12;GLI3;RTF1;FZD7;SPRY2;APC2;STAT6;RORA;PPARG
898,GO:0002278,0.332175575383071,0.951558368424207,1,4,eosinophil activation involved in immune response,BP,VAMP2
990,GO:0002447,0.332175575383071,0.951558368424207,1,4,eosinophil mediated immunity,BP,VAMP2
10436,GO:0043307,0.332175575383071,0.951558368424207,1,4,eosinophil activation,BP,VAMP2
10437,GO:0043308,0.332175575383071,0.951558368424207,1,4,eosinophil degranulation,BP,VAMP2
19734,GO:2000145,0.332365365213071,0.715873744764402,64,568,regulation of cell motility,BP,POSTN;SERPINE2;GPNMB;TP53INP1;APOE;EGFR;SFRP1;PIK3R1;CXCL14;KITLG;PLXNB1;MDM2;IFITM1;RHOBTB2;ARPIN;F2R;CAPN7;TRPV4;C5;MINK1;ITGA2;SEMA4G;FAM110C;MAP2K5;ITGA6;SRGAP3;NISCH;INSR;MMP28;DDT;PLXNB3;DOCK8;VEGFB;HYAL1;MMRN2;BBS2;IDH2;PODXL;MCTP1;SPRY2;ADARB1;LRP1;PLA2G7;RET;ZMYND8;DAB2IP;MYSM1;DLG5;BST2;PLXND1;DMTN;ACVR1B;LMNA;IRS2;ALOX15B;PBLD;PHPT1;SRPX2;ERBB2;PPARG;SYNE2;ACKR3;RIPK3;ECM1
9189,GO:0035583,0.332366188566319,0.956407372295931,1,3,sequestering of TGFbeta in extracellular matrix,BP,LTBP1
9060,GO:0035308,0.332419063876892,0.82384356163017,5,37,negative regulation of protein dephosphorylation,BP,ELFN2;CRY2;PHACTR3;PPP1R2;PPP1R35
12230,GO:0048521,0.332705162261425,0.951389580531286,1,4,negative regulation of behavior,BP,NMU
12865,GO:0051223,0.332770879842009,0.719867483131164,53,474,regulation of protein transport,BP,POSTN;SREBF1;EGFR;SFRP1;GLUD1;FERMT1;VPS11;ITPR3;MDM2;RAPGEF3;F2R;HPS4;TRPV4;NLGN2;ANK3;RHBDF1;PER2;C5;GLI3;VAMP2;NMU;TTN;TM7SF3;BMP6;MICALL2;PLA2G6;IDH2;IFI27;OSCP1;TNFRSF21;CDK5R1;HADH;RAB11FIP3;FBXW7;PFKFB2;RPH3AL;SLC2A1;NLRP1;GLUL;LRP1;PDE2A;PIK3C3;SYT7;DMTN;RSAD2;IRS2;ANO1;ALOX15B;PHPT1;ERBB2;GPR68;KCNS3;PEMT
12715,GO:0050998,0.332796195422065,0.894864633395424,2,11,nitric-oxide synthase binding,MF,SNTA1;DNM1
16184,GO:0090238,0.33302678874143,0.951286902856443,1,4,positive regulation of arachidonic acid secretion,BP,PLA2G6
15575,GO:0072077,0.333325626617255,0.894578958054206,2,11,renal vesicle morphogenesis,BP,KIF26B;STAT1
15581,GO:0072087,0.333325626617255,0.894578958054206,2,11,renal vesicle development,BP,KIF26B;STAT1
9862,GO:0042135,0.333660110630405,0.894398282224294,2,11,neurotransmitter catabolic process,BP,ALDH7A1;AMT
15300,GO:0071539,0.333691654341746,0.839569032361571,4,26,protein localization to centrosome,BP,NUDCD3;CEP192;CEP250;GOLGB1
5199,GO:0015798,0.333726912350116,0.956014251508947,1,3,myo-inositol transport,BP,PGAP1
12515,GO:0050680,0.33379439662975,0.776415469463024,11,86,negative regulation of epithelial cell proliferation,BP,APOE;SFRP1;STAT1;CTSV;CD109;FBXW7;DAB2IP;VDR;PBLD;PPARG;KLF9
9276,GO:0035726,0.333894971282138,0.951009097271851,1,4,common myeloid progenitor cell proliferation,BP,FBXO4
7877,GO:0032452,0.333953712121455,0.839826886431041,4,25,histone demethylase activity,MF,KDM3A;HR;PHF2;KDM4C
6574,GO:0022407,0.334199672861269,0.739418429691665,26,227,regulation of cell-cell adhesion,BP,SERPINE2;GPNMB;KIF26B;MAP3K14;PIK3R1;IL20RB;TRPV4;FLOT1;GLI2;ANK3;MINK1;TNFRSF14;GLI3;MAP2K5;ITGA6;DOCK8;PODXL;TNFRSF21;EFNB3;HFE;DLG5;DMTN;NRARP;CCDC88B;CD9;ERBB2
3632,GO:0008093,0.334732703408892,0.893817904874255,2,11,cytoskeletal adaptor activity,MF,OBSL1;BAIAP2
1284,GO:0003094,0.334955670606074,0.893697065890707,2,11,glomerular filtration,BP,SULF2;F2R
1151,GO:0002759,0.335012056513787,0.950650264959495,1,4,regulation of antimicrobial humoral response,BP,KLK5
3986,GO:0008853,0.335335941075525,0.950545934963746,1,4,exodeoxyribonuclease III activity,MF,TREX1
13514,GO:0055119,0.335415712403089,0.893447533390621,2,11,relaxation of cardiac muscle,BP,RGS2;GSTM2
3552,GO:0007588,0.33544492588385,0.859315862272352,3,20,excretion,BP,ADORA2B;MDK;KCNMA1
6827,GO:0030296,0.3355215300144,0.893390096760024,2,11,protein tyrosine kinase activator activity,MF,DGKQ;ERCC6
7116,GO:0030947,0.335568656804902,0.859820916535734,3,19,regulation of vascular endothelial growth factor receptor signaling pathway,BP,TMEM204;MMRN2;DAB2IP
19116,GO:1905114,0.335852315138041,0.719501803180428,48,428,cell surface receptor signaling pathway involved in cell-cell signaling,BP,APOE;APCDD1;FBXW4;CAPRIN2;DIXDC1;SFRP1;SULF2;WNT3;PRICKLE2;NFATC4;FERMT1;LZTS2;GLI2;NLGN2;ARHGEF19;WWTR1;GLI3;NAIP;IGFBP4;CELSR1;CDK14;BAIAP2;RTF1;FZD7;NPHP3;SHANK3;AGO4;APC2;FRAT1;GNG2;LRP1;NPHP4;WNK1;ZMYND8;DAB2IP;CALCOCO1;RNF213;TNRC6C;NRARP;KREMEN1;DLG4;IGFBP6;PTK7;TCF7;SHANK2;PLCB3;SMURF1;CTNNBIP1
7201,GO:0031100,0.335974598766914,0.799408400243952,7,55,animal organ regeneration,BP,EGFR;SRSF5;SULF2;GLI3;HFE;PTPN3;PPARG
8774,GO:0034465,0.335985511669651,0.950336299678789,1,4,response to carbon monoxide,BP,KCNMA1
4269,GO:0009628,0.336097624810908,0.704512749493936,94,863,response to abiotic stimulus,BP,POSTN;SERPINE2;SIK1;DDB2;TP53INP1;HSPA2;EGFR;CIRBP;PKD2;XPC;SLITRK6;SFRP1;MTHFR;MAP3K14;PIK3R1;BRSK1;TSC22D3;EYS;MC1R;STAT1;IMPACT;CRY2;NOS1;CRY1;NFATC4;SCARA3;HSF4;NDRG1;MDM2;CRTC1;POLH;PPL;SLC24A1;TRPV4;GLI2;PER2;CLCN6;UNC119;ITGA2;BHLHE40;NMU;TANC1;TTN;SUN1;ENDOG;SLC27A1;BMP6;B4GALT2;PDK1;VEGFB;SYNGAP1;HYAL1;CST3;TXNIP;ATP6V0A2;WRN;NET1;CA2;MAPK10;SHANK3;ADIRF;CYBA;ERCC6;KRT14;LRP11;KCNMA1;THRA;SLC2A1;TP53I13;NPHP4;PDE2A;RWDD3;DDHD2;FBXO4;IFI16;ERCC5;SCN2A;PRIMPOL;ZFP36L1;LMNA;APOLD1;ANO1;PCSK1N;CD9;GPR68;UVSSA;TH;RORA;PPARG;PRKACA;CLCN7;PER3;FOXP2;GCLC
4029,GO:0009063,0.336342141449714,0.784451450119529,9,74,cellular amino acid catabolic process,BP,GLUD1;NOS1;HMGCL;THNSL2;PRODH;ALDH4A1;ALDH7A1;GLUL;AMT
2275,GO:0005220,0.336420017775966,0.955229941922644,1,3,inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity,MF,ITPR3
7244,GO:0031210,0.336566179760653,0.891680899951542,2,12,phosphatidylcholine binding,MF,ESYT2;PLTP
12714,GO:0050997,0.336566179760653,0.891680899951542,2,12,quaternary ammonium group binding,MF,ESYT2;PLTP
10589,GO:0043578,0.336748717214704,0.955133644351462,1,3,nuclear matrix organization,BP,SUN1
16221,GO:0090292,0.336748717214704,0.955133644351462,1,3,nuclear matrix anchoring at nuclear membrane,BP,SUN1
8668,GO:0034260,0.336749834855716,0.820905231514451,5,36,negative regulation of GTPase activity,BP,GPSM1;RASA4;PLXNB3;SPRY2;DAB2IP
16041,GO:0089718,0.337326831764069,0.8924079033271,2,11,amino acid import across plasma membrane,BP,PER2;SLC36A4
14975,GO:0070915,0.33736555453442,0.949889167504773,1,4,lysophosphatidic acid receptor activity,MF,LPAR6
9376,GO:0035925,0.337415883587602,0.892359341447185,2,11,mRNA 3'-UTR AU-rich region binding,MF,ZFP36L2;ZFP36L1
14244,GO:0061326,0.337565875852344,0.790703441702386,8,60,renal tubule development,BP,PKD2;KIF26B;STAT1;WWTR1;GLI3;KLHL3;NPNT;CTNNBIP1
2166,GO:0005003,0.337882845085084,0.892104524339159,2,11,ephrin receptor activity,MF,EPHB2;EFNB3
2168,GO:0005005,0.337882845085084,0.892104524339159,2,11,transmembrane-ephrin receptor activity,MF,EPHB2;EFNB3
6347,GO:0021532,0.337884709707628,0.836233215375138,4,27,neural tube patterning,BP,PRKACB;GLI2;GLI3;IFT140
8443,GO:0033591,0.338222960674843,0.949610166641703,1,4,response to L-ascorbic acid,BP,ITGA2
6151,GO:0019471,0.338235746064581,0.890762116820025,2,12,4-hydroxyproline metabolic process,BP,PRODH;ALDH4A1
19347,GO:1905809,0.338300648517832,0.891876286116263,2,11,negative regulation of synapse organization,BP,APOE;NFATC4
12651,GO:0050878,0.338462850121099,0.726746423549183,34,306,regulation of body fluid levels,BP,SERPINE2;APOE;OAS2;EPHB2;DGKQ;PIK3R1;DOCK9;VAV3;ZFPM1;MYL9;PRKACB;CYP26B1;ITPR3;F2R;HPS4;BLOC1S4;TRPV4;ADAMTS13;ITGA2;SCNN1A;DOCK8;BLOC1S3;HMG20B;CYBA;TFPI2;GNG2;WNK1;VDR;DMTN;ALOXE3;CD9;PRKACA;DOCK6;SERPING1
17255,GO:0140007,0.338998485030288,0.949357015002401,1,4,KICSTOR complex,CC,C12ORF66
3662,GO:0008150,0.339182695544603,0.703830199773598,1154,11221,biological_process,BP,TNFAIP3;TGFBI;POSTN;TAGLN;ITGB6;HES2;SERPINE2;ZSCAN18;ULK2;GPNMB;TSC22D1;SIK1;SLFN5;SUGCT;EPM2A;MUC19;NPEPL1;DDB2;TP53INP1;MAP6;IFI6;PTHLH;SREBF1;AMACR;PYGB;MXRA5;NYNRIN;ACTA2;APOE;GPSM1;CES2;NT5E;ALS2CL;INPP5D;APCDD1;GAMT;FBXO41;OAS2;ADAM19;MN1;LMF1;PSD4;DDX60;HSPA2;FBXW4;EGFR;ESPN;TRIM65;HERC3;GIGYF1;PTPRS;CIRBP;FLNC;FAM20C;PKD2;CAPRIN2;MNT;XPC;APOBEC3C;SYT8;CXCR1;CPT2;RBM3;SYN1;ASH2L;DIXDC1;TRIM22;ALDH1A3;SRSF5;LRIG3;PLCD3;SLITRK6;CTSO;SFRP1;OBSL1;MTHFR;PERM1;SEC14L2;KCTD11;IFI44L;KIF26B;PCDH1;EPS8L2;EPHB2;RALGDS;TNS1;SYNC;GPX3;MAP3K14;GLUD1;BPHL;DCAF16;DGKQ;TMEM129;PIK3R1;ADAMTS7;EVI5L;BRSK1;TXNRD3;MARVELD1;RBCK1;KDM3A;ORAI3;CXCL14;DOCK9;TSC22D3;CUL9;NSUN7;EYS;EVC;RNF135;POU3F1;SULF2;WNT3;H6PD;DHTKD1;CAMKK1;HERC5;UBXN4;VAV3;ST6GALNAC2;UNK;HR;SMOC2;VWCE;CSPG4;ISG15;MVB12B;CYBRD1;ELFN2;HTRA1;SPATA18;TFCP2L1;TENM4;UNC119B;RGMA;PI4KAP2;KCNAB2;ZFPM1;KITLG;TP53I11;HOXC5;SDK2;MVD;ZDHHC1;ZNF362;CUL7;VAMP3;CITED4;SNN;IRF2BPL;NAPRT;REEP2;PRICKLE2;KCNJ15;MC1R;ASAP3;ZNF266;SRD5A3;OR2A4;C1QTNF6;STAT1;IMPACT;CAMK2N1;CRY2;MYL9;KRT15;HS1BP3;LGALS7B;WDR63;MARCKSL1;NSG1;UNC5B;UROS;SLC16A5;KDSR;ITGB5;COL10A1;GJD3;RAB43;RAB40B;THAP8;NOS1;PRKACB;ZNF704;HOXA3;CRY1;ZNF699;MAML3;ZFP41;SCMH1;KLF13;CRTAP;DIP2C;SDC3;BCAM;MAGEF1;PLEKHG5;NFATC4;PITPNM3;ZNF783;IQSEC2;HMGCL;PSMG4;SPDYE6;D2HGDH;BTBD2;SCARA3;FKBP5;RNF187;FERMT1;H1F0;CYP26B1;GAA;AP5Z1;CMPK2;THNSL2;HSF4;CNTRL;ZNF251;MICALL1;PIK3C2G;LIG1;CDK18;TBC1D8;PLXNB1;PLEKHG3;VPS11;SPEG;NDRG1;COL7A1;KCNC4;SPOCK1;SLC29A4;ITPR3;EAPP;NAGLU;MDM2;CRTC1;LZTS2;PLCD1;NDN;IFITM1;KCTD18;MLH3;NMRK1;DDX59;ST6GALNAC6;PPP2R2C;FCGRT;CSMD3;CHN2;ZNF662;TYSND1;LTBP4;PIK3IP1;OBSCN;IDUA;GOLGA8A;GPRC5C;HLA-B;TNFSF10;PRODH;HGSNAT;MYH11;PARVB;SYTL1;FKBP9;NDUFA4L2;ACTR1B;TNXB;RHOBTB2;UGT1A3;CERS4;CYP3A5;ACOT1;NEO1;RAPGEF3;PHACTR3;ZNF414;SPSB3;TCF25;ENDOD1;PCBP4;NINJ1;FAM210B;CTSV;NLGN4Y;POLH;SH3TC1;SPATA20;BLVRB;POLR2J2;OAS1;FLRT3;NUDCD3;RASA4;GAL3ST4;KCTD15;CRAT;KIF26A;B4GALT6;MLLT6;AP1G2;RGL4;RGS2;ARPIN;TMEM63C;ACAP3;IL20RB;ADGRB2;F2R;MLYCD;PPL;C2CD4C;HPS4;PHYH;MT1X;PDCD4;BLOC1S4;CGREF1;SPTB;SERPINB5;PPP1R3E;NYAP1;SLC24A1;ALPK1;ZNF160;CAPN7;SWT1;DNAH1;SLC27A3;ARSI;NEK9;TUBGCP5;RTN4RL1;ZFP36L2;ADGRF4;CLTCL1;TRPV4;TMC6;TMEM128;FLOT1;GLI2;AGAP4;TOM1L2;RHPN1;NLGN2;ADORA2B;CORO6;ANK3;KLF7;RNF165;NAT6;DHX32;ADAMTS13;LAMP3;TCEA2;PLCH2;RALGAPA1;MAPK8IP3;SPDYE5;GOLGA8B;SLC13A5;ZNF76;SOX12;CLMN;PIDD1;RIMS3;PARP6;AVL9;SLX1A;SLX1B;G6PC3;ATG16L2;ZNF747;SPG11;GJC2;KRBA1;ZCCHC11;ARHGEF19;RHBDF1;TSPAN18;SULT1E1;FBXO44;RASGEF1A;PER2;TMEM204;PITPNM2;CLCN6;MICALCL;PTGS1;UNC119;HEXA;FNDC4;FRS3;C5;FRMD4B;ZNF658;ARSD;WIPF1;SNTA1;PSKH1;ADGRL1;MINK1;PHF2;TBC1D19;NINL;ABHD14B;GSTM2;TCEAL1;AMIGO2;THBS3;TNFRSF14;WWTR1;MBOAT2;ASAP2;ARHGEF4;LHFPL2;ITGA2;SEMA4G;FAM110C;SYT15;ULK1;GLI3;SPPL2B;FGGY;FHOD3;PCSK1;TPGS1;THRAP3;ZNF558;IRX4;SMARCA1;AKAP7;BHLHE40;LRSAM1;VAMP2;ZNF655;NAIP;LTBP1;KHNYN;NMU;ZNF333;NEK8;MAP2K5;GAS8;BOC;ITGA6;LTBP3;KCNJ5;SRGAP3;CES3;BSN;SESN3;ZNF318;LZTS1;IGFBP4;MMP1;TCFL5;TRAK1;JARID2;NUPR1;PRR9;GPC2;NISCH;INSR;TST;IFI44;CCDC85B;HSF2BP;CELSR1;MMP28;GSN;ALDH4A1;CEP68;HEBP1;CHD3;CDK14;ST3GAL5;BAIAP2;TANC1;TTN;CBLC;TMC7;SCNN1A;DDT;ZNF18;PLXNB3;CEP126;SUN1;LPAR5;AHNAK2;CNTNAP3;RNPEPL1;PLEKHH2;TRIOBP;MXD4;POLD4;RIN1;CTSF;ZNF287;CD109;CYP2D7;NSUN5P2;PNMA1;PGLS;PMS2P3;ETAA1;RMI2;ZNF446;SCN4B;ARHGEF1;SEPT6;FBXL16;RAB11FIP4;VPS39;ZNF581;MGST2;DOCK8;TP53AIP1;DHX58;PILRB;ENDOG;SLC27A1;PGAP1;GID4;TM7SF3;NRSN2;RTF1;BLOC1S3;MDK;CASP14;IRF9;RICTOR;TMEM9;H2AFJ;BMP6;F8A1;NLRX1;B4GALT2;ETNK2;NIPAL2;PEX10;SLC2A3;TCIRG1;S100A4;MICALL2;MAP2K2;OPLAH;PDK1;VEGFB;ALDH7A1;GLI4;SQSTM1;CEP192;CABYR;PTK6;SLC12A7;TMEM8B;FZD7;ETV5;AKR7A2;LOXL1;SYNGAP1;NXPH4;FAM13A;FAM213A;FAT2;DLX3;TMEM117;EPB41L3;SHARPIN;HEXB;KDM4C;HYAL1;METTL23;CLCA2;ARHGAP33;H1FX;SH2D2A;UBOX5;NSMCE4A;ARRDC1;B3GNT9;ZNF608;WHAMMP3;CENPC;PLA2G6;CST3;FAM86C2P;PDIK1L;HOMER2;MMRN2;CAPNS2;GDF15;PEX7;BBS2;TXNIP;CTF1;THSD4;TCF4;ATP6V0A2;COL6A1;PEX11B;NPHP3;PSD3;LRRCC1;PLAG1;IDH2;CERCAM;MAP3K12;RCOR2;WRN;PODXL;SEPT5;IFI27;MALL;OSCP1;DNM1;MCM9;TNFRSF21;ZYG11B;MACROD1;IQCB1;KLHL24;PLD3;TREX1;LPIN3;ZDHHC12;OARD1;ABHD14A;MCTP1;CDK5R1;ATRX;REC8;ARHGAP27;AGAP6;NET1;ANO9;PIGZ;CA2;EFNB3;OSBPL10;PI4KAP1;POLR2J3;HOOK2;SESN1;EPB41L4A;MAPK10;NKTR;SHANK3;HFE;SCART1;ADIRF;HMG20B;CYBA;TRIM38;NID1;DTX3;AGO4;ERCC6;HADH;HCP5;RRM2B;SLIT3;KRT14;HLCS;SHC2;EDA2R;SPRY2;MRC2;FBXO2;WASH3P;MEF2D;IFT140;GABBR1;CREBRF;XRN1;AGAP7P;RAB11FIP3;TIGD5;LRP11;MLXIPL;CTSB;KLK5;TARBP1;FBXW7;KCNMA1;ANKRD28;GPR87;ING4;NUDT6;CDK5RAP3;ZNF862;ATXN1;LMO2;NOTCH2NL;NFIX;PAK6;TFPI2;CARF;DZIP1L;PGM1;MXI1;PFKFB2;PAQR6;RNF170;CHMP1B;THRA;TTC12;HSD11B1L;APC2;METTL21A;ACADS;ARAP1;ASTN2;GOLGA8N;ADARB1;RAI1;FMNL2;ELF1;MX2;IKZF4;DCAF10;RPH3AL;SLC2A1;ACACB;ACCS;OGDHL;NLRP1;C1RL;FRAT1;ZBTB34;ERMAP;REEP4;ZNF627;TK2;GPR155;LACTB2;IQCH;BEX2;GLUL;TNS2;TBC1D17;C17ORF97;MIF4GD;DBP;NDST2;NAB2;SLC38A4;EPM2AIP1;TP53I13;GNG2;FBXW5;PRR7;SRR;CAPG;TSPYL4;LRP1;KLHDC8B;LRRN3;HLA-A;PEG3;TSNARE1;NPHP4;RGS12;CCDC136;ATE1;ACP5;MPG;PLA2G7;SYNPO2;RNPEP;C12ORF66;CENPH;RFX2;MTURN;DLK2;KCNG1;ZNF554;BRINP1;SLC48A1;BDH1;CD99L2;DGCR2;MAP3K6;RIMKLB;PPCS;MYO3B;APPL2;DHRS4L2;HEXDC;SALL2;WNK1;PMEL;ZNF107;ZNF532;BBS1;ATXN10;JPH2;ZBTB20;PDE2A;ZNF334;SDHA;MAF;STK16;LTB4R2;RET;ZMYND8;PRX;DAB2IP;CASZ1;RWDD3;ACOX3;CALCOCO1;SLC37A2;TEAD2;MYSM1;DDHD2;SHROOM2;FBXO4;RNF213;OLFM2;RAPGEFL1;TSHZ2;PIK3C3;ZNF276;IFI16;SYT7;DALRD3;FGFR4;ERCC5;BBS5;EXOC2;IL20RA;PIK3R2;RETSAT;SCN2A;TEF;ZNF25;SETD4;OSBPL5;DHRS12;AREG;ABTB1;TMEM203;KLHL3;SNCB;ETFB;MYO9A;RPS6KA5;APBB3;ZNF630;DLG5;BTG1;BST2;ZNF687;VDR;LETMD1;RGL2;SNX21;ARHGEF17;CACNB3;MAMSTR;TNRC18;TNRC6C;ZFP28;DPY19L2P2;VIPR1;FAM3A;EFS;PLXND1;NADK;BBS10;ZMYM3;SIX5;HLTF;MARCH8;EHBP1;C20ORF194;PCSK6;ZNF789;TMEM80;MPPE1;ZNF563;TNS4;ZNF517;PCMTD2;TBC1D16;STK19;NDUFV3;TMCO6;LPAR6;C22ORF23;EML3;PPP1R2;DMTN;TPRN;ORAI2;FAHD2B;PPP1R35;STAT2;SGSM2;ARFGEF2;RASL10B;LMTK3;ALMS1;PCMTD1;WWC3;PHF1;ZNF292;SLC36A4;TMEM231;TFDP2;SNX1;PMP22;UCN2;GOLGA7B;OSBPL1A;NRARP;ACVR1B;TMX4;SHROOM4;ZNF737;TACC1;KREMEN1;CADM4;KDELC2;PRIMPOL;NECAB3;CCDC88B;DLG4;IGFL2;CCDC113;TNNI2;PPP2R3B;ESYT2;TSSK1B;ADCK5;IQSEC1;ZNF701;ALOXE3;NAT14;PANO1;PALB2;ENDOU;MPI;IGFBP6;NHSL1;MATN2;TCEAL4;ZNF91;NBEAL2;CD68;DUOX1;GALE;PTMS;WEE1;DYDC1;CCNG2;SLC22A15;TMEM143;GTF2IRD2;PTK7;DQX1;AMT;TCF7;SHANK2;RSAD2;TNFRSF25;ZFP36L1;XYLT1;LMNA;MXRA8;CLSTN3;GLMP;TOP3B;ACSL1;IL11;KAT2B;MARK4;TEP1;APOLD1;IRS2;DMXL2;IMPA2;CEP250;ANO1;CAPS;MBLAC2;METTL7A;ERN1;HSD17B14;SAC3D1;RNF141;IVNS1ABP;ALOX15B;RAD50;GPR21;ZNF439;TKFC;ANGEL2;ZMAT3;PNPO;MTR;MAN1B1;DHRS4;PEX1;ECI1;S100A6;TRERF1;UAP1L1;FAAH;SCYL3;EFEMP2;SCG5;ZSWIM8;APBB2;CBR4;TTC19;MFSD11;ARHGEF9;ISYNA1;SGSH;PBLD;DCAF8;RAPGEF5;TNFSF12;TAS1R3;CERS5;STAT6;PCSK1N;SOX13;PRDX5;PHPT1;NELFCD;GPR132;PHC2;SMPDL3B;TUB;KIF7;SLC43A1;GLB1;CPT1C;KLF8;DNAJC4;GSTM3;RDH12;KLHL29;CHD6;TRAF5;NAP1L5;GOLGB1;SRPX2;ACSS2;DPP7;TRIM2;CD9;RANBP9;CACNB1;HDAC11;PTPN3;CTSD;GJB5;COL13A1;ERBB2;SYNGR1;SPOCD1;PLCB3;GPR68;NUDT10;UVSSA;ZDHHC24;PAQR7;ARHGAP23;PQLC3;PPM1M;ABCA2;KMT5C;AKAP6;SLC2A11;TH;ATG14;MPP7;RORA;SSH3;PPARG;PRKACA;DOCK6;LDLRAP1;CXXC5;NPAP1;C6ORF120;POLM;FMNL3;ACOT2;GCNT4;ZNF572;SYNE2;PARD6G;ACKR3;PLTP;ZNF658B;SERPING1;SUCLG2;UCKL1;PARN;DDX12P;DOCK3;ZNF529;UFL1;LAMB2;IP6K2;RIPK3;NFASC;KLF9;PI4K2B;AIP;COG1;KCNS3;SCAND1;LONP2;PRMT3;SNX33;HARS2;CIT;ZFP90;EHHADH;MSH5;CLCN7;MAP1A;CCDC3;PER3;ZFP30;FOXP2;PTBP2;ZC3H6;HIVEP1;CALHM2;ECM2;SMURF1;NPNT;HERPUD2;TTLL1;EML2;CTNNBIP1;PEMT;ABCA11P;GLIPR1L2;TM4SF1;SERINC3;GCLC;ECM1
16647,GO:0097553,0.339233192101081,0.782483473923052,9,70,calcium ion transmembrane import into cytosol,BP,PKD2;NOS1;ITPR3;F2R;GSTM2;CYBA;JPH2;AKAP6;PRKACA
8023,GO:0032675,0.339280456529759,0.788951245968353,8,63,regulation of interleukin-6 production,BP,TNFAIP3;INPP5D;F2R;TRPV4;ADORA2B;NLRX1;CYBA;ZBTB20
275,GO:0000778,0.339361982267871,0.890140228464378,2,12,condensed nuclear chromosome kinetochore,CC,CENPC;REC8
17089,GO:0101003,0.33978768579319,0.81840204375442,5,37,ficolin-1-rich granule membrane,CC,GAA;SLC2A3;TCIRG1;NBEAL2;NFASC
8297,GO:0033141,0.339820241055984,0.949087946643536,1,4,positive regulation of peptidyl-serine phosphorylation of STAT protein,BP,RET
7651,GO:0032088,0.339927303487909,0.78820073544321,8,65,negative regulation of NF-kappaB transcription factor activity,BP,TNFAIP3;RBCK1;MAP2K5;NLRX1;CDK5RAP3;DAB2IP;RWDD3;UFL1
18426,GO:1903533,0.340025086516921,0.770638651843057,11,94,regulation of protein targeting,BP,SREBF1;VPS11;HPS4;ANK3;MICALL2;OSCP1;CDK5R1;FBXW7;DMTN;ERBB2;PEMT
13031,GO:0051541,0.340120252286532,0.948989501774549,1,4,elastin metabolic process,BP,CST3
6754,GO:0030193,0.340159675029748,0.805678186356686,6,47,regulation of blood coagulation,BP,SERPINE2;APOE;F2R;DMTN;CD9;SERPING1
17336,GO:1900046,0.340159675029748,0.805678186356686,6,47,regulation of hemostasis,BP,SERPINE2;APOE;F2R;DMTN;CD9;SERPING1
4747,GO:0010921,0.340340656598263,0.753040180391614,16,132,regulation of phosphatase activity,BP,ELFN2;CRY2;PPP2R2C;PHACTR3;ITGA2;CEP192;CDK5RAP3;WNK1;PPP1R2;PPP1R35;LMTK3;PPP2R3B;SPOCD1;AKAP6;RIPK3;NPNT
5400,GO:0016240,0.340372478124221,0.948906649294358,1,4,autophagosome membrane docking,BP,ATG14
19949,GO:2000551,0.340511456603206,0.948860962628492,1,4,regulation of T-helper 2 cell cytokine production,BP,RSAD2
5001,GO:0015145,0.340521599062852,0.890659114877918,2,11,monosaccharide transmembrane transporter activity,MF,SLC2A3;SLC2A1
13819,GO:0060441,0.340528069454465,0.856620399669274,3,19,epithelial tube branching involved in lung morphogenesis,BP,CELSR1;SPRY2;DLG5
6783,GO:0030226,0.340729640046143,0.953957464903755,1,3,apolipoprotein receptor activity,MF,LRP1
13676,GO:0060249,0.340775940822374,0.727467934431708,31,283,anatomical structure homeostasis,BP,TNFAIP3;INPP5D;EGFR;GAA;IL20RB;F2R;SLX1A;SLX1B;FGGY;POLD4;HOMER2;BBS2;NPHP3;WRN;IQCB1;ATRX;CA2;ERCC6;XRN1;NPHP4;ACP5;BBS1;FBXO4;IL20RA;BBS10;TEP1;RAD50;PBLD;TUB;RDH12;PARN
7035,GO:0030816,0.340811209529071,0.889337490402577,2,12,positive regulation of cAMP metabolic process,BP,PTHLH;RAPGEF3
13372,GO:0052696,0.341082482309166,0.948672992466602,1,4,flavonoid glucuronidation,BP,UGT1A3
13373,GO:0052697,0.341082482309166,0.948672992466602,1,4,xenobiotic glucuronidation,BP,UGT1A3
3378,GO:0007156,0.341196202800696,0.781447486860947,9,65,homophilic cell adhesion via plasma membrane adhesion molecules,BP,PCDH1;SDK2;AMIGO2;CELSR1;PLXNB3;FAT2;RET;CADM4;CLSTN3
7099,GO:0030903,0.341426252028368,0.890161441376457,2,11,notochord development,BP,GLI2;TEAD2
1050,GO:0002578,0.341474821110886,0.948543603824884,1,4,negative regulation of antigen processing and presentation,BP,HFE
7186,GO:0031083,0.341621013288882,0.887913398811226,2,13,BLOC-1 complex,CC,BLOC1S4;BLOC1S3
1714,GO:0004308,0.341750819839661,0.948452466205624,1,4,exo-alpha-sialidase activity,MF,GLB1
5772,GO:0016997,0.341750819839661,0.948452466205624,1,4,alpha-sialidase activity,MF,GLB1
16055,GO:0090036,0.341810934930127,0.889949485880982,2,11,regulation of protein kinase C signaling,BP,MC1R;PLA2G6
20038,GO:2000696,0.342064322633697,0.889809764380883,2,11,regulation of epithelial cell differentiation involved in kidney development,BP,STAT1;WWTR1
19489,GO:1990391,0.342084775688806,0.816951025050737,5,36,DNA repair complex,CC,XPC;MLH3;PMS2P3;WRN;MSH5
10687,GO:0043987,0.342211017137974,0.948300290121129,1,4,histone H3-S10 phosphorylation,BP,RPS6KA5
7391,GO:0031462,0.342327144577551,0.888494789170974,2,12,Cul2-RING ubiquitin ligase complex,CC,ZYG11B;ZSWIM8
11005,GO:0044854,0.342399706797429,0.948237817570727,1,4,plasma membrane raft assembly,BP,FLOT1
11008,GO:0044857,0.342399706797429,0.948237817570727,1,4,plasma membrane raft organization,BP,FLOT1
711,GO:0001937,0.342559839871297,0.8553004677472,3,19,negative regulation of endothelial cell proliferation,BP,APOE;STAT1;PPARG
11491,GO:0045992,0.342841176806479,0.855117297306465,3,19,negative regulation of embryonic development,BP,PRKACB;FZD7;NRARP
13602,GO:0060117,0.34318289836335,0.889191940350842,2,11,auditory receptor cell development,BP,SLITRK6;TRIOBP
12006,GO:0047631,0.343220792559829,0.944876337640749,1,5,ADP-ribose diphosphatase activity,MF,NUDT6
145,GO:0000298,0.343288259872403,0.947943023745756,1,4,endopolyphosphatase activity,MF,NUDT10
3863,GO:0008486,0.343288259872403,0.947943023745756,1,4,diphosphoinositol-polyphosphate diphosphatase activity,MF,NUDT10
5291,GO:0015961,0.343288259872403,0.947943023745756,1,4,diadenosine polyphosphate catabolic process,BP,NUDT10
8749,GO:0034431,0.343288259872403,0.947943023745756,1,4,bis(5'-adenosyl)-hexaphosphatase activity,MF,NUDT10
8750,GO:0034432,0.343288259872403,0.947943023745756,1,4,bis(5'-adenosyl)-pentaphosphatase activity,MF,NUDT10
13414,GO:0052840,0.343288259872403,0.947943023745756,1,4,inositol diphosphate tetrakisphosphate diphosphatase activity,MF,NUDT10
13415,GO:0052841,0.343288259872403,0.947943023745756,1,4,inositol bisdiphosphate tetrakisphosphate diphosphatase activity,MF,NUDT10
13416,GO:0052842,0.343288259872403,0.947943023745756,1,4,inositol diphosphate pentakisphosphate diphosphatase activity,MF,NUDT10
13417,GO:0052843,0.343288259872403,0.947943023745756,1,4,inositol-1-diphosphate-2,3,4,5,6-pentakisphosphate diphosphatase activity,MF,NUDT10
13418,GO:0052844,0.343288259872403,0.947943023745756,1,4,inositol-3-diphosphate-1,2,4,5,6-pentakisphosphate diphosphatase activity,MF,NUDT10
13419,GO:0052845,0.343288259872403,0.947943023745756,1,4,inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity,MF,NUDT10
13420,GO:0052846,0.343288259872403,0.947943023745756,1,4,inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 1-diphosphatase activity,MF,NUDT10
13421,GO:0052847,0.343288259872403,0.947943023745756,1,4,inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity,MF,NUDT10
13422,GO:0052848,0.343288259872403,0.947943023745756,1,4,inositol-3,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity,MF,NUDT10
15304,GO:0071543,0.343288259872403,0.947943023745756,1,4,diphosphoinositol polyphosphate metabolic process,BP,NUDT10
17784,GO:1901906,0.343288259872403,0.947943023745756,1,4,diadenosine pentaphosphate metabolic process,BP,NUDT10
17785,GO:1901907,0.343288259872403,0.947943023745756,1,4,diadenosine pentaphosphate catabolic process,BP,NUDT10
17786,GO:1901908,0.343288259872403,0.947943023745756,1,4,diadenosine hexaphosphate metabolic process,BP,NUDT10
17787,GO:1901909,0.343288259872403,0.947943023745756,1,4,diadenosine hexaphosphate catabolic process,BP,NUDT10
17788,GO:1901910,0.343288259872403,0.947943023745756,1,4,adenosine 5'-(hexahydrogen pentaphosphate) metabolic process,BP,NUDT10
17789,GO:1901911,0.343288259872403,0.947943023745756,1,4,adenosine 5'-(hexahydrogen pentaphosphate) catabolic process,BP,NUDT10
18158,GO:1902949,0.343413827744604,0.947901283596238,1,4,positive regulation of tau-protein kinase activity,BP,NAB2
11905,GO:0046965,0.343470705325896,0.889032704969471,2,11,retinoid X receptor binding,MF,VDR;PPARG
6497,GO:0021871,0.343605149672302,0.888958282769951,2,11,forebrain regionalization,BP,GLI3;PGAP1
16133,GO:0090170,0.343903182603416,0.947738425750751,1,4,regulation of Golgi inheritance,BP,MAP2K2
4583,GO:0010676,0.343907196740413,0.81586796319587,5,35,positive regulation of cellular carbohydrate metabolic process,BP,INSR;PFKFB2;EPM2AIP1;KAT2B;IRS2
11866,GO:0046890,0.343923618469256,0.752577809745434,15,128,regulation of lipid biosynthetic process,BP,SIK1;SREBF1;APOE;SEC14L2;DGKQ;MVD;SLC27A1;BMP6;PLA2G6;MLXIPL;FBXW7;ACACB;FGFR4;VDR;CCDC3
11181,GO:0045298,0.344336950173385,0.947593813251405,1,4,tubulin complex,CC,CDK5R1
16239,GO:0090315,0.34438782955141,0.947576835063031,1,4,negative regulation of protein targeting to membrane,BP,DMTN
5882,GO:0018023,0.344397480184746,0.814968828364277,5,37,peptidyl-lysine trimethylation,BP,RTF1;KDM4C;ATRX;SETD4;KMT5C
14810,GO:0070570,0.344635784049431,0.853342325572223,3,20,regulation of neuron projection regeneration,BP,PTPRS;RGMA;RTN4RL1
7250,GO:0031225,0.344690687870188,0.783931625517514,8,69,anchored component of membrane,CC,NT5E;SYN1;RGMA;RTN4RL1;GPC2;CD109;BST2;SMPDL3B
13668,GO:0060232,0.344703477747385,0.947471431353884,1,4,delamination,BP,TRPV4
13063,GO:0051592,0.345084124733261,0.76730312999637,11,82,response to calcium ion,BP,EGFR;PKD2;ITPR3;RASA4;TTN;ENDOG;TXNIP;KCNMA1;CARF;WNK1;DMTN
8549,GO:0033993,0.345311778368004,0.703652223220993,64,585,response to lipid,BP,TNFAIP3;POSTN;SREBF1;EGFR;SFRP1;KDM3A;WNT3;CRY2;NOS1;CRY1;NFATC4;HMGCL;CYP26B1;CMPK2;MDM2;FAM210B;CTSV;F2R;PDCD4;ZFP36L2;ADAMTS13;TNFRSF14;ITGA2;THRAP3;MGST2;ENDOG;MDK;BMP6;PTK6;FZD7;LOXL1;CST3;TXNIP;TNFRSF21;CA2;CYBA;SLIT3;CREBRF;XRN1;PAQR6;THRA;GNG2;SRR;ACP5;BRINP1;RET;DAB2IP;CALCOCO1;TEAD2;AREG;VDR;PTK7;TNFRSF25;ZFP36L1;ACSL1;GLB1;PAQR7;ABCA2;TH;RORA;PPARG;UFL1;KLF9;FOXP2
15212,GO:0071391,0.345362054996587,0.887983516638629,2,11,cellular response to estrogen stimulus,BP,SFRP1;MDM2
16751,GO:0098576,0.345444289946342,0.947223555873537,1,4,lumenal side of membrane,CC,BDH1
18329,GO:1903321,0.345600281432641,0.783398188295557,8,67,negative regulation of protein modification by small protein conjugation or removal,BP,TNFAIP3;ISG15;CRY1;PER2;HMG20B;UFL1;PRMT3;GCLC
8096,GO:0032792,0.34599972477689,0.94703724927588,1,4,negative regulation of CREB transcription factor activity,BP,SIK1
11419,GO:0045861,0.346120255385892,0.732883236258128,23,211,negative regulation of proteolysis,BP,SERPINE2;IFI6;CAMK2N1;COL7A1;SPOCK1;MDM2;SERPINB5;LAMP3;C5;NAIP;MAP2K5;CD109;CST3;HFE;TFPI2;IFI16;BST2;PANO1;PCSK1N;PRDX5;PTPN3;SERPING1;ECM1
11852,GO:0046873,0.34625457845593,0.731631955770654,24,200,metal ion transmembrane transporter activity,MF,PKD2;ORAI3;KCNAB2;KCNJ15;KCNC4;ITPR3;SLC24A1;TRPV4;SLC13A5;KCNJ5;SCNN1A;SCN4B;NIPAL2;SLC12A7;KCNMA1;KCNG1;JPH2;PDE2A;SHROOM2;SCN2A;CACNB3;ORAI2;CACNB1;KCNS3
8291,GO:0033133,0.346519403889947,0.946862579961562,1,4,positive regulation of glucokinase activity,BP,PFKFB2
3111,GO:0006689,0.34652176887324,0.946861784279793,1,4,ganglioside catabolic process,BP,HEXB
15429,GO:0071772,0.346538268160433,0.761275837259959,12,95,response to BMP,BP,SFRP1;ADAMTS7;HTRA1;RGMA;NEO1;PDCD4;RNF165;BMP6;GDF15;HFE;PCSK6;SMURF1
15430,GO:0071773,0.346538268160433,0.761275837259959,12,95,cellular response to BMP stimulus,BP,SFRP1;ADAMTS7;HTRA1;RGMA;NEO1;PDCD4;RNF165;BMP6;GDF15;HFE;PCSK6;SMURF1
1882,GO:0004565,0.346685744208862,0.946806598545471,1,4,beta-galactosidase activity,MF,GLB1
13190,GO:0051861,0.346739774253567,0.886024260485895,2,12,glycolipid binding,MF,HSPA2;MPPE1
15883,GO:0072676,0.346793396280337,0.812697995857617,5,39,lymphocyte migration,BP,CXCL14;DOCK8;RET;RIPK3;ECM1
14240,GO:0061318,0.346847559039344,0.887156102487652,2,11,renal filtration cell differentiation,BP,PODXL;LAMB2
15603,GO:0072112,0.346847559039344,0.887156102487652,2,11,glomerular visceral epithelial cell differentiation,BP,PODXL;LAMB2
15716,GO:0072311,0.346847559039344,0.887156102487652,2,11,glomerular epithelial cell differentiation,BP,PODXL;LAMB2
16316,GO:0090568,0.347010785573869,0.829783593056322,4,27,nuclear transcriptional repressor complex,CC,CHD3;APPL2;SALL2;TNRC18
13229,GO:0051928,0.347129834552878,0.790585859611843,7,55,positive regulation of calcium ion transport,BP,HSPA2;PKD2;F2R;GJC2;GSTM2;JPH2;AKAP6
7616,GO:0032021,0.347285341849594,0.946604512311265,1,4,NELF complex,CC,NELFCD
4891,GO:0014819,0.347298661515114,0.943435477166449,1,5,regulation of skeletal muscle contraction,BP,GSTM2
4619,GO:0010742,0.347330069692527,0.851571453340006,3,20,macrophage derived foam cell differentiation,BP,STAT1;ALOX15B;PPARG
16076,GO:0090077,0.347330069692527,0.851571453340006,3,20,foam cell differentiation,BP,STAT1;ALOX15B;PPARG
9432,GO:0036021,0.34748100372577,0.946538467749117,1,4,endolysosome lumen,CC,CTSB
14515,GO:0070044,0.347549469109865,0.946515346088319,1,4,synaptobrevin 2-SNAP-25-syntaxin-1a complex,CC,VAMP2
11190,GO:0045334,0.347599631573822,0.812570836691371,5,37,clathrin-coated endocytic vesicle,CC,APOE;EGFR;CLTCL1;CD9;LDLRAP1
1023,GO:0002524,0.347599722400144,0.946498371077638,1,4,hypersensitivity,BP,IL20RB
6217,GO:0019755,0.347771663460541,0.946440266847158,1,4,one-carbon compound transport,BP,CA2
7347,GO:0031397,0.347811109274733,0.789632002712798,7,58,negative regulation of protein ubiquitination,BP,TNFAIP3;ISG15;CRY1;PER2;UFL1;PRMT3;GCLC
1711,GO:0004305,0.347964094854169,0.946375193456981,1,4,ethanolamine kinase activity,MF,ETNK2
7370,GO:0031430,0.348004268534307,0.859315408099605,3,12,M band,CC,OBSL1;OBSCN;TTN
19377,GO:1905908,0.348082397959229,0.946335164077776,1,4,positive regulation of amyloid fibril formation,BP,APOE
16346,GO:0090669,0.348175274805602,0.946303725450736,1,4,telomerase RNA stabilization,BP,PARN
10540,GO:0043508,0.348590996237567,0.884980002005383,2,12,negative regulation of JUN kinase activity,BP,SFRP1;PDCD4
6802,GO:0030260,0.348621066398069,0.763535817151612,11,92,entry into host cell,BP,ITGB6;EGFR;ITGB5;IFITM1;TNFRSF14;ITGA2;GSN;EFNB3;TRIM38;CTSB;EXOC2
10861,GO:0044409,0.348621066398069,0.763535817151612,11,92,entry into host,BP,ITGB6;EGFR;ITGB5;IFITM1;TNFRSF14;ITGA2;GSN;EFNB3;TRIM38;CTSB;EXOC2
13175,GO:0051806,0.348621066398069,0.763535817151612,11,92,entry into cell of other organism involved in symbiotic interaction,BP,ITGB6;EGFR;ITGB5;IFITM1;TNFRSF14;ITGA2;GSN;EFNB3;TRIM38;CTSB;EXOC2
13182,GO:0051828,0.348621066398069,0.763535817151612,11,92,entry into other organism involved in symbiotic interaction,BP,ITGB6;EGFR;ITGB5;IFITM1;TNFRSF14;ITGA2;GSN;EFNB3;TRIM38;CTSB;EXOC2
3085,GO:0006659,0.34862814308387,0.946150272235139,1,4,phosphatidylserine biosynthetic process,BP,SLC27A1
2537,GO:0005795,0.348696763873397,0.75175247258079,14,116,Golgi stack,CC,SULF2;NSG1;B4GALNT4;GOLGA8A;GAL3ST4;B4GALT6;GOLGA8B;ASAP2;B4GALT2;ARAP1;GOLGA8N;NECAB3;GOLGB1;CIT
952,GO:0002371,0.348793202613451,0.946094276931865,1,4,dendritic cell cytokine production,BP,BST2
1138,GO:0002730,0.348793202613451,0.946094276931865,1,4,regulation of dendritic cell cytokine production,BP,BST2
8269,GO:0033083,0.348834689445619,0.946080197321094,1,4,regulation of immature T cell proliferation,BP,ERBB2
20218,GO:2001185,0.349109881798316,0.945986747951219,1,4,regulation of CD8-positive, alpha-beta T cell activation,BP,HFE
6918,GO:0030517,0.349117964888228,0.828280978894537,4,27,negative regulation of axon extension,BP,PTPRS;WNT3;SEMA4G;CDK5R1
3462,GO:0007276,0.349151187652762,0.710750163150361,42,376,gamete generation,BP,GAMT;HSPA2;TXNRD3;KDM3A;WNT3;ZFP41;SCMH1;CRTAP;CYP26B1;MLH3;CTSV;SPATA20;RGS2;DNAH1;MICALCL;TPGS1;TCFL5;HSF2BP;SUN1;SEPT6;CABYR;ETV5;HEXB;BBS2;MCM9;ATRX;REC8;AGO4;CCDC136;RFX2;TMEM203;BTG1;DPY19L2P2;SIX5;TSSK1B;PHC2;PAQR7;PRKACA;NPAP1;PARN;HERPUD2;TTLL1
10733,GO:0044126,0.349212882112995,0.945951746300859,1,4,regulation of growth of symbiont in host,BP,SQSTM1
10736,GO:0044144,0.349212882112995,0.945951746300859,1,4,modulation of growth of symbiont involved in interaction with host,BP,SQSTM1
3163,GO:0006775,0.349244317607736,0.849260099948969,3,22,fat-soluble vitamin metabolic process,BP,CYP26B1;VDR;PLTP
11055,GO:0045069,0.349290063300755,0.773637753840702,9,76,regulation of viral genome replication,BP,OAS2;APOBEC3C;ISG15;IFITM1;OAS1;ADARB1;IFI16;BST2;RSAD2
13778,GO:0060389,0.349497411433493,0.811144564685144,5,37,pathway-restricted SMAD protein phosphorylation,BP,BMP6;GDF15;HFE;ACVR1B;PBLD
12738,GO:0051026,0.349592861154187,0.945822503809714,1,4,chiasma assembly,BP,MSH5
12721,GO:0051006,0.349699527129766,0.945786190144751,1,4,positive regulation of lipoprotein lipase activity,BP,LMF1
14262,GO:0061365,0.349699527129766,0.945786190144751,1,4,positive regulation of triglyceride lipase activity,BP,LMF1
17498,GO:1900825,0.349819377448127,0.945745370539618,1,4,regulation of membrane depolarization during cardiac muscle cell action potential,BP,ANK3
12149,GO:0048284,0.349820808993368,0.741961821971812,17,145,organelle fusion,BP,SYT8;EVI5L;VAV3;VAMP3;TBC1D8;VPS11;SYTL1;C2CD4C;SPG11;SYT15;VAMP2;VPS39;TBC1D17;TSNARE1;SYT7;TBC1D16;SGSM2
6538,GO:0021955,0.34996699785755,0.850445321303491,3,19,central nervous system neuron axonogenesis,BP,EPHB2;GLI2;ADARB1
2245,GO:0005158,0.350161318677786,0.851008324255663,3,18,insulin receptor binding,MF,PIK3R1;SNX1;IRS2
11381,GO:0045780,0.350172782932125,0.885293243470744,2,11,positive regulation of bone resorption,BP,EGFR;CA2
11846,GO:0046852,0.350172782932125,0.885293243470744,2,11,positive regulation of bone remodeling,BP,EGFR;CA2
8461,GO:0033613,0.350373336835221,0.788148155419872,7,54,activating transcription factor binding,MF,DGKQ;ZFPM1;BHLHE40;IFI27;MEF2D;LMO2;PPARG
13181,GO:0051823,0.350474471450808,0.945521927215329,1,4,regulation of synapse structural plasticity,BP,SHANK3
17592,GO:1901300,0.35058790357071,0.945483181101117,1,4,positive regulation of hydrogen peroxide-mediated programmed cell death,BP,ENDOG
3121,GO:0006701,0.350589225136983,0.945482729583344,1,4,progesterone biosynthetic process,BP,DGKQ
14510,GO:0070034,0.350738832330342,0.848764393782501,3,21,telomerase RNA binding,MF,XRN1;TEP1;PARN
128,GO:0000268,0.350766389756204,0.945422180334327,1,4,peroxisome targeting sequence binding,MF,PEX7
12294,GO:0048661,0.350770343468341,0.787831002494355,7,54,positive regulation of smooth muscle cell proliferation,BP,EGFR;STAT1;MDM2;ITGA2;CYBA;MEF2D;ERN1
7477,GO:0031649,0.350906948830092,0.883667085043118,2,12,heat generation,BP,NMU;SLC27A1
2639,GO:0005976,0.35092684469054,0.766893737468258,10,80,polysaccharide metabolic process,BP,PYGB;GAA;PPP1R3E;PER2;INSR;B3GNT9;PGM1;EPM2AIP1;PPP1R2;IRS2
1265,GO:0003044,0.351175718009211,0.848473716206638,3,21,regulation of systemic arterial blood pressure mediated by a chemical signal,BP,F2R;CYBA;RASL10B
1547,GO:0003945,0.351306236832312,0.945237428706141,1,4,N-acetyllactosamine synthase activity,MF,B4GALT2
15827,GO:0072562,0.351374846220754,0.809245884848748,5,39,blood microparticle,CC,APOE;HSPA2;GSN;SLC2A1;SERPING1
19053,GO:1904956,0.351516768870852,0.945165276726503,1,4,regulation of midbrain dopaminergic neuron differentiation,BP,SFRP1
4711,GO:0010876,0.351650176115722,0.723737950309006,26,224,lipid localization,BP,APOE;CPT2;CRY1;PITPNM3;PITPNM2;SLC27A1;BMP6;HEXB;PLA2G6;ANO9;OSBPL10;FBXW7;ACACB;LRP1;SYT7;OSBPL5;OSBPL1A;ESYT2;ACSL1;APOLD1;IRS2;ABCA2;PPARG;LDLRAP1;PLTP;ABCA11P
4895,GO:0014824,0.351674984385194,0.945111016701359,1,4,artery smooth muscle contraction,BP,BBS2
4931,GO:0014891,0.35181868645807,0.945061706108715,1,4,striated muscle atrophy,BP,GSN
4184,GO:0009263,0.351879671522756,0.882096482809748,2,13,deoxyribonucleotide biosynthetic process,BP,CMPK2;RRM2B
10394,GO:0043244,0.351893237522904,0.766264728855493,10,78,regulation of protein complex disassembly,BP,SPTB;TRPV4;INSR;GSN;PLEKHH2;TRIOBP;APC2;CAPG;DMTN;MAP1A
11726,GO:0046579,0.351918637111608,0.825880950691173,4,28,positive regulation of Ras protein signal transduction,BP,KITLG;F2R;RASGEF1A;LPAR6
15347,GO:0071608,0.351930841546054,0.945023202200647,1,4,macrophage inflammatory protein-1 alpha production,BP,TRPV4
15370,GO:0071640,0.351930841546054,0.945023202200647,1,4,regulation of macrophage inflammatory protein 1 alpha production,BP,TRPV4
19604,GO:1990782,0.352070270019529,0.786947536096764,7,53,protein tyrosine kinase binding,MF,PIK3R1;PITPNM3;PITPNM2;CBLC;SQSTM1;SHC2;PIK3R2
3672,GO:0008171,0.352106429169261,0.847853689552672,3,21,O-methyltransferase activity,MF,TARBP1;PCMTD2;PCMTD1
4632,GO:0010757,0.352113166882417,0.944960573566932,1,4,negative regulation of plasminogen activation,BP,SERPINE2
6307,GO:0019956,0.352459816122881,0.882782705080311,2,12,chemokine binding,MF,CXCR1;ACKR3
5593,GO:0016627,0.352556187431113,0.795713385746279,6,49,oxidoreductase activity, acting on the CH-CH group of donors,MF,SRD5A3;BLVRB;ACADS;SDHA;ACOX3;RETSAT
3173,GO:0006787,0.352605171339025,0.941527246682738,1,5,porphyrin-containing compound catabolic process,BP,BLVRB
8233,GO:0033015,0.352605171339025,0.941527246682738,1,5,tetrapyrrole catabolic process,BP,BLVRB
9877,GO:0042167,0.352605171339025,0.941527246682738,1,5,heme catabolic process,BP,BLVRB
11570,GO:0046149,0.352605171339025,0.941527246682738,1,5,pigment catabolic process,BP,BLVRB
4352,GO:0009948,0.352707320343015,0.825313777566775,4,28,anterior/posterior axis specification,BP,WNT3;PGAP1;PCSK6;NRARP
4497,GO:0010528,0.353013896227951,0.882466359300196,2,12,regulation of transposition,BP,APOBEC3C;ZNF91
4498,GO:0010529,0.353013896227951,0.882466359300196,2,12,negative regulation of transposition,BP,APOBEC3C;ZNF91
1702,GO:0004197,0.353045806485467,0.770712446214386,9,74,cysteine-type endopeptidase activity,MF,CTSO;SFRP1;CTSV;CAPN7;CTSF;CASP14;CAPNS2;CTSB;CTSD
19812,GO:2000300,0.353073200924986,0.848389139425006,3,19,regulation of synaptic vesicle exocytosis,BP,SYN1;RIMS3;SEPT5
505,GO:0001568,0.35320258839093,0.702383764104869,50,434,blood vessel development,BP,TNFAIP3;TGFBI;GPNMB;ACTA2;APOE;PKD2;PLCD3;SFRP1;EPHB2;VAV3;CSPG4;CUL7;STAT1;UNC5B;HOXA3;NFATC4;MDM2;PLCD1;RAPGEF3;ADGRB2;C5;GLI3;LTBP1;MAP2K5;VEGFB;LOXL1;DLX3;HYAL1;SH2D2A;MMRN2;SPRY2;LRP1;DAB2IP;TEAD2;RNF213;FGFR4;BTG1;PLXND1;NRARP;PTK7;ZFP36L1;APOLD1;TNFSF12;SRPX2;ERBB2;RORA;PPARG;FMNL3;ACKR3;ECM1
15981,GO:0086012,0.353227076165965,0.883569061994012,2,11,membrane depolarization during cardiac muscle cell action potential,BP,ANK3;SCN4B
14629,GO:0070236,0.353314924710992,0.9445466972387,1,4,negative regulation of activation-induced cell death of T cells,BP,TSC22D3
13699,GO:0060287,0.353415186499473,0.944512083519159,1,4,epithelial cilium movement involved in determination of left/right asymmetry,BP,NPHP3
6893,GO:0030449,0.353547845544259,0.88216111390858,2,12,regulation of complement activation,BP,C5;SERPING1
19788,GO:2000257,0.353547845544259,0.88216111390858,2,12,regulation of protein activation cascade,BP,C5;SERPING1
17233,GO:0120035,0.353730000478377,0.702388677444731,49,429,regulation of plasma membrane bounded cell projection organization,BP,ULK2;APOE;ESPN;PTPRS;CAPRIN2;SFRP1;OBSL1;EPS8L2;EPHB2;EVI5L;WNT3;RGMA;CUL7;NFATC4;PLXNB1;SPOCK1;MDM2;CRTC1;CSMD3;ARPIN;RTN4RL1;TRPV4;SEMA4G;TRAK1;BAIAP2;PLXNB3;PTK6;SYNGAP1;PODXL;CDK5R1;EFNB3;SHANK3;IFT140;ARAP1;LRP1;RET;ZMYND8;DAB2IP;DLG5;PLXND1;DMTN;PMP22;DLG4;PTK7;SHANK2;ZSWIM8;SSH3;SYNE2;SMURF1
9283,GO:0035733,0.354061118940381,0.944288774353203,1,4,hepatic stellate cell activation,BP,GCLC
415,GO:0001103,0.354080085932088,0.823956985039751,4,29,RNA polymerase II repressing transcription factor binding,MF,BBS2;BBS1;BBS5;BBS10
804,GO:0002076,0.35413047163872,0.883056676405197,2,11,osteoblast development,BP,PTHLH;GLI2
6791,GO:0030239,0.354216001150436,0.810747214402815,5,28,myofibril assembly,BP,OBSL1;OBSCN;MYH11;FHOD3;TTN
2123,GO:0004920,0.35429297753853,0.944208485429267,1,4,interleukin-10 receptor activity,MF,IL20RB
4353,GO:0009950,0.354443560462482,0.882878842538354,2,11,dorsal/ventral axis specification,BP,SFRP1;WNT3
4707,GO:0010872,0.354507578094996,0.940833918109829,1,5,regulation of cholesterol esterification,BP,APOE
17911,GO:1902260,0.354686402765842,0.944072089244941,1,4,negative regulation of delayed rectifier potassium channel activity,BP,ANK3
7119,GO:0030950,0.354805592696763,0.881440565891363,2,12,establishment or maintenance of actin cytoskeleton polarity,BP,RHOBTB2;RICTOR
11259,GO:0045581,0.354907444826716,0.846542988515715,3,20,negative regulation of T cell differentiation,BP,GLI3;NRARP;ERBB2
6723,GO:0030141,0.354919291579637,0.69723547803795,57,539,secretory granule,CC,SERPINE2;PYGB;SYT8;CXCR1;KCNAB2;VAMP3;NAPRT;RAB40B;GAA;ITPR3;HGSNAT;ACTR1B;CTSV;HPS4;TMC6;LAMP3;HEXA;LHFPL2;PCSK1;VAMP2;GSN;BAIAP2;SUN1;CD109;SLC2A3;TCIRG1;VEGFB;LOXL1;HEXB;CST3;ATP6V0A2;CYBA;CTSB;KLK5;PGM1;RPH3AL;CCDC136;RNPEP;SYT7;BST2;TSSK1B;NBEAL2;CD68;METTL7A;SCG5;PCSK1N;GLB1;GOLGA1;DPP7;CD9;CTSD;SYNGR1;PRKACA;C6ORF120;SERPING1;NFASC;ECM1
6051,GO:0019201,0.354959577943877,0.846508146107494,3,20,nucleotide kinase activity,MF,CMPK2;DLG4;RAD50
15819,GO:0072553,0.355020384791761,0.943956143926874,1,4,terminal button organization,BP,NLGN2
12733,GO:0051021,0.355194530310464,0.943895630129538,1,4,GDP-dissociation inhibitor binding,MF,PLXNB3
12734,GO:0051022,0.355194530310464,0.943895630129538,1,4,Rho GDP-dissociation inhibitor binding,MF,PLXNB3
2437,GO:0005638,0.355501277745734,0.943788942813924,1,4,lamin filament,CC,LMNA
3098,GO:0006672,0.355571429058077,0.77549015020414,8,65,ceramide metabolic process,BP,ST6GALNAC6;CERS4;B4GALT6;ST3GAL5;HEXB;PLA2G6;ALOXE3;CERS5
16487,GO:0097209,0.355577680488308,0.943762350802824,1,4,epidermal lamellar body,CC,KLK5
7784,GO:0032332,0.355672189950719,0.882179704617664,2,11,positive regulation of chondrocyte differentiation,BP,GLI3;BMP6
6937,GO:0030552,0.355693161083453,0.88216775353066,2,11,cAMP binding,MF,RAPGEF3;PDE2A
12106,GO:0048188,0.355745697795968,0.880900591299608,2,12,Set1C/COMPASS complex,CC,ASH2L;DYDC1
11024,GO:0045010,0.355831918948496,0.806104404225116,5,38,actin nucleation,BP,ARPIN;WIPF1;GSN;WHAMMP3;WASH3P
1285,GO:0003096,0.355967619632829,0.94362651422084,1,4,renal sodium ion transport,BP,KLHL3
16793,GO:0098662,0.356113450734779,0.704924800190718,41,372,inorganic cation transmembrane transport,BP,HSPA2;PKD2;ORAI3;KCNAB2;KCNJ15;NOS1;KCNC4;ITPR3;NDUFA4L2;F2R;SLC24A1;TRPV4;ANK3;GJC2;SNTA1;GSTM2;VAMP2;KCNJ5;SCNN1A;SCN4B;NIPAL2;TCIRG1;SLC12A7;PLA2G6;ATP6V0A2;KLHL24;HFE;CYBA;KCNMA1;KCNG1;JPH2;PDE2A;SHROOM2;SCN2A;CACNB3;ORAI2;CACNB1;PTPN3;AKAP6;PRKACA;KCNS3
5843,GO:0017137,0.356128912907196,0.731850541773424,19,158,Rab GTPase binding,MF,ALS2CL;EVI5L;MICALL1;TBC1D8;NDRG1;SYTL1;HPS4;RIMS3;ULK1;GAS8;RIN1;RAB11FIP4;MICALL2;RAB11FIP3;RPH3AL;TBC1D17;TBC1D16;SGSM2;DMXL2
15855,GO:0072603,0.356291722003684,0.943513461751248,1,4,interleukin-5 secretion,BP,TNFRSF21
20017,GO:2000662,0.356291722003684,0.943513461751248,1,4,regulation of interleukin-5 secretion,BP,TNFRSF21
14199,GO:0061158,0.356340906867983,0.88179832169765,2,11,3'-UTR-mediated mRNA destabilization,BP,ZFP36L2;ZFP36L1
15627,GO:0072161,0.356366479719335,0.943487365595669,1,4,mesenchymal cell differentiation involved in kidney development,BP,STAT1
20148,GO:2001012,0.356366479719335,0.943487365595669,1,4,mesenchymal cell differentiation involved in renal system development,BP,STAT1
18436,GO:1903546,0.356419287918604,0.943468927118997,1,4,protein localization to photoreceptor outer segment,BP,TUB
20152,GO:2001016,0.356843536855322,0.943320664996926,1,4,positive regulation of skeletal muscle cell differentiation,BP,CYP26B1
8823,GO:0034618,0.356854900889448,0.943316690391482,1,4,arginine binding,MF,NOS1
20089,GO:2000786,0.356887240020438,0.881486288052967,2,11,positive regulation of autophagosome assembly,BP,ULK1;LRSAM1
5796,GO:0017049,0.356968855282861,0.845162709368459,3,20,GTP-Rho binding,MF,TRIOBP;WHAMMP3;NET1
15482,GO:0071875,0.357196621179178,0.881309408554024,2,11,adrenergic receptor signaling pathway,BP,NOS1;RGS2
3447,GO:0007258,0.357201485626561,0.943195390566204,1,4,JUN phosphorylation,BP,MAPK10
18198,GO:1903012,0.357255110760696,0.943176608543125,1,4,positive regulation of bone development,BP,GPR68
10520,GO:0043476,0.357542491923905,0.879865219145695,2,12,pigment accumulation,BP,BLOC1S3;SHROOM2
10521,GO:0043482,0.357542491923905,0.879865219145695,2,12,cellular pigment accumulation,BP,BLOC1S3;SHROOM2
18506,GO:1903715,0.357569282893518,0.943066495537065,1,4,regulation of aerobic respiration,BP,TRPV4
10962,GO:0044764,0.35805583395835,0.821076432284199,4,29,multi-organism cellular process,BP,DDX60;DHX58;NLRX1;TKFC
3999,GO:0008934,0.358178897472974,0.942852466940691,1,4,inositol monophosphate 1-phosphatase activity,MF,IMPA2
13408,GO:0052832,0.358178897472974,0.942852466940691,1,4,inositol monophosphate 3-phosphatase activity,MF,IMPA2
13409,GO:0052833,0.358178897472974,0.942852466940691,1,4,inositol monophosphate 4-phosphatase activity,MF,IMPA2
13410,GO:0052834,0.358178897472974,0.942852466940691,1,4,inositol monophosphate phosphatase activity,MF,IMPA2
11379,GO:0045778,0.358215060989602,0.781856692417059,7,54,positive regulation of ossification,BP,FAM20C;ISG15;IFITM1;GLI3;BMP6;NPNT;CTNNBIP1
1454,GO:0003696,0.358475283101216,0.942748234218099,1,4,satellite DNA binding,MF,MLH3
14011,GO:0060762,0.358602084220971,0.942703605846277,1,4,regulation of branching involved in mammary gland duct morphogenesis,BP,ETV5
8043,GO:0032713,0.358958572299405,0.942578025326014,1,4,negative regulation of interleukin-4 production,BP,ZFPM1
2107,GO:0004887,0.359068539218093,0.942539253621891,1,4,thyroid hormone receptor activity,MF,THRA
10591,GO:0043584,0.359129260163972,0.880201547275257,2,11,nose development,BP,ALDH1A3;GLI3
513,GO:0001578,0.359129284748777,0.791281950332454,6,45,microtubule bundle formation,BP,DNAH1;TPGS1;GAS8;BBS2;MARK4;TTLL1
3354,GO:0007089,0.359139825345584,0.942514111394126,1,4,traversing start control point of mitotic cell cycle,BP,MDM2
2958,GO:0006490,0.359247417101192,0.843060778645472,3,21,oligosaccharide-lipid intermediate biosynthetic process,BP,MVD;SRD5A3;PQLC3
9042,GO:0035272,0.359347798724686,0.803680742087828,5,37,exocrine system development,BP,EGFR;TFCP2L1;INSR;CST3;PLXND1
13885,GO:0060558,0.359382142615203,0.942428597735163,1,4,regulation of calcidiol 1-monooxygenase activity,BP,VDR
4509,GO:0010562,0.359412224526873,0.68631555380587,77,700,positive regulation of phosphorus metabolic process,BP,GPNMB;PTHLH;APOE;HSPA2;EGFR;PKD2;CAPRIN2;EPHB2;MAP3K14;DGKQ;CAMKK1;VAV3;CSPG4;KITLG;NOS1;PRKACB;RAPGEF3;F2R;TRPV4;FLOT1;ADORA2B;MAPK8IP3;UNC119;C5;MINK1;ITGA2;MAP2K5;ITGA6;IGFBP4;INSR;DDT;ETAA1;PILRB;SLC27A1;RICTOR;BMP6;MAP2K2;SQSTM1;PTK6;FZD7;PLA2G6;GDF15;CTF1;MAP3K12;CDK5R1;MAPK10;HFE;ERCC6;SHC2;EDA2R;SPRY2;MLXIPL;FBXW7;PAK6;PFKFB2;NAB2;MAP3K6;WNK1;RET;DAB2IP;FGFR4;AREG;RPS6KA5;ACVR1B;DLG4;TNFRSF25;ACSL1;IL11;ERN1;RAD50;ERBB2;AKAP6;ATG14;PRKACA;ACKR3;RIPK3;NPNT
11464,GO:0045937,0.359412224526873,0.68631555380587,77,700,positive regulation of phosphate metabolic process,BP,GPNMB;PTHLH;APOE;HSPA2;EGFR;PKD2;CAPRIN2;EPHB2;MAP3K14;DGKQ;CAMKK1;VAV3;CSPG4;KITLG;NOS1;PRKACB;RAPGEF3;F2R;TRPV4;FLOT1;ADORA2B;MAPK8IP3;UNC119;C5;MINK1;ITGA2;MAP2K5;ITGA6;IGFBP4;INSR;DDT;ETAA1;PILRB;SLC27A1;RICTOR;BMP6;MAP2K2;SQSTM1;PTK6;FZD7;PLA2G6;GDF15;CTF1;MAP3K12;CDK5R1;MAPK10;HFE;ERCC6;SHC2;EDA2R;SPRY2;MLXIPL;FBXW7;PAK6;PFKFB2;NAB2;MAP3K6;WNK1;RET;DAB2IP;FGFR4;AREG;RPS6KA5;ACVR1B;DLG4;TNFRSF25;ACSL1;IL11;ERN1;RAD50;ERBB2;AKAP6;ATG14;PRKACA;ACKR3;RIPK3;NPNT
14740,GO:0070444,0.359451461999521,0.942404120827989,1,4,oligodendrocyte progenitor proliferation,BP,GJC2
14741,GO:0070445,0.359451461999521,0.942404120827989,1,4,regulation of oligodendrocyte progenitor proliferation,BP,GJC2
6756,GO:0030195,0.359512030654947,0.819669900968759,4,30,negative regulation of blood coagulation,BP,SERPINE2;APOE;CD9;SERPING1
17337,GO:1900047,0.359512030654947,0.819669900968759,4,30,negative regulation of hemostasis,BP,SERPINE2;APOE;CD9;SERPING1
7101,GO:0030905,0.359529614588165,0.942376517347677,1,4,retromer, tubulation complex,CC,SNX1
6809,GO:0030274,0.359813575672313,0.942276155066148,1,4,LIM domain binding,MF,RPH3AL
10709,GO:0044058,0.359820939142432,0.878545996589306,2,12,regulation of digestive system process,BP,NMU;WNK1
757,GO:0001999,0.360003462035164,0.9422089833556,1,4,renal response to blood flow involved in circulatory renin-angiotensin regulation of systemic arterial blood pressure,BP,F2R
758,GO:0002001,0.360003462035164,0.9422089833556,1,4,renin secretion into blood stream,BP,F2R
4387,GO:0010042,0.360173589795715,0.878341180699398,2,12,response to manganese ion,BP,D2HGDH;TH
1607,GO:0004032,0.360218165339378,0.938723243859084,1,5,alditol:NADP+ 1-oxidoreductase activity,MF,AKR7A2
19465,GO:1990254,0.360309721894252,0.942100545377127,1,4,keratin filament binding,MF,KRT14
17068,GO:0099623,0.360327601914938,0.879512071220267,2,11,regulation of cardiac muscle cell membrane repolarization,BP,SNTA1;SCN4B
5899,GO:0018108,0.360578300999848,0.71435529088309,27,229,peptidyl-tyrosine phosphorylation,BP,EGFR;SFRP1;EPHB2;DGKQ;CSPG4;KITLG;CNTRL;UNC119;MAP2K5;INSR;TTN;CBLC;RICTOR;MAP2K2;PTK6;CTF1;ERCC6;FBXW7;STK16;RET;FGFR4;AREG;DMTN;DLG4;WEE1;IL11;ERBB2
15065,GO:0071072,0.360709186517642,0.941958921500069,1,4,negative regulation of phospholipid biosynthetic process,BP,SLC27A1
12900,GO:0051270,0.360874185866529,0.687653117794035,68,610,regulation of cellular component movement,BP,POSTN;SERPINE2;GPNMB;TP53INP1;APOE;EGFR;SFRP1;PIK3R1;CXCL14;WNT3;KITLG;PLXNB1;MDM2;IFITM1;RHOBTB2;ARPIN;F2R;CAPN7;TRPV4;C5;MINK1;ITGA2;SEMA4G;FAM110C;MAP2K5;ITGA6;SRGAP3;NISCH;INSR;MMP28;DDT;PLXNB3;DOCK8;VEGFB;HYAL1;MMRN2;BBS2;IDH2;PODXL;MCTP1;SPRY2;ARAP1;ADARB1;LRP1;PLA2G7;RET;ZMYND8;DAB2IP;MYSM1;DLG5;BST2;PLXND1;DMTN;ACVR1B;LMNA;IRS2;ALOX15B;ZSWIM8;PBLD;PHPT1;SRPX2;CD9;ERBB2;PPARG;SYNE2;ACKR3;RIPK3;ECM1
6252,GO:0019840,0.36115170137834,0.876716255682603,2,13,isoprenoid binding,MF,CYP26B1;UGT1A3
11004,GO:0044853,0.361311275032328,0.771274988607359,8,61,plasma membrane raft,CC,NOS1;F2R;FLOT1;INSR;KCNMA1;SLC2A1;AKAP6;PRKACA
7908,GO:0032489,0.361359219886718,0.941728015023059,1,4,regulation of Cdc42 protein signal transduction,BP,APOE
13854,GO:0060501,0.361388476236047,0.941717609466886,1,4,positive regulation of epithelial cell proliferation involved in lung morphogenesis,BP,FOXP2
7316,GO:0031333,0.361528934890069,0.752563168101674,11,92,negative regulation of protein complex assembly,BP,IMPACT;SPTB;ULK1;FHOD3;GSN;TRIOBP;THRA;CAPG;DMTN;EML2;CTNNBIP1
11603,GO:0046322,0.361592627324356,0.941644968105701,1,4,negative regulation of fatty acid oxidation,BP,ACACB
13757,GO:0060364,0.361624007842024,0.941633797386238,1,4,frontal suture morphogenesis,BP,GLI3
4422,GO:0010243,0.361706084694081,0.685871501598277,71,646,response to organonitrogen compound,BP,TNFAIP3;SREBF1;APOE;EGFR;PKD2;SRSF5;SFRP1;MTHFR;DGKQ;TMEM129;PIK3R1;UBXN4;STAT1;IMPACT;UROS;PRKACB;CRY1;MDM2;TNFSF10;RAPGEF3;TRPV4;ADAMTS13;GSTM2;ITGA2;VAMP2;NAIP;SESN3;INSR;GSN;BAIAP2;MGST2;SLC27A1;TCIRG1;HOMER2;ATP6V0A2;COL6A1;CA2;SESN1;CYBA;HADH;RRM2B;HLCS;FBXO2;XRN1;SLC2A1;NLRP1;EPM2AIP1;GNG2;SRR;LRP1;PDE2A;PIK3C3;PIK3R2;AREG;BTG1;DMTN;DUOX1;ZFP36L1;KAT2B;IRS2;GPR21;MAN1B1;CD9;CACNB1;AKAP6;TH;PPARG;PRKACA;UFL1;PEMT;GCLC
15893,GO:0072687,0.361745969120753,0.941590369780118,1,4,meiotic spindle,CC,HSPA2
3205,GO:0006842,0.361833515104809,0.941559184618057,1,4,tricarboxylic acid transport,BP,SLC13A5
4995,GO:0015137,0.361833515104809,0.941559184618057,1,4,citrate transmembrane transporter activity,MF,SLC13A5
4998,GO:0015142,0.361833515104809,0.941559184618057,1,4,tricarboxylic acid transmembrane transporter activity,MF,SLC13A5
5181,GO:0015746,0.361833515104809,0.941559184618057,1,4,citrate transport,BP,SLC13A5
5545,GO:0016553,0.361852447028539,0.87736379573802,2,12,base conversion or substitution editing,BP,APOBEC3C;ADARB1
9156,GO:0035521,0.362014623723668,0.941494639098272,1,4,monoubiquitinated histone deubiquitination,BP,MYSM1
9157,GO:0035522,0.362014623723668,0.941494639098272,1,4,monoubiquitinated histone H2A deubiquitination,BP,MYSM1
1918,GO:0004614,0.36204188982787,0.941484917963667,1,4,phosphoglucomutase activity,MF,PGM1
6291,GO:0019905,0.362202887169379,0.770280332006668,8,63,syntaxin binding,MF,SYT8;VAMP3;VPS11;SYTL1;C2CD4C;SYT15;VAMP2;SYT7
12660,GO:0050891,0.362258882672715,0.788812499458617,6,45,multicellular organismal water homeostasis,BP,PRKACB;CYP26B1;TRPV4;SCNN1A;ALOXE3;PRKACA
777,GO:0002036,0.36229316347448,0.941395285807718,1,4,regulation of L-glutamate import across plasma membrane,BP,PER2
4770,GO:0010958,0.36229316347448,0.941395285807718,1,4,regulation of amino acid import across plasma membrane,BP,PER2
11718,GO:0046546,0.362326573987198,0.751880921255669,11,92,development of primary male sexual characteristics,BP,SFRP1;KITLG;TNFSF10;CTSV;LHFPL2;NUPR1;INSR;CST3;ATRX;REC8;AGO4
1530,GO:0003917,0.362452690543995,0.941338337592914,1,4,DNA topoisomerase type I activity,MF,TOP3B
12152,GO:0048289,0.36247454955265,0.941330531722328,1,4,isotype switching to IgE isotypes,BP,STAT6
12155,GO:0048293,0.36247454955265,0.941330531722328,1,4,regulation of isotype switching to IgE isotypes,BP,STAT6
17728,GO:1901698,0.362603619825941,0.682474393682077,80,731,response to nitrogen compound,BP,TNFAIP3;SREBF1;APOE;EGFR;PKD2;SRSF5;SFRP1;MTHFR;DGKQ;TMEM129;PIK3R1;UBXN4;STAT1;IMPACT;UROS;PRKACB;CRY1;MDM2;TNFSF10;RAPGEF3;TRPV4;FLOT1;ADAMTS13;ZCCHC11;GSTM2;ITGA2;VAMP2;NAIP;SESN3;INSR;GSN;BAIAP2;MGST2;SLC27A1;TCIRG1;MAP2K2;HOMER2;ATP6V0A2;COL6A1;CDK5R1;ATRX;CA2;SESN1;CYBA;AGO4;HADH;RRM2B;HLCS;FBXO2;XRN1;SLC2A1;NLRP1;EPM2AIP1;GNG2;SRR;LRP1;PDE2A;PIK3C3;PIK3R2;AREG;BTG1;DMTN;DUOX1;ZFP36L1;KAT2B;IRS2;GPR21;MTR;MAN1B1;STAT6;GSTM3;CD9;CACNB1;AKAP6;TH;PPARG;PRKACA;UFL1;PEMT;GCLC
19261,GO:1905508,0.362647814415337,0.818512850811391,4,27,protein localization to microtubule organizing center,BP,NUDCD3;CEP192;CEP250;GOLGB1
8622,GO:0034154,0.362699892310677,0.941250024974365,1,4,toll-like receptor 7 signaling pathway,BP,RSAD2
3664,GO:0008154,0.362720147651607,0.730482312912691,17,147,actin polymerization or depolymerization,BP,EPS8L2;ARPIN;SPTB;WIPF1;FHOD3;GSN;BAIAP2;PLEKHH2;TRIOBP;RICTOR;MICALL2;WHAMMP3;WASH3P;CAPG;DMTN;SSH3;CIT
6201,GO:0019695,0.362882996840022,0.941184559174518,1,4,choline metabolic process,BP,ALDH7A1
5265,GO:0015914,0.363036507049762,0.787998180743317,6,46,phospholipid transport,BP,APOE;PITPNM3;PITPNM2;OSBPL10;OSBPL5;PLTP
13976,GO:0060712,0.363068844985088,0.876653242251483,2,12,spongiotrophoblast layer development,BP,ZFP36L1;GJB5
9260,GO:0035694,0.363134891090745,0.941094426662468,1,4,mitochondrial protein catabolic process,BP,SPATA18
3394,GO:0007173,0.363269907517757,0.742633045757247,13,108,epidermal growth factor receptor signaling pathway,BP,EGFR;PIK3R1;MVB12B;RHBDF1;CBLC;PTK6;SPRY2;FBXW7;ARAP1;DAB2IP;AREG;RPS6KA5;PTPN3
7120,GO:0030951,0.363302472019583,0.94103441673548,1,4,establishment or maintenance of microtubule cytoskeleton polarity,BP,LMNA
19113,GO:1905098,0.363339962814571,0.941020986394998,1,4,negative regulation of guanyl-nucleotide exchange factor activity,BP,GPSM1
12077,GO:0048070,0.363549186424579,0.876372097051729,2,12,regulation of developmental pigmentation,BP,KITLG;HPS4
14375,GO:0061647,0.363568513847289,0.800724634823141,5,36,histone H3-K9 modification,BP,KDM3A;JARID2;KDM4C;ATRX;KAT2B
16194,GO:0090257,0.363679621818563,0.738611094725051,14,118,regulation of muscle system process,BP,MYL9;NOS1;RGS2;F2R;ADORA2B;GSTM2;ITGA2;NMU;JARID2;TNNI2;LMNA;AKAP6;PRKACA;NPNT
6585,GO:0022604,0.363764810841152,0.699452504994737,39,336,regulation of cell morphogenesis,BP,POSTN;ULK2;APOE;PTPRS;CAPRIN2;OBSL1;EPHB2;WNT3;CUL7;NFATC4;PLXNB1;PARVB;RHOBTB2;ARPIN;WIPF1;SEMA4G;TRAK1;BAIAP2;PLXNB3;TRIOBP;SYNGAP1;EPB41L3;HEXB;CDK5R1;NET1;EFNB3;SHANK3;AGO4;ARAP1;FMNL2;RET;PLXND1;ZMYM3;DMTN;DLG4;ZSWIM8;SSH3;FMNL3;SMURF1
8040,GO:0032703,0.363889146638039,0.876172927069271,2,12,negative regulation of interleukin-2 production,BP,TNFAIP3;IL20RB
3328,GO:0007039,0.364031603044387,0.87608942027366,2,12,protein catabolic process in the vacuole,BP,TCIRG1;LRP1
15193,GO:0071362,0.364053360529893,0.940765072457123,1,4,cellular response to ether,BP,NFATC4
10527,GO:0043489,0.364083005634676,0.816675335784061,4,29,RNA stabilization,BP,CIRBP;THRAP3;ANGEL2;PARN
18530,GO:1903763,0.364119492979998,0.94074131505084,1,4,gap junction channel activity involved in cell communication by electrical coupling,MF,GJC2
3419,GO:0007205,0.364233605915078,0.840256356922448,3,20,protein kinase C-activating G-protein coupled receptor signaling pathway,BP,DGKQ;F2R;LRP1
4292,GO:0009725,0.364270385301729,0.683441657688842,71,645,response to hormone,BP,POSTN;SIK1;SREBF1;EGFR;SRSF5;SFRP1;PIK3R1;KDM3A;STAT1;CRY2;NOS1;PRKACB;CRY1;MDM2;TNFSF10;FAM210B;CTSV;ZFP36L2;TRPV4;ITGA2;THRAP3;VAMP2;SESN3;INSR;BAIAP2;ENDOG;SLC27A1;MDK;BMP6;TCIRG1;CST3;BBS2;TXNIP;ATP6V0A2;CDK5R1;CA2;CYBA;HADH;SLIT3;CREBRF;XRN1;CTSB;LMO2;PAQR6;THRA;SLC2A1;EPM2AIP1;GNG2;CALCOCO1;PIK3R2;AREG;BTG1;VDR;UCN2;ZFP36L1;ACSL1;KAT2B;IRS2;GPR21;TUB;GLB1;PAQR7;ABCA2;TH;RORA;PPARG;PRKACA;UFL1;KLF9;FOXP2;GCLC
10241,GO:0042989,0.36431445027258,0.934884856453835,1,6,sequestering of actin monomers,BP,GSN
17826,GO:1902035,0.364452734467376,0.940621513585394,1,4,positive regulation of hematopoietic stem cell proliferation,BP,KITLG
9460,GO:0036091,0.364454609457991,0.940620839104878,1,4,positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress,BP,CHD6
8741,GO:0034405,0.364552036312221,0.816331114332506,4,29,response to fluid shear stress,BP,PKD2;MAP2K5;CA2;TFPI2
5852,GO:0017153,0.364659643364932,0.94054705530432,1,4,sodium:dicarboxylate symporter activity,MF,SLC13A5
9365,GO:0035904,0.364682053671988,0.800161590476902,5,35,aorta development,BP,PKD2;LTBP1;LOXL1;LRP1;PLXND1
2570,GO:0005856,0.364724632167646,0.667630438912547,171,1561,cytoskeleton,CC,ITGB6;MAP6;ACTA2;INPP5D;DDX60;HSPA2;ESPN;FLNC;PKD2;CAPRIN2;SYN1;OBSL1;KIF26B;TNS1;SYNC;DGKQ;BRSK1;MARVELD1;EVC;KCNAB2;KITLG;CUL7;REEP2;OR2A4;MYL9;KRT15;WDR63;NOS1;PRKACB;FERMT1;H1F0;CNTRL;NDRG1;LZTS2;NDN;MYH11;PARVB;ACTR1B;RAPGEF3;NUDCD3;KIF26A;ADGRB2;PPL;SPTB;DNAH1;NEK9;TUBGCP5;CLTCL1;TRPV4;FLOT1;GLI2;CORO6;ANK3;RIMS3;UNC119;FRMD4B;WIPF1;SNTA1;PSKH1;NINL;RSPH3;FAM110C;GLI3;SPPL2B;FHOD3;TPGS1;NEK8;MAP2K5;GAS8;BSN;CCDC85B;GSN;CEP68;CHD3;BAIAP2;TTN;CEP126;PLEKHH2;TRIOBP;RIN1;SEPT6;RAB11FIP4;CASP14;MICALL2;MAP2K2;CEP192;CABYR;FRMD8;EPB41L3;ARHGAP33;PLA2G6;BBS2;LRRCC1;WRN;PODXL;SEPT5;DNM1;IQCB1;CDK5R1;OSBPL10;HOOK2;EPB41L4A;HFE;CYBA;CLIP2;KRT14;SPRY2;WASH3P;IFT140;RAB11FIP3;ING4;CDK5RAP3;CCDC92;DZIP1L;PGM1;TTC12;APC2;SLC2A1;REEP4;CAPG;NPHP4;SYNPO2;MYO3B;BBS1;DDHD2;SHROOM2;PIK3C3;BBS5;DEF6;KLHL3;MYO9A;APBB3;DLG5;TNS4;EML3;DMTN;ARFGEF2;ALMS1;PHF1;SHROOM4;TACC1;CCDC88B;DLG4;CCDC113;TNNI2;SHANK2;LMNA;KAT2B;MARK4;CEP250;SAC3D1;IVNS1ABP;ALOX15B;FAAH;TTC19;MYH16;KIF7;TRAF5;RANBP9;PTPN3;MPRIP;ABCA2;ATG14;SSH3;PRKACA;LDLRAP1;VMAC;SYNE2;MAP1A;TTLL1;EML2
7439,GO:0031581,0.364741874711234,0.876955463226177,2,11,hemidesmosome assembly,BP,ITGA6;KRT14
15700,GO:0072284,0.364755056436022,0.940512700875492,1,4,metanephric S-shaped body morphogenesis,BP,PKD2
16729,GO:0098528,0.36481004973394,0.940492894522802,1,4,skeletal muscle fiber differentiation,BP,CYP26B1
16497,GO:0097227,0.365245439571354,0.94033594361764,1,4,sperm annulus,CC,SEPT6
4125,GO:0009186,0.365292089007308,0.936810508412807,1,5,deoxyribonucleoside diphosphate metabolic process,BP,CMPK2
1986,GO:0004708,0.365444847339059,0.87525948626759,2,12,MAP kinase kinase activity,MF,MAP2K2;MAPK10
12557,GO:0050731,0.365476950834236,0.744570723424854,12,102,positive regulation of peptidyl-tyrosine phosphorylation,BP,DGKQ;CSPG4;KITLG;UNC119;RICTOR;PTK6;CTF1;ERCC6;FBXW7;AREG;DLG4;IL11
9946,GO:0042327,0.365540164562304,0.68192963262717,72,654,positive regulation of phosphorylation,BP,GPNMB;HSPA2;EGFR;PKD2;CAPRIN2;EPHB2;MAP3K14;DGKQ;CAMKK1;VAV3;CSPG4;KITLG;PRKACB;RAPGEF3;F2R;TRPV4;FLOT1;ADORA2B;MAPK8IP3;UNC119;C5;MINK1;MAP2K5;ITGA6;IGFBP4;INSR;DDT;ETAA1;PILRB;SLC27A1;RICTOR;BMP6;MAP2K2;SQSTM1;PTK6;FZD7;PLA2G6;GDF15;CTF1;MAP3K12;CDK5R1;MAPK10;HFE;ERCC6;SHC2;EDA2R;SPRY2;MLXIPL;FBXW7;PAK6;PFKFB2;NAB2;MAP3K6;WNK1;RET;DAB2IP;FGFR4;AREG;RPS6KA5;ACVR1B;DLG4;TNFRSF25;ACSL1;IL11;ERN1;RAD50;ERBB2;ATG14;PRKACA;ACKR3;RIPK3;NPNT
2641,GO:0005978,0.365557432318523,0.798923187649658,5,37,glycogen biosynthetic process,BP,PER2;INSR;PGM1;EPM2AIP1;IRS2
4174,GO:0009250,0.365557432318523,0.798923187649658,5,37,glucan biosynthetic process,BP,PER2;INSR;PGM1;EPM2AIP1;IRS2
12225,GO:0048514,0.365648245252581,0.694830795237356,43,374,blood vessel morphogenesis,BP,TNFAIP3;TGFBI;GPNMB;APOE;PKD2;PLCD3;SFRP1;EPHB2;VAV3;CSPG4;CUL7;STAT1;UNC5B;HOXA3;NFATC4;PLCD1;RAPGEF3;ADGRB2;C5;MAP2K5;VEGFB;HYAL1;SH2D2A;MMRN2;SPRY2;LRP1;DAB2IP;TEAD2;RNF213;FGFR4;BTG1;PLXND1;NRARP;ZFP36L1;APOLD1;TNFSF12;SRPX2;ERBB2;RORA;PPARG;FMNL3;ACKR3;ECM1
16462,GO:0097167,0.365680425613042,0.940178887799207,1,4,circadian regulation of translation,BP,PER2
2541,GO:0005801,0.365738865683566,0.785663348330254,6,47,cis-Golgi network,CC,PIK3R1;GOLGA8A;GOLGA8B;GOLGA8N;MPPE1;GOLGB1
14163,GO:0061086,0.365790750848495,0.940139014003655,1,4,negative regulation of histone H3-K27 methylation,BP,PHF1
4758,GO:0010940,0.365890081838417,0.936582747539334,1,5,positive regulation of necrotic cell death,BP,RIPK3
4150,GO:0009214,0.366170003714023,0.87612266016654,2,11,cyclic nucleotide catabolic process,BP,RAPGEF3;PDE2A
7481,GO:0031657,0.366348677885425,0.874727276406527,2,12,regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle,BP,EGFR;PKD2
13260,GO:0051969,0.366444326066988,0.939902467780017,1,4,regulation of transmission of nerve impulse,BP,ITGA2
19847,GO:2000347,0.367275670607733,0.939600763382107,1,4,positive regulation of hepatocyte proliferation,BP,TNFAIP3
12826,GO:0051156,0.367276859495416,0.837067838933546,3,22,glucose 6-phosphate metabolic process,BP,H6PD;G6PC3;PGLS
1696,GO:0004176,0.367469318462589,0.939530354583759,1,4,ATP-dependent peptidase activity,MF,LONP2
1269,GO:0003062,0.367590614821009,0.939486226822619,1,4,regulation of heart rate by chemical signal,BP,SREBF1
18288,GO:1903232,0.367702945192846,0.935889251236098,1,5,melanosome assembly,BP,HPS4
4252,GO:0009581,0.367841747200796,0.775351628694954,7,47,detection of external stimulus,BP,SERPINE2;PKD2;EYS;UNC119;ITGA2;TTN;ANO1
15101,GO:0071211,0.368180264637132,0.939271432796336,1,4,protein targeting to vacuole involved in autophagy,BP,SMURF1
2246,GO:0005159,0.368234584155701,0.873613182743068,2,12,insulin-like growth factor receptor binding,MF,PIK3R1;INSR
12587,GO:0050786,0.368251917608425,0.930430063475434,1,8,RAGE receptor binding,MF,S100A4
12568,GO:0050764,0.368345640367753,0.796512883411747,5,38,regulation of phagocytosis,BP,ITGA2;CYBA;SYT7;TUB;PPARG
2992,GO:0006537,0.368363776078484,0.939204489983603,1,4,glutamate biosynthetic process,BP,GLUD1
10993,GO:0044821,0.368391949558302,0.939194208660377,1,4,meiotic telomere tethering at nuclear periphery,BP,SUN1
14606,GO:0070197,0.368391949558302,0.939194208660377,1,4,meiotic attachment of telomere to nuclear envelope,BP,SUN1
16505,GO:0097240,0.368391949558302,0.939194208660377,1,4,chromosome attachment to the nuclear envelope,BP,SUN1
4461,GO:0010457,0.368596016159575,0.874701572860599,2,11,centriole-centriole cohesion,BP,CEP68;CEP250
12641,GO:0050865,0.369000509958282,0.698614003711473,34,308,regulation of cell activation,BP,TNFAIP3;SERPINE2;GPNMB;APOE;INPP5D;SFRP1;MAP3K14;PIK3R1;VAV3;CYP26B1;IL20RB;ZFP36L2;GLI2;ADORA2B;TNFRSF14;GLI3;GSN;DOCK8;TNFRSF21;EFNB3;HFE;DLG5;DMTN;NRARP;CCDC88B;ZFP36L1;IRS2;STAT6;SOX13;CD9;ERBB2;RORA;RIPK3;GCLC
11468,GO:0045944,0.369152582722733,0.674552010926803,87,788,positive regulation of transcription by RNA polymerase II,BP,SREBF1;EGFR;PKD2;CAPRIN2;ASH2L;PIK3R1;KDM3A;POU3F1;RGMA;ZFPM1;CITED4;IRF2BPL;MC1R;STAT1;NOS1;MAML3;KLF13;NFATC4;HSF4;EAPP;CRTC1;NDN;GLI2;KLF7;TCEA2;ZNF76;SOX12;ABHD14B;WWTR1;GLI3;THRAP3;MAP2K5;ITGA6;RTF1;BMP6;SQSTM1;ETV5;DLX3;HEXB;METTL23;TCF4;PLAG1;LPIN3;ATRX;ADIRF;MEF2D;CREBRF;MLXIPL;FBXW7;CDK5RAP3;LMO2;NFIX;CARF;THRA;RAI1;ELF1;IKZF4;DBP;PEG3;RFX2;SALL2;MAF;STK16;DAB2IP;CALCOCO1;TEAD2;MYSM1;IFI16;PIK3R2;TEF;RPS6KA5;VDR;MAMSTR;PLXND1;SIX5;HLTF;ZNF292;TFDP2;ACVR1B;GLMP;IL11;KAT2B;STAT6;CHD6;RORA;PPARG;NPNT
14343,GO:0061588,0.369191962426369,0.938901819372817,1,4,calcium activated phospholipid scrambling,BP,ANO9
14344,GO:0061589,0.369191962426369,0.938901819372817,1,4,calcium activated phosphatidylserine scrambling,BP,ANO9
14345,GO:0061590,0.369191962426369,0.938901819372817,1,4,calcium activated phosphatidylcholine scrambling,BP,ANO9
14346,GO:0061591,0.369191962426369,0.938901819372817,1,4,calcium activated galactosylceramide scrambling,BP,ANO9
2518,GO:0005773,0.36926966261646,0.68063575472023,65,601,vacuole,CC,TNFAIP3;TP53INP1;PYGB;CTSO;CSPG4;CYBRD1;NAPRT;NSG1;SDC3;GAA;VPS11;NAGLU;IDUA;HGSNAT;CTSV;HPS4;FLOT1;ANK3;LAMP3;ATG16L2;SPG11;CLCN6;DIRC2;HEXA;ARSD;ULK1;SPPL2B;GPC2;CTSF;VPS39;TMEM9;TCIRG1;SQSTM1;HEXB;HYAL1;CST3;ATP6V0A2;COL6A1;WASH3P;CTSB;TBC1D17;LRP1;PEG3;ACP5;C12ORF66;SLC48A1;PIK3C3;SYT7;BST2;MARCH8;SLC36A4;SNX1;CD68;GLMP;LAPTM4A;SGSH;GLB1;DPP7;CTSD;SYNGR1;ABCA2;ATG14;C6ORF120;PI4K2B;CLCN7
12398,GO:0048861,0.36959449316214,0.938754379477192,1,4,leukemia inhibitory factor signaling pathway,BP,CTF1
12335,GO:0048714,0.369835920860547,0.872663371577325,2,12,positive regulation of oligodendrocyte differentiation,BP,TENM4;PPARG
3872,GO:0008504,0.369845334953457,0.938662391207379,1,4,monoamine transmembrane transporter activity,MF,SLC29A4
17318,GO:1900019,0.369990472926913,0.938609128092681,1,4,regulation of protein kinase C activity,BP,EGFR
17319,GO:1900020,0.369990472926913,0.938609128092681,1,4,positive regulation of protein kinase C activity,BP,EGFR
6925,GO:0030534,0.370117868244921,0.763726345856133,8,63,adult behavior,BP,SLITRK6;TPGS1;HOMER2;BBS2;DNM1;EFNB3;SHANK3;SHANK2
10182,GO:0042799,0.370164621559395,0.938545181436477,1,4,histone methyltransferase activity (H4-K20 specific),MF,KMT5C
1402,GO:0003338,0.370264661861328,0.83613335037705,3,20,metanephros morphogenesis,BP,PKD2;KIF26B;STAT1
10943,GO:0044703,0.370347846534548,0.681529609342822,60,549,multi-organism reproductive process,BP,SERPINE2;PTHLH;GAMT;HSPA2;SYT8;TXNRD3;KDM3A;WNT3;TFCP2L1;ZFP41;SCMH1;CRTAP;CYP26B1;MLH3;CTSV;SPATA20;RGS2;DNAH1;MICALCL;LHFPL2;ITGA2;TPGS1;TCFL5;HSF2BP;SUN1;SEPT6;CABYR;ETV5;HEXB;PLA2G6;CST3;BBS2;MCM9;ATRX;REC8;HFE;AGO4;CTSB;THRA;SLC2A1;CCDC136;RFX2;TMEM203;BTG1;VDR;DPY19L2P2;SIX5;ACVR1B;TSSK1B;ENDOU;PHC2;CD9;PAQR7;TH;PRKACA;NPAP1;PARN;HERPUD2;TTLL1;GLIPR1L2
14282,GO:0061438,0.37046067910389,0.938436377327578,1,4,renal system vasculature morphogenesis,BP,PKD2
14283,GO:0061439,0.37046067910389,0.938436377327578,1,4,kidney vasculature morphogenesis,BP,PKD2
14582,GO:0070164,0.370465491194022,0.938434607868591,1,4,negative regulation of adiponectin secretion,BP,RAB11FIP3
19049,GO:1904951,0.370467576072391,0.694681659666844,37,329,positive regulation of establishment of protein localization,BP,POSTN;EGFR;GLUD1;FERMT1;VPS11;MDM2;RAPGEF3;F2R;HPS4;TRPV4;NLGN2;ANK3;C5;GLI3;VAMP2;NMU;TTN;TM7SF3;BMP6;MICALL2;PLA2G6;OSCP1;CDK5R1;FBXW7;PFKFB2;RPH3AL;NLRP1;GLUL;LRP1;TFDP2;IRS2;ANO1;ALOX15B;PHPT1;ERBB2;GPR68;PEMT
5987,GO:0018958,0.370478084873844,0.781884580641976,6,47,phenol-containing compound metabolic process,BP,DDT;PMEL;SNCB;DUOX1;TH;GCNT4
19154,GO:1905232,0.370509839141708,0.938418299179555,1,4,cellular response to L-glutamate,BP,BAIAP2
13516,GO:0055123,0.370659823864129,0.750304087252716,10,79,digestive system development,BP,EGFR;SFRP1;GLI2;GLI3;ITGA6;INSR;PTK6;NPHP3;RET;TCF7
14547,GO:0070098,0.370699172780122,0.834708309368557,3,22,chemokine-mediated signaling pathway,BP,CXCR1;SLIT3;ACKR3
5372,GO:0016185,0.37083361467307,0.938299152996255,1,4,synaptic vesicle budding from presynaptic endocytic zone membrane,BP,DNM1
16877,GO:0098844,0.37083361467307,0.938299152996255,1,4,postsynaptic endocytic zone membrane,CC,DNM1
16895,GO:0098884,0.37083361467307,0.938299152996255,1,4,postsynaptic neurotransmitter receptor internalization,BP,DNM1
16755,GO:0098586,0.371013049035958,0.79470986907657,5,37,cellular response to virus,BP,DDX60;VWCE;DHX58;NLRX1;TKFC
20276,GO:2001286,0.37137079496928,0.938101166556226,1,4,regulation of caveolin-mediated endocytosis,BP,UNC119
12124,GO:0048243,0.371410536423707,0.938086503855401,1,4,norepinephrine secretion,BP,NISCH
12496,GO:0050656,0.371488382416703,0.938057776267015,1,4,3'-phosphoadenosine 5'-phosphosulfate binding,MF,GAL3ST4
9402,GO:0035977,0.371800177019574,0.937942632991233,1,4,protein deglycosylation involved in glycoprotein catabolic process,BP,MAN1B1
16598,GO:0097466,0.371800177019574,0.937942632991233,1,4,ubiquitin-dependent glycoprotein ERAD pathway,BP,MAN1B1
18794,GO:1904382,0.371800177019574,0.937942632991233,1,4,mannose trimming involved in glycoprotein ERAD pathway,BP,MAN1B1
18878,GO:1904587,0.371800177019574,0.937942632991233,1,4,response to glycoprotein,BP,MAN1B1
14052,GO:0060872,0.371877736361185,0.937913970704682,1,4,semicircular canal development,BP,GLI3
11014,GO:0044877,0.371878079428059,0.675601908497825,73,662,protein-containing complex binding,MF,TGFBI;TAGLN;ITGB6;GPNMB;DDB2;APOE;EGFR;ESPN;FLNC;OBSL1;MTHFR;EPHB2;PIK3R1;RNF135;ISG15;IMPACT;CRTAP;MDM2;FCGRT;LTBP4;MYH11;TNXB;SPTB;TRPV4;CORO6;ADAMTS13;WIPF1;ITGA2;ULK1;SMARCA1;ITGA6;NISCH;INSR;GSN;TTN;TRIOBP;RTF1;RICTOR;MICALL2;WHAMMP3;WRN;TREX1;CDK5R1;NID1;ERCC6;KRT14;MRC2;CTSB;CAPG;LRP1;CENPH;DAB2IP;MYSM1;SHROOM2;LETMD1;DMTN;PHF1;SNX1;ACVR1B;SHROOM4;DLG4;KAT2B;IRS2;PEX1;CD9;UVSSA;LDLRAP1;SYNE2;LAMB2;RIPK3;ECM2;SMURF1;NPNT
5367,GO:0016174,0.372078521364886,0.937839732540293,1,4,NAD(P)H oxidase activity,MF,DUOX1
17321,GO:1900025,0.372094137458347,0.871317959211911,2,12,negative regulation of substrate adhesion-dependent cell spreading,BP,POSTN;DMTN
2521,GO:0005776,0.372263053598604,0.748577312145226,10,83,autophagosome,CC,TP53INP1;VPS11;ATG16L2;ULK1;SQSTM1;WASH3P;TBC1D17;PEG3;PIK3C3;ATG14
2602,GO:0005901,0.372438055930383,0.770464364897156,7,53,caveola,CC,NOS1;F2R;FLOT1;INSR;KCNMA1;SLC2A1;AKAP6
314,GO:0000827,0.372445287352086,0.937703985029535,1,4,inositol-1,3,4,5,6-pentakisphosphate kinase activity,MF,IP6K2
315,GO:0000828,0.372445287352086,0.937703985029535,1,4,inositol hexakisphosphate kinase activity,MF,IP6K2
316,GO:0000829,0.372445287352086,0.937703985029535,1,4,inositol heptakisphosphate kinase activity,MF,IP6K2
317,GO:0000832,0.372445287352086,0.937703985029535,1,4,inositol hexakisphosphate 5-kinase activity,MF,IP6K2
13376,GO:0052723,0.372445287352086,0.937703985029535,1,4,inositol hexakisphosphate 1-kinase activity,MF,IP6K2
13377,GO:0052724,0.372445287352086,0.937703985029535,1,4,inositol hexakisphosphate 3-kinase activity,MF,IP6K2
6901,GO:0030496,0.372897640036014,0.718938313417518,18,155,midbody,CC,OR2A4;CNTRL;CEP126;TRIOBP;SEPT6;RAB11FIP4;CENPC;RAB11FIP3;CHMP1B;APC2;SLC2A1;CAPG;KLHDC8B;PIK3C3;EXOC2;TACC1;TTC19;CIT
14692,GO:0070345,0.372984851484248,0.937503953214453,1,4,negative regulation of fat cell proliferation,BP,PER2
18546,GO:1903795,0.372996006324491,0.937499813671489,1,4,regulation of inorganic anion transmembrane transport,BP,ANO9
14549,GO:0070100,0.373001012782938,0.937497955728463,1,4,negative regulation of chemokine-mediated signaling pathway,BP,SLIT3
17867,GO:1902170,0.373056665466611,0.870742368443201,2,12,cellular response to reactive nitrogen species,BP,MTR;STAT6
150,GO:0000306,0.373068153691657,0.937473035862858,1,4,extrinsic component of vacuolar membrane,CC,ULK1
8785,GO:0034485,0.373585453678039,0.937280832783161,1,4,phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity,MF,INPP5D
3365,GO:0007127,0.373633500735322,0.760315178339142,8,67,meiosis I,BP,HSPA2;MLH3;SUN1;CENPC;REC8;AGO4;RAD50;MSH5
9491,GO:0036150,0.373731548174131,0.870338028874634,2,12,phosphatidylserine acyl-chain remodeling,BP,OSBPL10;OSBPL5
11028,GO:0045022,0.373772673120697,0.792302008597343,5,38,early endosome to late endosome transport,BP,VPS11;MAP2K2;HOOK2;WASH3P;PIK3C3
11667,GO:0046466,0.374073788253673,0.832367362270681,3,22,membrane lipid catabolic process,BP,MGST2;HEXB;SMPDL3B
17474,GO:1900452,0.374113417920767,0.937084296199102,1,4,regulation of long term synaptic depression,BP,SHANK3
2642,GO:0005979,0.374116265984791,0.834144248735627,3,19,regulation of glycogen biosynthetic process,BP,INSR;EPM2AIP1;IRS2
4774,GO:0010962,0.374116265984791,0.834144248735627,3,19,regulation of glucan biosynthetic process,BP,INSR;EPM2AIP1;IRS2
9822,GO:0042059,0.374134450344818,0.79177001298016,5,39,negative regulation of epidermal growth factor receptor signaling pathway,BP,EGFR;CBLC;SPRY2;DAB2IP;PTPN3
708,GO:0001934,0.374359059672696,0.674804087256939,68,620,positive regulation of protein phosphorylation,BP,GPNMB;HSPA2;EGFR;PKD2;CAPRIN2;EPHB2;MAP3K14;DGKQ;CAMKK1;CSPG4;KITLG;PRKACB;RAPGEF3;F2R;TRPV4;FLOT1;ADORA2B;MAPK8IP3;UNC119;C5;MINK1;MAP2K5;IGFBP4;INSR;DDT;ETAA1;PILRB;SLC27A1;RICTOR;BMP6;MAP2K2;SQSTM1;PTK6;FZD7;PLA2G6;GDF15;CTF1;MAP3K12;CDK5R1;MAPK10;HFE;ERCC6;SHC2;EDA2R;SPRY2;FBXW7;PAK6;NAB2;MAP3K6;WNK1;RET;DAB2IP;FGFR4;AREG;RPS6KA5;ACVR1B;DLG4;TNFRSF25;ACSL1;IL11;ERN1;RAD50;ERBB2;ATG14;PRKACA;ACKR3;RIPK3;NPNT
17229,GO:0120031,0.374463614027373,0.683417012213211,48,429,plasma membrane bounded cell projection assembly,BP,ESPN;EPS8L2;EVI5L;VAV3;UNC119B;CNTRL;PARVB;NUDCD3;DNAH1;UNC119;NINL;WWTR1;ARHGEF4;TPGS1;GAS8;ITGA6;GSN;PLXNB3;CEP126;SEPT6;CEP192;BBS2;NPHP3;PODXL;SEPT5;IQCB1;IFT140;DZIP1L;ARAP1;NPHP4;RFX2;BBS1;ATXN10;ZMYND8;BBS5;BBS10;TMEM80;DMTN;ALMS1;TMEM231;PMP22;CCDC113;MARK4;CEP250;SSH3;PRKACA;SYNE2;TTLL1
10298,GO:0043090,0.374628368891905,0.869799749894495,2,12,amino acid import,BP,PER2;SLC36A4
11333,GO:0045682,0.374694481627264,0.75954297836272,8,66,regulation of epidermis development,BP,FERMT1;CTSV;CD109;NAB2;MYSM1;VDR;ZFP36L1;ALOX15B
10504,GO:0043433,0.374711212480589,0.728758876410105,14,121,negative regulation of DNA binding transcription factor activity,BP,TNFAIP3;SIK1;PKD2;RBCK1;BHLHE40;MAP2K5;NLRX1;CDK5RAP3;MXI1;THRA;DAB2IP;RWDD3;UFL1;CTNNBIP1
727,GO:0001957,0.374754320741796,0.936845213376593,1,4,intramembranous ossification,BP,MN1
9454,GO:0036072,0.374754320741796,0.936845213376593,1,4,direct ossification,BP,MN1
12951,GO:0051353,0.374794640616315,0.808051238161145,4,31,positive regulation of oxidoreductase activity,BP,APOE;CYBA;VDR;RIPK3
14004,GO:0060750,0.375029967875754,0.936742215493998,1,4,epithelial cell proliferation involved in mammary gland duct elongation,BP,AREG
4706,GO:0010871,0.375384044143029,0.93660976148771,1,4,negative regulation of receptor biosynthetic process,BP,PPARG
16147,GO:0090188,0.375394417870694,0.936605878298274,1,4,negative regulation of pancreatic juice secretion,BP,WNK1
11312,GO:0045652,0.375736388277745,0.775232652273212,6,65,regulation of megakaryocyte differentiation,BP,ASH2L;ZFPM1;MYL9;AGO4;TNRC6C;KAT2B
10011,GO:0042462,0.375743297541744,0.869129014964564,2,12,eye photoreceptor cell development,BP,NAGLU;TH
15572,GO:0072074,0.375767894846084,0.869114198032448,2,12,kidney mesenchyme development,BP,PKD2;STAT1
12671,GO:0050908,0.376013704528342,0.93637379786396,1,4,detection of light stimulus involved in visual perception,BP,EYS
12703,GO:0050962,0.376013704528342,0.93637379786396,1,4,detection of light stimulus involved in sensory perception,BP,EYS
3502,GO:0007406,0.376029750511959,0.936367777672479,1,4,negative regulation of neuroblast proliferation,BP,KCTD11
2643,GO:0005980,0.376113163158563,0.832091822022723,3,20,glycogen catabolic process,BP,PYGB;GAA;PGM1
13724,GO:0060318,0.376482019094684,0.936197950669482,1,4,definitive erythrocyte differentiation,BP,ZFPM1
11668,GO:0046467,0.376500437493722,0.730624950318096,13,116,membrane lipid biosynthetic process,BP,KDSR;ST6GALNAC6;CERS4;GAL3ST4;B4GALT6;ST3GAL5;PGAP1;PLA2G6;PIGZ;MPPE1;ALOXE3;CERS5;PEMT
12450,GO:0050321,0.376779515545969,0.868504094259705,2,12,tau-protein kinase activity,MF,BRSK1;MARK4
1731,GO:0004331,0.376837258725048,0.93606436401486,1,4,fructose-2,6-bisphosphate 2-phosphatase activity,MF,PFKFB2
2659,GO:0006003,0.376837258725048,0.93606436401486,1,4,fructose 2,6-bisphosphate metabolic process,BP,PFKFB2
8333,GO:0033194,0.376854368087194,0.867336212982718,2,13,response to hydroperoxide,BP,TP53INP1;GPX3
12892,GO:0051258,0.376864570927114,0.705189875330865,23,204,protein polymerization,BP,EPS8L2;RGS2;ARPIN;SPTB;TUBGCP5;TRPV4;WIPF1;FHOD3;GSN;BAIAP2;TRIOBP;RICTOR;MICALL2;CEP192;WHAMMP3;DNM1;CDK5R1;WASH3P;MX2;CAPG;DMTN;RANBP9;EML2
16934,GO:0098957,0.37687425622131,0.936050441409766,1,4,anterograde axonal transport of mitochondrion,BP,TRAK1
10584,GO:0043568,0.377167897324316,0.935939874965992,1,4,positive regulation of insulin-like growth factor receptor signaling pathway,BP,IGFBP4
17551,GO:1901185,0.377248278226637,0.776260265093053,6,48,negative regulation of ERBB signaling pathway,BP,EGFR;CBLC;SPRY2;DAB2IP;PTPN3;ERBB2
10611,GO:0043622,0.377541038113584,0.935799205465675,1,4,cortical microtubule organization,BP,TRPV4
6731,GO:0030155,0.377629567856728,0.681024471011966,47,418,regulation of cell adhesion,BP,TGFBI;POSTN;SERPINE2;GPNMB;SFRP1;KIF26B;MAP3K14;PIK3R1;VAV3;SMOC2;FERMT1;PLXNB1;SPOCK1;NINJ1;IL20RB;TRPV4;FLOT1;GLI2;ANK3;MINK1;TNFRSF14;ITGA2;GLI3;MAP2K5;ITGA6;GSN;PLXNB3;TRIOBP;DOCK8;FZD7;HYAL1;PODXL;TNFRSF21;NET1;EFNB3;HFE;NID1;RET;DLG5;PLXND1;DMTN;NRARP;CCDC88B;CD9;ERBB2;ECM2;NPNT
14655,GO:0070290,0.377649274030526,0.935758366535376,1,4,N-acylphosphatidylethanolamine-specific phospholipase D activity,MF,PLD3
6706,GO:0030122,0.378077420843684,0.867719263577715,2,12,AP-2 adaptor complex,CC,EGFR;LDLRAP1
9797,GO:0040037,0.378279134602643,0.867597080181928,2,12,negative regulation of fibroblast growth factor receptor signaling pathway,BP,SULF2;SPRY2
6896,GO:0030478,0.378432707342182,0.935462292231699,1,4,actin cap,CC,GSN
16291,GO:0090482,0.378557117598561,0.867428606271759,2,12,vitamin transmembrane transporter activity,MF,SLC2A3;SLC2A1
12199,GO:0048406,0.378749860581865,0.935342197010385,1,4,nerve growth factor binding,MF,PCSK6
4955,GO:0015026,0.378864850870368,0.830175512417774,3,20,coreceptor activity,MF,RGMA;PTK7;ACKR3
15383,GO:0071664,0.379286116605513,0.935138823893607,1,4,catenin-TCF7L2 complex,CC,TCF4
11565,GO:0046135,0.379294818965977,0.864887602539539,2,14,pyrimidine nucleoside catabolic process,BP,NT5E;APOBEC3C
11144,GO:0045214,0.379371098474384,0.809689475265225,4,21,sarcomere organization,BP,OBSL1;OBSCN;FHOD3;TTN
18780,GO:1904352,0.379529276543754,0.935046477467734,1,4,positive regulation of protein catabolic process in the vacuole,BP,LRP1
4030,GO:0009064,0.379553566863353,0.774397833395764,6,48,glutamine family amino acid metabolic process,BP,GLUD1;NOS1;PRODH;ALDH4A1;GLUL;GCLC
1816,GO:0004468,0.379745165645593,0.934964420407166,1,4,lysine N-acetyltransferase activity, acting on acetyl phosphate as donor,MF,KAT2B
7419,GO:0031528,0.379989323357444,0.866558911379157,2,12,microvillus membrane,CC,SYTL1;PODXL
8030,GO:0032688,0.380028553933692,0.865398773284364,2,13,negative regulation of interferon-beta production,BP,PTPRS;NLRX1
4170,GO:0009240,0.380038517426157,0.931048606448915,1,5,isopentenyl diphosphate biosynthetic process,BP,MVD
11684,GO:0046490,0.380038517426157,0.931048606448915,1,5,isopentenyl diphosphate metabolic process,BP,MVD
6665,GO:0030031,0.380073972069548,0.677558478420039,49,439,cell projection assembly,BP,ESPN;EPS8L2;EVI5L;VAV3;UNC119B;CNTRL;PARVB;NUDCD3;DNAH1;UNC119;NINL;WWTR1;ARHGEF4;FAM110C;TPGS1;GAS8;ITGA6;GSN;PLXNB3;CEP126;SEPT6;CEP192;BBS2;NPHP3;PODXL;SEPT5;IQCB1;IFT140;DZIP1L;ARAP1;NPHP4;RFX2;BBS1;ATXN10;ZMYND8;BBS5;BBS10;TMEM80;DMTN;ALMS1;TMEM231;PMP22;CCDC113;MARK4;CEP250;SSH3;PRKACA;SYNE2;TTLL1
4749,GO:0010923,0.380163312835178,0.74801486493205,9,73,negative regulation of phosphatase activity,BP,ELFN2;CRY2;PHACTR3;CEP192;WNK1;PPP1R2;PPP1R35;LMTK3;SPOCD1
18222,GO:1903054,0.38019289780745,0.930986667831054,1,5,negative regulation of extracellular matrix organization,BP,CST3
19538,GO:1990564,0.38026519304207,0.930957650784522,1,5,protein polyufmylation,BP,UFL1
19550,GO:1990592,0.38026519304207,0.930957650784522,1,5,protein K69-linked ufmylation,BP,UFL1
7580,GO:0031956,0.380293079151875,0.934755879487635,1,4,medium-chain fatty acid-CoA ligase activity,MF,ACSL1
17125,GO:0102391,0.380293079151875,0.934755879487635,1,4,decanoate-CoA ligase activity,MF,ACSL1
16485,GO:0097205,0.380324681849991,0.866354857368907,2,12,renal filtration,BP,SULF2;F2R
7639,GO:0032058,0.380456194961444,0.934693717062974,1,4,positive regulation of translational initiation in response to stress,BP,IMPACT
13456,GO:0055013,0.380502290596506,0.776023871105604,6,38,cardiac muscle cell development,BP,OBSL1;MYH11;FHOD3;TTN;LMNA;AKAP6
5682,GO:0016801,0.380521199179655,0.865096822404641,2,13,hydrolase activity, acting on ether bonds,MF,AKR7A2;RNPEP
13908,GO:0060592,0.380585298835408,0.934644490648932,1,4,mammary gland formation,BP,GLI3
7936,GO:0032535,0.380627785960428,0.692078123749181,30,264,regulation of cellular component size,BP,ULK2;APOE;PTPRS;EPS8L2;WNT3;VAV3;ARPIN;SPTB;TRPV4;CLCN6;WIPF1;SEMA4G;FHOD3;GSN;BAIAP2;PLEKHH2;TRIOBP;RICTOR;SLC12A7;WHAMMP3;PEX11B;CDK5R1;SHANK3;WASH3P;KCNMA1;CAPG;RET;DMTN;SSH3;CIT
15137,GO:0071276,0.380663702405407,0.826800152953615,3,24,cellular response to cadmium ion,BP,EGFR;MT1X;GSN
20212,GO:2001179,0.380680582025176,0.930790782784809,1,5,regulation of interleukin-10 secretion,BP,TNFRSF21
19945,GO:2000542,0.380955388211974,0.934503252086358,1,4,negative regulation of gastrulation,BP,FZD7
10876,GO:0044430,0.380995518959095,0.655937632124059,130,1188,cytoskeletal part,CC,ITGB6;MAP6;HSPA2;ESPN;PKD2;CAPRIN2;OBSL1;KIF26B;SYNC;BRSK1;EVC;KCNAB2;CUL7;REEP2;OR2A4;MYL9;KRT15;WDR63;PRKACB;FERMT1;CNTRL;NDRG1;LZTS2;NDN;MYH11;ACTR1B;RAPGEF3;NUDCD3;KIF26A;ADGRB2;SPTB;DNAH1;NEK9;TUBGCP5;CLTCL1;TRPV4;FLOT1;GLI2;UNC119;WIPF1;PSKH1;NINL;FAM110C;GLI3;SPPL2B;FHOD3;TPGS1;NEK8;MAP2K5;GAS8;CCDC85B;GSN;CEP68;CHD3;BAIAP2;TTN;CEP126;PLEKHH2;TRIOBP;SEPT6;RAB11FIP4;CASP14;MICALL2;MAP2K2;CEP192;PLA2G6;BBS2;LRRCC1;WRN;PODXL;SEPT5;DNM1;IQCB1;CDK5R1;HOOK2;HFE;CYBA;CLIP2;KRT14;SPRY2;WASH3P;IFT140;RAB11FIP3;CDK5RAP3;CCDC92;DZIP1L;TTC12;APC2;SLC2A1;REEP4;CAPG;NPHP4;SYNPO2;MYO3B;BBS1;DDHD2;SHROOM2;PIK3C3;BBS5;MYO9A;DLG5;EML3;DMTN;ARFGEF2;ALMS1;PHF1;SHROOM4;TACC1;CCDC88B;CCDC113;TNNI2;SHANK2;LMNA;KAT2B;MARK4;CEP250;SAC3D1;TTC19;MYH16;KIF7;TRAF5;RANBP9;ABCA2;ATG14;PRKACA;LDLRAP1;VMAC;MAP1A;TTLL1;EML2
18457,GO:1903580,0.381018259384078,0.828057189008337,3,21,positive regulation of ATP metabolic process,BP,INSR;MLXIPL;PFKFB2
14125,GO:0061025,0.381104159166655,0.706957283243824,20,176,membrane fusion,BP,SYT8;EVI5L;VAV3;VAMP3;TBC1D8;VPS11;SYTL1;C2CD4C;SPG11;SYT15;VAMP2;VPS39;DNM1;MX2;TBC1D17;TSNARE1;SYT7;TBC1D16;SGSM2;CD9
12411,GO:0048878,0.381149682509852,0.667949609535404,69,641,chemical homeostasis,BP,IFI6;APOE;EGFR;PKD2;PIK3R1;CYBRD1;STAT1;CRY2;NOS1;PRKACB;CRY1;CYP26B1;ITPR3;NEO1;OAS1;F2R;MT1X;SLC24A1;TRPV4;ANK3;GSTM2;NMU;SESN3;INSR;SCNN1A;ENDOG;BMP6;TCIRG1;SLC12A7;HEXB;PLA2G6;HOMER2;ATP6V0A2;MALL;CA2;HFE;CYBA;MLXIPL;FBXW7;KCNMA1;RPH3AL;JPH2;ACOX3;FGFR4;PIK3R2;TMEM203;KLHL3;VDR;LETMD1;CACNB3;LPAR6;DLG4;ALOXE3;IRS2;DMXL2;ANO1;ERN1;GPR21;PHPT1;PTPN3;GPR68;ABCA2;AKAP6;TH;RORA;PPARG;PRKACA;LDLRAP1;GCLC
11373,GO:0045765,0.381208462687772,0.707010893057382,20,171,regulation of angiogenesis,BP,TNFAIP3;GPNMB;SFRP1;STAT1;RAPGEF3;ADGRB2;C5;MAP2K5;VEGFB;HYAL1;MMRN2;SPRY2;DAB2IP;BTG1;PLXND1;TNFSF12;SRPX2;ERBB2;PPARG;ECM1
16238,GO:0090314,0.381406981748073,0.82723129753171,3,22,positive regulation of protein targeting to membrane,BP,ANK3;CDK5R1;ERBB2
19535,GO:1990535,0.381494149962764,0.934297308169143,1,4,neuron projection maintenance,BP,INSR
18097,GO:1902803,0.381640954894385,0.828232587007287,3,20,regulation of synaptic vesicle transport,BP,SYN1;RIMS3;SEPT5
9044,GO:0035278,0.381641179195393,0.865552307371865,2,12,miRNA mediated inhibition of translation,BP,AGO4;TNRC6C
9794,GO:0040033,0.381641179195393,0.865552307371865,2,12,negative regulation of translation, ncRNA-mediated,BP,AGO4;TNRC6C
11480,GO:0045974,0.381641179195393,0.865552307371865,2,12,regulation of translation, ncRNA-mediated,BP,AGO4;TNRC6C
14297,GO:0061476,0.382009690852943,0.934099869079314,1,4,response to anticoagulant,BP,SFRP1
15290,GO:0071503,0.382009690852943,0.934099869079314,1,4,response to heparin,BP,SFRP1
15291,GO:0071504,0.382009690852943,0.934099869079314,1,4,cellular response to heparin,BP,SFRP1
17873,GO:1902177,0.38200993098372,0.930255114393642,1,5,positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,BP,FBXW7
12971,GO:0051402,0.382039884875279,0.710563949080466,18,159,neuron apoptotic process,BP,APOE;UNC5B;F2R;NAIP;MDK;SYNGAP1;MAP3K12;TNFRSF21;CDK5R1;FBXW7;ADARB1;NLRP1;LRP1;SCN2A;SNCB;TRIM2;CIT;GCLC
17468,GO:1900424,0.3823140165085,0.863995126155728,2,13,regulation of defense response to bacterium,BP,CYBA;KLK5
7740,GO:0032262,0.382315656572675,0.930131564745965,1,5,pyrimidine nucleotide salvage,BP,UCKL1
10104,GO:0042636,0.382354586479959,0.933967579806286,1,4,negative regulation of hair cycle,BP,FERMT1
3476,GO:0007320,0.382425225134446,0.93394046532656,1,4,insemination,BP,SERPINE2
11274,GO:0045601,0.382483258691245,0.827641168479684,3,20,regulation of endothelial cell differentiation,BP,BMP6;BTG1;APOLD1
50,GO:0000104,0.382511803709825,0.9300522277172,1,5,succinate dehydrogenase activity,MF,SDHA
2499,GO:0005749,0.382511803709825,0.9300522277172,1,5,mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone),CC,SDHA
3678,GO:0008177,0.382511803709825,0.9300522277172,1,5,succinate dehydrogenase (ubiquinone) activity,MF,SDHA
11163,GO:0045257,0.382511803709825,0.9300522277172,1,5,succinate dehydrogenase complex (ubiquinone),CC,SDHA
11168,GO:0045273,0.382511803709825,0.9300522277172,1,5,respiratory chain complex II,CC,SDHA
11172,GO:0045281,0.382511803709825,0.9300522277172,1,5,succinate dehydrogenase complex,CC,SDHA
11174,GO:0045283,0.382511803709825,0.9300522277172,1,5,fumarate reductase complex,CC,SDHA
11249,GO:0045541,0.382532945366005,0.930043673125846,1,5,negative regulation of cholesterol biosynthetic process,BP,APOE
16164,GO:0090206,0.382532945366005,0.930043673125846,1,5,negative regulation of cholesterol metabolic process,BP,APOE
17849,GO:1902105,0.382789015877327,0.709953898604393,18,157,regulation of leukocyte differentiation,BP,INPP5D;SFRP1;PIK3R1;ZFPM1;KITLG;CYP26B1;ZFP36L2;GLI2;GLI3;FAM213A;CA2;FBXW7;NRARP;ZFP36L1;SOX13;ERBB2;GPR68;CTNNBIP1
6288,GO:0019902,0.382954786657783,0.712531551246192,17,143,phosphatase binding,MF,EGFR;PIK3R1;STAT1;CRY2;CRY1;PHACTR3;CEP192;WNK1;DAB2IP;PIK3R2;TPRN;PPP1R35;DLG4;IRS2;STAT6;ERBB2;PPARG
6726,GO:0030148,0.382963132995608,0.745324282937754,9,76,sphingolipid biosynthetic process,BP,KDSR;ST6GALNAC6;CERS4;B4GALT6;ST3GAL5;PLA2G6;ALOXE3;CERS5;PEMT
7504,GO:0031697,0.383001975719697,0.933718825250052,1,4,beta-1 adrenergic receptor binding,MF,DLG4
13581,GO:0060073,0.383206003401357,0.933640310071994,1,4,micturition,BP,KCNMA1
6624,GO:0022890,0.38367248186189,0.689171999898494,30,269,inorganic cation transmembrane transporter activity,MF,PKD2;ORAI3;KCNAB2;KCNJ15;KCNC4;ITPR3;NDUFA4L2;TMEM63C;SLC24A1;TRPV4;SLC13A5;KCNJ5;SCNN1A;SCN4B;NIPAL2;TCIRG1;SLC12A7;ATP6V0A2;KCNMA1;KCNG1;JPH2;PDE2A;SHROOM2;SCN2A;CACNB3;ORAI2;ANO1;CACNB1;KCNS3;CALHM2
1099,GO:0002688,0.38372739155196,0.759859349064259,7,62,regulation of leukocyte chemotaxis,BP,CXCL14;TRPV4;C5;MMP28;DDT;VEGFB;PLA2G7
6372,GO:0021562,0.383877372771342,0.933381546449804,1,4,vestibulocochlear nerve development,BP,SLITRK6
12883,GO:0051249,0.384306529386663,0.692247778315246,27,245,regulation of lymphocyte activation,BP,TNFAIP3;GPNMB;INPP5D;SFRP1;MAP3K14;PIK3R1;VAV3;CYP26B1;IL20RB;ZFP36L2;GLI2;TNFRSF14;GLI3;GSN;DOCK8;TNFRSF21;EFNB3;HFE;DLG5;NRARP;CCDC88B;ZFP36L1;IRS2;STAT6;SOX13;ERBB2;RIPK3
15377,GO:0071651,0.384338974494793,0.933203273780335,1,4,positive regulation of chemokine (C-C motif) ligand 5 production,BP,TRPV4
5429,GO:0016289,0.384340204247657,0.861766076764493,2,14,CoA hydrolase activity,MF,ACOT1;ACOT2
15224,GO:0071404,0.384436216220781,0.863840449765334,2,12,cellular response to low-density lipoprotein particle stimulus,BP,CD9;PPARG
10106,GO:0042640,0.384501171518524,0.933140563027153,1,4,anagen,BP,FERMT1
13202,GO:0051884,0.384501171518524,0.933140563027153,1,4,regulation of timing of anagen,BP,FERMT1
16117,GO:0090148,0.384538318119403,0.863777710547253,2,12,membrane fission,BP,DNM1;MX2
95,GO:0000186,0.38459956090898,0.770904767551112,6,45,activation of MAPKK activity,BP,EGFR;MAP3K14;F2R;MAP3K12;ERCC6;MAP3K6
12217,GO:0048495,0.384606621342487,0.933099773220276,1,4,Roundabout binding,MF,SLIT3
5698,GO:0016829,0.384702751671571,0.719524888582034,14,129,lyase activity,MF,MVD;UROS;HMGCL;THNSL2;MLYCD;DDT;MGST2;CA2;GLUL;SRR;ALOXE3;TKFC;ECI1;EHHADH
14308,GO:0061512,0.385026993142189,0.800686914079598,4,30,protein localization to cilium,BP,BBS2;IFT140;BBS1;TUB
6425,GO:0021696,0.385243362002971,0.825696935780674,3,20,cerebellar cortex morphogenesis,BP,SERPINE2;GLI2;RORA
19794,GO:2000272,0.385275755971036,0.825053822063838,3,21,negative regulation of signaling receptor activity,BP,EPHB2;CBLC;HFE
3187,GO:0006811,0.38530275699707,0.65789566474203,92,857,ion transport,BP,SERPINE2;SIK1;APOE;HSPA2;PKD2;CPT2;EPHB2;ORAI3;TSC22D3;KCNAB2;KCNJ15;CRY2;SLC16A5;GJD3;NOS1;PITPNM3;KCNC4;ITPR3;NDUFA4L2;TMEM63C;F2R;SLC24A1;TRPV4;TMC6;NLGN2;ANK3;SLC13A5;GJC2;PER2;PITPNM2;CLCN6;SNTA1;MINK1;GSTM2;VAMP2;KCNJ5;TMC7;SCNN1A;SCN4B;SLC27A1;NIPAL2;SLC2A3;TCIRG1;SLC12A7;CLCA2;PLA2G6;HOMER2;ATP6V0A2;KLHL24;ANO9;CA2;OSBPL10;SHANK3;HFE;CYBA;KCNMA1;SLC2A1;ACACB;SLC38A4;KCNG1;WNK1;JPH2;PDE2A;SLC37A2;SHROOM2;SYT7;SCN2A;OSBPL5;KLHL3;VDR;CACNB3;ORAI2;SLC36A4;DLG4;SLC22A15;SHANK2;ACSL1;IRS2;ANO1;S100A6;SLC43A1;CACNB1;PTPN3;AKAP6;PPARG;PRKACA;PLTP;IP6K2;KCNS3;CLCN7;CALHM2;SERINC3
1132,GO:0002724,0.385752934310845,0.861869368014307,2,13,regulation of T cell cytokine production,BP,HFE;RSAD2
5183,GO:0015748,0.385967981363276,0.750059010170417,8,66,organophosphate ester transport,BP,APOE;PITPNM3;G6PC3;PITPNM2;OSBPL10;SLC37A2;OSBPL5;PLTP
13069,GO:0051599,0.386048416327729,0.932540526542301,1,4,response to hydrostatic pressure,BP,PKD2
3684,GO:0008188,0.386152638674748,0.928569609781856,1,5,neuropeptide receptor activity,MF,LTB4R2
12364,GO:0048786,0.386192625975461,0.825719727584416,3,19,presynaptic active zone,CC,SYN1;RIMS3;BSN
13822,GO:0060444,0.38625560353324,0.824981507371904,3,20,branching involved in mammary gland duct morphogenesis,BP,ETV5;AREG;VDR
5931,GO:0018212,0.386371704443982,0.690578399776292,27,232,peptidyl-tyrosine modification,BP,EGFR;SFRP1;EPHB2;DGKQ;CSPG4;KITLG;CNTRL;UNC119;MAP2K5;INSR;TTN;CBLC;RICTOR;MAP2K2;PTK6;CTF1;ERCC6;FBXW7;STK16;RET;FGFR4;AREG;DMTN;DLG4;WEE1;IL11;ERBB2
10795,GO:0044295,0.386871336827364,0.824545691152856,3,20,axonal growth cone,CC,FLRT3;BOC;TRAK1
14918,GO:0070827,0.38694364941468,0.93219183899222,1,4,chromatin maintenance,BP,MTHFR
7206,GO:0031106,0.386951488864489,0.862290648786485,2,12,septin ring organization,BP,SEPT6;SEPT5
11133,GO:0045197,0.387136130657852,0.799460116137276,4,29,establishment or maintenance of epithelial cell apical/basal polarity,BP,MYO9A;DLG5;DLG4;PTK7
15542,GO:0072010,0.387187410391449,0.862144832075711,2,12,glomerular epithelium development,BP,PODXL;LAMB2
3416,GO:0007200,0.387265687506112,0.798636432555528,4,31,phospholipase C-activating G-protein coupled receptor signaling pathway,BP,F2R;LTB4R2;LPAR6;ANO1
12846,GO:0051187,0.387352986326264,0.79765388441428,4,34,cofactor catabolic process,BP,GPX3;BLVRB;DUOX1;PRDX5
5699,GO:0016830,0.38751834734792,0.780762208128185,5,41,carbon-carbon lyase activity,MF,MVD;HMGCL;MLYCD;DDT;GLUL
3438,GO:0007229,0.387593967052789,0.749196415029108,8,62,integrin-mediated signaling pathway,BP,ITGB6;VAV3;ITGB5;FERMT1;ADAMTS13;ITGA2;ITGA6;DMTN
12649,GO:0050873,0.387788432521875,0.822706951706529,3,22,brown fat cell differentiation,BP,RGS2;TRPV4;ITGA6
1452,GO:0003690,0.387899324214719,0.662263912023431,67,603,double-stranded DNA binding,MF,HES2;SREBF1;DDX60;EGFR;MNT;XPC;KDM3A;HR;TFCP2L1;ZFPM1;STAT1;CRY2;ZNF704;CRY1;KLF13;NFATC4;H1F0;HSF4;NDN;MLH3;GLI2;KLF7;SOX12;PER2;ZNF658;GLI3;THRAP3;BHLHE40;TCFL5;JARID2;ETV5;CENPC;TCF4;PLAG1;MEF2D;CREBRF;MLXIPL;LMO2;CARF;MXI1;THRA;ELF1;DBP;RFX2;SALL2;ZMYND8;IFI16;ERCC5;TEF;VDR;TNRC18;SIX5;HLTF;TFDP2;KAT2B;IVNS1ABP;RAD50;STAT6;SOX13;KLF8;RORA;PPARG;MSH5;PER3;FOXP2;ZC3H6;HIVEP1
4618,GO:0010739,0.387994425243565,0.927812355808053,1,5,positive regulation of protein kinase A signaling,BP,MC1R
13667,GO:0060231,0.388018813649836,0.860459701307869,2,13,mesenchymal to epithelial transition,BP,STAT1;FZD7
8594,GO:0034114,0.388049972345915,0.860440266584534,2,13,regulation of heterotypic cell-cell adhesion,BP,FLOT1;MAP2K5
10345,GO:0043173,0.388167048302016,0.859374745405775,2,14,nucleotide salvage,BP,NAPRT;UCKL1
4253,GO:0009582,0.388459855698909,0.758196815207301,7,48,detection of abiotic stimulus,BP,SERPINE2;PKD2;EYS;UNC119;ITGA2;TTN;ANO1
8734,GO:0034394,0.388507319379917,0.780712931154391,5,38,protein localization to cell surface,BP,KCNAB2;HFE;ASTN2;SNX33;SMURF1
3556,GO:0007597,0.388556458098829,0.927580302045527,1,5,blood coagulation, intrinsic pathway,BP,SERPING1
9052,GO:0035295,0.388641868344681,0.659638253205178,73,649,tube development,BP,TNFAIP3;TGFBI;SERPINE2;GPNMB;SREBF1;APOE;EGFR;PKD2;PLCD3;SFRP1;KIF26B;EPHB2;VAV3;CSPG4;CUL7;STAT1;UNC5B;PRKACB;HOXA3;NFATC4;PLCD1;RAPGEF3;ADGRB2;GLI2;C5;WWTR1;GLI3;MAP2K5;ITGA6;CELSR1;VEGFB;PTK6;ETV5;HYAL1;SH2D2A;MMRN2;NPHP3;PODXL;ATRX;REC8;SPRY2;IFT140;THRA;LRP1;SALL2;RET;DAB2IP;TEAD2;RNF213;FGFR4;BBS5;AREG;KLHL3;DLG5;BTG1;VDR;PLXND1;NRARP;PTK7;TCF7;ZFP36L1;APOLD1;TNFSF12;SRPX2;ERBB2;RORA;PPARG;FMNL3;ACKR3;FOXP2;NPNT;CTNNBIP1;ECM1
4623,GO:0010746,0.388648729903344,0.931524655660164,1,4,regulation of plasma membrane long-chain fatty acid transport,BP,IRS2
4624,GO:0010748,0.388648729903344,0.931524655660164,1,4,negative regulation of plasma membrane long-chain fatty acid transport,BP,IRS2
9336,GO:0035859,0.388686577435219,0.860042897221495,2,13,Seh1-associated complex,CC,SESN3;SESN1
4356,GO:0009954,0.388904824210786,0.822475781076017,3,21,proximal/distal pattern formation,BP,CYP26B1;GLI2;GLI3
4290,GO:0009719,0.388904848721851,0.650326919974501,115,1059,response to endogenous stimulus,BP,POSTN;SIK1;SREBF1;MXRA5;APOE;EGFR;FAM20C;PKD2;SRSF5;SFRP1;PIK3R1;ADAMTS7;KDM3A;SULF2;HTRA1;RGMA;STAT1;IMPACT;CRY2;UROS;ITGB5;NOS1;PRKACB;CRY1;FERMT1;MICALL1;MDM2;LTBP4;TNFSF10;NEO1;RAPGEF3;FAM210B;CTSV;FLRT3;PDCD4;ZFP36L2;TRPV4;RNF165;FNDC4;FRS3;GSTM2;ITGA2;THRAP3;VAMP2;LTBP1;SESN3;INSR;BAIAP2;CD109;ENDOG;SLC27A1;MDK;BMP6;TCIRG1;HYAL1;CST3;GDF15;BBS2;TXNIP;ATP6V0A2;COL6A1;CDK5R1;CA2;SESN1;HFE;CYBA;HADH;SLIT3;SPRY2;CREBRF;XRN1;CTSB;LMO2;PAQR6;THRA;SLC2A1;EPM2AIP1;GNG2;LRP1;PDE2A;STK16;DAB2IP;CALCOCO1;FGFR4;PIK3R2;AREG;BTG1;VDR;PCSK6;DMTN;UCN2;ZFP36L1;ACSL1;KAT2B;IRS2;GPR21;PBLD;TUB;GLB1;CD9;CACNB1;ERBB2;PAQR7;ABCA2;AKAP6;TH;RORA;PPARG;PRKACA;UFL1;KLF9;FOXP2;SMURF1;NPNT;GCLC
15576,GO:0072078,0.388919899785042,0.767172812681815,6,46,nephron tubule morphogenesis,BP,PKD2;KIF26B;GLI3;KLHL3;NPNT;CTNNBIP1
1322,GO:0003175,0.389128647711876,0.931336141430103,1,4,tricuspid valve development,BP,ZFPM1
1330,GO:0003186,0.389128647711876,0.931336141430103,1,4,tricuspid valve morphogenesis,BP,ZFPM1
8486,GO:0033674,0.3892247956649,0.670628722417026,46,414,positive regulation of kinase activity,BP,EGFR;PKD2;EPHB2;MAP3K14;DGKQ;CAMKK1;VAV3;CSPG4;KITLG;PRKACB;F2R;ADORA2B;MAPK8IP3;UNC119;C5;MINK1;MAP2K5;INSR;ETAA1;PILRB;SLC27A1;RICTOR;MAP2K2;MAP3K12;CDK5R1;MAPK10;ERCC6;SHC2;SPRY2;FBXW7;PAK6;PFKFB2;NAB2;MAP3K6;WNK1;RET;DAB2IP;FGFR4;DLG4;ACSL1;ERN1;RAD50;ERBB2;ATG14;PRKACA;RIPK3
11998,GO:0047555,0.389317243986583,0.931261972331795,1,4,3',5'-cyclic-GMP phosphodiesterase activity,MF,PDE2A
3106,GO:0006684,0.389370693342901,0.859615239134238,2,13,sphingomyelin metabolic process,BP,SMPDL3B;PEMT
3418,GO:0007204,0.389665076155654,0.712110935549915,15,130,positive regulation of cytosolic calcium ion concentration,BP,PKD2;NOS1;ITPR3;F2R;TRPV4;GSTM2;NMU;PLA2G6;CYBA;JPH2;CACNB3;LPAR6;DLG4;AKAP6;PRKACA
6761,GO:0030202,0.389922948240099,0.931023433369227,1,4,heparin metabolic process,BP,NDST2
6769,GO:0030210,0.389922948240099,0.931023433369227,1,4,heparin biosynthetic process,BP,NDST2
20061,GO:2000739,0.39001250018333,0.93098812267652,1,4,regulation of mesenchymal stem cell differentiation,BP,LTBP3
14442,GO:0061821,0.390070045916412,0.930965426275881,1,4,telomeric D-loop binding,MF,WRN
5450,GO:0016324,0.390088630519492,0.698915079626255,20,171,apical plasma membrane,CC,EGFR;CSPG4;VAMP3;SLC29A4;TRPV4;SCNN1A;TCIRG1;PODXL;CYBA;KCNMA1;SLC2A1;SHROOM2;BST2;CACNB3;SHROOM4;DUOX1;SHANK2;ANO1;CD9;ERBB2
16189,GO:0090245,0.390183394767369,0.930920707301266,1,4,axis elongation involved in somitogenesis,BP,SFRP1
11352,GO:0045730,0.390187844636861,0.858103705494882,2,14,respiratory burst,BP,INSR;CYBA
9440,GO:0036041,0.390209090575909,0.924255353523391,1,6,long-chain fatty acid binding,MF,PPARG
732,GO:0001963,0.390311422892837,0.858025791296508,2,14,synaptic transmission, dopaminergic,BP,FLOT1;TH
13200,GO:0051882,0.390479967551283,0.857919491889895,2,14,mitochondrial depolarization,BP,IFI6;GCLC
2950,GO:0006479,0.390861069371484,0.705155453676739,17,149,protein methylation,BP,ASH2L;MTHFR;KDM3A;JARID2;RTF1;KDM4C;ATRX;METTL21A;SETD4;ETFB;BTG1;PCMTD2;PCMTD1;PHF1;DYDC1;KMT5C;PRMT3
3704,GO:0008213,0.390861069371484,0.705155453676739,17,149,protein alkylation,BP,ASH2L;MTHFR;KDM3A;JARID2;RTF1;KDM4C;ATRX;METTL21A;SETD4;ETFB;BTG1;PCMTD2;PCMTD1;PHF1;DYDC1;KMT5C;PRMT3
11332,GO:0045672,0.390891956079864,0.858661908973051,2,13,positive regulation of osteoclast differentiation,BP,CA2;GPR68
1801,GO:0004448,0.39124405616251,0.926464328358959,1,5,isocitrate dehydrogenase activity,MF,IDH2
10719,GO:0044090,0.391314180657653,0.859581616194663,2,12,positive regulation of vacuole organization,BP,ULK1;LRSAM1
2722,GO:0006102,0.391452060700446,0.926377522286296,1,5,isocitrate metabolic process,BP,IDH2
9705,GO:0038132,0.391614279691079,0.930354648796999,1,4,neuregulin binding,MF,ITGA6
7634,GO:0032052,0.391778872105718,0.92624100796496,1,5,bile acid binding,MF,VDR
5161,GO:0015705,0.392012697684087,0.930196526418162,1,4,iodide transport,BP,ANO1
7396,GO:0031467,0.392123915507531,0.926096709518904,1,5,Cul7-RING ubiquitin ligase complex,CC,CUL7
2084,GO:0004849,0.392170049557934,0.92607740297543,1,5,uridine kinase activity,MF,UCKL1
9698,GO:0038114,0.39221784675243,0.930115021316909,1,4,interleukin-21-mediated signaling pathway,BP,STAT1
16825,GO:0098756,0.39221784675243,0.930115021316909,1,4,response to interleukin-21,BP,STAT1
16826,GO:0098757,0.39221784675243,0.930115021316909,1,4,cellular response to interleukin-21,BP,STAT1
10370,GO:0043207,0.392366803007483,0.66308998897552,54,522,response to external biotic stimulus,BP,TNFAIP3;ACTA2;OAS2;DDX60;APOBEC3C;TRIM22;IFI44L;MAP3K14;HERC5;VWCE;ISG15;HTRA1;STAT1;NOS1;CMPK2;IFITM1;OAS1;F2R;PDCD4;ADAMTS13;WIPF1;TNFRSF14;LRSAM1;IFI44;BAIAP2;MGST2;DHX58;IRF9;BMP6;NLRX1;LOXL1;HYAL1;PLA2G6;TNFRSF21;CYBA;KLK5;ADARB1;MX2;NLRP1;SRR;ACP5;DAB2IP;IFI16;BST2;VDR;FAM3A;STAT2;CCDC88B;RSAD2;TNFRSF25;IVNS1ABP;TKFC;TH;SERINC3
13120,GO:0051707,0.392366803007483,0.66308998897552,54,522,response to other organism,BP,TNFAIP3;ACTA2;OAS2;DDX60;APOBEC3C;TRIM22;IFI44L;MAP3K14;HERC5;VWCE;ISG15;HTRA1;STAT1;NOS1;CMPK2;IFITM1;OAS1;F2R;PDCD4;ADAMTS13;WIPF1;TNFRSF14;LRSAM1;IFI44;BAIAP2;MGST2;DHX58;IRF9;BMP6;NLRX1;LOXL1;HYAL1;PLA2G6;TNFRSF21;CYBA;KLK5;ADARB1;MX2;NLRP1;SRR;ACP5;DAB2IP;IFI16;BST2;VDR;FAM3A;STAT2;CCDC88B;RSAD2;TNFRSF25;IVNS1ABP;TKFC;TH;SERINC3
9162,GO:0035529,0.392572655860271,0.925908785779675,1,5,NADH pyrophosphatase activity,MF,NUDT6
5130,GO:0015616,0.392812539215425,0.929878419467643,1,4,DNA translocase activity,MF,ATRX
8142,GO:0032878,0.393194165334202,0.820042753748939,3,20,regulation of establishment or maintenance of cell polarity,BP,GSN;DOCK8;RICTOR
10390,GO:0043237,0.393267354678467,0.929697134697004,1,4,laminin-1 binding,MF,NID1
13857,GO:0060509,0.393425372311044,0.929634082717252,1,4,Type I pneumocyte differentiation,BP,THRA
1120,GO:0002709,0.393480397899869,0.793547010617614,4,32,regulation of T cell mediated immunity,BP,IL20RB;HFE;RSAD2;RIPK3
7518,GO:0031730,0.394050140840759,0.925287972626335,1,5,CCR5 chemokine receptor binding,MF,STAT1
17797,GO:1901976,0.39414836400194,0.793364359905892,4,31,regulation of cell cycle checkpoint,BP,CRY1;NDRG1;ETAA1;FBXO4
11111,GO:0045162,0.394490385129645,0.929208210083627,1,4,clustering of voltage-gated sodium channels,BP,NFASC
15881,GO:0072674,0.394592660135891,0.929167229077493,1,4,multinuclear osteoclast differentiation,BP,CD109
15882,GO:0072675,0.394592660135891,0.929167229077493,1,4,osteoclast fusion,BP,CD109
8959,GO:0035051,0.394669267323439,0.724577589303425,11,83,cardiocyte differentiation,BP,SIK1;EGFR;OBSL1;TENM4;MYH11;PDCD4;FHOD3;TTN;FZD7;LMNA;AKAP6
11768,GO:0046643,0.394703090747044,0.929122963679292,1,4,regulation of gamma-delta T cell activation,BP,SOX13
7912,GO:0032495,0.394793202152625,0.857402205819633,2,12,response to muramyl dipeptide,BP,TNFAIP3;NLRP1
10505,GO:0043434,0.394799979465547,0.67556882966658,33,295,response to peptide hormone,BP,SREBF1;SRSF5;PIK3R1;STAT1;PRKACB;CRY1;MDM2;TNFSF10;TRPV4;VAMP2;SESN3;INSR;BAIAP2;SLC27A1;TCIRG1;ATP6V0A2;CA2;CYBA;HADH;SLC2A1;EPM2AIP1;GNG2;PIK3R2;AREG;BTG1;ZFP36L1;KAT2B;IRS2;GPR21;TH;PPARG;PRKACA;GCLC
8140,GO:0032876,0.394911043622838,0.929039560622075,1,4,negative regulation of DNA endoreduplication,BP,FBXW7
16964,GO:0099054,0.395031526139501,0.857252287493949,2,12,presynapse assembly,BP,NLGN4Y;NLGN2
15369,GO:0071639,0.395098092899531,0.92484571183405,1,5,positive regulation of monocyte chemotactic protein-1 production,BP,TRPV4
6106,GO:0019348,0.395119797783457,0.924836534897161,1,5,dolichol metabolic process,BP,SRD5A3
16774,GO:0098634,0.395254831224536,0.928901545480319,1,4,cell-matrix adhesion mediator activity,MF,ITGA2
16776,GO:0098639,0.395254831224536,0.928901545480319,1,4,collagen binding involved in cell-matrix adhesion,MF,ITGA2
12611,GO:0050818,0.395356000993085,0.761123986067455,6,50,regulation of coagulation,BP,SERPINE2;APOE;F2R;DMTN;CD9;SERPING1
14780,GO:0070527,0.395620536082722,0.774522352923164,5,40,platelet aggregation,BP,SERPINE2;MYL9;BLOC1S4;DMTN;CD9
62,GO:0000125,0.395887444899658,0.924511526606072,1,5,PCAF complex,CC,KAT2B
9779,GO:0040009,0.396216166950021,0.928514730476649,1,4,regulation of growth rate,BP,WRN
4304,GO:0009757,0.396417217235825,0.924286727227315,1,5,hexose mediated signaling,BP,MLXIPL
4413,GO:0010182,0.396417217235825,0.924286727227315,1,5,sugar mediated signaling pathway,BP,MLXIPL
4424,GO:0010255,0.396417217235825,0.924286727227315,1,5,glucose mediated signaling pathway,BP,MLXIPL
3112,GO:0006690,0.396441225744114,0.749334043154366,7,61,icosanoid metabolic process,BP,CES2;PTGS1;CYP2D7;MGST2;ALOXE3;ALOX15B;FAAH
13865,GO:0060526,0.396457553334211,0.928417398876144,1,4,prostate glandular acinus morphogenesis,BP,SFRP1
13866,GO:0060527,0.396457553334211,0.928417398876144,1,4,prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis,BP,SFRP1
18419,GO:1903524,0.396472735904889,0.791571648566412,4,31,positive regulation of blood circulation,BP,EGFR;RGS2;F2R;NMU
3280,GO:0006959,0.396734680406203,0.739272642336744,8,83,humoral immune response,BP,C5;PLA2G6;TNFRSF21;KLK5;C1RL;BST2;FAM3A;SERPING1
2546,GO:0005815,0.396887334460507,0.653620321038187,67,611,microtubule organizing center,CC,ITGB6;PKD2;CAPRIN2;OBSL1;BRSK1;EVC;CUL7;PRKACB;CNTRL;NDRG1;LZTS2;NDN;ACTR1B;ADGRB2;NEK9;TUBGCP5;FLOT1;UNC119;PSKH1;NINL;FAM110C;SPPL2B;TPGS1;NEK8;GAS8;CCDC85B;CEP68;CHD3;CEP126;TRIOBP;RAB11FIP4;CEP192;PLA2G6;BBS2;LRRCC1;WRN;PODXL;IQCB1;HOOK2;WASH3P;IFT140;RAB11FIP3;CDK5RAP3;CCDC92;DZIP1L;TTC12;CAPG;NPHP4;BBS1;DDHD2;BBS5;DLG5;ARFGEF2;ALMS1;PHF1;TACC1;CCDC88B;CCDC113;KAT2B;MARK4;CEP250;SAC3D1;TTC19;KIF7;TRAF5;ABCA2;PRKACA
14000,GO:0060745,0.39695873178627,0.928215051863262,1,4,mammary gland branching involved in pregnancy,BP,VDR
462,GO:0001501,0.397085219999788,0.671565227677136,35,307,skeletal system development,BP,TGFBI;POSTN;PTHLH;FBXW4;FAM20C;SFRP1;ADAMTS7;EVC;SULF2;ZFPM1;COL10A1;HOXA3;CYP26B1;PLXNB1;TRPV4;GLI2;THBS3;GLI3;IGFBP4;BMP6;HEXB;HYAL1;PEX7;BBS2;MEF2D;IFT140;FBXW7;THRA;RAI1;NAB2;ACP5;MAF;VDR;COL13A1;GPR68
1582,GO:0003995,0.397192688690268,0.854678802316494,2,13,acyl-CoA dehydrogenase activity,MF,ACADS;ACOX3
6980,GO:0030665,0.397218205840764,0.740363424775819,8,67,clathrin-coated vesicle membrane,CC,APOE;EGFR;VAMP3;AP1G2;CLTCL1;VAMP2;CD9;LDLRAP1
11851,GO:0046872,0.397376884373999,0.629023792981431,315,2931,metal ion binding,MF,TNFAIP3;POSTN;ZSCAN18;SIK1;NPEPL1;APOE;NT5E;OAS2;ADAM19;TRIM65;FAM20C;PKD2;CAPRIN2;APOBEC3C;SYT8;ASH2L;TRIM22;PLCD3;PCDH1;DGKQ;TMEM129;ADAMTS7;BRSK1;RBCK1;KDM3A;CUL9;EYS;RNF135;SULF2;VAV3;UNK;HR;SMOC2;VWCE;CYBRD1;ZFPM1;ZNF362;SNN;IRF2BPL;PRICKLE2;ASAP3;ZNF266;MYL9;COL10A1;THAP8;NOS1;PRKACB;ZNF704;ZNF699;ZFP41;KLF13;PITPNM3;HMGCL;RNF187;CYP26B1;ZNF251;MICALL1;LIG1;VPS11;SPOCK1;ITPR3;CYHR1;MDM2;PLCD1;NMRK1;DDX59;CHN2;ZNF662;LTBP4;OBSCN;TNFSF10;LENG9;SYTL1;FKBP9;CALML3;CYP3A5;ZNF414;ENDOD1;HAGHL;POLH;OAS1;RASA4;TRIM66;B4GALT6;MLLT6;ACAP3;C2CD4C;PHYH;MT1X;CGREF1;SLC24A1;ZNF160;ARSI;NEK9;ZFP36L2;GLI2;AGAP4;KLF7;RNF165;ADAMTS13;TCEA2;PLCH2;ZNF76;SLX1A;SLX1B;ZCCHC11;PITPNM2;PTGS1;DTNB;ZNF658;ARSD;PHF2;NINL;THBS3;ASAP2;ITGA2;SYT15;GLI3;ZNF558;LRSAM1;ZNF655;NAIP;LTBP1;ZNF333;NEK8;MAP2K5;ITGA6;LTBP3;BSN;ZNF318;MMP1;CELSR1;MMP28;GSN;CHD3;TTN;CBLC;ZNF18;RNPEPL1;ZNF287;CYP2D7;ZNF446;RAB11FIP4;ZNF581;DHX58;ENDOG;B4GALT2;PEX10;S100A4;MICALL2;MAP2K2;GLI4;SQSTM1;CABYR;LOXL1;FAT2;SHARPIN;KDM4C;CLCA2;UBOX5;ZNF608;ZCCHC24;CAPNS2;PLAG1;IDH2;WRN;TREX1;MCTP1;CDK5R1;ATRX;AGAP6;CA2;SHANK3;CYBA;TRIM38;NID1;DTX3;RRM2B;SLIT3;AGAP7P;RAB11FIP3;KCNMA1;ING4;ZNF862;LMO2;NOTCH2NL;DZIP1L;PGM1;RNF170;THRA;ARAP1;ASTN2;ADARB1;RAI1;IKZF4;RPH3AL;ACACB;OGDHL;ZBTB34;ZNF627;LACTB2;GLUL;TNS2;SRR;LRP1;PEG3;ACP5;RNPEP;DLK2;ZNF554;MAP3K6;RIMKLB;SALL2;WNK1;ZNF107;ZNF532;ZBTB20;PDE2A;ZNF334;RET;ZMYND8;CASZ1;MYSM1;DDHD2;RNF213;TSHZ2;ZNF276;SYT7;ERCC5;ZNF25;SNCB;MYO9A;RPS6KA5;ZNF630;ZNF687;VDR;PHF7;ZFP28;NADK;ZMYM3;NUDT8;HLTF;MARCH8;ZNF789;MPPE1;ZNF563;ZNF517;FAHD2B;LMTK3;PHF1;ZNF292;ACVR1B;ZNF737;PRIMPOL;NECAB3;PPP2R3B;ESYT2;TSSK1B;ZNF701;ALOXE3;ENDOU;MPI;MATN2;ZNF91;DUOX1;WEE1;RSAD2;ZFP36L1;CLSTN3;IMPA2;CAPS;MBLAC2;ERN1;RNF141;ALOX15B;RAD50;ZNF439;TKFC;ZMAT3;MTR;MAN1B1;S100A6;TRERF1;EFEMP2;ZSWIM8;SGSH;PHC2;ANKMY1;SMPDL3B;KLF8;TRAF5;TRIM2;PLCB3;NUDT10;PPM1M;TH;RORA;PPARG;CXXC5;POLM;ZNF572;ZNF658B;SUCLG2;PARN;ZNF529;KLF9;PRMT3;CIT;ZFP90;ZFP30;FOXP2;ZC3H6;HIVEP1;NPNT;GCLC
4833,GO:0014042,0.397599822813447,0.927955699602766,1,4,positive regulation of neuron maturation,BP,RET
12817,GO:0051147,0.397621516391002,0.721129162908532,11,93,regulation of muscle cell differentiation,BP,SIK1;CYP26B1;PDCD4;FLOT1;BOC;FZD7;GDF15;THRA;OLFM2;MAMSTR;AKAP6
20245,GO:2001235,0.39766041349192,0.701405810291676,16,150,positive regulation of apoptotic signaling pathway,BP,TP53INP1;SFRP1;RBCK1;NFATC4;TNFSF10;PIDD1;GSN;PLA2G6;FBXW7;RET;DAB2IP;IL20RA;TFDP2;TNFSF12;RIPK3;SERINC3
1233,GO:0002922,0.397885523193918,0.923661526666781,1,5,positive regulation of humoral immune response,BP,KLK5
9531,GO:0036295,0.398030554649456,0.8541449181377,2,13,cellular response to increased oxygen levels,BP,ATP6V0A2;PPARG
3606,GO:0008046,0.398649042911678,0.92752998640934,1,4,axon guidance receptor activity,MF,EPHB2
13596,GO:0060090,0.398736508241365,0.698113902589986,17,146,molecular adaptor activity,MF,TRIM22;OBSL1;PIK3R1;VAV3;VPS11;CHN2;FLRT3;ANK3;MAPK8IP3;BAIAP2;SH2D2A;ARRDC1;FBXW7;DAB2IP;RAD50;MPP7;LDLRAP1
10728,GO:0044110,0.398812893561634,0.923265022682186,1,5,growth involved in symbiotic interaction,BP,SQSTM1
10731,GO:0044116,0.398812893561634,0.923265022682186,1,5,growth of symbiont involved in interaction with host,BP,SQSTM1
10732,GO:0044117,0.398812893561634,0.923265022682186,1,5,growth of symbiont in host,BP,SQSTM1
5702,GO:0016833,0.398907289270454,0.923224592126222,1,5,oxo-acid-lyase activity,MF,HMGCL
741,GO:0001973,0.398938421074146,0.923211255208618,1,5,adenosine receptor signaling pathway,BP,ADORA2B
10293,GO:0043083,0.399059020462694,0.927363217804506,1,4,synaptic cleft,CC,LAMB2
20249,GO:2001239,0.39953794918312,0.788546631829371,4,33,regulation of extrinsic apoptotic signaling pathway in absence of ligand,BP,IFI6;UNC5B;MAP2K5;RET
11327,GO:0045667,0.399597932557352,0.731194478354636,9,74,regulation of osteoblast differentiation,BP,FAM20C;SFRP1;IFITM1;GLI3;BMP6;AREG;PRKACA;NPNT;CTNNBIP1
7165,GO:0031054,0.399631416570499,0.853122097887811,2,13,pre-miRNA processing,BP,ZCCHC11;AGO4
1427,GO:0003402,0.399910034079333,0.927016286261465,1,4,planar cell polarity pathway involved in axis elongation,BP,SFRP1
19686,GO:2000047,0.400113916392399,0.922706625554647,1,5,regulation of cell-cell adhesion mediated by cadherin,BP,FLOT1
5622,GO:0016701,0.400456084275391,0.851556340797205,2,14,oxidoreductase activity, acting on single donors with incorporation of molecular oxygen,MF,ALOXE3;ALOX15B
5623,GO:0016702,0.400456084275391,0.851556340797205,2,14,oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen,MF,ALOXE3;ALOX15B
8435,GO:0033567,0.400507341162973,0.922537276361686,1,5,DNA replication, Okazaki fragment processing,BP,LIG1
609,GO:0001778,0.400601300658975,0.926733721996043,1,4,plasma membrane repair,BP,SYT7
15159,GO:0071316,0.400969591847634,0.922338008892631,1,5,cellular response to nicotine,BP,TH
13217,GO:0051902,0.401301133077115,0.922194893176069,1,5,negative regulation of mitochondrial depolarization,BP,IFI6
18705,GO:1904180,0.401301133077115,0.922194893176069,1,5,negative regulation of membrane depolarization,BP,IFI6
12612,GO:0050819,0.401319352874939,0.787475372853157,4,32,negative regulation of coagulation,BP,SERPINE2;APOE;CD9;SERPING1
6910,GO:0030509,0.401458492217984,0.717971540610704,11,90,BMP signaling pathway,BP,SFRP1;HTRA1;RGMA;NEO1;PDCD4;RNF165;BMP6;GDF15;HFE;PCSK6;SMURF1
7999,GO:0032635,0.401485070335791,0.736701947145144,8,67,interleukin-6 production,BP,TNFAIP3;INPP5D;F2R;TRPV4;ADORA2B;NLRX1;CYBA;ZBTB20
6054,GO:0019205,0.401604359770488,0.769230469242162,5,42,nucleobase-containing compound kinase activity,MF,CMPK2;TK2;DLG4;RAD50;UCKL1
11442,GO:0045913,0.401614780201967,0.756717939613343,6,46,positive regulation of carbohydrate metabolic process,BP,INSR;MLXIPL;PFKFB2;EPM2AIP1;KAT2B;IRS2
11778,GO:0046661,0.40171556867773,0.712663717681299,12,103,male sex differentiation,BP,SFRP1;KITLG;TNFSF10;CTSV;LHFPL2;NUPR1;INSR;BMP6;CST3;ATRX;REC8;AGO4
9448,GO:0036056,0.402063908259915,0.92613362172368,1,4,filtration diaphragm,CC,PODXL
9449,GO:0036057,0.402063908259915,0.92613362172368,1,4,slit diaphragm,CC,PODXL
11628,GO:0046364,0.402275883114673,0.744530881150795,7,60,monosaccharide biosynthetic process,BP,SIK1;DGKQ;CRY1;G6PC3;PER2;PGM1;KAT2B
6058,GO:0019209,0.402276701753588,0.744813311763743,7,58,kinase activator activity,MF,DGKQ;ETAA1;MAP2K2;CDK5R1;ERCC6;SPRY2;WNK1
17548,GO:1901165,0.402333461092137,0.921748227886389,1,5,positive regulation of trophoblast cell migration,BP,ACVR1B
12802,GO:0051127,0.402813046918429,0.852313328037512,2,12,positive regulation of actin nucleation,BP,WIPF1;GSN
9835,GO:0042092,0.403675751206335,0.810684322132366,3,23,type 2 immune response,BP,RSAD2;STAT6;ECM1
3756,GO:0008299,0.403727799704057,0.810646083154324,3,23,isoprenoid biosynthetic process,BP,ALDH1A3;MVD;SRD5A3
9134,GO:0035493,0.403829144516792,0.850422853316947,2,13,SNARE complex assembly,BP,VAMP3;VPS11
11098,GO:0045132,0.404368077603668,0.753828626037848,6,49,meiotic chromosome segregation,BP,MLH3;SUN1;CENPC;REC8;AGO4;MSH5
2619,GO:0005938,0.404709687175003,0.674907488809423,26,224,cell cortex,CC,GPSM1;PKD2;COL10A1;RHOBTB2;RAPGEF3;SPTB;TRPV4;FLOT1;RIMS3;WIPF1;FAM110C;BSN;GSN;PLEKHH2;TRIOBP;SEPT6;ARHGAP33;SEPT5;HFE;ASTN2;SLC2A1;SHROOM2;EXOC2;DMTN;SHROOM4;DLG4
7047,GO:0030833,0.404851989482159,0.705448075287661,13,115,regulation of actin filament polymerization,BP,EPS8L2;ARPIN;SPTB;WIPF1;FHOD3;GSN;BAIAP2;TRIOBP;RICTOR;WHAMMP3;WASH3P;CAPG;DMTN
15801,GO:0072524,0.404982883665392,0.698184582076678,15,132,pyridine-containing compound metabolic process,BP,NT5E;H6PD;DHTKD1;KCNAB2;NAPRT;NMRK1;INSR;PGLS;IDH2;MLXIPL;PGM1;PFKFB2;OGDHL;NADK;PNPO
8271,GO:0033085,0.405068831786757,0.920557042910974,1,5,negative regulation of T cell differentiation in thymus,BP,ERBB2
14007,GO:0060754,0.40513460585317,0.920528262830731,1,5,positive regulation of mast cell chemotaxis,BP,VEGFB
12254,GO:0048565,0.405343988307607,0.726411723121766,9,72,digestive tract development,BP,EGFR;SFRP1;GLI2;GLI3;ITGA6;PTK6;NPHP3;RET;TCF7
1403,GO:0003339,0.405470938361323,0.92038099640877,1,5,regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,STAT1
8393,GO:0033344,0.405611268923881,0.809798744659903,3,22,cholesterol efflux,BP,APOE;LRP1;PLTP
12561,GO:0050747,0.405669491258033,0.920293978868139,1,5,positive regulation of lipoprotein metabolic process,BP,PEMT
17668,GO:1901568,0.405793055643869,0.7134635212848,11,99,fatty acid derivative metabolic process,BP,CES2;HMGCL;PTGS1;CYP2D7;MGST2;BDH1;ALOXE3;ACSL1;ALOX15B;FAAH;CBR4
4855,GO:0014070,0.405802181012116,0.644669148062454,68,629,response to organic cyclic compound,BP,POSTN;SREBF1;EGFR;PKD2;SFRP1;MTHFR;DGKQ;KDM3A;STAT1;IMPACT;CRY2;PRKACB;CRY1;NFATC4;MDM2;RAPGEF3;FAM210B;CTSV;ZFP36L2;FLOT1;GLI2;ZCCHC11;GSTM2;ITGA2;THRAP3;ITGA6;GSN;ENDOG;MDK;BMP6;MAP2K2;CST3;HOMER2;TXNIP;CA2;CYBA;AGO4;SLIT3;HLCS;CREBRF;XRN1;PAQR6;THRA;ACACB;TP53I13;GNG2;SRR;PDE2A;CALCOCO1;AREG;VDR;DMTN;DUOX1;ZFP36L1;ACSL1;GLB1;PAQR7;ABCA2;AKAP6;TH;RORA;PPARG;PRKACA;UFL1;KLF9;LONP2;FOXP2;GCLC
9476,GO:0036123,0.405902619175752,0.920191733390691,1,5,histone H3-K9 dimethylation,BP,KDM3A
16653,GO:0097581,0.405991500367352,0.733067073971874,8,65,lamellipodium organization,BP,VAV3;PARVB;ARPIN;ARHGEF4;PLXNB3;DMTN;SNX1;SSH3
8950,GO:0035025,0.406041654516911,0.848990081635846,2,13,positive regulation of Rho protein signal transduction,BP,F2R;LPAR6
5891,GO:0018076,0.406140819437109,0.924444756004028,1,4,N-terminal peptidyl-lysine acetylation,BP,KAT2B
7394,GO:0031465,0.406149331793297,0.920083441501697,1,5,Cul4B-RING E3 ubiquitin ligase complex,CC,DDB2
10721,GO:0044092,0.406455867912472,0.640605116780318,79,748,negative regulation of molecular function,BP,TNFAIP3;SERPINE2;SIK1;IFI6;APOE;GPSM1;PKD2;SFRP1;EPHB2;RBCK1;ELFN2;ZFPM1;CAMK2N1;CRY2;NOS1;NFATC4;COL7A1;SPOCK1;MDM2;PIK3IP1;PHACTR3;FLRT3;RASA4;RGS2;PDCD4;SERPINB5;RTN4RL1;ANK3;LAMP3;PER2;C5;GSTM2;WWTR1;BHLHE40;NAIP;MAP2K5;CBLC;PLXNB3;CD109;NLRX1;CEP192;PTK6;CST3;TXNIP;ANO9;HFE;SPRY2;GABBR1;GPR87;CDK5RAP3;TFPI2;MXI1;THRA;ADARB1;ACACB;WNK1;LTB4R2;DAB2IP;RWDD3;IFI16;SNCB;BST2;PPP1R2;PPP1R35;LMTK3;KAT2B;IRS2;SCG5;PCSK1N;PRDX5;PHPT1;SPOCD1;PPARG;SERPING1;UFL1;AIP;ZFP90;CTNNBIP1;ECM1
3513,GO:0007431,0.406663275333864,0.784006575776794,4,30,salivary gland development,BP,EGFR;TFCP2L1;CST3;PLXND1
3508,GO:0007417,0.406698177561066,0.644944620646114,65,587,central nervous system development,BP,SERPINE2;EGFR;PTPRS;PKD2;DIXDC1;ALDH1A3;SFRP1;EPHB2;GLUD1;POU3F1;WNT3;TENM4;SPOCK1;NAGLU;NDN;RTN4RL1;GLI2;SOX12;GJC2;AMIGO2;GLI3;SMARCA1;GAS8;JARID2;CELSR1;GSN;BAIAP2;SUN1;PGAP1;MDK;B4GALT2;SHARPIN;CST3;BBS2;WRN;TNFRSF21;CDK5R1;ATRX;SHANK3;CDK5RAP3;ATXN1;THRA;ADARB1;SLC2A1;SRR;LRP1;DAB2IP;SHROOM2;FGFR4;DLG5;ACVR1B;SHROOM4;TACC1;SHANK2;IRS2;CD9;HDAC11;ERBB2;TH;RORA;PPARG;SYNE2;LAMB2;FOXP2;PTBP2
2380,GO:0005516,0.406766093329017,0.694155250017355,16,126,calmodulin binding,MF,MAP6;EGFR;CAMKK1;MARCKSL1;NOS1;OBSCN;MYH11;RGS2;TRPV4;SNTA1;VAMP2;TTN;PLA2G6;IQCB1;SYT7;PLCB3
7487,GO:0031666,0.406799292890599,0.919797712336224,1,5,positive regulation of lipopolysaccharide-mediated signaling pathway,BP,BMP6
8107,GO:0032803,0.407059013345721,0.919683359981892,1,5,regulation of low-density lipoprotein particle receptor catabolic process,BP,APOE
16486,GO:0097208,0.407094020581666,0.919667938918077,1,5,alveolar lamellar body,CC,LAMP3
4640,GO:0010765,0.407769222105091,0.808806652408659,3,21,positive regulation of sodium ion transport,BP,NOS1;ANK3;SCN4B
10084,GO:0042605,0.407976162629845,0.846666487883864,2,14,peptide antigen binding,MF,HLA-B;HLA-A
9714,GO:0038166,0.408171050775255,0.919192598194082,1,5,angiotensin-activated signaling pathway,BP,CA2
5309,GO:0016020,0.4083434956338,0.614838239271686,593,5731,membrane,CC,TGFBI;ITGB6;SERPINE2;ULK2;GPNMB;MUC19;MAP6;IFI6;SREBF1;AMACR;PYGB;NYNRIN;APOE;GPSM1;NT5E;INPP5D;APCDD1;LOC441081;OAS2;ADAM19;LMF1;PSD4;HSPA2;EGFR;PTPRS;FLNC;PKD2;CAPRIN2;XPC;SYT8;CXCR1;CPT2;SYN1;ALDH1A3;LRIG3;PLCD3;SLITRK6;SFRP1;PCDH1;EPS8L2;EPHB2;SYNC;BPHL;DGKQ;TMEM129;PIK3R1;MARVELD1;KDM3A;ORAI3;DOCK9;EVC;SULF2;WNT3;UBXN4;VAV3;ST6GALNAC2;CSPG4;MVB12B;CYBRD1;ELFN2;HTRA1;SPATA18;TFCP2L1;TENM4;RGMA;PI4KAP2;KCNAB2;KITLG;TP53I11;SDK2;ZDHHC1;VAMP3;SNN;REEP2;PRICKLE2;KCNJ15;MC1R;ASAP3;SRD5A3;OR2A4;CSMD2;CAMK2N1;GRIP2;MARCKSL1;NSG1;UNC5B;SLC16A5;KDSR;ITGB5;GJD3;RAB43;RAB40B;NOS1;PRKACB;B4GALNT4;SDC3;BCAM;PLEKHG5;PITPNM3;HMGCL;SCARA3;FKBP5;TMEM200B;FERMT1;CYP26B1;GAA;AP5Z1;CNTRL;MICALL1;PIK3C2G;TBC1D8;PLXNB1;VPS11;NDRG1;COL7A1;KCNC4;SLC29A4;ITPR3;MDM2;CRTC1;LZTS2;PLCD1;IFITM1;ST6GALNAC6;FCGRT;CSMD3;CHN2;TYSND1;PIK3IP1;OBSCN;GOLGA8A;GPRC5C;HLA-B;TNFSF10;PRODH;HGSNAT;PARVB;SYTL1;NDUFA4L2;ACTR1B;RHOBTB2;UGT1A3;CERS4;CYP3A5;NEO1;RAPGEF3;ENDOD1;NINJ1;FAM210B;CTSV;NLGN4Y;BLVRB;OAS1;FLRT3;RASA4;GAL3ST4;CRAT;B4GALT6;AP1G2;RGS2;TMEM63C;ACAP3;IL20RB;ADGRB2;F2R;PPL;C2CD4C;HPS4;TMEM134;SPTB;SLC24A1;SLC27A3;RTN4RL1;ADGRF4;CLTCL1;TRPV4;TMC6;TMEM128;FLOT1;GLI2;AGAP4;NLGN2;ADORA2B;ANK3;LAMP3;PLCH2;MAPK8IP3;GOLGA8B;SLC13A5;CLMN;RIMS3;AVL9;G6PC3;ATG16L2;SPG11;GJC2;RHBDF1;TSPAN18;SULT1E1;TMEM204;PITPNM2;CLCN6;PTGS1;DIRC2;HEXA;FNDC4;FRS3;C5;SNTA1;PSKH1;ADGRL1;MINK1;AMIGO2;TNFRSF14;MBOAT2;ASAP2;ARHGEF4;LHFPL2;ITGA2;SEMA4G;SYT15;ULK1;SPPL2B;LRSAM1;VAMP2;NAIP;BOC;ITGA6;KCNJ5;LZTS1;PRR9;GPC2;NISCH;INSR;TST;CELSR1;GSN;CDK14;ST3GAL5;BAIAP2;TANC1;CBLC;TMC7;SCNN1A;PLXNB3;SUN1;LPAR5;AHNAK2;CNTNAP3;PLEKHH2;RIN1;CD109;CYP2D7;FAM171A2;SCN4B;ARHGEF1;SEPT6;RAB11FIP4;VPS39;MGST2;DOCK8;PILRB;SLC27A1;PGAP1;TM7SF3;NRSN2;SIRPB2;TMEM9;NLRX1;B4GALT2;TMCC3;NIPAL2;PEX10;SLC2A3;TCIRG1;MICALL2;MAP2K2;VEGFB;PTK6;SLC12A7;TMEM8B;FZD7;ETV5;SYNGAP1;FAT2;TMEM117;EPB41L3;HEXB;METTL23;CLCA2;ARHGAP33;ARRDC1;KIAA0319L;B3GNT9;PAQR4;WHAMMP3;CENPC;PLA2G6;MXRA7;CST3;HOMER2;CAPNS2;BBS2;ATP6V0A2;KLHDC2;COL6A1;PEX11B;PSD3;IDH2;CERCAM;MAP3K12;PODXL;SEPT5;IFI27;MALL;OSCP1;DNM1;TNFRSF21;PLD3;TREX1;LPIN3;ZDHHC12;ABHD14A;MCTP1;CDK5R1;ARHGAP27;AGAP6;NET1;ANO9;PIGZ;CA2;EFNB3;PI4KAP1;HOOK2;MAPK10;NKTR;SHANK3;HFE;SCART1;CYBA;AGO4;HADH;SHC2;EDA2R;SPRY2;MRC2;FBXO2;WASH3P;GABBR1;XRN1;AGAP7P;RAB11FIP3;LRP11;KCNMA1;ANKRD28;GPR87;CDK5RAP3;TMEM164;PAQR6;RNF170;CHMP1B;APC2;ARAP1;ASTN2;GOLGA8N;MX2;RPH3AL;SLC2A1;ACACB;ERMAP;REEP4;GPR155;TNS2;NDST2;SLC38A4;TP53I13;GNG2;PRR7;SRR;LRP1;LRRN3;HLA-A;TSNARE1;RGS12;CCDC136;ACP5;RNPEP;C12ORF66;DLK2;KCNG1;SLC48A1;BDH1;CD99L2;DGCR2;APPL2;WNK1;PMEL;BBS1;ATXN10;JPH2;PDE2A;SDHA;STK16;LTB4R2;RET;PRX;DAB2IP;ACOX3;SLC37A2;MYSM1;DDHD2;SHROOM2;RNF213;OLFM2;RAPGEFL1;PIK3C3;IFI16;SYT7;FGFR4;BBS5;EXOC2;IL20RA;PIK3R2;RETSAT;SCN2A;OSBPL5;AREG;ABTB1;TMEM203;DEF6;MYO9A;DLG5;BST2;LETMD1;SNX21;CACNB3;PHF7;TNRC18;DPY19L2P2;VIPR1;EFS;PLXND1;HLTF;MARCH8;EHBP1;PCSK6;TMEM80;MPPE1;NDUFV3;TMCO6;LRRC37A3;LPAR6;DMTN;ORAI2;SLC35E2B;STAT2;ARFGEF2;RASL10B;LMTK3;PCMTD1;SLC36A4;TMEM231;SNX1;PMP22;CA11;GOLGA7B;ACVR1B;TMX4;SHROOM4;APCDD1L;TACC1;KREMEN1;CADM4;NECAB3;CCDC88B;DLG4;ESYT2;ADCK5;IQSEC1;NAT14;ENDOU;NHSL1;NBEAL2;CD68;DUOX1;SLC22A15;TMEM143;SLC35G2;PTK7;SHANK2;RSAD2;TNFRSF25;NEMP2;XYLT1;LMNA;MXRA8;CLSTN3;GLMP;ACSL1;APOLD1;IRS2;DMXL2;ANO1;METTL7A;ERN1;RNF141;ALOX15B;RAD50;GPR21;LAPTM4A;ZMAT3;MAN1B1;DHRS4;PEX1;ECI1;S100A6;FAAH;APBB2;TTC19;MFSD11;CCDC90B;TNFSF12;TAS1R3;CERS5;STAT6;NELFCD;GPR132;SMPDL3B;TUB;SLC43A1;GOLGA1;CPT1C;DNAJC4;RDH12;TRAF5;GOLGB1;SRPX2;CD9;PLIN4;RANBP9;CACNB1;HDAC11;PTPN3;CTSD;GJB5;COL13A1;ERBB2;SYNGR1;PLCB3;GPR68;XKR9;ZDHHC24;PAQR7;PQLC3;ABCA2;AKAP6;SLC2A11;TH;ATG14;MPP7;PRKACA;LDLRAP1;DNAJC22;NPAP1;FMNL3;GCNT4;SYNE2;PARD6G;ACKR3;TMEM212;SUCLG2;UFL1;RIPK3;NFASC;KLF9;PI4K2B;AIP;COG1;KCNS3;LONP2;SNX33;CIT;CLCN7;CALHM2;SMURF1;NPNT;HERPUD2;PEMT;ABCA11P;OCIAD2;GLIPR1L2;TM4SF1;SERINC3
14040,GO:0060840,0.408367524334666,0.74027424196442,7,54,artery development,BP,APOE;PKD2;GLI3;LTBP1;LOXL1;LRP1;PLXND1
14481,GO:0061982,0.408628748893436,0.730301256107341,8,69,meiosis I cell cycle process,BP,HSPA2;MLH3;SUN1;CENPC;REC8;AGO4;RAD50;MSH5
2324,GO:0005337,0.408631068077875,0.918989042038206,1,5,nucleoside transmembrane transporter activity,MF,SLC29A4
5236,GO:0015858,0.408631068077875,0.918989042038206,1,5,nucleoside transport,BP,SLC29A4
17700,GO:1901642,0.408631068077875,0.918989042038206,1,5,nucleoside transmembrane transport,BP,SLC29A4
716,GO:0001942,0.408672006491747,0.730622043432187,8,66,hair follicle development,BP,APCDD1;EGFR;FERMT1;CTSV;CELSR1;CD109;MYSM1;ACVR1B
3087,GO:0006661,0.409221205770511,0.697967525472599,14,119,phosphatidylinositol biosynthetic process,BP,INPP5D;PIK3R1;PITPNM3;PIK3C2G;PITPNM2;SLC27A1;PGAP1;PIGZ;PIK3C3;FGFR4;PIK3R2;MPPE1;IRS2;PI4K2B
8203,GO:0032966,0.409352844289538,0.918669017677869,1,5,negative regulation of collagen biosynthetic process,BP,PPARG
2587,GO:0005882,0.409572314020159,0.729598907327597,8,68,intermediate filament,CC,SYNC;KRT15;CASP14;KRT14;SHANK2;LMNA;LDLRAP1;VMAC
263,GO:0000731,0.409812121017378,0.729390902002704,8,68,DNA synthesis involved in DNA repair,BP,ISG15;POLH;POLD4;RMI2;WRN;PRIMPOL;PALB2;RAD50
12589,GO:0050789,0.409861901931509,0.614161231922114,782,7502,regulation of biological process,BP,TNFAIP3;TGFBI;POSTN;ITGB6;HES2;SERPINE2;ZSCAN18;ULK2;GPNMB;TSC22D1;SIK1;EPM2A;MUC19;DDB2;TP53INP1;IFI6;PTHLH;SREBF1;ACTA2;APOE;GPSM1;NT5E;INPP5D;APCDD1;GAMT;OAS2;MN1;LMF1;PSD4;DDX60;HSPA2;FBXW4;EGFR;ESPN;TRIM65;GIGYF1;PTPRS;CIRBP;FAM20C;PKD2;CAPRIN2;MNT;XPC;APOBEC3C;SYT8;CXCR1;CPT2;RBM3;SYN1;ASH2L;DIXDC1;TRIM22;ALDH1A3;SRSF5;PLCD3;SLITRK6;SFRP1;OBSL1;MTHFR;PERM1;SEC14L2;KCTD11;KIF26B;EPS8L2;EPHB2;RALGDS;MAP3K14;GLUD1;DGKQ;PIK3R1;ADAMTS7;EVI5L;BRSK1;TXNRD3;RBCK1;KDM3A;CXCL14;DOCK9;TSC22D3;CUL9;EVC;RNF135;POU3F1;SULF2;WNT3;CAMKK1;HERC5;VAV3;UNK;HR;SMOC2;CSPG4;ISG15;MVB12B;ELFN2;HTRA1;TFCP2L1;TENM4;RGMA;PI4KAP2;KCNAB2;ZFPM1;KITLG;TP53I11;HOXC5;MVD;ZNF362;CUL7;VAMP3;CITED4;IRF2BPL;REEP2;PRICKLE2;KCNJ15;MC1R;ASAP3;ZNF266;OR2A4;STAT1;IMPACT;CAMK2N1;CRY2;MYL9;HS1BP3;MARCKSL1;NSG1;UNC5B;ITGB5;RAB43;RAB40B;THAP8;NOS1;PRKACB;ZNF704;HOXA3;CRY1;ZNF699;MAML3;ZFP41;SCMH1;KLF13;CRTAP;BCAM;MAGEF1;PLEKHG5;NFATC4;ZNF783;IQSEC2;SPDYE6;BTBD2;RNF187;FERMT1;CYP26B1;GAA;THNSL2;HSF4;CNTRL;ZNF251;PIK3C2G;TBC1D8;PLXNB1;PLEKHG3;VPS11;SPEG;NDRG1;COL7A1;KCNC4;SPOCK1;ITPR3;EAPP;MDM2;CRTC1;LZTS2;PLCD1;NDN;IFITM1;PPP2R2C;FCGRT;CSMD3;CHN2;ZNF662;TYSND1;LTBP4;PIK3IP1;OBSCN;GPRC5C;HLA-B;TNFSF10;PRODH;PARVB;SYTL1;RHOBTB2;NEO1;RAPGEF3;PHACTR3;ZNF414;TCF25;PCBP4;NINJ1;FAM210B;CTSV;NLGN4Y;POLH;OAS1;FLRT3;RASA4;KIF26A;MLLT6;RGL4;RGS2;ARPIN;ACAP3;IL20RB;ADGRB2;F2R;MLYCD;C2CD4C;HPS4;MT1X;PDCD4;CGREF1;SPTB;SERPINB5;NYAP1;SLC24A1;ZNF160;CAPN7;RTN4RL1;ZFP36L2;ADGRF4;CLTCL1;TRPV4;FLOT1;GLI2;AGAP4;TOM1L2;RHPN1;NLGN2;ADORA2B;ANK3;KLF7;RNF165;ADAMTS13;LAMP3;TCEA2;PLCH2;RALGAPA1;MAPK8IP3;SPDYE5;ZNF76;SOX12;CLMN;PIDD1;RIMS3;SLX1A;SLX1B;ZNF747;GJC2;ZCCHC11;ARHGEF19;RHBDF1;TSPAN18;SULT1E1;RASGEF1A;PER2;TMEM204;PITPNM2;CLCN6;PTGS1;UNC119;FNDC4;FRS3;C5;ZNF658;WIPF1;SNTA1;PSKH1;ADGRL1;MINK1;PHF2;NINL;ABHD14B;GSTM2;TCEAL1;AMIGO2;TNFRSF14;WWTR1;ASAP2;ARHGEF4;LHFPL2;ITGA2;SEMA4G;FAM110C;SYT15;ULK1;GLI3;SPPL2B;FHOD3;THRAP3;ZNF558;IRX4;SMARCA1;AKAP7;BHLHE40;LRSAM1;VAMP2;ZNF655;NAIP;LTBP1;NMU;ZNF333;NEK8;MAP2K5;GAS8;BOC;ITGA6;LTBP3;KCNJ5;SRGAP3;CES3;BSN;SESN3;ZNF318;LZTS1;IGFBP4;MMP1;TCFL5;TRAK1;JARID2;NUPR1;GPC2;NISCH;INSR;CCDC85B;CELSR1;MMP28;GSN;HEBP1;CHD3;CDK14;BAIAP2;TTN;CBLC;DDT;ZNF18;PLXNB3;LPAR5;AHNAK2;PLEKHH2;TRIOBP;MXD4;RIN1;ZNF287;CD109;PNMA1;PMS2P3;ETAA1;RMI2;ZNF446;SCN4B;ARHGEF1;RAB11FIP4;ZNF581;MGST2;DOCK8;TP53AIP1;DHX58;PILRB;ENDOG;SLC27A1;TM7SF3;RTF1;MDK;CASP14;IRF9;RICTOR;H2AFJ;BMP6;NLRX1;TCIRG1;S100A4;MICALL2;MAP2K2;PDK1;VEGFB;GLI4;SQSTM1;CEP192;PTK6;TMEM8B;FZD7;ETV5;SYNGAP1;NXPH4;FAM13A;FAM213A;DLX3;TMEM117;EPB41L3;SHARPIN;HEXB;KDM4C;HYAL1;METTL23;ARHGAP33;SH2D2A;NSMCE4A;ARRDC1;ZNF608;WHAMMP3;PLA2G6;CST3;HOMER2;MMRN2;GDF15;BBS2;TXNIP;CTF1;TCF4;ATP6V0A2;PEX11B;NPHP3;PSD3;PLAG1;IDH2;MAP3K12;RCOR2;WRN;PODXL;SEPT5;IFI27;OSCP1;DNM1;TNFRSF21;ZYG11B;IQCB1;KLHL24;TREX1;LPIN3;MCTP1;CDK5R1;ATRX;ARHGAP27;AGAP6;NET1;ANO9;CA2;EFNB3;PI4KAP1;SESN1;MAPK10;SHANK3;HFE;ADIRF;HMG20B;CYBA;TRIM38;NID1;DTX3;AGO4;ERCC6;HADH;RRM2B;SLIT3;SHC2;EDA2R;SPRY2;MRC2;FBXO2;WASH3P;MEF2D;IFT140;GABBR1;CREBRF;XRN1;AGAP7P;RAB11FIP3;MLXIPL;CTSB;KLK5;TARBP1;FBXW7;KCNMA1;GPR87;ING4;NUDT6;CDK5RAP3;ZNF862;ATXN1;LMO2;NOTCH2NL;NFIX;PAK6;TFPI2;CARF;DZIP1L;MXI1;PFKFB2;PAQR6;CHMP1B;THRA;APC2;ARAP1;ASTN2;ADARB1;RAI1;FMNL2;ELF1;MX2;IKZF4;RPH3AL;SLC2A1;ACACB;NLRP1;C1RL;FRAT1;ZBTB34;ERMAP;ZNF627;GPR155;BEX2;GLUL;TNS2;TBC1D17;MIF4GD;DBP;NAB2;EPM2AIP1;TP53I13;GNG2;FBXW5;CAPG;LRP1;LRRN3;HLA-A;PEG3;NPHP4;RGS12;ACP5;PLA2G7;SYNPO2;C12ORF66;RFX2;DLK2;KCNG1;ZNF554;BRINP1;MAP3K6;APPL2;SALL2;WNK1;ZNF107;ZNF532;JPH2;ZBTB20;PDE2A;ZNF334;MAF;STK16;LTB4R2;RET;ZMYND8;PRX;DAB2IP;CASZ1;RWDD3;CALCOCO1;TEAD2;MYSM1;DDHD2;FBXO4;RNF213;OLFM2;RAPGEFL1;TSHZ2;PIK3C3;ZNF276;IFI16;SYT7;FGFR4;ERCC5;EXOC2;IL20RA;PIK3R2;SCN2A;TEF;ZNF25;AREG;ABTB1;SNCB;MYO9A;RPS6KA5;APBB3;ZNF630;DLG5;BTG1;BST2;ZNF687;VDR;RGL2;ARHGEF17;CACNB3;MAMSTR;TNRC18;TNRC6C;ZFP28;VIPR1;FAM3A;EFS;PLXND1;BBS10;ZMYM3;SIX5;HLTF;PCSK6;ZNF789;ZNF563;ZNF517;TBC1D16;LPAR6;PPP1R2;DMTN;PPP1R35;STAT2;SGSM2;ARFGEF2;RASL10B;LMTK3;ALMS1;WWC3;PHF1;ZNF292;TMEM231;TFDP2;SNX1;PMP22;UCN2;NRARP;ACVR1B;TMX4;ZNF737;KREMEN1;NECAB3;CCDC88B;DLG4;TNNI2;PPP2R3B;TSSK1B;IQSEC1;ZNF701;ALOXE3;NAT14;PANO1;PALB2;ENDOU;IGFBP6;TCEAL4;ZNF91;DUOX1;WEE1;DYDC1;CCNG2;GTF2IRD2;PTK7;TCF7;SHANK2;RSAD2;TNFRSF25;ZFP36L1;LMNA;CLSTN3;GLMP;ACSL1;IL11;KAT2B;MARK4;APOLD1;IRS2;IMPA2;CEP250;ANO1;CAPS;ERN1;RNF141;IVNS1ABP;ALOX15B;RAD50;GPR21;ZNF439;TKFC;ANGEL2;ZMAT3;S100A6;TRERF1;SCG5;ZSWIM8;APBB2;ARHGEF9;PBLD;RAPGEF5;TNFSF12;TAS1R3;STAT6;PCSK1N;SOX13;PRDX5;PHPT1;NELFCD;GPR132;SMPDL3B;TUB;KIF7;KLF8;CHD6;TRAF5;GOLGB1;SRPX2;TRIM2;CD9;RANBP9;CACNB1;HDAC11;PTPN3;ERBB2;SYNGR1;SPOCD1;PLCB3;GPR68;PAQR7;ARHGAP23;ABCA2;KMT5C;AKAP6;TH;ATG14;MPP7;RORA;SSH3;PPARG;PRKACA;DOCK6;LDLRAP1;CXXC5;FMNL3;ZNF572;SYNE2;ACKR3;PLTP;ZNF658B;SERPING1;PARN;DOCK3;ZNF529;UFL1;IP6K2;RIPK3;KLF9;AIP;KCNS3;SCAND1;LONP2;PRMT3;SNX33;CIT;ZFP90;MAP1A;CCDC3;PER3;ZFP30;FOXP2;PTBP2;ZC3H6;HIVEP1;ECM2;SMURF1;NPNT;EML2;CTNNBIP1;PEMT;SERINC3;GCLC;ECM1
10042,GO:0042538,0.409953756056127,0.918401972652326,1,5,hyperosmotic salinity response,BP,TRPV4
1990,GO:0004713,0.409973073178879,0.697751606180716,14,111,protein tyrosine kinase activity,MF,EGFR;EPHB2;CNTRL;MAP2K5;INSR;TTN;MAP2K2;PTK6;EFNB3;STK16;RET;FGFR4;WEE1;ERBB2
8730,GO:0034390,0.410112918889872,0.84633538766815,2,13,smooth muscle cell apoptotic process,BP,PDCD4;PPARG
8731,GO:0034391,0.410112918889872,0.84633538766815,2,13,regulation of smooth muscle cell apoptotic process,BP,PDCD4;PPARG
9702,GO:0038128,0.410227389036454,0.780835996696871,4,31,ERBB2 signaling pathway,BP,EGFR;PIK3R1;PTK6;ERBB2
4175,GO:0009251,0.41033804829639,0.806910303750658,3,21,glucan catabolic process,BP,PYGB;GAA;PGM1
14310,GO:0061515,0.410385155665655,0.748987234049265,6,48,myeloid cell development,BP,FAM20C;ZFPM1;FAM210B;FBXW7;DMTN;GPR68
4036,GO:0009070,0.410757813916969,0.844837297054067,2,14,serine family amino acid biosynthetic process,BP,SRR;SERINC3
7723,GO:0032226,0.410759062914418,0.918043258100844,1,5,positive regulation of synaptic transmission, dopaminergic,BP,FLOT1
7709,GO:0032206,0.410988559506422,0.748286628127762,6,49,positive regulation of telomere maintenance,BP,SLX1A;SLX1B;ATRX;FBXO4;RAD50;PARN
16094,GO:0090100,0.411009081341052,0.728595685055153,8,66,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,BP,FERMT1;NEO1;RNF165;BMP6;GDF15;HFE;ACVR1B;NPNT
1413,GO:0003352,0.411232175783432,0.917832059371731,1,5,regulation of cilium movement,BP,BBS2
1414,GO:0003356,0.411232175783432,0.917832059371731,1,5,regulation of cilium beat frequency,BP,BBS2
13705,GO:0060295,0.411232175783432,0.917832059371731,1,5,regulation of cilium movement involved in cell motility,BP,BBS2
13706,GO:0060296,0.411232175783432,0.917832059371731,1,5,regulation of cilium beat frequency involved in ciliary motility,BP,BBS2
17821,GO:1902019,0.411232175783432,0.917832059371731,1,5,regulation of cilium-dependent cell motility,BP,BBS2
14010,GO:0060761,0.411448782296472,0.761200544254434,5,42,negative regulation of response to cytokine stimulus,BP,MAP2K5;SLIT3;PPARG;CCDC3;ECM1
2538,GO:0005796,0.411499136815365,0.748254781983198,6,47,Golgi lumen,CC,MUC19;WNT3;CSPG4;SDC3;GPC2;PCSK6
5848,GO:0017147,0.411647889530233,0.80594011340891,3,21,Wnt-protein binding,MF,APCDD1;SFRP1;FZD7
15021,GO:0070988,0.411713053282387,0.737081185122359,7,56,demethylation,BP,APOBEC3C;KDM3A;HR;HSF4;CYP3A5;PHF2;KDM4C
14115,GO:0061003,0.41177145100179,0.846521099366141,2,12,positive regulation of dendritic spine morphogenesis,BP,CAPRIN2;BAIAP2
17669,GO:1901569,0.41180816173729,0.917574481574856,1,5,fatty acid derivative catabolic process,BP,BDH1
9731,GO:0038202,0.411862251027074,0.779545465379058,4,31,TORC1 signaling,BP,DGKQ;SESN3;SESN1;C12ORF66
520,GO:0001608,0.411985630652826,0.917495017386816,1,5,G-protein coupled nucleotide receptor activity,MF,GPR87
9195,GO:0035589,0.411985630652826,0.917495017386816,1,5,G-protein coupled purinergic nucleotide receptor signaling pathway,BP,GPR87
11033,GO:0045028,0.411985630652826,0.917495017386816,1,5,G-protein coupled purinergic nucleotide receptor activity,MF,GPR87
13752,GO:0060352,0.412258647149189,0.917372677436217,1,5,cell adhesion molecule production,BP,FLOT1
401,GO:0001078,0.412452553518086,0.703109953214551,12,102,transcriptional repressor activity, RNA polymerase II proximal promoter sequence-specific DNA binding,MF,HES2;ZFPM1;NFATC4;BHLHE40;TCFL5;MLXIPL;ZBTB20;TSHZ2;IFI16;KLF8;ZFP90;FOXP2
18318,GO:1903301,0.412641127883357,0.917201096323332,1,5,positive regulation of hexokinase activity,BP,PFKFB2
16183,GO:0090237,0.41286394413468,0.917101038710717,1,5,regulation of arachidonic acid secretion,BP,PLA2G6
17626,GO:1901385,0.412876617834798,0.844519792716492,2,13,regulation of voltage-gated calcium channel activity,BP,CACNB3;CACNB1
7442,GO:0031585,0.413562618335024,0.921308755483571,1,4,regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity,BP,PKD2
3006,GO:0006552,0.414082117091382,0.916552676601885,1,5,leucine catabolic process,BP,HMGCL
10122,GO:0042695,0.414367016600971,0.916424103727086,1,5,thelarche,BP,AREG
13999,GO:0060744,0.414367016600971,0.916424103727086,1,5,mammary gland branching involved in thelarche,BP,AREG
19263,GO:1905516,0.414437612635186,0.916392225223044,1,5,positive regulation of fertilization,BP,LHFPL2
12636,GO:0050860,0.414613447677125,0.842283510146137,2,14,negative regulation of T cell receptor signaling pathway,BP,ELF1;PHPT1
5049,GO:0015245,0.415053918654904,0.916113602932983,1,5,fatty acid transmembrane transporter activity,MF,SLC27A1
3031,GO:0006578,0.415166571798431,0.91606261172574,1,5,amino-acid betaine biosynthetic process,BP,ALDH7A1
881,GO:0002248,0.415193155514159,0.916050576087558,1,5,connective tissue replacement involved in inflammatory response wound healing,BP,F2R
19098,GO:1905063,0.41524853821479,0.91602549840236,1,5,regulation of vascular smooth muscle cell differentiation,BP,PDCD4
2293,GO:0005253,0.415298923215444,0.758514839847194,5,40,anion channel activity,MF,CLCN6;CLCA2;ANO9;ANO1;CLCN7
8474,GO:0033632,0.41534137654523,0.915983450064035,1,5,regulation of cell-cell adhesion mediated by integrin,BP,PODXL
7192,GO:0031089,0.415593690515214,0.915869105684242,1,5,platelet dense granule lumen,CC,ECM1
9361,GO:0035897,0.415621387484652,0.915856547978119,1,5,proteolysis in other organism,BP,MAP2K2
13827,GO:0060452,0.4156736559669,0.915832846473196,1,5,positive regulation of cardiac muscle contraction,BP,RGS2
19712,GO:2000105,0.415690343467319,0.842660072301979,2,13,positive regulation of DNA-dependent DNA replication,BP,BMP6;ATRX
3673,GO:0008172,0.415760136442256,0.9157936221489,1,5,S-methyltransferase activity,MF,MTR
5664,GO:0016776,0.41579328113266,0.775750859254758,4,33,phosphotransferase activity, phosphate group as acceptor,MF,CMPK2;DLG4;RAD50;IP6K2
15991,GO:0086023,0.415865446713673,0.920319421479065,1,4,adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process,BP,NOS1
13828,GO:0060453,0.416013430214988,0.915678671920395,1,5,regulation of gastric acid secretion,BP,NMU
8021,GO:0032673,0.41604172640912,0.841332058528929,2,14,regulation of interleukin-4 production,BP,ZFPM1;IL20RB
16619,GO:0097501,0.41608215108733,0.910515448330965,1,7,stress response to metal ion,BP,MT1X
14620,GO:0070227,0.416369228754945,0.743211087113445,6,52,lymphocyte apoptotic process,BP,TSC22D3;GLI3;DOCK8;TNFRSF21;IRS2;RIPK3
945,GO:0002360,0.416374956660223,0.842205857562286,2,13,T cell lineage commitment,BP,ZFPM1;STAT6
1130,GO:0002719,0.416452083149986,0.841058154511406,2,14,negative regulation of cytokine production involved in immune response,BP,HFE;BST2
8643,GO:0034201,0.416570635050559,0.915425455831226,1,5,response to oleic acid,BP,ACSL1
18248,GO:1903136,0.416709724769168,0.912346429551417,1,6,cuprous ion binding,MF,SNCB
6755,GO:0030194,0.416764354838092,0.840849557321973,2,14,positive regulation of blood coagulation,BP,F2R;DMTN
17338,GO:1900048,0.416764354838092,0.840849557321973,2,14,positive regulation of hemostasis,BP,F2R;DMTN
7840,GO:0032407,0.416861605987376,0.915293038690335,1,5,MutSalpha complex binding,MF,TREX1
4944,GO:0014911,0.416912708137383,0.802018343470166,3,21,positive regulation of smooth muscle cell migration,BP,POSTN;MDM2;ITGA2
3477,GO:0007338,0.417098908021071,0.742592931551862,6,52,single fertilization,BP,SYT8;LHFPL2;HEXB;CCDC136;CD9;GLIPR1L2
12051,GO:0048016,0.417352873704811,0.775566441401646,4,30,inositol phosphate-mediated signaling,BP,NFATC4;ITPR3;ADGRB2;AKAP6
10625,GO:0043649,0.417446850741206,0.840393160746968,2,14,dicarboxylic acid catabolic process,BP,GLUD1;GLUL
8654,GO:0034235,0.417476555812408,0.915012757310942,1,5,GPI anchor binding,MF,MPPE1
12755,GO:0051050,0.417547013972295,0.634075175053963,66,606,positive regulation of transport,BP,POSTN;APOE;HSPA2;EGFR;PKD2;EPHB2;GLUD1;PIK3R1;NOS1;FERMT1;VPS11;MDM2;RAPGEF3;F2R;HPS4;CLTCL1;TRPV4;FLOT1;NLGN2;ADORA2B;ANK3;GJC2;C5;GSTM2;ITGA2;GLI3;VAMP2;NMU;INSR;TTN;SCN4B;TM7SF3;BMP6;MICALL2;PLA2G6;OSCP1;DNM1;CDK5R1;CA2;SHANK3;HFE;CYBA;FBXW7;PFKFB2;RPH3AL;NLRP1;GLUL;LRP1;WNK1;JPH2;SYT7;PIK3R2;RASL10B;TFDP2;IRS2;ANO1;ALOX15B;PHPT1;TUB;ERBB2;GPR68;AKAP6;PPARG;LDLRAP1;PLTP;PEMT
595,GO:0001763,0.417789880318469,0.683615721176667,16,135,morphogenesis of a branching structure,BP,PKD2;SFRP1;NFATC4;GLI2;GLI3;CELSR1;ETV5;SPRY2;AREG;DLG5;VDR;PLXND1;NRARP;COL13A1;NPNT;CTNNBIP1
19714,GO:2000107,0.418428467244142,0.773977861539147,4,32,negative regulation of leukocyte apoptotic process,BP,TSC22D3;KITLG;DOCK8;IRS2
2809,GO:0006269,0.418501494189865,0.914544325899211,1,5,DNA replication, synthesis of RNA primer,BP,PRIMPOL
8129,GO:0032839,0.418525142458253,0.800193487843207,3,22,dendrite cytoplasm,CC,TRAK1;BAIAP2;DLG4
20273,GO:2001275,0.418592689421295,0.842033752162439,2,12,positive regulation of glucose import in response to insulin stimulus,BP,PIK3R1;PIK3R2
4147,GO:0009211,0.4187007437751,0.911408093498803,1,6,pyrimidine deoxyribonucleoside triphosphate metabolic process,BP,CMPK2
1785,GO:0004415,0.418801967229275,0.91440669452778,1,5,hyalurononglucosaminidase activity,MF,HYAL1
18796,GO:1904385,0.418889415712666,0.839426278815357,2,14,cellular response to angiotensin,BP,CA2;CYBA
15860,GO:0072611,0.418914662817047,0.914355038732784,1,5,interleukin-13 secretion,BP,TNFRSF21
20020,GO:2000665,0.418914662817047,0.914355038732784,1,5,regulation of interleukin-13 secretion,BP,TNFRSF21
6215,GO:0019751,0.418922822528582,0.707544342854948,10,86,polyol metabolic process,BP,INPP5D;PLCD3;PLCD1;PLCH2;IMPA2;TKFC;ISYNA1;PLCB3;NUDT10;IP6K2
3928,GO:0008611,0.418932974440961,0.914346643460825,1,5,ether lipid biosynthetic process,BP,PEX7
11696,GO:0046504,0.418932974440961,0.914346643460825,1,5,glycerol ether biosynthetic process,BP,PEX7
17640,GO:1901503,0.418932974440961,0.914346643460825,1,5,ether biosynthetic process,BP,PEX7
13751,GO:0060351,0.418958968154978,0.840485376521042,2,13,cartilage development involved in endochondral bone morphogenesis,BP,TRPV4;THBS3
13092,GO:0051648,0.419069159516056,0.667947915800273,22,195,vesicle localization,BP,SYT8;SYN1;COL7A1;SYTL1;C2CD4C;BLOC1S4;NLGN2;RIMS3;SPG11;SYT15;TPGS1;VAMP2;TRAK1;BLOC1S3;BBS2;SEPT5;DNM1;ANKRD28;SHROOM2;SYT7;BBS5;AREG
18554,GO:1903817,0.419282593243563,0.914186256351296,1,5,negative regulation of voltage-gated potassium channel activity,BP,ANK3
19573,GO:1990712,0.419378148042433,0.914142388085749,1,5,HFE-transferrin receptor complex,CC,HFE
12374,GO:0048814,0.41949069753649,0.730394600413709,7,56,regulation of dendrite morphogenesis,BP,CAPRIN2;OBSL1;CUL7;NFATC4;BAIAP2;CDK5R1;SHANK3
16064,GO:0090051,0.419568321263474,0.840078253719722,2,13,negative regulation of cell migration involved in sprouting angiogenesis,BP,MAP2K5;MMRN2
9377,GO:0035926,0.419611367407633,0.914035260477808,1,5,chemokine (C-C motif) ligand 2 secretion,BP,POSTN
7974,GO:0032596,0.419794079481973,0.91395127465919,1,5,protein transport into membrane raft,BP,REEP2
1929,GO:0004630,0.41983279729263,0.91393347096127,1,5,phospholipase D activity,MF,PLD3
2097,GO:0004865,0.419950942682679,0.910815717735532,1,6,protein serine/threonine phosphatase inhibitor activity,MF,PPP1R2
5158,GO:0015698,0.420044924268568,0.706718420480166,10,84,inorganic anion transport,BP,CRY2;CLCN6;SLC12A7;CLCA2;ANO9;CA2;SLC37A2;ANO1;IP6K2;CLCN7
13035,GO:0051546,0.420141086314871,0.839695086815825,2,13,keratinocyte migration,BP,FERMT1;LTB4R2
17701,GO:1901652,0.420149179869608,0.647780709085146,37,336,response to peptide,BP,TNFAIP3;SREBF1;SRSF5;PIK3R1;STAT1;PRKACB;CRY1;MDM2;TNFSF10;TRPV4;VAMP2;SESN3;INSR;BAIAP2;SLC27A1;TCIRG1;ATP6V0A2;CA2;CYBA;HADH;SLC2A1;NLRP1;EPM2AIP1;GNG2;LRP1;PIK3R2;AREG;BTG1;ZFP36L1;KAT2B;IRS2;GPR21;CACNB1;TH;PPARG;PRKACA;GCLC
14388,GO:0061687,0.420236334972595,0.908511812785771,1,7,detoxification of inorganic compound,BP,MT1X
13013,GO:0051489,0.420652601533399,0.772934339716241,4,30,regulation of filopodium assembly,BP,ESPN;ARAP1;ZMYND8;DMTN
16244,GO:0090324,0.420926301430593,0.913429690335693,1,5,negative regulation of oxidative phosphorylation,BP,MLXIPL
20174,GO:2001046,0.421161684743202,0.913321007761928,1,5,positive regulation of integrin-mediated signaling pathway,BP,DMTN
7839,GO:0032405,0.42139242465756,0.913214386275329,1,5,MutLalpha complex binding,MF,TREX1
7743,GO:0032266,0.421412206102296,0.772326632281245,4,30,phosphatidylinositol-3-phosphate binding,MF,JPH2;DAB2IP;BBS5;SNX21
17365,GO:1900113,0.421603277473043,0.913116882539543,1,5,negative regulation of histone H3-K9 trimethylation,BP,KDM4C
15202,GO:0071377,0.421780021891113,0.797738801582078,3,22,cellular response to glucagon stimulus,BP,PRKACB;GNG2;PRKACA
1605,GO:0004030,0.421787900650178,0.913031451741309,1,5,aldehyde dehydrogenase [NAD(P)+] activity,MF,ALDH1A3
6712,GO:0030128,0.421805734231799,0.838578779764415,2,13,clathrin coat of endocytic vesicle,CC,EGFR;LDLRAP1
17049,GO:0099565,0.421833248787349,0.739313466282333,6,48,chemical synaptic transmission, postsynaptic,BP,NLGN2;BAIAP2;SHANK3;ZMYND8;DLG4;SHANK2
6672,GO:0030041,0.42191404019063,0.686087726998838,14,125,actin filament polymerization,BP,EPS8L2;ARPIN;SPTB;WIPF1;FHOD3;GSN;BAIAP2;TRIOBP;RICTOR;MICALL2;WHAMMP3;WASH3P;CAPG;DMTN
19146,GO:1905208,0.422061671222411,0.838406793287608,2,13,negative regulation of cardiocyte differentiation,BP,EGFR;FZD7
14213,GO:0061200,0.422167206539176,0.91285577022757,1,5,clathrin-sculpted gamma-aminobutyric acid transport vesicle,CC,VAMP2
14214,GO:0061202,0.422167206539176,0.91285577022757,1,5,clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane,CC,VAMP2
14146,GO:0061051,0.422172583200114,0.912853278342827,1,5,positive regulation of cell growth involved in cardiac muscle cell development,BP,AKAP6
11223,GO:0045414,0.422173655669097,0.912852781290753,1,5,regulation of interleukin-8 biosynthetic process,BP,MAP2K5
8265,GO:0033079,0.422257877594032,0.912813741596718,1,5,immature T cell proliferation,BP,ERBB2
13883,GO:0060556,0.42231351968117,0.912787943611737,1,5,regulation of vitamin D biosynthetic process,BP,VDR
6814,GO:0030279,0.422369938866028,0.752928199129138,5,39,negative regulation of ossification,BP,SFRP1;AREG;KREMEN1;SMURF1;ECM1
6698,GO:0030104,0.422574130303932,0.738682944098697,6,48,water homeostasis,BP,PRKACB;CYP26B1;TRPV4;SCNN1A;ALOXE3;PRKACA
10155,GO:0042755,0.422673083378477,0.836875953952084,2,14,eating behavior,BP,NMU;TH
12530,GO:0050699,0.422744129581675,0.796443756962705,3,23,WW domain binding,MF,TCEAL1;SCNN1A;TCEAL4
8029,GO:0032687,0.422821584388575,0.912552162346522,1,5,negative regulation of interferon-alpha production,BP,PTPRS
6018,GO:0019079,0.422858784110107,0.698169419107338,11,99,viral genome replication,BP,OAS2;APOBEC3C;ISG15;PIK3C2G;IFITM1;OAS1;ATG16L2;ADARB1;IFI16;BST2;RSAD2
15812,GO:0072537,0.422965162236425,0.912485458814461,1,5,fibroblast activation,BP,GCLC
8440,GO:0033578,0.42298171096703,0.912477768535896,1,5,protein glycosylation in Golgi,BP,LMF1
4549,GO:0010633,0.423051403298182,0.738276476016464,6,48,negative regulation of epithelial cell migration,BP,APOE;MAP2K5;MMRN2;DAB2IP;PBLD;PPARG
1596,GO:0004017,0.423285845508777,0.912336360294036,1,5,adenylate kinase activity,MF,RAD50
2703,GO:0006069,0.423387457435529,0.912289083616812,1,5,ethanol oxidation,BP,ACSS2
3188,GO:0006812,0.423390928424665,0.630296519040414,61,573,cation transport,BP,SERPINE2;SIK1;HSPA2;PKD2;EPHB2;ORAI3;KCNAB2;KCNJ15;NOS1;KCNC4;ITPR3;NDUFA4L2;TMEM63C;F2R;SLC24A1;TRPV4;NLGN2;ANK3;SLC13A5;GJC2;SNTA1;MINK1;GSTM2;VAMP2;KCNJ5;SCNN1A;SCN4B;NIPAL2;TCIRG1;SLC12A7;PLA2G6;HOMER2;ATP6V0A2;KLHL24;SHANK3;HFE;CYBA;KCNMA1;SLC38A4;KCNG1;WNK1;JPH2;PDE2A;SHROOM2;SYT7;SCN2A;KLHL3;VDR;CACNB3;ORAI2;SLC36A4;DLG4;SHANK2;ANO1;CACNB1;PTPN3;AKAP6;PRKACA;KCNS3;CALHM2;SERINC3
19144,GO:1905206,0.423541875050523,0.912217207592929,1,5,positive regulation of hydrogen peroxide-induced cell death,BP,ENDOG
12344,GO:0048739,0.423695570670896,0.857615176204399,2,6,cardiac muscle fiber development,BP,MYH11;TTN
6233,GO:0019788,0.423735461180583,0.909007509931217,1,6,NEDD8 transferase activity,MF,MDM2
15208,GO:0071385,0.42373814235241,0.751271501091037,5,41,cellular response to glucocorticoid stimulus,BP,EGFR;ZFP36L2;CREBRF;ZFP36L1;KLF9
18938,GO:1904724,0.423841249870795,0.768418955777979,4,36,tertiary granule lumen,CC,CST3;PGM1;METTL7A;CTSD
5399,GO:0016239,0.423878219265052,0.726435425143067,7,57,positive regulation of macroautophagy,BP,EPM2A;GPSM1;ULK1;LRSAM1;SESN3;SESN1;SMURF1
7698,GO:0032185,0.424034126110548,0.837078139829921,2,13,septin cytoskeleton organization,BP,SEPT6;SEPT5
13594,GO:0060088,0.424079752366496,0.911966555992749,1,5,auditory receptor cell stereocilium organization,BP,TRIOBP
19750,GO:2000179,0.424130004599499,0.795958067934336,3,22,positive regulation of neural precursor cell proliferation,BP,GLI2;GJC2;GLI3
14947,GO:0070873,0.424511096153314,0.796295512744293,3,21,regulation of glycogen metabolic process,BP,INSR;EPM2AIP1;IRS2
3427,GO:0007216,0.424762080571199,0.911647944502855,1,5,G-protein coupled glutamate receptor signaling pathway,BP,HOMER2
1839,GO:0004497,0.424767675645402,0.750412888299294,5,41,monooxygenase activity,MF,NOS1;CYP26B1;CYP3A5;CYP2D7;TH
4258,GO:0009597,0.424944189882905,0.911562786829059,1,5,detection of virus,BP,SERINC3
15669,GO:0072217,0.425403294898824,0.911347872148457,1,5,negative regulation of metanephros development,BP,STAT1
11735,GO:0046598,0.425435713718034,0.908187766610271,1,6,positive regulation of viral entry into host cell,BP,TRIM38
7027,GO:0030808,0.4254408304501,0.701708947710279,10,86,regulation of nucleotide biosynthetic process,BP,PTHLH;APOE;NOS1;ADORA2B;INSR;GABBR1;MLXIPL;GPR87;PFKFB2;LTB4R2
17456,GO:1900371,0.4254408304501,0.701708947710279,10,86,regulation of purine nucleotide biosynthetic process,BP,PTHLH;APOE;NOS1;ADORA2B;INSR;GABBR1;MLXIPL;GPR87;PFKFB2;LTB4R2
15247,GO:0071447,0.425583465624928,0.911263441719427,1,5,cellular response to hydroperoxide,BP,TP53INP1
2026,GO:0004767,0.42572189650099,0.911198536838158,1,5,sphingomyelin phosphodiesterase activity,MF,SMPDL3B
3745,GO:0008284,0.425827333026008,0.629671569576437,57,536,positive regulation of cell proliferation,BP,TNFAIP3;PTHLH;FBXW4;EGFR;ASH2L;SFRP1;VAV3;HTRA1;KITLG;MVD;STAT1;MARCKSL1;HOXA3;RNF187;HSF4;TBC1D8;EAPP;MDM2;F2R;GLI2;GJC2;WWTR1;ITGA2;GLI3;MAP2K5;LTBP3;INSR;PLXNB3;RICTOR;BMP6;TCIRG1;VEGFB;FZD7;ETV5;KDM4C;HYAL1;CST3;CTF1;PLAG1;CYBA;MEF2D;MLXIPL;GLUL;FGFR4;AREG;VIPR1;NRARP;CCDC88B;IL11;IRS2;ERN1;S100A6;TNFSF12;ERBB2;UFL1;FOXP2;ECM1
17933,GO:1902307,0.42593520019112,0.835792218844494,2,13,positive regulation of sodium ion transmembrane transport,BP,NOS1;ANK3
16898,GO:0098887,0.426012101698941,0.911062374078447,1,5,neurotransmitter receptor transport, endosome to postsynaptic membrane,BP,NSG1
11459,GO:0045932,0.42603272789918,0.834594007568703,2,14,negative regulation of muscle contraction,BP,RGS2;ADORA2B
2731,GO:0006111,0.426203318340059,0.794381067618732,3,22,regulation of gluconeogenesis,BP,SIK1;DGKQ;KAT2B
7289,GO:0031295,0.426236146567719,0.76770571767845,4,32,T cell costimulation,BP,MAP3K14;PIK3R1;TNFRSF14;EFNB3
8971,GO:0035089,0.426586315046448,0.835350583563079,2,13,establishment of apical/basal cell polarity,BP,MYO9A;PTK7
5501,GO:0016446,0.426641123884379,0.834179013038357,2,14,somatic hypermutation of immunoglobulin genes,BP,PMS2P3;POLM
1550,GO:0003951,0.42668742477196,0.835281947900679,2,13,NAD+ kinase activity,MF,DGKQ;NADK
6774,GO:0030216,0.426815657779874,0.674628308099977,16,151,keratinocyte differentiation,BP,POU3F1;KRT15;CYP26B1;CTSV;PPL;PRR9;CD109;CASP14;SHARPIN;TXNIP;KRT14;KLK5;VDR;PCSK6;ZFP36L1;ALOX15B
13946,GO:0060675,0.426880498171235,0.749169786950833,5,39,ureteric bud morphogenesis,BP,PKD2;KIF26B;GLI3;NPNT;CTNNBIP1
15633,GO:0072171,0.426880498171235,0.749169786950833,5,39,mesonephric tubule morphogenesis,BP,PKD2;KIF26B;GLI3;NPNT;CTNNBIP1
261,GO:0000729,0.427045752544742,0.793738709856377,3,22,DNA double-strand break processing,BP,SLX1A;SLX1B;RAD50
11669,GO:0046469,0.427160051221123,0.910522476253157,1,5,platelet activating factor metabolic process,BP,PLA2G7
12240,GO:0048537,0.427178965232694,0.91051356350842,1,5,mucosal-associated lymphoid tissue development,BP,RET
12243,GO:0048541,0.427178965232694,0.91051356350842,1,5,Peyer's patch development,BP,RET
18156,GO:1902947,0.42761672397567,0.910307124712591,1,5,regulation of tau-protein kinase activity,BP,NAB2
9871,GO:0042157,0.427686162441235,0.680549667796007,14,130,lipoprotein metabolic process,BP,APOE;ZDHHC1;RTN4RL1;CD109;PGAP1;ZDHHC12;PIGZ;LRP1;PIK3C3;MPPE1;GOLGA7B;APOLD1;ZDHHC24;PEMT
12689,GO:0050927,0.427762215834631,0.833412887302175,2,14,positive regulation of positive chemotaxis,BP,ITGA2;VEGFB
1995,GO:0004720,0.427907182214373,0.910169984878122,1,5,protein-lysine 6-oxidase activity,MF,LOXL1
1232,GO:0002921,0.427952033124363,0.91014879677289,1,5,negative regulation of humoral immune response,BP,SERPING1
8274,GO:0033089,0.428070570627104,0.910092783106206,1,5,positive regulation of T cell differentiation in thymus,BP,GLI2
17825,GO:1902033,0.428150844247409,0.910054838166703,1,5,regulation of hematopoietic stem cell proliferation,BP,KITLG
5373,GO:0016188,0.428159629853652,0.910050684639576,1,5,synaptic vesicle maturation,BP,DLG4
1941,GO:0004645,0.428218168245948,0.910023006669211,1,5,phosphorylase activity,MF,PYGB
9422,GO:0036005,0.428496922239848,0.90989113341117,1,5,response to macrophage colony-stimulating factor,BP,PDE2A
9423,GO:0036006,0.428496922239848,0.90989113341117,1,5,cellular response to macrophage colony-stimulating factor stimulus,BP,PDE2A
3125,GO:0006705,0.428550035000196,0.909865992973528,1,5,mineralocorticoid biosynthetic process,BP,BMP6
3703,GO:0008212,0.428550035000196,0.909865992973528,1,5,mineralocorticoid metabolic process,BP,BMP6
7785,GO:0032341,0.428550035000196,0.909865992973528,1,5,aldosterone metabolic process,BP,BMP6
7786,GO:0032342,0.428550035000196,0.909865992973528,1,5,aldosterone biosynthetic process,BP,BMP6
7787,GO:0032344,0.428550035000196,0.909865992973528,1,5,regulation of aldosterone metabolic process,BP,BMP6
7790,GO:0032347,0.428550035000196,0.909865992973528,1,5,regulation of aldosterone biosynthetic process,BP,BMP6
1435,GO:0003416,0.428597735082293,0.833982382128685,2,13,endochondral bone growth,BP,EVC;THBS3
4596,GO:0010714,0.428634567125736,0.832815474382826,2,14,positive regulation of collagen metabolic process,BP,F2R;ITGA2
8204,GO:0032967,0.428634567125736,0.832815474382826,2,14,positive regulation of collagen biosynthetic process,BP,F2R;ITGA2
7559,GO:0031915,0.428690636292228,0.90979941932757,1,5,positive regulation of synaptic plasticity,BP,EPHB2
16858,GO:0098814,0.428893932841764,0.909703105226341,1,5,spontaneous synaptic transmission,BP,NSG1
20246,GO:2001236,0.428953192047779,0.683390151333666,13,118,regulation of extrinsic apoptotic signaling pathway,BP,TNFAIP3;IFI6;SFRP1;RBCK1;UNC5B;TNFSF10;PIDD1;MAP2K5;ITGA6;RET;LMNA;TNFSF12;GCLC
3565,GO:0007608,0.429051750990964,0.832529380755751,2,14,sensory perception of smell,BP,OR2A4;BBS1
1799,GO:0004445,0.429119687650008,0.909596075399177,1,5,inositol-polyphosphate 5-phosphatase activity,MF,INPP5D
6073,GO:0019228,0.429149518814779,0.833606017227604,2,13,neuronal action potential,BP,ANK3;SCN2A
18543,GO:1903789,0.429274429883194,0.909522666336878,1,5,regulation of amino acid transmembrane transport,BP,PER2
4137,GO:0009200,0.42943033762278,0.830435914847738,2,16,deoxyribonucleoside triphosphate metabolic process,BP,CMPK2;RRM2B
12192,GO:0048387,0.429497934355286,0.909416570505118,1,5,negative regulation of retinoic acid receptor signaling pathway,BP,CYP26B1
11872,GO:0046903,0.42967372663242,0.612303877076225,105,993,secretion,BP,POSTN;ITGB6;SERPINE2;SREBF1;PYGB;OAS2;LMF1;EGFR;SYT8;CXCR1;SYN1;SFRP1;GLUD1;BRSK1;KCNAB2;VAMP3;NAPRT;RAB40B;CRY1;FERMT1;GAA;VPS11;KCNC4;ITPR3;LTBP4;HGSNAT;SYTL1;ACTR1B;RAPGEF3;ENDOD1;F2R;C2CD4C;TRPV4;TMC6;NLGN2;ADORA2B;RIMS3;RHBDF1;PER2;C5;LHFPL2;SYT15;VAMP2;NMU;NISCH;GSN;TTN;CD109;TM7SF3;BMP6;SLC2A3;TCIRG1;VEGFB;HEXB;PLA2G6;CST3;IDH2;SEPT5;TNFRSF21;MCTP1;CA2;HFE;CYBA;HADH;RAB11FIP3;CTSB;PGM1;PFKFB2;RPH3AL;SLC2A1;NLRP1;GLUL;WNK1;OLFM2;PIK3C3;SYT7;EXOC2;BST2;VDR;PCSK6;DMTN;ARFGEF2;RASL10B;NECAB3;NBEAL2;CD68;RSAD2;IL11;IRS2;ANO1;METTL7A;ALOX15B;SCG5;PHPT1;GLB1;DPP7;CD9;CTSD;SYNGR1;GPR68;C6ORF120;SERPING1;NFASC;KCNS3;ECM1
15295,GO:0071526,0.429880574968892,0.765924852503635,4,29,semaphorin-plexin signaling pathway,BP,PLXNB1;SEMA4G;PLXNB3;PLXND1
7520,GO:0031748,0.429884979694854,0.909232657763463,1,5,D1 dopamine receptor binding,MF,DLG4
8007,GO:0032648,0.429910659199462,0.746106783126587,5,41,regulation of interferon-beta production,BP,PTPRS;RNF135;FLOT1;NLRX1;ZBTB20
2584,GO:0005879,0.429935832911676,0.909208476310888,1,5,axonemal microtubule,CC,ARFGEF2
5574,GO:0016594,0.429949685872645,0.909201888323126,1,5,glycine binding,MF,SRR
14671,GO:0070314,0.429976073591228,0.909189338401703,1,5,G1 to G0 transition,BP,RAB11FIP4
7985,GO:0032611,0.430105210974057,0.745700611552378,5,42,interleukin-1 beta production,BP,TNFAIP3;F2R;NLRP1;ACP5;IFI16
7630,GO:0032048,0.430123092924882,0.83179351589692,2,14,cardiolipin metabolic process,BP,SLC27A1;PLA2G6
11494,GO:0045995,0.43037954640741,0.697444245030996,10,84,regulation of embryonic development,BP,SFRP1;TENM4;PRKACB;MAP2K5;INSR;CELSR1;FZD7;NPHP3;NRARP;PTK7
10544,GO:0043515,0.430532686482316,0.908924360172529,1,5,kinetochore binding,MF,CENPH
8614,GO:0034142,0.430674876594147,0.831413860344587,2,14,toll-like receptor 4 signaling pathway,BP,TNFAIP3;DAB2IP
3107,GO:0006685,0.430721567426955,0.908834331869777,1,5,sphingomyelin catabolic process,BP,SMPDL3B
19595,GO:1990763,0.430741520653648,0.908824818086487,1,5,arrestin family protein binding,MF,ARRDC1
20003,GO:2000646,0.431022643279854,0.908690710951637,1,5,positive regulation of receptor catabolic process,BP,APOE
14572,GO:0070141,0.431037307401644,0.908683712142755,1,5,response to UV-A,BP,EGFR
768,GO:0002024,0.431218465988122,0.90859722194821,1,5,diet induced thermogenesis,BP,TRPV4
3529,GO:0007512,0.431467079380328,0.908478442832831,1,5,adult heart development,BP,MEF2D
13660,GO:0060215,0.431502507619943,0.90846150849099,1,5,primitive hemopoiesis,BP,ZFPM1
2524,GO:0005779,0.431609868206881,0.829780579410938,2,15,integral component of peroxisomal membrane,CC,PEX10;PEX11B
7255,GO:0031231,0.431609868206881,0.829780579410938,2,15,intrinsic component of peroxisomal membrane,CC,PEX10;PEX11B
9086,GO:0035360,0.431673118712418,0.908379930412041,1,5,positive regulation of peroxisome proliferator activated receptor signaling pathway,BP,ALOX15B
12800,GO:0051125,0.431710921642551,0.790164875589083,3,22,regulation of actin nucleation,BP,ARPIN;WIPF1;GSN
2042,GO:0004791,0.431841211877601,0.905058068612691,1,6,thioredoxin-disulfide reductase activity,MF,TXNRD3
8913,GO:0034766,0.431902250087932,0.730301617521317,6,50,negative regulation of ion transmembrane transport,BP,PKD2;EPHB2;ANK3;GSTM2;ANO9;IRS2
3890,GO:0008527,0.432087891328796,0.902643299848152,1,7,taste receptor activity,MF,TAS1R3
3122,GO:0006702,0.432119542614627,0.908166254787914,1,5,androgen biosynthetic process,BP,SRD5A3
4472,GO:0010470,0.432536151493928,0.789529755626878,3,22,regulation of gastrulation,BP,TENM4;MAP2K5;FZD7
2213,GO:0005109,0.432713209124594,0.789393371861216,3,22,frizzled binding,MF,SFRP1;WNT3;FZD7
2219,GO:0005123,0.433148759201343,0.829706211342522,2,14,death receptor binding,MF,PIDD1;DAB2IP
12527,GO:0050693,0.433154507971056,0.907669671208334,1,5,LBD domain binding,MF,PPARG
5079,GO:0015318,0.43331105369643,0.63042116039234,43,397,inorganic molecular entity transmembrane transporter activity,MF,PKD2;ORAI3;KCNAB2;KCNJ15;SLC16A5;GJD3;KCNC4;ITPR3;NDUFA4L2;TMEM63C;SLC24A1;TRPV4;SLC13A5;CLCN6;KCNJ5;SCNN1A;SCN4B;SLC27A1;NIPAL2;TCIRG1;SLC12A7;CLCA2;ATP6V0A2;ANO9;KCNMA1;SLC38A4;KCNG1;JPH2;PDE2A;SLC37A2;SHROOM2;SCN2A;CACNB3;ORAI2;SLC36A4;DLG4;ANO1;SLC43A1;CACNB1;KCNS3;CLCN7;CALHM2;SERINC3
5881,GO:0018022,0.433403849528159,0.688899290906931,11,95,peptidyl-lysine methylation,BP,ASH2L;KDM3A;JARID2;RTF1;KDM4C;ATRX;METTL21A;SETD4;PHF1;DYDC1;KMT5C
12740,GO:0051029,0.433445321085704,0.904263992039096,1,6,rRNA transport,BP,TST
14625,GO:0070232,0.433629223527885,0.787575032291477,3,24,regulation of T cell apoptotic process,BP,TSC22D3;DOCK8;RIPK3
12137,GO:0048261,0.433634151567001,0.829370104076229,2,14,negative regulation of receptor-mediated endocytosis,BP,UNC119;DLG4
14245,GO:0061333,0.433659210038928,0.729184002667035,6,48,renal tubule morphogenesis,BP,PKD2;KIF26B;GLI3;KLHL3;NPNT;CTNNBIP1
10427,GO:0043297,0.433687260465241,0.729159810955015,6,48,apical junction assembly,BP,MICALL2;NPHP4;DLG5;MPP7;PRKACA;PARD6G
13532,GO:0060017,0.433759959539229,0.907378386732883,1,5,parathyroid gland development,BP,HOXA3
14096,GO:0060976,0.43389101690777,0.762246876021665,4,30,coronary vasculature development,BP,LTBP1;VEGFB;PLXND1;PTK7
2215,GO:0005113,0.433904402267033,0.907308809247729,1,5,patched binding,MF,BBS1
5133,GO:0015631,0.434096822469265,0.640562834498153,31,275,tubulin binding,MF,MAP6;DIXDC1;KIF26B;BRSK1;NDRG1;NDN;MYH11;KIF26A;RGS2;TUBGCP5;TRPV4;FAM110C;TPGS1;GAS8;LZTS1;DNM1;CDK5R1;HOOK2;CLIP2;WASH3P;APC2;MX2;REEP4;MYO3B;MYO9A;EML3;CCDC88B;MARK4;KIF7;MAP1A;EML2
14580,GO:0070162,0.434165989974606,0.907182719409943,1,5,adiponectin secretion,BP,RAB11FIP3
14581,GO:0070163,0.434165989974606,0.907182719409943,1,5,regulation of adiponectin secretion,BP,RAB11FIP3
3551,GO:0007586,0.434423381650086,0.742305079691395,5,41,digestion,BP,NMU;WNK1;VDR;UCN2;PBLD
2671,GO:0006023,0.434798480833444,0.693361325066789,10,85,aminoglycan biosynthetic process,BP,CSPG4;SDC3;B4GALT6;HEXA;GPC2;B4GALT2;HYAL1;B3GNT9;NDST2;XYLT1
19969,GO:2000587,0.434811725850316,0.906870999378919,1,5,negative regulation of platelet-derived growth factor receptor-beta signaling pathway,BP,LRP1
6945,GO:0030579,0.434914414717698,0.906821366828321,1,5,ubiquitin-dependent SMAD protein catabolic process,BP,SMURF1
8313,GO:0033162,0.43496485297217,0.903507947607918,1,6,melanosome membrane,CC,TH
11023,GO:0045009,0.43496485297217,0.903507947607918,1,6,chitosome,CC,TH
16365,GO:0090741,0.43496485297217,0.903507947607918,1,6,pigment granule membrane,CC,TH
13845,GO:0060484,0.435038224944552,0.90676150346051,1,5,lung-associated mesenchyme development,BP,PTK7
1643,GO:0004089,0.435261304804553,0.906653580934142,1,5,carbonate dehydratase activity,MF,CA2
11064,GO:0045078,0.435302680821345,0.906633555174561,1,5,positive regulation of interferon-gamma biosynthetic process,BP,ZFPM1
14699,GO:0070371,0.435345410727346,0.656629838792406,20,181,ERK1 and ERK2 cascade,BP,GPNMB;EGFR;EPHB2;CAMK2N1;F2R;ZFP36L2;TRPV4;INSR;DDT;MAP2K2;SPRY2;FBXW7;RET;DAB2IP;FGFR4;ZFP36L1;RANBP9;ERBB2;ACKR3;NPNT
1701,GO:0004190,0.435393853583531,0.828148700877042,2,14,aspartic-type endopeptidase activity,MF,SPPL2B;CTSD
14496,GO:0070001,0.435393853583531,0.828148700877042,2,14,aspartic-type peptidase activity,MF,SPPL2B;CTSD
7728,GO:0032231,0.43551480848986,0.707059646675199,8,66,regulation of actin filament bundle assembly,BP,SFRP1;PIK3R1;ASAP3;RAPGEF3;SHANK3;ARAP1;SYNPO2;ALMS1
11424,GO:0045875,0.435652748780432,0.90646401551248,1,5,negative regulation of sister chromatid cohesion,BP,ATRX
18544,GO:1903792,0.435686476104679,0.82911329251619,2,13,negative regulation of anion transport,BP,ANO9;IRS2
12464,GO:0050432,0.435806094325408,0.827861906405851,2,14,catecholamine secretion,BP,NISCH;SYT7
12055,GO:0048020,0.436019611670086,0.900645950090165,1,7,CCR chemokine receptor binding,MF,STAT1
9499,GO:0036159,0.43618771766746,0.906204551217532,1,5,inner dynein arm assembly,BP,DNAH1
6349,GO:0021534,0.436192801346905,0.906202083414328,1,5,cell proliferation in hindbrain,BP,RORA
6523,GO:0021924,0.436192801346905,0.906202083414328,1,5,cell proliferation in external granule layer,BP,RORA
6524,GO:0021930,0.436192801346905,0.906202083414328,1,5,cerebellar granule cell precursor proliferation,BP,RORA
18233,GO:1903078,0.436219943760009,0.741044745735047,5,40,positive regulation of protein localization to plasma membrane,BP,EGFR;EPHB2;PIK3R1;SQSTM1;LRP1
19416,GO:1990050,0.436423907966706,0.90277847023966,1,6,phosphatidic acid transporter activity,MF,PLTP
5246,GO:0015874,0.436591606977326,0.906008360042246,1,5,norepinephrine transport,BP,NISCH
1109,GO:0002698,0.436639912010358,0.705449091385396,8,71,negative regulation of immune effector process,BP,HTRA1;IL20RB;DHX58;NLRX1;HFE;BST2;TKFC;SERPING1
16145,GO:0090186,0.436643902750322,0.90598293812831,1,5,regulation of pancreatic juice secretion,BP,WNK1
535,GO:0001654,0.436706512837687,0.64618828312614,25,220,eye development,BP,EGFR;ALDH1A3;SLITRK6;EPHB2;SDK2;HSF4;NAGLU;NINJ1;GLI3;RAB11FIP4;BLOC1S3;BMP6;CST3;IFT140;NPHP4;SALL2;MAF;RET;SHROOM2;SIX5;TMEM231;TUB;TH;LAMB2;FOXP2
7842,GO:0032410,0.436763173468204,0.740325350883016,5,41,negative regulation of transporter activity,BP,PKD2;EPHB2;ANK3;GSTM2;ANO9
16339,GO:0090659,0.436779797314491,0.82835574270231,2,13,walking behavior,BP,SPG11;EFNB3
14005,GO:0060751,0.43679205927817,0.905910892945664,1,5,branch elongation involved in mammary gland duct branching,BP,AREG
12959,GO:0051382,0.436919351774672,0.827086164352,2,14,kinetochore assembly,BP,CENPC;CENPH
4139,GO:0009202,0.437154035826678,0.902412132257554,1,6,deoxyribonucleoside triphosphate biosynthetic process,BP,CMPK2
11248,GO:0045540,0.437185215689216,0.739967629969208,5,41,regulation of cholesterol biosynthetic process,BP,SREBF1;APOE;SEC14L2;MVD;ACACB
12895,GO:0051261,0.437271001102452,0.697782057895056,9,75,protein depolymerization,BP,SPTB;TRPV4;GSN;PLEKHH2;TRIOBP;APC2;CAPG;DMTN;MAP1A
18601,GO:1903909,0.437411808299998,0.905609143847904,1,5,regulation of receptor clustering,BP,GSN
17508,GO:1901020,0.437521290773252,0.825658125119428,2,15,negative regulation of calcium ion transmembrane transporter activity,BP,PKD2;GSTM2
7320,GO:0031338,0.437528190019352,0.725839850284033,6,48,regulation of vesicle fusion,BP,EVI5L;TBC1D8;VPS11;TBC1D17;TBC1D16;SGSM2
11299,GO:0045634,0.437623347015855,0.905506007743548,1,5,regulation of melanocyte differentiation,BP,KITLG
5015,GO:0015180,0.437795708693281,0.905421919703204,1,5,L-alanine transmembrane transporter activity,MF,SLC36A4
5207,GO:0015808,0.437795708693281,0.905421919703204,1,5,L-alanine transport,BP,SLC36A4
6621,GO:0022858,0.437795708693281,0.905421919703204,1,5,alanine transmembrane transporter activity,MF,SLC36A4
13230,GO:0051930,0.437837240508981,0.826445182966823,2,14,regulation of sensory perception of pain,BP,F2R;NMU
13231,GO:0051931,0.437837240508981,0.826445182966823,2,14,regulation of sensory perception,BP,F2R;NMU
20006,GO:2000649,0.438028726178211,0.758467599840717,4,31,regulation of sodium ion transmembrane transporter activity,BP,ANK3;SCN4B;KLHL24;PTPN3
6271,GO:0019870,0.438191463938853,0.905228667829874,1,5,potassium channel inhibitor activity,MF,WNK1
10190,GO:0042816,0.438264981981828,0.905192740557856,1,5,vitamin B6 metabolic process,BP,PNPO
8970,GO:0035088,0.43830483220771,0.7582409240793,4,31,establishment or maintenance of apical/basal cell polarity,BP,MYO9A;DLG5;DLG4;PTK7
14222,GO:0061245,0.43830483220771,0.7582409240793,4,31,establishment or maintenance of bipolar cell polarity,BP,MYO9A;DLG5;DLG4;PTK7
8722,GO:0034381,0.438383031291216,0.75713639902321,4,34,plasma lipoprotein particle clearance,BP,APOE;LMF1;CES3;LDLRAP1
8844,GO:0034650,0.438408479007653,0.905122590643883,1,5,cortisol metabolic process,BP,DGKQ
8845,GO:0034651,0.438408479007653,0.905122590643883,1,5,cortisol biosynthetic process,BP,DGKQ
19698,GO:2000064,0.438408479007653,0.905122590643883,1,5,regulation of cortisol biosynthetic process,BP,DGKQ
10344,GO:0043171,0.438581146149509,0.784260574488431,3,23,peptide catabolic process,BP,ADAMTS13;RNPEPL1;RNPEP
1557,GO:0003958,0.438675964753786,0.904991739788583,1,5,NADPH-hemoprotein reductase activity,MF,NOS1
6180,GO:0019563,0.438742795397222,0.904959029162742,1,5,glycerol catabolic process,BP,TKFC
1068,GO:0002634,0.438815064397674,0.90492364867101,1,5,regulation of germinal center formation,BP,TNFAIP3
12896,GO:0051262,0.439031010561846,0.682466368863907,11,116,protein tetramerization,BP,PKD2;ALDH1A3;GPX3;HMGCL;CRTC1;INSR;DNM1;ACACB;SRR;DHRS4;CBR4
19627,GO:1990868,0.439248855489178,0.904711103380615,1,5,response to chemokine,BP,DOCK8
19628,GO:1990869,0.439248855489178,0.904711103380615,1,5,cellular response to chemokine,BP,DOCK8
6666,GO:0030032,0.439316180629837,0.724083986752877,6,49,lamellipodium assembly,BP,VAV3;PARVB;ARHGEF4;PLXNB3;DMTN;SSH3
11251,GO:0045545,0.439335736593546,0.904668497909496,1,5,syndecan binding,MF,GPNMB
9390,GO:0035947,0.439470793002226,0.904602243832054,1,5,regulation of gluconeogenesis by regulation of transcription from RNA polymerase II promoter,BP,KAT2B
131,GO:0000272,0.439653370148642,0.784015357598462,3,22,polysaccharide catabolic process,BP,PYGB;GAA;PGM1
10771,GO:0044247,0.439653370148642,0.784015357598462,3,22,cellular polysaccharide catabolic process,BP,PYGB;GAA;PGM1
14185,GO:0061138,0.439804036832974,0.666346917239786,15,128,morphogenesis of a branching epithelium,BP,PKD2;SFRP1;NFATC4;GLI2;GLI3;CELSR1;ETV5;SPRY2;AREG;DLG5;VDR;PLXND1;NRARP;NPNT;CTNNBIP1
10363,GO:0043198,0.440010024936612,0.78373728377954,3,22,dendritic shaft,CC,BAIAP2;SYNGAP1;ZMYND8
11284,GO:0045618,0.44007546085444,0.824876961220926,2,14,positive regulation of keratinocyte differentiation,BP,VDR;ALOX15B
12258,GO:0048570,0.440091563147499,0.904297339217554,1,5,notochord morphogenesis,BP,GLI2
1327,GO:0003181,0.440485677431009,0.825774849625669,2,13,atrioventricular valve morphogenesis,BP,ZFPM1;MDM2
4522,GO:0010587,0.440493838433689,0.904099423042918,1,5,miRNA catabolic process,BP,ZCCHC11
10639,GO:0043696,0.440734404093784,0.903980942574611,1,5,dedifferentiation,BP,OLFM2
10640,GO:0043697,0.440734404093784,0.903980942574611,1,5,cell dedifferentiation,BP,OLFM2
9302,GO:0035771,0.440992851784544,0.903853551486622,1,5,interleukin-4-mediated signaling pathway,BP,STAT6
16105,GO:0090118,0.441209889444486,0.903746488834346,1,5,receptor-mediated endocytosis involved in cholesterol transport,BP,LDLRAP1
16834,GO:0098773,0.44125906470684,0.701677756215081,8,68,skin epidermis development,BP,APCDD1;EGFR;FERMT1;CTSV;CELSR1;CD109;MYSM1;ACVR1B
12216,GO:0048490,0.441269562546118,0.82301743667642,2,15,anterograde synaptic vesicle transport,BP,BLOC1S4;BLOC1S3
17017,GO:0099514,0.441269562546118,0.82301743667642,2,15,synaptic vesicle cytoskeletal transport,BP,BLOC1S4;BLOC1S3
17020,GO:0099517,0.441269562546118,0.82301743667642,2,15,synaptic vesicle transport along microtubule,BP,BLOC1S4;BLOC1S3
104,GO:0000217,0.441502878896894,0.781977291904241,3,23,DNA secondary structure binding,MF,XPC;WRN;ERCC5
2604,GO:0005903,0.441681351151831,0.710678268187511,7,58,brush border,CC,ESPN;RALGDS;CYBRD1;ITPR3;SCART1;SHANK2;PEMT
12028,GO:0047844,0.441785635691632,0.900067970747654,1,6,deoxycytidine deaminase activity,MF,APOBEC3C
8973,GO:0035091,0.441935545859042,0.648431870969574,21,185,phosphatidylinositol binding,MF,HS1BP3;PIK3C2G;ITPR3;PLCD1;NISCH;FZD7;ARHGAP33;ARAP1;JPH2;DAB2IP;SYT7;BBS5;OSBPL5;SNX21;MPPE1;SNX1;ESYT2;SNX29;TUB;LDLRAP1;SNX33
15985,GO:0086016,0.442176187650769,0.903268903212447,1,5,AV node cell action potential,BP,SCN4B
15994,GO:0086027,0.442176187650769,0.903268903212447,1,5,AV node cell to bundle of His cell signaling,BP,SCN4B
12334,GO:0048713,0.442181560097194,0.781445316944891,3,23,regulation of oligodendrocyte differentiation,BP,TENM4;TNFRSF21;PPARG
3181,GO:0006801,0.442375627889584,0.75353184539888,4,35,superoxide metabolic process,BP,EGFR;CYBA;ACP5;DUOX1
16587,GO:0097443,0.442438283524024,0.903139105069478,1,5,sorting endosome,CC,CLTCL1
14281,GO:0061437,0.442679797288102,0.82304286912615,2,14,renal system vasculature development,BP,ACTA2;PKD2
14284,GO:0061440,0.442679797288102,0.82304286912615,2,14,kidney vasculature development,BP,ACTA2;PKD2
17689,GO:1901621,0.44272321657196,0.902997871590263,1,5,negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,PRKACB
10413,GO:0043271,0.442860827257235,0.700119993692411,8,69,negative regulation of ion transport,BP,SERPINE2;PKD2;EPHB2;NOS1;ANK3;GSTM2;ANO9;IRS2
5596,GO:0016635,0.443055003949537,0.899419368456543,1,6,oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor,MF,SDHA
12874,GO:0051235,0.443156807261836,0.641511740440152,24,219,maintenance of location,BP,APOE;PKD2;NOS1;CRY1;GAA;ITPR3;F2R;ANK3;GSTM2;LTBP1;GSN;SUN1;EPB41L3;HEXB;CYBA;FBXW7;MXI1;THRA;ACACB;JPH2;AKAP6;PPARG;PRKACA;SYNE2
7058,GO:0030853,0.443186261042534,0.902768073792109,1,5,negative regulation of granulocyte differentiation,BP,INPP5D
17480,GO:1900542,0.443195691185361,0.67042479274089,13,115,regulation of purine nucleotide metabolic process,BP,PTHLH;APOE;PKD2;NOS1;RAPGEF3;ADORA2B;INSR;NPHP3;GABBR1;MLXIPL;GPR87;PFKFB2;LTB4R2
15858,GO:0072608,0.443293583910653,0.899297166121687,1,6,interleukin-10 secretion,BP,TNFRSF21
11250,GO:0045542,0.443393990073174,0.902664870419739,1,5,positive regulation of cholesterol biosynthetic process,BP,SREBF1
17611,GO:1901343,0.443474896087099,0.699950553099057,8,66,negative regulation of vasculature development,BP,STAT1;ADGRB2;PDCD4;MAP2K5;MMRN2;SPRY2;DAB2IP;PPARG
6362,GO:0021548,0.443496075438686,0.902614127102522,1,5,pons development,BP,CDK5R1
3900,GO:0008542,0.443498349702451,0.753960478445363,4,31,visual learning,BP,TANC1;B4GALT2;SYNGAP1;DDHD2
1703,GO:0004198,0.443534454086234,0.821411691411552,2,15,calcium-dependent cysteine-type endopeptidase activity,MF,CAPN7;CAPNS2
4045,GO:0009084,0.443741879708498,0.822292008835454,2,14,glutamine family amino acid biosynthetic process,BP,GLUD1;GLUL
16924,GO:0098927,0.44375082212733,0.734377996201665,5,41,vesicle-mediated transport between endosomal compartments,BP,VPS11;MAP2K2;HOOK2;WASH3P;PIK3C3
7829,GO:0032391,0.44381158058274,0.780165183553988,3,23,photoreceptor connecting cilium,CC,IQCB1;IFT140;NPHP4
19753,GO:2000191,0.443892081590274,0.822185685112083,2,14,regulation of fatty acid transport,BP,PLA2G6;IRS2
9363,GO:0035900,0.443995486034809,0.898937102181022,1,6,response to isolation stress,BP,TH
7288,GO:0031294,0.444086976580483,0.75274780040924,4,33,lymphocyte costimulation,BP,MAP3K14;PIK3R1;TNFRSF14;EFNB3
7627,GO:0032042,0.444124958811453,0.822020771388188,2,14,mitochondrial DNA metabolic process,BP,RRM2B;PRIMPOL
13586,GO:0060078,0.444141475988392,0.719881815485142,6,49,regulation of postsynaptic membrane potential,BP,NLGN2;BAIAP2;SHANK3;ZMYND8;DLG4;SHANK2
8737,GO:0034398,0.444215596804464,0.902255998577328,1,5,telomere tethering at nuclear periphery,BP,SUN1
12327,GO:0048705,0.444269243568903,0.662081937586696,15,130,skeletal system morphogenesis,BP,SFRP1;HOXA3;CYP26B1;TRPV4;THBS3;GLI3;BMP6;HYAL1;PEX7;MEF2D;IFT140;THRA;NAB2;ACP5;COL13A1
14647,GO:0070273,0.444430367165088,0.779678308759119,3,23,phosphatidylinositol-4-phosphate binding,MF,JPH2;DAB2IP;OSBPL5
255,GO:0000722,0.444470056773495,0.821776239142739,2,14,telomere maintenance via recombination,BP,TEP1;RAD50
4092,GO:0009148,0.444707961177569,0.818900292694986,2,17,pyrimidine nucleoside triphosphate biosynthetic process,BP,CMPK2;UCKL1
10918,GO:0044550,0.445051899731716,0.821363550313132,2,14,secondary metabolite biosynthetic process,BP,DDT;PMEL
6571,GO:0022404,0.445440774639491,0.697927079297342,8,68,molting cycle process,BP,APCDD1;EGFR;FERMT1;CTSV;CELSR1;CD109;MYSM1;ACVR1B
6572,GO:0022405,0.445440774639491,0.697927079297342,8,68,hair cycle process,BP,APCDD1;EGFR;FERMT1;CTSV;CELSR1;CD109;MYSM1;ACVR1B
3284,GO:0006972,0.445489955082433,0.821052513828716,2,14,hyperosmotic response,BP,TRPV4;SLC2A1
12695,GO:0050942,0.445709016859578,0.901510000614357,1,5,positive regulation of pigment cell differentiation,BP,KITLG
7073,GO:0030870,0.445876667687221,0.9014260292921,1,5,Mre11 complex,CC,RAD50
9660,GO:0038031,0.445934658963104,0.901396972564982,1,5,non-canonical Wnt signaling pathway via JNK cascade,BP,FZD7
2170,GO:0005007,0.446000062506188,0.901364195329343,1,5,fibroblast growth factor-activated receptor activity,MF,FGFR4
8758,GO:0034446,0.44602461491,0.697402191278693,8,68,substrate adhesion-dependent cell spreading,BP,POSTN;VAMP3;PARVB;TRIOBP;MICALL2;FZD7;NET1;DMTN
6794,GO:0030242,0.446154079417345,0.90128698172958,1,5,autophagy of peroxisome,BP,PIK3C3
6778,GO:0030220,0.446318762732195,0.82046324433943,2,14,platelet formation,BP,ZFPM1;NBEAL2
11019,GO:0045005,0.446520992508265,0.75107752343909,4,32,DNA-dependent DNA replication maintenance of fidelity,BP,ETAA1;WRN;ATRX;PRIMPOL
12076,GO:0048069,0.44674525053664,0.900990250661409,1,5,eye pigmentation,BP,HPS4
1580,GO:0003993,0.446788154274596,0.897496436323197,1,6,acid phosphatase activity,MF,ACP5
9796,GO:0040036,0.44686689106571,0.777756312939103,3,23,regulation of fibroblast growth factor receptor signaling pathway,BP,FAM20C;SULF2;SPRY2
18549,GO:1903798,0.447417947555133,0.819680157840101,2,14,regulation of production of miRNAs involved in gene silencing by miRNA,BP,EGFR;MAP2K2
127,GO:0000266,0.447679723595667,0.750113068929085,4,32,mitochondrial fission,BP,DNM1;MX2;DDHD2;STAT2
2772,GO:0006195,0.447816950672686,0.749314364079375,4,34,purine nucleotide catabolic process,BP,NT5E;RAPGEF3;PDE2A;NUDT10
13543,GO:0060028,0.447856322610546,0.900431022377733,1,5,convergent extension involved in axis elongation,BP,SFRP1
2782,GO:0006213,0.447924501981168,0.748346439591304,4,37,pyrimidine nucleoside metabolic process,BP,NT5E;APOBEC3C;TK2;UCKL1
402,GO:0001083,0.447932364720772,0.900392675054945,1,5,transcription factor activity, RNA polymerase II basal transcription factor binding,MF,TCF4
7659,GO:0032096,0.447976134055992,0.896879662718038,1,6,negative regulation of response to food,BP,BBS2
7662,GO:0032099,0.447976134055992,0.896879662718038,1,6,negative regulation of appetite,BP,BBS2
4067,GO:0009120,0.448042489705581,0.896845142997665,1,6,deoxyribonucleoside metabolic process,BP,TK2
9686,GO:0038094,0.448086993010732,0.70483535335478,7,59,Fc-gamma receptor signaling pathway,BP,PIK3R1;VAV3;FCGRT;WIPF1;BAIAP2;PLA2G6;PIK3R2
11363,GO:0045745,0.44822044560987,0.819107297099463,2,14,positive regulation of G-protein coupled receptor protein signaling pathway,BP,NOS1;KLK5
10346,GO:0043174,0.448346770873019,0.817070519806698,2,16,nucleoside salvage,BP,TK2;UCKL1
11235,GO:0045454,0.448376845915911,0.71478683219596,6,57,cell redox homeostasis,BP,TXNRD3;NOS1;CYBA;TMX4;PRDX5;GCLC
2384,GO:0005521,0.448441273771551,0.818949490462017,2,14,lamin binding,MF,SUN1;IFI27
10314,GO:0043121,0.448694806480717,0.900007661141438,1,5,neurotrophin binding,MF,PCSK6
18595,GO:1903900,0.448776370560772,0.669297102577767,12,112,regulation of viral life cycle,BP,OAS2;APOBEC3C;ISG15;IFITM1;OAS1;LAMP3;GSN;TRIM38;ADARB1;IFI16;BST2;RSAD2
8809,GO:0034594,0.448960840270121,0.899873097290766,1,5,phosphatidylinositol trisphosphate phosphatase activity,MF,INPP5D
3740,GO:0008277,0.449117221056014,0.686542510899196,9,80,regulation of G-protein coupled receptor protein signaling pathway,BP,DGKQ;NOS1;CRY1;RGS2;HOMER2;DNM1;KLK5;RPH3AL;RGS12
4726,GO:0010891,0.449183647025236,0.899760309281706,1,5,negative regulation of sequestering of triglyceride,BP,PPARG
5264,GO:0015911,0.449413752428564,0.899643741351673,1,5,plasma membrane long-chain fatty acid transport,BP,IRS2
8144,GO:0032880,0.449494650490632,0.600287905350403,74,690,regulation of protein localization,BP,POSTN;SREBF1;EGFR;TRIM22;SFRP1;EPHB2;GLUD1;PIK3R1;KCNAB2;FERMT1;VPS11;ITPR3;MDM2;LZTS2;RAPGEF3;F2R;HPS4;TRPV4;NLGN2;ANK3;RHBDF1;PER2;C5;GLI3;VAMP2;NMU;GSN;TTN;TM7SF3;BMP6;MICALL2;SQSTM1;PLA2G6;IDH2;IFI27;OSCP1;TNFRSF21;CDK5R1;HFE;HADH;RAB11FIP3;FBXW7;CDK5RAP3;DZIP1L;PFKFB2;ASTN2;RPH3AL;SLC2A1;NLRP1;GLUL;LRP1;PDE2A;ZMYND8;FBXO4;PIK3C3;SYT7;DMTN;TMEM231;TFDP2;RSAD2;LMNA;CLSTN3;IRS2;CEP250;ANO1;ALOX15B;PHPT1;ERBB2;GPR68;LDLRAP1;UFL1;KCNS3;SNX33;PEMT
19766,GO:2000210,0.449534685181054,0.896066929341612,1,6,positive regulation of anoikis,BP,SIK1
18375,GO:1903423,0.449545843610327,0.899576786791167,1,5,positive regulation of synaptic vesicle recycling,BP,DNM1
20267,GO:2001269,0.449876030881853,0.816874969383218,2,15,positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,TNFSF10;GSN
10671,GO:0043950,0.449932430321583,0.899380669043799,1,5,positive regulation of cAMP-mediated signaling,BP,NOS1
5026,GO:0015193,0.450092378247472,0.899299454896491,1,5,L-proline transmembrane transporter activity,MF,SLC36A4
9159,GO:0035524,0.450092378247472,0.899299454896491,1,5,proline transmembrane transport,BP,SLC36A4
10026,GO:0042492,0.450230823369091,0.899229125025398,1,5,gamma-delta T cell differentiation,BP,SOX13
8318,GO:0033173,0.450335279760546,0.775006886711849,3,23,calcineurin-NFAT signaling cascade,BP,NFATC4;ADGRB2;AKAP6
17190,GO:0106070,0.450443410776498,0.89912106983182,1,5,regulation of adenylate cyclase-activating G-protein coupled receptor signaling pathway,BP,NOS1
17610,GO:1901342,0.450628178727475,0.640125314475878,21,187,regulation of vasculature development,BP,TNFAIP3;GPNMB;SFRP1;STAT1;RAPGEF3;ADGRB2;PDCD4;C5;MAP2K5;VEGFB;HYAL1;MMRN2;SPRY2;DAB2IP;BTG1;PLXND1;TNFSF12;SRPX2;ERBB2;PPARG;ECM1
840,GO:0002154,0.450638957156147,0.899021610890693,1,5,thyroid hormone mediated signaling pathway,BP,THRA
17374,GO:1900122,0.450661464656835,0.895476822421961,1,6,positive regulation of receptor binding,BP,HFE
13015,GO:0051491,0.450858880181842,0.775199002225362,3,22,positive regulation of filopodium assembly,BP,ESPN;ARAP1;ZMYND8
7194,GO:0031091,0.451275924759328,0.713048514633494,6,52,platelet alpha granule,CC,SERPINE2;LHFPL2;CD109;VEGFB;CD9;SERPING1
14873,GO:0070695,0.451605349408451,0.898529161888764,1,5,FHF complex,CC,HOOK2
7808,GO:0032369,0.451811537102055,0.816531969477632,2,14,negative regulation of lipid transport,BP,CRY1;IRS2
10227,GO:0042954,0.451823473945512,0.898417798824958,1,5,lipoprotein transporter activity,MF,LRP1
20191,GO:2001138,0.451985979105502,0.894780438814896,1,6,regulation of phospholipid transport,BP,APOE
20192,GO:2001140,0.451985979105502,0.894780438814896,1,6,positive regulation of phospholipid transport,BP,APOE
5711,GO:0016846,0.452129961521625,0.892193331478,1,7,carbon-sulfur lyase activity,MF,MGST2
4966,GO:0015077,0.452679598773876,0.644862775077916,18,168,monovalent inorganic cation transmembrane transporter activity,MF,PKD2;KCNAB2;KCNJ15;KCNC4;NDUFA4L2;SLC24A1;SLC13A5;KCNJ5;SCNN1A;SCN4B;TCIRG1;SLC12A7;ATP6V0A2;KCNMA1;KCNG1;SHROOM2;SCN2A;KCNS3
8184,GO:0032934,0.452771638952031,0.745498811146425,4,33,sterol binding,MF,APOE;OSBPL10;OSBPL5;RORA
4438,GO:0010324,0.452857716107692,0.726293613695458,5,42,membrane invagination,BP,ITGA2;GSN;PPARG;SNX33;SMURF1
3185,GO:0006809,0.45321428792455,0.725985030655198,5,42,nitric oxide biosynthetic process,BP,PKD2;NOS1;INSR;ACP5;RORA
7212,GO:0031114,0.453247038616745,0.773298651337185,3,22,regulation of microtubule depolymerization,BP,TRPV4;APC2;MAP1A
14921,GO:0070830,0.453503347971445,0.726257812070164,5,40,bicellular tight junction assembly,BP,MICALL2;NPHP4;MPP7;PRKACA;PARD6G
2501,GO:0005751,0.453671290592904,0.886871692264801,1,10,mitochondrial respiratory chain complex IV,CC,NDUFA4L2
15401,GO:0071692,0.454044842536487,0.897279218812198,1,5,protein localization to extracellular region,BP,LTBP1
15402,GO:0071694,0.454044842536487,0.897279218812198,1,5,maintenance of protein location in extracellular region,BP,LTBP1
11820,GO:0046785,0.454210770349542,0.699362267160446,7,59,microtubule polymerization,BP,RGS2;TUBGCP5;TRPV4;CEP192;CDK5R1;RANBP9;EML2
4214,GO:0009378,0.454495540843788,0.897047215556217,1,5,four-way junction helicase activity,MF,WRN
13981,GO:0060718,0.454500275682412,0.897044776451167,1,5,chorionic trophoblast cell differentiation,BP,HTRA1
6112,GO:0019362,0.454612059739001,0.655665362585412,14,127,pyridine nucleotide metabolic process,BP,NT5E;H6PD;DHTKD1;KCNAB2;NAPRT;NMRK1;INSR;PGLS;IDH2;MLXIPL;PGM1;PFKFB2;OGDHL;NADK
11688,GO:0046496,0.454612059739001,0.655665362585412,14,127,nicotinamide nucleotide metabolic process,BP,NT5E;H6PD;DHTKD1;KCNAB2;NAPRT;NMRK1;INSR;PGLS;IDH2;MLXIPL;PGM1;PFKFB2;OGDHL;NADK
8267,GO:0033081,0.45474342968928,0.813351921638909,2,15,regulation of T cell differentiation in thymus,BP,GLI2;ERBB2
12260,GO:0048584,0.454749721320663,0.581540420892327,150,1432,positive regulation of response to stimulus,BP,TNFAIP3;GPNMB;MUC19;TP53INP1;INPP5D;DDX60;EGFR;PTPRS;PKD2;CAPRIN2;DIXDC1;TRIM22;SFRP1;EPHB2;MAP3K14;PIK3R1;RBCK1;CXCL14;EVC;SULF2;WNT3;VAV3;CSPG4;KITLG;MC1R;UNC5B;NOS1;PRKACB;MAML3;PLEKHG5;NFATC4;FERMT1;PLXNB1;CHN2;TNFSF10;NEO1;F2R;PDCD4;TRPV4;FLOT1;NLGN2;ADORA2B;RNF165;MAPK8IP3;PIDD1;RASGEF1A;C5;WIPF1;MINK1;GSTM2;ITGA2;FAM110C;LRSAM1;NAIP;MAP2K5;IGFBP4;INSR;GSN;BAIAP2;DDT;MGST2;DHX58;ENDOG;RICTOR;BMP6;NLRX1;S100A4;MAP2K2;VEGFB;PTK6;FZD7;SHARPIN;SH2D2A;NSMCE4A;PLA2G6;GDF15;CTF1;MAP3K12;TNFRSF21;MAPK10;SHANK3;HFE;CYBA;TRIM38;ERCC6;SHC2;EDA2R;SPRY2;CREBRF;CTSB;KLK5;FBXW7;CDK5RAP3;ARAP1;ELF1;C1RL;ERMAP;PLA2G7;MAP3K6;WNK1;JPH2;PDE2A;RET;DAB2IP;RWDD3;PIK3C3;IFI16;FGFR4;IL20RA;PIK3R2;RPS6KA5;DLG5;BST2;RGL2;CACNB3;LPAR6;DMTN;TFDP2;NRARP;ACVR1B;DLG4;SHANK2;RSAD2;TNFRSF25;IL11;KAT2B;IRS2;ANO1;ERN1;ALOX15B;TKFC;TNFSF12;STAT6;PHPT1;SMPDL3B;KIF7;TRAF5;ERBB2;GPR68;AKAP6;MPP7;PRKACA;LDLRAP1;CXXC5;ACKR3;SERPING1;RIPK3;NPNT;SERINC3;ECM1
19458,GO:1990204,0.45493193680312,0.687355146891063,8,89,oxidoreductase complex,CC,DHTKD1;PDK1;CYBA;RRM2B;OGDHL;SDHA;NDUFV3;CBR4
4540,GO:0010616,0.455017000128021,0.89677836760174,1,5,negative regulation of cardiac muscle adaptation,BP,LMNA
18294,GO:1903243,0.455017000128021,0.89677836760174,1,5,negative regulation of cardiac muscle hypertrophy in response to stress,BP,LMNA
16600,GO:0097470,0.455382355260071,0.896589733634592,1,5,ribbon synapse,CC,NPHP4
5378,GO:0016198,0.455410542758117,0.896575171143599,1,5,axon choice point recognition,BP,EFNB3
3440,GO:0007249,0.455423036023306,0.633269952199547,22,207,I-kappaB kinase/NF-kappaB signaling,BP,TNFAIP3;TRIM22;MAP3K14;RBCK1;STAT1;PLEKHG5;TNFSF10;F2R;NLRX1;S100A4;SQSTM1;SHARPIN;TRIM38;EDA2R;NLRP1;DAB2IP;BST2;TRAF5;RORA;CXXC5;RIPK3;ECM1
770,GO:0002026,0.455821810865138,0.813633111906864,2,14,regulation of the force of heart contraction,BP,NOS1;GAA
363,GO:0000982,0.455929641190743,0.620735105741115,30,270,transcription factor activity, RNA polymerase II proximal promoter sequence-specific DNA binding,MF,HES2;SREBF1;ZFPM1;KLF13;NFATC4;NDN;GLI2;KLF7;SOX12;GLI3;BHLHE40;TCFL5;DLX3;TCF4;PLAG1;MEF2D;MLXIPL;CARF;ELF1;DBP;ZBTB20;STK16;TSHZ2;IFI16;TEF;HLTF;ZNF292;KLF8;ZFP90;FOXP2
9452,GO:0036066,0.456364862049215,0.813238696709604,2,14,protein O-linked fucosylation,BP,ADAMTS7;ADAMTS13
4303,GO:0009756,0.456486404773723,0.892392195750062,1,6,carbohydrate mediated signaling,BP,MLXIPL
1357,GO:0003230,0.456606690497856,0.770612461606531,3,22,cardiac atrium development,BP,ZFPM1;MDM2;NPHP3
19393,GO:1905953,0.456692068748688,0.769926571040084,3,23,negative regulation of lipid localization,BP,CRY1;IRS2;PPARG
835,GO:0002138,0.456728369197602,0.89226282186658,1,6,retinoic acid biosynthetic process,BP,ALDH1A3
5348,GO:0016102,0.456728369197602,0.89226282186658,1,6,diterpenoid biosynthetic process,BP,ALDH1A3
14006,GO:0060753,0.456856381451396,0.892194335889433,1,6,regulation of mast cell chemotaxis,BP,VEGFB
8091,GO:0032786,0.456918336811348,0.769182439803666,3,24,positive regulation of DNA-templated transcription, elongation,BP,EAPP;RTF1;ERCC6
16613,GO:0097493,0.456982768629643,0.836688941071322,2,6,structural molecule activity conferring elasticity,MF,OBSL1;TTN
7594,GO:0031982,0.457215040821813,0.570229166892957,307,3040,vesicle,CC,TNFAIP3;TGFBI;ITGB6;SERPINE2;ULK2;GPNMB;MUC19;TP53INP1;MAP6;SREBF1;PYGB;MXRA5;ACTA2;APOE;NT5E;GAMT;HSPA2;EGFR;HERC3;PTPRS;FAM20C;PKD2;XPC;SYT8;CXCR1;SYN1;ALDH1A3;LRIG3;SFRP1;SEC14L2;EPS8L2;GPX3;BPHL;DGKQ;BRSK1;EYS;WNT3;VAV3;CSPG4;MVB12B;CYBRD1;HTRA1;RGMA;KCNAB2;ZDHHC1;VAMP3;NAPRT;REEP2;OR2A4;KRT15;LGALS7B;MARCKSL1;NSG1;ITGB5;RAB43;RAB40B;NOS1;PRKACB;BCAM;MAGEF1;PLEKHG5;FKBP5;GAA;MICALL1;VPS11;NDRG1;COL7A1;ITPR3;NAGLU;MDM2;LZTS2;PLCD1;LTBP4;PIK3IP1;IDUA;GPRC5C;HLA-B;TNFSF10;HGSNAT;MYH11;SYTL1;CALML3;ACTR1B;TNXB;RHOBTB2;RAPGEF3;ENDOD1;CTSV;BLVRB;GAL3ST4;AP1G2;RGL4;F2R;PPL;C2CD4C;HPS4;SERPINB5;CAPN7;RTN4RL1;CLTCL1;TRPV4;TMC6;FLOT1;TOM1L2;LAMP3;AVL9;SPG11;ZCCHC11;CLCN6;PTGS1;HEXA;C5;ARSD;WIPF1;MINK1;ABHD14B;GSTM2;LHFPL2;ULK1;SPPL2B;PCSK1;THRAP3;VAMP2;NAIP;LTBP3;CES3;TRAK1;NISCH;INSR;TST;GSN;HEBP1;BAIAP2;TTN;CBLC;SCNN1A;DDT;SUN1;AHNAK2;CTSF;CD109;PGLS;SEPT6;RAB11FIP4;VPS39;TM7SF3;NRSN2;BLOC1S3;CASP14;TMEM9;H2AFJ;BMP6;SLC2A3;TCIRG1;S100A4;MICALL2;MAP2K2;VEGFB;ALDH7A1;SQSTM1;FZD7;AKR7A2;LOXL1;FAM213A;FAT2;HEXB;HYAL1;ARRDC1;KIAA0319L;CST3;MMRN2;GDF15;THSD4;ATP6V0A2;COL6A1;PEX11B;IDH2;PODXL;SEPT5;MALL;DNM1;IQCB1;PLD3;ABHD14A;MCTP1;CA2;HFE;ADIRF;CYBA;NID1;RRM2B;KRT14;FBXO2;WASH3P;RAB11FIP3;CTSB;KLK5;KCNMA1;PGM1;CHMP1B;ARAP1;ASTN2;RPH3AL;SLC2A1;C1RL;GPR155;GLUL;TBC1D17;GNG2;CAPG;LRP1;HLA-A;CCDC136;ACP5;RNPEP;DLK2;SLC48A1;PPCS;APPL2;PMEL;STK16;RET;DAB2IP;SLC37A2;DDHD2;SHROOM2;PIK3C3;SYT7;FGFR4;AREG;ETFB;BST2;SNX21;MARCH8;EHBP1;TBC1D16;DMTN;SGSM2;ARFGEF2;SNX1;OSBPL1A;ACVR1B;CADM4;DLG4;TSSK1B;MPI;SNX29;IGFBP6;NBEAL2;CD68;GALE;MXRA8;CLSTN3;DMXL2;CEP250;ANO1;CAPS;MBLAC2;METTL7A;ALOX15B;TKFC;LAPTM4A;PNPO;MAN1B1;DHRS4;PEX1;ECI1;S100A6;EFEMP2;SCG5;SGSH;GAREM2;PBLD;PCSK1N;PRDX5;PHPT1;SMPDL3B;GLB1;GOLGA1;GSTM3;DPP7;CD9;HDAC11;CTSD;ERBB2;SYNGR1;ARHGAP23;ABCA2;TH;ATG14;PRKACA;LDLRAP1;NPAP1;C6ORF120;ACOT2;SYNE2;ACKR3;SERPING1;LAMB2;NFASC;PI4K2B;SNX33;CLCN7;SMURF1;NPNT;OCIAD2;ECM1
12863,GO:0051220,0.457269024065047,0.768900025821685,3,24,cytoplasmic sequestering of protein,BP,PKD2;MXI1;THRA
10176,GO:0042789,0.457445290368806,0.812452660148582,2,14,mRNA transcription by RNA polymerase II,BP,SREBF1;LMO2
14977,GO:0070920,0.457459132058316,0.811370749481836,2,15,regulation of production of small RNA involved in gene silencing by RNA,BP,EGFR;MAP2K2
813,GO:0002087,0.457460760802411,0.8955124300266,1,5,regulation of respiratory gaseous exchange by neurological system process,BP,NLGN2
5777,GO:0017002,0.458552432512055,0.894943701500919,1,5,activin-activated receptor activity,MF,ACVR1B
13567,GO:0060056,0.458646290124505,0.89123382484037,1,6,mammary gland involution,BP,VDR
5343,GO:0016093,0.458753524158977,0.891176107122643,1,6,polyprenol metabolic process,BP,SRD5A3
6904,GO:0030501,0.459177280747618,0.767925840440399,3,23,positive regulation of bone mineralization,BP,FAM20C;ISG15;BMP6
14587,GO:0070169,0.459177280747618,0.767925840440399,3,23,positive regulation of biomineral tissue development,BP,FAM20C;ISG15;BMP6
19791,GO:2000269,0.459192965453703,0.81117744087293,2,14,regulation of fibroblast apoptotic process,BP,SFRP1;BTG1
3660,GO:0008144,0.459286420293867,0.578366988627367,139,1268,drug binding,MF,ULK2;SIK1;SLFN5;PYGB;ACTA2;OAS2;DDX60;HSPA2;EGFR;FAM20C;SYN1;SFRP1;KIF26B;EPHB2;MAP3K14;GLUD1;DGKQ;BRSK1;CUL9;CAMKK1;MVD;NOS1;PRKACB;FKBP5;CMPK2;THNSL2;PIK3C2G;LIG1;CDK18;SPEG;ITPR3;MLH3;NMRK1;DDX59;OBSCN;MYH11;FKBP9;ACTR1B;CYP3A5;OAS1;KIF26A;ALPK1;DNAH1;NEK9;TRPV4;DHX32;CLCN6;PSKH1;MINK1;ULK1;THRAP3;SMARCA1;NAIP;NEK8;MAP2K5;INSR;CHD3;CDK14;TTN;SLFNL1;DHX58;NLRX1;ETNK2;MAP2K2;OPLAH;PDK1;PTK6;PDIK1L;MAP3K12;WRN;MCM9;ATRX;MAPK10;NKTR;ERCC6;HLCS;PAK6;PFKFB2;ACACB;ACCS;NLRP1;TK2;GLUL;SRR;MAP3K6;RIMKLB;MYO3B;WNK1;PDE2A;STK16;RET;PIK3C3;DALRD3;FGFR4;MYO9A;RPS6KA5;VDR;NADK;BBS10;HLTF;STK19;LMTK3;ACVR1B;TSSK1B;WEE1;PTK7;DQX1;ACSL1;MARK4;TEP1;ERN1;RAD50;TKFC;PNPO;MTR;PEX1;SCYL3;KIF7;CHD6;ACSS2;ERBB2;ABCA2;TH;PPARG;PRKACA;SUCLG2;UCKL1;DDX12P;IP6K2;RIPK3;PI4K2B;LONP2;HARS2;CIT;MSH5;CLCN7;TTLL1;ABCA11P;GCLC
11782,GO:0046676,0.459426905455406,0.767158657113806,3,24,negative regulation of insulin secretion,BP,SREBF1;SFRP1;HADH
16208,GO:0090278,0.459426905455406,0.767158657113806,3,24,negative regulation of peptide hormone secretion,BP,SREBF1;SFRP1;HADH
18706,GO:1904181,0.459476729178037,0.89078633652918,1,6,positive regulation of membrane depolarization,BP,ANK3
2880,GO:0006382,0.459588045621893,0.894402338492016,1,5,adenosine to inosine editing,BP,ADARB1
498,GO:0001554,0.459616676904183,0.894387346114349,1,5,luteolysis,BP,SLIT3
6777,GO:0030219,0.459647211427604,0.69225945212794,7,78,megakaryocyte differentiation,BP,ASH2L;ZFPM1;MYL9;AGO4;TNRC6C;IL11;KAT2B
12613,GO:0050820,0.459715245436436,0.809716359085888,2,15,positive regulation of coagulation,BP,F2R;DMTN
10790,GO:0044283,0.459739253860173,0.597098174133238,56,542,small molecule biosynthetic process,BP,SIK1;SREBF1;AMACR;APOE;NT5E;GAMT;ALDH1A3;SEC14L2;GLUD1;DGKQ;KDM3A;DHTKD1;CSPG4;MVD;SRD5A3;UROS;CRY1;HMGCL;THNSL2;RAPGEF3;MLYCD;G6PC3;PER2;PTGS1;INSR;MGST2;BMP6;HYAL1;MLXIPL;PGM1;PFKFB2;ACACB;OGDHL;TK2;GLUL;SRR;BDH1;RIMKLB;PDE2A;FGFR4;VDR;OSBPL1A;ALOXE3;KAT2B;IMPA2;ALOX15B;PNPO;MTR;CBR4;ISYNA1;ACSS2;NUDT10;PLTP;UCKL1;IP6K2;SERINC3
10340,GO:0043167,0.459945066799469,0.564600580460687,465,4376,ion binding,MF,TNFAIP3;POSTN;SERPINE2;ZSCAN18;ULK2;GPNMB;SIK1;SLFN5;NPEPL1;PYGB;ACTA2;APOE;NT5E;OAS2;ADAM19;PSD4;DDX60;HSPA2;EGFR;TRIM65;PTPRS;FAM20C;PKD2;CAPRIN2;APOBEC3C;SYT8;SYN1;ASH2L;TRIM22;ALDH1A3;PLCD3;SFRP1;MTHFR;SEC14L2;IFI44L;KIF26B;PCDH1;EPHB2;MAP3K14;GLUD1;DGKQ;TMEM129;ADAMTS7;BRSK1;TXNRD3;RBCK1;KDM3A;CUL9;EYS;RNF135;SULF2;DHTKD1;CAMKK1;VAV3;UNK;HR;SMOC2;VWCE;CYBRD1;ZFPM1;MVD;ZNF362;SNN;IRF2BPL;PRICKLE2;ASAP3;ZNF266;CRY2;MYL9;HS1BP3;COL10A1;RAB43;RAB40B;THAP8;NOS1;PRKACB;ZNF704;ZNF699;ZFP41;KLF13;PITPNM3;HMGCL;D2HGDH;RNF187;CYP26B1;CMPK2;THNSL2;ZNF251;MICALL1;PIK3C2G;LIG1;CDK18;VPS11;SPEG;SPOCK1;ITPR3;CYHR1;MDM2;PLCD1;MLH3;NMRK1;DDX59;CHN2;ZNF662;LTBP4;OBSCN;TNFSF10;PRODH;LENG9;MYH11;SYTL1;FKBP9;CALML3;ACTR1B;TNXB;RHOBTB2;UGT1A3;CYP3A5;RAPGEF3;ZNF414;ENDOD1;HAGHL;POLH;OAS1;RASA4;TRIM66;GAL3ST4;KIF26A;B4GALT6;MLLT6;ACAP3;C2CD4C;PHYH;MT1X;CGREF1;SLC24A1;ALPK1;ZNF160;DNAH1;ARSI;NEK9;RTN4RL1;ZFP36L2;TRPV4;GLI2;AGAP4;KLF7;RNF165;NAT6;DHX32;ADAMTS13;TCEA2;PLCH2;ZNF76;SLX1A;SLX1B;ZCCHC11;PITPNM2;CLCN6;PTGS1;DTNB;ZNF658;ARSD;PSKH1;MINK1;PHF2;NINL;GSTM2;THBS3;ASAP2;ITGA2;SYT15;ULK1;GLI3;THRAP3;ZNF558;SMARCA1;LRSAM1;VAMP2;ZNF655;NAIP;LTBP1;ZNF333;NEK8;MAP2K5;ITGA6;LTBP3;BSN;SESN3;ZNF318;MMP1;GPC2;NISCH;INSR;CELSR1;MMP28;GSN;CHD3;CDK14;TTN;CBLC;ZNF18;RNPEPL1;ZNF287;CYP2D7;SLFNL1;ZNF446;SEPT6;RAB11FIP4;ZNF581;DHX58;ENDOG;MDK;NLRX1;B4GALT2;ETNK2;PEX10;S100A4;MICALL2;MAP2K2;OPLAH;PDK1;VEGFB;GLI4;SQSTM1;CABYR;PTK6;FZD7;LOXL1;FAT2;SHARPIN;KDM4C;CLCA2;ARHGAP33;UBOX5;ZNF608;ZCCHC24;PDIK1L;CAPNS2;PLAG1;IDH2;MAP3K12;WRN;SEPT5;DNM1;MCM9;TREX1;MCTP1;CDK5R1;ATRX;AGAP6;CA2;OSBPL10;SESN1;MAPK10;SHANK3;CYBA;TRIM38;NID1;DTX3;ERCC6;HADH;RRM2B;SLIT3;HLCS;AGAP7P;RAB11FIP3;KCNMA1;ING4;ZNF862;LMO2;NOTCH2NL;PAK6;DZIP1L;PGM1;PFKFB2;RNF170;THRA;ACADS;ARAP1;ASTN2;ADARB1;RAI1;MX2;IKZF4;RPH3AL;ACACB;ACCS;OGDHL;NLRP1;ZBTB34;ZNF627;TK2;LACTB2;GLUL;TNS2;SRR;LRP1;PEG3;ACP5;PLA2G7;RNPEP;DLK2;ZNF554;MAP3K6;RIMKLB;MYO3B;SALL2;WNK1;ZNF107;ZNF532;JPH2;ARL11;ZBTB20;PDE2A;ZNF334;SDHA;STK16;RET;ZMYND8;DAB2IP;CASZ1;ACOX3;MYSM1;DDHD2;RNF213;TSHZ2;PIK3C3;ZNF276;SYT7;DALRD3;FGFR4;ERCC5;BBS5;ZNF25;OSBPL5;SNCB;MYO9A;RPS6KA5;ZNF630;ZNF687;VDR;SNX21;PHF7;ZFP28;NADK;BBS10;ZMYM3;NUDT8;HLTF;MARCH8;PCSK6;ZNF789;MPPE1;ZNF563;ZNF517;STK19;FAHD2B;RASL10B;LMTK3;PHF1;ZNF292;SNX1;OSBPL1A;ACVR1B;ZNF737;PRIMPOL;NECAB3;PPP2R3B;ESYT2;TSSK1B;ZNF701;ALOXE3;ENDOU;MPI;SNX29;MATN2;ZNF91;DUOX1;WEE1;PTK7;DQX1;RSAD2;ZFP36L1;CLSTN3;ACSL1;MARK4;TEP1;IMPA2;CAPS;MBLAC2;ERN1;RNF141;ALOX15B;RAD50;ZNF439;TKFC;ZMAT3;PNPO;MTR;MAN1B1;PEX1;S100A6;TRERF1;SCYL3;EFEMP2;SCG5;ZSWIM8;CBR4;SGSH;PHC2;ANKMY1;SMPDL3B;TUB;KIF7;KLF8;GSTM3;CHD6;TRAF5;ACSS2;TRIM2;COL13A1;ERBB2;PLCB3;NUDT10;PPM1M;ABCA2;TH;RORA;PPARG;PRKACA;LDLRAP1;CXXC5;POLM;ZNF572;PLTP;ZNF658B;SUCLG2;UCKL1;PARN;DDX12P;ZNF529;IP6K2;RIPK3;KLF9;PI4K2B;LONP2;PRMT3;SNX33;HARS2;CIT;ZFP90;MSH5;CLCN7;ZFP30;FOXP2;ZC3H6;HIVEP1;ECM2;SMURF1;NPNT;TTLL1;PEMT;ABCA11P;GCLC
13733,GO:0060331,0.459974770836752,0.890517398254863,1,6,negative regulation of response to interferon-gamma,BP,PPARG
13738,GO:0060336,0.459974770836752,0.890517398254863,1,6,negative regulation of interferon-gamma-mediated signaling pathway,BP,PPARG
11629,GO:0046365,0.45998985899405,0.719395839853663,5,45,monosaccharide catabolic process,BP,PGM1;PFKFB2;GALE;TKFC;GLB1
14624,GO:0070231,0.460052598496558,0.738693867491825,4,35,T cell apoptotic process,BP,TSC22D3;GLI3;DOCK8;RIPK3
7098,GO:0030902,0.460055030026683,0.670152246243094,10,86,hindbrain development,BP,SERPINE2;PTPRS;NAGLU;GLI2;MDK;B4GALT2;CDK5R1;RORA;FOXP2;PTBP2
15660,GO:0072205,0.460205320919468,0.894078806482052,1,5,metanephric collecting duct development,BP,DLG5
15802,GO:0072525,0.460272789831362,0.664010774015905,11,97,pyridine-containing compound biosynthetic process,BP,DHTKD1;NAPRT;NMRK1;INSR;IDH2;MLXIPL;PGM1;PFKFB2;OGDHL;NADK;PNPO
7686,GO:0032147,0.46037910673864,0.621850307381649,26,236,activation of protein kinase activity,BP,EGFR;MAP3K14;DGKQ;CSPG4;PRKACB;F2R;ADORA2B;MAPK8IP3;C5;MINK1;MAP2K5;INSR;PILRB;RICTOR;MAP2K2;MAP3K12;MAPK10;ERCC6;SHC2;PAK6;MAP3K6;WNK1;DAB2IP;ERN1;PRKACA;RIPK3
9057,GO:0035305,0.46053214240063,0.676296601018315,9,78,negative regulation of dephosphorylation,BP,ELFN2;CRY2;PHACTR3;CEP192;WNK1;PPP1R2;PPP1R35;LMTK3;SPOCD1
10409,GO:0043267,0.460618911692964,0.810133540730501,2,14,negative regulation of potassium ion transport,BP,NOS1;ANK3
1045,GO:0002568,0.460856218855855,0.893736960114715,1,5,somatic diversification of T cell receptor genes,BP,TCF7
1092,GO:0002681,0.460856218855855,0.893736960114715,1,5,somatic recombination of T cell receptor gene segments,BP,TCF7
8308,GO:0033153,0.460856218855855,0.893736960114715,1,5,T cell receptor V(D)J recombination,BP,TCF7
13948,GO:0060677,0.460863195040735,0.893733292427239,1,5,ureteric bud elongation,BP,KIF26B
8996,GO:0035162,0.460878832590575,0.809942925883401,2,14,embryonic hemopoiesis,BP,ZFPM1;KITLG
19164,GO:1905268,0.460963097321245,0.719775628933304,5,40,negative regulation of chromatin organization,BP,KDM3A;PHF2;JARID2;KDM4C;PHF1
1695,GO:0004175,0.461028853461446,0.624201058131206,24,229,endopeptidase activity,MF,ADAM19;CTSO;SFRP1;ADAMTS7;HTRA1;TYSND1;CTSV;CAPN7;ADAMTS13;RHBDF1;SPPL2B;PCSK1;MMP1;MMP28;CTSF;CASP14;CLCA2;CAPNS2;CTSB;KLK5;C1RL;PCSK6;CTSD;LONP2
17516,GO:1901033,0.461110484211521,0.889902535971387,1,6,positive regulation of response to reactive oxygen species,BP,ENDOG
13846,GO:0060485,0.461504687506672,0.636717293851006,18,161,mesenchyme development,BP,ACTA2;PKD2;SFRP1;KITLG;CUL7;STAT1;MDM2;PDCD4;WWTR1;SEMA4G;S100A4;RET;DAB2IP;TEAD2;DLG5;PTK7;ZFP36L1;PBLD
5689,GO:0016812,0.461699802367793,0.893292858627887,1,5,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides,MF,OPLAH
4053,GO:0009100,0.461756242702157,0.611581095160213,33,304,glycoprotein metabolic process,BP,MUC19;LMF1;ADAMTS7;SULF2;ST6GALNAC2;CSPG4;MVD;SRD5A3;ST6GALNAC6;IDUA;GAL3ST4;B4GALT6;ADAMTS13;HEXA;TRAK1;ST3GAL5;B4GALT2;VEGFB;HEXB;HYAL1;B3GNT9;CST3;FBXO2;NDST2;DPY19L2P2;PCSK6;NECAB3;MPI;XYLT1;MAN1B1;SGSH;PQLC3;GCNT4
16323,GO:0090599,0.46181555851767,0.893231825904449,1,5,alpha-glucosidase activity,MF,GAA
19754,GO:2000192,0.461840704781858,0.893218564490551,1,5,negative regulation of fatty acid transport,BP,IRS2
3018,GO:0006564,0.461947384073719,0.889448033689553,1,6,L-serine biosynthetic process,BP,SERINC3
641,GO:0001832,0.462008071722351,0.809113596142049,2,14,blastocyst growth,BP,RTF1;PALB2
8289,GO:0033131,0.462089475419237,0.889370747582218,1,6,regulation of glucokinase activity,BP,PFKFB2
17841,GO:1902083,0.462107995817018,0.893077537181109,1,5,negative regulation of peptidyl-cysteine S-nitrosylation,BP,SNTA1
19742,GO:2000169,0.462107995817018,0.893077537181109,1,5,regulation of peptidyl-cysteine S-nitrosylation,BP,SNTA1
16876,GO:0098843,0.46224345032584,0.889286958654123,1,6,postsynaptic endocytic zone,CC,DNM1
3120,GO:0006700,0.46235775021803,0.806825864901488,2,16,C21-steroid hormone biosynthetic process,BP,DGKQ;BMP6
12556,GO:0050730,0.462450432397613,0.641318588611125,16,148,regulation of peptidyl-tyrosine phosphorylation,BP,EGFR;SFRP1;DGKQ;CSPG4;KITLG;UNC119;CBLC;RICTOR;PTK6;CTF1;ERCC6;FBXW7;AREG;DMTN;DLG4;IL11
15885,GO:0072678,0.462452018090172,0.764186076788505,3,25,T cell migration,BP,DOCK8;RIPK3;ECM1
14626,GO:0070233,0.463010902926652,0.807285765061468,2,15,negative regulation of T cell apoptotic process,BP,TSC22D3;DOCK8
1201,GO:0002861,0.463061543136524,0.886206816227968,1,7,regulation of inflammatory response to antigenic stimulus,BP,IL20RB
8295,GO:0033139,0.463136224275219,0.888800332364697,1,6,regulation of peptidyl-serine phosphorylation of STAT protein,BP,RET
7329,GO:0031347,0.463192493978534,0.598664217210557,47,451,regulation of defense response,BP,TNFAIP3;MUC19;APOE;NT5E;DDX60;EGFR;PTPRS;RNF135;HERC5;HTRA1;STAT1;PRKACB;IL20RB;PDCD4;TRPV4;FLOT1;ADORA2B;FNDC4;C5;ITGA2;LRSAM1;DDT;MGST2;DHX58;RICTOR;NLRX1;SHARPIN;CYBA;CTSB;KLK5;NLRP1;ACP5;PLA2G7;PDE2A;DAB2IP;PIK3C3;IFI16;RPS6KA5;FAM3A;STAT2;RSAD2;TKFC;SMPDL3B;RORA;PPARG;PRKACA;SERPING1
17706,GO:1901657,0.463244984454988,0.655573755091569,12,116,glycosyl compound metabolic process,BP,NT5E;GAMT;APOBEC3C;AKR7A2;MACROD1;OARD1;TK2;DLG4;CBR4;TH;UCKL1;PEMT
18965,GO:1904781,0.463256657171815,0.892470114174253,1,5,positive regulation of protein localization to centrosome,BP,CEP250
13938,GO:0060666,0.463728719583583,0.892219837885559,1,5,dichotomous subdivision of terminal units involved in salivary gland branching,BP,PLXND1
16999,GO:0099172,0.463753896849122,0.807827610403185,2,14,presynapse organization,BP,NLGN4Y;NLGN2
506,GO:0001569,0.4637857227155,0.764194028677816,3,23,branching involved in blood vessel morphogenesis,BP,NFATC4;PLXND1;NRARP
456,GO:0001302,0.463890404662816,0.888388180703555,1,6,replicative cell aging,BP,WRN
8506,GO:0033700,0.464052600428958,0.888299414351902,1,6,phospholipid efflux,BP,APOE
14638,GO:0070257,0.46424517340258,0.888193964264303,1,6,positive regulation of mucus secretion,BP,CYBA
13088,GO:0051643,0.464258147218088,0.891938700066668,1,5,endoplasmic reticulum localization,BP,ESYT2
5013,GO:0015175,0.46431409892561,0.763191870247039,3,24,neutral amino acid transmembrane transporter activity,MF,SLC36A4;SLC43A1;SERINC3
12793,GO:0051117,0.464423376483815,0.701018066644578,6,54,ATPase binding,MF,PKD2;SNTA1;TCIRG1;ATP6V0A2;METTL21A;PTPN3
4368,GO:0009988,0.464483583051889,0.762049889678498,3,26,cell-cell recognition,BP,ST6GALNAC6;DOCK8;GLIPR1L2
12762,GO:0051057,0.464642808360445,0.735811742424451,4,32,positive regulation of small GTPase mediated signal transduction,BP,KITLG;F2R;RASGEF1A;LPAR6
4659,GO:0010810,0.464781075072201,0.639443478151753,16,140,regulation of cell-substrate adhesion,BP,POSTN;SFRP1;PIK3R1;SMOC2;FERMT1;SPOCK1;NINJ1;MINK1;ITGA6;TRIOBP;FZD7;NET1;NID1;DMTN;ECM2;NPNT
16747,GO:0098563,0.464851397909518,0.805921162100129,2,15,intrinsic component of synaptic vesicle membrane,CC,PTPRS;SYN1
2724,GO:0006104,0.464881549986335,0.887845038731559,1,6,succinyl-CoA metabolic process,BP,SUCLG2
10290,GO:0043068,0.46492729667256,0.595760210701299,49,470,positive regulation of programmed cell death,BP,SIK1;TP53INP1;INPP5D;ALDH1A3;SFRP1;RBCK1;VAV3;PLEKHG5;NFATC4;OBSCN;TNFSF10;F2R;PDCD4;PIDD1;ARHGEF19;ARHGEF4;ITGA6;NUPR1;GSN;PNMA1;ARHGEF1;ENDOG;SQSTM1;PLA2G6;TXNIP;IFI27;CDK5R1;NET1;FBXW7;KCNMA1;ING4;NLRP1;RET;DAB2IP;IL20RA;BTG1;VDR;ARHGEF17;TFDP2;PANO1;MARK4;ZMAT3;APBB2;ARHGEF9;TNFSF12;PPARG;IP6K2;RIPK3;SERINC3
12288,GO:0048643,0.465010756273863,0.806898917734934,2,14,positive regulation of skeletal muscle tissue development,BP,CYP26B1;FLOT1
3373,GO:0007144,0.465086826735811,0.88773233619208,1,6,female meiosis I,BP,MLH3
7729,GO:0032232,0.465328181427137,0.806663990286328,2,14,negative regulation of actin filament bundle assembly,BP,SHANK3;ARAP1
9289,GO:0035745,0.465345630015879,0.887590142322726,1,6,T-helper 2 cell cytokine production,BP,RSAD2
16530,GO:0097320,0.465608053544868,0.806456728012112,2,14,plasma membrane tubulation,BP,MICALL1;SNX33
6286,GO:0019900,0.465675886337161,0.58799850954085,64,584,kinase binding,MF,TNFAIP3;SIK1;SREBF1;ACTA2;EGFR;SYN1;TRIM22;SRSF5;EPHB2;DGKQ;PIK3R1;BRSK1;CSPG4;CAMK2N1;CRY1;PITPNM3;SPDYE6;PIK3IP1;RHOBTB2;NEK9;TRPV4;TOM1L2;MAPK8IP3;SPDYE5;PITPNM2;MICALCL;AKAP7;INSR;CEP68;TTN;CBLC;RICTOR;SQSTM1;SLC12A7;ARHGAP33;PLA2G6;FAM83C;MAP3K12;DNM1;CDK5R1;SHC2;SPRY2;CDK5RAP3;PFKFB2;SLC2A1;TNS2;FBXW5;WNK1;RET;DAB2IP;FGFR4;EXOC2;PIK3R2;BTG1;CACNB3;WWC3;DLG4;KAT2B;IRS2;CEP250;ERBB2;PRKACA;PARN;PER3
15151,GO:0071305,0.466354776381884,0.805903147331184,2,14,cellular response to vitamin D,BP,SFRP1;VDR
7666,GO:0032103,0.466435455194367,0.634315484561226,17,164,positive regulation of response to external stimulus,BP,DDX60;EGFR;CXCL14;PDCD4;TRPV4;ADORA2B;ITGA2;LRSAM1;DDT;MGST2;DHX58;BMP6;VEGFB;CYBA;KLK5;PLA2G7;PDE2A
19372,GO:1905898,0.466437955549786,0.733566083466904,4,34,positive regulation of response to endoplasmic reticulum stress,BP,PIK3R1;DAB2IP;ERN1;SERINC3
4779,GO:0010968,0.466451502699766,0.886981238568992,1,6,regulation of microtubule nucleation,BP,EML2
6974,GO:0030656,0.466646861024149,0.886873452245647,1,6,regulation of vitamin metabolic process,BP,VDR
11837,GO:0046835,0.46665345147175,0.761281811395103,3,24,carbohydrate phosphorylation,BP,FGGY;PFKFB2;TKFC
15561,GO:0072050,0.466844060928858,0.886764582717539,1,6,S-shaped body morphogenesis,BP,PKD2
3739,GO:0008276,0.467082228449053,0.677781249104647,8,72,protein methyltransferase activity,MF,ASH2L;METTL21A;SETD4;PCMTD2;PCMTD1;DYDC1;KMT5C;PRMT3
5810,GO:0017075,0.46715395563706,0.805309731216559,2,14,syntaxin-1 binding,MF,VAMP3;VAMP2
8498,GO:0033688,0.467169285113855,0.805298339014241,2,14,regulation of osteoblast proliferation,BP,SFRP1;PLXNB1
5352,GO:0016125,0.467223086683915,0.652185642459089,12,110,sterol metabolic process,BP,SREBF1;APOE;LMF1;SEC14L2;DGKQ;MVD;CYP26B1;ACACB;OSBPL5;OSBPL1A;TRERF1;LDLRAP1
16878,GO:0098845,0.467272778337755,0.886527664856402,1,6,postsynaptic endosome,CC,NSG1
880,GO:0002246,0.467450661948486,0.886429269108866,1,6,wound healing involved in inflammatory response,BP,F2R
12940,GO:0051342,0.467646968314026,0.886320619052042,1,6,regulation of cyclic-nucleotide phosphodiesterase activity,BP,AIP
8034,GO:0032692,0.467821411307231,0.80275001871604,2,16,negative regulation of interleukin-1 production,BP,TNFAIP3;ACP5
199,GO:0000421,0.467911836242914,0.759723552025428,3,25,autophagosome membrane,CC,ATG16L2;ULK1;ATG14
4717,GO:0010882,0.468108744887503,0.803493343524712,2,15,regulation of cardiac muscle contraction by calcium ion signaling,BP,GSTM2;PRKACA
3592,GO:0008017,0.468497367494113,0.617387696276024,24,212,microtubule binding,MF,MAP6;KIF26B;NDRG1;MYH11;KIF26A;TUBGCP5;TRPV4;TPGS1;GAS8;LZTS1;DNM1;HOOK2;CLIP2;APC2;MX2;REEP4;MYO3B;MYO9A;EML3;CCDC88B;MARK4;KIF7;MAP1A;EML2
13661,GO:0060216,0.468559750116267,0.804263504687403,2,14,definitive hemopoiesis,BP,ZFPM1;ZFP36L2
8067,GO:0032755,0.468595729808353,0.712293358767898,5,43,positive regulation of interleukin-6 production,BP,F2R;TRPV4;ADORA2B;CYBA;ZBTB20
5273,GO:0015925,0.468602115853459,0.885791015315932,1,6,galactosidase activity,MF,GLB1
13578,GO:0060070,0.468685409338291,0.615213370273866,25,236,canonical Wnt signaling pathway,BP,APOE;CAPRIN2;DIXDC1;SFRP1;SULF2;WNT3;FERMT1;LZTS2;WWTR1;GLI3;NAIP;IGFBP4;CDK14;FZD7;NPHP3;APC2;FRAT1;NPHP4;WNK1;DAB2IP;NRARP;KREMEN1;IGFBP6;PTK7;TCF7
10835,GO:0044344,0.468700188781666,0.650857733490494,12,109,cellular response to fibroblast growth factor stimulus,BP,POSTN;FAM20C;SFRP1;SULF2;FLRT3;ZFP36L2;FRS3;HYAL1;SPRY2;FGFR4;ZFP36L1;GCLC
14407,GO:0061734,0.468763968415023,0.889526766071352,1,5,parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization,BP,SMURF1
9932,GO:0042303,0.469011972490086,0.668361676393561,9,79,molting cycle,BP,APCDD1;EGFR;FERMT1;CTSV;CELSR1;CD109;KRT14;MYSM1;ACVR1B
10101,GO:0042633,0.469011972490086,0.668361676393561,9,79,hair cycle,BP,APCDD1;EGFR;FERMT1;CTSV;CELSR1;CD109;KRT14;MYSM1;ACVR1B
10702,GO:0044033,0.469162080011353,0.885479791456245,1,6,multi-organism metabolic process,BP,MAP2K2
10839,GO:0044351,0.469300155380935,0.885402966184266,1,6,macropinocytosis,BP,SNX33
9548,GO:0036336,0.469306071119919,0.802596837327856,2,15,dendritic cell migration,BP,CXCR1;DOCK8
18221,GO:1903053,0.469308540800729,0.759684393274795,3,23,regulation of extracellular matrix organization,BP,CST3;LRP1;FGFR4
1044,GO:0002566,0.469324986177768,0.802582656849558,2,15,somatic diversification of immune receptors via somatic mutation,BP,PMS2P3;POLM
13790,GO:0060401,0.469412724003066,0.661275748873815,10,88,cytosolic calcium ion transport,BP,PKD2;NOS1;ITPR3;F2R;GSTM2;CYBA;JPH2;CACNB3;AKAP6;PRKACA
6897,GO:0030479,0.469467597884593,0.88914699585817,1,5,actin cortical patch,CC,WIPF1
14373,GO:0061645,0.469467597884593,0.88914699585817,1,5,endocytic patch,CC,WIPF1
522,GO:0001614,0.469473970282268,0.885306208113834,1,6,purinergic nucleotide receptor activity,MF,GPR87
5524,GO:0016502,0.469473970282268,0.885306208113834,1,6,nucleotide receptor activity,MF,GPR87
134,GO:0000281,0.469559976352443,0.685331902027547,7,60,mitotic cytokinesis,BP,CUL7;ANK3;UNC119;SEPT6;SEPT5;SNX33;CIT
16885,GO:0098868,0.469600546447496,0.803486961285877,2,14,bone growth,BP,EVC;THBS3
9477,GO:0036124,0.469729910166224,0.803390325864163,2,14,histone H3-K9 trimethylation,BP,KDM4C;ATRX
4784,GO:0010976,0.469768532949326,0.621839728180112,21,186,positive regulation of neuron projection development,BP,APOE;CAPRIN2;OBSL1;WNT3;CUL7;PLXNB1;CRTC1;TRAK1;BAIAP2;PLXNB3;PTK6;SHANK3;RET;ZMYND8;DAB2IP;DLG5;PLXND1;DLG4;PTK7;SHANK2;SMURF1
8725,GO:0034384,0.469826622700072,0.885109733973073,1,6,high-density lipoprotein particle clearance,BP,APOE
6013,GO:0019068,0.469828010091311,0.730023076145041,4,36,virion assembly,BP,APOE;RAB43;LRSAM1;CHMP1B
10216,GO:0042921,0.47002744966644,0.803167964375086,2,14,glucocorticoid receptor signaling pathway,BP,CRY2;CRY1
16617,GO:0097499,0.470046835002186,0.884986936374543,1,6,protein localization to non-motile cilium,BP,TUB
12688,GO:0050926,0.470079878631038,0.802016269700145,2,15,regulation of positive chemotaxis,BP,ITGA2;VEGFB
6686,GO:0030062,0.47026128644064,0.884867269789193,1,6,mitochondrial tricarboxylic acid cycle enzyme complex,CC,SUCLG2
3696,GO:0008203,0.470342673567416,0.654373908962442,11,100,cholesterol metabolic process,BP,SREBF1;APOE;LMF1;SEC14L2;DGKQ;MVD;ACACB;OSBPL5;OSBPL1A;TRERF1;LDLRAP1
7982,GO:0032608,0.470629728899166,0.710495457746185,5,43,interferon-beta production,BP,PTPRS;RNF135;FLOT1;NLRX1;ZBTB20
3701,GO:0008210,0.471024583876847,0.800339165880767,2,16,estrogen metabolic process,BP,SULT1E1;HSD17B14
8751,GO:0034433,0.471214512860282,0.881606536025009,1,7,steroid esterification,BP,APOE
8752,GO:0034434,0.471214512860282,0.881606536025009,1,7,sterol esterification,BP,APOE
8753,GO:0034435,0.471214512860282,0.881606536025009,1,7,cholesterol esterification,BP,APOE
6193,GO:0019673,0.471445027102657,0.881474764004939,1,7,GDP-mannose metabolic process,BP,MPI
9493,GO:0036152,0.471611660970227,0.800864290773287,2,15,phosphatidylethanolamine acyl-chain remodeling,BP,MBOAT2;PLA2G6
13718,GO:0060312,0.471659721609668,0.884084952013568,1,6,regulation of blood vessel remodeling,BP,CST3
2658,GO:0006002,0.47181014913699,0.884000595178648,1,6,fructose 6-phosphate metabolic process,BP,MPI
3750,GO:0008290,0.472112808137779,0.883830749588244,1,6,F-actin capping protein complex,CC,CAPG
3512,GO:0007423,0.472267022942188,0.600393357605802,34,308,sensory organ development,BP,EGFR;ALDH1A3;LRIG3;SLITRK6;EPHB2;CXCL14;SDK2;CYP26B1;HSF4;NAGLU;NINJ1;GLI2;GLI3;CELSR1;TRIOBP;RAB11FIP4;BLOC1S3;BMP6;CST3;SPRY2;IFT140;NPHP4;MYO3B;SALL2;MAF;RET;SHROOM2;SIX5;TMEM231;PTK7;TUB;TH;LAMB2;FOXP2
12608,GO:0050815,0.472353854377441,0.883695364708782,1,6,phosphoserine residue binding,MF,RTF1
6813,GO:0030278,0.472426611494946,0.643025190179433,13,115,regulation of ossification,BP,FAM20C;SFRP1;ISG15;IFITM1;GLI3;BMP6;AREG;KREMEN1;PRKACA;SMURF1;NPNT;CTNNBIP1;ECM1
3108,GO:0006686,0.472472849526419,0.883628492832633,1,6,sphingomyelin biosynthetic process,BP,PEMT
3719,GO:0008239,0.472520377337,0.883601776610868,1,6,dipeptidyl-peptidase activity,MF,DPP7
5704,GO:0016836,0.472607978699597,0.727621659746811,4,36,hydro-lyase activity,MF,UROS;CA2;ECI1;EHHADH
20005,GO:2000648,0.472825998815322,0.756790876501523,3,23,positive regulation of stem cell proliferation,BP,KITLG;GLI3;LTBP3
7647,GO:0032075,0.473176896844798,0.798710346004909,2,16,positive regulation of nuclease activity,BP,DAB2IP;ERN1
17445,GO:1900272,0.473754082632098,0.88290689917953,1,6,negative regulation of long-term synaptic potentiation,BP,APOE
9701,GO:0038127,0.473799394644561,0.637633046421982,14,125,ERBB signaling pathway,BP,EGFR;PIK3R1;MVB12B;RHBDF1;CBLC;PTK6;SPRY2;FBXW7;ARAP1;DAB2IP;AREG;RPS6KA5;PTPN3;ERBB2
18637,GO:1903975,0.474080355277489,0.882722679905254,1,6,regulation of glial cell migration,BP,IDH2
16700,GO:0097720,0.474141766309066,0.755118318297185,3,24,calcineurin-mediated signaling,BP,NFATC4;ADGRB2;AKAP6
7701,GO:0032196,0.47418464350353,0.798921116129622,2,15,transposition,BP,APOBEC3C;ZNF91
6856,GO:0030332,0.474314596466934,0.754975173930584,3,24,cyclin binding,MF,CDK14;FBXW7;CDK5RAP3
16322,GO:0090596,0.474365295235863,0.630258831945839,16,141,sensory organ morphogenesis,BP,ALDH1A3;LRIG3;SLITRK6;EPHB2;SDK2;CYP26B1;NAGLU;GLI2;GLI3;CELSR1;TRIOBP;SPRY2;MYO3B;SHROOM2;PTK7;TH
3242,GO:0006898,0.474434498123554,0.624205240589244,18,165,receptor-mediated endocytosis,BP,APOE;CXCR1;SCARA3;MICALL1;CLTCL1;FLOT1;UNC119;DNM1;ARHGAP27;HFE;SCART1;LRP1;SNX1;DLG4;ENDOU;CD9;LDLRAP1;ACKR3
17536,GO:1901135,0.474585689233749,0.570719817834629,92,907,carbohydrate derivative metabolic process,BP,MUC19;PTHLH;APOE;NT5E;GAMT;LMF1;FAM20C;PKD2;APOBEC3C;ADAMTS7;SULF2;H6PD;DHTKD1;ST6GALNAC2;CSPG4;MVD;SRD5A3;NOS1;SDC3;CMPK2;NAGLU;ST6GALNAC6;IDUA;HGSNAT;RAPGEF3;GAL3ST4;B4GALT6;ARSI;ADORA2B;ADAMTS13;G6PC3;SULT1E1;HEXA;ARSD;ABHD14B;TRAK1;GPC2;INSR;ST3GAL5;PGLS;PGAP1;B4GALT2;TCIRG1;VEGFB;AKR7A2;HEXB;HYAL1;B3GNT9;CST3;ATP6V0A2;NPHP3;MACROD1;OARD1;PIGZ;RRM2B;FBXO2;GABBR1;MLXIPL;GPR87;PGM1;PFKFB2;OGDHL;TK2;NDST2;PPCS;PDE2A;SDHA;LTB4R2;DPY19L2P2;NADK;PCSK6;MPPE1;NDUFV3;KDELC2;NECAB3;DLG4;ESYT2;MPI;XYLT1;TKFC;MAN1B1;UAP1L1;CBR4;SGSH;GLB1;NUDT10;PQLC3;TH;RORA;GCNT4;UCKL1;PEMT
11171,GO:0045277,0.474860796888182,0.873565181778867,1,11,respiratory chain complex IV,CC,NDUFA4L2
12270,GO:0048608,0.474865973590097,0.599927231701438,32,295,reproductive structure development,BP,SERPINE2;EGFR;PKD2;PLCD3;SFRP1;HTRA1;KITLG;CUL7;PLCD1;TNFSF10;CTSV;SERPINB5;GLI2;GLI3;NUPR1;INSR;BMP6;ETNK2;DLX3;CST3;PLAG1;ATRX;REC8;AGO4;SLIT3;CTSB;VDR;TCF7;ZFP36L1;ALOX15B;GJB5;PPARG
9965,GO:0042368,0.474938195801604,0.882237432241438,1,6,vitamin D biosynthetic process,BP,VDR
7606,GO:0032000,0.475002553501646,0.88612995910092,1,5,positive regulation of fatty acid beta-oxidation,BP,IRS2
11122,GO:0045180,0.475114456327361,0.886068416970155,1,5,basal cortex,CC,PKD2
18095,GO:1902774,0.475317392185263,0.882022521136099,1,6,late endosome to lysosome transport,BP,VPS39
3161,GO:0006771,0.475685139694063,0.881813855909446,1,6,riboflavin metabolic process,BP,ACP5
5595,GO:0016634,0.475760428695497,0.881771106346123,1,6,oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor,MF,ACOX3
3605,GO:0008045,0.4764258041493,0.798353157556074,2,14,motor neuron axon guidance,BP,RNF165;ERBB2
8704,GO:0034361,0.476437998398344,0.878597326385542,1,7,very-low-density lipoprotein particle,CC,APOE
8726,GO:0034385,0.476437998398344,0.878597326385542,1,7,triglyceride-rich plasma lipoprotein particle,CC,APOE
4491,GO:0010519,0.476490258928559,0.881356183970623,1,6,negative regulation of phospholipase activity,BP,RGS2
10825,GO:0044332,0.476609015424406,0.885244385500089,1,5,Wnt signaling pathway involved in dorsal/ventral axis specification,BP,SFRP1
6775,GO:0030217,0.476640700886157,0.631194798905468,15,136,T cell differentiation,BP,ZFPM1;CYP26B1;ZFP36L2;GLI2;GLI3;FZD7;NRARP;TCF7;RSAD2;ZFP36L1;STAT6;SOX13;ERBB2;RORA;RIPK3
4676,GO:0010827,0.476694624362235,0.690711184371461,6,50,regulation of glucose transmembrane transport,BP,PIK3R1;CLTCL1;INSR;SLC2A1;PIK3R2;IRS2
7168,GO:0031057,0.476723884411259,0.725416570823142,4,32,negative regulation of histone modification,BP,KDM3A;JARID2;KDM4C;PHF1
446,GO:0001206,0.476727850709623,0.885178698612636,1,5,transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding,MF,HIVEP1
7900,GO:0032481,0.476751523761553,0.678309839491214,7,63,positive regulation of type I interferon production,BP,RNF135;STAT1;FLOT1;DHX58;ZBTB20;IFI16;STAT6
503,GO:0001561,0.476988985580828,0.881072105414927,1,6,fatty acid alpha-oxidation,BP,PHYH
15286,GO:0071499,0.477017713194299,0.881055728508194,1,6,cellular response to laminar fluid shear stress,BP,MAP2K5
3489,GO:0007368,0.477061140504386,0.668934728312448,8,69,determination of left/right symmetry,BP,PKD2;PSKH1;NEK8;GAS8;NPHP3;IFT140;BBS5;PCSK6
3914,GO:0008584,0.477591756219271,0.653357905669929,10,91,male gonad development,BP,SFRP1;KITLG;TNFSF10;CTSV;NUPR1;INSR;CST3;ATRX;REC8;AGO4
16152,GO:0090193,0.477650304659573,0.880694732184766,1,6,positive regulation of glomerulus development,BP,RET
13650,GO:0060198,0.4778951396849,0.880554823134211,1,6,clathrin-sculpted vesicle,CC,VAMP2
8205,GO:0032968,0.477929336035897,0.796074696098418,2,15,positive regulation of transcription elongation from RNA polymerase II promoter,BP,EAPP;RTF1
4965,GO:0015075,0.478149380304889,0.584087119735134,47,442,ion transmembrane transporter activity,MF,PKD2;ORAI3;KCNAB2;KCNJ15;SLC16A5;GJD3;KCNC4;ITPR3;NDUFA4L2;TMEM63C;SLC24A1;TRPV4;SLC13A5;CLCN6;KCNJ5;SCNN1A;SCN4B;SLC27A1;NIPAL2;SLC2A3;TCIRG1;SLC12A7;CLCA2;ATP6V0A2;ANO9;KCNMA1;SLC2A1;SLC38A4;KCNG1;JPH2;PDE2A;SLC37A2;SHROOM2;SCN2A;CACNB3;ORAI2;SLC36A4;DLG4;SLC22A15;ANO1;S100A6;SLC43A1;CACNB1;KCNS3;CLCN7;CALHM2;SERINC3
20247,GO:2001237,0.478178325241896,0.667417773383847,8,73,negative regulation of extrinsic apoptotic signaling pathway,BP,TNFAIP3;IFI6;UNC5B;TNFSF10;MAP2K5;ITGA6;LMNA;GCLC
6423,GO:0021694,0.47819714983149,0.884364502993947,1,5,cerebellar Purkinje cell layer formation,BP,RORA
6430,GO:0021702,0.47819714983149,0.884364502993947,1,5,cerebellar Purkinje cell differentiation,BP,RORA
1709,GO:0004303,0.478255073840511,0.877539068570953,1,7,estradiol 17-beta-dehydrogenase activity,MF,HSD17B14
13371,GO:0052695,0.478333100556726,0.880304287939513,1,6,cellular glucuronidation,BP,UGT1A3
14940,GO:0070857,0.478355763179438,0.880291314515242,1,6,regulation of bile acid biosynthetic process,BP,FGFR4
11359,GO:0045741,0.478519045071789,0.88019781528322,1,6,positive regulation of epidermal growth factor-activated receptor activity,BP,FBXW7
3409,GO:0007191,0.478571224138401,0.880167926256464,1,6,adenylate cyclase-activating dopamine receptor signaling pathway,BP,GNG2
3949,GO:0008654,0.478672219587964,0.605637497895122,25,231,phospholipid biosynthetic process,BP,INPP5D;DGKQ;PIK3R1;MVD;SRD5A3;PITPNM3;PIK3C2G;PITPNM2;MBOAT2;SLC27A1;PGAP1;ETNK2;HEXB;PLA2G6;LPIN3;PIGZ;DDHD2;PIK3C3;FGFR4;PIK3R2;MPPE1;IRS2;ISYNA1;PI4K2B;PEMT
18146,GO:1902930,0.4787146311012,0.688483236850856,6,52,regulation of alcohol biosynthetic process,BP,SREBF1;APOE;SEC14L2;MVD;ACACB;VDR
15281,GO:0071493,0.478754336186296,0.880062998307942,1,6,cellular response to UV-B,BP,HYAL1
15207,GO:0071384,0.478824744781101,0.702964720008604,5,44,cellular response to corticosteroid stimulus,BP,EGFR;ZFP36L2;CREBRF;ZFP36L1;KLF9
1447,GO:0003680,0.478905931024208,0.879976085336061,1,6,AT DNA binding,MF,H1F0
6776,GO:0030218,0.479055550873565,0.658903999017442,9,80,erythrocyte differentiation,BP,INPP5D;ZFPM1;STAT1;KLF13;FAM210B;THRA;DMTN;ACVR1B;ZFP36L1
9552,GO:0036344,0.47920271978529,0.795101798256868,2,15,platelet morphogenesis,BP,ZFPM1;NBEAL2
5550,GO:0016559,0.47933194447663,0.876909096349433,1,7,peroxisome fission,BP,PEX11B
734,GO:0001965,0.479509787901363,0.793876092280192,2,16,G-protein alpha-subunit binding,MF,RGS2;F2R
12221,GO:0048505,0.479790801146195,0.87946795025195,1,6,regulation of timing of cell differentiation,BP,SERPINE2
18370,GO:1903409,0.47996808983717,0.675349412019155,7,63,reactive oxygen species biosynthetic process,BP,PKD2;NOS1;INSR;CYBA;ACP5;DUOX1;RORA
11438,GO:0045907,0.480228208945741,0.794316458777663,2,15,positive regulation of vasoconstriction,BP,EGFR;F2R
13603,GO:0060119,0.480276844062734,0.750012284064021,3,24,inner ear receptor cell development,BP,SLITRK6;NAGLU;TRIOBP
9013,GO:0035234,0.480318782181532,0.879164092224806,1,6,ectopic germ cell programmed cell death,BP,KITLG
14294,GO:0061469,0.480361455271417,0.879139511705515,1,6,regulation of type B pancreatic cell proliferation,BP,SFRP1
5535,GO:0016525,0.48050973174824,0.675455692803275,7,59,negative regulation of angiogenesis,BP,STAT1;ADGRB2;MAP2K5;MMRN2;SPRY2;DAB2IP;PPARG
12801,GO:0051126,0.48052382373856,0.879045954559327,1,6,negative regulation of actin nucleation,BP,ARPIN
13489,GO:0055081,0.48070508466269,0.72195235751247,4,32,anion homeostasis,BP,APOE;SLC12A7;MLXIPL;FGFR4
10210,GO:0042895,0.480756298646655,0.878911919805267,1,6,antibiotic transmembrane transporter activity,MF,SLC13A5
8613,GO:0034141,0.480806540438404,0.878882939896658,1,6,positive regulation of toll-like receptor 3 signaling pathway,BP,FLOT1
10004,GO:0042447,0.480809271891637,0.878881364244942,1,6,hormone catabolic process,BP,SULT1E1
15272,GO:0071479,0.480921395889198,0.674470131272611,7,63,cellular response to ionizing radiation,BP,SFRP1;MDM2;WRN;NET1;CYBA;FBXO4;IFI16
11360,GO:0045742,0.480979306708129,0.748880420886467,3,25,positive regulation of epidermal growth factor receptor signaling pathway,BP,PTK6;FBXW7;ARAP1
4885,GO:0014807,0.481003014488338,0.87876956856621,1,6,regulation of somitogenesis,BP,NRARP
8684,GO:0034329,0.481082708728693,0.613173141236421,20,175,cell junction assembly,BP,FLNC;SFRP1;TNS1;GJD3;TRPV4;FLOT1;ITGA2;ITGA6;MICALL2;EPB41L3;KRT14;NPHP4;MYO9A;DLG5;DMTN;CD9;MPP7;PRKACA;PARD6G;NFASC
11639,GO:0046394,0.481086898451818,0.596066899049842,30,286,carboxylic acid biosynthetic process,BP,AMACR;GAMT;ALDH1A3;GLUD1;DHTKD1;CSPG4;UROS;THNSL2;MLYCD;PER2;PTGS1;INSR;MGST2;HYAL1;MLXIPL;PGM1;PFKFB2;ACACB;OGDHL;GLUL;SRR;RIMKLB;FGFR4;OSBPL1A;ALOXE3;ALOX15B;MTR;CBR4;ACSS2;SERINC3
13484,GO:0055075,0.481189976338386,0.794726782904809,2,14,potassium ion homeostasis,BP,SLC12A7;KCNMA1
2316,GO:0005319,0.481328006464779,0.656775176228301,9,80,lipid transporter activity,MF,APOE;PITPNM3;PITPNM2;SLC27A1;ANO9;OSBPL10;OSBPL5;OSBPL1A;PLTP
7364,GO:0031419,0.481332852697068,0.878579086731606,1,6,cobalamin binding,MF,MTR
17355,GO:1900101,0.48137020271835,0.748552506644751,3,25,regulation of endoplasmic reticulum unfolded protein response,BP,PIK3R1;DAB2IP;ERN1
19843,GO:2000343,0.481419110006897,0.875682129230471,1,7,positive regulation of chemokine (C-X-C motif) ligand 2 production,BP,POSTN
11727,GO:0046580,0.481504753198023,0.701328484279692,5,41,negative regulation of Ras protein signal transduction,BP,EPHB2;RASA4;SYNGAP1;SPRY2;DAB2IP
467,GO:0001508,0.481779462181273,0.664681001424103,8,68,action potential,BP,ANK3;SNTA1;KCNJ5;SCN4B;SCN2A;CACNB3;PTPN3;AKAP6
20171,GO:2001040,0.481875737140713,0.87826514596404,1,6,positive regulation of cellular response to drug,BP,ENDOG
1048,GO:0002576,0.481879134219339,0.656804057683188,9,75,platelet degranulation,BP,ENDOD1;LHFPL2;TTN;CD109;VEGFB;DMTN;CD9;SERPING1;ECM1
5922,GO:0018200,0.481888663196399,0.79204401125989,2,16,peptidyl-glutamic acid modification,BP,TPGS1;TTLL1
11535,GO:0046085,0.481894954221391,0.87825402336191,1,6,adenosine metabolic process,BP,NT5E
7076,GO:0030878,0.482053305983273,0.792914696806306,2,15,thyroid gland development,BP,HOXA3;THRA
9030,GO:0035256,0.482072437319202,0.878151267149443,1,6,G-protein coupled glutamate receptor binding,MF,HOMER2
6119,GO:0019370,0.482122593436633,0.875266797768113,1,7,leukotriene biosynthetic process,BP,MGST2
15962,GO:0080154,0.482192620661691,0.878081653285717,1,6,regulation of fertilization,BP,LHFPL2
17282,GO:0140097,0.482291355257052,0.613942803183233,19,179,catalytic activity, acting on DNA,MF,LIG1;POLH;SLX1A;SLX1B;SMARCA1;CHD3;POLD4;ENDOG;WRN;TREX1;ATRX;MPG;ERCC5;PRIMPOL;TOP3B;TEP1;RAD50;POLM;DDX12P
14101,GO:0060986,0.482490484864475,0.748157406156944,3,24,endocrine hormone secretion,BP,CRY1;BMP6;RAB11FIP3
1603,GO:0004028,0.482571396678108,0.877862084950969,1,6,3-chloroallyl aldehyde dehydrogenase activity,MF,ALDH1A3
8502,GO:0033692,0.482664063018218,0.684884599321656,6,52,cellular polysaccharide biosynthetic process,BP,PER2;INSR;B3GNT9;PGM1;EPM2AIP1;IRS2
358,GO:0000977,0.482677189298969,0.579709236333861,47,433,RNA polymerase II regulatory region sequence-specific DNA binding,MF,HES2;SREBF1;MNT;KDM3A;TFCP2L1;ZFPM1;STAT1;KLF13;NFATC4;HSF4;NDN;GLI2;KLF7;GLI3;BHLHE40;TCFL5;JARID2;ETV5;TCF4;PLAG1;MEF2D;CREBRF;MLXIPL;LMO2;CARF;MXI1;THRA;ELF1;DBP;RFX2;SALL2;ZMYND8;IFI16;TEF;VDR;SIX5;HLTF;TFDP2;KAT2B;STAT6;SOX13;KLF8;RORA;PPARG;FOXP2;ZC3H6;HIVEP1
7210,GO:0031112,0.482688769727453,0.747990931807511,3,24,positive regulation of microtubule polymerization or depolymerization,BP,RGS2;TRPV4;CDK5R1
2784,GO:0006216,0.482731380198936,0.874906648491632,1,7,cytidine catabolic process,BP,APOBEC3C
4363,GO:0009972,0.482731380198936,0.874906648491632,1,7,cytidine deamination,BP,APOBEC3C
11537,GO:0046087,0.482731380198936,0.874906648491632,1,7,cytidine metabolic process,BP,APOBEC3C
14202,GO:0061178,0.482925637395642,0.718627638016739,4,36,regulation of insulin secretion involved in cellular response to glucose stimulus,BP,PLA2G6;ANO1;PHPT1;GPR68
17995,GO:1902510,0.483185631584389,0.874637480645168,1,7,regulation of apoptotic DNA fragmentation,BP,ENDOG
559,GO:0001696,0.483305219564347,0.87743596980232,1,6,gastric acid secretion,BP,NMU
14595,GO:0070181,0.483559541611131,0.872281169019228,1,8,small ribosomal subunit rRNA binding,MF,CIRBP
3945,GO:0008645,0.484125400239725,0.662363298793526,8,69,hexose transmembrane transport,BP,PIK3R1;CLTCL1;INSR;SLC2A3;SLC2A1;PIK3R2;IRS2;SLC2A11
3510,GO:0007420,0.484310572057411,0.576896178094347,49,449,brain development,BP,SERPINE2;EGFR;PTPRS;DIXDC1;ALDH1A3;SFRP1;EPHB2;GLUD1;POU3F1;WNT3;NAGLU;RTN4RL1;GLI2;GJC2;AMIGO2;GLI3;SMARCA1;GAS8;BAIAP2;SUN1;PGAP1;MDK;B4GALT2;SHARPIN;CST3;BBS2;WRN;CDK5R1;ATRX;SHANK3;CDK5RAP3;ATXN1;THRA;SLC2A1;SRR;LRP1;DAB2IP;SHROOM2;DLG5;SHROOM4;TACC1;SHANK2;IRS2;CD9;TH;RORA;SYNE2;FOXP2;PTBP2
11988,GO:0047484,0.484468329285409,0.876758590745812,1,6,regulation of response to osmotic stress,BP,TRPV4
16696,GO:0097709,0.484505713945611,0.876736777973067,1,6,connective tissue replacement,BP,F2R
9863,GO:0042136,0.484563534376891,0.68296112989529,6,53,neurotransmitter biosynthetic process,BP,PKD2;NOS1;INSR;ACP5;TH;RORA
18809,GO:1904415,0.4847497134832,0.876594349950338,1,6,regulation of xenophagy,BP,LRSAM1
18810,GO:1904417,0.4847497134832,0.876594349950338,1,6,positive regulation of xenophagy,BP,LRSAM1
5327,GO:0016055,0.484875557557037,0.581664322542293,41,386,Wnt signaling pathway,BP,APOE;APCDD1;FBXW4;CAPRIN2;DIXDC1;SFRP1;SULF2;WNT3;PRICKLE2;NFATC4;FERMT1;LZTS2;ARHGEF19;WWTR1;GLI3;NAIP;IGFBP4;CELSR1;CDK14;RTF1;FZD7;NPHP3;AGO4;APC2;FRAT1;GNG2;LRP1;NPHP4;WNK1;DAB2IP;CALCOCO1;RNF213;TNRC6C;NRARP;KREMEN1;IGFBP6;PTK7;TCF7;PLCB3;SMURF1;CTNNBIP1
5838,GO:0017128,0.485005405353484,0.876444981487682,1,6,phospholipid scramblase activity,MF,ANO9
11085,GO:0045111,0.485188410405104,0.640347304346047,11,100,intermediate filament cytoskeleton,CC,DDX60;SYNC;KRT15;CASP14;KRT14;ING4;SHANK2;LMNA;LDLRAP1;VMAC;SYNE2
19748,GO:2000177,0.485503201637659,0.697466689893647,5,42,regulation of neural precursor cell proliferation,BP,KCTD11;GLI2;GJC2;GLI3;PTBP2
7968,GO:0032590,0.48550400561942,0.790250119378952,2,15,dendrite membrane,CC,KCNC4;INSR
18208,GO:1903034,0.485504182793634,0.639974874388759,11,101,regulation of response to wounding,BP,TNFAIP3;SERPINE2;APOE;PTPRS;RGMA;F2R;RTN4RL1;CD109;DMTN;CD9;SERPING1
7358,GO:0031410,0.485623119551517,0.549340263233274,167,1603,cytoplasmic vesicle,CC,SERPINE2;ULK2;GPNMB;TP53INP1;MAP6;SREBF1;PYGB;APOE;EGFR;HERC3;PTPRS;PKD2;SYT8;CXCR1;SYN1;LRIG3;DGKQ;BRSK1;WNT3;MVB12B;KCNAB2;VAMP3;NAPRT;OR2A4;NSG1;ITGB5;RAB43;RAB40B;PLEKHG5;GAA;MICALL1;VPS11;NDRG1;COL7A1;ITPR3;MDM2;IDUA;GPRC5C;HLA-B;HGSNAT;MYH11;SYTL1;ACTR1B;RHOBTB2;CTSV;AP1G2;RGL4;F2R;C2CD4C;HPS4;CLTCL1;TRPV4;TMC6;FLOT1;LAMP3;AVL9;SPG11;CLCN6;HEXA;WIPF1;LHFPL2;ULK1;SPPL2B;PCSK1;VAMP2;TRAK1;NISCH;INSR;GSN;BAIAP2;SUN1;AHNAK2;CD109;SEPT6;RAB11FIP4;VPS39;NRSN2;BLOC1S3;TMEM9;SLC2A3;TCIRG1;MICALL2;MAP2K2;VEGFB;SQSTM1;FZD7;LOXL1;HEXB;HYAL1;ARRDC1;KIAA0319L;CST3;ATP6V0A2;SEPT5;MALL;DNM1;MCTP1;HFE;CYBA;WASH3P;RAB11FIP3;CTSB;KLK5;PGM1;CHMP1B;ARAP1;ASTN2;RPH3AL;SLC2A1;TBC1D17;CAPG;LRP1;HLA-A;CCDC136;RNPEP;SLC48A1;APPL2;PMEL;STK16;RET;DAB2IP;DDHD2;PIK3C3;SYT7;FGFR4;AREG;BST2;SNX21;MARCH8;EHBP1;TBC1D16;DMTN;SGSM2;ARFGEF2;SNX1;OSBPL1A;DLG4;TSSK1B;NBEAL2;CD68;DMXL2;METTL7A;LAPTM4A;SCG5;PCSK1N;PRDX5;GLB1;GOLGA1;DPP7;CD9;CTSD;ERBB2;SYNGR1;ABCA2;TH;ATG14;PRKACA;LDLRAP1;C6ORF120;ACKR3;SERPING1;NFASC;PI4K2B;SNX33;CLCN7;OCIAD2;ECM1
1492,GO:0003836,0.485693326384969,0.876042529466366,1,6,beta-galactoside (CMP) alpha-2,3-sialyltransferase activity,MF,ST3GAL5
14138,GO:0061042,0.485832950926645,0.875960740915464,1,6,vascular wound healing,BP,TNFAIP3
10032,GO:0042500,0.48608382481914,0.875813696578581,1,6,aspartic endopeptidase activity, intramembrane cleaving,MF,SPPL2B
7470,GO:0031642,0.486176044574218,0.87575961530529,1,6,negative regulation of myelination,BP,TNFRSF21
5669,GO:0016782,0.486225189051562,0.695861142513564,5,46,transferase activity, transferring sulfur-containing groups,MF,SUGCT;GAL3ST4;SULT1E1;TST;NDST2
13892,GO:0060571,0.486230238325275,0.789686948297361,2,15,morphogenesis of an epithelial fold,BP,EGFR;GLI2
5895,GO:0018103,0.486354382091327,0.875654987497714,1,6,protein C-linked glycosylation,BP,DPY19L2P2
5930,GO:0018211,0.486354382091327,0.875654987497714,1,6,peptidyl-tryptophan modification,BP,DPY19L2P2
5951,GO:0018317,0.486354382091327,0.875654987497714,1,6,protein C-linked glycosylation via tryptophan,BP,DPY19L2P2
5968,GO:0018406,0.486354382091327,0.875654987497714,1,6,protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan,BP,DPY19L2P2
17078,GO:0099638,0.486367239141704,0.875647442241411,1,6,endosome to plasma membrane protein transport,BP,NSG1
17079,GO:0099639,0.486367239141704,0.875647442241411,1,6,neurotransmitter receptor transport, endosome to plasma membrane,BP,NSG1
12143,GO:0048268,0.486935178826837,0.789139493479572,2,15,clathrin coat assembly,BP,NSG1;CLTCL1
7678,GO:0032135,0.487011453232601,0.875268996588404,1,6,DNA insertion or deletion binding,MF,XPC
3433,GO:0007223,0.487399409220261,0.71608391690455,4,32,Wnt signaling pathway, calcium modulating pathway,BP,AGO4;GNG2;TNRC6C;PLCB3
11026,GO:0045017,0.487400153373236,0.600641543036756,23,211,glycerolipid biosynthetic process,BP,SIK1;SREBF1;INPP5D;DGKQ;PIK3R1;PITPNM3;PIK3C2G;PITPNM2;SLC27A1;PGAP1;ETNK2;PLA2G6;LPIN3;PIGZ;FBXW7;DDHD2;PIK3C3;FGFR4;PIK3R2;MPPE1;IRS2;PI4K2B;PEMT
12943,GO:0051345,0.487683975660214,0.568330520147389,59,555,positive regulation of hydrolase activity,BP,ALS2CL;LMF1;HSPA2;EGFR;SFRP1;EVI5L;DOCK9;VAV3;ASAP3;TBC1D8;PLXNB1;CHN2;TNFSF10;RAPGEF3;RASA4;RGS2;ACAP3;F2R;AGAP4;RALGAPA1;PIDD1;ARHGEF19;TBC1D19;ASAP2;ITGA2;ITGA6;SRGAP3;GSN;RIN1;ARHGEF1;DOCK8;SYNGAP1;FAM13A;ARHGAP33;WRN;IFI27;ARHGAP27;AGAP6;NET1;AGAP7P;APC2;ARAP1;NLRP1;TBC1D17;RGS12;DAB2IP;IFI16;PIK3R2;MYO9A;TBC1D16;SGSM2;IQSEC1;ERN1;ERBB2;ARHGAP23;AKAP6;PPARG;RIPK3;NPNT
3633,GO:0008094,0.487781470659559,0.650809613165812,9,79,DNA-dependent ATPase activity,MF,SMARCA1;CHD3;WRN;ATRX;ERCC6;RAD50;CHD6;DDX12P;MSH5
15175,GO:0071340,0.487791691512125,0.874809634302617,1,6,skeletal muscle acetylcholine-gated channel clustering,BP,ETV5
1528,GO:0003910,0.487836030354863,0.874783496756885,1,6,DNA ligase (ATP) activity,MF,LIG1
12997,GO:0051452,0.488050727049399,0.713813361406593,4,37,intracellular pH reduction,BP,TCIRG1;ATP6V0A2;CA2;DMXL2
13974,GO:0060710,0.488232638859362,0.874549538799337,1,6,chorio-allantoic fusion,BP,ZFP36L1
16959,GO:0099024,0.488239266464907,0.714600185223891,4,34,plasma membrane invagination,BP,ITGA2;GSN;PPARG;SNX33
12634,GO:0050858,0.488253770130565,0.787098270476846,2,16,negative regulation of antigen receptor-mediated signaling pathway,BP,ELF1;PHPT1
6646,GO:0030001,0.48826852979595,0.57351767532137,48,450,metal ion transport,BP,SERPINE2;SIK1;HSPA2;PKD2;ORAI3;KCNAB2;KCNJ15;NOS1;KCNC4;ITPR3;F2R;SLC24A1;TRPV4;ANK3;SLC13A5;GJC2;SNTA1;GSTM2;VAMP2;KCNJ5;SCNN1A;SCN4B;NIPAL2;TCIRG1;SLC12A7;PLA2G6;HOMER2;ATP6V0A2;KLHL24;HFE;CYBA;KCNMA1;SLC38A4;KCNG1;WNK1;JPH2;PDE2A;SHROOM2;SCN2A;KLHL3;VDR;CACNB3;ORAI2;CACNB1;PTPN3;AKAP6;PRKACA;KCNS3
596,GO:0001764,0.488297961193206,0.643691055877091,10,86,neuron migration,BP,UNK;SPOCK1;NDN;CELSR1;PEX7;CDK5R1;DAB2IP;NHSL1;MATN2;APBB2
12348,GO:0048745,0.488552511733489,0.789052646547181,2,14,smooth muscle tissue development,BP,PKD2;FOXP2
6584,GO:0022603,0.488588020192017,0.561203162508875,76,707,regulation of anatomical structure morphogenesis,BP,TNFAIP3;POSTN;ULK2;GPNMB;APOE;PTPRS;CAPRIN2;SFRP1;OBSL1;EPHB2;SULF2;WNT3;TENM4;CUL7;PRICKLE2;STAT1;NFATC4;PLXNB1;PARVB;RHOBTB2;RAPGEF3;ARPIN;ADGRB2;FLOT1;ARHGEF19;C5;WIPF1;SEMA4G;MAP2K5;TRAK1;CELSR1;BAIAP2;PLXNB3;TRIOBP;VEGFB;FZD7;ETV5;SYNGAP1;EPB41L3;HEXB;HYAL1;CST3;MMRN2;GDF15;NPHP3;CDK5R1;NET1;EFNB3;SHANK3;AGO4;SPRY2;FBXW7;ARAP1;FMNL2;RET;DAB2IP;DDHD2;BTG1;VDR;PLXND1;ZMYM3;DMTN;STAT2;NRARP;DLG4;PTK7;ZSWIM8;TNFSF12;SRPX2;ERBB2;SSH3;PPARG;FMNL3;FOXP2;SMURF1;ECM1
10488,GO:0043405,0.488938359183769,0.59109790099555,28,261,regulation of MAP kinase activity,BP,APOE;EGFR;SFRP1;EPHB2;MAP3K14;CSPG4;KITLG;RGS2;F2R;PDCD4;ADORA2B;MAPK8IP3;C5;MINK1;MAP2K5;INSR;CBLC;MAP2K2;MAP3K12;MAPK10;ERCC6;SHC2;SPRY2;CDK5RAP3;MAP3K6;DAB2IP;ERN1;ERBB2
10551,GO:0043524,0.488945369132201,0.642547847176397,10,92,negative regulation of neuron apoptotic process,BP,APOE;UNC5B;F2R;NAIP;MDK;SYNGAP1;MAP3K12;LRP1;SNCB;GCLC
5325,GO:0016053,0.488966826901679,0.588341065567197,30,287,organic acid biosynthetic process,BP,AMACR;GAMT;ALDH1A3;GLUD1;DHTKD1;CSPG4;UROS;THNSL2;MLYCD;PER2;PTGS1;INSR;MGST2;HYAL1;MLXIPL;PGM1;PFKFB2;ACACB;OGDHL;GLUL;SRR;RIMKLB;FGFR4;OSBPL1A;ALOXE3;ALOX15B;MTR;CBR4;ACSS2;SERINC3
13826,GO:0060449,0.48925141977105,0.873947250581434,1,6,bud elongation involved in lung branching,BP,SPRY2
14499,GO:0070006,0.489377841416863,0.787236457339626,2,15,metalloaminopeptidase activity,MF,RNPEPL1;RNPEP
9226,GO:0035627,0.489451682426359,0.873828635695192,1,6,ceramide transport,BP,PLTP
9770,GO:0039694,0.489513496555987,0.741673925564986,3,25,viral RNA genome replication,BP,APOBEC3C;PIK3C2G;ATG16L2
3203,GO:0006837,0.489532037153037,0.873781021287425,1,6,serotonin transport,BP,NOS1
713,GO:0001939,0.489690332187683,0.873687188662608,1,6,female pronucleus,CC,SLC2A1
11045,GO:0045056,0.489955260294355,0.786785220783313,2,15,transcytosis,BP,FCGRT;LRP1
12204,GO:0048471,0.489957650369076,0.568465450345231,54,510,perinuclear region of cytoplasm,CC,MAP6;OAS2;EGFR;OBSL1;SYNC;PIK3R1;HERC5;CUL7;VAMP3;STAT1;RAB40B;NOS1;PRKACB;PLEKHG5;NDRG1;CYHR1;TMEM134;MT1X;LAMP3;PER2;THBS3;ITGA2;VAMP2;TRAK1;GSN;RAB11FIP4;S100A4;MAP2K2;CST3;CDK5R1;HFE;CYBA;CTSB;APC2;PRR7;ATXN10;PDE2A;STK16;DEF6;DMTN;ARFGEF2;CEP250;S100A6;TNFSF12;PRDX5;GLB1;GOLGA1;ERBB2;AKAP6;PPARG;PRKACA;DOCK6;ACKR3;SERINC3
9895,GO:0042228,0.490235322835035,0.873363784194711,1,6,interleukin-8 biosynthetic process,BP,MAP2K5
4443,GO:0010359,0.490273325754917,0.873341212524617,1,6,regulation of anion channel activity,BP,ANO9
9684,GO:0038092,0.49033374539794,0.873305321103166,1,6,nodal signaling pathway,BP,ACVR1B
12866,GO:0051224,0.49086604516238,0.634589392541636,11,105,negative regulation of protein transport,BP,SREBF1;SFRP1;F2R;RHBDF1;IDH2;TNFRSF21;HADH;RAB11FIP3;PDE2A;DMTN;RSAD2
14622,GO:0070229,0.490866634354631,0.740011947325387,3,26,negative regulation of lymphocyte apoptotic process,BP,TSC22D3;DOCK8;IRS2
11058,GO:0045072,0.491030984672853,0.872890652763134,1,6,regulation of interferon-gamma biosynthetic process,BP,ZFPM1
4573,GO:0010661,0.491131527213282,0.78586436624385,2,15,positive regulation of muscle cell apoptotic process,BP,PDCD4;PPARG
602,GO:0001771,0.491230431561741,0.872771872188296,1,6,immunological synapse formation,BP,DOCK8
4722,GO:0010887,0.491273148087961,0.87274642289189,1,6,negative regulation of cholesterol storage,BP,PPARG
16808,GO:0098722,0.491588295184873,0.872558563778747,1,6,asymmetric stem cell division,BP,ETV5
2719,GO:0006098,0.492048730780201,0.783221589121935,2,17,pentose-phosphate shunt,BP,H6PD;PGLS
8991,GO:0035136,0.492463643261063,0.739717605345894,3,24,forelimb morphogenesis,BP,WNT3;RNF165;ATRX
1115,GO:0002704,0.492792022146769,0.738366600628322,3,26,negative regulation of leukocyte mediated immunity,BP,IL20RB;HFE;BST2
15910,GO:0072719,0.492894467601803,0.871778010992345,1,6,cellular response to cisplatin,BP,ADIRF
19792,GO:2000270,0.493138173054925,0.871632028406384,1,6,negative regulation of fibroblast apoptotic process,BP,SFRP1
15273,GO:0071480,0.493168159226843,0.738044576598575,3,26,cellular response to gamma radiation,BP,MDM2;WRN;CYBA
6486,GO:0021846,0.493285990941448,0.785359439198166,2,14,cell proliferation in forebrain,BP,DIXDC1;GLI3
7063,GO:0030858,0.493418636000416,0.709668824101247,4,35,positive regulation of epithelial cell differentiation,BP,BMP6;BTG1;VDR;ALOX15B
7485,GO:0031664,0.493550356040044,0.782933979871763,2,16,regulation of lipopolysaccharide-mediated signaling pathway,BP,TNFAIP3;BMP6
2386,GO:0005523,0.493726374720184,0.868285160706667,1,7,tropomyosin binding,MF,S100A6
10183,GO:0042800,0.493747994192857,0.782777729677825,2,16,histone methyltransferase activity (H3-K4 specific),MF,ASH2L;DYDC1
17058,GO:0099590,0.493806036186634,0.87123140959787,1,6,neurotransmitter receptor internalization,BP,DNM1
16695,GO:0097708,0.49386022068045,0.541145252154829,167,1605,intracellular vesicle,CC,SERPINE2;ULK2;GPNMB;TP53INP1;MAP6;SREBF1;PYGB;APOE;EGFR;HERC3;PTPRS;PKD2;SYT8;CXCR1;SYN1;LRIG3;DGKQ;BRSK1;WNT3;MVB12B;KCNAB2;VAMP3;NAPRT;OR2A4;NSG1;ITGB5;RAB43;RAB40B;PLEKHG5;GAA;MICALL1;VPS11;NDRG1;COL7A1;ITPR3;MDM2;IDUA;GPRC5C;HLA-B;HGSNAT;MYH11;SYTL1;ACTR1B;RHOBTB2;CTSV;AP1G2;RGL4;F2R;C2CD4C;HPS4;CLTCL1;TRPV4;TMC6;FLOT1;LAMP3;AVL9;SPG11;CLCN6;HEXA;WIPF1;LHFPL2;ULK1;SPPL2B;PCSK1;VAMP2;TRAK1;NISCH;INSR;GSN;BAIAP2;SUN1;AHNAK2;CD109;SEPT6;RAB11FIP4;VPS39;NRSN2;BLOC1S3;TMEM9;SLC2A3;TCIRG1;MICALL2;MAP2K2;VEGFB;SQSTM1;FZD7;LOXL1;HEXB;HYAL1;ARRDC1;KIAA0319L;CST3;ATP6V0A2;SEPT5;MALL;DNM1;MCTP1;HFE;CYBA;WASH3P;RAB11FIP3;CTSB;KLK5;PGM1;CHMP1B;ARAP1;ASTN2;RPH3AL;SLC2A1;TBC1D17;CAPG;LRP1;HLA-A;CCDC136;RNPEP;SLC48A1;APPL2;PMEL;STK16;RET;DAB2IP;DDHD2;PIK3C3;SYT7;FGFR4;AREG;BST2;SNX21;MARCH8;EHBP1;TBC1D16;DMTN;SGSM2;ARFGEF2;SNX1;OSBPL1A;DLG4;TSSK1B;NBEAL2;CD68;DMXL2;METTL7A;LAPTM4A;SCG5;PCSK1N;PRDX5;GLB1;GOLGA1;DPP7;CD9;CTSD;ERBB2;SYNGR1;ABCA2;TH;ATG14;PRKACA;LDLRAP1;C6ORF120;ACKR3;SERPING1;NFASC;PI4K2B;SNX33;CLCN7;OCIAD2;ECM1
5477,GO:0016413,0.49389889340773,0.871175643949759,1,6,O-acetyltransferase activity,MF,CRAT
6134,GO:0019405,0.494726783644235,0.87067774910584,1,6,alditol catabolic process,BP,TKFC
9252,GO:0035672,0.494815194615315,0.870624503776088,1,6,oligopeptide transmembrane transport,BP,CA2
6703,GO:0030119,0.494837974208952,0.68874734674655,5,43,AP-type membrane coat adaptor complex,CC,EGFR;AP5Z1;AP1G2;VPS39;LDLRAP1
3250,GO:0006910,0.495048836172848,0.870483724093121,1,6,phagocytosis, recognition,BP,TUB
6770,GO:0030212,0.495210678688694,0.736807550065079,3,25,hyaluronan metabolic process,BP,HEXA;HEXB;HYAL1
14291,GO:0061458,0.495252288585552,0.579914506878307,32,298,reproductive system development,BP,SERPINE2;EGFR;PKD2;PLCD3;SFRP1;HTRA1;KITLG;CUL7;PLCD1;TNFSF10;CTSV;SERPINB5;GLI2;GLI3;NUPR1;INSR;BMP6;ETNK2;DLX3;CST3;PLAG1;ATRX;REC8;AGO4;SLIT3;CTSB;VDR;TCF7;ZFP36L1;ALOX15B;GJB5;PPARG
19723,GO:2000117,0.495544764096966,0.65082101685273,8,76,negative regulation of cysteine-type endopeptidase activity,BP,IFI6;MDM2;LAMP3;NAIP;MAP2K5;CST3;IFI16;PRDX5
3170,GO:0006782,0.495682463138482,0.867083680263704,1,7,protoporphyrinogen IX biosynthetic process,BP,UROS
7637,GO:0032056,0.495789519363745,0.87003676131276,1,6,positive regulation of translation in response to stress,BP,IMPACT
9026,GO:0035252,0.495864555031515,0.869991424636309,1,6,UDP-xylosyltransferase activity,MF,XYLT1
9924,GO:0042285,0.495864555031515,0.869991424636309,1,6,xylosyltransferase activity,MF,XYLT1
16088,GO:0090090,0.496067352413956,0.619706757144714,13,128,negative regulation of canonical Wnt signaling pathway,BP,APOE;SFRP1;FERMT1;LZTS2;WWTR1;GLI3;IGFBP4;NPHP3;APC2;NPHP4;DAB2IP;KREMEN1;IGFBP6
14919,GO:0070828,0.496233804716444,0.781844508865147,2,15,heterochromatin organization,BP,MTHFR;TNRC18
5405,GO:0016247,0.496412405916551,0.650219547093178,8,74,channel regulator activity,MF,KCNAB2;NOS1;SNTA1;SCN4B;WNK1;PHPT1;PTPN3;KCNS3
11761,GO:0046636,0.496464274040411,0.781661951696302,2,15,negative regulation of alpha-beta T cell activation,BP,GLI3;HFE
3425,GO:0007214,0.496557347130402,0.86957234558838,1,6,gamma-aminobutyric acid signaling pathway,BP,GABBR1
4367,GO:0009987,0.496701282070083,0.538962956437045,1075,10477,cellular process,BP,TNFAIP3;TGFBI;POSTN;TAGLN;ITGB6;HES2;SERPINE2;ZSCAN18;ULK2;GPNMB;TSC22D1;SIK1;SLFN5;EPM2A;MUC19;DDB2;TP53INP1;MAP6;IFI6;PTHLH;SREBF1;AMACR;PYGB;NYNRIN;ACTA2;APOE;GPSM1;CES2;NT5E;ALS2CL;INPP5D;APCDD1;GAMT;FBXO41;OAS2;ADAM19;MN1;LMF1;PSD4;DDX60;HSPA2;FBXW4;EGFR;ESPN;TRIM65;HERC3;GIGYF1;PTPRS;CIRBP;FLNC;FAM20C;PKD2;CAPRIN2;MNT;XPC;APOBEC3C;SYT8;CXCR1;CPT2;RBM3;SYN1;ASH2L;DIXDC1;TRIM22;ALDH1A3;SRSF5;PLCD3;SLITRK6;CTSO;SFRP1;OBSL1;MTHFR;PERM1;SEC14L2;KCTD11;KIF26B;PCDH1;EPS8L2;EPHB2;RALGDS;TNS1;SYNC;GPX3;MAP3K14;GLUD1;BPHL;DCAF16;DGKQ;TMEM129;PIK3R1;ADAMTS7;EVI5L;BRSK1;TXNRD3;MARVELD1;RBCK1;KDM3A;CXCL14;DOCK9;TSC22D3;CUL9;EVC;RNF135;POU3F1;SULF2;WNT3;H6PD;DHTKD1;CAMKK1;HERC5;UBXN4;VAV3;ST6GALNAC2;UNK;HR;SMOC2;CSPG4;ISG15;MVB12B;CYBRD1;ELFN2;HTRA1;SPATA18;TFCP2L1;TENM4;UNC119B;RGMA;PI4KAP2;KCNAB2;ZFPM1;KITLG;TP53I11;HOXC5;SDK2;MVD;ZDHHC1;ZNF362;CUL7;VAMP3;CITED4;IRF2BPL;NAPRT;REEP2;PRICKLE2;KCNJ15;MC1R;ASAP3;ZNF266;SRD5A3;OR2A4;C1QTNF6;STAT1;IMPACT;CAMK2N1;CRY2;MYL9;KRT15;HS1BP3;LGALS7B;WDR63;MARCKSL1;NSG1;UNC5B;UROS;KDSR;ITGB5;COL10A1;GJD3;RAB43;RAB40B;THAP8;NOS1;PRKACB;ZNF704;HOXA3;CRY1;ZNF699;MAML3;ZFP41;SCMH1;KLF13;CRTAP;SDC3;BCAM;MAGEF1;PLEKHG5;NFATC4;PITPNM3;ZNF783;IQSEC2;HMGCL;PSMG4;SPDYE6;D2HGDH;BTBD2;FKBP5;RNF187;FERMT1;H1F0;CYP26B1;GAA;AP5Z1;CMPK2;THNSL2;HSF4;CNTRL;ZNF251;MICALL1;PIK3C2G;LIG1;CDK18;TBC1D8;PLXNB1;PLEKHG3;VPS11;SPEG;NDRG1;COL7A1;KCNC4;SPOCK1;ITPR3;EAPP;NAGLU;MDM2;CRTC1;LZTS2;PLCD1;NDN;IFITM1;KCTD18;MLH3;NMRK1;DDX59;ST6GALNAC6;PPP2R2C;FCGRT;CSMD3;CHN2;ZNF662;TYSND1;LTBP4;PIK3IP1;OBSCN;IDUA;GOLGA8A;GPRC5C;HLA-B;TNFSF10;PRODH;HGSNAT;MYH11;PARVB;SYTL1;FKBP9;NDUFA4L2;ACTR1B;TNXB;RHOBTB2;UGT1A3;CERS4;CYP3A5;ACOT1;NEO1;RAPGEF3;PHACTR3;ZNF414;SPSB3;TCF25;ENDOD1;PCBP4;FAM210B;CTSV;NLGN4Y;POLH;SPATA20;BLVRB;POLR2J2;OAS1;FLRT3;NUDCD3;RASA4;GAL3ST4;KCTD15;CRAT;KIF26A;B4GALT6;MLLT6;RGL4;RGS2;ARPIN;ACAP3;IL20RB;ADGRB2;F2R;MLYCD;PPL;C2CD4C;HPS4;PHYH;MT1X;PDCD4;BLOC1S4;CGREF1;SPTB;SERPINB5;PPP1R3E;NYAP1;SLC24A1;ALPK1;ZNF160;CAPN7;SWT1;DNAH1;SLC27A3;ARSI;NEK9;TUBGCP5;RTN4RL1;ZFP36L2;ADGRF4;CLTCL1;TRPV4;TMC6;FLOT1;GLI2;AGAP4;TOM1L2;RHPN1;NLGN2;ADORA2B;CORO6;ANK3;KLF7;RNF165;NAT6;DHX32;ADAMTS13;LAMP3;TCEA2;PLCH2;RALGAPA1;MAPK8IP3;SPDYE5;GOLGA8B;ZNF76;SOX12;CLMN;PIDD1;RIMS3;PARP6;AVL9;SLX1A;SLX1B;G6PC3;ATG16L2;ZNF747;SPG11;GJC2;ZCCHC11;ARHGEF19;RHBDF1;TSPAN18;SULT1E1;FBXO44;RASGEF1A;PER2;TMEM204;PITPNM2;CLCN6;MICALCL;PTGS1;UNC119;HEXA;FRS3;C5;FRMD4B;ZNF658;ARSD;WIPF1;SNTA1;PSKH1;ADGRL1;MINK1;PHF2;NINL;ABHD14B;GSTM2;TCEAL1;AMIGO2;THBS3;TNFRSF14;WWTR1;MBOAT2;ASAP2;ARHGEF4;LHFPL2;ITGA2;SEMA4G;FAM110C;SYT15;ULK1;GLI3;SPPL2B;FGGY;FHOD3;PCSK1;TPGS1;THRAP3;ZNF558;IRX4;SMARCA1;AKAP7;BHLHE40;LRSAM1;VAMP2;ZNF655;NAIP;LTBP1;NMU;ZNF333;NEK8;MAP2K5;GAS8;BOC;ITGA6;LTBP3;KCNJ5;SRGAP3;CES3;BSN;SESN3;ZNF318;LZTS1;IGFBP4;MMP1;TCFL5;TRAK1;JARID2;NUPR1;PRR9;GPC2;NISCH;INSR;TST;CCDC85B;HSF2BP;CELSR1;MMP28;GSN;ALDH4A1;CEP68;HEBP1;CHD3;CDK14;ST3GAL5;BAIAP2;TANC1;TTN;CBLC;DDT;ZNF18;PLXNB3;CEP126;SUN1;LPAR5;AHNAK2;CNTNAP3;RNPEPL1;PLEKHH2;TRIOBP;MXD4;POLD4;RIN1;CTSF;ZNF287;CD109;CYP2D7;NSUN5P2;PNMA1;PGLS;PMS2P3;ETAA1;RMI2;ZNF446;SCN4B;ARHGEF1;SEPT6;FBXL16;RAB11FIP4;VPS39;ZNF581;MGST2;DOCK8;TP53AIP1;DHX58;PILRB;ENDOG;SLC27A1;PGAP1;GID4;TM7SF3;RTF1;BLOC1S3;MDK;CASP14;IRF9;RICTOR;H2AFJ;BMP6;NLRX1;B4GALT2;ETNK2;PEX10;SLC2A3;TCIRG1;S100A4;MICALL2;MAP2K2;OPLAH;PDK1;VEGFB;ALDH7A1;GLI4;SQSTM1;CEP192;CABYR;PTK6;SLC12A7;TMEM8B;FZD7;ETV5;AKR7A2;LOXL1;SYNGAP1;NXPH4;FAM13A;FAM213A;FAT2;DLX3;TMEM117;EPB41L3;SHARPIN;HEXB;KDM4C;HYAL1;METTL23;ARHGAP33;H1FX;SH2D2A;UBOX5;NSMCE4A;ARRDC1;B3GNT9;ZNF608;WHAMMP3;CENPC;PLA2G6;CST3;PDIK1L;HOMER2;MMRN2;CAPNS2;GDF15;PEX7;BBS2;TXNIP;CTF1;THSD4;TCF4;ATP6V0A2;COL6A1;PEX11B;NPHP3;PSD3;LRRCC1;PLAG1;IDH2;MAP3K12;RCOR2;WRN;PODXL;SEPT5;IFI27;MALL;OSCP1;DNM1;MCM9;TNFRSF21;ZYG11B;MACROD1;IQCB1;KLHL24;TREX1;LPIN3;ZDHHC12;OARD1;MCTP1;CDK5R1;ATRX;REC8;ARHGAP27;AGAP6;NET1;ANO9;PIGZ;CA2;EFNB3;OSBPL10;PI4KAP1;POLR2J3;HOOK2;SESN1;EPB41L4A;MAPK10;NKTR;SHANK3;HFE;ADIRF;HMG20B;CYBA;TRIM38;NID1;DTX3;AGO4;ERCC6;HADH;RRM2B;SLIT3;KRT14;HLCS;SHC2;EDA2R;SPRY2;MRC2;FBXO2;WASH3P;MEF2D;IFT140;GABBR1;CREBRF;XRN1;AGAP7P;RAB11FIP3;MLXIPL;CTSB;KLK5;TARBP1;FBXW7;KCNMA1;ANKRD28;GPR87;ING4;NUDT6;CDK5RAP3;ZNF862;ATXN1;LMO2;NOTCH2NL;NFIX;PAK6;TFPI2;CARF;DZIP1L;PGM1;MXI1;PFKFB2;PAQR6;RNF170;CHMP1B;THRA;TTC12;APC2;METTL21A;ACADS;ARAP1;GOLGA8N;ADARB1;RAI1;FMNL2;ELF1;MX2;IKZF4;DCAF10;RPH3AL;SLC2A1;ACACB;OGDHL;NLRP1;FRAT1;ZBTB34;ERMAP;REEP4;ZNF627;TK2;GPR155;LACTB2;BEX2;GLUL;TNS2;TBC1D17;C17ORF97;MIF4GD;DBP;NDST2;NAB2;EPM2AIP1;TP53I13;GNG2;FBXW5;SRR;CAPG;TSPYL4;LRP1;KLHDC8B;LRRN3;HLA-A;PEG3;TSNARE1;NPHP4;RGS12;CCDC136;ATE1;ACP5;MPG;PLA2G7;SYNPO2;RNPEP;C12ORF66;CENPH;RFX2;DLK2;KCNG1;ZNF554;BRINP1;BDH1;MAP3K6;RIMKLB;PPCS;MYO3B;APPL2;SALL2;WNK1;PMEL;ZNF107;ZNF532;BBS1;ATXN10;JPH2;ZBTB20;PDE2A;ZNF334;SDHA;MAF;STK16;LTB4R2;RET;ZMYND8;PRX;DAB2IP;CASZ1;RWDD3;ACOX3;CALCOCO1;TEAD2;MYSM1;DDHD2;SHROOM2;FBXO4;RNF213;OLFM2;RAPGEFL1;TSHZ2;PIK3C3;ZNF276;IFI16;SYT7;DALRD3;FGFR4;ERCC5;BBS5;EXOC2;IL20RA;PIK3R2;RETSAT;SCN2A;TEF;ZNF25;SETD4;OSBPL5;AREG;ABTB1;TMEM203;KLHL3;SNCB;ETFB;MYO9A;RPS6KA5;APBB3;ZNF630;DLG5;BTG1;BST2;ZNF687;VDR;LETMD1;RGL2;ARHGEF17;CACNB3;MAMSTR;TNRC18;TNRC6C;ZFP28;DPY19L2P2;VIPR1;EFS;PLXND1;NADK;BBS10;ZMYM3;SIX5;HLTF;MARCH8;PCSK6;ZNF789;TMEM80;MPPE1;ZNF563;TNS4;ZNF517;PCMTD2;TBC1D16;STK19;NDUFV3;LPAR6;EML3;PPP1R2;DMTN;PPP1R35;STAT2;SGSM2;ARFGEF2;RASL10B;LMTK3;ALMS1;PCMTD1;WWC3;PHF1;ZNF292;TMEM231;TFDP2;SNX1;PMP22;UCN2;GOLGA7B;OSBPL1A;NRARP;ACVR1B;TMX4;SHROOM4;ZNF737;TACC1;KREMEN1;CADM4;KDELC2;PRIMPOL;NECAB3;CCDC88B;DLG4;CCDC113;TNNI2;PPP2R3B;ESYT2;TSSK1B;ADCK5;IQSEC1;ZNF701;ALOXE3;NAT14;PANO1;PALB2;ENDOU;MPI;IGFBP6;NHSL1;MATN2;TCEAL4;ZNF91;NBEAL2;CD68;DUOX1;PTMS;WEE1;DYDC1;CCNG2;GTF2IRD2;PTK7;DQX1;AMT;TCF7;SHANK2;RSAD2;TNFRSF25;ZFP36L1;XYLT1;LMNA;MXRA8;CLSTN3;GLMP;TOP3B;ACSL1;IL11;KAT2B;MARK4;TEP1;APOLD1;IRS2;DMXL2;IMPA2;CEP250;ANO1;CAPS;METTL7A;ERN1;HSD17B14;SAC3D1;RNF141;IVNS1ABP;ALOX15B;RAD50;GPR21;ZNF439;TKFC;ANGEL2;ZMAT3;PNPO;MTR;MAN1B1;DHRS4;PEX1;ECI1;S100A6;TRERF1;UAP1L1;FAAH;SCYL3;EFEMP2;SCG5;ZSWIM8;APBB2;CBR4;TTC19;ARHGEF9;ISYNA1;SGSH;PBLD;DCAF8;RAPGEF5;TNFSF12;TAS1R3;CERS5;STAT6;PCSK1N;SOX13;PRDX5;PHPT1;NELFCD;GPR132;SMPDL3B;TUB;KIF7;GLB1;CPT1C;KLF8;DNAJC4;GSTM3;RDH12;KLHL29;CHD6;TRAF5;NAP1L5;GOLGB1;SRPX2;ACSS2;DPP7;TRIM2;CD9;RANBP9;CACNB1;HDAC11;PTPN3;CTSD;GJB5;COL13A1;ERBB2;SYNGR1;SPOCD1;PLCB3;GPR68;NUDT10;UVSSA;ZDHHC24;PAQR7;ARHGAP23;PQLC3;PPM1M;ABCA2;KMT5C;AKAP6;TH;ATG14;MPP7;RORA;SSH3;PPARG;PRKACA;DOCK6;LDLRAP1;CXXC5;NPAP1;C6ORF120;POLM;FMNL3;ACOT2;GCNT4;ZNF572;SYNE2;PARD6G;ACKR3;PLTP;ZNF658B;SERPING1;SUCLG2;UCKL1;PARN;DDX12P;DOCK3;ZNF529;UFL1;LAMB2;IP6K2;RIPK3;NFASC;KLF9;PI4K2B;AIP;COG1;KCNS3;SCAND1;LONP2;PRMT3;SNX33;HARS2;CIT;ZFP90;EHHADH;MSH5;MAP1A;CCDC3;PER3;ZFP30;FOXP2;PTBP2;ZC3H6;HIVEP1;ECM2;SMURF1;NPNT;TTLL1;EML2;CTNNBIP1;PEMT;GLIPR1L2;SERINC3;GCLC;ECM1
10595,GO:0043588,0.496740429176525,0.587829912120827,25,239,skin development,BP,APCDD1;EGFR;POU3F1;KRT15;FERMT1;CYP26B1;CTSV;PPL;ITGA2;ITGA6;PRR9;CELSR1;CD109;CASP14;SHARPIN;TXNIP;KRT14;KLK5;MYSM1;VDR;PCSK6;ACVR1B;ALOXE3;ZFP36L1;ALOX15B
15095,GO:0071203,0.496869437046314,0.869383267440299,1,6,WASH complex,CC,WASH3P
94,GO:0000185,0.496893479424202,0.781321747047966,2,15,activation of MAPKKK activity,BP,MINK1;DAB2IP
8589,GO:0034109,0.496978324862472,0.671334265867951,6,54,homotypic cell-cell adhesion,BP,SERPINE2;MYL9;BLOC1S4;ANK3;DMTN;CD9
11084,GO:0045110,0.497167882395353,0.869202286641828,1,6,intermediate filament bundle assembly,BP,KRT14
11662,GO:0046461,0.497203608571096,0.78003569055138,2,16,neutral lipid catabolic process,BP,APOE;DDHD2
11665,GO:0046464,0.497203608571096,0.78003569055138,2,16,acylglycerol catabolic process,BP,APOE;DDHD2
14164,GO:0061087,0.497228209299422,0.869165683582815,1,6,positive regulation of histone H3-K27 methylation,BP,PHF1
4108,GO:0009165,0.497294710958944,0.588896575212635,24,233,nucleotide biosynthetic process,BP,PTHLH;APOE;DHTKD1;NAPRT;NOS1;CMPK2;NMRK1;ADORA2B;INSR;TCIRG1;ATP6V0A2;IDH2;RRM2B;GABBR1;MLXIPL;GPR87;PGM1;PFKFB2;OGDHL;TK2;PPCS;LTB4R2;NADK;UCKL1
11750,GO:0046624,0.497433825444386,0.869040876181512,1,6,sphingolipid transporter activity,MF,PLTP
15658,GO:0072203,0.497436685163407,0.869039139796885,1,6,cell proliferation involved in metanephros development,BP,STAT1
838,GO:0002151,0.497464724490297,0.86902211390589,1,6,G-quadruplex RNA binding,MF,XRN1
8300,GO:0033144,0.497479037418804,0.735421659254504,3,24,negative regulation of intracellular steroid hormone receptor signaling pathway,BP,SFRP1;CRY2;CRY1
13237,GO:0051938,0.497606904137979,0.868935757824137,1,6,L-glutamate import,BP,PER2
16805,GO:0098712,0.497606904137979,0.868935757824137,1,6,L-glutamate import across plasma membrane,BP,PER2
1587,GO:0004000,0.497885364221304,0.868766519744682,1,6,adenosine deaminase activity,MF,ADARB1
3888,GO:0008525,0.497940892799877,0.868732754213486,1,6,phosphatidylcholine transporter activity,MF,PLTP
286,GO:0000791,0.49809362350887,0.733332561465423,3,27,euchromatin,CC,ASH2L;H1F0;TCF7
12675,GO:0050912,0.498157023808888,0.863289588116218,1,8,detection of chemical stimulus involved in sensory perception of taste,BP,TAS1R3
12392,GO:0048854,0.498189330029113,0.735428671519984,3,23,brain morphogenesis,BP,BBS2;SHANK3;SHANK2
15146,GO:0071287,0.498192521218251,0.868579673329725,1,6,cellular response to manganese ion,BP,TH
332,GO:0000923,0.498199034032376,0.868575709626217,1,6,equatorial microtubule organizing center,CC,TUBGCP5
12978,GO:0051415,0.498199034032376,0.868575709626217,1,6,microtubule nucleation by interphase microtubule organizing center,BP,TUBGCP5
9781,GO:0040012,0.498204910176253,0.555053150800806,66,616,regulation of locomotion,BP,POSTN;SERPINE2;GPNMB;TP53INP1;APOE;EGFR;SFRP1;PIK3R1;CXCL14;WNT3;KITLG;PLXNB1;MDM2;IFITM1;RHOBTB2;ARPIN;F2R;CAPN7;TRPV4;C5;MINK1;ITGA2;SEMA4G;FAM110C;MAP2K5;ITGA6;SRGAP3;NISCH;INSR;MMP28;DDT;PLXNB3;DOCK8;VEGFB;HYAL1;MMRN2;BBS2;IDH2;PODXL;MCTP1;SPRY2;ADARB1;LRP1;PLA2G7;RET;ZMYND8;DAB2IP;MYSM1;DLG5;BST2;PLXND1;DMTN;ACVR1B;LMNA;IRS2;ALOX15B;ZSWIM8;PBLD;PHPT1;SRPX2;ERBB2;PPARG;SYNE2;ACKR3;RIPK3;ECM1
8179,GO:0032927,0.498263597009989,0.868536412242473,1,6,positive regulation of activin receptor signaling pathway,BP,ACVR1B
6415,GO:0021683,0.498301458072717,0.86851336383711,1,6,cerebellar granular layer morphogenesis,BP,SERPINE2
1589,GO:0004003,0.498306661776274,0.706013515803566,4,33,ATP-dependent DNA helicase activity,MF,CHD3;WRN;RAD50;DDX12P
3867,GO:0008494,0.498414388272364,0.865393654889771,1,7,translation activator activity,MF,MIF4GD
12816,GO:0051146,0.498526957692839,0.604026861375188,17,147,striated muscle cell differentiation,BP,SIK1;FLNC;OBSL1;NOS1;CYP26B1;OBSCN;MYH11;FLOT1;FHOD3;TANC1;TTN;FZD7;GDF15;THRA;MAMSTR;LMNA;AKAP6
15253,GO:0071455,0.498748450156152,0.868241049759972,1,6,cellular response to hyperoxia,BP,PPARG
14548,GO:0070099,0.498994207630324,0.868091172007302,1,6,regulation of chemokine-mediated signaling pathway,BP,SLIT3
3835,GO:0008443,0.49902233758955,0.868074009471801,1,6,phosphofructokinase activity,MF,PFKFB2
7085,GO:0030888,0.499078505367031,0.704611149504879,4,35,regulation of B cell proliferation,BP,INPP5D;VAV3;TNFRSF21;IRS2
12590,GO:0050790,0.499369840459395,0.53557604032095,168,1608,regulation of catalytic activity,BP,TNFAIP3;SERPINE2;IFI6;APOE;GPSM1;ALS2CL;OAS2;LMF1;HSPA2;EGFR;PKD2;SFRP1;EPHB2;RALGDS;MAP3K14;DGKQ;PIK3R1;EVI5L;DOCK9;CAMKK1;HERC5;VAV3;CSPG4;ELFN2;KITLG;ASAP3;CAMK2N1;CRY2;NOS1;PRKACB;SPDYE6;TBC1D8;PLXNB1;COL7A1;SPOCK1;MDM2;PPP2R2C;CHN2;PIK3IP1;TNFSF10;RAPGEF3;PHACTR3;OAS1;FLRT3;RASA4;RGS2;ACAP3;F2R;PDCD4;SERPINB5;RTN4RL1;AGAP4;ADORA2B;LAMP3;RALGAPA1;MAPK8IP3;SPDYE5;PIDD1;ARHGEF19;UNC119;C5;MINK1;TBC1D19;WWTR1;ASAP2;ITGA2;NAIP;MAP2K5;ITGA6;SRGAP3;INSR;GSN;TTN;CBLC;PLXNB3;RIN1;CD109;ETAA1;ARHGEF1;MGST2;DOCK8;PILRB;SLC27A1;RICTOR;MAP2K2;CEP192;PTK6;SYNGAP1;FAM13A;ARHGAP33;CST3;TXNIP;MAP3K12;WRN;IFI27;ZYG11B;CDK5R1;ARHGAP27;AGAP6;NET1;MAPK10;CYBA;ERCC6;SHC2;SPRY2;GABBR1;AGAP7P;CTSB;FBXW7;GPR87;CDK5RAP3;PAK6;TFPI2;PFKFB2;APC2;ARAP1;ADARB1;ACACB;NLRP1;TBC1D17;NAB2;EPM2AIP1;LRP1;RGS12;MAP3K6;WNK1;LTB4R2;RET;DAB2IP;IFI16;FGFR4;PIK3R2;SNCB;MYO9A;BST2;VDR;PLXND1;PCSK6;TBC1D16;PPP1R2;PPP1R35;SGSM2;LMTK3;DLG4;PPP2R3B;IQSEC1;ACSL1;KAT2B;IRS2;ERN1;RAD50;SCG5;PCSK1N;PRDX5;PHPT1;ERBB2;SPOCD1;ARHGAP23;AKAP6;ATG14;PPARG;PRKACA;SERPING1;PARN;RIPK3;AIP;NPNT;ECM1
17311,GO:0198738,0.49944312249434,0.567279504835893,41,388,cell-cell signaling by wnt,BP,APOE;APCDD1;FBXW4;CAPRIN2;DIXDC1;SFRP1;SULF2;WNT3;PRICKLE2;NFATC4;FERMT1;LZTS2;ARHGEF19;WWTR1;GLI3;NAIP;IGFBP4;CELSR1;CDK14;RTF1;FZD7;NPHP3;AGO4;APC2;FRAT1;GNG2;LRP1;NPHP4;WNK1;DAB2IP;CALCOCO1;RNF213;TNRC6C;NRARP;KREMEN1;IGFBP6;PTK7;TCF7;PLCB3;SMURF1;CTNNBIP1
12680,GO:0050918,0.499462443209941,0.703942634858119,4,36,positive chemotaxis,BP,GPNMB;ITGA2;PLXNB3;VEGFB
6739,GO:0030165,0.499577653130043,0.657546238678898,7,60,PDZ domain binding,MF,SNTA1;BAIAP2;MAP2K2;FZD7;SRR;DLG4;CIT
18775,GO:1904338,0.499605899565686,0.867717635855738,1,6,regulation of dopaminergic neuron differentiation,BP,SFRP1
15263,GO:0071468,0.499612802060161,0.867713416786952,1,6,cellular response to acidic pH,BP,IMPACT
14573,GO:0070142,0.499710920572124,0.867653433368433,1,6,synaptic vesicle budding,BP,DNM1
6931,GO:0030546,0.499822955483341,0.867584920356231,1,6,receptor activator activity,MF,DGKQ
19624,GO:1990845,0.49990613443587,0.867534038515947,1,6,adaptive thermogenesis,BP,TRPV4
4260,GO:0009607,0.500043363387178,0.557800032257053,55,549,response to biotic stimulus,BP,TNFAIP3;ACTA2;OAS2;DDX60;APOBEC3C;TRIM22;IFI44L;MAP3K14;HERC5;VWCE;ISG15;HTRA1;STAT1;NOS1;CMPK2;IFITM1;OAS1;F2R;PDCD4;ADAMTS13;WIPF1;TNFRSF14;LRSAM1;IFI44;BAIAP2;MGST2;DHX58;IRF9;BMP6;NLRX1;LOXL1;HYAL1;PLA2G6;TXNIP;TNFRSF21;CYBA;KLK5;ADARB1;MX2;NLRP1;SRR;ACP5;DAB2IP;IFI16;BST2;VDR;FAM3A;STAT2;CCDC88B;RSAD2;TNFRSF25;IVNS1ABP;TKFC;TH;SERINC3
14204,GO:0061180,0.500352216334579,0.668571430467917,6,52,mammary gland epithelium development,BP,WNT3;GLI2;ETV5;AREG;VDR;STAT6
5485,GO:0016421,0.500480684744061,0.867182223869467,1,6,CoA carboxylase activity,MF,ACACB
7158,GO:0031045,0.5005418951965,0.867144706428221,1,6,dense core granule,CC,SYT7
7574,GO:0031946,0.500753456615719,0.86701498102214,1,6,regulation of glucocorticoid biosynthetic process,BP,DGKQ
6911,GO:0030510,0.500934166187323,0.668229179664451,6,51,regulation of BMP signaling pathway,BP,SFRP1;HTRA1;NEO1;RNF165;PCSK6;SMURF1
2744,GO:0006140,0.501123177610528,0.615236792756355,13,120,regulation of nucleotide metabolic process,BP,PTHLH;APOE;PKD2;NOS1;RAPGEF3;ADORA2B;INSR;NPHP3;GABBR1;MLXIPL;GPR87;PFKFB2;LTB4R2
15988,GO:0086019,0.50119795550585,0.777893509149717,2,15,cell-cell signaling involved in cardiac conduction,BP,KCNJ5;SCN4B
14708,GO:0070383,0.501232916744618,0.863635306093065,1,7,DNA cytosine deamination,BP,APOBEC3C
12132,GO:0048255,0.501373894738984,0.731492649880835,3,25,mRNA stabilization,BP,CIRBP;THRAP3;ANGEL2
4620,GO:0010743,0.501425164382541,0.776659909968188,2,16,regulation of macrophage derived foam cell differentiation,BP,ALOX15B;PPARG
13745,GO:0060343,0.501457071626428,0.777686188899596,2,15,trabecula formation,BP,SFRP1;THBS3
14689,GO:0070341,0.50154143670437,0.866531068559948,1,6,fat cell proliferation,BP,PER2
14691,GO:0070344,0.50154143670437,0.866531068559948,1,6,regulation of fat cell proliferation,BP,PER2
7107,GO:0030915,0.501600635995363,0.863404793582791,1,7,Smc5-Smc6 complex,CC,NSMCE4A
17189,GO:0106068,0.501600635995363,0.863404793582791,1,7,SUMO ligase complex,CC,NSMCE4A
13916,GO:0060602,0.501628948774929,0.777548609321019,2,15,branch elongation of an epithelium,BP,SPRY2;AREG
15345,GO:0071605,0.501672316176841,0.863359829457628,1,7,monocyte chemotactic protein-1 production,BP,TRPV4
15367,GO:0071637,0.501672316176841,0.863359829457628,1,7,regulation of monocyte chemotactic protein-1 production,BP,TRPV4
14716,GO:0070405,0.501747937561785,0.730165238698033,3,27,ammonium ion binding,MF,ESYT2;TH;PLTP
19941,GO:2000535,0.501793958682756,0.866375743864827,1,6,regulation of entry of bacterium into host cell,BP,EXOC2
12949,GO:0051351,0.50208562684431,0.863100374163904,1,7,positive regulation of ligase activity,BP,RIPK3
19601,GO:1990776,0.502094861388567,0.776121749417084,2,16,response to angiotensin,BP,CA2;CYBA
15880,GO:0072673,0.502295949076392,0.777014255631383,2,15,lamellipodium morphogenesis,BP,ARPIN;SNX1
1331,GO:0003188,0.502415534124887,0.865992906317066,1,6,heart valve formation,BP,ZFPM1
3251,GO:0006911,0.502415913900114,0.730588847814483,3,25,phagocytosis, engulfment,BP,ITGA2;GSN;PPARG
7929,GO:0032525,0.502420801161369,0.865989659164504,1,6,somite rostral/caudal axis specification,BP,NRARP
2702,GO:0006068,0.50257151495757,0.862794943091193,1,7,ethanol catabolic process,BP,SULT1E1
8678,GO:0034310,0.50257151495757,0.862794943091193,1,7,primary alcohol catabolic process,BP,SULT1E1
3423,GO:0007212,0.502823828167695,0.729711160024422,3,26,dopamine receptor signaling pathway,BP,NSG1;GNG2;GPR21
5184,GO:0015749,0.502863353428124,0.644584601816073,8,70,monosaccharide transmembrane transport,BP,PIK3R1;CLTCL1;INSR;SLC2A3;SLC2A1;PIK3R2;IRS2;SLC2A11
6371,GO:0021561,0.502896019112681,0.865696470537978,1,6,facial nerve development,BP,ADARB1
6394,GO:0021610,0.502896019112681,0.865696470537978,1,6,facial nerve morphogenesis,BP,ADARB1
7881,GO:0032456,0.502914562993329,0.7015075737631,4,34,endocytic recycling,BP,MICALL1;RAB11FIP4;MICALL2;RAB11FIP3
20084,GO:2000778,0.502975773919932,0.775412756514433,2,16,positive regulation of interleukin-6 secretion,BP,F2R;TRPV4
20093,GO:2000794,0.503123852732573,0.86555575640227,1,6,regulation of epithelial cell proliferation involved in lung morphogenesis,BP,FOXP2
17832,GO:1902043,0.50330493148358,0.776204564740385,2,15,positive regulation of extrinsic apoptotic signaling pathway via death domain receptors,BP,SFRP1;PIDD1
8916,GO:0034773,0.503334292800197,0.865425697963189,1,6,histone H4-K20 trimethylation,BP,KMT5C
981,GO:0002438,0.503459430386717,0.86223563486168,1,7,acute inflammatory response to antigenic stimulus,BP,IL20RB
7967,GO:0032589,0.503510960101961,0.730208833067818,3,24,neuron projection membrane,CC,KCNC4;INSR;EPB41L3
2672,GO:0006024,0.503696690834257,0.635585155498996,9,80,glycosaminoglycan biosynthetic process,BP,CSPG4;SDC3;B4GALT6;HEXA;GPC2;B4GALT2;HYAL1;NDST2;XYLT1
13979,GO:0060716,0.503706441765228,0.774823735278818,2,16,labyrinthine layer blood vessel development,BP,PLCD3;PLCD1
12209,GO:0048483,0.504245132748497,0.729570898295581,3,24,autonomic nervous system development,BP,KIF26A;ADARB1;RET
15754,GO:0072378,0.504302058950036,0.8617034627617,1,7,blood coagulation, fibrin clot formation,BP,SERPING1
379,GO:0001012,0.504753226831651,0.557869577285216,47,436,RNA polymerase II regulatory region DNA binding,MF,HES2;SREBF1;MNT;KDM3A;TFCP2L1;ZFPM1;STAT1;KLF13;NFATC4;HSF4;NDN;GLI2;KLF7;GLI3;BHLHE40;TCFL5;JARID2;ETV5;TCF4;PLAG1;MEF2D;CREBRF;MLXIPL;LMO2;CARF;MXI1;THRA;ELF1;DBP;RFX2;SALL2;ZMYND8;IFI16;TEF;VDR;SIX5;HLTF;TFDP2;KAT2B;STAT6;SOX13;KLF8;RORA;PPARG;FOXP2;ZC3H6;HIVEP1
7780,GO:0032328,0.504908022240582,0.864450435551411,1,6,alanine transport,BP,SLC36A4
14728,GO:0070424,0.505280580512983,0.864218870627107,1,6,regulation of nucleotide-binding oligomerization domain containing signaling pathway,BP,TNFAIP3
15185,GO:0071353,0.505376887614142,0.72748609541349,3,26,cellular response to interleukin-4,BP,ADAMTS13;TCF7;STAT6
19041,GO:1904929,0.505408197031553,0.864139489698086,1,6,coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway,MF,PTK7
870,GO:0002221,0.505475997868754,0.610902138807396,13,122,pattern recognition receptor signaling pathway,BP,TNFAIP3;DDX60;PTPRS;FLOT1;DHX58;NLRX1;CYBA;CTSB;DAB2IP;PIK3C3;RSAD2;TKFC;SMPDL3B
8230,GO:0033010,0.50562971623454,0.864001625504305,1,6,paranodal junction,CC,NFASC
6270,GO:0019869,0.505756899062945,0.86078144588549,1,7,chloride channel inhibitor activity,MF,WNK1
17539,GO:1901142,0.505780400906309,0.863907792586993,1,6,insulin metabolic process,BP,ERN1
12726,GO:0051014,0.505784943511563,0.863904963191683,1,6,actin filament severing,BP,GSN
13860,GO:0060513,0.506059363030298,0.863733966338069,1,6,prostatic bud formation,BP,GLI2
10287,GO:0043065,0.506141743601343,0.555699716196082,48,467,positive regulation of apoptotic process,BP,SIK1;TP53INP1;INPP5D;ALDH1A3;SFRP1;RBCK1;VAV3;PLEKHG5;NFATC4;OBSCN;TNFSF10;F2R;PDCD4;PIDD1;ARHGEF19;ARHGEF4;ITGA6;NUPR1;GSN;PNMA1;ARHGEF1;ENDOG;SQSTM1;PLA2G6;TXNIP;IFI27;CDK5R1;NET1;FBXW7;KCNMA1;ING4;NLRP1;RET;DAB2IP;IL20RA;BTG1;VDR;ARHGEF17;TFDP2;PANO1;ZMAT3;APBB2;ARHGEF9;TNFSF12;PPARG;IP6K2;RIPK3;SERINC3
10964,GO:0044769,0.506273758542681,0.770992803436197,2,18,ATPase activity, coupled to transmembrane movement of ions, rotational mechanism,MF,TCIRG1;ATP6V0A2
11902,GO:0046961,0.506273758542681,0.770992803436197,2,18,proton-transporting ATPase activity, rotational mechanism,MF,TCIRG1;ATP6V0A2
16804,GO:0098711,0.506413645655317,0.863512993720272,1,6,iron ion import across plasma membrane,BP,HFE
14395,GO:0061702,0.50646878053459,0.860328807194643,1,7,inflammasome complex,CC,NLRP1
1529,GO:0003916,0.506539553180094,0.863434405491189,1,6,DNA topoisomerase activity,MF,TOP3B
11757,GO:0046632,0.506657581936452,0.662484767168843,6,53,alpha-beta T cell differentiation,BP,ZFPM1;GLI3;TCF7;RSAD2;STAT6;RORA
9165,GO:0035542,0.506773231246933,0.863288469854139,1,6,regulation of SNARE complex assembly,BP,VPS11
18661,GO:1904029,0.506812253523324,0.640118202895289,8,76,regulation of cyclin-dependent protein kinase activity,BP,TNFAIP3;EGFR;PKD2;HERC5;CAMK2N1;CDK5R1;CDK5RAP3;KAT2B
16527,GO:0097306,0.506854934418524,0.678254636111695,5,41,cellular response to alcohol,BP,TP53INP1;SFRP1;XRN1;GNG2;PPARG
6780,GO:0030223,0.506977733239359,0.86000460098664,1,7,neutrophil differentiation,BP,INPP5D
4621,GO:0010744,0.507013846869032,0.859981577447159,1,7,positive regulation of macrophage derived foam cell differentiation,BP,ALOX15B
19914,GO:2000465,0.507510710270595,0.862827221804227,1,6,regulation of glycogen (starch) synthase activity,BP,EPM2AIP1
6184,GO:0019626,0.507596721004282,0.859609630395896,1,7,short-chain fatty acid catabolic process,BP,ACADS
16373,GO:0097011,0.507645108745054,0.859578723531081,1,7,cellular response to granulocyte macrophage colony-stimulating factor stimulus,BP,ZFP36L2
16374,GO:0097012,0.507645108745054,0.859578723531081,1,7,response to granulocyte macrophage colony-stimulating factor,BP,ZFP36L2
3698,GO:0008206,0.50781975261551,0.725348552388036,3,26,bile acid metabolic process,BP,AMACR;FGFR4;OSBPL1A
6987,GO:0030674,0.507913887529597,0.604602024985053,14,128,protein binding, bridging,MF,TRIM22;OBSL1;PIK3R1;VAV3;VPS11;CHN2;FLRT3;ANK3;BAIAP2;SH2D2A;ARRDC1;FBXW7;RAD50;LDLRAP1
18147,GO:1902931,0.507916067251966,0.859405569941921,1,7,negative regulation of alcohol biosynthetic process,BP,APOE
19112,GO:1905097,0.508059184036707,0.862483513755896,1,6,regulation of guanyl-nucleotide exchange factor activity,BP,GPSM1
15086,GO:0071158,0.508094130097256,0.638787019705691,8,77,positive regulation of cell cycle arrest,BP,PKD2;MDM2;PCBP4;PIDD1;CDK5R1;DAB2IP;TFDP2;PRKACA
10358,GO:0043190,0.50817932036008,0.862408152271585,1,6,ATP-binding cassette (ABC) transporter complex,CC,ABCA2
4060,GO:0009111,0.508210564704189,0.859217213549786,1,7,vitamin catabolic process,BP,CYP26B1
16904,GO:0098903,0.508213433413036,0.862386748149186,1,6,regulation of membrane repolarization during action potential,BP,CACNB3
12760,GO:0051055,0.508261908467089,0.695991596585728,4,36,negative regulation of lipid biosynthetic process,BP,SIK1;APOE;SLC27A1;FBXW7
5546,GO:0016554,0.508286881240636,0.859168375293152,1,7,cytidine to uridine editing,BP,APOBEC3C
20076,GO:2000766,0.50835165728581,0.862299997314347,1,6,negative regulation of cytoplasmic translation,BP,UNK
9659,GO:0038030,0.50841670205228,0.862259161887762,1,6,non-canonical Wnt signaling pathway via MAPK cascade,BP,FZD7
17607,GO:1901339,0.508797724051132,0.862019792240961,1,6,regulation of store-operated calcium channel activity,BP,PLA2G6
15431,GO:0071774,0.508799290397844,0.612299241075092,12,112,response to fibroblast growth factor,BP,POSTN;FAM20C;SFRP1;SULF2;FLRT3;ZFP36L2;FRS3;HYAL1;SPRY2;FGFR4;ZFP36L1;GCLC
11605,GO:0046324,0.5088701569649,0.67610880918352,5,42,regulation of glucose import,BP,PIK3R1;CLTCL1;INSR;PIK3R2;IRS2
11368,GO:0045760,0.508962512826469,0.861916181044457,1,6,positive regulation of action potential,BP,ANK3
8288,GO:0033130,0.509041248903934,0.861866657303371,1,6,acetylcholine receptor binding,MF,DLG4
538,GO:0001657,0.509344394410356,0.648158617669272,7,61,ureteric bud development,BP,PKD2;SFRP1;KIF26B;GLI3;RET;NPNT;CTNNBIP1
8685,GO:0034330,0.509436473599364,0.579212254373167,23,204,cell junction organization,BP,FLNC;SFRP1;TNS1;SDK2;GJD3;F2R;TRPV4;FLOT1;NLGN2;ITGA2;ITGA6;MICALL2;EPB41L3;KRT14;NPHP4;MYO9A;DLG5;DMTN;CD9;MPP7;PRKACA;PARD6G;NFASC
4523,GO:0010591,0.509683447056357,0.724243168754603,3,25,regulation of lamellipodium assembly,BP,PLXNB3;DMTN;SSH3
1320,GO:0003171,0.509775759453766,0.770972598929873,2,15,atrioventricular valve development,BP,ZFPM1;MDM2
11415,GO:0045851,0.509802211068265,0.693985717053369,4,38,pH reduction,BP,TCIRG1;ATP6V0A2;CA2;DMXL2
12546,GO:0050715,0.509951490062273,0.6469934725446,7,65,positive regulation of cytokine secretion,BP,POSTN;FERMT1;F2R;TRPV4;C5;NLRP1;ALOX15B
5637,GO:0016725,0.510111773653241,0.861192138010818,1,6,oxidoreductase activity, acting on CH or CH2 groups,MF,RRM2B
2092,GO:0004859,0.510120886564036,0.855618894313384,1,8,phospholipase inhibitor activity,MF,SNCB
4760,GO:0010942,0.510275757489581,0.549829543067587,51,496,positive regulation of cell death,BP,SIK1;TP53INP1;INPP5D;ALDH1A3;SFRP1;RBCK1;VAV3;PLEKHG5;NFATC4;OBSCN;TNFSF10;PRODH;F2R;PDCD4;PIDD1;ARHGEF19;ARHGEF4;ITGA6;NUPR1;GSN;PNMA1;ARHGEF1;ENDOG;SQSTM1;PLA2G6;TXNIP;IFI27;CDK5R1;NET1;FBXW7;KCNMA1;ING4;NLRP1;LRP1;RET;DAB2IP;IL20RA;BTG1;VDR;ARHGEF17;TFDP2;PANO1;MARK4;ZMAT3;APBB2;ARHGEF9;TNFSF12;PPARG;IP6K2;RIPK3;SERINC3
16016,GO:0086067,0.510301528009782,0.861072348174015,1,6,AV node cell to bundle of His cell communication,BP,SCN4B
11488,GO:0045989,0.51037286568257,0.857829106861669,1,7,positive regulation of striated muscle contraction,BP,RGS2
18083,GO:1902743,0.510461100850462,0.694671323088459,4,34,regulation of lamellipodium organization,BP,ARPIN;PLXNB3;DMTN;SSH3
6269,GO:0019867,0.510577468007425,0.591576554851763,17,164,outer membrane,CC,BPHL;SPATA18;SNN;ITPR3;FAM210B;SLC24A1;ULK1;NLRX1;IFI27;ACACB;PDE2A;RETSAT;LETMD1;RSAD2;ACSL1;CPT1C;SYNE2
12639,GO:0050863,0.510590359410645,0.58623880833806,19,182,regulation of T cell activation,BP,GPNMB;MAP3K14;PIK3R1;CYP26B1;IL20RB;GLI2;TNFRSF14;GLI3;GSN;DOCK8;TNFRSF21;EFNB3;HFE;DLG5;NRARP;CCDC88B;SOX13;ERBB2;RIPK3
7935,GO:0032534,0.510597904604744,0.86088511081864,1,6,regulation of microvillus assembly,BP,PODXL
6790,GO:0030238,0.510624828989728,0.860868092867499,1,6,male sex determination,BP,INSR
3798,GO:0008378,0.510727535379537,0.722793307740396,3,26,galactosyltransferase activity,MF,B4GALT6;B4GALT2;B3GNT9
14449,GO:0061844,0.510757860337838,0.762713103256956,2,27,antimicrobial humoral immune response mediated by antimicrobial peptide,BP,KLK5;FAM3A
6787,GO:0030234,0.51090467281659,0.538920191685443,76,734,enzyme regulator activity,MF,SERPINE2;APOE;GPSM1;ALS2CL;EGFR;RALGDS;DGKQ;PIK3R1;EVI5L;VAV3;ELFN2;ASAP3;CAMK2N1;TBC1D8;PLXNB1;COL7A1;SPOCK1;PPP2R2C;CHN2;PHACTR3;FLRT3;RASA4;RGS2;ACAP3;SERPINB5;RTN4RL1;AGAP4;RALGAPA1;ARHGEF19;C5;TBC1D19;ASAP2;NAIP;SRGAP3;RIN1;CD109;ETAA1;ARHGEF1;MGST2;RICTOR;MAP2K2;SYNGAP1;FAM13A;ARHGAP33;CST3;TXNIP;CDK5R1;ARHGAP27;AGAP6;ERCC6;SPRY2;AGAP7P;FBXW7;TFPI2;ARAP1;NLRP1;TBC1D17;RGS12;APPL2;WNK1;DAB2IP;PIK3R2;SNCB;MYO9A;BST2;TBC1D16;PPP1R2;PPP1R35;SGSM2;PPP2R3B;KAT2B;SCG5;PCSK1N;PRDX5;ARHGAP23;SERPING1
389,GO:0001042,0.510991826427673,0.860635988044768,1,6,RNA polymerase I core binding,MF,ERBB2
8292,GO:0033135,0.511069298892375,0.628106811327332,9,84,regulation of peptidyl-serine phosphorylation,BP,EGFR;CAPRIN2;RAPGEF3;RICTOR;SPRY2;MLXIPL;RET;DMTN;IL11
9187,GO:0035581,0.511119963373413,0.86055488790395,1,6,sequestering of extracellular ligand from receptor,BP,LTBP1
5396,GO:0016235,0.511172811389382,0.6940229399808,4,34,aggresome,CC,TRIM66;SQSTM1;KLF8;SYNE2
14610,GO:0070201,0.511400898131285,0.547173544108159,54,513,regulation of establishment of protein localization,BP,POSTN;SREBF1;EGFR;SFRP1;GLUD1;FERMT1;VPS11;ITPR3;MDM2;RAPGEF3;F2R;HPS4;TRPV4;NLGN2;ANK3;RHBDF1;PER2;C5;GLI3;VAMP2;NMU;TTN;TM7SF3;BMP6;MICALL2;PLA2G6;IDH2;IFI27;OSCP1;TNFRSF21;CDK5R1;HADH;RAB11FIP3;FBXW7;PFKFB2;RPH3AL;SLC2A1;NLRP1;GLUL;LRP1;PDE2A;PIK3C3;SYT7;DMTN;TFDP2;RSAD2;IRS2;ANO1;ALOX15B;PHPT1;ERBB2;GPR68;KCNS3;PEMT
15316,GO:0071559,0.511659743848728,0.587976906244599,18,166,response to transforming growth factor beta,BP,POSTN;MXRA5;SFRP1;HTRA1;ITGB5;FERMT1;LTBP4;ZFP36L2;FNDC4;LTBP1;CD109;GDF15;PDE2A;STK16;ZFP36L1;PBLD;SMURF1;NPNT
16573,GO:0097413,0.5117143987217,0.85696334654175,1,7,Lewy body,CC,SQSTM1
11191,GO:0045335,0.511881382190671,0.61433968265647,11,105,phagocytic vesicle,CC,VAMP3;ITGB5;RAB43;HLA-B;GSN;TCIRG1;ATP6V0A2;CYBA;HLA-A;PIK3C3;SYT7
18282,GO:1903214,0.511917060659008,0.644855745676158,7,67,regulation of protein targeting to mitochondrion,BP,SREBF1;VPS11;HPS4;MICALL2;OSCP1;FBXW7;PEMT
14636,GO:0070255,0.511943038483021,0.856815444839673,1,7,regulation of mucus secretion,BP,CYBA
6905,GO:0030502,0.512047077944559,0.859967160826174,1,6,negative regulation of bone mineralization,BP,ECM1
8011,GO:0032652,0.512444452508528,0.671570758783882,5,47,regulation of interleukin-1 production,BP,TNFAIP3;F2R;NLRP1;ACP5;IFI16
5605,GO:0016651,0.512789166165505,0.642381633308153,7,83,oxidoreductase activity, acting on NAD(P)H,MF,TXNRD3;NOS1;CYBA;NDUFV3;DUOX1;DHRS4;CBR4
5196,GO:0015791,0.512969050961412,0.859381052839087,1,6,polyol transport,BP,PGAP1
8201,GO:0032964,0.513147448321251,0.720657729312801,3,26,collagen biosynthetic process,BP,F2R;ITGA2;PPARG
5855,GO:0017157,0.513377829922562,0.603254714732729,13,121,regulation of exocytosis,BP,SYT8;SYN1;RAB40B;SYTL1;C2CD4C;ADORA2B;RIMS3;SYT15;VAMP2;PLA2G6;SEPT5;RPH3AL;SYT7
14486,GO:0062014,0.513391089012759,0.643716425025022,7,65,negative regulation of small molecule metabolic process,BP,SIK1;APOE;GABBR1;MLXIPL;GPR87;ACACB;LTB4R2
19131,GO:1905165,0.51345799672931,0.859069559854579,1,6,regulation of lysosomal protein catabolic process,BP,LRP1
14200,GO:0061162,0.513529276401993,0.767906411329891,2,15,establishment of monopolar cell polarity,BP,MYO9A;PTK7
14247,GO:0061339,0.513529276401993,0.767906411329891,2,15,establishment or maintenance of monopolar cell polarity,BP,MYO9A;PTK7
5092,GO:0015368,0.513613147243971,0.858970621572471,1,6,calcium:cation antiporter activity,MF,SLC24A1
16383,GO:0097027,0.513768619377619,0.855630867219226,1,7,ubiquitin-protein transferase activator activity,MF,FBXW7
742,GO:0001974,0.513966407307094,0.720468785328937,3,25,blood vessel remodeling,BP,HOXA3;MDM2;CST3
1658,GO:0004115,0.514161058492282,0.858620850640618,1,6,3',5'-cyclic-AMP phosphodiesterase activity,MF,PDE2A
3919,GO:0008593,0.514217555803073,0.633361358380757,8,73,regulation of Notch signaling pathway,BP,POSTN;EGFR;MAML3;ARRDC1;FBXW7;DLK2;NRARP;KAT2B
5219,GO:0015824,0.514373759377813,0.858484912041302,1,6,proline transport,BP,SLC36A4
2840,GO:0006309,0.5145603696603,0.765019560853641,2,17,apoptotic DNA fragmentation,BP,H1F0;ENDOG
6298,GO:0019919,0.514648026074918,0.855057918424021,1,7,peptidyl-arginine methylation, to asymmetrical-dimethyl arginine,BP,PRMT3
9018,GO:0035242,0.514648026074918,0.855057918424021,1,7,protein-arginine omega-N asymmetric methyltransferase activity,MF,PRMT3
17514,GO:1901031,0.514651055422909,0.718832796468639,3,27,regulation of response to reactive oxygen species,BP,SESN3;ENDOG;SESN1
185,GO:0000403,0.514916687693005,0.858137525790649,1,6,Y-form DNA binding,MF,WRN
13151,GO:0051770,0.515173059924598,0.857973290568997,1,6,positive regulation of nitric-oxide synthase biosynthetic process,BP,STAT1
13646,GO:0060191,0.515376609859045,0.669283679069885,5,45,regulation of lipase activity,BP,LMF1;EGFR;RGS2;LRP1;PCSK6
13955,GO:0060687,0.51543484155738,0.857805458527792,1,6,regulation of branching involved in prostate gland morphogenesis,BP,SFRP1
13589,GO:0060081,0.515597223621834,0.854437800578569,1,7,membrane hyperpolarization,BP,CRTC1
10214,GO:0042908,0.515674062310752,0.857651974341343,1,6,xenobiotic transport,BP,SLC2A1
10215,GO:0042910,0.515674062310752,0.857651974341343,1,6,xenobiotic transmembrane transporter activity,MF,SLC2A1
3045,GO:0006600,0.516281860559274,0.853989424996476,1,7,creatine metabolic process,BP,GAMT
9987,GO:0042416,0.516318584308603,0.853965348231761,1,7,dopamine biosynthetic process,BP,TH
8464,GO:0033619,0.516353021800831,0.653151330722663,6,54,membrane protein proteolysis,BP,APOE;ADAM19;SPPL2B;RET;PTPN3;SNX33
4853,GO:0014068,0.516405358384376,0.68888143669426,4,35,positive regulation of phosphatidylinositol 3-kinase signaling,BP,UNC5B;PLXNB1;F2R;RGL2
8595,GO:0034115,0.516470178222764,0.853865932402926,1,7,negative regulation of heterotypic cell-cell adhesion,BP,MAP2K5
14822,GO:0070587,0.516470178222764,0.853865932402926,1,7,regulation of cell-cell adhesion involved in gastrulation,BP,MAP2K5
18316,GO:1903299,0.516525551895207,0.85382960688786,1,7,regulation of hexokinase activity,BP,PFKFB2
18964,GO:1904779,0.516672579998587,0.857010124479876,1,6,regulation of protein localization to centrosome,BP,CEP250
6494,GO:0021861,0.516869786038513,0.853603651602824,1,7,forebrain radial glial cell differentiation,BP,GLI3
13476,GO:0055062,0.517328197661056,0.856587636847785,1,6,phosphate ion homeostasis,BP,FGFR4
15787,GO:0072505,0.517328197661056,0.856587636847785,1,6,divalent inorganic anion homeostasis,BP,FGFR4
15788,GO:0072506,0.517328197661056,0.856587636847785,1,6,trivalent inorganic anion homeostasis,BP,FGFR4
1471,GO:0003730,0.517448159227047,0.652111870951814,6,54,mRNA 3'-UTR binding,MF,CIRBP;PCBP4;ZFP36L2;ZFP36L1;ANGEL2;PARN
3669,GO:0008168,0.517467153890009,0.581951333681455,18,175,methyltransferase activity,MF,GAMT;ASH2L;NSUN7;NSUN5P2;METTL23;FAM86C2P;TARBP1;METTL21A;SETD4;PCMTD2;PCMTD1;DYDC1;AMT;METTL7A;MTR;KMT5C;PRMT3;PEMT
10684,GO:0043983,0.517767787433366,0.853013105336243,1,7,histone H4-K12 acetylation,BP,ING4
3368,GO:0007131,0.517790222426595,0.687273427871439,4,36,reciprocal meiotic recombination,BP,MLH3;REC8;RAD50;MSH5
9327,GO:0035825,0.517790222426595,0.687273427871439,4,36,homologous recombination,BP,MLH3;REC8;RAD50;MSH5
3652,GO:0008134,0.518076677168867,0.541036246745563,53,504,transcription factor binding,MF,HES2;SIK1;GPX3;DGKQ;PIK3R1;KDM3A;TSC22D3;ZFPM1;STAT1;CRY1;NFATC4;CRTC1;GLI2;PER2;THRAP3;SMARCA1;BHLHE40;JARID2;BAIAP2;KDM4C;HYAL1;METTL23;BBS2;TCF4;RCOR2;IFI27;MEF2D;MLXIPL;CDK5RAP3;LMO2;THRA;IKZF4;NAB2;BBS1;ZMYND8;TEAD2;IFI16;BBS5;APBB3;VDR;BBS10;TFDP2;KAT2B;TRERF1;APBB2;CHD6;HDAC11;RORA;PPARG;CXXC5;AIP;PER3;FOXP2
11587,GO:0046209,0.518079555523944,0.666750338566247,5,45,nitric oxide metabolic process,BP,PKD2;NOS1;INSR;ACP5;RORA
6289,GO:0019903,0.518160128695519,0.608581024408567,11,100,protein phosphatase binding,MF,EGFR;PIK3R1;STAT1;PHACTR3;DAB2IP;PIK3R2;DLG4;IRS2;STAT6;ERBB2;PPARG
5204,GO:0015804,0.518806180164356,0.715631631479282,3,26,neutral amino acid transport,BP,SLC36A4;SLC43A1;SERINC3
19751,GO:2000181,0.518978711942098,0.638963461776415,7,61,negative regulation of blood vessel morphogenesis,BP,STAT1;ADGRB2;MAP2K5;MMRN2;SPRY2;DAB2IP;PPARG
9872,GO:0042158,0.519089631002092,0.607052790298058,11,109,lipoprotein biosynthetic process,BP,APOE;ZDHHC1;RTN4RL1;CD109;PGAP1;ZDHHC12;PIGZ;PIK3C3;MPPE1;GOLGA7B;ZDHHC24
5523,GO:0016500,0.519296028565375,0.855314507770221,1,6,protein-hormone receptor activity,MF,INSR
15974,GO:0086005,0.519418382745037,0.763048994835418,2,15,ventricular cardiac muscle cell action potential,BP,SNTA1;KCNJ5
4536,GO:0010612,0.519612808452431,0.855108852770803,1,6,regulation of cardiac muscle adaptation,BP,LMNA
18293,GO:1903242,0.519612808452431,0.855108852770803,1,6,regulation of cardiac muscle hypertrophy in response to stress,BP,LMNA
19886,GO:2000403,0.519785503238057,0.760676623675539,2,17,positive regulation of lymphocyte migration,BP,CXCL14;DOCK8
4515,GO:0010571,0.519832262116262,0.854966267116659,1,6,positive regulation of nuclear cell cycle DNA replication,BP,ATRX
10658,GO:0043903,0.520022150117943,0.579302069469627,18,179,regulation of symbiosis, encompassing mutualism through parasitism,BP,APOE;OAS2;APOBEC3C;ISG15;MVB12B;STAT1;IFITM1;OAS1;LAMP3;GSN;SQSTM1;TRIM38;ADARB1;IFI16;EXOC2;BST2;RSAD2;NELFCD
13491,GO:0055083,0.52007805438123,0.762501316191331,2,15,monovalent inorganic anion homeostasis,BP,SLC12A7;FGFR4
13663,GO:0060219,0.520172974395435,0.854744708959269,1,6,camera-type eye photoreceptor cell differentiation,BP,SDK2
11338,GO:0045687,0.520178936953716,0.714405507934654,3,26,positive regulation of glial cell differentiation,BP,SERPINE2;TENM4;PPARG
2253,GO:0005168,0.520680165362515,0.854414471114563,1,6,neurotrophin TRKA receptor binding,MF,PIK3R1
4251,GO:0009566,0.520744205875721,0.636402739337783,7,67,fertilization,BP,SYT8;LHFPL2;HEXB;REC8;CCDC136;CD9;GLIPR1L2
8134,GO:0032869,0.520762578113965,0.581758810931787,17,158,cellular response to insulin stimulus,BP,SREBF1;SRSF5;PIK3R1;STAT1;VAMP2;SESN3;INSR;BAIAP2;TCIRG1;ATP6V0A2;PIK3R2;ZFP36L1;KAT2B;IRS2;GPR21;PPARG;GCLC
14540,GO:0070087,0.520944675127553,0.854242045280053,1,6,chromo shadow domain binding,MF,ATRX
14033,GO:0060828,0.520988183386663,0.573489544122344,20,195,regulation of canonical Wnt signaling pathway,BP,APOE;CAPRIN2;DIXDC1;SFRP1;SULF2;FERMT1;LZTS2;WWTR1;GLI3;NAIP;IGFBP4;CDK14;NPHP3;APC2;NPHP4;WNK1;DAB2IP;NRARP;KREMEN1;IGFBP6
17259,GO:0140029,0.521365761147214,0.648026204248313,6,56,exocytic process,BP,VAMP3;RAB40B;VPS11;SEPT5;EXOC2;DMTN
1401,GO:0003337,0.521387220283314,0.850616725410039,1,7,mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,STAT1
17586,GO:1901293,0.521479940374823,0.564952017031146,24,236,nucleoside phosphate biosynthetic process,BP,PTHLH;APOE;DHTKD1;NAPRT;NOS1;CMPK2;NMRK1;ADORA2B;INSR;TCIRG1;ATP6V0A2;IDH2;RRM2B;GABBR1;MLXIPL;GPR87;PGM1;PFKFB2;OGDHL;TK2;PPCS;LTB4R2;NADK;UCKL1
12256,GO:0048568,0.521485014516187,0.557629259180647,29,269,embryonic organ development,BP,EGFR;PKD2;ALDH1A3;LRIG3;PLCD3;SLITRK6;EPHB2;ZFPM1;KITLG;HOXA3;NAGLU;PLCD1;GLI2;GLI3;CELSR1;TRIOBP;HYAL1;NPHP3;SPRY2;IFT140;MYO3B;TEAD2;BBS5;PALB2;PTK7;TCF7;ZFP36L1;GJB5;TH
8984,GO:0035112,0.521551862843347,0.853845717706003,1,6,genitalia morphogenesis,BP,TCF7
16321,GO:0090594,0.521656168629666,0.850437620775119,1,7,inflammatory response to wounding,BP,F2R
9795,GO:0040034,0.522006919397809,0.850203823934278,1,7,regulation of development, heterochronic,BP,SERPINE2
5097,GO:0015377,0.52238291992207,0.853302087670826,1,6,cation:chloride symporter activity,MF,SLC12A7
5099,GO:0015379,0.52238291992207,0.853302087670826,1,6,potassium:chloride symporter activity,MF,SLC12A7
11808,GO:0046719,0.522912819901503,0.849598851369061,1,7,regulation by virus of viral protein levels in host cell,BP,STAT1
194,GO:0000413,0.522960683992776,0.710118038039046,3,30,protein peptidyl-prolyl isomerization,BP,FKBP5;FKBP9;NKTR
1476,GO:0003755,0.522960683992776,0.710118038039046,3,30,peptidyl-prolyl cis-trans isomerase activity,MF,FKBP5;FKBP9;NKTR
11399,GO:0045823,0.523301383647218,0.757728902617102,2,17,positive regulation of heart contraction,BP,RGS2;NMU
11391,GO:0045807,0.523359998750304,0.616293855970033,9,83,positive regulation of endocytosis,BP,APOE;FLOT1;ITGA2;HFE;CYBA;LRP1;TUB;PPARG;LDLRAP1
15551,GO:0072033,0.523429965146275,0.85261523024898,1,6,renal vesicle formation,BP,KIF26B
18050,GO:1902652,0.52363613319429,0.60293107100615,11,104,secondary alcohol metabolic process,BP,SREBF1;APOE;LMF1;SEC14L2;DGKQ;MVD;ACACB;OSBPL5;OSBPL1A;TRERF1;LDLRAP1
5590,GO:0016620,0.52383382304953,0.71112794650425,3,26,oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor,MF,ALDH1A3;ALDH4A1;ALDH7A1
4630,GO:0010755,0.524744550828921,0.848370587127567,1,7,regulation of plasminogen activation,BP,SERPINE2
17906,GO:1902254,0.524760783472379,0.755637568707726,2,18,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator,BP,MDM2;RRM2B
8942,GO:0035005,0.524776440244135,0.851728759738017,1,6,1-phosphatidylinositol-4-phosphate 3-kinase activity,MF,PIK3C2G
5508,GO:0016461,0.525089888883156,0.848138268312855,1,7,unconventional myosin complex,CC,MYO9A
3445,GO:0007256,0.525252147830957,0.851414711511434,1,6,activation of JNKK activity,BP,ERCC6
13010,GO:0051480,0.525328266931435,0.583605433646334,15,141,regulation of cytosolic calcium ion concentration,BP,PKD2;NOS1;ITPR3;F2R;TRPV4;GSTM2;NMU;PLA2G6;CYBA;JPH2;CACNB3;LPAR6;DLG4;AKAP6;PRKACA
6582,GO:0022600,0.525336975536822,0.68062636138411,4,35,digestive system process,BP,NMU;WNK1;VDR;PBLD
802,GO:0002072,0.525421307738179,0.851302928742004,1,6,optic cup morphogenesis involved in camera-type eye development,BP,ALDH1A3
7056,GO:0030851,0.525538088872244,0.755842925853796,2,17,granulocyte differentiation,BP,INPP5D;ZFPM1
17778,GO:1901890,0.525859644007035,0.709851516124045,3,25,positive regulation of cell junction assembly,BP,SFRP1;FLOT1;NPHP4
3770,GO:0008324,0.526090598848947,0.549220567620334,32,306,cation transmembrane transporter activity,MF,PKD2;ORAI3;KCNAB2;KCNJ15;KCNC4;ITPR3;NDUFA4L2;TMEM63C;SLC24A1;TRPV4;SLC13A5;KCNJ5;SCNN1A;SCN4B;NIPAL2;TCIRG1;SLC12A7;ATP6V0A2;KCNMA1;KCNG1;JPH2;PDE2A;SHROOM2;SCN2A;CACNB3;ORAI2;SLC36A4;ANO1;CACNB1;KCNS3;CALHM2;SERINC3
5289,GO:0015959,0.526142024666335,0.847428990063065,1,7,diadenosine polyphosphate metabolic process,BP,NUDT10
15303,GO:0071542,0.526330578246183,0.756153306811119,2,16,dopaminergic neuron differentiation,BP,SFRP1;WNT3
13783,GO:0060394,0.526629141890394,0.847099854833153,1,7,negative regulation of pathway-restricted SMAD protein phosphorylation,BP,PBLD
8151,GO:0032890,0.526940767975325,0.708326751998388,3,26,regulation of organic acid transport,BP,PER2;PLA2G6;IRS2
15971,GO:0086002,0.526975608227868,0.709444113382673,3,24,cardiac muscle cell action potential involved in contraction,BP,SNTA1;KCNJ5;SCN4B
5027,GO:0015194,0.527071331660351,0.846800662285861,1,7,L-serine transmembrane transporter activity,MF,SERINC3
5220,GO:0015825,0.527071331660351,0.846800662285861,1,7,L-serine transport,BP,SERINC3
6623,GO:0022889,0.527071331660351,0.846800662285861,1,7,serine transmembrane transporter activity,MF,SERINC3
8135,GO:0032870,0.527252972852455,0.533557686503587,50,471,cellular response to hormone stimulus,BP,SIK1;SREBF1;EGFR;SRSF5;SFRP1;PIK3R1;KDM3A;STAT1;CRY2;PRKACB;CRY1;MDM2;FAM210B;ZFP36L2;ITGA2;THRAP3;VAMP2;SESN3;INSR;BAIAP2;SLC27A1;TCIRG1;BBS2;ATP6V0A2;CDK5R1;CA2;CYBA;SLIT3;CREBRF;CTSB;LMO2;PAQR6;THRA;GNG2;CALCOCO1;PIK3R2;VDR;UCN2;ZFP36L1;ACSL1;KAT2B;IRS2;GPR21;PAQR7;RORA;PPARG;PRKACA;UFL1;KLF9;GCLC
18741,GO:1904251,0.527546497702999,0.84647871793563,1,7,regulation of bile acid metabolic process,BP,FGFR4
6788,GO:0030235,0.527548893711679,0.846477093391161,1,7,nitric-oxide synthase regulator activity,MF,EGFR
12840,GO:0051180,0.52765070608305,0.754053892303479,2,17,vitamin transport,BP,SLC2A3;SLC2A1
10362,GO:0043197,0.527665421916228,0.599264213876743,11,100,dendritic spine,CC,NOS1;LZTS1;BAIAP2;DNM1;CDK5R1;SHANK3;FBXO2;ZMYND8;ARFGEF2;DLG4;SHANK2
16563,GO:0097384,0.527682308117423,0.846386617111109,1,7,cellular lipid biosynthetic process,BP,PEX7
17425,GO:1900223,0.527786995833633,0.849733684634763,1,6,positive regulation of amyloid-beta clearance,BP,LRP1
14645,GO:0070268,0.527852667378648,0.62893179300797,7,72,cornification,BP,KRT15;CYP26B1;PPL;CASP14;KRT14;KLK5;PCSK6
12652,GO:0050879,0.527894340158581,0.707464244485794,3,26,multicellular organismal movement,BP,GAA;GSTM2;TNNI2
12654,GO:0050881,0.527894340158581,0.707464244485794,3,26,musculoskeletal movement,BP,GAA;GSTM2;TNNI2
10571,GO:0043549,0.528221461744451,0.524335909224803,68,641,regulation of kinase activity,BP,TNFAIP3;APOE;EGFR;PKD2;SFRP1;EPHB2;MAP3K14;DGKQ;PIK3R1;CAMKK1;HERC5;VAV3;CSPG4;KITLG;CAMK2N1;PRKACB;SPDYE6;PIK3IP1;FLRT3;RGS2;F2R;PDCD4;RTN4RL1;ADORA2B;MAPK8IP3;SPDYE5;UNC119;C5;MINK1;WWTR1;MAP2K5;INSR;TTN;CBLC;ETAA1;PILRB;SLC27A1;RICTOR;MAP2K2;PTK6;MAP3K12;CDK5R1;MAPK10;ERCC6;SHC2;SPRY2;FBXW7;CDK5RAP3;PAK6;PFKFB2;ADARB1;NAB2;MAP3K6;WNK1;RET;DAB2IP;FGFR4;PIK3R2;DLG4;ACSL1;KAT2B;IRS2;ERN1;RAD50;ERBB2;ATG14;PRKACA;RIPK3
7747,GO:0032271,0.528253159047352,0.57723459574187,16,153,regulation of protein polymerization,BP,EPS8L2;RGS2;ARPIN;SPTB;WIPF1;FHOD3;GSN;BAIAP2;TRIOBP;RICTOR;WHAMMP3;CDK5R1;WASH3P;CAPG;DMTN;EML2
7417,GO:0031526,0.528786434780736,0.707207742215828,3,25,brush border membrane,CC,CYBRD1;SHANK2;PEMT
4634,GO:0010759,0.528813764864058,0.845617862340433,1,7,positive regulation of macrophage chemotaxis,BP,TRPV4
10075,GO:0042589,0.528936509311846,0.845534309338266,1,7,zymogen granule membrane,CC,VAMP2
5057,GO:0015269,0.529030862061886,0.845470062016561,1,7,calcium-activated potassium channel activity,MF,KCNMA1
9838,GO:0042095,0.529205152647893,0.845351335430859,1,7,interferon-gamma biosynthetic process,BP,ZFPM1
23,GO:0000045,0.529594929545292,0.610104185598843,9,84,autophagosome assembly,BP,ULK2;TP53INP1;ATG16L2;ULK1;LRSAM1;SYNPO2;PIK3C3;ATG14;SMURF1
381,GO:0001016,0.529746493816982,0.84498218156657,1,7,RNA polymerase III regulatory region DNA binding,MF,PRDX5
11083,GO:0045109,0.529970008927678,0.753070580246975,2,16,intermediate filament organization,BP,KLHL24;KRT14
4930,GO:0014889,0.530228254967481,0.844653156586108,1,7,muscle atrophy,BP,GSN
10850,GO:0044381,0.530474642491025,0.753773831356512,2,15,glucose import in response to insulin stimulus,BP,PIK3R1;PIK3R2
20271,GO:2001273,0.530474642491025,0.753773831356512,2,15,regulation of glucose import in response to insulin stimulus,BP,PIK3R1;PIK3R2
3123,GO:0006703,0.530489107298863,0.841912539769366,1,8,estrogen biosynthetic process,BP,HSD17B14
7997,GO:0032633,0.530671061641563,0.751483133619184,2,17,interleukin-4 production,BP,ZFPM1;IL20RB
11680,GO:0046485,0.530806242741917,0.844257789975441,1,7,ether lipid metabolic process,BP,PEX7
8051,GO:0032728,0.531140037597975,0.704518705362097,3,26,positive regulation of interferon-beta production,BP,RNF135;FLOT1;ZBTB20
15415,GO:0071711,0.531469048331963,0.752929553921921,2,15,basement membrane organization,BP,FERMT1;NID1
14064,GO:0060911,0.531478775254264,0.843796895211812,1,7,cardiac cell fate commitment,BP,TENM4
11418,GO:0045860,0.531795248762297,0.536668158428646,39,371,positive regulation of protein kinase activity,BP,EGFR;PKD2;MAP3K14;DGKQ;CAMKK1;CSPG4;KITLG;PRKACB;F2R;ADORA2B;MAPK8IP3;UNC119;C5;MINK1;MAP2K5;INSR;ETAA1;PILRB;SLC27A1;RICTOR;MAP2K2;MAP3K12;CDK5R1;MAPK10;ERCC6;SHC2;SPRY2;FBXW7;PAK6;NAB2;MAP3K6;WNK1;DAB2IP;DLG4;ACSL1;ERN1;ERBB2;PRKACA;RIPK3
15629,GO:0072163,0.531831268379693,0.626395856008616,7,62,mesonephric epithelium development,BP,PKD2;SFRP1;KIF26B;GLI3;RET;NPNT;CTNNBIP1
15630,GO:0072164,0.531831268379693,0.626395856008616,7,62,mesonephric tubule development,BP,PKD2;SFRP1;KIF26B;GLI3;RET;NPNT;CTNNBIP1
6120,GO:0019371,0.531841136231503,0.843548182700585,1,7,cyclooxygenase pathway,BP,PTGS1
13756,GO:0060363,0.531911045504079,0.843500168478131,1,7,cranial suture morphogenesis,BP,GLI3
9604,GO:0036480,0.532147499043438,0.843337696491123,1,7,neuron intrinsic apoptotic signaling pathway in response to oxidative stress,BP,FBXW7
18352,GO:1903376,0.532147499043438,0.843337696491123,1,7,regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,BP,FBXW7
7061,GO:0030856,0.532337722407142,0.600489394542855,10,93,regulation of epithelial cell differentiation,BP,STAT1;CTSV;WWTR1;CD109;BMP6;BTG1;VDR;ZFP36L1;APOLD1;ALOX15B
17552,GO:1901186,0.532394698162526,0.702864707463307,3,27,positive regulation of ERBB signaling pathway,BP,PTK6;FBXW7;ARAP1
8470,GO:0033628,0.532478420275119,0.702788294080319,3,27,regulation of cell adhesion mediated by integrin,BP,FERMT1;PODXL;RET
15267,GO:0071474,0.532581624865049,0.843039102655179,1,7,cellular hyperosmotic response,BP,SLC2A1
11816,GO:0046777,0.532584899346469,0.564765469022207,19,172,protein autophosphorylation,BP,ULK2;GPNMB;SIK1;EGFR;IMPACT;MINK1;ULK1;INSR;MAP2K2;PTK6;MAP3K12;WNK1;STK16;FGFR4;ACVR1B;ERN1;RAD50;ERBB2;RIPK3
9196,GO:0035590,0.532629113391687,0.84300641645348,1,7,purinergic nucleotide receptor signaling pathway,BP,GPR87
15724,GO:0072330,0.532771459560541,0.559589175832733,21,203,monocarboxylic acid biosynthetic process,BP,AMACR;ALDH1A3;DHTKD1;CSPG4;THNSL2;MLYCD;PER2;PTGS1;INSR;MLXIPL;PGM1;PFKFB2;ACACB;OGDHL;SRR;FGFR4;OSBPL1A;ALOXE3;ALOX15B;CBR4;ACSS2
3005,GO:0006551,0.533009722422039,0.842744277881232,1,7,leucine metabolic process,BP,HMGCL
7473,GO:0031645,0.5331517665978,0.842646371225271,1,7,negative regulation of neurological system process,BP,TNFRSF21
9732,GO:0038203,0.533199713285645,0.842613313737637,1,7,TORC2 signaling,BP,SESN3
13588,GO:0060080,0.533364086470071,0.845989801295006,1,6,inhibitory postsynaptic potential,BP,NLGN2
16448,GO:0097151,0.533364086470071,0.845989801295006,1,6,positive regulation of inhibitory postsynaptic potential,BP,NLGN2
16865,GO:0098828,0.533364086470071,0.845989801295006,1,6,modulation of inhibitory postsynaptic potential,BP,NLGN2
18591,GO:1903896,0.53402106874283,0.842046287929635,1,7,positive regulation of IRE1-mediated unfolded protein response,BP,DAB2IP
16122,GO:0090154,0.53411280467764,0.841982871834371,1,7,positive regulation of sphingolipid biosynthetic process,BP,PLA2G6
19816,GO:2000304,0.53411280467764,0.841982871834371,1,7,positive regulation of ceramide biosynthetic process,BP,PLA2G6
14290,GO:0061450,0.534169228297258,0.83934663987973,1,8,trophoblast cell migration,BP,ACVR1B
17546,GO:1901163,0.534169228297258,0.83934663987973,1,8,regulation of trophoblast cell migration,BP,ACVR1B
4302,GO:0009755,0.534178791261137,0.568437845209363,17,158,hormone-mediated signaling pathway,BP,SFRP1;KDM3A;CRY2;CRY1;THRAP3;SLC27A1;CREBRF;PAQR6;THRA;CALCOCO1;VDR;UCN2;ACSL1;PAQR7;RORA;PPARG;UFL1
13945,GO:0060674,0.534195219326135,0.70173217482638,3,26,placenta blood vessel development,BP,PKD2;PLCD3;PLCD1
9409,GO:0035987,0.534282283310069,0.67262296570072,4,34,endodermal cell differentiation,BP,ITGB5;COL7A1;RTF1;COL6A1
1663,GO:0004126,0.534303833472744,0.839252259814823,1,8,cytidine deaminase activity,MF,APOBEC3C
4091,GO:0009147,0.534326588344284,0.745984264189238,2,20,pyrimidine nucleoside triphosphate metabolic process,BP,CMPK2;UCKL1
10135,GO:0042726,0.534620098204171,0.841631873286467,1,7,flavin-containing compound metabolic process,BP,ACP5
8650,GO:0034219,0.534863155813447,0.61344032339527,8,72,carbohydrate transmembrane transport,BP,PIK3R1;CLTCL1;INSR;SLC2A3;SLC2A1;PIK3R2;IRS2;SLC2A11
324,GO:0000910,0.535136409335423,0.573913954126482,15,140,cytokinesis,BP,CUL7;OR2A4;RHOBTB2;ANK3;UNC119;NAIP;SEPT6;RAB11FIP4;SEPT5;RAB11FIP3;PAK6;PIK3C3;TTC19;SNX33;CIT
9936,GO:0042308,0.535228740930845,0.841210053158128,1,7,negative regulation of protein import into nucleus,BP,PDE2A
18880,GO:1904590,0.535228740930845,0.841210053158128,1,7,negative regulation of protein import,BP,PDE2A
8596,GO:0034116,0.535565884140609,0.840976067996708,1,7,positive regulation of heterotypic cell-cell adhesion,BP,FLOT1
14168,GO:0061097,0.535624119929827,0.634311691355044,6,56,regulation of protein tyrosine kinase activity,BP,UNC119;CBLC;PTK6;ERCC6;FBXW7;DLG4
15085,GO:0071157,0.535704736530652,0.746279618843498,2,18,negative regulation of cell cycle arrest,BP,MDM2;MLXIPL
3246,GO:0006904,0.535709417245013,0.670243377280025,4,37,vesicle docking involved in exocytosis,BP,VAMP3;RAB40B;VPS11;EXOC2
5833,GO:0017121,0.535791734500574,0.840819191752975,1,7,phospholipid scrambling,BP,ANO9
9885,GO:0042180,0.535850142701134,0.569305424914704,16,163,cellular ketone metabolic process,BP,SREBF1;DGKQ;KDSR;TYSND1;MLYCD;BMP6;PDK1;AKR7A2;MLXIPL;ACACB;FGFR4;IRS2;DHRS4;CBR4;PPARG;LONP2
730,GO:0001960,0.535860951967507,0.669793972533244,4,38,negative regulation of cytokine-mediated signaling pathway,BP,SLIT3;PPARG;CCDC3;ECM1
6936,GO:0030551,0.535899632563818,0.748000067536495,2,16,cyclic nucleotide binding,MF,RAPGEF3;PDE2A
4314,GO:0009798,0.535980287332414,0.634330029608754,6,54,axis specification,BP,SFRP1;WNT3;IRX4;PGAP1;PCSK6;NRARP
14862,GO:0070670,0.536014041639676,0.699552068763124,3,27,response to interleukin-4,BP,ADAMTS13;TCF7;STAT6
6384,GO:0021587,0.536058000385884,0.700585824483987,3,25,cerebellum morphogenesis,BP,SERPINE2;GLI2;RORA
5409,GO:0016255,0.536074100081705,0.840622912079783,1,7,attachment of GPI anchor to protein,BP,PGAP1
1408,GO:0003344,0.536192820808251,0.84406683257058,1,6,pericardium morphogenesis,BP,FLRT3
9438,GO:0036037,0.53629661464628,0.840468120611875,1,7,CD8-positive, alpha-beta T cell activation,BP,HFE
8979,GO:0035098,0.53629987542253,0.747655662427582,2,16,ESC/E(Z) complex,CC,JARID2;PHF1
12092,GO:0048148,0.536385330471534,0.840406377296925,1,7,behavioral response to cocaine,BP,HOMER2
5126,GO:0015556,0.536471957149248,0.840346072286569,1,7,C4-dicarboxylate transmembrane transporter activity,MF,SLC13A5
4157,GO:0009221,0.53663360444562,0.837612768609393,1,8,pyrimidine deoxyribonucleotide biosynthetic process,BP,CMPK2
4683,GO:0010835,0.536772787657807,0.840136529380072,1,7,regulation of protein ADP-ribosylation,BP,KAT2B
5320,GO:0016048,0.536776031346903,0.840134268976926,1,7,detection of temperature stimulus,BP,ANO1
12702,GO:0050961,0.536776031346903,0.840134268976926,1,7,detection of temperature stimulus involved in sensory perception,BP,ANO1
12704,GO:0050965,0.536776031346903,0.840134268976926,1,7,detection of temperature stimulus involved in sensory perception of pain,BP,ANO1
449,GO:0001223,0.536804545902724,0.747221009072333,2,16,transcription coactivator binding,MF,TEAD2;RORA
3272,GO:0006950,0.536867023953655,0.492054817501658,270,2653,response to stress,BP,TNFAIP3;POSTN;ITGB6;SERPINE2;ULK2;MUC19;DDB2;TP53INP1;IFI6;SREBF1;APOE;NT5E;OAS2;DDX60;HSPA2;EGFR;PTPRS;CIRBP;PKD2;XPC;APOBEC3C;ASH2L;TRIM22;SFRP1;MTHFR;IFI44L;GPX3;MAP3K14;DGKQ;TMEM129;PIK3R1;BRSK1;TXNRD3;DOCK9;TSC22D3;EYS;RNF135;SULF2;HERC5;UBXN4;VAV3;ISG15;HTRA1;SPATA18;RGMA;ZFPM1;CUL7;VAMP3;NAPRT;MC1R;STAT1;IMPACT;MYL9;RAB43;NOS1;PRKACB;CRY1;MAGEF1;NFATC4;HMGCL;BTBD2;SCARA3;CYP26B1;AP5Z1;HSF4;LIG1;NDRG1;ITPR3;MDM2;IFITM1;MLH3;HLA-B;PRODH;PCBP4;NINJ1;CTSV;POLH;OAS1;FLRT3;IL20RB;F2R;MLYCD;HPS4;MT1X;PDCD4;BLOC1S4;RTN4RL1;ZFP36L2;TRPV4;FLOT1;ADORA2B;ADAMTS13;MAPK8IP3;PIDD1;SLX1A;SLX1B;ARHGEF19;PER2;PTGS1;FNDC4;C5;MINK1;GSTM2;TNFRSF14;ITGA2;ULK1;GLI3;LRSAM1;NAIP;MAP2K5;SESN3;IGFBP4;NUPR1;CELSR1;GSN;DDT;POLD4;CD109;PNMA1;PMS2P3;ETAA1;RMI2;MGST2;DOCK8;DHX58;ENDOG;SLC27A1;TM7SF3;BLOC1S3;MDK;CASP14;IRF9;RICTOR;BMP6;NLRX1;TCIRG1;MAP2K2;PDK1;VEGFB;SQSTM1;PTK6;FZD7;ETV5;TMEM117;SHARPIN;HYAL1;NSMCE4A;PLA2G6;CST3;TXNIP;MAP3K12;WRN;IFI27;MCM9;TNFRSF21;MACROD1;TREX1;MCTP1;ATRX;REC8;NET1;CA2;SESN1;MAPK10;HFE;HMG20B;CYBA;TRIM38;ERCC6;HCP5;RRM2B;EDA2R;FBXO2;CREBRF;LRP11;CTSB;KLK5;FBXW7;KCNMA1;ING4;CDK5RAP3;PAK6;TFPI2;THRA;ADARB1;MX2;SLC2A1;NLRP1;C1RL;GLUL;GNG2;HLA-A;ACP5;MPG;PLA2G7;C12ORF66;BRINP1;MAP3K6;PDE2A;LTB4R2;RET;DAB2IP;RWDD3;FBXO4;PIK3C3;IFI16;SYT7;ERCC5;PIK3R2;SCN2A;AREG;ABTB1;RPS6KA5;BTG1;BST2;FAM3A;DMTN;STAT2;PHF1;TFDP2;UCN2;TMX4;PRIMPOL;CCDC88B;PALB2;MATN2;DUOX1;PTK7;RSAD2;TNFRSF25;ZFP36L1;LMNA;APOLD1;ANO1;ERN1;RAD50;TKFC;ZMAT3;MTR;MAN1B1;STAT6;PCSK1N;PRDX5;SMPDL3B;DNAJC4;GSTM3;CHD6;CD9;ERBB2;GPR68;UVSSA;TH;ATG14;RORA;PPARG;PRKACA;DOCK6;POLM;ACKR3;SERPING1;UFL1;LAMB2;IP6K2;MSH5;SMURF1;HERPUD2;CTNNBIP1;SERINC3;GCLC;ECM1
6277,GO:0019885,0.537238045787451,0.839812086669634,1,7,antigen processing and presentation of endogenous peptide antigen via MHC class I,BP,HFE
10460,GO:0043367,0.537263971379757,0.669099405822655,4,36,CD4-positive, alpha-beta T cell differentiation,BP,ZFPM1;RSAD2;STAT6;RORA
4535,GO:0010611,0.537299129717427,0.669411633171083,4,35,regulation of cardiac muscle hypertrophy,BP,RGS2;JARID2;LMNA;AKAP6
4879,GO:0014743,0.537299129717427,0.669411633171083,4,35,regulation of muscle hypertrophy,BP,RGS2;JARID2;LMNA;AKAP6
6342,GO:0021522,0.53733622816375,0.746762621424614,2,16,spinal cord motor neuron differentiation,BP,GLI2;GLI3
13170,GO:0051797,0.537373813785093,0.74572302098842,2,17,regulation of hair follicle development,BP,FERMT1;MYSM1
3009,GO:0006555,0.537446136862281,0.745660452478461,2,17,methionine metabolic process,BP,MTHFR;MTR
8610,GO:0034138,0.537990735434502,0.745189019769048,2,17,toll-like receptor 3 signaling pathway,BP,TNFAIP3;FLOT1
1527,GO:0003909,0.538217521870058,0.839127596263135,1,7,DNA ligase activity,MF,LIG1
15814,GO:0072539,0.538251870522209,0.839103556230351,1,7,T-helper 17 cell differentiation,BP,RORA
12421,GO:0050072,0.538297703709976,0.839071474557556,1,7,m7G(5')pppN diphosphatase activity,MF,NUDT10
4542,GO:0010623,0.53858264148137,0.838871930112918,1,7,programmed cell death involved in cell development,BP,KITLG
14635,GO:0070254,0.53884485334448,0.836046248253047,1,8,mucus secretion,BP,CYBA
17322,GO:1900026,0.538905834213512,0.696891669888231,3,27,positive regulation of substrate adhesion-dependent cell spreading,BP,TRIOBP;NET1;DMTN
14614,GO:0070207,0.538937380593396,0.743476646281582,2,18,protein homotrimerization,BP,HSF4;ATXN10
2827,GO:0006294,0.538987464107395,0.69589536407766,3,29,nucleotide-excision repair, preincision complex assembly,BP,DDB2;XPC;ERCC5
2857,GO:0006348,0.539113822762034,0.835855005655004,1,8,chromatin silencing at telomere,BP,DYDC1
13211,GO:0051896,0.539505861539859,0.577403892668405,13,122,regulation of protein kinase B signaling,BP,EGFR;PIK3R1;KITLG;MC1R;FAM110C;SESN3;INSR;RICTOR;SPRY2;FGFR4;PIK3R2;IRS2;ERBB2
9986,GO:0042415,0.539592065026399,0.838163665947651,1,7,norepinephrine metabolic process,BP,TH
11756,GO:0046631,0.539624352095392,0.618341594751736,7,65,alpha-beta T cell activation,BP,ZFPM1;GLI3;HFE;TCF7;RSAD2;STAT6;RORA
7397,GO:0031468,0.539825858794924,0.742703134857471,2,18,nuclear envelope reassembly,BP,REEP4;LMNA
12287,GO:0048642,0.539844574137089,0.837986161297988,1,7,negative regulation of skeletal muscle tissue development,BP,TSC22D3
14141,GO:0061045,0.540159728929508,0.645501177739136,5,46,negative regulation of wound healing,BP,SERPINE2;APOE;CD109;CD9;SERPING1
10493,GO:0043410,0.540234249874764,0.531865922397707,35,333,positive regulation of MAPK cascade,BP,GPNMB;EGFR;EPHB2;MAP3K14;CSPG4;KITLG;F2R;TRPV4;ADORA2B;MAPK8IP3;C5;MINK1;MAP2K5;IGFBP4;INSR;DDT;MAP2K2;FZD7;MAP3K12;MAPK10;ERCC6;SHC2;EDA2R;SPRY2;FBXW7;MAP3K6;RET;DAB2IP;FGFR4;TNFRSF25;IL11;ERN1;ERBB2;ACKR3;NPNT
5898,GO:0018107,0.540254954071232,0.592747321425164,10,92,peptidyl-threonine phosphorylation,BP,DGKQ;CAMKK1;PSKH1;ULK1;MAP3K12;CDK5R1;SPRY2;WNK1;DMTN;ACVR1B
588,GO:0001750,0.540450936149025,0.666426225684706,4,35,photoreceptor outer segment,CC,PTGS1;IQCB1;IFT140;SHANK2
11345,GO:0045721,0.540484587251856,0.837535661037487,1,7,negative regulation of gluconeogenesis,BP,SIK1
17670,GO:1901570,0.540587961755659,0.628987877876649,6,59,fatty acid derivative biosynthetic process,BP,HMGCL;PTGS1;MGST2;BDH1;ACSL1;CBR4
11046,GO:0045058,0.540649700171571,0.695800709705319,3,26,T cell selection,BP,ZFPM1;GLI3;STAT6
10266,GO:0043027,0.540873053430737,0.742685487277186,2,17,cysteine-type endopeptidase inhibitor activity involved in apoptotic process,MF,NAIP;PRDX5
1098,GO:0002687,0.54103514070392,0.616299974275214,7,70,positive regulation of leukocyte migration,BP,CXCL14;KITLG;TRPV4;ITGA2;DOCK8;VEGFB;PLA2G7
14868,GO:0070679,0.541217398814263,0.840610773993231,1,6,inositol 1,4,5 trisphosphate binding,MF,ITPR3
9371,GO:0035914,0.541316252651763,0.665256704653005,4,36,skeletal muscle cell differentiation,BP,CYP26B1;NUPR1;HMG20B;MEF2D
1105,GO:0002694,0.541403037510183,0.537479498159325,29,282,regulation of leukocyte activation,BP,TNFAIP3;GPNMB;INPP5D;SFRP1;MAP3K14;PIK3R1;VAV3;CYP26B1;IL20RB;ZFP36L2;GLI2;ADORA2B;TNFRSF14;GLI3;GSN;DOCK8;TNFRSF21;EFNB3;HFE;DLG5;NRARP;CCDC88B;ZFP36L1;IRS2;STAT6;SOX13;ERBB2;RORA;RIPK3
19998,GO:2000641,0.541404548741399,0.742222283953962,2,17,regulation of early endosome to late endosome transport,BP,VPS11;MAP2K2
10209,GO:0042891,0.541459494200459,0.836847790554396,1,7,antibiotic transport,BP,SLC13A5
3630,GO:0008091,0.541521795594166,0.840399730033258,1,6,spectrin,CC,SPTB
15800,GO:0072523,0.54154368111974,0.664403833420977,4,38,purine-containing compound catabolic process,BP,NT5E;RAPGEF3;PDE2A;NUDT10
4856,GO:0014072,0.541686520787105,0.741976345516718,2,17,response to isoquinoline alkaloid,BP,MDM2;SRR
10418,GO:0043278,0.541686520787105,0.741976345516718,2,17,response to morphine,BP,MDM2;SRR
11162,GO:0045254,0.541793326277673,0.83661179067758,1,7,pyruvate dehydrogenase complex,CC,PDK1
14979,GO:0070925,0.542099783323761,0.510721534302848,67,639,organelle assembly,BP,ULK2;TP53INP1;CIRBP;OBSL1;EVI5L;UNC119B;CNTRL;VPS11;OBSCN;GOLGA8A;MYH11;NUDCD3;HPS4;DNAH1;TUBGCP5;NLGN2;GOLGA8B;ATG16L2;SPG11;UNC119;NINL;WWTR1;ULK1;FHOD3;TPGS1;LRSAM1;NAIP;GAS8;GSN;TTN;CEP126;SEPT6;CEP192;CENPC;BBS2;NPHP3;SEPT5;IQCB1;SHANK3;IFT140;DZIP1L;CHMP1B;GOLGA8N;NPHP4;CCDC136;SYNPO2;CENPH;RFX2;BBS1;ATXN10;PIK3C3;SYT7;BBS5;BBS10;TMEM80;ALMS1;TMEM231;CCDC113;SHANK2;KAT2B;MARK4;CEP250;ATG14;PRKACA;SYNE2;SMURF1;TTLL1
539,GO:0001658,0.542125499653555,0.664834853879774,4,35,branching involved in ureteric bud morphogenesis,BP,PKD2;GLI3;NPNT;CTNNBIP1
9046,GO:0035280,0.542188525357891,0.836332106670996,1,7,miRNA loading onto RISC involved in gene silencing by miRNA,BP,AGO4
682,GO:0001893,0.54232384837821,0.694252291739813,3,26,maternal placenta development,BP,CTSV;CTSB;VDR
11862,GO:0046886,0.542538162128854,0.836084394786774,1,7,positive regulation of hormone biosynthetic process,BP,BMP6
15269,GO:0071476,0.542695807492198,0.835972621899237,1,7,cellular hypotonic response,BP,TRPV4
12563,GO:0050750,0.542705043842385,0.741086841784478,2,17,low-density lipoprotein particle receptor binding,MF,APOE;LDLRAP1
7366,GO:0031424,0.542824996656694,0.604237487787731,8,85,keratinization,BP,KRT15;CYP26B1;PPL;CASP14;SHARPIN;KRT14;KLK5;PCSK6
7582,GO:0031958,0.542902674315628,0.741934463838539,2,16,corticosteroid receptor signaling pathway,BP,CRY2;CRY1
3286,GO:0006975,0.542930362154099,0.83580622278623,1,7,DNA damage induced protein phosphorylation,BP,CRY1
7708,GO:0032205,0.543043436299033,0.663960980256955,4,35,negative regulation of telomere maintenance,BP,SLX1A;SLX1B;XRN1;RAD50
9458,GO:0036089,0.543156338123199,0.83564580050276,1,7,cleavage furrow formation,BP,SNX33
5717,GO:0016859,0.543539868890256,0.690872857314562,3,31,cis-trans isomerase activity,MF,FKBP5;FKBP9;NKTR
15144,GO:0071285,0.543612624902255,0.83532155198593,1,7,cellular response to lithium ion,BP,NFATC4
5719,GO:0016861,0.543683457985868,0.832582704599204,1,8,intramolecular oxidoreductase activity, interconverting aldoses and ketoses,MF,MPI
13094,GO:0051650,0.543855781535215,0.550830454692861,20,189,establishment of vesicle localization,BP,SYT8;SYN1;COL7A1;SYTL1;C2CD4C;BLOC1S4;RIMS3;SPG11;SYT15;VAMP2;TRAK1;BLOC1S3;BBS2;SEPT5;DNM1;ANKRD28;SHROOM2;SYT7;BBS5;AREG
20102,GO:2000810,0.543872539429946,0.741087782815748,2,16,regulation of bicellular tight junction assembly,BP,NPHP4;PRKACA
10786,GO:0044275,0.543921354797548,0.66277514172423,4,36,cellular carbohydrate catabolic process,BP,PYGB;GAA;PGM1;TKFC
12750,GO:0051045,0.544256105335543,0.834863535745092,1,7,negative regulation of membrane protein ectodomain proteolysis,BP,PTPN3
19048,GO:1904950,0.544937968392397,0.581514903939338,11,109,negative regulation of establishment of protein localization,BP,SREBF1;SFRP1;F2R;RHBDF1;IDH2;TNFRSF21;HADH;RAB11FIP3;PDE2A;DMTN;RSAD2
12601,GO:0050805,0.545159028637689,0.66159308075719,4,36,negative regulation of synaptic transmission,BP,SLC24A1;PLA2G6;SHANK3;SHANK2
11277,GO:0045604,0.545325010961087,0.6402721656476,5,47,regulation of epidermal cell differentiation,BP,CTSV;CD109;VDR;ZFP36L1;ALOX15B
15375,GO:0071649,0.545336398118516,0.834092645819882,1,7,regulation of chemokine (C-C motif) ligand 5 production,BP,TRPV4
18785,GO:1904357,0.545673349257943,0.691141998033502,3,26,negative regulation of telomere maintenance via telomere lengthening,BP,SLX1A;SLX1B;XRN1
12694,GO:0050932,0.54568838967967,0.833840935483743,1,7,regulation of pigment cell differentiation,BP,KITLG
7609,GO:0032007,0.54570777543921,0.661068354957957,4,36,negative regulation of TOR signaling,BP,EPM2A;SESN3;SESN1;C12ORF66
18065,GO:1902692,0.545752845237747,0.73944166676646,2,16,regulation of neuroblast proliferation,BP,KCTD11;GLI3
8340,GO:0033210,0.546046759805152,0.833584395057399,1,7,leptin-mediated signaling pathway,BP,BBS2
3938,GO:0008627,0.546450663970441,0.833294933594114,1,7,intrinsic apoptotic signaling pathway in response to osmotic stress,BP,SCN2A
7632,GO:0032050,0.546518840587938,0.83324604019005,1,7,clathrin heavy chain binding,MF,LRP1
17941,GO:1902337,0.546812240267096,0.833035514020032,1,7,regulation of apoptotic process involved in morphogenesis,BP,VDR
18947,GO:1904748,0.546812240267096,0.833035514020032,1,7,regulation of apoptotic process involved in development,BP,VDR
14024,GO:0060795,0.547024393074639,0.737294743547021,2,17,cell fate commitment involved in formation of primary germ layer,BP,RTF1;FZD7
633,GO:0001823,0.547084689209565,0.611297549971024,7,63,mesonephros development,BP,PKD2;SFRP1;KIF26B;GLI3;RET;NPNT;CTNNBIP1
14764,GO:0070491,0.547230682022994,0.622987875673277,6,56,repressing transcription factor binding,MF,STAT1;BBS2;BBS1;ZMYND8;BBS5;BBS10
13889,GO:0060562,0.547537531055968,0.539191921543098,24,221,epithelial tube morphogenesis,BP,PKD2;SFRP1;KIF26B;PRKACB;NFATC4;GLI2;GLI3;CELSR1;ETV5;NPHP3;PODXL;SPRY2;RET;TEAD2;BBS5;AREG;KLHL3;DLG5;VDR;PLXND1;NRARP;PTK7;NPNT;CTNNBIP1
11339,GO:0045713,0.547669302376732,0.832419492802092,1,7,low-density lipoprotein particle receptor biosynthetic process,BP,PPARG
9352,GO:0035878,0.547769908499963,0.832347079072139,1,7,nail development,BP,ITGA6
4275,GO:0009642,0.547964213034693,0.832207162791324,1,7,response to light intensity,BP,SLC24A1
10888,GO:0044447,0.547980978616683,0.737483110964006,2,16,axoneme part,CC,DNAH1;ARFGEF2
9889,GO:0042219,0.548054937590879,0.735474357289962,2,18,cellular modified amino acid catabolic process,BP,PRODH;ALDH4A1
2578,GO:0005869,0.54823048834001,0.829282758886597,1,8,dynactin complex,CC,ACTR1B
17688,GO:1901620,0.548286322067249,0.831975039437772,1,7,regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,PRKACB
14663,GO:0070301,0.5483848591503,0.609177197283974,7,69,cellular response to hydrogen peroxide,BP,TNFAIP3;IMPACT;MDM2;ENDOG;CST3;NET1;STAT6
2608,GO:0005913,0.548594666357067,0.599645090204855,8,74,cell-cell adherens junction,CC,NDRG1;FLOT1;ITGA6;BAIAP2;FAT2;SHROOM2;DLG5;CADM4
5569,GO:0016589,0.548682687832101,0.831689101376608,1,7,NURF complex,CC,SMARCA1
574,GO:0001726,0.548840358940015,0.560292592213888,15,138,ruffle,CC,PSD4;EPS8L2;ASAP3;FERMT1;TRPV4;FRMD4B;WIPF1;ARHGEF4;GSN;BAIAP2;PTK6;PSD3;PODXL;SPRY2;S100A6
2547,GO:0005816,0.548983425252186,0.83147192656541,1,7,spindle pole body,CC,TUBGCP5
6715,GO:0030132,0.549032293041025,0.735520933370472,2,17,clathrin coat of coated pit,CC,EGFR;LDLRAP1
8146,GO:0032885,0.54938941607506,0.688245083840873,3,25,regulation of polysaccharide biosynthetic process,BP,INSR;EPM2AIP1;IRS2
4328,GO:0009855,0.549474683022953,0.598770477761913,8,74,determination of bilateral symmetry,BP,PKD2;PSKH1;NEK8;GAS8;NPHP3;IFT140;BBS5;PCSK6
6909,GO:0030507,0.549502466918618,0.73614074373823,2,16,spectrin binding,MF,ANK3;DMTN
3796,GO:0008375,0.549538302376302,0.63594899720847,5,48,acetylglucosaminyltransferase activity,MF,HEXA;HEXB;B3GNT9;XYLT1;GCNT4
12963,GO:0051386,0.549540180107385,0.831069362744977,1,7,regulation of neurotrophin TRK receptor signaling pathway,BP,SPRY2
5415,GO:0016264,0.549643838113717,0.830994339458938,1,7,gap junction assembly,BP,GJD3
18473,GO:1903624,0.549653453627424,0.828241000239026,1,8,regulation of DNA catabolic process,BP,ENDOG
6111,GO:0019359,0.549694506654425,0.583176206781522,10,94,nicotinamide nucleotide biosynthetic process,BP,DHTKD1;NAPRT;NMRK1;INSR;IDH2;MLXIPL;PGM1;PFKFB2;OGDHL;NADK
6113,GO:0019363,0.549694506654425,0.583176206781522,10,94,pyridine nucleotide biosynthetic process,BP,DHTKD1;NAPRT;NMRK1;INSR;IDH2;MLXIPL;PGM1;PFKFB2;OGDHL;NADK
8558,GO:0034035,0.550350302306701,0.7334370986776,2,18,purine ribonucleoside bisphosphate metabolic process,BP,SULT1E1;ABHD14B
12461,GO:0050427,0.550350302306701,0.7334370986776,2,18,3'-phosphoadenosine 5'-phosphosulfate metabolic process,BP,SULT1E1;ABHD14B
6258,GO:0019855,0.550855022107436,0.827357943431532,1,8,calcium channel inhibitor activity,MF,PHPT1
18259,GO:1903170,0.551037700717908,0.732825209447607,2,18,negative regulation of calcium ion transmembrane transport,BP,PKD2;GSTM2
4832,GO:0014041,0.551047553754701,0.82997613065023,1,7,regulation of neuron maturation,BP,RET
1463,GO:0003720,0.551552215872169,0.826844137397165,1,8,telomerase activity,MF,TEP1
1561,GO:0003964,0.551552215872169,0.826844137397165,1,8,RNA-directed DNA polymerase activity,MF,TEP1
4318,GO:0009812,0.551817535028902,0.826648331719633,1,8,flavonoid metabolic process,BP,UGT1A3
10189,GO:0042813,0.55186581885221,0.734047610622086,2,16,Wnt-activated receptor activity,MF,SFRP1;FZD7
5046,GO:0015232,0.552113100721848,0.829200403345441,1,7,heme transporter activity,MF,SLC48A1
5254,GO:0015886,0.552113100721848,0.829200403345441,1,7,heme transport,BP,SLC48A1
1449,GO:0003684,0.552117884569063,0.605874924918271,7,66,damaged DNA binding,MF,DDB2;XPC;CRY2;POLH;WRN;MPG;MSH5
13975,GO:0060711,0.55219563751125,0.654501925277588,4,37,labyrinthine layer development,BP,PLCD3;PLCD1;ZFP36L1;GJB5
12821,GO:0051151,0.552380424776053,0.829005407075255,1,7,negative regulation of smooth muscle cell differentiation,BP,PDCD4
12938,GO:0051340,0.552498067080491,0.82614540393235,1,8,regulation of ligase activity,BP,RIPK3
7,GO:0000014,0.55257321862717,0.828864680699091,1,7,single-stranded DNA endodeoxyribonuclease activity,MF,RAD50
15397,GO:0071682,0.552911329854795,0.825839505419025,1,8,endocytic vesicle lumen,CC,APOE
13684,GO:0060263,0.552959983830436,0.82580346727481,1,8,regulation of respiratory burst,BP,INSR
8437,GO:0033572,0.553049885612842,0.682758218777827,3,29,transferrin transport,BP,TCIRG1;ATP6V0A2;HFE
9084,GO:0035358,0.553104436742977,0.828476514369831,1,7,regulation of peroxisome proliferator activated receptor signaling pathway,BP,ALOX15B
16952,GO:0098993,0.553179562565553,0.825640760892949,1,8,anchored component of synaptic vesicle membrane,CC,SYN1
2015,GO:0004745,0.553193616930911,0.82563034314611,1,8,retinol dehydrogenase activity,MF,RDH12
10461,GO:0043368,0.553210319048308,0.731807465115847,2,17,positive T cell selection,BP,ZFPM1;STAT6
2250,GO:0005165,0.553338299377562,0.828305436201639,1,7,neurotrophin receptor binding,MF,PIK3R1
2252,GO:0005167,0.553338299377562,0.828305436201639,1,7,neurotrophin TRK receptor binding,MF,PIK3R1
9400,GO:0035973,0.553520080013407,0.828172376390962,1,7,aggrephagy,BP,SQSTM1
6007,GO:0019058,0.553581370882564,0.529460210808739,26,255,viral life cycle,BP,ITGB6;APOE;OAS2;EGFR;APOBEC3C;ISG15;MVB12B;ITGB5;RAB43;PIK3C2G;IFITM1;OAS1;LAMP3;ATG16L2;TNFRSF14;ITGA2;LRSAM1;GSN;EFNB3;TRIM38;CTSB;CHMP1B;ADARB1;IFI16;BST2;RSAD2
13681,GO:0060259,0.553609449602264,0.828106933535805,1,7,regulation of feeding behavior,BP,NMU
6733,GO:0030157,0.553762474326972,0.827994837845126,1,7,pancreatic juice secretion,BP,WNK1
9860,GO:0042133,0.553779342232878,0.594248780232803,8,76,neurotransmitter metabolic process,BP,PKD2;NOS1;INSR;ALDH7A1;ACP5;AMT;TH;RORA
13450,GO:0055007,0.554027013085211,0.595320933330563,8,66,cardiac muscle cell differentiation,BP,SIK1;OBSL1;MYH11;FHOD3;TTN;FZD7;LMNA;AKAP6
15489,GO:0071887,0.554177075461612,0.603428474522445,7,69,leukocyte apoptotic process,BP,TSC22D3;KITLG;GLI3;DOCK8;TNFRSF21;IRS2;RIPK3
3082,GO:0006656,0.554291993280349,0.682039080743333,3,28,phosphatidylcholine biosynthetic process,BP,SLC27A1;LPIN3;PEMT
3069,GO:0006636,0.554379284494984,0.681501199859878,3,29,unsaturated fatty acid biosynthetic process,BP,PTGS1;ALOXE3;ALOX15B
666,GO:0001871,0.554489862642797,0.827461311321065,1,7,pattern binding,MF,ENDOU
6796,GO:0030247,0.554489862642797,0.827461311321065,1,7,polysaccharide binding,MF,ENDOU
16216,GO:0090287,0.554776639265607,0.544866264654655,18,169,regulation of cellular response to growth factor stimulus,BP,FAM20C;SFRP1;SULF2;HTRA1;FERMT1;LTBP4;NEO1;RNF165;TMEM204;LTBP1;CD109;MMRN2;SPRY2;DAB2IP;PCSK6;PBLD;SMURF1;NPNT
12410,GO:0048875,0.554930535440955,0.827137530016405,1,7,chemical homeostasis within a tissue,BP,HOMER2
16217,GO:0090288,0.554961504512922,0.577981635989272,10,93,negative regulation of cellular response to growth factor stimulus,BP,SFRP1;SULF2;HTRA1;LTBP1;CD109;MMRN2;SPRY2;DAB2IP;PBLD;SMURF1
10311,GO:0043116,0.555089169398976,0.827020872079824,1,7,negative regulation of vascular permeability,BP,PDE2A
16556,GO:0097371,0.555269294607526,0.826888343696413,1,7,MDM2/MDM4 family protein binding,MF,CDK5RAP3
9287,GO:0035743,0.555386762338654,0.823999431501502,1,8,CD4-positive, alpha-beta T cell cytokine production,BP,RSAD2
8244,GO:0033032,0.555791508550774,0.728570955739054,2,18,regulation of myeloid cell apoptotic process,BP,KITLG;THRA
817,GO:0002091,0.55585908657621,0.826453908741354,1,7,negative regulation of receptor internalization,BP,DLG4
14855,GO:0070663,0.55610794048203,0.564981311375877,12,120,regulation of leukocyte proliferation,BP,TNFAIP3;GPNMB;INPP5D;VAV3;KITLG;IL20RB;TNFRSF21;DLG5;CCDC88B;IRS2;ERBB2;RIPK3
5390,GO:0016229,0.556186200540574,0.726654170426718,2,20,steroid dehydrogenase activity,MF,SRD5A3;HSD17B14
7773,GO:0032305,0.556189115689893,0.823400155391504,1,8,positive regulation of icosanoid secretion,BP,PLA2G6
19755,GO:2000193,0.556189115689893,0.823400155391504,1,8,positive regulation of fatty acid transport,BP,PLA2G6
4346,GO:0009913,0.556216605020706,0.542990462269899,18,182,epidermal cell differentiation,BP,SLITRK6;POU3F1;KRT15;CYP26B1;CTSV;PPL;PRR9;TRIOBP;CD109;CASP14;SHARPIN;TXNIP;KRT14;KLK5;VDR;PCSK6;ZFP36L1;ALOX15B
11285,GO:0045619,0.556232718836523,0.576377182615682,10,97,regulation of lymphocyte differentiation,BP,INPP5D;SFRP1;CYP26B1;ZFP36L2;GLI2;GLI3;NRARP;ZFP36L1;SOX13;ERBB2
9853,GO:0042118,0.556394396188887,0.826058952472218,1,7,endothelial cell activation,BP,APOLD1
4645,GO:0010770,0.556516599924418,0.565115674434203,12,111,positive regulation of cell morphogenesis involved in differentiation,BP,CAPRIN2;OBSL1;WNT3;CUL7;PLXNB1;TRAK1;BAIAP2;PLXNB3;TRIOBP;NET1;PLXND1;DMTN
19257,GO:1905475,0.556609570159655,0.559972118813716,13,127,regulation of protein localization to membrane,BP,EGFR;EPHB2;PIK3R1;ANK3;GSN;SQSTM1;CDK5R1;LRP1;ZMYND8;DMTN;TFDP2;ERBB2;LDLRAP1
15515,GO:0071933,0.55663355810955,0.82588229574781,1,7,Arp2/3 complex binding,MF,WHAMMP3
6650,GO:0030007,0.556733821139485,0.82580819961539,1,7,cellular potassium ion homeostasis,BP,KCNMA1
14151,GO:0061061,0.557075851176593,0.509674332446814,41,378,muscle structure development,BP,TAGLN;SIK1;FLNC;OBSL1;CXCL14;TSC22D3;EVC;ZFPM1;NOS1;NFATC4;CYP26B1;SPEG;OBSCN;MYH11;PDCD4;FLOT1;RNF165;TMEM204;FHOD3;BOC;JARID2;NUPR1;TANC1;TTN;FZD7;GDF15;CTF1;HMG20B;MEF2D;THRA;ADARB1;JPH2;OLFM2;BTG1;MAMSTR;ZFP36L1;LMNA;AKAP6;RORA;FOXP2;NPNT
8187,GO:0032941,0.557154119326593,0.727344210232298,2,18,secretion by tissue,BP,CYBA;WNK1
12083,GO:0048103,0.557570620842203,0.728954677077258,2,16,somatic stem cell division,BP,ZFP36L2;FZD7
19375,GO:1905906,0.557664514141092,0.822294514840413,1,8,regulation of amyloid fibril formation,BP,APOE
12692,GO:0050930,0.557787143201713,0.822202404188213,1,8,induction of positive chemotaxis,BP,VEGFB
11421,GO:0045869,0.558073701712007,0.821987032367952,1,8,negative regulation of single stranded viral RNA replication via double stranded DNA intermediate,BP,APOBEC3C
10402,GO:0043255,0.558157079732541,0.612567942514393,6,54,regulation of carbohydrate biosynthetic process,BP,SIK1;DGKQ;INSR;EPM2AIP1;KAT2B;IRS2
17729,GO:1901699,0.558220559360522,0.504156264639713,47,446,cellular response to nitrogen compound,BP,SREBF1;EGFR;PKD2;SRSF5;SFRP1;PIK3R1;STAT1;IMPACT;UROS;PRKACB;MDM2;RAPGEF3;FLOT1;ZCCHC11;GSTM2;VAMP2;SESN3;INSR;BAIAP2;TCIRG1;MAP2K2;ATP6V0A2;COL6A1;CDK5R1;ATRX;CA2;SESN1;CYBA;AGO4;XRN1;GNG2;LRP1;PDE2A;PIK3R2;DMTN;ZFP36L1;KAT2B;IRS2;GPR21;MTR;STAT6;CACNB1;AKAP6;TH;PPARG;PRKACA;GCLC
10807,GO:0044309,0.558270774644007,0.568620358281961,11,102,neuron spine,CC,NOS1;LZTS1;BAIAP2;DNM1;CDK5R1;SHANK3;FBXO2;ZMYND8;ARFGEF2;DLG4;SHANK2
19925,GO:2000484,0.558572322859721,0.821611849127677,1,8,positive regulation of interleukin-8 secretion,BP,F2R
5116,GO:0015459,0.558975644078724,0.678089232857455,3,27,potassium channel regulator activity,MF,KCNAB2;WNK1;KCNS3
6819,GO:0030285,0.558984091561268,0.824139456388018,1,7,integral component of synaptic vesicle membrane,CC,PTPRS
6318,GO:0019985,0.559001980818746,0.647282930460368,4,39,translesion synthesis,BP,ISG15;POLH;POLD4;PRIMPOL
1049,GO:0002577,0.559058354242448,0.821245613671476,1,8,regulation of antigen processing and presentation,BP,HFE
4905,GO:0014841,0.559095200472276,0.824056774816726,1,7,skeletal muscle satellite cell proliferation,BP,SIX5
4906,GO:0014842,0.559095200472276,0.824056774816726,1,7,regulation of skeletal muscle satellite cell proliferation,BP,SIX5
4916,GO:0014856,0.559095200472276,0.824056774816726,1,7,skeletal muscle cell proliferation,BP,SIX5
4917,GO:0014857,0.559095200472276,0.824056774816726,1,7,regulation of skeletal muscle cell proliferation,BP,SIX5
7876,GO:0032451,0.559399136103201,0.64820608009552,4,35,demethylase activity,MF,KDM3A;HR;PHF2;KDM4C
9988,GO:0042417,0.55976909549623,0.724980782572344,2,18,dopamine metabolic process,BP,SNCB;TH
13050,GO:0051574,0.559849329773288,0.823494877116734,1,7,positive regulation of histone H3-K9 methylation,BP,JARID2
303,GO:0000813,0.559888994651017,0.820618505381752,1,8,ESCRT I complex,CC,MVB12B
17492,GO:1900746,0.560342496064214,0.823126748361352,1,7,regulation of vascular endothelial growth factor signaling pathway,BP,DAB2IP
18011,GO:1902547,0.560342496064214,0.823126748361352,1,7,regulation of cellular response to vascular endothelial growth factor stimulus,BP,DAB2IP
16279,GO:0090407,0.560401199369272,0.499444052295231,51,499,organophosphate biosynthetic process,BP,PTHLH;APOE;INPP5D;DGKQ;PIK3R1;DHTKD1;MVD;NAPRT;SRD5A3;NOS1;PITPNM3;CMPK2;PIK3C2G;NMRK1;ADORA2B;PITPNM2;MBOAT2;INSR;SLC27A1;PGAP1;ETNK2;TCIRG1;HEXB;PLA2G6;ATP6V0A2;IDH2;LPIN3;PIGZ;RRM2B;GABBR1;MLXIPL;GPR87;PGM1;PFKFB2;OGDHL;TK2;PPCS;LTB4R2;DDHD2;PIK3C3;FGFR4;PIK3R2;NADK;MPPE1;IRS2;PNPO;ISYNA1;UCKL1;IP6K2;PI4K2B;PEMT
1887,GO:0004571,0.560428555148478,0.823062454111299,1,7,mannosyl-oligosaccharide 1,2-alpha-mannosidase activity,MF,MAN1B1
14586,GO:0070168,0.56070163127827,0.822858332951431,1,7,negative regulation of biomineral tissue development,BP,ECM1
1456,GO:0003700,0.560872490844394,0.480139406130118,115,1088,DNA binding transcription factor activity,MF,HES2;ZSCAN18;TSC22D1;SREBF1;MNT;TRIM22;KDM3A;TSC22D3;POU3F1;HR;TFCP2L1;ZFPM1;HOXC5;ZNF266;STAT1;THAP8;HOXA3;ZNF699;KLF13;NFATC4;HSF4;ZNF251;NDN;TCF25;ZNF160;ZFP36L2;GLI2;KLF7;ZNF76;SOX12;ZNF658;TCEAL1;GLI3;ZNF558;IRX4;BHLHE40;ZNF655;ZNF333;LZTS1;TCFL5;JARID2;ZNF18;MXD4;ZNF287;ZNF446;IRF9;GLI4;ETV5;DLX3;TCF4;PLAG1;RCOR2;MEF2D;CREBRF;MLXIPL;LMO2;NFIX;CARF;MXI1;THRA;RAI1;ELF1;IKZF4;DBP;EPM2AIP1;PEG3;RFX2;ZNF554;SALL2;ZNF532;ZBTB20;ZNF334;MAF;STK16;TEAD2;MYSM1;TSHZ2;IFI16;TEF;ZNF25;ZNF630;VDR;ZFP28;ZMYM3;SIX5;HLTF;ZNF789;STAT2;PHF1;ZNF292;TFDP2;ZNF701;ZNF91;GTF2IRD2;TCF7;ZFP36L1;GLMP;IVNS1ABP;ZNF439;TRERF1;STAT6;SOX13;KLF8;GOLGB1;RORA;PPARG;ZNF572;ZNF529;KLF9;SCAND1;ZFP90;ZFP30;FOXP2;ZC3H6;HIVEP1
7661,GO:0032098,0.561011183889519,0.819768872533336,1,8,regulation of appetite,BP,BBS2
17269,GO:0140056,0.561205680424565,0.544084029086304,16,155,organelle localization by membrane tethering,BP,VAMP3;RAB40B;CNTRL;VPS11;NINL;CEP192;IQCB1;TSNARE1;NPHP4;EXOC2;ALMS1;ESYT2;MARK4;CEP250;ATG14;PRKACA
6581,GO:0022417,0.561553048334791,0.817150183032954,1,9,protein maturation by protein folding,BP,AIP
980,GO:0002437,0.561600149695597,0.722484266064832,2,19,inflammatory response to antigenic stimulus,BP,IL20RB;PNMA1
4985,GO:0015114,0.561680590072067,0.822125227407657,1,7,phosphate ion transmembrane transporter activity,MF,SLC37A2
4661,GO:0010812,0.561717733455011,0.624680984665096,5,45,negative regulation of cell-substrate adhesion,BP,POSTN;PIK3R1;SPOCK1;FZD7;DMTN
10111,GO:0042659,0.561818233199386,0.822021982711274,1,7,regulation of cell fate specification,BP,FZD7
6816,GO:0030282,0.561828387423107,0.60872264237264,6,55,bone mineralization,BP,GPNMB;PTHLH;FAM20C;ISG15;BMP6;ECM1
7668,GO:0032105,0.561859472275216,0.819124769991576,1,8,negative regulation of response to extracellular stimulus,BP,BBS2
7671,GO:0032108,0.561859472275216,0.819124769991576,1,8,negative regulation of response to nutrient levels,BP,BBS2
19968,GO:2000586,0.562055833840926,0.821843662801511,1,7,regulation of platelet-derived growth factor receptor-beta signaling pathway,BP,LRP1
13980,GO:0060717,0.562240965212335,0.821704635057108,1,7,chorion development,BP,HTRA1
5424,GO:0016279,0.562471374586565,0.623450981936224,5,47,protein-lysine N-methyltransferase activity,MF,ASH2L;METTL21A;SETD4;DYDC1;KMT5C
7658,GO:0032095,0.562703848254219,0.818482056136141,1,8,regulation of response to food,BP,BBS2
1328,GO:0003183,0.562730840247089,0.821336390241011,1,7,mitral valve morphogenesis,BP,ZFPM1
17703,GO:1901654,0.562933703163937,0.553623475765038,13,126,response to ketone,BP,SREBF1;EGFR;SFRP1;TXNIP;CYBA;SLIT3;XRN1;GNG2;GLB1;TH;PPARG;KLF9;FOXP2
3852,GO:0008469,0.56297510915241,0.818275244873452,1,8,histone-arginine N-methyltransferase activity,MF,PRMT3
8319,GO:0033176,0.563103535312723,0.720363638797431,2,20,proton-transporting V-type ATPase complex,CC,TCIRG1;ATP6V0A2
16473,GO:0097191,0.563281499586728,0.538739145098821,17,169,extrinsic apoptotic signaling pathway,BP,TNFAIP3;IFI6;SFRP1;PIK3R1;RBCK1;KITLG;UNC5B;TNFSF10;PIDD1;MAP2K5;ITGA6;RET;DAB2IP;ACVR1B;LMNA;TNFSF12;GCLC
10837,GO:0044346,0.563338368623513,0.722677981062349,2,17,fibroblast apoptotic process,BP,SFRP1;BTG1
4315,GO:0009799,0.563379015273713,0.584734752061932,8,75,specification of symmetry,BP,PKD2;PSKH1;NEK8;GAS8;NPHP3;IFT140;BBS5;PCSK6
16772,GO:0098632,0.563626540790915,0.673146999185785,3,28,cell-cell adhesion mediator activity,MF,BAIAP2;PLXNB3;NFASC
8585,GO:0034101,0.563724637073894,0.575857768501067,9,87,erythrocyte homeostasis,BP,INPP5D;ZFPM1;STAT1;KLF13;FAM210B;THRA;DMTN;ACVR1B;ZFP36L1
8497,GO:0033687,0.56385366066557,0.722208620894983,2,17,osteoblast proliferation,BP,SFRP1;PLXNB1
7611,GO:0032009,0.564213581648385,0.820218567476289,1,7,early phagosome,CC,SYT7
6682,GO:0030056,0.564243933340184,0.824094059852329,1,6,hemidesmosome,CC,ITGA6
2263,GO:0005179,0.56447342081161,0.719858754743946,2,19,hormone activity,MF,PTHLH;UCN2
9869,GO:0042148,0.564548752508913,0.817072261509884,1,8,strand invasion,BP,WRN
9418,GO:0035999,0.564779241062008,0.816895599874954,1,8,tetrahydrofolate interconversion,BP,MTHFR
14821,GO:0070586,0.564932102848224,0.81677837117373,1,8,cell-cell adhesion involved in gastrulation,BP,MAP2K5
18789,GO:1904377,0.564997658009388,0.621179961348034,5,46,positive regulation of protein localization to cell periphery,BP,EGFR;EPHB2;PIK3R1;SQSTM1;LRP1
12102,GO:0048172,0.565382837676544,0.819333645644285,1,7,regulation of short-term neuronal synaptic plasticity,BP,SYNGR1
6074,GO:0019229,0.565737949189873,0.671618673663985,3,27,regulation of vasoconstriction,BP,EGFR;F2R;PER2
8245,GO:0033033,0.565793558407895,0.816116751067692,1,8,negative regulation of myeloid cell apoptotic process,BP,KITLG
6837,GO:0030309,0.565810056339922,0.816104064044886,1,8,poly-N-acetyllactosamine metabolic process,BP,B3GNT9
6838,GO:0030311,0.565810056339922,0.816104064044886,1,8,poly-N-acetyllactosamine biosynthetic process,BP,B3GNT9
2865,GO:0006357,0.56608771951469,0.468757166092235,166,1591,regulation of transcription by RNA polymerase II,BP,HES2;ZSCAN18;TSC22D1;SREBF1;APOE;EGFR;PKD2;CAPRIN2;MNT;ASH2L;SFRP1;DGKQ;PIK3R1;KDM3A;TSC22D3;POU3F1;HTRA1;TFCP2L1;RGMA;ZFPM1;HOXC5;CITED4;IRF2BPL;MC1R;STAT1;IMPACT;CRY2;THAP8;NOS1;ZNF704;HOXA3;CRY1;MAML3;KLF13;NFATC4;HSF4;EAPP;MDM2;CRTC1;NDN;NEO1;TCF25;PDCD4;ZNF160;ZFP36L2;TRPV4;GLI2;KLF7;RNF165;TCEA2;ZNF76;SOX12;PER2;ABHD14B;TCEAL1;WWTR1;GLI3;THRAP3;IRX4;BHLHE40;MAP2K5;ITGA6;TCFL5;TRAK1;JARID2;NUPR1;CHD3;ZNF18;MXD4;ZNF446;RTF1;IRF9;BMP6;SQSTM1;ETV5;DLX3;HEXB;KDM4C;METTL23;ZNF608;GDF15;TXNIP;TCF4;PLAG1;RCOR2;IFI27;LPIN3;ATRX;HFE;ADIRF;MEF2D;CREBRF;MLXIPL;TARBP1;FBXW7;CDK5RAP3;LMO2;NFIX;CARF;MXI1;THRA;RAI1;ELF1;IKZF4;DBP;EPM2AIP1;PEG3;RFX2;SALL2;ZBTB20;PDE2A;MAF;STK16;ZMYND8;DAB2IP;CALCOCO1;TEAD2;MYSM1;TSHZ2;IFI16;PIK3R2;TEF;ZNF25;RPS6KA5;VDR;MAMSTR;PLXND1;ZMYM3;SIX5;HLTF;PCSK6;STAT2;WWC3;ZNF292;TFDP2;NRARP;ACVR1B;TCEAL4;ZNF91;GTF2IRD2;TCF7;ZFP36L1;GLMP;IL11;KAT2B;IVNS1ABP;TRERF1;STAT6;SOX13;KLF8;CHD6;ERBB2;ABCA2;RORA;PPARG;CXXC5;KLF9;ZFP90;PER3;FOXP2;ZC3H6;HIVEP1;SMURF1;NPNT;CTNNBIP1;ECM1
18900,GO:1904646,0.566572788701845,0.719723990448697,2,17,cellular response to amyloid-beta,BP,LRP1;CACNB1
400,GO:0001077,0.566704832282368,0.532724810297806,18,170,transcriptional activator activity, RNA polymerase II proximal promoter sequence-specific DNA binding,MF,SREBF1;KLF13;NDN;GLI2;KLF7;SOX12;GLI3;DLX3;TCF4;PLAG1;MEF2D;CARF;ELF1;DBP;STK16;TEF;HLTF;ZNF292
11238,GO:0045475,0.567056199291071,0.818061919094722,1,7,locomotor rhythm,BP,NAGLU
2998,GO:0006544,0.567775176056176,0.814588511770167,1,8,glycine metabolic process,BP,AMT
9492,GO:0036151,0.567822697503789,0.717625428583753,2,18,phosphatidylcholine acyl-chain remodeling,BP,MBOAT2;PLA2G6
13505,GO:0055102,0.567873368958804,0.812257037686633,1,9,lipase inhibitor activity,MF,SNCB
6915,GO:0030514,0.567976489969173,0.670006204252141,3,26,negative regulation of BMP signaling pathway,BP,SFRP1;HTRA1;SMURF1
19743,GO:2000171,0.567987045734927,0.718426446807792,2,17,negative regulation of dendrite development,BP,PTPRS;NFATC4
4512,GO:0010565,0.56804332051898,0.552670329153512,12,124,regulation of cellular ketone metabolic process,BP,SREBF1;DGKQ;TYSND1;MLYCD;BMP6;PDK1;MLXIPL;ACACB;FGFR4;IRS2;PPARG;LONP2
15403,GO:0071695,0.568191017814573,0.564532720849891,10,94,anatomical structure maturation,BP,FAM20C;TFCP2L1;FERMT1;PLXNB1;FAM210B;THBS3;CDK5R1;REC8;RET;NFASC
12822,GO:0051152,0.568218081938111,0.814245733898331,1,8,positive regulation of smooth muscle cell differentiation,BP,OLFM2
16472,GO:0097190,0.568327237603241,0.494310488316864,46,466,apoptotic signaling pathway,BP,TNFAIP3;TP53INP1;IFI6;MNT;SFRP1;PIK3R1;RBCK1;KITLG;UNC5B;NFATC4;MDM2;TNFSF10;PRODH;PIDD1;TNFRSF14;MAP2K5;ITGA6;NUPR1;GSN;CASP14;PDK1;TMEM117;PLA2G6;IFI27;TNFRSF21;ERCC6;RRM2B;EDA2R;FBXW7;RET;DAB2IP;IFI16;IL20RA;SCN2A;TFDP2;ACVR1B;TNFRSF25;LMNA;ERN1;IVNS1ABP;ZMAT3;TNFSF12;ACKR3;RIPK3;SERINC3;GCLC
1237,GO:0002931,0.568432155040831,0.668517984002158,3,28,response to ischemia,BP,MLYCD;PER2;SQSTM1
14621,GO:0070228,0.568563143677317,0.637609373706062,4,40,regulation of lymphocyte apoptotic process,BP,TSC22D3;DOCK8;IRS2;RIPK3
18381,GO:1903431,0.568634296183475,0.816856868780318,1,7,positive regulation of cell maturation,BP,RET
10316,GO:0043123,0.568650658174215,0.54340038390748,14,141,positive regulation of I-kappaB kinase/NF-kappaB signaling,BP,TRIM22;MAP3K14;RBCK1;PLEKHG5;TNFSF10;F2R;S100A4;SHARPIN;TRIM38;EDA2R;BST2;TRAF5;CXXC5;ECM1
7509,GO:0031702,0.568695756430654,0.81680982440389,1,7,type 1 angiotensin receptor binding,MF,ARAP1
13264,GO:0051974,0.568699581475046,0.813872586401944,1,8,negative regulation of telomerase activity,BP,PPARG
6700,GO:0030111,0.568805009138535,0.513974882996079,26,256,regulation of Wnt signaling pathway,BP,APOE;APCDD1;CAPRIN2;DIXDC1;SFRP1;SULF2;WNT3;NFATC4;FERMT1;LZTS2;WWTR1;GLI3;NAIP;IGFBP4;CDK14;NPHP3;APC2;LRP1;NPHP4;WNK1;DAB2IP;RNF213;NRARP;KREMEN1;IGFBP6;CTNNBIP1
16580,GO:0097428,0.568974556583103,0.809596939711687,1,10,protein maturation by iron-sulfur cluster transfer,BP,MAGEF1
3689,GO:0008194,0.569094937005117,0.563291529646646,10,98,UDP-glycosyltransferase activity,MF,B4GALNT4;UGT1A3;B4GALT6;HEXA;B4GALT2;HEXB;HYAL1;B3GNT9;XYLT1;GCNT4
8565,GO:0034046,0.569578051497352,0.816133543393718,1,7,poly(G) binding,MF,ATXN1
1038,GO:0002551,0.569675381137364,0.813114768496862,1,8,mast cell chemotaxis,BP,VEGFB
7372,GO:0031432,0.569953594577067,0.815845158605328,1,7,titin binding,MF,OBSCN
6799,GO:0030252,0.57007866066139,0.815749048246935,1,7,growth hormone secretion,BP,LTBP4
9937,GO:0042310,0.570319350965898,0.636786121415623,4,37,vasoconstriction,BP,EGFR;F2R;PER2;BBS2
7486,GO:0031665,0.570431786457976,0.812525855212664,1,8,negative regulation of lipopolysaccharide-mediated signaling pathway,BP,TNFAIP3
14754,GO:0070475,0.57052795144066,0.810175068946027,1,9,rRNA base methylation,BP,NSUN5P2
6339,GO:0021517,0.570854784049228,0.715784290681713,2,17,ventral spinal cord development,BP,GLI2;GLI3
13878,GO:0060544,0.570894220251176,0.713938149706038,2,19,regulation of necroptotic process,BP,RBCK1;RIPK3
4655,GO:0010803,0.571117045150474,0.613982145793065,5,51,regulation of tumor necrosis factor-mediated signaling pathway,BP,TNFAIP3;RBCK1;SPPL2B;SHARPIN;CCDC3
18666,GO:1904037,0.571289989512784,0.715382018267047,2,17,positive regulation of epithelial cell apoptotic process,BP,PDCD4;GSN
10989,GO:0044806,0.571295818213336,0.814811852296423,1,7,G-quadruplex DNA unwinding,BP,WRN
295,GO:0000800,0.571341501606971,0.814776611646537,1,7,lateral element,CC,REC8
12591,GO:0050792,0.571458848652354,0.533311222436642,16,164,regulation of viral process,BP,APOE;OAS2;APOBEC3C;ISG15;MVB12B;STAT1;IFITM1;OAS1;LAMP3;GSN;TRIM38;ADARB1;IFI16;BST2;RSAD2;NELFCD
7657,GO:0032094,0.571544804228218,0.714186669632233,2,18,response to food,BP,SREBF1;BBS2
17303,GO:0150011,0.571652567627132,0.814536526797356,1,7,regulation of neuron projection arborization,BP,DLG4
17304,GO:0150012,0.571652567627132,0.814536526797356,1,7,positive regulation of neuron projection arborization,BP,DLG4
6767,GO:0030208,0.571905651451835,0.814341032155426,1,7,dermatan sulfate biosynthetic process,BP,CSPG4
8229,GO:0033008,0.572009422435033,0.811293387181691,1,8,positive regulation of mast cell activation involved in immune response,BP,ADORA2B
10435,GO:0043306,0.572009422435033,0.811293387181691,1,8,positive regulation of mast cell degranulation,BP,ADORA2B
3661,GO:0008146,0.572036716462059,0.665022833510216,3,28,sulfotransferase activity,MF,GAL3ST4;SULT1E1;NDST2
7571,GO:0031943,0.572049025291331,0.811262376267733,1,8,regulation of glucocorticoid metabolic process,BP,DGKQ
733,GO:0001964,0.572230192271293,0.814090128704271,1,7,startle response,BP,SLITRK6
8294,GO:0033138,0.572275379010408,0.59753873318985,6,59,positive regulation of peptidyl-serine phosphorylation,BP,EGFR;CAPRIN2;RAPGEF3;SPRY2;RET;IL11
13977,GO:0060713,0.572468981885512,0.713328958819338,2,18,labyrinthine layer morphogenesis,BP,ZFP36L1;GJB5
5927,GO:0018208,0.572771074182568,0.632904180665287,4,42,peptidyl-proline modification,BP,CRTAP;FKBP5;FKBP9;NKTR
2995,GO:0006541,0.573149802812928,0.713659065352646,2,17,glutamine metabolic process,BP,GLUD1;GLUL
10254,GO:0043008,0.573231704348888,0.810334637831398,1,8,ATP-dependent protein binding,MF,PLA2G6
16048,GO:0090026,0.573316012241104,0.80797116466272,1,9,positive regulation of monocyte chemotaxis,BP,PLA2G7
136,GO:0000287,0.573341568325867,0.531718328547311,16,155,magnesium ion binding,MF,SIK1;BRSK1;PRKACB;HMGCL;IDH2;WRN;PGM1;GLUL;SRR;MAP3K6;WNK1;RPS6KA5;TSSK1B;WEE1;ERN1;GCLC
3360,GO:0007097,0.573704466240554,0.714237336587766,2,16,nuclear migration,BP,SUN1;SYNE2
13691,GO:0060272,0.573717240292888,0.809952842043024,1,8,embryonic skeletal joint morphogenesis,BP,HYAL1
14484,GO:0062012,0.574197152912691,0.498283077991089,34,337,regulation of small molecule metabolic process,BP,SIK1;PTHLH;SREBF1;APOE;LMF1;PKD2;SEC14L2;DGKQ;MVD;NOS1;TYSND1;RAPGEF3;MLYCD;ADORA2B;IGFBP4;INSR;BMP6;PDK1;NPHP3;GABBR1;MLXIPL;GPR87;PFKFB2;ACACB;EPM2AIP1;LTB4R2;FGFR4;VDR;KAT2B;IRS2;RORA;PPARG;LDLRAP1;LONP2
5166,GO:0015718,0.574201595806715,0.565315286365232,9,86,monocarboxylic acid transport,BP,APOE;CPT2;SLC16A5;SLC27A1;PLA2G6;ACACB;ACSL1;IRS2;PPARG
7781,GO:0032329,0.574307349206462,0.809488091769218,1,8,serine transport,BP,SERINC3
5071,GO:0015296,0.574362882766927,0.812435403127655,1,7,anion:cation symporter activity,MF,SLC12A7
17316,GO:1900016,0.574532640356375,0.809310449928221,1,8,negative regulation of cytokine production involved in inflammatory response,BP,PDCD4
5299,GO:0015991,0.574855790221738,0.709480210609211,2,20,ATP hydrolysis coupled proton transport,BP,TCIRG1;ATP6V0A2
20179,GO:2001057,0.574871449470414,0.610838321493624,5,48,reactive nitrogen species metabolic process,BP,PKD2;NOS1;INSR;ACP5;RORA
12820,GO:0051150,0.575416311684496,0.71058322242926,2,18,regulation of smooth muscle cell differentiation,BP,PDCD4;OLFM2
3575,GO:0007620,0.575419153246287,0.808610307148146,1,8,copulation,BP,SERPINE2
10944,GO:0044706,0.575420526753997,0.536711441853223,14,136,multi-multicellular organism process,BP,SERPINE2;PTHLH;TFCP2L1;CTSV;ITGA2;HEXB;PLA2G6;CST3;HFE;CTSB;SLC2A1;VDR;ACVR1B;ENDOU
6337,GO:0021515,0.575675246271961,0.711309376339398,2,17,cell differentiation in spinal cord,BP,GLI2;GLI3
18378,GO:1903428,0.575828620941354,0.661324559800594,3,28,positive regulation of reactive oxygen species biosynthetic process,BP,PKD2;INSR;CYBA
20254,GO:2001244,0.575899573661232,0.629301048415557,4,44,positive regulation of intrinsic apoptotic signaling pathway,BP,FBXW7;IL20RA;RIPK3;SERINC3
8139,GO:0032875,0.575915228405999,0.811224455950165,1,7,regulation of DNA endoreduplication,BP,FBXW7
2881,GO:0006383,0.576037906801787,0.609033790732155,5,51,transcription by RNA polymerase III,BP,ZNF76;NAB2;IVNS1ABP;PRDX5;ERBB2
12847,GO:0051188,0.576058960943168,0.509794700161225,24,240,cofactor biosynthetic process,BP,DHTKD1;NAPRT;UROS;NMRK1;MLYCD;INSR;MGST2;OPLAH;PDK1;IDH2;CYBA;MLXIPL;PGM1;PFKFB2;ACACB;OGDHL;PPCS;NADK;DUOX1;ACSL1;PNPO;CBR4;ACSS2;GCLC
16368,GO:0097001,0.57606101825494,0.808102255599618,1,8,ceramide binding,MF,PLTP
5739,GO:0016889,0.576138293113508,0.708277395496948,2,20,endodeoxyribonuclease activity, producing 3'-phosphomonoesters,MF,SLX1A;SLX1B
18662,GO:1904030,0.576139690395264,0.661020190381696,3,28,negative regulation of cyclin-dependent protein kinase activity,BP,TNFAIP3;CAMK2N1;KAT2B
19084,GO:1905037,0.576166088741706,0.563215339581257,9,87,autophagosome organization,BP,ULK2;TP53INP1;ATG16L2;ULK1;LRSAM1;SYNPO2;PIK3C3;ATG14;SMURF1
9303,GO:0035773,0.57622443463604,0.629997336325174,4,40,insulin secretion involved in cellular response to glucose stimulus,BP,PLA2G6;ANO1;PHPT1;GPR68
7838,GO:0032404,0.576377763948623,0.807851195095716,1,8,mismatch repair complex binding,MF,TREX1
13458,GO:0055015,0.576784085014817,0.807528797128662,1,8,ventricular cardiac muscle cell development,BP,LMNA
13993,GO:0060736,0.57690478761548,0.810449653211811,1,7,prostate gland growth,BP,PLAG1
11920,GO:0046983,0.576963563902964,0.470448225897043,82,849,protein dimerization activity,MF,HES2;SREBF1;APOE;EGFR;PKD2;MNT;ALDH1A3;PIK3R1;TENM4;MVD;STAT1;HMGCL;UGT1A3;POLR2J2;FLRT3;HPS4;FLOT1;RALGAPA1;HEXA;GSTM2;WWTR1;ITGA2;SPPL2B;BHLHE40;ZNF318;TCFL5;CELSR1;MXD4;RAB11FIP4;SLC27A1;H2AFJ;BMP6;VEGFB;SQSTM1;CABYR;HEXB;HOMER2;PEX7;TCF4;PEX11B;MAP3K12;WRN;DNM1;TREX1;POLR2J3;HMG20B;CYBA;HLCS;MEF2D;RAB11FIP3;MLXIPL;ZNF862;MXI1;IKZF4;ACCS;SRR;DLK2;PDE2A;DAB2IP;TEAD2;FBXO4;ERCC5;PIK3R2;BST2;SNX1;CADM4;GALE;IMPA2;ANO1;ERN1;PNPO;S100A6;TAS1R3;PRDX5;GSTM3;ERBB2;MPP7;PPARG;SUCLG2;HARS2;FOXP2;GCLC
10329,GO:0043140,0.576963868927744,0.810403322969479,1,7,ATP-dependent 3'-5' DNA helicase activity,MF,WRN
8580,GO:0034091,0.577239925879618,0.80716665502426,1,8,regulation of maintenance of sister chromatid cohesion,BP,ATRX
8630,GO:0034182,0.577239925879618,0.80716665502426,1,8,regulation of maintenance of mitotic sister chromatid cohesion,BP,ATRX
5224,GO:0015837,0.577566242208177,0.659149157059986,3,29,amine transport,BP,PER2;SYT7;TH
15228,GO:0071417,0.577765637839881,0.490106448858309,39,372,cellular response to organonitrogen compound,BP,SREBF1;EGFR;PKD2;SRSF5;SFRP1;PIK3R1;STAT1;IMPACT;UROS;PRKACB;MDM2;RAPGEF3;GSTM2;VAMP2;SESN3;INSR;BAIAP2;TCIRG1;ATP6V0A2;COL6A1;CA2;SESN1;CYBA;XRN1;GNG2;LRP1;PDE2A;PIK3R2;DMTN;ZFP36L1;KAT2B;IRS2;GPR21;CACNB1;AKAP6;TH;PPARG;PRKACA;GCLC
14956,GO:0070886,0.577943664613621,0.806606630280063,1,8,positive regulation of calcineurin-NFAT signaling cascade,BP,AKAP6
17188,GO:0106058,0.577943664613621,0.806606630280063,1,8,positive regulation of calcineurin-mediated signaling,BP,AKAP6
6722,GO:0030140,0.578034051676036,0.659163409454689,3,28,trans-Golgi network transport vesicle,CC,AP1G2;CLTCL1;LDLRAP1
6208,GO:0019730,0.578100274433148,0.654411665191208,3,43,antimicrobial humoral response,BP,PLA2G6;KLK5;FAM3A
1446,GO:0003678,0.578212315571056,0.607939409225486,5,46,DNA helicase activity,MF,CHD3;WRN;ATRX;RAD50;DDX12P
18902,GO:1904659,0.578347171145628,0.579625882934835,7,65,glucose transmembrane transport,BP,PIK3R1;CLTCL1;INSR;SLC2A3;SLC2A1;PIK3R2;IRS2
12911,GO:0051287,0.578436438001661,0.606611210213369,5,51,NAD binding,MF,ALDH1A3;GLUD1;IDH2;HADH;NUDT6
12266,GO:0048596,0.578546196307253,0.70972867366709,2,16,embryonic camera-type eye morphogenesis,BP,ALDH1A3;TH
5377,GO:0016197,0.578647839509893,0.520309537647137,18,176,endosomal transport,BP,MVB12B;VAMP3;NSG1;AP5Z1;MICALL1;CLTCL1;RAB11FIP4;VPS39;BLOC1S3;MICALL2;SQSTM1;WASH3P;RAB11FIP3;TBC1D17;SGSM2;ALMS1;SNX1;SNX33
15638,GO:0072176,0.578715743373197,0.809025902737369,1,7,nephric duct development,BP,PKD2
2194,GO:0005068,0.57935174717773,0.808524095402466,1,7,transmembrane receptor protein tyrosine kinase adaptor activity,MF,PIK3R1
11563,GO:0046133,0.579438149110206,0.80306910746789,1,9,pyrimidine ribonucleoside catabolic process,BP,APOBEC3C
19267,GO:1905523,0.579832332271096,0.805097998300323,1,8,positive regulation of macrophage migration,BP,TRPV4
1008,GO:0002483,0.580086359632683,0.804894455403439,1,8,antigen processing and presentation of endogenous peptide antigen,BP,HFE
1182,GO:0002829,0.580115511738246,0.804871087297671,1,8,negative regulation of type 2 immune response,BP,STAT6
15064,GO:0071071,0.580383916227712,0.80465584353388,1,8,regulation of phospholipid biosynthetic process,BP,SLC27A1
6727,GO:0030149,0.580392475366677,0.705042752159762,2,19,sphingolipid catabolic process,BP,HEXB;SMPDL3B
3820,GO:0008420,0.580508306317964,0.804556033621916,1,8,CTD phosphatase activity,MF,PPM1M
453,GO:0001227,0.580667998245277,0.521176552140216,17,163,transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific DNA binding,MF,HES2;MNT;ZFPM1;NFATC4;BHLHE40;TCFL5;JARID2;MLXIPL;MXI1;ZBTB20;TSHZ2;IFI16;TCF7;KLF8;ZFP90;FOXP2;HIVEP1
12228,GO:0048519,0.580743767700717,0.445030885711976,369,3626,negative regulation of biological process,BP,TNFAIP3;TGFBI;POSTN;HES2;SERPINE2;ULK2;GPNMB;SIK1;EPM2A;TP53INP1;IFI6;PTHLH;SREBF1;APOE;GPSM1;NT5E;INPP5D;APCDD1;OAS2;HSPA2;EGFR;ESPN;PTPRS;CIRBP;PKD2;CAPRIN2;MNT;XPC;APOBEC3C;DIXDC1;TRIM22;SFRP1;KCTD11;EPHB2;MAP3K14;DGKQ;PIK3R1;ADAMTS7;EVI5L;BRSK1;RBCK1;KDM3A;CXCL14;TSC22D3;RNF135;SULF2;WNT3;HERC5;UNK;HR;ISG15;ELFN2;HTRA1;TFCP2L1;RGMA;ZFPM1;KITLG;TP53I11;VAMP3;IRF2BPL;MC1R;STAT1;IMPACT;CAMK2N1;CRY2;UNC5B;NOS1;PRKACB;CRY1;SCMH1;KLF13;CRTAP;MAGEF1;NFATC4;FERMT1;CYP26B1;HSF4;PLXNB1;SPEG;NDRG1;COL7A1;SPOCK1;ITPR3;EAPP;MDM2;CRTC1;LZTS2;NDN;IFITM1;PIK3IP1;TNFSF10;RAPGEF3;PHACTR3;TCF25;PCBP4;CTSV;OAS1;FLRT3;RASA4;KIF26A;RGS2;ARPIN;IL20RB;ADGRB2;F2R;MT1X;PDCD4;CGREF1;SPTB;SERPINB5;SLC24A1;RTN4RL1;ZFP36L2;TRPV4;GLI2;TOM1L2;ADORA2B;ANK3;LAMP3;CLMN;PIDD1;SLX1A;SLX1B;GJC2;ZCCHC11;RHBDF1;PER2;UNC119;FNDC4;C5;ZNF658;SNTA1;PHF2;GSTM2;TCEAL1;AMIGO2;WWTR1;SEMA4G;ULK1;GLI3;FHOD3;THRAP3;BHLHE40;LRSAM1;ZNF655;NAIP;LTBP1;NMU;MAP2K5;GAS8;ITGA6;SRGAP3;SESN3;ZNF318;LZTS1;IGFBP4;TCFL5;JARID2;NUPR1;NISCH;INSR;CCDC85B;MMP28;GSN;CBLC;DDT;PLXNB3;PLEKHH2;TRIOBP;MXD4;CD109;ETAA1;DOCK8;DHX58;SLC27A1;TM7SF3;RTF1;MDK;H2AFJ;BMP6;NLRX1;MAP2K2;SQSTM1;CEP192;PTK6;FZD7;SYNGAP1;SHARPIN;KDM4C;HYAL1;ARRDC1;ZNF608;WHAMMP3;PLA2G6;CST3;MMRN2;BBS2;TXNIP;NPHP3;PLAG1;IDH2;MAP3K12;RCOR2;PODXL;IFI27;DNM1;TNFRSF21;IQCB1;MCTP1;CDK5R1;ATRX;ANO9;EFNB3;SESN1;SHANK3;HFE;HMG20B;CYBA;AGO4;HADH;RRM2B;SLIT3;SPRY2;FBXO2;GABBR1;CREBRF;XRN1;RAB11FIP3;MLXIPL;FBXW7;GPR87;ING4;CDK5RAP3;ATXN1;NFIX;TFPI2;MXI1;THRA;APC2;ARAP1;ASTN2;ADARB1;RAI1;ELF1;IKZF4;RPH3AL;ACACB;NLRP1;TNS2;NAB2;TP53I13;CAPG;LRP1;PEG3;NPHP4;RGS12;ACP5;C12ORF66;DLK2;BRINP1;SALL2;WNK1;JPH2;ZBTB20;PDE2A;MAF;LTB4R2;RET;ZMYND8;DAB2IP;RWDD3;TEAD2;FBXO4;RNF213;TSHZ2;IFI16;FGFR4;ERCC5;PIK3R2;AREG;SNCB;RPS6KA5;DLG5;BTG1;BST2;VDR;RGL2;TNRC18;TNRC6C;FAM3A;PLXND1;SIX5;PPP1R2;DMTN;PPP1R35;LMTK3;WWC3;PHF1;TFDP2;PMP22;NRARP;ACVR1B;KREMEN1;DLG4;PPP2R3B;PANO1;PALB2;IGFBP6;ZNF91;DYDC1;TCF7;SHANK2;RSAD2;ZFP36L1;LMNA;IL11;KAT2B;IRS2;ERN1;IVNS1ABP;ALOX15B;RAD50;GPR21;TKFC;ANGEL2;APBB2;PBLD;STAT6;PCSK1N;PRDX5;PHPT1;NELFCD;GPR132;SMPDL3B;KIF7;KLF8;CD9;RANBP9;PTPN3;ERBB2;SPOCD1;GPR68;AKAP6;ATG14;RORA;PPARG;PRKACA;CXXC5;ACKR3;SERPING1;PARN;UFL1;IP6K2;KLF9;PRMT3;SNX33;ZFP90;CCDC3;PER3;FOXP2;PTBP2;ZC3H6;HIVEP1;SMURF1;EML2;CTNNBIP1;PEMT;GCLC;ECM1
4724,GO:0010889,0.580897538417181,0.804243483516647,1,8,regulation of sequestering of triglyceride,BP,PPARG
950,GO:0002369,0.580994460305061,0.704473404911339,2,19,T cell cytokine production,BP,HFE;RSAD2
5423,GO:0016278,0.58100389525938,0.604643417350939,5,48,lysine N-methyltransferase activity,MF,ASH2L;METTL21A;SETD4;DYDC1;KMT5C
10350,GO:0043178,0.581392785395185,0.604028595552235,5,49,alcohol binding,MF,APOE;ITPR3;OSBPL10;ASTN2;OSBPL5
14734,GO:0070431,0.581508314387371,0.803752324673976,1,8,nucleotide-binding oligomerization domain containing 2 signaling pathway,BP,TNFAIP3
7180,GO:0031076,0.581509230710289,0.656813737361101,3,26,embryonic camera-type eye development,BP,ALDH1A3;IFT140;TH
9098,GO:0035385,0.581629662270624,0.80671915537355,1,7,Roundabout signaling pathway,BP,SLIT3
3725,GO:0008253,0.581654507227812,0.803634633968443,1,8,5'-nucleotidase activity,MF,NT5E
3830,GO:0008432,0.581792333044627,0.803523633385593,1,8,JUN kinase binding,MF,MAPK8IP3
12996,GO:0051451,0.581903093081804,0.803434398617097,1,8,myoblast migration,BP,NET1
10574,GO:0043552,0.582001997406111,0.705371551708631,2,17,positive regulation of phosphatidylinositol 3-kinase activity,BP,VAV3;ATG14
872,GO:0002224,0.58210189996835,0.55686283163898,9,90,toll-like receptor signaling pathway,BP,TNFAIP3;PTPRS;FLOT1;CYBA;CTSB;DAB2IP;PIK3C3;RSAD2;SMPDL3B
16312,GO:0090557,0.582177359810286,0.806283386587036,1,7,establishment of endothelial intestinal barrier,BP,PTPRS
6823,GO:0030291,0.582190998528372,0.65414984393591,3,30,protein serine/threonine kinase inhibitor activity,MF,SPRY2;WNK1;KAT2B
2284,GO:0005243,0.582478478607312,0.802970373518914,1,8,gap junction channel activity,MF,GJC2
5382,GO:0016208,0.582879360131498,0.800275496613953,1,9,AMP binding,MF,ACSS2
14050,GO:0060856,0.582936212029618,0.802600677500493,1,8,establishment of blood-brain barrier,BP,MXRA8
8641,GO:0034198,0.583337968606196,0.62315169480202,4,39,cellular response to amino acid starvation,BP,IMPACT;SESN3;SESN1;C12ORF66
17667,GO:1901567,0.583482879013234,0.700627894462147,2,21,fatty acid derivative binding,MF,HMGCL;PPARG
750,GO:0001991,0.583488578774873,0.802153896425144,1,8,regulation of systemic arterial blood pressure by circulatory renin-angiotensin,BP,F2R
16179,GO:0090232,0.583496024700658,0.802147868918017,1,8,positive regulation of spindle checkpoint,BP,NDRG1
10638,GO:0043691,0.583517813242692,0.802130230252658,1,8,reverse cholesterol transport,BP,APOE
12203,GO:0048469,0.583692121587451,0.555406306086196,9,88,cell maturation,BP,FAM20C;TFCP2L1;FAM210B;CABYR;REC8;RET;PPARG;PRKACA;NFASC
2197,GO:0005078,0.583791937549929,0.804994707752305,1,7,MAP-kinase scaffold activity,MF,MAPK8IP3
13228,GO:0051926,0.583873009409096,0.652927291877368,3,29,negative regulation of calcium ion transport,BP,PKD2;NOS1;GSTM2
12560,GO:0050746,0.583991950113525,0.801746122514362,1,8,regulation of lipoprotein metabolic process,BP,PEMT
6558,GO:0022010,0.584030256789936,0.801715066487042,1,8,central nervous system myelination,BP,TENM4
7763,GO:0032291,0.584030256789936,0.801715066487042,1,8,axon ensheathment in central nervous system,BP,TENM4
3795,GO:0008374,0.584112173018068,0.622680845861245,4,38,O-acyltransferase activity,MF,CPT2;CRAT;MBOAT2;CPT1C
7207,GO:0031109,0.584242433597141,0.555027612597348,9,86,microtubule polymerization or depolymerization,BP,RGS2;TUBGCP5;TRPV4;CEP192;CDK5R1;APC2;RANBP9;MAP1A;EML2
16780,GO:0098644,0.58475239630536,0.703886171558941,2,16,complex of collagen trimers,CC,COL7A1;TNXB
9677,GO:0038066,0.584924110174363,0.65236312513051,3,28,p38MAPK cascade,BP,MINK1;DAB2IP;ZFP36L1
7952,GO:0032559,0.58496321318802,0.454098254800236,126,1170,adenyl ribonucleotide binding,MF,ULK2;SIK1;SLFN5;ACTA2;OAS2;DDX60;HSPA2;EGFR;FAM20C;SYN1;KIF26B;EPHB2;MAP3K14;GLUD1;DGKQ;BRSK1;CUL9;CAMKK1;MVD;PRKACB;CMPK2;PIK3C2G;LIG1;CDK18;SPEG;MLH3;NMRK1;DDX59;OBSCN;MYH11;ACTR1B;RAPGEF3;OAS1;GAL3ST4;KIF26A;ALPK1;DNAH1;NEK9;TRPV4;DHX32;CLCN6;PSKH1;MINK1;ULK1;THRAP3;SMARCA1;NAIP;NEK8;MAP2K5;INSR;CHD3;CDK14;TTN;SLFNL1;DHX58;NLRX1;ETNK2;MAP2K2;OPLAH;PDK1;PTK6;PDIK1L;MAP3K12;WRN;MCM9;ATRX;MAPK10;ERCC6;HLCS;PAK6;PFKFB2;ACACB;NLRP1;TK2;GLUL;SRR;MAP3K6;RIMKLB;MYO3B;WNK1;PDE2A;STK16;RET;PIK3C3;DALRD3;FGFR4;MYO9A;RPS6KA5;NADK;BBS10;HLTF;STK19;LMTK3;ACVR1B;TSSK1B;WEE1;PTK7;DQX1;ACSL1;MARK4;TEP1;ERN1;RAD50;TKFC;PEX1;SCYL3;KIF7;CHD6;ACSS2;ERBB2;ABCA2;PRKACA;SUCLG2;UCKL1;DDX12P;IP6K2;RIPK3;PI4K2B;LONP2;HARS2;CIT;MSH5;CLCN7;TTLL1;ABCA11P;GCLC
454,GO:0001228,0.585645856529891,0.495346482497717,27,258,transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific DNA binding,MF,SREBF1;KLF13;NDN;GLI2;KLF7;ZNF76;SOX12;GLI3;ETV5;DLX3;TCF4;PLAG1;MEF2D;CREBRF;LMO2;CARF;ELF1;DBP;SALL2;MAF;STK16;TEF;HLTF;ZNF292;TFDP2;STAT6;RORA
8287,GO:0033129,0.585684666714874,0.80037051042237,1,8,positive regulation of histone phosphorylation,BP,RPS6KA5
6576,GO:0022409,0.586023552110349,0.525668418360796,14,139,positive regulation of cell-cell adhesion,BP,KIF26B;MAP3K14;PIK3R1;FLOT1;GLI2;ANK3;TNFRSF14;GLI3;ITGA6;DOCK8;PODXL;EFNB3;DMTN;CCDC88B
7208,GO:0031110,0.586051961649568,0.583862748700847,6,57,regulation of microtubule polymerization or depolymerization,BP,RGS2;TRPV4;CDK5R1;APC2;MAP1A;EML2
18145,GO:1902916,0.586252549887864,0.799907499710364,1,8,positive regulation of protein polyubiquitination,BP,FBXO4
9176,GO:0035567,0.58626251826731,0.529440058586959,13,132,non-canonical Wnt signaling pathway,BP,SFRP1;PRICKLE2;ARHGEF19;CELSR1;FZD7;NPHP3;AGO4;GNG2;RNF213;TNRC6C;PTK7;PLCB3;SMURF1
6380,GO:0021575,0.586388378119837,0.651426499122181,3,27,hindbrain morphogenesis,BP,SERPINE2;GLI2;RORA
11430,GO:0045893,0.586424339447278,0.45500228462247,110,1052,positive regulation of transcription, DNA-templated,BP,TP53INP1;SREBF1;EGFR;PKD2;CAPRIN2;ASH2L;SFRP1;SEC14L2;PIK3R1;KDM3A;POU3F1;RGMA;ZFPM1;CITED4;IRF2BPL;MC1R;STAT1;NOS1;MAML3;KLF13;NFATC4;RNF187;HSF4;EAPP;CRTC1;NDN;F2R;GLI2;KLF7;TCEA2;ZNF76;SOX12;PHF2;ABHD14B;WWTR1;GLI3;THRAP3;SMARCA1;MAP2K5;ITGA6;ZNF318;INSR;ZNF287;RTF1;MDK;BMP6;MAP2K2;SQSTM1;FZD7;ETV5;DLX3;HEXB;METTL23;TCF4;PLAG1;LPIN3;ATRX;ADIRF;ERCC6;MEF2D;CREBRF;MLXIPL;FBXW7;CDK5RAP3;LMO2;NFIX;CARF;THRA;RAI1;ELF1;IKZF4;DBP;PEG3;RFX2;SALL2;MAF;STK16;RET;DAB2IP;CASZ1;CALCOCO1;TEAD2;MYSM1;IFI16;PIK3R2;TEF;RPS6KA5;VDR;MAMSTR;PLXND1;SIX5;HLTF;PHF1;ZNF292;TFDP2;ACVR1B;TNNI2;NAT14;GLMP;IL11;KAT2B;IVNS1ABP;TRERF1;STAT6;CHD6;ERBB2;RORA;PPARG;ZFP90;NPNT
18406,GO:1903508,0.586424339447278,0.45500228462247,110,1052,positive regulation of nucleic acid-templated transcription,BP,TP53INP1;SREBF1;EGFR;PKD2;CAPRIN2;ASH2L;SFRP1;SEC14L2;PIK3R1;KDM3A;POU3F1;RGMA;ZFPM1;CITED4;IRF2BPL;MC1R;STAT1;NOS1;MAML3;KLF13;NFATC4;RNF187;HSF4;EAPP;CRTC1;NDN;F2R;GLI2;KLF7;TCEA2;ZNF76;SOX12;PHF2;ABHD14B;WWTR1;GLI3;THRAP3;SMARCA1;MAP2K5;ITGA6;ZNF318;INSR;ZNF287;RTF1;MDK;BMP6;MAP2K2;SQSTM1;FZD7;ETV5;DLX3;HEXB;METTL23;TCF4;PLAG1;LPIN3;ATRX;ADIRF;ERCC6;MEF2D;CREBRF;MLXIPL;FBXW7;CDK5RAP3;LMO2;NFIX;CARF;THRA;RAI1;ELF1;IKZF4;DBP;PEG3;RFX2;SALL2;MAF;STK16;RET;DAB2IP;CASZ1;CALCOCO1;TEAD2;MYSM1;IFI16;PIK3R2;TEF;RPS6KA5;VDR;MAMSTR;PLXND1;SIX5;HLTF;PHF1;ZNF292;TFDP2;ACVR1B;TNNI2;NAT14;GLMP;IL11;KAT2B;IVNS1ABP;TRERF1;STAT6;CHD6;ERBB2;RORA;PPARG;ZFP90;NPNT
15200,GO:0071375,0.58669732338844,0.500852821124703,23,222,cellular response to peptide hormone stimulus,BP,SREBF1;SRSF5;PIK3R1;STAT1;PRKACB;MDM2;VAMP2;SESN3;INSR;BAIAP2;TCIRG1;ATP6V0A2;CA2;CYBA;GNG2;PIK3R2;ZFP36L1;KAT2B;IRS2;GPR21;PPARG;PRKACA;GCLC
12558,GO:0050732,0.587064434654682,0.619385906276689,4,39,negative regulation of peptidyl-tyrosine phosphorylation,BP,SFRP1;CBLC;PTK6;DMTN
3124,GO:0006704,0.587153861442945,0.799171071849535,1,8,glucocorticoid biosynthetic process,BP,DGKQ
10141,GO:0042733,0.587309906993531,0.598457087608507,5,47,embryonic digit morphogenesis,BP,FBXW4;GLI2;GLI3;IFT140;TMEM231
20265,GO:2001267,0.587317545650502,0.697664750040973,2,20,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,TNFSF10;GSN
10534,GO:0043500,0.587370433696038,0.582335915751975,6,58,muscle adaptation,BP,RGS2;JARID2;GSN;CYBA;LMNA;AKAP6
15348,GO:0071609,0.587445456818751,0.798932408753094,1,8,chemokine (C-C motif) ligand 5 production,BP,TRPV4
3088,GO:0006662,0.587592076428834,0.796404495544887,1,9,glycerol ether metabolic process,BP,PEX7
12408,GO:0048873,0.58773689853015,0.698050651853716,2,19,homeostasis of number of cells within a tissue,BP,IL20RB;F2R
15789,GO:0072507,0.588049533269393,0.499346547390173,23,227,divalent inorganic cation homeostasis,BP,APOE;EGFR;PKD2;NOS1;ITPR3;F2R;MT1X;SLC24A1;TRPV4;ANK3;GSTM2;NMU;HEXB;PLA2G6;CYBA;JPH2;TMEM203;VDR;CACNB3;LPAR6;DLG4;AKAP6;PRKACA
16115,GO:0090140,0.588094845754146,0.698589744071135,2,18,regulation of mitochondrial fission,BP,DDHD2;STAT2
17952,GO:1902369,0.588182860013667,0.618563502425536,4,38,negative regulation of RNA catabolic process,BP,CIRBP;THRAP3;ANGEL2;PARN
404,GO:0001085,0.588222246578295,0.537673003530795,11,107,RNA polymerase II transcription factor binding,MF,ZFPM1;BHLHE40;BBS2;TCF4;IFI27;MEF2D;LMO2;BBS1;TEAD2;BBS5;BBS10
16062,GO:0090049,0.588234917807122,0.649069100131699,3,28,regulation of cell migration involved in sprouting angiogenesis,BP,MAP2K5;MMRN2;SRPX2
15970,GO:0086001,0.588316957272038,0.619106780029038,4,36,cardiac muscle cell action potential,BP,ANK3;SNTA1;KCNJ5;SCN4B
2516,GO:0005770,0.588430879241443,0.507512656214757,19,190,late endosome,CC,EGFR;MVB12B;NSG1;MICALL1;VPS11;F2R;CLTCL1;VPS39;TMEM9;MAP2K2;SQSTM1;CST3;CHMP1B;ASTN2;PMEL;PIK3C3;BST2;OSBPL1A;LAPTM4A
15243,GO:0071439,0.588629030071881,0.797961615657615,1,8,clathrin complex,CC,CLTCL1
18681,GO:1904063,0.588641678036564,0.617786281136325,4,39,negative regulation of cation transmembrane transport,BP,PKD2;EPHB2;ANK3;GSTM2
7052,GO:0030838,0.588738154856733,0.568161141184408,7,71,positive regulation of actin filament polymerization,BP,ARPIN;WIPF1;GSN;BAIAP2;RICTOR;WHAMMP3;WASH3P
15837,GO:0072577,0.588888458159939,0.648936926944602,3,27,endothelial cell apoptotic process,BP,TNFAIP3;PDCD4;DAB2IP
2665,GO:0006013,0.588901593108993,0.797737582163322,1,8,mannose metabolic process,BP,MPI
6765,GO:0030206,0.588910863935724,0.698802638923422,2,17,chondroitin sulfate biosynthetic process,BP,CSPG4;XYLT1
10397,GO:0043249,0.58891520782226,0.797726386903001,1,8,erythrocyte maturation,BP,FAM210B
19145,GO:1905207,0.588997338733226,0.648308105266376,3,28,regulation of cardiocyte differentiation,BP,EGFR;FZD7;AKAP6
10289,GO:0043067,0.589062066009158,0.451906778761489,112,1107,regulation of programmed cell death,BP,TNFAIP3;SIK1;TP53INP1;IFI6;APOE;INPP5D;EGFR;MNT;ALDH1A3;SFRP1;EPHB2;MAP3K14;PIK3R1;RBCK1;TSC22D3;VAV3;KITLG;STAT1;HS1BP3;UNC5B;PLEKHG5;NFATC4;NDRG1;MDM2;OBSCN;TNFSF10;F2R;PDCD4;GLI2;LAMP3;PIDD1;ARHGEF19;MINK1;AMIGO2;TNFRSF14;ARHGEF4;GLI3;NAIP;MAP2K5;ITGA6;NUPR1;INSR;GSN;PNMA1;ARHGEF1;DOCK8;TP53AIP1;ENDOG;TM7SF3;MDK;BMP6;MAP2K2;SQSTM1;SYNGAP1;PLA2G6;CST3;GDF15;TXNIP;MAP3K12;WRN;IFI27;TNFRSF21;CDK5R1;NET1;AGO4;RRM2B;SPRY2;CTSB;FBXW7;KCNMA1;ING4;PAK6;THRA;NLRP1;BEX2;LRP1;RET;DAB2IP;FGFR4;ERCC5;IL20RA;SNCB;DLG5;BTG1;VDR;RGL2;ARHGEF17;TFDP2;PANO1;PALB2;TCF7;TNFRSF25;ZFP36L1;LMNA;MARK4;IRS2;IVNS1ABP;ZMAT3;APBB2;ARHGEF9;TNFSF12;PRDX5;TRAF5;TRIM2;ERBB2;PPARG;ACKR3;UFL1;IP6K2;RIPK3;SERINC3;GCLC
13996,GO:0060740,0.589257611002509,0.698470600542252,2,17,prostate gland epithelium morphogenesis,BP,SFRP1;GLI2
3223,GO:0006874,0.5892690736665,0.504356842914917,20,196,cellular calcium ion homeostasis,BP,APOE;PKD2;NOS1;ITPR3;F2R;SLC24A1;TRPV4;GSTM2;NMU;HEXB;PLA2G6;CYBA;JPH2;TMEM203;VDR;CACNB3;LPAR6;DLG4;AKAP6;PRKACA
11578,GO:0046174,0.589448310575143,0.697291754072537,2,18,polyol catabolic process,BP,IMPA2;TKFC
7589,GO:0031968,0.589535981512904,0.514795329124332,16,162,organelle outer membrane,CC,BPHL;SPATA18;SNN;ITPR3;FAM210B;ULK1;NLRX1;IFI27;ACACB;PDE2A;RETSAT;LETMD1;RSAD2;ACSL1;CPT1C;SYNE2
4483,GO:0010508,0.589563418820784,0.542454400229477,10,96,positive regulation of autophagy,BP,EPM2A;TP53INP1;GPSM1;TRIM65;TRIM22;ULK1;LRSAM1;SESN3;SESN1;SMURF1
7629,GO:0032045,0.589631660257754,0.797136631822235,1,8,guanyl-nucleotide exchange factor complex,CC,ULK1
11242,GO:0045499,0.589658491897276,0.698086442859719,2,17,chemorepellent activity,MF,FLRT3;SEMA4G
16835,GO:0098779,0.589706059066561,0.797075319618501,1,8,positive regulation of mitophagy in response to mitochondrial depolarization,BP,SMURF1
17647,GO:1901526,0.589706059066561,0.797075319618501,1,8,positive regulation of mitophagy,BP,SMURF1
6694,GO:0030099,0.589819316873989,0.489272526519815,28,289,myeloid cell differentiation,BP,INPP5D;FAM20C;ASH2L;SFRP1;PIK3R1;ZFPM1;KITLG;STAT1;MYL9;KLF13;FAM210B;CD109;FAM213A;CA2;AGO4;FBXW7;THRA;IFI16;TNRC6C;DMTN;ACVR1B;NBEAL2;ZFP36L1;IL11;KAT2B;GPR68;PPARG;CTNNBIP1
15842,GO:0072584,0.589868226956757,0.7969416310209,1,8,caveolin-mediated endocytosis,BP,UNC119
3213,GO:0006857,0.589953114924305,0.796871625743097,1,8,oligopeptide transport,BP,CA2
20261,GO:2001256,0.590243754644795,0.796631811236751,1,8,regulation of store-operated calcium entry,BP,HOMER2
7189,GO:0031086,0.590277778255781,0.796603724276247,1,8,nuclear-transcribed mRNA catabolic process, deadenylation-independent decay,BP,ZFP36L1
18059,GO:1902680,0.590505632311791,0.450839771997043,110,1053,positive regulation of RNA biosynthetic process,BP,TP53INP1;SREBF1;EGFR;PKD2;CAPRIN2;ASH2L;SFRP1;SEC14L2;PIK3R1;KDM3A;POU3F1;RGMA;ZFPM1;CITED4;IRF2BPL;MC1R;STAT1;NOS1;MAML3;KLF13;NFATC4;RNF187;HSF4;EAPP;CRTC1;NDN;F2R;GLI2;KLF7;TCEA2;ZNF76;SOX12;PHF2;ABHD14B;WWTR1;GLI3;THRAP3;SMARCA1;MAP2K5;ITGA6;ZNF318;INSR;ZNF287;RTF1;MDK;BMP6;MAP2K2;SQSTM1;FZD7;ETV5;DLX3;HEXB;METTL23;TCF4;PLAG1;LPIN3;ATRX;ADIRF;ERCC6;MEF2D;CREBRF;MLXIPL;FBXW7;CDK5RAP3;LMO2;NFIX;CARF;THRA;RAI1;ELF1;IKZF4;DBP;PEG3;RFX2;SALL2;MAF;STK16;RET;DAB2IP;CASZ1;CALCOCO1;TEAD2;MYSM1;IFI16;PIK3R2;TEF;RPS6KA5;VDR;MAMSTR;PLXND1;SIX5;HLTF;PHF1;ZNF292;TFDP2;ACVR1B;TNNI2;NAT14;GLMP;IL11;KAT2B;IVNS1ABP;TRERF1;STAT6;CHD6;ERBB2;RORA;PPARG;ZFP90;NPNT
15871,GO:0072659,0.590589675162137,0.505458136245946,19,184,protein localization to plasma membrane,BP,EGFR;EPHB2;PIK3R1;VAMP3;NSG1;RAB40B;FLOT1;ANK3;VAMP2;SQSTM1;EPB41L3;BBS2;LRP1;BBS1;CACNB3;GOLGA7B;LDLRAP1;NFASC;SMURF1
723,GO:0001953,0.590757265711356,0.647069539345657,3,27,negative regulation of cell-matrix adhesion,BP,POSTN;PIK3R1;DMTN
8213,GO:0032982,0.591015892596513,0.79915399614029,1,7,myosin filament,CC,MYH11
8787,GO:0034498,0.591023021279262,0.795987822189097,1,8,early endosome to Golgi transport,BP,SNX1
10062,GO:0042574,0.591088067079908,0.795934002431225,1,8,retinal metabolic process,BP,ALDH1A3
4934,GO:0014896,0.591151665322304,0.580303239737107,6,49,muscle hypertrophy,BP,RGS2;JARID2;TTN;CYBA;LMNA;AKAP6
6280,GO:0019888,0.591177585109304,0.578087945708796,6,60,protein phosphatase regulator activity,MF,ELFN2;PPP2R2C;PHACTR3;PPP1R2;PPP1R35;PPP2R3B
14246,GO:0061337,0.591183583605691,0.566303745336307,7,66,cardiac conduction,BP,NOS1;ITPR3;KCNJ5;SCN4B;CACNB3;CACNB1;PRKACA
12730,GO:0051018,0.591313547513078,0.61571237890183,4,37,protein kinase A binding,MF,AKAP7;ARFGEF2;AKAP6;PRKACA
10594,GO:0043587,0.591455903324364,0.795629459311482,1,8,tongue morphogenesis,BP,CYP26B1
10477,GO:0043392,0.59154861668077,0.614533054034779,4,40,negative regulation of DNA binding,BP,PER2;IFI16;ZFP90;CTNNBIP1
5297,GO:0015988,0.591558799074526,0.692862973055454,2,21,energy coupled proton transmembrane transport, against electrochemical gradient,BP,TCIRG1;ATP6V0A2
6812,GO:0030277,0.591711970898643,0.795417261659455,1,8,maintenance of gastrointestinal epithelium,BP,PBLD
8145,GO:0032881,0.592079732592739,0.645744740082337,3,27,regulation of polysaccharide metabolic process,BP,INSR;EPM2AIP1;IRS2
2425,GO:0005605,0.592113845340013,0.696862870096517,2,16,basal lamina,CC,NID1;LAMB2
10626,GO:0043650,0.592324277637364,0.794909218918296,1,8,dicarboxylic acid biosynthetic process,BP,GLUD1
6773,GO:0030215,0.592394467510807,0.695456513501057,2,17,semaphorin receptor binding,MF,PLXNB1;SEMA4G
3008,GO:0006554,0.59242891463765,0.794822309563584,1,8,lysine catabolic process,BP,ALDH7A1
5703,GO:0016835,0.592440724920495,0.591941711053146,5,53,carbon-oxygen lyase activity,MF,UROS;THNSL2;CA2;ECI1;EHHADH
11788,GO:0046686,0.592486762939601,0.612533784038504,4,44,response to cadmium ion,BP,EGFR;MT1X;GSN;GCLC
1869,GO:0004536,0.592565800960839,0.576346584092842,6,62,deoxyribonuclease activity,MF,SLX1A;SLX1B;ENDOG;TREX1;ERCC5;RAD50
4101,GO:0009157,0.592619015303543,0.792217160247414,1,9,deoxyribonucleoside monophosphate biosynthetic process,BP,TK2
1436,GO:0003417,0.592619187013054,0.794664205827461,1,8,growth plate cartilage development,BP,THBS3
8103,GO:0032799,0.592871599912579,0.693102447488838,2,19,low-density lipoprotein receptor particle metabolic process,BP,APOE;PPARG
3753,GO:0008296,0.592877878312294,0.79199989058648,1,9,3'-5'-exodeoxyribonuclease activity,MF,TREX1
16031,GO:0086091,0.592901121637358,0.694967945105655,2,17,regulation of heart rate by cardiac conduction,BP,KCNJ5;SCN4B
433,GO:0001162,0.593057474308608,0.794299687080513,1,8,RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding,MF,ZC3H6
7077,GO:0030879,0.593285305036972,0.538597215730403,10,96,mammary gland development,BP,OAS2;WNT3;GLI2;ITGA2;GLI3;ETV5;AREG;VDR;IRS2;STAT6
11001,GO:0044848,0.593396460005077,0.794017439477492,1,8,biological phase,BP,FERMT1
11003,GO:0044851,0.593396460005077,0.794017439477492,1,8,hair cycle phase,BP,FERMT1
12377,GO:0048819,0.593396460005077,0.794017439477492,1,8,regulation of hair follicle maturation,BP,FERMT1
3777,GO:0008333,0.593661931087134,0.591710168758822,5,48,endosome to lysosome transport,BP,VPS11;TRAK1;VPS39;HOOK2;ATG14
11279,GO:0045606,0.593720853523855,0.692279252477463,2,19,positive regulation of epidermal cell differentiation,BP,VDR;ALOX15B
9963,GO:0042364,0.593783894894083,0.793694513051096,1,8,water-soluble vitamin biosynthetic process,BP,PNPO
12141,GO:0048265,0.593918242346361,0.793582450168986,1,8,response to pain,BP,RET
12696,GO:0050951,0.594054104805051,0.793469079316337,1,8,sensory perception of temperature stimulus,BP,ANO1
14701,GO:0070373,0.594171066305774,0.590962426393481,5,49,negative regulation of ERK1 and ERK2 cascade,BP,EPHB2;CAMK2N1;SPRY2;DAB2IP;RANBP9
13784,GO:0060395,0.594174708302204,0.612793523121993,4,37,SMAD protein signal transduction,BP,WWTR1;BMP6;GDF15;PBLD
10045,GO:0042542,0.594225964250887,0.537019960715168,10,104,response to hydrogen peroxide,BP,TNFAIP3;STAT1;IMPACT;MDM2;ENDOG;CST3;TXNIP;NET1;AREG;STAT6
18023,GO:1902570,0.594251251859574,0.790844480019888,1,9,protein localization to nucleolus,BP,WRN
11877,GO:0046914,0.594272634079722,0.454936795822334,75,734,transition metal ion binding,MF,TNFAIP3;NPEPL1;TRIM65;FAM20C;APOBEC3C;TRIM22;KDM3A;PRICKLE2;NOS1;HMGCL;CYP26B1;CYHR1;MDM2;TNFSF10;CYP3A5;TRIM66;PHYH;MT1X;GLI2;KLF7;RNF165;ADAMTS13;TCEA2;ZCCHC11;DTNB;PHF2;ZNF318;MMP1;MMP28;CHD3;CBLC;RNPEPL1;CYP2D7;DHX58;PEX10;S100A4;SQSTM1;LOXL1;KDM4C;ZCCHC24;WRN;CA2;SHANK3;TRIM38;THRA;IKZF4;LACTB2;GLUL;ACP5;RNPEP;ZNF276;SNCB;VDR;ZMYM3;HLTF;MARCH8;MPPE1;PRIMPOL;ALOXE3;ENDOU;MPI;ZNF91;ALOX15B;ZMAT3;MTR;S100A6;ZSWIM8;PHC2;TRAF5;TRIM2;PPM1M;TH;RORA;PPARG;CXXC5
15154,GO:0071310,0.594273097062381,0.438737415524908,183,1795,cellular response to organic substance,BP,TNFAIP3;POSTN;SIK1;TP53INP1;IFI6;SREBF1;INPP5D;OAS2;HSPA2;EGFR;FAM20C;PKD2;CXCR1;TRIM22;SRSF5;SFRP1;MAP3K14;PIK3R1;ADAMTS7;RBCK1;KDM3A;SULF2;WNT3;ISG15;HTRA1;RGMA;CUL7;VAMP3;STAT1;IMPACT;CRY2;UROS;ITGB5;RAB43;NOS1;PRKACB;CRY1;NFATC4;FERMT1;CYP26B1;CMPK2;MICALL1;MDM2;NDN;IFITM1;LTBP4;HLA-B;NEO1;RAPGEF3;FAM210B;OAS1;FLRT3;IL20RB;MT1X;PDCD4;RTN4RL1;ZFP36L2;FLOT1;GLI2;RNF165;ADAMTS13;ZCCHC11;TMEM204;FRS3;GSTM2;TNFRSF14;ITGA2;SPPL2B;THRAP3;VAMP2;LTBP1;MAP2K5;ITGA6;SESN3;MMP1;JARID2;INSR;GSN;BAIAP2;CD109;DOCK8;ENDOG;SLC27A1;TM7SF3;IRF9;BMP6;TCIRG1;MAP2K2;SQSTM1;PTK6;FZD7;SHARPIN;HYAL1;PLA2G6;MMRN2;GDF15;BBS2;CTF1;ATP6V0A2;COL6A1;IFI27;TNFRSF21;CDK5R1;CA2;SESN1;MAPK10;HFE;CYBA;TRIM38;AGO4;SLIT3;EDA2R;SPRY2;CREBRF;XRN1;MLXIPL;CTSB;CDK5RAP3;LMO2;PAQR6;THRA;ELF1;MX2;GNG2;LRP1;HLA-A;RFX2;BRINP1;PDE2A;STK16;RET;DAB2IP;CALCOCO1;TEAD2;FGFR4;IL20RA;PIK3R2;RPS6KA5;BST2;VDR;PCSK6;DMTN;STAT2;UCN2;CD68;DUOX1;PTK7;TCF7;RSAD2;TNFRSF25;ZFP36L1;LMNA;ACSL1;IL11;KAT2B;IRS2;ANO1;ERN1;GPR21;PBLD;TNFSF12;STAT6;PHPT1;CACNB1;ERBB2;SYNGR1;GPR68;PAQR7;AKAP6;TH;RORA;PPARG;PRKACA;ACKR3;UFL1;IP6K2;KLF9;AIP;CCDC3;SMURF1;NPNT;GCLC;ECM1
15390,GO:0071675,0.59447123992145,0.690751563845118,2,20,regulation of mononuclear cell migration,BP,TRPV4;PLA2G7
15192,GO:0071361,0.594902707167753,0.795960171740439,1,7,cellular response to ethanol,BP,TP53INP1
5859,GO:0017162,0.594917788387364,0.792747333852892,1,8,aryl hydrocarbon receptor binding,MF,AIP
14700,GO:0070372,0.594932444459591,0.506264235311402,17,168,regulation of ERK1 and ERK2 cascade,BP,GPNMB;EGFR;EPHB2;CAMK2N1;F2R;TRPV4;INSR;DDT;SPRY2;FBXW7;RET;DAB2IP;FGFR4;RANBP9;ERBB2;ACKR3;NPNT
4355,GO:0009953,0.595022534279666,0.590308136687543,5,48,dorsal/ventral pattern formation,BP,SFRP1;WNT3;PRKACB;GLI2;GLI3
13855,GO:0060502,0.595091189252173,0.792602212464672,1,8,epithelial cell proliferation involved in lung morphogenesis,BP,FOXP2
6714,GO:0030131,0.595132674686144,0.642150814053318,3,28,clathrin adaptor complex,CC,EGFR;AP1G2;LDLRAP1
9538,GO:0036310,0.595326879814051,0.792404843394079,1,8,annealing helicase activity,MF,SMARCA1
1176,GO:0002823,0.595351935709463,0.690694387924401,2,19,negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,IL20RB;HFE
4107,GO:0009164,0.595504751691414,0.68902449637242,2,21,nucleoside catabolic process,BP,NT5E;APOBEC3C
8183,GO:0032933,0.595914142929682,0.791912479599204,1,8,SREBP signaling pathway,BP,FBXW7
15288,GO:0071501,0.595914142929682,0.791912479599204,1,8,cellular response to sterol depletion,BP,FBXW7
15462,GO:0071837,0.596136282626616,0.791726018847486,1,8,HMG box domain binding,MF,HOXA3
10820,GO:0044327,0.596408420000816,0.791497427590557,1,8,dendritic spine head,CC,DNM1
19050,GO:1904953,0.596597664482559,0.791338359103191,1,8,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation,BP,WNT3
3430,GO:0007219,0.597343967464946,0.518205350732064,13,127,Notch signaling pathway,BP,POSTN;EGFR;STAT1;MAML3;MDK;ARRDC1;DTX3;FBXW7;NOTCH2NL;DLK2;PLXND1;NRARP;KAT2B
15982,GO:0086013,0.597616437882353,0.790480538145435,1,8,membrane repolarization during cardiac muscle cell action potential,BP,KCNJ5
16268,GO:0090383,0.597893245894037,0.686686733023086,2,21,phagosome acidification,BP,TCIRG1;ATP6V0A2
12973,GO:0051409,0.597923405934473,0.787732639813003,1,9,response to nitrosative stress,BP,GCLC
11126,GO:0045185,0.598389093733305,0.540093913416942,9,89,maintenance of protein location,BP,PKD2;ANK3;LTBP1;GSN;SUN1;EPB41L3;MXI1;THRA;SYNE2
9849,GO:0042110,0.598568016534714,0.481827768918362,27,268,T cell activation,BP,GPNMB;MAP3K14;PIK3R1;ZFPM1;CYP26B1;IL20RB;ZFP36L2;GLI2;TNFRSF14;GLI3;GSN;DOCK8;FZD7;TNFRSF21;EFNB3;HFE;DLG5;NRARP;CCDC88B;TCF7;RSAD2;ZFP36L1;STAT6;SOX13;ERBB2;RORA;RIPK3
2967,GO:0006506,0.598711758712509,0.636770960211728,3,32,GPI anchor biosynthetic process,BP,PGAP1;PIGZ;MPPE1
149,GO:0000305,0.598816047648599,0.685780623894215,2,21,response to oxygen radical,BP,TXNRD3;ERCC6
10487,GO:0043403,0.598973613634128,0.687157243535923,2,19,skeletal muscle tissue regeneration,BP,EYS;FZD7
6320,GO:0019992,0.599170055674336,0.789167499914797,1,8,diacylglycerol binding,MF,PLTP
11102,GO:0045141,0.599278553694742,0.789075582589222,1,8,meiotic telomere clustering,BP,SUN1
16173,GO:0090220,0.599278553694742,0.789075582589222,1,8,chromosome localization to nuclear envelope involved in homologous chromosome segregation,BP,SUN1
13806,GO:0060425,0.599326243899752,0.607175193768193,4,38,lung morphogenesis,BP,CELSR1;SPRY2;DLG5;FOXP2
15197,GO:0071372,0.59946871623271,0.788914411227275,1,8,cellular response to follicle-stimulating hormone stimulus,BP,GCLC
11737,GO:0046600,0.599511423190495,0.788878202969774,1,8,negative regulation of centriole replication,BP,KAT2B
15479,GO:0071872,0.599616452867938,0.788789136611181,1,8,cellular response to epinephrine stimulus,BP,PRKACA
9007,GO:0035196,0.59984222881931,0.606643673551652,4,38,production of miRNAs involved in gene silencing by miRNA,BP,EGFR;ZCCHC11;MAP2K2;AGO4
12305,GO:0048672,0.600221045203963,0.78576882997633,1,9,positive regulation of collateral sprouting,BP,WNT3
11673,GO:0046474,0.600282758400321,0.492996702021723,20,194,glycerophospholipid biosynthetic process,BP,INPP5D;DGKQ;PIK3R1;PITPNM3;PIK3C2G;PITPNM2;SLC27A1;PGAP1;ETNK2;PLA2G6;LPIN3;PIGZ;DDHD2;PIK3C3;FGFR4;PIK3R2;MPPE1;IRS2;PI4K2B;PEMT
18624,GO:1903955,0.600292407431172,0.568330313878965,6,62,positive regulation of protein targeting to mitochondrion,BP,VPS11;HPS4;MICALL2;OSCP1;FBXW7;PEMT
10295,GO:0043085,0.600301004053452,0.441680805067046,105,1021,positive regulation of catalytic activity,BP,APOE;ALS2CL;LMF1;HSPA2;EGFR;PKD2;SFRP1;EPHB2;MAP3K14;DGKQ;EVI5L;DOCK9;CAMKK1;VAV3;CSPG4;KITLG;ASAP3;NOS1;PRKACB;TBC1D8;PLXNB1;CHN2;TNFSF10;RAPGEF3;RASA4;RGS2;ACAP3;F2R;AGAP4;ADORA2B;RALGAPA1;MAPK8IP3;PIDD1;ARHGEF19;UNC119;C5;MINK1;TBC1D19;ASAP2;ITGA2;MAP2K5;ITGA6;SRGAP3;INSR;GSN;RIN1;ETAA1;ARHGEF1;MGST2;DOCK8;PILRB;SLC27A1;RICTOR;MAP2K2;SYNGAP1;FAM13A;ARHGAP33;MAP3K12;WRN;IFI27;CDK5R1;ARHGAP27;AGAP6;NET1;MAPK10;CYBA;ERCC6;SHC2;SPRY2;AGAP7P;FBXW7;PAK6;PFKFB2;APC2;ARAP1;NLRP1;TBC1D17;NAB2;EPM2AIP1;RGS12;MAP3K6;WNK1;RET;DAB2IP;IFI16;FGFR4;PIK3R2;MYO9A;VDR;TBC1D16;SGSM2;DLG4;IQSEC1;ACSL1;ERN1;RAD50;ERBB2;ARHGAP23;AKAP6;ATG14;PPARG;PRKACA;PARN;RIPK3;NPNT
4718,GO:0010883,0.600574997630862,0.636148742935799,3,29,regulation of lipid storage,BP,FBXW7;ACACB;PPARG
17286,GO:0140103,0.60068984560305,0.685472317237133,2,19,catalytic activity, acting on a glycoprotein,MF,B4GALNT4;GCNT4
19494,GO:1990403,0.600783653733445,0.787797516030882,1,8,embryonic brain development,BP,IFT140
17291,GO:0140131,0.600816226417561,0.785258008139292,1,9,positive regulation of lymphocyte chemotaxis,BP,CXCL14
18778,GO:1904350,0.600819706786276,0.787766833122779,1,8,regulation of protein catabolic process in the vacuole,BP,LRP1
5735,GO:0016885,0.601062689494091,0.787559959609071,1,8,ligase activity, forming carbon-carbon bonds,MF,ACACB
15856,GO:0072604,0.601114170296733,0.68505486131825,2,19,interleukin-6 secretion,BP,F2R;TRPV4
979,GO:0002433,0.601346787855588,0.567876197744455,6,58,immune response-regulating cell surface receptor signaling pathway involved in phagocytosis,BP,PIK3R1;VAV3;WIPF1;BAIAP2;PLA2G6;PIK3R2
9688,GO:0038096,0.601346787855588,0.567876197744455,6,58,Fc-gamma receptor signaling pathway involved in phagocytosis,BP,PIK3R1;VAV3;WIPF1;BAIAP2;PLA2G6;PIK3R2
2819,GO:0006284,0.60137153332692,0.604166282170459,4,41,base-excision repair,BP,LIG1;WRN;ERCC6;MPG
2438,GO:0005639,0.601406028451132,0.787267395952312,1,8,integral component of nuclear inner membrane,CC,SUN1
7254,GO:0031229,0.601406028451132,0.787267395952312,1,8,intrinsic component of nuclear inner membrane,CC,SUN1
10894,GO:0044453,0.601406028451132,0.787267395952312,1,8,nuclear membrane part,CC,SUN1
14015,GO:0060766,0.601506584585516,0.787181655796171,1,8,negative regulation of androgen receptor signaling pathway,BP,SFRP1
15283,GO:0071495,0.601847217894518,0.442316397344869,94,902,cellular response to endogenous stimulus,BP,POSTN;SIK1;SREBF1;EGFR;FAM20C;PKD2;SRSF5;SFRP1;PIK3R1;ADAMTS7;KDM3A;SULF2;HTRA1;RGMA;STAT1;IMPACT;CRY2;UROS;ITGB5;PRKACB;CRY1;FERMT1;MICALL1;MDM2;LTBP4;NEO1;RAPGEF3;FAM210B;FLRT3;PDCD4;ZFP36L2;RNF165;FRS3;GSTM2;ITGA2;THRAP3;VAMP2;LTBP1;SESN3;INSR;BAIAP2;CD109;SLC27A1;BMP6;TCIRG1;HYAL1;GDF15;BBS2;ATP6V0A2;COL6A1;CDK5R1;CA2;SESN1;HFE;CYBA;SLIT3;SPRY2;CREBRF;XRN1;CTSB;LMO2;PAQR6;THRA;GNG2;LRP1;PDE2A;STK16;DAB2IP;CALCOCO1;FGFR4;PIK3R2;VDR;PCSK6;DMTN;UCN2;ZFP36L1;ACSL1;KAT2B;IRS2;GPR21;PBLD;CACNB1;ERBB2;PAQR7;AKAP6;TH;RORA;PPARG;PRKACA;UFL1;KLF9;SMURF1;NPNT;GCLC
5627,GO:0016709,0.601907035479231,0.684273903006751,2,19,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen,MF,NOS1;CYP26B1
3067,GO:0006633,0.60192920091671,0.536052835200647,9,93,fatty acid biosynthetic process,BP,THNSL2;MLYCD;PTGS1;MLXIPL;ACACB;ALOXE3;ALOX15B;CBR4;ACSS2
5573,GO:0016593,0.601951235654945,0.786802221104679,1,8,Cdc73/Paf1 complex,CC,RTF1
5350,GO:0016114,0.602148739381139,0.784111192856811,1,9,terpenoid biosynthetic process,BP,ALDH1A3
705,GO:0001931,0.602731873208444,0.786134898713793,1,8,uropod,CC,FLOT1
7266,GO:0031254,0.602731873208444,0.786134898713793,1,8,cell trailing edge,CC,FLOT1
16251,GO:0090335,0.602841235005938,0.786041291352586,1,8,regulation of brown fat cell differentiation,BP,TRPV4
6050,GO:0019200,0.603113590244802,0.683083144828066,2,19,carbohydrate kinase activity,MF,FGGY;PFKFB2
7235,GO:0031167,0.603478943702622,0.681177157082977,2,21,rRNA methylation,BP,NSUN5P2;TARBP1
13341,GO:0052548,0.603536506360721,0.479458200937986,25,266,regulation of endopeptidase activity,BP,SERPINE2;IFI6;COL7A1;SPOCK1;MDM2;TNFSF10;F2R;SERPINB5;LAMP3;PIDD1;C5;NAIP;MAP2K5;GSN;CD109;CST3;IFI27;TFPI2;NLRP1;IFI16;BST2;PCSK1N;PRDX5;PPARG;SERPING1
7314,GO:0031331,0.603591678129273,0.47395226858666,29,281,positive regulation of cellular catabolic process,BP,TNFAIP3;EPM2A;TP53INP1;APOE;GPSM1;TRIM65;TRIM22;MAGEF1;VPS11;MDM2;RAPGEF3;ZFP36L2;ULK1;LRSAM1;SESN3;INSR;ENDOG;SESN1;MLXIPL;FBXW7;PFKFB2;LRP1;DAB2IP;TNRC6C;ZFP36L1;IRS2;SNX33;SMURF1;GCLC
9113,GO:0035435,0.603878403572725,0.785152063759432,1,8,phosphate ion transmembrane transport,BP,SLC37A2
3792,GO:0008361,0.604098716069543,0.511376025056255,13,123,regulation of cell size,BP,ULK2;APOE;PTPRS;WNT3;VAV3;TRPV4;CLCN6;SEMA4G;SLC12A7;CDK5R1;SHANK3;KCNMA1;RET
8784,GO:0034483,0.604192698461142,0.784882073357859,1,8,heparan sulfate sulfotransferase activity,MF,NDST2
12181,GO:0048368,0.604231420633404,0.784848792687434,1,8,lateral mesoderm development,BP,TEAD2
6903,GO:0030500,0.605035781486526,0.601272887803026,4,38,regulation of bone mineralization,BP,FAM20C;ISG15;BMP6;ECM1
17905,GO:1902253,0.605171463324508,0.678832246108593,2,22,regulation of intrinsic apoptotic signaling pathway by p53 class mediator,BP,MDM2;RRM2B
2268,GO:0005200,0.605188584068007,0.541296657430306,8,79,structural constituent of cytoskeleton,MF,KRT15;PPL;SPTB;TUBGCP5;ANK3;EPB41L3;EPB41L4A;KRT14
10299,GO:0043094,0.605203240439643,0.63013723618945,3,32,cellular metabolic compound salvage,BP,NAPRT;TK2;UCKL1
597,GO:0001765,0.60529071527162,0.781389652484172,1,9,membrane raft assembly,BP,FLOT1
1118,GO:0002707,0.605449233848126,0.679953692636485,2,20,negative regulation of lymphocyte mediated immunity,BP,IL20RB;HFE
17231,GO:0120033,0.60556190525364,0.680658240657942,2,19,negative regulation of plasma membrane bounded cell projection assembly,BP,EVI5L;PLXNB3
5594,GO:0016628,0.605887078661932,0.678783332319187,2,21,oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor,MF,SRD5A3;BLVRB
335,GO:0000931,0.606020614994987,0.783306961949428,1,8,gamma-tubulin large complex,CC,TUBGCP5
3737,GO:0008274,0.606020614994987,0.783306961949428,1,8,gamma-tubulin ring complex,CC,TUBGCP5
10554,GO:0043531,0.606032398468424,0.630569880401251,3,29,ADP binding,MF,GLUD1;ERN1;GCLC
5805,GO:0017062,0.60620811764491,0.78059037029642,1,9,respiratory chain complex III assembly,BP,TTC19
8801,GO:0034551,0.60620811764491,0.78059037029642,1,9,mitochondrial respiratory chain complex III assembly,BP,TTC19
8089,GO:0032784,0.606507556440111,0.599124384647871,4,40,regulation of DNA-templated transcription, elongation,BP,EAPP;TCEA2;RTF1;ERCC6
13534,GO:0060019,0.606658181571148,0.780197484362397,1,9,radial glial cell differentiation,BP,GLI3
1704,GO:0004222,0.606993088447266,0.561970823449143,6,58,metalloendopeptidase activity,MF,ADAM19;ADAMTS7;ADAMTS13;MMP1;MMP28;CLCA2
16171,GO:0090218,0.607118003597754,0.680026995135164,2,18,positive regulation of lipid kinase activity,BP,VAV3;ATG14
9021,GO:0035247,0.60720872904967,0.779716190245993,1,9,peptidyl-arginine omega-N-methylation,BP,PRMT3
78,GO:0000159,0.60737095332349,0.678859022602875,2,19,protein phosphatase type 2A complex,CC,PPP2R2C;PPP2R3B
6522,GO:0021915,0.607393595803859,0.507867533718167,13,124,neural tube development,BP,PKD2;SFRP1;PRKACB;GLI2;GLI3;CELSR1;NPHP3;IFT140;SALL2;TEAD2;PTK7;TCF7;ZFP36L1
5724,GO:0016868,0.607471439174192,0.779486258317487,1,9,intramolecular transferase activity, phosphotransferases,MF,PGM1
16756,GO:0098588,0.607822721216318,0.427323290972618,155,1514,bounding membrane of organelle,CC,MAP6;SREBF1;APOE;GPSM1;EGFR;PTPRS;PKD2;SYT8;CXCR1;SYN1;BPHL;EVC;WNT3;ST6GALNAC2;MVB12B;CYBRD1;SPATA18;KCNAB2;VAMP3;SNN;NSG1;RAB43;RAB40B;NOS1;B4GALNT4;SCARA3;GAA;MICALL1;VPS11;NDRG1;COL7A1;ITPR3;MDM2;ST6GALNAC6;GOLGA8A;HLA-B;HGSNAT;FAM210B;GAL3ST4;B4GALT6;AP1G2;C2CD4C;CLTCL1;TMC6;FLOT1;LAMP3;MAPK8IP3;GOLGA8B;ATG16L2;SPG11;RHBDF1;CLCN6;DIRC2;ASAP2;LHFPL2;ULK1;SPPL2B;VAMP2;INSR;ST3GAL5;SCNN1A;SUN1;CD109;RAB11FIP4;VPS39;TMEM9;NLRX1;B4GALT2;PEX10;SLC2A3;TCIRG1;MAP2K2;FZD7;KIAA0319L;B3GNT9;WHAMMP3;BBS2;ATP6V0A2;COL6A1;PEX11B;IFI27;MALL;MCTP1;SHANK3;CYBA;WASH3P;RAB11FIP3;ANKRD28;CHMP1B;ARAP1;GOLGA8N;RPH3AL;SLC2A1;ACACB;NDST2;LRP1;HLA-A;CCDC136;C12ORF66;SLC48A1;APPL2;PMEL;BBS1;JPH2;PDE2A;RET;PIK3C3;SYT7;BBS5;RETSAT;AREG;BST2;LETMD1;SNX21;MARCH8;MPPE1;DMTN;ARFGEF2;LMTK3;SLC36A4;TMEM231;SNX1;GOLGA7B;DLG4;NBEAL2;CD68;SHANK2;RSAD2;XYLT1;CLSTN3;GLMP;ACSL1;DMXL2;LAPTM4A;MAN1B1;DHRS4;PEX1;GOLGA1;CPT1C;GOLGB1;CD9;ERBB2;SYNGR1;ABCA2;AKAP6;TH;ATG14;LDLRAP1;GCNT4;SYNE2;NFASC;PI4K2B;COG1;CLCN7;SERINC3
2788,GO:0006222,0.60783287525137,0.779169635010789,1,9,UMP biosynthetic process,BP,UCKL1
4114,GO:0009173,0.60783287525137,0.779169635010789,1,9,pyrimidine ribonucleoside monophosphate metabolic process,BP,UCKL1
4115,GO:0009174,0.60783287525137,0.779169635010789,1,9,pyrimidine ribonucleoside monophosphate biosynthetic process,BP,UCKL1
11512,GO:0046049,0.60783287525137,0.779169635010789,1,9,UMP metabolic process,BP,UCKL1
12960,GO:0051383,0.607882216955854,0.678349382855737,2,19,kinetochore organization,BP,CENPC;CENPH
1321,GO:0003174,0.608061956748464,0.781538086999376,1,8,mitral valve development,BP,ZFPM1
11232,GO:0045446,0.608271778226406,0.548347372459669,7,67,endothelial cell differentiation,BP,PTPRS;RAPGEF3;BMP6;PDE2A;BTG1;APOLD1;GSTM3
10712,GO:0044065,0.608447239845647,0.781203057984677,1,8,regulation of respiratory system process,BP,NLGN2
17682,GO:1901611,0.608567272781417,0.778525279673361,1,9,phosphatidylglycerol binding,MF,PLTP
5119,GO:0015485,0.608589059742207,0.627479305460799,3,30,cholesterol binding,MF,APOE;OSBPL10;OSBPL5
16341,GO:0090662,0.608705949886313,0.675966938220792,2,21,ATP hydrolysis coupled transmembrane transport,BP,TCIRG1;ATP6V0A2
16992,GO:0099131,0.608705949886313,0.675966938220792,2,21,ATP hydrolysis coupled ion transmembrane transport,BP,TCIRG1;ATP6V0A2
14369,GO:0061640,0.609045325988245,0.547259171397108,7,69,cytoskeleton-dependent cytokinesis,BP,CUL7;ANK3;UNC119;SEPT6;SEPT5;SNX33;CIT
11693,GO:0046501,0.6091652455888,0.777999618644388,1,9,protoporphyrinogen IX metabolic process,BP,UROS
11717,GO:0046545,0.609199784003077,0.54709656250963,7,69,development of primary female sexual characteristics,BP,SFRP1;KITLG;LHFPL2;NUPR1;INSR;SLIT3;ACVR1B
130,GO:0000271,0.609227285749369,0.559452689777926,6,59,polysaccharide biosynthetic process,BP,PER2;INSR;B3GNT9;PGM1;EPM2AIP1;IRS2
7771,GO:0032303,0.60932995881896,0.777854665387272,1,9,regulation of icosanoid secretion,BP,PLA2G6
12763,GO:0051058,0.609377084891408,0.575611430652573,5,47,negative regulation of small GTPase mediated signal transduction,BP,EPHB2;RASA4;SYNGAP1;SPRY2;DAB2IP
18482,GO:1903649,0.60942667716289,0.676806730466754,2,19,regulation of cytoplasmic transport,BP,VPS11;MAP2K2
5051,GO:0015248,0.609499729417841,0.675910974614487,2,20,sterol transporter activity,MF,APOE;OSBPL1A
3893,GO:0008532,0.609756944450894,0.777478584354611,1,9,N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity,MF,B3GNT9
9174,GO:0035562,0.609811660382193,0.780013602672394,1,8,negative regulation of chromatin binding,BP,NFATC4
5653,GO:0016755,0.609908130444515,0.777345312042722,1,9,transferase activity, transferring amino-acyl groups,MF,ATE1
504,GO:0001562,0.610323323246869,0.776979016959449,1,9,response to protozoan,BP,CCDC88B
10199,GO:0042832,0.610323323246869,0.776979016959449,1,9,defense response to protozoan,BP,CCDC88B
9600,GO:0036475,0.610337838404532,0.675894448063308,2,19,neuron death in response to oxidative stress,BP,ENDOG;FBXW7
4186,GO:0009265,0.610428512848403,0.774831967475886,1,10,2'-deoxyribonucleotide biosynthetic process,BP,CMPK2
11635,GO:0046385,0.610428512848403,0.774831967475886,1,10,deoxyribose phosphate biosynthetic process,BP,CMPK2
4289,GO:0009713,0.610455411355473,0.776862393492723,1,9,catechol-containing compound biosynthetic process,BP,TH
9992,GO:0042423,0.610455411355473,0.776862393492723,1,9,catecholamine biosynthetic process,BP,TH
10256,GO:0043010,0.61048042794589,0.482444168656749,20,191,camera-type eye development,BP,EGFR;ALDH1A3;SLITRK6;EPHB2;SDK2;HSF4;NINJ1;GLI3;RAB11FIP4;IFT140;NPHP4;MAF;RET;SHROOM2;SIX5;TMEM231;TUB;TH;LAMB2;FOXP2
8346,GO:0033233,0.610527330783877,0.674880258650473,2,20,regulation of protein sumoylation,BP,HMG20B;RWDD3
7038,GO:0030819,0.610599322190886,0.776735281163438,1,9,positive regulation of cAMP biosynthetic process,BP,PTHLH
10005,GO:0042448,0.61083440200575,0.776527528953602,1,9,progesterone metabolic process,BP,DGKQ
20156,GO:2001023,0.610979374961063,0.593897730602909,4,42,regulation of response to drug,BP,PER2;ENDOG;ADIRF;SYT7
4837,GO:0014046,0.61128758308349,0.776126633701953,1,9,dopamine secretion,BP,SYT7
4845,GO:0014059,0.61128758308349,0.776126633701953,1,9,regulation of dopamine secretion,BP,SYT7
7508,GO:0031701,0.611334044136656,0.778680896935279,1,8,angiotensin receptor binding,MF,ARAP1
11110,GO:0045161,0.61163395008878,0.778417665623818,1,8,neuronal ion channel clustering,BP,NFASC
5644,GO:0016741,0.611765868953931,0.485697878570338,18,184,transferase activity, transferring one-carbon groups,MF,GAMT;ASH2L;NSUN7;NSUN5P2;METTL23;FAM86C2P;TARBP1;METTL21A;SETD4;PCMTD2;PCMTD1;DYDC1;AMT;METTL7A;MTR;KMT5C;PRMT3;PEMT
14468,GO:0061900,0.611920962681869,0.67522984959698,2,18,glial cell activation,BP,EGFR;LRP1
11440,GO:0045911,0.611955862026941,0.674270420456781,2,19,positive regulation of DNA recombination,BP,WRN;STAT6
19399,GO:1990001,0.612023502620296,0.778075409812391,1,8,inhibition of cysteine-type endopeptidase activity involved in apoptotic process,BP,NAIP
3741,GO:0008278,0.61203607777789,0.778064355026128,1,8,cohesin complex,CC,REC8
7331,GO:0031349,0.612126384319477,0.464833103816356,29,297,positive regulation of defense response,BP,TNFAIP3;MUC19;DDX60;EGFR;PTPRS;PRKACB;PDCD4;TRPV4;FLOT1;ADORA2B;ITGA2;LRSAM1;DDT;MGST2;DHX58;NLRX1;CYBA;CTSB;KLK5;PLA2G7;PDE2A;DAB2IP;PIK3C3;IFI16;RPS6KA5;RSAD2;TKFC;SMPDL3B;PRKACA
18578,GO:1903867,0.612232407133798,0.77789171035482,1,8,extraembryonic membrane development,BP,HTRA1
12962,GO:0051385,0.61232308386194,0.673074095054019,2,20,response to mineralocorticoid,BP,CYBA;TH
19478,GO:1990316,0.612486030821341,0.777668538255735,1,8,Atg1/ULK1 kinase complex,CC,ULK1
13084,GO:0051639,0.613030346401263,0.777189024301955,1,8,actin filament network formation,BP,FHOD3
7471,GO:0031643,0.613093592393673,0.777133258953363,1,8,positive regulation of myelination,BP,TENM4
399,GO:0001076,0.613316882520148,0.493566276487379,15,147,transcription factor activity, RNA polymerase II transcription factor binding,MF,POU3F1;CITED4;SOX12;THRAP3;BHLHE40;RTF1;TCF4;LMO2;THRA;ZMYND8;VDR;MAMSTR;TRERF1;RORA;PPARG
3699,GO:0008207,0.613460896568027,0.671181033590377,2,21,C21-steroid hormone metabolic process,BP,DGKQ;BMP6
5579,GO:0016600,0.61351352606825,0.776762735981865,1,8,flotillin complex,CC,FLOT1
2544,GO:0005813,0.613526105887548,0.44865926652506,45,440,centrosome,CC,ITGB6;CAPRIN2;OBSL1;BRSK1;CUL7;PRKACB;CNTRL;NDRG1;NDN;ACTR1B;ADGRB2;NEK9;TUBGCP5;FLOT1;UNC119;SPPL2B;TPGS1;NEK8;CCDC85B;CEP68;CHD3;CEP126;RAB11FIP4;CEP192;LRRCC1;WRN;IQCB1;HOOK2;IFT140;RAB11FIP3;CDK5RAP3;CCDC92;TTC12;NPHP4;BBS1;ALMS1;PHF1;CCDC88B;CCDC113;KAT2B;MARK4;CEP250;TTC19;TRAF5;PRKACA
14112,GO:0061000,0.613557069398012,0.776724290378328,1,8,negative regulation of dendritic spine development,BP,PTPRS
20000,GO:2000643,0.613606233955328,0.7766808758283,1,8,positive regulation of early endosome to late endosome transport,BP,VPS11
3139,GO:0006733,0.613657303991665,0.496720848381569,14,142,oxidoreduction coenzyme metabolic process,BP,NT5E;H6PD;DHTKD1;KCNAB2;NAPRT;NMRK1;INSR;PGLS;IDH2;MLXIPL;PGM1;PFKFB2;OGDHL;NADK
6620,GO:0022857,0.613903325979611,0.442986216129442,54,534,transmembrane transporter activity,MF,PKD2;ORAI3;KCNAB2;KCNJ15;SLC16A5;GJD3;KCNC4;SLC29A4;ITPR3;NDUFA4L2;TMEM63C;SLC24A1;TRPV4;SLC13A5;GJC2;CLCN6;KCNJ5;SCNN1A;SCN4B;SLC27A1;NIPAL2;SLC2A3;TCIRG1;SLC12A7;CLCA2;ATP6V0A2;ANO9;KCNMA1;SLC2A1;SLC38A4;KCNG1;SLC48A1;JPH2;PDE2A;SLC37A2;SHROOM2;SCN2A;CACNB3;ORAI2;SLC36A4;DLG4;SLC22A15;SLC35G2;ANO1;S100A6;SLC43A1;CACNB1;ABCA2;SLC2A11;KCNS3;CLCN7;CALHM2;ABCA11P;SERINC3
44,GO:0000096,0.614243609773846,0.62162073396913,3,30,sulfur amino acid metabolic process,BP,MTHFR;MTR;GCLC
10533,GO:0043497,0.614424358728079,0.773337427128493,1,9,regulation of protein heterodimerization activity,BP,DAB2IP
17084,GO:0099738,0.614454625896603,0.622364973443929,3,28,cell cortex region,CC,PKD2;RIMS3;BSN
15904,GO:0072711,0.614512672971562,0.775879343326191,1,8,cellular response to hydroxyurea,BP,ATRX
7230,GO:0031146,0.61466390186779,0.552171380785377,6,70,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,BP,FBXW4;WWTR1;FBXO2;FBXW7;FBXW5;FBXO4
7154,GO:0031032,0.61467001544204,0.49651406238334,14,125,actomyosin structure organization,BP,SFRP1;OBSL1;PIK3R1;ASAP3;ITGB5;OBSCN;MYH11;RAPGEF3;FHOD3;TTN;EPB41L3;EPB41L4A;ARAP1;ALMS1
6287,GO:0019901,0.61475354269366,0.441725204405999,55,524,protein kinase binding,MF,SIK1;SREBF1;ACTA2;EGFR;SYN1;TRIM22;SRSF5;EPHB2;PIK3R1;BRSK1;CSPG4;CAMK2N1;CRY1;PITPNM3;SPDYE6;RHOBTB2;NEK9;TRPV4;TOM1L2;MAPK8IP3;SPDYE5;PITPNM2;MICALCL;AKAP7;INSR;CEP68;TTN;CBLC;RICTOR;SQSTM1;SLC12A7;ARHGAP33;PLA2G6;FAM83C;MAP3K12;DNM1;CDK5R1;SHC2;SPRY2;CDK5RAP3;PFKFB2;FBXW5;WNK1;RET;DAB2IP;FGFR4;EXOC2;PIK3R2;CACNB3;KAT2B;IRS2;CEP250;ERBB2;PRKACA;PARN
8226,GO:0033005,0.61482099763276,0.772982946491984,1,9,positive regulation of mast cell activation,BP,ADORA2B
17590,GO:1901298,0.615070781286631,0.772759504934629,1,9,regulation of hydrogen peroxide-mediated programmed cell death,BP,ENDOG
17320,GO:1900024,0.615200938999705,0.5900245371382,4,40,regulation of substrate adhesion-dependent cell spreading,BP,POSTN;TRIOBP;NET1;DMTN
19681,GO:2000036,0.615235419831252,0.671892933013474,2,18,regulation of stem cell population maintenance,BP,KDM3A;KDM4C
2514,GO:0005768,0.615402465876051,0.435171384298864,69,677,endosome,CC,APOE;EGFR;DGKQ;MVB12B;VAMP3;OR2A4;NSG1;RAB43;RAB40B;MICALL1;VPS11;NDRG1;HLA-B;AP1G2;F2R;CLTCL1;FLOT1;LAMP3;AVL9;CLCN6;ULK1;SPPL2B;TRAK1;NISCH;INSR;RAB11FIP4;VPS39;TMEM9;TCIRG1;MICALL2;MAP2K2;SQSTM1;FZD7;CST3;ATP6V0A2;MCTP1;HFE;CYBA;WASH3P;RAB11FIP3;CTSB;CHMP1B;ASTN2;TBC1D17;LRP1;HLA-A;SLC48A1;APPL2;PMEL;RET;PIK3C3;FGFR4;BST2;SNX21;MARCH8;EHBP1;TBC1D16;ARFGEF2;SNX1;OSBPL1A;CD68;LAPTM4A;ERBB2;ABCA2;LDLRAP1;ACKR3;PI4K2B;SNX33;OCIAD2
9055,GO:0035303,0.615446939429465,0.487980448928132,16,156,regulation of dephosphorylation,BP,ELFN2;CRY2;PPP2R2C;PHACTR3;ITGA2;CEP192;CDK5RAP3;WNK1;PPP1R2;PPP1R35;LMTK3;PPP2R3B;SPOCD1;AKAP6;RIPK3;NPNT
3417,GO:0007202,0.615469804023482,0.772402230590189,1,9,activation of phospholipase C activity,BP,EGFR
7352,GO:0031402,0.615898800163389,0.774649574550959,1,8,sodium ion binding,MF,SLC24A1
10529,GO:0043491,0.616121783128409,0.490569955107041,15,148,protein kinase B signaling,BP,EGFR;PIK3R1;KITLG;MC1R;MDM2;FAM110C;SESN3;INSR;RICTOR;SPRY2;FGFR4;PIK3R2;ZFP36L1;IRS2;ERBB2
19852,GO:2000353,0.616172461933,0.774406200026124,1,8,positive regulation of endothelial cell apoptotic process,BP,PDCD4
9926,GO:0042288,0.616571670966784,0.771413521268788,1,9,MHC class I protein binding,MF,PILRB
10818,GO:0044325,0.616588561101425,0.529164689592547,8,80,ion channel binding,MF,PKD2;NOS1;ANK3;RIMS3;SNTA1;SCN4B;PHPT1;AKAP6
10235,GO:0042983,0.616689072298133,0.771307992225935,1,9,amyloid precursor protein biosynthetic process,BP,NECAB3
10236,GO:0042984,0.616689072298133,0.771307992225935,1,9,regulation of amyloid precursor protein biosynthetic process,BP,NECAB3
2983,GO:0006527,0.616777768868477,0.771228241580142,1,9,arginine catabolic process,BP,NOS1
17775,GO:1901881,0.616948054705216,0.771075073849377,1,9,positive regulation of protein depolymerization,BP,TRPV4
17710,GO:1901661,0.616970238717761,0.666942024666683,2,22,quinone metabolic process,BP,AKR7A2;CBR4
39,GO:0000079,0.617002151572224,0.538345989620028,7,73,regulation of cyclin-dependent protein serine/threonine kinase activity,BP,TNFAIP3;EGFR;PKD2;HERC5;CDK5R1;CDK5RAP3;KAT2B
16853,GO:0098805,0.617136947694248,0.42167195188491,122,1195,whole membrane,CC,ULK2;MAP6;SREBF1;APOE;INPP5D;EGFR;PTPRS;SYT8;CXCR1;SYN1;BPHL;MARVELD1;WNT3;MVB12B;CYBRD1;SPATA18;KCNAB2;VAMP3;SNN;NSG1;UNC5B;RAB43;RAB40B;NOS1;GAA;MICALL1;VPS11;NDRG1;ITPR3;MDM2;HLA-B;HGSNAT;FAM210B;AP1G2;F2R;C2CD4C;RTN4RL1;CLTCL1;TMC6;FLOT1;LAMP3;ATG16L2;SPG11;CLCN6;DIRC2;LHFPL2;ULK1;SPPL2B;VAMP2;INSR;CBLC;SUN1;CD109;RAB11FIP4;VPS39;TMEM9;NLRX1;PEX10;SLC2A3;TCIRG1;MAP2K2;FZD7;ATP6V0A2;COL6A1;PEX11B;PODXL;IFI27;MALL;MCTP1;CYBA;WASH3P;RAB11FIP3;KCNMA1;CHMP1B;RPH3AL;SLC2A1;ACACB;LRP1;HLA-A;CCDC136;C12ORF66;SLC48A1;APPL2;PMEL;PDE2A;RET;PIK3C3;SYT7;RETSAT;AREG;BST2;LETMD1;SNX21;MARCH8;SLC36A4;SNX1;DLG4;NBEAL2;CD68;RSAD2;GLMP;ACSL1;DMXL2;LAPTM4A;DHRS4;PEX1;STAT6;CPT1C;CD9;CTSD;ERBB2;SYNGR1;ABCA2;AKAP6;TH;ATG14;PRKACA;LDLRAP1;SYNE2;NFASC;PI4K2B;CLCN7
20172,GO:2001044,0.617249712765497,0.770803556394914,1,9,regulation of integrin-mediated signaling pathway,BP,DMTN
8152,GO:0032891,0.617655381382364,0.773084050715679,1,8,negative regulation of organic acid transport,BP,IRS2
1927,GO:0004623,0.617659905998652,0.667668815057473,2,20,phospholipase A2 activity,MF,PLA2G6;PLA2G7
3717,GO:0008237,0.6178502603162,0.512587445600857,10,99,metallopeptidase activity,MF,NPEPL1;ADAM19;ADAMTS7;ADAMTS13;MMP1;MMP28;RNPEPL1;CLCA2;RNPEP;MYSM1
10489,GO:0043406,0.6179667492657,0.474422489946855,20,197,positive regulation of MAP kinase activity,BP,EGFR;MAP3K14;CSPG4;KITLG;F2R;ADORA2B;MAPK8IP3;C5;MINK1;MAP2K5;INSR;MAP2K2;MAP3K12;MAPK10;ERCC6;SHC2;MAP3K6;DAB2IP;ERN1;ERBB2
4032,GO:0009066,0.618014075816464,0.586767620723506,4,41,aspartate family amino acid metabolic process,BP,MTHFR;THNSL2;ALDH7A1;MTR
9058,GO:0035306,0.618069783365856,0.587302810801053,4,39,positive regulation of dephosphorylation,BP,ITGA2;AKAP6;RIPK3;NPNT
16718,GO:0097756,0.618084280295404,0.587287490402564,4,39,negative regulation of blood vessel diameter,BP,EGFR;F2R;PER2;BBS2
12621,GO:0050839,0.618090902286405,0.448333318533864,39,388,cell adhesion molecule binding,MF,TGFBI;POSTN;ITGB6;GPNMB;EGFR;EPS8L2;DOCK9;TENM4;STAT1;MICALL1;NDRG1;LTBP4;TNXB;NLGN4Y;PPL;NLGN2;ANK3;ADAMTS13;ADGRL1;ITGA2;ITGA6;NISCH;BAIAP2;H1FX;CDK5R1;PAK6;FMNL2;CAPG;DAB2IP;SNX1;CADM4;ESYT2;CD9;MPRIP;PLCB3;MPP7;LAMB2;ECM2;NPNT
9979,GO:0042402,0.618156573802638,0.767882971395403,1,10,cellular biogenic amine catabolic process,BP,ALDH7A1
7566,GO:0031936,0.618182374785557,0.772612825640024,1,8,negative regulation of chromatin silencing,BP,PHF2
15394,GO:0071679,0.61825573782453,0.772547169246601,1,8,commissural neuron axon guidance,BP,EPHB2
19995,GO:2000637,0.618259657040651,0.667893946405542,2,19,positive regulation of gene silencing by miRNA,BP,EGFR;MAP2K2
795,GO:0002065,0.618295538241051,0.537343454505453,7,70,columnar/cuboidal epithelial cell differentiation,BP,FAM20C;SLITRK6;TRIOBP;BMP6;PTK6;DLX3;TMEM231
1676,GO:0004143,0.618745841056117,0.772108193295709,1,8,diacylglycerol kinase activity,MF,DGKQ
9806,GO:0042023,0.618839860568239,0.772023910779497,1,8,DNA endoreduplication,BP,FBXW7
13732,GO:0060330,0.618844353948946,0.666461513957276,2,20,regulation of response to interferon-gamma,BP,STAT1;PPARG
13736,GO:0060334,0.618844353948946,0.666461513957276,2,20,regulation of interferon-gamma-mediated signaling pathway,BP,STAT1;PPARG
15783,GO:0072498,0.61893685195687,0.769280649531147,1,9,embryonic skeletal joint development,BP,HYAL1
19638,GO:1990909,0.619076321527463,0.771811837359357,1,8,Wnt signalosome,CC,WNT3
7138,GO:0030991,0.619078986058545,0.771809446812297,1,8,intraciliary transport particle A,CC,IFT140
9920,GO:0042278,0.619164370927223,0.548166380202479,6,64,purine nucleoside metabolic process,BP,NT5E;GAMT;MACROD1;OARD1;DLG4;PEMT
13639,GO:0060174,0.619541622754451,0.771394102048478,1,8,limb bud formation,BP,WNT3
12385,GO:0048843,0.619620772344445,0.667444334982785,2,18,negative regulation of axon extension involved in axon guidance,BP,WNT3;SEMA4G
15517,GO:0071936,0.619699818512544,0.771251950076452,1,8,coreceptor activity involved in Wnt signaling pathway,MF,PTK7
15557,GO:0072044,0.619724253672288,0.771229987272018,1,8,collecting duct development,BP,DLG5
14696,GO:0070365,0.619784865942978,0.768512395542679,1,9,hepatocyte differentiation,BP,ITGA2
14894,GO:0070757,0.619792846033691,0.771168326818715,1,8,interleukin-35-mediated signaling pathway,BP,STAT1
1134,GO:0002726,0.620381305795458,0.767970932875065,1,9,positive regulation of T cell cytokine production,BP,RSAD2
17721,GO:1901678,0.620417268828744,0.767938255119651,1,9,iron coordination entity transport,BP,SLC48A1
2820,GO:0006285,0.620502110535736,0.765743386089832,1,10,base-excision repair, AP site formation,BP,MPG
12395,GO:0048857,0.620552512525463,0.58407900433883,4,41,neural nucleus development,BP,ALDH1A3;GLUD1;CDK5R1;FOXP2
14554,GO:0070106,0.620608020341892,0.770434597431078,1,8,interleukin-27-mediated signaling pathway,BP,STAT1
5274,GO:0015926,0.620774282840638,0.770284734132904,1,8,glucosidase activity,MF,GAA
18504,GO:1903708,0.620841655162556,0.503226826647649,11,111,positive regulation of hemopoiesis,BP,INPP5D;KITLG;STAT1;FAM210B;GLI2;GLI3;CA2;ACVR1B;ZFP36L1;GPR68;CTNNBIP1
540,GO:0001659,0.620857587879149,0.664403011629468,2,20,temperature homeostasis,BP,NMU;SLC27A1
2966,GO:0006505,0.620907973983825,0.613424791995594,3,33,GPI anchor metabolic process,BP,PGAP1;PIGZ;MPPE1
13236,GO:0051937,0.620982825477162,0.664274690086958,2,20,catecholamine transport,BP,NISCH;SYT7
8593,GO:0034113,0.621043751559704,0.614973733651514,3,29,heterotypic cell-cell adhesion,BP,FLOT1;MAP2K5;NFASC
1453,GO:0003691,0.621133867705378,0.76728641500303,1,9,double-stranded telomeric DNA binding,MF,RAD50
13226,GO:0051923,0.621243057874705,0.767186974558756,1,9,sulfation,BP,SULT1E1
16635,GO:0097531,0.621262796049519,0.767168995503245,1,9,mast cell migration,BP,VEGFB
3320,GO:0007028,0.621370546961762,0.769746689795922,1,8,cytoplasm organization,BP,TFCP2L1
18782,GO:1904354,0.621466213783049,0.76966027765701,1,8,negative regulation of telomere capping,BP,RAD50
2685,GO:0006048,0.621616182373426,0.766846931526345,1,9,UDP-N-acetylglucosamine biosynthetic process,BP,UAP1L1
5837,GO:0017127,0.621698356177027,0.764646648783915,1,10,cholesterol transporter activity,MF,APOE
14137,GO:0061041,0.621747670402501,0.523574218770675,8,81,regulation of wound healing,BP,TNFAIP3;SERPINE2;APOE;F2R;CD109;DMTN;CD9;SERPING1
1146,GO:0002753,0.621782978509957,0.561807317150172,5,50,cytoplasmic pattern recognition receptor signaling pathway,BP,TNFAIP3;DDX60;DHX58;NLRX1;TKFC
9103,GO:0035404,0.621846974857984,0.766636418904074,1,9,histone-serine phosphorylation,BP,RPS6KA5
17464,GO:1900402,0.621858553052936,0.769305642846317,1,8,regulation of carbohydrate metabolic process by regulation of transcription from RNA polymerase II promoter,BP,KAT2B
14351,GO:0061608,0.622003276968807,0.766493771930934,1,9,nuclear import signal receptor activity,MF,TMCO6
3595,GO:0008022,0.622085295277974,0.480823000084756,16,160,protein C-terminus binding,MF,BCAM;BAIAP2;TCF4;DNM1;SHANK3;ERCC6;ATXN1;MIF4GD;CALCOCO1;DLG4;CEP250;PEX1;ERBB2;PPARG;EML2;ECM1
8925,GO:0034968,0.622180822163329,0.515019130054599,9,89,histone lysine methylation,BP,ASH2L;KDM3A;JARID2;RTF1;KDM4C;ATRX;PHF1;DYDC1;KMT5C
14877,GO:0070700,0.622314847549162,0.766209230328393,1,9,BMP receptor binding,MF,BMP6
16495,GO:0097225,0.622407618059336,0.763994615152851,1,10,sperm midpiece,CC,SQSTM1
11347,GO:0045723,0.622588788304673,0.765958843835762,1,9,positive regulation of fatty acid biosynthetic process,BP,MLXIPL
18899,GO:1904645,0.62272456743809,0.663329666409361,2,19,response to amyloid-beta,BP,LRP1;CACNB1
4021,GO:0009055,0.623018204462081,0.530481119541019,7,88,electron transfer activity,MF,TXNRD3;NDUFA4L2;ALDH4A1;AKR7A2;CYBA;SDHA;ETFB
6444,GO:0021766,0.623276528018705,0.56021391303941,5,50,hippocampus development,BP,PTPRS;GLI3;MDK;BBS2;CDK5R1
13191,GO:0051864,0.623335171613817,0.767967320325915,1,8,histone demethylase activity (H3-K36 specific),MF,KDM4C
14792,GO:0070544,0.623335171613817,0.767967320325915,1,8,histone H3-K36 demethylation,BP,KDM4C
1173,GO:0002820,0.623596406835531,0.661589563411395,2,20,negative regulation of adaptive immune response,BP,IL20RB;HFE
14817,GO:0070578,0.623641324931199,0.764994974014445,1,9,RISC-loading complex,CC,AGO4
2387,GO:0005524,0.623643114650525,0.414941594805263,123,1151,ATP binding,MF,ULK2;SIK1;SLFN5;ACTA2;OAS2;DDX60;HSPA2;EGFR;FAM20C;SYN1;KIF26B;EPHB2;MAP3K14;GLUD1;DGKQ;BRSK1;CUL9;CAMKK1;MVD;PRKACB;CMPK2;PIK3C2G;LIG1;CDK18;SPEG;MLH3;NMRK1;DDX59;OBSCN;MYH11;ACTR1B;OAS1;KIF26A;ALPK1;DNAH1;NEK9;TRPV4;DHX32;CLCN6;PSKH1;MINK1;ULK1;THRAP3;SMARCA1;NAIP;NEK8;MAP2K5;INSR;CHD3;CDK14;TTN;SLFNL1;DHX58;NLRX1;ETNK2;MAP2K2;OPLAH;PDK1;PTK6;PDIK1L;MAP3K12;WRN;MCM9;ATRX;MAPK10;ERCC6;HLCS;PAK6;PFKFB2;ACACB;NLRP1;TK2;GLUL;SRR;MAP3K6;RIMKLB;MYO3B;WNK1;STK16;RET;PIK3C3;DALRD3;FGFR4;MYO9A;RPS6KA5;NADK;BBS10;HLTF;STK19;LMTK3;ACVR1B;TSSK1B;WEE1;PTK7;DQX1;ACSL1;MARK4;TEP1;ERN1;RAD50;TKFC;PEX1;SCYL3;KIF7;CHD6;ACSS2;ERBB2;ABCA2;PRKACA;SUCLG2;UCKL1;DDX12P;IP6K2;RIPK3;PI4K2B;LONP2;HARS2;CIT;MSH5;CLCN7;TTLL1;ABCA11P;GCLC
15600,GO:0072109,0.623651072136223,0.764986034308377,1,9,glomerular mesangium development,BP,ACTA2
15084,GO:0071156,0.623804854010848,0.512699566801659,9,96,regulation of cell cycle arrest,BP,PKD2;MDM2;PCBP4;PIDD1;CDK5R1;MLXIPL;DAB2IP;TFDP2;PRKACA
16151,GO:0090192,0.623857246971587,0.764796881246768,1,9,regulation of glomerulus development,BP,RET
9662,GO:0038034,0.623903612692296,0.558938565563088,5,53,signal transduction in absence of ligand,BP,IFI6;KITLG;UNC5B;MAP2K5;RET
16474,GO:0097192,0.623903612692296,0.558938565563088,5,53,extrinsic apoptotic signaling pathway in absence of ligand,BP,IFI6;KITLG;UNC5B;MAP2K5;RET
784,GO:0002043,0.623951360688209,0.764710500328899,1,9,blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,NRARP
5147,GO:0015682,0.624247468168225,0.610280238384366,3,32,ferric iron transport,BP,TCIRG1;ATP6V0A2;HFE
15793,GO:0072512,0.624247468168225,0.610280238384366,3,32,trivalent inorganic cation transport,BP,TCIRG1;ATP6V0A2;HFE
14585,GO:0070167,0.624289718264498,0.580701537894832,4,39,regulation of biomineral tissue development,BP,FAM20C;ISG15;BMP6;ECM1
17029,GO:0099528,0.624302579796109,0.764387932808409,1,9,G-protein coupled neurotransmitter receptor activity,MF,GABBR1
10074,GO:0042588,0.624824959312175,0.763907565741523,1,9,zymogen granule,CC,VAMP2
4702,GO:0010867,0.624901764559726,0.763836876803219,1,9,positive regulation of triglyceride biosynthetic process,BP,SREBF1
1112,GO:0002701,0.625039997098845,0.660100556992297,2,20,negative regulation of production of molecular mediator of immune response,BP,HFE;BST2
9787,GO:0040018,0.625160826655566,0.660822273664458,2,19,positive regulation of multicellular organism growth,BP,BBS2;GPR21
12200,GO:0048407,0.625180941205738,0.766286370193614,1,8,platelet-derived growth factor binding,MF,COL6A1
994,GO:0002456,0.625520888634453,0.557207766249588,5,53,T cell mediated immunity,BP,IL20RB;HFE;SCART1;RSAD2;RIPK3
14059,GO:0060900,0.625812230954357,0.765709391047004,1,8,embryonic camera-type eye formation,BP,ALDH1A3
12286,GO:0048641,0.626377316906453,0.609342380885525,3,29,regulation of skeletal muscle tissue development,BP,TSC22D3;CYP26B1;FLOT1
11977,GO:0047372,0.626540240467137,0.762325160274792,1,9,acylglycerol lipase activity,MF,FAAH
14782,GO:0070530,0.62687604860243,0.659049760986538,2,19,K63-linked polyubiquitin modification-dependent protein binding,MF,TNFAIP3;SQSTM1
17985,GO:1902475,0.627043500551611,0.608163796026187,3,30,L-alpha-amino acid transmembrane transport,BP,PER2;SLC36A4;SLC43A1
15813,GO:0072538,0.627053973807356,0.76184970516403,1,9,T-helper 17 type immune response,BP,RORA
2586,GO:0005881,0.627230477737437,0.555770628405757,5,51,cytoplasmic microtubule,CC,REEP2;TRPV4;CLIP2;APC2;ARFGEF2
14145,GO:0061050,0.627344195043408,0.761580798100349,1,9,regulation of cell growth involved in cardiac muscle cell development,BP,AKAP6
18175,GO:1902969,0.627389058046384,0.761539209884026,1,9,mitotic DNA replication,BP,LIG1
17820,GO:1902018,0.627541240703271,0.761398095923274,1,9,negative regulation of cilium assembly,BP,EVI5L
2961,GO:0006497,0.627708333979059,0.501519088119682,10,107,protein lipidation,BP,ZDHHC1;RTN4RL1;CD109;PGAP1;ZDHHC12;PIGZ;PIK3C3;MPPE1;GOLGA7B;ZDHHC24
12213,GO:0048487,0.627775944641368,0.606535195404503,3,32,beta-tubulin binding,MF,RGS2;TRPV4;CDK5R1
4203,GO:0009313,0.628553916077175,0.760457503233229,1,9,oligosaccharide catabolic process,BP,HEXB
6356,GO:0021542,0.628808071997062,0.760221008511692,1,9,dentate gyrus development,BP,MDK
12329,GO:0048708,0.628879174850217,0.575486108035299,4,40,astrocyte differentiation,BP,SERPINE2;EGFR;LRP1;LAMB2
13478,GO:0055065,0.628927039109011,0.443692446343018,32,323,metal ion homeostasis,BP,APOE;EGFR;PKD2;CYBRD1;NOS1;ITPR3;NEO1;F2R;MT1X;SLC24A1;TRPV4;ANK3;GSTM2;NMU;SCNN1A;BMP6;SLC12A7;HEXB;PLA2G6;ATP6V0A2;HFE;CYBA;KCNMA1;JPH2;TMEM203;VDR;LETMD1;CACNB3;LPAR6;DLG4;AKAP6;PRKACA
4162,GO:0009226,0.629058817760083,0.655166545698011,2,21,nucleotide-sugar biosynthetic process,BP,MPI;UAP1L1
18846,GO:1904526,0.629222558359173,0.759834954131183,1,9,regulation of microtubule binding,BP,GAS8
7800,GO:0032357,0.629263716789991,0.759796593901779,1,9,oxidized purine DNA binding,MF,WRN
16144,GO:0090185,0.629365925148546,0.759701314676031,1,9,negative regulation of kidney development,BP,STAT1
13091,GO:0051647,0.629577053368441,0.657200781802561,2,18,nucleus localization,BP,SUN1;SYNE2
16256,GO:0090343,0.629592173658648,0.757314785257146,1,10,positive regulation of cell aging,BP,LMNA
16027,GO:0086080,0.629726514788336,0.762108257076089,1,8,protein binding involved in heterotypic cell-cell adhesion,MF,NFASC
6939,GO:0030554,0.62981929069373,0.408169996670546,126,1182,adenyl nucleotide binding,MF,ULK2;SIK1;SLFN5;ACTA2;OAS2;DDX60;HSPA2;EGFR;FAM20C;SYN1;KIF26B;EPHB2;MAP3K14;GLUD1;DGKQ;BRSK1;CUL9;CAMKK1;MVD;PRKACB;CMPK2;PIK3C2G;LIG1;CDK18;SPEG;MLH3;NMRK1;DDX59;OBSCN;MYH11;ACTR1B;RAPGEF3;OAS1;GAL3ST4;KIF26A;ALPK1;DNAH1;NEK9;TRPV4;DHX32;CLCN6;PSKH1;MINK1;ULK1;THRAP3;SMARCA1;NAIP;NEK8;MAP2K5;INSR;CHD3;CDK14;TTN;SLFNL1;DHX58;NLRX1;ETNK2;MAP2K2;OPLAH;PDK1;PTK6;PDIK1L;MAP3K12;WRN;MCM9;ATRX;MAPK10;ERCC6;HLCS;PAK6;PFKFB2;ACACB;NLRP1;TK2;GLUL;SRR;MAP3K6;RIMKLB;MYO3B;WNK1;PDE2A;STK16;RET;PIK3C3;DALRD3;FGFR4;MYO9A;RPS6KA5;NADK;BBS10;HLTF;STK19;LMTK3;ACVR1B;TSSK1B;WEE1;PTK7;DQX1;ACSL1;MARK4;TEP1;ERN1;RAD50;TKFC;PEX1;SCYL3;KIF7;CHD6;ACSS2;ERBB2;ABCA2;PRKACA;SUCLG2;UCKL1;DDX12P;IP6K2;RIPK3;PI4K2B;LONP2;HARS2;CIT;MSH5;CLCN7;TTLL1;ABCA11P;GCLC
13726,GO:0060322,0.629907815057678,0.428598808195727,50,481,head development,BP,SERPINE2;EGFR;PTPRS;DIXDC1;ALDH1A3;SFRP1;EPHB2;GLUD1;POU3F1;WNT3;NAGLU;FLRT3;RTN4RL1;GLI2;GJC2;AMIGO2;GLI3;SMARCA1;GAS8;BAIAP2;SUN1;PGAP1;MDK;B4GALT2;SHARPIN;CST3;BBS2;WRN;CDK5R1;ATRX;SHANK3;CDK5RAP3;ATXN1;THRA;SLC2A1;SRR;LRP1;DAB2IP;SHROOM2;DLG5;SHROOM4;TACC1;SHANK2;IRS2;CD9;TH;RORA;SYNE2;FOXP2;PTBP2
18558,GO:1903825,0.630007513827452,0.514947072309907,8,79,organic acid transmembrane transport,BP,CPT2;SLC13A5;PER2;ACACB;SLC38A4;SLC36A4;IRS2;SLC43A1
19086,GO:1905039,0.630007513827452,0.514947072309907,8,79,carboxylic acid transmembrane transport,BP,CPT2;SLC13A5;PER2;ACACB;SLC38A4;SLC36A4;IRS2;SLC43A1
7830,GO:0032392,0.630319600826939,0.514398439981865,8,81,DNA geometric change,BP,DDB2;XPC;SMARCA1;CHD3;WRN;ATRX;RAD50;DDX12P
16938,GO:0098969,0.630849692826059,0.758314982622057,1,9,neurotransmitter receptor transport to postsynaptic membrane,BP,NSG1
18429,GO:1903539,0.630849692826059,0.758314982622057,1,9,protein localization to postsynaptic membrane,BP,NSG1
18430,GO:1903540,0.630849692826059,0.758314982622057,1,9,establishment of protein localization to postsynaptic membrane,BP,NSG1
9214,GO:0035612,0.630876809602153,0.761042216009175,1,8,AP-2 adaptor complex binding,MF,LDLRAP1
14008,GO:0060759,0.631048288052431,0.482310896834006,13,134,regulation of response to cytokine stimulus,BP,TNFAIP3;RBCK1;STAT1;SPPL2B;MAP2K5;SHARPIN;SLIT3;CREBRF;ELF1;STAT2;PPARG;CCDC3;ECM1
13864,GO:0060525,0.631125055809612,0.760811687022329,1,8,prostate glandular acinus development,BP,SFRP1
1021,GO:0002521,0.631769448628722,0.443133331727754,30,297,leukocyte differentiation,BP,INPP5D;FAM20C;SFRP1;PIK3R1;ZFPM1;KITLG;CYP26B1;ZFP36L2;GLI2;GLI3;CD109;FZD7;FAM213A;CA2;FBXW7;IFI16;NRARP;TCF7;RSAD2;ZFP36L1;IL11;STAT6;SOX13;ERBB2;GPR68;RORA;PPARG;POLM;RIPK3;CTNNBIP1
18545,GO:1903793,0.631808062502123,0.652292958116087,2,21,positive regulation of anion transport,BP,APOE;PLA2G6
4641,GO:0010766,0.63203783909324,0.757200590791651,1,9,negative regulation of sodium ion transport,BP,SERPINE2
3191,GO:0006816,0.632120677913775,0.457249502295715,21,208,calcium ion transport,BP,HSPA2;PKD2;ORAI3;NOS1;ITPR3;F2R;SLC24A1;TRPV4;GJC2;GSTM2;PLA2G6;HOMER2;CYBA;JPH2;PDE2A;VDR;CACNB3;ORAI2;CACNB1;AKAP6;PRKACA
2838,GO:0006307,0.632134031096609,0.754918476312377,1,10,DNA dealkylation involved in DNA repair,BP,MPG
10228,GO:0042974,0.63229813415417,0.653407097190059,2,19,retinoic acid receptor binding,MF,VDR;PPARG
3193,GO:0006820,0.632332498858317,0.438092518235976,34,334,anion transport,BP,APOE;CPT2;CRY2;SLC16A5;PITPNM3;SLC13A5;PER2;PITPNM2;CLCN6;VAMP2;SLC27A1;SLC2A3;SLC12A7;CLCA2;PLA2G6;ANO9;CA2;OSBPL10;SLC2A1;ACACB;SLC38A4;SLC37A2;OSBPL5;SLC36A4;SLC22A15;ACSL1;IRS2;ANO1;SLC43A1;PPARG;PLTP;IP6K2;CLCN7;SERINC3
14934,GO:0070848,0.632407025431196,0.42710685211457,48,469,response to growth factor,BP,POSTN;MXRA5;EGFR;FAM20C;SFRP1;ADAMTS7;SULF2;HTRA1;RGMA;ITGB5;NOS1;FERMT1;MICALL1;MDM2;NDN;LTBP4;NEO1;FLRT3;PDCD4;ZFP36L2;RNF165;TMEM204;FNDC4;FRS3;LTBP1;MAP2K5;INSR;BAIAP2;CD109;BMP6;HYAL1;MMRN2;GDF15;HFE;SPRY2;PDE2A;STK16;DAB2IP;FGFR4;PCSK6;ZFP36L1;ERN1;PBLD;ERBB2;TH;SMURF1;NPNT;GCLC
7923,GO:0032508,0.63243537091184,0.522075807423762,7,71,DNA duplex unwinding,BP,DDB2;XPC;CHD3;WRN;ATRX;RAD50;DDX12P
13679,GO:0060253,0.632580507942544,0.756690341272541,1,9,negative regulation of glial cell proliferation,BP,IDH2
7213,GO:0031115,0.63258112728811,0.756689758473335,1,9,negative regulation of microtubule polymerization,BP,EML2
13149,GO:0051767,0.632822725445266,0.756462337023139,1,9,nitric-oxide synthase biosynthetic process,BP,STAT1
13150,GO:0051769,0.632822725445266,0.756462337023139,1,9,regulation of nitric-oxide synthase biosynthetic process,BP,STAT1
8820,GO:0034614,0.632841431730184,0.489996683432878,11,118,cellular response to reactive oxygen species,BP,TNFAIP3;EGFR;PKD2;IMPACT;MDM2;ENDOG;CST3;NET1;MTR;STAT6;PRDX5
13016,GO:0051492,0.632887044407665,0.534233460598974,6,59,regulation of stress fiber assembly,BP,SFRP1;PIK3R1;ASAP3;RAPGEF3;ARAP1;ALMS1
7340,GO:0031386,0.633038202559461,0.750796332761774,1,12,protein tag,MF,ISG15
6573,GO:0022406,0.633069590521752,0.469088196362823,16,162,membrane docking,BP,VAMP3;RAB40B;CNTRL;VPS11;NINL;CEP192;IQCB1;TSNARE1;NPHP4;EXOC2;ALMS1;ESYT2;MARK4;CEP250;ATG14;PRKACA
9579,GO:0036442,0.633189217225821,0.650145541748623,2,22,proton-exporting ATPase activity,MF,TCIRG1;ATP6V0A2
3281,GO:0006968,0.633266599886693,0.651534266676832,2,20,cellular defense response,BP,ADORA2B;TCIRG1
3007,GO:0006553,0.633601967729818,0.755727742947273,1,9,lysine metabolic process,BP,ALDH7A1
15486,GO:0071880,0.633663091537457,0.758445266736266,1,8,adenylate cyclase-activating adrenergic receptor signaling pathway,BP,NOS1
4969,GO:0015081,0.633730136331218,0.52121788229749,7,67,sodium ion transmembrane transporter activity,MF,PKD2;SLC24A1;SLC13A5;SCNN1A;SCN4B;SHROOM2;SCN2A
16643,GO:0097542,0.633806067495311,0.569888595292056,4,41,ciliary tip,CC,GLI2;GLI3;IFT140;KIF7
13386,GO:0052745,0.633871690659549,0.651758221790312,2,19,inositol phosphate phosphatase activity,MF,INPP5D;IMPA2
5307,GO:0016018,0.633916924071864,0.753227256699573,1,10,cyclosporin A binding,MF,NKTR
18576,GO:1903861,0.634191905450898,0.757950018477968,1,8,positive regulation of dendrite extension,BP,SMURF1
5885,GO:0018026,0.634200810931715,0.755162092648492,1,9,peptidyl-lysine monomethylation,BP,SETD4
14978,GO:0070922,0.634341216187227,0.755029328873399,1,9,small RNA loading onto RISC,BP,AGO4
3747,GO:0008286,0.634380904347668,0.494781439897553,10,101,insulin receptor signaling pathway,BP,SREBF1;PIK3R1;SESN3;INSR;BAIAP2;TCIRG1;ATP6V0A2;PIK3R2;IRS2;GPR21
7057,GO:0030852,0.634505140393148,0.754874258345381,1,9,regulation of granulocyte differentiation,BP,INPP5D
11020,GO:0045006,0.634592265756789,0.750790624295786,1,11,DNA deamination,BP,APOBEC3C
3358,GO:0007095,0.634672891631196,0.65091670520922,2,19,mitotic G2 DNA damage checkpoint,BP,BRSK1;CDK5RAP3
18517,GO:1903729,0.634673479097475,0.754714935686394,1,9,regulation of plasma membrane organization,BP,GSN
12893,GO:0051259,0.635039278163781,0.433019151811632,36,381,protein complex oligomerization,BP,TNFAIP3;APOE;PKD2;TRIM22;ALDH1A3;KCTD11;GPX3;C1QTNF6;HMGCL;HSF4;KCNC4;ITPR3;CRTC1;KCTD18;TYSND1;HGSNAT;KCTD15;FLOT1;MMP1;INSR;SQSTM1;SHARPIN;COL6A1;PEX11B;DNM1;IKZF4;ACACB;GLUL;SRR;KCNG1;ATXN10;RNF213;DHRS4;CBR4;RIPK3;KCNS3
13880,GO:0060546,0.635378490344825,0.754046845900831,1,9,negative regulation of necroptotic process,BP,RBCK1
6587,GO:0022607,0.635573928495471,0.394044957334665,223,2214,cellular component assembly,BP,TNFAIP3;ULK2;DDB2;TP53INP1;APOE;HSPA2;ESPN;CIRBP;FLNC;PKD2;XPC;ASH2L;TRIM22;ALDH1A3;SRSF5;SLITRK6;SFRP1;OBSL1;KCTD11;EPS8L2;EPHB2;TNS1;GPX3;DGKQ;PIK3R1;EVI5L;VAV3;TENM4;UNC119B;SDK2;VAMP3;ASAP3;C1QTNF6;IMPACT;NSG1;ITGB5;GJD3;PRKACB;HMGCL;PSMG4;H1F0;HSF4;CNTRL;VPS11;COL7A1;KCNC4;ITPR3;MDM2;CRTC1;KCTD18;MLH3;TYSND1;OBSCN;GOLGA8A;HGSNAT;MYH11;PARVB;TNXB;RHOBTB2;RAPGEF3;NLGN4Y;FLRT3;NUDCD3;KCTD15;RGS2;ARPIN;ADGRB2;HPS4;SPTB;DNAH1;TUBGCP5;CLTCL1;TRPV4;FLOT1;NLGN2;ANK3;GOLGA8B;SOX12;SLX1A;SLX1B;ATG16L2;SPG11;UNC119;WIPF1;ADGRL1;NINL;AMIGO2;WWTR1;ARHGEF4;ITGA2;FAM110C;ULK1;FHOD3;TPGS1;LRSAM1;VAMP2;NAIP;GAS8;ITGA6;BSN;MMP1;INSR;GSN;BAIAP2;TTN;PLXNB3;CEP126;AHNAK2;TRIOBP;SEPT6;PILRB;RICTOR;TCIRG1;MICALL2;SQSTM1;CEP192;LOXL1;EPB41L3;SHARPIN;HYAL1;H1FX;WHAMMP3;CENPC;BBS2;THSD4;TCF4;ATP6V0A2;COL6A1;PEX11B;NPHP3;WRN;PODXL;SEPT5;DNM1;IQCB1;CDK5R1;ATRX;REC8;SHANK3;HFE;CYBA;AGO4;KRT14;WASH3P;IFT140;ANKRD28;DZIP1L;CHMP1B;THRA;ARAP1;GOLGA8N;MX2;IKZF4;SLC2A1;ACACB;NLRP1;GLUL;SRR;CAPG;TSPYL4;LRRN3;NPHP4;CCDC136;SYNPO2;CENPH;RFX2;KCNG1;BBS1;ATXN10;ZMYND8;PRX;DAB2IP;TEAD2;RNF213;PIK3C3;SYT7;ERCC5;BBS5;EXOC2;AREG;MYO9A;DLG5;TNRC18;PLXND1;BBS10;TMEM80;NDUFV3;DMTN;ALMS1;TMEM231;PMP22;DLG4;CCDC113;TCF7;SHANK2;CLSTN3;KAT2B;MARK4;DMXL2;CEP250;DHRS4;EFEMP2;CBR4;TTC19;NAP1L5;SRPX2;CD9;RANBP9;ATG14;MPP7;SSH3;PRKACA;SYNE2;PARD6G;RIPK3;NFASC;KCNS3;MSH5;PTBP2;SMURF1;TTLL1;EML2;CTNNBIP1
9279,GO:0035729,0.635609568100154,0.753827574894402,1,9,cellular response to hepatocyte growth factor stimulus,BP,GCLC
12268,GO:0048598,0.635654932187346,0.430083295185315,39,377,embryonic morphogenesis,BP,FBXW4;PKD2;ALDH1A3;LRIG3;SLITRK6;SFRP1;EPHB2;WNT3;TENM4;ITGB5;PRKACB;HOXA3;CYP26B1;COL7A1;NAGLU;FLRT3;GLI2;ITGA2;GLI3;MAP2K5;CELSR1;TRIOBP;RTF1;FZD7;HYAL1;COL6A1;NPHP3;SPRY2;IFT140;MYO3B;RET;TEAD2;BBS5;TMEM231;PTK7;TCF7;ZFP36L1;GJB5;TH
7795,GO:0032352,0.635659629917292,0.753780051748685,1,9,positive regulation of hormone metabolic process,BP,BMP6
7986,GO:0032612,0.635695821969612,0.546052189554147,5,54,interleukin-1 production,BP,TNFAIP3;F2R;NLRP1;ACP5;IFI16
265,GO:0000733,0.635757119943116,0.753687485881526,1,9,DNA strand renaturation,BP,SMARCA1
12681,GO:0050919,0.635950729580723,0.599627428349411,3,28,negative chemotaxis,BP,FLRT3;SEMA4G;SLIT3
11220,GO:0045408,0.636131041148829,0.753332210500281,1,9,regulation of interleukin-6 biosynthetic process,BP,INPP5D
10491,GO:0043408,0.636532517938061,0.422759918102389,48,474,regulation of MAPK cascade,BP,GPNMB;APOE;EGFR;SFRP1;EPHB2;MAP3K14;CSPG4;KITLG;CAMK2N1;RGS2;F2R;PDCD4;TRPV4;ADORA2B;MAPK8IP3;C5;MINK1;MAP2K5;IGFBP4;INSR;CBLC;DDT;BMP6;MAP2K2;FZD7;SYNGAP1;GDF15;MAP3K12;MAPK10;ERCC6;SHC2;EDA2R;SPRY2;FBXW7;CDK5RAP3;PAK6;MAP3K6;RET;DAB2IP;FGFR4;PIK3R2;TNFRSF25;IL11;ERN1;RANBP9;ERBB2;ACKR3;NPNT
11336,GO:0045685,0.636597238684844,0.566867062731171,4,41,regulation of glial cell differentiation,BP,SERPINE2;TENM4;TNFRSF21;PPARG
10538,GO:0043506,0.636638724649965,0.517793791265758,7,69,regulation of JUN kinase activity,BP,SFRP1;PDCD4;MAPK8IP3;ERCC6;MAP3K6;DAB2IP;ERN1
10384,GO:0043230,0.636755087167985,0.394399657374267,195,2033,extracellular organelle,CC,TNFAIP3;TGFBI;ITGB6;SERPINE2;MUC19;PYGB;MXRA5;ACTA2;APOE;NT5E;GAMT;HSPA2;PTPRS;FAM20C;PKD2;XPC;ALDH1A3;SFRP1;SEC14L2;EPS8L2;GPX3;BPHL;EYS;WNT3;VAV3;CSPG4;MVB12B;CYBRD1;HTRA1;RGMA;ZDHHC1;NAPRT;REEP2;KRT15;LGALS7B;MARCKSL1;ITGB5;RAB43;PRKACB;BCAM;MAGEF1;FKBP5;GAA;NDRG1;NAGLU;PLCD1;LTBP4;PIK3IP1;IDUA;GPRC5C;TNFSF10;MYH11;SYTL1;CALML3;ACTR1B;TNXB;RAPGEF3;ENDOD1;CTSV;BLVRB;GAL3ST4;PPL;SERPINB5;CAPN7;RTN4RL1;CLTCL1;TMC6;FLOT1;TOM1L2;SPG11;ZCCHC11;PTGS1;HEXA;C5;ARSD;MINK1;ABHD14B;GSTM2;THRAP3;VAMP2;NAIP;LTBP3;CES3;INSR;TST;GSN;HEBP1;BAIAP2;TTN;CBLC;SCNN1A;DDT;CTSF;PGLS;TM7SF3;CASP14;H2AFJ;SLC2A3;S100A4;ALDH7A1;SQSTM1;AKR7A2;FAM213A;FAT2;HEXB;HYAL1;ARRDC1;KIAA0319L;CST3;MMRN2;GDF15;THSD4;COL6A1;PEX11B;IDH2;PODXL;DNM1;IQCB1;PLD3;ABHD14A;CA2;ADIRF;NID1;RRM2B;KRT14;FBXO2;CTSB;KCNMA1;PGM1;CHMP1B;SLC2A1;C1RL;GPR155;GLUL;GNG2;CAPG;ACP5;RNPEP;DLK2;PPCS;APPL2;DAB2IP;SLC37A2;SHROOM2;SYT7;ETFB;BST2;OSBPL1A;ACVR1B;CADM4;MPI;SNX29;IGFBP6;GALE;MXRA8;CLSTN3;CEP250;ANO1;CAPS;MBLAC2;METTL7A;ALOX15B;TKFC;PNPO;MAN1B1;DHRS4;PEX1;ECI1;S100A6;EFEMP2;SGSH;GAREM2;PBLD;PCSK1N;PRDX5;PHPT1;SMPDL3B;GLB1;GSTM3;DPP7;CD9;HDAC11;CTSD;ARHGAP23;PRKACA;NPAP1;C6ORF120;ACOT2;SYNE2;SERPING1;LAMB2;NFASC;SMURF1;NPNT;ECM1
18443,GO:1903561,0.636755087167985,0.394399657374267,195,2033,extracellular vesicle,CC,TNFAIP3;TGFBI;ITGB6;SERPINE2;MUC19;PYGB;MXRA5;ACTA2;APOE;NT5E;GAMT;HSPA2;PTPRS;FAM20C;PKD2;XPC;ALDH1A3;SFRP1;SEC14L2;EPS8L2;GPX3;BPHL;EYS;WNT3;VAV3;CSPG4;MVB12B;CYBRD1;HTRA1;RGMA;ZDHHC1;NAPRT;REEP2;KRT15;LGALS7B;MARCKSL1;ITGB5;RAB43;PRKACB;BCAM;MAGEF1;FKBP5;GAA;NDRG1;NAGLU;PLCD1;LTBP4;PIK3IP1;IDUA;GPRC5C;TNFSF10;MYH11;SYTL1;CALML3;ACTR1B;TNXB;RAPGEF3;ENDOD1;CTSV;BLVRB;GAL3ST4;PPL;SERPINB5;CAPN7;RTN4RL1;CLTCL1;TMC6;FLOT1;TOM1L2;SPG11;ZCCHC11;PTGS1;HEXA;C5;ARSD;MINK1;ABHD14B;GSTM2;THRAP3;VAMP2;NAIP;LTBP3;CES3;INSR;TST;GSN;HEBP1;BAIAP2;TTN;CBLC;SCNN1A;DDT;CTSF;PGLS;TM7SF3;CASP14;H2AFJ;SLC2A3;S100A4;ALDH7A1;SQSTM1;AKR7A2;FAM213A;FAT2;HEXB;HYAL1;ARRDC1;KIAA0319L;CST3;MMRN2;GDF15;THSD4;COL6A1;PEX11B;IDH2;PODXL;DNM1;IQCB1;PLD3;ABHD14A;CA2;ADIRF;NID1;RRM2B;KRT14;FBXO2;CTSB;KCNMA1;PGM1;CHMP1B;SLC2A1;C1RL;GPR155;GLUL;GNG2;CAPG;ACP5;RNPEP;DLK2;PPCS;APPL2;DAB2IP;SLC37A2;SHROOM2;SYT7;ETFB;BST2;OSBPL1A;ACVR1B;CADM4;MPI;SNX29;IGFBP6;GALE;MXRA8;CLSTN3;CEP250;ANO1;CAPS;MBLAC2;METTL7A;ALOX15B;TKFC;PNPO;MAN1B1;DHRS4;PEX1;ECI1;S100A6;EFEMP2;SGSH;GAREM2;PBLD;PCSK1N;PRDX5;PHPT1;SMPDL3B;GLB1;GSTM3;DPP7;CD9;HDAC11;CTSD;ARHGAP23;PRKACA;NPAP1;C6ORF120;ACOT2;SYNE2;SERPING1;LAMB2;NFASC;SMURF1;NPNT;ECM1
2571,GO:0005858,0.636873661255274,0.75542678040182,1,8,axonemal dynein complex,CC,DNAH1
3760,GO:0008306,0.636918045771713,0.566813451930861,4,40,associative learning,BP,TANC1;B4GALT2;SYNGAP1;DDHD2
5282,GO:0015937,0.637038067458504,0.750245765303609,1,10,coenzyme A biosynthetic process,BP,PPCS
5783,GO:0017015,0.637073968244984,0.507219679316703,8,80,regulation of transforming growth factor beta receptor signaling pathway,BP,HTRA1;FERMT1;LTBP4;LTBP1;CD109;PBLD;SMURF1;NPNT
3542,GO:0007565,0.637275130349069,0.480357735764113,12,122,female pregnancy,BP,PTHLH;TFCP2L1;CTSV;ITGA2;PLA2G6;CST3;HFE;CTSB;SLC2A1;VDR;ACVR1B;ENDOU
11832,GO:0046827,0.637307708188823,0.647275360178665,2,20,positive regulation of protein export from nucleus,BP,MDM2;RAPGEF3
3296,GO:0006991,0.637398087939315,0.752125501703439,1,9,response to sterol depletion,BP,FBXW7
12379,GO:0048821,0.637466311567836,0.647107517727976,2,20,erythrocyte development,BP,FAM210B;DMTN
17972,GO:1902430,0.637548627311544,0.751981838714169,1,9,negative regulation of amyloid-beta formation,BP,APOE
16699,GO:0097718,0.637625749109115,0.596829884813873,3,30,disordered domain specific binding,MF,HSPA2;MDM2;TEAD2
11386,GO:0045793,0.637832272482625,0.751710980906692,1,9,positive regulation of cell size,BP,RET
6671,GO:0030038,0.637933735917034,0.516390060606724,7,69,contractile actin filament bundle assembly,BP,SFRP1;PIK3R1;ASAP3;ITGB5;RAPGEF3;ARAP1;ALMS1
10333,GO:0043149,0.637933735917034,0.516390060606724,7,69,stress fiber assembly,BP,SFRP1;PIK3R1;ASAP3;ITGB5;RAPGEF3;ARAP1;ALMS1
2805,GO:0006265,0.637975173457746,0.751574438503132,1,9,DNA topological change,BP,TOP3B
2392,GO:0005536,0.638096858304995,0.751458123938188,1,9,glucose binding,MF,SLC2A3
20001,GO:2000644,0.638632047486433,0.750946070548401,1,9,regulation of receptor catabolic process,BP,APOE
12578,GO:0050774,0.638800933731957,0.750784321419729,1,9,negative regulation of dendrite morphogenesis,BP,NFATC4
4720,GO:0010885,0.638968766294397,0.750623503578199,1,9,regulation of cholesterol storage,BP,PPARG
6536,GO:0021953,0.639224450657925,0.496718510059225,9,89,central nervous system neuron differentiation,BP,SFRP1;EPHB2;WNT3;SPOCK1;GLI2;GLI3;SHANK3;ADARB1;RORA
12712,GO:0050995,0.63923188580674,0.748134123500074,1,10,negative regulation of lipid catabolic process,BP,ACACB
15478,GO:0071871,0.639346418355946,0.750261351783231,1,9,response to epinephrine,BP,PRKACA
17328,GO:1900037,0.639351830259538,0.748018289434761,1,10,regulation of cellular response to hypoxia,BP,RWDD3
10018,GO:0042476,0.639355787931575,0.504748078679665,8,80,odontogenesis,BP,FAM20C;HTRA1;GLI2;GLI3;ITGA6;DLX3;CA2;KLK5
7998,GO:0032634,0.639694621292403,0.7499270915793,1,9,interleukin-5 production,BP,TNFRSF21
8022,GO:0032674,0.639694621292403,0.7499270915793,1,9,regulation of interleukin-5 production,BP,TNFRSF21
14133,GO:0061036,0.63969616581012,0.6456102583642,2,19,positive regulation of cartilage development,BP,GLI3;BMP6
11755,GO:0046629,0.639734313405539,0.749888967550008,1,9,gamma-delta T cell activation,BP,SOX13
9676,GO:0038065,0.63985601263303,0.752597607624788,1,8,collagen-activated signaling pathway,BP,ITGA2
3690,GO:0008195,0.639856684836421,0.749771403140787,1,9,phosphatidate phosphatase activity,MF,LPIN3
12993,GO:0051446,0.640189052479371,0.749451882656037,1,9,positive regulation of meiotic cell cycle,BP,INSR
13647,GO:0060192,0.640217555704777,0.747181051653889,1,10,negative regulation of lipase activity,BP,RGS2
6421,GO:0021692,0.640238430116183,0.752233060539529,1,8,cerebellar Purkinje cell layer morphogenesis,BP,RORA
19028,GO:1904896,0.640393750157329,0.747010400922901,1,10,ESCRT complex disassembly,BP,CHMP1B
19030,GO:1904903,0.640393750157329,0.747010400922901,1,10,ESCRT III complex disassembly,BP,CHMP1B
12490,GO:0050650,0.640396177491067,0.644866600160481,2,19,chondroitin sulfate proteoglycan biosynthetic process,BP,CSPG4;XYLT1
252,GO:0000717,0.640536254964813,0.642360131685726,2,22,nucleotide-excision repair, DNA duplex unwinding,BP,DDB2;XPC
8035,GO:0032693,0.640750015731046,0.746665081769731,1,10,negative regulation of interleukin-10 production,BP,TNFRSF21
17691,GO:1901623,0.641222588693801,0.746206485229659,1,10,regulation of lymphocyte chemotaxis,BP,CXCL14
14162,GO:0061085,0.641597119210249,0.748094847584566,1,9,regulation of histone H3-K27 methylation,BP,PHF1
8027,GO:0032682,0.641639158327579,0.745801721020026,1,10,negative regulation of chemokine production,BP,MAP2K5
11502,GO:0046033,0.64173106634196,0.745712352637912,1,10,AMP metabolic process,BP,NT5E
10372,GO:0043209,0.642004934927724,0.470373363039258,13,138,myelin sheath,CC,HSPA2;SYN1;NDRG1;ITPR3;GJC2;GSN;DNM1;CA2;GLUL;SDHA;PMP22;ERBB2;NFASC
8240,GO:0033028,0.642018476820433,0.641484210400509,2,21,myeloid cell apoptotic process,BP,KITLG;THRA
7373,GO:0031433,0.642129168324216,0.999999999999969,1,1,telethonin binding,MF,TTN
9416,GO:0035995,0.642129168324216,0.999999999999969,1,1,detection of muscle stretch,BP,TTN
7749,GO:0032273,0.642421528820817,0.492821282358911,9,94,positive regulation of protein polymerization,BP,RGS2;ARPIN;WIPF1;GSN;BAIAP2;RICTOR;WHAMMP3;CDK5R1;WASH3P
19123,GO:1905146,0.642564005735349,0.747159813221068,1,9,lysosomal protein catabolic process,BP,LRP1
15909,GO:0072718,0.642918122555391,0.746816710376963,1,9,response to cisplatin,BP,ADIRF
4943,GO:0014910,0.642991692508947,0.560196880676932,4,40,regulation of smooth muscle cell migration,BP,POSTN;MDM2;ITGA2;LRP1
72,GO:0000149,0.643071110766211,0.492282779985559,9,92,SNARE binding,MF,SYT8;VAMP3;VPS11;SYTL1;C2CD4C;SYT15;VAMP2;TSNARE1;SYT7
1183,GO:0002830,0.643080170749339,0.744397817781252,1,10,positive regulation of type 2 immune response,BP,RSAD2
774,GO:0002031,0.643138227872558,0.744341134288163,1,10,G-protein coupled receptor internalization,BP,DNM1
15569,GO:0072070,0.643301843936935,0.7464445286199,1,9,loop of Henle development,BP,PKD2
11919,GO:0046982,0.643475942766382,0.429078941693561,31,349,protein heterodimerization activity,MF,EGFR;PIK3R1;TENM4;UGT1A3;FLOT1;RALGAPA1;HEXA;ITGA2;BHLHE40;H2AFJ;BMP6;VEGFB;CABYR;HEXB;HOMER2;TCF4;HMG20B;CYBA;MEF2D;MLXIPL;IKZF4;TEAD2;PIK3R2;SNX1;TAS1R3;ERBB2;MPP7;PPARG;SUCLG2;FOXP2;GCLC
4622,GO:0010745,0.643519828229347,0.746232916519278,1,9,negative regulation of macrophage derived foam cell differentiation,BP,PPARG
8065,GO:0032753,0.643947491439124,0.743550035954158,1,10,positive regulation of interleukin-4 production,BP,IL20RB
14802,GO:0070561,0.643952244231643,0.745812747729397,1,9,vitamin D receptor signaling pathway,BP,VDR
109,GO:0000226,0.644044264105687,0.417496356043205,44,428,microtubule cytoskeleton organization,BP,MAP6;PKD2;DIXDC1;OBSL1;BRSK1;CUL9;CUL7;GOLGA8A;RGS2;DNAH1;TUBGCP5;TRPV4;GOLGA8B;NINL;TPGS1;NAIP;GAS8;CEP68;CHD3;CEP126;SUN1;CEP192;BBS2;CDK5R1;ATRX;HOOK2;SPRY2;CHMP1B;APC2;GOLGA8N;FBXW5;EML3;TACC1;CCDC88B;WEE1;LMNA;KAT2B;MARK4;CEP250;RANBP9;SYNE2;MAP1A;TTLL1;EML2
17302,GO:0150005,0.644288246885936,0.743216380411508,1,10,enzyme activator complex,CC,CDK5R1
17902,GO:1902237,0.64452737486692,0.742982040337908,1,10,positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,BP,SERINC3
6693,GO:0030098,0.644646563375897,0.446033549173233,20,201,lymphocyte differentiation,BP,INPP5D;SFRP1;PIK3R1;ZFPM1;CYP26B1;ZFP36L2;GLI2;GLI3;FZD7;NRARP;TCF7;RSAD2;ZFP36L1;IL11;STAT6;SOX13;ERBB2;RORA;POLM;RIPK3
7162,GO:0031050,0.644725028268737,0.558001930482281,4,41,dsRNA fragmentation,BP,EGFR;ZCCHC11;MAP2K2;AGO4
14976,GO:0070918,0.644725028268737,0.558001930482281,4,41,production of small RNA involved in gene silencing by RNA,BP,EGFR;ZCCHC11;MAP2K2;AGO4
5177,GO:0015740,0.644877683032012,0.744911759644513,1,9,C4-dicarboxylate transport,BP,SLC13A5
12803,GO:0051128,0.645066274890305,0.386579985811165,186,1798,regulation of cellular component organization,BP,POSTN;SERPINE2;ULK2;DDB2;SREBF1;APOE;HSPA2;EGFR;ESPN;PTPRS;CAPRIN2;DIXDC1;SLITRK6;SFRP1;OBSL1;MTHFR;EPS8L2;EPHB2;PIK3R1;EVI5L;KDM3A;CUL9;WNT3;HTRA1;RGMA;CUL7;ASAP3;OR2A4;IMPACT;NOS1;NFATC4;TBC1D8;PLXNB1;VPS11;SPOCK1;MDM2;CRTC1;CSMD3;LTBP4;TNFSF10;PARVB;RHOBTB2;RAPGEF3;CTSV;FLRT3;KIF26A;RGS2;ARPIN;ADGRB2;HPS4;SPTB;RTN4RL1;TRPV4;FLOT1;TOM1L2;NLGN2;SLX1A;SLX1B;ARHGEF19;UNC119;WIPF1;ADGRL1;PHF2;AMIGO2;ITGA2;SEMA4G;FAM110C;ULK1;FHOD3;LRSAM1;MAP2K5;IGFBP4;MMP1;TRAK1;JARID2;INSR;CCDC85B;CELSR1;GSN;BAIAP2;PLXNB3;PLEKHH2;TRIOBP;RMI2;ENDOG;RTF1;RICTOR;MICALL2;MAP2K2;SQSTM1;PTK6;ETV5;SYNGAP1;EPB41L3;HEXB;KDM4C;HYAL1;WHAMMP3;PLA2G6;CST3;GDF15;PODXL;OSCP1;MCTP1;CDK5R1;ATRX;NET1;EFNB3;SHANK3;HFE;CYBA;AGO4;SLIT3;SPRY2;WASH3P;IFT140;XRN1;FBXW7;CHMP1B;THRA;APC2;ARAP1;FMNL2;TBC1D17;FBXW5;CAPG;LRP1;LRRN3;NPHP4;SYNPO2;RET;ZMYND8;DAB2IP;DDHD2;FBXO4;SYT7;FGFR4;ERCC5;RPS6KA5;DLG5;BTG1;BST2;PLXND1;BBS10;ZMYM3;TBC1D16;DMTN;STAT2;SGSM2;ALMS1;PHF1;TFDP2;PMP22;ACVR1B;DLG4;IGFBP6;PTK7;SHANK2;LMNA;CLSTN3;KAT2B;CEP250;RAD50;ZSWIM8;APBB2;PHPT1;TUB;SRPX2;ERBB2;AKAP6;MPP7;SSH3;PPARG;PRKACA;LDLRAP1;FMNL3;SYNE2;PARN;IP6K2;SNX33;CIT;MAP1A;SMURF1;EML2;CTNNBIP1;PEMT
7933,GO:0032530,0.645450904801116,0.744352476978202,1,9,regulation of microvillus organization,BP,PODXL
4565,GO:0010649,0.645494798340853,0.744309612721174,1,9,regulation of cell communication by electrical coupling,BP,ANK3
5556,GO:0016571,0.645498071842803,0.476771702659972,11,111,histone methylation,BP,ASH2L;MTHFR;KDM3A;JARID2;RTF1;KDM4C;ATRX;PHF1;DYDC1;KMT5C;PRMT3
4464,GO:0010460,0.645558464960809,0.741969754893644,1,10,positive regulation of heart rate,BP,NMU
19259,GO:1905477,0.645578741201813,0.489389084629618,9,94,positive regulation of protein localization to membrane,BP,EGFR;EPHB2;PIK3R1;ANK3;SQSTM1;CDK5R1;LRP1;TFDP2;ERBB2
11945,GO:0047144,0.645599359601636,0.744207481533267,1,9,2-acylglycerol-3-phosphate O-acyltransferase activity,MF,MBOAT2
3485,GO:0007351,0.645725017103429,0.744084703681842,1,9,tripartite regional subdivision,BP,PCSK6
3921,GO:0008595,0.645725017103429,0.744084703681842,1,9,anterior/posterior axis specification, embryo,BP,PCSK6
16901,GO:0098900,0.645829830721203,0.588393011148724,3,29,regulation of action potential,BP,ANK3;CACNB3;PTPN3
8967,GO:0035068,0.645842921774872,0.743969460561617,1,9,micro-ribonucleoprotein complex,CC,AGO4
10267,GO:0043028,0.645874969851319,0.586992126981468,3,32,cysteine-type endopeptidase regulator activity involved in apoptotic process,MF,NAIP;NLRP1;PRDX5
4881,GO:0014745,0.646186029867698,0.743633874880955,1,9,negative regulation of muscle adaptation,BP,LMNA
17373,GO:1900121,0.646242828735529,0.741296219436625,1,10,negative regulation of receptor binding,BP,HFE
11462,GO:0045935,0.646567348297902,0.390177919131041,131,1273,positive regulation of nucleobase-containing compound metabolic process,BP,TP53INP1;PTHLH;SREBF1;APOE;EGFR;PKD2;CAPRIN2;ASH2L;SRSF5;SFRP1;SEC14L2;PIK3R1;KDM3A;POU3F1;RGMA;ZFPM1;KITLG;CITED4;IRF2BPL;MC1R;STAT1;NOS1;MAML3;KLF13;NFATC4;RNF187;HSF4;EAPP;CRTC1;NDN;RAPGEF3;F2R;ZFP36L2;GLI2;ADORA2B;KLF7;TCEA2;ZNF76;SOX12;SLX1A;SLX1B;PHF2;ABHD14B;WWTR1;GLI3;THRAP3;SMARCA1;MAP2K5;ITGA6;ZNF318;INSR;ZNF287;ENDOG;RTF1;MDK;BMP6;MAP2K2;SQSTM1;FZD7;ETV5;DLX3;HEXB;METTL23;CST3;TCF4;PLAG1;WRN;LPIN3;ATRX;ADIRF;ERCC6;MEF2D;CREBRF;MLXIPL;FBXW7;CDK5RAP3;LMO2;NFIX;CARF;PFKFB2;THRA;RAI1;ELF1;IKZF4;DBP;PEG3;RFX2;SALL2;MAF;STK16;RET;DAB2IP;CASZ1;CALCOCO1;TEAD2;MYSM1;FBXO4;IFI16;FGFR4;PIK3R2;TEF;AREG;RPS6KA5;VDR;MAMSTR;TNRC6C;PLXND1;SIX5;HLTF;PHF1;ZNF292;TFDP2;ACVR1B;TNNI2;NAT14;ZFP36L1;GLMP;IL11;KAT2B;ERN1;IVNS1ABP;RAD50;TRERF1;STAT6;CHD6;ERBB2;RORA;PPARG;PARN;ZFP90;NPNT
10403,GO:0043256,0.646587546312035,0.746121207545791,1,8,laminin complex,CC,LAMB2
6098,GO:0019321,0.646597862088298,0.739090434311586,1,11,pentose metabolic process,BP,FGGY
15194,GO:0071363,0.646681413900039,0.413371157154993,46,452,cellular response to growth factor stimulus,BP,POSTN;EGFR;FAM20C;SFRP1;ADAMTS7;SULF2;HTRA1;RGMA;ITGB5;NOS1;FERMT1;MICALL1;MDM2;NDN;LTBP4;NEO1;FLRT3;PDCD4;ZFP36L2;RNF165;TMEM204;FRS3;LTBP1;MAP2K5;INSR;BAIAP2;CD109;BMP6;HYAL1;MMRN2;GDF15;HFE;SPRY2;PDE2A;STK16;DAB2IP;FGFR4;PCSK6;ZFP36L1;ERN1;PBLD;ERBB2;TH;SMURF1;NPNT;GCLC
17506,GO:1901018,0.646823186045642,0.743009807042735,1,9,positive regulation of potassium ion transmembrane transporter activity,BP,AKAP6
2826,GO:0006293,0.647400610008793,0.635698822948568,2,21,nucleotide-excision repair, preincision complex stabilization,BP,DDB2;ERCC5
2828,GO:0006295,0.647400610008793,0.635698822948568,2,21,nucleotide-excision repair, DNA incision, 3'-to lesion,BP,DDB2;ERCC5
8736,GO:0034397,0.647401049677157,0.742442821928754,1,9,telomere localization,BP,SUN1
12888,GO:0051254,0.647545375221917,0.39138570895581,115,1114,positive regulation of RNA metabolic process,BP,TP53INP1;SREBF1;EGFR;PKD2;CAPRIN2;ASH2L;SRSF5;SFRP1;SEC14L2;PIK3R1;KDM3A;POU3F1;RGMA;ZFPM1;CITED4;IRF2BPL;MC1R;STAT1;NOS1;MAML3;KLF13;NFATC4;RNF187;HSF4;EAPP;CRTC1;NDN;F2R;ZFP36L2;GLI2;KLF7;TCEA2;ZNF76;SOX12;PHF2;ABHD14B;WWTR1;GLI3;THRAP3;SMARCA1;MAP2K5;ITGA6;ZNF318;INSR;ZNF287;RTF1;MDK;BMP6;MAP2K2;SQSTM1;FZD7;ETV5;DLX3;HEXB;METTL23;TCF4;PLAG1;LPIN3;ATRX;ADIRF;ERCC6;MEF2D;CREBRF;MLXIPL;FBXW7;CDK5RAP3;LMO2;NFIX;CARF;THRA;RAI1;ELF1;IKZF4;DBP;PEG3;RFX2;SALL2;MAF;STK16;RET;DAB2IP;CASZ1;CALCOCO1;TEAD2;MYSM1;IFI16;PIK3R2;TEF;RPS6KA5;VDR;MAMSTR;TNRC6C;PLXND1;SIX5;HLTF;PHF1;ZNF292;TFDP2;ACVR1B;TNNI2;NAT14;ZFP36L1;GLMP;IL11;KAT2B;ERN1;IVNS1ABP;TRERF1;STAT6;CHD6;ERBB2;RORA;PPARG;ZFP90;NPNT
13512,GO:0055117,0.64759275089826,0.554850194508645,4,41,regulation of cardiac muscle contraction,BP,NOS1;RGS2;GSTM2;PRKACA
7172,GO:0031062,0.647684248756414,0.585877953404532,3,30,positive regulation of histone methylation,BP,JARID2;RTF1;PHF1
12388,GO:0048846,0.647686873788151,0.586879552865011,3,28,axon extension involved in axon guidance,BP,WNT3;SEMA4G;SLIT3
17922,GO:1902284,0.647686873788151,0.586879552865011,3,28,neuron projection extension involved in neuron projection guidance,BP,WNT3;SEMA4G;SLIT3
977,GO:0002431,0.647788863811001,0.517669713658171,6,61,Fc receptor mediated stimulatory signaling pathway,BP,PIK3R1;VAV3;WIPF1;BAIAP2;PLA2G6;PIK3R2
15392,GO:0071677,0.648168437605141,0.737529984692701,1,11,positive regulation of mononuclear cell migration,BP,PLA2G7
6707,GO:0030123,0.648210884588012,0.741646641559317,1,9,AP-3 adaptor complex,CC,VPS39
5819,GO:0017091,0.648216483952605,0.63481645559498,2,21,AU-rich element binding,MF,ZFP36L2;ZFP36L1
11346,GO:0045722,0.648283622101963,0.741575039445549,1,9,positive regulation of gluconeogenesis,BP,KAT2B
10025,GO:0042491,0.648294807560918,0.635523309970322,2,20,inner ear auditory receptor cell differentiation,BP,SLITRK6;TRIOBP
16436,GO:0097120,0.648302713444059,0.635514761582622,2,20,receptor localization to synapse,BP,NSG1;DLG4
9238,GO:0035646,0.648481615053814,0.739083604640411,1,10,endosome to melanosome transport,BP,BLOC1S3
10523,GO:0043485,0.648481615053814,0.739083604640411,1,10,endosome to pigment granule transport,BP,BLOC1S3
12355,GO:0048757,0.648481615053814,0.739083604640411,1,10,pigment granule maturation,BP,BLOC1S3
9541,GO:0036314,0.648519689775891,0.636160854422592,2,19,response to sterol,BP,ABCA2;RORA
3936,GO:0008625,0.648815062889272,0.51608496724154,6,64,extrinsic apoptotic signaling pathway via death domain receptors,BP,TNFAIP3;SFRP1;PIK3R1;TNFSF10;PIDD1;DAB2IP
4638,GO:0010763,0.649279831373353,0.740592867713668,1,9,positive regulation of fibroblast migration,BP,DMTN
12939,GO:0051341,0.649302017492206,0.531167504737486,5,54,regulation of oxidoreductase activity,BP,APOE;EGFR;CYBA;VDR;RIPK3
8339,GO:0033209,0.649445223163582,0.466431982669105,12,138,tumor necrosis factor-mediated signaling pathway,BP,TNFAIP3;MAP3K14;RBCK1;STAT1;TNFRSF14;SPPL2B;SHARPIN;TNFRSF21;EDA2R;TNFRSF25;TNFSF12;CCDC3
11027,GO:0045019,0.649742064240548,0.737831627742788,1,10,negative regulation of nitric oxide biosynthetic process,BP,ACP5
18804,GO:1904406,0.649742064240548,0.737831627742788,1,10,negative regulation of nitric oxide metabolic process,BP,ACP5
3080,GO:0006654,0.649858635426411,0.583487125275414,3,30,phosphatidic acid biosynthetic process,BP,DGKQ;SLC27A1;DDHD2
12046,GO:0048011,0.64992181589775,0.633761256663153,2,20,neurotrophin TRK receptor signaling pathway,BP,NDN;SPRY2
3671,GO:0008170,0.649965320517787,0.502627758196176,7,74,N-methyltransferase activity,MF,ASH2L;METTL21A;SETD4;DYDC1;KMT5C;PRMT3;PEMT
13621,GO:0060148,0.650180887156824,0.633480158203202,2,20,positive regulation of posttranscriptional gene silencing,BP,EGFR;MAP2K2
14469,GO:0061912,0.65026261783075,0.551904620402006,4,41,selective autophagy,BP,LRSAM1;SQSTM1;ATG14;SMURF1
8012,GO:0032653,0.650405655464164,0.631723793684697,2,22,regulation of interleukin-10 production,BP,IL20RB;TNFRSF21
10608,GO:0043619,0.650597842580409,0.739289084385798,1,9,regulation of transcription from RNA polymerase II promoter in response to oxidative stress,BP,CHD6
11076,GO:0045091,0.650652479598192,0.736924512733746,1,10,regulation of single stranded viral RNA replication via double stranded DNA intermediate,BP,APOBEC3C
3038,GO:0006590,0.650681203105513,0.739206456933648,1,9,thyroid hormone generation,BP,DUOX1
8348,GO:0033235,0.650865450027848,0.736711972224746,1,10,positive regulation of protein sumoylation,BP,RWDD3
18811,GO:1904424,0.650910540386273,0.73897903387483,1,9,regulation of GTP binding,BP,GPSM1
15668,GO:0072216,0.650984787151498,0.736592819223082,1,10,positive regulation of metanephros development,BP,RET
4033,GO:0009067,0.651038885172849,0.631753055764744,2,21,aspartate family amino acid biosynthetic process,BP,THNSL2;MTR
19868,GO:2000379,0.651303750067983,0.52895649390802,5,54,positive regulation of reactive oxygen species metabolic process,BP,EGFR;PKD2;INSR;CYBA;RIPK3
18056,GO:1902668,0.651327766178699,0.633118775754218,2,19,negative regulation of axon guidance,BP,WNT3;SEMA4G
8528,GO:0033865,0.651332573863134,0.580592763465826,3,33,nucleoside bisphosphate metabolic process,BP,SULT1E1;ABHD14B;PPCS
8534,GO:0033875,0.651332573863134,0.580592763465826,3,33,ribonucleoside bisphosphate metabolic process,BP,SULT1E1;ABHD14B;PPCS
8555,GO:0034032,0.651332573863134,0.580592763465826,3,33,purine nucleoside bisphosphate metabolic process,BP,SULT1E1;ABHD14B;PPCS
16,GO:0000030,0.651495109509385,0.630536982093312,2,22,mannosyltransferase activity,MF,PIGZ;DPY19L2P2
8873,GO:0034698,0.651543207119018,0.631999634656465,2,20,response to gonadotropin,BP,CTSV;GCLC
7972,GO:0032594,0.651552590557445,0.631193648425282,2,21,protein transport within lipid bilayer,BP,REEP2;NSG1
17251,GO:0120103,0.651706606837395,0.73818844305937,1,9,centriolar subdistal appendage,CC,CNTRL
7618,GO:0032025,0.651733721125749,0.735844108604599,1,10,response to cobalt ion,BP,D2HGDH
12491,GO:0050651,0.652053292728506,0.737843573645737,1,9,dermatan sulfate proteoglycan biosynthetic process,BP,CSPG4
4064,GO:0009116,0.652286621398772,0.481605088334702,9,100,nucleoside metabolic process,BP,NT5E;GAMT;APOBEC3C;MACROD1;OARD1;TK2;DLG4;UCKL1;PEMT
15972,GO:0086003,0.65235879656149,0.581213910209362,3,29,cardiac muscle cell contraction,BP,SNTA1;KCNJ5;SCN4B
15500,GO:0071901,0.652545626090648,0.468800754326528,11,116,negative regulation of protein serine/threonine kinase activity,BP,TNFAIP3;APOE;SFRP1;RGS2;PDCD4;CBLC;SPRY2;CDK5RAP3;WNK1;DAB2IP;KAT2B
8926,GO:0034969,0.652649209878925,0.734926704502411,1,10,histone arginine methylation,BP,PRMT3
15140,GO:0071280,0.652824909650586,0.731298044308347,1,12,cellular response to copper ion,BP,MT1X
12860,GO:0051213,0.652846423274888,0.499698087268204,7,72,dioxygenase activity,MF,KDM3A;PHYH;PTGS1;PHF2;KDM4C;ALOXE3;ALOX15B
3424,GO:0007213,0.653151334278651,0.734422504948284,1,10,G-protein coupled acetylcholine receptor signaling pathway,BP,CDK5R1
14982,GO:0070932,0.653359871796669,0.630019119543032,2,20,histone H3 deacetylation,BP,PER2;HDAC11
15903,GO:0072710,0.653533467748612,0.736367265316738,1,9,response to hydroxyurea,BP,ATRX
2796,GO:0006241,0.65353905047048,0.730573609765874,1,12,CTP biosynthetic process,BP,UCKL1
11505,GO:0046036,0.65353905047048,0.730573609765874,1,12,CTP metabolic process,BP,UCKL1
3389,GO:0007167,0.653724076993744,0.394720528309298,71,689,enzyme linked receptor protein signaling pathway,BP,SREBF1;EGFR;GIGYF1;FAM20C;SFRP1;EPHB2;DGKQ;PIK3R1;SULF2;VAV3;CSPG4;MVB12B;HTRA1;RGMA;ITGB5;FERMT1;NDN;LTBP4;NEO1;FLRT3;PDCD4;RNF165;RHBDF1;TMEM204;FRS3;WWTR1;LTBP1;SESN3;IGFBP4;INSR;BAIAP2;CBLC;CD109;PILRB;BMP6;TCIRG1;VEGFB;PTK6;SH2D2A;MMRN2;GDF15;TXNIP;CTF1;ATP6V0A2;DNM1;CDK5R1;EFNB3;HFE;CYBA;SHC2;SPRY2;FBXW7;ARAP1;LRP1;RET;DAB2IP;FGFR4;PIK3R2;AREG;RPS6KA5;EFS;PCSK6;ACVR1B;IGFBP6;IRS2;GPR21;PBLD;PTPN3;ERBB2;SMURF1;NPNT
8347,GO:0033234,0.654086928186765,0.733481103403464,1,10,negative regulation of protein sumoylation,BP,HMG20B
17643,GO:1901522,0.654166627802164,0.629137310838731,2,20,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus,BP,CARF;CHD6
13483,GO:0055074,0.654282664473364,0.435650825953208,20,203,calcium ion homeostasis,BP,APOE;PKD2;NOS1;ITPR3;F2R;SLC24A1;TRPV4;GSTM2;NMU;HEXB;PLA2G6;CYBA;JPH2;TMEM203;VDR;CACNB3;LPAR6;DLG4;AKAP6;PRKACA
7123,GO:0030955,0.65441023339371,0.735489809637529,1,9,potassium ion binding,MF,SLC24A1
251,GO:0000715,0.654516917791351,0.626575287360119,2,23,nucleotide-excision repair, DNA damage recognition,BP,DDB2;XPC
889,GO:0002262,0.654525183484573,0.472702508980069,10,104,myeloid cell homeostasis,BP,INPP5D;ZFPM1;KITLG;STAT1;KLF13;FAM210B;THRA;DMTN;ACVR1B;ZFP36L1
6927,GO:0030539,0.65460561504417,0.735293971267557,1,9,male genitalia development,BP,BMP6
13340,GO:0052547,0.654704370998977,0.423859371118624,26,283,regulation of peptidase activity,BP,SERPINE2;IFI6;COL7A1;SPOCK1;MDM2;TNFSF10;F2R;SERPINB5;LAMP3;PIDD1;C5;NAIP;MAP2K5;GSN;CD109;CST3;IFI27;TFPI2;NLRP1;IFI16;BST2;PCSK1N;PRDX5;PPARG;SERPING1;ECM1
4192,GO:0009299,0.655118287051032,0.628095303254476,2,20,mRNA transcription,BP,SREBF1;LMO2
14584,GO:0070166,0.655245079096201,0.734652238935658,1,9,enamel mineralization,BP,FAM20C
9309,GO:0035791,0.655418221095786,0.734478278702399,1,9,platelet-derived growth factor receptor-beta signaling pathway,BP,LRP1
11678,GO:0046479,0.655425792908854,0.732129520478609,1,10,glycosphingolipid catabolic process,BP,HEXB
4332,GO:0009886,0.655569483499617,0.73198415582737,1,10,post-embryonic animal morphogenesis,BP,ATRX
14721,GO:0070411,0.655684025658328,0.734211048577669,1,9,I-SMAD binding,MF,SMURF1
729,GO:0001959,0.655738658009831,0.46014876390497,12,126,regulation of cytokine-mediated signaling pathway,BP,TNFAIP3;RBCK1;STAT1;SPPL2B;SHARPIN;SLIT3;CREBRF;ELF1;STAT2;PPARG;CCDC3;ECM1
5544,GO:0016540,0.656201729871336,0.731343830049818,1,10,protein autoprocessing,BP,CTSV
13367,GO:0052659,0.656300213111528,0.733590766304338,1,9,inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity,MF,INPP5D
10396,GO:0043248,0.656322043622674,0.72773640685776,1,12,proteasome assembly,BP,PSMG4
9014,GO:0035235,0.656528356315255,0.73336082662191,1,9,ionotropic glutamate receptor signaling pathway,BP,CDK5R1
19879,GO:2000392,0.656569004713112,0.733319842226899,1,9,regulation of lamellipodium morphogenesis,BP,ARPIN
11408,GO:0045838,0.656585110727073,0.730954983054326,1,10,positive regulation of membrane potential,BP,ANK3
17731,GO:1901701,0.656656799581683,0.391587797412273,71,706,cellular response to oxygen-containing compound,BP,TNFAIP3;TP53INP1;SREBF1;EGFR;PKD2;SRSF5;SFRP1;PIK3R1;WNT3;STAT1;IMPACT;PRKACB;NFATC4;CYP26B1;CMPK2;MDM2;RAPGEF3;FAM210B;PDCD4;ADAMTS13;ITGA2;VAMP2;SESN3;INSR;BAIAP2;ENDOG;BMP6;TCIRG1;PTK6;FZD7;PLA2G6;CST3;ATP6V0A2;COL6A1;CDK5R1;NET1;CA2;SESN1;CYBA;XRN1;MLXIPL;GNG2;LRP1;BRINP1;PDE2A;RET;DAB2IP;TEAD2;PIK3R2;VDR;DMTN;PTK7;ZFP36L1;KAT2B;IRS2;ANO1;ERN1;GPR21;MTR;STAT6;PRDX5;PHPT1;CACNB1;GPR68;AKAP6;TH;RORA;PPARG;PRKACA;KLF9;GCLC
18137,GO:1902905,0.656801440133515,0.450421506034785,14,145,positive regulation of supramolecular fiber organization,BP,APOE;SFRP1;RAPGEF3;RGS2;ARPIN;TRPV4;WIPF1;GSN;BAIAP2;RICTOR;WHAMMP3;CDK5R1;WASH3P;SYNPO2
13820,GO:0060442,0.656945655941182,0.732939848469023,1,9,branching involved in prostate gland morphogenesis,BP,SFRP1
11094,GO:0045125,0.657241841287068,0.730287892619216,1,10,bioactive lipid receptor activity,MF,LPAR6
4038,GO:0009072,0.657303476854727,0.728313800445581,1,11,aromatic amino acid family metabolic process,BP,TH
614,GO:0001783,0.657336902762744,0.624129481940249,2,22,B cell apoptotic process,BP,TNFRSF21;IRS2
16958,GO:0099023,0.657688616020128,0.506421366225689,6,63,tethering complex,CC,VPS11;VPS39;HOOK2;SYNPO2;EXOC2;COG1
2462,GO:0005677,0.65771274747154,0.732164668760997,1,9,chromatin silencing complex,CC,TNRC18
11611,GO:0046330,0.657897082486575,0.476155263261225,9,91,positive regulation of JNK cascade,BP,TRPV4;MAPK8IP3;MINK1;FZD7;ERCC6;EDA2R;MAP3K6;DAB2IP;ERN1
10234,GO:0042982,0.657927931496823,0.54283216730854,4,43,amyloid precursor protein metabolic process,BP,APOE;NSG1;NECAB3;LDLRAP1
19684,GO:2000042,0.658199703523538,0.731671685253035,1,9,negative regulation of double-strand break repair via homologous recombination,BP,MAGEF1
17851,GO:1902107,0.658220661872063,0.483692327355616,8,84,positive regulation of leukocyte differentiation,BP,INPP5D;KITLG;GLI2;GLI3;CA2;ZFP36L1;GPR68;CTNNBIP1
8054,GO:0032731,0.6584262995133,0.623653498002902,2,21,positive regulation of interleukin-1 beta production,BP,NLRP1;IFI16
16706,GO:0097731,0.658472130425708,0.521588187166513,5,51,9+0 non-motile cilium,CC,PTGS1;IQCB1;IFT140;NPHP4;SHANK2
16708,GO:0097733,0.658472130425708,0.521588187166513,5,51,photoreceptor cell cilium,CC,PTGS1;IQCB1;IFT140;NPHP4;SHANK2
4521,GO:0010586,0.658528788171514,0.623540294358677,2,21,miRNA metabolic process,BP,ZCCHC11;AGO4
52,GO:0000109,0.658583105003949,0.728921551544381,1,10,nucleotide-excision repair complex,CC,XPC
12919,GO:0051298,0.658650418195656,0.505663051116433,6,61,centrosome duplication,BP,PKD2;BRSK1;TUBGCP5;CHMP1B;FBXW5;KAT2B
4105,GO:0009162,0.658737447795378,0.726845111562108,1,11,deoxyribonucleoside monophosphate metabolic process,BP,TK2
11091,GO:0045121,0.658955710097535,0.430695593907828,20,200,membrane raft,CC,INPP5D;EGFR;MARVELD1;UNC5B;NOS1;F2R;RTN4RL1;FLOT1;INSR;CBLC;PODXL;MALL;KCNMA1;SLC2A1;RET;BST2;STAT6;CTSD;AKAP6;PRKACA
5906,GO:0018146,0.659019956153304,0.62299745636132,2,21,keratan sulfate biosynthetic process,BP,B4GALT6;B4GALT2
938,GO:0002347,0.659153447184276,0.728338946962761,1,10,response to tumor cell,BP,TXNIP
13477,GO:0055064,0.659322972652248,0.730531860676628,1,9,chloride ion homeostasis,BP,SLC12A7
266,GO:0000737,0.659323397201463,0.621933724459911,2,22,DNA catabolic process, endonucleolytic,BP,H1F0;ENDOG
14003,GO:0060749,0.659407189561528,0.728079441748798,1,10,mammary gland alveolus development,BP,AREG
14266,GO:0061377,0.659407189561528,0.728079441748798,1,10,mammary gland lobule development,BP,AREG
15786,GO:0072503,0.659503419675613,0.427799353311058,21,216,cellular divalent inorganic cation homeostasis,BP,APOE;PKD2;NOS1;ITPR3;F2R;MT1X;SLC24A1;TRPV4;GSTM2;NMU;HEXB;PLA2G6;CYBA;JPH2;TMEM203;VDR;CACNB3;LPAR6;DLG4;AKAP6;PRKACA
9155,GO:0035520,0.659520000353436,0.730331546914938,1,9,monoubiquitinated protein deubiquitination,BP,MYSM1
10550,GO:0043523,0.659686607744386,0.451287782093137,13,136,regulation of neuron apoptotic process,BP,APOE;UNC5B;F2R;NAIP;MDK;SYNGAP1;MAP3K12;CDK5R1;FBXW7;LRP1;SNCB;TRIM2;GCLC
6653,GO:0030011,0.659717048639934,0.730131097964246,1,9,maintenance of cell polarity,BP,DLG5
1872,GO:0004550,0.659816488103474,0.724141890633373,1,12,nucleoside diphosphate kinase activity,MF,CMPK2
5272,GO:0015924,0.659891488419723,0.729953552286752,1,9,mannosyl-oligosaccharide mannosidase activity,MF,MAN1B1
8915,GO:0034770,0.659918162808971,0.729926395058276,1,9,histone H4-K20 methylation,BP,KMT5C
11564,GO:0046134,0.659954398110757,0.619968489497967,2,24,pyrimidine nucleoside biosynthetic process,BP,TK2;UCKL1
1776,GO:0004386,0.660099038893729,0.447190167238789,14,137,helicase activity,MF,DDX60;DDX59;DHX32;SMARCA1;CHD3;DHX58;WRN;MCM9;ATRX;HLTF;DQX1;RAD50;CHD6;DDX12P
5206,GO:0015807,0.660118578983877,0.540650793810215,4,42,L-amino acid transport,BP,PER2;SLC36A4;SLC43A1;SERINC3
766,GO:0002020,0.660130259748112,0.473966334259787,9,88,protease binding,MF,TNFAIP3;TYSND1;FLOT1;TTN;CST3;CDK5R1;LRP1;LONP2;ECM1
16482,GO:0097200,0.660136962535536,0.72540588878028,1,11,cysteine-type endopeptidase activity involved in execution phase of apoptosis,MF,CASP14
10233,GO:0042981,0.660396726861701,0.378929304663877,109,1095,regulation of apoptotic process,BP,TNFAIP3;SIK1;TP53INP1;IFI6;APOE;INPP5D;EGFR;MNT;ALDH1A3;SFRP1;EPHB2;MAP3K14;PIK3R1;RBCK1;TSC22D3;VAV3;KITLG;STAT1;HS1BP3;UNC5B;PLEKHG5;NFATC4;NDRG1;MDM2;OBSCN;TNFSF10;F2R;PDCD4;GLI2;LAMP3;PIDD1;ARHGEF19;MINK1;AMIGO2;TNFRSF14;ARHGEF4;GLI3;NAIP;MAP2K5;ITGA6;NUPR1;INSR;GSN;PNMA1;ARHGEF1;DOCK8;TP53AIP1;ENDOG;MDK;BMP6;MAP2K2;SQSTM1;SYNGAP1;PLA2G6;GDF15;TXNIP;MAP3K12;WRN;IFI27;TNFRSF21;CDK5R1;NET1;AGO4;RRM2B;SPRY2;CTSB;FBXW7;KCNMA1;ING4;PAK6;THRA;NLRP1;BEX2;LRP1;RET;DAB2IP;FGFR4;ERCC5;IL20RA;SNCB;DLG5;BTG1;VDR;RGL2;ARHGEF17;TFDP2;PANO1;PALB2;TCF7;TNFRSF25;ZFP36L1;LMNA;IRS2;IVNS1ABP;ZMAT3;APBB2;ARHGEF9;TNFSF12;PRDX5;TRAF5;TRIM2;ERBB2;PPARG;ACKR3;UFL1;IP6K2;RIPK3;SERINC3;GCLC
7579,GO:0031954,0.660438400273868,0.622233697571489,2,20,positive regulation of protein autophosphorylation,BP,GPNMB;RAD50
2729,GO:0006109,0.660560830095897,0.450624360005131,13,130,regulation of carbohydrate metabolic process,BP,SIK1;DGKQ;MLYCD;IGFBP4;INSR;PDK1;MLXIPL;PFKFB2;ACACB;EPM2AIP1;KAT2B;IRS2;RORA
1301,GO:0003143,0.660622492308946,0.540670946886656,4,40,embryonic heart tube morphogenesis,BP,PKD2;NPHP3;TEAD2;BBS5
5706,GO:0016840,0.660839415717739,0.724681328233249,1,11,carbon-nitrogen lyase activity,MF,SRR
13095,GO:0051651,0.661071131618834,0.49035411580307,7,74,maintenance of location in cell,BP,APOE;GAA;ANK3;GSN;SUN1;EPB41L3;SYNE2
15805,GO:0072528,0.661148811505853,0.568599451031708,3,36,pyrimidine-containing compound biosynthetic process,BP,CMPK2;TK2;UCKL1
5608,GO:0016655,0.661561865116247,0.565115664315674,3,49,oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor,MF,NDUFV3;DHRS4;CBR4
10500,GO:0043422,0.661678528125223,0.725748059668772,1,10,protein kinase B binding,MF,SRSF5
5716,GO:0016857,0.661986708949786,0.725430556008331,1,10,racemase and epimerase activity, acting on carbohydrates and derivatives,MF,GALE
10596,GO:0043589,0.662007708447938,0.727792496306633,1,9,skin morphogenesis,BP,ITGA2
4364,GO:0009975,0.662049100442407,0.727750095160977,1,9,cyclase activity,MF,TKFC
5510,GO:0016469,0.66228789692017,0.61737042711779,2,24,proton-transporting two-sector ATPase complex,CC,TCIRG1;ATP6V0A2
18567,GO:1903844,0.662623824892887,0.479015852098955,8,82,regulation of cellular response to transforming growth factor beta stimulus,BP,HTRA1;FERMT1;LTBP4;LTBP1;CD109;PBLD;SMURF1;NPNT
19780,GO:2000243,0.662705393350637,0.568304635554451,3,32,positive regulation of reproductive process,BP,LHFPL2;INSR;ACVR1B
5613,GO:0016668,0.662834864830948,0.72261510713413,1,11,oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor,MF,TXNRD3
18484,GO:1903651,0.663178175192997,0.726591530079864,1,9,positive regulation of cytoplasmic transport,BP,VPS11
8662,GO:0034244,0.663216470836026,0.724160782983269,1,10,negative regulation of transcription elongation from RNA polymerase II promoter,BP,EAPP
645,GO:0001836,0.663319946128579,0.53540242510757,4,49,release of cytochrome c from mitochondria,BP,IFI6;TNFSF10;PLA2G6;LMNA
5712,GO:0016849,0.663351119921802,0.726413733217567,1,9,phosphorus-oxygen lyase activity,MF,TKFC
18055,GO:1902667,0.663431533018922,0.568864167327451,3,29,regulation of axon guidance,BP,WNT3;SEMA4G;ZSWIM8
8014,GO:0032656,0.663561390658805,0.723803832514709,1,10,regulation of interleukin-13 production,BP,TNFRSF21
1282,GO:0003091,0.663640345631318,0.618675829731329,2,20,renal water homeostasis,BP,PRKACB;PRKACA
5736,GO:0016886,0.663794691216663,0.723562193351852,1,10,ligase activity, forming phosphoric ester bonds,MF,LIG1
17799,GO:1901978,0.664103470309658,0.72324212803111,1,10,positive regulation of cell cycle checkpoint,BP,NDRG1
7011,GO:0030730,0.664368379936904,0.72296730857933,1,10,sequestering of triglyceride,BP,PPARG
16014,GO:0086065,0.664534136949234,0.566671325516676,3,31,cell communication involved in cardiac conduction,BP,KCNJ5;SCN4B;PRKACA
2589,GO:0005884,0.664648140327376,0.486489122231993,7,73,actin filament,CC,ESPN;PKD2;FERMT1;WIPF1;APC2;DMTN;SHROOM4
6603,GO:0022821,0.664966251394211,0.724748977506379,1,9,potassium ion antiporter activity,MF,SLC24A1
12914,GO:0051291,0.665155473540451,0.47471739655295,8,100,protein heterooligomerization,BP,C1QTNF6;ITPR3;INSR;SQSTM1;COL6A1;IKZF4;CBR4;RIPK3
6950,GO:0030594,0.665181477885628,0.615408025527716,2,22,neurotransmitter receptor activity,MF,GABBR1;GPR21
11815,GO:0046755,0.665309325662881,0.61459743151098,2,23,viral budding,BP,LRSAM1;CHMP1B
19713,GO:2000106,0.665363583364984,0.513087108935938,5,55,regulation of leukocyte apoptotic process,BP,TSC22D3;KITLG;DOCK8;IRS2;RIPK3
4200,GO:0009310,0.665468823383506,0.7198695703504,1,11,amine catabolic process,BP,ALDH7A1
13118,GO:0051704,0.665646570613123,0.36776028053124,155,1585,multi-organism process,BP,TNFAIP3;ITGB6;SERPINE2;ULK2;PTHLH;ACTA2;APOE;GAMT;OAS2;DDX60;HSPA2;EGFR;APOBEC3C;SYT8;TRIM22;IFI44L;MAP3K14;PIK3R1;TXNRD3;RBCK1;KDM3A;WNT3;HERC5;VWCE;ISG15;MVB12B;HTRA1;TFCP2L1;CUL7;STAT1;ITGB5;RAB43;RAB40B;NOS1;ZFP41;SCMH1;CRTAP;CYP26B1;CMPK2;PIK3C2G;MDM2;CRTC1;IFITM1;MLH3;HLA-B;CTSV;NLGN4Y;SPATA20;OAS1;AP1G2;RGS2;F2R;PDCD4;DNAH1;ADAMTS13;LAMP3;ATG16L2;MICALCL;WIPF1;TNFRSF14;LHFPL2;ITGA2;ULK1;TPGS1;LRSAM1;MMP1;TCFL5;INSR;IFI44;HSF2BP;GSN;BAIAP2;SUN1;SEPT6;RAB11FIP4;MGST2;DHX58;IRF9;BMP6;NLRX1;MAP2K2;SQSTM1;CABYR;ETV5;LOXL1;HEXB;HYAL1;PLA2G6;CST3;BBS2;MCM9;TNFRSF21;ATRX;REC8;EFNB3;SHANK3;HFE;CYBA;TRIM38;AGO4;CTSB;KLK5;FBXW7;ATXN1;CHMP1B;THRA;ADARB1;MX2;SLC2A1;NLRP1;SRR;HLA-A;CCDC136;ACP5;RFX2;BRINP1;DAB2IP;IFI16;EXOC2;TMEM203;BTG1;BST2;VDR;DPY19L2P2;FAM3A;SIX5;STAT2;ACVR1B;CCDC88B;DLG4;TSSK1B;ENDOU;SHANK2;RSAD2;TNFRSF25;KAT2B;IVNS1ABP;RAD50;TKFC;NELFCD;PHC2;CHD6;CD9;PAQR7;TH;PRKACA;NPAP1;GCNT4;ACKR3;UCKL1;PARN;HERPUD2;TTLL1;GLIPR1L2;SERINC3
7799,GO:0032356,0.665742085606128,0.721538844393454,1,10,oxidized DNA binding,MF,WRN
6986,GO:0030673,0.665824037006115,0.723861661708705,1,9,axolemma,CC,EPB41L3
7602,GO:0031996,0.665976166315985,0.721294868095992,1,10,thioesterase binding,MF,TRAF5
2366,GO:0005484,0.666045154966396,0.563759073018506,3,34,SNAP receptor activity,MF,VAMP3;VAMP2;TSNARE1
13881,GO:0060547,0.666053235662659,0.721214504652752,1,10,negative regulation of necrotic cell death,BP,RBCK1
569,GO:0001711,0.666274210268029,0.720983986097343,1,10,endodermal cell fate commitment,BP,RTF1
4948,GO:0015012,0.666482983378343,0.615498117902777,2,20,heparan sulfate proteoglycan biosynthetic process,BP,NDST2;XYLT1
9883,GO:0042177,0.666715554666777,0.465836991372917,9,98,negative regulation of protein catabolic process,BP,SERPINE2;EGFR;LAMP3;CST3;HFE;CDK5RAP3;DAB2IP;PANO1;PTPN3
13455,GO:0055012,0.666986578572065,0.720239849275315,1,10,ventricular cardiac muscle cell differentiation,BP,LMNA
2374,GO:0005504,0.667161623855464,0.715100212571203,1,13,fatty acid binding,MF,PPARG
18488,GO:1903671,0.667513814690584,0.614341313894173,2,20,negative regulation of sprouting angiogenesis,BP,MAP2K5;MMRN2
11670,GO:0046470,0.667601737484295,0.510564369278151,5,55,phosphatidylcholine metabolic process,BP,MBOAT2;SLC27A1;PLA2G6;LPIN3;PEMT
15496,GO:0071897,0.667657697811586,0.428601607710872,17,178,DNA biosynthetic process,BP,ISG15;LIG1;POLH;POLD4;RMI2;WRN;XRN1;TK2;FBXO4;FGFR4;PRIMPOL;PALB2;TEP1;RAD50;PPARG;POLM;PARN
7409,GO:0031507,0.667713596171088,0.71947883127536,1,10,heterochromatin assembly,BP,TNRC18
14525,GO:0070062,0.667745184815478,0.362607399470759,193,2024,extracellular exosome,CC,TNFAIP3;TGFBI;ITGB6;MUC19;PYGB;MXRA5;ACTA2;APOE;NT5E;GAMT;HSPA2;PTPRS;FAM20C;PKD2;XPC;ALDH1A3;SFRP1;SEC14L2;EPS8L2;GPX3;BPHL;EYS;WNT3;VAV3;CSPG4;MVB12B;CYBRD1;HTRA1;RGMA;ZDHHC1;NAPRT;REEP2;KRT15;LGALS7B;MARCKSL1;ITGB5;RAB43;PRKACB;BCAM;MAGEF1;FKBP5;GAA;NDRG1;NAGLU;PLCD1;LTBP4;PIK3IP1;IDUA;GPRC5C;TNFSF10;MYH11;SYTL1;CALML3;ACTR1B;TNXB;RAPGEF3;ENDOD1;CTSV;BLVRB;GAL3ST4;PPL;SERPINB5;CAPN7;RTN4RL1;CLTCL1;TMC6;FLOT1;TOM1L2;SPG11;ZCCHC11;PTGS1;HEXA;C5;ARSD;MINK1;ABHD14B;GSTM2;THRAP3;VAMP2;NAIP;LTBP3;CES3;INSR;TST;GSN;HEBP1;BAIAP2;TTN;CBLC;SCNN1A;DDT;CTSF;PGLS;TM7SF3;CASP14;H2AFJ;SLC2A3;S100A4;ALDH7A1;SQSTM1;AKR7A2;FAM213A;FAT2;HEXB;HYAL1;ARRDC1;KIAA0319L;CST3;MMRN2;GDF15;THSD4;COL6A1;PEX11B;IDH2;PODXL;DNM1;IQCB1;PLD3;ABHD14A;CA2;ADIRF;NID1;RRM2B;KRT14;FBXO2;CTSB;KCNMA1;PGM1;CHMP1B;SLC2A1;C1RL;GPR155;GLUL;GNG2;CAPG;ACP5;RNPEP;DLK2;PPCS;APPL2;DAB2IP;SLC37A2;SHROOM2;SYT7;ETFB;BST2;OSBPL1A;ACVR1B;CADM4;MPI;SNX29;IGFBP6;GALE;MXRA8;CLSTN3;CEP250;ANO1;CAPS;MBLAC2;METTL7A;ALOX15B;TKFC;PNPO;DHRS4;PEX1;ECI1;S100A6;EFEMP2;SGSH;GAREM2;PBLD;PCSK1N;PRDX5;PHPT1;SMPDL3B;GLB1;GSTM3;DPP7;CD9;HDAC11;CTSD;ARHGAP23;PRKACA;NPAP1;C6ORF120;ACOT2;SYNE2;SERPING1;LAMB2;NFASC;SMURF1;NPNT;ECM1
16882,GO:0098857,0.668438339641839,0.420410610822902,20,201,membrane microdomain,CC,INPP5D;EGFR;MARVELD1;UNC5B;NOS1;F2R;RTN4RL1;FLOT1;INSR;CBLC;PODXL;MALL;KCNMA1;SLC2A1;RET;BST2;STAT6;CTSD;AKAP6;PRKACA
16697,GO:0097711,0.66844751133529,0.464225201539755,9,94,ciliary basal body-plasma membrane docking,BP,CNTRL;NINL;CEP192;IQCB1;NPHP4;ALMS1;MARK4;CEP250;PRKACA
6848,GO:0030324,0.668448253699848,0.451715210782873,11,110,lung development,BP,SREBF1;EGFR;GLI2;GLI3;CELSR1;NPHP3;SPRY2;THRA;DLG5;PTK7;FOXP2
17702,GO:1901653,0.668688924518227,0.41072930663468,25,252,cellular response to peptide,BP,SREBF1;SRSF5;PIK3R1;STAT1;PRKACB;MDM2;VAMP2;SESN3;INSR;BAIAP2;TCIRG1;ATP6V0A2;CA2;CYBA;GNG2;LRP1;PIK3R2;ZFP36L1;KAT2B;IRS2;GPR21;CACNB1;PPARG;PRKACA;GCLC
10016,GO:0042474,0.668804025075276,0.716363177264384,1,11,middle ear morphogenesis,BP,NAGLU
3724,GO:0008252,0.669167788477638,0.717951830689174,1,10,nucleotidase activity,MF,NT5E
11886,GO:0046930,0.669314021062994,0.715824036991653,1,11,pore complex,CC,C5
2830,GO:0006297,0.66933872540546,0.610059468845226,2,23,nucleotide-excision repair, DNA gap filling,BP,LIG1;POLD4
9420,GO:0036003,0.669381808928103,0.610682077524836,2,22,positive regulation of transcription from RNA polymerase II promoter in response to stress,BP,HSF4;CHD6
9974,GO:0042391,0.669444866700487,0.421551926254169,19,194,regulation of membrane potential,BP,IFI6;CRTC1;NLGN2;ANK3;RIMS3;SNTA1;KCNJ5;BAIAP2;SCN4B;SHANK3;KCNMA1;ZMYND8;SCN2A;CACNB3;DLG4;SHANK2;PTPN3;AKAP6;GCLC
18953,GO:1904754,0.669538671162783,0.719993548959916,1,9,positive regulation of vascular associated smooth muscle cell migration,BP,MDM2
5670,GO:0016783,0.669554462547555,0.713933818607747,1,12,sulfurtransferase activity,MF,TST
9348,GO:0035871,0.669559076997361,0.719972184554213,1,9,protein K11-linked deubiquitination,BP,TNFAIP3
6284,GO:0019898,0.669660581453433,0.421456672995807,19,189,extrinsic component of membrane,CC,SERPINE2;PIK3R1;KCNAB2;MICALL1;PIK3C2G;SYTL1;ULK1;PTK6;APC2;GNG2;PIK3C3;PIK3R2;SNX1;DLG4;ESYT2;ALOX15B;S100A6;ATG14;SNX33
16891,GO:0098877,0.669679156491416,0.71741333395523,1,10,neurotransmitter receptor transport to plasma membrane,BP,NSG1
6951,GO:0030595,0.669772877852533,0.462082645316157,9,103,leukocyte chemotaxis,BP,CXCR1;CXCL14;VAV3;TRPV4;C5;MMP28;DDT;VEGFB;PLA2G7
19782,GO:2000251,0.669887847860476,0.715216472735305,1,11,positive regulation of actin cytoskeleton reorganization,BP,BAIAP2
17814,GO:1901998,0.670007443983147,0.559635416357273,3,33,toxin transport,BP,RAB43;RAB40B;DNM1
11228,GO:0045428,0.670322822661933,0.559678576584507,3,32,regulation of nitric oxide biosynthetic process,BP,PKD2;INSR;ACP5
15425,GO:0071732,0.670388937751809,0.716664578399388,1,10,cellular response to nitric oxide,BP,MTR
7578,GO:0031953,0.670769891146301,0.716262073047741,1,10,negative regulation of protein autophosphorylation,BP,IMPACT
11244,GO:0045504,0.671157617605388,0.715851956176413,1,10,dynein heavy chain binding,MF,WDR63
10633,GO:0043666,0.671291585078767,0.469157068247659,8,84,regulation of phosphoprotein phosphatase activity,BP,ELFN2;CRY2;PPP2R2C;PHACTR3;PPP1R2;PPP1R35;PPP2R3B;AKAP6
905,GO:0002287,0.671423036928467,0.558423850373364,3,32,alpha-beta T cell activation involved in immune response,BP,ZFPM1;STAT6;RORA
908,GO:0002293,0.671423036928467,0.558423850373364,3,32,alpha-beta T cell differentiation involved in immune response,BP,ZFPM1;STAT6;RORA
909,GO:0002294,0.671423036928467,0.558423850373364,3,32,CD4-positive, alpha-beta T cell differentiation involved in immune response,BP,ZFPM1;STAT6;RORA
9836,GO:0042093,0.671423036928467,0.558423850373364,3,32,T-helper cell differentiation,BP,ZFPM1;STAT6;RORA
8910,GO:0034763,0.671645618845889,0.49063945004141,6,64,negative regulation of transmembrane transport,BP,PKD2;EPHB2;ANK3;GSTM2;ANO9;IRS2
7219,GO:0031122,0.671792945331007,0.506603966724897,5,51,cytoplasmic microtubule organization,BP,TUBGCP5;TRPV4;CEP126;HOOK2;CCDC88B
5845,GO:0017144,0.671834019756854,0.384712461407562,49,530,drug metabolic process,BP,NT5E;GAMT;EGFR;FAM20C;PKD2;MTHFR;GPX3;DGKQ;KDM3A;DHTKD1;CSPG4;NOS1;HMGCL;IDUA;CYP3A5;SULT1E1;INSR;CYP2D7;TCIRG1;AKR7A2;ATP6V0A2;IDH2;CYBA;HLCS;MLXIPL;PGM1;PFKFB2;ACACB;OGDHL;SRR;ACP5;PLA2G7;BDH1;SDHA;SNCB;NADK;NDUFV3;DUOX1;AMT;ACSL1;PNPO;MTR;CBR4;PRDX5;ACSS2;TH;RORA;SUCLG2;PEMT
7641,GO:0032060,0.672115840897611,0.714836423487825,1,10,bleb assembly,BP,PMP22
6678,GO:0030049,0.67213733762298,0.616744527238783,2,14,muscle filament sliding,BP,TTN;TNNI2
8366,GO:0033275,0.67213733762298,0.616744527238783,2,14,actin-myosin filament sliding,BP,TTN;TNNI2
11700,GO:0046514,0.67235817127744,0.712589432244593,1,11,ceramide catabolic process,BP,HEXB
17805,GO:1901985,0.672406697614906,0.556896811151931,3,33,positive regulation of protein acetylation,BP,NOS1;RAPGEF3;RPS6KA5
9267,GO:0035710,0.672616823772651,0.526246123902552,4,43,CD4-positive, alpha-beta T cell activation,BP,ZFPM1;RSAD2;STAT6;RORA
3224,GO:0006875,0.672765858487281,0.403222284913974,27,280,cellular metal ion homeostasis,BP,APOE;PKD2;CYBRD1;NOS1;ITPR3;F2R;MT1X;SLC24A1;TRPV4;GSTM2;NMU;BMP6;HEXB;PLA2G6;ATP6V0A2;HFE;CYBA;KCNMA1;JPH2;TMEM203;VDR;LETMD1;CACNB3;LPAR6;DLG4;AKAP6;PRKACA
11413,GO:0045843,0.672808577736077,0.556840529888922,3,32,negative regulation of striated muscle tissue development,BP,TSC22D3;JARID2;FZD7
17769,GO:1901862,0.672808577736077,0.556840529888922,3,32,negative regulation of muscle tissue development,BP,TSC22D3;JARID2;FZD7
2481,GO:0005720,0.672925554501538,0.556303162511957,3,33,nuclear heterochromatin,CC,CENPC;ATRX;KMT5C
2697,GO:0006063,0.673021664864355,0.711880660184981,1,11,uronic acid metabolic process,BP,UGT1A3
6181,GO:0019585,0.673021664864355,0.711880660184981,1,11,glucuronate metabolic process,BP,UGT1A3
16841,GO:0098792,0.673101071849606,0.713789329633777,1,10,xenophagy,BP,LRSAM1
10936,GO:0044615,0.673248185061704,0.716088875472419,1,9,nuclear pore nuclear basket,CC,NPAP1
6978,GO:0030662,0.673268370214423,0.44083569796956,12,127,coated vesicle membrane,CC,SREBF1;APOE;EGFR;VAMP3;HLA-B;AP1G2;CLTCL1;VAMP2;HLA-A;AREG;CD9;LDLRAP1
10916,GO:0044548,0.673489902202353,0.711379653791557,1,11,S100 protein binding,MF,S100A6
11672,GO:0046473,0.673506582615318,0.556473150401224,3,31,phosphatidic acid metabolic process,BP,DGKQ;SLC27A1;DDHD2
9894,GO:0042226,0.67362029280735,0.713236304665252,1,10,interleukin-6 biosynthetic process,BP,INPP5D
5635,GO:0016723,0.673677426698646,0.713175400297962,1,10,oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor,MF,CYBRD1
14538,GO:0070085,0.673768888204047,0.414515044482231,20,205,glycosylation,BP,MUC19;LMF1;ADAMTS7;ST6GALNAC2;MVD;SRD5A3;ST6GALNAC6;B4GALT6;ADAMTS13;TRAK1;ST3GAL5;B4GALT2;VEGFB;B3GNT9;PIGZ;DPY19L2P2;MPI;MAN1B1;PQLC3;GCNT4
3458,GO:0007271,0.673780690114811,0.713065296597138,1,10,synaptic transmission, cholinergic,BP,APOE
5674,GO:0016788,0.673798457943669,0.379734100707628,55,557,hydrolase activity, acting on ester bonds,MF,CES2;NT5E;INPP5D;PTPRS;PLCD3;BPHL;SULF2;H6PD;PLCD1;PPP2R2C;ACOT1;ENDOD1;NLGN4Y;ARSI;NLGN2;PLCH2;SLX1A;SLX1B;G6PC3;ARSD;CES3;PGLS;ENDOG;PGAP1;PLA2G6;WRN;PLD3;TREX1;LPIN3;CA2;XRN1;PFKFB2;LACTB2;TNS2;ACP5;PLA2G7;PDE2A;DDHD2;ERCC5;MPPE1;PPP2R3B;ENDOU;IMPA2;ERN1;RAD50;FAAH;SGSH;PHPT1;SMPDL3B;PTPN3;PLCB3;PPM1M;SSH3;ACOT2;PARN
17018,GO:0099515,0.674279628804304,0.714995657327107,1,9,actin filament-based transport,BP,SYNE2
564,GO:0001706,0.674537947789055,0.524612441389605,4,41,endoderm formation,BP,ITGB5;COL7A1;RTF1;COL6A1
16332,GO:0090630,0.674539797749479,0.475772756998259,7,70,activation of GTPase activity,BP,EVI5L;TBC1D8;RALGAPA1;APC2;TBC1D17;TBC1D16;SGSM2
2183,GO:0005041,0.675135486485698,0.714086044984996,1,9,low-density lipoprotein particle receptor activity,MF,LRP1
59,GO:0000122,0.675189225196636,0.375720434599343,61,603,negative regulation of transcription by RNA polymerase II,BP,HES2;SREBF1;MNT;TSC22D3;TFCP2L1;ZFPM1;IRF2BPL;STAT1;IMPACT;CRY2;CRY1;NFATC4;HSF4;EAPP;MDM2;TCF25;TRPV4;GLI2;PER2;TCEAL1;WWTR1;GLI3;BHLHE40;MAP2K5;TCFL5;JARID2;MXD4;RTF1;BMP6;SQSTM1;ZNF608;TXNIP;RCOR2;IFI27;ATRX;MLXIPL;NFIX;MXI1;THRA;PEG3;SALL2;ZBTB20;PDE2A;MAF;ZMYND8;DAB2IP;TSHZ2;IFI16;VDR;WWC3;NRARP;TCF7;STAT6;KLF8;PPARG;CXXC5;ZFP90;PER3;FOXP2;HIVEP1;CTNNBIP1
1855,GO:0004520,0.675409231788881,0.522546121510064,4,45,endodeoxyribonuclease activity,MF,SLX1A;SLX1B;ERCC5;RAD50
13971,GO:0060707,0.675601556499539,0.711118397140999,1,10,trophoblast giant cell differentiation,BP,GJB5
17704,GO:1901655,0.675642696189352,0.486264158715907,6,63,cellular response to ketone,BP,EGFR;SFRP1;XRN1;GNG2;PPARG;KLF9
14280,GO:0061436,0.675737438485194,0.604201428012782,2,21,establishment of skin barrier,BP,CYP26B1;ALOXE3
11257,GO:0045579,0.675747455252205,0.710961955176962,1,10,positive regulation of B cell differentiation,BP,INPP5D
15317,GO:0071560,0.675906712292809,0.422709088628215,16,163,cellular response to transforming growth factor beta stimulus,BP,POSTN;SFRP1;HTRA1;ITGB5;FERMT1;LTBP4;ZFP36L2;LTBP1;CD109;GDF15;PDE2A;STK16;ZFP36L1;PBLD;SMURF1;NPNT
12975,GO:0051412,0.675940048119561,0.710755343524991,1,10,response to corticosterone,BP,TH
2806,GO:0006266,0.67609753048807,0.60236554066574,2,23,DNA ligation,BP,LIG1;POLD4
8006,GO:0032647,0.676132881145894,0.603749175731817,2,21,regulation of interferon-alpha production,BP,PTPRS;STAT1
15583,GO:0072089,0.676205849681676,0.473761917840581,7,71,stem cell proliferation,BP,KCTD11;WNT3;KITLG;FERMT1;GLI3;LTBP3;ZFP36L1
10419,GO:0043279,0.676206117721975,0.485476250185475,6,64,response to alkaloid,BP,MDM2;GSTM2;HOMER2;SRR;TH;PPARG
13555,GO:0060044,0.676523233106868,0.710129005091272,1,10,negative regulation of cardiac muscle cell proliferation,BP,JARID2
7687,GO:0032148,0.676572765787073,0.602498892016574,2,22,activation of protein kinase B activity,BP,INSR;RICTOR
7069,GO:0030865,0.676607309224004,0.522242494833052,4,41,cortical cytoskeleton organization,BP,TRPV4;WIPF1;EPB41L3;FMNL2
5788,GO:0017022,0.676803257303946,0.521455948142623,4,43,myosin binding,MF,TRAK1;GSN;TRIOBP;ARFGEF2
6912,GO:0030511,0.676883800091728,0.602889391266583,2,21,positive regulation of transforming growth factor beta receptor signaling pathway,BP,FERMT1;NPNT
18569,GO:1903846,0.676883800091728,0.602889391266583,2,21,positive regulation of cellular response to transforming growth factor beta stimulus,BP,FERMT1;NPNT
10813,GO:0044320,0.676896577331336,0.709727478753888,1,10,cellular response to leptin stimulus,BP,BBS2
8293,GO:0033137,0.677071770534174,0.601926659582729,2,22,negative regulation of peptidyl-serine phosphorylation,BP,MLXIPL;DMTN
7350,GO:0031400,0.677230998613086,0.381569833099402,45,457,negative regulation of protein modification process,BP,TNFAIP3;APOE;SFRP1;EPHB2;DGKQ;KDM3A;ISG15;ELFN2;IMPACT;CAMK2N1;CRY2;CRY1;CRTAP;PHACTR3;FLRT3;RGS2;PDCD4;RTN4RL1;PER2;SNTA1;WWTR1;JARID2;CBLC;CD109;PTK6;KDM4C;HMG20B;SPRY2;MLXIPL;CDK5RAP3;ADARB1;WNK1;DAB2IP;PIK3R2;PPP1R2;DMTN;PPP1R35;PHF1;KAT2B;PBLD;RANBP9;ATG14;UFL1;PRMT3;GCLC
6457,GO:0021783,0.677237677823295,0.709360250057898,1,10,preganglionic parasympathetic fiber development,BP,ADARB1
1666,GO:0004129,0.677307920304163,0.699562266545223,1,18,cytochrome-c oxidase activity,MF,NDUFA4L2
4947,GO:0015002,0.677307920304163,0.699562266545223,1,18,heme-copper terminal oxidase activity,MF,NDUFA4L2
5618,GO:0016676,0.677307920304163,0.699562266545223,1,18,oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor,MF,NDUFA4L2
2094,GO:0004861,0.677355632338583,0.707217462112273,1,11,cyclin-dependent protein serine/threonine kinase inhibitor activity,MF,KAT2B
3715,GO:0008235,0.677371308393388,0.551601152300208,3,32,metalloexopeptidase activity,MF,NPEPL1;RNPEPL1;RNPEP
18664,GO:1904035,0.677403488515911,0.521040644779835,4,42,regulation of epithelial cell apoptotic process,BP,TNFAIP3;PDCD4;GSN;ZFP36L1
16082,GO:0090084,0.677494906393443,0.709083077575079,1,10,negative regulation of inclusion body assembly,BP,HSPA2
12994,GO:0051447,0.67752134589299,0.709054576403816,1,10,negative regulation of meiotic cell cycle,BP,PRKACB
5323,GO:0016051,0.677593690665267,0.423924385188424,15,158,carbohydrate biosynthetic process,BP,SIK1;DGKQ;CRY1;ST6GALNAC6;G6PC3;PER2;INSR;B3GNT9;PGM1;SLC2A1;EPM2AIP1;KAT2B;IRS2;IMPA2;ISYNA1
13803,GO:0060421,0.678262538107948,0.601307391359943,2,21,positive regulation of heart growth,BP,ACACB;AKAP6
9024,GO:0035250,0.678351155488845,0.600456913754172,2,22,UDP-galactosyltransferase activity,MF,B4GALT6;B4GALT2
4823,GO:0014029,0.678589340290369,0.707901474171141,1,10,neural crest formation,BP,SFRP1
13467,GO:0055026,0.678741220512984,0.600757113541987,2,21,negative regulation of cardiac muscle tissue development,BP,JARID2;FZD7
6792,GO:0030240,0.67888626227377,0.812314666309051,1,2,skeletal muscle thin filament assembly,BP,TTN
3679,GO:0008179,0.67895303076336,0.707507985358091,1,10,adenylate cyclase binding,MF,AKAP6
11178,GO:0045295,0.679040890360757,0.70990642261534,1,9,gamma-catenin binding,MF,APC2
4757,GO:0010939,0.679519272180668,0.597809406338417,2,24,regulation of necrotic cell death,BP,RBCK1;RIPK3
8702,GO:0034356,0.679819308407701,0.706569056470213,1,10,NAD biosynthesis via nicotinamide riboside salvage pathway,BP,NAPRT
17953,GO:1902373,0.680331434791152,0.548181101083968,3,32,negative regulation of mRNA catabolic process,BP,CIRBP;THRAP3;ANGEL2
11604,GO:0046323,0.680441356268888,0.496739709641839,5,51,glucose import,BP,PIK3R1;CLTCL1;INSR;PIK3R2;IRS2
3397,GO:0007176,0.680625064185618,0.597835349365459,2,22,regulation of epidermal growth factor-activated receptor activity,BP,CBLC;FBXW7
432,GO:0001161,0.680667392766428,0.70564755654022,1,10,intronic transcription regulatory region sequence-specific DNA binding,MF,ZC3H6
10753,GO:0044213,0.680667392766428,0.70564755654022,1,10,intronic transcription regulatory region DNA binding,MF,ZC3H6
2409,GO:0005583,0.680699383794924,0.708117015841983,1,9,fibrillar collagen trimer,CC,TNXB
16779,GO:0098643,0.680699383794924,0.708117015841983,1,9,banded collagen fibril,CC,TNXB
16788,GO:0098656,0.680800999733146,0.420613190505052,15,152,anion transmembrane transport,BP,CPT2;SLC13A5;PER2;CLCN6;SLC12A7;CLCA2;ANO9;ACACB;SLC38A4;SLC37A2;SLC36A4;IRS2;ANO1;SLC43A1;CLCN7
4437,GO:0010314,0.680883358078697,0.705412533132813,1,10,phosphatidylinositol-5-phosphate binding,MF,JPH2
4354,GO:0009952,0.68099398906338,0.43252438021004,12,122,anterior/posterior pattern specification,BP,SFRP1;WNT3;HOXA3;SCMH1;GLI2;GLI3;CELSR1;PGAP1;PCSK6;NRARP;PALB2;CTNNBIP1
4453,GO:0010421,0.681056574322229,0.703188973294251,1,11,hydrogen peroxide-mediated programmed cell death,BP,ENDOG
16599,GO:0097468,0.681056574322229,0.703188973294251,1,11,programmed cell death in response to reactive oxygen species,BP,ENDOG
8334,GO:0033197,0.681556857811622,0.702641101252113,1,11,response to vitamin E,BP,PPARG
13601,GO:0060113,0.68161635961967,0.546691365993082,3,32,inner ear receptor cell differentiation,BP,SLITRK6;NAGLU;TRIOBP
5420,GO:0016273,0.681634109840336,0.702556430125257,1,11,arginine N-methyltransferase activity,MF,PRMT3
5421,GO:0016274,0.681634109840336,0.702556430125257,1,11,protein-arginine N-methyltransferase activity,MF,PRMT3
9020,GO:0035246,0.681634109840336,0.702556430125257,1,11,peptidyl-arginine N-methylation,BP,PRMT3
16450,GO:0097153,0.681635333832579,0.700867652469126,1,12,cysteine-type endopeptidase activity involved in apoptotic process,MF,CASP14
583,GO:0001738,0.681811208568121,0.43620520191173,11,121,morphogenesis of a polarized epithelium,BP,SFRP1;PRICKLE2;ARHGEF19;CELSR1;FZD7;NPHP3;ASTN2;MYO9A;DLG5;PTK7;SMURF1
642,GO:0001833,0.681977446908196,0.704219626953761,1,10,inner cell mass cell proliferation,BP,PALB2
14126,GO:0061028,0.682116567959093,0.54654556317033,3,31,establishment of endothelial barrier,BP,PTPRS;RAPGEF3;PDE2A
2110,GO:0004896,0.682737375947605,0.514355898978894,4,44,cytokine receptor activity,MF,CXCR1;IL20RB;IL20RA;ACKR3
4889,GO:0014812,0.683041512411671,0.493343528974207,5,53,muscle cell migration,BP,POSTN;MDM2;ITGA2;NET1;LRP1
9769,GO:0039692,0.683109474583516,0.700935739538659,1,11,single stranded viral RNA replication via double stranded DNA intermediate,BP,APOBEC3C
11839,GO:0046838,0.683292068906589,0.702781242804327,1,10,phosphorylated carbohydrate dephosphorylation,BP,IMPA2
11848,GO:0046855,0.683292068906589,0.702781242804327,1,10,inositol phosphate dephosphorylation,BP,IMPA2
12945,GO:0051347,0.68334274820123,0.373267885137585,48,482,positive regulation of transferase activity,BP,EGFR;PKD2;EPHB2;MAP3K14;DGKQ;CAMKK1;VAV3;CSPG4;KITLG;PRKACB;F2R;ADORA2B;MAPK8IP3;UNC119;C5;MINK1;MAP2K5;INSR;ETAA1;PILRB;SLC27A1;RICTOR;MAP2K2;MAP3K12;CDK5R1;MAPK10;ERCC6;SHC2;SPRY2;FBXW7;PAK6;PFKFB2;NAB2;EPM2AIP1;MAP3K6;WNK1;RET;DAB2IP;FGFR4;DLG4;ACSL1;ERN1;RAD50;ERBB2;ATG14;PRKACA;PARN;RIPK3
17830,GO:1902041,0.68349740269082,0.51347573006744,4,44,regulation of extrinsic apoptotic signaling pathway via death domain receptors,BP,TNFAIP3;SFRP1;TNFSF10;PIDD1
3944,GO:0008643,0.683699229343457,0.447221800497179,9,93,carbohydrate transport,BP,PIK3R1;CLTCL1;INSR;SLC2A3;SLC2A1;SLC37A2;PIK3R2;IRS2;SLC2A11
9878,GO:0042168,0.683734112858286,0.592921757743541,2,24,heme metabolic process,BP,UROS;BLVRB
4489,GO:0010517,0.684011790679607,0.543905717701196,3,32,regulation of phospholipase activity,BP,EGFR;RGS2;LRP1
4801,GO:0010998,0.68408631286171,0.701909557936302,1,10,regulation of translational initiation by eIF2 alpha phosphorylation,BP,IMPACT
20243,GO:2001233,0.68409435292533,0.389444480831737,28,303,regulation of apoptotic signaling pathway,BP,TNFAIP3;TP53INP1;IFI6;MNT;SFRP1;RBCK1;UNC5B;NFATC4;MDM2;TNFSF10;PIDD1;MAP2K5;ITGA6;GSN;PLA2G6;RRM2B;FBXW7;RET;DAB2IP;IL20RA;TFDP2;LMNA;IVNS1ABP;TNFSF12;ACKR3;RIPK3;SERINC3;GCLC
4057,GO:0009108,0.684152347491945,0.407784105734368,18,190,coenzyme biosynthetic process,BP,DHTKD1;NAPRT;NMRK1;MLYCD;INSR;PDK1;IDH2;MLXIPL;PGM1;PFKFB2;ACACB;OGDHL;PPCS;NADK;ACSL1;PNPO;CBR4;ACSS2
3965,GO:0008757,0.68440497130462,0.428305040774996,12,130,S-adenosylmethionine-dependent methyltransferase activity,MF,GAMT;ASH2L;NSUN5P2;TARBP1;METTL21A;SETD4;PCMTD2;PCMTD1;DYDC1;KMT5C;PRMT3;PEMT
7722,GO:0032225,0.684472442424049,0.699432357050808,1,11,regulation of synaptic transmission, dopaminergic,BP,FLOT1
17344,GO:1900078,0.684547556959632,0.594875403672805,2,20,positive regulation of cellular response to insulin stimulus,BP,PIK3R1;PIK3R2
6719,GO:0030136,0.684870980212108,0.428089957199758,12,124,clathrin-coated vesicle,CC,APOE;EGFR;VAMP3;VPS11;AP1G2;CLTCL1;VAMP2;MALL;ASTN2;LRP1;CD9;LDLRAP1
15501,GO:0071902,0.685046965566134,0.391423137741528,26,266,positive regulation of protein serine/threonine kinase activity,BP,EGFR;PKD2;MAP3K14;CSPG4;KITLG;F2R;ADORA2B;MAPK8IP3;C5;MINK1;MAP2K5;INSR;ETAA1;SLC27A1;MAP2K2;MAP3K12;CDK5R1;MAPK10;ERCC6;SHC2;SPRY2;MAP3K6;DAB2IP;ACSL1;ERN1;ERBB2
998,GO:0002467,0.685069637566657,0.700827561582979,1,10,germinal center formation,BP,TNFAIP3
6695,GO:0030100,0.685291126299571,0.415490522182107,15,156,regulation of endocytosis,BP,APOE;FLOT1;UNC119;ITGA2;LRSAM1;MCTP1;HFE;CYBA;LRP1;SYT7;DLG4;TUB;PPARG;LDLRAP1;SNX33
3137,GO:0006730,0.685373643266592,0.592322008337866,2,22,one-carbon metabolic process,BP,MTHFR;CA2
12789,GO:0051103,0.685432621759407,0.698369691340606,1,11,DNA ligation involved in DNA repair,BP,LIG1
7143,GO:0031010,0.685498175814227,0.700355051783502,1,10,ISWI-type complex,CC,SMARCA1
13852,GO:0060491,0.685880939141625,0.42690781945607,12,125,regulation of cell projection assembly,BP,ESPN;EPS8L2;EVI5L;FAM110C;PLXNB3;PODXL;IFT140;ARAP1;ZMYND8;DMTN;SSH3;SYNE2
14095,GO:0060973,0.686005512275696,0.699794895580273,1,10,cell migration involved in heart development,BP,FLRT3
12361,GO:0048769,0.686018762135382,0.806791090692597,1,2,sarcomerogenesis,BP,TTN
17505,GO:1901017,0.686041534218559,0.699755091842082,1,10,negative regulation of potassium ion transmembrane transporter activity,BP,ANK3
17623,GO:1901380,0.686041534218559,0.699755091842082,1,10,negative regulation of potassium ion transmembrane transport,BP,ANK3
13893,GO:0060572,0.686195156644543,0.699585294339566,1,10,morphogenesis of an epithelial bud,BP,GLI2
13492,GO:0055085,0.686244233052188,0.356374045269506,86,869,transmembrane transport,BP,HSPA2;PKD2;CPT2;EPHB2;PIK3R1;ORAI3;TSC22D3;KCNAB2;KCNJ15;SLC16A5;GJD3;NOS1;KCNC4;SLC29A4;ITPR3;NDUFA4L2;TMEM63C;F2R;SLC24A1;CLTCL1;TRPV4;NLGN2;ANK3;SLC13A5;GJC2;PER2;CLCN6;SNTA1;MINK1;GSTM2;VAMP2;KCNJ5;INSR;TST;SCNN1A;SCN4B;NIPAL2;PEX10;SLC2A3;TCIRG1;SLC12A7;CLCA2;PLA2G6;PEX7;ATP6V0A2;KLHL24;ANO9;CA2;SHANK3;HFE;CYBA;KCNMA1;SLC2A1;ACACB;GPR155;SLC38A4;KCNG1;WNK1;JPH2;PDE2A;SLC37A2;SHROOM2;PIK3R2;SCN2A;CACNB3;DMTN;ORAI2;SLC36A4;DLG4;SLC22A15;SHANK2;IRS2;ANO1;PEX1;S100A6;SLC43A1;CACNB1;PTPN3;ABCA2;AKAP6;SLC2A11;PRKACA;KCNS3;CLCN7;CALHM2;ABCA11P
16705,GO:0097730,0.686378962245242,0.474008995629121,6,63,non-motile cilium,CC,PKD2;PTGS1;IQCB1;IFT140;NPHP4;SHANK2
7965,GO:0032587,0.686571450634935,0.461859495374114,7,72,ruffle membrane,CC,PSD4;EPS8L2;FERMT1;TRPV4;ARHGEF4;PSD3;SPRY2
19691,GO:2000052,0.687160544751943,0.698516518064133,1,10,positive regulation of non-canonical Wnt signaling pathway,BP,SFRP1
5330,GO:0016064,0.687404965091112,0.487930004172687,5,55,immunoglobulin mediated immune response,BP,INPP5D;C5;C1RL;STAT6;SERPING1
6206,GO:0019724,0.687404965091112,0.487930004172687,5,55,B cell mediated immunity,BP,INPP5D;C5;C1RL;STAT6;SERPING1
2843,GO:0006312,0.687560108175483,0.58976563653513,2,22,mitotic recombination,BP,TEP1;RAD50
9841,GO:0042100,0.687588648249196,0.508471774945187,4,45,B cell proliferation,BP,INPP5D;VAV3;TNFRSF21;IRS2
3791,GO:0008360,0.687952094942248,0.424751573264992,12,122,regulation of cell shape,BP,PLXNB1;PARVB;RHOBTB2;WIPF1;BAIAP2;PLXNB3;EPB41L3;HEXB;ARAP1;PLXND1;DMTN;FMNL3
17325,GO:1900029,0.688005520038914,0.695507549610749,1,11,positive regulation of ruffle assembly,BP,EPS8L2
10657,GO:0043902,0.688007454519394,0.419706942649482,13,143,positive regulation of multi-organism process,BP,APOE;DDX60;MVB12B;LHFPL2;LRSAM1;DHX58;BMP6;CYBA;TRIM38;KLK5;ADARB1;ACVR1B;NELFCD
674,GO:0001885,0.688027004357815,0.508747881095999,4,42,endothelial cell development,BP,PTPRS;RAPGEF3;PDE2A;GSTM3
3391,GO:0007169,0.688104399783931,0.367110068174251,50,496,transmembrane receptor protein tyrosine kinase signaling pathway,BP,SREBF1;EGFR;GIGYF1;FAM20C;EPHB2;DGKQ;PIK3R1;SULF2;VAV3;CSPG4;MVB12B;NDN;FLRT3;RHBDF1;TMEM204;FRS3;SESN3;IGFBP4;INSR;BAIAP2;CBLC;PILRB;TCIRG1;VEGFB;PTK6;SH2D2A;MMRN2;TXNIP;ATP6V0A2;DNM1;CDK5R1;EFNB3;CYBA;SHC2;SPRY2;FBXW7;ARAP1;LRP1;RET;DAB2IP;FGFR4;PIK3R2;AREG;RPS6KA5;EFS;IGFBP6;IRS2;GPR21;PTPN3;ERBB2
7087,GO:0030890,0.688266720702172,0.588247962834389,2,23,positive regulation of B cell proliferation,BP,VAV3;IRS2
7989,GO:0032616,0.688803607416666,0.694615392830767,1,11,interleukin-13 production,BP,TNFRSF21
6126,GO:0019377,0.689340569423722,0.694013975769247,1,11,glycolipid catabolic process,BP,HEXB
11469,GO:0045945,0.6893957520486,0.696030353946445,1,10,positive regulation of transcription by RNA polymerase III,BP,ERBB2
13926,GO:0060627,0.689483009946673,0.377114005769668,34,343,regulation of vesicle-mediated transport,BP,APOE;SYT8;SYN1;EVI5L;RAB40B;TBC1D8;VPS11;SYTL1;C2CD4C;FLOT1;ADORA2B;RIMS3;UNC119;ITGA2;SYT15;LRSAM1;VAMP2;MAP2K2;PLA2G6;SEPT5;MCTP1;HFE;CYBA;RPH3AL;TBC1D17;LRP1;SYT7;TBC1D16;SGSM2;DLG4;TUB;PPARG;LDLRAP1;SNX33
2248,GO:0005161,0.689963088263916,0.695396735792882,1,10,platelet-derived growth factor receptor binding,MF,ERN1
7738,GO:0032259,0.69000446186745,0.384500091115285,27,283,methylation,BP,GAMT;ASH2L;MTHFR;KDM3A;NSUN7;JARID2;NSUN5P2;RTF1;KDM4C;METTL23;FAM86C2P;ATRX;TARBP1;METTL21A;SETD4;ETFB;BTG1;PCMTD2;PCMTD1;PHF1;DYDC1;AMT;METTL7A;MTR;KMT5C;PRMT3;PEMT
850,GO:0002178,0.690026197160063,0.693244683227229,1,11,palmitoyltransferase complex,CC,GOLGA7B
20060,GO:2000738,0.690114546646192,0.695227404932479,1,10,positive regulation of stem cell differentiation,BP,LTBP3
9465,GO:0036109,0.690122310645585,0.693136718851982,1,11,alpha-linolenic acid metabolic process,BP,ACSL1
12597,GO:0050801,0.690132008294469,0.370453766873681,41,422,ion homeostasis,BP,IFI6;APOE;EGFR;PKD2;CYBRD1;NOS1;ITPR3;NEO1;F2R;MT1X;SLC24A1;TRPV4;ANK3;GSTM2;NMU;SCNN1A;BMP6;TCIRG1;SLC12A7;HEXB;PLA2G6;ATP6V0A2;CA2;HFE;CYBA;MLXIPL;KCNMA1;JPH2;FGFR4;TMEM203;KLHL3;VDR;LETMD1;CACNB3;LPAR6;DLG4;DMXL2;PTPN3;AKAP6;PRKACA;GCLC
8852,GO:0034661,0.690169181426806,0.58600954054205,2,23,ncRNA catabolic process,BP,ZCCHC11;XRN1
800,GO:0002070,0.690369085510722,0.692859378283818,1,11,epithelial cell maturation,BP,TFCP2L1
965,GO:0002407,0.690385493044113,0.692840931450145,1,11,dendritic cell chemotaxis,BP,CXCR1
100,GO:0000212,0.690487406919371,0.694810226881559,1,10,meiotic spindle organization,BP,ATRX
13941,GO:0060669,0.690512910591817,0.586295321743369,2,22,embryonic placenta morphogenesis,BP,ZFP36L1;GJB5
10718,GO:0044089,0.690738698347411,0.372201188743959,38,382,positive regulation of cellular component biogenesis,BP,DDB2;ESPN;SLITRK6;SFRP1;EPS8L2;EPHB2;RAPGEF3;FLRT3;RGS2;ARPIN;ADGRB2;FLOT1;NLGN2;SLX1A;SLX1B;WIPF1;ADGRL1;AMIGO2;ULK1;LRSAM1;MMP1;GSN;BAIAP2;RICTOR;HYAL1;WHAMMP3;CDK5R1;WASH3P;ARAP1;LRRN3;NPHP4;SYNPO2;ZMYND8;ERCC5;DLG5;CLSTN3;SRPX2;MPP7
886,GO:0002253,0.691360721938142,0.374955722827647,34,355,activation of immune response,BP,TNFAIP3;MUC19;INPP5D;DDX60;PTPRS;PIK3R1;RBCK1;VAV3;PRKACB;FLOT1;C5;WIPF1;BAIAP2;DHX58;NLRX1;PLA2G6;TNFRSF21;CYBA;CTSB;ELF1;C1RL;ERMAP;DAB2IP;PIK3C3;IFI16;PIK3R2;RPS6KA5;CACNB3;RSAD2;TKFC;PHPT1;SMPDL3B;PRKACA;SERPING1
12332,GO:0048711,0.69138381911112,0.691716866345177,1,11,positive regulation of astrocyte differentiation,BP,SERPINE2
2704,GO:0006071,0.691790674899706,0.691257830625646,1,11,glycerol metabolic process,BP,TKFC
3628,GO:0008089,0.691791964435645,0.533987338352424,3,34,anterograde axonal transport,BP,BLOC1S4;TRAK1;BLOC1S3
19670,GO:2000010,0.691846042018643,0.691195320586496,1,11,positive regulation of protein localization to cell surface,BP,SNX33
20053,GO:2000725,0.691939000783117,0.584611857360497,2,22,regulation of cardiac muscle cell differentiation,BP,FZD7;AKAP6
4096,GO:0009152,0.692211730778697,0.404363549135327,16,173,purine ribonucleotide biosynthetic process,BP,PTHLH;APOE;DHTKD1;NOS1;ADORA2B;INSR;TCIRG1;ATP6V0A2;GABBR1;MLXIPL;GPR87;PGM1;PFKFB2;OGDHL;PPCS;LTB4R2
14198,GO:0061157,0.692364330989626,0.584871690915218,2,21,mRNA destabilization,BP,ZFP36L2;ZFP36L1
12190,GO:0048385,0.692398157841021,0.690571425215116,1,11,regulation of retinoic acid receptor signaling pathway,BP,CYP26B1
11751,GO:0046625,0.692439436537379,0.69052473968023,1,11,sphingolipid binding,MF,PLTP
20008,GO:2000651,0.69258881375056,0.692450530318443,1,10,positive regulation of sodium ion transmembrane transporter activity,BP,ANK3
8331,GO:0033189,0.692788044685633,0.69013024581405,1,11,response to vitamin A,BP,PPARG
9783,GO:0040014,0.693076861049767,0.502562587889022,4,43,regulation of multicellular organism growth,BP,GAMT;BBS2;RAI1;GPR21
11854,GO:0046875,0.693079356954371,0.583262191608845,2,22,ephrin receptor binding,MF,CDK5R1;EFNB3
6275,GO:0019883,0.693177257100469,0.68968933001794,1,11,antigen processing and presentation of endogenous antigen,BP,HFE
10102,GO:0042634,0.693522426983969,0.5827369549004,2,22,regulation of hair cycle,BP,FERMT1;MYSM1
12212,GO:0048486,0.693951547085866,0.688810695691587,1,11,parasympathetic nervous system development,BP,ADARB1
3270,GO:0006942,0.693976394490486,0.501242494994081,4,44,regulation of striated muscle contraction,BP,NOS1;RGS2;GSTM2;PRKACA
12281,GO:0048635,0.69403513600326,0.53171869955615,3,33,negative regulation of muscle organ development,BP,TSC22D3;JARID2;FZD7
12094,GO:0048156,0.694082424745277,0.688661984965062,1,11,tau protein binding,MF,APOE
2512,GO:0005766,0.694091696093801,0.422296050773299,11,123,primary lysosome,CC,PYGB;NAPRT;GAA;HEXA;HEXB;BST2;CD68;GLB1;DPP7;SYNGR1;C6ORF120
10068,GO:0042582,0.694091696093801,0.422296050773299,11,123,azurophil granule,CC,PYGB;NAPRT;GAA;HEXA;HEXB;BST2;CD68;GLB1;DPP7;SYNGR1;C6ORF120
706,GO:0001932,0.694304483897034,0.346009616338853,95,937,regulation of protein phosphorylation,BP,TNFAIP3;GPNMB;APOE;HSPA2;EGFR;PKD2;CAPRIN2;SFRP1;EPHB2;MAP3K14;DGKQ;CAMKK1;HERC5;CSPG4;KITLG;IMPACT;CAMK2N1;PRKACB;SPDYE6;RAPGEF3;FLRT3;RGS2;F2R;PDCD4;RTN4RL1;TRPV4;FLOT1;ADORA2B;MAPK8IP3;SPDYE5;GJC2;UNC119;C5;MINK1;WWTR1;MAP2K5;IGFBP4;INSR;TTN;CBLC;DDT;CD109;ETAA1;PILRB;SLC27A1;RICTOR;BMP6;MAP2K2;SQSTM1;PTK6;FZD7;SYNGAP1;PLA2G6;GDF15;CTF1;MAP3K12;CDK5R1;MAPK10;HFE;ERCC6;SHC2;EDA2R;SPRY2;MLXIPL;FBXW7;CDK5RAP3;PAK6;ADARB1;NAB2;MAP3K6;WNK1;RET;DAB2IP;FGFR4;PIK3R2;AREG;RPS6KA5;DMTN;STAT2;ACVR1B;DLG4;TNFRSF25;ACSL1;IL11;KAT2B;ERN1;RAD50;PBLD;RANBP9;ERBB2;ATG14;PRKACA;ACKR3;RIPK3;NPNT
4047,GO:0009086,0.694363772346046,0.688342109652186,1,11,methionine biosynthetic process,BP,MTR
10024,GO:0042490,0.694660292974368,0.530977533750707,3,33,mechanoreceptor differentiation,BP,SLITRK6;NAGLU;TRIOBP
20055,GO:2000727,0.694828884763927,0.687812729484081,1,11,positive regulation of cardiac muscle cell differentiation,BP,AKAP6
1005,GO:0002479,0.694897930003515,0.47756736344708,5,66,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,BP,VAMP3;ITGB5;HLA-B;CYBA;HLA-A
14492,GO:0065007,0.695055923198363,0.32748665923556,811,7896,biological regulation,BP,TNFAIP3;TGFBI;POSTN;ITGB6;HES2;SERPINE2;ZSCAN18;ULK2;GPNMB;TSC22D1;SIK1;EPM2A;MUC19;DDB2;TP53INP1;IFI6;PTHLH;SREBF1;ACTA2;APOE;GPSM1;NT5E;ALS2CL;INPP5D;APCDD1;GAMT;OAS2;MN1;LMF1;PSD4;DDX60;HSPA2;FBXW4;EGFR;ESPN;TRIM65;GIGYF1;PTPRS;CIRBP;FAM20C;PKD2;CAPRIN2;MNT;XPC;APOBEC3C;SYT8;CXCR1;CPT2;RBM3;SYN1;ASH2L;DIXDC1;TRIM22;ALDH1A3;SRSF5;PLCD3;SLITRK6;SFRP1;OBSL1;MTHFR;PERM1;SEC14L2;KCTD11;KIF26B;EPS8L2;EPHB2;RALGDS;MAP3K14;GLUD1;DGKQ;PIK3R1;ADAMTS7;EVI5L;BRSK1;TXNRD3;RBCK1;KDM3A;CXCL14;DOCK9;TSC22D3;CUL9;EVC;RNF135;POU3F1;SULF2;WNT3;CAMKK1;HERC5;VAV3;UNK;HR;SMOC2;CSPG4;ISG15;MVB12B;CYBRD1;ELFN2;HTRA1;TFCP2L1;TENM4;RGMA;PI4KAP2;KCNAB2;ZFPM1;KITLG;TP53I11;HOXC5;MVD;ZNF362;CUL7;VAMP3;CITED4;IRF2BPL;REEP2;PRICKLE2;KCNJ15;MC1R;ASAP3;ZNF266;SRD5A3;OR2A4;STAT1;IMPACT;CAMK2N1;CRY2;MYL9;HS1BP3;MARCKSL1;NSG1;UNC5B;ITGB5;RAB43;RAB40B;THAP8;NOS1;PRKACB;ZNF704;HOXA3;CRY1;ZNF699;MAML3;ZFP41;SCMH1;KLF13;CRTAP;BCAM;MAGEF1;PLEKHG5;NFATC4;ZNF783;IQSEC2;SPDYE6;BTBD2;RNF187;FERMT1;CYP26B1;GAA;THNSL2;HSF4;CNTRL;ZNF251;PIK3C2G;TBC1D8;PLXNB1;PLEKHG3;VPS11;SPEG;NDRG1;COL7A1;KCNC4;SPOCK1;ITPR3;EAPP;MDM2;CRTC1;LZTS2;PLCD1;NDN;IFITM1;PPP2R2C;FCGRT;CSMD3;CHN2;ZNF662;TYSND1;LTBP4;PIK3IP1;OBSCN;GPRC5C;HLA-B;TNFSF10;PRODH;PARVB;SYTL1;RHOBTB2;UGT1A3;NEO1;RAPGEF3;PHACTR3;ZNF414;TCF25;PCBP4;NINJ1;FAM210B;CTSV;NLGN4Y;POLH;OAS1;FLRT3;RASA4;KIF26A;MLLT6;RGL4;RGS2;ARPIN;ACAP3;IL20RB;ADGRB2;F2R;MLYCD;C2CD4C;HPS4;MT1X;PDCD4;BLOC1S4;CGREF1;SPTB;SERPINB5;NYAP1;SLC24A1;ZNF160;CAPN7;RTN4RL1;ZFP36L2;ADGRF4;CLTCL1;TRPV4;FLOT1;GLI2;AGAP4;TOM1L2;RHPN1;NLGN2;ADORA2B;ANK3;KLF7;RNF165;ADAMTS13;LAMP3;TCEA2;PLCH2;RALGAPA1;MAPK8IP3;SPDYE5;ZNF76;SOX12;CLMN;PIDD1;RIMS3;SLX1A;SLX1B;ZNF747;GJC2;ZCCHC11;ARHGEF19;RHBDF1;TSPAN18;SULT1E1;RASGEF1A;PER2;TMEM204;PITPNM2;CLCN6;PTGS1;UNC119;FNDC4;FRS3;C5;ZNF658;WIPF1;SNTA1;PSKH1;ADGRL1;MINK1;PHF2;TBC1D19;NINL;ABHD14B;GSTM2;TCEAL1;AMIGO2;TNFRSF14;WWTR1;ASAP2;ARHGEF4;LHFPL2;ITGA2;SEMA4G;FAM110C;SYT15;ULK1;GLI3;SPPL2B;FGGY;FHOD3;PCSK1;THRAP3;ZNF558;IRX4;SMARCA1;AKAP7;BHLHE40;LRSAM1;VAMP2;ZNF655;NAIP;LTBP1;NMU;ZNF333;NEK8;MAP2K5;GAS8;BOC;ITGA6;LTBP3;KCNJ5;SRGAP3;CES3;BSN;SESN3;ZNF318;LZTS1;IGFBP4;MMP1;TCFL5;TRAK1;JARID2;NUPR1;GPC2;NISCH;INSR;CCDC85B;CELSR1;MMP28;GSN;HEBP1;CHD3;CDK14;BAIAP2;TTN;CBLC;SCNN1A;DDT;ZNF18;PLXNB3;SUN1;LPAR5;AHNAK2;PLEKHH2;TRIOBP;MXD4;POLD4;RIN1;ZNF287;CD109;PNMA1;PMS2P3;ETAA1;RMI2;ZNF446;SCN4B;ARHGEF1;RAB11FIP4;ZNF581;MGST2;DOCK8;TP53AIP1;DHX58;PILRB;ENDOG;SLC27A1;TM7SF3;RTF1;BLOC1S3;MDK;CASP14;IRF9;RICTOR;H2AFJ;BMP6;NLRX1;TCIRG1;S100A4;MICALL2;MAP2K2;PDK1;VEGFB;ALDH7A1;GLI4;SQSTM1;CEP192;PTK6;SLC12A7;TMEM8B;FZD7;ETV5;SYNGAP1;NXPH4;FAM13A;FAM213A;DLX3;TMEM117;EPB41L3;SHARPIN;HEXB;KDM4C;HYAL1;METTL23;ARHGAP33;SH2D2A;NSMCE4A;ARRDC1;ZNF608;WHAMMP3;PLA2G6;CST3;HOMER2;MMRN2;GDF15;BBS2;TXNIP;CTF1;TCF4;ATP6V0A2;PEX11B;NPHP3;PSD3;PLAG1;IDH2;MAP3K12;RCOR2;WRN;PODXL;SEPT5;IFI27;MALL;OSCP1;DNM1;TNFRSF21;ZYG11B;IQCB1;KLHL24;TREX1;LPIN3;MCTP1;CDK5R1;ATRX;ARHGAP27;AGAP6;NET1;ANO9;CA2;EFNB3;PI4KAP1;SESN1;MAPK10;SHANK3;HFE;ADIRF;HMG20B;CYBA;TRIM38;NID1;DTX3;AGO4;ERCC6;HADH;RRM2B;SLIT3;SHC2;EDA2R;SPRY2;MRC2;FBXO2;WASH3P;MEF2D;IFT140;GABBR1;CREBRF;XRN1;AGAP7P;RAB11FIP3;MLXIPL;CTSB;KLK5;TARBP1;FBXW7;KCNMA1;GPR87;ING4;NUDT6;CDK5RAP3;ZNF862;ATXN1;LMO2;NOTCH2NL;NFIX;PAK6;TFPI2;CARF;DZIP1L;MXI1;PFKFB2;PAQR6;CHMP1B;THRA;APC2;ARAP1;ASTN2;ADARB1;RAI1;FMNL2;ELF1;MX2;IKZF4;RPH3AL;SLC2A1;ACACB;NLRP1;C1RL;FRAT1;ZBTB34;ERMAP;ZNF627;GPR155;BEX2;GLUL;TNS2;TBC1D17;MIF4GD;DBP;NAB2;EPM2AIP1;TP53I13;GNG2;FBXW5;CAPG;LRP1;LRRN3;HLA-A;PEG3;NPHP4;RGS12;ACP5;PLA2G7;SYNPO2;RNPEP;C12ORF66;RFX2;DLK2;KCNG1;ZNF554;BRINP1;MAP3K6;APPL2;SALL2;WNK1;ZNF107;ZNF532;BBS1;JPH2;ZBTB20;PDE2A;ZNF334;MAF;STK16;LTB4R2;RET;ZMYND8;PRX;DAB2IP;CASZ1;RWDD3;ACOX3;CALCOCO1;TEAD2;MYSM1;DDHD2;FBXO4;RNF213;OLFM2;RAPGEFL1;TSHZ2;PIK3C3;ZNF276;IFI16;SYT7;FGFR4;ERCC5;EXOC2;IL20RA;PIK3R2;RETSAT;SCN2A;TEF;ZNF25;AREG;ABTB1;TMEM203;KLHL3;SNCB;MYO9A;RPS6KA5;APBB3;ZNF630;DLG5;BTG1;BST2;ZNF687;VDR;LETMD1;RGL2;ARHGEF17;CACNB3;MAMSTR;TNRC18;TNRC6C;ZFP28;VIPR1;FAM3A;EFS;PLXND1;BBS10;ZMYM3;SIX5;HLTF;PCSK6;ZNF789;ZNF563;ZNF517;TBC1D16;LPAR6;PPP1R2;DMTN;PPP1R35;STAT2;SGSM2;ARFGEF2;RASL10B;LMTK3;ALMS1;WWC3;PHF1;ZNF292;TMEM231;TFDP2;SNX1;PMP22;UCN2;NRARP;ACVR1B;TMX4;ZNF737;KREMEN1;NECAB3;CCDC88B;DLG4;TNNI2;PPP2R3B;TSSK1B;IQSEC1;ZNF701;ALOXE3;NAT14;PANO1;PALB2;ENDOU;IGFBP6;TCEAL4;ZNF91;DUOX1;WEE1;DYDC1;CCNG2;GTF2IRD2;PTK7;AMT;TCF7;SHANK2;RSAD2;TNFRSF25;ZFP36L1;LMNA;CLSTN3;GLMP;ACSL1;IL11;KAT2B;MARK4;TEP1;APOLD1;IRS2;DMXL2;IMPA2;CEP250;ANO1;CAPS;ERN1;HSD17B14;RNF141;IVNS1ABP;ALOX15B;RAD50;GPR21;ZNF439;TKFC;ANGEL2;ZMAT3;DHRS4;S100A6;TRERF1;SCG5;ZSWIM8;APBB2;ARHGEF9;PBLD;RAPGEF5;TNFSF12;TAS1R3;STAT6;PCSK1N;SOX13;PRDX5;PHPT1;NELFCD;GPR132;SMPDL3B;TUB;KIF7;KLF8;RDH12;CHD6;TRAF5;GOLGB1;SRPX2;TRIM2;CD9;RANBP9;CACNB1;HDAC11;PTPN3;ERBB2;SYNGR1;SPOCD1;PLCB3;GPR68;PAQR7;ARHGAP23;ABCA2;KMT5C;AKAP6;TH;ATG14;MPP7;RORA;SSH3;PPARG;PRKACA;DOCK6;LDLRAP1;CXXC5;FMNL3;GCNT4;ZNF572;SYNE2;ACKR3;PLTP;ZNF658B;SERPING1;PARN;DOCK3;ZNF529;UFL1;IP6K2;RIPK3;KLF9;AIP;KCNS3;SCAND1;LONP2;PRMT3;SNX33;CIT;ZFP90;MAP1A;CCDC3;PER3;ZFP30;FOXP2;PTBP2;ZC3H6;HIVEP1;ECM2;SMURF1;NPNT;EML2;CTNNBIP1;PEMT;SERINC3;GCLC;ECM1
14092,GO:0060969,0.695062328537089,0.580907803791103,2,22,negative regulation of gene silencing,BP,PHF2;PPARG
1992,GO:0004715,0.695343480844474,0.530577993367292,3,32,non-membrane spanning protein tyrosine kinase activity,MF,PTK6;STK16;WEE1
13797,GO:0060413,0.695410362618769,0.689259274949497,1,10,atrial septum morphogenesis,BP,ZFPM1
16553,GO:0097366,0.695610549591742,0.580255224955375,2,22,response to bronchodilator,BP,MTR;TH
4146,GO:0009209,0.695670573563774,0.683635483623903,1,13,pyrimidine ribonucleoside triphosphate biosynthetic process,BP,UCKL1
16047,GO:0090025,0.695903350761413,0.684838819791381,1,12,regulation of monocyte chemotaxis,BP,PLA2G7
6913,GO:0030512,0.695913828464823,0.478213556103687,5,54,negative regulation of transforming growth factor beta receptor signaling pathway,BP,HTRA1;LTBP1;CD109;PBLD;SMURF1
7096,GO:0030900,0.696034891901559,0.384347094593669,23,230,forebrain development,BP,EGFR;PTPRS;DIXDC1;ALDH1A3;EPHB2;POU3F1;RTN4RL1;GLI2;GLI3;SUN1;PGAP1;MDK;BBS2;CDK5R1;ATRX;SHANK3;SLC2A1;LRP1;DAB2IP;TACC1;TH;SYNE2;FOXP2
8008,GO:0032649,0.696148666511732,0.497965651936036,4,47,regulation of interferon-gamma production,BP,ISG15;ZFPM1;IL20RB;RIPK3
7981,GO:0032607,0.696206473696794,0.579545037209739,2,22,interferon-alpha production,BP,PTPRS;STAT1
5655,GO:0016758,0.696728247901609,0.40609687948634,14,151,transferase activity, transferring hexosyl groups,MF,PYGB;B4GALNT4;UGT1A3;B4GALT6;HEXA;B4GALT2;HEXB;HYAL1;B3GNT9;PIGZ;DPY19L2P2;KDELC2;XYLT1;GCNT4
6977,GO:0030660,0.696763223559524,0.439907326772759,8,88,Golgi-associated vesicle membrane,CC,SREBF1;HLA-B;AP1G2;CLTCL1;SPPL2B;HLA-A;AREG;LDLRAP1
10958,GO:0044743,0.696868428163585,0.526638339743661,3,38,protein transmembrane import into intracellular organelle,BP,PEX10;PEX7;PEX1
13743,GO:0060341,0.697426768477326,0.352064211856102,61,615,regulation of cellular localization,BP,SREBF1;EGFR;PKD2;SYN1;EPHB2;PIK3R1;KCNAB2;REEP2;NOS1;VPS11;KCNC4;MDM2;LZTS2;RAPGEF3;F2R;HPS4;NLGN2;ADORA2B;ANK3;RIMS3;PER2;GSTM2;GLI3;VAMP2;GSN;MICALL2;MAP2K2;SQSTM1;PLA2G6;SEPT5;IFI27;OSCP1;DNM1;MCTP1;CDK5R1;HFE;CYBA;FBXW7;CDK5RAP3;ASTN2;MX2;LRP1;JPH2;PDE2A;ZMYND8;FBXO4;DMTN;TFDP2;ZFP36L1;LMNA;CEP250;ANO1;PHPT1;ERBB2;GPR68;ABCA2;AKAP6;PRKACA;LDLRAP1;SNX33;PEMT
12147,GO:0048278,0.697900403745873,0.475521740337329,5,56,vesicle docking,BP,VAMP3;RAB40B;VPS11;TSNARE1;EXOC2
3113,GO:0006691,0.698314850612392,0.682063680943951,1,12,leukotriene metabolic process,BP,MGST2
12507,GO:0050667,0.698392370628349,0.68373294141282,1,11,homocysteine metabolic process,BP,MTHFR
7987,GO:0032613,0.698731248494292,0.575191231844645,2,24,interleukin-10 production,BP,IL20RB;TNFRSF21
2813,GO:0006273,0.698948157747412,0.683092793737565,1,11,lagging strand elongation,BP,LIG1
20158,GO:2001025,0.699221719543849,0.681015018090656,1,12,positive regulation of response to drug,BP,ENDOG
3226,GO:0006879,0.699302657431337,0.494234889122868,4,47,cellular iron ion homeostasis,BP,CYBRD1;BMP6;ATP6V0A2;HFE
12713,GO:0050996,0.699420538889475,0.684677988629343,1,10,positive regulation of lipid catabolic process,BP,IRS2
12665,GO:0050900,0.69947132382837,0.384014774385503,21,224,leukocyte migration,BP,INPP5D;CXCR1;PIK3R1;CXCL14;VAV3;KITLG;SDC3;TRPV4;C5;ITGA2;ITGA6;MMP1;MMP28;DDT;DOCK8;VEGFB;PLA2G7;RET;PIK3R2;RIPK3;ECM1
10000,GO:0042440,0.699558670030899,0.493931316111979,4,47,pigment metabolic process,BP,UROS;BLVRB;DDT;PMEL
5929,GO:0018210,0.69970107638583,0.422220010108176,10,104,peptidyl-threonine modification,BP,DGKQ;CAMKK1;PSKH1;ULK1;MAP3K12;CDK5R1;SPRY2;WNK1;DMTN;ACVR1B
2989,GO:0006534,0.699810061193251,0.682098006892573,1,11,cysteine metabolic process,BP,GCLC
9550,GO:0036342,0.700029184975477,0.683977934614367,1,10,post-anal tail morphogenesis,BP,PALB2
8036,GO:0032695,0.70014169463203,0.681714575777576,1,11,negative regulation of interleukin-12 production,BP,ACP5
9228,GO:0035631,0.700463862304226,0.681341732589201,1,11,CD40 receptor complex,CC,TRAF5
8090,GO:0032785,0.700498656356281,0.681301444563088,1,11,negative regulation of DNA-templated transcription, elongation,BP,EAPP
3784,GO:0008349,0.700878521006875,0.682998946945528,1,10,MAP kinase kinase kinase kinase activity,MF,MINK1
14874,GO:0070696,0.700907772447848,0.680827421383689,1,11,transmembrane receptor protein serine/threonine kinase binding,MF,BMP6
15983,GO:0086014,0.700942700080838,0.682924871462648,1,10,atrial cardiac muscle cell action potential,BP,KCNJ5
15993,GO:0086026,0.700942700080838,0.682924871462648,1,10,atrial cardiac muscle cell to AV node cell signaling,BP,KCNJ5
16015,GO:0086066,0.700942700080838,0.682924871462648,1,10,atrial cardiac muscle cell to AV node cell communication,BP,KCNJ5
10051,GO:0042555,0.700949990095749,0.680778473512746,1,11,MCM complex,CC,MCM9
3315,GO:0007019,0.700962126944023,0.523876179689169,3,32,microtubule depolymerization,BP,TRPV4;APC2;MAP1A
6348,GO:0021533,0.701072609274021,0.682774887463158,1,10,cell differentiation in hindbrain,BP,RORA
17367,GO:1900115,0.70128942419024,0.680384707907033,1,11,extracellular regulation of signal transduction,BP,LTBP1
17368,GO:1900116,0.70128942419024,0.680384707907033,1,11,extracellular negative regulation of signal transduction,BP,LTBP1
3444,GO:0007254,0.701401560141938,0.397523919244375,15,156,JNK cascade,BP,EGFR;SFRP1;PDCD4;TRPV4;ADORA2B;MAPK8IP3;MINK1;FZD7;MAP3K12;MAPK10;ERCC6;EDA2R;MAP3K6;DAB2IP;ERN1
16520,GO:0097284,0.701480394642203,0.68016299774445,1,11,hepatocyte apoptotic process,BP,GSN
590,GO:0001755,0.701520423675312,0.522793627804758,3,33,neural crest cell migration,BP,KITLG;SEMA4G;RET
7214,GO:0031116,0.701962494497472,0.572640790099525,2,22,positive regulation of microtubule polymerization,BP,RGS2;CDK5R1
15896,GO:0072698,0.702223556954855,0.492025622589263,4,42,protein localization to microtubule cytoskeleton,BP,NUDCD3;CEP192;CEP250;GOLGB1
6159,GO:0019511,0.702305538694707,0.679203607410372,1,11,peptidyl-proline hydroxylation,BP,CRTAP
16166,GO:0090208,0.702385688656078,0.679110293903033,1,11,positive regulation of triglyceride metabolic process,BP,SREBF1
17371,GO:1900119,0.702426563178388,0.677286819888663,1,12,positive regulation of execution phase of apoptosis,BP,ENDOG
10374,GO:0043218,0.702535507234352,0.678935810884744,1,11,compact myelin,CC,PMP22
5798,GO:0017053,0.702675794104459,0.443175038923563,7,73,transcriptional repressor complex,CC,ZFPM1;GLI3;CHD3;RCOR2;APPL2;SALL2;TNRC18
2385,GO:0005522,0.702676219732999,0.680918740567173,1,10,profilin binding,MF,WIPF1
10941,GO:0044666,0.702760006017173,0.678674209749895,1,11,MLL3/4 complex,CC,ASH2L
9184,GO:0035578,0.702783840053338,0.454033411652663,6,70,azurophil granule lumen,CC,PYGB;NAPRT;HEXB;GLB1;DPP7;C6ORF120
10393,GO:0043243,0.703354390757024,0.570959016369281,2,22,positive regulation of protein complex disassembly,BP,TRPV4;INSR
13808,GO:0060428,0.703362361018077,0.570949372414637,2,22,lung epithelium development,BP,THRA;FOXP2
11078,GO:0045095,0.703384999983812,0.569579056451622,2,24,keratin filament,CC,CASP14;KRT14
6771,GO:0030213,0.70344440471255,0.67787563923966,1,11,hyaluronan biosynthetic process,BP,HYAL1
18200,GO:1903019,0.703535698731715,0.675988427475311,1,12,negative regulation of glycoprotein metabolic process,BP,CST3
6440,GO:0021761,0.703604886620138,0.453726809802893,6,65,limbic system development,BP,PTPRS;ALDH1A3;GLI3;MDK;BBS2;CDK5R1
4456,GO:0010447,0.703647360451436,0.677638518138144,1,11,response to acidic pH,BP,IMPACT
18130,GO:1902894,0.70375399170547,0.679666305565756,1,10,negative regulation of pri-miRNA transcription by RNA polymerase II,BP,NFATC4
18007,GO:1902532,0.703778558101296,0.358026463380836,38,391,negative regulation of intracellular signal transduction,BP,TNFAIP3;SERPINE2;EPM2A;APOE;PKD2;SFRP1;EPHB2;STAT1;CAMK2N1;MDM2;PIK3IP1;FLRT3;RASA4;RGS2;PDCD4;RTN4RL1;GSTM2;SESN3;CBLC;DHX58;NLRX1;SYNGAP1;SESN1;RRM2B;SPRY2;CDK5RAP3;NLRP1;C12ORF66;PDE2A;DAB2IP;PIK3R2;DLG5;WWC3;IVNS1ABP;TKFC;RANBP9;RORA;ACKR3
11080,GO:0045103,0.703886911651902,0.519948711349943,3,33,intermediate filament-based process,BP,SYNC;KLHL24;KRT14
1101,GO:0002690,0.704043438758781,0.488167067073954,4,49,positive regulation of leukocyte chemotaxis,BP,CXCL14;TRPV4;VEGFB;PLA2G7
11229,GO:0045429,0.704132710178616,0.570016512570993,2,22,positive regulation of nitric oxide biosynthetic process,BP,PKD2;INSR
18805,GO:1904407,0.704132710178616,0.570016512570993,2,22,positive regulation of nitric oxide metabolic process,BP,PKD2;INSR
11621,GO:0046349,0.704211224838753,0.676978992211541,1,11,amino sugar biosynthetic process,BP,UAP1L1
13682,GO:0060260,0.704233949984967,0.569190764491295,2,23,regulation of transcription initiation from RNA polymerase II promoter,BP,THRA;CTNNBIP1
4181,GO:0009260,0.704414182621827,0.387820618221033,17,185,ribonucleotide biosynthetic process,BP,PTHLH;APOE;DHTKD1;NOS1;ADORA2B;INSR;TCIRG1;ATP6V0A2;GABBR1;MLXIPL;GPR87;PGM1;PFKFB2;OGDHL;PPCS;LTB4R2;UCKL1
6914,GO:0030513,0.704438158315699,0.569646220165318,2,22,positive regulation of BMP signaling pathway,BP,NEO1;RNF165
12759,GO:0051054,0.704538843647723,0.387794293007035,17,181,positive regulation of DNA metabolic process,BP,EGFR;KITLG;GLI2;SLX1A;SLX1B;INSR;ENDOG;BMP6;CST3;WRN;ATRX;FBXO4;FGFR4;AREG;RAD50;STAT6;PARN
1225,GO:0002903,0.704853530709484,0.674440253581692,1,12,negative regulation of B cell apoptotic process,BP,IRS2
10282,GO:0043047,0.705016295170963,0.676035446094562,1,11,single-stranded telomeric DNA binding,MF,RAD50
305,GO:0000815,0.705072430501807,0.674182514991325,1,12,ESCRT III complex,CC,CHMP1B
16521,GO:0097286,0.70515567808986,0.675871862163441,1,11,iron ion import,BP,HFE
15044,GO:0071027,0.705157770772247,0.672578221665008,1,13,nuclear RNA surveillance,BP,XRN1
15045,GO:0071028,0.705157770772247,0.672578221665008,1,13,nuclear mRNA surveillance,BP,XRN1
12682,GO:0050920,0.705254634635261,0.409723620473132,11,121,regulation of chemotaxis,BP,CXCL14;WNT3;TRPV4;C5;ITGA2;SEMA4G;MMP28;DDT;VEGFB;PLA2G7;ZSWIM8
3322,GO:0007030,0.705625892228867,0.409697533398855,11,114,Golgi organization,BP,OBSL1;CUL7;RAB43;GOLGA8A;GOLGA8B;MAP2K2;GOLGA8N;GOLGB1;PI4K2B;COG1;CIT
9185,GO:0035579,0.706090873930992,0.466040683355245,5,55,specific granule membrane,CC,KCNAB2;HGSNAT;TMC6;SLC2A3;CYBA
11573,GO:0046165,0.706208328549031,0.414380846319817,10,110,alcohol biosynthetic process,BP,SREBF1;APOE;SEC14L2;MVD;SRD5A3;ACACB;VDR;IMPA2;ISYNA1;IP6K2
4652,GO:0010799,0.706292620307472,0.517045073249673,3,33,regulation of peptidyl-threonine phosphorylation,BP,DGKQ;SPRY2;DMTN
5294,GO:0015980,0.706536931284444,0.382355200624491,18,216,energy derivation by oxidation of organic compounds,BP,PYGB;DHTKD1;NFATC4;D2HGDH;GAA;PPP1R3E;PER2;INSR;IDH2;PGM1;OGDHL;EPM2AIP1;SDHA;ETFB;NDUFV3;PPP1R2;IRS2;SUCLG2
12407,GO:0048872,0.706595540301074,0.388387837300296,16,170,homeostasis of number of cells,BP,TNFAIP3;INPP5D;TSC22D3;ZFPM1;KITLG;STAT1;KLF13;FAM210B;IL20RB;F2R;THRA;DMTN;ACVR1B;ZFP36L1;GCNT4;RIPK3
15022,GO:0070989,0.706627566456964,0.674140317304709,1,11,oxidative demethylation,BP,CYP3A5
12723,GO:0051011,0.706631974348344,0.676302341255109,1,10,microtubule minus-end binding,MF,TUBGCP5
15225,GO:0071407,0.706733194439739,0.352610487254608,41,414,cellular response to organic cyclic compound,BP,EGFR;PKD2;SFRP1;KDM3A;STAT1;IMPACT;CRY2;CRY1;NFATC4;MDM2;RAPGEF3;FAM210B;ZFP36L2;FLOT1;GLI2;ZCCHC11;GSTM2;ITGA2;THRAP3;ITGA6;MAP2K2;CYBA;AGO4;CREBRF;XRN1;PAQR6;THRA;GNG2;PDE2A;CALCOCO1;VDR;DMTN;ZFP36L1;PAQR7;AKAP6;RORA;PPARG;PRKACA;UFL1;KLF9;GCLC
6194,GO:0019674,0.707117562116918,0.485146628391092,4,46,NAD metabolic process,BP,NT5E;NAPRT;NMRK1;NADK
18231,GO:1903076,0.707150654530489,0.449421680559145,6,66,regulation of protein localization to plasma membrane,BP,EGFR;EPHB2;PIK3R1;SQSTM1;LRP1;LDLRAP1
7577,GO:0031952,0.707608007360654,0.515452468116734,3,33,regulation of protein autophosphorylation,BP,GPNMB;IMPACT;RAD50
3448,GO:0007259,0.707656663847066,0.427238047358881,8,89,JAK-STAT cascade,BP,PKD2;STAT1;FLRT3;RTN4RL1;PTK6;CTF1;RET;STAT2
17350,GO:1900087,0.707683570361824,0.564991561197625,2,23,positive regulation of G1/S transition of mitotic cell cycle,BP,MDM2;HYAL1
6784,GO:0030228,0.707684755070203,0.675064625098552,1,10,lipoprotein particle receptor activity,MF,LRP1
12290,GO:0048645,0.70775085281526,0.514525010814585,3,35,animal organ formation,BP,HOXA3;GLI2;GLI3
19039,GO:1904925,0.70777835351846,0.672781292749238,1,11,positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization,BP,SMURF1
18574,GO:1903859,0.707984015827291,0.674712091208432,1,10,regulation of dendrite extension,BP,SMURF1
20251,GO:2001241,0.708118119641346,0.670579267968122,1,12,positive regulation of extrinsic apoptotic signaling pathway in absence of ligand,BP,RET
9037,GO:0035265,0.708182016853633,0.419264177179465,9,93,organ growth,BP,EVC;TENM4;THBS3;JARID2;PLAG1;SPRY2;ACACB;WWC3;AKAP6
12946,GO:0051348,0.708525800226442,0.37203544394977,22,236,negative regulation of transferase activity,BP,TNFAIP3;APOE;SFRP1;EPHB2;CAMK2N1;PIK3IP1;FLRT3;RGS2;PDCD4;RTN4RL1;WWTR1;CBLC;PTK6;SPRY2;CDK5RAP3;ADARB1;WNK1;DAB2IP;KAT2B;IRS2;PHPT1;PPARG
10598,GO:0043601,0.708615215303785,0.563207840989182,2,24,nuclear replisome,CC,POLD4;ERCC5
12936,GO:0051338,0.708979561565529,0.335709493456966,73,731,regulation of transferase activity,BP,TNFAIP3;APOE;EGFR;PKD2;SFRP1;EPHB2;MAP3K14;DGKQ;PIK3R1;CAMKK1;HERC5;VAV3;CSPG4;KITLG;CAMK2N1;PRKACB;SPDYE6;PIK3IP1;FLRT3;RGS2;F2R;PDCD4;RTN4RL1;ADORA2B;MAPK8IP3;SPDYE5;UNC119;C5;MINK1;WWTR1;MAP2K5;INSR;TTN;CBLC;ETAA1;PILRB;SLC27A1;RICTOR;MAP2K2;PTK6;MAP3K12;ZYG11B;CDK5R1;MAPK10;ERCC6;SHC2;SPRY2;FBXW7;CDK5RAP3;PAK6;PFKFB2;ADARB1;NAB2;EPM2AIP1;MAP3K6;WNK1;RET;DAB2IP;FGFR4;PIK3R2;DLG4;ACSL1;KAT2B;IRS2;ERN1;RAD50;PHPT1;ERBB2;ATG14;PPARG;PRKACA;PARN;RIPK3
2954,GO:0006486,0.709057618444591,0.377769048545786,19,199,protein glycosylation,BP,MUC19;LMF1;ADAMTS7;ST6GALNAC2;MVD;SRD5A3;ST6GALNAC6;B4GALT6;ADAMTS13;TRAK1;ST3GAL5;B4GALT2;VEGFB;B3GNT9;DPY19L2P2;MPI;MAN1B1;PQLC3;GCNT4
10495,GO:0043413,0.709057618444591,0.377769048545786,19,199,macromolecule glycosylation,BP,MUC19;LMF1;ADAMTS7;ST6GALNAC2;MVD;SRD5A3;ST6GALNAC6;B4GALT6;ADAMTS13;TRAK1;ST3GAL5;B4GALT2;VEGFB;B3GNT9;DPY19L2P2;MPI;MAN1B1;PQLC3;GCNT4
6740,GO:0030166,0.709171875405639,0.483714804632418,4,42,proteoglycan biosynthetic process,BP,CSPG4;GAL3ST4;NDST2;XYLT1
4713,GO:0010878,0.709402771436306,0.670855084610596,1,11,cholesterol storage,BP,PPARG
5617,GO:0016675,0.709496822533582,0.661735000040751,1,19,oxidoreductase activity, acting on a heme group of donors,MF,NDUFA4L2
773,GO:0002029,0.709543375610281,0.668882030602695,1,12,desensitization of G-protein coupled receptor protein signaling pathway,BP,DNM1
6569,GO:0022401,0.709543375610281,0.668882030602695,1,12,negative adaptation of signaling pathway,BP,DNM1
743,GO:0001975,0.709613303854553,0.670604763670774,1,11,response to amphetamine,BP,TH
10898,GO:0044458,0.709774138863893,0.668606563233578,1,12,motile cilium assembly,BP,BBS5
16484,GO:0097202,0.709812384399739,0.66856089065115,1,12,activation of cysteine-type endopeptidase activity,BP,IFI16
15055,GO:0071044,0.709847758579033,0.670325816570345,1,11,histone mRNA catabolic process,BP,XRN1
80,GO:0000164,0.70985298638722,0.670319594486188,1,11,protein phosphatase type 1 complex,CC,PPP1R2
21,GO:0000038,0.710118698371441,0.561363714301562,2,24,very long-chain fatty acid metabolic process,BP,ACOT1;ACOT2
12180,GO:0048365,0.710150009737429,0.46159497547205,5,53,Rac GTPase binding,MF,EPS8L2;VAV3;ARHGEF4;SRGAP3;PAK6
18182,GO:1902992,0.710209288409279,0.669895301510718,1,11,negative regulation of amyloid precursor protein catabolic process,BP,APOE
13445,GO:0055001,0.710372301202224,0.417267720921972,9,87,muscle cell development,BP,FLNC;OBSL1;NFATC4;OBSCN;MYH11;FHOD3;TTN;LMNA;AKAP6
15424,GO:0071731,0.710455558460571,0.66960177671974,1,11,response to nitric oxide,BP,MTR
3693,GO:0008200,0.710581409225786,0.560795021975715,2,24,ion channel inhibitor activity,MF,WNK1;PHPT1
14985,GO:0070935,0.710926882418022,0.66903941970802,1,11,3'-UTR-mediated mRNA stabilization,BP,ANGEL2
18082,GO:1902742,0.71094513794395,0.561702419326491,2,22,apoptotic process involved in development,BP,SLIT3;VDR
8370,GO:0033280,0.711172428156616,0.561423012389624,2,22,response to vitamin D,BP,SFRP1;VDR
13656,GO:0060211,0.711276482795656,0.668621791169778,1,11,regulation of nuclear-transcribed mRNA poly(A) tail shortening,BP,TNRC6C
13658,GO:0060213,0.711276482795656,0.668621791169778,1,11,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening,BP,TNRC6C
9217,GO:0035615,0.71129633705191,0.668598060580645,1,11,clathrin adaptor activity,MF,LDLRAP1
16821,GO:0098748,0.71129633705191,0.668598060580645,1,11,endocytic adaptor activity,MF,LDLRAP1
8485,GO:0033673,0.711582807208816,0.372642725831334,20,213,negative regulation of kinase activity,BP,TNFAIP3;APOE;SFRP1;EPHB2;CAMK2N1;PIK3IP1;FLRT3;RGS2;PDCD4;RTN4RL1;WWTR1;CBLC;PTK6;SPRY2;CDK5RAP3;ADARB1;WNK1;DAB2IP;KAT2B;IRS2
9678,GO:0038083,0.711592433195506,0.511022767179577,3,32,peptidyl-tyrosine autophosphorylation,BP,EGFR;INSR;PTK6
9183,GO:0035577,0.711773692759293,0.479315614671526,4,47,azurophil granule membrane,CC,GAA;BST2;CD68;SYNGR1
16816,GO:0098739,0.711912754248679,0.480134813542887,4,43,import across plasma membrane,BP,PER2;KCNJ5;HFE;SLC36A4
3755,GO:0008298,0.711930858508704,0.666022999565641,1,12,intracellular mRNA localization,BP,ZFP36L1
9278,GO:0035728,0.711978256671608,0.667782158982023,1,11,response to hepatocyte growth factor,BP,GCLC
19850,GO:2000351,0.712073711532631,0.560313776807355,2,22,regulation of endothelial cell apoptotic process,BP,TNFAIP3;PDCD4
4555,GO:0010639,0.712194773709575,0.360230526128486,27,280,negative regulation of organelle organization,BP,ESPN;EVI5L;KDM3A;ARPIN;SPTB;TOM1L2;SLX1A;SLX1B;PHF2;FHOD3;JARID2;GSN;PLEKHH2;TRIOBP;KDM4C;ATRX;SHANK3;XRN1;APC2;ARAP1;CAPG;DMTN;PHF1;LMNA;KAT2B;RAD50;EML2
16417,GO:0097094,0.712874116252779,0.666707783886303,1,11,craniofacial suture morphogenesis,BP,GLI3
6847,GO:0030323,0.71304127897889,0.401202212236569,11,114,respiratory tube development,BP,SREBF1;EGFR;GLI2;GLI3;CELSR1;NPHP3;SPRY2;THRA;DLG5;PTK7;FOXP2
8046,GO:0032717,0.71316439151174,0.664537959804766,1,12,negative regulation of interleukin-8 production,BP,MAP2K5
4272,GO:0009635,0.713166295445532,0.664535663511621,1,12,response to herbicide,BP,TH
2829,GO:0006296,0.713264957906816,0.507135832240159,3,37,nucleotide-excision repair, DNA incision, 5'-to lesion,BP,DDB2;POLD4;ERCC5
4558,GO:0010642,0.713340651979134,0.666147156146015,1,11,negative regulation of platelet-derived growth factor receptor signaling pathway,BP,LRP1
6717,GO:0030134,0.713583435438696,0.441553186107385,6,68,COPII-coated ER to Golgi transport vesicle,CC,SREBF1;COL7A1;HLA-B;HLA-A;DDHD2;AREG
9123,GO:0035458,0.713790564139114,0.663782052302018,1,12,cellular response to interferon-beta,BP,STAT1
14653,GO:0070286,0.714105385485659,0.665226515781154,1,11,axonemal dynein complex assembly,BP,DNAH1
18149,GO:1902936,0.71410560248706,0.441199536386114,6,66,phosphatidylinositol bisphosphate binding,MF,PLCD1;FZD7;JPH2;SYT7;SNX21;LDLRAP1
3537,GO:0007530,0.714299579079652,0.664992400186475,1,11,sex determination,BP,INSR
3479,GO:0007340,0.714331558207301,0.663127848870519,1,12,acrosome reaction,BP,SYT8
12632,GO:0050856,0.714354034095067,0.556138063483643,2,24,regulation of T cell receptor signaling pathway,BP,ELF1;PHPT1
10716,GO:0044087,0.714411371966177,0.331797224824686,67,666,regulation of cellular component biogenesis,BP,DDB2;APOE;HSPA2;ESPN;SLITRK6;SFRP1;EPS8L2;EPHB2;PIK3R1;EVI5L;ASAP3;IMPACT;VPS11;RAPGEF3;FLRT3;RGS2;ARPIN;ADGRB2;SPTB;FLOT1;NLGN2;SLX1A;SLX1B;WIPF1;ADGRL1;AMIGO2;FAM110C;ULK1;FHOD3;LRSAM1;MMP1;GSN;BAIAP2;PLXNB3;TRIOBP;RICTOR;HYAL1;WHAMMP3;PLA2G6;PODXL;CDK5R1;SHANK3;WASH3P;IFT140;CHMP1B;THRA;ARAP1;CAPG;LRRN3;NPHP4;SYNPO2;ZMYND8;DAB2IP;ERCC5;DLG5;BBS10;DMTN;ALMS1;CLSTN3;KAT2B;SRPX2;MPP7;SSH3;PRKACA;SYNE2;EML2;CTNNBIP1
1461,GO:0003713,0.71444016856462,0.360594684234178,25,260,transcription coactivator activity,MF,MNT;POU3F1;CITED4;MAML3;NFATC4;KLF7;SOX12;PER2;PHF2;WWTR1;THRAP3;LPIN3;ING4;THRA;CALCOCO1;MYSM1;VDR;GLMP;KAT2B;TRERF1;RORA;PPARG;RIPK3;AIP;SCAND1
7434,GO:0031572,0.714581185923071,0.506950510601846,3,33,G2 DNA damage checkpoint,BP,MAP3K14;BRSK1;CDK5RAP3
11049,GO:0045061,0.714661832117341,0.66455531622893,1,11,thymic T cell selection,BP,GLI3
907,GO:0002292,0.714690727256999,0.506425480548509,3,34,T cell differentiation involved in immune response,BP,ZFPM1;STAT6;RORA
12583,GO:0050779,0.714909477436458,0.556810204892693,2,22,RNA destabilization,BP,ZFP36L2;ZFP36L1
16537,GO:0097340,0.714973953360526,0.664178343978588,1,11,inhibition of cysteine-type endopeptidase activity,BP,NAIP
16538,GO:0097341,0.714973953360526,0.664178343978588,1,11,zymogen inhibition,BP,NAIP
1484,GO:0003823,0.715195989882071,0.555093800271995,2,24,antigen binding,MF,HLA-B;HLA-A
288,GO:0000793,0.715319205753309,0.375867487424328,17,175,condensed chromosome,CC,HSPA2;SYN1;MLH3;PHF2;TTN;SEPT6;NSMCE4A;CENPC;ATRX;REC8;RGS12;CENPH;ZNF276;TOP3B;RAD50;KMT5C;MSH5
11747,GO:0046621,0.715442996061159,0.55614874339132,2,22,negative regulation of organ growth,BP,JARID2;WWC3
417,GO:0001105,0.715451624794659,0.505882187304235,3,33,RNA polymerase II transcription coactivator activity,MF,POU3F1;CITED4;SOX12
14127,GO:0061029,0.715597403131355,0.663424313652323,1,11,eyelid development in camera-type eye,BP,EGFR
16158,GO:0090199,0.715816647381135,0.503405919592909,3,39,regulation of release of cytochrome c from mitochondria,BP,TNFSF10;PLA2G6;LMNA
5691,GO:0016814,0.715866471394365,0.554260915487142,2,24,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines,MF,APOBEC3C;ADARB1
17208,GO:0110020,0.715988168752444,0.439246003130865,6,64,regulation of actomyosin structure organization,BP,SFRP1;PIK3R1;ASAP3;RAPGEF3;ARAP1;ALMS1
10547,GO:0043518,0.716120899171315,0.660956627650679,1,12,negative regulation of DNA damage response, signal transduction by p53 class mediator,BP,MDM2
7707,GO:0032204,0.716328524227158,0.426830522825449,7,76,regulation of telomere maintenance,BP,SLX1A;SLX1B;ATRX;XRN1;FBXO4;RAD50;PARN
5813,GO:0017081,0.716733609804703,0.660210516893064,1,12,chloride channel regulator activity,MF,WNK1
17748,GO:1901797,0.717006872838541,0.552245858581518,2,25,negative regulation of signal transduction by p53 class mediator,BP,MDM2;RRM2B
20150,GO:2001014,0.717120196344354,0.661576709801266,1,11,regulation of skeletal muscle cell differentiation,BP,CYP26B1
11617,GO:0046339,0.717178604519837,0.66150567703112,1,11,diacylglycerol metabolic process,BP,DGKQ
7907,GO:0032488,0.717213304260151,0.661463471315433,1,11,Cdc42 protein signal transduction,BP,APOE
4929,GO:0014888,0.717261740479623,0.553888336732623,2,22,striated muscle adaptation,BP,GSN;LMNA
16523,GO:0097296,0.71726763851362,0.659559117969843,1,12,activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,TNFSF10
11701,GO:0046519,0.717321355181344,0.659493538472501,1,12,sphingoid metabolic process,BP,KDSR
6285,GO:0019899,0.717657881525787,0.311197367837452,187,1825,enzyme binding,MF,TNFAIP3;SIK1;SREBF1;ACTA2;ALS2CL;PSD4;HSPA2;EGFR;PKD2;SYN1;TRIM22;SRSF5;EPS8L2;EPHB2;RALGDS;DGKQ;PIK3R1;EVI5L;BRSK1;DOCK9;CUL9;VAV3;CSPG4;ISG15;KITLG;CUL7;MC1R;ASAP3;STAT1;CAMK2N1;CRY2;PRKACB;CRY1;PLEKHG5;PITPNM3;IQSEC2;SPDYE6;BTBD2;MICALL1;TBC1D8;PLEKHG3;NDRG1;MDM2;TYSND1;PIK3IP1;OBSCN;SYTL1;RHOBTB2;RAPGEF3;PHACTR3;RGL4;ACAP3;HPS4;SPTB;NEK9;TRPV4;FLOT1;AGAP4;TOM1L2;MAPK8IP3;SPDYE5;RIMS3;ARHGEF19;RASGEF1A;PITPNM2;MICALCL;FRS3;SNTA1;GSTM2;TNFRSF14;ASAP2;ARHGEF4;ULK1;GLI3;AKAP7;GAS8;SRGAP3;INSR;CEP68;TTN;CBLC;TRIOBP;RIN1;ARHGEF1;RAB11FIP4;DOCK8;RTF1;RICTOR;TCIRG1;MICALL2;SQSTM1;CEP192;SLC12A7;KDM4C;ARHGAP33;UBOX5;ARRDC1;WHAMMP3;PLA2G6;CST3;PEX7;TXNIP;ATP6V0A2;PSD3;FAM83C;MAP3K12;RCOR2;DNM1;IQCB1;CDK5R1;AGAP6;NET1;HLCS;SHC2;SPRY2;MEF2D;AGAP7P;RAB11FIP3;FBXW7;CDK5RAP3;PAK6;PFKFB2;METTL21A;ARAP1;FMNL2;RPH3AL;SLC2A1;NLRP1;TNS2;TBC1D17;FBXW5;LRP1;APPL2;WNK1;ATXN10;RET;DAB2IP;RAPGEFL1;FGFR4;EXOC2;PIK3R2;ABTB1;BTG1;RGL2;ARHGEF17;CACNB3;HLTF;TBC1D16;TPRN;PPP1R35;STAT2;SGSM2;ARFGEF2;WWC3;ACVR1B;DLG4;IQSEC1;KAT2B;TEP1;IRS2;DMXL2;CEP250;ERN1;ARHGEF9;RAPGEF5;STAT6;GSTM3;TRAF5;RANBP9;PTPN3;ERBB2;UVSSA;AKAP6;TH;ATG14;PPARG;PRKACA;DOCK6;FMNL3;PARN;UHRF1BP1;DOCK3;LONP2;CIT;EHHADH;PER3;ECM1
5744,GO:0016894,0.717716967449572,0.550811952605151,2,26,endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 3'-phosphomonoesters,MF,SLX1A;SLX1B
3468,GO:0007289,0.717728126453723,0.660836776317524,1,11,spermatid nucleus differentiation,BP,KDM3A
11417,GO:0045859,0.717808370678801,0.331451896484376,58,583,regulation of protein kinase activity,BP,TNFAIP3;APOE;EGFR;PKD2;SFRP1;EPHB2;MAP3K14;DGKQ;CAMKK1;HERC5;CSPG4;KITLG;CAMK2N1;PRKACB;SPDYE6;FLRT3;RGS2;F2R;PDCD4;RTN4RL1;ADORA2B;MAPK8IP3;SPDYE5;UNC119;C5;MINK1;WWTR1;MAP2K5;INSR;TTN;CBLC;ETAA1;PILRB;SLC27A1;RICTOR;MAP2K2;PTK6;MAP3K12;CDK5R1;MAPK10;ERCC6;SHC2;SPRY2;FBXW7;CDK5RAP3;PAK6;ADARB1;NAB2;MAP3K6;WNK1;DAB2IP;DLG4;ACSL1;KAT2B;ERN1;ERBB2;PRKACA;RIPK3
4636,GO:0010761,0.717887999091128,0.502883526290118,3,33,fibroblast migration,BP,TNS1;DMTN;SYNE2
4806,GO:0012507,0.717918822872027,0.472093782502851,4,46,ER to Golgi transport vesicle membrane,CC,SREBF1;HLA-B;HLA-A;AREG
4342,GO:0009896,0.717975406196809,0.348027893697192,32,327,positive regulation of catabolic process,BP,TNFAIP3;EPM2A;TP53INP1;APOE;GPSM1;TRIM65;TRIM22;MAGEF1;VPS11;MDM2;RAPGEF3;ZFP36L2;ULK1;LRSAM1;SESN3;INSR;ENDOG;SESN1;MLXIPL;FBXW7;PFKFB2;APC2;LRP1;DAB2IP;TNRC6C;SNX1;ZFP36L1;IRS2;TNFSF12;SNX33;SMURF1;GCLC
14340,GO:0061578,0.718154374838334,0.66031717782064,1,11,Lys63-specific deubiquitinase activity,MF,TNFAIP3
2515,GO:0005769,0.718523930753213,0.356081949375432,25,259,early endosome,CC,APOE;EGFR;MVB12B;NSG1;VPS11;HLA-B;F2R;FLOT1;LAMP3;TRAK1;NISCH;MAP2K2;HFE;WASH3P;ASTN2;LRP1;HLA-A;APPL2;RET;SNX21;MARCH8;TBC1D16;SNX1;LDLRAP1;ACKR3
16691,GO:0097696,0.718563423070973,0.414412071823408,8,90,STAT cascade,BP,PKD2;STAT1;FLRT3;RTN4RL1;PTK6;CTF1;RET;STAT2
6063,GO:0019215,0.718570691022451,0.659809051853024,1,11,intermediate filament binding,MF,KRT14
19603,GO:1990778,0.718644883223616,0.364855308002301,20,208,protein localization to cell periphery,BP,EGFR;EPHB2;PIK3R1;VAMP3;NSG1;RAB40B;FLOT1;ANK3;VAMP2;SQSTM1;EPB41L3;BBS2;LRP1;BBS1;CACNB3;GOLGA7B;TUB;LDLRAP1;NFASC;SMURF1
6820,GO:0030286,0.718764240959824,0.501410414154274,3,34,dynein complex,CC,WDR63;NUDCD3;DNAH1
11561,GO:0046131,0.719445541946048,0.548142658133939,2,27,pyrimidine ribonucleoside metabolic process,BP,APOBEC3C;UCKL1
15389,GO:0071674,0.719581162390535,0.548478974038772,2,26,mononuclear cell migration,BP,TRPV4;PLA2G7
20054,GO:2000726,0.719658059586905,0.65847892033894,1,11,negative regulation of cardiac muscle cell differentiation,BP,FZD7
6929,GO:0030544,0.720060347188226,0.499093035894522,3,36,Hsp70 protein binding,MF,MVD;METTL21A;ERN1
573,GO:0001725,0.720231957969891,0.469765327102092,4,44,stress fiber,CC,MICALL2;CYBA;SYNPO2;SHROOM4
16628,GO:0097517,0.720231957969891,0.469765327102092,4,44,contractile actin filament bundle,CC,MICALL2;CYBA;SYNPO2;SHROOM4
242,GO:0000578,0.720297229402727,0.550096625214496,2,22,embryonic axis specification,BP,PCSK6;NRARP
1657,GO:0004114,0.720462014400959,0.657492709605488,1,11,3',5'-cyclic-nucleotide phosphodiesterase activity,MF,PDE2A
2814,GO:0006275,0.72078605461541,0.404140957143202,9,99,regulation of DNA replication,BP,EGFR;KITLG;GLI2;INSR;BMP6;CST3;ATRX;FBXW7;AREG
11764,GO:0046639,0.720794120239033,0.657084627036707,1,11,negative regulation of alpha-beta T cell differentiation,BP,GLI3
15726,GO:0072332,0.720797843136294,0.432472124345425,6,72,intrinsic apoptotic signaling pathway by p53 class mediator,BP,MDM2;NUPR1;RRM2B;EDA2R;IFI16;ZMAT3
8762,GO:0034451,0.720806563909462,0.549458049335095,2,22,centriolar satellite,CC,FLOT1;CCDC113
10492,GO:0043409,0.720864646520413,0.386948815687853,12,130,negative regulation of MAPK cascade,BP,APOE;SFRP1;EPHB2;CAMK2N1;RGS2;PDCD4;CBLC;SPRY2;CDK5RAP3;DAB2IP;PIK3R2;RANBP9
13896,GO:0060575,0.720894167688136,0.655108251980686,1,12,intestinal epithelial cell differentiation,BP,PTK6
15799,GO:0072522,0.720957453153507,0.369153233085013,17,187,purine-containing compound biosynthetic process,BP,PTHLH;APOE;NT5E;DHTKD1;NOS1;ADORA2B;INSR;TCIRG1;ATP6V0A2;GABBR1;MLXIPL;GPR87;PGM1;PFKFB2;OGDHL;PPCS;LTB4R2
16475,GO:0097193,0.721070530834286,0.357934433664319,22,243,intrinsic apoptotic signaling pathway,BP,PIK3R1;NFATC4;MDM2;PRODH;NUPR1;CASP14;PDK1;TMEM117;ERCC6;RRM2B;EDA2R;FBXW7;DAB2IP;IFI16;IL20RA;SCN2A;ERN1;IVNS1ABP;ZMAT3;ACKR3;RIPK3;SERINC3
3813,GO:0008408,0.721095980276451,0.467984547117466,4,47,3'-5' exonuclease activity,MF,WRN;TREX1;RAD50;PARN
16121,GO:0090153,0.721099759679765,0.654854494480233,1,12,regulation of sphingolipid biosynthetic process,BP,PLA2G6
19085,GO:1905038,0.721099759679765,0.654854494480233,1,12,regulation of membrane lipid metabolic process,BP,PLA2G6
19815,GO:2000303,0.721099759679765,0.654854494480233,1,12,regulation of ceramide biosynthetic process,BP,PLA2G6
7182,GO:0031078,0.721230591125617,0.656547690040476,1,11,histone deacetylase activity (H3-K14 specific),MF,HDAC11
7626,GO:0032041,0.721230591125617,0.656547690040476,1,11,NAD-dependent histone deacetylase activity (H3-K14 specific),MF,HDAC11
6282,GO:0019896,0.721412396906477,0.656323830694826,1,11,axonal transport of mitochondrion,BP,TRAK1
1156,GO:0002764,0.721529699647687,0.342988948592561,33,349,immune response-regulating signaling pathway,BP,TNFAIP3;MUC19;INPP5D;DDX60;PTPRS;PIK3R1;RBCK1;VAV3;PRKACB;FCGRT;IL20RB;FLOT1;WIPF1;BAIAP2;DHX58;NLRX1;PLA2G6;TNFRSF21;MAPK10;CYBA;CTSB;ELF1;ERMAP;DAB2IP;PIK3C3;PIK3R2;RPS6KA5;CACNB3;RSAD2;TKFC;PHPT1;SMPDL3B;PRKACA
13614,GO:0060135,0.721552055849285,0.468150453625622,4,44,maternal process involved in female pregnancy,BP,CTSV;PLA2G6;CTSB;VDR
996,GO:0002460,0.721638420694501,0.385963242603393,12,132,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,TNFAIP3;INPP5D;IL20RB;C5;HFE;SCART1;C1RL;RSAD2;STAT6;RORA;SERPING1;RIPK3
14170,GO:0061099,0.721683444464739,0.546986273829198,2,24,negative regulation of protein tyrosine kinase activity,BP,CBLC;PTK6
10934,GO:0044613,0.721697966469971,0.654115261947849,1,12,nuclear pore central transport channel,CC,NPAP1
10076,GO:0042590,0.721713650829554,0.445430558902873,5,68,antigen processing and presentation of exogenous peptide antigen via MHC class I,BP,VAMP3;ITGB5;HLA-B;CYBA;HLA-A
9532,GO:0036296,0.721732357906921,0.546924730443415,2,24,response to increased oxygen levels,BP,ATP6V0A2;PPARG
11776,GO:0046658,0.722023821157237,0.545958936235201,2,25,anchored component of plasma membrane,CC,RTN4RL1;GPC2
10335,GO:0043154,0.722286341001963,0.430923956851504,6,70,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP,IFI6;MDM2;LAMP3;NAIP;MAP2K5;PRDX5
5302,GO:0016010,0.722384764257398,0.655124485361244,1,11,dystrophin-associated glycoprotein complex,CC,SNTA1
16342,GO:0090665,0.722384764257398,0.655124485361244,1,11,glycoprotein complex,CC,SNTA1
12465,GO:0050433,0.722394680978412,0.653252645238065,1,12,regulation of catecholamine secretion,BP,SYT7
16498,GO:0097228,0.722457477506874,0.653174807983576,1,12,sperm principal piece,CC,CABYR
17490,GO:1900744,0.722460957121251,0.54666163778455,2,23,regulation of p38MAPK cascade,BP,MINK1;DAB2IP
5654,GO:0016757,0.722582902086762,0.362425189866835,19,206,transferase activity, transferring glycosyl groups,MF,PYGB;ST6GALNAC2;NAPRT;B4GALNT4;ST6GALNAC6;UGT1A3;B4GALT6;PARP6;HEXA;ST3GAL5;B4GALT2;HEXB;HYAL1;B3GNT9;PIGZ;DPY19L2P2;KDELC2;XYLT1;GCNT4
4485,GO:0010510,0.722820361612299,0.654586079572027,1,11,regulation of acetyl-CoA biosynthetic process from pyruvate,BP,PDK1
5498,GO:0016442,0.722888199713761,0.654502167597612,1,11,RISC complex,CC,AGO4
7315,GO:0031332,0.722888199713761,0.654502167597612,1,11,RNAi effector complex,CC,AGO4
2960,GO:0006493,0.722897696801476,0.409657240370718,8,86,protein O-linked glycosylation,BP,MUC19;ADAMTS7;ST6GALNAC2;ADAMTS13;TRAK1;VEGFB;B3GNT9;GCNT4
17093,GO:0101023,0.723269544658229,0.654030149084186,1,11,vascular endothelial cell proliferation,BP,PPARG
19278,GO:1905562,0.723269544658229,0.654030149084186,1,11,regulation of vascular endothelial cell proliferation,BP,PPARG
9451,GO:0036065,0.723349738107241,0.545541177466585,2,23,fucosylation,BP,ADAMTS7;ADAMTS13
13446,GO:0055002,0.723476928167568,0.409788441509732,8,78,striated muscle cell development,BP,FLNC;OBSL1;OBSCN;MYH11;FHOD3;TTN;LMNA;AKAP6
12135,GO:0048259,0.723567234934892,0.444899984994479,5,56,regulation of receptor-mediated endocytosis,BP,FLOT1;UNC119;HFE;DLG4;LDLRAP1
3381,GO:0007159,0.723729275445225,0.366066401571251,17,185,leukocyte cell-cell adhesion,BP,GPNMB;NT5E;MAP3K14;PIK3R1;IL20RB;GLI2;TNFRSF14;GLI3;DOCK8;CERCAM;TNFRSF21;EFNB3;HFE;DLG5;NRARP;CCDC88B;ERBB2
463,GO:0001502,0.723954631059385,0.653180817997655,1,11,cartilage condensation,BP,THRA
16818,GO:0098743,0.723954631059385,0.653180817997655,1,11,cell aggregation,BP,THRA
12619,GO:0050832,0.724004058577247,0.647190281014837,1,15,defense response to fungus,BP,FAM3A
12337,GO:0048729,0.724034808065404,0.331250759758144,45,446,tissue morphogenesis,BP,ACTA2;EGFR;PKD2;ALDH1A3;SFRP1;KIF26B;WNT3;ZFPM1;PRICKLE2;STAT1;PRKACB;NFATC4;MDM2;CTSV;FLRT3;SERPINB5;GLI2;ARHGEF19;ITGA2;GLI3;CELSR1;TTN;FZD7;ETV5;NPHP3;PODXL;CA2;SPRY2;ASTN2;ADARB1;RET;TEAD2;BBS5;AREG;KLHL3;MYO9A;DLG5;VDR;PLXND1;NRARP;PTK7;GCNT4;SMURF1;NPNT;CTNNBIP1
18568,GO:1903845,0.724060822532251,0.444300883845772,5,56,negative regulation of cellular response to transforming growth factor beta stimulus,BP,HTRA1;LTBP1;CD109;PBLD;SMURF1
10485,GO:0043401,0.724127857358835,0.375195629400111,14,147,steroid hormone mediated signaling pathway,BP,SFRP1;KDM3A;CRY2;CRY1;THRAP3;CREBRF;PAQR6;THRA;CALCOCO1;VDR;PAQR7;RORA;PPARG;UFL1
12238,GO:0048535,0.724253458984615,0.650942511882585,1,12,lymph node development,BP,RIPK3
8761,GO:0034450,0.724355997503489,0.650814703190739,1,12,ubiquitin-ubiquitin ligase activity,MF,UBOX5
8431,GO:0033561,0.724376285595416,0.544244449250798,2,23,regulation of water loss via skin,BP,CYP26B1;ALOXE3
16159,GO:0090200,0.724420900663697,0.541871141092368,2,27,positive regulation of release of cytochrome c from mitochondria,BP,TNFSF10;PLA2G6
1457,GO:0003705,0.724436443342417,0.444023955196426,5,55,transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding,MF,BHLHE40;MEF2D;NFIX;TEAD2;HIVEP1
4034,GO:0009068,0.724567937965334,0.650550407478662,1,12,aspartate family amino acid catabolic process,BP,ALDH7A1
15475,GO:0071868,0.724723278714152,0.543805500455105,2,23,cellular response to monoamine stimulus,BP,GNG2;PRKACA
15477,GO:0071870,0.724723278714152,0.543805500455105,2,23,cellular response to catecholamine stimulus,BP,GNG2;PRKACA
13087,GO:0051642,0.724754466679551,0.544485269764387,2,22,centrosome localization,BP,SUN1;SYNE2
16367,GO:0095500,0.725040648537938,0.649960324121113,1,12,acetylcholine receptor signaling pathway,BP,CDK5R1
18564,GO:1903831,0.725040648537938,0.649960324121113,1,12,signal transduction involved in cellular response to ammonium ion,BP,CDK5R1
19121,GO:1905144,0.725040648537938,0.649960324121113,1,12,response to acetylcholine,BP,CDK5R1
19122,GO:1905145,0.725040648537938,0.649960324121113,1,12,cellular response to acetylcholine,BP,CDK5R1
6702,GO:0030118,0.725267351003158,0.463335382761069,4,45,clathrin coat,CC,EGFR;AP1G2;CLTCL1;LDLRAP1
6080,GO:0019239,0.725320109445357,0.541792497699686,2,25,deaminase activity,MF,APOBEC3C;ADARB1
1775,GO:0004385,0.725369146252194,0.651421678631385,1,11,guanylate kinase activity,MF,DLG4
10206,GO:0042866,0.725439421535058,0.415909228602363,7,77,pyruvate biosynthetic process,BP,DHTKD1;INSR;MLXIPL;PGM1;PFKFB2;OGDHL;SRR
2753,GO:0006164,0.725455826865303,0.366841286972372,16,177,purine nucleotide biosynthetic process,BP,PTHLH;APOE;DHTKD1;NOS1;ADORA2B;INSR;TCIRG1;ATP6V0A2;GABBR1;MLXIPL;GPR87;PGM1;PFKFB2;OGDHL;PPCS;LTB4R2
5983,GO:0018904,0.725553021830224,0.647744841517628,1,13,ether metabolic process,BP,PEX7
4145,GO:0009208,0.726124970777697,0.645682049487153,1,14,pyrimidine ribonucleoside triphosphate metabolic process,BP,UCKL1
16483,GO:0097201,0.726171857590583,0.648544867181827,1,12,negative regulation of transcription from RNA polymerase II promoter in response to stress,BP,IMPACT
6207,GO:0019725,0.72637953727743,0.324754530723647,52,545,cellular homeostasis,BP,APOE;PKD2;PIK3R1;TXNRD3;CYBRD1;NOS1;GAA;ITPR3;F2R;MT1X;SLC24A1;TRPV4;CLCN6;GSTM2;FGGY;NMU;POLD4;ENDOG;BMP6;TCIRG1;SLC12A7;HEXB;PLA2G6;ATP6V0A2;CA2;SHANK3;HFE;CYBA;MLXIPL;KCNMA1;TNS2;JPH2;FBXO4;PIK3R2;TMEM203;VDR;LETMD1;CACNB3;LPAR6;TMX4;DLG4;IRS2;DMXL2;ANO1;ERN1;PRDX5;PHPT1;GPR68;AKAP6;TH;PRKACA;GCLC
15191,GO:0071360,0.726437440031358,0.648211858663552,1,12,cellular response to exogenous dsRNA,BP,FLOT1
12296,GO:0048663,0.726491435450461,0.541563814155416,2,23,neuron fate commitment,BP,GLI2;GLI3
4106,GO:0009163,0.726511297010784,0.489852826687773,3,40,nucleoside biosynthetic process,BP,NT5E;TK2;UCKL1
11499,GO:0046030,0.72681025360192,0.649621805912285,1,11,inositol trisphosphate phosphatase activity,MF,INPP5D
7070,GO:0030866,0.726864729255209,0.491726888673329,3,33,cortical actin cytoskeleton organization,BP,WIPF1;EPB41L3;FMNL2
7467,GO:0031639,0.726902310372785,0.647628332900011,1,12,plasminogen activation,BP,SERPINE2
13490,GO:0055082,0.727223895509948,0.330186489378318,41,430,cellular chemical homeostasis,BP,APOE;PKD2;PIK3R1;CYBRD1;NOS1;ITPR3;F2R;MT1X;SLC24A1;TRPV4;GSTM2;NMU;ENDOG;BMP6;TCIRG1;HEXB;PLA2G6;ATP6V0A2;CA2;HFE;CYBA;MLXIPL;KCNMA1;JPH2;PIK3R2;TMEM203;VDR;LETMD1;CACNB3;LPAR6;DLG4;IRS2;DMXL2;ANO1;ERN1;PHPT1;GPR68;AKAP6;TH;PRKACA;GCLC
17624,GO:1901381,0.727286452395317,0.64902534933106,1,11,positive regulation of potassium ion transmembrane transport,BP,AKAP6
9873,GO:0042159,0.727296640641659,0.647132718487039,1,12,lipoprotein catabolic process,BP,APOE
3249,GO:0006909,0.727423509406513,0.371296403910058,14,150,phagocytosis,BP,PIK3R1;VAV3;SPG11;WIPF1;ITGA2;GSN;BAIAP2;PLA2G6;CYBA;LRP1;SYT7;PIK3R2;TUB;PPARG
12836,GO:0051174,0.727477772095631,0.306702563239037,122,1205,regulation of phosphorus metabolic process,BP,TNFAIP3;GPNMB;PTHLH;APOE;HSPA2;EGFR;FAM20C;PKD2;CAPRIN2;SFRP1;EPHB2;MAP3K14;DGKQ;PIK3R1;CAMKK1;HERC5;VAV3;CSPG4;ELFN2;KITLG;IMPACT;CAMK2N1;CRY2;NOS1;PRKACB;SPDYE6;PPP2R2C;PIK3IP1;RAPGEF3;PHACTR3;FLRT3;RGS2;F2R;PDCD4;RTN4RL1;TRPV4;FLOT1;ADORA2B;MAPK8IP3;SPDYE5;GJC2;UNC119;C5;MINK1;WWTR1;ITGA2;MAP2K5;ITGA6;IGFBP4;INSR;TTN;CBLC;DDT;CD109;ETAA1;PILRB;SLC27A1;RICTOR;BMP6;MAP2K2;PDK1;SQSTM1;CEP192;PTK6;FZD7;SYNGAP1;PLA2G6;GDF15;CTF1;NPHP3;MAP3K12;CDK5R1;MAPK10;HFE;ERCC6;SHC2;EDA2R;SPRY2;GABBR1;MLXIPL;FBXW7;GPR87;CDK5RAP3;PAK6;PFKFB2;ADARB1;NAB2;MAP3K6;WNK1;LTB4R2;RET;DAB2IP;FGFR4;PIK3R2;AREG;RPS6KA5;PPP1R2;DMTN;PPP1R35;STAT2;LMTK3;ACVR1B;DLG4;PPP2R3B;TNFRSF25;ACSL1;IL11;KAT2B;IRS2;ERN1;RAD50;PBLD;SRPX2;RANBP9;ERBB2;SPOCD1;AKAP6;ATG14;PRKACA;ACKR3;RIPK3;NPNT
13146,GO:0051764,0.727608284836649,0.648621760544851,1,11,actin crosslink formation,BP,BAIAP2
5943,GO:0018279,0.727678860564423,0.488958615913596,3,38,protein N-linked glycosylation via asparagine,BP,ST6GALNAC2;ST6GALNAC6;ST3GAL5
17802,GO:1901981,0.727733560449121,0.389618536525503,10,107,phosphatidylinositol phosphate binding,MF,PLCD1;FZD7;ARAP1;JPH2;DAB2IP;SYT7;BBS5;OSBPL5;SNX21;LDLRAP1
12647,GO:0050871,0.727763649437486,0.459783883647937,4,47,positive regulation of B cell activation,BP,INPP5D;VAV3;IRS2;STAT6
11377,GO:0045776,0.727764904502282,0.539286234771066,2,24,negative regulation of blood pressure,BP,NOS1;RNPEP
7552,GO:0031902,0.727853899331308,0.395498555766751,9,104,late endosome membrane,CC,MVB12B;NSG1;MICALL1;VPS11;VPS39;TMEM9;CHMP1B;PMEL;LAPTM4A
10415,GO:0043274,0.727928974555717,0.64821921768371,1,11,phospholipase binding,MF,DGKQ
16116,GO:0090141,0.72796745719508,0.646288262956123,1,12,positive regulation of mitochondrial fission,BP,DDHD2
15206,GO:0071383,0.728039788690367,0.358779437398019,18,189,cellular response to steroid hormone stimulus,BP,EGFR;SFRP1;KDM3A;CRY2;CRY1;ZFP36L2;THRAP3;CREBRF;PAQR6;THRA;CALCOCO1;VDR;ZFP36L1;PAQR7;RORA;PPARG;UFL1;KLF9
13384,GO:0052743,0.728195187274915,0.64788476271512,1,11,inositol tetrakisphosphate phosphatase activity,MF,INPP5D
18123,GO:1902882,0.728231484818274,0.438724041437483,5,59,regulation of response to oxidative stress,BP,SESN3;ENDOG;MCTP1;SESN1;FBXW7
16160,GO:0090201,0.728311128262107,0.644270538979764,1,13,negative regulation of release of cytochrome c from mitochondria,BP,LMNA
11637,GO:0046390,0.728508908945916,0.360555230522245,17,188,ribose phosphate biosynthetic process,BP,PTHLH;APOE;DHTKD1;NOS1;ADORA2B;INSR;TCIRG1;ATP6V0A2;GABBR1;MLXIPL;GPR87;PGM1;PFKFB2;OGDHL;PPCS;LTB4R2;UCKL1
4942,GO:0014909,0.728605607182858,0.459214589208035,4,45,smooth muscle cell migration,BP,POSTN;MDM2;ITGA2;LRP1
10347,GO:0043175,0.728831904055571,0.488495580974494,3,35,RNA polymerase core enzyme binding,MF,RTF1;ERBB2;UVSSA
12068,GO:0048038,0.72913682073374,0.641871470373906,1,14,quinone binding,MF,CBR4
8285,GO:0033127,0.729195789315804,0.644737595423912,1,12,regulation of histone phosphorylation,BP,RPS6KA5
16757,GO:0098589,0.72942768886275,0.352716229391812,20,208,membrane region,CC,INPP5D;EGFR;MARVELD1;UNC5B;NOS1;F2R;RTN4RL1;FLOT1;INSR;CBLC;PODXL;MALL;KCNMA1;SLC2A1;RET;BST2;STAT6;CTSD;AKAP6;PRKACA
8460,GO:0033612,0.729545289870808,0.644295340218506,1,12,receptor serine/threonine kinase binding,MF,BMP6
56,GO:0000118,0.72960115676019,0.437728198508288,5,55,histone deacetylase complex,CC,CHD3;APPL2;SALL2;TRERF1;HDAC11
8880,GO:0034707,0.729709210196216,0.644087757707737,1,12,chloride channel complex,CC,ANO1
359,GO:0000978,0.730017126531063,0.339237953420533,28,287,RNA polymerase II proximal promoter sequence-specific DNA binding,MF,HES2;SREBF1;ZFPM1;STAT1;KLF13;NFATC4;HSF4;NDN;GLI2;KLF7;GLI3;BHLHE40;TCFL5;TCF4;PLAG1;MEF2D;MLXIPL;LMO2;CARF;ELF1;RFX2;IFI16;VDR;SIX5;HLTF;STAT6;KLF8;FOXP2
3496,GO:0007389,0.730026365453611,0.344805434896062,24,248,pattern specification process,BP,PKD2;SFRP1;WNT3;PRKACB;HOXA3;SCMH1;CYP26B1;GLI2;PSKH1;GLI3;IRX4;NEK8;GAS8;CELSR1;PGAP1;SYNGAP1;NPHP3;IFT140;APC2;BBS5;PCSK6;NRARP;PALB2;CTNNBIP1
4026,GO:0009060,0.73005828210492,0.435274132366053,5,68,aerobic respiration,BP,DHTKD1;IDH2;OGDHL;SDHA;SUCLG2
693,GO:0001914,0.730170906389754,0.641911720422115,1,13,regulation of T cell mediated cytotoxicity,BP,RIPK3
1,GO:0000002,0.730684368867316,0.535554826936534,2,24,mitochondrial genome maintenance,BP,RRM2B;PRIMPOL
12472,GO:0050482,0.730875830656282,0.642607453598916,1,12,arachidonic acid secretion,BP,PLA2G6
18628,GO:1903963,0.730875830656282,0.642607453598916,1,12,arachidonate transport,BP,PLA2G6
11777,GO:0046660,0.730966432506563,0.409295524726538,7,77,female sex differentiation,BP,SFRP1;KITLG;LHFPL2;NUPR1;INSR;SLIT3;ACVR1B
1308,GO:0003158,0.731103849459554,0.409239512224094,7,76,endothelium development,BP,PTPRS;RAPGEF3;BMP6;PDE2A;BTG1;APOLD1;GSTM3
11476,GO:0045956,0.731483200256581,0.64183472696259,1,12,positive regulation of calcium ion-dependent exocytosis,BP,SYT7
4979,GO:0015103,0.731539104710033,0.408716800266224,7,76,inorganic anion transmembrane transporter activity,MF,CLCN6;SLC12A7;CLCA2;ANO9;SLC37A2;ANO1;CLCN7
12061,GO:0048026,0.731671256698107,0.641595187142763,1,12,positive regulation of mRNA splicing, via spliceosome,BP,THRAP3
2787,GO:0006221,0.731747928512916,0.532042469692985,2,28,pyrimidine nucleotide biosynthetic process,BP,CMPK2;UCKL1
3911,GO:0008574,0.732140038195352,0.53434646938472,2,23,ATP-dependent microtubule motor activity, plus-end-directed,MF,WDR63;KIF7
19637,GO:1990907,0.73215801301011,0.642874372207437,1,11,beta-catenin-TCF complex,CC,TCF4
19923,GO:2000482,0.732529828354524,0.638900976945891,1,13,regulation of interleukin-8 secretion,BP,F2R
5643,GO:0016740,0.733169641507844,0.29461653597863,192,1894,transferase activity,MF,TNFAIP3;ULK2;SIK1;SUGCT;DDB2;PYGB;GAMT;FBXO41;OAS2;FBXW4;EGFR;HERC3;FAM20C;CPT2;ASH2L;TRIM22;KCTD11;EPHB2;MAP3K14;DGKQ;TMEM129;PIK3R1;BRSK1;RBCK1;NSUN7;RNF135;CAMKK1;HERC5;ST6GALNAC2;PI4KAP2;KITLG;ZDHHC1;NAPRT;PRKACB;B4GALNT4;RNF187;CMPK2;CNTRL;PIK3C2G;CDK18;SPEG;MDM2;NMRK1;ST6GALNAC6;LTBP4;OBSCN;HGSNAT;UGT1A3;CERS4;SPSB3;POLH;POLR2J2;OAS1;GAL3ST4;CRAT;B4GALT6;ALPK1;NEK9;RNF165;NAT6;PARP6;ZNF747;ZCCHC11;SULT1E1;FBXO44;HEXA;PSKH1;MINK1;GSTM2;MBOAT2;ULK1;FGGY;LRSAM1;NAIP;LTBP1;NEK8;MAP2K5;INSR;TST;CDK14;ST3GAL5;TTN;CBLC;POLD4;NSUN5P2;FBXL16;MGST2;GID4;B4GALT2;ETNK2;MAP2K2;PDK1;SQSTM1;PTK6;SHARPIN;HEXB;HYAL1;METTL23;UBOX5;B3GNT9;FAM86C2P;PDIK1L;MAP3K12;ZYG11B;KLHL24;ZDHHC12;CDK5R1;PIGZ;EFNB3;PI4KAP1;POLR2J3;MAPK10;TRIM38;DTX3;FBXO2;TARBP1;FBXW7;ZNF862;PAK6;PFKFB2;RNF170;METTL21A;TK2;NDST2;FBXW5;KLHDC8B;ATE1;MAP3K6;MYO3B;WNK1;STK16;RET;FBXO4;RNF213;PIK3C3;FGFR4;PIK3R2;SETD4;KLHL3;RPS6KA5;DPY19L2P2;NADK;HLTF;MARCH8;PCMTD2;STK19;LMTK3;PCMTD1;GOLGA7B;ACVR1B;KDELC2;PRIMPOL;DLG4;TSSK1B;ADCK5;NAT14;WEE1;DYDC1;PTK7;AMT;XYLT1;KAT2B;MARK4;TEP1;IRS2;METTL7A;ERN1;RNF141;RAD50;TKFC;MTR;UAP1L1;CERS5;CPT1C;GSTM3;KLHL29;TRIM2;ERBB2;ZDHHC24;KMT5C;PRKACA;POLM;GCNT4;UCKL1;UFL1;IP6K2;RIPK3;PI4K2B;PRMT3;CIT;SMURF1;PEMT
5607,GO:0016653,0.733261600667804,0.639564059461557,1,12,oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor,MF,NOS1
4803,GO:0012501,0.733450329475485,0.297813063613593,145,1479,programmed cell death,BP,TNFAIP3;SIK1;TP53INP1;IFI6;APOE;INPP5D;EGFR;MNT;ALDH1A3;SFRP1;EPHB2;MAP3K14;PIK3R1;RBCK1;TSC22D3;VAV3;KITLG;STAT1;KRT15;HS1BP3;LGALS7B;NSG1;UNC5B;PLEKHG5;NFATC4;H1F0;CYP26B1;NDRG1;MDM2;OBSCN;TNFSF10;PRODH;CTSV;F2R;PPL;PDCD4;GLI2;LAMP3;PIDD1;ARHGEF19;MINK1;AMIGO2;TNFRSF14;ARHGEF4;GLI3;NAIP;MAP2K5;ITGA6;NUPR1;NISCH;INSR;GSN;PNMA1;ARHGEF1;DOCK8;TP53AIP1;ENDOG;TM7SF3;MDK;CASP14;BMP6;MAP2K2;PDK1;SQSTM1;SYNGAP1;TMEM117;EPB41L3;SHARPIN;PLA2G6;CST3;GDF15;TXNIP;PLAG1;MAP3K12;WRN;IFI27;TNFRSF21;CDK5R1;NET1;AGO4;ERCC6;RRM2B;SLIT3;KRT14;EDA2R;SPRY2;MEF2D;CTSB;KLK5;FBXW7;KCNMA1;ING4;CDK5RAP3;PAK6;THRA;ADARB1;NLRP1;BEX2;LRP1;PEG3;RET;DAB2IP;IFI16;FGFR4;ERCC5;IL20RA;SCN2A;SNCB;DLG5;BTG1;VDR;RGL2;ARHGEF17;PCSK6;TNS4;TFDP2;ACVR1B;KREMEN1;PANO1;PALB2;TNFRSF25;ZFP36L1;LMNA;MARK4;IRS2;ERN1;IVNS1ABP;ALOX15B;ZMAT3;APBB2;ARHGEF9;TNFSF12;PRDX5;TRAF5;TRIM2;ERBB2;PPARG;C6ORF120;ACKR3;UFL1;IP6K2;RIPK3;CIT;SERINC3;GCLC
12342,GO:0048736,0.733647944129426,0.372384260039957,12,125,appendage development,BP,FBXW4;WNT3;CYP26B1;GLI2;RNF165;GLI3;ITGA6;ATRX;IFT140;TMEM231;KREMEN1;KAT2B
13638,GO:0060173,0.733647944129426,0.372384260039957,12,125,limb development,BP,FBXW4;WNT3;CYP26B1;GLI2;RNF165;GLI3;ITGA6;ATRX;IFT140;TMEM231;KREMEN1;KAT2B
7351,GO:0031401,0.7339143213335,0.307659782548109,78,789,positive regulation of protein modification process,BP,GPNMB;SREBF1;HSPA2;EGFR;PKD2;CAPRIN2;EPHB2;MAP3K14;DGKQ;CAMKK1;CSPG4;KITLG;NOS1;PRKACB;RAPGEF3;F2R;TRPV4;FLOT1;ADORA2B;MAPK8IP3;UNC119;C5;MINK1;MAP2K5;IGFBP4;JARID2;NUPR1;INSR;DDT;ETAA1;PILRB;SLC27A1;RTF1;RICTOR;BMP6;MAP2K2;SQSTM1;PTK6;FZD7;PLA2G6;GDF15;CTF1;MAP3K12;CDK5R1;MAPK10;HFE;ERCC6;SHC2;EDA2R;SPRY2;FBXW7;CDK5RAP3;PAK6;NAB2;MAP3K6;WNK1;RET;DAB2IP;RWDD3;FBXO4;FGFR4;AREG;RPS6KA5;PHF1;ACVR1B;DLG4;TNFRSF25;ACSL1;IL11;ERN1;RAD50;ERBB2;AKAP6;ATG14;PRKACA;ACKR3;RIPK3;NPNT
12349,GO:0048747,0.734010840275278,0.485755587742129,3,27,muscle fiber development,BP,FLNC;MYH11;TTN
8724,GO:0034383,0.734155259438533,0.530482612858493,2,25,low-density lipoprotein particle clearance,BP,CES3;LDLRAP1
5406,GO:0016248,0.734251153572518,0.530358704874768,2,25,channel inhibitor activity,MF,WNK1;PHPT1
1985,GO:0004707,0.734316690356966,0.638211186574258,1,12,MAP kinase activity,MF,MAPK10
10027,GO:0042493,0.734461501890983,0.313378101413241,58,603,response to drug,BP,TNFAIP3;TP53INP1;SREBF1;EGFR;XPC;SFRP1;MTHFR;DGKQ;VAV3;STAT1;IMPACT;NOS1;PRKACB;MDM2;SLC13A5;PER2;GSTM2;ITGA2;GSN;BAIAP2;CYP2D7;ENDOG;MDK;VEGFB;CST3;HOMER2;TXNIP;CDK5R1;ATRX;NET1;CA2;ADIRF;CYBA;HADH;SLIT3;HLCS;XRN1;KCNMA1;RPH3AL;ACACB;NLRP1;TP53I13;SRR;PDE2A;RET;SYT7;AREG;SLC36A4;ACSL1;MTR;STAT6;ABCA2;TH;PPARG;UFL1;KLF9;PEMT;GCLC
15543,GO:0072012,0.734643889349538,0.637790769859277,1,12,glomerulus vasculature development,BP,ACTA2
2492,GO:0005741,0.734652528825422,0.366450917362526,13,147,mitochondrial outer membrane,CC,BPHL;SPATA18;SNN;FAM210B;ULK1;NLRX1;IFI27;ACACB;PDE2A;LETMD1;RSAD2;ACSL1;CPT1C
3596,GO:0008023,0.734939488378251,0.451097289693149,4,46,transcription elongation factor complex,CC,TCEA2;RTF1;ERCC6;NELFCD
9439,GO:0036038,0.735074739763812,0.635629004603037,1,13,MKS complex,CC,TMEM231
4759,GO:0010941,0.735092022436972,0.299357904946746,116,1185,regulation of cell death,BP,TNFAIP3;GPNMB;SIK1;TP53INP1;IFI6;APOE;INPP5D;EGFR;MNT;ALDH1A3;SFRP1;EPHB2;MAP3K14;PIK3R1;RBCK1;TSC22D3;VAV3;KITLG;STAT1;IMPACT;HS1BP3;UNC5B;PLEKHG5;NFATC4;NDRG1;MDM2;OBSCN;TNFSF10;PRODH;F2R;PDCD4;GLI2;LAMP3;PIDD1;ARHGEF19;MINK1;AMIGO2;TNFRSF14;ARHGEF4;GLI3;NAIP;MAP2K5;ITGA6;NUPR1;INSR;GSN;PNMA1;ARHGEF1;DOCK8;TP53AIP1;ENDOG;TM7SF3;MDK;BMP6;MAP2K2;SQSTM1;SYNGAP1;PLA2G6;CST3;GDF15;TXNIP;MAP3K12;WRN;IFI27;TNFRSF21;CDK5R1;NET1;AGO4;RRM2B;SPRY2;CTSB;FBXW7;KCNMA1;ING4;PAK6;THRA;NLRP1;BEX2;LRP1;RET;DAB2IP;TEAD2;FGFR4;ERCC5;IL20RA;SNCB;DLG5;BTG1;VDR;RGL2;ARHGEF17;TFDP2;PANO1;PALB2;TCF7;TNFRSF25;ZFP36L1;LMNA;MARK4;IRS2;IVNS1ABP;ZMAT3;APBB2;ARHGEF9;TNFSF12;PRDX5;TRAF5;TRIM2;ERBB2;PPARG;ACKR3;UFL1;IP6K2;RIPK3;SERINC3;GCLC
9585,GO:0036452,0.735395957008648,0.528319840453519,2,26,ESCRT complex,CC,MVB12B;CHMP1B
4656,GO:0010804,0.735492460517841,0.633717781793969,1,14,negative regulation of tumor necrosis factor-mediated signaling pathway,BP,CCDC3
8963,GO:0035064,0.73566574375813,0.430100142792368,5,56,methylated histone binding,MF,PHF2;ATRX;ING4;ZMYND8;PHF1
17263,GO:0140034,0.73566574375813,0.430100142792368,5,56,methylation-dependent protein binding,MF,PHF2;ATRX;ING4;ZMYND8;PHF1
2093,GO:0004860,0.735873061104747,0.414497904498509,6,70,protein kinase inhibitor activity,MF,CAMK2N1;FLRT3;RTN4RL1;SPRY2;WNK1;KAT2B
15274,GO:0071481,0.736025146571896,0.637927036378605,1,11,cellular response to X-ray,BP,SFRP1
1102,GO:0002691,0.736137674621046,0.635866153610755,1,12,regulation of cellular extravasation,BP,RIPK3
2461,GO:0005675,0.736274850118086,0.634077373351896,1,13,holo TFIIH complex,CC,ERCC5
15217,GO:0071396,0.736364155095557,0.323186173946268,37,382,cellular response to lipid,BP,TNFAIP3;SREBF1;EGFR;SFRP1;KDM3A;WNT3;CRY2;CRY1;NFATC4;CYP26B1;CMPK2;FAM210B;PDCD4;ZFP36L2;ADAMTS13;ITGA2;THRAP3;BMP6;PTK6;FZD7;CREBRF;PAQR6;THRA;GNG2;BRINP1;RET;DAB2IP;CALCOCO1;TEAD2;VDR;PTK7;ZFP36L1;PAQR7;RORA;PPARG;UFL1;KLF9
9272,GO:0035721,0.736384770535709,0.63554695763378,1,12,intraciliary retrograde transport,BP,IFT140
17139,GO:0102567,0.73645845041157,0.635451732801916,1,12,phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine),MF,PLA2G6
17140,GO:0102568,0.73645845041157,0.635451732801916,1,12,phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine),MF,PLA2G6
11805,GO:0046716,0.736562084728671,0.635317758730898,1,12,muscle cell cellular homeostasis,BP,GAA
8577,GO:0034086,0.736602206843021,0.635265879337731,1,12,maintenance of sister chromatid cohesion,BP,ATRX
8579,GO:0034088,0.736602206843021,0.635265879337731,1,12,maintenance of mitotic sister chromatid cohesion,BP,ATRX
16633,GO:0097529,0.7366829960357,0.401553472470942,7,86,myeloid leukocyte migration,BP,VAV3;TRPV4;C5;MMP28;DDT;VEGFB;PLA2G7
3861,GO:0008483,0.736713194854301,0.635122335067927,1,12,transaminase activity,MF,AMT
4675,GO:0010826,0.736767481501412,0.635052106989101,1,12,negative regulation of centrosome duplication,BP,KAT2B
1479,GO:0003777,0.736806531604806,0.393499432242891,8,82,microtubule motor activity,MF,KIF26B;WDR63;MYH11;KIF26A;DNAH1;MYO3B;MYO9A;KIF7
19037,GO:1904923,0.736865351155147,0.634925468634316,1,12,regulation of autophagy of mitochondrion in response to mitochondrial depolarization,BP,SMURF1
2943,GO:0006471,0.737076593278992,0.527304341132403,2,24,protein ADP-ribosylation,BP,PARP6;KAT2B
12509,GO:0050670,0.737096269937114,0.378124317644263,10,115,regulation of lymphocyte proliferation,BP,GPNMB;INPP5D;VAV3;IL20RB;TNFRSF21;DLG5;CCDC88B;IRS2;ERBB2;RIPK3
9886,GO:0042181,0.737515633552964,0.525566819182671,2,26,ketone biosynthetic process,BP,DGKQ;BMP6
1478,GO:0003774,0.73763309685089,0.384640398761246,9,94,motor activity,MF,KIF26B;WDR63;MYH11;KIF26A;DNAH1;MYO3B;MYO9A;MYH16;KIF7
17665,GO:1901565,0.738417620734456,0.299118543008037,95,979,organonitrogen compound catabolic process,BP,TNFAIP3;SERPINE2;APOE;NT5E;FBXW4;EGFR;APOBEC3C;CTSO;GLUD1;TMEM129;ADAMTS7;RBCK1;CUL9;UBXN4;CSPG4;ISG15;MVB12B;SPATA18;CUL7;NOS1;SDC3;MAGEF1;HMGCL;BTBD2;RNF187;THNSL2;VPS11;NAGLU;MDM2;IDUA;PRODH;HGSNAT;CYP3A5;RAPGEF3;SPSB3;CTSV;BLVRB;RNF165;ADAMTS13;LAMP3;RHBDF1;FBXO44;HEXA;WWTR1;LRSAM1;GPC2;TST;ALDH4A1;CBLC;RNPEPL1;CTSF;GID4;TCIRG1;ALDH7A1;SQSTM1;SHARPIN;HEXB;HYAL1;ARRDC1;CST3;HFE;FBXO2;CTSB;FBXW7;CDK5RAP3;APC2;GLUL;C17ORF97;FBXW5;LRP1;ATE1;RNPEP;PDE2A;DAB2IP;FBXO4;RNF213;ABTB1;KLHL3;SNX1;PANO1;AMT;MAN1B1;SGSH;TNFSF12;SMPDL3B;GLB1;PTPN3;CTSD;NUDT10;PRKACA;UFL1;LONP2;SNX33;SMURF1;GCLC
6644,GO:0023058,0.738554244025989,0.631114923037159,1,13,adaptation of signaling pathway,BP,DNM1
8981,GO:0035102,0.73859376050979,0.632682834185415,1,12,PRC1 complex,CC,PHC2
10678,GO:0043970,0.738717891431733,0.632521322623774,1,12,histone H3-K9 acetylation,BP,KAT2B
9959,GO:0042359,0.73871821196842,0.630901037427622,1,13,vitamin D metabolic process,BP,VDR
17538,GO:1901137,0.738719711370884,0.310894418458151,53,552,carbohydrate derivative biosynthetic process,BP,MUC19;PTHLH;APOE;NT5E;LMF1;ADAMTS7;DHTKD1;ST6GALNAC2;CSPG4;MVD;SRD5A3;NOS1;SDC3;CMPK2;ST6GALNAC6;GAL3ST4;B4GALT6;ADORA2B;ADAMTS13;HEXA;TRAK1;GPC2;INSR;ST3GAL5;PGAP1;B4GALT2;TCIRG1;VEGFB;HYAL1;B3GNT9;ATP6V0A2;PIGZ;RRM2B;GABBR1;MLXIPL;GPR87;PGM1;PFKFB2;OGDHL;TK2;NDST2;PPCS;LTB4R2;DPY19L2P2;MPPE1;NECAB3;MPI;XYLT1;MAN1B1;UAP1L1;PQLC3;GCNT4;UCKL1
2832,GO:0006301,0.738840267878602,0.445546968246798,4,49,postreplication repair,BP,ISG15;POLH;POLD4;PRIMPOL
5832,GO:0017119,0.738903586224883,0.632279595010472,1,12,Golgi transport complex,CC,COG1
10107,GO:0042641,0.738991382945769,0.426168413516476,5,55,actomyosin,CC,MICALL2;CYBA;SYNPO2;SHROOM4;KAT2B
2841,GO:0006310,0.739221453428966,0.341456638176479,20,215,DNA recombination,BP,MAGEF1;AP5Z1;MLH3;SLX1A;SLX1B;RMI2;ENDOG;NSMCE4A;WRN;MCM9;TREX1;ATRX;REC8;PALB2;TCF7;TEP1;RAD50;STAT6;POLM;MSH5
10637,GO:0043687,0.739611061677403,0.32709232046192,29,317,post-translational protein modification,BP,DDB2;APOE;FBXO41;FBXW4;FAM20C;OBSL1;DCAF16;CUL9;CUL7;CRTAP;SPSB3;ARSI;RTN4RL1;FBXO44;ARSD;LTBP1;IGFBP4;CD109;FBXL16;CST3;FBXO2;FBXW7;DCAF10;FBXW5;FBXO4;KLHL3;MXRA8;DCAF8;LAMB2
16554,GO:0097367,0.739768799582461,0.289672400516775,163,1583,carbohydrate derivative binding,MF,POSTN;SERPINE2;ULK2;GPNMB;SIK1;SLFN5;ACTA2;APOE;OAS2;DDX60;HSPA2;EGFR;PTPRS;FAM20C;SYN1;SFRP1;IFI44L;KIF26B;EPHB2;MAP3K14;GLUD1;DGKQ;BRSK1;CUL9;CAMKK1;SMOC2;MVD;RAB43;RAB40B;NOS1;PRKACB;CMPK2;PIK3C2G;LIG1;CDK18;SPEG;MLH3;NMRK1;DDX59;LTBP4;OBSCN;MYH11;ACTR1B;TNXB;RHOBTB2;RAPGEF3;OAS1;GAL3ST4;KIF26A;ALPK1;DNAH1;NEK9;RTN4RL1;TRPV4;DHX32;CLCN6;PSKH1;MINK1;THBS3;ITGA2;ULK1;THRAP3;SMARCA1;NAIP;NEK8;MAP2K5;GPC2;INSR;CHD3;CDK14;TTN;SLFNL1;SEPT6;DHX58;MDK;NLRX1;ETNK2;MAP2K2;OPLAH;PDK1;VEGFB;PTK6;PDIK1L;MAP3K12;WRN;SEPT5;DNM1;MCM9;OARD1;ATRX;MAPK10;NID1;ERCC6;HLCS;CTSB;PAK6;PFKFB2;MX2;ACACB;NLRP1;TK2;GLUL;SRR;LRP1;MAP3K6;RIMKLB;MYO3B;WNK1;ARL11;PDE2A;STK16;RET;PIK3C3;DALRD3;FGFR4;MYO9A;RPS6KA5;NADK;BBS10;HLTF;PCSK6;MPPE1;STK19;RASL10B;LMTK3;ACVR1B;TSSK1B;WEE1;PTK7;DQX1;ACSL1;MARK4;TEP1;ERN1;RAD50;TKFC;PNPO;PEX1;SCYL3;SCG5;KIF7;GLB1;CHD6;ACSS2;COL13A1;ERBB2;ABCA2;PRKACA;SUCLG2;UCKL1;DDX12P;IP6K2;RIPK3;PI4K2B;LONP2;HARS2;CIT;MSH5;CLCN7;ECM2;TTLL1;ABCA11P;GCLC
8813,GO:0034599,0.739920314706825,0.342629282210057,19,212,cellular response to oxidative stress,BP,TNFAIP3;TP53INP1;EGFR;PKD2;GPX3;IMPACT;MDM2;PRODH;ENDOG;PDK1;ETV5;CST3;NET1;CYBA;FBXW7;MTR;STAT6;PRDX5;CHD6
15442,GO:0071801,0.740407729256688,0.630316580879959,1,12,regulation of podosome assembly,BP,GSN
2940,GO:0006468,0.740459269330999,0.291661881089594,133,1316,protein phosphorylation,BP,TNFAIP3;ULK2;GPNMB;SIK1;APOE;HSPA2;EGFR;FAM20C;PKD2;CAPRIN2;SFRP1;EPHB2;MAP3K14;DGKQ;PIK3R1;BRSK1;CAMKK1;HERC5;CSPG4;KITLG;IMPACT;CAMK2N1;PRKACB;CRY1;SPDYE6;CNTRL;CDK18;SPEG;OBSCN;RAPGEF3;FLRT3;RASA4;RGS2;F2R;PDCD4;SPTB;ALPK1;NEK9;RTN4RL1;ZFP36L2;TRPV4;FLOT1;ADORA2B;MAPK8IP3;SPDYE5;GJC2;RASGEF1A;UNC119;FRS3;C5;PSKH1;MINK1;WWTR1;ULK1;NEK8;MAP2K5;IGFBP4;INSR;CDK14;TTN;CBLC;DDT;CD109;ETAA1;PILRB;SLC27A1;RICTOR;BMP6;MAP2K2;PDK1;SQSTM1;PTK6;FZD7;SYNGAP1;PLA2G6;PDIK1L;GDF15;CTF1;MAP3K12;CDK5R1;MAPK10;SHANK3;HFE;ERCC6;SHC2;EDA2R;SPRY2;MLXIPL;FBXW7;CDK5RAP3;PAK6;ADARB1;NAB2;MAP3K6;MYO3B;WNK1;STK16;RET;DAB2IP;PIK3C3;FGFR4;PIK3R2;AREG;RPS6KA5;STK19;DMTN;STAT2;LMTK3;ACVR1B;DLG4;TSSK1B;ADCK5;WEE1;PTK7;TNFRSF25;ZFP36L1;ACSL1;IL11;KAT2B;MARK4;IRS2;ERN1;RAD50;SCYL3;PBLD;RANBP9;ERBB2;ATG14;PRKACA;ACKR3;RIPK3;CIT;NPNT
4579,GO:0010667,0.740531677815393,0.630154421132601,1,12,negative regulation of cardiac muscle cell apoptotic process,BP,RGL2
12717,GO:0051000,0.740674800079274,0.629967101178081,1,12,positive regulation of nitric-oxide synthase activity,BP,APOE
12631,GO:0050855,0.740810262742644,0.629789731537831,1,12,regulation of B cell receptor signaling pathway,BP,ELF1
9256,GO:0035690,0.741044954591152,0.33555529547556,22,237,cellular response to drug,BP,TNFAIP3;TP53INP1;EGFR;SFRP1;IMPACT;MDM2;GSTM2;BAIAP2;ENDOG;CST3;CDK5R1;ATRX;NET1;ADIRF;CYBA;XRN1;PDE2A;MTR;STAT6;TH;KLF9;GCLC
13243,GO:0051952,0.741378550188762,0.521078519638265,2,25,regulation of amine transport,BP,PER2;SYT7
8357,GO:0033262,0.741390151703886,0.629029625411814,1,12,regulation of nuclear cell cycle DNA replication,BP,ATRX
14088,GO:0060965,0.741865289781902,0.628405829966125,1,12,negative regulation of gene silencing by miRNA,BP,PPARG
9868,GO:0042147,0.742026440143685,0.40721572554739,6,68,retrograde transport, endosome to Golgi,BP,VAMP3;CLTCL1;WASH3P;TBC1D17;SGSM2;SNX1
8821,GO:0034616,0.742059934173517,0.628150027703829,1,12,response to laminar fluid shear stress,BP,MAP2K5
14713,GO:0070402,0.742350715942957,0.626135523033894,1,13,NADPH binding,MF,CBR4
4766,GO:0010954,0.742637361722275,0.627390283032537,1,12,positive regulation of protein processing,BP,GSN
15190,GO:0071359,0.742640719037498,0.42111868668666,5,58,cellular response to dsRNA,BP,EGFR;FLOT1;ZCCHC11;MAP2K2;AGO4
11051,GO:0045063,0.742844234032248,0.627117769329159,1,12,T-helper 1 cell differentiation,BP,STAT6
4723,GO:0010888,0.742905943492741,0.627036446133232,1,12,negative regulation of lipid storage,BP,PPARG
15306,GO:0071545,0.743028739137467,0.626874575870908,1,12,inositol phosphate catabolic process,BP,IMPA2
12239,GO:0048536,0.743041809818602,0.519503544063663,2,24,spleen development,BP,JARID2;RIPK3
11658,GO:0046456,0.743181681321217,0.51762913070243,2,27,icosanoid biosynthetic process,BP,PTGS1;MGST2
4256,GO:0009593,0.743433664930835,0.517296963277113,2,27,detection of chemical stimulus,BP,OR2A4;TAS1R3
1386,GO:0003298,0.743443427711018,0.626327484356209,1,12,physiological muscle hypertrophy,BP,AKAP6
1389,GO:0003301,0.743443427711018,0.626327484356209,1,12,physiological cardiac muscle hypertrophy,BP,AKAP6
14144,GO:0061049,0.743443427711018,0.626327484356209,1,12,cell growth involved in cardiac muscle cell development,BP,AKAP6
18376,GO:1903426,0.743473273985053,0.439914617352766,4,48,regulation of reactive oxygen species biosynthetic process,BP,PKD2;INSR;CYBA;ACP5
9041,GO:0035270,0.743712803044563,0.40514162076073,6,68,endocrine system development,BP,HOXA3;GLI2;INSR;MDK;BMP6;THRA
5666,GO:0016779,0.743796962293123,0.364614098311952,11,128,nucleotidyltransferase activity,MF,OAS2;POLH;POLR2J2;OAS1;ZCCHC11;POLD4;POLR2J3;PRIMPOL;TEP1;UAP1L1;POLM
18516,GO:1903727,0.7438005311845,0.518504224028826,2,24,positive regulation of phospholipid metabolic process,BP,VAV3;ATG14
6752,GO:0030183,0.7438081339763,0.393659818017109,7,78,B cell differentiation,BP,INPP5D;SFRP1;PIK3R1;ZFP36L2;ZFP36L1;IL11;POLM
11090,GO:0045120,0.744178546422907,0.62535596232404,1,12,pronucleus,CC,SLC2A1
13848,GO:0060487,0.744179606803497,0.625354559373468,1,12,lung epithelial cell differentiation,BP,THRA
11897,GO:0046949,0.74443386264668,0.517057165570841,2,25,fatty-acyl-CoA biosynthetic process,BP,ACSL1;CBR4
15474,GO:0071867,0.744819306424005,0.517159830235564,2,24,response to monoamine,BP,GNG2;PRKACA
15476,GO:0071869,0.744819306424005,0.517159830235564,2,24,response to catecholamine,BP,GNG2;PRKACA
14522,GO:0070059,0.74491011539592,0.43788298979004,4,49,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,BP,TMEM117;DAB2IP;ERN1;SERINC3
3599,GO:0008028,0.744921212286957,0.516413295888715,2,25,monocarboxylic acid transmembrane transporter activity,MF,SLC16A5;SLC27A1
6922,GO:0030522,0.745107127900696,0.332876573858321,21,221,intracellular receptor signaling pathway,BP,TNFAIP3;SREBF1;DDX60;SFRP1;KDM3A;CRY2;CRY1;CYP26B1;THRAP3;DHX58;NLRX1;THRA;CALCOCO1;VDR;ALOXE3;GLMP;ALOX15B;TKFC;RORA;PPARG;UFL1
3117,GO:0006695,0.745210236730158,0.417754037966738,5,59,cholesterol biosynthetic process,BP,SREBF1;APOE;SEC14L2;MVD;ACACB
2205,GO:0005092,0.745324293982692,0.622195425045275,1,13,GDP-dissociation inhibitor activity,MF,GPSM1
8153,GO:0032892,0.74534326422949,0.622170174930533,1,13,positive regulation of organic acid transport,BP,PLA2G6
8786,GO:0034497,0.745526604426234,0.62356874561411,1,12,protein localization to phagophore assembly site,BP,PIK3C3
814,GO:0002088,0.745644084157675,0.437855832251835,4,45,lens development in camera-type eye,BP,SLITRK6;MAF;SHROOM2;SIX5
17253,GO:0120111,0.745732769161027,0.417100937411634,5,59,neuron projection cytoplasm,CC,BLOC1S4;TRAK1;BAIAP2;BLOC1S3;DLG4
7258,GO:0031234,0.745758432919343,0.402749769629242,6,67,extrinsic component of cytoplasmic side of plasma membrane,CC,KCNAB2;PTK6;GNG2;DLG4;ESYT2;S100A6
8955,GO:0035035,0.745899111006638,0.515731694081303,2,24,histone acetyltransferase binding,MF,STAT1;GLI3
11609,GO:0046328,0.746006846609578,0.357703954973756,12,129,regulation of JNK cascade,BP,EGFR;SFRP1;PDCD4;TRPV4;MAPK8IP3;MINK1;FZD7;ERCC6;EDA2R;MAP3K6;DAB2IP;ERN1
7090,GO:0030894,0.746025422533488,0.514389134599468,2,26,replisome,CC,POLD4;ERCC5
11145,GO:0045216,0.746140631331933,0.340774808585455,17,173,cell-cell junction organization,BP,SFRP1;SDK2;GJD3;F2R;TRPV4;NLGN2;ITGA2;MICALL2;EPB41L3;NPHP4;DLG5;DMTN;CD9;MPP7;PRKACA;PARD6G;NFASC
19727,GO:2000134,0.746246611717675,0.381161418189558,8,93,negative regulation of G1/S transition of mitotic cell cycle,BP,GPNMB;PKD2;MDM2;PCBP4;PIDD1;GJC2;ZNF655;TFDP2
7418,GO:0031527,0.746418619922129,0.62433955930733,1,11,filopodium membrane,CC,SYNE2
18148,GO:1902932,0.746421402035351,0.622378398644748,1,12,positive regulation of alcohol biosynthetic process,BP,SREBF1
1015,GO:0002507,0.746439670776852,0.622354062015753,1,12,tolerance induction,BP,TNFAIP3
11073,GO:0045087,0.746468480467348,0.303275481330208,51,551,innate immune response,BP,TNFAIP3;MUC19;IFI6;OAS2;DDX60;PTPRS;APOBEC3C;TRIM22;RNF135;HERC5;ISG15;VAMP3;STAT1;RAB43;PRKACB;IFITM1;HLA-B;OAS1;FLOT1;ADAMTS13;C5;NAIP;GSN;DHX58;IRF9;NLRX1;PTK6;IFI27;CYBA;TRIM38;CTSB;ADARB1;MX2;NLRP1;C1RL;HLA-A;DAB2IP;PIK3C3;IFI16;RPS6KA5;BST2;FAM3A;STAT2;RSAD2;TKFC;SMPDL3B;PPARG;PRKACA;SERPING1;IP6K2;SERINC3
3702,GO:0008211,0.746513525797182,0.620609704943775,1,13,glucocorticoid metabolic process,BP,DGKQ
2877,GO:0006376,0.746708213568523,0.51404661934789,2,25,mRNA splice site selection,BP,SRSF5;PTBP2
8189,GO:0032944,0.746719432188074,0.366645327861898,10,116,regulation of mononuclear cell proliferation,BP,GPNMB;INPP5D;VAV3;IL20RB;TNFRSF21;DLG5;CCDC88B;IRS2;ERBB2;RIPK3
1388,GO:0003300,0.746837883585977,0.417873117127923,5,48,cardiac muscle hypertrophy,BP,RGS2;JARID2;TTN;LMNA;AKAP6
4935,GO:0014897,0.746837883585977,0.417873117127923,5,48,striated muscle hypertrophy,BP,RGS2;JARID2;TTN;LMNA;AKAP6
1325,GO:0003179,0.746913508497456,0.515056477330005,2,23,heart valve morphogenesis,BP,ZFPM1;MDM2
5933,GO:0018216,0.746975216462737,0.619992546009396,1,13,peptidyl-arginine methylation,BP,PRMT3
8494,GO:0033683,0.747012968554338,0.463989798585655,3,39,nucleotide-excision repair, DNA incision,BP,DDB2;POLD4;ERCC5
12370,GO:0048806,0.747016808228033,0.514919439166369,2,23,genitalia development,BP,BMP6;TCF7
257,GO:0000724,0.747195790579359,0.372681319448321,9,101,double-strand break repair via homologous recombination,BP,MAGEF1;AP5Z1;SLX1A;SLX1B;WRN;MCM9;REC8;PALB2;RAD50
2511,GO:0005765,0.747222470357926,0.319848360607714,28,298,lysosomal membrane,CC,CYBRD1;GAA;VPS11;HGSNAT;FLOT1;LAMP3;SPG11;CLCN6;DIRC2;SPPL2B;VPS39;TMEM9;TCIRG1;ATP6V0A2;COL6A1;LRP1;C12ORF66;SLC48A1;SYT7;BST2;MARCH8;CD68;GLMP;LAPTM4A;SYNGR1;ABCA2;PI4K2B;CLCN7
16880,GO:0098852,0.747222470357926,0.319848360607714,28,298,lytic vacuole membrane,CC,CYBRD1;GAA;VPS11;HGSNAT;FLOT1;LAMP3;SPG11;CLCN6;DIRC2;SPPL2B;VPS39;TMEM9;TCIRG1;ATP6V0A2;COL6A1;LRP1;C12ORF66;SLC48A1;SYT7;BST2;MARCH8;CD68;GLMP;LAPTM4A;SYNGR1;ABCA2;PI4K2B;CLCN7
2195,GO:0005070,0.747675987058894,0.46441618897901,3,35,SH3/SH2 adaptor activity,MF,VAV3;CHN2;SH2D2A
13465,GO:0055024,0.747708530824883,0.434988153864854,4,46,regulation of cardiac muscle tissue development,BP,JARID2;FZD7;JPH2;AKAP6
10327,GO:0043138,0.747760677678237,0.620590694920856,1,12,3'-5' DNA helicase activity,MF,WRN
6068,GO:0019220,0.747807521415977,0.28536157099617,120,1192,regulation of phosphate metabolic process,BP,TNFAIP3;GPNMB;PTHLH;APOE;HSPA2;EGFR;PKD2;CAPRIN2;SFRP1;EPHB2;MAP3K14;DGKQ;PIK3R1;CAMKK1;HERC5;VAV3;CSPG4;ELFN2;KITLG;IMPACT;CAMK2N1;CRY2;NOS1;PRKACB;SPDYE6;PPP2R2C;PIK3IP1;RAPGEF3;PHACTR3;FLRT3;RGS2;F2R;PDCD4;RTN4RL1;TRPV4;FLOT1;ADORA2B;MAPK8IP3;SPDYE5;GJC2;UNC119;C5;MINK1;WWTR1;ITGA2;MAP2K5;ITGA6;IGFBP4;INSR;TTN;CBLC;DDT;CD109;ETAA1;PILRB;SLC27A1;RICTOR;BMP6;MAP2K2;SQSTM1;CEP192;PTK6;FZD7;SYNGAP1;PLA2G6;GDF15;CTF1;NPHP3;MAP3K12;CDK5R1;MAPK10;HFE;ERCC6;SHC2;EDA2R;SPRY2;GABBR1;MLXIPL;FBXW7;GPR87;CDK5RAP3;PAK6;PFKFB2;ADARB1;NAB2;MAP3K6;WNK1;LTB4R2;RET;DAB2IP;FGFR4;PIK3R2;AREG;RPS6KA5;PPP1R2;DMTN;PPP1R35;STAT2;LMTK3;ACVR1B;DLG4;PPP2R3B;TNFRSF25;ACSL1;IL11;KAT2B;IRS2;ERN1;RAD50;PBLD;SRPX2;RANBP9;ERBB2;SPOCD1;AKAP6;ATG14;PRKACA;ACKR3;RIPK3;NPNT
18687,GO:1904115,0.748019829244928,0.463288669165924,3,37,axon cytoplasm,CC,BLOC1S4;TRAK1;BLOC1S3
5918,GO:0018196,0.748070710918984,0.462615702648521,3,39,peptidyl-asparagine modification,BP,ST6GALNAC2;ST6GALNAC6;ST3GAL5
16142,GO:0090183,0.748462614645095,0.463043162698214,3,36,regulation of kidney development,BP,STAT1;WWTR1;RET
8106,GO:0032802,0.748605059105415,0.617806950259226,1,13,low-density lipoprotein particle receptor catabolic process,BP,APOE
6593,GO:0022616,0.748726089568137,0.511363254397131,2,25,DNA strand elongation,BP,LIG1;RAD50
4167,GO:0009235,0.749084159694581,0.617162423085919,1,13,cobalamin metabolic process,BP,MTR
1217,GO:0002888,0.7494645783133,0.616649982303838,1,13,positive regulation of myeloid leukocyte mediated immunity,BP,ADORA2B
17831,GO:1902042,0.749621996255921,0.509603700647993,2,26,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,BP,TNFAIP3;TNFSF10
8904,GO:0034755,0.74967222748976,0.618026424048028,1,12,iron ion transmembrane transport,BP,HFE
11800,GO:0046710,0.749682652112278,0.618012398744664,1,12,GDP metabolic process,BP,DLG4
3484,GO:0007350,0.749803291224402,0.617850058177798,1,12,blastoderm segmentation,BP,PCSK6
4899,GO:0014829,0.749894534268779,0.617727235286754,1,12,vascular smooth muscle contraction,BP,BBS2
138,GO:0000289,0.74990232638304,0.461518405085538,3,35,nuclear-transcribed mRNA poly(A) tail shortening,BP,ZCCHC11;TNRC6C;PARN
12934,GO:0051321,0.750003604839517,0.344994680206369,14,153,meiotic cell cycle,BP,HSPA2;PRKACB;CYP26B1;MLH3;TUBGCP5;ZNF318;INSR;SUN1;CENPC;ATRX;REC8;AGO4;RAD50;MSH5
14267,GO:0061383,0.750030374082716,0.461724032472647,3,34,trabecula morphogenesis,BP,SFRP1;PLXNB1;THBS3
13780,GO:0060391,0.750254805832989,0.617241936428995,1,12,positive regulation of SMAD protein signal transduction,BP,BMP6
18211,GO:1903037,0.750271392426089,0.341261073987282,15,167,regulation of leukocyte cell-cell adhesion,BP,GPNMB;MAP3K14;PIK3R1;IL20RB;GLI2;TNFRSF14;GLI3;DOCK8;TNFRSF21;EFNB3;HFE;DLG5;NRARP;CCDC88B;ERBB2
1989,GO:0004712,0.750350159757919,0.460583483800788,3,36,protein serine/threonine/tyrosine kinase activity,MF,MAP2K2;MAPK10;PRKACA
2582,GO:0005875,0.750491537013654,0.357123011947304,11,119,microtubule associated complex,CC,KIF26B;WDR63;ACTR1B;NUDCD3;KIF26A;DNAH1;CLIP2;KIF7;RANBP9;MAP1A;EML2
18784,GO:1904356,0.750709057389184,0.411017123971213,5,58,regulation of telomere maintenance via telomere lengthening,BP,SLX1A;SLX1B;XRN1;FBXO4;PARN
7797,GO:0032354,0.750984286903356,0.616257659895633,1,12,response to follicle-stimulating hormone,BP,GCLC
15449,GO:0071813,0.751002350663867,0.616233258878694,1,12,lipoprotein particle binding,MF,APOE
15450,GO:0071814,0.751002350663867,0.616233258878694,1,12,protein-lipid complex binding,MF,APOE
11431,GO:0045898,0.751509481079761,0.613885216889138,1,13,regulation of RNA polymerase II transcriptional preinitiation complex assembly,BP,THRA
12607,GO:0050812,0.751580255790613,0.615451896391512,1,12,regulation of acyl-CoA biosynthetic process,BP,PDK1
3254,GO:0006915,0.751673633457122,0.279390549757655,136,1390,apoptotic process,BP,TNFAIP3;SIK1;TP53INP1;IFI6;APOE;INPP5D;EGFR;MNT;ALDH1A3;SFRP1;EPHB2;MAP3K14;PIK3R1;RBCK1;TSC22D3;VAV3;KITLG;STAT1;HS1BP3;LGALS7B;NSG1;UNC5B;PLEKHG5;NFATC4;H1F0;NDRG1;MDM2;OBSCN;TNFSF10;PRODH;F2R;PDCD4;GLI2;LAMP3;PIDD1;ARHGEF19;MINK1;AMIGO2;TNFRSF14;ARHGEF4;GLI3;NAIP;MAP2K5;ITGA6;NUPR1;NISCH;INSR;GSN;PNMA1;ARHGEF1;DOCK8;TP53AIP1;ENDOG;MDK;CASP14;BMP6;MAP2K2;PDK1;SQSTM1;SYNGAP1;TMEM117;EPB41L3;SHARPIN;PLA2G6;CST3;GDF15;TXNIP;PLAG1;MAP3K12;WRN;IFI27;TNFRSF21;CDK5R1;NET1;AGO4;ERCC6;RRM2B;SLIT3;EDA2R;SPRY2;MEF2D;CTSB;FBXW7;KCNMA1;ING4;CDK5RAP3;PAK6;THRA;ADARB1;NLRP1;BEX2;LRP1;PEG3;RET;DAB2IP;IFI16;FGFR4;ERCC5;IL20RA;SCN2A;SNCB;DLG5;BTG1;VDR;RGL2;ARHGEF17;TNS4;TFDP2;ACVR1B;KREMEN1;PANO1;PALB2;TNFRSF25;ZFP36L1;LMNA;IRS2;ERN1;IVNS1ABP;ALOX15B;ZMAT3;APBB2;ARHGEF9;TNFSF12;PRDX5;TRAF5;TRIM2;ERBB2;PPARG;C6ORF120;ACKR3;UFL1;IP6K2;RIPK3;CIT;SERINC3;GCLC
18589,GO:1903894,0.751807104743139,0.613481383253093,1,13,regulation of IRE1-mediated unfolded protein response,BP,DAB2IP
5487,GO:0016423,0.752360492639127,0.612729537844952,1,13,tRNA (guanine) methyltransferase activity,MF,TARBP1
14641,GO:0070262,0.752404795475945,0.612669292076456,1,13,peptidyl-serine dephosphorylation,BP,PPP2R2C
7328,GO:0031346,0.752541009128035,0.317933878652379,25,257,positive regulation of cell projection organization,BP,APOE;ESPN;CAPRIN2;OBSL1;EPS8L2;WNT3;CUL7;PLXNB1;CRTC1;ITGA2;TRAK1;BAIAP2;PLXNB3;PTK6;SHANK3;ARAP1;RET;ZMYND8;DAB2IP;DLG5;PLXND1;DLG4;PTK7;SHANK2;SMURF1
17672,GO:1901575,0.752594587780026,0.276493033131077,157,1627,organic substance catabolic process,BP,TNFAIP3;SERPINE2;AMACR;PYGB;APOE;CES2;NT5E;OAS2;FBXW4;EGFR;CIRBP;APOBEC3C;CPT2;PLCD3;CTSO;GLUD1;TMEM129;ADAMTS7;RBCK1;CUL9;DHTKD1;UBXN4;CSPG4;ISG15;MVB12B;SPATA18;CUL7;SRD5A3;NOS1;SDC3;MAGEF1;HMGCL;BTBD2;RNF187;H1F0;CYP26B1;GAA;THNSL2;VPS11;NAGLU;MDM2;PLCD1;TYSND1;IDUA;PRODH;HGSNAT;CYP3A5;RAPGEF3;SPSB3;PCBP4;CTSV;BLVRB;CRAT;MLYCD;PHYH;ZFP36L2;RNF165;ADAMTS13;LAMP3;PLCH2;ZCCHC11;RHBDF1;SULT1E1;FBXO44;HEXA;WWTR1;THRAP3;LRSAM1;CES3;GPC2;INSR;TST;ALDH4A1;CBLC;RNPEPL1;CTSF;MGST2;ENDOG;GID4;TCIRG1;ALDH7A1;SQSTM1;SHARPIN;HEXB;HYAL1;ARRDC1;PLA2G6;CST3;PEX7;PLD3;LPIN3;HFE;AGO4;HADH;FBXO2;XRN1;MLXIPL;CTSB;FBXW7;CDK5RAP3;PGM1;PFKFB2;THRA;APC2;ACADS;ACACB;OGDHL;GLUL;C17ORF97;FBXW5;LRP1;ATE1;PLA2G7;RNPEP;BDH1;PDE2A;DAB2IP;ACOX3;DDHD2;FBXO4;RNF213;ABTB1;KLHL3;ETFB;TNRC6C;SNX1;PANO1;GALE;AMT;ZFP36L1;IRS2;IMPA2;ERN1;HSD17B14;TKFC;ANGEL2;MAN1B1;ECI1;TRERF1;FAAH;SGSH;TNFSF12;SMPDL3B;GLB1;CPT1C;PTPN3;CTSD;PLCB3;NUDT10;PRKACA;PARN;UFL1;LONP2;SNX33;EHHADH;SMURF1;GCLC
17819,GO:1902017,0.752990412487052,0.456798376027189,3,37,regulation of cilium assembly,BP,EVI5L;IFT140;SYNE2
12805,GO:0051130,0.753121122331474,0.284353715175143,90,905,positive regulation of cellular component organization,BP,DDB2;SREBF1;APOE;ESPN;CAPRIN2;SLITRK6;SFRP1;OBSL1;EPS8L2;EPHB2;WNT3;CUL7;NOS1;PLXNB1;VPS11;CRTC1;TNFSF10;RAPGEF3;FLRT3;RGS2;ARPIN;ADGRB2;HPS4;TRPV4;FLOT1;NLGN2;SLX1A;SLX1B;WIPF1;ADGRL1;AMIGO2;ITGA2;ULK1;LRSAM1;MMP1;TRAK1;JARID2;INSR;GSN;BAIAP2;PLXNB3;TRIOBP;ENDOG;RTF1;RICTOR;MICALL2;PTK6;HYAL1;WHAMMP3;PLA2G6;GDF15;OSCP1;CDK5R1;ATRX;NET1;SHANK3;HFE;CYBA;WASH3P;FBXW7;ARAP1;LRP1;LRRN3;NPHP4;SYNPO2;RET;ZMYND8;DAB2IP;DDHD2;FBXO4;ERCC5;RPS6KA5;DLG5;PLXND1;DMTN;PHF1;TFDP2;DLG4;PTK7;SHANK2;CLSTN3;RAD50;TUB;SRPX2;MPP7;PPARG;LDLRAP1;PARN;SMURF1;PEMT
10431,GO:0043302,0.753523391325893,0.611145450760063,1,13,positive regulation of leukocyte degranulation,BP,ADORA2B
3034,GO:0006584,0.753584003894155,0.504289051716187,2,26,catecholamine metabolic process,BP,SNCB;TH
4288,GO:0009712,0.753584003894155,0.504289051716187,2,26,catechol-containing compound metabolic process,BP,SNCB;TH
1655,GO:0004112,0.754033499556541,0.612119508202467,1,12,cyclic-nucleotide phosphodiesterase activity,MF,PDE2A
6032,GO:0019104,0.75432882659239,0.607391290838836,1,15,DNA N-glycosylase activity,MF,MPG
7211,GO:0031113,0.754547006188863,0.455084897950379,3,36,regulation of microtubule polymerization,BP,RGS2;CDK5R1;EML2
1095,GO:0002684,0.754705988920899,0.29131286079025,58,611,positive regulation of immune system process,BP,TNFAIP3;MUC19;INPP5D;DDX60;PTPRS;MAP3K14;PIK3R1;RBCK1;CXCL14;VAV3;KITLG;STAT1;PRKACB;FAM210B;TRPV4;FLOT1;GLI2;ADORA2B;C5;WIPF1;TNFRSF14;ITGA2;GLI3;BAIAP2;DOCK8;DHX58;NLRX1;VEGFB;PLA2G6;TNFRSF21;CA2;EFNB3;CYBA;CTSB;KLK5;ELF1;C1RL;ERMAP;PLA2G7;DAB2IP;PIK3C3;IFI16;PIK3R2;RPS6KA5;CACNB3;ACVR1B;CCDC88B;RSAD2;ZFP36L1;IRS2;TKFC;STAT6;PHPT1;SMPDL3B;GPR68;PRKACA;SERPING1;CTNNBIP1
4054,GO:0009101,0.754827957650836,0.316705587667706,24,253,glycoprotein biosynthetic process,BP,MUC19;LMF1;ADAMTS7;ST6GALNAC2;CSPG4;MVD;SRD5A3;ST6GALNAC6;GAL3ST4;B4GALT6;ADAMTS13;TRAK1;ST3GAL5;B4GALT2;VEGFB;B3GNT9;NDST2;DPY19L2P2;NECAB3;MPI;XYLT1;MAN1B1;PQLC3;GCNT4
2607,GO:0005912,0.754910379728063,0.299014698193552,42,445,adherens junction,CC,ITGB6;EGFR;FLNC;DIXDC1;TNS1;CSPG4;ASAP3;ITGB5;FERMT1;NDRG1;PARVB;FLRT3;TRPV4;FLOT1;TMEM204;FRMD4B;ITGA2;ITGA6;GSN;BAIAP2;TRIOBP;MAP2K2;FAT2;UBOX5;KLHL24;CYBA;MRC2;TNS2;LRP1;SYNPO2;CD99L2;SHROOM2;DLG5;TNS4;SHROOM4;CADM4;PTK7;CD9;MPRIP;MPP7;SYNE2;NFASC
7349,GO:0031399,0.754956362023998,0.277012593712518,126,1259,regulation of protein modification process,BP,TNFAIP3;GPNMB;SREBF1;APOE;HSPA2;EGFR;PKD2;CAPRIN2;SFRP1;MTHFR;EPHB2;MAP3K14;DGKQ;KDM3A;CAMKK1;HERC5;CSPG4;ISG15;ELFN2;KITLG;IMPACT;CAMK2N1;CRY2;NOS1;PRKACB;CRY1;CRTAP;SPDYE6;PPP2R2C;RAPGEF3;PHACTR3;FLRT3;RGS2;F2R;PDCD4;RTN4RL1;TRPV4;FLOT1;ADORA2B;MAPK8IP3;SPDYE5;GJC2;PER2;UNC119;C5;SNTA1;MINK1;WWTR1;MAP2K5;IGFBP4;JARID2;NUPR1;INSR;TTN;CBLC;DDT;CD109;ETAA1;PILRB;SLC27A1;RTF1;RICTOR;BMP6;MAP2K2;SQSTM1;PTK6;FZD7;SYNGAP1;KDM4C;PLA2G6;GDF15;CTF1;MAP3K12;ZYG11B;CDK5R1;ATRX;MAPK10;HFE;HMG20B;ERCC6;SHC2;EDA2R;SPRY2;FBXO2;MLXIPL;FBXW7;CDK5RAP3;PAK6;ADARB1;NAB2;MAP3K6;WNK1;RET;DAB2IP;RWDD3;FBXO4;FGFR4;PIK3R2;AREG;RPS6KA5;PPP1R2;DMTN;PPP1R35;STAT2;PHF1;ACVR1B;DLG4;PPP2R3B;TNFRSF25;ACSL1;IL11;KAT2B;ERN1;RAD50;PBLD;RANBP9;ERBB2;AKAP6;ATG14;PRKACA;ACKR3;UFL1;RIPK3;PRMT3;NPNT;GCLC
1868,GO:0004535,0.755164723311743,0.610574420179481,1,12,poly(A)-specific ribonuclease activity,MF,PARN
9335,GO:0035855,0.755400125300003,0.610252218617749,1,12,megakaryocyte development,BP,ZFPM1
16789,GO:0098657,0.755588380776974,0.29440486135989,49,500,import into cell,BP,APOE;SYT8;CXCR1;PIK3R1;VAV3;NOS1;SCARA3;MICALL1;NLGN4Y;C2CD4C;CLTCL1;FLOT1;NLGN2;SPG11;PER2;UNC119;WIPF1;ITGA2;LRSAM1;KCNJ5;GSN;BAIAP2;RIN1;PLA2G6;DNM1;MCTP1;ARHGAP27;HOOK2;HFE;SCART1;CYBA;MRC2;GLUL;LRP1;PIK3C3;SYT7;PIK3R2;EHBP1;SLC36A4;SNX1;DLG4;ESYT2;ENDOU;TUB;CD9;PPARG;LDLRAP1;ACKR3;SNX33
11891,GO:0046939,0.755705455196619,0.369652324091828,8,93,nucleotide phosphorylation,BP,DHTKD1;CMPK2;INSR;MLXIPL;PGM1;PFKFB2;OGDHL;RAD50
9075,GO:0035338,0.755780448180718,0.608054784684263,1,13,long-chain fatty-acyl-CoA biosynthetic process,BP,ACSL1
2519,GO:0005774,0.755956343508348,0.305683375722352,32,342,vacuolar membrane,CC,CYBRD1;GAA;VPS11;HGSNAT;FLOT1;LAMP3;ATG16L2;SPG11;CLCN6;DIRC2;ULK1;SPPL2B;VPS39;TMEM9;TCIRG1;ATP6V0A2;COL6A1;LRP1;C12ORF66;SLC48A1;SYT7;BST2;MARCH8;SLC36A4;CD68;GLMP;LAPTM4A;SYNGR1;ABCA2;ATG14;PI4K2B;CLCN7
3237,GO:0006892,0.75603617367537,0.36956716398829,8,89,post-Golgi vesicle-mediated transport,BP,VAMP3;ANK3;VAMP2;BBS2;BBS1;EXOC2;OSBPL5;ARFGEF2
19193,GO:1905331,0.756101585928748,0.609290722878485,1,12,negative regulation of morphogenesis of an epithelium,BP,STAT1
1523,GO:0003899,0.756348548592022,0.451227653015826,3,41,DNA-directed 5'-3' RNA polymerase activity,MF,POLR2J2;POLR2J3;PRIMPOL
16534,GO:0097329,0.756384201978068,0.608902751909516,1,12,response to antimetabolite,BP,ATRX
16113,GO:0090136,0.756405896663593,0.608872955807482,1,12,epithelial cell-cell adhesion,BP,ITGB5
8449,GO:0033598,0.756436122223312,0.501002273858832,2,25,mammary gland epithelial cell proliferation,BP,AREG;STAT6
1397,GO:0003333,0.756502274902288,0.423478086980519,4,47,amino acid transmembrane transport,BP,PER2;SLC38A4;SLC36A4;SLC43A1
12932,GO:0051315,0.756547318829411,0.60699980675352,1,13,attachment of mitotic spindle microtubules to kinetochore,BP,CENPC
8306,GO:0033151,0.756596167813447,0.608611546553894,1,12,V(D)J recombination,BP,TCF7
12072,GO:0048048,0.756751167332162,0.50186725005299,2,23,embryonic eye morphogenesis,BP,ALDH1A3;TH
2684,GO:0006047,0.756951020930858,0.606443438403405,1,13,UDP-N-acetylglucosamine metabolic process,BP,UAP1L1
3255,GO:0006919,0.757026113378183,0.387705646896635,6,76,activation of cysteine-type endopeptidase activity involved in apoptotic process,BP,TNFSF10;F2R;PIDD1;IFI27;NLRP1;PPARG
20032,GO:2000678,0.757113379435793,0.604787031309838,1,14,negative regulation of transcription regulatory region DNA binding,BP,PER2
11101,GO:0045137,0.757171840896953,0.340170846533829,13,144,development of primary sexual characteristics,BP,SFRP1;KITLG;TNFSF10;CTSV;LHFPL2;NUPR1;INSR;CST3;ATRX;REC8;AGO4;SLIT3;ACVR1B
3582,GO:0007628,0.75717879435603,0.607810134269256,1,12,adult walking behavior,BP,EFNB3
258,GO:0000725,0.757188842188119,0.36053878665076,9,102,recombinational repair,BP,MAGEF1;AP5Z1;SLX1A;SLX1B;WRN;MCM9;REC8;PALB2;RAD50
8056,GO:0032733,0.757245667675,0.604604113759821,1,14,positive regulation of interleukin-10 production,BP,IL20RB
17257,GO:0140013,0.75734484584797,0.36028338910445,9,103,meiotic nuclear division,BP,HSPA2;CYP26B1;MLH3;SUN1;CENPC;REC8;AGO4;RAD50;MSH5
6701,GO:0030117,0.757523708369987,0.367502990277519,8,92,membrane coat,CC,EGFR;AP5Z1;AP1G2;CLTCL1;VPS39;DNM1;CHMP1B;LDLRAP1
12205,GO:0048475,0.757523708369987,0.367502990277519,8,92,coated membrane,CC,EGFR;AP5Z1;AP1G2;CLTCL1;VPS39;DNM1;CHMP1B;LDLRAP1
1149,GO:0002757,0.757552188622501,0.305878858185125,30,325,immune response-activating signal transduction,BP,TNFAIP3;MUC19;INPP5D;DDX60;PTPRS;PIK3R1;RBCK1;VAV3;PRKACB;FLOT1;WIPF1;BAIAP2;DHX58;NLRX1;PLA2G6;TNFRSF21;CYBA;CTSB;ELF1;ERMAP;DAB2IP;PIK3C3;PIK3R2;RPS6KA5;CACNB3;RSAD2;TKFC;PHPT1;SMPDL3B;PRKACA
11991,GO:0047496,0.757676338653829,0.450958048571822,3,36,vesicle transport along microtubule,BP,BLOC1S4;TRAK1;BLOC1S3
4954,GO:0015020,0.757693105787463,0.605418920853528,1,13,glucuronosyltransferase activity,MF,UGT1A3
8661,GO:0034243,0.75772434799579,0.499254163153949,2,25,regulation of transcription elongation from RNA polymerase II promoter,BP,EAPP;RTF1
11671,GO:0046471,0.757803355672952,0.499146790662993,2,25,phosphatidylglycerol metabolic process,BP,SLC27A1;PLA2G6
18051,GO:1902653,0.757833022872941,0.401690432377221,5,60,secondary alcohol biosynthetic process,BP,SREBF1;APOE;SEC14L2;MVD;ACACB
787,GO:0002052,0.757864199183786,0.606865502026777,1,12,positive regulation of neuroblast proliferation,BP,GLI3
3442,GO:0007252,0.758010115800083,0.604980545899231,1,13,I-kappaB phosphorylation,BP,DAB2IP
10981,GO:0044794,0.758061322025146,0.604909695641714,1,13,positive regulation by host of viral process,BP,APOE
5659,GO:0016769,0.758238088481239,0.604665031216856,1,13,transferase activity, transferring nitrogenous groups,MF,AMT
6232,GO:0019787,0.758379918829735,0.297264120177924,39,403,ubiquitin-like protein transferase activity,MF,TNFAIP3;DDB2;FBXO41;FBXW4;HERC3;TMEM129;RBCK1;RNF135;HERC5;RNF187;MDM2;SPSB3;RNF165;ZNF747;FBXO44;LRSAM1;NAIP;CBLC;FBXL16;GID4;SHARPIN;UBOX5;ZYG11B;KLHL24;FBXO2;FBXW7;ZNF862;FBXW5;KLHDC8B;FBXO4;RNF213;KLHL3;HLTF;MARCH8;RNF141;KLHL29;TRIM2;UFL1;SMURF1
5164,GO:0015711,0.758397996766236,0.31116566818932,25,264,organic anion transport,BP,APOE;CPT2;SLC16A5;PITPNM3;SLC13A5;PER2;PITPNM2;VAMP2;SLC27A1;SLC2A3;PLA2G6;CA2;OSBPL10;SLC2A1;ACACB;SLC38A4;OSBPL5;SLC36A4;SLC22A15;ACSL1;IRS2;SLC43A1;PPARG;PLTP;SERINC3
13802,GO:0060420,0.758584094365716,0.449756593881346,3,36,regulation of heart growth,BP,JARID2;ACACB;AKAP6
8965,GO:0035066,0.758846029671238,0.497159773403809,2,26,positive regulation of histone acetylation,BP,NOS1;RPS6KA5
3398,GO:0007178,0.758999115895072,0.318883421837327,20,211,transmembrane receptor protein serine/threonine kinase signaling pathway,BP,SFRP1;HTRA1;RGMA;ITGB5;FERMT1;LTBP4;NEO1;PDCD4;RNF165;WWTR1;LTBP1;CD109;BMP6;GDF15;HFE;PCSK6;ACVR1B;PBLD;SMURF1;NPNT
3114,GO:0006692,0.759068977071244,0.496331843284,2,27,prostanoid metabolic process,BP,CES2;PTGS1
3115,GO:0006693,0.759068977071244,0.496331843284,2,27,prostaglandin metabolic process,BP,CES2;PTGS1
8076,GO:0032768,0.759089863758343,0.448442598469551,3,38,regulation of monooxygenase activity,BP,APOE;EGFR;VDR
16879,GO:0098847,0.759109088521684,0.603457524397446,1,13,sequence-specific single stranded DNA binding,MF,RAD50
9357,GO:0035886,0.759219861487697,0.603303722517166,1,13,vascular smooth muscle cell differentiation,BP,PDCD4
15857,GO:0072606,0.75922410379952,0.60185962744227,1,14,interleukin-8 secretion,BP,F2R
17707,GO:1901658,0.759383803639547,0.495417532770255,2,28,glycosyl compound catabolic process,BP,NT5E;APOBEC3C
3396,GO:0007175,0.759587395636158,0.602793046292762,1,13,negative regulation of epidermal growth factor-activated receptor activity,BP,CBLC
4719,GO:0010884,0.759632484892028,0.602730356449204,1,13,positive regulation of lipid storage,BP,ACACB
17708,GO:1901659,0.759726104220641,0.446504946201496,3,42,glycosyl compound biosynthetic process,BP,NT5E;TK2;UCKL1
1108,GO:0002697,0.759840899425059,0.321994721514437,18,200,regulation of immune effector process,BP,TNFAIP3;DDX60;HERC5;HTRA1;STAT1;IL20RB;ADORA2B;C5;DHX58;NLRX1;HFE;KLK5;BST2;RSAD2;TKFC;STAT6;SERPING1;RIPK3
3627,GO:0008088,0.760120869007249,0.418571322834718,4,48,axo-dendritic transport,BP,BLOC1S4;SPG11;TRAK1;BLOC1S3
9146,GO:0035510,0.760409040712769,0.495026352805039,2,26,DNA dealkylation,BP,APOBEC3C;MPG
10539,GO:0043507,0.760491585377968,0.398952723437198,5,56,positive regulation of JUN kinase activity,BP,MAPK8IP3;ERCC6;MAP3K6;DAB2IP;ERN1
3241,GO:0006897,0.760746389845253,0.291404035801182,44,453,endocytosis,BP,APOE;SYT8;CXCR1;PIK3R1;VAV3;SCARA3;MICALL1;NLGN4Y;C2CD4C;CLTCL1;FLOT1;NLGN2;SPG11;UNC119;WIPF1;ITGA2;LRSAM1;GSN;BAIAP2;RIN1;PLA2G6;DNM1;MCTP1;ARHGAP27;HOOK2;HFE;SCART1;CYBA;MRC2;LRP1;PIK3C3;SYT7;PIK3R2;EHBP1;SNX1;DLG4;ESYT2;ENDOU;TUB;CD9;PPARG;LDLRAP1;ACKR3;SNX33
7500,GO:0031690,0.760879284002396,0.600993410781914,1,13,adrenergic receptor binding,MF,DLG4
18941,GO:1904738,0.761000570659691,0.602517283279399,1,12,vascular associated smooth muscle cell migration,BP,MDM2
18951,GO:1904752,0.761000570659691,0.602517283279399,1,12,regulation of vascular associated smooth muscle cell migration,BP,MDM2
4202,GO:0009312,0.761140634391276,0.494025263979692,2,26,oligosaccharide biosynthetic process,BP,ST6GALNAC6;SLC2A1
9063,GO:0035315,0.761371904889769,0.494277708613663,2,25,hair cell differentiation,BP,SLITRK6;TRIOBP
15042,GO:0071025,0.761477722967764,0.597467476496718,1,15,RNA surveillance,BP,XRN1
15118,GO:0071236,0.761492327637442,0.355169333058847,9,104,cellular response to antibiotic,BP,TNFAIP3;TP53INP1;IMPACT;MDM2;ENDOG;CST3;NET1;XRN1;STAT6
8792,GO:0034505,0.761545287778991,0.601757778499008,1,12,tooth mineralization,BP,FAM20C
10588,GO:0043576,0.761848482330054,0.601334474332373,1,12,regulation of respiratory gaseous exchange,BP,NLGN2
4074,GO:0009129,0.761930977514757,0.598077539679393,1,14,pyrimidine nucleoside monophosphate metabolic process,BP,UCKL1
4075,GO:0009130,0.761930977514757,0.598077539679393,1,14,pyrimidine nucleoside monophosphate biosynthetic process,BP,UCKL1
2605,GO:0005905,0.761951865074055,0.396915385088763,5,57,clathrin-coated pit,CC,EGFR;CLTCL1;LRP1;LDLRAP1;ACKR3
4458,GO:0010453,0.762055887579082,0.599348110757998,1,13,regulation of cell fate commitment,BP,FZD7
19652,GO:1990939,0.762449952359444,0.445342940461568,3,34,ATP-dependent microtubule motor activity,MF,WDR63;DNAH1;KIF7
1854,GO:0004519,0.76254477746094,0.353640184136833,9,108,endonuclease activity,MF,ENDOD1;SLX1A;SLX1B;ENDOG;LACTB2;ERCC5;ENDOU;ERN1;RAD50
11742,GO:0046606,0.762705444700966,0.598437236145617,1,13,negative regulation of centrosome cycle,BP,KAT2B
6059,GO:0019210,0.762895528609042,0.380754265037533,6,72,kinase inhibitor activity,MF,CAMK2N1;FLRT3;RTN4RL1;SPRY2;WNK1;KAT2B
1469,GO:0003727,0.763211418094489,0.380469665338267,6,71,single-stranded RNA binding,MF,DDX60;DHX58;AGO4;ATXN1;THRA;LACTB2
816,GO:0002090,0.763243525170483,0.491708725050462,2,25,regulation of receptor internalization,BP,FLOT1;DLG4
720,GO:0001947,0.763452564151338,0.443630817584469,3,35,heart looping,BP,PKD2;NPHP3;BBS5
13210,GO:0051895,0.763525414108982,0.598986011261207,1,12,negative regulation of focal adhesion assembly,BP,DMTN
14448,GO:0061842,0.763725607597834,0.49166574887,2,24,microtubule organizing center localization,BP,SUN1;SYNE2
2247,GO:0005160,0.763928466698139,0.490765929159748,2,25,transforming growth factor beta receptor binding,MF,BMP6;GDF15
5324,GO:0016052,0.764023521958793,0.336073286010275,12,134,carbohydrate catabolic process,BP,PYGB;DHTKD1;GAA;INSR;HEXB;MLXIPL;PGM1;PFKFB2;OGDHL;GALE;TKFC;GLB1
12265,GO:0048593,0.764062756345701,0.379886913291868,6,67,camera-type eye morphogenesis,BP,ALDH1A3;EPHB2;SDK2;GLI3;SHROOM2;TH
5009,GO:0015171,0.764556008752932,0.412791084725727,4,48,amino acid transmembrane transporter activity,MF,SLC38A4;SLC36A4;SLC43A1;SERINC3
582,GO:0001736,0.764581630486449,0.351091776959258,9,109,establishment of planar polarity,BP,SFRP1;PRICKLE2;ARHGEF19;CELSR1;FZD7;NPHP3;ASTN2;PTK7;SMURF1
3386,GO:0007164,0.764581630486449,0.351091776959258,9,109,establishment of tissue polarity,BP,SFRP1;PRICKLE2;ARHGEF19;CELSR1;FZD7;NPHP3;ASTN2;PTK7;SMURF1
7469,GO:0031641,0.764667451982462,0.489747147204779,2,25,regulation of myelination,BP,TENM4;TNFRSF21
14806,GO:0070566,0.764790272669914,0.489577662847785,2,25,adenylyltransferase activity,MF,OAS2;OAS1
6057,GO:0019208,0.764794697229182,0.378469171639402,6,71,phosphatase regulator activity,MF,ELFN2;PPP2R2C;PHACTR3;PPP1R2;PPP1R35;PPP2R3B
5132,GO:0015630,0.765087360064581,0.270358877690889,96,965,microtubule cytoskeleton,CC,ITGB6;MAP6;HSPA2;PKD2;CAPRIN2;OBSL1;KIF26B;BRSK1;EVC;KCNAB2;CUL7;REEP2;OR2A4;WDR63;PRKACB;CNTRL;NDRG1;LZTS2;NDN;ACTR1B;NUDCD3;KIF26A;ADGRB2;DNAH1;NEK9;TUBGCP5;CLTCL1;TRPV4;FLOT1;UNC119;PSKH1;NINL;FAM110C;SPPL2B;TPGS1;NEK8;MAP2K5;GAS8;CCDC85B;CEP68;CHD3;BAIAP2;CEP126;TRIOBP;SEPT6;RAB11FIP4;MAP2K2;CEP192;PLA2G6;BBS2;LRRCC1;WRN;PODXL;SEPT5;DNM1;IQCB1;CDK5R1;HOOK2;CLIP2;SPRY2;WASH3P;IFT140;RAB11FIP3;CDK5RAP3;CCDC92;DZIP1L;TTC12;APC2;REEP4;CAPG;NPHP4;BBS1;DDHD2;SHROOM2;BBS5;DLG5;EML3;ARFGEF2;ALMS1;PHF1;TACC1;CCDC88B;CCDC113;KAT2B;MARK4;CEP250;SAC3D1;TTC19;KIF7;TRAF5;RANBP9;ABCA2;PRKACA;MAP1A;TTLL1;EML2
3940,GO:0008631,0.765179004855529,0.440028513705509,3,39,intrinsic apoptotic signaling pathway in response to oxidative stress,BP,PRODH;PDK1;FBXW7
9858,GO:0042129,0.765242779433445,0.366553793614125,7,85,regulation of T cell proliferation,BP,GPNMB;IL20RB;TNFRSF21;DLG5;CCDC88B;ERBB2;RIPK3
12538,GO:0050707,0.765280906879184,0.357728515197398,8,95,regulation of cytokine secretion,BP,POSTN;FERMT1;F2R;TRPV4;C5;TNFRSF21;NLRP1;ALOX15B
20258,GO:2001251,0.765447138032444,0.344374626572945,10,111,negative regulation of chromosome organization,BP,KDM3A;SLX1A;SLX1B;PHF2;JARID2;KDM4C;ATRX;XRN1;PHF1;RAD50
4673,GO:0010824,0.765545531397779,0.440145718638938,3,37,regulation of centrosome duplication,BP,CHMP1B;FBXW5;KAT2B
10824,GO:0044331,0.7655920717457,0.594367055732283,1,13,cell-cell adhesion mediated by cadherin,BP,FLOT1
7891,GO:0032467,0.765676107526152,0.488353907988957,2,25,positive regulation of cytokinesis,BP,OR2A4;CIT
3781,GO:0008344,0.765877913542661,0.439699711023451,3,37,adult locomotory behavior,BP,SLITRK6;DNM1;EFNB3
12580,GO:0050776,0.766036289847775,0.280477685675028,54,574,regulation of immune response,BP,TNFAIP3;MUC19;INPP5D;DDX60;PTPRS;PIK3R1;RBCK1;RNF135;VAV3;STAT1;PRKACB;IFITM1;FCGRT;HLA-B;IL20RB;FLOT1;ADORA2B;C5;WIPF1;SPPL2B;BAIAP2;DHX58;PILRB;NLRX1;PLA2G6;TNFRSF21;MAPK10;HFE;CYBA;CTSB;KLK5;ELF1;C1RL;ERMAP;HLA-A;DAB2IP;PIK3C3;IFI16;PIK3R2;RPS6KA5;BST2;CACNB3;FAM3A;STAT2;RSAD2;TKFC;STAT6;PHPT1;SMPDL3B;PPARG;PRKACA;SERPING1;RIPK3;ECM1
17075,GO:0099632,0.766286259166242,0.593382786873493,1,13,protein transport within plasma membrane,BP,NSG1
17077,GO:0099637,0.766286259166242,0.593382786873493,1,13,neurotransmitter receptor transport,BP,NSG1
4445,GO:0010369,0.766389575636997,0.593236115483831,1,13,chromocenter,CC,SCMH1
5014,GO:0015179,0.766523593292857,0.438832533012912,3,37,L-amino acid transmembrane transporter activity,MF,SLC36A4;SLC43A1;SERINC3
17230,GO:0120032,0.76656025470907,0.337648641480455,11,123,regulation of plasma membrane bounded cell projection assembly,BP,ESPN;EPS8L2;EVI5L;PLXNB3;PODXL;IFT140;ARAP1;ZMYND8;DMTN;SSH3;SYNE2
13566,GO:0060055,0.766708232254512,0.592783442975487,1,13,angiogenesis involved in wound healing,BP,TNFAIP3
10008,GO:0042454,0.766816103731708,0.589913765467976,1,15,ribonucleoside catabolic process,BP,APOBEC3C
6677,GO:0030048,0.766838405913675,0.366266385090357,7,69,actin filament-based movement,BP,WIPF1;SNTA1;KCNJ5;TTN;SCN4B;TNNI2;SYNE2
5624,GO:0016705,0.767021941485273,0.355797855710618,8,92,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen,MF,NOS1;CYP26B1;CYP3A5;PHYH;PTGS1;CYP2D7;KDM4C;TH
3313,GO:0007017,0.767266159717618,0.276907854793546,60,607,microtubule-based process,BP,MAP6;PKD2;DIXDC1;OBSL1;KIF26B;BRSK1;CUL9;CUL7;WDR63;GOLGA8A;MYH11;KIF26A;RGS2;BLOC1S4;DNAH1;TUBGCP5;TRPV4;GOLGA8B;SPG11;NINL;TPGS1;NAIP;GAS8;TRAK1;CEP68;CHD3;CEP126;SUN1;BLOC1S3;CEP192;CABYR;BBS2;NPHP3;CDK5R1;ATRX;HOOK2;SPRY2;IFT140;CHMP1B;APC2;GOLGA8N;FBXW5;MYO3B;MYO9A;EML3;TACC1;CCDC88B;WEE1;LMNA;KAT2B;MARK4;CEP250;PEX1;KIF7;RANBP9;ERBB2;SYNE2;MAP1A;TTLL1;EML2
6131,GO:0019400,0.767309160567746,0.590468682834775,1,14,alditol metabolic process,BP,TKFC
7435,GO:0031573,0.767463016335442,0.590249142896018,1,14,intra-S DNA damage checkpoint,BP,XPC
13246,GO:0051955,0.767512483392006,0.591638951218461,1,13,regulation of amino acid transport,BP,PER2
9820,GO:0042056,0.767562456027997,0.587750535263152,1,16,chemoattractant activity,MF,GPNMB
3951,GO:0008656,0.767778205737537,0.589799064909499,1,14,cysteine-type endopeptidase activator activity involved in apoptotic process,MF,NLRP1
8633,GO:0034185,0.767925823933012,0.592764729417146,1,12,apolipoprotein binding,MF,LRP1
9850,GO:0042113,0.768107496215346,0.327160755539609,13,144,B cell activation,BP,TNFAIP3;INPP5D;SFRP1;PIK3R1;VAV3;ZFP36L2;TNFRSF21;BST2;ZFP36L1;IL11;IRS2;STAT6;POLM
15804,GO:0072527,0.768142326919082,0.387671798354381,5,66,pyrimidine-containing compound metabolic process,BP,NT5E;APOBEC3C;CMPK2;TK2;UCKL1
3550,GO:0007585,0.768199012181661,0.436577601521395,3,37,respiratory gaseous exchange,BP,GAA;NDN;NLGN2
13579,GO:0060071,0.768238618582351,0.353789587576209,8,99,Wnt signaling pathway, planar cell polarity pathway,BP,SFRP1;PRICKLE2;ARHGEF19;CELSR1;FZD7;NPHP3;PTK7;SMURF1
3758,GO:0008301,0.76826285561768,0.590568540358513,1,13,DNA binding, bending,MF,TRERF1
15806,GO:0072529,0.768299223590476,0.483129682572565,2,28,pyrimidine-containing compound catabolic process,BP,NT5E;APOBEC3C
4581,GO:0010669,0.768450334941425,0.590300708202569,1,13,epithelial structure maintenance,BP,PBLD
1387,GO:0003299,0.768554360579607,0.591869094618649,1,12,muscle hypertrophy in response to stress,BP,LMNA
4928,GO:0014887,0.768554360579607,0.591869094618649,1,12,cardiac muscle adaptation,BP,LMNA
4936,GO:0014898,0.768554360579607,0.591869094618649,1,12,cardiac muscle hypertrophy in response to stress,BP,LMNA
5231,GO:0015849,0.76866437522114,0.316859481129499,16,174,organic acid transport,BP,APOE;CPT2;SLC16A5;SLC13A5;PER2;VAMP2;SLC27A1;PLA2G6;ACACB;SLC38A4;SLC36A4;ACSL1;IRS2;SLC43A1;PPARG;SERINC3
11893,GO:0046942,0.76866437522114,0.316859481129499,16,174,carboxylic acid transport,BP,APOE;CPT2;SLC16A5;SLC13A5;PER2;VAMP2;SLC27A1;PLA2G6;ACACB;SLC38A4;SLC36A4;ACSL1;IRS2;SLC43A1;PPARG;SERINC3
10185,GO:0042803,0.76893550928564,0.279525050004562,49,526,protein homodimerization activity,MF,APOE;PKD2;ALDH1A3;TENM4;MVD;STAT1;HMGCL;UGT1A3;FLRT3;HPS4;GSTM2;WWTR1;SPPL2B;BHLHE40;ZNF318;RAB11FIP4;SLC27A1;VEGFB;SQSTM1;HEXB;HOMER2;PEX7;TCF4;PEX11B;MAP3K12;WRN;TREX1;HLCS;MEF2D;RAB11FIP3;IKZF4;ACCS;SRR;DLK2;PDE2A;DAB2IP;FBXO4;ERCC5;BST2;SNX1;CADM4;GALE;IMPA2;ERN1;PNPO;S100A6;GSTM3;HARS2;FOXP2
681,GO:0001892,0.768990860962494,0.37326425178526,6,70,embryonic placenta development,BP,EGFR;PKD2;PLCD3;PLCD1;ZFP36L1;GJB5
6605,GO:0022829,0.769323366822742,0.587586242677679,1,14,wide pore channel activity,MF,GJC2
6887,GO:0030426,0.769351799758386,0.334421916891401,11,120,growth cone,CC,FLRT3;TRPV4;ADGRL1;BOC;TRAK1;MAP3K12;CDK5R1;ORAI2;SHANK2;APBB2;PTBP2
13060,GO:0051589,0.769627642375553,0.588615220821233,1,13,negative regulation of neurotransmitter transport,BP,NOS1
15196,GO:0071371,0.770092660308278,0.58794776807776,1,13,cellular response to gonadotropin stimulus,BP,GCLC
11328,GO:0045668,0.770115581711772,0.482184610098965,2,25,negative regulation of osteoblast differentiation,BP,SFRP1;AREG
3910,GO:0008569,0.770165283243237,0.591614850307314,1,11,ATP-dependent microtubule motor activity, minus-end-directed,MF,DNAH1
9981,GO:0042405,0.770253469509643,0.58943907938182,1,12,nuclear inclusion body,CC,ATXN1
4572,GO:0010660,0.770264123073683,0.433788668767769,3,37,regulation of muscle cell apoptotic process,BP,PDCD4;RGL2;PPARG
14634,GO:0070252,0.770268454445435,0.387564301236842,5,50,actin-mediated cell contraction,BP,SNTA1;KCNJ5;TTN;SCN4B;TNNI2
3519,GO:0007492,0.770563659735936,0.385831876172999,5,57,endoderm development,BP,ITGB5;COL7A1;RTF1;COL6A1;ZFP36L1
18101,GO:1902807,0.770767522261963,0.350852513682698,8,96,negative regulation of cell cycle G1/S phase transition,BP,GPNMB;PKD2;MDM2;PCBP4;PIDD1;GJC2;ZNF655;TFDP2
5395,GO:0016234,0.770968169244348,0.370866640093962,6,69,inclusion body,CC,TRIM66;SQSTM1;ATXN1;SNCB;KLF8;SYNE2
18502,GO:1903706,0.771484491226462,0.292046417900674,28,327,regulation of hemopoiesis,BP,INPP5D;ASH2L;SFRP1;PIK3R1;ZFPM1;KITLG;STAT1;MYL9;KLF13;CYP26B1;FAM210B;ZFP36L2;GLI2;GLI3;FAM213A;CA2;AGO4;FBXW7;LMO2;TNRC6C;NRARP;ACVR1B;ZFP36L1;KAT2B;SOX13;ERBB2;GPR68;CTNNBIP1
13841,GO:0060479,0.771510622931998,0.585906515201036,1,13,lung cell differentiation,BP,THRA
13876,GO:0060541,0.77155527997502,0.327195581068914,12,130,respiratory system development,BP,SREBF1;EGFR;ALDH1A3;GLI2;GLI3;CELSR1;NPHP3;SPRY2;THRA;DLG5;PTK7;FOXP2
5212,GO:0015813,0.771632279605316,0.585730959060942,1,13,L-glutamate transmembrane transport,BP,PER2
15499,GO:0071900,0.771952458253683,0.283454338053325,37,393,regulation of protein serine/threonine kinase activity,BP,TNFAIP3;APOE;EGFR;PKD2;SFRP1;EPHB2;MAP3K14;HERC5;CSPG4;KITLG;RGS2;F2R;PDCD4;ADORA2B;MAPK8IP3;C5;MINK1;MAP2K5;INSR;CBLC;ETAA1;SLC27A1;MAP2K2;MAP3K12;CDK5R1;MAPK10;ERCC6;SHC2;SPRY2;CDK5RAP3;MAP3K6;WNK1;DAB2IP;ACSL1;KAT2B;ERN1;ERBB2
3789,GO:0008356,0.772004087122235,0.585194008089779,1,13,asymmetric cell division,BP,ETV5
13929,GO:0060632,0.772156065607263,0.583501756927588,1,14,regulation of microtubule-based movement,BP,BBS2
6718,GO:0030135,0.77265510228602,0.304905225391275,19,208,coated vesicle,CC,SREBF1;APOE;EGFR;VAMP3;VPS11;COL7A1;IDUA;HLA-B;AP1G2;CLTCL1;VAMP2;MALL;ASTN2;LRP1;HLA-A;DDHD2;AREG;CD9;LDLRAP1
19404,GO:1990023,0.772657209311023,0.584249273067245,1,13,mitotic spindle midzone,CC,OR2A4
5336,GO:0016075,0.772659336583478,0.581501432700833,1,15,rRNA catabolic process,BP,XRN1
7866,GO:0032435,0.772799762791707,0.477323295030367,2,27,negative regulation of proteasomal ubiquitin-dependent protein catabolic process,BP,HFE;PANO1
11334,GO:0045683,0.772815442128369,0.584020098830649,1,13,negative regulation of epidermis development,BP,FERMT1
8697,GO:0034349,0.772834253127934,0.583992846601087,1,13,glial cell apoptotic process,BP,TNFRSF21
1175,GO:0002822,0.773011958986764,0.367796194831685,6,73,regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,TNFAIP3;IL20RB;HFE;RSAD2;STAT6;RIPK3
808,GO:0002082,0.773116323130052,0.582108927662657,1,14,regulation of oxidative phosphorylation,BP,MLXIPL
18327,GO:1903319,0.773361512412769,0.583228329173681,1,13,positive regulation of protein maturation,BP,GSN
562,GO:0001704,0.773781065700548,0.356480215174175,7,78,formation of primary germ layer,BP,WNT3;ITGB5;COL7A1;ITGA2;RTF1;FZD7;COL6A1
7922,GO:0032507,0.7741179857731,0.380595456354132,5,61,maintenance of protein location in cell,BP,ANK3;GSN;SUN1;EPB41L3;SYNE2
7449,GO:0031593,0.774181015848531,0.428469754368395,3,37,polyubiquitin modification-dependent protein binding,MF,TNFAIP3;SQSTM1;SHARPIN
2327,GO:0005343,0.774272904033803,0.581903829960145,1,13,organic acid:sodium symporter activity,MF,SLC13A5
13508,GO:0055106,0.774501459569811,0.57770689888416,1,16,ubiquitin-protein transferase regulator activity,MF,FBXW7
16657,GO:0097617,0.774563323607962,0.58148097180734,1,13,annealing activity,MF,SMARCA1
16832,GO:0098771,0.774851534044561,0.280917724490413,36,387,inorganic ion homeostasis,BP,APOE;EGFR;PKD2;CYBRD1;NOS1;ITPR3;NEO1;F2R;MT1X;SLC24A1;TRPV4;ANK3;GSTM2;NMU;SCNN1A;BMP6;TCIRG1;SLC12A7;HEXB;PLA2G6;ATP6V0A2;CA2;HFE;CYBA;KCNMA1;JPH2;FGFR4;TMEM203;VDR;LETMD1;CACNB3;LPAR6;DLG4;DMXL2;AKAP6;PRKACA
14122,GO:0061014,0.774931671333453,0.427777500942817,3,36,positive regulation of mRNA catabolic process,BP,ZFP36L2;TNRC6C;ZFP36L1
19749,GO:2000178,0.77523949330561,0.580494949772552,1,13,negative regulation of neural precursor cell proliferation,BP,KCTD11
7863,GO:0032432,0.775387187190829,0.398502422410933,4,48,actin filament bundle,CC,MICALL2;CYBA;SYNPO2;SHROOM4
8571,GO:0034062,0.775638092045968,0.424833811698034,3,43,5'-3' RNA polymerase activity,MF,POLR2J2;POLR2J3;PRIMPOL
16713,GO:0097747,0.775638092045968,0.424833811698034,3,43,RNA polymerase activity,MF,POLR2J2;POLR2J3;PRIMPOL
1150,GO:0002758,0.775670828339828,0.305743648634709,17,194,innate immune response-activating signal transduction,BP,TNFAIP3;MUC19;DDX60;PTPRS;PRKACB;FLOT1;DHX58;NLRX1;CYBA;CTSB;DAB2IP;PIK3C3;RPS6KA5;RSAD2;TKFC;SMPDL3B;PRKACA
18518,GO:1903747,0.77589414962828,0.344318483927258,8,98,regulation of establishment of protein localization to mitochondrion,BP,SREBF1;VPS11;HPS4;MICALL2;OSCP1;FBXW7;TFDP2;PEMT
2941,GO:0006469,0.776000207885326,0.303079786941034,18,201,negative regulation of protein kinase activity,BP,TNFAIP3;APOE;SFRP1;EPHB2;CAMK2N1;FLRT3;RGS2;PDCD4;RTN4RL1;WWTR1;CBLC;PTK6;SPRY2;CDK5RAP3;ADARB1;WNK1;DAB2IP;KAT2B
2712,GO:0006086,0.776109909780972,0.579222565193432,1,13,acetyl-CoA biosynthetic process from pyruvate,BP,PDK1
4439,GO:0010332,0.776268383529513,0.396918123227374,4,50,response to gamma radiation,BP,MDM2;WRN;CYBA;ERCC6
2449,GO:0005662,0.776313972950402,0.577440449657644,1,14,DNA replication factor A complex,CC,ERCC5
10048,GO:0042551,0.776368442320771,0.473391096069773,2,25,neuron maturation,BP,RET;NFASC
7247,GO:0031214,0.776470384626309,0.363823953903665,6,69,biomineral tissue development,BP,GPNMB;PTHLH;FAM20C;ISG15;BMP6;ECM1
794,GO:0002064,0.776532023043901,0.317126396576907,13,142,epithelial cell development,BP,ACTA2;PTPRS;SLITRK6;TFCP2L1;RAPGEF3;TRIOBP;BMP6;CST3;PODXL;ATRX;PDE2A;GSTM3;LAMB2
3478,GO:0007339,0.776675492415032,0.575629984882222,1,15,binding of sperm to zona pellucida,BP,GLIPR1L2
13552,GO:0060041,0.776721311375506,0.352759287580689,7,78,retina development in camera-type eye,BP,SDK2;RAB11FIP4;IFT140;NPHP4;RET;TUB;LAMB2
45,GO:0000097,0.776857243491529,0.576642613392738,1,14,sulfur amino acid biosynthetic process,BP,MTR
13021,GO:0051497,0.777056336784364,0.577835088309626,1,13,negative regulation of stress fiber assembly,BP,ARAP1
11322,GO:0045662,0.777320421196311,0.575961319949039,1,14,negative regulation of myoblast differentiation,BP,CXCL14
12168,GO:0048313,0.77732432003845,0.575955580867666,1,14,Golgi inheritance,BP,MAP2K2
11354,GO:0045736,0.777454699866732,0.471276332022036,2,26,negative regulation of cyclin-dependent protein serine/threonine kinase activity,BP,TNFAIP3;KAT2B
19736,GO:2000147,0.777871144874148,0.282897010519655,30,319,positive regulation of cell motility,BP,POSTN;GPNMB;EGFR;PIK3R1;CXCL14;KITLG;MDM2;F2R;CAPN7;TRPV4;ITGA2;SEMA4G;FAM110C;ITGA6;INSR;DOCK8;VEGFB;HYAL1;PODXL;SPRY2;PLA2G7;RET;DAB2IP;DMTN;ACVR1B;IRS2;PHPT1;SRPX2;SYNE2;ACKR3
365,GO:0000987,0.777882924696007,0.285100168883391,28,294,proximal promoter sequence-specific DNA binding,MF,HES2;SREBF1;ZFPM1;STAT1;KLF13;NFATC4;HSF4;NDN;GLI2;KLF7;GLI3;BHLHE40;TCFL5;TCF4;PLAG1;MEF2D;MLXIPL;LMO2;CARF;ELF1;RFX2;IFI16;VDR;SIX5;HLTF;STAT6;KLF8;FOXP2
8958,GO:0035050,0.778043335416251,0.395179485541147,4,47,embryonic heart tube development,BP,PKD2;NPHP3;TEAD2;BBS5
6683,GO:0030057,0.778189083839311,0.471432891269062,2,24,desmosome,CC,PPL;KLHL24
16178,GO:0090231,0.778531274054784,0.574175549943398,1,14,regulation of spindle checkpoint,BP,NDRG1
12661,GO:0050892,0.778595541023849,0.575569688874952,1,13,intestinal absorption,BP,VDR
18014,GO:1902555,0.778648256784978,0.468104443935042,2,29,endoribonuclease complex,CC,AGO4;ERN1
19202,GO:1905348,0.778648256784978,0.468104443935042,2,29,endonuclease complex,CC,AGO4;ERN1
8055,GO:0032732,0.778895316744819,0.468697353814892,2,27,positive regulation of interleukin-1 production,BP,NLRP1;IFI16
955,GO:0002376,0.779158686147308,0.246746437253021,179,1849,immune system process,BP,TNFAIP3;GPNMB;MUC19;IFI6;PYGB;INPP5D;OAS2;DDX60;PTPRS;FAM20C;APOBEC3C;CXCR1;ASH2L;TRIM22;SFRP1;IFI44L;MAP3K14;PIK3R1;RBCK1;CXCL14;TSC22D3;RNF135;DHTKD1;HERC5;VAV3;ISG15;HTRA1;KCNAB2;ZFPM1;KITLG;VAMP3;NAPRT;STAT1;MYL9;ITGB5;RAB43;PRKACB;HOXA3;KLF13;SDC3;CYP26B1;GAA;NDRG1;IFITM1;FCGRT;HLA-B;TNFSF10;HGSNAT;ACTR1B;FAM210B;CTSV;OAS1;KIF26A;IL20RB;ZNF160;ZFP36L2;TRPV4;TMC6;FLOT1;GLI2;ADORA2B;ADAMTS13;LAMP3;C5;WIPF1;TNFRSF14;ITGA2;GLI3;SPPL2B;VAMP2;NAIP;ITGA6;MMP1;JARID2;MMP28;GSN;BAIAP2;DDT;CTSF;CD109;PNMA1;PMS2P3;DOCK8;DHX58;PILRB;IRF9;BMP6;NLRX1;SLC2A3;TCIRG1;VEGFB;SQSTM1;PTK6;FZD7;FAM213A;HEXB;PLA2G6;CST3;ATP6V0A2;IFI27;TNFRSF21;CA2;EFNB3;MAPK10;HFE;SCART1;CYBA;TRIM38;AGO4;CTSB;KLK5;FBXW7;LMO2;PGM1;THRA;ADARB1;ELF1;MX2;NLRP1;C1RL;ERMAP;PRR7;LRP1;HLA-A;PLA2G7;RET;DAB2IP;PIK3C3;IFI16;PIK3R2;RPS6KA5;DLG5;BST2;CACNB3;TNRC6C;FAM3A;MARCH8;DMTN;STAT2;OSBPL1A;NRARP;ACVR1B;CCDC88B;ENDOU;NBEAL2;CD68;PTMS;TCF7;RSAD2;TNFRSF25;ZFP36L1;IL11;KAT2B;IRS2;METTL7A;TKFC;TNFSF12;STAT6;SOX13;PHPT1;SMPDL3B;GLB1;DPP7;CTSD;ERBB2;SYNGR1;GPR68;RORA;PPARG;PRKACA;C6ORF120;POLM;SERPING1;IP6K2;RIPK3;NFASC;CTNNBIP1;SERINC3;ECM1
13622,GO:0060149,0.77923020452065,0.573141649733813,1,14,negative regulation of posttranscriptional gene silencing,BP,PPARG
14090,GO:0060967,0.77923020452065,0.573141649733813,1,14,negative regulation of gene silencing by RNA,BP,PPARG
16733,GO:0098533,0.779550900211658,0.574158016087608,1,13,ATPase dependent transmembrane transport complex,CC,ABCA2
2613,GO:0005923,0.779760215671018,0.340218348273697,8,88,bicellular tight junction,CC,ANK3;FRMD4B;MICALL2;NPHP4;SHROOM2;PMP22;MPP7;PARD6G
20072,GO:2000758,0.780377790904757,0.4665815430019,2,27,positive regulation of peptidyl-lysine acetylation,BP,NOS1;RPS6KA5
9819,GO:0042054,0.78060254033565,0.391122591028186,4,50,histone methyltransferase activity,MF,ASH2L;DYDC1;KMT5C;PRMT3
4086,GO:0009142,0.780678484133446,0.32523318568701,10,120,nucleoside triphosphate biosynthetic process,BP,DHTKD1;CMPK2;INSR;TCIRG1;ATP6V0A2;MLXIPL;PGM1;PFKFB2;OGDHL;UCKL1
783,GO:0002042,0.780748102582849,0.419464991840935,3,37,cell migration involved in sprouting angiogenesis,BP,MAP2K5;MMRN2;SRPX2
1129,GO:0002718,0.78078861827231,0.418520260584506,3,40,regulation of cytokine production involved in immune response,BP,HFE;BST2;RSAD2
7667,GO:0032104,0.780984905002635,0.570535883167048,1,14,regulation of response to extracellular stimulus,BP,BBS2
7670,GO:0032107,0.780984905002635,0.570535883167048,1,14,regulation of response to nutrient levels,BP,BBS2
2850,GO:0006336,0.781146464804434,0.415870043240226,3,50,DNA replication-independent nucleosome assembly,BP,CENPC;ATRX;CENPH
12039,GO:0048002,0.781158652538176,0.31481330564565,12,149,antigen processing and presentation of peptide antigen,BP,VAMP3;ITGB5;HLA-B;ACTR1B;CTSV;KIF26A;CTSF;HFE;CYBA;HLA-A;OSBPL1A;CTSD
5380,GO:0016202,0.781223226329883,0.346838259750352,7,80,regulation of striated muscle tissue development,BP,TSC22D3;CYP26B1;FLOT1;JARID2;FZD7;JPH2;AKAP6
17768,GO:1901861,0.781223226329883,0.346838259750352,7,80,regulation of muscle tissue development,BP,TSC22D3;CYP26B1;FLOT1;JARID2;FZD7;JPH2;AKAP6
13156,GO:0051782,0.781334965921781,0.570014297822308,1,14,negative regulation of cell division,BP,TXNIP
3099,GO:0006677,0.781530807445504,0.569722243906225,1,14,glycosylceramide metabolic process,BP,ST6GALNAC6
7476,GO:0031648,0.781704313682432,0.417831793644068,3,38,protein destabilization,BP,MDM2;GSN;FBXO4
1000,GO:0002474,0.781939669434509,0.355375475296488,6,83,antigen processing and presentation of peptide antigen via MHC class I,BP,VAMP3;ITGB5;HLA-B;HFE;CYBA;HLA-A
11830,GO:0046825,0.781998292872742,0.417129599446286,3,39,regulation of protein export from nucleus,BP,MDM2;RAPGEF3;IFI27
1455,GO:0003697,0.782099603668852,0.336660743818216,8,96,single-stranded DNA binding,MF,XPC;CRY2;MLH3;PMS2P3;RTF1;TREX1;ERCC5;RAD50
19778,GO:2000241,0.782123373880888,0.355970567920611,6,74,regulation of reproductive process,BP,SFRP1;PRKACB;LHFPL2;NUPR1;INSR;ACVR1B
18373,GO:1903421,0.782157819224951,0.570284030535673,1,13,regulation of synaptic vesicle recycling,BP,DNM1
13487,GO:0055078,0.78221877368537,0.570193063840726,1,13,sodium ion homeostasis,BP,SCNN1A
3700,GO:0008209,0.782796474840438,0.567830391666265,1,14,androgen metabolic process,BP,SRD5A3
9375,GO:0035924,0.782873736372899,0.463534161182628,2,26,cellular response to vascular endothelial growth factor stimulus,BP,DAB2IP;ERN1
3666,GO:0008157,0.782945818265068,0.567606658002599,1,14,protein phosphatase 1 binding,MF,PHACTR3
11569,GO:0046148,0.78314018596344,0.41526884059973,3,40,pigment biosynthetic process,BP,UROS;DDT;PMEL
2457,GO:0005671,0.783407316805153,0.566914606855325,1,14,Ada2/Gcn5/Ada3 transcription activator complex,CC,KAT2B
13488,GO:0055080,0.783411451797712,0.271997583811901,35,379,cation homeostasis,BP,APOE;EGFR;PKD2;CYBRD1;NOS1;ITPR3;NEO1;F2R;MT1X;SLC24A1;TRPV4;ANK3;GSTM2;NMU;SCNN1A;BMP6;TCIRG1;SLC12A7;HEXB;PLA2G6;ATP6V0A2;CA2;HFE;CYBA;KCNMA1;JPH2;TMEM203;VDR;LETMD1;CACNB3;LPAR6;DLG4;DMXL2;AKAP6;PRKACA
15602,GO:0072111,0.7834402578724,0.566865170360021,1,14,cell proliferation involved in kidney development,BP,STAT1
6426,GO:0021697,0.783468221289723,0.568324513145793,1,13,cerebellar cortex formation,BP,RORA
12241,GO:0048538,0.783557406083484,0.41557900556681,3,37,thymus development,BP,HOXA3;JARID2;RIPK3
7365,GO:0031420,0.783561572180712,0.568184606642455,1,13,alkali metal ion binding,MF,SLC24A1
12913,GO:0051290,0.783645279967708,0.456866539318394,2,43,protein heterotetramerization,BP,INSR;CBR4
12383,GO:0048841,0.783778051794196,0.463436067966252,2,24,regulation of axon extension involved in axon guidance,BP,WNT3;SEMA4G
17088,GO:0101002,0.784092651101394,0.311340301832441,12,146,ficolin-1-rich granule,CC,GAA;ACTR1B;GSN;SLC2A3;TCIRG1;CST3;CTSB;PGM1;NBEAL2;GLB1;CTSD;NFASC
4337,GO:0009891,0.784200089879368,0.245156093423499,131,1318,positive regulation of biosynthetic process,BP,TP53INP1;PTHLH;SREBF1;APOE;EGFR;CIRBP;PKD2;CAPRIN2;RBM3;ASH2L;SFRP1;SEC14L2;PIK3R1;KDM3A;POU3F1;RGMA;ZFPM1;KITLG;CITED4;IRF2BPL;MC1R;STAT1;IMPACT;NOS1;MAML3;KLF13;NFATC4;RNF187;HSF4;EAPP;CRTC1;NDN;RAPGEF3;F2R;GLI2;ADORA2B;KLF7;TCEA2;ZNF76;SOX12;PHF2;ABHD14B;WWTR1;ITGA2;GLI3;THRAP3;SMARCA1;MAP2K5;ITGA6;ZNF318;INSR;ZNF287;RTF1;MDK;BMP6;MAP2K2;SQSTM1;FZD7;ETV5;DLX3;HEXB;METTL23;PLA2G6;CST3;TCF4;PLAG1;LPIN3;ATRX;ADIRF;CYBA;ERCC6;MEF2D;CREBRF;MLXIPL;FBXW7;CDK5RAP3;LMO2;NFIX;CARF;PFKFB2;THRA;RAI1;ELF1;IKZF4;DBP;EPM2AIP1;PEG3;RFX2;SALL2;MAF;STK16;RET;DAB2IP;CASZ1;CALCOCO1;TEAD2;MYSM1;FBXO4;IFI16;FGFR4;PIK3R2;TEF;AREG;RPS6KA5;VDR;MAMSTR;PLXND1;SIX5;HLTF;PHF1;ZNF292;TFDP2;ACVR1B;TNNI2;NAT14;GLMP;IL11;KAT2B;IRS2;IVNS1ABP;TRERF1;STAT6;CHD6;ERBB2;RORA;PPARG;PARN;ZFP90;CCDC3;NPNT;PEMT
6283,GO:0019897,0.784278789983786,0.327144475868757,9,102,extrinsic component of plasma membrane,CC,SERPINE2;KCNAB2;SYTL1;PTK6;APC2;GNG2;DLG4;ESYT2;S100A6
18216,GO:1903046,0.784299213701714,0.320954357161119,10,116,meiotic cell cycle process,BP,HSPA2;CYP26B1;MLH3;SUN1;CENPC;ATRX;REC8;AGO4;RAD50;MSH5
5460,GO:0016342,0.784598421514492,0.566627846936233,1,13,catenin complex,CC,APC2
5675,GO:0016790,0.785016047796507,0.458968322345033,2,29,thiolester hydrolase activity,MF,ACOT1;ACOT2
3876,GO:0008509,0.785218789368916,0.294617412972414,17,186,anion transmembrane transporter activity,MF,SLC16A5;SLC13A5;CLCN6;SLC27A1;SLC2A3;SLC12A7;CLCA2;ANO9;SLC2A1;SLC38A4;SLC37A2;SLC36A4;SLC22A15;ANO1;SLC43A1;CLCN7;SERINC3
10849,GO:0044380,0.785631345791791,0.384974337479445,4,47,protein localization to cytoskeleton,BP,NUDCD3;CEP192;CEP250;GOLGB1
16081,GO:0090083,0.78584111595841,0.563248033868333,1,14,regulation of inclusion body assembly,BP,HSPA2
12549,GO:0050718,0.786250512259126,0.562628460283193,1,14,positive regulation of interleukin-1 beta secretion,BP,NLRP1
17016,GO:0099513,0.786260602027537,0.262346251025243,45,468,polymeric cytoskeletal fiber,CC,MAP6;ESPN;PKD2;KIF26B;SYNC;KCNAB2;REEP2;KRT15;FERMT1;NDRG1;LZTS2;KIF26A;DNAH1;TUBGCP5;TRPV4;WIPF1;NINL;FAM110C;TPGS1;GAS8;BAIAP2;CASP14;MAP2K2;DNM1;CDK5R1;HOOK2;CLIP2;KRT14;SPRY2;CDK5RAP3;APC2;REEP4;SHROOM2;EML3;DMTN;ARFGEF2;SHROOM4;SHANK2;LMNA;KIF7;LDLRAP1;VMAC;MAP1A;TTLL1;EML2
8810,GO:0034595,0.786428893176218,0.563866838506304,1,13,phosphatidylinositol phosphate 5-phosphatase activity,MF,INPP5D
10991,GO:0044818,0.786571693772247,0.458195836247417,2,26,mitotic G2/M transition checkpoint,BP,BRSK1;CDK5RAP3
11748,GO:0046622,0.786836935541807,0.457811196588842,2,26,positive regulation of organ growth,BP,ACACB;AKAP6
7983,GO:0032609,0.787304284498255,0.381528061728653,4,53,interferon-gamma production,BP,ISG15;ZFPM1;IL20RB;RIPK3
9879,GO:0042169,0.787311986331001,0.457698625426136,2,25,SH2 domain binding,MF,TRPV4;SQSTM1
11707,GO:0046527,0.78742854848991,0.56084109668472,1,14,glucosyltransferase activity,MF,KDELC2
7905,GO:0032486,0.787492055738859,0.56225572743289,1,13,Rap protein signal transduction,BP,RAPGEF3
4329,GO:0009880,0.787556465809619,0.410342695213015,3,36,embryonic pattern specification,BP,PGAP1;PCSK6;NRARP
1878,GO:0004559,0.787576711492331,0.562127203086932,1,13,alpha-mannosidase activity,MF,MAN1B1
17270,GO:0140058,0.78759498637015,0.562099453567229,1,13,neuron projection arborization,BP,DLG4
15798,GO:0072521,0.787968827648172,0.267422821692007,34,394,purine-containing compound metabolic process,BP,PTHLH;APOE;NT5E;GAMT;FAM20C;PKD2;DHTKD1;NOS1;RAPGEF3;ADORA2B;SULT1E1;ABHD14B;INSR;TCIRG1;ATP6V0A2;NPHP3;MACROD1;OARD1;GABBR1;MLXIPL;GPR87;PGM1;PFKFB2;OGDHL;PPCS;PDE2A;SDHA;LTB4R2;NADK;NDUFV3;DLG4;NUDT10;RORA;PEMT
4915,GO:0014855,0.788012071641252,0.409374667947871,3,37,striated muscle cell proliferation,BP,TENM4;JARID2;SIX5
8572,GO:0034063,0.788441101081437,0.560812875512658,1,13,stress granule assembly,BP,CIRBP
12731,GO:0051019,0.788456654360242,0.455457270773027,2,26,mitogen-activated protein kinase binding,MF,MICALCL;CDK5RAP3
3154,GO:0006754,0.78862288895861,0.328404916531342,8,96,ATP biosynthetic process,BP,DHTKD1;INSR;TCIRG1;ATP6V0A2;MLXIPL;PGM1;PFKFB2;OGDHL
371,GO:0000993,0.788859822950947,0.454337847783201,2,27,RNA polymerase II core binding,MF,RTF1;UVSSA
18346,GO:1903364,0.788879561961045,0.315210349078952,10,117,positive regulation of cellular protein catabolic process,BP,TNFAIP3;APOE;MAGEF1;VPS11;MDM2;FBXW7;LRP1;DAB2IP;SMURF1;GCLC
3276,GO:0006955,0.788991511795646,0.241577668002142,116,1222,immune response,BP,TNFAIP3;MUC19;IFI6;PYGB;INPP5D;OAS2;DDX60;PTPRS;APOBEC3C;CXCR1;TRIM22;MAP3K14;PIK3R1;RBCK1;CXCL14;RNF135;HERC5;VAV3;ISG15;KCNAB2;ZFPM1;VAMP3;NAPRT;STAT1;RAB43;PRKACB;GAA;IFITM1;FCGRT;HLA-B;TNFSF10;HGSNAT;ACTR1B;OAS1;IL20RB;TMC6;FLOT1;ADORA2B;ADAMTS13;LAMP3;C5;WIPF1;TNFRSF14;SPPL2B;VAMP2;NAIP;GSN;BAIAP2;PNMA1;DHX58;PILRB;IRF9;BMP6;NLRX1;SLC2A3;TCIRG1;PTK6;HEXB;PLA2G6;CST3;ATP6V0A2;IFI27;TNFRSF21;MAPK10;HFE;SCART1;CYBA;TRIM38;CTSB;KLK5;PGM1;ADARB1;ELF1;MX2;NLRP1;C1RL;ERMAP;PRR7;LRP1;HLA-A;DAB2IP;PIK3C3;IFI16;PIK3R2;RPS6KA5;BST2;CACNB3;FAM3A;MARCH8;STAT2;ENDOU;NBEAL2;CD68;TCF7;RSAD2;TNFRSF25;METTL7A;TKFC;TNFSF12;STAT6;PHPT1;SMPDL3B;GLB1;DPP7;CTSD;SYNGR1;RORA;PPARG;PRKACA;C6ORF120;SERPING1;IP6K2;RIPK3;NFASC;SERINC3;ECM1
12818,GO:0051148,0.789064575030899,0.454571515855024,2,26,negative regulation of muscle cell differentiation,BP,PDCD4;FZD7
16135,GO:0090175,0.789275658116559,0.327248481869367,8,101,regulation of establishment of planar polarity,BP,SFRP1;PRICKLE2;ARHGEF19;CELSR1;FZD7;NPHP3;PTK7;SMURF1
14954,GO:0070884,0.789479536501502,0.557713068093682,1,14,regulation of calcineurin-NFAT signaling cascade,BP,AKAP6
17186,GO:0106056,0.789479536501502,0.557713068093682,1,14,regulation of calcineurin-mediated signaling,BP,AKAP6
11429,GO:0045892,0.789631223459076,0.245670177153605,85,892,negative regulation of transcription, DNA-templated,BP,HES2;SREBF1;MNT;SFRP1;TSC22D3;HR;TFCP2L1;ZFPM1;IRF2BPL;STAT1;IMPACT;CRY2;CRY1;SCMH1;NFATC4;HSF4;EAPP;MDM2;TCF25;PDCD4;TRPV4;GLI2;PER2;ZNF658;PHF2;TCEAL1;WWTR1;GLI3;BHLHE40;MAP2K5;ZNF318;TCFL5;JARID2;CCDC85B;MXD4;RTF1;H2AFJ;BMP6;SQSTM1;ZNF608;TXNIP;RCOR2;IFI27;CDK5R1;ATRX;MLXIPL;ING4;ATXN1;NFIX;MXI1;THRA;IKZF4;NAB2;PEG3;SALL2;ZBTB20;PDE2A;MAF;ZMYND8;DAB2IP;TSHZ2;IFI16;RPS6KA5;VDR;TNRC18;SIX5;WWC3;TFDP2;NRARP;ZNF91;DYDC1;TCF7;STAT6;PRDX5;NELFCD;KLF8;PPARG;CXXC5;ZFP90;PER3;FOXP2;ZC3H6;HIVEP1;CTNNBIP1;GCLC
11741,GO:0046605,0.790039879379999,0.378359880453511,4,50,regulation of centrosome cycle,BP,CHMP1B;FBXW5;KAT2B;CEP250
5281,GO:0015936,0.790294616340452,0.555155748252588,1,15,coenzyme A metabolic process,BP,PPCS
6278,GO:0019886,0.790304270666893,0.345324813366134,6,74,antigen processing and presentation of exogenous peptide antigen via MHC class II,BP,ACTR1B;CTSV;KIF26A;CTSF;OSBPL1A;CTSD
9542,GO:0036315,0.790611105708062,0.55749709366574,1,13,cellular response to sterol,BP,RORA
6250,GO:0019835,0.790631601602212,0.552495765205201,1,17,cytolysis,BP,C5
14551,GO:0070102,0.790710856651364,0.557344112439185,1,13,interleukin-6-mediated signaling pathway,BP,STAT1
5634,GO:0016722,0.790795513178878,0.555695115489215,1,14,oxidoreductase activity, oxidizing metal ions,MF,CYBRD1
5245,GO:0015872,0.790883005413359,0.554250984591583,1,15,dopamine transport,BP,SYT7
441,GO:0001190,0.790949018108043,0.37752787686928,4,48,transcriptional activator activity, RNA polymerase II transcription factor binding,MF,POU3F1;CITED4;SOX12;LMO2
885,GO:0002252,0.790972416358789,0.247605139333599,70,748,immune effector process,BP,TNFAIP3;PYGB;INPP5D;OAS2;DDX60;APOBEC3C;CXCR1;TRIM22;IFI44L;MAP3K14;PIK3R1;HERC5;VAV3;ISG15;HTRA1;KCNAB2;ZFPM1;NAPRT;STAT1;GAA;IFITM1;HGSNAT;ACTR1B;OAS1;IL20RB;TMC6;ADORA2B;C5;WIPF1;VAMP2;GSN;BAIAP2;DHX58;IRF9;NLRX1;SLC2A3;TCIRG1;HEXB;PLA2G6;CST3;HFE;SCART1;CYBA;CTSB;KLK5;PGM1;ADARB1;MX2;C1RL;LRP1;IFI16;PIK3R2;BST2;STAT2;NBEAL2;CD68;RSAD2;METTL7A;TKFC;STAT6;GLB1;DPP7;CTSD;SYNGR1;RORA;C6ORF120;SERPING1;RIPK3;NFASC;SERINC3
16620,GO:0097502,0.791064052716879,0.45062445512083,2,28,mannosylation,BP,PIGZ;DPY19L2P2
18362,GO:1903392,0.791389084212591,0.556302646776055,1,13,negative regulation of adherens junction organization,BP,DMTN
13463,GO:0055022,0.79142437427984,0.554727770641193,1,14,negative regulation of cardiac muscle tissue growth,BP,JARID2
14180,GO:0061117,0.79142437427984,0.554727770641193,1,14,negative regulation of heart growth,BP,JARID2
4682,GO:0010833,0.791550307474141,0.343692842651731,6,74,telomere maintenance via telomere lengthening,BP,SLX1A;SLX1B;XRN1;FBXO4;RAD50;PARN
10814,GO:0044321,0.791662707350619,0.554360640606328,1,14,response to leptin,BP,BBS2
10577,GO:0043558,0.791760031701159,0.554210640008617,1,14,regulation of translational initiation in response to stress,BP,IMPACT
3490,GO:0007369,0.791825991198837,0.306822366266026,11,121,gastrulation,BP,SFRP1;WNT3;TENM4;ITGB5;COL7A1;ITGA2;MAP2K5;RTF1;FZD7;COL6A1;NPHP3
11231,GO:0045445,0.791969262373886,0.37553483632244,4,51,myoblast differentiation,BP,CXCL14;BOC;BTG1;ZFP36L1
9890,GO:0042220,0.791980762569739,0.450305216948384,2,26,response to cocaine,BP,MDM2;HOMER2
19889,GO:2000406,0.792062556195005,0.552432020747262,1,15,positive regulation of T cell migration,BP,DOCK8
12280,GO:0048634,0.792074474428383,0.332815101492218,7,81,regulation of muscle organ development,BP,TSC22D3;CYP26B1;FLOT1;JARID2;FZD7;JPH2;AKAP6
12503,GO:0050663,0.792402432285343,0.316514225667531,9,109,cytokine secretion,BP,POSTN;ITGB6;FERMT1;F2R;TRPV4;C5;TNFRSF21;NLRP1;ALOX15B
5656,GO:0016763,0.792551625350627,0.40211079618572,3,40,transferase activity, transferring pentosyl groups,MF,NAPRT;PARP6;XYLT1
5886,GO:0018027,0.792559542920213,0.552976606642389,1,14,peptidyl-lysine dimethylation,BP,KDM3A
10268,GO:0043029,0.793194618728707,0.447495237003139,2,28,T cell homeostasis,BP,TSC22D3;RIPK3
13129,GO:0051721,0.793599436341956,0.447924659702081,2,26,protein phosphatase 2A binding,MF,STAT1;DAB2IP
16241,GO:0090317,0.793937847807049,0.445942848252785,2,29,negative regulation of intracellular protein transport,BP,PDE2A;DMTN
12992,GO:0051445,0.794008168771412,0.446789158587862,2,27,regulation of meiotic cell cycle,BP,PRKACB;INSR
4545,GO:0010628,0.794046474788361,0.234251585272634,134,1360,positive regulation of gene expression,BP,TP53INP1;SREBF1;ACTA2;EGFR;CIRBP;PKD2;CAPRIN2;RBM3;ASH2L;SRSF5;SFRP1;SEC14L2;EPHB2;DGKQ;PIK3R1;KDM3A;POU3F1;WNT3;RGMA;ZFPM1;CITED4;IRF2BPL;MC1R;STAT1;IMPACT;CAMK2N1;NOS1;MAML3;KLF13;NFATC4;RNF187;CYP26B1;HSF4;EAPP;MDM2;CRTC1;NDN;F2R;TRPV4;GLI2;ANK3;KLF7;LAMP3;TCEA2;ZNF76;SOX12;GJC2;PHF2;ABHD14B;WWTR1;ITGA2;GLI3;THRAP3;SMARCA1;MAP2K5;ITGA6;ZNF318;INSR;GSN;TTN;ZNF287;RTF1;MDK;BMP6;MAP2K2;SQSTM1;FZD7;ETV5;DLX3;HEXB;KDM4C;METTL23;TCF4;PLAG1;LPIN3;ATRX;HFE;ADIRF;ERCC6;SPRY2;MEF2D;CREBRF;MLXIPL;FBXW7;CDK5RAP3;LMO2;NFIX;CARF;THRA;RAI1;ELF1;IKZF4;DBP;PEG3;RFX2;SALL2;MAF;STK16;RET;DAB2IP;CASZ1;CALCOCO1;TEAD2;MYSM1;IFI16;FGFR4;PIK3R2;TEF;RPS6KA5;VDR;MAMSTR;PLXND1;SIX5;HLTF;PHF1;ZNF292;TFDP2;ACVR1B;TNNI2;NAT14;GLMP;IL11;KAT2B;ERN1;IVNS1ABP;ANGEL2;TRERF1;STAT6;CHD6;ERBB2;RORA;PPARG;ZFP90;NPNT
9463,GO:0036094,0.794224115857494,0.230499504598192,183,1811,small molecule binding,MF,ULK2;SIK1;SLFN5;PYGB;ACTA2;APOE;NT5E;OAS2;DDX60;HSPA2;EGFR;FAM20C;SYN1;ALDH1A3;MTHFR;SEC14L2;IFI44L;KIF26B;EPHB2;MAP3K14;GLUD1;DGKQ;BRSK1;TXNRD3;CUL9;H6PD;DHTKD1;CAMKK1;MVD;CRY2;RAB43;RAB40B;NOS1;PRKACB;CRY1;HMGCL;D2HGDH;CYP26B1;CMPK2;THNSL2;PIK3C2G;LIG1;CDK18;VPS11;SPEG;ITPR3;MLH3;NMRK1;DDX59;OBSCN;PRODH;MYH11;ACTR1B;RHOBTB2;UGT1A3;RAPGEF3;OAS1;GAL3ST4;KIF26A;PHYH;ALPK1;DNAH1;SLC27A3;NEK9;TRPV4;DHX32;CLCN6;PSKH1;MINK1;ULK1;THRAP3;SMARCA1;AKAP7;NAIP;NEK8;MAP2K5;SESN3;INSR;CHD3;CDK14;TTN;SLFNL1;SEPT6;DHX58;SLC27A1;NLRX1;ETNK2;SLC2A3;MAP2K2;OPLAH;PDK1;PTK6;PDIK1L;IDH2;MAP3K12;WRN;SEPT5;DNM1;MCM9;OARD1;ATRX;OSBPL10;SESN1;MAPK10;ERCC6;HADH;HLCS;NUDT6;PAK6;PFKFB2;ACADS;ASTN2;MX2;ACACB;ACCS;OGDHL;NLRP1;TK2;GLUL;SRR;MAP3K6;RIMKLB;MYO3B;WNK1;ARL11;PDE2A;SDHA;STK16;RET;ACOX3;PIK3C3;DALRD3;FGFR4;OSBPL5;MYO9A;RPS6KA5;VDR;NADK;BBS10;HLTF;STK19;RASL10B;LMTK3;ACVR1B;TSSK1B;DUOX1;WEE1;PTK7;DQX1;ACSL1;MARK4;TEP1;ERN1;RAD50;TKFC;PNPO;MTR;PEX1;SCYL3;SCG5;CBR4;KIF7;CHD6;ACSS2;ERBB2;ABCA2;TH;PPARG;PRKACA;SUCLG2;UCKL1;DDX12P;IP6K2;RIPK3;PI4K2B;LONP2;HARS2;CIT;MSH5;CLCN7;TTLL1;ABCA11P;GCLC
15121,GO:0071243,0.794311734260767,0.547797806788922,1,16,cellular response to arsenic-containing substance,BP,UROS
2945,GO:0006474,0.79431264660629,0.550259487437706,1,14,N-terminal protein amino acid acetylation,BP,KAT2B
3514,GO:0007435,0.794485793472706,0.446617301597453,2,26,salivary gland morphogenesis,BP,EGFR;PLXND1
18652,GO:1904019,0.794695959045324,0.353551492805559,5,60,epithelial cell apoptotic process,BP,TNFAIP3;PDCD4;GSN;DAB2IP;ZFP36L1
16209,GO:0090279,0.795679485422038,0.548130261637789,1,14,regulation of calcium ion import,BP,PKD2
2081,GO:0004842,0.795691338294355,0.257328189942988,36,379,ubiquitin-protein transferase activity,MF,TNFAIP3;DDB2;FBXO41;FBXW4;HERC3;TMEM129;RBCK1;RNF135;HERC5;RNF187;MDM2;SPSB3;RNF165;FBXO44;LRSAM1;NAIP;CBLC;FBXL16;GID4;SHARPIN;UBOX5;ZYG11B;KLHL24;FBXO2;FBXW7;FBXW5;KLHDC8B;FBXO4;RNF213;KLHL3;HLTF;MARCH8;RNF141;KLHL29;TRIM2;SMURF1
17645,GO:1901524,0.795797867985325,0.54794540161304,1,14,regulation of mitophagy,BP,SMURF1
14265,GO:0061371,0.795883432658195,0.398281863917409,3,37,determination of heart left/right asymmetry,BP,PKD2;NPHP3;BBS5
14579,GO:0070161,0.796062684480888,0.252316129155966,43,462,anchoring junction,CC,ITGB6;EGFR;FLNC;DIXDC1;TNS1;CSPG4;ASAP3;ITGB5;FERMT1;NDRG1;PARVB;FLRT3;PPL;TRPV4;FLOT1;TMEM204;FRMD4B;ITGA2;ITGA6;GSN;BAIAP2;TRIOBP;MAP2K2;FAT2;UBOX5;KLHL24;CYBA;MRC2;TNS2;LRP1;SYNPO2;CD99L2;SHROOM2;DLG5;TNS4;SHROOM4;CADM4;PTK7;CD9;MPRIP;MPP7;SYNE2;NFASC
12516,GO:0050681,0.796136451462306,0.397315727965883,3,39,androgen receptor binding,MF,KDM3A;KDM4C;FOXP2
724,GO:0001954,0.796155931499151,0.397582947101073,3,38,positive regulation of cell-matrix adhesion,BP,SFRP1;FERMT1;NINJ1
13493,GO:0055086,0.796165142946037,0.249476190808764,48,546,nucleobase-containing small molecule metabolic process,BP,PTHLH;APOE;NT5E;GAMT;FAM20C;PKD2;APOBEC3C;H6PD;DHTKD1;KCNAB2;NAPRT;NOS1;CMPK2;NMRK1;RAPGEF3;ADORA2B;SULT1E1;ABHD14B;INSR;PGLS;TCIRG1;ATP6V0A2;NPHP3;IDH2;MACROD1;OARD1;RRM2B;GABBR1;MLXIPL;GPR87;PGM1;PFKFB2;OGDHL;TK2;PPCS;PDE2A;SDHA;LTB4R2;NADK;NDUFV3;DLG4;MPI;RAD50;UAP1L1;NUDT10;RORA;UCKL1;PEMT
3946,GO:0008649,0.796489675833508,0.544392558211557,1,16,rRNA methyltransferase activity,MF,TARBP1
17285,GO:0140102,0.796489675833508,0.544392558211557,1,16,catalytic activity, acting on a rRNA,MF,TARBP1
17749,GO:1901798,0.796744161422392,0.543993095199175,1,16,positive regulation of signal transduction by p53 class mediator,BP,CDK5RAP3
2955,GO:0006487,0.797090635313816,0.336012457222991,6,78,protein N-linked glycosylation,BP,ST6GALNAC2;MVD;SRD5A3;ST6GALNAC6;ST3GAL5;PQLC3
15613,GO:0072132,0.797104675712895,0.442738642271027,2,26,mesenchyme morphogenesis,BP,ACTA2;MDM2
11787,GO:0046685,0.797291194626336,0.440977311305604,2,29,response to arsenic-containing substance,BP,UROS;GCLC
16838,GO:0098787,0.797365322993815,0.545490995395084,1,14,mRNA cleavage involved in mRNA processing,BP,ERN1
6628,GO:0023014,0.797380736955169,0.243866054744679,59,621,signal transduction by protein phosphorylation,BP,GPNMB;APOE;EGFR;SFRP1;EPHB2;MAP3K14;CSPG4;KITLG;CAMK2N1;RASA4;RGS2;F2R;PDCD4;SPTB;ZFP36L2;TRPV4;ADORA2B;MAPK8IP3;RASGEF1A;FRS3;C5;MINK1;MAP2K5;IGFBP4;INSR;CBLC;DDT;BMP6;MAP2K2;FZD7;SYNGAP1;GDF15;MAP3K12;MAPK10;SHANK3;ERCC6;SHC2;EDA2R;SPRY2;FBXW7;CDK5RAP3;PAK6;MAP3K6;WNK1;RET;DAB2IP;FGFR4;PIK3R2;ACVR1B;DLG4;TNFRSF25;ZFP36L1;IL11;IRS2;ERN1;RANBP9;ERBB2;ACKR3;NPNT
10138,GO:0042730,0.797520613234959,0.543924256615069,1,15,fibrinolysis,BP,SERPING1
14853,GO:0070661,0.797794325458594,0.290763535485604,13,156,leukocyte proliferation,BP,TNFAIP3;GPNMB;INPP5D;VAV3;KITLG;IL20RB;DOCK8;TNFRSF21;DLG5;CCDC88B;IRS2;ERBB2;RIPK3
796,GO:0002066,0.797799251136702,0.394949945465106,3,39,columnar/cuboidal epithelial cell development,BP,SLITRK6;TRIOBP;BMP6
8893,GO:0034724,0.797801305952765,0.392353833240157,3,51,DNA replication-independent nucleosome organization,BP,CENPC;ATRX;CENPH
19800,GO:2000279,0.797805302977228,0.441163485515757,2,27,negative regulation of DNA biosynthetic process,BP,XRN1;PPARG
18539,GO:1903779,0.797807521817778,0.395232891047495,3,38,regulation of cardiac conduction,BP,NOS1;ITPR3;PRKACA
19851,GO:2000352,0.797814375104566,0.54478552330515,1,14,negative regulation of endothelial cell apoptotic process,BP,TNFAIP3
390,GO:0001046,0.797834382221388,0.335631327804298,6,72,core promoter sequence-specific DNA binding,MF,KDM3A;STAT1;CRY1;THRAP3;RORA;PPARG
10052,GO:0042558,0.797851330663877,0.440144089786987,2,29,pteridine-containing compound metabolic process,BP,MTHFR;MTR
8515,GO:0033764,0.7980723062286,0.540889956680343,1,17,steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor,MF,HSD17B14
3540,GO:0007548,0.798105883541064,0.284303169754135,15,168,sex differentiation,BP,SFRP1;KITLG;TNFSF10;CTSV;LHFPL2;NUPR1;INSR;BMP6;CST3;ATRX;REC8;AGO4;SLIT3;ACVR1B;TCF7
2939,GO:0006465,0.798169619020904,0.541749454936111,1,16,signal peptide processing,BP,SPPL2B
18321,GO:1903307,0.798643714853509,0.439421162063005,2,28,positive regulation of regulated secretory pathway,BP,ADORA2B;SYT7
7655,GO:0032092,0.798652990931693,0.334336067361414,6,74,positive regulation of protein binding,BP,APOE;CAPRIN2;FLOT1;HFE;LRP1;PLXND1
2848,GO:0006334,0.798842834556754,0.321837111963683,7,116,nucleosome assembly,BP,H1F0;H1FX;CENPC;ATRX;TSPYL4;CENPH;NAP1L5
4700,GO:0010863,0.79905657434859,0.542828579176419,1,14,positive regulation of phospholipase C activity,BP,EGFR
10417,GO:0043277,0.799545572211142,0.438568400057602,2,27,apoptotic cell clearance,BP,SPG11;LRP1
336,GO:0000932,0.799625268994268,0.332946639838787,6,75,P-body,CC,APOBEC3C;BTBD2;SQSTM1;AGO4;XRN1;ZFP36L1
12165,GO:0048308,0.799874181967257,0.540208719326269,1,15,organelle inheritance,BP,MAP2K2
1380,GO:0003281,0.79998210530918,0.365100907295516,4,48,ventricular septum development,BP,ZFPM1;MDM2;LTBP1;PTK7
646,GO:0001837,0.800258850704999,0.313655424589599,8,94,epithelial to mesenchymal transition,BP,SFRP1;CUL7;PDCD4;WWTR1;S100A4;DAB2IP;DLG5;PBLD
14578,GO:0070160,0.800293002538705,0.313909787523728,8,90,occluding junction,CC,ANK3;FRMD4B;MICALL2;NPHP4;SHROOM2;PMP22;MPP7;PARD6G
4420,GO:0010226,0.800698181021319,0.540230132409831,1,14,response to lithium ion,BP,NFATC4
11451,GO:0045922,0.800699173365011,0.538899527911194,1,15,negative regulation of fatty acid metabolic process,BP,ACACB
8729,GO:0034389,0.800825986024802,0.538697972495558,1,15,lipid particle organization,BP,DDHD2
18345,GO:1903363,0.800912665693979,0.344496126315785,5,65,negative regulation of cellular protein catabolic process,BP,LAMP3;HFE;CDK5RAP3;DAB2IP;PANO1
11031,GO:0045026,0.800996644963753,0.537268825817427,1,16,plasma membrane fusion,BP,CD9
9717,GO:0038179,0.801461921978164,0.435698402796756,2,27,neurotrophin signaling pathway,BP,NDN;SPRY2
15734,GO:0072347,0.802015657536509,0.388916546665613,3,39,response to anesthetic,BP,MDM2;HOMER2;SRR
5353,GO:0016126,0.802060903934632,0.343065630795328,5,64,sterol biosynthetic process,BP,SREBF1;APOE;SEC14L2;MVD;ACACB
6199,GO:0019693,0.802146030024161,0.251978800993712,33,386,ribose phosphate metabolic process,BP,PTHLH;APOE;NT5E;FAM20C;PKD2;H6PD;DHTKD1;NOS1;RAPGEF3;ADORA2B;SULT1E1;ABHD14B;INSR;PGLS;TCIRG1;ATP6V0A2;NPHP3;GABBR1;MLXIPL;GPR87;PGM1;PFKFB2;OGDHL;PPCS;PDE2A;SDHA;LTB4R2;NADK;NDUFV3;DLG4;NUDT10;RORA;UCKL1
17372,GO:1900120,0.802198873131811,0.535350790491319,1,16,regulation of receptor binding,BP,HFE
3197,GO:0006826,0.802223912318778,0.387823421155278,3,42,iron ion transport,BP,TCIRG1;ATP6V0A2;HFE
69,GO:0000145,0.802456002548853,0.537432101376939,1,14,exocyst,CC,EXOC2
10063,GO:0042575,0.802479461403201,0.534902050015838,1,16,DNA polymerase complex,CC,POLD4
81,GO:0000165,0.802677029725,0.238639332504955,57,604,MAPK cascade,BP,GPNMB;APOE;EGFR;SFRP1;EPHB2;MAP3K14;CSPG4;KITLG;CAMK2N1;RASA4;RGS2;F2R;PDCD4;SPTB;ZFP36L2;TRPV4;ADORA2B;MAPK8IP3;RASGEF1A;FRS3;C5;MINK1;MAP2K5;IGFBP4;INSR;CBLC;DDT;BMP6;MAP2K2;FZD7;SYNGAP1;GDF15;MAP3K12;MAPK10;SHANK3;ERCC6;SHC2;EDA2R;SPRY2;FBXW7;CDK5RAP3;PAK6;MAP3K6;RET;DAB2IP;FGFR4;PIK3R2;DLG4;TNFRSF25;ZFP36L1;IL11;IRS2;ERN1;RANBP9;ERBB2;ACKR3;NPNT
15235,GO:0071425,0.802768535125532,0.53693292038686,1,14,hematopoietic stem cell proliferation,BP,KITLG
1319,GO:0003170,0.803054533816222,0.433837287279542,2,26,heart valve development,BP,ZFPM1;MDM2
12343,GO:0048738,0.803099297598153,0.288716362210678,12,126,cardiac muscle tissue development,BP,SIK1;OBSL1;TENM4;ZFPM1;MYH11;FHOD3;JARID2;TTN;FZD7;JPH2;LMNA;AKAP6
7311,GO:0031328,0.803128495254536,0.224931645171846,129,1304,positive regulation of cellular biosynthetic process,BP,TP53INP1;PTHLH;SREBF1;APOE;EGFR;CIRBP;PKD2;CAPRIN2;RBM3;ASH2L;SFRP1;SEC14L2;PIK3R1;KDM3A;POU3F1;RGMA;ZFPM1;KITLG;CITED4;IRF2BPL;MC1R;STAT1;IMPACT;NOS1;MAML3;KLF13;NFATC4;RNF187;HSF4;EAPP;CRTC1;NDN;RAPGEF3;F2R;GLI2;ADORA2B;KLF7;TCEA2;ZNF76;SOX12;PHF2;ABHD14B;WWTR1;ITGA2;GLI3;THRAP3;SMARCA1;MAP2K5;ITGA6;ZNF318;INSR;ZNF287;RTF1;MDK;BMP6;MAP2K2;SQSTM1;FZD7;ETV5;DLX3;HEXB;METTL23;PLA2G6;CST3;TCF4;PLAG1;LPIN3;ATRX;ADIRF;ERCC6;MEF2D;CREBRF;MLXIPL;FBXW7;CDK5RAP3;LMO2;NFIX;CARF;PFKFB2;THRA;RAI1;ELF1;IKZF4;DBP;EPM2AIP1;PEG3;RFX2;SALL2;MAF;STK16;RET;DAB2IP;CASZ1;CALCOCO1;TEAD2;MYSM1;FBXO4;IFI16;FGFR4;PIK3R2;TEF;AREG;RPS6KA5;VDR;MAMSTR;PLXND1;SIX5;HLTF;PHF1;ZNF292;TFDP2;ACVR1B;TNNI2;NAT14;GLMP;IL11;KAT2B;IRS2;IVNS1ABP;TRERF1;STAT6;CHD6;ERBB2;RORA;PPARG;PARN;ZFP90;NPNT;PEMT
3408,GO:0007190,0.803253858826035,0.536156730807267,1,14,activation of adenylate cyclase activity,BP,ADORA2B
2981,GO:0006525,0.803565817330755,0.534322699350739,1,15,arginine metabolic process,BP,NOS1
13047,GO:0051571,0.803653204100587,0.535517111855779,1,14,positive regulation of histone H3-K4 methylation,BP,RTF1
3166,GO:0006778,0.803865967092149,0.430701757041591,2,30,porphyrin-containing compound metabolic process,BP,UROS;BLVRB
10322,GO:0043130,0.803875995945928,0.340474460876185,5,65,ubiquitin binding,MF,TNFAIP3;RBCK1;SQSTM1;SHARPIN;MARK4
5857,GO:0017160,0.803992171654549,0.534973533013644,1,14,Ral GTPase binding,MF,EXOC2
761,GO:0002009,0.804057089403397,0.247016468563261,37,392,morphogenesis of an epithelium,BP,EGFR;PKD2;ALDH1A3;SFRP1;KIF26B;PRICKLE2;STAT1;PRKACB;NFATC4;CTSV;FLRT3;SERPINB5;GLI2;ARHGEF19;GLI3;CELSR1;FZD7;ETV5;NPHP3;PODXL;CA2;SPRY2;ASTN2;RET;TEAD2;BBS5;AREG;KLHL3;MYO9A;DLG5;VDR;PLXND1;NRARP;PTK7;SMURF1;NPNT;CTNNBIP1
11355,GO:0045737,0.804215423217586,0.430599901857605,2,29,positive regulation of cyclin-dependent protein serine/threonine kinase activity,BP,EGFR;PKD2
3553,GO:0007589,0.804455447312097,0.358099894418335,4,52,body fluid secretion,BP,OAS2;CYBA;WNK1;VDR
6704,GO:0030120,0.804602823325395,0.357894068206272,4,52,vesicle coat,CC,EGFR;AP1G2;CLTCL1;LDLRAP1
18456,GO:1903579,0.804642316012437,0.532592772752468,1,15,negative regulation of ATP metabolic process,BP,MLXIPL
7301,GO:0031312,0.805062381822006,0.42977693694721,2,28,extrinsic component of organelle membrane,CC,ULK1;ATG14
4138,GO:0009201,0.805400876503933,0.299874132247975,9,111,ribonucleoside triphosphate biosynthetic process,BP,DHTKD1;INSR;TCIRG1;ATP6V0A2;MLXIPL;PGM1;PFKFB2;OGDHL;UCKL1
7169,GO:0031058,0.805455730503962,0.325286245326994,6,74,positive regulation of histone modification,BP,SREBF1;NOS1;JARID2;RTF1;RPS6KA5;PHF1
4945,GO:0014912,0.805630732853936,0.530998954958948,1,15,negative regulation of smooth muscle cell migration,BP,LRP1
17580,GO:1901264,0.805694149418971,0.355865544882999,4,55,carbohydrate derivative transport,BP,SLC29A4;G6PC3;CYBA;SLC37A2
11463,GO:0045936,0.80580032723553,0.242422563795619,41,439,negative regulation of phosphate metabolic process,BP,TNFAIP3;APOE;SFRP1;EPHB2;DGKQ;ELFN2;IMPACT;CAMK2N1;CRY2;PIK3IP1;PHACTR3;FLRT3;RGS2;PDCD4;RTN4RL1;WWTR1;CBLC;CD109;SLC27A1;CEP192;PTK6;SPRY2;GABBR1;MLXIPL;GPR87;CDK5RAP3;ADARB1;WNK1;LTB4R2;DAB2IP;PIK3R2;PPP1R2;DMTN;PPP1R35;LMTK3;KAT2B;IRS2;PBLD;RANBP9;SPOCD1;ATG14
6858,GO:0030335,0.806094343286676,0.251323686144037,29,313,positive regulation of cell migration,BP,POSTN;GPNMB;EGFR;PIK3R1;CXCL14;KITLG;MDM2;F2R;CAPN7;TRPV4;ITGA2;SEMA4G;FAM110C;ITGA6;INSR;DOCK8;VEGFB;HYAL1;PODXL;SPRY2;PLA2G7;RET;DAB2IP;DMTN;ACVR1B;IRS2;SRPX2;SYNE2;ACKR3
1004,GO:0002478,0.806582360796686,0.287560017534971,11,141,antigen processing and presentation of exogenous peptide antigen,BP,VAMP3;ITGB5;HLA-B;ACTR1B;CTSV;KIF26A;CTSF;CYBA;HLA-A;OSBPL1A;CTSD
10597,GO:0043596,0.806640883018245,0.381698656905479,3,41,nuclear replication fork,CC,POLD4;ETAA1;ERCC5
17491,GO:1900745,0.806698270660252,0.529271673426546,1,15,positive regulation of p38MAPK cascade,BP,MINK1
4183,GO:0009262,0.806773734531419,0.42552797173915,2,32,deoxyribonucleotide metabolic process,BP,CMPK2;RRM2B
15433,GO:0071786,0.806779148869412,0.529140562202709,1,15,endoplasmic reticulum tubular network organization,BP,REEP2
18787,GO:1904375,0.806910123922142,0.323340007588053,6,74,regulation of protein localization to cell periphery,BP,EGFR;EPHB2;PIK3R1;SQSTM1;LRP1;LDLRAP1
11646,GO:0046425,0.80693759303069,0.323010154620989,6,77,regulation of JAK-STAT cascade,BP,FLRT3;RTN4RL1;PTK6;CTF1;CDK5R1;RET
10682,GO:0043981,0.80703193582662,0.528730543144143,1,15,histone H4-K5 acetylation,BP,ING4
10683,GO:0043982,0.80703193582662,0.528730543144143,1,15,histone H4-K8 acetylation,BP,ING4
14643,GO:0070266,0.8071607192282,0.426133956877899,2,29,necroptotic process,BP,RBCK1;RIPK3
868,GO:0002218,0.807162945315766,0.265781689482802,18,209,activation of innate immune response,BP,TNFAIP3;MUC19;DDX60;PTPRS;PRKACB;FLOT1;DHX58;NLRX1;CYBA;CTSB;DAB2IP;PIK3C3;IFI16;RPS6KA5;RSAD2;TKFC;SMPDL3B;PRKACA
13479,GO:0055067,0.807400873030194,0.31237995097935,7,86,monovalent inorganic cation homeostasis,BP,SCNN1A;TCIRG1;SLC12A7;ATP6V0A2;CA2;KCNMA1;DMXL2
5438,GO:0016307,0.807493746279413,0.529322286682547,1,14,phosphatidylinositol phosphate kinase activity,MF,PIK3C2G
18379,GO:1903429,0.807575129566053,0.527848317797646,1,15,regulation of cell maturation,BP,RET
5816,GO:0017085,0.807785073861225,0.527506909877652,1,15,response to insecticide,BP,TH
18520,GO:1903749,0.807866134823905,0.311462793701892,7,90,positive regulation of establishment of protein localization to mitochondrion,BP,VPS11;HPS4;MICALL2;OSCP1;FBXW7;TFDP2;PEMT
13605,GO:0060122,0.807977935332678,0.527193071137544,1,15,inner ear receptor cell stereocilium organization,BP,TRIOBP
8681,GO:0034314,0.808230699130323,0.424503758303328,2,29,Arp2/3 complex-mediated actin nucleation,BP,WHAMMP3;WASH3P
14925,GO:0070838,0.808317983889431,0.257400334364473,22,241,divalent metal ion transport,BP,HSPA2;PKD2;ORAI3;NOS1;ITPR3;F2R;SLC24A1;TRPV4;GJC2;GSTM2;NIPAL2;PLA2G6;HOMER2;CYBA;JPH2;PDE2A;VDR;CACNB3;ORAI2;CACNB1;AKAP6;PRKACA
13482,GO:0055072,0.808397394024206,0.33418169112683,5,66,iron ion homeostasis,BP,CYBRD1;NEO1;BMP6;ATP6V0A2;HFE
12722,GO:0051010,0.808594671018696,0.529091068157936,1,13,microtubule plus-end binding,MF,CLIP2
7885,GO:0032461,0.808712483801416,0.524825832727559,1,16,positive regulation of protein oligomerization,BP,MMP1
1011,GO:0002495,0.808832666531863,0.320563389147428,6,76,antigen processing and presentation of peptide antigen via MHC class II,BP,ACTR1B;CTSV;KIF26A;CTSF;OSBPL1A;CTSD
8231,GO:0033013,0.808912958290017,0.377909259957221,3,43,tetrapyrrole metabolic process,BP,UROS;BLVRB;MTR
12525,GO:0050691,0.80909392057999,0.423185522320315,2,29,regulation of defense response to virus by host,BP,TNFAIP3;STAT1
6888,GO:0030427,0.809336994457518,0.284764891823036,11,124,site of polarized growth,CC,FLRT3;TRPV4;ADGRL1;BOC;TRAK1;MAP3K12;CDK5R1;ORAI2;SHANK2;APBB2;PTBP2
7209,GO:0031111,0.80944216830917,0.423605201325476,2,27,negative regulation of microtubule polymerization or depolymerization,BP,APC2;EML2
507,GO:0001570,0.809616823624984,0.351426746257525,4,49,vasculogenesis,BP,CUL7;TEAD2;ZFP36L1;ACKR3
7913,GO:0032496,0.80964349323544,0.264904996600609,17,201,response to lipopolysaccharide,BP,TNFAIP3;NOS1;CMPK2;F2R;PDCD4;ADAMTS13;TNFRSF14;MGST2;BMP6;LOXL1;TNFRSF21;SRR;ACP5;DAB2IP;VDR;TNFRSF25;TH
16095,GO:0090101,0.809783502424571,0.319585944209473,6,73,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,BP,SFRP1;HTRA1;LTBP1;CD109;PBLD;SMURF1
3274,GO:0006953,0.80986526882618,0.522939321953924,1,16,acute-phase response,BP,HFE
4510,GO:0010563,0.809982435369695,0.23764153818795,41,440,negative regulation of phosphorus metabolic process,BP,TNFAIP3;APOE;SFRP1;EPHB2;DGKQ;ELFN2;IMPACT;CAMK2N1;CRY2;PIK3IP1;PHACTR3;FLRT3;RGS2;PDCD4;RTN4RL1;WWTR1;CBLC;CD109;SLC27A1;CEP192;PTK6;SPRY2;GABBR1;MLXIPL;GPR87;CDK5RAP3;ADARB1;WNK1;LTB4R2;DAB2IP;PIK3R2;PPP1R2;DMTN;PPP1R35;LMTK3;KAT2B;IRS2;PBLD;RANBP9;SPOCD1;ATG14
5271,GO:0015923,0.809999305830079,0.525237742898485,1,14,mannosidase activity,MF,MAN1B1
4065,GO:0009117,0.810001456205589,0.237423965163649,41,475,nucleotide metabolic process,BP,PTHLH;APOE;NT5E;FAM20C;PKD2;H6PD;DHTKD1;KCNAB2;NAPRT;NOS1;CMPK2;NMRK1;RAPGEF3;ADORA2B;SULT1E1;ABHD14B;INSR;PGLS;TCIRG1;ATP6V0A2;NPHP3;IDH2;RRM2B;GABBR1;MLXIPL;GPR87;PGM1;PFKFB2;OGDHL;TK2;PPCS;PDE2A;SDHA;LTB4R2;NADK;NDUFV3;DLG4;RAD50;NUDT10;RORA;UCKL1
7928,GO:0032516,0.810194889829174,0.524917455338867,1,14,positive regulation of phosphoprotein phosphatase activity,BP,AKAP6
12356,GO:0048762,0.810195081711555,0.279382319683997,12,137,mesenchymal cell differentiation,BP,SFRP1;KITLG;CUL7;STAT1;PDCD4;WWTR1;SEMA4G;S100A4;RET;DAB2IP;DLG5;PBLD
4022,GO:0009056,0.810320365038184,0.212789600659909,191,1986,catabolic process,BP,TNFAIP3;SERPINE2;ULK2;EPM2A;TP53INP1;SREBF1;AMACR;PYGB;APOE;GPSM1;CES2;NT5E;OAS2;FBXW4;EGFR;TRIM65;CIRBP;APOBEC3C;CPT2;TRIM22;PLCD3;CTSO;GPX3;GLUD1;TMEM129;ADAMTS7;RBCK1;CUL9;DHTKD1;UBXN4;CSPG4;ISG15;MVB12B;SPATA18;CUL7;SRD5A3;COL10A1;NOS1;SDC3;MAGEF1;HMGCL;BTBD2;RNF187;H1F0;CYP26B1;GAA;THNSL2;VPS11;COL7A1;NAGLU;MDM2;PLCD1;TYSND1;IDUA;PRODH;HGSNAT;CYP3A5;RAPGEF3;SPSB3;PCBP4;CTSV;BLVRB;CRAT;MLYCD;PHYH;ZFP36L2;RNF165;ADAMTS13;LAMP3;PLCH2;ATG16L2;ZCCHC11;RHBDF1;SULT1E1;FBXO44;HEXA;GSTM2;WWTR1;ULK1;THRAP3;LRSAM1;CES3;SESN3;LZTS1;MMP1;GPC2;INSR;TST;ALDH4A1;CBLC;RNPEPL1;CTSF;CYP2D7;VPS39;MGST2;ENDOG;GID4;TCIRG1;ALDH7A1;SQSTM1;SHARPIN;HEXB;HYAL1;ARRDC1;PLA2G6;CST3;PEX7;ATP6V0A2;COL6A1;PLD3;LPIN3;CDK5R1;SESN1;HFE;AGO4;HADH;MRC2;FBXO2;XRN1;MLXIPL;CTSB;FBXW7;CDK5RAP3;PGM1;PFKFB2;THRA;APC2;ACADS;ACACB;OGDHL;GLUL;TBC1D17;C17ORF97;FBXW5;LRP1;ATE1;PLA2G7;SYNPO2;RNPEP;BDH1;PDE2A;DAB2IP;ACOX3;DDHD2;FBXO4;RNF213;PIK3C3;IFI16;PIK3R2;ABTB1;KLHL3;ETFB;TNRC6C;SNX1;PANO1;DUOX1;GALE;AMT;ZFP36L1;ACSL1;IRS2;IMPA2;ERN1;HSD17B14;TKFC;ANGEL2;MAN1B1;ECI1;TRERF1;FAAH;SGSH;TNFSF12;PRDX5;SMPDL3B;GLB1;CPT1C;GSTM3;PTPN3;CTSD;COL13A1;PLCB3;NUDT10;ATG14;PRKACA;PARN;UFL1;LONP2;SNX33;EHHADH;SMURF1;GCLC
181,GO:0000394,0.810339302515763,0.521131372473665,1,17,RNA splicing, via endonucleolytic cleavage and ligation,BP,ERN1
200,GO:0000422,0.810583459256614,0.31811449569448,6,77,autophagy of mitochondrion,BP,SREBF1;SPATA18;SQSTM1;FBXW7;ATG14;SMURF1
14402,GO:0061726,0.810583459256614,0.31811449569448,6,77,mitochondrion disassembly,BP,SREBF1;SPATA18;SQSTM1;FBXW7;ATG14;SMURF1
12175,GO:0048339,0.810907951948366,0.523747960386722,1,14,paraxial mesoderm development,BP,TEAD2
4254,GO:0009583,0.811032641564175,0.420673109256444,2,28,detection of light stimulus,BP,EYS;UNC119
8575,GO:0034080,0.81109894317664,0.416641307170689,2,40,CENP-A containing nucleosome assembly,BP,CENPC;CENPH
14370,GO:0061641,0.81109894317664,0.416641307170689,2,40,CENP-A containing chromatin organization,BP,CENPC;CENPH
7551,GO:0031901,0.811363556855908,0.292422463061264,9,107,early endosome membrane,CC,EGFR;NSG1;HLA-B;WASH3P;HLA-A;APPL2;SNX21;MARCH8;SNX1
2754,GO:0006165,0.811820225362875,0.30645808431362,7,87,nucleoside diphosphate phosphorylation,BP,DHTKD1;CMPK2;INSR;MLXIPL;PGM1;PFKFB2;OGDHL
19147,GO:1905209,0.811897634747017,0.520770580194209,1,15,positive regulation of cardiocyte differentiation,BP,AKAP6
5072,GO:0015297,0.811966617949482,0.347723007952955,4,51,antiporter activity,MF,SLC24A1;CLCN6;SLC37A2;CLCN7
3470,GO:0007292,0.812074243938727,0.316396353766313,6,74,female gamete generation,BP,MLH3;HEXB;MCM9;REC8;PAQR7;PARN
722,GO:0001952,0.812140504796573,0.306444853942416,7,82,regulation of cell-matrix adhesion,BP,POSTN;SFRP1;PIK3R1;FERMT1;NINJ1;MINK1;DMTN
7175,GO:0031065,0.812221994402729,0.520235317640721,1,15,positive regulation of histone deacetylation,BP,SREBF1
6648,GO:0030003,0.812477308177968,0.242801949031479,30,334,cellular cation homeostasis,BP,APOE;PKD2;CYBRD1;NOS1;ITPR3;F2R;MT1X;SLC24A1;TRPV4;GSTM2;NMU;BMP6;TCIRG1;HEXB;PLA2G6;ATP6V0A2;CA2;HFE;CYBA;KCNMA1;JPH2;TMEM203;VDR;LETMD1;CACNB3;LPAR6;DLG4;DMXL2;AKAP6;PRKACA
16986,GO:0099106,0.812551821028208,0.346540734324283,4,53,ion channel regulator activity,MF,KCNAB2;WNK1;PHPT1;KCNS3
11610,GO:0046329,0.812615639934814,0.418237203606844,2,28,negative regulation of JNK cascade,BP,SFRP1;PDCD4
16063,GO:0090050,0.812650958565644,0.519526536873555,1,15,positive regulation of cell migration involved in sprouting angiogenesis,BP,SRPX2
815,GO:0002089,0.812698805692865,0.52079834362467,1,14,lens morphogenesis in camera-type eye,BP,SHROOM2
10511,GO:0043457,0.813303083338079,0.517270033844747,1,16,regulation of cellular respiration,BP,TRPV4
5883,GO:0018024,0.813543449076561,0.371885303683117,3,40,histone-lysine N-methyltransferase activity,MF,ASH2L;DYDC1;KMT5C
7392,GO:0031463,0.813573661069257,0.345445838536608,4,51,Cul3-RING ubiquitin ligase complex,CC,KLHL24;KLHDC8B;KLHL3;KLHL29
1474,GO:0003746,0.814112452029026,0.51592576351165,1,16,translation elongation factor activity,MF,ABTB1
5526,GO:0016505,0.814134481143661,0.515889124374108,1,16,peptidase activator activity involved in apoptotic process,MF,NLRP1
11828,GO:0046823,0.814295553011744,0.515621144642907,1,16,negative regulation of nucleocytoplasmic transport,BP,PDE2A
9944,GO:0042325,0.814572308662475,0.215606139946984,102,1038,regulation of phosphorylation,BP,TNFAIP3;GPNMB;APOE;HSPA2;EGFR;PKD2;CAPRIN2;SFRP1;EPHB2;MAP3K14;DGKQ;PIK3R1;CAMKK1;HERC5;VAV3;CSPG4;KITLG;IMPACT;CAMK2N1;PRKACB;SPDYE6;PIK3IP1;RAPGEF3;FLRT3;RGS2;F2R;PDCD4;RTN4RL1;TRPV4;FLOT1;ADORA2B;MAPK8IP3;SPDYE5;GJC2;UNC119;C5;MINK1;WWTR1;MAP2K5;ITGA6;IGFBP4;INSR;TTN;CBLC;DDT;CD109;ETAA1;PILRB;SLC27A1;RICTOR;BMP6;MAP2K2;SQSTM1;PTK6;FZD7;SYNGAP1;PLA2G6;GDF15;CTF1;MAP3K12;CDK5R1;MAPK10;HFE;ERCC6;SHC2;EDA2R;SPRY2;MLXIPL;FBXW7;CDK5RAP3;PAK6;PFKFB2;ADARB1;NAB2;MAP3K6;WNK1;RET;DAB2IP;FGFR4;PIK3R2;AREG;RPS6KA5;DMTN;STAT2;ACVR1B;DLG4;TNFRSF25;ACSL1;IL11;KAT2B;IRS2;ERN1;RAD50;PBLD;SRPX2;RANBP9;ERBB2;ATG14;PRKACA;ACKR3;RIPK3;NPNT
74,GO:0000151,0.814876311217874,0.246679368308011,24,267,ubiquitin ligase complex,CC,DDB2;FBXW4;DCAF16;RBCK1;CUL9;CUL7;BTBD2;SPSB3;FBXO44;SHARPIN;ZYG11B;KLHL24;FBXO2;FBXW7;DCAF10;FBXW5;KLHDC8B;FBXO4;ABTB1;KLHL3;ZSWIM8;DCAF8;PHC2;KLHL29
15792,GO:0072511,0.814924938593673,0.249501421532436,22,242,divalent inorganic cation transport,BP,HSPA2;PKD2;ORAI3;NOS1;ITPR3;F2R;SLC24A1;TRPV4;GJC2;GSTM2;NIPAL2;PLA2G6;HOMER2;CYBA;JPH2;PDE2A;VDR;CACNB3;ORAI2;CACNB1;AKAP6;PRKACA
5408,GO:0016254,0.814946788792373,0.51350011482151,1,17,preassembly of GPI anchor in ER membrane,BP,PIGZ
8529,GO:0033866,0.81503486510274,0.514389260832435,1,16,nucleoside bisphosphate biosynthetic process,BP,PPCS
8553,GO:0034030,0.81503486510274,0.514389260832435,1,16,ribonucleoside bisphosphate biosynthetic process,BP,PPCS
8556,GO:0034033,0.81503486510274,0.514389260832435,1,16,purine nucleoside bisphosphate biosynthetic process,BP,PPCS
5657,GO:0016765,0.815121158247311,0.36797158908617,3,47,transferase activity, transferring alkyl or aryl (other than methyl) groups,MF,GSTM2;MGST2;GSTM3
12386,GO:0048844,0.815198347939048,0.370017571674954,3,38,artery morphogenesis,BP,APOE;PKD2;LRP1
11772,GO:0046653,0.815263339354284,0.514007941620937,1,16,tetrahydrofolate metabolic process,BP,MTHFR
4569,GO:0010657,0.815293749461531,0.369307738947667,3,40,muscle cell apoptotic process,BP,PDCD4;RGL2;PPARG
7883,GO:0032459,0.815346003337517,0.413129394868026,2,30,regulation of protein oligomerization,BP,APOE;MMP1
5896,GO:0018105,0.815534954779565,0.253852339458709,19,210,peptidyl-serine phosphorylation,BP,EGFR;CAPRIN2;DGKQ;CAMKK1;RAPGEF3;PSKH1;ULK1;RICTOR;MAP2K2;MAP3K12;CDK5R1;SPRY2;MLXIPL;RET;RPS6KA5;DMTN;IL11;ERN1;PRKACA
7957,GO:0032570,0.815920632577076,0.412663011748191,2,29,response to progesterone,BP,SREBF1;TXNIP
19024,GO:1904892,0.816038721863743,0.310649287757535,6,78,regulation of STAT cascade,BP,FLRT3;RTN4RL1;PTK6;CTF1;CDK5R1;RET
17563,GO:1901215,0.816165548705622,0.275808692276982,11,131,negative regulation of neuron death,BP,GPNMB;APOE;UNC5B;F2R;NAIP;MDK;SYNGAP1;MAP3K12;LRP1;SNCB;GCLC
7285,GO:0031290,0.816324724817262,0.514771192914608,1,14,retinal ganglion cell axon guidance,BP,EPHB2
18342,GO:1903358,0.816459131172901,0.513189007868419,1,15,regulation of Golgi organization,BP,MAP2K2
11577,GO:0046173,0.816617381319018,0.366841148840004,3,42,polyol biosynthetic process,BP,IMPA2;ISYNA1;IP6K2
11254,GO:0045576,0.816925069627923,0.410673972980678,2,30,mast cell activation,BP,NDRG1;ADORA2B
11335,GO:0045684,0.816948554274836,0.410637383179876,2,30,positive regulation of epidermis development,BP,VDR;ALOX15B
7167,GO:0031056,0.816955276985064,0.279680428947289,10,117,regulation of histone modification,BP,SREBF1;MTHFR;KDM3A;NOS1;JARID2;RTF1;KDM4C;ATRX;RPS6KA5;PHF1
2839,GO:0006308,0.81736737955885,0.40998448706023,2,30,DNA catabolic process,BP,H1F0;ENDOG
16926,GO:0098930,0.817455893228092,0.365848908571019,3,41,axonal transport,BP,BLOC1S4;TRAK1;BLOC1S3
4728,GO:0010894,0.817471031730179,0.510308112142509,1,16,negative regulation of steroid biosynthetic process,BP,APOE
11465,GO:0045939,0.817471031730179,0.510308112142509,1,16,negative regulation of steroid metabolic process,BP,APOE
4576,GO:0010664,0.817531308803432,0.511389872362653,1,15,negative regulation of striated muscle cell apoptotic process,BP,RGL2
16240,GO:0090316,0.817658492181713,0.266167378215247,13,154,positive regulation of intracellular protein transport,BP,VPS11;MDM2;RAPGEF3;HPS4;ANK3;GLI3;VAMP2;MICALL2;OSCP1;CDK5R1;FBXW7;ERBB2;PEMT
11044,GO:0045055,0.817750904469115,0.225620437633389,47,512,regulated exocytosis,BP,PYGB;SYT8;CXCR1;SYN1;KCNAB2;VAMP3;NAPRT;GAA;HGSNAT;SYTL1;ACTR1B;ENDOD1;C2CD4C;TMC6;ADORA2B;RIMS3;LHFPL2;SYT15;VAMP2;GSN;TTN;CD109;SLC2A3;TCIRG1;VEGFB;HEXB;CST3;SEPT5;CYBA;CTSB;PGM1;RPH3AL;SYT7;BST2;DMTN;NBEAL2;CD68;METTL7A;GLB1;DPP7;CD9;CTSD;SYNGR1;C6ORF120;SERPING1;NFASC;ECM1
7886,GO:0032462,0.81780238388271,0.508710780391236,1,17,regulation of protein homooligomerization,BP,APOE
5917,GO:0018195,0.817986163482326,0.508400962319832,1,17,peptidyl-arginine modification,BP,PRMT3
12166,GO:0048311,0.818159134283043,0.511693467843279,1,14,mitochondrion distribution,BP,TRAK1
7239,GO:0031201,0.818195759605353,0.364266613771741,3,43,SNARE complex,CC,VAMP3;VAMP2;TSNARE1
16227,GO:0090303,0.81836426736007,0.4088537265695,2,29,positive regulation of wound healing,BP,F2R;DMTN
9925,GO:0042287,0.818535071668022,0.50851498130515,1,16,MHC protein binding,MF,PILRB
4155,GO:0009219,0.818669569908131,0.506325792414458,1,18,pyrimidine deoxyribonucleotide metabolic process,BP,CMPK2
360,GO:0000979,0.818817324800242,0.408144956455188,2,29,RNA polymerase II core promoter sequence-specific DNA binding,MF,KDM3A;STAT1
1467,GO:0003725,0.81882254244368,0.320153301258262,5,63,double-stranded RNA binding,MF,OAS2;DDX60;OAS1;DHX58;AGO4
15008,GO:0070971,0.818893489683281,0.509094595474708,1,15,endoplasmic reticulum exit site,CC,MPPE1
14528,GO:0070069,0.819135483564282,0.502709518051901,1,22,cytochrome complex,CC,NDUFA4L2
4156,GO:0009220,0.819152393245275,0.50550851466675,1,18,pyrimidine ribonucleotide biosynthetic process,BP,UCKL1
11562,GO:0046132,0.819152393245275,0.50550851466675,1,18,pyrimidine ribonucleoside biosynthetic process,BP,UCKL1
1396,GO:0003323,0.819215427192309,0.508550566940557,1,15,type B pancreatic cell development,BP,BMP6
13801,GO:0060419,0.819220452131043,0.337392609936787,4,51,heart growth,BP,TENM4;JARID2;ACACB;AKAP6
18561,GO:1903828,0.81945555207787,0.306091701123766,6,77,negative regulation of cellular protein localization,BP,LZTS2;ASTN2;PDE2A;FBXO4;DMTN;SNX33
10536,GO:0043502,0.819458207846476,0.337051743398276,4,51,regulation of muscle adaptation,BP,RGS2;JARID2;LMNA;AKAP6
472,GO:0001516,0.819476109970259,0.505882041500271,1,17,prostaglandin biosynthetic process,BP,PTGS1
11659,GO:0046457,0.819476109970259,0.505882041500271,1,17,prostanoid biosynthetic process,BP,PTGS1
329,GO:0000920,0.819501098566823,0.505839686600347,1,17,cell separation after cytokinesis,BP,CHMP1B
10558,GO:0043535,0.82005516198799,0.318307066082001,5,64,regulation of blood vessel endothelial cell migration,BP,APOE;MAP2K5;MMRN2;SRPX2;PPARG
9679,GO:0038084,0.820242024157322,0.506811751180821,1,15,vascular endothelial growth factor signaling pathway,BP,DAB2IP
10188,GO:0042809,0.820270165921624,0.506763999319248,1,15,vitamin D receptor binding,MF,THRAP3
1014,GO:0002504,0.820298573164343,0.304941076990159,6,77,antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,ACTR1B;CTSV;KIF26A;CTSF;OSBPL1A;CTSD
15876,GO:0072666,0.82042127478499,0.361703664642753,3,40,establishment of protein localization to vacuole,BP,TNFAIP3;WASH3P;SMURF1
5557,GO:0016572,0.820574686124552,0.40538820293494,2,29,histone phosphorylation,BP,MAP3K12;RPS6KA5
2581,GO:0005874,0.820603601060772,0.232506631670599,31,332,microtubule,CC,MAP6;KIF26B;KCNAB2;REEP2;NDRG1;LZTS2;KIF26A;DNAH1;TUBGCP5;TRPV4;NINL;FAM110C;TPGS1;GAS8;BAIAP2;MAP2K2;DNM1;CDK5R1;HOOK2;CLIP2;SPRY2;CDK5RAP3;APC2;REEP4;SHROOM2;EML3;ARFGEF2;KIF7;MAP1A;TTLL1;EML2
15875,GO:0072665,0.820860665576419,0.334859056924805,4,52,protein localization to vacuole,BP,TNFAIP3;WASH3P;C12ORF66;SMURF1
33,GO:0000062,0.820873694029526,0.503507630486814,1,17,fatty-acyl-CoA binding,MF,HMGCL
184,GO:0000400,0.821027862542979,0.504288537150261,1,16,four-way junction DNA binding,MF,WRN
2536,GO:0005794,0.821322977759775,0.206937033113246,112,1140,Golgi apparatus,CC,TGFBI;POSTN;MUC19;MAP6;PTHLH;SREBF1;APOE;GPSM1;ADAM19;LMF1;EGFR;FAM20C;SYN1;TRIM22;OBSL1;PIK3R1;CXCL14;SULF2;WNT3;ST6GALNAC2;CSPG4;ZDHHC1;CUL7;VAMP3;NSG1;RAB43;B4GALNT4;SDC3;SCARA3;H1F0;COL7A1;ST6GALNAC6;GOLGA8A;HLA-B;NEO1;GAL3ST4;B4GALT6;AP1G2;F2R;SPTB;CLTCL1;TMC6;ANK3;MAPK8IP3;GOLGA8B;PIDD1;RHBDF1;PTGS1;PSKH1;MINK1;ASAP2;SPPL2B;VAMP2;GAS8;GPC2;ST3GAL5;BAIAP2;B4GALT2;MAP2K2;AKR7A2;KIAA0319L;B3GNT9;GDF15;MALL;DNM1;ZDHHC12;CYBA;ANKRD28;APC2;ARAP1;GOLGA8N;SLC2A1;NDST2;HLA-A;PMEL;PDE2A;DDHD2;FGFR4;AREG;BST2;PHF7;PCSK6;MPPE1;ARFGEF2;LMTK3;SNX1;GOLGA7B;NECAB3;CCDC88B;IGFBP6;GOLGA6L4;SLC35G2;RSAD2;XYLT1;CLSTN3;LAPTM4A;MAN1B1;SCYL3;PCSK1N;GLB1;GOLGA1;GOLGB1;DPP7;ZDHHC24;LDLRAP1;FMNL3;GCNT4;PI4K2B;COG1;KCNS3;CIT;SERINC3
391,GO:0001047,0.821608424320692,0.273680726938529,10,117,core promoter binding,MF,KDM3A;STAT1;CRY1;THRAP3;IRF9;CALCOCO1;IFI16;TCF7;RORA;PPARG
20238,GO:2001224,0.821648367920774,0.505785545171271,1,14,positive regulation of neuron migration,BP,DAB2IP
6758,GO:0030199,0.821753164040731,0.404484369735529,2,27,collagen fibril organization,BP,TNXB;LOXL1
2403,GO:0005575,0.822431719587903,0.225083907269356,1192,11689,cellular_component,CC,TNFAIP3;TGFBI;POSTN;TAGLN;ITGB6;HES2;SERPINE2;ZSCAN18;ULK2;GPNMB;TSC22D1;SIK1;SLFN5;SUGCT;EPM2A;MUC19;NPEPL1;DDB2;TP53INP1;MAP6;IFI6;PTHLH;SREBF1;AMACR;PYGB;MXRA5;NYNRIN;ACTA2;APOE;GPSM1;CES2;NT5E;ALS2CL;INPP5D;APCDD1;GAMT;FBXO41;LOC441081;OAS2;ADAM19;MN1;LMF1;PSD4;DDX60;HSPA2;FBXW4;EGFR;ESPN;TRIM65;FAM117A;HERC3;GIGYF1;PTPRS;CIRBP;FLNC;FAM20C;PKD2;CAPRIN2;MNT;XPC;APOBEC3C;SYT8;CXCR1;CPT2;RBM3;SYN1;ASH2L;DIXDC1;TRIM22;ALDH1A3;SRSF5;LRIG3;PLCD3;SLITRK6;CTSO;SFRP1;OBSL1;MTHFR;PERM1;SEC14L2;KCTD11;IFI44L;KIF26B;PCDH1;EPS8L2;EPHB2;RALGDS;TNS1;SYNC;GPX3;MAP3K14;GLUD1;BPHL;DCAF16;DGKQ;TMEM129;PIK3R1;ADAMTS7;EVI5L;BRSK1;TXNRD3;MARVELD1;RBCK1;KDM3A;ORAI3;CXCL14;DOCK9;COL22A1;TSC22D3;CUL9;EYS;EVC;RNF135;POU3F1;SULF2;WNT3;H6PD;DHTKD1;CAMKK1;HERC5;UBXN4;VAV3;ST6GALNAC2;UNK;HR;SMOC2;VWCE;CSPG4;ISG15;MVB12B;CYBRD1;ELFN2;HTRA1;SPATA18;TFCP2L1;TENM4;UNC119B;RGMA;PI4KAP2;KCNAB2;ZFPM1;KITLG;TP53I11;HOXC5;SDK2;MVD;ZDHHC1;ZNF362;CUL7;VAMP3;CITED4;SNN;IRF2BPL;NAPRT;REEP2;PRICKLE2;KCNJ15;MC1R;ASAP3;ZNF266;SRD5A3;OR2A4;C1QTNF6;STAT1;IMPACT;CSMD2;CAMK2N1;CRY2;MYL9;GRIP2;KRT15;HS1BP3;LGALS7B;WDR63;MARCKSL1;NSG1;UNC5B;UROS;SLC16A5;KDSR;ITGB5;COL10A1;GJD3;RAB43;RAB40B;NOS1;PRKACB;ZNF704;HOXA3;B4GALNT4;CRY1;ZNF699;MAML3;ZFP41;SCMH1;KLF13;CRTAP;DIP2C;SDC3;BCAM;MAGEF1;PLEKHG5;NFATC4;PITPNM3;ZNF783;IQSEC2;HMGCL;D2HGDH;BTBD2;SCARA3;FKBP5;RNF187;TMEM200B;FERMT1;H1F0;CYP26B1;GAA;AP5Z1;CMPK2;THNSL2;HSF4;CNTRL;ZNF251;MICALL1;PIK3C2G;LIG1;CDK18;TBC1D8;PLXNB1;VPS11;SPEG;NDRG1;COL7A1;KCNC4;SPOCK1;SLC29A4;ITPR3;EAPP;NAGLU;CYHR1;MDM2;CRTC1;LZTS2;PLCD1;NDN;IFITM1;MLH3;NMRK1;DDX59;ST6GALNAC6;PPP2R2C;FCGRT;CSMD3;CHN2;ZNF662;TYSND1;LTBP4;PIK3IP1;OBSCN;IDUA;GOLGA8A;GPRC5C;HLA-B;TNFSF10;PRODH;HGSNAT;MYH11;PARVB;SYTL1;FKBP9;NDUFA4L2;CALML3;ACTR1B;TNXB;RHOBTB2;UGT1A3;CERS4;CYP3A5;ACOT1;NEO1;RAPGEF3;PHACTR3;ZNF414;SPSB3;TCF25;ENDOD1;PCBP4;NINJ1;FAM210B;CTSV;NLGN4Y;POLH;SH3TC1;SPATA20;BLVRB;POLR2J2;OAS1;FLRT3;NUDCD3;RASA4;TRIM66;GAL3ST4;CRAT;KIF26A;B4GALT6;MLLT6;AP1G2;RGL4;RGS2;ARPIN;TMEM63C;ACAP3;IL20RB;ADGRB2;F2R;MLYCD;PPL;C2CD4C;HPS4;PHYH;TMEM134;MT1X;PDCD4;BLOC1S4;CGREF1;SPTB;SERPINB5;NOL4L;NYAP1;SLC24A1;ALPK1;ZNF160;CAPN7;SWT1;DNAH1;SLC27A3;ARSI;NEK9;TUBGCP5;RTN4RL1;ZFP36L2;ADGRF4;CLTCL1;TRPV4;TMC6;TMEM128;FLOT1;GLI2;AGAP4;TOM1L2;RHPN1;NLGN2;ADORA2B;CORO6;ANK3;KLF7;RNF165;NAT6;DHX32;ADAMTS13;LAMP3;TCEA2;PLCH2;RALGAPA1;MAPK8IP3;GOLGA8B;SLC13A5;ZNF76;SOX12;CLMN;PIDD1;RIMS3;PARP6;AVL9;SLX1A;SLX1B;G6PC3;ATG16L2;ZNF747;SPG11;GJC2;KRBA1;ZCCHC11;ARHGEF19;RHBDF1;TSPAN18;SULT1E1;FBXO44;RASGEF1A;ANKS6;PER2;TMEM204;PITPNM2;CLCN6;MICALCL;PTGS1;UNC119;DIRC2;HEXA;FNDC4;FRS3;DTNB;C5;FRMD4B;ZNF658;ARSD;WIPF1;SNTA1;PSKH1;ADGRL1;MINK1;PHF2;NINL;ABHD14B;GSTM2;TCEAL1;AMIGO2;THBS3;TNFRSF14;WWTR1;MBOAT2;ASAP2;ARHGEF4;LHFPL2;ITGA2;SEMA4G;RSPH3;FAM110C;SYT15;ULK1;GLI3;SPPL2B;FGGY;FHOD3;PCSK1;TPGS1;THRAP3;ZNF558;IRX4;SMARCA1;AKAP7;BHLHE40;DGCR6L;LRSAM1;VAMP2;ZNF655;NAIP;LTBP1;KHNYN;NMU;ZNF333;NEK8;MAP2K5;GAS8;BOC;ITGA6;LTBP3;KCNJ5;SRGAP3;CES3;BSN;SESN3;ZNF318;LZTS1;IGFBP4;MMP1;TCFL5;C14ORF93;TRAK1;JARID2;NUPR1;PRR9;GPC2;NISCH;INSR;TST;IFI44;CCDC85B;HSF2BP;CELSR1;MMP28;GSN;ALDH4A1;CEP68;HEBP1;CHD3;CDK14;ST3GAL5;BAIAP2;TANC1;TTN;CBLC;TMC7;SCNN1A;DDT;ZNF18;PLXNB3;CEP126;SUN1;LPAR5;AHNAK2;CNTNAP3;RNPEPL1;PLEKHH2;TRIOBP;MXD4;POLD4;RIN1;DNAJC30;CTSF;ZNF287;CD109;CYP2D7;NSUN5P2;PNMA1;PGLS;PMS2P3;ETAA1;RMI2;FAM171A2;ZNF446;SCN4B;ARHGEF1;SEPT6;FBXL16;RAB11FIP4;VPS39;ZNF581;MGST2;DOCK8;TP53AIP1;DHX58;PILRB;ENDOG;SLC27A1;PGAP1;TM7SF3;NRSN2;RTF1;BLOC1S3;MDK;SIRPB2;CASP14;IRF9;RICTOR;TMEM9;H2AFJ;BMP6;F8A1;NLRX1;B4GALT2;TMCC3;ETNK2;NIPAL2;PEX10;SLC2A3;TCIRG1;S100A4;MICALL2;MAP2K2;OPLAH;PDK1;VEGFB;ALDH7A1;GLI4;SQSTM1;CEP192;CABYR;PTK6;SLC12A7;TMEM8B;FZD7;ETV5;AKR7A2;LOXL1;FNBP4;FRMD8;SYNGAP1;NXPH4;FAM13A;FAM213A;FAT2;DLX3;TMEM117;LGALS9C;EPB41L3;SHARPIN;HEXB;KDM4C;HYAL1;METTL23;CLCA2;ARHGAP33;H1FX;SH2D2A;UBOX5;NSMCE4A;ARRDC1;KIAA0319L;B3GNT9;PAQR4;WHAMMP3;CENPC;PLA2G6;MXRA7;CST3;PDIK1L;HOMER2;MMRN2;CAPNS2;GDF15;PEX7;BBS2;TXNIP;CTF1;THSD4;TCF4;ATP6V0A2;KLHDC2;COL6A1;PEX11B;NPHP3;PSD3;LRRCC1;PLAG1;IDH2;CERCAM;MAP3K12;RCOR2;WRN;PODXL;SEPT5;IFI27;MALL;OSCP1;OXLD1;DNM1;MCM9;TNFRSF21;ZYG11B;MACROD1;IQCB1;KLHL24;PLD3;TREX1;LPIN3;ZDHHC12;ABHD14A;MCTP1;CDK5R1;ATRX;REC8;ARHGAP27;AGAP6;NET1;ANO9;PIGZ;CA2;EFNB3;OSBPL10;PI4KAP1;POLR2J3;HOOK2;SESN1;EPB41L4A;MAPK10;NKTR;SHANK3;HFE;SCART1;ADIRF;HMG20B;CYBA;TRIM38;NID1;DTX3;AGO4;ERCC6;HADH;RRM2B;SLIT3;CLIP2;KRT14;HLCS;SHC2;EDA2R;SPRY2;MRC2;FBXO2;WASH3P;MEF2D;IFT140;GABBR1;CREBRF;XRN1;AGAP7P;RAB11FIP3;TIGD5;LRP11;MLXIPL;CTSB;KLK5;NBPF15;TARBP1;FBXW7;KCNMA1;ANKRD28;GPR87;ING4;NUDT6;CDK5RAP3;ZNF862;ATXN1;LMO2;NOTCH2NL;CCDC92;NFIX;PAK6;TFPI2;CARF;DZIP1L;PGM1;TMEM164;MXI1;PFKFB2;PAQR6;RNF170;CHMP1B;THRA;TTC12;HSD11B1L;APC2;METTL21A;ACADS;ARAP1;ASTN2;GOLGA8N;ADARB1;RAI1;FMNL2;ELF1;FAM185A;MX2;IKZF4;DCAF10;RPH3AL;SLC2A1;ACACB;OGDHL;NLRP1;C1RL;FRAT1;ZBTB34;ERMAP;REEP4;ZNF627;TK2;GPR155;LACTB2;IQCH;BEX2;GLUL;TNS2;TBC1D17;MIF4GD;DBP;NDST2;NAB2;SLC38A4;EPM2AIP1;TP53I13;GNG2;FBXW5;PRR7;SRR;CAPG;TSPYL4;LRP1;KLHDC8B;LRRN3;HLA-A;PEG3;TSNARE1;NPHP4;RGS12;CCDC136;ATE1;ACP5;MPG;PLA2G7;SYNPO2;RNPEP;C12ORF66;CENPH;RFX2;DLK2;KCNG1;ZNF554;BRINP1;SLC48A1;BDH1;CD99L2;DGCR2;MAP3K6;RIMKLB;PPCS;MYO3B;APPL2;DHRS4L2;HEXDC;SALL2;WNK1;PMEL;ZNF107;ZNF532;BBS1;ATXN10;JPH2;ARL11;ZBTB20;PDE2A;ZNF334;SDHA;MAF;STK16;LTB4R2;RET;ZMYND8;PRX;DAB2IP;CASZ1;RWDD3;ACOX3;CALCOCO1;SLC37A2;TEAD2;MYSM1;DDHD2;SHROOM2;FBXO4;RNF213;IGIP;OLFM2;RAPGEFL1;TSHZ2;PIK3C3;ZNF276;IFI16;SYT7;FGFR4;ERCC5;BBS5;EXOC2;IL20RA;PIK3R2;RETSAT;SCN2A;TEF;ZNF25;SETD4;OSBPL5;AREG;ABTB1;TMEM203;DEF6;KLHL3;SNCB;ETFB;MYO9A;RPS6KA5;APBB3;ZNF630;DLG5;BTG1;BST2;ZNF687;VDR;LETMD1;RGL2;SNX21;ARHGEF17;CACNB3;MAMSTR;PHF7;TNRC18;TNRC6C;ZFP28;DPY19L2P2;VIPR1;FAM3A;EFS;PLXND1;NADK;BBS10;ZMYM3;SIX5;HLTF;MARCH8;EHBP1;C20ORF194;PCSK6;ZNF789;TMEM80;MPPE1;ZNF563;TNS4;ZNF517;PCMTD2;TBC1D16;STK19;NDUFV3;TMCO6;LRRC37A3;LPAR6;C22ORF23;EML3;PPP1R2;DMTN;TPRN;ORAI2;SLC35E2B;STAT2;SGSM2;ARFGEF2;RASL10B;LMTK3;ALMS1;PCMTD1;WWC3;PHF1;ZNF292;SLC36A4;TMEM231;TFDP2;SNX1;PMP22;UCN2;CA11;GOLGA7B;OSBPL1A;ACVR1B;TMX4;SHROOM4;ZNF737;APCDD1L;TACC1;KREMEN1;CADM4;KDELC2;PRIMPOL;NECAB3;CCDC88B;DLG4;IGFL2;CCDC113;TNNI2;PPP2R3B;ESYT2;TSSK1B;ADCK5;IQSEC1;ZNF701;ALOXE3;NAT14;PANO1;PALB2;ENDOU;MPI;SNX29;IGFBP6;NHSL1;MATN2;TCEAL4;ZNF91;NBEAL2;CD68;DUOX1;GALE;PTMS;WEE1;DYDC1;R3HDM4;CCNG2;SLC22A15;TMEM143;GTF2IRD2;GOLGA6L4;SLC35G2;PTK7;DQX1;AMT;TCF7;SHANK2;RSAD2;TNFRSF25;NEMP2;ZFP36L1;XYLT1;LMNA;MXRA8;CLSTN3;GLMP;TOP3B;ACSL1;IL11;KAT2B;MARK4;TEP1;APOLD1;IRS2;DMXL2;IMPA2;CEP250;ANO1;CAPS;MBLAC2;METTL7A;ERN1;HSD17B14;SAC3D1;RNF141;IVNS1ABP;ALOX15B;RAD50;GPR21;ZNF439;TKFC;LAPTM4A;ANGEL2;ZMAT3;PNPO;MTR;MAN1B1;DHRS4;PEX1;ECI1;S100A6;TRERF1;UAP1L1;FAAH;SCYL3;EFEMP2;SCG5;ZSWIM8;APBB2;CBR4;TTC19;MFSD11;ARHGEF9;ISYNA1;SGSH;GAREM2;PBLD;DCAF8;CCDC90B;RAPGEF5;MYH16;TNFSF12;TAS1R3;CERS5;STAT6;PCSK1N;SOX13;PRDX5;PHPT1;NELFCD;GPR132;PHC2;SMPDL3B;TUB;KIF7;SLC43A1;GLB1;THEM6;GOLGA1;CPT1C;KLF8;DNAJC4;GSTM3;RDH12;KLHL29;CHD6;TRAF5;NAP1L5;GOLGB1;SRPX2;ACSS2;DPP7;TRIM2;CD9;PLIN4;RANBP9;CACNB1;C22ORF46;HDAC11;PTPN3;CTSD;GJB5;COL13A1;ERBB2;SYNGR1;MPRIP;PLCB3;GPR68;NUDT10;UVSSA;XKR9;ZDHHC24;PAQR7;ARHGAP23;PQLC3;PPM1M;ABCA2;KMT5C;AKAP6;SLC2A11;TH;ATG14;MPP7;RORA;SSH3;PPARG;PRKACA;DOCK6;LDLRAP1;DNAJC22;CXXC5;NPAP1;C6ORF120;POLM;FMNL3;ACOT2;GCNT4;VMAC;ZNF572;SYNE2;PARD6G;ACKR3;PLTP;ZNF658B;TMEM212;SERPING1;SUCLG2;UCKL1;PARN;DDX12P;DOCK3;ZNF529;UFL1;LAMB2;IP6K2;RIPK3;NFASC;KLF9;PI4K2B;AIP;COG1;KCNS3;SCAND1;LONP2;PRMT3;SNX33;HARS2;CIT;ZFP90;EHHADH;MSH5;CLCN7;MAP1A;CCDC3;PER3;ZFP30;FOXP2;PTBP2;ZC3H6;HIVEP1;CALHM2;ECM2;SMURF1;NPNT;HERPUD2;TTLL1;EML2;CTNNBIP1;PEMT;ABCA11P;OCIAD2;GLIPR1L2;TM4SF1;SERINC3;GCLC;ECM1
15965,GO:0080182,0.822895520860401,0.501098248167299,1,16,histone H3-K4 trimethylation,BP,RTF1
11695,GO:0046503,0.822940977169108,0.401231547900337,2,30,glycerolipid catabolic process,BP,APOE;DDHD2
14630,GO:0070242,0.822963712098216,0.500981377388881,1,16,thymocyte apoptotic process,BP,GLI3
364,GO:0000983,0.823158285889544,0.501838669226088,1,15,transcription factor activity, RNA polymerase II core promoter sequence-specific DNA binding,MF,STAT1
4225,GO:0009404,0.82317164842298,0.499578800702385,1,17,toxin metabolic process,BP,TH
10161,GO:0042762,0.823290018172489,0.501612843646729,1,15,regulation of sulfur metabolic process,BP,PDK1
4394,GO:0010092,0.823363482632799,0.500295670829652,1,16,specification of animal organ identity,BP,GLI3
14749,GO:0070469,0.823743701023252,0.327738790603027,4,78,respiratory chain,CC,NDUFA4L2;SDHA;NDUFV3;TTC19
10184,GO:0042802,0.823857519096312,0.204346516320885,110,1157,identical protein binding,MF,TNFAIP3;APOE;ALS2CL;APCDD1;EGFR;PKD2;ALDH1A3;SFRP1;KCTD11;EPHB2;GLUD1;RNF135;HTRA1;TENM4;MVD;C1QTNF6;STAT1;SDC3;ZNF783;HMGCL;MICALL1;COL7A1;MDM2;TNFSF10;UGT1A3;FLRT3;KCTD15;MLYCD;HPS4;TRPV4;NLGN2;FRS3;GSTM2;WWTR1;ULK1;SPPL2B;PCSK1;BHLHE40;ZNF318;NISCH;ALDH4A1;BAIAP2;TTN;PLEKHH2;RAB11FIP4;SLC27A1;S100A4;VEGFB;SQSTM1;PTK6;SHARPIN;HEXB;ARRDC1;CST3;HOMER2;PEX7;TCF4;PEX11B;MAP3K12;WRN;DNM1;TREX1;HOOK2;HLCS;MEF2D;RAB11FIP3;FBXW7;ATXN1;CHMP1B;IKZF4;SLC2A1;ACACB;ACCS;GLUL;NAB2;EPM2AIP1;SRR;DLK2;PMEL;ATXN10;PDE2A;DAB2IP;FBXO4;ERCC5;BST2;STAT2;SNX1;CADM4;ESYT2;GALE;IMPA2;ERN1;HSD17B14;PNPO;S100A6;PBLD;STAT6;PHC2;GSTM3;TRAF5;SRPX2;ERBB2;MPRIP;PPARG;UHRF1BP1;RIPK3;SCAND1;SNX33;HARS2;FOXP2
13074,GO:0051606,0.824005607455535,0.270576890812126,10,117,detection of stimulus,BP,SERPINE2;PKD2;EYS;OR2A4;UNC119;ITGA2;TTN;POLD4;ANO1;TAS1R3
8982,GO:0035107,0.824025990854676,0.276118217114278,9,104,appendage morphogenesis,BP,FBXW4;WNT3;CYP26B1;GLI2;RNF165;GLI3;ATRX;IFT140;TMEM231
8983,GO:0035108,0.824025990854676,0.276118217114278,9,104,limb morphogenesis,BP,FBXW4;WNT3;CYP26B1;GLI2;RNF165;GLI3;ATRX;IFT140;TMEM231
6667,GO:0030033,0.824041686050682,0.500322304910263,1,15,microvillus assembly,BP,PODXL
4094,GO:0009150,0.824058000233779,0.229027132470472,30,358,purine ribonucleotide metabolic process,BP,PTHLH;APOE;NT5E;FAM20C;PKD2;DHTKD1;NOS1;RAPGEF3;ADORA2B;SULT1E1;ABHD14B;INSR;TCIRG1;ATP6V0A2;NPHP3;GABBR1;MLXIPL;GPR87;PGM1;PFKFB2;OGDHL;PPCS;PDE2A;SDHA;LTB4R2;NADK;NDUFV3;DLG4;NUDT10;RORA
12902,GO:0051272,0.824111792649694,0.22921759033131,30,328,positive regulation of cellular component movement,BP,POSTN;GPNMB;EGFR;PIK3R1;CXCL14;KITLG;MDM2;F2R;CAPN7;TRPV4;ITGA2;SEMA4G;FAM110C;ITGA6;INSR;DOCK8;VEGFB;HYAL1;PODXL;SPRY2;PLA2G7;RET;DAB2IP;DMTN;ACVR1B;IRS2;PHPT1;SRPX2;SYNE2;ACKR3
12378,GO:0048820,0.824128155905979,0.500173629140779,1,15,hair follicle maturation,BP,FERMT1
11414,GO:0045844,0.824589471527621,0.355462893329134,3,40,positive regulation of striated muscle tissue development,BP,CYP26B1;FLOT1;AKAP6
12282,GO:0048636,0.824589471527621,0.355462893329134,3,40,positive regulation of muscle organ development,BP,CYP26B1;FLOT1;AKAP6
17770,GO:1901863,0.824589471527621,0.355462893329134,3,40,positive regulation of muscle tissue development,BP,CYP26B1;FLOT1;AKAP6
11258,GO:0045580,0.824596373824144,0.299052424214496,6,77,regulation of T cell differentiation,BP,CYP26B1;GLI2;GLI3;NRARP;SOX13;ERBB2
2717,GO:0006096,0.82469506739882,0.299104611289503,6,75,glycolytic process,BP,DHTKD1;INSR;MLXIPL;PGM1;PFKFB2;OGDHL
148,GO:0000303,0.824744240109857,0.49594458328717,1,18,response to superoxide,BP,ERCC6
18199,GO:1903018,0.824875042187555,0.398165846512609,2,30,regulation of glycoprotein metabolic process,BP,CST3;NECAB3
1224,GO:0002902,0.824959627062689,0.49650036077919,1,17,regulation of B cell apoptotic process,BP,IRS2
2815,GO:0006278,0.824997939419794,0.311139460415803,5,66,RNA-dependent DNA biosynthetic process,BP,XRN1;FBXO4;TEP1;RAD50;PARN
13550,GO:0060039,0.825060835490679,0.499938222796825,1,14,pericardium development,BP,FLRT3
8138,GO:0032874,0.82514168701556,0.274483867530652,9,107,positive regulation of stress-activated MAPK cascade,BP,TRPV4;MAPK8IP3;MINK1;FZD7;ERCC6;EDA2R;MAP3K6;DAB2IP;ERN1
3248,GO:0006907,0.825161582760103,0.497199751148815,1,16,pinocytosis,BP,SNX33
11752,GO:0046626,0.825203669333622,0.35427811233081,3,41,regulation of insulin receptor signaling pathway,BP,PIK3R1;SESN3;GPR21
18143,GO:1902914,0.825578855760407,0.497672637868675,1,15,regulation of protein polyubiquitination,BP,FBXO4
411,GO:0001098,0.825762654281274,0.353188755295625,3,42,basal transcription machinery binding,MF,RTF1;TCF4;UVSSA
412,GO:0001099,0.825762654281274,0.353188755295625,3,42,basal RNA polymerase II transcription machinery binding,MF,RTF1;TCF4;UVSSA
16993,GO:0099132,0.825856772671392,0.396604016279779,2,30,ATP hydrolysis coupled cation transmembrane transport,BP,TCIRG1;ATP6V0A2
1975,GO:0004693,0.825997886108865,0.396379203371522,2,30,cyclin-dependent protein serine/threonine kinase activity,MF,CDK18;CDK14
10065,GO:0042578,0.826146392103339,0.23324071790404,24,266,phosphoric ester hydrolase activity,MF,NT5E;INPP5D;PTPRS;PLCD3;PLCD1;PPP2R2C;PLCH2;G6PC3;PGAP1;PLD3;LPIN3;PFKFB2;TNS2;ACP5;PDE2A;MPPE1;PPP2R3B;IMPA2;PHPT1;SMPDL3B;PTPN3;PLCB3;PPM1M;SSH3
3718,GO:0008238,0.826298333969043,0.309426234468903,5,65,exopeptidase activity,MF,NPEPL1;CTSV;RNPEPL1;RNPEP;DPP7
6234,GO:0019789,0.826440935503826,0.494985230443598,1,16,SUMO transferase activity,MF,MDM2
12173,GO:0048333,0.826504168798252,0.496070802458153,1,15,mesodermal cell differentiation,BP,ITGA2
8956,GO:0035036,0.826636338167638,0.492666712263353,1,18,sperm-egg recognition,BP,GLIPR1L2
12629,GO:0050853,0.826765291034831,0.395580519216913,2,29,B cell receptor signaling pathway,BP,VAV3;ELF1
3545,GO:0007568,0.826882722464608,0.241752488296401,18,210,aging,BP,SREBF1;INPP5D;MNT;TFCP2L1;CTSV;PDCD4;RNF165;GSN;ENDOG;WRN;KRT14;SRR;LRP1;FBXO4;LMNA;TH;SERPING1;GCLC
12806,GO:0051131,0.82698739678247,0.492985989183765,1,17,chaperone-mediated protein complex assembly,BP,BBS10
3939,GO:0008630,0.827096800301642,0.285563208531236,7,93,intrinsic apoptotic signaling pathway in response to DNA damage,BP,PIK3R1;NFATC4;NUPR1;CASP14;ERCC6;IFI16;ACKR3
8279,GO:0033116,0.827365952502228,0.32496069014154,4,55,endoplasmic reticulum-Golgi intermediate compartment membrane,CC,COL7A1;WHAMMP3;AREG;MPPE1
591,GO:0001756,0.827648372185077,0.351122684402972,3,39,somitogenesis,BP,SFRP1;NRARP;PALB2
2802,GO:0006260,0.8279771399649,0.232295358817187,23,260,DNA replication,BP,EGFR;KITLG;LIG1;POLH;GLI2;INSR;POLD4;ETAA1;RMI2;BMP6;CST3;WRN;MCM9;TREX1;ATRX;RRM2B;FBXW7;ING4;NFIX;AREG;PRIMPOL;PTMS;RAD50
7554,GO:0031904,0.828411939430012,0.490502261442012,1,17,endosome lumen,CC,CTSB
3177,GO:0006793,0.828480604623141,0.191644222646027,232,2354,phosphorus metabolic process,BP,TNFAIP3;ULK2;GPNMB;SIK1;PTHLH;APOE;NT5E;INPP5D;HSPA2;EGFR;PTPRS;FAM20C;PKD2;CAPRIN2;PLCD3;SFRP1;EPHB2;MAP3K14;DGKQ;PIK3R1;BRSK1;H6PD;DHTKD1;CAMKK1;HERC5;VAV3;CSPG4;ELFN2;PI4KAP2;KCNAB2;KITLG;MVD;NAPRT;SRD5A3;IMPACT;CAMK2N1;CRY2;NOS1;PRKACB;CRY1;PITPNM3;HMGCL;SPDYE6;CMPK2;THNSL2;CNTRL;PIK3C2G;CDK18;SPEG;PLCD1;NMRK1;PPP2R2C;PIK3IP1;OBSCN;ACOT1;RAPGEF3;PHACTR3;FLRT3;RASA4;RGS2;F2R;MLYCD;PDCD4;SPTB;ALPK1;NEK9;RTN4RL1;ZFP36L2;TRPV4;FLOT1;ADORA2B;PLCH2;MAPK8IP3;SPDYE5;G6PC3;GJC2;SULT1E1;RASGEF1A;PITPNM2;UNC119;FRS3;C5;PSKH1;MINK1;ABHD14B;WWTR1;MBOAT2;ITGA2;ULK1;FGGY;NEK8;MAP2K5;ITGA6;IGFBP4;INSR;CDK14;TTN;CBLC;DDT;CD109;PGLS;ETAA1;PILRB;SLC27A1;PGAP1;RICTOR;BMP6;ETNK2;TCIRG1;MAP2K2;PDK1;SQSTM1;CEP192;PTK6;FZD7;SYNGAP1;HEXB;PLA2G6;PDIK1L;GDF15;CTF1;ATP6V0A2;NPHP3;IDH2;MAP3K12;LPIN3;CDK5R1;PIGZ;OSBPL10;PI4KAP1;MAPK10;SHANK3;HFE;ERCC6;RRM2B;SHC2;EDA2R;SPRY2;GABBR1;MLXIPL;FBXW7;GPR87;CDK5RAP3;PAK6;PGM1;PFKFB2;ADARB1;ACACB;OGDHL;TK2;TNS2;NAB2;ACP5;PLA2G7;MAP3K6;PPCS;MYO3B;WNK1;PDE2A;SDHA;STK16;LTB4R2;RET;DAB2IP;DDHD2;PIK3C3;FGFR4;PIK3R2;OSBPL5;AREG;RPS6KA5;NADK;MPPE1;STK19;NDUFV3;PPP1R2;DMTN;PPP1R35;STAT2;LMTK3;ACVR1B;DLG4;PPP2R3B;TSSK1B;ADCK5;MPI;WEE1;PTK7;TNFRSF25;ZFP36L1;ACSL1;IL11;KAT2B;MARK4;IRS2;IMPA2;ERN1;RAD50;TKFC;PNPO;UAP1L1;SCYL3;CBR4;ISYNA1;PBLD;PHPT1;SMPDL3B;SRPX2;ACSS2;RANBP9;PTPN3;ERBB2;SPOCD1;PLCB3;NUDT10;PPM1M;AKAP6;ATG14;RORA;SSH3;PRKACA;ACOT2;ACKR3;SUCLG2;UCKL1;IP6K2;RIPK3;PI4K2B;CIT;NPNT;PEMT;SERINC3
7466,GO:0031638,0.828485460736848,0.392006736457419,2,31,zymogen activation,BP,SERPINE2;IFI16
9056,GO:0035304,0.828664525391775,0.27605259441423,8,99,regulation of protein dephosphorylation,BP,ELFN2;CRY2;PPP2R2C;PHACTR3;PPP1R2;PPP1R35;PPP2R3B;AKAP6
8177,GO:0032925,0.828764668669068,0.49093762077777,1,16,regulation of activin receptor signaling pathway,BP,ACVR1B
10426,GO:0043296,0.828887982652126,0.269780016015777,9,103,apical junction complex,CC,ANK3;FRMD4B;MICALL2;NPHP4;SHROOM2;PMP22;SHROOM4;MPP7;PARD6G
3361,GO:0007098,0.82906961969757,0.269259092812173,9,108,centrosome cycle,BP,PKD2;BRSK1;TUBGCP5;CEP68;CHD3;CHMP1B;FBXW5;KAT2B;CEP250
17750,GO:1901799,0.829214496981145,0.347733534760681,3,43,negative regulation of proteasomal protein catabolic process,BP,LAMP3;HFE;PANO1
3153,GO:0006753,0.829220008471402,0.215310991743628,41,480,nucleoside phosphate metabolic process,BP,PTHLH;APOE;NT5E;FAM20C;PKD2;H6PD;DHTKD1;KCNAB2;NAPRT;NOS1;CMPK2;NMRK1;RAPGEF3;ADORA2B;SULT1E1;ABHD14B;INSR;PGLS;TCIRG1;ATP6V0A2;NPHP3;IDH2;RRM2B;GABBR1;MLXIPL;GPR87;PGM1;PFKFB2;OGDHL;TK2;PPCS;PDE2A;SDHA;LTB4R2;NADK;NDUFV3;DLG4;RAD50;NUDT10;RORA;UCKL1
16013,GO:0086064,0.829542721447627,0.489575006549361,1,16,cell communication by electrical coupling involved in cardiac conduction,BP,PRKACA
2615,GO:0005925,0.829798871991906,0.221510024773325,31,354,focal adhesion,CC,ITGB6;EGFR;FLNC;DIXDC1;TNS1;CSPG4;ASAP3;ITGB5;FERMT1;PARVB;FLRT3;TRPV4;FLOT1;ITGA2;ITGA6;GSN;TRIOBP;MAP2K2;UBOX5;CYBA;MRC2;TNS2;LRP1;SYNPO2;CD99L2;TNS4;PTK7;CD9;MPRIP;SYNE2;NFASC
5416,GO:0016266,0.829888979196694,0.347723217204904,3,39,O-glycan processing,BP,MUC19;ST6GALNAC2;GCNT4
10410,GO:0043268,0.829915218743314,0.490120866107347,1,15,positive regulation of potassium ion transport,BP,AKAP6
888,GO:0002260,0.830138308151559,0.346330071702777,3,43,lymphocyte homeostasis,BP,TNFAIP3;TSC22D3;RIPK3
11402,GO:0045830,0.830432385041822,0.488012365695717,1,16,positive regulation of isotype switching,BP,STAT6
6626,GO:0022900,0.830438774991231,0.266096574028512,9,142,electron transport chain,BP,TXNRD3;D2HGDH;NDUFA4L2;ALDH4A1;AKR7A2;CYBA;SDHA;ETFB;NDUFV3
14837,GO:0070628,0.830808464379348,0.485362552367272,1,18,proteasome binding,MF,ISG15
9430,GO:0036019,0.8311069066504,0.486824349545671,1,16,endolysosome,CC,CTSB
14973,GO:0070911,0.831327029014225,0.387064401370379,2,32,global genome nucleotide-excision repair,BP,DDB2;XPC
6276,GO:0019884,0.831378934837577,0.255829065572611,11,144,antigen processing and presentation of exogenous antigen,BP,VAMP3;ITGB5;HLA-B;ACTR1B;CTSV;KIF26A;CTSF;CYBA;HLA-A;OSBPL1A;CTSD
10009,GO:0042455,0.831639330203425,0.385888335725787,2,34,ribonucleoside biosynthetic process,BP,NT5E;UCKL1
18102,GO:1902808,0.831648168639611,0.387311411303621,2,30,positive regulation of cell cycle G1/S phase transition,BP,MDM2;HYAL1
12716,GO:0050999,0.831743499744372,0.387157301360693,2,30,regulation of nitric-oxide synthase activity,BP,APOE;EGFR
406,GO:0001091,0.831831576242238,0.485544861824466,1,16,RNA polymerase II basal transcription factor binding,MF,TCF4
4504,GO:0010557,0.831975612010541,0.194190585160445,122,1245,positive regulation of macromolecule biosynthetic process,BP,TP53INP1;SREBF1;EGFR;CIRBP;PKD2;CAPRIN2;RBM3;ASH2L;SFRP1;SEC14L2;PIK3R1;KDM3A;POU3F1;RGMA;ZFPM1;KITLG;CITED4;IRF2BPL;MC1R;STAT1;IMPACT;NOS1;MAML3;KLF13;NFATC4;RNF187;HSF4;EAPP;CRTC1;NDN;F2R;GLI2;KLF7;TCEA2;ZNF76;SOX12;PHF2;ABHD14B;WWTR1;ITGA2;GLI3;THRAP3;SMARCA1;MAP2K5;ITGA6;ZNF318;INSR;ZNF287;RTF1;MDK;BMP6;MAP2K2;SQSTM1;FZD7;ETV5;DLX3;HEXB;METTL23;CST3;TCF4;PLAG1;LPIN3;ATRX;ADIRF;ERCC6;MEF2D;CREBRF;MLXIPL;FBXW7;CDK5RAP3;LMO2;NFIX;CARF;THRA;RAI1;ELF1;IKZF4;DBP;EPM2AIP1;PEG3;RFX2;SALL2;MAF;STK16;RET;DAB2IP;CASZ1;CALCOCO1;TEAD2;MYSM1;FBXO4;IFI16;FGFR4;PIK3R2;TEF;AREG;RPS6KA5;VDR;MAMSTR;PLXND1;SIX5;HLTF;PHF1;ZNF292;TFDP2;ACVR1B;TNNI2;NAT14;GLMP;IL11;KAT2B;IRS2;IVNS1ABP;TRERF1;STAT6;CHD6;ERBB2;RORA;PPARG;PARN;ZFP90;NPNT
4671,GO:0010822,0.832205181887542,0.254958445588338,11,138,positive regulation of mitochondrion organization,BP,VPS11;TNFSF10;HPS4;MICALL2;PLA2G6;OSCP1;FBXW7;DDHD2;TFDP2;SMURF1;PEMT
287,GO:0000792,0.832337436205062,0.300751134348328,5,66,heterochromatin,CC,KDM4C;CENPC;ATRX;PHC2;KMT5C
500,GO:0001556,0.832558466886513,0.48425816277684,1,16,oocyte maturation,BP,REC8
13155,GO:0051781,0.832659535074166,0.317382563322139,4,54,positive regulation of cell division,BP,OR2A4;MDK;VEGFB;CIT
10722,GO:0044093,0.832712902132261,0.193371454423303,122,1255,positive regulation of molecular function,BP,APOE;GPSM1;ALS2CL;LMF1;HSPA2;EGFR;PKD2;CAPRIN2;TRIM22;SFRP1;EPHB2;MAP3K14;DGKQ;EVI5L;RBCK1;DOCK9;CAMKK1;VAV3;CSPG4;KITLG;ASAP3;NOS1;PRKACB;TBC1D8;PLXNB1;CRTC1;CHN2;TNFSF10;RAPGEF3;RASA4;RGS2;ACAP3;F2R;FLOT1;AGAP4;ADORA2B;ANK3;RALGAPA1;MAPK8IP3;PIDD1;ARHGEF19;UNC119;C5;MINK1;TBC1D19;GSTM2;ASAP2;ITGA2;MAP2K5;ITGA6;SRGAP3;INSR;GSN;RIN1;ETAA1;ARHGEF1;MGST2;DOCK8;PILRB;SLC27A1;RICTOR;MAP2K2;SYNGAP1;FAM13A;ARHGAP33;MAP3K12;WRN;IFI27;CDK5R1;ARHGAP27;AGAP6;NET1;MAPK10;SHANK3;HFE;CYBA;TRIM38;ERCC6;SHC2;EDA2R;SPRY2;AGAP7P;FBXW7;PAK6;PFKFB2;APC2;ARAP1;NLRP1;TBC1D17;NAB2;EPM2AIP1;LRP1;RGS12;MAP3K6;WNK1;JPH2;RET;DAB2IP;IFI16;FGFR4;PIK3R2;MYO9A;RPS6KA5;VDR;PLXND1;TBC1D16;SGSM2;DLG4;IQSEC1;ACSL1;ERN1;RAD50;TRAF5;ERBB2;ARHGAP23;AKAP6;ATG14;PPARG;PRKACA;PARN;RIPK3;NPNT
19008,GO:1904872,0.832760216392632,0.481908935050549,1,18,regulation of telomerase RNA localization to Cajal body,BP,PARN
3730,GO:0008266,0.832822963066554,0.483789146653747,1,16,poly(U) RNA binding,MF,ATXN1
14666,GO:0070304,0.832862762805842,0.264241455496426,9,108,positive regulation of stress-activated protein kinase signaling cascade,BP,TRPV4;MAPK8IP3;MINK1;FZD7;ERCC6;EDA2R;MAP3K6;DAB2IP;ERN1
8310,GO:0033158,0.832877614537249,0.483692181594942,1,16,regulation of protein import into nucleus, translocation,BP,PDE2A
18663,GO:1904031,0.832897698580763,0.384892780014119,2,31,positive regulation of cyclin-dependent protein kinase activity,BP,EGFR;PKD2
8078,GO:0032770,0.833268206274743,0.481941717300817,1,17,positive regulation of monooxygenase activity,BP,APOE
2965,GO:0006501,0.83334588263969,0.383795996354544,2,32,C-terminal protein lipidation,BP,RTN4RL1;CD109
3156,GO:0006757,0.833687137845437,0.286560217253314,6,76,ATP generation from ADP,BP,DHTKD1;INSR;MLXIPL;PGM1;PFKFB2;OGDHL
2614,GO:0005924,0.83369052045531,0.216907572972186,31,355,cell-substrate adherens junction,CC,ITGB6;EGFR;FLNC;DIXDC1;TNS1;CSPG4;ASAP3;ITGB5;FERMT1;PARVB;FLRT3;TRPV4;FLOT1;ITGA2;ITGA6;GSN;TRIOBP;MAP2K2;UBOX5;CYBA;MRC2;TNS2;LRP1;SYNPO2;CD99L2;TNS4;PTK7;CD9;MPRIP;SYNE2;NFASC
2776,GO:0006206,0.834194236016455,0.480292662501043,1,17,pyrimidine nucleobase metabolic process,BP,UCKL1
5842,GO:0017136,0.834536486017014,0.480739986065788,1,16,NAD-dependent histone deacetylase activity,MF,HDAC11
4958,GO:0015035,0.834838287191346,0.476621405165928,1,20,protein disulfide oxidoreductase activity,MF,TXNRD3
6537,GO:0021954,0.835078600289206,0.339256273487065,3,41,central nervous system neuron development,BP,EPHB2;GLI2;ADARB1
14722,GO:0070412,0.835179100012608,0.480797365089378,1,15,R-SMAD binding,MF,SMURF1
9811,GO:0042035,0.835293240212095,0.31350531144432,4,54,regulation of cytokine biosynthetic process,BP,INPP5D;ZFPM1;MAP2K5;ZNF287
13785,GO:0060396,0.835338852576944,0.480511669590727,1,15,growth hormone receptor signaling pathway,BP,PIK3R1
17856,GO:1902116,0.835577408261482,0.380928167989807,2,30,negative regulation of organelle assembly,BP,EVI5L;KAT2B
3710,GO:0008219,0.835626706711718,0.187866427097417,150,1566,cell death,BP,TNFAIP3;GPNMB;SIK1;TP53INP1;IFI6;APOE;INPP5D;EGFR;MNT;ALDH1A3;SFRP1;EPHB2;MAP3K14;PIK3R1;RBCK1;TSC22D3;VAV3;KITLG;STAT1;IMPACT;KRT15;HS1BP3;LGALS7B;NSG1;UNC5B;PLEKHG5;NFATC4;H1F0;CYP26B1;NDRG1;MDM2;OBSCN;TNFSF10;PRODH;CTSV;F2R;PPL;PDCD4;GLI2;LAMP3;PIDD1;ARHGEF19;MINK1;AMIGO2;TNFRSF14;ARHGEF4;GLI3;NAIP;MAP2K5;ITGA6;NUPR1;NISCH;INSR;GSN;PNMA1;ARHGEF1;DOCK8;TP53AIP1;ENDOG;TM7SF3;MDK;CASP14;BMP6;MAP2K2;PDK1;SQSTM1;SYNGAP1;TMEM117;EPB41L3;SHARPIN;PLA2G6;CST3;GDF15;TXNIP;PLAG1;MAP3K12;WRN;IFI27;TNFRSF21;CDK5R1;NET1;AGO4;ERCC6;RRM2B;SLIT3;KRT14;EDA2R;SPRY2;MEF2D;CTSB;KLK5;FBXW7;KCNMA1;ING4;CDK5RAP3;PAK6;THRA;ADARB1;NLRP1;BEX2;LRP1;PEG3;BRINP1;RET;DAB2IP;TEAD2;IFI16;FGFR4;ERCC5;IL20RA;SCN2A;SNCB;DLG5;BTG1;VDR;RGL2;ARHGEF17;PCSK6;TNS4;TFDP2;PMP22;ACVR1B;KREMEN1;PANO1;PALB2;TNFRSF25;ZFP36L1;LMNA;MARK4;IRS2;ERN1;IVNS1ABP;ALOX15B;ZMAT3;APBB2;ARHGEF9;TNFSF12;PRDX5;TRAF5;TRIM2;ERBB2;PPARG;C6ORF120;ACKR3;UFL1;IP6K2;RIPK3;CIT;SERINC3;GCLC
7608,GO:0032006,0.83588145647764,0.283404983517173,6,77,regulation of TOR signaling,BP,EPM2A;DGKQ;SESN3;RICTOR;SESN1;C12ORF66
7166,GO:0031055,0.836185931700892,0.37648004602545,2,42,chromatin remodeling at centromere,BP,CENPC;CENPH
1037,GO:0002548,0.836242404345359,0.47485180188939,1,19,monocyte chemotaxis,BP,PLA2G7
12547,GO:0050716,0.836311811876446,0.476501329767804,1,17,positive regulation of interleukin-1 secretion,BP,NLRP1
16777,GO:0098641,0.836385557855861,0.475430587114039,1,18,cadherin binding involved in cell-cell adhesion,MF,BAIAP2
4375,GO:0010008,0.83654885925188,0.212014798756161,33,368,endosome membrane,CC,EGFR;MVB12B;VAMP3;NSG1;MICALL1;VPS11;NDRG1;HLA-B;AP1G2;CLCN6;SPPL2B;INSR;RAB11FIP4;VPS39;TMEM9;TCIRG1;FZD7;ATP6V0A2;WASH3P;RAB11FIP3;CHMP1B;HLA-A;SLC48A1;APPL2;PMEL;RET;SNX21;MARCH8;SNX1;CD68;LAPTM4A;ERBB2;ABCA2
3293,GO:0006986,0.836675450230364,0.24196438663902,13,158,response to unfolded protein,BP,HSPA2;TMEM129;PIK3R1;UBXN4;CUL7;TM7SF3;CREBRF;CDK5RAP3;DAB2IP;LMNA;ERN1;DNAJC4;HERPUD2
2526,GO:0005783,0.836777108947372,0.188592443324008,125,1322,endoplasmic reticulum,CC,SREBF1;APOE;GPSM1;CES2;OAS2;LMF1;EGFR;FAM20C;PKD2;TMEM129;PIK3R1;ADAMTS7;TXNRD3;COL22A1;SULF2;WNT3;H6PD;UBXN4;RGMA;ZDHHC1;REEP2;SRD5A3;HS1BP3;NSG1;KDSR;COL10A1;NOS1;CRTAP;SCARA3;CYP26B1;COL7A1;ITPR3;HLA-B;FKBP9;UGT1A3;CERS4;CYP3A5;OAS1;FLRT3;CRAT;SLC27A3;ARSI;TMC6;ANK3;ADAMTS13;G6PC3;RHBDF1;PTGS1;FNDC4;ARSD;PSKH1;GSTM2;MBOAT2;ULK1;SPPL2B;LTBP1;CES3;IGFBP4;GPC2;BAIAP2;MGST2;SLC27A1;PGAP1;MAP2K2;SQSTM1;TMEM8B;TMEM117;B3GNT9;CST3;COL6A1;CERCAM;PLD3;TREX1;LPIN3;ZDHHC12;MCTP1;PIGZ;CYBA;FBXO2;RNF170;REEP4;GLUL;EPM2AIP1;HLA-A;BRINP1;PMEL;JPH2;PDE2A;SLC37A2;FGFR4;RETSAT;OSBPL5;AREG;TMEM203;PCSK6;MPPE1;TMX4;KDELC2;NECAB3;CCDC88B;DLG4;ESYT2;NBEAL2;RSAD2;XYLT1;MXRA8;CLSTN3;ACSL1;METTL7A;ERN1;MAN1B1;DHRS4;FAAH;CERS5;CPT1C;COL13A1;ZDHHC24;AKAP6;TH;ATG14;SYNE2;UFL1;LAMB2;CCDC3;PEMT
12843,GO:0051184,0.836782101185491,0.476715748648778,1,16,cofactor transmembrane transporter activity,MF,SLC48A1
1393,GO:0003309,0.83740077822966,0.475601369696528,1,16,type B pancreatic cell differentiation,BP,BMP6
13740,GO:0060338,0.837762489496995,0.377773864921359,2,29,regulation of type I interferon-mediated signaling pathway,BP,STAT1;STAT2
77,GO:0000154,0.837952264036009,0.375605135089841,2,34,rRNA modification,BP,NSUN5P2;TARBP1
4180,GO:0009259,0.837952407538508,0.21173686915475,31,372,ribonucleotide metabolic process,BP,PTHLH;APOE;NT5E;FAM20C;PKD2;DHTKD1;NOS1;RAPGEF3;ADORA2B;SULT1E1;ABHD14B;INSR;TCIRG1;ATP6V0A2;NPHP3;GABBR1;MLXIPL;GPR87;PGM1;PFKFB2;OGDHL;PPCS;PDE2A;SDHA;LTB4R2;NADK;NDUFV3;DLG4;NUDT10;RORA;UCKL1
17777,GO:1901889,0.838004732215504,0.475719886472109,1,15,negative regulation of cell junction assembly,BP,DMTN
276,GO:0000779,0.838014808377455,0.263193929422294,8,104,condensed chromosome, centromeric region,CC,PHF2;SEPT6;CENPC;ATRX;REC8;CENPH;ZNF276;KMT5C
14270,GO:0061387,0.838404321234257,0.280148271392995,6,74,regulation of extent of cell growth,BP,ULK2;APOE;PTPRS;WNT3;SEMA4G;CDK5R1
20244,GO:2001234,0.839302758128028,0.23846397609403,13,163,negative regulation of apoptotic signaling pathway,BP,TNFAIP3;IFI6;MNT;UNC5B;MDM2;TNFSF10;MAP2K5;ITGA6;RRM2B;LMNA;IVNS1ABP;ACKR3;GCLC
3814,GO:0008409,0.839349686756956,0.472074721414341,1,16,5'-3' exonuclease activity,MF,XRN1
5068,GO:0015293,0.839410158726633,0.278638553757773,6,75,symporter activity,MF,SLC16A5;SLC24A1;SLC13A5;SLC12A7;SLC38A4;SLC36A4
10478,GO:0043393,0.839457841838094,0.235390044665513,14,170,regulation of protein binding,BP,APOE;GPSM1;CAPRIN2;ZFPM1;NFATC4;FLOT1;GAS8;HFE;LRP1;DAB2IP;PLXND1;PRKACA;LDLRAP1;CTNNBIP1
16601,GO:0097472,0.839564209876751,0.373990287333833,2,31,cyclin-dependent protein kinase activity,MF,CDK18;CDK14
12128,GO:0048247,0.839810200731854,0.468395134302082,1,19,lymphocyte chemotaxis,BP,CXCL14
3532,GO:0007519,0.839830925035438,0.268502889643456,7,88,skeletal muscle tissue development,BP,TSC22D3;CYP26B1;FLOT1;NUPR1;HMG20B;MEF2D;FOXP2
5779,GO:0017004,0.840059158447002,0.372135792382139,2,34,cytochrome complex assembly,BP,CYBA;TTC19
7745,GO:0032269,0.840063746054097,0.191169282346896,78,847,negative regulation of cellular protein metabolic process,BP,TNFAIP3;SERPINE2;IFI6;APOE;EGFR;CIRBP;CAPRIN2;SFRP1;EPHB2;DGKQ;KDM3A;UNK;ISG15;ELFN2;IMPACT;CAMK2N1;CRY2;CRY1;CRTAP;COL7A1;SPOCK1;MDM2;PHACTR3;FLRT3;RGS2;PDCD4;SERPINB5;RTN4RL1;ZFP36L2;LAMP3;ZCCHC11;PER2;C5;SNTA1;WWTR1;NAIP;MAP2K5;JARID2;CBLC;CD109;MAP2K2;PTK6;KDM4C;CST3;HFE;HMG20B;AGO4;SPRY2;XRN1;MLXIPL;CDK5RAP3;TFPI2;ADARB1;WNK1;DAB2IP;IFI16;PIK3R2;BST2;TNRC6C;PPP1R2;DMTN;PPP1R35;PHF1;PANO1;ZFP36L1;KAT2B;PBLD;PCSK1N;PRDX5;RANBP9;PTPN3;ATG14;PPARG;SERPING1;UFL1;PRMT3;GCLC;ECM1
10007,GO:0042451,0.840144412410996,0.467033668759539,1,20,purine nucleoside biosynthetic process,BP,NT5E
11559,GO:0046129,0.840144412410996,0.467033668759539,1,20,purine ribonucleoside biosynthetic process,BP,NT5E
19731,GO:2000142,0.84032005159714,0.373136552218611,2,30,regulation of DNA-templated transcription, initiation,BP,THRA;CTNNBIP1
12872,GO:0051233,0.840519105284404,0.372807414016108,2,30,spindle midzone,CC,OR2A4;UNC119
2818,GO:0006283,0.840750547569679,0.287969427361966,5,73,transcription-coupled nucleotide-excision repair,BP,LIG1;POLD4;ERCC6;ERCC5;UVSSA
13648,GO:0060193,0.840929198685922,0.37212877547632,2,30,positive regulation of lipase activity,BP,LMF1;EGFR
7148,GO:0031016,0.841054621982367,0.329766210954795,3,42,pancreas development,BP,INSR;BMP6;NPHP3
8050,GO:0032727,0.841066241091813,0.468947944514916,1,16,positive regulation of interferon-alpha production,BP,STAT1
16852,GO:0098803,0.841250681104731,0.325912392690427,3,66,respiratory chain complex,CC,NDUFA4L2;SDHA;NDUFV3
9840,GO:0042098,0.84134289950292,0.258627823993075,8,105,T cell proliferation,BP,GPNMB;IL20RB;DOCK8;TNFRSF21;DLG5;CCDC88B;ERBB2;RIPK3
19722,GO:2000116,0.841599843985998,0.229841385123759,15,189,regulation of cysteine-type endopeptidase activity,BP,IFI6;MDM2;TNFSF10;F2R;LAMP3;PIDD1;NAIP;MAP2K5;GSN;CST3;IFI27;NLRP1;IFI16;PRDX5;PPARG
6255,GO:0019843,0.841675005318657,0.326476746373103,3,55,rRNA binding,MF,CIRBP;MDM2;TST
7375,GO:0031435,0.841683976635742,0.467817950312462,1,16,mitogen-activated protein kinase kinase kinase binding,MF,DAB2IP
652,GO:0001843,0.841901346959639,0.275126634587287,6,75,neural tube closure,BP,SFRP1;PRKACB;CELSR1;NPHP3;TEAD2;PTK7
13919,GO:0060606,0.841901346959639,0.275126634587287,6,75,tube closure,BP,SFRP1;PRKACB;CELSR1;NPHP3;TEAD2;PTK7
4976,GO:0015095,0.841901628904924,0.467419205432452,1,16,magnesium ion transmembrane transporter activity,MF,NIPAL2
5153,GO:0015693,0.841901628904924,0.467419205432452,1,16,magnesium ion transport,BP,NIPAL2
18563,GO:1903830,0.841901628904924,0.467419205432452,1,16,magnesium ion transmembrane transport,BP,NIPAL2
19861,GO:2000369,0.842020899686493,0.468413423321367,1,15,regulation of clathrin-dependent endocytosis,BP,UNC119
7776,GO:0032309,0.842050906061729,0.466080548892782,1,17,icosanoid secretion,BP,PLA2G6
13730,GO:0060326,0.842167327801307,0.241784018704731,11,144,cell chemotaxis,BP,CXCR1;CXCL14;VAV3;PLEKHG5;TRPV4;C5;MMP28;DDT;PLXNB3;VEGFB;PLA2G7
17447,GO:1900274,0.842186177313928,0.466897429142327,1,16,regulation of phospholipase C activity,BP,EGFR
11770,GO:0046649,0.842470216407588,0.20361356071187,35,389,lymphocyte activation,BP,TNFAIP3;GPNMB;INPP5D;SFRP1;MAP3K14;PIK3R1;VAV3;ZFPM1;CYP26B1;IL20RB;ZFP36L2;GLI2;TNFRSF14;GLI3;GSN;DOCK8;FZD7;TNFRSF21;EFNB3;HFE;DLG5;BST2;NRARP;CCDC88B;TCF7;RSAD2;ZFP36L1;IL11;IRS2;STAT6;SOX13;ERBB2;RORA;POLM;RIPK3
2401,GO:0005547,0.842505033834339,0.369936707055918,2,29,phosphatidylinositol-3,4,5-trisphosphate binding,MF,ARAP1;JPH2
4688,GO:0010842,0.842557052726385,0.467429924043026,1,15,retina layer formation,BP,SDK2
1783,GO:0004407,0.843095390438139,0.326581438097384,3,42,histone deacetylase activity,MF,CHD3;HMG20B;HDAC11
4556,GO:0010640,0.843120433840396,0.465180479358374,1,16,regulation of platelet-derived growth factor receptor signaling pathway,BP,LRP1
11374,GO:0045766,0.843432825221566,0.256115305686802,8,99,positive regulation of angiogenesis,BP,RAPGEF3;C5;VEGFB;HYAL1;BTG1;TNFSF12;SRPX2;ECM1
2540,GO:0005798,0.84371070087968,0.240021579253896,11,136,Golgi-associated vesicle,CC,SREBF1;COL7A1;HLA-B;AP1G2;CLTCL1;SPPL2B;HLA-A;STK16;DDHD2;AREG;LDLRAP1
18344,GO:1903362,0.844029505560289,0.222410668798787,17,203,regulation of cellular protein catabolic process,BP,TNFAIP3;APOE;MAGEF1;VPS11;MDM2;LAMP3;RHBDF1;HFE;FBXW7;CDK5RAP3;LRP1;DAB2IP;PANO1;PRKACA;UFL1;SMURF1;GCLC
1477,GO:0003756,0.844114527806829,0.46228043938282,1,17,protein disulfide isomerase activity,MF,TMX4
5722,GO:0016864,0.844114527806829,0.46228043938282,1,17,intramolecular oxidoreductase activity, transposing S-S bonds,MF,TMX4
8438,GO:0033574,0.844258127873097,0.365831606985645,2,32,response to testosterone,BP,XRN1;FOXP2
2959,GO:0006491,0.844504839670157,0.462625471207722,1,16,N-glycan processing,BP,MAN1B1
13500,GO:0055093,0.844796425805672,0.461018451272956,1,17,response to hyperoxia,BP,PPARG
2326,GO:0005342,0.844868198440901,0.261456192638142,7,89,organic acid transmembrane transporter activity,MF,SLC16A5;SLC13A5;SLC27A1;SLC38A4;SLC36A4;SLC43A1;SERINC3
11894,GO:0046943,0.844868198440901,0.261456192638142,7,89,carboxylic acid transmembrane transporter activity,MF,SLC16A5;SLC13A5;SLC27A1;SLC38A4;SLC36A4;SLC43A1;SERINC3
15020,GO:0070987,0.845055697170934,0.459593089912034,1,18,error-free translesion synthesis,BP,POLH
1379,GO:0003279,0.84513048689905,0.270647809355589,6,74,cardiac septum development,BP,ZFPM1;MDM2;LTBP1;NPHP3;PLXND1;PTK7
6795,GO:0030246,0.8452171469829,0.242411616613714,10,124,carbohydrate binding,MF,LGALS7B;GAA;PHYH;ADGRL1;SLC2A3;LGALS9C;MRC2;FBXO2;DGCR2;ENDOU
864,GO:0002200,0.84522438609032,0.298708916727375,4,54,somatic diversification of immune receptors,BP,PMS2P3;TCF7;STAT6;POLM
5516,GO:0016482,0.845446775402335,0.237919138932979,11,131,cytosolic transport,BP,VAMP3;VPS11;CLTCL1;MAP2K2;HOOK2;WASH3P;TBC1D17;PIK3C3;SYT7;SGSM2;SNX1
20059,GO:2000737,0.845576809500289,0.460638166425037,1,16,negative regulation of stem cell differentiation,BP,ZFP36L2
16077,GO:0090079,0.845717644734949,0.459308549410765,1,17,translation regulator activity, nucleic acid binding,MF,MIF4GD
607,GO:0001776,0.845876896369129,0.297425713319871,4,56,leukocyte homeostasis,BP,TNFAIP3;TSC22D3;KITLG;RIPK3
4066,GO:0009119,0.84603672031819,0.268524559750067,6,84,ribonucleoside metabolic process,BP,NT5E;GAMT;APOBEC3C;DLG4;UCKL1;PEMT
3171,GO:0006783,0.84652002863639,0.456868835215215,1,18,heme biosynthetic process,BP,UROS
7199,GO:0031098,0.8466230760481,0.213906130709077,20,228,stress-activated protein kinase signaling cascade,BP,EGFR;SFRP1;MAP3K14;PDCD4;TRPV4;ADORA2B;MAPK8IP3;MINK1;MAP2K5;MAP2K2;FZD7;MAP3K12;MAPK10;ERCC6;EDA2R;PAK6;MAP3K6;DAB2IP;ZFP36L1;ERN1
8031,GO:0032689,0.846907832091914,0.456144914218073,1,18,negative regulation of interferon-gamma production,BP,IL20RB
3598,GO:0008026,0.846933062610324,0.258722798395778,7,87,ATP-dependent helicase activity,MF,DDX59;DHX32;CHD3;WRN;DQX1;RAD50;DDX12P
14511,GO:0070035,0.846933062610324,0.258722798395778,7,87,purine NTP-dependent helicase activity,MF,DDX59;DHX32;CHD3;WRN;DQX1;RAD50;DDX12P
4109,GO:0009166,0.847218103805792,0.239706094034105,10,125,nucleotide catabolic process,BP,NT5E;DHTKD1;RAPGEF3;INSR;MLXIPL;PGM1;PFKFB2;OGDHL;PDE2A;NUDT10
3218,GO:0006865,0.847537518448203,0.266948634365372,6,77,amino acid transport,BP,PER2;VAMP2;SLC38A4;SLC36A4;SLC43A1;SERINC3
4143,GO:0009206,0.847610807068134,0.250070819740784,8,105,purine ribonucleoside triphosphate biosynthetic process,BP,DHTKD1;INSR;TCIRG1;ATP6V0A2;MLXIPL;PGM1;PFKFB2;OGDHL
18377,GO:1903427,0.847681723038741,0.454697192666454,1,18,negative regulation of reactive oxygen species biosynthetic process,BP,ACP5
17641,GO:1901505,0.848054239679558,0.359460306826985,2,32,carbohydrate derivative transmembrane transporter activity,MF,SLC29A4;SLC37A2
10976,GO:0044786,0.848226773448016,0.293737864011758,4,57,cell cycle DNA replication,BP,LIG1;POLD4;ATRX;FBXW7
12331,GO:0048710,0.848330338340996,0.454427470755917,1,17,regulation of astrocyte differentiation,BP,SERPINE2
19679,GO:2000027,0.848477790489068,0.22121671132415,15,183,regulation of organ morphogenesis,BP,TNFAIP3;SFRP1;SULF2;PRICKLE2;STAT1;ARHGEF19;CELSR1;FZD7;ETV5;NPHP3;FBXW7;VDR;PTK7;FOXP2;SMURF1
9474,GO:0036120,0.848605768054923,0.454980239549614,1,16,cellular response to platelet-derived growth factor stimulus,BP,HYAL1
7586,GO:0031965,0.848629089457551,0.208483267061926,22,251,nuclear membrane,CC,EGFR;PRICKLE2;ITPR3;CERS4;TMC6;SULT1E1;SUN1;CLCA2;CST3;KLHDC2;IFI27;RETSAT;TNRC18;DPY19L2P2;NEMP2;LMNA;ERN1;CERS5;STAT6;AKAP6;NPAP1;SYNE2
18467,GO:1903599,0.848651024164965,0.453825113802952,1,17,positive regulation of autophagy of mitochondrion,BP,SMURF1
16347,GO:0090670,0.848798550336763,0.451756572271061,1,19,RNA localization to Cajal body,BP,PARN
16348,GO:0090671,0.848798550336763,0.451756572271061,1,19,telomerase RNA localization to Cajal body,BP,PARN
16349,GO:0090672,0.848798550336763,0.451756572271061,1,19,telomerase RNA localization,BP,PARN
16353,GO:0090685,0.848798550336763,0.451756572271061,1,19,RNA localization to nucleus,BP,PARN
3287,GO:0006977,0.848838072265558,0.292545194082192,4,59,DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,BP,MDM2;PCBP4;PIDD1;TFDP2
17021,GO:0099518,0.849071856393324,0.317171293157228,3,42,vesicle cytoskeletal trafficking,BP,BLOC1S4;TRAK1;BLOC1S3
4804,GO:0012505,0.849072623659685,0.167588357365218,312,3158,endomembrane system,CC,TGFBI;POSTN;SERPINE2;MUC19;MAP6;PTHLH;SREBF1;PYGB;APOE;GPSM1;CES2;OAS2;ADAM19;LMF1;EGFR;PTPRS;FAM20C;PKD2;SYT8;CXCR1;SYN1;TRIM22;OBSL1;DGKQ;TMEM129;PIK3R1;ADAMTS7;EVI5L;BRSK1;TXNRD3;CXCL14;DOCK9;COL22A1;SULF2;WNT3;H6PD;UBXN4;ST6GALNAC2;CSPG4;MVB12B;RGMA;KCNAB2;ZDHHC1;CUL7;VAMP3;NAPRT;REEP2;PRICKLE2;SRD5A3;OR2A4;HS1BP3;NSG1;KDSR;COL10A1;RAB43;RAB40B;NOS1;B4GALNT4;CRTAP;SDC3;PITPNM3;SCARA3;H1F0;CYP26B1;GAA;MICALL1;TBC1D8;VPS11;NDRG1;COL7A1;ITPR3;ST6GALNAC6;GOLGA8A;HLA-B;HGSNAT;SYTL1;FKBP9;ACTR1B;UGT1A3;CERS4;CYP3A5;NEO1;RAPGEF3;CTSV;OAS1;FLRT3;GAL3ST4;CRAT;B4GALT6;AP1G2;F2R;C2CD4C;HPS4;SPTB;SLC27A3;ARSI;CLTCL1;TMC6;FLOT1;ANK3;ADAMTS13;LAMP3;MAPK8IP3;GOLGA8B;PIDD1;AVL9;G6PC3;RHBDF1;SULT1E1;PITPNM2;CLCN6;PTGS1;HEXA;FNDC4;ARSD;PSKH1;MINK1;GSTM2;MBOAT2;ASAP2;LHFPL2;ULK1;SPPL2B;PCSK1;VAMP2;LTBP1;GAS8;CES3;IGFBP4;TRAK1;GPC2;NISCH;INSR;GSN;ST3GAL5;BAIAP2;SUN1;CD109;SEPT6;RAB11FIP4;VPS39;MGST2;SLC27A1;PGAP1;NRSN2;BLOC1S3;TMEM9;B4GALT2;TMCC3;SLC2A3;TCIRG1;MICALL2;MAP2K2;VEGFB;SQSTM1;TMEM8B;FZD7;AKR7A2;LOXL1;TMEM117;HEXB;CLCA2;KIAA0319L;B3GNT9;CST3;GDF15;ATP6V0A2;KLHDC2;COL6A1;CERCAM;SEPT5;IFI27;MALL;DNM1;PLD3;TREX1;LPIN3;ZDHHC12;MCTP1;PIGZ;HFE;CYBA;FBXO2;WASH3P;RAB11FIP3;CTSB;KLK5;ANKRD28;CDK5RAP3;PGM1;RNF170;CHMP1B;APC2;ARAP1;ASTN2;GOLGA8N;MX2;RPH3AL;SLC2A1;ACACB;REEP4;GLUL;TBC1D17;NDST2;EPM2AIP1;LRP1;HLA-A;TSNARE1;CCDC136;RNPEP;BRINP1;SLC48A1;APPL2;PMEL;JPH2;PDE2A;RET;SLC37A2;DDHD2;PIK3C3;SYT7;FGFR4;RETSAT;OSBPL5;AREG;TMEM203;BST2;SNX21;PHF7;TNRC18;DPY19L2P2;MARCH8;EHBP1;PCSK6;MPPE1;TBC1D16;DMTN;SGSM2;ARFGEF2;LMTK3;SNX1;GOLGA7B;OSBPL1A;TMX4;KDELC2;NECAB3;CCDC88B;DLG4;ESYT2;TSSK1B;IGFBP6;NBEAL2;CD68;GOLGA6L4;SLC35G2;RSAD2;NEMP2;XYLT1;LMNA;MXRA8;CLSTN3;ACSL1;DMXL2;METTL7A;ERN1;LAPTM4A;MAN1B1;DHRS4;S100A6;FAAH;SCYL3;SCG5;CERS5;STAT6;PCSK1N;GLB1;GOLGA1;CPT1C;GOLGB1;DPP7;CD9;CTSD;COL13A1;ERBB2;SYNGR1;ZDHHC24;ABCA2;AKAP6;TH;ATG14;PRKACA;LDLRAP1;NPAP1;C6ORF120;FMNL3;GCNT4;SYNE2;ACKR3;SERPING1;UFL1;LAMB2;NFASC;PI4K2B;COG1;KCNS3;SNX33;CIT;CCDC3;PEMT;OCIAD2;SERINC3;ECM1
5475,GO:0016410,0.849121745914675,0.26443658458807,6,80,N-acyltransferase activity,MF,HGSNAT;CERS4;NAT6;NAT14;KAT2B;CERS5
16526,GO:0097305,0.849338268764227,0.241958384861455,9,112,response to alcohol,BP,TP53INP1;SFRP1;GSN;XRN1;GNG2;ABCA2;TH;PPARG;PEMT
13019,GO:0051495,0.849652348772663,0.22523923883996,13,158,positive regulation of cytoskeleton organization,BP,SFRP1;RAPGEF3;RGS2;ARPIN;TRPV4;WIPF1;GSN;BAIAP2;RICTOR;WHAMMP3;CDK5R1;WASH3P;SYNPO2
1172,GO:0002819,0.849668629808747,0.263575825712708,6,81,regulation of adaptive immune response,BP,TNFAIP3;IL20RB;HFE;RSAD2;STAT6;RIPK3
3336,GO:0007050,0.849918693265413,0.213061441791602,18,215,cell cycle arrest,BP,TP53INP1;PKD2;MDM2;PCBP4;CGREF1;PIDD1;WHAMMP3;CDK5R1;MLXIPL;ING4;BRINP1;DAB2IP;TFDP2;PPP2R3B;KAT2B;ERN1;APBB2;PRKACA
10035,GO:0042531,0.850540472862268,0.354909433856182,2,33,positive regulation of tyrosine phosphorylation of STAT protein,BP,PTK6;CTF1
3222,GO:0006873,0.850742784542423,0.197438348508262,30,342,cellular ion homeostasis,BP,APOE;PKD2;CYBRD1;NOS1;ITPR3;F2R;MT1X;SLC24A1;TRPV4;GSTM2;NMU;BMP6;TCIRG1;HEXB;PLA2G6;ATP6V0A2;CA2;HFE;CYBA;KCNMA1;JPH2;TMEM203;VDR;LETMD1;CACNB3;LPAR6;DLG4;DMXL2;AKAP6;PRKACA
8018,GO:0032663,0.850781010650267,0.355209453327288,2,31,regulation of interleukin-2 production,BP,TNFAIP3;IL20RB
11647,GO:0046426,0.85083851618247,0.35511170521241,2,31,negative regulation of JAK-STAT cascade,BP,FLRT3;RTN4RL1
19025,GO:1904893,0.85083851618247,0.35511170521241,2,31,negative regulation of STAT cascade,BP,FLRT3;RTN4RL1
7225,GO:0031128,0.851232564017847,0.448949915292128,1,17,developmental induction,BP,WNT3
9356,GO:0035883,0.851470869513711,0.448497512629462,1,17,enteroendocrine cell differentiation,BP,BMP6
17776,GO:1901888,0.851545482905059,0.273167980527476,5,64,regulation of cell junction assembly,BP,SFRP1;FLOT1;NPHP4;DMTN;PRKACA
7730,GO:0032233,0.851588529975369,0.312942180230485,3,43,positive regulation of actin filament bundle assembly,BP,SFRP1;RAPGEF3;SYNPO2
8931,GO:0034979,0.851680427038761,0.448099352659326,1,17,NAD-dependent protein deacetylase activity,MF,HDAC11
15203,GO:0071378,0.851838212285578,0.448871608832001,1,16,cellular response to growth hormone stimulus,BP,PIK3R1
18253,GO:1903146,0.851915063807743,0.312204101725029,3,44,regulation of autophagy of mitochondrion,BP,SREBF1;FBXW7;SMURF1
1863,GO:0004529,0.852101733610424,0.446348907974031,1,18,exodeoxyribonuclease activity,MF,TREX1
5745,GO:0016895,0.852101733610424,0.446348907974031,1,18,exodeoxyribonuclease activity, producing 5'-phosphomonoesters,MF,TREX1
10338,GO:0043162,0.852265699914489,0.446036573012702,1,18,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway,BP,MVB12B
14828,GO:0070603,0.852641844911605,0.271212606668837,5,67,SWI/SNF superfamily-type complex,CC,SMARCA1;CHD3;ATRX;APPL2;SALL2
3915,GO:0008585,0.852825534672634,0.270941542700373,5,67,female gonad development,BP,SFRP1;KITLG;NUPR1;INSR;SLIT3
2287,GO:0005246,0.853231126657638,0.444193671639852,1,18,calcium channel regulator activity,MF,PHPT1
11790,GO:0046688,0.853265413467833,0.441838443806683,1,21,response to copper ion,BP,MT1X
9039,GO:0035268,0.853320975995076,0.444021819472801,1,18,protein mannosylation,BP,DPY19L2P2
11736,GO:0046599,0.853373556075736,0.44487091755223,1,17,regulation of centriole replication,BP,KAT2B
15441,GO:0071800,0.853529133285449,0.444573234660639,1,17,podosome assembly,BP,GSN
4704,GO:0010869,0.853654899771192,0.444332464526599,1,17,regulation of receptor biosynthetic process,BP,PPARG
6681,GO:0030055,0.853768075797944,0.192961487717036,31,359,cell-substrate junction,CC,ITGB6;EGFR;FLNC;DIXDC1;TNS1;CSPG4;ASAP3;ITGB5;FERMT1;PARVB;FLRT3;TRPV4;FLOT1;ITGA2;ITGA6;GSN;TRIOBP;MAP2K2;UBOX5;CYBA;MRC2;TNS2;LRP1;SYNPO2;CD99L2;TNS4;PTK7;CD9;MPRIP;SYNE2;NFASC
4154,GO:0009218,0.853789372216718,0.441519335130698,1,20,pyrimidine ribonucleotide metabolic process,BP,UCKL1
2872,GO:0006366,0.853865724225692,0.166691696707653,172,1757,transcription by RNA polymerase II,BP,HES2;ZSCAN18;TSC22D1;SREBF1;APOE;EGFR;PKD2;CAPRIN2;MNT;ASH2L;SRSF5;SFRP1;DGKQ;PIK3R1;KDM3A;TSC22D3;POU3F1;HTRA1;TFCP2L1;RGMA;ZFPM1;HOXC5;CITED4;IRF2BPL;MC1R;STAT1;IMPACT;CRY2;THAP8;NOS1;ZNF704;HOXA3;CRY1;MAML3;KLF13;NFATC4;HSF4;EAPP;MDM2;CRTC1;NDN;NEO1;TCF25;POLR2J2;PDCD4;ZNF160;ZFP36L2;TRPV4;GLI2;KLF7;RNF165;TCEA2;ZNF76;SOX12;PER2;ABHD14B;TCEAL1;WWTR1;GLI3;THRAP3;IRX4;BHLHE40;MAP2K5;ITGA6;TCFL5;TRAK1;JARID2;NUPR1;HSF2BP;CHD3;ZNF18;MXD4;ZNF446;RTF1;IRF9;BMP6;SQSTM1;ETV5;DLX3;HEXB;KDM4C;METTL23;ZNF608;GDF15;TXNIP;TCF4;PLAG1;RCOR2;IFI27;LPIN3;ATRX;POLR2J3;HFE;ADIRF;ERCC6;MEF2D;CREBRF;MLXIPL;TARBP1;FBXW7;CDK5RAP3;LMO2;NFIX;CARF;MXI1;THRA;RAI1;ELF1;IKZF4;DBP;EPM2AIP1;PEG3;RFX2;SALL2;ZBTB20;PDE2A;MAF;STK16;ZMYND8;DAB2IP;CALCOCO1;TEAD2;MYSM1;TSHZ2;IFI16;PIK3R2;TEF;ZNF25;RPS6KA5;VDR;MAMSTR;PLXND1;ZMYM3;SIX5;HLTF;PCSK6;STAT2;WWC3;ZNF292;TFDP2;NRARP;ACVR1B;TCEAL4;ZNF91;GTF2IRD2;TCF7;ZFP36L1;GLMP;IL11;KAT2B;IVNS1ABP;TRERF1;STAT6;SOX13;NELFCD;KLF8;CHD6;ERBB2;ABCA2;RORA;PPARG;CXXC5;KLF9;ZFP90;PER3;FOXP2;ZC3H6;HIVEP1;SMURF1;NPNT;CTNNBIP1;ECM1
5746,GO:0016896,0.853982103549139,0.349379845323387,2,32,exoribonuclease activity, producing 5'-phosphomonoesters,MF,XRN1;PARN
8428,GO:0033558,0.854053191414591,0.309002788989514,3,43,protein deacetylase activity,MF,CHD3;HMG20B;HDAC11
14886,GO:0070734,0.854196979557255,0.442343274961162,1,18,histone H3-K27 methylation,BP,PHF1
4670,GO:0010821,0.854330728091521,0.213638210840126,15,187,regulation of mitochondrion organization,BP,SREBF1;VPS11;TNFSF10;HPS4;MICALL2;SQSTM1;PLA2G6;OSCP1;FBXW7;DDHD2;STAT2;TFDP2;LMNA;SMURF1;PEMT
9153,GO:0035518,0.85439914301936,0.442905332297024,1,17,histone H2A monoubiquitination,BP,DDB2
4089,GO:0009145,0.854528916860082,0.240486069560297,8,106,purine nucleoside triphosphate biosynthetic process,BP,DHTKD1;INSR;TCIRG1;ATP6V0A2;MLXIPL;PGM1;PFKFB2;OGDHL
1856,GO:0004521,0.854622242144985,0.307102278851946,3,48,endoribonuclease activity,MF,LACTB2;ENDOU;ERN1
3288,GO:0006978,0.854802213677606,0.441180330624274,1,18,DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,BP,ING4
283,GO:0000786,0.854869820177126,0.30316945602356,3,84,nucleosome,CC,H1F0;H2AFJ;H1FX
17816,GO:1902003,0.855017059402909,0.441717391334725,1,17,regulation of amyloid-beta formation,BP,APOE
16248,GO:0090329,0.855268554918865,0.306835633405728,3,44,regulation of DNA-dependent DNA replication,BP,BMP6;ATRX;FBXW7
9074,GO:0035337,0.855393399040101,0.346955751882769,2,32,fatty-acyl-CoA metabolic process,BP,ACSL1;CBR4
7363,GO:0031418,0.855875987726498,0.439110557557379,1,18,L-ascorbic acid binding,MF,PHYH
7176,GO:0031069,0.855978937655037,0.439862651096356,1,17,hair follicle morphogenesis,BP,CTSV
876,GO:0002230,0.85603607569155,0.438801257359092,1,18,positive regulation of defense response to virus by host,BP,STAT1
7030,GO:0030811,0.85611524496118,0.282148337676315,4,54,regulation of nucleotide catabolic process,BP,RAPGEF3;INSR;MLXIPL;PFKFB2
4235,GO:0009435,0.856205681336784,0.345556258527253,2,32,NAD biosynthetic process,BP,NAPRT;NMRK1
20259,GO:2001252,0.856522849213509,0.219479810162214,12,146,positive regulation of chromosome organization,BP,SREBF1;NOS1;SLX1A;SLX1B;JARID2;RTF1;ATRX;FBXO4;RPS6KA5;PHF1;RAD50;PARN
10145,GO:0042742,0.856564633519973,0.252751233726412,6,95,defense response to bacterium,BP,ISG15;PLA2G6;CYBA;KLK5;NLRP1;ACP5
18992,GO:1904837,0.856660753159704,0.342540098343559,2,40,beta-catenin-TCF complex assembly,BP,ASH2L;TCF7
13823,GO:0060445,0.85681294499309,0.439324142327703,1,16,branching involved in salivary gland morphogenesis,BP,PLXND1
8335,GO:0033198,0.857013138673398,0.436909439096493,1,18,response to ATP,BP,DGKQ
18058,GO:1902679,0.857110332583271,0.170641915334399,86,925,negative regulation of RNA biosynthetic process,BP,HES2;SREBF1;MNT;TRIM22;SFRP1;TSC22D3;HR;TFCP2L1;ZFPM1;IRF2BPL;STAT1;IMPACT;CRY2;CRY1;SCMH1;NFATC4;HSF4;EAPP;MDM2;TCF25;PDCD4;TRPV4;GLI2;PER2;ZNF658;PHF2;TCEAL1;WWTR1;GLI3;BHLHE40;MAP2K5;ZNF318;TCFL5;JARID2;CCDC85B;MXD4;RTF1;H2AFJ;BMP6;SQSTM1;ZNF608;TXNIP;RCOR2;IFI27;CDK5R1;ATRX;MLXIPL;ING4;ATXN1;NFIX;MXI1;THRA;IKZF4;NAB2;PEG3;SALL2;ZBTB20;PDE2A;MAF;ZMYND8;DAB2IP;TSHZ2;IFI16;RPS6KA5;VDR;TNRC18;SIX5;WWC3;TFDP2;NRARP;ZNF91;DYDC1;TCF7;STAT6;PRDX5;NELFCD;KLF8;PPARG;CXXC5;ZFP90;PER3;FOXP2;ZC3H6;HIVEP1;CTNNBIP1;GCLC
18405,GO:1903507,0.857110332583271,0.170641915334399,86,925,negative regulation of nucleic acid-templated transcription,BP,HES2;SREBF1;MNT;TRIM22;SFRP1;TSC22D3;HR;TFCP2L1;ZFPM1;IRF2BPL;STAT1;IMPACT;CRY2;CRY1;SCMH1;NFATC4;HSF4;EAPP;MDM2;TCF25;PDCD4;TRPV4;GLI2;PER2;ZNF658;PHF2;TCEAL1;WWTR1;GLI3;BHLHE40;MAP2K5;ZNF318;TCFL5;JARID2;CCDC85B;MXD4;RTF1;H2AFJ;BMP6;SQSTM1;ZNF608;TXNIP;RCOR2;IFI27;CDK5R1;ATRX;MLXIPL;ING4;ATXN1;NFIX;MXI1;THRA;IKZF4;NAB2;PEG3;SALL2;ZBTB20;PDE2A;MAF;ZMYND8;DAB2IP;TSHZ2;IFI16;RPS6KA5;VDR;TNRC18;SIX5;WWC3;TFDP2;NRARP;ZNF91;DYDC1;TCF7;STAT6;PRDX5;NELFCD;KLF8;PPARG;CXXC5;ZFP90;PER3;FOXP2;ZC3H6;HIVEP1;CTNNBIP1;GCLC
2271,GO:0005215,0.857361036106812,0.174895974816784,63,679,transporter activity,MF,APOE;PKD2;SYN1;ORAI3;KCNAB2;KCNJ15;SLC16A5;GJD3;PITPNM3;KCNC4;SLC29A4;ITPR3;NDUFA4L2;TMEM63C;SLC24A1;TRPV4;SLC13A5;GJC2;PITPNM2;CLCN6;KCNJ5;SCNN1A;SCN4B;SLC27A1;NIPAL2;SLC2A3;TCIRG1;SLC12A7;CLCA2;ATP6V0A2;ANO9;OSBPL10;KCNMA1;SLC2A1;SLC38A4;LRP1;KCNG1;SLC48A1;JPH2;PDE2A;SLC37A2;SHROOM2;SCN2A;OSBPL5;CACNB3;ORAI2;SLC36A4;OSBPL1A;DLG4;SLC22A15;SLC35G2;ANO1;S100A6;SLC43A1;CACNB1;ABCA2;SLC2A11;PLTP;KCNS3;CLCN7;CALHM2;ABCA11P;SERINC3
567,GO:0001709,0.857476638714902,0.436009541065817,1,18,cell fate determination,BP,CYP26B1
13464,GO:0055023,0.857746966249448,0.436435729126346,1,17,positive regulation of cardiac muscle tissue growth,BP,AKAP6
7404,GO:0031497,0.857821258072682,0.234841469259347,8,134,chromatin assembly,BP,H1F0;H1FX;CENPC;ATRX;TSPYL4;CENPH;TNRC18;NAP1L5
3554,GO:0007595,0.857860568858137,0.343058919649491,2,31,lactation,BP,OAS2;VDR
18418,GO:1903523,0.857917559930899,0.436103848880895,1,17,negative regulation of blood circulation,BP,F2R
4161,GO:0009225,0.858025313723045,0.34206924067204,2,33,nucleotide-sugar metabolic process,BP,MPI;UAP1L1
5649,GO:0016747,0.858194255048033,0.21123267988285,14,172,transferase activity, transferring acyl groups other than amino-acyl groups,MF,CPT2;ZDHHC1;HGSNAT;CERS4;CRAT;NAT6;MBOAT2;ZDHHC12;GOLGA7B;NAT14;KAT2B;CERS5;CPT1C;ZDHHC24
3372,GO:0007143,0.858240047697999,0.434523898275453,1,18,female meiotic nuclear division,BP,MLH3
1549,GO:0003950,0.858252592618754,0.435451431898427,1,17,NAD+ ADP-ribosyltransferase activity,MF,PARP6
17342,GO:1900076,0.858510101524285,0.278307723623342,4,55,regulation of cellular response to insulin stimulus,BP,PIK3R1;SESN3;PIK3R2;GPR21
14816,GO:0070577,0.858836454782376,0.435388626807211,1,16,lysine-acetylated histone binding,MF,ZMYND8
17262,GO:0140033,0.858836454782376,0.435388626807211,1,16,acetylation-dependent protein binding,MF,ZMYND8
5688,GO:0016811,0.858844892651309,0.261704695380379,5,70,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides,MF,CHD3;HMG20B;NDST2;FAAH;HDAC11
11774,GO:0046655,0.859330409986823,0.4323944663502,1,18,folic acid metabolic process,BP,MTHFR
6850,GO:0030326,0.860159899237791,0.240013837921732,7,88,embryonic limb morphogenesis,BP,FBXW4;WNT3;CYP26B1;GLI2;GLI3;IFT140;TMEM231
8985,GO:0035113,0.860159899237791,0.240013837921732,7,88,embryonic appendage morphogenesis,BP,FBXW4;WNT3;CYP26B1;GLI2;GLI3;IFT140;TMEM231
2714,GO:0006090,0.860168812479235,0.232844940991044,8,102,pyruvate metabolic process,BP,DHTKD1;INSR;PDK1;MLXIPL;PGM1;PFKFB2;OGDHL;SRR
12264,GO:0048592,0.860260304994896,0.239940118261565,7,87,eye morphogenesis,BP,ALDH1A3;EPHB2;SDK2;NAGLU;GLI3;SHROOM2;TH
904,GO:0002286,0.860355461527612,0.298407804081145,3,45,T cell activation involved in immune response,BP,ZFPM1;STAT6;RORA
9695,GO:0038111,0.860360295745335,0.425895640193257,1,25,interleukin-7-mediated signaling pathway,BP,IRS2
16829,GO:0098760,0.860360295745335,0.425895640193257,1,25,response to interleukin-7,BP,IRS2
16830,GO:0098761,0.860360295745335,0.425895640193257,1,25,cellular response to interleukin-7,BP,IRS2
1698,GO:0004180,0.860532159825932,0.430037176753633,1,18,carboxypeptidase activity,MF,CTSV
14488,GO:0065002,0.860623492509182,0.297078752677135,3,50,intracellular protein transmembrane transport,BP,PEX10;PEX7;PEX1
4267,GO:0009620,0.860625721696438,0.427556089814822,1,21,response to fungus,BP,FAM3A
6737,GO:0030162,0.860689961919777,0.176775871617195,45,517,regulation of proteolysis,BP,SERPINE2;IFI6;APOE;CAMK2N1;PRKACB;MAGEF1;BTBD2;COL7A1;SPOCK1;MDM2;LTBP4;TNFSF10;F2R;SERPINB5;LAMP3;PIDD1;RHBDF1;C5;NAIP;MAP2K5;GSN;CD109;CST3;IFI27;HFE;FBXW7;TFPI2;NLRP1;DAB2IP;IFI16;FGFR4;ABTB1;BST2;PANO1;PCSK1N;PRDX5;PTPN3;PPARG;PRKACA;SERPING1;UFL1;SNX33;SMURF1;GCLC;ECM1
5681,GO:0016799,0.860868251525011,0.427765319912106,1,20,hydrolase activity, hydrolyzing N-glycosyl compounds,MF,MPG
18487,GO:1903670,0.8612779499727,0.297324810388728,3,43,regulation of sprouting angiogenesis,BP,MAP2K5;MMRN2;SRPX2
15776,GO:0072431,0.86132766317249,0.273276604445584,4,60,signal transduction involved in mitotic G1 DNA damage checkpoint,BP,MDM2;PCBP4;PIDD1;TFDP2
17961,GO:1902400,0.86132766317249,0.273276604445584,4,60,intracellular signal transduction involved in G1 DNA damage checkpoint,BP,MDM2;PCBP4;PIDD1;TFDP2
6056,GO:0019207,0.861780055234845,0.209277945216622,13,162,kinase regulator activity,MF,DGKQ;PIK3R1;CAMK2N1;FLRT3;RTN4RL1;ETAA1;MAP2K2;CDK5R1;ERCC6;SPRY2;WNK1;PIK3R2;KAT2B
1339,GO:0003203,0.861950618570961,0.428194120122827,1,17,endocardial cushion morphogenesis,BP,MDM2
877,GO:0002237,0.86196909479405,0.199567397502036,17,210,response to molecule of bacterial origin,BP,TNFAIP3;NOS1;CMPK2;F2R;PDCD4;ADAMTS13;TNFRSF14;MGST2;BMP6;LOXL1;TNFRSF21;SRR;ACP5;DAB2IP;VDR;TNFRSF25;TH
16525,GO:0097300,0.861971814354871,0.334872776032292,2,34,programmed necrotic cell death,BP,RBCK1;RIPK3
2545,GO:0005814,0.862162834322133,0.224423924954963,9,112,centriole,CC,CEP192;LRRCC1;IQCB1;WASH3P;CCDC92;DZIP1L;CAPG;ALMS1;CEP250
13462,GO:0055021,0.862190330280765,0.335508927571079,2,31,regulation of cardiac muscle tissue growth,BP,JARID2;AKAP6
3178,GO:0006796,0.86225710091347,0.155498319238811,223,2282,phosphate-containing compound metabolic process,BP,TNFAIP3;ULK2;GPNMB;SIK1;PTHLH;APOE;NT5E;INPP5D;HSPA2;EGFR;PTPRS;FAM20C;PKD2;CAPRIN2;PLCD3;SFRP1;EPHB2;MAP3K14;DGKQ;PIK3R1;BRSK1;H6PD;DHTKD1;CAMKK1;HERC5;VAV3;CSPG4;ELFN2;PI4KAP2;KCNAB2;KITLG;MVD;NAPRT;SRD5A3;IMPACT;CAMK2N1;CRY2;NOS1;PRKACB;CRY1;PITPNM3;SPDYE6;CMPK2;THNSL2;CNTRL;PIK3C2G;CDK18;SPEG;PLCD1;NMRK1;PPP2R2C;PIK3IP1;OBSCN;RAPGEF3;PHACTR3;FLRT3;RASA4;RGS2;F2R;PDCD4;SPTB;ALPK1;NEK9;RTN4RL1;ZFP36L2;TRPV4;FLOT1;ADORA2B;PLCH2;MAPK8IP3;SPDYE5;G6PC3;GJC2;SULT1E1;RASGEF1A;PITPNM2;UNC119;FRS3;C5;PSKH1;MINK1;ABHD14B;WWTR1;MBOAT2;ITGA2;ULK1;FGGY;NEK8;MAP2K5;ITGA6;IGFBP4;INSR;CDK14;TTN;CBLC;DDT;CD109;PGLS;ETAA1;PILRB;SLC27A1;PGAP1;RICTOR;BMP6;ETNK2;TCIRG1;MAP2K2;PDK1;SQSTM1;CEP192;PTK6;FZD7;SYNGAP1;HEXB;PLA2G6;PDIK1L;GDF15;CTF1;ATP6V0A2;NPHP3;IDH2;MAP3K12;LPIN3;CDK5R1;PIGZ;OSBPL10;PI4KAP1;MAPK10;SHANK3;HFE;ERCC6;RRM2B;SHC2;EDA2R;SPRY2;GABBR1;MLXIPL;FBXW7;GPR87;CDK5RAP3;PAK6;PGM1;PFKFB2;ADARB1;OGDHL;TK2;TNS2;NAB2;ACP5;PLA2G7;MAP3K6;PPCS;MYO3B;WNK1;PDE2A;SDHA;STK16;LTB4R2;RET;DAB2IP;DDHD2;PIK3C3;FGFR4;PIK3R2;OSBPL5;AREG;RPS6KA5;NADK;MPPE1;STK19;NDUFV3;PPP1R2;DMTN;PPP1R35;STAT2;LMTK3;ACVR1B;DLG4;PPP2R3B;TSSK1B;ADCK5;MPI;WEE1;PTK7;TNFRSF25;ZFP36L1;ACSL1;IL11;KAT2B;MARK4;IRS2;IMPA2;ERN1;RAD50;TKFC;PNPO;SCYL3;ISYNA1;PBLD;PHPT1;SMPDL3B;SRPX2;RANBP9;PTPN3;ERBB2;SPOCD1;PLCB3;NUDT10;PPM1M;AKAP6;ATG14;RORA;SSH3;PRKACA;ACKR3;UCKL1;IP6K2;RIPK3;PI4K2B;CIT;NPNT;PEMT;SERINC3
16236,GO:0090312,0.862538652554208,0.426076959582385,1,18,positive regulation of protein deacetylation,BP,SREBF1
5376,GO:0016192,0.862714474445055,0.15894634602968,139,1436,vesicle-mediated transport,BP,PYGB;APOE;LMF1;HSPA2;SYT8;CXCR1;SYN1;PIK3R1;EVI5L;VAV3;MVB12B;KCNAB2;VAMP3;NAPRT;ASAP3;NSG1;RAB43;RAB40B;SCARA3;GAA;AP5Z1;MICALL1;TBC1D8;VPS11;COL7A1;FCGRT;HGSNAT;SYTL1;ACTR1B;ENDOD1;NLGN4Y;KIF26A;AP1G2;ACAP3;C2CD4C;BLOC1S4;SPTB;CLTCL1;TMC6;FLOT1;AGAP4;NLGN2;ADORA2B;ANK3;MAPK8IP3;RIMS3;SPG11;UNC119;WIPF1;ASAP2;LHFPL2;ITGA2;SYT15;LRSAM1;VAMP2;TRAK1;GSN;BAIAP2;TTN;RIN1;CD109;RAB11FIP4;VPS39;PGAP1;BLOC1S3;SLC2A3;TCIRG1;MICALL2;MAP2K2;VEGFB;SQSTM1;HEXB;WHAMMP3;PLA2G6;CST3;BBS2;SEPT5;DNM1;MCTP1;ARHGAP27;AGAP6;HOOK2;HFE;SCART1;CYBA;MRC2;WASH3P;AGAP7P;RAB11FIP3;CTSB;ANKRD28;PGM1;ARAP1;RPH3AL;TBC1D17;LRP1;TSNARE1;APPL2;BBS1;DDHD2;PIK3C3;SYT7;EXOC2;PIK3R2;OSBPL5;AREG;BST2;EHBP1;MPPE1;TBC1D16;DMTN;SGSM2;ARFGEF2;ALMS1;SNX1;OSBPL1A;DLG4;ESYT2;ENDOU;NBEAL2;CD68;METTL7A;TUB;GLB1;GOLGB1;DPP7;CD9;CTSD;SYNGR1;ATG14;PPARG;LDLRAP1;C6ORF120;ACKR3;SERPING1;NFASC;COG1;SNX33;ECM1
12576,GO:0050772,0.862874425128393,0.256078738144279,5,66,positive regulation of axonogenesis,BP,WNT3;PLXNB1;TRAK1;PLXNB3;PLXND1
10977,GO:0044788,0.86317464582007,0.424815269915777,1,18,modulation by host of viral process,BP,APOE
9299,GO:0035767,0.863457112658917,0.424253909545698,1,18,endothelial cell chemotaxis,BP,PLEKHG5
17289,GO:0140112,0.863508607174601,0.42330157591752,1,19,extracellular vesicle biogenesis,BP,ARRDC1
19165,GO:1905269,0.863704975252915,0.243348900883827,6,80,positive regulation of chromatin organization,BP,SREBF1;NOS1;JARID2;RTF1;RPS6KA5;PHF1
13044,GO:0051568,0.863824292057602,0.292744793607516,3,45,histone H3-K4 methylation,BP,ASH2L;RTF1;DYDC1
11500,GO:0046031,0.864018996989251,0.242888982347714,6,80,ADP metabolic process,BP,DHTKD1;INSR;MLXIPL;PGM1;PFKFB2;OGDHL
9473,GO:0036119,0.86402524507599,0.424076983796942,1,17,response to platelet-derived growth factor,BP,HYAL1
1861,GO:0004527,0.864043325472858,0.253912470378034,5,70,exonuclease activity,MF,WRN;TREX1;XRN1;RAD50;PARN
15028,GO:0070997,0.864193567601468,0.191830308525368,20,236,neuron death,BP,GPNMB;APOE;UNC5B;F2R;NAIP;ENDOG;MDK;SYNGAP1;MAP3K12;TNFRSF21;CDK5R1;FBXW7;ADARB1;NLRP1;LRP1;SCN2A;SNCB;TRIM2;CIT;GCLC
65,GO:0000132,0.864408957254657,0.422357711563885,1,18,establishment of mitotic spindle orientation,BP,SPRY2
5743,GO:0016893,0.864734163024839,0.329715277913531,2,35,endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters,MF,SLX1A;SLX1B
16476,GO:0097194,0.864736228950026,0.252774226962762,5,71,execution phase of apoptosis,BP,H1F0;ENDOG;CASP14;SHARPIN;CDK5RAP3
10879,GO:0044433,0.864779445310937,0.160502061657425,97,1039,cytoplasmic vesicle part,CC,ULK2;MAP6;SREBF1;PYGB;APOE;EGFR;PTPRS;PKD2;SYT8;CXCR1;SYN1;LRIG3;WNT3;MVB12B;KCNAB2;VAMP3;NAPRT;NSG1;RAB43;RAB40B;GAA;MICALL1;VPS11;NDRG1;ITPR3;MDM2;GPRC5C;HLA-B;HGSNAT;ACTR1B;AP1G2;C2CD4C;CLTCL1;TMC6;LAMP3;CLCN6;LHFPL2;SPPL2B;PCSK1;VAMP2;INSR;GSN;SUN1;AHNAK2;CD109;RAB11FIP4;VPS39;TMEM9;SLC2A3;TCIRG1;VEGFB;FZD7;HEXB;CST3;ATP6V0A2;MCTP1;CYBA;WASH3P;RAB11FIP3;CTSB;PGM1;CHMP1B;RPH3AL;LRP1;HLA-A;CCDC136;SLC48A1;APPL2;PMEL;RET;PIK3C3;SYT7;AREG;BST2;SNX21;MARCH8;SNX1;DLG4;NBEAL2;CD68;DMXL2;METTL7A;LAPTM4A;GLB1;DPP7;CD9;CTSD;ERBB2;SYNGR1;ABCA2;TH;LDLRAP1;C6ORF120;SERPING1;NFASC;SNX33;ECM1
992,GO:0002449,0.864790424012492,0.215811355482776,10,130,lymphocyte mediated immunity,BP,INPP5D;IL20RB;C5;HFE;SCART1;C1RL;RSAD2;STAT6;SERPING1;RIPK3
1113,GO:0002702,0.864898046086135,0.290603893338616,3,47,positive regulation of production of molecular mediator of immune response,BP,KLK5;RSAD2;STAT6
8196,GO:0032958,0.865057354157554,0.4220162876762,1,17,inositol phosphate biosynthetic process,BP,IP6K2
3410,GO:0007193,0.865275020258232,0.3300731387015,2,31,adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway,BP,RGS2;GABBR1
7097,GO:0030901,0.865481830905084,0.267050134228382,4,58,midbrain development,BP,SFRP1;GLUD1;WNT3;DLG5
10167,GO:0042772,0.865656586896423,0.419011151012473,1,19,DNA damage response, signal transduction resulting in transcription,BP,ING4
1125,GO:0002714,0.865721019922316,0.419732332640665,1,18,positive regulation of B cell mediated immunity,BP,STAT6
1220,GO:0002891,0.865721019922316,0.419732332640665,1,18,positive regulation of immunoglobulin mediated immune response,BP,STAT6
10853,GO:0044389,0.866315641282292,0.184073299709179,24,283,ubiquitin-like protein ligase binding,MF,EGFR;CUL9;ISG15;CUL7;MC1R;STAT1;PRKACB;BTBD2;MDM2;TNFRSF14;TRIOBP;SQSTM1;UBOX5;ARRDC1;TXNIP;FBXW7;CDK5RAP3;ABTB1;HLTF;STAT2;ACVR1B;TRAF5;PRKACA;PER3
883,GO:0002250,0.866475951860924,0.195837565033655,16,194,adaptive immune response,BP,TNFAIP3;INPP5D;IL20RB;LAMP3;C5;TNFRSF21;HFE;SCART1;C1RL;PRR7;MARCH8;RSAD2;STAT6;RORA;SERPING1;RIPK3
634,GO:0001824,0.866733619746526,0.287766006269558,3,46,blastocyst development,BP,RTF1;KDM4C;PALB2
15758,GO:0072384,0.866744843139036,0.250028034370389,5,68,organelle transport along microtubule,BP,BLOC1S4;TRAK1;SUN1;BLOC1S3;SYNE2
15869,GO:0072657,0.866984222202442,0.173063790584711,37,452,protein localization to membrane,BP,APOE;EGFR;EPHB2;PIK3R1;ZDHHC1;VAMP3;REEP2;NSG1;RAB40B;MICALL1;FLOT1;NLGN2;ANK3;VAMP2;GSN;SQSTM1;ETV5;SYNGAP1;EPB41L3;BBS2;ZDHHC12;CDK5R1;SHANK3;LRP1;BBS1;ZMYND8;CACNB3;DMTN;TFDP2;GOLGA7B;DLG4;TUB;ERBB2;ZDHHC24;LDLRAP1;NFASC;SMURF1
8104,GO:0032800,0.867047364956604,0.417064604569447,1,18,receptor biosynthetic process,BP,PPARG
10576,GO:0043555,0.86727097843686,0.416613468113009,1,18,regulation of translation in response to stress,BP,IMPACT
3314,GO:0007018,0.867301044853025,0.188002997468174,20,229,microtubule-based movement,BP,KIF26B;WDR63;MYH11;KIF26A;BLOC1S4;DNAH1;SPG11;GAS8;TRAK1;SUN1;BLOC1S3;CABYR;BBS2;NPHP3;IFT140;MYO3B;MYO9A;KIF7;SYNE2;TTLL1
3330,GO:0007041,0.867370830014381,0.229554826023922,7,90,lysosomal transport,BP,VPS11;HGSNAT;TRAK1;VPS39;HOOK2;WASH3P;ATG14
692,GO:0001913,0.867529169937825,0.414478491464085,1,20,T cell mediated cytotoxicity,BP,RIPK3
9772,GO:0039702,0.867816872322242,0.413896791924786,1,20,viral budding via host ESCRT complex,BP,CHMP1B
8987,GO:0035116,0.86792930638354,0.415282986981206,1,18,embryonic hindlimb morphogenesis,BP,WNT3
9231,GO:0035635,0.867950399347618,0.415240300797821,1,18,entry of bacterium into host cell,BP,EXOC2
18324,GO:1903313,0.868246425239058,0.262974117625037,4,56,positive regulation of mRNA metabolic process,BP,ZFP36L2;THRAP3;TNRC6C;ZFP36L1
14255,GO:0061351,0.868513616021912,0.236355724311483,6,79,neural precursor cell proliferation,BP,DIXDC1;KCTD11;GJC2;GLI3;RORA;PTBP2
5200,GO:0015800,0.868554931650581,0.324240097025526,2,31,acidic amino acid transport,BP,PER2;VAMP2
14881,GO:0070723,0.868914143720569,0.414241276791976,1,17,response to cholesterol,BP,ABCA2
14927,GO:0070841,0.869072188697157,0.412964967028951,1,18,inclusion body assembly,BP,HSPA2
17293,GO:0140142,0.869136007284573,0.412835218386306,1,18,nucleocytoplasmic carrier activity,MF,TMCO6
7889,GO:0032465,0.869324830906435,0.246110493326042,5,68,regulation of cytokinesis,BP,OR2A4;RAB11FIP4;RAB11FIP3;PIK3C3;CIT
798,GO:0002068,0.869342223392846,0.412415738168827,1,18,glandular epithelial cell development,BP,BMP6
137,GO:0000288,0.869374056137788,0.245658768175182,5,72,nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,BP,ZFP36L2;ZCCHC11;TNRC6C;ZFP36L1;PARN
16606,GO:0097484,0.869410628634237,0.413231725525259,1,17,dendrite extension,BP,SMURF1
5841,GO:0017134,0.869480939969095,0.411282315818373,1,19,fibroblast growth factor binding,MF,FGFR4
13071,GO:0051602,0.8695648455152,0.411962498514516,1,18,response to electrical stimulus,BP,TH
3228,GO:0006882,0.869586036418127,0.409617204086011,1,21,cellular zinc ion homeostasis,BP,MT1X
13480,GO:0055069,0.869586036418127,0.409617204086011,1,21,zinc ion homeostasis,BP,MT1X
3733,GO:0008270,0.869658728589141,0.16347898554256,53,576,zinc ion binding,MF,TNFAIP3;TRIM65;APOBEC3C;TRIM22;PRICKLE2;CYHR1;MDM2;TNFSF10;TRIM66;MT1X;GLI2;KLF7;RNF165;ADAMTS13;TCEA2;ZCCHC11;DTNB;PHF2;ZNF318;MMP1;MMP28;CHD3;CBLC;RNPEPL1;DHX58;PEX10;SQSTM1;KDM4C;ZCCHC24;CA2;SHANK3;TRIM38;THRA;IKZF4;LACTB2;RNPEP;ZNF276;VDR;ZMYM3;HLTF;MARCH8;MPI;ZNF91;ZMAT3;MTR;S100A6;ZSWIM8;PHC2;TRAF5;TRIM2;RORA;PPARG;CXXC5
3748,GO:0008287,0.869923571402921,0.282672560570395,3,45,protein serine/threonine phosphatase complex,CC,PPP2R2C;PPP1R2;PPP2R3B
18311,GO:1903293,0.869923571402921,0.282672560570395,3,45,phosphatase complex,CC,PPP2R2C;PPP1R2;PPP2R3B
13549,GO:0060038,0.869955077777495,0.321733031396069,2,31,cardiac muscle cell proliferation,BP,TENM4;JARID2
1117,GO:0002706,0.870019040498854,0.244676876281196,5,72,regulation of lymphocyte mediated immunity,BP,IL20RB;HFE;RSAD2;STAT6;RIPK3
15769,GO:0072413,0.870021367969402,0.25954106415627,4,61,signal transduction involved in mitotic cell cycle checkpoint,BP,MDM2;PCBP4;PIDD1;TFDP2
17962,GO:1902402,0.870021367969402,0.25954106415627,4,61,signal transduction involved in mitotic DNA damage checkpoint,BP,MDM2;PCBP4;PIDD1;TFDP2
17963,GO:1902403,0.870021367969402,0.25954106415627,4,61,signal transduction involved in mitotic DNA integrity checkpoint,BP,MDM2;PCBP4;PIDD1;TFDP2
14293,GO:0061462,0.870093312986334,0.321126337777404,2,32,protein localization to lysosome,BP,WASH3P;C12ORF66
10262,GO:0043022,0.870105815053692,0.281994599190592,3,47,ribosome binding,MF,IMPACT;RICTOR;LETMD1
18275,GO:1903203,0.870150249767169,0.410768744216368,1,18,regulation of oxidative stress-induced neuron death,BP,FBXW7
10764,GO:0044232,0.870172840039175,0.41072262230229,1,18,organelle membrane contact site,CC,ESYT2
14501,GO:0070011,0.870257078436864,0.173035177998529,31,359,peptidase activity, acting on L-amino acid peptides,MF,TNFAIP3;NPEPL1;ADAM19;CTSO;SFRP1;ADAMTS7;HTRA1;TYSND1;CTSV;CAPN7;ADAMTS13;RHBDF1;SPPL2B;PCSK1;MMP1;MMP28;RNPEPL1;CTSF;CASP14;CLCA2;CAPNS2;CTSB;KLK5;C1RL;RNPEP;MYSM1;PCSK6;ENDOU;DPP7;CTSD;LONP2
13874,GO:0060538,0.870378270193779,0.225088170490785,7,92,skeletal muscle organ development,BP,TSC22D3;CYP26B1;FLOT1;NUPR1;HMG20B;MEF2D;FOXP2
7714,GO:0032212,0.870510437998903,0.32004176063031,2,33,positive regulation of telomere maintenance via telomerase,BP,FBXO4;PARN
12207,GO:0048477,0.870520904938895,0.281678074531277,3,45,oogenesis,BP,HEXB;REC8;PAQR7
8849,GO:0034656,0.870625054011256,0.318946297705733,2,36,nucleobase-containing small molecule catabolic process,BP,NT5E;APOBEC3C
6547,GO:0021983,0.870741634094906,0.409559958095772,1,18,pituitary gland development,BP,GLI2
1111,GO:0002700,0.871082061208182,0.243055882397604,5,72,regulation of production of molecular mediator of immune response,BP,HFE;KLK5;BST2;RSAD2;STAT6
8227,GO:0033006,0.871105190730405,0.407964208378725,1,19,regulation of mast cell activation involved in immune response,BP,ADORA2B
10433,GO:0043304,0.871105190730405,0.407964208378725,1,19,regulation of mast cell degranulation,BP,ADORA2B
5500,GO:0016445,0.871143524224993,0.280639933895726,3,45,somatic diversification of immunoglobulins,BP,PMS2P3;STAT6;POLM
5401,GO:0016241,0.871164936700586,0.199842720998193,12,150,regulation of macroautophagy,BP,EPM2A;GPSM1;ULK1;LRSAM1;SESN3;LZTS1;ATP6V0A2;CDK5R1;SESN1;ERN1;PRKACA;SMURF1
16790,GO:0098659,0.871530787051396,0.318899235712893,2,31,inorganic cation import across plasma membrane,BP,KCNJ5;HFE
17056,GO:0099587,0.871530787051396,0.318899235712893,2,31,inorganic ion import across plasma membrane,BP,KCNJ5;HFE
9875,GO:0042165,0.871704009682878,0.406735469874997,1,19,neurotransmitter binding,MF,SRR
4577,GO:0010665,0.871706824624118,0.407580953354589,1,18,regulation of cardiac muscle cell apoptotic process,BP,RGL2
8105,GO:0032801,0.872277440492517,0.317194272390871,2,32,receptor catabolic process,BP,APOE;SMURF1
14773,GO:0070509,0.872495544377833,0.316800225847003,2,32,calcium ion import,BP,PKD2;TRPV4
13888,GO:0060561,0.872606998348433,0.405728325365993,1,18,apoptotic process involved in morphogenesis,BP,VDR
9073,GO:0035336,0.87264731837985,0.404793865535315,1,19,long-chain fatty-acyl-CoA metabolic process,BP,ACSL1
11081,GO:0045104,0.872726163326298,0.316383290876456,2,32,intermediate filament cytoskeleton organization,BP,KLHL24;KRT14
18792,GO:1904380,0.872735121446645,0.404612766468643,1,19,endoplasmic reticulum mannose trimming,BP,MAN1B1
5075,GO:0015301,0.87290144268772,0.405120875060588,1,18,anion:anion antiporter activity,MF,SLC37A2
2463,GO:0005680,0.873026398479694,0.402560112924464,1,21,anaphase-promoting complex,CC,CUL7
416,GO:0001104,0.873094664962425,0.229410373672814,6,81,RNA polymerase II transcription cofactor activity,MF,POU3F1;CITED4;SOX12;THRAP3;ZMYND8;TRERF1
2556,GO:0005834,0.873173038253078,0.403708580046454,1,19,heterotrimeric G-protein complex,CC,GNG2
19207,GO:1905360,0.873173038253078,0.403708580046454,1,19,GTPase complex,CC,GNG2
12824,GO:0051154,0.873441573072897,0.404004683647532,1,18,negative regulation of striated muscle cell differentiation,BP,FZD7
12326,GO:0048704,0.873860257238571,0.253937488596497,4,57,embryonic skeletal system morphogenesis,BP,HOXA3;GLI3;HYAL1;IFT140
9338,GO:0035861,0.873862790959232,0.314324201864706,2,32,site of double-strand break,CC,PHF1;RAD50
18277,GO:1903205,0.87391046930426,0.401419094109898,1,20,regulation of hydrogen peroxide-induced cell death,BP,ENDOG
3333,GO:0007044,0.874190418784493,0.228170050942873,6,76,cell-substrate junction assembly,BP,SFRP1;TNS1;ITGA2;ITGA6;KRT14;DMTN
1853,GO:0004518,0.874343470916728,0.189903726859929,14,178,nuclease activity,MF,ENDOD1;SLX1A;SLX1B;ENDOG;PGAP1;WRN;TREX1;XRN1;LACTB2;ERCC5;ENDOU;ERN1;RAD50;PARN
19020,GO:1904886,0.874437162961807,0.401940862275766,1,18,beta-catenin destruction complex disassembly,BP,FRAT1
9788,GO:0040019,0.874452836563824,0.401908304700848,1,18,positive regulation of embryonic development,BP,TENM4
17404,GO:1900180,0.874474522124907,0.227210536859209,6,83,regulation of protein localization to nucleus,BP,LZTS2;GLI3;CDK5RAP3;PDE2A;FBXO4;LMNA
6248,GO:0019829,0.874533121577377,0.31245982152784,2,34,cation-transporting ATPase activity,MF,TCIRG1;ATP6V0A2
793,GO:0002063,0.874562517804495,0.402636063972824,1,17,chondrocyte development,BP,SULF2
2376,GO:0005507,0.874769064544549,0.310951071660646,2,38,copper ion binding,MF,LOXL1;SNCB
9725,GO:0038191,0.874794094107364,0.402154573993601,1,17,neuropilin binding,MF,SEMA4G
1866,GO:0004532,0.874799101243185,0.311976257166315,2,34,exoribonuclease activity,MF,XRN1;PARN
11074,GO:0045088,0.874838212666968,0.173426515021339,24,286,regulation of innate immune response,BP,TNFAIP3;MUC19;DDX60;PTPRS;RNF135;STAT1;PRKACB;FLOT1;DHX58;NLRX1;CYBA;CTSB;DAB2IP;PIK3C3;IFI16;RPS6KA5;FAM3A;STAT2;RSAD2;TKFC;SMPDL3B;PPARG;PRKACA;SERPING1
6835,GO:0030307,0.874959877351434,0.206389840471496,9,117,positive regulation of cell growth,BP,EGFR;SFRP1;WNT3;MAP2K5;HYAL1;CYBA;ERBB2;AKAP6;SMURF1
7932,GO:0032528,0.875036307936536,0.400694825195017,1,18,microvillus organization,BP,PODXL
11456,GO:0045927,0.875338898946053,0.1887499777004,14,170,positive regulation of growth,BP,EGFR;SFRP1;WNT3;TFCP2L1;MAP2K5;INSR;HYAL1;BBS2;CYBA;ACACB;GPR21;ERBB2;AKAP6;SMURF1
12136,GO:0048260,0.875403062699572,0.311189454380717,2,33,positive regulation of receptor-mediated endocytosis,BP,HFE;LDLRAP1
2577,GO:0005868,0.875997637562051,0.397074624757617,1,20,cytoplasmic dynein complex,CC,NUDCD3
19047,GO:1904949,0.876530398887786,0.224278895860929,6,81,ATPase complex,CC,SMARCA1;CHD3;ATRX;APPL2;SALL2;ABCA2
9,GO:0000018,0.876586416941976,0.249447214089159,4,58,regulation of DNA recombination,BP,MAGEF1;WRN;RAD50;STAT6
11558,GO:0046128,0.876734523713526,0.248740279485676,4,62,purine ribonucleoside metabolic process,BP,NT5E;GAMT;DLG4;PEMT
15418,GO:0071715,0.876810689015075,0.396135422333123,1,19,icosanoid transport,BP,PLA2G6
17671,GO:1901571,0.876810689015075,0.396135422333123,1,19,fatty acid derivative transport,BP,PLA2G6
17585,GO:1901292,0.877303182506829,0.198575286503328,10,130,nucleoside phosphate catabolic process,BP,NT5E;DHTKD1;RAPGEF3;INSR;MLXIPL;PGM1;PFKFB2;OGDHL;PDE2A;NUDT10
16109,GO:0090130,0.877742245148009,0.179383524838273,17,200,tissue migration,BP,ACTA2;APOE;PLEKHG5;FERMT1;CAPN7;ITGA2;MAP2K5;FAT2;HYAL1;MMRN2;LTB4R2;DAB2IP;PLXND1;PBLD;TNFSF12;SRPX2;PPARG
13956,GO:0060688,0.87796004185245,0.306511240474945,2,33,regulation of morphogenesis of a branching structure,BP,SFRP1;ETV5
5452,GO:0016328,0.877973059556383,0.269146155296165,3,45,lateral plasma membrane,CC,NSG1;ANK3;SNTA1
1122,GO:0002711,0.878017349442624,0.392835271506027,1,20,positive regulation of T cell mediated immunity,BP,RSAD2
12630,GO:0050854,0.878093701069396,0.305954362528248,2,34,regulation of antigen receptor-mediated signaling pathway,BP,ELF1;PHPT1
3543,GO:0007566,0.87831682879189,0.305251780512045,2,35,embryo implantation,BP,CST3;ACVR1B
18210,GO:1903036,0.878325659313314,0.305528123582951,2,34,positive regulation of response to wounding,BP,F2R;DMTN
17717,GO:1901673,0.878532553455308,0.392511262371678,1,19,regulation of mitotic spindle assembly,BP,CHMP1B
2752,GO:0006163,0.878839441696479,0.163104958453641,30,373,purine nucleotide metabolic process,BP,PTHLH;APOE;NT5E;FAM20C;PKD2;DHTKD1;NOS1;RAPGEF3;ADORA2B;SULT1E1;ABHD14B;INSR;TCIRG1;ATP6V0A2;NPHP3;GABBR1;MLXIPL;GPR87;PGM1;PFKFB2;OGDHL;PPCS;PDE2A;SDHA;LTB4R2;NADK;NDUFV3;DLG4;NUDT10;RORA
442,GO:0001191,0.879150057030786,0.304010799302286,2,34,transcriptional repressor activity, RNA polymerase II transcription factor binding,MF,BHLHE40;ZMYND8
3797,GO:0008376,0.879201248148741,0.304227228204201,2,33,acetylgalactosaminyltransferase activity,MF,B4GALNT4;B3GNT9
1430,GO:0003407,0.87923283844528,0.304853980336012,2,31,neural retina development,BP,SDK2;RAB11FIP4
3319,GO:0007026,0.879468946608604,0.391380569482884,1,18,negative regulation of microtubule depolymerization,BP,APC2
15294,GO:0071514,0.879956050102026,0.390346574314754,1,18,genetic imprinting,BP,NDN
2811,GO:0006271,0.880022515589381,0.388591505282795,1,20,DNA strand elongation involved in DNA replication,BP,LIG1
11746,GO:0046620,0.880031693148919,0.244024764436373,4,57,regulation of organ growth,BP,JARID2;ACACB;WWC3;AKAP6
5121,GO:0015491,0.88017844509736,0.389873788692265,1,18,cation:cation antiporter activity,MF,SLC24A1
9425,GO:0036010,0.880324770594106,0.389562478481555,1,18,protein localization to endosome,BP,MICALL1
6917,GO:0030516,0.880450362113173,0.229084363432391,5,67,regulation of axon extension,BP,APOE;PTPRS;WNT3;SEMA4G;CDK5R1
5572,GO:0016592,0.880761180360927,0.30074305040196,2,35,mediator complex,CC,GLI3;THRAP3
4820,GO:0014020,0.880818950114378,0.217900098978826,6,80,primary neural tube formation,BP,SFRP1;PRKACB;CELSR1;NPHP3;TEAD2;PTK7
2977,GO:0006520,0.880848547120629,0.167946114107425,22,276,cellular amino acid metabolic process,BP,GAMT;MTHFR;GLUD1;BPHL;NOS1;CRTAP;HMGCL;THNSL2;PRODH;ALDH4A1;ALDH7A1;GLUL;SRR;RIMKLB;DALRD3;AMT;MTR;TH;HARS2;PEMT;SERINC3;GCLC
8838,GO:0034643,0.880849367501828,0.387593980117884,1,19,establishment of mitochondrion localization, microtubule-mediated,BP,TRAK1
11992,GO:0047497,0.880849367501828,0.387593980117884,1,19,mitochondrion transport along microtubule,BP,TRAK1
7153,GO:0031023,0.881227066757675,0.197615796817828,9,115,microtubule organizing center organization,BP,PKD2;BRSK1;TUBGCP5;CEP68;CHD3;CHMP1B;FBXW5;KAT2B;CEP250
15344,GO:0071604,0.881417225090258,0.38723223062151,1,18,transforming growth factor beta production,BP,LTBP3
11506,GO:0046037,0.881595419806526,0.386000410943092,1,19,GMP metabolic process,BP,DLG4
8994,GO:0035148,0.88167085455383,0.197026076769829,9,114,tube formation,BP,SFRP1;PRKACB;CELSR1;NPHP3;PODXL;RET;DAB2IP;TEAD2;PTK7
12537,GO:0050706,0.881876817426031,0.384635511834739,1,20,regulation of interleukin-1 beta secretion,BP,NLRP1
1344,GO:0003209,0.882142814589219,0.385678607285371,1,18,cardiac atrium morphogenesis,BP,ZFPM1
12998,GO:0051453,0.882164410581655,0.240087891851059,4,61,regulation of intracellular pH,BP,TCIRG1;ATP6V0A2;CA2;DMXL2
8356,GO:0033260,0.8823735901965,0.260936146389109,3,49,nuclear DNA replication,BP,LIG1;POLD4;ATRX
12283,GO:0048638,0.882644130502069,0.173015773586072,17,198,regulation of developmental growth,BP,ULK2;APOE;GAMT;PTPRS;SFRP1;WNT3;SEMA4G;JARID2;INSR;BBS2;CDK5R1;RAI1;ACACB;WWC3;GPR21;AKAP6;SMURF1
15637,GO:0072175,0.882681659086626,0.200773745572988,8,103,epithelial tube formation,BP,SFRP1;PRKACB;CELSR1;NPHP3;PODXL;RET;TEAD2;PTK7
4826,GO:0014033,0.882941961530688,0.239175969789712,4,58,neural crest cell differentiation,BP,SFRP1;KITLG;SEMA4G;RET
19765,GO:2000209,0.883205872388774,0.382543434912938,1,19,regulation of anoikis,BP,SIK1
16298,GO:0090503,0.883299228810388,0.296025507242496,2,35,RNA phosphodiester bond hydrolysis, exonucleolytic,BP,XRN1;PARN
12048,GO:0048013,0.883459006795495,0.223926325549156,5,72,ephrin receptor signaling pathway,BP,EPHB2;VAV3;DNM1;CDK5R1;EFNB3
7713,GO:0032211,0.883498969552602,0.38191175053706,1,19,negative regulation of telomere maintenance via telomerase,BP,XRN1
3212,GO:0006855,0.883620708596752,0.259303376790305,3,46,drug transmembrane transport,BP,SLC13A5;PER2;SLC36A4
19711,GO:2000104,0.883768550417851,0.381330057371628,1,19,negative regulation of DNA-dependent DNA replication,BP,FBXW7
12338,GO:0048730,0.883816493950007,0.38122653681972,1,19,epidermis morphogenesis,BP,CTSV
4044,GO:0009083,0.883821120131751,0.380454421598652,1,20,branched-chain amino acid catabolic process,BP,HMGCL
13723,GO:0060317,0.883843885150247,0.38116738380367,1,19,cardiac epithelial to mesenchymal transition,BP,PDCD4
11763,GO:0046638,0.883899648333913,0.380284832159981,1,20,positive regulation of alpha-beta T cell differentiation,BP,GLI3
10878,GO:0044432,0.883987773299623,0.139887709642676,88,958,endoplasmic reticulum part,CC,SREBF1;APOE;GPSM1;CES2;LMF1;EGFR;FAM20C;PKD2;TMEM129;PIK3R1;ADAMTS7;COL22A1;WNT3;H6PD;UBXN4;REEP2;SRD5A3;NSG1;KDSR;COL10A1;NOS1;CRTAP;SCARA3;CYP26B1;COL7A1;ITPR3;HLA-B;UGT1A3;CERS4;CYP3A5;FLRT3;ARSI;TMC6;ADAMTS13;G6PC3;RHBDF1;PTGS1;ARSD;PSKH1;MBOAT2;ULK1;SPPL2B;LTBP1;CES3;IGFBP4;MGST2;PGAP1;CST3;COL6A1;CERCAM;PLD3;TREX1;LPIN3;MCTP1;PIGZ;CYBA;RNF170;REEP4;HLA-A;PMEL;JPH2;SLC37A2;RETSAT;OSBPL5;AREG;TMEM203;MPPE1;KDELC2;NECAB3;ESYT2;RSAD2;XYLT1;MXRA8;CLSTN3;ACSL1;ERN1;MAN1B1;DHRS4;FAAH;CERS5;CPT1C;COL13A1;AKAP6;ATG14;SYNE2;UFL1;LAMB2;PEMT
334,GO:0000930,0.884262783600091,0.380261890708027,1,19,gamma-tubulin complex,CC,TUBGCP5
10891,GO:0044450,0.884352540572797,0.181986145860157,12,148,microtubule organizing center part,CC,TUBGCP5;FLOT1;CEP192;LRRCC1;IQCB1;WASH3P;CCDC92;DZIP1L;CAPG;ALMS1;CCDC113;CEP250
7014,GO:0030742,0.88472980953694,0.37848856855681,1,20,GTP-dependent protein binding,MF,RAPGEF5
4079,GO:0009135,0.884864228455094,0.203744617467654,7,94,purine nucleoside diphosphate metabolic process,BP,DHTKD1;INSR;MLXIPL;PGM1;PFKFB2;OGDHL;DLG4
4118,GO:0009179,0.884864228455094,0.203744617467654,7,94,purine ribonucleoside diphosphate metabolic process,BP,DHTKD1;INSR;MLXIPL;PGM1;PFKFB2;OGDHL;DLG4
14799,GO:0070555,0.885080969809819,0.187404196152324,10,140,response to interleukin-1,BP,SFRP1;MTHFR;ADAMTS7;SQSTM1;HYAL1;CYBA;DAB2IP;RPS6KA5;RORA;GCLC
12972,GO:0051403,0.885192589728134,0.169560633444134,17,205,stress-activated MAPK cascade,BP,EGFR;SFRP1;PDCD4;TRPV4;ADORA2B;MAPK8IP3;MINK1;MAP2K2;FZD7;MAP3K12;MAPK10;ERCC6;EDA2R;MAP3K6;DAB2IP;ZFP36L1;ERN1
10421,GO:0043281,0.885230325760968,0.17767862102719,13,174,regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP,IFI6;MDM2;TNFSF10;F2R;LAMP3;PIDD1;NAIP;MAP2K5;GSN;IFI27;NLRP1;PRDX5;PPARG
445,GO:0001205,0.885245577083502,0.37813114666158,1,19,transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific DNA binding,MF,MEF2D
11879,GO:0046916,0.885544480690573,0.220189432664164,5,78,cellular transition metal ion homeostasis,BP,CYBRD1;MT1X;BMP6;ATP6V0A2;HFE
2579,GO:0005871,0.885791974849887,0.255932366300104,3,44,kinesin complex,CC,KIF26B;KIF26A;KIF7
11353,GO:0045732,0.885885259661961,0.174547825957983,14,175,positive regulation of protein catabolic process,BP,TNFAIP3;APOE;MAGEF1;VPS11;MDM2;FBXW7;APC2;LRP1;DAB2IP;SNX1;TNFSF12;SNX33;SMURF1;GCLC
8136,GO:0032872,0.886024097983696,0.176895858291804,13,160,regulation of stress-activated MAPK cascade,BP,EGFR;SFRP1;PDCD4;TRPV4;MAPK8IP3;MINK1;MAP2K2;FZD7;ERCC6;EDA2R;MAP3K6;DAB2IP;ERN1
12885,GO:0051251,0.886065497511393,0.179437007750751,12,156,positive regulation of lymphocyte activation,BP,INPP5D;MAP3K14;PIK3R1;VAV3;GLI2;TNFRSF14;GLI3;DOCK8;EFNB3;CCDC88B;IRS2;STAT6
12882,GO:0051248,0.886126130283439,0.138538413271524,80,885,negative regulation of protein metabolic process,BP,TNFAIP3;SERPINE2;IFI6;APOE;INPP5D;EGFR;CIRBP;CAPRIN2;SFRP1;EPHB2;DGKQ;KDM3A;UNK;ISG15;ELFN2;ZFPM1;IMPACT;CAMK2N1;CRY2;CRY1;CRTAP;COL7A1;SPOCK1;MDM2;PHACTR3;FLRT3;RGS2;PDCD4;SERPINB5;RTN4RL1;ZFP36L2;LAMP3;ZCCHC11;PER2;C5;SNTA1;WWTR1;NAIP;MAP2K5;JARID2;CBLC;CD109;MAP2K2;PTK6;KDM4C;CST3;HFE;HMG20B;AGO4;SPRY2;XRN1;MLXIPL;CDK5RAP3;TFPI2;ADARB1;WNK1;DAB2IP;IFI16;PIK3R2;BST2;TNRC6C;PPP1R2;DMTN;PPP1R35;PHF1;PANO1;ZFP36L1;KAT2B;PBLD;PCSK1N;PRDX5;RANBP9;PTPN3;ATG14;PPARG;SERPING1;UFL1;PRMT3;GCLC;ECM1
6619,GO:0022853,0.886281208606909,0.290434946421359,2,35,active ion transmembrane transporter activity,MF,TCIRG1;ATP6V0A2
10094,GO:0042625,0.886281208606909,0.290434946421359,2,35,ATPase coupled ion transmembrane transporter activity,MF,TCIRG1;ATP6V0A2
4408,GO:0010165,0.886327197165651,0.290943525451161,2,33,response to X-ray,BP,SFRP1;ERCC6
3812,GO:0008406,0.886338021857185,0.182302746325616,11,141,gonad development,BP,SFRP1;KITLG;TNFSF10;CTSV;NUPR1;INSR;CST3;ATRX;REC8;AGO4;SLIT3
14527,GO:0070064,0.886548107097794,0.375293401368325,1,19,proline-rich region binding,MF,BAIAP2
3523,GO:0007498,0.886816237339078,0.218826090535261,5,70,mesoderm development,BP,WNT3;ITGA2;TEAD2;PALB2;ZFP36L1
6649,GO:0030004,0.886950459814352,0.218358360983391,5,73,cellular monovalent inorganic cation homeostasis,BP,TCIRG1;ATP6V0A2;CA2;KCNMA1;DMXL2
20086,GO:2000780,0.887217910703453,0.373827960748236,1,19,negative regulation of double-strand break repair,BP,MAGEF1
3201,GO:0006835,0.887572671919463,0.252462404811832,3,46,dicarboxylic acid transport,BP,SLC13A5;PER2;VAMP2
9832,GO:0042089,0.887819848294354,0.23095508537026,4,60,cytokine biosynthetic process,BP,INPP5D;ZFPM1;MAP2K5;ZNF287
18100,GO:1902806,0.887847623282021,0.180067469639773,11,146,regulation of cell cycle G1/S phase transition,BP,GPNMB;EGFR;PKD2;MDM2;PCBP4;PIDD1;GJC2;ZNF655;HYAL1;FBXW7;TFDP2
561,GO:0001702,0.887867419783396,0.373251835125331,1,18,gastrulation with mouth forming second,BP,TENM4
5160,GO:0015701,0.887960002614337,0.372199420956266,1,19,bicarbonate transport,BP,CA2
8309,GO:0033157,0.888006864030762,0.16578395914335,17,210,regulation of intracellular protein transport,BP,SREBF1;VPS11;MDM2;RAPGEF3;HPS4;ANK3;GLI3;VAMP2;MICALL2;IFI27;OSCP1;CDK5R1;FBXW7;PDE2A;DMTN;ERBB2;PEMT
3167,GO:0006779,0.888190354515139,0.370246193303523,1,21,porphyrin-containing compound biosynthetic process,BP,UROS
1494,GO:0003841,0.888206083288671,0.371658237658806,1,19,1-acylglycerol-3-phosphate O-acyltransferase activity,MF,MBOAT2
12787,GO:0051101,0.888541956358606,0.205568423383764,6,89,regulation of DNA binding,BP,PER2;ITGA2;IFI16;PPARG;ZFP90;CTNNBIP1
781,GO:0002040,0.888616375346789,0.216071919261664,5,69,sprouting angiogenesis,BP,MAP2K5;MMRN2;RNF213;NRARP;SRPX2
15952,GO:0080111,0.88888338552434,0.369405156307184,1,20,DNA demethylation,BP,APOBEC3C
3583,GO:0007631,0.888928851032549,0.285426847970365,2,35,feeding behavior,BP,NMU;TH
20088,GO:2000785,0.889125562781979,0.285339849231169,2,34,regulation of autophagosome assembly,BP,ULK1;LRSAM1
11771,GO:0046651,0.889170354959112,0.178172374864799,11,148,lymphocyte proliferation,BP,GPNMB;INPP5D;VAV3;IL20RB;DOCK8;TNFRSF21;DLG5;CCDC88B;IRS2;ERBB2;RIPK3
5453,GO:0016331,0.889474672719196,0.185826249487164,9,115,morphogenesis of embryonic epithelium,BP,ALDH1A3;SFRP1;PRKACB;GLI2;CELSR1;NPHP3;RET;TEAD2;PTK7
10454,GO:0043331,0.889630504079632,0.214120956025148,5,73,response to dsRNA,BP,EGFR;FLOT1;ZCCHC11;MAP2K2;AGO4
9786,GO:0040017,0.889743210404622,0.149811912010096,30,344,positive regulation of locomotion,BP,POSTN;GPNMB;EGFR;PIK3R1;CXCL14;KITLG;MDM2;F2R;CAPN7;TRPV4;ITGA2;SEMA4G;FAM110C;ITGA6;INSR;DOCK8;VEGFB;HYAL1;PODXL;SPRY2;PLA2G7;RET;DAB2IP;DMTN;ACVR1B;IRS2;PHPT1;SRPX2;SYNE2;ACKR3
7415,GO:0031519,0.889864414319802,0.248287513811962,3,47,PcG protein complex,CC,JARID2;PHF1;PHC2
10968,GO:0044773,0.88994993974267,0.195906440548354,7,99,mitotic DNA damage checkpoint,BP,XPC;BRSK1;MDM2;PCBP4;PIDD1;CDK5RAP3;TFDP2
14668,GO:0070306,0.889988136272501,0.367721841292261,1,19,lens fiber cell differentiation,BP,MAF
4537,GO:0010613,0.890228208532978,0.367189204493856,1,19,positive regulation of cardiac muscle hypertrophy,BP,AKAP6
4878,GO:0014742,0.890228208532978,0.367189204493856,1,19,positive regulation of muscle hypertrophy,BP,AKAP6
17369,GO:1900117,0.890236210826207,0.365726316633341,1,21,regulation of execution phase of apoptosis,BP,ENDOG
12887,GO:0051253,0.890258126926249,0.132355747736907,91,990,negative regulation of RNA metabolic process,BP,HES2;SREBF1;CIRBP;MNT;TRIM22;SFRP1;TSC22D3;HR;TFCP2L1;ZFPM1;IRF2BPL;STAT1;IMPACT;CRY2;CRY1;SCMH1;NFATC4;HSF4;EAPP;MDM2;TCF25;PDCD4;TRPV4;GLI2;PER2;ZNF658;PHF2;TCEAL1;WWTR1;GLI3;THRAP3;BHLHE40;MAP2K5;ZNF318;TCFL5;JARID2;CCDC85B;MXD4;RTF1;H2AFJ;BMP6;SQSTM1;ZNF608;TXNIP;RCOR2;IFI27;CDK5R1;ATRX;MLXIPL;ING4;ATXN1;NFIX;MXI1;THRA;IKZF4;NAB2;PEG3;SALL2;ZBTB20;PDE2A;MAF;ZMYND8;DAB2IP;TSHZ2;IFI16;RPS6KA5;VDR;TNRC18;SIX5;WWC3;TFDP2;NRARP;ZNF91;DYDC1;TCF7;ANGEL2;STAT6;PRDX5;NELFCD;KLF8;PPARG;CXXC5;PARN;ZFP90;PER3;FOXP2;PTBP2;ZC3H6;HIVEP1;CTNNBIP1;GCLC
7196,GO:0031093,0.890381803391139,0.282391095330401,2,36,platelet alpha granule lumen,CC,VEGFB;SERPING1
12090,GO:0048146,0.890460541527051,0.28224085431562,2,36,positive regulation of fibroblast proliferation,BP,EGFR;S100A6
2476,GO:0005697,0.890505128792993,0.364508601107767,1,22,telomerase holoenzyme complex,CC,TEP1
14664,GO:0070302,0.890756722171687,0.170418579809604,13,161,regulation of stress-activated protein kinase signaling cascade,BP,EGFR;SFRP1;PDCD4;TRPV4;MAPK8IP3;MINK1;MAP2K2;FZD7;ERCC6;EDA2R;MAP3K6;DAB2IP;ERN1
9090,GO:0035371,0.890790268360691,0.366787721234961,1,18,microtubule plus-end,CC,CLIP2
2497,GO:0005746,0.890894061315702,0.243760450842874,3,72,mitochondrial respiratory chain,CC,NDUFA4L2;SDHA;NDUFV3
5679,GO:0016796,0.890989173619535,0.24599009756447,3,49,exonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters,MF,TREX1;XRN1;PARN
13459,GO:0055017,0.891062806821252,0.246360365885302,3,46,cardiac muscle tissue growth,BP,TENM4;JARID2;AKAP6
9882,GO:0042176,0.89112049043503,0.151932481833062,25,300,regulation of protein catabolic process,BP,TNFAIP3;SERPINE2;APOE;EGFR;MAGEF1;VPS11;MDM2;LAMP3;RHBDF1;CST3;HFE;FBXW7;CDK5RAP3;APC2;LRP1;DAB2IP;SNX1;PANO1;TNFSF12;PTPN3;PRKACA;UFL1;SNX33;SMURF1;GCLC
5648,GO:0016746,0.891168086462788,0.16521924343651,15,190,transferase activity, transferring acyl groups,MF,CPT2;ZDHHC1;HGSNAT;CERS4;CRAT;NAT6;MBOAT2;ZDHHC12;ATE1;GOLGA7B;NAT14;KAT2B;CERS5;CPT1C;ZDHHC24
12778,GO:0051092,0.891172374795267,0.187962004528938,8,113,positive regulation of NF-kappaB transcription factor activity,BP,TRIM22;RBCK1;PIDD1;TRIM38;EDA2R;RPS6KA5;TRAF5;RIPK3
17315,GO:1900015,0.89128457491364,0.364079253814054,1,20,regulation of cytokine production involved in inflammatory response,BP,PDCD4
15447,GO:0071806,0.891496018186188,0.244397932632117,3,54,protein transmembrane transport,BP,PEX10;PEX7;PEX1
19685,GO:2000045,0.89157544491778,0.17836869176735,10,135,regulation of G1/S transition of mitotic cell cycle,BP,GPNMB;EGFR;PKD2;MDM2;PCBP4;PIDD1;GJC2;ZNF655;HYAL1;TFDP2
13873,GO:0060537,0.891630057209492,0.156871975989248,20,225,muscle tissue development,BP,SIK1;PKD2;OBSL1;TSC22D3;TENM4;ZFPM1;CYP26B1;MYH11;FLOT1;FHOD3;JARID2;NUPR1;TTN;FZD7;HMG20B;MEF2D;JPH2;LMNA;AKAP6;FOXP2
3713,GO:0008233,0.891736041422197,0.14598739993859,32,376,peptidase activity,MF,TNFAIP3;NPEPL1;ADAM19;CTSO;SFRP1;ADAMTS7;HTRA1;TYSND1;CTSV;CAPN7;ADAMTS13;RHBDF1;SPPL2B;PCSK1;MMP1;MMP28;RNPEPL1;CTSF;CASP14;CLCA2;CAPNS2;THSD4;CTSB;KLK5;C1RL;RNPEP;MYSM1;PCSK6;ENDOU;DPP7;CTSD;LONP2
7100,GO:0030904,0.891777946250679,0.362978006671156,1,20,retromer complex,CC,SNX1
8986,GO:0035115,0.892186103719619,0.362065157929361,1,20,embryonic forelimb morphogenesis,BP,WNT3
14353,GO:0061614,0.892247927563735,0.279676164130816,2,33,pri-miRNA transcription by RNA polymerase II,BP,NFATC4;PPARG
4187,GO:0009266,0.892329533886943,0.165798929378445,14,177,response to temperature stimulus,BP,TP53INP1;HSPA2;CIRBP;NOS1;HSF4;TRPV4;SLC27A1;LRP11;THRA;ANO1;PCSK1N;PPARG;PRKACA;GCLC
5904,GO:0018126,0.892371326870609,0.361650362867444,1,20,protein hydroxylation,BP,CRTAP
2662,GO:0006007,0.892405026952965,0.360890667790605,1,21,glucose catabolic process,BP,PFKFB2
12643,GO:0050867,0.89252588459936,0.165477463762572,14,180,positive regulation of cell activation,BP,INPP5D;MAP3K14;PIK3R1;VAV3;GLI2;ADORA2B;TNFRSF14;GLI3;DOCK8;EFNB3;DMTN;CCDC88B;IRS2;STAT6
19614,GO:1990823,0.892685951302188,0.209259876293016,5,73,response to leukemia inhibitory factor,BP,KDM3A;JARID2;SPRY2;RFX2;SYNGR1
19617,GO:1990830,0.892685951302188,0.209259876293016,5,73,cellular response to leukemia inhibitory factor,BP,KDM3A;JARID2;SPRY2;RFX2;SYNGR1
4076,GO:0009132,0.892718650678684,0.185805865583008,8,110,nucleoside diphosphate metabolic process,BP,DHTKD1;CMPK2;INSR;MLXIPL;PGM1;PFKFB2;OGDHL;DLG4
6279,GO:0019887,0.892822664228606,0.173110122337749,11,146,protein kinase regulator activity,MF,DGKQ;CAMK2N1;FLRT3;RTN4RL1;ETAA1;MAP2K2;CDK5R1;ERCC6;SPRY2;WNK1;KAT2B
606,GO:0001775,0.892830854486105,0.131120388163932,78,860,cell activation,BP,TNFAIP3;SERPINE2;GPNMB;PYGB;APOE;INPP5D;EGFR;CXCR1;SFRP1;MAP3K14;DGKQ;PIK3R1;VAV3;KCNAB2;ZFPM1;NAPRT;MYL9;CYP26B1;GAA;NDRG1;ITPR3;HGSNAT;ACTR1B;IL20RB;F2R;BLOC1S4;ZFP36L2;TMC6;GLI2;ADORA2B;ADAMTS13;TNFRSF14;GLI3;VAMP2;GSN;DOCK8;BLOC1S3;SLC2A3;TCIRG1;FZD7;HEXB;CST3;TNFRSF21;EFNB3;HFE;CYBA;CTSB;PGM1;GNG2;LRP1;DLG5;BST2;DMTN;NRARP;CCDC88B;NBEAL2;CD68;TCF7;RSAD2;ZFP36L1;IL11;APOLD1;IRS2;METTL7A;STAT6;SOX13;GLB1;DPP7;CD9;CTSD;ERBB2;SYNGR1;RORA;C6ORF120;POLM;RIPK3;NFASC;GCLC
18786,GO:1904358,0.893006868390748,0.277629235652904,2,35,positive regulation of telomere maintenance via telomere lengthening,BP,FBXO4;PARN
4838,GO:0014047,0.893058774751988,0.360866637001042,1,19,glutamate secretion,BP,VAMP2
5969,GO:0018410,0.893161745198574,0.276810785624963,2,37,C-terminal protein amino acid modification,BP,RTN4RL1;CD109
2505,GO:0005759,0.893253836939092,0.145169198035473,30,393,mitochondrial matrix,CC,GLUD1;DHTKD1;HMGCL;D2HGDH;PRODH;MLYCD;TST;ALDH4A1;TP53AIP1;PDK1;ALDH7A1;IDH2;HADH;ACADS;OGDHL;TK2;LACTB2;MPG;BDH1;PDE2A;ETFB;PRIMPOL;AMT;ECI1;CBR4;PRDX5;ACSS2;ACOT2;SUCLG2;HARS2
19623,GO:1990841,0.893407463194059,0.2774440270327,2,33,promoter-specific chromatin binding,MF,STAT1;GLI2
11783,GO:0046677,0.893440720524124,0.158518059249769,17,216,response to antibiotic,BP,TNFAIP3;TP53INP1;STAT1;IMPACT;UROS;MDM2;GSN;ENDOG;HYAL1;CST3;TXNIP;NET1;XRN1;AREG;STAT6;TH;PEMT
8188,GO:0032943,0.893951222163109,0.171450890357529,11,149,mononuclear cell proliferation,BP,GPNMB;INPP5D;VAV3;IL20RB;DOCK8;TNFRSF21;DLG5;CCDC88B;IRS2;ERBB2;RIPK3
3683,GO:0008187,0.894036495749279,0.357906036030129,1,20,poly-pyrimidine tract binding,MF,ATXN1
13097,GO:0051654,0.894181956461488,0.357577635026009,1,20,establishment of mitochondrion localization,BP,TRAK1
8280,GO:0033119,0.894354231439853,0.355886130647094,1,22,negative regulation of RNA splicing,BP,PTBP2
9846,GO:0042107,0.894735742663694,0.21936938137779,4,61,cytokine metabolic process,BP,INPP5D;ZFPM1;MAP2K5;ZNF287
4861,GO:0014706,0.894742160796284,0.154114007685508,19,216,striated muscle tissue development,BP,SIK1;OBSL1;TSC22D3;TENM4;ZFPM1;CYP26B1;MYH11;FLOT1;FHOD3;JARID2;NUPR1;TTN;FZD7;HMG20B;MEF2D;JPH2;LMNA;AKAP6;FOXP2
15946,GO:0080025,0.89476604098677,0.35625682468023,1,20,phosphatidylinositol-3,5-bisphosphate binding,MF,JPH2
547,GO:0001667,0.894872381153612,0.149153485275542,23,267,ameboidal-type cell migration,BP,APOE;TNS1;KITLG;PLEKHG5;FERMT1;CAPN7;ITGA2;SEMA4G;MAP2K5;FAT2;HYAL1;MMRN2;LTB4R2;RET;DAB2IP;PLXND1;DMTN;ACVR1B;PBLD;TNFSF12;SRPX2;PPARG;SYNE2
10883,GO:0044440,0.894906220186751,0.140934284323207,34,395,endosomal part,CC,EGFR;MVB12B;VAMP3;NSG1;MICALL1;VPS11;NDRG1;HLA-B;AP1G2;CLCN6;SPPL2B;INSR;RAB11FIP4;VPS39;TMEM9;TCIRG1;FZD7;ATP6V0A2;WASH3P;RAB11FIP3;CTSB;CHMP1B;HLA-A;SLC48A1;APPL2;PMEL;RET;SNX21;MARCH8;SNX1;CD68;LAPTM4A;ERBB2;ABCA2
4124,GO:0009185,0.895268229761441,0.188050461628088,7,96,ribonucleoside diphosphate metabolic process,BP,DHTKD1;INSR;MLXIPL;PGM1;PFKFB2;OGDHL;DLG4
8224,GO:0033003,0.895494046831007,0.353923048119508,1,21,regulation of mast cell activation,BP,ADORA2B
9599,GO:0036474,0.895543135571798,0.353193094176516,1,22,cell death in response to hydrogen peroxide,BP,ENDOG
19696,GO:2000059,0.895559264628006,0.272178203662249,2,37,negative regulation of ubiquitin-dependent protein catabolic process,BP,HFE;PANO1
6870,GO:0030371,0.895658679430303,0.354231598218872,1,20,translation repressor activity,MF,CIRBP
5687,GO:0016810,0.895680846988823,0.181392049503791,8,111,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds,MF,APOBEC3C;CHD3;OPLAH;HMG20B;ADARB1;NDST2;FAAH;HDAC11
4069,GO:0009124,0.896444532284214,0.171397108940868,10,136,nucleoside monophosphate biosynthetic process,BP,DHTKD1;INSR;TCIRG1;ATP6V0A2;MLXIPL;PGM1;PFKFB2;OGDHL;TK2;UCKL1
2198,GO:0005080,0.896524495889687,0.270818879559028,2,35,protein kinase C binding,MF,TRPV4;SQSTM1
4584,GO:0010677,0.896558117629042,0.352182720088225,1,20,negative regulation of cellular carbohydrate metabolic process,BP,SIK1
12189,GO:0048384,0.896563339603911,0.351488707849357,1,21,retinoic acid receptor signaling pathway,BP,CYP26B1
3501,GO:0007405,0.89663172472448,0.271191960196623,2,33,neuroblast proliferation,BP,KCTD11;GLI3
8993,GO:0035145,0.89664599951645,0.351300037935162,1,21,exon-exon junction complex,CC,THRAP3
3901,GO:0008543,0.896768856985672,0.193036147959738,6,86,fibroblast growth factor receptor signaling pathway,BP,FAM20C;SULF2;FLRT3;FRS3;SPRY2;FGFR4
948,GO:0002367,0.896793365313138,0.235429184409663,3,51,cytokine production involved in immune response,BP,HFE;BST2;RSAD2
113,GO:0000242,0.897013851063525,0.351897907606198,1,19,pericentriolar material,CC,CEP192
2786,GO:0006220,0.89702814816323,0.2684480950168,2,41,pyrimidine nucleotide metabolic process,BP,CMPK2;UCKL1
3399,GO:0007179,0.897349020691497,0.170305108326907,10,129,transforming growth factor beta receptor signaling pathway,BP,HTRA1;ITGB5;FERMT1;LTBP4;LTBP1;CD109;GDF15;PBLD;SMURF1;NPNT
5441,GO:0016310,0.897384567339842,0.119418787756008,157,1642,phosphorylation,BP,TNFAIP3;ULK2;GPNMB;SIK1;APOE;HSPA2;EGFR;FAM20C;PKD2;CAPRIN2;SFRP1;EPHB2;MAP3K14;DGKQ;PIK3R1;BRSK1;DHTKD1;CAMKK1;HERC5;VAV3;CSPG4;PI4KAP2;KITLG;IMPACT;CAMK2N1;PRKACB;CRY1;SPDYE6;CMPK2;CNTRL;PIK3C2G;CDK18;SPEG;NMRK1;PIK3IP1;OBSCN;RAPGEF3;FLRT3;RASA4;RGS2;F2R;PDCD4;SPTB;ALPK1;NEK9;RTN4RL1;ZFP36L2;TRPV4;FLOT1;ADORA2B;MAPK8IP3;SPDYE5;GJC2;RASGEF1A;UNC119;FRS3;C5;PSKH1;MINK1;WWTR1;ULK1;FGGY;NEK8;MAP2K5;ITGA6;IGFBP4;INSR;CDK14;TTN;CBLC;DDT;CD109;ETAA1;PILRB;SLC27A1;RICTOR;BMP6;ETNK2;MAP2K2;PDK1;SQSTM1;PTK6;FZD7;SYNGAP1;PLA2G6;PDIK1L;GDF15;CTF1;MAP3K12;CDK5R1;PI4KAP1;MAPK10;SHANK3;HFE;ERCC6;SHC2;EDA2R;SPRY2;MLXIPL;FBXW7;CDK5RAP3;PAK6;PGM1;PFKFB2;ADARB1;OGDHL;TK2;NAB2;MAP3K6;MYO3B;WNK1;SDHA;STK16;RET;DAB2IP;PIK3C3;FGFR4;PIK3R2;AREG;RPS6KA5;NADK;STK19;NDUFV3;DMTN;STAT2;LMTK3;ACVR1B;DLG4;TSSK1B;ADCK5;WEE1;PTK7;TNFRSF25;ZFP36L1;ACSL1;IL11;KAT2B;MARK4;IRS2;IMPA2;ERN1;RAD50;TKFC;SCYL3;PBLD;SRPX2;RANBP9;ERBB2;ATG14;PRKACA;ACKR3;UCKL1;IP6K2;RIPK3;PI4K2B;CIT;NPNT
15850,GO:0072593,0.897661273341827,0.163249001399906,12,162,reactive oxygen species metabolic process,BP,EGFR;PKD2;GPX3;NOS1;INSR;SESN1;CYBA;ACP5;DUOX1;PRDX5;RORA;RIPK3
4574,GO:0010662,0.897728720648745,0.349503652913583,1,20,regulation of striated muscle cell apoptotic process,BP,RGL2
13115,GO:0051701,0.897807898523078,0.163149987410845,12,157,interaction with host,BP,ITGB6;EGFR;ITGB5;IFITM1;TNFRSF14;ITGA2;INSR;GSN;EFNB3;TRIM38;CTSB;EXOC2
82,GO:0000166,0.897896741566318,0.11873070808243,160,1629,nucleotide binding,MF,ULK2;SIK1;SLFN5;ACTA2;NT5E;OAS2;DDX60;HSPA2;EGFR;FAM20C;SYN1;ALDH1A3;MTHFR;IFI44L;KIF26B;EPHB2;MAP3K14;GLUD1;DGKQ;BRSK1;TXNRD3;CUL9;H6PD;CAMKK1;MVD;CRY2;RAB43;RAB40B;NOS1;PRKACB;CRY1;D2HGDH;CMPK2;PIK3C2G;LIG1;CDK18;VPS11;SPEG;MLH3;NMRK1;DDX59;OBSCN;PRODH;MYH11;ACTR1B;RHOBTB2;RAPGEF3;OAS1;GAL3ST4;KIF26A;ALPK1;DNAH1;SLC27A3;NEK9;TRPV4;DHX32;CLCN6;PSKH1;MINK1;ULK1;THRAP3;SMARCA1;AKAP7;NAIP;NEK8;MAP2K5;INSR;CHD3;CDK14;TTN;SLFNL1;SEPT6;DHX58;SLC27A1;NLRX1;ETNK2;MAP2K2;OPLAH;PDK1;PTK6;PDIK1L;IDH2;MAP3K12;WRN;SEPT5;DNM1;MCM9;ATRX;MAPK10;ERCC6;HADH;HLCS;NUDT6;PAK6;PFKFB2;ACADS;MX2;ACACB;NLRP1;TK2;GLUL;SRR;MAP3K6;RIMKLB;MYO3B;WNK1;ARL11;PDE2A;SDHA;STK16;RET;ACOX3;PIK3C3;DALRD3;FGFR4;MYO9A;RPS6KA5;NADK;BBS10;HLTF;STK19;RASL10B;LMTK3;ACVR1B;TSSK1B;DUOX1;WEE1;PTK7;DQX1;ACSL1;MARK4;TEP1;ERN1;RAD50;TKFC;PNPO;PEX1;SCYL3;SCG5;CBR4;KIF7;CHD6;ACSS2;ERBB2;ABCA2;PRKACA;SUCLG2;UCKL1;DDX12P;IP6K2;RIPK3;PI4K2B;LONP2;HARS2;CIT;MSH5;CLCN7;TTLL1;ABCA11P;GCLC
3063,GO:0006626,0.897960464802298,0.177690398548171,8,120,protein targeting to mitochondrion,BP,SREBF1;VPS11;HPS4;MICALL2;OSCP1;FBXW7;AIP;PEMT
10496,GO:0043414,0.897963426350554,0.149653060050935,19,234,macromolecule methylation,BP,ASH2L;MTHFR;KDM3A;JARID2;NSUN5P2;RTF1;KDM4C;ATRX;TARBP1;METTL21A;SETD4;ETFB;BTG1;PCMTD2;PCMTD1;PHF1;DYDC1;KMT5C;PRMT3
17581,GO:1901265,0.898949529207202,0.117555899864354,160,1630,nucleoside phosphate binding,MF,ULK2;SIK1;SLFN5;ACTA2;NT5E;OAS2;DDX60;HSPA2;EGFR;FAM20C;SYN1;ALDH1A3;MTHFR;IFI44L;KIF26B;EPHB2;MAP3K14;GLUD1;DGKQ;BRSK1;TXNRD3;CUL9;H6PD;CAMKK1;MVD;CRY2;RAB43;RAB40B;NOS1;PRKACB;CRY1;D2HGDH;CMPK2;PIK3C2G;LIG1;CDK18;VPS11;SPEG;MLH3;NMRK1;DDX59;OBSCN;PRODH;MYH11;ACTR1B;RHOBTB2;RAPGEF3;OAS1;GAL3ST4;KIF26A;ALPK1;DNAH1;SLC27A3;NEK9;TRPV4;DHX32;CLCN6;PSKH1;MINK1;ULK1;THRAP3;SMARCA1;AKAP7;NAIP;NEK8;MAP2K5;INSR;CHD3;CDK14;TTN;SLFNL1;SEPT6;DHX58;SLC27A1;NLRX1;ETNK2;MAP2K2;OPLAH;PDK1;PTK6;PDIK1L;IDH2;MAP3K12;WRN;SEPT5;DNM1;MCM9;ATRX;MAPK10;ERCC6;HADH;HLCS;NUDT6;PAK6;PFKFB2;ACADS;MX2;ACACB;NLRP1;TK2;GLUL;SRR;MAP3K6;RIMKLB;MYO3B;WNK1;ARL11;PDE2A;SDHA;STK16;RET;ACOX3;PIK3C3;DALRD3;FGFR4;MYO9A;RPS6KA5;NADK;BBS10;HLTF;STK19;RASL10B;LMTK3;ACVR1B;TSSK1B;DUOX1;WEE1;PTK7;DQX1;ACSL1;MARK4;TEP1;ERN1;RAD50;TKFC;PNPO;PEX1;SCYL3;SCG5;CBR4;KIF7;CHD6;ACSS2;ERBB2;ABCA2;PRKACA;SUCLG2;UCKL1;DDX12P;IP6K2;RIPK3;PI4K2B;LONP2;HARS2;CIT;MSH5;CLCN7;TTLL1;ABCA11P;GCLC
4571,GO:0010659,0.898969148475899,0.346649195212126,1,20,cardiac muscle cell apoptotic process,BP,RGL2
3326,GO:0007034,0.89907197727934,0.171756226677014,9,119,vacuolar transport,BP,VPS11;HGSNAT;TRAK1;VPS39;HOOK2;WASH3P;CHMP1B;ATG14;SMURF1
7654,GO:0032091,0.899226356206585,0.198379572152644,5,78,negative regulation of protein binding,BP,GPSM1;ZFPM1;NFATC4;HFE;CTNNBIP1
16902,GO:0098901,0.899242861080755,0.346772167599092,1,19,regulation of cardiac muscle cell action potential,BP,ANK3
5928,GO:0018209,0.899250295768717,0.148040136154267,19,227,peptidyl-serine modification,BP,EGFR;CAPRIN2;DGKQ;CAMKK1;RAPGEF3;PSKH1;ULK1;RICTOR;MAP2K2;MAP3K12;CDK5R1;SPRY2;MLXIPL;RET;RPS6KA5;DMTN;IL11;ERN1;PRKACA
2311,GO:0005310,0.899291020778917,0.345905860809905,1,20,dicarboxylic acid transmembrane transporter activity,MF,SLC13A5
5318,GO:0016043,0.899452432633682,0.111926356920692,454,4588,cellular component organization,BP,TNFAIP3;TGFBI;POSTN;ITGB6;SERPINE2;ULK2;DDB2;TP53INP1;MAP6;IFI6;SREBF1;APOE;ALS2CL;ADAM19;HSPA2;EGFR;ESPN;PTPRS;CIRBP;FLNC;PKD2;CAPRIN2;XPC;SYT8;ASH2L;DIXDC1;TRIM22;ALDH1A3;SRSF5;SLITRK6;SFRP1;OBSL1;MTHFR;KCTD11;EPS8L2;EPHB2;TNS1;GPX3;GLUD1;DGKQ;PIK3R1;EVI5L;BRSK1;MARVELD1;KDM3A;CUL9;SULF2;WNT3;VAV3;UNK;HR;SMOC2;HTRA1;SPATA18;TFCP2L1;TENM4;UNC119B;RGMA;PI4KAP2;ZFPM1;SDK2;CUL7;VAMP3;REEP2;ASAP3;OR2A4;C1QTNF6;IMPACT;KRT15;NSG1;UNC5B;ITGB5;COL10A1;GJD3;RAB43;NOS1;PRKACB;SCMH1;NFATC4;IQSEC2;HMGCL;PSMG4;FERMT1;H1F0;CYP26B1;GAA;HSF4;CNTRL;MICALL1;TBC1D8;PLXNB1;VPS11;NDRG1;COL7A1;KCNC4;SPOCK1;ITPR3;NAGLU;MDM2;CRTC1;NDN;KCTD18;MLH3;CSMD3;TYSND1;LTBP4;OBSCN;GOLGA8A;TNFSF10;HGSNAT;MYH11;PARVB;SYTL1;TNXB;RHOBTB2;NEO1;RAPGEF3;CTSV;NLGN4Y;FLRT3;NUDCD3;KCTD15;KIF26A;RGS2;ARPIN;ADGRB2;F2R;PPL;C2CD4C;HPS4;BLOC1S4;SPTB;SERPINB5;NYAP1;DNAH1;NEK9;TUBGCP5;RTN4RL1;CLTCL1;TRPV4;FLOT1;GLI2;TOM1L2;NLGN2;CORO6;ANK3;KLF7;RNF165;GOLGA8B;SOX12;CLMN;SLX1A;SLX1B;ATG16L2;SPG11;ARHGEF19;PER2;CLCN6;UNC119;WIPF1;ADGRL1;MINK1;PHF2;NINL;AMIGO2;THBS3;WWTR1;ARHGEF4;ITGA2;SEMA4G;FAM110C;SYT15;ULK1;GLI3;FHOD3;TPGS1;SMARCA1;LRSAM1;VAMP2;NAIP;MAP2K5;GAS8;BOC;ITGA6;BSN;IGFBP4;MMP1;TRAK1;JARID2;NISCH;INSR;CCDC85B;CELSR1;GSN;CEP68;CHD3;BAIAP2;TANC1;TTN;PLXNB3;CEP126;SUN1;AHNAK2;PLEKHH2;TRIOBP;POLD4;RMI2;SEPT6;VPS39;PILRB;ENDOG;RTF1;BLOC1S3;RICTOR;H2AFJ;PEX10;TCIRG1;MICALL2;MAP2K2;SQSTM1;CEP192;PTK6;SLC12A7;FZD7;ETV5;LOXL1;SYNGAP1;EPB41L3;SHARPIN;HEXB;KDM4C;HYAL1;H1FX;WHAMMP3;CENPC;PLA2G6;CST3;CAPNS2;GDF15;PEX7;BBS2;THSD4;TCF4;ATP6V0A2;COL6A1;PEX11B;NPHP3;IDH2;MAP3K12;WRN;PODXL;SEPT5;MALL;OSCP1;DNM1;IQCB1;KLHL24;MCTP1;CDK5R1;ATRX;REC8;NET1;ANO9;EFNB3;PI4KAP1;HOOK2;EPB41L4A;SHANK3;HFE;HMG20B;CYBA;NID1;AGO4;RRM2B;SLIT3;KRT14;HLCS;SPRY2;WASH3P;IFT140;XRN1;KLK5;FBXW7;KCNMA1;ANKRD28;ING4;CDK5RAP3;PAK6;DZIP1L;CHMP1B;THRA;APC2;ARAP1;GOLGA8N;ADARB1;FMNL2;MX2;IKZF4;SLC2A1;ACACB;NLRP1;FRAT1;REEP4;GLUL;TBC1D17;FBXW5;SRR;CAPG;TSPYL4;LRP1;LRRN3;TSNARE1;NPHP4;CCDC136;PLA2G7;SYNPO2;CENPH;RFX2;KCNG1;PMEL;BBS1;ATXN10;RET;ZMYND8;PRX;DAB2IP;TEAD2;MYSM1;DDHD2;SHROOM2;FBXO4;RNF213;PIK3C3;SYT7;FGFR4;ERCC5;BBS5;EXOC2;AREG;SNCB;MYO9A;RPS6KA5;DLG5;BTG1;BST2;VDR;ARHGEF17;CACNB3;TNRC18;EFS;PLXND1;BBS10;ZMYM3;HLTF;TMEM80;TBC1D16;NDUFV3;EML3;DMTN;STAT2;SGSM2;ARFGEF2;ALMS1;PHF1;TMEM231;TFDP2;SNX1;PMP22;ACVR1B;SHROOM4;TACC1;PRIMPOL;CCDC88B;DLG4;CCDC113;IQSEC1;IGFBP6;MATN2;NBEAL2;WEE1;DYDC1;PTK7;TCF7;SHANK2;LMNA;CLSTN3;TOP3B;KAT2B;MARK4;TEP1;IRS2;DMXL2;CEP250;RAD50;MTR;DHRS4;PEX1;S100A6;EFEMP2;ZSWIM8;APBB2;CBR4;TTC19;PHPT1;TUB;CHD6;NAP1L5;GOLGB1;SRPX2;ACSS2;CD9;RANBP9;CACNB1;HDAC11;COL13A1;ERBB2;SYNGR1;KMT5C;AKAP6;ATG14;MPP7;SSH3;PPARG;PRKACA;LDLRAP1;FMNL3;SYNE2;PARD6G;PLTP;PARN;DDX12P;LAMB2;IP6K2;RIPK3;NFASC;PI4K2B;AIP;COG1;KCNS3;LONP2;PRMT3;SNX33;CIT;MSH5;MAP1A;PTBP2;ECM2;SMURF1;NPNT;TTLL1;EML2;CTNNBIP1;PEMT;GCLC
9880,GO:0042171,0.899475894798307,0.345478415416961,1,20,lysophosphatidic acid acyltransferase activity,MF,MBOAT2
15354,GO:0071617,0.899475894798307,0.345478415416961,1,20,lysophospholipid acyltransferase activity,MF,MBOAT2
5129,GO:0015605,0.899757495979818,0.344146496622296,1,21,organophosphate ester transmembrane transporter activity,MF,SLC37A2
7308,GO:0031325,0.900092548020178,0.11443413618209,212,2173,positive regulation of cellular metabolic process,BP,TNFAIP3;GPNMB;EPM2A;TP53INP1;PTHLH;SREBF1;APOE;GPSM1;HSPA2;EGFR;TRIM65;CIRBP;PKD2;CAPRIN2;RBM3;ASH2L;TRIM22;SRSF5;SFRP1;SEC14L2;EPHB2;MAP3K14;DGKQ;PIK3R1;KDM3A;POU3F1;CAMKK1;VAV3;CSPG4;RGMA;ZFPM1;KITLG;VAMP3;CITED4;IRF2BPL;MC1R;STAT1;IMPACT;NSG1;NOS1;PRKACB;MAML3;KLF13;MAGEF1;NFATC4;RNF187;HSF4;VPS11;EAPP;MDM2;CRTC1;NDN;TNFSF10;RAPGEF3;F2R;MLYCD;ZFP36L2;TRPV4;FLOT1;GLI2;ADORA2B;KLF7;TCEA2;MAPK8IP3;ZNF76;SOX12;PIDD1;SLX1A;SLX1B;UNC119;C5;MINK1;PHF2;ABHD14B;WWTR1;ITGA2;ULK1;GLI3;THRAP3;SMARCA1;LRSAM1;MAP2K5;ITGA6;SESN3;ZNF318;IGFBP4;JARID2;NUPR1;INSR;GSN;DDT;ZNF287;ETAA1;PILRB;ENDOG;SLC27A1;RTF1;MDK;RICTOR;BMP6;MAP2K2;SQSTM1;PTK6;FZD7;ETV5;DLX3;HEXB;METTL23;PLA2G6;CST3;GDF15;CTF1;TCF4;PLAG1;MAP3K12;WRN;IFI27;LPIN3;CDK5R1;ATRX;SESN1;MAPK10;HFE;ADIRF;CYBA;ERCC6;SHC2;EDA2R;SPRY2;MEF2D;CREBRF;MLXIPL;FBXW7;CDK5RAP3;LMO2;NFIX;PAK6;CARF;PFKFB2;THRA;ARAP1;RAI1;ELF1;IKZF4;ACACB;NLRP1;DBP;NAB2;EPM2AIP1;LRP1;PEG3;RFX2;MAP3K6;SALL2;WNK1;MAF;STK16;RET;DAB2IP;CASZ1;RWDD3;CALCOCO1;TEAD2;MYSM1;FBXO4;IFI16;FGFR4;PIK3R2;TEF;AREG;RPS6KA5;VDR;MAMSTR;TNRC6C;PLXND1;SIX5;HLTF;PHF1;ZNF292;TFDP2;ACVR1B;DLG4;TNNI2;NAT14;TNFRSF25;ZFP36L1;GLMP;ACSL1;IL11;KAT2B;IRS2;ERN1;IVNS1ABP;RAD50;TRERF1;STAT6;CHD6;ERBB2;AKAP6;ATG14;RORA;PPARG;PRKACA;ACKR3;PARN;RIPK3;SNX33;ZFP90;SMURF1;NPNT;PEMT;GCLC
2465,GO:0005682,0.90040013721454,0.342040593028318,1,22,U5 snRNP,CC,TEP1
8299,GO:0033143,0.900504299475948,0.209648478888771,4,61,regulation of intracellular steroid hormone receptor signaling pathway,BP,SFRP1;CRY2;CRY1;UFL1
14986,GO:0070936,0.901047721032303,0.228089640312158,3,49,protein K48-linked ubiquitination,BP,TNFAIP3;RNF187;KLHL3
11365,GO:0045747,0.901120963878026,0.262076424927587,2,34,positive regulation of Notch signaling pathway,BP,MAML3;KAT2B
6854,GO:0030330,0.901180377098996,0.178821238611742,7,101,DNA damage response, signal transduction by p53 class mediator,BP,NDRG1;MDM2;PCBP4;PIDD1;ATRX;ING4;TFDP2
12683,GO:0050921,0.901181062276036,0.195208811513128,5,78,positive regulation of chemotaxis,BP,CXCL14;TRPV4;ITGA2;VEGFB;PLA2G7
7484,GO:0031663,0.901256925603515,0.261018790293582,2,37,lipopolysaccharide-mediated signaling pathway,BP,TNFAIP3;BMP6
5563,GO:0016578,0.901335441313092,0.340479636610868,1,21,histone deubiquitination,BP,MYSM1
10524,GO:0043486,0.901515841053374,0.258491162662707,2,48,histone exchange,BP,CENPC;CENPH
20178,GO:2001056,0.901581058960056,0.172359966574685,8,118,positive regulation of cysteine-type endopeptidase activity,BP,TNFSF10;F2R;PIDD1;GSN;IFI27;NLRP1;IFI16;PPARG
3880,GO:0008514,0.901737659390658,0.163925504191886,10,131,organic anion transmembrane transporter activity,MF,SLC16A5;SLC13A5;SLC27A1;SLC2A3;SLC2A1;SLC38A4;SLC36A4;SLC22A15;SLC43A1;SERINC3
12519,GO:0050685,0.901822218345372,0.339343053310906,1,21,positive regulation of mRNA processing,BP,THRAP3
9273,GO:0035722,0.901831981369194,0.259216503448214,2,40,interleukin-12-mediated signaling pathway,BP,PDCD4;AIP
15181,GO:0071349,0.901831981369194,0.259216503448214,2,40,cellular response to interleukin-12,BP,PDCD4;AIP
4817,GO:0014014,0.901909601194575,0.33913875004114,1,21,negative regulation of gliogenesis,BP,IDH2
5073,GO:0015298,0.902126371943069,0.339310051690892,1,20,solute:cation antiporter activity,MF,SLC24A1
14642,GO:0070265,0.90237093367771,0.258357659706996,2,39,necrotic cell death,BP,RBCK1;RIPK3
18181,GO:1902991,0.902476395974206,0.337811553722756,1,21,regulation of amyloid precursor protein catabolic process,BP,APOE
1114,GO:0002703,0.902693576117083,0.1765031068834,7,101,regulation of leukocyte mediated immunity,BP,IL20RB;ADORA2B;HFE;BST2;RSAD2;STAT6;RIPK3
8024,GO:0032677,0.902725176788168,0.257874846239831,2,38,regulation of interleukin-8 production,BP,F2R;MAP2K5
9874,GO:0042162,0.902747572103751,0.258571060932859,2,35,telomeric DNA binding,MF,WRN;RAD50
9598,GO:0036473,0.902869611111763,0.205325366012973,4,64,cell death in response to oxidative stress,BP,PRODH;ENDOG;PDK1;FBXW7
718,GO:0001945,0.902967962173737,0.33733551240743,1,20,lymph vessel development,BP,TMEM204
13970,GO:0060706,0.903096126707403,0.336356387114915,1,21,cell differentiation involved in embryonic placenta development,BP,GJB5
7173,GO:0031063,0.9031795160305,0.336160262035274,1,21,regulation of histone deacetylation,BP,SREBF1
16231,GO:0090307,0.903183629859251,0.20508478739279,4,61,mitotic spindle assembly,BP,TUBGCP5;NAIP;CEP192;CHMP1B
4266,GO:0009617,0.903666739711761,0.137568241537722,23,296,response to bacterium,BP,TNFAIP3;ISG15;NOS1;CMPK2;F2R;PDCD4;ADAMTS13;TNFRSF14;BAIAP2;MGST2;BMP6;LOXL1;PLA2G6;TNFRSF21;CYBA;KLK5;NLRP1;SRR;ACP5;DAB2IP;VDR;TNFRSF25;TH
3060,GO:0006623,0.903721370271219,0.256907365128036,2,34,protein targeting to vacuole,BP,WASH3P;SMURF1
1445,GO:0003677,0.90376336216215,0.111227959011007,184,1915,DNA binding,MF,TNFAIP3;HES2;ZSCAN18;DDB2;SREBF1;DDX60;EGFR;MNT;XPC;ASH2L;KDM3A;POU3F1;HR;TFCP2L1;ZFPM1;HOXC5;ZDHHC1;ZNF362;ZNF266;STAT1;CRY2;THAP8;ZNF704;HOXA3;CRY1;ZNF699;ZFP41;KLF13;NFATC4;ZNF783;H1F0;HSF4;ZNF251;LIG1;NDN;MLH3;ZNF662;CERS4;ZNF414;TCF25;PCBP4;POLH;POLR2J2;ZNF160;ZFP36L2;GLI2;KLF7;TCEA2;ZNF76;SOX12;PER2;ZNF658;GLI3;THRAP3;ZNF558;IRX4;SMARCA1;BHLHE40;ZNF655;ZNF333;LZTS1;TCFL5;JARID2;NUPR1;CHD3;ZNF18;MXD4;ZNF287;PMS2P3;RMI2;ZNF446;ZNF581;DHX58;RTF1;IRF9;H2AFJ;GLI4;ETV5;DLX3;H1FX;CENPC;TCF4;PLAG1;RCOR2;WRN;MCM9;TREX1;ATRX;POLR2J3;HMG20B;ERCC6;MEF2D;CREBRF;XRN1;TIGD5;MLXIPL;ATXN1;LMO2;NFIX;CARF;MXI1;THRA;RAI1;ELF1;IKZF4;ZBTB34;ZNF627;DBP;EPM2AIP1;MPG;RFX2;ZNF554;SALL2;ZNF107;ZNF532;ZBTB20;ZNF334;MAF;ZMYND8;CASZ1;CALCOCO1;TEAD2;MYSM1;TSHZ2;ZNF276;IFI16;ERCC5;TEF;ZNF25;ZNF630;ZNF687;VDR;TNRC18;ZFP28;ZMYM3;SIX5;HLTF;ZNF789;ZNF563;ZNF517;STAT2;PHF1;ZNF292;TFDP2;ZNF737;ZNF701;NAT14;PALB2;ZNF91;GTF2IRD2;TCF7;ZFP36L1;GLMP;TOP3B;KAT2B;RNF141;IVNS1ABP;RAD50;ZNF439;TRERF1;CERS5;STAT6;SOX13;PRDX5;PHC2;KLF8;CHD6;GOLGB1;RORA;PPARG;CXXC5;POLM;ZNF572;ZNF658B;DDX12P;ZNF529;KLF9;ZFP90;MSH5;PER3;ZFP30;FOXP2;ZC3H6;HIVEP1
16362,GO:0090734,0.903828476623272,0.25641679680229,2,35,site of DNA damage,CC,PHF1;RAD50
2542,GO:0005802,0.903828953737926,0.152237823744351,13,167,trans-Golgi network,CC,TGFBI;POSTN;VAMP3;NSG1;RAB43;CLTCL1;VAMP2;ARAP1;ARFGEF2;PCSK1N;GOLGA1;PI4K2B;COG1
418,GO:0001106,0.904251715290676,0.333631692014618,1,21,RNA polymerase II transcription corepressor activity,MF,ZMYND8
13209,GO:0051894,0.904538070659452,0.333630815616027,1,20,positive regulation of focal adhesion assembly,BP,SFRP1
11356,GO:0045738,0.904787874685344,0.332362474542675,1,21,negative regulation of DNA repair,BP,MAGEF1
6969,GO:0030641,0.904909772603457,0.201834357263894,4,64,regulation of cellular pH,BP,TCIRG1;ATP6V0A2;CA2;DMXL2
17871,GO:1902175,0.905040090766607,0.330594398382394,1,23,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,BP,FBXW7
9173,GO:0035561,0.905218856136241,0.331339905058867,1,21,regulation of chromatin binding,BP,NFATC4
17323,GO:1900027,0.905653882108576,0.329693597648498,1,22,regulation of ruffle assembly,BP,EPS8L2
3344,GO:0007063,0.905764120461683,0.330043185466304,1,21,regulation of sister chromatid cohesion,BP,ATRX
8976,GO:0035094,0.905785124072604,0.329993168562011,1,21,response to nicotine,BP,TH
9009,GO:0035198,0.905852644860675,0.329832344216184,1,21,miRNA binding,MF,AGO4
7346,GO:0031396,0.905855048844203,0.151732544852174,12,162,regulation of protein ubiquitination,BP,TNFAIP3;ISG15;CRY1;PER2;ZYG11B;FBXO2;FBXW7;CDK5RAP3;FBXO4;UFL1;PRMT3;GCLC
2873,GO:0006367,0.906016503122861,0.154299852464761,11,150,transcription initiation from RNA polymerase II promoter,BP,MAML3;WWTR1;THRAP3;TCF4;THRA;TEAD2;VDR;KAT2B;RORA;PPARG;CTNNBIP1
9048,GO:0035282,0.906062218267302,0.200250363459106,4,60,segmentation,BP,SFRP1;PCSK6;NRARP;PALB2
92,GO:0000183,0.906547957051234,0.322062965114792,1,39,chromatin silencing at rDNA,BP,PHF2
38,GO:0000077,0.906614527813332,0.153509931262695,11,147,DNA damage checkpoint,BP,XPC;MAP3K14;BRSK1;CRY1;MDM2;PCBP4;PIDD1;ETAA1;CDK5RAP3;FBXO4;TFDP2
2533,GO:0005790,0.906626294712697,0.32737468937767,1,22,smooth endoplasmic reticulum,CC,TH
12646,GO:0050870,0.90667697524194,0.164835273563558,8,114,positive regulation of T cell activation,BP,MAP3K14;PIK3R1;GLI2;TNFRSF14;GLI3;DOCK8;EFNB3;CCDC88B
1073,GO:0002639,0.906885768471004,0.326754106426634,1,22,positive regulation of immunoglobulin production,BP,STAT6
3303,GO:0007004,0.906920833183035,0.198374804613089,4,64,telomere maintenance via telomerase,BP,XRN1;FBXO4;RAD50;PARN
17919,GO:1902275,0.907329621005947,0.152627294327179,11,141,regulation of chromatin organization,BP,SREBF1;MTHFR;KDM3A;NOS1;PHF2;JARID2;RTF1;KDM4C;ATRX;RPS6KA5;PHF1
7565,GO:0031935,0.907352788907185,0.326919977520546,1,20,regulation of chromatin silencing,BP,PHF2
13002,GO:0051457,0.907979712629984,0.324129232407757,1,22,maintenance of protein location in nucleus,BP,SUN1
11383,GO:0045786,0.908108899870814,0.119818447749393,46,534,negative regulation of cell cycle,BP,TNFAIP3;GPNMB;TP53INP1;EGFR;PKD2;XPC;MAP3K14;BRSK1;CAMK2N1;PRKACB;CRY1;NDRG1;MDM2;PCBP4;PDCD4;CGREF1;ZFP36L2;TOM1L2;PIDD1;GJC2;ZNF655;NUPR1;ETAA1;WHAMMP3;CDK5R1;ATRX;MLXIPL;FBXW7;ING4;CDK5RAP3;TP53I13;BRINP1;DAB2IP;FBXO4;BTG1;TFDP2;PPP2R3B;ZFP36L1;KAT2B;ERN1;ALOX15B;ANGEL2;APBB2;GPR132;PTPN3;PRKACA
7993,GO:0032623,0.908202417742535,0.24711524341423,2,37,interleukin-2 production,BP,TNFAIP3;IL20RB
9415,GO:0035994,0.908481474920679,0.331997004278637,1,13,response to muscle stretch,BP,TTN
13045,GO:0051569,0.908507330855688,0.323467933375508,1,21,regulation of histone H3-K4 methylation,BP,RTF1
12758,GO:0051053,0.90867441904114,0.161991945179891,8,109,negative regulation of DNA metabolic process,BP,MAGEF1;SLX1A;SLX1B;XRN1;FBXW7;ZNF91;RAD50;PPARG
6498,GO:0021872,0.909032584742048,0.245672232425579,2,36,forebrain generation of neurons,BP,GLI3;SHANK3
2715,GO:0006091,0.909702585787244,0.125788229855861,28,365,generation of precursor metabolites and energy,BP,PYGB;TXNRD3;DHTKD1;NFATC4;HMGCL;D2HGDH;GAA;NDUFA4L2;PPP1R3E;PER2;INSR;ALDH4A1;AKR7A2;IDH2;CYBA;MLXIPL;PGM1;PFKFB2;OGDHL;EPM2AIP1;BDH1;SDHA;ETFB;NDUFV3;PPP1R2;IRS2;ACSS2;SUCLG2
4042,GO:0009081,0.909733542744097,0.319892011289152,1,22,branched-chain amino acid metabolic process,BP,HMGCL
17567,GO:1901224,0.909755731595283,0.243958485764416,2,37,positive regulation of NIK/NF-kappaB signaling,BP,EGFR;PDCD4
14863,GO:0070671,0.909757475279553,0.24311254037143,2,41,response to interleukin-12,BP,PDCD4;AIP
10552,GO:0043525,0.910048564921005,0.243133561480374,2,38,positive regulation of neuron apoptotic process,BP,CDK5R1;FBXW7
11092,GO:0045123,0.910142488187716,0.319506962806736,1,21,cellular extravasation,BP,RIPK3
6274,GO:0019882,0.910172952632293,0.145456743487885,12,170,antigen processing and presentation,BP,VAMP3;ITGB5;HLA-B;ACTR1B;CTSV;KIF26A;CTSF;HFE;CYBA;HLA-A;OSBPL1A;CTSD
11471,GO:0045948,0.910247899329101,0.318642478960668,1,22,positive regulation of translational initiation,BP,IMPACT
10420,GO:0043280,0.910362652566638,0.164368859130102,7,108,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP,TNFSF10;F2R;PIDD1;GSN;IFI27;NLRP1;PPARG
20169,GO:2001038,0.910496204434959,0.317485042983368,1,23,regulation of cellular response to drug,BP,ENDOG
7827,GO:0032388,0.910516247246873,0.138844425209621,15,192,positive regulation of intracellular transport,BP,VPS11;MDM2;RAPGEF3;HPS4;ADORA2B;ANK3;GLI3;VAMP2;MICALL2;OSCP1;CDK5R1;FBXW7;ERBB2;LDLRAP1;PEMT
10522,GO:0043484,0.910619704187017,0.164284495992227,7,100,regulation of RNA splicing,BP,SRSF5;PIK3R1;THRAP3;AHNAK2;PRX;ERN1;PTBP2
635,GO:0001825,0.910894483679029,0.31706726282993,1,22,blastocyst formation,BP,KDM4C
1107,GO:0002696,0.910927193856556,0.142175816637431,13,173,positive regulation of leukocyte activation,BP,INPP5D;MAP3K14;PIK3R1;VAV3;GLI2;ADORA2B;TNFRSF14;GLI3;DOCK8;EFNB3;CCDC88B;IRS2;STAT6
11467,GO:0045943,0.910964794392221,0.317503038505161,1,21,positive regulation of transcription by RNA polymerase I,BP,ERBB2
613,GO:0001782,0.910967211017049,0.316889771248702,1,22,B cell homeostasis,BP,TNFAIP3
18981,GO:1904813,0.911064051870468,0.163239625604077,7,109,ficolin-1-rich granule lumen,CC,ACTR1B;GSN;CST3;CTSB;PGM1;GLB1;CTSD
14014,GO:0060765,0.91108632966482,0.316598924420132,1,22,regulation of androgen receptor signaling pathway,BP,SFRP1
3059,GO:0006622,0.911173869275866,0.316992239690314,1,21,protein targeting to lysosome,BP,WASH3P
17288,GO:0140110,0.911186738327798,0.105033228290929,135,1404,transcription regulator activity,MF,HES2;ZSCAN18;TSC22D1;SREBF1;MNT;TRIM22;KDM3A;TSC22D3;POU3F1;HR;TFCP2L1;ZFPM1;HOXC5;CITED4;ZNF266;STAT1;CRY2;THAP8;HOXA3;CRY1;ZNF699;MAML3;KLF13;NFATC4;HSF4;ZNF251;NDN;TCF25;ZNF160;ZFP36L2;GLI2;KLF7;ZNF76;SOX12;PER2;ZNF658;PHF2;TCEAL1;WWTR1;GLI3;THRAP3;ZNF558;IRX4;BHLHE40;ZNF655;ZNF333;LZTS1;TCFL5;JARID2;ZNF18;MXD4;ZNF287;ZNF446;RTF1;IRF9;GLI4;ETV5;DLX3;TCF4;PLAG1;RCOR2;LPIN3;MEF2D;CREBRF;MLXIPL;ING4;LMO2;NFIX;CARF;MXI1;THRA;RAI1;ELF1;IKZF4;DBP;NAB2;EPM2AIP1;PEG3;RFX2;ZNF554;SALL2;ZNF532;ZBTB20;ZNF334;MAF;STK16;ZMYND8;CALCOCO1;TEAD2;MYSM1;TSHZ2;IFI16;TEF;ZNF25;ZNF630;BTG1;VDR;MAMSTR;ZFP28;ZMYM3;SIX5;HLTF;ZNF789;STAT2;PHF1;ZNF292;TFDP2;ZNF701;ZNF91;GTF2IRD2;TCF7;ZFP36L1;GLMP;KAT2B;IVNS1ABP;ZNF439;TRERF1;STAT6;SOX13;KLF8;GOLGB1;RORA;PPARG;ZNF572;ZNF529;RIPK3;KLF9;AIP;SCAND1;ZFP90;PER3;ZFP30;FOXP2;ZC3H6;HIVEP1
1131,GO:0002720,0.911243828293675,0.315661665988483,1,23,positive regulation of cytokine production involved in immune response,BP,RSAD2
5790,GO:0017025,0.911331011455297,0.315448600197011,1,23,TBP-class protein binding,MF,THRA
9368,GO:0035909,0.911432589585792,0.317029504352666,1,20,aorta morphogenesis,BP,LRP1
14880,GO:0070717,0.911463401048282,0.316284003820318,1,21,poly-purine tract binding,MF,ATXN1
274,GO:0000777,0.911472292535807,0.169449913691694,6,92,condensed chromosome kinetochore,CC,PHF2;SEPT6;CENPC;REC8;CENPH;ZNF276
14156,GO:0061077,0.911568754766761,0.189968836859746,4,68,chaperone-mediated protein folding,BP,HSPA2;CRTAP;FKBP5;FKBP9
3260,GO:0006929,0.911962964932677,0.315059615175158,1,21,substrate-dependent cell migration,BP,ITGA2
75,GO:0000152,0.912088752973313,0.238540114078058,2,40,nuclear ubiquitin ligase complex,CC,CUL7;PHC2
1485,GO:0003824,0.912125101011036,0.0983387649030884,427,4347,catalytic activity,MF,TNFAIP3;ULK2;SIK1;SUGCT;NPEPL1;DDB2;AMACR;PYGB;CES2;NT5E;INPP5D;GAMT;FBXO41;OAS2;ADAM19;DDX60;HSPA2;FBXW4;EGFR;HERC3;PTPRS;FAM20C;APOBEC3C;CPT2;ASH2L;TRIM22;ALDH1A3;PLCD3;CTSO;SFRP1;MTHFR;KCTD11;KIF26B;EPHB2;GPX3;MAP3K14;GLUD1;BPHL;DGKQ;TMEM129;PIK3R1;ADAMTS7;BRSK1;TXNRD3;RBCK1;KDM3A;NSUN7;RNF135;SULF2;H6PD;DHTKD1;CAMKK1;HERC5;ST6GALNAC2;HR;CYBRD1;HTRA1;PI4KAP2;KCNAB2;KITLG;MVD;ZDHHC1;NAPRT;SRD5A3;WDR63;UROS;KDSR;RAB43;RAB40B;NOS1;PRKACB;B4GALNT4;DIP2C;HMGCL;D2HGDH;FKBP5;RNF187;CYP26B1;GAA;CMPK2;THNSL2;CNTRL;PIK3C2G;LIG1;CDK18;SPEG;NAGLU;MDM2;PLCD1;MLH3;NMRK1;DDX59;ST6GALNAC6;PPP2R2C;TYSND1;LTBP4;OBSCN;IDUA;PRODH;HGSNAT;MYH11;FKBP9;NDUFA4L2;RHOBTB2;UGT1A3;CERS4;CYP3A5;ACOT1;SPSB3;ENDOD1;HAGHL;CTSV;NLGN4Y;POLH;SPATA20;BLVRB;POLR2J2;OAS1;GAL3ST4;CRAT;KIF26A;B4GALT6;MLYCD;PHYH;ALPK1;CAPN7;DNAH1;SLC27A3;ARSI;NEK9;NLGN2;RNF165;NAT6;DHX32;ADAMTS13;PLCH2;PARP6;SLX1A;SLX1B;G6PC3;ZNF747;ZCCHC11;RHBDF1;SULT1E1;FBXO44;PTGS1;HEXA;ARSD;PSKH1;MINK1;PHF2;ABHD14B;GSTM2;MBOAT2;ULK1;SPPL2B;FGGY;PCSK1;TPGS1;SMARCA1;LRSAM1;NAIP;LTBP1;NEK8;MAP2K5;CES3;SESN3;MMP1;INSR;TST;MMP28;ALDH4A1;CHD3;CDK14;ST3GAL5;TTN;CBLC;DDT;RNPEPL1;POLD4;CTSF;CYP2D7;NSUN5P2;PGLS;PMS2P3;SEPT6;FBXL16;MGST2;DHX58;ENDOG;SLC27A1;PGAP1;GID4;CASP14;B4GALT2;ETNK2;TCIRG1;MAP2K2;OPLAH;PDK1;ALDH7A1;SQSTM1;PTK6;AKR7A2;LOXL1;SHARPIN;HEXB;KDM4C;HYAL1;METTL23;CLCA2;UBOX5;B3GNT9;PLA2G6;FAM86C2P;PDIK1L;CAPNS2;THSD4;ATP6V0A2;IDH2;MAP3K12;WRN;SEPT5;DNM1;MCM9;ZYG11B;MACROD1;KLHL24;PLD3;TREX1;LPIN3;ZDHHC12;OARD1;ABHD14A;CDK5R1;ATRX;PIGZ;CA2;EFNB3;PI4KAP1;POLR2J3;SESN1;MAPK10;NKTR;HMG20B;CYBA;TRIM38;DTX3;ERCC6;HADH;RRM2B;HLCS;FBXO2;XRN1;CTSB;KLK5;TARBP1;FBXW7;NUDT6;ZNF862;PAK6;PGM1;PFKFB2;RNF170;HSD11B1L;METTL21A;ACADS;ADARB1;MX2;ACACB;OGDHL;C1RL;TK2;LACTB2;GLUL;TNS2;NDST2;FBXW5;SRR;KLHDC8B;ATE1;ACP5;MPG;PLA2G7;RNPEP;BDH1;MAP3K6;RIMKLB;PPCS;MYO3B;DHRS4L2;HEXDC;WNK1;PDE2A;SDHA;STK16;RET;ACOX3;MYSM1;DDHD2;FBXO4;RNF213;PIK3C3;DALRD3;FGFR4;ERCC5;PIK3R2;RETSAT;SETD4;DHRS12;KLHL3;ETFB;MYO9A;RPS6KA5;DPY19L2P2;NADK;NUDT8;HLTF;MARCH8;PCSK6;MPPE1;PCMTD2;STK19;NDUFV3;FAHD2B;RASL10B;LMTK3;PCMTD1;GOLGA7B;ACVR1B;TMX4;KDELC2;PRIMPOL;DLG4;PPP2R3B;TSSK1B;ADCK5;ALOXE3;NAT14;ENDOU;MPI;DUOX1;GALE;WEE1;DYDC1;PTK7;DQX1;AMT;RSAD2;XYLT1;TOP3B;ACSL1;KAT2B;MARK4;TEP1;IRS2;IMPA2;MBLAC2;METTL7A;ERN1;HSD17B14;RNF141;ALOX15B;RAD50;TKFC;PNPO;MTR;MAN1B1;DHRS4;PEX1;ECI1;UAP1L1;FAAH;CBR4;ISYNA1;SGSH;PBLD;MYH16;CERS5;PRDX5;PHPT1;SMPDL3B;KIF7;GLB1;CPT1C;GSTM3;RDH12;KLHL29;CHD6;ACSS2;DPP7;TRIM2;HDAC11;PTPN3;CTSD;ERBB2;PLCB3;NUDT10;ZDHHC24;PPM1M;ABCA2;KMT5C;TH;SSH3;PRKACA;POLM;ACOT2;GCNT4;SUCLG2;UCKL1;PARN;DDX12P;UFL1;IP6K2;RIPK3;PI4K2B;LONP2;PRMT3;HARS2;CIT;EHHADH;MSH5;SMURF1;TTLL1;PEMT;ABCA11P;GCLC
4599,GO:0010717,0.912269212644562,0.189268896848682,4,62,regulation of epithelial to mesenchymal transition,BP,SFRP1;WWTR1;DAB2IP;PBLD
11806,GO:0046717,0.912272874412072,0.207343329861174,3,50,acid secretion,BP,VAMP2;NMU;PLA2G6
4100,GO:0009156,0.912374116076763,0.151821663002065,9,127,ribonucleoside monophosphate biosynthetic process,BP,DHTKD1;INSR;TCIRG1;ATP6V0A2;MLXIPL;PGM1;PFKFB2;OGDHL;UCKL1
3571,GO:0007616,0.912751475696907,0.313120860392591,1,21,long-term memory,BP,APOE
9627,GO:0036507,0.912961221962449,0.311998498036383,1,22,protein demannosylation,BP,MAN1B1
9628,GO:0036508,0.912961221962449,0.311998498036383,1,22,protein alpha-1,2-demannosylation,BP,MAN1B1
8646,GO:0034205,0.913747048936863,0.310057542539016,1,22,amyloid-beta formation,BP,APOE
19258,GO:1905476,0.913748636265078,0.310053614198318,1,22,negative regulation of protein localization to membrane,BP,DMTN
11439,GO:0045910,0.913822117564004,0.310476184392045,1,21,negative regulation of DNA recombination,BP,MAGEF1
11245,GO:0045505,0.913976091577289,0.31009467320958,1,21,dynein intermediate chain binding,MF,DNAH1
11287,GO:0045621,0.914210674344497,0.203451581591071,3,52,positive regulation of lymphocyte differentiation,BP,INPP5D;GLI2;GLI3
3778,GO:0008334,0.914278550793977,0.307688674577405,1,24,histone mRNA metabolic process,BP,XRN1
4255,GO:0009584,0.914315137315963,0.308649632191713,1,22,detection of visible light,BP,EYS
98,GO:0000209,0.914370108314016,0.124586576119744,22,275,protein polyubiquitination,BP,TNFAIP3;DDB2;FBXO41;FBXW4;TMEM129;RBCK1;HERC5;RNF187;RNF165;FBXO44;LRSAM1;FBXL16;SHARPIN;UBOX5;FBXO2;FBXW7;FBXW5;FBXO4;RNF213;KLHL3;MARCH8;SMURF1
4547,GO:0010631,0.914398349765753,0.13189930194128,16,198,epithelial cell migration,BP,APOE;PLEKHG5;FERMT1;CAPN7;ITGA2;MAP2K5;FAT2;HYAL1;MMRN2;LTB4R2;DAB2IP;PLXND1;PBLD;TNFSF12;SRPX2;PPARG
8137,GO:0032873,0.914503704226025,0.234196921603931,2,37,negative regulation of stress-activated MAPK cascade,BP,SFRP1;PDCD4
14665,GO:0070303,0.914503704226025,0.234196921603931,2,37,negative regulation of stress-activated protein kinase signaling cascade,BP,SFRP1;PDCD4
12328,GO:0048706,0.914734785027233,0.173077913504302,5,74,embryonic skeletal system development,BP,SULF2;HOXA3;GLI3;HYAL1;IFT140
15109,GO:0071222,0.914949336376392,0.157337410681449,7,104,cellular response to lipopolysaccharide,BP,TNFAIP3;CMPK2;PDCD4;ADAMTS13;BMP6;DAB2IP;VDR
14674,GO:0070317,0.915046371778832,0.23307016728837,2,37,negative regulation of G0 to G1 transition,BP,DAB2IP;TFDP2
2803,GO:0006261,0.915101290026,0.144200887004233,10,138,DNA-dependent DNA replication,BP,LIG1;POLD4;ETAA1;BMP6;WRN;MCM9;ATRX;RRM2B;FBXW7;PRIMPOL
3157,GO:0006760,0.915168461848226,0.305978582606199,1,23,folic acid-containing compound metabolic process,BP,MTHFR
4568,GO:0010656,0.915424901634673,0.305887633550435,1,22,negative regulation of muscle cell apoptotic process,BP,RGL2
12857,GO:0051205,0.91566522079231,0.231147269960194,2,40,protein insertion into membrane,BP,EGFR;TFDP2
8147,GO:0032886,0.915697292237833,0.135545210443877,13,166,regulation of microtubule-based process,BP,DIXDC1;RGS2;TRPV4;BBS2;CDK5R1;CHMP1B;APC2;FBXW5;KAT2B;CEP250;ERBB2;MAP1A;EML2
8176,GO:0032924,0.916207114526128,0.303931507417132,1,22,activin receptor signaling pathway,BP,ACVR1B
13085,GO:0051640,0.916528202453702,0.109579762677801,46,522,organelle localization,BP,MAP6;SYT8;SYN1;VAMP3;RAB40B;CNTRL;VPS11;COL7A1;SYTL1;C2CD4C;BLOC1S4;NLGN2;ADORA2B;RIMS3;SPG11;NINL;SYT15;TPGS1;VAMP2;TRAK1;SUN1;BLOC1S3;CEP192;CENPC;BBS2;SEPT5;DNM1;IQCB1;SPRY2;ANKRD28;CHMP1B;TSNARE1;NPHP4;SHROOM2;SYT7;BBS5;EXOC2;AREG;ALMS1;ESYT2;MARK4;CEP250;PEX1;ATG14;PRKACA;SYNE2
3654,GO:0008137,0.916582165531389,0.297767101748914,1,38,NADH dehydrogenase (ubiquinone) activity,MF,NDUFV3
12428,GO:0050136,0.916582165531389,0.297767101748914,1,38,NADH dehydrogenase (quinone) activity,MF,NDUFV3
14891,GO:0070741,0.916604313069699,0.303536550845367,1,21,response to interleukin-6,BP,STAT1
15186,GO:0071354,0.916604313069699,0.303536550845367,1,21,cellular response to interleukin-6,BP,STAT1
7712,GO:0032210,0.916757755731324,0.198779025188006,3,51,regulation of telomere maintenance via telomerase,BP,XRN1;FBXO4;PARN
9776,GO:0040001,0.916797830747017,0.302449095745161,1,22,establishment of mitotic spindle localization,BP,SPRY2
7966,GO:0032588,0.916829140924366,0.180964847085381,4,65,trans-Golgi network membrane,CC,VAMP3;NSG1;RAB43;COG1
3345,GO:0007064,0.916974301656031,0.302005370135627,1,22,mitotic sister chromatid cohesion,BP,ATRX
17019,GO:0099516,0.917306825273748,0.228586616377679,2,36,ion antiporter activity,MF,SLC24A1;SLC37A2
18651,GO:1904018,0.917476927288767,0.148436589837938,8,111,positive regulation of vasculature development,BP,RAPGEF3;C5;VEGFB;HYAL1;BTG1;TNFSF12;SRPX2;ECM1
11457,GO:0045930,0.917615164337616,0.12116873159327,21,273,negative regulation of mitotic cell cycle,BP,GPNMB;EGFR;PKD2;XPC;BRSK1;MDM2;PCBP4;ZFP36L2;TOM1L2;PIDD1;GJC2;ZNF655;ATRX;CDK5RAP3;BRINP1;BTG1;TFDP2;ZFP36L1;ANGEL2;GPR132;PTPN3
3052,GO:0006612,0.917632420861352,0.143135632988185,9,164,protein targeting to membrane,BP,ZDHHC1;MICALL1;ANK3;ZDHHC12;CDK5R1;DMTN;GOLGA7B;ERBB2;ZDHHC24
10401,GO:0043254,0.917845759614078,0.115499863366056,28,335,regulation of protein complex assembly,BP,DDB2;APOE;EPS8L2;IMPACT;VPS11;RGS2;ARPIN;SPTB;WIPF1;ULK1;FHOD3;MMP1;GSN;BAIAP2;TRIOBP;RICTOR;WHAMMP3;CDK5R1;WASH3P;THRA;CAPG;DAB2IP;ERCC5;BBS10;DMTN;MPP7;EML2;CTNNBIP1
17281,GO:0140096,0.917959389671954,0.0960426423562767,165,1701,catalytic activity, acting on a protein,MF,TNFAIP3;ULK2;SIK1;NPEPL1;DDB2;FBXO41;ADAM19;FBXW4;EGFR;HERC3;PTPRS;FAM20C;ASH2L;CTSO;SFRP1;EPHB2;MAP3K14;TMEM129;ADAMTS7;BRSK1;RBCK1;KDM3A;RNF135;CAMKK1;HERC5;HR;HTRA1;ZDHHC1;PRKACB;B4GALNT4;FKBP5;RNF187;CNTRL;CDK18;SPEG;MDM2;PPP2R2C;TYSND1;LTBP4;OBSCN;FKBP9;SPSB3;CTSV;ALPK1;CAPN7;NEK9;RNF165;ADAMTS13;ZNF747;RHBDF1;FBXO44;PSKH1;MINK1;PHF2;ULK1;SPPL2B;PCSK1;TPGS1;LRSAM1;NAIP;LTBP1;NEK8;MAP2K5;MMP1;INSR;MMP28;CHD3;CDK14;TTN;CBLC;RNPEPL1;CTSF;FBXL16;GID4;CASP14;MAP2K2;PDK1;SQSTM1;PTK6;LOXL1;SHARPIN;KDM4C;CLCA2;UBOX5;PDIK1L;CAPNS2;THSD4;MAP3K12;ZYG11B;KLHL24;ZDHHC12;CDK5R1;EFNB3;MAPK10;NKTR;HMG20B;HLCS;FBXO2;CTSB;KLK5;FBXW7;ZNF862;PAK6;METTL21A;C1RL;TNS2;FBXW5;KLHDC8B;ATE1;RNPEP;MAP3K6;MYO3B;WNK1;STK16;RET;MYSM1;FBXO4;RNF213;PIK3C3;FGFR4;SETD4;KLHL3;RPS6KA5;HLTF;MARCH8;PCSK6;PCMTD2;STK19;LMTK3;PCMTD1;GOLGA7B;ACVR1B;TMX4;PPP2R3B;TSSK1B;ADCK5;ENDOU;WEE1;DYDC1;PTK7;XYLT1;MARK4;ERN1;RNF141;PHPT1;KLHL29;DPP7;TRIM2;HDAC11;PTPN3;CTSD;ERBB2;ZDHHC24;PPM1M;KMT5C;SSH3;PRKACA;GCNT4;UFL1;RIPK3;LONP2;PRMT3;CIT;SMURF1;TTLL1
8574,GO:0034067,0.917978994800125,0.300071121643121,1,21,protein localization to Golgi apparatus,BP,OBSL1
18013,GO:1902554,0.918020142094787,0.167267426749882,5,78,serine/threonine protein kinase complex,CC,ULK1;CDK14;ERCC5;ACVR1B;ERN1
18328,GO:1903320,0.918218333433908,0.129805584784452,14,188,regulation of protein modification by small protein conjugation or removal,BP,TNFAIP3;ISG15;CRY1;PER2;ZYG11B;HMG20B;FBXO2;FBXW7;CDK5RAP3;RWDD3;FBXO4;UFL1;PRMT3;GCLC
4072,GO:0009127,0.91829831779134,0.147001096550158,8,116,purine nucleoside monophosphate biosynthetic process,BP,DHTKD1;INSR;TCIRG1;ATP6V0A2;MLXIPL;PGM1;PFKFB2;OGDHL
4111,GO:0009168,0.91829831779134,0.147001096550158,8,116,purine ribonucleoside monophosphate biosynthetic process,BP,DHTKD1;INSR;TCIRG1;ATP6V0A2;MLXIPL;PGM1;PFKFB2;OGDHL
18665,GO:1904036,0.918319606856611,0.298609420917603,1,22,negative regulation of epithelial cell apoptotic process,BP,TNFAIP3
11648,GO:0046427,0.918419695320192,0.225384962688806,2,40,positive regulation of JAK-STAT cascade,BP,PTK6;CTF1
7380,GO:0031440,0.918422079543817,0.298349781987768,1,22,regulation of mRNA 3'-end processing,BP,ZFP36L1
16111,GO:0090132,0.918429830235142,0.12631648958981,16,199,epithelium migration,BP,APOE;PLEKHG5;FERMT1;CAPN7;ITGA2;MAP2K5;FAT2;HYAL1;MMRN2;LTB4R2;DAB2IP;PLXND1;PBLD;TNFSF12;SRPX2;PPARG
11461,GO:0045934,0.918536875658775,0.0989380081913465,100,1095,negative regulation of nucleobase-containing compound metabolic process,BP,HES2;SREBF1;CIRBP;MNT;TRIM22;SFRP1;TSC22D3;HR;TFCP2L1;ZFPM1;IRF2BPL;STAT1;IMPACT;CRY2;CRY1;SCMH1;MAGEF1;NFATC4;HSF4;EAPP;MDM2;TCF25;PDCD4;TRPV4;GLI2;SLX1A;SLX1B;PER2;ZNF658;PHF2;TCEAL1;WWTR1;GLI3;THRAP3;BHLHE40;MAP2K5;ZNF318;TCFL5;JARID2;CCDC85B;MXD4;RTF1;H2AFJ;BMP6;SQSTM1;ZNF608;TXNIP;RCOR2;IFI27;CDK5R1;ATRX;GABBR1;XRN1;MLXIPL;FBXW7;GPR87;ING4;ATXN1;NFIX;MXI1;THRA;IKZF4;NAB2;PEG3;SALL2;ZBTB20;PDE2A;MAF;LTB4R2;ZMYND8;DAB2IP;TSHZ2;IFI16;RPS6KA5;VDR;TNRC18;SIX5;WWC3;TFDP2;NRARP;ZNF91;DYDC1;TCF7;RAD50;ANGEL2;STAT6;PRDX5;NELFCD;KLF8;PPARG;CXXC5;PARN;ZFP90;PER3;FOXP2;PTBP2;ZC3H6;HIVEP1;CTNNBIP1;GCLC
13020,GO:0051496,0.918849654958455,0.225107398779852,2,37,positive regulation of stress fiber assembly,BP,SFRP1;RAPGEF3
8000,GO:0032637,0.919147303156656,0.223852580227668,2,40,interleukin-8 production,BP,F2R;MAP2K5
8740,GO:0034404,0.919413673756125,0.132258641071249,12,166,nucleobase-containing small molecule biosynthetic process,BP,NT5E;DHTKD1;RAPGEF3;INSR;MLXIPL;PGM1;PFKFB2;OGDHL;TK2;PDE2A;NUDT10;UCKL1
4570,GO:0010658,0.919464898903951,0.295699679238221,1,22,striated muscle cell apoptotic process,BP,RGL2
15725,GO:0072331,0.919684276739515,0.120530547802843,19,246,signal transduction by p53 class mediator,BP,TP53INP1;NDRG1;MDM2;PCBP4;PIDD1;NUPR1;CHD3;RMI2;WRN;CDK5R1;ATRX;RRM2B;EDA2R;ING4;CDK5RAP3;IFI16;TFDP2;RAD50;ZMAT3
11189,GO:0045333,0.919887281142186,0.139893280074352,9,154,cellular respiration,BP,DHTKD1;NFATC4;D2HGDH;IDH2;OGDHL;SDHA;ETFB;NDUFV3;SUCLG2
1968,GO:0004683,0.919919353144286,0.294540265022517,1,22,calmodulin-dependent protein kinase activity,MF,CAMKK1
2266,GO:0005198,0.919984165015325,0.107074722200797,40,506,structural molecule activity,MF,APOE;OBSL1;SYNC;MARVELD1;MYL9;GRIP2;KRT15;OBSCN;MYH11;PPL;SPTB;TUBGCP5;CLTCL1;ANK3;MAPK8IP3;SNTA1;PRR9;TTN;SEPT6;EPB41L3;HOMER2;SEPT5;MALL;EPB41L4A;SHANK3;KRT14;TFPI2;NPHP4;KLHL3;DLG5;WWC3;SHANK2;LMNA;EFEMP2;AKAP6;MPP7;LDLRAP1;NPAP1;LAMB2;MAP1A
2847,GO:0006333,0.920183999372994,0.139407997650946,9,156,chromatin assembly or disassembly,BP,H1F0;CHD3;H1FX;CENPC;ATRX;TSPYL4;CENPH;TNRC18;NAP1L5
9396,GO:0035966,0.920399586114251,0.128682052978193,13,175,response to topologically incorrect protein,BP,HSPA2;TMEM129;PIK3R1;UBXN4;CUL7;TM7SF3;CREBRF;CDK5RAP3;DAB2IP;LMNA;ERN1;DNAJC4;HERPUD2
15841,GO:0072583,0.920454276225911,0.22194454198669,2,36,clathrin-dependent endocytosis,BP,UNC119;DNM1
10990,GO:0044815,0.920672753466674,0.188525001488949,3,91,DNA packaging complex,CC,H1F0;H2AFJ;H1FX
7433,GO:0031571,0.920724814477893,0.173783011085253,4,68,mitotic G1 DNA damage checkpoint,BP,MDM2;PCBP4;PIDD1;TFDP2
10992,GO:0044819,0.920724814477893,0.173783011085253,4,68,mitotic G1/S transition checkpoint,BP,MDM2;PCBP4;PIDD1;TFDP2
9831,GO:0042088,0.920960089804052,0.290837306784492,1,24,T-helper 1 type immune response,BP,STAT6
707,GO:0001933,0.920987049945594,0.11205589093623,27,326,negative regulation of protein phosphorylation,BP,TNFAIP3;APOE;SFRP1;EPHB2;DGKQ;IMPACT;CAMK2N1;FLRT3;RGS2;PDCD4;RTN4RL1;WWTR1;CBLC;CD109;PTK6;SPRY2;MLXIPL;CDK5RAP3;ADARB1;WNK1;DAB2IP;PIK3R2;DMTN;KAT2B;PBLD;RANBP9;ATG14
11495,GO:0046006,0.921079684713655,0.290076149760544,1,25,regulation of activated T cell proliferation,BP,RIPK3
17896,GO:1902230,0.921102003133234,0.28960077962968,1,26,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage,BP,ACKR3
8992,GO:0035137,0.921236787513869,0.291163513065752,1,22,hindlimb morphogenesis,BP,WNT3
1027,GO:0002534,0.921480251677857,0.28999549142759,1,23,cytokine production involved in inflammatory response,BP,PDCD4
10717,GO:0044088,0.921567795280558,0.219125592156657,2,38,regulation of vacuole organization,BP,ULK1;LRSAM1
647,GO:0001838,0.921623940247451,0.146946595107621,7,99,embryonic epithelial tube formation,BP,SFRP1;PRKACB;CELSR1;NPHP3;RET;TEAD2;PTK7
3233,GO:0006887,0.921637184184724,0.101770659494591,52,598,exocytosis,BP,PYGB;SYT8;CXCR1;SYN1;KCNAB2;VAMP3;NAPRT;RAB40B;GAA;VPS11;HGSNAT;SYTL1;ACTR1B;ENDOD1;C2CD4C;TMC6;ADORA2B;RIMS3;LHFPL2;SYT15;VAMP2;GSN;TTN;CD109;SLC2A3;TCIRG1;VEGFB;HEXB;PLA2G6;CST3;SEPT5;CYBA;CTSB;PGM1;RPH3AL;SYT7;EXOC2;BST2;DMTN;ARFGEF2;NBEAL2;CD68;METTL7A;GLB1;DPP7;CD9;CTSD;SYNGR1;C6ORF120;SERPING1;NFASC;ECM1
18140,GO:1902911,0.92165515397345,0.152974041412922,6,90,protein kinase complex,CC,ULK1;INSR;CDK14;ERCC5;ACVR1B;ERN1
11849,GO:0046856,0.921673381791017,0.290634088943331,1,21,phosphatidylinositol dephosphorylation,BP,INPP5D
3561,GO:0007602,0.921681431888838,0.289477357579799,1,23,phototransduction,BP,UNC119
8232,GO:0033014,0.921815247542128,0.28863811441264,1,24,tetrapyrrole biosynthetic process,BP,UROS
12867,GO:0051225,0.921913100032368,0.146443414747586,7,100,spindle assembly,BP,GOLGA8A;TUBGCP5;GOLGA8B;NAIP;CEP192;CHMP1B;GOLGA8N
10476,GO:0043388,0.921972368487527,0.217675823498527,2,41,positive regulation of DNA binding,BP,ITGA2;PPARG
2269,GO:0005201,0.922047949984027,0.21879426438474,2,35,extracellular matrix structural constituent,MF,TFPI2;EFEMP2
13554,GO:0060043,0.92210703831406,0.288920009493353,1,22,regulation of cardiac muscle cell proliferation,BP,JARID2
10969,GO:0044774,0.922125288861776,0.14591370206845,7,105,mitotic DNA integrity checkpoint,BP,XPC;BRSK1;MDM2;PCBP4;PIDD1;CDK5RAP3;TFDP2
14124,GO:0061024,0.922560912217844,0.0992319376089937,59,664,membrane organization,BP,APOE;EGFR;SYT8;EVI5L;MARVELD1;VAV3;VAMP3;REEP2;NSG1;MICALL1;TBC1D8;VPS11;NDRG1;COL7A1;SYTL1;NLGN4Y;C2CD4C;NEK9;CLTCL1;FLOT1;NLGN2;ANK3;SPG11;ITGA2;SYT15;VAMP2;GSN;BAIAP2;SUN1;AHNAK2;VPS39;ETV5;EPB41L3;MALL;DNM1;ANO9;SHANK3;ANKRD28;MX2;REEP4;TBC1D17;TSNARE1;ZMYND8;PRX;SYT7;AREG;TBC1D16;SGSM2;TFDP2;DLG4;LMNA;CD9;SYNGR1;PPARG;LDLRAP1;SYNE2;NFASC;SNX33;SMURF1
11829,GO:0046824,0.922662839233557,0.187491984358276,3,51,positive regulation of nucleocytoplasmic transport,BP,MDM2;RAPGEF3;GLI3
19371,GO:1905897,0.922925130114581,0.169904867946811,4,67,regulation of response to endoplasmic reticulum stress,BP,PIK3R1;DAB2IP;ERN1;SERINC3
11131,GO:0045191,0.922930431167629,0.286248166313882,1,23,regulation of isotype switching,BP,STAT6
20075,GO:2000765,0.922946948033025,0.28620531884927,1,23,regulation of cytoplasmic translation,BP,UNK
9619,GO:0036498,0.923497496136212,0.168871733986441,4,67,IRE1-mediated unfolded protein response,BP,CUL7;DAB2IP;LMNA;ERN1
8794,GO:0034508,0.923729083791884,0.212605226932538,2,50,centromere complex assembly,BP,CENPC;CENPH
3714,GO:0008234,0.923738805340871,0.128505432992171,11,149,cysteine-type peptidase activity,MF,TNFAIP3;CTSO;SFRP1;CTSV;CAPN7;CTSF;CASP14;CAPNS2;CTSB;MYSM1;CTSD
650,GO:0001841,0.923870062694262,0.14945940397802,6,87,neural tube formation,BP,SFRP1;PRKACB;CELSR1;NPHP3;TEAD2;PTK7
259,GO:0000726,0.923922875575281,0.167618748723758,4,74,non-recombinational repair,BP,SLX1A;SLX1B;RAD50;POLM
19192,GO:1905330,0.924289024960796,0.130374855707269,10,143,regulation of morphogenesis of an epithelium,BP,SFRP1;PRICKLE2;STAT1;ARHGEF19;CELSR1;FZD7;ETV5;NPHP3;PTK7;SMURF1
11760,GO:0046635,0.924593485222864,0.281423890807506,1,24,positive regulation of alpha-beta T cell activation,BP,GLI3
19026,GO:1904894,0.924756987800381,0.211706036672118,2,41,positive regulation of STAT cascade,BP,PTK6;CTF1
11759,GO:0046634,0.924773159301945,0.21204729550574,2,39,regulation of alpha-beta T cell activation,BP,GLI3;HFE
12582,GO:0050778,0.924791517022854,0.102223059790795,37,444,positive regulation of immune response,BP,TNFAIP3;MUC19;INPP5D;DDX60;PTPRS;PIK3R1;RBCK1;VAV3;PRKACB;FLOT1;ADORA2B;C5;WIPF1;BAIAP2;DHX58;NLRX1;PLA2G6;TNFRSF21;CYBA;CTSB;KLK5;ELF1;C1RL;ERMAP;DAB2IP;PIK3C3;IFI16;PIK3R2;RPS6KA5;CACNB3;RSAD2;TKFC;STAT6;PHPT1;SMPDL3B;PRKACA;SERPING1
5625,GO:0016706,0.925129842557054,0.211480407550357,2,38,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors,MF,PHYH;KDM4C
7825,GO:0032386,0.925146760968073,0.107261047376835,26,317,regulation of intracellular transport,BP,SREBF1;SYN1;REEP2;VPS11;MDM2;RAPGEF3;HPS4;ADORA2B;ANK3;RIMS3;GLI3;VAMP2;MICALL2;MAP2K2;SEPT5;IFI27;OSCP1;CDK5R1;FBXW7;MX2;PDE2A;DMTN;ERBB2;ABCA2;LDLRAP1;PEMT
7287,GO:0031293,0.925195669500465,0.280336013852098,1,23,membrane protein intracellular domain proteolysis,BP,SPPL2B
367,GO:0000989,0.925271813751511,0.0990807470094434,45,516,transcription factor activity, transcription factor binding,MF,MNT;TRIM22;POU3F1;HR;TFCP2L1;CITED4;CRY2;CRY1;MAML3;NFATC4;HSF4;KLF7;SOX12;PER2;PHF2;WWTR1;THRAP3;BHLHE40;MXD4;RTF1;TCF4;RCOR2;LPIN3;ING4;LMO2;MXI1;THRA;NAB2;ZMYND8;CALCOCO1;TEAD2;MYSM1;BTG1;VDR;MAMSTR;TFDP2;GLMP;KAT2B;TRERF1;RORA;PPARG;RIPK3;AIP;SCAND1;PER3
18489,GO:1903672,0.925478668095826,0.279592281884485,1,23,positive regulation of sprouting angiogenesis,BP,SRPX2
12535,GO:0050704,0.925580683705395,0.278385262229098,1,25,regulation of interleukin-1 secretion,BP,NLRP1
18363,GO:1903393,0.925604583578484,0.279796829879179,1,22,positive regulation of adherens junction organization,BP,SFRP1
16199,GO:0090263,0.925624361300732,0.140124629450531,7,110,positive regulation of canonical Wnt signaling pathway,BP,CAPRIN2;DIXDC1;SFRP1;SULF2;NAIP;WNK1;NRARP
5723,GO:0016866,0.925742097315295,0.277960719947071,1,25,intramolecular transferase activity,MF,PGM1
11123,GO:0045182,0.926111088915567,0.208960550123732,2,40,translation regulator activity,MF,CIRBP;MIF4GD
10973,GO:0044783,0.926281102738155,0.163674651926506,4,69,G1 DNA damage checkpoint,BP,MDM2;PCBP4;PIDD1;TFDP2
18219,GO:1903051,0.926478363650693,0.179620150032241,3,55,negative regulation of proteolysis involved in cellular protein catabolic process,BP,LAMP3;HFE;PANO1
12917,GO:0051294,0.926736432085124,0.276272820705814,1,23,establishment of spindle orientation,BP,SPRY2
11441,GO:0045912,0.927113393874272,0.275273457996237,1,23,negative regulation of carbohydrate metabolic process,BP,SIK1
17900,GO:1902235,0.927367893351523,0.273663617532587,1,25,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,BP,SERINC3
5476,GO:0016411,0.927423531582848,0.274449684034537,1,23,acylglycerol O-acyltransferase activity,MF,MBOAT2
2730,GO:0006110,0.927454416244771,0.178165431252613,3,51,regulation of glycolytic process,BP,INSR;MLXIPL;PFKFB2
13161,GO:0051787,0.927517996539461,0.273711548829364,1,24,misfolded protein binding,MF,HSPA2
12533,GO:0050702,0.927812854476945,0.272927044374383,1,24,interleukin-1 beta secretion,BP,NLRP1
7921,GO:0032506,0.927854573461539,0.273302405707643,1,23,cytokinetic process,BP,SNX33
5907,GO:0018149,0.927891708077606,0.27049949364975,1,30,peptide cross-linking,BP,PRR9
9945,GO:0042326,0.92795299284814,0.101804177438425,29,350,negative regulation of phosphorylation,BP,TNFAIP3;APOE;SFRP1;EPHB2;DGKQ;IMPACT;CAMK2N1;PIK3IP1;FLRT3;RGS2;PDCD4;RTN4RL1;WWTR1;CBLC;CD109;PTK6;SPRY2;MLXIPL;CDK5RAP3;ADARB1;WNK1;DAB2IP;PIK3R2;DMTN;KAT2B;IRS2;PBLD;RANBP9;ATG14
10269,GO:0043030,0.928096413226511,0.272171386497465,1,24,regulation of macrophage activation,BP,RORA
14526,GO:0070063,0.928284506371502,0.176298097815258,3,53,RNA polymerase binding,MF,RTF1;ERBB2;UVSSA
20252,GO:2001242,0.928291558899773,0.131072189233785,8,127,regulation of intrinsic apoptotic signaling pathway,BP,MDM2;RRM2B;FBXW7;IL20RA;IVNS1ABP;ACKR3;RIPK3;SERINC3
11827,GO:0046822,0.928522448834427,0.141511348038683,6,91,regulation of nucleocytoplasmic transport,BP,MDM2;RAPGEF3;GLI3;IFI27;MX2;PDE2A
4218,GO:0009394,0.928810871199397,0.268679197630622,1,28,2'-deoxyribonucleotide metabolic process,BP,CMPK2
18560,GO:1903827,0.928935217762233,0.0977659064235182,35,415,regulation of cellular protein localization,BP,SREBF1;EGFR;EPHB2;PIK3R1;KCNAB2;VPS11;MDM2;LZTS2;RAPGEF3;HPS4;ANK3;GLI3;VAMP2;GSN;MICALL2;SQSTM1;IFI27;OSCP1;CDK5R1;HFE;FBXW7;CDK5RAP3;ASTN2;LRP1;PDE2A;ZMYND8;FBXO4;DMTN;TFDP2;LMNA;CEP250;ERBB2;LDLRAP1;SNX33;PEMT
7826,GO:0032387,0.929154264186041,0.201968522251676,2,42,negative regulation of intracellular transport,BP,PDE2A;DMTN
9808,GO:0042026,0.929165351026917,0.268867537965863,1,25,protein refolding,BP,HSPA2
4339,GO:0009893,0.929177146745668,0.0818009447694584,227,2356,positive regulation of metabolic process,BP,TNFAIP3;GPNMB;EPM2A;TP53INP1;PTHLH;SREBF1;ACTA2;APOE;GPSM1;HSPA2;EGFR;TRIM65;CIRBP;PKD2;CAPRIN2;RBM3;ASH2L;TRIM22;SRSF5;SFRP1;SEC14L2;EPHB2;MAP3K14;DGKQ;PIK3R1;KDM3A;POU3F1;WNT3;CAMKK1;VAV3;CSPG4;RGMA;ZFPM1;KITLG;VAMP3;CITED4;IRF2BPL;MC1R;STAT1;IMPACT;CAMK2N1;NSG1;NOS1;PRKACB;MAML3;KLF13;MAGEF1;NFATC4;RNF187;CYP26B1;HSF4;VPS11;EAPP;MDM2;CRTC1;NDN;TNFSF10;RAPGEF3;F2R;MLYCD;ZFP36L2;TRPV4;FLOT1;GLI2;ADORA2B;ANK3;KLF7;LAMP3;TCEA2;MAPK8IP3;ZNF76;SOX12;PIDD1;SLX1A;SLX1B;GJC2;UNC119;C5;MINK1;PHF2;ABHD14B;WWTR1;ITGA2;ULK1;GLI3;THRAP3;SMARCA1;LRSAM1;MAP2K5;ITGA6;SESN3;ZNF318;IGFBP4;JARID2;NUPR1;INSR;GSN;TTN;DDT;ZNF287;ETAA1;PILRB;ENDOG;SLC27A1;RTF1;MDK;RICTOR;BMP6;MAP2K2;SQSTM1;PTK6;FZD7;ETV5;DLX3;HEXB;KDM4C;METTL23;PLA2G6;CST3;GDF15;CTF1;TCF4;PLAG1;MAP3K12;WRN;IFI27;LPIN3;CDK5R1;ATRX;SESN1;MAPK10;HFE;ADIRF;CYBA;ERCC6;SHC2;EDA2R;SPRY2;MEF2D;CREBRF;MLXIPL;FBXW7;CDK5RAP3;LMO2;NFIX;PAK6;CARF;PFKFB2;THRA;APC2;ARAP1;RAI1;ELF1;IKZF4;ACACB;NLRP1;DBP;NAB2;EPM2AIP1;LRP1;PEG3;RFX2;MAP3K6;SALL2;WNK1;MAF;STK16;RET;DAB2IP;CASZ1;RWDD3;CALCOCO1;TEAD2;MYSM1;FBXO4;IFI16;FGFR4;PIK3R2;TEF;AREG;RPS6KA5;VDR;MAMSTR;TNRC6C;PLXND1;SIX5;HLTF;PHF1;ZNF292;TFDP2;SNX1;ACVR1B;DLG4;TNNI2;NAT14;TNFRSF25;ZFP36L1;GLMP;ACSL1;IL11;KAT2B;IRS2;ERN1;IVNS1ABP;RAD50;ANGEL2;TRERF1;TNFSF12;STAT6;CHD6;ERBB2;AKAP6;ATG14;RORA;PPARG;PRKACA;LDLRAP1;ACKR3;PARN;RIPK3;SNX33;ZFP90;CCDC3;SMURF1;NPNT;PEMT;GCLC
482,GO:0001533,0.929178342421259,0.201311267507622,2,46,cornified envelope,CC,PPL;PRR9
10034,GO:0042509,0.929339674824893,0.201561393808101,2,42,regulation of tyrosine phosphorylation of STAT protein,BP,PTK6;CTF1
41,GO:0000083,0.929343394884193,0.268834016899946,1,24,regulation of transcription involved in G1/S transition of mitotic cell cycle,BP,TFDP2
13799,GO:0060415,0.929382236229929,0.175537313792953,3,43,muscle tissue morphogenesis,BP,ZFPM1;TTN;ADARB1
12618,GO:0050830,0.929517606299428,0.265365037917573,1,33,defense response to Gram-positive bacterium,BP,ACP5
546,GO:0001666,0.929560766413707,0.106995803946595,19,252,response to hypoxia,BP,POSTN;SFRP1;MTHFR;NOS1;NDRG1;MDM2;ITGA2;ENDOG;PDK1;VEGFB;CST3;CYBA;KCNMA1;RWDD3;ZFP36L1;LMNA;APOLD1;TH;RORA
2447,GO:0005657,0.929694071912626,0.157496167020086,4,68,replication fork,CC,POLD4;ETAA1;WRN;ERCC5
5286,GO:0015949,0.929795256016627,0.266040793419528,1,28,nucleobase-containing small molecule interconversion,BP,RRM2B
10545,GO:0043516,0.929881864175331,0.26694217942104,1,25,regulation of DNA damage response, signal transduction by p53 class mediator,BP,MDM2
6892,GO:0030433,0.930294810434974,0.156388883203996,4,68,ubiquitin-dependent ERAD pathway,BP,TMEM129;UBXN4;FBXO2;MAN1B1
10166,GO:0042771,0.930347283245502,0.199182077358476,2,43,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,NUPR1;IFI16
16318,GO:0090575,0.930621527970038,0.123876957303189,9,131,RNA polymerase II transcription factor complex,CC,TCF4;MXI1;THRA;TEAD2;ERCC5;VDR;TFDP2;RORA;PPARG
7946,GO:0032553,0.931000427214588,0.082290442955024,139,1435,ribonucleotide binding,MF,ULK2;SIK1;SLFN5;ACTA2;OAS2;DDX60;HSPA2;EGFR;FAM20C;SYN1;IFI44L;KIF26B;EPHB2;MAP3K14;GLUD1;DGKQ;BRSK1;CUL9;CAMKK1;MVD;RAB43;RAB40B;NOS1;PRKACB;CMPK2;PIK3C2G;LIG1;CDK18;SPEG;MLH3;NMRK1;DDX59;OBSCN;MYH11;ACTR1B;RHOBTB2;RAPGEF3;OAS1;GAL3ST4;KIF26A;ALPK1;DNAH1;NEK9;TRPV4;DHX32;CLCN6;PSKH1;MINK1;ULK1;THRAP3;SMARCA1;NAIP;NEK8;MAP2K5;INSR;CHD3;CDK14;TTN;SLFNL1;SEPT6;DHX58;NLRX1;ETNK2;MAP2K2;OPLAH;PDK1;PTK6;PDIK1L;MAP3K12;WRN;SEPT5;DNM1;MCM9;ATRX;MAPK10;ERCC6;HLCS;PAK6;PFKFB2;MX2;ACACB;NLRP1;TK2;GLUL;SRR;MAP3K6;RIMKLB;MYO3B;WNK1;ARL11;PDE2A;STK16;RET;PIK3C3;DALRD3;FGFR4;MYO9A;RPS6KA5;NADK;BBS10;HLTF;STK19;RASL10B;LMTK3;ACVR1B;TSSK1B;WEE1;PTK7;DQX1;ACSL1;MARK4;TEP1;ERN1;RAD50;TKFC;PNPO;PEX1;SCYL3;SCG5;KIF7;CHD6;ACSS2;ERBB2;ABCA2;PRKACA;SUCLG2;UCKL1;DDX12P;IP6K2;RIPK3;PI4K2B;LONP2;HARS2;CIT;MSH5;CLCN7;TTLL1;ABCA11P;GCLC
2973,GO:0006515,0.93104821055539,0.264233068485286,1,24,protein quality control for misfolded or incompletely synthesized proteins,BP,LONP2
7130,GO:0030970,0.931286691571367,0.26314443828271,1,25,retrograde protein transport, ER to cytosol,BP,TMEM129
18409,GO:1903513,0.931286691571367,0.26314443828271,1,25,endoplasmic reticulum to cytosol transport,BP,TMEM129
18213,GO:1903039,0.931325259259294,0.126463198110178,8,119,positive regulation of leukocyte cell-cell adhesion,BP,MAP3K14;PIK3R1;GLI2;TNFRSF14;GLI3;DOCK8;EFNB3;CCDC88B
19697,GO:2000060,0.931346987805105,0.144099727990076,5,81,positive regulation of ubiquitin-dependent protein catabolic process,BP,MAGEF1;MDM2;FBXW7;SMURF1;GCLC
3047,GO:0006605,0.931472924077176,0.0986879756897218,26,366,protein targeting,BP,SREBF1;ZDHHC1;MICALL1;VPS11;HPS4;ANK3;TRAK1;PEX10;MICALL2;PEX7;OSCP1;ZDHHC12;CDK5R1;WASH3P;FBXW7;DMTN;GOLGA7B;PEX1;ERBB2;SYNGR1;ZDHHC24;AKAP6;AIP;LONP2;SMURF1;PEMT
3300,GO:0006998,0.931670543073013,0.143583643084448,5,80,nuclear envelope organization,BP,NEK9;SUN1;REEP4;LMNA;SYNE2
13755,GO:0060359,0.931704959781157,0.153853149632734,4,67,response to ammonium ion,BP,MDM2;HOMER2;CDK5R1;SRR
565,GO:0001707,0.931751470537315,0.196964342933936,2,38,mesoderm formation,BP,WNT3;ITGA2
1553,GO:0003954,0.931789278414036,0.25787105391783,1,40,NADH dehydrogenase activity,MF,NDUFV3
12923,GO:0051302,0.931897234009751,0.12563446150286,8,116,regulation of cell division,BP,OR2A4;RAB11FIP4;MDK;VEGFB;TXNIP;RAB11FIP3;PIK3C3;CIT
7333,GO:0031365,0.93205040041782,0.261507332396461,1,24,N-terminal protein amino acid modification,BP,KAT2B
15310,GO:0071549,0.932078908707711,0.260989286997528,1,25,cellular response to dexamethasone stimulus,BP,EGFR
3231,GO:0006885,0.932250528652891,0.152699592946994,4,69,regulation of pH,BP,TCIRG1;ATP6V0A2;CA2;DMXL2
1336,GO:0003197,0.932410793854968,0.26100281017304,1,23,endocardial cushion development,BP,MDM2
1251,GO:0003007,0.933153918924328,0.112397995476082,12,149,heart morphogenesis,BP,PKD2;ZFPM1;GAA;MDM2;PDCD4;INSR;TTN;NPHP3;TEAD2;BBS5;PLXND1;TH
14771,GO:0070507,0.933191213357744,0.114389526903125,11,148,regulation of microtubule cytoskeleton organization,BP,DIXDC1;RGS2;TRPV4;CDK5R1;CHMP1B;APC2;FBXW5;KAT2B;CEP250;MAP1A;EML2
15357,GO:0071622,0.933281410718125,0.256577666163928,1,28,regulation of granulocyte chemotaxis,BP,TRPV4
8110,GO:0032806,0.933443753240005,0.257253087770489,1,25,carboxy-terminal domain protein kinase complex,CC,ERCC5
12786,GO:0051100,0.933766426145759,0.122483722686944,8,122,negative regulation of binding,BP,GPSM1;ZFPM1;NFATC4;PER2;HFE;IFI16;ZFP90;CTNNBIP1
8251,GO:0033043,0.933776593792868,0.0817454886152811,93,1012,regulation of organelle organization,BP,SREBF1;ESPN;DIXDC1;SFRP1;OBSL1;MTHFR;EPS8L2;PIK3R1;EVI5L;KDM3A;CUL9;CUL7;ASAP3;OR2A4;NOS1;TBC1D8;PLXNB1;VPS11;TNFSF10;RHOBTB2;RAPGEF3;CTSV;RGS2;ARPIN;HPS4;SPTB;TRPV4;TOM1L2;SLX1A;SLX1B;ARHGEF19;WIPF1;PHF2;ULK1;FHOD3;LRSAM1;JARID2;INSR;CELSR1;GSN;BAIAP2;PLEKHH2;TRIOBP;RMI2;RTF1;RICTOR;MICALL2;MAP2K2;SQSTM1;KDM4C;WHAMMP3;PLA2G6;OSCP1;CDK5R1;ATRX;SHANK3;WASH3P;IFT140;XRN1;FBXW7;CHMP1B;APC2;ARAP1;TBC1D17;FBXW5;CAPG;LRP1;SYNPO2;ZMYND8;DDHD2;FBXO4;RPS6KA5;BST2;TBC1D16;DMTN;STAT2;SGSM2;ALMS1;PHF1;TFDP2;LMNA;KAT2B;CEP250;RAD50;PHPT1;SSH3;SYNE2;PARN;CIT;MAP1A;SMURF1;EML2;PEMT
11409,GO:0045839,0.933844883790919,0.191567997664845,2,42,negative regulation of mitotic nuclear division,BP,TOM1L2;ATRX
13800,GO:0060416,0.934153970253647,0.256210813517341,1,23,response to growth hormone,BP,PIK3R1
17287,GO:0140104,0.93415524069836,0.25451978431021,1,27,molecular carrier activity,MF,TMCO6
2824,GO:0006289,0.934378491593594,0.12576876086421,7,113,nucleotide-excision repair,BP,DDB2;XPC;LIG1;POLD4;ERCC6;ERCC5;UVSSA
5066,GO:0015291,0.934466023883599,0.118010720684371,9,125,secondary active transmembrane transporter activity,MF,SLC16A5;SLC24A1;SLC13A5;CLCN6;SLC12A7;SLC38A4;SLC37A2;SLC36A4;CLCN7
7459,GO:0031625,0.934561055550576,0.0983068458439333,21,270,ubiquitin protein ligase binding,MF,EGFR;CUL9;ISG15;CUL7;MC1R;PRKACB;BTBD2;MDM2;TNFRSF14;TRIOBP;SQSTM1;UBOX5;ARRDC1;TXNIP;FBXW7;ABTB1;HLTF;ACVR1B;TRAF5;PRKACA;PER3
8068,GO:0032757,0.934627025050265,0.253588082706034,1,26,positive regulation of interleukin-8 production,BP,F2R
13466,GO:0055025,0.934784847985893,0.253988797784312,1,24,positive regulation of cardiac muscle tissue development,BP,AKAP6
10095,GO:0042626,0.934787898912584,0.148180746998458,4,66,ATPase activity, coupled to transmembrane movement of substances,MF,TCIRG1;ATP6V0A2;ABCA2;ABCA11P
4637,GO:0010762,0.934918154034648,0.253619155577838,1,24,regulation of fibroblast migration,BP,DMTN
366,GO:0000988,0.934936986582687,0.0870343032747612,45,521,transcription factor activity, protein binding,MF,MNT;TRIM22;POU3F1;HR;TFCP2L1;CITED4;CRY2;CRY1;MAML3;NFATC4;HSF4;KLF7;SOX12;PER2;PHF2;WWTR1;THRAP3;BHLHE40;MXD4;RTF1;TCF4;RCOR2;LPIN3;ING4;LMO2;MXI1;THRA;NAB2;ZMYND8;CALCOCO1;TEAD2;MYSM1;BTG1;VDR;MAMSTR;TFDP2;GLMP;KAT2B;TRERF1;RORA;PPARG;RIPK3;AIP;SCAND1;PER3
5560,GO:0016575,0.935021364948526,0.137708871103457,5,79,histone deacetylation,BP,SREBF1;PER2;CHD3;HMG20B;HDAC11
4490,GO:0010518,0.93512836557128,0.253035666538915,1,24,positive regulation of phospholipase activity,BP,EGFR
12151,GO:0048286,0.935147780382182,0.253456644983899,1,23,lung alveolus development,BP,FOXP2
11236,GO:0045471,0.935371934868966,0.146809029179451,4,70,response to ethanol,BP,TP53INP1;GSN;TH;PEMT
975,GO:0002429,0.935582738419482,0.100799269034667,17,228,immune response-activating cell surface receptor signaling pathway,BP,MUC19;INPP5D;PIK3R1;RBCK1;VAV3;PRKACB;WIPF1;BAIAP2;PLA2G6;TNFRSF21;ELF1;ERMAP;PIK3R2;RPS6KA5;CACNB3;PHPT1;PRKACA
13485,GO:0055076,0.935988685278496,0.12851704275944,6,100,transition metal ion homeostasis,BP,CYBRD1;NEO1;MT1X;BMP6;ATP6V0A2;HFE
10123,GO:0042698,0.936073650484164,0.187069039074657,2,39,ovulation cycle,BP,EGFR;SLIT3
16119,GO:0090150,0.936340021235023,0.0994531990167208,17,265,establishment of protein localization to membrane,BP,EGFR;ZDHHC1;VAMP3;REEP2;NSG1;MICALL1;ANK3;VAMP2;BBS2;ZDHHC12;CDK5R1;BBS1;DMTN;TFDP2;GOLGA7B;ERBB2;ZDHHC24
7695,GO:0032182,0.936386167696042,0.13512278740381,5,82,ubiquitin-like protein binding,MF,TNFAIP3;RBCK1;SQSTM1;SHARPIN;MARK4
7746,GO:0032270,0.9365420408885,0.0781041503159365,98,1080,positive regulation of cellular protein metabolic process,BP,TNFAIP3;GPNMB;SREBF1;APOE;HSPA2;EGFR;CIRBP;PKD2;CAPRIN2;RBM3;EPHB2;MAP3K14;DGKQ;CAMKK1;CSPG4;KITLG;IMPACT;NOS1;PRKACB;MAGEF1;VPS11;MDM2;TNFSF10;RAPGEF3;F2R;TRPV4;FLOT1;ADORA2B;MAPK8IP3;PIDD1;UNC119;C5;MINK1;ITGA2;MAP2K5;IGFBP4;JARID2;NUPR1;INSR;GSN;DDT;ETAA1;PILRB;SLC27A1;RTF1;RICTOR;BMP6;MAP2K2;SQSTM1;PTK6;FZD7;PLA2G6;GDF15;CTF1;MAP3K12;IFI27;CDK5R1;MAPK10;HFE;ERCC6;SHC2;EDA2R;SPRY2;FBXW7;CDK5RAP3;PAK6;NLRP1;NAB2;LRP1;MAP3K6;WNK1;RET;DAB2IP;RWDD3;FBXO4;IFI16;FGFR4;AREG;RPS6KA5;PHF1;ACVR1B;DLG4;TNFRSF25;ACSL1;IL11;ERN1;RAD50;ERBB2;AKAP6;ATG14;PPARG;PRKACA;ACKR3;RIPK3;SNX33;SMURF1;NPNT;GCLC
18195,GO:1903008,0.936735956328415,0.127380331482322,6,96,organelle disassembly,BP,SREBF1;SPATA18;SQSTM1;FBXW7;ATG14;SMURF1
3656,GO:0008139,0.936786338504338,0.24887966800873,1,23,nuclear localization sequence binding,MF,NPAP1
14148,GO:0061053,0.936807510692292,0.159487817211019,3,51,somite development,BP,SFRP1;NRARP;PALB2
12113,GO:0048207,0.936932321257519,0.158708163841172,3,56,vesicle targeting, rough ER to cis-Golgi,BP,COL7A1;ANKRD28;AREG
12114,GO:0048208,0.936932321257519,0.158708163841172,3,56,COPII vesicle coating,BP,COL7A1;ANKRD28;AREG
10557,GO:0043534,0.937080037491077,0.133983318941084,5,80,blood vessel endothelial cell migration,BP,APOE;MAP2K5;MMRN2;SRPX2;PPARG
2188,GO:0005048,0.937176036543519,0.18438408175121,2,40,signal sequence binding,MF,PEX7;NPAP1
17260,GO:0140030,0.937255939616901,0.117077811614784,8,114,modification-dependent protein binding,MF,TNFAIP3;PHF2;SQSTM1;SHARPIN;ATRX;ING4;ZMYND8;PHF1
1870,GO:0004540,0.937302811075385,0.133298556729456,5,86,ribonuclease activity,MF,XRN1;LACTB2;ENDOU;ERN1;PARN
6627,GO:0022904,0.937315093004684,0.142025604941928,4,94,respiratory electron transport chain,BP,D2HGDH;SDHA;ETFB;NDUFV3
5442,GO:0016311,0.937374695529778,0.08899702608822,30,359,dephosphorylation,BP,NT5E;INPP5D;PTPRS;ELFN2;CRY2;THNSL2;PPP2R2C;PHACTR3;G6PC3;ITGA2;CEP192;LPIN3;CDK5RAP3;PFKFB2;TNS2;ACP5;WNK1;PPP1R2;PPP1R35;LMTK3;PPP2R3B;IMPA2;PHPT1;PTPN3;SPOCD1;PPM1M;AKAP6;SSH3;RIPK3;NPNT
19961,GO:2000573,0.937396444950654,0.157765193062048,3,56,positive regulation of DNA biosynthetic process,BP,FBXO4;FGFR4;PARN
10453,GO:0043330,0.93745745034875,0.245692280091636,1,26,response to exogenous dsRNA,BP,FLOT1
4825,GO:0014032,0.937520862661958,0.157709328499926,3,54,neural crest cell development,BP,KITLG;SEMA4G;RET
15106,GO:0071219,0.937583195171811,0.12057966689867,7,109,cellular response to molecule of bacterial origin,BP,TNFAIP3;CMPK2;PDCD4;ADAMTS13;BMP6;DAB2IP;VDR
11450,GO:0045921,0.937790526680722,0.156963179000176,3,56,positive regulation of exocytosis,BP,ADORA2B;PLA2G6;SYT7
14857,GO:0070665,0.937920356488655,0.14182600096561,4,73,positive regulation of leukocyte proliferation,BP,VAV3;KITLG;CCDC88B;IRS2
9934,GO:0042306,0.937933848988076,0.182485301397096,2,41,regulation of protein import into nucleus,BP,GLI3;PDE2A
1249,GO:0003002,0.938287320893495,0.0995502908727102,15,196,regionalization,BP,SFRP1;WNT3;PRKACB;HOXA3;SCMH1;CYP26B1;GLI2;GLI3;CELSR1;PGAP1;IFT140;PCSK6;NRARP;PALB2;CTNNBIP1
3351,GO:0007080,0.938409906440737,0.181081449052235,2,43,mitotic metaphase plate congression,BP,CENPC;CHMP1B
14747,GO:0070461,0.93841092788179,0.243001857164176,1,26,SAGA-type complex,CC,KAT2B
12628,GO:0050852,0.938721369933281,0.110952934610026,9,141,T cell receptor signaling pathway,BP,INPP5D;PIK3R1;RBCK1;TNFRSF21;ELF1;ERMAP;PIK3R2;CACNB3;PHPT1
256,GO:0000723,0.938744192695965,0.108088152699996,10,153,telomere maintenance,BP,SLX1A;SLX1B;POLD4;WRN;ATRX;XRN1;FBXO4;TEP1;RAD50;PARN
12776,GO:0051090,0.938784767603873,0.0903460057748537,24,304,regulation of DNA binding transcription factor activity,BP,TNFAIP3;SIK1;PKD2;TRIM22;RBCK1;CRTC1;PIDD1;BHLHE40;MAP2K5;NLRX1;MAPK10;TRIM38;EDA2R;CDK5RAP3;MXI1;THRA;DAB2IP;RWDD3;RPS6KA5;TRAF5;PPARG;UFL1;RIPK3;CTNNBIP1
8824,GO:0034620,0.938811249325405,0.110989279609614,9,132,cellular response to unfolded protein,BP,HSPA2;PIK3R1;CUL7;TM7SF3;CREBRF;CDK5RAP3;DAB2IP;LMNA;ERN1
11260,GO:0045582,0.938836616634765,0.180258394067396,2,42,positive regulation of T cell differentiation,BP,GLI2;GLI3
1159,GO:0002768,0.939044888819307,0.093849697671553,19,251,immune response-regulating cell surface receptor signaling pathway,BP,MUC19;INPP5D;PIK3R1;RBCK1;VAV3;PRKACB;FCGRT;WIPF1;BAIAP2;PLA2G6;TNFRSF21;MAPK10;ELF1;ERMAP;PIK3R2;RPS6KA5;CACNB3;PHPT1;PRKACA
3348,GO:0007076,0.939120689448321,0.247286046151684,1,16,mitotic chromosome condensation,BP,TTN
7560,GO:0031929,0.939158453727459,0.123285956943159,6,94,TOR signaling,BP,EPM2A;DGKQ;SESN3;RICTOR;SESN1;C12ORF66
4514,GO:0010569,0.939282416457432,0.240923201496997,1,25,regulation of double-strand break repair via homologous recombination,BP,MAGEF1
899,GO:0002279,0.939511781863839,0.239875885722967,1,26,mast cell activation involved in immune response,BP,ADORA2B
10432,GO:0043303,0.939511781863839,0.239875885722967,1,26,mast cell degranulation,BP,ADORA2B
13262,GO:0051972,0.939583615851254,0.178543375731792,2,42,regulation of telomerase activity,BP,PPARG;PARN
16297,GO:0090502,0.93961252098077,0.15289114257791,3,60,RNA phosphodiester bond hydrolysis, endonucleolytic,BP,LACTB2;ENDOU;ERN1
4480,GO:0010501,0.939910957786589,0.177950177937965,2,41,RNA secondary structure unwinding,BP,DDX59;AGO4
2498,GO:0005747,0.940079866836267,0.234569268806073,1,42,mitochondrial respiratory chain complex I,CC,NDUFV3
7127,GO:0030964,0.940079866836267,0.234569268806073,1,42,NADH dehydrogenase complex,CC,NDUFV3
11166,GO:0045271,0.940079866836267,0.234569268806073,1,42,respiratory chain complex I,CC,NDUFV3
14673,GO:0070316,0.940166632978551,0.177360603466817,2,41,regulation of G0 to G1 transition,BP,DAB2IP;TFDP2
15767,GO:0072401,0.940579715777855,0.136832495777271,4,72,signal transduction involved in DNA integrity checkpoint,BP,MDM2;PCBP4;PIDD1;TFDP2
15771,GO:0072422,0.940579715777855,0.136832495777271,4,72,signal transduction involved in DNA damage checkpoint,BP,MDM2;PCBP4;PIDD1;TFDP2
17803,GO:1901983,0.940811531324256,0.150682097263271,3,57,regulation of protein acetylation,BP,NOS1;RAPGEF3;RPS6KA5
7704,GO:0032201,0.940908972933495,0.235516006859294,1,27,telomere maintenance via semi-conservative replication,BP,POLD4
5543,GO:0016538,0.941047601822149,0.234783062150673,1,28,cyclin-dependent protein serine/threonine kinase regulator activity,MF,KAT2B
2879,GO:0006379,0.941217242787014,0.234629568075214,1,27,mRNA cleavage,BP,ERN1
10515,GO:0043467,0.941438334433035,0.119370962872528,6,93,regulation of generation of precursor metabolites and energy,BP,TRPV4;INSR;MLXIPL;PFKFB2;EPM2AIP1;IRS2
14490,GO:0065004,0.941516130638597,0.0974110970432537,13,213,protein-DNA complex assembly,BP,DDB2;XPC;H1F0;SOX12;H1FX;CENPC;TCF4;ATRX;THRA;TSPYL4;CENPH;ERCC5;NAP1L5
7948,GO:0032555,0.941614196162946,0.0701676949635488,137,1424,purine ribonucleotide binding,MF,ULK2;SIK1;SLFN5;ACTA2;OAS2;DDX60;HSPA2;EGFR;FAM20C;SYN1;IFI44L;KIF26B;EPHB2;MAP3K14;GLUD1;DGKQ;BRSK1;CUL9;CAMKK1;MVD;RAB43;RAB40B;PRKACB;CMPK2;PIK3C2G;LIG1;CDK18;SPEG;MLH3;NMRK1;DDX59;OBSCN;MYH11;ACTR1B;RHOBTB2;RAPGEF3;OAS1;GAL3ST4;KIF26A;ALPK1;DNAH1;NEK9;TRPV4;DHX32;CLCN6;PSKH1;MINK1;ULK1;THRAP3;SMARCA1;NAIP;NEK8;MAP2K5;INSR;CHD3;CDK14;TTN;SLFNL1;SEPT6;DHX58;NLRX1;ETNK2;MAP2K2;OPLAH;PDK1;PTK6;PDIK1L;MAP3K12;WRN;SEPT5;DNM1;MCM9;ATRX;MAPK10;ERCC6;HLCS;PAK6;PFKFB2;MX2;ACACB;NLRP1;TK2;GLUL;SRR;MAP3K6;RIMKLB;MYO3B;WNK1;ARL11;PDE2A;STK16;RET;PIK3C3;DALRD3;FGFR4;MYO9A;RPS6KA5;NADK;BBS10;HLTF;STK19;RASL10B;LMTK3;ACVR1B;TSSK1B;WEE1;PTK7;DQX1;ACSL1;MARK4;TEP1;ERN1;RAD50;TKFC;PEX1;SCYL3;SCG5;KIF7;CHD6;ACSS2;ERBB2;ABCA2;PRKACA;SUCLG2;UCKL1;DDX12P;IP6K2;RIPK3;PI4K2B;LONP2;HARS2;CIT;MSH5;CLCN7;TTLL1;ABCA11P;GCLC
11075,GO:0045089,0.941687687698026,0.091079486704794,18,241,positive regulation of innate immune response,BP,TNFAIP3;MUC19;DDX60;PTPRS;PRKACB;FLOT1;DHX58;NLRX1;CYBA;CTSB;DAB2IP;PIK3C3;IFI16;RPS6KA5;RSAD2;TKFC;SMPDL3B;PRKACA
3449,GO:0007260,0.941708114326925,0.173338193155426,2,44,tyrosine phosphorylation of STAT protein,BP,PTK6;CTF1
20058,GO:2000736,0.941971317109766,0.117637403831268,6,121,regulation of stem cell differentiation,BP,KDM3A;ZFP36L2;LTBP3;KDM4C;LMO2;TEAD2
12764,GO:0051059,0.942008806782858,0.232345448558371,1,27,NF-kappaB binding,MF,CDK5RAP3
16132,GO:0090169,0.942213126836474,0.232502350681702,1,25,regulation of spindle assembly,BP,CHMP1B
6198,GO:0019692,0.942242887234485,0.230738422616389,1,30,deoxyribose phosphate metabolic process,BP,CMPK2
10715,GO:0044085,0.942875720263352,0.0663813737522239,230,2477,cellular component biogenesis,BP,TNFAIP3;ULK2;DDB2;TP53INP1;APOE;HSPA2;ESPN;CIRBP;FLNC;PKD2;XPC;ASH2L;TRIM22;ALDH1A3;SRSF5;SLITRK6;SFRP1;OBSL1;KCTD11;EPS8L2;EPHB2;TNS1;GPX3;DGKQ;PIK3R1;EVI5L;VAV3;TENM4;UNC119B;SDK2;VAMP3;ASAP3;C1QTNF6;IMPACT;NSG1;ITGB5;GJD3;PRKACB;HMGCL;PSMG4;H1F0;HSF4;CNTRL;VPS11;COL7A1;KCNC4;ITPR3;MDM2;CRTC1;KCTD18;MLH3;TYSND1;OBSCN;GOLGA8A;HGSNAT;MYH11;PARVB;TNXB;RHOBTB2;RAPGEF3;NLGN4Y;FLRT3;NUDCD3;KCTD15;RGS2;ARPIN;ADGRB2;HPS4;SPTB;DNAH1;TUBGCP5;CLTCL1;TRPV4;FLOT1;NLGN2;ANK3;GOLGA8B;SOX12;SLX1A;SLX1B;ATG16L2;SPG11;UNC119;ZNF658;WIPF1;ADGRL1;NINL;AMIGO2;WWTR1;ARHGEF4;ITGA2;FAM110C;ULK1;FHOD3;TPGS1;LRSAM1;VAMP2;NAIP;GAS8;ITGA6;BSN;MMP1;INSR;GSN;BAIAP2;TTN;PLXNB3;CEP126;AHNAK2;TRIOBP;NSUN5P2;SEPT6;PILRB;RICTOR;TCIRG1;MICALL2;SQSTM1;CEP192;LOXL1;EPB41L3;SHARPIN;HYAL1;H1FX;ARRDC1;WHAMMP3;CENPC;PLA2G6;BBS2;THSD4;TCF4;ATP6V0A2;COL6A1;PEX11B;NPHP3;WRN;PODXL;SEPT5;DNM1;IQCB1;CDK5R1;ATRX;REC8;SHANK3;HFE;CYBA;AGO4;KRT14;WASH3P;IFT140;TARBP1;ANKRD28;DZIP1L;CHMP1B;THRA;ARAP1;GOLGA8N;MX2;IKZF4;SLC2A1;ACACB;NLRP1;GLUL;SRR;CAPG;TSPYL4;LRRN3;NPHP4;CCDC136;SYNPO2;CENPH;RFX2;KCNG1;BBS1;ATXN10;ZMYND8;PRX;DAB2IP;TEAD2;RNF213;PIK3C3;SYT7;ERCC5;BBS5;EXOC2;SETD4;AREG;MYO9A;DLG5;TNRC18;PLXND1;BBS10;TMEM80;NDUFV3;DMTN;ALMS1;TMEM231;PMP22;DLG4;CCDC113;MPI;TCF7;SHANK2;CLSTN3;KAT2B;MARK4;DMXL2;CEP250;DHRS4;EFEMP2;CBR4;TTC19;NAP1L5;SRPX2;CD9;RANBP9;ATG14;MPP7;SSH3;PRKACA;SYNE2;PARD6G;RIPK3;NFASC;KCNS3;MSH5;PTBP2;SMURF1;TTLL1;EML2;CTNNBIP1
3942,GO:0008637,0.942913891345215,0.11642964507751,6,104,apoptotic mitochondrial changes,BP,IFI6;TNFSF10;PLA2G6;TFDP2;LMNA;GCLC
4530,GO:0010604,0.942953095930848,0.066632955628116,211,2211,positive regulation of macromolecule metabolic process,BP,TNFAIP3;GPNMB;TP53INP1;SREBF1;ACTA2;APOE;HSPA2;EGFR;CIRBP;PKD2;CAPRIN2;RBM3;ASH2L;SRSF5;SFRP1;SEC14L2;EPHB2;MAP3K14;DGKQ;PIK3R1;KDM3A;POU3F1;WNT3;CAMKK1;CSPG4;RGMA;ZFPM1;KITLG;VAMP3;CITED4;IRF2BPL;MC1R;STAT1;IMPACT;CAMK2N1;NSG1;NOS1;PRKACB;MAML3;KLF13;MAGEF1;NFATC4;RNF187;CYP26B1;HSF4;VPS11;EAPP;MDM2;CRTC1;NDN;TNFSF10;RAPGEF3;F2R;ZFP36L2;TRPV4;FLOT1;GLI2;ADORA2B;ANK3;KLF7;LAMP3;TCEA2;MAPK8IP3;ZNF76;SOX12;PIDD1;SLX1A;SLX1B;GJC2;UNC119;C5;MINK1;PHF2;ABHD14B;WWTR1;ITGA2;GLI3;THRAP3;SMARCA1;MAP2K5;ITGA6;ZNF318;IGFBP4;JARID2;NUPR1;INSR;GSN;TTN;DDT;ZNF287;ETAA1;PILRB;ENDOG;SLC27A1;RTF1;MDK;RICTOR;BMP6;MAP2K2;SQSTM1;PTK6;FZD7;ETV5;DLX3;HEXB;KDM4C;METTL23;PLA2G6;CST3;GDF15;CTF1;TCF4;PLAG1;MAP3K12;WRN;IFI27;LPIN3;CDK5R1;ATRX;MAPK10;HFE;ADIRF;ERCC6;SHC2;EDA2R;SPRY2;MEF2D;CREBRF;MLXIPL;FBXW7;CDK5RAP3;LMO2;NFIX;PAK6;CARF;THRA;APC2;ARAP1;RAI1;ELF1;IKZF4;NLRP1;DBP;NAB2;EPM2AIP1;LRP1;PEG3;RFX2;MAP3K6;SALL2;WNK1;MAF;STK16;RET;DAB2IP;CASZ1;RWDD3;CALCOCO1;TEAD2;MYSM1;FBXO4;IFI16;FGFR4;PIK3R2;TEF;AREG;RPS6KA5;VDR;MAMSTR;TNRC6C;PLXND1;SIX5;HLTF;PHF1;ZNF292;TFDP2;SNX1;ACVR1B;DLG4;TNNI2;NAT14;TNFRSF25;ZFP36L1;GLMP;ACSL1;IL11;KAT2B;IRS2;ERN1;IVNS1ABP;RAD50;ANGEL2;TRERF1;TNFSF12;STAT6;CHD6;ERBB2;AKAP6;ATG14;RORA;PPARG;PRKACA;ACKR3;PARN;RIPK3;SNX33;ZFP90;SMURF1;NPNT;PEMT;GCLC
15069,GO:0071103,0.943108988908847,0.0899618987268779,17,245,DNA conformation change,BP,DDB2;XPC;H1F0;SMARCA1;CHD3;TTN;H1FX;CENPC;WRN;ATRX;TSPYL4;CENPH;TNRC18;TOP3B;RAD50;NAP1L5;DDX12P
8895,GO:0034728,0.943300727288906,0.11034124846582,7,139,nucleosome organization,BP,H1F0;H1FX;CENPC;ATRX;TSPYL4;CENPH;NAP1L5
12982,GO:0051427,0.943418573597942,0.100951174545201,10,143,hormone receptor binding,MF,PTHLH;KDM3A;STAT1;CRY1;THRAP3;KDM4C;VDR;UCN2;PPARG;FOXP2
5800,GO:0017056,0.9435332351481,0.22865743336745,1,25,structural constituent of nuclear pore,MF,NPAP1
3234,GO:0006888,0.943590785275733,0.0963552736754319,12,170,ER to Golgi vesicle-mediated transport,BP,LMF1;COL7A1;SPTB;ANK3;PGAP1;WHAMMP3;ANKRD28;DDHD2;AREG;MPPE1;GOLGB1;COG1
13199,GO:0051881,0.943605511183567,0.168525909088264,2,47,regulation of mitochondrial membrane potential,BP,IFI6;GCLC
10815,GO:0044322,0.943748128265223,0.227642184663784,1,26,endoplasmic reticulum quality control compartment,CC,MAN1B1
7432,GO:0031570,0.943823944525755,0.0979905831145555,11,157,DNA integrity checkpoint,BP,XPC;MAP3K14;BRSK1;CRY1;MDM2;PCBP4;PIDD1;ETAA1;CDK5RAP3;FBXO4;TFDP2
18781,GO:1904353,0.943869198373759,0.227673632491912,1,25,regulation of telomere capping,BP,RAD50
7062,GO:0030857,0.943932839008442,0.227487029676429,1,25,negative regulation of epithelial cell differentiation,BP,STAT1
14607,GO:0070198,0.943953364290375,0.227040997335212,1,26,protein localization to chromosome, telomeric region,BP,ATRX
8417,GO:0033522,0.944142016341836,0.226873144326723,1,25,histone H2A ubiquitination,BP,DDB2
1116,GO:0002705,0.944149596112369,0.143669786837348,3,58,positive regulation of leukocyte mediated immunity,BP,ADORA2B;RSAD2;STAT6
12172,GO:0048332,0.944759869482732,0.166806210262696,2,40,mesoderm morphogenesis,BP,WNT3;ITGA2
12771,GO:0051085,0.94480396161987,0.224186038518587,1,27,chaperone cofactor-dependent protein refolding,BP,HSPA2
1123,GO:0002712,0.945033631300584,0.223863225319289,1,26,regulation of B cell mediated immunity,BP,STAT6
1218,GO:0002889,0.945033631300584,0.223863225319289,1,26,regulation of immunoglobulin mediated immune response,BP,STAT6
3029,GO:0006576,0.945065148120171,0.22308792520069,1,28,cellular biogenic amine metabolic process,BP,ALDH7A1
14758,GO:0070482,0.945253841025186,0.0834808764134836,21,280,response to oxygen levels,BP,POSTN;SFRP1;MTHFR;NOS1;NDRG1;MDM2;ITGA2;ENDOG;PDK1;VEGFB;CST3;ATP6V0A2;CYBA;KCNMA1;RWDD3;ZFP36L1;LMNA;APOLD1;TH;RORA;PPARG
19779,GO:2000242,0.945314515368212,0.222351876172817,1,28,negative regulation of reproductive process,BP,PRKACB
11393,GO:0045814,0.945495874295503,0.111486741554254,6,121,negative regulation of gene expression, epigenetic,BP,PHF2;JARID2;H2AFJ;TNRC18;PHF1;DYDC1
15765,GO:0072395,0.94553750423319,0.127225622558582,4,73,signal transduction involved in cell cycle checkpoint,BP,MDM2;PCBP4;PIDD1;TFDP2
2869,GO:0006362,0.945561128353941,0.221318903710639,1,29,transcription elongation from RNA polymerase I promoter,BP,ERCC6
12289,GO:0048644,0.945581806675042,0.14193805795868,3,46,muscle organ morphogenesis,BP,ZFPM1;TTN;ADARB1
17488,GO:1900739,0.945959741046007,0.220441716265502,1,28,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,BP,TFDP2
17489,GO:1900740,0.945959741046007,0.220441716265502,1,28,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,BP,TFDP2
12853,GO:0051196,0.946049078454621,0.12652304050393,4,68,regulation of coenzyme metabolic process,BP,INSR;PDK1;MLXIPL;PFKFB2
3349,GO:0007077,0.946129200975414,0.163246875118017,2,42,mitotic nuclear envelope disassembly,BP,NEK9;LMNA
20236,GO:2001222,0.946237606008755,0.221090253015707,1,24,regulation of neuron migration,BP,DAB2IP
16143,GO:0090184,0.946400569363924,0.219457630055202,1,27,positive regulation of kidney development,BP,RET
11029,GO:0045023,0.946443553387789,0.162499582742301,2,42,G0 to G1 transition,BP,DAB2IP;TFDP2
991,GO:0002448,0.946494262522554,0.219178581779006,1,27,mast cell mediated immunity,BP,ADORA2B
14786,GO:0070536,0.946635436456006,0.219489519355806,1,25,protein K63-linked deubiquitination,BP,TNFAIP3
7150,GO:0031018,0.946841123665977,0.218494844577615,1,26,endocrine pancreas development,BP,BMP6
19799,GO:2000278,0.947144689816984,0.115489119878448,5,84,regulation of DNA biosynthetic process,BP,XRN1;FBXO4;FGFR4;PPARG;PARN
2678,GO:0006040,0.947204805189501,0.217056594556558,1,27,amino sugar metabolic process,BP,UAP1L1
7313,GO:0031330,0.947714797024773,0.0884187848970387,13,181,negative regulation of cellular catabolic process,BP,CIRBP;LAMP3;THRAP3;LZTS1;CST3;HFE;CDK5RAP3;ACACB;DAB2IP;PANO1;ANGEL2;PTPN3;PARN
1215,GO:0002886,0.947730579964155,0.215479791101028,1,27,regulation of myeloid leukocyte mediated immunity,BP,ADORA2B
2057,GO:0004812,0.947847199864622,0.158866825310078,2,44,aminoacyl-tRNA ligase activity,MF,DALRD3;HARS2
5727,GO:0016875,0.947847199864622,0.158866825310078,2,44,ligase activity, forming carbon-oxygen bonds,MF,DALRD3;HARS2
4824,GO:0014031,0.947966845640031,0.135797531905248,3,56,mesenchymal cell development,BP,KITLG;SEMA4G;RET
12798,GO:0051123,0.948046573056394,0.214206673980542,1,28,RNA polymerase II transcriptional preinitiation complex assembly,BP,THRA
8978,GO:0035097,0.94815462997954,0.122278722751032,4,70,histone methyltransferase complex,CC,ASH2L;JARID2;PHF1;DYDC1
4506,GO:0010559,0.948180833756217,0.214124955132161,1,27,regulation of glycoprotein biosynthetic process,BP,NECAB3
3624,GO:0008080,0.948367129873884,0.121748068622943,4,72,N-acetyltransferase activity,MF,HGSNAT;NAT6;NAT14;KAT2B
11753,GO:0046627,0.948683166409622,0.212608440288873,1,27,negative regulation of insulin receptor signaling pathway,BP,GPR21
8052,GO:0032729,0.948802646794533,0.211925661623949,1,28,positive regulation of interferon-gamma production,BP,ZFPM1
10429,GO:0043300,0.948829755008946,0.212164901825124,1,27,regulation of leukocyte degranulation,BP,ADORA2B
9935,GO:0042307,0.949157872799432,0.211516696316978,1,26,positive regulation of protein import into nucleus,BP,GLI3
4416,GO:0010212,0.949187454652108,0.0942437675600396,9,135,response to ionizing radiation,BP,SFRP1;MDM2;WRN;NET1;CYBA;ERCC6;KRT14;FBXO4;IFI16
12284,GO:0048639,0.949251803206937,0.100951856416796,7,105,positive regulation of developmental growth,BP,WNT3;INSR;BBS2;ACACB;GPR21;AKAP6;SMURF1
5465,GO:0016363,0.949257572958704,0.10552354484788,6,95,nuclear matrix,CC,DGKQ;PHACTR3;HLCS;ATXN1;RGS12;TEP1
9518,GO:0036258,0.949356741164337,0.20994901217669,1,29,multivesicular body assembly,BP,CHMP1B
1110,GO:0002699,0.949439880983869,0.10503886541715,6,100,positive regulation of immune effector process,BP,DDX60;ADORA2B;DHX58;KLK5;RSAD2;STAT6
16581,GO:0097431,0.949461458738321,0.210593946604651,1,26,mitotic spindle pole,CC,OR2A4
983,GO:0002440,0.949928352394328,0.0995994548345419,7,112,production of molecular mediator of immune response,BP,PMS2P3;HFE;KLK5;BST2;RSAD2;STAT6;POLM
6738,GO:0030163,0.95020310344614,0.0647687209578151,64,742,protein catabolic process,BP,TNFAIP3;SERPINE2;APOE;FBXW4;EGFR;CTSO;TMEM129;ADAMTS7;RBCK1;CUL9;UBXN4;ISG15;MVB12B;SPATA18;CUL7;MAGEF1;BTBD2;RNF187;VPS11;MDM2;SPSB3;CTSV;RNF165;LAMP3;RHBDF1;FBXO44;WWTR1;LRSAM1;CBLC;CTSF;GID4;TCIRG1;SQSTM1;SHARPIN;ARRDC1;CST3;HFE;FBXO2;CTSB;FBXW7;CDK5RAP3;APC2;C17ORF97;FBXW5;LRP1;ATE1;DAB2IP;FBXO4;RNF213;ABTB1;KLHL3;SNX1;PANO1;MAN1B1;SGSH;TNFSF12;PTPN3;CTSD;PRKACA;UFL1;LONP2;SNX33;SMURF1;GCLC
10067,GO:0042581,0.950393394209296,0.103335305683292,6,100,specific granule,CC,KCNAB2;HGSNAT;TMC6;SLC2A3;CYBA;CTSD
11906,GO:0046966,0.950436745061162,0.207272627089621,1,27,thyroid hormone receptor binding,MF,THRAP3
4481,GO:0010506,0.950440353134544,0.0762644914141936,21,271,regulation of autophagy,BP,ULK2;EPM2A;TP53INP1;SREBF1;GPSM1;TRIM65;TRIM22;LAMP3;ULK1;LRSAM1;SESN3;LZTS1;ATP6V0A2;CDK5R1;SESN1;FBXW7;IFI16;PIK3R2;ERN1;PRKACA;SMURF1
10279,GO:0043044,0.950662471565594,0.129144659923606,3,69,ATP-dependent chromatin remodeling,BP,SMARCA1;CENPC;CENPH
12596,GO:0050798,0.950861699392168,0.205357696823481,1,29,activated T cell proliferation,BP,RIPK3
9529,GO:0036293,0.950864330443769,0.0770762589181376,19,260,response to decreased oxygen levels,BP,POSTN;SFRP1;MTHFR;NOS1;NDRG1;MDM2;ITGA2;ENDOG;PDK1;VEGFB;CST3;CYBA;KCNMA1;RWDD3;ZFP36L1;LMNA;APOLD1;TH;RORA
12400,GO:0048864,0.950890728090224,0.129457840703202,3,57,stem cell development,BP,KITLG;SEMA4G;RET
15074,GO:0071108,0.950980490077908,0.206317883332896,1,25,protein K48-linked deubiquitination,BP,TNFAIP3
15036,GO:0071011,0.951013316896349,0.204362572535893,1,31,precatalytic spliceosome,CC,TEP1
689,GO:0001910,0.951168211182183,0.204416581021411,1,29,regulation of leukocyte mediated cytotoxicity,BP,RIPK3
3680,GO:0008180,0.951295831920202,0.204317932877432,1,28,COP9 signalosome,CC,FLOT1
8930,GO:0034976,0.951597875528126,0.076891548096859,18,242,response to endoplasmic reticulum stress,BP,TMEM129;PIK3R1;UBXN4;CUL7;FLOT1;TMEM117;PLA2G6;FBXO2;CREBRF;CDK5RAP3;DAB2IP;PIK3R2;TMX4;LMNA;ERN1;MAN1B1;UFL1;SERINC3
5156,GO:0015696,0.951758405062523,0.149277153448013,2,45,ammonium transport,BP,NOS1;SYT7
11394,GO:0045815,0.951870843774566,0.126160889403398,3,77,positive regulation of gene expression, epigenetic,BP,PHF2;ERCC6;KAT2B
9933,GO:0042304,0.95208755633215,0.201873667015182,1,28,regulation of fatty acid biosynthetic process,BP,MLXIPL
3676,GO:0008175,0.95214191184564,0.201705342986004,1,28,tRNA methyltransferase activity,MF,TARBP1
1177,GO:0002824,0.952159956144754,0.148294593977478,2,45,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,RSAD2;STAT6
13553,GO:0060042,0.952181488425001,0.202605024698826,1,25,retina morphogenesis in camera-type eye,BP,SDK2
11649,GO:0046434,0.952199594300843,0.0830973358151687,12,172,organophosphate catabolic process,BP,NT5E;DHTKD1;RAPGEF3;INSR;MLXIPL;PGM1;PFKFB2;OGDHL;PDE2A;IMPA2;SMPDL3B;NUDT10
9234,GO:0035639,0.952203339503426,0.0579851143904921,134,1405,purine ribonucleoside triphosphate binding,MF,ULK2;SIK1;SLFN5;ACTA2;OAS2;DDX60;HSPA2;EGFR;FAM20C;SYN1;IFI44L;KIF26B;EPHB2;MAP3K14;GLUD1;DGKQ;BRSK1;CUL9;CAMKK1;MVD;RAB43;RAB40B;PRKACB;CMPK2;PIK3C2G;LIG1;CDK18;SPEG;MLH3;NMRK1;DDX59;OBSCN;MYH11;ACTR1B;RHOBTB2;OAS1;KIF26A;ALPK1;DNAH1;NEK9;TRPV4;DHX32;CLCN6;PSKH1;MINK1;ULK1;THRAP3;SMARCA1;NAIP;NEK8;MAP2K5;INSR;CHD3;CDK14;TTN;SLFNL1;SEPT6;DHX58;NLRX1;ETNK2;MAP2K2;OPLAH;PDK1;PTK6;PDIK1L;MAP3K12;WRN;SEPT5;DNM1;MCM9;ATRX;MAPK10;ERCC6;HLCS;PAK6;PFKFB2;MX2;ACACB;NLRP1;TK2;GLUL;SRR;MAP3K6;RIMKLB;MYO3B;WNK1;ARL11;STK16;RET;PIK3C3;DALRD3;FGFR4;MYO9A;RPS6KA5;NADK;BBS10;HLTF;STK19;RASL10B;LMTK3;ACVR1B;TSSK1B;WEE1;PTK7;DQX1;ACSL1;MARK4;TEP1;ERN1;RAD50;TKFC;PEX1;SCYL3;SCG5;KIF7;CHD6;ACSS2;ERBB2;ABCA2;PRKACA;SUCLG2;UCKL1;DDX12P;IP6K2;RIPK3;PI4K2B;LONP2;HARS2;CIT;MSH5;CLCN7;TTLL1;ABCA11P;GCLC
12841,GO:0051181,0.952345251676534,0.200783279531461,1,29,cofactor transport,BP,SLC48A1
12269,GO:0048599,0.952355927550095,0.201356146413543,1,27,oocyte development,BP,REC8
19695,GO:2000058,0.952399447162617,0.0917814204515449,8,126,regulation of ubiquitin-dependent protein catabolic process,BP,MAGEF1;MDM2;HFE;FBXW7;PANO1;UFL1;SMURF1;GCLC
12043,GO:0048008,0.952452618846462,0.148118445161959,2,41,platelet-derived growth factor receptor signaling pathway,BP,TXNIP;LRP1
10416,GO:0043276,0.952519665283466,0.200847557553383,1,27,anoikis,BP,SIK1
18562,GO:1903829,0.952537618948045,0.0726476092181739,22,285,positive regulation of cellular protein localization,BP,EGFR;EPHB2;PIK3R1;VPS11;MDM2;RAPGEF3;HPS4;ANK3;GLI3;VAMP2;MICALL2;SQSTM1;OSCP1;CDK5R1;FBXW7;CDK5RAP3;LRP1;TFDP2;CEP250;ERBB2;SNX33;PEMT
16386,GO:0097035,0.952604842429455,0.200921501332704,1,26,regulation of membrane lipid distribution,BP,ANO9
7252,GO:0031227,0.952678818044459,0.0912904760865182,8,127,intrinsic component of endoplasmic reticulum membrane,CC,PKD2;HLA-B;G6PC3;SPPL2B;HLA-A;SLC37A2;ESYT2;ERN1
12541,GO:0050710,0.952745145051633,0.199541816689446,1,29,negative regulation of cytokine secretion,BP,TNFRSF21
1119,GO:0002708,0.952835897111962,0.146635652677651,2,45,positive regulation of lymphocyte mediated immunity,BP,RSAD2;STAT6
4219,GO:0009395,0.953078564236552,0.198794280856013,1,28,phospholipid catabolic process,BP,SMPDL3B
3925,GO:0008608,0.953310441948363,0.198070523289067,1,28,attachment of spindle microtubules to kinetochore,BP,CENPC
3244,GO:0006901,0.953886684532165,0.122735124454573,3,60,vesicle coating,BP,COL7A1;ANKRD28;AREG
653,GO:0001844,0.954218374725061,0.194668414759425,1,30,protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,BP,TFDP2
6583,GO:0022602,0.954242150719024,0.195794877596051,1,26,ovulation cycle process,BP,SLIT3
15356,GO:0071621,0.954300712726704,0.142478490941156,2,50,granulocyte chemotaxis,BP,VAV3;TRPV4
4341,GO:0009895,0.954311658089591,0.0758222066472772,15,208,negative regulation of catabolic process,BP,SERPINE2;EGFR;CIRBP;LAMP3;THRAP3;LZTS1;CST3;HFE;CDK5RAP3;ACACB;DAB2IP;PANO1;ANGEL2;PTPN3;PARN
5397,GO:0016236,0.954383289238017,0.071309483810563,20,269,macroautophagy,BP,ULK2;EPM2A;TP53INP1;GPSM1;ATG16L2;ULK1;LRSAM1;SESN3;LZTS1;TCIRG1;SQSTM1;ATP6V0A2;CDK5R1;SESN1;SYNPO2;PIK3C3;ERN1;ATG14;PRKACA;SMURF1
9517,GO:0036257,0.95446345529683,0.193897876388143,1,30,multivesicular body organization,BP,CHMP1B
12881,GO:0051247,0.954476146455142,0.0565877004072664,103,1147,positive regulation of protein metabolic process,BP,TNFAIP3;GPNMB;SREBF1;APOE;HSPA2;EGFR;CIRBP;PKD2;CAPRIN2;RBM3;EPHB2;MAP3K14;DGKQ;CAMKK1;CSPG4;ZFPM1;KITLG;IMPACT;NOS1;PRKACB;MAGEF1;VPS11;MDM2;TNFSF10;RAPGEF3;F2R;TRPV4;FLOT1;ADORA2B;MAPK8IP3;PIDD1;UNC119;C5;MINK1;ITGA2;MAP2K5;IGFBP4;JARID2;NUPR1;INSR;GSN;DDT;ETAA1;PILRB;SLC27A1;RTF1;RICTOR;BMP6;MAP2K2;SQSTM1;PTK6;FZD7;PLA2G6;GDF15;CTF1;MAP3K12;IFI27;CDK5R1;MAPK10;HFE;ERCC6;SHC2;EDA2R;SPRY2;FBXW7;CDK5RAP3;PAK6;APC2;NLRP1;NAB2;LRP1;MAP3K6;WNK1;RET;DAB2IP;RWDD3;FBXO4;IFI16;FGFR4;AREG;RPS6KA5;PHF1;SNX1;ACVR1B;DLG4;TNFRSF25;ACSL1;IL11;ERN1;RAD50;TNFSF12;ERBB2;AKAP6;ATG14;PPARG;PRKACA;ACKR3;RIPK3;SNX33;SMURF1;NPNT;PEMT;GCLC
19590,GO:1990752,0.954502201868551,0.195337009477079,1,25,microtubule end,CC,CLIP2
2435,GO:0005635,0.954674963448056,0.0659138226251669,30,375,nuclear envelope,CC,SREBF1;EGFR;UBXN4;PRICKLE2;RAB40B;ITPR3;CERS4;TMC6;SULT1E1;INSR;SUN1;MGST2;CLCA2;CST3;KLHDC2;IFI27;TREX1;MX2;RETSAT;TNRC18;DPY19L2P2;NEMP2;LMNA;ERN1;S100A6;CERS5;STAT6;AKAP6;NPAP1;SYNE2
6921,GO:0030521,0.954729730916699,0.121037881542601,3,58,androgen receptor signaling pathway,BP,SFRP1;KDM3A;THRAP3
5811,GO:0017076,0.954734806467831,0.0549285308881717,137,1438,purine nucleotide binding,MF,ULK2;SIK1;SLFN5;ACTA2;OAS2;DDX60;HSPA2;EGFR;FAM20C;SYN1;IFI44L;KIF26B;EPHB2;MAP3K14;GLUD1;DGKQ;BRSK1;CUL9;CAMKK1;MVD;RAB43;RAB40B;PRKACB;CMPK2;PIK3C2G;LIG1;CDK18;SPEG;MLH3;NMRK1;DDX59;OBSCN;MYH11;ACTR1B;RHOBTB2;RAPGEF3;OAS1;GAL3ST4;KIF26A;ALPK1;DNAH1;NEK9;TRPV4;DHX32;CLCN6;PSKH1;MINK1;ULK1;THRAP3;SMARCA1;NAIP;NEK8;MAP2K5;INSR;CHD3;CDK14;TTN;SLFNL1;SEPT6;DHX58;NLRX1;ETNK2;MAP2K2;OPLAH;PDK1;PTK6;PDIK1L;MAP3K12;WRN;SEPT5;DNM1;MCM9;ATRX;MAPK10;ERCC6;HLCS;PAK6;PFKFB2;MX2;ACACB;NLRP1;TK2;GLUL;SRR;MAP3K6;RIMKLB;MYO3B;WNK1;ARL11;PDE2A;STK16;RET;PIK3C3;DALRD3;FGFR4;MYO9A;RPS6KA5;NADK;BBS10;HLTF;STK19;RASL10B;LMTK3;ACVR1B;TSSK1B;WEE1;PTK7;DQX1;ACSL1;MARK4;TEP1;ERN1;RAD50;TKFC;PEX1;SCYL3;SCG5;KIF7;CHD6;ACSS2;ERBB2;ABCA2;PRKACA;SUCLG2;UCKL1;DDX12P;IP6K2;RIPK3;PI4K2B;LONP2;HARS2;CIT;MSH5;CLCN7;TTLL1;ABCA11P;GCLC
18218,GO:1903050,0.954764602969513,0.0790535904659111,12,176,regulation of proteolysis involved in cellular protein catabolic process,BP,MAGEF1;MDM2;LAMP3;RHBDF1;HFE;FBXW7;DAB2IP;PANO1;PRKACA;UFL1;SMURF1;GCLC
17343,GO:1900077,0.954845261361764,0.193248308187404,1,28,negative regulation of cellular response to insulin stimulus,BP,GPR21
18220,GO:1903052,0.9548552403865,0.0952866365259331,6,100,positive regulation of proteolysis involved in cellular protein catabolic process,BP,MAGEF1;MDM2;FBXW7;DAB2IP;SMURF1;GCLC
18879,GO:1904589,0.954878706314513,0.141583278662854,2,45,regulation of protein import,BP,GLI3;PDE2A
5105,GO:0015399,0.955017036687407,0.108440521096601,4,73,primary active transmembrane transporter activity,MF,TCIRG1;ATP6V0A2;ABCA2;ABCA11P
5106,GO:0015405,0.955017036687407,0.108440521096601,4,73,P-P-bond-hydrolysis-driven transmembrane transporter activity,MF,TCIRG1;ATP6V0A2;ABCA2;ABCA11P
12835,GO:0051173,0.955316621506914,0.0528148917617961,198,2088,positive regulation of nitrogen compound metabolic process,BP,TNFAIP3;GPNMB;TP53INP1;PTHLH;SREBF1;APOE;HSPA2;EGFR;CIRBP;PKD2;CAPRIN2;RBM3;ASH2L;SRSF5;SFRP1;SEC14L2;EPHB2;MAP3K14;DGKQ;PIK3R1;KDM3A;POU3F1;CAMKK1;CSPG4;RGMA;ZFPM1;KITLG;CITED4;IRF2BPL;MC1R;STAT1;IMPACT;NOS1;PRKACB;MAML3;KLF13;MAGEF1;NFATC4;RNF187;HSF4;VPS11;EAPP;MDM2;CRTC1;NDN;TNFSF10;RAPGEF3;F2R;ZFP36L2;TRPV4;FLOT1;GLI2;ADORA2B;KLF7;TCEA2;MAPK8IP3;ZNF76;SOX12;PIDD1;SLX1A;SLX1B;UNC119;C5;MINK1;PHF2;ABHD14B;WWTR1;ITGA2;GLI3;THRAP3;SMARCA1;MAP2K5;ITGA6;ZNF318;IGFBP4;JARID2;NUPR1;INSR;GSN;DDT;ZNF287;ETAA1;PILRB;ENDOG;SLC27A1;RTF1;MDK;RICTOR;BMP6;MAP2K2;SQSTM1;PTK6;FZD7;ETV5;DLX3;HEXB;METTL23;PLA2G6;CST3;GDF15;CTF1;TCF4;PLAG1;MAP3K12;WRN;IFI27;LPIN3;CDK5R1;ATRX;MAPK10;HFE;ADIRF;ERCC6;SHC2;EDA2R;SPRY2;MEF2D;CREBRF;MLXIPL;FBXW7;CDK5RAP3;LMO2;NFIX;PAK6;CARF;PFKFB2;THRA;APC2;RAI1;ELF1;IKZF4;NLRP1;DBP;NAB2;LRP1;PEG3;RFX2;MAP3K6;SALL2;WNK1;MAF;STK16;RET;DAB2IP;CASZ1;RWDD3;CALCOCO1;TEAD2;MYSM1;FBXO4;IFI16;FGFR4;PIK3R2;TEF;AREG;RPS6KA5;VDR;MAMSTR;TNRC6C;PLXND1;SIX5;HLTF;PHF1;ZNF292;TFDP2;SNX1;ACVR1B;DLG4;TNNI2;NAT14;TNFRSF25;ZFP36L1;GLMP;ACSL1;IL11;KAT2B;ERN1;IVNS1ABP;RAD50;TRERF1;TNFSF12;STAT6;CHD6;ERBB2;AKAP6;ATG14;RORA;PPARG;PRKACA;ACKR3;PARN;RIPK3;SNX33;ZFP90;SMURF1;NPNT;PEMT;GCLC
16533,GO:0097327,0.955438844881987,0.107587024503349,4,73,response to antineoplastic agent,BP,EGFR;ATRX;ADIRF;XRN1
20154,GO:2001021,0.956045863187075,0.117864422531815,3,62,negative regulation of response to DNA damage stimulus,BP,MAGEF1;MDM2;ACKR3
3530,GO:0007517,0.9562485124823,0.0702377104818828,18,226,muscle organ development,BP,TAGLN;TSC22D3;EVC;ZFPM1;CYP26B1;SPEG;FLOT1;JARID2;NUPR1;TTN;FZD7;CTF1;HMG20B;MEF2D;ADARB1;JPH2;AKAP6;FOXP2
5553,GO:0016567,0.956305452586718,0.0576545434238214,60,709,protein ubiquitination,BP,TNFAIP3;DDB2;FBXO41;FBXW4;HERC3;TRIM22;KCTD11;DCAF16;TMEM129;RBCK1;CUL9;RNF135;HERC5;ISG15;CUL7;RAB40B;CRY1;MAGEF1;RNF187;MDM2;SPSB3;RNF165;FBXO44;PER2;WWTR1;LRSAM1;NAIP;CBLC;FBXL16;GID4;RTF1;PEX10;SHARPIN;UBOX5;ARRDC1;ZYG11B;KLHL24;TRIM38;DTX3;FBXO2;FBXW7;CDK5RAP3;RNF170;DCAF10;FBXW5;KLHDC8B;FBXO4;RNF213;KLHL3;HLTF;MARCH8;RNF141;DCAF8;KLHL29;TRIM2;UVSSA;UFL1;PRMT3;SMURF1;GCLC
6501,GO:0021879,0.956357738107903,0.188441226456049,1,28,forebrain neuron differentiation,BP,SHANK3
825,GO:0002102,0.95640145876209,0.188606625393656,1,27,podosome,CC,GSN
4310,GO:0009790,0.956459705528908,0.0576183088002278,59,665,embryo development,BP,FBXW4;EGFR;PKD2;ALDH1A3;LRIG3;PLCD3;SLITRK6;SFRP1;EPHB2;SULF2;WNT3;TENM4;ZFPM1;KITLG;ITGB5;PRKACB;HOXA3;CYP26B1;COL7A1;NAGLU;PLCD1;FLRT3;GLI2;C5;ITGA2;GLI3;MAP2K5;INSR;CELSR1;TRIOBP;ENDOG;PGAP1;RTF1;RICTOR;ETNK2;FZD7;KDM4C;HYAL1;COL6A1;NPHP3;CDK5R1;SPRY2;IFT140;MYO3B;SALL2;RET;TEAD2;BBS5;PCSK6;TMEM231;NRARP;ACVR1B;DLG4;PALB2;PTK7;TCF7;ZFP36L1;GJB5;TH
2738,GO:0006120,0.956555964201048,0.18474592426062,1,45,mitochondrial electron transport, NADH to ubiquinone,BP,NDUFV3
5472,GO:0016407,0.956595675617194,0.0975475107198447,5,88,acetyltransferase activity,MF,HGSNAT;CRAT;NAT6;NAT14;KAT2B
13425,GO:0052866,0.956678204633963,0.188048933471967,1,26,phosphatidylinositol phosphate phosphatase activity,MF,INPP5D
12532,GO:0050701,0.956702857279589,0.186790562997652,1,30,interleukin-1 secretion,BP,NLRP1
12063,GO:0048029,0.956741442047047,0.13680875427742,2,46,monosaccharide binding,MF,PHYH;SLC2A3
12785,GO:0051099,0.95675567355726,0.0816798063446363,9,140,positive regulation of binding,BP,APOE;GPSM1;CAPRIN2;FLOT1;ITGA2;HFE;LRP1;PLXND1;PPARG
12989,GO:0051438,0.956767031194712,0.136529424672277,2,48,regulation of ubiquitin-protein transferase activity,BP,ZYG11B;FBXW7
10940,GO:0044665,0.956807687024601,0.186717843326902,1,29,MLL1/2 complex,CC,ASH2L
15174,GO:0071339,0.956807687024601,0.186717843326902,1,29,MLL1 complex,CC,ASH2L
4763,GO:0010950,0.957152349132403,0.0835606397859569,8,134,positive regulation of endopeptidase activity,BP,TNFSF10;F2R;PIDD1;GSN;IFI27;NLRP1;IFI16;PPARG
15104,GO:0071216,0.957185022974251,0.083623670826978,8,127,cellular response to biotic stimulus,BP,TNFAIP3;CMPK2;PDCD4;ADAMTS13;BMP6;TXNIP;DAB2IP;VDR
4371,GO:0009994,0.957186433834107,0.18578351016506,1,28,oocyte differentiation,BP,REC8
20253,GO:2001243,0.957263463801033,0.103610762005432,4,79,negative regulation of intrinsic apoptotic signaling pathway,BP,MDM2;RRM2B;IVNS1ABP;ACKR3
7703,GO:0032200,0.957514204153974,0.0780495589001112,10,166,telomere organization,BP,SLX1A;SLX1B;POLD4;WRN;ATRX;XRN1;FBXO4;TEP1;RAD50;PARN
17232,GO:0120034,0.957585571405107,0.103266686706532,4,72,positive regulation of plasma membrane bounded cell projection assembly,BP,ESPN;EPS8L2;ARAP1;ZMYND8
12839,GO:0051179,0.957979223267419,0.0479943153178324,419,4300,localization,BP,TNFAIP3;POSTN;ITGB6;SERPINE2;GPNMB;SIK1;TP53INP1;MAP6;SREBF1;PYGB;APOE;INPP5D;APCDD1;OAS2;LMF1;HSPA2;EGFR;PKD2;SYT8;CXCR1;CPT2;SYN1;DIXDC1;TRIM22;SRSF5;SFRP1;OBSL1;EPHB2;TNS1;GLUD1;TMEM129;PIK3R1;EVI5L;BRSK1;MARVELD1;ORAI3;CXCL14;TSC22D3;WNT3;VAV3;UNK;CSPG4;MVB12B;UNC119B;KCNAB2;KITLG;ZDHHC1;VAMP3;NAPRT;REEP2;KCNJ15;ASAP3;CRY2;NSG1;SLC16A5;GJD3;RAB43;RAB40B;NOS1;CRY1;SDC3;PLEKHG5;PITPNM3;SCARA3;FERMT1;GAA;AP5Z1;CNTRL;MICALL1;PIK3C2G;TBC1D8;PLXNB1;VPS11;COL7A1;KCNC4;SPOCK1;SLC29A4;ITPR3;MDM2;LZTS2;NDN;IFITM1;MLH3;FCGRT;LTBP4;OBSCN;HGSNAT;SYTL1;NDUFA4L2;ACTR1B;RHOBTB2;RAPGEF3;ENDOD1;NLGN4Y;FLRT3;NUDCD3;KIF26A;AP1G2;ARPIN;TMEM63C;ACAP3;F2R;C2CD4C;HPS4;BLOC1S4;SPTB;SLC24A1;CAPN7;DNAH1;CLTCL1;TRPV4;TMC6;FLOT1;AGAP4;TOM1L2;NLGN2;ADORA2B;ANK3;MAPK8IP3;SLC13A5;RIMS3;AVL9;G6PC3;ATG16L2;SPG11;GJC2;RHBDF1;RASGEF1A;PER2;PITPNM2;CLCN6;UNC119;C5;WIPF1;SNTA1;MINK1;NINL;GSTM2;ASAP2;LHFPL2;ITGA2;SEMA4G;FAM110C;SYT15;ULK1;GLI3;TPGS1;AKAP7;LRSAM1;VAMP2;LTBP1;NMU;MAP2K5;GAS8;ITGA6;KCNJ5;SRGAP3;BSN;MMP1;TRAK1;NISCH;INSR;TST;CELSR1;MMP28;GSN;CEP68;BAIAP2;TTN;TMC7;SCNN1A;DDT;PLXNB3;SUN1;RIN1;CD109;SCN4B;SEPT6;RAB11FIP4;VPS39;DOCK8;SLC27A1;PGAP1;TM7SF3;BLOC1S3;MDK;BMP6;NIPAL2;PEX10;SLC2A3;TCIRG1;MICALL2;MAP2K2;VEGFB;SQSTM1;CEP192;PTK6;SLC12A7;ETV5;SYNGAP1;FAT2;EPB41L3;HEXB;HYAL1;CLCA2;ARHGAP33;ARRDC1;WHAMMP3;CENPC;PLA2G6;CST3;HOMER2;MMRN2;PEX7;BBS2;TXNIP;ATP6V0A2;IDH2;WRN;PODXL;SEPT5;IFI27;MALL;OSCP1;DNM1;TNFRSF21;IQCB1;KLHL24;ZDHHC12;MCTP1;CDK5R1;ATRX;ARHGAP27;AGAP6;NET1;ANO9;CA2;OSBPL10;HOOK2;SHANK3;HFE;SCART1;CYBA;HADH;SPRY2;MRC2;WASH3P;IFT140;AGAP7P;RAB11FIP3;CTSB;FBXW7;KCNMA1;ANKRD28;CDK5RAP3;ATXN1;PAK6;DZIP1L;PGM1;MXI1;PFKFB2;CHMP1B;THRA;APC2;ARAP1;ASTN2;ADARB1;MX2;RPH3AL;SLC2A1;ACACB;NLRP1;GPR155;GLUL;TBC1D17;SLC38A4;LRP1;TSNARE1;NPHP4;PLA2G7;C12ORF66;KCNG1;SLC48A1;APPL2;WNK1;BBS1;JPH2;PDE2A;LTB4R2;RET;ZMYND8;DAB2IP;SLC37A2;MYSM1;DDHD2;SHROOM2;FBXO4;OLFM2;PIK3C3;SYT7;FGFR4;BBS5;EXOC2;PIK3R2;SCN2A;OSBPL5;AREG;KLHL3;DLG5;BTG1;BST2;VDR;SNX21;CACNB3;EFS;PLXND1;EHBP1;PCSK6;MPPE1;TNS4;TBC1D16;TMCO6;DMTN;ORAI2;SGSM2;ARFGEF2;RASL10B;ALMS1;SLC36A4;TMEM231;TFDP2;SNX1;GOLGA7B;OSBPL1A;ACVR1B;NECAB3;CCDC88B;DLG4;ESYT2;ENDOU;NHSL1;MATN2;NBEAL2;CD68;SLC22A15;PTK7;SHANK2;RSAD2;ZFP36L1;LMNA;CLSTN3;ACSL1;IL11;MARK4;APOLD1;IRS2;CEP250;ANO1;METTL7A;ALOX15B;ZMAT3;PEX1;S100A6;SCYL3;SCG5;ZSWIM8;APBB2;PBLD;TNFSF12;PHPT1;TUB;SLC43A1;GLB1;GOLGB1;SRPX2;DPP7;CD9;CACNB1;PTPN3;CTSD;ERBB2;SYNGR1;GPR68;ZDHHC24;ABCA2;AKAP6;SLC2A11;TH;ATG14;MPP7;PPARG;PRKACA;LDLRAP1;NPAP1;C6ORF120;FMNL3;SYNE2;ACKR3;PLTP;SERPING1;PARN;UFL1;IP6K2;RIPK3;NFASC;AIP;COG1;KCNS3;LONP2;SNX33;CLCN7;CALHM2;SMURF1;NPNT;TTLL1;PEMT;ABCA11P;SERINC3;ECM1
18129,GO:1902893,0.958115765680578,0.183083438622465,1,27,regulation of pri-miRNA transcription by RNA polymerase II,BP,NFATC4
12990,GO:0051443,0.958184131963455,0.182021317554259,1,30,positive regulation of ubiquitin-protein transferase activity,BP,FBXW7
10516,GO:0043470,0.958192606752022,0.11337823810995,3,58,regulation of carbohydrate catabolic process,BP,INSR;MLXIPL;PFKFB2
17895,GO:1902229,0.958219058273706,0.181225796593721,1,33,regulation of intrinsic apoptotic signaling pathway in response to DNA damage,BP,ACKR3
10772,GO:0044248,0.958649509931115,0.0496688714504817,162,1800,cellular catabolic process,BP,TNFAIP3;ULK2;EPM2A;TP53INP1;SREBF1;AMACR;PYGB;APOE;GPSM1;NT5E;OAS2;FBXW4;TRIM65;CIRBP;APOBEC3C;CPT2;TRIM22;CTSO;GPX3;GLUD1;TMEM129;ADAMTS7;RBCK1;CUL9;DHTKD1;UBXN4;CSPG4;ISG15;MVB12B;SPATA18;CUL7;SRD5A3;NOS1;MAGEF1;HMGCL;BTBD2;RNF187;H1F0;CYP26B1;GAA;THNSL2;VPS11;MDM2;TYSND1;IDUA;PRODH;CYP3A5;RAPGEF3;SPSB3;PCBP4;CTSV;BLVRB;CRAT;MLYCD;PHYH;ZFP36L2;RNF165;ADAMTS13;LAMP3;ATG16L2;ZCCHC11;RHBDF1;SULT1E1;FBXO44;HEXA;GSTM2;WWTR1;ULK1;THRAP3;LRSAM1;SESN3;LZTS1;INSR;TST;ALDH4A1;CBLC;RNPEPL1;CTSF;CYP2D7;VPS39;MGST2;ENDOG;GID4;TCIRG1;ALDH7A1;SQSTM1;SHARPIN;HEXB;HYAL1;ARRDC1;CST3;PEX7;ATP6V0A2;LPIN3;CDK5R1;SESN1;HFE;AGO4;HADH;FBXO2;XRN1;MLXIPL;CTSB;FBXW7;CDK5RAP3;PGM1;PFKFB2;ACADS;ACACB;OGDHL;GLUL;TBC1D17;C17ORF97;FBXW5;LRP1;ATE1;SYNPO2;RNPEP;BDH1;PDE2A;DAB2IP;ACOX3;DDHD2;FBXO4;RNF213;PIK3C3;IFI16;PIK3R2;ABTB1;KLHL3;ETFB;TNRC6C;PANO1;DUOX1;AMT;ZFP36L1;ACSL1;IRS2;ERN1;TKFC;ANGEL2;MAN1B1;ECI1;FAAH;SGSH;PRDX5;SMPDL3B;GLB1;CPT1C;GSTM3;PTPN3;CTSD;NUDT10;ATG14;PRKACA;PARN;UFL1;LONP2;SNX33;EHHADH;SMURF1;GCLC
2535,GO:0005793,0.958727144838133,0.0881400890571156,6,102,endoplasmic reticulum-Golgi intermediate compartment,CC,COL7A1;WHAMMP3;DDHD2;AREG;MPPE1;GOLGB1
13158,GO:0051784,0.958857291131875,0.131347766794411,2,47,negative regulation of nuclear division,BP,TOM1L2;ATRX
86,GO:0000175,0.959062994047739,0.179165083689969,1,30,3'-5'-exoribonuclease activity,MF,PARN
8964,GO:0035065,0.959143908901399,0.130724634840378,2,46,regulation of histone acetylation,BP,NOS1;RPS6KA5
11351,GO:0045727,0.959148709688552,0.0873113593362414,6,104,positive regulation of translation,BP,CIRBP;RBM3;IMPACT;ITGA2;ERBB2;PPARG
14480,GO:0061980,0.959221703897052,0.179181852262547,1,28,regulatory RNA binding,MF,AGO4
15892,GO:0072686,0.959231251947008,0.0925363109667252,5,86,mitotic spindle,CC,PKD2;OR2A4;IQCB1;CAPG;EML2
10440,GO:0043312,0.959338047183174,0.0610262051232846,26,351,neutrophil degranulation,BP,PYGB;CXCR1;KCNAB2;NAPRT;GAA;HGSNAT;ACTR1B;TMC6;GSN;SLC2A3;TCIRG1;HEXB;CST3;CYBA;CTSB;PGM1;BST2;NBEAL2;CD68;METTL7A;GLB1;DPP7;CTSD;SYNGR1;C6ORF120;NFASC
18323,GO:1903312,0.959362868574773,0.110620136544951,3,60,negative regulation of mRNA metabolic process,BP,CIRBP;THRAP3;ANGEL2
9513,GO:0036230,0.95957356827101,0.0602922085721715,27,363,granulocyte activation,BP,PYGB;CXCR1;KCNAB2;NAPRT;GAA;HGSNAT;ACTR1B;TMC6;VAMP2;GSN;SLC2A3;TCIRG1;HEXB;CST3;CYBA;CTSB;PGM1;BST2;NBEAL2;CD68;METTL7A;GLB1;DPP7;CTSD;SYNGR1;C6ORF120;NFASC
1997,GO:0004722,0.959743113863349,0.109700780511518,3,61,protein serine/threonine phosphatase activity,MF,PPP2R2C;PPP2R3B;PPM1M
20206,GO:2001169,0.959817586702447,0.109666101727175,3,59,regulation of ATP biosynthetic process,BP,INSR;MLXIPL;PFKFB2
15251,GO:0071453,0.959897614724518,0.0724373393804011,11,171,cellular response to oxygen levels,BP,SFRP1;NDRG1;MDM2;ENDOG;PDK1;ATP6V0A2;RWDD3;ZFP36L1;LMNA;RORA;PPARG
11762,GO:0046637,0.959909719044318,0.17665032241765,1,29,regulation of alpha-beta T cell differentiation,BP,GLI3
4959,GO:0015036,0.959983689554439,0.175282171862635,1,34,disulfide oxidoreductase activity,MF,TXNRD3
10564,GO:0043542,0.960113179805835,0.0761077430173189,9,136,endothelial cell migration,BP,APOE;PLEKHG5;MAP2K5;MMRN2;DAB2IP;PLXND1;TNFSF12;SRPX2;PPARG
5676,GO:0016791,0.96020154839444,0.0669244657254131,15,207,phosphatase activity,MF,NT5E;INPP5D;PTPRS;PPP2R2C;G6PC3;LPIN3;PFKFB2;TNS2;ACP5;PPP2R3B;IMPA2;PHPT1;PTPN3;PPM1M;SSH3
5402,GO:0016242,0.960592244718573,0.174401093013992,1,29,negative regulation of macroautophagy,BP,LZTS1
2969,GO:0006508,0.960653961159172,0.0488532741154848,111,1254,proteolysis,BP,TNFAIP3;SERPINE2;NPEPL1;DDB2;IFI6;APOE;ADAM19;FBXW4;CTSO;SFRP1;TMEM129;ADAMTS7;RBCK1;CUL9;RNF135;UBXN4;ISG15;MVB12B;HTRA1;TENM4;CUL7;CAMK2N1;PRKACB;MAGEF1;BTBD2;RNF187;COL7A1;SPOCK1;MDM2;TYSND1;LTBP4;TNFSF10;SPSB3;CTSV;F2R;SERPINB5;CAPN7;RNF165;ADAMTS13;LAMP3;PIDD1;RHBDF1;FBXO44;C5;WWTR1;GLI3;SPPL2B;PCSK1;NAIP;MAP2K5;MMP1;MMP28;GSN;CBLC;RNPEPL1;CTSF;CD109;GID4;CASP14;MAP2K2;SQSTM1;SHARPIN;CLCA2;ARRDC1;CST3;CAPNS2;THSD4;IFI27;HFE;FBXO2;CTSB;KLK5;FBXW7;TFPI2;NLRP1;C1RL;C17ORF97;FBXW5;ATE1;RNPEP;RET;DAB2IP;MYSM1;FBXO4;RNF213;PIK3C3;IFI16;FGFR4;ABTB1;KLHL3;BST2;PCSK6;PANO1;ENDOU;KAT2B;MAN1B1;SCG5;PCSK1N;PRDX5;DPP7;PTPN3;CTSD;PPARG;PRKACA;SERPING1;UFL1;LONP2;SNX33;SMURF1;GCLC;ECM1
9032,GO:0035258,0.960832645702079,0.0964808735194432,4,74,steroid hormone receptor binding,MF,KDM3A;KDM4C;PPARG;FOXP2
902,GO:0002283,0.960853648999609,0.0589141308880277,26,352,neutrophil activation involved in immune response,BP,PYGB;CXCR1;KCNAB2;NAPRT;GAA;HGSNAT;ACTR1B;TMC6;GSN;SLC2A3;TCIRG1;HEXB;CST3;CYBA;CTSB;PGM1;BST2;NBEAL2;CD68;METTL7A;GLB1;DPP7;CTSD;SYNGR1;C6ORF120;NFASC
2489,GO:0005737,0.961026423260277,0.0447212211190548,827,8355,cytoplasm,CC,TNFAIP3;TGFBI;POSTN;TAGLN;SERPINE2;ULK2;GPNMB;TSC22D1;SIK1;SUGCT;MUC19;NPEPL1;TP53INP1;MAP6;IFI6;PTHLH;SREBF1;AMACR;PYGB;ACTA2;APOE;GPSM1;CES2;NT5E;ALS2CL;INPP5D;GAMT;FBXO41;OAS2;ADAM19;LMF1;DDX60;HSPA2;FBXW4;EGFR;ESPN;TRIM65;FAM117A;HERC3;PTPRS;CIRBP;FLNC;FAM20C;PKD2;CAPRIN2;XPC;APOBEC3C;SYT8;CXCR1;CPT2;RBM3;SYN1;DIXDC1;TRIM22;ALDH1A3;SRSF5;LRIG3;PLCD3;CTSO;SFRP1;OBSL1;MTHFR;PERM1;SEC14L2;KCTD11;IFI44L;KIF26B;EPS8L2;EPHB2;RALGDS;TNS1;SYNC;MAP3K14;GLUD1;BPHL;DGKQ;TMEM129;PIK3R1;ADAMTS7;BRSK1;TXNRD3;MARVELD1;RBCK1;KDM3A;CXCL14;DOCK9;COL22A1;TSC22D3;CUL9;EVC;RNF135;SULF2;WNT3;H6PD;DHTKD1;CAMKK1;HERC5;UBXN4;VAV3;ST6GALNAC2;UNK;VWCE;CSPG4;ISG15;MVB12B;CYBRD1;HTRA1;SPATA18;TFCP2L1;TENM4;UNC119B;RGMA;PI4KAP2;KCNAB2;ZFPM1;KITLG;MVD;ZDHHC1;CUL7;VAMP3;CITED4;SNN;NAPRT;REEP2;PRICKLE2;ASAP3;SRD5A3;OR2A4;STAT1;IMPACT;CRY2;MYL9;GRIP2;KRT15;HS1BP3;LGALS7B;MARCKSL1;NSG1;UROS;KDSR;ITGB5;COL10A1;RAB43;RAB40B;NOS1;PRKACB;B4GALNT4;CRY1;CRTAP;SDC3;PLEKHG5;NFATC4;PITPNM3;IQSEC2;HMGCL;D2HGDH;BTBD2;SCARA3;FKBP5;RNF187;FERMT1;H1F0;CYP26B1;GAA;AP5Z1;CMPK2;CNTRL;MICALL1;PIK3C2G;LIG1;CDK18;VPS11;NDRG1;COL7A1;SPOCK1;ITPR3;EAPP;NAGLU;CYHR1;MDM2;CRTC1;LZTS2;PLCD1;NDN;NMRK1;DDX59;ST6GALNAC6;PPP2R2C;CHN2;TYSND1;OBSCN;IDUA;GOLGA8A;GPRC5C;HLA-B;PRODH;HGSNAT;MYH11;PARVB;SYTL1;FKBP9;NDUFA4L2;ACTR1B;RHOBTB2;UGT1A3;CERS4;CYP3A5;ACOT1;NEO1;RAPGEF3;SPSB3;ENDOD1;PCBP4;FAM210B;CTSV;POLH;BLVRB;OAS1;FLRT3;NUDCD3;RASA4;GAL3ST4;CRAT;KIF26A;B4GALT6;AP1G2;RGL4;RGS2;ACAP3;F2R;MLYCD;PPL;C2CD4C;HPS4;PHYH;TMEM134;MT1X;PDCD4;BLOC1S4;SPTB;SERPINB5;NOL4L;ALPK1;CAPN7;DNAH1;SLC27A3;ARSI;NEK9;TUBGCP5;RTN4RL1;ZFP36L2;CLTCL1;TRPV4;TMC6;FLOT1;GLI2;AGAP4;RHPN1;ANK3;RNF165;NAT6;DHX32;ADAMTS13;LAMP3;PLCH2;RALGAPA1;MAPK8IP3;GOLGA8B;CLMN;PIDD1;RIMS3;AVL9;G6PC3;ATG16L2;SPG11;ZCCHC11;ARHGEF19;RHBDF1;SULT1E1;FBXO44;RASGEF1A;ANKS6;PER2;PITPNM2;CLCN6;MICALCL;PTGS1;UNC119;DIRC2;HEXA;FNDC4;DTNB;FRMD4B;ARSD;WIPF1;SNTA1;PSKH1;MINK1;NINL;ABHD14B;GSTM2;THBS3;WWTR1;MBOAT2;ASAP2;ARHGEF4;LHFPL2;ITGA2;RSPH3;FAM110C;ULK1;GLI3;SPPL2B;FHOD3;PCSK1;TPGS1;AKAP7;BHLHE40;LRSAM1;VAMP2;ZNF655;NAIP;LTBP1;NEK8;MAP2K5;GAS8;SRGAP3;CES3;BSN;SESN3;ZNF318;LZTS1;IGFBP4;TRAK1;JARID2;NUPR1;PRR9;GPC2;NISCH;INSR;TST;IFI44;CCDC85B;HSF2BP;MMP28;GSN;ALDH4A1;CEP68;HEBP1;CHD3;CDK14;ST3GAL5;BAIAP2;TTN;SCNN1A;DDT;CEP126;SUN1;AHNAK2;RNPEPL1;PLEKHH2;TRIOBP;POLD4;RIN1;DNAJC30;CTSF;CD109;CYP2D7;PNMA1;PGLS;RMI2;ARHGEF1;SEPT6;FBXL16;RAB11FIP4;VPS39;MGST2;DOCK8;TP53AIP1;DHX58;ENDOG;SLC27A1;PGAP1;NRSN2;BLOC1S3;MDK;CASP14;IRF9;RICTOR;TMEM9;BMP6;NLRX1;B4GALT2;ETNK2;PEX10;SLC2A3;TCIRG1;S100A4;MICALL2;MAP2K2;OPLAH;PDK1;VEGFB;ALDH7A1;SQSTM1;CEP192;CABYR;PTK6;TMEM8B;FZD7;AKR7A2;LOXL1;SYNGAP1;FAM13A;FAM213A;TMEM117;LGALS9C;EPB41L3;SHARPIN;HEXB;HYAL1;METTL23;CLCA2;ARHGAP33;SH2D2A;ARRDC1;KIAA0319L;B3GNT9;WHAMMP3;CENPC;PLA2G6;CST3;HOMER2;CAPNS2;GDF15;PEX7;BBS2;TXNIP;ATP6V0A2;COL6A1;PEX11B;NPHP3;LRRCC1;IDH2;CERCAM;MAP3K12;WRN;PODXL;SEPT5;IFI27;MALL;OXLD1;DNM1;MACROD1;IQCB1;KLHL24;PLD3;TREX1;LPIN3;ZDHHC12;ABHD14A;MCTP1;CDK5R1;ARHGAP27;AGAP6;NET1;PIGZ;CA2;OSBPL10;PI4KAP1;HOOK2;SESN1;EPB41L4A;MAPK10;NKTR;SHANK3;HFE;SCART1;ADIRF;CYBA;TRIM38;DTX3;AGO4;HADH;RRM2B;SLIT3;CLIP2;KRT14;HLCS;SHC2;SPRY2;FBXO2;WASH3P;MEF2D;IFT140;GABBR1;XRN1;AGAP7P;RAB11FIP3;MLXIPL;CTSB;KLK5;NBPF15;FBXW7;ANKRD28;ING4;NUDT6;CDK5RAP3;ATXN1;NOTCH2NL;CCDC92;PAK6;DZIP1L;PGM1;MXI1;PFKFB2;RNF170;CHMP1B;THRA;TTC12;APC2;METTL21A;ACADS;ARAP1;ASTN2;GOLGA8N;ADARB1;RAI1;FMNL2;FAM185A;MX2;RPH3AL;SLC2A1;ACACB;OGDHL;NLRP1;FRAT1;ERMAP;REEP4;TK2;GPR155;LACTB2;BEX2;GLUL;TBC1D17;MIF4GD;NDST2;EPM2AIP1;TP53I13;FBXW5;PRR7;SRR;CAPG;LRP1;KLHDC8B;HLA-A;PEG3;TSNARE1;NPHP4;RGS12;CCDC136;ATE1;ACP5;MPG;PLA2G7;SYNPO2;RNPEP;C12ORF66;CENPH;RFX2;BRINP1;SLC48A1;BDH1;RIMKLB;PPCS;MYO3B;APPL2;HEXDC;WNK1;PMEL;BBS1;ATXN10;JPH2;PDE2A;SDHA;MAF;STK16;RET;ZMYND8;PRX;DAB2IP;CASZ1;RWDD3;ACOX3;CALCOCO1;SLC37A2;TEAD2;DDHD2;SHROOM2;FBXO4;RNF213;OLFM2;PIK3C3;IFI16;SYT7;FGFR4;BBS5;EXOC2;PIK3R2;RETSAT;OSBPL5;AREG;ABTB1;TMEM203;DEF6;KLHL3;SNCB;ETFB;MYO9A;RPS6KA5;APBB3;DLG5;BTG1;BST2;ZNF687;VDR;LETMD1;SNX21;ARHGEF17;CACNB3;PHF7;TNRC18;TNRC6C;EFS;NADK;ZMYM3;SIX5;HLTF;MARCH8;EHBP1;PCSK6;MPPE1;TNS4;PCMTD2;TBC1D16;NDUFV3;EML3;PPP1R2;DMTN;STAT2;SGSM2;ARFGEF2;LMTK3;ALMS1;PCMTD1;WWC3;PHF1;SLC36A4;TFDP2;SNX1;GOLGA7B;OSBPL1A;ACVR1B;TMX4;SHROOM4;TACC1;KDELC2;PRIMPOL;NECAB3;CCDC88B;DLG4;CCDC113;TNNI2;ESYT2;TSSK1B;IQSEC1;ALOXE3;ENDOU;MPI;IGFBP6;NBEAL2;CD68;GALE;WEE1;CCNG2;TMEM143;GTF2IRD2;GOLGA6L4;SLC35G2;DQX1;AMT;SHANK2;RSAD2;TNFRSF25;ZFP36L1;XYLT1;LMNA;MXRA8;CLSTN3;GLMP;ACSL1;IL11;KAT2B;MARK4;TEP1;APOLD1;IRS2;DMXL2;IMPA2;CEP250;ANO1;CAPS;METTL7A;ERN1;HSD17B14;SAC3D1;IVNS1ABP;ALOX15B;TKFC;LAPTM4A;ANGEL2;PNPO;MTR;MAN1B1;DHRS4;PEX1;ECI1;S100A6;TRERF1;UAP1L1;FAAH;SCYL3;SCG5;APBB2;CBR4;TTC19;ARHGEF9;ISYNA1;SGSH;PBLD;DCAF8;CCDC90B;TNFSF12;CERS5;STAT6;PCSK1N;PRDX5;PHPT1;TUB;KIF7;GLB1;GOLGA1;CPT1C;KLF8;GSTM3;TRAF5;GOLGB1;SRPX2;ACSS2;DPP7;TRIM2;CD9;PLIN4;RANBP9;PTPN3;CTSD;COL13A1;ERBB2;SYNGR1;MPRIP;PLCB3;NUDT10;ZDHHC24;ARHGAP23;ABCA2;AKAP6;TH;ATG14;SSH3;PPARG;PRKACA;DOCK6;LDLRAP1;CXXC5;C6ORF120;FMNL3;ACOT2;GCNT4;VMAC;SYNE2;PARD6G;ACKR3;SERPING1;SUCLG2;UCKL1;PARN;DOCK3;UFL1;LAMB2;RIPK3;NFASC;KLF9;PI4K2B;AIP;COG1;KCNS3;LONP2;PRMT3;SNX33;HARS2;CIT;EHHADH;CLCN7;MAP1A;CCDC3;PER3;HIVEP1;SMURF1;NPNT;TTLL1;EML2;CTNNBIP1;PEMT;OCIAD2;SERINC3;GCLC;ECM1
13451,GO:0055008,0.961305886559017,0.126553927942854,2,36,cardiac muscle tissue morphogenesis,BP,ZFPM1;TTN
1590,GO:0004004,0.961315277079538,0.106282169146935,3,59,ATP-dependent RNA helicase activity,MF,DDX59;DHX32;DQX1
19536,GO:1990542,0.961335658803144,0.105764269222438,3,67,mitochondrial transmembrane transport,BP,CPT2;TST;ACACB
15179,GO:0071347,0.961394214448443,0.079198769944696,7,124,cellular response to interleukin-1,BP,SFRP1;ADAMTS7;SQSTM1;HYAL1;DAB2IP;RPS6KA5;RORA
1460,GO:0003712,0.961477147179823,0.0547549078075017,37,455,transcription cofactor activity,MF,MNT;TRIM22;POU3F1;HR;TFCP2L1;CITED4;MAML3;NFATC4;HSF4;KLF7;SOX12;PER2;PHF2;WWTR1;THRAP3;BHLHE40;MXD4;RCOR2;LPIN3;ING4;MXI1;THRA;NAB2;ZMYND8;CALCOCO1;MYSM1;BTG1;VDR;TFDP2;GLMP;KAT2B;TRERF1;RORA;PPARG;RIPK3;AIP;SCAND1
12467,GO:0050435,0.961493860871296,0.171410226341539,1,29,amyloid-beta metabolic process,BP,APOE
7610,GO:0032008,0.961498450879097,0.171142388150229,1,30,positive regulation of TOR signaling,BP,RICTOR
18273,GO:1903201,0.96156386034133,0.124299736383908,2,48,regulation of oxidative stress-induced cell death,BP,ENDOG;FBXW7
14184,GO:0061136,0.961667268694824,0.0713428561300364,10,155,regulation of proteasomal protein catabolic process,BP,MDM2;LAMP3;RHBDF1;HFE;FBXW7;DAB2IP;PANO1;PRKACA;UFL1;GCLC
18881,GO:1904591,0.961688454901672,0.17076173454568,1,29,positive regulation of protein import,BP,GLI3
1043,GO:0002562,0.962118466636698,0.123172062983539,2,45,somatic diversification of immune receptors via germline recombination within a single locus,BP,TCF7;STAT6
5499,GO:0016444,0.962118466636698,0.123172062983539,2,45,somatic cell DNA recombination,BP,TCF7;STAT6
7850,GO:0032418,0.962195295982828,0.122661982257797,2,48,lysosome localization,BP,MAP6;ADORA2B
6441,GO:0021762,0.9622104342116,0.168531997361322,1,31,substantia nigra development,BP,GLUD1
3236,GO:0006891,0.962310674483686,0.168430361560351,1,30,intra-Golgi vesicle-mediated transport,BP,COG1
10775,GO:0044257,0.962383259656206,0.0508301737736571,53,635,cellular protein catabolic process,BP,TNFAIP3;APOE;FBXW4;CTSO;TMEM129;ADAMTS7;RBCK1;CUL9;UBXN4;ISG15;MVB12B;SPATA18;CUL7;MAGEF1;BTBD2;RNF187;VPS11;MDM2;SPSB3;CTSV;RNF165;LAMP3;RHBDF1;FBXO44;WWTR1;CBLC;CTSF;GID4;TCIRG1;SQSTM1;SHARPIN;ARRDC1;HFE;FBXO2;CTSB;FBXW7;CDK5RAP3;C17ORF97;FBXW5;LRP1;ATE1;DAB2IP;FBXO4;RNF213;ABTB1;KLHL3;PANO1;MAN1B1;PRKACA;UFL1;LONP2;SMURF1;GCLC
8688,GO:0034333,0.962560877053332,0.0930612702066039,4,70,adherens junction assembly,BP,SFRP1;ITGA2;DLG5;DMTN
10239,GO:0042987,0.962566820476333,0.167571184090084,1,30,amyloid precursor protein catabolic process,BP,APOE
17565,GO:1901222,0.962751086004745,0.12131287522714,2,47,regulation of NIK/NF-kappaB signaling,BP,EGFR;PDCD4
12627,GO:0050851,0.96299245472664,0.0690643853867543,10,162,antigen receptor-mediated signaling pathway,BP,INPP5D;PIK3R1;RBCK1;VAV3;TNFRSF21;ELF1;ERMAP;PIK3R2;CACNB3;PHPT1
12856,GO:0051204,0.963020343156299,0.165595885065945,1,32,protein insertion into mitochondrial membrane,BP,TFDP2
8013,GO:0032655,0.96317739410578,0.165283655717915,1,31,regulation of interleukin-12 production,BP,ACP5
7137,GO:0030990,0.963265418395288,0.165218246503128,1,30,intraciliary transport particle,CC,IFT140
6880,GO:0030397,0.963282063918597,0.120026467448261,2,46,membrane disassembly,BP,NEK9;LMNA
12767,GO:0051081,0.963282063918597,0.120026467448261,2,46,nuclear envelope disassembly,BP,NEK9;LMNA
2907,GO:0006418,0.963553988493234,0.119021720160817,2,49,tRNA aminoacylation for protein translation,BP,DALRD3;HARS2
1305,GO:0003151,0.963642709085834,0.119186338788455,2,45,outflow tract morphogenesis,BP,ZFPM1;PLXND1
3362,GO:0007099,0.963690034784396,0.164028257917242,1,29,centriole replication,BP,KAT2B
12834,GO:0051172,0.964041241208554,0.0434044100507445,162,1773,negative regulation of nitrogen compound metabolic process,BP,TNFAIP3;HES2;SERPINE2;IFI6;SREBF1;APOE;INPP5D;EGFR;CIRBP;CAPRIN2;MNT;TRIM22;SFRP1;EPHB2;DGKQ;KDM3A;TSC22D3;UNK;HR;ISG15;ELFN2;TFCP2L1;ZFPM1;IRF2BPL;STAT1;IMPACT;CAMK2N1;CRY2;CRY1;SCMH1;CRTAP;MAGEF1;NFATC4;HSF4;COL7A1;SPOCK1;EAPP;MDM2;PHACTR3;TCF25;FLRT3;RGS2;PDCD4;SERPINB5;RTN4RL1;ZFP36L2;TRPV4;GLI2;LAMP3;SLX1A;SLX1B;ZCCHC11;PER2;C5;ZNF658;SNTA1;PHF2;TCEAL1;WWTR1;GLI3;THRAP3;BHLHE40;NAIP;MAP2K5;ZNF318;TCFL5;JARID2;CCDC85B;CBLC;MXD4;CD109;RTF1;H2AFJ;BMP6;MAP2K2;SQSTM1;PTK6;KDM4C;ZNF608;CST3;TXNIP;RCOR2;IFI27;CDK5R1;ATRX;HFE;HMG20B;AGO4;SPRY2;GABBR1;XRN1;MLXIPL;FBXW7;GPR87;ING4;CDK5RAP3;ATXN1;NFIX;TFPI2;MXI1;THRA;ADARB1;IKZF4;NAB2;PEG3;ACP5;SALL2;WNK1;ZBTB20;PDE2A;MAF;LTB4R2;ZMYND8;DAB2IP;TSHZ2;IFI16;PIK3R2;RPS6KA5;BST2;VDR;TNRC18;TNRC6C;SIX5;PPP1R2;DMTN;PPP1R35;WWC3;PHF1;TFDP2;NRARP;PANO1;ZNF91;DYDC1;TCF7;ZFP36L1;KAT2B;RAD50;ANGEL2;PBLD;STAT6;PCSK1N;PRDX5;NELFCD;KLF8;RANBP9;PTPN3;ATG14;PPARG;CXXC5;SERPING1;PARN;UFL1;PRMT3;ZFP90;PER3;FOXP2;PTBP2;ZC3H6;HIVEP1;CTNNBIP1;GCLC;ECM1
7178,GO:0031072,0.964055633663868,0.078174505188584,6,103,heat shock protein binding,MF,HSPA2;MVD;FKBP5;METTL23;METTL21A;ERN1
10877,GO:0044431,0.964126489837311,0.047638356059094,62,715,Golgi apparatus part,CC,TGFBI;POSTN;MUC19;SREBF1;GPSM1;EGFR;PIK3R1;SULF2;WNT3;ST6GALNAC2;CSPG4;VAMP3;NSG1;RAB43;B4GALNT4;SDC3;SCARA3;COL7A1;ST6GALNAC6;GOLGA8A;HLA-B;GAL3ST4;B4GALT6;AP1G2;CLTCL1;MAPK8IP3;GOLGA8B;RHBDF1;ASAP2;SPPL2B;VAMP2;GPC2;ST3GAL5;B4GALT2;KIAA0319L;B3GNT9;MALL;ANKRD28;ARAP1;GOLGA8N;SLC2A1;NDST2;HLA-A;AREG;PCSK6;MPPE1;ARFGEF2;LMTK3;GOLGA7B;NECAB3;XYLT1;CLSTN3;MAN1B1;PCSK1N;GOLGA1;GOLGB1;LDLRAP1;GCNT4;PI4K2B;COG1;CIT;SERINC3
4450,GO:0010390,0.964181837439329,0.162355736474819,1,29,histone monoubiquitination,BP,DDB2
1466,GO:0003724,0.964322685249964,0.0993370816245681,3,60,RNA helicase activity,MF,DDX59;DHX32;DQX1
7595,GO:0031983,0.964353086253461,0.0604148470068073,15,230,vesicle lumen,CC,PYGB;APOE;EGFR;NAPRT;ACTR1B;PCSK1;GSN;VEGFB;HEXB;GLB1;DPP7;CTSD;C6ORF120;SERPING1;ECM1
4228,GO:0009408,0.96441131092765,0.0687407639946425,9,140,response to heat,BP,TP53INP1;HSPA2;NOS1;HSF4;TRPV4;LRP11;ANO1;PRKACA;GCLC
5525,GO:0016504,0.964489271546278,0.160618772906713,1,32,peptidase activator activity,MF,NLRP1
10428,GO:0043299,0.964503962478214,0.0530865275888653,28,377,leukocyte degranulation,BP,PYGB;CXCR1;KCNAB2;NAPRT;GAA;HGSNAT;ACTR1B;TMC6;ADORA2B;VAMP2;GSN;SLC2A3;TCIRG1;HEXB;CST3;CYBA;CTSB;PGM1;BST2;NBEAL2;CD68;METTL7A;GLB1;DPP7;CTSD;SYNGR1;C6ORF120;NFASC
3682,GO:0008186,0.964637494079366,0.0986100606915992,3,60,RNA-dependent ATPase activity,MF,DDX59;DHX32;DQX1
12399,GO:0048863,0.964639488107111,0.0631871225352351,12,200,stem cell differentiation,BP,SFRP1;KDM3A;WNT3;KITLG;ZFP36L2;SEMA4G;LTBP3;JARID2;KDM4C;LMO2;RET;TEAD2
3245,GO:0006903,0.964915422590396,0.0877946824317379,4,77,vesicle targeting,BP,COL7A1;SEPT5;ANKRD28;AREG
9533,GO:0036297,0.964919032225592,0.115517749159775,2,48,interstrand cross-link repair,BP,SLX1A;SLX1B
13208,GO:0051893,0.964974033323358,0.115780340033681,2,44,regulation of focal adhesion assembly,BP,SFRP1;DMTN
16100,GO:0090109,0.964974033323358,0.115780340033681,2,44,regulation of cell-substrate junction assembly,BP,SFRP1;DMTN
7128,GO:0030968,0.9649933924023,0.0728172213238107,7,117,endoplasmic reticulum unfolded protein response,BP,PIK3R1;CUL7;CREBRF;CDK5RAP3;DAB2IP;LMNA;ERN1
6919,GO:0030518,0.965005316941609,0.0728709811135621,7,113,intracellular steroid hormone receptor signaling pathway,BP,SFRP1;KDM3A;CRY2;CRY1;THRAP3;CALCOCO1;UFL1
2864,GO:0006356,0.96504903460869,0.159145034124715,1,30,regulation of transcription by RNA polymerase I,BP,ERBB2
15254,GO:0071456,0.965049061639774,0.0675223776995052,9,150,cellular response to hypoxia,BP,SFRP1;NDRG1;MDM2;ENDOG;PDK1;RWDD3;ZFP36L1;LMNA;RORA
9847,GO:0042108,0.965152486199056,0.158789805606696,1,30,positive regulation of cytokine biosynthetic process,BP,ZFPM1
6899,GO:0030488,0.965310931131255,0.157806399927986,1,32,tRNA methylation,BP,TARBP1
2454,GO:0005667,0.965461163430002,0.0558315655997335,19,260,transcription factor complex,CC,POU3F1;ZFPM1;NFATC4;WWTR1;TCF4;RCOR2;MLXIPL;LMO2;MXI1;THRA;TEAD2;ERCC5;VDR;TFDP2;TCF7;IVNS1ABP;TRERF1;RORA;PPARG
16103,GO:0090114,0.965728579811543,0.0959057810267321,3,63,COPII-coated vesicle budding,BP,COL7A1;ANKRD28;AREG
797,GO:0002067,0.965811588741209,0.156518747327968,1,30,glandular epithelial cell differentiation,BP,BMP6
4956,GO:0015030,0.965945971264355,0.112530429913315,2,51,Cajal body,CC,TRIM22;ANGEL2
9059,GO:0035307,0.965952739722934,0.156030604536594,1,30,positive regulation of protein dephosphorylation,BP,AKAP6
16467,GO:0097178,0.966072519324607,0.155391119037543,1,31,ruffle assembly,BP,EPS8L2
1174,GO:0002821,0.966393493675208,0.111504550294292,2,49,positive regulation of adaptive immune response,BP,RSAD2;STAT6
10197,GO:0042826,0.966602536629594,0.0779085225047077,5,89,histone deacetylase binding,MF,CRY1;GLI3;MEF2D;KAT2B;UHRF1BP1
5278,GO:0015932,0.966606110057664,0.153330453816593,1,32,nucleobase-containing compound transmembrane transporter activity,MF,SLC29A4
11840,GO:0046839,0.966606906153966,0.153999359371439,1,29,phospholipid dephosphorylation,BP,INPP5D
20031,GO:2000677,0.966643522313189,0.153200367090848,1,32,regulation of transcription regulatory region DNA binding,BP,PER2
12109,GO:0048199,0.966844156623303,0.0932510410863858,3,64,vesicle targeting, to, from or within Golgi,BP,COL7A1;ANKRD28;AREG
7988,GO:0032615,0.966889107755886,0.152345311193569,1,32,interleukin-12 production,BP,ACP5
17810,GO:1901991,0.96688942203318,0.0584598252868898,13,202,negative regulation of mitotic cell cycle phase transition,BP,GPNMB;PKD2;BRSK1;MDM2;PCBP4;ZFP36L2;PIDD1;GJC2;ZNF655;CDK5RAP3;TFDP2;ZFP36L1;GPR132
780,GO:0002039,0.966936823575984,0.0931990946804268,3,61,p53 binding,MF,MDM2;TEP1;ZMAT3
14727,GO:0070423,0.96712172623603,0.151741235652979,1,31,nucleotide-binding oligomerization domain containing signaling pathway,BP,TNFAIP3
13727,GO:0060323,0.967135989990401,0.151913351696808,1,30,head morphogenesis,BP,WNT3
9419,GO:0036002,0.967155717303897,0.15141482857001,1,32,pre-mRNA binding,MF,PTBP2
16734,GO:0098534,0.967266779095279,0.151455449117191,1,30,centriole assembly,BP,KAT2B
12233,GO:0048524,0.967480841858459,0.0759832073764949,5,95,positive regulation of viral process,BP,APOE;MVB12B;TRIM38;ADARB1;NELFCD
6749,GO:0030177,0.967535957899182,0.0654216267853751,8,135,positive regulation of Wnt signaling pathway,BP,CAPRIN2;DIXDC1;SFRP1;SULF2;WNT3;NAIP;WNK1;NRARP
6003,GO:0019048,0.967699123316908,0.149937729378168,1,30,modulation by virus of host morphology or physiology,BP,INSR
7436,GO:0031577,0.967727495175689,0.14941138400458,1,32,spindle checkpoint,BP,NDRG1
2543,GO:0005811,0.96829208754182,0.0898486060202769,3,64,lipid droplet,CC,RSAD2;METTL7A;PLIN4
11056,GO:0045070,0.968461681895948,0.147027044727368,1,31,positive regulation of viral genome replication,BP,ADARB1
12770,GO:0051084,0.968577672975767,0.146412156177828,1,32,'de novo' posttranslational protein folding,BP,HSPA2
13197,GO:0051879,0.968683334913653,0.146241354198671,1,31,Hsp90 protein binding,MF,ERN1
531,GO:0001650,0.968747409751256,0.0659043095096808,7,118,fibrillar center,CC,MAP3K14;TFCP2L1;B3GNT9;SESN1;PAK6;RSAD2;IP6K2
19021,GO:1904888,0.96885353680505,0.10513709807842,2,46,cranial skeletal system development,BP,GLI3;IFT140
8944,GO:0035019,0.96902742185352,0.104393380425867,2,49,somatic stem cell population maintenance,BP,SFRP1;ZFP36L2
15309,GO:0071548,0.969153667709745,0.144366085757754,1,32,response to dexamethasone,BP,EGFR
10984,GO:0044798,0.969301650296402,0.0584936723412395,10,157,nuclear transcription factor complex,CC,NFATC4;TCF4;MXI1;THRA;TEAD2;ERCC5;VDR;TFDP2;RORA;PPARG
12916,GO:0051293,0.96951229182563,0.143503220856728,1,30,establishment of spindle localization,BP,SPRY2
9854,GO:0042119,0.969569803101243,0.0466215438645106,26,359,neutrophil activation,BP,PYGB;CXCR1;KCNAB2;NAPRT;GAA;HGSNAT;ACTR1B;TMC6;GSN;SLC2A3;TCIRG1;HEXB;CST3;CYBA;CTSB;PGM1;BST2;NBEAL2;CD68;METTL7A;GLB1;DPP7;CTSD;SYNGR1;C6ORF120;NFASC
1462,GO:0003714,0.969762455922179,0.0550269278527365,12,178,transcription corepressor activity,MF,MNT;TRIM22;HR;TFCP2L1;HSF4;WWTR1;BHLHE40;MXD4;RCOR2;MXI1;NAB2;ZMYND8
12924,GO:0051303,0.970035134730098,0.085661591609468,3,65,establishment of chromosome localization,BP,SUN1;CENPC;CHMP1B
956,GO:0002377,0.970087184295233,0.0855859934783362,3,64,immunoglobulin production,BP,PMS2P3;STAT6;POLM
13796,GO:0060412,0.970302166196288,0.140663859245456,1,30,ventricular septum morphogenesis,BP,ZFPM1
9349,GO:0035872,0.970346139296439,0.140092889023088,1,32,nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway,BP,TNFAIP3
273,GO:0000776,0.97039593474027,0.0627919133465856,7,121,kinetochore,CC,PHF2;SEPT6;CENPC;REC8;CENPH;ZNF276;KAT2B
8667,GO:0034250,0.970707388264737,0.0621953402981716,7,122,positive regulation of cellular amide metabolic process,BP,CIRBP;RBM3;IMPACT;ITGA2;PLA2G6;ERBB2;PPARG
895,GO:0002275,0.970780541798576,0.0442822476178676,28,382,myeloid cell activation involved in immune response,BP,PYGB;CXCR1;KCNAB2;NAPRT;GAA;HGSNAT;ACTR1B;TMC6;ADORA2B;VAMP2;GSN;SLC2A3;TCIRG1;HEXB;CST3;CYBA;CTSB;PGM1;BST2;NBEAL2;CD68;METTL7A;GLB1;DPP7;CTSD;SYNGR1;C6ORF120;NFASC
9031,GO:0035257,0.970856610863215,0.059527399285529,8,130,nuclear hormone receptor binding,MF,KDM3A;STAT1;CRY1;THRAP3;KDM4C;VDR;PPARG;FOXP2
2947,GO:0006476,0.970878092239304,0.0692092091178352,5,90,protein deacetylation,BP,SREBF1;PER2;CHD3;HMG20B;HDAC11
10276,GO:0043039,0.970878895259396,0.0990794418211708,2,52,tRNA aminoacylation,BP,DALRD3;HARS2
8302,GO:0033146,0.970913040094114,0.138240955517497,1,31,regulation of intracellular estrogen receptor signaling pathway,BP,UFL1
10165,GO:0042770,0.97091473632463,0.0618226975946466,7,121,signal transduction in response to DNA damage,BP,NDRG1;MDM2;PCBP4;PIDD1;ATRX;ING4;TFDP2
5829,GO:0017112,0.970979752684923,0.0990298373027859,2,49,Rab guanyl-nucleotide exchange factor activity,MF,ALS2CL;RIN1
10859,GO:0044403,0.970985178446683,0.0394149788258655,56,714,symbiont process,BP,ITGB6;ULK2;APOE;OAS2;EGFR;APOBEC3C;TRIM22;PIK3R1;RBCK1;ISG15;MVB12B;CUL7;STAT1;ITGB5;RAB43;PIK3C2G;MDM2;CRTC1;IFITM1;HLA-B;OAS1;AP1G2;LAMP3;ATG16L2;TNFRSF14;ITGA2;ULK1;LRSAM1;MMP1;INSR;GSN;SEPT6;RAB11FIP4;DHX58;NLRX1;SQSTM1;EFNB3;TRIM38;CTSB;FBXW7;CHMP1B;ADARB1;NLRP1;HLA-A;IFI16;EXOC2;BST2;STAT2;RSAD2;KAT2B;IVNS1ABP;RAD50;NELFCD;CHD6;ACKR3;UCKL1
20070,GO:2000756,0.971095430751664,0.0986300414881632,2,50,regulation of peptidyl-lysine acetylation,BP,NOS1;RPS6KA5
5737,GO:0016887,0.971209444601685,0.0437520322056272,28,349,ATPase activity,MF,HSPA2;KIF26B;WDR63;MLH3;DDX59;KIF26A;DNAH1;DHX32;SMARCA1;CHD3;PMS2P3;TCIRG1;ATP6V0A2;WRN;ATRX;ERCC6;RNF213;HLTF;DQX1;RAD50;PEX1;KIF7;CHD6;ABCA2;DDX12P;LONP2;MSH5;ABCA11P
10291,GO:0043069,0.971213827379994,0.0396555764150392,51,626,negative regulation of programmed cell death,BP,TNFAIP3;IFI6;APOE;EGFR;MNT;SFRP1;EPHB2;PIK3R1;RBCK1;TSC22D3;KITLG;UNC5B;MDM2;TNFSF10;F2R;PDCD4;GLI2;LAMP3;PIDD1;AMIGO2;GLI3;NAIP;MAP2K5;ITGA6;INSR;DOCK8;TM7SF3;MDK;SQSTM1;SYNGAP1;MAP3K12;AGO4;RRM2B;SPRY2;LRP1;RET;FGFR4;ERCC5;SNCB;RGL2;PALB2;TCF7;LMNA;IRS2;IVNS1ABP;APBB2;PRDX5;ERBB2;ACKR3;UFL1;GCLC
6602,GO:0022804,0.971268085553573,0.0505728963922883,14,200,active transmembrane transporter activity,MF,SLC16A5;SLC29A4;SLC24A1;SLC13A5;CLCN6;TCIRG1;SLC12A7;ATP6V0A2;SLC38A4;SLC37A2;SLC36A4;ABCA2;CLCN7;ABCA11P
10742,GO:0044183,0.971354638478406,0.13608157322792,1,34,protein binding involved in protein folding,MF,HSPA2
12850,GO:0051193,0.971586326456739,0.0733954572359699,4,77,regulation of cofactor metabolic process,BP,INSR;PDK1;MLXIPL;PFKFB2
12510,GO:0050671,0.971809169865331,0.0812272116011197,3,69,positive regulation of lymphocyte proliferation,BP,VAV3;CCDC88B;IRS2
16545,GO:0097352,0.971813037791428,0.134410259527593,1,34,autophagosome maturation,BP,ATG14
2975,GO:0006517,0.971945040870294,0.134281299910918,1,32,protein deglycosylation,BP,MAN1B1
18597,GO:1903902,0.972009130953056,0.0960151512810079,2,51,positive regulation of viral life cycle,BP,TRIM38;ADARB1
2845,GO:0006323,0.972050063912117,0.055197148224353,9,166,DNA packaging,BP,H1F0;TTN;H1FX;CENPC;ATRX;TSPYL4;CENPH;TNRC18;NAP1L5
4311,GO:0009791,0.972069876694553,0.0723987882546565,4,75,post-embryonic development,BP,NDN;ETNK2;ATRX;FOXP2
17562,GO:1901214,0.972083394361918,0.0492303907214869,14,206,regulation of neuron death,BP,GPNMB;APOE;UNC5B;F2R;NAIP;MDK;SYNGAP1;MAP3K12;CDK5R1;FBXW7;LRP1;SNCB;TRIM2;GCLC
15867,GO:0072655,0.972117916103014,0.0551543197166827,9,157,establishment of protein localization to mitochondrion,BP,SREBF1;VPS11;HPS4;MICALL2;OSCP1;FBXW7;TFDP2;AIP;PEMT
6949,GO:0030593,0.97213482746341,0.13277685188674,1,37,neutrophil chemotaxis,BP,VAV3
989,GO:0002446,0.972188867754265,0.0428750177808394,26,361,neutrophil mediated immunity,BP,PYGB;CXCR1;KCNAB2;NAPRT;GAA;HGSNAT;ACTR1B;TMC6;GSN;SLC2A3;TCIRG1;HEXB;CST3;CYBA;CTSB;PGM1;BST2;NBEAL2;CD68;METTL7A;GLB1;DPP7;CTSD;SYNGR1;C6ORF120;NFASC
2852,GO:0006338,0.972251764862404,0.0549362596358593,9,155,chromatin remodeling,BP,SCMH1;SMARCA1;CENPC;ATRX;HMG20B;CENPH;MYSM1;TNRC18;KAT2B
10526,GO:0043488,0.972258952516644,0.0568501972928139,8,141,regulation of mRNA stability,BP,CIRBP;PCBP4;ZFP36L2;THRAP3;XRN1;ZFP36L1;ANGEL2;PARN
16229,GO:0090305,0.972292684716346,0.0466784923542997,17,250,nucleic acid phosphodiester bond hydrolysis,BP,DDB2;H1F0;ENDOD1;SLX1A;SLX1B;POLD4;ENDOG;PGAP1;WRN;TREX1;XRN1;LACTB2;ERCC5;ENDOU;ERN1;RAD50;PARN
16235,GO:0090311,0.972456803199908,0.132400551232937,1,32,regulation of protein deacetylation,BP,SREBF1
13263,GO:0051973,0.972462249822921,0.13219944351624,1,33,positive regulation of telomerase activity,BP,PARN
7323,GO:0031341,0.97249458645305,0.131750539020499,1,35,regulation of cell killing,BP,RIPK3
10530,GO:0043492,0.972514967639696,0.0713790045340409,4,76,ATPase activity, coupled to movement of substances,MF,TCIRG1;ATP6V0A2;ABCA2;ABCA11P
12416,GO:0050000,0.972800059446227,0.0789538600581774,3,66,chromosome localization,BP,SUN1;CENPC;CHMP1B
1358,GO:0003231,0.972976597225591,0.0703894051955624,4,75,cardiac ventricle development,BP,ZFPM1;MDM2;LTBP1;PTK7
19866,GO:2000377,0.973149409594893,0.0605110010722892,6,110,regulation of reactive oxygen species metabolic process,BP,EGFR;PKD2;INSR;CYBA;ACP5;RIPK3
6748,GO:0030176,0.973377056695651,0.0571465112879486,7,124,integral component of endoplasmic reticulum membrane,CC,PKD2;HLA-B;G6PC3;SPPL2B;HLA-A;SLC37A2;ERN1
11989,GO:0047485,0.973442710782601,0.0637704761220278,5,96,protein N-terminus binding,MF,MDM2;ERCC6;ZMYND8;ERCC5;EXOC2
116,GO:0000245,0.973496631441573,0.0917038199137415,2,53,spliceosomal complex assembly,BP,SRSF5;PTBP2
10275,GO:0043038,0.973581678452189,0.0914637944639363,2,53,amino acid activation,BP,DALRD3;HARS2
987,GO:0002444,0.973705886042454,0.0401285548199459,28,385,myeloid leukocyte mediated immunity,BP,PYGB;CXCR1;KCNAB2;NAPRT;GAA;HGSNAT;ACTR1B;TMC6;ADORA2B;VAMP2;GSN;SLC2A3;TCIRG1;HEXB;CST3;CYBA;CTSB;PGM1;BST2;NBEAL2;CD68;METTL7A;GLB1;DPP7;CTSD;SYNGR1;C6ORF120;NFASC
15120,GO:0071242,0.973746509371866,0.127437169963752,1,33,cellular response to ammonium ion,BP,CDK5R1
3334,GO:0007045,0.973824684245622,0.0766858425056908,3,61,cell-substrate adherens junction assembly,BP,SFRP1;ITGA2;DMTN
12071,GO:0048041,0.973824684245622,0.0766858425056908,3,61,focal adhesion assembly,BP,SFRP1;ITGA2;DMTN
8256,GO:0033048,0.973839542647301,0.12692325361799,1,34,negative regulation of mitotic sister chromatid segregation,BP,ATRX
9397,GO:0035967,0.973932425086939,0.0520304781414201,9,147,cellular response to topologically incorrect protein,BP,HSPA2;PIK3R1;CUL7;TM7SF3;CREBRF;CDK5RAP3;DAB2IP;LMNA;ERN1
8191,GO:0032946,0.973970184889844,0.0759340600125533,3,70,positive regulation of mononuclear cell proliferation,BP,VAV3;CCDC88B;IRS2
12237,GO:0048534,0.973999564022374,0.036208106443841,49,616,hematopoietic or lymphoid organ development,BP,INPP5D;FAM20C;ASH2L;SFRP1;PIK3R1;DHTKD1;KCNAB2;ZFPM1;KITLG;STAT1;MYL9;HOXA3;KLF13;CYP26B1;FAM210B;ZNF160;ZFP36L2;GLI2;GLI3;JARID2;CD109;FZD7;FAM213A;CA2;AGO4;FBXW7;LMO2;THRA;RET;IFI16;TNRC6C;DMTN;NRARP;ACVR1B;NBEAL2;TCF7;RSAD2;ZFP36L1;IL11;KAT2B;STAT6;SOX13;ERBB2;GPR68;RORA;PPARG;POLM;RIPK3;CTNNBIP1
17513,GO:1901030,0.974041672505837,0.126011405634373,1,35,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,BP,TFDP2
19720,GO:2000113,0.974154408027786,0.03306591048653,97,1114,negative regulation of cellular macromolecule biosynthetic process,BP,HES2;SREBF1;EGFR;CIRBP;CAPRIN2;MNT;SFRP1;TSC22D3;UNK;HR;TFCP2L1;ZFPM1;IRF2BPL;STAT1;IMPACT;CRY2;CRY1;SCMH1;NFATC4;HSF4;EAPP;MDM2;TCF25;PDCD4;ZFP36L2;TRPV4;GLI2;ZCCHC11;PER2;ZNF658;PHF2;TCEAL1;WWTR1;GLI3;BHLHE40;MAP2K5;ZNF318;TCFL5;JARID2;CCDC85B;MXD4;RTF1;H2AFJ;BMP6;MAP2K2;SQSTM1;ZNF608;TXNIP;RCOR2;IFI27;CDK5R1;ATRX;AGO4;XRN1;MLXIPL;FBXW7;ING4;ATXN1;NFIX;MXI1;THRA;IKZF4;NAB2;PEG3;SALL2;ZBTB20;PDE2A;MAF;ZMYND8;DAB2IP;TSHZ2;IFI16;RPS6KA5;VDR;TNRC18;TNRC6C;SIX5;WWC3;TFDP2;NRARP;ZNF91;DYDC1;TCF7;ZFP36L1;STAT6;PRDX5;NELFCD;KLF8;PPARG;CXXC5;ZFP90;PER3;FOXP2;ZC3H6;HIVEP1;CTNNBIP1;GCLC
5094,GO:0015370,0.974336584566717,0.125589502439952,1,31,solute:sodium symporter activity,MF,SLC13A5
13795,GO:0060411,0.974462426278105,0.0893256539359065,2,48,cardiac septum morphogenesis,BP,ZFPM1;MDM2
18361,GO:1903391,0.974471757032032,0.0893802127868092,2,47,regulation of adherens junction organization,BP,SFRP1;DMTN
731,GO:0001961,0.974541483003297,0.124455308686266,1,33,positive regulation of cytokine-mediated signaling pathway,BP,CREBRF
7307,GO:0031324,0.974554571164871,0.030918758536689,172,1888,negative regulation of cellular metabolic process,BP,TNFAIP3;HES2;SERPINE2;SIK1;IFI6;SREBF1;APOE;INPP5D;EGFR;CIRBP;CAPRIN2;MNT;TRIM22;SFRP1;EPHB2;DGKQ;KDM3A;TSC22D3;UNK;HR;ISG15;ELFN2;TFCP2L1;ZFPM1;IRF2BPL;STAT1;IMPACT;CAMK2N1;CRY2;CRY1;SCMH1;CRTAP;MAGEF1;NFATC4;HSF4;COL7A1;SPOCK1;EAPP;MDM2;PIK3IP1;PHACTR3;TCF25;FLRT3;RGS2;PDCD4;SERPINB5;RTN4RL1;ZFP36L2;TRPV4;GLI2;LAMP3;SLX1A;SLX1B;ZCCHC11;PER2;C5;ZNF658;SNTA1;PHF2;TCEAL1;WWTR1;GLI3;THRAP3;BHLHE40;NAIP;MAP2K5;ZNF318;LZTS1;TCFL5;JARID2;CCDC85B;CBLC;MXD4;CD109;SLC27A1;RTF1;H2AFJ;BMP6;MAP2K2;SQSTM1;CEP192;PTK6;KDM4C;ZNF608;CST3;TXNIP;RCOR2;IFI27;CDK5R1;ATRX;HFE;HMG20B;AGO4;SPRY2;GABBR1;XRN1;MLXIPL;FBXW7;GPR87;ING4;CDK5RAP3;ATXN1;NFIX;TFPI2;MXI1;THRA;ADARB1;IKZF4;ACACB;NAB2;PEG3;ACP5;SALL2;WNK1;ZBTB20;PDE2A;MAF;LTB4R2;ZMYND8;DAB2IP;TSHZ2;IFI16;PIK3R2;RPS6KA5;BST2;VDR;TNRC18;TNRC6C;SIX5;PPP1R2;DMTN;PPP1R35;LMTK3;WWC3;PHF1;TFDP2;NRARP;DLG4;PANO1;ZNF91;DYDC1;TCF7;ZFP36L1;KAT2B;IRS2;RAD50;ANGEL2;PBLD;STAT6;PCSK1N;PRDX5;NELFCD;KLF8;RANBP9;PTPN3;SPOCD1;ATG14;PPARG;CXXC5;SERPING1;PARN;UFL1;PRMT3;ZFP90;PER3;FOXP2;PTBP2;ZC3H6;HIVEP1;CTNNBIP1;GCLC;ECM1
986,GO:0002443,0.974715625310586,0.0366746541935338,38,499,leukocyte mediated immunity,BP,PYGB;INPP5D;CXCR1;KCNAB2;NAPRT;GAA;HGSNAT;ACTR1B;IL20RB;TMC6;ADORA2B;C5;VAMP2;GSN;SLC2A3;TCIRG1;HEXB;CST3;HFE;SCART1;CYBA;CTSB;PGM1;C1RL;BST2;NBEAL2;CD68;RSAD2;METTL7A;STAT6;GLB1;DPP7;CTSD;SYNGR1;C6ORF120;SERPING1;RIPK3;NFASC
3665,GO:0008156,0.974728462481085,0.123750083667974,1,33,negative regulation of DNA replication,BP,FBXW7
4967,GO:0015078,0.974736264276004,0.0738784410594736,3,75,proton transmembrane transporter activity,MF,NDUFA4L2;TCIRG1;ATP6V0A2
3896,GO:0008536,0.974746330234679,0.123857046516898,1,32,Ran GTPase binding,MF,RANBP9
18124,GO:1902883,0.974827272647879,0.123059335851357,1,35,negative regulation of response to oxidative stress,BP,MCTP1
1340,GO:0003205,0.974964191807647,0.0570555448258836,6,102,cardiac chamber development,BP,ZFPM1;MDM2;LTBP1;NPHP3;PLXND1;PTK7
10963,GO:0044766,0.975169353128021,0.0730588553092368,3,68,multi-organism transport,BP,MVB12B;RAB40B;BST2
18027,GO:1902579,0.975169353128021,0.0730588553092368,3,68,multi-organism localization,BP,MVB12B;RAB40B;BST2
8220,GO:0032993,0.975252893937828,0.0531999204923111,7,163,protein-DNA complex,CC,H1F0;SOX12;NUPR1;POLD4;H2AFJ;H1FX;ERCC5
11503,GO:0046034,0.975341661119393,0.0455859497587222,12,208,ATP metabolic process,BP,FAM20C;DHTKD1;INSR;TCIRG1;ATP6V0A2;MLXIPL;PGM1;PFKFB2;OGDHL;SDHA;NADK;NDUFV3
17855,GO:1902115,0.975360397373871,0.0495153111520914,9,143,regulation of organelle assembly,BP,EVI5L;VPS11;ULK1;LRSAM1;GSN;IFT140;CHMP1B;KAT2B;SYNE2
174,GO:0000381,0.975603484187735,0.120429625530143,1,33,regulation of alternative mRNA splicing, via spliceosome,BP,THRAP3
7317,GO:0031334,0.975639535375816,0.0442891268008833,13,197,positive regulation of protein complex assembly,BP,DDB2;RGS2;ARPIN;WIPF1;MMP1;GSN;BAIAP2;RICTOR;WHAMMP3;CDK5R1;WASH3P;ERCC5;MPP7
865,GO:0002204,0.975673770569336,0.120161444256935,1,33,somatic recombination of immunoglobulin genes involved in immune response,BP,STAT6
866,GO:0002208,0.975673770569336,0.120161444256935,1,33,somatic diversification of immunoglobulins involved in immune response,BP,STAT6
11130,GO:0045190,0.975673770569336,0.120161444256935,1,33,isotype switching,BP,STAT6
7931,GO:0032527,0.975800943799128,0.119514889000151,1,34,protein exit from endoplasmic reticulum,BP,TMEM129
4061,GO:0009112,0.975890363217862,0.119022142521806,1,35,nucleobase metabolic process,BP,UCKL1
15941,GO:0075733,0.975944298492328,0.0847875403248,2,52,intracellular transport of virus,BP,MVB12B;BST2
12323,GO:0048701,0.975957717208198,0.119246482663767,1,32,embryonic cranial skeleton morphogenesis,BP,IFT140
6855,GO:0030331,0.975969850653909,0.119029302788345,1,33,estrogen receptor binding,MF,PPARG
2853,GO:0006342,0.975983603422246,0.06291862434223,4,107,chromatin silencing,BP,PHF2;H2AFJ;TNRC18;DYDC1
17465,GO:1900407,0.976067436472782,0.0843685231267463,2,53,regulation of cellular response to oxidative stress,BP,ENDOG;FBXW7
1071,GO:0002637,0.976144517914784,0.118199816241281,1,34,regulation of immunoglobulin production,BP,STAT6
10092,GO:0042623,0.976197853560555,0.038424263843304,22,290,ATPase activity, coupled,MF,HSPA2;WDR63;DDX59;DNAH1;DHX32;SMARCA1;CHD3;TCIRG1;ATP6V0A2;WRN;ATRX;ERCC6;DQX1;RAD50;PEX1;KIF7;CHD6;ABCA2;DDX12P;LONP2;MSH5;ABCA11P
3337,GO:0007051,0.976340886450408,0.0463169084407784,10,156,spindle organization,BP,GOLGA8A;TUBGCP5;GOLGA8B;NAIP;CHD3;CEP126;CEP192;ATRX;CHMP1B;GOLGA8N
10164,GO:0042769,0.976348552472297,0.116992278316348,1,37,DNA damage response, detection of DNA damage,BP,POLD4
6692,GO:0030097,0.976371186951079,0.0333824900577704,46,587,hemopoiesis,BP,INPP5D;FAM20C;ASH2L;SFRP1;PIK3R1;DHTKD1;KCNAB2;ZFPM1;KITLG;STAT1;MYL9;KLF13;CYP26B1;FAM210B;ZNF160;ZFP36L2;GLI2;GLI3;CD109;FZD7;FAM213A;CA2;AGO4;FBXW7;LMO2;THRA;IFI16;TNRC6C;DMTN;NRARP;ACVR1B;NBEAL2;TCF7;RSAD2;ZFP36L1;IL11;KAT2B;STAT6;SOX13;ERBB2;GPR68;RORA;PPARG;POLM;RIPK3;CTNNBIP1
6351,GO:0021536,0.976492852100605,0.117019736152504,1,33,diencephalon development,BP,GLI2
32,GO:0000060,0.976578392220885,0.116382362538202,1,35,protein import into nucleus, translocation,BP,PDE2A
4548,GO:0010632,0.97658754069167,0.0458910436674049,10,155,regulation of epithelial cell migration,BP,APOE;CAPN7;ITGA2;MAP2K5;HYAL1;MMRN2;DAB2IP;PBLD;SRPX2;PPARG
7193,GO:0031090,0.976592094320142,0.0281942786508044,200,2219,organelle membrane,CC,ULK2;MAP6;SREBF1;APOE;GPSM1;EGFR;PTPRS;PKD2;SYT8;CXCR1;CPT2;SYN1;LRIG3;BPHL;DGKQ;EVC;WNT3;ST6GALNAC2;MVB12B;CYBRD1;SPATA18;KCNAB2;VAMP3;SNN;PRICKLE2;NSG1;RAB43;RAB40B;NOS1;B4GALNT4;HMGCL;SCARA3;CYP26B1;GAA;MICALL1;VPS11;NDRG1;COL7A1;ITPR3;MDM2;ST6GALNAC6;GOLGA8A;GPRC5C;HLA-B;PRODH;HGSNAT;NDUFA4L2;CERS4;CYP3A5;FAM210B;GAL3ST4;CRAT;B4GALT6;AP1G2;C2CD4C;SLC27A3;CLTCL1;TMC6;FLOT1;LAMP3;MAPK8IP3;GOLGA8B;ATG16L2;SPG11;RHBDF1;SULT1E1;CLCN6;PTGS1;DIRC2;ASAP2;LHFPL2;ULK1;SPPL2B;VAMP2;INSR;TST;ST3GAL5;SCNN1A;SUN1;AHNAK2;CD109;RAB11FIP4;VPS39;MGST2;TMEM9;NLRX1;B4GALT2;PEX10;SLC2A3;TCIRG1;MAP2K2;FZD7;CLCA2;KIAA0319L;B3GNT9;WHAMMP3;CST3;BBS2;ATP6V0A2;KLHDC2;COL6A1;PEX11B;IDH2;IFI27;MALL;DNM1;MCTP1;SHANK3;CYBA;HADH;FBXO2;WASH3P;RAB11FIP3;ANKRD28;CHMP1B;ARAP1;GOLGA8N;MX2;RPH3AL;SLC2A1;ACACB;NDST2;LRP1;HLA-A;CCDC136;C12ORF66;SLC48A1;BDH1;APPL2;PMEL;BBS1;JPH2;PDE2A;SDHA;RET;PIK3C3;SYT7;BBS5;RETSAT;AREG;BST2;LETMD1;SNX21;TNRC18;DPY19L2P2;MARCH8;MPPE1;NDUFV3;DMTN;ARFGEF2;LMTK3;SLC36A4;TMEM231;SNX1;GOLGA7B;DLG4;NBEAL2;CD68;SHANK2;RSAD2;NEMP2;XYLT1;LMNA;CLSTN3;GLMP;ACSL1;DMXL2;ERN1;LAPTM4A;MAN1B1;DHRS4;PEX1;ECI1;FAAH;TTC19;CCDC90B;CERS5;STAT6;GOLGA1;CPT1C;GOLGB1;CD9;ERBB2;SYNGR1;ABCA2;AKAP6;TH;ATG14;LDLRAP1;NPAP1;GCNT4;SYNE2;NFASC;PI4K2B;COG1;SNX33;CLCN7;PEMT;OCIAD2;SERINC3
7310,GO:0031327,0.976628851213355,0.0297689897968318,105,1202,negative regulation of cellular biosynthetic process,BP,HES2;SIK1;SREBF1;INPP5D;EGFR;CIRBP;CAPRIN2;MNT;TRIM22;SFRP1;TSC22D3;UNK;HR;TFCP2L1;ZFPM1;IRF2BPL;STAT1;IMPACT;CRY2;CRY1;SCMH1;NFATC4;HSF4;EAPP;MDM2;TCF25;PDCD4;ZFP36L2;TRPV4;GLI2;ZCCHC11;PER2;ZNF658;PHF2;TCEAL1;WWTR1;GLI3;BHLHE40;MAP2K5;ZNF318;TCFL5;JARID2;CCDC85B;MXD4;SLC27A1;RTF1;H2AFJ;BMP6;MAP2K2;SQSTM1;ZNF608;TXNIP;RCOR2;IFI27;CDK5R1;ATRX;AGO4;GABBR1;XRN1;MLXIPL;FBXW7;GPR87;ING4;ATXN1;NFIX;MXI1;THRA;IKZF4;NAB2;PEG3;ACP5;SALL2;ZBTB20;PDE2A;MAF;LTB4R2;ZMYND8;DAB2IP;TSHZ2;IFI16;RPS6KA5;VDR;TNRC18;TNRC6C;SIX5;WWC3;TFDP2;NRARP;ZNF91;DYDC1;TCF7;ZFP36L1;STAT6;PRDX5;NELFCD;KLF8;PPARG;CXXC5;ZFP90;PER3;FOXP2;ZC3H6;HIVEP1;CTNNBIP1;GCLC
12768,GO:0051082,0.97690817952032,0.0563749351750162,5,102,unfolded protein binding,MF,HSPA2;NUDCD3;SCG5;DNAJC4;AIP
14820,GO:0070585,0.976944905230963,0.0465104756682466,9,160,protein localization to mitochondrion,BP,SREBF1;VPS11;HPS4;MICALL2;OSCP1;FBXW7;TFDP2;AIP;PEMT
3655,GO:0008138,0.9770812419883,0.114439245250238,1,35,protein tyrosine/serine/threonine phosphatase activity,MF,SSH3
12930,GO:0051310,0.977103784891696,0.0813625819298062,2,53,metaphase plate congression,BP,CENPC;CHMP1B
4068,GO:0009123,0.977182002709169,0.0389900655264339,17,271,nucleoside monophosphate metabolic process,BP,NT5E;FAM20C;DHTKD1;INSR;TCIRG1;ATP6V0A2;MLXIPL;PGM1;PFKFB2;OGDHL;TK2;SDHA;NADK;NDUFV3;DLG4;NUDT10;UCKL1
11179,GO:0045296,0.977229301878558,0.0371954058239433,21,296,cadherin binding,MF,EGFR;EPS8L2;DOCK9;STAT1;MICALL1;NDRG1;PPL;ANK3;ITGA6;BAIAP2;H1FX;CDK5R1;PAK6;FMNL2;CAPG;DAB2IP;SNX1;ESYT2;MPRIP;PLCB3;MPP7
4526,GO:0010594,0.977240523818108,0.0523977500721327,6,107,regulation of endothelial cell migration,BP,APOE;MAP2K5;MMRN2;DAB2IP;SRPX2;PPARG
1026,GO:0002532,0.977449597149994,0.113008265301738,1,35,production of molecular mediator involved in inflammatory response,BP,PDCD4
5313,GO:0016032,0.977612833829045,0.031126970317408,52,679,viral process,BP,ITGB6;APOE;OAS2;EGFR;APOBEC3C;TRIM22;PIK3R1;RBCK1;ISG15;MVB12B;CUL7;STAT1;ITGB5;RAB43;PIK3C2G;MDM2;CRTC1;IFITM1;HLA-B;OAS1;AP1G2;LAMP3;ATG16L2;TNFRSF14;ITGA2;LRSAM1;MMP1;INSR;GSN;SEPT6;RAB11FIP4;DHX58;NLRX1;EFNB3;TRIM38;CTSB;FBXW7;CHMP1B;ADARB1;NLRP1;HLA-A;IFI16;BST2;STAT2;RSAD2;KAT2B;IVNS1ABP;RAD50;NELFCD;CHD6;ACKR3;UCKL1
9530,GO:0036294,0.978013477031699,0.0445966669075697,9,157,cellular response to decreased oxygen levels,BP,SFRP1;NDRG1;MDM2;ENDOG;PDK1;RWDD3;ZFP36L1;LMNA;RORA
4104,GO:0009161,0.978202103016114,0.0379191953916114,16,259,ribonucleoside monophosphate metabolic process,BP,NT5E;FAM20C;DHTKD1;INSR;TCIRG1;ATP6V0A2;MLXIPL;PGM1;PFKFB2;OGDHL;SDHA;NADK;NDUFV3;DLG4;NUDT10;UCKL1
10288,GO:0043066,0.978384136452198,0.0303960182895484,49,613,negative regulation of apoptotic process,BP,TNFAIP3;IFI6;APOE;EGFR;MNT;SFRP1;EPHB2;PIK3R1;TSC22D3;KITLG;UNC5B;MDM2;TNFSF10;F2R;PDCD4;GLI2;LAMP3;PIDD1;AMIGO2;GLI3;NAIP;MAP2K5;ITGA6;INSR;DOCK8;MDK;SQSTM1;SYNGAP1;MAP3K12;AGO4;RRM2B;SPRY2;LRP1;RET;FGFR4;ERCC5;SNCB;RGL2;PALB2;TCF7;LMNA;IRS2;IVNS1ABP;APBB2;PRDX5;ERBB2;ACKR3;UFL1;GCLC
16634,GO:0097530,0.978434643518861,0.0771899853882497,2,58,granulocyte migration,BP,VAV3;TRPV4
5259,GO:0015893,0.978439683084755,0.0531759624048205,5,98,drug transport,BP,SLC13A5;PER2;CA2;SYT7;SLC36A4
5792,GO:0017038,0.978455557824843,0.0425077821719392,10,165,protein import,BP,APOE;GLI3;PEX10;PEX7;TXNIP;PDE2A;TMCO6;PEX1;NPAP1;SNX33
3674,GO:0008173,0.978468179232536,0.0772458852298472,2,55,RNA methyltransferase activity,MF,NSUN5P2;TARBP1
4336,GO:0009890,0.978580575470531,0.0273442351959711,106,1218,negative regulation of biosynthetic process,BP,HES2;SIK1;SREBF1;APOE;INPP5D;EGFR;CIRBP;CAPRIN2;MNT;TRIM22;SFRP1;TSC22D3;UNK;HR;TFCP2L1;ZFPM1;IRF2BPL;STAT1;IMPACT;CRY2;CRY1;SCMH1;NFATC4;HSF4;EAPP;MDM2;TCF25;PDCD4;ZFP36L2;TRPV4;GLI2;ZCCHC11;PER2;ZNF658;PHF2;TCEAL1;WWTR1;GLI3;BHLHE40;MAP2K5;ZNF318;TCFL5;JARID2;CCDC85B;MXD4;SLC27A1;RTF1;H2AFJ;BMP6;MAP2K2;SQSTM1;ZNF608;TXNIP;RCOR2;IFI27;CDK5R1;ATRX;AGO4;GABBR1;XRN1;MLXIPL;FBXW7;GPR87;ING4;ATXN1;NFIX;MXI1;THRA;IKZF4;NAB2;PEG3;ACP5;SALL2;ZBTB20;PDE2A;MAF;LTB4R2;ZMYND8;DAB2IP;TSHZ2;IFI16;RPS6KA5;VDR;TNRC18;TNRC6C;SIX5;WWC3;TFDP2;NRARP;ZNF91;DYDC1;TCF7;ZFP36L1;STAT6;PRDX5;NELFCD;KLF8;PPARG;CXXC5;ZFP90;PER3;FOXP2;ZC3H6;HIVEP1;CTNNBIP1;GCLC
10867,GO:0044419,0.978730572094112,0.029333431351125,56,728,interspecies interaction between organisms,BP,ITGB6;ULK2;APOE;OAS2;EGFR;APOBEC3C;TRIM22;PIK3R1;RBCK1;ISG15;MVB12B;CUL7;STAT1;ITGB5;RAB43;PIK3C2G;MDM2;CRTC1;IFITM1;HLA-B;OAS1;AP1G2;LAMP3;ATG16L2;TNFRSF14;ITGA2;ULK1;LRSAM1;MMP1;INSR;GSN;SEPT6;RAB11FIP4;DHX58;NLRX1;SQSTM1;EFNB3;TRIM38;CTSB;FBXW7;CHMP1B;ADARB1;NLRP1;HLA-A;IFI16;EXOC2;BST2;STAT2;RSAD2;KAT2B;IVNS1ABP;RAD50;NELFCD;CHD6;ACKR3;UCKL1
13098,GO:0051656,0.978909100296509,0.0331603873479068,26,348,establishment of organelle localization,BP,SYT8;SYN1;COL7A1;SYTL1;C2CD4C;BLOC1S4;ADORA2B;RIMS3;SPG11;SYT15;VAMP2;TRAK1;SUN1;BLOC1S3;CENPC;BBS2;SEPT5;DNM1;SPRY2;ANKRD28;CHMP1B;SHROOM2;SYT7;BBS5;AREG;SYNE2
12922,GO:0051301,0.978949034994863,0.0306131189405166,40,506,cell division,BP,DIXDC1;CUL7;OR2A4;CNTRL;LIG1;LZTS2;RHOBTB2;NEK9;ZFP36L2;ANK3;UNC119;WWTR1;NAIP;CDK14;TRIOBP;SEPT6;RAB11FIP4;MDK;VEGFB;FZD7;ETV5;CENPC;TXNIP;LRRCC1;SEPT5;RAB11FIP3;PAK6;CHMP1B;REEP4;KLHDC8B;PIK3C3;TACC1;WEE1;CCNG2;MARK4;SAC3D1;TTC19;PARD6G;SNX33;CIT
15465,GO:0071840,0.978998612307875,0.0243225231337957,460,4797,cellular component organization or biogenesis,BP,TNFAIP3;TGFBI;POSTN;ITGB6;SERPINE2;ULK2;DDB2;TP53INP1;MAP6;IFI6;SREBF1;APOE;ALS2CL;ADAM19;HSPA2;EGFR;ESPN;PTPRS;CIRBP;FLNC;PKD2;CAPRIN2;XPC;SYT8;ASH2L;DIXDC1;TRIM22;ALDH1A3;SRSF5;SLITRK6;SFRP1;OBSL1;MTHFR;KCTD11;EPS8L2;EPHB2;TNS1;GPX3;GLUD1;DGKQ;PIK3R1;EVI5L;BRSK1;MARVELD1;KDM3A;CUL9;SULF2;WNT3;VAV3;UNK;HR;SMOC2;HTRA1;SPATA18;TFCP2L1;TENM4;UNC119B;RGMA;PI4KAP2;ZFPM1;SDK2;CUL7;VAMP3;REEP2;ASAP3;OR2A4;C1QTNF6;IMPACT;KRT15;NSG1;UNC5B;ITGB5;COL10A1;GJD3;RAB43;NOS1;PRKACB;SCMH1;NFATC4;IQSEC2;HMGCL;PSMG4;FERMT1;H1F0;CYP26B1;GAA;HSF4;CNTRL;MICALL1;TBC1D8;PLXNB1;VPS11;NDRG1;COL7A1;KCNC4;SPOCK1;ITPR3;NAGLU;MDM2;CRTC1;NDN;KCTD18;MLH3;CSMD3;TYSND1;LTBP4;OBSCN;GOLGA8A;TNFSF10;HGSNAT;MYH11;PARVB;SYTL1;TNXB;RHOBTB2;NEO1;RAPGEF3;CTSV;NLGN4Y;FLRT3;NUDCD3;KCTD15;KIF26A;RGS2;ARPIN;ADGRB2;F2R;PPL;C2CD4C;HPS4;BLOC1S4;SPTB;SERPINB5;NYAP1;DNAH1;NEK9;TUBGCP5;RTN4RL1;CLTCL1;TRPV4;FLOT1;GLI2;TOM1L2;NLGN2;CORO6;ANK3;KLF7;RNF165;GOLGA8B;SOX12;CLMN;SLX1A;SLX1B;ATG16L2;SPG11;ARHGEF19;PER2;CLCN6;UNC119;ZNF658;WIPF1;ADGRL1;MINK1;PHF2;NINL;AMIGO2;THBS3;WWTR1;ARHGEF4;ITGA2;SEMA4G;FAM110C;SYT15;ULK1;GLI3;FHOD3;TPGS1;SMARCA1;LRSAM1;VAMP2;NAIP;MAP2K5;GAS8;BOC;ITGA6;BSN;IGFBP4;MMP1;TRAK1;JARID2;NISCH;INSR;CCDC85B;CELSR1;GSN;CEP68;CHD3;BAIAP2;TANC1;TTN;PLXNB3;CEP126;SUN1;AHNAK2;PLEKHH2;TRIOBP;POLD4;NSUN5P2;RMI2;SEPT6;VPS39;PILRB;ENDOG;RTF1;BLOC1S3;RICTOR;H2AFJ;PEX10;TCIRG1;MICALL2;MAP2K2;SQSTM1;CEP192;PTK6;SLC12A7;FZD7;ETV5;LOXL1;SYNGAP1;EPB41L3;SHARPIN;HEXB;KDM4C;HYAL1;H1FX;ARRDC1;WHAMMP3;CENPC;PLA2G6;CST3;CAPNS2;GDF15;PEX7;BBS2;THSD4;TCF4;ATP6V0A2;COL6A1;PEX11B;NPHP3;IDH2;MAP3K12;WRN;PODXL;SEPT5;MALL;OSCP1;DNM1;IQCB1;KLHL24;MCTP1;CDK5R1;ATRX;REC8;NET1;ANO9;EFNB3;PI4KAP1;HOOK2;EPB41L4A;SHANK3;HFE;HMG20B;CYBA;NID1;AGO4;RRM2B;SLIT3;KRT14;HLCS;SPRY2;WASH3P;IFT140;XRN1;KLK5;TARBP1;FBXW7;KCNMA1;ANKRD28;ING4;CDK5RAP3;PAK6;DZIP1L;CHMP1B;THRA;APC2;ARAP1;GOLGA8N;ADARB1;FMNL2;MX2;IKZF4;SLC2A1;ACACB;NLRP1;FRAT1;REEP4;GLUL;TBC1D17;FBXW5;SRR;CAPG;TSPYL4;LRP1;LRRN3;TSNARE1;NPHP4;CCDC136;PLA2G7;SYNPO2;CENPH;RFX2;KCNG1;PMEL;BBS1;ATXN10;RET;ZMYND8;PRX;DAB2IP;TEAD2;MYSM1;DDHD2;SHROOM2;FBXO4;RNF213;PIK3C3;SYT7;FGFR4;ERCC5;BBS5;EXOC2;SETD4;AREG;SNCB;MYO9A;RPS6KA5;DLG5;BTG1;BST2;VDR;ARHGEF17;CACNB3;TNRC18;EFS;PLXND1;BBS10;ZMYM3;HLTF;TMEM80;TBC1D16;NDUFV3;EML3;DMTN;STAT2;SGSM2;ARFGEF2;ALMS1;PHF1;TMEM231;TFDP2;SNX1;PMP22;ACVR1B;SHROOM4;TACC1;PRIMPOL;CCDC88B;DLG4;CCDC113;IQSEC1;MPI;IGFBP6;MATN2;NBEAL2;WEE1;DYDC1;PTK7;TCF7;SHANK2;LMNA;CLSTN3;TOP3B;KAT2B;MARK4;TEP1;IRS2;DMXL2;CEP250;RAD50;MTR;DHRS4;PEX1;S100A6;EFEMP2;ZSWIM8;APBB2;CBR4;TTC19;PHPT1;TUB;CHD6;NAP1L5;GOLGB1;SRPX2;ACSS2;CD9;RANBP9;CACNB1;HDAC11;COL13A1;ERBB2;SYNGR1;KMT5C;AKAP6;ATG14;MPP7;SSH3;PPARG;PRKACA;LDLRAP1;FMNL3;SYNE2;PARD6G;PLTP;PARN;DDX12P;LAMB2;IP6K2;RIPK3;NFASC;PI4K2B;AIP;COG1;KCNS3;LONP2;PRMT3;SNX33;CIT;MSH5;MAP1A;PTBP2;ECM2;SMURF1;NPNT;TTLL1;EML2;CTNNBIP1;PEMT;GCLC
8738,GO:0034399,0.979202088605024,0.0459846015237547,7,120,nuclear periphery,CC,DGKQ;PHACTR3;HLCS;ATXN1;RGS12;LMNA;TEP1
6246,GO:0019827,0.979326327068507,0.0457288606867927,7,121,stem cell population maintenance,BP,SFRP1;KDM3A;ZFP36L2;ZCCHC11;RTF1;FZD7;KDM4C
13655,GO:0060205,0.979339590862042,0.0373203645992574,14,229,cytoplasmic vesicle lumen,CC,PYGB;APOE;NAPRT;ACTR1B;PCSK1;GSN;VEGFB;HEXB;GLB1;DPP7;CTSD;C6ORF120;SERPING1;ECM1
8254,GO:0033046,0.979346164140408,0.105402012342555,1,36,negative regulation of sister chromatid segregation,BP,ATRX
13269,GO:0051985,0.979346164140408,0.105402012342555,1,36,negative regulation of chromosome segregation,BP,ATRX
10695,GO:0044003,0.979384170888754,0.105523628346211,1,34,modification by symbiont of host morphology or physiology,BP,INSR
5580,GO:0016601,0.979466874670978,0.105193110158297,1,34,Rac protein signal transduction,BP,NISCH
3353,GO:0007088,0.979700127260474,0.0430715605222105,8,139,regulation of mitotic nuclear division,BP,OBSL1;CUL9;CUL7;TOM1L2;INSR;ATRX;CHMP1B;FBXW5
4071,GO:0009126,0.979732685496145,0.0360227104062879,15,248,purine nucleoside monophosphate metabolic process,BP,NT5E;FAM20C;DHTKD1;INSR;TCIRG1;ATP6V0A2;MLXIPL;PGM1;PFKFB2;OGDHL;SDHA;NADK;NDUFV3;DLG4;NUDT10
4110,GO:0009167,0.979732685496145,0.0360227104062879,15,248,purine ribonucleoside monophosphate metabolic process,BP,NT5E;FAM20C;DHTKD1;INSR;TCIRG1;ATP6V0A2;MLXIPL;PGM1;PFKFB2;OGDHL;SDHA;NADK;NDUFV3;DLG4;NUDT10
9186,GO:0035580,0.9797853534989,0.103405090079225,1,38,specific granule lumen,CC,CTSD
151,GO:0000307,0.980217946834667,0.101784063739337,1,37,cyclin-dependent protein kinase holoenzyme complex,CC,CDK14
959,GO:0002381,0.980228129438611,0.101995665342643,1,35,immunoglobulin production involved in immunoglobulin mediated immune response,BP,STAT6
3546,GO:0007569,0.980228365918889,0.0535981652787999,4,85,cell aging,BP,MNT;PDCD4;WRN;LMNA
14390,GO:0061695,0.980470379926493,0.0343351526906231,16,241,transferase complex, transferring phosphorus-containing groups,CC,PIK3R1;PIK3C2G;POLR2J2;ULK1;INSR;CDK14;POLD4;RTF1;POLR2J3;PIK3C3;ERCC5;PIK3R2;ACVR1B;ERN1;CHD6;ATG14
7400,GO:0031490,0.980507460893043,0.0528033789460519,4,92,chromatin DNA binding,MF,KDM3A;HR;H1F0;THRA
16810,GO:0098727,0.980598758265875,0.0432119090734233,7,122,maintenance of cell number,BP,SFRP1;KDM3A;ZFP36L2;ZCCHC11;RTF1;FZD7;KDM4C
19867,GO:2000378,0.980674720800293,0.0999375172932014,1,37,negative regulation of reactive oxygen species metabolic process,BP,ACP5
5571,GO:0016591,0.980687761822276,0.0482286315584204,5,103,DNA-directed RNA polymerase II, holoenzyme,CC,POLR2J2;RTF1;POLR2J3;ERCC5;CHD6
13882,GO:0060548,0.980940747651668,0.0265116626657959,55,683,negative regulation of cell death,BP,TNFAIP3;GPNMB;IFI6;APOE;EGFR;MNT;SFRP1;EPHB2;PIK3R1;RBCK1;TSC22D3;KITLG;IMPACT;UNC5B;MDM2;TNFSF10;F2R;PDCD4;GLI2;LAMP3;PIDD1;AMIGO2;GLI3;NAIP;MAP2K5;ITGA6;INSR;DOCK8;TM7SF3;MDK;SQSTM1;SYNGAP1;CST3;MAP3K12;AGO4;RRM2B;SPRY2;LRP1;RET;TEAD2;FGFR4;ERCC5;SNCB;RGL2;PALB2;TCF7;LMNA;IRS2;IVNS1ABP;APBB2;PRDX5;ERBB2;ACKR3;UFL1;GCLC
13072,GO:0051603,0.98095185753083,0.0271318776025054,47,592,proteolysis involved in cellular protein catabolic process,BP,TNFAIP3;FBXW4;CTSO;TMEM129;ADAMTS7;RBCK1;CUL9;UBXN4;ISG15;MVB12B;CUL7;MAGEF1;BTBD2;RNF187;MDM2;SPSB3;CTSV;RNF165;LAMP3;RHBDF1;FBXO44;WWTR1;CBLC;CTSF;GID4;SQSTM1;SHARPIN;ARRDC1;HFE;FBXO2;CTSB;FBXW7;C17ORF97;FBXW5;ATE1;DAB2IP;FBXO4;RNF213;ABTB1;KLHL3;PANO1;MAN1B1;PRKACA;UFL1;LONP2;SMURF1;GCLC
17811,GO:1901992,0.980958416481945,0.0698014826286489,2,55,positive regulation of mitotic cell cycle phase transition,BP,MDM2;HYAL1
10674,GO:0043966,0.981132733210111,0.069272909309008,2,55,histone H3 acetylation,BP,ING4;KAT2B
13096,GO:0051653,0.981299378976285,0.0977736053516311,1,34,spindle localization,BP,SPRY2
3299,GO:0006997,0.981364129447876,0.0416730054615621,7,124,nucleus organization,BP,KDM3A;NEK9;SUN1;CHMP1B;REEP4;LMNA;SYNE2
6281,GO:0019894,0.981467950827843,0.0970815087883753,1,34,kinesin binding,MF,MAPK8IP3
13670,GO:0060236,0.981479887236558,0.0968987574295394,1,35,regulation of mitotic spindle organization,BP,CHMP1B
16255,GO:0090342,0.981534525254089,0.0964296715089369,1,37,regulation of cell aging,BP,LMNA
8086,GO:0032781,0.981639403446108,0.0956802860550159,1,40,positive regulation of ATPase activity,BP,HSPA2
3253,GO:0006914,0.981946698975349,0.0275336709227504,32,426,autophagy,BP,ULK2;EPM2A;TP53INP1;SREBF1;GPSM1;TRIM65;TRIM22;SPATA18;VPS11;LAMP3;ATG16L2;ULK1;LRSAM1;SESN3;LZTS1;VPS39;TCIRG1;SQSTM1;ATP6V0A2;CDK5R1;SESN1;FBXW7;TBC1D17;SYNPO2;PIK3C3;IFI16;PIK3R2;ERN1;CTSD;ATG14;PRKACA;SMURF1
14470,GO:0061919,0.981946698975349,0.0275336709227504,32,426,process utilizing autophagic mechanism,BP,ULK2;EPM2A;TP53INP1;SREBF1;GPSM1;TRIM65;TRIM22;SPATA18;VPS11;LAMP3;ATG16L2;ULK1;LRSAM1;SESN3;LZTS1;VPS39;TCIRG1;SQSTM1;ATP6V0A2;CDK5R1;SESN1;FBXW7;TBC1D17;SYNPO2;PIK3C3;IFI16;PIK3R2;ERN1;CTSD;ATG14;PRKACA;SMURF1
9624,GO:0036503,0.982007813374974,0.0493882538073884,4,86,ERAD pathway,BP,TMEM129;UBXN4;FBXO2;MAN1B1
22,GO:0000041,0.982040231970861,0.0553819156408229,3,74,transition metal ion transport,BP,TCIRG1;ATP6V0A2;HFE
11823,GO:0046794,0.982049696499508,0.0664753466360695,2,55,transport of virus,BP,MVB12B;BST2
13090,GO:0051646,0.982063460452707,0.0944913795753387,1,35,mitochondrion localization,BP,TRAK1
6578,GO:0022411,0.982078927724182,0.0268860257960331,35,475,cellular component disassembly,BP,SREBF1;HSPA2;HTRA1;SPATA18;H1F0;CTSV;SPTB;NEK9;TRPV4;FLOT1;MMP1;INSR;GSN;PLEKHH2;TRIOBP;ENDOG;SQSTM1;SHARPIN;CST3;CAPNS2;NID1;KLK5;FBXW7;CDK5RAP3;CHMP1B;APC2;FRAT1;CAPG;LRP1;FGFR4;DMTN;LMNA;ATG14;MAP1A;SMURF1
10170,GO:0042775,0.982261473058846,0.0650185251474482,2,79,mitochondrial ATP synthesis coupled electron transport,BP,SDHA;NDUFV3
3243,GO:0006900,0.982361413543568,0.0485482407578421,4,86,vesicle budding from membrane,BP,COL7A1;DNM1;ANKRD28;AREG
15457,GO:0071824,0.982368094001939,0.0328433825819579,13,237,protein-DNA complex subunit organization,BP,DDB2;XPC;H1F0;SOX12;H1FX;CENPC;TCF4;ATRX;THRA;TSPYL4;CENPH;ERCC5;NAP1L5
18032,GO:1902600,0.982416487484881,0.0542012986988282,3,82,proton transmembrane transport,BP,NDUFA4L2;TCIRG1;ATP6V0A2
2737,GO:0006119,0.982438488483273,0.0538870748895309,3,96,oxidative phosphorylation,BP,MLXIPL;SDHA;NDUFV3
12784,GO:0051098,0.982479653129732,0.0298166685217354,19,281,regulation of binding,BP,APOE;GPSM1;CAPRIN2;ZFPM1;NFATC4;FLOT1;PER2;ITGA2;GAS8;HFE;LRP1;DAB2IP;IFI16;PLXND1;PPARG;PRKACA;LDLRAP1;ZFP90;CTNNBIP1
10525,GO:0043487,0.982519017476248,0.0376137529384325,8,148,regulation of RNA stability,BP,CIRBP;PCBP4;ZFP36L2;THRAP3;XRN1;ZFP36L1;ANGEL2;PARN
14121,GO:0061013,0.982660210831644,0.036012118679858,9,160,regulation of mRNA catabolic process,BP,CIRBP;PCBP4;ZFP36L2;THRAP3;XRN1;TNRC6C;ZFP36L1;ANGEL2;PARN
7420,GO:0031529,0.982722815743329,0.0915095873252568,1,37,ruffle organization,BP,EPS8L2
17807,GO:1901988,0.982738658138062,0.0322856156076431,13,215,negative regulation of cell cycle phase transition,BP,GPNMB;PKD2;BRSK1;MDM2;PCBP4;ZFP36L2;PIDD1;GJC2;ZNF655;CDK5RAP3;TFDP2;ZFP36L1;GPR132
11183,GO:0045321,0.982757891962849,0.0236874057261128,62,766,leukocyte activation,BP,TNFAIP3;GPNMB;PYGB;INPP5D;CXCR1;SFRP1;MAP3K14;PIK3R1;VAV3;KCNAB2;ZFPM1;NAPRT;CYP26B1;GAA;NDRG1;HGSNAT;ACTR1B;IL20RB;ZFP36L2;TMC6;GLI2;ADORA2B;TNFRSF14;GLI3;VAMP2;GSN;DOCK8;SLC2A3;TCIRG1;FZD7;HEXB;CST3;TNFRSF21;EFNB3;HFE;CYBA;CTSB;PGM1;DLG5;BST2;NRARP;CCDC88B;NBEAL2;CD68;TCF7;RSAD2;ZFP36L1;IL11;IRS2;METTL7A;STAT6;SOX13;GLB1;DPP7;CTSD;ERBB2;SYNGR1;RORA;C6ORF120;POLM;RIPK3;NFASC
12108,GO:0048194,0.982790897884919,0.053489263781458,3,71,Golgi vesicle budding,BP,COL7A1;ANKRD28;AREG
7312,GO:0031329,0.983395556634564,0.0231896479683212,56,691,regulation of cellular catabolic process,BP,TNFAIP3;ULK2;EPM2A;TP53INP1;SREBF1;APOE;GPSM1;TRIM65;CIRBP;TRIM22;MAGEF1;VPS11;MDM2;TYSND1;RAPGEF3;PCBP4;MLYCD;ZFP36L2;LAMP3;RHBDF1;ULK1;THRAP3;LRSAM1;SESN3;LZTS1;INSR;ENDOG;CST3;ATP6V0A2;CDK5R1;SESN1;HFE;XRN1;MLXIPL;FBXW7;CDK5RAP3;PFKFB2;ACACB;LRP1;DAB2IP;IFI16;PIK3R2;TNRC6C;PANO1;ZFP36L1;IRS2;ERN1;ANGEL2;PTPN3;PRKACA;PARN;UFL1;LONP2;SNX33;SMURF1;GCLC
15852,GO:0072595,0.983401826758629,0.0885520059870852,1,38,maintenance of protein localization in organelle,BP,SUN1
12107,GO:0048193,0.983545246787333,0.027236186094551,22,308,Golgi vesicle transport,BP,LMF1;VAMP3;COL7A1;KIF26A;SPTB;ANK3;VAMP2;PGAP1;WHAMMP3;BBS2;ANKRD28;BBS1;DDHD2;EXOC2;OSBPL5;AREG;MPPE1;SGSM2;ARFGEF2;SNX1;GOLGB1;COG1
4765,GO:0010952,0.983651457115457,0.035409320986205,8,150,positive regulation of peptidase activity,BP,TNFSF10;F2R;PIDD1;GSN;IFI27;NLRP1;IFI16;PPARG
14009,GO:0060760,0.983723798988976,0.0872962215565981,1,37,positive regulation of response to cytokine stimulus,BP,CREBRF
10168,GO:0042773,0.983816003735137,0.0602143289891522,2,80,ATP synthesis coupled electron transport,BP,SDHA;NDUFV3
6803,GO:0030261,0.983846304944038,0.088077519401502,1,28,chromosome condensation,BP,TTN
2860,GO:0006352,0.983858586620129,0.0310235282190801,12,205,DNA-templated transcription, initiation,BP,MAML3;WWTR1;THRAP3;TCF4;THRA;TEAD2;VDR;NAT14;KAT2B;RORA;PPARG;CTNNBIP1
4426,GO:0010257,0.983860076073806,0.0854247466709788,1,55,NADH dehydrogenase complex assembly,BP,NDUFV3
8212,GO:0032981,0.983860076073806,0.0854247466709788,1,55,mitochondrial respiratory chain complex I assembly,BP,NDUFV3
1443,GO:0003674,0.983895994412639,0.0215023123146341,1141,11305,molecular_function,MF,TNFAIP3;TGFBI;POSTN;TAGLN;ITGB6;HES2;SERPINE2;ZSCAN18;ULK2;GPNMB;TSC22D1;SIK1;SLFN5;SUGCT;EPM2A;NPEPL1;DDB2;TP53INP1;MAP6;IFI6;PTHLH;SREBF1;AMACR;PYGB;MXRA5;NYNRIN;ACTA2;APOE;GPSM1;CES2;NT5E;ALS2CL;INPP5D;APCDD1;GAMT;FBXO41;OAS2;ADAM19;MN1;PSD4;DDX60;HSPA2;FBXW4;EGFR;ESPN;TRIM65;HERC3;GIGYF1;PTPRS;CIRBP;FLNC;FAM20C;PKD2;CAPRIN2;MNT;XPC;APOBEC3C;SYT8;CXCR1;CPT2;RBM3;SYN1;ASH2L;DIXDC1;TRIM22;ALDH1A3;SRSF5;PLCD3;CTSO;SFRP1;OBSL1;MTHFR;SEC14L2;KCTD11;IFI44L;KIF26B;PCDH1;EPS8L2;EPHB2;RALGDS;TNS1;SYNC;GPX3;MAP3K14;GLUD1;BPHL;DCAF16;DGKQ;TMEM129;PIK3R1;ADAMTS7;EVI5L;BRSK1;TXNRD3;MARVELD1;RBCK1;KDM3A;ORAI3;CXCL14;DOCK9;TSC22D3;CUL9;NSUN7;EYS;RNF135;POU3F1;SULF2;WNT3;H6PD;DHTKD1;CAMKK1;HERC5;UBXN4;VAV3;ST6GALNAC2;UNK;HR;SMOC2;VWCE;CSPG4;ISG15;MVB12B;CYBRD1;ELFN2;HTRA1;SPATA18;TFCP2L1;TENM4;UNC119B;RGMA;PI4KAP2;KCNAB2;ZFPM1;KITLG;HOXC5;MVD;ZDHHC1;ZNF362;CUL7;VAMP3;CITED4;SNN;IRF2BPL;NAPRT;REEP2;PRICKLE2;KCNJ15;MC1R;ASAP3;ZNF266;SRD5A3;OR2A4;C1QTNF6;STAT1;IMPACT;CAMK2N1;CRY2;MYL9;GRIP2;KRT15;HS1BP3;LGALS7B;WDR63;MARCKSL1;NSG1;UNC5B;UROS;SLC16A5;KDSR;ITGB5;COL10A1;GJD3;RAB43;RAB40B;THAP8;NOS1;PRKACB;ZNF704;HOXA3;B4GALNT4;CRY1;ZNF699;MAML3;ZFP41;SCMH1;KLF13;CRTAP;DIP2C;SDC3;BCAM;MAGEF1;PLEKHG5;NFATC4;PITPNM3;ZNF783;IQSEC2;HMGCL;SPDYE6;D2HGDH;BTBD2;SCARA3;FKBP5;RNF187;H1F0;CYP26B1;GAA;AP5Z1;CMPK2;THNSL2;HSF4;CNTRL;ZNF251;MICALL1;PIK3C2G;LIG1;CDK18;TBC1D8;PLXNB1;PLEKHG3;VPS11;SPEG;NDRG1;COL7A1;KCNC4;SPOCK1;SLC29A4;ITPR3;NAGLU;CYHR1;MDM2;CRTC1;LZTS2;PLCD1;NDN;IFITM1;MLH3;NMRK1;DDX59;ST6GALNAC6;PPP2R2C;FCGRT;CHN2;ZNF662;TYSND1;LTBP4;PIK3IP1;OBSCN;IDUA;GPRC5C;TYMSOS;HLA-B;TNFSF10;PRODH;HGSNAT;LENG9;MYH11;PARVB;SYTL1;FKBP9;NDUFA4L2;CALML3;ACTR1B;TNXB;RHOBTB2;UGT1A3;CERS4;CYP3A5;ACOT1;NEO1;RAPGEF3;PHACTR3;ZNF414;SPSB3;TCF25;ENDOD1;PCBP4;HAGHL;NINJ1;CTSV;NLGN4Y;POLH;SPATA20;BLVRB;POLR2J2;OAS1;FLRT3;NUDCD3;RASA4;TRIM66;GAL3ST4;KCTD15;CRAT;KIF26A;B4GALT6;MLLT6;AP1G2;RGL4;RGS2;ARPIN;TMEM63C;ACAP3;IL20RB;ADGRB2;F2R;MLYCD;PPL;C2CD4C;HPS4;PHYH;TMEM134;MT1X;PDCD4;BLOC1S4;CGREF1;SPTB;SERPINB5;NOL4L;SLC24A1;ALPK1;ZNF160;CAPN7;DNAH1;SLC27A3;ARSI;NEK9;TUBGCP5;RTN4RL1;ZFP36L2;ADGRF4;CLTCL1;TRPV4;TMC6;TMEM128;FLOT1;GLI2;AGAP4;TOM1L2;RHPN1;NLGN2;ADORA2B;CORO6;ANK3;KLF7;RNF165;NAT6;DHX32;ADAMTS13;TCEA2;PLCH2;RALGAPA1;MAPK8IP3;SPDYE5;SLC13A5;ZNF76;SOX12;CLMN;PIDD1;RIMS3;PARP6;SLX1A;SLX1B;G6PC3;ZNF747;SPG11;GJC2;KRBA1;ZCCHC11;ARHGEF19;RHBDF1;SULT1E1;FBXO44;RASGEF1A;ANKS6;PER2;PITPNM2;CLCN6;MICALCL;PTGS1;UNC119;HEXA;FRS3;DTNB;C5;ZNF658;ARSD;WIPF1;SNTA1;PSKH1;ADGRL1;MINK1;PHF2;TBC1D19;NINL;ABHD14B;GSTM2;TCEAL1;AMIGO2;THBS3;TNFRSF14;WWTR1;MBOAT2;ASAP2;ARHGEF4;LHFPL2;ITGA2;SEMA4G;RSPH3;FAM110C;SYT15;ULK1;GLI3;SPPL2B;FGGY;FHOD3;PCSK1;TPGS1;WDR90;THRAP3;ZNF558;IRX4;SMARCA1;AKAP7;BHLHE40;DGCR6L;LRSAM1;VAMP2;ZNF655;NAIP;LTBP1;KHNYN;NMU;ZNF333;NEK8;MAP2K5;GAS8;BOC;ITGA6;LTBP3;KCNJ5;SRGAP3;CES3;BSN;SESN3;ZNF318;LZTS1;IGFBP4;MMP1;TCFL5;C14ORF93;TRAK1;JARID2;NUPR1;PRR9;GPC2;NISCH;INSR;TST;CCDC85B;HSF2BP;CELSR1;MMP28;GSN;ALDH4A1;CEP68;HEBP1;LRRC20;CHD3;CDK14;ST3GAL5;BAIAP2;TTN;CBLC;FAM167A;SCNN1A;DDT;ZNF18;PLXNB3;CEP126;SUN1;LPAR5;AHNAK2;RNPEPL1;PLEKHH2;TRIOBP;MXD4;POLD4;RIN1;ATXN7L1;CTSF;ZNF287;CD109;CYP2D7;NSUN5P2;PNMA1;PGLS;SLFNL1;PMS2P3;ETAA1;RMI2;ZNF446;SCN4B;ARHGEF1;SEPT6;FBXL16;RAB11FIP4;ZNF581;MGST2;DOCK8;TP53AIP1;DHX58;PILRB;ENDOG;SLC27A1;PGAP1;GID4;TM7SF3;NRSN2;RTF1;BLOC1S3;MDK;CASP14;IRF9;RICTOR;TMEM9;H2AFJ;BMP6;F8A1;NLRX1;B4GALT2;TMCC3;ETNK2;NIPAL2;PEX10;SLC2A3;TCIRG1;S100A4;MICALL2;MAP2K2;OPLAH;PDK1;VEGFB;ALDH7A1;GLI4;SQSTM1;CEP192;CABYR;PTK6;SLC12A7;TMEM8B;FZD7;ETV5;AKR7A2;LOXL1;FNBP4;FRMD8;SYNGAP1;NXPH4;FAM13A;FAM213A;FAT2;DLX3;TMEM117;LGALS9C;EPB41L3;SHARPIN;HEXB;KDM4C;HYAL1;METTL23;CLCA2;ARHGAP33;H1FX;SH2D2A;UBOX5;NSMCE4A;ARRDC1;KIAA0319L;B3GNT9;ZNF608;WHAMMP3;CENPC;PLA2G6;ZCCHC24;CST3;FAM86C2P;PDIK1L;HOMER2;MMRN2;CAPNS2;GDF15;PEX7;BBS2;TXNIP;CTF1;THSD4;TCF4;ATP6V0A2;COL6A1;PEX11B;NPHP3;PSD3;FAM83C;PLAG1;IDH2;MAP3K12;RCOR2;WRN;PODXL;SEPT5;IFI27;MALL;DNM1;MCM9;TNFRSF21;ZYG11B;MACROD1;IQCB1;KLHL24;PLD3;TREX1;LPIN3;ZDHHC12;OARD1;ABHD14A;MCTP1;CDK5R1;ATRX;REC8;ARHGAP27;AGAP6;NET1;ANO9;PIGZ;CA2;EFNB3;OSBPL10;PI4KAP1;POLR2J3;HOOK2;SESN1;EPB41L4A;MAPK10;NKTR;SHANK3;HFE;SCART1;ADIRF;HMG20B;CYBA;TRIM38;NID1;DTX3;AGO4;ERCC6;HADH;RRM2B;SLIT3;CLIP2;KRT14;HLCS;SHC2;EDA2R;SPRY2;MRC2;FBXO2;WASH3P;MEF2D;IFT140;GABBR1;CREBRF;XRN1;AGAP7P;RAB11FIP3;TIGD5;LRP11;MLXIPL;CTSB;KLK5;TARBP1;FBXW7;KCNMA1;ANKRD28;GPR87;ING4;NUDT6;CDK5RAP3;ZNF862;ATXN1;LMO2;NOTCH2NL;CCDC92;NFIX;PAK6;TFPI2;CARF;DZIP1L;PGM1;MXI1;PFKFB2;PAQR6;RNF170;CHMP1B;THRA;HSD11B1L;APC2;METTL21A;ACADS;ARAP1;ASTN2;ADARB1;RAI1;FMNL2;ELF1;MX2;IKZF4;RPH3AL;SLC2A1;ACACB;ACCS;OGDHL;NLRP1;C1RL;FRAT1;ZBTB34;ERMAP;REEP4;ZNF627;TK2;GPR155;LACTB2;IQCH;BEX2;GLUL;TNS2;TBC1D17;MIF4GD;DBP;NDST2;NAB2;SLC38A4;EPM2AIP1;TP53I13;GNG2;FBXW5;SRR;CAPG;TSPYL4;LRP1;KLHDC8B;HLA-A;PEG3;TSNARE1;NPHP4;RGS12;ATE1;ACP5;MPG;PLA2G7;SYNPO2;RNPEP;CENPH;RFX2;DLK2;KCNG1;ZNF554;BRINP1;SLC48A1;BDH1;CD99L2;DGCR2;MAP3K6;RIMKLB;PPCS;MYO3B;APPL2;DHRS4L2;HEXDC;SALL2;WNK1;PMEL;ZNF107;ZNF532;BBS1;ATXN10;GUCD1;JPH2;ARL11;ZBTB20;PDE2A;ZNF334;SDHA;MAF;STK16;LTB4R2;RET;ZMYND8;PRX;DAB2IP;CASZ1;RWDD3;ACOX3;CALCOCO1;SLC37A2;TEAD2;MYSM1;DDHD2;PCED1A;SHROOM2;FBXO4;RNF213;OLFM2;RAPGEFL1;TSHZ2;PIK3C3;ZNF276;IFI16;SYT7;DALRD3;FGFR4;ERCC5;BBS5;EXOC2;IL20RA;PIK3R2;RETSAT;SCN2A;TEF;ZNF25;SETD4;OSBPL5;DHRS12;AREG;ABTB1;TMEM203;DEF6;KLHL3;SNCB;ETFB;MYO9A;RPS6KA5;APBB3;ZNF630;DLG5;BTG1;BST2;ZNF687;VDR;LETMD1;RGL2;PABPC4L;SNX21;ARHGEF17;CACNB3;MAMSTR;PHF7;TNRC18;TNRC6C;ZFP28;DPY19L2P2;VIPR1;FAM3A;EFS;PLXND1;NADK;BBS10;ZMYM3;SIX5;NUDT8;HLTF;MARCH8;C20ORF194;PCED1B;PCSK6;ZNF789;MPPE1;ZNF563;TNS4;ZNF517;PCMTD2;TBC1D16;STK19;NDUFV3;TMCO6;LPAR6;C22ORF23;EML3;PPP1R2;DMTN;TPRN;ORAI2;FAHD2B;PPP1R35;STAT2;SGSM2;ARFGEF2;RASL10B;LMTK3;ALMS1;PCMTD1;WWC3;PHF1;ZNF292;SLC36A4;TMEM231;TFDP2;SNX1;PMP22;UCN2;GOLGA7B;OSBPL1A;ACVR1B;TMX4;SHROOM4;ZNF737;TACC1;KREMEN1;CADM4;KDELC2;PRIMPOL;NECAB3;CCDC88B;DLG4;IGFL2;CCDC113;TNNI2;PPP2R3B;ESYT2;TSSK1B;ADCK5;IQSEC1;ZNF701;ALOXE3;NAT14;PALB2;ENDOU;MPI;SNX29;IGFBP6;MATN2;TCEAL4;ZNF91;DUOX1;GALE;WEE1;DYDC1;R3HDM4;SLC22A15;TMEM143;GTF2IRD2;SLC35G2;PTK7;DQX1;AMT;TCF7;SHANK2;RSAD2;TNFRSF25;ZFP36L1;XYLT1;LMNA;MXRA8;CLSTN3;GLMP;TOP3B;ACSL1;IL11;KAT2B;MARK4;TEP1;APOLD1;IRS2;DMXL2;IMPA2;CEP250;ANO1;CAPS;MBLAC2;METTL7A;ERN1;HSD17B14;SAC3D1;RNF141;IVNS1ABP;ALOX15B;RAD50;GPR21;ZNF439;TKFC;LAPTM4A;ANGEL2;ZMAT3;PNPO;MTR;MAN1B1;DHRS4;PEX1;ECI1;S100A6;TRERF1;FSD2;UAP1L1;FAAH;SCYL3;EFEMP2;SCG5;ZSWIM8;APBB2;CBR4;TTC19;MFSD11;ARHGEF9;ISYNA1;SGSH;PBLD;DCAF8;CCDC90B;RAPGEF5;MYH16;TNFSF12;TAS1R3;CERS5;STAT6;PCSK1N;SOX13;PRDX5;PHPT1;NELFCD;GPR132;PHC2;ANKMY1;SMPDL3B;TUB;KIF7;SLC43A1;GLB1;GOLGA1;CPT1C;KLF8;DNAJC4;GSTM3;RDH12;KLHL29;CHD6;TRAF5;GOLGB1;SRPX2;ACSS2;DPP7;TRIM2;CD9;RANBP9;CACNB1;HDAC11;PTPN3;CTSD;COL13A1;ERBB2;SYNGR1;MPRIP;PLCB3;GPR68;NUDT10;UVSSA;ZDHHC24;PAQR7;ARHGAP23;PPM1M;ABCA2;KMT5C;AKAP6;SLC2A11;TH;ATG14;MPP7;RORA;SSH3;PPARG;PRKACA;DOCK6;LDLRAP1;CXXC5;NPAP1;POLM;FMNL3;ACOT2;GCNT4;ZNF572;SYNE2;PARD6G;ACKR3;PLTP;ZNF658B;SERPING1;SUCLG2;UCKL1;PARN;DDX12P;UHRF1BP1;DOCK3;ZNF529;UFL1;LAMB2;IP6K2;RIPK3;NFASC;KLF9;PI4K2B;AIP;COG1;KCNS3;SCAND1;LONP2;PRMT3;SNX33;HARS2;CIT;ZFP90;EHHADH;MSH5;CLCN7;MAP1A;PER3;ZFP30;FOXP2;PTBP2;ZC3H6;HIVEP1;CALHM2;ECM2;SMURF1;NPNT;HERPUD2;TTLL1;EML2;CTNNBIP1;PEMT;ABCA11P;TM4SF1;SERINC3;GCLC;ECM1
4085,GO:0009141,0.983962411022205,0.0290327963399623,15,257,nucleoside triphosphate metabolic process,BP,FAM20C;DHTKD1;CMPK2;INSR;TCIRG1;ATP6V0A2;RRM2B;MLXIPL;PGM1;PFKFB2;OGDHL;SDHA;NADK;NDUFV3;UCKL1
8917,GO:0034774,0.98403506448413,0.0300410864835946,13,221,secretory granule lumen,CC,PYGB;NAPRT;ACTR1B;PCSK1;GSN;VEGFB;HEXB;GLB1;DPP7;CTSD;C6ORF120;SERPING1;ECM1
11410,GO:0045840,0.984215722527566,0.0850972946605533,1,38,positive regulation of mitotic nuclear division,BP,INSR
7901,GO:0032482,0.98435946832948,0.059123522963004,2,59,Rab protein signal transduction,BP,RAB43;RAB40B
5069,GO:0015294,0.984382681019482,0.0593141090490553,2,53,solute:cation symporter activity,MF,SLC13A5;SLC12A7
4672,GO:0010823,0.984492879182891,0.0837204537005618,1,40,negative regulation of mitochondrion organization,BP,LMNA
16849,GO:0098800,0.984496591130121,0.0484023614467232,3,99,inner mitochondrial membrane protein complex,CC,NDUFA4L2;SDHA;NDUFV3
16069,GO:0090068,0.984499200410871,0.0287214542061624,14,218,positive regulation of cell cycle process,BP,PKD2;OR2A4;MDM2;PCBP4;PIDD1;INSR;RAB11FIP4;HYAL1;CDK5R1;ATRX;DAB2IP;TFDP2;PRKACA;CIT
9203,GO:0035601,0.984575082865379,0.0396683109501709,5,99,protein deacylation,BP,SREBF1;PER2;CHD3;HMG20B;HDAC11
8791,GO:0034504,0.984775818713055,0.0288260681417396,13,203,protein localization to nucleus,BP,MDM2;LZTS2;GLI3;SUN1;TXNIP;WRN;CDK5RAP3;PDE2A;FBXO4;TMCO6;LMNA;NPAP1;SYNE2
1020,GO:0002520,0.984780252083647,0.0216376944992481,51,653,immune system development,BP,TNFAIP3;INPP5D;FAM20C;ASH2L;SFRP1;PIK3R1;DHTKD1;KCNAB2;ZFPM1;KITLG;STAT1;MYL9;HOXA3;KLF13;CYP26B1;FAM210B;ZNF160;ZFP36L2;GLI2;GLI3;JARID2;CD109;PMS2P3;FZD7;FAM213A;CA2;AGO4;FBXW7;LMO2;THRA;RET;IFI16;TNRC6C;DMTN;NRARP;ACVR1B;NBEAL2;TCF7;RSAD2;ZFP36L1;IL11;KAT2B;STAT6;SOX13;ERBB2;GPR68;RORA;PPARG;POLM;RIPK3;CTNNBIP1
17406,GO:1900182,0.984838999147307,0.0577315207750069,2,56,positive regulation of protein localization to nucleus,BP,GLI3;CDK5RAP3
2490,GO:0005739,0.984854478259348,0.0193935324750075,115,1427,mitochondrion,CC,SUGCT;IFI6;AMACR;OAS2;HSPA2;CAPRIN2;XPC;CPT2;GLUD1;BPHL;TXNRD3;DHTKD1;SPATA18;TFCP2L1;SNN;HS1BP3;UROS;NOS1;CRY1;HMGCL;D2HGDH;CMPK2;LIG1;PRODH;NDUFA4L2;FAM210B;OAS1;CRAT;RGS2;MLYCD;PPL;PHYH;SLC27A3;DHX32;ULK1;TRAK1;JARID2;TST;ALDH4A1;POLD4;DNAJC30;CYP2D7;TP53AIP1;ENDOG;SLC27A1;CASP14;NLRX1;TCIRG1;MAP2K2;PDK1;ALDH7A1;TMEM8B;PLA2G6;TXNIP;IDH2;IFI27;OXLD1;DNM1;MACROD1;MAPK10;NKTR;CYBA;HADH;RRM2B;SLIT3;HLCS;CTSB;NUDT6;ACADS;RAI1;MX2;ACACB;OGDHL;TK2;LACTB2;GLUL;MPG;BDH1;PDE2A;SDHA;ACOX3;SNCB;ETFB;LETMD1;TNRC18;NDUFV3;TFDP2;PRIMPOL;TMEM143;AMT;RSAD2;TNFRSF25;ACSL1;ERN1;DHRS4;ECI1;CBR4;TTC19;DCAF8;CCDC90B;PRDX5;CPT1C;ACSS2;TH;PRKACA;ACOT2;SYNE2;SUCLG2;RIPK3;HARS2;EHHADH;HIVEP1;SMURF1;PEMT;OCIAD2
5502,GO:0016447,0.984948862630928,0.0820478057263034,1,37,somatic recombination of immunoglobulin gene segments,BP,STAT6
12466,GO:0050434,0.985005194961031,0.0815157005229955,1,40,positive regulation of viral transcription,BP,NELFCD
2534,GO:0005791,0.985171329349095,0.0564455166805379,2,62,rough endoplasmic reticulum,CC,BAIAP2;GLUL
7006,GO:0030705,0.985181231006492,0.0313049587055835,9,152,cytoskeleton-dependent intracellular transport,BP,BLOC1S4;SPG11;TRAK1;SUN1;BLOC1S3;HOOK2;IFT140;CCDC88B;SYNE2
8881,GO:0034708,0.985209629785487,0.041609695409783,4,90,methyltransferase complex,CC,ASH2L;JARID2;PHF1;DYDC1
14964,GO:0070897,0.985347961293341,0.0801199356109543,1,39,DNA-templated transcriptional preinitiation complex assembly,BP,THRA
16812,GO:0098732,0.985580919467349,0.0373745316012544,5,100,macromolecule deacylation,BP,SREBF1;PER2;CHD3;HMG20B;HDAC11
12150,GO:0048285,0.985661558652498,0.0231141900059647,26,352,organelle fission,BP,HSPA2;OBSL1;CUL9;CUL7;CYP26B1;MLH3;TUBGCP5;TOM1L2;NAIP;INSR;TTN;SUN1;CEP192;CENPC;PEX11B;DNM1;ATRX;REC8;AGO4;CHMP1B;MX2;FBXW5;DDHD2;STAT2;RAD50;MSH5
3635,GO:0008104,0.985854251878966,0.0173895815353741,185,2055,protein localization,BP,TNFAIP3;POSTN;ITGB6;SREBF1;APOE;LMF1;EGFR;PKD2;TRIM22;SRSF5;SFRP1;OBSL1;EPHB2;GLUD1;TMEM129;PIK3R1;EVI5L;MARVELD1;MVB12B;UNC119B;KCNAB2;ZDHHC1;VAMP3;REEP2;NSG1;RAB43;RAB40B;FERMT1;AP5Z1;MICALL1;TBC1D8;VPS11;ITPR3;MDM2;LZTS2;MLH3;OBSCN;SYTL1;RAPGEF3;NUDCD3;AP1G2;F2R;HPS4;CLTCL1;TRPV4;FLOT1;TOM1L2;NLGN2;ANK3;ATG16L2;RHBDF1;PER2;UNC119;C5;ITGA2;ULK1;GLI3;AKAP7;LRSAM1;VAMP2;LTBP1;NMU;GAS8;BSN;TRAK1;CELSR1;GSN;CEP68;BAIAP2;TTN;SUN1;SEPT6;VPS39;PGAP1;TM7SF3;BMP6;PEX10;TCIRG1;MICALL2;SQSTM1;CEP192;ETV5;SYNGAP1;EPB41L3;ARHGAP33;ARRDC1;PLA2G6;PEX7;BBS2;TXNIP;ATP6V0A2;IDH2;WRN;SEPT5;IFI27;MALL;OSCP1;TNFRSF21;ZDHHC12;CDK5R1;ATRX;HOOK2;SHANK3;HFE;HADH;WASH3P;IFT140;RAB11FIP3;FBXW7;CDK5RAP3;DZIP1L;MXI1;PFKFB2;CHMP1B;THRA;ASTN2;MX2;RPH3AL;SLC2A1;NLRP1;GLUL;TBC1D17;LRP1;TSNARE1;C12ORF66;BBS1;PDE2A;ZMYND8;SHROOM2;FBXO4;OLFM2;PIK3C3;SYT7;BBS5;EXOC2;PIK3R2;DLG5;SNX21;CACNB3;EHBP1;TNS4;TBC1D16;TMCO6;DMTN;SGSM2;ARFGEF2;TMEM231;TFDP2;SNX1;GOLGA7B;NECAB3;DLG4;RSAD2;LMNA;CLSTN3;IRS2;CEP250;ANO1;ALOX15B;ZMAT3;PEX1;SCG5;PHPT1;TUB;GOLGB1;ERBB2;SYNGR1;GPR68;ZDHHC24;AKAP6;MPP7;PPARG;LDLRAP1;NPAP1;SYNE2;UFL1;NFASC;AIP;COG1;KCNS3;LONP2;SNX33;SMURF1;NPNT;PEMT
2560,GO:0005844,0.985899459959401,0.0539113893007113,2,69,polysome,CC,UNK;IMPACT
4190,GO:0009295,0.986009895412616,0.0771361333970689,1,40,nucleoid,CC,MPG
10109,GO:0042645,0.986009895412616,0.0771361333970689,1,40,mitochondrial nucleoid,CC,MPG
13029,GO:0051539,0.986016336703073,0.0770244598918834,1,41,4 iron, 4 sulfur cluster binding,MF,RSAD2
869,GO:0002220,0.986045275438482,0.0394984821069581,4,94,innate immune response activating cell surface receptor signaling pathway,BP,MUC19;PRKACB;RPS6KA5;PRKACA
871,GO:0002223,0.986045275438482,0.0394984821069581,4,94,stimulatory C-type lectin receptor signaling pathway,BP,MUC19;PRKACB;RPS6KA5;PRKACA
4505,GO:0010558,0.986130195579036,0.0181221645987015,99,1160,negative regulation of macromolecule biosynthetic process,BP,HES2;SREBF1;INPP5D;EGFR;CIRBP;CAPRIN2;MNT;TRIM22;SFRP1;TSC22D3;UNK;HR;TFCP2L1;ZFPM1;IRF2BPL;STAT1;IMPACT;CRY2;CRY1;SCMH1;NFATC4;HSF4;EAPP;MDM2;TCF25;PDCD4;ZFP36L2;TRPV4;GLI2;ZCCHC11;PER2;ZNF658;PHF2;TCEAL1;WWTR1;GLI3;BHLHE40;MAP2K5;ZNF318;TCFL5;JARID2;CCDC85B;MXD4;RTF1;H2AFJ;BMP6;MAP2K2;SQSTM1;ZNF608;TXNIP;RCOR2;IFI27;CDK5R1;ATRX;AGO4;XRN1;MLXIPL;FBXW7;ING4;ATXN1;NFIX;MXI1;THRA;IKZF4;NAB2;PEG3;SALL2;ZBTB20;PDE2A;MAF;ZMYND8;DAB2IP;TSHZ2;IFI16;RPS6KA5;VDR;TNRC18;TNRC6C;SIX5;WWC3;TFDP2;NRARP;ZNF91;DYDC1;TCF7;ZFP36L1;STAT6;PRDX5;NELFCD;KLF8;PPARG;CXXC5;ZFP90;PER3;FOXP2;ZC3H6;HIVEP1;CTNNBIP1;GCLC
9284,GO:0035735,0.986255878257,0.0761391304645964,1,39,intraciliary transport involved in cilium assembly,BP,IFT140
7401,GO:0031491,0.986403881188946,0.0523734576300186,2,66,nucleosome binding,MF,SMARCA1;PHF1
17747,GO:1901796,0.986531165017477,0.0286689040894337,9,161,regulation of signal transduction by p53 class mediator,BP,TP53INP1;MDM2;CHD3;RMI2;WRN;CDK5R1;RRM2B;CDK5RAP3;RAD50
12757,GO:0051052,0.986605686931759,0.0222565989916594,23,324,regulation of DNA metabolic process,BP,EGFR;KITLG;MAGEF1;POLH;GLI2;SLX1A;SLX1B;INSR;ENDOG;BMP6;CST3;WRN;ATRX;XRN1;FBXW7;FBXO4;FGFR4;AREG;ZNF91;RAD50;STAT6;PPARG;PARN
2867,GO:0006360,0.986608849746904,0.0519346674290117,2,59,transcription by RNA polymerase I,BP,ERCC6;ERBB2
18455,GO:1903578,0.986894290432808,0.0423401541434118,3,73,regulation of ATP metabolic process,BP,INSR;MLXIPL;PFKFB2
16175,GO:0090224,0.987024962725553,0.0728050731884636,1,38,regulation of spindle organization,BP,CHMP1B
468,GO:0001510,0.987033041394547,0.0504853434060889,2,61,RNA methylation,BP,NSUN5P2;TARBP1
9006,GO:0035195,0.98707815218348,0.0315519095155489,6,134,gene silencing by miRNA,BP,EGFR;ZCCHC11;MAP2K2;AGO4;TNRC6C;PPARG
9851,GO:0042116,0.987199980503632,0.0719301878941848,1,39,macrophage activation,BP,RORA
11357,GO:0045739,0.98721432879389,0.0717818585391848,1,40,positive regulation of DNA repair,BP,EGFR
19472,GO:1990266,0.987230103993944,0.0714153183690067,1,44,neutrophil migration,BP,VAV3
10565,GO:0043543,0.987250695886506,0.0250338128382199,12,198,protein acylation,BP,ZDHHC1;NOS1;RAPGEF3;NAT6;NUPR1;ZDHHC12;ING4;RPS6KA5;GOLGA7B;KAT2B;ZDHHC24;EHHADH
2810,GO:0006270,0.987406995056962,0.0708352615045042,1,41,DNA replication initiation,BP,MCM9
17751,GO:1901800,0.987522623974054,0.0358715192203206,4,91,positive regulation of proteasomal protein catabolic process,BP,MDM2;FBXW7;DAB2IP;GCLC
488,GO:0001541,0.987622293657091,0.0699407823964613,1,40,ovarian follicle development,BP,KITLG
2863,GO:0006355,0.987650542635424,0.0148573577679739,263,2830,regulation of transcription, DNA-templated,BP,TNFAIP3;HES2;ZSCAN18;TSC22D1;SIK1;TP53INP1;SREBF1;APOE;MN1;EGFR;PKD2;CAPRIN2;MNT;ASH2L;TRIM22;SFRP1;PERM1;SEC14L2;DGKQ;PIK3R1;RBCK1;KDM3A;TSC22D3;POU3F1;HR;HTRA1;TFCP2L1;RGMA;ZFPM1;HOXC5;ZNF362;CITED4;IRF2BPL;MC1R;ZNF266;STAT1;IMPACT;CRY2;THAP8;NOS1;ZNF704;HOXA3;CRY1;ZNF699;MAML3;ZFP41;SCMH1;KLF13;NFATC4;ZNF783;RNF187;HSF4;ZNF251;EAPP;MDM2;CRTC1;NDN;ZNF662;NEO1;ZNF414;TCF25;MLLT6;F2R;PDCD4;ZNF160;ZFP36L2;TRPV4;GLI2;KLF7;RNF165;TCEA2;ZNF76;SOX12;PIDD1;ZNF747;PER2;ZNF658;PHF2;ABHD14B;TCEAL1;WWTR1;GLI3;THRAP3;ZNF558;IRX4;SMARCA1;BHLHE40;ZNF655;ZNF333;MAP2K5;ITGA6;ZNF318;LZTS1;TCFL5;TRAK1;JARID2;NUPR1;INSR;CCDC85B;CHD3;ZNF18;MXD4;ZNF287;PMS2P3;ZNF446;ZNF581;RTF1;MDK;IRF9;H2AFJ;BMP6;NLRX1;MAP2K2;GLI4;SQSTM1;FZD7;ETV5;DLX3;HEXB;KDM4C;METTL23;ZNF608;GDF15;TXNIP;TCF4;PLAG1;RCOR2;IFI27;LPIN3;CDK5R1;ATRX;MAPK10;HFE;ADIRF;HMG20B;TRIM38;ERCC6;EDA2R;MEF2D;CREBRF;MLXIPL;TARBP1;FBXW7;ING4;CDK5RAP3;ZNF862;ATXN1;LMO2;NFIX;PAK6;CARF;MXI1;THRA;RAI1;ELF1;IKZF4;ZBTB34;ZNF627;DBP;NAB2;EPM2AIP1;PEG3;RFX2;ZNF554;SALL2;ZNF107;ZNF532;ZBTB20;PDE2A;ZNF334;MAF;STK16;RET;ZMYND8;DAB2IP;CASZ1;RWDD3;CALCOCO1;TEAD2;MYSM1;TSHZ2;ZNF276;IFI16;PIK3R2;TEF;ZNF25;RPS6KA5;APBB3;ZNF630;BTG1;ZNF687;VDR;MAMSTR;TNRC18;ZFP28;PLXND1;ZMYM3;SIX5;HLTF;PCSK6;ZNF789;ZNF563;ZNF517;STAT2;WWC3;PHF1;ZNF292;TFDP2;NRARP;ACVR1B;ZNF737;TNNI2;ZNF701;NAT14;TCEAL4;ZNF91;DYDC1;GTF2IRD2;TCF7;ZFP36L1;GLMP;IL11;KAT2B;ERN1;RNF141;IVNS1ABP;ZNF439;TRERF1;APBB2;STAT6;SOX13;PRDX5;NELFCD;KLF8;CHD6;TRAF5;GOLGB1;HDAC11;ERBB2;ABCA2;KMT5C;RORA;PPARG;CXXC5;ZNF572;ZNF658B;ZNF529;UFL1;RIPK3;KLF9;SCAND1;PRMT3;ZFP90;PER3;ZFP30;FOXP2;ZC3H6;HIVEP1;SMURF1;NPNT;CTNNBIP1;GCLC;ECM1
4780,GO:0010970,0.987878696601339,0.0283425442159611,7,131,transport along microtubule,BP,BLOC1S4;SPG11;TRAK1;SUN1;BLOC1S3;IFT140;SYNE2
16987,GO:0099111,0.987878696601339,0.0283425442159611,7,131,microtubule-based transport,BP,BLOC1S4;SPG11;TRAK1;SUN1;BLOC1S3;IFT140;SYNE2
4554,GO:0010638,0.9879414857211,0.0181420255236893,39,511,positive regulation of organelle organization,BP,SREBF1;SFRP1;NOS1;VPS11;TNFSF10;RAPGEF3;RGS2;ARPIN;HPS4;TRPV4;SLX1A;SLX1B;WIPF1;ULK1;LRSAM1;JARID2;INSR;GSN;BAIAP2;RTF1;RICTOR;MICALL2;WHAMMP3;PLA2G6;OSCP1;CDK5R1;ATRX;WASH3P;FBXW7;SYNPO2;DDHD2;FBXO4;RPS6KA5;PHF1;TFDP2;RAD50;PARN;SMURF1;PEMT
4762,GO:0010948,0.988049113103833,0.0208856791548803,19,295,negative regulation of cell cycle process,BP,GPNMB;PKD2;BRSK1;MDM2;PCBP4;ZFP36L2;TOM1L2;PIDD1;GJC2;ZNF655;ATRX;MLXIPL;FBXW7;CDK5RAP3;DAB2IP;TFDP2;ZFP36L1;KAT2B;GPR132
2935,GO:0006457,0.988056561695836,0.0235448643492902,12,210,protein folding,BP,HSPA2;CRTAP;FKBP5;LTBP4;FKBP9;NUDCD3;NKTR;TTC12;GNG2;TMX4;DNAJC4;AIP
20153,GO:2001020,0.988063325768738,0.0256974437079068,9,162,regulation of response to DNA damage stimulus,BP,EGFR;CRY1;MAGEF1;MDM2;POLH;ETAA1;NSMCE4A;FBXO4;ACKR3
4600,GO:0010718,0.988085093950396,0.0680003202962137,1,38,positive regulation of epithelial to mesenchymal transition,BP,WWTR1
18017,GO:1902562,0.988095820003753,0.0677087929069016,1,41,H4 histone acetyltransferase complex,CC,KAT2B
7865,GO:0032434,0.98813034999563,0.0314147169105137,5,107,regulation of proteasomal ubiquitin-dependent protein catabolic process,BP,MDM2;HFE;PANO1;UFL1;GCLC
16840,GO:0098791,0.988153751798484,0.0169473571951735,53,658,Golgi subcompartment,CC,TGFBI;POSTN;SREBF1;GPSM1;EGFR;SULF2;ST6GALNAC2;VAMP3;NSG1;RAB43;B4GALNT4;SCARA3;COL7A1;ST6GALNAC6;GOLGA8A;HLA-B;GAL3ST4;B4GALT6;AP1G2;CLTCL1;MAPK8IP3;GOLGA8B;RHBDF1;ASAP2;SPPL2B;VAMP2;ST3GAL5;B4GALT2;KIAA0319L;B3GNT9;MALL;ANKRD28;ARAP1;GOLGA8N;SLC2A1;NDST2;HLA-A;AREG;ARFGEF2;LMTK3;GOLGA7B;NECAB3;XYLT1;CLSTN3;MAN1B1;PCSK1N;GOLGA1;GOLGB1;GCNT4;PI4K2B;COG1;CIT;SERINC3
2532,GO:0005789,0.988160483608064,0.0164942031455304,63,792,endoplasmic reticulum membrane,CC,SREBF1;GPSM1;LMF1;EGFR;PKD2;TMEM129;UBXN4;REEP2;SRD5A3;NSG1;KDSR;NOS1;SCARA3;CYP26B1;ITPR3;HLA-B;UGT1A3;CERS4;CYP3A5;FLRT3;TMC6;G6PC3;RHBDF1;PTGS1;PSKH1;MBOAT2;ULK1;SPPL2B;MGST2;PGAP1;PLD3;TREX1;LPIN3;MCTP1;PIGZ;CYBA;RNF170;REEP4;HLA-A;PMEL;JPH2;SLC37A2;RETSAT;OSBPL5;AREG;TMEM203;NECAB3;ESYT2;RSAD2;XYLT1;CLSTN3;ACSL1;ERN1;MAN1B1;DHRS4;FAAH;CERS5;CPT1C;AKAP6;ATG14;SYNE2;UFL1;PEMT
17511,GO:1901028,0.988161728874162,0.0672656646629841,1,43,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,BP,TFDP2
3292,GO:0006984,0.988261649672794,0.0670257634697856,1,40,ER-nucleus signaling pathway,BP,FBXW7
4340,GO:0009894,0.988310639692614,0.0163359789055009,62,768,regulation of catabolic process,BP,TNFAIP3;SERPINE2;ULK2;EPM2A;TP53INP1;SREBF1;APOE;GPSM1;EGFR;TRIM65;CIRBP;TRIM22;MAGEF1;VPS11;MDM2;TYSND1;RAPGEF3;PCBP4;MLYCD;ZFP36L2;LAMP3;RHBDF1;ULK1;THRAP3;LRSAM1;SESN3;LZTS1;INSR;ENDOG;CST3;ATP6V0A2;CDK5R1;SESN1;HFE;XRN1;MLXIPL;FBXW7;CDK5RAP3;PFKFB2;THRA;APC2;ACACB;LRP1;DAB2IP;IFI16;PIK3R2;TNRC6C;SNX1;PANO1;ZFP36L1;IRS2;ERN1;ANGEL2;TNFSF12;PTPN3;PRKACA;PARN;UFL1;LONP2;SNX33;SMURF1;GCLC
19424,GO:1990089,0.98838694385789,0.0665297463217634,1,39,response to nerve growth factor,BP,MICALL1
19425,GO:1990090,0.98838694385789,0.0665297463217634,1,39,cellular response to nerve growth factor stimulus,BP,MICALL1
2834,GO:0006303,0.988401908955272,0.0458038727442537,2,67,double-strand break repair via nonhomologous end joining,BP,RAD50;POLM
2433,GO:0005623,0.988415715880272,0.0152103274425064,1117,11090,cell,CC,TNFAIP3;TGFBI;POSTN;TAGLN;ITGB6;HES2;SERPINE2;ZSCAN18;ULK2;GPNMB;TSC22D1;SIK1;SLFN5;SUGCT;EPM2A;MUC19;NPEPL1;DDB2;TP53INP1;MAP6;IFI6;PTHLH;SREBF1;AMACR;PYGB;ACTA2;APOE;GPSM1;CES2;NT5E;ALS2CL;INPP5D;APCDD1;GAMT;FBXO41;OAS2;ADAM19;LMF1;PSD4;DDX60;HSPA2;FBXW4;EGFR;ESPN;TRIM65;FAM117A;HERC3;PTPRS;CIRBP;FLNC;FAM20C;PKD2;CAPRIN2;MNT;XPC;APOBEC3C;SYT8;CXCR1;CPT2;RBM3;SYN1;ASH2L;DIXDC1;TRIM22;ALDH1A3;SRSF5;LRIG3;PLCD3;SLITRK6;CTSO;SFRP1;OBSL1;MTHFR;PERM1;SEC14L2;KCTD11;IFI44L;KIF26B;PCDH1;EPS8L2;EPHB2;RALGDS;TNS1;SYNC;MAP3K14;GLUD1;BPHL;DCAF16;DGKQ;TMEM129;PIK3R1;ADAMTS7;EVI5L;BRSK1;TXNRD3;MARVELD1;RBCK1;KDM3A;CXCL14;DOCK9;COL22A1;TSC22D3;CUL9;EVC;RNF135;POU3F1;SULF2;WNT3;H6PD;DHTKD1;CAMKK1;HERC5;UBXN4;VAV3;ST6GALNAC2;UNK;HR;VWCE;CSPG4;ISG15;MVB12B;CYBRD1;HTRA1;SPATA18;TFCP2L1;TENM4;UNC119B;RGMA;PI4KAP2;KCNAB2;ZFPM1;KITLG;HOXC5;SDK2;MVD;ZDHHC1;ZNF362;CUL7;VAMP3;CITED4;SNN;IRF2BPL;NAPRT;REEP2;PRICKLE2;KCNJ15;MC1R;ASAP3;ZNF266;SRD5A3;OR2A4;STAT1;IMPACT;CSMD2;CAMK2N1;CRY2;MYL9;GRIP2;KRT15;HS1BP3;LGALS7B;WDR63;MARCKSL1;NSG1;UNC5B;UROS;SLC16A5;KDSR;ITGB5;COL10A1;GJD3;RAB43;RAB40B;NOS1;PRKACB;ZNF704;HOXA3;B4GALNT4;CRY1;ZNF699;MAML3;ZFP41;SCMH1;KLF13;CRTAP;SDC3;BCAM;PLEKHG5;NFATC4;PITPNM3;ZNF783;IQSEC2;HMGCL;D2HGDH;BTBD2;SCARA3;FKBP5;RNF187;FERMT1;H1F0;CYP26B1;GAA;AP5Z1;CMPK2;HSF4;CNTRL;ZNF251;MICALL1;PIK3C2G;LIG1;CDK18;TBC1D8;PLXNB1;VPS11;SPEG;NDRG1;COL7A1;KCNC4;SPOCK1;SLC29A4;ITPR3;EAPP;NAGLU;CYHR1;MDM2;CRTC1;LZTS2;PLCD1;NDN;IFITM1;MLH3;NMRK1;DDX59;ST6GALNAC6;PPP2R2C;FCGRT;CSMD3;CHN2;ZNF662;TYSND1;PIK3IP1;OBSCN;IDUA;GOLGA8A;GPRC5C;HLA-B;TNFSF10;PRODH;HGSNAT;MYH11;PARVB;SYTL1;FKBP9;NDUFA4L2;ACTR1B;TNXB;RHOBTB2;UGT1A3;CERS4;CYP3A5;ACOT1;NEO1;RAPGEF3;PHACTR3;ZNF414;SPSB3;TCF25;ENDOD1;PCBP4;FAM210B;CTSV;NLGN4Y;POLH;BLVRB;POLR2J2;OAS1;FLRT3;NUDCD3;RASA4;TRIM66;GAL3ST4;CRAT;KIF26A;B4GALT6;MLLT6;AP1G2;RGL4;RGS2;ARPIN;ACAP3;IL20RB;ADGRB2;F2R;MLYCD;PPL;C2CD4C;HPS4;PHYH;TMEM134;MT1X;PDCD4;BLOC1S4;SPTB;SERPINB5;NOL4L;NYAP1;SLC24A1;ALPK1;ZNF160;CAPN7;SWT1;DNAH1;SLC27A3;ARSI;NEK9;TUBGCP5;RTN4RL1;ZFP36L2;CLTCL1;TRPV4;TMC6;FLOT1;GLI2;AGAP4;TOM1L2;RHPN1;NLGN2;ADORA2B;CORO6;ANK3;KLF7;RNF165;NAT6;DHX32;ADAMTS13;LAMP3;TCEA2;PLCH2;RALGAPA1;MAPK8IP3;GOLGA8B;SLC13A5;ZNF76;SOX12;CLMN;PIDD1;RIMS3;PARP6;AVL9;SLX1A;SLX1B;G6PC3;ATG16L2;ZNF747;SPG11;GJC2;ZCCHC11;ARHGEF19;RHBDF1;TSPAN18;SULT1E1;FBXO44;RASGEF1A;ANKS6;PER2;TMEM204;PITPNM2;CLCN6;MICALCL;PTGS1;UNC119;DIRC2;HEXA;FNDC4;FRS3;DTNB;C5;FRMD4B;ZNF658;ARSD;WIPF1;SNTA1;PSKH1;ADGRL1;MINK1;PHF2;NINL;ABHD14B;GSTM2;TCEAL1;AMIGO2;THBS3;TNFRSF14;WWTR1;MBOAT2;ASAP2;ARHGEF4;LHFPL2;ITGA2;SEMA4G;RSPH3;FAM110C;SYT15;ULK1;GLI3;SPPL2B;FGGY;FHOD3;PCSK1;TPGS1;THRAP3;ZNF558;IRX4;SMARCA1;AKAP7;BHLHE40;DGCR6L;LRSAM1;VAMP2;ZNF655;NAIP;LTBP1;NMU;ZNF333;NEK8;MAP2K5;GAS8;BOC;ITGA6;KCNJ5;SRGAP3;CES3;BSN;SESN3;ZNF318;LZTS1;IGFBP4;TCFL5;TRAK1;JARID2;NUPR1;PRR9;GPC2;NISCH;INSR;TST;IFI44;CCDC85B;HSF2BP;CELSR1;MMP28;GSN;ALDH4A1;CEP68;HEBP1;CHD3;CDK14;ST3GAL5;BAIAP2;TANC1;TTN;CBLC;SCNN1A;DDT;ZNF18;PLXNB3;CEP126;SUN1;LPAR5;AHNAK2;CNTNAP3;RNPEPL1;PLEKHH2;TRIOBP;MXD4;POLD4;RIN1;DNAJC30;CTSF;ZNF287;CD109;CYP2D7;NSUN5P2;PNMA1;PGLS;PMS2P3;ETAA1;RMI2;ZNF446;SCN4B;ARHGEF1;SEPT6;FBXL16;RAB11FIP4;VPS39;ZNF581;MGST2;DOCK8;TP53AIP1;DHX58;PILRB;ENDOG;SLC27A1;PGAP1;TM7SF3;NRSN2;RTF1;BLOC1S3;MDK;SIRPB2;CASP14;IRF9;RICTOR;TMEM9;H2AFJ;BMP6;F8A1;NLRX1;B4GALT2;TMCC3;ETNK2;PEX10;SLC2A3;TCIRG1;S100A4;MICALL2;MAP2K2;OPLAH;PDK1;VEGFB;ALDH7A1;GLI4;SQSTM1;CEP192;CABYR;PTK6;SLC12A7;TMEM8B;FZD7;ETV5;AKR7A2;LOXL1;FNBP4;FRMD8;SYNGAP1;FAM13A;FAM213A;FAT2;DLX3;TMEM117;LGALS9C;EPB41L3;SHARPIN;HEXB;KDM4C;HYAL1;METTL23;CLCA2;ARHGAP33;H1FX;SH2D2A;UBOX5;NSMCE4A;ARRDC1;KIAA0319L;B3GNT9;WHAMMP3;CENPC;PLA2G6;CST3;PDIK1L;HOMER2;CAPNS2;GDF15;PEX7;BBS2;TXNIP;TCF4;ATP6V0A2;KLHDC2;COL6A1;PEX11B;NPHP3;PSD3;LRRCC1;PLAG1;IDH2;CERCAM;MAP3K12;RCOR2;WRN;PODXL;SEPT5;IFI27;MALL;OSCP1;OXLD1;DNM1;MCM9;TNFRSF21;ZYG11B;MACROD1;IQCB1;KLHL24;PLD3;TREX1;LPIN3;ZDHHC12;ABHD14A;MCTP1;CDK5R1;ATRX;REC8;ARHGAP27;AGAP6;NET1;ANO9;PIGZ;CA2;EFNB3;OSBPL10;PI4KAP1;POLR2J3;HOOK2;SESN1;EPB41L4A;MAPK10;NKTR;SHANK3;HFE;SCART1;ADIRF;HMG20B;CYBA;TRIM38;NID1;DTX3;AGO4;ERCC6;HADH;RRM2B;SLIT3;CLIP2;KRT14;HLCS;SHC2;EDA2R;SPRY2;MRC2;FBXO2;WASH3P;MEF2D;IFT140;GABBR1;CREBRF;XRN1;AGAP7P;RAB11FIP3;TIGD5;LRP11;MLXIPL;CTSB;KLK5;NBPF15;TARBP1;FBXW7;KCNMA1;ANKRD28;GPR87;ING4;NUDT6;CDK5RAP3;ZNF862;ATXN1;LMO2;NOTCH2NL;CCDC92;NFIX;PAK6;CARF;DZIP1L;PGM1;MXI1;PFKFB2;PAQR6;RNF170;CHMP1B;THRA;TTC12;HSD11B1L;APC2;METTL21A;ACADS;ARAP1;ASTN2;GOLGA8N;ADARB1;RAI1;FMNL2;ELF1;FAM185A;MX2;IKZF4;DCAF10;RPH3AL;SLC2A1;ACACB;OGDHL;NLRP1;FRAT1;ZBTB34;ERMAP;REEP4;ZNF627;TK2;GPR155;LACTB2;BEX2;GLUL;TNS2;TBC1D17;MIF4GD;DBP;NDST2;NAB2;SLC38A4;EPM2AIP1;TP53I13;GNG2;FBXW5;PRR7;SRR;CAPG;TSPYL4;LRP1;KLHDC8B;HLA-A;PEG3;TSNARE1;NPHP4;RGS12;CCDC136;ATE1;ACP5;MPG;PLA2G7;SYNPO2;RNPEP;C12ORF66;CENPH;RFX2;KCNG1;ZNF554;BRINP1;SLC48A1;BDH1;CD99L2;MAP3K6;RIMKLB;PPCS;MYO3B;APPL2;HEXDC;SALL2;WNK1;PMEL;ZNF107;ZNF532;BBS1;ATXN10;JPH2;ARL11;ZBTB20;PDE2A;ZNF334;SDHA;MAF;STK16;LTB4R2;RET;ZMYND8;PRX;DAB2IP;CASZ1;RWDD3;ACOX3;CALCOCO1;SLC37A2;TEAD2;MYSM1;DDHD2;SHROOM2;FBXO4;RNF213;OLFM2;RAPGEFL1;TSHZ2;PIK3C3;ZNF276;IFI16;SYT7;FGFR4;ERCC5;BBS5;EXOC2;IL20RA;PIK3R2;RETSAT;SCN2A;TEF;ZNF25;SETD4;OSBPL5;AREG;ABTB1;TMEM203;DEF6;KLHL3;SNCB;ETFB;MYO9A;RPS6KA5;APBB3;ZNF630;DLG5;BTG1;BST2;ZNF687;VDR;LETMD1;RGL2;SNX21;ARHGEF17;CACNB3;MAMSTR;PHF7;TNRC18;TNRC6C;ZFP28;DPY19L2P2;VIPR1;EFS;PLXND1;NADK;BBS10;ZMYM3;SIX5;HLTF;MARCH8;EHBP1;PCSK6;ZNF789;TMEM80;MPPE1;ZNF563;TNS4;ZNF517;PCMTD2;TBC1D16;STK19;NDUFV3;TMCO6;LPAR6;EML3;PPP1R2;DMTN;TPRN;ORAI2;STAT2;SGSM2;ARFGEF2;RASL10B;LMTK3;ALMS1;PCMTD1;WWC3;PHF1;ZNF292;SLC36A4;TMEM231;TFDP2;SNX1;PMP22;UCN2;CA11;GOLGA7B;OSBPL1A;ACVR1B;TMX4;SHROOM4;ZNF737;TACC1;KREMEN1;CADM4;KDELC2;PRIMPOL;NECAB3;CCDC88B;DLG4;CCDC113;TNNI2;PPP2R3B;ESYT2;TSSK1B;IQSEC1;ZNF701;ALOXE3;NAT14;PANO1;PALB2;ENDOU;MPI;IGFBP6;TCEAL4;ZNF91;NBEAL2;CD68;DUOX1;GALE;PTMS;WEE1;DYDC1;R3HDM4;CCNG2;SLC22A15;TMEM143;GTF2IRD2;GOLGA6L4;SLC35G2;PTK7;DQX1;AMT;TCF7;SHANK2;RSAD2;TNFRSF25;NEMP2;ZFP36L1;XYLT1;LMNA;MXRA8;CLSTN3;GLMP;TOP3B;ACSL1;IL11;KAT2B;MARK4;TEP1;APOLD1;IRS2;DMXL2;IMPA2;CEP250;ANO1;CAPS;METTL7A;ERN1;HSD17B14;SAC3D1;IVNS1ABP;ALOX15B;RAD50;GPR21;ZNF439;TKFC;LAPTM4A;ANGEL2;ZMAT3;PNPO;MTR;MAN1B1;DHRS4;PEX1;ECI1;S100A6;TRERF1;UAP1L1;FAAH;SCYL3;SCG5;ZSWIM8;APBB2;CBR4;TTC19;ARHGEF9;ISYNA1;SGSH;PBLD;DCAF8;CCDC90B;RAPGEF5;MYH16;TNFSF12;TAS1R3;CERS5;STAT6;PCSK1N;SOX13;PRDX5;PHPT1;NELFCD;GPR132;PHC2;SMPDL3B;TUB;KIF7;SLC43A1;GLB1;GOLGA1;CPT1C;KLF8;GSTM3;RDH12;KLHL29;CHD6;TRAF5;NAP1L5;GOLGB1;SRPX2;ACSS2;DPP7;TRIM2;CD9;PLIN4;RANBP9;CACNB1;HDAC11;PTPN3;CTSD;GJB5;COL13A1;ERBB2;SYNGR1;MPRIP;PLCB3;GPR68;NUDT10;UVSSA;ZDHHC24;PAQR7;ARHGAP23;PPM1M;ABCA2;KMT5C;AKAP6;SLC2A11;TH;ATG14;MPP7;RORA;SSH3;PPARG;PRKACA;DOCK6;LDLRAP1;CXXC5;NPAP1;C6ORF120;POLM;FMNL3;ACOT2;GCNT4;VMAC;ZNF572;SYNE2;PARD6G;ACKR3;ZNF658B;SERPING1;SUCLG2;UCKL1;PARN;DDX12P;DOCK3;ZNF529;UFL1;LAMB2;IP6K2;RIPK3;NFASC;KLF9;PI4K2B;AIP;COG1;KCNS3;SCAND1;LONP2;PRMT3;SNX33;HARS2;CIT;ZFP90;EHHADH;MSH5;CLCN7;MAP1A;CCDC3;PER3;ZFP30;FOXP2;PTBP2;ZC3H6;HIVEP1;CALHM2;SMURF1;NPNT;TTLL1;EML2;CTNNBIP1;PEMT;ABCA11P;OCIAD2;TM4SF1;SERINC3;GCLC;ECM1
10559,GO:0043536,0.988556361770425,0.0656693930727386,1,40,positive regulation of blood vessel endothelial cell migration,BP,SRPX2
272,GO:0000775,0.988607166378647,0.0238436396150903,10,173,chromosome, centromeric region,CC,PHF2;SEPT6;KDM4C;CENPC;ATRX;REC8;CENPH;ZNF276;KAT2B;KMT5C
1996,GO:0004721,0.98870665101357,0.0254213276651527,8,144,phosphoprotein phosphatase activity,MF,PTPRS;PPP2R2C;TNS2;PPP2R3B;PHPT1;PTPN3;PPM1M;SSH3
10612,GO:0043624,0.988855085708102,0.0240799580250299,9,179,cellular protein complex disassembly,BP,SPTB;TRPV4;GSN;PLEKHH2;TRIOBP;APC2;CAPG;DMTN;MAP1A
8247,GO:0033036,0.988937888725451,0.0135804762128877,205,2265,macromolecule localization,BP,TNFAIP3;POSTN;ITGB6;SREBF1;APOE;LMF1;EGFR;PKD2;CPT2;TRIM22;SRSF5;SFRP1;OBSL1;EPHB2;GLUD1;TMEM129;PIK3R1;EVI5L;MARVELD1;MVB12B;UNC119B;KCNAB2;ZDHHC1;VAMP3;REEP2;NSG1;RAB43;RAB40B;CRY1;PITPNM3;FERMT1;AP5Z1;MICALL1;TBC1D8;VPS11;ITPR3;MDM2;LZTS2;MLH3;OBSCN;SYTL1;RAPGEF3;NUDCD3;AP1G2;F2R;HPS4;CLTCL1;TRPV4;FLOT1;TOM1L2;NLGN2;ANK3;ATG16L2;RHBDF1;PER2;PITPNM2;UNC119;C5;ITGA2;ULK1;GLI3;AKAP7;LRSAM1;VAMP2;LTBP1;NMU;GAS8;BSN;TRAK1;TST;CELSR1;GSN;CEP68;BAIAP2;TTN;SUN1;SEPT6;VPS39;SLC27A1;PGAP1;TM7SF3;BMP6;PEX10;TCIRG1;MICALL2;SQSTM1;CEP192;ETV5;SYNGAP1;EPB41L3;HEXB;ARHGAP33;ARRDC1;PLA2G6;PEX7;BBS2;TXNIP;ATP6V0A2;IDH2;WRN;SEPT5;IFI27;MALL;OSCP1;TNFRSF21;ZDHHC12;CDK5R1;ATRX;ANO9;OSBPL10;HOOK2;SHANK3;HFE;HADH;WASH3P;IFT140;RAB11FIP3;FBXW7;CDK5RAP3;DZIP1L;MXI1;PFKFB2;CHMP1B;THRA;ASTN2;MX2;RPH3AL;SLC2A1;ACACB;NLRP1;GLUL;TBC1D17;LRP1;TSNARE1;C12ORF66;BBS1;PDE2A;ZMYND8;SHROOM2;FBXO4;OLFM2;PIK3C3;SYT7;BBS5;EXOC2;PIK3R2;OSBPL5;DLG5;SNX21;CACNB3;EHBP1;TNS4;TBC1D16;TMCO6;DMTN;SGSM2;ARFGEF2;TMEM231;TFDP2;SNX1;GOLGA7B;OSBPL1A;NECAB3;DLG4;ESYT2;RSAD2;ZFP36L1;LMNA;CLSTN3;ACSL1;APOLD1;IRS2;CEP250;ANO1;ALOX15B;ZMAT3;PEX1;SCG5;PHPT1;TUB;GOLGB1;ERBB2;SYNGR1;GPR68;ZDHHC24;ABCA2;AKAP6;MPP7;PPARG;LDLRAP1;NPAP1;SYNE2;PLTP;PARN;UFL1;NFASC;AIP;COG1;KCNS3;LONP2;SNX33;SMURF1;NPNT;PEMT;ABCA11P
9065,GO:0035326,0.988993677707862,0.0364220568408972,3,74,enhancer binding,MF,ZNF704;RAI1;HIVEP1
18404,GO:1903506,0.989004768531532,0.0132622926865165,264,2847,regulation of nucleic acid-templated transcription,BP,TNFAIP3;HES2;ZSCAN18;TSC22D1;SIK1;TP53INP1;SREBF1;APOE;MN1;EGFR;PKD2;CAPRIN2;MNT;ASH2L;TRIM22;SFRP1;PERM1;SEC14L2;DGKQ;PIK3R1;RBCK1;KDM3A;TSC22D3;POU3F1;HR;HTRA1;TFCP2L1;RGMA;ZFPM1;HOXC5;ZNF362;CITED4;IRF2BPL;MC1R;ZNF266;STAT1;IMPACT;CRY2;THAP8;NOS1;ZNF704;HOXA3;CRY1;ZNF699;MAML3;ZFP41;SCMH1;KLF13;NFATC4;ZNF783;RNF187;HSF4;ZNF251;EAPP;MDM2;CRTC1;NDN;ZNF662;NEO1;ZNF414;TCF25;MLLT6;F2R;PDCD4;ZNF160;ZFP36L2;TRPV4;GLI2;KLF7;RNF165;TCEA2;ZNF76;SOX12;PIDD1;ZNF747;PER2;ZNF658;PHF2;ABHD14B;TCEAL1;WWTR1;GLI3;THRAP3;ZNF558;IRX4;SMARCA1;BHLHE40;ZNF655;ZNF333;MAP2K5;ITGA6;ZNF318;LZTS1;TCFL5;TRAK1;JARID2;NUPR1;INSR;CCDC85B;CHD3;ZNF18;MXD4;ZNF287;PMS2P3;ZNF446;ZNF581;RTF1;MDK;IRF9;H2AFJ;BMP6;NLRX1;MAP2K2;GLI4;SQSTM1;FZD7;ETV5;DLX3;HEXB;KDM4C;METTL23;ZNF608;GDF15;TXNIP;TCF4;PLAG1;RCOR2;IFI27;LPIN3;CDK5R1;ATRX;MAPK10;HFE;ADIRF;HMG20B;TRIM38;ERCC6;EDA2R;MEF2D;CREBRF;MLXIPL;TARBP1;FBXW7;ING4;CDK5RAP3;ZNF862;ATXN1;LMO2;NFIX;PAK6;CARF;MXI1;THRA;RAI1;ELF1;IKZF4;ZBTB34;ZNF627;DBP;NAB2;EPM2AIP1;PEG3;RFX2;ZNF554;SALL2;ZNF107;ZNF532;ZBTB20;PDE2A;ZNF334;MAF;STK16;RET;ZMYND8;DAB2IP;CASZ1;RWDD3;CALCOCO1;TEAD2;MYSM1;TSHZ2;ZNF276;IFI16;PIK3R2;TEF;ZNF25;RPS6KA5;APBB3;ZNF630;BTG1;ZNF687;VDR;MAMSTR;TNRC18;ZFP28;PLXND1;ZMYM3;SIX5;HLTF;PCSK6;ZNF789;ZNF563;ZNF517;STAT2;WWC3;PHF1;ZNF292;TFDP2;NRARP;ACVR1B;ZNF737;TNNI2;ZNF701;NAT14;TCEAL4;ZNF91;DYDC1;GTF2IRD2;TCF7;ZFP36L1;GLMP;IL11;KAT2B;ERN1;RNF141;IVNS1ABP;ZNF439;TRERF1;APBB2;STAT6;SOX13;PRDX5;NELFCD;KLF8;CHD6;TRAF5;GOLGB1;HDAC11;ERBB2;ABCA2;KMT5C;RORA;PPARG;CXXC5;ZNF572;ZNF658B;ZNF529;UFL1;RIPK3;KLF9;AIP;SCAND1;PRMT3;ZFP90;PER3;ZFP30;FOXP2;ZC3H6;HIVEP1;SMURF1;NPNT;CTNNBIP1;GCLC;ECM1
20193,GO:2001141,0.989358485100073,0.0128457495798041,264,2849,regulation of RNA biosynthetic process,BP,TNFAIP3;HES2;ZSCAN18;TSC22D1;SIK1;TP53INP1;SREBF1;APOE;MN1;EGFR;PKD2;CAPRIN2;MNT;ASH2L;TRIM22;SFRP1;PERM1;SEC14L2;DGKQ;PIK3R1;RBCK1;KDM3A;TSC22D3;POU3F1;HR;HTRA1;TFCP2L1;RGMA;ZFPM1;HOXC5;ZNF362;CITED4;IRF2BPL;MC1R;ZNF266;STAT1;IMPACT;CRY2;THAP8;NOS1;ZNF704;HOXA3;CRY1;ZNF699;MAML3;ZFP41;SCMH1;KLF13;NFATC4;ZNF783;RNF187;HSF4;ZNF251;EAPP;MDM2;CRTC1;NDN;ZNF662;NEO1;ZNF414;TCF25;MLLT6;F2R;PDCD4;ZNF160;ZFP36L2;TRPV4;GLI2;KLF7;RNF165;TCEA2;ZNF76;SOX12;PIDD1;ZNF747;PER2;ZNF658;PHF2;ABHD14B;TCEAL1;WWTR1;GLI3;THRAP3;ZNF558;IRX4;SMARCA1;BHLHE40;ZNF655;ZNF333;MAP2K5;ITGA6;ZNF318;LZTS1;TCFL5;TRAK1;JARID2;NUPR1;INSR;CCDC85B;CHD3;ZNF18;MXD4;ZNF287;PMS2P3;ZNF446;ZNF581;RTF1;MDK;IRF9;H2AFJ;BMP6;NLRX1;MAP2K2;GLI4;SQSTM1;FZD7;ETV5;DLX3;HEXB;KDM4C;METTL23;ZNF608;GDF15;TXNIP;TCF4;PLAG1;RCOR2;IFI27;LPIN3;CDK5R1;ATRX;MAPK10;HFE;ADIRF;HMG20B;TRIM38;ERCC6;EDA2R;MEF2D;CREBRF;MLXIPL;TARBP1;FBXW7;ING4;CDK5RAP3;ZNF862;ATXN1;LMO2;NFIX;PAK6;CARF;MXI1;THRA;RAI1;ELF1;IKZF4;ZBTB34;ZNF627;DBP;NAB2;EPM2AIP1;PEG3;RFX2;ZNF554;SALL2;ZNF107;ZNF532;ZBTB20;PDE2A;ZNF334;MAF;STK16;RET;ZMYND8;DAB2IP;CASZ1;RWDD3;CALCOCO1;TEAD2;MYSM1;TSHZ2;ZNF276;IFI16;PIK3R2;TEF;ZNF25;RPS6KA5;APBB3;ZNF630;BTG1;ZNF687;VDR;MAMSTR;TNRC18;ZFP28;PLXND1;ZMYM3;SIX5;HLTF;PCSK6;ZNF789;ZNF563;ZNF517;STAT2;WWC3;PHF1;ZNF292;TFDP2;NRARP;ACVR1B;ZNF737;TNNI2;ZNF701;NAT14;TCEAL4;ZNF91;DYDC1;GTF2IRD2;TCF7;ZFP36L1;GLMP;IL11;KAT2B;ERN1;RNF141;IVNS1ABP;ZNF439;TRERF1;APBB2;STAT6;SOX13;PRDX5;NELFCD;KLF8;CHD6;TRAF5;GOLGB1;HDAC11;ERBB2;ABCA2;KMT5C;RORA;PPARG;CXXC5;ZNF572;ZNF658B;ZNF529;UFL1;RIPK3;KLF9;AIP;SCAND1;PRMT3;ZFP90;PER3;ZFP30;FOXP2;ZC3H6;HIVEP1;SMURF1;NPNT;CTNNBIP1;GCLC;ECM1
16864,GO:0098827,0.989541446240999,0.0146461424990061,63,796,endoplasmic reticulum subcompartment,CC,SREBF1;GPSM1;LMF1;EGFR;PKD2;TMEM129;UBXN4;REEP2;SRD5A3;NSG1;KDSR;NOS1;SCARA3;CYP26B1;ITPR3;HLA-B;UGT1A3;CERS4;CYP3A5;FLRT3;TMC6;G6PC3;RHBDF1;PTGS1;PSKH1;MBOAT2;ULK1;SPPL2B;MGST2;PGAP1;PLD3;TREX1;LPIN3;MCTP1;PIGZ;CYBA;RNF170;REEP4;HLA-A;PMEL;JPH2;SLC37A2;RETSAT;OSBPL5;AREG;TMEM203;NECAB3;ESYT2;RSAD2;XYLT1;CLSTN3;ACSL1;ERN1;MAN1B1;DHRS4;FAAH;CERS5;CPT1C;AKAP6;ATG14;SYNE2;UFL1;PEMT
10901,GO:0044464,0.989847785541167,0.0133821205485804,1116,11085,cell part,CC,TNFAIP3;TGFBI;POSTN;TAGLN;ITGB6;HES2;SERPINE2;ZSCAN18;ULK2;GPNMB;TSC22D1;SIK1;SLFN5;SUGCT;EPM2A;MUC19;NPEPL1;DDB2;TP53INP1;MAP6;IFI6;PTHLH;SREBF1;AMACR;PYGB;ACTA2;APOE;GPSM1;CES2;NT5E;ALS2CL;INPP5D;APCDD1;GAMT;FBXO41;OAS2;ADAM19;LMF1;PSD4;DDX60;HSPA2;FBXW4;EGFR;ESPN;TRIM65;FAM117A;HERC3;PTPRS;CIRBP;FLNC;FAM20C;PKD2;CAPRIN2;MNT;XPC;APOBEC3C;SYT8;CXCR1;CPT2;RBM3;SYN1;ASH2L;DIXDC1;TRIM22;ALDH1A3;SRSF5;LRIG3;PLCD3;SLITRK6;CTSO;SFRP1;OBSL1;MTHFR;PERM1;SEC14L2;KCTD11;IFI44L;KIF26B;PCDH1;EPS8L2;EPHB2;RALGDS;TNS1;SYNC;MAP3K14;GLUD1;BPHL;DCAF16;DGKQ;TMEM129;PIK3R1;ADAMTS7;EVI5L;BRSK1;TXNRD3;MARVELD1;RBCK1;KDM3A;CXCL14;DOCK9;COL22A1;TSC22D3;CUL9;EVC;RNF135;POU3F1;SULF2;WNT3;H6PD;DHTKD1;CAMKK1;HERC5;UBXN4;VAV3;ST6GALNAC2;UNK;HR;VWCE;CSPG4;ISG15;MVB12B;CYBRD1;HTRA1;SPATA18;TFCP2L1;TENM4;UNC119B;RGMA;PI4KAP2;KCNAB2;ZFPM1;KITLG;HOXC5;SDK2;MVD;ZDHHC1;ZNF362;CUL7;VAMP3;CITED4;SNN;IRF2BPL;NAPRT;REEP2;PRICKLE2;KCNJ15;MC1R;ASAP3;ZNF266;SRD5A3;OR2A4;STAT1;IMPACT;CSMD2;CAMK2N1;CRY2;MYL9;GRIP2;KRT15;HS1BP3;LGALS7B;WDR63;MARCKSL1;NSG1;UNC5B;UROS;SLC16A5;KDSR;ITGB5;COL10A1;GJD3;RAB43;RAB40B;NOS1;PRKACB;ZNF704;HOXA3;B4GALNT4;CRY1;ZNF699;MAML3;ZFP41;SCMH1;KLF13;CRTAP;SDC3;BCAM;PLEKHG5;NFATC4;PITPNM3;ZNF783;IQSEC2;HMGCL;D2HGDH;BTBD2;SCARA3;FKBP5;RNF187;FERMT1;H1F0;CYP26B1;GAA;AP5Z1;CMPK2;HSF4;CNTRL;ZNF251;MICALL1;PIK3C2G;LIG1;CDK18;TBC1D8;PLXNB1;VPS11;SPEG;NDRG1;COL7A1;KCNC4;SPOCK1;SLC29A4;ITPR3;EAPP;NAGLU;CYHR1;MDM2;CRTC1;LZTS2;PLCD1;NDN;IFITM1;MLH3;NMRK1;DDX59;ST6GALNAC6;PPP2R2C;FCGRT;CSMD3;CHN2;ZNF662;TYSND1;PIK3IP1;OBSCN;IDUA;GOLGA8A;GPRC5C;HLA-B;TNFSF10;PRODH;HGSNAT;MYH11;PARVB;SYTL1;FKBP9;NDUFA4L2;ACTR1B;TNXB;RHOBTB2;UGT1A3;CERS4;CYP3A5;ACOT1;NEO1;RAPGEF3;PHACTR3;ZNF414;SPSB3;TCF25;ENDOD1;PCBP4;FAM210B;CTSV;NLGN4Y;POLH;BLVRB;POLR2J2;OAS1;FLRT3;NUDCD3;RASA4;TRIM66;GAL3ST4;CRAT;KIF26A;B4GALT6;MLLT6;AP1G2;RGL4;RGS2;ARPIN;ACAP3;IL20RB;ADGRB2;F2R;MLYCD;PPL;C2CD4C;HPS4;PHYH;TMEM134;MT1X;PDCD4;BLOC1S4;SPTB;SERPINB5;NOL4L;NYAP1;SLC24A1;ALPK1;ZNF160;CAPN7;SWT1;DNAH1;SLC27A3;ARSI;NEK9;TUBGCP5;RTN4RL1;ZFP36L2;CLTCL1;TRPV4;TMC6;FLOT1;GLI2;AGAP4;TOM1L2;RHPN1;NLGN2;ADORA2B;CORO6;ANK3;KLF7;RNF165;NAT6;DHX32;ADAMTS13;LAMP3;TCEA2;PLCH2;RALGAPA1;MAPK8IP3;GOLGA8B;SLC13A5;ZNF76;SOX12;CLMN;PIDD1;RIMS3;PARP6;AVL9;SLX1A;SLX1B;G6PC3;ATG16L2;ZNF747;SPG11;GJC2;ZCCHC11;ARHGEF19;RHBDF1;TSPAN18;SULT1E1;FBXO44;RASGEF1A;ANKS6;PER2;TMEM204;PITPNM2;CLCN6;MICALCL;PTGS1;UNC119;DIRC2;HEXA;FNDC4;FRS3;DTNB;C5;FRMD4B;ZNF658;ARSD;WIPF1;SNTA1;PSKH1;ADGRL1;MINK1;PHF2;NINL;ABHD14B;GSTM2;TCEAL1;AMIGO2;THBS3;TNFRSF14;WWTR1;MBOAT2;ASAP2;ARHGEF4;LHFPL2;ITGA2;SEMA4G;RSPH3;FAM110C;SYT15;ULK1;GLI3;SPPL2B;FHOD3;PCSK1;TPGS1;THRAP3;ZNF558;IRX4;SMARCA1;AKAP7;BHLHE40;DGCR6L;LRSAM1;VAMP2;ZNF655;NAIP;LTBP1;NMU;ZNF333;NEK8;MAP2K5;GAS8;BOC;ITGA6;KCNJ5;SRGAP3;CES3;BSN;SESN3;ZNF318;LZTS1;IGFBP4;TCFL5;TRAK1;JARID2;NUPR1;PRR9;GPC2;NISCH;INSR;TST;IFI44;CCDC85B;HSF2BP;CELSR1;MMP28;GSN;ALDH4A1;CEP68;HEBP1;CHD3;CDK14;ST3GAL5;BAIAP2;TANC1;TTN;CBLC;SCNN1A;DDT;ZNF18;PLXNB3;CEP126;SUN1;LPAR5;AHNAK2;CNTNAP3;RNPEPL1;PLEKHH2;TRIOBP;MXD4;POLD4;RIN1;DNAJC30;CTSF;ZNF287;CD109;CYP2D7;NSUN5P2;PNMA1;PGLS;PMS2P3;ETAA1;RMI2;ZNF446;SCN4B;ARHGEF1;SEPT6;FBXL16;RAB11FIP4;VPS39;ZNF581;MGST2;DOCK8;TP53AIP1;DHX58;PILRB;ENDOG;SLC27A1;PGAP1;TM7SF3;NRSN2;RTF1;BLOC1S3;MDK;SIRPB2;CASP14;IRF9;RICTOR;TMEM9;H2AFJ;BMP6;F8A1;NLRX1;B4GALT2;TMCC3;ETNK2;PEX10;SLC2A3;TCIRG1;S100A4;MICALL2;MAP2K2;OPLAH;PDK1;VEGFB;ALDH7A1;GLI4;SQSTM1;CEP192;CABYR;PTK6;SLC12A7;TMEM8B;FZD7;ETV5;AKR7A2;LOXL1;FNBP4;FRMD8;SYNGAP1;FAM13A;FAM213A;FAT2;DLX3;TMEM117;LGALS9C;EPB41L3;SHARPIN;HEXB;KDM4C;HYAL1;METTL23;CLCA2;ARHGAP33;H1FX;SH2D2A;UBOX5;NSMCE4A;ARRDC1;KIAA0319L;B3GNT9;WHAMMP3;CENPC;PLA2G6;CST3;PDIK1L;HOMER2;CAPNS2;GDF15;PEX7;BBS2;TXNIP;TCF4;ATP6V0A2;KLHDC2;COL6A1;PEX11B;NPHP3;PSD3;LRRCC1;PLAG1;IDH2;CERCAM;MAP3K12;RCOR2;WRN;PODXL;SEPT5;IFI27;MALL;OSCP1;OXLD1;DNM1;MCM9;TNFRSF21;ZYG11B;MACROD1;IQCB1;KLHL24;PLD3;TREX1;LPIN3;ZDHHC12;ABHD14A;MCTP1;CDK5R1;ATRX;REC8;ARHGAP27;AGAP6;NET1;ANO9;PIGZ;CA2;EFNB3;OSBPL10;PI4KAP1;POLR2J3;HOOK2;SESN1;EPB41L4A;MAPK10;NKTR;SHANK3;HFE;SCART1;ADIRF;HMG20B;CYBA;TRIM38;NID1;DTX3;AGO4;ERCC6;HADH;RRM2B;SLIT3;CLIP2;KRT14;HLCS;SHC2;EDA2R;SPRY2;MRC2;FBXO2;WASH3P;MEF2D;IFT140;GABBR1;CREBRF;XRN1;AGAP7P;RAB11FIP3;TIGD5;LRP11;MLXIPL;CTSB;KLK5;NBPF15;TARBP1;FBXW7;KCNMA1;ANKRD28;GPR87;ING4;NUDT6;CDK5RAP3;ZNF862;ATXN1;LMO2;NOTCH2NL;CCDC92;NFIX;PAK6;CARF;DZIP1L;PGM1;MXI1;PFKFB2;PAQR6;RNF170;CHMP1B;THRA;TTC12;HSD11B1L;APC2;METTL21A;ACADS;ARAP1;ASTN2;GOLGA8N;ADARB1;RAI1;FMNL2;ELF1;FAM185A;MX2;IKZF4;DCAF10;RPH3AL;SLC2A1;ACACB;OGDHL;NLRP1;FRAT1;ZBTB34;ERMAP;REEP4;ZNF627;TK2;GPR155;LACTB2;BEX2;GLUL;TNS2;TBC1D17;MIF4GD;DBP;NDST2;NAB2;SLC38A4;EPM2AIP1;TP53I13;GNG2;FBXW5;PRR7;SRR;CAPG;TSPYL4;LRP1;KLHDC8B;HLA-A;PEG3;TSNARE1;NPHP4;RGS12;CCDC136;ATE1;ACP5;MPG;PLA2G7;SYNPO2;RNPEP;C12ORF66;CENPH;RFX2;KCNG1;ZNF554;BRINP1;SLC48A1;BDH1;CD99L2;MAP3K6;RIMKLB;PPCS;MYO3B;APPL2;HEXDC;SALL2;WNK1;PMEL;ZNF107;ZNF532;BBS1;ATXN10;JPH2;ARL11;ZBTB20;PDE2A;ZNF334;SDHA;MAF;STK16;LTB4R2;RET;ZMYND8;PRX;DAB2IP;CASZ1;RWDD3;ACOX3;CALCOCO1;SLC37A2;TEAD2;MYSM1;DDHD2;SHROOM2;FBXO4;RNF213;OLFM2;RAPGEFL1;TSHZ2;PIK3C3;ZNF276;IFI16;SYT7;FGFR4;ERCC5;BBS5;EXOC2;IL20RA;PIK3R2;RETSAT;SCN2A;TEF;ZNF25;SETD4;OSBPL5;AREG;ABTB1;TMEM203;DEF6;KLHL3;SNCB;ETFB;MYO9A;RPS6KA5;APBB3;ZNF630;DLG5;BTG1;BST2;ZNF687;VDR;LETMD1;RGL2;SNX21;ARHGEF17;CACNB3;MAMSTR;PHF7;TNRC18;TNRC6C;ZFP28;DPY19L2P2;VIPR1;EFS;PLXND1;NADK;BBS10;ZMYM3;SIX5;HLTF;MARCH8;EHBP1;PCSK6;ZNF789;TMEM80;MPPE1;ZNF563;TNS4;ZNF517;PCMTD2;TBC1D16;STK19;NDUFV3;TMCO6;LPAR6;EML3;PPP1R2;DMTN;TPRN;ORAI2;STAT2;SGSM2;ARFGEF2;RASL10B;LMTK3;ALMS1;PCMTD1;WWC3;PHF1;ZNF292;SLC36A4;TMEM231;TFDP2;SNX1;PMP22;UCN2;CA11;GOLGA7B;OSBPL1A;ACVR1B;TMX4;SHROOM4;ZNF737;TACC1;KREMEN1;CADM4;KDELC2;PRIMPOL;NECAB3;CCDC88B;DLG4;CCDC113;TNNI2;PPP2R3B;ESYT2;TSSK1B;IQSEC1;ZNF701;ALOXE3;NAT14;PANO1;PALB2;ENDOU;MPI;IGFBP6;TCEAL4;ZNF91;NBEAL2;CD68;DUOX1;GALE;PTMS;WEE1;DYDC1;R3HDM4;CCNG2;SLC22A15;TMEM143;GTF2IRD2;GOLGA6L4;SLC35G2;PTK7;DQX1;AMT;TCF7;SHANK2;RSAD2;TNFRSF25;NEMP2;ZFP36L1;XYLT1;LMNA;MXRA8;CLSTN3;GLMP;TOP3B;ACSL1;IL11;KAT2B;MARK4;TEP1;APOLD1;IRS2;DMXL2;IMPA2;CEP250;ANO1;CAPS;METTL7A;ERN1;HSD17B14;SAC3D1;IVNS1ABP;ALOX15B;RAD50;GPR21;ZNF439;TKFC;LAPTM4A;ANGEL2;ZMAT3;PNPO;MTR;MAN1B1;DHRS4;PEX1;ECI1;S100A6;TRERF1;UAP1L1;FAAH;SCYL3;SCG5;ZSWIM8;APBB2;CBR4;TTC19;ARHGEF9;ISYNA1;SGSH;PBLD;DCAF8;CCDC90B;RAPGEF5;MYH16;TNFSF12;TAS1R3;CERS5;STAT6;PCSK1N;SOX13;PRDX5;PHPT1;NELFCD;GPR132;PHC2;SMPDL3B;TUB;KIF7;SLC43A1;GLB1;GOLGA1;CPT1C;KLF8;GSTM3;RDH12;KLHL29;CHD6;TRAF5;NAP1L5;GOLGB1;SRPX2;ACSS2;DPP7;TRIM2;CD9;PLIN4;RANBP9;CACNB1;HDAC11;PTPN3;CTSD;GJB5;COL13A1;ERBB2;SYNGR1;MPRIP;PLCB3;GPR68;NUDT10;UVSSA;ZDHHC24;PAQR7;ARHGAP23;PPM1M;ABCA2;KMT5C;AKAP6;SLC2A11;TH;ATG14;MPP7;RORA;SSH3;PPARG;PRKACA;DOCK6;LDLRAP1;CXXC5;NPAP1;C6ORF120;POLM;FMNL3;ACOT2;GCNT4;VMAC;ZNF572;SYNE2;PARD6G;ACKR3;ZNF658B;SERPING1;SUCLG2;UCKL1;PARN;DDX12P;DOCK3;ZNF529;UFL1;LAMB2;IP6K2;RIPK3;NFASC;KLF9;PI4K2B;AIP;COG1;KCNS3;SCAND1;LONP2;PRMT3;SNX33;HARS2;CIT;ZFP90;EHHADH;MSH5;CLCN7;MAP1A;CCDC3;PER3;ZFP30;FOXP2;PTBP2;ZC3H6;HIVEP1;CALHM2;SMURF1;NPNT;TTLL1;EML2;CTNNBIP1;PEMT;ABCA11P;OCIAD2;TM4SF1;SERINC3;GCLC;ECM1
9072,GO:0035335,0.989873332643792,0.0338797343941221,3,75,peptidyl-tyrosine dephosphorylation,BP,PTPRS;PTPN3;SSH3
3335,GO:0007049,0.98988996040098,0.0129042958756235,136,1543,cell cycle,BP,TNFAIP3;GPNMB;SIK1;TP53INP1;HSPA2;EGFR;PKD2;MNT;XPC;DIXDC1;SRSF5;SFRP1;OBSL1;KCTD11;MAP3K14;BRSK1;MARVELD1;CUL9;HERC5;CUL7;OR2A4;CAMK2N1;PRKACB;CRY1;CYP26B1;CNTRL;LIG1;NDRG1;MDM2;LZTS2;MLH3;PPP2R2C;GOLGA8A;RHOBTB2;PCBP4;RGS2;PDCD4;CGREF1;NEK9;TUBGCP5;ZFP36L2;CLTCL1;TOM1L2;ANK3;GOLGA8B;PIDD1;GJC2;PER2;UNC119;MINK1;NINL;ZNF655;NAIP;MAP2K5;ZNF318;LZTS1;NUPR1;INSR;CEP68;CHD3;CDK14;TTN;CEP126;SUN1;TRIOBP;POLD4;ETAA1;RMI2;SEPT6;RAB11FIP4;MAP2K2;CEP192;PTK6;TMEM8B;HYAL1;WHAMMP3;CENPC;TXNIP;LRRCC1;SEPT5;CDK5R1;ATRX;REC8;HMG20B;AGO4;SPRY2;RAB11FIP3;MLXIPL;FBXW7;ING4;CDK5RAP3;PAK6;CHMP1B;ARAP1;GOLGA8N;ADARB1;MX2;REEP4;BEX2;TP53I13;FBXW5;KLHDC8B;CENPH;BRINP1;APPL2;DAB2IP;FBXO4;PIK3C3;BTG1;ALMS1;TFDP2;ACVR1B;TACC1;PPP2R3B;WEE1;CCNG2;ZFP36L1;LMNA;KAT2B;MARK4;CEP250;ERN1;SAC3D1;ALOX15B;RAD50;ANGEL2;APBB2;TTC19;GPR132;PTPN3;PRKACA;PARD6G;DDX12P;SNX33;CIT;MSH5
4782,GO:0010972,0.989893753815769,0.0336322371564541,3,87,negative regulation of G2/M transition of mitotic cell cycle,BP,BRSK1;CDK5RAP3;GPR132
894,GO:0002274,0.989919039445371,0.016089128784272,30,431,myeloid leukocyte activation,BP,PYGB;CXCR1;KCNAB2;NAPRT;GAA;NDRG1;HGSNAT;ACTR1B;TMC6;ADORA2B;VAMP2;GSN;SLC2A3;TCIRG1;HEXB;CST3;CYBA;CTSB;PGM1;BST2;NBEAL2;CD68;METTL7A;GLB1;DPP7;CTSD;SYNGR1;RORA;C6ORF120;NFASC
4136,GO:0009199,0.989952176199262,0.0196047413491347,13,239,ribonucleoside triphosphate metabolic process,BP,FAM20C;DHTKD1;INSR;TCIRG1;ATP6V0A2;MLXIPL;PGM1;PFKFB2;OGDHL;SDHA;NADK;NDUFV3;UCKL1
9881,GO:0042175,0.990001319568761,0.0139962347243991,64,807,nuclear outer membrane-endoplasmic reticulum membrane network,CC,SREBF1;GPSM1;LMF1;EGFR;PKD2;TMEM129;PIK3R1;UBXN4;REEP2;SRD5A3;NSG1;KDSR;NOS1;SCARA3;CYP26B1;ITPR3;HLA-B;UGT1A3;CERS4;CYP3A5;FLRT3;TMC6;G6PC3;RHBDF1;PTGS1;PSKH1;MBOAT2;ULK1;SPPL2B;MGST2;PGAP1;PLD3;TREX1;LPIN3;MCTP1;PIGZ;CYBA;RNF170;REEP4;HLA-A;PMEL;JPH2;SLC37A2;RETSAT;OSBPL5;AREG;TMEM203;NECAB3;ESYT2;RSAD2;XYLT1;CLSTN3;ACSL1;ERN1;MAN1B1;DHRS4;FAAH;CERS5;CPT1C;AKAP6;ATG14;SYNE2;UFL1;PEMT
10261,GO:0043021,0.990135404846009,0.0266480885558418,5,110,ribonucleoprotein complex binding,MF,RNF135;IMPACT;MDM2;RICTOR;LETMD1
11613,GO:0046332,0.990219312671919,0.0399366431160986,2,57,SMAD binding,MF,ACVR1B;SMURF1
10885,GO:0044444,0.990370891845866,0.0113119237259039,692,7160,cytoplasmic part,CC,TNFAIP3;TGFBI;POSTN;SERPINE2;ULK2;GPNMB;SUGCT;MUC19;TP53INP1;MAP6;IFI6;PTHLH;SREBF1;AMACR;PYGB;ACTA2;APOE;GPSM1;CES2;NT5E;ALS2CL;INPP5D;GAMT;FBXO41;OAS2;ADAM19;LMF1;DDX60;HSPA2;FBXW4;EGFR;TRIM65;HERC3;PTPRS;CIRBP;FLNC;FAM20C;PKD2;CAPRIN2;XPC;APOBEC3C;SYT8;CXCR1;CPT2;RBM3;SYN1;DIXDC1;TRIM22;ALDH1A3;SRSF5;LRIG3;PLCD3;CTSO;SFRP1;OBSL1;MTHFR;SEC14L2;EPS8L2;EPHB2;RALGDS;SYNC;MAP3K14;GLUD1;BPHL;DGKQ;TMEM129;PIK3R1;ADAMTS7;BRSK1;TXNRD3;RBCK1;CXCL14;DOCK9;COL22A1;TSC22D3;CUL9;RNF135;SULF2;WNT3;H6PD;DHTKD1;CAMKK1;HERC5;UBXN4;VAV3;ST6GALNAC2;CSPG4;ISG15;MVB12B;CYBRD1;HTRA1;SPATA18;TFCP2L1;UNC119B;RGMA;KCNAB2;MVD;ZDHHC1;CUL7;VAMP3;SNN;NAPRT;REEP2;ASAP3;SRD5A3;OR2A4;STAT1;CRY2;MYL9;GRIP2;KRT15;HS1BP3;NSG1;UROS;KDSR;ITGB5;COL10A1;RAB43;RAB40B;NOS1;PRKACB;B4GALNT4;CRY1;CRTAP;SDC3;PLEKHG5;NFATC4;PITPNM3;HMGCL;D2HGDH;BTBD2;SCARA3;FKBP5;RNF187;FERMT1;H1F0;CYP26B1;GAA;AP5Z1;CMPK2;CNTRL;MICALL1;PIK3C2G;LIG1;VPS11;NDRG1;COL7A1;ITPR3;NAGLU;CYHR1;MDM2;CRTC1;LZTS2;PLCD1;NDN;NMRK1;ST6GALNAC6;PPP2R2C;CHN2;TYSND1;OBSCN;IDUA;GOLGA8A;GPRC5C;HLA-B;PRODH;HGSNAT;MYH11;PARVB;SYTL1;FKBP9;NDUFA4L2;ACTR1B;RHOBTB2;UGT1A3;CERS4;CYP3A5;ACOT1;NEO1;RAPGEF3;SPSB3;ENDOD1;PCBP4;FAM210B;CTSV;POLH;BLVRB;OAS1;FLRT3;RASA4;GAL3ST4;CRAT;KIF26A;B4GALT6;AP1G2;RGL4;RGS2;ACAP3;F2R;MLYCD;PPL;C2CD4C;HPS4;PHYH;TMEM134;MT1X;PDCD4;BLOC1S4;SPTB;NOL4L;DNAH1;SLC27A3;ARSI;NEK9;TUBGCP5;ZFP36L2;CLTCL1;TRPV4;TMC6;FLOT1;GLI2;AGAP4;RHPN1;ANK3;DHX32;ADAMTS13;LAMP3;MAPK8IP3;GOLGA8B;PIDD1;RIMS3;AVL9;G6PC3;ATG16L2;SPG11;ZCCHC11;ARHGEF19;RHBDF1;SULT1E1;FBXO44;RASGEF1A;PER2;PITPNM2;CLCN6;PTGS1;UNC119;DIRC2;HEXA;FNDC4;ARSD;WIPF1;PSKH1;MINK1;NINL;ABHD14B;GSTM2;THBS3;WWTR1;MBOAT2;ASAP2;ARHGEF4;LHFPL2;ITGA2;FAM110C;ULK1;GLI3;SPPL2B;FHOD3;PCSK1;AKAP7;LRSAM1;VAMP2;LTBP1;MAP2K5;GAS8;SRGAP3;CES3;BSN;ZNF318;IGFBP4;TRAK1;JARID2;NUPR1;GPC2;NISCH;INSR;TST;HSF2BP;GSN;ALDH4A1;CEP68;CDK14;ST3GAL5;BAIAP2;TTN;SUN1;AHNAK2;PLEKHH2;TRIOBP;POLD4;RIN1;DNAJC30;CTSF;CD109;CYP2D7;PGLS;RMI2;ARHGEF1;SEPT6;FBXL16;RAB11FIP4;VPS39;MGST2;DOCK8;TP53AIP1;ENDOG;SLC27A1;PGAP1;NRSN2;BLOC1S3;CASP14;IRF9;RICTOR;TMEM9;NLRX1;B4GALT2;ETNK2;PEX10;SLC2A3;TCIRG1;S100A4;MICALL2;MAP2K2;OPLAH;PDK1;VEGFB;ALDH7A1;SQSTM1;CEP192;CABYR;PTK6;TMEM8B;FZD7;AKR7A2;LOXL1;SYNGAP1;FAM13A;TMEM117;LGALS9C;EPB41L3;SHARPIN;HEXB;HYAL1;CLCA2;ARHGAP33;SH2D2A;ARRDC1;KIAA0319L;B3GNT9;WHAMMP3;CENPC;PLA2G6;CST3;HOMER2;CAPNS2;GDF15;PEX7;BBS2;TXNIP;ATP6V0A2;COL6A1;PEX11B;NPHP3;LRRCC1;IDH2;CERCAM;MAP3K12;SEPT5;IFI27;MALL;OXLD1;DNM1;MACROD1;IQCB1;PLD3;TREX1;LPIN3;ZDHHC12;MCTP1;CDK5R1;ARHGAP27;AGAP6;NET1;PIGZ;CA2;OSBPL10;HOOK2;SESN1;MAPK10;NKTR;SHANK3;HFE;ADIRF;CYBA;TRIM38;AGO4;HADH;RRM2B;SLIT3;CLIP2;KRT14;HLCS;SHC2;SPRY2;FBXO2;WASH3P;IFT140;XRN1;AGAP7P;RAB11FIP3;MLXIPL;CTSB;KLK5;FBXW7;ANKRD28;ING4;NUDT6;CDK5RAP3;ATXN1;CCDC92;DZIP1L;PGM1;MXI1;PFKFB2;RNF170;CHMP1B;THRA;APC2;ACADS;ARAP1;ASTN2;GOLGA8N;ADARB1;RAI1;FMNL2;FAM185A;MX2;RPH3AL;SLC2A1;ACACB;OGDHL;NLRP1;FRAT1;REEP4;TK2;LACTB2;GLUL;TBC1D17;MIF4GD;NDST2;EPM2AIP1;FBXW5;PRR7;CAPG;LRP1;KLHDC8B;HLA-A;PEG3;TSNARE1;NPHP4;RGS12;CCDC136;ACP5;MPG;SYNPO2;RNPEP;C12ORF66;CENPH;BRINP1;SLC48A1;BDH1;RIMKLB;PPCS;APPL2;WNK1;PMEL;BBS1;ATXN10;JPH2;PDE2A;SDHA;STK16;RET;DAB2IP;CASZ1;ACOX3;CALCOCO1;SLC37A2;TEAD2;DDHD2;SHROOM2;FBXO4;RNF213;PIK3C3;IFI16;SYT7;FGFR4;BBS5;EXOC2;PIK3R2;RETSAT;OSBPL5;AREG;ABTB1;TMEM203;DEF6;KLHL3;SNCB;ETFB;MYO9A;APBB3;BST2;ZNF687;LETMD1;SNX21;ARHGEF17;CACNB3;PHF7;TNRC18;TNRC6C;NADK;MARCH8;EHBP1;PCSK6;MPPE1;TNS4;TBC1D16;NDUFV3;PPP1R2;DMTN;STAT2;SGSM2;ARFGEF2;LMTK3;ALMS1;WWC3;SLC36A4;TFDP2;SNX1;GOLGA7B;OSBPL1A;ACVR1B;TMX4;SHROOM4;KDELC2;PRIMPOL;NECAB3;CCDC88B;DLG4;CCDC113;TNNI2;ESYT2;TSSK1B;ALOXE3;MPI;IGFBP6;NBEAL2;CD68;GALE;TMEM143;GOLGA6L4;SLC35G2;AMT;SHANK2;RSAD2;TNFRSF25;ZFP36L1;XYLT1;LMNA;MXRA8;CLSTN3;GLMP;ACSL1;KAT2B;MARK4;APOLD1;IRS2;DMXL2;IMPA2;CEP250;METTL7A;ERN1;HSD17B14;IVNS1ABP;ALOX15B;TKFC;LAPTM4A;PNPO;MTR;MAN1B1;DHRS4;PEX1;ECI1;S100A6;TRERF1;UAP1L1;FAAH;SCYL3;SCG5;CBR4;TTC19;ARHGEF9;ISYNA1;SGSH;DCAF8;CCDC90B;TNFSF12;CERS5;STAT6;PCSK1N;PRDX5;PHPT1;TUB;GLB1;GOLGA1;CPT1C;KLF8;GSTM3;TRAF5;GOLGB1;ACSS2;DPP7;CD9;PLIN4;RANBP9;CTSD;COL13A1;ERBB2;SYNGR1;MPRIP;PLCB3;NUDT10;ZDHHC24;ARHGAP23;ABCA2;AKAP6;TH;ATG14;PPARG;PRKACA;DOCK6;LDLRAP1;CXXC5;C6ORF120;FMNL3;ACOT2;GCNT4;SYNE2;PARD6G;ACKR3;SERPING1;SUCLG2;UCKL1;PARN;DOCK3;UFL1;LAMB2;RIPK3;NFASC;KLF9;PI4K2B;AIP;COG1;KCNS3;LONP2;PRMT3;SNX33;HARS2;CIT;EHHADH;CLCN7;MAP1A;CCDC3;HIVEP1;SMURF1;NPNT;CTNNBIP1;PEMT;OCIAD2;SERINC3;GCLC;ECM1
14366,GO:0061630,0.990391065886014,0.0193233880404349,12,197,ubiquitin protein ligase activity,MF,HERC3;TMEM129;HERC5;MDM2;RNF165;LRSAM1;CBLC;GID4;UBOX5;FBXO4;HLTF;SMURF1
3338,GO:0007052,0.990499061807992,0.0258187865630112,5,105,mitotic spindle organization,BP,TUBGCP5;NAIP;CEP126;CEP192;CHMP1B
13536,GO:0060021,0.990510315495338,0.0389304024035898,2,57,roof of mouth development,BP,EPHB2;GLI3
9685,GO:0038093,0.990511130036381,0.0216732535585926,8,155,Fc receptor signaling pathway,BP,PIK3R1;VAV3;FCGRT;WIPF1;BAIAP2;PLA2G6;MAPK10;PIK3R2
4477,GO:0010494,0.990524574922865,0.0563865027488682,1,40,cytoplasmic stress granule,CC,CIRBP
4023,GO:0009057,0.990564740307529,0.0126028451651251,92,1128,macromolecule catabolic process,BP,TNFAIP3;SERPINE2;PYGB;APOE;OAS2;FBXW4;EGFR;CIRBP;CTSO;TMEM129;ADAMTS7;RBCK1;CUL9;UBXN4;CSPG4;ISG15;MVB12B;SPATA18;CUL7;SDC3;MAGEF1;BTBD2;RNF187;H1F0;GAA;VPS11;NAGLU;MDM2;IDUA;HGSNAT;SPSB3;PCBP4;CTSV;ZFP36L2;RNF165;LAMP3;ZCCHC11;RHBDF1;FBXO44;HEXA;WWTR1;THRAP3;LRSAM1;GPC2;CBLC;CTSF;ENDOG;GID4;TCIRG1;SQSTM1;SHARPIN;HEXB;HYAL1;ARRDC1;CST3;HFE;AGO4;FBXO2;XRN1;CTSB;FBXW7;CDK5RAP3;PGM1;APC2;C17ORF97;FBXW5;LRP1;ATE1;DAB2IP;FBXO4;RNF213;ABTB1;KLHL3;TNRC6C;SNX1;PANO1;ZFP36L1;ERN1;ANGEL2;MAN1B1;SGSH;TNFSF12;GLB1;PTPN3;CTSD;PRKACA;PARN;UFL1;LONP2;SNX33;SMURF1;GCLC
1999,GO:0004725,0.990686852798987,0.0314981486571229,3,76,protein tyrosine phosphatase activity,MF,PTPRS;PTPN3;SSH3
5849,GO:0017148,0.990714878074107,0.0186794095840399,12,215,negative regulation of translation,BP,EGFR;CIRBP;CAPRIN2;UNK;ZFP36L2;ZCCHC11;MAP2K2;AGO4;XRN1;TNRC6C;ZFP36L1;PPARG
15957,GO:0080134,0.990833930120926,0.0124616239777501,81,982,regulation of response to stress,BP,TNFAIP3;SERPINE2;MUC19;APOE;NT5E;DDX60;EGFR;PTPRS;SFRP1;PIK3R1;RNF135;HERC5;HTRA1;RGMA;STAT1;IMPACT;PRKACB;CRY1;MAGEF1;MDM2;POLH;IL20RB;F2R;PDCD4;RTN4RL1;TRPV4;FLOT1;ADORA2B;MAPK8IP3;FNDC4;C5;MINK1;ITGA2;LRSAM1;SESN3;DDT;CD109;ETAA1;MGST2;DHX58;ENDOG;RICTOR;NLRX1;MAP2K2;FZD7;SHARPIN;NSMCE4A;MCTP1;SESN1;CYBA;ERCC6;EDA2R;CTSB;KLK5;FBXW7;NLRP1;ACP5;PLA2G7;MAP3K6;PDE2A;DAB2IP;RWDD3;FBXO4;PIK3C3;IFI16;RPS6KA5;FAM3A;DMTN;STAT2;RSAD2;LMNA;ERN1;TKFC;SMPDL3B;CD9;RORA;PPARG;PRKACA;ACKR3;SERPING1;SERINC3
5048,GO:0015238,0.990954516155239,0.03727030640076,2,61,drug transmembrane transporter activity,MF,SLC13A5;SLC36A4
9005,GO:0035194,0.99115610785553,0.0224653404815368,6,140,posttranscriptional gene silencing by RNA,BP,EGFR;ZCCHC11;MAP2K2;AGO4;TNRC6C;PPARG
5394,GO:0016233,0.991157384383636,0.0527390720737151,1,51,telomere capping,BP,RAD50
4410,GO:0010171,0.991205559120208,0.0530095097754515,1,41,body morphogenesis,BP,WNT3
13728,GO:0060324,0.991256341796664,0.0527604602037828,1,41,face development,BP,ALDH1A3
17857,GO:1902117,0.991282135968387,0.036176487933388,2,59,positive regulation of organelle assembly,BP,ULK1;LRSAM1
13157,GO:0051783,0.991481008773832,0.0196704206723338,8,152,regulation of nuclear division,BP,OBSL1;CUL9;CUL7;TOM1L2;INSR;ATRX;CHMP1B;FBXW5
4478,GO:0010498,0.991603000009867,0.013639363534842,29,416,proteasomal protein catabolic process,BP,FBXW4;TMEM129;RBCK1;UBXN4;BTBD2;RNF187;MDM2;SPSB3;RNF165;LAMP3;RHBDF1;FBXO44;WWTR1;GID4;SHARPIN;HFE;FBXO2;FBXW7;FBXW5;ATE1;DAB2IP;FBXO4;ABTB1;PANO1;MAN1B1;PRKACA;UFL1;SMURF1;GCLC
11000,GO:0044843,0.99166271895956,0.0161977216608617,14,233,cell cycle G1/S phase transition,BP,GPNMB;EGFR;PKD2;MDM2;PCBP4;PIDD1;GJC2;ZNF655;HYAL1;FBXW7;TFDP2;ACVR1B;WEE1;GPR132
3321,GO:0007029,0.991857812788818,0.0496702000043176,1,43,endoplasmic reticulum organization,BP,REEP2
2835,GO:0006304,0.99188317313946,0.0279034969230198,3,80,DNA modification,BP,APOBEC3C;ATRX;MPG
5497,GO:0016441,0.991889101549457,0.020785400985401,6,141,posttranscriptional gene silencing,BP,EGFR;ZCCHC11;MAP2K2;AGO4;TNRC6C;PPARG
12880,GO:0051246,0.99197043585887,0.0100575978476143,178,2010,regulation of protein metabolic process,BP,TNFAIP3;SERPINE2;GPNMB;IFI6;SREBF1;APOE;INPP5D;HSPA2;EGFR;CIRBP;PKD2;CAPRIN2;RBM3;SFRP1;MTHFR;EPHB2;MAP3K14;DGKQ;KDM3A;CAMKK1;HERC5;UNK;CSPG4;ISG15;ELFN2;ZFPM1;KITLG;IMPACT;CAMK2N1;CRY2;NOS1;PRKACB;CRY1;CRTAP;MAGEF1;SPDYE6;BTBD2;VPS11;COL7A1;SPOCK1;MDM2;PPP2R2C;LTBP4;TNFSF10;RAPGEF3;PHACTR3;FLRT3;RGS2;F2R;PDCD4;SERPINB5;RTN4RL1;ZFP36L2;TRPV4;FLOT1;ADORA2B;LAMP3;MAPK8IP3;SPDYE5;PIDD1;GJC2;ZCCHC11;RHBDF1;PER2;UNC119;C5;SNTA1;MINK1;WWTR1;ITGA2;NAIP;MAP2K5;IGFBP4;JARID2;NUPR1;INSR;GSN;TTN;CBLC;DDT;ZNF287;CD109;ETAA1;PILRB;SLC27A1;RTF1;RICTOR;BMP6;MAP2K2;SQSTM1;PTK6;FZD7;SYNGAP1;KDM4C;PLA2G6;CST3;GDF15;CTF1;MAP3K12;IFI27;ZYG11B;CDK5R1;ATRX;MAPK10;HFE;HMG20B;AGO4;ERCC6;SHC2;EDA2R;SPRY2;FBXO2;XRN1;MLXIPL;FBXW7;CDK5RAP3;PAK6;TFPI2;APC2;ADARB1;NLRP1;MIF4GD;NAB2;LRP1;MAP3K6;WNK1;RET;DAB2IP;RWDD3;FBXO4;IFI16;FGFR4;PIK3R2;AREG;ABTB1;RPS6KA5;BST2;TNRC6C;PPP1R2;DMTN;PPP1R35;STAT2;PHF1;SNX1;ACVR1B;NECAB3;DLG4;PPP2R3B;PANO1;TNFRSF25;ZFP36L1;ACSL1;IL11;KAT2B;ERN1;RAD50;PBLD;TNFSF12;PCSK1N;PRDX5;RANBP9;PTPN3;ERBB2;AKAP6;ATG14;PPARG;PRKACA;ACKR3;SERPING1;UFL1;RIPK3;PRMT3;SNX33;SMURF1;NPNT;PEMT;GCLC;ECM1
13159,GO:0051785,0.992005853854185,0.0488787827255822,1,44,positive regulation of nuclear division,BP,INSR
7744,GO:0032268,0.992009154579062,0.0100676500362797,167,1897,regulation of cellular protein metabolic process,BP,TNFAIP3;SERPINE2;GPNMB;IFI6;SREBF1;APOE;HSPA2;EGFR;CIRBP;PKD2;CAPRIN2;RBM3;SFRP1;MTHFR;EPHB2;MAP3K14;DGKQ;KDM3A;CAMKK1;HERC5;UNK;CSPG4;ISG15;ELFN2;KITLG;IMPACT;CAMK2N1;CRY2;NOS1;PRKACB;CRY1;CRTAP;MAGEF1;SPDYE6;VPS11;COL7A1;SPOCK1;MDM2;PPP2R2C;TNFSF10;RAPGEF3;PHACTR3;FLRT3;RGS2;F2R;PDCD4;SERPINB5;RTN4RL1;ZFP36L2;TRPV4;FLOT1;ADORA2B;LAMP3;MAPK8IP3;SPDYE5;PIDD1;GJC2;ZCCHC11;RHBDF1;PER2;UNC119;C5;SNTA1;MINK1;WWTR1;ITGA2;NAIP;MAP2K5;IGFBP4;JARID2;NUPR1;INSR;GSN;TTN;CBLC;DDT;CD109;ETAA1;PILRB;SLC27A1;RTF1;RICTOR;BMP6;MAP2K2;SQSTM1;PTK6;FZD7;SYNGAP1;KDM4C;PLA2G6;CST3;GDF15;CTF1;MAP3K12;IFI27;ZYG11B;CDK5R1;ATRX;MAPK10;HFE;HMG20B;AGO4;ERCC6;SHC2;EDA2R;SPRY2;FBXO2;XRN1;MLXIPL;FBXW7;CDK5RAP3;PAK6;TFPI2;ADARB1;NLRP1;MIF4GD;NAB2;LRP1;MAP3K6;WNK1;RET;DAB2IP;RWDD3;FBXO4;IFI16;FGFR4;PIK3R2;AREG;RPS6KA5;BST2;TNRC6C;PPP1R2;DMTN;PPP1R35;STAT2;PHF1;ACVR1B;DLG4;PPP2R3B;PANO1;TNFRSF25;ZFP36L1;ACSL1;IL11;KAT2B;ERN1;RAD50;PBLD;PCSK1N;PRDX5;RANBP9;PTPN3;ERBB2;AKAP6;ATG14;PPARG;PRKACA;ACKR3;SERPING1;UFL1;RIPK3;PRMT3;SNX33;SMURF1;NPNT;GCLC;ECM1
17517,GO:1901068,0.992086751190089,0.0483760079981963,1,46,guanosine-containing compound metabolic process,BP,DLG4
40,GO:0000082,0.992102687979619,0.015735423945175,13,221,G1/S transition of mitotic cell cycle,BP,GPNMB;EGFR;PKD2;MDM2;PCBP4;PIDD1;GJC2;ZNF655;HYAL1;TFDP2;ACVR1B;WEE1;GPR132
9843,GO:0042102,0.992217645794486,0.0476751236687098,1,47,positive regulation of T cell proliferation,BP,CCDC88B
5555,GO:0016570,0.992283506405194,0.0127005687919718,28,388,histone modification,BP,DDB2;SREBF1;ASH2L;MTHFR;KDM3A;HR;NOS1;HSF4;PER2;PHF2;JARID2;CHD3;RTF1;KDM4C;MAP3K12;ATRX;HMG20B;HLCS;ING4;ZMYND8;MYSM1;RPS6KA5;PHF1;DYDC1;KAT2B;HDAC11;KMT5C;PRMT3
8666,GO:0034249,0.992351668301831,0.0152589467028824,13,231,negative regulation of cellular amide metabolic process,BP,APOE;EGFR;CIRBP;CAPRIN2;UNK;ZFP36L2;ZCCHC11;MAP2K2;AGO4;XRN1;TNRC6C;ZFP36L1;PPARG
18113,GO:1902850,0.992418320841842,0.0196584912761401,6,122,microtubule cytoskeleton organization involved in mitosis,BP,TUBGCP5;NAIP;CEP126;CEP192;SPRY2;CHMP1B
12777,GO:0051091,0.9924760701837,0.0163063389552825,10,182,positive regulation of DNA binding transcription factor activity,BP,TRIM22;RBCK1;CRTC1;PIDD1;TRIM38;EDA2R;RPS6KA5;TRAF5;PPARG;RIPK3
17564,GO:1901216,0.992543528073384,0.0315648056692479,2,64,positive regulation of neuron death,BP,CDK5R1;FBXW7
10953,GO:0044728,0.99260428670296,0.0313889658660262,2,62,DNA methylation or demethylation,BP,APOBEC3C;ATRX
285,GO:0000790,0.992664161311807,0.0134171845998337,18,303,nuclear chromatin,CC,ASH2L;STAT1;H1F0;SMARCA1;CHD3;H2AFJ;KDM4C;CENPC;TCF4;ATRX;MEF2D;APPL2;SALL2;CALCOCO1;TCF7;RAD50;STAT6;KMT5C
430,GO:0001158,0.992679293768841,0.0310956970590866,2,63,enhancer sequence-specific DNA binding,MF,ZNF704;HIVEP1
560,GO:0001701,0.992694419748414,0.0138276199256578,16,248,in utero embryonic development,BP,EGFR;PKD2;PLCD3;PLCD1;GLI2;C5;GLI3;ENDOG;RTF1;ETNK2;KDM4C;TMEM231;ACVR1B;PALB2;ZFP36L1;GJB5
13134,GO:0051726,0.992771737176989,0.00989629914252628,82,999,regulation of cell cycle,BP,TNFAIP3;GPNMB;SIK1;TP53INP1;EGFR;PKD2;MNT;XPC;SRSF5;SFRP1;OBSL1;MAP3K14;BRSK1;CUL9;HERC5;CUL7;OR2A4;CAMK2N1;PRKACB;CRY1;CNTRL;NDRG1;MDM2;PCBP4;PDCD4;CGREF1;ZFP36L2;TOM1L2;PIDD1;GJC2;PER2;MINK1;NINL;ZNF655;MAP2K5;NUPR1;INSR;CDK14;ETAA1;RMI2;RAB11FIP4;MAP2K2;CEP192;PTK6;TMEM8B;HYAL1;WHAMMP3;CDK5R1;ATRX;RAB11FIP3;MLXIPL;FBXW7;ING4;CDK5RAP3;PAK6;CHMP1B;ADARB1;MX2;BEX2;TP53I13;FBXW5;BRINP1;DAB2IP;FBXO4;PIK3C3;BTG1;ALMS1;TFDP2;PPP2R3B;WEE1;CCNG2;ZFP36L1;KAT2B;CEP250;ERN1;ALOX15B;ANGEL2;APBB2;GPR132;PTPN3;PRKACA;CIT
7872,GO:0032446,0.992809866646835,0.0102502191626741,62,789,protein modification by small protein conjugation,BP,TNFAIP3;DDB2;FBXO41;FBXW4;HERC3;TRIM22;KCTD11;DCAF16;TMEM129;RBCK1;CUL9;RNF135;HERC5;ISG15;CUL7;RAB40B;CRY1;MAGEF1;RNF187;MDM2;SPSB3;RNF165;FBXO44;PER2;WWTR1;LRSAM1;NAIP;CBLC;FBXL16;GID4;RTF1;PEX10;SHARPIN;UBOX5;ARRDC1;ZYG11B;KLHL24;HMG20B;TRIM38;DTX3;FBXO2;FBXW7;CDK5RAP3;RNF170;DCAF10;FBXW5;KLHDC8B;RWDD3;FBXO4;RNF213;KLHL3;HLTF;MARCH8;RNF141;DCAF8;KLHL29;TRIM2;UVSSA;UFL1;PRMT3;SMURF1;GCLC
14379,GO:0061659,0.992824614247058,0.0147633908281818,12,202,ubiquitin-like protein ligase activity,MF,HERC3;TMEM129;HERC5;MDM2;RNF165;LRSAM1;CBLC;GID4;UBOX5;FBXO4;HLTF;SMURF1
5612,GO:0016667,0.992880840830083,0.0442000125679754,1,50,oxidoreductase activity, acting on a sulfur group of donors,MF,TXNRD3
36,GO:0000075,0.99302346215926,0.0143739188297447,12,208,cell cycle checkpoint,BP,XPC;MAP3K14;BRSK1;CRY1;NDRG1;MDM2;PCBP4;PIDD1;ETAA1;CDK5RAP3;FBXO4;TFDP2
17808,GO:1901989,0.993192328577773,0.0291686970207273,2,66,positive regulation of cell cycle phase transition,BP,MDM2;HYAL1
3304,GO:0007005,0.993219589276464,0.0109009224995407,32,484,mitochondrion organization,BP,IFI6;SREBF1;GLUD1;SPATA18;HMGCL;VPS11;TNFSF10;HPS4;TRAK1;MICALL2;SQSTM1;SHARPIN;PLA2G6;IDH2;OSCP1;DNM1;RRM2B;FBXW7;MX2;DDHD2;NDUFV3;STAT2;TFDP2;PRIMPOL;LMNA;TTC19;ACSS2;ATG14;AIP;SMURF1;PEMT;GCLC
4142,GO:0009205,0.993223738503281,0.0139501912560999,12,233,purine ribonucleoside triphosphate metabolic process,BP,FAM20C;DHTKD1;INSR;TCIRG1;ATP6V0A2;MLXIPL;PGM1;PFKFB2;OGDHL;SDHA;NADK;NDUFV3
173,GO:0000380,0.993424818170663,0.0416002804324522,1,45,alternative mRNA splicing, via spliceosome,BP,THRAP3
2936,GO:0006458,0.993487509394849,0.0411897865369555,1,47,'de novo' protein folding,BP,HSPA2
4312,GO:0009792,0.993537625523919,0.0105103551679174,31,421,embryo development ending in birth or egg hatching,BP,EGFR;PKD2;PLCD3;SFRP1;SULF2;PRKACB;HOXA3;PLCD1;GLI2;C5;GLI3;CELSR1;ENDOG;RTF1;RICTOR;ETNK2;KDM4C;HYAL1;NPHP3;CDK5R1;IFT140;SALL2;TEAD2;TMEM231;NRARP;ACVR1B;PALB2;PTK7;TCF7;ZFP36L1;GJB5
16542,GO:0097345,0.99370608639417,0.0399722682261968,1,49,mitochondrial outer membrane permeabilization,BP,TFDP2
7475,GO:0031647,0.993759125938869,0.0129638575853876,12,212,regulation of protein stability,BP,SREBF1;PIK3R1;CRTAP;VPS11;MDM2;HPS4;FLOT1;GSN;FBXW7;FBXO4;PANO1;PER3
2836,GO:0006305,0.993808849508821,0.0396327202082377,1,44,DNA alkylation,BP,ATRX
2837,GO:0006306,0.993808849508821,0.0396327202082377,1,44,DNA methylation,BP,ATRX
20155,GO:2001022,0.993836014971829,0.0267766075033543,2,67,positive regulation of response to DNA damage stimulus,BP,EGFR;NSMCE4A
8252,GO:0033044,0.99386902125644,0.0113733491196091,18,278,regulation of chromosome organization,BP,SREBF1;MTHFR;KDM3A;NOS1;SLX1A;SLX1B;PHF2;JARID2;RMI2;RTF1;KDM4C;ATRX;XRN1;FBXO4;RPS6KA5;PHF1;RAD50;PARN
2817,GO:0006282,0.993973149490918,0.0215001108511501,3,83,regulation of DNA repair,BP,EGFR;MAGEF1;POLH
2928,GO:0006446,0.994288185540171,0.0250530277841337,2,69,regulation of translational initiation,BP,IMPACT;MIF4GD
6920,GO:0030520,0.99430303730519,0.0369623040169793,1,45,intracellular estrogen receptor signaling pathway,BP,UFL1
11420,GO:0045862,0.994359241524284,0.0106692453138312,17,281,positive regulation of proteolysis,BP,APOE;MAGEF1;MDM2;TNFSF10;F2R;PIDD1;GSN;IFI27;FBXW7;NLRP1;DAB2IP;IFI16;FGFR4;PPARG;SNX33;SMURF1;GCLC
13188,GO:0051851,0.994397346614862,0.036343163987902,1,48,modification by host of symbiont morphology or physiology,BP,APOE
10513,GO:0043462,0.994407817185573,0.03618814797588,1,51,regulation of ATPase activity,BP,HSPA2
2367,GO:0005488,0.994410603566349,0.00700147130470568,1011,10132,binding,MF,TNFAIP3;TGFBI;POSTN;TAGLN;ITGB6;HES2;SERPINE2;ZSCAN18;ULK2;GPNMB;TSC22D1;SIK1;SLFN5;EPM2A;NPEPL1;DDB2;TP53INP1;MAP6;IFI6;PTHLH;SREBF1;AMACR;PYGB;NYNRIN;ACTA2;APOE;GPSM1;NT5E;ALS2CL;INPP5D;APCDD1;OAS2;ADAM19;PSD4;DDX60;HSPA2;FBXW4;EGFR;ESPN;TRIM65;GIGYF1;PTPRS;CIRBP;FLNC;FAM20C;PKD2;CAPRIN2;MNT;XPC;APOBEC3C;SYT8;CXCR1;RBM3;SYN1;ASH2L;DIXDC1;TRIM22;ALDH1A3;SRSF5;PLCD3;SFRP1;OBSL1;MTHFR;SEC14L2;KCTD11;IFI44L;KIF26B;PCDH1;EPS8L2;EPHB2;RALGDS;TNS1;GPX3;MAP3K14;GLUD1;DCAF16;DGKQ;TMEM129;PIK3R1;ADAMTS7;EVI5L;BRSK1;TXNRD3;RBCK1;KDM3A;ORAI3;CXCL14;DOCK9;TSC22D3;CUL9;NSUN7;EYS;RNF135;POU3F1;SULF2;WNT3;H6PD;DHTKD1;CAMKK1;HERC5;UBXN4;VAV3;UNK;HR;SMOC2;VWCE;CSPG4;ISG15;MVB12B;CYBRD1;HTRA1;SPATA18;TFCP2L1;TENM4;UNC119B;RGMA;ZFPM1;KITLG;HOXC5;MVD;ZDHHC1;ZNF362;CUL7;VAMP3;SNN;IRF2BPL;NAPRT;REEP2;PRICKLE2;KCNJ15;MC1R;ASAP3;ZNF266;C1QTNF6;STAT1;IMPACT;CAMK2N1;CRY2;MYL9;GRIP2;KRT15;HS1BP3;LGALS7B;WDR63;MARCKSL1;NSG1;UNC5B;UROS;ITGB5;COL10A1;GJD3;RAB43;RAB40B;THAP8;NOS1;PRKACB;ZNF704;HOXA3;CRY1;ZNF699;ZFP41;SCMH1;KLF13;CRTAP;SDC3;BCAM;MAGEF1;PLEKHG5;NFATC4;PITPNM3;ZNF783;IQSEC2;HMGCL;SPDYE6;D2HGDH;BTBD2;SCARA3;FKBP5;RNF187;H1F0;CYP26B1;GAA;AP5Z1;CMPK2;THNSL2;HSF4;CNTRL;ZNF251;MICALL1;PIK3C2G;LIG1;CDK18;TBC1D8;PLXNB1;PLEKHG3;VPS11;SPEG;NDRG1;COL7A1;SPOCK1;ITPR3;CYHR1;MDM2;CRTC1;LZTS2;PLCD1;NDN;IFITM1;MLH3;NMRK1;DDX59;PPP2R2C;FCGRT;CHN2;ZNF662;TYSND1;LTBP4;PIK3IP1;OBSCN;IDUA;TYMSOS;HLA-B;TNFSF10;PRODH;LENG9;MYH11;PARVB;SYTL1;FKBP9;CALML3;ACTR1B;TNXB;RHOBTB2;UGT1A3;CERS4;CYP3A5;NEO1;RAPGEF3;PHACTR3;ZNF414;SPSB3;TCF25;ENDOD1;PCBP4;HAGHL;NINJ1;CTSV;NLGN4Y;POLH;POLR2J2;OAS1;FLRT3;NUDCD3;RASA4;TRIM66;GAL3ST4;KCTD15;CRAT;KIF26A;B4GALT6;MLLT6;AP1G2;RGL4;RGS2;ARPIN;ACAP3;IL20RB;ADGRB2;F2R;MLYCD;PPL;C2CD4C;HPS4;PHYH;TMEM134;MT1X;PDCD4;BLOC1S4;CGREF1;SPTB;SERPINB5;NOL4L;SLC24A1;ALPK1;ZNF160;CAPN7;DNAH1;SLC27A3;ARSI;NEK9;TUBGCP5;RTN4RL1;ZFP36L2;CLTCL1;TRPV4;TMC6;TMEM128;FLOT1;GLI2;AGAP4;TOM1L2;RHPN1;NLGN2;CORO6;ANK3;KLF7;RNF165;NAT6;DHX32;ADAMTS13;TCEA2;PLCH2;RALGAPA1;MAPK8IP3;SPDYE5;ZNF76;SOX12;CLMN;PIDD1;RIMS3;SLX1A;SLX1B;ZNF747;SPG11;ZCCHC11;ARHGEF19;RHBDF1;SULT1E1;FBXO44;RASGEF1A;ANKS6;PER2;PITPNM2;CLCN6;MICALCL;PTGS1;UNC119;HEXA;FRS3;DTNB;C5;ZNF658;ARSD;WIPF1;SNTA1;PSKH1;ADGRL1;MINK1;PHF2;TBC1D19;NINL;ABHD14B;GSTM2;TCEAL1;AMIGO2;THBS3;TNFRSF14;WWTR1;ASAP2;ARHGEF4;ITGA2;SEMA4G;RSPH3;FAM110C;SYT15;ULK1;GLI3;SPPL2B;FHOD3;PCSK1;TPGS1;WDR90;THRAP3;ZNF558;IRX4;SMARCA1;AKAP7;BHLHE40;DGCR6L;LRSAM1;VAMP2;ZNF655;NAIP;LTBP1;KHNYN;NMU;ZNF333;NEK8;MAP2K5;GAS8;BOC;ITGA6;LTBP3;KCNJ5;SRGAP3;BSN;SESN3;ZNF318;LZTS1;IGFBP4;MMP1;TCFL5;C14ORF93;TRAK1;JARID2;NUPR1;GPC2;NISCH;INSR;TST;CCDC85B;HSF2BP;CELSR1;MMP28;GSN;ALDH4A1;CEP68;HEBP1;LRRC20;CHD3;CDK14;BAIAP2;TTN;CBLC;FAM167A;SCNN1A;DDT;ZNF18;PLXNB3;CEP126;SUN1;AHNAK2;RNPEPL1;PLEKHH2;TRIOBP;MXD4;POLD4;RIN1;ATXN7L1;ZNF287;CD109;CYP2D7;NSUN5P2;PNMA1;PGLS;SLFNL1;PMS2P3;ETAA1;RMI2;ZNF446;SCN4B;ARHGEF1;SEPT6;RAB11FIP4;ZNF581;MGST2;DOCK8;DHX58;PILRB;ENDOG;SLC27A1;RTF1;BLOC1S3;MDK;CASP14;IRF9;RICTOR;H2AFJ;BMP6;NLRX1;B4GALT2;TMCC3;ETNK2;PEX10;SLC2A3;TCIRG1;S100A4;MICALL2;MAP2K2;OPLAH;PDK1;VEGFB;ALDH7A1;GLI4;SQSTM1;CEP192;CABYR;PTK6;SLC12A7;TMEM8B;FZD7;ETV5;AKR7A2;LOXL1;FNBP4;FRMD8;SYNGAP1;NXPH4;FAT2;DLX3;LGALS9C;EPB41L3;SHARPIN;HEXB;KDM4C;HYAL1;METTL23;CLCA2;ARHGAP33;H1FX;SH2D2A;UBOX5;NSMCE4A;ARRDC1;KIAA0319L;ZNF608;WHAMMP3;CENPC;PLA2G6;ZCCHC24;CST3;PDIK1L;HOMER2;MMRN2;CAPNS2;GDF15;PEX7;BBS2;TXNIP;CTF1;TCF4;ATP6V0A2;COL6A1;PEX11B;NPHP3;PSD3;FAM83C;PLAG1;IDH2;MAP3K12;RCOR2;WRN;PODXL;SEPT5;IFI27;MALL;DNM1;MCM9;MACROD1;IQCB1;KLHL24;PLD3;TREX1;OARD1;MCTP1;CDK5R1;ATRX;REC8;ARHGAP27;AGAP6;NET1;ANO9;CA2;EFNB3;OSBPL10;POLR2J3;HOOK2;SESN1;EPB41L4A;MAPK10;NKTR;SHANK3;HFE;HMG20B;CYBA;TRIM38;NID1;DTX3;AGO4;ERCC6;HADH;RRM2B;SLIT3;CLIP2;KRT14;HLCS;SHC2;EDA2R;SPRY2;MRC2;FBXO2;WASH3P;MEF2D;IFT140;GABBR1;CREBRF;XRN1;AGAP7P;RAB11FIP3;TIGD5;LRP11;MLXIPL;CTSB;KLK5;TARBP1;FBXW7;KCNMA1;ANKRD28;ING4;NUDT6;CDK5RAP3;ZNF862;ATXN1;LMO2;NOTCH2NL;CCDC92;NFIX;PAK6;CARF;DZIP1L;PGM1;MXI1;PFKFB2;PAQR6;RNF170;CHMP1B;THRA;APC2;METTL21A;ACADS;ARAP1;ASTN2;ADARB1;RAI1;FMNL2;ELF1;MX2;IKZF4;RPH3AL;SLC2A1;ACACB;ACCS;OGDHL;NLRP1;FRAT1;ZBTB34;ERMAP;REEP4;ZNF627;TK2;LACTB2;BEX2;GLUL;TNS2;TBC1D17;MIF4GD;DBP;NAB2;EPM2AIP1;GNG2;FBXW5;SRR;CAPG;TSPYL4;LRP1;HLA-A;PEG3;TSNARE1;NPHP4;ATE1;ACP5;MPG;PLA2G7;SYNPO2;RNPEP;CENPH;RFX2;DLK2;ZNF554;BRINP1;SLC48A1;CD99L2;DGCR2;MAP3K6;RIMKLB;MYO3B;APPL2;SALL2;WNK1;PMEL;ZNF107;ZNF532;BBS1;ATXN10;GUCD1;JPH2;ARL11;ZBTB20;PDE2A;ZNF334;SDHA;MAF;STK16;RET;ZMYND8;PRX;DAB2IP;CASZ1;RWDD3;ACOX3;CALCOCO1;TEAD2;MYSM1;DDHD2;PCED1A;SHROOM2;FBXO4;RNF213;OLFM2;RAPGEFL1;TSHZ2;PIK3C3;ZNF276;IFI16;SYT7;DALRD3;FGFR4;ERCC5;BBS5;EXOC2;IL20RA;PIK3R2;TEF;ZNF25;OSBPL5;AREG;ABTB1;TMEM203;DEF6;KLHL3;SNCB;ETFB;MYO9A;RPS6KA5;APBB3;ZNF630;DLG5;BTG1;BST2;ZNF687;VDR;LETMD1;RGL2;PABPC4L;SNX21;ARHGEF17;CACNB3;PHF7;TNRC18;TNRC6C;ZFP28;VIPR1;EFS;PLXND1;NADK;BBS10;ZMYM3;SIX5;NUDT8;HLTF;MARCH8;C20ORF194;PCED1B;PCSK6;ZNF789;MPPE1;ZNF563;TNS4;ZNF517;TBC1D16;STK19;NDUFV3;TMCO6;C22ORF23;EML3;PPP1R2;DMTN;TPRN;ORAI2;FAHD2B;PPP1R35;STAT2;SGSM2;ARFGEF2;RASL10B;LMTK3;ALMS1;WWC3;PHF1;ZNF292;TMEM231;TFDP2;SNX1;PMP22;UCN2;OSBPL1A;ACVR1B;SHROOM4;ZNF737;TACC1;KREMEN1;CADM4;PRIMPOL;NECAB3;CCDC88B;DLG4;IGFL2;CCDC113;TNNI2;PPP2R3B;ESYT2;TSSK1B;ADCK5;IQSEC1;ZNF701;ALOXE3;NAT14;PALB2;ENDOU;MPI;SNX29;IGFBP6;MATN2;TCEAL4;ZNF91;DUOX1;GALE;WEE1;DYDC1;R3HDM4;GTF2IRD2;PTK7;DQX1;TCF7;SHANK2;RSAD2;TNFRSF25;ZFP36L1;LMNA;CLSTN3;GLMP;TOP3B;ACSL1;IL11;KAT2B;MARK4;TEP1;APOLD1;IRS2;DMXL2;IMPA2;CEP250;ANO1;CAPS;MBLAC2;ERN1;HSD17B14;SAC3D1;RNF141;IVNS1ABP;ALOX15B;RAD50;ZNF439;TKFC;LAPTM4A;ANGEL2;ZMAT3;PNPO;MTR;MAN1B1;DHRS4;PEX1;S100A6;TRERF1;FSD2;FAAH;SCYL3;EFEMP2;SCG5;ZSWIM8;APBB2;CBR4;TTC19;ARHGEF9;ISYNA1;SGSH;PBLD;DCAF8;CCDC90B;RAPGEF5;TNFSF12;TAS1R3;CERS5;STAT6;PCSK1N;SOX13;PRDX5;PHPT1;NELFCD;PHC2;ANKMY1;SMPDL3B;TUB;KIF7;GLB1;GOLGA1;CPT1C;KLF8;DNAJC4;GSTM3;RDH12;CHD6;TRAF5;GOLGB1;SRPX2;ACSS2;TRIM2;CD9;RANBP9;HDAC11;PTPN3;CTSD;COL13A1;ERBB2;SYNGR1;MPRIP;PLCB3;NUDT10;UVSSA;ZDHHC24;PAQR7;PPM1M;ABCA2;KMT5C;AKAP6;TH;ATG14;MPP7;RORA;SSH3;PPARG;PRKACA;DOCK6;LDLRAP1;CXXC5;NPAP1;POLM;FMNL3;ACOT2;ZNF572;SYNE2;PARD6G;ACKR3;PLTP;ZNF658B;SERPING1;SUCLG2;UCKL1;PARN;DDX12P;UHRF1BP1;DOCK3;ZNF529;UFL1;LAMB2;IP6K2;RIPK3;NFASC;KLF9;PI4K2B;AIP;COG1;SCAND1;LONP2;PRMT3;SNX33;HARS2;CIT;ZFP90;EHHADH;MSH5;CLCN7;MAP1A;PER3;ZFP30;FOXP2;PTBP2;ZC3H6;HIVEP1;ECM2;SMURF1;NPNT;HERPUD2;TTLL1;EML2;CTNNBIP1;PEMT;ABCA11P;TM4SF1;GCLC;ECM1
3048,GO:0006606,0.99444546796736,0.0159664972981724,5,113,protein import into nucleus,BP,GLI3;TXNIP;PDE2A;TMCO6;NPAP1
8687,GO:0034332,0.994472609025177,0.0175277374797376,4,92,adherens junction organization,BP,SFRP1;ITGA2;DLG5;DMTN
5559,GO:0016574,0.994537896478612,0.0356976331570768,1,45,histone ubiquitination,BP,DDB2
762,GO:0002011,0.994549039175111,0.0356777720957381,1,44,morphogenesis of an epithelial sheet,BP,FLRT3
9672,GO:0038061,0.994650884646528,0.0169092284185915,4,110,NIK/NF-kappaB signaling,BP,EGFR;MAP3K14;PDCD4;RIPK3
5554,GO:0016569,0.994666753149381,0.00895686873038939,28,396,covalent chromatin modification,BP,DDB2;SREBF1;ASH2L;MTHFR;KDM3A;HR;NOS1;HSF4;PER2;PHF2;JARID2;CHD3;RTF1;KDM4C;MAP3K12;ATRX;HMG20B;HLCS;ING4;ZMYND8;MYSM1;RPS6KA5;PHF1;DYDC1;KAT2B;HDAC11;KMT5C;PRMT3
2862,GO:0006354,0.994730085112674,0.0151946436808993,5,121,DNA-templated transcription, elongation,BP,EAPP;TCEA2;RTF1;ERCC6;NELFCD
5223,GO:0015833,0.994805869369502,0.00680883599854906,127,1520,peptide transport,BP,POSTN;ITGB6;SREBF1;APOE;LMF1;EGFR;SRSF5;SFRP1;GLUD1;TMEM129;EVI5L;MVB12B;UNC119B;ZDHHC1;VAMP3;REEP2;NSG1;RAB43;RAB40B;FERMT1;AP5Z1;MICALL1;TBC1D8;VPS11;ITPR3;MDM2;LTBP4;SYTL1;RAPGEF3;AP1G2;F2R;HPS4;CLTCL1;TRPV4;TOM1L2;NLGN2;ANK3;ATG16L2;RHBDF1;PER2;UNC119;C5;GLI3;LRSAM1;VAMP2;NMU;TRAK1;TTN;VPS39;PGAP1;TM7SF3;BMP6;PEX10;TCIRG1;MICALL2;ARHGAP33;ARRDC1;PLA2G6;PEX7;BBS2;TXNIP;ATP6V0A2;IDH2;IFI27;OSCP1;TNFRSF21;ZDHHC12;CDK5R1;CA2;HOOK2;HFE;HADH;WASH3P;RAB11FIP3;FBXW7;PFKFB2;CHMP1B;ASTN2;MX2;RPH3AL;SLC2A1;NLRP1;GLUL;TBC1D17;LRP1;TSNARE1;BBS1;PDE2A;OLFM2;PIK3C3;SYT7;BBS5;EXOC2;PIK3R2;SNX21;EHBP1;TBC1D16;TMCO6;DMTN;SGSM2;ARFGEF2;RASL10B;SNX1;GOLGA7B;NECAB3;RSAD2;IRS2;ANO1;ALOX15B;ZMAT3;PEX1;SCG5;PHPT1;ERBB2;SYNGR1;GPR68;ZDHHC24;AKAP6;PPARG;NPAP1;AIP;COG1;KCNS3;LONP2;SNX33;SMURF1;PEMT
6145,GO:0019438,0.994817869428664,0.00628730311760656,316,3429,aromatic compound biosynthetic process,BP,TNFAIP3;HES2;ZSCAN18;TSC22D1;SIK1;TP53INP1;PTHLH;SREBF1;APOE;NT5E;MN1;EGFR;PKD2;CAPRIN2;MNT;ASH2L;TRIM22;SRSF5;SFRP1;PERM1;SEC14L2;DGKQ;PIK3R1;RBCK1;KDM3A;TSC22D3;POU3F1;DHTKD1;HR;ISG15;HTRA1;TFCP2L1;RGMA;ZFPM1;HOXC5;ZNF362;CITED4;IRF2BPL;NAPRT;MC1R;ZNF266;STAT1;IMPACT;CRY2;UROS;THAP8;NOS1;ZNF704;HOXA3;CRY1;ZNF699;MAML3;ZFP41;SCMH1;KLF13;NFATC4;ZNF783;RNF187;CMPK2;HSF4;ZNF251;LIG1;EAPP;MDM2;CRTC1;NDN;NMRK1;ZNF662;NEO1;RAPGEF3;ZNF414;TCF25;POLH;POLR2J2;MLLT6;F2R;PDCD4;ZNF160;SWT1;ZFP36L2;TRPV4;GLI2;ADORA2B;KLF7;RNF165;TCEA2;ZNF76;SOX12;PIDD1;ZNF747;PER2;ZNF658;PHF2;ABHD14B;TCEAL1;WWTR1;GLI3;THRAP3;ZNF558;IRX4;SMARCA1;BHLHE40;ZNF655;ZNF333;MAP2K5;ITGA6;ZNF318;LZTS1;TCFL5;TRAK1;JARID2;NUPR1;INSR;CCDC85B;HSF2BP;CHD3;DDT;ZNF18;MXD4;POLD4;ZNF287;PMS2P3;RMI2;ZNF446;ZNF581;RTF1;MDK;IRF9;H2AFJ;BMP6;NLRX1;TCIRG1;MAP2K2;GLI4;SQSTM1;FZD7;ETV5;DLX3;HEXB;KDM4C;METTL23;ZNF608;GDF15;TXNIP;TCF4;ATP6V0A2;PLAG1;IDH2;RCOR2;WRN;IFI27;LPIN3;CDK5R1;ATRX;POLR2J3;MAPK10;HFE;ADIRF;HMG20B;TRIM38;ERCC6;RRM2B;EDA2R;MEF2D;GABBR1;CREBRF;XRN1;MLXIPL;TARBP1;FBXW7;GPR87;ING4;CDK5RAP3;ZNF862;ATXN1;LMO2;NFIX;PAK6;CARF;PGM1;MXI1;PFKFB2;THRA;RAI1;ELF1;IKZF4;OGDHL;ZBTB34;ZNF627;TK2;DBP;NAB2;EPM2AIP1;PEG3;RGS12;RFX2;ZNF554;PPCS;SALL2;PMEL;ZNF107;ZNF532;ZBTB20;PDE2A;ZNF334;MAF;STK16;LTB4R2;RET;ZMYND8;DAB2IP;CASZ1;RWDD3;CALCOCO1;TEAD2;MYSM1;FBXO4;TSHZ2;ZNF276;IFI16;FGFR4;PIK3R2;TEF;ZNF25;RPS6KA5;APBB3;ZNF630;BTG1;ZNF687;VDR;MAMSTR;TNRC18;ZFP28;PLXND1;NADK;ZMYM3;SIX5;HLTF;PCSK6;ZNF789;ZNF563;ZNF517;STAT2;WWC3;PHF1;ZNF292;TFDP2;NRARP;ACVR1B;ZNF737;PRIMPOL;TNNI2;ZNF701;NAT14;PALB2;MPI;TCEAL4;ZNF91;DYDC1;GTF2IRD2;TCF7;ZFP36L1;GLMP;IL11;KAT2B;TEP1;ERN1;RNF141;IVNS1ABP;RAD50;ZNF439;PNPO;TRERF1;UAP1L1;APBB2;STAT6;SOX13;PRDX5;NELFCD;KLF8;CHD6;TRAF5;GOLGB1;HDAC11;ERBB2;SPOCD1;NUDT10;ABCA2;KMT5C;TH;RORA;PPARG;CXXC5;POLM;ZNF572;ZNF658B;UCKL1;PARN;ZNF529;UFL1;RIPK3;KLF9;AIP;SCAND1;PRMT3;ZFP90;PER3;ZFP30;FOXP2;ZC3H6;HIVEP1;SMURF1;NPNT;CTNNBIP1;GCLC;ECM1
12614,GO:0050821,0.994843594065628,0.0138570031797554,6,133,protein stabilization,BP,PIK3R1;CRTAP;HPS4;FLOT1;FBXW7;PER3
4449,GO:0010389,0.994846888684628,0.0119205817257118,9,180,regulation of G2/M transition of mitotic cell cycle,BP,BRSK1;CNTRL;NINL;CEP192;CDK5RAP3;ALMS1;CEP250;GPR132;PRKACA
8278,GO:0033108,0.99485834362478,0.0226718460642581,2,89,mitochondrial respiratory chain complex assembly,BP,NDUFV3;TTC19
17854,GO:1902110,0.994903559426127,0.0335065074336442,1,51,positive regulation of mitochondrial membrane permeability involved in apoptotic process,BP,TFDP2
68,GO:0000139,0.994904419180478,0.00781596569826115,44,582,Golgi membrane,CC,SREBF1;GPSM1;EGFR;ST6GALNAC2;VAMP3;NSG1;RAB43;B4GALNT4;SCARA3;COL7A1;ST6GALNAC6;GOLGA8A;HLA-B;GAL3ST4;B4GALT6;AP1G2;MAPK8IP3;GOLGA8B;RHBDF1;ASAP2;SPPL2B;ST3GAL5;B4GALT2;KIAA0319L;B3GNT9;MALL;ANKRD28;ARAP1;GOLGA8N;SLC2A1;NDST2;HLA-A;AREG;ARFGEF2;LMTK3;GOLGA7B;XYLT1;CLSTN3;MAN1B1;GOLGA1;GOLGB1;GCNT4;COG1;SERINC3
8817,GO:0034605,0.994915055222271,0.0147481054706758,5,114,cellular response to heat,BP,HSPA2;HSF4;TRPV4;ANO1;PRKACA
14087,GO:0060964,0.994943806266532,0.0182894952479508,3,103,regulation of gene silencing by miRNA,BP,EGFR;MAP2K2;PPARG
8253,GO:0033045,0.994973454985758,0.0224476914552661,2,69,regulation of sister chromatid segregation,BP,RMI2;ATRX
133,GO:0000280,0.995078773247709,0.00889365201622531,21,316,nuclear division,BP,HSPA2;OBSL1;CUL9;CUL7;CYP26B1;MLH3;TUBGCP5;TOM1L2;NAIP;INSR;TTN;SUN1;CEP192;CENPC;ATRX;REC8;AGO4;CHMP1B;FBXW5;RAD50;MSH5
16296,GO:0090501,0.99508347899228,0.0142703075726579,5,123,RNA phosphodiester bond hydrolysis,BP,XRN1;LACTB2;ENDOU;ERN1;PARN
1448,GO:0003682,0.995122359114728,0.00804495483772048,31,437,chromatin binding,MF,SREBF1;EGFR;MNT;ASH2L;KDM3A;HR;STAT1;NFATC4;H1F0;MLH3;GLI2;GLI3;SMARCA1;JARID2;NUPR1;DLX3;KDM4C;WRN;ATRX;REC8;HMG20B;ERCC6;THRA;ZMYND8;CALCOCO1;TSHZ2;TNRC18;PHF1;PRIMPOL;KAT2B;PPARG
2833,GO:0006302,0.995157920875031,0.0108642502571864,10,194,double-strand break repair,BP,MAGEF1;AP5Z1;SLX1A;SLX1B;WRN;MCM9;REC8;PALB2;RAD50;POLM
688,GO:0001909,0.995205633465435,0.0318193785746277,1,52,leukocyte mediated cytotoxicity,BP,RIPK3
10207,GO:0042886,0.99526530774087,0.00621771473953615,128,1534,amide transport,BP,POSTN;ITGB6;SREBF1;APOE;LMF1;EGFR;SRSF5;SFRP1;GLUD1;TMEM129;EVI5L;MVB12B;UNC119B;ZDHHC1;VAMP3;REEP2;NSG1;RAB43;RAB40B;FERMT1;AP5Z1;MICALL1;TBC1D8;VPS11;ITPR3;MDM2;LTBP4;SYTL1;RAPGEF3;AP1G2;F2R;HPS4;CLTCL1;TRPV4;TOM1L2;NLGN2;ANK3;ATG16L2;RHBDF1;PER2;UNC119;C5;GLI3;LRSAM1;VAMP2;NMU;TRAK1;TTN;VPS39;PGAP1;TM7SF3;BMP6;PEX10;TCIRG1;MICALL2;ARHGAP33;ARRDC1;PLA2G6;PEX7;BBS2;TXNIP;ATP6V0A2;IDH2;IFI27;OSCP1;TNFRSF21;ZDHHC12;CDK5R1;CA2;HOOK2;HFE;HADH;WASH3P;RAB11FIP3;FBXW7;PFKFB2;CHMP1B;ASTN2;MX2;RPH3AL;SLC2A1;NLRP1;GLUL;TBC1D17;LRP1;TSNARE1;BBS1;PDE2A;OLFM2;PIK3C3;SYT7;BBS5;EXOC2;PIK3R2;SNX21;EHBP1;TBC1D16;TMCO6;DMTN;SGSM2;ARFGEF2;RASL10B;SNX1;GOLGA7B;NECAB3;RSAD2;IRS2;ANO1;ALOX15B;ZMAT3;PEX1;SCG5;PHPT1;ERBB2;SYNGR1;GPR68;ZDHHC24;AKAP6;PPARG;NPAP1;PLTP;AIP;COG1;KCNS3;LONP2;SNX33;SMURF1;PEMT
9826,GO:0042073,0.995305355364882,0.0313526155960965,1,49,intraciliary transport,BP,IFT140
4088,GO:0009144,0.995307336279508,0.00992820006450688,12,240,purine nucleoside triphosphate metabolic process,BP,FAM20C;DHTKD1;INSR;TCIRG1;ATP6V0A2;MLXIPL;PGM1;PFKFB2;OGDHL;SDHA;NADK;NDUFV3
14489,GO:0065003,0.995312788986233,0.00623246840793243,115,1418,protein-containing complex assembly,BP,TNFAIP3;DDB2;APOE;CIRBP;PKD2;XPC;ASH2L;TRIM22;ALDH1A3;SRSF5;OBSL1;KCTD11;EPS8L2;GPX3;DGKQ;VAMP3;C1QTNF6;IMPACT;NSG1;PRKACB;HMGCL;PSMG4;H1F0;HSF4;VPS11;COL7A1;KCNC4;ITPR3;MDM2;CRTC1;KCTD18;TYSND1;HGSNAT;MYH11;KCTD15;RGS2;ARPIN;SPTB;DNAH1;TUBGCP5;CLTCL1;TRPV4;FLOT1;SOX12;WIPF1;ULK1;FHOD3;VAMP2;MMP1;INSR;GSN;BAIAP2;TTN;TRIOBP;SEPT6;PILRB;RICTOR;TCIRG1;MICALL2;SQSTM1;CEP192;SHARPIN;H1FX;WHAMMP3;CENPC;TCF4;ATP6V0A2;COL6A1;PEX11B;SEPT5;DNM1;CDK5R1;ATRX;HFE;CYBA;AGO4;WASH3P;ANKRD28;THRA;MX2;IKZF4;SLC2A1;ACACB;NLRP1;GLUL;SRR;CAPG;TSPYL4;CENPH;KCNG1;ATXN10;DAB2IP;TEAD2;RNF213;ERCC5;EXOC2;AREG;BBS10;NDUFV3;DMTN;DLG4;TCF7;DMXL2;DHRS4;CBR4;TTC19;NAP1L5;RANBP9;MPP7;PRKACA;RIPK3;KCNS3;PTBP2;EML2;CTNNBIP1
8847,GO:0034654,0.995395441885761,0.00560580305200458,311,3383,nucleobase-containing compound biosynthetic process,BP,TNFAIP3;HES2;ZSCAN18;TSC22D1;SIK1;TP53INP1;PTHLH;SREBF1;APOE;NT5E;MN1;EGFR;PKD2;CAPRIN2;MNT;ASH2L;TRIM22;SRSF5;SFRP1;PERM1;SEC14L2;DGKQ;PIK3R1;RBCK1;KDM3A;TSC22D3;POU3F1;DHTKD1;HR;ISG15;HTRA1;TFCP2L1;RGMA;ZFPM1;HOXC5;ZNF362;CITED4;IRF2BPL;NAPRT;MC1R;ZNF266;STAT1;IMPACT;CRY2;THAP8;NOS1;ZNF704;HOXA3;CRY1;ZNF699;MAML3;ZFP41;SCMH1;KLF13;NFATC4;ZNF783;RNF187;CMPK2;HSF4;ZNF251;LIG1;EAPP;MDM2;CRTC1;NDN;NMRK1;ZNF662;NEO1;RAPGEF3;ZNF414;TCF25;POLH;POLR2J2;MLLT6;F2R;PDCD4;ZNF160;SWT1;ZFP36L2;TRPV4;GLI2;ADORA2B;KLF7;RNF165;TCEA2;ZNF76;SOX12;PIDD1;ZNF747;PER2;ZNF658;PHF2;ABHD14B;TCEAL1;WWTR1;GLI3;THRAP3;ZNF558;IRX4;SMARCA1;BHLHE40;ZNF655;ZNF333;MAP2K5;ITGA6;ZNF318;LZTS1;TCFL5;TRAK1;JARID2;NUPR1;INSR;CCDC85B;HSF2BP;CHD3;ZNF18;MXD4;POLD4;ZNF287;PMS2P3;RMI2;ZNF446;ZNF581;RTF1;MDK;IRF9;H2AFJ;BMP6;NLRX1;TCIRG1;MAP2K2;GLI4;SQSTM1;FZD7;ETV5;DLX3;HEXB;KDM4C;METTL23;ZNF608;GDF15;TXNIP;TCF4;ATP6V0A2;PLAG1;IDH2;RCOR2;WRN;IFI27;LPIN3;CDK5R1;ATRX;POLR2J3;MAPK10;HFE;ADIRF;HMG20B;TRIM38;ERCC6;RRM2B;EDA2R;MEF2D;GABBR1;CREBRF;XRN1;MLXIPL;TARBP1;FBXW7;GPR87;ING4;CDK5RAP3;ZNF862;ATXN1;LMO2;NFIX;PAK6;CARF;PGM1;MXI1;PFKFB2;THRA;RAI1;ELF1;IKZF4;OGDHL;ZBTB34;ZNF627;TK2;DBP;NAB2;EPM2AIP1;PEG3;RGS12;RFX2;ZNF554;PPCS;SALL2;ZNF107;ZNF532;ZBTB20;PDE2A;ZNF334;MAF;STK16;LTB4R2;RET;ZMYND8;DAB2IP;CASZ1;RWDD3;CALCOCO1;TEAD2;MYSM1;FBXO4;TSHZ2;ZNF276;IFI16;FGFR4;PIK3R2;TEF;ZNF25;RPS6KA5;APBB3;ZNF630;BTG1;ZNF687;VDR;MAMSTR;TNRC18;ZFP28;PLXND1;NADK;ZMYM3;SIX5;HLTF;PCSK6;ZNF789;ZNF563;ZNF517;STAT2;WWC3;PHF1;ZNF292;TFDP2;NRARP;ACVR1B;ZNF737;PRIMPOL;TNNI2;ZNF701;NAT14;PALB2;MPI;TCEAL4;ZNF91;DYDC1;GTF2IRD2;TCF7;ZFP36L1;GLMP;IL11;KAT2B;TEP1;ERN1;RNF141;IVNS1ABP;RAD50;ZNF439;TRERF1;UAP1L1;APBB2;STAT6;SOX13;PRDX5;NELFCD;KLF8;CHD6;TRAF5;GOLGB1;HDAC11;ERBB2;SPOCD1;NUDT10;ABCA2;KMT5C;RORA;PPARG;CXXC5;POLM;ZNF572;ZNF658B;UCKL1;PARN;ZNF529;UFL1;RIPK3;KLF9;AIP;SCAND1;PRMT3;ZFP90;PER3;ZFP30;FOXP2;ZC3H6;HIVEP1;SMURF1;NPNT;CTNNBIP1;GCLC;ECM1
890,GO:0002263,0.995431403625088,0.00750093360680261,32,471,cell activation involved in immune response,BP,PYGB;CXCR1;KCNAB2;ZFPM1;NAPRT;GAA;HGSNAT;ACTR1B;TMC6;ADORA2B;VAMP2;GSN;SLC2A3;TCIRG1;HEXB;CST3;CYBA;CTSB;PGM1;LRP1;BST2;NBEAL2;CD68;METTL7A;STAT6;GLB1;DPP7;CTSD;SYNGR1;RORA;C6ORF120;NFASC
2944,GO:0006473,0.99544931602092,0.011099304855411,8,162,protein acetylation,BP,NOS1;RAPGEF3;NAT6;NUPR1;ING4;RPS6KA5;KAT2B;EHHADH
5758,GO:0016925,0.995531893416549,0.0165258616232656,3,85,protein sumoylation,BP,MDM2;HMG20B;RWDD3
3343,GO:0007062,0.995769727354832,0.0124805564065654,5,120,sister chromatid cohesion,BP,CENPC;ATRX;REC8;FBXW7;CENPH
20085,GO:2000779,0.99579297616882,0.0286136128836389,1,49,regulation of double-strand break repair,BP,MAGEF1
5994,GO:0019003,0.995796713778139,0.0285127790922913,1,52,GDP binding,MF,SUCLG2
18088,GO:1902750,0.995830068995829,0.0154715726211593,3,97,negative regulation of cell cycle G2/M phase transition,BP,BRSK1;CDK5RAP3;GPR132
18062,GO:1902686,0.995870723708613,0.028068407170672,1,53,mitochondrial outer membrane permeabilization involved in programmed cell death,BP,TFDP2
9687,GO:0038095,0.99587147947682,0.01343103555877,4,110,Fc-epsilon receptor signaling pathway,BP,PIK3R1;VAV3;MAPK10;PIK3R2
4550,GO:0010634,0.995982569111553,0.0131516195446142,4,101,positive regulation of epithelial cell migration,BP,CAPN7;ITGA2;HYAL1;SRPX2
13620,GO:0060147,0.995988965509165,0.0149042662357294,3,106,regulation of posttranscriptional gene silencing,BP,EGFR;MAP2K2;PPARG
14089,GO:0060966,0.995988965509165,0.0149042662357294,3,106,regulation of gene silencing by RNA,BP,EGFR;MAP2K2;PPARG
1470,GO:0003729,0.995994225971859,0.00946297380114154,9,180,mRNA binding,MF,CIRBP;UNK;PCBP4;ZFP36L2;ADARB1;ZFP36L1;ANGEL2;PARN;PTBP2
361,GO:0000980,0.996205808868962,0.0262204066839223,1,50,RNA polymerase II distal enhancer sequence-specific DNA binding,MF,HIVEP1
917,GO:0002312,0.99622384891443,0.0261159476458433,1,50,B cell activation involved in immune response,BP,STAT6
17852,GO:1902108,0.99624554511531,0.02589704432223,1,54,regulation of mitochondrial membrane permeability involved in apoptotic process,BP,TFDP2
7867,GO:0032436,0.996251346973994,0.017393779102164,2,72,positive regulation of proteasomal ubiquitin-dependent protein catabolic process,BP,MDM2;GCLC
18330,GO:1903322,0.99626726443433,0.0122896969914055,4,107,positive regulation of protein modification by small protein conjugation or removal,BP,FBXW7;CDK5RAP3;RWDD3;FBXO4
10255,GO:0043009,0.996293476834458,0.00629508784212842,29,411,chordate embryonic development,BP,EGFR;PKD2;PLCD3;SFRP1;SULF2;PRKACB;HOXA3;PLCD1;GLI2;C5;GLI3;CELSR1;ENDOG;RTF1;ETNK2;KDM4C;HYAL1;NPHP3;IFT140;SALL2;TEAD2;TMEM231;NRARP;ACVR1B;PALB2;PTK7;TCF7;ZFP36L1;GJB5
5584,GO:0016605,0.996360244712226,0.0137903660900284,3,86,PML body,CC,TP53INP1;SQSTM1;ATRX
13116,GO:0051702,0.996372712328497,0.0252029174149302,1,52,interaction with symbiont,BP,APOE
3285,GO:0006974,0.996396291795916,0.00538315553279727,55,740,cellular response to DNA damage stimulus,BP,DDB2;EGFR;XPC;ASH2L;MAP3K14;PIK3R1;BRSK1;VAV3;ISG15;SPATA18;MC1R;CRY1;MAGEF1;NFATC4;AP5Z1;LIG1;NDRG1;MDM2;MLH3;PCBP4;POLH;PIDD1;SLX1A;SLX1B;NUPR1;POLD4;PMS2P3;ETAA1;RMI2;CASP14;NSMCE4A;WRN;MCM9;MACROD1;TREX1;ATRX;REC8;ERCC6;RRM2B;ING4;CDK5RAP3;MPG;FBXO4;IFI16;ERCC5;PHF1;TFDP2;PRIMPOL;PALB2;RAD50;ZMAT3;UVSSA;POLM;ACKR3;MSH5
42,GO:0000086,0.996397567929507,0.00778561775420939,12,225,G2/M transition of mitotic cell cycle,BP,BRSK1;CNTRL;NINL;CDK14;CEP192;CDK5RAP3;ALMS1;WEE1;CEP250;GPR132;PRKACA;CIT
4957,GO:0015031,0.996406246629148,0.00477383919288918,124,1502,protein transport,BP,POSTN;ITGB6;SREBF1;APOE;LMF1;EGFR;SRSF5;SFRP1;GLUD1;TMEM129;EVI5L;MVB12B;UNC119B;ZDHHC1;VAMP3;REEP2;NSG1;RAB43;RAB40B;FERMT1;AP5Z1;MICALL1;TBC1D8;VPS11;ITPR3;MDM2;SYTL1;RAPGEF3;AP1G2;F2R;HPS4;CLTCL1;TRPV4;TOM1L2;NLGN2;ANK3;ATG16L2;RHBDF1;PER2;UNC119;C5;GLI3;LRSAM1;VAMP2;NMU;TRAK1;TTN;VPS39;PGAP1;TM7SF3;BMP6;PEX10;TCIRG1;MICALL2;ARHGAP33;ARRDC1;PLA2G6;PEX7;BBS2;TXNIP;ATP6V0A2;IDH2;IFI27;OSCP1;TNFRSF21;ZDHHC12;CDK5R1;HOOK2;HFE;HADH;WASH3P;RAB11FIP3;FBXW7;PFKFB2;CHMP1B;ASTN2;MX2;RPH3AL;SLC2A1;NLRP1;GLUL;TBC1D17;LRP1;TSNARE1;BBS1;PDE2A;OLFM2;PIK3C3;SYT7;BBS5;EXOC2;PIK3R2;SNX21;EHBP1;TBC1D16;TMCO6;DMTN;SGSM2;ARFGEF2;SNX1;GOLGA7B;NECAB3;RSAD2;IRS2;ANO1;ALOX15B;ZMAT3;PEX1;SCG5;PHPT1;ERBB2;SYNGR1;GPR68;ZDHHC24;AKAP6;PPARG;NPAP1;AIP;COG1;KCNS3;LONP2;SNX33;SMURF1;PEMT
3356,GO:0007093,0.996423951351527,0.00935356523148401,7,153,mitotic cell cycle checkpoint,BP,XPC;BRSK1;MDM2;PCBP4;PIDD1;CDK5RAP3;TFDP2
7348,GO:0031398,0.996441369913353,0.0134871601805621,3,91,positive regulation of protein ubiquitination,BP,FBXW7;CDK5RAP3;FBXO4
278,GO:0000781,0.996494433956806,0.00974346223836904,6,146,chromosome, telomeric region,CC,NSMCE4A;WRN;ATRX;DYDC1;TEP1;RAD50
3483,GO:0007346,0.996497456130648,0.00553370883170503,41,573,regulation of mitotic cell cycle,BP,GPNMB;SIK1;EGFR;PKD2;XPC;OBSL1;MAP3K14;BRSK1;CUL9;CUL7;CNTRL;MDM2;PCBP4;ZFP36L2;TOM1L2;PIDD1;GJC2;MINK1;NINL;ZNF655;MAP2K5;INSR;MAP2K2;CEP192;TMEM8B;HYAL1;ATRX;CDK5RAP3;PAK6;CHMP1B;FBXW5;BRINP1;BTG1;ALMS1;TFDP2;ZFP36L1;CEP250;ANGEL2;GPR132;PTPN3;PRKACA
17617,GO:1901362,0.996568820023731,0.00419304577983319,323,3524,organic cyclic compound biosynthetic process,BP,TNFAIP3;HES2;ZSCAN18;TSC22D1;SIK1;TP53INP1;PTHLH;SREBF1;AMACR;APOE;NT5E;MN1;EGFR;PKD2;CAPRIN2;MNT;ASH2L;TRIM22;SRSF5;SFRP1;PERM1;SEC14L2;DGKQ;PIK3R1;RBCK1;KDM3A;TSC22D3;POU3F1;DHTKD1;HR;ISG15;HTRA1;TFCP2L1;RGMA;ZFPM1;HOXC5;MVD;ZNF362;CITED4;IRF2BPL;NAPRT;MC1R;ZNF266;SRD5A3;STAT1;IMPACT;CRY2;UROS;THAP8;NOS1;ZNF704;HOXA3;CRY1;ZNF699;MAML3;ZFP41;SCMH1;KLF13;NFATC4;ZNF783;RNF187;CMPK2;HSF4;ZNF251;LIG1;EAPP;MDM2;CRTC1;NDN;NMRK1;ZNF662;NEO1;RAPGEF3;ZNF414;TCF25;POLH;POLR2J2;MLLT6;F2R;PDCD4;ZNF160;SWT1;ZFP36L2;TRPV4;GLI2;ADORA2B;KLF7;RNF165;TCEA2;ZNF76;SOX12;PIDD1;ZNF747;PER2;ZNF658;PHF2;ABHD14B;TCEAL1;WWTR1;GLI3;THRAP3;ZNF558;IRX4;SMARCA1;BHLHE40;ZNF655;ZNF333;MAP2K5;ITGA6;ZNF318;LZTS1;TCFL5;TRAK1;JARID2;NUPR1;INSR;CCDC85B;HSF2BP;CHD3;DDT;ZNF18;MXD4;POLD4;ZNF287;PMS2P3;RMI2;ZNF446;ZNF581;RTF1;MDK;IRF9;H2AFJ;BMP6;NLRX1;TCIRG1;MAP2K2;GLI4;SQSTM1;FZD7;ETV5;DLX3;HEXB;KDM4C;METTL23;ZNF608;GDF15;TXNIP;TCF4;ATP6V0A2;PLAG1;IDH2;RCOR2;WRN;IFI27;LPIN3;CDK5R1;ATRX;POLR2J3;MAPK10;HFE;ADIRF;HMG20B;TRIM38;ERCC6;RRM2B;EDA2R;MEF2D;GABBR1;CREBRF;XRN1;MLXIPL;TARBP1;FBXW7;GPR87;ING4;CDK5RAP3;ZNF862;ATXN1;LMO2;NFIX;PAK6;CARF;PGM1;MXI1;PFKFB2;THRA;RAI1;ELF1;IKZF4;ACACB;OGDHL;ZBTB34;ZNF627;TK2;DBP;NAB2;EPM2AIP1;PEG3;RGS12;RFX2;ZNF554;PPCS;SALL2;PMEL;ZNF107;ZNF532;ZBTB20;PDE2A;ZNF334;MAF;STK16;LTB4R2;RET;ZMYND8;DAB2IP;CASZ1;RWDD3;CALCOCO1;TEAD2;MYSM1;FBXO4;TSHZ2;ZNF276;IFI16;FGFR4;PIK3R2;TEF;ZNF25;RPS6KA5;APBB3;ZNF630;BTG1;ZNF687;VDR;MAMSTR;TNRC18;ZFP28;PLXND1;NADK;ZMYM3;SIX5;HLTF;PCSK6;ZNF789;ZNF563;ZNF517;STAT2;WWC3;PHF1;ZNF292;TFDP2;OSBPL1A;NRARP;ACVR1B;ZNF737;PRIMPOL;TNNI2;ZNF701;NAT14;PALB2;MPI;TCEAL4;ZNF91;DYDC1;GTF2IRD2;TCF7;ZFP36L1;GLMP;IL11;KAT2B;TEP1;ERN1;HSD17B14;RNF141;IVNS1ABP;RAD50;ZNF439;PNPO;TRERF1;UAP1L1;APBB2;STAT6;SOX13;PRDX5;NELFCD;KLF8;CHD6;TRAF5;GOLGB1;HDAC11;ERBB2;SPOCD1;NUDT10;ABCA2;KMT5C;TH;RORA;PPARG;CXXC5;POLM;ZNF572;PLTP;ZNF658B;UCKL1;PARN;ZNF529;UFL1;RIPK3;KLF9;AIP;SCAND1;PRMT3;ZFP90;PER3;ZFP30;FOXP2;ZC3H6;HIVEP1;SMURF1;NPNT;CTNNBIP1;GCLC;ECM1
12886,GO:0051252,0.996630215498409,0.0041619702042119,276,3024,regulation of RNA metabolic process,BP,TNFAIP3;HES2;ZSCAN18;TSC22D1;SIK1;TP53INP1;SREBF1;APOE;OAS2;MN1;EGFR;CIRBP;PKD2;CAPRIN2;MNT;ASH2L;TRIM22;SRSF5;SFRP1;PERM1;SEC14L2;DGKQ;PIK3R1;RBCK1;KDM3A;TSC22D3;POU3F1;HR;HTRA1;TFCP2L1;RGMA;ZFPM1;HOXC5;ZNF362;CITED4;IRF2BPL;MC1R;ZNF266;STAT1;IMPACT;CRY2;THAP8;NOS1;ZNF704;HOXA3;CRY1;ZNF699;MAML3;ZFP41;SCMH1;KLF13;NFATC4;ZNF783;RNF187;HSF4;ZNF251;EAPP;MDM2;CRTC1;NDN;ZNF662;NEO1;ZNF414;TCF25;PCBP4;OAS1;MLLT6;F2R;PDCD4;ZNF160;ZFP36L2;TRPV4;GLI2;KLF7;RNF165;TCEA2;ZNF76;SOX12;PIDD1;ZNF747;PER2;ZNF658;PHF2;ABHD14B;TCEAL1;WWTR1;GLI3;THRAP3;ZNF558;IRX4;SMARCA1;BHLHE40;ZNF655;ZNF333;MAP2K5;ITGA6;ZNF318;LZTS1;TCFL5;TRAK1;JARID2;NUPR1;INSR;CCDC85B;CHD3;ZNF18;AHNAK2;MXD4;ZNF287;PMS2P3;ZNF446;ZNF581;RTF1;MDK;IRF9;H2AFJ;BMP6;NLRX1;MAP2K2;GLI4;SQSTM1;FZD7;ETV5;DLX3;HEXB;KDM4C;METTL23;ZNF608;GDF15;TXNIP;TCF4;PLAG1;RCOR2;IFI27;LPIN3;CDK5R1;ATRX;MAPK10;HFE;ADIRF;HMG20B;TRIM38;ERCC6;EDA2R;MEF2D;CREBRF;XRN1;MLXIPL;TARBP1;FBXW7;ING4;CDK5RAP3;ZNF862;ATXN1;LMO2;NFIX;PAK6;CARF;MXI1;THRA;RAI1;ELF1;IKZF4;ZBTB34;ZNF627;DBP;NAB2;EPM2AIP1;PEG3;RFX2;ZNF554;SALL2;ZNF107;ZNF532;ZBTB20;PDE2A;ZNF334;MAF;STK16;RET;ZMYND8;PRX;DAB2IP;CASZ1;RWDD3;CALCOCO1;TEAD2;MYSM1;TSHZ2;ZNF276;IFI16;PIK3R2;TEF;ZNF25;RPS6KA5;APBB3;ZNF630;BTG1;ZNF687;VDR;MAMSTR;TNRC18;TNRC6C;ZFP28;PLXND1;ZMYM3;SIX5;HLTF;PCSK6;ZNF789;ZNF563;ZNF517;STAT2;WWC3;PHF1;ZNF292;TFDP2;NRARP;ACVR1B;ZNF737;TNNI2;ZNF701;NAT14;TCEAL4;ZNF91;DYDC1;GTF2IRD2;TCF7;ZFP36L1;GLMP;IL11;KAT2B;ERN1;RNF141;IVNS1ABP;ZNF439;ANGEL2;TRERF1;APBB2;STAT6;SOX13;PRDX5;NELFCD;KLF8;CHD6;TRAF5;GOLGB1;HDAC11;ERBB2;ABCA2;KMT5C;RORA;PPARG;CXXC5;ZNF572;ZNF658B;PARN;ZNF529;UFL1;RIPK3;KLF9;AIP;SCAND1;PRMT3;ZFP90;PER3;ZFP30;FOXP2;PTBP2;ZC3H6;HIVEP1;SMURF1;NPNT;CTNNBIP1;GCLC;ECM1
9311,GO:0035794,0.996654547596372,0.0234865701272921,1,55,positive regulation of mitochondrial membrane permeability,BP,TFDP2
19325,GO:1905710,0.996654547596372,0.0234865701272921,1,55,positive regulation of membrane permeability,BP,TFDP2
1782,GO:0004402,0.996686813924945,0.0233785529572835,1,51,histone acetyltransferase activity,MF,KAT2B
5905,GO:0018130,0.99669180306975,0.00405271120205021,314,3432,heterocycle biosynthetic process,BP,TNFAIP3;HES2;ZSCAN18;TSC22D1;SIK1;TP53INP1;PTHLH;SREBF1;APOE;NT5E;MN1;EGFR;PKD2;CAPRIN2;MNT;ASH2L;TRIM22;SRSF5;SFRP1;PERM1;SEC14L2;DGKQ;PIK3R1;RBCK1;KDM3A;TSC22D3;POU3F1;DHTKD1;HR;ISG15;HTRA1;TFCP2L1;RGMA;ZFPM1;HOXC5;ZNF362;CITED4;IRF2BPL;NAPRT;MC1R;ZNF266;STAT1;IMPACT;CRY2;UROS;THAP8;NOS1;ZNF704;HOXA3;CRY1;ZNF699;MAML3;ZFP41;SCMH1;KLF13;NFATC4;ZNF783;RNF187;CMPK2;HSF4;ZNF251;LIG1;EAPP;MDM2;CRTC1;NDN;NMRK1;ZNF662;NEO1;RAPGEF3;ZNF414;TCF25;POLH;POLR2J2;MLLT6;F2R;PDCD4;ZNF160;SWT1;ZFP36L2;TRPV4;GLI2;ADORA2B;KLF7;RNF165;TCEA2;ZNF76;SOX12;PIDD1;ZNF747;PER2;ZNF658;PHF2;ABHD14B;TCEAL1;WWTR1;GLI3;THRAP3;ZNF558;IRX4;SMARCA1;BHLHE40;ZNF655;ZNF333;MAP2K5;ITGA6;ZNF318;LZTS1;TCFL5;TRAK1;JARID2;NUPR1;INSR;CCDC85B;HSF2BP;CHD3;ZNF18;MXD4;POLD4;ZNF287;PMS2P3;RMI2;ZNF446;ZNF581;RTF1;MDK;IRF9;H2AFJ;BMP6;NLRX1;TCIRG1;MAP2K2;GLI4;SQSTM1;FZD7;ETV5;DLX3;HEXB;KDM4C;METTL23;ZNF608;GDF15;TXNIP;TCF4;ATP6V0A2;PLAG1;IDH2;RCOR2;WRN;IFI27;LPIN3;CDK5R1;ATRX;POLR2J3;MAPK10;HFE;ADIRF;HMG20B;TRIM38;ERCC6;RRM2B;EDA2R;MEF2D;GABBR1;CREBRF;XRN1;MLXIPL;TARBP1;FBXW7;GPR87;ING4;CDK5RAP3;ZNF862;ATXN1;LMO2;NFIX;PAK6;CARF;PGM1;MXI1;PFKFB2;THRA;RAI1;ELF1;IKZF4;OGDHL;ZBTB34;ZNF627;TK2;DBP;NAB2;EPM2AIP1;PEG3;RGS12;RFX2;ZNF554;PPCS;SALL2;ZNF107;ZNF532;ZBTB20;PDE2A;ZNF334;MAF;STK16;LTB4R2;RET;ZMYND8;DAB2IP;CASZ1;RWDD3;CALCOCO1;TEAD2;MYSM1;FBXO4;TSHZ2;ZNF276;IFI16;FGFR4;PIK3R2;TEF;ZNF25;RPS6KA5;APBB3;ZNF630;BTG1;ZNF687;VDR;MAMSTR;TNRC18;ZFP28;PLXND1;NADK;ZMYM3;SIX5;HLTF;PCSK6;ZNF789;ZNF563;ZNF517;STAT2;WWC3;PHF1;ZNF292;TFDP2;NRARP;ACVR1B;ZNF737;PRIMPOL;TNNI2;ZNF701;NAT14;PALB2;MPI;TCEAL4;ZNF91;DYDC1;GTF2IRD2;TCF7;ZFP36L1;GLMP;IL11;KAT2B;TEP1;ERN1;RNF141;IVNS1ABP;RAD50;ZNF439;PNPO;TRERF1;UAP1L1;APBB2;STAT6;SOX13;PRDX5;NELFCD;KLF8;CHD6;TRAF5;GOLGB1;HDAC11;ERBB2;SPOCD1;NUDT10;ABCA2;KMT5C;RORA;PPARG;CXXC5;POLM;ZNF572;PLTP;ZNF658B;UCKL1;PARN;ZNF529;UFL1;RIPK3;KLF9;AIP;SCAND1;PRMT3;ZFP90;PER3;ZFP30;FOXP2;ZC3H6;HIVEP1;SMURF1;NPNT;CTNNBIP1;GCLC;ECM1
2379,GO:0005515,0.996695369973061,0.0040009307904259,810,8304,protein binding,MF,TNFAIP3;TGFBI;POSTN;TAGLN;ITGB6;HES2;SERPINE2;ULK2;GPNMB;TSC22D1;SIK1;EPM2A;DDB2;TP53INP1;MAP6;IFI6;PTHLH;SREBF1;AMACR;PYGB;ACTA2;APOE;GPSM1;ALS2CL;INPP5D;APCDD1;OAS2;ADAM19;PSD4;DDX60;HSPA2;FBXW4;EGFR;ESPN;GIGYF1;PTPRS;CIRBP;FLNC;FAM20C;PKD2;CAPRIN2;MNT;XPC;APOBEC3C;SYT8;CXCR1;RBM3;SYN1;ASH2L;DIXDC1;TRIM22;ALDH1A3;SRSF5;SFRP1;OBSL1;KCTD11;KIF26B;EPS8L2;EPHB2;RALGDS;TNS1;GPX3;MAP3K14;GLUD1;DCAF16;DGKQ;PIK3R1;ADAMTS7;EVI5L;BRSK1;RBCK1;KDM3A;ORAI3;CXCL14;DOCK9;TSC22D3;CUL9;RNF135;WNT3;CAMKK1;HERC5;UBXN4;VAV3;CSPG4;ISG15;MVB12B;CYBRD1;HTRA1;SPATA18;TENM4;UNC119B;RGMA;ZFPM1;KITLG;MVD;CUL7;VAMP3;NAPRT;REEP2;KCNJ15;MC1R;ASAP3;ZNF266;C1QTNF6;STAT1;IMPACT;CAMK2N1;CRY2;GRIP2;KRT15;WDR63;MARCKSL1;NSG1;UNC5B;ITGB5;COL10A1;GJD3;RAB43;THAP8;NOS1;PRKACB;HOXA3;CRY1;ZNF699;SCMH1;KLF13;SDC3;BCAM;MAGEF1;PLEKHG5;NFATC4;PITPNM3;ZNF783;IQSEC2;HMGCL;SPDYE6;BTBD2;SCARA3;FKBP5;RNF187;H1F0;AP5Z1;THNSL2;CNTRL;MICALL1;CDK18;TBC1D8;PLXNB1;PLEKHG3;VPS11;SPEG;NDRG1;COL7A1;ITPR3;CYHR1;MDM2;CRTC1;LZTS2;PLCD1;NDN;IFITM1;MLH3;NMRK1;PPP2R2C;FCGRT;CHN2;TYSND1;LTBP4;PIK3IP1;OBSCN;IDUA;TYMSOS;HLA-B;TNFSF10;MYH11;PARVB;SYTL1;CALML3;ACTR1B;TNXB;RHOBTB2;UGT1A3;NEO1;RAPGEF3;PHACTR3;ZNF414;SPSB3;TCF25;NINJ1;CTSV;NLGN4Y;POLH;POLR2J2;OAS1;FLRT3;NUDCD3;KCTD15;CRAT;KIF26A;MLLT6;AP1G2;RGL4;RGS2;ARPIN;ACAP3;IL20RB;ADGRB2;F2R;MLYCD;PPL;C2CD4C;HPS4;PHYH;TMEM134;MT1X;PDCD4;BLOC1S4;SPTB;SERPINB5;NOL4L;SLC24A1;CAPN7;DNAH1;ARSI;NEK9;TUBGCP5;RTN4RL1;ZFP36L2;CLTCL1;TRPV4;TMC6;TMEM128;FLOT1;GLI2;AGAP4;TOM1L2;RHPN1;NLGN2;CORO6;ANK3;RNF165;DHX32;ADAMTS13;TCEA2;RALGAPA1;MAPK8IP3;SPDYE5;CLMN;PIDD1;RIMS3;SLX1A;SLX1B;ZNF747;SPG11;ZCCHC11;ARHGEF19;RHBDF1;SULT1E1;FBXO44;RASGEF1A;ANKS6;PER2;PITPNM2;MICALCL;UNC119;HEXA;FRS3;DTNB;C5;WIPF1;SNTA1;PSKH1;ADGRL1;MINK1;PHF2;TBC1D19;NINL;ABHD14B;GSTM2;TCEAL1;AMIGO2;TNFRSF14;WWTR1;ASAP2;ARHGEF4;ITGA2;SEMA4G;RSPH3;FAM110C;SYT15;ULK1;GLI3;SPPL2B;FHOD3;PCSK1;TPGS1;WDR90;THRAP3;SMARCA1;AKAP7;BHLHE40;DGCR6L;LRSAM1;VAMP2;ZNF655;NAIP;LTBP1;NMU;NEK8;MAP2K5;GAS8;BOC;ITGA6;LTBP3;KCNJ5;SRGAP3;SESN3;ZNF318;LZTS1;IGFBP4;TCFL5;C14ORF93;TRAK1;JARID2;NUPR1;GPC2;NISCH;INSR;CCDC85B;HSF2BP;CELSR1;GSN;ALDH4A1;CEP68;LRRC20;CHD3;CDK14;BAIAP2;TTN;CBLC;FAM167A;SCNN1A;DDT;ZNF18;PLXNB3;CEP126;SUN1;AHNAK2;PLEKHH2;TRIOBP;MXD4;POLD4;RIN1;ATXN7L1;CD109;PNMA1;PGLS;ETAA1;SCN4B;ARHGEF1;SEPT6;RAB11FIP4;ZNF581;MGST2;DOCK8;DHX58;PILRB;ENDOG;SLC27A1;RTF1;BLOC1S3;MDK;CASP14;IRF9;RICTOR;H2AFJ;BMP6;NLRX1;TMCC3;PEX10;TCIRG1;S100A4;MICALL2;MAP2K2;PDK1;VEGFB;ALDH7A1;SQSTM1;CEP192;CABYR;PTK6;SLC12A7;TMEM8B;FZD7;ETV5;AKR7A2;FNBP4;FRMD8;SYNGAP1;NXPH4;DLX3;LGALS9C;EPB41L3;SHARPIN;HEXB;KDM4C;HYAL1;METTL23;ARHGAP33;H1FX;SH2D2A;UBOX5;NSMCE4A;ARRDC1;KIAA0319L;WHAMMP3;PLA2G6;CST3;PDIK1L;HOMER2;MMRN2;GDF15;PEX7;BBS2;TXNIP;CTF1;TCF4;ATP6V0A2;COL6A1;PEX11B;NPHP3;PSD3;FAM83C;MAP3K12;RCOR2;WRN;PODXL;SEPT5;IFI27;MALL;DNM1;MACROD1;IQCB1;KLHL24;PLD3;TREX1;OARD1;CDK5R1;ATRX;ARHGAP27;AGAP6;NET1;ANO9;CA2;EFNB3;POLR2J3;HOOK2;SESN1;EPB41L4A;MAPK10;SHANK3;HFE;HMG20B;CYBA;TRIM38;NID1;DTX3;AGO4;ERCC6;RRM2B;SLIT3;CLIP2;KRT14;HLCS;SHC2;EDA2R;SPRY2;MRC2;FBXO2;WASH3P;MEF2D;IFT140;GABBR1;CREBRF;XRN1;AGAP7P;RAB11FIP3;LRP11;MLXIPL;CTSB;KLK5;FBXW7;KCNMA1;ANKRD28;ING4;NUDT6;CDK5RAP3;ZNF862;ATXN1;LMO2;NOTCH2NL;CCDC92;NFIX;PAK6;DZIP1L;PGM1;MXI1;PFKFB2;RNF170;CHMP1B;THRA;APC2;METTL21A;ARAP1;ADARB1;RAI1;FMNL2;ELF1;MX2;IKZF4;RPH3AL;SLC2A1;ACACB;ACCS;OGDHL;NLRP1;FRAT1;ERMAP;REEP4;ZNF627;LACTB2;BEX2;GLUL;TNS2;TBC1D17;MIF4GD;NAB2;EPM2AIP1;GNG2;FBXW5;SRR;CAPG;TSPYL4;LRP1;HLA-A;TSNARE1;NPHP4;ATE1;MPG;SYNPO2;CENPH;RFX2;DLK2;BRINP1;SLC48A1;CD99L2;MYO3B;APPL2;SALL2;WNK1;PMEL;BBS1;ATXN10;GUCD1;JPH2;ARL11;PDE2A;ZNF334;SDHA;MAF;STK16;RET;ZMYND8;PRX;DAB2IP;RWDD3;ACOX3;CALCOCO1;TEAD2;MYSM1;PCED1A;SHROOM2;FBXO4;OLFM2;RAPGEFL1;TSHZ2;PIK3C3;ZNF276;IFI16;SYT7;DALRD3;FGFR4;ERCC5;BBS5;EXOC2;IL20RA;PIK3R2;TEF;AREG;ABTB1;TMEM203;DEF6;KLHL3;ETFB;MYO9A;RPS6KA5;APBB3;DLG5;BTG1;BST2;ZNF687;VDR;LETMD1;RGL2;ARHGEF17;CACNB3;PHF7;TNRC6C;VIPR1;EFS;PLXND1;NADK;BBS10;SIX5;HLTF;C20ORF194;PCED1B;PCSK6;MPPE1;TNS4;TBC1D16;TMCO6;C22ORF23;EML3;PPP1R2;DMTN;TPRN;ORAI2;PPP1R35;STAT2;SGSM2;ARFGEF2;ALMS1;WWC3;PHF1;TMEM231;TFDP2;SNX1;PMP22;UCN2;OSBPL1A;ACVR1B;SHROOM4;TACC1;KREMEN1;CADM4;PRIMPOL;NECAB3;CCDC88B;DLG4;IGFL2;CCDC113;TNNI2;PPP2R3B;ESYT2;TSSK1B;ADCK5;IQSEC1;ALOXE3;PALB2;ENDOU;IGFBP6;MATN2;TCEAL4;GALE;WEE1;DYDC1;GTF2IRD2;PTK7;TCF7;SHANK2;RSAD2;TNFRSF25;ZFP36L1;LMNA;TOP3B;IL11;KAT2B;MARK4;TEP1;IRS2;DMXL2;IMPA2;CEP250;ANO1;ERN1;HSD17B14;SAC3D1;RAD50;ZNF439;TKFC;LAPTM4A;ZMAT3;PNPO;MTR;DHRS4;PEX1;S100A6;TRERF1;FSD2;FAAH;SCYL3;EFEMP2;SCG5;APBB2;CBR4;TTC19;ARHGEF9;ISYNA1;PBLD;DCAF8;CCDC90B;RAPGEF5;TNFSF12;TAS1R3;STAT6;PCSK1N;SOX13;PRDX5;PHPT1;NELFCD;PHC2;KIF7;GLB1;GOLGA1;CPT1C;DNAJC4;GSTM3;RDH12;CHD6;TRAF5;GOLGB1;SRPX2;TRIM2;CD9;RANBP9;HDAC11;PTPN3;CTSD;COL13A1;ERBB2;SYNGR1;MPRIP;PLCB3;NUDT10;UVSSA;ZDHHC24;KMT5C;AKAP6;TH;ATG14;MPP7;RORA;SSH3;PPARG;PRKACA;DOCK6;LDLRAP1;CXXC5;POLM;FMNL3;ACOT2;ZNF572;SYNE2;PARD6G;ACKR3;SERPING1;SUCLG2;UCKL1;PARN;UHRF1BP1;DOCK3;UFL1;LAMB2;IP6K2;RIPK3;NFASC;AIP;COG1;SCAND1;LONP2;PRMT3;SNX33;HARS2;CIT;EHHADH;MSH5;MAP1A;PER3;FOXP2;HIVEP1;ECM2;SMURF1;NPNT;HERPUD2;EML2;CTNNBIP1;TM4SF1;GCLC;ECM1
17809,GO:1901990,0.996696958752837,0.00602632816932142,22,356,regulation of mitotic cell cycle phase transition,BP,GPNMB;EGFR;PKD2;XPC;BRSK1;CNTRL;MDM2;PCBP4;ZFP36L2;PIDD1;GJC2;NINL;ZNF655;CEP192;HYAL1;CDK5RAP3;ALMS1;TFDP2;ZFP36L1;CEP250;GPR132;PRKACA
13469,GO:0055029,0.99673350475306,0.00986950480709919,5,127,nuclear DNA-directed RNA polymerase complex,CC,POLR2J2;RTF1;POLR2J3;ERCC5;CHD6
2859,GO:0006351,0.996810970523226,0.00394934618107179,270,2975,transcription, DNA-templated,BP,TNFAIP3;HES2;ZSCAN18;TSC22D1;SIK1;TP53INP1;SREBF1;APOE;MN1;EGFR;PKD2;CAPRIN2;MNT;ASH2L;TRIM22;SRSF5;SFRP1;PERM1;SEC14L2;DGKQ;PIK3R1;RBCK1;KDM3A;TSC22D3;POU3F1;HR;HTRA1;TFCP2L1;RGMA;ZFPM1;HOXC5;ZNF362;CITED4;IRF2BPL;MC1R;ZNF266;STAT1;IMPACT;CRY2;THAP8;NOS1;ZNF704;HOXA3;CRY1;ZNF699;MAML3;ZFP41;SCMH1;KLF13;NFATC4;ZNF783;RNF187;HSF4;ZNF251;EAPP;MDM2;CRTC1;NDN;ZNF662;NEO1;ZNF414;TCF25;POLR2J2;MLLT6;F2R;PDCD4;ZNF160;SWT1;ZFP36L2;TRPV4;GLI2;KLF7;RNF165;TCEA2;ZNF76;SOX12;PIDD1;ZNF747;PER2;ZNF658;PHF2;ABHD14B;TCEAL1;WWTR1;GLI3;THRAP3;ZNF558;IRX4;SMARCA1;BHLHE40;ZNF655;ZNF333;MAP2K5;ITGA6;ZNF318;LZTS1;TCFL5;TRAK1;JARID2;NUPR1;INSR;CCDC85B;HSF2BP;CHD3;ZNF18;MXD4;ZNF287;PMS2P3;ZNF446;ZNF581;RTF1;MDK;IRF9;H2AFJ;BMP6;NLRX1;MAP2K2;GLI4;SQSTM1;FZD7;ETV5;DLX3;HEXB;KDM4C;METTL23;ZNF608;GDF15;TXNIP;TCF4;PLAG1;RCOR2;IFI27;LPIN3;CDK5R1;ATRX;POLR2J3;MAPK10;HFE;ADIRF;HMG20B;TRIM38;ERCC6;EDA2R;MEF2D;CREBRF;MLXIPL;TARBP1;FBXW7;ING4;CDK5RAP3;ZNF862;ATXN1;LMO2;NFIX;PAK6;CARF;MXI1;THRA;RAI1;ELF1;IKZF4;ZBTB34;ZNF627;DBP;NAB2;EPM2AIP1;PEG3;RGS12;RFX2;ZNF554;SALL2;ZNF107;ZNF532;ZBTB20;PDE2A;ZNF334;MAF;STK16;RET;ZMYND8;DAB2IP;CASZ1;RWDD3;CALCOCO1;TEAD2;MYSM1;TSHZ2;ZNF276;IFI16;PIK3R2;TEF;ZNF25;RPS6KA5;APBB3;ZNF630;BTG1;ZNF687;VDR;MAMSTR;TNRC18;ZFP28;PLXND1;ZMYM3;SIX5;HLTF;PCSK6;ZNF789;ZNF563;ZNF517;STAT2;WWC3;PHF1;ZNF292;TFDP2;NRARP;ACVR1B;ZNF737;TNNI2;ZNF701;NAT14;TCEAL4;ZNF91;DYDC1;GTF2IRD2;TCF7;ZFP36L1;GLMP;IL11;KAT2B;ERN1;RNF141;IVNS1ABP;ZNF439;TRERF1;APBB2;STAT6;SOX13;PRDX5;NELFCD;KLF8;CHD6;TRAF5;GOLGB1;HDAC11;ERBB2;SPOCD1;ABCA2;KMT5C;RORA;PPARG;CXXC5;ZNF572;ZNF658B;ZNF529;UFL1;RIPK3;KLF9;SCAND1;PRMT3;ZFP90;PER3;ZFP30;FOXP2;ZC3H6;HIVEP1;SMURF1;NPNT;CTNNBIP1;GCLC;ECM1
947,GO:0002366,0.996825306197104,0.00534336312194039,31,468,leukocyte activation involved in immune response,BP,PYGB;CXCR1;KCNAB2;ZFPM1;NAPRT;GAA;HGSNAT;ACTR1B;TMC6;ADORA2B;VAMP2;GSN;SLC2A3;TCIRG1;HEXB;CST3;CYBA;CTSB;PGM1;BST2;NBEAL2;CD68;METTL7A;STAT6;GLB1;DPP7;CTSD;SYNGR1;RORA;C6ORF120;NFASC
15409,GO:0071702,0.996868533430171,0.00404509663134786,166,1934,organic substance transport,BP,POSTN;ITGB6;SREBF1;APOE;LMF1;EGFR;CPT2;SRSF5;SFRP1;GLUD1;TMEM129;PIK3R1;EVI5L;MVB12B;UNC119B;ZDHHC1;VAMP3;REEP2;NSG1;SLC16A5;RAB43;RAB40B;NOS1;CRY1;PITPNM3;FERMT1;AP5Z1;MICALL1;TBC1D8;VPS11;SLC29A4;ITPR3;MDM2;LTBP4;SYTL1;RAPGEF3;AP1G2;F2R;HPS4;CLTCL1;TRPV4;FLOT1;TOM1L2;NLGN2;ANK3;SLC13A5;G6PC3;ATG16L2;RHBDF1;PER2;PITPNM2;UNC119;C5;GLI3;LRSAM1;VAMP2;NMU;TRAK1;NISCH;INSR;TST;TTN;VPS39;SLC27A1;PGAP1;TM7SF3;BMP6;PEX10;SLC2A3;TCIRG1;MICALL2;ARHGAP33;ARRDC1;PLA2G6;PEX7;BBS2;TXNIP;ATP6V0A2;IDH2;IFI27;OSCP1;TNFRSF21;ZDHHC12;CDK5R1;ANO9;CA2;OSBPL10;HOOK2;HFE;CYBA;HADH;WASH3P;RAB11FIP3;FBXW7;PFKFB2;CHMP1B;ASTN2;MX2;RPH3AL;SLC2A1;ACACB;NLRP1;GLUL;TBC1D17;SLC38A4;LRP1;TSNARE1;SLC48A1;BBS1;PDE2A;SLC37A2;OLFM2;PIK3C3;SYT7;BBS5;EXOC2;PIK3R2;OSBPL5;SNX21;EHBP1;TBC1D16;TMCO6;DMTN;SGSM2;ARFGEF2;RASL10B;SLC36A4;SNX1;GOLGA7B;OSBPL1A;NECAB3;ESYT2;SLC22A15;RSAD2;ZFP36L1;ACSL1;APOLD1;IRS2;ANO1;ALOX15B;ZMAT3;PEX1;SCG5;PHPT1;SLC43A1;ERBB2;SYNGR1;GPR68;ZDHHC24;ABCA2;AKAP6;SLC2A11;TH;PPARG;LDLRAP1;NPAP1;PLTP;AIP;COG1;KCNS3;LONP2;SNX33;SMURF1;PEMT;ABCA11P;SERINC3
8081,GO:0032774,0.996936906055789,0.00379459126872721,272,2999,RNA biosynthetic process,BP,TNFAIP3;HES2;ZSCAN18;TSC22D1;SIK1;TP53INP1;SREBF1;APOE;MN1;EGFR;PKD2;CAPRIN2;MNT;ASH2L;TRIM22;SRSF5;SFRP1;PERM1;SEC14L2;DGKQ;PIK3R1;RBCK1;KDM3A;TSC22D3;POU3F1;HR;HTRA1;TFCP2L1;RGMA;ZFPM1;HOXC5;ZNF362;CITED4;IRF2BPL;MC1R;ZNF266;STAT1;IMPACT;CRY2;THAP8;NOS1;ZNF704;HOXA3;CRY1;ZNF699;MAML3;ZFP41;SCMH1;KLF13;NFATC4;ZNF783;RNF187;HSF4;ZNF251;EAPP;MDM2;CRTC1;NDN;ZNF662;NEO1;ZNF414;TCF25;POLR2J2;MLLT6;F2R;PDCD4;ZNF160;SWT1;ZFP36L2;TRPV4;GLI2;KLF7;RNF165;TCEA2;ZNF76;SOX12;PIDD1;ZNF747;PER2;ZNF658;PHF2;ABHD14B;TCEAL1;WWTR1;GLI3;THRAP3;ZNF558;IRX4;SMARCA1;BHLHE40;ZNF655;ZNF333;MAP2K5;ITGA6;ZNF318;LZTS1;TCFL5;TRAK1;JARID2;NUPR1;INSR;CCDC85B;HSF2BP;CHD3;ZNF18;MXD4;ZNF287;PMS2P3;ZNF446;ZNF581;RTF1;MDK;IRF9;H2AFJ;BMP6;NLRX1;MAP2K2;GLI4;SQSTM1;FZD7;ETV5;DLX3;HEXB;KDM4C;METTL23;ZNF608;GDF15;TXNIP;TCF4;PLAG1;RCOR2;IFI27;LPIN3;CDK5R1;ATRX;POLR2J3;MAPK10;HFE;ADIRF;HMG20B;TRIM38;ERCC6;EDA2R;MEF2D;CREBRF;MLXIPL;TARBP1;FBXW7;ING4;CDK5RAP3;ZNF862;ATXN1;LMO2;NFIX;PAK6;CARF;MXI1;THRA;RAI1;ELF1;IKZF4;ZBTB34;ZNF627;DBP;NAB2;EPM2AIP1;PEG3;RGS12;RFX2;ZNF554;SALL2;ZNF107;ZNF532;ZBTB20;PDE2A;ZNF334;MAF;STK16;RET;ZMYND8;DAB2IP;CASZ1;RWDD3;CALCOCO1;TEAD2;MYSM1;TSHZ2;ZNF276;IFI16;PIK3R2;TEF;ZNF25;RPS6KA5;APBB3;ZNF630;BTG1;ZNF687;VDR;MAMSTR;TNRC18;ZFP28;PLXND1;ZMYM3;SIX5;HLTF;PCSK6;ZNF789;ZNF563;ZNF517;STAT2;WWC3;PHF1;ZNF292;TFDP2;NRARP;ACVR1B;ZNF737;PRIMPOL;TNNI2;ZNF701;NAT14;TCEAL4;ZNF91;DYDC1;GTF2IRD2;TCF7;ZFP36L1;GLMP;IL11;KAT2B;ERN1;RNF141;IVNS1ABP;ZNF439;TRERF1;APBB2;STAT6;SOX13;PRDX5;NELFCD;KLF8;CHD6;TRAF5;GOLGB1;HDAC11;ERBB2;SPOCD1;ABCA2;KMT5C;RORA;PPARG;CXXC5;ZNF572;ZNF658B;ZNF529;UFL1;RIPK3;KLF9;AIP;SCAND1;PRMT3;ZFP90;PER3;ZFP30;FOXP2;ZC3H6;HIVEP1;SMURF1;NPNT;CTNNBIP1;GCLC;ECM1
16681,GO:0097659,0.996975425774046,0.0037488597636057,271,2989,nucleic acid-templated transcription,BP,TNFAIP3;HES2;ZSCAN18;TSC22D1;SIK1;TP53INP1;SREBF1;APOE;MN1;EGFR;PKD2;CAPRIN2;MNT;ASH2L;TRIM22;SRSF5;SFRP1;PERM1;SEC14L2;DGKQ;PIK3R1;RBCK1;KDM3A;TSC22D3;POU3F1;HR;HTRA1;TFCP2L1;RGMA;ZFPM1;HOXC5;ZNF362;CITED4;IRF2BPL;MC1R;ZNF266;STAT1;IMPACT;CRY2;THAP8;NOS1;ZNF704;HOXA3;CRY1;ZNF699;MAML3;ZFP41;SCMH1;KLF13;NFATC4;ZNF783;RNF187;HSF4;ZNF251;EAPP;MDM2;CRTC1;NDN;ZNF662;NEO1;ZNF414;TCF25;POLR2J2;MLLT6;F2R;PDCD4;ZNF160;SWT1;ZFP36L2;TRPV4;GLI2;KLF7;RNF165;TCEA2;ZNF76;SOX12;PIDD1;ZNF747;PER2;ZNF658;PHF2;ABHD14B;TCEAL1;WWTR1;GLI3;THRAP3;ZNF558;IRX4;SMARCA1;BHLHE40;ZNF655;ZNF333;MAP2K5;ITGA6;ZNF318;LZTS1;TCFL5;TRAK1;JARID2;NUPR1;INSR;CCDC85B;HSF2BP;CHD3;ZNF18;MXD4;ZNF287;PMS2P3;ZNF446;ZNF581;RTF1;MDK;IRF9;H2AFJ;BMP6;NLRX1;MAP2K2;GLI4;SQSTM1;FZD7;ETV5;DLX3;HEXB;KDM4C;METTL23;ZNF608;GDF15;TXNIP;TCF4;PLAG1;RCOR2;IFI27;LPIN3;CDK5R1;ATRX;POLR2J3;MAPK10;HFE;ADIRF;HMG20B;TRIM38;ERCC6;EDA2R;MEF2D;CREBRF;MLXIPL;TARBP1;FBXW7;ING4;CDK5RAP3;ZNF862;ATXN1;LMO2;NFIX;PAK6;CARF;MXI1;THRA;RAI1;ELF1;IKZF4;ZBTB34;ZNF627;DBP;NAB2;EPM2AIP1;PEG3;RGS12;RFX2;ZNF554;SALL2;ZNF107;ZNF532;ZBTB20;PDE2A;ZNF334;MAF;STK16;RET;ZMYND8;DAB2IP;CASZ1;RWDD3;CALCOCO1;TEAD2;MYSM1;TSHZ2;ZNF276;IFI16;PIK3R2;TEF;ZNF25;RPS6KA5;APBB3;ZNF630;BTG1;ZNF687;VDR;MAMSTR;TNRC18;ZFP28;PLXND1;ZMYM3;SIX5;HLTF;PCSK6;ZNF789;ZNF563;ZNF517;STAT2;WWC3;PHF1;ZNF292;TFDP2;NRARP;ACVR1B;ZNF737;TNNI2;ZNF701;NAT14;TCEAL4;ZNF91;DYDC1;GTF2IRD2;TCF7;ZFP36L1;GLMP;IL11;KAT2B;ERN1;RNF141;IVNS1ABP;ZNF439;TRERF1;APBB2;STAT6;SOX13;PRDX5;NELFCD;KLF8;CHD6;TRAF5;GOLGB1;HDAC11;ERBB2;SPOCD1;ABCA2;KMT5C;RORA;PPARG;CXXC5;ZNF572;ZNF658B;ZNF529;UFL1;RIPK3;KLF9;AIP;SCAND1;PRMT3;ZFP90;PER3;ZFP30;FOXP2;ZC3H6;HIVEP1;SMURF1;NPNT;CTNNBIP1;GCLC;ECM1
202,GO:0000428,0.997003779158125,0.00912720776461933,5,128,DNA-directed RNA polymerase complex,CC,POLR2J2;RTF1;POLR2J3;ERCC5;CHD6
2082,GO:0004843,0.99708686932693,0.0139916018133216,2,70,thiol-dependent ubiquitin-specific protease activity,MF,TNFAIP3;MYSM1
13662,GO:0060218,0.997087449078699,0.013795787766444,2,100,hematopoietic stem cell differentiation,BP,SFRP1;LMO2
10607,GO:0043618,0.997129039896027,0.0111093943310393,3,101,regulation of transcription from RNA polymerase II promoter in response to stress,BP,IMPACT;HSF4;CHD6
2942,GO:0006470,0.997162305871368,0.00594647099867431,14,243,protein dephosphorylation,BP,PTPRS;ELFN2;CRY2;PPP2R2C;PHACTR3;TNS2;PPP1R2;PPP1R35;PPP2R3B;PHPT1;PTPN3;PPM1M;AKAP6;SSH3
7159,GO:0031047,0.997219925779691,0.00787768674716725,6,155,gene silencing by RNA,BP,EGFR;ZCCHC11;MAP2K2;AGO4;TNRC6C;PPARG
8425,GO:0033554,0.997253093574639,0.00364031927336421,135,1614,cellular response to stress,BP,TNFAIP3;DDB2;TP53INP1;SREBF1;APOE;HSPA2;EGFR;PTPRS;PKD2;XPC;ASH2L;SFRP1;GPX3;MAP3K14;TMEM129;PIK3R1;BRSK1;UBXN4;VAV3;ISG15;SPATA18;RGMA;CUL7;MC1R;IMPACT;CRY1;MAGEF1;NFATC4;AP5Z1;HSF4;LIG1;NDRG1;MDM2;MLH3;PRODH;PCBP4;CTSV;POLH;PDCD4;RTN4RL1;TRPV4;FLOT1;ADORA2B;MAPK8IP3;PIDD1;SLX1A;SLX1B;MINK1;GSTM2;ULK1;MAP2K5;SESN3;NUPR1;POLD4;PMS2P3;ETAA1;RMI2;ENDOG;TM7SF3;CASP14;MAP2K2;PDK1;SQSTM1;FZD7;ETV5;TMEM117;NSMCE4A;PLA2G6;CST3;MAP3K12;WRN;MCM9;MACROD1;TREX1;ATRX;REC8;NET1;CA2;SESN1;MAPK10;HFE;CYBA;ERCC6;RRM2B;EDA2R;FBXO2;CREBRF;FBXW7;ING4;CDK5RAP3;PAK6;TFPI2;SLC2A1;GLUL;MPG;C12ORF66;MAP3K6;DAB2IP;RWDD3;FBXO4;PIK3C3;IFI16;ERCC5;PIK3R2;SCN2A;PHF1;TFDP2;TMX4;PRIMPOL;PALB2;MATN2;ZFP36L1;LMNA;ANO1;ERN1;RAD50;ZMAT3;MTR;MAN1B1;STAT6;PRDX5;GSTM3;CHD6;UVSSA;ATG14;RORA;PPARG;PRKACA;POLM;ACKR3;UFL1;LAMB2;MSH5;SMURF1;SERINC3
7078,GO:0030880,0.997294989498923,0.00831742978886329,5,130,RNA polymerase complex,CC,POLR2J2;RTF1;POLR2J3;ERCC5;CHD6
14406,GO:0061733,0.997375455632627,0.019171060761677,1,53,peptide-lysine-N-acetyltransferase activity,MF,KAT2B
17664,GO:1901564,0.997392493070286,0.00315189305452704,451,4899,organonitrogen compound metabolic process,BP,TNFAIP3;TGFBI;SERPINE2;ULK2;GPNMB;SIK1;MUC19;NPEPL1;DDB2;IFI6;PTHLH;SREBF1;APOE;NT5E;INPP5D;GAMT;FBXO41;ADAM19;LMF1;HSPA2;FBXW4;EGFR;HERC3;PTPRS;CIRBP;FAM20C;PKD2;CAPRIN2;APOBEC3C;RBM3;ASH2L;TRIM22;CTSO;SFRP1;OBSL1;MTHFR;KCTD11;EPHB2;MAP3K14;GLUD1;BPHL;DCAF16;DGKQ;TMEM129;PIK3R1;ADAMTS7;BRSK1;RBCK1;KDM3A;CUL9;RNF135;SULF2;H6PD;DHTKD1;CAMKK1;HERC5;UBXN4;ST6GALNAC2;UNK;HR;CSPG4;ISG15;MVB12B;ELFN2;HTRA1;SPATA18;TENM4;KCNAB2;ZFPM1;KITLG;MVD;ZDHHC1;CUL7;NAPRT;SRD5A3;IMPACT;CAMK2N1;CRY2;NSG1;UROS;KDSR;RAB40B;NOS1;PRKACB;CRY1;CRTAP;SDC3;MAGEF1;HMGCL;SPDYE6;D2HGDH;BTBD2;FKBP5;RNF187;CMPK2;THNSL2;HSF4;CNTRL;CDK18;VPS11;SPEG;COL7A1;SPOCK1;NAGLU;MDM2;NMRK1;ST6GALNAC6;PPP2R2C;TYSND1;LTBP4;OBSCN;IDUA;TNFSF10;PRODH;HGSNAT;FKBP9;CERS4;CYP3A5;RAPGEF3;PHACTR3;SPSB3;CTSV;BLVRB;FLRT3;RASA4;GAL3ST4;CRAT;B4GALT6;RGS2;F2R;PDCD4;SPTB;SERPINB5;ALPK1;CAPN7;ARSI;NEK9;RTN4RL1;ZFP36L2;TRPV4;FLOT1;ADORA2B;RNF165;NAT6;ADAMTS13;LAMP3;MAPK8IP3;SPDYE5;PIDD1;PARP6;ZNF747;GJC2;RHBDF1;SULT1E1;FBXO44;RASGEF1A;PER2;UNC119;HEXA;FRS3;C5;ARSD;SNTA1;PSKH1;MINK1;PHF2;ABHD14B;GSTM2;WWTR1;MBOAT2;ITGA2;ULK1;GLI3;SPPL2B;PCSK1;TPGS1;LRSAM1;NAIP;LTBP1;NEK8;MAP2K5;IGFBP4;MMP1;TRAK1;JARID2;NUPR1;PRR9;GPC2;INSR;TST;MMP28;GSN;ALDH4A1;CHD3;CDK14;ST3GAL5;TTN;CBLC;DDT;RNPEPL1;TRIOBP;CTSF;ZNF287;CD109;PGLS;ETAA1;FBXL16;MGST2;PILRB;SLC27A1;PGAP1;GID4;RTF1;CASP14;RICTOR;BMP6;B4GALT2;PEX10;TCIRG1;MAP2K2;OPLAH;PDK1;VEGFB;ALDH7A1;SQSTM1;PTK6;FZD7;LOXL1;SYNGAP1;SHARPIN;HEXB;KDM4C;HYAL1;CLCA2;UBOX5;ARRDC1;B3GNT9;PLA2G6;CST3;PDIK1L;CAPNS2;GDF15;CTF1;THSD4;ATP6V0A2;NPHP3;IDH2;MAP3K12;IFI27;ZYG11B;MACROD1;KLHL24;LPIN3;ZDHHC12;OARD1;CDK5R1;ATRX;PIGZ;OSBPL10;MAPK10;NKTR;SHANK3;HFE;HMG20B;TRIM38;DTX3;AGO4;ERCC6;HLCS;SHC2;EDA2R;SPRY2;FBXO2;GABBR1;XRN1;MLXIPL;CTSB;KLK5;FBXW7;GPR87;ING4;CDK5RAP3;ZNF862;PAK6;TFPI2;PGM1;PFKFB2;RNF170;APC2;METTL21A;ADARB1;DCAF10;ACACB;OGDHL;NLRP1;C1RL;TK2;GLUL;TNS2;C17ORF97;MIF4GD;NDST2;NAB2;FBXW5;SRR;LRP1;KLHDC8B;ATE1;ACP5;PLA2G7;RNPEP;MAP3K6;RIMKLB;PPCS;MYO3B;WNK1;PDE2A;SDHA;STK16;LTB4R2;RET;ZMYND8;DAB2IP;RWDD3;MYSM1;FBXO4;RNF213;PIK3C3;IFI16;DALRD3;FGFR4;PIK3R2;SETD4;OSBPL5;AREG;ABTB1;KLHL3;SNCB;ETFB;RPS6KA5;BTG1;BST2;TNRC6C;DPY19L2P2;NADK;HLTF;MARCH8;PCSK6;MPPE1;PCMTD2;STK19;NDUFV3;PPP1R2;DMTN;PPP1R35;STAT2;LMTK3;PCMTD1;PHF1;SNX1;GOLGA7B;ACVR1B;NECAB3;DLG4;PPP2R3B;ESYT2;TSSK1B;ADCK5;ALOXE3;PANO1;ENDOU;MPI;IGFBP6;DUOX1;WEE1;DYDC1;PTK7;AMT;TNFRSF25;ZFP36L1;XYLT1;MXRA8;ACSL1;IL11;KAT2B;MARK4;APOLD1;IRS2;ERN1;RNF141;RAD50;PNPO;MTR;MAN1B1;SCYL3;SCG5;SGSH;PBLD;DCAF8;TNFSF12;CERS5;PCSK1N;PRDX5;PHPT1;SMPDL3B;GLB1;CPT1C;GSTM3;KLHL29;DPP7;TRIM2;RANBP9;HDAC11;PTPN3;CTSD;ERBB2;NUDT10;UVSSA;ZDHHC24;PQLC3;PPM1M;KMT5C;AKAP6;TH;ATG14;RORA;SSH3;PPARG;PRKACA;LDLRAP1;GCNT4;ACKR3;SERPING1;UCKL1;UFL1;LAMB2;RIPK3;AIP;LONP2;PRMT3;SNX33;HARS2;CIT;EHHADH;SMURF1;NPNT;TTLL1;PEMT;SERINC3;GCLC;ECM1
9976,GO:0042393,0.997408761385814,0.0066140333283656,8,172,histone binding,MF,STAT1;CTSV;PHF2;ATRX;ING4;ZMYND8;MYSM1;PHF1
2874,GO:0006368,0.99744673774334,0.0100277759802017,3,97,transcription elongation from RNA polymerase II promoter,BP,EAPP;RTF1;NELFCD
2816,GO:0006281,0.997453694798208,0.00430004730976657,32,485,DNA repair,BP,DDB2;EGFR;XPC;ISG15;MC1R;MAGEF1;AP5Z1;LIG1;MLH3;POLH;SLX1A;SLX1B;POLD4;PMS2P3;ETAA1;RMI2;NSMCE4A;WRN;MCM9;TREX1;ATRX;REC8;ERCC6;RRM2B;MPG;ERCC5;PRIMPOL;PALB2;RAD50;UVSSA;POLM;MSH5
4249,GO:0009451,0.997471621370762,0.00782047887595609,5,132,RNA modification,BP,APOBEC3C;NSUN5P2;TARBP1;ADARB1;PARN
10337,GO:0043161,0.997489250825865,0.00459752219020053,23,371,proteasome-mediated ubiquitin-dependent protein catabolic process,BP,FBXW4;TMEM129;RBCK1;UBXN4;BTBD2;RNF187;MDM2;SPSB3;RNF165;WWTR1;GID4;SHARPIN;HFE;FBXO2;FBXW7;FBXW5;FBXO4;ABTB1;PANO1;MAN1B1;UFL1;SMURF1;GCLC
5585,GO:0016607,0.997554955193368,0.00459512404353273,21,339,nuclear speck,CC,TRIM22;SRSF5;DGKQ;CRY2;MAML3;NFATC4;AP5Z1;HSF4;GLI2;PSKH1;GLI3;THRAP3;RMI2;FNBP4;PLAG1;WRN;IFI16;PHF7;STK19;LMNA;PRKACA
3186,GO:0006810,0.99760267708875,0.00296260221611352,303,3343,transport,BP,POSTN;ITGB6;SERPINE2;SIK1;SREBF1;PYGB;APOE;OAS2;LMF1;HSPA2;EGFR;PKD2;SYT8;CXCR1;CPT2;SYN1;SRSF5;SFRP1;EPHB2;GLUD1;TMEM129;PIK3R1;EVI5L;BRSK1;ORAI3;TSC22D3;VAV3;MVB12B;UNC119B;KCNAB2;ZDHHC1;VAMP3;NAPRT;REEP2;KCNJ15;ASAP3;CRY2;NSG1;SLC16A5;GJD3;RAB43;RAB40B;NOS1;CRY1;PITPNM3;SCARA3;FERMT1;GAA;AP5Z1;MICALL1;TBC1D8;VPS11;COL7A1;KCNC4;SLC29A4;ITPR3;MDM2;FCGRT;LTBP4;HGSNAT;SYTL1;NDUFA4L2;ACTR1B;RAPGEF3;ENDOD1;NLGN4Y;KIF26A;AP1G2;TMEM63C;ACAP3;F2R;C2CD4C;HPS4;BLOC1S4;SPTB;SLC24A1;CLTCL1;TRPV4;TMC6;FLOT1;AGAP4;TOM1L2;NLGN2;ADORA2B;ANK3;MAPK8IP3;SLC13A5;RIMS3;G6PC3;ATG16L2;SPG11;GJC2;RHBDF1;PER2;PITPNM2;CLCN6;UNC119;C5;WIPF1;SNTA1;MINK1;GSTM2;ASAP2;LHFPL2;ITGA2;SYT15;GLI3;LRSAM1;VAMP2;NMU;KCNJ5;TRAK1;NISCH;INSR;TST;GSN;BAIAP2;TTN;TMC7;SCNN1A;SUN1;RIN1;CD109;SCN4B;RAB11FIP4;VPS39;SLC27A1;PGAP1;TM7SF3;BLOC1S3;BMP6;NIPAL2;PEX10;SLC2A3;TCIRG1;MICALL2;MAP2K2;VEGFB;SQSTM1;SLC12A7;HEXB;CLCA2;ARHGAP33;ARRDC1;WHAMMP3;PLA2G6;CST3;HOMER2;PEX7;BBS2;TXNIP;ATP6V0A2;IDH2;SEPT5;IFI27;OSCP1;DNM1;TNFRSF21;KLHL24;ZDHHC12;MCTP1;CDK5R1;ARHGAP27;AGAP6;ANO9;CA2;OSBPL10;HOOK2;SHANK3;HFE;SCART1;CYBA;HADH;MRC2;WASH3P;IFT140;AGAP7P;RAB11FIP3;CTSB;FBXW7;KCNMA1;ANKRD28;ATXN1;PGM1;PFKFB2;CHMP1B;ARAP1;ASTN2;MX2;RPH3AL;SLC2A1;ACACB;NLRP1;GPR155;GLUL;TBC1D17;SLC38A4;LRP1;TSNARE1;KCNG1;SLC48A1;APPL2;WNK1;BBS1;JPH2;PDE2A;SLC37A2;DDHD2;SHROOM2;OLFM2;PIK3C3;SYT7;BBS5;EXOC2;PIK3R2;SCN2A;OSBPL5;AREG;KLHL3;BST2;VDR;SNX21;CACNB3;EHBP1;PCSK6;MPPE1;TBC1D16;TMCO6;DMTN;ORAI2;SGSM2;ARFGEF2;RASL10B;ALMS1;SLC36A4;TFDP2;SNX1;GOLGA7B;OSBPL1A;NECAB3;CCDC88B;DLG4;ESYT2;ENDOU;NBEAL2;CD68;SLC22A15;SHANK2;RSAD2;ZFP36L1;ACSL1;IL11;APOLD1;IRS2;ANO1;METTL7A;ALOX15B;ZMAT3;PEX1;S100A6;SCG5;PHPT1;TUB;SLC43A1;GLB1;GOLGB1;DPP7;CD9;CACNB1;PTPN3;CTSD;ERBB2;SYNGR1;GPR68;ZDHHC24;ABCA2;AKAP6;SLC2A11;TH;ATG14;PPARG;PRKACA;LDLRAP1;NPAP1;C6ORF120;SYNE2;ACKR3;PLTP;SERPING1;IP6K2;NFASC;AIP;COG1;KCNS3;LONP2;SNX33;CLCN7;CALHM2;SMURF1;PEMT;ABCA11P;SERINC3;ECM1
14091,GO:0060968,0.997687954088644,0.00795298399402247,4,127,regulation of gene silencing,BP,EGFR;PHF2;MAP2K2;PPARG
6303,GO:0019941,0.997739323815458,0.00374132517554786,36,523,modification-dependent protein catabolic process,BP,TNFAIP3;FBXW4;TMEM129;RBCK1;CUL9;UBXN4;ISG15;MVB12B;CUL7;MAGEF1;BTBD2;RNF187;MDM2;SPSB3;RNF165;WWTR1;CBLC;GID4;SQSTM1;SHARPIN;ARRDC1;HFE;FBXO2;FBXW7;C17ORF97;FBXW5;ATE1;FBXO4;RNF213;ABTB1;KLHL3;PANO1;MAN1B1;UFL1;SMURF1;GCLC
2938,GO:0006464,0.997742107140882,0.00280842192294823,281,3078,cellular protein modification process,BP,TNFAIP3;ULK2;GPNMB;SIK1;MUC19;DDB2;SREBF1;APOE;FBXO41;LMF1;HSPA2;FBXW4;EGFR;HERC3;PTPRS;FAM20C;PKD2;CAPRIN2;ASH2L;TRIM22;SFRP1;OBSL1;MTHFR;KCTD11;EPHB2;MAP3K14;DCAF16;DGKQ;TMEM129;PIK3R1;ADAMTS7;BRSK1;RBCK1;KDM3A;CUL9;RNF135;CAMKK1;HERC5;ST6GALNAC2;HR;CSPG4;ISG15;ELFN2;KITLG;MVD;ZDHHC1;CUL7;SRD5A3;IMPACT;CAMK2N1;CRY2;RAB40B;NOS1;PRKACB;CRY1;CRTAP;MAGEF1;SPDYE6;FKBP5;RNF187;HSF4;CNTRL;CDK18;SPEG;MDM2;ST6GALNAC6;PPP2R2C;OBSCN;FKBP9;RAPGEF3;PHACTR3;SPSB3;FLRT3;RASA4;B4GALT6;RGS2;F2R;PDCD4;SPTB;ALPK1;ARSI;NEK9;RTN4RL1;ZFP36L2;TRPV4;FLOT1;ADORA2B;RNF165;NAT6;ADAMTS13;MAPK8IP3;SPDYE5;PARP6;ZNF747;GJC2;FBXO44;RASGEF1A;PER2;UNC119;FRS3;C5;ARSD;SNTA1;PSKH1;MINK1;PHF2;WWTR1;ULK1;TPGS1;LRSAM1;NAIP;LTBP1;NEK8;MAP2K5;IGFBP4;TRAK1;JARID2;NUPR1;PRR9;INSR;CHD3;CDK14;ST3GAL5;TTN;CBLC;DDT;TRIOBP;CD109;ETAA1;FBXL16;PILRB;SLC27A1;PGAP1;GID4;RTF1;RICTOR;BMP6;B4GALT2;PEX10;MAP2K2;PDK1;VEGFB;SQSTM1;PTK6;FZD7;LOXL1;SYNGAP1;SHARPIN;KDM4C;UBOX5;ARRDC1;B3GNT9;PLA2G6;CST3;PDIK1L;GDF15;CTF1;MAP3K12;ZYG11B;MACROD1;KLHL24;ZDHHC12;CDK5R1;ATRX;PIGZ;MAPK10;NKTR;SHANK3;HFE;HMG20B;TRIM38;DTX3;ERCC6;HLCS;SHC2;EDA2R;SPRY2;FBXO2;MLXIPL;FBXW7;ING4;CDK5RAP3;ZNF862;PAK6;RNF170;METTL21A;ADARB1;DCAF10;TNS2;C17ORF97;NAB2;FBXW5;KLHDC8B;ATE1;MAP3K6;RIMKLB;MYO3B;WNK1;STK16;RET;ZMYND8;DAB2IP;RWDD3;MYSM1;FBXO4;RNF213;PIK3C3;FGFR4;PIK3R2;SETD4;AREG;KLHL3;ETFB;RPS6KA5;BTG1;DPY19L2P2;HLTF;MARCH8;MPPE1;PCMTD2;STK19;PPP1R2;DMTN;PPP1R35;STAT2;LMTK3;PCMTD1;PHF1;GOLGA7B;ACVR1B;DLG4;PPP2R3B;TSSK1B;ADCK5;MPI;WEE1;DYDC1;PTK7;TNFRSF25;ZFP36L1;MXRA8;ACSL1;IL11;KAT2B;MARK4;IRS2;ERN1;RNF141;RAD50;MAN1B1;SCYL3;PBLD;DCAF8;PHPT1;KLHL29;TRIM2;RANBP9;HDAC11;PTPN3;ERBB2;UVSSA;ZDHHC24;PQLC3;PPM1M;KMT5C;AKAP6;ATG14;SSH3;PRKACA;GCNT4;ACKR3;UFL1;LAMB2;RIPK3;PRMT3;CIT;EHHADH;SMURF1;NPNT;TTLL1;GCLC
9505,GO:0036211,0.997742107140882,0.00280842192294823,281,3078,protein modification process,BP,TNFAIP3;ULK2;GPNMB;SIK1;MUC19;DDB2;SREBF1;APOE;FBXO41;LMF1;HSPA2;FBXW4;EGFR;HERC3;PTPRS;FAM20C;PKD2;CAPRIN2;ASH2L;TRIM22;SFRP1;OBSL1;MTHFR;KCTD11;EPHB2;MAP3K14;DCAF16;DGKQ;TMEM129;PIK3R1;ADAMTS7;BRSK1;RBCK1;KDM3A;CUL9;RNF135;CAMKK1;HERC5;ST6GALNAC2;HR;CSPG4;ISG15;ELFN2;KITLG;MVD;ZDHHC1;CUL7;SRD5A3;IMPACT;CAMK2N1;CRY2;RAB40B;NOS1;PRKACB;CRY1;CRTAP;MAGEF1;SPDYE6;FKBP5;RNF187;HSF4;CNTRL;CDK18;SPEG;MDM2;ST6GALNAC6;PPP2R2C;OBSCN;FKBP9;RAPGEF3;PHACTR3;SPSB3;FLRT3;RASA4;B4GALT6;RGS2;F2R;PDCD4;SPTB;ALPK1;ARSI;NEK9;RTN4RL1;ZFP36L2;TRPV4;FLOT1;ADORA2B;RNF165;NAT6;ADAMTS13;MAPK8IP3;SPDYE5;PARP6;ZNF747;GJC2;FBXO44;RASGEF1A;PER2;UNC119;FRS3;C5;ARSD;SNTA1;PSKH1;MINK1;PHF2;WWTR1;ULK1;TPGS1;LRSAM1;NAIP;LTBP1;NEK8;MAP2K5;IGFBP4;TRAK1;JARID2;NUPR1;PRR9;INSR;CHD3;CDK14;ST3GAL5;TTN;CBLC;DDT;TRIOBP;CD109;ETAA1;FBXL16;PILRB;SLC27A1;PGAP1;GID4;RTF1;RICTOR;BMP6;B4GALT2;PEX10;MAP2K2;PDK1;VEGFB;SQSTM1;PTK6;FZD7;LOXL1;SYNGAP1;SHARPIN;KDM4C;UBOX5;ARRDC1;B3GNT9;PLA2G6;CST3;PDIK1L;GDF15;CTF1;MAP3K12;ZYG11B;MACROD1;KLHL24;ZDHHC12;CDK5R1;ATRX;PIGZ;MAPK10;NKTR;SHANK3;HFE;HMG20B;TRIM38;DTX3;ERCC6;HLCS;SHC2;EDA2R;SPRY2;FBXO2;MLXIPL;FBXW7;ING4;CDK5RAP3;ZNF862;PAK6;RNF170;METTL21A;ADARB1;DCAF10;TNS2;C17ORF97;NAB2;FBXW5;KLHDC8B;ATE1;MAP3K6;RIMKLB;MYO3B;WNK1;STK16;RET;ZMYND8;DAB2IP;RWDD3;MYSM1;FBXO4;RNF213;PIK3C3;FGFR4;PIK3R2;SETD4;AREG;KLHL3;ETFB;RPS6KA5;BTG1;DPY19L2P2;HLTF;MARCH8;MPPE1;PCMTD2;STK19;PPP1R2;DMTN;PPP1R35;STAT2;LMTK3;PCMTD1;PHF1;GOLGA7B;ACVR1B;DLG4;PPP2R3B;TSSK1B;ADCK5;MPI;WEE1;DYDC1;PTK7;TNFRSF25;ZFP36L1;MXRA8;ACSL1;IL11;KAT2B;MARK4;IRS2;ERN1;RNF141;RAD50;MAN1B1;SCYL3;PBLD;DCAF8;PHPT1;KLHL29;TRIM2;RANBP9;HDAC11;PTPN3;ERBB2;UVSSA;ZDHHC24;PQLC3;PPM1M;KMT5C;AKAP6;ATG14;SSH3;PRKACA;GCNT4;ACKR3;UFL1;LAMB2;RIPK3;PRMT3;CIT;EHHADH;SMURF1;NPNT;TTLL1;GCLC
16630,GO:0097525,0.997789012543173,0.0164555323708777,1,62,spliceosomal snRNP complex,CC,TEP1
4546,GO:0010629,0.997800045348488,0.00299301964571107,114,1428,negative regulation of gene expression,BP,HES2;SERPINE2;TP53INP1;SREBF1;EGFR;CIRBP;CAPRIN2;MNT;SFRP1;DGKQ;TSC22D3;UNK;HR;TFCP2L1;ZFPM1;IRF2BPL;STAT1;IMPACT;CRY2;CRY1;SCMH1;NFATC4;FERMT1;HSF4;EAPP;MDM2;TCF25;PCBP4;PDCD4;ZFP36L2;TRPV4;GLI2;ZCCHC11;PER2;ZNF658;PHF2;TCEAL1;WWTR1;GLI3;THRAP3;BHLHE40;NAIP;MAP2K5;ZNF318;TCFL5;JARID2;CCDC85B;MXD4;RTF1;H2AFJ;BMP6;MAP2K2;SQSTM1;ZNF608;BBS2;TXNIP;PLAG1;RCOR2;IFI27;CDK5R1;ATRX;AGO4;SLIT3;XRN1;MLXIPL;ING4;ATXN1;NFIX;MXI1;THRA;IKZF4;ACACB;NAB2;PEG3;SALL2;ZBTB20;PDE2A;MAF;ZMYND8;DAB2IP;TSHZ2;IFI16;RPS6KA5;VDR;TNRC18;TNRC6C;SIX5;WWC3;PHF1;TFDP2;NRARP;ACVR1B;ZNF91;DYDC1;TCF7;ZFP36L1;ERN1;ANGEL2;STAT6;PRDX5;NELFCD;KLF8;PPARG;CXXC5;SERPING1;PARN;ZFP90;PER3;FOXP2;PTBP2;ZC3H6;HIVEP1;CTNNBIP1;GCLC
2553,GO:0005829,0.99794757319342,0.00251178754679885,376,4103,cytosol,CC,TNFAIP3;SERPINE2;ULK2;TP53INP1;PTHLH;SREBF1;ACTA2;GPSM1;NT5E;ALS2CL;INPP5D;GAMT;FBXO41;OAS2;DDX60;HSPA2;FBXW4;TRIM65;HERC3;FLNC;CAPRIN2;SYN1;DIXDC1;TRIM22;ALDH1A3;SRSF5;PLCD3;SFRP1;OBSL1;MTHFR;SEC14L2;EPS8L2;EPHB2;RALGDS;SYNC;MAP3K14;DGKQ;PIK3R1;RBCK1;DOCK9;TSC22D3;CUL9;RNF135;DHTKD1;CAMKK1;HERC5;UBXN4;VAV3;ISG15;MVB12B;HTRA1;UNC119B;KCNAB2;MVD;CUL7;VAMP3;NAPRT;ASAP3;STAT1;CRY2;MYL9;GRIP2;KRT15;UROS;NOS1;PRKACB;PLEKHG5;NFATC4;PITPNM3;BTBD2;FKBP5;RNF187;FERMT1;CNTRL;PIK3C2G;NDRG1;MDM2;CRTC1;LZTS2;PLCD1;NDN;NMRK1;PPP2R2C;CHN2;OBSCN;GOLGA8A;MYH11;PARVB;ACTR1B;RHOBTB2;ACOT1;SPSB3;ENDOD1;PCBP4;POLH;BLVRB;OAS1;FLRT3;RASA4;KIF26A;RGS2;ACAP3;MLYCD;PPL;HPS4;PDCD4;BLOC1S4;SPTB;NOL4L;NEK9;TUBGCP5;ZFP36L2;CLTCL1;GLI2;AGAP4;RHPN1;ANK3;GOLGA8B;PIDD1;SPG11;ZCCHC11;ARHGEF19;SULT1E1;FBXO44;RASGEF1A;PITPNM2;UNC119;WIPF1;MINK1;NINL;ABHD14B;GSTM2;WWTR1;ASAP2;ARHGEF4;ULK1;GLI3;AKAP7;LRSAM1;VAMP2;MAP2K5;SRGAP3;CES3;ZNF318;NUPR1;NISCH;HSF2BP;GSN;CEP68;CDK14;BAIAP2;TTN;AHNAK2;PLEKHH2;POLD4;RIN1;DNAJC30;PGLS;RMI2;ARHGEF1;FBXL16;DOCK8;ENDOG;SLC27A1;BLOC1S3;CASP14;IRF9;RICTOR;ETNK2;MICALL2;MAP2K2;OPLAH;ALDH7A1;SQSTM1;CEP192;CABYR;PTK6;AKR7A2;SYNGAP1;FAM13A;LGALS9C;EPB41L3;SHARPIN;CLCA2;ARHGAP33;SH2D2A;CENPC;PLA2G6;HOMER2;CAPNS2;PEX7;BBS2;TXNIP;NPHP3;IDH2;MAP3K12;IQCB1;TREX1;CDK5R1;ARHGAP27;AGAP6;NET1;CA2;OSBPL10;HOOK2;SESN1;MAPK10;NKTR;SHANK3;ADIRF;TRIM38;AGO4;RRM2B;KRT14;HLCS;SHC2;SPRY2;FBXO2;WASH3P;XRN1;AGAP7P;RAB11FIP3;MLXIPL;KLK5;FBXW7;ANKRD28;ING4;CDK5RAP3;ATXN1;PGM1;MXI1;PFKFB2;CHMP1B;THRA;APC2;ARAP1;ADARB1;FMNL2;FAM185A;MX2;SLC2A1;ACACB;OGDHL;NLRP1;FRAT1;GLUL;TBC1D17;MIF4GD;FBXW5;KLHDC8B;NPHP4;RGS12;ACP5;SYNPO2;CENPH;RIMKLB;PPCS;APPL2;WNK1;BBS1;ATXN10;PDE2A;STK16;RET;DAB2IP;CASZ1;CALCOCO1;TEAD2;DDHD2;FBXO4;RNF213;PIK3C3;IFI16;SYT7;BBS5;EXOC2;PIK3R2;OSBPL5;ABTB1;DEF6;KLHL3;SNCB;ETFB;MYO9A;APBB3;BST2;ZNF687;ARHGEF17;CACNB3;PHF7;TNRC18;TNRC6C;NADK;EHBP1;TNS4;TBC1D16;DMTN;STAT2;ARFGEF2;ALMS1;WWC3;SNX1;OSBPL1A;ACVR1B;DLG4;CCDC113;TNNI2;ALOXE3;MPI;GALE;SHANK2;TNFRSF25;ZFP36L1;LMNA;GLMP;MARK4;APOLD1;IRS2;IMPA2;CEP250;HSD17B14;IVNS1ABP;ALOX15B;TKFC;PNPO;MTR;PEX1;S100A6;TRERF1;UAP1L1;ARHGEF9;ISYNA1;DCAF8;STAT6;PRDX5;PHPT1;TUB;GOLGA1;KLF8;GSTM3;TRAF5;ACSS2;DPP7;PLIN4;RANBP9;ERBB2;MPRIP;PLCB3;NUDT10;ARHGAP23;TH;ATG14;PPARG;PRKACA;DOCK6;LDLRAP1;CXXC5;FMNL3;PARD6G;UCKL1;PARN;DOCK3;UFL1;RIPK3;KLF9;PI4K2B;AIP;KCNS3;PRMT3;SNX33;CIT;EHHADH;MAP1A;SMURF1;CTNNBIP1;GCLC
17806,GO:1901987,0.997982032193926,0.00373721457560943,23,378,regulation of cell cycle phase transition,BP,GPNMB;EGFR;PKD2;XPC;BRSK1;CNTRL;MDM2;PCBP4;ZFP36L2;PIDD1;GJC2;NINL;ZNF655;CEP192;HYAL1;FBXW7;CDK5RAP3;ALMS1;TFDP2;ZFP36L1;CEP250;GPR132;PRKACA
13178,GO:0051817,0.99800800612529,0.00999476814115212,2,77,modification of morphology or physiology of other organism involved in symbiotic interaction,BP,APOE;INSR
5505,GO:0016458,0.998018968698108,0.00458474481525428,11,237,gene silencing,BP,EGFR;SCMH1;ZCCHC11;PHF2;H2AFJ;MAP2K2;AGO4;TNRC18;TNRC6C;DYDC1;PPARG
10893,GO:0044452,0.998052028951039,0.00535559972850389,7,163,nucleolar part,CC,MAP3K14;TFCP2L1;B3GNT9;SESN1;PAK6;RSAD2;IP6K2
5915,GO:0018193,0.998056751751738,0.00282562475540569,74,940,peptidyl-amino acid modification,BP,EGFR;CAPRIN2;ASH2L;SFRP1;EPHB2;DGKQ;KDM3A;CAMKK1;ST6GALNAC2;CSPG4;KITLG;ZDHHC1;NOS1;CRTAP;FKBP5;CNTRL;MDM2;ST6GALNAC6;FKBP9;RAPGEF3;UNC119;SNTA1;PSKH1;ULK1;TPGS1;MAP2K5;JARID2;INSR;ST3GAL5;TTN;CBLC;RTF1;RICTOR;MAP2K2;PTK6;KDM4C;CTF1;MAP3K12;ZDHHC12;CDK5R1;ATRX;NKTR;HMG20B;ERCC6;SPRY2;MLXIPL;FBXW7;ING4;METTL21A;WNK1;STK16;RET;RWDD3;FGFR4;SETD4;AREG;RPS6KA5;DPY19L2P2;DMTN;PHF1;GOLGA7B;ACVR1B;DLG4;WEE1;DYDC1;IL11;KAT2B;ERN1;ERBB2;ZDHHC24;KMT5C;PRKACA;PRMT3;TTLL1
13026,GO:0051536,0.998079176541553,0.0146066500919148,1,61,iron-sulfur cluster binding,MF,RSAD2
13030,GO:0051540,0.998079176541553,0.0146066500919148,1,61,metal cluster binding,MF,RSAD2
15411,GO:0071705,0.998085290759973,0.00254839368202447,141,1702,nitrogen compound transport,BP,POSTN;ITGB6;SREBF1;APOE;LMF1;EGFR;SRSF5;SFRP1;GLUD1;TMEM129;EVI5L;MVB12B;UNC119B;ZDHHC1;VAMP3;REEP2;NSG1;RAB43;RAB40B;NOS1;FERMT1;AP5Z1;MICALL1;TBC1D8;VPS11;SLC29A4;ITPR3;MDM2;LTBP4;SYTL1;RAPGEF3;AP1G2;F2R;HPS4;CLTCL1;TRPV4;FLOT1;TOM1L2;NLGN2;ANK3;ATG16L2;RHBDF1;PER2;UNC119;C5;GLI3;LRSAM1;VAMP2;NMU;TRAK1;NISCH;TST;TTN;VPS39;PGAP1;TM7SF3;BMP6;PEX10;TCIRG1;MICALL2;ARHGAP33;ARRDC1;PLA2G6;PEX7;BBS2;TXNIP;ATP6V0A2;IDH2;IFI27;OSCP1;TNFRSF21;ZDHHC12;CDK5R1;CA2;HOOK2;HFE;CYBA;HADH;WASH3P;RAB11FIP3;FBXW7;PFKFB2;CHMP1B;ASTN2;MX2;RPH3AL;SLC2A1;NLRP1;GLUL;TBC1D17;SLC38A4;LRP1;TSNARE1;SLC48A1;BBS1;PDE2A;OLFM2;PIK3C3;SYT7;BBS5;EXOC2;PIK3R2;SNX21;EHBP1;TBC1D16;TMCO6;DMTN;SGSM2;ARFGEF2;RASL10B;SLC36A4;SNX1;GOLGA7B;NECAB3;RSAD2;ZFP36L1;IRS2;ANO1;ALOX15B;ZMAT3;PEX1;SCG5;PHPT1;SLC43A1;ERBB2;SYNGR1;GPR68;ZDHHC24;AKAP6;TH;PPARG;NPAP1;PLTP;AIP;COG1;KCNS3;LONP2;SNX33;SMURF1;PEMT;SERINC3
2442,GO:0005643,0.998100478449117,0.00959236067367435,2,76,nuclear pore,CC,MX2;NPAP1
60,GO:0000123,0.998115523516641,0.00950899655850795,2,79,histone acetyltransferase complex,CC,ING4;KAT2B
18087,GO:1902749,0.998126439461692,0.00468645637323928,9,195,regulation of cell cycle G2/M phase transition,BP,BRSK1;CNTRL;NINL;CEP192;CDK5RAP3;ALMS1;CEP250;GPR132;PRKACA
2971,GO:0006511,0.998144154946084,0.00311754927349846,35,515,ubiquitin-dependent protein catabolic process,BP,TNFAIP3;FBXW4;TMEM129;RBCK1;CUL9;UBXN4;MVB12B;CUL7;MAGEF1;BTBD2;RNF187;MDM2;SPSB3;RNF165;WWTR1;CBLC;GID4;SQSTM1;SHARPIN;ARRDC1;HFE;FBXO2;FBXW7;C17ORF97;FBXW5;ATE1;FBXO4;RNF213;ABTB1;KLHL3;PANO1;MAN1B1;UFL1;SMURF1;GCLC
11818,GO:0046782,0.998187987092381,0.0139075145875378,1,60,regulation of viral transcription,BP,NELFCD
9593,GO:0036464,0.998213393223542,0.00494922509968413,7,161,cytoplasmic ribonucleoprotein granule,CC,CIRBP;APOBEC3C;BTBD2;SQSTM1;AGO4;XRN1;ZFP36L1
10609,GO:0043620,0.998223389447732,0.00723609359606081,3,106,regulation of DNA-templated transcription in response to stress,BP,IMPACT;HSF4;CHD6
9790,GO:0040029,0.998272329922715,0.00364530573197898,15,290,regulation of gene expression, epigenetic,BP,EGFR;ZCCHC11;PHF2;JARID2;H2AFJ;MAP2K2;AGO4;ERCC6;IFI16;TNRC18;TNRC6C;PHF1;DYDC1;KAT2B;PPARG
903,GO:0002285,0.998356018034428,0.00677619632038864,3,97,lymphocyte activation involved in immune response,BP,ZFPM1;STAT6;RORA
11125,GO:0045184,0.998388074828225,0.00217775647022077,129,1583,establishment of protein localization,BP,TNFAIP3;POSTN;ITGB6;SREBF1;APOE;LMF1;EGFR;SRSF5;SFRP1;GLUD1;TMEM129;EVI5L;MVB12B;UNC119B;ZDHHC1;VAMP3;REEP2;NSG1;RAB43;RAB40B;FERMT1;AP5Z1;MICALL1;TBC1D8;VPS11;ITPR3;MDM2;SYTL1;RAPGEF3;AP1G2;F2R;HPS4;CLTCL1;TRPV4;TOM1L2;NLGN2;ANK3;ATG16L2;RHBDF1;PER2;UNC119;C5;ITGA2;GLI3;LRSAM1;VAMP2;NMU;TRAK1;TTN;VPS39;PGAP1;TM7SF3;BMP6;PEX10;TCIRG1;MICALL2;ARHGAP33;ARRDC1;PLA2G6;PEX7;BBS2;TXNIP;ATP6V0A2;IDH2;IFI27;OSCP1;TNFRSF21;ZDHHC12;CDK5R1;HOOK2;HFE;HADH;WASH3P;RAB11FIP3;FBXW7;PFKFB2;CHMP1B;ASTN2;MX2;RPH3AL;SLC2A1;NLRP1;GLUL;TBC1D17;LRP1;TSNARE1;BBS1;PDE2A;OLFM2;PIK3C3;SYT7;BBS5;EXOC2;PIK3R2;SNX21;EHBP1;TBC1D16;TMCO6;DMTN;SGSM2;ARFGEF2;TFDP2;SNX1;GOLGA7B;NECAB3;DLG4;RSAD2;IRS2;ANO1;ALOX15B;ZMAT3;PEX1;SCG5;PHPT1;ERBB2;SYNGR1;GPR68;ZDHHC24;AKAP6;PPARG;NPAP1;AIP;COG1;KCNS3;LONP2;SNX33;SMURF1;NPNT;PEMT
10620,GO:0043632,0.99845330686338,0.00260215958307573,36,532,modification-dependent macromolecule catabolic process,BP,TNFAIP3;FBXW4;TMEM129;RBCK1;CUL9;UBXN4;ISG15;MVB12B;CUL7;MAGEF1;BTBD2;RNF187;MDM2;SPSB3;RNF165;WWTR1;CBLC;GID4;SQSTM1;SHARPIN;ARRDC1;HFE;FBXO2;FBXW7;C17ORF97;FBXW5;ATE1;FBXO4;RNF213;ABTB1;KLHL3;PANO1;MAN1B1;UFL1;SMURF1;GCLC
1341,GO:0003206,0.998472942146287,0.00791795854282081,2,76,cardiac chamber morphogenesis,BP,ZFPM1;MDM2
8255,GO:0033047,0.998486796926615,0.0119190613829267,1,60,regulation of mitotic sister chromatid segregation,BP,ATRX
10999,GO:0044839,0.998499229226208,0.00344076075079124,12,239,cell cycle G2/M phase transition,BP,BRSK1;CNTRL;NINL;CDK14;CEP192;CDK5RAP3;ALMS1;WEE1;CEP250;GPR132;PRKACA;CIT
10675,GO:0043967,0.998508324760726,0.011783030580042,1,59,histone H4 acetylation,BP,ING4
4531,GO:0010605,0.998512118763619,0.00195400400981934,168,2012,negative regulation of macromolecule metabolic process,BP,TNFAIP3;HES2;SERPINE2;TP53INP1;IFI6;SREBF1;APOE;INPP5D;EGFR;CIRBP;CAPRIN2;MNT;TRIM22;SFRP1;EPHB2;DGKQ;KDM3A;TSC22D3;UNK;HR;ISG15;ELFN2;TFCP2L1;ZFPM1;IRF2BPL;STAT1;IMPACT;CAMK2N1;CRY2;CRY1;SCMH1;CRTAP;MAGEF1;NFATC4;FERMT1;HSF4;COL7A1;SPOCK1;EAPP;MDM2;PHACTR3;TCF25;PCBP4;FLRT3;RGS2;PDCD4;SERPINB5;RTN4RL1;ZFP36L2;TRPV4;GLI2;LAMP3;SLX1A;SLX1B;ZCCHC11;PER2;C5;ZNF658;SNTA1;PHF2;TCEAL1;WWTR1;GLI3;THRAP3;BHLHE40;NAIP;MAP2K5;ZNF318;TCFL5;JARID2;CCDC85B;CBLC;MXD4;CD109;RTF1;H2AFJ;BMP6;MAP2K2;SQSTM1;PTK6;KDM4C;ZNF608;CST3;BBS2;TXNIP;PLAG1;RCOR2;IFI27;CDK5R1;ATRX;HFE;HMG20B;AGO4;SLIT3;SPRY2;XRN1;MLXIPL;FBXW7;ING4;CDK5RAP3;ATXN1;NFIX;TFPI2;MXI1;THRA;ADARB1;IKZF4;ACACB;NAB2;PEG3;SALL2;WNK1;ZBTB20;PDE2A;MAF;ZMYND8;DAB2IP;TSHZ2;IFI16;PIK3R2;RPS6KA5;BST2;VDR;TNRC18;TNRC6C;SIX5;PPP1R2;DMTN;PPP1R35;WWC3;PHF1;TFDP2;NRARP;ACVR1B;DLG4;PANO1;ZNF91;DYDC1;TCF7;ZFP36L1;KAT2B;ERN1;RAD50;ANGEL2;PBLD;STAT6;PCSK1N;PRDX5;NELFCD;KLF8;RANBP9;PTPN3;ATG14;PPARG;CXXC5;SERPING1;PARN;UFL1;PRMT3;ZFP90;PER3;FOXP2;PTBP2;ZC3H6;HIVEP1;CTNNBIP1;GCLC;ECM1
686,GO:0001906,0.99855414665618,0.0113974594057723,1,68,cell killing,BP,RIPK3
12832,GO:0051170,0.998587205194521,0.00461012825606428,5,133,import into nucleus,BP,GLI3;TXNIP;PDE2A;TMCO6;NPAP1
7596,GO:0031984,0.998593739655818,0.00196718877324333,102,1271,organelle subcompartment,CC,TGFBI;POSTN;SREBF1;GPSM1;LMF1;EGFR;PKD2;TMEM129;SULF2;UBXN4;ST6GALNAC2;VAMP3;REEP2;SRD5A3;NSG1;KDSR;RAB43;NOS1;B4GALNT4;SCARA3;CYP26B1;COL7A1;ITPR3;ST6GALNAC6;GOLGA8A;HLA-B;UGT1A3;CERS4;CYP3A5;FLRT3;GAL3ST4;B4GALT6;AP1G2;CLTCL1;TMC6;MAPK8IP3;GOLGA8B;G6PC3;RHBDF1;PTGS1;PSKH1;MBOAT2;ASAP2;ULK1;SPPL2B;VAMP2;ST3GAL5;MGST2;PGAP1;B4GALT2;KIAA0319L;B3GNT9;MALL;PLD3;TREX1;LPIN3;MCTP1;PIGZ;CYBA;ANKRD28;RNF170;ARAP1;GOLGA8N;SLC2A1;REEP4;NDST2;HLA-A;PMEL;JPH2;SLC37A2;RETSAT;OSBPL5;AREG;TMEM203;ARFGEF2;LMTK3;GOLGA7B;NECAB3;ESYT2;RSAD2;XYLT1;CLSTN3;ACSL1;ERN1;MAN1B1;DHRS4;FAAH;CERS5;PCSK1N;GOLGA1;CPT1C;GOLGB1;AKAP6;ATG14;GCNT4;SYNE2;UFL1;PI4K2B;COG1;CIT;PEMT;SERINC3
2504,GO:0005758,0.998608532705328,0.0110078951373966,1,71,mitochondrial intermembrane space,CC,TXNIP
17258,GO:0140014,0.998687099267984,0.00296066021923066,13,238,mitotic nuclear division,BP,OBSL1;CUL9;CUL7;TUBGCP5;TOM1L2;NAIP;INSR;TTN;CEP192;CENPC;ATRX;CHMP1B;FBXW5
3204,GO:0006839,0.998726470731653,0.00294783113590314,12,249,mitochondrial transport,BP,SREBF1;CPT2;VPS11;HPS4;TST;MICALL2;OSCP1;FBXW7;ACACB;TFDP2;AIP;PEMT
8647,GO:0034212,0.998735011046199,0.0102182063744305,1,60,peptide N-acetyltransferase activity,MF,KAT2B
6067,GO:0019219,0.998737246231271,0.00158273921211695,296,3269,regulation of nucleobase-containing compound metabolic process,BP,TNFAIP3;HES2;ZSCAN18;TSC22D1;SIK1;TP53INP1;PTHLH;SREBF1;APOE;OAS2;MN1;EGFR;CIRBP;PKD2;CAPRIN2;MNT;ASH2L;TRIM22;SRSF5;SFRP1;PERM1;SEC14L2;DGKQ;PIK3R1;RBCK1;KDM3A;TSC22D3;POU3F1;HR;HTRA1;TFCP2L1;RGMA;ZFPM1;KITLG;HOXC5;ZNF362;CITED4;IRF2BPL;MC1R;ZNF266;STAT1;IMPACT;CRY2;THAP8;NOS1;ZNF704;HOXA3;CRY1;ZNF699;MAML3;ZFP41;SCMH1;KLF13;MAGEF1;NFATC4;ZNF783;RNF187;HSF4;ZNF251;EAPP;MDM2;CRTC1;NDN;ZNF662;NEO1;RAPGEF3;ZNF414;TCF25;PCBP4;POLH;OAS1;MLLT6;F2R;PDCD4;ZNF160;ZFP36L2;TRPV4;GLI2;ADORA2B;KLF7;RNF165;TCEA2;ZNF76;SOX12;PIDD1;SLX1A;SLX1B;ZNF747;PER2;ZNF658;PHF2;ABHD14B;TCEAL1;WWTR1;GLI3;THRAP3;ZNF558;IRX4;SMARCA1;BHLHE40;ZNF655;ZNF333;MAP2K5;ITGA6;ZNF318;LZTS1;TCFL5;TRAK1;JARID2;NUPR1;INSR;CCDC85B;CHD3;ZNF18;AHNAK2;MXD4;ZNF287;PMS2P3;ZNF446;ZNF581;ENDOG;RTF1;MDK;IRF9;H2AFJ;BMP6;NLRX1;MAP2K2;GLI4;SQSTM1;FZD7;ETV5;DLX3;HEXB;KDM4C;METTL23;ZNF608;CST3;GDF15;TXNIP;TCF4;NPHP3;PLAG1;RCOR2;WRN;IFI27;LPIN3;CDK5R1;ATRX;MAPK10;HFE;ADIRF;HMG20B;TRIM38;ERCC6;EDA2R;MEF2D;GABBR1;CREBRF;XRN1;MLXIPL;TARBP1;FBXW7;GPR87;ING4;CDK5RAP3;ZNF862;ATXN1;LMO2;NFIX;PAK6;CARF;MXI1;PFKFB2;THRA;RAI1;ELF1;IKZF4;ZBTB34;ZNF627;DBP;NAB2;EPM2AIP1;PEG3;RFX2;ZNF554;SALL2;ZNF107;ZNF532;ZBTB20;PDE2A;ZNF334;MAF;STK16;LTB4R2;RET;ZMYND8;PRX;DAB2IP;CASZ1;RWDD3;CALCOCO1;TEAD2;MYSM1;FBXO4;TSHZ2;ZNF276;IFI16;FGFR4;PIK3R2;TEF;ZNF25;AREG;RPS6KA5;APBB3;ZNF630;BTG1;ZNF687;VDR;MAMSTR;TNRC18;TNRC6C;ZFP28;PLXND1;ZMYM3;SIX5;HLTF;PCSK6;ZNF789;ZNF563;ZNF517;STAT2;WWC3;PHF1;ZNF292;TFDP2;NRARP;ACVR1B;ZNF737;TNNI2;ZNF701;NAT14;TCEAL4;ZNF91;DYDC1;GTF2IRD2;TCF7;ZFP36L1;GLMP;IL11;KAT2B;ERN1;RNF141;IVNS1ABP;RAD50;ZNF439;ANGEL2;TRERF1;APBB2;STAT6;SOX13;PRDX5;NELFCD;KLF8;CHD6;TRAF5;GOLGB1;HDAC11;ERBB2;ABCA2;KMT5C;RORA;PPARG;CXXC5;ZNF572;ZNF658B;PARN;ZNF529;UFL1;RIPK3;KLF9;AIP;SCAND1;PRMT3;ZFP90;PER3;ZFP30;FOXP2;PTBP2;ZC3H6;HIVEP1;SMURF1;NPNT;CTNNBIP1;GCLC;ECM1
2485,GO:0005730,0.998793887814657,0.00184565911410824,60,836,nucleolus,CC,CIRBP;XPC;CPT2;RBM3;SRSF5;PCDH1;MAP3K14;TFCP2L1;STAT1;ITPR3;MDM2;DDX59;CTSV;RGS2;GLI2;SPG11;ZCCHC11;PER2;PHF2;ABHD14B;ZNF655;CHD3;POLD4;NSUN5P2;PNMA1;RTF1;PDK1;H1FX;B3GNT9;WRN;PODXL;SESN1;ERCC6;CTSB;FBXW7;CDK5RAP3;ATXN1;PAK6;CARF;MXI1;ADARB1;MIF4GD;CAPG;RGS12;CENPH;ZNF554;SDHA;RNF213;IFI16;SETD4;ABTB1;HLTF;IQSEC1;PANO1;WEE1;RSAD2;ZMAT3;TRERF1;PARN;IP6K2
342,GO:0000956,0.99879398821154,0.00342331683712154,7,200,nuclear-transcribed mRNA catabolic process,BP,ZFP36L2;ZCCHC11;THRAP3;XRN1;TNRC6C;ZFP36L1;PARN
11384,GO:0045787,0.998813919195755,0.00246523659687982,17,302,positive regulation of cell cycle,BP,EGFR;PKD2;OR2A4;MDM2;PCBP4;PIDD1;INSR;RAB11FIP4;PTK6;HYAL1;CDK5R1;ATRX;MLXIPL;DAB2IP;TFDP2;PRKACA;CIT
5991,GO:0018995,0.998849588099823,0.00940775834569799,1,61,host,CC,MVB12B
10632,GO:0043657,0.998849588099823,0.00940775834569799,1,61,host cell,CC,MVB12B
10755,GO:0044215,0.998849588099823,0.00940775834569799,1,61,other organism,CC,MVB12B
10756,GO:0044216,0.998849588099823,0.00940775834569799,1,61,other organism cell,CC,MVB12B
10757,GO:0044217,0.998849588099823,0.00940775834569799,1,61,other organism part,CC,MVB12B
3298,GO:0006996,0.998857527368341,0.00144243931298319,275,3090,organelle organization,BP,SERPINE2;ULK2;DDB2;TP53INP1;MAP6;IFI6;SREBF1;APOE;ALS2CL;HSPA2;ESPN;CIRBP;PKD2;XPC;SYT8;ASH2L;DIXDC1;SFRP1;OBSL1;MTHFR;EPS8L2;GLUD1;PIK3R1;EVI5L;BRSK1;KDM3A;CUL9;VAV3;HR;SPATA18;UNC119B;PI4KAP2;ZFPM1;CUL7;VAMP3;REEP2;ASAP3;OR2A4;KRT15;ITGB5;RAB43;NOS1;SCMH1;IQSEC2;HMGCL;H1F0;CYP26B1;GAA;HSF4;CNTRL;TBC1D8;PLXNB1;VPS11;COL7A1;NAGLU;MLH3;OBSCN;GOLGA8A;TNFSF10;MYH11;PARVB;SYTL1;TNXB;RHOBTB2;RAPGEF3;CTSV;NUDCD3;RGS2;ARPIN;F2R;PPL;C2CD4C;HPS4;BLOC1S4;SPTB;DNAH1;NEK9;TUBGCP5;TRPV4;TOM1L2;NLGN2;CORO6;ANK3;GOLGA8B;SLX1A;SLX1B;ATG16L2;SPG11;ARHGEF19;PER2;UNC119;WIPF1;MINK1;PHF2;NINL;WWTR1;SYT15;ULK1;FHOD3;TPGS1;SMARCA1;LRSAM1;VAMP2;NAIP;GAS8;TRAK1;JARID2;NISCH;INSR;CELSR1;GSN;CEP68;CHD3;BAIAP2;TTN;CEP126;SUN1;PLEKHH2;TRIOBP;POLD4;RMI2;SEPT6;VPS39;RTF1;BLOC1S3;RICTOR;H2AFJ;PEX10;TCIRG1;MICALL2;MAP2K2;SQSTM1;CEP192;EPB41L3;SHARPIN;HEXB;KDM4C;H1FX;WHAMMP3;CENPC;PLA2G6;PEX7;BBS2;ATP6V0A2;PEX11B;NPHP3;IDH2;MAP3K12;WRN;SEPT5;OSCP1;DNM1;IQCB1;KLHL24;CDK5R1;ATRX;REC8;PI4KAP1;HOOK2;EPB41L4A;SHANK3;HMG20B;AGO4;RRM2B;KRT14;HLCS;SPRY2;WASH3P;IFT140;XRN1;FBXW7;ANKRD28;ING4;PAK6;DZIP1L;CHMP1B;APC2;ARAP1;GOLGA8N;FMNL2;MX2;REEP4;TBC1D17;FBXW5;CAPG;TSPYL4;LRP1;TSNARE1;NPHP4;CCDC136;SYNPO2;CENPH;RFX2;PMEL;BBS1;ATXN10;ZMYND8;MYSM1;DDHD2;SHROOM2;FBXO4;PIK3C3;SYT7;BBS5;AREG;RPS6KA5;BST2;ARHGEF17;TNRC18;EFS;BBS10;ZMYM3;HLTF;TMEM80;TBC1D16;NDUFV3;EML3;DMTN;STAT2;SGSM2;ARFGEF2;ALMS1;PHF1;TMEM231;TFDP2;SNX1;SHROOM4;TACC1;PRIMPOL;CCDC88B;DLG4;CCDC113;IQSEC1;WEE1;DYDC1;PTK7;SHANK2;LMNA;TOP3B;KAT2B;MARK4;TEP1;CEP250;RAD50;PEX1;TTC19;PHPT1;CHD6;NAP1L5;GOLGB1;ACSS2;RANBP9;HDAC11;KMT5C;ATG14;SSH3;PRKACA;FMNL3;SYNE2;PARN;DDX12P;PI4K2B;AIP;COG1;LONP2;PRMT3;SNX33;CIT;MSH5;MAP1A;SMURF1;TTLL1;EML2;PEMT;GCLC
14769,GO:0070498,0.998914688970937,0.00580397474665181,2,93,interleukin-1-mediated signaling pathway,BP,SQSTM1;RPS6KA5
4482,GO:0010507,0.998928103074018,0.00885823692161506,1,60,negative regulation of autophagy,BP,LZTS1
11871,GO:0046902,0.998936395756166,0.00875842280714486,1,66,regulation of mitochondrial membrane permeability,BP,TFDP2
672,GO:0001883,0.998938187551384,0.0023088729894194,15,283,purine nucleoside binding,MF,IFI44L;GLUD1;RAB43;RAB40B;RHOBTB2;INSR;SEPT6;SEPT5;DNM1;OARD1;MX2;ARL11;RASL10B;SCG5;SUCLG2
10895,GO:0044454,0.998957748886591,0.00189308799287811,28,463,nuclear chromosome part,CC,HSPA2;SYN1;ASH2L;STAT1;H1F0;MLH3;SLX1A;SLX1B;SMARCA1;CHD3;POLD4;ETAA1;H2AFJ;KDM4C;CENPC;TCF4;ATRX;REC8;MEF2D;APPL2;SALL2;CALCOCO1;ERCC5;TCF7;RAD50;STAT6;KMT5C;MSH5
6924,GO:0030532,0.998991296788585,0.00834906373449578,1,69,small nuclear ribonucleoprotein complex,CC,TEP1
8825,GO:0034622,0.999007594399213,0.00152314940183342,61,880,cellular protein-containing complex assembly,BP,DDB2;CIRBP;XPC;SRSF5;OBSL1;EPS8L2;DGKQ;VAMP3;NSG1;PSMG4;H1F0;VPS11;MYH11;RGS2;ARPIN;SPTB;DNAH1;TUBGCP5;CLTCL1;TRPV4;SOX12;WIPF1;FHOD3;GSN;BAIAP2;TTN;TRIOBP;SEPT6;PILRB;RICTOR;TCIRG1;MICALL2;CEP192;H1FX;WHAMMP3;CENPC;TCF4;ATP6V0A2;SEPT5;DNM1;CDK5R1;ATRX;CYBA;AGO4;WASH3P;THRA;MX2;CAPG;TSPYL4;CENPH;ERCC5;EXOC2;BBS10;NDUFV3;DMTN;DMXL2;TTC19;NAP1L5;RANBP9;PTBP2;EML2
10780,GO:0044265,0.999038382575066,0.00144223262873279,70,962,cellular macromolecule catabolic process,BP,TNFAIP3;APOE;OAS2;FBXW4;CIRBP;CTSO;TMEM129;ADAMTS7;RBCK1;CUL9;UBXN4;ISG15;MVB12B;SPATA18;CUL7;MAGEF1;BTBD2;RNF187;H1F0;VPS11;MDM2;SPSB3;PCBP4;CTSV;ZFP36L2;RNF165;LAMP3;ZCCHC11;RHBDF1;FBXO44;WWTR1;THRAP3;CBLC;CTSF;ENDOG;GID4;TCIRG1;SQSTM1;SHARPIN;ARRDC1;CST3;HFE;AGO4;FBXO2;XRN1;CTSB;FBXW7;CDK5RAP3;C17ORF97;FBXW5;LRP1;ATE1;DAB2IP;FBXO4;RNF213;ABTB1;KLHL3;TNRC6C;PANO1;ZFP36L1;ERN1;ANGEL2;MAN1B1;SGSH;PRKACA;PARN;UFL1;LONP2;SMURF1;GCLC
5583,GO:0016604,0.999049443276815,0.00154665910094145,46,649,nuclear body,CC,TP53INP1;TRIM22;SRSF5;DGKQ;HR;CRY2;MAML3;NFATC4;H1F0;AP5Z1;HSF4;MDM2;CRTC1;OBSCN;GLI2;PSKH1;WWTR1;GLI3;THRAP3;BHLHE40;PLEKHH2;RMI2;SQSTM1;PTK6;FNBP4;UBOX5;NSMCE4A;CENPC;KLHDC2;PLAG1;WRN;ATRX;HMG20B;AGO4;CREBRF;IKZF4;ZBTB20;IFI16;PHF7;STK19;TCF7;LMNA;ANGEL2;RAPGEF5;PRKACA;HIVEP1
5673,GO:0016787,0.999057038171142,0.00126504400943438,153,1822,hydrolase activity,MF,TNFAIP3;NPEPL1;CES2;NT5E;INPP5D;ADAM19;DDX60;HSPA2;PTPRS;APOBEC3C;PLCD3;CTSO;SFRP1;KIF26B;BPHL;ADAMTS7;SULF2;H6PD;HTRA1;WDR63;RAB43;RAB40B;GAA;NAGLU;PLCD1;MLH3;DDX59;PPP2R2C;TYSND1;IDUA;MYH11;RHOBTB2;ACOT1;ENDOD1;HAGHL;CTSV;NLGN4Y;KIF26A;CAPN7;DNAH1;ARSI;NLGN2;DHX32;ADAMTS13;PLCH2;SLX1A;SLX1B;G6PC3;RHBDF1;HEXA;ARSD;ABHD14B;SPPL2B;PCSK1;SMARCA1;CES3;MMP1;MMP28;CHD3;RNPEPL1;CTSF;PGLS;PMS2P3;SEPT6;DHX58;ENDOG;PGAP1;CASP14;TCIRG1;OPLAH;AKR7A2;HEXB;HYAL1;CLCA2;PLA2G6;CAPNS2;THSD4;ATP6V0A2;WRN;SEPT5;DNM1;MCM9;MACROD1;PLD3;TREX1;LPIN3;OARD1;ABHD14A;ATRX;CA2;HMG20B;ERCC6;XRN1;CTSB;KLK5;NUDT6;PFKFB2;ADARB1;MX2;C1RL;LACTB2;TNS2;NDST2;ACP5;MPG;PLA2G7;RNPEP;MYO3B;HEXDC;PDE2A;MYSM1;DDHD2;RNF213;ERCC5;MYO9A;NUDT8;HLTF;PCSK6;MPPE1;FAHD2B;RASL10B;PPP2R3B;ENDOU;DQX1;IMPA2;MBLAC2;ERN1;RAD50;MAN1B1;PEX1;FAAH;SGSH;MYH16;PHPT1;SMPDL3B;KIF7;GLB1;CHD6;DPP7;HDAC11;PTPN3;CTSD;PLCB3;NUDT10;PPM1M;ABCA2;SSH3;ACOT2;PARN;DDX12P;LONP2;MSH5;ABCA11P
12873,GO:0051234,0.99908374697019,0.00115228277823801,307,3427,establishment of localization,BP,TNFAIP3;POSTN;ITGB6;SERPINE2;SIK1;SREBF1;PYGB;APOE;OAS2;LMF1;HSPA2;EGFR;PKD2;SYT8;CXCR1;CPT2;SYN1;SRSF5;SFRP1;EPHB2;GLUD1;TMEM129;PIK3R1;EVI5L;BRSK1;ORAI3;TSC22D3;VAV3;MVB12B;UNC119B;KCNAB2;ZDHHC1;VAMP3;NAPRT;REEP2;KCNJ15;ASAP3;CRY2;NSG1;SLC16A5;GJD3;RAB43;RAB40B;NOS1;CRY1;PITPNM3;SCARA3;FERMT1;GAA;AP5Z1;MICALL1;TBC1D8;VPS11;COL7A1;KCNC4;SLC29A4;ITPR3;MDM2;FCGRT;LTBP4;HGSNAT;SYTL1;NDUFA4L2;ACTR1B;RAPGEF3;ENDOD1;NLGN4Y;KIF26A;AP1G2;TMEM63C;ACAP3;F2R;C2CD4C;HPS4;BLOC1S4;SPTB;SLC24A1;CLTCL1;TRPV4;TMC6;FLOT1;AGAP4;TOM1L2;NLGN2;ADORA2B;ANK3;MAPK8IP3;SLC13A5;RIMS3;G6PC3;ATG16L2;SPG11;GJC2;RHBDF1;PER2;PITPNM2;CLCN6;UNC119;C5;WIPF1;SNTA1;MINK1;GSTM2;ASAP2;LHFPL2;ITGA2;SYT15;GLI3;LRSAM1;VAMP2;NMU;KCNJ5;TRAK1;NISCH;INSR;TST;GSN;BAIAP2;TTN;TMC7;SCNN1A;SUN1;RIN1;CD109;SCN4B;RAB11FIP4;VPS39;SLC27A1;PGAP1;TM7SF3;BLOC1S3;BMP6;NIPAL2;PEX10;SLC2A3;TCIRG1;MICALL2;MAP2K2;VEGFB;SQSTM1;SLC12A7;HEXB;CLCA2;ARHGAP33;ARRDC1;WHAMMP3;CENPC;PLA2G6;CST3;HOMER2;PEX7;BBS2;TXNIP;ATP6V0A2;IDH2;SEPT5;IFI27;OSCP1;DNM1;TNFRSF21;KLHL24;ZDHHC12;MCTP1;CDK5R1;ARHGAP27;AGAP6;ANO9;CA2;OSBPL10;HOOK2;SHANK3;HFE;SCART1;CYBA;HADH;SPRY2;MRC2;WASH3P;IFT140;AGAP7P;RAB11FIP3;CTSB;FBXW7;KCNMA1;ANKRD28;ATXN1;PGM1;PFKFB2;CHMP1B;ARAP1;ASTN2;MX2;RPH3AL;SLC2A1;ACACB;NLRP1;GPR155;GLUL;TBC1D17;SLC38A4;LRP1;TSNARE1;KCNG1;SLC48A1;APPL2;WNK1;BBS1;JPH2;PDE2A;SLC37A2;DDHD2;SHROOM2;OLFM2;PIK3C3;SYT7;BBS5;EXOC2;PIK3R2;SCN2A;OSBPL5;AREG;KLHL3;BST2;VDR;SNX21;CACNB3;EHBP1;PCSK6;MPPE1;TBC1D16;TMCO6;DMTN;ORAI2;SGSM2;ARFGEF2;RASL10B;ALMS1;SLC36A4;TFDP2;SNX1;GOLGA7B;OSBPL1A;NECAB3;CCDC88B;DLG4;ESYT2;ENDOU;NBEAL2;CD68;SLC22A15;SHANK2;RSAD2;ZFP36L1;ACSL1;IL11;APOLD1;IRS2;ANO1;METTL7A;ALOX15B;ZMAT3;PEX1;S100A6;SCG5;PHPT1;TUB;SLC43A1;GLB1;GOLGB1;DPP7;CD9;CACNB1;PTPN3;CTSD;ERBB2;SYNGR1;GPR68;ZDHHC24;ABCA2;AKAP6;SLC2A11;TH;ATG14;PPARG;PRKACA;LDLRAP1;NPAP1;C6ORF120;SYNE2;ACKR3;PLTP;SERPING1;IP6K2;NFASC;AIP;COG1;KCNS3;LONP2;SNX33;CLCN7;CALHM2;SMURF1;NPNT;PEMT;ABCA11P;SERINC3;ECM1
7954,GO:0032561,0.999087128845083,0.00200228521179017,15,285,guanyl ribonucleotide binding,MF,IFI44L;GLUD1;RAB43;RAB40B;RHOBTB2;INSR;SEPT6;SEPT5;DNM1;MX2;ARL11;PDE2A;RASL10B;SCG5;SUCLG2
12059,GO:0048024,0.999093414101418,0.0076444105883948,1,63,regulation of mRNA splicing, via spliceosome,BP,THRAP3
9301,GO:0035770,0.999113559712193,0.00259054838202737,7,170,ribonucleoprotein granule,CC,CIRBP;APOBEC3C;BTBD2;SQSTM1;AGO4;XRN1;ZFP36L1
5992,GO:0019001,0.999142417484004,0.00188766572578391,15,286,guanyl nucleotide binding,MF,IFI44L;GLUD1;RAB43;RAB40B;RHOBTB2;INSR;SEPT6;SEPT5;DNM1;MX2;ARL11;PDE2A;RASL10B;SCG5;SUCLG2
2946,GO:0006475,0.999142580639422,0.00291829591917409,5,138,internal protein amino acid acetylation,BP,NOS1;ING4;RPS6KA5;KAT2B;EHHADH
8214,GO:0032984,0.999166479030643,0.00192520358203739,13,274,protein-containing complex disassembly,BP,SPTB;TRPV4;INSR;GSN;PLEKHH2;TRIOBP;CHMP1B;APC2;FRAT1;CAPG;DMTN;ATG14;MAP1A
2875,GO:0006369,0.999218130279691,0.00669332662701945,1,69,termination of RNA polymerase II transcription,BP,SRSF5
7261,GO:0031248,0.99922695928237,0.00430406156349027,2,88,protein acetyltransferase complex,CC,ING4;KAT2B
17989,GO:1902493,0.99922695928237,0.00430406156349027,2,88,acetyltransferase complex,CC,ING4;KAT2B
7221,GO:0031124,0.999227022085991,0.00430375033056609,2,88,mRNA 3'-end processing,BP,SRSF5;ZFP36L1
4338,GO:0009892,0.999246561137292,0.000997290122006998,180,2161,negative regulation of metabolic process,BP,TNFAIP3;HES2;SERPINE2;SIK1;TP53INP1;IFI6;SREBF1;APOE;INPP5D;EGFR;CIRBP;CAPRIN2;MNT;TRIM22;SFRP1;EPHB2;DGKQ;KDM3A;TSC22D3;UNK;HR;ISG15;ELFN2;TFCP2L1;ZFPM1;IRF2BPL;STAT1;IMPACT;CAMK2N1;CRY2;CRY1;SCMH1;CRTAP;MAGEF1;NFATC4;FERMT1;HSF4;COL7A1;SPOCK1;EAPP;MDM2;PIK3IP1;PHACTR3;TCF25;PCBP4;FLRT3;RGS2;PDCD4;SERPINB5;RTN4RL1;ZFP36L2;TRPV4;GLI2;LAMP3;SLX1A;SLX1B;ZCCHC11;PER2;C5;ZNF658;SNTA1;PHF2;TCEAL1;WWTR1;GLI3;THRAP3;BHLHE40;NAIP;MAP2K5;ZNF318;LZTS1;TCFL5;JARID2;CCDC85B;CBLC;MXD4;CD109;SLC27A1;RTF1;H2AFJ;BMP6;MAP2K2;SQSTM1;CEP192;PTK6;KDM4C;ZNF608;CST3;BBS2;TXNIP;PLAG1;RCOR2;IFI27;CDK5R1;ATRX;HFE;HMG20B;AGO4;SLIT3;SPRY2;GABBR1;XRN1;MLXIPL;FBXW7;GPR87;ING4;CDK5RAP3;ATXN1;NFIX;TFPI2;MXI1;THRA;ADARB1;IKZF4;ACACB;NAB2;PEG3;ACP5;SALL2;WNK1;ZBTB20;PDE2A;MAF;LTB4R2;ZMYND8;DAB2IP;TSHZ2;IFI16;PIK3R2;RPS6KA5;BST2;VDR;TNRC18;TNRC6C;SIX5;PPP1R2;DMTN;PPP1R35;LMTK3;WWC3;PHF1;TFDP2;NRARP;ACVR1B;DLG4;PANO1;ZNF91;DYDC1;TCF7;ZFP36L1;KAT2B;IRS2;ERN1;RAD50;ANGEL2;PBLD;STAT6;PCSK1N;PRDX5;NELFCD;KLF8;RANBP9;PTPN3;SPOCD1;ATG14;PPARG;CXXC5;SERPING1;PARN;UFL1;PRMT3;ZFP90;PER3;FOXP2;PTBP2;ZC3H6;HIVEP1;CTNNBIP1;GCLC;ECM1
9325,GO:0035821,0.999260800198712,0.00412576892206394,2,93,modification of morphology or physiology of other organism,BP,APOE;INSR
4511,GO:0010564,0.999264247702014,0.00123209139893826,42,620,regulation of cell cycle process,BP,GPNMB;EGFR;PKD2;XPC;SFRP1;OBSL1;BRSK1;CUL9;CUL7;OR2A4;CNTRL;MDM2;PCBP4;ZFP36L2;TOM1L2;PIDD1;GJC2;NINL;ZNF655;INSR;RMI2;RAB11FIP4;CEP192;HYAL1;CDK5R1;ATRX;RAB11FIP3;MLXIPL;FBXW7;CDK5RAP3;CHMP1B;FBXW5;DAB2IP;PIK3C3;ALMS1;TFDP2;ZFP36L1;KAT2B;CEP250;GPR132;PRKACA;CIT
13267,GO:0051983,0.999311041072712,0.00388448932585571,2,88,regulation of chromosome segregation,BP,RMI2;ATRX
6268,GO:0019866,0.999311497813587,0.00134073142646214,23,450,organelle inner membrane,CC,CPT2;HMGCL;PRODH;NDUFA4L2;CRAT;TST;SUN1;IDH2;IFI27;HADH;BDH1;PDE2A;SDHA;LETMD1;DPY19L2P2;NDUFV3;RSAD2;NEMP2;ERN1;ECI1;TTC19;NPAP1;OCIAD2
10875,GO:0044429,0.999317141372469,0.00108158643737908,55,851,mitochondrial part,CC,CPT2;GLUD1;BPHL;DHTKD1;SPATA18;SNN;HMGCL;D2HGDH;PRODH;NDUFA4L2;FAM210B;CRAT;MLYCD;SLC27A3;ULK1;TST;ALDH4A1;TP53AIP1;NLRX1;PDK1;ALDH7A1;TXNIP;IDH2;IFI27;DNM1;HADH;ACADS;MX2;ACACB;OGDHL;TK2;LACTB2;MPG;BDH1;PDE2A;SDHA;ETFB;LETMD1;NDUFV3;PRIMPOL;AMT;RSAD2;ACSL1;ECI1;CBR4;TTC19;CCDC90B;PRDX5;CPT1C;ACSS2;ACOT2;SUCLG2;HARS2;PEMT;OCIAD2
19460,GO:1990234,0.999317465236913,0.00110413953955563,50,715,transferase complex,CC,DDB2;FBXW4;ASH2L;DCAF16;PIK3R1;RBCK1;CUL9;DHTKD1;CUL7;BTBD2;PIK3C2G;SPSB3;POLR2J2;FBXO44;ULK1;JARID2;INSR;CDK14;POLD4;RTF1;SHARPIN;NSMCE4A;ZYG11B;KLHL24;POLR2J3;FBXO2;FBXW7;ING4;DCAF10;OGDHL;FBXW5;KLHDC8B;FBXO4;PIK3C3;ERCC5;PIK3R2;ABTB1;KLHL3;PHF1;GOLGA7B;ACVR1B;DYDC1;KAT2B;ERN1;ZSWIM8;DCAF8;PHC2;KLHL29;CHD6;ATG14
851,GO:0002181,0.999330790006896,0.00579321926312217,1,85,cytoplasmic translation,BP,UNK
2972,GO:0006513,0.999345307980774,0.00575131218088298,1,65,protein monoubiquitination,BP,DDB2
671,GO:0001882,0.999370954837776,0.00140865092814341,15,291,nucleoside binding,MF,IFI44L;GLUD1;RAB43;RAB40B;RHOBTB2;INSR;SEPT6;SEPT5;DNM1;OARD1;MX2;ARL11;RASL10B;SCG5;SUCLG2
7590,GO:0031970,0.999377578079989,0.00545667792115835,1,78,organelle envelope lumen,CC,TXNIP
2388,GO:0005525,0.999381582720357,0.00141884945167174,14,278,GTP binding,MF,IFI44L;GLUD1;RAB43;RAB40B;RHOBTB2;INSR;SEPT6;SEPT5;DNM1;MX2;ARL11;RASL10B;SCG5;SUCLG2
3908,GO:0008565,0.999420831374782,0.00514536900585903,1,71,protein transporter activity,MF,LRP1
16314,GO:0090559,0.99942789664464,0.00509044756209471,1,71,regulation of membrane permeability,BP,TFDP2
17827,GO:1902036,0.99943951435238,0.00494052681194362,1,95,regulation of hematopoietic stem cell differentiation,BP,LMO2
2801,GO:0006259,0.999448913203435,0.000865559745211007,60,846,DNA metabolic process,BP,DDB2;NYNRIN;NT5E;EGFR;XPC;APOBEC3C;ISG15;KITLG;MC1R;MAGEF1;H1F0;AP5Z1;LIG1;MLH3;POLH;GLI2;SLX1A;SLX1B;SMARCA1;IGFBP4;INSR;POLD4;PMS2P3;ETAA1;RMI2;ENDOG;BMP6;NSMCE4A;CST3;WRN;MCM9;TREX1;ATRX;REC8;ERCC6;RRM2B;XRN1;FBXW7;ING4;NFIX;TK2;MPG;FBXO4;FGFR4;ERCC5;AREG;PRIMPOL;PALB2;ZNF91;PTMS;TCF7;TOP3B;TEP1;RAD50;STAT6;UVSSA;PPARG;POLM;PARN;MSH5
331,GO:0000922,0.999450701644927,0.00193792839949902,5,142,spindle pole,CC,OR2A4;TUBGCP5;UNC119;FAM110C;ALMS1
6570,GO:0022402,0.999461551384358,0.000791098787384404,88,1137,cell cycle process,BP,GPNMB;TP53INP1;HSPA2;EGFR;PKD2;XPC;SFRP1;OBSL1;BRSK1;CUL9;CUL7;OR2A4;CYP26B1;CNTRL;LIG1;MDM2;MLH3;GOLGA8A;RHOBTB2;PCBP4;CGREF1;NEK9;TUBGCP5;ZFP36L2;TOM1L2;ANK3;GOLGA8B;PIDD1;GJC2;UNC119;NINL;ZNF655;NAIP;LZTS1;INSR;CEP68;CHD3;CDK14;TTN;CEP126;SUN1;POLD4;RMI2;SEPT6;RAB11FIP4;CEP192;HYAL1;WHAMMP3;CENPC;SEPT5;CDK5R1;ATRX;REC8;AGO4;SPRY2;RAB11FIP3;MLXIPL;FBXW7;ING4;CDK5RAP3;PAK6;CHMP1B;ARAP1;GOLGA8N;REEP4;FBXW5;CENPH;BRINP1;DAB2IP;PIK3C3;ALMS1;TFDP2;ACVR1B;PPP2R3B;WEE1;ZFP36L1;LMNA;KAT2B;CEP250;ERN1;RAD50;APBB2;TTC19;GPR132;PRKACA;SNX33;CIT;MSH5
7943,GO:0032550,0.999487340425847,0.00118852386096366,14,281,purine ribonucleoside binding,MF,IFI44L;GLUD1;RAB43;RAB40B;RHOBTB2;INSR;SEPT6;SEPT5;DNM1;MX2;ARL11;RASL10B;SCG5;SUCLG2
9590,GO:0036459,0.999502808576616,0.00290426974841551,2,87,thiol-dependent ubiquitinyl hydrolase activity,MF,TNFAIP3;MYSM1
17090,GO:0101005,0.999502808576616,0.00290426974841551,2,87,ubiquitinyl hydrolase activity,MF,TNFAIP3;MYSM1
16797,GO:0098687,0.999505837091416,0.00109681069336069,16,312,chromosomal region,CC,SCMH1;PHF2;SEPT6;KDM4C;NSMCE4A;CENPC;WRN;ATRX;REC8;CENPH;ZNF276;DYDC1;KAT2B;TEP1;RAD50;KMT5C
110,GO:0000228,0.999540550533442,0.000849748741901976,30,494,nuclear chromosome,CC,HSPA2;SYN1;ASH2L;STAT1;H1F0;MLH3;SLX1A;SLX1B;SMARCA1;CHD3;TTN;POLD4;ETAA1;H2AFJ;KDM4C;CENPC;TCF4;ATRX;REC8;MEF2D;RGS12;APPL2;SALL2;CALCOCO1;ERCC5;TCF7;RAD50;STAT6;KMT5C;MSH5
17284,GO:0140101,0.999546994457605,0.00210524373341781,3,118,catalytic activity, acting on a tRNA,MF,TARBP1;DALRD3;HARS2
2892,GO:0006400,0.999558751237706,0.0040463794204318,1,74,tRNA modification,BP,TARBP1
8790,GO:0034502,0.999586758286207,0.00382488275484503,1,72,protein localization to chromosome,BP,ATRX
4527,GO:0010595,0.999601853919539,0.00370698705014356,1,70,positive regulation of endothelial cell migration,BP,SRPX2
17254,GO:0120114,0.999614287122082,0.00358419810052604,1,79,Sm-like protein family complex,CC,TEP1
7942,GO:0032549,0.99961873493921,0.000898327558302108,14,285,ribonucleoside binding,MF,IFI44L;GLUD1;RAB43;RAB40B;RHOBTB2;INSR;SEPT6;SEPT5;DNM1;MX2;ARL11;RASL10B;SCG5;SUCLG2
7293,GO:0031300,0.999620111538914,0.00137587513434809,5,154,intrinsic component of organelle membrane,CC,PTPRS;SYN1;SUN1;PEX10;PEX11B
7587,GO:0031966,0.999629299594027,0.000678519700215569,32,577,mitochondrial membrane,CC,CPT2;BPHL;SPATA18;SNN;HMGCL;PRODH;NDUFA4L2;FAM210B;CRAT;SLC27A3;ULK1;TST;NLRX1;IDH2;IFI27;DNM1;HADH;MX2;ACACB;BDH1;PDE2A;SDHA;LETMD1;NDUFV3;RSAD2;ACSL1;ECI1;TTC19;CCDC90B;CPT1C;PEMT;OCIAD2
5558,GO:0016573,0.999638283470755,0.00147347444680383,4,131,histone acetylation,BP,NOS1;ING4;RPS6KA5;KAT2B
282,GO:0000785,0.999657197984787,0.00067397739689296,25,456,chromatin,CC,ASH2L;KDM3A;HR;STAT1;H1F0;SMARCA1;CHD3;H2AFJ;KDM4C;H1FX;CENPC;TCF4;ATRX;HLCS;MEF2D;APPL2;SALL2;MAF;CALCOCO1;TNRC18;TCF7;RAD50;STAT6;PHC2;KMT5C
17616,GO:1901361,0.99966299852804,0.000614780733655272,33,571,organic cyclic compound catabolic process,BP,APOE;NT5E;OAS2;CIRBP;APOBEC3C;DHTKD1;H1F0;PRODH;RAPGEF3;PCBP4;BLVRB;ZFP36L2;ZCCHC11;SULT1E1;THRAP3;INSR;ALDH4A1;ENDOG;AGO4;XRN1;MLXIPL;PGM1;PFKFB2;OGDHL;PDE2A;TNRC6C;ZFP36L1;ERN1;HSD17B14;ANGEL2;TRERF1;NUDT10;PARN
10725,GO:0044106,0.999671988383084,0.00310029094280395,1,83,cellular amine metabolic process,BP,ALDH7A1
7220,GO:0031123,0.999680718912002,0.00153133346855049,3,119,RNA 3'-end processing,BP,SRSF5;ZCCHC11;ZFP36L1
6170,GO:0019538,0.999689043957622,0.000393239427345721,375,4203,protein metabolic process,BP,TNFAIP3;TGFBI;SERPINE2;ULK2;GPNMB;SIK1;MUC19;NPEPL1;DDB2;IFI6;SREBF1;APOE;INPP5D;FBXO41;ADAM19;LMF1;HSPA2;FBXW4;EGFR;HERC3;PTPRS;CIRBP;FAM20C;PKD2;CAPRIN2;RBM3;ASH2L;TRIM22;CTSO;SFRP1;OBSL1;MTHFR;KCTD11;EPHB2;MAP3K14;DCAF16;DGKQ;TMEM129;PIK3R1;ADAMTS7;BRSK1;RBCK1;KDM3A;CUL9;RNF135;SULF2;CAMKK1;HERC5;UBXN4;ST6GALNAC2;UNK;HR;CSPG4;ISG15;MVB12B;ELFN2;HTRA1;SPATA18;TENM4;ZFPM1;KITLG;MVD;ZDHHC1;CUL7;SRD5A3;IMPACT;CAMK2N1;CRY2;NSG1;RAB40B;NOS1;PRKACB;CRY1;CRTAP;MAGEF1;SPDYE6;D2HGDH;BTBD2;FKBP5;RNF187;HSF4;CNTRL;CDK18;VPS11;SPEG;COL7A1;SPOCK1;MDM2;ST6GALNAC6;PPP2R2C;TYSND1;LTBP4;OBSCN;IDUA;TNFSF10;FKBP9;RAPGEF3;PHACTR3;SPSB3;CTSV;FLRT3;RASA4;GAL3ST4;B4GALT6;RGS2;F2R;PDCD4;SPTB;SERPINB5;ALPK1;CAPN7;ARSI;NEK9;RTN4RL1;ZFP36L2;TRPV4;FLOT1;ADORA2B;RNF165;NAT6;ADAMTS13;LAMP3;MAPK8IP3;SPDYE5;PIDD1;PARP6;ZNF747;GJC2;RHBDF1;FBXO44;RASGEF1A;PER2;UNC119;HEXA;FRS3;C5;ARSD;SNTA1;PSKH1;MINK1;PHF2;WWTR1;ITGA2;ULK1;GLI3;SPPL2B;PCSK1;TPGS1;LRSAM1;NAIP;LTBP1;NEK8;MAP2K5;IGFBP4;MMP1;TRAK1;JARID2;NUPR1;PRR9;INSR;MMP28;GSN;CHD3;CDK14;ST3GAL5;TTN;CBLC;DDT;RNPEPL1;TRIOBP;CTSF;ZNF287;CD109;ETAA1;FBXL16;PILRB;SLC27A1;PGAP1;GID4;RTF1;CASP14;RICTOR;BMP6;B4GALT2;PEX10;TCIRG1;MAP2K2;PDK1;VEGFB;SQSTM1;PTK6;FZD7;LOXL1;SYNGAP1;SHARPIN;HEXB;KDM4C;HYAL1;CLCA2;UBOX5;ARRDC1;B3GNT9;PLA2G6;CST3;PDIK1L;CAPNS2;GDF15;CTF1;THSD4;MAP3K12;IFI27;ZYG11B;MACROD1;KLHL24;ZDHHC12;CDK5R1;ATRX;PIGZ;MAPK10;NKTR;SHANK3;HFE;HMG20B;TRIM38;DTX3;AGO4;ERCC6;HLCS;SHC2;EDA2R;SPRY2;FBXO2;XRN1;MLXIPL;CTSB;KLK5;FBXW7;ING4;CDK5RAP3;ZNF862;PAK6;TFPI2;RNF170;APC2;METTL21A;ADARB1;DCAF10;NLRP1;C1RL;TNS2;C17ORF97;MIF4GD;NDST2;NAB2;FBXW5;LRP1;KLHDC8B;ATE1;RNPEP;MAP3K6;RIMKLB;MYO3B;WNK1;STK16;RET;ZMYND8;DAB2IP;RWDD3;MYSM1;FBXO4;RNF213;PIK3C3;IFI16;DALRD3;FGFR4;PIK3R2;SETD4;AREG;ABTB1;KLHL3;ETFB;RPS6KA5;BTG1;BST2;TNRC6C;DPY19L2P2;HLTF;MARCH8;PCSK6;MPPE1;PCMTD2;STK19;PPP1R2;DMTN;PPP1R35;STAT2;LMTK3;PCMTD1;PHF1;SNX1;GOLGA7B;ACVR1B;NECAB3;DLG4;PPP2R3B;TSSK1B;ADCK5;PANO1;ENDOU;MPI;IGFBP6;WEE1;DYDC1;PTK7;TNFRSF25;ZFP36L1;XYLT1;MXRA8;ACSL1;IL11;KAT2B;MARK4;APOLD1;IRS2;ERN1;RNF141;RAD50;MAN1B1;SCYL3;SCG5;SGSH;PBLD;DCAF8;TNFSF12;PCSK1N;PRDX5;PHPT1;KLHL29;DPP7;TRIM2;RANBP9;HDAC11;PTPN3;CTSD;ERBB2;UVSSA;ZDHHC24;PQLC3;PPM1M;KMT5C;AKAP6;ATG14;SSH3;PPARG;PRKACA;LDLRAP1;GCNT4;ACKR3;SERPING1;UFL1;LAMB2;RIPK3;AIP;LONP2;PRMT3;SNX33;HARS2;CIT;EHHADH;SMURF1;NPNT;TTLL1;PEMT;GCLC;ECM1
11458,GO:0045931,0.999694077410274,0.00147567792989499,3,114,positive regulation of mitotic cell cycle,BP,MDM2;INSR;HYAL1
879,GO:0002244,0.999694847559372,0.00125148118000031,4,158,hematopoietic progenitor cell differentiation,BP,SFRP1;DHTKD1;KCNAB2;LMO2
10896,GO:0044455,0.999712639599856,0.0011822491715314,4,166,mitochondrial membrane part,CC,NDUFA4L2;BDH1;SDHA;NDUFV3
7294,GO:0031301,0.999713825999719,0.00118527199147031,4,140,integral component of organelle membrane,CC,PTPRS;SUN1;PEX10;PEX11B
5963,GO:0018393,0.999721107518807,0.0011596675901566,4,134,internal peptidyl-lysine acetylation,BP,NOS1;ING4;RPS6KA5;KAT2B
16857,GO:0098813,0.999721623193888,0.000706830862114177,12,251,nuclear chromosome segregation,BP,MLH3;TTN;SUN1;RMI2;CENPC;ATRX;REC8;AGO4;FBXW7;CHMP1B;CENPH;MSH5
5925,GO:0018205,0.999724958705833,0.000605344029614052,18,337,peptidyl-lysine modification,BP,ASH2L;KDM3A;NOS1;MDM2;JARID2;RTF1;KDM4C;ATRX;HMG20B;ING4;METTL21A;RWDD3;SETD4;RPS6KA5;PHF1;DYDC1;KAT2B;KMT5C
17666,GO:1901566,0.999734463161898,0.000382181883219157,112,1518,organonitrogen compound biosynthetic process,BP,MUC19;PTHLH;APOE;NT5E;INPP5D;GAMT;LMF1;EGFR;CIRBP;CAPRIN2;RBM3;GLUD1;ADAMTS7;DHTKD1;ST6GALNAC2;UNK;CSPG4;ZFPM1;MVD;ZDHHC1;NAPRT;SRD5A3;IMPACT;UROS;KDSR;NOS1;SDC3;CMPK2;THNSL2;NMRK1;ST6GALNAC6;CERS4;GAL3ST4;B4GALT6;RGS2;RTN4RL1;ZFP36L2;ADORA2B;ADAMTS13;PER2;HEXA;GSTM2;ITGA2;PCSK1;MAP2K5;TRAK1;GPC2;INSR;ST3GAL5;CD109;MGST2;SLC27A1;PGAP1;B4GALT2;TCIRG1;MAP2K2;OPLAH;VEGFB;ALDH7A1;HYAL1;B3GNT9;PLA2G6;ATP6V0A2;IDH2;LPIN3;ZDHHC12;PIGZ;AGO4;GABBR1;XRN1;MLXIPL;GPR87;PGM1;PFKFB2;OGDHL;TK2;GLUL;MIF4GD;NDST2;SRR;RIMKLB;PPCS;LTB4R2;PIK3C3;DALRD3;ABTB1;TNRC6C;DPY19L2P2;NADK;MPPE1;GOLGA7B;NECAB3;ALOXE3;MPI;ZFP36L1;XYLT1;PNPO;MTR;MAN1B1;CERS5;GSTM3;ERBB2;ZDHHC24;PQLC3;TH;PPARG;GCNT4;UCKL1;HARS2;PEMT;SERINC3;GCLC
12830,GO:0051168,0.999764176869596,0.000755235072897134,7,187,nuclear export,BP,SRSF5;MDM2;RAPGEF3;IFI27;ATXN1;NPAP1;SMURF1
2549,GO:0005819,0.999765220667223,0.000554246375620551,15,297,spindle,CC,HSPA2;PKD2;OR2A4;TUBGCP5;CLTCL1;UNC119;FAM110C;MAP2K5;SEPT6;RAB11FIP4;IQCB1;CAPG;ALMS1;SAC3D1;EML2
17649,GO:1901532,0.99977155310331,0.00223110896207202,1,103,regulation of hematopoietic progenitor cell differentiation,BP,LMO2
3235,GO:0006890,0.999787442281039,0.00211922091054263,1,77,retrograde vesicle-mediated transport, Golgi to ER,BP,KIF26A
10494,GO:0043412,0.999794904136615,0.000266286275839996,286,3237,macromolecule modification,BP,TNFAIP3;ULK2;GPNMB;SIK1;MUC19;DDB2;SREBF1;APOE;FBXO41;LMF1;HSPA2;FBXW4;EGFR;HERC3;PTPRS;FAM20C;PKD2;CAPRIN2;APOBEC3C;ASH2L;TRIM22;SFRP1;OBSL1;MTHFR;KCTD11;EPHB2;MAP3K14;DCAF16;DGKQ;TMEM129;PIK3R1;ADAMTS7;BRSK1;RBCK1;KDM3A;CUL9;RNF135;CAMKK1;HERC5;ST6GALNAC2;HR;CSPG4;ISG15;ELFN2;KITLG;MVD;ZDHHC1;CUL7;SRD5A3;IMPACT;CAMK2N1;CRY2;RAB40B;NOS1;PRKACB;CRY1;CRTAP;MAGEF1;SPDYE6;FKBP5;RNF187;HSF4;CNTRL;CDK18;SPEG;MDM2;ST6GALNAC6;PPP2R2C;OBSCN;FKBP9;RAPGEF3;PHACTR3;SPSB3;FLRT3;RASA4;B4GALT6;RGS2;F2R;PDCD4;SPTB;ALPK1;ARSI;NEK9;RTN4RL1;ZFP36L2;TRPV4;FLOT1;ADORA2B;RNF165;NAT6;ADAMTS13;MAPK8IP3;SPDYE5;PARP6;ZNF747;GJC2;FBXO44;RASGEF1A;PER2;UNC119;FRS3;C5;ARSD;SNTA1;PSKH1;MINK1;PHF2;WWTR1;ULK1;TPGS1;LRSAM1;NAIP;LTBP1;NEK8;MAP2K5;IGFBP4;TRAK1;JARID2;NUPR1;PRR9;INSR;CHD3;CDK14;ST3GAL5;TTN;CBLC;DDT;TRIOBP;CD109;NSUN5P2;ETAA1;FBXL16;PILRB;SLC27A1;PGAP1;GID4;RTF1;RICTOR;BMP6;B4GALT2;PEX10;MAP2K2;PDK1;VEGFB;SQSTM1;PTK6;FZD7;LOXL1;SYNGAP1;SHARPIN;KDM4C;UBOX5;ARRDC1;B3GNT9;PLA2G6;CST3;PDIK1L;GDF15;CTF1;MAP3K12;ZYG11B;MACROD1;KLHL24;ZDHHC12;CDK5R1;ATRX;PIGZ;MAPK10;NKTR;SHANK3;HFE;HMG20B;TRIM38;DTX3;ERCC6;HLCS;SHC2;EDA2R;SPRY2;FBXO2;MLXIPL;TARBP1;FBXW7;ING4;CDK5RAP3;ZNF862;PAK6;RNF170;METTL21A;ADARB1;DCAF10;TNS2;C17ORF97;NAB2;FBXW5;KLHDC8B;ATE1;MPG;MAP3K6;RIMKLB;MYO3B;WNK1;STK16;RET;ZMYND8;DAB2IP;RWDD3;MYSM1;FBXO4;RNF213;PIK3C3;FGFR4;PIK3R2;SETD4;AREG;KLHL3;ETFB;RPS6KA5;BTG1;DPY19L2P2;HLTF;MARCH8;MPPE1;PCMTD2;STK19;PPP1R2;DMTN;PPP1R35;STAT2;LMTK3;PCMTD1;PHF1;GOLGA7B;ACVR1B;DLG4;PPP2R3B;TSSK1B;ADCK5;MPI;WEE1;DYDC1;PTK7;TNFRSF25;ZFP36L1;MXRA8;ACSL1;IL11;KAT2B;MARK4;IRS2;ERN1;RNF141;RAD50;MAN1B1;SCYL3;PBLD;DCAF8;PHPT1;KLHL29;TRIM2;RANBP9;HDAC11;PTPN3;ERBB2;UVSSA;ZDHHC24;PQLC3;PPM1M;KMT5C;AKAP6;ATG14;SSH3;PRKACA;GCNT4;ACKR3;PARN;UFL1;LAMB2;RIPK3;PRMT3;CIT;EHHADH;SMURF1;NPNT;TTLL1;GCLC
12518,GO:0050684,0.999805470735179,0.00124044471095363,2,99,regulation of mRNA processing,BP,THRAP3;ZFP36L1
4198,GO:0009308,0.999805569527021,0.00194563024934217,1,88,amine metabolic process,BP,ALDH7A1
12497,GO:0050657,0.999814057079059,0.000649919797239518,6,173,nucleic acid transport,BP,SRSF5;FLOT1;TST;MX2;ZFP36L1;NPAP1
12498,GO:0050658,0.999814057079059,0.000649919797239518,6,173,RNA transport,BP,SRSF5;FLOT1;TST;MX2;ZFP36L1;NPAP1
5279,GO:0015934,0.999817602132558,0.0018190639170427,1,115,large ribosomal subunit,CC,RBM3
6229,GO:0019783,0.999817721107093,0.00117070927670628,2,97,ubiquitin-like protein-specific protease activity,MF,TNFAIP3;MYSM1
3653,GO:0008135,0.999822266607361,0.00180322771954042,1,81,translation factor activity, RNA binding,MF,ABTB1
5964,GO:0018394,0.999827442001084,0.000744198427492272,4,140,peptidyl-lysine acetylation,BP,NOS1;ING4;RPS6KA5;KAT2B
17283,GO:0140098,0.999830422954442,0.000397051805523909,16,331,catalytic activity, acting on RNA,MF,DDX59;POLR2J2;DHX32;ZCCHC11;NSUN5P2;POLR2J3;XRN1;TARBP1;LACTB2;DALRD3;PRIMPOL;ENDOU;DQX1;ERN1;PARN;HARS2
19719,GO:2000112,0.999857378655992,0.000186579313070635,281,3208,regulation of cellular macromolecule biosynthetic process,BP,TNFAIP3;HES2;ZSCAN18;TSC22D1;SIK1;TP53INP1;SREBF1;APOE;MN1;EGFR;CIRBP;PKD2;CAPRIN2;MNT;RBM3;ASH2L;TRIM22;SFRP1;PERM1;SEC14L2;DGKQ;PIK3R1;RBCK1;KDM3A;TSC22D3;POU3F1;UNK;HR;HTRA1;TFCP2L1;RGMA;ZFPM1;KITLG;HOXC5;ZNF362;CITED4;IRF2BPL;MC1R;ZNF266;STAT1;IMPACT;CRY2;THAP8;NOS1;ZNF704;HOXA3;CRY1;ZNF699;MAML3;ZFP41;SCMH1;KLF13;NFATC4;ZNF783;RNF187;HSF4;ZNF251;EAPP;MDM2;CRTC1;NDN;ZNF662;NEO1;ZNF414;TCF25;MLLT6;RGS2;F2R;PDCD4;ZNF160;ZFP36L2;TRPV4;GLI2;KLF7;RNF165;TCEA2;ZNF76;SOX12;PIDD1;ZNF747;ZCCHC11;PER2;ZNF658;PHF2;ABHD14B;TCEAL1;WWTR1;ITGA2;GLI3;THRAP3;ZNF558;IRX4;SMARCA1;BHLHE40;ZNF655;ZNF333;MAP2K5;ITGA6;ZNF318;LZTS1;TCFL5;TRAK1;JARID2;NUPR1;INSR;CCDC85B;CHD3;ZNF18;MXD4;ZNF287;PMS2P3;ZNF446;ZNF581;RTF1;MDK;IRF9;H2AFJ;BMP6;NLRX1;MAP2K2;GLI4;SQSTM1;FZD7;ETV5;DLX3;HEXB;KDM4C;METTL23;ZNF608;CST3;GDF15;TXNIP;TCF4;PLAG1;RCOR2;IFI27;LPIN3;CDK5R1;ATRX;MAPK10;HFE;ADIRF;HMG20B;TRIM38;AGO4;ERCC6;EDA2R;MEF2D;CREBRF;XRN1;MLXIPL;TARBP1;FBXW7;ING4;CDK5RAP3;ZNF862;ATXN1;LMO2;NFIX;PAK6;CARF;MXI1;THRA;RAI1;ELF1;IKZF4;ZBTB34;ZNF627;MIF4GD;DBP;NAB2;EPM2AIP1;PEG3;RFX2;ZNF554;SALL2;ZNF107;ZNF532;ZBTB20;PDE2A;ZNF334;MAF;STK16;RET;ZMYND8;DAB2IP;CASZ1;RWDD3;CALCOCO1;TEAD2;MYSM1;FBXO4;TSHZ2;ZNF276;IFI16;FGFR4;PIK3R2;TEF;ZNF25;AREG;RPS6KA5;APBB3;ZNF630;BTG1;ZNF687;VDR;MAMSTR;TNRC18;TNRC6C;ZFP28;PLXND1;ZMYM3;SIX5;HLTF;PCSK6;ZNF789;ZNF563;ZNF517;STAT2;WWC3;PHF1;ZNF292;TFDP2;NRARP;ACVR1B;ZNF737;NECAB3;TNNI2;ZNF701;NAT14;TCEAL4;ZNF91;DYDC1;GTF2IRD2;TCF7;ZFP36L1;GLMP;IL11;KAT2B;IRS2;ERN1;RNF141;IVNS1ABP;ZNF439;TRERF1;APBB2;STAT6;SOX13;PRDX5;NELFCD;KLF8;CHD6;TRAF5;GOLGB1;HDAC11;ERBB2;ABCA2;KMT5C;RORA;PPARG;CXXC5;ZNF572;ZNF658B;PARN;ZNF529;UFL1;RIPK3;KLF9;SCAND1;PRMT3;ZFP90;PER3;ZFP30;FOXP2;ZC3H6;HIVEP1;SMURF1;NPNT;CTNNBIP1;GCLC;ECM1
7309,GO:0031326,0.999858186138516,0.000184781953592502,295,3351,regulation of cellular biosynthetic process,BP,TNFAIP3;HES2;ZSCAN18;TSC22D1;SIK1;TP53INP1;PTHLH;SREBF1;APOE;INPP5D;MN1;EGFR;CIRBP;PKD2;CAPRIN2;MNT;RBM3;ASH2L;TRIM22;SFRP1;PERM1;SEC14L2;DGKQ;PIK3R1;RBCK1;KDM3A;TSC22D3;POU3F1;UNK;HR;HTRA1;TFCP2L1;RGMA;ZFPM1;KITLG;HOXC5;ZNF362;CITED4;IRF2BPL;MC1R;ZNF266;STAT1;IMPACT;CRY2;THAP8;NOS1;ZNF704;HOXA3;CRY1;ZNF699;MAML3;ZFP41;SCMH1;KLF13;NFATC4;ZNF783;RNF187;HSF4;ZNF251;EAPP;MDM2;CRTC1;NDN;ZNF662;NEO1;RAPGEF3;ZNF414;TCF25;MLLT6;RGS2;F2R;PDCD4;ZNF160;ZFP36L2;TRPV4;GLI2;ADORA2B;KLF7;RNF165;TCEA2;ZNF76;SOX12;PIDD1;ZNF747;ZCCHC11;PER2;ZNF658;PHF2;ABHD14B;TCEAL1;WWTR1;ITGA2;GLI3;THRAP3;ZNF558;IRX4;SMARCA1;BHLHE40;ZNF655;ZNF333;MAP2K5;ITGA6;ZNF318;LZTS1;TCFL5;TRAK1;JARID2;NUPR1;INSR;CCDC85B;CHD3;ZNF18;MXD4;ZNF287;PMS2P3;ZNF446;ZNF581;SLC27A1;RTF1;MDK;IRF9;H2AFJ;BMP6;NLRX1;MAP2K2;PDK1;GLI4;SQSTM1;FZD7;ETV5;DLX3;HEXB;KDM4C;METTL23;ZNF608;PLA2G6;CST3;GDF15;TXNIP;TCF4;PLAG1;RCOR2;IFI27;LPIN3;CDK5R1;ATRX;MAPK10;HFE;ADIRF;HMG20B;TRIM38;AGO4;ERCC6;EDA2R;MEF2D;GABBR1;CREBRF;XRN1;MLXIPL;TARBP1;FBXW7;GPR87;ING4;CDK5RAP3;ZNF862;ATXN1;LMO2;NFIX;PAK6;CARF;MXI1;PFKFB2;THRA;RAI1;ELF1;IKZF4;ZBTB34;ZNF627;MIF4GD;DBP;NAB2;EPM2AIP1;PEG3;ACP5;RFX2;ZNF554;SALL2;ZNF107;ZNF532;ZBTB20;PDE2A;ZNF334;MAF;STK16;LTB4R2;RET;ZMYND8;DAB2IP;CASZ1;RWDD3;CALCOCO1;TEAD2;MYSM1;FBXO4;TSHZ2;ZNF276;IFI16;FGFR4;PIK3R2;TEF;ZNF25;AREG;RPS6KA5;APBB3;ZNF630;BTG1;ZNF687;VDR;MAMSTR;TNRC18;TNRC6C;ZFP28;PLXND1;ZMYM3;SIX5;HLTF;PCSK6;ZNF789;ZNF563;ZNF517;STAT2;WWC3;PHF1;ZNF292;TFDP2;NRARP;ACVR1B;ZNF737;NECAB3;TNNI2;ZNF701;NAT14;TCEAL4;ZNF91;DYDC1;GTF2IRD2;TCF7;ZFP36L1;GLMP;IL11;KAT2B;IRS2;ERN1;RNF141;IVNS1ABP;ZNF439;TRERF1;APBB2;STAT6;SOX13;PRDX5;NELFCD;KLF8;CHD6;TRAF5;GOLGB1;HDAC11;ERBB2;ABCA2;KMT5C;RORA;PPARG;CXXC5;ZNF572;ZNF658B;PARN;ZNF529;UFL1;RIPK3;KLF9;AIP;SCAND1;PRMT3;ZFP90;PER3;ZFP30;FOXP2;ZC3H6;HIVEP1;SMURF1;NPNT;CTNNBIP1;PEMT;GCLC;ECM1
12875,GO:0051236,0.999860287987394,0.000497698369589223,6,176,establishment of RNA localization,BP,SRSF5;FLOT1;TST;MX2;ZFP36L1;NPAP1
2846,GO:0006325,0.999865158753368,0.000241014141897383,41,660,chromatin organization,BP,DDB2;SREBF1;ASH2L;MTHFR;KDM3A;HR;ZFPM1;NOS1;SCMH1;H1F0;HSF4;PER2;PHF2;SMARCA1;JARID2;CHD3;RTF1;H2AFJ;KDM4C;H1FX;CENPC;MAP3K12;ATRX;HMG20B;HLCS;ING4;TSPYL4;CENPH;ZMYND8;MYSM1;RPS6KA5;TNRC18;HLTF;PHF1;DYDC1;KAT2B;CHD6;NAP1L5;HDAC11;KMT5C;PRMT3
281,GO:0000784,0.999869271415196,0.000859562383070455,2,114,nuclear chromosome, telomeric region,CC,ATRX;RAD50
5828,GO:0017111,0.99986992150655,0.000230398338263797,43,647,nucleoside-triphosphatase activity,MF,DDX60;HSPA2;KIF26B;WDR63;RAB43;RAB40B;MLH3;DDX59;MYH11;RHOBTB2;KIF26A;DNAH1;DHX32;SMARCA1;CHD3;PMS2P3;SEPT6;DHX58;TCIRG1;ATP6V0A2;WRN;SEPT5;DNM1;MCM9;ATRX;ERCC6;MX2;MYO3B;RNF213;MYO9A;HLTF;RASL10B;DQX1;RAD50;PEX1;MYH16;KIF7;CHD6;ABCA2;DDX12P;LONP2;MSH5;ABCA11P
2491,GO:0005740,0.999881390875305,0.000224754960020936,33,617,mitochondrial envelope,CC,CPT2;BPHL;SPATA18;SNN;HMGCL;PRODH;NDUFA4L2;FAM210B;CRAT;SLC27A3;ULK1;TST;NLRX1;TXNIP;IDH2;IFI27;DNM1;HADH;MX2;ACACB;BDH1;PDE2A;SDHA;LETMD1;NDUFV3;RSAD2;ACSL1;ECI1;TTC19;CCDC90B;CPT1C;PEMT;OCIAD2
4335,GO:0009889,0.999884732946988,0.000150532006296108,299,3401,regulation of biosynthetic process,BP,TNFAIP3;HES2;ZSCAN18;TSC22D1;SIK1;TP53INP1;PTHLH;SREBF1;APOE;INPP5D;MN1;EGFR;CIRBP;PKD2;CAPRIN2;MNT;RBM3;ASH2L;TRIM22;SFRP1;PERM1;SEC14L2;DGKQ;PIK3R1;RBCK1;KDM3A;TSC22D3;POU3F1;UNK;HR;HTRA1;TFCP2L1;RGMA;ZFPM1;KITLG;HOXC5;MVD;ZNF362;CITED4;IRF2BPL;MC1R;ZNF266;STAT1;IMPACT;CRY2;THAP8;NOS1;ZNF704;HOXA3;CRY1;ZNF699;MAML3;ZFP41;SCMH1;KLF13;NFATC4;ZNF783;RNF187;HSF4;ZNF251;EAPP;MDM2;CRTC1;NDN;ZNF662;NEO1;RAPGEF3;ZNF414;TCF25;MLLT6;RGS2;F2R;PDCD4;ZNF160;ZFP36L2;TRPV4;GLI2;ADORA2B;KLF7;RNF165;TCEA2;ZNF76;SOX12;PIDD1;ZNF747;ZCCHC11;PER2;ZNF658;PHF2;ABHD14B;TCEAL1;WWTR1;ITGA2;GLI3;THRAP3;ZNF558;IRX4;SMARCA1;BHLHE40;ZNF655;ZNF333;MAP2K5;ITGA6;ZNF318;LZTS1;TCFL5;TRAK1;JARID2;NUPR1;INSR;CCDC85B;CHD3;ZNF18;MXD4;ZNF287;PMS2P3;ZNF446;ZNF581;SLC27A1;RTF1;MDK;IRF9;H2AFJ;BMP6;NLRX1;MAP2K2;PDK1;GLI4;SQSTM1;FZD7;ETV5;DLX3;HEXB;KDM4C;METTL23;ZNF608;PLA2G6;CST3;GDF15;TXNIP;TCF4;PLAG1;RCOR2;IFI27;LPIN3;CDK5R1;ATRX;MAPK10;HFE;ADIRF;HMG20B;CYBA;TRIM38;AGO4;ERCC6;EDA2R;MEF2D;GABBR1;CREBRF;XRN1;MLXIPL;TARBP1;FBXW7;GPR87;ING4;CDK5RAP3;ZNF862;ATXN1;LMO2;NFIX;PAK6;CARF;MXI1;PFKFB2;THRA;RAI1;ELF1;IKZF4;ACACB;ZBTB34;ZNF627;MIF4GD;DBP;NAB2;EPM2AIP1;PEG3;ACP5;RFX2;ZNF554;SALL2;ZNF107;ZNF532;ZBTB20;PDE2A;ZNF334;MAF;STK16;LTB4R2;RET;ZMYND8;DAB2IP;CASZ1;RWDD3;CALCOCO1;TEAD2;MYSM1;FBXO4;TSHZ2;ZNF276;IFI16;FGFR4;PIK3R2;TEF;ZNF25;AREG;RPS6KA5;APBB3;ZNF630;BTG1;ZNF687;VDR;MAMSTR;TNRC18;TNRC6C;ZFP28;PLXND1;ZMYM3;SIX5;HLTF;PCSK6;ZNF789;ZNF563;ZNF517;STAT2;WWC3;PHF1;ZNF292;TFDP2;NRARP;ACVR1B;ZNF737;NECAB3;TNNI2;ZNF701;NAT14;TCEAL4;ZNF91;DYDC1;GTF2IRD2;TCF7;ZFP36L1;GLMP;IL11;KAT2B;IRS2;ERN1;RNF141;IVNS1ABP;ZNF439;TRERF1;APBB2;STAT6;SOX13;PRDX5;NELFCD;KLF8;CHD6;TRAF5;GOLGB1;HDAC11;ERBB2;ABCA2;KMT5C;RORA;PPARG;CXXC5;ZNF572;ZNF658B;PARN;ZNF529;UFL1;RIPK3;KLF9;AIP;SCAND1;PRMT3;ZFP90;CCDC3;PER3;ZFP30;FOXP2;ZC3H6;HIVEP1;SMURF1;NPNT;CTNNBIP1;PEMT;GCLC;ECM1
10886,GO:0044445,0.999891357535014,0.000427329576308655,5,203,cytosolic part,CC,HPS4;BLOC1S4;BLOC1S3;RRM2B;NLRP1
2906,GO:0006417,0.999892214489149,0.000242818075157364,19,385,regulation of translation,BP,EGFR;CIRBP;CAPRIN2;RBM3;UNK;IMPACT;RGS2;ZFP36L2;ZCCHC11;PER2;ITGA2;MAP2K2;AGO4;XRN1;MIF4GD;TNRC6C;ZFP36L1;ERBB2;PPARG
10967,GO:0044772,0.999897666488878,0.000206903653164026,27,483,mitotic cell cycle phase transition,BP,GPNMB;EGFR;PKD2;XPC;BRSK1;CNTRL;MDM2;PCBP4;ZFP36L2;PIDD1;GJC2;NINL;ZNF655;LZTS1;CDK14;CEP192;HYAL1;CDK5RAP3;ALMS1;TFDP2;ACVR1B;WEE1;ZFP36L1;CEP250;GPR132;PRKACA;CIT
10667,GO:0043933,0.99989789715027,0.000147753175302417,125,1667,protein-containing complex subunit organization,BP,TNFAIP3;DDB2;APOE;CIRBP;PKD2;XPC;ASH2L;TRIM22;ALDH1A3;SRSF5;OBSL1;KCTD11;EPS8L2;GPX3;DGKQ;VAMP3;C1QTNF6;IMPACT;NSG1;PRKACB;HMGCL;PSMG4;H1F0;HSF4;VPS11;COL7A1;KCNC4;ITPR3;MDM2;CRTC1;KCTD18;TYSND1;HGSNAT;MYH11;TNXB;KCTD15;RGS2;ARPIN;SPTB;DNAH1;TUBGCP5;CLTCL1;TRPV4;FLOT1;SOX12;WIPF1;ULK1;FHOD3;VAMP2;MMP1;INSR;GSN;BAIAP2;TTN;PLEKHH2;TRIOBP;SEPT6;PILRB;RICTOR;TCIRG1;MICALL2;SQSTM1;CEP192;LOXL1;SHARPIN;H1FX;WHAMMP3;CENPC;TCF4;ATP6V0A2;COL6A1;PEX11B;SEPT5;DNM1;CDK5R1;ATRX;HFE;CYBA;AGO4;WASH3P;ANKRD28;CHMP1B;THRA;APC2;MX2;IKZF4;SLC2A1;ACACB;NLRP1;FRAT1;GLUL;SRR;CAPG;TSPYL4;PLA2G7;CENPH;KCNG1;ATXN10;DAB2IP;TEAD2;RNF213;ERCC5;EXOC2;AREG;BBS10;NDUFV3;DMTN;DLG4;TCF7;DMXL2;DHRS4;CBR4;TTC19;NAP1L5;RANBP9;ATG14;MPP7;PRKACA;PLTP;RIPK3;KCNS3;MAP1A;PTBP2;EML2;CTNNBIP1
13086,GO:0051641,0.999903610725482,0.000133163412796592,178,2178,cellular localization,BP,TNFAIP3;MAP6;SREBF1;APOE;LMF1;EGFR;PKD2;SYT8;CPT2;SYN1;SRSF5;OBSL1;EPHB2;TMEM129;PIK3R1;EVI5L;BRSK1;MARVELD1;MVB12B;KCNAB2;ZDHHC1;VAMP3;REEP2;NSG1;RAB43;RAB40B;NOS1;GAA;AP5Z1;CNTRL;MICALL1;TBC1D8;VPS11;COL7A1;KCNC4;ITPR3;MDM2;LZTS2;OBSCN;SYTL1;RAPGEF3;NLGN4Y;NUDCD3;AP1G2;F2R;C2CD4C;HPS4;BLOC1S4;SPTB;CLTCL1;FLOT1;TOM1L2;NLGN2;ADORA2B;ANK3;RIMS3;SPG11;PER2;WIPF1;NINL;GSTM2;SYT15;GLI3;TPGS1;LRSAM1;VAMP2;GAS8;TRAK1;CELSR1;GSN;CEP68;SUN1;SEPT6;RAB11FIP4;VPS39;PGAP1;BLOC1S3;PEX10;MICALL2;MAP2K2;SQSTM1;CEP192;ETV5;SYNGAP1;EPB41L3;WHAMMP3;CENPC;PLA2G6;PEX7;BBS2;TXNIP;WRN;SEPT5;IFI27;MALL;OSCP1;DNM1;IQCB1;ZDHHC12;MCTP1;CDK5R1;ATRX;HOOK2;SHANK3;HFE;CYBA;SPRY2;WASH3P;IFT140;RAB11FIP3;FBXW7;ANKRD28;CDK5RAP3;ATXN1;CHMP1B;ASTN2;MX2;RPH3AL;ACACB;TBC1D17;LRP1;TSNARE1;NPHP4;C12ORF66;BBS1;JPH2;PDE2A;ZMYND8;DDHD2;SHROOM2;FBXO4;PIK3C3;SYT7;BBS5;EXOC2;AREG;CACNB3;MPPE1;TBC1D16;TMCO6;DMTN;SGSM2;ALMS1;TFDP2;SNX1;GOLGA7B;CCDC88B;DLG4;ESYT2;ZFP36L1;LMNA;MARK4;CEP250;ANO1;PEX1;SCG5;PHPT1;TUB;GOLGB1;ERBB2;SYNGR1;GPR68;ZDHHC24;ABCA2;AKAP6;TH;ATG14;PRKACA;LDLRAP1;NPAP1;SYNE2;NFASC;AIP;COG1;LONP2;SNX33;SMURF1;PEMT
93,GO:0000184,0.999905674885171,0.00100719219457029,1,119,nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,BP,PARN
4503,GO:0010556,0.999910761729021,0.000117535316795755,284,3256,regulation of macromolecule biosynthetic process,BP,TNFAIP3;HES2;ZSCAN18;TSC22D1;SIK1;TP53INP1;SREBF1;APOE;INPP5D;MN1;EGFR;CIRBP;PKD2;CAPRIN2;MNT;RBM3;ASH2L;TRIM22;SFRP1;PERM1;SEC14L2;DGKQ;PIK3R1;RBCK1;KDM3A;TSC22D3;POU3F1;UNK;HR;HTRA1;TFCP2L1;RGMA;ZFPM1;KITLG;HOXC5;ZNF362;CITED4;IRF2BPL;MC1R;ZNF266;STAT1;IMPACT;CRY2;THAP8;NOS1;ZNF704;HOXA3;CRY1;ZNF699;MAML3;ZFP41;SCMH1;KLF13;NFATC4;ZNF783;RNF187;HSF4;ZNF251;EAPP;MDM2;CRTC1;NDN;ZNF662;NEO1;ZNF414;TCF25;MLLT6;RGS2;F2R;PDCD4;ZNF160;ZFP36L2;TRPV4;GLI2;KLF7;RNF165;TCEA2;ZNF76;SOX12;PIDD1;ZNF747;ZCCHC11;PER2;ZNF658;PHF2;ABHD14B;TCEAL1;WWTR1;ITGA2;GLI3;THRAP3;ZNF558;IRX4;SMARCA1;BHLHE40;ZNF655;ZNF333;MAP2K5;ITGA6;ZNF318;LZTS1;TCFL5;TRAK1;JARID2;NUPR1;INSR;CCDC85B;CHD3;ZNF18;MXD4;ZNF287;PMS2P3;ZNF446;ZNF581;RTF1;MDK;IRF9;H2AFJ;BMP6;NLRX1;MAP2K2;GLI4;SQSTM1;FZD7;ETV5;DLX3;HEXB;KDM4C;METTL23;ZNF608;PLA2G6;CST3;GDF15;TXNIP;TCF4;PLAG1;RCOR2;IFI27;LPIN3;CDK5R1;ATRX;MAPK10;HFE;ADIRF;HMG20B;TRIM38;AGO4;ERCC6;EDA2R;MEF2D;CREBRF;XRN1;MLXIPL;TARBP1;FBXW7;ING4;CDK5RAP3;ZNF862;ATXN1;LMO2;NFIX;PAK6;CARF;MXI1;THRA;RAI1;ELF1;IKZF4;ZBTB34;ZNF627;MIF4GD;DBP;NAB2;EPM2AIP1;PEG3;RFX2;ZNF554;SALL2;ZNF107;ZNF532;ZBTB20;PDE2A;ZNF334;MAF;STK16;RET;ZMYND8;DAB2IP;CASZ1;RWDD3;CALCOCO1;TEAD2;MYSM1;FBXO4;TSHZ2;ZNF276;IFI16;FGFR4;PIK3R2;TEF;ZNF25;AREG;RPS6KA5;APBB3;ZNF630;BTG1;ZNF687;VDR;MAMSTR;TNRC18;TNRC6C;ZFP28;PLXND1;ZMYM3;SIX5;HLTF;PCSK6;ZNF789;ZNF563;ZNF517;STAT2;WWC3;PHF1;ZNF292;TFDP2;NRARP;ACVR1B;ZNF737;NECAB3;TNNI2;ZNF701;NAT14;TCEAL4;ZNF91;DYDC1;GTF2IRD2;TCF7;ZFP36L1;GLMP;IL11;KAT2B;IRS2;ERN1;RNF141;IVNS1ABP;ZNF439;TRERF1;APBB2;STAT6;SOX13;PRDX5;NELFCD;KLF8;CHD6;TRAF5;GOLGB1;HDAC11;ERBB2;ABCA2;KMT5C;RORA;PPARG;CXXC5;ZNF572;ZNF658B;PARN;ZNF529;UFL1;RIPK3;KLF9;AIP;SCAND1;PRMT3;ZFP90;PER3;ZFP30;FOXP2;ZC3H6;HIVEP1;SMURF1;NPNT;CTNNBIP1;GCLC;ECM1
10782,GO:0044270,0.999910821533028,0.000177199606444706,29,545,cellular nitrogen compound catabolic process,BP,NT5E;OAS2;CIRBP;APOBEC3C;DHTKD1;H1F0;CYP3A5;RAPGEF3;PCBP4;BLVRB;ZFP36L2;ZCCHC11;THRAP3;INSR;TST;ENDOG;AGO4;XRN1;MLXIPL;PGM1;PFKFB2;OGDHL;PDE2A;TNRC6C;ZFP36L1;ERN1;ANGEL2;NUDT10;PARN
2494,GO:0005743,0.99991191102615,0.000207323405016002,17,407,mitochondrial inner membrane,CC,CPT2;HMGCL;PRODH;NDUFA4L2;CRAT;TST;IDH2;HADH;BDH1;PDE2A;SDHA;LETMD1;NDUFV3;RSAD2;ECI1;TTC19;OCIAD2
11796,GO:0046700,0.999913212120879,0.000172626820723745,29,545,heterocycle catabolic process,BP,NT5E;OAS2;CIRBP;APOBEC3C;DHTKD1;H1F0;PRODH;RAPGEF3;PCBP4;BLVRB;ZFP36L2;ZCCHC11;THRAP3;INSR;ALDH4A1;ENDOG;AGO4;XRN1;MLXIPL;PGM1;PFKFB2;OGDHL;PDE2A;TNRC6C;ZFP36L1;ERN1;ANGEL2;NUDT10;PARN
35,GO:0000070,0.999916563890067,0.00038014632510201,4,141,mitotic sister chromatid segregation,BP,TTN;CENPC;ATRX;CHMP1B
16847,GO:0098798,0.99992466970343,0.000303136372490063,5,218,mitochondrial protein complex,CC,NDUFA4L2;PDK1;SDHA;NDUFV3;SUCLG2
5509,GO:0016462,0.999925691093335,0.000132497209163389,45,685,pyrophosphatase activity,MF,DDX60;HSPA2;KIF26B;WDR63;RAB43;RAB40B;MLH3;DDX59;MYH11;RHOBTB2;KIF26A;DNAH1;DHX32;SMARCA1;CHD3;PMS2P3;SEPT6;DHX58;TCIRG1;ATP6V0A2;WRN;SEPT5;DNM1;MCM9;ATRX;ERCC6;NUDT6;MX2;MYO3B;RNF213;MYO9A;HLTF;RASL10B;DQX1;RAD50;PEX1;MYH16;KIF7;CHD6;NUDT10;ABCA2;DDX12P;LONP2;MSH5;ABCA11P
18217,GO:1903047,0.999925950390329,0.000128702094660798,50,757,mitotic cell cycle process,BP,GPNMB;EGFR;PKD2;XPC;OBSL1;BRSK1;CUL9;CUL7;CNTRL;LIG1;MDM2;PCBP4;NEK9;TUBGCP5;ZFP36L2;TOM1L2;ANK3;PIDD1;GJC2;UNC119;NINL;ZNF655;NAIP;LZTS1;INSR;CDK14;TTN;CEP126;SEPT6;CEP192;HYAL1;CENPC;SEPT5;ATRX;SPRY2;CDK5RAP3;CHMP1B;REEP4;FBXW5;ALMS1;TFDP2;ACVR1B;WEE1;ZFP36L1;LMNA;CEP250;GPR132;PRKACA;SNX33;CIT
13093,GO:0051649,0.999928715641578,0.000103614841280734,128,1667,establishment of localization in cell,BP,SREBF1;APOE;LMF1;PKD2;SYT8;CPT2;SYN1;SRSF5;TMEM129;EVI5L;BRSK1;MVB12B;ZDHHC1;VAMP3;REEP2;NSG1;RAB43;RAB40B;NOS1;AP5Z1;MICALL1;TBC1D8;VPS11;COL7A1;KCNC4;ITPR3;MDM2;SYTL1;RAPGEF3;NLGN4Y;AP1G2;F2R;C2CD4C;HPS4;BLOC1S4;SPTB;CLTCL1;TOM1L2;NLGN2;ADORA2B;ANK3;RIMS3;SPG11;PER2;GSTM2;SYT15;GLI3;VAMP2;TRAK1;SUN1;RAB11FIP4;VPS39;PGAP1;BLOC1S3;PEX10;MICALL2;MAP2K2;SQSTM1;WHAMMP3;CENPC;PLA2G6;PEX7;BBS2;TXNIP;SEPT5;IFI27;OSCP1;DNM1;ZDHHC12;MCTP1;CDK5R1;HOOK2;CYBA;SPRY2;WASH3P;IFT140;RAB11FIP3;FBXW7;ANKRD28;ATXN1;CHMP1B;MX2;RPH3AL;ACACB;TBC1D17;TSNARE1;JPH2;PDE2A;DDHD2;SHROOM2;PIK3C3;SYT7;BBS5;AREG;CACNB3;MPPE1;TBC1D16;TMCO6;DMTN;SGSM2;ALMS1;TFDP2;SNX1;GOLGA7B;CCDC88B;ANO1;PEX1;SCG5;PHPT1;GOLGB1;ERBB2;SYNGR1;GPR68;ZDHHC24;ABCA2;AKAP6;TH;ATG14;PRKACA;LDLRAP1;NPAP1;SYNE2;AIP;COG1;LONP2;SNX33;SMURF1;PEMT
5693,GO:0016817,0.999930080937338,0.000124902024092208,45,687,hydrolase activity, acting on acid anhydrides,MF,DDX60;HSPA2;KIF26B;WDR63;RAB43;RAB40B;MLH3;DDX59;MYH11;RHOBTB2;KIF26A;DNAH1;DHX32;SMARCA1;CHD3;PMS2P3;SEPT6;DHX58;TCIRG1;ATP6V0A2;WRN;SEPT5;DNM1;MCM9;ATRX;ERCC6;NUDT6;MX2;MYO3B;RNF213;MYO9A;HLTF;RASL10B;DQX1;RAD50;PEX1;MYH16;KIF7;CHD6;NUDT10;ABCA2;DDX12P;LONP2;MSH5;ABCA11P
5694,GO:0016818,0.999930080937338,0.000124902024092208,45,687,hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides,MF,DDX60;HSPA2;KIF26B;WDR63;RAB43;RAB40B;MLH3;DDX59;MYH11;RHOBTB2;KIF26A;DNAH1;DHX32;SMARCA1;CHD3;PMS2P3;SEPT6;DHX58;TCIRG1;ATP6V0A2;WRN;SEPT5;DNM1;MCM9;ATRX;ERCC6;NUDT6;MX2;MYO3B;RNF213;MYO9A;HLTF;RASL10B;DQX1;RAD50;PEX1;MYH16;KIF7;CHD6;NUDT10;ABCA2;DDX12P;LONP2;MSH5;ABCA11P
3341,GO:0007059,0.999931381793485,0.000176467172028304,14,299,chromosome segregation,BP,MLH3;NEK8;TTN;SUN1;RMI2;CENPC;ATRX;REC8;AGO4;FBXW7;CHMP1B;CENPH;TOP3B;MSH5
3051,GO:0006611,0.999931482183687,0.000280032693989466,5,170,protein export from nucleus,BP,SRSF5;MDM2;RAPGEF3;IFI27;SMURF1
14848,GO:0070647,0.999931597507061,0.000112048692975408,66,950,protein modification by small protein conjugation or removal,BP,TNFAIP3;DDB2;FBXO41;FBXW4;HERC3;TRIM22;KCTD11;DCAF16;TMEM129;RBCK1;CUL9;RNF135;HERC5;ISG15;CUL7;RAB40B;CRY1;MAGEF1;RNF187;MDM2;SPSB3;RNF165;ZNF747;FBXO44;PER2;WWTR1;LRSAM1;NAIP;CBLC;FBXL16;GID4;RTF1;PEX10;SHARPIN;UBOX5;ARRDC1;ZYG11B;KLHL24;HMG20B;TRIM38;DTX3;FBXO2;FBXW7;CDK5RAP3;ZNF862;RNF170;DCAF10;FBXW5;KLHDC8B;RWDD3;MYSM1;FBXO4;RNF213;KLHL3;HLTF;MARCH8;KAT2B;RNF141;DCAF8;KLHL29;TRIM2;UVSSA;UFL1;PRMT3;SMURF1;GCLC
132,GO:0000278,0.999933437583214,0.000110211149862797,63,907,mitotic cell cycle,BP,GPNMB;SIK1;EGFR;PKD2;XPC;OBSL1;MAP3K14;BRSK1;CUL9;CUL7;CNTRL;LIG1;MDM2;PPP2R2C;PCBP4;NEK9;TUBGCP5;ZFP36L2;CLTCL1;TOM1L2;ANK3;PIDD1;GJC2;UNC119;MINK1;NINL;ZNF655;NAIP;MAP2K5;LZTS1;INSR;CDK14;TTN;CEP126;SEPT6;MAP2K2;CEP192;TMEM8B;HYAL1;CENPC;SEPT5;ATRX;SPRY2;CDK5RAP3;PAK6;CHMP1B;REEP4;FBXW5;BRINP1;BTG1;ALMS1;TFDP2;ACVR1B;WEE1;ZFP36L1;LMNA;CEP250;ANGEL2;GPR132;PTPN3;PRKACA;SNX33;CIT
15851,GO:0072594,0.999937510859186,0.000136990152536653,22,459,establishment of protein localization to organelle,BP,TNFAIP3;SREBF1;VPS11;HPS4;GLI3;LRSAM1;PEX10;MICALL2;PEX7;TXNIP;OSCP1;WASH3P;FBXW7;PDE2A;TMCO6;TFDP2;PEX1;NPAP1;AIP;LONP2;SMURF1;PEMT
2464,GO:0005681,0.999944409374145,0.000229829412349509,5,181,spliceosomal complex,CC,DHX32;DQX1;TEP1;IVNS1ABP;PTBP2
8397,GO:0033365,0.999946873196963,9.60913573561072e-05,44,728,protein localization to organelle,BP,TNFAIP3;SREBF1;OBSL1;MICALL1;VPS11;MDM2;LZTS2;OBSCN;NUDCD3;HPS4;GLI3;LRSAM1;CEP68;SUN1;PEX10;MICALL2;CEP192;PEX7;BBS2;TXNIP;WRN;OSCP1;ATRX;WASH3P;IFT140;FBXW7;CDK5RAP3;C12ORF66;BBS1;PDE2A;FBXO4;TMCO6;TFDP2;LMNA;CEP250;PEX1;TUB;GOLGB1;NPAP1;SYNE2;AIP;LONP2;SMURF1;PEMT
2894,GO:0006402,0.999948499649075,0.000141948111184121,12,322,mRNA catabolic process,BP,CIRBP;PCBP4;ZFP36L2;ZCCHC11;THRAP3;AGO4;XRN1;TNRC6C;ZFP36L1;ERN1;ANGEL2;PARN
307,GO:0000819,0.999949817025579,0.000166110726199382,8,215,sister chromatid segregation,BP,TTN;RMI2;CENPC;ATRX;REC8;FBXW7;CHMP1B;CENPH
8665,GO:0034248,0.999950242317608,0.00011196297649953,21,424,regulation of cellular amide metabolic process,BP,APOE;EGFR;CIRBP;CAPRIN2;RBM3;UNK;IMPACT;RGS2;ZFP36L2;ZCCHC11;PER2;ITGA2;MAP2K2;PLA2G6;AGO4;XRN1;MIF4GD;TNRC6C;ZFP36L1;ERBB2;PPARG
15950,GO:0080090,0.999950989395377,6.34606457396305e-05,406,4500,regulation of primary metabolic process,BP,TNFAIP3;HES2;SERPINE2;ZSCAN18;GPNMB;TSC22D1;SIK1;TP53INP1;IFI6;PTHLH;SREBF1;APOE;INPP5D;OAS2;MN1;LMF1;HSPA2;EGFR;CIRBP;PKD2;CAPRIN2;MNT;CPT2;RBM3;ASH2L;TRIM22;SRSF5;SFRP1;MTHFR;PERM1;SEC14L2;EPHB2;MAP3K14;DGKQ;PIK3R1;RBCK1;KDM3A;TSC22D3;POU3F1;CAMKK1;HERC5;VAV3;UNK;HR;CSPG4;ISG15;ELFN2;HTRA1;TFCP2L1;RGMA;ZFPM1;KITLG;HOXC5;MVD;ZNF362;CITED4;IRF2BPL;MC1R;ZNF266;STAT1;IMPACT;CAMK2N1;CRY2;THAP8;NOS1;PRKACB;ZNF704;HOXA3;CRY1;ZNF699;MAML3;ZFP41;SCMH1;KLF13;CRTAP;MAGEF1;NFATC4;ZNF783;SPDYE6;BTBD2;RNF187;HSF4;ZNF251;VPS11;COL7A1;SPOCK1;EAPP;MDM2;CRTC1;NDN;PPP2R2C;ZNF662;TYSND1;LTBP4;PIK3IP1;TNFSF10;NEO1;RAPGEF3;PHACTR3;ZNF414;TCF25;PCBP4;POLH;OAS1;FLRT3;MLLT6;RGS2;F2R;MLYCD;PDCD4;SERPINB5;ZNF160;RTN4RL1;ZFP36L2;TRPV4;FLOT1;GLI2;ADORA2B;KLF7;RNF165;LAMP3;TCEA2;MAPK8IP3;SPDYE5;ZNF76;SOX12;PIDD1;SLX1A;SLX1B;ZNF747;GJC2;ZCCHC11;RHBDF1;PER2;UNC119;C5;ZNF658;SNTA1;MINK1;PHF2;ABHD14B;TCEAL1;WWTR1;ITGA2;GLI3;THRAP3;ZNF558;IRX4;SMARCA1;BHLHE40;ZNF655;NAIP;ZNF333;MAP2K5;ITGA6;ZNF318;LZTS1;IGFBP4;TCFL5;TRAK1;JARID2;NUPR1;INSR;CCDC85B;GSN;CHD3;TTN;CBLC;DDT;ZNF18;AHNAK2;MXD4;ZNF287;CD109;PMS2P3;ETAA1;ZNF446;ZNF581;PILRB;ENDOG;SLC27A1;RTF1;MDK;IRF9;RICTOR;H2AFJ;BMP6;NLRX1;MAP2K2;PDK1;GLI4;SQSTM1;PTK6;FZD7;ETV5;SYNGAP1;DLX3;HEXB;KDM4C;METTL23;ZNF608;PLA2G6;CST3;GDF15;TXNIP;CTF1;TCF4;NPHP3;PLAG1;MAP3K12;RCOR2;WRN;IFI27;TNFRSF21;ZYG11B;LPIN3;CDK5R1;ATRX;MAPK10;HFE;ADIRF;HMG20B;TRIM38;AGO4;ERCC6;SHC2;EDA2R;SPRY2;FBXO2;MEF2D;GABBR1;CREBRF;XRN1;MLXIPL;TARBP1;FBXW7;GPR87;ING4;CDK5RAP3;ZNF862;ATXN1;LMO2;NFIX;PAK6;TFPI2;CARF;MXI1;PFKFB2;THRA;APC2;ADARB1;RAI1;ELF1;IKZF4;ACACB;NLRP1;ZBTB34;ZNF627;MIF4GD;DBP;NAB2;EPM2AIP1;LRP1;PEG3;RFX2;ZNF554;MAP3K6;SALL2;WNK1;ZNF107;ZNF532;ZBTB20;PDE2A;ZNF334;MAF;STK16;LTB4R2;RET;ZMYND8;PRX;DAB2IP;CASZ1;RWDD3;CALCOCO1;TEAD2;MYSM1;FBXO4;TSHZ2;ZNF276;IFI16;FGFR4;PIK3R2;TEF;ZNF25;AREG;ABTB1;RPS6KA5;APBB3;ZNF630;BTG1;BST2;ZNF687;VDR;MAMSTR;TNRC18;TNRC6C;ZFP28;PLXND1;ZMYM3;SIX5;HLTF;PCSK6;ZNF789;ZNF563;ZNF517;PPP1R2;DMTN;PPP1R35;STAT2;WWC3;PHF1;ZNF292;TFDP2;SNX1;NRARP;ACVR1B;ZNF737;NECAB3;DLG4;TNNI2;PPP2R3B;ZNF701;NAT14;PANO1;TCEAL4;ZNF91;DYDC1;GTF2IRD2;TCF7;TNFRSF25;ZFP36L1;GLMP;ACSL1;IL11;KAT2B;IRS2;ERN1;RNF141;IVNS1ABP;RAD50;ZNF439;ANGEL2;TRERF1;APBB2;PBLD;TNFSF12;STAT6;PCSK1N;SOX13;PRDX5;NELFCD;KLF8;CHD6;TRAF5;GOLGB1;RANBP9;HDAC11;PTPN3;ERBB2;ABCA2;KMT5C;AKAP6;ATG14;RORA;PPARG;PRKACA;LDLRAP1;CXXC5;ZNF572;ACKR3;ZNF658B;SERPING1;PARN;ZNF529;UFL1;RIPK3;KLF9;AIP;SCAND1;LONP2;PRMT3;SNX33;ZFP90;CCDC3;PER3;ZFP30;FOXP2;PTBP2;ZC3H6;HIVEP1;SMURF1;NPNT;CTNNBIP1;PEMT;GCLC;ECM1
15038,GO:0071013,0.999951122225561,0.000562178068094117,1,96,catalytic step 2 spliceosome,CC,TEP1
4470,GO:0010468,0.999951681076458,6.38616256071765e-05,305,3511,regulation of gene expression,BP,TNFAIP3;HES2;SERPINE2;ZSCAN18;TSC22D1;SIK1;TP53INP1;PTHLH;SREBF1;ACTA2;APOE;MN1;EGFR;CIRBP;PKD2;CAPRIN2;MNT;RBM3;ASH2L;TRIM22;SRSF5;SFRP1;PERM1;SEC14L2;EPHB2;DGKQ;PIK3R1;RBCK1;KDM3A;TSC22D3;POU3F1;WNT3;UNK;HR;HTRA1;TFCP2L1;RGMA;ZFPM1;HOXC5;ZNF362;CITED4;IRF2BPL;MC1R;ZNF266;STAT1;IMPACT;CAMK2N1;CRY2;THAP8;NOS1;PRKACB;ZNF704;HOXA3;CRY1;ZNF699;MAML3;ZFP41;SCMH1;KLF13;NFATC4;ZNF783;RNF187;FERMT1;CYP26B1;HSF4;ZNF251;EAPP;MDM2;CRTC1;NDN;ZNF662;NEO1;ZNF414;TCF25;PCBP4;MLLT6;RGS2;F2R;PDCD4;ZNF160;ZFP36L2;TRPV4;GLI2;ANK3;KLF7;RNF165;LAMP3;TCEA2;ZNF76;SOX12;PIDD1;ZNF747;GJC2;ZCCHC11;PER2;C5;ZNF658;PHF2;ABHD14B;TCEAL1;WWTR1;ITGA2;GLI3;THRAP3;ZNF558;IRX4;SMARCA1;BHLHE40;ZNF655;NAIP;ZNF333;MAP2K5;ITGA6;ZNF318;LZTS1;TCFL5;TRAK1;JARID2;NUPR1;INSR;CCDC85B;GSN;CHD3;TTN;ZNF18;AHNAK2;MXD4;ZNF287;PMS2P3;ZNF446;ZNF581;RTF1;MDK;IRF9;RICTOR;H2AFJ;BMP6;NLRX1;MAP2K2;GLI4;SQSTM1;FZD7;ETV5;DLX3;HEXB;KDM4C;METTL23;ZNF608;GDF15;BBS2;TXNIP;TCF4;PLAG1;RCOR2;IFI27;LPIN3;CDK5R1;ATRX;MAPK10;HFE;ADIRF;HMG20B;TRIM38;AGO4;ERCC6;SLIT3;EDA2R;SPRY2;MEF2D;CREBRF;XRN1;MLXIPL;TARBP1;FBXW7;ING4;CDK5RAP3;ZNF862;ATXN1;LMO2;NFIX;PAK6;CARF;MXI1;THRA;RAI1;ELF1;IKZF4;ACACB;ZBTB34;ZNF627;MIF4GD;DBP;NAB2;EPM2AIP1;PEG3;RFX2;ZNF554;SALL2;ZNF107;ZNF532;ZBTB20;PDE2A;ZNF334;MAF;STK16;RET;ZMYND8;PRX;DAB2IP;CASZ1;RWDD3;CALCOCO1;TEAD2;MYSM1;FBXO4;TSHZ2;ZNF276;IFI16;FGFR4;PIK3R2;TEF;ZNF25;RPS6KA5;APBB3;ZNF630;BTG1;ZNF687;VDR;MAMSTR;TNRC18;TNRC6C;ZFP28;PLXND1;ZMYM3;SIX5;HLTF;PCSK6;ZNF789;ZNF563;ZNF517;STAT2;WWC3;PHF1;ZNF292;TFDP2;NRARP;ACVR1B;ZNF737;TNNI2;ZNF701;NAT14;TCEAL4;ZNF91;DYDC1;GTF2IRD2;TCF7;ZFP36L1;GLMP;IL11;KAT2B;ERN1;RNF141;IVNS1ABP;ZNF439;ANGEL2;TRERF1;APBB2;STAT6;SOX13;PRDX5;NELFCD;KLF8;CHD6;TRAF5;GOLGB1;HDAC11;ERBB2;ABCA2;KMT5C;ATG14;RORA;PPARG;CXXC5;ZNF572;ZNF658B;SERPING1;PARN;ZNF529;UFL1;RIPK3;KLF9;SCAND1;PRMT3;ZFP90;PER3;ZFP30;FOXP2;PTBP2;ZC3H6;HIVEP1;SMURF1;NPNT;CTNNBIP1;GCLC;ECM1
2432,GO:0005622,0.999951788840368,6.8193311545782e-05,1033,10517,intracellular,CC,TNFAIP3;TGFBI;POSTN;TAGLN;ITGB6;HES2;SERPINE2;ZSCAN18;ULK2;GPNMB;TSC22D1;SIK1;SLFN5;SUGCT;EPM2A;MUC19;NPEPL1;DDB2;TP53INP1;MAP6;IFI6;PTHLH;SREBF1;AMACR;PYGB;ACTA2;APOE;GPSM1;CES2;NT5E;ALS2CL;INPP5D;GAMT;FBXO41;OAS2;ADAM19;LMF1;DDX60;HSPA2;FBXW4;EGFR;ESPN;TRIM65;FAM117A;HERC3;PTPRS;CIRBP;FLNC;FAM20C;PKD2;CAPRIN2;MNT;XPC;APOBEC3C;SYT8;CXCR1;CPT2;RBM3;SYN1;ASH2L;DIXDC1;TRIM22;ALDH1A3;SRSF5;LRIG3;PLCD3;CTSO;SFRP1;OBSL1;MTHFR;PERM1;SEC14L2;KCTD11;IFI44L;KIF26B;PCDH1;EPS8L2;EPHB2;RALGDS;TNS1;SYNC;MAP3K14;GLUD1;BPHL;DCAF16;DGKQ;TMEM129;PIK3R1;ADAMTS7;EVI5L;BRSK1;TXNRD3;MARVELD1;RBCK1;KDM3A;CXCL14;DOCK9;COL22A1;TSC22D3;CUL9;EVC;RNF135;POU3F1;SULF2;WNT3;H6PD;DHTKD1;CAMKK1;HERC5;UBXN4;VAV3;ST6GALNAC2;UNK;HR;VWCE;CSPG4;ISG15;MVB12B;CYBRD1;HTRA1;SPATA18;TFCP2L1;TENM4;UNC119B;RGMA;PI4KAP2;KCNAB2;ZFPM1;KITLG;HOXC5;MVD;ZDHHC1;ZNF362;CUL7;VAMP3;CITED4;SNN;IRF2BPL;NAPRT;REEP2;PRICKLE2;MC1R;ASAP3;ZNF266;SRD5A3;OR2A4;STAT1;IMPACT;CAMK2N1;CRY2;MYL9;GRIP2;KRT15;HS1BP3;LGALS7B;WDR63;MARCKSL1;NSG1;UROS;KDSR;ITGB5;COL10A1;RAB43;RAB40B;NOS1;PRKACB;ZNF704;HOXA3;B4GALNT4;CRY1;ZNF699;MAML3;ZFP41;SCMH1;KLF13;CRTAP;SDC3;PLEKHG5;NFATC4;PITPNM3;ZNF783;IQSEC2;HMGCL;D2HGDH;BTBD2;SCARA3;FKBP5;RNF187;FERMT1;H1F0;CYP26B1;GAA;AP5Z1;CMPK2;HSF4;CNTRL;ZNF251;MICALL1;PIK3C2G;LIG1;CDK18;TBC1D8;PLXNB1;VPS11;SPEG;NDRG1;COL7A1;SPOCK1;ITPR3;EAPP;NAGLU;CYHR1;MDM2;CRTC1;LZTS2;PLCD1;NDN;MLH3;NMRK1;DDX59;ST6GALNAC6;PPP2R2C;CHN2;ZNF662;TYSND1;OBSCN;IDUA;GOLGA8A;GPRC5C;HLA-B;PRODH;HGSNAT;MYH11;PARVB;SYTL1;FKBP9;NDUFA4L2;ACTR1B;TNXB;RHOBTB2;UGT1A3;CERS4;CYP3A5;ACOT1;NEO1;RAPGEF3;PHACTR3;ZNF414;SPSB3;TCF25;ENDOD1;PCBP4;FAM210B;CTSV;POLH;BLVRB;POLR2J2;OAS1;FLRT3;NUDCD3;RASA4;TRIM66;GAL3ST4;CRAT;KIF26A;B4GALT6;MLLT6;AP1G2;RGL4;RGS2;ACAP3;ADGRB2;F2R;MLYCD;PPL;C2CD4C;HPS4;PHYH;TMEM134;MT1X;PDCD4;BLOC1S4;SPTB;SERPINB5;NOL4L;NYAP1;ALPK1;ZNF160;CAPN7;SWT1;DNAH1;SLC27A3;ARSI;NEK9;TUBGCP5;RTN4RL1;ZFP36L2;CLTCL1;TRPV4;TMC6;FLOT1;GLI2;AGAP4;TOM1L2;RHPN1;ADORA2B;CORO6;ANK3;KLF7;RNF165;NAT6;DHX32;ADAMTS13;LAMP3;TCEA2;PLCH2;RALGAPA1;MAPK8IP3;GOLGA8B;ZNF76;SOX12;CLMN;PIDD1;RIMS3;PARP6;AVL9;SLX1A;SLX1B;G6PC3;ATG16L2;ZNF747;SPG11;ZCCHC11;ARHGEF19;RHBDF1;SULT1E1;FBXO44;RASGEF1A;ANKS6;PER2;PITPNM2;CLCN6;MICALCL;PTGS1;UNC119;DIRC2;HEXA;FNDC4;FRS3;DTNB;FRMD4B;ZNF658;ARSD;WIPF1;SNTA1;PSKH1;ADGRL1;MINK1;PHF2;NINL;ABHD14B;GSTM2;TCEAL1;AMIGO2;THBS3;WWTR1;MBOAT2;ASAP2;ARHGEF4;LHFPL2;ITGA2;RSPH3;FAM110C;ULK1;GLI3;SPPL2B;FHOD3;PCSK1;TPGS1;THRAP3;ZNF558;IRX4;SMARCA1;AKAP7;BHLHE40;DGCR6L;LRSAM1;VAMP2;ZNF655;NAIP;LTBP1;ZNF333;NEK8;MAP2K5;GAS8;BOC;SRGAP3;CES3;BSN;SESN3;ZNF318;LZTS1;IGFBP4;TCFL5;TRAK1;JARID2;NUPR1;PRR9;GPC2;NISCH;INSR;TST;IFI44;CCDC85B;HSF2BP;CELSR1;MMP28;GSN;ALDH4A1;CEP68;HEBP1;CHD3;CDK14;ST3GAL5;BAIAP2;TTN;CBLC;SCNN1A;DDT;ZNF18;CEP126;SUN1;AHNAK2;RNPEPL1;PLEKHH2;TRIOBP;MXD4;POLD4;RIN1;DNAJC30;CTSF;ZNF287;CD109;CYP2D7;NSUN5P2;PNMA1;PGLS;PMS2P3;ETAA1;RMI2;ZNF446;ARHGEF1;SEPT6;FBXL16;RAB11FIP4;VPS39;ZNF581;MGST2;DOCK8;TP53AIP1;DHX58;ENDOG;SLC27A1;PGAP1;NRSN2;RTF1;BLOC1S3;MDK;CASP14;IRF9;RICTOR;TMEM9;H2AFJ;BMP6;F8A1;NLRX1;B4GALT2;ETNK2;PEX10;SLC2A3;TCIRG1;S100A4;MICALL2;MAP2K2;OPLAH;PDK1;VEGFB;ALDH7A1;GLI4;SQSTM1;CEP192;CABYR;PTK6;TMEM8B;FZD7;ETV5;AKR7A2;LOXL1;FNBP4;FRMD8;SYNGAP1;FAM13A;FAM213A;FAT2;DLX3;TMEM117;LGALS9C;EPB41L3;SHARPIN;HEXB;KDM4C;HYAL1;METTL23;CLCA2;ARHGAP33;H1FX;SH2D2A;UBOX5;NSMCE4A;ARRDC1;KIAA0319L;B3GNT9;WHAMMP3;CENPC;PLA2G6;CST3;PDIK1L;HOMER2;CAPNS2;GDF15;PEX7;BBS2;TXNIP;TCF4;ATP6V0A2;KLHDC2;COL6A1;PEX11B;NPHP3;LRRCC1;PLAG1;IDH2;CERCAM;MAP3K12;RCOR2;WRN;PODXL;SEPT5;IFI27;MALL;OXLD1;DNM1;MCM9;ZYG11B;MACROD1;IQCB1;KLHL24;PLD3;TREX1;LPIN3;ZDHHC12;ABHD14A;MCTP1;CDK5R1;ATRX;REC8;ARHGAP27;AGAP6;NET1;ANO9;PIGZ;CA2;OSBPL10;PI4KAP1;POLR2J3;HOOK2;SESN1;EPB41L4A;MAPK10;NKTR;SHANK3;HFE;SCART1;ADIRF;HMG20B;CYBA;TRIM38;DTX3;AGO4;ERCC6;HADH;RRM2B;SLIT3;CLIP2;KRT14;HLCS;SHC2;EDA2R;SPRY2;FBXO2;WASH3P;MEF2D;IFT140;GABBR1;CREBRF;XRN1;AGAP7P;RAB11FIP3;TIGD5;MLXIPL;CTSB;KLK5;NBPF15;TARBP1;FBXW7;ANKRD28;ING4;NUDT6;CDK5RAP3;ZNF862;ATXN1;LMO2;NOTCH2NL;CCDC92;NFIX;PAK6;CARF;DZIP1L;PGM1;MXI1;PFKFB2;RNF170;CHMP1B;THRA;TTC12;HSD11B1L;APC2;METTL21A;ACADS;ARAP1;ASTN2;GOLGA8N;ADARB1;RAI1;FMNL2;ELF1;FAM185A;MX2;IKZF4;DCAF10;RPH3AL;SLC2A1;ACACB;OGDHL;NLRP1;FRAT1;ZBTB34;ERMAP;REEP4;ZNF627;TK2;GPR155;LACTB2;BEX2;GLUL;TNS2;TBC1D17;MIF4GD;DBP;NDST2;NAB2;EPM2AIP1;TP53I13;GNG2;FBXW5;PRR7;SRR;CAPG;TSPYL4;LRP1;KLHDC8B;HLA-A;PEG3;TSNARE1;NPHP4;RGS12;CCDC136;ATE1;ACP5;MPG;PLA2G7;SYNPO2;RNPEP;C12ORF66;CENPH;RFX2;ZNF554;BRINP1;SLC48A1;BDH1;MAP3K6;RIMKLB;PPCS;MYO3B;APPL2;HEXDC;SALL2;WNK1;PMEL;ZNF107;ZNF532;BBS1;ATXN10;JPH2;ARL11;ZBTB20;PDE2A;ZNF334;SDHA;MAF;STK16;LTB4R2;RET;ZMYND8;PRX;DAB2IP;CASZ1;RWDD3;ACOX3;CALCOCO1;SLC37A2;TEAD2;MYSM1;DDHD2;SHROOM2;FBXO4;RNF213;OLFM2;RAPGEFL1;TSHZ2;PIK3C3;ZNF276;IFI16;SYT7;FGFR4;ERCC5;BBS5;EXOC2;PIK3R2;RETSAT;SCN2A;TEF;ZNF25;SETD4;OSBPL5;AREG;ABTB1;TMEM203;DEF6;KLHL3;SNCB;ETFB;MYO9A;RPS6KA5;APBB3;ZNF630;DLG5;BTG1;BST2;ZNF687;VDR;LETMD1;RGL2;SNX21;ARHGEF17;CACNB3;MAMSTR;PHF7;TNRC18;TNRC6C;ZFP28;DPY19L2P2;EFS;NADK;ZMYM3;SIX5;HLTF;MARCH8;EHBP1;PCSK6;ZNF789;MPPE1;ZNF563;TNS4;ZNF517;PCMTD2;TBC1D16;STK19;NDUFV3;TMCO6;LPAR6;EML3;PPP1R2;DMTN;STAT2;SGSM2;ARFGEF2;LMTK3;ALMS1;PCMTD1;WWC3;PHF1;ZNF292;SLC36A4;TFDP2;SNX1;UCN2;GOLGA7B;OSBPL1A;ACVR1B;TMX4;SHROOM4;ZNF737;TACC1;KDELC2;PRIMPOL;NECAB3;CCDC88B;DLG4;CCDC113;TNNI2;PPP2R3B;ESYT2;TSSK1B;IQSEC1;ZNF701;ALOXE3;NAT14;PANO1;PALB2;ENDOU;MPI;IGFBP6;TCEAL4;ZNF91;NBEAL2;CD68;GALE;PTMS;WEE1;DYDC1;R3HDM4;CCNG2;TMEM143;GTF2IRD2;GOLGA6L4;SLC35G2;DQX1;AMT;TCF7;SHANK2;RSAD2;TNFRSF25;NEMP2;ZFP36L1;XYLT1;LMNA;MXRA8;CLSTN3;GLMP;TOP3B;ACSL1;IL11;KAT2B;MARK4;TEP1;APOLD1;IRS2;DMXL2;IMPA2;CEP250;ANO1;CAPS;METTL7A;ERN1;HSD17B14;SAC3D1;IVNS1ABP;ALOX15B;RAD50;ZNF439;TKFC;LAPTM4A;ANGEL2;ZMAT3;PNPO;MTR;MAN1B1;DHRS4;PEX1;ECI1;S100A6;TRERF1;UAP1L1;FAAH;SCYL3;SCG5;ZSWIM8;APBB2;CBR4;TTC19;ARHGEF9;ISYNA1;SGSH;PBLD;DCAF8;CCDC90B;RAPGEF5;MYH16;TNFSF12;CERS5;STAT6;PCSK1N;SOX13;PRDX5;PHPT1;NELFCD;PHC2;TUB;KIF7;GLB1;GOLGA1;CPT1C;KLF8;GSTM3;RDH12;KLHL29;CHD6;TRAF5;NAP1L5;GOLGB1;SRPX2;ACSS2;DPP7;TRIM2;CD9;PLIN4;RANBP9;HDAC11;PTPN3;CTSD;COL13A1;ERBB2;SYNGR1;MPRIP;PLCB3;NUDT10;UVSSA;ZDHHC24;ARHGAP23;PPM1M;ABCA2;KMT5C;AKAP6;SLC2A11;TH;ATG14;MPP7;RORA;SSH3;PPARG;PRKACA;DOCK6;LDLRAP1;CXXC5;NPAP1;C6ORF120;POLM;FMNL3;ACOT2;GCNT4;VMAC;ZNF572;SYNE2;PARD6G;ACKR3;ZNF658B;SERPING1;SUCLG2;UCKL1;PARN;DDX12P;DOCK3;ZNF529;UFL1;LAMB2;IP6K2;RIPK3;NFASC;KLF9;PI4K2B;AIP;COG1;KCNS3;SCAND1;LONP2;PRMT3;SNX33;HARS2;CIT;ZFP90;EHHADH;MSH5;CLCN7;MAP1A;CCDC3;PER3;ZFP30;FOXP2;PTBP2;ZC3H6;HIVEP1;SMURF1;NPNT;TTLL1;EML2;CTNNBIP1;PEMT;ABCA11P;OCIAD2;SERINC3;GCLC;ECM1
1537,GO:0003924,0.999952522072962,0.000157323105624126,8,227,GTPase activity,MF,RAB43;RAB40B;RHOBTB2;SEPT6;SEPT5;DNM1;MX2;RASL10B
10965,GO:0044770,0.999953818766365,9.51318220337517e-05,28,510,cell cycle phase transition,BP,GPNMB;EGFR;PKD2;XPC;BRSK1;CNTRL;MDM2;PCBP4;ZFP36L2;PIDD1;GJC2;NINL;ZNF655;LZTS1;CDK14;CEP192;HYAL1;FBXW7;CDK5RAP3;ALMS1;TFDP2;ACVR1B;WEE1;ZFP36L1;CEP250;GPR132;PRKACA;CIT
5277,GO:0015931,0.999954100564808,0.000162429159529451,7,207,nucleobase-containing compound transport,BP,SRSF5;SLC29A4;FLOT1;TST;MX2;ZFP36L1;NPAP1
3305,GO:0007006,0.999956894294662,0.000501113064131207,1,99,mitochondrial membrane organization,BP,TFDP2
2895,GO:0006403,0.9999575996773,0.000150697039715983,7,209,RNA localization,BP,SRSF5;FLOT1;TST;MX2;ZFP36L1;NPAP1;PARN
12739,GO:0051028,0.999959103594349,0.00023082468380838,3,135,mRNA transport,BP,SRSF5;MX2;ZFP36L1
8848,GO:0034655,0.99996182214646,8.08707700165812e-05,26,520,nucleobase-containing compound catabolic process,BP,NT5E;OAS2;CIRBP;APOBEC3C;DHTKD1;H1F0;RAPGEF3;PCBP4;ZFP36L2;ZCCHC11;THRAP3;INSR;ENDOG;AGO4;XRN1;MLXIPL;PGM1;PFKFB2;OGDHL;PDE2A;TNRC6C;ZFP36L1;ERN1;ANGEL2;NUDT10;PARN
10382,GO:0043228,0.999962731535884,4.98886778696721e-05,276,3271,non-membrane-bounded organelle,CC,ITGB6;MAP6;ACTA2;INPP5D;DDX60;HSPA2;ESPN;CIRBP;FLNC;PKD2;CAPRIN2;XPC;APOBEC3C;CPT2;RBM3;SYN1;ASH2L;SRSF5;OBSL1;KIF26B;PCDH1;TNS1;SYNC;MAP3K14;DGKQ;BRSK1;MARVELD1;KDM3A;EVC;HR;TFCP2L1;KCNAB2;KITLG;CUL7;REEP2;OR2A4;STAT1;MYL9;KRT15;WDR63;NOS1;PRKACB;SCMH1;BTBD2;FERMT1;H1F0;CNTRL;NDRG1;ITPR3;MDM2;LZTS2;NDN;MLH3;DDX59;OBSCN;MYH11;PARVB;ACTR1B;RAPGEF3;CTSV;NUDCD3;KIF26A;RGS2;ADGRB2;PPL;SPTB;DNAH1;NEK9;TUBGCP5;CLTCL1;TRPV4;FLOT1;GLI2;CORO6;ANK3;RIMS3;SLX1A;SLX1B;SPG11;ZCCHC11;PER2;UNC119;FRMD4B;WIPF1;SNTA1;PSKH1;PHF2;NINL;ABHD14B;RSPH3;FAM110C;GLI3;SPPL2B;FHOD3;TPGS1;SMARCA1;ZNF655;NEK8;MAP2K5;GAS8;BSN;CCDC85B;GSN;CEP68;CHD3;BAIAP2;TTN;CEP126;AHNAK2;PLEKHH2;TRIOBP;POLD4;RIN1;NSUN5P2;PNMA1;ETAA1;SEPT6;RAB11FIP4;RTF1;CASP14;H2AFJ;MICALL2;MAP2K2;PDK1;SQSTM1;CEP192;CABYR;FRMD8;EPB41L3;KDM4C;ARHGAP33;H1FX;NSMCE4A;B3GNT9;CENPC;PLA2G6;CST3;BBS2;TCF4;LRRCC1;WRN;PODXL;SEPT5;DNM1;IQCB1;CDK5R1;ATRX;REC8;OSBPL10;HOOK2;SESN1;EPB41L4A;HFE;HMG20B;CYBA;AGO4;ERCC6;CLIP2;KRT14;HLCS;SPRY2;WASH3P;MEF2D;IFT140;XRN1;RAB11FIP3;CTSB;FBXW7;ING4;CDK5RAP3;ATXN1;CCDC92;PAK6;CARF;DZIP1L;PGM1;MXI1;TTC12;APC2;ADARB1;SLC2A1;REEP4;MIF4GD;CAPG;NPHP4;RGS12;MPG;SYNPO2;CENPH;ZNF554;MYO3B;APPL2;SALL2;BBS1;JPH2;SDHA;MAF;CALCOCO1;DDHD2;SHROOM2;RNF213;PIK3C3;ZNF276;IFI16;ERCC5;BBS5;SETD4;ABTB1;DEF6;KLHL3;MYO9A;APBB3;DLG5;TNRC18;HLTF;TNS4;EML3;DMTN;ARFGEF2;ALMS1;PHF1;SHROOM4;TACC1;CCDC88B;DLG4;CCDC113;TNNI2;IQSEC1;PANO1;WEE1;DYDC1;TCF7;SHANK2;RSAD2;ZFP36L1;LMNA;TOP3B;KAT2B;MARK4;TEP1;CEP250;METTL7A;SAC3D1;IVNS1ABP;ALOX15B;RAD50;ZMAT3;TRERF1;FAAH;TTC19;MYH16;STAT6;PHC2;KIF7;TRAF5;PLIN4;RANBP9;PTPN3;MPRIP;UVSSA;ABCA2;KMT5C;ATG14;SSH3;PRKACA;LDLRAP1;VMAC;SYNE2;PARN;IP6K2;PRMT3;MSH5;MAP1A;NPNT;TTLL1;EML2
10386,GO:0043232,0.999962731535884,4.98886778696721e-05,276,3271,intracellular non-membrane-bounded organelle,CC,ITGB6;MAP6;ACTA2;INPP5D;DDX60;HSPA2;ESPN;CIRBP;FLNC;PKD2;CAPRIN2;XPC;APOBEC3C;CPT2;RBM3;SYN1;ASH2L;SRSF5;OBSL1;KIF26B;PCDH1;TNS1;SYNC;MAP3K14;DGKQ;BRSK1;MARVELD1;KDM3A;EVC;HR;TFCP2L1;KCNAB2;KITLG;CUL7;REEP2;OR2A4;STAT1;MYL9;KRT15;WDR63;NOS1;PRKACB;SCMH1;BTBD2;FERMT1;H1F0;CNTRL;NDRG1;ITPR3;MDM2;LZTS2;NDN;MLH3;DDX59;OBSCN;MYH11;PARVB;ACTR1B;RAPGEF3;CTSV;NUDCD3;KIF26A;RGS2;ADGRB2;PPL;SPTB;DNAH1;NEK9;TUBGCP5;CLTCL1;TRPV4;FLOT1;GLI2;CORO6;ANK3;RIMS3;SLX1A;SLX1B;SPG11;ZCCHC11;PER2;UNC119;FRMD4B;WIPF1;SNTA1;PSKH1;PHF2;NINL;ABHD14B;RSPH3;FAM110C;GLI3;SPPL2B;FHOD3;TPGS1;SMARCA1;ZNF655;NEK8;MAP2K5;GAS8;BSN;CCDC85B;GSN;CEP68;CHD3;BAIAP2;TTN;CEP126;AHNAK2;PLEKHH2;TRIOBP;POLD4;RIN1;NSUN5P2;PNMA1;ETAA1;SEPT6;RAB11FIP4;RTF1;CASP14;H2AFJ;MICALL2;MAP2K2;PDK1;SQSTM1;CEP192;CABYR;FRMD8;EPB41L3;KDM4C;ARHGAP33;H1FX;NSMCE4A;B3GNT9;CENPC;PLA2G6;CST3;BBS2;TCF4;LRRCC1;WRN;PODXL;SEPT5;DNM1;IQCB1;CDK5R1;ATRX;REC8;OSBPL10;HOOK2;SESN1;EPB41L4A;HFE;HMG20B;CYBA;AGO4;ERCC6;CLIP2;KRT14;HLCS;SPRY2;WASH3P;MEF2D;IFT140;XRN1;RAB11FIP3;CTSB;FBXW7;ING4;CDK5RAP3;ATXN1;CCDC92;PAK6;CARF;DZIP1L;PGM1;MXI1;TTC12;APC2;ADARB1;SLC2A1;REEP4;MIF4GD;CAPG;NPHP4;RGS12;MPG;SYNPO2;CENPH;ZNF554;MYO3B;APPL2;SALL2;BBS1;JPH2;SDHA;MAF;CALCOCO1;DDHD2;SHROOM2;RNF213;PIK3C3;ZNF276;IFI16;ERCC5;BBS5;SETD4;ABTB1;DEF6;KLHL3;MYO9A;APBB3;DLG5;TNRC18;HLTF;TNS4;EML3;DMTN;ARFGEF2;ALMS1;PHF1;SHROOM4;TACC1;CCDC88B;DLG4;CCDC113;TNNI2;IQSEC1;PANO1;WEE1;DYDC1;TCF7;SHANK2;RSAD2;ZFP36L1;LMNA;TOP3B;KAT2B;MARK4;TEP1;CEP250;METTL7A;SAC3D1;IVNS1ABP;ALOX15B;RAD50;ZMAT3;TRERF1;FAAH;TTC19;MYH16;STAT6;PHC2;KIF7;TRAF5;PLIN4;RANBP9;PTPN3;MPRIP;UVSSA;ABCA2;KMT5C;ATG14;SSH3;PRKACA;LDLRAP1;VMAC;SYNE2;PARN;IP6K2;PRMT3;MSH5;MAP1A;NPNT;TTLL1;EML2
7588,GO:0031967,0.999963007332261,6.25550410171022e-05,61,972,organelle envelope,CC,SREBF1;EGFR;CPT2;BPHL;UBXN4;SPATA18;SNN;PRICKLE2;RAB40B;HMGCL;ITPR3;PRODH;NDUFA4L2;CERS4;FAM210B;CRAT;SLC27A3;TMC6;SULT1E1;ULK1;INSR;TST;SUN1;MGST2;NLRX1;CLCA2;CST3;TXNIP;KLHDC2;IDH2;IFI27;DNM1;TREX1;HADH;MX2;ACACB;BDH1;PDE2A;SDHA;RETSAT;LETMD1;TNRC18;DPY19L2P2;NDUFV3;RSAD2;NEMP2;LMNA;ACSL1;ERN1;ECI1;S100A6;TTC19;CCDC90B;CERS5;STAT6;CPT1C;AKAP6;NPAP1;SYNE2;PEMT;OCIAD2
7592,GO:0031975,0.999963007332261,6.25550410171022e-05,61,972,envelope,CC,SREBF1;EGFR;CPT2;BPHL;UBXN4;SPATA18;SNN;PRICKLE2;RAB40B;HMGCL;ITPR3;PRODH;NDUFA4L2;CERS4;FAM210B;CRAT;SLC27A3;TMC6;SULT1E1;ULK1;INSR;TST;SUN1;MGST2;NLRX1;CLCA2;CST3;TXNIP;KLHDC2;IDH2;IFI27;DNM1;TREX1;HADH;MX2;ACACB;BDH1;PDE2A;SDHA;RETSAT;LETMD1;TNRC18;DPY19L2P2;NDUFV3;RSAD2;NEMP2;LMNA;ACSL1;ERN1;ECI1;S100A6;TTC19;CCDC90B;CERS5;STAT6;CPT1C;AKAP6;NPAP1;SYNE2;PEMT;OCIAD2
12833,GO:0051171,0.999963927785221,4.70026538419643e-05,393,4384,regulation of nitrogen compound metabolic process,BP,TNFAIP3;HES2;SERPINE2;ZSCAN18;GPNMB;TSC22D1;SIK1;TP53INP1;IFI6;PTHLH;SREBF1;APOE;INPP5D;OAS2;MN1;HSPA2;EGFR;CIRBP;PKD2;CAPRIN2;MNT;RBM3;ASH2L;TRIM22;SRSF5;SFRP1;MTHFR;PERM1;SEC14L2;EPHB2;MAP3K14;DGKQ;PIK3R1;RBCK1;KDM3A;TSC22D3;POU3F1;CAMKK1;HERC5;UNK;HR;CSPG4;ISG15;ELFN2;HTRA1;TFCP2L1;RGMA;ZFPM1;KITLG;HOXC5;ZNF362;CITED4;IRF2BPL;MC1R;ZNF266;STAT1;IMPACT;CAMK2N1;CRY2;THAP8;NOS1;PRKACB;ZNF704;HOXA3;CRY1;ZNF699;MAML3;ZFP41;SCMH1;KLF13;CRTAP;MAGEF1;NFATC4;ZNF783;SPDYE6;BTBD2;RNF187;HSF4;ZNF251;VPS11;COL7A1;SPOCK1;EAPP;MDM2;CRTC1;NDN;PPP2R2C;ZNF662;LTBP4;TNFSF10;NEO1;RAPGEF3;PHACTR3;ZNF414;TCF25;PCBP4;POLH;OAS1;FLRT3;MLLT6;RGS2;F2R;PDCD4;SERPINB5;ZNF160;RTN4RL1;ZFP36L2;TRPV4;FLOT1;GLI2;ADORA2B;KLF7;RNF165;LAMP3;TCEA2;MAPK8IP3;SPDYE5;ZNF76;SOX12;PIDD1;SLX1A;SLX1B;ZNF747;GJC2;ZCCHC11;RHBDF1;PER2;UNC119;C5;ZNF658;SNTA1;MINK1;PHF2;ABHD14B;TCEAL1;WWTR1;ITGA2;GLI3;THRAP3;ZNF558;IRX4;SMARCA1;BHLHE40;ZNF655;NAIP;ZNF333;MAP2K5;ITGA6;ZNF318;LZTS1;IGFBP4;TCFL5;TRAK1;JARID2;NUPR1;INSR;CCDC85B;GSN;CHD3;TTN;CBLC;DDT;ZNF18;AHNAK2;MXD4;ZNF287;CD109;PMS2P3;ETAA1;ZNF446;ZNF581;PILRB;ENDOG;SLC27A1;RTF1;MDK;IRF9;RICTOR;H2AFJ;BMP6;NLRX1;MAP2K2;GLI4;SQSTM1;PTK6;FZD7;ETV5;SYNGAP1;DLX3;HEXB;KDM4C;METTL23;ZNF608;PLA2G6;CST3;GDF15;TXNIP;CTF1;TCF4;NPHP3;PLAG1;MAP3K12;RCOR2;WRN;IFI27;ZYG11B;LPIN3;CDK5R1;ATRX;MAPK10;HFE;ADIRF;HMG20B;TRIM38;AGO4;ERCC6;SHC2;EDA2R;SPRY2;FBXO2;MEF2D;GABBR1;CREBRF;XRN1;MLXIPL;TARBP1;FBXW7;GPR87;ING4;CDK5RAP3;ZNF862;ATXN1;LMO2;NFIX;PAK6;TFPI2;CARF;MXI1;PFKFB2;THRA;APC2;ADARB1;RAI1;ELF1;IKZF4;NLRP1;ZBTB34;ZNF627;MIF4GD;DBP;NAB2;EPM2AIP1;LRP1;PEG3;ACP5;RFX2;ZNF554;MAP3K6;SALL2;WNK1;ZNF107;ZNF532;ZBTB20;PDE2A;ZNF334;MAF;STK16;LTB4R2;RET;ZMYND8;PRX;DAB2IP;CASZ1;RWDD3;CALCOCO1;TEAD2;MYSM1;FBXO4;TSHZ2;ZNF276;IFI16;FGFR4;PIK3R2;TEF;ZNF25;AREG;ABTB1;RPS6KA5;APBB3;ZNF630;BTG1;BST2;ZNF687;VDR;MAMSTR;TNRC18;TNRC6C;ZFP28;PLXND1;ZMYM3;SIX5;HLTF;PCSK6;ZNF789;ZNF563;ZNF517;PPP1R2;DMTN;PPP1R35;STAT2;WWC3;PHF1;ZNF292;TFDP2;SNX1;NRARP;ACVR1B;ZNF737;NECAB3;DLG4;TNNI2;PPP2R3B;ZNF701;NAT14;PANO1;TCEAL4;ZNF91;DYDC1;GTF2IRD2;TCF7;TNFRSF25;ZFP36L1;GLMP;ACSL1;IL11;KAT2B;ERN1;RNF141;IVNS1ABP;RAD50;ZNF439;ANGEL2;TRERF1;APBB2;PBLD;TNFSF12;STAT6;PCSK1N;SOX13;PRDX5;NELFCD;KLF8;CHD6;TRAF5;GOLGB1;RANBP9;HDAC11;PTPN3;ERBB2;ABCA2;KMT5C;AKAP6;ATG14;RORA;PPARG;PRKACA;CXXC5;ZNF572;ACKR3;ZNF658B;SERPING1;PARN;ZNF529;UFL1;RIPK3;KLF9;AIP;SCAND1;PRMT3;SNX33;ZFP90;PER3;ZFP30;FOXP2;PTBP2;ZC3H6;HIVEP1;SMURF1;NPNT;CTNNBIP1;PEMT;GCLC;ECM1
10892,GO:0044451,0.999968932613325,5.17901598131482e-05,67,972,nucleoplasm part,CC,TP53INP1;ASH2L;TRIM22;SRSF5;DGKQ;HR;CRY2;MAML3;NFATC4;H1F0;AP5Z1;HSF4;MDM2;CRTC1;OBSCN;POLR2J2;GLI2;TCEA2;PSKH1;WWTR1;GLI3;THRAP3;BHLHE40;JARID2;CHD3;PLEKHH2;RMI2;RTF1;SQSTM1;PTK6;FNBP4;UBOX5;NSMCE4A;CENPC;KLHDC2;PLAG1;WRN;ATRX;POLR2J3;HMG20B;AGO4;ERCC6;CREBRF;ING4;ATXN1;IKZF4;APPL2;SALL2;ZBTB20;IFI16;ERCC5;PHF7;TNRC18;STK19;PHF1;DYDC1;TCF7;LMNA;KAT2B;ANGEL2;TRERF1;RAPGEF5;NELFCD;CHD6;HDAC11;PRKACA;HIVEP1
2893,GO:0006401,0.999972723369321,7.49994754013838e-05,13,346,RNA catabolic process,BP,OAS2;CIRBP;PCBP4;ZFP36L2;ZCCHC11;THRAP3;AGO4;XRN1;TNRC6C;ZFP36L1;ERN1;ANGEL2;PARN
7306,GO:0031323,0.999973088829605,3.50975282386335e-05,415,4612,regulation of cellular metabolic process,BP,TNFAIP3;HES2;SERPINE2;ZSCAN18;ULK2;GPNMB;TSC22D1;SIK1;EPM2A;TP53INP1;IFI6;PTHLH;SREBF1;APOE;GPSM1;INPP5D;OAS2;MN1;LMF1;HSPA2;EGFR;TRIM65;CIRBP;FAM20C;PKD2;CAPRIN2;MNT;RBM3;ASH2L;TRIM22;SRSF5;SFRP1;MTHFR;PERM1;SEC14L2;EPHB2;MAP3K14;DGKQ;PIK3R1;RBCK1;KDM3A;TSC22D3;POU3F1;CAMKK1;HERC5;VAV3;UNK;HR;CSPG4;ISG15;ELFN2;HTRA1;TFCP2L1;RGMA;ZFPM1;KITLG;HOXC5;ZNF362;VAMP3;CITED4;IRF2BPL;MC1R;ZNF266;STAT1;IMPACT;CAMK2N1;CRY2;NSG1;THAP8;NOS1;PRKACB;ZNF704;HOXA3;CRY1;ZNF699;MAML3;ZFP41;SCMH1;KLF13;CRTAP;MAGEF1;NFATC4;ZNF783;SPDYE6;RNF187;HSF4;ZNF251;VPS11;COL7A1;SPOCK1;EAPP;MDM2;CRTC1;NDN;PPP2R2C;ZNF662;TYSND1;PIK3IP1;TNFSF10;NEO1;RAPGEF3;PHACTR3;ZNF414;TCF25;PCBP4;POLH;OAS1;FLRT3;MLLT6;RGS2;F2R;MLYCD;PDCD4;SERPINB5;ZNF160;RTN4RL1;ZFP36L2;TRPV4;FLOT1;GLI2;ADORA2B;KLF7;RNF165;LAMP3;TCEA2;MAPK8IP3;SPDYE5;ZNF76;SOX12;PIDD1;SLX1A;SLX1B;ZNF747;GJC2;ZCCHC11;RHBDF1;PER2;UNC119;C5;ZNF658;SNTA1;MINK1;PHF2;ABHD14B;TCEAL1;WWTR1;ITGA2;ULK1;GLI3;THRAP3;ZNF558;IRX4;SMARCA1;BHLHE40;LRSAM1;ZNF655;NAIP;ZNF333;MAP2K5;ITGA6;SESN3;ZNF318;LZTS1;IGFBP4;TCFL5;TRAK1;JARID2;NUPR1;INSR;CCDC85B;GSN;CHD3;TTN;CBLC;DDT;ZNF18;AHNAK2;MXD4;ZNF287;CD109;PMS2P3;ETAA1;ZNF446;ZNF581;PILRB;ENDOG;SLC27A1;RTF1;MDK;IRF9;RICTOR;H2AFJ;BMP6;NLRX1;MAP2K2;PDK1;GLI4;SQSTM1;CEP192;PTK6;FZD7;ETV5;SYNGAP1;DLX3;HEXB;KDM4C;METTL23;ZNF608;PLA2G6;CST3;GDF15;TXNIP;CTF1;TCF4;ATP6V0A2;NPHP3;PLAG1;MAP3K12;RCOR2;WRN;IFI27;ZYG11B;LPIN3;CDK5R1;ATRX;SESN1;MAPK10;HFE;ADIRF;HMG20B;CYBA;TRIM38;AGO4;ERCC6;SHC2;EDA2R;SPRY2;FBXO2;MEF2D;GABBR1;CREBRF;XRN1;MLXIPL;TARBP1;FBXW7;GPR87;ING4;CDK5RAP3;ZNF862;ATXN1;LMO2;NFIX;PAK6;TFPI2;CARF;MXI1;PFKFB2;THRA;ARAP1;ADARB1;RAI1;ELF1;IKZF4;ACACB;NLRP1;ZBTB34;ZNF627;MIF4GD;DBP;NAB2;EPM2AIP1;LRP1;PEG3;ACP5;RFX2;ZNF554;MAP3K6;SALL2;WNK1;ZNF107;ZNF532;ZBTB20;PDE2A;ZNF334;MAF;STK16;LTB4R2;RET;ZMYND8;PRX;DAB2IP;CASZ1;RWDD3;CALCOCO1;TEAD2;MYSM1;FBXO4;TSHZ2;ZNF276;IFI16;FGFR4;PIK3R2;TEF;ZNF25;AREG;RPS6KA5;APBB3;ZNF630;BTG1;BST2;ZNF687;VDR;MAMSTR;TNRC18;TNRC6C;ZFP28;PLXND1;ZMYM3;SIX5;HLTF;PCSK6;ZNF789;ZNF563;ZNF517;TBC1D16;PPP1R2;DMTN;PPP1R35;STAT2;LMTK3;WWC3;PHF1;ZNF292;TFDP2;NRARP;ACVR1B;ZNF737;NECAB3;DLG4;TNNI2;PPP2R3B;ZNF701;NAT14;PANO1;TCEAL4;ZNF91;DYDC1;GTF2IRD2;TCF7;TNFRSF25;ZFP36L1;GLMP;ACSL1;IL11;KAT2B;IRS2;ERN1;RNF141;IVNS1ABP;RAD50;ZNF439;ANGEL2;TRERF1;APBB2;PBLD;STAT6;PCSK1N;SOX13;PRDX5;NELFCD;KLF8;CHD6;TRAF5;GOLGB1;SRPX2;RANBP9;HDAC11;PTPN3;ERBB2;SPOCD1;ABCA2;KMT5C;AKAP6;ATG14;RORA;PPARG;PRKACA;CXXC5;ZNF572;ACKR3;ZNF658B;SERPING1;PARN;ZNF529;UFL1;RIPK3;KLF9;AIP;SCAND1;LONP2;PRMT3;SNX33;ZFP90;PER3;ZFP30;FOXP2;PTBP2;ZC3H6;HIVEP1;SMURF1;NPNT;CTNNBIP1;PEMT;GCLC;ECM1
18322,GO:1903311,0.999974494617169,8.27459791313826e-05,9,250,regulation of mRNA metabolic process,BP,CIRBP;PCBP4;ZFP36L2;THRAP3;XRN1;TNRC6C;ZFP36L1;ANGEL2;PARN
15958,GO:0080135,0.999978829607438,4.39111429829793e-05,30,535,regulation of cellular response to stress,BP,EGFR;PTPRS;SFRP1;PIK3R1;RGMA;IMPACT;CRY1;MAGEF1;MDM2;POLH;PDCD4;RTN4RL1;TRPV4;MAPK8IP3;MINK1;ETAA1;ENDOG;MAP2K2;FZD7;NSMCE4A;ERCC6;EDA2R;FBXW7;MAP3K6;DAB2IP;RWDD3;FBXO4;ERN1;ACKR3;SERINC3
14883,GO:0070727,0.999979941354613,3.08207883928839e-05,107,1466,cellular macromolecule localization,BP,TNFAIP3;SREBF1;APOE;EGFR;SRSF5;OBSL1;EPHB2;TMEM129;PIK3R1;EVI5L;KCNAB2;ZDHHC1;VAMP3;REEP2;NSG1;RAB43;RAB40B;MICALL1;TBC1D8;VPS11;MDM2;LZTS2;OBSCN;SYTL1;RAPGEF3;NUDCD3;AP1G2;HPS4;CLTCL1;FLOT1;TOM1L2;NLGN2;ANK3;GLI3;LRSAM1;VAMP2;GAS8;TRAK1;CELSR1;GSN;CEP68;SUN1;SEPT6;VPS39;PEX10;MICALL2;SQSTM1;CEP192;ETV5;SYNGAP1;EPB41L3;PEX7;BBS2;TXNIP;WRN;SEPT5;IFI27;OSCP1;ZDHHC12;CDK5R1;ATRX;SHANK3;HFE;WASH3P;IFT140;FBXW7;CDK5RAP3;ASTN2;RPH3AL;TBC1D17;LRP1;TSNARE1;C12ORF66;BBS1;PDE2A;ZMYND8;FBXO4;PIK3C3;CACNB3;TBC1D16;TMCO6;DMTN;SGSM2;TFDP2;SNX1;GOLGA7B;DLG4;ZFP36L1;LMNA;CEP250;PEX1;SCG5;TUB;GOLGB1;ERBB2;SYNGR1;ZDHHC24;AKAP6;LDLRAP1;NPAP1;SYNE2;NFASC;AIP;LONP2;SNX33;SMURF1;PEMT
10873,GO:0044427,0.999980442439585,3.60265521943135e-05,46,771,chromosomal part,CC,HSPA2;SYN1;ASH2L;KDM3A;HR;STAT1;SCMH1;H1F0;MLH3;SLX1A;SLX1B;PHF2;SMARCA1;CHD3;POLD4;ETAA1;SEPT6;H2AFJ;KDM4C;H1FX;NSMCE4A;CENPC;TCF4;WRN;ATRX;REC8;HLCS;MEF2D;CENPH;APPL2;SALL2;MAF;CALCOCO1;ZNF276;ERCC5;TNRC18;PHF1;DYDC1;TCF7;KAT2B;TEP1;RAD50;STAT6;PHC2;KMT5C;MSH5
8819,GO:0034613,0.999981112457488,2.91057127724856e-05,106,1456,cellular protein localization,BP,TNFAIP3;SREBF1;APOE;EGFR;SRSF5;OBSL1;EPHB2;TMEM129;PIK3R1;EVI5L;KCNAB2;ZDHHC1;VAMP3;REEP2;NSG1;RAB43;RAB40B;MICALL1;TBC1D8;VPS11;MDM2;LZTS2;OBSCN;SYTL1;RAPGEF3;NUDCD3;AP1G2;HPS4;CLTCL1;FLOT1;TOM1L2;NLGN2;ANK3;GLI3;LRSAM1;VAMP2;GAS8;TRAK1;CELSR1;GSN;CEP68;SUN1;SEPT6;VPS39;PEX10;MICALL2;SQSTM1;CEP192;ETV5;SYNGAP1;EPB41L3;PEX7;BBS2;TXNIP;WRN;SEPT5;IFI27;OSCP1;ZDHHC12;CDK5R1;ATRX;SHANK3;HFE;WASH3P;IFT140;FBXW7;CDK5RAP3;ASTN2;RPH3AL;TBC1D17;LRP1;TSNARE1;C12ORF66;BBS1;PDE2A;ZMYND8;FBXO4;PIK3C3;CACNB3;TBC1D16;TMCO6;DMTN;SGSM2;TFDP2;SNX1;GOLGA7B;DLG4;LMNA;CEP250;PEX1;SCG5;TUB;GOLGB1;ERBB2;SYNGR1;ZDHHC24;AKAP6;LDLRAP1;NPAP1;SYNE2;NFASC;AIP;LONP2;SNX33;SMURF1;PEMT
4533,GO:0010608,0.999982213375749,3.924501260022e-05,25,504,posttranscriptional regulation of gene expression,BP,EGFR;CIRBP;CAPRIN2;RBM3;UNK;IMPACT;PCBP4;RGS2;ZFP36L2;ZCCHC11;PER2;ITGA2;THRAP3;MAP2K2;AGO4;XRN1;MIF4GD;FBXO4;TNRC6C;ZFP36L1;ANGEL2;ERBB2;ATG14;PPARG;PARN
2861,GO:0006353,0.999983799723349,0.000205318253677031,1,107,DNA-templated transcription, termination,BP,SRSF5
2904,GO:0006414,0.999984319091648,0.000197931445995397,1,125,translational elongation,BP,ABTB1
10783,GO:0044271,0.999987030747054,1.73286476096131e-05,337,3948,cellular nitrogen compound biosynthetic process,BP,TNFAIP3;HES2;ZSCAN18;TSC22D1;SIK1;TP53INP1;PTHLH;SREBF1;APOE;NT5E;MN1;EGFR;CIRBP;PKD2;CAPRIN2;MNT;RBM3;ASH2L;TRIM22;SRSF5;SFRP1;PERM1;SEC14L2;DGKQ;PIK3R1;RBCK1;KDM3A;TSC22D3;POU3F1;DHTKD1;UNK;HR;ISG15;HTRA1;TFCP2L1;RGMA;ZFPM1;HOXC5;ZNF362;CITED4;IRF2BPL;NAPRT;MC1R;ZNF266;STAT1;IMPACT;CRY2;UROS;THAP8;NOS1;ZNF704;HOXA3;CRY1;ZNF699;MAML3;ZFP41;SCMH1;KLF13;NFATC4;ZNF783;RNF187;CMPK2;HSF4;ZNF251;LIG1;EAPP;MDM2;CRTC1;NDN;NMRK1;ST6GALNAC6;ZNF662;CERS4;NEO1;RAPGEF3;ZNF414;TCF25;POLH;POLR2J2;B4GALT6;MLLT6;RGS2;F2R;PDCD4;ZNF160;SWT1;ZFP36L2;TRPV4;GLI2;ADORA2B;KLF7;RNF165;TCEA2;ZNF76;SOX12;PIDD1;ZNF747;PER2;ZNF658;PHF2;ABHD14B;TCEAL1;WWTR1;ITGA2;GLI3;PCSK1;THRAP3;ZNF558;IRX4;SMARCA1;BHLHE40;ZNF655;ZNF333;MAP2K5;ITGA6;ZNF318;LZTS1;TCFL5;TRAK1;JARID2;NUPR1;INSR;CCDC85B;HSF2BP;CHD3;ST3GAL5;ZNF18;MXD4;POLD4;ZNF287;PMS2P3;RMI2;ZNF446;ZNF581;MGST2;RTF1;MDK;IRF9;H2AFJ;BMP6;NLRX1;TCIRG1;MAP2K2;OPLAH;ALDH7A1;GLI4;SQSTM1;FZD7;ETV5;DLX3;HEXB;KDM4C;METTL23;ZNF608;PLA2G6;GDF15;TXNIP;TCF4;ATP6V0A2;PLAG1;IDH2;RCOR2;WRN;IFI27;LPIN3;CDK5R1;ATRX;POLR2J3;MAPK10;HFE;ADIRF;HMG20B;TRIM38;AGO4;ERCC6;RRM2B;EDA2R;MEF2D;GABBR1;CREBRF;XRN1;MLXIPL;TARBP1;FBXW7;GPR87;ING4;CDK5RAP3;ZNF862;ATXN1;LMO2;NFIX;PAK6;CARF;PGM1;MXI1;PFKFB2;THRA;RAI1;ELF1;IKZF4;OGDHL;ZBTB34;ZNF627;TK2;MIF4GD;DBP;NAB2;EPM2AIP1;PEG3;RGS12;ACP5;RFX2;ZNF554;PPCS;SALL2;ZNF107;ZNF532;ZBTB20;PDE2A;ZNF334;MAF;STK16;LTB4R2;RET;ZMYND8;DAB2IP;CASZ1;RWDD3;CALCOCO1;TEAD2;MYSM1;FBXO4;TSHZ2;ZNF276;IFI16;DALRD3;FGFR4;PIK3R2;TEF;ZNF25;ABTB1;RPS6KA5;APBB3;ZNF630;BTG1;ZNF687;VDR;MAMSTR;TNRC18;TNRC6C;ZFP28;PLXND1;NADK;ZMYM3;SIX5;HLTF;PCSK6;ZNF789;ZNF563;ZNF517;STAT2;WWC3;PHF1;ZNF292;TFDP2;NRARP;ACVR1B;ZNF737;PRIMPOL;TNNI2;ZNF701;ALOXE3;NAT14;PALB2;MPI;TCEAL4;ZNF91;DYDC1;GTF2IRD2;TCF7;ZFP36L1;GLMP;IL11;KAT2B;TEP1;ERN1;RNF141;IVNS1ABP;RAD50;ZNF439;PNPO;TRERF1;UAP1L1;APBB2;CERS5;STAT6;SOX13;PRDX5;NELFCD;KLF8;CHD6;TRAF5;GOLGB1;HDAC11;ERBB2;SPOCD1;NUDT10;ABCA2;KMT5C;RORA;PPARG;CXXC5;POLM;ZNF572;ZNF658B;UCKL1;PARN;ZNF529;UFL1;RIPK3;KLF9;AIP;SCAND1;PRMT3;HARS2;ZFP90;PER3;ZFP30;FOXP2;ZC3H6;HIVEP1;SMURF1;NPNT;CTNNBIP1;PEMT;GCLC;ECM1
3252,GO:0006913,0.999987750537708,3.62502729712718e-05,12,301,nucleocytoplasmic transport,BP,SRSF5;MDM2;RAPGEF3;GLI3;TXNIP;IFI27;ATXN1;MX2;PDE2A;TMCO6;NPAP1;SMURF1
6146,GO:0019439,0.999987825278375,2.65212323462421e-05,27,554,aromatic compound catabolic process,BP,NT5E;OAS2;CIRBP;APOBEC3C;DHTKD1;H1F0;RAPGEF3;PCBP4;BLVRB;ZFP36L2;ZCCHC11;THRAP3;INSR;ENDOG;AGO4;XRN1;MLXIPL;PGM1;PFKFB2;OGDHL;PDE2A;TNRC6C;ZFP36L1;ERN1;ANGEL2;NUDT10;PARN
2898,GO:0006406,0.99998810976007,0.000155112081520095,1,103,mRNA export from nucleus,BP,SRSF5
15237,GO:0071427,0.99998810976007,0.000155112081520095,1,103,mRNA-containing ribonucleoprotein complex export from nucleus,BP,SRSF5
7940,GO:0032543,0.999988606487278,0.000147637515899543,1,129,mitochondrial translation,BP,HARS2
15410,GO:0071704,0.999988965966396,1.45215027442504e-05,740,7907,organic substance metabolic process,BP,TNFAIP3;TGFBI;HES2;SERPINE2;ZSCAN18;ULK2;GPNMB;TSC22D1;SIK1;MUC19;NPEPL1;DDB2;TP53INP1;IFI6;PTHLH;SREBF1;AMACR;PYGB;NYNRIN;ACTA2;APOE;CES2;NT5E;INPP5D;GAMT;FBXO41;OAS2;ADAM19;MN1;LMF1;HSPA2;FBXW4;EGFR;HERC3;PTPRS;CIRBP;FAM20C;PKD2;CAPRIN2;MNT;XPC;APOBEC3C;CXCR1;CPT2;RBM3;ASH2L;TRIM22;ALDH1A3;SRSF5;PLCD3;CTSO;SFRP1;OBSL1;MTHFR;PERM1;SEC14L2;KCTD11;EPHB2;MAP3K14;GLUD1;BPHL;DCAF16;DGKQ;TMEM129;PIK3R1;ADAMTS7;BRSK1;RBCK1;KDM3A;TSC22D3;CUL9;RNF135;POU3F1;SULF2;WNT3;H6PD;DHTKD1;CAMKK1;HERC5;UBXN4;VAV3;ST6GALNAC2;UNK;HR;CSPG4;ISG15;MVB12B;ELFN2;HTRA1;SPATA18;TFCP2L1;TENM4;RGMA;PI4KAP2;KCNAB2;ZFPM1;KITLG;HOXC5;MVD;ZDHHC1;ZNF362;CUL7;VAMP3;CITED4;IRF2BPL;NAPRT;MC1R;ZNF266;SRD5A3;STAT1;IMPACT;CAMK2N1;CRY2;NSG1;UROS;KDSR;RAB40B;THAP8;NOS1;PRKACB;ZNF704;HOXA3;CRY1;ZNF699;MAML3;ZFP41;SCMH1;KLF13;CRTAP;SDC3;MAGEF1;NFATC4;PITPNM3;ZNF783;HMGCL;SPDYE6;D2HGDH;BTBD2;FKBP5;RNF187;FERMT1;H1F0;CYP26B1;GAA;AP5Z1;CMPK2;THNSL2;HSF4;CNTRL;ZNF251;PIK3C2G;LIG1;CDK18;VPS11;SPEG;COL7A1;SPOCK1;EAPP;NAGLU;MDM2;CRTC1;PLCD1;NDN;MLH3;NMRK1;DDX59;ST6GALNAC6;PPP2R2C;ZNF662;TYSND1;LTBP4;PIK3IP1;OBSCN;IDUA;TNFSF10;PRODH;HGSNAT;FKBP9;UGT1A3;CERS4;CYP3A5;ACOT1;NEO1;RAPGEF3;PHACTR3;ZNF414;SPSB3;TCF25;ENDOD1;PCBP4;CTSV;POLH;BLVRB;POLR2J2;OAS1;FLRT3;RASA4;GAL3ST4;CRAT;B4GALT6;MLLT6;RGS2;F2R;MLYCD;PHYH;PDCD4;SPTB;SERPINB5;PPP1R3E;ALPK1;ZNF160;CAPN7;SWT1;SLC27A3;ARSI;NEK9;RTN4RL1;ZFP36L2;TRPV4;FLOT1;GLI2;ADORA2B;ANK3;KLF7;RNF165;NAT6;DHX32;ADAMTS13;LAMP3;TCEA2;PLCH2;MAPK8IP3;SPDYE5;ZNF76;SOX12;PIDD1;PARP6;SLX1A;SLX1B;G6PC3;ZNF747;GJC2;ZCCHC11;RHBDF1;SULT1E1;FBXO44;RASGEF1A;PER2;PITPNM2;PTGS1;UNC119;HEXA;FRS3;C5;ZNF658;ARSD;SNTA1;PSKH1;MINK1;PHF2;ABHD14B;GSTM2;TCEAL1;WWTR1;MBOAT2;ITGA2;ULK1;GLI3;SPPL2B;FGGY;PCSK1;TPGS1;THRAP3;ZNF558;IRX4;SMARCA1;BHLHE40;LRSAM1;ZNF655;NAIP;LTBP1;ZNF333;NEK8;MAP2K5;ITGA6;CES3;ZNF318;LZTS1;IGFBP4;MMP1;TCFL5;TRAK1;JARID2;NUPR1;PRR9;GPC2;NISCH;INSR;TST;CCDC85B;HSF2BP;MMP28;GSN;ALDH4A1;CHD3;CDK14;ST3GAL5;TTN;CBLC;DDT;ZNF18;AHNAK2;RNPEPL1;TRIOBP;MXD4;POLD4;CTSF;ZNF287;CD109;CYP2D7;NSUN5P2;PGLS;PMS2P3;ETAA1;RMI2;ZNF446;FBXL16;ZNF581;MGST2;PILRB;ENDOG;SLC27A1;PGAP1;GID4;RTF1;MDK;CASP14;IRF9;RICTOR;H2AFJ;BMP6;NLRX1;B4GALT2;ETNK2;PEX10;SLC2A3;TCIRG1;MAP2K2;OPLAH;PDK1;VEGFB;ALDH7A1;GLI4;SQSTM1;PTK6;FZD7;ETV5;AKR7A2;LOXL1;SYNGAP1;DLX3;SHARPIN;HEXB;KDM4C;HYAL1;METTL23;CLCA2;UBOX5;NSMCE4A;ARRDC1;B3GNT9;ZNF608;PLA2G6;CST3;PDIK1L;CAPNS2;GDF15;PEX7;BBS2;TXNIP;CTF1;THSD4;TCF4;ATP6V0A2;NPHP3;PLAG1;IDH2;MAP3K12;RCOR2;WRN;IFI27;DNM1;MCM9;TNFRSF21;ZYG11B;MACROD1;KLHL24;PLD3;TREX1;LPIN3;ZDHHC12;OARD1;CDK5R1;ATRX;REC8;PIGZ;OSBPL10;PI4KAP1;POLR2J3;MAPK10;NKTR;SHANK3;HFE;ADIRF;HMG20B;TRIM38;DTX3;AGO4;ERCC6;HADH;RRM2B;SLIT3;HLCS;SHC2;EDA2R;SPRY2;FBXO2;MEF2D;GABBR1;CREBRF;XRN1;MLXIPL;CTSB;KLK5;TARBP1;FBXW7;GPR87;ING4;CDK5RAP3;ZNF862;ATXN1;LMO2;NFIX;PAK6;TFPI2;CARF;PGM1;MXI1;PFKFB2;RNF170;THRA;APC2;METTL21A;ACADS;ARAP1;ADARB1;RAI1;ELF1;IKZF4;DCAF10;SLC2A1;ACACB;OGDHL;NLRP1;C1RL;ZBTB34;ZNF627;TK2;LACTB2;GLUL;TNS2;C17ORF97;MIF4GD;DBP;NDST2;NAB2;EPM2AIP1;FBXW5;SRR;LRP1;KLHDC8B;PEG3;RGS12;ATE1;ACP5;MPG;PLA2G7;RNPEP;RFX2;ZNF554;BDH1;MAP3K6;RIMKLB;PPCS;MYO3B;HEXDC;SALL2;WNK1;PMEL;ZNF107;ZNF532;ZBTB20;PDE2A;ZNF334;SDHA;MAF;STK16;LTB4R2;RET;ZMYND8;PRX;DAB2IP;CASZ1;RWDD3;ACOX3;CALCOCO1;TEAD2;MYSM1;DDHD2;FBXO4;RNF213;TSHZ2;PIK3C3;ZNF276;IFI16;DALRD3;FGFR4;ERCC5;PIK3R2;RETSAT;TEF;ZNF25;SETD4;OSBPL5;AREG;ABTB1;KLHL3;SNCB;ETFB;RPS6KA5;APBB3;ZNF630;BTG1;BST2;ZNF687;VDR;MAMSTR;TNRC18;TNRC6C;ZFP28;DPY19L2P2;PLXND1;NADK;ZMYM3;SIX5;HLTF;MARCH8;PCSK6;ZNF789;MPPE1;ZNF563;ZNF517;PCMTD2;TBC1D16;STK19;NDUFV3;PPP1R2;DMTN;PPP1R35;STAT2;ARFGEF2;LMTK3;PCMTD1;WWC3;PHF1;ZNF292;TFDP2;SNX1;GOLGA7B;OSBPL1A;NRARP;ACVR1B;ZNF737;KDELC2;PRIMPOL;NECAB3;DLG4;TNNI2;PPP2R3B;ESYT2;TSSK1B;ADCK5;ZNF701;ALOXE3;NAT14;PANO1;PALB2;ENDOU;MPI;IGFBP6;TCEAL4;ZNF91;DUOX1;GALE;PTMS;WEE1;DYDC1;GTF2IRD2;PTK7;DQX1;AMT;TCF7;TNFRSF25;ZFP36L1;XYLT1;MXRA8;GLMP;TOP3B;ACSL1;IL11;KAT2B;MARK4;TEP1;APOLD1;IRS2;IMPA2;ERN1;HSD17B14;RNF141;IVNS1ABP;ALOX15B;RAD50;ZNF439;TKFC;ANGEL2;PNPO;MTR;MAN1B1;DHRS4;ECI1;TRERF1;UAP1L1;FAAH;SCYL3;SCG5;APBB2;CBR4;ISYNA1;SGSH;PBLD;DCAF8;TNFSF12;CERS5;STAT6;PCSK1N;SOX13;PRDX5;PHPT1;NELFCD;SMPDL3B;GLB1;CPT1C;KLF8;GSTM3;RDH12;KLHL29;CHD6;TRAF5;GOLGB1;ACSS2;DPP7;TRIM2;CD9;RANBP9;HDAC11;PTPN3;CTSD;ERBB2;SPOCD1;PLCB3;NUDT10;UVSSA;ZDHHC24;PQLC3;PPM1M;ABCA2;KMT5C;AKAP6;TH;ATG14;RORA;SSH3;PPARG;PRKACA;LDLRAP1;CXXC5;POLM;ACOT2;GCNT4;ZNF572;ACKR3;PLTP;ZNF658B;SERPING1;SUCLG2;UCKL1;PARN;DDX12P;ZNF529;UFL1;LAMB2;IP6K2;RIPK3;KLF9;PI4K2B;AIP;SCAND1;LONP2;PRMT3;SNX33;HARS2;CIT;ZFP90;EHHADH;MSH5;CCDC3;PER3;ZFP30;FOXP2;PTBP2;ZC3H6;HIVEP1;SMURF1;NPNT;TTLL1;CTNNBIP1;PEMT;SERINC3;GCLC;ECM1
12831,GO:0051169,0.999989991080247,2.98832439079847e-05,12,304,nuclear transport,BP,SRSF5;MDM2;RAPGEF3;GLI3;TXNIP;IFI27;ATXN1;MX2;PDE2A;TMCO6;NPAP1;SMURF1
2897,GO:0006405,0.999991432241551,6.98816418405181e-05,2,133,RNA export from nucleus,BP,SRSF5;NPAP1
3663,GO:0008152,0.999991478327786,1.13081692833907e-05,776,8262,metabolic process,BP,TNFAIP3;TGFBI;HES2;SERPINE2;ZSCAN18;ULK2;GPNMB;TSC22D1;SIK1;SUGCT;EPM2A;MUC19;NPEPL1;DDB2;TP53INP1;IFI6;PTHLH;SREBF1;AMACR;PYGB;NYNRIN;ACTA2;APOE;GPSM1;CES2;NT5E;INPP5D;GAMT;FBXO41;OAS2;ADAM19;MN1;LMF1;HSPA2;FBXW4;EGFR;TRIM65;HERC3;PTPRS;CIRBP;FAM20C;PKD2;CAPRIN2;MNT;XPC;APOBEC3C;CXCR1;CPT2;RBM3;ASH2L;TRIM22;ALDH1A3;SRSF5;PLCD3;CTSO;SFRP1;OBSL1;MTHFR;PERM1;SEC14L2;KCTD11;EPHB2;GPX3;MAP3K14;GLUD1;BPHL;DCAF16;DGKQ;TMEM129;PIK3R1;ADAMTS7;BRSK1;TXNRD3;RBCK1;KDM3A;TSC22D3;CUL9;NSUN7;RNF135;POU3F1;SULF2;WNT3;H6PD;DHTKD1;CAMKK1;HERC5;UBXN4;VAV3;ST6GALNAC2;UNK;HR;CSPG4;ISG15;MVB12B;CYBRD1;ELFN2;HTRA1;SPATA18;TFCP2L1;TENM4;RGMA;PI4KAP2;KCNAB2;ZFPM1;KITLG;HOXC5;MVD;ZDHHC1;ZNF362;CUL7;VAMP3;CITED4;IRF2BPL;NAPRT;MC1R;ZNF266;SRD5A3;STAT1;IMPACT;CAMK2N1;CRY2;NSG1;UROS;KDSR;COL10A1;RAB40B;THAP8;NOS1;PRKACB;ZNF704;HOXA3;CRY1;ZNF699;MAML3;ZFP41;SCMH1;KLF13;CRTAP;DIP2C;SDC3;MAGEF1;NFATC4;PITPNM3;ZNF783;HMGCL;SPDYE6;D2HGDH;BTBD2;FKBP5;RNF187;FERMT1;H1F0;CYP26B1;GAA;AP5Z1;CMPK2;THNSL2;HSF4;CNTRL;ZNF251;PIK3C2G;LIG1;CDK18;VPS11;SPEG;COL7A1;SPOCK1;EAPP;NAGLU;MDM2;CRTC1;PLCD1;NDN;MLH3;NMRK1;DDX59;ST6GALNAC6;PPP2R2C;ZNF662;TYSND1;LTBP4;PIK3IP1;OBSCN;IDUA;TNFSF10;PRODH;HGSNAT;FKBP9;NDUFA4L2;TNXB;UGT1A3;CERS4;CYP3A5;ACOT1;NEO1;RAPGEF3;PHACTR3;ZNF414;SPSB3;TCF25;ENDOD1;PCBP4;CTSV;POLH;BLVRB;POLR2J2;OAS1;FLRT3;RASA4;GAL3ST4;CRAT;B4GALT6;MLLT6;RGS2;F2R;MLYCD;PHYH;PDCD4;SPTB;SERPINB5;PPP1R3E;ALPK1;ZNF160;CAPN7;SWT1;SLC27A3;ARSI;NEK9;RTN4RL1;ZFP36L2;TRPV4;FLOT1;GLI2;ADORA2B;ANK3;KLF7;RNF165;NAT6;DHX32;ADAMTS13;LAMP3;TCEA2;PLCH2;MAPK8IP3;SPDYE5;ZNF76;SOX12;PIDD1;PARP6;SLX1A;SLX1B;G6PC3;ATG16L2;ZNF747;GJC2;ZCCHC11;RHBDF1;SULT1E1;FBXO44;RASGEF1A;PER2;PITPNM2;PTGS1;UNC119;HEXA;FRS3;C5;ZNF658;ARSD;SNTA1;PSKH1;MINK1;PHF2;ABHD14B;GSTM2;TCEAL1;WWTR1;MBOAT2;ITGA2;ULK1;GLI3;SPPL2B;FGGY;PCSK1;TPGS1;THRAP3;ZNF558;IRX4;SMARCA1;BHLHE40;LRSAM1;ZNF655;NAIP;LTBP1;ZNF333;NEK8;MAP2K5;ITGA6;CES3;SESN3;ZNF318;LZTS1;IGFBP4;MMP1;TCFL5;TRAK1;JARID2;NUPR1;PRR9;GPC2;NISCH;INSR;TST;CCDC85B;HSF2BP;MMP28;GSN;ALDH4A1;CHD3;CDK14;ST3GAL5;TTN;CBLC;DDT;ZNF18;AHNAK2;RNPEPL1;TRIOBP;MXD4;POLD4;CTSF;ZNF287;CD109;CYP2D7;NSUN5P2;PGLS;PMS2P3;ETAA1;RMI2;ZNF446;FBXL16;VPS39;ZNF581;MGST2;PILRB;ENDOG;SLC27A1;PGAP1;GID4;RTF1;MDK;CASP14;IRF9;RICTOR;H2AFJ;BMP6;NLRX1;B4GALT2;ETNK2;PEX10;SLC2A3;TCIRG1;MAP2K2;OPLAH;PDK1;VEGFB;ALDH7A1;GLI4;SQSTM1;CEP192;PTK6;FZD7;ETV5;AKR7A2;LOXL1;SYNGAP1;FAM213A;DLX3;SHARPIN;HEXB;KDM4C;HYAL1;METTL23;CLCA2;UBOX5;NSMCE4A;ARRDC1;B3GNT9;ZNF608;PLA2G6;CST3;FAM86C2P;PDIK1L;CAPNS2;GDF15;PEX7;BBS2;TXNIP;CTF1;THSD4;TCF4;ATP6V0A2;COL6A1;NPHP3;PLAG1;IDH2;MAP3K12;RCOR2;WRN;IFI27;DNM1;MCM9;TNFRSF21;ZYG11B;MACROD1;KLHL24;PLD3;TREX1;LPIN3;ZDHHC12;OARD1;ABHD14A;CDK5R1;ATRX;REC8;PIGZ;CA2;OSBPL10;PI4KAP1;POLR2J3;SESN1;MAPK10;NKTR;SHANK3;HFE;ADIRF;HMG20B;CYBA;TRIM38;DTX3;AGO4;ERCC6;HADH;RRM2B;SLIT3;HLCS;SHC2;EDA2R;SPRY2;MRC2;FBXO2;MEF2D;GABBR1;CREBRF;XRN1;MLXIPL;CTSB;KLK5;TARBP1;FBXW7;GPR87;ING4;CDK5RAP3;ZNF862;ATXN1;LMO2;NFIX;PAK6;TFPI2;CARF;PGM1;MXI1;PFKFB2;RNF170;THRA;HSD11B1L;APC2;METTL21A;ACADS;ARAP1;ADARB1;RAI1;ELF1;IKZF4;DCAF10;SLC2A1;ACACB;ACCS;OGDHL;NLRP1;C1RL;ZBTB34;ZNF627;TK2;LACTB2;GLUL;TNS2;TBC1D17;C17ORF97;MIF4GD;DBP;NDST2;NAB2;EPM2AIP1;FBXW5;SRR;LRP1;KLHDC8B;PEG3;RGS12;ATE1;ACP5;MPG;PLA2G7;SYNPO2;RNPEP;RFX2;ZNF554;BDH1;MAP3K6;RIMKLB;PPCS;MYO3B;DHRS4L2;HEXDC;SALL2;WNK1;PMEL;ZNF107;ZNF532;ZBTB20;PDE2A;ZNF334;SDHA;MAF;STK16;LTB4R2;RET;ZMYND8;PRX;DAB2IP;CASZ1;RWDD3;ACOX3;CALCOCO1;TEAD2;MYSM1;DDHD2;FBXO4;RNF213;TSHZ2;PIK3C3;ZNF276;IFI16;DALRD3;FGFR4;ERCC5;PIK3R2;RETSAT;TEF;ZNF25;SETD4;OSBPL5;DHRS12;AREG;ABTB1;KLHL3;SNCB;ETFB;RPS6KA5;APBB3;ZNF630;BTG1;BST2;ZNF687;VDR;MAMSTR;TNRC18;TNRC6C;ZFP28;DPY19L2P2;PLXND1;NADK;ZMYM3;SIX5;HLTF;MARCH8;PCSK6;ZNF789;MPPE1;ZNF563;ZNF517;PCMTD2;TBC1D16;STK19;NDUFV3;PPP1R2;DMTN;FAHD2B;PPP1R35;STAT2;ARFGEF2;LMTK3;PCMTD1;WWC3;PHF1;ZNF292;TFDP2;SNX1;GOLGA7B;OSBPL1A;NRARP;ACVR1B;TMX4;ZNF737;KDELC2;PRIMPOL;NECAB3;DLG4;TNNI2;PPP2R3B;ESYT2;TSSK1B;ADCK5;ZNF701;ALOXE3;NAT14;PANO1;PALB2;ENDOU;MPI;IGFBP6;TCEAL4;ZNF91;DUOX1;GALE;PTMS;WEE1;DYDC1;GTF2IRD2;PTK7;DQX1;AMT;TCF7;TNFRSF25;ZFP36L1;XYLT1;MXRA8;GLMP;TOP3B;ACSL1;IL11;KAT2B;MARK4;TEP1;APOLD1;IRS2;IMPA2;METTL7A;ERN1;HSD17B14;RNF141;IVNS1ABP;ALOX15B;RAD50;ZNF439;TKFC;ANGEL2;PNPO;MTR;MAN1B1;DHRS4;ECI1;TRERF1;UAP1L1;FAAH;SCYL3;SCG5;APBB2;CBR4;TTC19;ISYNA1;SGSH;PBLD;DCAF8;TNFSF12;CERS5;STAT6;PCSK1N;SOX13;PRDX5;PHPT1;NELFCD;SMPDL3B;GLB1;CPT1C;KLF8;GSTM3;RDH12;KLHL29;CHD6;TRAF5;GOLGB1;SRPX2;ACSS2;DPP7;TRIM2;CD9;RANBP9;HDAC11;PTPN3;CTSD;COL13A1;ERBB2;SPOCD1;PLCB3;NUDT10;UVSSA;ZDHHC24;PQLC3;PPM1M;ABCA2;KMT5C;AKAP6;TH;ATG14;RORA;SSH3;PPARG;PRKACA;LDLRAP1;CXXC5;POLM;ACOT2;GCNT4;ZNF572;ACKR3;PLTP;ZNF658B;SERPING1;SUCLG2;UCKL1;PARN;DDX12P;ZNF529;UFL1;LAMB2;IP6K2;RIPK3;KLF9;PI4K2B;AIP;SCAND1;LONP2;PRMT3;SNX33;HARS2;CIT;ZFP90;EHHADH;MSH5;CCDC3;PER3;ZFP30;FOXP2;PTBP2;ZC3H6;HIVEP1;SMURF1;NPNT;TTLL1;CTNNBIP1;PEMT;SERINC3;GCLC;ECM1
3232,GO:0006886,0.999991604730279,1.50562856422661e-05,56,917,intracellular protein transport,BP,SREBF1;SRSF5;TMEM129;EVI5L;ZDHHC1;REEP2;NSG1;RAB43;RAB40B;MICALL1;TBC1D8;VPS11;MDM2;SYTL1;RAPGEF3;AP1G2;HPS4;CLTCL1;TOM1L2;ANK3;GLI3;VAMP2;TRAK1;VPS39;PEX10;MICALL2;PEX7;TXNIP;IFI27;OSCP1;ZDHHC12;CDK5R1;WASH3P;FBXW7;RPH3AL;TBC1D17;TSNARE1;PDE2A;TBC1D16;TMCO6;DMTN;SGSM2;SNX1;GOLGA7B;PEX1;SCG5;ERBB2;SYNGR1;ZDHHC24;AKAP6;NPAP1;AIP;LONP2;SNX33;SMURF1;PEMT
11874,GO:0046907,0.999992861751696,1.12773704255607e-05,103,1456,intracellular transport,BP,SREBF1;APOE;LMF1;SYT8;CPT2;SYN1;SRSF5;TMEM129;EVI5L;MVB12B;ZDHHC1;VAMP3;REEP2;NSG1;RAB43;RAB40B;AP5Z1;MICALL1;TBC1D8;VPS11;COL7A1;MDM2;SYTL1;RAPGEF3;AP1G2;C2CD4C;HPS4;BLOC1S4;SPTB;CLTCL1;TOM1L2;ADORA2B;ANK3;RIMS3;SPG11;SYT15;GLI3;VAMP2;TRAK1;SUN1;RAB11FIP4;VPS39;PGAP1;BLOC1S3;PEX10;MICALL2;MAP2K2;SQSTM1;WHAMMP3;PEX7;BBS2;TXNIP;SEPT5;IFI27;OSCP1;DNM1;ZDHHC12;CDK5R1;HOOK2;WASH3P;IFT140;RAB11FIP3;FBXW7;ANKRD28;ATXN1;MX2;RPH3AL;ACACB;TBC1D17;TSNARE1;PDE2A;DDHD2;PIK3C3;SYT7;BBS5;AREG;MPPE1;TBC1D16;TMCO6;DMTN;SGSM2;ALMS1;SNX1;GOLGA7B;CCDC88B;PEX1;SCG5;GOLGB1;ERBB2;SYNGR1;ZDHHC24;ABCA2;AKAP6;ATG14;LDLRAP1;NPAP1;SYNE2;AIP;COG1;LONP2;SNX33;SMURF1;PEMT
10781,GO:0044267,0.999993749080701,8.44681122982807e-06,332,3915,cellular protein metabolic process,BP,TNFAIP3;TGFBI;SERPINE2;ULK2;GPNMB;SIK1;MUC19;DDB2;IFI6;SREBF1;APOE;FBXO41;LMF1;HSPA2;FBXW4;EGFR;HERC3;PTPRS;CIRBP;FAM20C;PKD2;CAPRIN2;RBM3;ASH2L;TRIM22;CTSO;SFRP1;OBSL1;MTHFR;KCTD11;EPHB2;MAP3K14;DCAF16;DGKQ;TMEM129;PIK3R1;ADAMTS7;BRSK1;RBCK1;KDM3A;CUL9;RNF135;CAMKK1;HERC5;UBXN4;ST6GALNAC2;UNK;HR;CSPG4;ISG15;MVB12B;ELFN2;SPATA18;KITLG;MVD;ZDHHC1;CUL7;SRD5A3;IMPACT;CAMK2N1;CRY2;RAB40B;NOS1;PRKACB;CRY1;CRTAP;MAGEF1;SPDYE6;D2HGDH;BTBD2;FKBP5;RNF187;HSF4;CNTRL;CDK18;VPS11;SPEG;COL7A1;SPOCK1;MDM2;ST6GALNAC6;PPP2R2C;OBSCN;TNFSF10;FKBP9;RAPGEF3;PHACTR3;SPSB3;CTSV;FLRT3;RASA4;B4GALT6;RGS2;F2R;PDCD4;SPTB;SERPINB5;ALPK1;ARSI;NEK9;RTN4RL1;ZFP36L2;TRPV4;FLOT1;ADORA2B;RNF165;NAT6;ADAMTS13;LAMP3;MAPK8IP3;SPDYE5;PIDD1;PARP6;ZNF747;GJC2;RHBDF1;FBXO44;RASGEF1A;PER2;UNC119;FRS3;C5;ARSD;SNTA1;PSKH1;MINK1;PHF2;WWTR1;ITGA2;ULK1;SPPL2B;TPGS1;LRSAM1;NAIP;LTBP1;NEK8;MAP2K5;IGFBP4;MMP1;TRAK1;JARID2;NUPR1;PRR9;INSR;GSN;CHD3;CDK14;ST3GAL5;TTN;CBLC;DDT;TRIOBP;CTSF;CD109;ETAA1;FBXL16;PILRB;SLC27A1;PGAP1;GID4;RTF1;RICTOR;BMP6;B4GALT2;PEX10;TCIRG1;MAP2K2;PDK1;VEGFB;SQSTM1;PTK6;FZD7;LOXL1;SYNGAP1;SHARPIN;HEXB;KDM4C;UBOX5;ARRDC1;B3GNT9;PLA2G6;CST3;PDIK1L;GDF15;CTF1;MAP3K12;IFI27;ZYG11B;MACROD1;KLHL24;ZDHHC12;CDK5R1;ATRX;PIGZ;MAPK10;NKTR;SHANK3;HFE;HMG20B;TRIM38;DTX3;AGO4;ERCC6;HLCS;SHC2;EDA2R;SPRY2;FBXO2;XRN1;MLXIPL;CTSB;FBXW7;ING4;CDK5RAP3;ZNF862;PAK6;TFPI2;RNF170;METTL21A;ADARB1;DCAF10;NLRP1;TNS2;C17ORF97;MIF4GD;NAB2;FBXW5;LRP1;KLHDC8B;ATE1;MAP3K6;RIMKLB;MYO3B;WNK1;STK16;RET;ZMYND8;DAB2IP;RWDD3;MYSM1;FBXO4;RNF213;PIK3C3;IFI16;DALRD3;FGFR4;PIK3R2;SETD4;AREG;ABTB1;KLHL3;ETFB;RPS6KA5;BTG1;BST2;TNRC6C;DPY19L2P2;HLTF;MARCH8;MPPE1;PCMTD2;STK19;PPP1R2;DMTN;PPP1R35;STAT2;LMTK3;PCMTD1;PHF1;GOLGA7B;ACVR1B;DLG4;PPP2R3B;TSSK1B;ADCK5;PANO1;MPI;IGFBP6;WEE1;DYDC1;PTK7;TNFRSF25;ZFP36L1;MXRA8;ACSL1;IL11;KAT2B;MARK4;IRS2;ERN1;RNF141;RAD50;MAN1B1;SCYL3;PBLD;DCAF8;PCSK1N;PRDX5;PHPT1;KLHL29;TRIM2;RANBP9;HDAC11;PTPN3;ERBB2;UVSSA;ZDHHC24;PQLC3;PPM1M;KMT5C;AKAP6;ATG14;SSH3;PPARG;PRKACA;GCNT4;ACKR3;SERPING1;UFL1;LAMB2;RIPK3;LONP2;PRMT3;SNX33;HARS2;CIT;EHHADH;SMURF1;NPNT;TTLL1;GCLC;ECM1
10777,GO:0044260,0.999994502617348,7.23983147107709e-06,567,6229,cellular macromolecule metabolic process,BP,TNFAIP3;TGFBI;HES2;SERPINE2;ZSCAN18;ULK2;GPNMB;TSC22D1;SIK1;MUC19;DDB2;TP53INP1;IFI6;SREBF1;PYGB;NYNRIN;APOE;NT5E;FBXO41;OAS2;MN1;LMF1;HSPA2;FBXW4;EGFR;HERC3;PTPRS;CIRBP;FAM20C;PKD2;CAPRIN2;MNT;XPC;APOBEC3C;CXCR1;RBM3;ASH2L;TRIM22;SRSF5;CTSO;SFRP1;OBSL1;MTHFR;PERM1;SEC14L2;KCTD11;EPHB2;MAP3K14;DCAF16;DGKQ;TMEM129;PIK3R1;ADAMTS7;BRSK1;RBCK1;KDM3A;TSC22D3;CUL9;RNF135;POU3F1;SULF2;CAMKK1;HERC5;UBXN4;ST6GALNAC2;UNK;HR;CSPG4;ISG15;MVB12B;ELFN2;HTRA1;SPATA18;TFCP2L1;RGMA;ZFPM1;KITLG;HOXC5;MVD;ZDHHC1;ZNF362;CUL7;VAMP3;CITED4;IRF2BPL;MC1R;ZNF266;SRD5A3;STAT1;IMPACT;CAMK2N1;CRY2;NSG1;RAB40B;THAP8;NOS1;PRKACB;ZNF704;HOXA3;CRY1;ZNF699;MAML3;ZFP41;SCMH1;KLF13;CRTAP;MAGEF1;NFATC4;ZNF783;SPDYE6;D2HGDH;BTBD2;FKBP5;RNF187;H1F0;GAA;AP5Z1;HSF4;CNTRL;ZNF251;LIG1;CDK18;VPS11;SPEG;COL7A1;SPOCK1;EAPP;MDM2;CRTC1;NDN;MLH3;ST6GALNAC6;PPP2R2C;ZNF662;OBSCN;IDUA;TNFSF10;FKBP9;NEO1;RAPGEF3;PHACTR3;ZNF414;SPSB3;TCF25;PCBP4;CTSV;POLH;POLR2J2;FLRT3;RASA4;GAL3ST4;B4GALT6;MLLT6;RGS2;F2R;PDCD4;SPTB;SERPINB5;PPP1R3E;ALPK1;ZNF160;SWT1;ARSI;NEK9;RTN4RL1;ZFP36L2;TRPV4;FLOT1;GLI2;ADORA2B;KLF7;RNF165;NAT6;ADAMTS13;LAMP3;TCEA2;MAPK8IP3;SPDYE5;ZNF76;SOX12;PIDD1;PARP6;SLX1A;SLX1B;ZNF747;GJC2;ZCCHC11;RHBDF1;FBXO44;RASGEF1A;PER2;UNC119;HEXA;FRS3;C5;ZNF658;ARSD;SNTA1;PSKH1;MINK1;PHF2;ABHD14B;TCEAL1;WWTR1;ITGA2;ULK1;GLI3;SPPL2B;TPGS1;THRAP3;ZNF558;IRX4;SMARCA1;BHLHE40;LRSAM1;ZNF655;NAIP;LTBP1;ZNF333;NEK8;MAP2K5;ITGA6;ZNF318;LZTS1;IGFBP4;MMP1;TCFL5;TRAK1;JARID2;NUPR1;PRR9;INSR;CCDC85B;HSF2BP;GSN;CHD3;CDK14;ST3GAL5;TTN;CBLC;DDT;ZNF18;TRIOBP;MXD4;POLD4;CTSF;ZNF287;CD109;NSUN5P2;PMS2P3;ETAA1;RMI2;ZNF446;FBXL16;ZNF581;PILRB;ENDOG;SLC27A1;PGAP1;GID4;RTF1;MDK;IRF9;RICTOR;H2AFJ;BMP6;NLRX1;B4GALT2;PEX10;TCIRG1;MAP2K2;PDK1;VEGFB;GLI4;SQSTM1;PTK6;FZD7;ETV5;LOXL1;SYNGAP1;DLX3;SHARPIN;HEXB;KDM4C;HYAL1;METTL23;UBOX5;NSMCE4A;ARRDC1;B3GNT9;ZNF608;PLA2G6;CST3;PDIK1L;GDF15;TXNIP;CTF1;TCF4;PLAG1;MAP3K12;RCOR2;WRN;IFI27;DNM1;MCM9;ZYG11B;MACROD1;KLHL24;TREX1;LPIN3;ZDHHC12;CDK5R1;ATRX;REC8;PIGZ;POLR2J3;MAPK10;NKTR;SHANK3;HFE;ADIRF;HMG20B;TRIM38;DTX3;AGO4;ERCC6;RRM2B;HLCS;SHC2;EDA2R;SPRY2;FBXO2;MEF2D;CREBRF;XRN1;MLXIPL;CTSB;TARBP1;FBXW7;ING4;CDK5RAP3;ZNF862;ATXN1;LMO2;NFIX;PAK6;TFPI2;CARF;PGM1;MXI1;RNF170;THRA;METTL21A;ARAP1;ADARB1;RAI1;ELF1;IKZF4;DCAF10;NLRP1;ZBTB34;ZNF627;TK2;TNS2;C17ORF97;MIF4GD;DBP;NDST2;NAB2;EPM2AIP1;FBXW5;LRP1;KLHDC8B;PEG3;RGS12;ATE1;MPG;RFX2;ZNF554;MAP3K6;RIMKLB;MYO3B;SALL2;WNK1;ZNF107;ZNF532;ZBTB20;PDE2A;ZNF334;MAF;STK16;RET;ZMYND8;DAB2IP;CASZ1;RWDD3;CALCOCO1;TEAD2;MYSM1;FBXO4;RNF213;TSHZ2;PIK3C3;ZNF276;IFI16;DALRD3;FGFR4;ERCC5;PIK3R2;TEF;ZNF25;SETD4;AREG;ABTB1;KLHL3;ETFB;RPS6KA5;APBB3;ZNF630;BTG1;BST2;ZNF687;VDR;MAMSTR;TNRC18;TNRC6C;ZFP28;DPY19L2P2;PLXND1;ZMYM3;SIX5;HLTF;MARCH8;PCSK6;ZNF789;MPPE1;ZNF563;ZNF517;PCMTD2;TBC1D16;STK19;PPP1R2;DMTN;PPP1R35;STAT2;ARFGEF2;LMTK3;PCMTD1;WWC3;PHF1;ZNF292;TFDP2;SNX1;GOLGA7B;NRARP;ACVR1B;ZNF737;PRIMPOL;NECAB3;DLG4;TNNI2;PPP2R3B;TSSK1B;ADCK5;ZNF701;NAT14;PANO1;PALB2;MPI;IGFBP6;TCEAL4;ZNF91;PTMS;WEE1;DYDC1;GTF2IRD2;PTK7;TCF7;TNFRSF25;ZFP36L1;XYLT1;MXRA8;GLMP;TOP3B;ACSL1;IL11;KAT2B;MARK4;TEP1;IRS2;ERN1;RNF141;IVNS1ABP;RAD50;ZNF439;ANGEL2;MAN1B1;TRERF1;SCYL3;APBB2;SGSH;PBLD;DCAF8;STAT6;PCSK1N;SOX13;PRDX5;PHPT1;NELFCD;KLF8;KLHL29;CHD6;TRAF5;GOLGB1;TRIM2;CD9;RANBP9;HDAC11;PTPN3;ERBB2;SPOCD1;UVSSA;ZDHHC24;PQLC3;PPM1M;ABCA2;KMT5C;AKAP6;ATG14;RORA;SSH3;PPARG;PRKACA;LDLRAP1;CXXC5;POLM;GCNT4;ZNF572;ACKR3;ZNF658B;SERPING1;PARN;ZNF529;UFL1;LAMB2;RIPK3;KLF9;SCAND1;LONP2;PRMT3;SNX33;HARS2;CIT;ZFP90;EHHADH;MSH5;PER3;ZFP30;FOXP2;ZC3H6;HIVEP1;SMURF1;NPNT;TTLL1;CTNNBIP1;GCLC;ECM1
3600,GO:0008033,0.999995388944371,6.45826820592029e-05,1,120,tRNA processing,BP,TARBP1
6595,GO:0022618,0.999995775753904,2.31059116416892e-05,4,193,ribonucleoprotein complex assembly,BP,CIRBP;SRSF5;AGO4;PTBP2
10767,GO:0044238,0.999996056143594,5.24650968212643e-06,714,7693,primary metabolic process,BP,TNFAIP3;TGFBI;HES2;SERPINE2;ZSCAN18;ULK2;GPNMB;TSC22D1;SIK1;MUC19;NPEPL1;DDB2;TP53INP1;IFI6;PTHLH;SREBF1;AMACR;PYGB;NYNRIN;APOE;CES2;NT5E;INPP5D;GAMT;FBXO41;OAS2;ADAM19;MN1;LMF1;HSPA2;FBXW4;EGFR;HERC3;PTPRS;CIRBP;FAM20C;PKD2;CAPRIN2;MNT;XPC;APOBEC3C;CPT2;RBM3;ASH2L;TRIM22;ALDH1A3;SRSF5;PLCD3;CTSO;SFRP1;OBSL1;MTHFR;PERM1;SEC14L2;KCTD11;EPHB2;MAP3K14;GLUD1;BPHL;DCAF16;DGKQ;TMEM129;PIK3R1;ADAMTS7;BRSK1;RBCK1;KDM3A;TSC22D3;CUL9;RNF135;POU3F1;SULF2;H6PD;DHTKD1;CAMKK1;HERC5;UBXN4;VAV3;ST6GALNAC2;UNK;HR;CSPG4;ISG15;MVB12B;ELFN2;HTRA1;SPATA18;TFCP2L1;TENM4;RGMA;PI4KAP2;KCNAB2;ZFPM1;KITLG;HOXC5;MVD;ZDHHC1;ZNF362;CUL7;CITED4;IRF2BPL;NAPRT;MC1R;ZNF266;SRD5A3;STAT1;IMPACT;CAMK2N1;CRY2;NSG1;KDSR;RAB40B;THAP8;NOS1;PRKACB;ZNF704;HOXA3;CRY1;ZNF699;MAML3;ZFP41;SCMH1;KLF13;CRTAP;SDC3;MAGEF1;NFATC4;PITPNM3;ZNF783;HMGCL;SPDYE6;D2HGDH;BTBD2;FKBP5;RNF187;H1F0;CYP26B1;GAA;AP5Z1;CMPK2;THNSL2;HSF4;CNTRL;ZNF251;PIK3C2G;LIG1;CDK18;VPS11;SPEG;COL7A1;SPOCK1;EAPP;MDM2;CRTC1;PLCD1;NDN;MLH3;NMRK1;DDX59;ST6GALNAC6;PPP2R2C;ZNF662;TYSND1;LTBP4;PIK3IP1;OBSCN;IDUA;TNFSF10;PRODH;FKBP9;UGT1A3;CERS4;CYP3A5;ACOT1;NEO1;RAPGEF3;PHACTR3;ZNF414;SPSB3;TCF25;ENDOD1;PCBP4;CTSV;POLH;POLR2J2;OAS1;FLRT3;RASA4;GAL3ST4;CRAT;B4GALT6;MLLT6;RGS2;F2R;MLYCD;PHYH;PDCD4;SPTB;SERPINB5;PPP1R3E;ALPK1;ZNF160;CAPN7;SWT1;SLC27A3;ARSI;NEK9;RTN4RL1;ZFP36L2;TRPV4;FLOT1;GLI2;ADORA2B;KLF7;RNF165;NAT6;DHX32;ADAMTS13;LAMP3;TCEA2;PLCH2;MAPK8IP3;SPDYE5;ZNF76;SOX12;PIDD1;PARP6;SLX1A;SLX1B;G6PC3;ZNF747;GJC2;ZCCHC11;RHBDF1;SULT1E1;FBXO44;RASGEF1A;PER2;PITPNM2;PTGS1;UNC119;HEXA;FRS3;C5;ZNF658;ARSD;SNTA1;PSKH1;MINK1;PHF2;ABHD14B;GSTM2;TCEAL1;WWTR1;MBOAT2;ITGA2;ULK1;GLI3;SPPL2B;FGGY;PCSK1;TPGS1;THRAP3;ZNF558;IRX4;SMARCA1;BHLHE40;LRSAM1;ZNF655;NAIP;LTBP1;ZNF333;NEK8;MAP2K5;ITGA6;CES3;ZNF318;LZTS1;IGFBP4;MMP1;TCFL5;TRAK1;JARID2;NUPR1;PRR9;GPC2;NISCH;INSR;CCDC85B;HSF2BP;MMP28;GSN;ALDH4A1;CHD3;CDK14;ST3GAL5;TTN;CBLC;DDT;ZNF18;AHNAK2;RNPEPL1;TRIOBP;MXD4;POLD4;CTSF;ZNF287;CD109;CYP2D7;NSUN5P2;PGLS;PMS2P3;ETAA1;RMI2;ZNF446;FBXL16;ZNF581;MGST2;PILRB;ENDOG;SLC27A1;PGAP1;GID4;RTF1;MDK;CASP14;IRF9;RICTOR;H2AFJ;BMP6;NLRX1;B4GALT2;ETNK2;PEX10;SLC2A3;TCIRG1;MAP2K2;PDK1;VEGFB;ALDH7A1;GLI4;SQSTM1;PTK6;FZD7;ETV5;AKR7A2;LOXL1;SYNGAP1;DLX3;SHARPIN;HEXB;KDM4C;HYAL1;METTL23;CLCA2;UBOX5;NSMCE4A;ARRDC1;B3GNT9;ZNF608;PLA2G6;CST3;PDIK1L;CAPNS2;GDF15;PEX7;TXNIP;CTF1;THSD4;TCF4;ATP6V0A2;NPHP3;PLAG1;IDH2;MAP3K12;RCOR2;WRN;IFI27;MCM9;TNFRSF21;ZYG11B;MACROD1;KLHL24;PLD3;TREX1;LPIN3;ZDHHC12;OARD1;CDK5R1;ATRX;REC8;PIGZ;OSBPL10;PI4KAP1;POLR2J3;MAPK10;NKTR;SHANK3;HFE;ADIRF;HMG20B;TRIM38;DTX3;AGO4;ERCC6;HADH;RRM2B;HLCS;SHC2;EDA2R;SPRY2;FBXO2;MEF2D;GABBR1;CREBRF;XRN1;MLXIPL;CTSB;KLK5;TARBP1;FBXW7;GPR87;ING4;CDK5RAP3;ZNF862;ATXN1;LMO2;NFIX;PAK6;TFPI2;CARF;PGM1;MXI1;PFKFB2;RNF170;THRA;APC2;METTL21A;ACADS;ADARB1;RAI1;ELF1;IKZF4;DCAF10;SLC2A1;ACACB;OGDHL;NLRP1;C1RL;ZBTB34;ZNF627;TK2;LACTB2;GLUL;TNS2;C17ORF97;MIF4GD;DBP;NDST2;NAB2;EPM2AIP1;FBXW5;SRR;LRP1;KLHDC8B;PEG3;RGS12;ATE1;MPG;PLA2G7;RNPEP;RFX2;ZNF554;MAP3K6;RIMKLB;PPCS;MYO3B;HEXDC;SALL2;WNK1;ZNF107;ZNF532;ZBTB20;PDE2A;ZNF334;SDHA;MAF;STK16;LTB4R2;RET;ZMYND8;PRX;DAB2IP;CASZ1;RWDD3;ACOX3;CALCOCO1;TEAD2;MYSM1;DDHD2;FBXO4;RNF213;TSHZ2;PIK3C3;ZNF276;IFI16;DALRD3;FGFR4;ERCC5;PIK3R2;RETSAT;TEF;ZNF25;SETD4;OSBPL5;AREG;ABTB1;KLHL3;ETFB;RPS6KA5;APBB3;ZNF630;BTG1;BST2;ZNF687;VDR;MAMSTR;TNRC18;TNRC6C;ZFP28;DPY19L2P2;PLXND1;NADK;ZMYM3;SIX5;HLTF;MARCH8;PCSK6;ZNF789;MPPE1;ZNF563;ZNF517;PCMTD2;STK19;NDUFV3;PPP1R2;DMTN;PPP1R35;STAT2;LMTK3;PCMTD1;WWC3;PHF1;ZNF292;TFDP2;SNX1;GOLGA7B;OSBPL1A;NRARP;ACVR1B;ZNF737;KDELC2;PRIMPOL;NECAB3;DLG4;TNNI2;PPP2R3B;ESYT2;TSSK1B;ADCK5;ZNF701;ALOXE3;NAT14;PANO1;PALB2;ENDOU;MPI;IGFBP6;TCEAL4;ZNF91;GALE;PTMS;WEE1;DYDC1;GTF2IRD2;PTK7;DQX1;AMT;TCF7;TNFRSF25;ZFP36L1;XYLT1;MXRA8;GLMP;TOP3B;ACSL1;IL11;KAT2B;MARK4;TEP1;APOLD1;IRS2;IMPA2;ERN1;HSD17B14;RNF141;IVNS1ABP;ALOX15B;RAD50;ZNF439;TKFC;ANGEL2;MTR;MAN1B1;DHRS4;ECI1;TRERF1;UAP1L1;FAAH;SCYL3;SCG5;APBB2;CBR4;ISYNA1;SGSH;PBLD;DCAF8;TNFSF12;CERS5;STAT6;PCSK1N;SOX13;PRDX5;PHPT1;NELFCD;SMPDL3B;GLB1;CPT1C;KLF8;RDH12;KLHL29;CHD6;TRAF5;GOLGB1;ACSS2;DPP7;TRIM2;RANBP9;HDAC11;PTPN3;CTSD;ERBB2;SPOCD1;PLCB3;NUDT10;UVSSA;ZDHHC24;PQLC3;PPM1M;ABCA2;KMT5C;AKAP6;TH;ATG14;RORA;SSH3;PPARG;PRKACA;LDLRAP1;CXXC5;POLM;ACOT2;GCNT4;ZNF572;ACKR3;PLTP;ZNF658B;SERPING1;SUCLG2;UCKL1;PARN;DDX12P;ZNF529;UFL1;LAMB2;IP6K2;RIPK3;KLF9;PI4K2B;AIP;SCAND1;LONP2;PRMT3;SNX33;HARS2;CIT;ZFP90;EHHADH;MSH5;CCDC3;PER3;ZFP30;FOXP2;PTBP2;ZC3H6;HIVEP1;SMURF1;NPNT;TTLL1;CTNNBIP1;PEMT;SERINC3;GCLC;ECM1
13680,GO:0060255,0.999997409123565,3.49260371257792e-06,400,4568,regulation of macromolecule metabolic process,BP,TNFAIP3;HES2;SERPINE2;ZSCAN18;GPNMB;TSC22D1;SIK1;TP53INP1;IFI6;PTHLH;SREBF1;ACTA2;APOE;INPP5D;OAS2;MN1;HSPA2;EGFR;CIRBP;PKD2;CAPRIN2;MNT;RBM3;ASH2L;TRIM22;SRSF5;SFRP1;MTHFR;PERM1;SEC14L2;EPHB2;MAP3K14;DGKQ;PIK3R1;RBCK1;KDM3A;TSC22D3;POU3F1;WNT3;CAMKK1;HERC5;UNK;HR;CSPG4;ISG15;ELFN2;HTRA1;TFCP2L1;RGMA;ZFPM1;KITLG;HOXC5;ZNF362;VAMP3;CITED4;IRF2BPL;MC1R;ZNF266;STAT1;IMPACT;CAMK2N1;CRY2;NSG1;THAP8;NOS1;PRKACB;ZNF704;HOXA3;CRY1;ZNF699;MAML3;ZFP41;SCMH1;KLF13;CRTAP;MAGEF1;NFATC4;ZNF783;SPDYE6;BTBD2;RNF187;FERMT1;CYP26B1;HSF4;ZNF251;VPS11;COL7A1;SPOCK1;EAPP;MDM2;CRTC1;NDN;PPP2R2C;ZNF662;LTBP4;TNFSF10;NEO1;RAPGEF3;PHACTR3;ZNF414;TCF25;PCBP4;POLH;OAS1;FLRT3;MLLT6;RGS2;F2R;PDCD4;SERPINB5;ZNF160;RTN4RL1;ZFP36L2;TRPV4;FLOT1;GLI2;ADORA2B;ANK3;KLF7;RNF165;LAMP3;TCEA2;MAPK8IP3;SPDYE5;ZNF76;SOX12;PIDD1;SLX1A;SLX1B;ZNF747;GJC2;ZCCHC11;RHBDF1;PER2;UNC119;C5;ZNF658;SNTA1;MINK1;PHF2;ABHD14B;TCEAL1;WWTR1;ITGA2;GLI3;THRAP3;ZNF558;IRX4;SMARCA1;BHLHE40;ZNF655;NAIP;ZNF333;MAP2K5;ITGA6;ZNF318;LZTS1;IGFBP4;TCFL5;TRAK1;JARID2;NUPR1;INSR;CCDC85B;GSN;CHD3;TTN;CBLC;DDT;ZNF18;AHNAK2;MXD4;ZNF287;CD109;PMS2P3;ETAA1;ZNF446;ZNF581;PILRB;ENDOG;SLC27A1;RTF1;MDK;IRF9;RICTOR;H2AFJ;BMP6;NLRX1;MAP2K2;GLI4;SQSTM1;PTK6;FZD7;ETV5;SYNGAP1;DLX3;HEXB;KDM4C;METTL23;ZNF608;PLA2G6;CST3;GDF15;BBS2;TXNIP;CTF1;TCF4;PLAG1;MAP3K12;RCOR2;WRN;IFI27;ZYG11B;LPIN3;CDK5R1;ATRX;MAPK10;HFE;ADIRF;HMG20B;TRIM38;AGO4;ERCC6;SLIT3;SHC2;EDA2R;SPRY2;FBXO2;MEF2D;CREBRF;XRN1;MLXIPL;TARBP1;FBXW7;ING4;CDK5RAP3;ZNF862;ATXN1;LMO2;NFIX;PAK6;TFPI2;CARF;MXI1;THRA;APC2;ARAP1;ADARB1;RAI1;ELF1;IKZF4;ACACB;NLRP1;ZBTB34;ZNF627;MIF4GD;DBP;NAB2;EPM2AIP1;LRP1;PEG3;RFX2;ZNF554;MAP3K6;SALL2;WNK1;ZNF107;ZNF532;ZBTB20;PDE2A;ZNF334;MAF;STK16;RET;ZMYND8;PRX;DAB2IP;CASZ1;RWDD3;CALCOCO1;TEAD2;MYSM1;FBXO4;TSHZ2;ZNF276;IFI16;FGFR4;PIK3R2;TEF;ZNF25;AREG;ABTB1;RPS6KA5;APBB3;ZNF630;BTG1;BST2;ZNF687;VDR;MAMSTR;TNRC18;TNRC6C;ZFP28;PLXND1;ZMYM3;SIX5;HLTF;PCSK6;ZNF789;ZNF563;ZNF517;TBC1D16;PPP1R2;DMTN;PPP1R35;STAT2;WWC3;PHF1;ZNF292;TFDP2;SNX1;NRARP;ACVR1B;ZNF737;NECAB3;DLG4;TNNI2;PPP2R3B;ZNF701;NAT14;PANO1;TCEAL4;ZNF91;DYDC1;GTF2IRD2;TCF7;TNFRSF25;ZFP36L1;GLMP;ACSL1;IL11;KAT2B;IRS2;ERN1;RNF141;IVNS1ABP;RAD50;ZNF439;ANGEL2;TRERF1;APBB2;PBLD;TNFSF12;STAT6;PCSK1N;SOX13;PRDX5;NELFCD;KLF8;CHD6;TRAF5;GOLGB1;RANBP9;HDAC11;PTPN3;ERBB2;ABCA2;KMT5C;AKAP6;ATG14;RORA;PPARG;PRKACA;CXXC5;ZNF572;ACKR3;ZNF658B;SERPING1;PARN;ZNF529;UFL1;RIPK3;KLF9;AIP;SCAND1;PRMT3;SNX33;ZFP90;PER3;ZFP30;FOXP2;PTBP2;ZC3H6;HIVEP1;SMURF1;NPNT;CTNNBIP1;PEMT;GCLC;ECM1
10773,GO:0044249,0.999997615484851,3.20811261218944e-06,419,4828,cellular biosynthetic process,BP,TNFAIP3;HES2;ZSCAN18;TSC22D1;SIK1;MUC19;TP53INP1;PTHLH;SREBF1;AMACR;APOE;NT5E;INPP5D;GAMT;MN1;LMF1;EGFR;CIRBP;PKD2;CAPRIN2;MNT;RBM3;ASH2L;TRIM22;ALDH1A3;SRSF5;SFRP1;PERM1;SEC14L2;GLUD1;DGKQ;PIK3R1;ADAMTS7;RBCK1;KDM3A;TSC22D3;POU3F1;DHTKD1;ST6GALNAC2;UNK;HR;CSPG4;ISG15;HTRA1;TFCP2L1;RGMA;ZFPM1;KITLG;HOXC5;MVD;ZDHHC1;ZNF362;CITED4;IRF2BPL;NAPRT;MC1R;ZNF266;SRD5A3;STAT1;IMPACT;CRY2;UROS;KDSR;THAP8;NOS1;ZNF704;HOXA3;CRY1;ZNF699;MAML3;ZFP41;SCMH1;KLF13;NFATC4;PITPNM3;ZNF783;HMGCL;RNF187;CMPK2;THNSL2;HSF4;ZNF251;PIK3C2G;LIG1;EAPP;MDM2;CRTC1;NDN;NMRK1;ST6GALNAC6;ZNF662;CERS4;NEO1;RAPGEF3;ZNF414;TCF25;POLH;POLR2J2;GAL3ST4;B4GALT6;MLLT6;RGS2;F2R;MLYCD;PDCD4;ZNF160;SWT1;RTN4RL1;ZFP36L2;TRPV4;GLI2;ADORA2B;KLF7;RNF165;ADAMTS13;TCEA2;ZNF76;SOX12;PIDD1;ZNF747;PER2;PITPNM2;PTGS1;ZNF658;PHF2;ABHD14B;GSTM2;TCEAL1;WWTR1;MBOAT2;ITGA2;GLI3;PCSK1;THRAP3;ZNF558;IRX4;SMARCA1;BHLHE40;ZNF655;ZNF333;MAP2K5;ITGA6;ZNF318;LZTS1;TCFL5;TRAK1;JARID2;NUPR1;INSR;CCDC85B;HSF2BP;CHD3;ST3GAL5;DDT;ZNF18;MXD4;POLD4;ZNF287;CD109;PMS2P3;ETAA1;RMI2;ZNF446;ZNF581;MGST2;SLC27A1;PGAP1;RTF1;MDK;IRF9;H2AFJ;BMP6;NLRX1;B4GALT2;ETNK2;TCIRG1;MAP2K2;OPLAH;PDK1;VEGFB;ALDH7A1;GLI4;SQSTM1;FZD7;ETV5;DLX3;HEXB;KDM4C;HYAL1;METTL23;B3GNT9;ZNF608;PLA2G6;CST3;GDF15;PEX7;TXNIP;TCF4;ATP6V0A2;PLAG1;IDH2;RCOR2;WRN;IFI27;MCM9;TREX1;LPIN3;ZDHHC12;CDK5R1;ATRX;PIGZ;POLR2J3;MAPK10;HFE;ADIRF;HMG20B;CYBA;TRIM38;AGO4;ERCC6;RRM2B;EDA2R;MEF2D;GABBR1;CREBRF;XRN1;MLXIPL;TARBP1;FBXW7;GPR87;ING4;CDK5RAP3;ZNF862;ATXN1;LMO2;NFIX;PAK6;CARF;PGM1;MXI1;PFKFB2;THRA;RAI1;ELF1;IKZF4;SLC2A1;ACACB;OGDHL;ZBTB34;ZNF627;TK2;GLUL;MIF4GD;DBP;NDST2;NAB2;EPM2AIP1;SRR;PEG3;RGS12;ACP5;RFX2;ZNF554;BDH1;RIMKLB;PPCS;SALL2;PMEL;ZNF107;ZNF532;ZBTB20;PDE2A;ZNF334;MAF;STK16;LTB4R2;RET;ZMYND8;DAB2IP;CASZ1;RWDD3;CALCOCO1;TEAD2;MYSM1;DDHD2;FBXO4;TSHZ2;PIK3C3;ZNF276;IFI16;DALRD3;FGFR4;PIK3R2;TEF;ZNF25;AREG;ABTB1;RPS6KA5;APBB3;ZNF630;BTG1;ZNF687;VDR;MAMSTR;TNRC18;TNRC6C;ZFP28;DPY19L2P2;PLXND1;NADK;ZMYM3;SIX5;HLTF;PCSK6;ZNF789;MPPE1;ZNF563;ZNF517;STAT2;WWC3;PHF1;ZNF292;TFDP2;GOLGA7B;OSBPL1A;NRARP;ACVR1B;ZNF737;PRIMPOL;NECAB3;TNNI2;ZNF701;ALOXE3;NAT14;PALB2;MPI;TCEAL4;ZNF91;DUOX1;PTMS;DYDC1;GTF2IRD2;TCF7;ZFP36L1;XYLT1;GLMP;ACSL1;IL11;KAT2B;TEP1;IRS2;IMPA2;ERN1;HSD17B14;RNF141;IVNS1ABP;ALOX15B;RAD50;ZNF439;PNPO;MTR;MAN1B1;TRERF1;UAP1L1;APBB2;CBR4;ISYNA1;CERS5;STAT6;SOX13;PRDX5;NELFCD;KLF8;GSTM3;CHD6;TRAF5;GOLGB1;ACSS2;HDAC11;ERBB2;SPOCD1;NUDT10;ZDHHC24;PQLC3;ABCA2;KMT5C;TH;RORA;PPARG;CXXC5;POLM;GCNT4;ZNF572;PLTP;ZNF658B;UCKL1;PARN;ZNF529;UFL1;RIPK3;KLF9;PI4K2B;AIP;SCAND1;PRMT3;HARS2;ZFP90;PER3;ZFP30;FOXP2;ZC3H6;HIVEP1;SMURF1;NPNT;CTNNBIP1;PEMT;SERINC3;GCLC;ECM1
6070,GO:0019222,0.999997661686607,3.14094539802682e-06,433,4903,regulation of metabolic process,BP,TNFAIP3;HES2;SERPINE2;ZSCAN18;ULK2;GPNMB;TSC22D1;SIK1;EPM2A;TP53INP1;IFI6;PTHLH;SREBF1;ACTA2;APOE;GPSM1;INPP5D;OAS2;MN1;LMF1;HSPA2;EGFR;TRIM65;CIRBP;FAM20C;PKD2;CAPRIN2;MNT;CPT2;RBM3;ASH2L;TRIM22;SRSF5;SFRP1;MTHFR;PERM1;SEC14L2;EPHB2;MAP3K14;DGKQ;PIK3R1;RBCK1;KDM3A;TSC22D3;POU3F1;WNT3;CAMKK1;HERC5;VAV3;UNK;HR;CSPG4;ISG15;ELFN2;HTRA1;TFCP2L1;RGMA;ZFPM1;KITLG;HOXC5;MVD;ZNF362;VAMP3;CITED4;IRF2BPL;MC1R;ZNF266;STAT1;IMPACT;CAMK2N1;CRY2;NSG1;THAP8;NOS1;PRKACB;ZNF704;HOXA3;CRY1;ZNF699;MAML3;ZFP41;SCMH1;KLF13;CRTAP;MAGEF1;NFATC4;ZNF783;SPDYE6;BTBD2;RNF187;FERMT1;CYP26B1;HSF4;ZNF251;VPS11;COL7A1;SPOCK1;EAPP;MDM2;CRTC1;NDN;PPP2R2C;ZNF662;TYSND1;LTBP4;PIK3IP1;TNFSF10;NEO1;RAPGEF3;PHACTR3;ZNF414;TCF25;PCBP4;POLH;OAS1;FLRT3;MLLT6;RGS2;F2R;MLYCD;PDCD4;SERPINB5;ZNF160;RTN4RL1;ZFP36L2;TRPV4;FLOT1;GLI2;ADORA2B;ANK3;KLF7;RNF165;LAMP3;TCEA2;MAPK8IP3;SPDYE5;ZNF76;SOX12;PIDD1;SLX1A;SLX1B;ZNF747;GJC2;ZCCHC11;RHBDF1;PER2;UNC119;C5;ZNF658;SNTA1;MINK1;PHF2;ABHD14B;TCEAL1;WWTR1;ITGA2;ULK1;GLI3;THRAP3;ZNF558;IRX4;SMARCA1;BHLHE40;LRSAM1;ZNF655;NAIP;ZNF333;MAP2K5;ITGA6;SESN3;ZNF318;LZTS1;IGFBP4;TCFL5;TRAK1;JARID2;NUPR1;INSR;CCDC85B;GSN;CHD3;TTN;CBLC;DDT;ZNF18;AHNAK2;MXD4;ZNF287;CD109;PMS2P3;ETAA1;ZNF446;ZNF581;PILRB;ENDOG;SLC27A1;RTF1;MDK;IRF9;RICTOR;H2AFJ;BMP6;NLRX1;MAP2K2;PDK1;GLI4;SQSTM1;CEP192;PTK6;FZD7;ETV5;SYNGAP1;DLX3;HEXB;KDM4C;METTL23;ZNF608;PLA2G6;CST3;GDF15;BBS2;TXNIP;CTF1;TCF4;ATP6V0A2;NPHP3;PLAG1;MAP3K12;RCOR2;WRN;IFI27;TNFRSF21;ZYG11B;LPIN3;CDK5R1;ATRX;SESN1;MAPK10;HFE;ADIRF;HMG20B;CYBA;TRIM38;AGO4;ERCC6;SLIT3;SHC2;EDA2R;SPRY2;FBXO2;MEF2D;GABBR1;CREBRF;XRN1;MLXIPL;TARBP1;FBXW7;GPR87;ING4;CDK5RAP3;ZNF862;ATXN1;LMO2;NFIX;PAK6;TFPI2;CARF;MXI1;PFKFB2;THRA;APC2;ARAP1;ADARB1;RAI1;ELF1;IKZF4;ACACB;NLRP1;ZBTB34;ZNF627;MIF4GD;DBP;NAB2;EPM2AIP1;LRP1;PEG3;ACP5;RFX2;ZNF554;MAP3K6;SALL2;WNK1;ZNF107;ZNF532;ZBTB20;PDE2A;ZNF334;MAF;STK16;LTB4R2;RET;ZMYND8;PRX;DAB2IP;CASZ1;RWDD3;CALCOCO1;TEAD2;MYSM1;FBXO4;TSHZ2;ZNF276;IFI16;FGFR4;PIK3R2;TEF;ZNF25;AREG;ABTB1;RPS6KA5;APBB3;ZNF630;BTG1;BST2;ZNF687;VDR;MAMSTR;TNRC18;TNRC6C;ZFP28;PLXND1;ZMYM3;SIX5;HLTF;PCSK6;ZNF789;ZNF563;ZNF517;TBC1D16;PPP1R2;DMTN;PPP1R35;STAT2;LMTK3;WWC3;PHF1;ZNF292;TFDP2;SNX1;NRARP;ACVR1B;ZNF737;NECAB3;DLG4;TNNI2;PPP2R3B;ZNF701;NAT14;PANO1;TCEAL4;ZNF91;DYDC1;GTF2IRD2;TCF7;TNFRSF25;ZFP36L1;GLMP;ACSL1;IL11;KAT2B;IRS2;ERN1;RNF141;IVNS1ABP;RAD50;ZNF439;ANGEL2;TRERF1;APBB2;PBLD;TNFSF12;STAT6;PCSK1N;SOX13;PRDX5;NELFCD;KLF8;CHD6;TRAF5;GOLGB1;SRPX2;RANBP9;HDAC11;PTPN3;ERBB2;SPOCD1;ABCA2;KMT5C;AKAP6;ATG14;RORA;PPARG;PRKACA;LDLRAP1;CXXC5;ZNF572;ACKR3;ZNF658B;SERPING1;PARN;ZNF529;UFL1;RIPK3;KLF9;AIP;SCAND1;LONP2;PRMT3;SNX33;ZFP90;CCDC3;PER3;ZFP30;FOXP2;PTBP2;ZC3H6;HIVEP1;SMURF1;NPNT;CTNNBIP1;PEMT;GCLC;ECM1
15236,GO:0071426,0.999997965090125,3.03575230871898e-05,1,121,ribonucleoprotein complex export from nucleus,BP,SRSF5
2903,GO:0006413,0.99999811154096,1.68587262927314e-05,2,185,translational initiation,BP,IMPACT;MIF4GD
15090,GO:0071166,0.999998168072003,2.75346320154834e-05,1,122,ribonucleoprotein complex localization,BP,SRSF5
15459,GO:0071826,0.999998415102093,9.14924758429194e-06,4,204,ribonucleoprotein complex subunit organization,BP,CIRBP;SRSF5;AGO4;PTBP2
10855,GO:0044391,0.999998555507479,2.17232005707855e-05,1,182,ribosomal subunit,CC,RBM3
2891,GO:0006399,0.999998745101048,8.79794323304133e-06,3,184,tRNA metabolic process,BP,TARBP1;DALRD3;HARS2
4024,GO:0009058,0.999998866342543,1.53743011435358e-06,427,4934,biosynthetic process,BP,TNFAIP3;HES2;ZSCAN18;TSC22D1;SIK1;MUC19;TP53INP1;PTHLH;SREBF1;AMACR;APOE;NT5E;INPP5D;GAMT;MN1;LMF1;EGFR;CIRBP;PKD2;CAPRIN2;MNT;RBM3;ASH2L;TRIM22;ALDH1A3;SRSF5;SFRP1;PERM1;SEC14L2;GLUD1;DGKQ;PIK3R1;ADAMTS7;RBCK1;KDM3A;TSC22D3;POU3F1;DHTKD1;ST6GALNAC2;UNK;HR;CSPG4;ISG15;HTRA1;TFCP2L1;RGMA;ZFPM1;KITLG;HOXC5;MVD;ZDHHC1;ZNF362;CITED4;IRF2BPL;NAPRT;MC1R;ZNF266;SRD5A3;STAT1;IMPACT;CRY2;UROS;KDSR;THAP8;NOS1;ZNF704;HOXA3;CRY1;ZNF699;MAML3;ZFP41;SCMH1;KLF13;SDC3;NFATC4;PITPNM3;ZNF783;HMGCL;RNF187;CMPK2;THNSL2;HSF4;ZNF251;PIK3C2G;LIG1;EAPP;MDM2;CRTC1;NDN;NMRK1;ST6GALNAC6;ZNF662;CERS4;NEO1;RAPGEF3;ZNF414;TCF25;POLH;POLR2J2;GAL3ST4;B4GALT6;MLLT6;RGS2;F2R;MLYCD;PDCD4;ZNF160;SWT1;RTN4RL1;ZFP36L2;TRPV4;GLI2;ADORA2B;KLF7;RNF165;ADAMTS13;TCEA2;ZNF76;SOX12;PIDD1;G6PC3;ZNF747;PER2;PITPNM2;PTGS1;HEXA;ZNF658;PHF2;ABHD14B;GSTM2;TCEAL1;WWTR1;MBOAT2;ITGA2;GLI3;PCSK1;THRAP3;ZNF558;IRX4;SMARCA1;BHLHE40;ZNF655;ZNF333;MAP2K5;ITGA6;ZNF318;LZTS1;TCFL5;TRAK1;JARID2;NUPR1;GPC2;INSR;CCDC85B;HSF2BP;CHD3;ST3GAL5;DDT;ZNF18;MXD4;POLD4;ZNF287;CD109;PMS2P3;ETAA1;RMI2;ZNF446;ZNF581;MGST2;SLC27A1;PGAP1;RTF1;MDK;IRF9;H2AFJ;BMP6;NLRX1;B4GALT2;ETNK2;TCIRG1;MAP2K2;OPLAH;PDK1;VEGFB;ALDH7A1;GLI4;SQSTM1;FZD7;ETV5;DLX3;HEXB;KDM4C;HYAL1;METTL23;B3GNT9;ZNF608;PLA2G6;CST3;GDF15;PEX7;TXNIP;TCF4;ATP6V0A2;PLAG1;IDH2;RCOR2;WRN;IFI27;MCM9;TREX1;LPIN3;ZDHHC12;CDK5R1;ATRX;PIGZ;POLR2J3;MAPK10;HFE;ADIRF;HMG20B;CYBA;TRIM38;AGO4;ERCC6;RRM2B;EDA2R;MEF2D;GABBR1;CREBRF;XRN1;MLXIPL;TARBP1;FBXW7;GPR87;ING4;CDK5RAP3;ZNF862;ATXN1;LMO2;NFIX;PAK6;CARF;PGM1;MXI1;PFKFB2;THRA;RAI1;ELF1;IKZF4;SLC2A1;ACACB;ACCS;OGDHL;ZBTB34;ZNF627;TK2;GLUL;MIF4GD;DBP;NDST2;NAB2;EPM2AIP1;SRR;PEG3;RGS12;ACP5;RFX2;ZNF554;BDH1;RIMKLB;PPCS;SALL2;PMEL;ZNF107;ZNF532;ZBTB20;PDE2A;ZNF334;MAF;STK16;LTB4R2;RET;ZMYND8;DAB2IP;CASZ1;RWDD3;CALCOCO1;TEAD2;MYSM1;DDHD2;FBXO4;TSHZ2;PIK3C3;ZNF276;IFI16;DALRD3;FGFR4;PIK3R2;TEF;ZNF25;AREG;ABTB1;RPS6KA5;APBB3;ZNF630;BTG1;ZNF687;VDR;MAMSTR;TNRC18;TNRC6C;ZFP28;DPY19L2P2;PLXND1;NADK;ZMYM3;SIX5;HLTF;PCSK6;ZNF789;MPPE1;ZNF563;ZNF517;STAT2;WWC3;PHF1;ZNF292;TFDP2;GOLGA7B;OSBPL1A;NRARP;ACVR1B;ZNF737;PRIMPOL;NECAB3;TNNI2;ZNF701;ALOXE3;NAT14;PALB2;MPI;TCEAL4;ZNF91;DUOX1;PTMS;DYDC1;GTF2IRD2;TCF7;ZFP36L1;XYLT1;GLMP;ACSL1;IL11;KAT2B;TEP1;IRS2;IMPA2;ERN1;HSD17B14;RNF141;IVNS1ABP;ALOX15B;RAD50;ZNF439;PNPO;MTR;MAN1B1;TRERF1;UAP1L1;APBB2;CBR4;ISYNA1;PBLD;CERS5;STAT6;SOX13;PRDX5;NELFCD;KLF8;GSTM3;CHD6;TRAF5;GOLGB1;ACSS2;HDAC11;ERBB2;SPOCD1;NUDT10;ZDHHC24;PQLC3;ABCA2;KMT5C;TH;RORA;PPARG;CXXC5;POLM;GCNT4;ZNF572;PLTP;ZNF658B;UCKL1;PARN;ZNF529;UFL1;IP6K2;RIPK3;KLF9;PI4K2B;AIP;SCAND1;PRMT3;HARS2;ZFP90;CCDC3;PER3;ZFP30;FOXP2;ZC3H6;HIVEP1;SMURF1;NPNT;CTNNBIP1;PEMT;SERINC3;GCLC;ECM1
4025,GO:0009059,0.999998888500251,1.53047980275146e-06,347,4111,macromolecule biosynthetic process,BP,TNFAIP3;HES2;ZSCAN18;TSC22D1;SIK1;MUC19;TP53INP1;SREBF1;APOE;INPP5D;MN1;LMF1;EGFR;CIRBP;PKD2;CAPRIN2;MNT;RBM3;ASH2L;TRIM22;SRSF5;SFRP1;PERM1;SEC14L2;DGKQ;PIK3R1;ADAMTS7;RBCK1;KDM3A;TSC22D3;POU3F1;ST6GALNAC2;UNK;HR;CSPG4;ISG15;HTRA1;TFCP2L1;RGMA;ZFPM1;KITLG;HOXC5;MVD;ZDHHC1;ZNF362;CITED4;IRF2BPL;MC1R;ZNF266;SRD5A3;STAT1;IMPACT;CRY2;THAP8;NOS1;ZNF704;HOXA3;CRY1;ZNF699;MAML3;ZFP41;SCMH1;KLF13;SDC3;NFATC4;ZNF783;RNF187;HSF4;ZNF251;LIG1;EAPP;MDM2;CRTC1;NDN;ST6GALNAC6;ZNF662;NEO1;ZNF414;TCF25;POLH;POLR2J2;GAL3ST4;B4GALT6;MLLT6;RGS2;F2R;PDCD4;ZNF160;SWT1;RTN4RL1;ZFP36L2;TRPV4;GLI2;KLF7;RNF165;ADAMTS13;TCEA2;ZNF76;SOX12;PIDD1;ZNF747;PER2;HEXA;ZNF658;PHF2;ABHD14B;TCEAL1;WWTR1;ITGA2;GLI3;THRAP3;ZNF558;IRX4;SMARCA1;BHLHE40;ZNF655;ZNF333;MAP2K5;ITGA6;ZNF318;LZTS1;TCFL5;TRAK1;JARID2;NUPR1;GPC2;INSR;CCDC85B;HSF2BP;CHD3;ST3GAL5;ZNF18;MXD4;POLD4;ZNF287;CD109;PMS2P3;ETAA1;RMI2;ZNF446;ZNF581;PGAP1;RTF1;MDK;IRF9;H2AFJ;BMP6;NLRX1;B4GALT2;MAP2K2;VEGFB;GLI4;SQSTM1;FZD7;ETV5;DLX3;HEXB;KDM4C;HYAL1;METTL23;B3GNT9;ZNF608;PLA2G6;CST3;GDF15;TXNIP;TCF4;PLAG1;RCOR2;WRN;IFI27;MCM9;TREX1;LPIN3;ZDHHC12;CDK5R1;ATRX;PIGZ;POLR2J3;MAPK10;HFE;ADIRF;HMG20B;TRIM38;AGO4;ERCC6;RRM2B;EDA2R;MEF2D;CREBRF;XRN1;MLXIPL;TARBP1;FBXW7;ING4;CDK5RAP3;ZNF862;ATXN1;LMO2;NFIX;PAK6;CARF;PGM1;MXI1;THRA;RAI1;ELF1;IKZF4;ZBTB34;ZNF627;TK2;MIF4GD;DBP;NDST2;NAB2;EPM2AIP1;PEG3;RGS12;RFX2;ZNF554;SALL2;ZNF107;ZNF532;ZBTB20;PDE2A;ZNF334;MAF;STK16;RET;ZMYND8;DAB2IP;CASZ1;RWDD3;CALCOCO1;TEAD2;MYSM1;FBXO4;TSHZ2;PIK3C3;ZNF276;IFI16;DALRD3;FGFR4;PIK3R2;TEF;ZNF25;AREG;ABTB1;RPS6KA5;APBB3;ZNF630;BTG1;ZNF687;VDR;MAMSTR;TNRC18;TNRC6C;ZFP28;DPY19L2P2;PLXND1;ZMYM3;SIX5;HLTF;PCSK6;ZNF789;MPPE1;ZNF563;ZNF517;STAT2;WWC3;PHF1;ZNF292;TFDP2;GOLGA7B;NRARP;ACVR1B;ZNF737;PRIMPOL;NECAB3;TNNI2;ZNF701;NAT14;PALB2;MPI;TCEAL4;ZNF91;PTMS;DYDC1;GTF2IRD2;TCF7;ZFP36L1;XYLT1;GLMP;IL11;KAT2B;TEP1;IRS2;ERN1;RNF141;IVNS1ABP;RAD50;ZNF439;MAN1B1;TRERF1;APBB2;STAT6;SOX13;PRDX5;NELFCD;KLF8;CHD6;TRAF5;GOLGB1;HDAC11;ERBB2;SPOCD1;ZDHHC24;PQLC3;ABCA2;KMT5C;RORA;PPARG;CXXC5;POLM;GCNT4;ZNF572;ZNF658B;PARN;ZNF529;UFL1;RIPK3;KLF9;AIP;SCAND1;PRMT3;HARS2;ZFP90;PER3;ZFP30;FOXP2;ZC3H6;HIVEP1;SMURF1;NPNT;CTNNBIP1;GCLC;ECM1
10871,GO:0044424,0.999998888695788,1.65511127283834e-06,1009,10396,intracellular part,CC,TNFAIP3;TGFBI;POSTN;TAGLN;ITGB6;HES2;SERPINE2;ZSCAN18;ULK2;GPNMB;TSC22D1;SIK1;SLFN5;SUGCT;EPM2A;MUC19;NPEPL1;DDB2;TP53INP1;MAP6;IFI6;PTHLH;SREBF1;AMACR;PYGB;ACTA2;APOE;GPSM1;CES2;NT5E;ALS2CL;INPP5D;GAMT;FBXO41;OAS2;ADAM19;LMF1;DDX60;HSPA2;FBXW4;EGFR;ESPN;TRIM65;FAM117A;HERC3;PTPRS;CIRBP;FLNC;FAM20C;PKD2;CAPRIN2;MNT;XPC;APOBEC3C;SYT8;CXCR1;CPT2;RBM3;SYN1;ASH2L;DIXDC1;TRIM22;ALDH1A3;SRSF5;LRIG3;PLCD3;CTSO;SFRP1;OBSL1;MTHFR;PERM1;SEC14L2;KCTD11;IFI44L;KIF26B;PCDH1;EPS8L2;EPHB2;RALGDS;TNS1;SYNC;MAP3K14;GLUD1;BPHL;DCAF16;DGKQ;TMEM129;PIK3R1;ADAMTS7;BRSK1;TXNRD3;MARVELD1;RBCK1;KDM3A;CXCL14;DOCK9;COL22A1;TSC22D3;CUL9;EVC;RNF135;POU3F1;SULF2;WNT3;H6PD;DHTKD1;CAMKK1;HERC5;UBXN4;VAV3;ST6GALNAC2;UNK;HR;VWCE;CSPG4;ISG15;MVB12B;CYBRD1;HTRA1;SPATA18;TFCP2L1;TENM4;UNC119B;RGMA;PI4KAP2;KCNAB2;ZFPM1;KITLG;HOXC5;MVD;ZDHHC1;ZNF362;CUL7;VAMP3;CITED4;SNN;IRF2BPL;NAPRT;REEP2;PRICKLE2;ASAP3;ZNF266;SRD5A3;OR2A4;STAT1;IMPACT;CRY2;MYL9;GRIP2;KRT15;HS1BP3;LGALS7B;WDR63;MARCKSL1;NSG1;UROS;KDSR;ITGB5;COL10A1;RAB43;RAB40B;NOS1;PRKACB;ZNF704;HOXA3;B4GALNT4;CRY1;ZNF699;MAML3;ZFP41;SCMH1;KLF13;CRTAP;SDC3;PLEKHG5;NFATC4;PITPNM3;ZNF783;IQSEC2;HMGCL;D2HGDH;BTBD2;SCARA3;FKBP5;RNF187;FERMT1;H1F0;CYP26B1;GAA;AP5Z1;CMPK2;HSF4;CNTRL;ZNF251;MICALL1;PIK3C2G;LIG1;CDK18;VPS11;SPEG;NDRG1;COL7A1;SPOCK1;ITPR3;EAPP;NAGLU;CYHR1;MDM2;CRTC1;LZTS2;PLCD1;NDN;MLH3;NMRK1;DDX59;ST6GALNAC6;PPP2R2C;CHN2;ZNF662;TYSND1;OBSCN;IDUA;GOLGA8A;GPRC5C;HLA-B;PRODH;HGSNAT;MYH11;PARVB;SYTL1;FKBP9;NDUFA4L2;ACTR1B;RHOBTB2;UGT1A3;CERS4;CYP3A5;ACOT1;NEO1;RAPGEF3;PHACTR3;ZNF414;SPSB3;TCF25;ENDOD1;PCBP4;FAM210B;CTSV;POLH;BLVRB;POLR2J2;OAS1;FLRT3;NUDCD3;RASA4;TRIM66;GAL3ST4;CRAT;KIF26A;B4GALT6;MLLT6;AP1G2;RGL4;RGS2;ACAP3;ADGRB2;F2R;MLYCD;PPL;C2CD4C;HPS4;PHYH;TMEM134;MT1X;PDCD4;BLOC1S4;SPTB;SERPINB5;NOL4L;ALPK1;ZNF160;CAPN7;SWT1;DNAH1;SLC27A3;ARSI;NEK9;TUBGCP5;RTN4RL1;ZFP36L2;CLTCL1;TRPV4;TMC6;FLOT1;GLI2;AGAP4;RHPN1;CORO6;ANK3;KLF7;RNF165;NAT6;DHX32;ADAMTS13;LAMP3;TCEA2;PLCH2;RALGAPA1;MAPK8IP3;GOLGA8B;ZNF76;SOX12;CLMN;PIDD1;RIMS3;AVL9;SLX1A;SLX1B;G6PC3;ATG16L2;SPG11;ZCCHC11;ARHGEF19;RHBDF1;SULT1E1;FBXO44;RASGEF1A;ANKS6;PER2;PITPNM2;CLCN6;MICALCL;PTGS1;UNC119;DIRC2;HEXA;FNDC4;DTNB;FRMD4B;ZNF658;ARSD;WIPF1;SNTA1;PSKH1;MINK1;PHF2;NINL;ABHD14B;GSTM2;TCEAL1;AMIGO2;THBS3;WWTR1;MBOAT2;ASAP2;ARHGEF4;LHFPL2;ITGA2;RSPH3;FAM110C;ULK1;GLI3;SPPL2B;FHOD3;PCSK1;TPGS1;THRAP3;ZNF558;IRX4;SMARCA1;AKAP7;BHLHE40;DGCR6L;LRSAM1;VAMP2;ZNF655;NAIP;LTBP1;ZNF333;NEK8;MAP2K5;GAS8;BOC;SRGAP3;CES3;BSN;SESN3;ZNF318;LZTS1;IGFBP4;TCFL5;TRAK1;JARID2;NUPR1;PRR9;GPC2;NISCH;INSR;TST;IFI44;CCDC85B;HSF2BP;CELSR1;MMP28;GSN;ALDH4A1;CEP68;HEBP1;CHD3;CDK14;ST3GAL5;BAIAP2;TTN;CBLC;SCNN1A;DDT;ZNF18;CEP126;SUN1;AHNAK2;RNPEPL1;PLEKHH2;TRIOBP;MXD4;POLD4;RIN1;DNAJC30;CTSF;ZNF287;CD109;CYP2D7;NSUN5P2;PNMA1;PGLS;PMS2P3;ETAA1;RMI2;ZNF446;ARHGEF1;SEPT6;FBXL16;RAB11FIP4;VPS39;ZNF581;MGST2;DOCK8;TP53AIP1;DHX58;ENDOG;SLC27A1;PGAP1;NRSN2;RTF1;BLOC1S3;MDK;CASP14;IRF9;RICTOR;TMEM9;H2AFJ;BMP6;F8A1;NLRX1;B4GALT2;ETNK2;PEX10;SLC2A3;TCIRG1;S100A4;MICALL2;MAP2K2;OPLAH;PDK1;VEGFB;ALDH7A1;GLI4;SQSTM1;CEP192;CABYR;PTK6;TMEM8B;FZD7;ETV5;AKR7A2;LOXL1;FNBP4;FRMD8;SYNGAP1;FAM13A;FAM213A;FAT2;DLX3;TMEM117;LGALS9C;EPB41L3;SHARPIN;HEXB;KDM4C;HYAL1;METTL23;CLCA2;ARHGAP33;H1FX;SH2D2A;UBOX5;NSMCE4A;ARRDC1;KIAA0319L;B3GNT9;WHAMMP3;CENPC;PLA2G6;CST3;PDIK1L;HOMER2;CAPNS2;GDF15;PEX7;BBS2;TXNIP;TCF4;ATP6V0A2;KLHDC2;COL6A1;PEX11B;NPHP3;LRRCC1;PLAG1;IDH2;CERCAM;MAP3K12;RCOR2;WRN;PODXL;SEPT5;IFI27;MALL;OXLD1;DNM1;MCM9;ZYG11B;MACROD1;IQCB1;KLHL24;PLD3;TREX1;LPIN3;ZDHHC12;ABHD14A;MCTP1;CDK5R1;ATRX;REC8;ARHGAP27;AGAP6;NET1;PIGZ;CA2;OSBPL10;PI4KAP1;POLR2J3;HOOK2;SESN1;EPB41L4A;MAPK10;NKTR;SHANK3;HFE;SCART1;ADIRF;HMG20B;CYBA;TRIM38;DTX3;AGO4;ERCC6;HADH;RRM2B;SLIT3;CLIP2;KRT14;HLCS;SHC2;SPRY2;FBXO2;WASH3P;MEF2D;IFT140;GABBR1;CREBRF;XRN1;AGAP7P;RAB11FIP3;TIGD5;MLXIPL;CTSB;KLK5;NBPF15;TARBP1;FBXW7;ANKRD28;ING4;NUDT6;CDK5RAP3;ZNF862;ATXN1;LMO2;NOTCH2NL;CCDC92;NFIX;PAK6;CARF;DZIP1L;PGM1;MXI1;PFKFB2;RNF170;CHMP1B;THRA;TTC12;HSD11B1L;APC2;METTL21A;ACADS;ARAP1;ASTN2;GOLGA8N;ADARB1;RAI1;FMNL2;ELF1;FAM185A;MX2;IKZF4;DCAF10;RPH3AL;SLC2A1;ACACB;OGDHL;NLRP1;FRAT1;ZBTB34;ERMAP;REEP4;ZNF627;TK2;GPR155;LACTB2;BEX2;GLUL;TBC1D17;MIF4GD;DBP;NDST2;NAB2;EPM2AIP1;TP53I13;GNG2;FBXW5;PRR7;SRR;CAPG;TSPYL4;LRP1;KLHDC8B;HLA-A;PEG3;TSNARE1;NPHP4;RGS12;CCDC136;ATE1;ACP5;MPG;PLA2G7;SYNPO2;RNPEP;C12ORF66;CENPH;RFX2;ZNF554;BRINP1;SLC48A1;BDH1;RIMKLB;PPCS;MYO3B;APPL2;HEXDC;SALL2;WNK1;PMEL;ZNF107;ZNF532;BBS1;ATXN10;JPH2;ZBTB20;PDE2A;ZNF334;SDHA;MAF;STK16;LTB4R2;RET;ZMYND8;PRX;DAB2IP;CASZ1;RWDD3;ACOX3;CALCOCO1;SLC37A2;TEAD2;MYSM1;DDHD2;SHROOM2;FBXO4;RNF213;OLFM2;TSHZ2;PIK3C3;ZNF276;IFI16;SYT7;FGFR4;ERCC5;BBS5;EXOC2;PIK3R2;RETSAT;TEF;ZNF25;SETD4;OSBPL5;AREG;ABTB1;TMEM203;DEF6;KLHL3;SNCB;ETFB;MYO9A;RPS6KA5;APBB3;ZNF630;DLG5;BTG1;BST2;ZNF687;VDR;LETMD1;SNX21;ARHGEF17;CACNB3;MAMSTR;PHF7;TNRC18;TNRC6C;ZFP28;DPY19L2P2;EFS;NADK;ZMYM3;SIX5;HLTF;MARCH8;EHBP1;PCSK6;ZNF789;MPPE1;ZNF563;TNS4;ZNF517;PCMTD2;TBC1D16;STK19;NDUFV3;LPAR6;EML3;PPP1R2;DMTN;STAT2;SGSM2;ARFGEF2;LMTK3;ALMS1;PCMTD1;WWC3;PHF1;ZNF292;SLC36A4;TFDP2;SNX1;GOLGA7B;OSBPL1A;ACVR1B;TMX4;SHROOM4;ZNF737;TACC1;KDELC2;PRIMPOL;NECAB3;CCDC88B;DLG4;CCDC113;TNNI2;PPP2R3B;ESYT2;TSSK1B;IQSEC1;ZNF701;ALOXE3;NAT14;PANO1;PALB2;ENDOU;MPI;IGFBP6;TCEAL4;ZNF91;NBEAL2;CD68;GALE;PTMS;WEE1;DYDC1;R3HDM4;CCNG2;TMEM143;GTF2IRD2;GOLGA6L4;SLC35G2;DQX1;AMT;TCF7;SHANK2;RSAD2;TNFRSF25;NEMP2;ZFP36L1;XYLT1;LMNA;MXRA8;CLSTN3;GLMP;TOP3B;ACSL1;IL11;KAT2B;MARK4;TEP1;APOLD1;IRS2;DMXL2;IMPA2;CEP250;ANO1;CAPS;METTL7A;ERN1;HSD17B14;SAC3D1;IVNS1ABP;ALOX15B;RAD50;ZNF439;TKFC;LAPTM4A;ANGEL2;ZMAT3;PNPO;MTR;MAN1B1;DHRS4;PEX1;ECI1;S100A6;TRERF1;UAP1L1;FAAH;SCYL3;SCG5;ZSWIM8;APBB2;CBR4;TTC19;ARHGEF9;ISYNA1;SGSH;PBLD;DCAF8;CCDC90B;RAPGEF5;MYH16;TNFSF12;CERS5;STAT6;PCSK1N;SOX13;PRDX5;PHPT1;NELFCD;PHC2;TUB;KIF7;GLB1;GOLGA1;CPT1C;KLF8;GSTM3;KLHL29;CHD6;TRAF5;NAP1L5;GOLGB1;SRPX2;ACSS2;DPP7;TRIM2;CD9;PLIN4;RANBP9;HDAC11;PTPN3;CTSD;COL13A1;ERBB2;SYNGR1;MPRIP;PLCB3;NUDT10;UVSSA;ZDHHC24;ARHGAP23;PPM1M;ABCA2;KMT5C;AKAP6;SLC2A11;TH;ATG14;MPP7;RORA;SSH3;PPARG;PRKACA;DOCK6;LDLRAP1;CXXC5;NPAP1;C6ORF120;POLM;FMNL3;ACOT2;GCNT4;VMAC;ZNF572;SYNE2;PARD6G;ACKR3;ZNF658B;SERPING1;SUCLG2;UCKL1;PARN;DDX12P;DOCK3;ZNF529;UFL1;LAMB2;IP6K2;RIPK3;NFASC;KLF9;PI4K2B;AIP;COG1;KCNS3;SCAND1;LONP2;PRMT3;SNX33;HARS2;CIT;ZFP90;EHHADH;MSH5;CLCN7;MAP1A;CCDC3;PER3;ZFP30;FOXP2;PTBP2;ZC3H6;HIVEP1;SMURF1;NPNT;TTLL1;EML2;CTNNBIP1;PEMT;ABCA11P;OCIAD2;SERINC3;GCLC;ECM1
8840,GO:0034645,0.999998926490911,1.48138650380506e-06,340,4041,cellular macromolecule biosynthetic process,BP,TNFAIP3;HES2;ZSCAN18;TSC22D1;SIK1;MUC19;TP53INP1;SREBF1;APOE;MN1;LMF1;EGFR;CIRBP;PKD2;CAPRIN2;MNT;RBM3;ASH2L;TRIM22;SRSF5;SFRP1;PERM1;SEC14L2;DGKQ;PIK3R1;ADAMTS7;RBCK1;KDM3A;TSC22D3;POU3F1;ST6GALNAC2;UNK;HR;CSPG4;ISG15;HTRA1;TFCP2L1;RGMA;ZFPM1;KITLG;HOXC5;MVD;ZDHHC1;ZNF362;CITED4;IRF2BPL;MC1R;ZNF266;SRD5A3;STAT1;IMPACT;CRY2;THAP8;NOS1;ZNF704;HOXA3;CRY1;ZNF699;MAML3;ZFP41;SCMH1;KLF13;NFATC4;ZNF783;RNF187;HSF4;ZNF251;LIG1;EAPP;MDM2;CRTC1;NDN;ST6GALNAC6;ZNF662;NEO1;ZNF414;TCF25;POLH;POLR2J2;GAL3ST4;B4GALT6;MLLT6;RGS2;F2R;PDCD4;ZNF160;SWT1;RTN4RL1;ZFP36L2;TRPV4;GLI2;KLF7;RNF165;ADAMTS13;TCEA2;ZNF76;SOX12;PIDD1;ZNF747;PER2;ZNF658;PHF2;ABHD14B;TCEAL1;WWTR1;ITGA2;GLI3;THRAP3;ZNF558;IRX4;SMARCA1;BHLHE40;ZNF655;ZNF333;MAP2K5;ITGA6;ZNF318;LZTS1;TCFL5;TRAK1;JARID2;NUPR1;INSR;CCDC85B;HSF2BP;CHD3;ST3GAL5;ZNF18;MXD4;POLD4;ZNF287;CD109;PMS2P3;ETAA1;RMI2;ZNF446;ZNF581;PGAP1;RTF1;MDK;IRF9;H2AFJ;BMP6;NLRX1;B4GALT2;MAP2K2;VEGFB;GLI4;SQSTM1;FZD7;ETV5;DLX3;HEXB;KDM4C;METTL23;B3GNT9;ZNF608;CST3;GDF15;TXNIP;TCF4;PLAG1;RCOR2;WRN;IFI27;MCM9;TREX1;LPIN3;ZDHHC12;CDK5R1;ATRX;PIGZ;POLR2J3;MAPK10;HFE;ADIRF;HMG20B;TRIM38;AGO4;ERCC6;RRM2B;EDA2R;MEF2D;CREBRF;XRN1;MLXIPL;TARBP1;FBXW7;ING4;CDK5RAP3;ZNF862;ATXN1;LMO2;NFIX;PAK6;CARF;PGM1;MXI1;THRA;RAI1;ELF1;IKZF4;ZBTB34;ZNF627;TK2;MIF4GD;DBP;NDST2;NAB2;EPM2AIP1;PEG3;RGS12;RFX2;ZNF554;SALL2;ZNF107;ZNF532;ZBTB20;PDE2A;ZNF334;MAF;STK16;RET;ZMYND8;DAB2IP;CASZ1;RWDD3;CALCOCO1;TEAD2;MYSM1;FBXO4;TSHZ2;PIK3C3;ZNF276;IFI16;DALRD3;FGFR4;PIK3R2;TEF;ZNF25;AREG;ABTB1;RPS6KA5;APBB3;ZNF630;BTG1;ZNF687;VDR;MAMSTR;TNRC18;TNRC6C;ZFP28;DPY19L2P2;PLXND1;ZMYM3;SIX5;HLTF;PCSK6;ZNF789;MPPE1;ZNF563;ZNF517;STAT2;WWC3;PHF1;ZNF292;TFDP2;GOLGA7B;NRARP;ACVR1B;ZNF737;PRIMPOL;NECAB3;TNNI2;ZNF701;NAT14;PALB2;MPI;TCEAL4;ZNF91;PTMS;DYDC1;GTF2IRD2;TCF7;ZFP36L1;XYLT1;GLMP;IL11;KAT2B;TEP1;IRS2;ERN1;RNF141;IVNS1ABP;RAD50;ZNF439;MAN1B1;TRERF1;APBB2;STAT6;SOX13;PRDX5;NELFCD;KLF8;CHD6;TRAF5;GOLGB1;HDAC11;ERBB2;SPOCD1;ZDHHC24;PQLC3;ABCA2;KMT5C;RORA;PPARG;CXXC5;POLM;GCNT4;ZNF572;ZNF658B;PARN;ZNF529;UFL1;RIPK3;KLF9;SCAND1;PRMT3;HARS2;ZFP90;PER3;ZFP30;FOXP2;ZC3H6;HIVEP1;SMURF1;NPNT;CTNNBIP1;GCLC;ECM1
10600,GO:0043603,0.999998977374347,2.00878841870658e-06,48,905,cellular amide metabolic process,BP,APOE;EGFR;CIRBP;CAPRIN2;RBM3;MTHFR;UNK;IMPACT;ST6GALNAC6;CERS4;B4GALT6;RGS2;ZFP36L2;ADAMTS13;PER2;GSTM2;ITGA2;SPPL2B;PCSK1;ST3GAL5;RNPEPL1;MGST2;MAP2K2;OPLAH;HEXB;PLA2G6;AGO4;HLCS;XRN1;ACACB;MIF4GD;RNPEP;DALRD3;ABTB1;TNRC6C;PCSK6;ALOXE3;ZFP36L1;SCG5;CERS5;PCSK1N;SMPDL3B;GSTM3;ERBB2;PPARG;HARS2;PEMT;GCLC
17673,GO:1901576,0.999999170079369,1.13053277270713e-06,422,4893,organic substance biosynthetic process,BP,TNFAIP3;HES2;ZSCAN18;TSC22D1;SIK1;MUC19;TP53INP1;PTHLH;SREBF1;AMACR;APOE;NT5E;INPP5D;GAMT;MN1;LMF1;EGFR;CIRBP;PKD2;CAPRIN2;MNT;RBM3;ASH2L;TRIM22;ALDH1A3;SRSF5;SFRP1;PERM1;SEC14L2;GLUD1;DGKQ;PIK3R1;ADAMTS7;RBCK1;KDM3A;TSC22D3;POU3F1;DHTKD1;ST6GALNAC2;UNK;HR;CSPG4;ISG15;HTRA1;TFCP2L1;RGMA;ZFPM1;KITLG;HOXC5;MVD;ZDHHC1;ZNF362;CITED4;IRF2BPL;NAPRT;MC1R;ZNF266;SRD5A3;STAT1;IMPACT;CRY2;UROS;KDSR;THAP8;NOS1;ZNF704;HOXA3;CRY1;ZNF699;MAML3;ZFP41;SCMH1;KLF13;SDC3;NFATC4;PITPNM3;ZNF783;HMGCL;RNF187;CMPK2;THNSL2;HSF4;ZNF251;PIK3C2G;LIG1;EAPP;MDM2;CRTC1;NDN;NMRK1;ST6GALNAC6;ZNF662;CERS4;NEO1;RAPGEF3;ZNF414;TCF25;POLH;POLR2J2;GAL3ST4;B4GALT6;MLLT6;RGS2;F2R;MLYCD;PDCD4;ZNF160;SWT1;RTN4RL1;ZFP36L2;TRPV4;GLI2;ADORA2B;KLF7;RNF165;ADAMTS13;TCEA2;ZNF76;SOX12;PIDD1;G6PC3;ZNF747;PER2;PITPNM2;PTGS1;HEXA;ZNF658;PHF2;ABHD14B;GSTM2;TCEAL1;WWTR1;MBOAT2;ITGA2;GLI3;PCSK1;THRAP3;ZNF558;IRX4;SMARCA1;BHLHE40;ZNF655;ZNF333;MAP2K5;ITGA6;ZNF318;LZTS1;TCFL5;TRAK1;JARID2;NUPR1;GPC2;INSR;CCDC85B;HSF2BP;CHD3;ST3GAL5;DDT;ZNF18;MXD4;POLD4;ZNF287;CD109;PMS2P3;ETAA1;RMI2;ZNF446;ZNF581;MGST2;SLC27A1;PGAP1;RTF1;MDK;IRF9;H2AFJ;BMP6;NLRX1;B4GALT2;ETNK2;TCIRG1;MAP2K2;OPLAH;PDK1;VEGFB;ALDH7A1;GLI4;SQSTM1;FZD7;ETV5;DLX3;HEXB;KDM4C;HYAL1;METTL23;B3GNT9;ZNF608;PLA2G6;CST3;GDF15;PEX7;TXNIP;TCF4;ATP6V0A2;PLAG1;IDH2;RCOR2;WRN;IFI27;MCM9;TREX1;LPIN3;ZDHHC12;CDK5R1;ATRX;PIGZ;POLR2J3;MAPK10;HFE;ADIRF;HMG20B;TRIM38;AGO4;ERCC6;RRM2B;EDA2R;MEF2D;GABBR1;CREBRF;XRN1;MLXIPL;TARBP1;FBXW7;GPR87;ING4;CDK5RAP3;ZNF862;ATXN1;LMO2;NFIX;PAK6;CARF;PGM1;MXI1;PFKFB2;THRA;RAI1;ELF1;IKZF4;SLC2A1;ACACB;OGDHL;ZBTB34;ZNF627;TK2;GLUL;MIF4GD;DBP;NDST2;NAB2;EPM2AIP1;SRR;PEG3;RGS12;RFX2;ZNF554;BDH1;RIMKLB;PPCS;SALL2;PMEL;ZNF107;ZNF532;ZBTB20;PDE2A;ZNF334;MAF;STK16;LTB4R2;RET;ZMYND8;DAB2IP;CASZ1;RWDD3;CALCOCO1;TEAD2;MYSM1;DDHD2;FBXO4;TSHZ2;PIK3C3;ZNF276;IFI16;DALRD3;FGFR4;PIK3R2;TEF;ZNF25;AREG;ABTB1;RPS6KA5;APBB3;ZNF630;BTG1;ZNF687;VDR;MAMSTR;TNRC18;TNRC6C;ZFP28;DPY19L2P2;PLXND1;NADK;ZMYM3;SIX5;HLTF;PCSK6;ZNF789;MPPE1;ZNF563;ZNF517;STAT2;WWC3;PHF1;ZNF292;TFDP2;GOLGA7B;OSBPL1A;NRARP;ACVR1B;ZNF737;PRIMPOL;NECAB3;TNNI2;ZNF701;ALOXE3;NAT14;PALB2;MPI;TCEAL4;ZNF91;PTMS;DYDC1;GTF2IRD2;TCF7;ZFP36L1;XYLT1;GLMP;ACSL1;IL11;KAT2B;TEP1;IRS2;IMPA2;ERN1;HSD17B14;RNF141;IVNS1ABP;ALOX15B;RAD50;ZNF439;PNPO;MTR;MAN1B1;TRERF1;UAP1L1;APBB2;CBR4;ISYNA1;CERS5;STAT6;SOX13;PRDX5;NELFCD;KLF8;GSTM3;CHD6;TRAF5;GOLGB1;ACSS2;HDAC11;ERBB2;SPOCD1;NUDT10;ZDHHC24;PQLC3;ABCA2;KMT5C;TH;RORA;PPARG;CXXC5;POLM;GCNT4;ZNF572;PLTP;ZNF658B;UCKL1;PARN;ZNF529;UFL1;IP6K2;RIPK3;KLF9;PI4K2B;AIP;SCAND1;PRMT3;HARS2;ZFP90;CCDC3;PER3;ZFP30;FOXP2;ZC3H6;HIVEP1;SMURF1;NPNT;CTNNBIP1;PEMT;SERINC3;GCLC;ECM1
17268,GO:0140053,0.999999174159729,1.30123543435712e-05,1,153,mitochondrial gene expression,BP,HARS2
7407,GO:0031503,0.999999215662084,4.11832584686422e-06,5,217,protein-containing complex localization,BP,SRSF5;NSG1;DNM1;IFT140;DLG4
2475,GO:0005694,0.999999259282158,1.44441150620067e-06,51,882,chromosome,CC,HSPA2;SYN1;ASH2L;KDM3A;HR;STAT1;SCMH1;H1F0;MLH3;SLX1A;SLX1B;PHF2;SMARCA1;CHD3;TTN;POLD4;ETAA1;SEPT6;H2AFJ;KDM4C;H1FX;NSMCE4A;CENPC;TCF4;WRN;ATRX;REC8;HMG20B;HLCS;MEF2D;RGS12;CENPH;APPL2;SALL2;MAF;CALCOCO1;ZNF276;ERCC5;TNRC18;PHF1;DYDC1;TCF7;TOP3B;KAT2B;TEP1;RAD50;STAT6;PHC2;UVSSA;KMT5C;MSH5
16456,GO:0097159,0.99999937547028,8.56823551506666e-07,399,4613,organic cyclic compound binding,MF,TNFAIP3;HES2;ZSCAN18;ULK2;SIK1;SLFN5;DDB2;SREBF1;PYGB;NYNRIN;ACTA2;APOE;NT5E;OAS2;DDX60;HSPA2;EGFR;CIRBP;FAM20C;CAPRIN2;MNT;XPC;APOBEC3C;RBM3;SYN1;ASH2L;ALDH1A3;SRSF5;MTHFR;SEC14L2;IFI44L;KIF26B;EPHB2;TNS1;MAP3K14;GLUD1;DGKQ;BRSK1;TXNRD3;KDM3A;CUL9;NSUN7;POU3F1;H6PD;DHTKD1;CAMKK1;HERC5;UNK;HR;TFCP2L1;ZFPM1;HOXC5;MVD;ZDHHC1;ZNF362;ZNF266;STAT1;CRY2;RAB43;RAB40B;THAP8;NOS1;PRKACB;ZNF704;HOXA3;CRY1;ZNF699;ZFP41;KLF13;NFATC4;ZNF783;D2HGDH;FKBP5;H1F0;CYP26B1;CMPK2;THNSL2;HSF4;ZNF251;PIK3C2G;LIG1;CDK18;VPS11;SPEG;MDM2;NDN;MLH3;NMRK1;DDX59;ZNF662;OBSCN;PRODH;MYH11;FKBP9;ACTR1B;RHOBTB2;CERS4;CYP3A5;RAPGEF3;ZNF414;TCF25;ENDOD1;PCBP4;POLH;POLR2J2;OAS1;GAL3ST4;KIF26A;PDCD4;ALPK1;ZNF160;DNAH1;SLC27A3;NEK9;ZFP36L2;TRPV4;GLI2;KLF7;DHX32;TCEA2;ZNF76;SOX12;ZNF747;ZCCHC11;SULT1E1;PER2;CLCN6;PTGS1;ZNF658;PSKH1;MINK1;ULK1;GLI3;THRAP3;ZNF558;IRX4;SMARCA1;AKAP7;BHLHE40;ZNF655;NAIP;KHNYN;ZNF333;NEK8;MAP2K5;ZNF318;LZTS1;TCFL5;C14ORF93;JARID2;NUPR1;INSR;TST;HEBP1;CHD3;CDK14;TTN;ZNF18;AHNAK2;MXD4;ZNF287;CYP2D7;NSUN5P2;SLFNL1;PMS2P3;RMI2;ZNF446;ARHGEF1;SEPT6;ZNF581;DHX58;ENDOG;SLC27A1;RTF1;IRF9;H2AFJ;NLRX1;ETNK2;S100A4;MAP2K2;OPLAH;PDK1;GLI4;PTK6;ETV5;DLX3;H1FX;ZNF608;CENPC;ZCCHC24;PDIK1L;TCF4;PLAG1;IDH2;MAP3K12;RCOR2;WRN;SEPT5;DNM1;MCM9;TREX1;OARD1;ATRX;OSBPL10;POLR2J3;MAPK10;HMG20B;CYBA;AGO4;ERCC6;HADH;HLCS;MEF2D;CREBRF;XRN1;TIGD5;MLXIPL;TARBP1;NUDT6;ZNF862;ATXN1;LMO2;NFIX;PAK6;CARF;DZIP1L;MXI1;PFKFB2;PAQR6;THRA;ACADS;ADARB1;RAI1;ELF1;MX2;IKZF4;ACACB;ACCS;OGDHL;NLRP1;ZBTB34;ZNF627;TK2;LACTB2;GLUL;MIF4GD;DBP;EPM2AIP1;SRR;LRP1;HLA-A;PEG3;MPG;RFX2;ZNF554;SLC48A1;MAP3K6;RIMKLB;MYO3B;SALL2;WNK1;ZNF107;ZNF532;ARL11;ZBTB20;PDE2A;ZNF334;SDHA;MAF;STK16;RET;ZMYND8;PRX;CASZ1;ACOX3;CALCOCO1;TEAD2;MYSM1;TSHZ2;PIK3C3;ZNF276;IFI16;DALRD3;FGFR4;ERCC5;TEF;ZNF25;OSBPL5;ABTB1;MYO9A;RPS6KA5;ZNF630;BST2;ZNF687;VDR;PABPC4L;TNRC18;TNRC6C;ZFP28;NADK;BBS10;ZMYM3;SIX5;HLTF;ZNF789;ZNF563;ZNF517;STK19;NDUFV3;STAT2;RASL10B;LMTK3;PHF1;ZNF292;TFDP2;ACVR1B;ZNF737;TSSK1B;ZNF701;NAT14;PALB2;ENDOU;ZNF91;DUOX1;WEE1;R3HDM4;GTF2IRD2;PTK7;DQX1;TCF7;ZFP36L1;GLMP;TOP3B;ACSL1;KAT2B;MARK4;TEP1;ERN1;RNF141;IVNS1ABP;RAD50;ZNF439;TKFC;ANGEL2;ZMAT3;PNPO;MTR;PEX1;TRERF1;SCYL3;SCG5;CBR4;CERS5;STAT6;SOX13;PRDX5;NELFCD;PHC2;KIF7;KLF8;CHD6;GOLGB1;ACSS2;ERBB2;PAQR7;ABCA2;TH;RORA;PPARG;PRKACA;CXXC5;POLM;ZNF572;ZNF658B;SUCLG2;UCKL1;PARN;DDX12P;ZNF529;IP6K2;RIPK3;KLF9;PI4K2B;LONP2;PRMT3;HARS2;CIT;ZFP90;MSH5;CLCN7;PER3;ZFP30;FOXP2;PTBP2;ZC3H6;HIVEP1;TTLL1;ABCA11P;GCLC
5564,GO:0016579,0.999999516324931,2.33645579645179e-06,6,244,protein deubiquitination,BP,TNFAIP3;DDB2;RNF135;MDM2;MYSM1;KAT2B
6022,GO:0019083,0.999999610725245,6.42807096667104e-06,1,171,viral transcription,BP,NELFCD
10766,GO:0044237,0.999999622489187,5.17622299845101e-07,726,7889,cellular metabolic process,BP,TNFAIP3;TGFBI;HES2;SERPINE2;ZSCAN18;ULK2;GPNMB;TSC22D1;SIK1;EPM2A;MUC19;DDB2;TP53INP1;IFI6;PTHLH;SREBF1;AMACR;PYGB;NYNRIN;APOE;GPSM1;CES2;NT5E;INPP5D;GAMT;FBXO41;OAS2;MN1;LMF1;HSPA2;FBXW4;EGFR;TRIM65;HERC3;PTPRS;CIRBP;FAM20C;PKD2;CAPRIN2;MNT;XPC;APOBEC3C;CXCR1;CPT2;RBM3;ASH2L;TRIM22;ALDH1A3;SRSF5;PLCD3;CTSO;SFRP1;OBSL1;MTHFR;PERM1;SEC14L2;KCTD11;EPHB2;GPX3;MAP3K14;GLUD1;BPHL;DCAF16;DGKQ;TMEM129;PIK3R1;ADAMTS7;BRSK1;TXNRD3;RBCK1;KDM3A;TSC22D3;CUL9;RNF135;POU3F1;SULF2;H6PD;DHTKD1;CAMKK1;HERC5;UBXN4;VAV3;ST6GALNAC2;UNK;HR;CSPG4;ISG15;MVB12B;ELFN2;HTRA1;SPATA18;TFCP2L1;RGMA;PI4KAP2;KCNAB2;ZFPM1;KITLG;HOXC5;MVD;ZDHHC1;ZNF362;CUL7;VAMP3;CITED4;IRF2BPL;NAPRT;MC1R;ZNF266;SRD5A3;STAT1;IMPACT;CAMK2N1;CRY2;NSG1;UROS;KDSR;RAB40B;THAP8;NOS1;PRKACB;ZNF704;HOXA3;CRY1;ZNF699;MAML3;ZFP41;SCMH1;KLF13;CRTAP;SDC3;MAGEF1;NFATC4;PITPNM3;ZNF783;HMGCL;SPDYE6;D2HGDH;BTBD2;FKBP5;RNF187;H1F0;CYP26B1;GAA;AP5Z1;CMPK2;THNSL2;HSF4;CNTRL;ZNF251;PIK3C2G;LIG1;CDK18;VPS11;SPEG;COL7A1;SPOCK1;EAPP;MDM2;CRTC1;PLCD1;NDN;MLH3;NMRK1;DDX59;ST6GALNAC6;PPP2R2C;ZNF662;TYSND1;PIK3IP1;OBSCN;IDUA;TNFSF10;PRODH;FKBP9;NDUFA4L2;UGT1A3;CERS4;CYP3A5;ACOT1;NEO1;RAPGEF3;PHACTR3;ZNF414;SPSB3;TCF25;ENDOD1;PCBP4;CTSV;POLH;BLVRB;POLR2J2;OAS1;FLRT3;RASA4;GAL3ST4;CRAT;B4GALT6;MLLT6;RGS2;F2R;MLYCD;PHYH;PDCD4;SPTB;SERPINB5;PPP1R3E;ALPK1;ZNF160;SWT1;SLC27A3;ARSI;NEK9;RTN4RL1;ZFP36L2;TRPV4;FLOT1;GLI2;ADORA2B;KLF7;RNF165;NAT6;DHX32;ADAMTS13;LAMP3;TCEA2;PLCH2;MAPK8IP3;SPDYE5;ZNF76;SOX12;PIDD1;PARP6;SLX1A;SLX1B;G6PC3;ATG16L2;ZNF747;GJC2;ZCCHC11;RHBDF1;SULT1E1;FBXO44;RASGEF1A;PER2;PITPNM2;PTGS1;UNC119;HEXA;FRS3;C5;ZNF658;ARSD;SNTA1;PSKH1;MINK1;PHF2;ABHD14B;GSTM2;TCEAL1;WWTR1;MBOAT2;ITGA2;ULK1;GLI3;SPPL2B;FGGY;PCSK1;TPGS1;THRAP3;ZNF558;IRX4;SMARCA1;BHLHE40;LRSAM1;ZNF655;NAIP;LTBP1;ZNF333;NEK8;MAP2K5;ITGA6;CES3;SESN3;ZNF318;LZTS1;IGFBP4;MMP1;TCFL5;TRAK1;JARID2;NUPR1;PRR9;GPC2;INSR;TST;CCDC85B;HSF2BP;GSN;ALDH4A1;CHD3;CDK14;ST3GAL5;TTN;CBLC;DDT;ZNF18;AHNAK2;RNPEPL1;TRIOBP;MXD4;POLD4;CTSF;ZNF287;CD109;CYP2D7;NSUN5P2;PGLS;PMS2P3;ETAA1;RMI2;ZNF446;FBXL16;VPS39;ZNF581;MGST2;PILRB;ENDOG;SLC27A1;PGAP1;GID4;RTF1;MDK;IRF9;RICTOR;H2AFJ;BMP6;NLRX1;B4GALT2;ETNK2;PEX10;SLC2A3;TCIRG1;MAP2K2;OPLAH;PDK1;VEGFB;ALDH7A1;GLI4;SQSTM1;CEP192;PTK6;FZD7;ETV5;AKR7A2;LOXL1;SYNGAP1;DLX3;SHARPIN;HEXB;KDM4C;HYAL1;METTL23;UBOX5;NSMCE4A;ARRDC1;B3GNT9;ZNF608;PLA2G6;CST3;PDIK1L;GDF15;PEX7;TXNIP;CTF1;TCF4;ATP6V0A2;NPHP3;PLAG1;IDH2;MAP3K12;RCOR2;WRN;IFI27;DNM1;MCM9;ZYG11B;MACROD1;KLHL24;TREX1;LPIN3;ZDHHC12;OARD1;CDK5R1;ATRX;REC8;PIGZ;CA2;OSBPL10;PI4KAP1;POLR2J3;SESN1;MAPK10;NKTR;SHANK3;HFE;ADIRF;HMG20B;CYBA;TRIM38;DTX3;AGO4;ERCC6;HADH;RRM2B;HLCS;SHC2;EDA2R;SPRY2;FBXO2;MEF2D;GABBR1;CREBRF;XRN1;MLXIPL;CTSB;TARBP1;FBXW7;GPR87;ING4;CDK5RAP3;ZNF862;ATXN1;LMO2;NFIX;PAK6;TFPI2;CARF;PGM1;MXI1;PFKFB2;RNF170;THRA;METTL21A;ACADS;ARAP1;ADARB1;RAI1;ELF1;IKZF4;DCAF10;SLC2A1;ACACB;OGDHL;NLRP1;ZBTB34;ZNF627;TK2;LACTB2;GLUL;TNS2;TBC1D17;C17ORF97;MIF4GD;DBP;NDST2;NAB2;EPM2AIP1;FBXW5;SRR;LRP1;KLHDC8B;PEG3;RGS12;ATE1;ACP5;MPG;PLA2G7;SYNPO2;RNPEP;RFX2;ZNF554;BDH1;MAP3K6;RIMKLB;PPCS;MYO3B;SALL2;WNK1;PMEL;ZNF107;ZNF532;ZBTB20;PDE2A;ZNF334;SDHA;MAF;STK16;LTB4R2;RET;ZMYND8;PRX;DAB2IP;CASZ1;RWDD3;ACOX3;CALCOCO1;TEAD2;MYSM1;DDHD2;FBXO4;RNF213;TSHZ2;PIK3C3;ZNF276;IFI16;DALRD3;FGFR4;ERCC5;PIK3R2;RETSAT;TEF;ZNF25;SETD4;OSBPL5;AREG;ABTB1;KLHL3;SNCB;ETFB;RPS6KA5;APBB3;ZNF630;BTG1;BST2;ZNF687;VDR;MAMSTR;TNRC18;TNRC6C;ZFP28;DPY19L2P2;PLXND1;NADK;ZMYM3;SIX5;HLTF;MARCH8;PCSK6;ZNF789;MPPE1;ZNF563;ZNF517;PCMTD2;TBC1D16;STK19;NDUFV3;PPP1R2;DMTN;PPP1R35;STAT2;ARFGEF2;LMTK3;PCMTD1;WWC3;PHF1;ZNF292;TFDP2;SNX1;GOLGA7B;OSBPL1A;NRARP;ACVR1B;ZNF737;KDELC2;PRIMPOL;NECAB3;DLG4;TNNI2;PPP2R3B;ESYT2;TSSK1B;ADCK5;ZNF701;ALOXE3;NAT14;PANO1;PALB2;ENDOU;MPI;IGFBP6;TCEAL4;ZNF91;DUOX1;PTMS;WEE1;DYDC1;GTF2IRD2;PTK7;DQX1;AMT;TCF7;TNFRSF25;ZFP36L1;XYLT1;MXRA8;GLMP;TOP3B;ACSL1;IL11;KAT2B;MARK4;TEP1;IRS2;IMPA2;ERN1;HSD17B14;RNF141;IVNS1ABP;ALOX15B;RAD50;ZNF439;TKFC;ANGEL2;PNPO;MTR;MAN1B1;DHRS4;ECI1;TRERF1;UAP1L1;FAAH;SCYL3;SCG5;APBB2;CBR4;ISYNA1;SGSH;PBLD;DCAF8;CERS5;STAT6;PCSK1N;SOX13;PRDX5;PHPT1;NELFCD;SMPDL3B;GLB1;CPT1C;KLF8;GSTM3;RDH12;KLHL29;CHD6;TRAF5;GOLGB1;SRPX2;ACSS2;TRIM2;CD9;RANBP9;HDAC11;PTPN3;CTSD;ERBB2;SPOCD1;PLCB3;NUDT10;UVSSA;ZDHHC24;PQLC3;PPM1M;ABCA2;KMT5C;AKAP6;TH;ATG14;RORA;SSH3;PPARG;PRKACA;LDLRAP1;CXXC5;POLM;ACOT2;GCNT4;ZNF572;ACKR3;PLTP;ZNF658B;SERPING1;SUCLG2;UCKL1;PARN;DDX12P;ZNF529;UFL1;LAMB2;IP6K2;RIPK3;KLF9;PI4K2B;AIP;SCAND1;LONP2;PRMT3;SNX33;HARS2;CIT;ZFP90;EHHADH;MSH5;PER3;ZFP30;FOXP2;PTBP2;ZC3H6;HIVEP1;SMURF1;NPNT;TTLL1;CTNNBIP1;PEMT;SERINC3;GCLC;ECM1
2559,GO:0005840,0.999999703524389,2.94478004144234e-06,2,225,ribosome,CC,RBM3;PRMT3
17618,GO:1901363,0.999999710482836,4.01281810162866e-07,393,4576,heterocyclic compound binding,MF,TNFAIP3;HES2;ZSCAN18;ULK2;SIK1;SLFN5;DDB2;SREBF1;PYGB;NYNRIN;ACTA2;NT5E;OAS2;DDX60;HSPA2;EGFR;CIRBP;FAM20C;CAPRIN2;MNT;XPC;APOBEC3C;RBM3;SYN1;ASH2L;ALDH1A3;SRSF5;MTHFR;SEC14L2;IFI44L;KIF26B;EPHB2;TNS1;MAP3K14;GLUD1;DGKQ;BRSK1;TXNRD3;KDM3A;CUL9;NSUN7;POU3F1;H6PD;DHTKD1;CAMKK1;HERC5;UNK;HR;TFCP2L1;ZFPM1;HOXC5;MVD;ZDHHC1;ZNF362;ZNF266;STAT1;CRY2;RAB43;RAB40B;THAP8;NOS1;PRKACB;ZNF704;HOXA3;CRY1;ZNF699;ZFP41;KLF13;NFATC4;ZNF783;D2HGDH;FKBP5;H1F0;CYP26B1;CMPK2;THNSL2;HSF4;ZNF251;PIK3C2G;LIG1;CDK18;VPS11;SPEG;MDM2;NDN;MLH3;NMRK1;DDX59;ZNF662;OBSCN;PRODH;MYH11;FKBP9;ACTR1B;RHOBTB2;CERS4;CYP3A5;RAPGEF3;ZNF414;TCF25;ENDOD1;PCBP4;POLH;POLR2J2;OAS1;GAL3ST4;KIF26A;PDCD4;ALPK1;ZNF160;DNAH1;SLC27A3;NEK9;ZFP36L2;TRPV4;GLI2;KLF7;DHX32;TCEA2;ZNF76;SOX12;ZNF747;ZCCHC11;PER2;CLCN6;PTGS1;ZNF658;PSKH1;MINK1;ULK1;GLI3;THRAP3;ZNF558;IRX4;SMARCA1;AKAP7;BHLHE40;ZNF655;NAIP;KHNYN;ZNF333;NEK8;MAP2K5;ZNF318;LZTS1;TCFL5;C14ORF93;JARID2;NUPR1;INSR;TST;HEBP1;CHD3;CDK14;TTN;ZNF18;AHNAK2;MXD4;ZNF287;CYP2D7;NSUN5P2;SLFNL1;PMS2P3;RMI2;ZNF446;ARHGEF1;SEPT6;ZNF581;DHX58;ENDOG;SLC27A1;RTF1;IRF9;H2AFJ;NLRX1;ETNK2;S100A4;MAP2K2;OPLAH;PDK1;GLI4;PTK6;ETV5;DLX3;H1FX;ZNF608;CENPC;ZCCHC24;PDIK1L;TCF4;PLAG1;IDH2;MAP3K12;RCOR2;WRN;SEPT5;DNM1;MCM9;TREX1;OARD1;ATRX;POLR2J3;MAPK10;HMG20B;CYBA;AGO4;ERCC6;HADH;HLCS;MEF2D;CREBRF;XRN1;TIGD5;MLXIPL;TARBP1;NUDT6;ZNF862;ATXN1;LMO2;NFIX;PAK6;CARF;DZIP1L;MXI1;PFKFB2;THRA;ACADS;ADARB1;RAI1;ELF1;MX2;IKZF4;ACACB;ACCS;OGDHL;NLRP1;ZBTB34;ZNF627;TK2;LACTB2;GLUL;MIF4GD;DBP;EPM2AIP1;SRR;LRP1;HLA-A;PEG3;MPG;RFX2;ZNF554;SLC48A1;MAP3K6;RIMKLB;MYO3B;SALL2;WNK1;ZNF107;ZNF532;ARL11;ZBTB20;PDE2A;ZNF334;SDHA;MAF;STK16;RET;ZMYND8;PRX;CASZ1;ACOX3;CALCOCO1;TEAD2;MYSM1;TSHZ2;PIK3C3;ZNF276;IFI16;DALRD3;FGFR4;ERCC5;TEF;ZNF25;ABTB1;MYO9A;RPS6KA5;ZNF630;BST2;ZNF687;VDR;PABPC4L;TNRC18;TNRC6C;ZFP28;NADK;BBS10;ZMYM3;SIX5;HLTF;ZNF789;ZNF563;ZNF517;STK19;NDUFV3;STAT2;RASL10B;LMTK3;PHF1;ZNF292;TFDP2;ACVR1B;ZNF737;TSSK1B;ZNF701;NAT14;PALB2;ENDOU;ZNF91;DUOX1;WEE1;R3HDM4;GTF2IRD2;PTK7;DQX1;TCF7;ZFP36L1;GLMP;TOP3B;ACSL1;KAT2B;MARK4;TEP1;ERN1;RNF141;IVNS1ABP;RAD50;ZNF439;TKFC;ANGEL2;ZMAT3;PNPO;MTR;PEX1;TRERF1;SCYL3;SCG5;CBR4;CERS5;STAT6;SOX13;PRDX5;NELFCD;PHC2;KIF7;KLF8;CHD6;GOLGB1;ACSS2;ERBB2;ABCA2;TH;RORA;PPARG;PRKACA;CXXC5;POLM;ZNF572;ZNF658B;SUCLG2;UCKL1;PARN;DDX12P;ZNF529;IP6K2;RIPK3;KLF9;PI4K2B;LONP2;PRMT3;HARS2;CIT;ZFP90;MSH5;CLCN7;PER3;ZFP30;FOXP2;PTBP2;ZC3H6;HIVEP1;TTLL1;ABCA11P;GCLC
10601,GO:0043604,0.999999750235215,5.70235193741411e-07,33,732,amide biosynthetic process,BP,EGFR;CIRBP;CAPRIN2;RBM3;UNK;IMPACT;ST6GALNAC6;CERS4;B4GALT6;RGS2;ZFP36L2;PER2;ITGA2;PCSK1;ST3GAL5;MGST2;MAP2K2;OPLAH;PLA2G6;AGO4;XRN1;MIF4GD;DALRD3;ABTB1;TNRC6C;ALOXE3;ZFP36L1;CERS5;ERBB2;PPARG;HARS2;PEMT;GCLC
12903,GO:0051276,0.999999779782456,4.16699195078561e-07,63,1046,chromosome organization,BP,DDB2;SREBF1;HSPA2;XPC;ASH2L;MTHFR;KDM3A;HR;ZFPM1;NOS1;SCMH1;H1F0;HSF4;MLH3;SLX1A;SLX1B;PER2;PHF2;SMARCA1;JARID2;CHD3;TTN;SUN1;POLD4;RMI2;RTF1;H2AFJ;KDM4C;H1FX;CENPC;MAP3K12;WRN;ATRX;REC8;HMG20B;AGO4;HLCS;XRN1;FBXW7;ING4;CHMP1B;TSPYL4;CENPH;ZMYND8;MYSM1;FBXO4;RPS6KA5;TNRC18;HLTF;PHF1;DYDC1;TOP3B;KAT2B;TEP1;RAD50;CHD6;NAP1L5;HDAC11;KMT5C;PARN;DDX12P;PRMT3;MSH5
14847,GO:0070646,0.999999877962432,6.25964993477689e-07,6,259,protein modification by small protein removal,BP,TNFAIP3;DDB2;RNF135;MDM2;MYSM1;KAT2B
17990,GO:1902494,0.99999991202774,1.62069507945495e-07,75,1231,catalytic complex,CC,DDB2;FBXW4;ASH2L;DCAF16;PIK3R1;RBCK1;CUL9;DHTKD1;CUL7;WDR63;BTBD2;PIK3C2G;PPP2R2C;SPSB3;POLR2J2;NUDCD3;DNAH1;FBXO44;ULK1;SMARCA1;JARID2;INSR;CHD3;CDK14;POLD4;RTF1;PDK1;SHARPIN;NSMCE4A;ZYG11B;KLHL24;ATRX;POLR2J3;CYBA;AGO4;RRM2B;FBXO2;FBXW7;ING4;DCAF10;OGDHL;GNG2;FBXW5;KLHDC8B;APPL2;SALL2;SDHA;FBXO4;PIK3C3;ERCC5;PIK3R2;ABTB1;KLHL3;NDUFV3;PPP1R2;PHF1;GOLGA7B;ACVR1B;PPP2R3B;DYDC1;KAT2B;TEP1;ERN1;TRERF1;ZSWIM8;CBR4;DCAF8;PHC2;KLHL29;CHD6;HDAC11;ABCA2;ATG14;SUCLG2;GCLC
6019,GO:0019080,0.999999916167513,1.52185549324975e-06,1,185,viral gene expression,BP,NELFCD
2976,GO:0006518,0.999999928804414,1.64434726866929e-07,35,782,peptide metabolic process,BP,APOE;EGFR;CIRBP;CAPRIN2;RBM3;UNK;IMPACT;RGS2;ZFP36L2;ADAMTS13;PER2;GSTM2;ITGA2;SPPL2B;PCSK1;RNPEPL1;MGST2;MAP2K2;OPLAH;AGO4;XRN1;MIF4GD;RNPEP;DALRD3;ABTB1;TNRC6C;PCSK6;ZFP36L1;SCG5;PCSK1N;GSTM3;ERBB2;PPARG;HARS2;GCLC
10343,GO:0043170,0.999999941731694,8.09699466608996e-08,616,6854,macromolecule metabolic process,BP,TNFAIP3;TGFBI;HES2;SERPINE2;ZSCAN18;ULK2;GPNMB;TSC22D1;SIK1;MUC19;NPEPL1;DDB2;TP53INP1;IFI6;PTHLH;SREBF1;PYGB;NYNRIN;ACTA2;APOE;NT5E;INPP5D;FBXO41;OAS2;ADAM19;MN1;LMF1;HSPA2;FBXW4;EGFR;HERC3;PTPRS;CIRBP;FAM20C;PKD2;CAPRIN2;MNT;XPC;APOBEC3C;CXCR1;RBM3;ASH2L;TRIM22;SRSF5;CTSO;SFRP1;OBSL1;MTHFR;PERM1;SEC14L2;KCTD11;EPHB2;MAP3K14;DCAF16;DGKQ;TMEM129;PIK3R1;ADAMTS7;BRSK1;RBCK1;KDM3A;TSC22D3;CUL9;RNF135;POU3F1;SULF2;WNT3;CAMKK1;HERC5;UBXN4;ST6GALNAC2;UNK;HR;CSPG4;ISG15;MVB12B;ELFN2;HTRA1;SPATA18;TFCP2L1;TENM4;RGMA;ZFPM1;KITLG;HOXC5;MVD;ZDHHC1;ZNF362;CUL7;VAMP3;CITED4;IRF2BPL;MC1R;ZNF266;SRD5A3;STAT1;IMPACT;CAMK2N1;CRY2;NSG1;RAB40B;THAP8;NOS1;PRKACB;ZNF704;HOXA3;CRY1;ZNF699;MAML3;ZFP41;SCMH1;KLF13;CRTAP;SDC3;MAGEF1;NFATC4;ZNF783;SPDYE6;D2HGDH;BTBD2;FKBP5;RNF187;FERMT1;H1F0;CYP26B1;GAA;AP5Z1;HSF4;CNTRL;ZNF251;LIG1;CDK18;VPS11;SPEG;COL7A1;SPOCK1;EAPP;NAGLU;MDM2;CRTC1;NDN;MLH3;DDX59;ST6GALNAC6;PPP2R2C;ZNF662;TYSND1;LTBP4;OBSCN;IDUA;TNFSF10;HGSNAT;FKBP9;NEO1;RAPGEF3;PHACTR3;ZNF414;SPSB3;TCF25;ENDOD1;PCBP4;CTSV;POLH;POLR2J2;OAS1;FLRT3;RASA4;GAL3ST4;B4GALT6;MLLT6;RGS2;F2R;PDCD4;SPTB;SERPINB5;PPP1R3E;ALPK1;ZNF160;CAPN7;SWT1;ARSI;NEK9;RTN4RL1;ZFP36L2;TRPV4;FLOT1;GLI2;ADORA2B;ANK3;KLF7;RNF165;NAT6;DHX32;ADAMTS13;LAMP3;TCEA2;MAPK8IP3;SPDYE5;ZNF76;SOX12;PIDD1;PARP6;SLX1A;SLX1B;ZNF747;GJC2;ZCCHC11;RHBDF1;FBXO44;RASGEF1A;PER2;UNC119;HEXA;FRS3;C5;ZNF658;ARSD;SNTA1;PSKH1;MINK1;PHF2;ABHD14B;TCEAL1;WWTR1;ITGA2;ULK1;GLI3;SPPL2B;PCSK1;TPGS1;THRAP3;ZNF558;IRX4;SMARCA1;BHLHE40;LRSAM1;ZNF655;NAIP;LTBP1;ZNF333;NEK8;MAP2K5;ITGA6;ZNF318;LZTS1;IGFBP4;MMP1;TCFL5;TRAK1;JARID2;NUPR1;PRR9;GPC2;INSR;CCDC85B;HSF2BP;MMP28;GSN;CHD3;CDK14;ST3GAL5;TTN;CBLC;DDT;ZNF18;AHNAK2;RNPEPL1;TRIOBP;MXD4;POLD4;CTSF;ZNF287;CD109;NSUN5P2;PMS2P3;ETAA1;RMI2;ZNF446;FBXL16;ZNF581;PILRB;ENDOG;SLC27A1;PGAP1;GID4;RTF1;MDK;CASP14;IRF9;RICTOR;H2AFJ;BMP6;NLRX1;B4GALT2;PEX10;TCIRG1;MAP2K2;PDK1;VEGFB;GLI4;SQSTM1;PTK6;FZD7;ETV5;LOXL1;SYNGAP1;DLX3;SHARPIN;HEXB;KDM4C;HYAL1;METTL23;CLCA2;UBOX5;NSMCE4A;ARRDC1;B3GNT9;ZNF608;PLA2G6;CST3;PDIK1L;CAPNS2;GDF15;BBS2;TXNIP;CTF1;THSD4;TCF4;PLAG1;MAP3K12;RCOR2;WRN;IFI27;DNM1;MCM9;ZYG11B;MACROD1;KLHL24;TREX1;LPIN3;ZDHHC12;CDK5R1;ATRX;REC8;PIGZ;POLR2J3;MAPK10;NKTR;SHANK3;HFE;ADIRF;HMG20B;TRIM38;DTX3;AGO4;ERCC6;RRM2B;SLIT3;HLCS;SHC2;EDA2R;SPRY2;FBXO2;MEF2D;CREBRF;XRN1;MLXIPL;CTSB;KLK5;TARBP1;FBXW7;ING4;CDK5RAP3;ZNF862;ATXN1;LMO2;NFIX;PAK6;TFPI2;CARF;PGM1;MXI1;RNF170;THRA;APC2;METTL21A;ARAP1;ADARB1;RAI1;ELF1;IKZF4;DCAF10;ACACB;NLRP1;C1RL;ZBTB34;ZNF627;TK2;LACTB2;TNS2;C17ORF97;MIF4GD;DBP;NDST2;NAB2;EPM2AIP1;FBXW5;LRP1;KLHDC8B;PEG3;RGS12;ATE1;MPG;RNPEP;RFX2;ZNF554;MAP3K6;RIMKLB;MYO3B;SALL2;WNK1;ZNF107;ZNF532;ZBTB20;PDE2A;ZNF334;MAF;STK16;RET;ZMYND8;PRX;DAB2IP;CASZ1;RWDD3;CALCOCO1;TEAD2;MYSM1;FBXO4;RNF213;TSHZ2;PIK3C3;ZNF276;IFI16;DALRD3;FGFR4;ERCC5;PIK3R2;TEF;ZNF25;SETD4;AREG;ABTB1;KLHL3;ETFB;RPS6KA5;APBB3;ZNF630;BTG1;BST2;ZNF687;VDR;MAMSTR;TNRC18;TNRC6C;ZFP28;DPY19L2P2;PLXND1;ZMYM3;SIX5;HLTF;MARCH8;PCSK6;ZNF789;MPPE1;ZNF563;ZNF517;PCMTD2;TBC1D16;STK19;PPP1R2;DMTN;PPP1R35;STAT2;ARFGEF2;LMTK3;PCMTD1;WWC3;PHF1;ZNF292;TFDP2;SNX1;GOLGA7B;NRARP;ACVR1B;ZNF737;PRIMPOL;NECAB3;DLG4;TNNI2;PPP2R3B;TSSK1B;ADCK5;ZNF701;NAT14;PANO1;PALB2;ENDOU;MPI;IGFBP6;TCEAL4;ZNF91;PTMS;WEE1;DYDC1;GTF2IRD2;PTK7;DQX1;TCF7;TNFRSF25;ZFP36L1;XYLT1;MXRA8;GLMP;TOP3B;ACSL1;IL11;KAT2B;MARK4;TEP1;APOLD1;IRS2;ERN1;RNF141;IVNS1ABP;RAD50;ZNF439;ANGEL2;MAN1B1;TRERF1;SCYL3;SCG5;APBB2;SGSH;PBLD;DCAF8;TNFSF12;STAT6;PCSK1N;SOX13;PRDX5;PHPT1;NELFCD;GLB1;KLF8;KLHL29;CHD6;TRAF5;GOLGB1;DPP7;TRIM2;CD9;RANBP9;HDAC11;PTPN3;CTSD;ERBB2;SPOCD1;UVSSA;ZDHHC24;PQLC3;PPM1M;ABCA2;KMT5C;AKAP6;ATG14;RORA;SSH3;PPARG;PRKACA;LDLRAP1;CXXC5;POLM;GCNT4;ZNF572;ACKR3;ZNF658B;SERPING1;PARN;ZNF529;UFL1;LAMB2;RIPK3;KLF9;AIP;SCAND1;LONP2;PRMT3;SNX33;HARS2;CIT;ZFP90;EHHADH;MSH5;PER3;ZFP30;FOXP2;PTBP2;ZC3H6;HIVEP1;SMURF1;NPNT;TTLL1;CTNNBIP1;PEMT;GCLC;ECM1
17615,GO:1901360,0.999999972060752,3.96904083368234e-08,407,4862,organic cyclic compound metabolic process,BP,TNFAIP3;HES2;ZSCAN18;TSC22D1;SIK1;DDB2;TP53INP1;PTHLH;SREBF1;AMACR;NYNRIN;APOE;NT5E;GAMT;OAS2;MN1;LMF1;EGFR;CIRBP;FAM20C;PKD2;CAPRIN2;MNT;XPC;APOBEC3C;RBM3;ASH2L;TRIM22;SRSF5;SFRP1;MTHFR;PERM1;SEC14L2;DGKQ;PIK3R1;RBCK1;KDM3A;TSC22D3;POU3F1;H6PD;DHTKD1;HR;ISG15;HTRA1;TFCP2L1;RGMA;KCNAB2;ZFPM1;KITLG;HOXC5;MVD;ZNF362;CITED4;IRF2BPL;NAPRT;MC1R;ZNF266;SRD5A3;STAT1;IMPACT;CRY2;UROS;THAP8;NOS1;ZNF704;HOXA3;CRY1;ZNF699;MAML3;ZFP41;SCMH1;KLF13;MAGEF1;NFATC4;ZNF783;RNF187;H1F0;CYP26B1;AP5Z1;CMPK2;HSF4;ZNF251;LIG1;EAPP;MDM2;CRTC1;NDN;MLH3;NMRK1;DDX59;ZNF662;PRODH;CYP3A5;NEO1;RAPGEF3;ZNF414;TCF25;ENDOD1;PCBP4;POLH;BLVRB;POLR2J2;OAS1;MLLT6;F2R;PDCD4;ZNF160;SWT1;ZFP36L2;TRPV4;GLI2;ADORA2B;KLF7;RNF165;DHX32;TCEA2;ZNF76;SOX12;PIDD1;SLX1A;SLX1B;ZNF747;ZCCHC11;SULT1E1;PER2;ZNF658;PHF2;ABHD14B;GSTM2;TCEAL1;WWTR1;GLI3;THRAP3;ZNF558;IRX4;SMARCA1;BHLHE40;ZNF655;ZNF333;MAP2K5;ITGA6;ZNF318;LZTS1;IGFBP4;TCFL5;TRAK1;JARID2;NUPR1;INSR;CCDC85B;HSF2BP;ALDH4A1;CHD3;DDT;ZNF18;AHNAK2;MXD4;POLD4;ZNF287;NSUN5P2;PGLS;PMS2P3;ETAA1;RMI2;ZNF446;ZNF581;ENDOG;PGAP1;RTF1;MDK;IRF9;H2AFJ;BMP6;NLRX1;TCIRG1;MAP2K2;GLI4;SQSTM1;FZD7;ETV5;AKR7A2;DLX3;HEXB;KDM4C;METTL23;NSMCE4A;ZNF608;CST3;GDF15;TXNIP;TCF4;ATP6V0A2;NPHP3;PLAG1;IDH2;RCOR2;WRN;IFI27;MCM9;MACROD1;TREX1;LPIN3;OARD1;CDK5R1;ATRX;REC8;POLR2J3;MAPK10;HFE;ADIRF;HMG20B;TRIM38;AGO4;ERCC6;RRM2B;HLCS;EDA2R;MEF2D;GABBR1;CREBRF;XRN1;MLXIPL;TARBP1;FBXW7;GPR87;ING4;CDK5RAP3;ZNF862;ATXN1;LMO2;NFIX;PAK6;CARF;PGM1;MXI1;PFKFB2;THRA;ADARB1;RAI1;ELF1;IKZF4;ACACB;OGDHL;ZBTB34;ZNF627;TK2;LACTB2;DBP;NAB2;EPM2AIP1;PEG3;RGS12;ACP5;MPG;RFX2;ZNF554;PPCS;SALL2;PMEL;ZNF107;ZNF532;ZBTB20;PDE2A;ZNF334;SDHA;MAF;STK16;LTB4R2;RET;ZMYND8;PRX;DAB2IP;CASZ1;RWDD3;CALCOCO1;TEAD2;MYSM1;FBXO4;TSHZ2;ZNF276;IFI16;DALRD3;FGFR4;ERCC5;PIK3R2;TEF;ZNF25;OSBPL5;AREG;SNCB;RPS6KA5;APBB3;ZNF630;BTG1;ZNF687;VDR;MAMSTR;TNRC18;TNRC6C;ZFP28;PLXND1;NADK;ZMYM3;SIX5;HLTF;PCSK6;ZNF789;ZNF563;ZNF517;NDUFV3;STAT2;WWC3;PHF1;ZNF292;TFDP2;OSBPL1A;NRARP;ACVR1B;ZNF737;PRIMPOL;DLG4;TNNI2;ZNF701;NAT14;PALB2;ENDOU;MPI;TCEAL4;ZNF91;DUOX1;PTMS;DYDC1;GTF2IRD2;DQX1;TCF7;ZFP36L1;GLMP;TOP3B;IL11;KAT2B;TEP1;ERN1;HSD17B14;RNF141;IVNS1ABP;RAD50;ZNF439;ANGEL2;PNPO;MTR;DHRS4;TRERF1;UAP1L1;APBB2;CBR4;STAT6;SOX13;PRDX5;NELFCD;KLF8;GSTM3;CHD6;TRAF5;GOLGB1;HDAC11;ERBB2;SPOCD1;NUDT10;UVSSA;ABCA2;KMT5C;TH;RORA;PPARG;PRKACA;LDLRAP1;CXXC5;POLM;GCNT4;ZNF572;PLTP;ZNF658B;UCKL1;PARN;DDX12P;ZNF529;UFL1;RIPK3;KLF9;AIP;SCAND1;PRMT3;HARS2;ZFP90;MSH5;PER3;ZFP30;FOXP2;PTBP2;ZC3H6;HIVEP1;SMURF1;NPNT;CTNNBIP1;PEMT;GCLC;ECM1
3183,GO:0006807,0.999999975763064,3.41095779242008e-08,664,7377,nitrogen compound metabolic process,BP,TNFAIP3;TGFBI;HES2;SERPINE2;ZSCAN18;ULK2;GPNMB;TSC22D1;SIK1;MUC19;NPEPL1;DDB2;TP53INP1;IFI6;PTHLH;SREBF1;NYNRIN;APOE;NT5E;INPP5D;GAMT;FBXO41;OAS2;ADAM19;MN1;LMF1;HSPA2;FBXW4;EGFR;HERC3;PTPRS;CIRBP;FAM20C;PKD2;CAPRIN2;MNT;XPC;APOBEC3C;RBM3;ASH2L;TRIM22;SRSF5;CTSO;SFRP1;OBSL1;MTHFR;PERM1;SEC14L2;KCTD11;EPHB2;MAP3K14;GLUD1;BPHL;DCAF16;DGKQ;TMEM129;PIK3R1;ADAMTS7;BRSK1;RBCK1;KDM3A;TSC22D3;CUL9;RNF135;POU3F1;SULF2;H6PD;DHTKD1;CAMKK1;HERC5;UBXN4;ST6GALNAC2;UNK;HR;CSPG4;ISG15;MVB12B;ELFN2;HTRA1;SPATA18;TFCP2L1;TENM4;RGMA;KCNAB2;ZFPM1;KITLG;HOXC5;MVD;ZDHHC1;ZNF362;CUL7;CITED4;IRF2BPL;NAPRT;MC1R;ZNF266;SRD5A3;STAT1;IMPACT;CAMK2N1;CRY2;NSG1;UROS;KDSR;RAB40B;THAP8;NOS1;PRKACB;ZNF704;HOXA3;CRY1;ZNF699;MAML3;ZFP41;SCMH1;KLF13;CRTAP;SDC3;MAGEF1;NFATC4;ZNF783;HMGCL;SPDYE6;D2HGDH;BTBD2;FKBP5;RNF187;H1F0;AP5Z1;CMPK2;THNSL2;HSF4;CNTRL;ZNF251;LIG1;CDK18;VPS11;SPEG;COL7A1;SPOCK1;EAPP;NAGLU;MDM2;CRTC1;NDN;MLH3;NMRK1;DDX59;ST6GALNAC6;PPP2R2C;ZNF662;TYSND1;LTBP4;OBSCN;IDUA;TNFSF10;PRODH;HGSNAT;FKBP9;CERS4;CYP3A5;NEO1;RAPGEF3;PHACTR3;ZNF414;SPSB3;TCF25;ENDOD1;PCBP4;CTSV;POLH;BLVRB;POLR2J2;OAS1;FLRT3;RASA4;GAL3ST4;CRAT;B4GALT6;MLLT6;RGS2;F2R;PDCD4;SPTB;SERPINB5;ALPK1;ZNF160;CAPN7;SWT1;ARSI;NEK9;RTN4RL1;ZFP36L2;TRPV4;FLOT1;GLI2;ADORA2B;KLF7;RNF165;NAT6;DHX32;ADAMTS13;LAMP3;TCEA2;MAPK8IP3;SPDYE5;ZNF76;SOX12;PIDD1;PARP6;SLX1A;SLX1B;ZNF747;GJC2;ZCCHC11;RHBDF1;SULT1E1;FBXO44;RASGEF1A;PER2;UNC119;HEXA;FRS3;C5;ZNF658;ARSD;SNTA1;PSKH1;MINK1;PHF2;ABHD14B;GSTM2;TCEAL1;WWTR1;MBOAT2;ITGA2;ULK1;GLI3;SPPL2B;PCSK1;TPGS1;THRAP3;ZNF558;IRX4;SMARCA1;BHLHE40;LRSAM1;ZNF655;NAIP;LTBP1;ZNF333;NEK8;MAP2K5;ITGA6;ZNF318;LZTS1;IGFBP4;MMP1;TCFL5;TRAK1;JARID2;NUPR1;PRR9;GPC2;INSR;TST;CCDC85B;HSF2BP;MMP28;GSN;ALDH4A1;CHD3;CDK14;ST3GAL5;TTN;CBLC;DDT;ZNF18;AHNAK2;RNPEPL1;TRIOBP;MXD4;POLD4;CTSF;ZNF287;CD109;NSUN5P2;PGLS;PMS2P3;ETAA1;RMI2;ZNF446;FBXL16;ZNF581;MGST2;PILRB;ENDOG;SLC27A1;PGAP1;GID4;RTF1;MDK;CASP14;IRF9;RICTOR;H2AFJ;BMP6;NLRX1;B4GALT2;PEX10;TCIRG1;MAP2K2;OPLAH;PDK1;VEGFB;ALDH7A1;GLI4;SQSTM1;PTK6;FZD7;ETV5;AKR7A2;LOXL1;SYNGAP1;DLX3;SHARPIN;HEXB;KDM4C;HYAL1;METTL23;CLCA2;UBOX5;NSMCE4A;ARRDC1;B3GNT9;ZNF608;PLA2G6;CST3;PDIK1L;CAPNS2;GDF15;TXNIP;CTF1;THSD4;TCF4;ATP6V0A2;NPHP3;PLAG1;IDH2;MAP3K12;RCOR2;WRN;IFI27;MCM9;ZYG11B;MACROD1;KLHL24;TREX1;LPIN3;ZDHHC12;OARD1;CDK5R1;ATRX;REC8;PIGZ;OSBPL10;POLR2J3;MAPK10;NKTR;SHANK3;HFE;ADIRF;HMG20B;TRIM38;DTX3;AGO4;ERCC6;RRM2B;HLCS;SHC2;EDA2R;SPRY2;FBXO2;MEF2D;GABBR1;CREBRF;XRN1;MLXIPL;CTSB;KLK5;TARBP1;FBXW7;GPR87;ING4;CDK5RAP3;ZNF862;ATXN1;LMO2;NFIX;PAK6;TFPI2;CARF;PGM1;MXI1;PFKFB2;RNF170;THRA;APC2;METTL21A;ADARB1;RAI1;ELF1;IKZF4;DCAF10;ACACB;OGDHL;NLRP1;C1RL;ZBTB34;ZNF627;TK2;LACTB2;GLUL;TNS2;C17ORF97;MIF4GD;DBP;NDST2;NAB2;EPM2AIP1;FBXW5;SRR;LRP1;KLHDC8B;PEG3;RGS12;ATE1;ACP5;MPG;PLA2G7;RNPEP;RFX2;ZNF554;MAP3K6;RIMKLB;PPCS;MYO3B;SALL2;WNK1;ZNF107;ZNF532;ZBTB20;PDE2A;ZNF334;SDHA;MAF;STK16;LTB4R2;RET;ZMYND8;PRX;DAB2IP;CASZ1;RWDD3;CALCOCO1;TEAD2;MYSM1;FBXO4;RNF213;TSHZ2;PIK3C3;ZNF276;IFI16;DALRD3;FGFR4;ERCC5;PIK3R2;TEF;ZNF25;SETD4;OSBPL5;AREG;ABTB1;KLHL3;SNCB;ETFB;RPS6KA5;APBB3;ZNF630;BTG1;BST2;ZNF687;VDR;MAMSTR;TNRC18;TNRC6C;ZFP28;DPY19L2P2;PLXND1;NADK;ZMYM3;SIX5;HLTF;MARCH8;PCSK6;ZNF789;MPPE1;ZNF563;ZNF517;PCMTD2;STK19;NDUFV3;PPP1R2;DMTN;PPP1R35;STAT2;LMTK3;PCMTD1;WWC3;PHF1;ZNF292;TFDP2;SNX1;GOLGA7B;NRARP;ACVR1B;ZNF737;PRIMPOL;NECAB3;DLG4;TNNI2;PPP2R3B;ESYT2;TSSK1B;ADCK5;ZNF701;ALOXE3;NAT14;PANO1;PALB2;ENDOU;MPI;IGFBP6;TCEAL4;ZNF91;DUOX1;PTMS;WEE1;DYDC1;GTF2IRD2;PTK7;DQX1;AMT;TCF7;TNFRSF25;ZFP36L1;XYLT1;MXRA8;GLMP;TOP3B;ACSL1;IL11;KAT2B;MARK4;TEP1;APOLD1;IRS2;ERN1;RNF141;IVNS1ABP;RAD50;ZNF439;ANGEL2;PNPO;MTR;MAN1B1;TRERF1;UAP1L1;SCYL3;SCG5;APBB2;CBR4;SGSH;PBLD;DCAF8;TNFSF12;CERS5;STAT6;PCSK1N;SOX13;PRDX5;PHPT1;NELFCD;SMPDL3B;GLB1;CPT1C;KLF8;GSTM3;KLHL29;CHD6;TRAF5;GOLGB1;DPP7;TRIM2;RANBP9;HDAC11;PTPN3;CTSD;ERBB2;SPOCD1;NUDT10;UVSSA;ZDHHC24;PQLC3;PPM1M;ABCA2;KMT5C;AKAP6;TH;ATG14;RORA;SSH3;PPARG;PRKACA;LDLRAP1;CXXC5;POLM;GCNT4;ZNF572;ACKR3;ZNF658B;SERPING1;UCKL1;PARN;DDX12P;ZNF529;UFL1;LAMB2;RIPK3;KLF9;AIP;SCAND1;LONP2;PRMT3;SNX33;HARS2;CIT;ZFP90;EHHADH;MSH5;PER3;ZFP30;FOXP2;PTBP2;ZC3H6;HIVEP1;SMURF1;NPNT;TTLL1;CTNNBIP1;PEMT;SERINC3;GCLC;ECM1
10380,GO:0043226,0.999999987627699,1.87449630939237e-08,924,9761,organelle,CC,TNFAIP3;TGFBI;POSTN;ITGB6;HES2;SERPINE2;ZSCAN18;ULK2;GPNMB;TSC22D1;SIK1;SLFN5;SUGCT;EPM2A;MUC19;NPEPL1;DDB2;TP53INP1;MAP6;IFI6;PTHLH;SREBF1;AMACR;PYGB;MXRA5;ACTA2;APOE;GPSM1;CES2;NT5E;INPP5D;GAMT;OAS2;ADAM19;LMF1;DDX60;HSPA2;EGFR;ESPN;TRIM65;HERC3;PTPRS;CIRBP;FLNC;FAM20C;PKD2;CAPRIN2;MNT;XPC;APOBEC3C;SYT8;CXCR1;CPT2;RBM3;SYN1;ASH2L;TRIM22;ALDH1A3;SRSF5;LRIG3;CTSO;SFRP1;OBSL1;PERM1;SEC14L2;KIF26B;PCDH1;EPS8L2;EPHB2;RALGDS;TNS1;SYNC;GPX3;MAP3K14;GLUD1;BPHL;DCAF16;DGKQ;TMEM129;PIK3R1;ADAMTS7;BRSK1;TXNRD3;MARVELD1;KDM3A;CXCL14;COL22A1;TSC22D3;EYS;EVC;POU3F1;SULF2;WNT3;H6PD;DHTKD1;CAMKK1;UBXN4;VAV3;ST6GALNAC2;HR;CSPG4;ISG15;MVB12B;CYBRD1;HTRA1;SPATA18;TFCP2L1;TENM4;UNC119B;RGMA;KCNAB2;ZFPM1;KITLG;HOXC5;ZDHHC1;ZNF362;CUL7;VAMP3;CITED4;SNN;IRF2BPL;NAPRT;REEP2;PRICKLE2;ASAP3;ZNF266;SRD5A3;OR2A4;STAT1;CAMK2N1;CRY2;MYL9;KRT15;HS1BP3;LGALS7B;WDR63;MARCKSL1;NSG1;UROS;KDSR;ITGB5;COL10A1;RAB43;RAB40B;NOS1;PRKACB;ZNF704;HOXA3;B4GALNT4;CRY1;ZNF699;MAML3;ZFP41;SCMH1;KLF13;CRTAP;SDC3;BCAM;MAGEF1;PLEKHG5;NFATC4;ZNF783;HMGCL;D2HGDH;BTBD2;SCARA3;FKBP5;RNF187;FERMT1;H1F0;CYP26B1;GAA;AP5Z1;CMPK2;HSF4;CNTRL;ZNF251;MICALL1;LIG1;CDK18;VPS11;SPEG;NDRG1;COL7A1;SPOCK1;ITPR3;EAPP;NAGLU;CYHR1;MDM2;CRTC1;LZTS2;PLCD1;NDN;MLH3;DDX59;ST6GALNAC6;ZNF662;TYSND1;LTBP4;PIK3IP1;OBSCN;IDUA;GOLGA8A;GPRC5C;HLA-B;TNFSF10;PRODH;HGSNAT;MYH11;PARVB;SYTL1;FKBP9;NDUFA4L2;CALML3;ACTR1B;TNXB;RHOBTB2;UGT1A3;CERS4;CYP3A5;NEO1;RAPGEF3;PHACTR3;ZNF414;TCF25;ENDOD1;FAM210B;CTSV;NLGN4Y;POLH;BLVRB;POLR2J2;OAS1;FLRT3;NUDCD3;TRIM66;GAL3ST4;CRAT;KIF26A;B4GALT6;MLLT6;AP1G2;RGL4;RGS2;ACAP3;ADGRB2;F2R;MLYCD;PPL;C2CD4C;HPS4;PHYH;MT1X;PDCD4;SPTB;SERPINB5;NOL4L;ZNF160;CAPN7;SWT1;DNAH1;SLC27A3;ARSI;NEK9;TUBGCP5;RTN4RL1;ZFP36L2;CLTCL1;TRPV4;TMC6;FLOT1;GLI2;AGAP4;TOM1L2;CORO6;ANK3;KLF7;RNF165;DHX32;ADAMTS13;LAMP3;TCEA2;RALGAPA1;MAPK8IP3;GOLGA8B;ZNF76;SOX12;PIDD1;RIMS3;AVL9;SLX1A;SLX1B;G6PC3;ATG16L2;SPG11;ZCCHC11;RHBDF1;SULT1E1;ANKS6;PER2;CLCN6;PTGS1;UNC119;DIRC2;HEXA;FNDC4;C5;FRMD4B;ZNF658;ARSD;WIPF1;SNTA1;PSKH1;MINK1;PHF2;NINL;ABHD14B;GSTM2;TCEAL1;AMIGO2;WWTR1;MBOAT2;ASAP2;LHFPL2;ITGA2;RSPH3;FAM110C;ULK1;GLI3;SPPL2B;FHOD3;PCSK1;TPGS1;THRAP3;ZNF558;IRX4;SMARCA1;AKAP7;BHLHE40;DGCR6L;VAMP2;ZNF655;NAIP;LTBP1;ZNF333;NEK8;MAP2K5;GAS8;BOC;LTBP3;CES3;BSN;SESN3;ZNF318;LZTS1;IGFBP4;TCFL5;TRAK1;JARID2;NUPR1;GPC2;NISCH;INSR;TST;CCDC85B;CELSR1;GSN;ALDH4A1;CEP68;HEBP1;CHD3;CDK14;ST3GAL5;BAIAP2;TANC1;TTN;CBLC;SCNN1A;DDT;ZNF18;CEP126;SUN1;AHNAK2;PLEKHH2;TRIOBP;MXD4;POLD4;RIN1;DNAJC30;CTSF;ZNF287;CD109;CYP2D7;NSUN5P2;PNMA1;PGLS;PMS2P3;ETAA1;RMI2;ZNF446;SEPT6;RAB11FIP4;VPS39;ZNF581;MGST2;TP53AIP1;ENDOG;SLC27A1;PGAP1;TM7SF3;NRSN2;RTF1;BLOC1S3;CASP14;IRF9;TMEM9;H2AFJ;BMP6;F8A1;NLRX1;B4GALT2;PEX10;SLC2A3;TCIRG1;S100A4;MICALL2;MAP2K2;PDK1;VEGFB;ALDH7A1;GLI4;SQSTM1;CEP192;CABYR;PTK6;TMEM8B;FZD7;ETV5;AKR7A2;LOXL1;FNBP4;FRMD8;SYNGAP1;FAM213A;FAT2;DLX3;TMEM117;EPB41L3;SHARPIN;HEXB;KDM4C;HYAL1;METTL23;CLCA2;ARHGAP33;H1FX;UBOX5;NSMCE4A;ARRDC1;KIAA0319L;B3GNT9;WHAMMP3;CENPC;PLA2G6;CST3;PDIK1L;HOMER2;MMRN2;GDF15;PEX7;BBS2;TXNIP;THSD4;TCF4;ATP6V0A2;KLHDC2;COL6A1;PEX11B;NPHP3;PSD3;LRRCC1;PLAG1;IDH2;CERCAM;RCOR2;WRN;PODXL;SEPT5;IFI27;MALL;OXLD1;DNM1;MCM9;MACROD1;IQCB1;PLD3;TREX1;LPIN3;ZDHHC12;ABHD14A;MCTP1;CDK5R1;ATRX;REC8;ARHGAP27;AGAP6;NET1;PIGZ;CA2;OSBPL10;POLR2J3;HOOK2;SESN1;EPB41L4A;MAPK10;NKTR;SHANK3;HFE;ADIRF;HMG20B;CYBA;NID1;AGO4;ERCC6;HADH;RRM2B;SLIT3;CLIP2;KRT14;HLCS;SPRY2;FBXO2;WASH3P;MEF2D;IFT140;CREBRF;XRN1;AGAP7P;RAB11FIP3;TIGD5;MLXIPL;CTSB;KLK5;TARBP1;FBXW7;KCNMA1;ANKRD28;ING4;NUDT6;CDK5RAP3;ZNF862;ATXN1;LMO2;CCDC92;NFIX;PAK6;CARF;DZIP1L;PGM1;MXI1;PFKFB2;RNF170;CHMP1B;THRA;TTC12;HSD11B1L;APC2;METTL21A;ACADS;ARAP1;ASTN2;GOLGA8N;ADARB1;RAI1;ELF1;MX2;IKZF4;DCAF10;RPH3AL;SLC2A1;ACACB;OGDHL;NLRP1;C1RL;FRAT1;ZBTB34;REEP4;ZNF627;TK2;GPR155;LACTB2;BEX2;GLUL;TBC1D17;MIF4GD;DBP;NDST2;NAB2;EPM2AIP1;GNG2;PRR7;CAPG;TSPYL4;LRP1;HLA-A;PEG3;NPHP4;RGS12;CCDC136;ATE1;ACP5;MPG;SYNPO2;RNPEP;C12ORF66;CENPH;RFX2;DLK2;ZNF554;BRINP1;SLC48A1;BDH1;PPCS;MYO3B;APPL2;HEXDC;SALL2;PMEL;ZNF107;ZNF532;BBS1;JPH2;ZBTB20;PDE2A;ZNF334;SDHA;MAF;STK16;LTB4R2;RET;ZMYND8;PRX;DAB2IP;CASZ1;RWDD3;ACOX3;CALCOCO1;SLC37A2;TEAD2;MYSM1;DDHD2;SHROOM2;RNF213;OLFM2;TSHZ2;PIK3C3;ZNF276;IFI16;SYT7;FGFR4;ERCC5;BBS5;PIK3R2;RETSAT;TEF;ZNF25;SETD4;OSBPL5;AREG;ABTB1;TMEM203;DEF6;KLHL3;SNCB;ETFB;MYO9A;RPS6KA5;APBB3;ZNF630;DLG5;BTG1;BST2;ZNF687;VDR;LETMD1;SNX21;MAMSTR;PHF7;TNRC18;ZFP28;DPY19L2P2;BBS10;ZMYM3;SIX5;HLTF;MARCH8;EHBP1;PCSK6;ZNF789;TMEM80;MPPE1;ZNF563;TNS4;ZNF517;TBC1D16;STK19;NDUFV3;LPAR6;EML3;DMTN;TPRN;STAT2;SGSM2;ARFGEF2;LMTK3;ALMS1;PHF1;ZNF292;SLC36A4;TMEM231;TFDP2;SNX1;GOLGA7B;OSBPL1A;ACVR1B;TMX4;SHROOM4;ZNF737;TACC1;CADM4;KDELC2;PRIMPOL;NECAB3;CCDC88B;DLG4;CCDC113;TNNI2;PPP2R3B;ESYT2;TSSK1B;IQSEC1;ZNF701;NAT14;PANO1;PALB2;MPI;SNX29;IGFBP6;TCEAL4;ZNF91;NBEAL2;CD68;GALE;PTMS;WEE1;DYDC1;R3HDM4;TMEM143;GTF2IRD2;GOLGA6L4;SLC35G2;DQX1;AMT;TCF7;SHANK2;RSAD2;TNFRSF25;NEMP2;ZFP36L1;XYLT1;LMNA;MXRA8;CLSTN3;GLMP;TOP3B;ACSL1;KAT2B;MARK4;TEP1;APOLD1;DMXL2;CEP250;ANO1;CAPS;MBLAC2;METTL7A;ERN1;SAC3D1;IVNS1ABP;ALOX15B;RAD50;ZNF439;TKFC;LAPTM4A;ANGEL2;ZMAT3;PNPO;MAN1B1;DHRS4;PEX1;ECI1;S100A6;TRERF1;FAAH;SCYL3;EFEMP2;SCG5;APBB2;CBR4;TTC19;SGSH;GAREM2;PBLD;DCAF8;CCDC90B;RAPGEF5;MYH16;CERS5;STAT6;PCSK1N;SOX13;PRDX5;PHPT1;NELFCD;PHC2;SMPDL3B;TUB;KIF7;GLB1;GOLGA1;CPT1C;KLF8;GSTM3;CHD6;TRAF5;NAP1L5;GOLGB1;ACSS2;DPP7;CD9;PLIN4;RANBP9;HDAC11;PTPN3;CTSD;COL13A1;ERBB2;SYNGR1;MPRIP;PLCB3;NUDT10;UVSSA;ZDHHC24;ARHGAP23;PPM1M;ABCA2;KMT5C;AKAP6;SLC2A11;TH;ATG14;MPP7;RORA;SSH3;PPARG;PRKACA;LDLRAP1;CXXC5;NPAP1;C6ORF120;POLM;FMNL3;ACOT2;GCNT4;VMAC;ZNF572;SYNE2;ACKR3;ZNF658B;SERPING1;SUCLG2;UCKL1;PARN;DDX12P;ZNF529;UFL1;LAMB2;IP6K2;RIPK3;NFASC;KLF9;PI4K2B;AIP;COG1;KCNS3;SCAND1;LONP2;PRMT3;SNX33;HARS2;CIT;ZFP90;EHHADH;MSH5;CLCN7;MAP1A;CCDC3;PER3;ZFP30;FOXP2;PTBP2;ZC3H6;HIVEP1;SMURF1;NPNT;TTLL1;EML2;CTNNBIP1;PEMT;ABCA11P;OCIAD2;SERINC3;ECM1
3800,GO:0008380,0.999999991834462,3.30536994403767e-08,11,391,RNA splicing,BP,SRSF5;PIK3R1;DHX32;THRAP3;AHNAK2;PRX;DQX1;TEP1;ERN1;IVNS1ABP;PTBP2
10278,GO:0043043,0.999999991950777,2.22545516865769e-08,25,671,peptide biosynthetic process,BP,EGFR;CIRBP;CAPRIN2;RBM3;UNK;IMPACT;RGS2;ZFP36L2;PER2;ITGA2;PCSK1;MGST2;MAP2K2;OPLAH;AGO4;XRN1;MIF4GD;DALRD3;ABTB1;TNRC6C;ZFP36L1;ERBB2;PPARG;HARS2;GCLC
3134,GO:0006725,0.999999993791823,9.05981833501652e-09,390,4728,cellular aromatic compound metabolic process,BP,TNFAIP3;HES2;ZSCAN18;TSC22D1;SIK1;DDB2;TP53INP1;PTHLH;SREBF1;NYNRIN;APOE;NT5E;GAMT;OAS2;MN1;EGFR;CIRBP;FAM20C;PKD2;CAPRIN2;MNT;XPC;APOBEC3C;RBM3;ASH2L;TRIM22;SRSF5;SFRP1;MTHFR;PERM1;SEC14L2;DGKQ;PIK3R1;RBCK1;KDM3A;TSC22D3;POU3F1;H6PD;DHTKD1;HR;ISG15;HTRA1;TFCP2L1;RGMA;KCNAB2;ZFPM1;KITLG;HOXC5;ZNF362;CITED4;IRF2BPL;NAPRT;MC1R;ZNF266;STAT1;IMPACT;CRY2;UROS;THAP8;NOS1;ZNF704;HOXA3;CRY1;ZNF699;MAML3;ZFP41;SCMH1;KLF13;MAGEF1;NFATC4;ZNF783;RNF187;H1F0;AP5Z1;CMPK2;HSF4;ZNF251;LIG1;EAPP;MDM2;CRTC1;NDN;MLH3;NMRK1;DDX59;ZNF662;NEO1;RAPGEF3;ZNF414;TCF25;ENDOD1;PCBP4;POLH;BLVRB;POLR2J2;OAS1;MLLT6;F2R;PDCD4;ZNF160;SWT1;ZFP36L2;TRPV4;GLI2;ADORA2B;KLF7;RNF165;DHX32;TCEA2;ZNF76;SOX12;PIDD1;SLX1A;SLX1B;ZNF747;ZCCHC11;SULT1E1;PER2;ZNF658;PHF2;ABHD14B;GSTM2;TCEAL1;WWTR1;GLI3;THRAP3;ZNF558;IRX4;SMARCA1;BHLHE40;ZNF655;ZNF333;MAP2K5;ITGA6;ZNF318;LZTS1;IGFBP4;TCFL5;TRAK1;JARID2;NUPR1;INSR;CCDC85B;HSF2BP;CHD3;DDT;ZNF18;AHNAK2;MXD4;POLD4;ZNF287;NSUN5P2;PGLS;PMS2P3;ETAA1;RMI2;ZNF446;ZNF581;ENDOG;PGAP1;RTF1;MDK;IRF9;H2AFJ;BMP6;NLRX1;TCIRG1;MAP2K2;GLI4;SQSTM1;FZD7;ETV5;AKR7A2;DLX3;HEXB;KDM4C;METTL23;NSMCE4A;ZNF608;CST3;GDF15;TXNIP;TCF4;ATP6V0A2;NPHP3;PLAG1;IDH2;RCOR2;WRN;IFI27;MCM9;MACROD1;TREX1;LPIN3;OARD1;CDK5R1;ATRX;REC8;POLR2J3;MAPK10;HFE;ADIRF;HMG20B;TRIM38;AGO4;ERCC6;RRM2B;EDA2R;MEF2D;GABBR1;CREBRF;XRN1;MLXIPL;TARBP1;FBXW7;GPR87;ING4;CDK5RAP3;ZNF862;ATXN1;LMO2;NFIX;PAK6;CARF;PGM1;MXI1;PFKFB2;THRA;ADARB1;RAI1;ELF1;IKZF4;OGDHL;ZBTB34;ZNF627;TK2;LACTB2;DBP;NAB2;EPM2AIP1;PEG3;RGS12;MPG;RFX2;ZNF554;PPCS;SALL2;PMEL;ZNF107;ZNF532;ZBTB20;PDE2A;ZNF334;SDHA;MAF;STK16;LTB4R2;RET;ZMYND8;PRX;DAB2IP;CASZ1;RWDD3;CALCOCO1;TEAD2;MYSM1;FBXO4;TSHZ2;ZNF276;IFI16;DALRD3;FGFR4;ERCC5;PIK3R2;TEF;ZNF25;AREG;SNCB;RPS6KA5;APBB3;ZNF630;BTG1;ZNF687;VDR;MAMSTR;TNRC18;TNRC6C;ZFP28;PLXND1;NADK;ZMYM3;SIX5;HLTF;PCSK6;ZNF789;ZNF563;ZNF517;NDUFV3;STAT2;WWC3;PHF1;ZNF292;TFDP2;NRARP;ACVR1B;ZNF737;PRIMPOL;DLG4;TNNI2;ZNF701;NAT14;PALB2;ENDOU;MPI;TCEAL4;ZNF91;DUOX1;PTMS;DYDC1;GTF2IRD2;DQX1;TCF7;ZFP36L1;GLMP;TOP3B;IL11;KAT2B;TEP1;ERN1;RNF141;IVNS1ABP;RAD50;ZNF439;ANGEL2;PNPO;MTR;TRERF1;UAP1L1;APBB2;CBR4;STAT6;SOX13;PRDX5;NELFCD;KLF8;GSTM3;CHD6;TRAF5;GOLGB1;HDAC11;ERBB2;SPOCD1;NUDT10;UVSSA;ABCA2;KMT5C;TH;RORA;PPARG;PRKACA;CXXC5;POLM;GCNT4;ZNF572;ZNF658B;UCKL1;PARN;DDX12P;ZNF529;UFL1;RIPK3;KLF9;AIP;SCAND1;PRMT3;HARS2;ZFP90;MSH5;PER3;ZFP30;FOXP2;PTBP2;ZC3H6;HIVEP1;SMURF1;NPNT;CTNNBIP1;PEMT;GCLC;ECM1
16228,GO:0090304,0.999999994155374,8.63621181995922e-09,339,4176,nucleic acid metabolic process,BP,TNFAIP3;HES2;ZSCAN18;TSC22D1;SIK1;DDB2;TP53INP1;SREBF1;NYNRIN;APOE;NT5E;OAS2;MN1;EGFR;CIRBP;PKD2;CAPRIN2;MNT;XPC;APOBEC3C;RBM3;ASH2L;TRIM22;SRSF5;SFRP1;PERM1;SEC14L2;DGKQ;PIK3R1;RBCK1;KDM3A;TSC22D3;POU3F1;HR;ISG15;HTRA1;TFCP2L1;RGMA;ZFPM1;KITLG;HOXC5;ZNF362;CITED4;IRF2BPL;MC1R;ZNF266;STAT1;IMPACT;CRY2;THAP8;NOS1;ZNF704;HOXA3;CRY1;ZNF699;MAML3;ZFP41;SCMH1;KLF13;MAGEF1;NFATC4;ZNF783;RNF187;H1F0;AP5Z1;HSF4;ZNF251;LIG1;EAPP;MDM2;CRTC1;NDN;MLH3;DDX59;ZNF662;NEO1;ZNF414;TCF25;ENDOD1;PCBP4;POLH;POLR2J2;OAS1;MLLT6;F2R;PDCD4;ZNF160;SWT1;ZFP36L2;TRPV4;GLI2;KLF7;RNF165;DHX32;TCEA2;ZNF76;SOX12;PIDD1;SLX1A;SLX1B;ZNF747;ZCCHC11;PER2;ZNF658;PHF2;ABHD14B;TCEAL1;WWTR1;GLI3;THRAP3;ZNF558;IRX4;SMARCA1;BHLHE40;ZNF655;ZNF333;MAP2K5;ITGA6;ZNF318;LZTS1;IGFBP4;TCFL5;TRAK1;JARID2;NUPR1;INSR;CCDC85B;HSF2BP;CHD3;ZNF18;AHNAK2;MXD4;POLD4;ZNF287;NSUN5P2;PMS2P3;ETAA1;RMI2;ZNF446;ZNF581;ENDOG;PGAP1;RTF1;MDK;IRF9;H2AFJ;BMP6;NLRX1;MAP2K2;GLI4;SQSTM1;FZD7;ETV5;DLX3;HEXB;KDM4C;METTL23;NSMCE4A;ZNF608;CST3;GDF15;TXNIP;TCF4;PLAG1;RCOR2;WRN;IFI27;MCM9;TREX1;LPIN3;CDK5R1;ATRX;REC8;POLR2J3;MAPK10;HFE;ADIRF;HMG20B;TRIM38;AGO4;ERCC6;RRM2B;EDA2R;MEF2D;CREBRF;XRN1;MLXIPL;TARBP1;FBXW7;ING4;CDK5RAP3;ZNF862;ATXN1;LMO2;NFIX;PAK6;CARF;MXI1;THRA;ADARB1;RAI1;ELF1;IKZF4;ZBTB34;ZNF627;TK2;LACTB2;DBP;NAB2;EPM2AIP1;PEG3;RGS12;MPG;RFX2;ZNF554;SALL2;ZNF107;ZNF532;ZBTB20;PDE2A;ZNF334;MAF;STK16;RET;ZMYND8;PRX;DAB2IP;CASZ1;RWDD3;CALCOCO1;TEAD2;MYSM1;FBXO4;TSHZ2;ZNF276;IFI16;DALRD3;FGFR4;ERCC5;PIK3R2;TEF;ZNF25;AREG;RPS6KA5;APBB3;ZNF630;BTG1;ZNF687;VDR;MAMSTR;TNRC18;TNRC6C;ZFP28;PLXND1;ZMYM3;SIX5;HLTF;PCSK6;ZNF789;ZNF563;ZNF517;STAT2;WWC3;PHF1;ZNF292;TFDP2;NRARP;ACVR1B;ZNF737;PRIMPOL;TNNI2;ZNF701;NAT14;PALB2;ENDOU;TCEAL4;ZNF91;PTMS;DYDC1;GTF2IRD2;DQX1;TCF7;ZFP36L1;GLMP;TOP3B;IL11;KAT2B;TEP1;ERN1;RNF141;IVNS1ABP;RAD50;ZNF439;ANGEL2;TRERF1;APBB2;STAT6;SOX13;PRDX5;NELFCD;KLF8;CHD6;TRAF5;GOLGB1;HDAC11;ERBB2;SPOCD1;UVSSA;ABCA2;KMT5C;RORA;PPARG;PRKACA;CXXC5;POLM;ZNF572;ZNF658B;PARN;ZNF529;UFL1;RIPK3;KLF9;AIP;SCAND1;PRMT3;HARS2;ZFP90;MSH5;PER3;ZFP30;FOXP2;PTBP2;ZC3H6;HIVEP1;SMURF1;NPNT;CTNNBIP1;GCLC;ECM1
5331,GO:0016070,0.99999999417136,8.72280648262417e-09,299,3761,RNA metabolic process,BP,TNFAIP3;HES2;ZSCAN18;TSC22D1;SIK1;TP53INP1;SREBF1;APOE;OAS2;MN1;EGFR;CIRBP;PKD2;CAPRIN2;MNT;APOBEC3C;RBM3;ASH2L;TRIM22;SRSF5;SFRP1;PERM1;SEC14L2;DGKQ;PIK3R1;RBCK1;KDM3A;TSC22D3;POU3F1;HR;HTRA1;TFCP2L1;RGMA;ZFPM1;HOXC5;ZNF362;CITED4;IRF2BPL;MC1R;ZNF266;STAT1;IMPACT;CRY2;THAP8;NOS1;ZNF704;HOXA3;CRY1;ZNF699;MAML3;ZFP41;SCMH1;KLF13;NFATC4;ZNF783;RNF187;HSF4;ZNF251;LIG1;EAPP;MDM2;CRTC1;NDN;DDX59;ZNF662;NEO1;ZNF414;TCF25;PCBP4;POLR2J2;OAS1;MLLT6;F2R;PDCD4;ZNF160;SWT1;ZFP36L2;TRPV4;GLI2;KLF7;RNF165;DHX32;TCEA2;ZNF76;SOX12;PIDD1;ZNF747;ZCCHC11;PER2;ZNF658;PHF2;ABHD14B;TCEAL1;WWTR1;GLI3;THRAP3;ZNF558;IRX4;SMARCA1;BHLHE40;ZNF655;ZNF333;MAP2K5;ITGA6;ZNF318;LZTS1;TCFL5;TRAK1;JARID2;NUPR1;INSR;CCDC85B;HSF2BP;CHD3;ZNF18;AHNAK2;MXD4;ZNF287;NSUN5P2;PMS2P3;ZNF446;ZNF581;RTF1;MDK;IRF9;H2AFJ;BMP6;NLRX1;MAP2K2;GLI4;SQSTM1;FZD7;ETV5;DLX3;HEXB;KDM4C;METTL23;ZNF608;GDF15;TXNIP;TCF4;PLAG1;RCOR2;IFI27;LPIN3;CDK5R1;ATRX;POLR2J3;MAPK10;HFE;ADIRF;HMG20B;TRIM38;AGO4;ERCC6;EDA2R;MEF2D;CREBRF;XRN1;MLXIPL;TARBP1;FBXW7;ING4;CDK5RAP3;ZNF862;ATXN1;LMO2;NFIX;PAK6;CARF;MXI1;THRA;ADARB1;RAI1;ELF1;IKZF4;ZBTB34;ZNF627;LACTB2;DBP;NAB2;EPM2AIP1;PEG3;RGS12;RFX2;ZNF554;SALL2;ZNF107;ZNF532;ZBTB20;PDE2A;ZNF334;MAF;STK16;RET;ZMYND8;PRX;DAB2IP;CASZ1;RWDD3;CALCOCO1;TEAD2;MYSM1;TSHZ2;ZNF276;IFI16;DALRD3;PIK3R2;TEF;ZNF25;RPS6KA5;APBB3;ZNF630;BTG1;ZNF687;VDR;MAMSTR;TNRC18;TNRC6C;ZFP28;PLXND1;ZMYM3;SIX5;HLTF;PCSK6;ZNF789;ZNF563;ZNF517;STAT2;WWC3;PHF1;ZNF292;TFDP2;NRARP;ACVR1B;ZNF737;PRIMPOL;TNNI2;ZNF701;NAT14;ENDOU;TCEAL4;ZNF91;DYDC1;GTF2IRD2;DQX1;TCF7;ZFP36L1;GLMP;IL11;KAT2B;TEP1;ERN1;RNF141;IVNS1ABP;ZNF439;ANGEL2;TRERF1;APBB2;STAT6;SOX13;PRDX5;NELFCD;KLF8;CHD6;TRAF5;GOLGB1;HDAC11;ERBB2;SPOCD1;ABCA2;KMT5C;RORA;PPARG;PRKACA;CXXC5;ZNF572;ZNF658B;PARN;ZNF529;UFL1;RIPK3;KLF9;AIP;SCAND1;PRMT3;HARS2;ZFP90;PER3;ZFP30;FOXP2;PTBP2;ZC3H6;HIVEP1;SMURF1;NPNT;CTNNBIP1;GCLC;ECM1
11679,GO:0046483,0.999999996680473,4.89920827023698e-09,387,4713,heterocycle metabolic process,BP,TNFAIP3;HES2;ZSCAN18;TSC22D1;SIK1;DDB2;TP53INP1;PTHLH;SREBF1;NYNRIN;APOE;NT5E;GAMT;OAS2;MN1;EGFR;CIRBP;FAM20C;PKD2;CAPRIN2;MNT;XPC;APOBEC3C;RBM3;ASH2L;TRIM22;SRSF5;SFRP1;MTHFR;PERM1;SEC14L2;DGKQ;PIK3R1;RBCK1;KDM3A;TSC22D3;POU3F1;H6PD;DHTKD1;HR;ISG15;HTRA1;TFCP2L1;RGMA;KCNAB2;ZFPM1;KITLG;HOXC5;ZNF362;CITED4;IRF2BPL;NAPRT;MC1R;ZNF266;STAT1;IMPACT;CRY2;UROS;THAP8;NOS1;ZNF704;HOXA3;CRY1;ZNF699;MAML3;ZFP41;SCMH1;KLF13;MAGEF1;NFATC4;ZNF783;RNF187;H1F0;AP5Z1;CMPK2;HSF4;ZNF251;LIG1;EAPP;MDM2;CRTC1;NDN;MLH3;NMRK1;DDX59;ZNF662;PRODH;NEO1;RAPGEF3;ZNF414;TCF25;ENDOD1;PCBP4;POLH;BLVRB;POLR2J2;OAS1;MLLT6;F2R;PDCD4;ZNF160;SWT1;ZFP36L2;TRPV4;GLI2;ADORA2B;KLF7;RNF165;DHX32;TCEA2;ZNF76;SOX12;PIDD1;SLX1A;SLX1B;ZNF747;ZCCHC11;SULT1E1;PER2;ZNF658;PHF2;ABHD14B;TCEAL1;WWTR1;GLI3;THRAP3;ZNF558;IRX4;SMARCA1;BHLHE40;ZNF655;ZNF333;MAP2K5;ITGA6;ZNF318;LZTS1;IGFBP4;TCFL5;TRAK1;JARID2;NUPR1;INSR;CCDC85B;HSF2BP;ALDH4A1;CHD3;ZNF18;AHNAK2;MXD4;POLD4;ZNF287;NSUN5P2;PGLS;PMS2P3;ETAA1;RMI2;ZNF446;ZNF581;ENDOG;PGAP1;RTF1;MDK;IRF9;H2AFJ;BMP6;NLRX1;TCIRG1;MAP2K2;GLI4;SQSTM1;FZD7;ETV5;DLX3;HEXB;KDM4C;METTL23;NSMCE4A;ZNF608;CST3;GDF15;TXNIP;TCF4;ATP6V0A2;NPHP3;PLAG1;IDH2;RCOR2;WRN;IFI27;MCM9;MACROD1;TREX1;LPIN3;OARD1;CDK5R1;ATRX;REC8;POLR2J3;MAPK10;HFE;ADIRF;HMG20B;TRIM38;AGO4;ERCC6;RRM2B;HLCS;EDA2R;MEF2D;GABBR1;CREBRF;XRN1;MLXIPL;TARBP1;FBXW7;GPR87;ING4;CDK5RAP3;ZNF862;ATXN1;LMO2;NFIX;PAK6;CARF;PGM1;MXI1;PFKFB2;THRA;ADARB1;RAI1;ELF1;IKZF4;ACACB;OGDHL;ZBTB34;ZNF627;TK2;LACTB2;DBP;NAB2;EPM2AIP1;PEG3;RGS12;ACP5;MPG;RFX2;ZNF554;PPCS;SALL2;ZNF107;ZNF532;ZBTB20;PDE2A;ZNF334;SDHA;MAF;STK16;LTB4R2;RET;ZMYND8;PRX;DAB2IP;CASZ1;RWDD3;CALCOCO1;TEAD2;MYSM1;FBXO4;TSHZ2;ZNF276;IFI16;DALRD3;FGFR4;ERCC5;PIK3R2;TEF;ZNF25;AREG;RPS6KA5;APBB3;ZNF630;BTG1;ZNF687;VDR;MAMSTR;TNRC18;TNRC6C;ZFP28;PLXND1;NADK;ZMYM3;SIX5;HLTF;PCSK6;ZNF789;ZNF563;ZNF517;NDUFV3;STAT2;WWC3;PHF1;ZNF292;TFDP2;NRARP;ACVR1B;ZNF737;PRIMPOL;DLG4;TNNI2;ZNF701;NAT14;PALB2;ENDOU;MPI;TCEAL4;ZNF91;PTMS;DYDC1;GTF2IRD2;DQX1;TCF7;ZFP36L1;GLMP;TOP3B;IL11;KAT2B;TEP1;ERN1;RNF141;IVNS1ABP;RAD50;ZNF439;ANGEL2;PNPO;MTR;TRERF1;UAP1L1;APBB2;STAT6;SOX13;PRDX5;NELFCD;KLF8;CHD6;TRAF5;GOLGB1;HDAC11;ERBB2;SPOCD1;NUDT10;UVSSA;ABCA2;KMT5C;TH;RORA;PPARG;PRKACA;CXXC5;POLM;ZNF572;PLTP;ZNF658B;UCKL1;PARN;DDX12P;ZNF529;UFL1;RIPK3;KLF9;AIP;SCAND1;PRMT3;HARS2;ZFP90;MSH5;PER3;ZFP30;FOXP2;PTBP2;ZC3H6;HIVEP1;SMURF1;NPNT;CTNNBIP1;PEMT;GCLC;ECM1
2871,GO:0006364,0.999999997649339,2.97965389785321e-08,2,255,rRNA processing,BP,NSUN5P2;TARBP1
5333,GO:0016072,0.999999998414259,1.51698059385496e-08,3,283,rRNA metabolic process,BP,NSUN5P2;XRN1;TARBP1
2743,GO:0006139,0.999999998738512,1.95085768903894e-09,375,4611,nucleobase-containing compound metabolic process,BP,TNFAIP3;HES2;ZSCAN18;TSC22D1;SIK1;DDB2;TP53INP1;PTHLH;SREBF1;NYNRIN;APOE;NT5E;GAMT;OAS2;MN1;EGFR;CIRBP;FAM20C;PKD2;CAPRIN2;MNT;XPC;APOBEC3C;RBM3;ASH2L;TRIM22;SRSF5;SFRP1;PERM1;SEC14L2;DGKQ;PIK3R1;RBCK1;KDM3A;TSC22D3;POU3F1;H6PD;DHTKD1;HR;ISG15;HTRA1;TFCP2L1;RGMA;KCNAB2;ZFPM1;KITLG;HOXC5;ZNF362;CITED4;IRF2BPL;NAPRT;MC1R;ZNF266;STAT1;IMPACT;CRY2;THAP8;NOS1;ZNF704;HOXA3;CRY1;ZNF699;MAML3;ZFP41;SCMH1;KLF13;MAGEF1;NFATC4;ZNF783;RNF187;H1F0;AP5Z1;CMPK2;HSF4;ZNF251;LIG1;EAPP;MDM2;CRTC1;NDN;MLH3;NMRK1;DDX59;ZNF662;NEO1;RAPGEF3;ZNF414;TCF25;ENDOD1;PCBP4;POLH;POLR2J2;OAS1;MLLT6;F2R;PDCD4;ZNF160;SWT1;ZFP36L2;TRPV4;GLI2;ADORA2B;KLF7;RNF165;DHX32;TCEA2;ZNF76;SOX12;PIDD1;SLX1A;SLX1B;ZNF747;ZCCHC11;SULT1E1;PER2;ZNF658;PHF2;ABHD14B;TCEAL1;WWTR1;GLI3;THRAP3;ZNF558;IRX4;SMARCA1;BHLHE40;ZNF655;ZNF333;MAP2K5;ITGA6;ZNF318;LZTS1;IGFBP4;TCFL5;TRAK1;JARID2;NUPR1;INSR;CCDC85B;HSF2BP;CHD3;ZNF18;AHNAK2;MXD4;POLD4;ZNF287;NSUN5P2;PGLS;PMS2P3;ETAA1;RMI2;ZNF446;ZNF581;ENDOG;PGAP1;RTF1;MDK;IRF9;H2AFJ;BMP6;NLRX1;TCIRG1;MAP2K2;GLI4;SQSTM1;FZD7;ETV5;DLX3;HEXB;KDM4C;METTL23;NSMCE4A;ZNF608;CST3;GDF15;TXNIP;TCF4;ATP6V0A2;NPHP3;PLAG1;IDH2;RCOR2;WRN;IFI27;MCM9;MACROD1;TREX1;LPIN3;OARD1;CDK5R1;ATRX;REC8;POLR2J3;MAPK10;HFE;ADIRF;HMG20B;TRIM38;AGO4;ERCC6;RRM2B;EDA2R;MEF2D;GABBR1;CREBRF;XRN1;MLXIPL;TARBP1;FBXW7;GPR87;ING4;CDK5RAP3;ZNF862;ATXN1;LMO2;NFIX;PAK6;CARF;PGM1;MXI1;PFKFB2;THRA;ADARB1;RAI1;ELF1;IKZF4;OGDHL;ZBTB34;ZNF627;TK2;LACTB2;DBP;NAB2;EPM2AIP1;PEG3;RGS12;MPG;RFX2;ZNF554;PPCS;SALL2;ZNF107;ZNF532;ZBTB20;PDE2A;ZNF334;SDHA;MAF;STK16;LTB4R2;RET;ZMYND8;PRX;DAB2IP;CASZ1;RWDD3;CALCOCO1;TEAD2;MYSM1;FBXO4;TSHZ2;ZNF276;IFI16;DALRD3;FGFR4;ERCC5;PIK3R2;TEF;ZNF25;AREG;RPS6KA5;APBB3;ZNF630;BTG1;ZNF687;VDR;MAMSTR;TNRC18;TNRC6C;ZFP28;PLXND1;NADK;ZMYM3;SIX5;HLTF;PCSK6;ZNF789;ZNF563;ZNF517;NDUFV3;STAT2;WWC3;PHF1;ZNF292;TFDP2;NRARP;ACVR1B;ZNF737;PRIMPOL;DLG4;TNNI2;ZNF701;NAT14;PALB2;ENDOU;MPI;TCEAL4;ZNF91;PTMS;DYDC1;GTF2IRD2;DQX1;TCF7;ZFP36L1;GLMP;TOP3B;IL11;KAT2B;TEP1;ERN1;RNF141;IVNS1ABP;RAD50;ZNF439;ANGEL2;TRERF1;UAP1L1;APBB2;STAT6;SOX13;PRDX5;NELFCD;KLF8;CHD6;TRAF5;GOLGB1;HDAC11;ERBB2;SPOCD1;NUDT10;UVSSA;ABCA2;KMT5C;RORA;PPARG;PRKACA;CXXC5;POLM;ZNF572;ZNF658B;UCKL1;PARN;DDX12P;ZNF529;UFL1;RIPK3;KLF9;AIP;SCAND1;PRMT3;HARS2;ZFP90;MSH5;PER3;ZFP30;FOXP2;PTBP2;ZC3H6;HIVEP1;SMURF1;NPNT;CTNNBIP1;PEMT;GCLC;ECM1
171,GO:0000377,0.999999998752366,8.54689941441157e-09,5,298,RNA splicing, via transesterification reactions with bulged adenosine as nucleophile,BP,SRSF5;DHX32;THRAP3;DQX1;PTBP2
183,GO:0000398,0.999999998752366,8.54689941441157e-09,5,298,mRNA splicing, via spliceosome,BP,SRSF5;DHX32;THRAP3;DQX1;PTBP2
170,GO:0000375,0.999999999031704,6.6932657431462e-09,5,301,RNA splicing, via transesterification reactions,BP,SRSF5;DHX32;THRAP3;DQX1;PTBP2
9903,GO:0042254,0.999999999186708,6.56098157459173e-09,4,317,ribosome biogenesis,BP,ZNF658;NSUN5P2;TARBP1;SETD4
7591,GO:0031974,0.999999999620877,6.45980326545209e-10,340,4303,membrane-enclosed lumen,CC,ITGB6;MUC19;DDB2;TP53INP1;PTHLH;SREBF1;AMACR;PYGB;APOE;CES2;NT5E;OAS2;HSPA2;EGFR;TRIM65;CIRBP;FAM20C;MNT;XPC;CPT2;RBM3;SYN1;ASH2L;TRIM22;SRSF5;PCDH1;MAP3K14;GLUD1;DCAF16;DGKQ;ADAMTS7;BRSK1;KDM3A;COL22A1;POU3F1;WNT3;H6PD;DHTKD1;HR;CSPG4;ISG15;TFCP2L1;ZFPM1;HOXC5;CITED4;IRF2BPL;NAPRT;ASAP3;STAT1;CRY2;NSG1;COL10A1;NOS1;PRKACB;HOXA3;MAML3;SCMH1;CRTAP;SDC3;NFATC4;HMGCL;D2HGDH;FKBP5;RNF187;H1F0;GAA;AP5Z1;HSF4;LIG1;COL7A1;ITPR3;NAGLU;CYHR1;MDM2;CRTC1;NDN;MLH3;DDX59;OBSCN;IDUA;PRODH;ACTR1B;NEO1;PHACTR3;CTSV;POLH;BLVRB;POLR2J2;OAS1;TRIM66;CRAT;RGS2;MLYCD;PHYH;NOL4L;ARSI;GLI2;ADAMTS13;TCEA2;SOX12;PIDD1;SLX1A;SLX1B;ATG16L2;SPG11;ZCCHC11;PER2;HEXA;ARSD;PSKH1;PHF2;ABHD14B;TCEAL1;WWTR1;GLI3;SPPL2B;PCSK1;THRAP3;SMARCA1;BHLHE40;ZNF655;LTBP1;BOC;CES3;ZNF318;IGFBP4;JARID2;GPC2;INSR;TST;CELSR1;GSN;ALDH4A1;CHD3;BAIAP2;TTN;PLEKHH2;POLD4;CTSF;NSUN5P2;PNMA1;ETAA1;RMI2;TP53AIP1;RTF1;IRF9;H2AFJ;B4GALT2;PDK1;VEGFB;ALDH7A1;SQSTM1;PTK6;ETV5;FNBP4;HEXB;KDM4C;HYAL1;H1FX;UBOX5;NSMCE4A;B3GNT9;CENPC;CST3;PDIK1L;PEX7;TXNIP;TCF4;KLHDC2;COL6A1;PLAG1;IDH2;CERCAM;WRN;PODXL;DNM1;MACROD1;IQCB1;CDK5R1;ATRX;REC8;ARHGAP27;POLR2J3;SESN1;MAPK10;NKTR;ADIRF;HMG20B;AGO4;ERCC6;HADH;RRM2B;HLCS;MEF2D;CREBRF;RAB11FIP3;MLXIPL;CTSB;FBXW7;ANKRD28;ING4;CDK5RAP3;ATXN1;LMO2;CCDC92;PAK6;CARF;PGM1;MXI1;PFKFB2;THRA;HSD11B1L;METTL21A;ACADS;ARAP1;ADARB1;RAI1;ELF1;IKZF4;DCAF10;OGDHL;NLRP1;ZBTB34;TK2;LACTB2;MIF4GD;EPM2AIP1;CAPG;RGS12;MPG;CENPH;ZNF554;BDH1;APPL2;SALL2;ZBTB20;PDE2A;SDHA;LTB4R2;CASZ1;ACOX3;CALCOCO1;TEAD2;MYSM1;RNF213;OLFM2;IFI16;ERCC5;SETD4;ABTB1;DEF6;ETFB;RPS6KA5;ZNF687;VDR;LETMD1;PHF7;TNRC18;ZMYM3;HLTF;PCSK6;ZNF789;MPPE1;STK19;NDUFV3;STAT2;PHF1;TFDP2;KDELC2;PRIMPOL;CCDC113;PPP2R3B;IQSEC1;PANO1;PALB2;WEE1;DYDC1;GTF2IRD2;AMT;TCF7;RSAD2;LMNA;MXRA8;KAT2B;TEP1;APOLD1;METTL7A;IVNS1ABP;RAD50;ANGEL2;ZMAT3;PNPO;ECI1;TRERF1;CBR4;SGSH;DCAF8;RAPGEF5;STAT6;SOX13;PRDX5;NELFCD;PHC2;GLB1;KLF8;CHD6;ACSS2;DPP7;HDAC11;CTSD;COL13A1;PLCB3;UVSSA;KMT5C;MPP7;RORA;PPARG;PRKACA;CXXC5;NPAP1;C6ORF120;POLM;ACOT2;SYNE2;SERPING1;SUCLG2;PARN;LAMB2;IP6K2;KLF9;AIP;LONP2;HARS2;EHHADH;MSH5;CLCN7;HIVEP1;SMURF1;CTNNBIP1;ECM1
10387,GO:0043233,0.999999999620877,6.45980326545209e-10,340,4303,organelle lumen,CC,ITGB6;MUC19;DDB2;TP53INP1;PTHLH;SREBF1;AMACR;PYGB;APOE;CES2;NT5E;OAS2;HSPA2;EGFR;TRIM65;CIRBP;FAM20C;MNT;XPC;CPT2;RBM3;SYN1;ASH2L;TRIM22;SRSF5;PCDH1;MAP3K14;GLUD1;DCAF16;DGKQ;ADAMTS7;BRSK1;KDM3A;COL22A1;POU3F1;WNT3;H6PD;DHTKD1;HR;CSPG4;ISG15;TFCP2L1;ZFPM1;HOXC5;CITED4;IRF2BPL;NAPRT;ASAP3;STAT1;CRY2;NSG1;COL10A1;NOS1;PRKACB;HOXA3;MAML3;SCMH1;CRTAP;SDC3;NFATC4;HMGCL;D2HGDH;FKBP5;RNF187;H1F0;GAA;AP5Z1;HSF4;LIG1;COL7A1;ITPR3;NAGLU;CYHR1;MDM2;CRTC1;NDN;MLH3;DDX59;OBSCN;IDUA;PRODH;ACTR1B;NEO1;PHACTR3;CTSV;POLH;BLVRB;POLR2J2;OAS1;TRIM66;CRAT;RGS2;MLYCD;PHYH;NOL4L;ARSI;GLI2;ADAMTS13;TCEA2;SOX12;PIDD1;SLX1A;SLX1B;ATG16L2;SPG11;ZCCHC11;PER2;HEXA;ARSD;PSKH1;PHF2;ABHD14B;TCEAL1;WWTR1;GLI3;SPPL2B;PCSK1;THRAP3;SMARCA1;BHLHE40;ZNF655;LTBP1;BOC;CES3;ZNF318;IGFBP4;JARID2;GPC2;INSR;TST;CELSR1;GSN;ALDH4A1;CHD3;BAIAP2;TTN;PLEKHH2;POLD4;CTSF;NSUN5P2;PNMA1;ETAA1;RMI2;TP53AIP1;RTF1;IRF9;H2AFJ;B4GALT2;PDK1;VEGFB;ALDH7A1;SQSTM1;PTK6;ETV5;FNBP4;HEXB;KDM4C;HYAL1;H1FX;UBOX5;NSMCE4A;B3GNT9;CENPC;CST3;PDIK1L;PEX7;TXNIP;TCF4;KLHDC2;COL6A1;PLAG1;IDH2;CERCAM;WRN;PODXL;DNM1;MACROD1;IQCB1;CDK5R1;ATRX;REC8;ARHGAP27;POLR2J3;SESN1;MAPK10;NKTR;ADIRF;HMG20B;AGO4;ERCC6;HADH;RRM2B;HLCS;MEF2D;CREBRF;RAB11FIP3;MLXIPL;CTSB;FBXW7;ANKRD28;ING4;CDK5RAP3;ATXN1;LMO2;CCDC92;PAK6;CARF;PGM1;MXI1;PFKFB2;THRA;HSD11B1L;METTL21A;ACADS;ARAP1;ADARB1;RAI1;ELF1;IKZF4;DCAF10;OGDHL;NLRP1;ZBTB34;TK2;LACTB2;MIF4GD;EPM2AIP1;CAPG;RGS12;MPG;CENPH;ZNF554;BDH1;APPL2;SALL2;ZBTB20;PDE2A;SDHA;LTB4R2;CASZ1;ACOX3;CALCOCO1;TEAD2;MYSM1;RNF213;OLFM2;IFI16;ERCC5;SETD4;ABTB1;DEF6;ETFB;RPS6KA5;ZNF687;VDR;LETMD1;PHF7;TNRC18;ZMYM3;HLTF;PCSK6;ZNF789;MPPE1;STK19;NDUFV3;STAT2;PHF1;TFDP2;KDELC2;PRIMPOL;CCDC113;PPP2R3B;IQSEC1;PANO1;PALB2;WEE1;DYDC1;GTF2IRD2;AMT;TCF7;RSAD2;LMNA;MXRA8;KAT2B;TEP1;APOLD1;METTL7A;IVNS1ABP;RAD50;ANGEL2;ZMAT3;PNPO;ECI1;TRERF1;CBR4;SGSH;DCAF8;RAPGEF5;STAT6;SOX13;PRDX5;NELFCD;PHC2;GLB1;KLF8;CHD6;ACSS2;DPP7;HDAC11;CTSD;COL13A1;PLCB3;UVSSA;KMT5C;MPP7;RORA;PPARG;PRKACA;CXXC5;NPAP1;C6ORF120;POLM;ACOT2;SYNE2;SERPING1;SUCLG2;PARN;LAMB2;IP6K2;KLF9;AIP;LONP2;HARS2;EHHADH;MSH5;CLCN7;HIVEP1;SMURF1;CTNNBIP1;ECM1
14503,GO:0070013,0.999999999620877,6.45980326545209e-10,340,4303,intracellular organelle lumen,CC,ITGB6;MUC19;DDB2;TP53INP1;PTHLH;SREBF1;AMACR;PYGB;APOE;CES2;NT5E;OAS2;HSPA2;EGFR;TRIM65;CIRBP;FAM20C;MNT;XPC;CPT2;RBM3;SYN1;ASH2L;TRIM22;SRSF5;PCDH1;MAP3K14;GLUD1;DCAF16;DGKQ;ADAMTS7;BRSK1;KDM3A;COL22A1;POU3F1;WNT3;H6PD;DHTKD1;HR;CSPG4;ISG15;TFCP2L1;ZFPM1;HOXC5;CITED4;IRF2BPL;NAPRT;ASAP3;STAT1;CRY2;NSG1;COL10A1;NOS1;PRKACB;HOXA3;MAML3;SCMH1;CRTAP;SDC3;NFATC4;HMGCL;D2HGDH;FKBP5;RNF187;H1F0;GAA;AP5Z1;HSF4;LIG1;COL7A1;ITPR3;NAGLU;CYHR1;MDM2;CRTC1;NDN;MLH3;DDX59;OBSCN;IDUA;PRODH;ACTR1B;NEO1;PHACTR3;CTSV;POLH;BLVRB;POLR2J2;OAS1;TRIM66;CRAT;RGS2;MLYCD;PHYH;NOL4L;ARSI;GLI2;ADAMTS13;TCEA2;SOX12;PIDD1;SLX1A;SLX1B;ATG16L2;SPG11;ZCCHC11;PER2;HEXA;ARSD;PSKH1;PHF2;ABHD14B;TCEAL1;WWTR1;GLI3;SPPL2B;PCSK1;THRAP3;SMARCA1;BHLHE40;ZNF655;LTBP1;BOC;CES3;ZNF318;IGFBP4;JARID2;GPC2;INSR;TST;CELSR1;GSN;ALDH4A1;CHD3;BAIAP2;TTN;PLEKHH2;POLD4;CTSF;NSUN5P2;PNMA1;ETAA1;RMI2;TP53AIP1;RTF1;IRF9;H2AFJ;B4GALT2;PDK1;VEGFB;ALDH7A1;SQSTM1;PTK6;ETV5;FNBP4;HEXB;KDM4C;HYAL1;H1FX;UBOX5;NSMCE4A;B3GNT9;CENPC;CST3;PDIK1L;PEX7;TXNIP;TCF4;KLHDC2;COL6A1;PLAG1;IDH2;CERCAM;WRN;PODXL;DNM1;MACROD1;IQCB1;CDK5R1;ATRX;REC8;ARHGAP27;POLR2J3;SESN1;MAPK10;NKTR;ADIRF;HMG20B;AGO4;ERCC6;HADH;RRM2B;HLCS;MEF2D;CREBRF;RAB11FIP3;MLXIPL;CTSB;FBXW7;ANKRD28;ING4;CDK5RAP3;ATXN1;LMO2;CCDC92;PAK6;CARF;PGM1;MXI1;PFKFB2;THRA;HSD11B1L;METTL21A;ACADS;ARAP1;ADARB1;RAI1;ELF1;IKZF4;DCAF10;OGDHL;NLRP1;ZBTB34;TK2;LACTB2;MIF4GD;EPM2AIP1;CAPG;RGS12;MPG;CENPH;ZNF554;BDH1;APPL2;SALL2;ZBTB20;PDE2A;SDHA;LTB4R2;CASZ1;ACOX3;CALCOCO1;TEAD2;MYSM1;RNF213;OLFM2;IFI16;ERCC5;SETD4;ABTB1;DEF6;ETFB;RPS6KA5;ZNF687;VDR;LETMD1;PHF7;TNRC18;ZMYM3;HLTF;PCSK6;ZNF789;MPPE1;STK19;NDUFV3;STAT2;PHF1;TFDP2;KDELC2;PRIMPOL;CCDC113;PPP2R3B;IQSEC1;PANO1;PALB2;WEE1;DYDC1;GTF2IRD2;AMT;TCF7;RSAD2;LMNA;MXRA8;KAT2B;TEP1;APOLD1;METTL7A;IVNS1ABP;RAD50;ANGEL2;ZMAT3;PNPO;ECI1;TRERF1;CBR4;SGSH;DCAF8;RAPGEF5;STAT6;SOX13;PRDX5;NELFCD;PHC2;GLB1;KLF8;CHD6;ACSS2;DPP7;HDAC11;CTSD;COL13A1;PLCB3;UVSSA;KMT5C;MPP7;RORA;PPARG;PRKACA;CXXC5;NPAP1;C6ORF120;POLM;ACOT2;SYNE2;SERPING1;SUCLG2;PARN;LAMB2;IP6K2;KLF9;AIP;LONP2;HARS2;EHHADH;MSH5;CLCN7;HIVEP1;SMURF1;CTNNBIP1;ECM1
2902,GO:0006412,0.999999999650211,1.18966160344044e-09,21,652,translation,BP,EGFR;CIRBP;CAPRIN2;RBM3;UNK;IMPACT;RGS2;ZFP36L2;PER2;ITGA2;MAP2K2;AGO4;XRN1;MIF4GD;DALRD3;ABTB1;TNRC6C;ZFP36L1;ERBB2;PPARG;HARS2
1444,GO:0003676,0.999999999803601,3.83653653681579e-10,242,3235,nucleic acid binding,MF,TNFAIP3;HES2;ZSCAN18;DDB2;SREBF1;NYNRIN;OAS2;DDX60;EGFR;CIRBP;CAPRIN2;MNT;XPC;APOBEC3C;RBM3;ASH2L;SRSF5;TNS1;KDM3A;NSUN7;POU3F1;HERC5;UNK;HR;TFCP2L1;ZFPM1;HOXC5;ZDHHC1;ZNF362;ZNF266;STAT1;CRY2;THAP8;ZNF704;HOXA3;CRY1;ZNF699;ZFP41;KLF13;NFATC4;ZNF783;H1F0;HSF4;ZNF251;LIG1;MDM2;NDN;MLH3;DDX59;ZNF662;CERS4;ZNF414;TCF25;ENDOD1;PCBP4;POLH;POLR2J2;OAS1;PDCD4;ZNF160;ZFP36L2;GLI2;KLF7;DHX32;TCEA2;ZNF76;SOX12;ZNF747;ZCCHC11;PER2;ZNF658;GLI3;THRAP3;ZNF558;IRX4;SMARCA1;BHLHE40;ZNF655;KHNYN;ZNF333;ZNF318;LZTS1;TCFL5;C14ORF93;JARID2;NUPR1;TST;CHD3;ZNF18;AHNAK2;MXD4;ZNF287;NSUN5P2;PMS2P3;RMI2;ZNF446;ARHGEF1;ZNF581;DHX58;ENDOG;RTF1;IRF9;H2AFJ;S100A4;GLI4;ETV5;DLX3;H1FX;ZNF608;CENPC;ZCCHC24;TCF4;PLAG1;RCOR2;WRN;DNM1;MCM9;TREX1;ATRX;POLR2J3;HMG20B;AGO4;ERCC6;MEF2D;CREBRF;XRN1;TIGD5;MLXIPL;TARBP1;ZNF862;ATXN1;LMO2;NFIX;CARF;DZIP1L;MXI1;THRA;ADARB1;RAI1;ELF1;IKZF4;ZBTB34;ZNF627;LACTB2;MIF4GD;DBP;EPM2AIP1;LRP1;HLA-A;PEG3;MPG;RFX2;ZNF554;SALL2;ZNF107;ZNF532;ZBTB20;ZNF334;MAF;ZMYND8;PRX;CASZ1;CALCOCO1;TEAD2;MYSM1;TSHZ2;ZNF276;IFI16;ERCC5;TEF;ZNF25;ABTB1;ZNF630;BST2;ZNF687;VDR;PABPC4L;TNRC18;TNRC6C;ZFP28;ZMYM3;SIX5;HLTF;ZNF789;ZNF563;ZNF517;NDUFV3;STAT2;PHF1;ZNF292;TFDP2;ZNF737;ZNF701;NAT14;PALB2;ENDOU;ZNF91;R3HDM4;GTF2IRD2;DQX1;TCF7;ZFP36L1;GLMP;TOP3B;KAT2B;TEP1;RNF141;IVNS1ABP;RAD50;ZNF439;ANGEL2;ZMAT3;TRERF1;CERS5;STAT6;SOX13;PRDX5;NELFCD;PHC2;KLF8;CHD6;GOLGB1;RORA;PPARG;CXXC5;POLM;ZNF572;ZNF658B;PARN;DDX12P;ZNF529;KLF9;PRMT3;HARS2;ZFP90;MSH5;PER3;ZFP30;FOXP2;PTBP2;ZC3H6;HIVEP1
2434,GO:0005634,0.999999999809166,3.55639665355924e-10,483,5707,nucleus,CC,TNFAIP3;ITGB6;HES2;ZSCAN18;TSC22D1;SIK1;SLFN5;EPM2A;NPEPL1;DDB2;TP53INP1;PTHLH;SREBF1;APOE;NT5E;GAMT;OAS2;HSPA2;EGFR;TRIM65;CIRBP;CAPRIN2;MNT;XPC;APOBEC3C;CPT2;RBM3;SYN1;ASH2L;TRIM22;ALDH1A3;SRSF5;PERM1;SEC14L2;PCDH1;EPHB2;RALGDS;MAP3K14;DCAF16;DGKQ;PIK3R1;BRSK1;TXNRD3;MARVELD1;KDM3A;TSC22D3;POU3F1;CAMKK1;UBXN4;HR;ISG15;MVB12B;TFCP2L1;TENM4;ZFPM1;HOXC5;ZNF362;CUL7;CITED4;IRF2BPL;PRICKLE2;ASAP3;ZNF266;STAT1;CRY2;KRT15;LGALS7B;NSG1;RAB40B;NOS1;PRKACB;ZNF704;HOXA3;CRY1;ZNF699;MAML3;ZFP41;SCMH1;KLF13;NFATC4;ZNF783;FKBP5;RNF187;H1F0;AP5Z1;HSF4;ZNF251;LIG1;CDK18;SPEG;NDRG1;ITPR3;EAPP;CYHR1;MDM2;CRTC1;NDN;MLH3;DDX59;ZNF662;OBSCN;CERS4;NEO1;PHACTR3;ZNF414;TCF25;CTSV;POLH;BLVRB;POLR2J2;OAS1;TRIM66;MLLT6;RGS2;PPL;MT1X;PDCD4;NOL4L;ZNF160;CAPN7;SWT1;NEK9;ZFP36L2;TMC6;FLOT1;GLI2;AGAP4;KLF7;RNF165;DHX32;TCEA2;RALGAPA1;ZNF76;SOX12;PIDD1;SLX1A;SLX1B;ATG16L2;SPG11;ZCCHC11;SULT1E1;PER2;ZNF658;PSKH1;PHF2;ABHD14B;TCEAL1;AMIGO2;WWTR1;ITGA2;FAM110C;GLI3;SPPL2B;THRAP3;ZNF558;IRX4;SMARCA1;AKAP7;BHLHE40;DGCR6L;ZNF655;NAIP;ZNF333;NEK8;MAP2K5;BOC;BSN;SESN3;ZNF318;TCFL5;TRAK1;JARID2;NUPR1;INSR;CCDC85B;CELSR1;GSN;CEP68;CHD3;CDK14;BAIAP2;TTN;CBLC;ZNF18;SUN1;AHNAK2;PLEKHH2;TRIOBP;MXD4;POLD4;ZNF287;NSUN5P2;PNMA1;PMS2P3;ETAA1;RMI2;ZNF446;ZNF581;MGST2;ENDOG;RTF1;CASP14;IRF9;H2AFJ;F8A1;B4GALT2;S100A4;MAP2K2;PDK1;ALDH7A1;GLI4;SQSTM1;CABYR;PTK6;TMEM8B;ETV5;FNBP4;FAT2;DLX3;KDM4C;METTL23;CLCA2;H1FX;UBOX5;NSMCE4A;B3GNT9;CENPC;CST3;PDIK1L;GDF15;TXNIP;TCF4;KLHDC2;PLAG1;RCOR2;WRN;PODXL;IFI27;DNM1;MCM9;MACROD1;IQCB1;TREX1;LPIN3;CDK5R1;ATRX;REC8;ARHGAP27;AGAP6;NET1;POLR2J3;SESN1;MAPK10;NKTR;ADIRF;HMG20B;CYBA;AGO4;ERCC6;HADH;RRM2B;KRT14;HLCS;SPRY2;MEF2D;CREBRF;XRN1;AGAP7P;RAB11FIP3;TIGD5;MLXIPL;CTSB;TARBP1;FBXW7;ANKRD28;ING4;NUDT6;CDK5RAP3;ZNF862;ATXN1;LMO2;CCDC92;NFIX;PAK6;CARF;MXI1;PFKFB2;CHMP1B;THRA;HSD11B1L;METTL21A;ACADS;ARAP1;ADARB1;RAI1;ELF1;MX2;IKZF4;DCAF10;SLC2A1;ACACB;NLRP1;ZBTB34;ZNF627;BEX2;GLUL;MIF4GD;DBP;NAB2;EPM2AIP1;PRR7;CAPG;TSPYL4;LRP1;PEG3;NPHP4;RGS12;ATE1;MPG;SYNPO2;CENPH;RFX2;ZNF554;BDH1;APPL2;HEXDC;SALL2;ZNF107;ZNF532;ZBTB20;PDE2A;ZNF334;SDHA;MAF;LTB4R2;ZMYND8;PRX;CASZ1;RWDD3;CALCOCO1;TEAD2;MYSM1;RNF213;OLFM2;TSHZ2;ZNF276;IFI16;ERCC5;PIK3R2;RETSAT;TEF;ZNF25;SETD4;AREG;ABTB1;DEF6;RPS6KA5;APBB3;ZNF630;BTG1;ZNF687;VDR;LETMD1;MAMSTR;PHF7;TNRC18;ZFP28;DPY19L2P2;ZMYM3;SIX5;HLTF;ZNF789;MPPE1;ZNF563;ZNF517;STK19;NDUFV3;STAT2;PHF1;ZNF292;TFDP2;ZNF737;TACC1;PRIMPOL;NECAB3;CCDC113;TNNI2;PPP2R3B;TSSK1B;IQSEC1;ZNF701;NAT14;PANO1;PALB2;TCEAL4;ZNF91;PTMS;WEE1;DYDC1;R3HDM4;GTF2IRD2;DQX1;AMT;TCF7;RSAD2;NEMP2;ZFP36L1;LMNA;GLMP;TOP3B;KAT2B;TEP1;APOLD1;ERN1;IVNS1ABP;ALOX15B;RAD50;ZNF439;TKFC;ANGEL2;ZMAT3;PNPO;DHRS4;S100A6;TRERF1;APBB2;DCAF8;RAPGEF5;CERS5;STAT6;SOX13;PRDX5;NELFCD;PHC2;TUB;KLF8;GSTM3;CHD6;NAP1L5;ACSS2;RANBP9;HDAC11;ERBB2;PLCB3;NUDT10;UVSSA;PPM1M;KMT5C;AKAP6;SLC2A11;TH;MPP7;RORA;SSH3;PPARG;PRKACA;CXXC5;NPAP1;POLM;ZNF572;SYNE2;ACKR3;ZNF658B;UCKL1;PARN;DDX12P;ZNF529;IP6K2;KLF9;AIP;SCAND1;LONP2;ZFP90;MSH5;CLCN7;PER3;ZFP30;FOXP2;PTBP2;ZC3H6;HIVEP1;SMURF1;CTNNBIP1
11107,GO:0045153,0.999999999944584,0.922327004652544,0,1,electron transporter, transferring electrons within CoQH2-cytochrome c reductase complex activity,MF,
19513,GO:1990439,0.99999999995123,0.898437681212856,0,1,MAP kinase serine/threonine phosphatase activity,MF,
4377,GO:0010015,0.99999999995235,0.9428146804249,0,1,root morphogenesis,BP,
4391,GO:0010053,0.99999999995235,0.9428146804249,0,1,root epidermal cell differentiation,BP,
4392,GO:0010054,0.99999999995235,0.9428146804249,0,1,trichoblast differentiation,BP,
6596,GO:0022622,0.99999999995235,0.9428146804249,0,1,root system development,BP,
7526,GO:0031763,0.99999999995235,0.9428146804249,0,1,galanin receptor binding,MF,
7527,GO:0031764,0.99999999995235,0.9428146804249,0,1,type 1 galanin receptor binding,MF,
7528,GO:0031765,0.99999999995235,0.9428146804249,0,1,type 2 galanin receptor binding,MF,
7529,GO:0031766,0.99999999995235,0.9428146804249,0,1,type 3 galanin receptor binding,MF,
12179,GO:0048364,0.99999999995235,0.9428146804249,0,1,root development,BP,
12358,GO:0048764,0.99999999995235,0.9428146804249,0,1,trichoblast maturation,BP,
12359,GO:0048765,0.99999999995235,0.9428146804249,0,1,root hair cell differentiation,BP,
12360,GO:0048767,0.99999999995235,0.9428146804249,0,1,root hair elongation,BP,
13008,GO:0051464,0.99999999995235,0.9428146804249,0,1,positive regulation of cortisol secretion,BP,
15961,GO:0080147,0.99999999995235,0.9428146804249,0,1,root hair cell development,BP,
16313,GO:0090558,0.99999999995235,0.9428146804249,0,1,plant epidermis development,BP,
16331,GO:0090627,0.99999999995235,0.9428146804249,0,1,plant epidermal cell differentiation,BP,
17008,GO:0099402,0.99999999995235,0.9428146804249,0,1,plant organ development,BP,
18035,GO:1902606,0.99999999995235,0.9428146804249,0,1,regulation of large conductance calcium-activated potassium channel activity,BP,
18036,GO:1902608,0.99999999995235,0.9428146804249,0,1,positive regulation of large conductance calcium-activated potassium channel activity,BP,
18127,GO:1902890,0.99999999995235,0.9428146804249,0,1,regulation of root hair elongation,BP,
18128,GO:1902891,0.99999999995235,0.9428146804249,0,1,negative regulation of root hair elongation,BP,
18584,GO:1903888,0.99999999995235,0.9428146804249,0,1,regulation of plant epidermal cell differentiation,BP,
18585,GO:1903889,0.99999999995235,0.9428146804249,0,1,negative regulation of plant epidermal cell differentiation,BP,
19218,GO:1905392,0.99999999995235,0.9428146804249,0,1,plant organ morphogenesis,BP,
19230,GO:1905421,0.99999999995235,0.9428146804249,0,1,regulation of plant organ morphogenesis,BP,
19231,GO:1905422,0.99999999995235,0.9428146804249,0,1,negative regulation of plant organ morphogenesis,BP,
19701,GO:2000067,0.99999999995235,0.9428146804249,0,1,regulation of root morphogenesis,BP,
19801,GO:2000280,0.99999999995235,0.9428146804249,0,1,regulation of root development,BP,
20128,GO:2000851,0.99999999995235,0.9428146804249,0,1,positive regulation of glucocorticoid secretion,BP,
1960,GO:0004671,0.999999999953103,0.880923908673422,0,1,protein C-terminal S-isoprenylcysteine carboxyl O-methyltransferase activity,MF,
2356,GO:0005456,0.999999999954995,0.904892120846209,0,1,CMP-N-acetylneuraminate transmembrane transporter activity,MF,
5191,GO:0015782,0.999999999954995,0.904892120846209,0,1,CMP-N-acetylneuraminate transmembrane transport,BP,
3101,GO:0006679,0.999999999955765,0.799667225242973,0,2,glucosylceramide biosynthetic process,BP,
704,GO:0001928,0.999999999956386,0.900978741928096,0,1,regulation of exocyst assembly,BP,
13640,GO:0060178,0.999999999956386,0.900978741928096,0,1,regulation of exocyst localization,BP,
11320,GO:0045660,0.999999999956447,0.902641143240996,0,1,positive regulation of neutrophil differentiation,BP,
15562,GO:0072053,0.999999999958264,0.792494242534989,0,2,renal inner medulla development,BP,
15563,GO:0072054,0.999999999958264,0.792494242534989,0,2,renal outer medulla development,BP,
11711,GO:0046534,0.999999999958547,0.882491357202345,0,1,positive regulation of photoreceptor cell differentiation,BP,
17362,GO:1900109,0.999999999958701,0.835287931883258,0,2,regulation of histone H3-K9 dimethylation,BP,
17363,GO:1900110,0.999999999958701,0.835287931883258,0,2,negative regulation of histone H3-K9 dimethylation,BP,
19203,GO:1905349,0.999999999959217,0.922796147502366,0,1,ciliary transition zone assembly,BP,
16571,GO:0097409,0.999999999959425,0.902979800149675,0,1,glial cytoplasmic inclusion,CC,
16574,GO:0097414,0.999999999959425,0.902979800149675,0,1,classical Lewy body,CC,
16597,GO:0097462,0.999999999959425,0.902979800149675,0,1,Lewy neurite,CC,
19412,GO:1990038,0.999999999959425,0.902979800149675,0,1,Lewy body corona,CC,
1070,GO:0002636,0.999999999959754,0.91101416464138,0,1,positive regulation of germinal center formation,BP,
2751,GO:0006157,0.999999999959754,0.91101416464138,0,1,deoxyadenosine catabolic process,BP,
9942,GO:0042321,0.999999999959754,0.91101416464138,0,1,negative regulation of circadian sleep/wake cycle, sleep,BP,
9943,GO:0042323,0.999999999959754,0.91101416464138,0,1,negative regulation of circadian sleep/wake cycle, non-REM sleep,BP,
11538,GO:0046090,0.999999999959754,0.91101416464138,0,1,deoxyadenosine metabolic process,BP,
11549,GO:0046111,0.999999999959754,0.91101416464138,0,1,xanthine biosynthetic process,BP,
11555,GO:0046124,0.999999999959754,0.91101416464138,0,1,purine deoxyribonucleoside catabolic process,BP,
13634,GO:0060167,0.999999999959754,0.91101416464138,0,1,regulation of adenosine receptor signaling pathway,BP,
13635,GO:0060169,0.999999999959754,0.91101416464138,0,1,negative regulation of adenosine receptor signaling pathway,BP,
13794,GO:0060407,0.999999999959754,0.91101416464138,0,1,negative regulation of penile erection,BP,
14637,GO:0070256,0.999999999959754,0.91101416464138,0,1,negative regulation of mucus secretion,BP,
1905,GO:0004595,0.999999999960114,0.900843164792996,0,1,pantetheine-phosphate adenylyltransferase activity,MF,
13130,GO:0051722,0.999999999960736,0.900438991423262,0,1,protein C-terminal methylesterase activity,MF,
13131,GO:0051723,0.999999999960736,0.900438991423262,0,1,protein methylesterase activity,MF,
9690,GO:0038101,0.999999999960743,0.906414122891787,0,1,sequestering of nodal from receptor via nodal binding,BP,
17361,GO:1900108,0.999999999960743,0.906414122891787,0,1,negative regulation of nodal signaling pathway,BP,
17388,GO:1900146,0.999999999960743,0.906414122891787,0,1,negative regulation of nodal signaling pathway involved in determination of left/right asymmetry,BP,
17403,GO:1900176,0.999999999960743,0.906414122891787,0,1,negative regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,BP,
369,GO:0000991,0.999999999960815,0.803452532932398,0,2,transcription factor activity, core RNA polymerase II binding,MF,
11077,GO:0045092,0.999999999961719,0.890983427252475,0,1,interleukin-18 receptor complex,CC,
2478,GO:0005713,0.99999999996182,0.900422299981282,0,1,recombination nodule,CC,
2479,GO:0005715,0.99999999996182,0.900422299981282,0,1,late recombination nodule,CC,
10285,GO:0043060,0.99999999996182,0.900422299981282,0,1,meiotic metaphase I plate congression,BP,
12891,GO:0051257,0.99999999996182,0.900422299981282,0,1,meiotic spindle midzone assembly,BP,
12931,GO:0051311,0.99999999996182,0.900422299981282,0,1,meiotic metaphase plate congression,BP,
4698,GO:0010859,0.999999999961989,0.883017740972195,0,1,calcium-dependent cysteine-type endopeptidase inhibitor activity,MF,
8,GO:0000015,0.999999999962055,0.904812422603396,0,1,phosphopyruvate hydratase complex,CC,
1933,GO:0004634,0.999999999962055,0.904812422603396,0,1,phosphopyruvate hydratase activity,MF,
6314,GO:0019964,0.999999999962133,0.892725915253711,0,1,interferon-gamma binding,MF,
19488,GO:1990390,0.999999999962133,0.892725915253711,0,1,protein K33-linked ubiquitination,BP,
5914,GO:0018192,0.999999999962568,0.900453668506993,0,1,enzyme active site formation via cysteine modification to L-cysteine persulfide,BP,
7873,GO:0032447,0.999999999962568,0.900453668506993,0,1,protein urmylation,BP,
9928,GO:0042292,0.999999999962568,0.900453668506993,0,1,URM1 activating enzyme activity,MF,
14349,GO:0061604,0.999999999962568,0.900453668506993,0,1,molybdopterin-synthase sulfurtransferase activity,MF,
14350,GO:0061605,0.999999999962568,0.900453668506993,0,1,molybdopterin-synthase adenylyltransferase activity,MF,
16862,GO:0098822,0.999999999962568,0.900453668506993,0,1,peptidyl-cysteine modification to L-cysteine persulfide,BP,
12487,GO:0050613,0.999999999962636,0.808273717917207,0,2,delta14-sterol reductase activity,MF,
3977,GO:0008803,0.999999999962951,0.932191325276195,0,1,bis(5'-nucleosyl)-tetraphosphatase (symmetrical) activity,MF,
12452,GO:0050337,0.999999999962956,0.953646805725533,0,1,thiosulfate-thiol sulfurtransferase activity,MF,
3486,GO:0007352,0.99999999996305,0.873011569075023,0,1,zygotic specification of dorsal/ventral axis,BP,
17426,GO:1900224,0.99999999996305,0.873011569075023,0,1,positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,BP,
19871,GO:2000382,0.99999999996305,0.873011569075023,0,1,positive regulation of mesoderm development,BP,
4206,GO:0009330,0.99999999996308,0.782109013056832,0,2,DNA topoisomerase complex (ATP-hydrolyzing),CC,
4662,GO:0010813,0.999999999963176,0.803476055952774,0,2,neuropeptide catabolic process,BP,
2359,GO:0005461,0.999999999963532,0.8791244773889,0,1,UDP-glucuronic acid transmembrane transporter activity,MF,
5194,GO:0015787,0.999999999963532,0.8791244773889,0,1,UDP-glucuronic acid transmembrane transport,BP,
13058,GO:0051586,0.999999999963941,0.910762099653298,0,1,positive regulation of dopamine uptake involved in synaptic transmission,BP,
13240,GO:0051944,0.999999999963941,0.910762099653298,0,1,positive regulation of catecholamine uptake involved in synaptic transmission,BP,
12444,GO:0050290,0.999999999963979,0.881149841352207,0,1,sphingomyelin phosphodiesterase D activity,MF,
9204,GO:0035602,0.999999999964199,0.885238875133071,0,1,fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow,BP,
9205,GO:0035603,0.999999999964199,0.885238875133071,0,1,fibroblast growth factor receptor signaling pathway involved in hemopoiesis,BP,
9206,GO:0035604,0.999999999964199,0.885238875133071,0,1,fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow,BP,
13910,GO:0060595,0.999999999964199,0.885238875133071,0,1,fibroblast growth factor receptor signaling pathway involved in mammary gland specification,BP,
13923,GO:0060615,0.999999999964199,0.885238875133071,0,1,mammary gland bud formation,BP,
13933,GO:0060648,0.999999999964199,0.885238875133071,0,1,mammary gland bud morphogenesis,BP,
13939,GO:0060667,0.999999999964199,0.885238875133071,0,1,branch elongation involved in salivary gland morphogenesis,BP,
14068,GO:0060915,0.999999999964199,0.885238875133071,0,1,mesenchymal cell differentiation involved in lung development,BP,
785,GO:0002046,0.999999999964294,0.932813683220394,0,1,opsin binding,MF,
9561,GO:0036372,0.999999999964294,0.932813683220394,0,1,opsin transport,BP,
14939,GO:0070856,0.999999999964552,0.879404328545809,0,1,myosin VI light chain binding,MF,
14899,GO:0070773,0.999999999964631,0.917060606905622,0,1,protein-N-terminal glutamine amidohydrolase activity,MF,
15305,GO:0071544,0.999999999964631,0.917060606905622,0,1,diphosphoinositol polyphosphate catabolic process,BP,
10046,GO:0042543,0.999999999964694,0.955792263143995,0,1,protein N-linked glycosylation via arginine,BP,
439,GO:0001181,0.999999999965226,0.808073906779625,0,2,transcription factor activity, core RNA polymerase I binding,MF,
13936,GO:0060664,0.999999999965249,0.792376159639761,0,2,epithelial cell proliferation involved in salivary gland morphogenesis,BP,
13357,GO:0052642,0.999999999965274,0.90490818620163,0,1,lysophosphatidic acid phosphatase activity,MF,
20288,GO:2001311,0.999999999965274,0.90490818620163,0,1,lysobisphosphatidic acid metabolic process,BP,
14998,GO:0070950,0.999999999965315,0.898937848100442,0,1,regulation of neutrophil mediated killing of bacterium,BP,
14999,GO:0070951,0.999999999965315,0.898937848100442,0,1,regulation of neutrophil mediated killing of gram-negative bacterium,BP,
15003,GO:0070962,0.999999999965315,0.898937848100442,0,1,positive regulation of neutrophil mediated killing of bacterium,BP,
15004,GO:0070963,0.999999999965315,0.898937848100442,0,1,positive regulation of neutrophil mediated killing of gram-negative bacterium,BP,
16157,GO:0090198,0.999999999965315,0.898937848100442,0,1,negative regulation of chemokine secretion,BP,
16385,GO:0097029,0.999999999965315,0.898937848100442,0,1,mature conventional dendritic cell differentiation,BP,
17382,GO:1900135,0.999999999965315,0.898937848100442,0,1,positive regulation of renin secretion into blood stream,BP,
19062,GO:1904977,0.999999999965315,0.898937848100442,0,1,lymphatic endothelial cell migration,BP,
16693,GO:0097699,0.999999999965343,0.882497185053846,0,1,vascular endothelial cell response to fluid shear stress,BP,
17696,GO:1901631,0.99999999996535,0.87743827580909,0,1,positive regulation of presynaptic membrane organization,BP,
18799,GO:1904393,0.99999999996535,0.87743827580909,0,1,regulation of skeletal muscle acetylcholine-gated channel clustering,BP,
18800,GO:1904395,0.99999999996535,0.87743827580909,0,1,positive regulation of skeletal muscle acetylcholine-gated channel clustering,BP,
11789,GO:0046687,0.999999999965402,0.927283440769864,0,1,response to chromate,BP,
15123,GO:0071247,0.999999999965402,0.927283440769864,0,1,cellular response to chromate,BP,
17888,GO:1902220,0.999999999965402,0.927283440769864,0,1,positive regulation of intrinsic apoptotic signaling pathway in response to osmotic stress,BP,
10231,GO:0042978,0.999999999965427,0.794300214233535,0,2,ornithine decarboxylase activator activity,MF,
17917,GO:1902269,0.999999999965427,0.794300214233535,0,2,positive regulation of polyamine transmembrane transport,BP,
8375,GO:0033291,0.999999999965436,0.966175576328338,0,1,eukaryotic 80S initiation complex,CC,
8772,GO:0034463,0.999999999965436,0.966175576328338,0,1,90S preribosome assembly,BP,
1542,GO:0003939,0.999999999965458,0.900296752978603,0,1,L-iditol 2-dehydrogenase activity,MF,
2696,GO:0006062,0.999999999965458,0.900296752978603,0,1,sorbitol catabolic process,BP,
6136,GO:0019407,0.999999999965458,0.900296752978603,0,1,hexitol catabolic process,BP,
6162,GO:0019519,0.999999999965458,0.900296752978603,0,1,pentitol metabolic process,BP,
6165,GO:0019527,0.999999999965458,0.900296752978603,0,1,pentitol catabolic process,BP,
7305,GO:0031320,0.999999999965458,0.900296752978603,0,1,hexitol dehydrogenase activity,MF,
11706,GO:0046526,0.999999999965458,0.900296752978603,0,1,D-xylulose reductase activity,MF,
12827,GO:0051160,0.999999999965458,0.900296752978603,0,1,L-xylitol catabolic process,BP,
12828,GO:0051164,0.999999999965458,0.900296752978603,0,1,L-xylitol metabolic process,BP,
19593,GO:1990758,0.999999999965562,0.904579545525509,0,1,mitotic sister chromatid biorientation,BP,
13126,GO:0051715,0.999999999965565,0.803028810134521,0,3,cytolysis in other organism,BP,
13788,GO:0060399,0.999999999965725,0.77382704592731,0,2,positive regulation of growth hormone receptor signaling pathway,BP,
10163,GO:0042766,0.999999999965758,0.8770641123995,0,1,nucleosome mobilization,BP,
4056,GO:0009107,0.99999999996577,0.907540444692435,0,1,lipoate biosynthetic process,BP,
5771,GO:0016992,0.99999999996577,0.907540444692435,0,1,lipoate synthase activity,MF,
14652,GO:0070283,0.99999999996577,0.907540444692435,0,1,radical SAM enzyme activity,MF,
19170,GO:1905277,0.999999999965774,0.897381102940585,0,1,negative regulation of epithelial tube formation,BP,
19976,GO:2000606,0.999999999965774,0.897381102940585,0,1,regulation of cell proliferation involved in mesonephros development,BP,
19977,GO:2000607,0.999999999965774,0.897381102940585,0,1,negative regulation of cell proliferation involved in mesonephros development,BP,
20041,GO:2000699,0.999999999965774,0.897381102940585,0,1,fibroblast growth factor receptor signaling pathway involved in ureteric bud formation,BP,
20042,GO:2000701,0.999999999965774,0.897381102940585,0,1,glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation,BP,
20043,GO:2000702,0.999999999965774,0.897381102940585,0,1,regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation,BP,
20044,GO:2000703,0.999999999965774,0.897381102940585,0,1,negative regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation,BP,
20056,GO:2000733,0.999999999965774,0.897381102940585,0,1,regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation,BP,
20057,GO:2000734,0.999999999965774,0.897381102940585,0,1,negative regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation,BP,
179,GO:0000390,0.999999999965826,0.82942848826515,0,2,spliceosomal complex disassembly,BP,
6386,GO:0021590,0.999999999965864,0.77868515885001,0,2,cerebellum maturation,BP,
6420,GO:0021691,0.999999999965864,0.77868515885001,0,2,cerebellar Purkinje cell layer maturation,BP,
6428,GO:0021699,0.999999999965864,0.77868515885001,0,2,cerebellar cortex maturation,BP,
18850,GO:1904530,0.999999999965933,0.897065344355512,0,1,negative regulation of actin filament binding,BP,
18892,GO:1904617,0.999999999965933,0.897065344355512,0,1,negative regulation of actin binding,BP,
17987,GO:1902480,0.999999999965982,0.900513485022014,0,1,protein localization to mitotic spindle,BP,
3769,GO:0008321,0.999999999966012,0.773843193011587,0,2,Ral guanyl-nucleotide exchange factor activity,MF,
18812,GO:1904426,0.999999999966093,0.790767877383573,0,2,positive regulation of GTP binding,BP,
18034,GO:1902605,0.999999999966126,0.899677214074444,0,1,heterotrimeric G-protein complex assembly,BP,
11705,GO:0046525,0.999999999966136,0.906473832040438,0,1,xylosylprotein 4-beta-galactosyltransferase activity,MF,
5392,GO:0016231,0.99999999996614,0.880151298580864,0,1,beta-N-acetylglucosaminidase activity,MF,
17109,GO:0102166,0.99999999996614,0.880151298580864,0,1,[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-threonine O-N-acetyl-alpha-D-glucosaminase activity,MF,
17110,GO:0102167,0.99999999996614,0.880151298580864,0,1,[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine O-N-acetyl-alpha-D-glucosaminase activity,MF,
17141,GO:0102571,0.99999999996614,0.880151298580864,0,1,[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine/L-threonine O-N-acetyl-alpha-D-glucosaminase activity,MF,
2016,GO:0004747,0.999999999966247,0.922816647328236,0,1,ribokinase activity,MF,
7817,GO:0032378,0.999999999966342,0.890480556875278,0,1,negative regulation of intracellular lipid transport,BP,
7820,GO:0032381,0.999999999966342,0.890480556875278,0,1,negative regulation of intracellular sterol transport,BP,
7823,GO:0032384,0.999999999966342,0.890480556875278,0,1,negative regulation of intracellular cholesterol transport,BP,
19293,GO:1905596,0.999999999966342,0.890480556875278,0,1,negative regulation of low-density lipoprotein particle receptor binding,BP,
19295,GO:1905598,0.999999999966342,0.890480556875278,0,1,negative regulation of low-density lipoprotein receptor activity,BP,
19298,GO:1905601,0.999999999966342,0.890480556875278,0,1,negative regulation of receptor-mediated endocytosis involved in cholesterol transport,BP,
17690,GO:1901622,0.999999999966541,0.900175458155549,0,1,positive regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,
4271,GO:0009631,0.999999999966687,0.880189028068655,0,1,cold acclimation,BP,
11599,GO:0046317,0.999999999966687,0.880189028068655,0,1,regulation of glucosylceramide biosynthetic process,BP,
11600,GO:0046318,0.999999999966687,0.880189028068655,0,1,negative regulation of glucosylceramide biosynthetic process,BP,
18238,GO:1903108,0.999999999966687,0.880189028068655,0,1,regulation of mitochondrial transcription,BP,
18239,GO:1903109,0.999999999966687,0.880189028068655,0,1,positive regulation of mitochondrial transcription,BP,
3435,GO:0007225,0.999999999966766,0.881157221297241,0,1,patched ligand maturation,BP,
9233,GO:0035638,0.999999999966766,0.881157221297241,0,1,signal maturation,BP,
9116,GO:0035441,0.999999999966784,0.876804531190573,0,1,cell migration involved in vasculogenesis,BP,
7766,GO:0032298,0.999999999966785,0.901037079936304,0,1,positive regulation of DNA-dependent DNA replication initiation,BP,
16437,GO:0097123,0.999999999966785,0.901037079936304,0,1,cyclin A1-CDK2 complex,CC,
8891,GO:0034722,0.999999999966795,0.912354765572823,0,1,gamma-glutamyl-peptidase activity,MF,
14475,GO:0061944,0.999999999966824,0.883294831727665,0,1,negative regulation of protein K48-linked ubiquitination,BP,
15391,GO:0071676,0.999999999966841,0.794374433113214,0,2,negative regulation of mononuclear cell migration,BP,
16049,GO:0090027,0.999999999966841,0.794374433113214,0,2,negative regulation of monocyte chemotaxis,BP,
1945,GO:0004651,0.999999999966871,0.801511177407793,0,2,polynucleotide 5'-phosphatase activity,MF,
16725,GO:0098507,0.999999999966871,0.801511177407793,0,2,polynucleotide 5' dephosphorylation,BP,
9288,GO:0035744,0.999999999966945,0.925037291845126,0,1,T-helper 1 cell cytokine production,BP,
9896,GO:0042231,0.999999999966945,0.925037291845126,0,1,interleukin-13 biosynthetic process,BP,
3086,GO:0006660,0.999999999966972,0.905427390878929,0,1,phosphatidylserine catabolic process,BP,
11205,GO:0045352,0.999999999966972,0.905427390878929,0,1,interleukin-1 Type I receptor antagonist activity,MF,
11206,GO:0045353,0.999999999966972,0.905427390878929,0,1,interleukin-1 Type II receptor antagonist activity,MF,
2651,GO:0005991,0.999999999967083,0.898362041065836,0,1,trehalose metabolic process,BP,
14723,GO:0070413,0.999999999967083,0.898362041065836,0,1,trehalose metabolism in response to stress,BP,
1601,GO:0004022,0.999999999967084,0.814147307093378,0,2,alcohol dehydrogenase (NAD) activity,MF,
2593,GO:0005889,0.999999999967198,0.794372975197129,0,2,potassium:proton exchanging ATPase complex,CC,
15595,GO:0072103,0.999999999967206,0.794324567558878,0,2,glomerulus vasculature morphogenesis,BP,
15596,GO:0072104,0.999999999967206,0.794324567558878,0,2,glomerular capillary formation,BP,
17660,GO:1901555,0.999999999967228,0.878694812299738,0,1,response to paclitaxel,BP,
19323,GO:1905705,0.999999999967228,0.878694812299738,0,1,cellular response to paclitaxel,BP,
12193,GO:0048388,0.999999999967259,0.809744896854013,0,2,endosomal lumen acidification,BP,
107,GO:0000224,0.999999999967276,0.900277371988559,0,1,peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity,MF,
18009,GO:1902544,0.999999999967313,0.841319682910915,0,2,regulation of DNA N-glycosylase activity,BP,
24,GO:0000048,0.999999999967378,0.900654071884056,0,1,peptidyltransferase activity,MF,
1248,GO:0002951,0.999999999967378,0.900654071884056,0,1,leukotriene-C(4) hydrolase,MF,
123,GO:0000254,0.99999999996742,0.807922499754113,0,2,C-4 methylsterol oxidase activity,MF,
1826,GO:0004483,0.99999999996742,0.807922499754113,0,2,mRNA (nucleoside-2'-O-)-methyltransferase activity,MF,
2887,GO:0006393,0.99999999996742,0.807922499754113,0,2,termination of mitochondrial transcription,BP,
3209,GO:0006850,0.99999999996742,0.807922499754113,0,2,mitochondrial pyruvate transmembrane transport,BP,
4008,GO:0008988,0.99999999996742,0.807922499754113,0,2,rRNA (adenine-N6-)-methyltransferase activity,MF,
7718,GO:0032217,0.99999999996742,0.807922499754113,0,2,riboflavin transmembrane transporter activity,MF,
7719,GO:0032218,0.99999999996742,0.807922499754113,0,2,riboflavin transport,BP,
8102,GO:0032798,0.99999999996742,0.807922499754113,0,2,Swi5-Sfr1 complex,CC,
9584,GO:0036451,0.99999999996742,0.807922499754113,0,2,cap mRNA methylation,BP,
15337,GO:0071595,0.99999999996742,0.807922499754113,0,2,Nem1-Spo7 phosphatase complex,CC,
15945,GO:0080023,0.99999999996742,0.807922499754113,0,2,3R-hydroxyacyl-CoA dehydratase activity,MF,
16528,GO:0097309,0.99999999996742,0.807922499754113,0,2,cap1 mRNA methylation,BP,
19428,GO:1990112,0.99999999996742,0.807922499754113,0,2,RQC complex,CC,
19429,GO:1990116,0.99999999996742,0.807922499754113,0,2,ribosome-associated ubiquitin-dependent protein catabolic process,BP,
19631,GO:1990879,0.99999999996742,0.807922499754113,0,2,CST complex,CC,
4651,GO:0010797,0.999999999967447,0.922205363745832,0,1,regulation of multivesicular body size involved in endosome transport,BP,
11087,GO:0045113,0.999999999967508,0.839710962031914,0,2,regulation of integrin biosynthetic process,BP,
19466,GO:1990256,0.999999999967534,0.86958284645852,0,1,signal clustering,BP,
12565,GO:0050757,0.999999999967561,0.900029137605713,0,1,thymidylate synthase biosynthetic process,BP,
12566,GO:0050758,0.999999999967561,0.900029137605713,0,1,regulation of thymidylate synthase biosynthetic process,BP,
12567,GO:0050760,0.999999999967561,0.900029137605713,0,1,negative regulation of thymidylate synthase biosynthetic process,BP,
4294,GO:0009737,0.99999999996772,0.883171272060222,0,1,response to abscisic acid,BP,
4295,GO:0009738,0.99999999996772,0.883171272060222,0,1,abscisic acid-activated signaling pathway,BP,
4308,GO:0009787,0.99999999996772,0.883171272060222,0,1,regulation of abscisic acid-activated signaling pathway,BP,
4309,GO:0009789,0.99999999996772,0.883171272060222,0,1,positive regulation of abscisic acid-activated signaling pathway,BP,
15103,GO:0071215,0.99999999996772,0.883171272060222,0,1,cellular response to abscisic acid stimulus,BP,
17633,GO:1901419,0.99999999996772,0.883171272060222,0,1,regulation of response to alcohol,BP,
17634,GO:1901421,0.99999999996772,0.883171272060222,0,1,positive regulation of response to alcohol,BP,
19395,GO:1905957,0.99999999996772,0.883171272060222,0,1,regulation of cellular response to alcohol,BP,
19396,GO:1905959,0.99999999996772,0.883171272060222,0,1,positive regulation of cellular response to alcohol,BP,
4487,GO:0010512,0.999999999967736,0.808630987344576,0,2,negative regulation of phosphatidylinositol biosynthetic process,BP,
9306,GO:0035788,0.999999999967736,0.808630987344576,0,2,cell migration involved in metanephros development,BP,
9307,GO:0035789,0.999999999967736,0.808630987344576,0,2,metanephric mesenchymal cell migration,BP,
9310,GO:0035793,0.999999999967736,0.808630987344576,0,2,positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway,BP,
17430,GO:1900238,0.999999999967736,0.808630987344576,0,2,regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway,BP,
19971,GO:2000589,0.999999999967736,0.808630987344576,0,2,regulation of metanephric mesenchymal cell migration,BP,
19972,GO:2000591,0.999999999967736,0.808630987344576,0,2,positive regulation of metanephric mesenchymal cell migration,BP,
17760,GO:1901842,0.999999999967756,0.912979984992136,0,1,negative regulation of high voltage-gated calcium channel activity,BP,
111,GO:0000229,0.99999999996779,0.909475339268864,0,1,cytoplasmic chromosome,CC,
126,GO:0000262,0.99999999996779,0.909475339268864,0,1,mitochondrial chromosome,CC,
160,GO:0000332,0.999999999967798,0.961656019073089,0,1,template for synthesis of G-rich strand of telomere DNA activity,MF,
238,GO:0000496,0.999999999967798,0.961656019073089,0,1,base pairing,MF,
239,GO:0000497,0.999999999967798,0.961656019073089,0,1,base pairing with DNA,MF,
1464,GO:0003721,0.999999999967798,0.961656019073089,0,1,telomerase RNA reverse transcriptase activity,MF,
18686,GO:1904106,0.999999999967841,0.898771906949529,0,1,protein localization to microvillus,BP,
19057,GO:1904970,0.999999999967841,0.898771906949529,0,1,brush border assembly,BP,
1787,GO:0004418,0.999999999967991,0.913057388015843,0,1,hydroxymethylbilane synthase activity,MF,
5910,GO:0018160,0.999999999967991,0.913057388015843,0,1,peptidyl-pyrromethane cofactor linkage,BP,
15744,GO:0072361,0.999999999968031,0.766905419012362,0,2,regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter,BP,
16795,GO:0098679,0.999999999968031,0.766905419012362,0,2,regulation of carbohydrate catabolic process by regulation of transcription from RNA polymerase II promoter,BP,
3850,GO:0008466,0.999999999968162,0.905005463700907,0,1,glycogenin glucosyltransferase activity,MF,
17144,GO:0102751,0.999999999968162,0.905005463700907,0,1,UDP-alpha-D-glucose:glucosyl-glycogenin alpha-D-glucosyltransferase activity,MF,
19013,GO:1904878,0.999999999968283,0.872986798126415,0,1,negative regulation of calcium ion transmembrane transport via high voltage-gated calcium channel,BP,
17496,GO:1900753,0.999999999968316,0.883150970907048,0,1,doxorubicin transport,BP,
14789,GO:0070539,0.999999999968343,0.892121245913729,0,1,linoleic acid binding,MF,
4588,GO:0010698,0.999999999968352,0.850904508444625,0,2,acetyltransferase activator activity,MF,
9141,GO:0035504,0.999999999968404,0.91211539075647,0,1,regulation of myosin light chain kinase activity,BP,
9142,GO:0035505,0.999999999968404,0.91211539075647,0,1,positive regulation of myosin light chain kinase activity,BP,
10319,GO:0043126,0.999999999968404,0.91211539075647,0,1,regulation of 1-phosphatidylinositol 4-kinase activity,BP,
10320,GO:0043128,0.999999999968404,0.91211539075647,0,1,positive regulation of 1-phosphatidylinositol 4-kinase activity,BP,
11566,GO:0046136,0.999999999968404,0.91211539075647,0,1,positive regulation of vitamin metabolic process,BP,
13884,GO:0060557,0.999999999968404,0.91211539075647,0,1,positive regulation of vitamin D biosynthetic process,BP,
13886,GO:0060559,0.999999999968404,0.91211539075647,0,1,positive regulation of calcidiol 1-monooxygenase activity,BP,
5414,GO:0016263,0.999999999968451,0.817407494719757,0,2,glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity,MF,
5417,GO:0016267,0.999999999968451,0.817407494719757,0,2,O-glycan processing, core 1,BP,
10246,GO:0042998,0.999999999968597,0.783941005708745,0,2,positive regulation of Golgi to plasma membrane protein transport,BP,
1916,GO:0004611,0.999999999968649,0.902885304954087,0,1,phosphoenolpyruvate carboxykinase activity,MF,
1917,GO:0004613,0.999999999968649,0.902885304954087,0,1,phosphoenolpyruvate carboxykinase (GTP) activity,MF,
6173,GO:0019543,0.999999999968649,0.902885304954087,0,1,propionate catabolic process,BP,
11608,GO:0046327,0.999999999968649,0.902885304954087,0,1,glycerol biosynthetic process from pyruvate,BP,
9716,GO:0038172,0.999999999968673,0.79954944748269,0,2,interleukin-33-mediated signaling pathway,BP,
19548,GO:1990589,0.999999999968679,0.79283244076895,0,2,ATF4-CREB1 transcription factor complex,CC,
1779,GO:0004395,0.999999999968687,0.920146557690191,0,1,hexaprenyldihydroxybenzoate methyltransferase activity,MF,
3823,GO:0008425,0.999999999968687,0.920146557690191,0,1,2-polyprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity,MF,
3953,GO:0008689,0.999999999968687,0.920146557690191,0,1,3-demethylubiquinone-9 3-O-methyltransferase activity,MF,
4452,GO:0010420,0.999999999968687,0.920146557690191,0,1,polyprenyldihydroxybenzoate methyltransferase activity,MF,
4649,GO:0010795,0.999999999968687,0.920146557690191,0,1,regulation of ubiquinone biosynthetic process,BP,
6946,GO:0030580,0.999999999968687,0.920146557690191,0,1,quinone cofactor methyltransferase activity,MF,
10923,GO:0044595,0.999999999968687,0.920146557690191,0,1,decaprenyldihydroxybenzoate methyltransferase activity,MF,
10924,GO:0044596,0.999999999968687,0.920146557690191,0,1,3-demethylubiquinone-10 3-O-methyltransferase activity,MF,
13144,GO:0051750,0.999999999968687,0.920146557690191,0,1,delta3,5-delta2,4-dienoyl-CoA isomerase activity,MF,
14320,GO:0061542,0.999999999968687,0.920146557690191,0,1,3-demethylubiquinone-n 3-O-methyltransferase activity,MF,
6808,GO:0030272,0.999999999968704,0.937405667451742,0,1,5-formyltetrahydrofolate cyclo-ligase activity,MF,
13774,GO:0060383,0.999999999968763,0.885267085413535,0,1,positive regulation of DNA strand elongation,BP,
19253,GO:1905464,0.999999999968763,0.885267085413535,0,1,positive regulation of DNA duplex unwinding,BP,
19338,GO:1905774,0.999999999968763,0.885267085413535,0,1,regulation of DNA helicase activity,BP,
19339,GO:1905776,0.999999999968763,0.885267085413535,0,1,positive regulation of DNA helicase activity,BP,
19654,GO:1990955,0.999999999968763,0.885267085413535,0,1,G-rich single-stranded DNA binding,MF,
3819,GO:0008419,0.999999999968765,0.899992989626475,0,1,RNA lariat debranching enzyme activity,MF,
1029,GO:0002537,0.999999999968783,0.878011128540782,0,1,nitric oxide production involved in inflammatory response,BP,
14292,GO:0061459,0.999999999968783,0.878011128540782,0,1,L-arginine transmembrane transporter activity,MF,
16660,GO:0097625,0.999999999968783,0.878011128540782,0,1,low-affinity basic amino acid transmembrane transporter activity,MF,
16661,GO:0097626,0.999999999968783,0.878011128540782,0,1,low-affinity L-arginine transmembrane transporter activity,MF,
16662,GO:0097627,0.999999999968783,0.878011128540782,0,1,high-affinity L-ornithine transmembrane transporter activity,MF,
16671,GO:0097639,0.999999999968783,0.878011128540782,0,1,L-lysine import across plasma membrane,BP,
16672,GO:0097640,0.999999999968783,0.878011128540782,0,1,L-ornithine import across plasma membrane,BP,
6406,GO:0021649,0.999999999968885,0.900389057665856,0,1,vestibulocochlear nerve structural organization,BP,
9680,GO:0038085,0.999999999968885,0.900389057665856,0,1,vascular endothelial growth factor binding,MF,
13710,GO:0060301,0.999999999968885,0.900389057665856,0,1,positive regulation of cytokine activity,BP,
14326,GO:0061552,0.999999999968885,0.900389057665856,0,1,ganglion morphogenesis,BP,
16558,GO:0097374,0.999999999968885,0.900389057665856,0,1,sensory neuron axon guidance,BP,
17954,GO:1902378,0.999999999968885,0.900389057665856,0,1,VEGF-activated neuropilin signaling pathway involved in axon guidance,BP,
18991,GO:1904835,0.999999999968885,0.900389057665856,0,1,dorsal root ganglion morphogenesis,BP,
19087,GO:1905040,0.999999999968885,0.900389057665856,0,1,otic placode development,BP,
15826,GO:0072560,0.999999999968954,0.896783858544352,0,1,type B pancreatic cell maturation,BP,
15015,GO:0070981,0.999999999968971,0.900753784865539,0,1,L-asparagine biosynthetic process,BP,
15016,GO:0070982,0.999999999968971,0.900753784865539,0,1,L-asparagine metabolic process,BP,
16114,GO:0090138,0.99999999996908,0.890146907593469,0,1,regulation of actin cytoskeleton organization by cell-cell adhesion,BP,
12397,GO:0048859,0.999999999969111,0.816603581440098,0,2,formation of anatomical boundary,BP,
2328,GO:0005344,0.999999999969184,0.903071481199416,0,1,oxygen carrier activity,MF,
12031,GO:0047888,0.999999999969184,0.903071481199416,0,1,fatty acid peroxidase activity,MF,
1606,GO:0004031,0.999999999969347,0.880502521964552,0,1,aldehyde oxidase activity,MF,
5591,GO:0016623,0.999999999969347,0.880502521964552,0,1,oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor,MF,
17150,GO:0102797,0.999999999969347,0.880502521964552,0,1,geranial:oxygen oxidoreductase activity,MF,
17151,GO:0102798,0.999999999969347,0.880502521964552,0,1,heptaldehyde:oxygen oxidoreductase activity,MF,
997,GO:0002461,0.999999999969355,0.900770912666562,0,1,tolerance induction dependent upon immune response,BP,
1019,GO:0002519,0.999999999969355,0.900770912666562,0,1,natural killer cell tolerance induction,BP,
1078,GO:0002652,0.999999999969355,0.900770912666562,0,1,regulation of tolerance induction dependent upon immune response,BP,
8042,GO:0032712,0.999999999969355,0.900770912666562,0,1,negative regulation of interleukin-3 production,BP,
15379,GO:0071656,0.999999999969355,0.900770912666562,0,1,negative regulation of granulocyte colony-stimulating factor production,BP,
17578,GO:1901257,0.999999999969355,0.900770912666562,0,1,negative regulation of macrophage colony-stimulating factor production,BP,
5034,GO:0015211,0.999999999969355,0.90040774317086,0,1,purine nucleoside transmembrane transporter activity,MF,
5076,GO:0015307,0.999999999969377,0.81510967276927,0,2,drug:proton antiporter activity,MF,
11744,GO:0046618,0.999999999969377,0.81510967276927,0,2,drug export,BP,
19232,GO:1905424,0.999999999969386,0.811955356035805,0,2,regulation of Wnt-mediated midbrain dopaminergic neuron differentiation,BP,
19233,GO:1905426,0.999999999969386,0.811955356035805,0,2,positive regulation of Wnt-mediated midbrain dopaminergic neuron differentiation,BP,
19095,GO:1905051,0.999999999969488,0.850895264816834,0,2,regulation of base-excision repair,BP,
19096,GO:1905053,0.999999999969488,0.850895264816834,0,2,positive regulation of base-excision repair,BP,
13869,GO:0060532,0.99999999996951,0.783622011508762,0,2,bronchus cartilage development,BP,
14188,GO:0061145,0.99999999996951,0.783622011508762,0,2,lung smooth muscle development,BP,
18472,GO:1903621,0.999999999969535,0.903120989674367,0,1,protein localization to photoreceptor connecting cilium,BP,
18301,GO:1903276,0.999999999969669,0.817387391358104,0,2,regulation of sodium ion export across plasma membrane,BP,
18302,GO:1903278,0.999999999969669,0.817387391358104,0,2,positive regulation of sodium ion export across plasma membrane,BP,
18309,GO:1903288,0.999999999969669,0.817387391358104,0,2,positive regulation of potassium ion import,BP,
9724,GO:0038190,0.999999999969711,0.803196106623885,0,2,VEGF-activated neuropilin signaling pathway,BP,
17940,GO:1902336,0.999999999969711,0.803196106623885,0,2,positive regulation of retinal ganglion cell axon guidance,BP,
3952,GO:0008670,0.999999999969743,0.837413780210255,0,2,2,4-dienoyl-CoA reductase (NADPH) activity,MF,
8384,GO:0033316,0.999999999969773,0.897720133683397,0,1,meiotic spindle assembly checkpoint,BP,
10971,GO:0044779,0.999999999969773,0.897720133683397,0,1,meiotic spindle checkpoint,BP,
10975,GO:0044785,0.999999999969773,0.897720133683397,0,1,metaphase/anaphase transition of meiotic cell cycle,BP,
17847,GO:1902102,0.999999999969773,0.897720133683397,0,1,regulation of metaphase/anaphase transition of meiotic cell cycle,BP,
17848,GO:1902103,0.999999999969773,0.897720133683397,0,1,negative regulation of metaphase/anaphase transition of meiotic cell cycle,BP,
18237,GO:1903096,0.999999999969773,0.897720133683397,0,1,protein localization to meiotic spindle midzone,BP,
19118,GO:1905132,0.999999999969773,0.897720133683397,0,1,regulation of meiotic chromosome separation,BP,
19119,GO:1905133,0.999999999969773,0.897720133683397,0,1,negative regulation of meiotic chromosome separation,BP,
19206,GO:1905359,0.999999999969773,0.897720133683397,0,1,protein localization to meiotic spindle,BP,
1864,GO:0004530,0.999999999969778,0.783477333342028,0,2,deoxyribonuclease I activity,MF,
3472,GO:0007308,0.999999999969794,0.900201307379047,0,1,oocyte construction,BP,
3473,GO:0007309,0.999999999969794,0.900201307379047,0,1,oocyte axis specification,BP,
3474,GO:0007314,0.999999999969794,0.900201307379047,0,1,oocyte anterior/posterior axis specification,BP,
3475,GO:0007315,0.999999999969794,0.900201307379047,0,1,pole plasm assembly,BP,
3790,GO:0008358,0.999999999969794,0.900201307379047,0,1,maternal determination of anterior/posterior axis, embryo,BP,
7008,GO:0030719,0.999999999969794,0.900201307379047,0,1,P granule organization,BP,
9297,GO:0035755,0.999999999969794,0.900201307379047,0,1,cardiolipin hydrolase activity,MF,
5008,GO:0015168,0.99999999996981,0.812311058487701,0,2,glycerol transmembrane transporter activity,MF,
5054,GO:0015254,0.99999999996981,0.812311058487701,0,2,glycerol channel activity,MF,
5197,GO:0015793,0.99999999996981,0.812311058487701,0,2,glycerol transport,BP,
2322,GO:0005332,0.999999999969833,0.902584187737735,0,1,gamma-aminobutyric acid:sodium symporter activity,MF,
5020,GO:0015185,0.999999999969833,0.902584187737735,0,1,gamma-aminobutyric acid transmembrane transporter activity,MF,
6539,GO:0021956,0.999999999969833,0.902584187737735,0,1,central nervous system interneuron axonogenesis,BP,
6512,GO:0021894,0.999999999969886,0.928835307769893,0,1,cerebral cortex GABAergic interneuron development,BP,
1033,GO:0002542,0.999999999969893,0.902072304935812,0,1,Factor XII activation,BP,
13224,GO:0051919,0.999999999969893,0.902072304935812,0,1,positive regulation of fibrinolysis,BP,
4015,GO:0009020,0.999999999970093,0.902974481232021,0,1,tRNA (guanosine-2'-O-)-methyltransferase activity,MF,
13368,GO:0052666,0.999999999970093,0.902974481232021,0,1,tRNA (cytosine-2'-O-)-methyltransferase activity,MF,
17185,GO:0106050,0.999999999970093,0.902974481232021,0,1,tRNA 2'-O-methyltransferase activity,MF,
9387,GO:0035938,0.999999999970142,0.87917431513165,0,1,estradiol secretion,BP,
20133,GO:2000864,0.999999999970142,0.87917431513165,0,1,regulation of estradiol secretion,BP,
7622,GO:0032029,0.999999999970248,0.869694241522083,0,1,myosin tail binding,MF,
4534,GO:0010609,0.999999999970262,0.810310962529223,0,2,mRNA localization resulting in posttranscriptional regulation of gene expression,BP,
1907,GO:0004597,0.999999999970331,0.890615709529774,0,1,peptide-aspartate beta-dioxygenase activity,MF,
340,GO:0000941,0.999999999970397,0.900993465675739,0,1,condensed nuclear chromosome inner kinetochore,CC,
13001,GO:0051456,0.999999999970397,0.900993465675739,0,1,attachment of spindle microtubules to kinetochore involved in meiotic sister chromatid segregation,BP,
16225,GO:0090299,0.999999999970565,0.907822185787933,0,1,regulation of neural crest formation,BP,
16226,GO:0090301,0.999999999970565,0.907822185787933,0,1,negative regulation of neural crest formation,BP,
19823,GO:2000314,0.999999999970565,0.907822185787933,0,1,negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
15751,GO:0072368,0.999999999970582,0.775212829600507,0,2,regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter,BP,
528,GO:0001640,0.999999999970587,0.879364150163528,0,1,adenylate cyclase inhibiting G-protein coupled glutamate receptor activity,MF,
529,GO:0001642,0.999999999970587,0.879364150163528,0,1,group III metabotropic glutamate receptor activity,MF,
3413,GO:0007196,0.999999999970587,0.879364150163528,0,1,adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway,BP,
9329,GO:0035841,0.999999999970587,0.879364150163528,0,1,new growing cell tip,CC,
16950,GO:0098988,0.999999999970587,0.879364150163528,0,1,G-protein coupled glutamate receptor activity,MF,
8073,GO:0032764,0.999999999970608,0.812217116723207,0,2,negative regulation of mast cell cytokine production,BP,
9560,GO:0036371,0.999999999970616,0.877284552908886,0,1,protein localization to T-tubule,BP,
16005,GO:0086046,0.999999999970616,0.877284552908886,0,1,membrane depolarization during SA node cell action potential,BP,
16908,GO:0098907,0.999999999970616,0.877284552908886,0,1,regulation of SA node cell action potential,BP,
1919,GO:0004615,0.999999999970681,0.828136938874264,0,2,phosphomannomutase activity,MF,
3515,GO:0007439,0.999999999970689,0.898297212438558,0,1,ectodermal digestive tract development,BP,
9507,GO:0036215,0.999999999970689,0.898297212438558,0,1,response to stem cell factor,BP,
9508,GO:0036216,0.999999999970689,0.898297212438558,0,1,cellular response to stem cell factor stimulus,BP,
9693,GO:0038109,0.999999999970689,0.898297212438558,0,1,Kit signaling pathway,BP,
12272,GO:0048611,0.999999999970689,0.898297212438558,0,1,embryonic ectodermal digestive tract development,BP,
13520,GO:0060002,0.999999999970691,0.773279898942946,0,2,plus-end directed microfilament motor activity,MF,
1970,GO:0004687,0.999999999970735,0.770391261770248,0,2,myosin light chain kinase activity,MF,
4844,GO:0014054,0.999999999970756,0.884944113473881,0,1,positive regulation of gamma-aminobutyric acid secretion,BP,
5520,GO:0016492,0.999999999970756,0.884944113473881,0,1,G-protein coupled neurotensin receptor activity,MF,
1551,GO:0003952,0.999999999970808,0.900474796378231,0,1,NAD+ synthase (glutamine-hydrolyzing) activity,MF,
1578,GO:0003990,0.999999999970808,0.900474796378231,0,1,acetylcholinesterase activity,MF,
4819,GO:0014016,0.999999999970808,0.900474796378231,0,1,neuroblast differentiation,BP,
11655,GO:0046448,0.999999999970808,0.900474796378231,0,1,tropane alkaloid metabolic process,BP,
12585,GO:0050783,0.999999999970808,0.900474796378231,0,1,cocaine metabolic process,BP,
17829,GO:1902038,0.99999999997083,0.893058171826837,0,1,positive regulation of hematopoietic stem cell differentiation,BP,
17909,GO:1902257,0.99999999997083,0.893058171826837,0,1,negative regulation of apoptotic process involved in outflow tract morphogenesis,BP,
1804,GO:0004452,0.999999999970891,0.826458414455152,0,2,isopentenyl-diphosphate delta-isomerase activity,MF,
12709,GO:0050992,0.999999999970891,0.826458414455152,0,2,dimethylallyl diphosphate biosynthetic process,BP,
12710,GO:0050993,0.999999999970891,0.826458414455152,0,2,dimethylallyl diphosphate metabolic process,BP,
11704,GO:0046523,0.99999999997097,0.89699455698774,0,1,S-methyl-5-thioribose-1-phosphate isomerase activity,MF,
4358,GO:0009956,0.999999999970971,0.887183035944385,0,1,radial pattern formation,BP,
2351,GO:0005427,0.999999999970983,0.896616009547136,0,1,proton-dependent oligopeptide secondary active transmembrane transporter activity,MF,
5082,GO:0015322,0.999999999970983,0.896616009547136,0,1,secondary active oligopeptide transmembrane transporter activity,MF,
2085,GO:0004850,0.999999999970995,0.904940443135034,0,1,uridine phosphorylase activity,MF,
2785,GO:0006218,0.999999999970995,0.904940443135034,0,1,uridine catabolic process,BP,
11547,GO:0046108,0.999999999970995,0.904940443135034,0,1,uridine metabolic process,BP,
3993,GO:0008893,0.999999999971053,0.929659630652482,0,1,guanosine-3',5'-bis(diphosphate) 3'-diphosphatase activity,MF,
5678,GO:0016794,0.999999999971053,0.929659630652482,0,1,diphosphoric monoester hydrolase activity,MF,
2128,GO:0004931,0.999999999971063,0.902273222688136,0,1,extracellularly ATP-gated cation channel activity,MF,
5532,GO:0016519,0.999999999971063,0.902273222688136,0,1,gastric inhibitory peptide receptor activity,MF,
9095,GO:0035381,0.999999999971063,0.902273222688136,0,1,ATP-gated ion channel activity,MF,
9726,GO:0038192,0.999999999971063,0.902273222688136,0,1,gastric inhibitory peptide signaling pathway,BP,
14228,GO:0061301,0.999999999971099,0.878236358245863,0,1,cerebellum vasculature morphogenesis,BP,
9622,GO:0036501,0.999999999971187,0.882933092425699,0,1,UFD1-NPL4 complex,CC,
1164,GO:0002785,0.999999999971188,0.890172514437688,0,1,negative regulation of antimicrobial peptide production,BP,
1166,GO:0002787,0.999999999971188,0.890172514437688,0,1,negative regulation of antibacterial peptide production,BP,
3783,GO:0008348,0.999999999971188,0.890172514437688,0,1,negative regulation of antimicrobial humoral response,BP,
1512,GO:0003875,0.99999999997119,0.893121831329824,0,1,ADP-ribosylarginine hydrolase activity,MF,
608,GO:0001777,0.999999999971195,0.941121037225569,0,1,T cell homeostatic proliferation,BP,
944,GO:0002358,0.999999999971195,0.941121037225569,0,1,B cell homeostatic proliferation,BP,
8207,GO:0032976,0.999999999971195,0.941121037225569,0,1,release of matrix enzymes from mitochondria,BP,
16444,GO:0097144,0.999999999971195,0.941121037225569,0,1,BAX complex,CC,
19430,GO:1990117,0.999999999971195,0.941121037225569,0,1,B cell receptor apoptotic signaling pathway,BP,
2143,GO:0004960,0.999999999971247,0.900937644743686,0,1,thromboxane receptor activity,MF,
2144,GO:0004961,0.999999999971247,0.900937644743686,0,1,thromboxane A2 receptor activity,MF,
5316,GO:0016036,0.999999999971247,0.900937644743686,0,1,cellular response to phosphate starvation,BP,
7318,GO:0031335,0.999999999971247,0.900937644743686,0,1,regulation of sulfur amino acid metabolic process,BP,
7319,GO:0031337,0.999999999971247,0.900937644743686,0,1,positive regulation of sulfur amino acid metabolic process,BP,
9323,GO:0035814,0.999999999971247,0.900937644743686,0,1,negative regulation of renal sodium excretion,BP,
9727,GO:0038193,0.999999999971247,0.900937644743686,0,1,thromboxane A2 signaling pathway,BP,
12506,GO:0050666,0.999999999971247,0.900937644743686,0,1,regulation of homocysteine metabolic process,BP,
12508,GO:0050668,0.999999999971247,0.900937644743686,0,1,positive regulation of homocysteine metabolic process,BP,
13940,GO:0060668,0.999999999971265,0.890789753324759,0,1,regulation of branching involved in salivary gland morphogenesis by extracellular matrix-epithelial cell signaling,BP,
19436,GO:1990134,0.999999999971272,0.880325632360366,0,1,epithelial cell apoptotic process involved in palatal shelf morphogenesis,BP,
859,GO:0002192,0.999999999971274,0.852633817289259,0,2,IRES-dependent translational initiation of linear mRNA,BP,
17207,GO:0110017,0.999999999971274,0.852633817289259,0,2,cap-independent translational initiation of linear mRNA,BP,
10649,GO:0043843,0.999999999971311,0.900231007191397,0,1,ADP-specific glucokinase activity,MF,
19385,GO:1905937,0.999999999971348,0.935401104959777,0,1,negative regulation of germ cell proliferation,BP,
19786,GO:2000255,0.999999999971348,0.935401104959777,0,1,negative regulation of male germ cell proliferation,BP,
14287,GO:0061444,0.99999999997135,0.87945326318616,0,1,endocardial cushion cell development,BP,
16434,GO:0097118,0.999999999971369,0.878745442368726,0,1,neuroligin clustering involved in postsynaptic membrane assembly,BP,
18748,GO:1904265,0.999999999971371,0.879281159015232,0,1,ubiquitin-specific protease activity involved in negative regulation of retrograde protein transport, ER to cytosol,MF,
2119,GO:0004913,0.999999999971412,0.900597037772919,0,1,interleukin-4 receptor activity,MF,
3175,GO:0006789,0.99999999997145,0.90063301822007,0,1,bilirubin conjugation,BP,
9264,GO:0035700,0.999999999971487,0.905444833986234,0,1,astrocyte chemotaxis,BP,
9487,GO:0036145,0.999999999971487,0.905444833986234,0,1,dendritic cell homeostasis,BP,
19912,GO:2000458,0.999999999971487,0.905444833986234,0,1,regulation of astrocyte chemotaxis,BP,
14712,GO:0070401,0.999999999971491,0.817758270896115,0,2,NADP+ binding,MF,
3865,GO:0008489,0.999999999971514,0.898775468729921,0,1,UDP-galactose:glucosylceramide beta-1,4-galactosyltransferase activity,MF,
11960,GO:0047263,0.999999999971514,0.898775468729921,0,1,N-acylsphingosine galactosyltransferase activity,MF,
13033,GO:0051543,0.999999999971548,0.900673086471896,0,1,regulation of elastin biosynthetic process,BP,
13034,GO:0051545,0.999999999971548,0.900673086471896,0,1,negative regulation of elastin biosynthetic process,BP,
4448,GO:0010387,0.999999999971582,0.900862230152649,0,1,COP9 signalosome assembly,BP,
6158,GO:0019510,0.999999999971582,0.900862230152649,0,1,S-adenosylhomocysteine catabolic process,BP,
15135,GO:0071268,0.999999999971582,0.900862230152649,0,1,homocysteine biosynthetic process,BP,
16344,GO:0090667,0.999999999971596,0.877630816928876,0,1,cell chemotaxis to vascular endothelial growth factor,BP,
16345,GO:0090668,0.999999999971596,0.877630816928876,0,1,endothelial cell chemotaxis to vascular endothelial growth factor,BP,
10759,GO:0044220,0.999999999971598,0.880837731858863,0,1,host cell perinuclear region of cytoplasm,CC,
12423,GO:0050104,0.99999999997174,0.912085652001521,0,1,L-gulonate 3-dehydrogenase activity,MF,
9774,GO:0039713,0.999999999971773,0.893090011875159,0,1,viral factory,CC,
9775,GO:0039714,0.999999999971773,0.893090011875159,0,1,cytoplasmic viral factory,CC,
15795,GO:0072517,0.999999999971773,0.893090011875159,0,1,host cell viral assembly compartment,CC,
17449,GO:1900276,0.999999999971773,0.893090011875159,0,1,regulation of proteinase activated receptor activity,BP,
17486,GO:1900736,0.999999999971773,0.893090011875159,0,1,regulation of phospholipase C-activating G-protein coupled receptor signaling pathway,BP,
17487,GO:1900737,0.999999999971773,0.893090011875159,0,1,negative regulation of phospholipase C-activating G-protein coupled receptor signaling pathway,BP,
2090,GO:0004856,0.999999999971791,0.889789631633052,0,1,xylulokinase activity,MF,
2654,GO:0005998,0.999999999971791,0.889789631633052,0,1,xylulose catabolic process,BP,
17116,GO:0102339,0.999999999971792,0.900268673042826,0,1,3-oxo-arachidoyl-CoA reductase activity,MF,
17117,GO:0102340,0.999999999971792,0.900268673042826,0,1,3-oxo-behenoyl-CoA reductase activity,MF,
17118,GO:0102341,0.999999999971792,0.900268673042826,0,1,3-oxo-lignoceroyl-CoA reductase activity,MF,
17119,GO:0102342,0.999999999971792,0.900268673042826,0,1,3-oxo-cerotoyl-CoA reductase activity,MF,
19718,GO:2000111,0.999999999971816,0.820989372768248,0,2,positive regulation of macrophage apoptotic process,BP,
1755,GO:0004360,0.999999999971826,0.87647713450997,0,1,glutamine-fructose-6-phosphate transaminase (isomerizing) activity,MF,
14794,GO:0070548,0.999999999971826,0.87647713450997,0,1,L-glutamine aminotransferase activity,MF,
11981,GO:0047395,0.99999999997187,0.898527262250221,0,1,glycerophosphoinositol glycerophosphodiesterase activity,MF,
12003,GO:0047620,0.99999999997187,0.898527262250221,0,1,acylglycerol kinase activity,MF,
10300,GO:0043095,0.999999999971882,0.946440756031114,0,1,regulation of GTP cyclohydrolase I activity,BP,
10306,GO:0043105,0.999999999971882,0.946440756031114,0,1,negative regulation of GTP cyclohydrolase I activity,BP,
10917,GO:0044549,0.999999999971882,0.946440756031114,0,1,GTP cyclohydrolase binding,MF,
17921,GO:1902283,0.999999999971961,0.885984701717715,0,1,negative regulation of primary amine oxidase activity,BP,
751,GO:0001992,0.999999999971965,0.883157728730623,0,1,regulation of systemic arterial blood pressure by vasopressin,BP,
2158,GO:0004990,0.999999999971965,0.883157728730623,0,1,oxytocin receptor activity,MF,
2308,GO:0005298,0.999999999971965,0.883157728730623,0,1,proline:sodium symporter activity,MF,
10056,GO:0042564,0.999999999971965,0.883157728730623,0,1,NLS-dependent protein nuclear import complex,CC,
5304,GO:0016012,0.99999999997202,0.801263496056877,0,2,sarcoglycan complex,CC,
13292,GO:0052151,0.999999999972076,0.816568457003037,0,2,positive regulation by symbiont of host apoptotic process,BP,
13617,GO:0060139,0.999999999972076,0.816568457003037,0,2,positive regulation of apoptotic process by virus,BP,
19224,GO:1905404,0.999999999972127,0.910957858437681,0,1,positive regulation of activated CD8-positive, alpha-beta T cell apoptotic process,BP,
2655,GO:0005999,0.999999999972162,0.830435546037383,0,2,xylulose biosynthetic process,BP,
5647,GO:0016744,0.999999999972162,0.830435546037383,0,2,transferase activity, transferring aldehyde or ketonic groups,MF,
6264,GO:0019862,0.999999999972231,0.910187143785105,0,1,IgA binding,MF,
14993,GO:0070944,0.999999999972269,0.815725920636705,0,2,neutrophil mediated killing of bacterium,BP,
14994,GO:0070945,0.999999999972269,0.815725920636705,0,2,neutrophil mediated killing of gram-negative bacterium,BP,
1981,GO:0004703,0.999999999972287,0.808693066473593,0,2,G-protein coupled receptor kinase activity,MF,
12013,GO:0047696,0.999999999972287,0.808693066473593,0,2,beta-adrenergic receptor kinase activity,MF,
5337,GO:0016077,0.999999999972289,0.87944091641936,0,1,snoRNA catabolic process,BP,
9339,GO:0035862,0.999999999972289,0.87944091641936,0,1,dITP metabolic process,BP,
9340,GO:0035863,0.999999999972289,0.87944091641936,0,1,dITP catabolic process,BP,
12664,GO:0050897,0.999999999972289,0.87944091641936,0,1,cobalt ion binding,MF,
16561,GO:0097382,0.999999999972289,0.87944091641936,0,1,deoxynucleoside-diphosphatase activity,MF,
16562,GO:0097383,0.999999999972289,0.87944091641936,0,1,dIDP diphosphatase activity,MF,
17697,GO:1901639,0.999999999972289,0.87944091641936,0,1,XDP catabolic process,BP,
17698,GO:1901640,0.999999999972289,0.87944091641936,0,1,XTP binding,MF,
17699,GO:1901641,0.999999999972289,0.87944091641936,0,1,ITP binding,MF,
19400,GO:1990003,0.999999999972289,0.87944091641936,0,1,IDP phosphatase activity,MF,
5756,GO:0016920,0.999999999972315,0.878557620798663,0,1,pyroglutamyl-peptidase activity,MF,
5301,GO:0016005,0.999999999972317,0.792581190025416,0,2,phospholipase A2 activator activity,MF,
12111,GO:0048203,0.999999999972379,0.812096278455107,0,2,vesicle targeting, trans-Golgi to endosome,BP,
4897,GO:0014826,0.999999999972397,0.901788208430651,0,1,vein smooth muscle contraction,BP,
6753,GO:0030185,0.999999999972397,0.901788208430651,0,1,nitric oxide transport,BP,
7440,GO:0031583,0.999999999972397,0.901788208430651,0,1,phospholipase D-activating G-protein coupled receptor signaling pathway,BP,
7511,GO:0031705,0.999999999972397,0.901788208430651,0,1,bombesin receptor binding,MF,
7512,GO:0031707,0.999999999972397,0.901788208430651,0,1,endothelin A receptor binding,MF,
7513,GO:0031708,0.999999999972397,0.901788208430651,0,1,endothelin B receptor binding,MF,
9324,GO:0035815,0.999999999972397,0.901788208430651,0,1,positive regulation of renal sodium excretion,BP,
9939,GO:0042313,0.999999999972397,0.901788208430651,0,1,protein kinase C deactivation,BP,
10351,GO:0043179,0.999999999972397,0.901788208430651,0,1,rhythmic excitation,BP,
15413,GO:0071707,0.999999999972436,0.92006927013533,0,1,immunoglobulin heavy chain V-D-J recombination,BP,
16547,GO:0097356,0.99999999997244,0.878072590069789,0,1,perinucleolar compartment,CC,
9080,GO:0035354,0.99999999997246,0.893627806147453,0,1,Toll-like receptor 1-Toll-like receptor 2 protein complex,CC,
9699,GO:0038123,0.99999999997246,0.893627806147453,0,1,toll-like receptor TLR1:TLR2 signaling pathway,BP,
10029,GO:0042495,0.99999999997246,0.893627806147453,0,1,detection of triacyl bacterial lipopeptide,BP,
10031,GO:0042497,0.99999999997246,0.893627806147453,0,1,triacyl lipopeptide binding,MF,
15421,GO:0071725,0.99999999997246,0.893627806147453,0,1,response to triacyl bacterial lipopeptide,BP,
15423,GO:0071727,0.99999999997246,0.893627806147453,0,1,cellular response to triacyl bacterial lipopeptide,BP,
13502,GO:0055095,0.999999999972476,0.888102667362663,0,1,lipoprotein particle mediated signaling,BP,
13503,GO:0055096,0.999999999972476,0.888102667362663,0,1,low-density lipoprotein particle mediated signaling,BP,
14457,GO:0061880,0.999999999972492,0.906966324054612,0,1,regulation of anterograde axonal transport of mitochondrion,BP,
14458,GO:0061881,0.999999999972492,0.906966324054612,0,1,positive regulation of anterograde axonal transport of mitochondrion,BP,
2778,GO:0006208,0.999999999972542,0.808261317622442,0,2,pyrimidine nucleobase catabolic process,BP,
2779,GO:0006210,0.999999999972542,0.808261317622442,0,2,thymine catabolic process,BP,
6262,GO:0019859,0.999999999972542,0.808261317622442,0,2,thymine metabolic process,BP,
2562,GO:0005846,0.999999999972565,0.793456990732464,0,2,nuclear cap binding complex,CC,
6346,GO:0021527,0.999999999972574,0.87982178962813,0,1,spinal cord association neuron differentiation,BP,
16654,GO:0097598,0.999999999972574,0.87982178962813,0,1,sperm cytoplasmic droplet,CC,
11821,GO:0046786,0.999999999972607,0.880628617937511,0,1,viral replication complex formation and maintenance,BP,
20016,GO:2000661,0.999999999972607,0.880628617937511,0,1,positive regulation of interleukin-1-mediated signaling pathway,BP,
5418,GO:0016269,0.99999999997262,0.900372443309603,0,1,O-glycan processing, core 3,BP,
11956,GO:0047224,0.99999999997262,0.900372443309603,0,1,acetylgalactosaminyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity,MF,
1729,GO:0004326,0.999999999972666,0.900376599201137,0,1,tetrahydrofolylpolyglutamate synthase activity,MF,
1840,GO:0004498,0.999999999972666,0.900376599201137,0,1,calcidiol 1-monooxygenase activity,MF,
3984,GO:0008841,0.999999999972666,0.900376599201137,0,1,dihydrofolate synthase activity,MF,
11870,GO:0046901,0.999999999972666,0.900376599201137,0,1,tetrahydrofolylpolyglutamate biosynthetic process,BP,
8445,GO:0033593,0.999999999972691,0.870691770382324,0,1,BRCA2-MAGE-D1 complex,CC,
8540,GO:0033906,0.999999999972719,0.813910926337143,0,2,hyaluronoglucuronidase activity,MF,
637,GO:0001827,0.999999999972749,0.775121552741065,0,2,inner cell mass cell fate commitment,BP,
638,GO:0001828,0.999999999972749,0.775121552741065,0,2,inner cell mass cellular morphogenesis,BP,
1889,GO:0004573,0.999999999972762,0.899723841585984,0,1,mannosyl-oligosaccharide glucosidase activity,MF,
3905,GO:0008555,0.99999999997277,0.87984396400507,0,1,chloride-transporting ATPase activity,MF,
18565,GO:1903837,0.999999999972775,0.900411899012312,0,1,regulation of mRNA 3'-UTR binding,BP,
18566,GO:1903839,0.999999999972775,0.900411899012312,0,1,positive regulation of mRNA 3'-UTR binding,BP,
8405,GO:0033477,0.999999999972786,0.902622036186288,0,1,S-methylmethionine metabolic process,BP,
11946,GO:0047150,0.999999999972786,0.902622036186288,0,1,betaine-homocysteine S-methyltransferase activity,MF,
14363,GO:0061627,0.999999999972786,0.902622036186288,0,1,S-methylmethionine-homocysteine S-methyltransferase activity,MF,
6107,GO:0019353,0.999999999972831,0.899805663937618,0,1,protoporphyrinogen IX biosynthetic process from glutamate,BP,
8419,GO:0033526,0.999999999972831,0.899805663937618,0,1,tetrapyrrole biosynthetic process from glutamate,BP,
18499,GO:1903699,0.999999999972836,0.869664410911805,0,1,tarsal gland development,BP,
18505,GO:1903709,0.999999999972836,0.869664410911805,0,1,uterine gland development,BP,
9138,GO:0035500,0.999999999972854,0.799345677109758,0,2,MH2 domain binding,MF,
19882,GO:2000395,0.999999999972874,0.848419042227005,0,2,regulation of ubiquitin-dependent endocytosis,BP,
19883,GO:2000397,0.999999999972874,0.848419042227005,0,2,positive regulation of ubiquitin-dependent endocytosis,BP,
1771,GO:0004378,0.999999999972882,0.898750443992759,0,1,GDP-Man:Man1GlcNAc2-PP-Dol alpha-1,3-mannosyltransferase activity,MF,
17142,GO:0102704,0.999999999972882,0.898750443992759,0,1,GDP-Man:Man2GlcNAc2-PP-dolichol alpha-1,6-mannosyltransferase activity,MF,
1885,GO:0004568,0.999999999972887,0.801501415174367,0,2,chitinase activity,MF,
2676,GO:0006030,0.999999999972887,0.801501415174367,0,2,chitin metabolic process,BP,
2677,GO:0006032,0.999999999972887,0.801501415174367,0,2,chitin catabolic process,BP,
3614,GO:0008061,0.999999999972887,0.801501415174367,0,2,chitin binding,MF,
16254,GO:0090341,0.999999999972913,0.91040398761416,0,1,negative regulation of secretion of lysosomal enzymes,BP,
490,GO:0001543,0.999999999972959,0.878029305316152,0,1,ovarian follicle rupture,BP,
19518,GO:1990448,0.999999999972963,0.878997223321543,0,1,exon-exon junction complex binding,MF,
4589,GO:0010700,0.999999999972973,0.89704013210551,0,1,negative regulation of norepinephrine secretion,BP,
7499,GO:0031686,0.999999999972973,0.89704013210551,0,1,A1 adenosine receptor binding,MF,
11035,GO:0045032,0.999999999972973,0.89704013210551,0,1,ADP-activated adenosine receptor activity,MF,
3688,GO:0008193,0.999999999972975,0.813094660046129,0,2,tRNA guanylyltransferase activity,MF,
1261,GO:0003017,0.999999999973006,0.875604568824912,0,1,lymph circulation,BP,
3608,GO:0008048,0.999999999973014,0.900942903614393,0,1,calcium sensitive guanylate cyclase activator activity,MF,
236,GO:0000494,0.999999999973022,0.92410413105258,0,1,box C/D snoRNA 3'-end processing,BP,
8545,GO:0033967,0.999999999973022,0.92410413105258,0,1,box C/D snoRNA metabolic process,BP,
8923,GO:0034963,0.999999999973022,0.92410413105258,0,1,box C/D snoRNA processing,BP,
9424,GO:0036009,0.999999999973022,0.92410413105258,0,1,protein-glutamine N-methyltransferase activity,MF,
19467,GO:1990258,0.999999999973022,0.92410413105258,0,1,histone glutamine methylation,BP,
19468,GO:1990259,0.999999999973022,0.92410413105258,0,1,histone-glutamine methyltransferase activity,MF,
15067,GO:0071074,0.999999999973055,0.903511318018206,0,1,eukaryotic initiation factor eIF2 binding,MF,
18491,GO:1903674,0.999999999973055,0.903511318018206,0,1,regulation of cap-dependent translational initiation,BP,
18492,GO:1903676,0.999999999973055,0.903511318018206,0,1,positive regulation of cap-dependent translational initiation,BP,
17834,GO:1902045,0.999999999973061,0.900678229889192,0,1,negative regulation of Fas signaling pathway,BP,
19931,GO:2000504,0.999999999973061,0.900678229889192,0,1,positive regulation of blood vessel remodeling,BP,
3525,GO:0007500,0.99999999997307,0.813563152992451,0,2,mesodermal cell fate determination,BP,
3780,GO:0008343,0.999999999973083,0.877447908072639,0,1,adult feeding behavior,BP,
15959,GO:0080144,0.999999999973095,0.798632059524273,0,2,amino acid homeostasis,BP,
7710,GO:0032207,0.999999999973103,0.898800277725201,0,1,regulation of telomere maintenance via recombination,BP,
7711,GO:0032208,0.999999999973103,0.898800277725201,0,1,negative regulation of telomere maintenance via recombination,BP,
18413,GO:1903517,0.999999999973103,0.898800277725201,0,1,negative regulation of single strand break repair,BP,
18534,GO:1903770,0.999999999973103,0.898800277725201,0,1,negative regulation of beta-galactosidase activity,BP,
18556,GO:1903823,0.999999999973103,0.898800277725201,0,1,telomere single strand break repair,BP,
18557,GO:1903824,0.999999999973103,0.898800277725201,0,1,negative regulation of telomere single strand break repair,BP,
3032,GO:0006580,0.999999999973115,0.899857164933909,0,1,ethanolamine metabolic process,BP,
18255,GO:1903165,0.999999999973115,0.899857164933909,0,1,response to polycyclic arene,BP,
18910,GO:1904681,0.999999999973115,0.899857164933909,0,1,response to 3-methylcholanthrene,BP,
28,GO:0000053,0.999999999973117,0.904694825804967,0,1,argininosuccinate metabolic process,BP,
1619,GO:0004055,0.999999999973117,0.904694825804967,0,1,argininosuccinate synthase activity,MF,
20241,GO:2001228,0.999999999973177,0.753290328860698,0,2,regulation of response to gamma radiation,BP,
11515,GO:0046056,0.999999999973183,0.819346005949682,0,2,dADP metabolic process,BP,
1829,GO:0004486,0.999999999973196,0.892674634560452,0,1,methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity,MF,
10445,GO:0043317,0.999999999973196,0.892674634560452,0,1,regulation of cytotoxic T cell degranulation,BP,
10446,GO:0043318,0.999999999973196,0.892674634560452,0,1,negative regulation of cytotoxic T cell degranulation,BP,
12772,GO:0051086,0.999999999973201,0.902911290118933,0,1,chaperone mediated protein folding independent of cofactor,BP,
13142,GO:0051747,0.999999999973202,0.85029338610985,0,2,cytosine C-5 DNA demethylase activity,MF,
8561,GO:0034039,0.999999999973244,0.8171345133725,0,2,8-oxo-7,8-dihydroguanine DNA N-glycosylase activity,MF,
18483,GO:1903650,0.999999999973286,0.86940379042709,0,2,negative regulation of cytoplasmic transport,BP,
19999,GO:2000642,0.999999999973286,0.86940379042709,0,2,negative regulation of early endosome to late endosome transport,BP,
15321,GO:0071566,0.9999999999733,0.898433736868489,0,1,UFM1 activating enzyme activity,MF,
2104,GO:0004882,0.999999999973332,0.895108428390591,0,1,androgen receptor activity,MF,
9385,GO:0035935,0.999999999973332,0.895108428390591,0,1,androgen secretion,BP,
16458,GO:0097162,0.999999999973332,0.895108428390591,0,1,MADS box domain binding,MF,
20119,GO:2000834,0.999999999973332,0.895108428390591,0,1,regulation of androgen secretion,BP,
20120,GO:2000836,0.999999999973332,0.895108428390591,0,1,positive regulation of androgen secretion,BP,
957,GO:0002378,0.999999999973339,0.882450799563551,0,1,immunoglobulin biosynthetic process,BP,
6999,GO:0030690,0.999999999973395,0.899338900611392,0,1,Noc1p-Noc2p complex,CC,
7000,GO:0030691,0.999999999973395,0.899338900611392,0,1,Noc2p-Noc3p complex,CC,
471,GO:0001515,0.999999999973433,0.902788387645144,0,1,opioid peptide activity,MF,
1773,GO:0004382,0.999999999973435,0.805186847765573,0,2,guanosine-diphosphatase activity,MF,
469,GO:0001512,0.999999999973467,0.925251597997055,0,1,dihydronicotinamide riboside quinone reductase activity,MF,
18806,GO:1904408,0.999999999973467,0.925251597997055,0,1,melatonin binding,MF,
19291,GO:1905594,0.999999999973467,0.925251597997055,0,1,resveratrol binding,MF,
157,GO:0000320,0.999999999973489,0.780750322273939,0,2,re-entry into mitotic cell cycle,BP,
1768,GO:0004375,0.999999999973495,0.888174869522188,0,1,glycine dehydrogenase (decarboxylating) activity,MF,
5600,GO:0016642,0.999999999973495,0.888174869522188,0,1,oxidoreductase activity, acting on the CH-NH2 group of donors, disulfide as acceptor,MF,
9516,GO:0036255,0.999999999973495,0.888174869522188,0,1,response to methylamine,BP,
14651,GO:0070280,0.999999999973495,0.888174869522188,0,1,pyridoxal binding,MF,
18391,GO:1903442,0.999999999973495,0.888174869522188,0,1,response to lipoic acid,BP,
19418,GO:1990070,0.999999999973499,0.943402679857219,0,1,TRAPPI protein complex,CC,
8861,GO:0034677,0.999999999973502,0.888934206243869,0,1,integrin alpha7-beta1 complex,CC,
8864,GO:0034681,0.999999999973502,0.888934206243869,0,1,integrin alpha11-beta1 complex,CC,
13769,GO:0060378,0.999999999973502,0.877744051920709,0,1,regulation of brood size,BP,
397,GO:0001074,0.999999999973503,0.900161049347439,0,1,transcription factor activity, RNA polymerase II proximal promoter sequence-specific DNA binding involved in preinitiation complex assembly,MF,
403,GO:0001084,0.999999999973503,0.900161049347439,0,1,transcription factor activity, TFIID-class binding,MF,
8423,GO:0033552,0.999999999973503,0.900161049347439,0,1,response to vitamin B3,BP,
16066,GO:0090065,0.999999999973533,0.973086172829877,0,1,regulation of production of siRNA involved in RNA interference,BP,
16796,GO:0098680,0.999999999973533,0.973086172829877,0,1,template-free RNA nucleotidyltransferase,MF,
18501,GO:1903704,0.999999999973533,0.973086172829877,0,1,negative regulation of production of siRNA involved in RNA interference,BP,
19542,GO:1990572,0.999999999973533,0.973086172829877,0,1,TERT-RMRP complex,CC,
6422,GO:0021693,0.999999999973541,0.7857963368518,0,2,cerebellar Purkinje cell layer structural organization,BP,
6427,GO:0021698,0.999999999973541,0.7857963368518,0,2,cerebellar cortex structural organization,BP,
5770,GO:0016979,0.999999999973596,0.914856152769495,0,1,lipoate-protein ligase activity,MF,
5839,GO:0017130,0.999999999973607,0.878811532331671,0,1,poly(C) RNA binding,MF,
16752,GO:0098577,0.999999999973607,0.878811532331671,0,1,inactive sex chromosome,CC,
18126,GO:1902889,0.999999999973607,0.878811532331671,0,1,protein localization to spindle microtubule,BP,
19475,GO:1990280,0.999999999973607,0.878811532331671,0,1,RNA localization to chromatin,BP,
7778,GO:0032311,0.999999999973613,0.90369893878375,0,1,angiogenin-PRI complex,CC,
1518,GO:0003882,0.999999999973637,0.900459984858182,0,1,CDP-diacylglycerol-serine O-phosphatidyltransferase activity,MF,
4278,GO:0009646,0.99999999997365,0.894918024846327,0,1,response to absence of light,BP,
6948,GO:0030586,0.99999999997365,0.894918024846327,0,1,[methionine synthase] reductase activity,MF,
7339,GO:0031380,0.99999999997365,0.894918024846327,0,1,nuclear RNA-directed RNA polymerase complex,CC,
12469,GO:0050444,0.99999999997365,0.894918024846327,0,1,aquacobalamin reductase (NADPH) activity,MF,
15278,GO:0071485,0.99999999997365,0.894918024846327,0,1,cellular response to absence of light,BP,
18667,GO:1904041,0.99999999997365,0.894918024846327,0,1,regulation of cystathionine beta-synthase activity,BP,
18668,GO:1904042,0.99999999997365,0.894918024846327,0,1,negative regulation of cystathionine beta-synthase activity,BP,
19553,GO:1990603,0.99999999997365,0.894918024846327,0,1,dark adaptation,BP,
4016,GO:0009032,0.999999999973657,0.907867909962844,0,1,thymidine phosphorylase activity,MF,
5363,GO:0016154,0.999999999973657,0.907867909962844,0,1,pyrimidine-nucleoside phosphorylase activity,MF,
18537,GO:1903775,0.999999999973691,0.805926656130029,0,2,regulation of DNA double-strand break processing,BP,
5455,GO:0016333,0.999999999973698,0.898492469816974,0,1,morphogenesis of follicular epithelium,BP,
5456,GO:0016334,0.999999999973698,0.898492469816974,0,1,establishment or maintenance of polarity of follicular epithelium,BP,
9900,GO:0042247,0.999999999973698,0.898492469816974,0,1,establishment of planar polarity of follicular epithelium,BP,
10108,GO:0042643,0.999999999973698,0.898492469816974,0,1,actomyosin, actin portion,CC,
7699,GO:0032190,0.999999999973759,0.836913736137457,0,2,acrosin binding,MF,
9317,GO:0035803,0.999999999973759,0.836913736137457,0,2,egg coat formation,BP,
12159,GO:0048297,0.999999999973775,0.901559077006358,0,1,negative regulation of isotype switching to IgA isotypes,BP,
14574,GO:0070143,0.999999999973784,0.880970332611991,0,1,mitochondrial alanyl-tRNA aminoacylation,BP,
16899,GO:0098888,0.999999999973866,0.878364342928284,0,1,extrinsic component of presynaptic membrane,CC,
16900,GO:0098890,0.999999999973866,0.878364342928284,0,1,extrinsic component of postsynaptic membrane,CC,
17007,GO:0099243,0.999999999973866,0.878364342928284,0,1,extrinsic component of synaptic membrane,CC,
4586,GO:0010693,0.999999999973883,0.776307834027791,0,2,negative regulation of alkaline phosphatase activity,BP,
13454,GO:0055011,0.999999999973973,0.907029728515367,0,1,atrial cardiac muscle cell differentiation,BP,
13457,GO:0055014,0.999999999973973,0.907029728515367,0,1,atrial cardiac muscle cell development,BP,
15388,GO:0071673,0.999999999973986,0.89678905650824,0,1,positive regulation of smooth muscle cell chemotaxis,BP,
18861,GO:1904565,0.999999999973986,0.89678905650824,0,1,response to 1-oleoyl-sn-glycerol 3-phosphate,BP,
18862,GO:1904566,0.999999999973986,0.89678905650824,0,1,cellular response to 1-oleoyl-sn-glycerol 3-phosphate,BP,
5804,GO:0017061,0.999999999974008,0.880601853449236,0,1,S-methyl-5-thioadenosine phosphorylase activity,MF,
8455,GO:0033604,0.999999999974071,0.789935969501385,0,2,negative regulation of catecholamine secretion,BP,
9867,GO:0042144,0.99999999997409,0.792907214161065,0,2,vacuole fusion, non-autophagic,BP,
16651,GO:0097576,0.99999999997409,0.792907214161065,0,2,vacuole fusion,BP,
5840,GO:0017133,0.999999999974101,0.900683404936511,0,1,mitochondrial electron transfer flavoprotein complex,CC,
10645,GO:0043783,0.999999999974101,0.900683404936511,0,1,oxidoreductase activity, oxidizing metal ions with flavin as acceptor,MF,
11160,GO:0045251,0.999999999974101,0.900683404936511,0,1,electron transfer flavoprotein complex,CC,
20073,GO:2000759,0.999999999974144,0.880741162299199,0,1,regulation of N-terminal peptidyl-lysine acetylation,BP,
20074,GO:2000761,0.999999999974144,0.880741162299199,0,1,positive regulation of N-terminal peptidyl-lysine acetylation,BP,
19584,GO:1990742,0.999999999974158,0.846697236942739,0,2,microvesicle,CC,
6344,GO:0021524,0.999999999974173,0.814430927694879,0,2,visceral motor neuron differentiation,BP,
5113,GO:0015439,0.999999999974174,0.898122219133665,0,1,heme-transporting ATPase activity,MF,
17994,GO:1902504,0.999999999974174,0.898122219133665,0,1,regulation of signal transduction involved in mitotic G2 DNA damage checkpoint,BP,
3983,GO:0008832,0.999999999974191,0.895995541722989,0,1,dGTPase activity,MF,
5677,GO:0016793,0.999999999974191,0.895995541722989,0,1,triphosphoric monoester hydrolase activity,MF,
7953,GO:0032560,0.999999999974191,0.895995541722989,0,1,guanyl deoxyribonucleotide binding,MF,
7956,GO:0032567,0.999999999974191,0.895995541722989,0,1,dGTP binding,MF,
4348,GO:0009918,0.999999999974218,0.89998258114112,0,1,sterol delta7 reductase activity,MF,
5122,GO:0015499,0.999999999974218,0.89998258114112,0,1,formate transmembrane transporter activity,MF,
5138,GO:0015660,0.999999999974218,0.89998258114112,0,1,formate efflux transmembrane transporter activity,MF,
5170,GO:0015724,0.999999999974218,0.89998258114112,0,1,formate transport,BP,
5198,GO:0015797,0.999999999974218,0.89998258114112,0,1,mannitol transport,BP,
5357,GO:0016131,0.999999999974218,0.89998258114112,0,1,brassinosteroid metabolic process,BP,
5358,GO:0016132,0.999999999974218,0.89998258114112,0,1,brassinosteroid biosynthetic process,BP,
11809,GO:0046724,0.999999999974218,0.89998258114112,0,1,oxalic acid secretion,BP,
12001,GO:0047598,0.999999999974218,0.89998258114112,0,1,7-dehydrocholesterol reductase activity,MF,
19120,GO:1905143,0.99999999997422,0.910568389109577,0,1,eukaryotic translation initiation factor 2 complex assembly,BP,
15554,GO:0072038,0.999999999974232,0.786337015759901,0,2,mesenchymal stem cell maintenance involved in nephron morphogenesis,BP,
15555,GO:0072039,0.999999999974232,0.786337015759901,0,2,regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis,BP,
15556,GO:0072040,0.999999999974232,0.786337015759901,0,2,negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis,BP,
17541,GO:1901145,0.999999999974232,0.786337015759901,0,2,mesenchymal cell apoptotic process involved in nephron morphogenesis,BP,
18907,GO:1904673,0.999999999974232,0.786337015759901,0,2,negative regulation of somatic stem cell population maintenance,BP,
14417,GO:0061750,0.999999999974247,0.900759454885855,0,1,acid sphingomyelin phosphodiesterase activity,MF,
2174,GO:0005011,0.999999999974276,0.881021418556542,0,1,macrophage colony-stimulating factor receptor activity,MF,
10448,GO:0043321,0.999999999974283,0.791125524230148,0,2,regulation of natural killer cell degranulation,BP,
10449,GO:0043323,0.999999999974283,0.791125524230148,0,2,positive regulation of natural killer cell degranulation,BP,
3195,GO:0006824,0.999999999974304,0.797503357451378,0,2,cobalt ion transport,BP,
16919,GO:0098920,0.999999999974304,0.899747360357224,0,1,retrograde trans-synaptic signaling by lipid,BP,
16920,GO:0098921,0.999999999974304,0.899747360357224,0,1,retrograde trans-synaptic signaling by endocannabinoid,BP,
3505,GO:0007412,0.999999999974315,0.821323868080246,0,2,axon target recognition,BP,
8962,GO:0035063,0.999999999974346,0.889846885746759,0,1,nuclear speck organization,BP,
16039,GO:0089709,0.999999999974347,0.810134486549223,0,2,L-histidine transmembrane transport,BP,
14676,GO:0070320,0.999999999974385,0.899933297277413,0,1,inward rectifier potassium channel inhibitor activity,MF,
17348,GO:1900085,0.999999999974385,0.899933297277413,0,1,negative regulation of peptidyl-tyrosine autophosphorylation,BP,
18465,GO:1903596,0.999999999974385,0.899933297277413,0,1,regulation of gap junction assembly,BP,
18466,GO:1903598,0.999999999974385,0.899933297277413,0,1,positive regulation of gap junction assembly,BP,
18469,GO:1903609,0.999999999974385,0.899933297277413,0,1,negative regulation of inward rectifier potassium channel activity,BP,
2798,GO:0006253,0.999999999974391,0.926335339325656,0,1,dCTP catabolic process,BP,
11520,GO:0046065,0.999999999974391,0.926335339325656,0,1,dCTP metabolic process,BP,
12027,GO:0047840,0.999999999974391,0.926335339325656,0,1,dCTP diphosphatase activity,MF,
3742,GO:0008281,0.999999999974393,0.881322314878945,0,1,sulfonylurea receptor activity,MF,
14514,GO:0070042,0.9999999999744,0.897678732855591,0,1,rRNA (uridine-N3-)-methyltransferase activity,MF,
19829,GO:2000321,0.999999999974422,0.839276479362033,0,2,positive regulation of T-helper 17 cell differentiation,BP,
19837,GO:2000330,0.999999999974422,0.839276479362033,0,2,positive regulation of T-helper 17 cell lineage commitment,BP,
11721,GO:0046554,0.999999999974425,0.918590806539734,0,1,malate dehydrogenase (NADP+) activity,MF,
2616,GO:0005927,0.999999999974426,0.910734301135103,0,1,muscle tendon junction,CC,
8648,GO:0034213,0.999999999974426,0.910734301135103,0,1,quinolinate catabolic process,BP,
11853,GO:0046874,0.999999999974426,0.910734301135103,0,1,quinolinate metabolic process,BP,
1351,GO:0003221,0.999999999974456,0.872950692228957,0,1,right ventricular cardiac muscle tissue morphogenesis,BP,
1354,GO:0003226,0.999999999974456,0.872950692228957,0,1,right ventricular compact myocardium morphogenesis,BP,
6364,GO:0021553,0.999999999974456,0.872950692228957,0,1,olfactory nerve development,BP,
8208,GO:0032977,0.999999999974465,0.882151650797376,0,1,membrane insertase activity,MF,
8209,GO:0032978,0.999999999974465,0.882151650797376,0,1,protein insertion into membrane from inner side,BP,
8210,GO:0032979,0.999999999974465,0.882151650797376,0,1,protein insertion into mitochondrial membrane from inner side,BP,
18917,GO:1904691,0.999999999974466,0.901588685851494,0,1,negative regulation of type B pancreatic cell proliferation,BP,
4611,GO:0010731,0.999999999974504,0.900719201715563,0,1,protein glutathionylation,BP,
4612,GO:0010732,0.999999999974504,0.900719201715563,0,1,regulation of protein glutathionylation,BP,
4613,GO:0010734,0.999999999974504,0.900719201715563,0,1,negative regulation of protein glutathionylation,BP,
1649,GO:0004103,0.999999999974517,0.817494044079113,0,2,choline kinase activity,MF,
20181,GO:2001070,0.999999999974524,0.792188907243941,0,2,starch binding,MF,
601,GO:0001770,0.999999999974574,0.878549335828274,0,1,establishment of natural killer cell polarity,BP,
17981,GO:1902464,0.999999999974576,0.882799554778111,0,1,regulation of histone H3-K27 trimethylation,BP,
17982,GO:1902466,0.999999999974576,0.882799554778111,0,1,positive regulation of histone H3-K27 trimethylation,BP,
8639,GO:0034196,0.999999999974582,0.900146405166726,0,1,acylglycerol transport,BP,
8640,GO:0034197,0.999999999974582,0.900146405166726,0,1,triglyceride transport,BP,
10857,GO:0044395,0.999999999974582,0.900146405166726,0,1,protein targeting to vacuolar membrane,BP,
17477,GO:1900483,0.999999999974582,0.900146405166726,0,1,regulation of protein targeting to vacuolar membrane,BP,
8859,GO:0034673,0.999999999974607,0.773630921546641,0,2,inhibin-betaglycan-ActRII complex,CC,
17593,GO:1901301,0.999999999974644,0.793350741286673,0,2,regulation of cargo loading into COPII-coated vesicle,BP,
16866,GO:0098829,0.99999999997467,0.879107532594768,0,1,intestinal folate absorption,BP,
18822,GO:1904447,0.99999999997467,0.879107532594768,0,1,folic acid import across plasma membrane,BP,
2274,GO:0005219,0.999999999974673,0.933030257616249,0,1,ryanodine-sensitive calcium-release channel activity,MF,
14591,GO:0070176,0.999999999974681,0.905137546096588,0,1,DRM complex,CC,
7242,GO:0031208,0.999999999974688,0.791135197541355,0,2,POZ domain binding,MF,
14239,GO:0061317,0.999999999974711,0.815165136501719,0,2,canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,BP,
17587,GO:1901295,0.999999999974711,0.815165136501719,0,2,regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,BP,
19101,GO:1905066,0.999999999974711,0.815165136501719,0,2,regulation of canonical Wnt signaling pathway involved in heart development,BP,
2164,GO:0005000,0.999999999974719,0.791097614954851,0,2,vasopressin receptor activity,MF,
5398,GO:0016237,0.999999999974738,0.88046639950161,0,1,lysosomal microautophagy,BP,
6224,GO:0019778,0.999999999974738,0.88046639950161,0,1,Atg12 activating enzyme activity,MF,
6225,GO:0019779,0.999999999974738,0.88046639950161,0,1,Atg8 activating enzyme activity,MF,
8894,GO:0034727,0.999999999974738,0.88046639950161,0,1,piecemeal microautophagy of the nucleus,BP,
9750,GO:0039521,0.999999999974738,0.88046639950161,0,1,suppression by virus of host autophagy,BP,
2025,GO:0004766,0.999999999974742,0.919761543773598,0,1,spermidine synthase activity,MF,
11507,GO:0046038,0.999999999974825,0.914723588922612,0,1,GMP catabolic process,BP,
13365,GO:0052657,0.999999999974825,0.914723588922612,0,1,guanine phosphoribosyltransferase activity,MF,
2306,GO:0005294,0.999999999974852,0.874685348943471,0,1,neutral L-amino acid secondary active transmembrane transporter activity,MF,
5083,GO:0015327,0.999999999974852,0.874685348943471,0,1,cystine:glutamate antiporter activity,MF,
5084,GO:0015328,0.999999999974852,0.874685348943471,0,1,cystine secondary active transmembrane transporter activity,MF,
17723,GO:1901680,0.999999999974852,0.874685348943471,0,1,sulfur-containing amino acid secondary active transmembrane transporter activity,MF,
7697,GO:0032184,0.999999999974877,0.624355005639288,0,4,SUMO polymer binding,MF,
8644,GO:0034203,0.999999999974896,0.880201442775942,0,1,glycolipid translocation,BP,
13973,GO:0060709,0.999999999974907,0.899029818905691,0,1,glycogen cell differentiation involved in embryonic placenta development,BP,
17085,GO:0100002,0.999999999974907,0.899029818905691,0,1,negative regulation of protein kinase activity by protein phosphorylation,BP,
9433,GO:0036022,0.999999999974922,0.808126251321934,0,2,limb joint morphogenesis,BP,
9434,GO:0036023,0.999999999974922,0.808126251321934,0,2,embryonic skeletal limb joint morphogenesis,BP,
1893,GO:0004578,0.999999999974927,0.886862132208769,0,1,chitobiosyldiphosphodolichol beta-mannosyltransferase activity,MF,
6047,GO:0019187,0.999999999974927,0.886862132208769,0,1,beta-1,4-mannosyltransferase activity,MF,
12743,GO:0051032,0.999999999974927,0.886862132208769,0,1,nucleic acid transmembrane transporter activity,MF,
12744,GO:0051033,0.999999999974927,0.886862132208769,0,1,RNA transmembrane transporter activity,MF,
18913,GO:1904685,0.999999999974931,0.793276495363065,0,2,positive regulation of metalloendopeptidase activity,BP,
17278,GO:0140074,0.99999999997494,0.880068063819309,0,1,cardiac endothelial to mesenchymal transition,BP,
14013,GO:0060764,0.999999999975027,0.80776539834177,0,2,cell-cell signaling involved in mammary gland development,BP,
8041,GO:0032707,0.99999999997506,0.900642862387302,0,1,negative regulation of interleukin-23 production,BP,
12019,GO:0047747,0.99999999997506,0.900642862387302,0,1,cholate-CoA ligase activity,MF,
16378,GO:0097018,0.999999999975076,0.900343258179097,0,1,renal albumin absorption,BP,
17385,GO:1900141,0.999999999975076,0.900343258179097,0,1,regulation of oligodendrocyte apoptotic process,BP,
17386,GO:1900142,0.999999999975076,0.900343258179097,0,1,negative regulation of oligodendrocyte apoptotic process,BP,
19939,GO:2000532,0.999999999975076,0.900343258179097,0,1,regulation of renal albumin absorption,BP,
19940,GO:2000533,0.999999999975076,0.900343258179097,0,1,negative regulation of renal albumin absorption,BP,
15176,GO:0071344,0.99999999997508,0.835491350816769,0,2,diphosphate metabolic process,BP,
3528,GO:0007509,0.999999999975102,0.879049013896026,0,1,mesoderm migration involved in gastrulation,BP,
3622,GO:0008078,0.999999999975102,0.879049013896026,0,1,mesodermal cell migration,BP,
99,GO:0000210,0.999999999975115,0.892469138125387,0,1,NAD+ diphosphatase activity,MF,
3146,GO:0006742,0.999999999975115,0.892469138125387,0,1,NADP catabolic process,BP,
6114,GO:0019364,0.999999999975115,0.892469138125387,0,1,pyridine nucleotide catabolic process,BP,
6196,GO:0019677,0.999999999975115,0.892469138125387,0,1,NAD catabolic process,BP,
17818,GO:1902010,0.999999999975115,0.892469138125387,0,1,negative regulation of translation in response to endoplasmic reticulum stress,BP,
3133,GO:0006722,0.99999999997516,0.900556712140583,0,1,triterpenoid metabolic process,BP,
6212,GO:0019742,0.99999999997516,0.900556712140583,0,1,pentacyclic triterpenoid metabolic process,BP,
19038,GO:1904924,0.99999999997516,0.900556712140583,0,1,negative regulation of mitophagy in response to mitochondrial depolarization,BP,
19212,GO:1905370,0.99999999997516,0.900556712140583,0,1,serine-type endopeptidase complex,CC,
7095,GO:0030899,0.999999999975171,0.931243523223468,0,1,calcium-dependent ATPase activity,MF,
7384,GO:0031444,0.999999999975171,0.931243523223468,0,1,slow-twitch skeletal muscle fiber contraction,BP,
3723,GO:0008251,0.999999999975208,0.791098664686961,0,2,tRNA-specific adenosine deaminase activity,MF,
13207,GO:0051892,0.99999999997523,0.883892851031749,0,1,negative regulation of cardioblast differentiation,BP,
20036,GO:2000690,0.99999999997523,0.883892851031749,0,1,regulation of cardiac muscle cell myoblast differentiation,BP,
20037,GO:2000691,0.99999999997523,0.883892851031749,0,1,negative regulation of cardiac muscle cell myoblast differentiation,BP,
13963,GO:0060697,0.999999999975258,0.899456181776942,0,1,positive regulation of phospholipid catabolic process,BP,
17396,GO:1900161,0.999999999975258,0.899456181776942,0,1,regulation of phospholipid scramblase activity,BP,
17397,GO:1900163,0.999999999975258,0.899456181776942,0,1,positive regulation of phospholipid scramblase activity,BP,
20066,GO:2000752,0.999999999975258,0.899456181776942,0,1,regulation of glucosylceramide catabolic process,BP,
20067,GO:2000753,0.999999999975258,0.899456181776942,0,1,positive regulation of glucosylceramide catabolic process,BP,
20068,GO:2000754,0.999999999975258,0.899456181776942,0,1,regulation of sphingomyelin catabolic process,BP,
20069,GO:2000755,0.999999999975258,0.899456181776942,0,1,positive regulation of sphingomyelin catabolic process,BP,
10643,GO:0043739,0.999999999975314,0.895448490120116,0,1,G/U mismatch-specific uracil-DNA glycosylase activity,MF,
8517,GO:0033768,0.999999999975322,0.806267255184885,0,2,SUMO-targeted ubiquitin ligase complex,CC,
1240,GO:0002940,0.999999999975325,0.810100607745033,0,2,tRNA N2-guanine methylation,BP,
18037,GO:1902612,0.999999999975357,0.899656286795811,0,1,regulation of anti-Mullerian hormone signaling pathway,BP,
18038,GO:1902613,0.999999999975357,0.899656286795811,0,1,negative regulation of anti-Mullerian hormone signaling pathway,BP,
19470,GO:1990262,0.999999999975357,0.899656286795811,0,1,anti-Mullerian hormone signaling pathway,BP,
15048,GO:0071031,0.999999999975372,0.833757930445021,0,2,nuclear mRNA surveillance of mRNA 3'-end processing,BP,
15060,GO:0071049,0.999999999975372,0.833757930445021,0,2,nuclear retention of pre-mRNA with aberrant 3'-ends at the site of transcription,BP,
3857,GO:0008478,0.999999999975379,0.878228342355031,0,1,pyridoxal kinase activity,MF,
4242,GO:0009443,0.999999999975379,0.878228342355031,0,1,pyridoxal 5'-phosphate salvage,BP,
16970,GO:0099073,0.999999999975391,0.789311289351806,0,2,mitochondrion-derived vesicle,CC,
9054,GO:0035299,0.999999999975394,0.882818391330479,0,1,inositol pentakisphosphate 2-kinase activity,MF,
1833,GO:0004490,0.999999999975397,0.909578829685825,0,1,methylglutaconyl-CoA hydratase activity,MF,
12417,GO:0050011,0.999999999975397,0.909578829685825,0,1,itaconyl-CoA hydratase activity,MF,
8835,GO:0034640,0.999999999975398,0.895690376063559,0,1,establishment of mitochondrion localization by microtubule attachment,BP,
16985,GO:0099098,0.999999999975398,0.895690376063559,0,1,microtubule polymerization based movement,BP,
14966,GO:0070899,0.999999999975424,0.897958041732796,0,1,mitochondrial tRNA wobble uridine modification,BP,
3184,GO:0006808,0.999999999975444,0.835655011435385,0,2,regulation of nitrogen utilization,BP,
11779,GO:0046666,0.999999999975444,0.835655011435385,0,2,retinal cell programmed cell death,BP,
9651,GO:0038018,0.99999999997545,0.775291066311985,0,2,Wnt receptor catabolic process,BP,
16213,GO:0090284,0.999999999975489,0.878385204384127,0,1,positive regulation of protein glycosylation in Golgi,BP,
17193,GO:0106073,0.999999999975512,0.783668085484202,0,2,dolichyl pyrophosphate Glc2Man9GlcNAc2 alpha-1,2-glucosyltransferase activity,MF,
16897,GO:0098886,0.999999999975512,0.791109420905543,0,2,modification of dendritic spine,BP,
14374,GO:0061646,0.999999999975513,0.880542314583977,0,1,positive regulation of glutamate neurotransmitter secretion in response to membrane depolarization,BP,
17742,GO:1901740,0.999999999975532,0.90296386793359,0,1,negative regulation of myoblast fusion,BP,
18618,GO:1903943,0.999999999975532,0.90296386793359,0,1,regulation of hepatocyte apoptotic process,BP,
18619,GO:1903944,0.999999999975532,0.90296386793359,0,1,negative regulation of hepatocyte apoptotic process,BP,
19578,GO:1990729,0.999999999975532,0.90296386793359,0,1,primary miRNA modification,BP,
19586,GO:1990744,0.999999999975532,0.90296386793359,0,1,primary miRNA methylation,BP,
14455,GO:0061851,0.99999999997554,0.899764646251146,0,1,leading edge of lamellipodium,CC,
18774,GO:1904328,0.99999999997554,0.899764646251146,0,1,regulation of myofibroblast contraction,BP,
19596,GO:1990764,0.99999999997554,0.899764646251146,0,1,myofibroblast contraction,BP,
14435,GO:0061792,0.999999999975541,0.879404986634474,0,1,secretory granule maturation,BP,
19528,GO:1990502,0.999999999975541,0.879404986634474,0,1,dense core granule maturation,BP,
15393,GO:0071678,0.999999999975549,0.877843797071025,0,1,olfactory bulb axon guidance,BP,
10744,GO:0044194,0.999999999975567,0.732321954823254,0,3,cytolytic granule,CC,
16455,GO:0097158,0.999999999975581,0.908287397082531,0,1,pre-mRNA intronic pyrimidine-rich binding,MF,
18588,GO:1903893,0.999999999975595,0.900362042164602,0,1,positive regulation of ATF6-mediated unfolded protein response,BP,
17203,GO:0106104,0.999999999975646,0.790840913411121,0,2,regulation of glutamate receptor clustering,BP,
18932,GO:1904717,0.999999999975646,0.790840913411121,0,2,regulation of AMPA glutamate receptor clustering,BP,
15919,GO:0072749,0.999999999975654,0.904972868795987,0,1,cellular response to cytochalasin B,BP,
16918,GO:0098918,0.999999999975654,0.904972868795987,0,1,structural constituent of synapse,MF,
16942,GO:0098973,0.999999999975654,0.904972868795987,0,1,structural constituent of postsynaptic actin cytoskeleton,MF,
16943,GO:0098974,0.999999999975654,0.904972868795987,0,1,postsynaptic actin cytoskeleton organization,BP,
17004,GO:0099186,0.999999999975654,0.904972868795987,0,1,structural constituent of postsynapse,MF,
17005,GO:0099188,0.999999999975654,0.904972868795987,0,1,postsynaptic cytoskeleton organization,BP,
17602,GO:1901328,0.999999999975654,0.904972868795987,0,1,response to cytochalasin B,BP,
7801,GO:0032358,0.999999999975683,0.939556622259248,0,1,oxidized pyrimidine DNA binding,MF,
14299,GO:0061481,0.999999999975683,0.939556622259248,0,1,response to TNF agonist,BP,
18010,GO:1902546,0.999999999975683,0.939556622259248,0,1,positive regulation of DNA N-glycosylase activity,BP,
20270,GO:2001272,0.999999999975683,0.939556622259248,0,1,positive regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis,BP,
9308,GO:0035790,0.999999999975698,0.887959015983072,0,1,platelet-derived growth factor receptor-alpha signaling pathway,BP,
19966,GO:2000583,0.999999999975698,0.887959015983072,0,1,regulation of platelet-derived growth factor receptor-alpha signaling pathway,BP,
19967,GO:2000584,0.999999999975698,0.887959015983072,0,1,negative regulation of platelet-derived growth factor receptor-alpha signaling pathway,BP,
15794,GO:0072513,0.999999999975741,0.941436656692072,0,1,positive regulation of secondary heart field cardioblast proliferation,BP,
19216,GO:1905384,0.999999999975782,0.814742115172962,0,2,regulation of protein localization to presynapse,BP,
19217,GO:1905386,0.999999999975782,0.814742115172962,0,2,positive regulation of protein localization to presynapse,BP,
16295,GO:0090500,0.999999999975789,0.815672256174464,0,2,endocardial cushion to mesenchymal transition,BP,
18931,GO:1904716,0.999999999975817,0.90065031919946,0,1,positive regulation of chaperone-mediated autophagy,BP,
3973,GO:0008794,0.999999999975829,0.935997879389304,0,1,arsenate reductase (glutaredoxin) activity,MF,
6952,GO:0030611,0.999999999975829,0.935997879389304,0,1,arsenate reductase activity,MF,
4080,GO:0009136,0.99999999997583,0.839706181635777,0,2,purine nucleoside diphosphate biosynthetic process,BP,
4119,GO:0009180,0.99999999997583,0.839706181635777,0,2,purine ribonucleoside diphosphate biosynthetic process,BP,
4127,GO:0009188,0.99999999997583,0.839706181635777,0,2,ribonucleoside diphosphate biosynthetic process,BP,
18115,GO:1902856,0.999999999975847,0.783715043449362,0,2,negative regulation of non-motile cilium assembly,BP,
17149,GO:0102773,0.999999999975853,0.882555932016544,0,1,dihydroceramide kinase activity,MF,
12140,GO:0048264,0.99999999997587,0.897922787946911,0,1,determination of ventral identity,BP,
20260,GO:2001253,0.99999999997587,0.897922787946911,0,1,regulation of histone H3-K36 trimethylation,BP,
14313,GO:0061519,0.99999999997588,0.891112672122612,0,1,macrophage homeostasis,BP,
1431,GO:0003408,0.999999999975891,0.771416086269663,0,2,optic cup formation involved in camera-type eye development,BP,
3043,GO:0006597,0.999999999975899,0.81213113791797,0,2,spermine biosynthetic process,BP,
10677,GO:0043969,0.999999999975933,0.876262886755174,0,1,histone H2B acetylation,BP,
14471,GO:0061920,0.999999999975933,0.876262886755174,0,1,protein propionyltransferase activity,MF,
14472,GO:0061921,0.999999999975933,0.876262886755174,0,1,peptidyl-lysine propionylation,BP,
17272,GO:0140064,0.999999999975933,0.876262886755174,0,1,peptide crotonyltransferase activity,MF,
17273,GO:0140065,0.999999999975933,0.876262886755174,0,1,peptide butyryltransferase activity,MF,
17275,GO:0140067,0.999999999975933,0.876262886755174,0,1,peptidyl-lysine butyrylation,BP,
17276,GO:0140068,0.999999999975933,0.876262886755174,0,1,histone crotonyltransferase activity,MF,
17277,GO:0140069,0.999999999975933,0.876262886755174,0,1,histone butyryltransferase activity,MF,
17087,GO:0100057,0.999999999975956,0.877944386269498,0,1,regulation of phenotypic switching by transcription from RNA polymerase II promoter,BP,
18986,GO:1904826,0.999999999975956,0.877944386269498,0,1,regulation of hydrogen sulfide biosynthetic process,BP,
18987,GO:1904828,0.999999999975956,0.877944386269498,0,1,positive regulation of hydrogen sulfide biosynthetic process,BP,
18572,GO:1903850,0.999999999976003,0.899962902834047,0,1,regulation of cristae formation,BP,
18573,GO:1903852,0.999999999976003,0.899962902834047,0,1,positive regulation of cristae formation,BP,
18855,GO:1904542,0.999999999976003,0.899962902834047,0,1,regulation of free ubiquitin chain polymerization,BP,
18856,GO:1904544,0.999999999976003,0.899962902834047,0,1,positive regulation of free ubiquitin chain polymerization,BP,
19016,GO:1904881,0.999999999976003,0.899962902834047,0,1,cellular response to hydrogen sulfide,BP,
2003,GO:0004729,0.999999999976016,0.90609313476362,0,1,oxygen-dependent protoporphyrinogen oxidase activity,MF,
14913,GO:0070818,0.999999999976016,0.90609313476362,0,1,protoporphyrinogen oxidase activity,MF,
8391,GO:0033342,0.999999999976036,0.900305290708678,0,1,negative regulation of collagen binding,BP,
5749,GO:0016900,0.999999999976051,0.864598672138862,0,2,oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor,MF,
11936,GO:0047057,0.999999999976051,0.864598672138862,0,2,vitamin-K-epoxide reductase (warfarin-sensitive) activity,MF,
1538,GO:0003933,0.999999999976076,0.90303344105321,0,1,GTP cyclohydrolase activity,MF,
1539,GO:0003934,0.999999999976076,0.90303344105321,0,1,GTP cyclohydrolase I activity,MF,
9417,GO:0035998,0.999999999976076,0.90303344105321,0,1,7,8-dihydroneopterin 3'-triphosphate biosynthetic process,BP,
15257,GO:0071460,0.999999999976096,0.85091848831841,0,2,cellular response to cell-matrix adhesion,BP,
16099,GO:0090108,0.999999999976136,0.901974431761218,0,1,positive regulation of high-density lipoprotein particle assembly,BP,
16146,GO:0090187,0.999999999976136,0.901974431761218,0,1,positive regulation of pancreatic juice secretion,BP,
16253,GO:0090340,0.999999999976136,0.901974431761218,0,1,positive regulation of secretion of lysosomal enzymes,BP,
457,GO:0001306,0.999999999976139,0.930540460601289,0,1,age-dependent response to oxidative stress,BP,
458,GO:0001315,0.999999999976139,0.930540460601289,0,1,age-dependent response to reactive oxygen species,BP,
1272,GO:0003068,0.999999999976139,0.930540460601289,0,1,regulation of systemic arterial blood pressure by acetylcholine,BP,
1273,GO:0003069,0.999999999976139,0.930540460601289,0,1,acetylcholine-mediated vasodilation involved in regulation of systemic arterial blood pressure,BP,
1274,GO:0003070,0.999999999976139,0.930540460601289,0,1,regulation of systemic arterial blood pressure by neurotransmitter,BP,
3547,GO:0007571,0.999999999976139,0.930540460601289,0,1,age-dependent general metabolic decline,BP,
19672,GO:2000015,0.999999999976143,0.751163043783089,0,3,regulation of determination of dorsal identity,BP,
3816,GO:0008413,0.999999999976167,0.853950352308212,0,2,8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity,MF,
9164,GO:0035539,0.999999999976167,0.853950352308212,0,2,8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity,MF,
1487,GO:0003827,0.999999999976187,0.807968421354159,0,2,alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity,MF,
1691,GO:0004168,0.999999999976218,0.901220746962503,0,1,dolichol kinase activity,MF,
10283,GO:0043048,0.999999999976218,0.901220746962503,0,1,dolichyl monophosphate biosynthetic process,BP,
12074,GO:0048058,0.999999999976219,0.894622938609488,0,1,compound eye corneal lens development,BP,
12350,GO:0048749,0.999999999976219,0.894622938609488,0,1,compound eye development,BP,
7545,GO:0031867,0.999999999976254,0.888042688965091,0,1,EP4 subtype prostaglandin E2 receptor binding,MF,
3135,GO:0006726,0.999999999976254,0.880878678575092,0,1,eye pigment biosynthetic process,BP,
5371,GO:0016182,0.999999999976254,0.880878678575092,0,1,synaptic vesicle budding from endosome,BP,
10001,GO:0042441,0.999999999976254,0.880878678575092,0,1,eye pigment metabolic process,BP,
10450,GO:0043324,0.999999999976254,0.880878678575092,0,1,pigment metabolic process involved in developmental pigmentation,BP,
10519,GO:0043474,0.999999999976254,0.880878678575092,0,1,pigment metabolic process involved in pigmentation,BP,
16867,GO:0098830,0.999999999976254,0.880878678575092,0,1,presynaptic endosome,CC,
17327,GO:1900036,0.999999999976257,0.900731485658934,0,1,positive regulation of cellular response to heat,BP,
3788,GO:0008355,0.999999999976275,0.882812103625389,0,1,olfactory learning,BP,
2159,GO:0004992,0.999999999976276,0.884840901972719,0,1,platelet activating factor receptor activity,MF,
4992,GO:0015130,0.999999999976276,0.884840901972719,0,1,mevalonate transmembrane transporter activity,MF,
5172,GO:0015728,0.999999999976276,0.884840901972719,0,1,mevalonate transport,BP,
10443,GO:0043315,0.999999999976276,0.884840901972719,0,1,positive regulation of neutrophil degranulation,BP,
13154,GO:0051780,0.999999999976276,0.884840901972719,0,1,behavioral response to nutrient,BP,
15128,GO:0071258,0.999999999976276,0.884840901972719,0,1,cellular response to gravity,BP,
18020,GO:1902565,0.999999999976276,0.884840901972719,0,1,positive regulation of neutrophil activation,BP,
18153,GO:1902941,0.999999999976276,0.884840901972719,0,1,regulation of voltage-gated chloride channel activity,BP,
18154,GO:1902943,0.999999999976276,0.884840901972719,0,1,positive regulation of voltage-gated chloride channel activity,BP,
18548,GO:1903797,0.999999999976276,0.884840901972719,0,1,positive regulation of inorganic anion transmembrane transport,BP,
18761,GO:1904298,0.999999999976276,0.884840901972719,0,1,regulation of transcytosis,BP,
18762,GO:1904300,0.999999999976276,0.884840901972719,0,1,positive regulation of transcytosis,BP,
18763,GO:1904301,0.999999999976276,0.884840901972719,0,1,regulation of maternal process involved in parturition,BP,
18764,GO:1904303,0.999999999976276,0.884840901972719,0,1,positive regulation of maternal process involved in parturition,BP,
18769,GO:1904316,0.999999999976276,0.884840901972719,0,1,response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine,BP,
18770,GO:1904317,0.999999999976276,0.884840901972719,0,1,cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine,BP,
12813,GO:0051140,0.999999999976283,0.860050976625186,0,2,regulation of NK T cell proliferation,BP,
12814,GO:0051142,0.999999999976283,0.860050976625186,0,2,positive regulation of NK T cell proliferation,BP,
13106,GO:0051673,0.999999999976295,0.823080882564846,0,2,membrane disruption in other organism,BP,
20104,GO:2000812,0.999999999976314,0.887534485544257,0,1,regulation of barbed-end actin filament capping,BP,
15989,GO:0086020,0.999999999976335,0.786961439272762,0,2,gap junction channel activity involved in SA node cell-atrial cardiac muscle cell electrical coupling,MF,
15990,GO:0086021,0.999999999976335,0.786961439272762,0,2,SA node cell to atrial cardiac muscle cell communication by electrical coupling,BP,
16008,GO:0086053,0.999999999976335,0.786961439272762,0,2,AV node cell to bundle of His cell communication by electrical coupling,BP,
16024,GO:0086077,0.999999999976335,0.786961439272762,0,2,gap junction channel activity involved in AV node cell-bundle of His cell electrical coupling,MF,
18312,GO:1903294,0.999999999976344,0.781122659083238,0,2,regulation of glutamate secretion, neurotransmission,BP,
18313,GO:1903296,0.999999999976344,0.781122659083238,0,2,positive regulation of glutamate secretion, neurotransmission,BP,
858,GO:0002191,0.999999999976355,0.717934363425659,0,3,cap-dependent translational initiation,BP,
14120,GO:0061010,0.999999999976358,0.873654715200837,0,1,gall bladder development,BP,
14432,GO:0061780,0.999999999976358,0.873654715200837,0,1,mitotic cohesin loading,BP,
14795,GO:0070550,0.999999999976358,0.873654715200837,0,1,rDNA condensation,BP,
19182,GO:1905309,0.999999999976358,0.873654715200837,0,1,positive regulation of cohesin loading,BP,
19225,GO:1905405,0.999999999976358,0.873654715200837,0,1,regulation of mitotic cohesin loading,BP,
19226,GO:1905406,0.999999999976358,0.873654715200837,0,1,positive regulation of mitotic cohesin loading,BP,
2760,GO:0006172,0.999999999976391,0.900885014676359,0,1,ADP biosynthetic process,BP,
16496,GO:0097226,0.999999999976391,0.900885014676359,0,1,sperm mitochondrial sheath,CC,
3162,GO:0006772,0.999999999976405,0.905204616199897,0,1,thiamine metabolic process,BP,
9958,GO:0042357,0.999999999976405,0.905204616199897,0,1,thiamine diphosphate metabolic process,BP,
12451,GO:0050333,0.999999999976405,0.905204616199897,0,1,thiamin-triphosphatase activity,MF,
7065,GO:0030860,0.999999999976408,0.792052942315879,0,2,regulation of polarized epithelial cell differentiation,BP,
3585,GO:0007634,0.999999999976449,0.900481179646533,0,1,optokinetic behavior,BP,
14055,GO:0060876,0.999999999976449,0.900481179646533,0,1,semicircular canal formation,BP,
16195,GO:0090258,0.999999999976456,0.791593049160222,0,2,negative regulation of mitochondrial fission,BP,
3751,GO:0008294,0.999999999976456,0.867638022551072,0,1,calcium- and calmodulin-responsive adenylate cyclase activity,MF,
916,GO:0002309,0.999999999976459,0.94007553991546,0,1,T cell proliferation involved in immune response,BP,
16906,GO:0098905,0.999999999976469,0.842769205809342,0,2,regulation of bundle of His cell action potential,BP,
5454,GO:0016332,0.999999999976473,0.887188732368887,0,1,establishment or maintenance of polarity of embryonic epithelium,BP,
15566,GO:0072060,0.999999999976473,0.887188732368887,0,1,outer medullary collecting duct development,BP,
7950,GO:0032557,0.999999999976476,0.713908503352228,0,3,pyrimidine ribonucleotide binding,MF,
16246,GO:0090326,0.999999999976477,0.894894092721943,0,1,positive regulation of locomotion involved in locomotory behavior,BP,
18108,GO:1902823,0.999999999976477,0.894894092721943,0,1,negative regulation of late endosome to lysosome transport,BP,
18334,GO:1903336,0.999999999976477,0.894894092721943,0,1,negative regulation of vacuolar transport,BP,
19838,GO:2000331,0.999999999976477,0.894894092721943,0,1,regulation of terminal button organization,BP,
4695,GO:0010856,0.999999999976502,0.895013463547556,0,1,adenylate cyclase activator activity,MF,
11714,GO:0046541,0.999999999976505,0.899673060863884,0,1,saliva secretion,BP,
1588,GO:0004001,0.999999999976547,0.902095521689913,0,1,adenosine kinase activity,MF,
2001,GO:0004727,0.999999999976547,0.902095521689913,0,1,prenylated protein tyrosine phosphatase activity,MF,
2758,GO:0006169,0.999999999976547,0.902095521689913,0,1,adenosine salvage,BP,
2762,GO:0006175,0.999999999976547,0.902095521689913,0,1,dATP biosynthetic process,BP,
4606,GO:0010726,0.999999999976556,0.808791762251886,0,2,positive regulation of hydrogen peroxide metabolic process,BP,
15289,GO:0071502,0.999999999976587,0.736786347420445,0,3,cellular response to temperature stimulus,BP,
2336,GO:0005366,0.999999999976599,0.878637148424601,0,1,myo-inositol:proton symporter activity,MF,
460,GO:0001401,0.999999999976609,0.810427278357993,0,2,mitochondrial sorting and assembly machinery complex,CC,
3860,GO:0008482,0.999999999976624,0.900737004323145,0,1,sulfite oxidase activity,MF,
9857,GO:0042128,0.999999999976624,0.900737004323145,0,1,nitrate assimilation,BP,
6516,GO:0021898,0.999999999976634,0.725206194153087,0,3,commitment of multipotent stem cells to neuronal lineage in forebrain,BP,
16768,GO:0098625,0.999999999976647,0.888478270316803,0,1,methylselenol reductase activity,MF,
16769,GO:0098626,0.999999999976647,0.888478270316803,0,1,methylseleninic acid reductase activity,MF,
16889,GO:0098875,0.999999999976652,0.881175785857945,0,1,epididymosome,CC,
18099,GO:1902805,0.999999999976652,0.775445559419889,0,2,positive regulation of synaptic vesicle transport,BP,
19814,GO:2000302,0.999999999976652,0.775445559419889,0,2,positive regulation of synaptic vesicle exocytosis,BP,
8389,GO:0033328,0.999999999976704,0.890822013143361,0,1,peroxisome membrane targeting sequence binding,MF,
9464,GO:0036105,0.999999999976704,0.890822013143361,0,1,peroxisome membrane class-1 targeting sequence binding,MF,
17378,GO:1900130,0.999999999976704,0.890822013143361,0,1,regulation of lipid binding,BP,
17379,GO:1900131,0.999999999976704,0.890822013143361,0,1,negative regulation of lipid binding,BP,
8664,GO:0034247,0.999999999976707,0.919190729313606,0,1,snoRNA splicing,BP,
15437,GO:0071796,0.999999999976707,0.919190729313606,0,1,K6-linked polyubiquitin modification-dependent protein binding,MF,
16223,GO:0090297,0.999999999976721,0.919684969040485,0,1,positive regulation of mitochondrial DNA replication,BP,
17767,GO:1901860,0.999999999976721,0.919684969040485,0,1,positive regulation of mitochondrial DNA metabolic process,BP,
19413,GO:1990046,0.999999999976721,0.919684969040485,0,1,stress-induced mitochondrial fusion,BP,
1772,GO:0004379,0.999999999976728,0.775339488390315,0,2,glycylpeptide N-tetradecanoyltransferase activity,MF,
5875,GO:0018008,0.999999999976728,0.775339488390315,0,2,N-terminal peptidyl-glycine N-myristoylation,BP,
6033,GO:0019107,0.999999999976728,0.775339488390315,0,2,myristoyltransferase activity,MF,
13007,GO:0051463,0.999999999976729,0.879258483348819,0,1,negative regulation of cortisol secretion,BP,
13608,GO:0060125,0.999999999976729,0.879258483348819,0,1,negative regulation of growth hormone secretion,BP,
20151,GO:2001015,0.999999999976742,0.787404025354336,0,2,negative regulation of skeletal muscle cell differentiation,BP,
739,GO:0001971,0.999999999976771,0.877889702198386,0,1,negative regulation of activation of membrane attack complex,BP,
20160,GO:2001027,0.999999999976786,0.769897047918091,0,2,negative regulation of endothelial cell chemotaxis,BP,
2121,GO:0004917,0.999999999976787,0.905038228366527,0,1,interleukin-7 receptor activity,MF,
19152,GO:1905223,0.99999999997679,0.879208235189101,0,1,epicardium morphogenesis,BP,
13519,GO:0060001,0.999999999976798,0.8764172513175,0,1,minus-end directed microfilament motor activity,MF,
11108,GO:0045155,0.999999999976824,0.811404640938239,0,2,electron transporter, transferring electrons from CoQH2-cytochrome c reductase complex and cytochrome c oxidase complex activity,MF,
19970,GO:2000588,0.999999999976827,0.774954683121129,0,2,positive regulation of platelet-derived growth factor receptor-beta signaling pathway,BP,
4994,GO:0015136,0.999999999976828,0.894604740564168,0,1,sialic acid transmembrane transporter activity,MF,
5125,GO:0015538,0.999999999976828,0.894604740564168,0,1,sialic acid:proton symporter activity,MF,
5176,GO:0015739,0.999999999976828,0.894604740564168,0,1,sialic acid transport,BP,
2240,GO:0005151,0.9999999999769,0.796651994585139,0,2,interleukin-1, Type II receptor binding,MF,
6330,GO:0021503,0.999999999976906,0.87679453798836,0,1,neural fold bending,BP,
9131,GO:0035485,0.999999999976917,0.904436806890616,0,1,adenine/guanine mispair binding,MF,
3557,GO:0007598,0.999999999976943,0.900688612110178,0,1,blood coagulation, extrinsic pathway,BP,
17558,GO:1901202,0.999999999976943,0.900688612110178,0,1,negative regulation of extracellular matrix assembly,BP,
18364,GO:1903394,0.999999999976943,0.900688612110178,0,1,protein localization to kinetochore involved in kinetochore assembly,BP,
834,GO:0002135,0.999999999976953,0.900262110967405,0,1,CTP binding,MF,
5821,GO:0017098,0.999999999976953,0.900262110967405,0,1,sulfonylurea receptor binding,MF,
17629,GO:1901388,0.999999999976953,0.900262110967405,0,1,regulation of transforming growth factor beta activation,BP,
17630,GO:1901389,0.999999999976953,0.900262110967405,0,1,negative regulation of transforming growth factor beta activation,BP,
18485,GO:1903659,0.999999999976953,0.900262110967405,0,1,regulation of complement-dependent cytotoxicity,BP,
18486,GO:1903660,0.999999999976953,0.900262110967405,0,1,negative regulation of complement-dependent cytotoxicity,BP,
19641,GO:1990913,0.999999999976953,0.900262110967405,0,1,sperm head plasma membrane,CC,
19642,GO:1990917,0.999999999976953,0.900262110967405,0,1,ooplasm,CC,
2459,GO:0005673,0.999999999976957,0.817824851614316,0,2,transcription factor TFIIE complex,CC,
10819,GO:0044326,0.999999999976963,0.796958133070306,0,2,dendritic spine neck,CC,
5764,GO:0016941,0.99999999997697,0.893019937164454,0,1,natriuretic peptide receptor activity,MF,
13696,GO:0060283,0.99999999997697,0.893019937164454,0,1,negative regulation of oocyte development,BP,
13837,GO:0060465,0.99999999997697,0.893019937164454,0,1,pharynx development,BP,
17409,GO:1900194,0.99999999997697,0.893019937164454,0,1,negative regulation of oocyte maturation,BP,
19364,GO:1905880,0.99999999997697,0.893019937164454,0,1,negative regulation of oogenesis,BP,
18613,GO:1903929,0.999999999976972,0.896375153786287,0,1,primary palate development,BP,
1978,GO:0004698,0.99999999997698,0.876269520568244,0,1,calcium-dependent protein kinase C activity,MF,
9102,GO:0035403,0.99999999997698,0.876269520568244,0,1,histone kinase activity (H3-T6 specific),MF,
9107,GO:0035408,0.99999999997698,0.876269520568244,0,1,histone H3-T6 phosphorylation,BP,
20047,GO:2000707,0.99999999997698,0.876269520568244,0,1,positive regulation of dense core granule biogenesis,BP,
3807,GO:0008398,0.999999999976988,0.897308277238353,0,1,sterol 14-demethylase activity,MF,
8408,GO:0033488,0.999999999976988,0.897308277238353,0,1,cholesterol biosynthetic process via 24,25-dihydrolanosterol,BP,
499,GO:0001555,0.999999999977,0.807794675816677,0,2,oocyte growth,BP,
7446,GO:0031590,0.999999999977,0.807794675816677,0,2,wybutosine metabolic process,BP,
7447,GO:0031591,0.999999999977,0.807794675816677,0,2,wybutosine biosynthetic process,BP,
15641,GO:0072179,0.999999999977033,0.812490693940602,0,2,nephric duct formation,BP,
16831,GO:0098770,0.999999999977045,0.77364816763429,0,2,FBXO family protein binding,MF,
13403,GO:0052827,0.99999999997706,0.805044557591908,0,2,inositol pentakisphosphate phosphatase activity,MF,
10247,GO:0042999,0.999999999977073,0.881805888475594,0,1,regulation of Golgi to plasma membrane CFTR protein transport,BP,
10250,GO:0043002,0.999999999977073,0.881805888475594,0,1,negative regulation of Golgi to plasma membrane CFTR protein transport,BP,
10251,GO:0043004,0.999999999977073,0.881805888475594,0,1,cytoplasmic sequestering of CFTR protein,BP,
18031,GO:1902595,0.999999999977084,0.82308752277935,0,2,regulation of DNA replication origin binding,BP,
7772,GO:0032304,0.999999999977101,0.880322536029266,0,1,negative regulation of icosanoid secretion,BP,
17384,GO:1900139,0.999999999977101,0.880322536029266,0,1,negative regulation of arachidonic acid secretion,BP,
14447,GO:0061833,0.999999999977114,0.795923708763357,0,2,protein localization to tricellular tight junction,BP,
19290,GO:1905590,0.999999999977132,0.896752609931501,0,1,fibronectin fibril organization,BP,
19836,GO:2000329,0.999999999977132,0.896752609931501,0,1,negative regulation of T-helper 17 cell lineage commitment,BP,
7226,GO:0031133,0.999999999977146,0.808091525445124,0,2,regulation of axon diameter,BP,
2256,GO:0005171,0.999999999977162,0.902182716593306,0,1,hepatocyte growth factor receptor binding,MF,
10434,GO:0043305,0.999999999977164,0.815267586629751,0,2,negative regulation of mast cell degranulation,BP,
19097,GO:1905062,0.99999999997717,0.899809307814715,0,1,positive regulation of cardioblast proliferation,BP,
18177,GO:1902977,0.999999999977176,0.903378848121395,0,1,mitotic DNA replication preinitiation complex assembly,BP,
5,GO:0000011,0.999999999977196,0.898849243900945,0,1,vacuole inheritance,BP,
333,GO:0000928,0.999999999977196,0.898849243900945,0,1,gamma-tubulin small complex, spindle pole body,CC,
643,GO:0001834,0.999999999977196,0.898849243900945,0,1,trophectodermal cell proliferation,BP,
1563,GO:0003972,0.999999999977196,0.898849243900945,0,1,RNA ligase (ATP) activity,MF,
1638,GO:0004083,0.999999999977196,0.898849243900945,0,1,bisphosphoglycerate 2-phosphatase activity,MF,
2014,GO:0004743,0.999999999977196,0.898849243900945,0,1,pyruvate kinase activity,MF,
2733,GO:0006113,0.999999999977196,0.898849243900945,0,1,fermentation,BP,
2761,GO:0006174,0.999999999977196,0.898849243900945,0,1,dADP phosphorylation,BP,
2768,GO:0006186,0.999999999977196,0.898849243900945,0,1,dGDP phosphorylation,BP,
2951,GO:0006480,0.999999999977196,0.898849243900945,0,1,N-terminal protein amino acid methylation,BP,
3155,GO:0006756,0.999999999977196,0.898849243900945,0,1,AMP phosphorylation,BP,
3374,GO:0007146,0.999999999977196,0.898849243900945,0,1,meiotic recombination nodule assembly,BP,
3840,GO:0008452,0.999999999977196,0.898849243900945,0,1,RNA ligase activity,MF,
3841,GO:0008453,0.999999999977196,0.898849243900945,0,1,alanine-glyoxylate transaminase activity,MF,
3954,GO:0008700,0.999999999977196,0.898849243900945,0,1,4-hydroxy-2-oxoglutarate aldolase activity,MF,
3972,GO:0008792,0.999999999977196,0.898849243900945,0,1,arginine decarboxylase activity,MF,
4103,GO:0009159,0.999999999977196,0.898849243900945,0,1,deoxyribonucleoside monophosphate catabolic process,BP,
4236,GO:0009436,0.999999999977196,0.898849243900945,0,1,glyoxylate catabolic process,BP,
4428,GO:0010260,0.999999999977196,0.898849243900945,0,1,animal organ senescence,BP,
4442,GO:0010348,0.999999999977196,0.898849243900945,0,1,lithium:proton antiporter activity,MF,
4814,GO:0014011,0.999999999977196,0.898849243900945,0,1,Schwann cell proliferation involved in axon regeneration,BP,
5030,GO:0015203,0.999999999977196,0.898849243900945,0,1,polyamine transmembrane transporter activity,MF,
5067,GO:0015292,0.999999999977196,0.898849243900945,0,1,uniporter activity,MF,
5120,GO:0015489,0.999999999977196,0.898849243900945,0,1,putrescine transmembrane transporter activity,MF,
5230,GO:0015847,0.999999999977196,0.898849243900945,0,1,putrescine transport,BP,
5492,GO:0016430,0.999999999977196,0.898849243900945,0,1,tRNA (adenine-N6-)-methyltransferase activity,MF,
5576,GO:0016596,0.999999999977196,0.898849243900945,0,1,thienylcyclohexylpiperidine binding,MF,
5709,GO:0016843,0.999999999977196,0.898849243900945,0,1,amine-lyase activity,MF,
5710,GO:0016844,0.999999999977196,0.898849243900945,0,1,strictosidine synthase activity,MF,
5814,GO:0017082,0.999999999977196,0.898849243900945,0,1,mineralocorticoid receptor activity,MF,
5866,GO:0017178,0.999999999977196,0.898849243900945,0,1,diphthine-ammonia ligase activity,MF,
5877,GO:0018011,0.999999999977196,0.898849243900945,0,1,N-terminal peptidyl-alanine methylation,BP,
5878,GO:0018012,0.999999999977196,0.898849243900945,0,1,N-terminal peptidyl-alanine trimethylation,BP,
5879,GO:0018013,0.999999999977196,0.898849243900945,0,1,N-terminal peptidyl-glycine methylation,BP,
5880,GO:0018016,0.999999999977196,0.898849243900945,0,1,N-terminal peptidyl-proline dimethylation,BP,
5884,GO:0018025,0.999999999977196,0.898849243900945,0,1,calmodulin-lysine N-methyltransferase activity,MF,
5916,GO:0018194,0.999999999977196,0.898849243900945,0,1,peptidyl-alanine modification,BP,
6189,GO:0019659,0.999999999977196,0.898849243900945,0,1,glucose catabolic process to lactate,BP,
6190,GO:0019660,0.999999999977196,0.898849243900945,0,1,glycolytic fermentation,BP,
6191,GO:0019661,0.999999999977196,0.898849243900945,0,1,glucose catabolic process to lactate via pyruvate,BP,
6192,GO:0019666,0.999999999977196,0.898849243900945,0,1,nitrogenous compound fermentation,BP,
6237,GO:0019799,0.999999999977196,0.898849243900945,0,1,tubulin N-acetyltransferase activity,MF,
6321,GO:0020003,0.999999999977196,0.898849243900945,0,1,symbiont-containing vacuole,CC,
6806,GO:0030264,0.999999999977196,0.898849243900945,0,1,nuclear fragmentation involved in apoptotic nuclear change,BP,
6895,GO:0030474,0.999999999977196,0.898849243900945,0,1,spindle pole body duplication,BP,
6967,GO:0030629,0.999999999977196,0.898849243900945,0,1,U6 snRNA 3'-end binding,MF,
7013,GO:0030735,0.999999999977196,0.898849243900945,0,1,carnosine N-methyltransferase activity,MF,
7126,GO:0030961,0.999999999977196,0.898849243900945,0,1,peptidyl-arginine hydroxylation,BP,
7656,GO:0032093,0.999999999977196,0.898849243900945,0,1,SAM domain binding,MF,
7736,GO:0032253,0.999999999977196,0.898849243900945,0,1,dense core granule localization,BP,
8459,GO:0033609,0.999999999977196,0.898849243900945,0,1,oxalate metabolic process,BP,
8700,GO:0034353,0.999999999977196,0.898849243900945,0,1,RNA pyrophosphohydrolase activity,MF,
8782,GO:0034477,0.999999999977196,0.898849243900945,0,1,U6 snRNA 3'-end processing,BP,
8796,GO:0034512,0.999999999977196,0.898849243900945,0,1,box C/D snoRNA binding,MF,
8940,GO:0034998,0.999999999977196,0.898849243900945,0,1,oligosaccharyltransferase I complex,CC,
9137,GO:0035498,0.999999999977196,0.898849243900945,0,1,carnosine metabolic process,BP,
9177,GO:0035568,0.999999999977196,0.898849243900945,0,1,N-terminal peptidyl-proline methylation,BP,
9178,GO:0035570,0.999999999977196,0.898849243900945,0,1,N-terminal peptidyl-serine methylation,BP,
9179,GO:0035572,0.999999999977196,0.898849243900945,0,1,N-terminal peptidyl-serine dimethylation,BP,
9180,GO:0035573,0.999999999977196,0.898849243900945,0,1,N-terminal peptidyl-serine trimethylation,BP,
9544,GO:0036317,0.999999999977196,0.898849243900945,0,1,tyrosyl-RNA phosphodiesterase activity,MF,
9866,GO:0042140,0.999999999977196,0.898849243900945,0,1,late meiotic recombination nodule assembly,BP,
10169,GO:0042774,0.999999999977196,0.898849243900945,0,1,plasma membrane ATP synthesis coupled electron transport,BP,
10187,GO:0042806,0.999999999977196,0.898849243900945,0,1,fucose binding,MF,
10224,GO:0042946,0.999999999977196,0.898849243900945,0,1,glucoside transport,BP,
10225,GO:0042947,0.999999999977196,0.898849243900945,0,1,glucoside transmembrane transporter activity,MF,
10514,GO:0043465,0.999999999977196,0.898849243900945,0,1,regulation of fermentation,BP,
10821,GO:0044328,0.999999999977196,0.898849243900945,0,1,canonical Wnt signaling pathway involved in positive regulation of endothelial cell migration,BP,
10822,GO:0044329,0.999999999977196,0.898849243900945,0,1,canonical Wnt signaling pathway involved in positive regulation of cell-cell adhesion,BP,
10823,GO:0044330,0.999999999977196,0.898849243900945,0,1,canonical Wnt signaling pathway involved in positive regulation of wound healing,BP,
10938,GO:0044648,0.999999999977196,0.898849243900945,0,1,histone H3-K4 dimethylation,BP,
10956,GO:0044732,0.999999999977196,0.898849243900945,0,1,mitotic spindle pole body,CC,
10957,GO:0044736,0.999999999977196,0.898849243900945,0,1,acid-sensing ion channel activity,MF,
11124,GO:0045183,0.999999999977196,0.898849243900945,0,1,translation factor activity, non-nucleic acid binding,MF,
11579,GO:0046176,0.999999999977196,0.898849243900945,0,1,aldonic acid catabolic process,BP,
11580,GO:0046177,0.999999999977196,0.898849243900945,0,1,D-gluconate catabolic process,BP,
11598,GO:0046316,0.999999999977196,0.898849243900945,0,1,gluconokinase activity,MF,
11814,GO:0046745,0.999999999977196,0.898849243900945,0,1,viral capsid secondary envelopment,BP,
11924,GO:0046996,0.999999999977196,0.898849243900945,0,1,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, with NAD(P)H as one donor, and the other dehydrogenated,MF,
11929,GO:0047017,0.999999999977196,0.898849243900945,0,1,prostaglandin-F synthase activity,MF,
12018,GO:0047734,0.999999999977196,0.898849243900945,0,1,CDP-glycerol diphosphatase activity,MF,
12420,GO:0050046,0.999999999977196,0.898849243900945,0,1,lathosterol oxidase activity,MF,
12429,GO:0050144,0.999999999977196,0.898849243900945,0,1,nucleoside deoxyribosyltransferase activity,MF,
12453,GO:0050346,0.999999999977196,0.898849243900945,0,1,trans-L-3-hydroxyproline dehydratase activity,MF,
12677,GO:0050915,0.999999999977196,0.898849243900945,0,1,sensory perception of sour taste,BP,
12921,GO:0051300,0.999999999977196,0.898849243900945,0,1,spindle pole body organization,BP,
12929,GO:0051308,0.999999999977196,0.898849243900945,0,1,male meiosis chromosome separation,BP,
12979,GO:0051417,0.999999999977196,0.898849243900945,0,1,microtubule nucleation by spindle pole body,BP,
13110,GO:0051685,0.999999999977196,0.898849243900945,0,1,maintenance of ER location,BP,
13436,GO:0052907,0.999999999977196,0.898849243900945,0,1,23S rRNA (adenine(1618)-N(6))-methyltransferase activity,MF,
13437,GO:0052909,0.999999999977196,0.898849243900945,0,1,18S rRNA (adenine(1779)-N(6)/adenine(1780)-N(6))-dimethyltransferase activity,MF,
13731,GO:0060327,0.999999999977196,0.898849243900945,0,1,cytoplasmic actin-based contraction involved in cell motility,BP,
13924,GO:0060620,0.999999999977196,0.898849243900945,0,1,regulation of cholesterol import,BP,
14056,GO:0060887,0.999999999977196,0.898849243900945,0,1,limb epidermis development,BP,
14201,GO:0061163,0.999999999977196,0.898849243900945,0,1,endoplasmic reticulum polarization,BP,
14302,GO:0061495,0.999999999977196,0.898849243900945,0,1,gamma-tubulin small complex, mitotic spindle pole body,CC,
14306,GO:0061508,0.999999999977196,0.898849243900945,0,1,CDP phosphorylation,BP,
14328,GO:0061565,0.999999999977196,0.898849243900945,0,1,dAMP phosphorylation,BP,
14329,GO:0061566,0.999999999977196,0.898849243900945,0,1,CMP phosphorylation,BP,
14330,GO:0061567,0.999999999977196,0.898849243900945,0,1,dCMP phosphorylation,BP,
14331,GO:0061568,0.999999999977196,0.898849243900945,0,1,GDP phosphorylation,BP,
14332,GO:0061569,0.999999999977196,0.898849243900945,0,1,UDP phosphorylation,BP,
14333,GO:0061570,0.999999999977196,0.898849243900945,0,1,dCDP phosphorylation,BP,
14334,GO:0061571,0.999999999977196,0.898849243900945,0,1,TDP phosphorylation,BP,
14336,GO:0061573,0.999999999977196,0.898849243900945,0,1,actin filament bundle retrograde transport,BP,
14387,GO:0061685,0.999999999977196,0.898849243900945,0,1,diphthine methylesterase activity,MF,
14495,GO:0065010,0.999999999977196,0.898849243900945,0,1,extracellular membrane-bounded organelle,CC,
14566,GO:0070130,0.999999999977196,0.898849243900945,0,1,negative regulation of mitochondrial translation,BP,
14583,GO:0070165,0.999999999977196,0.898849243900945,0,1,positive regulation of adiponectin secretion,BP,
14640,GO:0070260,0.999999999977196,0.898849243900945,0,1,5'-tyrosyl-DNA phosphodiesterase activity,MF,
14796,GO:0070551,0.999999999977196,0.898849243900945,0,1,endoribonuclease activity, cleaving siRNA-paired mRNA,MF,
14798,GO:0070553,0.999999999977196,0.898849243900945,0,1,nicotinic acid receptor activity,MF,
14813,GO:0070573,0.999999999977196,0.898849243900945,0,1,metallodipeptidase activity,MF,
14838,GO:0070631,0.999999999977196,0.898849243900945,0,1,spindle pole body localization,BP,
14839,GO:0070632,0.999999999977196,0.898849243900945,0,1,establishment of spindle pole body localization,BP,
14850,GO:0070650,0.999999999977196,0.898849243900945,0,1,actin filament bundle distribution,BP,
14872,GO:0070694,0.999999999977196,0.898849243900945,0,1,deoxyribonucleoside 5'-monophosphate N-glycosidase activity,MF,
14896,GO:0070762,0.999999999977196,0.898849243900945,0,1,nuclear pore transmembrane ring,CC,
15234,GO:0071424,0.999999999977196,0.898849243900945,0,1,rRNA (cytosine-N4-)-methyltransferase activity,MF,
15435,GO:0071789,0.999999999977196,0.898849243900945,0,1,spindle pole body localization to nuclear envelope,BP,
15436,GO:0071790,0.999999999977196,0.898849243900945,0,1,establishment of spindle pole body localization to nuclear envelope,BP,
15488,GO:0071885,0.999999999977196,0.898849243900945,0,1,N-terminal protein N-methyltransferase activity,MF,
15514,GO:0071931,0.999999999977196,0.898849243900945,0,1,positive regulation of transcription involved in G1/S transition of mitotic cell cycle,BP,
15911,GO:0072720,0.999999999977196,0.898849243900945,0,1,response to dithiothreitol,BP,
15947,GO:0080048,0.999999999977196,0.898849243900945,0,1,GDP-D-glucose phosphorylase activity,MF,
15998,GO:0086038,0.999999999977196,0.898849243900945,0,1,calcium:sodium antiporter activity involved in regulation of cardiac muscle cell membrane potential,MF,
16329,GO:0090624,0.999999999977196,0.898849243900945,0,1,endoribonuclease activity, cleaving miRNA-paired mRNA,MF,
16330,GO:0090625,0.999999999977196,0.898849243900945,0,1,mRNA cleavage involved in gene silencing by siRNA,BP,
16529,GO:0097310,0.999999999977196,0.898849243900945,0,1,cap2 mRNA methylation,BP,
16642,GO:0097541,0.999999999977196,0.898849243900945,0,1,axonemal basal plate,CC,
16664,GO:0097630,0.999999999977196,0.898849243900945,0,1,intrinsic component of omegasome membrane,CC,
16665,GO:0097631,0.999999999977196,0.898849243900945,0,1,integral component of omegasome membrane,CC,
16680,GO:0097655,0.999999999977196,0.898849243900945,0,1,serpin family protein binding,MF,
16698,GO:0097712,0.999999999977196,0.898849243900945,0,1,vesicle targeting, trans-Golgi to periciliary membrane compartment,BP,
16770,GO:0098629,0.999999999977196,0.898849243900945,0,1,trans-Golgi network membrane organization,BP,
16809,GO:0098725,0.999999999977196,0.898849243900945,0,1,symmetric cell division,BP,
17022,GO:0099519,0.999999999977196,0.898849243900945,0,1,dense core granule cytoskeletal transport,BP,
17138,GO:0102524,0.999999999977196,0.898849243900945,0,1,tRNAPhe (7-(3-amino-3-carboxypropyl)wyosine37-C2)-hydroxylase activity,MF,
17239,GO:0120048,0.999999999977196,0.898849243900945,0,1,U6 snRNA (adenine-(43)-N(6))-methyltransferase activity,MF,
17240,GO:0120049,0.999999999977196,0.898849243900945,0,1,snRNA (adenine-N6)-methylation,BP,
17390,GO:1900148,0.999999999977196,0.898849243900945,0,1,negative regulation of Schwann cell migration,BP,
17501,GO:1901003,0.999999999977196,0.898849243900945,0,1,negative regulation of fermentation,BP,
17600,GO:1901318,0.999999999977196,0.898849243900945,0,1,negative regulation of flagellated sperm motility,BP,
17644,GO:1901523,0.999999999977196,0.898849243900945,0,1,icosanoid catabolic process,BP,
17792,GO:1901950,0.999999999977196,0.898849243900945,0,1,dense core granule transport,BP,
17859,GO:1902145,0.999999999977196,0.898849243900945,0,1,regulation of response to cell cycle checkpoint signaling,BP,
17860,GO:1902151,0.999999999977196,0.898849243900945,0,1,regulation of response to DNA integrity checkpoint signaling,BP,
17861,GO:1902153,0.999999999977196,0.898849243900945,0,1,regulation of response to DNA damage checkpoint signaling,BP,
17957,GO:1902387,0.999999999977196,0.898849243900945,0,1,ceramide 1-phosphate binding,MF,
17958,GO:1902388,0.999999999977196,0.898849243900945,0,1,ceramide 1-phosphate transporter activity,MF,
17959,GO:1902389,0.999999999977196,0.898849243900945,0,1,ceramide 1-phosphate transport,BP,
18063,GO:1902688,0.999999999977196,0.898849243900945,0,1,regulation of NAD metabolic process,BP,
18064,GO:1902689,0.999999999977196,0.898849243900945,0,1,negative regulation of NAD metabolic process,BP,
18141,GO:1902912,0.999999999977196,0.898849243900945,0,1,pyruvate kinase complex,CC,
18299,GO:1903259,0.999999999977196,0.898849243900945,0,1,exon-exon junction complex disassembly,BP,
18656,GO:1904023,0.999999999977196,0.898849243900945,0,1,regulation of glucose catabolic process to lactate via pyruvate,BP,
18657,GO:1904024,0.999999999977196,0.898849243900945,0,1,negative regulation of glucose catabolic process to lactate via pyruvate,BP,
18660,GO:1904028,0.999999999977196,0.898849243900945,0,1,positive regulation of collagen fibril organization,BP,
18928,GO:1904713,0.999999999977196,0.898849243900945,0,1,beta-catenin destruction complex binding,MF,
18962,GO:1904777,0.999999999977196,0.898849243900945,0,1,negative regulation of protein localization to cell cortex,BP,
18978,GO:1904806,0.999999999977196,0.898849243900945,0,1,regulation of protein oxidation,BP,
18979,GO:1904808,0.999999999977196,0.898849243900945,0,1,positive regulation of protein oxidation,BP,
19090,GO:1905044,0.999999999977196,0.898849243900945,0,1,regulation of Schwann cell proliferation involved in axon regeneration,BP,
19091,GO:1905045,0.999999999977196,0.898849243900945,0,1,negative regulation of Schwann cell proliferation involved in axon regeneration,BP,
19172,GO:1905279,0.999999999977196,0.898849243900945,0,1,regulation of retrograde transport, endosome to Golgi,BP,
19201,GO:1905344,0.999999999977196,0.898849243900945,0,1,prostaglandin catabolic process,BP,
19236,GO:1905435,0.999999999977196,0.898849243900945,0,1,regulation of histone H3-K4 trimethylation,BP,
19237,GO:1905437,0.999999999977196,0.898849243900945,0,1,positive regulation of histone H3-K4 trimethylation,BP,
19307,GO:1905642,0.999999999977196,0.898849243900945,0,1,negative regulation of DNA methylation,BP,
19415,GO:1990048,0.999999999977196,0.898849243900945,0,1,anterograde neuronal dense core vesicle transport,BP,
19469,GO:1990261,0.999999999977196,0.898849243900945,0,1,pre-mRNA catabolic process,BP,
19541,GO:1990570,0.999999999977196,0.898849243900945,0,1,GDP-mannose transmembrane transport,BP,
19582,GO:1990738,0.999999999977196,0.898849243900945,0,1,pseudouridine 5'-phosphatase activity,MF,
19591,GO:1990755,0.999999999977196,0.898849243900945,0,1,mitotic spindle microtubule depolymerization,BP,
19663,GO:2000003,0.999999999977196,0.898849243900945,0,1,positive regulation of DNA damage checkpoint,BP,
20051,GO:2000722,0.999999999977196,0.898849243900945,0,1,regulation of cardiac vascular smooth muscle cell differentiation,BP,
20052,GO:2000724,0.999999999977196,0.898849243900945,0,1,positive regulation of cardiac vascular smooth muscle cell differentiation,BP,
20136,GO:2000909,0.999999999977196,0.898849243900945,0,1,regulation of sterol import,BP,
16376,GO:0097016,0.999999999977213,0.775432069513532,0,2,L27 domain binding,MF,
15956,GO:0080129,0.999999999977214,0.927394639379499,0,1,proteasome core complex assembly,BP,
18292,GO:1903238,0.999999999977221,0.778115538719895,0,2,positive regulation of leukocyte tethering or rolling,BP,
15820,GO:0072554,0.999999999977224,0.900671805501555,0,1,blood vessel lumenization,BP,
17554,GO:1901189,0.999999999977224,0.900671805501555,0,1,positive regulation of ephrin receptor signaling pathway,BP,
17589,GO:1901297,0.999999999977224,0.900671805501555,0,1,positive regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,BP,
19103,GO:1905068,0.999999999977224,0.900671805501555,0,1,positive regulation of canonical Wnt signaling pathway involved in heart development,BP,
17256,GO:0140009,0.999999999977226,0.890326368933614,0,1,L-aspartate import across plasma membrane,BP,
9865,GO:0042138,0.999999999977244,0.900734240385309,0,1,meiotic DNA double-strand break formation,BP,
10679,GO:0043972,0.999999999977248,0.881232470167644,0,1,histone H3-K23 acetylation,BP,
10690,GO:0043994,0.999999999977248,0.881232470167644,0,1,histone acetyltransferase activity (H3-K23 specific),MF,
1627,GO:0004066,0.999999999977266,0.811047807327479,0,2,asparagine synthase (glutamine-hydrolyzing) activity,MF,
2985,GO:0006529,0.999999999977266,0.811047807327479,0,2,asparagine biosynthetic process,BP,
5973,GO:0018467,0.999999999977269,0.90001342567441,0,1,formaldehyde dehydrogenase activity,MF,
13218,GO:0051903,0.999999999977269,0.90001342567441,0,1,S-(hydroxymethyl)glutathione dehydrogenase activity,MF,
10652,GO:0043874,0.999999999977282,0.902437595416043,0,1,acireductone synthase activity,MF,
20225,GO:2001199,0.999999999977289,0.909840548427641,0,1,negative regulation of dendritic cell differentiation,BP,
3004,GO:0006550,0.999999999977294,0.819332479269435,0,2,isoleucine catabolic process,BP,
15524,GO:0071953,0.999999999977308,0.90017426608517,0,1,elastic fiber,CC,
5102,GO:0015389,0.999999999977312,0.901115606665185,0,1,pyrimidine- and adenine-specific:sodium symporter activity,MF,
5103,GO:0015390,0.999999999977312,0.901115606665185,0,1,purine-specific nucleoside:sodium symporter activity,MF,
5104,GO:0015391,0.999999999977312,0.901115606665185,0,1,nucleobase:cation symporter activity,MF,
18752,GO:1904274,0.999999999977312,0.901115606665185,0,1,tricellular tight junction assembly,BP,
12775,GO:0051089,0.999999999977314,0.88688440245802,0,1,constitutive protein ectodomain proteolysis,BP,
7503,GO:0031694,0.999999999977332,0.925855996853667,0,1,alpha-2A adrenergic receptor binding,MF,
17555,GO:1901193,0.999999999977332,0.925855996853667,0,1,regulation of formation of translation preinitiation complex,BP,
17556,GO:1901194,0.999999999977332,0.925855996853667,0,1,negative regulation of formation of translation preinitiation complex,BP,
18915,GO:1904689,0.999999999977332,0.925855996853667,0,1,negative regulation of cytoplasmic translational initiation,BP,
7848,GO:0032416,0.999999999977348,0.902528321646915,0,1,negative regulation of sodium:proton antiporter activity,BP,
16522,GO:0097291,0.999999999977348,0.902528321646915,0,1,renal phosphate ion absorption,BP,
2186,GO:0005046,0.999999999977354,0.819173883700489,0,2,KDEL sequence binding,MF,
9809,GO:0042030,0.999999999977385,0.773163718752121,0,2,ATPase inhibitor activity,MF,
1738,GO:0004339,0.99999999997739,0.879076448624563,0,1,glucan 1,4-alpha-glucosidase activity,MF,
2645,GO:0005982,0.99999999997739,0.879076448624563,0,1,starch metabolic process,BP,
2646,GO:0005983,0.99999999997739,0.879076448624563,0,1,starch catabolic process,BP,
10770,GO:0044245,0.99999999997739,0.879076448624563,0,1,polysaccharide digestion,BP,
12615,GO:0050822,0.999999999977397,0.892276013450174,0,1,peptide stabilization,BP,
12616,GO:0050823,0.999999999977397,0.892276013450174,0,1,peptide antigen stabilization,BP,
779,GO:0002038,0.999999999977402,0.90095351184462,0,1,positive regulation of L-glutamate import across plasma membrane,BP,
4714,GO:0010879,0.999999999977402,0.90095351184462,0,1,cholesterol transport involved in cholesterol storage,BP,
9079,GO:0035352,0.999999999977402,0.90095351184462,0,1,NAD transmembrane transport,BP,
10324,GO:0043132,0.999999999977402,0.90095351184462,0,1,NAD transport,BP,
10932,GO:0044610,0.999999999977402,0.90095351184462,0,1,FMN transmembrane transporter activity,MF,
13132,GO:0051724,0.999999999977402,0.90095351184462,0,1,NAD transmembrane transporter activity,MF,
5965,GO:0018395,0.999999999977427,0.890738155708831,0,1,peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine,BP,
6553,GO:0021998,0.999999999977427,0.890738155708831,0,1,neural plate mediolateral regionalization,BP,
8510,GO:0033746,0.999999999977427,0.890738155708831,0,1,histone demethylase activity (H3-R2 specific),MF,
8511,GO:0033749,0.999999999977427,0.890738155708831,0,1,histone demethylase activity (H4-R3 specific),MF,
12174,GO:0048338,0.999999999977427,0.890738155708831,0,1,mesoderm structural organization,BP,
12178,GO:0048352,0.999999999977427,0.890738155708831,0,1,paraxial mesoderm structural organization,BP,
14533,GO:0070077,0.999999999977427,0.890738155708831,0,1,histone arginine demethylation,BP,
14534,GO:0070078,0.999999999977427,0.890738155708831,0,1,histone H3-R2 demethylation,BP,
14535,GO:0070079,0.999999999977427,0.890738155708831,0,1,histone H4-R3 demethylation,BP,
18807,GO:1904412,0.999999999977427,0.890738155708831,0,1,regulation of cardiac ventricle development,BP,
18808,GO:1904414,0.999999999977427,0.890738155708831,0,1,positive regulation of cardiac ventricle development,BP,
19173,GO:1905285,0.999999999977427,0.890738155708831,0,1,fibrous ring of heart morphogenesis,BP,
1350,GO:0003220,0.999999999977444,0.876279460442295,0,1,left ventricular cardiac muscle tissue morphogenesis,BP,
1364,GO:0003251,0.999999999977444,0.876279460442295,0,1,positive regulation of cell proliferation involved in heart valve morphogenesis,BP,
6955,GO:0030616,0.999999999977444,0.876279460442295,0,1,transforming growth factor beta receptor, common-partner cytoplasmic mediator activity,MF,
9035,GO:0035262,0.999999999977444,0.876279460442295,0,1,gonad morphogenesis,BP,
14136,GO:0061040,0.999999999977444,0.876279460442295,0,1,female gonad morphogenesis,BP,
19180,GO:1905304,0.999999999977444,0.876279460442295,0,1,regulation of cardiac myofibril assembly,BP,
19181,GO:1905305,0.999999999977444,0.876279460442295,0,1,negative regulation of cardiac myofibril assembly,BP,
5461,GO:0016344,0.999999999977445,0.79807303134949,0,2,meiotic chromosome movement towards spindle pole,BP,
9127,GO:0035470,0.999999999977473,0.905013638932165,0,1,positive regulation of vascular wound healing,BP,
13958,GO:0060690,0.999999999977473,0.905013638932165,0,1,epithelial cell differentiation involved in salivary gland development,BP,
13959,GO:0060691,0.999999999977473,0.905013638932165,0,1,epithelial cell maturation involved in salivary gland development,BP,
17353,GO:1900098,0.999999999977473,0.905013638932165,0,1,regulation of plasma cell differentiation,BP,
17354,GO:1900100,0.999999999977473,0.905013638932165,0,1,positive regulation of plasma cell differentiation,BP,
18401,GO:1903489,0.999999999977473,0.905013638932165,0,1,positive regulation of lactation,BP,
658,GO:0001850,0.999999999977475,0.904671585296823,0,1,complement component C3a binding,MF,
659,GO:0001851,0.999999999977475,0.904671585296823,0,1,complement component C3b binding,MF,
17502,GO:1901004,0.999999999977477,0.919876673795403,0,1,ubiquinone-6 metabolic process,BP,
17503,GO:1901006,0.999999999977477,0.919876673795403,0,1,ubiquinone-6 biosynthetic process,BP,
16357,GO:0090722,0.999999999977501,0.773090215418559,0,2,receptor-receptor interaction,MF,
18998,GO:1904849,0.999999999977501,0.773090215418559,0,2,positive regulation of cell chemotaxis to fibroblast growth factor,BP,
19948,GO:2000546,0.999999999977501,0.773090215418559,0,2,positive regulation of endothelial cell chemotaxis to fibroblast growth factor,BP,
5946,GO:0018293,0.999999999977506,0.922530424773454,0,1,protein-FAD linkage,BP,
16625,GO:0097510,0.999999999977533,0.902122911440313,0,1,base-excision repair, AP site formation via deaminated base removal,BP,
20034,GO:2000683,0.999999999977539,0.806964451513029,0,2,regulation of cellular response to X-ray,BP,
1583,GO:0003996,0.999999999977553,0.901008417350252,0,1,acyl-CoA ligase activity,MF,
8771,GO:0034462,0.999999999977553,0.901008417350252,0,1,small-subunit processome assembly,BP,
16739,GO:0098547,0.999999999977553,0.901008417350252,0,1,lumenal side of Golgi membrane,CC,
556,GO:0001680,0.999999999977562,0.900915198925966,0,1,tRNA 3'-terminal CCA addition,BP,
2056,GO:0004810,0.999999999977562,0.900915198925966,0,1,tRNA adenylyltransferase activity,MF,
13442,GO:0052927,0.999999999977562,0.900915198925966,0,1,CTP:tRNA cytidylyltransferase activity,MF,
13443,GO:0052928,0.999999999977562,0.900915198925966,0,1,CTP:3'-cytidine-tRNA cytidylyltransferase activity,MF,
13444,GO:0052929,0.999999999977562,0.900915198925966,0,1,ATP:3'-cytidine-cytidine-tRNA adenylyltransferase activity,MF,
19612,GO:1990817,0.999999999977562,0.900915198925966,0,1,RNA adenylyltransferase activity,MF,
19221,GO:1905397,0.999999999977569,0.82235934491952,0,2,activated CD8-positive, alpha-beta T cell apoptotic process,BP,
19222,GO:1905402,0.999999999977569,0.82235934491952,0,2,regulation of activated CD8-positive, alpha-beta T cell apoptotic process,BP,
6552,GO:0021997,0.999999999977581,0.771685424626529,0,2,neural plate axis specification,BP,
7737,GO:0032258,0.999999999977581,0.810276484414731,0,2,protein localization by the Cvt pathway,BP,
5403,GO:0016243,0.999999999977604,0.886160573692766,0,1,regulation of autophagosome size,BP,
5934,GO:0018217,0.999999999977604,0.886160573692766,0,1,peptidyl-aspartic acid phosphorylation,BP,
14128,GO:0061030,0.999999999977604,0.886160573692766,0,1,epithelial cell differentiation involved in mammary gland alveolus development,BP,
19115,GO:1905103,0.999999999977604,0.886160573692766,0,1,integral component of lysosomal membrane,CC,
19651,GO:1990938,0.999999999977604,0.886160573692766,0,1,peptidyl-aspartic acid autophosphorylation,BP,
5329,GO:0016062,0.999999999977609,0.900215121939115,0,1,adaptation of rhodopsin mediated signaling,BP,
9558,GO:0036367,0.999999999977609,0.900215121939115,0,1,light adaption,BP,
1656,GO:0004113,0.999999999977631,0.880018650913991,0,1,2',3'-cyclic-nucleotide 3'-phosphodiesterase activity,MF,
13637,GO:0060171,0.999999999977637,0.881102506308214,0,1,stereocilium membrane,CC,
2302,GO:0005287,0.999999999977655,0.790772334060604,0,2,high-affinity basic amino acid transmembrane transporter activity,MF,
2303,GO:0005289,0.999999999977655,0.790772334060604,0,2,high-affinity arginine transmembrane transporter activity,MF,
2305,GO:0005292,0.999999999977655,0.790772334060604,0,2,high-affinity lysine transmembrane transporter activity,MF,
1837,GO:0004494,0.999999999977676,0.898313515765384,0,1,methylmalonyl-CoA mutase activity,MF,
1757,GO:0004362,0.999999999977679,0.900935898437898,0,1,glutathione-disulfide reductase activity,MF,
5193,GO:0015786,0.999999999977679,0.900935898437898,0,1,UDP-glucose transmembrane transport,BP,
4393,GO:0010070,0.999999999977687,0.900537673453072,0,1,zygote asymmetric cell division,BP,
15456,GO:0071821,0.999999999977725,0.878493845514179,0,1,FANCM-MHF complex,CC,
9623,GO:0036502,0.999999999977728,0.896710783838187,0,1,Derlin-1-VIMP complex,CC,
901,GO:0002282,0.999999999977752,0.900010536747057,0,1,microglial cell activation involved in immune response,BP,
1767,GO:0004373,0.999999999977776,0.8930326852373,0,1,glycogen (starch) synthase activity,MF,
14321,GO:0061547,0.999999999977776,0.8930326852373,0,1,glycogen synthase activity, transferring glucose-1-phosphate,MF,
3548,GO:0007576,0.999999999977777,0.900259916065832,0,1,nucleolar fragmentation,BP,
2686,GO:0006049,0.999999999977786,0.898640778735534,0,1,UDP-N-acetylglucosamine catabolic process,BP,
8131,GO:0032848,0.99999999997779,0.887941131842902,0,1,negative regulation of cellular pH reduction,BP,
10468,GO:0043375,0.99999999997779,0.887941131842902,0,1,CD8-positive, alpha-beta T cell lineage commitment,BP,
11780,GO:0046668,0.99999999997779,0.887941131842902,0,1,regulation of retinal cell programmed cell death,BP,
11781,GO:0046671,0.99999999997779,0.887941131842902,0,1,negative regulation of retinal cell programmed cell death,BP,
1428,GO:0003404,0.999999999977791,0.894822125865691,0,1,optic vesicle morphogenesis,BP,
1432,GO:0003409,0.999999999977791,0.894822125865691,0,1,optic cup structural organization,BP,
6398,GO:0021622,0.999999999977791,0.894822125865691,0,1,oculomotor nerve morphogenesis,BP,
6399,GO:0021623,0.999999999977791,0.894822125865691,0,1,oculomotor nerve formation,BP,
14590,GO:0070172,0.999999999977791,0.894822125865691,0,1,positive regulation of tooth mineralization,BP,
2105,GO:0004883,0.999999999977831,0.878999803092068,0,1,glucocorticoid receptor activity,MF,
9670,GO:0038051,0.999999999977831,0.878999803092068,0,1,glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity,MF,
2228,GO:0005132,0.999999999977837,0.845067346955015,0,2,type I interferon receptor binding,MF,
6866,GO:0030350,0.99999999997784,0.783811837760244,0,2,iron-responsive element binding,MF,
5464,GO:0016362,0.999999999977851,0.75659182188969,0,2,activin receptor activity, type II,MF,
1736,GO:0004336,0.999999999977865,0.898721581590722,0,1,galactosylceramidase activity,MF,
3105,GO:0006683,0.999999999977865,0.898721581590722,0,1,galactosylceramide catabolic process,BP,
6125,GO:0019376,0.999999999977865,0.898721581590722,0,1,galactolipid catabolic process,BP,
12967,GO:0051391,0.999999999977871,0.88669086471946,0,1,tRNA acetylation,BP,
12968,GO:0051392,0.999999999977871,0.88669086471946,0,1,tRNA N-acetyltransferase activity,MF,
18980,GO:1904812,0.999999999977871,0.88669086471946,0,1,rRNA acetylation involved in maturation of SSU-rRNA,BP,
19632,GO:1990882,0.999999999977871,0.88669086471946,0,1,rRNA acetylation,BP,
19633,GO:1990883,0.999999999977871,0.88669086471946,0,1,rRNA cytidine N-acetyltransferase activity,MF,
19634,GO:1990884,0.999999999977871,0.88669086471946,0,1,RNA acetylation,BP,
16020,GO:0086072,0.99999999997789,0.900416057203545,0,1,AV node cell-bundle of His cell adhesion involved in cell communication,BP,
16028,GO:0086082,0.99999999997789,0.900416057203545,0,1,cell adhesive protein binding involved in AV node cell-bundle of His cell communication,MF,
3339,GO:0007056,0.999999999977904,0.812171325561468,0,2,spindle assembly involved in female meiosis,BP,
3340,GO:0007057,0.999999999977904,0.812171325561468,0,2,spindle assembly involved in female meiosis I,BP,
17658,GO:1901551,0.999999999977917,0.884321056122955,0,1,negative regulation of endothelial cell development,BP,
18250,GO:1903141,0.999999999977917,0.884321056122955,0,1,negative regulation of establishment of endothelial barrier,BP,
15567,GO:0072061,0.999999999977924,0.811939467553446,0,2,inner medullary collecting duct development,BP,
18921,GO:1904700,0.999999999977931,0.900136505012139,0,1,granulosa cell apoptotic process,BP,
18926,GO:1904708,0.999999999977931,0.900136505012139,0,1,regulation of granulosa cell apoptotic process,BP,
5108,GO:0015420,0.999999999977934,0.879170414393671,0,1,cobalamin-transporting ATPase activity,MF,
5110,GO:0015431,0.999999999977934,0.879170414393671,0,1,glutathione S-conjugate-exporting ATPase activity,MF,
8831,GO:0034634,0.999999999977934,0.879170414393671,0,1,glutathione transmembrane transporter activity,MF,
8918,GO:0034775,0.999999999977934,0.879170414393671,0,1,glutathione transmembrane transport,BP,
9118,GO:0035443,0.999999999977934,0.879170414393671,0,1,tripeptide transmembrane transport,BP,
10219,GO:0042937,0.999999999977934,0.879170414393671,0,1,tripeptide transmembrane transporter activity,MF,
11749,GO:0046623,0.999999999977934,0.879170414393671,0,1,sphingolipid-translocating ATPase activity,MF,
15534,GO:0071997,0.999999999977934,0.879170414393671,0,1,glutathione S-conjugate-transporting ATPase activity,MF,
16960,GO:0099039,0.999999999977934,0.879170414393671,0,1,sphingolipid translocation,BP,
10694,GO:0043998,0.999999999977942,0.8943852483307,0,1,H2A histone acetyltransferase activity,MF,
3414,GO:0007197,0.999999999977955,0.794502410927007,0,2,adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway,BP,
5752,GO:0016907,0.999999999977955,0.794502410927007,0,2,G-protein coupled acetylcholine receptor activity,MF,
1482,GO:0003796,0.999999999977965,0.911673599813946,0,1,lysozyme activity,MF,
9115,GO:0035438,0.999999999977976,0.907222384173895,0,1,cyclic-di-GMP binding,MF,
14305,GO:0061507,0.999999999977976,0.907222384173895,0,1,cyclic-GMP-AMP binding,MF,
17874,GO:1902178,0.999999999977981,0.883558388752562,0,1,fibroblast growth factor receptor apoptotic signaling pathway,BP,
13868,GO:0060529,0.999999999977983,0.780411547251457,0,2,squamous basal epithelial stem cell differentiation involved in prostate gland acinus development,BP,
11798,GO:0046707,0.999999999977984,0.801262366462128,0,2,IDP metabolic process,BP,
11799,GO:0046709,0.999999999977984,0.801262366462128,0,2,IDP catabolic process,BP,
7290,GO:0031296,0.999999999978008,0.923290484383871,0,1,B cell costimulation,BP,
11961,GO:0047273,0.999999999978018,0.894641121933863,0,1,galactosylgalactosylglucosylceramide beta-D-acetylgalactosaminyltransferase activity,MF,
16692,GO:0097698,0.999999999978028,0.912384870184414,0,1,telomere maintenance via base-excision repair,BP,
8548,GO:0033989,0.999999999978029,0.899869177512879,0,1,3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity,MF,
9466,GO:0036111,0.999999999978029,0.899869177512879,0,1,very long-chain fatty-acyl-CoA metabolic process,BP,
10922,GO:0044594,0.999999999978029,0.899869177512879,0,1,17-beta-hydroxysteroid dehydrogenase (NAD+) activity,MF,
3727,GO:0008260,0.999999999978042,0.891436045323151,0,1,3-oxoacid CoA-transferase activity,MF,
10277,GO:0043041,0.999999999978042,0.891436045323151,0,1,amino acid activation for nonribosomal peptide biosynthetic process,BP,
4890,GO:0014816,0.999999999978052,0.771476895764409,0,2,skeletal muscle satellite cell differentiation,BP,
2117,GO:0004909,0.999999999978055,0.795075595086127,0,2,interleukin-1, Type I, activating receptor activity,MF,
16726,GO:0098508,0.999999999978061,0.811998039020272,0,2,endothelial to hematopoietic transition,BP,
1784,GO:0004408,0.999999999978103,0.900875177217197,0,1,holocytochrome-c synthase activity,MF,
5778,GO:0017003,0.999999999978103,0.900875177217197,0,1,protein-heme linkage,BP,
5781,GO:0017006,0.999999999978103,0.900875177217197,0,1,protein-tetrapyrrole linkage,BP,
5889,GO:0018063,0.999999999978103,0.900875177217197,0,1,cytochrome c-heme linkage,BP,
16514,GO:0097274,0.999999999978104,0.785270281208362,0,2,urea homeostasis,BP,
1613,GO:0004044,0.999999999978127,0.889133634870544,0,1,amidophosphoribosyltransferase activity,MF,
14428,GO:0061770,0.999999999978141,0.901419023774233,0,1,translation elongation factor binding,MF,
14598,GO:0070184,0.999999999978141,0.901419023774233,0,1,mitochondrial tyrosyl-tRNA aminoacylation,BP,
15817,GO:0072545,0.999999999978141,0.901419023774233,0,1,tyrosine binding,MF,
18150,GO:1902937,0.999999999978141,0.901419023774233,0,1,inward rectifier potassium channel complex,CC,
18993,GO:1904842,0.999999999978141,0.901419023774233,0,1,response to nitroglycerin,BP,
18994,GO:1904843,0.999999999978141,0.901419023774233,0,1,cellular response to nitroglycerin,BP,
8769,GO:0034458,0.999999999978152,0.793821301914888,0,2,3'-5' RNA helicase activity,MF,
912,GO:0002299,0.999999999978184,0.910363123833648,0,1,alpha-beta intraepithelial T cell differentiation,BP,
913,GO:0002300,0.999999999978184,0.910363123833648,0,1,CD8-positive, alpha-beta intraepithelial T cell differentiation,BP,
914,GO:0002304,0.999999999978184,0.910363123833648,0,1,gamma-delta intraepithelial T cell differentiation,BP,
915,GO:0002305,0.999999999978184,0.910363123833648,0,1,CD8-positive, gamma-delta intraepithelial T cell differentiation,BP,
2911,GO:0006422,0.999999999978193,0.900739777534267,0,1,aspartyl-tRNA aminoacylation,BP,
15969,GO:0085032,0.999999999978215,0.895084732346851,0,1,modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade,BP,
6830,GO:0030299,0.999999999978244,0.725814695867074,0,3,intestinal cholesterol absorption,BP,
10768,GO:0044241,0.999999999978244,0.725814695867074,0,3,lipid digestion,BP,
16881,GO:0098856,0.999999999978244,0.725814695867074,0,3,intestinal lipid absorption,BP,
8928,GO:0034971,0.999999999978255,0.898189696315121,0,1,histone H3-R17 methylation,BP,
9237,GO:0035642,0.999999999978255,0.898189696315121,0,1,histone methyltransferase activity (H3-R17 specific),MF,
9927,GO:0042289,0.99999999997829,0.835660328661121,0,2,MHC class II protein binding,MF,
14577,GO:0070159,0.999999999978302,0.900608874428912,0,1,mitochondrial threonyl-tRNA aminoacylation,BP,
14463,GO:0061890,0.999999999978338,0.818850552701845,0,2,positive regulation of astrocyte activation,BP,
18642,GO:1903980,0.999999999978338,0.818850552701845,0,2,positive regulation of microglial cell activation,BP,
11141,GO:0045210,0.99999999997836,0.773770240092775,0,2,FasL biosynthetic process,BP,
8530,GO:0033867,0.999999999978367,0.908240081201076,0,1,Fas-activated serine/threonine kinase activity,MF,
3207,GO:0006844,0.999999999978374,0.814220340934229,0,2,acyl carnitine transport,BP,
5042,GO:0015227,0.999999999978374,0.814220340934229,0,2,acyl carnitine transmembrane transporter activity,MF,
3720,GO:0008240,0.999999999978374,0.785852069588767,0,2,tripeptidyl-peptidase activity,MF,
6001,GO:0019045,0.999999999978387,0.770821050905252,0,2,latent virus replication,BP,
6002,GO:0019046,0.999999999978387,0.770821050905252,0,2,release from viral latency,BP,
13041,GO:0051562,0.99999999997839,0.807455523699266,0,2,negative regulation of mitochondrial calcium ion concentration,BP,
949,GO:0002368,0.999999999978405,0.900788401141962,0,1,B cell cytokine production,BP,
1194,GO:0002842,0.999999999978405,0.900788401141962,0,1,positive regulation of T cell mediated immune response to tumor cell,BP,
9553,GO:0036351,0.999999999978405,0.900788401141962,0,1,histone H2A-K13 ubiquitination,BP,
9554,GO:0036352,0.999999999978405,0.900788401141962,0,1,histone H2A-K15 ubiquitination,BP,
10817,GO:0044324,0.999999999978412,0.936097727448033,0,1,regulation of transcription involved in anterior/posterior axis specification,BP,
19673,GO:2000016,0.999999999978412,0.936097727448033,0,1,negative regulation of determination of dorsal identity,BP,
878,GO:0002238,0.999999999978417,0.880336027612476,0,1,response to molecule of fungal origin,BP,
940,GO:0002351,0.999999999978417,0.880336027612476,0,1,serotonin production involved in inflammatory response,BP,
985,GO:0002442,0.999999999978417,0.880336027612476,0,1,serotonin secretion involved in inflammatory response,BP,
1040,GO:0002554,0.999999999978417,0.880336027612476,0,1,serotonin secretion by platelet,BP,
6242,GO:0019814,0.999999999978417,0.880336027612476,0,1,immunoglobulin complex,CC,
6243,GO:0019815,0.999999999978417,0.880336027612476,0,1,B cell receptor complex,CC,
8064,GO:0032752,0.999999999978417,0.880336027612476,0,1,positive regulation of interleukin-3 production,BP,
9893,GO:0042223,0.999999999978417,0.880336027612476,0,1,interleukin-3 biosynthetic process,BP,
11216,GO:0045399,0.999999999978417,0.880336027612476,0,1,regulation of interleukin-3 biosynthetic process,BP,
11217,GO:0045401,0.999999999978417,0.880336027612476,0,1,positive regulation of interleukin-3 biosynthetic process,BP,
11226,GO:0045423,0.999999999978417,0.880336027612476,0,1,regulation of granulocyte macrophage colony-stimulating factor biosynthetic process,BP,
11227,GO:0045425,0.999999999978417,0.880336027612476,0,1,positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process,BP,
15113,GO:0071226,0.999999999978417,0.880336027612476,0,1,cellular response to molecule of fungal origin,BP,
5780,GO:0017005,0.999999999978421,0.890454837635618,0,1,3'-tyrosyl-DNA phosphodiesterase activity,MF,
4226,GO:0009405,0.999999999978422,0.773770726033734,0,2,pathogenesis,BP,
1559,GO:0003962,0.999999999978428,0.906112230400931,0,1,cystathionine gamma-synthase activity,MF,
1662,GO:0004123,0.999999999978428,0.906112230400931,0,1,cystathionine gamma-lyase activity,MF,
5941,GO:0018272,0.999999999978428,0.906112230400931,0,1,protein-pyridoxal-5-phosphate linkage via peptidyl-N6-pyridoxal phosphate-L-lysine,BP,
9358,GO:0035887,0.999999999978428,0.906112230400931,0,1,aortic smooth muscle cell differentiation,BP,
10905,GO:0044524,0.999999999978428,0.906112230400931,0,1,protein sulfhydration,BP,
10912,GO:0044540,0.999999999978428,0.906112230400931,0,1,L-cystine L-cysteine-lyase (deaminating),MF,
12038,GO:0047982,0.999999999978428,0.906112230400931,0,1,homocysteine desulfhydrase activity,MF,
15133,GO:0071266,0.999999999978428,0.906112230400931,0,1,'de novo' L-methionine biosynthetic process,BP,
15960,GO:0080146,0.999999999978428,0.906112230400931,0,1,L-cysteine desulfhydrase activity,MF,
18988,GO:1904829,0.999999999978428,0.906112230400931,0,1,regulation of aortic smooth muscle cell differentiation,BP,
18989,GO:1904831,0.999999999978428,0.906112230400931,0,1,positive regulation of aortic smooth muscle cell differentiation,BP,
2313,GO:0005314,0.999999999978473,0.800937472650674,0,2,high-affinity glutamate transmembrane transporter activity,MF,
5123,GO:0015501,0.999999999978473,0.800937472650674,0,2,glutamate:sodium symporter activity,MF,
4990,GO:0015127,0.999999999978484,0.880249340027886,0,1,bilirubin transmembrane transporter activity,MF,
5154,GO:0015694,0.999999999978484,0.880249340027886,0,1,mercury ion transport,BP,
5169,GO:0015723,0.999999999978484,0.880249340027886,0,1,bilirubin transport,BP,
6973,GO:0030653,0.999999999978484,0.880249340027886,0,1,beta-lactam antibiotic metabolic process,BP,
9940,GO:0042316,0.999999999978484,0.880249340027886,0,1,penicillin metabolic process,BP,
17527,GO:1901086,0.999999999978484,0.880249340027886,0,1,benzylpenicillin metabolic process,BP,
15355,GO:0071619,0.999999999978485,0.900923766613951,0,1,phosphorylation of RNA polymerase II C-terminal domain serine 2 residues,BP,
20202,GO:2001163,0.999999999978485,0.900923766613951,0,1,regulation of phosphorylation of RNA polymerase II C-terminal domain serine 2 residues,BP,
20203,GO:2001165,0.999999999978485,0.900923766613951,0,1,positive regulation of phosphorylation of RNA polymerase II C-terminal domain serine 2 residues,BP,
15349,GO:0071611,0.999999999978524,0.810501569673749,0,2,granulocyte colony-stimulating factor production,BP,
15378,GO:0071655,0.999999999978524,0.810501569673749,0,2,regulation of granulocyte colony-stimulating factor production,BP,
19437,GO:1990136,0.999999999978528,0.900332774490256,0,1,linoleate 9S-lipoxygenase activity,MF,
7385,GO:0031445,0.999999999978535,0.794390030069229,0,2,regulation of heterochromatin assembly,BP,
7386,GO:0031453,0.999999999978535,0.794390030069229,0,2,positive regulation of heterochromatin assembly,BP,
11389,GO:0045799,0.999999999978535,0.794390030069229,0,2,positive regulation of chromatin assembly or disassembly,BP,
1058,GO:0002586,0.999999999978545,0.858339016472748,0,2,regulation of antigen processing and presentation of peptide antigen via MHC class II,BP,
14815,GO:0070576,0.999999999978578,0.806751549782812,0,2,vitamin D 24-hydroxylase activity,MF,
4794,GO:0010989,0.999999999978581,0.719446428640728,0,3,negative regulation of low-density lipoprotein particle clearance,BP,
17975,GO:1902445,0.999999999978604,0.785938549071191,0,3,regulation of mitochondrial membrane permeability involved in programmed necrotic cell death,BP,
1747,GO:0004349,0.999999999978611,0.892687458460178,0,1,glutamate 5-kinase activity,MF,
1748,GO:0004350,0.999999999978611,0.892687458460178,0,1,glutamate-5-semialdehyde dehydrogenase activity,MF,
3040,GO:0006592,0.999999999978611,0.892687458460178,0,1,ornithine biosynthetic process,BP,
5815,GO:0017084,0.999999999978611,0.892687458460178,0,1,delta1-pyrroline-5-carboxylate synthetase activity,MF,
6052,GO:0019202,0.999999999978611,0.892687458460178,0,1,amino acid kinase activity,MF,
19067,GO:1904990,0.999999999978616,0.900484380064728,0,1,regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway,BP,
19068,GO:1904992,0.999999999978616,0.900484380064728,0,1,positive regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway,BP,
1719,GO:0004313,0.999999999978642,0.876730372979961,0,1,[acyl-carrier-protein] S-acetyltransferase activity,MF,
1722,GO:0004316,0.999999999978642,0.876730372979961,0,1,3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity,MF,
1723,GO:0004317,0.999999999978642,0.876730372979961,0,1,3-hydroxypalmitoyl-[acyl-carrier-protein] dehydratase activity,MF,
1724,GO:0004319,0.999999999978642,0.876730372979961,0,1,enoyl-[acyl-carrier-protein] reductase (NADPH, B-specific) activity,MF,
6044,GO:0019171,0.999999999978642,0.876730372979961,0,1,3-hydroxyacyl-[acyl-carrier-protein] dehydratase activity,MF,
11941,GO:0047117,0.999999999978642,0.876730372979961,0,1,enoyl-[acyl-carrier-protein] reductase (NADPH, A-specific) activity,MF,
11986,GO:0047451,0.999999999978642,0.876730372979961,0,1,3-hydroxyoctanoyl-[acyl-carrier-protein] dehydratase activity,MF,
17105,GO:0102131,0.999999999978642,0.876730372979961,0,1,3-oxo-glutaryl-[acp] methyl ester reductase activity,MF,
17106,GO:0102132,0.999999999978642,0.876730372979961,0,1,3-oxo-pimeloyl-[acp] methyl ester reductase activity,MF,
9188,GO:0035582,0.999999999978662,0.711286250521995,0,3,sequestering of BMP in extracellular matrix,BP,
14833,GO:0070618,0.999999999978668,0.899879348630681,0,1,Grb2-Sos complex,CC,
2949,GO:0006478,0.999999999978679,0.814697827973549,0,2,peptidyl-tyrosine sulfation,BP,
3856,GO:0008476,0.999999999978679,0.814697827973549,0,2,protein-tyrosine sulfotransferase activity,MF,
978,GO:0002432,0.999999999978692,0.882774563141554,0,1,granuloma formation,BP,
9606,GO:0036482,0.999999999978749,0.841332125949701,0,2,neuron intrinsic apoptotic signaling pathway in response to hydrogen peroxide,BP,
18167,GO:1902958,0.999999999978749,0.841332125949701,0,2,positive regulation of mitochondrial electron transport, NADH to ubiquinone,BP,
18357,GO:1903383,0.999999999978749,0.841332125949701,0,2,regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway,BP,
18358,GO:1903384,0.999999999978749,0.841332125949701,0,2,negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway,BP,
9354,GO:0035880,0.999999999978774,0.801064245580614,0,2,embryonic nail plate morphogenesis,BP,
15017,GO:0070984,0.999999999978777,0.884591214943322,0,1,SET domain binding,MF,
19905,GO:2000427,0.999999999978805,0.773446376903258,0,2,positive regulation of apoptotic cell clearance,BP,
16439,GO:0097125,0.999999999978816,0.817111478325432,0,2,cyclin B1-CDK1 complex,CC,
8520,GO:0033823,0.999999999978826,0.898088110633439,0,1,procollagen glucosyltransferase activity,MF,
13135,GO:0051728,0.999999999978826,0.898088110633439,0,1,cell cycle switching, mitotic to meiotic cell cycle,BP,
13136,GO:0051729,0.999999999978826,0.898088110633439,0,1,germline cell cycle switching, mitotic to meiotic cell cycle,BP,
13644,GO:0060184,0.999999999978826,0.898088110633439,0,1,cell cycle switching,BP,
9607,GO:0036483,0.999999999978832,0.881960327760425,0,1,neuron intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,BP,
18355,GO:1903381,0.999999999978832,0.881960327760425,0,1,regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway,BP,
18356,GO:1903382,0.999999999978832,0.881960327760425,0,1,negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway,BP,
4492,GO:0010520,0.999999999978836,0.806869606875195,0,2,regulation of reciprocal meiotic recombination,BP,
3845,GO:0008457,0.999999999978844,0.885044176337861,0,1,beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity,MF,
11959,GO:0047256,0.999999999978844,0.885044176337861,0,1,lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity,MF,
16626,GO:0097512,0.999999999978888,0.947654091882681,0,1,cardiac myofibril,CC,
18896,GO:1904631,0.999999999978897,0.90104486433761,0,1,response to glucoside,BP,
15157,GO:0071314,0.999999999978908,0.89940787580636,0,1,cellular response to cocaine,BP,
17947,GO:1902362,0.999999999978908,0.89940787580636,0,1,melanocyte apoptotic process,BP,
4802,GO:0010999,0.999999999978909,0.882442162534441,0,1,regulation of eIF2 alpha phosphorylation by heme,BP,
11492,GO:0045993,0.999999999978909,0.882442162534441,0,1,negative regulation of translational initiation by iron,BP,
11923,GO:0046986,0.999999999978909,0.882442162534441,0,1,negative regulation of hemoglobin biosynthetic process,BP,
1652,GO:0004108,0.999999999978912,0.898156081598322,0,1,citrate (Si)-synthase activity,MF,
9578,GO:0036440,0.999999999978912,0.898156081598322,0,1,citrate synthase activity,MF,
18776,GO:1904339,0.999999999978967,0.878537905043127,0,1,negative regulation of dopaminergic neuron differentiation,BP,
10617,GO:0043629,0.999999999978976,0.877389149829459,0,1,ncRNA polyadenylation,BP,
10618,GO:0043630,0.999999999978976,0.877389149829459,0,1,ncRNA polyadenylation involved in polyadenylation-dependent ncRNA catabolic process,BP,
11097,GO:0045131,0.999999999978987,0.89814763914173,0,1,pre-mRNA branch point binding,MF,
1620,GO:0004056,0.999999999979018,0.902631574425197,0,1,argininosuccinate lyase activity,MF,
10006,GO:0042450,0.999999999979018,0.902631574425197,0,1,arginine biosynthetic process via ornithine,BP,
14106,GO:0060994,0.999999999979021,0.805513340822213,0,2,regulation of transcription from RNA polymerase II promoter involved in kidney development,BP,
8489,GO:0033678,0.999999999979042,0.899956754783008,0,1,5'-3' DNA/RNA helicase activity,MF,
8493,GO:0033682,0.999999999979042,0.899956754783008,0,1,ATP-dependent 5'-3' DNA/RNA helicase activity,MF,
11443,GO:0045914,0.999999999979043,0.807541328991314,0,2,negative regulation of catecholamine metabolic process,BP,
11477,GO:0045963,0.999999999979043,0.807541328991314,0,2,negative regulation of dopamine metabolic process,BP,
7675,GO:0032127,0.999999999979055,0.896541669031603,0,1,dense core granule membrane,CC,
15063,GO:0071065,0.999999999979055,0.896541669031603,0,1,alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex,CC,
15077,GO:0071133,0.999999999979055,0.896541669031603,0,1,alpha9-beta1 integrin-ADAM8 complex,CC,
15810,GO:0072535,0.999999999979055,0.896541669031603,0,1,tumor necrosis factor (ligand) superfamily member 11 production,BP,
15887,GO:0072680,0.999999999979055,0.896541669031603,0,1,extracellular matrix-dependent thymocyte migration,BP,
15888,GO:0072681,0.999999999979055,0.896541669031603,0,1,fibronectin-dependent thymocyte migration,BP,
19817,GO:2000307,0.999999999979055,0.896541669031603,0,1,regulation of tumor necrosis factor (ligand) superfamily member 11 production,BP,
19818,GO:2000309,0.999999999979055,0.896541669031603,0,1,positive regulation of tumor necrosis factor (ligand) superfamily member 11 production,BP,
19892,GO:2000410,0.999999999979055,0.896541669031603,0,1,regulation of thymocyte migration,BP,
19893,GO:2000412,0.999999999979055,0.896541669031603,0,1,positive regulation of thymocyte migration,BP,
19894,GO:2000413,0.999999999979055,0.896541669031603,0,1,regulation of fibronectin-dependent thymocyte migration,BP,
19895,GO:2000415,0.999999999979055,0.896541669031603,0,1,positive regulation of fibronectin-dependent thymocyte migration,BP,
16397,GO:0097055,0.999999999979056,0.81005840997523,0,2,agmatine biosynthetic process,BP,
17545,GO:1901162,0.999999999979056,0.81005840997523,0,2,primary amino compound biosynthetic process,BP,
1226,GO:0002904,0.999999999979065,0.751662003923302,0,3,positive regulation of B cell apoptotic process,BP,
8543,GO:0033961,0.99999999997907,0.906036125931868,0,1,cis-stilbene-oxide hydrolase activity,MF,
2690,GO:0006055,0.999999999979107,0.921164155508357,0,1,CMP-N-acetylneuraminate biosynthetic process,BP,
11634,GO:0046381,0.999999999979107,0.921164155508357,0,1,CMP-N-acetylneuraminate metabolic process,BP,
11985,GO:0047444,0.999999999979107,0.921164155508357,0,1,N-acylneuraminate-9-phosphate synthase activity,MF,
12470,GO:0050462,0.999999999979107,0.921164155508357,0,1,N-acetylneuraminate synthase activity,MF,
1242,GO:0002944,0.999999999979137,0.790145905262042,0,2,cyclin K-CDK12 complex,CC,
18004,GO:1902528,0.999999999979209,0.87685502874088,0,1,regulation of protein linear polyubiquitination,BP,
18005,GO:1902530,0.999999999979209,0.87685502874088,0,1,positive regulation of protein linear polyubiquitination,BP,
20278,GO:2001288,0.999999999979209,0.87685502874088,0,1,positive regulation of caveolin-mediated endocytosis,BP,
20269,GO:2001271,0.999999999979237,0.702074690260317,0,3,negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis,BP,
18587,GO:1903892,0.99999999997926,0.801526905740114,0,2,negative regulation of ATF6-mediated unfolded protein response,BP,
19767,GO:2000211,0.999999999979261,0.880320477491293,0,1,regulation of glutamate metabolic process,BP,
19768,GO:2000212,0.999999999979261,0.880320477491293,0,1,negative regulation of glutamate metabolic process,BP,
12700,GO:0050957,0.999999999979326,0.886511207313528,0,1,equilibrioception,BP,
16034,GO:0086098,0.999999999979328,0.797015780227544,0,2,angiotensin-activated signaling pathway involved in heart process,BP,
198,GO:0000417,0.999999999979341,0.885872683811881,0,1,HIR complex,CC,
7005,GO:0030702,0.999999999979341,0.885872683811881,0,1,chromatin silencing at centromere,BP,
19104,GO:1905069,0.999999999979341,0.885872683811881,0,1,allantois development,BP,
8296,GO:0033140,0.999999999979359,0.813265385585739,0,2,negative regulation of peptidyl-serine phosphorylation of STAT protein,BP,
5428,GO:0016287,0.999999999979395,0.899872580652146,0,1,glycerone-phosphate O-acyltransferase activity,MF,
6879,GO:0030395,0.9999999999794,0.955267976792823,0,1,lactose binding,MF,
8597,GO:0034117,0.9999999999794,0.955267976792823,0,1,erythrocyte aggregation,BP,
8598,GO:0034118,0.9999999999794,0.955267976792823,0,1,regulation of erythrocyte aggregation,BP,
8599,GO:0034120,0.9999999999794,0.955267976792823,0,1,positive regulation of erythrocyte aggregation,BP,
12064,GO:0048030,0.9999999999794,0.955267976792823,0,1,disaccharide binding,MF,
1900,GO:0004587,0.999999999979403,0.902733584086322,0,1,ornithine-oxo-acid transaminase activity,MF,
4397,GO:0010121,0.999999999979403,0.902733584086322,0,1,arginine catabolic process to proline via ornithine,BP,
6156,GO:0019493,0.999999999979403,0.902733584086322,0,1,arginine catabolic process to proline,BP,
6174,GO:0019544,0.999999999979403,0.902733584086322,0,1,arginine catabolic process to glutamate,BP,
19405,GO:1990026,0.999999999979406,0.891908141243814,0,1,hippocampal mossy fiber expansion,CC,
5053,GO:0015252,0.999999999979424,0.896897537442322,0,1,proton channel activity,MF,
9119,GO:0035445,0.999999999979424,0.896897537442322,0,1,borate transmembrane transport,BP,
11803,GO:0046713,0.999999999979424,0.896897537442322,0,1,borate transport,BP,
11804,GO:0046715,0.999999999979424,0.896897537442322,0,1,active borate transmembrane transporter activity,MF,
10248,GO:0043000,0.999999999979468,0.805784283926105,0,2,Golgi to plasma membrane CFTR protein transport,BP,
9902,GO:0042253,0.999999999979473,0.814337013049409,0,2,granulocyte macrophage colony-stimulating factor biosynthetic process,BP,
18109,GO:1902824,0.999999999979481,0.83964683496584,0,2,positive regulation of late endosome to lysosome transport,BP,
18335,GO:1903337,0.999999999979481,0.83964683496584,0,2,positive regulation of vacuolar transport,BP,
8906,GO:0034757,0.99999999997949,0.876714817911107,0,1,negative regulation of iron ion transport,BP,
8907,GO:0034759,0.99999999997949,0.876714817911107,0,1,regulation of iron ion transmembrane transport,BP,
8908,GO:0034760,0.99999999997949,0.876714817911107,0,1,negative regulation of iron ion transmembrane transport,BP,
1672,GO:0004138,0.999999999979498,0.931102373466731,0,1,deoxyguanosine kinase activity,MF,
3933,GO:0008617,0.999999999979498,0.931102373466731,0,1,guanosine metabolic process,BP,
5283,GO:0015938,0.999999999979498,0.931102373466731,0,1,coenzyme A catabolic process,BP,
8531,GO:0033869,0.999999999979498,0.931102373466731,0,1,nucleoside bisphosphate catabolic process,BP,
8554,GO:0034031,0.999999999979498,0.931102373466731,0,1,ribonucleoside bisphosphate catabolic process,BP,
8557,GO:0034034,0.999999999979498,0.931102373466731,0,1,purine nucleoside bisphosphate catabolic process,BP,
625,GO:0001809,0.999999999979503,0.915596309283641,0,1,positive regulation of type IV hypersensitivity,BP,
13838,GO:0060467,0.999999999979503,0.915596309283641,0,1,negative regulation of fertilization,BP,
19855,GO:2000359,0.999999999979503,0.915596309283641,0,1,regulation of binding of sperm to zona pellucida,BP,
19856,GO:2000360,0.999999999979503,0.915596309283641,0,1,negative regulation of binding of sperm to zona pellucida,BP,
19875,GO:2000387,0.999999999979503,0.915596309283641,0,1,regulation of antral ovarian follicle growth,BP,
19876,GO:2000388,0.999999999979503,0.915596309283641,0,1,positive regulation of antral ovarian follicle growth,BP,
2020,GO:0004751,0.999999999979507,0.904534075956096,0,1,ribose-5-phosphate isomerase activity,MF,
6943,GO:0030576,0.99999999997953,0.71915554297331,0,3,Cajal body organization,BP,
17212,GO:0110025,0.999999999979539,0.897481809215114,0,1,DNA strand resection involved in replication fork processing,BP,
17213,GO:0110026,0.999999999979539,0.897481809215114,0,1,regulation of DNA strand resection involved in replication fork processing,BP,
16491,GO:0097213,0.999999999979544,0.90105074221077,0,1,regulation of lysosomal membrane permeability,BP,
10816,GO:0044323,0.999999999979553,0.786995011177974,0,2,retinoic acid-responsive element binding,MF,
3785,GO:0008352,0.999999999979556,0.89996596024458,0,1,katanin complex,CC,
19776,GO:2000233,0.999999999979571,0.790707144688263,0,2,negative regulation of rRNA processing,BP,
6891,GO:0030432,0.999999999979574,0.834814048835421,0,2,peristalsis,BP,
3390,GO:0007168,0.999999999979577,0.804552275915477,0,2,receptor guanylyl cyclase signaling pathway,BP,
15047,GO:0071030,0.999999999979581,0.815653668919473,0,2,nuclear mRNA surveillance of spliceosomal pre-mRNA splicing,BP,
15059,GO:0071048,0.999999999979581,0.815653668919473,0,2,nuclear retention of unspliced pre-mRNA at the site of transcription,BP,
193,GO:0000412,0.999999999979588,0.898876831525866,0,1,histone peptidyl-prolyl isomerization,BP,
11723,GO:0046573,0.999999999979593,0.90838255647938,0,1,lactonohydrolase activity,MF,
17097,GO:0102007,0.999999999979593,0.90838255647938,0,1,acyl-L-homoserine-lactone lactonohydrolase activity,MF,
5589,GO:0016618,0.999999999979602,0.740859183678403,0,3,hydroxypyruvate reductase activity,MF,
6807,GO:0030267,0.999999999979602,0.740859183678403,0,3,glyoxylate reductase (NADP) activity,MF,
1440,GO:0003430,0.999999999979606,0.792631253505136,0,2,growth plate cartilage chondrocyte growth,BP,
7378,GO:0031438,0.999999999979608,0.897318029819111,0,1,negative regulation of mRNA cleavage,BP,
18935,GO:1904721,0.999999999979608,0.897318029819111,0,1,negative regulation of mRNA endonucleolytic cleavage involved in unfolded protein response,BP,
7010,GO:0030729,0.999999999979608,0.894409735601258,0,1,acetoacetate-CoA ligase activity,MF,
12024,GO:0047760,0.999999999979608,0.894409735601258,0,1,butyrate-CoA ligase activity,MF,
13265,GO:0051977,0.999999999979613,0.901265128777319,0,1,lysophospholipid transport,BP,
13266,GO:0051978,0.999999999979613,0.901265128777319,0,1,lysophospholipid transporter activity,MF,
17136,GO:0102521,0.999999999979628,0.805452045794389,0,2,tRNA-4-demethylwyosine synthase activity,MF,
1546,GO:0003944,0.999999999979646,0.901184611866161,0,1,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase activity,MF,
5427,GO:0016286,0.999999999979651,0.900340117252553,0,1,small conductance calcium-activated potassium channel activity,MF,
1912,GO:0004607,0.999999999979669,0.916847348138964,0,1,phosphatidylcholine-sterol O-acyltransferase activity,MF,
9110,GO:0035425,0.999999999979674,0.718852628110667,0,3,autocrine signaling,BP,
8960,GO:0035054,0.999999999979676,0.896562964554649,0,1,embryonic heart tube anterior/posterior pattern specification,BP,
12746,GO:0051040,0.999999999979676,0.896562964554649,0,1,regulation of calcium-independent cell-cell adhesion,BP,
12747,GO:0051042,0.999999999979676,0.896562964554649,0,1,negative regulation of calcium-independent cell-cell adhesion,BP,
13611,GO:0060128,0.999999999979676,0.896562964554649,0,1,corticotropin hormone secreting cell differentiation,BP,
14026,GO:0060804,0.999999999979676,0.896562964554649,0,1,positive regulation of Wnt signaling pathway by BMP signaling pathway,BP,
14882,GO:0070724,0.999999999979676,0.896562964554649,0,1,BMP receptor complex,CC,
268,GO:0000741,0.999999999979678,0.906064578225323,0,1,karyogamy,BP,
3482,GO:0007344,0.999999999979678,0.906064578225323,0,1,pronuclear fusion,BP,
13138,GO:0051732,0.999999999979678,0.906064578225323,0,1,polyribonucleotide kinase activity,MF,
13141,GO:0051736,0.999999999979678,0.906064578225323,0,1,ATP-dependent polyribonucleotide 5'-hydroxyl-kinase activity,MF,
16494,GO:0097224,0.999999999979678,0.906064578225323,0,1,sperm connecting piece,CC,
2682,GO:0006045,0.99999999997969,0.78186699045311,0,2,N-acetylglucosamine biosynthetic process,BP,
17522,GO:1901073,0.99999999997969,0.78186699045311,0,2,glucosamine-containing compound biosynthetic process,BP,
17960,GO:1902396,0.999999999979711,0.887211540347852,0,1,protein localization to bicellular tight junction,BP,
5426,GO:0016282,0.999999999979717,0.882314870361435,0,1,eukaryotic 43S preinitiation complex,CC,
2934,GO:0006452,0.999999999979717,0.807967432005651,0,2,translational frameshifting,BP,
11436,GO:0045905,0.999999999979717,0.807967432005651,0,2,positive regulation of translational termination,BP,
7498,GO:0031685,0.999999999979718,0.794360900356869,0,2,adenosine receptor binding,MF,
14378,GO:0061656,0.999999999979748,0.922734699068078,0,1,SUMO conjugating enzyme activity,MF,
18265,GO:1903182,0.999999999979748,0.922734699068078,0,1,regulation of SUMO transferase activity,BP,
18524,GO:1903755,0.999999999979748,0.922734699068078,0,1,positive regulation of SUMO transferase activity,BP,
19481,GO:1990356,0.999999999979748,0.922734699068078,0,1,sumoylated E2 ligase complex,CC,
15325,GO:0071573,0.999999999979778,0.898538784630095,0,1,shelterin complex assembly,BP,
18969,GO:1904790,0.999999999979778,0.898538784630095,0,1,regulation of shelterin complex assembly,BP,
18970,GO:1904792,0.999999999979778,0.898538784630095,0,1,positive regulation of shelterin complex assembly,BP,
18999,GO:1904850,0.999999999979778,0.898538784630095,0,1,negative regulation of establishment of protein localization to telomere,BP,
19033,GO:1904910,0.999999999979778,0.898538784630095,0,1,regulation of establishment of RNA localization to telomere,BP,
19034,GO:1904911,0.999999999979778,0.898538784630095,0,1,negative regulation of establishment of RNA localization to telomere,BP,
19035,GO:1904913,0.999999999979778,0.898538784630095,0,1,regulation of establishment of protein-containing complex localization to telomere,BP,
19036,GO:1904914,0.999999999979778,0.898538784630095,0,1,negative regulation of establishment of protein-containing complex localization to telomere,BP,
14341,GO:0061580,0.999999999979778,0.885007637766717,0,1,colon epithelial cell migration,BP,
14929,GO:0070843,0.999999999979778,0.885007637766717,0,1,misfolded protein transport,BP,
14930,GO:0070844,0.999999999979778,0.885007637766717,0,1,polyubiquitinated protein transport,BP,
14931,GO:0070845,0.999999999979778,0.885007637766717,0,1,polyubiquitinated misfolded protein transport,BP,
14932,GO:0070846,0.999999999979778,0.885007637766717,0,1,Hsp90 deacetylation,BP,
2154,GO:0004979,0.999999999979788,0.904127041008902,0,1,beta-endorphin receptor activity,MF,
7465,GO:0031635,0.999999999979788,0.904127041008902,0,1,adenylate cyclase-inhibiting opioid receptor signaling pathway,BP,
7660,GO:0032097,0.999999999979788,0.904127041008902,0,1,positive regulation of response to food,BP,
7663,GO:0032100,0.999999999979788,0.904127041008902,0,1,positive regulation of appetite,BP,
9668,GO:0038047,0.999999999979788,0.904127041008902,0,1,morphine receptor activity,MF,
11703,GO:0046521,0.999999999979788,0.904127041008902,0,1,sphingoid catabolic process,BP,
14260,GO:0061358,0.999999999979788,0.904127041008902,0,1,negative regulation of Wnt protein secretion,BP,
1526,GO:0003908,0.999999999979788,0.920185254739487,0,1,methylated-DNA-[protein]-cysteine S-methyltransferase activity,MF,
1800,GO:0004446,0.999999999979805,0.899142695761496,0,1,inositol-hexakisphosphate phosphatase activity,MF,
6867,GO:0030351,0.999999999979805,0.899142695761496,0,1,inositol-1,3,4,5,6-pentakisphosphate 3-phosphatase activity,MF,
8518,GO:0033787,0.999999999979805,0.899142695761496,0,1,cyanocobalamin reductase (cyanide-eliminating) activity,MF,
8744,GO:0034417,0.999999999979805,0.899142695761496,0,1,bisphosphoglycerate 3-phosphatase activity,MF,
13402,GO:0052826,0.999999999979805,0.899142695761496,0,1,inositol hexakisphosphate 2-phosphatase activity,MF,
17993,GO:1902499,0.999999999979805,0.899142695761496,0,1,positive regulation of protein autoubiquitination,BP,
1158,GO:0002767,0.99999999997981,0.81649320540673,0,2,immune response-inhibiting cell surface receptor signaling pathway,BP,
9800,GO:0042007,0.999999999979812,0.914657540182354,0,1,interleukin-18 binding,MF,
5807,GO:0017065,0.999999999979839,0.910160228311531,0,1,single-strand selective uracil DNA N-glycosylase activity,MF,
14550,GO:0070101,0.999999999979868,0.799121083219668,0,2,positive regulation of chemokine-mediated signaling pathway,BP,
14867,GO:0070678,0.999999999979869,0.899902640898117,0,1,preprotein binding,MF,
9917,GO:0042275,0.999999999979898,0.911499467126185,0,1,error-free postreplication DNA repair,BP,
1566,GO:0003975,0.999999999979916,0.901495838421285,0,1,UDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosaminephosphotransferase activity,MF,
4004,GO:0008963,0.999999999979916,0.901495838421285,0,1,phospho-N-acetylmuramoyl-pentapeptide-transferase activity,MF,
16659,GO:0097623,0.999999999979919,0.792789118337265,0,2,potassium ion export across plasma membrane,BP,
491,GO:0001544,0.999999999979919,0.878296460067696,0,1,initiation of primordial ovarian follicle growth,BP,
960,GO:0002384,0.999999999979921,0.884912550295502,0,1,hepatic immune response,BP,
14556,GO:0070119,0.999999999979921,0.884912550295502,0,1,ciliary neurotrophic factor binding,MF,
17866,GO:1902167,0.999999999979922,0.953762097186226,0,1,positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,
18977,GO:1904803,0.999999999979922,0.953762097186226,0,1,regulation of translation involved in cellular response to UV,BP,
7870,GO:0032440,0.999999999979926,0.920691537376895,0,1,2-alkenal reductase [NAD(P)] activity,MF,
19306,GO:1905636,0.999999999979926,0.920691537376895,0,1,positive regulation of RNA polymerase II regulatory region sequence-specific DNA binding,BP,
19227,GO:1905407,0.999999999979934,0.895001559345644,0,1,regulation of creatine transmembrane transporter activity,BP,
19228,GO:1905408,0.999999999979934,0.895001559345644,0,1,negative regulation of creatine transmembrane transporter activity,BP,
5650,GO:0016748,0.999999999979935,0.809843741828512,0,2,succinyltransferase activity,MF,
19333,GO:1905767,0.999999999979965,0.878866676203043,0,1,regulation of double-stranded telomeric DNA binding,BP,
19334,GO:1905768,0.999999999979965,0.878866676203043,0,1,negative regulation of double-stranded telomeric DNA binding,BP,
6353,GO:0021539,0.999999999979977,0.819772830182561,0,2,subthalamus development,BP,
12418,GO:0050023,0.999999999979987,0.904169175420786,0,1,L-fuconate dehydratase activity,MF,
17576,GO:1901255,0.999999999979989,0.799528168605503,0,2,nucleotide-excision repair involved in interstrand cross-link repair,BP,
6226,GO:0019780,0.99999999998,0.879118847573624,0,1,FAT10 activating enzyme activity,MF,
1730,GO:0004329,0.999999999980004,0.795188518326058,0,2,formate-tetrahydrofolate ligase activity,MF,
4178,GO:0009257,0.999999999980004,0.795188518326058,0,2,10-formyltetrahydrofolate biosynthetic process,BP,
8487,GO:0033676,0.999999999980007,0.915056161770649,0,1,double-stranded DNA-dependent ATPase activity,MF,
18204,GO:1903027,0.999999999980019,0.877978200744749,0,1,regulation of opsonization,BP,
18205,GO:1903028,0.999999999980019,0.877978200744749,0,1,positive regulation of opsonization,BP,
3994,GO:0008894,0.999999999980043,0.899697741374776,0,1,guanosine-5'-triphosphate,3'-diphosphate diphosphatase activity,MF,
8099,GO:0032795,0.999999999980044,0.928020992534045,0,1,heterotrimeric G-protein binding,MF,
4912,GO:0014852,0.99999999998006,0.899013661020325,0,1,regulation of skeletal muscle contraction by neural stimulation via neuromuscular junction,BP,
4913,GO:0014853,0.99999999998006,0.899013661020325,0,1,regulation of excitatory postsynaptic membrane potential involved in skeletal muscle contraction,BP,
5787,GO:0017020,0.99999999998006,0.899013661020325,0,1,myosin phosphatase regulator activity,MF,
16379,GO:0097020,0.99999999998006,0.894027581079114,0,1,COPII adaptor activity,MF,
7715,GO:0032213,0.999999999980129,0.807599422157937,0,2,regulation of telomere maintenance via semi-conservative replication,BP,
7716,GO:0032214,0.999999999980129,0.807599422157937,0,2,negative regulation of telomere maintenance via semi-conservative replication,BP,
18853,GO:1904534,0.999999999980129,0.807599422157937,0,2,negative regulation of telomeric loop disassembly,BP,
19341,GO:1905778,0.999999999980129,0.807599422157937,0,2,negative regulation of exonuclease activity,BP,
19352,GO:1905838,0.999999999980129,0.807599422157937,0,2,regulation of telomeric D-loop disassembly,BP,
19353,GO:1905839,0.999999999980129,0.807599422157937,0,2,negative regulation of telomeric D-loop disassembly,BP,
936,GO:0002337,0.999999999980133,0.813766674057114,0,2,B-1a B cell differentiation,BP,
19898,GO:2000418,0.99999999998016,0.806919915125686,0,2,positive regulation of eosinophil migration,BP,
13221,GO:0051908,0.99999999998016,0.895984361679972,0,1,double-stranded DNA 5'-3' exodeoxyribonuclease activity,MF,
20180,GO:2001069,0.999999999980168,0.809056423659899,0,2,glycogen binding,MF,
13804,GO:0060423,0.999999999980182,0.804865558808348,0,2,foregut regionalization,BP,
13805,GO:0060424,0.999999999980182,0.804865558808348,0,2,lung field specification,BP,
13853,GO:0060492,0.999999999980182,0.804865558808348,0,2,lung induction,BP,
1137,GO:0002729,0.999999999980185,0.834085361790985,0,2,positive regulation of natural killer cell cytokine production,BP,
4773,GO:0010961,0.999999999980191,0.773618079974538,0,2,cellular magnesium ion homeostasis,BP,
8264,GO:0033078,0.999999999980207,0.798547747932105,0,2,extrathymic T cell differentiation,BP,
8663,GO:0034245,0.999999999980222,0.888307868722864,0,1,mitochondrial DNA-directed RNA polymerase complex,CC,
9484,GO:0036138,0.999999999980226,0.878728030964189,0,1,peptidyl-histidine hydroxylation,BP,
9485,GO:0036139,0.999999999980226,0.878728030964189,0,1,peptidyl-histidine dioxygenase activity,MF,
9486,GO:0036140,0.999999999980226,0.878728030964189,0,1,peptidyl-asparagine 3-dioxygenase activity,MF,
9908,GO:0042265,0.999999999980226,0.878728030964189,0,1,peptidyl-asparagine hydroxylation,BP,
17103,GO:0102113,0.999999999980226,0.878728030964189,0,1,hypoxia-inducible factor-asparagine oxygenase activity,MF,
10680,GO:0043973,0.999999999980227,0.901195784532196,0,1,histone H3-K4 acetylation,BP,
8148,GO:0032887,0.999999999980228,0.878430842881035,0,1,regulation of spindle elongation,BP,
8149,GO:0032888,0.999999999980228,0.878430842881035,0,1,regulation of mitotic spindle elongation,BP,
13468,GO:0055028,0.999999999980228,0.878430842881035,0,1,cortical microtubule,CC,
13472,GO:0055048,0.999999999980228,0.878430842881035,0,1,anastral spindle assembly,BP,
15533,GO:0071988,0.999999999980228,0.878430842881035,0,1,protein localization to spindle pole body,BP,
17214,GO:0110028,0.999999999980228,0.878430842881035,0,1,positive regulation of mitotic spindle organization,BP,
17948,GO:1902363,0.999999999980228,0.878430842881035,0,1,regulation of protein localization to spindle pole body,BP,
17949,GO:1902365,0.999999999980228,0.878430842881035,0,1,positive regulation of protein localization to spindle pole body,BP,
18111,GO:1902846,0.999999999980228,0.878430842881035,0,1,positive regulation of mitotic spindle elongation,BP,
19330,GO:1905720,0.999999999980228,0.878430842881035,0,1,cytoplasmic microtubule bundle,CC,
6907,GO:0030505,0.999999999980243,0.77025578071913,0,2,inorganic diphosphate transport,BP,
2052,GO:0004803,0.999999999980258,0.781501166725228,0,2,transposase activity,MF,
8087,GO:0032782,0.999999999980262,0.814678290591107,0,2,bile acid secretion,BP,
2171,GO:0005008,0.999999999980267,0.878958998347473,0,1,hepatocyte growth factor-activated receptor activity,MF,
18949,GO:1904750,0.999999999980267,0.878958998347473,0,1,negative regulation of protein localization to nucleolus,BP,
11972,GO:0047325,0.99999999998028,0.895355356921668,0,1,inositol tetrakisphosphate 1-kinase activity,MF,
13378,GO:0052725,0.99999999998028,0.895355356921668,0,1,inositol-1,3,4-trisphosphate 6-kinase activity,MF,
13379,GO:0052726,0.99999999998028,0.895355356921668,0,1,inositol-1,3,4-trisphosphate 5-kinase activity,MF,
13401,GO:0052825,0.99999999998028,0.895355356921668,0,1,inositol-1,3,4,5,6-pentakisphosphate 1-phosphatase activity,MF,
13406,GO:0052830,0.99999999998028,0.895355356921668,0,1,inositol-1,3,4,6-tetrakisphosphate 6-phosphatase activity,MF,
13407,GO:0052831,0.99999999998028,0.895355356921668,0,1,inositol-1,3,4,6-tetrakisphosphate 1-phosphatase activity,MF,
13411,GO:0052835,0.99999999998028,0.895355356921668,0,1,inositol-3,4,6-trisphosphate 1-kinase activity,MF,
6139,GO:0019417,0.999999999980284,0.791130581587876,0,2,sulfur oxidation,BP,
1959,GO:0004668,0.999999999980284,0.896029023768183,0,1,protein-arginine deiminase activity,MF,
2124,GO:0004921,0.999999999980284,0.896029023768183,0,1,interleukin-11 receptor activity,MF,
5894,GO:0018101,0.999999999980284,0.896029023768183,0,1,protein citrullination,BP,
6316,GO:0019970,0.999999999980284,0.896029023768183,0,1,interleukin-11 binding,MF,
9575,GO:0036414,0.999999999980284,0.896029023768183,0,1,histone citrullination,BP,
9707,GO:0038154,0.999999999980284,0.896029023768183,0,1,interleukin-11-mediated signaling pathway,BP,
10666,GO:0043932,0.999999999980291,0.807624178021893,0,2,ossification involved in bone remodeling,BP,
1668,GO:0004133,0.999999999980294,0.878424363264832,0,1,glycogen debranching enzyme activity,MF,
1669,GO:0004134,0.999999999980294,0.878424363264832,0,1,4-alpha-glucanotransferase activity,MF,
1670,GO:0004135,0.999999999980294,0.878424363264832,0,1,amylo-alpha-1,6-glucosidase activity,MF,
10272,GO:0043033,0.999999999980294,0.878424363264832,0,1,isoamylase complex,CC,
17135,GO:0102500,0.999999999980294,0.878424363264832,0,1,beta-maltose 4-alpha-glucanotransferase activity,MF,
5582,GO:0016603,0.999999999980303,0.817490398556064,0,2,glutaminyl-peptide cyclotransferase activity,MF,
5870,GO:0017186,0.999999999980303,0.817490398556064,0,2,peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase,BP,
12673,GO:0050910,0.999999999980307,0.790611228046697,0,2,detection of mechanical stimulus involved in sensory perception of sound,BP,
8629,GO:0034166,0.999999999980313,0.894713706235919,0,1,toll-like receptor 10 signaling pathway,BP,
10599,GO:0043602,0.999999999980316,0.900339069511703,0,1,nitrate catabolic process,BP,
11588,GO:0046210,0.999999999980316,0.900339069511703,0,1,nitric oxide catabolic process,BP,
12017,GO:0047726,0.999999999980316,0.900339069511703,0,1,iron-cytochrome-c reductase activity,MF,
16258,GO:0090345,0.999999999980316,0.900339069511703,0,1,cellular organohalogen metabolic process,BP,
16259,GO:0090346,0.999999999980316,0.900339069511703,0,1,cellular organofluorine metabolic process,BP,
10650,GO:0043849,0.999999999980327,0.898659326163914,0,1,Ras palmitoyltransferase activity,MF,
8743,GO:0034416,0.999999999980356,0.808186287929459,0,2,bisphosphoglycerate phosphatase activity,MF,
2473,GO:0005690,0.999999999980369,0.810083533776125,0,2,U4atac snRNP,CC,
15031,GO:0071005,0.999999999980369,0.810083533776125,0,2,U2-type precatalytic spliceosome,CC,
3873,GO:0008506,0.999999999980369,0.798954406002545,0,2,sucrose:proton symporter activity,MF,
3881,GO:0008515,0.999999999980369,0.798954406002545,0,2,sucrose transmembrane transporter activity,MF,
4284,GO:0009669,0.999999999980369,0.798954406002545,0,2,sucrose:cation symporter activity,MF,
5004,GO:0015154,0.999999999980369,0.798954406002545,0,2,disaccharide transmembrane transporter activity,MF,
5005,GO:0015157,0.999999999980369,0.798954406002545,0,2,oligosaccharide transmembrane transporter activity,MF,
5187,GO:0015766,0.999999999980369,0.798954406002545,0,2,disaccharide transport,BP,
5188,GO:0015770,0.999999999980369,0.798954406002545,0,2,sucrose transport,BP,
5189,GO:0015772,0.999999999980369,0.798954406002545,0,2,oligosaccharide transport,BP,
10703,GO:0044035,0.999999999980371,0.908418422391137,0,1,multi-organism catabolic process,BP,
10730,GO:0044115,0.999999999980371,0.908418422391137,0,1,development of symbiont involved in interaction with host,BP,
10737,GO:0044145,0.999999999980371,0.908418422391137,0,1,modulation of development of symbiont involved in interaction with host,BP,
10739,GO:0044147,0.999999999980371,0.908418422391137,0,1,negative regulation of development of symbiont involved in interaction with host,BP,
10955,GO:0044730,0.999999999980371,0.908418422391137,0,1,bone sialoprotein binding,MF,
13304,GO:0052214,0.999999999980371,0.908418422391137,0,1,metabolism of substance in other organism involved in symbiotic interaction,BP,
13305,GO:0052227,0.999999999980371,0.908418422391137,0,1,catabolism of substance in other organism involved in symbiotic interaction,BP,
13306,GO:0052229,0.999999999980371,0.908418422391137,0,1,metabolism of macromolecule in other organism involved in symbiotic interaction,BP,
13318,GO:0052360,0.999999999980371,0.908418422391137,0,1,catabolism by host of symbiont macromolecule,BP,
13319,GO:0052361,0.999999999980371,0.908418422391137,0,1,catabolism by organism of macromolecule in other organism involved in symbiotic interaction,BP,
13320,GO:0052362,0.999999999980371,0.908418422391137,0,1,catabolism by host of symbiont protein,BP,
13321,GO:0052363,0.999999999980371,0.908418422391137,0,1,catabolism by organism of protein in other organism involved in symbiotic interaction,BP,
13322,GO:0052364,0.999999999980371,0.908418422391137,0,1,catabolism by host of substance in symbiont,BP,
13326,GO:0052416,0.999999999980371,0.908418422391137,0,1,metabolism by host of symbiont macromolecule,BP,
13327,GO:0052417,0.999999999980371,0.908418422391137,0,1,metabolism by host of symbiont protein,BP,
13328,GO:0052418,0.999999999980371,0.908418422391137,0,1,metabolism by organism of protein in other organism involved in symbiotic interaction,BP,
13329,GO:0052419,0.999999999980371,0.908418422391137,0,1,metabolism by host of substance in symbiont,BP,
19289,GO:1905581,0.999999999980371,0.908418422391137,0,1,positive regulation of low-density lipoprotein particle clearance,BP,
19294,GO:1905597,0.999999999980371,0.908418422391137,0,1,positive regulation of low-density lipoprotein particle receptor binding,BP,
19296,GO:1905599,0.999999999980371,0.908418422391137,0,1,positive regulation of low-density lipoprotein receptor activity,BP,
15258,GO:0071461,0.999999999980372,0.829309344371235,0,2,cellular response to redox state,BP,
12737,GO:0051025,0.999999999980398,0.807588195119759,0,2,negative regulation of immunoglobulin secretion,BP,
1636,GO:0004081,0.999999999980398,0.838598198700195,0,2,bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) activity,MF,
3974,GO:0008796,0.999999999980398,0.838598198700195,0,2,bis(5'-nucleosyl)-tetraphosphatase activity,MF,
1597,GO:0004018,0.999999999980421,0.912718691491742,0,1,N6-(1,2-dicarboxyethyl)AMP AMP-lyase (fumarate-forming) activity,MF,
14835,GO:0070626,0.999999999980421,0.912718691491742,0,1,(S)-2-(5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamido)succinate AMP-lyase (fumarate-forming) activity,MF,
7284,GO:0031289,0.999999999980429,0.897576338879299,0,1,actin phosphorylation,BP,
10561,GO:0043538,0.999999999980429,0.897576338879299,0,1,regulation of actin phosphorylation,BP,
18498,GO:1903697,0.999999999980433,0.894188500152852,0,1,negative regulation of microvillus assembly,BP,
826,GO:0002114,0.999999999980536,0.888386830036525,0,1,interleukin-33 receptor activity,MF,
7831,GO:0032393,0.999999999980548,0.8400556165515,0,2,MHC class I receptor activity,MF,
2687,GO:0006050,0.999999999980551,0.909946429187562,0,1,mannosamine metabolic process,BP,
2688,GO:0006051,0.999999999980551,0.909946429187562,0,1,N-acetylmannosamine metabolic process,BP,
11095,GO:0045127,0.999999999980551,0.909946429187562,0,1,N-acetylglucosamine kinase activity,MF,
5959,GO:0018350,0.999999999980564,0.90059468826793,0,1,protein esterification,BP,
10776,GO:0044258,0.999999999980564,0.90059468826793,0,1,intestinal lipid catabolic process,BP,
15508,GO:0071920,0.999999999980566,0.81188219209868,0,2,cleavage body,CC,
16129,GO:0090164,0.999999999980573,0.790103283198637,0,2,asymmetric Golgi ribbon formation,BP,
1511,GO:0003874,0.999999999980701,0.934857570616126,0,1,6-pyruvoyltetrahydropterin synthase activity,MF,
4241,GO:0009441,0.999999999980701,0.934857570616126,0,1,glycolate metabolic process,BP,
5953,GO:0018323,0.999999999980701,0.934857570616126,0,1,enzyme active site formation via L-cysteine sulfinic acid,BP,
8677,GO:0034309,0.999999999980701,0.934857570616126,0,1,primary alcohol biosynthetic process,BP,
9596,GO:0036470,0.999999999980701,0.934857570616126,0,1,tyrosine 3-monooxygenase activator activity,MF,
9597,GO:0036471,0.999999999980701,0.934857570616126,0,1,cellular response to glyoxal,BP,
9603,GO:0036478,0.999999999980701,0.934857570616126,0,1,L-dopa decarboxylase activator activity,MF,
9638,GO:0036524,0.999999999980701,0.934857570616126,0,1,protein deglycase activity,MF,
9639,GO:0036525,0.999999999980701,0.934857570616126,0,1,protein deglycation,BP,
9640,GO:0036526,0.999999999980701,0.934857570616126,0,1,peptidyl-cysteine deglycation,BP,
9641,GO:0036527,0.999999999980701,0.934857570616126,0,1,peptidyl-arginine deglycation,BP,
9642,GO:0036528,0.999999999980701,0.934857570616126,0,1,peptidyl-lysine deglycation,BP,
9643,GO:0036529,0.999999999980701,0.934857570616126,0,1,protein deglycation, glyoxal removal,BP,
9644,GO:0036530,0.999999999980701,0.934857570616126,0,1,protein deglycation, methylglyoxal removal,BP,
9645,GO:0036531,0.999999999980701,0.934857570616126,0,1,glutathione deglycation,BP,
11194,GO:0045340,0.999999999980701,0.934857570616126,0,1,mercury ion binding,MF,
11596,GO:0046295,0.999999999980701,0.934857570616126,0,1,glycolate biosynthetic process,BP,
17181,GO:0106044,0.999999999980701,0.934857570616126,0,1,guanine deglycation,BP,
17182,GO:0106045,0.999999999980701,0.934857570616126,0,1,guanine deglycation, methylglyoxal removal,BP,
17183,GO:0106046,0.999999999980701,0.934857570616126,0,1,guanine deglycation, glyoxal removal,BP,
17266,GO:0140041,0.999999999980701,0.934857570616126,0,1,cellular detoxification of methylglyoxal,BP,
17716,GO:1901671,0.999999999980701,0.934857570616126,0,1,positive regulation of superoxide dismutase activity,BP,
18229,GO:1903072,0.999999999980701,0.934857570616126,0,1,regulation of death-inducing signaling complex assembly,BP,
18230,GO:1903073,0.999999999980701,0.934857570616126,0,1,negative regulation of death-inducing signaling complex assembly,BP,
18244,GO:1903122,0.999999999980701,0.934857570616126,0,1,negative regulation of TRAIL-activated apoptotic signaling pathway,BP,
18256,GO:1903167,0.999999999980701,0.934857570616126,0,1,regulation of pyrroline-5-carboxylate reductase activity,BP,
18257,GO:1903168,0.999999999980701,0.934857570616126,0,1,positive regulation of pyrroline-5-carboxylate reductase activity,BP,
18261,GO:1903176,0.999999999980701,0.934857570616126,0,1,regulation of tyrosine 3-monooxygenase activity,BP,
18262,GO:1903178,0.999999999980701,0.934857570616126,0,1,positive regulation of tyrosine 3-monooxygenase activity,BP,
18266,GO:1903184,0.999999999980701,0.934857570616126,0,1,L-dopa metabolic process,BP,
18267,GO:1903185,0.999999999980701,0.934857570616126,0,1,L-dopa biosynthetic process,BP,
18268,GO:1903189,0.999999999980701,0.934857570616126,0,1,glyoxal metabolic process,BP,
18269,GO:1903195,0.999999999980701,0.934857570616126,0,1,regulation of L-dopa biosynthetic process,BP,
18270,GO:1903197,0.999999999980701,0.934857570616126,0,1,positive regulation of L-dopa biosynthetic process,BP,
18271,GO:1903198,0.999999999980701,0.934857570616126,0,1,regulation of L-dopa decarboxylase activity,BP,
18272,GO:1903200,0.999999999980701,0.934857570616126,0,1,positive regulation of L-dopa decarboxylase activity,BP,
18990,GO:1904833,0.999999999980701,0.934857570616126,0,1,positive regulation of removal of superoxide radicals,BP,
19798,GO:2000277,0.999999999980701,0.934857570616126,0,1,positive regulation of oxidative phosphorylation uncoupler activity,BP,
19804,GO:2000284,0.999999999980701,0.934857570616126,0,1,positive regulation of cellular amino acid biosynthetic process,BP,
6871,GO:0030372,0.999999999980728,0.880963626821016,0,1,high molecular weight B cell growth factor receptor binding,MF,
1745,GO:0004347,0.999999999980731,0.9018529682949,0,1,glucose-6-phosphate isomerase activity,MF,
6082,GO:0019242,0.999999999980731,0.9018529682949,0,1,methylglyoxal biosynthetic process,BP,
2358,GO:0005459,0.999999999980736,0.83687645148817,0,2,UDP-galactose transmembrane transporter activity,MF,
15727,GO:0072334,0.999999999980736,0.83687645148817,0,2,UDP-galactose transmembrane transport,BP,
8898,GO:0034739,0.999999999980738,0.818779443330075,0,2,histone deacetylase activity (H4-K16 specific),MF,
11038,GO:0045041,0.999999999980744,0.821179156671684,0,2,protein import into mitochondrial intermembrane space,BP,
7542,GO:0031859,0.99999999998077,0.903597861422528,0,1,platelet activating factor receptor binding,MF,
9864,GO:0042137,0.99999999998077,0.903597861422528,0,1,sequestering of neurotransmitter,BP,
15040,GO:0071020,0.999999999980771,0.821344009171137,0,2,post-spliceosomal complex,CC,
5762,GO:0016938,0.999999999980773,0.89839805373769,0,1,kinesin I complex,CC,
1564,GO:0003973,0.999999999980786,0.879395075528578,0,1,(S)-2-hydroxy-acid oxidase activity,MF,
6313,GO:0019962,0.999999999980786,0.879395075528578,0,1,type I interferon binding,MF,
11997,GO:0047545,0.999999999980786,0.879395075528578,0,1,2-hydroxyglutarate dehydrogenase activity,MF,
1728,GO:0004325,0.99999999998079,0.878354414355515,0,1,ferrochelatase activity,MF,
4609,GO:0010729,0.999999999980804,0.90233257977167,0,1,positive regulation of hydrogen peroxide biosynthetic process,BP,
2629,GO:0005956,0.999999999980814,0.832904833490664,0,2,protein kinase CK2 complex,CC,
1560,GO:0003963,0.999999999980816,0.810167015651692,0,2,RNA-3'-phosphate cyclase activity,MF,
2623,GO:0005945,0.999999999980825,0.802921696132473,0,2,6-phosphofructokinase complex,CC,
2364,GO:0005477,0.999999999980835,0.891811189206987,0,1,pyruvate secondary active transmembrane transporter activity,MF,
10132,GO:0042720,0.99999999998087,0.85847885291246,0,2,mitochondrial inner membrane peptidase complex,CC,
8536,GO:0033882,0.999999999980872,0.924526310400392,0,1,choloyl-CoA hydrolase activity,MF,
11150,GO:0045222,0.999999999980872,0.924526310400392,0,1,CD4 biosynthetic process,BP,
11151,GO:0045223,0.999999999980872,0.924526310400392,0,1,regulation of CD4 biosynthetic process,BP,
11152,GO:0045225,0.999999999980872,0.924526310400392,0,1,negative regulation of CD4 biosynthetic process,BP,
13398,GO:0052815,0.999999999980872,0.924526310400392,0,1,medium-chain acyl-CoA hydrolase activity,MF,
2417,GO:0005592,0.999999999980881,0.878333355197452,0,1,collagen type XI trimer,CC,
4165,GO:0009233,0.999999999980882,0.890390575964251,0,1,menaquinone metabolic process,BP,
4166,GO:0009234,0.999999999980882,0.890390575964251,0,1,menaquinone biosynthetic process,BP,
7700,GO:0032194,0.999999999980882,0.890390575964251,0,1,ubiquinone biosynthetic process via 3,4-dihydroxy-5-polyprenylbenzoate,BP,
9967,GO:0042371,0.999999999980882,0.890390575964251,0,1,vitamin K biosynthetic process,BP,
15748,GO:0072365,0.999999999980887,0.876473103972855,0,1,regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter,BP,
856,GO:0002189,0.999999999980897,0.900278455473946,0,1,ribose phosphate diphosphokinase complex,CC,
18427,GO:1903537,0.999999999980907,0.809899633522947,0,2,meiotic cell cycle process involved in oocyte maturation,BP,
18428,GO:1903538,0.999999999980907,0.809899633522947,0,2,regulation of meiotic cell cycle process involved in oocyte maturation,BP,
253,GO:0000718,0.999999999980923,0.906453883060353,0,1,nucleotide-excision repair, DNA damage removal,BP,
1673,GO:0004139,0.999999999980923,0.906453883060353,0,1,deoxyribose-phosphate aldolase activity,MF,
10838,GO:0044349,0.999999999980923,0.906453883060353,0,1,DNA excision,BP,
11642,GO:0046403,0.999999999980923,0.906453883060353,0,1,polynucleotide 3'-phosphatase activity,MF,
16721,GO:0098503,0.999999999980923,0.906453883060353,0,1,DNA 3' dephosphorylation,BP,
16722,GO:0098504,0.999999999980923,0.906453883060353,0,1,DNA 3' dephosphorylation involved in DNA repair,BP,
16724,GO:0098506,0.999999999980923,0.906453883060353,0,1,polynucleotide 3' dephosphorylation,BP,
8376,GO:0033292,0.999999999980929,0.769462272186584,0,2,T-tubule organization,BP,
2486,GO:0005731,0.999999999980933,0.9066350743182,0,1,nucleolus organizer region,CC,
3347,GO:0007072,0.999999999980933,0.9066350743182,0,1,positive regulation of transcription involved in exit from mitosis,BP,
7074,GO:0030874,0.999999999980933,0.9066350743182,0,1,nucleolar chromatin,CC,
16557,GO:0097372,0.999999999980933,0.9066350743182,0,1,NAD-dependent histone deacetylase activity (H3-K18 specific),MF,
14997,GO:0070949,0.999999999980938,0.821311503706227,0,2,regulation of neutrophil mediated killing of symbiont cell,BP,
15001,GO:0070960,0.999999999980938,0.821311503706227,0,2,positive regulation of neutrophil mediated cytotoxicity,BP,
15002,GO:0070961,0.999999999980938,0.821311503706227,0,2,positive regulation of neutrophil mediated killing of symbiont cell,BP,
18688,GO:1904116,0.999999999980978,0.708398825349861,0,3,response to vasopressin,BP,
18689,GO:1904117,0.999999999980978,0.708398825349861,0,3,cellular response to vasopressin,BP,
668,GO:0001878,0.999999999980995,0.90081230334825,0,1,response to yeast,BP,
4217,GO:0009386,0.999999999980995,0.90081230334825,0,1,translational attenuation,BP,
14452,GO:0061847,0.999999999980995,0.90081230334825,0,1,response to cholecystokinin,BP,
15299,GO:0071538,0.999999999980995,0.90081230334825,0,1,SH2 domain-mediated complex assembly,BP,
19622,GO:1990839,0.999999999980995,0.90081230334825,0,1,response to endothelin,BP,
19626,GO:1990859,0.999999999980995,0.90081230334825,0,1,cellular response to endothelin,BP,
2416,GO:0005591,0.999999999981015,0.900065131395623,0,1,collagen type VIII trimer,CC,
2422,GO:0005598,0.999999999981015,0.900065131395623,0,1,short-chain collagen trimer,CC,
7112,GO:0030935,0.999999999981015,0.900065131395623,0,1,sheet-forming collagen trimer,CC,
16782,GO:0098646,0.999999999981015,0.900065131395623,0,1,collagen sheet,CC,
14616,GO:0070209,0.999999999981034,0.894311642733946,0,1,ASTRA complex,CC,
18617,GO:1903939,0.999999999981034,0.894311642733946,0,1,regulation of TORC2 signaling,BP,
18845,GO:1904515,0.999999999981034,0.894311642733946,0,1,positive regulation of TORC2 signaling,BP,
12033,GO:0047915,0.999999999981039,0.9073966986332,0,1,ganglioside galactosyltransferase activity,MF,
2360,GO:0005462,0.999999999981049,0.792208518086037,0,2,UDP-N-acetylglucosamine transmembrane transporter activity,MF,
19540,GO:1990569,0.999999999981049,0.792208518086037,0,2,UDP-N-acetylglucosamine transmembrane transport,BP,
6265,GO:0019863,0.999999999981067,0.915089632027398,0,1,IgE binding,MF,
11292,GO:0045626,0.999999999981074,0.792320551162161,0,2,negative regulation of T-helper 1 cell differentiation,BP,
2212,GO:0005105,0.999999999981084,0.900913495077498,0,1,type 1 fibroblast growth factor receptor binding,MF,
16263,GO:0090365,0.999999999981085,0.901301328596605,0,1,regulation of mRNA modification,BP,
16264,GO:0090367,0.999999999981085,0.901301328596605,0,1,negative regulation of mRNA modification,BP,
18283,GO:1903215,0.999999999981085,0.901301328596605,0,1,negative regulation of protein targeting to mitochondrion,BP,
20194,GO:2001144,0.999999999981085,0.901301328596605,0,1,regulation of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity,BP,
20195,GO:2001145,0.999999999981085,0.901301328596605,0,1,negative regulation of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity,BP,
10125,GO:0042700,0.999999999981108,0.881640862280091,0,1,luteinizing hormone signaling pathway,BP,
12095,GO:0048160,0.999999999981108,0.881640862280091,0,1,primary follicle stage,BP,
19141,GO:1905203,0.999999999981108,0.808657995698043,0,2,regulation of connective tissue replacement,BP,
15292,GO:0071505,0.999999999981111,0.806092082301237,0,2,response to mycophenolic acid,BP,
15293,GO:0071506,0.999999999981111,0.806092082301237,0,2,cellular response to mycophenolic acid,BP,
14426,GO:0061768,0.999999999981117,0.880776681127139,0,1,magnesium:sodium antiporter activity,MF,
15322,GO:0071567,0.999999999981128,0.839472426522077,0,2,UFM1 hydrolase activity,MF,
2636,GO:0005969,0.999999999981135,0.877418957367262,0,1,serine-pyruvate aminotransferase complex,CC,
5374,GO:0016189,0.999999999981135,0.877418957367262,0,1,synaptic vesicle to endosome fusion,BP,
2111,GO:0004897,0.999999999981141,0.692645166163851,0,3,ciliary neurotrophic factor receptor activity,MF,
14557,GO:0070120,0.999999999981141,0.692645166163851,0,3,ciliary neurotrophic factor-mediated signaling pathway,BP,
11966,GO:0047290,0.999999999981154,0.908192941441995,0,1,(alpha-N-acetylneuraminyl-2,3-beta-galactosyl-1,3)-N-acetyl-galactosaminide 6-alpha-sialyltransferase activity,MF,
18654,GO:1904021,0.999999999981154,0.89343880273361,0,1,negative regulation of G-protein coupled receptor internalization,BP,
309,GO:0000821,0.999999999981157,0.876185344367288,0,1,regulation of arginine metabolic process,BP,
8352,GO:0033241,0.999999999981157,0.876185344367288,0,1,regulation of cellular amine catabolic process,BP,
8353,GO:0033242,0.999999999981157,0.876185344367288,0,1,negative regulation of cellular amine catabolic process,BP,
9610,GO:0036487,0.999999999981157,0.876185344367288,0,1,nitric-oxide synthase inhibitor activity,MF,
15484,GO:0071878,0.999999999981157,0.876185344367288,0,1,negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway,BP,
16815,GO:0098736,0.999999999981157,0.876185344367288,0,1,negative regulation of the force of heart contraction,BP,
17299,GO:0140199,0.999999999981157,0.876185344367288,0,1,negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process,BP,
17345,GO:1900081,0.999999999981157,0.876185344367288,0,1,regulation of arginine catabolic process,BP,
17346,GO:1900082,0.999999999981157,0.876185344367288,0,1,negative regulation of arginine catabolic process,BP,
18296,GO:1903248,0.999999999981157,0.876185344367288,0,1,regulation of citrulline biosynthetic process,BP,
18297,GO:1903249,0.999999999981157,0.876185344367288,0,1,negative regulation of citrulline biosynthetic process,BP,
19803,GO:2000283,0.999999999981157,0.876185344367288,0,1,negative regulation of cellular amino acid biosynthetic process,BP,
8868,GO:0034686,0.999999999981162,0.769964732042995,0,2,integrin alphav-beta8 complex,CC,
9343,GO:0035866,0.999999999981162,0.769964732042995,0,2,alphav-beta3 integrin-PKCalpha complex,CC,
19512,GO:1990430,0.999999999981162,0.769964732042995,0,2,extracellular matrix protein binding,MF,
15761,GO:0072387,0.999999999981163,0.801393905881928,0,2,flavin adenine dinucleotide metabolic process,BP,
7669,GO:0032106,0.999999999981169,0.733909024114013,0,3,positive regulation of response to extracellular stimulus,BP,
7672,GO:0032109,0.999999999981169,0.733909024114013,0,3,positive regulation of response to nutrient levels,BP,
8430,GO:0033560,0.999999999981169,0.887109186925833,0,1,folate reductase activity,MF,
13193,GO:0051870,0.999999999981169,0.887109186925833,0,1,methotrexate binding,MF,
15963,GO:0080163,0.999999999981176,0.900586510247429,0,1,regulation of protein serine/threonine phosphatase activity,BP,
3821,GO:0008422,0.999999999981177,0.783325093661315,0,2,beta-glucosidase activity,MF,
2775,GO:0006203,0.999999999981178,0.765124745695579,0,3,dGTP catabolic process,BP,
13609,GO:0060126,0.999999999981182,0.799490462936662,0,2,somatotropin secreting cell differentiation,BP,
3637,GO:0008107,0.999999999981189,0.793072591587474,0,2,galactoside 2-alpha-L-fucosyltransferase activity,MF,
7224,GO:0031127,0.999999999981189,0.793072591587474,0,2,alpha-(1,2)-fucosyltransferase activity,MF,
16640,GO:0097536,0.999999999981196,0.899844992304568,0,1,thymus epithelium morphogenesis,BP,
247,GO:0000706,0.999999999981216,0.792665041460787,0,2,meiotic DNA double-strand break processing,BP,
19643,GO:1990918,0.999999999981216,0.792665041460787,0,2,double-strand break repair involved in meiotic recombination,BP,
7335,GO:0031370,0.999999999981226,0.881138820420385,0,1,eukaryotic initiation factor 4G binding,MF,
7648,GO:0032076,0.999999999981232,0.899787233896668,0,1,negative regulation of deoxyribonuclease activity,BP,
9543,GO:0036316,0.999999999981232,0.899787233896668,0,1,SREBP-SCAP complex retention in endoplasmic reticulum,BP,
13969,GO:0060703,0.999999999981232,0.899787233896668,0,1,deoxyribonuclease inhibitor activity,MF,
14693,GO:0070346,0.999999999981232,0.899787233896668,0,1,positive regulation of fat cell proliferation,BP,
17594,GO:1901303,0.999999999981232,0.899787233896668,0,1,negative regulation of cargo loading into COPII-coated vesicle,BP,
17996,GO:1902511,0.999999999981232,0.899787233896668,0,1,negative regulation of apoptotic DNA fragmentation,BP,
18474,GO:1903625,0.999999999981232,0.899787233896668,0,1,negative regulation of DNA catabolic process,BP,
43,GO:0000095,0.999999999981247,0.901094903702162,0,1,S-adenosyl-L-methionine transmembrane transporter activity,MF,
5205,GO:0015805,0.999999999981247,0.901094903702162,0,1,S-adenosyl-L-methionine transport,BP,
17793,GO:1901962,0.999999999981247,0.901094903702162,0,1,S-adenosyl-L-methionine transmembrane transport,BP,
4404,GO:0010157,0.999999999981253,0.877677622222641,0,1,response to chlorate,BP,
16425,GO:0097108,0.999999999981253,0.877677622222641,0,1,hedgehog family protein binding,MF,
16905,GO:0098904,0.999999999981257,0.807122539579767,0,2,regulation of AV node cell action potential,BP,
15081,GO:0071144,0.999999999981258,0.76781526076653,0,2,heteromeric SMAD protein complex,CC,
18384,GO:1903434,0.999999999981275,0.887792741516483,0,1,negative regulation of constitutive secretory pathway,BP,
1314,GO:0003164,0.999999999981277,0.77506911885953,0,2,His-Purkinje system development,BP,
1886,GO:0004569,0.999999999981277,0.881895663552936,0,1,glycoprotein endo-alpha-1,2-mannosidase activity,MF,
6370,GO:0021560,0.99999999998129,0.8051811415234,0,2,abducens nerve development,BP,
6389,GO:0021598,0.99999999998129,0.8051811415234,0,2,abducens nerve morphogenesis,BP,
6390,GO:0021599,0.99999999998129,0.8051811415234,0,2,abducens nerve formation,BP,
18372,GO:1903420,0.999999999981294,0.879168851459926,0,1,protein localization to endoplasmic reticulum tubular network,BP,
4212,GO:0009372,0.999999999981312,0.895061006050273,0,1,quorum sensing,BP,
9570,GO:0036398,0.999999999981312,0.895061006050273,0,1,TCR signalosome,CC,
9571,GO:0036399,0.999999999981312,0.895061006050273,0,1,TCR signalosome assembly,BP,
12409,GO:0048874,0.999999999981312,0.895061006050273,0,1,homeostasis of number of cells in a free-living population,BP,
13287,GO:0052097,0.999999999981312,0.895061006050273,0,1,interspecies quorum sensing,BP,
13288,GO:0052106,0.999999999981312,0.895061006050273,0,1,quorum sensing involved in interaction with host,BP,
13987,GO:0060730,0.999999999981312,0.895061006050273,0,1,regulation of intestinal epithelial structure maintenance,BP,
13988,GO:0060731,0.999999999981312,0.895061006050273,0,1,positive regulation of intestinal epithelial structure maintenance,BP,
14879,GO:0070715,0.999999999981312,0.895061006050273,0,1,sodium-dependent organic cation transport,BP,
15328,GO:0071579,0.999999999981322,0.902428684723005,0,1,regulation of zinc ion transport,BP,
15329,GO:0071580,0.999999999981322,0.902428684723005,0,1,regulation of zinc ion transmembrane transport,BP,
15330,GO:0071581,0.999999999981322,0.902428684723005,0,1,regulation of zinc ion transmembrane import,BP,
15331,GO:0071582,0.999999999981322,0.902428684723005,0,1,negative regulation of zinc ion transport,BP,
15332,GO:0071583,0.999999999981322,0.902428684723005,0,1,negative regulation of zinc ion transmembrane transport,BP,
15333,GO:0071584,0.999999999981322,0.902428684723005,0,1,negative regulation of zinc ion transmembrane import,BP,
15334,GO:0071585,0.999999999981322,0.902428684723005,0,1,detoxification of cadmium ion,BP,
19447,GO:1990170,0.999999999981322,0.902428684723005,0,1,stress response to cadmium ion,BP,
1017,GO:0002514,0.999999999981322,0.881474476393635,0,1,B cell tolerance induction,BP,
1076,GO:0002649,0.999999999981322,0.881474476393635,0,1,regulation of tolerance induction to self antigen,BP,
1077,GO:0002651,0.999999999981322,0.881474476393635,0,1,positive regulation of tolerance induction to self antigen,BP,
1079,GO:0002661,0.999999999981322,0.881474476393635,0,1,regulation of B cell tolerance induction,BP,
1080,GO:0002663,0.999999999981322,0.881474476393635,0,1,positive regulation of B cell tolerance induction,BP,
2178,GO:0005026,0.999999999981322,0.881474476393635,0,1,transforming growth factor beta receptor activity, type II,MF,
19187,GO:1905317,0.999999999981322,0.881474476393635,0,1,inferior endocardial cushion morphogenesis,BP,
6962,GO:0030623,0.999999999981335,0.878289708417961,0,1,U5 snRNA binding,MF,
644,GO:0001835,0.999999999981336,0.895413627337504,0,1,blastocyst hatching,BP,
9003,GO:0035188,0.999999999981336,0.895413627337504,0,1,hatching,BP,
15398,GO:0071684,0.999999999981336,0.895413627337504,0,1,organism emergence from protective structure,BP,
1835,GO:0004492,0.999999999981354,0.90166826684064,0,1,methylmalonyl-CoA decarboxylase activity,MF,
1263,GO:0003025,0.999999999981363,0.78596459555547,0,2,regulation of systemic arterial blood pressure by baroreceptor feedback,BP,
19089,GO:1905042,0.999999999981377,0.901039020406892,0,1,negative regulation of epithelium regeneration,BP,
11472,GO:0045950,0.99999999998138,0.809292449591604,0,2,negative regulation of mitotic recombination,BP,
1760,GO:0004365,0.9999999999814,0.918331266915727,0,1,glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity,MF,
6247,GO:0019828,0.9999999999814,0.918331266915727,0,1,aspartic-type endopeptidase inhibitor activity,MF,
9207,GO:0035605,0.9999999999814,0.918331266915727,0,1,peptidyl-cysteine S-nitrosylase activity,MF,
10654,GO:0043891,0.9999999999814,0.918331266915727,0,1,glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity,MF,
12014,GO:0047708,0.999999999981419,0.902034139223909,0,1,biotinidase activity,MF,
13771,GO:0060380,0.999999999981419,0.902034139223909,0,1,regulation of single-stranded telomeric DNA binding,BP,
13772,GO:0060381,0.999999999981419,0.902034139223909,0,1,positive regulation of single-stranded telomeric DNA binding,BP,
519,GO:0001605,0.999999999981426,0.880401954105174,0,1,adrenomedullin receptor activity,MF,
2136,GO:0004948,0.999999999981426,0.880401954105174,0,1,calcitonin receptor activity,MF,
15165,GO:0071324,0.999999999981426,0.880401954105174,0,1,cellular response to disaccharide stimulus,BP,
15167,GO:0071329,0.999999999981426,0.880401954105174,0,1,cellular response to sucrose stimulus,BP,
18252,GO:1903143,0.999999999981426,0.880401954105174,0,1,adrenomedullin receptor complex,CC,
19500,GO:1990409,0.999999999981426,0.880401954105174,0,1,adrenomedullin binding,MF,
3056,GO:0006617,0.999999999981428,0.84449201784305,0,2,SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition,BP,
12475,GO:0050508,0.999999999981434,0.795199945996135,0,2,glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity,MF,
12476,GO:0050509,0.999999999981434,0.795199945996135,0,2,N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity,MF,
5393,GO:0016232,0.999999999981435,0.899322503318926,0,1,HNK-1 sulfotransferase activity,MF,
1622,GO:0004060,0.999999999981444,0.902410950843433,0,1,arylamine N-acetyltransferase activity,MF,
4268,GO:0009624,0.999999999981454,0.900111244945953,0,1,response to nematode,BP,
4286,GO:0009692,0.999999999981454,0.900111244945953,0,1,ethylene metabolic process,BP,
4287,GO:0009698,0.999999999981454,0.900111244945953,0,1,phenylpropanoid metabolic process,BP,
4316,GO:0009804,0.999999999981454,0.900111244945953,0,1,coumarin metabolic process,BP,
5628,GO:0016711,0.999999999981454,0.900111244945953,0,1,flavonoid 3'-monooxygenase activity,MF,
6102,GO:0019341,0.999999999981454,0.900111244945953,0,1,dibenzo-p-dioxin catabolic process,BP,
10508,GO:0043449,0.999999999981454,0.900111244945953,0,1,cellular alkene metabolic process,BP,
15618,GO:0072137,0.999999999981458,0.854874184443363,0,1,condensed mesenchymal cell proliferation,BP,
2748,GO:0006148,0.999999999981462,0.90053989663859,0,1,inosine catabolic process,BP,
3142,GO:0006738,0.999999999981462,0.90053989663859,0,1,nicotinamide riboside catabolic process,BP,
11687,GO:0046495,0.999999999981462,0.90053989663859,0,1,nicotinamide riboside metabolic process,BP,
14842,GO:0070637,0.999999999981462,0.90053989663859,0,1,pyridine nucleoside metabolic process,BP,
14843,GO:0070638,0.999999999981462,0.90053989663859,0,1,pyridine nucleoside catabolic process,BP,
11825,GO:0046813,0.999999999981499,0.821210440260451,0,2,receptor-mediated virion attachment to host cell,BP,
2239,GO:0005150,0.999999999981502,0.806713285953954,0,2,interleukin-1, Type I receptor binding,MF,
2372,GO:0005502,0.999999999981508,0.881382853700117,0,1,11-cis retinal binding,MF,
2373,GO:0005503,0.999999999981508,0.881382853700117,0,1,all-trans retinal binding,MF,
14464,GO:0061896,0.999999999981508,0.881382853700117,0,1,all-trans retinol 3,4-desaturase activity,MF,
14465,GO:0061897,0.999999999981508,0.881382853700117,0,1,all-trans retinal 3,4-desaturase activity,MF,
14466,GO:0061898,0.999999999981508,0.881382853700117,0,1,all-trans retinoic acid 3,4-desaturase activity,MF,
14467,GO:0061899,0.999999999981508,0.881382853700117,0,1,11-cis-retinal 3,4-desaturase activity,MF,
14396,GO:0061709,0.999999999981516,0.878944476589497,0,1,reticulophagy,BP,
10377,GO:0043221,0.999999999981526,0.887710157679681,0,1,SMC family protein binding,MF,
7448,GO:0031592,0.999999999981535,0.877527026573247,0,1,centrosomal corona,CC,
18825,GO:1904454,0.999999999981535,0.877527026573247,0,1,ubiquitin-specific protease activity involved in positive regulation of ERAD pathway,MF,
18303,GO:1903279,0.999999999981539,0.797144496227483,0,2,regulation of calcium:sodium antiporter activity,BP,
18304,GO:1903281,0.999999999981539,0.797144496227483,0,2,positive regulation of calcium:sodium antiporter activity,BP,
5533,GO:0016520,0.999999999981561,0.881784446121279,0,1,growth hormone-releasing hormone receptor activity,MF,
3996,GO:0008900,0.999999999981564,0.891267859649143,0,1,potassium:proton exchanging ATPase activity,MF,
5466,GO:0016401,0.999999999981574,0.794396619928051,0,2,palmitoyl-CoA oxidase activity,MF,
14648,GO:0070274,0.999999999981582,0.822432598443741,0,2,RES complex,CC,
3576,GO:0007621,0.999999999981585,0.878131912171698,0,1,negative regulation of female receptivity,BP,
16350,GO:0090673,0.999999999981589,0.878275033999386,0,1,endothelial cell-matrix adhesion,BP,
3732,GO:0008269,0.99999999998159,0.901180172903897,0,1,JAK pathway signal transduction adaptor activity,MF,
4317,GO:0009810,0.99999999998159,0.901180172903897,0,1,stilbene metabolic process,BP,
8538,GO:0033885,0.99999999998159,0.901180172903897,0,1,10-hydroxy-9-(phosphonooxy)octadecanoate phosphatase activity,MF,
11592,GO:0046272,0.99999999998159,0.901180172903897,0,1,stilbene catabolic process,BP,
15346,GO:0071606,0.999999999981596,0.90274843634927,0,1,chemokine (C-C motif) ligand 4 production,BP,
15373,GO:0071643,0.999999999981596,0.90274843634927,0,1,regulation of chemokine (C-C motif) ligand 4 production,BP,
15374,GO:0071644,0.999999999981596,0.90274843634927,0,1,negative regulation of chemokine (C-C motif) ligand 4 production,BP,
15861,GO:0072615,0.999999999981596,0.90274843634927,0,1,interleukin-17 secretion,BP,
19108,GO:1905076,0.999999999981596,0.90274843634927,0,1,regulation of interleukin-17 secretion,BP,
19109,GO:1905077,0.999999999981596,0.90274843634927,0,1,negative regulation of interleukin-17 secretion,BP,
19223,GO:1905403,0.999999999981596,0.90274843634927,0,1,negative regulation of activated CD8-positive, alpha-beta T cell apoptotic process,BP,
2900,GO:0006408,0.999999999981604,0.817052604461823,0,2,snRNA export from nucleus,BP,
11209,GO:0045356,0.999999999981605,0.790315490115433,0,2,positive regulation of interferon-alpha biosynthetic process,BP,
6684,GO:0030060,0.999999999981606,0.762515248515155,0,3,L-malate dehydrogenase activity,MF,
16053,GO:0090034,0.999999999981612,0.804703672502655,0,2,regulation of chaperone-mediated protein complex assembly,BP,
16054,GO:0090035,0.999999999981612,0.804703672502655,0,2,positive regulation of chaperone-mediated protein complex assembly,BP,
13902,GO:0060584,0.999999999981614,0.795662883090571,0,2,regulation of prostaglandin-endoperoxide synthase activity,BP,
13903,GO:0060585,0.999999999981614,0.795662883090571,0,2,positive regulation of prostaglandin-endoperoxide synthase activity,BP,
19380,GO:1905918,0.999999999981637,0.901413690275682,0,1,regulation of CoA-transferase activity,BP,
19381,GO:1905920,0.999999999981637,0.901413690275682,0,1,positive regulation of CoA-transferase activity,BP,
6021,GO:0019082,0.999999999981642,0.884412720647215,0,1,viral protein processing,BP,
16288,GO:0090472,0.999999999981642,0.884412720647215,0,1,dibasic protein processing,BP,
9201,GO:0035598,0.999999999981644,0.895072872966959,0,1,N6-threonylcarbomyladenosine methylthiotransferase activity,MF,
14398,GO:0061712,0.999999999981644,0.895072872966959,0,1,tRNA (N(6)-L-threonylcarbamoyladenosine(37)-C(2))-methylthiotransferase,MF,
17439,GO:1900248,0.999999999981649,0.773723160734716,0,2,negative regulation of cytoplasmic translational elongation,BP,
1508,GO:0003870,0.999999999981659,0.90072327612679,0,1,5-aminolevulinate synthase activity,MF,
5651,GO:0016749,0.999999999981659,0.90072327612679,0,1,N-succinyltransferase activity,MF,
2361,GO:0005464,0.999999999981663,0.87881855627309,0,1,UDP-xylose transmembrane transporter activity,MF,
5195,GO:0015790,0.999999999981663,0.87881855627309,0,1,UDP-xylose transmembrane transport,BP,
1362,GO:0003249,0.99999999998168,0.761377942002124,0,2,cell proliferation involved in heart valve morphogenesis,BP,
1363,GO:0003250,0.99999999998168,0.761377942002124,0,2,regulation of cell proliferation involved in heart valve morphogenesis,BP,
20092,GO:2000793,0.99999999998168,0.761377942002124,0,2,cell proliferation involved in heart valve development,BP,
2964,GO:0006500,0.999999999981719,0.901547385986379,0,1,N-terminal protein palmitoylation,BP,
5876,GO:0018009,0.999999999981719,0.901547385986379,0,1,N-terminal peptidyl-L-cysteine N-palmitoylation,BP,
13686,GO:0060265,0.999999999981732,0.939143348259625,0,1,positive regulation of respiratory burst involved in inflammatory response,BP,
19953,GO:2000562,0.999999999981734,0.802588529551332,0,2,negative regulation of CD4-positive, alpha-beta T cell proliferation,BP,
6496,GO:0021870,0.999999999981803,0.879400372058044,0,1,Cajal-Retzius cell differentiation,BP,
18973,GO:1904797,0.999999999981803,0.879400372058044,0,1,negative regulation of core promoter binding,BP,
15831,GO:0072570,0.999999999981812,0.895523766264499,0,1,ADP-D-ribose binding,MF,
2411,GO:0005586,0.999999999981826,0.879722807645283,0,1,collagen type III trimer,CC,
4484,GO:0010509,0.999999999981826,0.879722807645283,0,1,polyamine homeostasis,BP,
9923,GO:0042284,0.999999999981839,0.904297686310348,0,1,sphingolipid delta-4 desaturase activity,MF,
6779,GO:0030222,0.999999999981843,0.890673692251743,0,1,eosinophil differentiation,BP,
11304,GO:0045643,0.999999999981843,0.890673692251743,0,1,regulation of eosinophil differentiation,BP,
11305,GO:0045645,0.999999999981843,0.890673692251743,0,1,positive regulation of eosinophil differentiation,BP,
2167,GO:0005004,0.999999999981851,0.879208997614174,0,1,GPI-linked ephrin receptor activity,MF,
16453,GO:0097156,0.999999999981851,0.879208997614174,0,1,fasciculation of motor neuron axon,BP,
16457,GO:0097161,0.999999999981851,0.879208997614174,0,1,DH domain binding,MF,
18834,GO:1904477,0.999999999981851,0.879208997614174,0,1,positive regulation of Ras GTPase binding,BP,
19114,GO:1905099,0.999999999981851,0.879208997614174,0,1,positive regulation of guanyl-nucleotide exchange factor activity,BP,
20185,GO:2001108,0.999999999981851,0.879208997614174,0,1,positive regulation of Rho guanyl-nucleotide exchange factor activity,BP,
4248,GO:0009450,0.99999999998187,0.77503063463272,0,2,gamma-aminobutyric acid catabolic process,BP,
10745,GO:0044205,0.999999999981871,0.713112705868536,0,3,'de novo' UMP biosynthetic process,BP,
1727,GO:0004324,0.999999999981873,0.903686176453752,0,1,ferredoxin-NADP+ reductase activity,MF,
4962,GO:0015039,0.999999999981873,0.903686176453752,0,1,NADPH-adrenodoxin reductase activity,MF,
5641,GO:0016730,0.999999999981873,0.903686176453752,0,1,oxidoreductase activity, acting on iron-sulfur proteins as donors,MF,
5642,GO:0016731,0.999999999981873,0.903686176453752,0,1,oxidoreductase activity, acting on iron-sulfur proteins as donors, NAD or NADP as acceptor,MF,
3878,GO:0008511,0.999999999981873,0.878759859318258,0,1,sodium:potassium:chloride symporter activity,MF,
4285,GO:0009674,0.999999999981873,0.878759859318258,0,1,potassium:sodium symporter activity,MF,
5098,GO:0015378,0.999999999981873,0.878759859318258,0,1,sodium:chloride symporter activity,MF,
11388,GO:0045795,0.999999999981873,0.878759859318258,0,1,positive regulation of cell volume,BP,
11917,GO:0046979,0.999999999981881,0.736974942996436,0,3,TAP2 binding,MF,
10240,GO:0042988,0.999999999981885,0.880062930745161,0,1,X11-like protein binding,MF,
2496,GO:0005745,0.99999999998189,0.808241868911042,0,2,m-AAA complex,CC,
15702,GO:0072287,0.99999999998191,0.862260009841263,0,1,metanephric distal tubule morphogenesis,BP,
15296,GO:0071528,0.999999999981921,0.887487945940382,0,1,tRNA re-export from nucleus,BP,
1786,GO:0004416,0.999999999981923,0.81750639942303,0,2,hydroxyacylglutathione hydrolase activity,MF,
6083,GO:0019243,0.999999999981923,0.81750639942303,0,2,methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione,BP,
13066,GO:0051596,0.999999999981923,0.81750639942303,0,2,methylglyoxal catabolic process,BP,
14403,GO:0061727,0.999999999981923,0.81750639942303,0,2,methylglyoxal catabolic process to lactate,BP,
18074,GO:1902725,0.999999999981934,0.879316260653799,0,1,negative regulation of satellite cell differentiation,BP,
8475,GO:0033633,0.999999999981937,0.880800821343265,0,1,negative regulation of cell-cell adhesion mediated by integrin,BP,
4847,GO:0014062,0.999999999981947,0.815073793110909,0,2,regulation of serotonin secretion,BP,
10223,GO:0042942,0.999999999981961,0.900177837679331,0,1,D-serine transport,BP,
63,GO:0000126,0.999999999981962,0.776194364188367,0,2,transcription factor TFIIIB complex,CC,
384,GO:0001026,0.999999999981962,0.776194364188367,0,2,TFIIIB-type transcription factor activity,MF,
846,GO:0002169,0.99999999998198,0.801192592678125,0,2,3-methylcrotonyl-CoA carboxylase complex, mitochondrial,CC,
1828,GO:0004485,0.99999999998198,0.801192592678125,0,2,methylcrotonoyl-CoA carboxylase activity,MF,
19140,GO:1905202,0.99999999998198,0.801192592678125,0,2,methylcrotonoyl-CoA carboxylase complex,CC,
2335,GO:0005365,0.999999999981983,0.764635159667006,0,2,myo-inositol transmembrane transporter activity,MF,
3765,GO:0008311,0.999999999981984,0.823684122380265,0,2,double-stranded DNA 3'-5' exodeoxyribonuclease activity,MF,
789,GO:0002054,0.999999999981994,0.765325625515657,0,3,nucleobase binding,MF,
791,GO:0002060,0.999999999981994,0.765325625515657,0,3,purine nucleobase binding,MF,
20173,GO:2001045,0.999999999981995,0.781559450927312,0,2,negative regulation of integrin-mediated signaling pathway,BP,
3646,GO:0008120,0.999999999982009,0.90852661191233,0,1,ceramide glucosyltransferase activity,MF,
17148,GO:0102769,0.999999999982009,0.90852661191233,0,1,dihydroceramide glucosyltransferase activity,MF,
7080,GO:0030882,0.999999999982015,0.888711435185339,0,1,lipid antigen binding,MF,
7081,GO:0030883,0.999999999982015,0.888711435185339,0,1,endogenous lipid antigen binding,MF,
7082,GO:0030884,0.999999999982015,0.888711435185339,0,1,exogenous lipid antigen binding,MF,
12041,GO:0048006,0.999999999982015,0.888711435185339,0,1,antigen processing and presentation, endogenous lipid antigen via MHC class Ib,BP,
17127,GO:0102485,0.999999999982047,0.780143815815552,0,2,dATP phosphohydrolase activity,MF,
17128,GO:0102486,0.999999999982047,0.780143815815552,0,2,dCTP phosphohydrolase activity,MF,
17129,GO:0102487,0.999999999982047,0.780143815815552,0,2,dUTP phosphohydrolase activity,MF,
17130,GO:0102488,0.999999999982047,0.780143815815552,0,2,dTTP phosphohydrolase activity,MF,
17131,GO:0102489,0.999999999982047,0.780143815815552,0,2,GTP phosphohydrolase activity,MF,
17132,GO:0102490,0.999999999982047,0.780143815815552,0,2,8-oxo-dGTP phosphohydrolase activity,MF,
17133,GO:0102491,0.999999999982047,0.780143815815552,0,2,dGTP phosphohydrolase activity,MF,
18639,GO:1903977,0.999999999982049,0.791006897519123,0,2,positive regulation of glial cell migration,BP,
485,GO:0001537,0.999999999982061,0.792736851588074,0,2,N-acetylgalactosamine 4-O-sulfotransferase activity,MF,
6971,GO:0030644,0.999999999982063,0.804687538138786,0,2,cellular chloride ion homeostasis,BP,
13659,GO:0060214,0.999999999982063,0.81710687804096,0,2,endocardium formation,BP,
9626,GO:0036506,0.999999999982064,0.711305802841382,0,3,maintenance of unfolded protein,BP,
18790,GO:1904378,0.999999999982064,0.711305802841382,0,3,maintenance of unfolded protein involved in ERAD pathway,BP,
14296,GO:0061474,0.999999999982069,0.900264302056124,0,1,phagolysosome membrane,CC,
12724,GO:0051012,0.999999999982082,0.797964206301295,0,2,microtubule sliding,BP,
1884,GO:0004567,0.999999999982094,0.894568300668999,0,1,beta-mannosidase activity,MF,
4451,GO:0010412,0.999999999982094,0.894568300668999,0,1,mannan metabolic process,BP,
11623,GO:0046355,0.999999999982094,0.894568300668999,0,1,mannan catabolic process,BP,
4001,GO:0008941,0.999999999982112,0.813063444307811,0,2,nitric oxide dioxygenase activity,MF,
5626,GO:0016708,0.999999999982112,0.813063444307811,0,2,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of two atoms of oxygen into one donor,MF,
8324,GO:0033181,0.999999999982119,0.907596235210021,0,1,plasma membrane proton-transporting V-type ATPase complex,CC,
15122,GO:0071245,0.999999999982122,0.89048698794547,0,1,cellular response to carbon monoxide,BP,
18368,GO:1903406,0.999999999982122,0.89048698794547,0,1,regulation of sodium:potassium-exchanging ATPase activity,BP,
18369,GO:1903408,0.999999999982122,0.89048698794547,0,1,positive regulation of sodium:potassium-exchanging ATPase activity,BP,
19703,GO:2000077,0.999999999982123,0.791805963022654,0,2,negative regulation of type B pancreatic cell development,BP,
19027,GO:1904895,0.999999999982151,0.907753932910244,0,1,ESCRT complex assembly,BP,
19029,GO:1904902,0.999999999982151,0.907753932910244,0,1,ESCRT III complex assembly,BP,
11793,GO:0046695,0.999999999982155,0.746994131974234,0,3,SLIK (SAGA-like) complex,CC,
1009,GO:0002488,0.999999999982173,0.885923427796643,0,1,antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway,BP,
1010,GO:0002489,0.999999999982173,0.885923427796643,0,1,antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent,BP,
8793,GO:0034506,0.999999999982173,0.885923427796643,0,1,chromosome, centromeric core domain,CC,
11908,GO:0046968,0.999999999982173,0.885923427796643,0,1,peptide antigen transport,BP,
11918,GO:0046980,0.999999999982173,0.885923427796643,0,1,tapasin binding,MF,
15740,GO:0072356,0.999999999982173,0.885923427796643,0,1,chromosome passenger complex localization to kinetochore,BP,
10378,GO:0043224,0.99999999998219,0.870766900036435,0,2,nuclear SCF ubiquitin ligase complex,CC,
18679,GO:1904059,0.999999999982194,0.861397407706278,0,1,regulation of locomotor rhythm,BP,
5413,GO:0016262,0.999999999982208,0.714868768504703,0,3,protein N-acetylglucosaminyltransferase activity,MF,
12699,GO:0050955,0.999999999982213,0.884876640000442,0,1,thermoception,BP,
12701,GO:0050960,0.999999999982213,0.884876640000442,0,1,detection of temperature stimulus involved in thermoception,BP,
12706,GO:0050968,0.999999999982213,0.884876640000442,0,1,detection of chemical stimulus involved in sensory perception of pain,BP,
13829,GO:0060454,0.999999999982213,0.884876640000442,0,1,positive regulation of gastric acid secretion,BP,
16168,GO:0090210,0.999999999982213,0.884876640000442,0,1,regulation of establishment of blood-brain barrier,BP,
16169,GO:0090212,0.999999999982213,0.884876640000442,0,1,negative regulation of establishment of blood-brain barrier,BP,
16656,GO:0097603,0.999999999982213,0.884876640000442,0,1,temperature-gated ion channel activity,MF,
17678,GO:1901594,0.999999999982213,0.884876640000442,0,1,response to capsazepine,BP,
452,GO:0001226,0.999999999982216,0.894953869027413,0,1,RNA polymerase II transcription corepressor binding,MF,
3822,GO:0008424,0.999999999982216,0.894953869027413,0,1,glycoprotein 6-alpha-L-fucosyltransferase activity,MF,
9453,GO:0036071,0.999999999982216,0.894953869027413,0,1,N-glycan fucosylation,BP,
11881,GO:0046921,0.999999999982216,0.894953869027413,0,1,alpha-(1->6)-fucosyltransferase activity,MF,
8899,GO:0034750,0.99999999998222,0.786099903789421,0,2,Scrib-APC-beta-catenin complex,CC,
1842,GO:0004500,0.99999999998222,0.897595080719553,0,1,dopamine beta-monooxygenase activity,MF,
3037,GO:0006589,0.99999999998222,0.897595080719553,0,1,octopamine biosynthetic process,BP,
11614,GO:0046333,0.99999999998222,0.897595080719553,0,1,octopamine metabolic process,BP,
11314,GO:0045654,0.99999999998223,0.821990192087785,0,2,positive regulation of megakaryocyte differentiation,BP,
3874,GO:0008507,0.999999999982232,0.891229055417148,0,1,sodium:iodide symporter activity,MF,
4974,GO:0015093,0.999999999982234,0.779609560602151,0,2,ferrous iron transmembrane transporter activity,MF,
5148,GO:0015684,0.999999999982234,0.779609560602151,0,2,ferrous iron transport,BP,
18579,GO:1903874,0.999999999982234,0.779609560602151,0,2,ferrous iron transmembrane transport,BP,
11025,GO:0045016,0.999999999982236,0.89426245463153,0,1,mitochondrial magnesium ion transmembrane transport,BP,
15018,GO:0070985,0.999999999982245,0.83481931396398,0,2,TFIIK complex,CC,
2120,GO:0004915,0.999999999982258,0.792898755456677,0,2,interleukin-6 receptor activity,MF,
2598,GO:0005896,0.999999999982258,0.792898755456677,0,2,interleukin-6 receptor complex,CC,
6317,GO:0019981,0.999999999982258,0.792898755456677,0,2,interleukin-6 binding,MF,
14555,GO:0070110,0.999999999982258,0.792898755456677,0,2,ciliary neurotrophic factor receptor complex,CC,
1805,GO:0004454,0.99999999998226,0.900531029126516,0,1,ketohexokinase activity,MF,
11129,GO:0045188,0.999999999982264,0.801339005062057,0,2,regulation of circadian sleep/wake cycle, non-REM sleep,BP,
9741,GO:0039502,0.999999999982267,0.880030955957548,0,1,suppression by virus of host type I interferon-mediated signaling pathway,BP,
9742,GO:0039503,0.999999999982267,0.880030955957548,0,1,suppression by virus of host innate immune response,BP,
9746,GO:0039514,0.999999999982267,0.880030955957548,0,1,suppression by virus of host JAK-STAT cascade,BP,
9762,GO:0039562,0.999999999982267,0.880030955957548,0,1,suppression by virus of host STAT activity,BP,
9763,GO:0039563,0.999999999982267,0.880030955957548,0,1,suppression by virus of host STAT1 activity,BP,
9764,GO:0039564,0.999999999982267,0.880030955957548,0,1,suppression by virus of host STAT2 activity,BP,
10863,GO:0044414,0.999999999982267,0.880030955957548,0,1,suppression of host defenses,BP,
13184,GO:0051833,0.999999999982267,0.880030955957548,0,1,suppression of defenses of other organism involved in symbiotic interaction,BP,
13276,GO:0052029,0.999999999982267,0.880030955957548,0,1,negative regulation by symbiont of host signal transduction pathway,BP,
13278,GO:0052037,0.999999999982267,0.880030955957548,0,1,negative regulation by symbiont of host defense response,BP,
13293,GO:0052167,0.999999999982267,0.880030955957548,0,1,modulation by symbiont of host innate immune response,BP,
13294,GO:0052170,0.999999999982267,0.880030955957548,0,1,negative regulation by symbiont of host innate immune response,BP,
13312,GO:0052261,0.999999999982267,0.880030955957548,0,1,suppression of defense response of other organism involved in symbiotic interaction,BP,
13313,GO:0052306,0.999999999982267,0.880030955957548,0,1,modulation by organism of innate immune response in other organism involved in symbiotic interaction,BP,
13314,GO:0052309,0.999999999982267,0.880030955957548,0,1,negative regulation by organism of innate immune response in other organism involved in symbiotic interaction,BP,
13335,GO:0052493,0.999999999982267,0.880030955957548,0,1,negative regulation by organism of signal transduction in other organism involved in symbiotic interaction,BP,
13345,GO:0052561,0.999999999982267,0.880030955957548,0,1,negative regulation by organism of immune response of other organism involved in symbiotic interaction,BP,
13346,GO:0052562,0.999999999982267,0.880030955957548,0,1,negative regulation by symbiont of host immune response,BP,
15926,GO:0075109,0.999999999982267,0.880030955957548,0,1,modulation by symbiont of host receptor-mediated signal transduction,BP,
15927,GO:0075111,0.999999999982267,0.880030955957548,0,1,negative regulation by symbiont of host receptor-mediated signal transduction,BP,
15928,GO:0075112,0.999999999982267,0.880030955957548,0,1,modulation by symbiont of host transmembrane receptor-mediated signal transduction,BP,
15929,GO:0075114,0.999999999982267,0.880030955957548,0,1,negative regulation by symbiont of host transmembrane receptor-mediated signal transduction,BP,
16937,GO:0098968,0.999999999982267,0.880030955957548,0,1,neurotransmitter receptor transport postsynaptic membrane to endosome,BP,
13951,GO:0060683,0.999999999982283,0.899545380765988,0,1,regulation of branching involved in salivary gland morphogenesis by epithelial-mesenchymal signaling,BP,
19492,GO:1990401,0.999999999982283,0.899545380765988,0,1,embryonic lung development,BP,
18053,GO:1902659,0.999999999982294,0.734931440517139,0,3,regulation of glucose mediated signaling pathway,BP,
18054,GO:1902661,0.999999999982294,0.734931440517139,0,3,positive regulation of glucose mediated signaling pathway,BP,
4689,GO:0010845,0.999999999982298,0.900052848350851,0,1,positive regulation of reciprocal meiotic recombination,BP,
5043,GO:0015228,0.9999999999823,0.72728676350579,0,3,coenzyme A transmembrane transporter activity,MF,
5250,GO:0015880,0.9999999999823,0.72728676350579,0,3,coenzyme A transport,BP,
9077,GO:0035349,0.9999999999823,0.72728676350579,0,3,coenzyme A transmembrane transport,BP,
15068,GO:0071077,0.9999999999823,0.72728676350579,0,3,adenosine 3',5'-bisphosphate transmembrane transporter activity,MF,
15072,GO:0071106,0.9999999999823,0.72728676350579,0,3,adenosine 3',5'-bisphosphate transmembrane transport,BP,
15955,GO:0080122,0.9999999999823,0.72728676350579,0,3,AMP transmembrane transporter activity,MF,
756,GO:0001998,0.999999999982301,0.903426524399194,0,1,angiotensin-mediated vasoconstriction involved in regulation of systemic arterial blood pressure,BP,
776,GO:0002034,0.999999999982301,0.903426524399194,0,1,regulation of blood vessel diameter by renin-angiotensin,BP,
1276,GO:0003072,0.999999999982301,0.903426524399194,0,1,renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure,BP,
18490,GO:1903673,0.999999999982301,0.903426524399194,0,1,mitotic cleavage furrow formation,BP,
18920,GO:1904695,0.999999999982301,0.903426524399194,0,1,positive regulation of vascular smooth muscle contraction,BP,
17523,GO:1901074,0.999999999982302,0.878781801837561,0,1,regulation of engulfment of apoptotic cell,BP,
17524,GO:1901076,0.999999999982302,0.878781801837561,0,1,positive regulation of engulfment of apoptotic cell,BP,
9637,GO:0036518,0.999999999982303,0.790230772477563,0,2,chemorepulsion of dopaminergic neuron axon,BP,
14372,GO:0061643,0.999999999982303,0.790230772477563,0,2,chemorepulsion of axon,BP,
3834,GO:0008442,0.999999999982315,0.90276834907503,0,1,3-hydroxyisobutyrate dehydrogenase activity,MF,
15992,GO:0086024,0.999999999982316,0.877273200181226,0,1,adenylate cyclase-activating adrenergic receptor signaling pathway involved in positive regulation of heart rate,BP,
17300,GO:0140200,0.999999999982316,0.877273200181226,0,1,adenylate cyclase-activating adrenergic receptor signaling pathway involved in regulation of heart rate,BP,
17526,GO:1901078,0.999999999982316,0.877273200181226,0,1,negative regulation of relaxation of muscle,BP,
17783,GO:1901898,0.999999999982316,0.877273200181226,0,1,negative regulation of relaxation of cardiac muscle,BP,
16896,GO:0098885,0.999999999982322,0.878411363857697,0,1,modification of postsynaptic actin cytoskeleton,BP,
16996,GO:0099159,0.999999999982322,0.878411363857697,0,1,regulation of modification of postsynaptic structure,BP,
17391,GO:1900149,0.999999999982322,0.878411363857697,0,1,positive regulation of Schwann cell migration,BP,
18749,GO:1904266,0.999999999982322,0.878411363857697,0,1,regulation of Schwann cell chemotaxis,BP,
18750,GO:1904268,0.999999999982322,0.878411363857697,0,1,positive regulation of Schwann cell chemotaxis,BP,
19168,GO:1905274,0.999999999982322,0.878411363857697,0,1,regulation of modification of postsynaptic actin cytoskeleton,BP,
19589,GO:1990751,0.999999999982322,0.878411363857697,0,1,Schwann cell chemotaxis,BP,
14047,GO:0060849,0.999999999982336,0.796120094323048,0,2,regulation of transcription involved in lymphatic endothelial cell fate commitment,BP,
11067,GO:0045081,0.999999999982363,0.890796204612054,0,1,negative regulation of interleukin-10 biosynthetic process,BP,
18310,GO:1903292,0.99999999998238,0.800874727807565,0,2,protein localization to Golgi membrane,BP,
17869,GO:1902173,0.999999999982396,0.896195104340021,0,1,negative regulation of keratinocyte apoptotic process,BP,
14502,GO:0070012,0.999999999982403,0.809700684377088,0,2,oligopeptidase activity,MF,
1824,GO:0004479,0.999999999982445,0.899647802162241,0,1,methionyl-tRNA formyltransferase activity,MF,
6319,GO:0019988,0.999999999982445,0.899647802162241,0,1,charged-tRNA amino acid modification,BP,
15523,GO:0071951,0.999999999982445,0.899647802162241,0,1,conversion of methionyl-tRNA to N-formyl-methionyl-tRNA,BP,
17790,GO:1901917,0.999999999982445,0.899647802162241,0,1,regulation of exoribonuclease activity,BP,
17791,GO:1901919,0.999999999982445,0.899647802162241,0,1,positive regulation of exoribonuclease activity,BP,
19342,GO:1905779,0.999999999982445,0.899647802162241,0,1,positive regulation of exonuclease activity,BP,
9210,GO:0035608,0.999999999982446,0.79362379355894,0,2,protein deglutamylation,BP,
11882,GO:0046922,0.99999999998247,0.802208866305016,0,2,peptide-O-fucosyltransferase activity,MF,
19014,GO:1904879,0.999999999982472,0.796561586926301,0,2,positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel,BP,
2823,GO:0006288,0.999999999982473,0.741385218068047,0,3,base-excision repair, DNA ligation,BP,
1361,GO:0003247,0.999999999982477,0.908406456118731,0,1,post-embryonic cardiac muscle cell growth involved in heart morphogenesis,BP,
1555,GO:0003956,0.999999999982477,0.908406456118731,0,1,NAD(P)+-protein-arginine ADP-ribosyltransferase activity,MF,
2483,GO:0005724,0.999999999982477,0.908406456118731,0,1,nuclear telomeric heterochromatin,CC,
7411,GO:0031509,0.999999999982477,0.908406456118731,0,1,telomeric heterochromatin assembly,BP,
7569,GO:0031940,0.999999999982477,0.908406456118731,0,1,positive regulation of chromatin silencing at telomere,BP,
18078,GO:1902732,0.999999999982477,0.908406456118731,0,1,positive regulation of chondrocyte proliferation,BP,
19272,GO:1905547,0.999999999982477,0.908406456118731,0,1,regulation of telomeric heterochromatin assembly,BP,
19273,GO:1905549,0.999999999982477,0.908406456118731,0,1,positive regulation of telomeric heterochromatin assembly,BP,
8385,GO:0033319,0.999999999982477,0.901818610765125,0,1,UDP-D-xylose metabolic process,BP,
8386,GO:0033320,0.999999999982477,0.901818610765125,0,1,UDP-D-xylose biosynthetic process,BP,
12070,GO:0048040,0.999999999982477,0.901818610765125,0,1,UDP-glucuronate decarboxylase activity,MF,
14560,GO:0070123,0.99999999998248,0.879155505657339,0,1,transforming growth factor beta receptor activity, type III,MF,
4923,GO:0014876,0.999999999982483,0.915938885951408,0,1,response to injury involved in regulation of muscle adaptation,BP,
20025,GO:2000670,0.999999999982495,0.78863655552921,0,2,positive regulation of dendritic cell apoptotic process,BP,
15220,GO:0071400,0.99999999998253,0.792029428465652,0,2,cellular response to oleic acid,BP,
9257,GO:0035691,0.999999999982561,0.918368234448514,0,1,macrophage migration inhibitory factor signaling pathway,BP,
9259,GO:0035693,0.999999999982561,0.918368234448514,0,1,NOS2-CD74 complex,CC,
10110,GO:0042658,0.999999999982561,0.918368234448514,0,1,MHC class II protein binding, via antigen binding groove,MF,
117,GO:0000246,0.999999999982582,0.883631866954118,0,1,delta24(24-1) sterol reductase activity,MF,
12488,GO:0050614,0.999999999982582,0.883631866954118,0,1,delta24-sterol reductase activity,MF,
16287,GO:0090461,0.999999999982582,0.883631866954118,0,1,glutamate homeostasis,BP,
897,GO:0002277,0.999999999982599,0.93679972502795,0,1,myeloid dendritic cell activation involved in immune response,BP,
1054,GO:0002582,0.999999999982599,0.93679972502795,0,1,positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,
1057,GO:0002585,0.999999999982599,0.93679972502795,0,1,positive regulation of antigen processing and presentation of peptide antigen,BP,
1060,GO:0002588,0.999999999982599,0.93679972502795,0,1,positive regulation of antigen processing and presentation of peptide antigen via MHC class II,BP,
5789,GO:0017024,0.999999999982599,0.93679972502795,0,1,myosin I binding,MF,
17080,GO:0099640,0.999999999982599,0.93679972502795,0,1,axo-dendritic protein transport,BP,
17081,GO:0099641,0.999999999982599,0.93679972502795,0,1,anterograde axonal protein transport,BP,
19784,GO:2000253,0.999999999982606,0.787632723799424,0,2,positive regulation of feeding behavior,BP,
3643,GO:0008117,0.999999999982615,0.879588539702761,0,1,sphinganine-1-phosphate aldolase activity,MF,
6231,GO:0019785,0.999999999982657,0.798863919815588,0,2,ISG15-specific protease activity,MF,
15277,GO:0071484,0.999999999982669,0.787478666028893,0,2,cellular response to light intensity,BP,
1316,GO:0003166,0.99999999998268,0.881122398876079,0,1,bundle of His development,BP,
1317,GO:0003167,0.99999999998268,0.881122398876079,0,1,atrioventricular bundle cell differentiation,BP,
13911,GO:0060596,0.99999999998268,0.881122398876079,0,1,mammary placode formation,BP,
14077,GO:0060932,0.99999999998268,0.881122398876079,0,1,His-Purkinje system cell differentiation,BP,
19271,GO:1905538,0.999999999982691,0.792461779287318,0,2,polysome binding,MF,
3,GO:0000009,0.999999999982695,0.900628137126132,0,1,alpha-1,6-mannosyltransferase activity,MF,
13438,GO:0052917,0.999999999982695,0.900628137126132,0,1,dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase activity,MF,
9646,GO:0038001,0.999999999982719,0.813981918748747,0,2,paracrine signaling,BP,
10791,GO:0044284,0.99999999998273,0.93654839853967,0,1,mitochondrial crista junction,CC,
437,GO:0001172,0.999999999982737,0.855350591438988,0,2,transcription, RNA-templated,BP,
1562,GO:0003968,0.999999999982737,0.855350591438988,0,2,RNA-directed 5'-3' RNA polymerase activity,MF,
2799,GO:0006256,0.999999999982751,0.898557904775298,0,1,UDP catabolic process,BP,
4084,GO:0009140,0.999999999982751,0.898557904775298,0,1,pyrimidine nucleoside diphosphate catabolic process,BP,
4132,GO:0009193,0.999999999982751,0.898557904775298,0,1,pyrimidine ribonucleoside diphosphate metabolic process,BP,
4133,GO:0009195,0.999999999982751,0.898557904775298,0,1,pyrimidine ribonucleoside diphosphate catabolic process,BP,
4158,GO:0009222,0.999999999982751,0.898557904775298,0,1,pyrimidine ribonucleotide catabolic process,BP,
11511,GO:0046048,0.999999999982751,0.898557904775298,0,1,UDP metabolic process,BP,
2369,GO:0005497,0.999999999982754,0.943885944449413,0,1,androgen binding,MF,
3859,GO:0008481,0.999999999982776,0.812175026822931,0,2,sphinganine kinase activity,MF,
5797,GO:0017050,0.999999999982776,0.812175026822931,0,2,D-erythro-sphingosine kinase activity,MF,
10211,GO:0042903,0.999999999982777,0.799246253613609,0,2,tubulin deacetylase activity,MF,
13839,GO:0060474,0.999999999982799,0.859313639310545,0,2,positive regulation of flagellated sperm motility involved in capacitation,BP,
4987,GO:0015117,0.999999999982805,0.903789305300253,0,1,thiosulfate transmembrane transporter activity,MF,
4993,GO:0015131,0.999999999982805,0.903789305300253,0,1,oxaloacetate transmembrane transporter activity,MF,
5163,GO:0015709,0.999999999982805,0.903789305300253,0,1,thiosulfate transport,BP,
5173,GO:0015729,0.999999999982805,0.903789305300253,0,1,oxaloacetate transport,BP,
5179,GO:0015743,0.999999999982805,0.903789305300253,0,1,malate transport,BP,
15233,GO:0071423,0.999999999982805,0.903789305300253,0,1,malate transmembrane transport,BP,
17944,GO:1902356,0.999999999982805,0.903789305300253,0,1,oxaloacetate(2-) transmembrane transport,BP,
4828,GO:0014036,0.99999999998281,0.887041359860427,0,1,neural crest cell fate specification,BP,
6077,GO:0019236,0.99999999998281,0.887041359860427,0,1,response to pheromone,BP,
9222,GO:0035622,0.99999999998281,0.887041359860427,0,1,intrahepatic bile duct development,BP,
12402,GO:0048866,0.99999999998281,0.887041359860427,0,1,stem cell fate specification,BP,
13533,GO:0060018,0.99999999998281,0.887041359860427,0,1,astrocyte fate commitment,BP,
13664,GO:0060221,0.99999999998281,0.887041359860427,0,1,retinal rod cell differentiation,BP,
13861,GO:0060516,0.99999999998281,0.887041359860427,0,1,primary prostatic bud elongation,BP,
13862,GO:0060517,0.99999999998281,0.887041359860427,0,1,epithelial cell proliferation involved in prostatic bud elongation,BP,
14021,GO:0060784,0.99999999998281,0.887041359860427,0,1,regulation of cell proliferation involved in tissue homeostasis,BP,
5616,GO:0016672,0.999999999982814,0.859898167146974,0,2,oxidoreductase activity, acting on a sulfur group of donors, quinone or similar compound as acceptor,MF,
11117,GO:0045174,0.999999999982814,0.859898167146974,0,2,glutathione dehydrogenase (ascorbate) activity,MF,
12486,GO:0050610,0.999999999982814,0.859898167146974,0,2,methylarsonate reductase activity,MF,
3619,GO:0008073,0.999999999982824,0.835769820678765,0,2,ornithine decarboxylase inhibitor activity,MF,
17916,GO:1902268,0.999999999982824,0.835769820678765,0,2,negative regulation of polyamine transmembrane transport,BP,
7160,GO:0031048,0.999999999982827,0.792956123512381,0,2,chromatin silencing by small RNA,BP,
19811,GO:2000299,0.999999999982839,0.89407719200729,0,1,negative regulation of Rho-dependent protein serine/threonine kinase activity,BP,
8837,GO:0034642,0.999999999982844,0.888283627704761,0,1,mitochondrion migration along actin filament,BP,
5128,GO:0015578,0.999999999982876,0.900451566794356,0,1,mannose transmembrane transporter activity,MF,
5186,GO:0015761,0.999999999982876,0.900451566794356,0,1,mannose transmembrane transport,BP,
5112,GO:0015433,0.999999999982898,0.790479446595904,0,2,peptide antigen-transporting ATPase activity,MF,
5059,GO:0015272,0.999999999982905,0.897278941618825,0,1,ATP-activated inward rectifier potassium channel activity,MF,
18939,GO:1904732,0.999999999982912,0.84446867365626,0,2,regulation of electron transfer activity,BP,
19055,GO:1904959,0.999999999982912,0.84446867365626,0,2,regulation of cytochrome-c oxidase activity,BP,
6128,GO:0019389,0.999999999982922,0.900022032677705,0,1,glucuronoside metabolic process,BP,
6129,GO:0019391,0.999999999982922,0.900022032677705,0,1,glucuronoside catabolic process,BP,
17124,GO:0102390,0.999999999982922,0.900022032677705,0,1,mycophenolic acid acyl-glucuronide esterase activity,MF,
125,GO:0000257,0.999999999982937,0.916529992293353,0,1,nitrilase activity,MF,
5692,GO:0016815,0.999999999982937,0.916529992293353,0,1,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in nitriles,MF,
9957,GO:0042356,0.999999999982937,0.916529992293353,0,1,GDP-4-dehydro-D-rhamnose reductase activity,MF,
12485,GO:0050577,0.999999999982937,0.916529992293353,0,1,GDP-L-fucose synthase activity,MF,
19281,GO:1905572,0.999999999982943,0.899208640184069,0,1,ganglioside GM1 transport to membrane,BP,
19283,GO:1905574,0.999999999982943,0.899208640184069,0,1,ganglioside GM2 binding,MF,
19284,GO:1905575,0.999999999982943,0.899208640184069,0,1,ganglioside GM3 binding,MF,
19286,GO:1905577,0.999999999982943,0.899208640184069,0,1,ganglioside GP1c binding,MF,
1653,GO:0004109,0.999999999982949,0.810134182454996,0,2,coproporphyrinogen oxidase activity,MF,
1618,GO:0004053,0.999999999982962,0.824793279387532,0,2,arginase activity,MF,
6175,GO:0019547,0.999999999982962,0.824793279387532,0,2,arginine catabolic process to ornithine,BP,
12482,GO:0050560,0.99999999998297,0.894101965385758,0,1,aspartate-tRNA(Asn) ligase activity,MF,
14575,GO:0070145,0.99999999998297,0.894101965385758,0,1,mitochondrial asparaginyl-tRNA aminoacylation,BP,
3342,GO:0007060,0.999999999982971,0.809336542985887,0,2,male meiosis chromosome segregation,BP,
58,GO:0000121,0.999999999982984,0.896721257561023,0,1,glycerol-1-phosphatase activity,MF,
9892,GO:0042222,0.999999999982984,0.896721257561023,0,1,interleukin-1 biosynthetic process,BP,
10325,GO:0043136,0.999999999982984,0.896721257561023,0,1,glycerol-3-phosphatase activity,MF,
11213,GO:0045360,0.999999999982984,0.896721257561023,0,1,regulation of interleukin-1 biosynthetic process,BP,
11214,GO:0045362,0.999999999982984,0.896721257561023,0,1,positive regulation of interleukin-1 biosynthetic process,BP,
12550,GO:0050720,0.999999999982984,0.896721257561023,0,1,interleukin-1 beta biosynthetic process,BP,
12551,GO:0050722,0.999999999982984,0.896721257561023,0,1,regulation of interleukin-1 beta biosynthetic process,BP,
12552,GO:0050725,0.999999999982984,0.896721257561023,0,1,positive regulation of interleukin-1 beta biosynthetic process,BP,
15709,GO:0072303,0.999999999982984,0.896721257561023,0,1,positive regulation of glomerular metanephric mesangial cell proliferation,BP,
6660,GO:0030021,0.999999999983002,0.897259319909106,0,1,extracellular matrix structural constituent conferring compression resistance,MF,
6863,GO:0030345,0.999999999983002,0.897259319909106,0,1,structural constituent of tooth enamel,MF,
7540,GO:0031849,0.999999999983005,0.889021299771088,0,1,olfactory receptor binding,MF,
1949,GO:0004655,0.999999999983013,0.89611787858727,0,1,porphobilinogen synthase activity,MF,
19001,GO:1904854,0.999999999983013,0.89611787858727,0,1,proteasome core complex binding,MF,
13205,GO:0051890,0.999999999983019,0.777861302142462,0,2,regulation of cardioblast differentiation,BP,
1836,GO:0004493,0.999999999983019,0.938117479503831,0,1,methylmalonyl-CoA epimerase activity,MF,
11685,GO:0046491,0.999999999983019,0.938117479503831,0,1,L-methylmalonyl-CoA metabolic process,BP,
6789,GO:0030237,0.999999999983024,0.797396721442149,0,2,female sex determination,BP,
9515,GO:0036250,0.999999999983026,0.903320040026474,0,1,peroxisome transport along microtubule,BP,
10950,GO:0044721,0.999999999983026,0.903320040026474,0,1,protein import into peroxisome matrix, substrate release,BP,
8539,GO:0033897,0.999999999983046,0.92076995616104,0,1,ribonuclease T2 activity,MF,
5748,GO:0016899,0.999999999983048,0.781687588886622,0,2,oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor,MF,
1798,GO:0004441,0.999999999983065,0.901828853903988,0,1,inositol-1,4-bisphosphate 1-phosphatase activity,MF,
13405,GO:0052829,0.999999999983065,0.901828853903988,0,1,inositol-1,3,4-trisphosphate 1-phosphatase activity,MF,
11987,GO:0047464,0.999999999983089,0.880318423491319,0,1,heparosan-N-sulfate-glucuronate 5-epimerase activity,MF,
12458,GO:0050379,0.999999999983089,0.880318423491319,0,1,UDP-glucuronate 5'-epimerase activity,MF,
16212,GO:0090283,0.999999999983089,0.71634909245281,0,3,regulation of protein glycosylation in Golgi,BP,
2317,GO:0005324,0.999999999983091,0.801865138923765,0,2,long-chain fatty acid transporter activity,MF,
5263,GO:0015910,0.999999999983091,0.801865138923765,0,2,peroxisomal long-chain fatty acid import,BP,
8841,GO:0034647,0.999999999983106,0.766578390735551,0,2,histone demethylase activity (H3-trimethyl-K4 specific),MF,
8890,GO:0034721,0.999999999983106,0.766578390735551,0,2,histone H3-K4 demethylation, trimethyl-H3-K4-specific,BP,
16685,GO:0097681,0.999999999983127,0.757422315309508,0,2,double-strand break repair via alternative nonhomologous end joining,BP,
10127,GO:0042704,0.999999999983146,0.788659765097324,0,2,uterine wall breakdown,BP,
7338,GO:0031379,0.999999999983149,0.87082988363176,0,2,RNA-directed RNA polymerase complex,CC,
5903,GO:0018125,0.99999999998315,0.735626728881768,0,3,peptidyl-cysteine methylation,BP,
19594,GO:1990761,0.999999999983154,0.803390755955858,0,2,growth cone lamellipodium,CC,
2033,GO:0004775,0.999999999983173,0.823217828426474,0,2,succinate-CoA ligase (ADP-forming) activity,MF,
17935,GO:1902309,0.999999999983183,0.796627013596142,0,2,negative regulation of peptidyl-serine dephosphorylation,BP,
11970,GO:0047322,0.999999999983188,0.770384268776419,0,2,[hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity,MF,
12459,GO:0050405,0.999999999983188,0.770384268776419,0,2,[acetyl-CoA carboxylase] kinase activity,MF,
12129,GO:0048250,0.99999999998319,0.82330149102936,0,2,iron import into the mitochondrion,BP,
135,GO:0000285,0.999999999983191,0.716258987233214,0,3,1-phosphatidylinositol-3-phosphate 5-kinase activity,MF,
7652,GO:0032089,0.999999999983197,0.790902007192923,0,2,NACHT domain binding,MF,
18060,GO:1902683,0.999999999983199,0.796168520110464,0,2,regulation of receptor localization to synapse,BP,
16400,GO:0097058,0.999999999983201,0.905162616618022,0,1,CRLF-CLCF1 complex,CC,
16401,GO:0097059,0.999999999983201,0.905162616618022,0,1,CNTFR-CLCF1 complex,CC,
1688,GO:0004164,0.999999999983214,0.905255372319498,0,1,diphthine synthase activity,MF,
1733,GO:0004333,0.999999999983214,0.905255372319498,0,1,fumarate hydratase activity,MF,
306,GO:0000818,0.999999999983215,0.811214966590114,0,2,nuclear MIS12/MIND complex,CC,
15729,GO:0072338,0.999999999983221,0.601830091654043,0,4,cellular lactam metabolic process,BP,
8693,GO:0034342,0.999999999983224,0.810401231295023,0,2,response to type III interferon,BP,
6388,GO:0021592,0.999999999983244,0.879943272217888,0,1,fourth ventricle development,BP,
6551,GO:0021993,0.999999999983244,0.879943272217888,0,1,initiation of neural tube closure,BP,
4010,GO:0009000,0.999999999983276,0.900428550836198,0,1,selenocysteine lyase activity,MF,
9514,GO:0036245,0.999999999983279,0.803955289961028,0,2,cellular response to menadione,BP,
382,GO:0001018,0.999999999983284,0.810020038726657,0,2,mitochondrial promoter sequence-specific DNA binding,MF,
4738,GO:0010908,0.999999999983303,0.711671001427997,0,3,regulation of heparan sulfate proteoglycan biosynthetic process,BP,
4739,GO:0010909,0.999999999983303,0.711671001427997,0,3,positive regulation of heparan sulfate proteoglycan biosynthetic process,BP,
18076,GO:1902730,0.999999999983303,0.711671001427997,0,3,positive regulation of proteoglycan biosynthetic process,BP,
8567,GO:0034057,0.999999999983309,0.79752538720386,0,2,RNA strand-exchange activity,MF,
6617,GO:0022849,0.999999999983313,0.880208627367743,0,1,glutamate-gated calcium ion channel activity,MF,
6419,GO:0021688,0.99999999998335,0.894665343313013,0,1,cerebellar molecular layer formation,BP,
14049,GO:0060853,0.99999999998335,0.894665343313013,0,1,Notch signaling pathway involved in arterial endothelial cell fate commitment,BP,
1552,GO:0003953,0.999999999983366,0.912294678054347,0,1,NAD+ nucleosidase activity,MF,
12427,GO:0050135,0.999999999983366,0.912294678054347,0,1,NAD(P)+ nucleosidase activity,MF,
14438,GO:0061809,0.999999999983366,0.912294678054347,0,1,NAD+ nucleotidase, cyclic ADP-ribose generating,MF,
3428,GO:0007217,0.999999999983373,0.900210538201257,0,1,tachykinin receptor signaling pathway,BP,
4381,GO:0010034,0.999999999983388,0.891824118608411,0,1,response to acetate,BP,
17209,GO:0110021,0.999999999983398,0.803422490653652,0,2,cardiac muscle myoblast proliferation,BP,
17210,GO:0110022,0.999999999983398,0.803422490653652,0,2,regulation of cardiac muscle myoblast proliferation,BP,
17211,GO:0110024,0.999999999983398,0.803422490653652,0,2,positive regulation of cardiac muscle myoblast proliferation,BP,
1591,GO:0004008,0.999999999983403,0.77081481161325,0,2,copper-exporting ATPase activity,MF,
10635,GO:0043682,0.999999999983403,0.77081481161325,0,2,copper-transporting ATPase activity,MF,
13521,GO:0060003,0.999999999983403,0.77081481161325,0,2,copper ion export,BP,
16506,GO:0097241,0.999999999983417,0.811085265555526,0,2,hematopoietic stem cell migration to bone marrow,BP,
10653,GO:0043890,0.999999999983418,0.900640390942883,0,1,N-acetylgalactosamine-6-sulfatase activity,MF,
6417,GO:0021685,0.999999999983419,0.878323332998532,0,1,cerebellar granular layer structural organization,BP,
13562,GO:0060051,0.999999999983424,0.815546945200723,0,2,negative regulation of protein glycosylation,BP,
16214,GO:0090285,0.999999999983424,0.815546945200723,0,2,negative regulation of protein glycosylation in Golgi,BP,
1144,GO:0002740,0.999999999983425,0.908623524290575,0,1,negative regulation of cytokine secretion involved in immune response,BP,
1208,GO:0002874,0.999999999983425,0.908623524290575,0,1,regulation of chronic inflammatory response to antigenic stimulus,BP,
1209,GO:0002875,0.999999999983425,0.908623524290575,0,1,negative regulation of chronic inflammatory response to antigenic stimulus,BP,
2234,GO:0005141,0.999999999983425,0.908623524290575,0,1,interleukin-10 receptor binding,MF,
18677,GO:1904057,0.999999999983425,0.908623524290575,0,1,negative regulation of sensory perception of pain,BP,
13540,GO:0060025,0.999999999983437,0.792795527102486,0,2,regulation of synaptic activity,BP,
9497,GO:0036157,0.999999999983438,0.713829468928553,0,3,outer dynein arm,CC,
1377,GO:0003275,0.999999999983452,0.785927942523648,0,2,apoptotic process involved in outflow tract morphogenesis,BP,
17908,GO:1902256,0.999999999983452,0.785927942523648,0,2,regulation of apoptotic process involved in outflow tract morphogenesis,BP,
8368,GO:0033277,0.999999999983476,0.792187854603204,0,2,abortive mitotic cell cycle,BP,
17720,GO:1901676,0.999999999983477,0.88712052345213,0,1,positive regulation of histone H3-K27 acetylation,BP,
16391,GO:0097045,0.999999999983521,0.881014525849682,0,1,phosphatidylserine exposure on blood platelet,BP,
17930,GO:1902304,0.999999999983521,0.881014525849682,0,1,positive regulation of potassium ion export,BP,
1069,GO:0002635,0.999999999983526,0.871697034163154,0,1,negative regulation of germinal center formation,BP,
15647,GO:0072190,0.999999999983549,0.803128355316157,0,2,ureter urothelium development,BP,
15648,GO:0072191,0.999999999983549,0.803128355316157,0,2,ureter smooth muscle development,BP,
15650,GO:0072193,0.999999999983549,0.803128355316157,0,2,ureter smooth muscle cell differentiation,BP,
15652,GO:0072197,0.999999999983549,0.803128355316157,0,2,ureter morphogenesis,BP,
5531,GO:0016517,0.999999999983563,0.902694321112073,0,1,interleukin-12 receptor activity,MF,
9803,GO:0042019,0.999999999983563,0.902694321112073,0,1,interleukin-23 binding,MF,
9804,GO:0042020,0.999999999983563,0.902694321112073,0,1,interleukin-23 receptor activity,MF,
9805,GO:0042022,0.999999999983563,0.902694321112073,0,1,interleukin-12 receptor complex,CC,
15811,GO:0072536,0.999999999983563,0.902694321112073,0,1,interleukin-23 receptor complex,CC,
6474,GO:0021822,0.999999999983578,0.901521396342177,0,1,negative regulation of cell motility involved in cerebral cortex radial glia guided migration,BP,
557,GO:0001681,0.999999999983602,0.899166944768755,0,1,sialate O-acetylesterase activity,MF,
3649,GO:0008126,0.999999999983602,0.899166944768755,0,1,acetylesterase activity,MF,
19565,GO:1990666,0.999999999983621,0.783569326417273,0,2,PCSK9-LDLR complex,CC,
7493,GO:0031673,0.999999999983624,0.847910946973939,0,1,H zone,CC,
15371,GO:0071641,0.999999999983644,0.805493154567298,0,2,negative regulation of macrophage inflammatory protein 1 alpha production,BP,
3518,GO:0007468,0.999999999983664,0.902126851092897,0,1,regulation of rhodopsin gene expression,BP,
11423,GO:0045872,0.999999999983664,0.902126851092897,0,1,positive regulation of rhodopsin gene expression,BP,
1236,GO:0002930,0.999999999983665,0.880121844642983,0,1,trabecular meshwork development,BP,
2506,GO:0005760,0.999999999983668,0.778970228742945,0,2,gamma DNA polymerase complex,CC,
2129,GO:0004935,0.999999999983678,0.813180748947488,0,2,adrenergic receptor activity,MF,
6039,GO:0019145,0.99999999998368,0.900345350294682,0,1,aminobutyraldehyde dehydrogenase activity,MF,
8507,GO:0033737,0.99999999998368,0.900345350294682,0,1,1-pyrroline dehydrogenase activity,MF,
9861,GO:0042134,0.99999999998368,0.838815489167954,0,2,rRNA primary transcript binding,MF,
11939,GO:0047105,0.99999999998368,0.900345350294682,0,1,4-trimethylammoniobutyraldehyde dehydrogenase activity,MF,
532,GO:0001651,0.99999999998369,0.83062451327714,0,2,dense fibrillar component,CC,
18701,GO:1904170,0.999999999983693,0.881011088911866,0,1,regulation of bleb assembly,BP,
18702,GO:1904172,0.999999999983693,0.881011088911866,0,1,positive regulation of bleb assembly,BP,
9181,GO:0035574,0.999999999983698,0.790449096711452,0,2,histone H4-K20 demethylation,BP,
9182,GO:0035575,0.999999999983698,0.790449096711452,0,2,histone demethylase activity (H4-K20 specific),MF,
15823,GO:0072557,0.999999999983722,0.851887085512547,0,2,IPAF inflammasome complex,CC,
9652,GO:0038021,0.999999999983723,0.883835119435775,0,1,leptin receptor activity,MF,
18943,GO:1904743,0.999999999983726,0.768781658528187,0,2,negative regulation of telomeric DNA binding,BP,
11112,GO:0045163,0.999999999983727,0.787213261279891,0,2,clustering of voltage-gated potassium channels,BP,
2076,GO:0004831,0.999999999983743,0.808389331027699,0,2,tyrosine-tRNA ligase activity,MF,
2926,GO:0006437,0.999999999983743,0.808389331027699,0,2,tyrosyl-tRNA aminoacylation,BP,
18365,GO:1903400,0.999999999983745,0.694494179586054,0,3,L-arginine transmembrane transport,BP,
6786,GO:0030233,0.999999999983758,0.908263717137847,0,1,deoxynucleotide transmembrane transporter activity,MF,
6832,GO:0030302,0.999999999983758,0.908263717137847,0,1,deoxynucleotide transport,BP,
7132,GO:0030974,0.999999999983758,0.908263717137847,0,1,thiamine pyrophosphate transmembrane transport,BP,
15056,GO:0071045,0.999999999983758,0.908263717137847,0,1,nuclear histone mRNA catabolic process,BP,
15361,GO:0071629,0.999999999983758,0.908263717137847,0,1,cytoplasm protein quality control by the ubiquitin-proteasome system,BP,
16283,GO:0090422,0.999999999983758,0.908263717137847,0,1,thiamine pyrophosphate transmembrane transporter activity,MF,
4276,GO:0009644,0.999999999983766,0.793593877140748,0,2,response to high light intensity,BP,
11106,GO:0045145,0.999999999983767,0.805347215538116,0,2,single-stranded DNA 5'-3' exodeoxyribonuclease activity,MF,
13982,GO:0060720,0.999999999983783,0.820880130966258,0,2,spongiotrophoblast cell proliferation,BP,
13983,GO:0060721,0.999999999983783,0.820880130966258,0,2,regulation of spongiotrophoblast cell proliferation,BP,
13984,GO:0060722,0.999999999983783,0.820880130966258,0,2,cell proliferation involved in embryonic placenta development,BP,
13985,GO:0060723,0.999999999983783,0.820880130966258,0,2,regulation of cell proliferation involved in embryonic placenta development,BP,
16170,GO:0090214,0.999999999983783,0.820880130966258,0,2,spongiotrophoblast layer developmental growth,BP,
428,GO:0001147,0.999999999983796,0.778216053734447,0,2,transcription termination site sequence-specific DNA binding,MF,
431,GO:0001160,0.999999999983796,0.778216053734447,0,2,transcription termination site DNA binding,MF,
15976,GO:0086007,0.999999999983804,0.785160260427899,0,2,voltage-gated calcium channel activity involved in cardiac muscle cell action potential,MF,
17761,GO:1901843,0.999999999983804,0.785160260427899,0,2,positive regulation of high voltage-gated calcium channel activity,BP,
1639,GO:0004084,0.999999999983813,0.797101673535303,0,2,branched-chain-amino-acid transaminase activity,MF,
4043,GO:0009082,0.999999999983813,0.797101673535303,0,2,branched-chain amino acid biosynthetic process,BP,
4051,GO:0009098,0.999999999983813,0.797101673535303,0,2,leucine biosynthetic process,BP,
4052,GO:0009099,0.999999999983813,0.797101673535303,0,2,valine biosynthetic process,BP,
13362,GO:0052654,0.999999999983813,0.797101673535303,0,2,L-leucine transaminase activity,MF,
13363,GO:0052655,0.999999999983813,0.797101673535303,0,2,L-valine transaminase activity,MF,
13364,GO:0052656,0.999999999983813,0.797101673535303,0,2,L-isoleucine transaminase activity,MF,
6154,GO:0019482,0.999999999983813,0.799426632244337,0,2,beta-alanine metabolic process,BP,
10966,GO:0044771,0.999999999983815,0.806224191213608,0,2,meiotic cell cycle phase transition,BP,
17812,GO:1901993,0.999999999983815,0.806224191213608,0,2,regulation of meiotic cell cycle phase transition,BP,
17813,GO:1901994,0.999999999983815,0.806224191213608,0,2,negative regulation of meiotic cell cycle phase transition,BP,
1556,GO:0003957,0.999999999983815,0.88142824042648,0,1,NAD(P)+ transhydrogenase (B-specific) activity,MF,
3961,GO:0008746,0.999999999983815,0.88142824042648,0,1,NAD(P)+ transhydrogenase activity,MF,
3963,GO:0008750,0.999999999983815,0.88142824042648,0,1,NAD(P)+ transhydrogenase (AB-specific) activity,MF,
5606,GO:0016652,0.999999999983815,0.88142824042648,0,1,oxidoreductase activity, acting on NAD(P)H, NAD(P) as acceptor,MF,
9224,GO:0035624,0.999999999983851,0.782224080843442,0,2,receptor transactivation,BP,
13998,GO:0060743,0.999999999983852,0.900239980153202,0,1,epithelial cell maturation involved in prostate gland development,BP,
7959,GO:0032574,0.999999999983857,0.886597964444194,0,1,5'-3' RNA helicase activity,MF,
7960,GO:0032575,0.999999999983857,0.886597964444194,0,1,ATP-dependent 5'-3' RNA helicase activity,MF,
11595,GO:0046294,0.999999999983882,0.830652428623154,0,2,formaldehyde catabolic process,BP,
19644,GO:1990923,0.999999999983885,0.797953247520934,0,2,PET complex,CC,
7892,GO:0032468,0.999999999983903,0.892327552807939,0,1,Golgi calcium ion homeostasis,BP,
14718,GO:0070408,0.999999999983918,0.879600904987695,0,1,carbamoyl phosphate metabolic process,BP,
14719,GO:0070409,0.999999999983918,0.879600904987695,0,1,carbamoyl phosphate biosynthetic process,BP,
18507,GO:1903717,0.999999999983918,0.879600904987695,0,1,response to ammonia,BP,
18508,GO:1903718,0.999999999983918,0.879600904987695,0,1,cellular response to ammonia,BP,
15891,GO:0072684,0.999999999983934,0.888271516983425,0,1,mitochondrial tRNA 3'-trailer cleavage, endonucleolytic,BP,
9954,GO:0042352,0.999999999983945,0.887030087604361,0,1,GDP-L-fucose salvage,BP,
12435,GO:0050201,0.999999999983945,0.887030087604361,0,1,fucokinase activity,MF,
6414,GO:0021682,0.999999999983948,0.879629544412492,0,1,nerve maturation,BP,
19687,GO:2000048,0.999999999983948,0.838920109986801,0,2,negative regulation of cell-cell adhesion mediated by cadherin,BP,
11428,GO:0045887,0.999999999983954,0.878269373290191,0,1,positive regulation of synaptic growth at neuromuscular junction,BP,
1506,GO:0003867,0.999999999983959,0.880612494655922,0,1,4-aminobutyrate transaminase activity,MF,
4843,GO:0014053,0.999999999983959,0.880612494655922,0,1,negative regulation of gamma-aminobutyric acid secretion,BP,
7684,GO:0032144,0.999999999983959,0.880612494655922,0,1,4-aminobutyrate transaminase complex,CC,
7685,GO:0032145,0.999999999983959,0.880612494655922,0,1,succinate-semialdehyde dehydrogenase binding,MF,
8453,GO:0033602,0.999999999983959,0.880612494655922,0,1,negative regulation of dopamine secretion,BP,
8727,GO:0034386,0.999999999983959,0.880612494655922,0,1,4-aminobutyrate:2-oxoglutarate transaminase activity,MF,
11969,GO:0047298,0.999999999983959,0.880612494655922,0,1,(S)-3-amino-2-methylpropionate transaminase activity,MF,
14315,GO:0061528,0.999999999983959,0.880612494655922,0,1,aspartate secretion,BP,
18823,GO:1904448,0.999999999983959,0.880612494655922,0,1,regulation of aspartate secretion,BP,
18824,GO:1904450,0.999999999983959,0.880612494655922,0,1,positive regulation of aspartate secretion,BP,
19015,GO:1904880,0.999999999983986,0.810303853841537,0,2,response to hydrogen sulfide,BP,
18414,GO:1903518,0.999999999984008,0.799054234442394,0,2,positive regulation of single strand break repair,BP,
4691,GO:0010848,0.999999999984013,0.895096584163628,0,1,regulation of chromatin disassembly,BP,
14317,GO:0061535,0.999999999984041,0.677937707234773,0,3,glutamate secretion, neurotransmission,BP,
11930,GO:0047021,0.999999999984049,0.921045527957936,0,1,15-hydroxyprostaglandin dehydrogenase (NADP+) activity,MF,
12438,GO:0050221,0.999999999984049,0.921045527957936,0,1,prostaglandin-E2 9-reductase activity,MF,
15525,GO:0071955,0.999999999984054,0.773832131174699,0,2,recycling endosome to Golgi transport,BP,
4664,GO:0010815,0.999999999984054,0.63663095993221,0,4,bradykinin catabolic process,BP,
9509,GO:0036219,0.999999999984063,0.946330996511336,0,1,GTP diphosphatase activity,MF,
10945,GO:0044713,0.999999999984063,0.946330996511336,0,1,2-hydroxy-adenosine triphosphate pyrophosphatase activity,MF,
10946,GO:0044714,0.999999999984063,0.946330996511336,0,1,2-hydroxy-(deoxy)adenosine-triphosphate pyrophosphatase activity,MF,
12012,GO:0047693,0.999999999984063,0.946330996511336,0,1,ATP diphosphatase activity,MF,
11032,GO:0045027,0.999999999984074,0.901764898590457,0,1,DNA end binding,MF,
13551,GO:0060040,0.999999999984075,0.799241978542543,0,2,retinal bipolar neuron differentiation,BP,
17885,GO:1902216,0.999999999984076,0.877826059232903,0,1,positive regulation of interleukin-4-mediated signaling pathway,BP,
16043,GO:0090009,0.999999999984094,0.604266405976112,0,4,primitive streak formation,BP,
119,GO:0000248,0.999999999984107,0.793444841234552,0,2,C-5 sterol desaturase activity,MF,
14878,GO:0070704,0.999999999984107,0.793444841234552,0,2,sterol desaturase activity,MF,
6634,GO:0023025,0.999999999984119,0.807502144024637,0,2,MHC class Ib protein complex binding,MF,
6637,GO:0023030,0.999999999984119,0.807502144024637,0,2,MHC class Ib protein binding, via antigen binding groove,MF,
12499,GO:0050659,0.999999999984121,0.7752862112356,0,2,N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity,MF,
7461,GO:0031627,0.999999999984168,0.719085244553557,0,3,telomeric loop formation,BP,
976,GO:0002430,0.99999999998417,0.900870299535409,0,1,complement receptor mediated signaling pathway,BP,
1925,GO:0004621,0.99999999998417,0.900870299535409,0,1,glycosylphosphatidylinositol phospholipase D activity,MF,
2968,GO:0006507,0.99999999998417,0.900870299535409,0,1,GPI anchor release,BP,
4730,GO:0010897,0.99999999998417,0.900870299535409,0,1,negative regulation of triglyceride catabolic process,BP,
8551,GO:0034014,0.99999999998417,0.900870299535409,0,1,response to triglyceride,BP,
15221,GO:0071401,0.99999999998417,0.900870299535409,0,1,cellular response to triglyceride,BP,
15597,GO:0072106,0.999999999984176,0.748242106723413,0,3,regulation of ureteric bud formation,BP,
15598,GO:0072107,0.999999999984176,0.748242106723413,0,3,positive regulation of ureteric bud formation,BP,
19171,GO:1905278,0.999999999984176,0.748242106723413,0,3,positive regulation of epithelial tube formation,BP,
3868,GO:0008495,0.999999999984177,0.898001774214307,0,1,protoheme IX farnesyltransferase activity,MF,
12065,GO:0048033,0.999999999984177,0.898001774214307,0,1,heme o metabolic process,BP,
12066,GO:0048034,0.999999999984177,0.898001774214307,0,1,heme O biosynthetic process,BP,
9373,GO:0035921,0.999999999984183,0.901798288239784,0,1,desmosome disassembly,BP,
17462,GO:1900387,0.999999999984183,0.901798288239784,0,1,negative regulation of cell-cell adhesion by negative regulation of transcription from RNA polymerase II promoter,BP,
11618,GO:0046340,0.99999999998419,0.799310152238791,0,2,diacylglycerol catabolic process,BP,
9704,GO:0038131,0.999999999984199,0.80857170585516,0,2,neuregulin receptor activity,MF,
19522,GO:1990456,0.9999999999842,0.888054670649755,0,1,mitochondrion-endoplasmic reticulum membrane tethering,BP,
1770,GO:0004377,0.999999999984201,0.900283860500126,0,1,GDP-Man:Man3GlcNAc2-PP-Dol alpha-1,2-mannosyltransferase activity,MF,
958,GO:0002380,0.999999999984214,0.8822871549167,0,1,immunoglobulin secretion involved in immune response,BP,
1974,GO:0004692,0.99999999998423,0.88824731524557,0,1,cGMP-dependent protein kinase activity,MF,
188,GO:0000406,0.999999999984232,0.790322293749918,0,2,double-strand/single-strand DNA junction binding,MF,
7694,GO:0032181,0.999999999984232,0.790322293749918,0,2,dinucleotide repeat insertion binding,MF,
7770,GO:0032302,0.999999999984232,0.790322293749918,0,2,MutSbeta complex,CC,
9085,GO:0035359,0.999999999984233,0.885642954336846,0,1,negative regulation of peroxisome proliferator activated receptor signaling pathway,BP,
7389,GO:0031460,0.99999999998424,0.88067816405257,0,1,glycine betaine transport,BP,
14044,GO:0060844,0.999999999984259,0.805792237365281,0,2,arterial endothelial cell fate commitment,BP,
1507,GO:0003868,0.999999999984277,0.905187784011647,0,1,4-hydroxyphenylpyruvate dioxygenase activity,MF,
17192,GO:0106072,0.99999999998428,0.792174352249926,0,2,negative regulation of adenylate cyclase-activating G-protein coupled receptor signaling pathway,BP,
8569,GO:0034059,0.999999999984292,0.698550669814648,0,3,response to anoxia,BP,
11018,GO:0045004,0.999999999984296,0.783468529644662,0,2,DNA replication proofreading,BP,
4211,GO:0009368,0.999999999984296,0.832917528655596,0,2,endopeptidase Clp complex,CC,
6833,GO:0030305,0.999999999984312,0.905729968611226,0,1,heparanase activity,MF,
3918,GO:0008592,0.999999999984316,0.895552622737045,0,1,regulation of Toll signaling pathway,BP,
9897,GO:0042241,0.999999999984316,0.895552622737045,0,1,interleukin-18 biosynthetic process,BP,
11215,GO:0045381,0.999999999984316,0.895552622737045,0,1,regulation of interleukin-18 biosynthetic process,BP,
11366,GO:0045751,0.999999999984316,0.895552622737045,0,1,negative regulation of Toll signaling pathway,BP,
16555,GO:0097368,0.999999999984317,0.715310517011791,0,3,establishment of Sertoli cell barrier,BP,
12182,GO:0048369,0.99999999998432,0.783538009446725,0,2,lateral mesoderm morphogenesis,BP,
12183,GO:0048370,0.99999999998432,0.783538009446725,0,2,lateral mesoderm formation,BP,
12184,GO:0048371,0.99999999998432,0.783538009446725,0,2,lateral mesodermal cell differentiation,BP,
12185,GO:0048372,0.99999999998432,0.783538009446725,0,2,lateral mesodermal cell fate commitment,BP,
12186,GO:0048377,0.99999999998432,0.783538009446725,0,2,lateral mesodermal cell fate specification,BP,
12187,GO:0048378,0.99999999998432,0.783538009446725,0,2,regulation of lateral mesodermal cell fate specification,BP,
19709,GO:2000097,0.999999999984325,0.807041635981155,0,2,regulation of smooth muscle cell-matrix adhesion,BP,
14871,GO:0070685,0.999999999984327,0.901696706896625,0,1,macropinocytic cup,CC,
3776,GO:0008332,0.999999999984329,0.903239163996833,0,1,low voltage-gated calcium channel activity,MF,
14248,GO:0061341,0.99999999998434,0.773885527648767,0,2,non-canonical Wnt signaling pathway involved in heart development,BP,
14250,GO:0061346,0.99999999998434,0.773885527648767,0,2,planar cell polarity pathway involved in heart morphogenesis,BP,
8298,GO:0033142,0.999999999984343,0.901258012922561,0,1,progesterone receptor binding,MF,
6458,GO:0021784,0.999999999984347,0.948264821262396,0,1,postganglionic parasympathetic fiber development,BP,
18241,GO:1903116,0.999999999984352,0.784937884126877,0,2,positive regulation of actin filament-based movement,BP,
18540,GO:1903781,0.999999999984352,0.784937884126877,0,2,positive regulation of cardiac conduction,BP,
18621,GO:1903949,0.999999999984352,0.784937884126877,0,2,positive regulation of atrial cardiac muscle cell action potential,BP,
18096,GO:1902775,0.999999999984369,0.700037683057478,0,3,mitochondrial large ribosomal subunit assembly,BP,
2073,GO:0004828,0.99999999998437,0.81504398072687,0,2,serine-tRNA ligase activity,MF,
2923,GO:0006434,0.99999999998437,0.81504398072687,0,2,seryl-tRNA aminoacylation,BP,
2362,GO:0005471,0.999999999984376,0.738824535436163,0,3,ATP:ADP antiporter activity,MF,
5033,GO:0015207,0.999999999984376,0.738824535436163,0,3,adenine transmembrane transporter activity,MF,
12431,GO:0050146,0.999999999984401,0.879894248524429,0,1,nucleoside phosphotransferase activity,MF,
7177,GO:0031071,0.999999999984424,0.900620865325635,0,1,cysteine desulfurase activity,MF,
19635,GO:1990889,0.999999999984424,0.904155091799733,0,1,H4K20me3 modified histone binding,MF,
19362,GO:1905878,0.999999999984425,0.874416081488911,0,1,invadopodium disassembly,BP,
19382,GO:1905927,0.999999999984425,0.874416081488911,0,1,regulation of invadopodium disassembly,BP,
19383,GO:1905929,0.999999999984425,0.874416081488911,0,1,positive regulation of invadopodium disassembly,BP,
896,GO:0002276,0.999999999984428,0.797484645295022,0,2,basophil activation involved in immune response,BP,
11253,GO:0045575,0.999999999984428,0.797484645295022,0,2,basophil activation,BP,
1288,GO:0003100,0.999999999984436,0.6456278944908,0,4,regulation of systemic arterial blood pressure by endothelin,BP,
7507,GO:0031700,0.999999999984452,0.913717420132366,0,1,adrenomedullin receptor binding,MF,
9270,GO:0035718,0.999999999984456,0.83795525862401,0,2,macrophage migration inhibitory factor binding,MF,
6865,GO:0030348,0.999999999984458,0.796058987843582,0,2,syntaxin-3 binding,MF,
3263,GO:0006933,0.999999999984462,0.815572679642589,0,2,negative regulation of cell adhesion involved in substrate-bound cell migration,BP,
4357,GO:0009955,0.999999999984463,0.901198032029447,0,1,adaxial/abaxial pattern specification,BP,
9266,GO:0035709,0.999999999984463,0.901198032029447,0,1,memory T cell activation,BP,
16285,GO:0090427,0.999999999984463,0.901198032029447,0,1,activation of meiosis,BP,
19671,GO:2000011,0.999999999984463,0.901198032029447,0,1,regulation of adaxial/abaxial pattern formation,BP,
19957,GO:2000567,0.999999999984463,0.901198032029447,0,1,regulation of memory T cell activation,BP,
19958,GO:2000568,0.999999999984463,0.901198032029447,0,1,positive regulation of memory T cell activation,BP,
20177,GO:2001055,0.999999999984463,0.901198032029447,0,1,positive regulation of mesenchymal cell apoptotic process,BP,
11043,GO:0045054,0.999999999984481,0.725552555800862,0,3,constitutive secretory pathway,BP,
8519,GO:0033814,0.99999999998449,0.914591647136265,0,1,propanoyl-CoA C-acyltransferase activity,MF,
12489,GO:0050632,0.99999999998449,0.914591647136265,0,1,propionyl-CoA C2-trimethyltridecanoyltransferase activity,MF,
14788,GO:0070538,0.99999999998449,0.914591647136265,0,1,oleic acid binding,MF,
17619,GO:1901373,0.99999999998449,0.914591647136265,0,1,lipid hydroperoxide transport,BP,
8275,GO:0033091,0.999999999984509,0.900158625357296,0,1,positive regulation of immature T cell proliferation,BP,
4210,GO:0009360,0.999999999984537,0.899837963637252,0,1,DNA polymerase III complex,CC,
10748,GO:0044208,0.999999999984543,0.821058834277181,0,2,'de novo' AMP biosynthetic process,BP,
7464,GO:0031630,0.999999999984547,0.887103522075288,0,1,regulation of synaptic vesicle fusion to presynaptic active zone membrane,BP,
17177,GO:0106022,0.999999999984547,0.887103522075288,0,1,positive regulation of vesicle docking,BP,
9689,GO:0038098,0.999999999984552,0.902244061038404,0,1,sequestering of BMP from receptor via BMP binding,BP,
6410,GO:0021678,0.999999999984561,0.792289831619923,0,3,third ventricle development,BP,
7802,GO:0032361,0.999999999984566,0.902546823472475,0,1,pyridoxal phosphate catabolic process,BP,
10192,GO:0042820,0.999999999984566,0.902546823472475,0,1,vitamin B6 catabolic process,BP,
16909,GO:0098908,0.999999999984568,0.795221982472613,0,2,regulation of neuronal action potential,BP,
7341,GO:0031389,0.99999999998457,0.898807326222918,0,1,Rad17 RFC-like complex,CC,
12792,GO:0051107,0.99999999998457,0.898807326222918,0,1,negative regulation of DNA ligation,BP,
12950,GO:0051352,0.99999999998457,0.898807326222918,0,1,negative regulation of ligase activity,BP,
19011,GO:1904876,0.99999999998457,0.898807326222918,0,1,negative regulation of DNA ligase activity,BP,
3887,GO:0008523,0.999999999984577,0.894780028793551,0,1,sodium-dependent multivitamin transmembrane transporter activity,MF,
5248,GO:0015878,0.999999999984577,0.894780028793551,0,1,biotin transport,BP,
5255,GO:0015887,0.999999999984577,0.894780028793551,0,1,pantothenate transmembrane transport,BP,
16382,GO:0097026,0.99999999998459,0.877288804142099,0,1,dendritic cell dendrite assembly,BP,
1845,GO:0004506,0.999999999984594,0.898062368827361,0,1,squalene monooxygenase activity,MF,
18462,GO:1903589,0.999999999984601,0.812375951512434,0,2,positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,
16118,GO:0090149,0.999999999984604,0.794482626738303,0,2,mitochondrial membrane fission,BP,
7007,GO:0030718,0.999999999984606,0.888084655531504,0,1,germ-line stem cell population maintenance,BP,
8804,GO:0034584,0.999999999984606,0.888084655531504,0,1,piRNA binding,MF,
18756,GO:1904289,0.999999999984607,0.792228698967656,0,2,regulation of mitotic DNA damage checkpoint,BP,
1245,GO:0002947,0.999999999984633,0.884980347994178,0,1,tumor necrosis factor receptor superfamily complex,CC,
14364,GO:0061628,0.999999999984633,0.790827533057265,0,2,H3K27me3 modified histone binding,MF,
19726,GO:2000124,0.999999999984633,0.795079891065862,0,2,regulation of endocannabinoid signaling pathway,BP,
5362,GO:0016150,0.999999999984639,0.908868858548283,0,1,translation release factor activity, codon nonspecific,MF,
17638,GO:1901491,0.999999999984647,0.785380176533472,0,2,negative regulation of lymphangiogenesis,BP,
3412,GO:0007195,0.99999999998465,0.789409243138465,0,2,adenylate cyclase-inhibiting dopamine receptor signaling pathway,BP,
1746,GO:0004348,0.999999999984678,0.802169014065278,0,2,glucosylceramidase activity,MF,
2041,GO:0004790,0.99999999998469,0.900235502784816,0,1,thioether S-methyltransferase activity,MF,
7015,GO:0030748,0.99999999998469,0.900235502784816,0,1,amine N-methyltransferase activity,MF,
17143,GO:0102707,0.99999999998469,0.900235502784816,0,1,S-adenosyl-L-methionine:beta-alanine N-methyltransferase activity,MF,
5978,GO:0018773,0.999999999984695,0.907440726519297,0,1,acetylpyruvate hydrolase activity,MF,
8800,GO:0034545,0.999999999984695,0.907440726519297,0,1,fumarylpyruvate hydrolase activity,MF,
12004,GO:0047621,0.999999999984695,0.907440726519297,0,1,acylpyruvate hydrolase activity,MF,
13342,GO:0052550,0.999999999984695,0.907440726519297,0,1,response to defense-related reactive oxygen species production by other organism involved in symbiotic interaction,BP,
13348,GO:0052567,0.999999999984695,0.907440726519297,0,1,response to defense-related host reactive oxygen species production,BP,
13028,GO:0051538,0.999999999984698,0.741903375274771,0,3,3 iron, 4 sulfur cluster binding,MF,
17853,GO:1902109,0.999999999984717,0.753717956264825,0,3,negative regulation of mitochondrial membrane permeability involved in apoptotic process,BP,
10865,GO:0044416,0.99999999998472,0.822463775974942,0,2,induction by symbiont of host defense response,BP,
11812,GO:0046730,0.99999999998472,0.822463775974942,0,2,induction of host immune response by virus,BP,
11813,GO:0046732,0.99999999998472,0.822463775974942,0,2,active induction of host immune response by virus,BP,
13310,GO:0052251,0.99999999998472,0.822463775974942,0,2,induction by organism of defense response of other organism involved in symbiotic interaction,BP,
13337,GO:0052509,0.99999999998472,0.822463775974942,0,2,positive regulation by symbiont of host defense response,BP,
13338,GO:0052510,0.99999999998472,0.822463775974942,0,2,positive regulation by organism of defense response of other organism involved in symbiotic interaction,BP,
3534,GO:0007525,0.999999999984725,0.719015646500582,0,2,somatic muscle development,BP,
388,GO:0001034,0.999999999984736,0.905046446118653,0,1,RNA polymerase III transcription factor activity, sequence-specific DNA binding,MF,
355,GO:0000973,0.999999999984749,0.71538314760679,0,3,posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery,BP,
14684,GO:0070335,0.999999999984756,0.878492788469147,0,1,aspartate binding,MF,
11239,GO:0045485,0.999999999984759,0.882743521882329,0,1,omega-6 fatty acid desaturase activity,MF,
14212,GO:0061198,0.999999999984763,0.708012389796688,0,3,fungiform papilla formation,BP,
8337,GO:0033204,0.999999999984764,0.900392171227574,0,1,ribonuclease P RNA binding,MF,
8560,GO:0034038,0.999999999984772,0.923311187500334,0,1,deoxyhypusine synthase activity,MF,
16141,GO:0090182,0.999999999984792,0.821154600866509,0,2,regulation of secretion of lysosomal enzymes,BP,
11974,GO:0047341,0.999999999984797,0.893286944614544,0,1,fucose-1-phosphate guanylyltransferase activity,MF,
16532,GO:0097325,0.999999999984802,0.791070344154495,0,2,melanocyte proliferation,BP,
7973,GO:0032595,0.999999999984815,0.901331045733227,0,1,B cell receptor transport within lipid bilayer,BP,
7975,GO:0032597,0.999999999984815,0.901331045733227,0,1,B cell receptor transport into membrane raft,BP,
7976,GO:0032599,0.999999999984815,0.901331045733227,0,1,protein transport out of membrane raft,BP,
7977,GO:0032600,0.999999999984815,0.901331045733227,0,1,chemokine receptor transport out of membrane raft,BP,
8167,GO:0032913,0.999999999984815,0.901331045733227,0,1,negative regulation of transforming growth factor beta3 production,BP,
8457,GO:0033606,0.999999999984815,0.901331045733227,0,1,chemokine receptor transport within lipid bilayer,BP,
15620,GO:0072139,0.999999999984815,0.901331045733227,0,1,glomerular parietal epithelial cell differentiation,BP,
20078,GO:2000768,0.999999999984815,0.901331045733227,0,1,positive regulation of nephron tubule epithelial cell differentiation,BP,
14906,GO:0070780,0.999999999984817,0.825717379034214,0,2,dihydrosphingosine-1-phosphate phosphatase activity,MF,
15689,GO:0072262,0.999999999984845,0.805222203391743,0,2,metanephric glomerular mesangial cell proliferation involved in metanephros development,BP,
15707,GO:0072301,0.999999999984845,0.805222203391743,0,2,regulation of metanephric glomerular mesangial cell proliferation,BP,
11489,GO:0045990,0.999999999984853,0.638833653477345,0,4,carbon catabolite regulation of transcription,BP,
11490,GO:0045991,0.999999999984853,0.638833653477345,0,4,carbon catabolite activation of transcription,BP,
4980,GO:0015105,0.999999999984874,0.919494158660315,0,1,arsenite transmembrane transporter activity,MF,
5159,GO:0015700,0.999999999984874,0.919494158660315,0,1,arsenite transport,BP,
2994,GO:0006540,0.999999999984889,0.792661176675969,0,2,glutamate decarboxylation to succinate,BP,
9791,GO:0040030,0.999999999984894,0.888588452206309,0,1,regulation of molecular function, epigenetic,BP,
10274,GO:0043035,0.999999999984894,0.888588452206309,0,1,chromatin insulator sequence binding,MF,
3871,GO:0008503,0.999999999984911,0.84617811875381,0,2,benzodiazepine receptor activity,MF,
204,GO:0000430,0.999999999984919,0.822972664370756,0,2,regulation of transcription from RNA polymerase II promoter by glucose,BP,
206,GO:0000432,0.999999999984919,0.822972664370756,0,2,positive regulation of transcription from RNA polymerase II promoter by glucose,BP,
2321,GO:0005330,0.999999999984937,0.882062395035013,0,1,dopamine:sodium symporter activity,MF,
2323,GO:0005335,0.999999999984937,0.882062395035013,0,1,serotonin:sodium symporter activity,MF,
4849,GO:0014064,0.999999999984937,0.882062395035013,0,1,positive regulation of serotonin secretion,BP,
6241,GO:0019811,0.999999999984937,0.882062395035013,0,1,cocaine binding,MF,
6532,GO:0021941,0.999999999984937,0.882062395035013,0,1,negative regulation of cerebellar granule cell precursor proliferation,BP,
16068,GO:0090067,0.999999999984937,0.882062395035013,0,1,regulation of thalamus size,BP,
2569,GO:0005854,0.999999999984941,0.816881785125874,0,2,nascent polypeptide-associated complex,CC,
14544,GO:0070095,0.999999999984942,0.896277294491717,0,1,fructose-6-phosphate binding,MF,
1599,GO:0004020,0.999999999984947,0.799264198760869,0,2,adenylylsulfate kinase activity,MF,
2037,GO:0004779,0.999999999984947,0.799264198760869,0,2,sulfate adenylyltransferase activity,MF,
2038,GO:0004781,0.999999999984947,0.799264198760869,0,2,sulfate adenylyltransferase (ATP) activity,MF,
16065,GO:0090063,0.999999999984951,0.629914717613707,0,4,positive regulation of microtubule nucleation,BP,
4435,GO:0010309,0.999999999984959,0.907573885477544,0,1,acireductone dioxygenase [iron(II)-requiring] activity,MF,
19539,GO:1990565,0.999999999984959,0.907573885477544,0,1,HSP90-CDC37 chaperone complex,CC,
6304,GO:0019948,0.99999999998496,0.81030914418473,0,2,SUMO activating enzyme activity,MF,
9723,GO:0038189,0.999999999984967,0.636824006813848,0,4,neuropilin signaling pathway,BP,
10693,GO:0043997,0.999999999985007,0.896804632953896,0,1,histone acetyltransferase activity (H4-K12 specific),MF,
17195,GO:0106075,0.999999999985007,0.896804632953896,0,1,peptide N-succinyltransferase activity,MF,
17197,GO:0106078,0.999999999985007,0.896804632953896,0,1,histone succinyltransferase activity,MF,
15408,GO:0071701,0.99999999998502,0.880791725254994,0,1,regulation of MAPK export from nucleus,BP,
4810,GO:0014004,0.999999999985022,0.79767625603152,0,2,microglia differentiation,BP,
4811,GO:0014005,0.999999999985022,0.79767625603152,0,2,microglia development,BP,
1609,GO:0004034,0.99999999998503,0.900391133384383,0,1,aldose 1-epimerase activity,MF,
9388,GO:0035945,0.99999999998503,0.900391133384383,0,1,mitochondrial ncRNA surveillance,BP,
9389,GO:0035946,0.99999999998503,0.900391133384383,0,1,mitochondrial mRNA surveillance,BP,
15043,GO:0071026,0.99999999998503,0.900391133384383,0,1,cytoplasmic RNA surveillance,BP,
20113,GO:2000827,0.99999999998503,0.900391133384383,0,1,mitochondrial RNA surveillance,BP,
8495,GO:0033684,0.999999999985035,0.787509595804514,0,2,regulation of luteinizing hormone secretion,BP,
8496,GO:0033686,0.999999999985035,0.787509595804514,0,2,positive regulation of luteinizing hormone secretion,BP,
3641,GO:0008113,0.999999999985037,0.837387846893373,0,2,peptide-methionine (S)-S-oxide reductase activity,MF,
1585,GO:0003998,0.999999999985043,0.876108007154073,0,2,acylphosphatase activity,MF,
14383,GO:0061669,0.999999999985047,0.775997056962428,0,2,spontaneous neurotransmitter secretion,BP,
19065,GO:1904980,0.999999999985069,0.878547260858064,0,1,positive regulation of endosome organization,BP,
2013,GO:0004742,0.999999999985074,0.88318485234557,0,1,dihydrolipoyllysine-residue acetyltransferase activity,MF,
6923,GO:0030523,0.999999999985074,0.88318485234557,0,1,dihydrolipoamide S-acyltransferase activity,MF,
10414,GO:0043273,0.999999999985076,0.879818366843645,0,1,CTPase activity,MF,
7607,GO:0032002,0.999999999985099,0.811848170265529,0,2,interleukin-28 receptor complex,CC,
2008,GO:0004736,0.999999999985121,0.88599495456212,0,1,pyruvate carboxylase activity,MF,
4863,GO:0014717,0.999999999985122,0.819894639631723,0,2,regulation of satellite cell activation involved in skeletal muscle regeneration,BP,
4864,GO:0014718,0.999999999985122,0.819894639631723,0,2,positive regulation of satellite cell activation involved in skeletal muscle regeneration,BP,
4938,GO:0014901,0.999999999985122,0.819894639631723,0,2,satellite cell activation involved in skeletal muscle regeneration,BP,
18476,GO:1903630,0.999999999985123,0.922084031951313,0,1,regulation of aminoacyl-tRNA ligase activity,BP,
18477,GO:1903632,0.999999999985123,0.922084031951313,0,1,positive regulation of aminoacyl-tRNA ligase activity,BP,
8634,GO:0034186,0.999999999985129,0.648781106518378,0,4,apolipoprotein A-I binding,MF,
15439,GO:0071798,0.999999999985141,0.800940165541568,0,2,response to prostaglandin D,BP,
15440,GO:0071799,0.999999999985141,0.800940165541568,0,2,cellular response to prostaglandin D stimulus,BP,
16541,GO:0097344,0.999999999985149,0.817026622020278,0,2,Rix1 complex,CC,
17926,GO:1902296,0.999999999985157,0.894941928203212,0,1,DNA strand elongation involved in cell cycle DNA replication,BP,
17939,GO:1902319,0.999999999985157,0.894941928203212,0,1,DNA strand elongation involved in nuclear cell cycle DNA replication,BP,
18178,GO:1902983,0.999999999985157,0.894941928203212,0,1,DNA strand elongation involved in mitotic DNA replication,BP,
3074,GO:0006642,0.99999999998518,0.703637945073192,0,3,triglyceride mobilization,BP,
4541,GO:0010621,0.999999999985196,0.927083782247875,0,1,negative regulation of transcription by transcription factor localization,BP,
9500,GO:0036164,0.999999999985196,0.927083782247875,0,1,cell-abiotic substrate adhesion,BP,
10729,GO:0044111,0.999999999985204,0.798653681642515,0,2,development involved in symbiotic interaction,BP,
2050,GO:0004801,0.999999999985217,0.92096661785547,0,1,sedoheptulose-7-phosphate:D-glyceraldehyde-3-phosphate glyceronetransferase activity,MF,
19440,GO:1990145,0.999999999985226,0.80081516517258,0,2,maintenance of translational fidelity,BP,
8411,GO:0033499,0.999999999985233,0.82606226270412,0,2,galactose catabolic process via UDP-galactose,BP,
809,GO:0002083,0.999999999985241,0.908334888902912,0,1,4-hydroxybenzoate decaprenyltransferase activity,MF,
11968,GO:0047293,0.999999999985241,0.908334888902912,0,1,4-hydroxybenzoate nonaprenyltransferase activity,MF,
14359,GO:0061622,0.999999999985244,0.821097892992053,0,2,glycolytic process through glucose-1-phosphate,BP,
9258,GO:0035692,0.999999999985245,0.808557299600562,0,2,macrophage migration inhibitory factor receptor complex,CC,
13949,GO:0060678,0.999999999985261,0.9009642421263,0,1,dichotomous subdivision of terminal units involved in ureteric bud branching,BP,
15608,GO:0072127,0.999999999985261,0.9009642421263,0,1,renal capsule development,BP,
15609,GO:0072128,0.999999999985261,0.9009642421263,0,1,renal capsule morphogenesis,BP,
15610,GO:0072129,0.999999999985261,0.9009642421263,0,1,renal capsule formation,BP,
15611,GO:0072130,0.999999999985261,0.9009642421263,0,1,renal capsule specification,BP,
15665,GO:0072213,0.999999999985261,0.9009642421263,0,1,metanephric capsule development,BP,
15690,GO:0072265,0.999999999985261,0.9009642421263,0,1,metanephric capsule morphogenesis,BP,
15691,GO:0072266,0.999999999985261,0.9009642421263,0,1,metanephric capsule formation,BP,
15692,GO:0072267,0.999999999985261,0.9009642421263,0,1,metanephric capsule specification,BP,
14356,GO:0061618,0.999999999985276,0.870524538281413,0,1,sublamina densa,CC,
2260,GO:0005175,0.999999999985279,0.948654856886681,0,1,CD27 receptor binding,MF,
14774,GO:0070510,0.999999999985293,0.87851018208673,0,1,regulation of histone H4-K20 methylation,BP,
14775,GO:0070512,0.999999999985293,0.87851018208673,0,1,positive regulation of histone H4-K20 methylation,BP,
8290,GO:0033132,0.999999999985295,0.823202567737645,0,2,negative regulation of glucokinase activity,BP,
18317,GO:1903300,0.999999999985295,0.823202567737645,0,2,negative regulation of hexokinase activity,BP,
20002,GO:2000645,0.999999999985298,0.707940920873387,0,3,negative regulation of receptor catabolic process,BP,
5740,GO:0016890,0.999999999985314,0.805338297797692,0,2,site-specific endodeoxyribonuclease activity, specific for altered base,MF,
4215,GO:0009383,0.999999999985328,0.794210736654086,0,2,rRNA (cytosine-C5-)-methyltransferase activity,MF,
19877,GO:2000389,0.99999999998533,0.709425258567512,0,3,regulation of neutrophil extravasation,BP,
19878,GO:2000391,0.99999999998533,0.709425258567512,0,3,positive regulation of neutrophil extravasation,BP,
10136,GO:0042727,0.999999999985348,0.812377780898546,0,2,flavin-containing compound biosynthetic process,BP,
14264,GO:0061370,0.999999999985354,0.79848764674204,0,2,testosterone biosynthetic process,BP,
15905,GO:0072714,0.999999999985356,0.906198733773119,0,1,response to selenite ion,BP,
15906,GO:0072715,0.999999999985356,0.906198733773119,0,1,cellular response to selenite ion,BP,
18865,GO:1904569,0.999999999985356,0.906198733773119,0,1,regulation of selenocysteine incorporation,BP,
18866,GO:1904570,0.999999999985356,0.906198733773119,0,1,negative regulation of selenocysteine incorporation,BP,
18867,GO:1904572,0.999999999985356,0.906198733773119,0,1,negative regulation of mRNA binding,BP,
18868,GO:1904573,0.999999999985356,0.906198733773119,0,1,regulation of selenocysteine insertion sequence binding,BP,
18869,GO:1904574,0.999999999985356,0.906198733773119,0,1,negative regulation of selenocysteine insertion sequence binding,BP,
19149,GO:1905215,0.999999999985356,0.906198733773119,0,1,negative regulation of RNA binding,BP,
5361,GO:0016149,0.999999999985363,0.889865985370199,0,1,translation release factor activity, codon specific,MF,
1715,GO:0004309,0.999999999985383,0.619262945340056,0,4,exopolyphosphatase activity,MF,
3180,GO:0006798,0.999999999985383,0.619262945340056,0,4,polyphosphate catabolic process,BP,
5209,GO:0015810,0.999999999985384,0.793939579187146,0,2,aspartate transmembrane transport,BP,
10528,GO:0043490,0.999999999985384,0.793939579187146,0,2,malate-aspartate shuttle,BP,
2502,GO:0005753,0.999999999985386,0.901234587460658,0,1,mitochondrial proton-transporting ATP synthase complex,CC,
4692,GO:0010849,0.999999999985386,0.901234587460658,0,1,regulation of proton-transporting ATPase activity, rotational mechanism,BP,
19797,GO:2000276,0.999999999985386,0.901234587460658,0,1,negative regulation of oxidative phosphorylation uncoupler activity,BP,
3531,GO:0007518,0.999999999985391,0.900644100744975,0,1,myoblast fate determination,BP,
19891,GO:2000409,0.999999999985408,0.904341231594214,0,1,positive regulation of T cell extravasation,BP,
19909,GO:2000451,0.999999999985408,0.904341231594214,0,1,positive regulation of CD8-positive, alpha-beta T cell extravasation,BP,
19911,GO:2000454,0.999999999985408,0.904341231594214,0,1,positive regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation,BP,
19802,GO:2000282,0.99999999998541,0.819102454359846,0,2,regulation of cellular amino acid biosynthetic process,BP,
85,GO:0000173,0.999999999985411,0.90811087120968,0,1,inactivation of MAPK activity involved in osmosensory signaling pathway,BP,
9277,GO:0035727,0.999999999985411,0.806529075429187,0,2,lysophosphatidic acid binding,MF,
820,GO:0002094,0.99999999998542,0.812807441096002,0,2,polyprenyltransferase activity,MF,
7371,GO:0031431,0.999999999985433,0.797851658181877,0,2,Dbf4-dependent protein kinase complex,CC,
3982,GO:0008829,0.999999999985439,0.904780835417822,0,1,dCTP deaminase activity,MF,
13657,GO:0060212,0.999999999985439,0.904780835417822,0,1,negative regulation of nuclear-transcribed mRNA poly(A) tail shortening,BP,
17394,GO:1900152,0.999999999985439,0.904780835417822,0,1,negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,BP,
9353,GO:0035879,0.999999999985443,0.705311788083628,0,3,plasma membrane lactate transport,BP,
5568,GO:0016586,0.99999999998545,0.774717688292634,0,2,RSC-type complex,CC,
1694,GO:0004174,0.99999999998546,0.80654979746525,0,2,electron-transferring-flavoprotein dehydrogenase activity,MF,
5604,GO:0016649,0.99999999998546,0.80654979746525,0,2,oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor,MF,
14103,GO:0060988,0.999999999985472,0.796483526028902,0,2,lipid tube assembly,BP,
3962,GO:0008747,0.999999999985474,0.910431282758102,0,1,N-acetylneuraminate lyase activity,MF,
4152,GO:0009216,0.999999999985477,0.810840626795206,0,2,purine deoxyribonucleoside triphosphate biosynthetic process,BP,
8927,GO:0034970,0.99999999998548,0.808395796604096,0,2,histone H3-R2 methylation,BP,
5527,GO:0016507,0.999999999985482,0.897538690464487,0,1,mitochondrial fatty acid beta-oxidation multienzyme complex,CC,
9478,GO:0036125,0.999999999985482,0.897538690464487,0,1,fatty acid beta-oxidation multienzyme complex,CC,
8969,GO:0035087,0.999999999985494,0.64988008240891,0,4,siRNA loading onto RISC involved in RNA interference,BP,
18933,GO:1904719,0.999999999985505,0.900470553207539,0,1,positive regulation of AMPA glutamate receptor clustering,BP,
2307,GO:0005295,0.999999999985518,0.895770140306234,0,1,neutral amino acid:sodium symporter activity,MF,
5096,GO:0015375,0.999999999985518,0.895770140306234,0,1,glycine:sodium symporter activity,MF,
7510,GO:0031704,0.999999999985518,0.895770140306234,0,1,apelin receptor binding,MF,
10481,GO:0043396,0.999999999985518,0.895770140306234,0,1,corticotropin-releasing hormone secretion,BP,
10482,GO:0043397,0.999999999985518,0.895770140306234,0,1,regulation of corticotropin-releasing hormone secretion,BP,
13009,GO:0051466,0.999999999985518,0.895770140306234,0,1,positive regulation of corticotropin-releasing hormone secretion,BP,
13529,GO:0060012,0.999999999985518,0.895770140306234,0,1,synaptic transmission, glycinergic,BP,
13598,GO:0060092,0.999999999985518,0.895770140306234,0,1,regulation of synaptic transmission, glycinergic,BP,
13643,GO:0060183,0.999999999985518,0.895770140306234,0,1,apelin receptor signaling pathway,BP,
14318,GO:0061536,0.999999999985518,0.895770140306234,0,1,glycine secretion,BP,
14319,GO:0061537,0.999999999985518,0.895770140306234,0,1,glycine secretion, neurotransmission,BP,
18655,GO:1904022,0.999999999985518,0.895770140306234,0,1,positive regulation of G-protein coupled receptor internalization,BP,
20198,GO:2001151,0.999999999985518,0.895770140306234,0,1,regulation of renal water transport,BP,
20199,GO:2001153,0.999999999985518,0.895770140306234,0,1,positive regulation of renal water transport,BP,
1365,GO:0003252,0.999999999985518,0.868888510694157,0,1,negative regulation of cell proliferation involved in heart valve morphogenesis,BP,
11922,GO:0046985,0.999999999985542,0.740483417294356,0,3,positive regulation of hemoglobin biosynthetic process,BP,
4775,GO:0010963,0.99999999998556,0.913653804778066,0,1,regulation of L-arginine import,BP,
14995,GO:0070947,0.99999999998556,0.913653804778066,0,1,neutrophil mediated killing of fungus,BP,
15000,GO:0070953,0.99999999998556,0.913653804778066,0,1,regulation of neutrophil mediated killing of fungus,BP,
15005,GO:0070965,0.99999999998556,0.913653804778066,0,1,positive regulation of neutrophil mediated killing of fungus,BP,
19950,GO:2000552,0.99999999998556,0.913653804778066,0,1,negative regulation of T-helper 2 cell cytokine production,BP,
14093,GO:0060971,0.999999999985563,0.69977254007738,0,3,embryonic heart tube left/right pattern formation,BP,
1734,GO:0004334,0.999999999985582,0.913463910260159,0,1,fumarylacetoacetase activity,MF,
15644,GO:0072185,0.999999999985592,0.900662892540763,0,1,metanephric cap development,BP,
15645,GO:0072186,0.999999999985592,0.900662892540763,0,1,metanephric cap morphogenesis,BP,
16091,GO:0090094,0.999999999985592,0.900662892540763,0,1,metanephric cap mesenchymal cell proliferation involved in metanephros development,BP,
16092,GO:0090095,0.999999999985592,0.900662892540763,0,1,regulation of metanephric cap mesenchymal cell proliferation,BP,
16093,GO:0090096,0.999999999985592,0.900662892540763,0,1,positive regulation of metanephric cap mesenchymal cell proliferation,BP,
16931,GO:0098943,0.999999999985597,0.805782236180705,0,2,neurotransmitter receptor transport, postsynaptic endosome to lysosome,BP,
19760,GO:2000199,0.999999999985605,0.897070377561898,0,1,positive regulation of ribonucleoprotein complex localization,BP,
19761,GO:2000200,0.999999999985605,0.897070377561898,0,1,regulation of ribosomal subunit export from nucleus,BP,
19762,GO:2000202,0.999999999985605,0.897070377561898,0,1,positive regulation of ribosomal subunit export from nucleus,BP,
19763,GO:2000206,0.999999999985605,0.897070377561898,0,1,regulation of ribosomal small subunit export from nucleus,BP,
19764,GO:2000208,0.999999999985605,0.897070377561898,0,1,positive regulation of ribosomal small subunit export from nucleus,BP,
3879,GO:0008513,0.999999999985616,0.901239236590438,0,1,secondary active organic cation transmembrane transporter activity,MF,
1895,GO:0004581,0.99999999998564,0.923999105911205,0,1,dolichyl-phosphate beta-glucosyltransferase activity,MF,
1234,GO:0002923,0.999999999985652,0.9009824017145,0,1,regulation of humoral immune response mediated by circulating immunoglobulin,BP,
1235,GO:0002924,0.999999999985652,0.9009824017145,0,1,negative regulation of humoral immune response mediated by circulating immunoglobulin,BP,
9845,GO:0042105,0.999999999985652,0.9009824017145,0,1,alpha-beta T cell receptor complex,CC,
2735,GO:0006116,0.999999999985655,0.794081934948891,0,2,NADH oxidation,BP,
12899,GO:0051267,0.999999999985662,0.895483277426004,0,1,CP2 mannose-ethanolamine phosphotransferase activity,MF,
13506,GO:0055103,0.999999999985662,0.895483277426004,0,1,ligase regulator activity,MF,
19993,GO:2000631,0.999999999985662,0.895483277426004,0,1,regulation of pre-miRNA processing,BP,
19994,GO:2000632,0.999999999985662,0.895483277426004,0,1,negative regulation of pre-miRNA processing,BP,
892,GO:0002266,0.999999999985663,0.811327366383622,0,2,follicular dendritic cell activation,BP,
893,GO:0002268,0.999999999985663,0.811327366383622,0,2,follicular dendritic cell differentiation,BP,
8355,GO:0033257,0.999999999985663,0.811327366383622,0,2,Bcl3/NF-kappaB2 complex,CC,
1375,GO:0003273,0.999999999985669,0.707786176088331,0,3,cell migration involved in endocardial cushion formation,BP,
2068,GO:0004823,0.999999999985701,0.778708172177422,0,2,leucine-tRNA ligase activity,MF,
2918,GO:0006429,0.999999999985701,0.778708172177422,0,2,leucyl-tRNA aminoacylation,BP,
18186,GO:1902996,0.999999999985715,0.783866004126109,0,2,regulation of neurofibrillary tangle assembly,BP,
14649,GO:0070278,0.999999999985726,0.807652297662503,0,2,extracellular matrix constituent secretion,BP,
7246,GO:0031213,0.999999999985732,0.781262573691693,0,2,RSF complex,CC,
496,GO:0001552,0.999999999985734,0.903171178178356,0,1,ovarian follicle atresia,BP,
19854,GO:2000355,0.999999999985734,0.903171178178356,0,1,negative regulation of ovarian follicle development,BP,
19166,GO:1905271,0.999999999985743,0.951187445974603,0,1,regulation of proton-transporting ATP synthase activity, rotational mechanism,BP,
19167,GO:1905273,0.999999999985743,0.951187445974603,0,1,positive regulation of proton-transporting ATP synthase activity, rotational mechanism,BP,
4658,GO:0010808,0.999999999985743,0.879175094148553,0,1,positive regulation of synaptic vesicle priming,BP,
10803,GO:0044305,0.999999999985743,0.879175094148553,0,1,calyx of Held,CC,
14434,GO:0061789,0.999999999985743,0.879175094148553,0,1,dense core granule priming,BP,
1541,GO:0003938,0.999999999985745,0.816696539201929,0,2,IMP dehydrogenase activity,MF,
12010,GO:0047676,0.999999999985781,0.880061472134635,0,1,arachidonate-CoA ligase activity,MF,
7496,GO:0031682,0.999999999985792,0.897655609391422,0,1,G-protein gamma-subunit binding,MF,
18094,GO:1902773,0.999999999985792,0.897655609391422,0,1,GTPase activator complex,CC,
7832,GO:0032395,0.999999999985805,0.768527501571465,0,3,MHC class II receptor activity,MF,
16591,GO:0097450,0.999999999985825,0.795129018411429,0,2,astrocyte end-foot,CC,
16592,GO:0097451,0.999999999985825,0.795129018411429,0,2,glial limiting end-foot,CC,
1667,GO:0004132,0.999999999985832,0.902294262706566,0,1,dCMP deaminase activity,MF,
16668,GO:0097636,0.999999999985875,0.795609360380443,0,2,intrinsic component of autophagosome membrane,CC,
16669,GO:0097637,0.999999999985875,0.795609360380443,0,2,integral component of autophagosome membrane,CC,
9898,GO:0042245,0.999999999985885,0.795375846160745,0,2,RNA repair,BP,
6334,GO:0021512,0.999999999985887,0.883881260102054,0,1,spinal cord anterior/posterior patterning,BP,
15552,GO:0072034,0.999999999985896,0.787045156597641,0,2,renal vesicle induction,BP,
9223,GO:0035623,0.999999999985909,0.895529541851849,0,1,renal glucose absorption,BP,
7343,GO:0031392,0.999999999985913,0.642898025046366,0,4,regulation of prostaglandin biosynthetic process,BP,
20274,GO:2001279,0.999999999985913,0.642898025046366,0,4,regulation of unsaturated fatty acid biosynthetic process,BP,
1915,GO:0004610,0.999999999985919,0.90256544533443,0,1,phosphoacetylglucosamine mutase activity,MF,
14605,GO:0070195,0.999999999985921,0.883110617300757,0,1,growth hormone receptor complex,CC,
12588,GO:0050787,0.999999999985926,0.822901887141599,0,2,detoxification of mercury ion,BP,
18872,GO:1904578,0.999999999985932,0.749454202333672,0,3,response to thapsigargin,BP,
18873,GO:1904579,0.999999999985932,0.749454202333672,0,3,cellular response to thapsigargin,BP,
16982,GO:0099093,0.999999999985939,0.790770622235369,0,2,calcium export from the mitochondrion,BP,
630,GO:0001820,0.999999999985946,0.717523732263674,0,3,serotonin secretion,BP,
9151,GO:0035516,0.999999999985961,0.883595007131583,0,1,oxidative DNA demethylase activity,MF,
14690,GO:0070343,0.999999999985961,0.883595007131583,0,1,white fat cell proliferation,BP,
14694,GO:0070350,0.999999999985961,0.883595007131583,0,1,regulation of white fat cell proliferation,BP,
19649,GO:1990931,0.999999999985961,0.883595007131583,0,1,RNA N6-methyladenosine dioxygenase activity,MF,
18245,GO:1903126,0.999999999985969,0.901564955073706,0,1,negative regulation of centriole-centriole cohesion,BP,
20209,GO:2001173,0.999999999985969,0.901564955073706,0,1,regulation of histone H2B conserved C-terminal lysine ubiquitination,BP,
19251,GO:1905462,0.999999999985973,0.77868563603896,0,2,regulation of DNA duplex unwinding,BP,
15480,GO:0071873,0.999999999985993,0.892636148324093,0,1,response to norepinephrine,BP,
15481,GO:0071874,0.999999999985993,0.892636148324093,0,1,cellular response to norepinephrine stimulus,BP,
6868,GO:0030366,0.999999999985998,0.830455220224473,0,2,molybdopterin synthase activity,MF,
2460,GO:0005674,0.999999999986001,0.82237895980929,0,2,transcription factor TFIIF complex,CC,
3728,GO:0008263,0.999999999986009,0.806266756932123,0,2,pyrimidine-specific mismatch base pair DNA N-glycosylase activity,MF,
5469,GO:0016404,0.999999999986014,0.882430675999224,0,1,15-hydroxyprostaglandin dehydrogenase (NAD+) activity,MF,
11957,GO:0047237,0.999999999986022,0.799608841219554,0,2,glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity,MF,
2338,GO:0005368,0.999999999986028,0.879087963836221,0,1,taurine transmembrane transporter activity,MF,
2339,GO:0005369,0.999999999986028,0.879087963836221,0,1,taurine:sodium symporter activity,MF,
5175,GO:0015734,0.999999999986028,0.879087963836221,0,1,taurine transport,BP,
3395,GO:0007174,0.999999999986043,0.901074597325155,0,1,epidermal growth factor catabolic process,BP,
7851,GO:0032419,0.999999999986043,0.901074597325155,0,1,extrinsic component of lysosome membrane,CC,
19064,GO:1904979,0.999999999986043,0.901074597325155,0,1,negative regulation of endosome organization,BP,
19208,GO:1905365,0.999999999986043,0.901074597325155,0,1,regulation of intralumenal vesicle formation,BP,
19209,GO:1905366,0.999999999986043,0.901074597325155,0,1,negative regulation of intralumenal vesicle formation,BP,
3838,GO:0008448,0.999999999986046,0.904556765062029,0,1,N-acetylglucosamine-6-phosphate deacetylase activity,MF,
1491,GO:0003835,0.999999999986056,0.776628111093691,0,2,beta-galactoside alpha-2,6-sialyltransferase activity,MF,
5970,GO:0018423,0.999999999986059,0.82602615738465,0,2,protein C-terminal leucine carboxyl O-methyltransferase activity,MF,
1534,GO:0003921,0.99999999998606,0.900430636538787,0,1,GMP synthase activity,MF,
1535,GO:0003922,0.99999999998606,0.900430636538787,0,1,GMP synthase (glutamine-hydrolyzing) activity,MF,
370,GO:0000992,0.999999999986063,0.791076456795855,0,2,polymerase III regulatory region sequence-specific DNA binding,MF,
374,GO:0001002,0.999999999986063,0.791076456795855,0,2,RNA polymerase III type 1 promoter sequence-specific DNA binding,MF,
375,GO:0001003,0.999999999986063,0.791076456795855,0,2,RNA polymerase III type 2 promoter sequence-specific DNA binding,MF,
18777,GO:1904340,0.999999999986065,0.734864913210364,0,3,positive regulation of dopaminergic neuron differentiation,BP,
19054,GO:1904958,0.999999999986065,0.734864913210364,0,3,positive regulation of midbrain dopaminergic neuron differentiation,BP,
7556,GO:0031906,0.999999999986076,0.817314565849802,0,2,late endosome lumen,CC,
16608,GO:0097486,0.999999999986076,0.817314565849802,0,2,multivesicular body lumen,CC,
16616,GO:0097498,0.999999999986076,0.794587735395995,0,2,endothelial tube lumen extension,BP,
2929,GO:0006447,0.999999999986089,0.776299668925663,0,2,regulation of translational initiation by iron,BP,
1740,GO:0004342,0.999999999986094,0.813847136493818,0,2,glucosamine-6-phosphate deaminase activity,MF,
2680,GO:0006043,0.999999999986094,0.813847136493818,0,2,glucosamine catabolic process,BP,
16940,GO:0098971,0.99999999998612,0.781608688080495,0,2,anterograde dendritic transport of neurotransmitter receptor complex,BP,
14725,GO:0070418,0.999999999986121,0.880084482042884,0,1,DNA-dependent protein kinase complex,CC,
17098,GO:0102008,0.999999999986136,0.880379856709799,0,1,cytosolic dipeptidase activity,MF,
17159,GO:0103046,0.999999999986136,0.880379856709799,0,1,alanylglutamate dipeptidase activity,MF,
8621,GO:0034150,0.999999999986146,0.87953304677256,0,1,toll-like receptor 6 signaling pathway,BP,
9081,GO:0035355,0.999999999986146,0.87953304677256,0,1,Toll-like receptor 2-Toll-like receptor 6 protein complex,CC,
19448,GO:1990172,0.999999999986146,0.87953304677256,0,1,G-protein coupled receptor catabolic process,BP,
3956,GO:0008709,0.999999999986147,0.93399985135977,0,1,cholate 7-alpha-dehydrogenase activity,MF,
6817,GO:0030283,0.999999999986147,0.93399985135977,0,1,testosterone dehydrogenase [NAD(P)] activity,MF,
11927,GO:0047015,0.999999999986147,0.93399985135977,0,1,3-hydroxy-2-methylbutyryl-CoA dehydrogenase activity,MF,
13396,GO:0052812,0.999999999986163,0.78282433138095,0,2,phosphatidylinositol-3,4-bisphosphate 5-kinase activity,MF,
2036,GO:0004778,0.999999999986164,0.908647861603203,0,1,succinyl-CoA hydrolase activity,MF,
8093,GO:0032788,0.999999999986164,0.908647861603203,0,1,saturated monocarboxylic acid metabolic process,BP,
8094,GO:0032789,0.999999999986164,0.908647861603203,0,1,unsaturated monocarboxylic acid metabolic process,BP,
2049,GO:0004799,0.999999999986173,0.909735348805569,0,1,thymidylate synthase activity,MF,
6026,GO:0019088,0.999999999986173,0.909735348805569,0,1,immortalization of host cell by virus,BP,
6325,GO:0020021,0.999999999986173,0.909735348805569,0,1,immortalization of host cell,BP,
9829,GO:0042083,0.999999999986173,0.909735348805569,0,1,5,10-methylenetetrahydrofolate-dependent methyltransferase activity,MF,
15697,GO:0072278,0.99999999998618,0.80368073042404,0,2,metanephric comma-shaped body morphogenesis,BP,
8193,GO:0032954,0.999999999986187,0.786555063519596,0,2,regulation of cytokinetic process,BP,
18386,GO:1903436,0.999999999986187,0.786555063519596,0,2,regulation of mitotic cytokinetic process,BP,
18387,GO:1903438,0.999999999986187,0.786555063519596,0,2,positive regulation of mitotic cytokinetic process,BP,
18402,GO:1903490,0.999999999986187,0.786555063519596,0,2,positive regulation of mitotic cytokinesis,BP,
9834,GO:0042091,0.99999999998621,0.805360468078599,0,2,interleukin-10 biosynthetic process,BP,
11060,GO:0045074,0.99999999998621,0.805360468078599,0,2,regulation of interleukin-10 biosynthetic process,BP,
18449,GO:1903569,0.999999999986219,0.900645340870073,0,1,positive regulation of protein localization to ciliary membrane,BP,
15694,GO:0072272,0.99999999998622,0.813744293461478,0,2,proximal/distal pattern formation involved in metanephric nephron development,BP,
16518,GO:0097278,0.999999999986222,0.809683790485042,0,2,complement-dependent cytotoxicity,BP,
1136,GO:0002728,0.999999999986244,0.882476824700721,0,1,negative regulation of natural killer cell cytokine production,BP,
9712,GO:0038163,0.999999999986252,0.932669625948964,0,1,thrombopoietin-mediated signaling pathway,BP,
19386,GO:1905938,0.999999999986252,0.932669625948964,0,1,positive regulation of germ cell proliferation,BP,
19787,GO:2000256,0.999999999986252,0.932669625948964,0,1,positive regulation of male germ cell proliferation,BP,
16176,GO:0090226,0.999999999986261,0.940179631605292,0,1,regulation of microtubule nucleation by Ran protein signal transduction,BP,
3947,GO:0008650,0.999999999986265,0.891384291880196,0,1,rRNA (uridine-2'-O-)-methyltransferase activity,MF,
2427,GO:0005607,0.999999999986267,0.774185550044701,0,2,laminin-2 complex,CC,
8222,GO:0032996,0.999999999986279,0.90409914505939,0,1,Bcl3-Bcl10 complex,CC,
11068,GO:0045082,0.999999999986279,0.90409914505939,0,1,positive regulation of interleukin-10 biosynthetic process,BP,
2040,GO:0004784,0.999999999986285,0.727293298335043,0,4,superoxide dismutase activity,MF,
5633,GO:0016721,0.999999999986285,0.727293298335043,0,4,oxidoreductase activity, acting on superoxide radicals as acceptor,MF,
14970,GO:0070903,0.999999999986285,0.902869810483096,0,1,mitochondrial tRNA thio-modification,BP,
1515,GO:0003878,0.99999999998629,0.883140851453207,0,1,ATP citrate synthase activity,MF,
4208,GO:0009346,0.99999999998629,0.883140851453207,0,1,citrate lyase complex,CC,
20149,GO:2001013,0.999999999986299,0.774694694629511,0,2,epithelial cell proliferation involved in renal tubule morphogenesis,BP,
1030,GO:0002538,0.9999999999863,0.896412979768398,0,1,arachidonic acid metabolite production involved in inflammatory response,BP,
1031,GO:0002540,0.9999999999863,0.896412979768398,0,1,leukotriene production involved in inflammatory response,BP,
9132,GO:0035490,0.9999999999863,0.896412979768398,0,1,regulation of leukotriene production involved in inflammatory response,BP,
9133,GO:0035491,0.9999999999863,0.896412979768398,0,1,positive regulation of leukotriene production involved in inflammatory response,BP,
14140,GO:0061044,0.9999999999863,0.896412979768398,0,1,negative regulation of vascular wound healing,BP,
17604,GO:1901331,0.9999999999863,0.896412979768398,0,1,positive regulation of odontoblast differentiation,BP,
18142,GO:1902913,0.9999999999863,0.896412979768398,0,1,positive regulation of neuroepithelial cell differentiation,BP,
19710,GO:2000098,0.9999999999863,0.896412979768398,0,1,negative regulation of smooth muscle cell-matrix adhesion,BP,
422,GO:0001128,0.999999999986304,0.917167740941657,0,1,RNA polymerase II transcription coactivator activity involved in preinitiation complex assembly,MF,
2087,GO:0004853,0.999999999986308,0.91569868117836,0,1,uroporphyrinogen decarboxylase activity,MF,
4325,GO:0009841,0.999999999986311,0.900670526469383,0,1,mitochondrial endopeptidase Clp complex,CC,
5381,GO:0016206,0.999999999986319,0.808584865117717,0,2,catechol O-methyltransferase activity,MF,
17101,GO:0102084,0.999999999986319,0.808584865117717,0,2,L-dopa O-methyltransferase activity,MF,
17153,GO:0102938,0.999999999986319,0.808584865117717,0,2,orcinol O-methyltransferase activity,MF,
2061,GO:0004816,0.999999999986324,0.809884828299037,0,2,asparagine-tRNA ligase activity,MF,
17312,GO:1900003,0.999999999986329,0.761253426772686,0,3,regulation of serine-type endopeptidase activity,BP,
17313,GO:1900004,0.999999999986329,0.761253426772686,0,3,negative regulation of serine-type endopeptidase activity,BP,
18024,GO:1902571,0.999999999986329,0.761253426772686,0,3,regulation of serine-type peptidase activity,BP,
18025,GO:1902572,0.999999999986329,0.761253426772686,0,3,negative regulation of serine-type peptidase activity,BP,
4179,GO:0009258,0.999999999986333,0.78727207584358,0,2,10-formyltetrahydrofolate catabolic process,BP,
5364,GO:0016155,0.999999999986333,0.78727207584358,0,2,formyltetrahydrofolate dehydrogenase activity,MF,
14150,GO:0061055,0.999999999986347,0.775556587825537,0,2,myotome development,BP,
6874,GO:0030377,0.999999999986352,0.914005645499891,0,1,urokinase plasminogen activator receptor activity,MF,
9729,GO:0038195,0.999999999986352,0.914005645499891,0,1,urokinase plasminogen activator signaling pathway,BP,
12306,GO:0048674,0.999999999986363,0.900476921604094,0,1,collateral sprouting of injured axon,BP,
12314,GO:0048686,0.999999999986363,0.900476921604094,0,1,regulation of sprouting of injured axon,BP,
12315,GO:0048687,0.999999999986363,0.900476921604094,0,1,positive regulation of sprouting of injured axon,BP,
12316,GO:0048688,0.999999999986363,0.900476921604094,0,1,negative regulation of sprouting of injured axon,BP,
12317,GO:0048689,0.999999999986363,0.900476921604094,0,1,formation of growth cone in injured axon,BP,
12318,GO:0048693,0.999999999986363,0.900476921604094,0,1,regulation of collateral sprouting of injured axon,BP,
12319,GO:0048694,0.999999999986363,0.900476921604094,0,1,positive regulation of collateral sprouting of injured axon,BP,
19287,GO:1905578,0.999999999986363,0.900476921604094,0,1,regulation of ERBB3 signaling pathway,BP,
19288,GO:1905580,0.999999999986363,0.900476921604094,0,1,positive regulation of ERBB3 signaling pathway,BP,
19390,GO:1905942,0.999999999986363,0.900476921604094,0,1,regulation of formation of growth cone in injured axon,BP,
19391,GO:1905943,0.999999999986363,0.900476921604094,0,1,negative regulation of formation of growth cone in injured axon,BP,
3217,GO:0006864,0.999999999986365,0.805039004509252,0,2,pyrimidine nucleotide transport,BP,
5038,GO:0015218,0.999999999986365,0.805039004509252,0,2,pyrimidine nucleotide transmembrane transporter activity,MF,
19533,GO:1990519,0.999999999986365,0.805039004509252,0,2,pyrimidine nucleotide import into mitochondrion,BP,
2353,GO:0005436,0.99999999998637,0.796756566193869,0,2,sodium:phosphate symporter activity,MF,
5080,GO:0015319,0.99999999998637,0.796756566193869,0,2,sodium:inorganic phosphate symporter activity,MF,
5081,GO:0015321,0.99999999998637,0.796756566193869,0,2,sodium-dependent phosphate transmembrane transporter activity,MF,
2005,GO:0004731,0.999999999986371,0.793008587203204,0,2,purine-nucleoside phosphorylase activity,MF,
14456,GO:0061857,0.999999999986384,0.797856600769316,0,2,endoplasmic reticulum stress-induced pre-emptive quality control,BP,
15087,GO:0071159,0.999999999986386,0.845771149616727,0,2,NF-kappaB complex,CC,
5142,GO:0015671,0.999999999986386,0.813355900085047,0,2,oxygen transport,BP,
17925,GO:1902292,0.999999999986392,0.92364358268921,0,1,cell cycle DNA replication initiation,BP,
17938,GO:1902315,0.999999999986392,0.92364358268921,0,1,nuclear cell cycle DNA replication initiation,BP,
18176,GO:1902975,0.999999999986392,0.92364358268921,0,1,mitotic DNA replication initiation,BP,
10982,GO:0044795,0.999999999986404,0.924611144096277,0,1,trans-Golgi network to recycling endosome transport,BP,
11824,GO:0046811,0.999999999986407,0.879625307804341,0,1,histone deacetylase inhibitor activity,MF,
11015,GO:0044878,0.99999999998641,0.676501137889097,0,4,mitotic cytokinesis checkpoint,BP,
8814,GO:0034602,0.999999999986414,0.883507526982435,0,1,oxoglutarate dehydrogenase (NAD+) activity,MF,
14131,GO:0061034,0.999999999986414,0.883507526982435,0,1,olfactory bulb mitral cell layer development,BP,
18860,GO:1904562,0.999999999986418,0.770432631531886,0,2,phosphatidylinositol 5-phosphate metabolic process,BP,
214,GO:0000448,0.999999999986422,0.791547321985637,0,2,cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
16006,GO:0086047,0.999999999986446,0.885477017094055,0,1,membrane depolarization during Purkinje myocyte cell action potential,BP,
18711,GO:1904199,0.999999999986446,0.885477017094055,0,1,positive regulation of regulation of vascular smooth muscle cell membrane depolarization,BP,
19580,GO:1990736,0.999999999986446,0.885477017094055,0,1,regulation of vascular smooth muscle cell membrane depolarization,BP,
4401,GO:0010139,0.999999999986448,0.908943306867233,0,1,pyrimidine deoxyribonucleotide salvage,BP,
4407,GO:0010164,0.999999999986448,0.908943306867233,0,1,response to cesium ion,BP,
6862,GO:0030343,0.999999999986448,0.908943306867233,0,1,vitamin D3 25-hydroxylase activity,MF,
14845,GO:0070643,0.999999999986448,0.908943306867233,0,1,vitamin D 25-hydroxylase activity,MF,
3866,GO:0008493,0.99999999998648,0.904148064557585,0,1,tetracycline transmembrane transporter activity,MF,
5260,GO:0015904,0.99999999998648,0.904148064557585,0,1,tetracycline transport,BP,
11481,GO:0045976,0.99999999998648,0.792473899105873,0,2,negative regulation of mitotic cell cycle, embryonic,BP,
5658,GO:0016768,0.999999999986523,0.907157759199103,0,1,spermine synthase activity,MF,
4650,GO:0010796,0.999999999986529,0.751824085664629,0,3,regulation of multivesicular body size,BP,
419,GO:0001112,0.999999999986544,0.897715547707002,0,1,DNA-templated transcriptional open complex formation,BP,
420,GO:0001113,0.999999999986544,0.897715547707002,0,1,transcriptional open complex formation at RNA polymerase II promoter,BP,
421,GO:0001120,0.999999999986544,0.897715547707002,0,1,protein-DNA complex remodeling,BP,
8028,GO:0032685,0.999999999986557,0.895238206374506,0,1,negative regulation of granulocyte macrophage colony-stimulating factor production,BP,
17878,GO:1902202,0.999999999986563,0.811331571172214,0,2,regulation of hepatocyte growth factor receptor signaling pathway,BP,
17333,GO:1900042,0.99999999998657,0.769382342276777,0,2,positive regulation of interleukin-2 secretion,BP,
235,GO:0000493,0.999999999986582,0.814232213056398,0,2,box H/ACA snoRNP assembly,BP,
2259,GO:0005174,0.99999999998659,0.90089496299528,0,1,CD40 receptor binding,MF,
1901,GO:0004588,0.999999999986597,0.899978080564193,0,1,orotate phosphoribosyltransferase activity,MF,
1902,GO:0004590,0.999999999986597,0.899978080564193,0,1,orotidine-5'-phosphate decarboxylase activity,MF,
15770,GO:0072414,0.999999999986606,0.878565881910239,0,1,response to mitotic cell cycle checkpoint signaling,BP,
15777,GO:0072432,0.999999999986606,0.878565881910239,0,1,response to G1 DNA damage checkpoint signaling,BP,
6822,GO:0030290,0.999999999986613,0.891293731250548,0,1,sphingolipid activator protein activity,MF,
7859,GO:0032428,0.999999999986613,0.891293731250548,0,1,beta-N-acetylgalactosaminidase activity,MF,
167,GO:0000349,0.999999999986614,0.81056704746572,0,2,generation of catalytic spliceosome for first transesterification step,BP,
15454,GO:0071819,0.999999999986618,0.850383852741902,0,2,DUBm complex,CC,
2220,GO:0005124,0.999999999986628,0.900562375685324,0,1,scavenger receptor binding,MF,
5422,GO:0016277,0.999999999986628,0.900562375685324,0,1,[myelin basic protein]-arginine N-methyltransferase activity,MF,
17752,GO:1901804,0.999999999986628,0.900562375685324,0,1,beta-glucoside metabolic process,BP,
17753,GO:1901805,0.999999999986628,0.900562375685324,0,1,beta-glucoside catabolic process,BP,
18827,GO:1904457,0.999999999986628,0.900562375685324,0,1,positive regulation of neuronal action potential,BP,
5980,GO:0018872,0.999999999986643,0.900420218240556,0,1,arsonoacetate metabolic process,BP,
7016,GO:0030791,0.999999999986643,0.900420218240556,0,1,arsenite methyltransferase activity,MF,
7017,GO:0030792,0.999999999986643,0.900420218240556,0,1,methylarsonite methyltransferase activity,MF,
9314,GO:0035800,0.999999999986646,0.813027484443601,0,2,deubiquitinase activator activity,MF,
19740,GO:2000158,0.999999999986646,0.813027484443601,0,2,positive regulation of ubiquitin-specific protease activity,BP,
2666,GO:0006014,0.999999999986662,0.76997125004768,0,3,D-ribose metabolic process,BP,
5888,GO:0018057,0.999999999986675,0.715965653149561,0,3,peptidyl-lysine oxidation,BP,
13592,GO:0060086,0.999999999986675,0.806683941722838,0,2,circadian temperature homeostasis,BP,
2030,GO:0004772,0.99999999998668,0.893564910982545,0,1,sterol O-acyltransferase activity,MF,
8897,GO:0034736,0.99999999998668,0.893564910982545,0,1,cholesterol O-acyltransferase activity,MF,
18445,GO:1903565,0.99999999998668,0.893564910982545,0,1,negative regulation of protein localization to cilium,BP,
18448,GO:1903568,0.99999999998668,0.893564910982545,0,1,negative regulation of protein localization to ciliary membrane,BP,
5091,GO:0015367,0.999999999986693,0.905462321216616,0,1,oxoglutarate:malate antiporter activity,MF,
5178,GO:0015742,0.999999999986693,0.905462321216616,0,1,alpha-ketoglutarate transport,BP,
17929,GO:1902302,0.99999999998671,0.775604067494348,0,2,regulation of potassium ion export,BP,
13564,GO:0060053,0.999999999986717,0.791401022088441,0,2,neurofilament cytoskeleton,CC,
5981,GO:0018879,0.999999999986721,0.811195900056379,0,2,biphenyl metabolic process,BP,
47,GO:0000099,0.999999999986727,0.614458349139363,0,4,sulfur amino acid transmembrane transporter activity,MF,
13652,GO:0060200,0.999999999986771,0.880917374573936,0,1,clathrin-sculpted acetylcholine transport vesicle,CC,
13653,GO:0060201,0.999999999986771,0.880917374573936,0,1,clathrin-sculpted acetylcholine transport vesicle membrane,CC,
16820,GO:0098746,0.999999999986771,0.880917374573936,0,1,fast, calcium ion-dependent exocytosis of neurotransmitter,BP,
5215,GO:0015819,0.99999999998678,0.903815457356632,0,1,lysine transport,BP,
455,GO:0001300,0.999999999986787,0.803791902107455,0,2,chronological cell aging,BP,
14959,GO:0070889,0.999999999986794,0.810623937004901,0,2,platelet alpha granule organization,BP,
16360,GO:0090725,0.999999999986794,0.831644399121325,0,2,peripheral region of growth cone,CC,
18132,GO:1902896,0.999999999986816,0.797449840003824,0,2,terminal web assembly,BP,
11633,GO:0046380,0.999999999986824,0.888576185873414,0,1,N-acetylneuraminate biosynthetic process,BP,
12426,GO:0050124,0.999999999986824,0.888576185873414,0,1,N-acylneuraminate-9-phosphatase activity,MF,
18171,GO:1902962,0.99999999998683,0.774583937136974,0,2,regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process,BP,
18172,GO:1902963,0.99999999998683,0.774583937136974,0,2,negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process,BP,
10647,GO:0043812,0.99999999998683,0.700795086411416,0,3,phosphatidylinositol-4-phosphate phosphatase activity,MF,
5975,GO:0018585,0.999999999986848,0.901400444339048,0,1,fluorene oxygenase activity,MF,
5985,GO:0018917,0.999999999986848,0.901400444339048,0,1,fluorene metabolic process,BP,
12351,GO:0048752,0.999999999986864,0.7161269821028,0,3,semicircular canal morphogenesis,BP,
14086,GO:0060957,0.99999999998687,0.898333804940101,0,1,endocardial cell fate commitment,BP,
14288,GO:0061445,0.99999999998687,0.898333804940101,0,1,endocardial cushion cell fate commitment,BP,
8779,GO:0034474,0.999999999986903,0.878626070475616,0,1,U2 snRNA 3'-end processing,BP,
8533,GO:0033872,0.999999999986907,0.902306971296791,0,1,[heparan sulfate]-glucosamine 3-sulfotransferase 3 activity,MF,
12170,GO:0048319,0.999999999986914,0.785516923593189,0,2,axial mesoderm morphogenesis,BP,
17969,GO:1902423,0.99999999998693,0.792211865758583,0,2,regulation of attachment of mitotic spindle microtubules to kinetochore,BP,
17970,GO:1902425,0.99999999998693,0.792211865758583,0,2,positive regulation of attachment of mitotic spindle microtubules to kinetochore,BP,
4319,GO:0009814,0.999999999986942,0.901211608416386,0,1,defense response, incompatible interaction,BP,
4320,GO:0009817,0.999999999986942,0.901211608416386,0,1,defense response to fungus, incompatible interaction,BP,
19185,GO:1905313,0.999999999986942,0.901211608416386,0,1,transforming growth factor beta receptor signaling pathway involved in heart development,BP,
19493,GO:1990402,0.999999999986942,0.901211608416386,0,1,embryonic liver development,BP,
17435,GO:1900244,0.999999999986951,0.795348850728713,0,2,positive regulation of synaptic vesicle endocytosis,BP,
1965,GO:0004676,0.999999999986954,0.878590522060984,0,1,3-phosphoinositide-dependent protein kinase activity,MF,
11192,GO:0045337,0.999999999986956,0.732438273539054,0,3,farnesyl diphosphate biosynthetic process,BP,
13054,GO:0051582,0.999999999986964,0.820547756749995,0,2,positive regulation of neurotransmitter uptake,BP,
18570,GO:1903847,0.999999999986975,0.773278714951861,0,2,regulation of aorta morphogenesis,BP,
18571,GO:1903849,0.999999999986975,0.773278714951861,0,2,positive regulation of aorta morphogenesis,BP,
6089,GO:0019276,0.999999999986983,0.899003910618492,0,1,UDP-N-acetylgalactosamine metabolic process,BP,
9022,GO:0035248,0.999999999986983,0.899003910618492,0,1,alpha-1,4-N-acetylgalactosaminyltransferase activity,MF,
20200,GO:2001160,0.999999999986984,0.815339119973036,0,2,regulation of histone H3-K79 methylation,BP,
20201,GO:2001162,0.999999999986984,0.815339119973036,0,2,positive regulation of histone H3-K79 methylation,BP,
14965,GO:0070898,0.999999999986985,0.871448393804099,0,1,RNA polymerase III transcriptional preinitiation complex assembly,BP,
19354,GO:1905843,0.999999999986988,0.87145335147412,0,1,regulation of cellular response to gamma radiation,BP,
640,GO:0001831,0.999999999986992,0.87884089133512,0,1,trophectodermal cellular morphogenesis,BP,
5529,GO:0016509,0.999999999987024,0.728193626217021,0,3,long-chain-3-hydroxyacyl-CoA dehydrogenase activity,MF,
1617,GO:0004052,0.999999999987046,0.81088000166558,0,2,arachidonate 12-lipoxygenase activity,MF,
1741,GO:0004343,0.999999999987075,0.886996326643103,0,1,glucosamine 6-phosphate N-acetyltransferase activity,MF,
4591,GO:0010705,0.999999999987076,0.881876030208646,0,1,meiotic DNA double-strand break processing involved in reciprocal meiotic recombination,BP,
16000,GO:0086040,0.999999999987076,0.881876030208646,0,1,sodium:proton antiporter activity involved in regulation of cardiac muscle cell membrane potential,MF,
16032,GO:0086092,0.999999999987076,0.881876030208646,0,1,regulation of the force of heart contraction by cardiac conduction,BP,
17062,GO:0099606,0.999999999987081,0.876475522566968,0,1,microtubule plus-end directed mitotic chromosome migration,BP,
17063,GO:0099607,0.999999999987081,0.876475522566968,0,1,lateral attachment of mitotic spindle microtubules to kinetochore,BP,
1084,GO:0002669,0.999999999987088,0.879178206446014,0,1,positive regulation of T cell anergy,BP,
1230,GO:0002913,0.999999999987088,0.879178206446014,0,1,positive regulation of lymphocyte anergy,BP,
6027,GO:0019089,0.999999999987088,0.879178206446014,0,1,transmission of virus,BP,
10697,GO:0044007,0.999999999987088,0.879178206446014,0,1,dissemination or transmission of symbiont from host,BP,
13180,GO:0051821,0.999999999987088,0.879178206446014,0,1,dissemination or transmission of organism from other organism involved in symbiotic interaction,BP,
11775,GO:0046657,0.999999999987101,0.826128611978491,0,2,folic acid catabolic process,BP,
15075,GO:0071109,0.999999999987103,0.767983802726654,0,2,superior temporal gyrus development,BP,
9966,GO:0042369,0.999999999987105,0.806989401442491,0,2,vitamin D catabolic process,BP,
18070,GO:1902715,0.999999999987112,0.774489262030196,0,2,positive regulation of interferon-gamma secretion,BP,
1373,GO:0003270,0.999999999987117,0.875319970882377,0,1,Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation,BP,
14043,GO:0060843,0.999999999987117,0.875319970882377,0,1,venous endothelial cell differentiation,BP,
9243,GO:0035659,0.999999999987118,0.906737337195764,0,1,Wnt signaling pathway involved in wound healing, spreading of epidermal cells,BP,
11114,GO:0045167,0.999999999987118,0.906737337195764,0,1,asymmetric protein localization involved in cell fate determination,BP,
14710,GO:0070390,0.999999999987118,0.906737337195764,0,1,transcription export complex 2,CC,
19022,GO:1904889,0.999999999987118,0.906737337195764,0,1,regulation of excitatory synapse assembly,BP,
19023,GO:1904891,0.999999999987118,0.906737337195764,0,1,positive regulation of excitatory synapse assembly,BP,
2031,GO:0004773,0.999999999987123,0.87919290748205,0,1,steryl-sulfatase activity,MF,
16714,GO:0097749,0.999999999987123,0.87919290748205,0,1,membrane tubulation,BP,
14552,GO:0070103,0.999999999987124,0.906924281090481,0,1,regulation of interleukin-6-mediated signaling pathway,BP,
14553,GO:0070104,0.999999999987124,0.906924281090481,0,1,negative regulation of interleukin-6-mediated signaling pathway,BP,
17879,GO:1902205,0.999999999987124,0.906924281090481,0,1,regulation of interleukin-2-mediated signaling pathway,BP,
17880,GO:1902206,0.999999999987124,0.906924281090481,0,1,negative regulation of interleukin-2-mediated signaling pathway,BP,
17884,GO:1902215,0.999999999987124,0.906924281090481,0,1,negative regulation of interleukin-4-mediated signaling pathway,BP,
17893,GO:1902227,0.999999999987124,0.906924281090481,0,1,negative regulation of macrophage colony-stimulating factor signaling pathway,BP,
17899,GO:1902233,0.999999999987124,0.906924281090481,0,1,negative regulation of positive thymic T cell selection,BP,
18632,GO:1903970,0.999999999987124,0.906924281090481,0,1,negative regulation of response to macrophage colony-stimulating factor,BP,
18635,GO:1903973,0.999999999987124,0.906924281090481,0,1,negative regulation of cellular response to macrophage colony-stimulating factor stimulus,BP,
3604,GO:0008043,0.999999999987125,0.864632548093275,0,2,intracellular ferritin complex,CC,
14654,GO:0070288,0.999999999987125,0.864632548093275,0,2,ferritin complex,CC,
7546,GO:0031870,0.999999999987128,0.87940827139546,0,1,thromboxane A2 receptor binding,MF,
396,GO:0001069,0.999999999987136,0.775815152056345,0,2,regulatory region RNA binding,MF,
8268,GO:0033082,0.999999999987139,0.8806111598083,0,1,regulation of extrathymic T cell differentiation,BP,
19564,GO:1990654,0.999999999987139,0.8806111598083,0,1,sebum secreting cell proliferation,BP,
16875,GO:0098842,0.999999999987145,0.811765680695718,0,2,postsynaptic early endosome,CC,
8652,GO:0034224,0.999999999987146,0.901014083803178,0,1,cellular response to zinc ion starvation,BP,
8739,GO:0034402,0.999999999987155,0.792207677505231,0,2,recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex,BP,
3095,GO:0006669,0.999999999987157,0.898305372084793,0,1,sphinganine-1-phosphate biosynthetic process,BP,
16888,GO:0098871,0.999999999987175,0.907136307779901,0,1,postsynaptic actin cytoskeleton,CC,
17052,GO:0099571,0.999999999987175,0.907136307779901,0,1,postsynaptic cytoskeleton,CC,
9482,GO:0036135,0.999999999987181,0.789550607543052,0,2,Schwann cell migration,BP,
17389,GO:1900147,0.999999999987181,0.789550607543052,0,2,regulation of Schwann cell migration,BP,
14943,GO:0070860,0.999999999987186,0.900815339469549,0,1,RNA polymerase I core factor complex,CC,
12000,GO:0047578,0.999999999987188,0.900457877476896,0,1,4-hydroxyglutamate transaminase activity,MF,
6452,GO:0021778,0.99999999998719,0.875990220559501,0,1,oligodendrocyte cell fate specification,BP,
6453,GO:0021779,0.99999999998719,0.875990220559501,0,1,oligodendrocyte cell fate commitment,BP,
6454,GO:0021780,0.99999999998719,0.875990220559501,0,1,glial cell fate specification,BP,
18948,GO:1904749,0.999999999987195,0.664539727205014,0,4,regulation of protein localization to nucleolus,BP,
7536,GO:0031826,0.999999999987207,0.740671105354263,0,3,type 2A serotonin receptor binding,MF,
12057,GO:0048022,0.999999999987208,0.772944487581528,0,2,negative regulation of melanin biosynthetic process,BP,
17460,GO:1900377,0.999999999987208,0.772944487581528,0,2,negative regulation of secondary metabolite biosynthetic process,BP,
1857,GO:0004522,0.999999999987209,0.91026814377262,0,1,ribonuclease A activity,MF,
3971,GO:0008785,0.999999999987209,0.91026814377262,0,1,alkyl hydroperoxide reductase activity,MF,
2002,GO:0004728,0.99999999998722,0.900156194766982,0,1,signal transducer, downstream of receptor, with protein tyrosine phosphatase activity,MF,
4009,GO:0008995,0.99999999998722,0.900156194766982,0,1,ribonuclease E activity,MF,
16191,GO:0090247,0.99999999998722,0.900156194766982,0,1,cell motility involved in somitogenic axis elongation,BP,
16192,GO:0090249,0.99999999998722,0.900156194766982,0,1,regulation of cell motility involved in somitogenic axis elongation,BP,
17569,GO:1901229,0.99999999998722,0.900156194766982,0,1,regulation of non-canonical Wnt signaling pathway via JNK cascade,BP,
17570,GO:1901231,0.99999999998722,0.900156194766982,0,1,positive regulation of non-canonical Wnt signaling pathway via JNK cascade,BP,
17571,GO:1901232,0.99999999998722,0.900156194766982,0,1,regulation of convergent extension involved in axis elongation,BP,
17572,GO:1901233,0.99999999998722,0.900156194766982,0,1,negative regulation of convergent extension involved in axis elongation,BP,
19312,GO:1905661,0.999999999987222,0.802156250731625,0,2,regulation of telomerase RNA reverse transcriptase activity,BP,
19313,GO:1905663,0.999999999987222,0.802156250731625,0,2,positive regulation of telomerase RNA reverse transcriptase activity,BP,
17603,GO:1901329,0.99999999998725,0.810883267718985,0,2,regulation of odontoblast differentiation,BP,
1778,GO:0004394,0.999999999987256,0.884608455713526,0,1,heparan sulfate 2-O-sulfotransferase activity,MF,
15231,GO:0071421,0.999999999987276,0.785052512001291,0,2,manganese ion transmembrane transport,BP,
1312,GO:0003162,0.999999999987279,0.769937104761826,0,2,atrioventricular node development,BP,
3421,GO:0007207,0.999999999987298,0.811101180969552,0,2,phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway,BP,
3731,GO:0008267,0.9999999999873,0.877420339639537,0,1,poly-glutamine tract binding,MF,
17794,GO:1901963,0.999999999987302,0.808772069911001,0,2,regulation of cell proliferation involved in outflow tract morphogenesis,BP,
4454,GO:0010428,0.999999999987303,0.879517855093332,0,1,methyl-CpNpG binding,MF,
7681,GO:0032139,0.999999999987316,0.725087420016086,0,3,dinucleotide insertion or deletion binding,MF,
17147,GO:0102758,0.999999999987318,0.924020094264349,0,1,very-long-chain enoyl-CoA reductase activity,MF,
7460,GO:0031626,0.999999999987322,0.880043535612116,0,1,beta-endorphin binding,MF,
8108,GO:0032804,0.999999999987325,0.803409117544529,0,2,negative regulation of low-density lipoprotein particle receptor catabolic process,BP,
9947,GO:0042328,0.999999999987333,0.697692434653997,0,3,heparan sulfate N-acetylglucosaminyltransferase activity,MF,
1197,GO:0002857,0.999999999987352,0.791662821499716,0,2,positive regulation of natural killer cell mediated immune response to tumor cell,BP,
1200,GO:0002860,0.999999999987352,0.791662821499716,0,2,positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target,BP,
7653,GO:0032090,0.999999999987378,0.835540132699261,0,2,Pyrin domain binding,MF,
1598,GO:0004019,0.99999999998738,0.899582038352808,0,1,adenylosuccinate synthase activity,MF,
5892,GO:0018094,0.999999999987389,0.893489295740005,0,1,protein polyglycylation,BP,
14887,GO:0070735,0.999999999987389,0.893489295740005,0,1,protein-glycine ligase activity,MF,
14888,GO:0070736,0.999999999987389,0.893489295740005,0,1,protein-glycine ligase activity, initiating,MF,
9047,GO:0035281,0.999999999987416,0.816773972460362,0,2,pre-miRNA export from nucleus,BP,
10057,GO:0042565,0.999999999987416,0.816773972460362,0,2,RNA nuclear export complex,CC,
1896,GO:0004582,0.999999999987425,0.813987522311064,0,3,dolichyl-phosphate beta-D-mannosyltransferase activity,MF,
8328,GO:0033185,0.999999999987425,0.813987522311064,0,3,dolichol-phosphate-mannose synthase complex,CC,
10724,GO:0044105,0.999999999987425,0.940023532485379,0,1,L-xylulose reductase (NAD+) activity,MF,
12419,GO:0050038,0.999999999987425,0.940023532485379,0,1,L-xylulose reductase (NADP+) activity,MF,
18720,GO:1904211,0.999999999987444,0.797202016700498,0,2,membrane protein proteolysis involved in retrograde protein transport, ER to cytosol,BP,
18291,GO:1903237,0.999999999987449,0.94096356671347,0,1,negative regulation of leukocyte tethering or rolling,BP,
4207,GO:0009331,0.999999999987452,0.780255530388666,0,2,glycerol-3-phosphate dehydrogenase complex,CC,
1647,GO:0004096,0.999999999987452,0.813493580181964,0,2,catalase activity,MF,
7951,GO:0032558,0.999999999987459,0.760411605912299,0,3,adenyl deoxyribonucleotide binding,MF,
7955,GO:0032564,0.999999999987459,0.760411605912299,0,3,dATP binding,MF,
7683,GO:0032143,0.999999999987466,0.791920673358332,0,2,single thymine insertion binding,MF,
7769,GO:0032301,0.999999999987466,0.791920673358332,0,2,MutSalpha complex,CC,
19527,GO:1990498,0.999999999987467,0.770322395151356,0,2,mitotic spindle microtubule,CC,
4796,GO:0010991,0.999999999987468,0.773858496716555,0,2,negative regulation of SMAD protein complex assembly,BP,
1954,GO:0004660,0.999999999987469,0.817674892116794,0,2,protein farnesyltransferase activity,MF,
2633,GO:0005965,0.999999999987469,0.817674892116794,0,2,protein farnesyltransferase complex,CC,
9392,GO:0035962,0.99999999998747,0.888018746768189,0,1,response to interleukin-13,BP,
9393,GO:0035963,0.99999999998747,0.888018746768189,0,1,cellular response to interleukin-13,BP,
12443,GO:0050277,0.99999999998747,0.888018746768189,0,1,sedoheptulokinase activity,MF,
15506,GO:0071914,0.99999999998747,0.888018746768189,0,1,prominosome,CC,
16413,GO:0097086,0.999999999987472,0.890249397197678,0,1,amniotic stem cell differentiation,BP,
20046,GO:2000706,0.999999999987472,0.890249397197678,0,1,negative regulation of dense core granule biogenesis,BP,
20062,GO:2000740,0.999999999987472,0.890249397197678,0,1,negative regulation of mesenchymal stem cell differentiation,BP,
20095,GO:2000797,0.999999999987472,0.890249397197678,0,1,regulation of amniotic stem cell differentiation,BP,
20096,GO:2000798,0.999999999987472,0.890249397197678,0,1,negative regulation of amniotic stem cell differentiation,BP,
1581,GO:0003994,0.999999999987476,0.80203676985479,0,2,aconitate hydratase activity,MF,
7353,GO:0031403,0.99999999998748,0.784777986798765,0,2,lithium ion binding,MF,
2771,GO:0006193,0.999999999987495,0.927017372258682,0,1,ITP catabolic process,BP,
4140,GO:0009203,0.999999999987495,0.927017372258682,0,1,ribonucleoside triphosphate catabolic process,BP,
4144,GO:0009207,0.999999999987495,0.927017372258682,0,1,purine ribonucleoside triphosphate catabolic process,BP,
9510,GO:0036220,0.999999999987495,0.927017372258682,0,1,ITP diphosphatase activity,MF,
9511,GO:0036222,0.999999999987495,0.927017372258682,0,1,XTP diphosphatase activity,MF,
17023,GO:0099522,0.999999999987502,0.902264855835151,0,1,region of cytosol,CC,
17024,GO:0099523,0.999999999987502,0.902264855835151,0,1,presynaptic cytosol,CC,
17025,GO:0099524,0.999999999987502,0.902264855835151,0,1,postsynaptic cytosol,CC,
18957,GO:1904764,0.999999999987502,0.902264855835151,0,1,chaperone-mediated autophagy translocation complex disassembly,BP,
19618,GO:1990832,0.999999999987502,0.902264855835151,0,1,slow axonal transport,BP,
19619,GO:1990833,0.999999999987502,0.902264855835151,0,1,clathrin-uncoating ATPase activity,MF,
8954,GO:0035034,0.999999999987524,0.808284481459605,0,2,histone acetyltransferase regulator activity,MF,
1762,GO:0004367,0.999999999987533,0.887165960089972,0,1,glycerol-3-phosphate dehydrogenase [NAD+] activity,MF,
11576,GO:0046168,0.999999999987533,0.887165960089972,0,1,glycerol-3-phosphate catabolic process,BP,
9669,GO:0038049,0.999999999987535,0.76522688180481,0,2,transcription factor activity, ligand-activated RNA polymerase II transcription factor binding,MF,
3420,GO:0007206,0.99999999998756,0.884198067809749,0,1,phospholipase C-activating G-protein coupled glutamate receptor signaling pathway,BP,
15428,GO:0071765,0.99999999998756,0.884198067809749,0,1,nuclear inner membrane organization,BP,
10405,GO:0043259,0.999999999987562,0.671839101443456,0,3,laminin-10 complex,CC,
13840,GO:0060478,0.999999999987568,0.82693408192585,0,2,acrosomal vesicle exocytosis,BP,
19859,GO:2000367,0.999999999987568,0.82693408192585,0,2,regulation of acrosomal vesicle exocytosis,BP,
19860,GO:2000368,0.999999999987568,0.82693408192585,0,2,positive regulation of acrosomal vesicle exocytosis,BP,
2937,GO:0006463,0.999999999987572,0.889196210810678,0,1,steroid hormone receptor complex assembly,BP,
7376,GO:0031436,0.99999999998758,0.790768217399538,0,2,BRCA1-BARD1 complex,CC,
2844,GO:0006313,0.999999999987585,0.885822227613466,0,1,transposition, DNA-mediated,BP,
3869,GO:0008496,0.999999999987609,0.883888984906107,0,1,mannan endo-1,6-alpha-mannosidase activity,MF,
19556,GO:1990617,0.999999999987615,0.848703927572208,0,2,CHOP-ATF4 complex,CC,
966,GO:0002408,0.99999999998762,0.879748658855488,0,1,myeloid dendritic cell chemotaxis,BP,
18528,GO:1903760,0.999999999987625,0.780405589142705,0,2,regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization,BP,
19078,GO:1905024,0.999999999987625,0.780405589142705,0,2,regulation of membrane repolarization during ventricular cardiac muscle cell action potential,BP,
1394,GO:0003310,0.999999999987627,0.913590347895106,0,1,pancreatic A cell differentiation,BP,
6368,GO:0021558,0.999999999987627,0.913590347895106,0,1,trochlear nerve development,BP,
11482,GO:0045977,0.999999999987627,0.913590347895106,0,1,positive regulation of mitotic cell cycle, embryonic,BP,
13632,GO:0060164,0.999999999987627,0.913590347895106,0,1,regulation of timing of neuron differentiation,BP,
14172,GO:0061102,0.999999999987627,0.913590347895106,0,1,stomach neuroendocrine cell differentiation,BP,
14173,GO:0061105,0.999999999987627,0.913590347895106,0,1,regulation of stomach neuroendocrine cell differentiation,BP,
14174,GO:0061106,0.999999999987627,0.913590347895106,0,1,negative regulation of stomach neuroendocrine cell differentiation,BP,
15455,GO:0071820,0.999999999987627,0.913590347895106,0,1,N-box binding,MF,
15570,GO:0072071,0.999999999987627,0.913590347895106,0,1,kidney interstitial fibroblast differentiation,BP,
15621,GO:0072141,0.999999999987627,0.913590347895106,0,1,renal interstitial fibroblast development,BP,
19771,GO:2000226,0.999999999987627,0.913590347895106,0,1,regulation of pancreatic A cell differentiation,BP,
19772,GO:2000227,0.999999999987627,0.913590347895106,0,1,negative regulation of pancreatic A cell differentiation,BP,
18045,GO:1902626,0.999999999987632,0.808826934757753,0,3,assembly of large subunit precursor of preribosome,BP,
9457,GO:0036085,0.999999999987637,0.89587203564467,0,1,GDP-fucose import into Golgi lumen,BP,
6263,GO:0019860,0.999999999987639,0.815838563057352,0,2,uracil metabolic process,BP,
16012,GO:0086057,0.999999999987643,0.887828248942155,0,1,voltage-gated calcium channel activity involved in bundle of His cell action potential,MF,
19450,GO:1990174,0.999999999987643,0.887828248942155,0,1,phosphodiesterase decapping endonuclease activity,MF,
16245,GO:0090325,0.999999999987651,0.791653178255099,0,2,regulation of locomotion involved in locomotory behavior,BP,
19010,GO:1904875,0.999999999987658,0.810430072660725,0,2,regulation of DNA ligase activity,BP,
11794,GO:0046696,0.999999999987665,0.808044986968931,0,2,lipopolysaccharide receptor complex,CC,
7357,GO:0031407,0.999999999987665,0.900652819170057,0,1,oxylipin metabolic process,BP,
12037,GO:0047977,0.999999999987665,0.900652819170057,0,1,hepoxilin-epoxide hydrolase activity,MF,
17746,GO:1901751,0.999999999987665,0.900652819170057,0,1,leukotriene A4 metabolic process,BP,
20282,GO:2001300,0.999999999987665,0.900652819170057,0,1,lipoxin metabolic process,BP,
20283,GO:2001301,0.999999999987665,0.900652819170057,0,1,lipoxin biosynthetic process,BP,
20284,GO:2001302,0.999999999987665,0.900652819170057,0,1,lipoxin A4 metabolic process,BP,
20285,GO:2001303,0.999999999987665,0.900652819170057,0,1,lipoxin A4 biosynthetic process,BP,
20286,GO:2001304,0.999999999987665,0.900652819170057,0,1,lipoxin B4 metabolic process,BP,
20287,GO:2001306,0.999999999987665,0.900652819170057,0,1,lipoxin B4 biosynthetic process,BP,
7612,GO:0032010,0.999999999987673,0.726984622599941,0,3,phagolysosome,CC,
15268,GO:0071475,0.999999999987674,0.736798327731124,0,3,cellular hyperosmotic salinity response,BP,
15832,GO:0072572,0.999999999987678,0.901524262656759,0,1,poly-ADP-D-ribose binding,MF,
8261,GO:0033065,0.99999999998768,0.841345057212602,0,2,Rad51C-XRCC3 complex,CC,
3885,GO:0008520,0.999999999987689,0.878678040978808,0,1,L-ascorbate:sodium symporter activity,MF,
5044,GO:0015229,0.999999999987689,0.878678040978808,0,1,L-ascorbic acid transmembrane transporter activity,MF,
5252,GO:0015882,0.999999999987689,0.878678040978808,0,1,L-ascorbic acid transmembrane transport,BP,
14960,GO:0070890,0.999999999987689,0.878678040978808,0,1,sodium-dependent L-ascorbate transmembrane transporter activity,MF,
14971,GO:0070904,0.999999999987689,0.878678040978808,0,1,transepithelial L-ascorbic acid transport,BP,
17176,GO:0106020,0.999999999987691,0.799253343015366,0,2,regulation of vesicle docking,BP,
5093,GO:0015369,0.999999999987693,0.879768574952421,0,1,calcium:proton antiporter activity,MF,
12812,GO:0051139,0.999999999987693,0.879768574952421,0,1,metal ion:proton antiporter activity,MF,
1661,GO:0004122,0.999999999987707,0.900129004961073,0,1,cystathionine beta-synthase activity,MF,
2990,GO:0006535,0.999999999987707,0.900129004961073,0,1,cysteine biosynthetic process from serine,BP,
4050,GO:0009093,0.999999999987707,0.900129004961073,0,1,cysteine catabolic process,BP,
5611,GO:0016662,0.999999999987707,0.900129004961073,0,1,oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor,MF,
6148,GO:0019448,0.999999999987707,0.900129004961073,0,1,L-cysteine catabolic process,BP,
12460,GO:0050421,0.999999999987707,0.900129004961073,0,1,nitrite reductase (NO-forming) activity,MF,
14506,GO:0070025,0.999999999987707,0.900129004961073,0,1,carbon monoxide binding,MF,
16855,GO:0098809,0.999999999987707,0.900129004961073,0,1,nitrite reductase activity,MF,
7726,GO:0032229,0.999999999987712,0.819732358900569,0,2,negative regulation of synaptic transmission, GABAergic,BP,
254,GO:0000720,0.999999999987734,0.729985215707204,0,3,pyrimidine dimer repair by nucleotide-excision repair,BP,
296,GO:0000801,0.999999999987753,0.884734716959253,0,1,central element,CC,
6376,GO:0021569,0.999999999987764,0.909423851304992,0,1,rhombomere 3 development,BP,
6377,GO:0021570,0.999999999987764,0.909423851304992,0,1,rhombomere 4 development,BP,
2179,GO:0005030,0.999999999987764,0.878609876483742,0,1,neurotrophin receptor activity,MF,
4467,GO:0010465,0.999999999987764,0.878609876483742,0,1,nerve growth factor receptor activity,MF,
6876,GO:0030379,0.999999999987764,0.878609876483742,0,1,neurotensin receptor activity, non-G-protein coupled,MF,
2077,GO:0004832,0.999999999987775,0.692970863838929,0,3,valine-tRNA ligase activity,MF,
2927,GO:0006438,0.999999999987775,0.692970863838929,0,3,valyl-tRNA aminoacylation,BP,
6404,GO:0021644,0.999999999987775,0.911042380150664,0,1,vagus nerve morphogenesis,BP,
15066,GO:0071073,0.999999999987801,0.728840246998133,0,3,positive regulation of phospholipid biosynthetic process,BP,
5088,GO:0015350,0.999999999987808,0.790476769401161,0,2,methotrexate transmembrane transporter activity,MF,
13249,GO:0051958,0.999999999987808,0.790476769401161,0,2,methotrexate transport,BP,
15916,GO:0072739,0.999999999987816,0.812316577150985,0,2,response to anisomycin,BP,
2162,GO:0004998,0.99999999998782,0.880097470039117,0,1,transferrin receptor activity,MF,
4973,GO:0015091,0.99999999998782,0.880097470039117,0,1,ferric iron transmembrane transporter activity,MF,
8436,GO:0033570,0.99999999998782,0.880097470039117,0,1,transferrin transmembrane transporter activity,MF,
15791,GO:0072510,0.99999999998782,0.880097470039117,0,1,trivalent inorganic cation transmembrane transporter activity,MF,
10218,GO:0042923,0.999999999987842,0.814436306681702,0,2,neuropeptide binding,MF,
3670,GO:0008169,0.999999999987852,0.730778765623571,0,3,C-methyltransferase activity,MF,
17454,GO:1900369,0.999999999987856,0.855399822834171,0,2,negative regulation of RNA interference,BP,
1876,GO:0004557,0.999999999987858,0.813446077111906,0,2,alpha-galactosidase activity,MF,
552,GO:0001674,0.999999999987862,0.79622607243512,0,2,female germ cell nucleus,CC,
10071,GO:0042585,0.999999999987862,0.79622607243512,0,2,germinal vesicle,CC,
8735,GO:0034395,0.999999999987875,0.910678829591547,0,1,regulation of transcription from RNA polymerase II promoter in response to iron,BP,
17349,GO:1900086,0.999999999987877,0.689786608857432,0,3,positive regulation of peptidyl-tyrosine autophosphorylation,BP,
8694,GO:0034343,0.999999999987919,0.706417617980828,0,3,type III interferon production,BP,
8695,GO:0034344,0.999999999987919,0.706417617980828,0,3,regulation of type III interferon production,BP,
5494,GO:0016434,0.99999999998792,0.713861527832389,0,3,rRNA (cytosine) methyltransferase activity,MF,
1532,GO:0003919,0.99999999998793,0.902833937165369,0,1,FMN adenylyltransferase activity,MF,
3149,GO:0006747,0.99999999998793,0.902833937165369,0,1,FAD biosynthetic process,BP,
11653,GO:0046443,0.99999999998793,0.902833937165369,0,1,FAD metabolic process,BP,
15762,GO:0072388,0.99999999998793,0.902833937165369,0,1,flavin adenine dinucleotide biosynthetic process,BP,
19105,GO:1905071,0.999999999987936,0.787904133151467,0,2,occluding junction disassembly,BP,
19106,GO:1905073,0.999999999987936,0.787904133151467,0,2,regulation of occluding junction disassembly,BP,
19107,GO:1905075,0.999999999987936,0.787904133151467,0,2,positive regulation of occluding junction disassembly,BP,
2854,GO:0006343,0.999999999987939,0.887976916388729,0,1,establishment of chromatin silencing,BP,
10080,GO:0042595,0.999999999987939,0.887976916388729,0,1,behavioral response to starvation,BP,
15245,GO:0071441,0.999999999987939,0.887976916388729,0,1,negative regulation of histone H3-K14 acetylation,BP,
20010,GO:2000654,0.999999999987939,0.887976916388729,0,1,regulation of cellular response to testosterone stimulus,BP,
20011,GO:2000655,0.999999999987939,0.887976916388729,0,1,negative regulation of cellular response to testosterone stimulus,BP,
18286,GO:1903225,0.999999999987962,0.770339246703062,0,2,negative regulation of endodermal cell differentiation,BP,
19757,GO:2000195,0.999999999987963,0.811014471924625,0,2,negative regulation of female gonad development,BP,
5028,GO:0015195,0.999999999987966,0.883525637923051,0,1,L-threonine transmembrane transporter activity,MF,
5221,GO:0015826,0.999999999987966,0.883525637923051,0,1,threonine transport,BP,
8806,GO:0034589,0.999999999987966,0.883525637923051,0,1,hydroxyproline transport,BP,
8807,GO:0034590,0.999999999987966,0.883525637923051,0,1,L-hydroxyproline transmembrane transporter activity,MF,
1486,GO:0003826,0.999999999987971,0.815014488264981,0,2,alpha-ketoacid dehydrogenase activity,MF,
1504,GO:0003863,0.999999999987971,0.815014488264981,0,2,3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity,MF,
974,GO:0002428,0.999999999987973,0.749526680921328,0,3,antigen processing and presentation of peptide antigen via MHC class Ib,BP,
8747,GO:0034423,0.999999999987987,0.90004455719893,0,1,autophagosome lumen,CC,
19901,GO:2000422,0.999999999987987,0.90004455719893,0,1,regulation of eosinophil chemotaxis,BP,
19902,GO:2000424,0.999999999987987,0.90004455719893,0,1,positive regulation of eosinophil chemotaxis,BP,
1600,GO:0004021,0.999999999987988,0.887063932122103,0,1,L-alanine:2-oxoglutarate aminotransferase activity,MF,
2979,GO:0006522,0.999999999987988,0.887063932122103,0,1,alanine metabolic process,BP,
2980,GO:0006524,0.999999999987988,0.887063932122103,0,1,alanine catabolic process,BP,
4040,GO:0009078,0.999999999987988,0.887063932122103,0,1,pyruvate family amino acid metabolic process,BP,
4041,GO:0009080,0.999999999987988,0.887063932122103,0,1,pyruvate family amino acid catabolic process,BP,
10204,GO:0042851,0.999999999987988,0.887063932122103,0,1,L-alanine metabolic process,BP,
10205,GO:0042853,0.999999999987988,0.887063932122103,0,1,L-alanine catabolic process,BP,
12007,GO:0047635,0.999999999987988,0.887063932122103,0,1,alanine-oxo-acid transaminase activity,MF,
1346,GO:0003213,0.999999999987989,0.769881888071817,0,2,cardiac right atrium morphogenesis,BP,
1214,GO:0002885,0.999999999987994,0.805851318982637,0,2,positive regulation of hypersensitivity,BP,
2580,GO:0005873,0.999999999988013,0.696166069717855,0,3,plus-end kinesin complex,CC,
14177,GO:0061110,0.999999999988015,0.780088825613537,0,2,dense core granule biogenesis,BP,
20045,GO:2000705,0.999999999988015,0.780088825613537,0,2,regulation of dense core granule biogenesis,BP,
16802,GO:0098705,0.999999999988017,0.881045741472817,0,1,copper ion import across plasma membrane,BP,
196,GO:0000415,0.999999999988026,0.879198673051028,0,1,negative regulation of histone H3-K36 methylation,BP,
10021,GO:0042483,0.999999999988026,0.879198673051028,0,1,negative regulation of odontogenesis,BP,
14589,GO:0070171,0.999999999988026,0.879198673051028,0,1,negative regulation of tooth mineralization,BP,
18353,GO:1903377,0.999999999988028,0.668927709025231,0,4,negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,BP,
1296,GO:0003131,0.999999999988032,0.899252259259554,0,1,mesodermal-endodermal cell signaling,BP,
7161,GO:0031049,0.999999999988032,0.899252259259554,0,1,programmed DNA elimination,BP,
7163,GO:0031052,0.999999999988032,0.899252259259554,0,1,chromosome breakage,BP,
9139,GO:0035501,0.999999999988032,0.899252259259554,0,1,MH1 domain binding,MF,
9403,GO:0035978,0.999999999988032,0.899252259259554,0,1,histone H2A-S139 phosphorylation,BP,
20035,GO:2000685,0.999999999988032,0.899252259259554,0,1,positive regulation of cellular response to X-ray,BP,
11115,GO:0045168,0.999999999988034,0.817350894066632,0,2,cell-cell signaling involved in cell fate commitment,BP,
11612,GO:0046331,0.999999999988034,0.817350894066632,0,2,lateral inhibition,BP,
1417,GO:0003363,0.999999999988037,0.879467640665655,0,1,lamellipodium assembly involved in ameboidal cell migration,BP,
9648,GO:0038003,0.999999999988042,0.655577545356823,0,4,opioid receptor signaling pathway,BP,
15931,GO:0075341,0.999999999988053,0.900851057567231,0,1,host cell PML body,CC,
16806,GO:0098713,0.999999999988072,0.900957074960963,0,1,leucine import across plasma membrane,BP,
18552,GO:1903801,0.999999999988072,0.900957074960963,0,1,L-leucine import across plasma membrane,BP,
7398,GO:0031475,0.999999999988073,0.911528386337841,0,1,myosin V complex,CC,
18671,GO:1904046,0.999999999988074,0.846942954369649,0,2,negative regulation of vascular endothelial growth factor production,BP,
11143,GO:0045213,0.999999999988074,0.818896860162142,0,2,neurotransmitter receptor metabolic process,BP,
5768,GO:0016972,0.999999999988082,0.628781689084737,0,4,thiol oxidase activity,MF,
943,GO:0002357,0.99999999998809,0.899577517549666,0,1,defense response to tumor cell,BP,
15308,GO:0071547,0.99999999998809,0.899577517549666,0,1,piP-body,CC,
3991,GO:0008890,0.999999999988096,0.909761584775044,0,1,glycine C-acetyltransferase activity,MF,
6161,GO:0019518,0.999999999988096,0.909761584775044,0,1,L-threonine catabolic process to glycine,BP,
232,GO:0000481,0.9999999999881,0.890841373001736,0,1,maturation of 5S rRNA,BP,
8566,GO:0034056,0.9999999999881,0.701878494800108,0,3,estrogen response element binding,MF,
10801,GO:0044302,0.999999999988128,0.695720190967662,0,3,dentate gyrus mossy fiber,CC,
5238,GO:0015862,0.99999999998814,0.900745352025518,0,1,uridine transport,BP,
1790,GO:0004421,0.999999999988185,0.892520564922194,0,1,hydroxymethylglutaryl-CoA synthase activity,MF,
3709,GO:0008218,0.999999999988185,0.892520564922194,0,1,bioluminescence,BP,
4277,GO:0009645,0.999999999988185,0.892520564922194,0,1,response to low light intensity stimulus,BP,
4402,GO:0010142,0.999999999988185,0.892520564922194,0,1,farnesyl diphosphate biosynthetic process, mevalonate pathway,BP,
11792,GO:0046690,0.999999999988185,0.892520564922194,0,1,response to tellurium ion,BP,
18091,GO:1902767,0.999999999988185,0.892520564922194,0,1,isoprenoid biosynthetic process via mevalonate,BP,
11153,GO:0045226,0.999999999988199,0.805518402039545,0,2,extracellular polysaccharide biosynthetic process,BP,
11632,GO:0046379,0.999999999988199,0.805518402039545,0,2,extracellular polysaccharide metabolic process,BP,
1883,GO:0004566,0.999999999988205,0.815899658583866,0,2,beta-glucuronidase activity,MF,
6023,GO:0019085,0.999999999988206,0.789155307985168,0,2,early viral transcription,BP,
2795,GO:0006238,0.999999999988207,0.920927215350567,0,1,CMP salvage,BP,
4160,GO:0009224,0.999999999988207,0.920927215350567,0,1,CMP biosynthetic process,BP,
11504,GO:0046035,0.999999999988207,0.920927215350567,0,1,CMP metabolic process,BP,
9921,GO:0042281,0.999999999988209,0.810464540213454,0,2,dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity,MF,
9158,GO:0035523,0.999999999988214,0.616415841876602,0,4,protein K29-linked deubiquitination,BP,
1721,GO:0004315,0.999999999988215,0.806375640524636,0,2,3-oxoacyl-[acyl-carrier-protein] synthase activity,MF,
7573,GO:0031945,0.999999999988223,0.887280176430142,0,1,positive regulation of glucocorticoid metabolic process,BP,
7576,GO:0031948,0.999999999988223,0.887280176430142,0,1,positive regulation of glucocorticoid biosynthetic process,BP,
14002,GO:0060748,0.999999999988223,0.887280176430142,0,1,tertiary branching involved in mammary gland duct morphogenesis,BP,
14149,GO:0061054,0.999999999988223,0.887280176430142,0,1,dermatome development,BP,
14205,GO:0061183,0.999999999988223,0.887280176430142,0,1,regulation of dermatome development,BP,
14206,GO:0061184,0.999999999988223,0.887280176430142,0,1,positive regulation of dermatome development,BP,
14215,GO:0061205,0.999999999988223,0.887280176430142,0,1,paramesonephric duct development,BP,
14263,GO:0061369,0.999999999988223,0.887280176430142,0,1,negative regulation of testicular blood vessel morphogenesis,BP,
19676,GO:2000019,0.999999999988223,0.887280176430142,0,1,negative regulation of male gonad development,BP,
19700,GO:2000066,0.999999999988223,0.887280176430142,0,1,positive regulation of cortisol biosynthetic process,BP,
19769,GO:2000224,0.999999999988223,0.887280176430142,0,1,regulation of testosterone biosynthetic process,BP,
19770,GO:2000225,0.999999999988223,0.887280176430142,0,1,negative regulation of testosterone biosynthetic process,BP,
16280,GO:0090409,0.999999999988225,0.900871922409532,0,1,malonyl-CoA synthetase activity,MF,
16281,GO:0090410,0.999999999988225,0.900871922409532,0,1,malonate catabolic process,BP,
8003,GO:0032641,0.999999999988231,0.89705022623587,0,1,lymphotoxin A production,BP,
8074,GO:0032765,0.999999999988231,0.89705022623587,0,1,positive regulation of mast cell cytokine production,BP,
9848,GO:0042109,0.999999999988231,0.89705022623587,0,1,lymphotoxin A biosynthetic process,BP,
14938,GO:0070853,0.999999999988238,0.770332351943107,0,2,myosin VI binding,MF,
14337,GO:0061574,0.999999999988243,0.716354449990781,0,3,ASAP complex,CC,
11034,GO:0045031,0.999999999988252,0.809884707261313,0,2,ATP-activated adenosine receptor activity,MF,
5773,GO:0016998,0.999999999988262,0.815547437043895,0,2,cell wall macromolecule catabolic process,BP,
7939,GO:0032542,0.999999999988267,0.803418595034932,0,2,sulfiredoxin activity,MF,
2079,GO:0004835,0.999999999988279,0.880106016119621,0,1,tubulin-tyrosine ligase activity,MF,
5911,GO:0018166,0.999999999988279,0.880106016119621,0,1,C-terminal protein-tyrosinylation,BP,
5952,GO:0018322,0.999999999988279,0.880106016119621,0,1,protein tyrosinylation,BP,
4848,GO:0014063,0.99999999998829,0.924062095989079,0,1,negative regulation of serotonin secretion,BP,
7355,GO:0031405,0.999999999988294,0.872150472679849,0,1,lipoic acid binding,MF,
10644,GO:0043754,0.999999999988294,0.872150472679849,0,1,dihydrolipoyllysine-residue (2-methylpropanoyl)transferase activity,MF,
831,GO:0002127,0.999999999988303,0.91410243011238,0,1,tRNA wobble base cytosine methylation,BP,
1244,GO:0002946,0.999999999988303,0.91410243011238,0,1,tRNA C5-cytosine methylation,BP,
19443,GO:1990166,0.999999999988308,0.72765363515997,0,3,protein localization to site of double-strand break,BP,
15336,GO:0071593,0.999999999988311,0.711806947843652,0,3,lymphocyte aggregation,BP,
4359,GO:0009957,0.999999999988313,0.7904908003071,0,2,epidermal cell fate specification,BP,
13793,GO:0060406,0.999999999988338,0.792219312040945,0,2,positive regulation of penile erection,BP,
19544,GO:1990575,0.999999999988338,0.797954237534731,0,2,mitochondrial L-ornithine transmembrane transport,BP,
8015,GO:0032658,0.999999999988342,0.905392636774745,0,1,regulation of interleukin-15 production,BP,
8059,GO:0032738,0.999999999988342,0.905392636774745,0,1,positive regulation of interleukin-15 production,BP,
9246,GO:0035664,0.999999999988342,0.905392636774745,0,1,TIRAP-dependent toll-like receptor signaling pathway,BP,
9247,GO:0035665,0.999999999988342,0.905392636774745,0,1,TIRAP-dependent toll-like receptor 4 signaling pathway,BP,
4003,GO:0008962,0.999999999988408,0.812435801711374,0,2,phosphatidylglycerophosphatase activity,MF,
14505,GO:0070022,0.999999999988411,0.612701783805044,0,4,transforming growth factor beta receptor complex,CC,
4301,GO:0009753,0.999999999988414,0.835569178146407,0,2,response to jasmonic acid,BP,
5976,GO:0018636,0.999999999988414,0.835569178146407,0,2,phenanthrene 9,10-monooxygenase activity,MF,
11931,GO:0047023,0.999999999988414,0.835569178146407,0,2,androsterone dehydrogenase activity,MF,
11938,GO:0047086,0.999999999988414,0.835569178146407,0,2,ketosteroid monooxygenase activity,MF,
11940,GO:0047115,0.999999999988414,0.835569178146407,0,2,trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity,MF,
15216,GO:0071395,0.999999999988414,0.835569178146407,0,2,cellular response to jasmonic acid stimulus,BP,
13189,GO:0051852,0.999999999988419,0.68439958034343,0,4,disruption by host of symbiont cells,BP,
13194,GO:0051873,0.999999999988419,0.68439958034343,0,4,killing by host of symbiont cells,BP,
9617,GO:0036496,0.99999999998842,0.822226277007747,0,2,regulation of translational initiation by eIF2 alpha dephosphorylation,BP,
5488,GO:0016426,0.999999999988429,0.654377580288481,0,4,tRNA (adenine) methyltransferase activity,MF,
11663,GO:0046462,0.999999999988448,0.813835694104322,0,2,monoacylglycerol metabolic process,BP,
13360,GO:0052651,0.999999999988448,0.813835694104322,0,2,monoacylglycerol catabolic process,BP,
2161,GO:0004996,0.999999999988452,0.887651401786999,0,1,thyroid-stimulating hormone receptor activity,MF,
9728,GO:0038194,0.999999999988452,0.887651401786999,0,1,thyroid-stimulating hormone signaling pathway,BP,
9733,GO:0039003,0.999999999988452,0.887651401786999,0,1,pronephric field specification,BP,
9736,GO:0039017,0.999999999988452,0.887651401786999,0,1,pattern specification involved in pronephros development,BP,
10137,GO:0042728,0.999999999988452,0.887651401786999,0,1,flavin-containing compound catabolic process,BP,
14746,GO:0070460,0.999999999988452,0.887651401786999,0,1,thyroid-stimulating hormone secretion,BP,
15536,GO:0072003,0.999999999988452,0.887651401786999,0,1,kidney rudiment formation,BP,
15537,GO:0072004,0.999999999988452,0.887651401786999,0,1,kidney field specification,BP,
15549,GO:0072025,0.999999999988452,0.887651401786999,0,1,distal convoluted tubule development,BP,
15568,GO:0072069,0.999999999988452,0.887651401786999,0,1,DCT cell differentiation,BP,
15672,GO:0072221,0.999999999988452,0.887651401786999,0,1,metanephric distal convoluted tubule development,BP,
15681,GO:0072240,0.999999999988452,0.887651401786999,0,1,metanephric DCT cell differentiation,BP,
15710,GO:0072304,0.999999999988452,0.887651401786999,0,1,regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis,BP,
15711,GO:0072305,0.999999999988452,0.887651401786999,0,1,negative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis,BP,
15714,GO:0072309,0.999999999988452,0.887651401786999,0,1,mesenchymal stem cell maintenance involved in metanephric nephron morphogenesis,BP,
15763,GO:0072389,0.999999999988452,0.887651401786999,0,1,flavin adenine dinucleotide catabolic process,BP,
17411,GO:1900200,0.999999999988452,0.887651401786999,0,1,mesenchymal cell apoptotic process involved in metanephros development,BP,
17412,GO:1900204,0.999999999988452,0.887651401786999,0,1,apoptotic process involved in metanephric collecting duct development,BP,
17413,GO:1900205,0.999999999988452,0.887651401786999,0,1,apoptotic process involved in metanephric nephron tubule development,BP,
17416,GO:1900211,0.999999999988452,0.887651401786999,0,1,regulation of mesenchymal cell apoptotic process involved in metanephros development,BP,
17417,GO:1900212,0.999999999988452,0.887651401786999,0,1,negative regulation of mesenchymal cell apoptotic process involved in metanephros development,BP,
17418,GO:1900214,0.999999999988452,0.887651401786999,0,1,regulation of apoptotic process involved in metanephric collecting duct development,BP,
17419,GO:1900215,0.999999999988452,0.887651401786999,0,1,negative regulation of apoptotic process involved in metanephric collecting duct development,BP,
17420,GO:1900217,0.999999999988452,0.887651401786999,0,1,regulation of apoptotic process involved in metanephric nephron tubule development,BP,
17421,GO:1900218,0.999999999988452,0.887651401786999,0,1,negative regulation of apoptotic process involved in metanephric nephron tubule development,BP,
17542,GO:1901147,0.999999999988452,0.887651401786999,0,1,mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis,BP,
18192,GO:1903004,0.999999999988452,0.887651401786999,0,1,regulation of protein K63-linked deubiquitination,BP,
18193,GO:1903006,0.999999999988452,0.887651401786999,0,1,positive regulation of protein K63-linked deubiquitination,BP,
18194,GO:1903007,0.999999999988452,0.887651401786999,0,1,positive regulation of Lys63-specific deubiquitinase activity,BP,
19973,GO:2000592,0.999999999988452,0.887651401786999,0,1,regulation of metanephric DCT cell differentiation,BP,
19974,GO:2000594,0.999999999988452,0.887651401786999,0,1,positive regulation of metanephric DCT cell differentiation,BP,
19980,GO:2000612,0.999999999988452,0.887651401786999,0,1,regulation of thyroid-stimulating hormone secretion,BP,
3997,GO:0008903,0.999999999988506,0.926642402762533,0,1,hydroxypyruvate isomerase activity,MF,
13196,GO:0051877,0.99999999998851,0.806852459129843,0,2,pigment granule aggregation in cell center,BP,
6008,GO:0019060,0.999999999988523,0.856629872134289,0,2,intracellular transport of viral protein in host cell,BP,
6947,GO:0030581,0.999999999988523,0.856629872134289,0,2,symbiont intracellular protein transport in host,BP,
13121,GO:0051708,0.999999999988523,0.856629872134289,0,2,intracellular protein transport in other organism involved in symbiotic interaction,BP,
702,GO:0001923,0.999999999988534,0.716391012579987,0,3,B-1 B cell differentiation,BP,
3989,GO:0008887,0.999999999988537,0.895564150254756,0,1,glycerate kinase activity,MF,
8975,GO:0035093,0.999999999988546,0.772827939602058,0,2,spermatogenesis, exchange of chromosomal proteins,BP,
9546,GO:0036333,0.999999999988549,0.900045944839817,0,1,hepatocyte homeostasis,BP,
18960,GO:1904772,0.999999999988549,0.900045944839817,0,1,response to tetrachloromethane,BP,
18703,GO:1904177,0.99999999998855,0.690130054489421,0,3,regulation of adipose tissue development,BP,
18704,GO:1904179,0.99999999998855,0.690130054489421,0,3,positive regulation of adipose tissue development,BP,
2207,GO:0005094,0.999999999988551,0.833714313822964,0,2,Rho GDP-dissociation inhibitor activity,MF,
144,GO:0000296,0.999999999988551,0.900868679670927,0,1,spermine transport,BP,
15012,GO:0070976,0.999999999988553,0.899798334237696,0,1,TIR domain binding,MF,
3883,GO:0008518,0.999999999988557,0.899190886526826,0,1,reduced folate carrier activity,MF,
16872,GO:0098838,0.999999999988557,0.899190886526826,0,1,reduced folate transmembrane transport,BP,
12122,GO:0048239,0.999999999988565,0.810423716715851,0,2,negative regulation of DNA recombination at telomere,BP,
15894,GO:0072695,0.999999999988565,0.810423716715851,0,2,regulation of DNA recombination at telomere,BP,
782,GO:0002041,0.999999999988565,0.900865448939334,0,1,intussusceptive angiogenesis,BP,
1003,GO:0002477,0.999999999988569,0.932334509335308,0,1,antigen processing and presentation of exogenous peptide antigen via MHC class Ib,BP,
1007,GO:0002481,0.999999999988569,0.932334509335308,0,1,antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent,BP,
4378,GO:0010025,0.999999999988582,0.793494544263722,0,2,wax biosynthetic process,BP,
4409,GO:0010166,0.999999999988582,0.793494544263722,0,2,wax metabolic process,BP,
15944,GO:0080019,0.999999999988582,0.793494544263722,0,2,fatty-acyl-CoA reductase (alcohol-forming) activity,MF,
17155,GO:0102965,0.999999999988582,0.793494544263722,0,2,alcohol-forming fatty acyl-CoA reductase activity,MF,
5019,GO:0015184,0.999999999988592,0.781018559945042,0,2,L-cystine transmembrane transporter activity,MF,
5210,GO:0015811,0.999999999988592,0.781018559945042,0,2,L-cystine transport,BP,
15198,GO:0071373,0.99999999998862,0.809402585672191,0,2,cellular response to luteinizing hormone stimulus,BP,
18629,GO:1903964,0.999999999988626,0.791922267318697,0,2,monounsaturated fatty acid metabolic process,BP,
18630,GO:1903966,0.999999999988626,0.791922267318697,0,2,monounsaturated fatty acid biosynthetic process,BP,
2022,GO:0004756,0.999999999988631,0.810979063077579,0,2,selenide, water dikinase activity,MF,
5412,GO:0016260,0.999999999988631,0.810979063077579,0,2,selenocysteine biosynthetic process,BP,
5668,GO:0016781,0.999999999988631,0.810979063077579,0,2,phosphotransferase activity, paired acceptors,MF,
14682,GO:0070329,0.999999999988631,0.810979063077579,0,2,tRNA seleno-modification,BP,
15032,GO:0071006,0.999999999988633,0.725969755390576,0,3,U2-type catalytic step 1 spliceosome,CC,
14130,GO:0061032,0.999999999988636,0.897971200660243,0,1,visceral serous pericardium development,BP,
15631,GO:0072166,0.999999999988636,0.897971200660243,0,1,posterior mesonephric tubule development,BP,
15705,GO:0072299,0.999999999988636,0.897971200660243,0,1,negative regulation of metanephric glomerulus development,BP,
15708,GO:0072302,0.999999999988636,0.897971200660243,0,1,negative regulation of metanephric glomerular mesangial cell proliferation,BP,
7717,GO:0032216,0.999999999988638,0.901000912773262,0,1,glucosaminyl-phosphotidylinositol O-acyltransferase activity,MF,
7962,GO:0032581,0.999999999988639,0.904407219524529,0,1,ER-dependent peroxisome organization,BP,
17202,GO:0106101,0.999999999988639,0.904407219524529,0,1,ER-dependent peroxisome localization,BP,
4888,GO:0014810,0.999999999988649,0.942601592816943,0,1,positive regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion,BP,
1825,GO:0004482,0.999999999988656,0.879318380250453,0,1,mRNA (guanine-N7-)-methyltransferase activity,MF,
7424,GO:0031533,0.999999999988656,0.879318380250453,0,1,mRNA cap methyltransferase complex,CC,
17170,GO:0106005,0.999999999988656,0.879318380250453,0,1,RNA 5'-cap (guanine-N7)-methylation,BP,
13711,GO:0060302,0.999999999988657,0.821221463500307,0,2,negative regulation of cytokine activity,BP,
3810,GO:0008404,0.999999999988658,0.904197459434251,0,1,arachidonic acid 14,15-epoxygenase activity,MF,
3811,GO:0008405,0.999999999988658,0.904197459434251,0,1,arachidonic acid 11,12-epoxygenase activity,MF,
15351,GO:0071614,0.999999999988658,0.904197459434251,0,1,linoleic acid epoxygenase activity,MF,
19605,GO:1990784,0.999999999988666,0.885812170829427,0,1,response to dsDNA,BP,
19607,GO:1990786,0.999999999988666,0.885812170829427,0,1,cellular response to dsDNA,BP,
2010,GO:0004739,0.999999999988668,0.814409352540565,0,2,pyruvate dehydrogenase (acetyl-transferring) activity,MF,
1188,GO:0002835,0.999999999988669,0.804087612149706,0,2,negative regulation of response to tumor cell,BP,
1191,GO:0002838,0.999999999988669,0.804087612149706,0,2,negative regulation of immune response to tumor cell,BP,
1196,GO:0002856,0.999999999988669,0.804087612149706,0,2,negative regulation of natural killer cell mediated immune response to tumor cell,BP,
1199,GO:0002859,0.999999999988669,0.804087612149706,0,2,negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target,BP,
6829,GO:0030298,0.999999999988672,0.921761996303091,0,1,receptor signaling protein tyrosine kinase activator activity,MF,
7516,GO:0031726,0.999999999988672,0.921761996303091,0,1,CCR1 chemokine receptor binding,MF,
7517,GO:0031729,0.999999999988672,0.921761996303091,0,1,CCR4 chemokine receptor binding,MF,
11826,GO:0046817,0.999999999988672,0.921761996303091,0,1,chemokine receptor antagonist activity,MF,
13689,GO:0060268,0.999999999988679,0.743596435385197,0,3,negative regulation of respiratory burst,BP,
2175,GO:0005021,0.9999999999887,0.792191660296409,0,2,vascular endothelial growth factor-activated receptor activity,MF,
18757,GO:1904290,0.999999999988703,0.882104109427842,0,1,negative regulation of mitotic DNA damage checkpoint,BP,
11501,GO:0046032,0.999999999988705,0.91111310076442,0,1,ADP catabolic process,BP,
17064,GO:0099609,0.999999999988721,0.773605057739413,0,2,microtubule lateral binding,MF,
13863,GO:0060523,0.999999999988737,0.778310305164553,0,2,prostate epithelial cord elongation,BP,
13282,GO:0052047,0.999999999988742,0.876880887920012,0,1,interaction with other organism via secreted substance involved in symbiotic interaction,BP,
18733,GO:1904235,0.999999999988742,0.876880887920012,0,1,regulation of substrate-dependent cell migration, cell attachment to substrate,BP,
18734,GO:1904237,0.999999999988742,0.876880887920012,0,1,positive regulation of substrate-dependent cell migration, cell attachment to substrate,BP,
20228,GO:2001202,0.999999999988742,0.876880887920012,0,1,negative regulation of transforming growth factor-beta secretion,BP,
19268,GO:1905524,0.999999999988745,0.877859573342868,0,1,negative regulation of protein autoubiquitination,BP,
15914,GO:0072737,0.999999999988777,0.811431287944,0,2,response to diamide,BP,
15915,GO:0072738,0.999999999988777,0.811431287944,0,2,cellular response to diamide,BP,
13057,GO:0051585,0.999999999988777,0.896342628299234,0,1,negative regulation of dopamine uptake involved in synaptic transmission,BP,
13081,GO:0051620,0.999999999988777,0.896342628299234,0,1,norepinephrine uptake,BP,
13082,GO:0051621,0.999999999988777,0.896342628299234,0,1,regulation of norepinephrine uptake,BP,
13083,GO:0051622,0.999999999988777,0.896342628299234,0,1,negative regulation of norepinephrine uptake,BP,
13241,GO:0051945,0.999999999988777,0.896342628299234,0,1,negative regulation of catecholamine uptake involved in synaptic transmission,BP,
18166,GO:1902957,0.999999999988777,0.896342628299234,0,1,negative regulation of mitochondrial electron transport, NADH to ubiquinone,BP,
18305,GO:1903282,0.999999999988777,0.896342628299234,0,1,regulation of glutathione peroxidase activity,BP,
18306,GO:1903284,0.999999999988777,0.896342628299234,0,1,positive regulation of glutathione peroxidase activity,BP,
18307,GO:1903285,0.999999999988777,0.896342628299234,0,1,positive regulation of hydrogen peroxide catabolic process,BP,
19242,GO:1905447,0.999999999988777,0.896342628299234,0,1,negative regulation of mitochondrial ATP synthesis coupled electron transport,BP,
19808,GO:2000295,0.999999999988777,0.896342628299234,0,1,regulation of hydrogen peroxide catabolic process,BP,
19917,GO:2000468,0.999999999988777,0.896342628299234,0,1,regulation of peroxidase activity,BP,
19918,GO:2000470,0.999999999988777,0.896342628299234,0,1,positive regulation of peroxidase activity,BP,
11050,GO:0045062,0.999999999988779,0.906819968397438,0,1,extrathymic T cell selection,BP,
15041,GO:0071021,0.999999999988779,0.906819968397438,0,1,U2-type post-spliceosomal complex,CC,
6100,GO:0019323,0.99999999998878,0.682296842806441,0,4,pentose catabolic process,BP,
14517,GO:0070051,0.99999999998878,0.791760075372557,0,2,fibrinogen binding,MF,
16420,GO:0097102,0.999999999988786,0.805539253473198,0,2,endothelial tip cell fate specification,BP,
694,GO:0001915,0.999999999988787,0.724256669615055,0,3,negative regulation of T cell mediated cytotoxicity,BP,
19071,GO:1904996,0.999999999988794,0.684822713926577,0,3,positive regulation of leukocyte adhesion to vascular endothelial cell,BP,
16265,GO:0090370,0.9999999999888,0.883428548231546,0,1,negative regulation of cholesterol efflux,BP,
20257,GO:2001247,0.9999999999888,0.883428548231546,0,1,positive regulation of phosphatidylcholine biosynthetic process,BP,
4941,GO:0014908,0.999999999988806,0.87926876891864,0,1,myotube differentiation involved in skeletal muscle regeneration,BP,
495,GO:0001550,0.999999999988807,0.775576918875715,0,2,ovarian cumulus expansion,BP,
12097,GO:0048165,0.999999999988807,0.775576918875715,0,2,fused antrum stage,BP,
16686,GO:0097682,0.999999999988811,0.901732103690338,0,1,intracellular phosphatidylinositol-3,5-bisphosphate-sensitive cation channel activity,MF,
8482,GO:0033650,0.999999999988812,0.905951392382056,0,1,host cell mitochondrion,CC,
10743,GO:0044190,0.999999999988812,0.905951392382056,0,1,host cell mitochondrial envelope,CC,
15781,GO:0072492,0.999999999988812,0.905951392382056,0,1,host cell mitochondrial intermembrane space,CC,
14178,GO:0061113,0.999999999988821,0.797949274020556,0,2,pancreas morphogenesis,BP,
1659,GO:0004117,0.999999999988823,0.89981655393183,0,1,calmodulin-dependent cyclic-nucleotide phosphodiesterase activity,MF,
2039,GO:0004782,0.999999999988823,0.89981655393183,0,1,sulfinoalanine decarboxylase activity,MF,
3843,GO:0008455,0.999999999988823,0.89981655393183,0,1,alpha-1,6-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity,MF,
3892,GO:0008531,0.999999999988823,0.89981655393183,0,1,riboflavin kinase activity,MF,
4164,GO:0009231,0.999999999988823,0.89981655393183,0,1,riboflavin biosynthetic process,BP,
4222,GO:0009398,0.999999999988823,0.89981655393183,0,1,FMN biosynthetic process,BP,
9984,GO:0042412,0.999999999988823,0.89981655393183,0,1,taurine biosynthetic process,BP,
11597,GO:0046305,0.999999999988823,0.89981655393183,0,1,alkanesulfonate biosynthetic process,BP,
11654,GO:0046444,0.999999999988823,0.89981655393183,0,1,FMN metabolic process,BP,
5087,GO:0015349,0.999999999988841,0.794289582690758,0,2,thyroid hormone transmembrane transporter activity,MF,
8150,GO:0032889,0.999999999988868,0.900303160291516,0,1,regulation of vacuole fusion, non-autophagic,BP,
3002,GO:0006548,0.999999999988877,0.805800157475944,0,2,histidine catabolic process,BP,
13393,GO:0052805,0.999999999988877,0.805800157475944,0,2,imidazole-containing compound catabolic process,BP,
14875,GO:0070697,0.999999999988879,0.792054202372036,0,2,activin receptor binding,MF,
14876,GO:0070699,0.999999999988879,0.792054202372036,0,2,type II activin receptor binding,MF,
11888,GO:0046933,0.999999999988907,0.789500702522269,0,3,proton-transporting ATP synthase activity, rotational mechanism,MF,
19608,GO:1990791,0.999999999988913,0.804286652659138,0,2,dorsal root ganglion development,BP,
13810,GO:0060430,0.999999999988914,0.774464751628024,0,2,lung saccule development,BP,
2062,GO:0004817,0.999999999988916,0.813616348855933,0,2,cysteine-tRNA ligase activity,MF,
2912,GO:0006423,0.999999999988916,0.813616348855933,0,2,cysteinyl-tRNA aminoacylation,BP,
11012,GO:0044868,0.999999999988919,0.879134085570055,0,1,modulation by host of viral molecular function,BP,
19160,GO:1905255,0.999999999988919,0.879134085570055,0,1,regulation of RNA binding transcription factor activity,BP,
19657,GO:1990968,0.999999999988919,0.879134085570055,0,1,modulation by host of RNA binding by virus,BP,
19658,GO:1990969,0.999999999988919,0.879134085570055,0,1,modulation by host of viral RNA-binding transcription factor activity,BP,
2627,GO:0005954,0.99999999998893,0.900405665976341,0,1,calcium- and calmodulin-dependent protein kinase complex,CC,
12023,GO:0047757,0.999999999988931,0.775592630862023,0,2,chondroitin-glucuronate 5-epimerase activity,MF,
1271,GO:0003065,0.999999999988935,0.905289426676008,0,1,positive regulation of heart rate by epinephrine,BP,
14778,GO:0070524,0.999999999988963,0.914939320427357,0,1,11-beta-hydroxysteroid dehydrogenase (NADP+) activity,MF,
13128,GO:0051717,0.999999999988967,0.790979737239965,0,2,inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity,MF,
7990,GO:0032618,0.999999999988993,0.821583650644983,0,2,interleukin-15 production,BP,
3094,GO:0006668,0.999999999988996,0.803783348322158,0,2,sphinganine-1-phosphate metabolic process,BP,
1756,GO:0004361,0.999999999988998,0.906757926657493,0,1,glutaryl-CoA dehydrogenase activity,MF,
2264,GO:0005183,0.999999999988998,0.906757926657493,0,1,gonadotropin hormone-releasing hormone activity,MF,
7421,GO:0031530,0.999999999988998,0.906757926657493,0,1,gonadotropin-releasing hormone receptor binding,MF,
19402,GO:1990008,0.999999999988998,0.906757926657493,0,1,neurosecretory vesicle,CC,
13953,GO:0060685,0.999999999988999,0.705449050118806,0,3,regulation of prostatic bud formation,BP,
13954,GO:0060686,0.999999999988999,0.705449050118806,0,3,negative regulation of prostatic bud formation,BP,
5956,GO:0018343,0.999999999989003,0.73545198773424,0,3,protein farnesylation,BP,
1648,GO:0004098,0.999999999989003,0.90361036887896,0,1,cerebroside-sulfatase activity,MF,
10942,GO:0044691,0.999999999989008,0.779453823679256,0,2,tooth eruption,BP,
14166,GO:0061091,0.999999999989019,0.880330815698817,0,1,regulation of phospholipid translocation,BP,
14167,GO:0061092,0.999999999989019,0.880330815698817,0,1,positive regulation of phospholipid translocation,BP,
963,GO:0002396,0.999999999989022,0.903474764909249,0,1,MHC protein complex assembly,BP,
964,GO:0002397,0.999999999989022,0.903474764909249,0,1,MHC class I protein complex assembly,BP,
1012,GO:0002501,0.999999999989022,0.903474764909249,0,1,peptide antigen assembly with MHC protein complex,BP,
1013,GO:0002502,0.999999999989022,0.903474764909249,0,1,peptide antigen assembly with MHC class I protein complex,BP,
18650,GO:1904017,0.99999999998904,0.772698092712165,0,2,cellular response to Thyroglobulin triiodothyronine,BP,
4788,GO:0010982,0.999999999989062,0.797098620469412,0,2,regulation of high-density lipoprotein particle clearance,BP,
4789,GO:0010983,0.999999999989062,0.797098620469412,0,2,positive regulation of high-density lipoprotein particle clearance,BP,
13025,GO:0051525,0.999999999989072,0.77206683309502,0,2,NFAT protein binding,MF,
10474,GO:0043385,0.999999999989074,0.899689577958301,0,1,mycotoxin metabolic process,BP,
10475,GO:0043387,0.999999999989074,0.899689577958301,0,1,mycotoxin catabolic process,BP,
11590,GO:0046222,0.999999999989074,0.899689577958301,0,1,aflatoxin metabolic process,BP,
11591,GO:0046223,0.999999999989074,0.899689577958301,0,1,aflatoxin catabolic process,BP,
17620,GO:1901376,0.999999999989074,0.899689577958301,0,1,organic heteropentacyclic compound metabolic process,BP,
17621,GO:1901377,0.999999999989074,0.899689577958301,0,1,organic heteropentacyclic compound catabolic process,BP,
18541,GO:1903786,0.999999999989074,0.899689577958301,0,1,regulation of glutathione biosynthetic process,BP,
18542,GO:1903788,0.999999999989074,0.899689577958301,0,1,positive regulation of glutathione biosynthetic process,BP,
19826,GO:2000318,0.999999999989076,0.677939039075068,0,4,positive regulation of T-helper 17 type immune response,BP,
17892,GO:1902226,0.999999999989077,0.816684801213054,0,2,regulation of macrophage colony-stimulating factor signaling pathway,BP,
18631,GO:1903969,0.999999999989077,0.816684801213054,0,2,regulation of response to macrophage colony-stimulating factor,BP,
18634,GO:1903972,0.999999999989077,0.816684801213054,0,2,regulation of cellular response to macrophage colony-stimulating factor stimulus,BP,
17452,GO:1900365,0.99999999998908,0.699918352597332,0,3,positive regulation of mRNA polyadenylation,BP,
4926,GO:0014883,0.99999999998909,0.633128931076297,0,4,transition between fast and slow fiber,BP,
2225,GO:0005129,0.999999999989096,0.942761371863467,0,1,granulocyte macrophage colony-stimulating factor receptor binding,MF,
8552,GO:0034021,0.999999999989096,0.942761371863467,0,1,response to silicon dioxide,BP,
5239,GO:0015864,0.999999999989104,0.811668500916845,0,2,pyrimidine nucleoside transport,BP,
17584,GO:1901291,0.999999999989123,0.903480834848433,0,1,negative regulation of double-strand break repair via single-strand annealing,BP,
118,GO:0000247,0.99999999998913,0.924653610526922,0,1,C-8 sterol isomerase activity,MF,
2028,GO:0004769,0.99999999998913,0.924653610526922,0,1,steroid delta-isomerase activity,MF,
10072,GO:0042586,0.99999999998913,0.924653610526922,0,1,peptide deformylase activity,MF,
2078,GO:0004833,0.999999999989138,0.910079735774936,0,1,tryptophan 2,3-dioxygenase activity,MF,
8513,GO:0033754,0.999999999989138,0.910079735774936,0,1,indoleamine 2,3-dioxygenase activity,MF,
8672,GO:0034275,0.999999999989138,0.910079735774936,0,1,kynurenic acid metabolic process,BP,
8673,GO:0034276,0.999999999989138,0.910079735774936,0,1,kynurenic acid biosynthetic process,BP,
9523,GO:0036269,0.999999999989138,0.910079735774936,0,1,swimming behavior,BP,
1841,GO:0004499,0.999999999989147,0.901507144562607,0,1,N,N-dimethylaniline monooxygenase activity,MF,
12011,GO:0047685,0.999999999989153,0.91192281809515,0,1,amine sulfotransferase activity,MF,
7269,GO:0031260,0.999999999989153,0.927796587648288,0,1,pseudopodium membrane,CC,
1898,GO:0004584,0.999999999989155,0.900660363050649,0,1,dolichyl-phosphate-mannose-glycolipid alpha-mannosyltransferase activity,MF,
9128,GO:0035473,0.999999999989157,0.802816468172376,0,2,lipase binding,MF,
4984,GO:0015112,0.999999999989168,0.899990028936255,0,1,nitrate transmembrane transporter activity,MF,
5162,GO:0015706,0.999999999989168,0.899990028936255,0,1,nitrate transport,BP,
2726,GO:0006106,0.999999999989176,0.734901091434999,0,3,fumarate metabolic process,BP,
9321,GO:0035812,0.999999999989177,0.812447806811924,0,2,renal sodium excretion,BP,
9322,GO:0035813,0.999999999989177,0.812447806811924,0,2,regulation of renal sodium excretion,BP,
347,GO:0000961,0.999999999989178,0.790052319254213,0,2,negative regulation of mitochondrial RNA catabolic process,BP,
18398,GO:1903464,0.999999999989189,0.806335919595463,0,2,negative regulation of mitotic cell cycle DNA replication,BP,
1735,GO:0004335,0.999999999989192,0.821539986453598,0,2,galactokinase activity,MF,
8491,GO:0033680,0.999999999989197,0.793438299385526,0,2,ATP-dependent DNA/RNA helicase activity,MF,
3978,GO:0008808,0.999999999989199,0.888484378698655,0,1,cardiolipin synthase activity,MF,
6940,GO:0030572,0.999999999989199,0.888484378698655,0,1,phosphatidyltransferase activity,MF,
10456,GO:0043337,0.999999999989199,0.888484378698655,0,1,CDP-diacylglycerol-phosphatidylglycerol phosphatidyltransferase activity,MF,
19326,GO:1905711,0.999999999989199,0.888484378698655,0,1,response to phosphatidylethanolamine,BP,
5445,GO:0016316,0.999999999989205,0.778087762418817,0,2,phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity,MF,
5858,GO:0017161,0.999999999989205,0.778087762418817,0,2,inositol-1,3,4-trisphosphate 4-phosphatase activity,MF,
8812,GO:0034597,0.999999999989205,0.778087762418817,0,2,phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity,MF,
13404,GO:0052828,0.999999999989205,0.778087762418817,0,2,inositol-3,4-bisphosphate 4-phosphatase activity,MF,
667,GO:0001875,0.999999999989226,0.711539640358103,0,3,lipopolysaccharide receptor activity,MF,
9697,GO:0038113,0.999999999989229,0.774425873050042,0,2,interleukin-9-mediated signaling pathway,BP,
15070,GO:0071104,0.999999999989229,0.774425873050042,0,2,response to interleukin-9,BP,
15187,GO:0071355,0.999999999989229,0.774425873050042,0,2,cellular response to interleukin-9,BP,
409,GO:0001096,0.999999999989247,0.890057369403622,0,1,TFIIF-class transcription factor binding,MF,
4455,GO:0010430,0.999999999989253,0.881298531613234,0,1,fatty acid omega-oxidation,BP,
10201,GO:0042835,0.999999999989253,0.881298531613234,0,1,BRE binding,MF,
15417,GO:0071713,0.999999999989253,0.881298531613234,0,1,para-aminobenzoyl-glutamate hydrolase activity,MF,
906,GO:0002291,0.99999999998926,0.82427984000413,0,2,T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,BP,
19937,GO:2000520,0.99999999998926,0.82427984000413,0,2,regulation of immunological synapse formation,BP,
19938,GO:2000521,0.99999999998926,0.82427984000413,0,2,negative regulation of immunological synapse formation,BP,
20221,GO:2001188,0.99999999998926,0.82427984000413,0,2,regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,BP,
20222,GO:2001189,0.99999999998926,0.82427984000413,0,2,negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,BP,
6934,GO:0030549,0.999999999989266,0.924887765619333,0,1,acetylcholine receptor activator activity,MF,
55,GO:0000117,0.999999999989269,0.879662319403963,0,1,regulation of transcription involved in G2/M transition of mitotic cell cycle,BP,
15338,GO:0071596,0.999999999989269,0.677681549956777,0,3,ubiquitin-dependent protein catabolic process via the N-end rule pathway,BP,
12297,GO:0048664,0.999999999989271,0.756551960375832,0,3,neuron fate determination,BP,
8169,GO:0032915,0.999999999989289,0.901655775687691,0,1,positive regulation of transforming growth factor beta2 production,BP,
16387,GO:0097036,0.999999999989295,0.914037867695953,0,1,regulation of plasma membrane sterol distribution,BP,
14870,GO:0070682,0.999999999989299,0.734081971765379,0,3,proteasome regulatory particle assembly,BP,
11584,GO:0046203,0.999999999989312,0.837504516509217,0,2,spermidine catabolic process,BP,
209,GO:0000438,0.999999999989316,0.746280073845883,0,3,core TFIIH complex portion of holo TFIIH complex,CC,
19153,GO:1905224,0.999999999989316,0.77613603439132,0,2,clathrin-coated pit assembly,BP,
2699,GO:0006065,0.99999999998932,0.710118236375568,0,3,UDP-glucuronate biosynthetic process,BP,
11641,GO:0046398,0.99999999998932,0.710118236375568,0,3,UDP-glucuronate metabolic process,BP,
8173,GO:0032919,0.999999999989346,0.933344118365569,0,1,spermine acetylation,BP,
8174,GO:0032920,0.999999999989346,0.933344118365569,0,1,putrescine acetylation,BP,
11585,GO:0046204,0.999999999989346,0.933344118365569,0,1,nor-spermidine metabolic process,BP,
12449,GO:0050313,0.999999999989346,0.933344118365569,0,1,sulfur dioxygenase activity,MF,
2694,GO:0006060,0.999999999989348,0.823936529491085,0,2,sorbitol metabolic process,BP,
11631,GO:0046370,0.999999999989348,0.823936529491085,0,2,fructose biosynthetic process,BP,
7479,GO:0031651,0.999999999989349,0.884643063919798,0,1,negative regulation of heat generation,BP,
7506,GO:0031699,0.999999999989349,0.884643063919798,0,1,beta-3 adrenergic receptor binding,MF,
14436,GO:0061798,0.999999999989349,0.884643063919798,0,1,GTP 3',8'-cyclase activity,MF,
14437,GO:0061799,0.999999999989349,0.884643063919798,0,1,cyclic pyranopterin monophosphate synthase activity,MF,
16247,GO:0090327,0.999999999989349,0.884643063919798,0,1,negative regulation of locomotion involved in locomotory behavior,BP,
15082,GO:0071148,0.999999999989355,0.770016935581066,0,2,TEAD-1-YAP complex,CC,
5949,GO:0018312,0.999999999989363,0.801069921567537,0,2,peptidyl-serine ADP-ribosylation,BP,
19495,GO:1990404,0.999999999989363,0.801069921567537,0,2,protein ADP-ribosylase activity,MF,
1938,GO:0004642,0.999999999989364,0.879817516372078,0,1,phosphoribosylformylglycinamidine synthase activity,MF,
17224,GO:0120012,0.999999999989364,0.879817516372078,0,1,intermembrane sphingolipid transfer,BP,
17226,GO:0120016,0.999999999989364,0.879817516372078,0,1,intermembrane sphingolipid transfer activity,MF,
17227,GO:0120017,0.999999999989364,0.879817516372078,0,1,intermembrane ceramide transfer activity,MF,
10364,GO:0043199,0.999999999989367,0.719461108844105,0,3,sulfate binding,MF,
8865,GO:0034683,0.999999999989388,0.87869677829767,0,1,integrin alphav-beta3 complex,CC,
11341,GO:0045715,0.999999999989388,0.87869677829767,0,1,negative regulation of low-density lipoprotein particle receptor biosynthetic process,BP,
12562,GO:0050748,0.999999999989388,0.87869677829767,0,1,negative regulation of lipoprotein metabolic process,BP,
13286,GO:0052066,0.999999999989388,0.87869677829767,0,1,entry of symbiont into host cell by promotion of host phagocytosis,BP,
13296,GO:0052190,0.999999999989388,0.87869677829767,0,1,modulation by symbiont of host phagocytosis,BP,
13297,GO:0052191,0.999999999989388,0.87869677829767,0,1,positive regulation by symbiont of host phagocytosis,BP,
13307,GO:0052231,0.999999999989388,0.87869677829767,0,1,modulation of phagocytosis in other organism involved in symbiotic interaction,BP,
13323,GO:0052370,0.999999999989388,0.87869677829767,0,1,entry of organism into cell of other organism by promotion of phagocytosis in other organism involved in symbiotic interaction,BP,
13339,GO:0052522,0.999999999989388,0.87869677829767,0,1,positive regulation by organism of phagocytosis in other organism involved in symbiotic interaction,BP,
19942,GO:2000536,0.999999999989388,0.87869677829767,0,1,negative regulation of entry of bacterium into host cell,BP,
15507,GO:0071918,0.999999999989402,0.794198838951018,0,2,urea transmembrane transport,BP,
19060,GO:1904975,0.999999999989402,0.780482632860158,0,2,response to bleomycin,BP,
19061,GO:1904976,0.999999999989402,0.780482632860158,0,2,cellular response to bleomycin,BP,
11246,GO:0045509,0.999999999989406,0.802151527125321,0,2,interleukin-27 receptor activity,MF,
6009,GO:0019061,0.999999999989408,0.900918616288926,0,1,uncoating of virus,BP,
16395,GO:0097051,0.999999999989414,0.687235168520544,0,3,establishment of protein localization to endoplasmic reticulum membrane,BP,
9386,GO:0035936,0.999999999989422,0.878752180750679,0,1,testosterone secretion,BP,
20121,GO:2000843,0.999999999989422,0.878752180750679,0,1,regulation of testosterone secretion,BP,
20122,GO:2000845,0.999999999989422,0.878752180750679,0,1,positive regulation of testosterone secretion,BP,
18849,GO:1904529,0.999999999989427,0.789106481826099,0,2,regulation of actin filament binding,BP,
18891,GO:1904616,0.999999999989427,0.789106481826099,0,2,regulation of actin binding,BP,
10497,GO:0043415,0.999999999989432,0.644718076406421,0,4,positive regulation of skeletal muscle tissue regeneration,BP,
10498,GO:0043416,0.999999999989432,0.644718076406421,0,4,regulation of skeletal muscle tissue regeneration,BP,
19738,GO:2000156,0.999999999989436,0.798032385432465,0,2,regulation of retrograde vesicle-mediated transport, Golgi to ER,BP,
13814,GO:0060435,0.99999999998944,0.917781155811958,0,1,bronchiole development,BP,
13842,GO:0060480,0.99999999998944,0.917781155811958,0,1,lung goblet cell differentiation,BP,
6228,GO:0019782,0.999999999989445,0.89445863697929,0,1,ISG15 activating enzyme activity,MF,
10947,GO:0044715,0.999999999989453,0.84085988593093,0,2,8-oxo-dGDP phosphatase activity,MF,
6659,GO:0030020,0.999999999989468,0.707631966494582,0,3,extracellular matrix structural constituent conferring tensile strength,MF,
805,GO:0002079,0.999999999989473,0.785627641575789,0,2,inner acrosomal membrane,CC,
16670,GO:0097638,0.999999999989476,0.771119908866726,0,2,L-arginine import across plasma membrane,BP,
10442,GO:0043314,0.999999999989486,0.773265106227816,0,2,negative regulation of neutrophil degranulation,BP,
18019,GO:1902564,0.999999999989486,0.773265106227816,0,2,negative regulation of neutrophil activation,BP,
6944,GO:0030578,0.999999999989493,0.620295532517024,0,4,PML body organization,BP,
5149,GO:0015688,0.999999999989495,0.847589386679995,0,2,iron chelate transport,BP,
5258,GO:0015891,0.999999999989495,0.847589386679995,0,2,siderophore transport,BP,
327,GO:0000916,0.999999999989499,0.901306234265165,0,1,actomyosin contractile ring contraction,BP,
9506,GO:0036213,0.999999999989499,0.901306234265165,0,1,contractile ring contraction,BP,
2051,GO:0004802,0.999999999989507,0.901706290731341,0,1,transketolase activity,MF,
5603,GO:0016647,0.999999999989532,0.818132602439777,0,2,oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor,MF,
11732,GO:0046592,0.999999999989532,0.818132602439777,0,2,polyamine oxidase activity,MF,
13430,GO:0052901,0.999999999989532,0.818132602439777,0,2,spermine:oxygen oxidoreductase (spermidine-forming) activity,MF,
9436,GO:0036034,0.999999999989535,0.81054491676876,0,2,mediator complex assembly,BP,
20210,GO:2001176,0.999999999989535,0.81054491676876,0,2,regulation of mediator complex assembly,BP,
20211,GO:2001178,0.999999999989535,0.81054491676876,0,2,positive regulation of mediator complex assembly,BP,
3937,GO:0008626,0.999999999989537,0.721464338922981,0,3,granzyme-mediated apoptotic signaling pathway,BP,
4493,GO:0010521,0.999999999989543,0.740387525716831,0,3,telomerase inhibitor activity,MF,
1498,GO:0003846,0.999999999989554,0.800976161957402,0,2,2-acylglycerol O-acyltransferase activity,MF,
1677,GO:0004144,0.999999999989554,0.800976161957402,0,2,diacylglycerol O-acyltransferase activity,MF,
12439,GO:0050252,0.999999999989554,0.800976161957402,0,2,retinol O-fatty-acyltransferase activity,MF,
11350,GO:0045726,0.999999999989557,0.880051360472015,0,1,positive regulation of integrin biosynthetic process,BP,
13206,GO:0051891,0.999999999989557,0.880051360472015,0,1,positive regulation of cardioblast differentiation,BP,
18500,GO:1903701,0.999999999989557,0.880051360472015,0,1,substantia propria of cornea development,BP,
12586,GO:0050785,0.999999999989557,0.917347043218529,0,1,advanced glycation end-product receptor activity,MF,
18884,GO:1904596,0.999999999989557,0.917347043218529,0,1,regulation of connective tissue replacement involved in inflammatory response wound healing,BP,
18885,GO:1904597,0.999999999989557,0.917347043218529,0,1,negative regulation of connective tissue replacement involved in inflammatory response wound healing,BP,
18886,GO:1904599,0.999999999989557,0.917347043218529,0,1,advanced glycation end-product binding,MF,
18887,GO:1904603,0.999999999989557,0.917347043218529,0,1,regulation of advanced glycation end-product receptor activity,BP,
18888,GO:1904604,0.999999999989557,0.917347043218529,0,1,negative regulation of advanced glycation end-product receptor activity,BP,
19142,GO:1905204,0.999999999989557,0.917347043218529,0,1,negative regulation of connective tissue replacement,BP,
7599,GO:0031990,0.999999999989565,0.787709647495639,0,2,mRNA export from nucleus in response to heat stress,BP,
9703,GO:0038129,0.999999999989568,0.810976725266366,0,2,ERBB3 signaling pathway,BP,
12347,GO:0048743,0.999999999989573,0.788262024555721,0,2,positive regulation of skeletal muscle fiber development,BP,
19986,GO:2000620,0.999999999989575,0.772631513189786,0,2,positive regulation of histone H4-K16 acetylation,BP,
7231,GO:0031151,0.999999999989597,0.878144838811688,0,1,histone methyltransferase activity (H3-K79 specific),MF,
7994,GO:0032625,0.999999999989602,0.891494269287605,0,1,interleukin-21 production,BP,
15863,GO:0072619,0.999999999989602,0.891494269287605,0,1,interleukin-21 secretion,BP,
6227,GO:0019781,0.999999999989608,0.815758019004528,0,2,NEDD8 activating enzyme activity,MF,
13439,GO:0052918,0.999999999989618,0.879256638851404,0,1,dol-P-Man:Man(8)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase activity,MF,
13441,GO:0052926,0.999999999989618,0.879256638851404,0,1,dol-P-Man:Man(6)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase activity,MF,
11446,GO:0045917,0.999999999989622,0.796235122337348,0,2,positive regulation of complement activation,BP,
19790,GO:2000259,0.999999999989622,0.796235122337348,0,2,positive regulation of protein activation cascade,BP,
20114,GO:2000828,0.999999999989624,0.794991010013789,0,2,regulation of parathyroid hormone secretion,BP,
6514,GO:0021896,0.999999999989636,0.763642563503006,0,2,forebrain astrocyte differentiation,BP,
6515,GO:0021897,0.999999999989636,0.763642563503006,0,2,forebrain astrocyte development,BP,
18247,GO:1903135,0.999999999989636,0.7453429189383,0,3,cupric ion binding,MF,
2231,GO:0005136,0.999999999989639,0.896815002678846,0,1,interleukin-4 receptor binding,MF,
4000,GO:0008940,0.999999999989639,0.714024262742108,0,3,nitrate reductase activity,MF,
855,GO:0002188,0.999999999989641,0.690604523861773,0,3,translation reinitiation,BP,
1572,GO:0003983,0.999999999989641,0.901501480941457,0,1,UTP:glucose-1-phosphate uridylyltransferase activity,MF,
13143,GO:0051748,0.999999999989641,0.901501480941457,0,1,UTP-monosaccharide-1-phosphate uridylyltransferase activity,MF,
161,GO:0000333,0.999999999989654,0.845629247263883,0,2,telomerase catalytic core complex,CC,
7530,GO:0031775,0.999999999989655,0.877107417959864,0,1,lutropin-choriogonadotropic hormone receptor binding,MF,
7894,GO:0032470,0.999999999989655,0.877107417959864,0,1,positive regulation of endoplasmic reticulum calcium ion concentration,BP,
15999,GO:0086039,0.999999999989655,0.877107417959864,0,1,calcium-transporting ATPase activity involved in regulation of cardiac muscle cell membrane potential,MF,
18411,GO:1903515,0.999999999989655,0.877107417959864,0,1,calcium ion transport from cytosol to endoplasmic reticulum,BP,
19410,GO:1990036,0.999999999989655,0.877107417959864,0,1,calcium ion import into sarcoplasmic reticulum,BP,
11139,GO:0045208,0.999999999989661,0.891448983935393,0,1,MAPK phosphatase export from nucleus,BP,
11140,GO:0045209,0.999999999989661,0.891448983935393,0,1,MAPK phosphatase export from nucleus, leptomycin B sensitive,BP,
7544,GO:0031862,0.999999999989662,0.780942547443943,0,2,prostanoid receptor binding,MF,
13613,GO:0060134,0.999999999989663,0.693812431350948,0,3,prepulse inhibition,BP,
14038,GO:0060838,0.999999999989684,0.716306742508729,0,3,lymphatic endothelial cell fate commitment,BP,
2045,GO:0004794,0.999999999989685,0.915291264072443,0,1,L-threonine ammonia-lyase activity,MF,
1838,GO:0004496,0.999999999989691,0.901956111606731,0,1,mevalonate kinase activity,MF,
13427,GO:0052894,0.999999999989691,0.901956111606731,0,1,norspermine:oxygen oxidoreductase activity,MF,
13428,GO:0052895,0.999999999989691,0.901956111606731,0,1,N1-acetylspermine:oxygen oxidoreductase (N1-acetylspermidine-forming) activity,MF,
7638,GO:0032057,0.999999999989691,0.621917250680737,0,4,negative regulation of translational initiation in response to stress,BP,
17261,GO:0140031,0.999999999989692,0.80854322443141,0,2,phosphorylation-dependent protein binding,MF,
9551,GO:0036343,0.999999999989704,0.956142635184183,0,1,psychomotor behavior,BP,
9199,GO:0035596,0.999999999989725,0.807653632470329,0,2,methylthiotransferase activity,MF,
9202,GO:0035600,0.999999999989725,0.807653632470329,0,2,tRNA methylthiolation,BP,
12473,GO:0050497,0.999999999989725,0.807653632470329,0,2,transferase activity, transferring alkylthio groups,MF,
10307,GO:0043111,0.999999999989734,0.809243817944964,0,2,replication fork arrest,BP,
3465,GO:0007284,0.99999999998976,0.781000382435102,0,2,spermatogonial cell division,BP,
13571,GO:0060060,0.999999999989769,0.878502288467208,0,1,post-embryonic retina morphogenesis in camera-type eye,BP,
14825,GO:0070593,0.999999999989769,0.878502288467208,0,1,dendrite self-avoidance,BP,
16289,GO:0090480,0.999999999989781,0.707649419763124,0,3,purine nucleotide-sugar transmembrane transport,BP,
11148,GO:0045219,0.999999999989793,0.879782055702131,0,1,regulation of FasL biosynthetic process,BP,
11149,GO:0045221,0.999999999989793,0.879782055702131,0,1,negative regulation of FasL biosynthetic process,BP,
13003,GO:0051458,0.999999999989793,0.78892232540401,0,2,corticotropin secretion,BP,
13004,GO:0051459,0.999999999989793,0.78892232540401,0,2,regulation of corticotropin secretion,BP,
13005,GO:0051461,0.999999999989793,0.78892232540401,0,2,positive regulation of corticotropin secretion,BP,
1892,GO:0004577,0.999999999989793,0.833850003303695,0,2,N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase activity,MF,
2693,GO:0006059,0.999999999989794,0.755180939242452,0,3,hexitol metabolic process,BP,
299,GO:0000806,0.999999999989803,0.793024097284282,0,2,Y chromosome,CC,
19435,GO:1990131,0.999999999989822,0.748389733585045,0,3,Gtr1-Gtr2 GTPase complex,CC,
19501,GO:1990410,0.999999999989824,0.804431083789868,0,2,adrenomedullin receptor signaling pathway,BP,
7345,GO:0031394,0.999999999989829,0.807345108327971,0,2,positive regulation of prostaglandin biosynthetic process,BP,
20275,GO:2001280,0.999999999989829,0.807345108327971,0,2,positive regulation of unsaturated fatty acid biosynthetic process,BP,
14800,GO:0070557,0.99999999998983,0.826825066695987,0,2,PCNA-p21 complex,CC,
3494,GO:0007387,0.999999999989832,0.899796493028961,0,1,anterior compartment pattern formation,BP,
3495,GO:0007388,0.999999999989832,0.899796493028961,0,1,posterior compartment specification,BP,
1520,GO:0003886,0.999999999989842,0.689336082362096,0,3,DNA (cytosine-5-)-methyltransferase activity,MF,
8083,GO:0032776,0.999999999989842,0.689336082362096,0,3,DNA methylation on cytosine,BP,
16104,GO:0090116,0.999999999989842,0.689336082362096,0,3,C-5 methylation of cytosine,BP,
8387,GO:0033326,0.999999999989844,0.880603178909178,0,1,cerebrospinal fluid secretion,BP,
10762,GO:0044228,0.999999999989848,0.881190755931503,0,1,host cell surface,CC,
19384,GO:1905936,0.999999999989852,0.872416700705989,0,2,regulation of germ cell proliferation,BP,
19785,GO:2000254,0.999999999989852,0.872416700705989,0,2,regulation of male germ cell proliferation,BP,
4446,GO:0010370,0.999999999989864,0.80143307553572,0,2,perinucleolar chromocenter,CC,
17126,GO:0102420,0.999999999989864,0.638671396055533,0,4,sn-1-glycerol-3-phosphate C16:0-DCA-CoA acyl transferase activity,MF,
9200,GO:0035597,0.999999999989867,0.902341172840412,0,1,N6-isopentenyladenosine methylthiotransferase activity,MF,
14569,GO:0070138,0.999999999989869,0.700438930563488,0,3,ubiquitin-like protein-specific isopeptidase activity,MF,
14571,GO:0070140,0.999999999989869,0.700438930563488,0,3,SUMO-specific isopeptidase activity,MF,
15098,GO:0071207,0.999999999989874,0.799186673682177,0,2,histone pre-mRNA stem-loop binding,MF,
13871,GO:0060535,0.99999999998988,0.711445552541468,0,3,trachea cartilage morphogenesis,BP,
8286,GO:0033128,0.999999999989882,0.813092295710027,0,2,negative regulation of histone phosphorylation,BP,
3875,GO:0008508,0.999999999989884,0.824273304887087,0,2,bile acid:sodium symporter activity,MF,
14804,GO:0070563,0.999999999989887,0.793787023776073,0,2,negative regulation of vitamin D receptor signaling pathway,BP,
9269,GO:0035712,0.999999999989888,0.895155728870511,0,1,T-helper 2 cell activation,BP,
19959,GO:2000569,0.999999999989888,0.895155728870511,0,1,regulation of T-helper 2 cell activation,BP,
19960,GO:2000570,0.999999999989888,0.895155728870511,0,1,positive regulation of T-helper 2 cell activation,BP,
16478,GO:0097196,0.999999999989898,0.811812601245833,0,2,Shu complex,CC,
11201,GO:0045348,0.999999999989904,0.730178725265529,0,3,positive regulation of MHC class II biosynthetic process,BP,
19277,GO:1905555,0.999999999989925,0.799083708282699,0,2,positive regulation blood vessel branching,BP,
925,GO:0002322,0.999999999989925,0.779088176174878,0,2,B cell proliferation involved in immune response,BP,
16388,GO:0097037,0.999999999989928,0.893147271790064,0,1,heme export,BP,
5203,GO:0015803,0.999999999989934,0.715705156765945,0,3,branched-chain amino acid transport,BP,
3969,GO:0008781,0.999999999989936,0.834698973168391,0,2,N-acylneuraminate cytidylyltransferase activity,MF,
14028,GO:0060816,0.999999999989937,0.780197624700928,0,2,random inactivation of X chromosome,BP,
6312,GO:0019961,0.999999999989939,0.785049587935376,0,2,interferon binding,MF,
2746,GO:0006145,0.99999999998994,0.611025243986184,0,4,purine nucleobase catabolic process,BP,
5040,GO:0015222,0.999999999989944,0.797021500782912,0,2,serotonin transmembrane transporter activity,MF,
16302,GO:0090521,0.99999999998995,0.62660866872352,0,4,glomerular visceral epithelial cell migration,BP,
9000,GO:0035175,0.999999999989955,0.906799242281503,0,1,histone kinase activity (H3-S10 specific),MF,
15738,GO:0072354,0.999999999989955,0.906799242281503,0,1,histone kinase activity (H3-T3 specific),MF,
15739,GO:0072355,0.999999999989955,0.906799242281503,0,1,histone H3-T3 phosphorylation,BP,
3021,GO:0006567,0.999999999989966,0.832691067866387,0,2,threonine catabolic process,BP,
1920,GO:0004616,0.99999999998997,0.724983266416408,0,3,phosphogluconate dehydrogenase (decarboxylating) activity,MF,
5306,GO:0016015,0.999999999989977,0.817800000422591,0,2,morphogen activity,MF,
3924,GO:0008607,0.99999999998998,0.730865270094103,0,3,phosphorylase kinase regulator activity,MF,
1650,GO:0004104,0.999999999989984,0.810291405272216,0,2,cholinesterase activity,MF,
8359,GO:0033265,0.999999999989984,0.810291405272216,0,2,choline binding,MF,
14546,GO:0070097,0.999999999989987,0.774943909381302,0,2,delta-catenin binding,MF,
5109,GO:0015421,0.999999999989996,0.891862902448616,0,1,oligopeptide-transporting ATPase activity,MF,
2363,GO:0005476,0.999999999990008,0.800961071148063,0,2,carnitine:acyl carnitine antiporter activity,MF,
14748,GO:0070463,0.999999999990016,0.892648979466181,0,1,tubulin-dependent ATPase activity,MF,
12667,GO:0050904,0.999999999990023,0.789949978814629,0,2,diapedesis,BP,
2112,GO:0004900,0.999999999990045,0.904326676913326,0,1,erythropoietin receptor activity,MF,
9711,GO:0038162,0.999999999990045,0.904326676913326,0,1,erythropoietin-mediated signaling pathway,BP,
673,GO:0001884,0.999999999990058,0.791926031036892,0,2,pyrimidine nucleoside binding,MF,
833,GO:0002134,0.999999999990058,0.791926031036892,0,2,UTP binding,MF,
7944,GO:0032551,0.999999999990058,0.791926031036892,0,2,pyrimidine ribonucleoside binding,MF,
16327,GO:0090615,0.999999999990062,0.796587314151041,0,2,mitochondrial mRNA processing,BP,
4872,GO:0014735,0.999999999990073,0.802609346457416,0,2,regulation of muscle atrophy,BP,
4873,GO:0014736,0.999999999990073,0.802609346457416,0,2,negative regulation of muscle atrophy,BP,
14271,GO:0061394,0.999999999990077,0.817945615976985,0,2,regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance,BP,
11925,GO:0047006,0.999999999990082,0.915904456583214,0,1,17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity,MF,
11934,GO:0047042,0.999999999990082,0.915904456583214,0,1,androsterone dehydrogenase (B-specific) activity,MF,
12016,GO:0047718,0.999999999990082,0.915904456583214,0,1,indanol dehydrogenase activity,MF,
19219,GO:1905394,0.999999999990104,0.713165287206806,0,3,retromer complex binding,MF,
18480,GO:1903644,0.999999999990115,0.85975961242936,0,2,regulation of chaperone-mediated protein folding,BP,
3023,GO:0006569,0.999999999990117,0.743855251163943,0,3,tryptophan catabolic process,BP,
6147,GO:0019441,0.999999999990117,0.743855251163943,0,3,tryptophan catabolic process to kynurenine,BP,
9997,GO:0042436,0.999999999990117,0.743855251163943,0,3,indole-containing compound catabolic process,BP,
11589,GO:0046218,0.999999999990117,0.743855251163943,0,3,indolalkylamine catabolic process,BP,
7262,GO:0031249,0.99999999999012,0.90052003562577,0,1,denatured protein binding,MF,
17956,GO:1902380,0.99999999999012,0.90052003562577,0,1,positive regulation of endoribonuclease activity,BP,
18936,GO:1904722,0.99999999999012,0.90052003562577,0,1,positive regulation of mRNA endonucleolytic cleavage involved in unfolded protein response,BP,
17833,GO:1902044,0.999999999990121,0.794258355082863,0,2,regulation of Fas signaling pathway,BP,
17608,GO:1901340,0.999999999990125,0.884939596340528,0,1,negative regulation of store-operated calcium channel activity,BP,
16595,GO:0097457,0.999999999990133,0.77520037319525,0,2,hippocampal mossy fiber,CC,
9528,GO:0036292,0.999999999990134,0.814061184551278,0,2,DNA rewinding,BP,
9611,GO:0036488,0.999999999990148,0.84678440088327,0,2,CHOP-C/EBP complex,CC,
6956,GO:0030617,0.999999999990156,0.897210040987875,0,1,transforming growth factor beta receptor, inhibitory cytoplasmic mediator activity,MF,
11730,GO:0046587,0.999999999990158,0.897913937528709,0,1,positive regulation of calcium-dependent cell-cell adhesion,BP,
18863,GO:1904567,0.999999999990158,0.897913937528709,0,1,response to wortmannin,BP,
18864,GO:1904568,0.999999999990158,0.897913937528709,0,1,cellular response to wortmannin,BP,
19563,GO:1990646,0.999999999990158,0.897913937528709,0,1,cellular response to prolactin,BP,
14923,GO:0070836,0.999999999990159,0.727011234827979,0,3,caveola assembly,BP,
14220,GO:0061218,0.999999999990161,0.732863202641333,0,3,negative regulation of mesonephros development,BP,
16822,GO:0098749,0.99999999999017,0.881663537609404,0,1,cerebellar neuron development,BP,
1739,GO:0004340,0.999999999990172,0.694209354249324,0,3,glucokinase activity,MF,
1780,GO:0004396,0.999999999990172,0.694209354249324,0,3,hexokinase activity,MF,
3988,GO:0008865,0.999999999990172,0.694209354249324,0,3,fructokinase activity,MF,
6042,GO:0019158,0.999999999990172,0.694209354249324,0,3,mannokinase activity,MF,
4093,GO:0009149,0.999999999990173,0.837416941907766,0,2,pyrimidine nucleoside triphosphate catabolic process,BP,
4149,GO:0009213,0.999999999990173,0.837416941907766,0,2,pyrimidine deoxyribonucleoside triphosphate catabolic process,BP,
7949,GO:0032556,0.999999999990173,0.837416941907766,0,2,pyrimidine deoxyribonucleotide binding,MF,
7720,GO:0032222,0.999999999990175,0.874509559000005,0,1,regulation of synaptic transmission, cholinergic,BP,
7721,GO:0032224,0.999999999990175,0.874509559000005,0,1,positive regulation of synaptic transmission, cholinergic,BP,
4865,GO:0014719,0.99999999999019,0.743417238388418,0,3,skeletal muscle satellite cell activation,BP,
7752,GO:0032276,0.999999999990192,0.709812518837781,0,3,regulation of gonadotropin secretion,BP,
7754,GO:0032278,0.999999999990192,0.709812518837781,0,3,positive regulation of gonadotropin secretion,BP,
11856,GO:0046880,0.999999999990192,0.709812518837781,0,3,regulation of follicle-stimulating hormone secretion,BP,
11857,GO:0046881,0.999999999990192,0.709812518837781,0,3,positive regulation of follicle-stimulating hormone secretion,BP,
8850,GO:0034657,0.999999999990196,0.642559020808686,0,4,GID complex,CC,
2734,GO:0006114,0.99999999999021,0.72993461721098,0,3,glycerol biosynthetic process,BP,
6308,GO:0019957,0.999999999990212,0.810376764665425,0,2,C-C chemokine binding,MF,
17980,GO:1902463,0.999999999990214,0.835379818001215,0,2,protein localization to cell leading edge,BP,
18795,GO:1904383,0.999999999990217,0.901424377437173,0,1,response to sodium phosphate,BP,
18876,GO:1904585,0.999999999990217,0.901424377437173,0,1,response to putrescine,BP,
18877,GO:1904586,0.999999999990217,0.901424377437173,0,1,cellular response to putrescine,BP,
19616,GO:1990828,0.999999999990217,0.901424377437173,0,1,hepatocyte dedifferentiation,BP,
9320,GO:0035811,0.999999999990218,0.879299181396084,0,1,negative regulation of urine volume,BP,
9616,GO:0036494,0.999999999990222,0.879691713128019,0,1,positive regulation of translation initiation in response to endoplasmic reticulum stress,BP,
1103,GO:0002692,0.999999999990224,0.650060638005691,0,4,negative regulation of cellular extravasation,BP,
15796,GO:0072518,0.999999999990236,0.879154717218503,0,1,Rho-dependent protein serine/threonine kinase activity,MF,
17308,GO:0150031,0.999999999990236,0.879154717218503,0,1,regulation of protein localization to lysosome,BP,
17309,GO:0150033,0.999999999990236,0.879154717218503,0,1,negative regulation of protein localization to lysosome,BP,
9793,GO:0040032,0.999999999990249,0.903756823925519,0,1,post-embryonic body morphogenesis,BP,
16504,GO:0097238,0.999999999990249,0.855568232879285,0,2,cellular response to methylglyoxal,BP,
14227,GO:0061300,0.999999999990252,0.800529560600757,0,2,cerebellum vasculature development,BP,
14277,GO:0061428,0.999999999990252,0.645757927099356,0,4,negative regulation of transcription from RNA polymerase II promoter in response to hypoxia,BP,
197,GO:0000416,0.999999999990253,0.889409814230129,0,1,positive regulation of histone H3-K36 methylation,BP,
6295,GO:0019912,0.999999999990265,0.811751372500927,0,2,cyclin-dependent protein kinase activating kinase activity,MF,
6873,GO:0030375,0.99999999999027,0.693095026746714,0,3,thyroid hormone receptor coactivator activity,MF,
4163,GO:0009227,0.999999999990271,0.743059317974884,0,3,nucleotide-sugar catabolic process,BP,
3917,GO:0008591,0.999999999990302,0.905071163309743,0,1,regulation of Wnt signaling pathway, calcium modulating pathway,BP,
10114,GO:0042662,0.999999999990302,0.905071163309743,0,1,negative regulation of mesodermal cell fate specification,BP,
11392,GO:0045813,0.999999999990302,0.905071163309743,0,1,positive regulation of Wnt signaling pathway, calcium modulating pathway,BP,
14414,GO:0061743,0.999999999990302,0.905071163309743,0,1,motor learning,BP,
16079,GO:0090081,0.999999999990302,0.905071163309743,0,1,regulation of heart induction by regulation of canonical Wnt signaling pathway,BP,
16080,GO:0090082,0.999999999990302,0.905071163309743,0,1,positive regulation of heart induction by negative regulation of canonical Wnt signaling pathway,BP,
16266,GO:0090381,0.999999999990302,0.905071163309743,0,1,regulation of heart induction,BP,
16894,GO:0098883,0.999999999990302,0.905071163309743,0,1,synapse disassembly,BP,
17086,GO:0100012,0.999999999990302,0.905071163309743,0,1,regulation of heart induction by canonical Wnt signaling pathway,BP,
17588,GO:1901296,0.999999999990302,0.905071163309743,0,1,negative regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,BP,
17601,GO:1901321,0.999999999990302,0.905071163309743,0,1,positive regulation of heart induction,BP,
18922,GO:1904701,0.999999999990302,0.905071163309743,0,1,Wnt-Frizzled-LRP5/6 complex assembly,BP,
18927,GO:1904711,0.999999999990302,0.905071163309743,0,1,regulation of Wnt-Frizzled-LRP5/6 complex assembly,BP,
18937,GO:1904723,0.999999999990302,0.905071163309743,0,1,negative regulation of Wnt-Frizzled-LRP5/6 complex assembly,BP,
19102,GO:1905067,0.999999999990302,0.905071163309743,0,1,negative regulation of canonical Wnt signaling pathway involved in heart development,BP,
19336,GO:1905771,0.999999999990302,0.905071163309743,0,1,negative regulation of mesodermal cell differentiation,BP,
19374,GO:1905903,0.999999999990302,0.905071163309743,0,1,negative regulation of mesoderm formation,BP,
16930,GO:0098939,0.999999999990319,0.879067349227164,0,1,dendritic transport of mitochondrion,BP,
16941,GO:0098972,0.999999999990319,0.879067349227164,0,1,anterograde dendritic transport of mitochondrion,BP,
6447,GO:0021771,0.999999999990326,0.879620545358658,0,1,lateral geniculate nucleus development,BP,
9941,GO:0042320,0.999999999990326,0.879620545358658,0,1,regulation of circadian sleep/wake cycle, REM sleep,BP,
13591,GO:0060084,0.999999999990326,0.879620545358658,0,1,synaptic transmission involved in micturition,BP,
493,GO:0001546,0.99999999999033,0.908099191024512,0,1,preantral ovarian follicle growth,BP,
1684,GO:0004155,0.99999999999033,0.908099191024512,0,1,6,7-dihydropteridine reductase activity,MF,
12096,GO:0048162,0.99999999999033,0.908099191024512,0,1,multi-layer follicle stage,BP,
17719,GO:1901675,0.99999999999033,0.878931630698336,0,1,negative regulation of histone H3-K27 acetylation,BP,
19659,GO:1990983,0.999999999990333,0.900168282337144,0,1,tRNA demethylation,BP,
19660,GO:1990984,0.999999999990333,0.900168282337144,0,1,tRNA demethylase activity,MF,
3010,GO:0006556,0.999999999990335,0.811040081991201,0,2,S-adenosylmethionine biosynthetic process,BP,
12144,GO:0048269,0.999999999990335,0.811040081991201,0,2,methionine adenosyltransferase complex,CC,
5267,GO:0015917,0.999999999990336,0.601562953181094,0,4,aminophospholipid transport,BP,
15612,GO:0072131,0.999999999990339,0.699135543081302,0,3,kidney mesenchyme morphogenesis,BP,
15614,GO:0072133,0.999999999990339,0.699135543081302,0,3,metanephric mesenchyme morphogenesis,BP,
14400,GO:0061723,0.999999999990341,0.791449415099554,0,2,glycophagy,BP,
18105,GO:1902816,0.999999999990342,0.638779938121506,0,4,regulation of protein localization to microtubule,BP,
18106,GO:1902817,0.999999999990342,0.638779938121506,0,4,negative regulation of protein localization to microtubule,BP,
18163,GO:1902954,0.999999999990351,0.765407868187327,0,2,regulation of early endosome to recycling endosome transport,BP,
16196,GO:0090259,0.99999999999037,0.707159964817646,0,3,regulation of retinal ganglion cell axon guidance,BP,
18719,GO:1904210,0.999999999990371,0.915767120296967,0,1,VCP-NPL4-UFD1 AAA ATPase complex assembly,BP,
18736,GO:1904239,0.999999999990371,0.915767120296967,0,1,regulation of VCP-NPL4-UFD1 AAA ATPase complex assembly,BP,
18737,GO:1904240,0.999999999990371,0.915767120296967,0,1,negative regulation of VCP-NPL4-UFD1 AAA ATPase complex assembly,BP,
14680,GO:0070327,0.999999999990387,0.699156408739021,0,3,thyroid hormone transport,BP,
18371,GO:1903416,0.999999999990396,0.724205550227085,0,3,response to glycoside,BP,
3437,GO:0007228,0.999999999990405,0.782992093261386,0,2,positive regulation of hh target transcription factor activity,BP,
1514,GO:0003877,0.999999999990414,0.901703090323607,0,1,ATP adenylyltransferase activity,MF,
2069,GO:0004824,0.999999999990414,0.901703090323607,0,1,lysine-tRNA ligase activity,MF,
2919,GO:0006430,0.999999999990414,0.901703090323607,0,1,lysyl-tRNA aminoacylation,BP,
15443,GO:0071802,0.999999999990431,0.884370899693746,0,1,negative regulation of podosome assembly,BP,
16011,GO:0086056,0.999999999990431,0.884370899693746,0,1,voltage-gated calcium channel activity involved in AV node cell action potential,MF,
16913,GO:0098912,0.999999999990431,0.884370899693746,0,1,membrane depolarization during atrial cardiac muscle cell action potential,BP,
14342,GO:0061582,0.999999999990434,0.778140695943324,0,2,intestinal epithelial cell migration,BP,
8863,GO:0034680,0.99999999999044,0.782302806257251,0,2,integrin alpha10-beta1 complex,CC,
15933,GO:0075519,0.999999999990446,0.947322101499003,0,1,microtubule-dependent intracellular transport of viral material,BP,
15934,GO:0075521,0.999999999990446,0.947322101499003,0,1,microtubule-dependent intracellular transport of viral material towards nucleus,BP,
15938,GO:0075606,0.999999999990446,0.947322101499003,0,1,transport of viral material towards nucleus,BP,
16411,GO:0097070,0.999999999990446,0.87959178308035,0,1,ductus arteriosus closure,BP,
16512,GO:0097272,0.999999999990446,0.87959178308035,0,1,ammonia homeostasis,BP,
16513,GO:0097273,0.999999999990446,0.87959178308035,0,1,creatinine homeostasis,BP,
16515,GO:0097275,0.999999999990446,0.87959178308035,0,1,cellular ammonia homeostasis,BP,
16516,GO:0097276,0.999999999990446,0.87959178308035,0,1,cellular creatinine homeostasis,BP,
16517,GO:0097277,0.999999999990446,0.87959178308035,0,1,cellular urea homeostasis,BP,
3618,GO:0008066,0.999999999990451,0.600006263878122,0,4,glutamate receptor activity,MF,
5977,GO:0018738,0.99999999999046,0.922939824740837,0,1,S-formylglutathione hydrolase activity,MF,
15368,GO:0071638,0.999999999990464,0.823881474456964,0,2,negative regulation of monocyte chemotactic protein-1 production,BP,
17648,GO:1901529,0.999999999990468,0.795330204280846,0,2,positive regulation of anion channel activity,BP,
14763,GO:0070489,0.999999999990483,0.886457324141577,0,1,T cell aggregation,BP,
12424,GO:0050115,0.999999999990484,0.880700758426963,0,1,myosin-light-chain-phosphatase activity,MF,
4055,GO:0009106,0.999999999990506,0.808795586123968,0,2,lipoate metabolic process,BP,
7134,GO:0030981,0.999999999990508,0.693792865875568,0,3,cortical microtubule cytoskeleton,CC,
12412,GO:0048880,0.999999999990517,0.791494114648415,0,2,sensory system development,BP,
14421,GO:0061757,0.999999999990524,0.898565523418063,0,1,leukocyte adhesion to arterial endothelial cell,BP,
19072,GO:1904997,0.999999999990524,0.898565523418063,0,1,regulation of leukocyte adhesion to arterial endothelial cell,BP,
19073,GO:1904998,0.999999999990524,0.898565523418063,0,1,negative regulation of leukocyte adhesion to arterial endothelial cell,BP,
16007,GO:0086048,0.999999999990531,0.786142380545198,0,2,membrane depolarization during bundle of His cell action potential,BP,
11310,GO:0045650,0.999999999990537,0.817455165688372,0,2,negative regulation of macrophage differentiation,BP,
13475,GO:0055059,0.99999999999054,0.620022926712751,0,4,asymmetric neuroblast division,BP,
13612,GO:0060129,0.999999999990546,0.795494166625006,0,2,thyroid-stimulating hormone-secreting cell differentiation,BP,
518,GO:0001595,0.999999999990553,0.923518682156344,0,1,angiotensin receptor activity,MF,
2134,GO:0004945,0.999999999990553,0.923518682156344,0,1,angiotensin type II receptor activity,MF,
3118,GO:0006696,0.999999999990562,0.812919771629286,0,2,ergosterol biosynthetic process,BP,
3697,GO:0008204,0.999999999990562,0.812919771629286,0,2,ergosterol metabolic process,BP,
6328,GO:0021501,0.999999999990568,0.901866883097518,0,1,prechordal plate formation,BP,
6361,GO:0021547,0.999999999990568,0.901866883097518,0,1,midbrain-hindbrain boundary initiation,BP,
20064,GO:2000742,0.999999999990568,0.901866883097518,0,1,regulation of anterior head development,BP,
20065,GO:2000744,0.999999999990568,0.901866883097518,0,1,positive regulation of anterior head development,BP,
1899,GO:0004586,0.999999999990574,0.716436421105756,0,3,ornithine decarboxylase activity,MF,
8402,GO:0033387,0.999999999990574,0.716436421105756,0,3,putrescine biosynthetic process from ornithine,BP,
9405,GO:0035983,0.999999999990582,0.721588555359621,0,3,response to trichostatin A,BP,
9406,GO:0035984,0.999999999990582,0.721588555359621,0,3,cellular response to trichostatin A,BP,
267,GO:0000738,0.999999999990585,0.661809270734281,0,4,DNA catabolic process, exonucleolytic,BP,
4223,GO:0009400,0.999999999990602,0.899148786724424,0,1,signal transducer, downstream of receptor, with serine/threonine phosphatase activity,MF,
8709,GO:0034366,0.999999999990602,0.899148786724424,0,1,spherical high-density lipoprotein particle,CC,
18112,GO:1902847,0.999999999990602,0.899148786724424,0,1,regulation of neuronal signal transduction,BP,
18188,GO:1902998,0.999999999990602,0.899148786724424,0,1,positive regulation of neurofibrillary tangle assembly,BP,
19367,GO:1905891,0.999999999990602,0.899148786724424,0,1,regulation of cellular response to thapsigargin,BP,
19368,GO:1905892,0.999999999990602,0.899148786724424,0,1,negative regulation of cellular response to thapsigargin,BP,
19369,GO:1905894,0.999999999990602,0.899148786724424,0,1,regulation of cellular response to tunicamycin,BP,
19370,GO:1905895,0.999999999990602,0.899148786724424,0,1,negative regulation of cellular response to tunicamycin,BP,
16488,GO:0097210,0.999999999990612,0.792859192759227,0,2,response to gonadotropin-releasing hormone,BP,
16489,GO:0097211,0.999999999990612,0.792859192759227,0,2,cellular response to gonadotropin-releasing hormone,BP,
1952,GO:0004658,0.999999999990615,0.81463265377192,0,2,propionyl-CoA carboxylase activity,MF,
5944,GO:0018282,0.999999999990616,0.791159263896275,0,2,metal incorporation into metallo-sulfur cluster,BP,
5945,GO:0018283,0.999999999990616,0.791159263896275,0,2,iron incorporation into metallo-sulfur cluster,BP,
492,GO:0001545,0.999999999990624,0.885647884314767,0,1,primary ovarian follicle growth,BP,
15214,GO:0071393,0.999999999990624,0.885647884314767,0,1,cellular response to progesterone stimulus,BP,
8562,GO:0034040,0.999999999990625,0.702019013637771,0,3,lipid-transporting ATPase activity,MF,
8329,GO:0033186,0.999999999990628,0.706885602067333,0,3,CAF-1 complex,CC,
5961,GO:0018364,0.999999999990635,0.881585902019966,0,2,peptidyl-glutamine methylation,BP,
13978,GO:0060715,0.999999999990649,0.713570138081508,0,3,syncytiotrophoblast cell differentiation involved in labyrinthine layer development,BP,
5447,GO:0016321,0.99999999999066,0.728558752851232,0,3,female meiosis chromosome segregation,BP,
5446,GO:0016320,0.999999999990667,0.807005151099483,0,2,endoplasmic reticulum membrane fusion,BP,
1500,GO:0003854,0.99999999999067,0.737224974751284,0,3,3-beta-hydroxy-delta5-steroid dehydrogenase activity,MF,
4011,GO:0009007,0.999999999990673,0.890044589470596,0,1,site-specific DNA-methyltransferase (adenine-specific) activity,MF,
8082,GO:0032775,0.999999999990673,0.890044589470596,0,1,DNA methylation on adenine,BP,
19516,GO:1990442,0.999999999990686,0.79713508651,0,3,intrinsic apoptotic signaling pathway in response to nitrosative stress,BP,
17763,GO:1901856,0.99999999999069,0.807428971759301,0,2,negative regulation of cellular respiration,BP,
2007,GO:0004735,0.999999999990699,0.819853475085106,0,2,pyrroline-5-carboxylate reductase activity,MF,
19502,GO:1990414,0.9999999999907,0.631527981058534,0,4,replication-born double-strand break repair via sister chromatid exchange,BP,
9034,GO:0035261,0.999999999990727,0.763367026891977,0,2,external genitalia morphogenesis,BP,
4950,GO:0015015,0.999999999990731,0.624420889584154,0,4,heparan sulfate proteoglycan biosynthetic process, enzymatic modification,BP,
16057,GO:0090038,0.999999999990736,0.795752123156291,0,2,negative regulation of protein kinase C signaling,BP,
17455,GO:1900370,0.999999999990755,0.879832262268734,0,1,positive regulation of RNA interference,BP,
1567,GO:0003976,0.999999999990763,0.730166357692447,0,3,UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity,MF,
8872,GO:0034696,0.999999999990798,0.811740856504554,0,2,response to prostaglandin F,BP,
11433,GO:0045900,0.999999999990799,0.638421569162739,0,4,negative regulation of translational elongation,BP,
14523,GO:0070060,0.999999999990804,0.875665438645406,0,1,'de novo' actin filament nucleation,BP,
6860,GO:0030337,0.999999999990813,0.824663777880927,0,2,DNA polymerase processivity factor activity,MF,
13111,GO:0051686,0.999999999990815,0.868483448984534,0,1,establishment of ER localization,BP,
16981,GO:0099089,0.999999999990815,0.868483448984534,0,1,establishment of endoplasmic reticulum localization to postsynapse,BP,
10093,GO:0042624,0.999999999990821,0.947709501766209,0,1,ATPase activity, uncoupled,MF,
13986,GO:0060729,0.999999999990821,0.720970150929796,0,3,intestinal epithelial structure maintenance,BP,
11372,GO:0045764,0.999999999990828,0.842243414155871,0,2,positive regulation of cellular amino acid metabolic process,BP,
10614,GO:0043626,0.999999999990836,0.91747310804263,0,1,PCNA complex,CC,
10983,GO:0044796,0.999999999990836,0.91747310804263,0,1,DNA polymerase processivity factor complex,CC,
16451,GO:0097154,0.999999999990838,0.679424934645756,0,4,GABAergic neuron differentiation,BP,
338,GO:0000939,0.999999999990841,0.741594930182629,0,3,condensed chromosome inner kinetochore,CC,
12389,GO:0048850,0.999999999990853,0.773292696210785,0,2,hypophysis morphogenesis,BP,
7218,GO:0031120,0.999999999990858,0.743223860777409,0,4,snRNA pseudouridine synthesis,BP,
15954,GO:0080121,0.999999999990861,0.807877819701857,0,2,AMP transport,BP,
18847,GO:1904527,0.999999999990863,0.710090176752247,0,3,negative regulation of microtubule binding,BP,
2004,GO:0004730,0.999999999990881,0.907731270945468,0,1,pseudouridylate synthase activity,MF,
14969,GO:0070902,0.999999999990881,0.907731270945468,0,1,mitochondrial tRNA pseudouridine synthesis,BP,
12455,GO:0050353,0.999999999990882,0.899074440709521,0,1,trimethyllysine dioxygenase activity,MF,
10118,GO:0042668,0.999999999990913,0.839346575179299,0,2,auditory receptor cell fate determination,BP,
20141,GO:2000978,0.999999999990913,0.839346575179299,0,2,negative regulation of forebrain neuron differentiation,BP,
16452,GO:0097155,0.999999999990914,0.766408141138867,0,2,fasciculation of sensory neuron axon,BP,
754,GO:0001996,0.999999999990915,0.71577767351469,0,3,positive regulation of heart rate by epinephrine-norepinephrine,BP,
1395,GO:0003321,0.999999999990915,0.71577767351469,0,3,positive regulation of blood pressure by epinephrine-norepinephrine,BP,
8490,GO:0033679,0.999999999990937,0.881649910301911,0,1,3'-5' DNA/RNA helicase activity,MF,
8492,GO:0033681,0.999999999990937,0.881649910301911,0,1,ATP-dependent 3'-5' DNA/RNA helicase activity,MF,
8770,GO:0034459,0.999999999990937,0.881649910301911,0,1,ATP-dependent 3'-5' RNA helicase activity,MF,
9771,GO:0039695,0.999999999990937,0.881649910301911,0,1,DNA-templated viral transcription,BP,
19058,GO:1904971,0.999999999990937,0.881649910301911,0,1,regulation of viral translation,BP,
19059,GO:1904973,0.999999999990937,0.881649910301911,0,1,positive regulation of viral translation,BP,
19137,GO:1905172,0.999999999990937,0.881649910301911,0,1,RISC complex binding,MF,
19322,GO:1905698,0.999999999990937,0.881649910301911,0,1,positive regulation of polysome binding,BP,
19532,GO:1990518,0.999999999990937,0.881649910301911,0,1,single-stranded DNA-dependent ATP-dependent 3'-5' DNA helicase activity,MF,
16649,GO:0097574,0.999999999990939,0.788490931807714,0,2,lateral part of cell,CC,
16650,GO:0097575,0.999999999990939,0.788490931807714,0,2,lateral cell cortex,CC,
1310,GO:0003160,0.999999999990943,0.644155175507815,0,4,endocardium morphogenesis,BP,
18833,GO:1904475,0.99999999999096,0.772762159643344,0,2,regulation of Ras GTPase binding,BP,
20184,GO:2001106,0.99999999999096,0.772762159643344,0,2,regulation of Rho guanyl-nucleotide exchange factor activity,BP,
1270,GO:0003064,0.999999999990976,0.904444228767748,0,1,regulation of heart rate by hormone,BP,
19378,GO:1905912,0.999999999990976,0.904444228767748,0,1,regulation of calcium ion export across plasma membrane,BP,
19379,GO:1905913,0.999999999990976,0.904444228767748,0,1,negative regulation of calcium ion export across plasma membrane,BP,
17399,GO:1900165,0.999999999990989,0.71286493720573,0,3,negative regulation of interleukin-6 secretion,BP,
6223,GO:0019777,0.999999999991025,0.829379930200444,0,2,Atg12 transferase activity,MF,
5865,GO:0017177,0.99999999999103,0.887245818804101,0,1,glucosidase II complex,CC,
8541,GO:0033919,0.99999999999103,0.887245818804101,0,1,glucan 1,3-alpha-glucosidase activity,MF,
16324,GO:0090600,0.99999999999103,0.887245818804101,0,1,alpha-1,3-glucosidase activity,MF,
19213,GO:1905371,0.999999999991033,0.80199427911401,0,2,ceramide phosphoethanolamine metabolic process,BP,
19214,GO:1905373,0.999999999991033,0.80199427911401,0,2,ceramide phosphoethanolamine biosynthetic process,BP,
11065,GO:0045079,0.999999999991033,0.907551580441908,0,1,negative regulation of chemokine biosynthetic process,BP,
14757,GO:0070481,0.999999999991044,0.898677766195386,0,1,nuclear-transcribed mRNA catabolic process, non-stop decay,BP,
14851,GO:0070651,0.999999999991044,0.898677766195386,0,1,nonfunctional rRNA decay,BP,
8468,GO:0033625,0.999999999991045,0.796055611610878,0,2,positive regulation of integrin activation,BP,
17934,GO:1902308,0.999999999991045,0.717443150695549,0,3,regulation of peptidyl-serine dephosphorylation,BP,
1189,GO:0002836,0.999999999991073,0.713106596719071,0,3,positive regulation of response to tumor cell,BP,
1192,GO:0002839,0.999999999991073,0.713106596719071,0,3,positive regulation of immune response to tumor cell,BP,
576,GO:0001729,0.999999999991079,0.792992023382353,0,2,ceramide kinase activity,MF,
6483,GO:0021840,0.999999999991084,0.900616049961642,0,1,directional guidance of interneurons involved in migration from the subpallium to the cortex,BP,
6484,GO:0021842,0.999999999991084,0.900616049961642,0,1,chemorepulsion involved in interneuron migration from the subpallium to the cortex,BP,
14487,GO:0065001,0.999999999991096,0.773431837858302,0,2,specification of axis polarity,BP,
19611,GO:1990812,0.999999999991098,0.709408607339723,0,3,growth cone filopodium,CC,
15279,GO:0071486,0.999999999991101,0.879955064745508,0,1,cellular response to high light intensity,BP,
16602,GO:0097473,0.999999999991101,0.879955064745508,0,1,retinal rod cell apoptotic process,BP,
19403,GO:1990009,0.999999999991101,0.879955064745508,0,1,retinal cell apoptotic process,BP,
18001,GO:1902524,0.999999999991105,0.811570372543345,0,2,positive regulation of protein K48-linked ubiquitination,BP,
7910,GO:0032493,0.999999999991121,0.711594094036248,0,3,response to bacterial lipoprotein,BP,
14687,GO:0070339,0.999999999991121,0.711594094036248,0,3,response to bacterial lipopeptide,BP,
15107,GO:0071220,0.999999999991121,0.711594094036248,0,3,cellular response to bacterial lipoprotein,BP,
15108,GO:0071221,0.999999999991121,0.711594094036248,0,3,cellular response to bacterial lipopeptide,BP,
6543,GO:0021966,0.999999999991131,0.880452265840034,0,1,corticospinal neuron axon guidance,BP,
6544,GO:0021972,0.999999999991131,0.880452265840034,0,1,corticospinal neuron axon guidance through spinal cord,BP,
12686,GO:0050924,0.999999999991131,0.880452265840034,0,1,positive regulation of negative chemotaxis,BP,
12691,GO:0050929,0.999999999991131,0.880452265840034,0,1,induction of negative chemotaxis,BP,
15358,GO:0071623,0.999999999991131,0.880452265840034,0,1,negative regulation of granulocyte chemotaxis,BP,
16046,GO:0090024,0.999999999991131,0.880452265840034,0,1,negative regulation of neutrophil chemotaxis,BP,
16197,GO:0090260,0.999999999991131,0.880452265840034,0,1,negative regulation of retinal ganglion cell axon guidance,BP,
18043,GO:1902623,0.999999999991131,0.880452265840034,0,1,negative regulation of neutrophil migration,BP,
9766,GO:0039656,0.999999999991135,0.812306529999495,0,2,modulation by virus of host gene expression,BP,
11817,GO:0046778,0.999999999991135,0.812306529999495,0,2,modification by virus of host mRNA processing,BP,
3851,GO:0008467,0.999999999991138,0.735777392659771,0,3,[heparan sulfate]-glucosamine 3-sulfotransferase 1 activity,MF,
9520,GO:0036261,0.999999999991139,0.889776917780211,0,1,7-methylguanosine cap hypermethylation,BP,
15089,GO:0071164,0.999999999991139,0.889776917780211,0,1,RNA trimethylguanosine synthase activity,MF,
4631,GO:0010756,0.99999999999115,0.733627231200304,0,3,positive regulation of plasminogen activation,BP,
10970,GO:0044778,0.999999999991158,0.811609214402238,0,2,meiotic DNA integrity checkpoint,BP,
14376,GO:0061649,0.999999999991164,0.698853153676325,0,3,ubiquitin modification-dependent histone binding,MF,
16951,GO:0098989,0.999999999991166,0.801035597242747,0,2,NMDA selective glutamate receptor signaling pathway,BP,
19549,GO:1990590,0.999999999991174,0.81641206576933,0,2,ATF1-ATF4 transcription factor complex,CC,
9709,GO:0038158,0.999999999991178,0.810588277715736,0,2,granulocyte colony-stimulating factor signaling pathway,BP,
778,GO:0002037,0.999999999991188,0.901618845655021,0,1,negative regulation of L-glutamate import across plasma membrane,BP,
8380,GO:0033301,0.999999999991188,0.88948549887986,0,1,cell cycle comprising mitosis without cytokinesis,BP,
1962,GO:0004673,0.999999999991196,0.945401752084733,0,1,protein histidine kinase activity,MF,
5897,GO:0018106,0.999999999991196,0.945401752084733,0,1,peptidyl-histidine phosphorylation,BP,
19066,GO:1904983,0.999999999991203,0.901606715118396,0,1,glycine import into mitochondrion,BP,
11868,GO:0046899,0.999999999991211,0.808976736804396,0,2,nucleoside triphosphate adenylate kinase activity,MF,
4831,GO:0014040,0.999999999991215,0.786216481460231,0,2,positive regulation of Schwann cell differentiation,BP,
12145,GO:0048270,0.999999999991217,0.901870377234474,0,1,methionine adenosyltransferase regulator activity,MF,
14829,GO:0070611,0.999999999991223,0.900036182133169,0,1,histone methyltransferase activity (H3-R2 specific),MF,
14830,GO:0070612,0.999999999991223,0.900036182133169,0,1,histone methyltransferase activity (H2A-R3 specific),MF,
7416,GO:0031523,0.999999999991232,0.788771522401753,0,2,Myb complex,CC,
1754,GO:0004359,0.999999999991234,0.71577988434187,0,3,glutaminase activity,MF,
14644,GO:0070267,0.999999999991236,0.891190255615611,0,1,oncosis,BP,
8434,GO:0033566,0.999999999991242,0.80943229769962,0,2,gamma-tubulin complex localization,BP,
15071,GO:0071105,0.999999999991245,0.881023145661524,0,1,response to interleukin-11,BP,
15180,GO:0071348,0.999999999991245,0.881023145661524,0,1,cellular response to interleukin-11,BP,
9562,GO:0036374,0.999999999991269,0.729662474813562,0,3,glutathione hydrolase activity,MF,
17154,GO:0102953,0.999999999991269,0.729662474813562,0,3,hypoglycin A gamma-glutamyl transpeptidase activity,MF,
17163,GO:0103068,0.999999999991269,0.729662474813562,0,3,leukotriene C4 gamma-glutamyl transferase activity,MF,
17744,GO:1901748,0.999999999991269,0.729662474813562,0,3,leukotriene D4 metabolic process,BP,
17745,GO:1901750,0.999999999991269,0.729662474813562,0,3,leukotriene D4 biosynthetic process,BP,
2781,GO:0006212,0.999999999991271,0.896794251566786,0,1,uracil catabolic process,BP,
2783,GO:0006214,0.999999999991271,0.896794251566786,0,1,thymidine catabolic process,BP,
4421,GO:0010232,0.999999999991271,0.896794251566786,0,1,vascular transport,BP,
5830,GO:0017113,0.999999999991271,0.896794251566786,0,1,dihydropyrimidine dehydrogenase (NADP+) activity,MF,
6155,GO:0019483,0.999999999991271,0.896794251566786,0,1,beta-alanine biosynthetic process,BP,
11557,GO:0046127,0.999999999991271,0.896794251566786,0,1,pyrimidine deoxyribonucleoside catabolic process,BP,
13627,GO:0060156,0.999999999991271,0.896794251566786,0,1,milk ejection reflex,BP,
18348,GO:1903367,0.999999999991271,0.896794251566786,0,1,positive regulation of fear response,BP,
20147,GO:2000987,0.999999999991271,0.896794251566786,0,1,positive regulation of behavioral fear response,BP,
1810,GO:0004462,0.999999999991278,0.902174654214783,0,1,lactoylglutathione lyase activity,MF,
320,GO:0000839,0.999999999991318,0.717174587659619,0,3,Hrd1p ubiquitin ligase ERAD-L complex,CC,
8638,GO:0034191,0.999999999991321,0.712592027142547,0,3,apolipoprotein A-I receptor binding,MF,
16874,GO:0098840,0.999999999991331,0.842036800787061,0,2,protein transport along microtubule,BP,
16989,GO:0099118,0.999999999991331,0.842036800787061,0,2,microtubule-based protein transport,BP,
17614,GO:1901355,0.999999999991335,0.792354115206612,0,2,response to rapamycin,BP,
3743,GO:0008282,0.999999999991335,0.790783238900398,0,2,inward rectifying potassium channel,CC,
18432,GO:1903542,0.999999999991335,0.805398348278368,0,2,negative regulation of exosomal secretion,BP,
618,GO:0001792,0.999999999991336,0.883713812755753,0,1,polymeric immunoglobulin receptor activity,MF,
15886,GO:0072679,0.999999999991337,0.801774228579715,0,2,thymocyte migration,BP,
14397,GO:0061711,0.999999999991339,0.820261880752052,0,2,N(6)-L-threonylcarbamoyladenine synthase activity,MF,
1002,GO:0002476,0.999999999991344,0.803934888989046,0,2,antigen processing and presentation of endogenous peptide antigen via MHC class Ib,BP,
17199,GO:0106088,0.999999999991346,0.878767513946091,0,1,regulation of cell adhesion involved in sprouting angiogenesis,BP,
17200,GO:0106089,0.999999999991346,0.878767513946091,0,1,negative regulation of cell adhesion involved in sprouting angiogenesis,BP,
17246,GO:0120077,0.999999999991346,0.878767513946091,0,1,angiogenic sprout fusion,BP,
17247,GO:0120078,0.999999999991346,0.878767513946091,0,1,cell adhesion involved in sprouting angiogenesis,BP,
3848,GO:0008460,0.999999999991355,0.903560555732102,0,1,dTDP-glucose 4,6-dehydratase activity,MF,
17340,GO:1900062,0.999999999991386,0.889548680431541,0,1,regulation of replicative cell aging,BP,
9494,GO:0036153,0.999999999991387,0.899360483475193,0,1,triglyceride acyl-chain remodeling,BP,
12897,GO:0051264,0.999999999991387,0.899360483475193,0,1,mono-olein transacylation activity,MF,
12898,GO:0051265,0.999999999991387,0.899360483475193,0,1,diolein transacylation activity,MF,
15363,GO:0071633,0.999999999991387,0.899105749902143,0,1,dihydroceramidase activity,MF,
2145,GO:0004962,0.999999999991411,0.88821106228611,0,1,endothelin receptor activity,MF,
16035,GO:0086100,0.999999999991411,0.88821106228611,0,1,endothelin receptor signaling pathway,BP,
16262,GO:0090362,0.999999999991421,0.795585442904793,0,2,positive regulation of platelet-derived growth factor production,BP,
11951,GO:0047186,0.999999999991423,0.887429957420827,0,1,N-acetylneuraminate 7-O(or 9-O)-acetyltransferase activity,MF,
4999,GO:0015143,0.999999999991427,0.90408525499006,0,1,urate transmembrane transporter activity,MF,
5182,GO:0015747,0.999999999991427,0.90408525499006,0,1,urate transport,BP,
15774,GO:0072428,0.999999999991427,0.90408525499006,0,1,signal transduction involved in intra-S DNA damage checkpoint,BP,
17732,GO:1901702,0.999999999991427,0.90408525499006,0,1,salt transmembrane transporter activity,MF,
18611,GO:1903925,0.999999999991427,0.90408525499006,0,1,response to bisphenol A,BP,
18612,GO:1903926,0.999999999991427,0.90408525499006,0,1,cellular response to bisphenol A,BP,
12718,GO:0051001,0.999999999991428,0.668506093189734,0,4,negative regulation of nitric-oxide synthase activity,BP,
1822,GO:0004477,0.999999999991443,0.645306774094073,0,4,methenyltetrahydrofolate cyclohydrolase activity,MF,
1831,GO:0004488,0.999999999991443,0.645306774094073,0,4,methylenetetrahydrofolate dehydrogenase (NADP+) activity,MF,
13992,GO:0060735,0.999999999991448,0.916459882835711,0,1,regulation of eIF2 alpha phosphorylation by dsRNA,BP,
18046,GO:1902629,0.999999999991448,0.916459882835711,0,1,regulation of mRNA stability involved in cellular response to UV,BP,
16638,GO:0097534,0.999999999991457,0.78991460292283,0,2,lymphoid lineage cell migration,BP,
16639,GO:0097535,0.999999999991457,0.78991460292283,0,2,lymphoid lineage cell migration into thymus,BP,
619,GO:0001794,0.99999999999146,0.880146302379475,0,1,type IIa hypersensitivity,BP,
620,GO:0001796,0.99999999999146,0.880146302379475,0,1,regulation of type IIa hypersensitivity,BP,
621,GO:0001798,0.99999999999146,0.880146302379475,0,1,positive regulation of type IIa hypersensitivity,BP,
738,GO:0001970,0.99999999999146,0.880146302379475,0,1,positive regulation of activation of membrane attack complex,BP,
988,GO:0002445,0.99999999999146,0.880146302379475,0,1,type II hypersensitivity,BP,
1221,GO:0002892,0.99999999999146,0.880146302379475,0,1,regulation of type II hypersensitivity,BP,
1222,GO:0002894,0.99999999999146,0.880146302379475,0,1,positive regulation of type II hypersensitivity,BP,
7514,GO:0031714,0.99999999999146,0.880146302379475,0,1,C5a anaphylatoxin chemotactic receptor binding,MF,
7515,GO:0031715,0.99999999999146,0.880146302379475,0,1,C5L2 anaphylatoxin chemotactic receptor binding,MF,
19445,GO:1990168,0.999999999991467,0.70247249928163,0,3,protein K33-linked deubiquitination,BP,
9467,GO:0036112,0.999999999991467,0.819978316629441,0,2,medium-chain fatty-acyl-CoA metabolic process,BP,
6343,GO:0021523,0.999999999991477,0.815968763949499,0,2,somatic motor neuron differentiation,BP,
7724,GO:0032227,0.999999999991478,0.697547384276262,0,3,negative regulation of synaptic transmission, dopaminergic,BP,
15011,GO:0070975,0.999999999991479,0.878238645162105,0,1,FHA domain binding,MF,
8521,GO:0033829,0.999999999991486,0.735410637406093,0,3,O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity,MF,
2255,GO:0005170,0.99999999999149,0.8798854939946,0,1,neurotrophin TRKC receptor binding,MF,
3491,GO:0007371,0.999999999991502,0.889221273731587,0,1,ventral midline determination,BP,
13673,GO:0060245,0.999999999991502,0.889221273731587,0,1,detection of cell density,BP,
13674,GO:0060246,0.999999999991502,0.889221273731587,0,1,detection of cell density by contact stimulus,BP,
13675,GO:0060248,0.999999999991502,0.889221273731587,0,1,detection of cell density by contact stimulus involved in contact inhibition,BP,
15553,GO:0072036,0.999999999991502,0.889221273731587,0,1,mesenchymal to epithelial transition involved in renal vesicle formation,BP,
15701,GO:0072285,0.999999999991502,0.889221273731587,0,1,mesenchymal to epithelial transition involved in metanephric renal vesicle formation,BP,
7635,GO:0032053,0.999999999991502,0.790023865581107,0,2,ciliary basal body organization,BP,
1679,GO:0004146,0.999999999991515,0.823489684163716,0,2,dihydrofolate reductase activity,MF,
9211,GO:0035609,0.999999999991518,0.882633584671167,0,1,C-terminal protein deglutamylation,BP,
9212,GO:0035610,0.999999999991518,0.882633584671167,0,1,protein side chain deglutamylation,BP,
657,GO:0001849,0.999999999991524,0.835051433975334,0,2,complement component C1q binding,MF,
18699,GO:1904167,0.999999999991544,0.872919026258736,0,1,regulation of thyroid hormone receptor activity,BP,
18700,GO:1904168,0.999999999991544,0.872919026258736,0,1,negative regulation of thyroid hormone receptor activity,BP,
34,GO:0000064,0.999999999991547,0.617608422379214,0,4,L-ornithine transmembrane transporter activity,MF,
7572,GO:0031944,0.999999999991554,0.638352939036956,0,4,negative regulation of glucocorticoid metabolic process,BP,
7575,GO:0031947,0.999999999991554,0.638352939036956,0,4,negative regulation of glucocorticoid biosynthetic process,BP,
16052,GO:0090032,0.999999999991554,0.638352939036956,0,4,negative regulation of steroid hormone biosynthetic process,BP,
6443,GO:0021764,0.99999999999156,0.762998954432636,0,2,amygdala development,BP,
15493,GO:0071894,0.999999999991562,0.805359993514165,0,2,histone H2B conserved C-terminal lysine ubiquitination,BP,
3926,GO:0008609,0.999999999991567,0.87787529197504,0,1,alkylglycerone-phosphate synthase activity,MF,
9298,GO:0035766,0.999999999991581,0.686711303856636,0,3,cell chemotaxis to fibroblast growth factor,BP,
9300,GO:0035768,0.999999999991581,0.686711303856636,0,3,endothelial cell chemotaxis to fibroblast growth factor,BP,
18997,GO:1904847,0.999999999991581,0.686711303856636,0,3,regulation of cell chemotaxis to fibroblast growth factor,BP,
19947,GO:2000544,0.999999999991581,0.686711303856636,0,3,regulation of endothelial cell chemotaxis to fibroblast growth factor,BP,
11069,GO:0045083,0.999999999991589,0.885206088789045,0,1,negative regulation of interleukin-12 biosynthetic process,BP,
8433,GO:0033565,0.999999999991592,0.709962900188411,0,3,ESCRT-0 complex,CC,
19414,GO:1990047,0.999999999991599,0.900901657625506,0,1,spindle matrix,CC,
1516,GO:0003880,0.999999999991604,0.727651900064332,0,3,protein C-terminal carboxyl O-methyltransferase activity,MF,
2952,GO:0006481,0.999999999991604,0.727651900064332,0,3,C-terminal protein methylation,BP,
7108,GO:0030916,0.999999999991614,0.618253773107924,0,4,otic vesicle formation,BP,
15341,GO:0071600,0.999999999991614,0.618253773107924,0,4,otic vesicle morphogenesis,BP,
11724,GO:0046577,0.999999999991634,0.888903162302327,0,1,long-chain-alcohol oxidase activity,MF,
16428,GO:0097111,0.999999999991678,0.772543471169724,0,2,endoplasmic reticulum-Golgi intermediate compartment organization,BP,
20012,GO:2000656,0.999999999991679,0.903934992353605,0,1,regulation of apolipoprotein binding,BP,
20013,GO:2000657,0.999999999991679,0.903934992353605,0,1,negative regulation of apolipoprotein binding,BP,
13147,GO:0051765,0.999999999991685,0.810487651302886,0,2,inositol tetrakisphosphate kinase activity,MF,
11907,GO:0046967,0.999999999991686,0.795871641564952,0,2,cytosol to ER transport,BP,
3985,GO:0008852,0.999999999991686,0.8992262193295,0,1,exodeoxyribonuclease I activity,MF,
476,GO:0001520,0.999999999991696,0.789527478234369,0,2,outer dense fiber,CC,
15921,GO:0072752,0.999999999991704,0.879011797313671,0,1,cellular response to rapamycin,BP,
7906,GO:0032487,0.999999999991708,0.689966763730753,0,3,regulation of Rap protein signal transduction,BP,
243,GO:0000700,0.999999999991709,0.669010520133539,0,4,mismatch base pair DNA N-glycosylase activity,MF,
19474,GO:1990275,0.999999999991716,0.898893927653778,0,1,preribosome binding,MF,
11979,GO:0047389,0.999999999991717,0.78840370678318,0,2,glycerophosphocholine phosphodiesterase activity,MF,
7628,GO:0032044,0.999999999991718,0.811513365283964,0,2,DSIF complex,CC,
14756,GO:0070478,0.999999999991724,0.884395961150217,0,1,nuclear-transcribed mRNA catabolic process, 3'-5' exonucleolytic nonsense-mediated decay,BP,
20110,GO:2000823,0.999999999991727,0.704598282829048,0,4,regulation of androgen receptor activity,BP,
20111,GO:2000825,0.999999999991727,0.704598282829048,0,4,positive regulation of androgen receptor activity,BP,
17903,GO:1902238,0.999999999991739,0.884379243150123,0,1,regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator,BP,
17904,GO:1902239,0.999999999991739,0.884379243150123,0,1,negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator,BP,
19433,GO:1990127,0.999999999991739,0.884379243150123,0,1,intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator,BP,
5391,GO:0016230,0.999999999991744,0.816259868557657,0,2,sphingomyelin phosphodiesterase activator activity,MF,
3967,GO:0008768,0.99999999999176,0.938321811171921,0,1,UDP-sugar diphosphatase activity,MF,
18950,GO:1904751,0.999999999991762,0.756075282197562,0,3,positive regulation of protein localization to nucleolus,BP,
16727,GO:0098518,0.999999999991763,0.726520059317986,0,3,polynucleotide phosphatase activity,MF,
15209,GO:0071386,0.999999999991777,0.77181101568704,0,2,cellular response to corticosterone stimulus,BP,
9414,GO:0035993,0.99999999999178,0.815827792631735,0,2,deltoid tuberosity development,BP,
14594,GO:0070180,0.999999999991782,0.95399291602225,0,1,large ribosomal subunit rRNA binding,MF,
14755,GO:0070476,0.999999999991782,0.95399291602225,0,1,rRNA (guanine-N7)-methylation,BP,
129,GO:0000270,0.999999999991799,0.835626604802174,0,2,peptidoglycan metabolic process,BP,
3960,GO:0008745,0.999999999991799,0.835626604802174,0,2,N-acetylmuramoyl-L-alanine amidase activity,MF,
4176,GO:0009253,0.999999999991799,0.835626604802174,0,2,peptidoglycan catabolic process,BP,
5308,GO:0016019,0.999999999991799,0.835626604802174,0,2,peptidoglycan receptor activity,MF,
13123,GO:0051710,0.999999999991799,0.835626604802174,0,2,regulation of cytolysis in other organism,BP,
13125,GO:0051714,0.999999999991799,0.835626604802174,0,2,positive regulation of cytolysis in other organism,BP,
12034,GO:0047933,0.999999999991802,0.876707026747308,0,1,glucose-1,6-bisphosphate synthase activity,MF,
11082,GO:0045105,0.999999999991805,0.89121612162284,0,1,intermediate filament polymerization or depolymerization,BP,
18616,GO:1903937,0.999999999991805,0.89121612162284,0,1,response to acrylamide,BP,
1808,GO:0004459,0.999999999991821,0.748524520824435,0,3,L-lactate dehydrogenase activity,MF,
10270,GO:0043031,0.999999999991855,0.649115157525783,0,4,negative regulation of macrophage activation,BP,
11010,GO:0044860,0.999999999991859,0.643930754226999,0,4,protein localization to plasma membrane raft,BP,
11138,GO:0045204,0.999999999991861,0.691850043247617,0,3,MAPK export from nucleus,BP,
7679,GO:0032137,0.999999999991863,0.713048911681898,0,3,guanine/thymine mispair binding,MF,
18180,GO:1902990,0.999999999991866,0.714152401005712,0,3,mitotic telomere maintenance via semi-conservative replication,BP,
19640,GO:1990911,0.999999999991869,0.813289152587089,0,2,response to psychosocial stress,BP,
14597,GO:0070183,0.999999999991893,0.899303146551798,0,1,mitochondrial tryptophanyl-tRNA aminoacylation,BP,
10469,GO:0043376,0.999999999991913,0.890854281172695,0,1,regulation of CD8-positive, alpha-beta T cell differentiation,BP,
18956,GO:1904762,0.999999999991921,0.886191953326027,0,1,positive regulation of myofibroblast differentiation,BP,
9595,GO:0036466,0.999999999991922,0.776948290244596,0,2,synaptic vesicle recycling via endosome,BP,
18740,GO:1904247,0.999999999991927,0.897288733111435,0,1,positive regulation of polynucleotide adenylyltransferase activity,BP,
2410,GO:0005584,0.999999999991931,0.773732640066788,0,2,collagen type I trimer,CC,
6533,GO:0021942,0.999999999991933,0.710911456452346,0,3,radial glia guided migration of Purkinje cell,BP,
511,GO:0001575,0.99999999999194,0.814904832469266,0,2,globoside metabolic process,BP,
4389,GO:0010044,0.999999999991949,0.657859835920669,0,4,response to aluminum ion,BP,
4261,GO:0009608,0.99999999999196,0.822758089124792,0,2,response to symbiont,BP,
4262,GO:0009609,0.99999999999196,0.822758089124792,0,2,response to symbiotic bacterium,BP,
16366,GO:0093001,0.999999999991969,0.895849457144257,0,1,glycolysis from storage polysaccharide through glucose-1-phosphate,BP,
11811,GO:0046726,0.999999999991972,0.624862713173319,0,4,positive regulation by virus of viral protein levels in host cell,BP,
1716,GO:0004310,0.999999999991987,0.901719150507221,0,1,farnesyl-diphosphate farnesyltransferase activity,MF,
5835,GO:0017125,0.999999999991987,0.88114432354736,0,1,deoxycytidyl transferase activity,MF,
7157,GO:0031038,0.999999999991987,0.901719150507221,0,1,myosin II filament organization,BP,
10548,GO:0043519,0.999999999991987,0.901719150507221,0,1,regulation of myosin II filament organization,BP,
13273,GO:0051996,0.999999999991987,0.901719150507221,0,1,squalene synthase activity,MF,
10604,GO:0043614,0.999999999992003,0.778363898178884,0,2,multi-eIF complex,CC,
1415,GO:0003357,0.999999999992009,0.771854873091646,0,2,noradrenergic neuron differentiation,BP,
1818,GO:0004471,0.999999999992018,0.710504445616774,0,3,malate dehydrogenase (decarboxylating) (NAD+) activity,MF,
1819,GO:0004473,0.999999999992018,0.710504445616774,0,3,malate dehydrogenase (decarboxylating) (NADP+) activity,MF,
19174,GO:1905286,0.999999999992021,0.811113942066655,0,2,serine-type peptidase complex,CC,
7555,GO:0031905,0.999999999992033,0.741794400355479,0,3,early endosome lumen,CC,
14025,GO:0060800,0.999999999992042,0.790626330038593,0,2,regulation of cell differentiation involved in embryonic placenta development,BP,
1758,GO:0004363,0.999999999992046,0.903572954912806,0,1,glutathione synthase activity,MF,
6075,GO:0019230,0.999999999992071,0.772585765536902,0,2,proprioception,BP,
14704,GO:0070376,0.99999999999208,0.898821369995707,0,1,regulation of ERK5 cascade,BP,
14705,GO:0070377,0.99999999999208,0.898821369995707,0,1,negative regulation of ERK5 cascade,BP,
17032,GO:0099532,0.999999999992085,0.772889429781067,0,2,synaptic vesicle endosomal processing,BP,
2585,GO:0005880,0.999999999992107,0.913385209635012,0,1,nuclear microtubule,CC,
8755,GO:0034437,0.99999999999212,0.800167159933382,0,2,glycoprotein transporter activity,MF,
4792,GO:0010986,0.999999999992127,0.637138727295049,0,4,positive regulation of lipoprotein particle clearance,BP,
3172,GO:0006784,0.999999999992137,0.788949046588173,0,2,heme a biosynthetic process,BP,
11571,GO:0046160,0.999999999992137,0.788949046588173,0,2,heme a metabolic process,BP,
11497,GO:0046015,0.999999999992141,0.659805392327101,0,4,regulation of transcription by glucose,BP,
16871,GO:0098837,0.999999999992146,0.7301805091061,0,3,postsynaptic recycling endosome,CC,
13509,GO:0055108,0.999999999992149,0.902778352597883,0,1,Golgi to transport vesicle transport,BP,
19487,GO:1990386,0.999999999992149,0.902778352597883,0,1,mitotic cleavage furrow ingression,BP,
19547,GO:1990583,0.999999999992149,0.902778352597883,0,1,phospholipase D activator activity,MF,
7367,GO:0031427,0.999999999992158,0.703354880568233,0,3,response to methotrexate,BP,
17927,GO:1902298,0.999999999992162,0.7845232546894,0,2,cell cycle DNA replication maintenance of fidelity,BP,
19509,GO:1990426,0.999999999992162,0.7845232546894,0,2,mitotic recombination-dependent replication fork processing,BP,
19530,GO:1990505,0.999999999992162,0.7845232546894,0,2,mitotic DNA replication maintenance of fidelity,BP,
18422,GO:1903527,0.999999999992172,0.684159247364153,0,3,positive regulation of membrane tubulation,BP,
3500,GO:0007403,0.999999999992172,0.893274265073576,0,1,glial cell fate determination,BP,
14018,GO:0060769,0.999999999992172,0.893274265073576,0,1,positive regulation of epithelial cell proliferation involved in prostate gland development,BP,
14242,GO:0061324,0.999999999992172,0.893274265073576,0,1,canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation,BP,
18839,GO:1904499,0.999999999992172,0.893274265073576,0,1,regulation of chromatin-mediated maintenance of transcription,BP,
18840,GO:1904501,0.999999999992172,0.893274265073576,0,1,positive regulation of chromatin-mediated maintenance of transcription,BP,
18971,GO:1904793,0.999999999992172,0.893274265073576,0,1,regulation of euchromatin binding,BP,
7583,GO:0031959,0.999999999992187,0.790904266730376,0,2,mineralocorticoid receptor signaling pathway,BP,
6674,GO:0030043,0.999999999992204,0.673151547929915,0,4,actin filament fragmentation,BP,
19423,GO:1990086,0.999999999992219,0.698020023738262,0,3,lens fiber cell apoptotic process,BP,
15703,GO:0072289,0.999999999992229,0.78737447521567,0,2,metanephric nephron tubule formation,BP,
15280,GO:0071492,0.999999999992231,0.795646846506258,0,2,cellular response to UV-A,BP,
2601,GO:0005900,0.999999999992245,0.797853651161619,0,2,oncostatin-M receptor complex,CC,
887,GO:0002254,0.999999999992259,0.813049674928539,0,2,kinin cascade,BP,
942,GO:0002353,0.999999999992259,0.813049674928539,0,2,plasma kallikrein-kinin cascade,BP,
13607,GO:0060124,0.999999999992269,0.788619093660791,0,2,positive regulation of growth hormone secretion,BP,
18696,GO:1904154,0.999999999992273,0.723875806941221,0,3,positive regulation of retrograde protein transport, ER to cytosol,BP,
11915,GO:0046977,0.999999999992282,0.652883834723833,0,4,TAP binding,MF,
11916,GO:0046978,0.999999999992282,0.652883834723833,0,4,TAP1 binding,MF,
16750,GO:0098575,0.999999999992296,0.812947951167611,0,2,lumenal side of lysosomal membrane,CC,
7568,GO:0031938,0.999999999992301,0.820628615232788,0,2,regulation of chromatin silencing at telomere,BP,
16446,GO:0097149,0.999999999992308,0.70820401999032,0,3,centralspindlin complex,CC,
7706,GO:0032203,0.999999999992321,0.904233034058231,0,1,telomere formation via telomerase,BP,
10459,GO:0043366,0.999999999992346,0.795310605870241,0,2,beta selection,BP,
18606,GO:1903918,0.999999999992348,0.87804739888925,0,1,regulation of actin filament severing,BP,
18607,GO:1903919,0.999999999992348,0.87804739888925,0,1,negative regulation of actin filament severing,BP,
11167,GO:0045272,0.999999999992369,0.78686995868272,0,3,plasma membrane respiratory chain complex I,CC,
15158,GO:0071315,0.999999999992374,0.705027607228278,0,3,cellular response to morphine,BP,
15160,GO:0071317,0.999999999992374,0.705027607228278,0,3,cellular response to isoquinoline alkaloid,BP,
4768,GO:0010956,0.999999999992377,0.79701061161647,0,2,negative regulation of calcidiol 1-monooxygenase activity,BP,
677,GO:0001888,0.999999999992379,0.790524578705334,0,2,glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity,MF,
17575,GO:1901254,0.999999999992382,0.883037492590196,0,1,positive regulation of intracellular transport of viral material,BP,
18079,GO:1902737,0.999999999992382,0.883037492590196,0,1,dendritic filopodium,CC,
17424,GO:1900222,0.99999999999239,0.803952682907703,0,2,negative regulation of amyloid-beta clearance,BP,
1419,GO:0003366,0.999999999992391,0.879395738920414,0,1,cell-matrix adhesion involved in ameboidal cell migration,BP,
8857,GO:0034669,0.999999999992391,0.879395738920414,0,1,integrin alpha4-beta7 complex,CC,
19598,GO:1990771,0.999999999992391,0.879395738920414,0,1,clathrin-dependent extracellular exosome endocytosis,BP,
13813,GO:0060434,0.999999999992399,0.793520184788874,0,2,bronchus morphogenesis,BP,
13872,GO:0060536,0.999999999992406,0.641562067415866,0,4,cartilage morphogenesis,BP,
19674,GO:2000017,0.999999999992416,0.802450607293249,0,2,positive regulation of determination of dorsal identity,BP,
16466,GO:0097177,0.99999999999244,0.753630019117739,0,3,mitochondrial ribosome binding,MF,
2842,GO:0006311,0.999999999992458,0.896477519432824,0,1,meiotic gene conversion,BP,
5386,GO:0016213,0.999999999992458,0.896477519432824,0,1,linoleoyl-CoA desaturase activity,MF,
11096,GO:0045128,0.999999999992458,0.896477519432824,0,1,negative regulation of reciprocal meiotic recombination,BP,
17215,GO:0110029,0.999999999992458,0.896477519432824,0,1,negative regulation of meiosis I,BP,
5671,GO:0016784,0.999999999992462,0.912887432220431,0,1,3-mercaptopyruvate sulfurtransferase activity,MF,
6257,GO:0019853,0.999999999992462,0.912887432220431,0,1,L-ascorbic acid biosynthetic process,BP,
6699,GO:0030108,0.999999999992462,0.912887432220431,0,1,HLA-A specific activating MHC class I receptor activity,MF,
7833,GO:0032397,0.999999999992462,0.912887432220431,0,1,activating MHC class I receptor activity,MF,
10202,GO:0042839,0.999999999992462,0.912887432220431,0,1,D-glucuronate metabolic process,BP,
10203,GO:0042840,0.999999999992462,0.912887432220431,0,1,D-glucuronate catabolic process,BP,
12036,GO:0047939,0.999999999992462,0.912887432220431,0,1,L-glucuronate reductase activity,MF,
5050,GO:0015247,0.999999999992463,0.684961948630292,0,3,aminophospholipid transmembrane transporter activity,MF,
4300,GO:0009750,0.999999999992469,0.647110380268629,0,4,response to fructose,BP,
10581,GO:0043564,0.999999999992479,0.80508935020508,0,2,Ku70:Ku80 complex,CC,
5285,GO:0015942,0.99999999999248,0.748589872924461,0,3,formate metabolic process,BP,
9345,GO:0035868,0.999999999992484,0.78493030962979,0,2,alphav-beta3 integrin-HMGB1 complex,CC,
1950,GO:0004656,0.999999999992489,0.729225612503193,0,3,procollagen-proline 4-dioxygenase activity,MF,
9111,GO:0035426,0.999999999992493,0.618481265678283,0,4,extracellular matrix-cell signaling,BP,
14980,GO:0070926,0.999999999992499,0.887698390860022,0,1,regulation of ATP:ADP antiporter activity,BP,
16991,GO:0099130,0.999999999992513,0.901111433972193,0,1,estrogen binding,MF,
18610,GO:1903924,0.999999999992513,0.901111433972193,0,1,estradiol binding,MF,
18513,GO:1903724,0.999999999992522,0.893828312747276,0,1,positive regulation of centriole elongation,BP,
10935,GO:0044614,0.999999999992525,0.617965138075154,0,4,nuclear pore cytoplasmic filaments,CC,
2106,GO:0004886,0.99999999999253,0.790812638739554,0,2,9-cis retinoic acid receptor activity,MF,
7702,GO:0032197,0.999999999992538,0.886962649930702,0,1,transposition, RNA-mediated,BP,
19451,GO:1990175,0.999999999992538,0.886962649930702,0,1,EH domain binding,MF,
769,GO:0002025,0.999999999992541,0.902239922987849,0,1,norepinephrine-epinephrine-mediated vasodilation involved in regulation of systemic arterial blood pressure,BP,
2132,GO:0004939,0.999999999992541,0.902239922987849,0,1,beta-adrenergic receptor activity,MF,
2133,GO:0004941,0.999999999992541,0.902239922987849,0,1,beta2-adrenergic receptor activity,MF,
12958,GO:0051380,0.999999999992541,0.902239922987849,0,1,norepinephrine binding,MF,
14459,GO:0061884,0.999999999992541,0.902239922987849,0,1,regulation of mini excitatory postsynaptic potential,BP,
14460,GO:0061885,0.999999999992541,0.902239922987849,0,1,positive regulation of mini excitatory postsynaptic potential,BP,
16860,GO:0098816,0.999999999992541,0.902239922987849,0,1,mini excitatory postsynaptic potential,BP,
7896,GO:0032472,0.999999999992547,0.805675717851376,0,2,Golgi calcium ion transport,BP,
83,GO:0000171,0.999999999992567,0.793556131521112,0,2,ribonuclease MRP activity,MF,
7519,GO:0031731,0.999999999992568,0.930767897160131,0,2,CCR6 chemokine receptor binding,MF,
3668,GO:0008160,0.999999999992571,0.900093103887043,0,1,protein tyrosine phosphatase activator activity,MF,
10058,GO:0042567,0.999999999992571,0.900093103887043,0,1,insulin-like growth factor ternary complex,CC,
18658,GO:1904026,0.999999999992573,0.809215971660738,0,2,regulation of collagen fibril organization,BP,
7072,GO:0030868,0.999999999992585,0.727038407405291,0,3,smooth endoplasmic reticulum membrane,CC,
16578,GO:0097425,0.999999999992585,0.727038407405291,0,3,smooth endoplasmic reticulum part,CC,
3809,GO:0008403,0.999999999992591,0.89628820947036,0,1,25-hydroxycholecalciferol-24-hydroxylase activity,MF,
6861,GO:0030342,0.999999999992591,0.89628820947036,0,1,1-alpha,25-dihydroxyvitamin D3 24-hydroxylase activity,MF,
8141,GO:0032877,0.999999999992594,0.782385679796587,0,2,positive regulation of DNA endoreduplication,BP,
11011,GO:0044861,0.999999999992597,0.795041507949289,0,2,protein transport into plasma membrane raft,BP,
533,GO:0001652,0.999999999992599,0.659873048013984,0,4,granular component,CC,
13152,GO:0051771,0.999999999992609,0.75746079004166,0,3,negative regulation of nitric-oxide synthase biosynthetic process,BP,
6374,GO:0021564,0.999999999992615,0.794462158806008,0,2,vagus nerve development,BP,
2244,GO:0005157,0.999999999992631,0.90050696649396,0,1,macrophage colony-stimulating factor receptor binding,MF,
10023,GO:0042488,0.999999999992631,0.90050696649396,0,1,positive regulation of odontogenesis of dentin-containing tooth,BP,
13920,GO:0060611,0.999999999992631,0.90050696649396,0,1,mammary gland fat development,BP,
17894,GO:1902228,0.999999999992631,0.90050696649396,0,1,positive regulation of macrophage colony-stimulating factor signaling pathway,BP,
18602,GO:1903911,0.999999999992631,0.712031917448312,0,3,positive regulation of receptor clustering,BP,
18633,GO:1903971,0.999999999992631,0.90050696649396,0,1,positive regulation of response to macrophage colony-stimulating factor,BP,
18636,GO:1903974,0.999999999992631,0.90050696649396,0,1,positive regulation of cellular response to macrophage colony-stimulating factor stimulus,BP,
18691,GO:1904124,0.999999999992631,0.90050696649396,0,1,microglial cell migration,BP,
18692,GO:1904139,0.999999999992631,0.90050696649396,0,1,regulation of microglial cell migration,BP,
18693,GO:1904141,0.999999999992631,0.90050696649396,0,1,positive regulation of microglial cell migration,BP,
19568,GO:1990682,0.999999999992631,0.90050696649396,0,1,CSF1-CSF1R complex,CC,
6442,GO:0021763,0.999999999992641,0.901066584075589,0,1,subthalamic nucleus development,BP,
13610,GO:0060127,0.999999999992641,0.901066584075589,0,1,prolactin secreting cell differentiation,BP,
13833,GO:0060459,0.999999999992641,0.901066584075589,0,1,left lung development,BP,
13834,GO:0060460,0.999999999992641,0.901066584075589,0,1,left lung morphogenesis,BP,
13898,GO:0060577,0.999999999992641,0.901066584075589,0,1,pulmonary vein morphogenesis,BP,
13899,GO:0060578,0.999999999992641,0.901066584075589,0,1,superior vena cava morphogenesis,BP,
14129,GO:0061031,0.999999999992641,0.901066584075589,0,1,endodermal digestive tract morphogenesis,BP,
17942,GO:1902338,0.999999999992648,0.70222932948135,0,3,negative regulation of apoptotic process involved in morphogenesis,BP,
18945,GO:1904746,0.999999999992648,0.70222932948135,0,3,negative regulation of apoptotic process involved in development,BP,
20255,GO:2001245,0.999999999992653,0.783342930558727,0,2,regulation of phosphatidylcholine biosynthetic process,BP,
9225,GO:0035625,0.999999999992656,0.8914877999578,0,1,epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway,BP,
1391,GO:0003307,0.999999999992683,0.730833609031449,0,3,regulation of Wnt signaling pathway involved in heart development,BP,
16869,GO:0098833,0.999999999992687,0.880527237997582,0,1,presynaptic endocytic zone,CC,
16870,GO:0098835,0.999999999992687,0.880527237997582,0,1,presynaptic endocytic zone membrane,CC,
8535,GO:0033878,0.999999999992689,0.888380746527021,0,1,hormone-sensitive lipase activity,MF,
10501,GO:0043423,0.999999999992703,0.883205292187685,0,1,3-phosphoinositide-dependent protein kinase binding,MF,
19943,GO:2000537,0.999999999992703,0.883205292187685,0,1,regulation of B cell chemotaxis,BP,
19944,GO:2000538,0.999999999992703,0.883205292187685,0,1,positive regulation of B cell chemotaxis,BP,
8362,GO:0033269,0.999999999992717,0.797625183749379,0,2,internode region of axon,CC,
9170,GO:0035552,0.999999999992722,0.723800192680289,0,3,oxidative single-stranded DNA demethylation,BP,
3836,GO:0008444,0.999999999992723,0.901243903639061,0,1,CDP-diacylglycerol-glycerol-3-phosphate 3-phosphatidyltransferase activity,MF,
5375,GO:0016191,0.999999999992752,0.613697806096118,0,4,synaptic vesicle uncoating,BP,
11247,GO:0045519,0.999999999992758,0.929751834114111,0,1,interleukin-23 receptor binding,MF,
14893,GO:0070743,0.999999999992758,0.929751834114111,0,1,interleukin-23 complex,CC,
9673,GO:0038062,0.999999999992763,0.888066659357613,0,1,protein tyrosine kinase collagen receptor activity,MF,
571,GO:0001714,0.999999999992781,0.672416873837367,0,4,endodermal cell fate specification,BP,
2418,GO:0005593,0.999999999992781,0.622450793613453,0,4,FACIT collagen trimer,CC,
2653,GO:0005997,0.999999999992785,0.694572265413807,0,4,xylulose metabolic process,BP,
6038,GO:0019144,0.999999999992803,0.8404500683581,0,2,ADP-sugar diphosphatase activity,MF,
19647,GO:1990928,0.999999999992805,0.780082353618876,0,2,response to amino acid starvation,BP,
15721,GO:0072320,0.999999999992825,0.697856012438125,0,3,volume-sensitive chloride channel activity,MF,
16464,GO:0097169,0.999999999992828,0.798040452393793,0,3,AIM2 inflammasome complex,CC,
237,GO:0000495,0.999999999992832,0.90018611834467,0,1,box H/ACA snoRNA 3'-end processing,BP,
2736,GO:0006117,0.999999999992832,0.90018611834467,0,1,acetaldehyde metabolic process,BP,
8546,GO:0033979,0.999999999992832,0.90018611834467,0,1,box H/ACA snoRNA metabolic process,BP,
8924,GO:0034964,0.999999999992832,0.90018611834467,0,1,box H/ACA snoRNA processing,BP,
9160,GO:0035525,0.999999999992832,0.90018611834467,0,1,NF-kappaB p50/p65 complex,CC,
1160,GO:0002774,0.999999999992834,0.897410025989081,0,1,Fc receptor mediated inhibitory signaling pathway,BP,
14859,GO:0070667,0.999999999992834,0.897410025989081,0,1,negative regulation of mast cell proliferation,BP,
12769,GO:0051083,0.999999999992835,0.815776863954365,0,2,'de novo' cotranslational protein folding,BP,
11731,GO:0046588,0.999999999992844,0.936197685202498,0,1,negative regulation of calcium-dependent cell-cell adhesion,BP,
15948,GO:0080058,0.99999999999285,0.916670663361037,0,1,protein deglutathionylation,BP,
16648,GO:0097573,0.99999999999285,0.916670663361037,0,1,glutathione oxidoreductase activity,MF,
4642,GO:0010767,0.999999999992885,0.694505583539779,0,3,regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage,BP,
19248,GO:1905458,0.999999999992886,0.886478845740955,0,1,positive regulation of lymphoid progenitor cell differentiation,BP,
19746,GO:2000174,0.999999999992886,0.886478845740955,0,1,regulation of pro-T cell differentiation,BP,
19747,GO:2000176,0.999999999992886,0.886478845740955,0,1,positive regulation of pro-T cell differentiation,BP,
16438,GO:0097124,0.999999999992887,0.810392561682501,0,2,cyclin A2-CDK2 complex,CC,
6732,GO:0030156,0.999999999992891,0.945021069763979,0,1,benzodiazepine receptor binding,MF,
6471,GO:0021816,0.999999999992892,0.790500108480379,0,2,extension of a leading process involved in cell motility in cerebral cortex radial glia guided migration,BP,
5820,GO:0017095,0.999999999992893,0.782340437418066,0,2,heparan sulfate 6-O-sulfotransferase activity,MF,
13575,GO:0060066,0.999999999992899,0.809957845189776,0,2,oviduct development,BP,
8745,GO:0034418,0.999999999992918,0.81176626876406,0,2,urate biosynthetic process,BP,
9953,GO:0042351,0.999999999992936,0.831751665317169,0,2,'de novo' GDP-L-fucose biosynthetic process,BP,
19576,GO:1990723,0.999999999992948,0.780860277645951,0,2,cytoplasmic periphery of the nuclear pore complex,CC,
542,GO:0001661,0.999999999992955,0.792917129265948,0,2,conditioned taste aversion,BP,
6724,GO:0030144,0.999999999992959,0.717302881905622,0,3,alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity,MF,
11225,GO:0045416,0.999999999992972,0.789786524539649,0,2,positive regulation of interleukin-8 biosynthetic process,BP,
2035,GO:0004777,0.999999999992974,0.880115467989697,0,1,succinate-semialdehyde dehydrogenase (NAD+) activity,MF,
4013,GO:0009013,0.999999999992974,0.880115467989697,0,1,succinate-semialdehyde dehydrogenase [NAD(P)+] activity,MF,
10323,GO:0043131,0.999999999992974,0.880115467989697,0,1,erythrocyte enucleation,BP,
10458,GO:0043354,0.999999999992974,0.880115467989697,0,1,enucleate erythrocyte maturation,BP,
14473,GO:0061930,0.999999999992974,0.880115467989697,0,1,regulation of erythrocyte enucleation,BP,
14474,GO:0061931,0.999999999992974,0.880115467989697,0,1,positive regulation of erythrocyte enucleation,BP,
16325,GO:0090601,0.999999999992974,0.880115467989697,0,1,enucleation,BP,
18110,GO:1902838,0.999999999992974,0.880115467989697,0,1,regulation of nuclear migration along microtubule,BP,
13388,GO:0052794,0.999999999992976,0.81147113067467,0,2,exo-alpha-(2->3)-sialidase activity,MF,
13389,GO:0052795,0.999999999992976,0.81147113067467,0,2,exo-alpha-(2->6)-sialidase activity,MF,
13390,GO:0052796,0.999999999992976,0.81147113067467,0,2,exo-alpha-(2->8)-sialidase activity,MF,
6367,GO:0021557,0.999999999992977,0.817494137968504,0,2,oculomotor nerve development,BP,
12955,GO:0051377,0.999999999992981,0.706130215010637,0,3,mannose-ethanolamine phosphotransferase activity,MF,
1318,GO:0003169,0.999999999992987,0.780831186137184,0,2,coronary vein morphogenesis,BP,
14084,GO:0060948,0.999999999992987,0.780831186137184,0,2,cardiac vascular smooth muscle cell development,BP,
14286,GO:0061443,0.999999999992997,0.79003384057458,0,2,endocardial cushion cell differentiation,BP,
13352,GO:0052593,0.999999999993021,0.797447634023168,0,2,tryptamine:oxygen oxidoreductase (deaminating) activity,MF,
13353,GO:0052594,0.999999999993021,0.797447634023168,0,2,aminoacetone:oxygen oxidoreductase(deaminating) activity,MF,
13354,GO:0052595,0.999999999993021,0.797447634023168,0,2,aliphatic-amine oxidase activity,MF,
13355,GO:0052596,0.999999999993021,0.797447634023168,0,2,phenethylamine:oxygen oxidoreductase (deaminating) activity,MF,
15923,GO:0072757,0.999999999993029,0.635596751732353,0,4,cellular response to camptothecin,BP,
6906,GO:0030504,0.999999999993029,0.87715403410801,0,1,inorganic diphosphate transmembrane transporter activity,MF,
18069,GO:1902714,0.999999999993033,0.808762321055773,0,2,negative regulation of interferon-gamma secretion,BP,
4297,GO:0009744,0.999999999993041,0.709294456788315,0,3,response to sucrose,BP,
8675,GO:0034285,0.999999999993041,0.709294456788315,0,3,response to disaccharide,BP,
15756,GO:0072382,0.999999999993042,0.861427774650899,0,1,minus-end-directed vesicle transport along microtubule,BP,
14029,GO:0060819,0.999999999993047,0.772766395145934,0,2,inactivation of X chromosome by genetic imprinting,BP,
12029,GO:0047860,0.999999999993055,0.91991512182574,0,1,diiodophenylpyruvate reductase activity,MF,
18773,GO:1904327,0.999999999993059,0.790001432705264,0,2,protein localization to cytosolic proteasome complex,BP,
18791,GO:1904379,0.999999999993059,0.790001432705264,0,2,protein localization to cytosolic proteasome complex involved in ERAD pathway,BP,
450,GO:0001224,0.999999999993063,0.691451354461105,0,3,RNA polymerase II transcription cofactor binding,MF,
4488,GO:0010513,0.999999999993064,0.825029188943571,0,2,positive regulation of phosphatidylinositol biosynthetic process,BP,
16260,GO:0090360,0.999999999993064,0.717613538273461,0,3,platelet-derived growth factor production,BP,
16261,GO:0090361,0.999999999993064,0.717613538273461,0,3,regulation of platelet-derived growth factor production,BP,
16544,GO:0097350,0.999999999993095,0.720281601742974,0,3,neutrophil clearance,BP,
8467,GO:0033624,0.999999999993131,0.784730037444001,0,2,negative regulation of integrin activation,BP,
13824,GO:0060447,0.999999999993149,0.877948705444919,0,1,bud outgrowth involved in lung branching,BP,
13995,GO:0060739,0.999999999993149,0.877948705444919,0,1,mesenchymal-epithelial cell signaling involved in prostate gland development,BP,
15318,GO:0071561,0.999999999993161,0.880298131606056,0,1,nucleus-vacuole junction,CC,
10798,GO:0044299,0.999999999993169,0.879080569666064,0,1,C-fiber,CC,
8683,GO:0034316,0.999999999993182,0.636039483901052,0,4,negative regulation of Arp2/3 complex-mediated actin nucleation,BP,
6851,GO:0030327,0.999999999993184,0.710039545712327,0,3,prenylated protein catabolic process,BP,
1865,GO:0004531,0.999999999993188,0.902482588933336,0,1,deoxyribonuclease II activity,MF,
3436,GO:0007227,0.999999999993202,0.694302937454338,0,3,signal transduction downstream of smoothened,BP,
18333,GO:1903335,0.999999999993204,0.676338094433831,0,4,regulation of vacuolar transport,BP,
6166,GO:0019530,0.999999999993208,0.699413013038886,0,3,taurine metabolic process,BP,
6200,GO:0019694,0.999999999993208,0.699413013038886,0,3,alkanesulfonate metabolic process,BP,
19979,GO:2000611,0.999999999993209,0.796553298169197,0,2,positive regulation of thyroid hormone generation,BP,
1934,GO:0004637,0.999999999993211,0.8930135619451,0,1,phosphoribosylamine-glycine ligase activity,MF,
1937,GO:0004641,0.999999999993211,0.8930135619451,0,1,phosphoribosylformylglycinamidine cyclo-ligase activity,MF,
1940,GO:0004644,0.999999999993211,0.8930135619451,0,1,phosphoribosylglycinamide formyltransferase activity,MF,
16766,GO:0098619,0.999999999993211,0.903648108819123,0,1,selenocysteine-tRNA ligase activity,MF,
18385,GO:1903435,0.999999999993213,0.89939487223645,0,1,positive regulation of constitutive secretory pathway,BP,
9330,GO:0035844,0.999999999993223,0.702166487459937,0,3,cloaca development,BP,
19196,GO:1905335,0.999999999993229,0.864437105632315,0,1,regulation of aggrephagy,BP,
19197,GO:1905337,0.999999999993229,0.864437105632315,0,1,positive regulation of aggrephagy,BP,
15636,GO:0072174,0.999999999993232,0.698605725800901,0,3,metanephric tubule formation,BP,
15778,GO:0072434,0.999999999993244,0.782662335359836,0,2,signal transduction involved in mitotic G2 DNA damage checkpoint,BP,
843,GO:0002159,0.999999999993251,0.622044057024904,0,4,desmosome assembly,BP,
14197,GO:0061156,0.999999999993259,0.702059022634663,0,3,pulmonary artery morphogenesis,BP,
11493,GO:0045994,0.999999999993263,0.879728595676481,0,1,positive regulation of translational initiation by iron,BP,
5979,GO:0018812,0.999999999993275,0.652714642235973,0,4,3-hydroxyacyl-CoA dehydratase activity,MF,
17108,GO:0102158,0.999999999993275,0.652714642235973,0,4,very-long-chain 3-hydroxyacyl-CoA dehydratase activity,MF,
17120,GO:0102343,0.999999999993275,0.652714642235973,0,4,3-hydroxy-arachidoyl-CoA dehydratase activity,MF,
17121,GO:0102344,0.999999999993275,0.652714642235973,0,4,3-hydroxy-behenoyl-CoA dehydratase activity,MF,
17122,GO:0102345,0.999999999993275,0.652714642235973,0,4,3-hydroxy-lignoceroyl-CoA dehydratase activity,MF,
19462,GO:1990246,0.999999999993275,0.652714642235973,0,4,uniplex complex,CC,
18511,GO:1903722,0.999999999993287,0.836884264371009,0,2,regulation of centriole elongation,BP,
9347,GO:0035870,0.99999999999329,0.815250477895301,0,2,dITP diphosphatase activity,MF,
16084,GO:0090086,0.99999999999329,0.776190456370901,0,3,negative regulation of protein deubiquitination,BP,
1295,GO:0003130,0.999999999993291,0.811749892967157,0,2,BMP signaling pathway involved in heart induction,BP,
1297,GO:0003133,0.999999999993291,0.811749892967157,0,2,endodermal-mesodermal cell signaling,BP,
1298,GO:0003134,0.999999999993291,0.811749892967157,0,2,endodermal-mesodermal cell signaling involved in heart induction,BP,
15619,GO:0072138,0.999999999993291,0.811749892967157,0,2,mesenchymal cell proliferation involved in ureteric bud development,BP,
7174,GO:0031064,0.999999999993294,0.766971665660697,0,2,negative regulation of histone deacetylation,BP,
17518,GO:1901069,0.999999999993307,0.833817312901192,0,2,guanosine-containing compound catabolic process,BP,
14157,GO:0061078,0.999999999993312,0.955035454540997,0,1,positive regulation of prostaglandin secretion involved in immune response,BP,
16243,GO:0090323,0.999999999993312,0.955035454540997,0,1,prostaglandin secretion involved in immune response,BP,
18478,GO:1903636,0.999999999993312,0.955035454540997,0,1,regulation of protein import into mitochondrial outer membrane,BP,
18479,GO:1903638,0.999999999993312,0.955035454540997,0,1,positive regulation of protein import into mitochondrial outer membrane,BP,
18481,GO:1903645,0.999999999993312,0.955035454540997,0,1,negative regulation of chaperone-mediated protein folding,BP,
15615,GO:0072134,0.999999999993321,0.776262114112688,0,2,nephrogenic mesenchyme morphogenesis,BP,
1246,GO:0002949,0.999999999993328,0.741955151602119,0,3,tRNA threonylcarbamoyladenosine modification,BP,
13847,GO:0060486,0.999999999993332,0.790085409338184,0,2,Clara cell differentiation,BP,
16863,GO:0098826,0.999999999993335,0.656249646106556,0,4,endoplasmic reticulum tubular network membrane,CC,
19151,GO:1905222,0.999999999993344,0.896684549618227,0,1,atrioventricular canal morphogenesis,BP,
7383,GO:0031443,0.999999999993345,0.878756502890443,0,1,fast-twitch skeletal muscle fiber contraction,BP,
3061,GO:0006624,0.999999999993349,0.849477874313348,0,2,vacuolar protein processing,BP,
15995,GO:0086028,0.999999999993353,0.662514277544582,0,4,bundle of His cell to Purkinje myocyte signaling,BP,
16002,GO:0086043,0.999999999993353,0.662514277544582,0,4,bundle of His cell action potential,BP,
19076,GO:1905006,0.999999999993353,0.795395723287061,0,2,negative regulation of epithelial to mesenchymal transition involved in endocardial cushion formation,BP,
14588,GO:0070170,0.999999999993354,0.786717386011022,0,2,regulation of tooth mineralization,BP,
3907,GO:0008559,0.99999999999336,0.61905232328674,0,4,xenobiotic transmembrane transporting ATPase activity,MF,
8869,GO:0034693,0.999999999993371,0.900434811442126,0,1,U11/U12 snRNP,CC,
14543,GO:0070094,0.999999999993375,0.900173072465359,0,1,positive regulation of glucagon secretion,BP,
17715,GO:1901668,0.999999999993377,0.840290963998537,0,2,regulation of superoxide dismutase activity,BP,
8957,GO:0035037,0.999999999993382,0.882167642906483,0,1,sperm entry,BP,
19401,GO:1990005,0.999999999993383,0.81503173297292,0,2,granular vesicle,CC,
9799,GO:0042000,0.999999999993395,0.900536563456634,0,1,translocation of peptides or proteins into host,BP,
10707,GO:0044053,0.999999999993395,0.900536563456634,0,1,translocation of peptides or proteins into host cell cytoplasm,BP,
13177,GO:0051808,0.999999999993395,0.900536563456634,0,1,translocation of peptides or proteins into other organism involved in symbiotic interaction,BP,
8374,GO:0033290,0.999999999993403,0.884617091921197,0,1,eukaryotic 48S preinitiation complex,CC,
10747,GO:0044207,0.999999999993403,0.884617091921197,0,1,translation initiation ternary complex,CC,
7361,GO:0031416,0.999999999993413,0.816755826074996,0,2,NatB complex,CC,
17540,GO:1901143,0.999999999993418,0.785583395525164,0,2,insulin catabolic process,BP,
3403,GO:0007185,0.999999999993432,0.592616138898657,0,4,transmembrane receptor protein tyrosine phosphatase signaling pathway,BP,
16022,GO:0086075,0.99999999999344,0.70572763802895,0,3,gap junction channel activity involved in cardiac conduction electrical coupling,MF,
10134,GO:0042723,0.999999999993442,0.732186897738529,0,3,thiamine-containing compound metabolic process,BP,
12987,GO:0051433,0.999999999993442,0.882026312514662,0,1,BH2 domain binding,MF,
12117,GO:0048211,0.999999999993449,0.798659153041863,0,2,Golgi vesicle docking,BP,
5954,GO:0018335,0.999999999993457,0.634850549837624,0,4,protein succinylation,BP,
17196,GO:0106077,0.999999999993457,0.634850549837624,0,4,histone succinylation,BP,
8053,GO:0032730,0.999999999993458,0.678062164157436,0,4,positive regulation of interleukin-1 alpha production,BP,
10986,GO:0044803,0.99999999999347,0.643682214337197,0,4,multi-organism membrane organization,BP,
13937,GO:0060665,0.999999999993474,0.879660675180598,0,1,regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling,BP,
16205,GO:0090272,0.999999999993474,0.879660675180598,0,1,negative regulation of fibroblast growth factor production,BP,
18399,GO:1903465,0.999999999993474,0.879660675180598,0,1,positive regulation of mitotic cell cycle DNA replication,BP,
20115,GO:2000830,0.999999999993474,0.879660675180598,0,1,positive regulation of parathyroid hormone secretion,BP,
18086,GO:1902746,0.999999999993481,0.900546592292584,0,1,regulation of lens fiber cell differentiation,BP,
11184,GO:0045322,0.999999999993483,0.807404180260048,0,2,unmethylated CpG binding,MF,
16552,GO:0097363,0.999999999993487,0.790760894480652,0,2,protein O-GlcNAc transferase activity,MF,
18523,GO:1903753,0.999999999993509,0.633007296895559,0,4,negative regulation of p38MAPK cascade,BP,
3538,GO:0007538,0.999999999993514,0.780408441221381,0,2,primary sex determination,BP,
3539,GO:0007542,0.999999999993514,0.780408441221381,0,2,primary sex determination, germ-line,BP,
5989,GO:0018992,0.999999999993514,0.780408441221381,0,2,germ-line sex determination,BP,
6029,GO:0019100,0.999999999993514,0.780408441221381,0,2,male germ-line sex determination,BP,
1509,GO:0003872,0.999999999993516,0.722656189747446,0,3,6-phosphofructokinase activity,MF,
16369,GO:0097003,0.999999999993518,0.799290801729407,0,2,adipokinetic hormone receptor activity,MF,
5298,GO:0015990,0.999999999993524,0.942282696710146,0,1,electron transport coupled proton transport,BP,
1781,GO:0004397,0.999999999993532,0.896488238275947,0,1,histidine ammonia-lyase activity,MF,
2109,GO:0004890,0.999999999993532,0.896488238275947,0,1,GABA-A receptor activity,MF,
2282,GO:0005237,0.999999999993532,0.896488238275947,0,1,inhibitory extracellular ligand-gated ion channel activity,MF,
6178,GO:0019556,0.999999999993532,0.896488238275947,0,1,histidine catabolic process to glutamate and formamide,BP,
6179,GO:0019557,0.999999999993532,0.896488238275947,0,1,histidine catabolic process to glutamate and formate,BP,
6618,GO:0022851,0.999999999993532,0.896488238275947,0,1,GABA-gated chloride ion channel activity,MF,
10602,GO:0043606,0.999999999993532,0.896488238275947,0,1,formamide metabolic process,BP,
16984,GO:0099095,0.999999999993532,0.896488238275947,0,1,ligand-gated anion channel activity,MF,
18066,GO:1902710,0.999999999993532,0.896488238275947,0,1,GABA receptor complex,CC,
18067,GO:1902711,0.999999999993532,0.896488238275947,0,1,GABA-A receptor complex,CC,
6366,GO:0021555,0.999999999993555,0.803900126507878,0,2,midbrain-hindbrain boundary morphogenesis,BP,
4643,GO:0010768,0.999999999993559,0.77178468748565,0,2,negative regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage,BP,
18942,GO:1904742,0.99999999999356,0.644437062768382,0,4,regulation of telomeric DNA binding,BP,
8503,GO:0033693,0.999999999993562,0.712581506834409,0,3,neurofilament bundle assembly,BP,
19989,GO:2000625,0.999999999993563,0.793385325612014,0,2,regulation of miRNA catabolic process,BP,
19990,GO:2000627,0.999999999993563,0.793385325612014,0,2,positive regulation of miRNA catabolic process,BP,
2332,GO:0005350,0.999999999993565,0.809020148869606,0,2,pyrimidine nucleobase transmembrane transporter activity,MF,
5235,GO:0015855,0.999999999993565,0.809020148869606,0,2,pyrimidine nucleobase transport,BP,
18985,GO:1904823,0.999999999993565,0.809020148869606,0,2,purine nucleobase transmembrane transport,BP,
8079,GO:0032771,0.999999999993565,0.88365409910439,0,1,regulation of monophenol monooxygenase activity,BP,
8080,GO:0032773,0.999999999993565,0.88365409910439,0,1,positive regulation of monophenol monooxygenase activity,BP,
8166,GO:0032912,0.999999999993565,0.88365409910439,0,1,negative regulation of transforming growth factor beta2 production,BP,
12058,GO:0048023,0.999999999993565,0.88365409910439,0,1,positive regulation of melanin biosynthetic process,BP,
13169,GO:0051796,0.999999999993565,0.88365409910439,0,1,negative regulation of timing of catagen,BP,
14060,GO:0060901,0.999999999993565,0.88365409910439,0,1,regulation of hair cycle by canonical Wnt signaling pathway,BP,
18138,GO:1902908,0.999999999993565,0.88365409910439,0,1,regulation of melanosome transport,BP,
18139,GO:1902910,0.999999999993565,0.88365409910439,0,1,positive regulation of melanosome transport,BP,
1513,GO:0003876,0.999999999993566,0.785359123189069,0,2,AMP deaminase activity,MF,
12005,GO:0047623,0.999999999993566,0.785359123189069,0,2,adenosine-phosphate deaminase activity,MF,
5803,GO:0017060,0.99999999999357,0.808648790063886,0,2,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity,MF,
4205,GO:0009328,0.999999999993581,0.658164129887592,0,4,phenylalanine-tRNA ligase complex,CC,
9481,GO:0036132,0.999999999993589,0.729157811449753,0,3,13-prostaglandin reductase activity,MF,
11995,GO:0047522,0.999999999993589,0.729157811449753,0,3,15-oxoprostaglandin 13-oxidase activity,MF,
1385,GO:0003294,0.999999999993592,0.803875722837138,0,2,atrial ventricular junction remodeling,BP,
4561,GO:0010645,0.999999999993592,0.803875722837138,0,2,regulation of cell communication by chemical coupling,BP,
4567,GO:0010652,0.999999999993592,0.803875722837138,0,2,positive regulation of cell communication by chemical coupling,BP,
19220,GO:1905395,0.999999999993596,0.833528453531828,0,2,response to flavonoid,BP,
687,GO:0001907,0.999999999993599,0.749869657102247,0,3,killing by symbiont of host cells,BP,
10696,GO:0044004,0.999999999993599,0.749869657102247,0,3,disruption by symbiont of host cell,BP,
10910,GO:0044533,0.999999999993599,0.749869657102247,0,3,positive regulation of apoptotic process in other organism,BP,
13281,GO:0052042,0.999999999993599,0.749869657102247,0,3,positive regulation by symbiont of host programmed cell death,BP,
13317,GO:0052330,0.999999999993599,0.749869657102247,0,3,positive regulation by organism of programmed cell death in other organism involved in symbiotic interaction,BP,
13336,GO:0052501,0.999999999993599,0.749869657102247,0,3,positive regulation by organism of apoptotic process in other organism involved in symbiotic interaction,BP,
9229,GO:0035633,0.9999999999936,0.794907599492484,0,2,maintenance of permeability of blood-brain barrier,BP,
14601,GO:0070191,0.999999999993601,0.811822725625832,0,2,methionine-R-sulfoxide reductase activity,MF,
6592,GO:0022615,0.999999999993604,0.671205717965715,0,4,protein to membrane docking,BP,
10140,GO:0042732,0.999999999993611,0.836418117955871,0,2,D-xylose metabolic process,BP,
18359,GO:1903385,0.999999999993614,0.785491812185445,0,2,regulation of homophilic cell adhesion,BP,
862,GO:0002196,0.999999999993615,0.903679809018437,0,1,Ser-tRNA(Ala) hydrolase activity,MF,
4977,GO:0015098,0.999999999993615,0.903679809018437,0,1,molybdate ion transmembrane transporter activity,MF,
5150,GO:0015689,0.999999999993615,0.903679809018437,0,1,molybdate ion transport,BP,
13065,GO:0051595,0.999999999993621,0.751973557486253,0,3,response to methylglyoxal,BP,
19421,GO:1990074,0.999999999993636,0.892108339464716,0,1,polyuridylation-dependent mRNA catabolic process,BP,
16854,GO:0098808,0.99999999999365,0.811640306525998,0,2,mRNA cap binding,MF,
19388,GO:1905940,0.999999999993654,0.719582490159659,0,3,negative regulation of gonad development,BP,
7084,GO:0030886,0.99999999999366,0.818454935790824,0,2,negative regulation of myeloid dendritic cell activation,BP,
721,GO:0001951,0.999999999993662,0.702218526379856,0,3,intestinal D-glucose absorption,BP,
17167,GO:0106001,0.999999999993662,0.702218526379856,0,3,intestinal hexose absorption,BP,
12015,GO:0047710,0.999999999993665,0.927595294492644,0,1,bis(5'-adenosyl)-triphosphatase activity,MF,
11525,GO:0046070,0.999999999993667,0.712397997854727,0,4,dGTP metabolic process,BP,
4014,GO:0009019,0.99999999999367,0.638984104201234,0,4,tRNA (guanine-N1-)-methyltransferase activity,MF,
9221,GO:0035621,0.99999999999367,0.794236772497223,0,2,ER to Golgi ceramide transport,BP,
3979,GO:0008817,0.999999999993695,0.884854283574376,0,1,cob(I)yrinic acid a,c-diamide adenosyltransferase activity,MF,
3929,GO:0008612,0.999999999993698,0.674240045150977,0,4,peptidyl-lysine modification to peptidyl-hypusine,BP,
19630,GO:1990876,0.999999999993698,0.878987735238947,0,1,cytoplasmic side of nuclear pore,CC,
9076,GO:0035339,0.999999999993699,0.674331656019586,0,4,SPOTS complex,CC,
5145,GO:0015679,0.999999999993708,0.772415595863509,0,2,plasma membrane copper ion transport,BP,
48,GO:0000101,0.999999999993709,0.702517280756165,0,3,sulfur amino acid transport,BP,
16760,GO:0098594,0.999999999993727,0.944912513923821,0,1,mucin granule,CC,
9004,GO:0035189,0.999999999993731,0.714449473828574,0,3,Rb-E2F complex,CC,
120,GO:0000250,0.999999999993738,0.883869691501245,0,1,lanosterol synthase activity,MF,
7431,GO:0031559,0.999999999993738,0.883869691501245,0,1,oxidosqualene cyclase activity,MF,
1685,GO:0004157,0.999999999993746,0.882021189537139,0,1,dihydropyrimidinase activity,MF,
18673,GO:1904048,0.999999999993746,0.882021189537139,0,1,regulation of spontaneous neurotransmitter secretion,BP,
18674,GO:1904050,0.999999999993746,0.882021189537139,0,1,positive regulation of spontaneous neurotransmitter secretion,BP,
19178,GO:1905301,0.999999999993746,0.882021189537139,0,1,regulation of macropinocytosis,BP,
19179,GO:1905302,0.999999999993746,0.882021189537139,0,1,negative regulation of macropinocytosis,BP,
14171,GO:0061101,0.999999999993762,0.664068873860484,0,4,neuroendocrine cell differentiation,BP,
7109,GO:0030917,0.999999999993762,0.633463070604768,0,4,midbrain-hindbrain boundary development,BP,
2767,GO:0006185,0.999999999993764,0.932096015474494,0,1,dGDP biosynthetic process,BP,
4113,GO:0009170,0.999999999993764,0.932096015474494,0,1,purine deoxyribonucleoside monophosphate metabolic process,BP,
4122,GO:0009183,0.999999999993764,0.932096015474494,0,1,purine deoxyribonucleoside diphosphate biosynthetic process,BP,
11514,GO:0046054,0.999999999993764,0.932096015474494,0,1,dGMP metabolic process,BP,
11801,GO:0046711,0.999999999993764,0.932096015474494,0,1,GDP biosynthetic process,BP,
18959,GO:1904768,0.999999999993774,0.825540551899775,0,2,all-trans-retinol binding,MF,
9615,GO:0036493,0.999999999993777,0.715971551645527,0,3,positive regulation of translation in response to endoplasmic reticulum stress,BP,
2800,GO:0006258,0.999999999993787,0.826883975664178,0,2,UDP-glucose catabolic process,BP,
9681,GO:0038086,0.999999999993789,0.892063156937587,0,1,VEGF-activated platelet-derived growth factor receptor signaling pathway,BP,
9683,GO:0038091,0.999999999993789,0.892063156937587,0,1,positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway,BP,
16636,GO:0097532,0.999999999993789,0.892063156937587,0,1,stress response to acid chemical,BP,
16637,GO:0097533,0.999999999993789,0.892063156937587,0,1,cellular stress response to acid chemical,BP,
18450,GO:1903570,0.999999999993789,0.892063156937587,0,1,regulation of protein kinase D signaling,BP,
18451,GO:1903572,0.999999999993789,0.892063156937587,0,1,positive regulation of protein kinase D signaling,BP,
19426,GO:1990108,0.999999999993813,0.78788537061689,0,2,protein linear deubiquitination,BP,
8874,GO:0034699,0.999999999993814,0.711575133928385,0,3,response to luteinizing hormone,BP,
1827,GO:0004484,0.99999999999382,0.882427809628306,0,1,mRNA guanylyltransferase activity,MF,
12457,GO:0050355,0.99999999999382,0.882427809628306,0,1,triphosphatase activity,MF,
9239,GO:0035650,0.999999999993824,0.673228253711174,0,4,AP-1 adaptor complex binding,MF,
10827,GO:0044335,0.999999999993826,0.873775487012757,0,1,canonical Wnt signaling pathway involved in neural crest cell differentiation,BP,
19694,GO:2000055,0.999999999993826,0.873775487012757,0,1,positive regulation of Wnt signaling pathway involved in dorsal/ventral axis specification,BP,
15029,GO:0071001,0.999999999993826,0.747856469127431,0,3,U4/U6 snRNP,CC,
2455,GO:0005668,0.999999999993832,0.828702358748434,0,2,RNA polymerase transcription factor SL1 complex,CC,
11745,GO:0046619,0.999999999993842,0.788575015074525,0,2,optic placode formation involved in camera-type eye formation,BP,
19833,GO:2000325,0.999999999993865,0.879337999035708,0,1,regulation of ligand-dependent nuclear receptor transcription coactivator activity,BP,
19834,GO:2000327,0.999999999993865,0.879337999035708,0,1,positive regulation of ligand-dependent nuclear receptor transcription coactivator activity,BP,
4049,GO:0009092,0.999999999993871,0.664622488446445,0,4,homoserine metabolic process,BP,
6105,GO:0019346,0.999999999993871,0.664622488446445,0,4,transsulfuration,BP,
3818,GO:0008418,0.999999999993871,0.926422911324976,0,1,protein-N-terminal asparagine amidohydrolase activity,MF,
5365,GO:0016160,0.999999999993873,0.792295642393432,0,2,amylase activity,MF,
20190,GO:2001137,0.999999999993876,0.693726668188243,0,3,positive regulation of endocytic recycling,BP,
11728,GO:0046581,0.999999999993878,0.697520379549491,0,3,intercellular canaliculus,CC,
10472,GO:0043382,0.99999999999388,0.751565558373188,0,3,positive regulation of memory T cell differentiation,BP,
19558,GO:1990622,0.999999999993885,0.844518817256448,0,2,CHOP-ATF3 complex,CC,
15376,GO:0071650,0.9999999999939,0.738584560871234,0,3,negative regulation of chemokine (C-C motif) ligand 5 production,BP,
12380,GO:0048822,0.999999999993902,0.696057570053361,0,3,enucleate erythrocyte development,BP,
20226,GO:2001200,0.999999999993921,0.819459222929886,0,2,positive regulation of dendritic cell differentiation,BP,
7304,GO:0031315,0.999999999993935,0.878639157744766,0,1,extrinsic component of mitochondrial outer membrane,CC,
3802,GO:0008384,0.999999999993936,0.707975231553869,0,3,IkappaB kinase activity,MF,
4007,GO:0008973,0.999999999993938,0.895460094310616,0,1,phosphopentomutase activity,MF,
15673,GO:0072223,0.999999999993942,0.723833848562478,0,3,metanephric glomerular mesangium development,BP,
15680,GO:0072239,0.999999999993942,0.723833848562478,0,3,metanephric glomerulus vasculature development,BP,
16078,GO:0090080,0.999999999993945,0.773571284330813,0,2,positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway,BP,
1545,GO:0003943,0.999999999993965,0.797065395439404,0,2,N-acetylgalactosamine-4-sulfatase activity,MF,
6355,GO:0021541,0.999999999993981,0.884129395189213,0,1,ammon gyrus development,BP,
13504,GO:0055100,0.999999999993995,0.709837085156722,0,3,adiponectin binding,MF,
17475,GO:1900453,0.999999999994014,0.810044736357702,0,2,negative regulation of long term synaptic depression,BP,
9700,GO:0038124,0.999999999994028,0.785966078857804,0,2,toll-like receptor TLR6:TLR2 signaling pathway,BP,
10028,GO:0042494,0.999999999994028,0.785966078857804,0,2,detection of bacterial lipoprotein,BP,
10030,GO:0042496,0.999999999994028,0.785966078857804,0,2,detection of diacyl bacterial lipopeptide,BP,
14688,GO:0070340,0.999999999994028,0.785966078857804,0,2,detection of bacterial lipopeptide,BP,
15420,GO:0071724,0.999999999994028,0.785966078857804,0,2,response to diacyl bacterial lipopeptide,BP,
15422,GO:0071726,0.999999999994028,0.785966078857804,0,2,cellular response to diacyl bacterial lipopeptide,BP,
7549,GO:0031893,0.99999999999406,0.901204800589738,0,1,vasopressin receptor binding,MF,
7550,GO:0031896,0.99999999999406,0.901204800589738,0,1,V2 vasopressin receptor binding,MF,
4604,GO:0010722,0.999999999994069,0.878469439271603,0,1,regulation of ferrochelatase activity,BP,
8934,GO:0034986,0.999999999994069,0.878469439271603,0,1,iron chaperone activity,MF,
18729,GO:1904229,0.999999999994069,0.878469439271603,0,1,regulation of succinate dehydrogenase activity,BP,
18730,GO:1904231,0.999999999994069,0.878469439271603,0,1,positive regulation of succinate dehydrogenase activity,BP,
18731,GO:1904232,0.999999999994069,0.878469439271603,0,1,regulation of aconitate hydratase activity,BP,
18732,GO:1904234,0.999999999994069,0.878469439271603,0,1,positive regulation of aconitate hydratase activity,BP,
1289,GO:0003104,0.999999999994073,0.652435768796664,0,4,positive regulation of glomerular filtration,BP,
7232,GO:0031161,0.999999999994078,0.896584215883708,0,1,phosphatidylinositol catabolic process,BP,
6005,GO:0019050,0.999999999994083,0.751112370954085,0,3,suppression by virus of host apoptotic process,BP,
9751,GO:0039526,0.999999999994083,0.751112370954085,0,3,modulation by virus of host apoptotic process,BP,
203,GO:0000429,0.999999999994105,0.723159203588304,0,3,carbon catabolite regulation of transcription from RNA polymerase II promoter,BP,
208,GO:0000436,0.999999999994105,0.723159203588304,0,3,carbon catabolite activation of transcription from RNA polymerase II promoter,BP,
17294,GO:0140161,0.999999999994111,0.743963988061718,0,3,monocarboxylate:sodium symporter activity,MF,
1483,GO:0003810,0.999999999994115,0.725900633331499,0,3,protein-glutamine gamma-glutamyltransferase activity,MF,
10586,GO:0043570,0.999999999994119,0.618795388361028,0,4,maintenance of DNA repeat elements,BP,
4097,GO:0009153,0.99999999999412,0.840834546303238,0,2,purine deoxyribonucleotide biosynthetic process,BP,
9647,GO:0038002,0.999999999994125,0.879860327079206,0,1,endocrine signaling,BP,
6490,GO:0021855,0.999999999994134,0.713646044625245,0,3,hypothalamus cell migration,BP,
11624,GO:0046356,0.999999999994138,0.839411546101805,0,2,acetyl-CoA catabolic process,BP,
5257,GO:0015889,0.999999999994141,0.738917584128494,0,3,cobalamin transport,BP,
15752,GO:0072369,0.999999999994153,0.785146559557602,0,2,regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter,BP,
4370,GO:0009992,0.999999999994161,0.901313628022382,0,1,cellular water homeostasis,BP,
108,GO:0000225,0.999999999994162,0.924738642441264,0,1,N-acetylglucosaminylphosphatidylinositol deacetylase activity,MF,
17485,GO:1900673,0.999999999994172,0.811155177392953,0,2,olefin metabolic process,BP,
19471,GO:1990264,0.999999999994173,0.80606618745567,0,2,peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity,BP,
17651,GO:1901534,0.999999999994174,0.791668493523299,0,2,positive regulation of hematopoietic progenitor cell differentiation,BP,
17757,GO:1901837,0.999999999994176,0.814220239744388,0,2,negative regulation of transcription of nucleolar large rRNA by RNA polymerase I,BP,
9328,GO:0035838,0.999999999994194,0.777725801517696,0,2,growing cell tip,CC,
7561,GO:0031930,0.999999999994196,0.913275446826446,0,1,mitochondria-nucleus signaling pathway,BP,
9745,GO:0039513,0.999999999994201,0.899595496869799,0,1,suppression by virus of host catalytic activity,BP,
9747,GO:0039516,0.999999999994201,0.899595496869799,0,1,modulation by virus of host catalytic activity,BP,
9765,GO:0039650,0.999999999994201,0.899595496869799,0,1,suppression by virus of host cysteine-type endopeptidase activity involved in apoptotic process,BP,
13283,GO:0052053,0.999999999994201,0.899595496869799,0,1,negative regulation by symbiont of host catalytic activity,BP,
13290,GO:0052148,0.999999999994201,0.899595496869799,0,1,modulation by symbiont of host catalytic activity,BP,
13299,GO:0052199,0.999999999994201,0.899595496869799,0,1,negative regulation of catalytic activity in other organism involved in symbiotic interaction,BP,
8242,GO:0033030,0.999999999994208,0.8793504545191,0,1,negative regulation of neutrophil apoptotic process,BP,
10398,GO:0043250,0.999999999994217,0.912026296803619,0,1,sodium-dependent organic anion transmembrane transporter activity,MF,
10399,GO:0043251,0.999999999994217,0.912026296803619,0,1,sodium-dependent organic anion transport,BP,
19505,GO:1990418,0.999999999994224,0.81362720022296,0,2,response to insulin-like growth factor stimulus,BP,
18575,GO:1903860,0.99999999999428,0.798421713975309,0,2,negative regulation of dendrite extension,BP,
19744,GO:2000172,0.99999999999428,0.798421713975309,0,2,regulation of branching morphogenesis of a nerve,BP,
5127,GO:0015562,0.999999999994285,0.634039328576423,0,4,efflux transmembrane transporter activity,MF,
15078,GO:0071139,0.999999999994295,0.791420225681498,0,2,resolution of recombination intermediates,BP,
15079,GO:0071140,0.999999999994295,0.791420225681498,0,2,resolution of mitotic recombination intermediates,BP,
8920,GO:0034777,0.999999999994297,0.901064590424917,0,1,recycling endosome lumen,CC,
15142,GO:0071283,0.999999999994308,0.840804265317268,0,2,cellular response to iron(III) ion,BP,
3346,GO:0007066,0.999999999994309,0.934709920657988,0,1,female meiosis sister chromatid cohesion,BP,
9010,GO:0035226,0.999999999994314,0.897298511660118,0,1,glutamate-cysteine ligase catalytic subunit binding,MF,
9011,GO:0035227,0.999999999994314,0.897298511660118,0,1,regulation of glutamate-cysteine ligase activity,BP,
9012,GO:0035229,0.999999999994314,0.897298511660118,0,1,positive regulation of glutamate-cysteine ligase activity,BP,
5818,GO:0017089,0.999999999994323,0.813072178085228,0,2,glycolipid transporter activity,MF,
17525,GO:1901077,0.999999999994326,0.623195509125875,0,4,regulation of relaxation of muscle,BP,
861,GO:0002194,0.999999999994327,0.897366596829032,0,1,hepatocyte cell migration,BP,
10284,GO:0043049,0.999999999994327,0.897366596829032,0,1,otic placode formation,BP,
14179,GO:0061114,0.999999999994327,0.897366596829032,0,1,branching involved in pancreas morphogenesis,BP,
14941,GO:0070858,0.999999999994327,0.897366596829032,0,1,negative regulation of bile acid biosynthetic process,BP,
16284,GO:0090425,0.999999999994327,0.897366596829032,0,1,acinar cell differentiation,BP,
18742,GO:1904252,0.999999999994327,0.897366596829032,0,1,negative regulation of bile acid metabolic process,BP,
20142,GO:2000979,0.999999999994327,0.897366596829032,0,1,positive regulation of forebrain neuron differentiation,BP,
5151,GO:0015691,0.99999999999433,0.714901061646352,0,3,cadmium ion transport,BP,
14814,GO:0070574,0.99999999999433,0.714901061646352,0,3,cadmium ion transmembrane transport,BP,
12492,GO:0050652,0.999999999994335,0.88944763807894,0,1,dermatan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process,BP,
12493,GO:0050653,0.999999999994335,0.88944763807894,0,1,chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process,BP,
7871,GO:0032444,0.999999999994335,0.764991203885481,0,2,activin responsive factor complex,CC,
153,GO:0000309,0.999999999994341,0.781832503787004,0,2,nicotinamide-nucleotide adenylyltransferase activity,MF,
6108,GO:0019355,0.999999999994341,0.781832503787004,0,2,nicotinamide nucleotide biosynthetic process from aspartate,BP,
8828,GO:0034627,0.999999999994341,0.781832503787004,0,2,'de novo' NAD biosynthetic process,BP,
8829,GO:0034628,0.999999999994341,0.781832503787004,0,2,'de novo' NAD biosynthetic process from aspartate,BP,
2340,GO:0005372,0.999999999994354,0.668129390076863,0,4,water transmembrane transporter activity,MF,
5052,GO:0015250,0.999999999994354,0.668129390076863,0,4,water channel activity,MF,
16773,GO:0098633,0.999999999994363,0.900288170104945,0,1,collagen fibril binding,MF,
18659,GO:1904027,0.999999999994363,0.900288170104945,0,1,negative regulation of collagen fibril organization,BP,
12868,GO:0051228,0.999999999994366,0.880083726273309,0,1,mitotic spindle disassembly,BP,
12869,GO:0051230,0.999999999994366,0.880083726273309,0,1,spindle disassembly,BP,
7462,GO:0031628,0.999999999994371,0.628567362578001,0,4,opioid receptor binding,MF,
7541,GO:0031852,0.999999999994371,0.628567362578001,0,4,mu-type opioid receptor binding,MF,
9344,GO:0035867,0.999999999994386,0.765402319421909,0,2,alphav-beta3 integrin-IGF-1-IGF1R complex,CC,
13515,GO:0055120,0.999999999994393,0.92947558968056,0,1,striated muscle dense body,CC,
15136,GO:0071275,0.999999999994426,0.901467940150284,0,1,cellular response to aluminum ion,BP,
19318,GO:1905672,0.999999999994426,0.901467940150284,0,1,negative regulation of lysosome organization,BP,
17434,GO:1900243,0.999999999994434,0.879983334288092,0,1,negative regulation of synaptic vesicle endocytosis,BP,
19127,GO:1905154,0.999999999994434,0.879983334288092,0,1,negative regulation of membrane invagination,BP,
19129,GO:1905161,0.999999999994434,0.879983334288092,0,1,protein localization to phagocytic vesicle,BP,
19130,GO:1905162,0.999999999994434,0.879983334288092,0,1,regulation of phagosome maturation,BP,
19135,GO:1905169,0.999999999994434,0.879983334288092,0,1,regulation of protein localization to phagocytic vesicle,BP,
19136,GO:1905171,0.999999999994434,0.879983334288092,0,1,positive regulation of protein localization to phagocytic vesicle,BP,
19254,GO:1905468,0.999999999994434,0.879983334288092,0,1,regulation of clathrin-coated pit assembly,BP,
19255,GO:1905469,0.999999999994434,0.879983334288092,0,1,negative regulation of clathrin-coated pit assembly,BP,
10150,GO:0042748,0.999999999994449,0.702293468823835,0,3,circadian sleep/wake cycle, non-REM sleep,BP,
11965,GO:0047288,0.999999999994459,0.799644690944234,0,2,monosialoganglioside sialyltransferase activity,MF,
12477,GO:0050510,0.999999999994461,0.626717619358677,0,4,N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity,MF,
18169,GO:1902960,0.999999999994469,0.785282818606964,0,2,negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process,BP,
19158,GO:1905246,0.999999999994469,0.785282818606964,0,2,negative regulation of aspartic-type peptidase activity,BP,
8657,GO:0034238,0.999999999994474,0.886339719892704,0,1,macrophage fusion,BP,
8658,GO:0034239,0.999999999994474,0.886339719892704,0,1,regulation of macrophage fusion,BP,
8659,GO:0034241,0.999999999994474,0.886339719892704,0,1,positive regulation of macrophage fusion,BP,
17801,GO:1901980,0.999999999994486,0.873834922265443,0,1,positive regulation of inward rectifier potassium channel activity,BP,
15463,GO:0071838,0.999999999994491,0.657247355575915,0,4,cell proliferation in bone marrow,BP,
8326,GO:0033183,0.999999999994499,0.69279592984072,0,3,negative regulation of histone ubiquitination,BP,
17597,GO:1901314,0.999999999994499,0.69279592984072,0,3,regulation of histone H2A K63-linked ubiquitination,BP,
17598,GO:1901315,0.999999999994499,0.69279592984072,0,3,negative regulation of histone H2A K63-linked ubiquitination,BP,
10904,GO:0044501,0.9999999999945,0.787693307821904,0,2,modulation of signal transduction in other organism,BP,
13275,GO:0052027,0.9999999999945,0.787693307821904,0,2,modulation by symbiont of host signal transduction pathway,BP,
13309,GO:0052250,0.9999999999945,0.787693307821904,0,2,modulation of signal transduction in other organism involved in symbiotic interaction,BP,
2631,GO:0005960,0.999999999994501,0.809965930724931,0,2,glycine cleavage complex,CC,
9144,GO:0035508,0.999999999994508,0.879683035822423,0,1,positive regulation of myosin-light-chain-phosphatase activity,BP,
1675,GO:0004142,0.999999999994512,0.723330684974599,0,3,diacylglycerol cholinephosphotransferase activity,MF,
8537,GO:0033883,0.999999999994522,0.835819132077438,0,2,pyridoxal phosphatase activity,MF,
1016,GO:0002513,0.999999999994528,0.712876157405306,0,3,tolerance induction to self antigen,BP,
11448,GO:0045919,0.999999999994533,0.683707026687803,0,4,positive regulation of cytolysis,BP,
7115,GO:0030943,0.999999999994534,0.730057077874142,0,3,mitochondrion targeting sequence binding,MF,
19461,GO:1990239,0.999999999994538,0.647366391808712,0,4,steroid hormone binding,MF,
2291,GO:0005250,0.999999999994539,0.793587972165718,0,2,A-type (transient outward) potassium channel activity,MF,
11375,GO:0045769,0.999999999994542,0.871934925592394,0,1,negative regulation of asymmetric cell division,BP,
1720,GO:0004314,0.999999999994543,0.791756040273394,0,2,[acyl-carrier-protein] S-malonyltransferase activity,MF,
5483,GO:0016419,0.999999999994543,0.791756040273394,0,2,S-malonyltransferase activity,MF,
5484,GO:0016420,0.999999999994543,0.791756040273394,0,2,malonyltransferase activity,MF,
14102,GO:0060987,0.999999999994544,0.900773802003438,0,1,lipid tube,CC,
1957,GO:0004663,0.999999999994554,0.661805420969978,0,4,Rab geranylgeranyltransferase activity,MF,
12393,GO:0048855,0.999999999994555,0.879197521634219,0,1,adenohypophysis morphogenesis,BP,
15547,GO:0072019,0.999999999994567,0.901530011306619,0,1,proximal convoluted tubule development,BP,
15675,GO:0072229,0.999999999994567,0.901530011306619,0,1,metanephric proximal convoluted tubule development,BP,
18117,GO:1902858,0.999999999994567,0.901530011306619,0,1,propionyl-CoA metabolic process,BP,
18118,GO:1902860,0.999999999994567,0.901530011306619,0,1,propionyl-CoA biosynthetic process,BP,
8635,GO:0034188,0.999999999994589,0.767162121982506,0,2,apolipoprotein A-I receptor activity,MF,
16310,GO:0090554,0.999999999994589,0.767162121982506,0,2,phosphatidylcholine-translocating ATPase activity,MF,
16311,GO:0090556,0.999999999994589,0.767162121982506,0,2,phosphatidylserine-translocating ATPase activity,MF,
10988,GO:0044805,0.99999999999459,0.78274947747694,0,2,late nucleophagy,BP,
16294,GO:0090498,0.999999999994594,0.79204149193012,0,2,extrinsic component of Golgi membrane,CC,
8798,GO:0034515,0.999999999994596,0.804573790152368,0,2,proteasome storage granule,CC,
8156,GO:0032899,0.999999999994596,0.887453127850776,0,1,regulation of neurotrophin production,BP,
8157,GO:0032901,0.999999999994596,0.887453127850776,0,1,positive regulation of neurotrophin production,BP,
8843,GO:0034649,0.999999999994596,0.887453127850776,0,1,histone demethylase activity (H3-monomethyl-K4 specific),MF,
12198,GO:0048403,0.999999999994596,0.887453127850776,0,1,brain-derived neurotrophic factor binding,MF,
348,GO:0000962,0.999999999994597,0.793921153880169,0,2,positive regulation of mitochondrial RNA catabolic process,BP,
11030,GO:0045025,0.999999999994597,0.793921153880169,0,2,mitochondrial degradosome,CC,
13762,GO:0060370,0.999999999994604,0.879599569003577,0,1,susceptibility to T cell mediated cytotoxicity,BP,
191,GO:0000409,0.999999999994604,0.878733848226173,0,1,regulation of transcription by galactose,BP,
192,GO:0000411,0.999999999994604,0.878733848226173,0,1,positive regulation of transcription by galactose,BP,
205,GO:0000431,0.999999999994604,0.878733848226173,0,1,regulation of transcription from RNA polymerase II promoter by galactose,BP,
207,GO:0000435,0.999999999994604,0.878733848226173,0,1,positive regulation of transcription from RNA polymerase II promoter by galactose,BP,
15026,GO:0070993,0.99999999999461,0.78050122738767,0,2,translation preinitiation complex,CC,
1571,GO:0003980,0.999999999994612,0.767773698510401,0,2,UDP-glucose:glycoprotein glucosyltransferase activity,MF,
16548,GO:0097359,0.999999999994612,0.767773698510401,0,2,UDP-glucosylation,BP,
8211,GO:0032980,0.999999999994617,0.900533239759162,0,1,keratinocyte activation,BP,
5410,GO:0016256,0.999999999994619,0.809964193942354,0,2,N-glycan processing to lysosome,BP,
14424,GO:0061763,0.999999999994621,0.809011816576206,0,2,multivesicular body-lysosome fusion,BP,
13301,GO:0052203,0.999999999994632,0.81509322391424,0,2,modulation of catalytic activity in other organism involved in symbiotic interaction,BP,
9045,GO:0035279,0.99999999999464,0.800973795538109,0,2,mRNA cleavage involved in gene silencing by miRNA,BP,
16844,GO:0098795,0.99999999999464,0.800973795538109,0,2,mRNA cleavage involved in gene silencing,BP,
15940,GO:0075732,0.999999999994644,0.776137794531544,0,2,viral penetration into host nucleus,BP,
18030,GO:1902594,0.999999999994644,0.776137794531544,0,2,multi-organism nuclear import,BP,
14672,GO:0070315,0.999999999994647,0.802578793454094,0,2,G1 to G0 transition involved in cell differentiation,BP,
13709,GO:0060300,0.999999999994652,0.739406339683735,0,3,regulation of cytokine activity,BP,
10951,GO:0044725,0.999999999994662,0.871755599891624,0,1,chromatin reprogramming in the zygote,BP,
10952,GO:0044727,0.999999999994662,0.871755599891624,0,1,DNA demethylation of male pronucleus,BP,
19496,GO:1990405,0.999999999994671,0.616108813997012,0,4,protein antigen binding,MF,
13918,GO:0060605,0.999999999994673,0.728050159103237,0,3,tube lumen cavitation,BP,
13935,GO:0060662,0.999999999994673,0.728050159103237,0,3,salivary gland cavitation,BP,
3667,GO:0008158,0.999999999994684,0.820670731287541,0,2,hedgehog receptor activity,MF,
19639,GO:1990910,0.99999999999469,0.751346747296249,0,3,response to hypobaric hypoxia,BP,
4460,GO:0010455,0.999999999994691,0.664313496917429,0,4,positive regulation of cell fate commitment,BP,
8168,GO:0032914,0.999999999994692,0.715570980235665,0,3,positive regulation of transforming growth factor beta1 production,BP,
16957,GO:0099022,0.999999999994694,0.817190328204909,0,2,vesicle tethering,BP,
16961,GO:0099044,0.999999999994694,0.817190328204909,0,2,vesicle tethering to endoplasmic reticulum,BP,
13145,GO:0051754,0.999999999994701,0.714240324305811,0,3,meiotic sister chromatid cohesion, centromeric,BP,
5385,GO:0016212,0.99999999999471,0.811403803686981,0,2,kynurenine-oxoglutarate transaminase activity,MF,
9483,GO:0036137,0.99999999999471,0.811403803686981,0,2,kynurenine aminotransferase activity,MF,
16396,GO:0097052,0.99999999999471,0.811403803686981,0,2,L-kynurenine metabolic process,BP,
8185,GO:0032937,0.999999999994717,0.715525883493603,0,3,SREBP-SCAP-Insig complex,CC,
17800,GO:1901979,0.99999999999473,0.786384155726351,0,2,regulation of inward rectifier potassium channel activity,BP,
16098,GO:0090107,0.999999999994737,0.721923461783025,0,3,regulation of high-density lipoprotein particle assembly,BP,
5346,GO:0016098,0.999999999994748,0.896763037699965,0,1,monoterpenoid metabolic process,BP,
8504,GO:0033695,0.999999999994748,0.896763037699965,0,1,oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor,MF,
8921,GO:0034875,0.999999999994748,0.896763037699965,0,1,caffeine oxidase activity,MF,
15352,GO:0071615,0.999999999994748,0.896763037699965,0,1,oxidative deethylation,BP,
15448,GO:0071812,0.999999999994748,0.896763037699965,0,1,positive regulation of fever generation by positive regulation of prostaglandin secretion,BP,
15467,GO:0071848,0.999999999994748,0.896763037699965,0,1,positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling,BP,
16675,GO:0097644,0.999999999994768,0.824268553461477,0,2,calcitonin family binding,MF,
18388,GO:1903439,0.999999999994768,0.824268553461477,0,2,calcitonin family receptor complex,CC,
19497,GO:1990406,0.999999999994768,0.824268553461477,0,2,CGRP receptor complex,CC,
19499,GO:1990408,0.999999999994768,0.824268553461477,0,2,calcitonin gene-related peptide receptor signaling pathway,BP,
8524,GO:0033858,0.999999999994771,0.896331765430646,0,1,N-acetylgalactosamine kinase activity,MF,
2757,GO:0006168,0.999999999994782,0.780781683914416,0,3,adenine salvage,BP,
11533,GO:0046083,0.999999999994782,0.780781683914416,0,3,adenine metabolic process,BP,
11534,GO:0046084,0.999999999994782,0.780781683914416,0,3,adenine biosynthetic process,BP,
18835,GO:1904481,0.999999999994783,0.900443176978381,0,1,response to tetrahydrofolate,BP,
18836,GO:1904482,0.999999999994783,0.900443176978381,0,1,cellular response to tetrahydrofolate,BP,
1791,GO:0004422,0.999999999994806,0.826260689857339,0,2,hypoxanthine phosphoribosyltransferase activity,MF,
2764,GO:0006178,0.999999999994806,0.826260689857339,0,2,guanine salvage,BP,
7741,GO:0032263,0.999999999994806,0.826260689857339,0,2,GMP salvage,BP,
11541,GO:0046099,0.999999999994806,0.826260689857339,0,2,guanine biosynthetic process,BP,
16956,GO:0099011,0.99999999999484,0.779909696891072,0,2,neuronal dense core vesicle exocytosis,BP,
17026,GO:0099525,0.99999999999484,0.779909696891072,0,2,presynaptic dense core vesicle exocytosis,BP,
14937,GO:0070852,0.999999999994843,0.692622196954268,0,3,cell body fiber,CC,
10734,GO:0044128,0.999999999994844,0.880223196001137,0,1,positive regulation of growth of symbiont in host,BP,
10740,GO:0044148,0.999999999994844,0.880223196001137,0,1,positive regulation of growth of symbiont involved in interaction with host,BP,
2217,GO:0005115,0.999999999994846,0.879555352568817,0,1,receptor tyrosine kinase-like orphan receptor binding,MF,
6407,GO:0021650,0.999999999994846,0.879555352568817,0,1,vestibulocochlear nerve formation,BP,
9636,GO:0036517,0.999999999994846,0.879555352568817,0,1,chemoattraction of serotonergic neuron axon,BP,
13203,GO:0051885,0.999999999994846,0.879555352568817,0,1,positive regulation of timing of anagen,BP,
13545,GO:0060031,0.999999999994846,0.879555352568817,0,1,mediolateral intercalation,BP,
13576,GO:0060067,0.999999999994846,0.879555352568817,0,1,cervix development,BP,
13913,GO:0060599,0.999999999994846,0.879555352568817,0,1,lateral sprouting involved in mammary gland duct morphogenesis,BP,
14020,GO:0060775,0.999999999994846,0.879555352568817,0,1,planar cell polarity pathway involved in gastrula mediolateral intercalation,BP,
14027,GO:0060809,0.999999999994846,0.879555352568817,0,1,mesodermal to mesenchymal transition involved in gastrulation,BP,
14251,GO:0061347,0.999999999994846,0.879555352568817,0,1,planar cell polarity pathway involved in outflow tract morphogenesis,BP,
14252,GO:0061348,0.999999999994846,0.879555352568817,0,1,planar cell polarity pathway involved in ventricular septum morphogenesis,BP,
14253,GO:0061349,0.999999999994846,0.879555352568817,0,1,planar cell polarity pathway involved in cardiac right atrium morphogenesis,BP,
14254,GO:0061350,0.999999999994846,0.879555352568817,0,1,planar cell polarity pathway involved in cardiac muscle tissue morphogenesis,BP,
14256,GO:0061354,0.999999999994846,0.879555352568817,0,1,planar cell polarity pathway involved in pericardium morphogenesis,BP,
14371,GO:0061642,0.999999999994846,0.879555352568817,0,1,chemoattraction of axon,BP,
17955,GO:1902379,0.999999999994846,0.879555352568817,0,1,chemoattractant activity involved in axon guidance,MF,
19042,GO:1904933,0.999999999994846,0.879555352568817,0,1,regulation of cell proliferation in midbrain,BP,
19043,GO:1904934,0.999999999994846,0.879555352568817,0,1,negative regulation of cell proliferation in midbrain,BP,
19052,GO:1904955,0.999999999994846,0.879555352568817,0,1,planar cell polarity pathway involved in midbrain dopaminergic neuron differentiation,BP,
19238,GO:1905438,0.999999999994846,0.879555352568817,0,1,non-canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation,BP,
4751,GO:0010931,0.999999999994846,0.877101564641603,0,1,macrophage tolerance induction,BP,
4752,GO:0010932,0.999999999994846,0.877101564641603,0,1,regulation of macrophage tolerance induction,BP,
4753,GO:0010933,0.999999999994846,0.877101564641603,0,1,positive regulation of macrophage tolerance induction,BP,
4475,GO:0010484,0.999999999994857,0.616282984697877,0,4,H3 histone acetyltransferase activity,MF,
9964,GO:0042365,0.999999999994861,0.745607792409023,0,3,water-soluble vitamin catabolic process,BP,
13628,GO:0060157,0.999999999994871,0.775400570653551,0,2,urinary bladder development,BP,
176,GO:0000386,0.999999999994895,0.709952244262746,0,3,second spliceosomal transesterification activity,MF,
3846,GO:0008458,0.999999999994898,0.895401989761285,0,1,carnitine O-octanoyltransferase activity,MF,
5478,GO:0016414,0.999999999994898,0.895401989761285,0,1,O-octanoyltransferase activity,MF,
5479,GO:0016415,0.999999999994898,0.895401989761285,0,1,octanoyltransferase activity,MF,
3912,GO:0008579,0.999999999994906,0.879938637486586,0,1,JUN kinase phosphatase activity,MF,
19419,GO:1990071,0.999999999994911,0.828923220993448,0,2,TRAPPII protein complex,CC,
14045,GO:0060846,0.999999999994912,0.725513156575262,0,3,blood vessel endothelial cell fate commitment,BP,
14046,GO:0060847,0.999999999994912,0.725513156575262,0,3,endothelial cell fate specification,BP,
16419,GO:0097101,0.999999999994912,0.725513156575262,0,3,blood vessel endothelial cell fate specification,BP,
8858,GO:0034670,0.999999999994912,0.874477481178319,0,1,chemotaxis to arachidonic acid,BP,
6103,GO:0019343,0.99999999999492,0.815610992326612,0,2,cysteine biosynthetic process via cystathionine,BP,
10484,GO:0043400,0.999999999994924,0.828972528628749,0,2,cortisol secretion,BP,
13006,GO:0051462,0.999999999994924,0.828972528628749,0,2,regulation of cortisol secretion,BP,
919,GO:0002314,0.999999999994933,0.82049637039237,0,2,germinal center B cell differentiation,BP,
7676,GO:0032129,0.999999999994935,0.806636482053698,0,2,histone deacetylase activity (H3-K9 specific),MF,
11909,GO:0046969,0.999999999994935,0.806636482053698,0,2,NAD-dependent histone deacetylase activity (H3-K9 specific),MF,
19557,GO:1990619,0.999999999994935,0.806636482053698,0,2,histone H3-K9 deacetylation,BP,
2236,GO:0005143,0.999999999994938,0.794287909660796,0,2,interleukin-12 receptor binding,MF,
5216,GO:0015820,0.999999999994944,0.795678881301463,0,2,leucine transport,BP,
9807,GO:0042025,0.999999999994952,0.700503392060713,0,3,host cell nucleus,CC,
10723,GO:0044094,0.999999999994952,0.700503392060713,0,3,host cell nuclear part,CC,
13387,GO:0052746,0.999999999994954,0.790427415165716,0,2,inositol phosphorylation,BP,
8887,GO:0034718,0.999999999994962,0.879800934025601,0,1,SMN-Gemin2 complex,CC,
1531,GO:0003918,0.999999999994978,0.774069826494408,0,2,DNA topoisomerase type II (ATP-hydrolyzing) activity,MF,
14304,GO:0061505,0.999999999994978,0.774069826494408,0,2,DNA topoisomerase II activity,MF,
2599,GO:0005898,0.999999999994985,0.88609812109358,0,1,interleukin-13 receptor complex,CC,
11266,GO:0045590,0.999999999994986,0.89156543048602,0,1,negative regulation of regulatory T cell differentiation,BP,
18643,GO:1903984,0.999999999994995,0.698200163404972,0,3,positive regulation of TRAIL-activated apoptotic signaling pathway,BP,
9366,GO:0035905,0.999999999995002,0.708099128132465,0,3,ascending aorta development,BP,
9369,GO:0035910,0.999999999995002,0.708099128132465,0,3,ascending aorta morphogenesis,BP,
17352,GO:1900095,0.999999999995005,0.872675900931351,0,1,regulation of dosage compensation by inactivation of X chromosome,BP,
10126,GO:0042701,0.999999999995018,0.791595304453493,0,2,progesterone secretion,BP,
16230,GO:0090306,0.999999999995026,0.625770156892064,0,4,spindle assembly involved in meiosis,BP,
10805,GO:0044307,0.999999999995028,0.867685240439537,0,1,dendritic branch,CC,
14098,GO:0060978,0.999999999995034,0.791620860307347,0,2,angiogenesis involved in coronary vascular morphogenesis,BP,
4875,GO:0014739,0.999999999995034,0.898252050189098,0,1,positive regulation of muscle hyperplasia,BP,
18287,GO:1903231,0.999999999995034,0.898252050189098,0,1,mRNA binding involved in posttranscriptional gene silencing,MF,
10452,GO:0043328,0.999999999995036,0.702700358940437,0,4,protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway,BP,
1334,GO:0003193,0.999999999995045,0.896396784579435,0,1,pulmonary valve formation,BP,
9374,GO:0035922,0.999999999995045,0.896396784579435,0,1,foramen ovale closure,BP,
16003,GO:0086044,0.999999999995045,0.896396784579435,0,1,atrial cardiac muscle cell to AV node cell communication by electrical coupling,BP,
16009,GO:0086054,0.999999999995045,0.896396784579435,0,1,bundle of His cell to Purkinje myocyte communication by electrical coupling,BP,
16010,GO:0086055,0.999999999995045,0.896396784579435,0,1,Purkinje myocyte to ventricular cardiac muscle cell communication by electrical coupling,BP,
16023,GO:0086076,0.999999999995045,0.896396784579435,0,1,gap junction channel activity involved in atrial cardiac muscle cell-AV node cell electrical coupling,MF,
16025,GO:0086078,0.999999999995045,0.896396784579435,0,1,gap junction channel activity involved in bundle of His cell-Purkinje myocyte electrical coupling,MF,
16026,GO:0086079,0.999999999995045,0.896396784579435,0,1,gap junction channel activity involved in Purkinje myocyte-ventricular cardiac muscle cell electrical coupling,MF,
16907,GO:0098906,0.999999999995045,0.896396784579435,0,1,regulation of Purkinje myocyte action potential,BP,
19406,GO:1990029,0.999999999995045,0.896396784579435,0,1,vasomotion,BP,
20242,GO:2001229,0.999999999995052,0.864420649481329,0,1,negative regulation of response to gamma radiation,BP,
11947,GO:0047159,0.999999999995057,0.886718327437879,0,1,1-alkenylglycerophosphocholine O-acyltransferase activity,MF,
11952,GO:0047191,0.999999999995057,0.886718327437879,0,1,1-alkylglycerophosphocholine O-acyltransferase activity,MF,
20256,GO:2001246,0.999999999995057,0.886718327437879,0,1,negative regulation of phosphatidylcholine biosynthetic process,BP,
12765,GO:0051066,0.99999999999506,0.820037334179158,0,2,dihydrobiopterin metabolic process,BP,
20029,GO:2000675,0.999999999995068,0.626458073748749,0,4,negative regulation of type B pancreatic cell apoptotic process,BP,
6878,GO:0030389,0.999999999995073,0.948042427808703,0,1,fructosamine metabolic process,BP,
14030,GO:0060821,0.999999999995075,0.876381410043131,0,1,inactivation of X chromosome by DNA methylation,BP,
16461,GO:0097166,0.999999999995075,0.876381410043131,0,1,lens epithelial cell proliferation,BP,
20186,GO:2001109,0.999999999995075,0.876381410043131,0,1,regulation of lens epithelial cell proliferation,BP,
20187,GO:2001111,0.999999999995075,0.876381410043131,0,1,positive regulation of lens epithelial cell proliferation,BP,
8170,GO:0032916,0.999999999995079,0.769104659271552,0,2,positive regulation of transforming growth factor beta3 production,BP,
9522,GO:0036266,0.999999999995088,0.90024999016427,0,1,Cdc48p-Npl4p-Vms1p AAA ATPase complex,CC,
15878,GO:0072671,0.999999999995088,0.90024999016427,0,1,mitochondria-associated ubiquitin-dependent protein catabolic process,BP,
1496,GO:0003844,0.99999999999509,0.896958939366884,0,1,1,4-alpha-glucan branching enzyme activity,MF,
17145,GO:0102752,0.99999999999509,0.896958939366884,0,1,1,4-alpha-glucan branching enzyme activity (using a glucosylated glycogenin as primer for glycogen synthesis),MF,
19198,GO:1905340,0.999999999995096,0.660737064671155,0,4,regulation of protein localization to kinetochore,BP,
19200,GO:1905342,0.999999999995096,0.660737064671155,0,4,positive regulation of protein localization to kinetochore,BP,
9913,GO:0042271,0.9999999999951,0.777374217909323,0,2,susceptibility to natural killer cell mediated cytotoxicity,BP,
13068,GO:0051598,0.999999999995101,0.881758446817081,0,1,meiotic recombination checkpoint,BP,
7103,GO:0030910,0.999999999995109,0.705096117044684,0,3,olfactory placode formation,BP,
15406,GO:0071698,0.999999999995109,0.705096117044684,0,3,olfactory placode development,BP,
15407,GO:0071699,0.999999999995109,0.705096117044684,0,3,olfactory placode morphogenesis,BP,
14519,GO:0070053,0.999999999995126,0.791998950968674,0,2,thrombospondin receptor activity,MF,
2227,GO:0005131,0.999999999995138,0.616864369456186,0,4,growth hormone receptor binding,MF,
3645,GO:0008119,0.999999999995138,0.895425256607105,0,1,thiopurine S-methyltransferase activity,MF,
12049,GO:0048014,0.999999999995142,0.879961072805931,0,1,Tie signaling pathway,BP,
12690,GO:0050928,0.999999999995142,0.879961072805931,0,1,negative regulation of positive chemotaxis,BP,
8951,GO:0035026,0.999999999995149,0.78880821950756,0,2,leading edge cell differentiation,BP,
8935,GO:0034987,0.99999999999518,0.876659303943646,0,1,immunoglobulin receptor binding,MF,
8936,GO:0034988,0.99999999999518,0.876659303943646,0,1,Fc-gamma receptor I complex binding,MF,
13764,GO:0060372,0.99999999999518,0.876659303943646,0,1,regulation of atrial cardiac muscle cell membrane repolarization,BP,
19074,GO:1905000,0.99999999999518,0.876659303943646,0,1,regulation of membrane repolarization during atrial cardiac muscle cell action potential,BP,
19292,GO:1905595,0.999999999995186,0.80892160997893,0,2,regulation of low-density lipoprotein particle receptor binding,BP,
19566,GO:1990667,0.999999999995186,0.80892160997893,0,2,PCSK9-AnxA2 complex,CC,
4898,GO:0014827,0.999999999995188,0.901090810948896,0,1,intestine smooth muscle contraction,BP,
4731,GO:0010898,0.999999999995195,0.79357573953651,0,2,positive regulation of triglyceride catabolic process,BP,
14186,GO:0061140,0.999999999995218,0.742354972898459,0,3,lung secretory cell differentiation,BP,
106,GO:0000221,0.999999999995225,0.710917435096786,0,3,vacuolar proton-transporting V-type ATPase, V1 domain,CC,
837,GO:0002144,0.999999999995225,0.901745150781228,0,1,cytosolic tRNA wobble base thiouridylase complex,CC,
2241,GO:0005152,0.999999999995228,0.715184047631184,0,3,interleukin-1 receptor antagonist activity,MF,
14324,GO:0061550,0.999999999995228,0.622070686477082,0,4,cranial ganglion development,BP,
124,GO:0000255,0.999999999995248,0.777300667392946,0,2,allantoin metabolic process,BP,
4821,GO:0014022,0.999999999995258,0.709762741972643,0,3,neural plate elongation,BP,
6555,GO:0022007,0.999999999995258,0.709762741972643,0,3,convergent extension involved in neural plate elongation,BP,
11208,GO:0045355,0.999999999995279,0.829256207247582,0,2,negative regulation of interferon-alpha biosynthetic process,BP,
4500,GO:0010536,0.99999999999528,0.857005604560061,0,2,positive regulation of activation of Janus kinase activity,BP,
10842,GO:0044355,0.999999999995283,0.913845125537061,0,1,clearance of foreign intracellular DNA,BP,
10843,GO:0044356,0.999999999995283,0.913845125537061,0,1,clearance of foreign intracellular DNA by conversion of DNA cytidine to uridine,BP,
16962,GO:0099046,0.999999999995283,0.913845125537061,0,1,clearance of foreign intracellular nucleic acids,BP,
18894,GO:1904627,0.999999999995283,0.913845125537061,0,1,response to phorbol 13-acetate 12-myristate,BP,
18895,GO:1904628,0.999999999995283,0.913845125537061,0,1,cellular response to phorbol 13-acetate 12-myristate,BP,
933,GO:0002332,0.999999999995292,0.879663143243179,0,1,transitional stage B cell differentiation,BP,
934,GO:0002333,0.999999999995292,0.879663143243179,0,1,transitional one stage B cell differentiation,BP,
18851,GO:1904531,0.999999999995292,0.879663143243179,0,1,positive regulation of actin filament binding,BP,
18893,GO:1904618,0.999999999995292,0.879663143243179,0,1,positive regulation of actin binding,BP,
19417,GO:1990051,0.999999999995292,0.879663143243179,0,1,activation of protein kinase C activity,BP,
19928,GO:2000491,0.999999999995305,0.896304562488425,0,1,positive regulation of hepatic stellate cell activation,BP,
20019,GO:2000664,0.99999999999531,0.722805346231003,0,3,positive regulation of interleukin-5 secretion,BP,
20022,GO:2000667,0.99999999999531,0.722805346231003,0,3,positive regulation of interleukin-13 secretion,BP,
13037,GO:0051548,0.999999999995313,0.7724424860728,0,2,negative regulation of keratinocyte migration,BP,
13247,GO:0051956,0.999999999995316,0.710588262400844,0,3,negative regulation of amino acid transport,BP,
18934,GO:1904720,0.999999999995318,0.808045411470444,0,2,regulation of mRNA endonucleolytic cleavage involved in unfolded protein response,BP,
8696,GO:0034346,0.999999999995323,0.897650974205667,0,1,positive regulation of type III interferon production,BP,
1369,GO:0003257,0.999999999995332,0.883421425466834,0,1,positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation,BP,
4615,GO:0010736,0.999999999995332,0.883421425466834,0,1,serum response element binding,MF,
4903,GO:0014835,0.999999999995332,0.883421425466834,0,1,myoblast differentiation involved in skeletal muscle regeneration,BP,
17568,GO:1901228,0.999999999995332,0.883421425466834,0,1,positive regulation of transcription from RNA polymerase II promoter involved in heart development,BP,
17738,GO:1901726,0.999999999995333,0.871942155643796,0,1,negative regulation of histone deacetylase activity,BP,
10455,GO:0043335,0.999999999995337,0.815207220586336,0,2,protein unfolding,BP,
15169,GO:0071332,0.999999999995339,0.814489522026354,0,2,cellular response to fructose stimulus,BP,
4440,GO:0010335,0.999999999995341,0.882298216323499,0,1,response to non-ionic osmotic stress,BP,
8542,GO:0033925,0.999999999995341,0.882298216323499,0,1,mannosyl-glycoprotein endo-beta-N-acetylglucosaminidase activity,MF,
15265,GO:0071471,0.999999999995341,0.882298216323499,0,1,cellular response to non-ionic osmotic stress,BP,
5047,GO:0015234,0.999999999995341,0.80887735339985,0,2,thiamine transmembrane transporter activity,MF,
15516,GO:0071934,0.999999999995341,0.80887735339985,0,2,thiamine transmembrane transport,BP,
13527,GO:0060010,0.999999999995344,0.894598671293389,0,1,Sertoli cell fate commitment,BP,
10555,GO:0043532,0.999999999995345,0.878895784848231,0,1,angiostatin binding,MF,
801,GO:0002071,0.999999999995349,0.806065894807597,0,2,glandular epithelial cell maturation,BP,
11643,GO:0046404,0.999999999995357,0.721754324189013,0,3,ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity,MF,
13139,GO:0051733,0.999999999995357,0.721754324189013,0,3,polydeoxyribonucleotide kinase activity,MF,
13140,GO:0051734,0.999999999995357,0.721754324189013,0,3,ATP-dependent polynucleotide kinase activity,MF,
8088,GO:0032783,0.999999999995365,0.628736687647348,0,4,ELL-EAF complex,CC,
7083,GO:0030885,0.999999999995374,0.760988476740233,0,3,regulation of myeloid dendritic cell activation,BP,
10424,GO:0043293,0.999999999995393,0.795751199704443,0,2,apoptosome,CC,
15088,GO:0071163,0.999999999995397,0.749665216015122,0,3,DNA replication preinitiation complex assembly,BP,
7395,GO:0031466,0.999999999995411,0.677873192960389,0,4,Cul5-RING ubiquitin ligase complex,CC,
13370,GO:0052692,0.999999999995432,0.914624574186358,0,1,raffinose alpha-galactosidase activity,MF,
16559,GO:0097376,0.999999999995432,0.914624574186358,0,1,interneuron axon guidance,BP,
3579,GO:0007624,0.999999999995436,0.884800902040266,0,1,ultradian rhythm,BP,
9099,GO:0035400,0.999999999995443,0.879917248390201,0,1,histone tyrosine kinase activity,MF,
9100,GO:0035401,0.999999999995443,0.879917248390201,0,1,histone kinase activity (H3-Y41 specific),MF,
9105,GO:0035406,0.999999999995443,0.879917248390201,0,1,histone-tyrosine phosphorylation,BP,
9108,GO:0035409,0.999999999995443,0.879917248390201,0,1,histone H3-Y41 phosphorylation,BP,
6462,GO:0021796,0.99999999999545,0.714334636072365,0,3,cerebral cortex regionalization,BP,
1654,GO:0004111,0.999999999995454,0.658300236210764,0,4,creatine kinase activity,MF,
5270,GO:0015920,0.999999999995457,0.899892733119504,0,1,lipopolysaccharide transport,BP,
7914,GO:0032497,0.999999999995457,0.899892733119504,0,1,detection of lipopolysaccharide,BP,
14770,GO:0070506,0.999999999995457,0.899892733119504,0,1,high-density lipoprotein particle receptor activity,MF,
1943,GO:0004648,0.999999999995464,0.901640289522468,0,1,O-phospho-L-serine:2-oxoglutarate aminotransferase activity,MF,
1637,GO:0004082,0.999999999995467,0.743145976292932,0,3,bisphosphoglycerate mutase activity,MF,
1923,GO:0004619,0.999999999995467,0.743145976292932,0,3,phosphoglycerate mutase activity,MF,
11712,GO:0046538,0.999999999995467,0.743145976292932,0,3,2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity,MF,
10931,GO:0044609,0.999999999995468,0.810347899456751,0,2,DBIRD complex,CC,
16317,GO:0090571,0.999999999995469,0.732300464651838,0,3,RNA polymerase II transcription repressor complex,CC,
15307,GO:0071546,0.999999999995469,0.798892879249014,0,2,pi-body,CC,
1497,GO:0003845,0.999999999995472,0.827027262794965,0,2,11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity,MF,
11903,GO:0046963,0.999999999995475,0.813796180995756,0,2,3'-phosphoadenosine 5'-phosphosulfate transport,BP,
11904,GO:0046964,0.999999999995475,0.813796180995756,0,2,3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity,MF,
18015,GO:1902559,0.999999999995475,0.813796180995756,0,2,3'-phospho-5'-adenylyl sulfate transmembrane transport,BP,
16131,GO:0090168,0.999999999995482,0.65268695563661,0,4,Golgi reassembly,BP,
11395,GO:0045819,0.999999999995498,0.886929058159448,0,1,positive regulation of glycogen catabolic process,BP,
11954,GO:0047220,0.999999999995514,0.899478462132421,0,1,galactosylxylosylprotein 3-beta-galactosyltransferase activity,MF,
16674,GO:0097643,0.999999999995516,0.936247705158252,0,1,amylin receptor activity,MF,
18389,GO:1903440,0.999999999995516,0.936247705158252,0,1,amylin receptor complex,CC,
19498,GO:1990407,0.999999999995516,0.936247705158252,0,1,calcitonin gene-related peptide binding,MF,
2118,GO:0004910,0.999999999995524,0.914232026415185,0,1,interleukin-1, Type II, blocking receptor activity,MF,
8032,GO:0032690,0.999999999995524,0.914232026415185,0,1,negative regulation of interleukin-1 alpha production,BP,
12543,GO:0050712,0.999999999995524,0.914232026415185,0,1,negative regulation of interleukin-1 alpha secretion,BP,
18684,GO:1904098,0.99999999999553,0.716443098178372,0,3,regulation of protein O-linked glycosylation,BP,
18685,GO:1904100,0.99999999999553,0.716443098178372,0,3,positive regulation of protein O-linked glycosylation,BP,
9737,GO:0039019,0.999999999995554,0.783368812080815,0,2,pronephric nephron development,BP,
11165,GO:0045263,0.999999999995555,0.915494282065535,0,1,proton-transporting ATP synthase complex, coupling factor F(o),CC,
5379,GO:0016199,0.999999999995558,0.607960385874186,0,4,axon midline choice point recognition,BP,
6133,GO:0019402,0.999999999995563,0.916565103574718,0,1,galactitol metabolic process,BP,
14360,GO:0061623,0.999999999995563,0.916565103574718,0,1,glycolytic process from galactose,BP,
9715,GO:0038171,0.999999999995573,0.715357000839272,0,3,cannabinoid signaling pathway,BP,
15511,GO:0071926,0.999999999995573,0.715357000839272,0,3,endocannabinoid signaling pathway,BP,
17376,GO:1900126,0.999999999995582,0.70506496738085,0,3,negative regulation of hyaluronan biosynthetic process,BP,
807,GO:0002081,0.999999999995599,0.87731001088654,0,1,outer acrosomal membrane,CC,
311,GO:0000823,0.999999999995601,0.905221491603926,0,1,inositol-1,4,5-trisphosphate 6-kinase activity,MF,
312,GO:0000824,0.999999999995601,0.905221491603926,0,1,inositol tetrakisphosphate 3-kinase activity,MF,
313,GO:0000825,0.999999999995601,0.905221491603926,0,1,inositol tetrakisphosphate 6-kinase activity,MF,
11973,GO:0047326,0.999999999995601,0.905221491603926,0,1,inositol tetrakisphosphate 5-kinase activity,MF,
6998,GO:0030689,0.999999999995631,0.734000721532997,0,3,Noc complex,CC,
19351,GO:1905832,0.999999999995631,0.603250455483686,0,4,positive regulation of spindle assembly,BP,
1349,GO:0003219,0.999999999995637,0.794101553395229,0,2,cardiac right ventricle formation,BP,
16998,GO:0099170,0.999999999995638,0.71331150735428,0,3,postsynaptic modulation of chemical synaptic transmission,BP,
17041,GO:0099547,0.999999999995638,0.71331150735428,0,3,regulation of translation at synapse, modulating synaptic transmission,BP,
17054,GO:0099578,0.999999999995638,0.71331150735428,0,3,regulation of translation at postsynapse, modulating synaptic transmission,BP,
9426,GO:0036015,0.999999999995647,0.762919919311726,0,3,response to interleukin-3,BP,
9427,GO:0036016,0.999999999995647,0.762919919311726,0,3,cellular response to interleukin-3,BP,
9650,GO:0038016,0.999999999995647,0.804097984117823,0,2,insulin receptor internalization,BP,
4907,GO:0014843,0.999999999995654,0.878862093306962,0,1,growth factor dependent regulation of skeletal muscle satellite cell proliferation,BP,
10112,GO:0042660,0.999999999995654,0.878862093306962,0,1,positive regulation of cell fate specification,BP,
17160,GO:0103053,0.999999999995655,0.841081955066256,0,2,1-ethyladenine demethylase activity,MF,
1766,GO:0004372,0.999999999995659,0.811330725280201,0,2,glycine hydroxymethyltransferase activity,MF,
2044,GO:0004793,0.999999999995659,0.811330725280201,0,2,threonine aldolase activity,MF,
2999,GO:0006545,0.999999999995659,0.811330725280201,0,2,glycine biosynthetic process,BP,
3959,GO:0008732,0.999999999995659,0.811330725280201,0,2,L-allo-threonine aldolase activity,MF,
6088,GO:0019264,0.999999999995659,0.811330725280201,0,2,glycine biosynthetic process from serine,BP,
6591,GO:0022614,0.999999999995659,0.698604824629437,0,3,membrane to membrane docking,BP,
16181,GO:0090234,0.999999999995662,0.709803524322816,0,3,regulation of kinetochore assembly,BP,
9334,GO:0035853,0.999999999995679,0.882365280094059,0,1,chromosome passenger complex localization to spindle midzone,BP,
9591,GO:0036461,0.999999999995685,0.844379923568503,0,2,BLOC-2 complex binding,MF,
1065,GO:0002606,0.999999999995695,0.714873734470808,0,3,positive regulation of dendritic cell antigen processing and presentation,BP,
8305,GO:0033149,0.999999999995696,0.782120135319895,0,2,FFAT motif binding,MF,
1378,GO:0003278,0.999999999995705,0.708000936268977,0,3,apoptotic process involved in heart morphogenesis,BP,
18870,GO:1904576,0.999999999995707,0.816467536012529,0,2,response to tunicamycin,BP,
18871,GO:1904577,0.999999999995707,0.816467536012529,0,2,cellular response to tunicamycin,BP,
3521,GO:0007495,0.999999999995712,0.896162067909563,0,1,visceral mesoderm-endoderm interaction involved in midgut development,BP,
14759,GO:0070483,0.999999999995712,0.896162067909563,0,1,detection of hypoxia,BP,
18000,GO:1902523,0.999999999995718,0.784595946296046,0,2,positive regulation of protein K63-linked ubiquitination,BP,
9167,GO:0035546,0.99999999999572,0.603434487917794,0,4,interferon-beta secretion,BP,
9168,GO:0035547,0.99999999999572,0.603434487917794,0,4,regulation of interferon-beta secretion,BP,
9169,GO:0035549,0.99999999999572,0.603434487917794,0,4,positive regulation of interferon-beta secretion,BP,
19510,GO:1990428,0.999999999995721,0.784401738339766,0,2,miRNA transport,BP,
18723,GO:1904217,0.999999999995723,0.730945148382784,0,3,regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity,BP,
18724,GO:1904219,0.999999999995723,0.730945148382784,0,3,positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity,BP,
18726,GO:1904222,0.999999999995723,0.730945148382784,0,3,positive regulation of serine C-palmitoyltransferase activity,BP,
14135,GO:0061038,0.99999999999574,0.605641254779822,0,4,uterus morphogenesis,BP,
4862,GO:0014707,0.999999999995762,0.900618454434615,0,1,branchiomeric skeletal muscle development,BP,
9618,GO:0036497,0.999999999995762,0.900618454434615,0,1,eIF2alpha dephosphorylation in response to endoplasmic reticulum stress,BP,
17936,GO:1902310,0.999999999995762,0.900618454434615,0,1,positive regulation of peptidyl-serine dephosphorylation,BP,
18604,GO:1903916,0.999999999995762,0.900618454434615,0,1,regulation of endoplasmic reticulum stress-induced eIF2 alpha dephosphorylation,BP,
18605,GO:1903917,0.999999999995762,0.900618454434615,0,1,positive regulation of endoplasmic reticulum stress-induced eIF2 alpha dephosphorylation,BP,
8248,GO:0033037,0.999999999995763,0.879603305762606,0,1,polysaccharide localization,BP,
13952,GO:0060684,0.999999999995772,0.652766870915294,0,4,epithelial-mesenchymal cell signaling,BP,
9051,GO:0035290,0.99999999999578,0.70642708406343,0,3,trunk segmentation,BP,
9608,GO:0036484,0.99999999999578,0.70642708406343,0,3,trunk neural crest cell migration,BP,
9609,GO:0036486,0.99999999999578,0.70642708406343,0,3,ventral trunk neural crest cell migration,BP,
17549,GO:1901166,0.99999999999578,0.70642708406343,0,3,neural crest cell migration involved in autonomic nervous system development,BP,
3206,GO:0006843,0.999999999995784,0.909270418575261,0,1,mitochondrial citrate transmembrane transport,BP,
16060,GO:0090044,0.999999999995784,0.909270418575261,0,1,positive regulation of tubulin deacetylation,BP,
19537,GO:1990546,0.999999999995784,0.909270418575261,0,1,mitochondrial tricarboxylic acid transmembrane transport,BP,
121,GO:0000252,0.999999999995786,0.909346941426474,0,1,C-3 sterol dehydrogenase (C-4 sterol decarboxylase) activity,MF,
11926,GO:0047012,0.999999999995786,0.909346941426474,0,1,sterol-4-alpha-carboxylate 3-dehydrogenase (decarboxylating) activity,MF,
17161,GO:0103066,0.999999999995786,0.909346941426474,0,1,4alpha-carboxy-4beta-methyl-5alpha-cholesta-8-en-3beta-ol:NAD(P)+ 3-oxidoreductase (decarboxylating) activity,MF,
17162,GO:0103067,0.999999999995786,0.909346941426474,0,1,4alpha-carboxy-5alpha-cholesta-8-en-3beta-ol:NAD(P)+ 3-dehydrogenase (decarboxylating) activity,MF,
15350,GO:0071612,0.999999999995795,0.86975918420116,0,1,IP-10 production,BP,
15381,GO:0071658,0.999999999995795,0.86975918420116,0,1,regulation of IP-10 production,BP,
15382,GO:0071660,0.999999999995795,0.86975918420116,0,1,positive regulation of IP-10 production,BP,
13777,GO:0060386,0.999999999995796,0.879614193397333,0,1,synapse assembly involved in innervation,BP,
6046,GO:0019185,0.999999999995804,0.793287391104163,0,2,snRNA-activating protein complex,CC,
12871,GO:0051232,0.999999999995806,0.900630574309057,0,1,meiotic spindle elongation,BP,
90,GO:0000179,0.999999999995808,0.672488458638974,0,4,rRNA (adenine-N6,N6-)-dimethyltransferase activity,MF,
3025,GO:0006572,0.999999999995813,0.75858765329387,0,3,tyrosine catabolic process,BP,
1179,GO:0002826,0.999999999995826,0.642305740126767,0,4,negative regulation of T-helper 1 type immune response,BP,
19110,GO:1905089,0.999999999995842,0.86830137989936,0,1,regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization,BP,
19111,GO:1905090,0.999999999995842,0.86830137989936,0,1,negative regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization,BP,
15558,GO:0072047,0.999999999995851,0.673440554143928,0,4,proximal/distal pattern formation involved in nephron development,BP,
15579,GO:0072081,0.999999999995851,0.673440554143928,0,4,specification of nephron tubule identity,BP,
15580,GO:0072086,0.999999999995851,0.673440554143928,0,4,specification of loop of Henle identity,BP,
15747,GO:0072364,0.999999999995854,0.765993723095473,0,2,regulation of cellular ketone metabolic process by regulation of transcription from RNA polymerase II promoter,BP,
13792,GO:0060405,0.999999999995856,0.721710247025772,0,3,regulation of penile erection,BP,
16224,GO:0090298,0.99999999999587,0.707978107183027,0,3,negative regulation of mitochondrial DNA replication,BP,
17766,GO:1901859,0.99999999999587,0.707978107183027,0,3,negative regulation of mitochondrial DNA metabolic process,BP,
18586,GO:1903891,0.999999999995873,0.639762499071666,0,4,regulation of ATF6-mediated unfolded protein response,BP,
6708,GO:0030124,0.999999999995888,0.652536253706313,0,4,AP-4 adaptor complex,CC,
6041,GO:0019153,0.999999999995897,0.909398171713757,0,1,protein-disulfide reductase (glutathione) activity,MF,
15821,GO:0072555,0.999999999995897,0.909398171713757,0,1,17-beta-ketosteroid reductase activity,MF,
15840,GO:0072582,0.999999999995897,0.909398171713757,0,1,17-beta-hydroxysteroid dehydrogenase (NADP+) activity,MF,
16440,GO:0097129,0.999999999995898,0.739098076989504,0,3,cyclin D2-CDK4 complex,CC,
5085,GO:0015333,0.999999999995907,0.709462013127353,0,3,peptide:proton symporter activity,MF,
6475,GO:0021823,0.999999999995908,0.773177571318535,0,2,cerebral cortex tangential migration using cell-cell interactions,BP,
6479,GO:0021827,0.999999999995908,0.773177571318535,0,2,postnatal olfactory bulb interneuron migration,BP,
6482,GO:0021836,0.999999999995908,0.773177571318535,0,2,chemorepulsion involved in postnatal olfactory bulb interneuron migration,BP,
1594,GO:0004014,0.999999999995908,0.895255830020531,0,1,adenosylmethionine decarboxylase activity,MF,
3011,GO:0006557,0.999999999995908,0.895255830020531,0,1,S-adenosylmethioninamine biosynthetic process,BP,
6240,GO:0019810,0.999999999995908,0.895255830020531,0,1,putrescine binding,MF,
11691,GO:0046499,0.999999999995908,0.895255830020531,0,1,S-adenosylmethioninamine metabolic process,BP,
1921,GO:0004617,0.999999999995911,0.902375831346351,0,1,phosphoglycerate dehydrogenase activity,MF,
8505,GO:0033699,0.999999999995911,0.902375831346351,0,1,DNA 5'-adenosine monophosphate hydrolase activity,MF,
17252,GO:0120108,0.999999999995911,0.902375831346351,0,1,DNA-3'-diphospho-5'-guanosine diphosphatase,MF,
19442,GO:1990165,0.999999999995911,0.902375831346351,0,1,single-strand break-containing DNA binding,MF,
6378,GO:0021571,0.999999999995913,0.894176154641021,0,1,rhombomere 5 development,BP,
6379,GO:0021572,0.999999999995913,0.894176154641021,0,1,rhombomere 6 development,BP,
9049,GO:0035283,0.999999999995913,0.894176154641021,0,1,central nervous system segmentation,BP,
9050,GO:0035284,0.999999999995913,0.894176154641021,0,1,brain segmentation,BP,
18308,GO:1903286,0.999999999995918,0.719584046603144,0,3,regulation of potassium ion import,BP,
3638,GO:0008108,0.999999999995925,0.917455070932691,0,1,UDP-glucose:hexose-1-phosphate uridylyltransferase activity,MF,
5314,GO:0016034,0.999999999995925,0.917455070932691,0,1,maleylacetoacetate isomerase activity,MF,
17094,GO:0101030,0.999999999995925,0.917455070932691,0,1,tRNA-guanine transglycosylation,BP,
6249,GO:0019834,0.999999999995926,0.755402426151553,0,3,phospholipase A2 inhibitor activity,MF,
1879,GO:0004560,0.999999999995951,0.813104543884915,0,2,alpha-L-fucosidase activity,MF,
5275,GO:0015928,0.999999999995951,0.813104543884915,0,2,fucosidase activity,MF,
5990,GO:0018993,0.999999999995951,0.898707045817242,0,1,somatic sex determination,BP,
6030,GO:0019101,0.999999999995951,0.898707045817242,0,1,female somatic sex determination,BP,
13531,GO:0060014,0.999999999995951,0.898707045817242,0,1,granulosa cell differentiation,BP,
16585,GO:0097441,0.999999999995961,0.715107545689679,0,3,basal dendrite,CC,
14507,GO:0070026,0.999999999995971,0.840343089703113,0,2,nitric oxide binding,MF,
8407,GO:0033484,0.999999999995975,0.74071787530957,0,3,nitric oxide homeostasis,BP,
5817,GO:0017087,0.999999999995975,0.887018824632291,0,1,mitochondrial processing peptidase complex,CC,
10659,GO:0043914,0.999999999995975,0.887018824632291,0,1,NADPH:sulfur oxidoreductase activity,MF,
11155,GO:0045234,0.999999999995976,0.905358058385357,0,1,protein palmitoleylation,BP,
11716,GO:0046544,0.999999999995998,0.880196097607202,0,1,development of secondary male sexual characteristics,BP,
2309,GO:0005308,0.999999999996011,0.891772397004588,0,1,creatine transmembrane transporter activity,MF,
2310,GO:0005309,0.999999999996011,0.891772397004588,0,1,creatine:sodium symporter activity,MF,
5251,GO:0015881,0.999999999996011,0.891772397004588,0,1,creatine transmembrane transport,BP,
927,GO:0002325,0.999999999996014,0.923810586508718,0,1,natural killer cell differentiation involved in immune response,BP,
8122,GO:0032824,0.999999999996014,0.923810586508718,0,1,negative regulation of natural killer cell differentiation,BP,
8124,GO:0032826,0.999999999996014,0.923810586508718,0,1,regulation of natural killer cell differentiation involved in immune response,BP,
8125,GO:0032827,0.999999999996014,0.923810586508718,0,1,negative regulation of natural killer cell differentiation involved in immune response,BP,
512,GO:0001576,0.999999999996015,0.901846047831176,0,1,globoside biosynthetic process,BP,
1548,GO:0003948,0.999999999996015,0.901846047831176,0,1,N4-(beta-N-acetylglucosaminyl)-L-asparaginase activity,MF,
12478,GO:0050512,0.999999999996015,0.901846047831176,0,1,lactosylceramide 4-alpha-galactosyltransferase activity,MF,
15899,GO:0072706,0.999999999996017,0.900207086676335,0,1,response to sodium dodecyl sulfate,BP,
15900,GO:0072707,0.999999999996017,0.900207086676335,0,1,cellular response to sodium dodecyl sulfate,BP,
1519,GO:0003883,0.999999999996024,0.797067388918819,0,2,CTP synthase activity,MF,
10750,GO:0044210,0.999999999996024,0.797067388918819,0,2,'de novo' CTP biosynthetic process,BP,
10806,GO:0044308,0.999999999996025,0.773331840767228,0,2,axonal spine,CC,
10438,GO:0043309,0.999999999996029,0.823057823935484,0,2,regulation of eosinophil degranulation,BP,
10439,GO:0043311,0.999999999996029,0.823057823935484,0,2,positive regulation of eosinophil degranulation,BP,
18021,GO:1902566,0.999999999996029,0.823057823935484,0,2,regulation of eosinophil activation,BP,
18022,GO:1902568,0.999999999996029,0.823057823935484,0,2,positive regulation of eosinophil activation,BP,
244,GO:0000701,0.999999999996029,0.829790523037021,0,2,purine-specific mismatch base pair DNA N-glycosylase activity,MF,
746,GO:0001978,0.999999999996038,0.901298882789711,0,1,regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback,BP,
747,GO:0001983,0.999999999996038,0.901298882789711,0,1,baroreceptor response to increased systemic arterial blood pressure,BP,
748,GO:0001985,0.999999999996038,0.901298882789711,0,1,negative regulation of heart rate involved in baroreceptor response to increased systemic arterial blood pressure,BP,
753,GO:0001994,0.999999999996038,0.901298882789711,0,1,norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure,BP,
755,GO:0001997,0.999999999996038,0.901298882789711,0,1,positive regulation of the force of heart contraction by epinephrine-norepinephrine,BP,
1287,GO:0003099,0.999999999996038,0.901298882789711,0,1,positive regulation of the force of heart contraction by chemical signal,BP,
2130,GO:0004936,0.999999999996038,0.901298882789711,0,1,alpha-adrenergic receptor activity,MF,
2131,GO:0004937,0.999999999996038,0.901298882789711,0,1,alpha1-adrenergic receptor activity,MF,
18644,GO:1903995,0.999999999996038,0.901298882789711,0,1,regulation of non-membrane spanning protein tyrosine kinase activity,BP,
18645,GO:1903997,0.999999999996038,0.901298882789711,0,1,positive regulation of non-membrane spanning protein tyrosine kinase activity,BP,
8396,GO:0033364,0.999999999996038,0.864476567340472,0,1,mast cell secretory granule organization,BP,
3995,GO:0008897,0.999999999996056,0.899049054759488,0,1,holo-[acyl-carrier-protein] synthase activity,MF,
6468,GO:0021812,0.999999999996068,0.879533625938214,0,1,neuronal-glial interaction involved in cerebral cortex radial glia guided migration,BP,
10404,GO:0043257,0.999999999996068,0.879533625938214,0,1,laminin-8 complex,CC,
699,GO:0001920,0.999999999996076,0.713690418789328,0,3,negative regulation of receptor recycling,BP,
18983,GO:1904815,0.999999999996077,0.81172440948023,0,2,negative regulation of protein localization to chromosome, telomeric region,BP,
13943,GO:0060671,0.999999999996105,0.71379960403655,0,3,epithelial cell differentiation involved in embryonic placenta development,BP,
13944,GO:0060672,0.999999999996105,0.71379960403655,0,3,epithelial cell morphogenesis involved in placental branching,BP,
103,GO:0000215,0.999999999996112,0.837105765115908,0,2,tRNA 2'-phosphotransferase activity,MF,
2812,GO:0006272,0.999999999996114,0.708354163918313,0,3,leading strand elongation,BP,
3089,GO:0006663,0.999999999996122,0.719502118114863,0,3,platelet activating factor biosynthetic process,BP,
14063,GO:0060907,0.999999999996143,0.722384761793302,0,3,positive regulation of macrophage cytokine production,BP,
10040,GO:0042536,0.999999999996169,0.736676463600551,0,3,negative regulation of tumor necrosis factor biosynthetic process,BP,
3847,GO:0008459,0.999999999996177,0.791513580844493,0,2,chondroitin 6-sulfotransferase activity,MF,
973,GO:0002424,0.999999999996177,0.80466624479748,0,2,T cell mediated immune response to tumor cell,BP,
1193,GO:0002840,0.999999999996177,0.80466624479748,0,2,regulation of T cell mediated immune response to tumor cell,BP,
8112,GO:0032808,0.999999999996179,0.615952710200222,0,4,lacrimal gland development,BP,
1411,GO:0003350,0.999999999996204,0.792991415669997,0,2,pulmonary myocardium development,BP,
246,GO:0000703,0.999999999996205,0.845053478752682,0,2,oxidized pyrimidine nucleobase lesion DNA N-glycosylase activity,MF,
4245,GO:0009447,0.99999999999621,0.784139873118996,0,3,putrescine catabolic process,BP,
14955,GO:0070885,0.999999999996212,0.70856114685046,0,3,negative regulation of calcineurin-NFAT signaling cascade,BP,
17187,GO:0106057,0.999999999996212,0.70856114685046,0,3,negative regulation of calcineurin-mediated signaling,BP,
15828,GO:0072563,0.999999999996228,0.815253555302344,0,2,endothelial microparticle,CC,
11367,GO:0045759,0.999999999996236,0.803633162460201,0,2,negative regulation of action potential,BP,
6405,GO:0021648,0.999999999996242,0.791933422838291,0,2,vestibulocochlear nerve morphogenesis,BP,
7344,GO:0031393,0.999999999996242,0.796342705698589,0,2,negative regulation of prostaglandin biosynthetic process,BP,
9534,GO:0036301,0.999999999996246,0.722543382815483,0,3,macrophage colony-stimulating factor production,BP,
17577,GO:1901256,0.999999999996246,0.722543382815483,0,3,regulation of macrophage colony-stimulating factor production,BP,
1850,GO:0004515,0.999999999996255,0.687731892350554,0,3,nicotinate-nucleotide adenylyltransferase activity,MF,
7151,GO:0031021,0.999999999996255,0.757613770862482,0,3,interphase microtubule organizing center,CC,
9968,GO:0042373,0.999999999996269,0.709026280758155,0,4,vitamin K metabolic process,BP,
16219,GO:0090290,0.999999999996274,0.929797981509671,0,1,positive regulation of osteoclast proliferation,BP,
14444,GO:0061827,0.999999999996282,0.820170358755397,0,2,sperm head,CC,
1813,GO:0004465,0.999999999996296,0.717714762206469,0,3,lipoprotein lipase activity,MF,
4663,GO:0010814,0.999999999996318,0.880156330092278,0,1,substance P catabolic process,BP,
4665,GO:0010816,0.999999999996318,0.880156330092278,0,1,calcitonin catabolic process,BP,
7295,GO:0031302,0.999999999996318,0.880156330092278,0,1,intrinsic component of endosome membrane,CC,
8922,GO:0034959,0.999999999996318,0.880156330092278,0,1,endothelin maturation,BP,
5824,GO:0017102,0.999999999996318,0.807271872995016,0,2,methionyl glutamyl tRNA synthetase complex,CC,
8462,GO:0033615,0.999999999996335,0.724248396687748,0,3,mitochondrial proton-transporting ATP synthase complex assembly,BP,
19310,GO:1905651,0.99999999999634,0.69592564798977,0,3,regulation of artery morphogenesis,BP,
19311,GO:1905653,0.99999999999634,0.69592564798977,0,3,positive regulation of artery morphogenesis,BP,
7403,GO:0031493,0.999999999996344,0.722374582679609,0,3,nucleosomal histone binding,MF,
18497,GO:1903691,0.999999999996345,0.768165096212154,0,2,positive regulation of wound healing, spreading of epidermal cells,BP,
8448,GO:0033597,0.999999999996351,0.901448720128589,0,1,mitotic checkpoint complex,CC,
19476,GO:1990298,0.999999999996351,0.901448720128589,0,1,bub1-bub3 complex,CC,
9587,GO:0036455,0.999999999996372,0.926008091129131,0,1,iron-sulfur transferase activity,MF,
2405,GO:0005577,0.999999999996377,0.694262230288457,0,3,fibrinogen complex,CC,
20205,GO:2001168,0.999999999996382,0.623392884206168,0,4,positive regulation of histone H2B ubiquitination,BP,
6845,GO:0030321,0.999999999996386,0.790859892897319,0,2,transepithelial chloride transport,BP,
2114,GO:0004905,0.99999999999639,0.804483312136381,0,2,type I interferon receptor activity,MF,
11132,GO:0045196,0.999999999996421,0.780742875153302,0,2,establishment or maintenance of neuroblast polarity,BP,
11136,GO:0045200,0.999999999996421,0.780742875153302,0,2,establishment of neuroblast polarity,BP,
9743,GO:0039506,0.999999999996425,0.791663262403774,0,2,modulation by virus of host molecular function,BP,
9744,GO:0039507,0.999999999996425,0.791663262403774,0,2,suppression by virus of host molecular function,BP,
13284,GO:0052055,0.999999999996425,0.791663262403774,0,2,modulation by symbiont of host molecular function,BP,
13285,GO:0052056,0.999999999996425,0.791663262403774,0,2,negative regulation by symbiont of host molecular function,BP,
18068,GO:1902713,0.999999999996436,0.626350369366704,0,4,regulation of interferon-gamma secretion,BP,
17613,GO:1901350,0.999999999996437,0.878577715452592,0,1,cell-cell signaling involved in cell-cell junction organization,BP,
16180,GO:0090233,0.999999999996437,0.899909184826651,0,1,negative regulation of spindle checkpoint,BP,
17971,GO:1902426,0.999999999996437,0.899909184826651,0,1,deactivation of mitotic spindle assembly checkpoint,BP,
19199,GO:1905341,0.999999999996437,0.899909184826651,0,1,negative regulation of protein localization to kinetochore,BP,
18098,GO:1902804,0.999999999996438,0.717250295629517,0,3,negative regulation of synaptic vesicle transport,BP,
19813,GO:2000301,0.999999999996438,0.717250295629517,0,3,negative regulation of synaptic vesicle exocytosis,BP,
585,GO:0001740,0.999999999996464,0.713551891022802,0,3,Barr body,CC,
14908,GO:0070782,0.999999999996466,0.901435145505929,0,1,phosphatidylserine exposure on apoptotic cell surface,BP,
17883,GO:1902214,0.999999999996478,0.796113574477128,0,2,regulation of interleukin-4-mediated signaling pathway,BP,
13539,GO:0060024,0.999999999996501,0.793307233695933,0,2,rhythmic synaptic transmission,BP,
2349,GO:0005415,0.999999999996503,0.811364254623167,0,2,nucleoside:sodium symporter activity,MF,
5237,GO:0015860,0.999999999996503,0.811364254623167,0,2,purine nucleoside transmembrane transport,BP,
11933,GO:0047035,0.999999999996504,0.843042193400437,0,2,testosterone dehydrogenase (NAD+) activity,MF,
8573,GO:0034066,0.999999999996506,0.82590340381847,0,2,RIC1-RGP1 guanyl-nucleotide exchange factor complex,CC,
11342,GO:0045716,0.999999999996512,0.732300985950154,0,3,positive regulation of low-density lipoprotein particle receptor biosynthetic process,BP,
18603,GO:1903912,0.999999999996517,0.630002024336763,0,4,negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation,BP,
14272,GO:0061395,0.999999999996519,0.906645249225827,0,1,positive regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance,BP,
4305,GO:0009758,0.999999999996525,0.876277804700493,0,1,carbohydrate utilization,BP,
4871,GO:0014734,0.999999999996525,0.876277804700493,0,1,skeletal muscle hypertrophy,BP,
10603,GO:0043610,0.999999999996525,0.876277804700493,0,1,regulation of carbohydrate utilization,BP,
17988,GO:1902488,0.999999999996525,0.876277804700493,0,1,cholangiocyte apoptotic process,BP,
18648,GO:1904000,0.999999999996525,0.876277804700493,0,1,positive regulation of eating behavior,BP,
18675,GO:1904054,0.999999999996525,0.876277804700493,0,1,regulation of cholangiocyte proliferation,BP,
18676,GO:1904056,0.999999999996525,0.876277804700493,0,1,positive regulation of cholangiocyte proliferation,BP,
18707,GO:1904192,0.999999999996525,0.876277804700493,0,1,regulation of cholangiocyte apoptotic process,BP,
18708,GO:1904193,0.999999999996525,0.876277804700493,0,1,negative regulation of cholangiocyte apoptotic process,BP,
18709,GO:1904195,0.999999999996525,0.876277804700493,0,1,regulation of granulosa cell proliferation,BP,
18710,GO:1904197,0.999999999996525,0.876277804700493,0,1,positive regulation of granulosa cell proliferation,BP,
18712,GO:1904200,0.999999999996525,0.876277804700493,0,1,iodide transmembrane transport,BP,
18713,GO:1904201,0.999999999996525,0.876277804700493,0,1,regulation of iodide transport,BP,
18714,GO:1904202,0.999999999996525,0.876277804700493,0,1,negative regulation of iodide transport,BP,
18715,GO:1904204,0.999999999996525,0.876277804700493,0,1,regulation of skeletal muscle hypertrophy,BP,
18716,GO:1904206,0.999999999996525,0.876277804700493,0,1,positive regulation of skeletal muscle hypertrophy,BP,
18721,GO:1904212,0.999999999996525,0.876277804700493,0,1,regulation of iodide transmembrane transport,BP,
18722,GO:1904213,0.999999999996525,0.876277804700493,0,1,negative regulation of iodide transmembrane transport,BP,
19571,GO:1990705,0.999999999996525,0.876277804700493,0,1,cholangiocyte proliferation,BP,
19583,GO:1990739,0.999999999996525,0.876277804700493,0,1,granulosa cell proliferation,BP,
4834,GO:0014043,0.999999999996537,0.802481022890195,0,2,negative regulation of neuron maturation,BP,
18940,GO:1904734,0.999999999996542,0.963223546055671,0,1,positive regulation of electron transfer activity,BP,
19056,GO:1904960,0.999999999996542,0.963223546055671,0,1,positive regulation of cytochrome-c oxidase activity,BP,
9087,GO:0035363,0.999999999996547,0.650666106685168,0,4,histone locus body,CC,
7053,GO:0030846,0.999999999996547,0.871628456360614,0,1,termination of RNA polymerase II transcription, poly(A)-coupled,BP,
7430,GO:0031554,0.999999999996547,0.871628456360614,0,1,regulation of DNA-templated transcription, termination,BP,
13891,GO:0060566,0.999999999996547,0.871628456360614,0,1,positive regulation of DNA-templated transcription, termination,BP,
18882,GO:1904594,0.999999999996547,0.871628456360614,0,1,regulation of termination of RNA polymerase II transcription,BP,
18883,GO:1904595,0.999999999996547,0.871628456360614,0,1,positive regulation of termination of RNA polymerase II transcription,BP,
20097,GO:2000804,0.999999999996547,0.871628456360614,0,1,regulation of termination of RNA polymerase II transcription, poly(A)-coupled,BP,
20098,GO:2000806,0.999999999996547,0.871628456360614,0,1,positive regulation of termination of RNA polymerase II transcription, poly(A)-coupled,BP,
4742,GO:0010915,0.999999999996551,0.874445483748604,0,2,regulation of very-low-density lipoprotein particle clearance,BP,
4743,GO:0010916,0.999999999996551,0.874445483748604,0,2,negative regulation of very-low-density lipoprotein particle clearance,BP,
14061,GO:0060903,0.99999999999656,0.799315047262429,0,2,positive regulation of meiosis I,BP,
1399,GO:0003335,0.999999999996562,0.900266489394026,0,1,corneocyte development,BP,
1400,GO:0003336,0.999999999996562,0.900266489394026,0,1,corneocyte desquamation,BP,
19327,GO:1905715,0.999999999996562,0.900266489394026,0,1,regulation of cornification,BP,
19328,GO:1905716,0.999999999996562,0.900266489394026,0,1,negative regulation of cornification,BP,
685,GO:0001905,0.999999999996577,0.772661132724154,0,2,activation of membrane attack complex,BP,
737,GO:0001969,0.999999999996577,0.772661132724154,0,2,regulation of activation of membrane attack complex,BP,
526,GO:0001635,0.999999999996586,0.741695771972998,0,3,calcitonin gene-related peptide receptor activity,MF,
16673,GO:0097642,0.999999999996586,0.741695771972998,0,3,calcitonin family receptor activity,MF,
10506,GO:0043435,0.999999999996608,0.900145173774656,0,1,response to corticotropin-releasing hormone,BP,
15201,GO:0071376,0.999999999996608,0.900145173774656,0,1,cellular response to corticotropin-releasing hormone stimulus,BP,
11656,GO:0046449,0.999999999996611,0.683730581087312,0,3,creatinine metabolic process,BP,
9990,GO:0042420,0.999999999996631,0.652896221368928,0,4,dopamine catabolic process,BP,
11293,GO:0045627,0.999999999996634,0.726889276055316,0,3,positive regulation of T-helper 1 cell differentiation,BP,
2075,GO:0004830,0.999999999996639,0.809246280807919,0,2,tryptophan-tRNA ligase activity,MF,
2925,GO:0006436,0.999999999996639,0.809246280807919,0,2,tryptophanyl-tRNA aminoacylation,BP,
5486,GO:0016422,0.999999999996641,0.731825872086305,0,3,mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity,MF,
5171,GO:0015727,0.999999999996648,0.628984684375703,0,4,lactate transport,BP,
9350,GO:0035873,0.999999999996648,0.628984684375703,0,4,lactate transmembrane transport,BP,
19243,GO:1905448,0.99999999999665,0.687442345272878,0,4,positive regulation of mitochondrial ATP synthesis coupled electron transport,BP,
1811,GO:0004463,0.999999999996681,0.901952466742155,0,1,leukotriene-A4 hydrolase activity,MF,
6072,GO:0019227,0.999999999996692,0.721703394318184,0,3,neuronal action potential propagation,BP,
16887,GO:0098870,0.999999999996692,0.721703394318184,0,3,action potential propagation,BP,
12390,GO:0048852,0.999999999996703,0.697021235139662,0,3,diencephalon morphogenesis,BP,
17907,GO:1902255,0.999999999996706,0.841495925266419,0,3,positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator,BP,
372,GO:0000994,0.999999999996709,0.905497428306908,0,1,RNA polymerase III core binding,MF,
2261,GO:0005176,0.999999999996717,0.83296312174624,0,2,ErbB-2 class receptor binding,MF,
5490,GO:0016428,0.999999999996732,0.648837958062941,0,4,tRNA (cytosine-5-)-methyltransferase activity,MF,
15912,GO:0072733,0.999999999996745,0.738316580545325,0,3,response to staurosporine,BP,
15913,GO:0072734,0.999999999996745,0.738316580545325,0,3,cellular response to staurosporine,BP,
7260,GO:0031247,0.999999999996749,0.811782814828839,0,2,actin rod assembly,BP,
19885,GO:2000402,0.999999999996749,0.698005775193151,0,3,negative regulation of lymphocyte migration,BP,
6825,GO:0030294,0.999999999996752,0.90117795984257,0,1,receptor signaling protein tyrosine kinase inhibitor activity,MF,
15100,GO:0071209,0.999999999996766,0.774316352841401,0,3,U7 snRNA binding,MF,
9101,GO:0035402,0.999999999996776,0.807857845881628,0,2,histone kinase activity (H3-T11 specific),MF,
9106,GO:0035407,0.999999999996776,0.807857845881628,0,2,histone H3-T11 phosphorylation,BP,
14249,GO:0061343,0.999999999996779,0.612134847015671,0,4,cell adhesion involved in heart morphogenesis,BP,
17274,GO:0140066,0.999999999996783,0.783404770274483,0,2,peptidyl-lysine crotonylation,BP,
19579,GO:1990730,0.999999999996785,0.791470985668971,0,2,VCP-NSFL1C complex,CC,
11070,GO:0045084,0.999999999996786,0.722533178513736,0,3,positive regulation of interleukin-12 biosynthetic process,BP,
11963,GO:0047277,0.999999999996788,0.903082424610767,0,1,globoside alpha-N-acetylgalactosaminyltransferase activity,MF,
13022,GO:0051499,0.999999999996791,0.82375297342608,0,2,D-aminoacyl-tRNA deacylase activity,MF,
13023,GO:0051500,0.999999999996791,0.82375297342608,0,2,D-tyrosyl-tRNA(Tyr) deacylase activity,MF,
6687,GO:0030070,0.999999999996795,0.710157967099322,0,3,insulin processing,BP,
860,GO:0002193,0.999999999996801,0.693445370317396,0,3,MAML1-RBP-Jkappa- ICN1 complex,CC,
11784,GO:0046680,0.999999999996807,0.901832280465673,0,1,response to DDT,BP,
20082,GO:2000775,0.999999999996807,0.901832280465673,0,1,histone H3-S10 phosphorylation involved in chromosome condensation,BP,
17914,GO:1902263,0.999999999996812,0.725411176729367,0,3,apoptotic process involved in embryonic digit morphogenesis,BP,
15527,GO:0071962,0.999999999996817,0.755685152720204,0,3,mitotic sister chromatid cohesion, centromeric,BP,
12177,GO:0048341,0.999999999996821,0.629885019430143,0,4,paraxial mesoderm formation,BP,
19529,GO:1990504,0.999999999996822,0.685841538052196,0,3,dense core granule exocytosis,BP,
19915,GO:2000466,0.999999999996828,0.70926142668132,0,3,negative regulation of glycogen (starch) synthase activity,BP,
932,GO:0002331,0.99999999999683,0.766027685204565,0,2,pre-B cell allelic exclusion,BP,
5491,GO:0016429,0.99999999999683,0.728037083795754,0,3,tRNA (adenine-N1-)-methyltransferase activity,MF,
14478,GO:0061953,0.99999999999683,0.728037083795754,0,3,mRNA (adenine-N1-)-methyltransferase activity,MF,
12276,GO:0048627,0.999999999996839,0.819868100232607,0,2,myoblast development,BP,
1383,GO:0003289,0.999999999996839,0.69627191926593,0,3,atrial septum primum morphogenesis,BP,
4815,GO:0014012,0.999999999996845,0.663799174251685,0,4,peripheral nervous system axon regeneration,BP,
16445,GO:0097145,0.99999999999685,0.90124858866912,0,1,BAK complex,CC,
19870,GO:2000381,0.999999999996872,0.634337301273095,0,4,negative regulation of mesoderm development,BP,
2855,GO:0006344,0.999999999996872,0.616089531369373,0,4,maintenance of chromatin silencing,BP,
7003,GO:0030696,0.999999999996873,0.896407584036457,0,1,tRNA (m5U54) methyltransferase activity,MF,
7004,GO:0030697,0.999999999996873,0.896407584036457,0,1,S-adenosylmethionine-dependent tRNA (m5U54) methyltransferase activity,MF,
6631,GO:0023021,0.999999999996878,0.729610264670542,0,3,termination of signal transduction,BP,
19427,GO:1990111,0.999999999996885,0.698865232667107,0,4,spermatoproteasome complex,CC,
579,GO:0001732,0.999999999996889,0.794527301784348,0,2,formation of cytoplasmic translation initiation complex,BP,
9286,GO:0035740,0.999999999996894,0.809055133300049,0,2,CD8-positive, alpha-beta T cell proliferation,BP,
19955,GO:2000564,0.999999999996894,0.809055133300049,0,2,regulation of CD8-positive, alpha-beta T cell proliferation,BP,
15400,GO:0071691,0.999999999996899,0.878702667323771,0,1,cardiac muscle thin filament assembly,BP,
3842,GO:0008454,0.999999999996905,0.791359325019621,0,2,alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity,MF,
18447,GO:1903567,0.999999999996909,0.804777388920687,0,2,regulation of protein localization to ciliary membrane,BP,
775,GO:0002032,0.999999999996914,0.81525512578152,0,2,desensitization of G-protein coupled receptor protein signaling pathway by arrestin,BP,
13844,GO:0060482,0.999999999996914,0.722377912068397,0,3,lobar bronchus development,BP,
4227,GO:0009407,0.999999999996929,0.699903306602217,0,4,toxin catabolic process,BP,
16923,GO:0098926,0.999999999996951,0.878682984927647,0,1,postsynaptic signal transduction,BP,
17028,GO:0099527,0.999999999996951,0.878682984927647,0,1,postsynapse to nucleus signaling pathway,BP,
1488,GO:0003828,0.999999999996963,0.774334647952882,0,2,alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity,MF,
18536,GO:1903774,0.999999999996968,0.738725048395221,0,3,positive regulation of viral budding via host ESCRT complex,BP,
1574,GO:0003986,0.999999999996987,0.78035710228118,0,3,acetyl-CoA hydrolase activity,MF,
13173,GO:0051800,0.999999999996989,0.879713996745421,0,1,phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity,MF,
20100,GO:2000808,0.999999999996989,0.879713996745421,0,1,negative regulation of synaptic vesicle clustering,BP,
14325,GO:0061551,0.999999999996994,0.696416720882908,0,3,trigeminal ganglion development,BP,
8754,GO:0034436,0.999999999997005,0.745822882436826,0,3,glycoprotein transport,BP,
11553,GO:0046121,0.999999999997011,0.740547630995734,0,3,deoxyribonucleoside catabolic process,BP,
13448,GO:0055005,0.999999999997016,0.789466123141615,0,2,ventricular cardiac myofibril assembly,BP,
13631,GO:0060161,0.999999999997018,0.721975126586439,0,3,positive regulation of dopamine receptor signaling pathway,BP,
18061,GO:1902685,0.999999999997021,0.883743903831078,0,1,positive regulation of receptor localization to synapse,BP,
15606,GO:0072125,0.999999999997024,0.720222042329225,0,3,negative regulation of glomerular mesangial cell proliferation,BP,
16153,GO:0090194,0.999999999997024,0.720222042329225,0,3,negative regulation of glomerulus development,BP,
17221,GO:0110095,0.999999999997031,0.77653351762107,0,3,cellular detoxification of aldehyde,BP,
2910,GO:0006421,0.999999999997035,0.724105759020123,0,3,asparaginyl-tRNA aminoacylation,BP,
13994,GO:0060737,0.999999999997042,0.690376816817751,0,3,prostate gland morphogenetic growth,BP,
823,GO:0002100,0.999999999997047,0.879287674278231,0,1,tRNA wobble adenosine to inosine editing,BP,
2148,GO:0004968,0.999999999997047,0.879287674278231,0,1,gonadotropin-releasing hormone receptor activity,MF,
8901,GO:0034752,0.999999999997047,0.879287674278231,0,1,cytosolic aryl hydrocarbon receptor complex,CC,
8902,GO:0034753,0.999999999997047,0.879287674278231,0,1,nuclear aryl hydrocarbon receptor complex,CC,
13374,GO:0052717,0.999999999997047,0.879287674278231,0,1,tRNA-specific adenosine-34 deaminase activity,MF,
13375,GO:0052718,0.999999999997047,0.879287674278231,0,1,tRNA-specific adenosine-34 deaminase complex,CC,
8394,GO:0033353,0.999999999997051,0.628644635543962,0,4,S-adenosylmethionine cycle,BP,
15248,GO:0071449,0.999999999997051,0.935748740370973,0,1,cellular response to lipid hydroperoxide,BP,
19896,GO:2000416,0.999999999997059,0.720929643344349,0,3,regulation of eosinophil migration,BP,
9577,GO:0036438,0.999999999997078,0.640338072023868,0,4,maintenance of lens transparency,BP,
922,GO:0002317,0.999999999997084,0.782995134772807,0,3,plasma cell differentiation,BP,
9671,GO:0038052,0.999999999997084,0.791681233073724,0,2,RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding,MF,
15451,GO:0071816,0.999999999997086,0.665644197826427,0,4,tail-anchored membrane protein insertion into ER membrane,BP,
3968,GO:0008775,0.999999999997103,0.904718158973646,0,1,acetate CoA-transferase activity,MF,
4326,GO:0009850,0.999999999997103,0.904718158973646,0,1,auxin metabolic process,BP,
4327,GO:0009852,0.999999999997103,0.904718158973646,0,1,auxin catabolic process,BP,
4398,GO:0010124,0.999999999997103,0.904718158973646,0,1,phenylacetate catabolic process,BP,
10139,GO:0042731,0.999999999997108,0.652236813843339,0,4,PH domain binding,MF,
17410,GO:1900195,0.999999999997109,0.813746564743634,0,2,positive regulation of oocyte maturation,BP,
7849,GO:0032417,0.999999999997109,0.79746120329904,0,2,positive regulation of sodium:proton antiporter activity,BP,
2320,GO:0005329,0.999999999997115,0.775911948828885,0,2,dopamine transmembrane transporter activity,MF,
19810,GO:2000298,0.999999999997127,0.805183087058893,0,2,regulation of Rho-dependent protein serine/threonine kinase activity,BP,
5440,GO:0016309,0.99999999999713,0.700520368673242,0,3,1-phosphatidylinositol-5-phosphate 4-kinase activity,MF,
7091,GO:0030895,0.99999999999713,0.813988559077956,0,2,apolipoprotein B mRNA editing enzyme complex,CC,
19982,GO:2000616,0.999999999997142,0.795496612368624,0,2,negative regulation of histone H3-K9 acetylation,BP,
16343,GO:0090666,0.999999999997144,0.662203869017623,0,4,scaRNA localization to Cajal body,BP,
11842,GO:0046848,0.999999999997144,0.915973353393388,0,1,hydroxyapatite binding,MF,
1437,GO:0003418,0.999999999997144,0.628334180792005,0,4,growth plate cartilage chondrocyte differentiation,BP,
1441,GO:0003431,0.999999999997144,0.628334180792005,0,4,growth plate cartilage chondrocyte development,BP,
2679,GO:0006041,0.999999999997149,0.651512694724032,0,4,glucosamine metabolic process,BP,
17483,GO:1900623,0.999999999997155,0.788107995783969,0,2,regulation of monocyte aggregation,BP,
17484,GO:1900625,0.999999999997155,0.788107995783969,0,2,positive regulation of monocyte aggregation,BP,
1359,GO:0003241,0.999999999997163,0.713682837108267,0,3,growth involved in heart morphogenesis,BP,
16623,GO:0097505,0.999999999997166,0.879605701920932,0,1,Rad6-Rad18 complex,CC,
19308,GO:1905643,0.999999999997178,0.8794796730535,0,1,positive regulation of DNA methylation,BP,
20107,GO:2000820,0.999999999997178,0.8794796730535,0,1,negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation,BP,
19655,GO:1990966,0.999999999997188,0.642082481457996,0,4,ATP generation from poly-ADP-D-ribose,BP,
4607,GO:0010727,0.9999999999972,0.620552817978156,0,4,negative regulation of hydrogen peroxide metabolic process,BP,
17560,GO:1901207,0.999999999997216,0.886468079645999,0,1,regulation of heart looping,BP,
18529,GO:1903762,0.999999999997216,0.886468079645999,0,1,positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization,BP,
18620,GO:1903947,0.999999999997216,0.886468079645999,0,1,positive regulation of ventricular cardiac muscle cell action potential,BP,
18622,GO:1903952,0.999999999997216,0.886468079645999,0,1,regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization,BP,
18623,GO:1903954,0.999999999997216,0.886468079645999,0,1,positive regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization,BP,
19079,GO:1905026,0.999999999997216,0.886468079645999,0,1,positive regulation of membrane repolarization during ventricular cardiac muscle cell action potential,BP,
19081,GO:1905033,0.999999999997216,0.886468079645999,0,1,positive regulation of membrane repolarization during cardiac muscle cell action potential,BP,
9907,GO:0042264,0.999999999997224,0.782599597815531,0,2,peptidyl-aspartic acid hydroxylation,BP,
3729,GO:0008265,0.999999999997224,0.899701799516255,0,1,Mo-molybdopterin cofactor sulfurase activity,MF,
17152,GO:0102867,0.999999999997224,0.899701799516255,0,1,molybdenum cofactor sulfurtransferase activity,MF,
11099,GO:0045134,0.999999999997236,0.650907288373133,0,4,uridine-diphosphatase activity,MF,
18090,GO:1902766,0.999999999997257,0.829174780765253,0,2,skeletal muscle satellite cell migration,BP,
19729,GO:2000137,0.99999999999727,0.786691495163051,0,2,negative regulation of cell proliferation involved in heart morphogenesis,BP,
10115,GO:0042663,0.999999999997319,0.814686230822778,0,2,regulation of endodermal cell fate specification,BP,
14119,GO:0061009,0.999999999997344,0.729786646329533,0,3,common bile duct development,BP,
17965,GO:1902412,0.999999999997366,0.690800680774564,0,3,regulation of mitotic cytokinesis,BP,
14042,GO:0060842,0.99999999999737,0.70530974875149,0,3,arterial endothelial cell differentiation,BP,
15111,GO:0071224,0.999999999997384,0.714936238353511,0,3,cellular response to peptidoglycan,BP,
4882,GO:0014802,0.999999999997394,0.83006119163285,0,2,terminal cisterna,CC,
661,GO:0001865,0.999999999997406,0.605870132395226,0,4,NK T cell differentiation,BP,
12810,GO:0051136,0.999999999997406,0.605870132395226,0,4,regulation of NK T cell differentiation,BP,
3130,GO:0006713,0.999999999997422,0.905306519131663,0,1,glucocorticoid catabolic process,BP,
17055,GO:0099580,0.999999999997425,0.879434528814851,0,1,ion antiporter activity involved in regulation of postsynaptic membrane potential,MF,
1615,GO:0004046,0.999999999997425,0.742001905714094,0,3,aminoacylase activity,MF,
1355,GO:0003228,0.999999999997427,0.655273466938719,0,4,atrial cardiac muscle tissue development,BP,
13452,GO:0055009,0.999999999997427,0.655273466938719,0,4,atrial cardiac muscle tissue morphogenesis,BP,
5039,GO:0015220,0.999999999997428,0.63560341996541,0,4,choline transmembrane transporter activity,MF,
3849,GO:0008465,0.999999999997438,0.921203767908439,0,1,glycerate dehydrogenase activity,MF,
10954,GO:0044729,0.999999999997438,0.713646933571368,0,3,hemi-methylated DNA-binding,MF,
1053,GO:0002581,0.999999999997445,0.805901497158326,0,2,negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,
11212,GO:0045359,0.999999999997447,0.638602329073595,0,4,positive regulation of interferon-beta biosynthetic process,BP,
13625,GO:0060154,0.999999999997461,0.735258191036374,0,3,cellular process regulating host cell cycle in response to virus,BP,
292,GO:0000797,0.999999999997468,0.880859655083129,0,1,condensin core heterodimer,CC,
4247,GO:0009449,0.999999999997472,0.70611041175638,0,3,gamma-aminobutyric acid biosynthetic process,BP,
19610,GO:1990809,0.999999999997506,0.656247050129552,0,4,endoplasmic reticulum tubular network membrane organization,BP,
7455,GO:0031620,0.999999999997513,0.721656429568322,0,3,regulation of fever generation,BP,
7456,GO:0031622,0.999999999997513,0.721656429568322,0,3,positive regulation of fever generation,BP,
18,GO:0000033,0.999999999997521,0.74283305084004,0,3,alpha-1,3-mannosyltransferase activity,MF,
2067,GO:0004822,0.999999999997542,0.786655851957302,0,2,isoleucine-tRNA ligase activity,MF,
2917,GO:0006428,0.999999999997542,0.786655851957302,0,2,isoleucyl-tRNA aminoacylation,BP,
3650,GO:0008127,0.99999999999756,0.918889608131973,0,1,quercetin 2,3-dioxygenase activity,MF,
1041,GO:0002560,0.999999999997561,0.884429521697487,0,1,basophil mediated immunity,BP,
1042,GO:0002561,0.999999999997561,0.884429521697487,0,1,basophil degranulation,BP,
8478,GO:0033644,0.999999999997561,0.884429521697487,0,1,host cell membrane,CC,
10758,GO:0044218,0.999999999997561,0.884429521697487,0,1,other organism cell membrane,CC,
10760,GO:0044221,0.999999999997561,0.884429521697487,0,1,host cell synapse,CC,
10763,GO:0044231,0.999999999997561,0.884429521697487,0,1,host cell presynaptic membrane,CC,
10787,GO:0044279,0.999999999997561,0.884429521697487,0,1,other organism membrane,CC,
15822,GO:0072556,0.999999999997561,0.884429521697487,0,1,other organism presynaptic membrane,CC,
1764,GO:0004370,0.999999999997565,0.777404724171238,0,2,glycerol kinase activity,MF,
11575,GO:0046167,0.999999999997565,0.777404724171238,0,2,glycerol-3-phosphate biosynthetic process,BP,
8732,GO:0034392,0.999999999997567,0.7119774362998,0,3,negative regulation of smooth muscle cell apoptotic process,BP,
4614,GO:0010735,0.999999999997581,0.691340843496869,0,3,positive regulation of transcription via serum response element binding,BP,
2574,GO:0005862,0.999999999997587,0.663566005573056,0,4,muscle thin filament tropomyosin,CC,
18026,GO:1902576,0.9999999999976,0.651172103349226,0,4,negative regulation of nuclear cell cycle DNA replication,BP,
19239,GO:1905443,0.999999999997602,0.882281636578105,0,1,regulation of clathrin coat assembly,BP,
19240,GO:1905445,0.999999999997602,0.882281636578105,0,1,positive regulation of clathrin coat assembly,BP,
20106,GO:2000819,0.999999999997603,0.799893273228244,0,2,regulation of nucleotide-excision repair,BP,
443,GO:0001192,0.999999999997604,0.937913571843982,0,1,maintenance of transcriptional fidelity during DNA-templated transcription elongation,BP,
444,GO:0001193,0.999999999997604,0.937913571843982,0,1,maintenance of transcriptional fidelity during DNA-templated transcription elongation from RNA polymerase II promoter,BP,
9043,GO:0035276,0.999999999997604,0.879727300739097,0,1,ethanol binding,MF,
9249,GO:0035668,0.999999999997604,0.879727300739097,0,1,TRAM-dependent toll-like receptor signaling pathway,BP,
9250,GO:0035669,0.999999999997604,0.879727300739097,0,1,TRAM-dependent toll-like receptor 4 signaling pathway,BP,
20162,GO:2001029,0.999999999997604,0.879727300739097,0,1,regulation of cellular glucuronidation,BP,
20163,GO:2001031,0.999999999997604,0.879727300739097,0,1,positive regulation of cellular glucuronidation,BP,
16973,GO:0099077,0.999999999997609,0.879593668836049,0,1,histone-dependent DNA binding,MF,
19319,GO:1905687,0.999999999997609,0.879593668836049,0,1,regulation of diacylglycerol kinase activity,BP,
19320,GO:1905689,0.999999999997609,0.879593668836049,0,1,positive regulation of diacylglycerol kinase activity,BP,
1888,GO:0004572,0.999999999997625,0.773858147735529,0,2,mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity,MF,
13798,GO:0060414,0.999999999997626,0.693099235763092,0,3,aorta smooth muscle tissue morphogenesis,BP,
5018,GO:0015183,0.999999999997632,0.714140544685674,0,3,L-aspartate transmembrane transporter activity,MF,
14259,GO:0061357,0.999999999997632,0.709096482134156,0,3,positive regulation of Wnt protein secretion,BP,
11949,GO:0047179,0.999999999997637,0.856739126135556,0,2,platelet-activating factor acetyltransferase activity,MF,
13991,GO:0060734,0.999999999997644,0.881508641156858,0,1,regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation,BP,
11264,GO:0045588,0.999999999997651,0.774858278328188,0,2,positive regulation of gamma-delta T cell differentiation,BP,
15419,GO:0071723,0.999999999997652,0.698481100159198,0,3,lipopeptide binding,MF,
7996,GO:0032632,0.999999999997656,0.792972572994328,0,2,interleukin-3 production,BP,
8020,GO:0032672,0.999999999997656,0.792972572994328,0,2,regulation of interleukin-3 production,BP,
1732,GO:0004332,0.999999999997665,0.82724709175727,0,2,fructose-bisphosphate aldolase activity,MF,
14114,GO:0061002,0.99999999999767,0.703725966789737,0,3,negative regulation of dendritic spine morphogenesis,BP,
2747,GO:0006147,0.999999999997679,0.879792148242689,0,1,guanine catabolic process,BP,
3992,GO:0008892,0.999999999997679,0.879792148242689,0,1,guanine deaminase activity,MF,
15464,GO:0071839,0.999999999997681,0.671899546619244,0,4,apoptotic process in bone marrow,BP,
4463,GO:0010459,0.999999999997686,0.683681513919354,0,4,negative regulation of heart rate,BP,
4733,GO:0010900,0.999999999997699,0.960876370816203,0,1,negative regulation of phosphatidylcholine catabolic process,BP,
6636,GO:0023029,0.9999999999977,0.642642663352895,0,4,MHC class Ib protein binding,MF,
12026,GO:0047801,0.999999999997708,0.901582720255774,0,1,L-cysteine:2-oxoglutarate aminotransferase activity,MF,
9002,GO:0035184,0.999999999997711,0.641892093270042,0,4,histone threonine kinase activity,MF,
9104,GO:0035405,0.999999999997711,0.641892093270042,0,4,histone-threonine phosphorylation,BP,
17099,GO:0102009,0.999999999997713,0.903724573504172,0,1,proline dipeptidase activity,MF,
6965,GO:0030627,0.99999999999773,0.829721247864926,0,2,pre-mRNA 5'-splice site binding,MF,
19161,GO:1905258,0.999999999997752,0.851558850400817,0,2,regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway,BP,
19162,GO:1905259,0.999999999997752,0.851558850400817,0,2,negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway,BP,
383,GO:0001025,0.999999999997762,0.671183978886849,0,3,RNA polymerase III transcription factor binding,MF,
429,GO:0001156,0.999999999997762,0.671183978886849,0,3,TFIIIC-class transcription factor binding,MF,
53,GO:0000110,0.999999999997772,0.715295741441998,0,3,nucleotide-excision repair factor 1 complex,CC,
19609,GO:1990796,0.999999999997782,0.898457341340034,0,1,photoreceptor cell terminal bouton,CC,
10339,GO:0043163,0.999999999997794,0.78681603445743,0,2,cell envelope organization,BP,
11154,GO:0045229,0.999999999997794,0.78681603445743,0,2,external encapsulating structure organization,BP,
1579,GO:0003991,0.999999999997803,0.901959762849802,0,1,acetylglutamate kinase activity,MF,
1611,GO:0004042,0.999999999997803,0.901959762849802,0,1,acetyl-CoA:L-glutamate N-acetyltransferase activity,MF,
17158,GO:0103045,0.999999999997803,0.901959762849802,0,1,methione N-acyltransferase activity,MF,
20090,GO:2000790,0.999999999997812,0.778932419716955,0,2,regulation of mesenchymal cell proliferation involved in lung development,BP,
20091,GO:2000791,0.999999999997812,0.778932419716955,0,2,negative regulation of mesenchymal cell proliferation involved in lung development,BP,
14083,GO:0060947,0.999999999997814,0.6199938882661,0,4,cardiac vascular smooth muscle cell differentiation,BP,
1651,GO:0004105,0.999999999997814,0.800378682893382,0,2,choline-phosphate cytidylyltransferase activity,MF,
5045,GO:0015230,0.999999999997826,0.808850134183593,0,2,FAD transmembrane transporter activity,MF,
9078,GO:0035350,0.999999999997826,0.808850134183593,0,2,FAD transmembrane transport,BP,
16359,GO:0090724,0.999999999997829,0.635758852104752,0,4,central region of growth cone,CC,
8742,GO:0034414,0.99999999999784,0.800398081755657,0,2,tRNA 3'-trailer cleavage, endonucleolytic,BP,
10172,GO:0042779,0.99999999999784,0.800398081755657,0,2,tRNA 3'-trailer cleavage,BP,
10174,GO:0042781,0.99999999999784,0.800398081755657,0,2,3'-tRNA processing endoribonuclease activity,MF,
19163,GO:1905267,0.99999999999784,0.800398081755657,0,2,endonucleolytic cleavage involved in tRNA processing,BP,
11657,GO:0046452,0.999999999997845,0.742598334229884,0,3,dihydrofolate metabolic process,BP,
6434,GO:0021730,0.999999999997866,0.877227555071658,0,1,trigeminal sensory nucleus development,BP,
6435,GO:0021740,0.999999999997866,0.877227555071658,0,1,principal sensory nucleus of trigeminal nerve development,BP,
14187,GO:0061141,0.999999999997866,0.877227555071658,0,1,lung ciliated cell differentiation,BP,
20094,GO:2000795,0.999999999997866,0.877227555071658,0,1,negative regulation of epithelial cell proliferation involved in lung morphogenesis,BP,
16971,GO:0099074,0.999999999997867,0.805363839304366,0,2,mitochondrion to lysosome transport,BP,
16972,GO:0099075,0.999999999997867,0.805363839304366,0,2,mitochondrion-derived vesicle mediated transport,BP,
5512,GO:0016476,0.999999999997868,0.711809092555336,0,3,regulation of embryonic cell shape,BP,
5921,GO:0018199,0.999999999997868,0.662385426120466,0,4,peptidyl-glutamine modification,BP,
11479,GO:0045967,0.999999999997871,0.762023010719786,0,2,negative regulation of growth rate,BP,
921,GO:0002316,0.999999999997873,0.883796940696313,0,1,follicular B cell differentiation,BP,
5950,GO:0018315,0.999999999997873,0.883796940696313,0,1,molybdenum incorporation into molybdenum-molybdopterin complex,BP,
9813,GO:0042040,0.999999999997873,0.883796940696313,0,1,metal incorporation into metallo-molybdopterin complex,BP,
14347,GO:0061598,0.999999999997873,0.883796940696313,0,1,molybdopterin adenylyltransferase activity,MF,
14348,GO:0061599,0.999999999997873,0.883796940696313,0,1,molybdopterin molybdotransferase activity,MF,
15839,GO:0072579,0.999999999997873,0.883796940696313,0,1,glycine receptor clustering,BP,
16429,GO:0097112,0.999999999997873,0.883796940696313,0,1,gamma-aminobutyric acid receptor clustering,BP,
6163,GO:0019520,0.999999999997877,0.811777405510076,0,2,aldonic acid metabolic process,BP,
6164,GO:0019521,0.999999999997877,0.811777405510076,0,2,D-gluconate metabolic process,BP,
19796,GO:2000275,0.999999999997879,0.842521026520265,0,2,regulation of oxidative phosphorylation uncoupler activity,BP,
19581,GO:1990737,0.999999999997882,0.706977094517407,0,3,response to manganese-induced endoplasmic reticulum stress,BP,
8603,GO:0034124,0.999999999997897,0.804887254404056,0,2,regulation of MyD88-dependent toll-like receptor signaling pathway,BP,
19625,GO:1990851,0.999999999997905,0.689185957814321,0,3,Wnt-Frizzled-LRP5/6 complex,CC,
8439,GO:0033577,0.99999999999791,0.809123143351438,0,2,protein glycosylation in endoplasmic reticulum,BP,
14761,GO:0070487,0.99999999999793,0.636773639151791,0,4,monocyte aggregation,BP,
2299,GO:0005275,0.999999999997938,0.897806590819562,0,1,amine transmembrane transporter activity,MF,
5055,GO:0015265,0.999999999997938,0.897806590819562,0,1,urea channel activity,MF,
10232,GO:0042979,0.999999999997938,0.663829728929322,0,4,ornithine decarboxylase regulator activity,MF,
17915,GO:1902267,0.999999999997938,0.663829728929322,0,4,regulation of polyamine transmembrane transport,BP,
11370,GO:0045762,0.999999999997944,0.772771744482238,0,2,positive regulation of adenylate cyclase activity,BP,
6132,GO:0019401,0.999999999997949,0.668013743972901,0,4,alditol biosynthetic process,BP,
3935,GO:0008623,0.99999999999795,0.791960569020265,0,2,CHRAC,CC,
1082,GO:0002666,0.999999999997952,0.641660976239297,0,4,positive regulation of T cell tolerance induction,BP,
2821,GO:0006286,0.999999999997952,0.839451949078948,0,2,base-excision repair, base-free sugar-phosphate removal,BP,
7321,GO:0031339,0.999999999997959,0.704971877102221,0,3,negative regulation of vesicle fusion,BP,
14561,GO:0070124,0.999999999997978,0.835910523106484,0,2,mitochondrial translational initiation,BP,
1966,GO:0004677,0.999999999997981,0.677381690098896,0,3,DNA-dependent protein kinase activity,MF,
13109,GO:0051684,0.999999999997982,0.694896827675364,0,3,maintenance of Golgi location,BP,
16689,GO:0097694,0.999999999997991,0.686725631262902,0,3,establishment of RNA localization to telomere,BP,
16690,GO:0097695,0.999999999997991,0.686725631262902,0,3,establishment of protein-containing complex localization to telomere,BP,
5218,GO:0015822,0.999999999998012,0.615289442705886,0,4,ornithine transport,BP,
18341,GO:1903352,0.999999999998012,0.615289442705886,0,4,L-ornithine transmembrane transport,BP,
19269,GO:1905535,0.999999999998015,0.880001351803931,0,1,regulation of eukaryotic translation initiation factor 4F complex assembly,BP,
19270,GO:1905537,0.999999999998015,0.880001351803931,0,1,positive regulation of eukaryotic translation initiation factor 4F complex assembly,BP,
19301,GO:1905610,0.999999999998015,0.880001351803931,0,1,regulation of mRNA cap binding,BP,
19302,GO:1905612,0.999999999998015,0.880001351803931,0,1,positive regulation of mRNA cap binding,BP,
13510,GO:0055113,0.99999999999802,0.871714136363615,0,1,epiboly involved in gastrulation with mouth forming second,BP,
17628,GO:1901387,0.999999999998029,0.696613982118242,0,3,positive regulation of voltage-gated calcium channel activity,BP,
12440,GO:0050253,0.999999999998051,0.7917304253609,0,2,retinyl-palmitate esterase activity,MF,
11147,GO:0045218,0.999999999998062,0.707745159177702,0,3,zonula adherens maintenance,BP,
1268,GO:0003057,0.999999999998065,0.730327715008129,0,3,regulation of the force of heart contraction by chemical signal,BP,
1517,GO:0003881,0.999999999998066,0.904002721216744,0,1,CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity,MF,
1623,GO:0004061,0.999999999998081,0.907072224562261,0,1,arylformamidase activity,MF,
4778,GO:0010967,0.999999999998081,0.907072224562261,0,1,regulation of polyamine biosynthetic process,BP,
7146,GO:0031013,0.999999999998081,0.907072224562261,0,1,troponin I binding,MF,
13429,GO:0052899,0.999999999998081,0.907072224562261,0,1,N(1),N(12)-diacetylspermine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity,MF,
13431,GO:0052902,0.999999999998081,0.907072224562261,0,1,spermidine:oxygen oxidoreductase (3-aminopropanal-forming) activity,MF,
13432,GO:0052903,0.999999999998081,0.907072224562261,0,1,N1-acetylspermine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity,MF,
13433,GO:0052904,0.999999999998081,0.907072224562261,0,1,N1-acetylspermidine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity,MF,
17595,GO:1901304,0.999999999998081,0.907072224562261,0,1,regulation of spermidine biosynthetic process,BP,
17596,GO:1901307,0.999999999998081,0.907072224562261,0,1,positive regulation of spermidine biosynthetic process,BP,
4927,GO:0014886,0.999999999998084,0.789898895491696,0,2,transition between slow and fast fiber,BP,
18493,GO:1903677,0.999999999998094,0.733636773926647,0,3,regulation of cap-independent translational initiation,BP,
18494,GO:1903679,0.999999999998094,0.733636773926647,0,3,positive regulation of cap-independent translational initiation,BP,
5901,GO:0018117,0.999999999998094,0.908145977988624,0,1,protein adenylylation,BP,
5913,GO:0018175,0.999999999998094,0.908145977988624,0,1,protein nucleotidylation,BP,
10928,GO:0044601,0.999999999998094,0.908145977988624,0,1,protein denucleotidylation,BP,
10929,GO:0044602,0.999999999998094,0.908145977988624,0,1,protein deadenylylation,BP,
10930,GO:0044603,0.999999999998094,0.908145977988624,0,1,protein adenylylhydrolase activity,MF,
14885,GO:0070733,0.999999999998094,0.908145977988624,0,1,protein adenylyltransferase activity,MF,
7362,GO:0031417,0.9999999999981,0.688959613200246,0,3,NatC complex,CC,
4323,GO:0009826,0.999999999998123,0.794964777906564,0,2,unidimensional cell growth,BP,
3318,GO:0007023,0.999999999998131,0.686358970653232,0,4,post-chaperonin tubulin folding pathway,BP,
3227,GO:0006880,0.999999999998131,0.780345650014034,0,3,intracellular sequestering of iron ion,BP,
16652,GO:0097577,0.999999999998131,0.780345650014034,0,3,sequestering of iron ion,BP,
6245,GO:0019826,0.999999999998134,0.792307136196483,0,2,oxygen sensor activity,MF,
14992,GO:0070943,0.999999999998142,0.745279819252235,0,3,neutrophil mediated killing of symbiont cell,BP,
1969,GO:0004686,0.99999999999815,0.878184510475518,0,1,elongation factor-2 kinase activity,MF,
15252,GO:0071454,0.99999999999815,0.878184510475518,0,1,cellular response to anoxia,BP,
10156,GO:0042756,0.999999999998154,0.745403811332012,0,3,drinking behavior,BP,
2382,GO:0005519,0.999999999998157,0.886446579253432,0,1,cytoskeletal regulatory protein binding,MF,
1241,GO:0002943,0.999999999998165,0.663246239124224,0,4,tRNA dihydrouridine synthesis,BP,
5850,GO:0017150,0.999999999998165,0.663246239124224,0,4,tRNA dihydrouridine synthase activity,MF,
9285,GO:0035739,0.999999999998168,0.636024997216683,0,4,CD4-positive, alpha-beta T cell proliferation,BP,
19952,GO:2000561,0.999999999998168,0.636024997216683,0,4,regulation of CD4-positive, alpha-beta T cell proliferation,BP,
17528,GO:1901090,0.999999999998168,0.809553590579216,0,2,regulation of protein tetramerization,BP,
17529,GO:1901091,0.999999999998168,0.809553590579216,0,2,negative regulation of protein tetramerization,BP,
17530,GO:1901093,0.999999999998168,0.809553590579216,0,2,regulation of protein homotetramerization,BP,
17531,GO:1901094,0.999999999998168,0.809553590579216,0,2,negative regulation of protein homotetramerization,BP,
17347,GO:1900084,0.99999999999817,0.620742325348958,0,4,regulation of peptidyl-tyrosine autophosphorylation,BP,
6322,GO:0020012,0.999999999998171,0.791851438920918,0,2,evasion or tolerance of host immune response,BP,
6992,GO:0030682,0.999999999998171,0.791851438920918,0,2,evasion or tolerance of host defense response,BP,
6993,GO:0030683,0.999999999998171,0.791851438920918,0,2,evasion or tolerance by virus of host immune response,BP,
13174,GO:0051805,0.999999999998171,0.791851438920918,0,2,evasion or tolerance of immune response of other organism involved in symbiotic interaction,BP,
13176,GO:0051807,0.999999999998171,0.791851438920918,0,2,evasion or tolerance of defense response of other organism involved in symbiotic interaction,BP,
15587,GO:0072095,0.999999999998176,0.79613350663196,0,2,regulation of branch elongation involved in ureteric bud branching,BP,
3853,GO:0008470,0.999999999998188,0.881647645535702,0,1,isovaleryl-CoA dehydrogenase activity,MF,
19919,GO:2000474,0.999999999998189,0.885682473662224,0,1,regulation of opioid receptor signaling pathway,BP,
15745,GO:0072362,0.999999999998189,0.877516187090166,0,1,regulation of glycolytic process by negative regulation of transcription from RNA polymerase II promoter,BP,
4721,GO:0010886,0.999999999998195,0.709808736952266,0,3,positive regulation of cholesterol storage,BP,
19805,GO:2000286,0.999999999998197,0.719705532247471,0,3,receptor internalization involved in canonical Wnt signaling pathway,BP,
2315,GO:0005316,0.9999999999982,0.894977728835445,0,1,high-affinity inorganic phosphate:sodium symporter activity,MF,
10085,GO:0042608,0.999999999998204,0.73706150150656,0,3,T cell receptor binding,MF,
8885,GO:0034714,0.999999999998205,0.710735135075565,0,3,type III transforming growth factor beta receptor binding,MF,
19519,GO:1990450,0.999999999998206,0.901839151908953,0,1,linear polyubiquitin binding,MF,
9691,GO:0038107,0.99999999999821,0.71635686502051,0,3,nodal signaling pathway involved in determination of left/right asymmetry,BP,
17351,GO:1900094,0.99999999999821,0.71635686502051,0,3,regulation of transcription from RNA polymerase II promoter involved in determination of left/right symmetry,BP,
17398,GO:1900164,0.99999999999821,0.71635686502051,0,3,nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,BP,
12838,GO:0051177,0.999999999998215,0.667594842983888,0,4,meiotic sister chromatid cohesion,BP,
15846,GO:0072589,0.99999999999822,0.750390794316215,0,4,box H/ACA scaRNP complex,CC,
17173,GO:0106017,0.999999999998221,0.684477118625923,0,3,phosphatidylinositol-3,4-bisphosphate phosphatase activity,MF,
2421,GO:0005597,0.999999999998227,0.879656311872644,0,1,collagen type XVI trimer,CC,
5672,GO:0016785,0.999999999998227,0.879656311872644,0,1,transferase activity, transferring selenium-containing groups,MF,
16767,GO:0098621,0.999999999998227,0.879656311872644,0,1,phosphoseryl-selenocysteinyl-tRNA selenium transferase activity,MF,
8980,GO:0035101,0.999999999998236,0.712018243970342,0,3,FACT complex,CC,
10711,GO:0044062,0.999999999998239,0.733244421842026,0,3,regulation of excretion,BP,
14903,GO:0070777,0.999999999998239,0.787880093466278,0,2,D-aspartate transport,BP,
14905,GO:0070779,0.999999999998239,0.787880093466278,0,2,D-aspartate import across plasma membrane,BP,
16684,GO:0097680,0.999999999998249,0.702664618773534,0,3,double-strand break repair via classical nonhomologous end joining,BP,
13424,GO:0052858,0.999999999998255,0.891345478585593,0,1,peptidyl-lysine acetyltransferase activity,MF,
13166,GO:0051793,0.999999999998262,0.711189477191516,0,3,medium-chain fatty acid catabolic process,BP,
9166,GO:0035544,0.999999999998265,0.882410655543292,0,1,negative regulation of SNARE complex assembly,BP,
18793,GO:1904381,0.999999999998276,0.778595928107453,0,2,Golgi apparatus mannose trimming,BP,
16715,GO:0097752,0.999999999998281,0.726663322809141,0,3,regulation of DNA stability,BP,
14462,GO:0061889,0.999999999998283,0.879950312202132,0,1,negative regulation of astrocyte activation,BP,
18641,GO:1903979,0.999999999998283,0.879950312202132,0,1,negative regulation of microglial cell activation,BP,
3400,GO:0007181,0.99999999999829,0.805094278061794,0,2,transforming growth factor beta receptor complex assembly,BP,
6801,GO:0030259,0.999999999998291,0.646918826083812,0,4,lipid glycosylation,BP,
6360,GO:0021546,0.999999999998296,0.813178078448855,0,2,rhombomere development,BP,
4169,GO:0009237,0.999999999998301,0.898618380646805,0,1,siderophore metabolic process,BP,
6092,GO:0019290,0.999999999998301,0.898618380646805,0,1,siderophore biosynthetic process,BP,
15984,GO:0086015,0.999999999998302,0.786386008136062,0,2,SA node cell action potential,BP,
15987,GO:0086018,0.999999999998302,0.786386008136062,0,2,SA node cell to atrial cardiac muscle cell signaling,BP,
11187,GO:0045329,0.999999999998308,0.656035753145053,0,4,carnitine biosynthetic process,BP,
16252,GO:0090336,0.99999999999832,0.715335026982224,0,3,positive regulation of brown fat cell differentiation,BP,
2270,GO:0005212,0.999999999998336,0.768714676658047,0,3,structural constituent of eye lens,MF,
19526,GO:1990481,0.999999999998337,0.660248202410294,0,4,mRNA pseudouridine synthesis,BP,
18854,GO:1904535,0.999999999998338,0.88187358470861,0,1,positive regulation of telomeric loop disassembly,BP,
16677,GO:0097647,0.99999999999834,0.772325112421349,0,3,amylin receptor signaling pathway,BP,
19560,GO:1990635,0.999999999998345,0.633474031367273,0,4,proximal dendrite,CC,
3752,GO:0008295,0.999999999998354,0.673095722001803,0,4,spermidine biosynthetic process,BP,
2201,GO:0005087,0.999999999998357,0.692015559589319,0,4,Ran guanyl-nucleotide exchange factor activity,MF,
1683,GO:0004152,0.999999999998368,0.901989203352531,0,1,dihydroorotate dehydrogenase activity,MF,
18454,GO:1903576,0.999999999998368,0.901989203352531,0,1,response to L-arginine,BP,
14618,GO:0070213,0.999999999998377,0.617635093940171,0,4,protein auto-ADP-ribosylation,BP,
7531,GO:0031798,0.999999999998395,0.877909670011531,0,1,type 1 metabotropic glutamate receptor binding,MF,
14445,GO:0061828,0.999999999998395,0.877909670011531,0,1,apical tubulobulbar complex,CC,
14446,GO:0061829,0.999999999998395,0.877909670011531,0,1,basal tubulobulbar complex,CC,
3097,GO:0006671,0.999999999998409,0.88292020478332,0,1,phytosphingosine metabolic process,BP,
14900,GO:0070774,0.999999999998409,0.88292020478332,0,1,phytoceramidase activity,MF,
15342,GO:0071602,0.999999999998409,0.88292020478332,0,1,phytosphingosine biosynthetic process,BP,
175,GO:0000384,0.999999999998412,0.825400426912622,0,2,first spliceosomal transesterification activity,MF,
9706,GO:0038145,0.999999999998416,0.719501892879086,0,3,macrophage colony-stimulating factor signaling pathway,BP,
14670,GO:0070309,0.999999999998417,0.635794502655384,0,4,lens fiber cell morphogenesis,BP,
5786,GO:0017018,0.99999999999842,0.774500352526359,0,2,myosin phosphatase activity,MF,
18206,GO:1903031,0.999999999998423,0.813697368054375,0,2,regulation of microtubule plus-end binding,BP,
18207,GO:1903033,0.999999999998423,0.813697368054375,0,2,positive regulation of microtubule plus-end binding,BP,
6661,GO:0030023,0.999999999998434,0.666850666825684,0,3,extracellular matrix constituent conferring elasticity,MF,
6521,GO:0021914,0.999999999998456,0.798270926347171,0,2,negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning,BP,
10222,GO:0042940,0.999999999998456,0.709217824376178,0,3,D-amino acid transport,BP,
1028,GO:0002536,0.999999999998465,0.846200131116666,0,2,respiratory burst involved in inflammatory response,BP,
13685,GO:0060264,0.999999999998465,0.846200131116666,0,2,regulation of respiratory burst involved in inflammatory response,BP,
13687,GO:0060266,0.999999999998465,0.846200131116666,0,2,negative regulation of respiratory burst involved in inflammatory response,BP,
3774,GO:0008330,0.999999999998466,0.662930337382378,0,4,protein tyrosine/threonine phosphatase activity,MF,
3738,GO:0008275,0.999999999998487,0.628726051143021,0,4,gamma-tubulin small complex,CC,
10860,GO:0044406,0.999999999998489,0.66526634846625,0,4,adhesion of symbiont to host,BP,
17759,GO:1901841,0.999999999998507,0.646934881702784,0,4,regulation of high voltage-gated calcium channel activity,BP,
6990,GO:0030678,0.999999999998508,0.755645583361569,0,3,mitochondrial ribonuclease P complex,CC,
16711,GO:0097745,0.999999999998508,0.755645583361569,0,3,mitochondrial tRNA 5'-end processing,BP,
17862,GO:1902162,0.999999999998511,0.859072031068656,0,2,regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,BP,
17863,GO:1902164,0.999999999998511,0.859072031068656,0,2,positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,BP,
17461,GO:1900378,0.999999999998521,0.775789182050303,0,2,positive regulation of secondary metabolite biosynthetic process,BP,
764,GO:0002017,0.999999999998528,0.903921560280691,0,1,regulation of blood volume by renal aldosterone,BP,
9748,GO:0039519,0.999999999998538,0.774550727906674,0,2,modulation by virus of host autophagy,BP,
10119,GO:0042670,0.999999999998548,0.705993800300472,0,3,retinal cone cell differentiation,BP,
11720,GO:0046549,0.999999999998548,0.705993800300472,0,3,retinal cone cell development,BP,
11053,GO:0045065,0.999999999998558,0.808718208969889,0,2,cytotoxic T cell differentiation,BP,
11261,GO:0045583,0.999999999998558,0.808718208969889,0,2,regulation of cytotoxic T cell differentiation,BP,
11262,GO:0045585,0.999999999998558,0.808718208969889,0,2,positive regulation of cytotoxic T cell differentiation,BP,
5997,GO:0019034,0.999999999998562,0.777618260931157,0,2,viral replication complex,CC,
16480,GO:0097198,0.99999999999859,0.787293812166327,0,2,histone H3-K36 trimethylation,BP,
18412,GO:1903516,0.999999999998613,0.718176241053387,0,3,regulation of single strand break repair,BP,
15560,GO:0072049,0.999999999998616,0.674545475649332,0,4,comma-shaped body morphogenesis,BP,
13032,GO:0051542,0.999999999998628,0.78962469250125,0,2,elastin biosynthetic process,BP,
4431,GO:0010269,0.999999999998636,0.76128658144037,0,3,response to selenium ion,BP,
5551,GO:0016560,0.99999999999864,0.636460957558422,0,4,protein import into peroxisome matrix, docking,BP,
18421,GO:1903526,0.999999999998644,0.786046001864357,0,2,negative regulation of membrane tubulation,BP,
18215,GO:1903045,0.999999999998652,0.879648204071495,0,1,neural crest cell migration involved in sympathetic nervous system development,BP,
15544,GO:0072014,0.999999999998667,0.635580630163184,0,4,proximal tubule development,BP,
18461,GO:1903588,0.999999999998683,0.722471697806905,0,3,negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,
18958,GO:1904766,0.999999999998688,0.878734816461198,0,1,negative regulation of macroautophagy by TORC1 signaling,BP,
5912,GO:0018171,0.999999999998689,0.683523072193761,0,4,peptidyl-cysteine oxidation,BP,
5496,GO:0016436,0.999999999998698,0.800168690830169,0,2,rRNA (uridine) methyltransferase activity,MF,
13395,GO:0052811,0.999999999998703,0.61146004602638,0,4,1-phosphatidylinositol-3-phosphate 4-kinase activity,MF,
7234,GO:0031166,0.999999999998705,0.705021976952859,0,3,integral component of vacuolar membrane,CC,
7300,GO:0031310,0.999999999998705,0.705021976952859,0,3,intrinsic component of vacuolar membrane,CC,
7187,GO:0031084,0.999999999998708,0.699863317680743,0,3,BLOC-2 complex,CC,
5256,GO:0015888,0.999999999998713,0.800479933882488,0,2,thiamine transport,BP,
10668,GO:0043946,0.999999999998718,0.906074085480112,0,1,positive regulation of catalytic activity in other organism involved in symbiotic interaction,BP,
10669,GO:0043947,0.999999999998718,0.906074085480112,0,1,positive regulation by host of symbiont catalytic activity,BP,
13330,GO:0052422,0.999999999998718,0.906074085480112,0,1,modulation by host of symbiont catalytic activity,BP,
15240,GO:0071435,0.999999999998719,0.698442253328594,0,3,potassium ion export,BP,
17414,GO:1900208,0.99999999999872,0.831519130660872,0,2,regulation of cardiolipin metabolic process,BP,
17415,GO:1900210,0.99999999999872,0.831519130660872,0,2,positive regulation of cardiolipin metabolic process,BP,
10499,GO:0043418,0.999999999998733,0.725384422782515,0,3,homocysteine catabolic process,BP,
3093,GO:0006667,0.999999999998748,0.793995744425538,0,2,sphinganine metabolic process,BP,
11697,GO:0046511,0.999999999998748,0.793995744425538,0,2,sphinganine biosynthetic process,BP,
12020,GO:0047750,0.999999999998763,0.862481109489193,0,2,cholestenol delta-isomerase activity,MF,
2503,GO:0005757,0.999999999998768,0.69065007165263,0,4,mitochondrial permeability transition pore complex,CC,
16861,GO:0098821,0.999999999998774,0.681037370083184,0,3,BMP receptor activity,MF,
18263,GO:1903179,0.999999999998785,0.836593285854128,0,2,regulation of dopamine biosynthetic process,BP,
18264,GO:1903181,0.999999999998785,0.836593285854128,0,2,positive regulation of dopamine biosynthetic process,BP,
9092,GO:0035373,0.99999999999879,0.763300404704899,0,2,chondroitin sulfate proteoglycan binding,MF,
6345,GO:0021526,0.999999999998796,0.904043815635174,0,1,medial motor column neuron differentiation,BP,
18039,GO:1902616,0.999999999998796,0.904043815635174,0,1,acyl carnitine transmembrane transport,BP,
10826,GO:0044334,0.999999999998801,0.791773853445444,0,2,canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition,BP,
16124,GO:0090156,0.999999999998815,0.746019367336972,0,3,cellular sphingolipid homeostasis,BP,
4291,GO:0009720,0.999999999998817,0.898126465431946,0,1,detection of hormone stimulus,BP,
8563,GO:0034041,0.999999999998817,0.898126465431946,0,1,sterol-transporting ATPase activity,MF,
2446,GO:0005656,0.99999999999882,0.739319814497258,0,3,nuclear pre-replicative complex,CC,
2807,GO:0006267,0.99999999999882,0.739319814497258,0,3,pre-replicative complex assembly involved in nuclear cell cycle DNA replication,BP,
9566,GO:0036387,0.99999999999882,0.739319814497258,0,3,pre-replicative complex,CC,
9567,GO:0036388,0.99999999999882,0.739319814497258,0,3,pre-replicative complex assembly,BP,
17928,GO:1902299,0.99999999999882,0.739319814497258,0,3,pre-replicative complex assembly involved in cell cycle DNA replication,BP,
11447,GO:0045918,0.999999999998822,0.87420364183659,0,2,negative regulation of cytolysis,BP,
10407,GO:0043262,0.999999999998828,0.729228504415639,0,3,adenosine-diphosphatase activity,MF,
17627,GO:1901386,0.999999999998828,0.650448096448353,0,4,negative regulation of voltage-gated calcium channel activity,BP,
19853,GO:2000354,0.999999999998829,0.664055497152376,0,4,regulation of ovarian follicle development,BP,
10848,GO:0044378,0.999999999998832,0.802946300713953,0,2,non-sequence-specific DNA binding, bending,MF,
10090,GO:0042613,0.999999999998838,0.775641377341156,0,3,MHC class II protein complex,CC,
14034,GO:0060830,0.999999999998846,0.73092523623236,0,3,ciliary receptor clustering involved in smoothened signaling pathway,BP,
11295,GO:0045629,0.99999999999885,0.720210160096593,0,3,negative regulation of T-helper 2 cell differentiation,BP,
14751,GO:0070471,0.999999999998851,0.699028866141302,0,3,uterine smooth muscle contraction,BP,
14752,GO:0070472,0.999999999998851,0.699028866141302,0,3,regulation of uterine smooth muscle contraction,BP,
14753,GO:0070474,0.999999999998851,0.699028866141302,0,3,positive regulation of uterine smooth muscle contraction,BP,
7673,GO:0032116,0.999999999998854,0.78527479546493,0,2,SMC loading complex,CC,
16354,GO:0090694,0.999999999998854,0.78527479546493,0,2,Scc2-Scc4 cohesin loading complex,CC,
1540,GO:0003937,0.999999999998866,0.901784860509304,0,1,IMP cyclohydrolase activity,MF,
1939,GO:0004643,0.999999999998866,0.901784860509304,0,1,phosphoribosylaminoimidazolecarboxamide formyltransferase activity,MF,
13391,GO:0052798,0.999999999998866,0.901784860509304,0,1,beta-galactoside alpha-2,3-sialyltransferase activity,MF,
1046,GO:0002572,0.999999999998866,0.795500992030943,0,2,pro-T cell differentiation,BP,
20024,GO:2000669,0.999999999998868,0.793365663621873,0,2,negative regulation of dendritic cell apoptotic process,BP,
11164,GO:0045259,0.999999999998872,0.825068881098044,0,2,proton-transporting ATP synthase complex,CC,
7429,GO:0031547,0.999999999998872,0.774550635493804,0,2,brain-derived neurotrophic factor receptor signaling pathway,BP,
6104,GO:0019344,0.999999999998873,0.734570590277859,0,3,cysteine biosynthetic process,BP,
3922,GO:0008597,0.999999999998877,0.816870361288847,0,2,calcium-dependent protein serine/threonine phosphatase regulator activity,MF,
1911,GO:0004605,0.999999999998891,0.713361467807308,0,3,phosphatidate cytidylyltransferase activity,MF,
5388,GO:0016222,0.999999999998901,0.809337821925591,0,2,procollagen-proline 4-dioxygenase complex,CC,
11937,GO:0047066,0.999999999998927,0.934513447094557,0,1,phospholipid-hydroperoxide glutathione peroxidase activity,MF,
16694,GO:0097707,0.999999999998927,0.934513447094557,0,1,ferroptosis,BP,
17219,GO:0110075,0.999999999998927,0.934513447094557,0,1,regulation of ferroptosis,BP,
17220,GO:0110076,0.999999999998927,0.934513447094557,0,1,negative regulation of ferroptosis,BP,
11574,GO:0046166,0.999999999998931,0.823556373899297,0,2,glyceraldehyde-3-phosphate biosynthetic process,BP,
1438,GO:0003419,0.999999999998932,0.808667866879732,0,2,growth plate cartilage chondrocyte proliferation,BP,
1439,GO:0003420,0.999999999998932,0.808667866879732,0,2,regulation of growth plate cartilage chondrocyte proliferation,BP,
931,GO:0002329,0.999999999998934,0.59492318353809,0,4,pre-B cell differentiation,BP,
8977,GO:0035095,0.999999999998973,0.623335368029581,0,4,behavioral response to nicotine,BP,
16716,GO:0097753,0.999999999998983,0.888502712993642,0,1,membrane bending,BP,
2126,GO:0004924,0.999999999999008,0.69697401397987,0,3,oncostatin-M receptor activity,MF,
9713,GO:0038165,0.999999999999008,0.69697401397987,0,3,oncostatin-M-mediated signaling pathway,BP,
11630,GO:0046368,0.999999999999012,0.66025690628978,0,4,GDP-L-fucose metabolic process,BP,
11722,GO:0046570,0.999999999999016,0.920379271812402,0,1,methylthioribulose 1-phosphate dehydratase activity,MF,
14793,GO:0070545,0.999999999999018,0.644427456541697,0,4,PeBoW complex,CC,
15053,GO:0071042,0.999999999999019,0.678097670885143,0,4,nuclear polyadenylation-dependent mRNA catabolic process,BP,
15058,GO:0071047,0.999999999999019,0.678097670885143,0,4,polyadenylation-dependent mRNA catabolic process,BP,
15343,GO:0071603,0.999999999999034,0.786811365862925,0,2,endothelial cell-cell adhesion,BP,
3864,GO:0008488,0.999999999999036,0.896315451495115,0,1,gamma-glutamyl carboxylase activity,MF,
8802,GO:0034552,0.999999999999043,0.690015943864177,0,4,respiratory chain complex II assembly,BP,
8803,GO:0034553,0.999999999999043,0.690015943864177,0,4,mitochondrial respiratory chain complex II assembly,BP,
752,GO:0001993,0.999999999999047,0.645785151699082,0,4,regulation of systemic arterial blood pressure by norepinephrine-epinephrine,BP,
2357,GO:0005457,0.999999999999051,0.787299984370792,0,2,GDP-fucose transmembrane transporter activity,MF,
5192,GO:0015783,0.999999999999051,0.787299984370792,0,2,GDP-fucose transmembrane transport,BP,
9456,GO:0036080,0.999999999999051,0.787299984370792,0,2,purine nucleotide-sugar transmembrane transporter activity,MF,
7847,GO:0032415,0.999999999999054,0.719717763594135,0,3,regulation of sodium:proton antiporter activity,BP,
9372,GO:0035915,0.999999999999064,0.902186758040585,0,1,pore formation in membrane of other organism,BP,
19865,GO:2000374,0.999999999999064,0.902186758040585,0,1,regulation of oxygen metabolic process,BP,
1844,GO:0004505,0.999999999999077,0.838826273368349,0,2,phenylalanine 4-monooxygenase activity,MF,
3648,GO:0008124,0.999999999999077,0.838826273368349,0,2,4-alpha-hydroxytetrahydrobiopterin dehydratase activity,MF,
18290,GO:1903236,0.99999999999908,0.732168999106045,0,3,regulation of leukocyte tethering or rolling,BP,
18826,GO:1904455,0.999999999999085,0.774144734500106,0,2,ubiquitin-specific protease activity involved in negative regulation of ERAD pathway,MF,
18901,GO:1904647,0.999999999999089,0.875635950697054,0,1,response to rotenone,BP,
19317,GO:1905671,0.999999999999099,0.715687826615414,0,3,regulation of lysosome organization,BP,
7753,GO:0032277,0.999999999999108,0.901356334792842,0,1,negative regulation of gonadotropin secretion,BP,
10541,GO:0043509,0.999999999999108,0.901356334792842,0,1,activin A complex,CC,
10542,GO:0043511,0.999999999999108,0.901356334792842,0,1,inhibin complex,CC,
10543,GO:0043512,0.999999999999108,0.901356334792842,0,1,inhibin A complex,CC,
11063,GO:0045077,0.999999999999108,0.901356334792842,0,1,negative regulation of interferon-gamma biosynthetic process,BP,
11858,GO:0046882,0.999999999999108,0.901356334792842,0,1,negative regulation of follicle-stimulating hormone secretion,BP,
12104,GO:0048180,0.999999999999108,0.901356334792842,0,1,activin complex,CC,
13692,GO:0060278,0.999999999999108,0.901356334792842,0,1,regulation of ovulation,BP,
13693,GO:0060279,0.999999999999108,0.901356334792842,0,1,positive regulation of ovulation,BP,
2054,GO:0004807,0.999999999999109,0.913338108662653,0,1,triose-phosphate isomerase activity,MF,
8039,GO:0032701,0.99999999999911,0.813427458312186,0,2,negative regulation of interleukin-18 production,BP,
8997,GO:0035166,0.999999999999113,0.708380279341739,0,3,post-embryonic hemopoiesis,BP,
15246,GO:0071442,0.999999999999114,0.719717232264242,0,3,positive regulation of histone H3-K14 acetylation,BP,
5355,GO:0016128,0.999999999999118,0.731600633144944,0,3,phytosteroid metabolic process,BP,
5356,GO:0016129,0.999999999999118,0.731600633144944,0,3,phytosteroid biosynthetic process,BP,
3262,GO:0006931,0.999999999999125,0.717044260860592,0,3,substrate-dependent cell migration, cell attachment to substrate,BP,
17104,GO:0102121,0.999999999999136,0.809393490865334,0,2,ceramidase activity,MF,
10130,GO:0042713,0.99999999999914,0.685480196150615,0,3,sperm ejaculation,BP,
7902,GO:0032483,0.999999999999141,0.618950583249287,0,4,regulation of Rab protein signal transduction,BP,
18437,GO:1903547,0.999999999999148,0.857448059295137,0,2,regulation of growth hormone activity,BP,
1956,GO:0004662,0.999999999999153,0.818087349532292,0,2,CAAX-protein geranylgeranyltransferase activity,MF,
2626,GO:0005953,0.999999999999153,0.818087349532292,0,2,CAAX-protein geranylgeranyltransferase complex,CC,
13440,GO:0052925,0.999999999999162,0.911571842381898,0,1,dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase activity,MF,
8896,GO:0034729,0.999999999999163,0.715970521621695,0,3,histone H3-K79 methylation,BP,
5548,GO:0016557,0.999999999999172,0.752186070379048,0,3,peroxisome membrane biogenesis,BP,
13325,GO:0052405,0.999999999999177,0.763870681282668,0,3,negative regulation by host of symbiont molecular function,BP,
9525,GO:0036284,0.999999999999188,0.800668915980797,0,2,tubulobulbar complex,CC,
9280,GO:0035730,0.999999999999189,0.93358637539008,0,1,S-nitrosoglutathione binding,MF,
9281,GO:0035731,0.999999999999189,0.93358637539008,0,1,dinitrosyl-iron complex binding,MF,
9282,GO:0035732,0.999999999999189,0.93358637539008,0,1,nitric oxide storage,BP,
4539,GO:0010615,0.999999999999191,0.881525894883472,0,1,positive regulation of cardiac muscle adaptation,BP,
18295,GO:1903244,0.999999999999191,0.881525894883472,0,1,positive regulation of cardiac muscle hypertrophy in response to stress,BP,
19143,GO:1905205,0.999999999999191,0.881525894883472,0,1,positive regulation of connective tissue replacement,BP,
3687,GO:0008192,0.999999999999224,0.717482349790799,0,3,RNA guanylyltransferase activity,MF,
13435,GO:0052906,0.999999999999224,0.879945607107185,0,1,tRNA (guanine(37)-N(1))-methyltransferase activity,MF,
10699,GO:0044028,0.999999999999225,0.78961073511994,0,2,DNA hypomethylation,BP,
10700,GO:0044029,0.999999999999225,0.78961073511994,0,2,hypomethylation of CpG island,BP,
16682,GO:0097676,0.999999999999228,0.687348090024816,0,3,histone H3-K36 dimethylation,BP,
19070,GO:1904995,0.99999999999923,0.845512770179287,0,2,negative regulation of leukocyte adhesion to vascular endothelial cell,BP,
7412,GO:0031510,0.999999999999231,0.740304760034263,0,3,SUMO activating enzyme complex,CC,
2789,GO:0006226,0.999999999999242,0.74139677224106,0,3,dUMP biosynthetic process,BP,
10105,GO:0042637,0.999999999999253,0.660715607290861,0,4,catagen,BP,
13167,GO:0051794,0.999999999999253,0.660715607290861,0,4,regulation of timing of catagen,BP,
16398,GO:0097056,0.999999999999259,0.650181141129101,0,4,selenocysteinyl-tRNA(Sec) biosynthetic process,BP,
1573,GO:0003985,0.999999999999259,0.73679736992865,0,3,acetyl-CoA C-acetyltransferase activity,MF,
17248,GO:0120092,0.999999999999265,0.894039991766637,0,1,crotonyl-CoA hydratase activity,MF,
17249,GO:0120093,0.999999999999265,0.894039991766637,0,1,regulation of peptidyl-lysine crotonylation,BP,
17250,GO:0120094,0.999999999999265,0.894039991766637,0,1,negative regulation of peptidyl-lysine crotonylation,BP,
9801,GO:0042008,0.999999999999277,0.892017959779795,0,1,interleukin-18 receptor activity,MF,
15986,GO:0086017,0.999999999999277,0.793730241743556,0,2,Purkinje myocyte action potential,BP,
15996,GO:0086029,0.999999999999277,0.793730241743556,0,2,Purkinje myocyte to ventricular cardiac muscle cell signaling,BP,
16017,GO:0086068,0.999999999999277,0.793730241743556,0,2,Purkinje myocyte to ventricular cardiac muscle cell communication,BP,
19555,GO:1990613,0.999999999999277,0.892017959779795,0,1,mitochondrial membrane fusion,BP,
18521,GO:1903750,0.999999999999278,0.67451159517299,0,4,regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide,BP,
18522,GO:1903751,0.999999999999278,0.67451159517299,0,4,negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide,BP,
1629,GO:0004070,0.999999999999281,0.772712812886618,0,2,aspartate carbamoyltransferase activity,MF,
1641,GO:0004087,0.999999999999281,0.772712812886618,0,2,carbamoyl-phosphate synthase (ammonia) activity,MF,
1642,GO:0004088,0.999999999999281,0.772712812886618,0,2,carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity,MF,
1682,GO:0004151,0.999999999999281,0.772712812886618,0,2,dihydroorotase activity,MF,
5646,GO:0016743,0.999999999999281,0.772712812886618,0,2,carboxyl- or carbamoyltransferase activity,MF,
10907,GO:0044530,0.999999999999296,0.697618054818663,0,3,supraspliceosomal complex,CC,
8766,GO:0034455,0.999999999999307,0.711238510314523,0,3,t-UTP complex,CC,
17553,GO:1901187,0.999999999999312,0.791863970025091,0,2,regulation of ephrin receptor signaling pathway,BP,
13380,GO:0052735,0.999999999999316,0.711821883536416,0,3,tRNA (cytosine-3-)-methyltransferase activity,MF,
11435,GO:0045903,0.999999999999318,0.786842757845095,0,3,positive regulation of translational fidelity,BP,
7834,GO:0032398,0.999999999999324,0.907462807726232,0,1,MHC class Ib protein complex,CC,
8001,GO:0032639,0.999999999999324,0.907462807726232,0,1,TRAIL production,BP,
8025,GO:0032679,0.999999999999324,0.907462807726232,0,1,regulation of TRAIL production,BP,
8069,GO:0032759,0.999999999999324,0.907462807726232,0,1,positive regulation of TRAIL production,BP,
19956,GO:2000566,0.999999999999324,0.907462807726232,0,1,positive regulation of CD8-positive, alpha-beta T cell proliferation,BP,
20220,GO:2001187,0.999999999999324,0.907462807726232,0,1,positive regulation of CD8-positive, alpha-beta T cell activation,BP,
304,GO:0000814,0.999999999999348,0.754576441571033,0,3,ESCRT II complex,CC,
17074,GO:0099631,0.99999999999936,0.854764055779446,0,2,postsynaptic endocytic zone cytoplasmic component,CC,
15434,GO:0071787,0.999999999999364,0.656488798127162,0,4,endoplasmic reticulum tubular network formation,BP,
14423,GO:0061762,0.999999999999371,0.774371912735059,0,2,CAMKK-AMPK signaling cascade,BP,
16954,GO:0099004,0.999999999999371,0.774371912735059,0,2,calmodulin dependent kinase signaling pathway,BP,
12093,GO:0048149,0.999999999999378,0.617246928582234,0,4,behavioral response to ethanol,BP,
3858,GO:0008479,0.999999999999392,0.698095104263917,0,4,queuine tRNA-ribosyltransferase activity,MF,
15497,GO:0071898,0.999999999999396,0.728530158368058,0,3,regulation of estrogen receptor binding,BP,
15498,GO:0071899,0.999999999999396,0.728530158368058,0,3,negative regulation of estrogen receptor binding,BP,
4971,GO:0015086,0.999999999999399,0.88456543279523,0,1,cadmium ion transmembrane transporter activity,MF,
4972,GO:0015087,0.999999999999399,0.88456543279523,0,1,cobalt ion transmembrane transporter activity,MF,
4975,GO:0015094,0.999999999999399,0.88456543279523,0,1,lead ion transmembrane transporter activity,MF,
5152,GO:0015692,0.999999999999399,0.88456543279523,0,1,lead ion transport,BP,
14836,GO:0070627,0.999999999999399,0.88456543279523,0,1,ferrous iron import,BP,
14917,GO:0070826,0.999999999999399,0.88456543279523,0,1,paraferritin complex,CC,
3307,GO:0007008,0.999999999999408,0.893815816240176,0,1,outer mitochondrial membrane organization,BP,
5312,GO:0016031,0.999999999999408,0.893815816240176,0,1,tRNA import into mitochondrion,BP,
14545,GO:0070096,0.999999999999408,0.893815816240176,0,1,mitochondrial outer membrane translocase complex assembly,BP,
19155,GO:1905242,0.999999999999408,0.893815816240176,0,1,response to 3,3',5-triiodo-L-thyronine,BP,
7240,GO:0031204,0.999999999999426,0.740395296320502,0,3,posttranslational protein targeting to membrane, translocation,BP,
19012,GO:1904877,0.999999999999428,0.901680849398452,0,1,positive regulation of DNA ligase activity,BP,
18697,GO:1904155,0.999999999999431,0.894305499320673,0,1,DN2 thymocyte differentiation,BP,
18698,GO:1904156,0.999999999999431,0.894305499320673,0,1,DN3 thymocyte differentiation,BP,
12548,GO:0050717,0.999999999999435,0.753592772022566,0,3,positive regulation of interleukin-1 alpha secretion,BP,
6329,GO:0021502,0.999999999999442,0.785016225075608,0,2,neural fold elevation formation,BP,
8953,GO:0035033,0.999999999999444,0.804533927443328,0,2,histone deacetylase regulator activity,MF,
10099,GO:0042631,0.999999999999463,0.891339009909334,0,1,cellular response to water deprivation,BP,
6846,GO:0030322,0.999999999999467,0.811276785113574,0,2,stabilization of membrane potential,BP,
5767,GO:0016971,0.999999999999503,0.713634519708878,0,3,flavin-linked sulfhydryl oxidase activity,MF,
2594,GO:0005890,0.999999999999506,0.640227450341074,0,4,sodium:potassium-exchanging ATPase complex,CC,
16465,GO:0097176,0.999999999999514,0.665670909880878,0,4,epoxide metabolic process,BP,
9305,GO:0035787,0.999999999999526,0.711475766100386,0,3,cell migration involved in kidney development,BP,
4846,GO:0014061,0.999999999999535,0.714350504365441,0,3,regulation of norepinephrine secretion,BP,
11962,GO:0047275,0.999999999999536,0.891759465024867,0,1,glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity,MF,
10355,GO:0043185,0.999999999999548,0.901902103967296,0,1,vascular endothelial growth factor receptor 3 binding,MF,
14834,GO:0070625,0.999999999999548,0.901902103967296,0,1,zymogen granule exocytosis,BP,
18444,GO:1903564,0.999999999999549,0.618466377393593,0,4,regulation of protein localization to cilium,BP,
6081,GO:0019240,0.99999999999955,0.604346931721205,0,4,citrulline biosynthetic process,BP,
11982,GO:0047408,0.999999999999552,0.807545310617434,0,2,alkenylglycerophosphocholine hydrolase activity,MF,
11983,GO:0047409,0.999999999999552,0.807545310617434,0,2,alkenylglycerophosphoethanolamine hydrolase activity,MF,
9435,GO:0036033,0.999999999999559,0.59303830375665,0,4,mediator complex binding,MF,
19063,GO:1904978,0.999999999999564,0.697506079226155,0,3,regulation of endosome organization,BP,
7286,GO:0031291,0.999999999999567,0.74617478696764,0,3,Ran protein signal transduction,BP,
5521,GO:0016493,0.999999999999568,0.806381911000878,0,2,C-C chemokine receptor activity,MF,
14300,GO:0061484,0.999999999999572,0.70371941150782,0,3,hematopoietic stem cell homeostasis,BP,
3104,GO:0006682,0.999999999999575,0.72376624550745,0,3,galactosylceramide biosynthetic process,BP,
6124,GO:0019375,0.999999999999575,0.72376624550745,0,3,galactolipid biosynthetic process,BP,
4552,GO:0010636,0.999999999999581,0.791441975340478,0,2,positive regulation of mitochondrial fusion,BP,
11510,GO:0046041,0.999999999999584,0.834330527834443,0,2,ITP metabolic process,BP,
14639,GO:0070259,0.99999999999959,0.800376648016061,0,2,tyrosyl-DNA phosphodiesterase activity,MF,
5763,GO:0016939,0.999999999999593,0.694269360526033,0,3,kinesin II complex,CC,
5090,GO:0015362,0.999999999999628,0.885564459878476,0,1,high-affinity sodium:dicarboxylate symporter activity,MF,
4005,GO:0008967,0.999999999999642,0.809172223204897,0,2,phosphoglycolate phosphatase activity,MF,
7227,GO:0031134,0.999999999999643,0.716297767513405,0,3,sister chromatid biorientation,BP,
14123,GO:0061015,0.999999999999645,0.842004012533818,0,2,snRNA import into nucleus,BP,
1342,GO:0003207,0.99999999999965,0.612901826082131,0,4,cardiac chamber formation,BP,
1345,GO:0003211,0.99999999999965,0.612901826082131,0,4,cardiac ventricle formation,BP,
19517,GO:1990446,0.99999999999966,0.684000083225069,0,4,U1 snRNP binding,MF,
1286,GO:0003097,0.999999999999661,0.653761751986829,0,4,renal water transport,BP,
18918,GO:1904693,0.999999999999664,0.691557267457725,0,3,midbrain morphogenesis,BP,
9749,GO:0039520,0.999999999999666,0.879716491059127,0,1,induction by virus of host autophagy,BP,
20217,GO:2001184,0.999999999999681,0.79558805780587,0,2,positive regulation of interleukin-12 secretion,BP,
11252,GO:0045569,0.999999999999689,0.655184036827395,0,4,TRAIL binding,MF,
6323,GO:0020016,0.99999999999969,0.700177903220255,0,3,ciliary pocket,CC,
6324,GO:0020018,0.99999999999969,0.700177903220255,0,3,ciliary pocket membrane,CC,
6416,GO:0021684,0.999999999999695,0.634047872253639,0,4,cerebellar granular layer formation,BP,
6431,GO:0021707,0.999999999999695,0.634047872253639,0,4,cerebellar granule cell differentiation,BP,
12160,GO:0048298,0.999999999999697,0.655479832756004,0,4,positive regulation of isotype switching to IgA isotypes,BP,
18446,GO:1903566,0.999999999999703,0.6921567433873,0,3,positive regulation of protein localization to cilium,BP,
999,GO:0002468,0.999999999999704,0.628761652780036,0,4,dendritic cell antigen processing and presentation,BP,
1063,GO:0002604,0.999999999999704,0.628761652780036,0,4,regulation of dendritic cell antigen processing and presentation,BP,
17448,GO:1900275,0.999999999999705,0.785609226858489,0,2,negative regulation of phospholipase C activity,BP,
5844,GO:0017143,0.999999999999709,0.810035618815954,0,2,insecticide metabolic process,BP,
7501,GO:0031691,0.999999999999715,0.814319726289404,0,2,alpha-1A adrenergic receptor binding,MF,
7502,GO:0031692,0.999999999999715,0.814319726289404,0,2,alpha-1B adrenergic receptor binding,MF,
7525,GO:0031762,0.999999999999715,0.814319726289404,0,2,follicle-stimulating hormone receptor binding,MF,
10124,GO:0042699,0.999999999999715,0.814319726289404,0,2,follicle-stimulating hormone signaling pathway,BP,
3593,GO:0008020,0.999999999999718,0.807801704573352,0,2,G-protein coupled photoreceptor activity,MF,
6487,GO:0021847,0.99999999999972,0.778700095244836,0,2,ventricular zone neuroblast division,BP,
9209,GO:0035607,0.99999999999972,0.778700095244836,0,2,fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development,BP,
7645,GO:0032072,0.999999999999737,0.893299620452408,0,1,regulation of restriction endodeoxyribonuclease activity,BP,
7855,GO:0032423,0.999999999999737,0.893299620452408,0,1,regulation of mismatch repair,BP,
7856,GO:0032425,0.999999999999737,0.893299620452408,0,1,positive regulation of mismatch repair,BP,
9268,GO:0035711,0.999999999999737,0.893299620452408,0,1,T-helper 1 cell activation,BP,
19904,GO:2000426,0.999999999999737,0.893299620452408,0,1,negative regulation of apoptotic cell clearance,BP,
14410,GO:0061738,0.999999999999742,0.726856303298656,0,3,late endosomal microautophagy,BP,
13630,GO:0060159,0.999999999999752,0.659803860960051,0,4,regulation of dopamine receptor signaling pathway,BP,
4307,GO:0009786,0.999999999999753,0.798066563660836,0,2,regulation of asymmetric cell division,BP,
16211,GO:0090281,0.999999999999771,0.728591615427256,0,3,negative regulation of calcium ion import,BP,
5733,GO:0016882,0.999999999999777,0.837110842580647,0,2,cyclo-ligase activity,MF,
8243,GO:0033031,0.999999999999782,0.648105757392023,0,4,positive regulation of neutrophil apoptotic process,BP,
19444,GO:1990167,0.999999999999784,0.701314018659148,0,3,protein K27-linked deubiquitination,BP,
1124,GO:0002713,0.999999999999785,0.645510557054203,0,4,negative regulation of B cell mediated immunity,BP,
1219,GO:0002890,0.999999999999785,0.645510557054203,0,4,negative regulation of immunoglobulin mediated immune response,BP,
2060,GO:0004815,0.999999999999786,0.805345561268016,0,2,aspartate-tRNA ligase activity,MF,
7854,GO:0032422,0.999999999999795,0.710607813690656,0,3,purine-rich negative regulatory element binding,MF,
1674,GO:0004140,0.999999999999796,0.812725303412636,0,2,dephospho-CoA kinase activity,MF,
19176,GO:1905292,0.999999999999799,0.705860340781414,0,3,regulation of neural crest cell differentiation,BP,
19177,GO:1905294,0.999999999999799,0.705860340781414,0,3,positive regulation of neural crest cell differentiation,BP,
19183,GO:1905310,0.999999999999799,0.705860340781414,0,3,regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis,BP,
19184,GO:1905312,0.999999999999799,0.705860340781414,0,3,positive regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis,BP,
3886,GO:0008521,0.999999999999801,0.899969006661037,0,1,acetyl-CoA transmembrane transporter activity,MF,
5247,GO:0015876,0.999999999999801,0.899969006661037,0,1,acetyl-CoA transport,BP,
5266,GO:0015916,0.999999999999801,0.899969006661037,0,1,fatty-acyl-CoA transport,BP,
17605,GO:1901337,0.999999999999801,0.899969006661037,0,1,thioester transport,BP,
2157,GO:0004985,0.999999999999824,0.74021667316368,0,3,opioid receptor activity,MF,
2223,GO:0005127,0.999999999999824,0.708498441771319,0,3,ciliary neurotrophic factor receptor binding,MF,
3644,GO:0008118,0.999999999999834,0.901109353671698,0,1,N-acetyllactosaminide alpha-2,3-sialyltransferase activity,MF,
11996,GO:0047536,0.999999999999834,0.901109353671698,0,1,2-aminoadipate transaminase activity,MF,
3079,GO:0006651,0.999999999999836,0.878382467122602,0,1,diacylglycerol biosynthetic process,BP,
16745,GO:0098560,0.999999999999837,0.809187607595936,0,2,cytoplasmic side of late endosome membrane,CC,
3826,GO:0008428,0.999999999999861,0.717062600079228,0,3,ribonuclease inhibitor activity,MF,
5503,GO:0016453,0.999999999999893,0.670294065220251,0,4,C-acetyltransferase activity,MF,
13964,GO:0060698,0.999999999999899,0.793490171801406,0,2,endoribonuclease inhibitor activity,MF,
13967,GO:0060701,0.999999999999899,0.793490171801406,0,2,negative regulation of ribonuclease activity,BP,
13968,GO:0060702,0.999999999999899,0.793490171801406,0,2,negative regulation of endoribonuclease activity,BP,
2484,GO:0005726,0.99999999999993,0.613123975002205,0,4,perichromatin fibrils,CC,
15679,GO:0072237,0.999999999999933,0.777343706298966,0,2,metanephric proximal tubule development,BP,
19247,GO:1905457,0.999999999999934,0.734682886771414,0,3,negative regulation of lymphoid progenitor cell differentiation,BP,
20139,GO:2000974,0.999999999999934,0.734682886771414,0,3,negative regulation of pro-B cell differentiation,BP,
15854,GO:0072602,0.999999999999962,0.628469530507757,0,4,interleukin-4 secretion,BP,
11729,GO:0046586,0.999999999999988,0.840619944153712,0,2,regulation of calcium-dependent cell-cell adhesion,BP,
346,GO:0000960,0.999999999999999,0.627211790987087,0,4,regulation of mitochondrial RNA catabolic process,BP,
6,GO:0000012,1,0.40283583045484,0,8,single strand break repair,BP,
11,GO:0000022,1,0.327130021764784,0,10,mitotic spindle elongation,BP,
14,GO:0000027,1,0.099355003432567,0,26,ribosomal large subunit assembly,BP,
15,GO:0000028,1,0.290986016984151,0,18,ribosomal small subunit assembly,BP,
25,GO:0000049,1,0.0030963921005663,0,54,tRNA binding,MF,
26,GO:0000050,1,0.343021866464279,0,10,urea cycle,BP,
27,GO:0000052,1,0.444565702138789,0,7,citrulline metabolic process,BP,
29,GO:0000054,1,0.299084603990651,0,13,ribosomal subunit export from nucleus,BP,
30,GO:0000055,1,0.469649725988876,0,8,ribosomal large subunit export from nucleus,BP,
31,GO:0000056,1,0.524048426318881,0,7,ribosomal small subunit export from nucleus,BP,
37,GO:0000076,1,0.177505138927589,0,16,DNA replication checkpoint,BP,
46,GO:0000098,1,0.463011174715489,0,7,sulfur amino acid catabolic process,BP,
57,GO:0000120,1,0.596359479321912,0,5,RNA polymerase I transcription factor complex,CC,
61,GO:0000124,1,0.275444817512784,0,13,SAGA complex,CC,
64,GO:0000127,1,0.522904290749992,0,6,transcription factor TFIIIC complex,CC,
67,GO:0000138,1,0.543121073934872,0,6,Golgi trans cisterna,CC,
70,GO:0000146,1,0.161833906223907,0,14,microfilament motor activity,MF,
73,GO:0000150,1,0.445893961096357,0,8,recombinase activity,MF,
76,GO:0000153,1,0.314652375717411,0,11,cytoplasmic ubiquitin ligase complex,CC,
84,GO:0000172,1,0.565498955422789,0,6,ribonuclease MRP complex,CC,
87,GO:0000176,1,0.317141242742758,0,13,nuclear exosome (RNase complex),CC,
88,GO:0000177,1,0.222088663516214,0,15,cytoplasmic exosome (RNase complex),CC,
89,GO:0000178,1,0.111676503947394,0,22,exosome (RNase complex),CC,
91,GO:0000182,1,0.306202907977049,0,10,rDNA binding,MF,
97,GO:0000188,1,0.0870080634309661,0,23,inactivation of MAPK activity,BP,
112,GO:0000235,1,0.39284199918633,0,8,astral microtubule,CC,
114,GO:0000243,1,0.469522801179304,0,8,commitment complex,CC,
115,GO:0000244,1,0.289564947843591,0,11,spliceosomal tri-snRNP complex assembly,BP,
139,GO:0000290,1,0.373837088119192,0,9,deadenylation-dependent decapping of nuclear-transcribed mRNA,BP,
140,GO:0000291,1,0.0336254509039819,0,35,nuclear-transcribed mRNA catabolic process, exonucleolytic,BP,
143,GO:0000295,1,0.312091371384198,0,11,adenine nucleotide transmembrane transporter activity,MF,
154,GO:0000313,1,0.00123638373497916,0,84,organellar ribosome,CC,
155,GO:0000314,1,0.105449399438211,0,28,organellar small ribosomal subunit,CC,
156,GO:0000315,1,0.0171347869712629,0,51,organellar large ribosomal subunit,CC,
162,GO:0000338,1,0.363062087778277,0,10,protein deneddylation,BP,
163,GO:0000339,1,0.156129082388274,0,17,RNA cap binding,MF,
164,GO:0000340,1,0.35365264825455,0,9,RNA 7-methylguanosine cap binding,MF,
165,GO:0000346,1,0.260774282324559,0,13,transcription export complex,CC,
166,GO:0000347,1,0.551228933499343,0,6,THO complex,CC,
177,GO:0000387,1,0.0283977793664106,0,36,spliceosomal snRNP assembly,BP,
178,GO:0000389,1,0.521159943601233,0,6,mRNA 3'-splice site recognition,BP,
180,GO:0000393,1,0.60018384795594,0,5,spliceosomal conformational changes to generate catalytic conformation,BP,
182,GO:0000395,1,0.599128445007776,0,5,mRNA 5'-splice site recognition,BP,
190,GO:0000408,1,0.626502530781927,0,5,EKC/KEOPS complex,CC,
210,GO:0000439,1,0.384628014119585,0,9,core TFIIH complex,CC,
212,GO:0000445,1,0.551228933499343,0,6,THO complex part of transcription export complex,CC,
213,GO:0000447,1,0.41866146861621,0,9,endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
219,GO:0000459,1,0.508945123913841,0,7,exonucleolytic trimming involved in rRNA processing,BP,
220,GO:0000460,1,0.0371414157205175,0,33,maturation of 5.8S rRNA,BP,
222,GO:0000462,1,0.0282225886912974,0,37,maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
223,GO:0000463,1,0.399747803742137,0,10,maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
224,GO:0000466,1,0.107112042124007,0,22,maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
225,GO:0000467,1,0.508945123913841,0,7,exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
226,GO:0000469,1,0.0732912748343944,0,26,cleavage involved in rRNA processing,BP,
227,GO:0000470,1,0.104761425199969,0,24,maturation of LSU-rRNA,BP,
229,GO:0000478,1,0.205063946152031,0,15,endonucleolytic cleavage involved in rRNA processing,BP,
230,GO:0000479,1,0.227757978885832,0,14,endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
231,GO:0000480,1,0.512108656780658,0,6,endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
233,GO:0000491,1,0.402966539863482,0,9,small nucleolar ribonucleoprotein complex assembly,BP,
234,GO:0000492,1,0.494962140862627,0,7,box C/D snoRNP assembly,BP,
240,GO:0000502,1,0.00291744607297277,0,63,proteasome complex,CC,
241,GO:0000506,1,0.435513862545578,0,9,glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex,CC,
245,GO:0000702,1,0.648753897145905,0,5,oxidized base lesion DNA N-glycosylase activity,MF,
248,GO:0000707,1,0.444991179813771,0,8,meiotic DNA recombinase assembly,BP,
250,GO:0000712,1,0.359849204718342,0,9,resolution of meiotic recombination intermediates,BP,
260,GO:0000727,1,0.597619422287185,0,5,double-strand break repair via break-induced replication,BP,
262,GO:0000730,1,0.359890674928322,0,10,DNA recombinase assembly,BP,
271,GO:0000774,1,0.316010159971749,0,11,adenyl-nucleotide exchange factor activity,MF,
279,GO:0000782,1,0.341197603356684,0,10,telomere cap complex,CC,
280,GO:0000783,1,0.341197603356684,0,10,nuclear telomere cap complex,CC,
284,GO:0000788,1,0.222720051452287,0,31,nuclear nucleosome,CC,
291,GO:0000796,1,0.41339458743178,0,7,condensin complex,CC,
297,GO:0000803,1,0.0584489534172827,0,25,sex chromosome,CC,
298,GO:0000805,1,0.437201465069303,0,7,X chromosome,CC,
300,GO:0000808,1,0.380775866830977,0,9,origin recognition complex,CC,
302,GO:0000812,1,0.34406851028152,0,10,Swr1 complex,CC,
318,GO:0000835,1,0.500302639092315,0,6,ER ubiquitin ligase complex,CC,
319,GO:0000836,1,0.567511742326632,0,5,Hrd1p ubiquitin ligase complex,CC,
321,GO:0000900,1,0.307792489172925,0,10,translation repressor activity, mRNA regulatory element binding,MF,
325,GO:0000912,1,0.490106354611796,0,6,assembly of actomyosin apparatus involved in cytokinesis,BP,
326,GO:0000915,1,0.490106354611796,0,6,actomyosin contractile ring assembly,BP,
339,GO:0000940,1,0.231964737465187,0,13,condensed chromosome outer kinetochore,CC,
343,GO:0000957,1,0.555884250776046,0,5,mitochondrial RNA catabolic process,BP,
345,GO:0000959,1,0.0118384169657278,0,41,mitochondrial RNA metabolic process,BP,
349,GO:0000963,1,0.185609157370724,0,16,mitochondrial RNA processing,BP,
351,GO:0000965,1,0.600430794364704,0,5,mitochondrial RNA 3'-end processing,BP,
352,GO:0000966,1,0.127161842253567,0,21,RNA 5'-end processing,BP,
354,GO:0000972,1,0.455640041522079,0,7,transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery,BP,
356,GO:0000974,1,0.253879325334059,0,13,Prp19 complex,CC,
368,GO:0000990,1,0.357921395247407,0,9,transcription factor activity, core RNA polymerase binding,MF,
380,GO:0001013,1,0.403789499483523,0,8,RNA polymerase I regulatory region DNA binding,MF,
385,GO:0001030,1,0.551670063685318,0,5,RNA polymerase III type 1 promoter DNA binding,MF,
386,GO:0001031,1,0.551670063685318,0,5,RNA polymerase III type 2 promoter DNA binding,MF,
392,GO:0001054,1,0.359538193662681,0,11,RNA polymerase I activity,MF,
394,GO:0001056,1,0.237255818058655,0,15,RNA polymerase III activity,MF,
398,GO:0001075,1,0.49835401281665,0,6,transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly,MF,
408,GO:0001094,1,0.37704189422008,0,9,TFIID-class transcription factor binding,MF,
427,GO:0001135,1,0.44769753509224,0,7,transcription factor activity, RNA polymerase II transcription factor recruiting,MF,
434,GO:0001163,1,0.403789499483523,0,8,RNA polymerase I regulatory region sequence-specific DNA binding,MF,
435,GO:0001164,1,0.403789499483523,0,8,RNA polymerase I CORE element sequence-specific DNA binding,MF,
440,GO:0001188,1,0.403789499483523,0,8,RNA polymerase I transcriptional preinitiation complex assembly,BP,
461,GO:0001405,1,0.597035772692519,0,5,presequence translocase-associated import motor,CC,
470,GO:0001514,1,0.461444416281191,0,7,selenocysteine incorporation,BP,
473,GO:0001517,1,0.559048503394694,0,5,N-acetylglucosamine 6-O-sulfotransferase activity,MF,
477,GO:0001522,1,0.183025256606881,0,18,pseudouridine synthesis,BP,
481,GO:0001530,1,0.378724731338701,0,10,lipopolysaccharide binding,MF,
489,GO:0001542,1,0.486579491836827,0,6,ovulation from ovarian follicle,BP,
494,GO:0001547,1,0.548306328896434,0,5,antral ovarian follicle growth,BP,
497,GO:0001553,1,0.545014925745084,0,5,luteinization,BP,
515,GO:0001580,1,0.557488474036462,0,7,detection of chemical stimulus involved in sensory perception of bitter taste,BP,
541,GO:0001660,1,0.519485683545431,0,6,fever generation,BP,
549,GO:0001671,1,0.100617672767933,0,22,ATPase activator activity,MF,
550,GO:0001672,1,0.431825598913669,0,7,regulation of chromatin assembly or disassembly,BP,
558,GO:0001682,1,0.335909582155431,0,12,tRNA 5'-leader removal,BP,
568,GO:0001710,1,0.518202865092655,0,6,mesodermal cell fate commitment,BP,
575,GO:0001727,1,0.565382924964413,0,5,lipid kinase activity,MF,
578,GO:0001731,1,0.417901165801193,0,8,formation of translation preinitiation complex,BP,
584,GO:0001739,1,0.522387612493689,0,6,sex chromatin,CC,
586,GO:0001741,1,0.29983924731984,0,11,XY body,CC,
594,GO:0001759,1,0.312711759020713,0,11,organ induction,BP,
603,GO:0001772,1,0.113102187450672,0,19,immunological synapse,CC,
604,GO:0001773,1,0.248948491163946,0,14,myeloid dendritic cell activation,BP,
605,GO:0001774,1,0.196811836041127,0,14,microglial cell activation,BP,
610,GO:0001779,1,0.208168919519045,0,14,natural killer cell differentiation,BP,
611,GO:0001780,1,0.356360134929591,0,9,neutrophil homeostasis,BP,
612,GO:0001781,1,0.569886532786662,0,5,neutrophil apoptotic process,BP,
617,GO:0001787,1,0.60738437000282,0,5,natural killer cell proliferation,BP,
631,GO:0001821,1,0.479503756880782,0,8,histamine secretion,BP,
636,GO:0001826,1,0.539027085580729,0,5,inner cell mass cell differentiation,BP,
639,GO:0001829,1,0.330103122690173,0,10,trophectodermal cell differentiation,BP,
648,GO:0001839,1,0.563863345160254,0,5,neural plate morphogenesis,BP,
649,GO:0001840,1,0.388610390955057,0,8,neural plate development,BP,
651,GO:0001842,1,0.576937928577667,0,5,neural fold formation,BP,
655,GO:0001846,1,0.603853394085938,0,5,opsonin binding,MF,
656,GO:0001848,1,0.603298598364586,0,5,complement binding,MF,
675,GO:0001886,1,0.44702660929644,0,7,endothelial cell morphogenesis,BP,
680,GO:0001891,1,0.184368803150912,0,15,phagocytic cup,CC,
690,GO:0001911,1,0.354075733125635,0,10,negative regulation of leukocyte mediated cytotoxicity,BP,
691,GO:0001912,1,0.168687782030028,0,17,positive regulation of leukocyte mediated cytotoxicity,BP,
695,GO:0001916,1,0.449752501384822,0,8,positive regulation of T cell mediated cytotoxicity,BP,
714,GO:0001940,1,0.56041913720483,0,5,male pronucleus,CC,
719,GO:0001946,1,0.273237838744899,0,11,lymphangiogenesis,BP,
725,GO:0001955,1,0.579939866097543,0,5,blood vessel maturation,BP,
726,GO:0001956,1,0.354594434824493,0,9,positive regulation of neurotransmitter secretion,BP,
735,GO:0001967,1,0.446869576336994,0,7,suckling behavior,BP,
736,GO:0001968,1,0.143442271706206,0,17,fibronectin binding,MF,
799,GO:0002069,1,0.537412820059996,0,6,columnar/cuboidal epithelial cell maturation,BP,
810,GO:0002084,1,0.385117705215053,0,9,protein depalmitoylation,BP,
818,GO:0002092,1,0.180848925536009,0,15,positive regulation of receptor internalization,BP,
821,GO:0002097,1,0.183895021358252,0,16,tRNA wobble base modification,BP,
822,GO:0002098,1,0.28679369118055,0,12,tRNA wobble uridine modification,BP,
844,GO:0002161,1,0.259531902257712,0,12,aminoacyl-tRNA editing activity,MF,
845,GO:0002162,1,0.404612142962437,0,7,dystroglycan binding,MF,
852,GO:0002182,1,0.294524844284965,0,11,cytoplasmic translational elongation,BP,
853,GO:0002183,1,0.147365171642537,0,18,cytoplasmic translational initiation,BP,
857,GO:0002190,1,0.625497930302741,0,5,cap-independent translational initiation,BP,
863,GO:0002199,1,0.482209187440553,0,7,zona pellucida receptor complex,CC,
874,GO:0002227,1,0.623118277493786,0,10,innate immune response in mucosa,BP,
875,GO:0002228,1,0.0235748379943153,0,36,natural killer cell mediated immunity,BP,
884,GO:0002251,1,0.347740381882839,0,15,organ or tissue specific immune response,BP,
900,GO:0002281,1,0.497669483440546,0,6,macrophage activation involved in immune response,BP,
918,GO:0002313,1,0.200428218830729,0,15,mature B cell differentiation involved in immune response,BP,
920,GO:0002315,1,0.390109884053866,0,8,marginal zone B cell differentiation,BP,
924,GO:0002320,1,0.219571117341118,0,13,lymphoid progenitor cell differentiation,BP,
926,GO:0002323,1,0.400995737887233,0,9,natural killer cell activation involved in immune response,BP,
929,GO:0002327,1,0.459968189138782,0,6,immature B cell differentiation,BP,
930,GO:0002328,1,0.343474117468041,0,9,pro-B cell differentiation,BP,
935,GO:0002335,1,0.126603306708105,0,19,mature B cell differentiation,BP,
939,GO:0002349,1,0.61917346546001,0,5,histamine production involved in inflammatory response,BP,
954,GO:0002374,1,0.290054942891268,0,11,cytokine secretion involved in immune response,BP,
961,GO:0002385,1,0.393003203810119,0,14,mucosal immune response,BP,
970,GO:0002418,1,0.421724039747995,0,8,immune response to tumor cell,BP,
984,GO:0002441,1,0.61917346546001,0,5,histamine secretion involved in inflammatory response,BP,
1001,GO:0002475,1,0.519892408518425,0,6,antigen processing and presentation via MHC class Ib,BP,
1018,GO:0002517,1,0.564101949697301,0,5,T cell tolerance induction,BP,
1022,GO:0002523,1,0.656570806459782,0,5,leukocyte migration involved in inflammatory response,BP,
1039,GO:0002553,1,0.61917346546001,0,5,histamine secretion by mast cell,BP,
1072,GO:0002638,1,0.500105486646067,0,6,negative regulation of immunoglobulin production,BP,
1074,GO:0002643,1,0.355302157885372,0,9,regulation of tolerance induction,BP,
1075,GO:0002645,1,0.562775564249807,0,5,positive regulation of tolerance induction,BP,
1081,GO:0002664,1,0.564101949697301,0,5,regulation of T cell tolerance induction,BP,
1087,GO:0002675,1,0.350681320997083,0,10,positive regulation of acute inflammatory response,BP,
1104,GO:0002693,1,0.449500482920673,0,7,positive regulation of cellular extravasation,BP,
1126,GO:0002715,1,0.143349695187765,0,18,regulation of natural killer cell mediated immunity,BP,
1127,GO:0002716,1,0.385138370758954,0,9,negative regulation of natural killer cell mediated immunity,BP,
1128,GO:0002717,1,0.337992546218894,0,10,positive regulation of natural killer cell mediated immunity,BP,
1143,GO:0002739,1,0.367944787170117,0,9,regulation of cytokine secretion involved in immune response,BP,
1145,GO:0002741,1,0.452275034190565,0,7,positive regulation of cytokine secretion involved in immune response,BP,
1147,GO:0002755,1,0.0717095771198768,0,24,MyD88-dependent toll-like receptor signaling pathway,BP,
1148,GO:0002756,1,0.0630771895730592,0,26,MyD88-independent toll-like receptor signaling pathway,BP,
1178,GO:0002825,1,0.316436138027455,0,11,regulation of T-helper 1 type immune response,BP,
1180,GO:0002827,1,0.492782129914601,0,7,positive regulation of T-helper 1 type immune response,BP,
1187,GO:0002834,1,0.512161625282571,0,6,regulation of response to tumor cell,BP,
1190,GO:0002837,1,0.512161625282571,0,6,regulation of immune response to tumor cell,BP,
1239,GO:0002934,1,0.340178192931378,0,9,desmosome organization,BP,
1267,GO:0003056,1,0.562407814530516,0,5,regulation of vascular smooth muscle contraction,BP,
1281,GO:0003085,1,0.381844845488149,0,9,negative regulation of systemic arterial blood pressure,BP,
1293,GO:0003128,1,0.602442098513149,0,5,heart field specification,BP,
1302,GO:0003148,1,0.15605924129099,0,16,outflow tract septum morphogenesis,BP,
1303,GO:0003149,1,0.394134973041793,0,8,membranous septum morphogenesis,BP,
1306,GO:0003156,1,0.120588917687164,0,20,regulation of animal organ formation,BP,
1307,GO:0003157,1,0.360952858846687,0,9,endocardium development,BP,
1309,GO:0003159,1,0.309328701806344,0,11,morphogenesis of an endothelium,BP,
1311,GO:0003161,1,0.340164186954151,0,9,cardiac conduction system development,BP,
1324,GO:0003177,1,0.478588547037592,0,6,pulmonary valve development,BP,
1329,GO:0003184,1,0.478588547037592,0,6,pulmonary valve morphogenesis,BP,
1337,GO:0003198,1,0.278620564996898,0,11,epithelial to mesenchymal transition involved in endocardial cushion formation,BP,
1343,GO:0003208,1,0.00795506406743943,0,41,cardiac ventricle morphogenesis,BP,
1347,GO:0003214,1,0.494153187523669,0,6,cardiac left ventricle morphogenesis,BP,
1348,GO:0003215,1,0.24075930908882,0,12,cardiac right ventricle morphogenesis,BP,
1352,GO:0003222,1,0.258629673300088,0,11,ventricular trabecula myocardium morphogenesis,BP,
1353,GO:0003223,1,0.475858977615183,0,6,ventricular compact myocardium morphogenesis,BP,
1356,GO:0003229,1,0.0222968215519108,0,32,ventricular cardiac muscle tissue development,BP,
1370,GO:0003263,1,0.621998539330781,0,5,cardioblast proliferation,BP,
1371,GO:0003264,1,0.54441988909902,0,6,regulation of cardioblast proliferation,BP,
1372,GO:0003266,1,0.605065357951649,0,5,regulation of secondary heart field cardioblast proliferation,BP,
1374,GO:0003272,1,0.219798043837978,0,13,endocardial cushion formation,BP,
1390,GO:0003306,1,0.505160482599561,0,6,Wnt signaling pathway involved in heart development,BP,
1398,GO:0003334,1,0.284439926644646,0,11,keratinocyte development,BP,
1422,GO:0003376,1,0.369494279800677,0,9,sphingosine-1-phosphate signaling pathway,BP,
1423,GO:0003382,1,0.0779151025548862,0,22,epithelial cell morphogenesis,BP,
1433,GO:0003413,1,0.440595463170332,0,7,chondrocyte differentiation involved in endochondral bone morphogenesis,BP,
1442,GO:0003433,1,0.566237033910649,0,5,chondrocyte development involved in endochondral bone morphogenesis,BP,
1450,GO:0003688,1,0.214084166359209,0,14,DNA replication origin binding,MF,
1451,GO:0003689,1,0.432378220114985,0,8,DNA clamp loader activity,MF,
1465,GO:0003723,1,0,65,1482,RNA binding,MF,OAS2;DDX60;CIRBP;CAPRIN2;APOBEC3C;RBM3;SRSF5;TNS1;NSUN7;HERC5;UNK;H1F0;MDM2;DDX59;PCBP4;OAS1;PDCD4;ZFP36L2;DHX32;ZCCHC11;THRAP3;KHNYN;C14ORF93;TST;CHD3;AHNAK2;NSUN5P2;ARHGEF1;DHX58;RTF1;S100A4;H1FX;ZCCHC24;DNM1;AGO4;XRN1;TARBP1;ATXN1;THRA;ADARB1;LACTB2;MIF4GD;LRP1;HLA-A;PRX;IFI16;ABTB1;BST2;PABPC4L;TNRC6C;HLTF;NDUFV3;ENDOU;DQX1;ZFP36L1;TOP3B;TEP1;ANGEL2;ZMAT3;NELFCD;GOLGB1;PARN;DDX12P;HARS2;PTBP2
1472,GO:0003735,1,2.16799353682268e-05,0,154,structural constituent of ribosome,MF,
1473,GO:0003743,1,0.00613045272682785,0,49,translation initiation factor activity,MF,
1475,GO:0003747,1,0.51146770977782,0,6,translation release factor activity,MF,
1481,GO:0003785,1,0.155643302435147,0,18,actin monomer binding,MF,
1525,GO:0003906,1,0.284199444837978,0,13,DNA-(apurinic or apyrimidinic site) endonuclease activity,MF,
1536,GO:0003923,1,0.582554533611244,0,5,GPI-anchor transamidase activity,MF,
1576,GO:0003988,1,0.542546432050319,0,6,acetyl-CoA C-acyltransferase activity,MF,
1592,GO:0004012,1,0.187964152546082,0,13,phospholipid-translocating ATPase activity,MF,
1595,GO:0004016,1,0.464178799009969,0,6,adenylate cyclase activity,MF,
1665,GO:0004128,1,0.487144033065272,0,7,cytochrome-b5 reductase activity, acting on NAD(P)H,MF,
1692,GO:0004169,1,0.639214613638985,0,5,dolichyl-phosphate-mannose-protein mannosyltransferase activity,MF,
1699,GO:0004181,1,0.359617306738357,0,9,metallocarboxypeptidase activity,MF,
1700,GO:0004185,1,0.408454508981858,0,8,serine-type carboxypeptidase activity,MF,
1706,GO:0004298,1,0.263665880222305,0,18,threonine-type endopeptidase activity,MF,
1718,GO:0004312,1,0.385500741083233,0,9,fatty acid synthase activity,MF,
1761,GO:0004366,1,0.574700835127516,0,5,glycerol-3-phosphate O-acyltransferase activity,MF,
1774,GO:0004383,1,0.464178799009969,0,6,guanylate cyclase activity,MF,
1796,GO:0004438,1,0.180851584097105,0,14,phosphatidylinositol-3-phosphatase activity,MF,
1797,GO:0004439,1,0.389333874165593,0,8,phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity,MF,
1858,GO:0004523,1,0.563241928097544,0,6,RNA-DNA hybrid ribonuclease activity,MF,
1860,GO:0004526,1,0.369866267228202,0,11,ribonuclease P activity,MF,
1871,GO:0004549,1,0.21751523690627,0,16,tRNA-specific ribonuclease activity,MF,
1891,GO:0004576,1,0.38777839227392,0,10,oligosaccharyl transferase activity,MF,
1894,GO:0004579,1,0.419697965709942,0,9,dolichyl-diphosphooligosaccharide-protein glycotransferase activity,MF,
1906,GO:0004596,1,0.346511181456997,0,10,peptide alpha-N-acetyltransferase activity,MF,
1926,GO:0004622,1,0.172162460467425,0,16,lysophospholipase activity,MF,
1946,GO:0004652,1,0.387183510853944,0,8,polynucleotide adenylyltransferase activity,MF,
1947,GO:0004653,1,0.248347818217923,0,12,polypeptide N-acetylgalactosaminyltransferase activity,MF,
1953,GO:0004659,1,0.198065161633433,0,15,prenyltransferase activity,MF,
1955,GO:0004661,1,0.595422278729518,0,5,protein geranylgeranyltransferase activity,MF,
1967,GO:0004679,1,0.446639289477224,0,7,AMP-activated protein kinase activity,MF,
1971,GO:0004689,1,0.551765284682707,0,5,phosphorylase kinase activity,MF,
1977,GO:0004697,1,0.244076175570196,0,12,protein kinase C activity,MF,
1988,GO:0004711,1,0.433547020222657,0,7,ribosomal protein S6 kinase activity,MF,
1998,GO:0004723,1,0.439189023495906,0,7,calcium-dependent protein serine/threonine phosphatase activity,MF,
2000,GO:0004726,1,0.412116438581676,0,8,non-membrane spanning protein tyrosine phosphatase activity,MF,
2009,GO:0004738,1,0.576838124275385,0,5,pyruvate dehydrogenase activity,MF,
2024,GO:0004758,1,0.569513821909048,0,5,serine C-palmitoyltransferase activity,MF,
2071,GO:0004826,1,0.595252342585718,0,5,phenylalanine-tRNA ligase activity,MF,
2080,GO:0004839,1,0.555553204775201,0,5,ubiquitin activating enzyme activity,MF,
2083,GO:0004844,1,0.613319167473931,0,5,uracil DNA N-glycosylase activity,MF,
2095,GO:0004862,1,0.48416482830692,0,7,cAMP-dependent protein kinase inhibitor activity,MF,
2113,GO:0004904,1,0.587826885653907,0,5,interferon receptor activity,MF,
2116,GO:0004908,1,0.575973447591792,0,5,interleukin-1 receptor activity,MF,
2165,GO:0005001,1,0.284555757708228,0,10,transmembrane receptor protein tyrosine phosphatase activity,MF,
2187,GO:0005047,1,0.587996739425387,0,5,signal recognition particle binding,MF,
2189,GO:0005049,1,0.373263001019767,0,8,nuclear export signal receptor activity,MF,
2196,GO:0005072,1,0.384620082296395,0,8,transforming growth factor beta receptor, cytoplasmic mediator activity,MF,
2208,GO:0005095,1,0.307380049645426,0,11,GTPase inhibitor activity,MF,
2214,GO:0005112,1,0.160484922947281,0,15,Notch binding,MF,
2216,GO:0005114,1,0.446493218728007,0,7,type II transforming growth factor beta receptor binding,MF,
2233,GO:0005138,1,0.582590417085117,0,5,interleukin-6 receptor binding,MF,
2238,GO:0005149,1,0.376457593512887,0,9,interleukin-1 receptor binding,MF,
2276,GO:0005225,1,0.376237953883965,0,8,volume-sensitive anion channel activity,MF,
2279,GO:0005230,1,0.313875584587808,0,10,extracellular ligand-gated ion channel activity,MF,
2280,GO:0005231,1,0.396489398713353,0,8,excitatory extracellular ligand-gated ion channel activity,MF,
2301,GO:0005283,1,0.44717458870984,0,7,amino acid:sodium symporter activity,MF,
2312,GO:0005313,1,0.500243977785638,0,6,L-glutamate transmembrane transporter activity,MF,
2318,GO:0005326,1,0.0702150919383533,0,23,neurotransmitter transporter activity,MF,
2319,GO:0005328,1,0.306752089170834,0,10,neurotransmitter:sodium symporter activity,MF,
2325,GO:0005338,1,0.311865611211168,0,11,nucleotide-sugar transmembrane transporter activity,MF,
2329,GO:0005345,1,0.597692678569763,0,5,purine nucleobase transmembrane transporter activity,MF,
2330,GO:0005346,1,0.312091371384198,0,11,purine ribonucleotide transmembrane transporter activity,MF,
2331,GO:0005347,1,0.426088370410987,0,8,ATP transmembrane transporter activity,MF,
2333,GO:0005351,1,0.40539772994254,0,8,carbohydrate:proton symporter activity,MF,
2341,GO:0005375,1,0.521795795558034,0,6,copper ion transmembrane transporter activity,MF,
2342,GO:0005381,1,0.509315333753674,0,6,iron ion transmembrane transporter activity,MF,
2344,GO:0005385,1,0.189240996954503,0,15,zinc ion transmembrane transporter activity,MF,
2345,GO:0005388,1,0.371809116400788,0,8,calcium-transporting ATPase activity,MF,
2346,GO:0005391,1,0.570590502229011,0,5,sodium:potassium-exchanging ATPase activity,MF,
2347,GO:0005402,1,0.282736160756943,0,11,carbohydrate:cation symporter activity,MF,
2350,GO:0005416,1,0.351297084697418,0,9,amino acid:cation symporter activity,MF,
2354,GO:0005451,1,0.347126125075513,0,9,monovalent cation:proton antiporter activity,MF,
2355,GO:0005452,1,0.241779752150149,0,12,inorganic anion exchanger activity,MF,
2378,GO:0005513,1,0.42405966328524,0,8,detection of calcium ion,BP,
2393,GO:0005537,1,0.413265849829924,0,8,mannose binding,MF,
2395,GO:0005540,1,0.422509373707749,0,8,hyaluronic acid binding,MF,
2396,GO:0005542,1,0.561653155026422,0,6,folic acid binding,MF,
2399,GO:0005545,1,0.232034034753902,0,12,1-phosphatidylinositol binding,MF,
2412,GO:0005587,1,0.521398138498046,0,5,collagen type IV trimer,CC,
2440,GO:0005641,1,0.449244685595413,0,7,nuclear envelope lumen,CC,
2441,GO:0005642,1,0.553739005556564,0,5,annulate lamellae,CC,
2445,GO:0005655,1,0.510483664755369,0,8,nucleolar ribonuclease P complex,CC,
2448,GO:0005658,1,0.522366537732505,0,6,alpha DNA polymerase:primase complex,CC,
2450,GO:0005663,1,0.546207259389599,0,6,DNA replication factor C complex,CC,
2451,GO:0005664,1,0.380775866830977,0,9,nuclear origin of replication recognition complex,CC,
2453,GO:0005666,1,0.196182739131156,0,17,DNA-directed RNA polymerase III complex,CC,
2456,GO:0005669,1,0.0285300839751276,0,35,transcription factor TFIID complex,CC,
2466,GO:0005683,1,0.588225430427122,0,7,U7 snRNP,CC,
2467,GO:0005684,1,0.00308205582469618,0,58,U2-type spliceosomal complex,CC,
2468,GO:0005685,1,0.152117659113928,0,20,U1 snRNP,CC,
2469,GO:0005686,1,0.15931677647861,0,20,U2 snRNP,CC,
2470,GO:0005687,1,0.380259719265401,0,11,U4 snRNP,CC,
2471,GO:0005688,1,0.540161212396548,0,8,U6 snRNP,CC,
2472,GO:0005689,1,0.100596255431895,0,26,U12-type spliceosomal complex,CC,
2487,GO:0005732,1,0.145189872431477,0,24,small nucleolar ribonucleoprotein complex,CC,
2488,GO:0005736,1,0.317374040905102,0,12,DNA-directed RNA polymerase I complex,CC,
2493,GO:0005742,1,0.501630330856716,0,8,mitochondrial outer membrane translocase complex,CC,
2495,GO:0005744,1,0.293297661302787,0,13,mitochondrial inner membrane presequence translocase complex,CC,
2500,GO:0005750,1,0.365426439077042,0,11,mitochondrial respiratory chain complex III,CC,
2507,GO:0005761,1,0.00123638373497916,0,84,mitochondrial ribosome,CC,
2508,GO:0005762,1,0.0171347869712629,0,51,mitochondrial large ribosomal subunit,CC,
2509,GO:0005763,1,0.105449399438211,0,28,mitochondrial small ribosomal subunit,CC,
2528,GO:0005785,1,0.507645695301757,0,7,signal recognition particle receptor complex,CC,
2529,GO:0005786,1,0.56880361262686,0,6,signal recognition particle, endoplasmic reticulum targeting,CC,
2530,GO:0005787,1,0.635594889901951,0,5,signal peptidase complex,CC,
2539,GO:0005797,1,0.481252192883906,0,7,Golgi medial cisterna,CC,
2548,GO:0005818,1,0.39284199918633,0,8,aster,CC,
2550,GO:0005826,1,0.552410177172965,0,5,actomyosin contractile ring,CC,
2551,GO:0005827,1,0.559226583539458,0,5,polar microtubule,CC,
2552,GO:0005828,1,0.428792195831075,0,7,kinetochore microtubule,CC,
2554,GO:0005832,1,0.340696821859933,0,10,chaperonin-containing T-complex,CC,
2557,GO:0005838,1,0.132115872202096,0,21,proteasome regulatory particle,CC,
2558,GO:0005839,1,0.205018454500438,0,20,proteasome core complex,CC,
2561,GO:0005845,1,0.300449743661395,0,11,mRNA cap binding complex,CC,
2563,GO:0005847,1,0.165420866679908,0,16,mRNA cleavage and polyadenylation specificity factor complex,CC,
2564,GO:0005849,1,0.131777338511706,0,18,mRNA cleavage factor complex,CC,
2566,GO:0005851,1,0.53676433900653,0,6,eukaryotic translation initiation factor 2B complex,CC,
2567,GO:0005852,1,0.186458964090713,0,17,eukaryotic translation initiation factor 3 complex,CC,
2583,GO:0005876,1,0.00166058694250174,0,56,spindle microtubule,CC,
2590,GO:0005885,1,0.391039804163699,0,10,Arp2/3 protein complex,CC,
2596,GO:0005892,1,0.565214046095947,0,5,acetylcholine-gated channel complex,CC,
2609,GO:0005915,1,0.434923067849205,0,7,zonula adherens,CC,
2610,GO:0005916,1,0.490835764360149,0,6,fascia adherens,CC,
2624,GO:0005947,1,0.588181907714795,0,5,mitochondrial alpha-ketoglutarate dehydrogenase complex,CC,
2632,GO:0005964,1,0.551765284682707,0,5,phosphorylase kinase complex,CC,
2660,GO:0006004,1,0.234958677599552,0,13,fucose metabolic process,BP,
2663,GO:0006011,1,0.512762130064243,0,6,UDP-glucose metabolic process,BP,
2681,GO:0006044,1,0.233724647916843,0,13,N-acetylglucosamine metabolic process,BP,
2689,GO:0006054,1,0.335404182843404,0,10,N-acetylneuraminate metabolic process,BP,
2698,GO:0006064,1,0.626951062701395,0,5,glucuronate catabolic process,BP,
2705,GO:0006072,1,0.431420310708651,0,7,glycerol-3-phosphate metabolic process,BP,
2727,GO:0006107,1,0.390976921449274,0,9,oxaloacetate metabolic process,BP,
2728,GO:0006108,1,0.543458807603865,0,6,malate metabolic process,BP,
2740,GO:0006122,1,0.284929569269024,0,13,mitochondrial electron transport, ubiquinol to cytochrome c,BP,
2741,GO:0006123,1,0.401361904271796,0,14,mitochondrial electron transport, cytochrome c to oxygen,BP,
2745,GO:0006144,1,0.130747296424458,0,19,purine nucleobase metabolic process,BP,
2749,GO:0006152,1,0.554690513605347,0,6,purine nucleoside catabolic process,BP,
2755,GO:0006166,1,0.620207213751952,0,5,purine ribonucleoside salvage,BP,
2756,GO:0006167,1,0.630076548976658,0,5,AMP biosynthetic process,BP,
2763,GO:0006177,1,0.607574691216063,0,5,GMP biosynthetic process,BP,
2766,GO:0006183,1,0.47279298490946,0,9,GTP biosynthetic process,BP,
2769,GO:0006188,1,0.333536752067006,0,10,IMP biosynthetic process,BP,
2770,GO:0006189,1,0.514133429437031,0,6,'de novo' IMP biosynthetic process,BP,
2777,GO:0006207,1,0.494115535665507,0,6,'de novo' pyrimidine nucleobase biosynthetic process,BP,
2791,GO:0006228,1,0.508584595537985,0,8,UTP biosynthetic process,BP,
2797,GO:0006244,1,0.31801916631046,0,12,pyrimidine nucleotide catabolic process,BP,
2808,GO:0006268,1,0.466372701411864,0,7,DNA unwinding involved in DNA replication,BP,
2822,GO:0006287,1,0.572580458931289,0,5,base-excision repair, gap-filling,BP,
2849,GO:0006335,1,0.168892130632262,0,32,DNA replication-dependent nucleosome assembly,BP,
2851,GO:0006337,1,0.169032737841311,0,16,nucleosome disassembly,BP,
2856,GO:0006346,1,0.177350250596902,0,15,methylation-dependent chromatin silencing,BP,
2858,GO:0006349,1,0.208392782006035,0,13,regulation of gene expression by genetic imprinting,BP,
2868,GO:0006361,1,0.028366091121461,0,35,transcription initiation from RNA polymerase I promoter,BP,
2870,GO:0006363,1,0.0492324224261221,0,30,termination of RNA polymerase I transcription,BP,
2876,GO:0006370,1,0.0413274073854521,0,32,7-methylguanosine mRNA capping,BP,
2878,GO:0006378,1,0.0121470024106603,0,39,mRNA polyadenylation,BP,
2882,GO:0006384,1,0.453211141408382,0,7,transcription initiation from RNA polymerase III promoter,BP,
2884,GO:0006388,1,0.265021895072586,0,14,tRNA splicing, via endonucleolytic cleavage and ligation,BP,
2885,GO:0006390,1,0.244496374350188,0,13,mitochondrial transcription,BP,
2888,GO:0006396,1,0,22,876,RNA processing,BP,EGFR;RBM3;SRSF5;PIK3R1;DHX32;ZCCHC11;THRAP3;AHNAK2;NSUN5P2;MAP2K2;AGO4;TARBP1;ATXN1;ADARB1;PRX;DQX1;ZFP36L1;TEP1;ERN1;IVNS1ABP;PRKACA;PTBP2
2890,GO:0006398,1,0.57073571359407,0,5,mRNA 3'-end processing by stem-loop binding and cleavage,BP,
2901,GO:0006409,1,0.0260748073155128,0,32,tRNA export from nucleus,BP,
2905,GO:0006415,1,0.000211216872835067,0,100,translational termination,BP,
2921,GO:0006432,1,0.595252342585718,0,5,phenylalanyl-tRNA aminoacylation,BP,
2930,GO:0006448,1,0.158637815267919,0,17,regulation of translational elongation,BP,
2931,GO:0006449,1,0.460278567835851,0,7,regulation of translational termination,BP,
2932,GO:0006450,1,0.152130304595893,0,19,regulation of translational fidelity,BP,
2933,GO:0006451,1,0.461444416281191,0,7,translational readthrough,BP,
2948,GO:0006477,1,0.565101115723288,0,5,protein sulfation,BP,
2962,GO:0006498,1,0.551943710066697,0,5,N-terminal protein lipidation,BP,
2978,GO:0006521,1,0.00999482080357778,0,51,regulation of cellular amino acid metabolic process,BP,
2982,GO:0006526,1,0.569087729702433,0,5,arginine biosynthetic process,BP,
2986,GO:0006531,1,0.516496040505767,0,6,aspartate metabolic process,BP,
3022,GO:0006568,1,0.59130241188421,0,5,tryptophan metabolic process,BP,
3026,GO:0006573,1,0.410281162444671,0,8,valine metabolic process,BP,
3036,GO:0006586,1,0.59130241188421,0,5,indolalkylamine metabolic process,BP,
3039,GO:0006591,1,0.476064483258776,0,7,ornithine metabolic process,BP,
3041,GO:0006595,1,0.263061789850603,0,14,polyamine metabolic process,BP,
3042,GO:0006596,1,0.305305006521401,0,12,polyamine biosynthetic process,BP,
3044,GO:0006598,1,0.652992171989156,0,5,polyamine catabolic process,BP,
3049,GO:0006607,1,0.0894712471831708,0,20,NLS-bearing protein import into nucleus,BP,
3050,GO:0006610,1,0.401181119986051,0,8,ribosomal protein import into nucleus,BP,
3053,GO:0006613,1,0.00160233080180106,0,96,cotranslational protein targeting to membrane,BP,
3054,GO:0006614,1,0.00279383982869078,0,91,SRP-dependent cotranslational protein targeting to membrane,BP,
3055,GO:0006616,1,0.598985828720956,0,6,SRP-dependent cotranslational protein targeting to membrane, translocation,BP,
3057,GO:0006620,1,0.479971115349046,0,7,posttranslational protein targeting to endoplasmic reticulum membrane,BP,
3058,GO:0006621,1,0.432136201001325,0,8,protein retention in ER lumen,BP,
3064,GO:0006627,1,0.561131878887678,0,6,protein processing involved in protein targeting to mitochondrion,BP,
3083,GO:0006657,1,0.473208664083953,0,7,CDP-choline pathway,BP,
3096,GO:0006670,1,0.361850658749928,0,10,sphingosine metabolic process,BP,
3100,GO:0006678,1,0.458765119418601,0,7,glucosylceramide metabolic process,BP,
3103,GO:0006681,1,0.517237512964381,0,6,galactosylceramide metabolic process,BP,
3136,GO:0006729,1,0.521009754506911,0,7,tetrahydrobiopterin biosynthetic process,BP,
3140,GO:0006734,1,0.0623607639020321,0,26,NADH metabolic process,BP,
3141,GO:0006735,1,0.166803700554042,0,17,NADH regeneration,BP,
3147,GO:0006743,1,0.224589029396483,0,15,ubiquinone metabolic process,BP,
3148,GO:0006744,1,0.254613775289238,0,14,ubiquinone biosynthetic process,BP,
3152,GO:0006751,1,0.612360544361963,0,5,glutathione catabolic process,BP,
3165,GO:0006777,1,0.521604050604218,0,6,Mo-molybdopterin cofactor biosynthetic process,BP,
3179,GO:0006797,1,0.556782838637221,0,5,polyphosphate metabolic process,BP,
3196,GO:0006825,1,0.160324786458651,0,18,copper ion transport,BP,
3199,GO:0006829,1,0.148992621650371,0,17,zinc ion transport,BP,
3200,GO:0006833,1,0.528206828087817,0,6,water transport,BP,
3210,GO:0006851,1,0.118300706106501,0,20,mitochondrial calcium ion transmembrane transport,BP,
3215,GO:0006862,1,0.183619850688273,0,16,nucleotide transport,BP,
3216,GO:0006863,1,0.546360579255792,0,6,purine nucleobase transport,BP,
3225,GO:0006878,1,0.275385006994185,0,13,cellular copper ion homeostasis,BP,
3229,GO:0006883,1,0.38794554269284,0,8,cellular sodium ion homeostasis,BP,
3239,GO:0006895,1,0.0996914530144712,0,19,Golgi to endosome transport,BP,
3240,GO:0006896,1,0.204123742542035,0,14,Golgi to vacuole transport,BP,
3258,GO:0006925,1,0.252594803180971,0,13,inflammatory cell apoptotic process,BP,
3261,GO:0006930,1,0.401004470460404,0,8,substrate-dependent cell migration, cell extension,BP,
3291,GO:0006983,1,0.321772594565296,0,10,ER overload response,BP,
3297,GO:0006995,1,0.391613737731856,0,10,cellular response to nitrogen starvation,BP,
3301,GO:0006999,1,0.18069266034261,0,15,nuclear pore organization,BP,
3302,GO:0007000,1,0.464896177087166,0,7,nucleolus organization,BP,
3306,GO:0007007,1,0.125502966696449,0,22,inner mitochondrial membrane organization,BP,
3317,GO:0007021,1,0.549642584162715,0,7,tubulin complex assembly,BP,
3331,GO:0007042,1,0.472064665350072,0,8,lysosomal lumen acidification,BP,
3355,GO:0007091,1,0.00577093159218653,0,48,metaphase/anaphase transition of mitotic cell cycle,BP,
3357,GO:0007094,1,0.0435848586134665,0,29,mitotic spindle assembly checkpoint,BP,
3359,GO:0007096,1,0.204387540975576,0,15,regulation of exit from mitosis,BP,
3363,GO:0007100,1,0.233535894584469,0,13,mitotic centrosome separation,BP,
3369,GO:0007135,1,0.535679474077839,0,6,meiosis II,BP,
3393,GO:0007172,1,0.446867425336774,0,7,signal complex assembly,BP,
3401,GO:0007182,1,0.493417548908718,0,6,common-partner SMAD protein phosphorylation,BP,
3402,GO:0007183,1,0.27722309249313,0,11,SMAD protein complex assembly,BP,
3431,GO:0007220,1,0.189890454149178,0,15,Notch receptor processing,BP,
3441,GO:0007250,1,0.168396546799511,0,16,activation of NF-kappaB-inducing kinase activity,BP,
3443,GO:0007253,1,0.513207155283801,0,7,cytoplasmic sequestering of NF-kappaB,BP,
3457,GO:0007270,1,0.489461029899447,0,6,neuron-neuron synaptic transmission,BP,
3492,GO:0007379,1,0.300055606955746,0,11,segment specification,BP,
3493,GO:0007386,1,0.572305248291741,0,5,compartment pattern specification,BP,
3516,GO:0007440,1,0.459456769800892,0,6,foregut morphogenesis,BP,
3541,GO:0007549,1,0.241128262439619,0,12,dosage compensation,BP,
3544,GO:0007567,1,0.37148723765017,0,9,parturition,BP,
3562,GO:0007603,1,0.170171076602921,0,16,phototransduction, visible light,BP,
3586,GO:0007635,1,0.443135844982564,0,7,chemosensory behavior,BP,
3597,GO:0008024,1,0.394149471334291,0,8,cyclin/CDK positive transcription elongation factor complex,CC,
3612,GO:0008053,1,0.131889286633449,0,20,mitochondrial fusion,BP,
3620,GO:0008074,1,0.464178799009969,0,6,guanylate cyclase complex, soluble,CC,
3623,GO:0008079,1,0.51146770977782,0,6,translation termination factor activity,MF,
3629,GO:0008090,1,0.461133083056742,0,7,retrograde axonal transport,BP,
3647,GO:0008121,1,0.552137407003278,0,7,ubiquinol-cytochrome-c reductase activity,MF,
3659,GO:0008143,1,0.204793550281205,0,14,poly(A) binding,MF,
3675,GO:0008174,1,0.378404865355373,0,9,mRNA methyltransferase activity,MF,
3685,GO:0008190,1,0.42281392057033,0,8,eukaryotic initiation factor 4E binding,MF,
3706,GO:0008215,1,0.574341641491879,0,6,spermine metabolic process,BP,
3707,GO:0008216,1,0.53721132148963,0,7,spermidine metabolic process,BP,
3711,GO:0008227,1,0.43269384847964,0,8,G-protein coupled amine receptor activity,MF,
3721,GO:0008242,1,0.42836144525478,0,8,omega peptidase activity,MF,
3722,GO:0008250,1,0.345956895670852,0,12,oligosaccharyltransferase complex,CC,
3734,GO:0008271,1,0.558383502500569,0,5,secondary active sulfate transmembrane transporter activity,MF,
3735,GO:0008272,1,0.451361353593707,0,7,sulfate transport,BP,
3754,GO:0008297,1,0.53337478416321,0,6,single-stranded DNA exodeoxyribonuclease activity,MF,
3766,GO:0008312,1,0.512595582721018,0,7,7S RNA binding,MF,
3767,GO:0008318,1,0.467859764335356,0,7,protein prenyltransferase activity,MF,
3768,GO:0008320,1,0.32767149315731,0,13,protein transmembrane transporter activity,MF,
3771,GO:0008327,1,0.172339215709445,0,16,methyl-CpG binding,MF,
3773,GO:0008329,1,0.478376854238182,0,7,signaling pattern recognition receptor activity,MF,
3786,GO:0008353,1,0.188500212316664,0,16,RNA polymerase II carboxy-terminal domain kinase activity,MF,
3787,GO:0008354,1,0.457501928960823,0,7,germ cell migration,BP,
3803,GO:0008385,1,0.377932118068827,0,9,IkappaB kinase complex,CC,
3817,GO:0008417,1,0.325601483026615,0,10,fucosyltransferase activity,MF,
3854,GO:0008474,1,0.348835217150553,0,10,palmitoyl-(protein) hydrolase activity,MF,
3870,GO:0008499,1,0.346205142694338,0,10,UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity,MF,
3877,GO:0008510,1,0.53285761779215,0,5,sodium:bicarbonate symporter activity,MF,
3884,GO:0008519,1,0.150338686482879,0,17,ammonium transmembrane transporter activity,MF,
3895,GO:0008535,1,0.0961144133348917,0,24,respiratory chain complex IV assembly,BP,
3898,GO:0008540,1,0.312090982688753,0,12,proteasome regulatory particle, base subcomplex,CC,
3899,GO:0008541,1,0.508176285139275,0,7,proteasome regulatory particle, lid subcomplex,CC,
3904,GO:0008553,1,0.376646148921554,0,9,proton-exporting ATPase activity, phosphorylative mechanism,MF,
3906,GO:0008556,1,0.570590502229011,0,5,potassium-transporting ATPase activity,MF,
3909,GO:0008568,1,0.324148948974918,0,10,microtubule-severing ATPase activity,MF,
3923,GO:0008603,1,0.58675148871508,0,5,cAMP-dependent protein kinase regulator activity,MF,
3934,GO:0008622,1,0.611579567012683,0,5,epsilon DNA polymerase complex,CC,
3941,GO:0008635,1,0.390215781189793,0,9,activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c,BP,
3943,GO:0008641,1,0.32983396468551,0,10,ubiquitin-like modifier activating enzyme activity,MF,
3981,GO:0008823,1,0.567888443486541,0,5,cupric reductase activity,MF,
4006,GO:0008970,1,0.461938455792507,0,7,phosphatidylcholine 1-acylhydrolase activity,MF,
4012,GO:0009008,1,0.564531892964044,0,5,DNA-methyltransferase activity,MF,
4018,GO:0009048,1,0.296206156371263,0,10,dosage compensation by inactivation of X chromosome,BP,
4020,GO:0009052,1,0.600851348448978,0,5,pentose-phosphate shunt, non-oxidative branch,BP,
4039,GO:0009074,1,0.477189035994142,0,8,aromatic amino acid family catabolic process,BP,
4058,GO:0009109,1,0.329476673990231,0,11,coenzyme catabolic process,BP,
4062,GO:0009113,1,0.264080104398796,0,13,purine nucleobase biosynthetic process,BP,
4078,GO:0009134,1,0.491061560716752,0,7,nucleoside diphosphate catabolic process,BP,
4087,GO:0009143,1,0.338596628780776,0,11,nucleoside triphosphate catabolic process,BP,
4090,GO:0009146,1,0.568215594251683,0,6,purine nucleoside triphosphate catabolic process,BP,
4095,GO:0009151,1,0.393109963526399,0,10,purine deoxyribonucleotide metabolic process,BP,
4099,GO:0009155,1,0.558735812391981,0,6,purine deoxyribonucleotide catabolic process,BP,
4116,GO:0009176,1,0.607291677716211,0,5,pyrimidine deoxyribonucleoside monophosphate metabolic process,BP,
4117,GO:0009177,1,0.607291677716211,0,5,pyrimidine deoxyribonucleoside monophosphate biosynthetic process,BP,
4130,GO:0009191,1,0.546005459666996,0,6,ribonucleoside diphosphate catabolic process,BP,
4141,GO:0009204,1,0.513274078642922,0,7,deoxyribonucleoside triphosphate catabolic process,BP,
4151,GO:0009215,1,0.431278660906591,0,9,purine deoxyribonucleoside triphosphate metabolic process,BP,
4153,GO:0009217,1,0.612969282561324,0,5,purine deoxyribonucleoside triphosphate catabolic process,BP,
4159,GO:0009223,1,0.353953898108521,0,11,pyrimidine deoxyribonucleotide catabolic process,BP,
4173,GO:0009249,1,0.578067413037235,0,7,protein lipoylation,BP,
4177,GO:0009256,1,0.563797683397111,0,5,10-formyltetrahydrofolate metabolic process,BP,
4185,GO:0009264,1,0.179153819051369,0,18,deoxyribonucleotide catabolic process,BP,
4193,GO:0009301,1,0.00094433680311863,0,67,snRNA transcription,BP,
4194,GO:0009303,1,0.0607791306558662,0,26,rRNA transcription,BP,
4195,GO:0009304,1,0.465725689280537,0,7,tRNA transcription,BP,
4199,GO:0009309,1,0.274011625502323,0,13,amine biosynthetic process,BP,
4220,GO:0009396,1,0.40181122896493,0,9,folic acid-containing compound biosynthetic process,BP,
4224,GO:0009403,1,0.586149725348988,0,5,toxin biosynthetic process,BP,
4238,GO:0009438,1,0.621776710156341,0,5,methylglyoxal metabolic process,BP,
4243,GO:0009445,1,0.506237414503426,0,7,putrescine metabolic process,BP,
4244,GO:0009446,1,0.585633056936076,0,5,putrescine biosynthetic process,BP,
4250,GO:0009452,1,0.0367610543102195,0,33,7-methylguanosine RNA capping,BP,
4257,GO:0009595,1,0.363455664364115,0,9,detection of biotic stimulus,BP,
4270,GO:0009629,1,0.526147648528428,0,6,response to gravity,BP,
4324,GO:0009838,1,0.608051846540745,0,5,abscission,BP,
4345,GO:0009912,1,0.582478610161123,0,5,auditory receptor cell fate commitment,BP,
4349,GO:0009922,1,0.584514507810071,0,5,fatty acid elongase activity,MF,
4351,GO:0009931,1,0.464608901916314,0,7,calcium-dependent protein serine/threonine kinase activity,MF,
4365,GO:0009982,1,0.264630734010449,0,13,pseudouridine synthase activity,MF,
4374,GO:0010002,1,0.390722987147431,0,8,cardioblast differentiation,BP,
4376,GO:0010009,1,0.589332334852302,0,5,cytoplasmic side of endosome membrane,CC,
4379,GO:0010032,1,0.529008538243051,0,5,meiotic chromosome condensation,BP,
4386,GO:0010041,1,0.597591276808871,0,5,response to iron(III) ion,BP,
4403,GO:0010155,1,0.439045910344365,0,9,regulation of proton transport,BP,
4411,GO:0010172,1,0.297202009662736,0,10,embryonic body morphogenesis,BP,
4417,GO:0010216,1,0.486886116336056,0,6,maintenance of DNA methylation,BP,
4423,GO:0010248,1,0.54928192631067,0,6,establishment or maintenance of transmembrane electrochemical gradient,BP,
4429,GO:0010265,1,0.528777862599314,0,6,SCF complex assembly,BP,
4433,GO:0010286,1,0.62444535176509,0,5,heat acclimation,BP,
4434,GO:0010288,1,0.115755965754093,0,20,response to lead ion,BP,
4436,GO:0010310,1,0.343429273235521,0,10,regulation of hydrogen peroxide metabolic process,BP,
4447,GO:0010385,1,0.573838791047128,0,5,double-stranded methylated DNA binding,MF,
4457,GO:0010452,1,0.342170917539566,0,9,histone H3-K36 methylation,BP,
4462,GO:0010458,1,0.0626956899673398,0,26,exit from mitosis,BP,
4476,GO:0010485,1,0.129136283837845,0,18,H4 histone acetyltransferase activity,MF,
4479,GO:0010499,1,0.162988990384349,0,22,proteasomal ubiquitin-independent protein catabolic process,BP,
4507,GO:0010560,1,0.234687852836315,0,13,positive regulation of glycoprotein biosynthetic process,BP,
4508,GO:0010561,1,0.314375101781174,0,11,negative regulation of glycoprotein biosynthetic process,BP,
4524,GO:0010592,1,0.204212420092426,0,14,positive regulation of lamellipodium assembly,BP,
4529,GO:0010603,1,0.417297762906548,0,7,regulation of cytoplasmic mRNA processing body assembly,BP,
4532,GO:0010606,1,0.53305242747962,0,5,positive regulation of cytoplasmic mRNA processing body assembly,BP,
4551,GO:0010635,1,0.418735438292947,0,8,regulation of mitochondrial fusion,BP,
4553,GO:0010637,1,0.588102341279134,0,5,negative regulation of mitochondrial fusion,BP,
4575,GO:0010663,1,0.494825164297515,0,6,positive regulation of striated muscle cell apoptotic process,BP,
4578,GO:0010666,1,0.494825164297515,0,6,positive regulation of cardiac muscle cell apoptotic process,BP,
4639,GO:0010764,1,0.521726641473884,0,6,negative regulation of fibroblast migration,BP,
4648,GO:0010793,1,0.558725733208863,0,5,regulation of mRNA export from nucleus,BP,
4653,GO:0010800,1,0.0909909493685652,0,21,positive regulation of peptidyl-threonine phosphorylation,BP,
4657,GO:0010807,1,0.497843121375568,0,6,regulation of synaptic vesicle priming,BP,
4667,GO:0010818,1,0.360406541903926,0,10,T cell chemotaxis,BP,
4668,GO:0010819,1,0.500669139358871,0,7,regulation of T cell chemotaxis,BP,
4669,GO:0010820,1,0.500669139358871,0,7,positive regulation of T cell chemotaxis,BP,
4674,GO:0010825,1,0.495908474760894,0,6,positive regulation of centrosome duplication,BP,
4678,GO:0010829,1,0.30052692702135,0,11,negative regulation of glucose transmembrane transport,BP,
4681,GO:0010832,1,0.551212917802594,0,5,negative regulation of myotube differentiation,BP,
4686,GO:0010838,1,0.551549093267035,0,5,positive regulation of keratinocyte proliferation,BP,
4696,GO:0010857,1,0.418103347145041,0,8,calcium-dependent protein kinase activity,MF,
4705,GO:0010870,1,0.342867810410154,0,10,positive regulation of receptor biosynthetic process,BP,
4740,GO:0010911,1,0.434129187993315,0,7,regulation of isomerase activity,BP,
4741,GO:0010912,1,0.434129187993315,0,7,positive regulation of isomerase activity,BP,
4744,GO:0010917,1,0.444028584821386,0,8,negative regulation of mitochondrial membrane potential,BP,
4745,GO:0010918,1,0.477007038510511,0,7,positive regulation of mitochondrial membrane potential,BP,
4746,GO:0010919,1,0.441296456033326,0,7,regulation of inositol phosphate biosynthetic process,BP,
4754,GO:0010934,1,0.332097994778839,0,10,macrophage cytokine production,BP,
4755,GO:0010935,1,0.415460687133152,0,8,regulation of macrophage cytokine production,BP,
4756,GO:0010936,1,0.575207640273015,0,5,negative regulation of macrophage cytokine production,BP,
4761,GO:0010944,1,0.547785308813993,0,6,negative regulation of transcription by competitive promoter binding,BP,
4776,GO:0010965,1,0.00546020220522459,0,49,regulation of mitotic sister chromatid separation,BP,
4781,GO:0010971,1,0.12294454194158,0,19,positive regulation of G2/M transition of mitotic cell cycle,BP,
4790,GO:0010984,1,0.332030313152737,0,11,regulation of lipoprotein particle clearance,BP,
4791,GO:0010985,1,0.629093422179641,0,5,negative regulation of lipoprotein particle clearance,BP,
4793,GO:0010988,1,0.541512798783197,0,6,regulation of low-density lipoprotein particle clearance,BP,
4797,GO:0010992,1,0.477774677936475,0,7,ubiquitin recycling,BP,
4798,GO:0010994,1,0.616649777750251,0,5,free ubiquitin chain polymerization,BP,
4800,GO:0010997,1,0.567212076779545,0,5,anaphase-promoting complex binding,MF,
4813,GO:0014010,1,0.539129807831211,0,5,Schwann cell proliferation,BP,
4839,GO:0014048,1,0.57387735725887,0,5,regulation of glutamate secretion,BP,
4841,GO:0014051,1,0.524769783962625,0,5,gamma-aminobutyric acid secretion,BP,
4870,GO:0014733,1,0.389753885540983,0,8,regulation of skeletal muscle adaptation,BP,
4914,GO:0014854,1,0.396467114042486,0,8,response to inactivity,BP,
4921,GO:0014870,1,0.4844423020055,0,6,response to muscle inactivity,BP,
4922,GO:0014874,1,0.434334521709338,0,7,response to stimulus involved in regulation of muscle adaptation,BP,
4924,GO:0014877,1,0.538986996956229,0,5,response to muscle inactivity involved in regulation of muscle adaptation,BP,
4932,GO:0014894,1,0.538986996956229,0,5,response to denervation involved in regulation of muscle adaptation,BP,
4940,GO:0014904,1,0.184274989221194,0,15,myotube cell development,BP,
4960,GO:0015037,1,0.342529205276955,0,12,peptide disulfide oxidoreductase activity,MF,
4961,GO:0015038,1,0.664671465451587,0,5,glutathione disulfide oxidoreductase activity,MF,
4978,GO:0015101,1,0.171765328031256,0,16,organic cation transmembrane transporter activity,MF,
4981,GO:0015106,1,0.266754995423409,0,11,bicarbonate transmembrane transporter activity,MF,
4986,GO:0015116,1,0.504636908396118,0,6,sulfate transmembrane transporter activity,MF,
5006,GO:0015165,1,0.387356877849533,0,9,pyrimidine nucleotide-sugar transmembrane transporter activity,MF,
5010,GO:0015172,1,0.500243977785638,0,6,acidic amino acid transmembrane transporter activity,MF,
5012,GO:0015174,1,0.411914535196302,0,8,basic amino acid transmembrane transporter activity,MF,
5016,GO:0015181,1,0.565291797070935,0,5,arginine transmembrane transporter activity,MF,
5022,GO:0015187,1,0.572689388688811,0,5,glycine transmembrane transporter activity,MF,
5023,GO:0015189,1,0.565291797070935,0,5,L-lysine transmembrane transporter activity,MF,
5032,GO:0015205,1,0.525151241255966,0,6,nucleobase transmembrane transporter activity,MF,
5035,GO:0015215,1,0.204780101540078,0,15,nucleotide transmembrane transporter activity,MF,
5036,GO:0015216,1,0.312091371384198,0,11,purine nucleotide transmembrane transporter activity,MF,
5037,GO:0015217,1,0.383562319088282,0,9,ADP transmembrane transporter activity,MF,
5065,GO:0015288,1,0.552723686409185,0,6,porin activity,MF,
5070,GO:0015295,1,0.134026458577574,0,18,solute:proton symporter activity,MF,
5074,GO:0015299,1,0.249462891320794,0,12,solute:proton antiporter activity,MF,
5086,GO:0015347,1,0.394461518398541,0,8,sodium-independent organic anion transmembrane transporter activity,MF,
5100,GO:0015385,1,0.387908472564129,0,8,sodium:proton antiporter activity,MF,
5101,GO:0015386,1,0.431592451968699,0,7,potassium:proton antiporter activity,MF,
5115,GO:0015450,1,0.575347068548874,0,7,P-P-bond-hydrolysis-driven protein transmembrane transporter activity,MF,
5117,GO:0015464,1,0.462004818516662,0,7,acetylcholine receptor activity,MF,
5134,GO:0015643,1,0.463005142903538,0,7,toxic substance binding,MF,
5136,GO:0015651,1,0.511820677815153,0,6,quaternary ammonium group transmembrane transporter activity,MF,
5139,GO:0015662,1,0.0775857923064053,0,22,ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism,MF,
5144,GO:0015677,1,0.385588260502428,0,8,copper ion import,BP,
5155,GO:0015695,1,0.0603960006590284,0,25,organic cation transport,BP,
5157,GO:0015697,1,0.396527818312826,0,8,quaternary ammonium group transport,BP,
5167,GO:0015721,1,0.234739355834712,0,13,bile acid and bile salt transport,BP,
5174,GO:0015732,1,0.437508718767475,0,8,prostaglandin transport,BP,
5190,GO:0015780,1,0.280943126872475,0,12,nucleotide-sugar transmembrane transport,BP,
5202,GO:0015802,1,0.419771207662369,0,8,basic amino acid transport,BP,
5208,GO:0015809,1,0.518155916981115,0,6,arginine transport,BP,
5211,GO:0015812,1,0.473623657458361,0,6,gamma-aminobutyric acid transport,BP,
5213,GO:0015816,1,0.503846334085052,0,6,glycine transport,BP,
5225,GO:0015838,1,0.500564235593895,0,6,amino-acid betaine transport,BP,
5229,GO:0015846,1,0.529899653559296,0,6,polyamine transport,BP,
5233,GO:0015851,1,0.480044739968304,0,7,nucleobase transport,BP,
5240,GO:0015865,1,0.279852918742476,0,12,purine nucleotide transport,BP,
5241,GO:0015866,1,0.383562319088282,0,9,ADP transport,BP,
5242,GO:0015867,1,0.382084780516613,0,9,ATP transport,BP,
5243,GO:0015868,1,0.279852918742476,0,12,purine ribonucleotide transport,BP,
5244,GO:0015871,1,0.49168151782901,0,6,choline transport,BP,
5253,GO:0015884,1,0.593613241470695,0,5,folic acid transport,BP,
5280,GO:0015935,1,0.00740127962096218,0,68,small ribosomal subunit,CC,
5284,GO:0015939,1,0.588195673482964,0,5,pantothenate metabolic process,BP,
5300,GO:0016004,1,0.42147622536551,0,8,phospholipase activator activity,MF,
5311,GO:0016024,1,0.223764083670899,0,13,CDP-diacylglycerol biosynthetic process,BP,
5319,GO:0016045,1,0.454273025284996,0,7,detection of bacterium,BP,
5328,GO:0016056,1,0.230893819366131,0,13,rhodopsin mediated signaling pathway,BP,
5334,GO:0016073,1,0.000207845383305917,0,84,snRNA metabolic process,BP,
5335,GO:0016074,1,0.35587553910168,0,12,snoRNA metabolic process,BP,
5338,GO:0016078,1,0.565075752162403,0,6,tRNA catabolic process,BP,
5341,GO:0016081,1,0.497090358990147,0,6,synaptic vesicle docking,BP,
5342,GO:0016082,1,0.275781322844786,0,11,synaptic vesicle priming,BP,
5360,GO:0016139,1,0.477444959259051,0,7,glycoside catabolic process,BP,
5369,GO:0016176,1,0.572518740513955,0,5,superoxide-generating NADPH oxidase activator activity,MF,
5370,GO:0016180,1,0.104022176483933,0,22,snRNA processing,BP,
5389,GO:0016226,1,0.156093104638741,0,20,iron-sulfur cluster assembly,BP,
5404,GO:0016246,1,0.202219413317159,0,15,RNA interference,BP,
5419,GO:0016272,1,0.604222786132186,0,7,prefoldin complex,CC,
5425,GO:0016281,1,0.373444200878849,0,9,eukaryotic translation initiation factor 4F complex,CC,
5439,GO:0016308,1,0.493527163654435,0,6,1-phosphatidylinositol-4-phosphate 5-kinase activity,MF,
5448,GO:0016322,1,0.494983842453154,0,6,neuron remodeling,BP,
5451,GO:0016327,1,0.236632006018473,0,13,apicolateral plasma membrane,CC,
5457,GO:0016338,1,0.450242043430536,0,8,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules,BP,
5458,GO:0016339,1,0.182387573778398,0,15,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules,BP,
5473,GO:0016408,1,0.256977226917288,0,13,C-acyltransferase activity,MF,
5489,GO:0016427,1,0.416968773989636,0,8,tRNA (cytosine) methyltransferase activity,MF,
5493,GO:0016433,1,0.546664080397664,0,6,rRNA (adenine) methyltransferase activity,MF,
5504,GO:0016454,1,0.569513821909048,0,5,C-palmitoyltransferase activity,MF,
5530,GO:0016514,1,0.218605918881145,0,13,SWI/SNF complex,CC,
5538,GO:0016530,1,0.618670637180704,0,6,metallochaperone activity,MF,
5539,GO:0016531,1,0.704286185374829,0,5,copper chaperone activity,MF,
5547,GO:0016556,1,0.208992558982875,0,15,mRNA modification,BP,
5565,GO:0016580,1,0.278645871309618,0,11,Sin3 complex,CC,
5567,GO:0016584,1,0.526093983620519,0,7,nucleosome positioning,BP,
5587,GO:0016615,1,0.541729432111941,0,6,malate dehydrogenase activity,MF,
5610,GO:0016661,1,0.594638127367976,0,5,oxidoreductase activity, acting on other nitrogenous compounds as donors,MF,
5614,GO:0016670,1,0.448535586252189,0,7,oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor,MF,
5615,GO:0016671,1,0.309802196814361,0,12,oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor,MF,
5619,GO:0016679,1,0.496959483586461,0,8,oxidoreductase activity, acting on diphenols and related substances as donors,MF,
5620,GO:0016681,1,0.552137407003278,0,7,oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor,MF,
5632,GO:0016717,1,0.563251043522846,0,5,oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water,MF,
5645,GO:0016742,1,0.462674639649001,0,7,hydroxymethyl-, formyl- and related transferase activity,MF,
5663,GO:0016775,1,0.6223457428111,0,5,phosphotransferase activity, nitrogenous group as acceptor,MF,
5667,GO:0016780,1,0.144394586061809,0,18,phosphotransferase activity, for other substituted phosphate groups,MF,
5685,GO:0016805,1,0.452843324960243,0,7,dipeptidase activity,MF,
5690,GO:0016813,1,0.541578304780005,0,6,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines,MF,
5701,GO:0016832,1,0.480918326460761,0,7,aldehyde-lyase activity,MF,
5708,GO:0016842,1,0.510857131292769,0,7,amidine-lyase activity,MF,
5734,GO:0016884,1,0.342689551049221,0,10,carbon-nitrogen ligase activity, with glutamine as amido-N-donor,MF,
5741,GO:0016891,1,0.0674206003968008,0,27,endoribonuclease activity, producing 5'-phosphomonoesters,MF,
5742,GO:0016892,1,0.555131853052258,0,6,endoribonuclease activity, producing 3'-phosphomonoesters,MF,
5755,GO:0016918,1,0.612213108198584,0,6,retinal binding,MF,
5757,GO:0016922,1,0.108861880872784,0,19,ligand-dependent nuclear receptor binding,MF,
5759,GO:0016926,1,0.442239726510191,0,7,protein desumoylation,BP,
5760,GO:0016929,1,0.487328359727133,0,6,SUMO-specific protease activity,MF,
5769,GO:0016973,1,0.348566983163118,0,10,poly(A)+ mRNA export from nucleus,BP,
5785,GO:0017017,1,0.279783841661901,0,12,MAP kinase tyrosine/serine/threonine phosphatase activity,MF,
5802,GO:0017059,1,0.424811279588335,0,8,serine C-palmitoyltransferase complex,CC,
5808,GO:0017069,1,0.023178626854749,0,38,snRNA binding,MF,
5809,GO:0017070,1,0.34835591150667,0,11,U6 snRNA binding,MF,
5823,GO:0017101,1,0.28345098415143,0,12,aminoacyl-tRNA synthetase multienzyme complex,CC,
5827,GO:0017110,1,0.249548012060031,0,13,nucleoside-diphosphatase activity,MF,
5851,GO:0017151,1,0.451561293057276,0,7,DEAD/H-box RNA helicase binding,MF,
5860,GO:0017166,1,0.293353347196111,0,10,vinculin binding,MF,
5862,GO:0017169,1,0.492316323043364,0,7,CDP-alcohol phosphatidyltransferase activity,MF,
5864,GO:0017176,1,0.532025310702659,0,7,phosphatidylinositol N-acetylglucosaminyltransferase activity,MF,
5867,GO:0017182,1,0.380735131505682,0,9,peptidyl-diphthamide metabolic process,BP,
5868,GO:0017183,1,0.380735131505682,0,9,peptidyl-diphthamide biosynthetic process from peptidyl-histidine,BP,
5869,GO:0017185,1,0.41569464750599,0,8,peptidyl-lysine hydroxylation,BP,
5872,GO:0017196,1,0.515461993615931,0,6,N-terminal peptidyl-methionine acetylation,BP,
5890,GO:0018065,1,0.397281737423369,0,11,protein-cofactor linkage,BP,
5909,GO:0018158,1,0.408929768544628,0,9,protein oxidation,BP,
5924,GO:0018202,1,0.316247783442092,0,11,peptidyl-histidine modification,BP,
5926,GO:0018206,1,0.343745081837297,0,10,peptidyl-methionine modification,BP,
5937,GO:0018242,1,0.223200417529041,0,13,protein O-linked glycosylation via serine,BP,
5938,GO:0018243,1,0.248347818217923,0,12,protein O-linked glycosylation via threonine,BP,
5955,GO:0018342,1,0.369667996135237,0,9,protein prenylation,BP,
5957,GO:0018344,1,0.523099195163371,0,6,protein geranylgeranylation,BP,
5967,GO:0018401,1,0.576803076961292,0,5,peptidyl-proline hydroxylation to 4-hydroxy-L-proline,BP,
5999,GO:0019042,1,0.303167923347062,0,11,viral latency,BP,
6000,GO:0019043,1,0.393382191576129,0,9,establishment of viral latency,BP,
6006,GO:0019054,1,0.106118494862477,0,20,modulation by virus of host process,BP,
6017,GO:0019076,1,0.026408328357795,0,33,viral release from host cell,BP,
6020,GO:0019081,1,0.218698656715633,0,14,viral translation,BP,
6031,GO:0019103,1,0.558644961220859,0,6,pyrimidine nucleotide binding,MF,
6048,GO:0019198,1,0.284555757708228,0,10,transmembrane receptor protein phosphatase activity,MF,
6060,GO:0019211,1,0.33796541836934,0,10,phosphatase activator activity,MF,
6079,GO:0019238,1,0.525457381230581,0,6,cyclohydrolase activity,MF,
6087,GO:0019262,1,0.609832591362112,0,5,N-acetylneuraminate catabolic process,BP,
6094,GO:0019317,1,0.499406801558661,0,6,fucose catabolic process,BP,
6101,GO:0019336,1,0.5859529636718,0,5,phenol-containing compound catabolic process,BP,
6116,GO:0019367,1,0.584514507810071,0,5,fatty acid elongation, saturated fatty acid,BP,
6117,GO:0019368,1,0.584514507810071,0,5,fatty acid elongation, unsaturated fatty acid,BP,
6122,GO:0019373,1,0.520962541930849,0,6,epoxygenase P450 pathway,BP,
6123,GO:0019374,1,0.517237512964381,0,6,galactolipid metabolic process,BP,
6142,GO:0019430,1,0.234992041718324,0,15,removal of superoxide radicals,BP,
6157,GO:0019509,1,0.59538448635573,0,5,L-methionine salvage from methylthioadenosine,BP,
6167,GO:0019531,1,0.558383502500569,0,5,oxalate transmembrane transporter activity,MF,
6168,GO:0019532,1,0.558383502500569,0,5,oxalate transport,BP,
6183,GO:0019614,1,0.5859529636718,0,5,catechol-containing compound catabolic process,BP,
6185,GO:0019627,1,0.343021866464279,0,10,urea metabolic process,BP,
6187,GO:0019640,1,0.626951062701395,0,5,glucuronate catabolic process to xylulose 5-phosphate,BP,
6188,GO:0019646,1,0.401361904271796,0,14,aerobic electron transport chain,BP,
6204,GO:0019720,1,0.521604050604218,0,6,Mo-molybdopterin cofactor metabolic process,BP,
6220,GO:0019773,1,0.588880863105138,0,7,proteasome core complex, alpha-subunit complex,CC,
6221,GO:0019774,1,0.497329497206185,0,10,proteasome core complex, beta-subunit complex,CC,
6230,GO:0019784,1,0.507376251028091,0,7,NEDD8-specific protease activity,MF,
6236,GO:0019798,1,0.529510743016723,0,6,procollagen-proline dioxygenase activity,MF,
6253,GO:0019841,1,0.683959892117279,0,5,retinol binding,MF,
6259,GO:0019856,1,0.494115535665507,0,6,pyrimidine nucleobase biosynthetic process,BP,
6272,GO:0019871,1,0.54927281142614,0,5,sodium channel inhibitor activity,MF,
6292,GO:0019907,1,0.482642104171487,0,7,cyclin-dependent protein kinase activating kinase holoenzyme complex,CC,
6293,GO:0019908,1,0.173714652472177,0,16,nuclear cyclin-dependent protein kinase holoenzyme complex,CC,
6315,GO:0019966,1,0.479601834436334,0,7,interleukin-1 binding,MF,
6326,GO:0020027,1,0.416495893351133,0,8,hemoglobin metabolic process,BP,
6350,GO:0021535,1,0.301636254762804,0,10,cell migration in hindbrain,BP,
6369,GO:0021559,1,0.499817859976294,0,6,trigeminal nerve development,BP,
6387,GO:0021591,1,0.157579277182594,0,17,ventricular system development,BP,
6393,GO:0021604,1,0.564575928989089,0,5,cranial nerve structural organization,BP,
6395,GO:0021612,1,0.564575928989089,0,5,facial nerve structural organization,BP,
6408,GO:0021670,1,0.41106901938611,0,8,lateral ventricle development,BP,
6448,GO:0021772,1,0.142464976269299,0,16,olfactory bulb development,BP,
6455,GO:0021781,1,0.574271405124653,0,5,glial cell fate commitment,BP,
6459,GO:0021785,1,0.473240600888577,0,6,branchiomotor neuron axon guidance,BP,
6460,GO:0021794,1,0.432569502831564,0,7,thalamus development,BP,
6466,GO:0021800,1,0.538596194136818,0,5,cerebral cortex tangential migration,BP,
6489,GO:0021854,1,0.315134982738617,0,11,hypothalamus development,BP,
6492,GO:0021859,1,0.548200303190076,0,5,pyramidal neuron differentiation,BP,
6493,GO:0021860,1,0.548200303190076,0,5,pyramidal neuron development,BP,
6499,GO:0021873,1,0.481452326490304,0,6,forebrain neuroblast division,BP,
6500,GO:0021877,1,0.56010718703499,0,5,forebrain neuron fate commitment,BP,
6504,GO:0021884,1,0.160475950630721,0,16,forebrain neuron development,BP,
6508,GO:0021889,1,0.492807020095354,0,6,olfactory bulb interneuron differentiation,BP,
6509,GO:0021891,1,0.538832213419513,0,5,olfactory bulb interneuron development,BP,
6513,GO:0021895,1,0.325706680563269,0,10,cerebral cortex neuron differentiation,BP,
6518,GO:0021903,1,0.571508666268551,0,5,rostrocaudal neural tube patterning,BP,
6525,GO:0021932,1,0.44194102937009,0,7,hindbrain radial glia guided cell migration,BP,
6545,GO:0021978,1,0.579828058766527,0,5,telencephalon regionalization,BP,
6548,GO:0021984,1,0.575696634956874,0,5,adenohypophysis development,BP,
6550,GO:0021988,1,0.127389252182562,0,17,olfactory lobe development,BP,
6554,GO:0021999,1,0.57704882118397,0,5,neural plate anterior/posterior regionalization,BP,
6568,GO:0022400,1,0.286096082404411,0,11,regulation of rhodopsin mediated signaling pathway,BP,
6590,GO:0022613,1,3.88982550682422e-11,8,447,ribonucleoprotein complex biogenesis,BP,CIRBP;SRSF5;ZNF658;NSUN5P2;AGO4;TARBP1;SETD4;PTBP2
6597,GO:0022624,1,0.103163950517954,0,24,proteasome accessory complex,CC,
6598,GO:0022625,1,0.0118921448406535,0,63,cytosolic large ribosomal subunit,CC,
6599,GO:0022626,1,0.000430210412754375,0,110,cytosolic ribosome,CC,
6600,GO:0022627,1,0.0545677974724181,0,43,cytosolic small ribosomal subunit,CC,
6604,GO:0022824,1,0.393201144905621,0,8,transmitter-gated ion channel activity,MF,
6608,GO:0022835,1,0.393201144905621,0,8,transmitter-gated channel activity,MF,
6622,GO:0022884,1,0.290567581114184,0,14,macromolecule transmembrane transporter activity,MF,
6630,GO:0023019,1,0.359833192270502,0,9,signal transduction involved in regulation of gene expression,BP,
6632,GO:0023023,1,0.296466310125072,0,12,MHC protein complex binding,MF,
6635,GO:0023026,1,0.367204095692795,0,10,MHC class II protein complex binding,MF,
6647,GO:0030002,1,0.491909299576683,0,6,cellular anion homeostasis,BP,
6651,GO:0030008,1,0.306977685712877,0,13,TRAPP complex,CC,
6654,GO:0030014,1,0.179789264303384,0,15,CCR4-NOT complex,CC,
6655,GO:0030015,1,0.573505458934709,0,5,CCR4-NOT core complex,CC,
6679,GO:0030050,1,0.476221697611466,0,6,vesicle transport along actin filament,BP,
6685,GO:0030061,1,0.579426877127548,0,5,mitochondrial crista,CC,
6688,GO:0030071,1,0.0083075021465078,0,45,regulation of mitotic metaphase/anaphase transition,BP,
6691,GO:0030091,1,0.532385485541137,0,7,protein repair,BP,
6696,GO:0030101,1,0.0168843754306144,0,39,natural killer cell activation,BP,
6710,GO:0030126,1,0.210271190893144,0,15,COPI vesicle coat,CC,
6711,GO:0030127,1,0.204445366365325,0,14,COPII vesicle coat,CC,
6720,GO:0030137,1,0.0906329995475336,0,23,COPI-coated vesicle,CC,
6728,GO:0030150,1,0.182685353442369,0,18,protein import into mitochondrial matrix,BP,
6743,GO:0030169,1,0.480115417250007,0,6,low-density lipoprotein particle binding,MF,
6745,GO:0030173,1,0.0203357467255554,0,36,integral component of Golgi membrane,CC,
6746,GO:0030174,1,0.526532393573083,0,6,regulation of DNA-dependent DNA replication initiation,BP,
6782,GO:0030225,1,0.0679683095042553,0,24,macrophage differentiation,BP,
6810,GO:0030275,1,0.17975114062094,0,16,LRR domain binding,MF,
6815,GO:0030280,1,0.327726089431372,0,11,structural constituent of epidermis,MF,
6818,GO:0030284,1,0.568300894449259,0,5,estrogen receptor activity,MF,
6844,GO:0030320,1,0.491909299576683,0,6,cellular monovalent inorganic anion homeostasis,BP,
6864,GO:0030346,1,0.526998351778045,0,6,protein phosphatase 2B binding,MF,
6869,GO:0030368,1,0.508764776343615,0,6,interleukin-17 receptor activity,MF,
6883,GO:0030422,1,0.413461578554086,0,9,production of siRNA involved in RNA interference,BP,
6900,GO:0030490,1,0.0054726223689692,0,53,maturation of SSU-rRNA,BP,
6902,GO:0030497,1,0.352445425425396,0,10,fatty acid elongation,BP,
6916,GO:0030515,1,0.0532506672978229,0,30,snoRNA binding,MF,
6928,GO:0030540,1,0.312927277901748,0,10,female genitalia development,BP,
6932,GO:0030547,1,0.212017993337133,0,15,receptor inhibitor activity,MF,
6933,GO:0030548,1,0.556426875291242,0,6,acetylcholine receptor regulator activity,MF,
6942,GO:0030575,1,0.35641954587421,0,9,nuclear body organization,BP,
6958,GO:0030619,1,0.490309866861752,0,7,U1 snRNA binding,MF,
6959,GO:0030620,1,0.58290669258544,0,6,U2 snRNA binding,MF,
6960,GO:0030621,1,0.508832944167195,0,6,U4 snRNA binding,MF,
6966,GO:0030628,1,0.577412492761782,0,6,pre-mRNA 3'-splice site binding,MF,
6979,GO:0030663,1,0.157659907489433,0,18,COPI-coated vesicle membrane,CC,
6989,GO:0030677,1,0.310465269156507,0,13,ribonuclease P complex,CC,
6991,GO:0030681,1,0.410945684986081,0,10,multimeric ribonuclease P complex,CC,
6994,GO:0030684,1,0.00041446783404485,0,74,preribosome,CC,
6995,GO:0030686,1,0.0329900782003394,0,32,90S preribosome,CC,
6996,GO:0030687,1,0.0830115264289475,0,24,preribosome, large subunit precursor,CC,
6997,GO:0030688,1,0.265813108191145,0,12,preribosome, small subunit precursor,CC,
7009,GO:0030728,1,0.251602611906065,0,12,ovulation,BP,
7031,GO:0030812,1,0.393619301503767,0,8,negative regulation of nucleotide catabolic process,BP,
7050,GO:0030836,1,0.47485439610663,0,7,positive regulation of actin filament depolymerization,BP,
7059,GO:0030854,1,0.584735447589032,0,5,positive regulation of granulocyte differentiation,BP,
7071,GO:0030867,1,0.104936457257633,0,25,rough endoplasmic reticulum membrane,CC,
7092,GO:0030896,1,0.583097182281916,0,5,checkpoint clamp complex,CC,
7094,GO:0030898,1,0.380460275487403,0,8,actin-dependent ATPase activity,MF,
7106,GO:0030914,1,0.287100678510408,0,12,STAGA complex,CC,
7118,GO:0030949,1,0.442719377119043,0,7,positive regulation of vascular endothelial growth factor receptor signaling pathway,BP,
7122,GO:0030953,1,0.426963242082445,0,7,astral microtubule organization,BP,
7125,GO:0030957,1,0.339683207525376,0,10,Tat protein binding,MF,
7139,GO:0030992,1,0.133756316203398,0,19,intraciliary transport particle B,CC,
7144,GO:0031011,1,0.225160065160527,0,15,Ino80 complex,CC,
7164,GO:0031053,1,0.314544153219631,0,10,primary miRNA processing,BP,
7181,GO:0031077,1,0.482002152651896,0,7,post-embryonic camera-type eye development,BP,
7183,GO:0031080,1,0.326098280629476,0,10,nuclear pore outer ring,CC,
7190,GO:0031087,1,0.456376624961787,0,7,deadenylation-independent decapping of nuclear-transcribed mRNA,BP,
7191,GO:0031088,1,0.583068587872964,0,5,platelet dense granule membrane,CC,
7216,GO:0031118,1,0.50818802729801,0,8,rRNA pseudouridine synthesis,BP,
7217,GO:0031119,1,0.503248652209305,0,7,tRNA pseudouridine synthesis,BP,
7222,GO:0031125,1,0.360103127097502,0,12,rRNA 3'-end processing,BP,
7223,GO:0031126,1,0.549291011803454,0,7,snoRNA 3'-end processing,BP,
7228,GO:0031143,1,0.267684856876035,0,12,pseudopodium,CC,
7229,GO:0031145,1,0.000868009167371257,0,77,anaphase-promoting complex-dependent catabolic process,BP,
7233,GO:0031163,1,0.156093104638741,0,20,metallo-sulfur cluster assembly,BP,
7243,GO:0031209,1,0.383739731517525,0,8,SCAR complex,CC,
7245,GO:0031211,1,0.424811279588335,0,8,endoplasmic reticulum palmitoyltransferase complex,CC,
7253,GO:0031228,1,0.0132545597217963,0,40,intrinsic component of Golgi membrane,CC,
7257,GO:0031233,1,0.288170614327278,0,12,intrinsic component of external side of plasma membrane,CC,
7270,GO:0031261,1,0.595975914792866,0,5,DNA replication preinitiation complex,CC,
7272,GO:0031264,1,0.381693690375134,0,9,death-inducing signaling complex,CC,
7273,GO:0031265,1,0.523487615664025,0,6,CD95 death-inducing signaling complex,CC,
7275,GO:0031268,1,0.283053441309019,0,12,pseudopodium organization,BP,
7276,GO:0031269,1,0.305103901297005,0,11,pseudopodium assembly,BP,
7277,GO:0031272,1,0.386033011238426,0,9,regulation of pseudopodium assembly,BP,
7278,GO:0031274,1,0.386033011238426,0,9,positive regulation of pseudopodium assembly,BP,
7292,GO:0031298,1,0.374333619655879,0,9,replication fork protection complex,CC,
7296,GO:0031304,1,0.0287114502426954,0,36,intrinsic component of mitochondrial inner membrane,CC,
7297,GO:0031305,1,0.0287114502426954,0,36,integral component of mitochondrial inner membrane,CC,
7298,GO:0031306,1,0.103261242107776,0,22,intrinsic component of mitochondrial outer membrane,CC,
7299,GO:0031307,1,0.117142833291736,0,21,integral component of mitochondrial outer membrane,CC,
7302,GO:0031313,1,0.459878123954295,0,7,extrinsic component of endosome membrane,CC,
7303,GO:0031314,1,0.573836711804689,0,5,extrinsic component of mitochondrial inner membrane,CC,
7322,GO:0031340,1,0.509322475167632,0,6,positive regulation of vesicle fusion,BP,
7324,GO:0031342,1,0.318732646110212,0,11,negative regulation of cell killing,BP,
7325,GO:0031343,1,0.105625033237995,0,22,positive regulation of cell killing,BP,
7332,GO:0031362,1,0.388326054806346,0,9,anchored component of external side of plasma membrane,CC,
7334,GO:0031369,1,0.0547360658081114,0,28,translation initiation factor binding,MF,
7336,GO:0031371,1,0.42910008637065,0,8,ubiquitin conjugating enzyme complex,CC,
7342,GO:0031390,1,0.435443527448176,0,8,Ctf18 RFC-like complex,CC,
7359,GO:0031414,1,0.373992427751441,0,9,N-terminal protein acetyltransferase complex,CC,
7368,GO:0031428,1,0.616089190730425,0,5,box C/D snoRNP complex,CC,
7369,GO:0031429,1,0.687767505722532,0,5,box H/ACA snoRNP complex,CC,
7381,GO:0031441,1,0.357937042217343,0,9,negative regulation of mRNA 3'-end processing,BP,
7382,GO:0031442,1,0.357855513678903,0,9,positive regulation of mRNA 3'-end processing,BP,
7393,GO:0031464,1,0.280259007025712,0,12,Cul4A-RING E3 ubiquitin ligase complex,CC,
7399,GO:0031489,1,0.25231545721786,0,13,myosin V binding,MF,
7402,GO:0031492,1,0.0273766635543918,0,42,nucleosomal DNA binding,MF,
7405,GO:0031498,1,0.151276498892202,0,17,chromatin disassembly,BP,
7426,GO:0031543,1,0.33872382435397,0,10,peptidyl-proline dioxygenase activity,MF,
7428,GO:0031545,1,0.519693411369866,0,6,peptidyl-proline 4-dioxygenase activity,MF,
7441,GO:0031584,1,0.593345335422814,0,5,activation of phospholipase D activity,BP,
7444,GO:0031588,1,0.354919292745551,0,9,nucleotide-activated protein kinase complex,CC,
7451,GO:0031595,1,0.465397167435595,0,8,nuclear proteasome complex,CC,
7452,GO:0031597,1,0.299043685224146,0,12,cytosolic proteasome complex,CC,
7453,GO:0031616,1,0.403639129169005,0,9,spindle pole centrosome,CC,
7458,GO:0031624,1,0.0377666309309273,0,28,ubiquitin conjugating enzyme binding,MF,
7463,GO:0031629,1,0.345899502166675,0,10,synaptic vesicle fusion to presynaptic active zone membrane,BP,
7468,GO:0031640,1,0.250945853046261,0,18,killing of cells of other organism,BP,
7482,GO:0031658,1,0.47891879692229,0,7,negative regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle,BP,
7497,GO:0031683,1,0.267407396684773,0,12,G-protein beta/gamma-subunit complex binding,MF,
7535,GO:0031821,1,0.514363396631506,0,6,G-protein coupled serotonin receptor binding,MF,
7539,GO:0031848,1,0.325298444386572,0,10,protection from non-homologous end joining at telomere,BP,
7562,GO:0031931,1,0.445987810517797,0,7,TORC1 complex,CC,
7567,GO:0031937,1,0.384688343215616,0,8,positive regulation of chromatin silencing,BP,
7598,GO:0031987,1,0.393749577172653,0,8,locomotion involved in locomotory behavior,BP,
7623,GO:0032036,1,0.585683545045982,0,5,myosin heavy chain binding,MF,
7624,GO:0032039,1,0.215707516925485,0,13,integrator complex,CC,
7625,GO:0032040,1,0.0316924499975925,0,33,small-subunit processome,CC,
7636,GO:0032055,1,0.504092461092118,0,6,negative regulation of translation in response to stress,BP,
7640,GO:0032059,1,0.447427577788857,0,7,bleb,CC,
7643,GO:0032070,1,0.404229392060274,0,9,regulation of deoxyribonuclease activity,BP,
7644,GO:0032071,1,0.489718696196588,0,7,regulation of endodeoxyribonuclease activity,BP,
7646,GO:0032074,1,0.521026554816708,0,6,negative regulation of nuclease activity,BP,
7649,GO:0032077,1,0.618118938648484,0,5,positive regulation of deoxyribonuclease activity,BP,
7674,GO:0032119,1,0.460216875405281,0,8,sequestering of zinc ion,BP,
7696,GO:0032183,1,0.218109689142088,0,13,SUMO binding,MF,
7732,GO:0032239,1,0.148275699814078,0,16,regulation of nucleobase-containing compound transport,BP,
7734,GO:0032241,1,0.441624134421802,0,7,positive regulation of nucleobase-containing compound transport,BP,
7739,GO:0032261,1,0.503867864366386,0,7,purine nucleotide salvage,BP,
7750,GO:0032274,1,0.439498964688683,0,7,gonadotropin secretion,BP,
7751,GO:0032275,1,0.549314494858813,0,5,luteinizing hormone secretion,BP,
7774,GO:0032306,1,0.635565744585954,0,5,regulation of prostaglandin secretion,BP,
7775,GO:0032308,1,0.635565744585954,0,5,positive regulation of prostaglandin secretion,BP,
7777,GO:0032310,1,0.56081683906848,0,6,prostaglandin secretion,BP,
7779,GO:0032324,1,0.473650049287869,0,7,molybdopterin cofactor biosynthetic process,BP,
7794,GO:0032351,1,0.451358624966492,0,7,negative regulation of hormone metabolic process,BP,
7796,GO:0032353,1,0.451358624966492,0,7,negative regulation of hormone biosynthetic process,BP,
7803,GO:0032364,1,0.579559987284371,0,5,oxygen homeostasis,BP,
7864,GO:0032433,1,0.238673961329054,0,12,filopodium tip,CC,
7874,GO:0032449,1,0.571174087816387,0,5,CBM complex,CC,
7878,GO:0032453,1,0.471963982939387,0,6,histone demethylase activity (H3-K4 specific),MF,
7884,GO:0032460,1,0.246487612588025,0,13,negative regulation of protein oligomerization,BP,
7887,GO:0032463,1,0.322743937019011,0,11,negative regulation of protein homooligomerization,BP,
7888,GO:0032464,1,0.549816378100312,0,6,positive regulation of protein homooligomerization,BP,
7890,GO:0032466,1,0.529243647068118,0,6,negative regulation of cytokinesis,BP,
7893,GO:0032469,1,0.11343596820289,0,20,endoplasmic reticulum calcium ion homeostasis,BP,
7895,GO:0032471,1,0.513533393764113,0,7,negative regulation of endoplasmic reticulum calcium ion concentration,BP,
7911,GO:0032494,1,0.563825765208862,0,5,response to peptidoglycan,BP,
7924,GO:0032509,1,0.116683935332565,0,20,endosome transport via multivesicular body sorting pathway,BP,
7925,GO:0032510,1,0.501582207792144,0,6,endosome to lysosome transport via multivesicular body sorting pathway,BP,
7926,GO:0032511,1,0.455228389620337,0,8,late endosome to vacuole transport via multivesicular body sorting pathway,BP,
7937,GO:0032536,1,0.519423025406251,0,6,regulation of cell projection size,BP,
7938,GO:0032541,1,0.591490515643567,0,5,cortical endoplasmic reticulum,CC,
7945,GO:0032552,1,0.570507303252995,0,6,deoxyribonucleotide binding,MF,
7969,GO:0032591,1,0.480156188789612,0,6,dendritic spine membrane,CC,
7970,GO:0032592,1,0.00140101343579756,0,65,integral component of mitochondrial membrane,CC,
7971,GO:0032593,1,0.524548908700448,0,6,insulin-responsive compartment,CC,
7979,GO:0032604,1,0.431436255915913,0,8,granulocyte macrophage colony-stimulating factor production,BP,
7984,GO:0032610,1,0.590324209186484,0,6,interleukin-1 alpha production,BP,
7991,GO:0032620,1,0.273273121234612,0,13,interleukin-17 production,BP,
7992,GO:0032621,1,0.508545924028514,0,6,interleukin-18 production,BP,
7995,GO:0032627,1,0.615064846901637,0,5,interleukin-23 production,BP,
8005,GO:0032645,1,0.431436255915913,0,8,regulation of granulocyte macrophage colony-stimulating factor production,BP,
8009,GO:0032650,1,0.619888330894182,0,5,regulation of interleukin-1 alpha production,BP,
8016,GO:0032660,1,0.330772952674696,0,11,regulation of interleukin-17 production,BP,
8017,GO:0032661,1,0.573882897524106,0,5,regulation of interleukin-18 production,BP,
8019,GO:0032667,1,0.615064846901637,0,5,regulation of interleukin-23 production,BP,
8038,GO:0032700,1,0.596993008891576,0,5,negative regulation of interleukin-17 production,BP,
8049,GO:0032725,1,0.481955025798506,0,7,positive regulation of granulocyte macrophage colony-stimulating factor production,BP,
8057,GO:0032735,1,0.156982417743676,0,18,positive regulation of interleukin-12 production,BP,
8058,GO:0032736,1,0.469087722902243,0,7,positive regulation of interleukin-13 production,BP,
8060,GO:0032740,1,0.499429124279891,0,7,positive regulation of interleukin-17 production,BP,
8062,GO:0032743,1,0.122067948112856,0,19,positive regulation of interleukin-2 production,BP,
8066,GO:0032754,1,0.453474271308951,0,7,positive regulation of interleukin-5 production,BP,
8077,GO:0032769,1,0.477514961383548,0,7,negative regulation of monooxygenase activity,BP,
8085,GO:0032780,1,0.472231184594308,0,7,negative regulation of ATPase activity,BP,
8095,GO:0032790,1,0.430484478440255,0,8,ribosome disassembly,BP,
8101,GO:0032797,1,0.316501009209127,0,11,SMN complex,CC,
8116,GO:0032814,1,0.153338683296457,0,18,regulation of natural killer cell activation,BP,
8117,GO:0032815,1,0.619638227832721,0,5,negative regulation of natural killer cell activation,BP,
8118,GO:0032816,1,0.281205001954058,0,12,positive regulation of natural killer cell activation,BP,
8121,GO:0032823,1,0.373728719134966,0,9,regulation of natural killer cell differentiation,BP,
8123,GO:0032825,1,0.45946196755481,0,7,positive regulation of natural killer cell differentiation,BP,
8154,GO:0032897,1,0.106020685216371,0,21,negative regulation of viral transcription,BP,
8159,GO:0032905,1,0.501635140713275,0,6,transforming growth factor beta1 production,BP,
8160,GO:0032906,1,0.478795866968716,0,6,transforming growth factor beta2 production,BP,
8162,GO:0032908,1,0.501635140713275,0,6,regulation of transforming growth factor beta1 production,BP,
8163,GO:0032909,1,0.478795866968716,0,6,regulation of transforming growth factor beta2 production,BP,
8178,GO:0032926,1,0.45987899995869,0,7,negative regulation of activin receptor signaling pathway,BP,
8195,GO:0032957,1,0.387091113673792,0,8,inositol trisphosphate metabolic process,BP,
8197,GO:0032959,1,0.491722370815449,0,6,inositol trisphosphate biosynthetic process,BP,
8215,GO:0032986,1,0.145204239075373,0,18,protein-DNA complex disassembly,BP,
8216,GO:0032988,1,0.254673340327945,0,13,ribonucleoprotein complex disassembly,BP,
8241,GO:0033029,1,0.569886532786662,0,5,regulation of neutrophil apoptotic process,BP,
8246,GO:0033034,1,0.532050830027142,0,6,positive regulation of myeloid cell apoptotic process,BP,
8249,GO:0033038,1,0.630876883033208,0,6,bitter taste receptor activity,MF,
8259,GO:0033061,1,0.399951841999551,0,9,DNA recombinase mediator complex,CC,
8260,GO:0033063,1,0.495097904224992,0,7,Rad51B-Rad51C-Rad51D-XRCC2 complex,CC,
8301,GO:0033145,1,0.25796166365153,0,13,positive regulation of intracellular steroid hormone receptor signaling pathway,BP,
8303,GO:0033147,1,0.344475153110667,0,9,negative regulation of intracellular estrogen receptor signaling pathway,BP,
8304,GO:0033148,1,0.40603806292288,0,8,positive regulation of intracellular estrogen receptor signaling pathway,BP,
8312,GO:0033160,1,0.339996346640455,0,9,positive regulation of protein import into nucleus, translocation,BP,
8317,GO:0033170,1,0.432378220114985,0,8,protein-DNA loading ATPase activity,MF,
8321,GO:0033178,1,0.375869967956815,0,10,proton-transporting two-sector ATPase complex, catalytic domain,CC,
8323,GO:0033180,1,0.453917313322156,0,8,proton-transporting V-type ATPase, V1 domain,CC,
8325,GO:0033182,1,0.314378221961278,0,10,regulation of histone ubiquitination,BP,
8327,GO:0033184,1,0.559285035754542,0,5,positive regulation of histone ubiquitination,BP,
8332,GO:0033192,1,0.549906095517312,0,5,calmodulin-dependent protein phosphatase activity,MF,
8336,GO:0033202,1,0.225160065160527,0,15,DNA helicase complex,CC,
8342,GO:0033216,1,0.57353809565193,0,5,ferric iron import,BP,
8349,GO:0033238,1,0.00414247026445513,0,59,regulation of cellular amine metabolic process,BP,
8351,GO:0033240,1,0.494675326166887,0,7,positive regulation of cellular amine metabolic process,BP,
8354,GO:0033256,1,0.47713094314929,0,7,I-kappaB/NF-kappaB complex,CC,
8367,GO:0033276,1,0.229197014742285,0,14,transcription factor TFTC complex,CC,
8378,GO:0033299,1,0.586112228332163,0,5,secretion of lysosomal enzymes,BP,
8382,GO:0033313,1,0.576471789730876,0,5,meiotic cell cycle checkpoint,BP,
8383,GO:0033314,1,0.418348071974011,0,8,mitotic DNA replication checkpoint,BP,
8388,GO:0033327,1,0.510456377280513,0,6,Leydig cell differentiation,BP,
8404,GO:0033391,1,0.493670599308424,0,6,chromatoid body,CC,
8406,GO:0033483,1,0.429233204690809,0,8,gas homeostasis,BP,
8418,GO:0033523,1,0.253667515105164,0,12,histone H2B ubiquitination,BP,
8422,GO:0033549,1,0.247589962788456,0,13,MAP kinase phosphatase activity,MF,
8441,GO:0033588,1,0.59292821939842,0,5,Elongator holoenzyme complex,CC,
8444,GO:0033592,1,0.557321054384509,0,5,RNA strand annealing activity,MF,
8450,GO:0033599,1,0.155839399521299,0,17,regulation of mammary gland epithelial cell proliferation,BP,
8452,GO:0033601,1,0.383965164486187,0,8,positive regulation of mammary gland epithelial cell proliferation,BP,
8456,GO:0033605,1,0.597757938997648,0,5,positive regulation of catecholamine secretion,BP,
8463,GO:0033617,1,0.146402572205434,0,20,mitochondrial respiratory chain complex IV assembly,BP,
8465,GO:0033622,1,0.272157191736991,0,11,integrin activation,BP,
8466,GO:0033623,1,0.497795496439136,0,6,regulation of integrin activation,BP,
8471,GO:0033629,1,0.461698744333421,0,7,negative regulation of cell adhesion mediated by integrin,BP,
8477,GO:0033643,1,0.349598546315848,0,9,host cell part,CC,
8479,GO:0033646,1,0.448654019947903,0,7,host intracellular part,CC,
8480,GO:0033647,1,0.566734896102092,0,5,host intracellular organelle,CC,
8481,GO:0033648,1,0.566734896102092,0,5,host intracellular membrane-bounded organelle,CC,
8500,GO:0033690,1,0.497592781794179,0,6,positive regulation of osteoblast proliferation,BP,
8512,GO:0033750,1,0.299084603990651,0,13,ribosome localization,BP,
8544,GO:0033962,1,0.119905937499762,0,18,cytoplasmic mRNA processing body assembly,BP,
8559,GO:0034036,1,0.509882144844813,0,6,purine ribonucleoside bisphosphate biosynthetic process,BP,
8576,GO:0034085,1,0.450912805099579,0,7,establishment of sister chromatid cohesion,BP,
8582,GO:0034093,1,0.591887389081841,0,5,positive regulation of maintenance of sister chromatid cohesion,BP,
8584,GO:0034098,1,0.357650679954097,0,9,VCP-NPL4-UFD1 AAA ATPase complex,CC,
8617,GO:0034145,1,0.580687209254417,0,5,positive regulation of toll-like receptor 4 signaling pathway,BP,
8632,GO:0034184,1,0.591887389081841,0,5,positive regulation of maintenance of mitotic sister chromatid cohesion,BP,
8645,GO:0034204,1,0.145926933424136,0,15,lipid translocation,BP,
8649,GO:0034214,1,0.399474415615642,0,8,protein hexamerization,BP,
8653,GO:0034227,1,0.605527909937088,0,5,tRNA thio-modification,BP,
8655,GO:0034236,1,0.3004389505445,0,11,protein kinase A catalytic subunit binding,MF,
8679,GO:0034311,1,0.188425129690525,0,17,diol metabolic process,BP,
8680,GO:0034312,1,0.228248704901646,0,15,diol biosynthetic process,BP,
8682,GO:0034315,1,0.204073229089223,0,14,regulation of Arp2/3 complex-mediated actin nucleation,BP,
8698,GO:0034350,1,0.449290003299507,0,7,regulation of glial cell apoptotic process,BP,
8699,GO:0034351,1,0.449290003299507,0,7,negative regulation of glial cell apoptotic process,BP,
8720,GO:0034379,1,0.548255539863321,0,6,very-low-density lipoprotein particle assembly,BP,
8728,GO:0034388,1,0.512177722550684,0,6,Pwp2p-containing subcomplex of 90S preribosome,CC,
8748,GO:0034427,1,0.400586041147852,0,10,nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5',BP,
8763,GO:0034452,1,0.292460821807845,0,10,dynactin binding,MF,
8764,GO:0034453,1,0.0643197049917154,0,23,microtubule anchoring,BP,
8765,GO:0034454,1,0.327940971522451,0,9,microtubule anchoring at centrosome,BP,
8776,GO:0034471,1,0.162447733674366,0,19,ncRNA 5'-end processing,BP,
8777,GO:0034472,1,0.24897406689509,0,14,snRNA 3'-end processing,BP,
8780,GO:0034475,1,0.50780096885046,0,8,U4 snRNA 3'-end processing,BP,
8789,GO:0034501,1,0.185892348353048,0,16,protein localization to kinetochore,BP,
8795,GO:0034511,1,0.53076639019246,0,6,U3 snoRNA binding,MF,
8797,GO:0034513,1,0.687767505722532,0,5,box H/ACA snoRNA binding,MF,
8799,GO:0034518,1,0.270030919085223,0,12,RNA cap binding complex,CC,
8805,GO:0034587,1,0.4125105205103,0,8,piRNA metabolic process,BP,
8808,GO:0034593,1,0.0623062167807125,0,23,phosphatidylinositol bisphosphate phosphatase activity,MF,
8811,GO:0034596,1,0.378050609598362,0,8,phosphatidylinositol phosphate 4-phosphatase activity,MF,
8815,GO:0034603,1,0.576838124275385,0,5,pyruvate dehydrogenase [NAD(P)+] activity,MF,
8816,GO:0034604,1,0.576838124275385,0,5,pyruvate dehydrogenase (NAD+) activity,MF,
8826,GO:0034625,1,0.584514507810071,0,5,fatty acid elongation, monounsaturated fatty acid,BP,
8827,GO:0034626,1,0.584514507810071,0,5,fatty acid elongation, polyunsaturated fatty acid,BP,
8830,GO:0034629,1,0.110885569164246,0,20,cellular protein-containing complex localization,BP,
8834,GO:0034638,1,0.56590400760773,0,6,phosphatidylcholine catabolic process,BP,
8853,GO:0034663,1,0.439898833359009,0,8,endoplasmic reticulum chaperone complex,CC,
8882,GO:0034709,1,0.380862145724153,0,12,methylosome,CC,
8884,GO:0034713,1,0.412074553235179,0,8,type I transforming growth factor beta receptor binding,MF,
8886,GO:0034715,1,0.616258692944333,0,6,pICln-Sm protein complex,CC,
8888,GO:0034719,1,0.237404426214568,0,16,SMN-Sm protein complex,CC,
8889,GO:0034720,1,0.471963982939387,0,6,histone H3-K4 demethylation,BP,
8892,GO:0034723,1,0.168892130632262,0,32,DNA replication-dependent nucleosome organization,BP,
8929,GO:0034975,1,0.214312377950408,0,14,protein folding in endoplasmic reticulum,BP,
8932,GO:0034982,1,0.371270786246485,0,10,mitochondrial protein processing,BP,
8933,GO:0034983,1,0.4940699865665,0,6,peptidyl-lysine deacetylation,BP,
8945,GO:0035020,1,0.176673550767737,0,15,regulation of Rac protein signal transduction,BP,
8949,GO:0035024,1,0.136110440515246,0,17,negative regulation of Rho protein signal transduction,BP,
8966,GO:0035067,1,0.20853956396802,0,14,negative regulation of histone acetylation,BP,
8972,GO:0035090,1,0.574259170991434,0,5,maintenance of apical/basal cell polarity,BP,
8998,GO:0035173,1,0.210389239793681,0,14,histone kinase activity,MF,
8999,GO:0035174,1,0.52208093318222,0,6,histone serine kinase activity,MF,
9008,GO:0035197,1,0.344275404547443,0,9,siRNA binding,MF,
9025,GO:0035251,1,0.468130891905877,0,7,UDP-glucosyltransferase activity,MF,
9027,GO:0035253,1,0.350236075388935,0,9,ciliary rootlet,CC,
9033,GO:0035259,1,0.280654684188011,0,11,glucocorticoid receptor binding,MF,
9038,GO:0035267,1,0.132683769981436,0,19,NuA4 histone acetyltransferase complex,CC,
9040,GO:0035269,1,0.31199015888904,0,12,protein O-linked mannosylation,BP,
9061,GO:0035312,1,0.507629087787012,0,6,5'-3' exodeoxyribonuclease activity,MF,
9062,GO:0035313,1,0.209132412857987,0,13,wound healing, spreading of epidermal cells,BP,
9064,GO:0035325,1,0.462462399826901,0,8,Toll-like receptor binding,MF,
9066,GO:0035327,1,0.125142490390011,0,20,transcriptionally active chromatin,CC,
9071,GO:0035333,1,0.264593566994869,0,12,Notch receptor processing, ligand-dependent,BP,
9082,GO:0035356,1,0.606963575452145,0,5,cellular triglyceride homeostasis,BP,
9091,GO:0035372,1,0.220043717064874,0,13,protein localization to microtubule,BP,
9094,GO:0035376,1,0.588935996520231,0,5,sterol import,BP,
9112,GO:0035434,1,0.521795795558034,0,6,copper ion transmembrane transport,BP,
9114,GO:0035437,1,0.303885650749588,0,11,maintenance of protein localization in endoplasmic reticulum,BP,
9122,GO:0035457,1,0.350776347374831,0,9,cellular response to interferon-alpha,BP,
9124,GO:0035459,1,0.0974918172678904,0,20,cargo loading into vesicle,BP,
9125,GO:0035461,1,0.406034067236416,0,8,vitamin transmembrane transport,BP,
9136,GO:0035497,1,0.293201263633649,0,11,cAMP response element binding,MF,
9143,GO:0035507,1,0.529775142712199,0,5,regulation of myosin-light-chain-phosphatase activity,BP,
9147,GO:0035511,1,0.605554517948425,0,5,oxidative DNA demethylation,BP,
9175,GO:0035563,1,0.272258540538598,0,12,positive regulation of chromatin binding,BP,
9215,GO:0035613,1,0.185088460616189,0,15,RNA stem-loop binding,MF,
9241,GO:0035655,1,0.609904857628777,0,5,interleukin-18-mediated signaling pathway,BP,
9248,GO:0035666,1,0.081647988387304,0,24,TRIF-dependent toll-like receptor signaling pathway,BP,
9274,GO:0035723,1,0.395058991652687,0,8,interleukin-15-mediated signaling pathway,BP,
9291,GO:0035748,1,0.491041641062604,0,6,myelin sheath abaxonal region,CC,
9292,GO:0035749,1,0.566485790295987,0,5,myelin sheath adaxonal region,CC,
9294,GO:0035751,1,0.347335182793123,0,11,regulation of lysosomal lumen pH,BP,
9312,GO:0035795,1,0.627260458190507,0,5,negative regulation of mitochondrial membrane permeability,BP,
9318,GO:0035809,1,0.421338189288138,0,8,regulation of urine volume,BP,
9319,GO:0035810,1,0.573115643049775,0,5,positive regulation of urine volume,BP,
9359,GO:0035890,1,0.026408328357795,0,33,exit from host,BP,
9360,GO:0035891,1,0.026408328357795,0,33,exit from host cell,BP,
9367,GO:0035907,1,0.568794339129895,0,5,dorsal aorta development,BP,
9394,GO:0035964,1,0.519570625306458,0,6,COPI-coated vesicle budding,BP,
9395,GO:0035965,1,0.578572675618247,0,5,cardiolipin acyl-chain remodeling,BP,
9398,GO:0035970,1,0.196733045838411,0,15,peptidyl-threonine dephosphorylation,BP,
9401,GO:0035976,1,0.617596989156269,0,5,transcription factor AP-1 complex,CC,
9410,GO:0035988,1,0.443047053119727,0,7,chondrocyte proliferation,BP,
9431,GO:0036020,1,0.258953498136281,0,12,endolysosome membrane,CC,
9489,GO:0036148,1,0.281934552980868,0,11,phosphatidylglycerol acyl-chain remodeling,BP,
9490,GO:0036149,1,0.460473854041811,0,7,phosphatidylinositol acyl-chain remodeling,BP,
9495,GO:0036155,1,0.573564940412662,0,5,acylglycerol acyl-chain remodeling,BP,
9498,GO:0036158,1,0.525692521227416,0,6,outer dynein arm assembly,BP,
9519,GO:0036260,1,0.0367610543102195,0,33,RNA capping,BP,
9535,GO:0036302,1,0.5421960245035,0,5,atrioventricular canal development,BP,
9536,GO:0036303,1,0.18885209460238,0,14,lymph vessel morphogenesis,BP,
9555,GO:0036353,1,0.413155869236922,0,8,histone H2A-K119 monoubiquitination,BP,
9563,GO:0036376,1,0.44246633200246,0,7,sodium ion export across plasma membrane,BP,
9572,GO:0036402,1,0.576073702433359,0,6,proteasome-activating ATPase activity,MF,
9580,GO:0036444,1,0.413544171171055,0,8,calcium import into the mitochondrion,BP,
9581,GO:0036445,1,0.298427788716674,0,10,neuronal stem cell division,BP,
9583,GO:0036449,1,0.419172742826721,0,7,microtubule minus-end,CC,
9592,GO:0036462,1,0.480988964272666,0,7,TRAIL-activated apoptotic signaling pathway,BP,
9605,GO:0036481,1,0.558932768480886,0,6,intrinsic apoptotic signaling pathway in response to hydrogen peroxide,BP,
9612,GO:0036490,1,0.392590454569911,0,8,regulation of translation in response to endoplasmic reticulum stress,BP,
9613,GO:0036491,1,0.439925588848006,0,7,regulation of translation initiation in response to endoplasmic reticulum stress,BP,
9614,GO:0036492,1,0.488500170476957,0,6,eiF2alpha phosphorylation in response to endoplasmic reticulum stress,BP,
9620,GO:0036499,1,0.1435091323631,0,18,PERK-mediated unfolded protein response,BP,
9621,GO:0036500,1,0.342988360679056,0,10,ATF6-mediated unfolded protein response,BP,
9633,GO:0036513,1,0.327443555622763,0,10,Derlin-1 retrotranslocation complex,CC,
9634,GO:0036514,1,0.536068185064916,0,5,dopaminergic neuron axon guidance,BP,
9663,GO:0038036,1,0.5173798971637,0,6,sphingosine-1-phosphate receptor activity,MF,
9674,GO:0038063,1,0.410411989738635,0,7,collagen-activated tyrosine kinase receptor signaling pathway,BP,
9682,GO:0038089,1,0.578457998626905,0,5,positive regulation of cell migration by vascular endothelial growth factor signaling pathway,BP,
9694,GO:0038110,1,0.429839194649708,0,7,interleukin-2-mediated signaling pathway,BP,
9708,GO:0038155,1,0.51723979802956,0,6,interleukin-23-mediated signaling pathway,BP,
9718,GO:0038180,1,0.401100740847905,0,8,nerve growth factor signaling pathway,BP,
9722,GO:0038187,1,0.478376854238182,0,7,pattern recognition receptor activity,MF,
9785,GO:0040016,1,0.452418697145935,0,7,embryonic cleavage,BP,
9789,GO:0040020,1,0.169130630799441,0,16,regulation of meiotic nuclear division,BP,
9792,GO:0040031,1,0.60098058303048,0,6,snRNA modification,BP,
9810,GO:0042033,1,0.444158310835812,0,8,chemokine biosynthetic process,BP,
9815,GO:0042044,1,0.280416257519134,0,12,fluid transport,BP,
9816,GO:0042045,1,0.592132829896094,0,5,epithelial fluid transport,BP,
9817,GO:0042048,1,0.541429001331681,0,5,olfactory behavior,BP,
9818,GO:0042053,1,0.386100286476436,0,9,regulation of dopamine metabolic process,BP,
9825,GO:0042069,1,0.386100286476436,0,9,regulation of catecholamine metabolic process,BP,
9827,GO:0042074,1,0.469046477180907,0,6,cell migration involved in gastrulation,BP,
9833,GO:0042090,1,0.56253765685752,0,5,interleukin-12 biosynthetic process,BP,
9837,GO:0042094,1,0.345786872523981,0,10,interleukin-2 biosynthetic process,BP,
9842,GO:0042101,1,0.454348902788063,0,7,T cell receptor complex,CC,
9844,GO:0042104,1,0.207804852623581,0,16,positive regulation of activated T cell proliferation,BP,
9852,GO:0042117,1,0.568641785630355,0,5,monocyte activation,BP,
9876,GO:0042166,1,0.578395505630174,0,5,acetylcholine binding,MF,
9904,GO:0042255,1,0.00977744068761481,0,54,ribosome assembly,BP,
9905,GO:0042256,1,0.605344800150969,0,5,mature ribosome assembly,BP,
9906,GO:0042262,1,0.666436646077781,0,5,DNA protection,BP,
9909,GO:0042267,1,0.0298341158476671,0,34,natural killer cell mediated cytotoxicity,BP,
9910,GO:0042268,1,0.597673407806675,0,6,regulation of cytolysis,BP,
9911,GO:0042269,1,0.175334484828782,0,16,regulation of natural killer cell mediated cytotoxicity,BP,
9915,GO:0042273,1,0.00237496487083003,0,67,ribosomal large subunit biogenesis,BP,
9916,GO:0042274,1,0.00156031564480569,0,70,ribosomal small subunit biogenesis,BP,
9918,GO:0042276,1,0.142077524372347,0,19,error-prone translesion synthesis,BP,
9931,GO:0042301,1,0.52279143001531,0,6,phosphate ion binding,MF,
9955,GO:0042354,1,0.499406801558661,0,6,L-fucose metabolic process,BP,
9956,GO:0042355,1,0.499406801558661,0,6,L-fucose catabolic process,BP,
9972,GO:0042382,1,0.508478803060038,0,6,paraspeckles,CC,
9975,GO:0042392,1,0.599595287597937,0,5,sphingosine-1-phosphate phosphatase activity,MF,
9978,GO:0042401,1,0.274011625502323,0,13,cellular biogenic amine biosynthetic process,BP,
9983,GO:0042407,1,0.230504055980295,0,15,cristae formation,BP,
9993,GO:0042424,1,0.5859529636718,0,5,catecholamine catabolic process,BP,
9996,GO:0042430,1,0.41827879845572,0,8,indole-containing compound metabolic process,BP,
9999,GO:0042439,1,0.578199052267151,0,5,ethanolamine-containing compound metabolic process,BP,
10015,GO:0042473,1,0.524946268166855,0,6,outer ear morphogenesis,BP,
10019,GO:0042481,1,0.295007298377145,0,11,regulation of odontogenesis,BP,
10020,GO:0042482,1,0.587078120838153,0,5,positive regulation of odontogenesis,BP,
10022,GO:0042487,1,0.579106944935553,0,5,regulation of odontogenesis of dentin-containing tooth,BP,
10036,GO:0042532,1,0.306361845290741,0,11,negative regulation of tyrosine phosphorylation of STAT protein,BP,
10037,GO:0042533,1,0.421342882923788,0,8,tumor necrosis factor biosynthetic process,BP,
10038,GO:0042534,1,0.421342882923788,0,8,regulation of tumor necrosis factor biosynthetic process,BP,
10044,GO:0042541,1,0.521866315790949,0,6,hemoglobin biosynthetic process,BP,
10053,GO:0042559,1,0.261267110245932,0,14,pteridine-containing compound biosynthetic process,BP,
10064,GO:0042577,1,0.473541498842452,0,7,lipid phosphatase activity,MF,
10069,GO:0042583,1,0.565632005986206,0,5,chromaffin granule,CC,
10073,GO:0042587,1,0.571956869869441,0,5,glycogen granule,CC,
10086,GO:0042609,1,0.593673244651568,0,5,CD4 receptor binding,MF,
10091,GO:0042622,1,0.487841602726518,0,6,photoreceptor outer segment membrane,CC,
10098,GO:0042629,1,0.353057152258368,0,10,mast cell granule,CC,
10103,GO:0042635,1,0.36016311888301,0,10,positive regulation of hair cycle,BP,
10121,GO:0042693,1,0.527793867794025,0,6,muscle cell fate commitment,BP,
10131,GO:0042719,1,0.666705951067492,0,5,mitochondrial intermembrane space protein transporter complex,CC,
10133,GO:0042721,1,0.645291805375584,0,5,mitochondrial inner membrane protein insertion complex,CC,
10159,GO:0042760,1,0.584175051410318,0,5,very long-chain fatty acid catabolic process,BP,
10160,GO:0042761,1,0.352445425425396,0,10,very long-chain fatty acid biosynthetic process,BP,
10162,GO:0042765,1,0.582554533611244,0,5,GPI-anchor transamidase complex,CC,
10173,GO:0042780,1,0.493288691717538,0,7,tRNA 3'-end processing,BP,
10175,GO:0042788,1,0.12995238963632,0,29,polysomal ribosome,CC,
10177,GO:0042790,1,0.269282889791297,0,12,nucleolar large rRNA transcription by RNA polymerase I,BP,
10178,GO:0042791,1,0.522904290749992,0,6,5S class rRNA transcription by RNA polymerase III,BP,
10179,GO:0042795,1,0.00094433680311863,0,67,snRNA transcription by RNA polymerase II,BP,
10180,GO:0042796,1,0.516123677443056,0,6,snRNA transcription by RNA polymerase III,BP,
10181,GO:0042797,1,0.522904290749992,0,6,tRNA transcription by RNA polymerase III,BP,
10200,GO:0042834,1,0.470914638273463,0,7,peptidoglycan binding,MF,
10208,GO:0042887,1,0.0527286973234095,0,29,amide transmembrane transporter activity,MF,
10230,GO:0042976,1,0.486380031105536,0,7,activation of Janus kinase activity,BP,
10237,GO:0042985,1,0.526366450527177,0,6,negative regulation of amyloid precursor protein biosynthetic process,BP,
10244,GO:0042996,1,0.560240953618497,0,5,regulation of Golgi to plasma membrane protein transport,BP,
10257,GO:0043011,1,0.391073951877894,0,9,myeloid dendritic cell differentiation,BP,
10263,GO:0043023,1,0.326706662211296,0,11,ribosomal large subunit binding,MF,
10264,GO:0043024,1,0.222553436867239,0,14,ribosomal small subunit binding,MF,
10271,GO:0043032,1,0.271422203332953,0,12,positive regulation of macrophage activation,BP,
10280,GO:0043045,1,0.497883496904923,0,6,DNA methylation involved in embryo development,BP,
10281,GO:0043046,1,0.459410653683997,0,7,DNA methylation involved in gamete generation,BP,
10301,GO:0043096,1,0.64028816269963,0,5,purine nucleobase salvage,BP,
10303,GO:0043101,1,0.272365559429022,0,13,purine-containing compound salvage,BP,
10304,GO:0043102,1,0.537383875613078,0,6,amino acid salvage,BP,
10321,GO:0043129,1,0.556967449832134,0,5,surfactant homeostasis,BP,
10328,GO:0043139,1,0.468697987024025,0,7,5'-3' DNA helicase activity,MF,
10330,GO:0043141,1,0.589141150606727,0,5,ATP-dependent 5'-3' DNA helicase activity,MF,
10331,GO:0043142,1,0.237380273096706,0,13,single-stranded DNA-dependent ATPase activity,MF,
10332,GO:0043144,1,0.504881928044113,0,8,snoRNA processing,BP,
10356,GO:0043186,1,0.486605653701281,0,7,P granule,CC,
10357,GO:0043189,1,0.132683769981436,0,19,H4/H2A histone acetyltransferase complex,CC,
10368,GO:0043203,1,0.549389623473768,0,6,axon hillock,CC,
10376,GO:0043220,1,0.399937336675225,0,8,Schmidt-Lanterman incisure,CC,
10379,GO:0043225,1,0.368610107150069,0,8,ATPase-coupled anion transmembrane transporter activity,MF,
10391,GO:0043240,1,0.295824862339768,0,11,Fanconi anaemia nuclear complex,CC,
10395,GO:0043247,1,0.229426520270109,0,13,telomere maintenance in response to DNA damage,BP,
10400,GO:0043252,1,0.314885063590047,0,10,sodium-independent organic anion transport,BP,
10430,GO:0043301,1,0.562710515023883,0,5,negative regulation of leukocyte degranulation,BP,
10447,GO:0043320,1,0.513723401548131,0,6,natural killer cell degranulation,BP,
10451,GO:0043325,1,0.148693067906407,0,17,phosphatidylinositol-3,4-bisphosphate binding,MF,
10457,GO:0043353,1,0.479425738874332,0,6,enucleate erythrocyte differentiation,BP,
10463,GO:0043370,1,0.144862149244271,0,18,regulation of CD4-positive, alpha-beta T cell differentiation,BP,
10464,GO:0043371,1,0.31835186682609,0,10,negative regulation of CD4-positive, alpha-beta T cell differentiation,BP,
10465,GO:0043372,1,0.368992797865844,0,10,positive regulation of CD4-positive, alpha-beta T cell differentiation,BP,
10467,GO:0043374,1,0.56586349861129,0,5,CD8-positive, alpha-beta T cell differentiation,BP,
10470,GO:0043379,1,0.587499123720664,0,5,memory T cell differentiation,BP,
10509,GO:0043455,1,0.400448550720771,0,8,regulation of secondary metabolic process,BP,
10517,GO:0043471,1,0.382806795759059,0,9,regulation of cellular carbohydrate catabolic process,BP,
10532,GO:0043496,1,0.126380051320544,0,20,regulation of protein homodimerization activity,BP,
10535,GO:0043501,1,0.28073157268649,0,11,skeletal muscle adaptation,BP,
10546,GO:0043517,1,0.303408821358968,0,11,positive regulation of DNA damage response, signal transduction by p53 class mediator,BP,
10549,GO:0043522,1,0.35365647514306,0,10,leucine zipper domain binding,MF,
10553,GO:0043527,1,0.608682633938929,0,5,tRNA methyltransferase complex,CC,
10567,GO:0043545,1,0.473650049287869,0,7,molybdopterin cofactor metabolic process,BP,
10568,GO:0043546,1,0.498048210943412,0,6,molybdopterin cofactor binding,MF,
10580,GO:0043562,1,0.391613737731856,0,10,cellular response to nitrogen levels,BP,
10616,GO:0043628,1,0.0723359679833805,0,27,ncRNA 3'-end processing,BP,
10619,GO:0043631,1,0.00952941186147472,0,41,RNA polyadenylation,BP,
10621,GO:0043633,1,0.446102903765644,0,8,polyadenylation-dependent RNA catabolic process,BP,
10622,GO:0043634,1,0.505957948048873,0,7,polyadenylation-dependent ncRNA catabolic process,BP,
10628,GO:0043652,1,0.440455861115966,0,8,engulfment of apoptotic cell,BP,
10629,GO:0043653,1,0.477648749744467,0,8,mitochondrial fragmentation involved in apoptotic process,BP,
10631,GO:0043656,1,0.448654019947903,0,7,intracellular region of host,CC,
10648,GO:0043813,1,0.535921145361153,0,5,phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity,MF,
10661,GO:0043921,1,0.0692947557648821,0,24,modulation by host of viral transcription,BP,
10662,GO:0043922,1,0.34267787263151,0,10,negative regulation by host of viral transcription,BP,
10663,GO:0043923,1,0.161145672841686,0,16,positive regulation by host of viral transcription,BP,
10664,GO:0043928,1,0.0401315515533462,0,33,exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay,BP,
10676,GO:0043968,1,0.181908973802998,0,16,histone H2A acetylation,BP,
10685,GO:0043984,1,0.11585046175431,0,19,histone H4-K16 acetylation,BP,
10686,GO:0043985,1,0.53049539553246,0,6,histone H4-R3 methylation,BP,
10691,GO:0043995,1,0.322682629749116,0,10,histone acetyltransferase activity (H4-K5 specific),MF,
10692,GO:0043996,1,0.322682629749116,0,10,histone acetyltransferase activity (H4-K8 specific),MF,
10701,GO:0044030,1,0.19381291606954,0,14,regulation of DNA methylation,BP,
10713,GO:0044068,1,0.0677586006156047,0,24,modulation by symbiont of host cellular process,BP,
10741,GO:0044154,1,0.464325522454506,0,7,histone H3-K14 acetylation,BP,
10765,GO:0044233,1,0.263178497424357,0,12,ER-mitochondrion membrane contact site,CC,
10793,GO:0044292,1,0.330276184050636,0,10,dendrite terminus,CC,
10794,GO:0044294,1,0.435635932096917,0,7,dendritic growth cone,CC,
10812,GO:0044319,1,0.0582857980882418,0,25,wound healing, spreading of cells,BP,
10844,GO:0044359,1,0.531582165831282,0,6,modulation of molecular function in other organism,BP,
10845,GO:0044362,1,0.604697273612893,0,5,negative regulation of molecular function in other organism,BP,
10846,GO:0044364,1,0.250945853046261,0,18,disruption of cells of other organism,BP,
10852,GO:0044388,1,0.638579150689809,0,5,small protein activating enzyme binding,MF,
10854,GO:0044390,1,0.0240403289270935,0,33,ubiquitin-like protein conjugating enzyme binding,MF,
10866,GO:0044417,1,0.400984906911443,0,9,translocation of molecules into host,BP,
10908,GO:0044531,1,0.537391555905436,0,6,modulation of programmed cell death in other organism,BP,
10909,GO:0044532,1,0.537391555905436,0,6,modulation of apoptotic process in other organism,BP,
10913,GO:0044545,1,0.590222979148693,0,5,NSL complex,CC,
10914,GO:0044546,1,0.355360894871651,0,9,NLRP3 inflammasome complex assembly,BP,
10915,GO:0044547,1,0.569031023961225,0,5,DNA topoisomerase binding,MF,
10974,GO:0044784,1,0.00577093159218653,0,48,metaphase/anaphase transition of cell cycle,BP,
10978,GO:0044789,1,0.552866592537256,0,5,modulation by host of viral release from host cell,BP,
10979,GO:0044791,1,0.552866592537256,0,5,positive regulation by host of viral release from host cell,BP,
10987,GO:0044804,1,0.136529880516306,0,18,autophagy of nucleus,BP,
10994,GO:0044827,1,0.255918652192809,0,12,modulation by host of viral genome replication,BP,
10996,GO:0044829,1,0.452392186887094,0,7,positive regulation by host of viral genome replication,BP,
10998,GO:0044837,1,0.441709425733647,0,7,actomyosin contractile ring organization,BP,
11002,GO:0044849,1,0.378483219662717,0,9,estrous cycle,BP,
11017,GO:0045003,1,0.359890674928322,0,10,double-strand break repair via synthesis-dependent strand annealing,BP,
11022,GO:0045008,1,0.45237006168077,0,8,depyrimidination,BP,
11036,GO:0045039,1,0.619773754362079,0,6,protein import into mitochondrial inner membrane,BP,
11037,GO:0045040,1,0.596457044619287,0,6,protein import into mitochondrial outer membrane,BP,
11039,GO:0045046,1,0.514801104116857,0,6,protein import into peroxisome membrane,BP,
11040,GO:0045047,1,0.00104545723862136,0,101,protein targeting to ER,BP,
11041,GO:0045048,1,0.584797689563005,0,5,protein insertion into ER membrane,BP,
11042,GO:0045053,1,0.507399693217555,0,5,protein retention in Golgi apparatus,BP,
11047,GO:0045059,1,0.521045938301202,0,6,positive thymic T cell selection,BP,
11052,GO:0045064,1,0.392531388936704,0,9,T-helper 2 cell differentiation,BP,
11054,GO:0045066,1,0.216711789267803,0,14,regulatory T cell differentiation,BP,
11059,GO:0045073,1,0.480174553452175,0,7,regulation of chemokine biosynthetic process,BP,
11061,GO:0045075,1,0.56253765685752,0,5,regulation of interleukin-12 biosynthetic process,BP,
11062,GO:0045076,1,0.466037927091786,0,7,regulation of interleukin-2 biosynthetic process,BP,
11066,GO:0045080,1,0.529114587361787,0,6,positive regulation of chemokine biosynthetic process,BP,
11072,GO:0045086,1,0.514327169487523,0,6,positive regulation of interleukin-2 biosynthetic process,BP,
11088,GO:0045116,1,0.277260332458755,0,14,protein neddylation,BP,
11089,GO:0045117,1,0.22331991120388,0,15,azole transport,BP,
11105,GO:0045144,1,0.601477918183291,0,5,meiotic sister chromatid segregation,BP,
11121,GO:0045179,1,0.566624265906798,0,5,apical cortex,CC,
11135,GO:0045199,1,0.574259170991434,0,5,maintenance of epithelial cell apical/basal polarity,BP,
11156,GO:0045236,1,0.458437238241315,0,8,CXCR chemokine receptor binding,MF,
11170,GO:0045275,1,0.365426439077042,0,11,respiratory chain complex III,CC,
11175,GO:0045292,1,0.185412042477744,0,16,mRNA cis splicing, via spliceosome,BP,
11177,GO:0045294,1,0.403003077716392,0,8,alpha-catenin binding,MF,
11186,GO:0045324,1,0.322660954392869,0,11,late endosome to vacuole transport,BP,
11188,GO:0045332,1,0.165818461010026,0,14,phospholipid translocation,BP,
11196,GO:0045342,1,0.572201424208214,0,5,MHC class II biosynthetic process,BP,
11199,GO:0045346,1,0.572201424208214,0,5,regulation of MHC class II biosynthetic process,BP,
11203,GO:0045350,1,0.529715085224065,0,6,interferon-beta biosynthetic process,BP,
11204,GO:0045351,1,0.434474384881259,0,8,type I interferon biosynthetic process,BP,
11210,GO:0045357,1,0.529715085224065,0,6,regulation of interferon-beta biosynthetic process,BP,
11222,GO:0045410,1,0.510051913031884,0,6,positive regulation of interleukin-6 biosynthetic process,BP,
11241,GO:0045495,1,0.486605653701281,0,7,pole plasm,CC,
11265,GO:0045589,1,0.216711789267803,0,14,regulation of regulatory T cell differentiation,BP,
11267,GO:0045591,1,0.54413563333403,0,6,positive regulation of regulatory T cell differentiation,BP,
11275,GO:0045602,1,0.557883788129009,0,5,negative regulation of endothelial cell differentiation,BP,
11278,GO:0045605,1,0.328632260722266,0,10,negative regulation of epidermal cell differentiation,BP,
11280,GO:0045607,1,0.59077143294868,0,5,regulation of inner ear auditory receptor cell differentiation,BP,
11283,GO:0045617,1,0.510500269108454,0,6,negative regulation of keratinocyte differentiation,BP,
11288,GO:0045622,1,0.200787272951969,0,15,regulation of T-helper cell differentiation,BP,
11289,GO:0045623,1,0.356410967938219,0,9,negative regulation of T-helper cell differentiation,BP,
11290,GO:0045624,1,0.409835287497827,0,9,positive regulation of T-helper cell differentiation,BP,
11291,GO:0045625,1,0.575894718596787,0,5,regulation of T-helper 1 cell differentiation,BP,
11294,GO:0045628,1,0.483881454372492,0,7,regulation of T-helper 2 cell differentiation,BP,
11297,GO:0045631,1,0.59077143294868,0,5,regulation of mechanoreceptor differentiation,BP,
11309,GO:0045649,1,0.286904783258124,0,11,regulation of macrophage differentiation,BP,
11311,GO:0045651,1,0.351033221737184,0,9,positive regulation of macrophage differentiation,BP,
11313,GO:0045653,1,0.464391924520851,0,17,negative regulation of megakaryocyte differentiation,BP,
11337,GO:0045686,1,0.262498129644166,0,12,negative regulation of glial cell differentiation,BP,
11340,GO:0045714,1,0.500265179481548,0,6,regulation of low-density lipoprotein particle receptor biosynthetic process,BP,
11343,GO:0045717,1,0.281351135046654,0,12,negative regulation of fatty acid biosynthetic process,BP,
11344,GO:0045719,1,0.54932493878353,0,5,negative regulation of glycogen biosynthetic process,BP,
11348,GO:0045724,1,0.129968616365011,0,18,positive regulation of cilium assembly,BP,
11361,GO:0045743,1,0.525753774438251,0,6,positive regulation of fibroblast growth factor receptor signaling pathway,BP,
11376,GO:0045773,1,0.0199724966415948,0,33,positive regulation of axon extension,BP,
11385,GO:0045792,1,0.436849232776777,0,7,negative regulation of cell size,BP,
11396,GO:0045820,1,0.49854193493415,0,6,negative regulation of glycolytic process,BP,
11398,GO:0045822,1,0.325276383691959,0,10,negative regulation of heart contraction,BP,
11405,GO:0045835,1,0.505151530074612,0,6,negative regulation of meiotic nuclear division,BP,
11406,GO:0045836,1,0.50761852652385,0,6,positive regulation of meiotic nuclear division,BP,
11407,GO:0045837,1,0.444028584821386,0,8,negative regulation of membrane potential,BP,
11411,GO:0045841,1,0.0387363200787464,0,30,negative regulation of mitotic metaphase/anaphase transition,BP,
11412,GO:0045842,1,0.428008523469902,0,8,positive regulation of mitotic metaphase/anaphase transition,BP,
11425,GO:0045876,1,0.329494635928159,0,10,positive regulation of sister chromatid cohesion,BP,
11432,GO:0045899,1,0.350554748638425,0,10,positive regulation of RNA polymerase II transcriptional preinitiation complex assembly,BP,
11437,GO:0045906,1,0.492061874560065,0,6,negative regulation of vasoconstriction,BP,
11444,GO:0045915,1,0.605373264275401,0,5,positive regulation of catecholamine metabolic process,BP,
11449,GO:0045920,1,0.14908635234009,0,17,negative regulation of exocytosis,BP,
11470,GO:0045947,1,0.146955225866786,0,18,negative regulation of translational initiation,BP,
11473,GO:0045953,1,0.436465405172572,0,8,negative regulation of natural killer cell mediated cytotoxicity,BP,
11474,GO:0045954,1,0.401960849245485,0,8,positive regulation of natural killer cell mediated cytotoxicity,BP,
11475,GO:0045955,1,0.45223238239247,0,7,negative regulation of calcium ion-dependent exocytosis,BP,
11478,GO:0045964,1,0.605373264275401,0,5,positive regulation of dopamine metabolic process,BP,
11496,GO:0046007,1,0.420963475914628,0,8,negative regulation of activated T cell proliferation,BP,
11508,GO:0046039,1,0.0646061834721676,0,27,GTP metabolic process,BP,
11509,GO:0046040,1,0.263949093481827,0,12,IMP metabolic process,BP,
11513,GO:0046051,1,0.457710463999498,0,9,UTP metabolic process,BP,
11518,GO:0046060,1,0.649472261724431,0,5,dATP metabolic process,BP,
11542,GO:0046100,1,0.610779786244731,0,5,hypoxanthine metabolic process,BP,
11550,GO:0046112,1,0.130386817082355,0,19,nucleobase biosynthetic process,BP,
11551,GO:0046113,1,0.550686165742795,0,5,nucleobase catabolic process,BP,
11560,GO:0046130,1,0.554690513605347,0,6,purine ribonucleoside catabolic process,BP,
11568,GO:0046146,1,0.521009754506911,0,7,tetrahydrobiopterin metabolic process,BP,
11582,GO:0046185,1,0.407764900717175,0,9,aldehyde catabolic process,BP,
11606,GO:0046325,1,0.406822140815842,0,8,negative regulation of glucose import,BP,
11619,GO:0046341,1,0.202258522152031,0,14,CDP-diacylglycerol metabolic process,BP,
11620,GO:0046348,1,0.439172649543949,0,8,amino sugar catabolic process,BP,
11636,GO:0046386,1,0.160400228317851,0,19,deoxyribose phosphate catabolic process,BP,
11644,GO:0046415,1,0.57408443091866,0,5,urate metabolic process,BP,
11651,GO:0046439,1,0.565838898306616,0,5,L-cysteine metabolic process,BP,
11674,GO:0046475,1,0.205247404154064,0,15,glycerophospholipid catabolic process,BP,
11675,GO:0046476,1,0.578738264411948,0,5,glycosylceramide biosynthetic process,BP,
11676,GO:0046477,1,0.527409230769329,0,6,glycosylceramide catabolic process,BP,
11698,GO:0046512,1,0.438282503602968,0,8,sphingosine biosynthetic process,BP,
11702,GO:0046520,1,0.389109479788868,0,9,sphingoid biosynthetic process,BP,
11709,GO:0046532,1,0.556031331904159,0,5,regulation of photoreceptor cell differentiation,BP,
11713,GO:0046540,1,0.0975772629262573,0,24,U4/U6 x U5 tri-snRNP complex,CC,
11739,GO:0046602,1,0.410625425793921,0,8,regulation of mitotic centrosome separation,BP,
11743,GO:0046607,1,0.361226581522743,0,9,positive regulation of centrosome cycle,BP,
11754,GO:0046628,1,0.380649375192038,0,8,positive regulation of insulin receptor signaling pathway,BP,
11758,GO:0046633,1,0.247246248509935,0,13,alpha-beta T cell proliferation,BP,
11765,GO:0046640,1,0.308199821760569,0,11,regulation of alpha-beta T cell proliferation,BP,
11766,GO:0046641,1,0.490060452745492,0,7,positive regulation of alpha-beta T cell proliferation,BP,
11773,GO:0046654,1,0.476121521380558,0,7,tetrahydrofolate biosynthetic process,BP,
11791,GO:0046689,1,0.601045389087212,0,5,response to mercury ion,BP,
11797,GO:0046703,1,0.475982525144514,0,9,natural killer cell lectin-like receptor binding,MF,
11819,GO:0046784,1,0.445304107510005,0,8,viral mRNA export from host cell nucleus,BP,
11831,GO:0046826,1,0.519805447381045,0,7,negative regulation of protein export from nucleus,BP,
11833,GO:0046831,1,0.167062490727755,0,15,regulation of RNA export from nucleus,BP,
11835,GO:0046833,1,0.441624134421802,0,7,positive regulation of RNA export from nucleus,BP,
11838,GO:0046836,1,0.602753160122504,0,5,glycolipid transport,BP,
11878,GO:0046915,1,0.0455399372020449,0,28,transition metal ion transmembrane transporter activity,MF,
11880,GO:0046920,1,0.572046473656201,0,5,alpha-(1->3)-fucosyltransferase activity,MF,
11883,GO:0046923,1,0.608866257999907,0,5,ER retention sequence binding,MF,
11885,GO:0046929,1,0.398960919887063,0,8,negative regulation of neurotransmitter secretion,BP,
11887,GO:0046931,1,0.190584624119848,0,15,pore complex assembly,BP,
11892,GO:0046940,1,0.604180835936843,0,5,nucleoside monophosphate phosphorylation,BP,
11911,GO:0046972,1,0.322682629749116,0,10,histone acetyltransferase activity (H4-K16 specific),MF,
11912,GO:0046974,1,0.558925971573082,0,5,histone methyltransferase activity (H3-K9 specific),MF,
11913,GO:0046975,1,0.487436874391916,0,6,histone methyltransferase activity (H3-K36 specific),MF,
11914,GO:0046976,1,0.563362361192893,0,5,histone methyltransferase activity (H3-K27 specific),MF,
11944,GO:0047134,1,0.640016529313934,0,5,protein-disulfide reductase activity,MF,
11950,GO:0047184,1,0.574019116026877,0,5,1-acylglycerophosphocholine O-acyltransferase activity,MF,
11984,GO:0047429,1,0.406940277826378,0,9,nucleoside-triphosphate diphosphatase activity,MF,
11993,GO:0047498,1,0.509315491856106,0,6,calcium-dependent phospholipase A2 activity,MF,
12047,GO:0048012,1,0.300908719396383,0,11,hepatocyte growth factor receptor signaling pathway,BP,
12054,GO:0048019,1,0.362384072702861,0,10,receptor antagonist activity,MF,
12060,GO:0048025,1,0.161886107387009,0,17,negative regulation of mRNA splicing, via spliceosome,BP,
12062,GO:0048027,1,0.124727848083158,0,22,mRNA 5'-UTR binding,MF,
12069,GO:0048039,1,0.566606939960945,0,6,ubiquinone binding,MF,
12073,GO:0048050,1,0.565546864967779,0,6,post-embryonic eye morphogenesis,BP,
12081,GO:0048096,1,0.416911994686222,0,8,chromatin-mediated maintenance of transcription,BP,
12110,GO:0048200,1,0.519570625306458,0,6,Golgi transport vesicle coating,BP,
12112,GO:0048205,1,0.519570625306458,0,6,COPI coating of Golgi vesicle,BP,
12119,GO:0048227,1,0.432393969747407,0,8,plasma membrane to endosome transport,BP,
12138,GO:0048262,1,0.608515884558962,0,5,determination of dorsal/ventral asymmetry,BP,
12142,GO:0048266,1,0.56687328460078,0,5,behavioral response to pain,BP,
12146,GO:0048273,1,0.507633557052414,0,6,mitogen-activated protein kinase p38 binding,MF,
12148,GO:0048280,1,0.35010553694168,0,10,vesicle fusion with Golgi apparatus,BP,
12153,GO:0048290,1,0.528449205619416,0,6,isotype switching to IgA isotypes,BP,
12154,GO:0048291,1,0.412511295090667,0,8,isotype switching to IgG isotypes,BP,
12158,GO:0048296,1,0.590932734069138,0,5,regulation of isotype switching to IgA isotypes,BP,
12161,GO:0048302,1,0.457975048731957,0,7,regulation of isotype switching to IgG isotypes,BP,
12162,GO:0048304,1,0.574175015978026,0,5,positive regulation of isotype switching to IgG isotypes,BP,
12163,GO:0048305,1,0.320677586164117,0,11,immunoglobulin secretion,BP,
12167,GO:0048312,1,0.482991797653844,0,6,intracellular distribution of mitochondria,BP,
12169,GO:0048318,1,0.616525070747376,0,5,axial mesoderm development,BP,
12176,GO:0048340,1,0.430721208993851,0,7,paraxial mesoderm morphogenesis,BP,
12206,GO:0048476,1,0.62522249793155,0,5,Holliday junction resolvase complex,CC,
12208,GO:0048478,1,0.452463106349359,0,7,replication fork protection,BP,
12211,GO:0048485,1,0.217561543499115,0,13,sympathetic nervous system development,BP,
12220,GO:0048500,1,0.423575301893557,0,9,signal recognition particle,CC,
12235,GO:0048531,1,0.282941331169932,0,12,beta-1,3-galactosyltransferase activity,MF,
12236,GO:0048532,1,0.313374453553672,0,10,anatomical structure arrangement,BP,
12246,GO:0048548,1,0.358755409454433,0,9,regulation of pinocytosis,BP,
12248,GO:0048550,1,0.578759149836493,0,5,negative regulation of pinocytosis,BP,
12253,GO:0048563,1,0.497996865363685,0,7,post-embryonic animal organ morphogenesis,BP,
12257,GO:0048569,1,0.218857945579374,0,14,post-embryonic animal organ development,BP,
12273,GO:0048617,1,0.524937378653968,0,5,embryonic foregut morphogenesis,BP,
12324,GO:0048702,1,0.445243316034269,0,7,embryonic neurocranium morphogenesis,BP,
12325,GO:0048703,1,0.435582921246272,0,7,embryonic viscerocranium morphogenesis,BP,
12333,GO:0048712,1,0.559379971221173,0,5,negative regulation of astrocyte differentiation,BP,
12336,GO:0048715,1,0.416418902155085,0,8,negative regulation of oligodendrocyte differentiation,BP,
12341,GO:0048733,1,0.553809766035695,0,5,sebaceous gland development,BP,
12345,GO:0048741,1,0.225852111151099,0,13,skeletal muscle fiber development,BP,
12346,GO:0048742,1,0.549716544583088,0,5,regulation of skeletal muscle fiber development,BP,
12354,GO:0048755,1,0.558601733987909,0,5,branching morphogenesis of a nerve,BP,
12384,GO:0048842,1,0.464657748482459,0,6,positive regulation of axon extension involved in axon guidance,BP,
12387,GO:0048845,1,0.348187147703972,0,9,venous blood vessel morphogenesis,BP,
12391,GO:0048853,1,0.429061409960093,0,7,forebrain morphogenesis,BP,
12413,GO:0048934,1,0.505877555979718,0,6,peripheral nervous system neuron differentiation,BP,
12414,GO:0048935,1,0.505877555979718,0,6,peripheral nervous system neuron development,BP,
12430,GO:0050145,1,0.604180835936843,0,5,nucleoside phosphate kinase activity,MF,
12462,GO:0050428,1,0.509882144844813,0,6,3'-phosphoadenosine 5'-phosphosulfate biosynthetic process,BP,
12520,GO:0050686,1,0.0519033728639736,0,27,negative regulation of mRNA processing,BP,
12523,GO:0050689,1,0.608823941490269,0,5,negative regulation of defense response to virus by host,BP,
12524,GO:0050690,1,0.103360532765709,0,21,regulation of defense response to virus by virus,BP,
12531,GO:0050700,1,0.308273275479296,0,11,CARD domain binding,MF,
12534,GO:0050703,1,0.65608955165471,0,5,interleukin-1 alpha secretion,BP,
12542,GO:0050711,1,0.445713831696285,0,8,negative regulation of interleukin-1 secretion,BP,
12544,GO:0050713,1,0.604736052120939,0,5,negative regulation of interleukin-1 beta secretion,BP,
12564,GO:0050755,1,0.444158310835812,0,8,chemokine metabolic process,BP,
12569,GO:0050765,1,0.378151319295143,0,9,negative regulation of phagocytosis,BP,
12617,GO:0050829,1,0.161450434329738,0,23,defense response to Gram-negative bacterium,BP,
12623,GO:0050847,1,0.432031173811365,0,7,progesterone receptor signaling pathway,BP,
12633,GO:0050857,1,0.310735419611037,0,11,positive regulation of antigen receptor-mediated signaling pathway,BP,
12638,GO:0050862,1,0.48906201507379,0,7,positive regulation of T cell receptor signaling pathway,BP,
12655,GO:0050882,1,0.468184030587117,0,6,voluntary musculoskeletal movement,BP,
12666,GO:0050901,1,0.358579343150986,0,9,leukocyte tethering or rolling,BP,
12725,GO:0051013,1,0.512885807266411,0,6,microtubule severing,BP,
12735,GO:0051023,1,0.403941384833957,0,9,regulation of immunoglobulin secretion,BP,
12736,GO:0051024,1,0.610290559734325,0,5,positive regulation of immunoglobulin secretion,BP,
12742,GO:0051031,1,0.0232983621194546,0,33,tRNA transport,BP,
12745,GO:0051036,1,0.596020765388432,0,5,regulation of endosome size,BP,
12773,GO:0051087,1,0.000253278227453067,0,79,chaperone binding,MF,
12781,GO:0051095,1,0.381728479956064,0,9,regulation of helicase activity,BP,
12782,GO:0051096,1,0.52822690419418,0,6,positive regulation of helicase activity,BP,
12790,GO:0051105,1,0.521567030340799,0,6,regulation of DNA ligation,BP,
12791,GO:0051106,1,0.580315258843283,0,5,positive regulation of DNA ligation,BP,
12807,GO:0051132,1,0.614173524625713,0,5,NK T cell activation,BP,
12829,GO:0051167,1,0.626951062701395,0,5,xylulose 5-phosphate metabolic process,BP,
12842,GO:0051182,1,0.463631346233062,0,7,coenzyme transport,BP,
12844,GO:0051185,1,0.518181862103078,0,6,coenzyme transmembrane transporter activity,MF,
12848,GO:0051189,1,0.473650049287869,0,7,prosthetic group metabolic process,BP,
12852,GO:0051195,1,0.351307456802128,0,9,negative regulation of cofactor metabolic process,BP,
12855,GO:0051198,1,0.49854193493415,0,6,negative regulation of coenzyme metabolic process,BP,
12870,GO:0051231,1,0.294595339793914,0,11,spindle elongation,BP,
12876,GO:0051238,1,0.345506509020114,0,12,sequestering of metal ion,BP,
12889,GO:0051255,1,0.333927104496167,0,10,spindle midzone assembly,BP,
12890,GO:0051256,1,0.415092276800551,0,8,mitotic spindle midzone assembly,BP,
12910,GO:0051286,1,0.541828842804619,0,5,cell tip,CC,
12915,GO:0051292,1,0.31750847053338,0,10,nuclear pore complex assembly,BP,
12920,GO:0051299,1,0.207610148628701,0,14,centrosome separation,BP,
12925,GO:0051304,1,0.000611331548405183,0,68,chromosome separation,BP,
12926,GO:0051305,1,0.555056634132042,0,5,chromosome movement towards spindle pole,BP,
12927,GO:0051306,1,0.00438294619748366,0,51,mitotic sister chromatid separation,BP,
12928,GO:0051307,1,0.255144762255722,0,12,meiotic chromosome separation,BP,
12952,GO:0051354,1,0.339337861380744,0,10,negative regulation of oxidoreductase activity,BP,
12970,GO:0051400,1,0.425983696522598,0,8,BH domain binding,MF,
12991,GO:0051444,1,0.303608828773071,0,13,negative regulation of ubiquitin-protein transferase activity,BP,
12995,GO:0051450,1,0.433103121062608,0,8,myoblast proliferation,BP,
13024,GO:0051503,1,0.279852918742476,0,12,adenine nucleotide transport,BP,
13027,GO:0051537,1,0.15902865615619,0,19,2 iron, 2 sulfur cluster binding,MF,
13036,GO:0051547,1,0.383858425357106,0,8,regulation of keratinocyte migration,BP,
13038,GO:0051549,1,0.497012995685458,0,6,positive regulation of keratinocyte migration,BP,
13039,GO:0051560,1,0.148260551622027,0,18,mitochondrial calcium ion homeostasis,BP,
13040,GO:0051561,1,0.409450998832226,0,9,positive regulation of mitochondrial calcium ion concentration,BP,
13051,GO:0051575,1,0.570973711702092,0,5,5'-deoxyribose-5-phosphate lyase activity,MF,
13055,GO:0051583,1,0.575557917419241,0,6,dopamine uptake involved in synaptic transmission,BP,
13061,GO:0051590,1,0.155644373803804,0,17,positive regulation of neurotransmitter transport,BP,
13067,GO:0051597,1,0.502323939435348,0,6,response to methylmercury,BP,
13070,GO:0051601,1,0.5634924537834,0,5,exocyst localization,BP,
13076,GO:0051608,1,0.421771747487882,0,9,histamine transport,BP,
13089,GO:0051645,1,0.25850615436788,0,12,Golgi localization,BP,
13099,GO:0051657,1,0.373023863510829,0,8,maintenance of organelle location,BP,
13101,GO:0051661,1,0.536912355261232,0,5,maintenance of centrosome location,BP,
13108,GO:0051683,1,0.477869198802377,0,7,establishment of Golgi localization,BP,
13122,GO:0051709,1,0.51458195547115,0,7,regulation of killing of cells of other organism,BP,
13124,GO:0051712,1,0.51458195547115,0,7,positive regulation of killing of cells of other organism,BP,
13148,GO:0051766,1,0.563053375700706,0,5,inositol trisphosphate kinase activity,MF,
13153,GO:0051775,1,0.375133955045219,0,10,response to redox state,BP,
13162,GO:0051788,1,0.0870428364246746,0,22,response to misfolded protein,BP,
13164,GO:0051791,1,0.480352356337076,0,7,medium-chain fatty acid metabolic process,BP,
13171,GO:0051798,1,0.36016311888301,0,10,positive regulation of hair follicle development,BP,
13179,GO:0051818,1,0.558823886898284,0,6,disruption of cells of other organism involved in symbiotic interaction,BP,
13187,GO:0051836,1,0.400984906911443,0,9,translocation of molecules into other organism involved in symbiotic interaction,BP,
13201,GO:0051883,1,0.558823886898284,0,6,killing of cells in other organism involved in symbiotic interaction,BP,
13213,GO:0051898,1,0.0225289955627185,0,34,negative regulation of protein kinase B signaling,BP,
13222,GO:0051917,1,0.513015197947618,0,6,regulation of fibrinolysis,BP,
13234,GO:0051934,1,0.575557917419241,0,6,catecholamine uptake involved in synaptic transmission,BP,
13244,GO:0051953,1,0.571312330564551,0,5,negative regulation of amine transport,BP,
13245,GO:0051954,1,0.276424419279232,0,12,positive regulation of amine transport,BP,
13248,GO:0051957,1,0.507935535487444,0,6,positive regulation of amino acid transport,BP,
13268,GO:0051984,1,0.053203840767911,0,26,positive regulation of chromosome segregation,BP,
13270,GO:0051987,1,0.571560398363765,0,5,positive regulation of attachment of spindle microtubules to kinetochore,BP,
13271,GO:0051988,1,0.256420206379984,0,12,regulation of attachment of spindle microtubules to kinetochore,BP,
13279,GO:0052040,1,0.537391555905436,0,6,modulation by symbiont of host programmed cell death,BP,
13289,GO:0052126,1,0.026408328357795,0,33,movement in host environment,BP,
13291,GO:0052150,1,0.58520467512483,0,5,modulation by symbiont of host apoptotic process,BP,
13295,GO:0052173,1,0.519717118626007,0,6,response to defenses of other organism involved in symbiotic interaction,BP,
13298,GO:0052192,1,0.026408328357795,0,33,movement in environment of other organism involved in symbiotic interaction,BP,
13300,GO:0052200,1,0.519717118626007,0,6,response to host defenses,BP,
13302,GO:0052204,1,0.604697273612893,0,5,negative regulation of molecular function in other organism involved in symbiotic interaction,BP,
13303,GO:0052205,1,0.531582165831282,0,6,modulation of molecular function in other organism involved in symbiotic interaction,BP,
13308,GO:0052248,1,0.537391555905436,0,6,modulation of programmed cell death in other organism involved in symbiotic interaction,BP,
13315,GO:0052312,1,0.0692947557648821,0,24,modulation of transcription in other organism involved in symbiotic interaction,BP,
13332,GO:0052433,1,0.537391555905436,0,6,modulation by organism of apoptotic process in other organism involved in symbiotic interaction,BP,
13333,GO:0052472,1,0.0692947557648821,0,24,modulation by host of symbiont transcription,BP,
13347,GO:0052564,1,0.590946123059579,0,5,response to immune response of other organism involved in symbiotic interaction,BP,
13349,GO:0052572,1,0.590946123059579,0,5,response to host immune response,BP,
13356,GO:0052629,1,0.257823311905622,0,11,phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity,MF,
13358,GO:0052646,1,0.390369188276672,0,8,alditol phosphate metabolic process,BP,
13366,GO:0052658,1,0.494695893453605,0,6,inositol-1,4,5-trisphosphate 5-phosphatase activity,MF,
13385,GO:0052744,1,0.180851584097105,0,14,phosphatidylinositol monophosphate phosphatase activity,MF,
13423,GO:0052851,1,0.567888443486541,0,5,ferric-chelate reductase (NADPH) activity,MF,
13453,GO:0055010,1,0.0365750645314199,0,28,ventricular cardiac muscle tissue morphogenesis,BP,
13474,GO:0055057,1,0.298427788716674,0,10,neuroblast division,BP,
13481,GO:0055070,1,0.209354655283996,0,16,copper ion homeostasis,BP,
13507,GO:0055105,1,0.649533231707099,0,6,ubiquitin-protein transferase inhibitor activity,MF,
13518,GO:0055131,1,0.599631548125577,0,5,C3HC4-type RING finger domain binding,MF,
13535,GO:0060020,1,0.504677259547486,0,6,Bergmann glial cell differentiation,BP,
13537,GO:0060022,1,0.549315427078659,0,5,hard palate development,BP,
13548,GO:0060037,1,0.13852202139632,0,17,pharyngeal system development,BP,
13556,GO:0060045,1,0.246338915825083,0,12,positive regulation of cardiac muscle cell proliferation,BP,
13557,GO:0060046,1,0.588236689154329,0,5,regulation of acrosome reaction,BP,
13560,GO:0060049,1,0.292751014324741,0,11,regulation of protein glycosylation,BP,
13561,GO:0060050,1,0.408857885712187,0,8,positive regulation of protein glycosylation,BP,
13563,GO:0060052,1,0.465629137029204,0,7,neurofilament cytoskeleton organization,BP,
13570,GO:0060059,1,0.518937826779479,0,5,embryonic retina morphogenesis in camera-type eye,BP,
13574,GO:0060065,1,0.209423383221402,0,13,uterus development,BP,
13577,GO:0060068,1,0.512375250358747,0,6,vagina development,BP,
13597,GO:0060091,1,0.599717800892934,0,5,kinocilium,CC,
13604,GO:0060120,1,0.582478610161123,0,5,inner ear receptor cell fate commitment,BP,
13616,GO:0060137,1,0.522728105798562,0,6,maternal process involved in parturition,BP,
13666,GO:0060229,1,0.42147622536551,0,8,lipase activator activity,MF,
13671,GO:0060242,1,0.471993905904276,0,7,contact inhibition,BP,
13683,GO:0060261,1,0.16015507215139,0,17,positive regulation of transcription initiation from RNA polymerase II promoter,BP,
13694,GO:0060281,1,0.517151578697916,0,6,regulation of oocyte development,BP,
13703,GO:0060293,1,0.486605653701281,0,7,germ plasm,CC,
13712,GO:0060304,1,0.536390427784335,0,5,regulation of phosphatidylinositol dephosphorylation,BP,
13729,GO:0060325,1,0.0552517121336143,0,25,face morphogenesis,BP,
13741,GO:0060339,1,0.449438158200869,0,7,negative regulation of type I interferon-mediated signaling pathway,BP,
13742,GO:0060340,1,0.349160468483493,0,9,positive regulation of type I interferon-mediated signaling pathway,BP,
13747,GO:0060347,1,0.410814724797601,0,8,heart trabecula formation,BP,
13760,GO:0060368,1,0.52099857357537,0,6,regulation of Fc receptor mediated stimulatory signaling pathway,BP,
13770,GO:0060379,1,0.444014415943485,0,7,cardiac muscle cell myoblast differentiation,BP,
13786,GO:0060397,1,0.341928276946987,0,9,JAK-STAT cascade involved in growth hormone signaling pathway,BP,
13812,GO:0060433,1,0.406604711807116,0,8,bronchus development,BP,
13816,GO:0060438,1,0.190522801822182,0,15,trachea development,BP,
13817,GO:0060439,1,0.36703935337531,0,9,trachea morphogenesis,BP,
13818,GO:0060440,1,0.516000427549917,0,6,trachea formation,BP,
13835,GO:0060462,1,0.537044138868048,0,5,lung lobe development,BP,
13836,GO:0060463,1,0.537044138868048,0,5,lung lobe morphogenesis,BP,
13870,GO:0060534,1,0.448399278701306,0,7,trachea cartilage development,BP,
13875,GO:0060539,1,0.570581049654722,0,5,diaphragm development,BP,
13897,GO:0060576,1,0.393349942994932,0,9,intestinal epithelial cell development,BP,
13906,GO:0060590,1,0.0245131481590196,0,35,ATPase regulator activity,MF,
13921,GO:0060612,1,0.0597929272314385,0,25,adipose tissue development,BP,
13922,GO:0060613,1,0.516534854862712,0,6,fat pad development,BP,
13927,GO:0060628,1,0.26077125298485,0,12,regulation of ER to Golgi vesicle-mediated transport,BP,
13931,GO:0060638,1,0.561672257980922,0,5,mesenchymal-epithelial cell signaling,BP,
13932,GO:0060644,1,0.299051070962969,0,11,mammary gland epithelial cell differentiation,BP,
13942,GO:0060670,1,0.334456589218535,0,10,branching involved in labyrinthine layer morphogenesis,BP,
13960,GO:0060693,1,0.559152728133599,0,5,regulation of branching involved in salivary gland morphogenesis,BP,
13962,GO:0060696,1,0.616400615057363,0,5,regulation of phospholipid catabolic process,BP,
13989,GO:0060732,1,0.499687891401554,0,6,positive regulation of inositol phosphate biosynthetic process,BP,
13997,GO:0060742,1,0.391218002064272,0,8,epithelial cell differentiation involved in prostate gland development,BP,
14016,GO:0060767,1,0.381887753450274,0,9,epithelial cell proliferation involved in prostate gland development,BP,
14017,GO:0060768,1,0.430553694219809,0,8,regulation of epithelial cell proliferation involved in prostate gland development,BP,
14019,GO:0060770,1,0.550722112660209,0,6,negative regulation of epithelial cell proliferation involved in prostate gland development,BP,
14022,GO:0060788,1,0.290643292707772,0,11,ectodermal placode formation,BP,
14023,GO:0060789,1,0.532559793319544,0,6,hair follicle placode formation,BP,
14036,GO:0060836,1,0.49067525321624,0,6,lymphatic endothelial cell differentiation,BP,
14037,GO:0060837,1,0.505318479752454,0,6,blood vessel endothelial cell differentiation,BP,
14039,GO:0060839,1,0.466787973954058,0,7,endothelial cell fate commitment,BP,
14041,GO:0060841,1,0.231755124903243,0,12,venous blood vessel development,BP,
14057,GO:0060896,1,0.396570516157747,0,8,neural plate pattern specification,BP,
14058,GO:0060897,1,0.513972990242543,0,6,neural plate regionalization,BP,
14067,GO:0060914,1,0.333752636706418,0,11,heart formation,BP,
14073,GO:0060923,1,0.579353747893398,0,5,cardiac muscle cell fate commitment,BP,
14094,GO:0060972,1,0.170192959953214,0,16,left/right pattern formation,BP,
14097,GO:0060977,1,0.294607375418473,0,10,coronary vasculature morphogenesis,BP,
14100,GO:0060982,1,0.43523703389296,0,7,coronary artery morphogenesis,BP,
14116,GO:0061004,1,0.487570167580176,0,7,pattern specification involved in kidney development,BP,
14152,GO:0061072,1,0.5427271089644,0,5,iris morphogenesis,BP,
14158,GO:0061081,1,0.618849229457701,0,5,positive regulation of myeloid leukocyte cytokine production involved in immune response,BP,
14159,GO:0061082,1,0.231003714647727,0,14,myeloid leukocyte cytokine production,BP,
14165,GO:0061088,1,0.500261420300357,0,6,regulation of sequestering of zinc ion,BP,
14181,GO:0061133,1,0.648023639698405,0,5,endopeptidase activator activity,MF,
14195,GO:0061154,1,0.309328701806344,0,11,endothelial tube morphogenesis,BP,
14203,GO:0061179,1,0.533963235060044,0,7,negative regulation of insulin secretion involved in cellular response to glucose stimulus,BP,
14217,GO:0061213,1,0.220567358299413,0,14,positive regulation of mesonephros development,BP,
14219,GO:0061217,1,0.180088796347663,0,16,regulation of mesonephros development,BP,
14225,GO:0061298,1,0.318501292738271,0,9,retina vasculature development in camera-type eye,BP,
14226,GO:0061299,1,0.475173137231402,0,6,retina vasculature morphogenesis in camera-type eye,BP,
14232,GO:0061307,1,0.410855438923979,0,8,cardiac neural crest cell differentiation involved in heart development,BP,
14233,GO:0061308,1,0.410855438923979,0,8,cardiac neural crest cell development involved in heart development,BP,
14234,GO:0061309,1,0.510961622185341,0,6,cardiac neural crest cell development involved in outflow tract morphogenesis,BP,
14235,GO:0061311,1,0.161812584311321,0,16,cell surface receptor signaling pathway involved in heart development,BP,
14236,GO:0061312,1,0.590056768174772,0,5,BMP signaling pathway involved in heart development,BP,
14237,GO:0061314,1,0.543017892247393,0,5,Notch signaling involved in heart development,BP,
14241,GO:0061323,1,0.308545849580797,0,11,cell proliferation involved in heart morphogenesis,BP,
14268,GO:0061384,1,0.0668379890462542,0,23,heart trabecula morphogenesis,BP,
14275,GO:0061418,1,0.00108860467943669,0,71,regulation of transcription from RNA polymerase II promoter in response to hypoxia,BP,
14276,GO:0061419,1,0.560644235488124,0,5,positive regulation of transcription from RNA polymerase II promoter in response to hypoxia,BP,
14298,GO:0061478,1,0.34143744142665,0,9,response to platelet aggregation inhibitor,BP,
14322,GO:0061548,1,0.389796868574813,0,8,ganglion development,BP,
14323,GO:0061549,1,0.492496256297692,0,6,sympathetic ganglion development,BP,
14354,GO:0061615,1,0.152866814466282,0,18,glycolytic process through fructose-6-phosphate,BP,
14355,GO:0061617,1,0.478799480950208,0,8,MICOS complex,CC,
14357,GO:0061620,1,0.152866814466282,0,18,glycolytic process through glucose-6-phosphate,BP,
14358,GO:0061621,1,0.166803700554042,0,17,canonical glycolysis,BP,
14362,GO:0061626,1,0.509134315712299,0,6,pharyngeal arch artery morphogenesis,BP,
14367,GO:0061631,1,0.066724026365966,0,26,ubiquitin conjugating enzyme activity,MF,
14377,GO:0061650,1,0.0615574704180512,0,27,ubiquitin-like protein conjugating enzyme activity,MF,
14381,GO:0061665,1,0.582136313180868,0,5,SUMO ligase activity,MF,
14382,GO:0061668,1,0.518474103746877,0,6,mitochondrial ribosome assembly,BP,
14384,GO:0061673,1,0.571513960273378,0,5,mitotic spindle astral microtubule,CC,
14385,GO:0061676,1,0.506710064520874,0,6,importin-alpha family protein binding,MF,
14386,GO:0061684,1,0.332207549804535,0,10,chaperone-mediated autophagy,BP,
14399,GO:0061718,1,0.166803700554042,0,17,glucose catabolic process to pyruvate,BP,
14401,GO:0061724,1,0.497922305398676,0,6,lipophagy,BP,
14405,GO:0061732,1,0.527665278393901,0,6,mitochondrial acetyl-CoA biosynthetic process from pyruvate,BP,
14420,GO:0061756,1,0.283524889400087,0,11,leukocyte adhesion to vascular endothelial cell,BP,
14482,GO:0061983,1,0.535679474077839,0,6,meiosis II cell cycle process,BP,
14483,GO:0062009,1,0.387833326199068,0,8,secondary palate development,BP,
14497,GO:0070003,1,0.263665880222305,0,18,threonine-type peptidase activity,MF,
14500,GO:0070008,1,0.322892444375147,0,10,serine-type exopeptidase activity,MF,
14562,GO:0070125,1,0.000971747410700094,0,86,mitochondrial translational elongation,BP,
14563,GO:0070126,1,0.000789726898446683,0,88,mitochondrial translational termination,BP,
14564,GO:0070127,1,0.417266905037693,0,8,tRNA aminoacylation for mitochondrial protein translation,BP,
14565,GO:0070129,1,0.154338826160323,0,18,regulation of mitochondrial translation,BP,
14567,GO:0070131,1,0.322244424622234,0,11,positive regulation of mitochondrial translation,BP,
14596,GO:0070182,1,0.155086023919579,0,18,DNA polymerase binding,MF,
14599,GO:0070187,1,0.524694250626634,0,6,shelterin complex,CC,
14608,GO:0070199,1,0.0900130391222791,0,23,establishment of protein localization to chromosome,BP,
14609,GO:0070200,1,0.219862043373146,0,14,establishment of protein localization to telomere,BP,
14611,GO:0070202,1,0.316337467904229,0,11,regulation of establishment of protein localization to chromosome,BP,
14612,GO:0070203,1,0.351967952828844,0,10,regulation of establishment of protein localization to telomere,BP,
14623,GO:0070230,1,0.309368929648932,0,12,positive regulation of lymphocyte apoptotic process,BP,
14627,GO:0070234,1,0.411665515915545,0,9,positive regulation of T cell apoptotic process,BP,
14631,GO:0070243,1,0.300498695993561,0,11,regulation of thymocyte apoptotic process,BP,
14632,GO:0070244,1,0.515023014678015,0,6,negative regulation of thymocyte apoptotic process,BP,
14633,GO:0070245,1,0.583635571658079,0,5,positive regulation of thymocyte apoptotic process,BP,
14646,GO:0070269,1,0.450605276067971,0,8,pyroptosis,BP,
14669,GO:0070307,1,0.365054793109943,0,9,lens fiber cell development,BP,
14695,GO:0070358,1,0.597568213272569,0,5,actin polymerization-dependent cell motility,BP,
14698,GO:0070370,1,0.62444535176509,0,5,cellular heat acclimation,BP,
14711,GO:0070391,1,0.579123226704881,0,5,response to lipoteichoic acid,BP,
14720,GO:0070410,1,0.418705810871727,0,7,co-SMAD binding,MF,
14724,GO:0070417,1,0.434444780136078,0,7,cellular response to cold,BP,
14726,GO:0070419,1,0.448591016069508,0,7,nonhomologous end joining complex,CC,
14760,GO:0070486,1,0.367746668309224,0,10,leukocyte aggregation,BP,
14772,GO:0070508,1,0.588935996520231,0,5,cholesterol import,BP,
14776,GO:0070513,1,0.449988224835783,0,8,death domain binding,MF,
14779,GO:0070525,1,0.265163392138057,0,13,tRNA threonylcarbamoyladenosine metabolic process,BP,
14783,GO:0070531,1,0.575052833058622,0,5,BRCA1-A complex,CC,
14784,GO:0070534,1,0.0120636431768159,0,40,protein K63-linked ubiquitination,BP,
14785,GO:0070535,1,0.548960873951686,0,5,histone H2A K63-linked ubiquitination,BP,
14803,GO:0070562,1,0.501071481171314,0,6,regulation of vitamin D receptor signaling pathway,BP,
14807,GO:0070567,1,0.379017774139164,0,9,cytidylyltransferase activity,MF,
14808,GO:0070568,1,0.582697091269513,0,5,guanylyltransferase activity,MF,
14819,GO:0070584,1,0.119811237288107,0,21,mitochondrion morphogenesis,BP,
14826,GO:0070601,1,0.428333932295683,0,8,centromeric sister chromatid cohesion,BP,
14840,GO:0070633,1,0.302755521222159,0,11,transepithelial transport,BP,
14852,GO:0070652,1,0.420518429502106,0,8,HAUS complex,CC,
14861,GO:0070669,1,0.385930282317729,0,8,response to interleukin-2,BP,
14864,GO:0070672,1,0.347643119161991,0,9,response to interleukin-15,BP,
14865,GO:0070673,1,0.441368013102485,0,8,response to interleukin-18,BP,
14892,GO:0070742,1,0.264647059092893,0,12,C2H2 zinc finger domain binding,MF,
14895,GO:0070761,1,0.543051406930639,0,6,pre-snoRNP complex,CC,
14897,GO:0070765,1,0.529736429896644,0,6,gamma-secretase complex,CC,
14901,GO:0070775,1,0.437876337219153,0,7,H3 histone acetyltransferase complex,CC,
14902,GO:0070776,1,0.437876337219153,0,7,MOZ/MORF histone acetyltransferase complex,CC,
14909,GO:0070813,1,0.610068131653523,0,5,hydrogen sulfide metabolic process,BP,
14912,GO:0070816,1,0.194423452375311,0,15,phosphorylation of RNA polymerase II C-terminal domain,BP,
14916,GO:0070822,1,0.203073360734862,0,14,Sin3-type complex,CC,
14922,GO:0070831,1,0.414577676691096,0,7,basement membrane assembly,BP,
14926,GO:0070840,1,0.110733173188047,0,18,dynein complex binding,MF,
14933,GO:0070847,1,0.455026760896658,0,8,core mediator complex,CC,
14944,GO:0070861,1,0.116084907311642,0,19,regulation of protein exit from endoplasmic reticulum,BP,
14945,GO:0070862,1,0.346767847089413,0,10,negative regulation of protein exit from endoplasmic reticulum,BP,
14946,GO:0070863,1,0.381373038435332,0,8,positive regulation of protein exit from endoplasmic reticulum,BP,
14948,GO:0070874,1,0.54932493878353,0,5,negative regulation of glycogen metabolic process,BP,
14952,GO:0070878,1,0.386612592678062,0,8,primary miRNA binding,MF,
14953,GO:0070883,1,0.589615403872631,0,5,pre-miRNA binding,MF,
14967,GO:0070900,1,0.399897179997859,0,9,mitochondrial tRNA modification,BP,
14983,GO:0070933,1,0.346257945568207,0,9,histone H4 deacetylation,BP,
14987,GO:0070937,1,0.548772222060694,0,5,CRD-mediated mRNA stability complex,CC,
14988,GO:0070938,1,0.27068412276072,0,11,contractile ring,CC,
14990,GO:0070940,1,0.575309142693335,0,5,dephosphorylation of RNA polymerase II C-terminal domain,BP,
15007,GO:0070970,1,0.388661489414651,0,8,interleukin-2 secretion,BP,
15009,GO:0070972,1,6.8548178218109e-05,0,125,protein localization to endoplasmic reticulum,BP,
15014,GO:0070979,1,0.072249439770469,0,27,protein K11-linked ubiquitination,BP,
15019,GO:0070986,1,0.261105681215499,0,12,left/right axis specification,BP,
15023,GO:0070990,1,0.567992748438711,0,6,snRNP binding,MF,
15030,GO:0071004,1,0.180933126017846,0,17,U2-type prespliceosome,CC,
15033,GO:0071007,1,0.0564107422331505,0,29,U2-type catalytic step 2 spliceosome,CC,
15035,GO:0071010,1,0.110408955760348,0,22,prespliceosome,CC,
15037,GO:0071012,1,0.522329720118282,0,6,catalytic step 1 spliceosome,CC,
15039,GO:0071014,1,0.393589528997871,0,9,post-mRNA release spliceosomal complex,CC,
15046,GO:0071029,1,0.576696796254355,0,6,nuclear ncRNA surveillance,BP,
15049,GO:0071033,1,0.61659583478702,0,5,nuclear retention of pre-mRNA at the site of transcription,BP,
15051,GO:0071035,1,0.576696796254355,0,6,nuclear polyadenylation-dependent rRNA catabolic process,BP,
15052,GO:0071038,1,0.641174059028082,0,5,nuclear polyadenylation-dependent tRNA catabolic process,BP,
15057,GO:0071046,1,0.576696796254355,0,6,nuclear polyadenylation-dependent ncRNA catabolic process,BP,
15061,GO:0071051,1,0.660358619710167,0,5,polyadenylation-dependent snoRNA 3'-end processing,BP,
15080,GO:0071141,1,0.424385634564123,0,7,SMAD protein complex,CC,
15091,GO:0071168,1,0.0946313428681084,0,22,protein localization to chromatin,BP,
15092,GO:0071169,1,0.456012419543418,0,8,establishment of protein localization to chromatin,BP,
15093,GO:0071173,1,0.0435848586134665,0,29,spindle assembly checkpoint,BP,
15094,GO:0071174,1,0.0435848586134665,0,29,mitotic spindle checkpoint,BP,
15096,GO:0071204,1,0.534264202014522,0,6,histone pre-mRNA 3'end processing complex,CC,
15105,GO:0071218,1,0.107356603812914,0,20,cellular response to misfolded protein,BP,
15110,GO:0071223,1,0.579123226704881,0,5,cellular response to lipoteichoic acid,BP,
15125,GO:0071253,1,0.568813528959375,0,5,connexin binding,MF,
15127,GO:0071257,1,0.558394279821379,0,5,cellular response to electrical stimulus,BP,
15132,GO:0071265,1,0.486905732779692,0,7,L-methionine biosynthetic process,BP,
15134,GO:0071267,1,0.537383875613078,0,6,L-methionine salvage,BP,
15161,GO:0071318,1,0.307043660740182,0,11,cellular response to ATP,BP,
15182,GO:0071350,1,0.395058991652687,0,8,cellular response to interleukin-15,BP,
15183,GO:0071351,1,0.609904857628777,0,5,cellular response to interleukin-18,BP,
15184,GO:0071352,1,0.385930282317729,0,8,cellular response to interleukin-2,BP,
15211,GO:0071389,1,0.523308315164942,0,6,cellular response to mineralocorticoid stimulus,BP,
15215,GO:0071394,1,0.462956567110595,0,7,cellular response to testosterone stimulus,BP,
15218,GO:0071397,1,0.266956493107476,0,11,cellular response to cholesterol,BP,
15238,GO:0071428,1,0.242743044781811,0,15,rRNA-containing ribonucleoprotein complex export from nucleus,BP,
15239,GO:0071431,1,0.0260748073155128,0,32,tRNA-containing ribonucleoprotein complex export from nucleus,BP,
15241,GO:0071437,1,0.224837844296459,0,13,invadopodium,CC,
15244,GO:0071440,1,0.57440728506924,0,5,regulation of histone H3-K14 acetylation,BP,
15249,GO:0071450,1,0.199500342216649,0,17,cellular response to oxygen radical,BP,
15250,GO:0071451,1,0.199500342216649,0,17,cellular response to superoxide,BP,
15256,GO:0071459,1,0.120467173887256,0,20,protein localization to chromosome, centromeric region,BP,
15287,GO:0071500,1,0.622025427315946,0,5,cellular response to nitrosative stress,BP,
15302,GO:0071541,1,0.507762286251052,0,7,eukaryotic translation initiation factor 3 complex, eIF3m,CC,
15311,GO:0071550,1,0.447624287594501,0,8,death-inducing signaling complex assembly,BP,
15314,GO:0071557,1,0.538021637748725,0,5,histone H3-K27 demethylation,BP,
15315,GO:0071558,1,0.538021637748725,0,5,histone demethylase activity (H3-K27 specific),MF,
15319,GO:0071564,1,0.25503586634264,0,12,npBAF complex,CC,
15320,GO:0071565,1,0.242386476126432,0,12,nBAF complex,CC,
15326,GO:0071577,1,0.189240996954503,0,15,zinc ion transmembrane transport,BP,
15327,GO:0071578,1,0.508172726256373,0,6,zinc ion import across plasma membrane,BP,
15339,GO:0071598,1,0.597905635569411,0,5,neuronal ribonucleoprotein granule,CC,
15340,GO:0071599,1,0.433164181075333,0,7,otic vesicle development,BP,
15359,GO:0071624,1,0.200569641019592,0,18,positive regulation of granulocyte chemotaxis,BP,
15364,GO:0071634,1,0.134496675653966,0,17,regulation of transforming growth factor beta production,BP,
15365,GO:0071635,1,0.502641273946138,0,6,negative regulation of transforming growth factor beta production,BP,
15366,GO:0071636,1,0.391965789797146,0,8,positive regulation of transforming growth factor beta production,BP,
15385,GO:0071670,1,0.597301752585363,0,5,smooth muscle cell chemotaxis,BP,
15395,GO:0071680,1,0.549228697271014,0,5,response to indole-3-methanol,BP,
15396,GO:0071681,1,0.549228697271014,0,5,cellular response to indole-3-methanol,BP,
15404,GO:0071696,1,0.261664517334473,0,12,ectodermal placode development,BP,
15405,GO:0071697,1,0.290643292707772,0,11,ectodermal placode morphogenesis,BP,
15416,GO:0071712,1,0.305525895385385,0,11,ER-associated misfolded protein catabolic process,BP,
15427,GO:0071763,1,0.512053959277113,0,6,nuclear membrane organization,BP,
15432,GO:0071782,1,0.139375285379212,0,18,endoplasmic reticulum tubular network,CC,
15444,GO:0071803,1,0.365070772064666,0,9,positive regulation of podosome assembly,BP,
15452,GO:0071817,1,0.614506566855098,0,5,MMXD complex,CC,
15468,GO:0071850,1,0.225719413295851,0,14,mitotic cell cycle arrest,BP,
15470,GO:0071863,1,0.581796868260002,0,5,regulation of cell proliferation in bone marrow,BP,
15471,GO:0071864,1,0.581796868260002,0,5,positive regulation of cell proliferation in bone marrow,BP,
15490,GO:0071888,1,0.443401759238548,0,8,macrophage apoptotic process,BP,
15509,GO:0071921,1,0.505910812532852,0,6,cohesin loading,BP,
15510,GO:0071922,1,0.562870704639256,0,5,regulation of cohesin loading,BP,
15518,GO:0071941,1,0.308944378529323,0,11,nitrogen cycle metabolic process,BP,
15529,GO:0071971,1,0.522905273456267,0,6,extracellular exosome assembly,BP,
15530,GO:0071985,1,0.0481387233813801,0,28,multivesicular body sorting pathway,BP,
15531,GO:0071986,1,0.528134336169664,0,6,Ragulator complex,CC,
15559,GO:0072048,1,0.487570167580176,0,7,renal system pattern specification,BP,
15577,GO:0072079,1,0.320195121218048,0,11,nephron tubule formation,BP,
15601,GO:0072110,1,0.472638693832952,0,7,glomerular mesangial cell proliferation,BP,
15605,GO:0072124,1,0.472638693832952,0,7,regulation of glomerular mesangial cell proliferation,BP,
15624,GO:0072148,1,0.269968780213594,0,12,epithelial cell fate commitment,BP,
15635,GO:0072173,1,0.444835870314506,0,7,metanephric tubule morphogenesis,BP,
15640,GO:0072178,1,0.55511341531976,0,5,nephric duct morphogenesis,BP,
15698,GO:0072282,1,0.501381002129943,0,6,metanephric nephron tubule morphogenesis,BP,
15719,GO:0072318,1,0.55369548089042,0,5,clathrin coat disassembly,BP,
15720,GO:0072319,1,0.499024378754199,0,6,vesicle uncoating,BP,
15722,GO:0072321,1,0.402677530491392,0,10,chaperone-mediated protein transport,BP,
15728,GO:0072337,1,0.258366378586271,0,12,modified amino acid transport,BP,
15733,GO:0072345,1,0.563764069470278,0,5,NAADP-sensitive calcium-release channel activity,MF,
15735,GO:0072348,1,0.0947830660681079,0,21,sulfur compound transport,BP,
15736,GO:0072349,1,0.338378003357801,0,9,modified amino acid transmembrane transporter activity,MF,
15741,GO:0072357,1,0.437768311950913,0,7,PTW/PP1 phosphatase complex,CC,
15757,GO:0072383,1,0.420202537170073,0,7,plus-end-directed vesicle transport along microtubule,BP,
15760,GO:0072386,1,0.369574636024254,0,8,plus-end-directed organelle transport along microtubule,BP,
15764,GO:0072393,1,0.257597847756027,0,11,microtubule anchoring at microtubule organizing center,BP,
15766,GO:0072396,1,0.503436762309105,0,6,response to cell cycle checkpoint signaling,BP,
15768,GO:0072402,1,0.503436762309105,0,6,response to DNA integrity checkpoint signaling,BP,
15772,GO:0072423,1,0.503436762309105,0,6,response to DNA damage checkpoint signaling,BP,
15773,GO:0072425,1,0.281097409941423,0,11,signal transduction involved in G2 DNA damage checkpoint,BP,
15779,GO:0072487,1,0.571143841377729,0,5,MSL complex,CC,
15780,GO:0072488,1,0.470871360609184,0,7,ammonium transmembrane transport,BP,
15790,GO:0072509,1,0.131403186491433,0,18,divalent inorganic cation transmembrane transporter activity,MF,
15807,GO:0072530,1,0.431052436451272,0,8,purine-containing compound transmembrane transport,BP,
15808,GO:0072531,1,0.526757386609154,0,6,pyrimidine-containing compound transmembrane transport,BP,
15816,GO:0072542,1,0.476609591825069,0,7,protein phosphatase activator activity,MF,
15818,GO:0072546,1,0.340876792823388,0,10,ER membrane protein complex,CC,
15825,GO:0072559,1,0.561022145693392,0,6,NLRP3 inflammasome complex,CC,
15845,GO:0072588,1,0.634213101330257,0,8,box H/ACA RNP complex,CC,
15853,GO:0072599,1,0.000716934879710224,0,104,establishment of protein localization to endoplasmic reticulum,BP,
15864,GO:0072641,1,0.479404782261232,0,6,type I interferon secretion,BP,
15865,GO:0072642,1,0.479404782261232,0,6,interferon-alpha secretion,BP,
15866,GO:0072643,1,0.359206992493414,0,9,interferon-gamma secretion,BP,
15868,GO:0072656,1,0.595832408991894,0,5,maintenance of protein location in mitochondrion,BP,
15877,GO:0072669,1,0.544677572989754,0,7,tRNA-splicing ligase complex,CC,
15884,GO:0072677,1,0.536965238236204,0,6,eosinophil migration,BP,
15895,GO:0072697,1,0.286832268229022,0,11,protein localization to cell cortex,BP,
15930,GO:0075136,1,0.519717118626007,0,6,response to host,BP,
15935,GO:0075522,1,0.337493125984293,0,10,IRES-dependent viral translational initiation,BP,
15936,GO:0075525,1,0.59599274689922,0,5,viral translational termination-reinitiation,BP,
15939,GO:0075713,1,0.435771497773983,0,8,establishment of integrated proviral latency,BP,
15943,GO:0080009,1,0.351367009386812,0,10,mRNA methylation,BP,
15949,GO:0080084,1,0.551670063685318,0,5,5S rDNA binding,MF,
15967,GO:0085020,1,0.502040673763256,0,7,protein K6-linked ubiquitination,BP,
15973,GO:0086004,1,0.0932615589574552,0,20,regulation of cardiac muscle cell contraction,BP,
16001,GO:0086042,1,0.481991363129829,0,6,cardiac muscle cell-cardiac muscle cell adhesion,BP,
16018,GO:0086069,1,0.354587956055529,0,9,bundle of His cell to Purkinje myocyte communication,BP,
16021,GO:0086073,1,0.535326809211033,0,5,bundle of His cell-Purkinje myocyte adhesion involved in cell communication,BP,
16029,GO:0086083,1,0.535326809211033,0,5,cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication,MF,
16038,GO:0089701,1,0.647768828309026,0,5,U2AF,CC,
16042,GO:0089720,1,0.560573046124794,0,6,caspase binding,MF,
16044,GO:0090022,1,0.158480109905356,0,19,regulation of neutrophil chemotaxis,BP,
16045,GO:0090023,1,0.224206604891325,0,16,positive regulation of neutrophil chemotaxis,BP,
16058,GO:0090042,1,0.365265653680326,0,9,tubulin deacetylation,BP,
16059,GO:0090043,1,0.457077482404003,0,7,regulation of tubulin deacetylation,BP,
16061,GO:0090045,1,0.525249806079707,0,6,positive regulation of deacetylase activity,BP,
16070,GO:0090069,1,0.239465897172551,0,13,regulation of ribosome biogenesis,BP,
16071,GO:0090070,1,0.435455828051083,0,8,positive regulation of ribosome biogenesis,BP,
16073,GO:0090073,1,0.434668641391852,0,8,positive regulation of protein homodimerization activity,BP,
16074,GO:0090074,1,0.570346627828558,0,5,negative regulation of protein homodimerization activity,BP,
16083,GO:0090085,1,0.308258627383478,0,11,regulation of protein deubiquitination,BP,
16101,GO:0090110,1,0.215291317405943,0,13,cargo loading into COPII-coated vesicle,BP,
16120,GO:0090151,1,0.369591874030518,0,12,establishment of protein localization to mitochondrial membrane,BP,
16125,GO:0090158,1,0.59152553140342,0,5,endoplasmic reticulum membrane organization,BP,
16126,GO:0090160,1,0.398850256232314,0,8,Golgi to lysosome transport,BP,
16127,GO:0090161,1,0.267644288281504,0,11,Golgi ribbon formation,BP,
16130,GO:0090166,1,0.520306070813259,0,6,Golgi disassembly,BP,
16148,GO:0090189,1,0.246941704539516,0,13,regulation of branching involved in ureteric bud morphogenesis,BP,
16149,GO:0090190,1,0.302431017386065,0,11,positive regulation of branching involved in ureteric bud morphogenesis,BP,
16182,GO:0090235,1,0.421545883363811,0,7,regulation of metaphase plate congression,BP,
16185,GO:0090239,1,0.313200330213621,0,11,regulation of histone H4 acetylation,BP,
16186,GO:0090240,1,0.487228253175068,0,7,positive regulation of histone H4 acetylation,BP,
16200,GO:0090266,1,0.247496592673437,0,13,regulation of mitotic cell cycle spindle assembly checkpoint,BP,
16201,GO:0090267,1,0.46542665465393,0,7,positive regulation of mitotic cell cycle spindle assembly checkpoint,BP,
16210,GO:0090280,1,0.566646639280565,0,5,positive regulation of calcium ion import,BP,
16232,GO:0090308,1,0.382293727753993,0,8,regulation of methylation-dependent chromatin silencing,BP,
16257,GO:0090344,1,0.124630158558431,0,19,negative regulation of cell aging,BP,
16274,GO:0090398,1,0.00385974745190806,0,51,cellular senescence,BP,
16275,GO:0090399,1,0.290834132811267,0,11,replicative senescence,BP,
16276,GO:0090400,1,0.4544366609185,0,7,stress-induced premature senescence,BP,
16286,GO:0090435,1,0.485115619619751,0,7,protein localization to nuclear envelope,BP,
16290,GO:0090481,1,0.34895560811414,0,10,pyrimidine nucleotide-sugar transmembrane transport,BP,
16292,GO:0090493,1,0.575557917419241,0,6,catecholamine uptake,BP,
16293,GO:0090494,1,0.575557917419241,0,6,dopamine uptake,BP,
16299,GO:0090504,1,0.0507926781588445,0,26,epiboly,BP,
16300,GO:0090505,1,0.0582857980882418,0,25,epiboly involved in wound healing,BP,
16301,GO:0090520,1,0.369494279800677,0,9,sphingolipid mediated signaling pathway,BP,
16305,GO:0090533,1,0.448436164850373,0,7,cation-transporting ATPase complex,CC,
16319,GO:0090576,1,0.40582169078547,0,8,RNA polymerase III transcription factor complex,CC,
16326,GO:0090611,1,0.582058032983818,0,5,ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway,BP,
16333,GO:0090646,1,0.287973703132007,0,12,mitochondrial tRNA processing,BP,
16334,GO:0090647,1,0.520933557402397,0,6,modulation of age-related behavioral decline,BP,
16335,GO:0090649,1,0.549062849311131,0,5,response to oxygen-glucose deprivation,BP,
16336,GO:0090650,1,0.549062849311131,0,5,cellular response to oxygen-glucose deprivation,BP,
16340,GO:0090661,1,0.721610461238863,0,5,box H/ACA telomerase RNP complex,CC,
16355,GO:0090713,1,0.587499123720664,0,5,immunological memory process,BP,
16356,GO:0090715,1,0.587499123720664,0,5,immunological memory formation process,BP,
16358,GO:0090723,1,0.300744498462612,0,11,growth cone part,CC,
16363,GO:0090735,1,0.359890674928322,0,10,DNA repair complex assembly,BP,
16384,GO:0097028,1,0.170372012221635,0,17,dendritic cell differentiation,BP,
16394,GO:0097050,1,0.406638668284422,0,8,type B pancreatic cell apoptotic process,BP,
16405,GO:0097064,1,0.0158254984390623,0,37,ncRNA export from nucleus,BP,
16412,GO:0097084,1,0.516427988218551,0,6,vascular smooth muscle cell development,BP,
16418,GO:0097100,1,0.609032364827261,0,5,supercoiled DNA binding,MF,
16443,GO:0097136,1,0.532177121186223,0,6,Bcl-2 family protein complex,CC,
16447,GO:0097150,1,0.114987605258852,0,18,neuronal stem cell population maintenance,BP,
16449,GO:0097152,1,0.446224143568139,0,7,mesenchymal cell apoptotic process,BP,
16454,GO:0097157,1,0.399604471379754,0,8,pre-mRNA intronic binding,MF,
16460,GO:0097165,1,0.565958512243057,0,5,nuclear stress granule,CC,
16479,GO:0097197,1,0.575057263560128,0,5,tetraspanin-enriched microdomain,CC,
16481,GO:0097199,1,0.608619657790338,0,5,cysteine-type endopeptidase activity involved in apoptotic signaling pathway,MF,
16509,GO:0097255,1,0.610837326733181,0,5,R2TP complex,CC,
16531,GO:0097322,1,0.511339312495416,0,6,7SK snRNA binding,MF,
16539,GO:0097342,1,0.516055228966102,0,6,ripoptosome,CC,
16543,GO:0097346,1,0.0936976839971355,0,23,INO80-type complex,CC,
16546,GO:0097354,1,0.369667996135237,0,9,prenylation,BP,
16560,GO:0097381,1,0.552108480739016,0,5,photoreceptor disc membrane,CC,
16575,GO:0097418,1,0.561811809889337,0,5,neurofibrillary tangle,CC,
16577,GO:0097422,1,0.575239744662455,0,5,tubular endosome,CC,
16579,GO:0097427,1,0.550504084521117,0,5,microtubule bundle,CC,
16582,GO:0097433,1,0.582081336971608,0,5,dense body,CC,
16584,GO:0097440,1,0.270805189939103,0,11,apical dendrite,CC,
16590,GO:0097449,1,0.51583283144884,0,6,astrocyte projection,CC,
16622,GO:0097504,1,0.313919483702271,0,11,Gemini of coiled bodies,CC,
16624,GO:0097506,1,0.613319167473931,0,5,deaminated base DNA N-glycosylase activity,MF,
16631,GO:0097526,1,0.0686262146771279,0,29,spliceosomal tri-snRNP complex,CC,
16641,GO:0097539,1,0.307027776292544,0,10,ciliary transition fiber,CC,
16646,GO:0097550,1,0.540293277706004,0,6,transcriptional preinitiation complex,CC,
16655,GO:0097602,1,0.170730427152251,0,17,cullin family protein binding,MF,
16683,GO:0097677,1,0.543491057653505,0,6,STAT family protein binding,MF,
16707,GO:0097732,1,0.599717800892934,0,5,9+2 non-motile cilium,CC,
16709,GO:0097734,1,0.169558355964024,0,17,extracellular exosome biogenesis,BP,
16719,GO:0098501,1,0.609850649973145,0,5,polynucleotide dephosphorylation,BP,
16723,GO:0098505,1,0.335418955151035,0,10,G-rich strand telomeric DNA binding,MF,
16728,GO:0098519,1,0.581050591700721,0,5,nucleotide phosphatase activity, acting on free nucleotides,MF,
16732,GO:0098532,1,0.587081123288035,0,6,histone H3-K27 trimethylation,BP,
16738,GO:0098543,1,0.454273025284996,0,7,detection of other organism,BP,
16743,GO:0098556,1,0.763563040978017,0,5,cytoplasmic side of rough endoplasmic reticulum membrane,CC,
16748,GO:0098573,1,0.0012344331025927,0,66,intrinsic component of mitochondrial membrane,CC,
16753,GO:0098581,1,0.408769412292155,0,8,detection of external biotic stimulus,BP,
16764,GO:0098599,1,0.348835217150553,0,10,palmitoyl hydrolase activity,MF,
16778,GO:0098642,1,0.4692663754927,0,6,network-forming collagen trimer,CC,
16781,GO:0098645,1,0.4692663754927,0,6,collagen network,CC,
16785,GO:0098651,1,0.4692663754927,0,6,basement membrane collagen trimer,CC,
16801,GO:0098703,1,0.494855859239026,0,6,calcium ion import across plasma membrane,BP,
16807,GO:0098719,1,0.336028473272928,0,9,sodium ion import across plasma membrane,BP,
16813,GO:0098734,1,0.348835217150553,0,10,macromolecule depalmitoylation,BP,
16837,GO:0098781,1,5.64892288227453e-05,0,93,ncRNA transcription,BP,
16839,GO:0098789,1,0.28314492439758,0,11,pre-mRNA cleavage required for polyadenylation,BP,
16848,GO:0098799,1,0.326368469209441,0,12,outer mitochondrial membrane protein complex,CC,
16910,GO:0098909,1,0.569720610561695,0,5,regulation of cardiac muscle cell action potential involved in regulation of contraction,BP,
16911,GO:0098910,1,0.541077648680324,0,5,regulation of atrial cardiac muscle cell action potential,BP,
16912,GO:0098911,1,0.33281237194942,0,9,regulation of ventricular cardiac muscle cell action potential,BP,
16935,GO:0098960,1,0.576347305559099,0,5,postsynaptic neurotransmitter receptor activity,MF,
16974,GO:0099078,1,0.46999032774082,0,8,BORC complex,CC,
16988,GO:0099116,1,0.229209304631239,0,16,tRNA 5'-end processing,BP,
16994,GO:0099133,1,0.368610107150069,0,8,ATP hydrolysis coupled anion transmembrane transport,BP,
17011,GO:0099500,1,0.345899502166675,0,10,vesicle fusion to plasma membrane,BP,
17030,GO:0099529,1,0.576347305559099,0,5,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential,MF,
17048,GO:0099563,1,0.248174174469935,0,12,modification of synaptic structure,BP,
17060,GO:0099602,1,0.556426875291242,0,6,neurotransmitter receptor regulator activity,MF,
17095,GO:0101031,1,0.309181172854547,0,11,chaperone complex,CC,
17113,GO:0102336,1,0.584514507810071,0,5,3-oxo-arachidoyl-CoA synthase activity,MF,
17114,GO:0102337,1,0.584514507810071,0,5,3-oxo-cerotoyl-CoA synthase activity,MF,
17115,GO:0102338,1,0.584514507810071,0,5,3-oxo-lignoceronyl-CoA synthase activity,MF,
17146,GO:0102756,1,0.584514507810071,0,5,very-long-chain 3-ketoacyl-CoA synthase activity,MF,
17174,GO:0106018,1,0.178894950936085,0,14,phosphatidylinositol-3,5-bisphosphate phosphatase activity,MF,
17175,GO:0106019,1,0.302878425598248,0,10,phosphatidylinositol-4,5-bisphosphate phosphatase activity,MF,
17184,GO:0106049,1,0.575102178264311,0,5,regulation of cellular response to osmotic stress,BP,
17194,GO:0106074,1,0.259531902257712,0,12,aminoacyl-tRNA metabolism involved in translational fidelity,BP,
17206,GO:0110011,1,0.524500899078806,0,5,regulation of basement membrane organization,BP,
17222,GO:0110096,1,0.640406941663724,0,5,cellular response to aldehyde,BP,
17223,GO:0120009,1,0.577905699856743,0,5,intermembrane lipid transfer,BP,
17225,GO:0120013,1,0.577905699856743,0,5,intermembrane lipid transfer activity,MF,
17264,GO:0140035,1,0.496829670322196,0,6,ubiquitination-like modification-dependent protein binding,MF,
17265,GO:0140036,1,0.496829670322196,0,6,ubiquitin-dependent protein binding,MF,
17271,GO:0140059,1,0.564465590849859,0,5,dendrite arborization,BP,
17279,GO:0140078,1,0.380577759135879,0,10,class I DNA-(apurinic or apyrimidinic site) endonuclease activity,MF,
17280,GO:0140080,1,0.380577759135879,0,10,class III/IV DNA-(apurinic or apyrimidinic site) endonuclease activity,MF,
17290,GO:0140115,1,0.350729008408135,0,9,export across plasma membrane,BP,
17317,GO:1900017,1,0.368796720095271,0,9,positive regulation of cytokine production involved in inflammatory response,BP,
17326,GO:1900034,1,0.000292074099219674,0,72,regulation of cellular response to heat,BP,
17329,GO:1900038,1,0.523008602056117,0,6,negative regulation of cellular response to hypoxia,BP,
17331,GO:1900040,1,0.556097596697972,0,5,regulation of interleukin-2 secretion,BP,
17334,GO:1900044,1,0.374662422021899,0,8,regulation of protein K63-linked ubiquitination,BP,
17335,GO:1900045,1,0.544099940455677,0,5,negative regulation of protein K63-linked ubiquitination,BP,
17356,GO:1900102,1,0.297294817513175,0,11,negative regulation of endoplasmic reticulum unfolded protein response,BP,
17370,GO:1900118,1,0.466422399197928,0,7,negative regulation of execution phase of apoptosis,BP,
17375,GO:1900125,1,0.502160703914044,0,6,regulation of hyaluronan biosynthetic process,BP,
17408,GO:1900193,1,0.588504162327078,0,5,regulation of oocyte maturation,BP,
17427,GO:1900225,1,0.355360894871651,0,9,regulation of NLRP3 inflammasome complex assembly,BP,
17433,GO:1900242,1,0.485407241199259,0,6,regulation of synaptic vesicle endocytosis,BP,
17438,GO:1900247,1,0.294524844284965,0,11,regulation of cytoplasmic translational elongation,BP,
17442,GO:1900262,1,0.546319676839276,0,6,regulation of DNA-directed DNA polymerase activity,BP,
17443,GO:1900264,1,0.546319676839276,0,6,positive regulation of DNA-directed DNA polymerase activity,BP,
17450,GO:1900363,1,0.25298321789236,0,12,regulation of mRNA polyadenylation,BP,
17451,GO:1900364,1,0.397679861279536,0,8,negative regulation of mRNA polyadenylation,BP,
17466,GO:1900408,1,0.03149000573541,0,33,negative regulation of cellular response to oxidative stress,BP,
17469,GO:1900425,1,0.574148852710012,0,5,negative regulation of defense response to bacterium,BP,
17500,GO:1900864,1,0.399897179997859,0,9,mitochondrial RNA modification,BP,
17512,GO:1901029,1,0.506157060391244,0,7,negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,BP,
17515,GO:1901032,1,0.270583962600539,0,13,negative regulation of response to reactive oxygen species,BP,
17519,GO:1901070,1,0.327782106452781,0,13,guanosine-containing compound biosynthetic process,BP,
17520,GO:1901071,1,0.169010568724117,0,16,glucosamine-containing compound metabolic process,BP,
17521,GO:1901072,1,0.589999585114013,0,5,glucosamine-containing compound catabolic process,BP,
17532,GO:1901096,1,0.308456596503652,0,10,regulation of autophagosome maturation,BP,
17534,GO:1901098,1,0.480053987031492,0,6,positive regulation of autophagosome maturation,BP,
17543,GO:1901159,1,0.626951062701395,0,5,xylulose 5-phosphate biosynthetic process,BP,
17544,GO:1901160,1,0.452055446257854,0,7,primary amino compound metabolic process,BP,
17557,GO:1901201,1,0.260114872250389,0,11,regulation of extracellular matrix assembly,BP,
17559,GO:1901203,1,0.368694077015095,0,8,positive regulation of extracellular matrix assembly,BP,
17561,GO:1901213,1,0.410878133609509,0,8,regulation of transcription from RNA polymerase II promoter involved in heart development,BP,
17566,GO:1901223,1,0.436939425688234,0,8,negative regulation of NIK/NF-kappaB signaling,BP,
17591,GO:1901299,1,0.592843684899821,0,5,negative regulation of hydrogen peroxide-mediated programmed cell death,BP,
17631,GO:1901407,1,0.379717425264538,0,9,regulation of phosphorylation of RNA polymerase II C-terminal domain,BP,
17632,GO:1901409,1,0.478972585142242,0,7,positive regulation of phosphorylation of RNA polymerase II C-terminal domain,BP,
17646,GO:1901525,1,0.497946832768472,0,6,negative regulation of mitophagy,BP,
17650,GO:1901533,1,0.534756057318372,0,6,negative regulation of hematopoietic progenitor cell differentiation,BP,
17652,GO:1901535,1,0.54069554173286,0,5,regulation of DNA demethylation,BP,
17655,GO:1901538,1,0.497883496904923,0,6,changes to DNA methylation involved in embryo development,BP,
17657,GO:1901550,1,0.393322313972297,0,8,regulation of endothelial cell development,BP,
17663,GO:1901563,1,0.559419314597433,0,5,response to camptothecin,BP,
17683,GO:1901612,1,0.537057040137466,0,6,cardiolipin binding,MF,
17687,GO:1901618,1,0.182538472537267,0,15,organic hydroxy compound transmembrane transporter activity,MF,
17709,GO:1901660,1,0.494907151461852,0,6,calcium ion export,BP,
17712,GO:1901663,1,0.254613775289238,0,14,quinone biosynthetic process,BP,
17722,GO:1901679,1,0.427677453072758,0,8,nucleotide transmembrane transport,BP,
17725,GO:1901682,1,0.127755763498619,0,18,sulfur compound transmembrane transporter activity,MF,
17734,GO:1901722,1,0.308852785424905,0,11,regulation of cell proliferation involved in kidney development,BP,
17735,GO:1901723,1,0.581496560697922,0,5,negative regulation of cell proliferation involved in kidney development,BP,
17736,GO:1901724,1,0.531282313401178,0,6,positive regulation of cell proliferation involved in kidney development,BP,
17737,GO:1901725,1,0.487264939570855,0,6,regulation of histone deacetylase activity,BP,
17756,GO:1901836,1,0.298963028267901,0,11,regulation of transcription of nucleolar large rRNA by RNA polymerase I,BP,
17758,GO:1901838,1,0.36723852806155,0,9,positive regulation of transcription of nucleolar large rRNA by RNA polymerase I,BP,
17762,GO:1901844,1,0.461252289186316,0,7,regulation of cell communication by electrical coupling involved in cardiac conduction,BP,
17764,GO:1901857,1,0.63462206732408,0,5,positive regulation of cellular respiration,BP,
17796,GO:1901970,1,0.428008523469902,0,8,positive regulation of mitotic sister chromatid separation,BP,
17798,GO:1901977,1,0.52346978459597,0,6,negative regulation of cell cycle checkpoint,BP,
17804,GO:1901984,1,0.146702676921248,0,18,negative regulation of protein acetylation,BP,
17817,GO:1902004,1,0.366661920127336,0,9,positive regulation of amyloid-beta formation,BP,
17824,GO:1902031,1,0.52669258380464,0,6,regulation of NADP metabolic process,BP,
17835,GO:1902047,1,0.588236164796454,0,5,polyamine transmembrane transport,BP,
17839,GO:1902074,1,0.279925089477758,0,12,response to salt,BP,
17840,GO:1902075,1,0.537093896245168,0,6,cellular response to salt,BP,
17844,GO:1902099,1,0.0083075021465078,0,45,regulation of metaphase/anaphase transition of cell cycle,BP,
17845,GO:1902100,1,0.0387363200787464,0,30,negative regulation of metaphase/anaphase transition of cell cycle,BP,
17846,GO:1902101,1,0.428008523469902,0,8,positive regulation of metaphase/anaphase transition of cell cycle,BP,
17864,GO:1902165,1,0.256226556315099,0,15,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,
17865,GO:1902166,1,0.299082268158213,0,13,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,
17872,GO:1902176,1,0.203714027427816,0,16,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,BP,
17875,GO:1902186,1,0.0400576085394883,0,29,regulation of viral release from host cell,BP,
17876,GO:1902187,1,0.202725303760794,0,14,negative regulation of viral release from host cell,BP,
17877,GO:1902188,1,0.200427374256795,0,15,positive regulation of viral release from host cell,BP,
17886,GO:1902218,1,0.575102178264311,0,5,regulation of intrinsic apoptotic signaling pathway in response to osmotic stress,BP,
17897,GO:1902231,1,0.590264561709475,0,6,positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage,BP,
17901,GO:1902236,1,0.253644411643656,0,13,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,BP,
17932,GO:1902306,1,0.408439418350485,0,8,negative regulation of sodium ion transmembrane transport,BP,
17945,GO:1902358,1,0.504636908396118,0,6,sulfate transmembrane transport,BP,
17964,GO:1902410,1,0.515748734904348,0,6,mitotic cytokinetic process,BP,
17967,GO:1902415,1,0.386350924559444,0,9,regulation of mRNA binding,BP,
17968,GO:1902416,1,0.474731905982744,0,7,positive regulation of mRNA binding,BP,
17977,GO:1902459,1,0.538299583729094,0,5,positive regulation of stem cell population maintenance,BP,
17998,GO:1902513,1,0.508050627754902,0,6,regulation of organelle transport along microtubule,BP,
18002,GO:1902525,1,0.621131765186846,0,5,regulation of protein monoubiquitination,BP,
18028,GO:1902581,1,0.599050914401797,0,5,multi-organism cellular localization,BP,
18029,GO:1902583,1,0.599050914401797,0,5,multi-organism intracellular transport,BP,
18042,GO:1902622,1,0.112371902392109,0,22,regulation of neutrophil migration,BP,
18044,GO:1902624,1,0.158991213488143,0,19,positive regulation of neutrophil migration,BP,
18052,GO:1902656,1,0.494855859239026,0,6,calcium ion import into cytosol,BP,
18057,GO:1902669,1,0.419285608372545,0,7,positive regulation of axon guidance,BP,
18080,GO:1902739,1,0.479404782261232,0,6,regulation of interferon-alpha secretion,BP,
18081,GO:1902741,1,0.479404782261232,0,6,positive regulation of interferon-alpha secretion,BP,
18085,GO:1902745,1,0.111857142445857,0,19,positive regulation of lamellipodium organization,BP,
18089,GO:1902751,1,0.080554860817779,0,23,positive regulation of cell cycle G2/M phase transition,BP,
18114,GO:1902855,1,0.32896256071538,0,10,regulation of non-motile cilium assembly,BP,
18116,GO:1902857,1,0.466312941445198,0,7,positive regulation of non-motile cilium assembly,BP,
18131,GO:1902895,1,0.112451660573272,0,19,positive regulation of pri-miRNA transcription by RNA polymerase II,BP,
18134,GO:1902902,1,0.316742575117478,0,11,negative regulation of autophagosome assembly,BP,
18144,GO:1902915,1,0.480571591766631,0,6,negative regulation of protein polyubiquitination,BP,
18155,GO:1902946,1,0.374492025973332,0,8,protein localization to early endosome,BP,
18168,GO:1902959,1,0.39926112769798,0,8,regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process,BP,
18170,GO:1902961,1,0.508496643049595,0,6,positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process,BP,
18173,GO:1902965,1,0.472693788613283,0,6,regulation of protein localization to early endosome,BP,
18174,GO:1902966,1,0.472693788613283,0,6,positive regulation of protein localization to early endosome,BP,
18183,GO:1902993,1,0.297920699600743,0,11,positive regulation of amyloid precursor protein catabolic process,BP,
18191,GO:1903003,1,0.51433584948911,0,6,positive regulation of protein deubiquitination,BP,
18201,GO:1903020,1,0.190751916080592,0,15,positive regulation of glycoprotein metabolic process,BP,
18202,GO:1903025,1,0.487660889984231,0,8,regulation of RNA polymerase II regulatory region sequence-specific DNA binding,BP,
18203,GO:1903026,1,0.688472589391245,0,5,negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding,BP,
18223,GO:1903055,1,0.242100649506187,0,12,positive regulation of extracellular matrix organization,BP,
18226,GO:1903069,1,0.383732584561436,0,9,regulation of ER-associated ubiquitin-dependent protein catabolic process,BP,
18228,GO:1903071,1,0.473495027466926,0,7,positive regulation of ER-associated ubiquitin-dependent protein catabolic process,BP,
18232,GO:1903077,1,0.147356775198229,0,17,negative regulation of protein localization to plasma membrane,BP,
18240,GO:1903115,1,0.083896442485344,0,21,regulation of actin filament-based movement,BP,
18249,GO:1903140,1,0.393322313972297,0,8,regulation of establishment of endothelial barrier,BP,
18254,GO:1903147,1,0.422945321683144,0,8,negative regulation of autophagy of mitochondrion,BP,
18274,GO:1903202,1,0.03149000573541,0,33,negative regulation of oxidative stress-induced cell death,BP,
18276,GO:1903204,1,0.21119758069678,0,14,negative regulation of oxidative stress-induced neuron death,BP,
18278,GO:1903206,1,0.270583962600539,0,13,negative regulation of hydrogen peroxide-induced cell death,BP,
18298,GO:1903251,1,0.567133369666127,0,5,multi-ciliated epithelial cell differentiation,BP,
18300,GO:1903265,1,0.444940691517127,0,8,positive regulation of tumor necrosis factor-mediated signaling pathway,BP,
18314,GO:1903297,1,0.59020916408815,0,5,regulation of hypoxia-induced intrinsic apoptotic signaling pathway,BP,
18315,GO:1903298,1,0.59020916408815,0,5,negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway,BP,
18320,GO:1903306,1,0.25438223296526,0,12,negative regulation of regulated secretory pathway,BP,
18331,GO:1903332,1,0.488812394698373,0,7,regulation of protein folding,BP,
18332,GO:1903333,1,0.61252090211661,0,5,negative regulation of protein folding,BP,
18339,GO:1903350,1,0.291853318339783,0,11,response to dopamine,BP,
18340,GO:1903351,1,0.291853318339783,0,11,cellular response to dopamine,BP,
18343,GO:1903361,1,0.586332721333088,0,5,protein localization to basolateral plasma membrane,BP,
18367,GO:1903405,1,0.392428044757062,0,9,protein localization to nuclear body,BP,
18403,GO:1903504,1,0.247496592673437,0,13,regulation of mitotic spindle checkpoint,BP,
18420,GO:1903525,1,0.537741298029786,0,5,regulation of membrane tubulation,BP,
18431,GO:1903541,1,0.22951094535722,0,14,regulation of exosomal secretion,BP,
18433,GO:1903543,1,0.22951094535722,0,14,positive regulation of exosomal secretion,BP,
18438,GO:1903551,1,0.522905273456267,0,6,regulation of extracellular exosome assembly,BP,
18452,GO:1903573,1,0.0206587729820973,0,36,negative regulation of response to endoplasmic reticulum stress,BP,
18460,GO:1903587,1,0.586886406121147,0,5,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,
18468,GO:1903608,1,0.447517205888804,0,7,protein localization to cytoplasmic stress granule,BP,
18495,GO:1903689,1,0.45799134370755,0,6,regulation of wound healing, spreading of epidermal cells,BP,
18535,GO:1903772,1,0.612313693532686,0,5,regulation of viral budding via host ESCRT complex,BP,
18550,GO:1903799,1,0.390167849854181,0,8,negative regulation of production of miRNAs involved in gene silencing by miRNA,BP,
18577,GO:1903862,1,0.610186980220989,0,5,positive regulation of oxidative phosphorylation,BP,
18592,GO:1903897,1,0.366477796583708,0,9,regulation of PERK-mediated unfolded protein response,BP,
18593,GO:1903898,1,0.576990852038422,0,5,negative regulation of PERK-mediated unfolded protein response,BP,
18614,GO:1903935,1,0.531727460050514,0,6,response to sodium arsenite,BP,
18615,GO:1903936,1,0.596660096392615,0,5,cellular response to sodium arsenite,BP,
18694,GO:1904152,1,0.278926579119295,0,12,regulation of retrograde protein transport, ER to cytosol,BP,
18695,GO:1904153,1,0.385420275662622,0,9,negative regulation of retrograde protein transport, ER to cytosol,BP,
18744,GO:1904259,1,0.524500899078806,0,5,regulation of basement membrane assembly involved in embryonic body morphogenesis,BP,
18745,GO:1904261,1,0.524500899078806,0,5,positive regulation of basement membrane assembly involved in embryonic body morphogenesis,BP,
18747,GO:1904263,1,0.428639919919932,0,8,positive regulation of TORC1 signaling,BP,
18758,GO:1904292,1,0.0569707731836565,0,26,regulation of ERAD pathway,BP,
18759,GO:1904293,1,0.248581974560151,0,13,negative regulation of ERAD pathway,BP,
18760,GO:1904294,1,0.234258563162361,0,13,positive regulation of ERAD pathway,BP,
18768,GO:1904315,1,0.576347305559099,0,5,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential,MF,
18771,GO:1904321,1,0.377319999971592,0,8,response to forskolin,BP,
18772,GO:1904322,1,0.377319999971592,0,8,cellular response to forskolin,BP,
18783,GO:1904355,1,0.168827961289922,0,16,positive regulation of telomere capping,BP,
18788,GO:1904376,1,0.11831268079248,0,19,negative regulation of protein localization to cell periphery,BP,
18830,GO:1904467,1,0.300266177706209,0,10,regulation of tumor necrosis factor secretion,BP,
18832,GO:1904469,1,0.420186464351223,0,7,positive regulation of tumor necrosis factor secretion,BP,
18841,GO:1904502,1,0.552614842347337,0,5,regulation of lipophagy,BP,
18842,GO:1904504,1,0.552614842347337,0,5,positive regulation of lipophagy,BP,
18848,GO:1904528,1,0.524832010457539,0,6,positive regulation of microtubule binding,BP,
18903,GO:1904666,1,0.200470547455821,0,18,regulation of ubiquitin protein ligase activity,BP,
18904,GO:1904667,1,0.6756470121517,0,6,negative regulation of ubiquitin protein ligase activity,BP,
18905,GO:1904668,1,0.296828100373612,0,12,positive regulation of ubiquitin protein ligase activity,BP,
18909,GO:1904680,1,0.129299966972373,0,21,peptide transmembrane transporter activity,MF,
18911,GO:1904683,1,0.477093204532736,0,6,regulation of metalloendopeptidase activity,BP,
18914,GO:1904688,1,0.595168315518377,0,5,regulation of cytoplasmic translational initiation,BP,
18929,GO:1904714,1,0.519400422676221,0,6,regulation of chaperone-mediated autophagy,BP,
18961,GO:1904776,1,0.497759214126157,0,6,regulation of protein localization to cell cortex,BP,
18963,GO:1904778,1,0.55380206528646,0,5,positive regulation of protein localization to cell cortex,BP,
18972,GO:1904796,1,0.572462103968495,0,5,regulation of core promoter binding,BP,
18982,GO:1904814,1,0.252002678848876,0,13,regulation of protein localization to chromosome, telomeric region,BP,
18984,GO:1904816,1,0.310515137999363,0,11,positive regulation of protein localization to chromosome, telomeric region,BP,
19000,GO:1904851,1,0.391743426608733,0,9,positive regulation of establishment of protein localization to telomere,BP,
19004,GO:1904867,1,0.392428044757062,0,9,protein localization to Cajal body,BP,
19006,GO:1904869,1,0.434019706794316,0,8,regulation of protein localization to Cajal body,BP,
19007,GO:1904871,1,0.434019706794316,0,8,positive regulation of protein localization to Cajal body,BP,
19009,GO:1904874,1,0.236591984585251,0,15,positive regulation of telomerase RNA localization to Cajal body,BP,
19019,GO:1904885,1,0.551903153706112,0,5,beta-catenin destruction complex assembly,BP,
19044,GO:1904938,1,0.536068185064916,0,5,planar cell polarity pathway involved in axon guidance,BP,
19069,GO:1904994,1,0.578996277437909,0,5,regulation of leukocyte adhesion to vascular endothelial cell,BP,
19075,GO:1905005,1,0.496472759522997,0,6,regulation of epithelial to mesenchymal transition involved in endocardial cushion formation,BP,
19077,GO:1905007,1,0.549334624663655,0,5,positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation,BP,
19092,GO:1905048,1,0.23720044419694,0,13,regulation of metallopeptidase activity,BP,
19093,GO:1905049,1,0.501065547306832,0,6,negative regulation of metallopeptidase activity,BP,
19094,GO:1905050,1,0.473589998367303,0,7,positive regulation of metallopeptidase activity,BP,
19148,GO:1905214,1,0.298774252157456,0,11,regulation of RNA binding,BP,
19150,GO:1905216,1,0.417649858337265,0,8,positive regulation of RNA binding,BP,
19156,GO:1905244,1,0.392378690293164,0,8,regulation of modification of synaptic structure,BP,
19157,GO:1905245,1,0.39926112769798,0,8,regulation of aspartic-type peptidase activity,BP,
19159,GO:1905247,1,0.508496643049595,0,6,positive regulation of aspartic-type peptidase activity,BP,
19186,GO:1905314,1,0.339960405126351,0,9,semi-lunar valve development,BP,
19191,GO:1905323,1,0.501322650906403,0,6,telomerase holoenzyme complex assembly,BP,
19194,GO:1905332,1,0.0931458694544828,0,21,positive regulation of morphogenesis of an epithelium,BP,
19204,GO:1905354,1,0.111676503947394,0,22,exoribonuclease complex,CC,
19210,GO:1905368,1,0.000330995988062536,0,85,peptidase complex,CC,
19211,GO:1905369,1,0.00262600591099232,0,64,endopeptidase complex,CC,
19241,GO:1905446,1,0.616163223780054,0,5,regulation of mitochondrial ATP synthesis coupled electron transport,BP,
19246,GO:1905456,1,0.451655684582895,0,7,regulation of lymphoid progenitor cell differentiation,BP,
19280,GO:1905564,1,0.306068450659306,0,10,positive regulation of vascular endothelial cell proliferation,BP,
19305,GO:1905634,1,0.493497711646348,0,6,regulation of protein localization to chromatin,BP,
19315,GO:1905666,1,0.343197793196209,0,9,regulation of protein localization to endosome,BP,
19316,GO:1905668,1,0.343197793196209,0,9,positive regulation of protein localization to endosome,BP,
19324,GO:1905709,1,0.627260458190507,0,5,negative regulation of membrane permeability,BP,
19348,GO:1905818,1,0.00391229464297181,0,52,regulation of chromosome separation,BP,
19349,GO:1905819,1,0.036653900428138,0,31,negative regulation of chromosome separation,BP,
19350,GO:1905820,1,0.375942594046164,0,9,positive regulation of chromosome separation,BP,
19363,GO:1905879,1,0.517151578697916,0,6,regulation of oogenesis,BP,
19389,GO:1905941,1,0.514294083435421,0,6,positive regulation of gonad development,BP,
19397,GO:1905961,1,0.424811279588335,0,8,protein-cysteine S-palmitoyltransferase complex,CC,
19431,GO:1990124,1,0.443900533769772,0,7,messenger ribonucleoprotein complex,CC,
19434,GO:1990130,1,0.580663162468574,0,5,GATOR1 complex,CC,
19439,GO:1990144,1,0.537717313664685,0,6,intrinsic apoptotic signaling pathway in response to hypoxia,BP,
19449,GO:1990173,1,0.34538814568049,0,10,protein localization to nucleoplasm,BP,
19454,GO:1990182,1,0.169558355964024,0,17,exosomal secretion,BP,
19459,GO:1990226,1,0.58532673560133,0,5,histone methyltransferase binding,MF,
19463,GO:1990247,1,0.436642737458652,0,7,N6-methyladenosine-containing RNA binding,MF,
19477,GO:1990314,1,0.397974284782763,0,8,cellular response to insulin-like growth factor stimulus,BP,
19484,GO:1990380,1,0.324754063813907,0,9,Lys48-specific deubiquitinase activity,MF,
19485,GO:1990381,1,0.229608966128749,0,13,ubiquitin-specific protease binding,MF,
19504,GO:1990416,1,0.494415688286728,0,6,cellular response to brain-derived neurotrophic factor stimulus,BP,
19514,GO:1990440,1,0.395018550515272,0,9,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress,BP,
19567,GO:1990668,1,0.53143670201624,0,6,vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane,BP,
19577,GO:1990726,1,0.717688602069688,0,5,Lsm1-7-Pat1 complex,CC,
19600,GO:1990774,1,0.268198339903615,0,11,tumor necrosis factor secretion,BP,
19613,GO:1990822,1,0.565388291610587,0,5,basic amino acid transmembrane transport,BP,
19615,GO:1990825,1,0.338686754931667,0,10,sequence-specific mRNA binding,MF,
19653,GO:1990948,1,0.719978000406884,0,5,ubiquitin ligase inhibitor activity,MF,
19662,GO:2000002,1,0.581718786960858,0,5,negative regulation of DNA damage checkpoint,BP,
19675,GO:2000018,1,0.562763000804892,0,5,regulation of male gonad development,BP,
19702,GO:2000074,1,0.469690884409153,0,7,regulation of type B pancreatic cell development,BP,
19708,GO:2000096,1,0.496544984939673,0,6,positive regulation of Wnt signaling pathway, planar cell polarity pathway,BP,
19715,GO:2000108,1,0.129685940561502,0,20,positive regulation of leukocyte apoptotic process,BP,
19716,GO:2000109,1,0.542776698866396,0,6,regulation of macrophage apoptotic process,BP,
19725,GO:2000121,1,0.5364389970874,0,6,regulation of removal of superoxide radicals,BP,
19728,GO:2000136,1,0.299722459720458,0,11,regulation of cell proliferation involved in heart morphogenesis,BP,
19730,GO:2000138,1,0.570301731719997,0,5,positive regulation of cell proliferation involved in heart morphogenesis,BP,
19733,GO:2000144,1,0.0783508246860227,0,23,positive regulation of DNA-templated transcription, initiation,BP,
19759,GO:2000197,1,0.50119069767165,0,6,regulation of ribonucleoprotein complex localization,BP,
19775,GO:2000232,1,0.30291340765867,0,11,regulation of rRNA processing,BP,
19777,GO:2000234,1,0.435455828051083,0,8,positive regulation of rRNA processing,BP,
19806,GO:2000288,1,0.531448410453076,0,6,positive regulation of myoblast proliferation,BP,
19807,GO:2000291,1,0.465801864217987,0,7,regulation of myoblast proliferation,BP,
19824,GO:2000316,1,0.485853443547253,0,7,regulation of T-helper 17 type immune response,BP,
19827,GO:2000319,1,0.601512601695149,0,5,regulation of T-helper 17 cell differentiation,BP,
19863,GO:2000371,1,0.492063122075453,0,6,regulation of DNA topoisomerase (ATP-hydrolyzing) activity,BP,
19864,GO:2000373,1,0.492063122075453,0,6,positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity,BP,
19869,GO:2000380,1,0.433838974595461,0,7,regulation of mesoderm development,BP,
19881,GO:2000394,1,0.548170467430864,0,5,positive regulation of lamellipodium morphogenesis,BP,
19920,GO:2000479,1,0.267668524928923,0,12,regulation of cAMP-dependent protein kinase activity,BP,
19921,GO:2000480,1,0.479520283201386,0,7,negative regulation of cAMP-dependent protein kinase activity,BP,
19924,GO:2000483,1,0.606123530429632,0,5,negative regulation of interleukin-8 secretion,BP,
19934,GO:2000514,1,0.0755759734772545,0,24,regulation of CD4-positive, alpha-beta T cell activation,BP,
19935,GO:2000515,1,0.255453568592444,0,12,negative regulation of CD4-positive, alpha-beta T cell activation,BP,
19936,GO:2000516,1,0.261689199114418,0,13,positive regulation of CD4-positive, alpha-beta T cell activation,BP,
19962,GO:2000574,1,0.449087275409368,0,8,regulation of microtubule motor activity,BP,
19963,GO:2000576,1,0.636095635083037,0,5,positive regulation of microtubule motor activity,BP,
19975,GO:2000601,1,0.489346378147523,0,6,positive regulation of Arp2/3 complex-mediated actin nucleation,BP,
19981,GO:2000615,1,0.32959783666823,0,10,regulation of histone H3-K9 acetylation,BP,
19983,GO:2000617,1,0.51238298579893,0,6,positive regulation of histone H3-K9 acetylation,BP,
19984,GO:2000618,1,0.565644037178781,0,5,regulation of histone H4-K16 acetylation,BP,
19991,GO:2000628,1,0.470415283048507,0,7,regulation of miRNA metabolic process,BP,
19992,GO:2000630,1,0.58463406897203,0,5,positive regulation of miRNA metabolic process,BP,
20007,GO:2000650,1,0.43154496004587,0,7,negative regulation of sodium ion transmembrane transporter activity,BP,
20014,GO:2000659,1,0.521022968240543,0,6,regulation of interleukin-1-mediated signaling pathway,BP,
20028,GO:2000674,1,0.406638668284422,0,8,regulation of type B pancreatic cell apoptotic process,BP,
20033,GO:2000679,1,0.20382705011301,0,15,positive regulation of transcription regulatory region DNA binding,BP,
20071,GO:2000757,1,0.156941557618967,0,17,negative regulation of peptidyl-lysine acetylation,BP,
20077,GO:2000767,1,0.410359328849383,0,8,positive regulation of cytoplasmic translation,BP,
20079,GO:2000772,1,0.0347552378826109,0,31,regulation of cellular senescence,BP,
20080,GO:2000773,1,0.210096067026173,0,14,negative regulation of cellular senescence,BP,
20081,GO:2000774,1,0.413140315830292,0,9,positive regulation of cellular senescence,BP,
20087,GO:2000781,1,0.203409359730713,0,14,positive regulation of double-strand break repair,BP,
20103,GO:2000811,1,0.227393157776813,0,13,negative regulation of anoikis,BP,
20105,GO:2000816,1,0.036653900428138,0,31,negative regulation of mitotic sister chromatid separation,BP,
20112,GO:2000826,1,0.0661277095706531,0,24,regulation of heart morphogenesis,BP,
20138,GO:2000973,1,0.509527372255259,0,6,regulation of pro-B cell differentiation,BP,
20143,GO:2000980,1,0.59077143294868,0,5,regulation of inner ear receptor cell differentiation,BP,
20157,GO:2001024,1,0.151429339894715,0,18,negative regulation of response to drug,BP,
20159,GO:2001026,1,0.259296464265673,0,12,regulation of endothelial cell chemotaxis,BP,
20161,GO:2001028,1,0.379270390889342,0,9,positive regulation of endothelial cell chemotaxis,BP,
20164,GO:2001032,1,0.302337635485088,0,11,regulation of double-strand break repair via nonhomologous end joining,BP,
20165,GO:2001033,1,0.601394499396316,0,5,negative regulation of double-strand break repair via nonhomologous end joining,BP,
20166,GO:2001034,1,0.559226655469635,0,5,positive regulation of double-strand break repair via nonhomologous end joining,BP,
20170,GO:2001039,1,0.270583962600539,0,13,negative regulation of cellular response to drug,BP,
20175,GO:2001053,1,0.507413173599911,0,6,regulation of mesenchymal cell apoptotic process,BP,
20176,GO:2001054,1,0.563070188343895,0,5,negative regulation of mesenchymal cell apoptotic process,BP,
20188,GO:2001135,1,0.397213585698128,0,8,regulation of endocytic recycling,BP,
20204,GO:2001166,1,0.562006899113351,0,5,regulation of histone H2B ubiquitination,BP,
20207,GO:2001170,1,0.357608607191564,0,9,negative regulation of ATP biosynthetic process,BP,
20223,GO:2001197,1,0.524500899078806,0,5,basement membrane assembly involved in embryonic body morphogenesis,BP,
20233,GO:2001212,1,0.440769153631805,0,7,regulation of vasculogenesis,BP,
20235,GO:2001214,1,0.569454782842925,0,5,positive regulation of vasculogenesis,BP,
20237,GO:2001223,1,0.499962160937921,0,6,negative regulation of neuron migration,BP,
20266,GO:2001268,1,0.637743531621718,0,5,negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,
10385,GO:0043231,1,0,723,8297,intracellular membrane-bounded organelle,CC,TNFAIP3;TGFBI;POSTN;ITGB6;HES2;ZSCAN18;TSC22D1;SIK1;SLFN5;SUGCT;EPM2A;MUC19;NPEPL1;DDB2;TP53INP1;MAP6;IFI6;PTHLH;SREBF1;AMACR;PYGB;APOE;GPSM1;CES2;NT5E;GAMT;OAS2;ADAM19;LMF1;HSPA2;EGFR;TRIM65;CIRBP;FAM20C;PKD2;CAPRIN2;MNT;XPC;APOBEC3C;CPT2;RBM3;SYN1;ASH2L;TRIM22;ALDH1A3;SRSF5;CTSO;OBSL1;PERM1;SEC14L2;PCDH1;EPHB2;RALGDS;MAP3K14;GLUD1;BPHL;DCAF16;DGKQ;TMEM129;PIK3R1;ADAMTS7;BRSK1;TXNRD3;MARVELD1;KDM3A;CXCL14;COL22A1;TSC22D3;POU3F1;SULF2;WNT3;H6PD;DHTKD1;CAMKK1;UBXN4;ST6GALNAC2;HR;CSPG4;ISG15;MVB12B;CYBRD1;SPATA18;TFCP2L1;TENM4;RGMA;ZFPM1;HOXC5;ZDHHC1;ZNF362;CUL7;VAMP3;CITED4;SNN;IRF2BPL;NAPRT;REEP2;PRICKLE2;ASAP3;ZNF266;SRD5A3;STAT1;CRY2;KRT15;HS1BP3;LGALS7B;NSG1;UROS;KDSR;COL10A1;RAB43;RAB40B;NOS1;PRKACB;ZNF704;HOXA3;B4GALNT4;CRY1;ZNF699;MAML3;ZFP41;SCMH1;KLF13;CRTAP;SDC3;NFATC4;ZNF783;HMGCL;D2HGDH;SCARA3;FKBP5;RNF187;H1F0;CYP26B1;GAA;AP5Z1;CMPK2;HSF4;ZNF251;LIG1;CDK18;VPS11;SPEG;NDRG1;COL7A1;ITPR3;EAPP;NAGLU;CYHR1;MDM2;CRTC1;NDN;MLH3;DDX59;ST6GALNAC6;ZNF662;TYSND1;OBSCN;IDUA;GOLGA8A;HLA-B;PRODH;HGSNAT;FKBP9;NDUFA4L2;RHOBTB2;UGT1A3;CERS4;CYP3A5;NEO1;PHACTR3;ZNF414;TCF25;FAM210B;CTSV;POLH;BLVRB;POLR2J2;OAS1;FLRT3;TRIM66;GAL3ST4;CRAT;B4GALT6;MLLT6;AP1G2;RGS2;ACAP3;F2R;MLYCD;PPL;HPS4;PHYH;MT1X;PDCD4;SPTB;NOL4L;ZNF160;CAPN7;SWT1;SLC27A3;ARSI;NEK9;ZFP36L2;CLTCL1;TMC6;FLOT1;GLI2;AGAP4;ANK3;KLF7;RNF165;DHX32;ADAMTS13;LAMP3;TCEA2;RALGAPA1;MAPK8IP3;GOLGA8B;ZNF76;SOX12;PIDD1;SLX1A;SLX1B;G6PC3;ATG16L2;SPG11;ZCCHC11;RHBDF1;SULT1E1;PER2;CLCN6;PTGS1;DIRC2;HEXA;FNDC4;ZNF658;ARSD;PSKH1;MINK1;PHF2;ABHD14B;GSTM2;TCEAL1;AMIGO2;WWTR1;MBOAT2;ASAP2;ITGA2;FAM110C;ULK1;GLI3;SPPL2B;THRAP3;ZNF558;IRX4;SMARCA1;AKAP7;BHLHE40;DGCR6L;VAMP2;ZNF655;NAIP;LTBP1;ZNF333;NEK8;MAP2K5;GAS8;BOC;CES3;BSN;SESN3;ZNF318;IGFBP4;TCFL5;TRAK1;JARID2;NUPR1;GPC2;INSR;TST;CCDC85B;CELSR1;GSN;ALDH4A1;CEP68;CHD3;CDK14;ST3GAL5;BAIAP2;TTN;CBLC;ZNF18;SUN1;AHNAK2;PLEKHH2;TRIOBP;MXD4;POLD4;DNAJC30;CTSF;ZNF287;CYP2D7;NSUN5P2;PNMA1;PMS2P3;ETAA1;RMI2;ZNF446;VPS39;ZNF581;MGST2;TP53AIP1;ENDOG;SLC27A1;PGAP1;RTF1;CASP14;IRF9;TMEM9;H2AFJ;F8A1;NLRX1;B4GALT2;PEX10;TCIRG1;S100A4;MAP2K2;PDK1;ALDH7A1;GLI4;SQSTM1;CABYR;PTK6;TMEM8B;ETV5;AKR7A2;FNBP4;FAT2;DLX3;TMEM117;HEXB;KDM4C;HYAL1;METTL23;CLCA2;H1FX;UBOX5;NSMCE4A;KIAA0319L;B3GNT9;WHAMMP3;CENPC;PLA2G6;CST3;PDIK1L;GDF15;PEX7;TXNIP;TCF4;ATP6V0A2;KLHDC2;COL6A1;PEX11B;PLAG1;IDH2;CERCAM;RCOR2;WRN;PODXL;IFI27;MALL;OXLD1;DNM1;MCM9;MACROD1;IQCB1;PLD3;TREX1;LPIN3;ZDHHC12;MCTP1;CDK5R1;ATRX;REC8;ARHGAP27;AGAP6;NET1;PIGZ;POLR2J3;HOOK2;SESN1;MAPK10;NKTR;ADIRF;HMG20B;CYBA;AGO4;ERCC6;HADH;RRM2B;SLIT3;KRT14;HLCS;SPRY2;FBXO2;WASH3P;MEF2D;CREBRF;XRN1;AGAP7P;RAB11FIP3;TIGD5;MLXIPL;CTSB;TARBP1;FBXW7;ANKRD28;ING4;NUDT6;CDK5RAP3;ZNF862;ATXN1;LMO2;CCDC92;NFIX;PAK6;CARF;MXI1;PFKFB2;RNF170;CHMP1B;THRA;HSD11B1L;APC2;METTL21A;ACADS;ARAP1;GOLGA8N;ADARB1;RAI1;ELF1;MX2;IKZF4;DCAF10;SLC2A1;ACACB;OGDHL;NLRP1;FRAT1;ZBTB34;REEP4;ZNF627;TK2;LACTB2;BEX2;GLUL;TBC1D17;MIF4GD;DBP;NDST2;NAB2;EPM2AIP1;PRR7;CAPG;TSPYL4;LRP1;HLA-A;PEG3;NPHP4;RGS12;ATE1;ACP5;MPG;SYNPO2;C12ORF66;CENPH;RFX2;ZNF554;BRINP1;SLC48A1;BDH1;APPL2;HEXDC;SALL2;PMEL;ZNF107;ZNF532;JPH2;ZBTB20;PDE2A;ZNF334;SDHA;MAF;LTB4R2;RET;ZMYND8;PRX;CASZ1;RWDD3;ACOX3;CALCOCO1;SLC37A2;TEAD2;MYSM1;DDHD2;RNF213;OLFM2;TSHZ2;PIK3C3;ZNF276;IFI16;SYT7;FGFR4;ERCC5;PIK3R2;RETSAT;TEF;ZNF25;SETD4;OSBPL5;AREG;ABTB1;TMEM203;DEF6;SNCB;ETFB;RPS6KA5;APBB3;ZNF630;BTG1;BST2;ZNF687;VDR;LETMD1;MAMSTR;PHF7;TNRC18;ZFP28;DPY19L2P2;ZMYM3;SIX5;HLTF;MARCH8;PCSK6;ZNF789;MPPE1;ZNF563;ZNF517;STK19;NDUFV3;LPAR6;DMTN;STAT2;ARFGEF2;LMTK3;PHF1;ZNF292;SLC36A4;TFDP2;SNX1;GOLGA7B;TMX4;ZNF737;TACC1;KDELC2;PRIMPOL;NECAB3;CCDC88B;DLG4;CCDC113;TNNI2;PPP2R3B;ESYT2;TSSK1B;IQSEC1;ZNF701;NAT14;PANO1;PALB2;IGFBP6;TCEAL4;ZNF91;NBEAL2;CD68;PTMS;WEE1;DYDC1;R3HDM4;TMEM143;GTF2IRD2;GOLGA6L4;SLC35G2;DQX1;AMT;TCF7;RSAD2;TNFRSF25;NEMP2;ZFP36L1;XYLT1;LMNA;MXRA8;CLSTN3;GLMP;TOP3B;ACSL1;KAT2B;TEP1;APOLD1;METTL7A;ERN1;IVNS1ABP;ALOX15B;RAD50;ZNF439;TKFC;LAPTM4A;ANGEL2;ZMAT3;PNPO;MAN1B1;DHRS4;PEX1;ECI1;S100A6;TRERF1;FAAH;SCYL3;APBB2;CBR4;TTC19;SGSH;DCAF8;CCDC90B;RAPGEF5;CERS5;STAT6;PCSK1N;SOX13;PRDX5;NELFCD;PHC2;TUB;GLB1;GOLGA1;CPT1C;KLF8;GSTM3;CHD6;NAP1L5;GOLGB1;ACSS2;DPP7;PLIN4;RANBP9;HDAC11;CTSD;COL13A1;ERBB2;SYNGR1;PLCB3;NUDT10;UVSSA;ZDHHC24;PPM1M;ABCA2;KMT5C;AKAP6;SLC2A11;TH;ATG14;MPP7;RORA;SSH3;PPARG;PRKACA;LDLRAP1;CXXC5;NPAP1;C6ORF120;POLM;FMNL3;ACOT2;GCNT4;ZNF572;SYNE2;ACKR3;ZNF658B;SUCLG2;UCKL1;PARN;DDX12P;ZNF529;UFL1;LAMB2;IP6K2;RIPK3;KLF9;PI4K2B;AIP;COG1;KCNS3;SCAND1;LONP2;HARS2;CIT;ZFP90;EHHADH;MSH5;CLCN7;CCDC3;PER3;ZFP30;FOXP2;PTBP2;ZC3H6;HIVEP1;SMURF1;CTNNBIP1;PEMT;ABCA11P;OCIAD2;SERINC3
2072,GO:0004827,1.00000000000001,0.734006017811279,0,3,proline-tRNA ligase activity,MF,
2922,GO:0006433,1.00000000000001,0.734006017811279,0,3,prolyl-tRNA aminoacylation,BP,
8851,GO:0034660,1.00000000000001,0,8,545,ncRNA metabolic process,BP,ZCCHC11;NSUN5P2;AGO4;XRN1;TARBP1;DALRD3;PARN;HARS2
16441,GO:0097134,1.00000000000001,0.814576215671755,0,2,cyclin E1-CDK2 complex,CC,
19636,GO:1990904,1.00000000000002,0,16,702,ribonucleoprotein complex,CC,CIRBP;APOBEC3C;RBM3;UNK;IMPACT;BTBD2;DHX32;SQSTM1;AGO4;XRN1;DQX1;ZFP36L1;TEP1;IVNS1ABP;PRMT3;PTBP2
5332,GO:0016071,1.00000000000003,0,20,737,mRNA metabolic process,BP,SREBF1;CIRBP;SRSF5;PCBP4;ZFP36L2;DHX32;ZCCHC11;THRAP3;AGO4;XRN1;LMO2;ADARB1;TNRC6C;DQX1;ZFP36L1;ERN1;ANGEL2;PRKACA;PARN;PTBP2
1686,GO:0004161,1.00000000000003,0.820655217194517,0,2,dimethylallyltranstransferase activity,MF,
1737,GO:0004337,1.00000000000003,0.820655217194517,0,2,geranyltranstransferase activity,MF,
8398,GO:0033383,1.00000000000003,0.820655217194517,0,2,geranyl diphosphate metabolic process,BP,
8399,GO:0033384,1.00000000000003,0.820655217194517,0,2,geranyl diphosphate biosynthetic process,BP,
11964,GO:0047280,1.00000000000004,0.881841967927159,0,1,nicotinamide phosphoribosyltransferase activity,MF,
15607,GO:0072126,1.00000000000004,0.656313900022218,0,4,positive regulation of glomerular mesangial cell proliferation,BP,
13907,GO:0060591,1.00000000000004,0.708263860166772,0,3,chondroblast differentiation,BP,
19040,GO:1904928,1.00000000000006,0.769031078193969,0,2,coreceptor activity involved in canonical Wnt signaling pathway,MF,
10563,GO:0043541,1.00000000000006,0.798381625918764,0,2,UDP-N-acetylglucosamine transferase complex,CC,
195,GO:0000414,1.00000000000009,0.608962206308053,0,4,regulation of histone H3-K36 methylation,BP,
249,GO:0000710,1.0000000000001,0.62457946312643,0,4,meiotic mismatch repair,BP,
4693,GO:0010851,1.0000000000001,0.814585129032497,0,2,cyclase regulator activity,MF,
4694,GO:0010853,1.0000000000001,0.814585129032497,0,2,cyclase activator activity,MF,
6797,GO:0030249,1.0000000000001,0.814585129032497,0,2,guanylate cyclase regulator activity,MF,
6798,GO:0030250,1.0000000000001,0.814585129032497,0,2,guanylate cyclase activator activity,MF,
8523,GO:0033857,1.00000000000011,0.774019448437721,0,2,diphosphoinositol-pentakisphosphate kinase activity,MF,
17102,GO:0102092,1.00000000000011,0.774019448437721,0,2,5-diphosphoinositol pentakisphosphate 3-kinase activity,MF,
13957,GO:0060689,1.00000000000013,0.711421699632393,0,3,cell differentiation involved in salivary gland development,BP,
3169,GO:0006781,1.00000000000013,0.90136658588902,0,1,succinyl-CoA pathway,BP,
13807,GO:0060426,1.00000000000015,0.737528149848831,0,3,lung vasculature development,BP,
5831,GO:0017116,1.00000000000016,0.709261951042283,0,3,single-stranded DNA-dependent ATP-dependent DNA helicase activity,MF,
1922,GO:0004618,1.00000000000017,0.900511308698014,0,1,phosphoglycerate kinase activity,MF,
294,GO:0000799,1.00000000000019,0.683585314373593,0,3,nuclear condensin complex,CC,
14739,GO:0070436,1.0000000000002,0.790867913375636,0,2,Grb2-EGFR complex,CC,
10887,GO:0044446,1.00000000000021,0,600,7061,intracellular organelle part,CC,TGFBI;POSTN;ITGB6;ULK2;MUC19;DDB2;TP53INP1;MAP6;PTHLH;SREBF1;AMACR;PYGB;APOE;GPSM1;CES2;NT5E;OAS2;LMF1;HSPA2;EGFR;ESPN;TRIM65;PTPRS;CIRBP;FAM20C;PKD2;CAPRIN2;MNT;XPC;SYT8;CXCR1;CPT2;RBM3;SYN1;ASH2L;TRIM22;SRSF5;LRIG3;OBSL1;KIF26B;PCDH1;SYNC;MAP3K14;GLUD1;BPHL;DCAF16;DGKQ;TMEM129;PIK3R1;ADAMTS7;BRSK1;KDM3A;COL22A1;EVC;POU3F1;SULF2;WNT3;H6PD;DHTKD1;UBXN4;ST6GALNAC2;HR;CSPG4;ISG15;MVB12B;CYBRD1;SPATA18;TFCP2L1;KCNAB2;ZFPM1;HOXC5;CUL7;VAMP3;CITED4;SNN;IRF2BPL;NAPRT;REEP2;PRICKLE2;ASAP3;SRD5A3;OR2A4;STAT1;CRY2;MYL9;KRT15;WDR63;NSG1;KDSR;COL10A1;RAB43;RAB40B;NOS1;PRKACB;HOXA3;B4GALNT4;MAML3;SCMH1;CRTAP;SDC3;NFATC4;HMGCL;D2HGDH;SCARA3;FKBP5;RNF187;FERMT1;H1F0;CYP26B1;GAA;AP5Z1;HSF4;CNTRL;MICALL1;LIG1;VPS11;NDRG1;COL7A1;ITPR3;NAGLU;CYHR1;MDM2;CRTC1;LZTS2;NDN;MLH3;DDX59;ST6GALNAC6;OBSCN;IDUA;GOLGA8A;GPRC5C;HLA-B;PRODH;HGSNAT;MYH11;NDUFA4L2;ACTR1B;UGT1A3;CERS4;CYP3A5;NEO1;RAPGEF3;PHACTR3;FAM210B;CTSV;POLH;BLVRB;POLR2J2;OAS1;FLRT3;NUDCD3;TRIM66;GAL3ST4;CRAT;KIF26A;B4GALT6;AP1G2;RGS2;ADGRB2;MLYCD;C2CD4C;PHYH;SPTB;NOL4L;DNAH1;SLC27A3;ARSI;NEK9;TUBGCP5;CLTCL1;TRPV4;TMC6;FLOT1;GLI2;DHX32;ADAMTS13;LAMP3;TCEA2;MAPK8IP3;GOLGA8B;SOX12;PIDD1;SLX1A;SLX1B;G6PC3;ATG16L2;SPG11;ZCCHC11;RHBDF1;SULT1E1;PER2;CLCN6;PTGS1;UNC119;DIRC2;HEXA;ARSD;WIPF1;PSKH1;PHF2;NINL;ABHD14B;TCEAL1;WWTR1;MBOAT2;ASAP2;LHFPL2;FAM110C;ULK1;GLI3;SPPL2B;FHOD3;PCSK1;TPGS1;THRAP3;SMARCA1;BHLHE40;VAMP2;ZNF655;LTBP1;NEK8;MAP2K5;GAS8;BOC;CES3;ZNF318;IGFBP4;JARID2;GPC2;INSR;TST;CCDC85B;CELSR1;GSN;ALDH4A1;CEP68;CHD3;ST3GAL5;BAIAP2;TTN;CEP126;SUN1;AHNAK2;PLEKHH2;TRIOBP;POLD4;CTSF;CD109;NSUN5P2;PNMA1;PMS2P3;ETAA1;RMI2;SEPT6;RAB11FIP4;VPS39;MGST2;TP53AIP1;PGAP1;RTF1;CASP14;IRF9;TMEM9;H2AFJ;NLRX1;B4GALT2;PEX10;SLC2A3;TCIRG1;MICALL2;MAP2K2;PDK1;VEGFB;ALDH7A1;SQSTM1;CEP192;PTK6;FZD7;ETV5;FNBP4;HEXB;KDM4C;HYAL1;CLCA2;H1FX;UBOX5;NSMCE4A;KIAA0319L;B3GNT9;CENPC;PLA2G6;CST3;PDIK1L;PEX7;BBS2;TXNIP;TCF4;ATP6V0A2;KLHDC2;COL6A1;PEX11B;LRRCC1;PLAG1;IDH2;CERCAM;WRN;PODXL;SEPT5;IFI27;MALL;DNM1;MACROD1;IQCB1;PLD3;TREX1;LPIN3;MCTP1;CDK5R1;ATRX;REC8;ARHGAP27;PIGZ;POLR2J3;HOOK2;SESN1;MAPK10;NKTR;HFE;ADIRF;HMG20B;CYBA;AGO4;ERCC6;HADH;RRM2B;CLIP2;KRT14;HLCS;SPRY2;WASH3P;MEF2D;IFT140;CREBRF;RAB11FIP3;MLXIPL;CTSB;FBXW7;ANKRD28;ING4;CDK5RAP3;ATXN1;LMO2;CCDC92;PAK6;CARF;DZIP1L;PGM1;MXI1;PFKFB2;RNF170;CHMP1B;THRA;TTC12;HSD11B1L;APC2;METTL21A;ACADS;ARAP1;GOLGA8N;ADARB1;RAI1;ELF1;MX2;IKZF4;DCAF10;RPH3AL;SLC2A1;ACACB;OGDHL;NLRP1;ZBTB34;REEP4;TK2;LACTB2;MIF4GD;NDST2;EPM2AIP1;CAPG;LRP1;HLA-A;NPHP4;RGS12;CCDC136;MPG;SYNPO2;C12ORF66;CENPH;ZNF554;SLC48A1;BDH1;MYO3B;APPL2;SALL2;PMEL;BBS1;JPH2;ZBTB20;PDE2A;SDHA;MAF;LTB4R2;RET;CASZ1;ACOX3;CALCOCO1;SLC37A2;TEAD2;MYSM1;DDHD2;SHROOM2;RNF213;OLFM2;PIK3C3;ZNF276;IFI16;SYT7;ERCC5;BBS5;RETSAT;SETD4;OSBPL5;AREG;ABTB1;TMEM203;DEF6;ETFB;MYO9A;RPS6KA5;DLG5;BST2;ZNF687;VDR;LETMD1;SNX21;PHF7;TNRC18;DPY19L2P2;ZMYM3;HLTF;MARCH8;PCSK6;ZNF789;MPPE1;STK19;NDUFV3;EML3;DMTN;STAT2;ARFGEF2;LMTK3;ALMS1;PHF1;SLC36A4;TFDP2;SNX1;GOLGA7B;SHROOM4;TACC1;KDELC2;PRIMPOL;NECAB3;CCDC88B;DLG4;CCDC113;TNNI2;PPP2R3B;ESYT2;IQSEC1;PANO1;PALB2;NBEAL2;CD68;WEE1;DYDC1;GTF2IRD2;DQX1;AMT;TCF7;SHANK2;RSAD2;NEMP2;XYLT1;LMNA;MXRA8;CLSTN3;GLMP;ACSL1;KAT2B;MARK4;TEP1;APOLD1;DMXL2;CEP250;METTL7A;ERN1;SAC3D1;IVNS1ABP;RAD50;LAPTM4A;ANGEL2;ZMAT3;PNPO;MAN1B1;DHRS4;PEX1;ECI1;S100A6;TRERF1;FAAH;CBR4;TTC19;SGSH;DCAF8;CCDC90B;RAPGEF5;MYH16;CERS5;STAT6;PCSK1N;SOX13;PRDX5;NELFCD;PHC2;KIF7;GLB1;GOLGA1;CPT1C;KLF8;CHD6;TRAF5;GOLGB1;ACSS2;DPP7;CD9;RANBP9;HDAC11;CTSD;COL13A1;ERBB2;SYNGR1;PLCB3;UVSSA;ABCA2;KMT5C;AKAP6;TH;ATG14;MPP7;RORA;PPARG;PRKACA;LDLRAP1;CXXC5;NPAP1;C6ORF120;POLM;ACOT2;GCNT4;VMAC;SYNE2;SERPING1;SUCLG2;PARN;UFL1;LAMB2;IP6K2;NFASC;KLF9;PI4K2B;AIP;COG1;LONP2;SNX33;HARS2;CIT;EHHADH;MSH5;CLCN7;MAP1A;PTBP2;HIVEP1;SMURF1;TTLL1;EML2;CTNNBIP1;PEMT;OCIAD2;SERINC3;ECM1
14229,GO:0061302,1.00000000000023,0.716692037579271,0,3,smooth muscle cell-matrix adhesion,BP,
3219,GO:0006867,1.00000000000023,0.899507580791968,0,1,asparagine transport,BP,
5017,GO:0015182,1.00000000000023,0.899507580791968,0,1,L-asparagine transmembrane transporter activity,MF,
5024,GO:0015190,1.00000000000023,0.899507580791968,0,1,L-leucine transmembrane transporter activity,MF,
5025,GO:0015191,1.00000000000023,0.899507580791968,0,1,L-methionine transmembrane transporter activity,MF,
5137,GO:0015658,1.00000000000023,0.899507580791968,0,1,branched-chain amino acid transmembrane transporter activity,MF,
5217,GO:0015821,1.00000000000023,0.899507580791968,0,1,methionine transport,BP,
10651,GO:0043865,1.00000000000023,0.899507580791968,0,1,methionine transmembrane transporter activity,MF,
19409,GO:1990034,1.00000000000024,0.714383039039558,0,3,calcium ion export across plasma membrane,BP,
18049,GO:1902636,1.00000000000025,0.839654511490254,0,2,kinociliary basal body,CC,
2444,GO:0005654,1.00000000000026,0,211,3040,nucleoplasm,CC,ITGB6;DDB2;TP53INP1;PTHLH;SREBF1;NT5E;OAS2;TRIM65;CIRBP;MNT;XPC;CPT2;RBM3;ASH2L;TRIM22;SRSF5;DCAF16;DGKQ;BRSK1;KDM3A;POU3F1;HR;ISG15;ZFPM1;HOXC5;CITED4;IRF2BPL;ASAP3;STAT1;CRY2;NOS1;PRKACB;HOXA3;MAML3;SCMH1;NFATC4;FKBP5;RNF187;H1F0;AP5Z1;HSF4;LIG1;ITPR3;CYHR1;MDM2;CRTC1;NDN;OBSCN;NEO1;PHACTR3;POLH;BLVRB;POLR2J2;OAS1;TRIM66;NOL4L;GLI2;TCEA2;SOX12;PIDD1;SLX1A;SLX1B;ATG16L2;PSKH1;PHF2;TCEAL1;WWTR1;GLI3;SPPL2B;THRAP3;SMARCA1;BHLHE40;BOC;ZNF318;JARID2;CELSR1;CHD3;BAIAP2;PLEKHH2;POLD4;RMI2;RTF1;IRF9;B4GALT2;SQSTM1;PTK6;ETV5;FNBP4;KDM4C;UBOX5;NSMCE4A;CENPC;PDIK1L;KLHDC2;PLAG1;WRN;DNM1;MACROD1;IQCB1;CDK5R1;ATRX;ARHGAP27;POLR2J3;MAPK10;NKTR;ADIRF;HMG20B;AGO4;ERCC6;HADH;RRM2B;MEF2D;CREBRF;RAB11FIP3;MLXIPL;FBXW7;ANKRD28;ING4;ATXN1;LMO2;CCDC92;CARF;PFKFB2;THRA;HSD11B1L;METTL21A;ACADS;ARAP1;ADARB1;RAI1;ELF1;IKZF4;DCAF10;NLRP1;ZBTB34;EPM2AIP1;CAPG;MPG;CENPH;BDH1;APPL2;SALL2;ZBTB20;LTB4R2;CASZ1;TEAD2;MYSM1;OLFM2;IFI16;ERCC5;DEF6;RPS6KA5;ZNF687;VDR;LETMD1;PHF7;TNRC18;ZMYM3;HLTF;ZNF789;MPPE1;STK19;NDUFV3;STAT2;PHF1;TFDP2;CCDC113;PPP2R3B;PALB2;WEE1;DYDC1;GTF2IRD2;AMT;TCF7;LMNA;KAT2B;APOLD1;IVNS1ABP;RAD50;ANGEL2;ZMAT3;PNPO;TRERF1;DCAF8;RAPGEF5;STAT6;SOX13;NELFCD;PHC2;KLF8;CHD6;ACSS2;HDAC11;PLCB3;UVSSA;KMT5C;MPP7;RORA;PPARG;PRKACA;CXXC5;NPAP1;POLM;SYNE2;IP6K2;KLF9;AIP;CLCN7;HIVEP1;SMURF1;CTNNBIP1
13048,GO:0051572,1.00000000000027,0.69774137351901,0,3,negative regulation of histone H3-K4 methylation,BP,
7425,GO:0031536,1.00000000000027,0.699069885015524,0,4,positive regulation of exit from mitosis,BP,
6238,GO:0019808,1.00000000000027,0.773923747461139,0,3,polyamine binding,MF,
2630,GO:0005958,1.00000000000029,0.695070902016853,0,3,DNA-dependent protein kinase-DNA ligase 4 complex,CC,
951,GO:0002370,1.0000000000003,0.736047418570649,0,3,natural killer cell cytokine production,BP,
1135,GO:0002727,1.0000000000003,0.736047418570649,0,3,regulation of natural killer cell cytokine production,BP,
1323,GO:0003176,1.00000000000031,0.648023591916365,0,4,aortic valve development,BP,
1326,GO:0003180,1.00000000000031,0.648023591916365,0,4,aortic valve morphogenesis,BP,
4628,GO:0010752,1.00000000000031,0.776833347403612,0,2,regulation of cGMP-mediated signaling,BP,
7414,GO:0031515,1.00000000000031,0.729605607669046,0,3,tRNA (m1A) methyltransferase complex,CC,
16593,GO:0097452,1.00000000000032,0.657774311307108,0,4,GAIT complex,CC,
6546,GO:0021979,1.00000000000033,0.655897130266087,0,4,hypothalamus cell differentiation,BP,
18383,GO:1903433,1.00000000000034,0.798468096976903,0,2,regulation of constitutive secretory pathway,BP,
7735,GO:0032252,1.00000000000034,0.687285030479566,0,3,secretory granule localization,BP,
5168,GO:0015722,1.00000000000034,0.704764524294111,0,3,canalicular bile acid transport,BP,
18974,GO:1904798,1.00000000000035,0.650997585310895,0,4,positive regulation of core promoter binding,BP,
17476,GO:1900477,1.00000000000035,0.90192353650243,0,1,negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter,BP,
8447,GO:0033596,1.00000000000036,0.687153595395446,0,3,TSC1-TSC2 complex,CC,
19303,GO:1905616,1.00000000000038,0.790979868388086,0,2,regulation of miRNA mediated inhibition of translation,BP,
19304,GO:1905618,1.00000000000038,0.790979868388086,0,2,positive regulation of miRNA mediated inhibition of translation,BP,
8161,GO:0032907,1.00000000000039,0.693202681117871,0,3,transforming growth factor beta3 production,BP,
8164,GO:0032910,1.00000000000039,0.693202681117871,0,3,regulation of transforming growth factor beta3 production,BP,
14950,GO:0070876,1.0000000000004,0.640645055369195,0,4,SOSS complex,CC,
4081,GO:0009137,1.0000000000004,0.658778698084236,0,4,purine nucleoside diphosphate catabolic process,BP,
4120,GO:0009181,1.0000000000004,0.658778698084236,0,4,purine ribonucleoside diphosphate catabolic process,BP,
16222,GO:0090296,1.00000000000041,0.651101365395682,0,4,regulation of mitochondrial DNA replication,BP,
17765,GO:1901858,1.00000000000041,0.651101365395682,0,4,regulation of mitochondrial DNA metabolic process,BP,
14706,GO:0070381,1.00000000000042,0.793915147789275,0,2,endosome to plasma membrane transport vesicle,CC,
17171,GO:0106014,1.00000000000043,0.82401393287809,0,2,regulation of inflammatory response to wounding,BP,
17172,GO:0106015,1.00000000000043,0.82401393287809,0,2,negative regulation of inflammatory response to wounding,BP,
1914,GO:0004609,1.00000000000044,0.811323509344157,0,2,phosphatidylserine decarboxylase activity,MF,
2628,GO:0005955,1.00000000000044,0.619900061389236,0,4,calcineurin complex,CC,
12134,GO:0048257,1.00000000000044,0.809452303835851,0,2,3'-flap endonuclease activity,MF,
14311,GO:0061517,1.00000000000045,0.809236014032346,0,2,macrophage proliferation,BP,
14312,GO:0061518,1.00000000000045,0.809236014032346,0,2,microglial cell proliferation,BP,
1875,GO:0004556,1.00000000000045,0.901291573385348,0,1,alpha-amylase activity,MF,
17157,GO:0103025,1.00000000000045,0.901291573385348,0,1,alpha-amylase activity (releasing maltohexaose),MF,
1712,GO:0004306,1.00000000000047,0.90422589957,0,1,ethanolamine-phosphate cytidylyltransferase activity,MF,
662,GO:0001866,1.00000000000048,0.690082258407584,0,4,NK T cell proliferation,BP,
16629,GO:0097524,1.00000000000049,0.633896632233179,0,4,sperm plasma membrane,CC,
218,GO:0000455,1.00000000000049,0.816004737130405,0,2,enzyme-directed rRNA pseudouridine synthesis,BP,
5214,GO:0015817,1.0000000000005,0.899448669813906,0,1,histidine transport,BP,
7523,GO:0031753,1.0000000000005,0.899448669813906,0,1,endothelial differentiation G-protein coupled receptor binding,MF,
7524,GO:0031755,1.0000000000005,0.899448669813906,0,1,Edg-2 lysophosphatidic acid receptor binding,MF,
4996,GO:0015140,1.0000000000005,0.818340438229634,0,2,malate transmembrane transporter activity,MF,
2115,GO:0004906,1.0000000000005,0.812470465254874,0,2,interferon-gamma receptor activity,MF,
1338,GO:0003199,1.00000000000051,0.911226793338906,0,1,endocardial cushion to mesenchymal transition involved in heart valve formation,BP,
4822,GO:0014028,1.00000000000051,0.911226793338906,0,1,notochord formation,BP,
9468,GO:0036114,1.00000000000051,0.911226793338906,0,1,medium-chain fatty-acyl-CoA catabolic process,BP,
9469,GO:0036115,1.00000000000051,0.911226793338906,0,1,fatty-acyl-CoA catabolic process,BP,
9470,GO:0036116,1.00000000000051,0.911226793338906,0,1,long-chain fatty-acyl-CoA catabolic process,BP,
17478,GO:1900533,1.00000000000051,0.911226793338906,0,1,palmitic acid metabolic process,BP,
17479,GO:1900535,1.00000000000051,0.911226793338906,0,1,palmitic acid biosynthetic process,BP,
2644,GO:0005981,1.00000000000051,0.636008289331575,0,4,regulation of glycogen catabolic process,BP,
19346,GO:1905799,1.00000000000052,0.948543308486404,0,1,regulation of intraciliary retrograde transport,BP,
16136,GO:0090176,1.00000000000053,0.879673408156506,0,1,microtubule cytoskeleton organization involved in establishment of planar polarity,BP,
6213,GO:0019747,1.00000000000054,0.936699112967092,0,1,regulation of isoprenoid metabolic process,BP,
18670,GO:1904045,1.00000000000056,0.901166958422056,0,1,cellular response to aldosterone,BP,
790,GO:0002055,1.00000000000057,0.944966780115762,0,1,adenine binding,MF,
1586,GO:0003999,1.00000000000057,0.944966780115762,0,1,adenine phosphoribosyltransferase activity,MF,
9564,GO:0036378,1.00000000000057,0.81838457531357,0,2,calcitriol biosynthetic process from calciol,BP,
17635,GO:1901474,1.00000000000059,0.65440115686115,0,4,azole transmembrane transporter activity,MF,
12988,GO:0051434,1.0000000000006,0.667895389976446,0,4,BH3 domain binding,MF,
1693,GO:0004170,1.00000000000061,0.904016381136685,0,1,dUTP diphosphatase activity,MF,
11531,GO:0046080,1.00000000000061,0.904016381136685,0,1,dUTP metabolic process,BP,
11532,GO:0046081,1.00000000000061,0.904016381136685,0,1,dUTP catabolic process,BP,
5303,GO:0016011,1.00000000000062,0.704798953092634,0,3,dystroglycan complex,CC,
3019,GO:0006565,1.00000000000062,0.741839318897975,0,3,L-serine catabolic process,BP,
14316,GO:0061534,1.00000000000065,0.867925893790316,0,1,gamma-aminobutyric acid secretion, neurotransmission,BP,
17301,GO:0150003,1.00000000000065,0.722228883815536,0,3,regulation of spontaneous synaptic transmission,BP,
11519,GO:0046061,1.00000000000068,0.772442660666413,0,3,dATP catabolic process,BP,
9315,GO:0035801,1.00000000000068,0.812932088250558,0,2,adrenal cortex development,BP,
9316,GO:0035802,1.00000000000068,0.812932088250558,0,2,adrenal cortex formation,BP,
14524,GO:0070061,1.00000000000069,0.731483465423782,0,3,fructose binding,MF,
6354,GO:0021540,1.0000000000007,0.68024557952976,0,4,corpus callosum morphogenesis,BP,
2555,GO:0005833,1.00000000000071,0.898113715007474,0,1,hemoglobin complex,CC,
16278,GO:0090403,1.00000000000071,0.712664387632856,0,3,oxidative stress-induced premature senescence,BP,
3833,GO:0008441,1.00000000000072,0.790941554463288,0,2,3'(2'),5'-bisphosphate nucleotidase activity,MF,
9154,GO:0035519,1.00000000000072,0.695354921897604,0,4,protein K29-linked ubiquitination,BP,
11071,GO:0045085,1.00000000000073,0.906160172139457,0,1,negative regulation of interleukin-2 biosynthetic process,BP,
16819,GO:0098745,1.00000000000073,0.906160172139457,0,1,Dcp1-Dcp2 complex,CC,
17754,GO:1901834,1.00000000000073,0.906160172139457,0,1,regulation of deadenylation-independent decapping of nuclear-transcribed mRNA,BP,
17755,GO:1901835,1.00000000000073,0.906160172139457,0,1,positive regulation of deadenylation-independent decapping of nuclear-transcribed mRNA,BP,
18739,GO:1904246,1.00000000000073,0.906160172139457,0,1,negative regulation of polynucleotide adenylyltransferase activity,BP,
2695,GO:0006061,1.00000000000074,0.915190274504623,0,1,sorbitol biosynthetic process,BP,
5986,GO:0018931,1.00000000000074,0.915190274504623,0,1,naphthalene metabolic process,BP,
6135,GO:0019406,1.00000000000074,0.915190274504623,0,1,hexitol biosynthetic process,BP,
10646,GO:0043795,1.00000000000074,0.915190274504623,0,1,glyceraldehyde oxidoreductase activity,MF,
16282,GO:0090420,1.00000000000074,0.915190274504623,0,1,naphthalene-containing compound metabolic process,BP,
15746,GO:0072363,1.00000000000075,0.873962401887143,0,1,regulation of glycolytic process by positive regulation of transcription from RNA polymerase II promoter,BP,
15749,GO:0072366,1.00000000000075,0.873962401887143,0,1,regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter,BP,
51,GO:0000105,1.00000000000075,0.803995714471867,0,2,histidine biosynthetic process,BP,
9952,GO:0042350,1.00000000000076,0.737775483173775,0,3,GDP-L-fucose biosynthetic process,BP,
344,GO:0000958,1.00000000000076,0.703651233105957,0,3,mitochondrial mRNA catabolic process,BP,
9666,GO:0038042,1.00000000000077,0.679938286938004,0,4,dimeric G-protein coupled receptor signaling pathway,BP,
16676,GO:0097646,1.00000000000077,0.679938286938004,0,4,calcitonin family receptor signaling pathway,BP,
2074,GO:0004829,1.00000000000078,0.724451088285293,0,3,threonine-tRNA ligase activity,MF,
2924,GO:0006435,1.00000000000078,0.724451088285293,0,3,threonyl-tRNA aminoacylation,BP,
18725,GO:1904220,1.00000000000079,0.656991634799577,0,4,regulation of serine C-palmitoyltransferase activity,BP,
228,GO:0000472,1.0000000000008,0.709024262348008,0,3,endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
353,GO:0000967,1.0000000000008,0.709024262348008,0,3,rRNA 5'-end processing,BP,
8119,GO:0032817,1.00000000000081,0.686448717507722,0,4,regulation of natural killer cell proliferation,BP,
8120,GO:0032819,1.00000000000081,0.686448717507722,0,4,positive regulation of natural killer cell proliferation,BP,
5482,GO:0016418,1.00000000000083,0.774304888175384,0,2,S-acetyltransferase activity,MF,
18653,GO:1904020,1.00000000000085,0.800307775178087,0,2,regulation of G-protein coupled receptor internalization,BP,
3837,GO:0008446,1.00000000000085,0.907507104552563,0,1,GDP-mannose 4,6-dehydratase activity,MF,
13494,GO:0055087,1.00000000000085,0.718387726972218,0,3,Ski complex,CC,
14657,GO:0070292,1.00000000000085,0.880029575259312,0,1,N-acylphosphatidylethanolamine metabolic process,BP,
17111,GO:0102200,1.00000000000085,0.880029575259312,0,1,N-acetylphosphatidylethanolamine-hydrolysing phospholipas activity,MF,
15809,GO:0072534,1.00000000000086,0.877198836661746,0,1,perineuronal net,CC,
17377,GO:1900127,1.00000000000086,0.712287146164704,0,3,positive regulation of hyaluronan biosynthetic process,BP,
4952,GO:0015018,1.00000000000089,0.913941319243966,0,1,galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity,MF,
17973,GO:1902442,1.00000000000089,0.88924635493924,0,1,regulation of ripoptosome assembly involved in necroptotic process,BP,
17974,GO:1902443,1.00000000000089,0.88924635493924,0,1,negative regulation of ripoptosome assembly involved in necroptotic process,BP,
1602,GO:0004027,1.00000000000093,0.921681832860306,0,1,alcohol sulfotransferase activity,MF,
11876,GO:0046912,1.00000000000094,0.707923167657682,0,3,transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer,MF,
15112,GO:0071225,1.00000000000097,0.619653759622115,0,4,cellular response to muramyl dipeptide,BP,
2568,GO:0005853,1.000000000001,0.764680136536869,0,3,eukaryotic translation elongation factor 1 complex,CC,
13331,GO:0052428,1.00000000000101,0.671525807596677,0,4,modulation by host of symbiont molecular function,BP,
8501,GO:0033691,1.00000000000101,0.777609931964271,0,2,sialic acid binding,MF,
6541,GO:0021960,1.00000000000101,0.694293480430756,0,3,anterior commissure morphogenesis,BP,
1725,GO:0004320,1.00000000000102,0.794185174121622,0,2,oleoyl-[acyl-carrier-protein] hydrolase activity,MF,
5431,GO:0016295,1.00000000000102,0.794185174121622,0,2,myristoyl-[acyl-carrier-protein] hydrolase activity,MF,
5432,GO:0016296,1.00000000000102,0.794185174121622,0,2,palmitoyl-[acyl-carrier-protein] hydrolase activity,MF,
5433,GO:0016297,1.00000000000102,0.794185174121622,0,2,acyl-[acyl-carrier-protein] hydrolase activity,MF,
18496,GO:1903690,1.00000000000104,0.596279496709826,0,4,negative regulation of wound healing, spreading of epidermal cells,BP,
15663,GO:0072209,1.00000000000104,0.898941194769306,0,1,metanephric mesangial cell differentiation,BP,
15686,GO:0072254,1.00000000000104,0.898941194769306,0,1,metanephric glomerular mesangial cell differentiation,BP,
15687,GO:0072255,1.00000000000104,0.898941194769306,0,1,metanephric glomerular mesangial cell development,BP,
17432,GO:1900241,1.00000000000104,0.898941194769306,0,1,positive regulation of phenotypic switching,BP,
19139,GO:1905176,1.00000000000104,0.898941194769306,0,1,positive regulation of vascular smooth muscle cell dedifferentiation,BP,
4830,GO:0014038,1.00000000000105,0.712349198018382,0,3,regulation of Schwann cell differentiation,BP,
1034,GO:0002543,1.00000000000107,0.793511272879453,0,2,activation of blood coagulation via clotting cascade,BP,
1503,GO:0003860,1.00000000000107,0.903302567084879,0,1,3-hydroxyisobutyryl-CoA hydrolase activity,MF,
15099,GO:0071208,1.00000000000108,0.723384177910005,0,4,histone pre-mRNA DCP binding,MF,
14984,GO:0070934,1.00000000000109,0.62014982079181,0,4,CRD-mediated mRNA stabilization,BP,
16627,GO:0097513,1.00000000000109,0.677383776109428,0,3,myosin II filament,CC,
1935,GO:0004638,1.00000000000109,0.894299354443724,0,1,phosphoribosylaminoimidazole carboxylase activity,MF,
1936,GO:0004639,1.00000000000109,0.894299354443724,0,1,phosphoribosylaminoimidazolesuccinocarboxamide synthase activity,MF,
16442,GO:0097135,1.0000000000011,0.810679063694158,0,2,cyclin E2-CDK2 complex,CC,
19456,GO:1990189,1.00000000000114,0.838260905020886,0,2,peptide-serine-N-acetyltransferase activity,MF,
8350,GO:0033239,1.00000000000115,0.622839751440173,0,4,negative regulation of cellular amine metabolic process,BP,
6086,GO:0019255,1.00000000000115,0.813657033746741,0,2,glucose 1-phosphate metabolic process,BP,
475,GO:0001519,1.00000000000117,0.889378323087679,0,1,peptide amidation,BP,
1843,GO:0004504,1.00000000000117,0.889378323087679,0,1,peptidylglycine monooxygenase activity,MF,
1908,GO:0004598,1.00000000000117,0.889378323087679,0,1,peptidylamidoglycolate lyase activity,MF,
5887,GO:0018032,1.00000000000117,0.889378323087679,0,1,protein amidation,BP,
7238,GO:0031179,1.00000000000117,0.889378323087679,0,1,peptide modification,BP,
1300,GO:0003140,1.00000000000117,0.636979640355077,0,4,determination of left/right asymmetry in lateral mesoderm,BP,
2088,GO:0004854,1.00000000000117,0.774483543576132,0,2,xanthine dehydrogenase activity,MF,
4063,GO:0009115,1.00000000000117,0.774483543576132,0,2,xanthine catabolic process,BP,
5638,GO:0016726,1.00000000000117,0.774483543576132,0,2,oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor,MF,
9407,GO:0035985,1.00000000000118,0.678992984499239,0,4,senescence-associated heterochromatin focus,CC,
10238,GO:0042986,1.00000000000119,0.806935719702424,0,2,positive regulation of amyloid precursor protein biosynthetic process,BP,
15386,GO:0071671,1.00000000000119,0.665973046007719,0,4,regulation of smooth muscle cell chemotaxis,BP,
9265,GO:0035701,1.0000000000012,0.71199052827071,0,3,hematopoietic stem cell migration,BP,
9442,GO:0036046,1.0000000000012,0.896531004764207,0,1,protein demalonylation,BP,
9443,GO:0036047,1.0000000000012,0.896531004764207,0,1,peptidyl-lysine demalonylation,BP,
9444,GO:0036048,1.0000000000012,0.896531004764207,0,1,protein desuccinylation,BP,
9445,GO:0036049,1.0000000000012,0.896531004764207,0,1,peptidyl-lysine desuccinylation,BP,
9446,GO:0036054,1.0000000000012,0.896531004764207,0,1,protein-malonyllysine demalonylase activity,MF,
9447,GO:0036055,1.0000000000012,0.896531004764207,0,1,protein-succinyllysine desuccinylase activity,MF,
14391,GO:0061697,1.0000000000012,0.896531004764207,0,1,protein-glutaryllysine deglutarylase activity,MF,
14392,GO:0061698,1.0000000000012,0.896531004764207,0,1,protein deglutarylation,BP,
14393,GO:0061699,1.0000000000012,0.896531004764207,0,1,peptidyl-lysine deglutarylation,BP,
2267,GO:0005199,1.00000000000121,0.893990317565359,0,1,structural constituent of cell wall,MF,
15384,GO:0071665,1.00000000000121,0.893990317565359,0,1,gamma-catenin-TCF7L2 complex,CC,
7558,GO:0031914,1.00000000000122,0.732242694169676,0,3,negative regulation of synaptic plasticity,BP,
2314,GO:0005315,1.00000000000124,0.698861552974564,0,3,inorganic phosphate transmembrane transporter activity,MF,
7522,GO:0031752,1.00000000000124,0.776363812475921,0,2,D5 dopamine receptor binding,MF,
17659,GO:1901552,1.00000000000125,0.789734926491402,0,2,positive regulation of endothelial cell development,BP,
18251,GO:1903142,1.00000000000125,0.789734926491402,0,2,positive regulation of establishment of endothelial barrier,BP,
12040,GO:0048003,1.00000000000125,0.693686998770397,0,3,antigen processing and presentation of lipid antigen via MHC class Ib,BP,
12042,GO:0048007,1.00000000000125,0.693686998770397,0,3,antigen processing and presentation, exogenous lipid antigen via MHC class Ib,BP,
4946,GO:0014916,1.00000000000125,0.690072679231154,0,3,regulation of lung blood pressure,BP,
3198,GO:0006828,1.00000000000128,0.695129549915454,0,3,manganese ion transport,BP,
6381,GO:0021577,1.00000000000128,0.886554502792297,0,1,hindbrain structural organization,BP,
6385,GO:0021589,1.00000000000128,0.886554502792297,0,1,cerebellum structural organization,BP,
14062,GO:0060904,1.00000000000128,0.886554502792297,0,1,regulation of protein folding in endoplasmic reticulum,BP,
18767,GO:1904313,1.00000000000128,0.886554502792297,0,1,response to methamphetamine hydrochloride,BP,
2063,GO:0004818,1.00000000000129,0.780920865707507,0,2,glutamate-tRNA ligase activity,MF,
2913,GO:0006424,1.00000000000129,0.780920865707507,0,2,glutamyl-tRNA aminoacylation,BP,
4168,GO:0009236,1.00000000000129,0.699709657061904,0,3,cobalamin biosynthetic process,BP,
660,GO:0001855,1.0000000000013,0.909748461458941,0,1,complement component C4b binding,MF,
20268,GO:2001270,1.00000000000131,0.659626717069958,0,4,regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis,BP,
4415,GO:0010193,1.00000000000132,0.812337505546027,0,2,response to ozone,BP,
102,GO:0000214,1.00000000000133,0.664611590541823,0,4,tRNA-intron endonuclease complex,CC,
1802,GO:0004449,1.00000000000134,0.745759222940427,0,3,isocitrate dehydrogenase (NAD+) activity,MF,
15025,GO:0070992,1.00000000000134,0.867066662209834,0,2,translation initiation complex,CC,
17992,GO:1902498,1.00000000000135,0.692856735213895,0,3,regulation of protein autoubiquitination,BP,
169,GO:0000354,1.00000000000135,0.786228563638229,0,2,cis assembly of pre-catalytic spliceosome,BP,
7593,GO:0031981,1.00000000000137,0,257,3516,nuclear lumen,CC,ITGB6;DDB2;TP53INP1;PTHLH;SREBF1;NT5E;OAS2;HSPA2;TRIM65;CIRBP;MNT;XPC;CPT2;RBM3;SYN1;ASH2L;TRIM22;SRSF5;PCDH1;MAP3K14;DCAF16;DGKQ;BRSK1;KDM3A;POU3F1;HR;ISG15;TFCP2L1;ZFPM1;HOXC5;CITED4;IRF2BPL;ASAP3;STAT1;CRY2;NOS1;PRKACB;HOXA3;MAML3;SCMH1;NFATC4;FKBP5;RNF187;H1F0;AP5Z1;HSF4;LIG1;ITPR3;CYHR1;MDM2;CRTC1;NDN;MLH3;DDX59;OBSCN;NEO1;PHACTR3;CTSV;POLH;BLVRB;POLR2J2;OAS1;TRIM66;RGS2;NOL4L;GLI2;TCEA2;SOX12;PIDD1;SLX1A;SLX1B;ATG16L2;SPG11;ZCCHC11;PER2;PSKH1;PHF2;ABHD14B;TCEAL1;WWTR1;GLI3;SPPL2B;THRAP3;SMARCA1;BHLHE40;ZNF655;BOC;ZNF318;JARID2;INSR;CELSR1;CHD3;BAIAP2;TTN;PLEKHH2;POLD4;NSUN5P2;PNMA1;ETAA1;RMI2;RTF1;IRF9;H2AFJ;B4GALT2;PDK1;SQSTM1;PTK6;ETV5;FNBP4;KDM4C;H1FX;UBOX5;NSMCE4A;B3GNT9;CENPC;PDIK1L;TCF4;KLHDC2;PLAG1;WRN;PODXL;DNM1;MACROD1;IQCB1;CDK5R1;ATRX;REC8;ARHGAP27;POLR2J3;SESN1;MAPK10;NKTR;ADIRF;HMG20B;AGO4;ERCC6;HADH;RRM2B;HLCS;MEF2D;CREBRF;RAB11FIP3;MLXIPL;CTSB;FBXW7;ANKRD28;ING4;CDK5RAP3;ATXN1;LMO2;CCDC92;PAK6;CARF;MXI1;PFKFB2;THRA;HSD11B1L;METTL21A;ACADS;ARAP1;ADARB1;RAI1;ELF1;IKZF4;DCAF10;NLRP1;ZBTB34;MIF4GD;EPM2AIP1;CAPG;RGS12;MPG;CENPH;ZNF554;BDH1;APPL2;SALL2;ZBTB20;SDHA;LTB4R2;CASZ1;CALCOCO1;TEAD2;MYSM1;RNF213;OLFM2;IFI16;ERCC5;SETD4;ABTB1;DEF6;RPS6KA5;ZNF687;VDR;LETMD1;PHF7;TNRC18;ZMYM3;HLTF;ZNF789;MPPE1;STK19;NDUFV3;STAT2;PHF1;TFDP2;CCDC113;PPP2R3B;IQSEC1;PANO1;PALB2;WEE1;DYDC1;GTF2IRD2;AMT;TCF7;RSAD2;LMNA;KAT2B;TEP1;APOLD1;IVNS1ABP;RAD50;ANGEL2;ZMAT3;PNPO;TRERF1;DCAF8;RAPGEF5;STAT6;SOX13;NELFCD;PHC2;KLF8;CHD6;ACSS2;HDAC11;PLCB3;UVSSA;KMT5C;MPP7;RORA;PPARG;PRKACA;CXXC5;NPAP1;POLM;SYNE2;PARN;IP6K2;KLF9;AIP;MSH5;CLCN7;HIVEP1;SMURF1;CTNNBIP1
5459,GO:0016340,1.00000000000137,0.772610408817278,0,2,calcium-dependent cell-matrix adhesion,BP,
14996,GO:0070948,1.00000000000138,0.736744825460522,0,3,regulation of neutrophil mediated cytotoxicity,BP,
16511,GO:0097267,1.00000000000139,0.62594206617732,0,4,omega-hydroxylase P450 pathway,BP,
7547,GO:0031871,1.0000000000014,0.710712042202627,0,3,proteinase activated receptor binding,MF,
9569,GO:0036396,1.0000000000014,0.738034653328108,0,3,RNA N6-methyladenosine methyltransferase complex,CC,
11176,GO:0045293,1.0000000000014,0.738034653328108,0,3,mRNA editing complex,CC,
14942,GO:0070859,1.00000000000143,0.72934377325217,0,3,positive regulation of bile acid biosynthetic process,BP,
18743,GO:1904253,1.00000000000143,0.72934377325217,0,3,positive regulation of bile acid metabolic process,BP,
14069,GO:0060916,1.00000000000143,0.615913668992201,0,4,mesenchymal cell proliferation involved in lung development,BP,
9512,GO:0036228,1.00000000000143,0.795735356204042,0,2,protein localization to nuclear inner membrane,BP,
19954,GO:2000563,1.00000000000145,0.792499818705742,0,2,positive regulation of CD4-positive, alpha-beta T cell proliferation,BP,
6935,GO:0030550,1.0000000000015,0.727149567772268,0,3,acetylcholine receptor inhibitor activity,MF,
9635,GO:0036515,1.0000000000015,0.59668317514326,0,4,serotonergic neuron axon guidance,BP,
1769,GO:0004376,1.00000000000152,0.6567175384323,0,4,glycolipid mannosyltransferase activity,MF,
15815,GO:0072540,1.00000000000152,0.662645979037475,0,4,T-helper 17 cell lineage commitment,BP,
8235,GO:0033018,1.00000000000154,0.807214732286278,0,2,sarcoplasmic reticulum lumen,CC,
7410,GO:0031508,1.00000000000154,0.829019289619155,0,2,pericentric heterochromatin assembly,BP,
217,GO:0000454,1.00000000000154,0.801674817168473,0,3,snoRNA guided rRNA pseudouridine synthesis,BP,
9088,GO:0035368,1.00000000000154,0.640557283166912,0,4,selenocysteine insertion sequence binding,MF,
11860,GO:0046884,1.00000000000155,0.625409933314408,0,4,follicle-stimulating hormone secretion,BP,
882,GO:0002249,1.00000000000156,0.772935186213697,0,2,lymphocyte anergy,BP,
1083,GO:0002667,1.00000000000156,0.772935186213697,0,2,regulation of T cell anergy,BP,
1207,GO:0002870,1.00000000000156,0.772935186213697,0,2,T cell anergy,BP,
1229,GO:0002911,1.00000000000156,0.772935186213697,0,2,regulation of lymphocyte anergy,BP,
7682,GO:0032142,1.00000000000158,0.698137686983837,0,3,single guanine insertion binding,MF,
14066,GO:0060913,1.00000000000159,0.899794648291305,0,1,cardiac cell fate determination,BP,
15380,GO:0071657,1.00000000000159,0.899794648291305,0,1,positive regulation of granulocyte colony-stimulating factor production,BP,
17579,GO:1901258,1.00000000000159,0.899794648291305,0,1,positive regulation of macrophage colony-stimulating factor production,BP,
8605,GO:0034128,1.00000000000159,0.709692798433346,0,3,negative regulation of MyD88-independent toll-like receptor signaling pathway,BP,
11586,GO:0046208,1.0000000000016,0.75776603285593,0,3,spermine catabolic process,BP,
3894,GO:0008534,1.0000000000016,0.712809709018382,0,4,oxidized purine nucleobase lesion DNA N-glycosylase activity,MF,
15902,GO:0072709,1.00000000000161,0.803546915772234,0,2,cellular response to sorbitol,BP,
6616,GO:0022848,1.00000000000161,0.642919574782968,0,4,acetylcholine-gated cation-selective channel activity,MF,
5923,GO:0018201,1.00000000000161,0.696898083666912,0,3,peptidyl-glycine modification,BP,
14866,GO:0070676,1.00000000000162,0.746219563241549,0,3,intralumenal vesicle formation,BP,
14418,GO:0061752,1.00000000000163,0.811361345980678,0,2,telomeric repeat-containing RNA binding,MF,
6534,GO:0021943,1.00000000000164,0.621735299677082,0,4,formation of radial glial scaffolds,BP,
12432,GO:0050152,1.00000000000166,0.919799884747021,0,1,omega-amidase activity,MF,
1140,GO:0002732,1.00000000000167,0.882326014419129,0,1,positive regulation of dendritic cell cytokine production,BP,
7915,GO:0032498,1.00000000000167,0.882326014419129,0,1,detection of muramyl dipeptide,BP,
7916,GO:0032499,1.00000000000167,0.882326014419129,0,1,detection of peptidoglycan,BP,
7917,GO:0032500,1.00000000000167,0.882326014419129,0,1,muramyl dipeptide binding,MF,
19857,GO:2000361,1.00000000000167,0.882326014419129,0,1,regulation of prostaglandin-E synthase activity,BP,
19858,GO:2000363,1.00000000000167,0.882326014419129,0,1,positive regulation of prostaglandin-E synthase activity,BP,
2019,GO:0004750,1.00000000000168,0.900840027879651,0,1,ribulose-phosphate 3-epimerase activity,MF,
16658,GO:0097621,1.00000000000168,0.900840027879651,0,1,monoamine oxidase activity,MF,
7427,GO:0031544,1.00000000000168,0.65192438112906,0,4,peptidyl-proline 3-dioxygenase activity,MF,
10196,GO:0042825,1.00000000000169,0.710122267659354,0,3,TAP complex,CC,
10212,GO:0042904,1.00000000000169,0.728835117166666,0,3,9-cis-retinoic acid biosynthetic process,BP,
10213,GO:0042905,1.00000000000169,0.728835117166666,0,3,9-cis-retinoic acid metabolic process,BP,
4046,GO:0009085,1.0000000000017,0.790728382906357,0,2,lysine biosynthetic process,BP,
6273,GO:0019878,1.0000000000017,0.790728382906357,0,2,lysine biosynthetic process via aminoadipic acid,BP,
4836,GO:0014045,1.00000000000171,0.644312544305112,0,4,establishment of endothelial blood-brain barrier,BP,
6557,GO:0022009,1.00000000000171,0.644312544305112,0,4,central nervous system vasculogenesis,BP,
3726,GO:0008254,1.00000000000172,0.878409192082729,0,1,3'-nucleotidase activity,MF,
1944,GO:0004649,1.00000000000175,0.801801163823978,0,2,poly(ADP-ribose) glycohydrolase activity,MF,
14433,GO:0061783,1.00000000000176,0.761808250488836,0,3,peptidoglycan muralytic activity,MF,
10326,GO:0043137,1.00000000000176,0.668354805343549,0,4,DNA replication, removal of RNA primer,BP,
9148,GO:0035513,1.00000000000177,0.646496246067286,0,4,oxidative RNA demethylation,BP,
9150,GO:0035515,1.00000000000177,0.646496246067286,0,4,oxidative RNA demethylase activity,MF,
13811,GO:0060431,1.00000000000178,0.717877735893794,0,3,primary lung bud formation,BP,
9230,GO:0035634,1.00000000000178,0.870474731245812,0,2,response to stilbenoid,BP,
14257,GO:0061355,1.00000000000179,0.64109526994545,0,4,Wnt protein secretion,BP,
14258,GO:0061356,1.00000000000179,0.64109526994545,0,4,regulation of Wnt protein secretion,BP,
10997,GO:0044830,1.00000000000179,0.793628177617429,0,2,modulation by host of viral RNA genome replication,BP,
13223,GO:0051918,1.0000000000018,0.632367848322979,0,4,negative regulation of fibrinolysis,BP,
5993,GO:0019002,1.0000000000018,0.799496718291344,0,2,GMP binding,MF,
759,GO:0002002,1.0000000000018,0.650903704003993,0,4,regulation of angiotensin levels in blood,BP,
760,GO:0002003,1.0000000000018,0.650903704003993,0,4,angiotensin maturation,BP,
1223,GO:0002901,1.00000000000182,0.716743000127343,0,4,mature B cell apoptotic process,BP,
1227,GO:0002905,1.00000000000182,0.716743000127343,0,4,regulation of mature B cell apoptotic process,BP,
1228,GO:0002906,1.00000000000182,0.716743000127343,0,4,negative regulation of mature B cell apoptotic process,BP,
16759,GO:0098592,1.00000000000182,0.716052290473245,0,3,cytoplasmic side of apical plasma membrane,CC,
982,GO:0002439,1.00000000000182,0.818537914479085,0,2,chronic inflammatory response to antigenic stimulus,BP,
12837,GO:0051176,1.00000000000184,0.71160824682643,0,3,positive regulation of sulfur metabolic process,BP,
308,GO:0000820,1.00000000000184,0.771313545610082,0,2,regulation of glutamine family amino acid metabolic process,BP,
11371,GO:0045763,1.00000000000184,0.771313545610082,0,2,negative regulation of cellular amino acid metabolic process,BP,
15024,GO:0070991,1.00000000000185,0.722254531441162,0,3,medium-chain-acyl-CoA dehydrogenase activity,MF,
16703,GO:0097726,1.00000000000185,0.926138772790431,0,1,LEM domain binding,MF,
11086,GO:0045112,1.00000000000187,0.736183726776328,0,3,integrin biosynthetic process,BP,
8532,GO:0033871,1.00000000000188,0.903104411575861,0,1,[heparan sulfate]-glucosamine 3-sulfotransferase 2 activity,MF,
11910,GO:0046970,1.00000000000188,0.903104411575861,0,1,NAD-dependent histone deacetylase activity (H4-K16 specific),MF,
14279,GO:0061433,1.00000000000188,0.903104411575861,0,1,cellular response to caloric restriction,BP,
14742,GO:0070446,1.00000000000188,0.903104411575861,0,1,negative regulation of oligodendrocyte progenitor proliferation,BP,
16550,GO:0097361,1.00000000000189,0.670378719848135,0,4,CIA complex,CC,
4880,GO:0014744,1.00000000000189,0.693840516147896,0,3,positive regulation of muscle adaptation,BP,
13486,GO:0055077,1.0000000000019,0.723984031317403,0,3,gap junction hemi-channel activity,MF,
6562,GO:0022027,1.00000000000193,0.584318676491451,0,4,interkinetic nuclear migration,BP,
11738,GO:0046601,1.00000000000193,0.71022616045791,0,3,positive regulation of centriole replication,BP,
17267,GO:0140052,1.00000000000193,0.712114685979839,0,3,cellular response to oxidised low-density lipoprotein particle stimulus,BP,
6964,GO:0030626,1.00000000000194,0.802647891950673,0,2,U12 snRNA binding,MF,
2365,GO:0005483,1.00000000000194,0.714010005594259,0,3,soluble NSF attachment protein activity,MF,
2065,GO:0004820,1.00000000000195,0.818161282398685,0,2,glycine-tRNA ligase activity,MF,
2915,GO:0006426,1.00000000000195,0.818161282398685,0,2,glycyl-tRNA aminoacylation,BP,
14576,GO:0070150,1.00000000000195,0.818161282398685,0,2,mitochondrial glycyl-tRNA aminoacylation,BP,
10537,GO:0043504,1.00000000000198,0.703079698049512,0,3,mitochondrial DNA repair,BP,
16744,GO:0098559,1.00000000000198,0.729481567730809,0,3,cytoplasmic side of early endosome membrane,CC,
10874,GO:0044428,1.00000000000199,0,284,3795,nuclear part,CC,ITGB6;DDB2;TP53INP1;PTHLH;SREBF1;NT5E;OAS2;HSPA2;EGFR;TRIM65;CIRBP;MNT;XPC;CPT2;RBM3;SYN1;ASH2L;TRIM22;SRSF5;PCDH1;MAP3K14;DCAF16;DGKQ;BRSK1;KDM3A;POU3F1;UBXN4;HR;ISG15;TFCP2L1;ZFPM1;HOXC5;CUL7;CITED4;IRF2BPL;PRICKLE2;ASAP3;STAT1;CRY2;RAB40B;NOS1;PRKACB;HOXA3;MAML3;SCMH1;NFATC4;FKBP5;RNF187;H1F0;AP5Z1;HSF4;LIG1;ITPR3;CYHR1;MDM2;CRTC1;NDN;MLH3;DDX59;OBSCN;CERS4;NEO1;PHACTR3;CTSV;POLH;BLVRB;POLR2J2;OAS1;TRIM66;RGS2;NOL4L;TMC6;FLOT1;GLI2;DHX32;TCEA2;SOX12;PIDD1;SLX1A;SLX1B;ATG16L2;SPG11;ZCCHC11;SULT1E1;PER2;PSKH1;PHF2;ABHD14B;TCEAL1;WWTR1;GLI3;SPPL2B;THRAP3;SMARCA1;BHLHE40;ZNF655;BOC;ZNF318;JARID2;INSR;CELSR1;CHD3;BAIAP2;TTN;SUN1;PLEKHH2;POLD4;NSUN5P2;PNMA1;PMS2P3;ETAA1;RMI2;MGST2;RTF1;IRF9;H2AFJ;B4GALT2;PDK1;SQSTM1;PTK6;ETV5;FNBP4;KDM4C;CLCA2;H1FX;UBOX5;NSMCE4A;B3GNT9;CENPC;CST3;PDIK1L;TCF4;KLHDC2;PLAG1;WRN;PODXL;IFI27;DNM1;MACROD1;IQCB1;TREX1;CDK5R1;ATRX;REC8;ARHGAP27;POLR2J3;SESN1;MAPK10;NKTR;ADIRF;HMG20B;AGO4;ERCC6;HADH;RRM2B;HLCS;MEF2D;CREBRF;RAB11FIP3;MLXIPL;CTSB;FBXW7;ANKRD28;ING4;CDK5RAP3;ATXN1;LMO2;CCDC92;PAK6;CARF;MXI1;PFKFB2;THRA;HSD11B1L;METTL21A;ACADS;ARAP1;ADARB1;RAI1;ELF1;MX2;IKZF4;DCAF10;NLRP1;ZBTB34;MIF4GD;EPM2AIP1;CAPG;RGS12;MPG;CENPH;ZNF554;BDH1;APPL2;SALL2;ZBTB20;SDHA;LTB4R2;CASZ1;CALCOCO1;TEAD2;MYSM1;RNF213;OLFM2;IFI16;ERCC5;RETSAT;SETD4;ABTB1;DEF6;RPS6KA5;ZNF687;VDR;LETMD1;PHF7;TNRC18;DPY19L2P2;ZMYM3;HLTF;ZNF789;MPPE1;STK19;NDUFV3;STAT2;PHF1;TFDP2;CCDC113;PPP2R3B;IQSEC1;PANO1;PALB2;WEE1;DYDC1;GTF2IRD2;DQX1;AMT;TCF7;RSAD2;NEMP2;LMNA;KAT2B;TEP1;APOLD1;ERN1;IVNS1ABP;RAD50;ANGEL2;ZMAT3;PNPO;S100A6;TRERF1;DCAF8;RAPGEF5;CERS5;STAT6;SOX13;NELFCD;PHC2;KLF8;CHD6;ACSS2;HDAC11;PLCB3;UVSSA;KMT5C;AKAP6;MPP7;RORA;PPARG;PRKACA;CXXC5;NPAP1;POLM;SYNE2;PARN;IP6K2;KLF9;AIP;MSH5;CLCN7;PTBP2;HIVEP1;SMURF1;CTNNBIP1
17217,GO:0110057,1.00000000000199,0.87975563172369,0,1,regulation of blood vessel endothelial cell differentiation,BP,
17218,GO:0110059,1.00000000000199,0.87975563172369,0,1,negative regulation of blood vessel endothelial cell differentiation,BP,
16632,GO:0097527,1.000000000002,0.648647682012024,0,4,necroptotic signaling pathway,BP,
13381,GO:0052739,1.00000000000201,0.901996627809911,0,1,phosphatidylserine 1-acylhydrolase activity,MF,
13382,GO:0052740,1.00000000000201,0.901996627809911,0,1,1-acyl-2-lysophosphatidylserine acylhydrolase activity,MF,
18857,GO:1904550,1.00000000000201,0.901996627809911,0,1,response to arachidonic acid,BP,
19832,GO:2000324,1.00000000000201,0.901996627809911,0,1,positive regulation of glucocorticoid receptor signaling pathway,BP,
18738,GO:1904245,1.00000000000202,0.813080234183588,0,2,regulation of polynucleotide adenylyltransferase activity,BP,
6668,GO:0030035,1.00000000000202,0.696599621686801,0,3,microspike assembly,BP,
410,GO:0001097,1.00000000000204,0.718698835185496,0,3,TFIIH-class transcription factor binding,MF,
20083,GO:2000777,1.00000000000204,0.813374205550315,0,2,positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia,BP,
13925,GO:0060623,1.00000000000207,0.721948547803625,0,3,regulation of chromosome condensation,BP,
1932,GO:0004633,1.00000000000208,0.90113245980756,0,1,phosphopantothenoylcysteine decarboxylase activity,MF,
15997,GO:0086036,1.00000000000209,0.616823200521978,0,4,regulation of cardiac muscle cell membrane potential,BP,
937,GO:0002339,1.00000000000209,0.848179476948691,0,2,B cell selection,BP,
941,GO:0002352,1.00000000000209,0.848179476948691,0,2,B cell negative selection,BP,
17937,GO:1902311,1.00000000000209,0.905603815285824,0,1,regulation of copper ion transmembrane transport,BP,
3615,GO:0008063,1.00000000000212,0.644893870361784,0,4,Toll signaling pathway,BP,
8314,GO:0033167,1.00000000000212,0.873403243475809,0,1,ARC complex,CC,
8315,GO:0033168,1.00000000000212,0.873403243475809,0,1,conversion of ds siRNA to ss siRNA involved in RNA interference,BP,
9574,GO:0036404,1.00000000000212,0.873403243475809,0,1,conversion of ds siRNA to ss siRNA,BP,
18360,GO:1903387,1.00000000000212,0.879940949029148,0,1,positive regulation of homophilic cell adhesion,BP,
2023,GO:0004757,1.00000000000213,0.913432400176236,0,1,sepiapterin reductase activity,MF,
18397,GO:1903463,1.00000000000215,0.709286247454979,0,3,regulation of mitotic cell cycle DNA replication,BP,
5089,GO:0015355,1.00000000000216,0.663457142959679,0,4,secondary active monocarboxylate transmembrane transporter activity,MF,
3804,GO:0008391,1.00000000000216,0.813835668521858,0,2,arachidonic acid monooxygenase activity,MF,
3805,GO:0008392,1.00000000000216,0.813835668521858,0,2,arachidonic acid epoxygenase activity,MF,
4543,GO:0010624,1.00000000000216,0.613035443903054,0,4,regulation of Schwann cell proliferation,BP,
4544,GO:0010626,1.00000000000216,0.613035443903054,0,4,negative regulation of Schwann cell proliferation,BP,
18289,GO:1903233,1.00000000000216,0.772319925611939,0,2,regulation of calcium ion-dependent exocytosis of neurotransmitter,BP,
2391,GO:0005534,1.00000000000218,0.736649341147252,0,3,galactose binding,MF,
11543,GO:0046101,1.00000000000219,0.676189384530374,0,4,hypoxanthine biosynthetic process,BP,
2058,GO:0004813,1.00000000000222,0.711786027348134,0,3,alanine-tRNA ligase activity,MF,
2908,GO:0006419,1.00000000000222,0.711786027348134,0,3,alanyl-tRNA aminoacylation,BP,
17001,GO:0099174,1.00000000000222,0.705854066254373,0,3,regulation of presynapse organization,BP,
19300,GO:1905606,1.00000000000222,0.705854066254373,0,3,regulation of presynapse assembly,BP,
18814,GO:1904428,1.00000000000223,0.707420246270622,0,3,negative regulation of tubulin deacetylation,BP,
1979,GO:0004699,1.00000000000223,0.705932200672787,0,3,calcium-independent protein kinase C activity,MF,
19561,GO:1990637,1.00000000000224,0.714988015692533,0,3,response to prolactin,BP,
9761,GO:0039552,1.00000000000226,0.879745911261107,0,1,RIG-I binding,MF,
4590,GO:0010701,1.00000000000226,0.796357680968028,0,2,positive regulation of norepinephrine secretion,BP,
1425,GO:0003400,1.00000000000227,0.901371740716292,0,1,regulation of COPII vesicle coating,BP,
2204,GO:0005090,1.00000000000227,0.901371740716292,0,1,Sar guanyl-nucleotide exchange factor activity,MF,
13934,GO:0060661,1.00000000000227,0.901371740716292,0,1,submandibular salivary gland formation,BP,
15171,GO:0071335,1.00000000000227,0.901371740716292,0,1,hair follicle cell proliferation,BP,
15172,GO:0071336,1.00000000000227,0.901371740716292,0,1,regulation of hair follicle cell proliferation,BP,
15173,GO:0071338,1.00000000000227,0.901371740716292,0,1,positive regulation of hair follicle cell proliferation,BP,
16102,GO:0090113,1.00000000000227,0.901371740716292,0,1,regulation of ER to Golgi vesicle-mediated transport by GTP hydrolysis,BP,
3220,GO:0006868,1.00000000000227,0.632209402745631,0,4,glutamine transport,BP,
5021,GO:0015186,1.00000000000227,0.632209402745631,0,4,L-glutamine transmembrane transporter activity,MF,
12247,GO:0048549,1.00000000000228,0.620000715429428,0,4,positive regulation of pinocytosis,BP,
5662,GO:0016774,1.00000000000228,0.725042774358133,0,3,phosphotransferase activity, carboxyl group as acceptor,MF,
19570,GO:1990700,1.00000000000229,0.886817707938347,0,1,nucleolar chromatin organization,BP,
13498,GO:0055091,1.0000000000023,0.609892443600503,0,4,phospholipid homeostasis,BP,
438,GO:0001179,1.0000000000023,0.90418329794412,0,1,RNA polymerase I transcription factor binding,MF,
19737,GO:2000152,1.0000000000023,0.69862301079372,0,4,regulation of ubiquitin-specific protease activity,BP,
17137,GO:0102522,1.00000000000232,0.901158233481725,0,1,tRNA 4-demethylwyosine alpha-amino-alpha-carboxypropyltransferase activity,MF,
10810,GO:0044316,1.00000000000234,0.889498127237528,0,1,cone cell pedicle,CC,
7379,GO:0031439,1.00000000000234,0.794992943135029,0,2,positive regulation of mRNA cleavage,BP,
2419,GO:0005594,1.00000000000234,0.809460722021981,0,2,collagen type IX trimer,CC,
14193,GO:0061152,1.00000000000235,0.823983683376215,0,2,trachea submucosa development,BP,
14194,GO:0061153,1.00000000000235,0.823983683376215,0,2,trachea gland development,BP,
12365,GO:0048787,1.00000000000235,0.620829740696467,0,4,presynaptic active zone membrane,CC,
15199,GO:0071374,1.00000000000236,0.78549725517404,0,2,cellular response to parathyroid hormone stimulus,BP,
8919,GO:0034776,1.00000000000236,0.776753961492463,0,2,response to histamine,BP,
15230,GO:0071420,1.00000000000236,0.776753961492463,0,2,cellular response to histamine,BP,
14216,GO:0061209,1.00000000000236,0.728435645692233,0,3,cell proliferation involved in mesonephros development,BP,
19321,GO:1905696,1.00000000000239,0.775843138326186,0,2,regulation of polysome binding,BP,
4121,GO:0009182,1.0000000000024,0.763700181567132,0,3,purine deoxyribonucleoside diphosphate metabolic process,BP,
11521,GO:0046066,1.0000000000024,0.763700181567132,0,3,dGDP metabolic process,BP,
5003,GO:0015152,1.0000000000024,0.901725615391646,0,1,glucose-6-phosphate transmembrane transporter activity,MF,
7621,GO:0032028,1.0000000000024,0.901725615391646,0,1,myosin head/neck binding,MF,
4627,GO:0010751,1.00000000000242,0.770658270839143,0,2,negative regulation of nitric oxide mediated signal transduction,BP,
13843,GO:0060481,1.00000000000244,0.814248721761389,0,2,lobar bronchus epithelium development,BP,
13629,GO:0060158,1.00000000000245,0.666951242161349,0,4,phospholipase C-activating dopamine receptor signaling pathway,BP,
2420,GO:0005595,1.00000000000245,0.874221699626986,0,1,collagen type XII trimer,CC,
5234,GO:0015853,1.00000000000246,0.675382051424776,0,4,adenine transport,BP,
18590,GO:1903895,1.00000000000246,0.643076794218244,0,4,negative regulation of IRE1-mediated unfolded protein response,BP,
16150,GO:0090191,1.00000000000246,0.816683436606618,0,2,negative regulation of branching involved in ureteric bud morphogenesis,BP,
7733,GO:0032240,1.00000000000247,0.769220605750153,0,2,negative regulation of nucleobase-containing compound transport,BP,
11834,GO:0046832,1.00000000000247,0.769220605750153,0,2,negative regulation of RNA export from nucleus,BP,
17913,GO:1902262,1.00000000000247,0.666076324648992,0,4,apoptotic process involved in blood vessel morphogenesis,BP,
6411,GO:0021679,1.00000000000248,0.802938041992264,0,2,cerebellar molecular layer development,BP,
6418,GO:0021687,1.00000000000248,0.802938041992264,0,2,cerebellar molecular layer morphogenesis,BP,
8063,GO:0032747,1.00000000000251,0.757819848825882,0,3,positive regulation of interleukin-23 production,BP,
9655,GO:0038025,1.00000000000251,0.787695666559613,0,2,reelin receptor activity,MF,
8198,GO:0032960,1.00000000000252,0.628850378228516,0,4,regulation of inositol trisphosphate biosynthetic process,BP,
19985,GO:2000619,1.00000000000252,0.732148114834577,0,3,negative regulation of histone H4-K16 acetylation,BP,
2254,GO:0005169,1.00000000000253,0.819964226846414,0,2,neurotrophin TRKB receptor binding,MF,
19282,GO:1905573,1.00000000000253,0.812416102251349,0,2,ganglioside GM1 binding,MF,
19285,GO:1905576,1.00000000000253,0.812416102251349,0,2,ganglioside GT1b binding,MF,
2150,GO:0004970,1.00000000000254,0.682345065259949,0,3,ionotropic glutamate receptor activity,MF,
2151,GO:0004972,1.00000000000254,0.682345065259949,0,3,NMDA glutamate receptor activity,MF,
8775,GO:0034470,1.00000000000254,0,4,396,ncRNA processing,BP,ZCCHC11;NSUN5P2;AGO4;TARBP1
19125,GO:1905152,1.00000000000256,0.879514312848714,0,1,positive regulation of voltage-gated sodium channel activity,BP,
2055,GO:0004809,1.00000000000256,0.731504641952813,0,3,tRNA (guanine-N2-)-methyltransferase activity,MF,
6478,GO:0021826,1.00000000000257,0.80531286789634,0,2,substrate-independent telencephalic tangential migration,BP,
6481,GO:0021830,1.00000000000257,0.80531286789634,0,2,interneuron migration from the subpallium to the cortex,BP,
6485,GO:0021843,1.00000000000257,0.80531286789634,0,2,substrate-independent telencephalic tangential interneuron migration,BP,
8832,GO:0034635,1.00000000000258,0.793467746240649,0,2,glutathione transport,BP,
10221,GO:0042939,1.00000000000258,0.793467746240649,0,2,tripeptide transport,BP,
9661,GO:0038033,1.00000000000262,0.748110042105438,0,3,positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway,BP,
9333,GO:0035851,1.00000000000263,0.898247920775141,0,1,Krueppel-associated box domain binding,MF,
9459,GO:0036090,1.00000000000265,0.814378297374927,0,2,cleavage furrow ingression,BP,
3471,GO:0007296,1.00000000000267,0.61465700343414,0,4,vitellogenesis,BP,
9982,GO:0042406,1.00000000000267,0.662157850927045,0,4,extrinsic component of endoplasmic reticulum membrane,CC,
1304,GO:0003150,1.00000000000268,0.616750251777764,0,4,muscular septum morphogenesis,BP,
6476,GO:0021824,1.00000000000269,0.792017031159086,0,2,cerebral cortex tangential migration using cell-axon interactions,BP,
6480,GO:0021828,1.00000000000269,0.792017031159086,0,2,gonadotrophin-releasing hormone neuronal migration to the hypothalamus,BP,
6491,GO:0021856,1.00000000000269,0.792017031159086,0,2,hypothalamic tangential migration using cell-axon interactions,BP,
13776,GO:0060385,1.00000000000269,0.792017031159086,0,2,axonogenesis involved in innervation,BP,
18351,GO:1903375,1.00000000000269,0.792017031159086,0,2,facioacoustic ganglion development,BP,
16611,GO:0097490,1.0000000000027,0.62152214902831,0,4,sympathetic neuron projection extension,BP,
16612,GO:0097491,1.0000000000027,0.62152214902831,0,4,sympathetic neuron projection guidance,BP,
19340,GO:1905777,1.00000000000271,0.726541702670317,0,3,regulation of exonuclease activity,BP,
14797,GO:0070552,1.00000000000271,0.728015110328729,0,3,BRISC complex,CC,
10906,GO:0044528,1.00000000000271,0.647430259704916,0,4,regulation of mitochondrial mRNA stability,BP,
19844,GO:2000344,1.00000000000272,0.665199022539197,0,4,positive regulation of acrosome reaction,BP,
16234,GO:0090310,1.00000000000273,0.786831323393397,0,2,negative regulation of methylation-dependent chromatin silencing,BP,
3677,GO:0008176,1.00000000000274,0.834301657069488,0,2,tRNA (guanine-N7-)-methyltransferase activity,MF,
17169,GO:0106004,1.00000000000274,0.834301657069488,0,2,tRNA (guanine-N7)-methylation,BP,
1368,GO:0003256,1.00000000000274,0.696444001028274,0,3,regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation,BP,
6446,GO:0021769,1.00000000000276,0.702963503468652,0,3,orbitofrontal cortex development,BP,
3903,GO:0008545,1.00000000000277,0.794791041264752,0,2,JUN kinase kinase activity,MF,
13042,GO:0051563,1.00000000000278,0.784975368768497,0,2,smooth endoplasmic reticulum calcium ion homeostasis,BP,
9295,GO:0035752,1.0000000000028,0.90360411062732,0,1,lysosomal lumen pH elevation,BP,
1678,GO:0004145,1.00000000000281,0.864483742020111,0,2,diamine N-acetyltransferase activity,MF,
6239,GO:0019809,1.00000000000281,0.864483742020111,0,2,spermidine binding,MF,
8171,GO:0032917,1.00000000000281,0.864483742020111,0,2,polyamine acetylation,BP,
8172,GO:0032918,1.00000000000281,0.864483742020111,0,2,spermidine acetylation,BP,
1059,GO:0002587,1.00000000000282,0.916250460910649,0,1,negative regulation of antigen processing and presentation of peptide antigen via MHC class II,BP,
10811,GO:0044317,1.00000000000282,0.916250460910649,0,1,rod spherule,CC,
3295,GO:0006990,1.00000000000283,0.717102416479618,0,3,positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response,BP,
4991,GO:0015129,1.00000000000284,0.711965078971588,0,3,lactate transmembrane transporter activity,MF,
1203,GO:0002863,1.00000000000284,0.753347035414287,0,3,positive regulation of inflammatory response to antigenic stimulus,BP,
1206,GO:0002866,1.00000000000284,0.753347035414287,0,3,positive regulation of acute inflammatory response to antigenic stimulus,BP,
18509,GO:1903719,1.00000000000284,0.745679557722416,0,3,regulation of I-kappaB phosphorylation,BP,
18510,GO:1903721,1.00000000000284,0.745679557722416,0,3,positive regulation of I-kappaB phosphorylation,BP,
4246,GO:0009448,1.00000000000288,0.621436555096582,0,4,gamma-aminobutyric acid metabolic process,BP,
11544,GO:0046102,1.00000000000291,0.738514634374395,0,3,inosine metabolic process,BP,
1713,GO:0004307,1.00000000000291,0.836078179443842,0,2,ethanolaminephosphotransferase activity,MF,
6639,GO:0023041,1.00000000000292,0.733427751704933,0,3,neuronal signal transduction,BP,
4559,GO:0010643,1.00000000000294,0.721801014739992,0,3,cell communication by chemical coupling,BP,
19100,GO:1905065,1.00000000000294,0.730292612673389,0,3,positive regulation of vascular smooth muscle cell differentiation,BP,
451,GO:0001225,1.00000000000296,0.77262893312048,0,2,RNA polymerase II transcription coactivator binding,MF,
7054,GO:0030849,1.00000000000296,0.880133150416235,0,1,autosome,CC,
3526,GO:0007501,1.00000000000297,0.709143683469148,0,3,mesodermal cell fate specification,BP,
10113,GO:0042661,1.00000000000297,0.709143683469148,0,3,regulation of mesodermal cell fate specification,BP,
19335,GO:1905770,1.00000000000297,0.709143683469148,0,3,regulation of mesodermal cell differentiation,BP,
19373,GO:1905902,1.00000000000297,0.709143683469148,0,3,regulation of mesoderm formation,BP,
6261,GO:0019858,1.00000000000298,0.830689167391023,0,2,cytosine metabolic process,BP,
12436,GO:0050211,1.00000000000298,0.807238305945483,0,2,procollagen galactosyltransferase activity,MF,
9547,GO:0036335,1.000000000003,0.879970843414166,0,1,intestinal stem cell homeostasis,BP,
16944,GO:0098976,1.00000000000301,0.627201379056441,0,4,excitatory chemical synaptic transmission,BP,
18843,GO:1904505,1.00000000000302,0.625192797163955,0,4,regulation of telomere maintenance in response to DNA damage,BP,
18844,GO:1904506,1.00000000000302,0.625192797163955,0,4,negative regulation of telomere maintenance in response to DNA damage,BP,
18040,GO:1902617,1.00000000000302,0.643641957116363,0,4,response to fluoride,BP,
19503,GO:1990415,1.00000000000303,0.717130429908692,0,3,Pex17p-Pex14p docking complex,CC,
19511,GO:1990429,1.00000000000303,0.717130429908692,0,3,peroxisomal importomer complex,CC,
12685,GO:0050923,1.00000000000305,0.680004427329024,0,3,regulation of negative chemotaxis,BP,
7263,GO:0031251,1.00000000000306,0.774002317298964,0,2,PAN complex,CC,
8358,GO:0033263,1.00000000000308,0.617896850271084,0,4,CORVET complex,CC,
7603,GO:0031997,1.00000000000308,0.731714216602218,0,3,N-terminal myristoylation domain binding,MF,
12941,GO:0051343,1.00000000000308,0.731714216602218,0,3,positive regulation of cyclic-nucleotide phosphodiesterase activity,BP,
49,GO:0000103,1.00000000000308,0.736656204032491,0,3,sulfate assimilation,BP,
12116,GO:0048210,1.00000000000311,0.733956102742783,0,3,Golgi vesicle fusion to target membrane,BP,
7742,GO:0032264,1.00000000000312,0.648887062366138,0,4,IMP salvage,BP,
12985,GO:0051430,1.00000000000312,0.796252365048526,0,2,corticotropin-releasing hormone receptor 1 binding,MF,
6140,GO:0019418,1.00000000000313,0.724570586311623,0,4,sulfide oxidation,BP,
14619,GO:0070221,1.00000000000313,0.724570586311623,0,4,sulfide oxidation, using sulfide:quinone oxidoreductase,BP,
14559,GO:0070122,1.00000000000314,0.630834165900121,0,4,isopeptidase activity,MF,
5561,GO:0016576,1.00000000000314,0.716100062109254,0,3,histone dephosphorylation,BP,
8783,GO:0034481,1.00000000000315,0.627973053866117,0,4,chondroitin sulfotransferase activity,MF,
6024,GO:0019086,1.00000000000316,0.649428911348953,0,4,late viral transcription,BP,
18852,GO:1904533,1.00000000000316,0.712185183897578,0,3,regulation of telomeric loop disassembly,BP,
6010,GO:0019062,1.00000000000316,0.739292149790223,0,3,virion attachment to host cell,BP,
10939,GO:0044650,1.00000000000316,0.739292149790223,0,3,adhesion of symbiont to host cell,BP,
10383,GO:0043229,1.00000000000318,0,853,9291,intracellular organelle,CC,TNFAIP3;TGFBI;POSTN;ITGB6;HES2;SERPINE2;ZSCAN18;ULK2;GPNMB;TSC22D1;SIK1;SLFN5;SUGCT;EPM2A;MUC19;NPEPL1;DDB2;TP53INP1;MAP6;IFI6;PTHLH;SREBF1;AMACR;PYGB;ACTA2;APOE;GPSM1;CES2;NT5E;INPP5D;GAMT;OAS2;ADAM19;LMF1;DDX60;HSPA2;EGFR;ESPN;TRIM65;HERC3;PTPRS;CIRBP;FLNC;FAM20C;PKD2;CAPRIN2;MNT;XPC;APOBEC3C;SYT8;CXCR1;CPT2;RBM3;SYN1;ASH2L;TRIM22;ALDH1A3;SRSF5;LRIG3;CTSO;OBSL1;PERM1;SEC14L2;KIF26B;PCDH1;EPHB2;RALGDS;TNS1;SYNC;MAP3K14;GLUD1;BPHL;DCAF16;DGKQ;TMEM129;PIK3R1;ADAMTS7;BRSK1;TXNRD3;MARVELD1;KDM3A;CXCL14;COL22A1;TSC22D3;EVC;POU3F1;SULF2;WNT3;H6PD;DHTKD1;CAMKK1;UBXN4;ST6GALNAC2;HR;CSPG4;ISG15;MVB12B;CYBRD1;SPATA18;TFCP2L1;TENM4;RGMA;KCNAB2;ZFPM1;KITLG;HOXC5;ZDHHC1;ZNF362;CUL7;VAMP3;CITED4;SNN;IRF2BPL;NAPRT;REEP2;PRICKLE2;ASAP3;ZNF266;SRD5A3;OR2A4;STAT1;CRY2;MYL9;KRT15;HS1BP3;LGALS7B;WDR63;NSG1;UROS;KDSR;ITGB5;COL10A1;RAB43;RAB40B;NOS1;PRKACB;ZNF704;HOXA3;B4GALNT4;CRY1;ZNF699;MAML3;ZFP41;SCMH1;KLF13;CRTAP;SDC3;PLEKHG5;NFATC4;ZNF783;HMGCL;D2HGDH;BTBD2;SCARA3;FKBP5;RNF187;FERMT1;H1F0;CYP26B1;GAA;AP5Z1;CMPK2;HSF4;CNTRL;ZNF251;MICALL1;LIG1;CDK18;VPS11;SPEG;NDRG1;COL7A1;ITPR3;EAPP;NAGLU;CYHR1;MDM2;CRTC1;LZTS2;NDN;MLH3;DDX59;ST6GALNAC6;ZNF662;TYSND1;OBSCN;IDUA;GOLGA8A;GPRC5C;HLA-B;PRODH;HGSNAT;MYH11;PARVB;SYTL1;FKBP9;NDUFA4L2;ACTR1B;RHOBTB2;UGT1A3;CERS4;CYP3A5;NEO1;RAPGEF3;PHACTR3;ZNF414;TCF25;FAM210B;CTSV;POLH;BLVRB;POLR2J2;OAS1;FLRT3;NUDCD3;TRIM66;GAL3ST4;CRAT;KIF26A;B4GALT6;MLLT6;AP1G2;RGL4;RGS2;ACAP3;ADGRB2;F2R;MLYCD;PPL;C2CD4C;HPS4;PHYH;MT1X;PDCD4;SPTB;NOL4L;ZNF160;CAPN7;SWT1;DNAH1;SLC27A3;ARSI;NEK9;TUBGCP5;ZFP36L2;CLTCL1;TRPV4;TMC6;FLOT1;GLI2;AGAP4;CORO6;ANK3;KLF7;RNF165;DHX32;ADAMTS13;LAMP3;TCEA2;RALGAPA1;MAPK8IP3;GOLGA8B;ZNF76;SOX12;PIDD1;RIMS3;AVL9;SLX1A;SLX1B;G6PC3;ATG16L2;SPG11;ZCCHC11;RHBDF1;SULT1E1;PER2;CLCN6;PTGS1;UNC119;DIRC2;HEXA;FNDC4;FRMD4B;ZNF658;ARSD;WIPF1;SNTA1;PSKH1;MINK1;PHF2;NINL;ABHD14B;GSTM2;TCEAL1;AMIGO2;WWTR1;MBOAT2;ASAP2;LHFPL2;ITGA2;RSPH3;FAM110C;ULK1;GLI3;SPPL2B;FHOD3;PCSK1;TPGS1;THRAP3;ZNF558;IRX4;SMARCA1;AKAP7;BHLHE40;DGCR6L;VAMP2;ZNF655;NAIP;LTBP1;ZNF333;NEK8;MAP2K5;GAS8;BOC;CES3;BSN;SESN3;ZNF318;IGFBP4;TCFL5;TRAK1;JARID2;NUPR1;GPC2;NISCH;INSR;TST;CCDC85B;CELSR1;GSN;ALDH4A1;CEP68;CHD3;CDK14;ST3GAL5;BAIAP2;TTN;CBLC;ZNF18;CEP126;SUN1;AHNAK2;PLEKHH2;TRIOBP;MXD4;POLD4;RIN1;DNAJC30;CTSF;ZNF287;CD109;CYP2D7;NSUN5P2;PNMA1;PMS2P3;ETAA1;RMI2;ZNF446;SEPT6;RAB11FIP4;VPS39;ZNF581;MGST2;TP53AIP1;ENDOG;SLC27A1;PGAP1;NRSN2;RTF1;BLOC1S3;CASP14;IRF9;TMEM9;H2AFJ;F8A1;NLRX1;B4GALT2;PEX10;SLC2A3;TCIRG1;S100A4;MICALL2;MAP2K2;PDK1;VEGFB;ALDH7A1;GLI4;SQSTM1;CEP192;CABYR;PTK6;TMEM8B;FZD7;ETV5;AKR7A2;LOXL1;FNBP4;FRMD8;FAT2;DLX3;TMEM117;EPB41L3;HEXB;KDM4C;HYAL1;METTL23;CLCA2;ARHGAP33;H1FX;UBOX5;NSMCE4A;ARRDC1;KIAA0319L;B3GNT9;WHAMMP3;CENPC;PLA2G6;CST3;PDIK1L;GDF15;PEX7;BBS2;TXNIP;TCF4;ATP6V0A2;KLHDC2;COL6A1;PEX11B;LRRCC1;PLAG1;IDH2;CERCAM;RCOR2;WRN;PODXL;SEPT5;IFI27;MALL;OXLD1;DNM1;MCM9;MACROD1;IQCB1;PLD3;TREX1;LPIN3;ZDHHC12;MCTP1;CDK5R1;ATRX;REC8;ARHGAP27;AGAP6;NET1;PIGZ;OSBPL10;POLR2J3;HOOK2;SESN1;EPB41L4A;MAPK10;NKTR;HFE;ADIRF;HMG20B;CYBA;AGO4;ERCC6;HADH;RRM2B;SLIT3;CLIP2;KRT14;HLCS;SPRY2;FBXO2;WASH3P;MEF2D;IFT140;CREBRF;XRN1;AGAP7P;RAB11FIP3;TIGD5;MLXIPL;CTSB;KLK5;TARBP1;FBXW7;ANKRD28;ING4;NUDT6;CDK5RAP3;ZNF862;ATXN1;LMO2;CCDC92;NFIX;PAK6;CARF;DZIP1L;PGM1;MXI1;PFKFB2;RNF170;CHMP1B;THRA;TTC12;HSD11B1L;APC2;METTL21A;ACADS;ARAP1;ASTN2;GOLGA8N;ADARB1;RAI1;ELF1;MX2;IKZF4;DCAF10;RPH3AL;SLC2A1;ACACB;OGDHL;NLRP1;FRAT1;ZBTB34;REEP4;ZNF627;TK2;LACTB2;BEX2;GLUL;TBC1D17;MIF4GD;DBP;NDST2;NAB2;EPM2AIP1;PRR7;CAPG;TSPYL4;LRP1;HLA-A;PEG3;NPHP4;RGS12;CCDC136;ATE1;ACP5;MPG;SYNPO2;RNPEP;C12ORF66;CENPH;RFX2;ZNF554;BRINP1;SLC48A1;BDH1;MYO3B;APPL2;HEXDC;SALL2;PMEL;ZNF107;ZNF532;BBS1;JPH2;ZBTB20;PDE2A;ZNF334;SDHA;MAF;STK16;LTB4R2;RET;ZMYND8;PRX;DAB2IP;CASZ1;RWDD3;ACOX3;CALCOCO1;SLC37A2;TEAD2;MYSM1;DDHD2;SHROOM2;RNF213;OLFM2;TSHZ2;PIK3C3;ZNF276;IFI16;SYT7;FGFR4;ERCC5;BBS5;PIK3R2;RETSAT;TEF;ZNF25;SETD4;OSBPL5;AREG;ABTB1;TMEM203;DEF6;KLHL3;SNCB;ETFB;MYO9A;RPS6KA5;APBB3;ZNF630;DLG5;BTG1;BST2;ZNF687;VDR;LETMD1;SNX21;MAMSTR;PHF7;TNRC18;ZFP28;DPY19L2P2;ZMYM3;SIX5;HLTF;MARCH8;EHBP1;PCSK6;ZNF789;MPPE1;ZNF563;TNS4;ZNF517;TBC1D16;STK19;NDUFV3;LPAR6;EML3;DMTN;STAT2;SGSM2;ARFGEF2;LMTK3;ALMS1;PHF1;ZNF292;SLC36A4;TFDP2;SNX1;GOLGA7B;OSBPL1A;TMX4;SHROOM4;ZNF737;TACC1;KDELC2;PRIMPOL;NECAB3;CCDC88B;DLG4;CCDC113;TNNI2;PPP2R3B;ESYT2;TSSK1B;IQSEC1;ZNF701;NAT14;PANO1;PALB2;IGFBP6;TCEAL4;ZNF91;NBEAL2;CD68;PTMS;WEE1;DYDC1;R3HDM4;TMEM143;GTF2IRD2;GOLGA6L4;SLC35G2;DQX1;AMT;TCF7;SHANK2;RSAD2;TNFRSF25;NEMP2;ZFP36L1;XYLT1;LMNA;MXRA8;CLSTN3;GLMP;TOP3B;ACSL1;KAT2B;MARK4;TEP1;APOLD1;DMXL2;CEP250;METTL7A;ERN1;SAC3D1;IVNS1ABP;ALOX15B;RAD50;ZNF439;TKFC;LAPTM4A;ANGEL2;ZMAT3;PNPO;MAN1B1;DHRS4;PEX1;ECI1;S100A6;TRERF1;FAAH;SCYL3;SCG5;APBB2;CBR4;TTC19;SGSH;DCAF8;CCDC90B;RAPGEF5;MYH16;CERS5;STAT6;PCSK1N;SOX13;PRDX5;NELFCD;PHC2;TUB;KIF7;GLB1;GOLGA1;CPT1C;KLF8;GSTM3;CHD6;TRAF5;NAP1L5;GOLGB1;ACSS2;DPP7;CD9;PLIN4;RANBP9;HDAC11;PTPN3;CTSD;COL13A1;ERBB2;SYNGR1;MPRIP;PLCB3;NUDT10;UVSSA;ZDHHC24;PPM1M;ABCA2;KMT5C;AKAP6;SLC2A11;TH;ATG14;MPP7;RORA;SSH3;PPARG;PRKACA;LDLRAP1;CXXC5;NPAP1;C6ORF120;POLM;FMNL3;ACOT2;GCNT4;VMAC;ZNF572;SYNE2;ACKR3;ZNF658B;SERPING1;SUCLG2;UCKL1;PARN;DDX12P;ZNF529;UFL1;LAMB2;IP6K2;RIPK3;NFASC;KLF9;PI4K2B;AIP;COG1;KCNS3;SCAND1;LONP2;PRMT3;SNX33;HARS2;CIT;ZFP90;EHHADH;MSH5;CLCN7;MAP1A;CCDC3;PER3;ZFP30;FOXP2;PTBP2;ZC3H6;HIVEP1;SMURF1;NPNT;TTLL1;EML2;CTNNBIP1;PEMT;ABCA11P;OCIAD2;SERINC3;ECM1
17653,GO:1901536,1.00000000000319,0.806063110630359,0,2,negative regulation of DNA demethylation,BP,
824,GO:0002101,1.00000000000319,0.729590501134246,0,3,tRNA wobble cytosine modification,BP,
2226,GO:0005130,1.00000000000319,0.911615391030204,0,1,granulocyte colony-stimulating factor receptor binding,MF,
12720,GO:0051005,1.0000000000032,0.763493612711002,0,3,negative regulation of lipoprotein lipase activity,BP,
17639,GO:1901492,1.00000000000322,0.793015068791875,0,2,positive regulation of lymphangiogenesis,BP,
4884,GO:0014806,1.00000000000323,0.819996526693828,0,2,smooth muscle hyperplasia,BP,
9549,GO:0036337,1.00000000000323,0.628357772787643,0,4,Fas signaling pathway,BP,
7025,GO:0030806,1.00000000000323,0.789645476178949,0,2,negative regulation of cyclic nucleotide catabolic process,BP,
7040,GO:0030821,1.00000000000323,0.789645476178949,0,2,negative regulation of cAMP catabolic process,BP,
8283,GO:0033122,1.00000000000323,0.789645476178949,0,2,negative regulation of purine nucleotide catabolic process,BP,
9198,GO:0035594,1.00000000000326,0.726389238807852,0,3,ganglioside binding,MF,
3001,GO:0006547,1.00000000000328,0.64783512712921,0,4,histidine metabolic process,BP,
13392,GO:0052803,1.00000000000328,0.64783512712921,0,4,imidazole-containing compound metabolic process,BP,
854,GO:0002184,1.0000000000033,0.789904426414968,0,2,cytoplasmic translational termination,BP,
19276,GO:1905553,1.00000000000331,0.73311177594629,0,3,regulation of blood vessel branching,BP,
17637,GO:1901490,1.00000000000332,0.622790266405829,0,4,regulation of lymphangiogenesis,BP,
6503,GO:0021882,1.00000000000332,0.811563054652046,0,2,regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment,BP,
6511,GO:0021893,1.00000000000332,0.811563054652046,0,2,cerebral cortex GABAergic interneuron fate commitment,BP,
9355,GO:0035881,1.00000000000332,0.811563054652046,0,2,amacrine cell differentiation,BP,
14154,GO:0061074,1.00000000000332,0.811563054652046,0,2,regulation of neural retina development,BP,
14155,GO:0061075,1.00000000000332,0.811563054652046,0,2,positive regulation of neural retina development,BP,
18119,GO:1902866,1.00000000000332,0.811563054652046,0,2,regulation of retina development in camera-type eye,BP,
18120,GO:1902868,1.00000000000332,0.811563054652046,0,2,positive regulation of retina development in camera-type eye,BP,
18121,GO:1902869,1.00000000000332,0.811563054652046,0,2,regulation of amacrine cell differentiation,BP,
18122,GO:1902871,1.00000000000332,0.811563054652046,0,2,positive regulation of amacrine cell differentiation,BP,
6506,GO:0021886,1.00000000000333,0.739099670982681,0,3,hypothalamus gonadotrophin-releasing hormone neuron differentiation,BP,
6507,GO:0021888,1.00000000000333,0.739099670982681,0,3,hypothalamus gonadotrophin-releasing hormone neuron development,BP,
16123,GO:0090155,1.00000000000333,0.656618192445415,0,4,negative regulation of sphingolipid biosynthetic process,BP,
17339,GO:1900060,1.00000000000333,0.656618192445415,0,4,negative regulation of ceramide biosynthetic process,BP,
928,GO:0002326,1.00000000000334,0.678303386900646,0,3,B cell lineage commitment,BP,
9370,GO:0035912,1.00000000000335,0.63547322056475,0,4,dorsal aorta morphogenesis,BP,
4876,GO:0014740,1.00000000000335,0.809088547932473,0,2,negative regulation of muscle hyperplasia,BP,
13695,GO:0060282,1.00000000000336,0.715108779607061,0,3,positive regulation of oocyte development,BP,
19365,GO:1905881,1.00000000000336,0.715108779607061,0,3,positive regulation of oogenesis,BP,
16927,GO:0098935,1.00000000000337,0.687069242124838,0,3,dendritic transport,BP,
16929,GO:0098937,1.00000000000337,0.687069242124838,0,3,anterograde dendritic transport,BP,
13394,GO:0052810,1.00000000000339,0.889296571386451,0,1,1-phosphatidylinositol-5-kinase activity,MF,
14762,GO:0070488,1.00000000000339,0.91999936237384,0,2,neutrophil aggregation,BP,
1628,GO:0004069,1.0000000000034,0.811830080970464,0,2,L-aspartate:2-oxoglutarate aminotransferase activity,MF,
2987,GO:0006532,1.0000000000034,0.811830080970464,0,2,aspartate biosynthetic process,BP,
2988,GO:0006533,1.0000000000034,0.811830080970464,0,2,aspartate catabolic process,BP,
6176,GO:0019550,1.0000000000034,0.811830080970464,0,2,glutamate catabolic process to aspartate,BP,
6177,GO:0019551,1.0000000000034,0.811830080970464,0,2,glutamate catabolic process to 2-oxoglutarate,BP,
4,GO:0000010,1.00000000000341,0.81026788527449,0,2,trans-hexaprenyltranstransferase activity,MF,
12454,GO:0050347,1.00000000000341,0.81026788527449,0,2,trans-octaprenyltranstransferase activity,MF,
16500,GO:0097231,1.00000000000342,0.906675842490205,0,1,cell motility in response to calcium ion,BP,
19575,GO:1990716,1.00000000000342,0.906675842490205,0,1,axonemal central apparatus,CC,
11616,GO:0046338,1.00000000000342,0.802440402519536,0,2,phosphatidylethanolamine catabolic process,BP,
11540,GO:0046098,1.00000000000344,0.652177349656371,0,4,guanine metabolic process,BP,
1247,GO:0002950,1.00000000000344,0.71297506456438,0,3,ceramide phosphoethanolamine synthase activity,MF,
8330,GO:0033188,1.00000000000344,0.71297506456438,0,3,sphingomyelin synthase activity,MF,
11990,GO:0047493,1.00000000000344,0.71297506456438,0,3,ceramide cholinephosphotransferase activity,MF,
15143,GO:0071284,1.00000000000345,0.61921717846522,0,4,cellular response to lead ion,BP,
18165,GO:1902956,1.00000000000345,0.754110137005637,0,3,regulation of mitochondrial electron transport, NADH to ubiquinone,BP,
14143,GO:0061047,1.00000000000346,0.728720511251345,0,3,positive regulation of branching involved in lung morphogenesis,BP,
10870,GO:0044422,1.00000000000347,0,617,7156,organelle part,CC,TGFBI;POSTN;ITGB6;ULK2;MUC19;DDB2;TP53INP1;MAP6;PTHLH;SREBF1;AMACR;PYGB;APOE;GPSM1;CES2;NT5E;OAS2;LMF1;HSPA2;EGFR;ESPN;TRIM65;PTPRS;CIRBP;FLNC;FAM20C;PKD2;CAPRIN2;MNT;XPC;SYT8;CXCR1;CPT2;RBM3;SYN1;ASH2L;TRIM22;SRSF5;LRIG3;OBSL1;KIF26B;PCDH1;EPS8L2;SYNC;MAP3K14;GLUD1;BPHL;DCAF16;DGKQ;TMEM129;PIK3R1;ADAMTS7;BRSK1;KDM3A;COL22A1;EVC;POU3F1;SULF2;WNT3;H6PD;DHTKD1;UBXN4;ST6GALNAC2;HR;CSPG4;ISG15;MVB12B;CYBRD1;SPATA18;TFCP2L1;UNC119B;KCNAB2;ZFPM1;HOXC5;CUL7;VAMP3;CITED4;SNN;IRF2BPL;NAPRT;REEP2;PRICKLE2;ASAP3;SRD5A3;OR2A4;STAT1;CRY2;MYL9;KRT15;WDR63;NSG1;KDSR;COL10A1;RAB43;RAB40B;NOS1;PRKACB;HOXA3;B4GALNT4;MAML3;SCMH1;CRTAP;SDC3;NFATC4;HMGCL;D2HGDH;SCARA3;FKBP5;RNF187;FERMT1;H1F0;CYP26B1;GAA;AP5Z1;HSF4;CNTRL;MICALL1;LIG1;VPS11;NDRG1;COL7A1;ITPR3;NAGLU;CYHR1;MDM2;CRTC1;LZTS2;NDN;MLH3;DDX59;ST6GALNAC6;OBSCN;IDUA;GOLGA8A;GPRC5C;HLA-B;PRODH;HGSNAT;MYH11;PARVB;NDUFA4L2;ACTR1B;UGT1A3;CERS4;CYP3A5;NEO1;RAPGEF3;PHACTR3;FAM210B;CTSV;POLH;BLVRB;POLR2J2;OAS1;FLRT3;NUDCD3;TRIM66;GAL3ST4;CRAT;KIF26A;B4GALT6;AP1G2;RGS2;ADGRB2;MLYCD;C2CD4C;PHYH;SPTB;NOL4L;DNAH1;SLC27A3;ARSI;NEK9;TUBGCP5;CLTCL1;TRPV4;TMC6;FLOT1;GLI2;ANK3;DHX32;ADAMTS13;LAMP3;TCEA2;MAPK8IP3;GOLGA8B;SOX12;PIDD1;SLX1A;SLX1B;G6PC3;ATG16L2;SPG11;ZCCHC11;RHBDF1;SULT1E1;PER2;CLCN6;PTGS1;UNC119;DIRC2;HEXA;ARSD;WIPF1;PSKH1;PHF2;NINL;ABHD14B;TCEAL1;WWTR1;MBOAT2;ASAP2;LHFPL2;FAM110C;ULK1;GLI3;SPPL2B;FHOD3;PCSK1;TPGS1;THRAP3;SMARCA1;BHLHE40;VAMP2;ZNF655;LTBP1;NEK8;MAP2K5;GAS8;BOC;CES3;ZNF318;IGFBP4;JARID2;GPC2;INSR;TST;CCDC85B;CELSR1;GSN;ALDH4A1;CEP68;CHD3;ST3GAL5;BAIAP2;TTN;SCNN1A;CEP126;SUN1;AHNAK2;PLEKHH2;TRIOBP;POLD4;CTSF;CD109;NSUN5P2;PNMA1;PMS2P3;ETAA1;RMI2;SEPT6;RAB11FIP4;VPS39;MGST2;TP53AIP1;PGAP1;RTF1;CASP14;IRF9;TMEM9;H2AFJ;NLRX1;B4GALT2;PEX10;SLC2A3;TCIRG1;MICALL2;MAP2K2;PDK1;VEGFB;ALDH7A1;SQSTM1;CEP192;CABYR;PTK6;FZD7;ETV5;FNBP4;HEXB;KDM4C;HYAL1;CLCA2;H1FX;UBOX5;NSMCE4A;KIAA0319L;B3GNT9;WHAMMP3;CENPC;PLA2G6;CST3;PDIK1L;HOMER2;PEX7;BBS2;TXNIP;TCF4;ATP6V0A2;KLHDC2;COL6A1;PEX11B;NPHP3;LRRCC1;PLAG1;IDH2;CERCAM;WRN;PODXL;SEPT5;IFI27;MALL;DNM1;MACROD1;IQCB1;PLD3;TREX1;LPIN3;MCTP1;CDK5R1;ATRX;REC8;ARHGAP27;PIGZ;POLR2J3;HOOK2;SESN1;MAPK10;NKTR;SHANK3;HFE;ADIRF;HMG20B;CYBA;AGO4;ERCC6;HADH;RRM2B;CLIP2;KRT14;HLCS;SPRY2;FBXO2;WASH3P;MEF2D;IFT140;CREBRF;RAB11FIP3;MLXIPL;CTSB;FBXW7;ANKRD28;ING4;CDK5RAP3;ATXN1;LMO2;CCDC92;PAK6;CARF;DZIP1L;PGM1;MXI1;PFKFB2;RNF170;CHMP1B;THRA;TTC12;HSD11B1L;APC2;METTL21A;ACADS;ARAP1;GOLGA8N;ADARB1;RAI1;ELF1;MX2;IKZF4;DCAF10;RPH3AL;SLC2A1;ACACB;OGDHL;NLRP1;ZBTB34;REEP4;TK2;LACTB2;MIF4GD;NDST2;EPM2AIP1;CAPG;LRP1;HLA-A;NPHP4;RGS12;CCDC136;MPG;SYNPO2;C12ORF66;CENPH;ZNF554;SLC48A1;BDH1;MYO3B;APPL2;SALL2;PMEL;BBS1;JPH2;ZBTB20;PDE2A;SDHA;MAF;LTB4R2;RET;CASZ1;ACOX3;CALCOCO1;SLC37A2;TEAD2;MYSM1;DDHD2;SHROOM2;RNF213;OLFM2;PIK3C3;ZNF276;IFI16;SYT7;ERCC5;BBS5;RETSAT;SETD4;OSBPL5;AREG;ABTB1;TMEM203;DEF6;ETFB;MYO9A;RPS6KA5;DLG5;BST2;ZNF687;VDR;LETMD1;SNX21;PHF7;TNRC18;DPY19L2P2;ZMYM3;HLTF;MARCH8;PCSK6;ZNF789;TMEM80;MPPE1;STK19;NDUFV3;EML3;DMTN;TPRN;STAT2;ARFGEF2;LMTK3;ALMS1;PHF1;SLC36A4;TMEM231;TFDP2;SNX1;GOLGA7B;SHROOM4;TACC1;KDELC2;PRIMPOL;NECAB3;CCDC88B;DLG4;CCDC113;TNNI2;PPP2R3B;ESYT2;IQSEC1;PANO1;PALB2;NBEAL2;CD68;WEE1;DYDC1;GTF2IRD2;DQX1;AMT;TCF7;SHANK2;RSAD2;NEMP2;XYLT1;LMNA;MXRA8;CLSTN3;GLMP;ACSL1;KAT2B;MARK4;TEP1;APOLD1;DMXL2;CEP250;METTL7A;ERN1;SAC3D1;IVNS1ABP;RAD50;LAPTM4A;ANGEL2;ZMAT3;PNPO;MAN1B1;DHRS4;PEX1;ECI1;S100A6;TRERF1;FAAH;CBR4;TTC19;SGSH;DCAF8;CCDC90B;RAPGEF5;MYH16;CERS5;STAT6;PCSK1N;SOX13;PRDX5;NELFCD;PHC2;KIF7;GLB1;GOLGA1;CPT1C;KLF8;GSTM3;CHD6;TRAF5;GOLGB1;ACSS2;DPP7;CD9;RANBP9;HDAC11;CTSD;COL13A1;ERBB2;SYNGR1;PLCB3;UVSSA;ABCA2;KMT5C;AKAP6;TH;ATG14;MPP7;RORA;PPARG;PRKACA;LDLRAP1;CXXC5;NPAP1;C6ORF120;POLM;ACOT2;GCNT4;VMAC;SYNE2;SERPING1;SUCLG2;PARN;UFL1;LAMB2;IP6K2;NFASC;KLF9;PI4K2B;AIP;COG1;LONP2;SNX33;HARS2;CIT;EHHADH;MSH5;CLCN7;MAP1A;PTBP2;HIVEP1;SMURF1;NPNT;TTLL1;EML2;CTNNBIP1;PEMT;OCIAD2;SERINC3;ECM1
12191,GO:0048386,1.00000000000347,0.640876909096341,0,4,positive regulation of retinoic acid receptor signaling pathway,BP,
7811,GO:0032372,1.00000000000348,0.669093871535923,0,4,negative regulation of sterol transport,BP,
7814,GO:0032375,1.00000000000348,0.669093871535923,0,4,negative regulation of cholesterol transport,BP,
5041,GO:0015226,1.00000000000348,0.646075525915954,0,4,carnitine transmembrane transporter activity,MF,
5249,GO:0015879,1.00000000000348,0.646075525915954,0,4,carnitine transport,BP,
19359,GO:1905863,1.00000000000348,0.786759712193103,0,2,invadopodium organization,BP,
8413,GO:0033503,1.0000000000035,0.638569918344758,0,4,HULC complex,CC,
1424,GO:0003383,1.00000000000352,0.68032844221422,0,3,apical constriction,BP,
1614,GO:0004045,1.00000000000354,0.724031247603804,0,4,aminoacyl-tRNA hydrolase activity,MF,
5871,GO:0017187,1.00000000000354,0.690594888029355,0,4,peptidyl-glutamic acid carboxylation,BP,
5932,GO:0018214,1.00000000000354,0.690594888029355,0,4,protein carboxylation,BP,
11901,GO:0046958,1.00000000000355,0.89520290579136,0,1,nonassociative learning,BP,
6729,GO:0030151,1.00000000000357,0.654706359134605,0,4,molybdenum ion binding,MF,
4949,GO:0015014,1.00000000000358,0.617162783345007,0,4,heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process,BP,
4209,GO:0009353,1.00000000000358,0.917890516008947,0,1,mitochondrial oxoglutarate dehydrogenase complex,CC,
7422,GO:0031531,1.00000000000358,0.917890516008947,0,1,thyrotropin-releasing hormone receptor binding,MF,
4869,GO:0014732,1.00000000000361,0.720458792942848,0,3,skeletal muscle atrophy,BP,
2474,GO:0005691,1.00000000000362,0.882978482679504,0,1,U6atac snRNP,CC,
6963,GO:0030624,1.00000000000362,0.882978482679504,0,1,U6atac snRNA binding,MF,
18458,GO:1903584,1.00000000000362,0.882978482679504,0,1,regulation of histone deubiquitination,BP,
18459,GO:1903586,1.00000000000362,0.882978482679504,0,1,positive regulation of histone deubiquitination,BP,
16955,GO:0099010,1.00000000000362,0.694902602146288,0,3,modification of postsynaptic structure,BP,
13669,GO:0060235,1.00000000000364,0.683046045054853,0,3,lens induction in camera-type eye,BP,
8071,GO:0032762,1.00000000000367,0.728586168819441,0,3,mast cell cytokine production,BP,
8072,GO:0032763,1.00000000000367,0.728586168819441,0,3,regulation of mast cell cytokine production,BP,
17547,GO:1901164,1.00000000000368,0.779498474887005,0,3,negative regulation of trophoblast cell migration,BP,
18092,GO:1902769,1.00000000000369,0.871796963673287,0,1,regulation of choline O-acetyltransferase activity,BP,
18093,GO:1902771,1.00000000000369,0.871796963673287,0,1,positive regulation of choline O-acetyltransferase activity,BP,
18157,GO:1902948,1.00000000000369,0.871796963673287,0,1,negative regulation of tau-protein kinase activity,BP,
18164,GO:1902955,1.00000000000369,0.871796963673287,0,1,positive regulation of early endosome to recycling endosome transport,BP,
18187,GO:1902997,1.00000000000369,0.871796963673287,0,1,negative regulation of neurofibrillary tangle assembly,BP,
3970,GO:0008783,1.0000000000037,0.9012253427092,0,1,agmatinase activity,MF,
8403,GO:0033388,1.0000000000037,0.9012253427092,0,1,putrescine biosynthetic process from arginine,BP,
5908,GO:0018153,1.0000000000037,0.81029493088601,0,2,isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine,BP,
5939,GO:0018262,1.0000000000037,0.81029493088601,0,2,isopeptide cross-linking,BP,
11434,GO:0045901,1.00000000000374,0.725653708869876,0,3,positive regulation of translational elongation,BP,
8578,GO:0034087,1.00000000000374,0.778718501510103,0,2,establishment of mitotic sister chromatid cohesion,BP,
2242,GO:0005153,1.00000000000375,0.806084569224829,0,2,interleukin-8 receptor binding,MF,
15512,GO:0071929,1.00000000000375,0.806084569224829,0,2,alpha-tubulin acetylation,BP,
211,GO:0000444,1.00000000000378,0.651547450271625,0,4,MIS12/MIND type complex,CC,
12156,GO:0048294,1.00000000000379,0.794718799214653,0,2,negative regulation of isotype switching to IgE isotypes,BP,
11416,GO:0045852,1.00000000000382,0.722077908740467,0,3,pH elevation,BP,
12999,GO:0051454,1.00000000000382,0.722077908740467,0,3,intracellular pH elevation,BP,
12121,GO:0048237,1.00000000000384,0.820668502902177,0,2,rough endoplasmic reticulum lumen,CC,
5847,GO:0017146,1.00000000000384,0.604022277847128,0,4,NMDA selective glutamate receptor complex,CC,
16072,GO:0090071,1.00000000000384,0.625201455936333,0,4,negative regulation of ribosome biogenesis,BP,
8100,GO:0032796,1.00000000000384,0.797892189135089,0,2,uropod organization,BP,
13787,GO:0060398,1.00000000000385,0.682174986051202,0,3,regulation of growth hormone receptor signaling pathway,BP,
12483,GO:0050561,1.00000000000386,0.88709785950405,0,1,glutamate-tRNA(Gln) ligase activity,MF,
3375,GO:0007147,1.00000000000387,0.890647917979105,0,1,female meiosis II,BP,
8974,GO:0035092,1.00000000000387,0.682439030048156,0,3,sperm chromatin condensation,BP,
158,GO:0000322,1.00000000000388,0.726100628937503,0,3,storage vacuole,CC,
4918,GO:0014858,1.0000000000039,0.774746455584778,0,2,positive regulation of skeletal muscle cell proliferation,BP,
18073,GO:1902724,1.0000000000039,0.774746455584778,0,2,positive regulation of skeletal muscle satellite cell proliferation,BP,
18075,GO:1902728,1.0000000000039,0.774746455584778,0,2,positive regulation of growth factor dependent skeletal muscle satellite cell proliferation,BP,
3975,GO:0008798,1.0000000000039,0.879612338814467,0,1,beta-aspartyl-peptidase activity,MF,
14981,GO:0070931,1.0000000000039,0.879612338814467,0,1,Golgi-associated vesicle lumen,CC,
1817,GO:0004470,1.00000000000391,0.653588461440851,0,4,malic enzyme activity,MF,
15849,GO:0072592,1.00000000000392,0.812881010190803,0,2,oxygen metabolic process,BP,
10471,GO:0043380,1.00000000000393,0.670295026031064,0,4,regulation of memory T cell differentiation,BP,
13011,GO:0051481,1.00000000000393,0.68242629276058,0,3,negative regulation of cytosolic calcium ion concentration,BP,
7124,GO:0030956,1.00000000000396,0.766805677103372,0,3,glutamyl-tRNA(Gln) amidotransferase complex,CC,
12484,GO:0050567,1.00000000000396,0.766805677103372,0,3,glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity,MF,
14869,GO:0070681,1.00000000000396,0.766805677103372,0,3,glutaminyl-tRNAGln biosynthesis via transamidation,BP,
79,GO:0000160,1.00000000000396,0.889624626661615,0,1,phosphorelay signal transduction system,BP,
19134,GO:1905168,1.00000000000396,0.889624626661615,0,1,positive regulation of double-strand break repair via homologous recombination,BP,
1570,GO:0003979,1.00000000000396,0.896040164999878,0,1,UDP-glucose 6-dehydrogenase activity,MF,
6633,GO:0023024,1.00000000000396,0.896040164999878,0,1,MHC class I protein complex binding,MF,
5007,GO:0015166,1.00000000000397,0.621093717932634,0,4,polyol transmembrane transporter activity,MF,
14805,GO:0070564,1.00000000000397,0.811746112653153,0,2,positive regulation of vitamin D receptor signaling pathway,BP,
1032,GO:0002541,1.00000000000397,0.812479117050627,0,2,activation of plasma proteins involved in acute inflammatory response,BP,
7237,GO:0031177,1.00000000000398,0.790537402246274,0,3,phosphopantetheine binding,MF,
9208,GO:0035606,1.00000000000398,0.876237610565799,0,2,peptidyl-cysteine S-trans-nitrosylation,BP,
12311,GO:0048680,1.00000000000398,0.679724172242793,0,4,positive regulation of axon regeneration,BP,
14812,GO:0070572,1.00000000000398,0.679724172242793,0,4,positive regulation of neuron projection regeneration,BP,
11958,GO:0047238,1.00000000000399,0.628771050241706,0,4,glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity,MF,
146,GO:0000301,1.000000000004,0.726151153630743,0,3,retrograde transport, vesicle recycling within Golgi,BP,
2027,GO:0004768,1.00000000000401,0.709925892937131,0,3,stearoyl-CoA 9-desaturase activity,MF,
5387,GO:0016215,1.00000000000401,0.709925892937131,0,3,acyl-CoA desaturase activity,MF,
5998,GO:0019035,1.00000000000401,0.879616311585846,0,1,viral integration complex,CC,
11422,GO:0045870,1.00000000000401,0.879616311585846,0,1,positive regulation of single stranded viral RNA replication via double stranded DNA intermediate,BP,
19252,GO:1905463,1.00000000000401,0.879616311585846,0,1,negative regulation of DNA duplex unwinding,BP,
18227,GO:1903070,1.00000000000401,0.730088174584557,0,3,negative regulation of ER-associated ubiquitin-dependent protein catabolic process,BP,
811,GO:0002085,1.00000000000402,0.715428069676043,0,3,inhibition of neuroepithelial cell differentiation,BP,
11281,GO:0045608,1.00000000000402,0.715428069676043,0,3,negative regulation of inner ear auditory receptor cell differentiation,BP,
8225,GO:0033004,1.00000000000405,0.732339541288918,0,3,negative regulation of mast cell activation,BP,
8228,GO:0033007,1.00000000000405,0.732339541288918,0,3,negative regulation of mast cell activation involved in immune response,BP,
12056,GO:0048021,1.00000000000407,0.682998182541538,0,3,regulation of melanin biosynthetic process,BP,
2142,GO:0004957,1.00000000000408,0.893451432080024,0,1,prostaglandin E receptor activity,MF,
15889,GO:0072682,1.00000000000408,0.893451432080024,0,1,eosinophil extravasation,BP,
19897,GO:2000417,1.00000000000408,0.893451432080024,0,1,negative regulation of eosinophil migration,BP,
19899,GO:2000419,1.00000000000408,0.893451432080024,0,1,regulation of eosinophil extravasation,BP,
19900,GO:2000420,1.00000000000408,0.893451432080024,0,1,negative regulation of eosinophil extravasation,BP,
7001,GO:0030692,1.00000000000409,0.816170199728479,0,2,Noc4p-Nop14p complex,CC,
5540,GO:0016532,1.00000000000409,0.762240352914503,0,3,superoxide dismutase copper chaperone activity,MF,
17739,GO:1901727,1.0000000000041,0.631619044612054,0,4,positive regulation of histone deacetylase activity,BP,
15901,GO:0072708,1.00000000000411,0.649944778289008,0,4,response to sorbitol,BP,
12022,GO:0047756,1.00000000000413,0.793417101919922,0,2,chondroitin 4-sulfotransferase activity,MF,
9995,GO:0042428,1.00000000000415,0.620244132140778,0,4,serotonin metabolic process,BP,
19005,GO:1904868,1.00000000000415,0.764286981147172,0,2,telomerase catalytic core complex assembly,BP,
19017,GO:1904882,1.00000000000415,0.764286981147172,0,2,regulation of telomerase catalytic core complex assembly,BP,
19018,GO:1904884,1.00000000000415,0.764286981147172,0,2,positive regulation of telomerase catalytic core complex assembly,BP,
14928,GO:0070842,1.00000000000415,0.695496510423134,0,3,aggresome assembly,BP,
4795,GO:0010990,1.00000000000415,0.685770180429836,0,3,regulation of SMAD protein complex assembly,BP,
18162,GO:1902953,1.00000000000418,0.626061810635135,0,4,positive regulation of ER to Golgi vesicle-mediated transport,BP,
18916,GO:1904690,1.0000000000042,0.642848439778254,0,4,positive regulation of cytoplasmic translational initiation,BP,
17642,GO:1901509,1.00000000000421,0.791896492162049,0,2,regulation of endothelial tube morphogenesis,BP,
15918,GO:0072741,1.00000000000421,0.697866242060123,0,3,protein localization to cell division site,BP,
18242,GO:1903119,1.00000000000421,0.697866242060123,0,3,protein localization to actin cytoskeleton,BP,
18838,GO:1904498,1.00000000000421,0.697866242060123,0,3,protein localization to mitotic actomyosin contractile ring,BP,
19452,GO:1990179,1.00000000000421,0.697866242060123,0,3,protein localization to actomyosin contractile ring,BP,
1823,GO:0004478,1.00000000000422,0.899294776360582,0,1,methionine adenosyltransferase activity,MF,
1392,GO:0003308,1.00000000000422,0.811446089086769,0,2,negative regulation of Wnt signaling pathway involved in heart development,BP,
8746,GO:0034421,1.00000000000423,0.710629105495423,0,3,post-translational protein acetylation,BP,
13583,GO:0060075,1.00000000000423,0.713421654413361,0,3,regulation of resting membrane potential,BP,
9152,GO:0035517,1.00000000000424,0.693259030649762,0,3,PR-DUB complex,CC,
16162,GO:0090204,1.00000000000424,0.75215025946473,0,3,protein localization to nuclear pore,BP,
12635,GO:0050859,1.00000000000425,0.721226776564226,0,3,negative regulation of B cell receptor signaling pathway,BP,
9503,GO:0036194,1.00000000000425,0.755827428370647,0,3,muscle cell projection,CC,
9504,GO:0036195,1.00000000000425,0.755827428370647,0,3,muscle cell projection membrane,CC,
172,GO:0000379,1.00000000000425,0.733532920039755,0,3,tRNA-type intron splice site recognition and cleavage,BP,
5107,GO:0015410,1.00000000000425,0.707606699612612,0,3,manganese-transporting ATPase activity,MF,
18559,GO:1903826,1.00000000000426,0.627675842026189,0,4,arginine transmembrane transport,BP,
7650,GO:0032079,1.0000000000043,0.673737798153036,0,4,positive regulation of endodeoxyribonuclease activity,BP,
350,GO:0000964,1.00000000000431,0.666279581691474,0,4,mitochondrial RNA 5'-end processing,BP,
11554,GO:0046122,1.00000000000431,0.848242710022069,0,2,purine deoxyribonucleoside metabolic process,BP,
19088,GO:1905041,1.00000000000432,0.79116903117307,0,2,regulation of epithelium regeneration,BP,
19491,GO:1990399,1.00000000000432,0.79116903117307,0,2,epithelium regeneration,BP,
14231,GO:0061304,1.00000000000432,0.597964030219311,0,4,retinal blood vessel morphogenesis,BP,
18512,GO:1903723,1.00000000000433,0.936297752468732,0,1,negative regulation of centriole elongation,BP,
19680,GO:2000035,1.00000000000435,0.72555871790901,0,3,regulation of stem cell division,BP,
17332,GO:1900041,1.00000000000435,0.722833887663963,0,3,negative regulation of interleukin-2 secretion,BP,
12808,GO:0051133,1.00000000000436,0.765461614732408,0,3,regulation of NK T cell activation,BP,
12809,GO:0051135,1.00000000000436,0.765461614732408,0,3,positive regulation of NK T cell activation,BP,
14210,GO:0061196,1.00000000000438,0.622544640593753,0,4,fungiform papilla development,BP,
14211,GO:0061197,1.00000000000438,0.622544640593753,0,4,fungiform papilla morphogenesis,BP,
7114,GO:0030942,1.00000000000439,0.751075689885788,0,3,endoplasmic reticulum signal peptide binding,MF,
16588,GO:0097444,1.00000000000439,0.880145473099375,0,1,spine apparatus,CC,
19205,GO:1905355,1.00000000000439,0.880145473099375,0,1,spine apparatus assembly,BP,
2792,GO:0006231,1.0000000000044,0.739109481561763,0,3,dTMP biosynthetic process,BP,
11527,GO:0046073,1.0000000000044,0.739109481561763,0,3,dTMP metabolic process,BP,
1216,GO:0002887,1.00000000000441,0.630391262734912,0,4,negative regulation of myeloid leukocyte mediated immunity,BP,
17459,GO:1900376,1.00000000000442,0.599610685859244,0,4,regulation of secondary metabolite biosynthetic process,BP,
923,GO:0002318,1.00000000000442,0.720489283190962,0,3,myeloid progenitor cell differentiation,BP,
2413,GO:0005588,1.00000000000442,0.677341102134792,0,3,collagen type V trimer,CC,
6526,GO:0021934,1.00000000000443,0.76576903143008,0,2,hindbrain tangential cell migration,BP,
6527,GO:0021935,1.00000000000443,0.76576903143008,0,2,cerebellar granule cell precursor tangential migration,BP,
3601,GO:0008035,1.00000000000446,0.645049053889089,0,4,high-density lipoprotein particle binding,MF,
17705,GO:1901656,1.00000000000446,0.793811102589581,0,2,glycoside transport,BP,
2780,GO:0006211,1.00000000000447,0.667331423192035,0,3,5-methylcytosine catabolic process,BP,
6260,GO:0019857,1.00000000000447,0.667331423192035,0,3,5-methylcytosine metabolic process,BP,
2899,GO:0006407,1.00000000000447,0.743959597171019,0,3,rRNA export from nucleus,BP,
11869,GO:0046900,1.00000000000447,0.821456396233068,0,2,tetrahydrofolylpolyglutamate metabolic process,BP,
9219,GO:0035617,1.00000000000448,0.71355213831976,0,3,stress granule disassembly,BP,
9293,GO:0035750,1.00000000000448,0.879854165626954,0,1,protein localization to myelin sheath abaxonal region,BP,
10642,GO:0043734,1.00000000000448,0.676282152924043,0,4,DNA-N1-methyladenine dioxygenase activity,MF,
14715,GO:0070404,1.0000000000045,0.762371017784393,0,3,NADH binding,MF,
3524,GO:0007499,1.00000000000451,0.881593841494049,0,1,ectoderm and mesoderm interaction,BP,
12371,GO:0048807,1.00000000000451,0.881593841494049,0,1,female genitalia morphogenesis,BP,
18908,GO:1904674,1.00000000000451,0.881593841494049,0,1,positive regulation of somatic stem cell population maintenance,BP,
13734,GO:0060332,1.00000000000452,0.690325059775652,0,3,positive regulation of response to interferon-gamma,BP,
13737,GO:0060335,1.00000000000452,0.690325059775652,0,3,positive regulation of interferon-gamma-mediated signaling pathway,BP,
7241,GO:0031205,1.00000000000452,0.840081402744134,0,2,endoplasmic reticulum Sec complex,CC,
13014,GO:0051490,1.00000000000453,0.733039129982787,0,3,negative regulation of filopodium assembly,BP,
11498,GO:0046016,1.00000000000455,0.727017455446214,0,3,positive regulation of transcription by glucose,BP,
3651,GO:0008131,1.00000000000457,0.706036897414536,0,3,primary amine oxidase activity,MF,
9253,GO:0035673,1.00000000000457,0.618454144633846,0,4,oligopeptide transmembrane transporter activity,MF,
13773,GO:0060382,1.00000000000459,0.778258702850996,0,2,regulation of DNA strand elongation,BP,
4690,GO:0010847,1.00000000000459,0.623275410251125,0,4,regulation of chromatin assembly,BP,
18816,GO:1904430,1.0000000000046,0.707830358648628,0,3,negative regulation of t-circle formation,BP,
18107,GO:1902822,1.00000000000462,0.751383030975275,0,3,regulation of late endosome to lysosome transport,BP,
14512,GO:0070037,1.00000000000462,0.929292037850723,0,1,rRNA (pseudouridine) methyltransferase activity,MF,
7788,GO:0032345,1.00000000000467,0.718052600563607,0,3,negative regulation of aldosterone metabolic process,BP,
7791,GO:0032348,1.00000000000467,0.718052600563607,0,3,negative regulation of aldosterone biosynthetic process,BP,
19699,GO:2000065,1.00000000000467,0.718052600563607,0,3,negative regulation of cortisol biosynthetic process,BP,
14365,GO:0061629,1.00000000000467,0.712882226748757,0,3,RNA polymerase II sequence-specific DNA binding transcription factor binding,MF,
11740,GO:0046604,1.00000000000468,0.728544754306271,0,3,positive regulation of mitotic centrosome separation,BP,
15298,GO:0071535,1.00000000000468,0.655823579801728,0,4,RING-like zinc finger domain binding,MF,
18831,GO:1904468,1.00000000000468,0.714769626153512,0,3,negative regulation of tumor necrosis factor secretion,BP,
15803,GO:0072526,1.00000000000468,0.660594302853994,0,4,pyridine-containing compound catabolic process,BP,
9576,GO:0036435,1.0000000000047,0.730289303988436,0,3,K48-linked polyubiquitin modification-dependent protein binding,MF,
8276,GO:0033093,1.00000000000471,0.630139465506267,0,4,Weibel-Palade body,CC,
14389,GO:0061689,1.00000000000471,0.712717514331641,0,3,tricellular tight junction,CC,
16037,GO:0089700,1.00000000000474,0.702353018817368,0,3,protein kinase D signaling,BP,
10630,GO:0043654,1.00000000000474,0.705923898864427,0,3,recognition of apoptotic cell,BP,
18640,GO:1903978,1.00000000000476,0.627888127963036,0,4,regulation of microglial cell activation,BP,
10375,GO:0043219,1.00000000000477,0.640456058310825,0,4,lateral loop,CC,
3144,GO:0006740,1.00000000000477,0.715093146549162,0,3,NADPH regeneration,BP,
7731,GO:0032237,1.00000000000478,0.619209767002476,0,4,activation of store-operated calcium channel activity,BP,
17609,GO:1901341,1.00000000000478,0.619209767002476,0,4,positive regulation of store-operated calcium channel activity,BP,
14269,GO:0061386,1.00000000000478,0.770607864983516,0,2,closure of optic fissure,BP,
12376,GO:0048818,1.00000000000479,0.657650252681138,0,4,positive regulation of hair follicle maturation,BP,
9601,GO:0036476,1.0000000000048,0.764443689012054,0,3,neuron death in response to hydrogen peroxide,BP,
18279,GO:1903207,1.0000000000048,0.764443689012054,0,3,regulation of hydrogen peroxide-induced neuron death,BP,
18280,GO:1903208,1.0000000000048,0.764443689012054,0,3,negative regulation of hydrogen peroxide-induced neuron death,BP,
3164,GO:0006776,1.0000000000048,0.747959396169113,0,3,vitamin A metabolic process,BP,
18594,GO:1903899,1.0000000000048,0.716596963571147,0,3,positive regulation of PERK-mediated unfolded protein response,BP,
10441,GO:0043313,1.00000000000482,0.602302109023692,0,4,regulation of neutrophil degranulation,BP,
18018,GO:1902563,1.00000000000482,0.602302109023692,0,4,regulation of neutrophil activation,BP,
15759,GO:0072385,1.00000000000482,0.604715780945373,0,4,minus-end-directed organelle transport along microtubule,BP,
11710,GO:0046533,1.00000000000484,0.63009920564471,0,4,negative regulation of photoreceptor cell differentiation,BP,
11822,GO:0046790,1.00000000000485,0.704649474827735,0,3,virion binding,MF,
18519,GO:1903748,1.00000000000485,0.64269291283973,0,4,negative regulation of establishment of protein localization to mitochondrion,BP,
3913,GO:0008582,1.00000000000487,0.772266264327706,0,2,regulation of synaptic growth at neuromuscular junction,BP,
9408,GO:0035986,1.00000000000487,0.750584144538046,0,3,senescence-associated heterochromatin focus assembly,BP,
2125,GO:0004923,1.00000000000488,0.78274603045713,0,2,leukemia inhibitory factor receptor activity,MF,
10195,GO:0042824,1.0000000000049,0.64155945222981,0,4,MHC class I peptide loading complex,CC,
18234,GO:1903093,1.0000000000049,0.754943193107263,0,3,regulation of protein K48-linked deubiquitination,BP,
1384,GO:0003292,1.00000000000492,0.879618428762753,0,1,cardiac septum cell differentiation,BP,
14072,GO:0060922,1.00000000000492,0.879618428762753,0,1,atrioventricular node cell differentiation,BP,
14075,GO:0060928,1.00000000000492,0.879618428762753,0,1,atrioventricular node cell development,BP,
15513,GO:0071930,1.00000000000494,0.69728087225762,0,3,negative regulation of transcription involved in G1/S transition of mitotic cell cycle,BP,
1382,GO:0003284,1.00000000000495,0.624115985347134,0,4,septum primum development,BP,
18470,GO:1903613,1.00000000000496,0.879869025849124,0,1,regulation of protein tyrosine phosphatase activity,BP,
18471,GO:1903615,1.00000000000496,0.879869025849124,0,1,positive regulation of protein tyrosine phosphatase activity,BP,
16089,GO:0090091,1.00000000000497,0.623785689951342,0,4,positive regulation of extracellular matrix disassembly,BP,
1792,GO:0004423,1.00000000000498,0.879569346973236,0,1,iduronate-2-sulfatase activity,MF,
11955,GO:0047223,1.00000000000499,0.728375338894672,0,3,beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity,MF,
6488,GO:0021849,1.00000000000499,0.794805491503616,0,2,neuroblast division in subventricular zone,BP,
8277,GO:0033106,1.00000000000501,0.828461012397759,0,2,cis-Golgi network membrane,CC,
15297,GO:0071532,1.00000000000504,0.625116587031676,0,4,ankyrin repeat binding,MF,
2750,GO:0006154,1.00000000000504,0.820093773808715,0,2,adenosine catabolic process,BP,
11545,GO:0046103,1.00000000000504,0.820093773808715,0,2,inosine biosynthetic process,BP,
14107,GO:0060995,1.00000000000504,0.789660411234158,0,2,cell-cell signaling involved in kidney development,BP,
14223,GO:0061289,1.00000000000504,0.789660411234158,0,2,Wnt signaling pathway involved in kidney development,BP,
14224,GO:0061290,1.00000000000504,0.789660411234158,0,2,canonical Wnt signaling pathway involved in metanephric kidney development,BP,
15659,GO:0072204,1.00000000000504,0.789660411234158,0,2,cell-cell signaling involved in metanephros development,BP,
3990,GO:0008889,1.00000000000506,0.708387668335821,0,3,glycerophosphodiester phosphodiesterase activity,MF,
18779,GO:1904351,1.00000000000507,0.714529427282254,0,3,negative regulation of protein catabolic process in the vacuole,BP,
19132,GO:1905166,1.00000000000507,0.714529427282254,0,3,negative regulation of lysosomal protein catabolic process,BP,
17341,GO:1900063,1.00000000000507,0.69227377979255,0,3,regulation of peroxisome organization,BP,
13707,GO:0060297,1.00000000000512,0.614255350002437,0,4,regulation of sarcomere organization,BP,
14717,GO:0070407,1.00000000000513,0.896825360715165,0,1,oxidation-dependent protein catabolic process,BP,
12126,GO:0048245,1.00000000000514,0.670409900178238,0,4,eosinophil chemotaxis,BP,
12536,GO:0050705,1.00000000000515,0.688944204995266,0,4,regulation of interleukin-1 alpha secretion,BP,
16198,GO:0090261,1.00000000000516,0.67983244938577,0,4,positive regulation of inclusion body assembly,BP,
12774,GO:0051088,1.00000000000516,0.700757780287834,0,3,PMA-inducible membrane protein ectodomain proteolysis,BP,
8400,GO:0033385,1.00000000000517,0.899349732159835,0,1,geranylgeranyl diphosphate metabolic process,BP,
8401,GO:0033386,1.00000000000517,0.899349732159835,0,1,geranylgeranyl diphosphate biosynthetic process,BP,
436,GO:0001165,1.00000000000517,0.881837132537728,0,1,RNA polymerase I upstream control element sequence-specific DNA binding,MF,
1493,GO:0003839,1.00000000000517,0.697295447354981,0,4,gamma-glutamylcyclotransferase activity,MF,
1763,GO:0004368,1.00000000000518,0.879503005532,0,1,glycerol-3-phosphate dehydrogenase activity,MF,
2742,GO:0006127,1.00000000000518,0.879503005532,0,1,glycerophosphate shuttle,BP,
5750,GO:0016901,1.00000000000518,0.879503005532,0,1,oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor,MF,
13350,GO:0052590,1.00000000000518,0.879503005532,0,1,sn-glycerol-3-phosphate:ubiquinone oxidoreductase activity,MF,
13351,GO:0052591,1.00000000000518,0.879503005532,0,1,sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity,MF,
13789,GO:0060400,1.00000000000518,0.881582764698448,0,1,negative regulation of growth hormone receptor signaling pathway,BP,
2012,GO:0004741,1.00000000000519,0.688963840966004,0,3,[pyruvate dehydrogenase (lipoamide)] phosphatase activity,MF,
1376,GO:0003274,1.00000000000519,0.696851746624974,0,3,endocardial cushion fusion,BP,
1410,GO:0003348,1.00000000000521,0.620522063712581,0,4,cardiac endothelial cell differentiation,BP,
14085,GO:0060956,1.00000000000521,0.620522063712581,0,4,endocardial cell differentiation,BP,
16406,GO:0097065,1.00000000000522,0.6305885454248,0,4,anterior head development,BP,
14767,GO:0070494,1.00000000000522,0.716049026641908,0,3,regulation of thrombin-activated receptor signaling pathway,BP,
14768,GO:0070495,1.00000000000522,0.716049026641908,0,3,negative regulation of thrombin-activated receptor signaling pathway,BP,
19677,GO:2000020,1.00000000000523,0.634284053071697,0,4,positive regulation of male gonad development,BP,
3488,GO:0007356,1.00000000000524,0.812978372439426,0,2,thorax and anterior abdomen determination,BP,
20182,GO:2001074,1.00000000000524,0.812978372439426,0,2,regulation of metanephric ureteric bud development,BP,
20183,GO:2001076,1.00000000000524,0.812978372439426,0,2,positive regulation of metanephric ureteric bud development,BP,
6338,GO:0021516,1.00000000000524,0.710387486584608,0,3,dorsal spinal cord development,BP,
8075,GO:0032767,1.00000000000525,0.747800544046018,0,3,copper-dependent protein binding,MF,
14841,GO:0070634,1.00000000000526,0.717652621783718,0,3,transepithelial ammonium transport,BP,
7088,GO:0030891,1.00000000000527,0.683179923900849,0,4,VCB complex,CC,
387,GO:0001032,1.00000000000529,0.629612219264176,0,4,RNA polymerase III type 3 promoter DNA binding,MF,
5443,GO:0016312,1.00000000000529,0.628530763848455,0,4,inositol bisphosphate phosphatase activity,MF,
12229,GO:0048520,1.0000000000053,0.632070558918658,0,4,positive regulation of behavior,BP,
14600,GO:0070189,1.0000000000053,0.669793348820101,0,4,kynurenine metabolic process,BP,
2102,GO:0004874,1.00000000000531,0.77462813621398,0,2,aryl hydrocarbon receptor activity,MF,
19704,GO:2000078,1.00000000000532,0.831567149732138,0,2,positive regulation of type B pancreatic cell development,BP,
2343,GO:0005384,1.00000000000534,0.625903091794383,0,4,manganese ion transmembrane transporter activity,MF,
15062,GO:0071062,1.00000000000534,0.883759008127212,0,1,alphav-beta3 integrin-vitronectin complex,CC,
7585,GO:0031962,1.00000000000535,0.87951401704432,0,1,mineralocorticoid receptor binding,MF,
13700,GO:0060290,1.00000000000535,0.87951401704432,0,1,transdifferentiation,BP,
14425,GO:0061767,1.00000000000535,0.87951401704432,0,1,negative regulation of lung blood pressure,BP,
3642,GO:0008116,1.00000000000535,0.879680751847103,0,1,prostaglandin-I synthase activity,MF,
13831,GO:0060456,1.00000000000537,0.714358783763872,0,3,positive regulation of digestive system process,BP,
8836,GO:0034641,1.0000000000054,0,412,5141,cellular nitrogen compound metabolic process,BP,TNFAIP3;HES2;ZSCAN18;TSC22D1;SIK1;DDB2;TP53INP1;PTHLH;SREBF1;NYNRIN;APOE;NT5E;GAMT;OAS2;MN1;EGFR;CIRBP;FAM20C;PKD2;CAPRIN2;MNT;XPC;APOBEC3C;RBM3;ASH2L;TRIM22;SRSF5;SFRP1;MTHFR;PERM1;SEC14L2;DGKQ;PIK3R1;RBCK1;KDM3A;TSC22D3;POU3F1;H6PD;DHTKD1;UNK;HR;ISG15;HTRA1;TFCP2L1;RGMA;KCNAB2;ZFPM1;KITLG;HOXC5;ZNF362;CITED4;IRF2BPL;NAPRT;MC1R;ZNF266;STAT1;IMPACT;CRY2;UROS;THAP8;NOS1;ZNF704;HOXA3;CRY1;ZNF699;MAML3;ZFP41;SCMH1;KLF13;MAGEF1;NFATC4;ZNF783;RNF187;H1F0;AP5Z1;CMPK2;HSF4;ZNF251;LIG1;EAPP;MDM2;CRTC1;NDN;MLH3;NMRK1;DDX59;ST6GALNAC6;ZNF662;CERS4;CYP3A5;NEO1;RAPGEF3;ZNF414;TCF25;ENDOD1;PCBP4;POLH;BLVRB;POLR2J2;OAS1;CRAT;B4GALT6;MLLT6;RGS2;F2R;PDCD4;ZNF160;SWT1;ZFP36L2;TRPV4;GLI2;ADORA2B;KLF7;RNF165;DHX32;ADAMTS13;TCEA2;ZNF76;SOX12;PIDD1;SLX1A;SLX1B;ZNF747;ZCCHC11;SULT1E1;PER2;ZNF658;PHF2;ABHD14B;GSTM2;TCEAL1;WWTR1;ITGA2;GLI3;SPPL2B;PCSK1;THRAP3;ZNF558;IRX4;SMARCA1;BHLHE40;ZNF655;ZNF333;MAP2K5;ITGA6;ZNF318;LZTS1;IGFBP4;TCFL5;TRAK1;JARID2;NUPR1;INSR;TST;CCDC85B;HSF2BP;CHD3;ST3GAL5;ZNF18;AHNAK2;RNPEPL1;MXD4;POLD4;ZNF287;NSUN5P2;PGLS;PMS2P3;ETAA1;RMI2;ZNF446;ZNF581;MGST2;ENDOG;PGAP1;RTF1;MDK;IRF9;H2AFJ;BMP6;NLRX1;TCIRG1;MAP2K2;OPLAH;ALDH7A1;GLI4;SQSTM1;FZD7;ETV5;DLX3;HEXB;KDM4C;METTL23;NSMCE4A;ZNF608;PLA2G6;CST3;GDF15;TXNIP;TCF4;ATP6V0A2;NPHP3;PLAG1;IDH2;RCOR2;WRN;IFI27;MCM9;MACROD1;TREX1;LPIN3;OARD1;CDK5R1;ATRX;REC8;POLR2J3;MAPK10;HFE;ADIRF;HMG20B;TRIM38;AGO4;ERCC6;RRM2B;HLCS;EDA2R;MEF2D;GABBR1;CREBRF;XRN1;MLXIPL;TARBP1;FBXW7;GPR87;ING4;CDK5RAP3;ZNF862;ATXN1;LMO2;NFIX;PAK6;CARF;PGM1;MXI1;PFKFB2;THRA;ADARB1;RAI1;ELF1;IKZF4;ACACB;OGDHL;ZBTB34;ZNF627;TK2;LACTB2;MIF4GD;DBP;NAB2;EPM2AIP1;PEG3;RGS12;ACP5;MPG;RNPEP;RFX2;ZNF554;PPCS;SALL2;ZNF107;ZNF532;ZBTB20;PDE2A;ZNF334;SDHA;MAF;STK16;LTB4R2;RET;ZMYND8;PRX;DAB2IP;CASZ1;RWDD3;CALCOCO1;TEAD2;MYSM1;FBXO4;TSHZ2;ZNF276;IFI16;DALRD3;FGFR4;ERCC5;PIK3R2;TEF;ZNF25;AREG;ABTB1;RPS6KA5;APBB3;ZNF630;BTG1;ZNF687;VDR;MAMSTR;TNRC18;TNRC6C;ZFP28;PLXND1;NADK;ZMYM3;SIX5;HLTF;PCSK6;ZNF789;ZNF563;ZNF517;NDUFV3;STAT2;WWC3;PHF1;ZNF292;TFDP2;NRARP;ACVR1B;ZNF737;PRIMPOL;DLG4;TNNI2;ZNF701;ALOXE3;NAT14;PALB2;ENDOU;MPI;TCEAL4;ZNF91;PTMS;DYDC1;GTF2IRD2;DQX1;TCF7;ZFP36L1;GLMP;TOP3B;IL11;KAT2B;TEP1;ERN1;RNF141;IVNS1ABP;RAD50;ZNF439;ANGEL2;PNPO;TRERF1;UAP1L1;SCG5;APBB2;CERS5;STAT6;PCSK1N;SOX13;PRDX5;NELFCD;SMPDL3B;CPT1C;KLF8;GSTM3;CHD6;TRAF5;GOLGB1;HDAC11;ERBB2;SPOCD1;NUDT10;UVSSA;ABCA2;KMT5C;TH;RORA;PPARG;PRKACA;CXXC5;POLM;ZNF572;ZNF658B;UCKL1;PARN;DDX12P;ZNF529;UFL1;RIPK3;KLF9;AIP;SCAND1;PRMT3;HARS2;ZFP90;MSH5;PER3;ZFP30;FOXP2;PTBP2;ZC3H6;HIVEP1;SMURF1;NPNT;CTNNBIP1;PEMT;GCLC;ECM1
19648,GO:1990930,1.00000000000541,0.910026285880417,0,1,RNA N1-methyladenosine dioxygenase activity,MF,
18285,GO:1903224,1.00000000000542,0.62755771972061,0,4,regulation of endodermal cell differentiation,BP,
17383,GO:1900138,1.00000000000543,0.72671556034813,0,3,negative regulation of phospholipase A2 activity,BP,
6953,GO:0030613,1.00000000000545,0.804855974788357,0,3,oxidoreductase activity, acting on phosphorus or arsenic in donors,MF,
6954,GO:0030614,1.00000000000545,0.804855974788357,0,3,oxidoreductase activity, acting on phosphorus or arsenic in donors, disulfide as acceptor,MF,
5078,GO:0015317,1.00000000000546,0.907374752000136,0,1,phosphate:proton symporter activity,MF,
19903,GO:2000425,1.00000000000548,0.690903281119248,0,3,regulation of apoptotic cell clearance,BP,
3966,GO:0008761,1.00000000000548,0.879920557947844,0,1,UDP-N-acetylglucosamine 2-epimerase activity,MF,
4216,GO:0009384,1.00000000000548,0.879920557947844,0,1,N-acylmannosamine kinase activity,MF,
6463,GO:0021797,1.00000000000548,0.893608949036626,0,1,forebrain anterior/posterior pattern specification,BP,
6502,GO:0021881,1.00000000000548,0.893608949036626,0,1,Wnt-activated signaling pathway involved in forebrain neuron fate commitment,BP,
12171,GO:0048320,1.00000000000548,0.893608949036626,0,1,axial mesoderm formation,BP,
14031,GO:0060823,1.00000000000548,0.893608949036626,0,1,canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
20216,GO:2001183,1.0000000000055,0.903841758371966,0,1,negative regulation of interleukin-12 secretion,BP,
13137,GO:0051731,1.00000000000552,0.634337064060045,0,4,polynucleotide 5'-hydroxyl-kinase activity,MF,
13606,GO:0060123,1.00000000000552,0.60526521044894,0,4,regulation of growth hormone secretion,BP,
1429,GO:0003406,1.00000000000553,0.709013264978196,0,3,retinal pigment epithelium development,BP,
12030,GO:0047874,1.00000000000553,0.901687175110758,0,1,dolichyldiphosphatase activity,MF,
2963,GO:0006499,1.00000000000554,0.612243346742498,0,4,N-terminal protein myristoylation,BP,
5962,GO:0018377,1.00000000000554,0.612243346742498,0,4,protein myristoylation,BP,
5468,GO:0016403,1.00000000000554,0.813221946455062,0,2,dimethylargininase activity,MF,
676,GO:0001887,1.00000000000555,0.648761220717345,0,4,selenium compound metabolic process,BP,
5982,GO:0018894,1.00000000000555,0.726396462167297,0,3,dibenzo-p-dioxin metabolic process,BP,
581,GO:0001735,1.00000000000556,0.792068007744372,0,2,prenylcysteine oxidase activity,MF,
6852,GO:0030328,1.00000000000556,0.792068007744372,0,2,prenylcysteine catabolic process,BP,
6853,GO:0030329,1.00000000000556,0.792068007744372,0,2,prenylcysteine metabolic process,BP,
18802,GO:1904398,1.00000000000556,0.770616746940313,0,2,positive regulation of neuromuscular junction development,BP,
5514,GO:0016479,1.00000000000557,0.713778188753353,0,3,negative regulation of transcription by RNA polymerase I,BP,
14568,GO:0070137,1.00000000000558,0.610106832431876,0,4,ubiquitin-like protein-specific endopeptidase activity,MF,
14570,GO:0070139,1.00000000000558,0.610106832431876,0,4,SUMO-specific endopeptidase activity,MF,
7377,GO:0031437,1.00000000000559,0.71334716326639,0,3,regulation of mRNA cleavage,BP,
15862,GO:0072616,1.0000000000056,0.886197193132408,0,1,interleukin-18 secretion,BP,
4840,GO:0014049,1.00000000000561,0.640268581281923,0,4,positive regulation of glutamate secretion,BP,
12115,GO:0048209,1.00000000000561,0.793219125221577,0,2,regulation of vesicle targeting, to, from or within Golgi,BP,
15879,GO:0072672,1.00000000000563,0.624129848709656,0,4,neutrophil extravasation,BP,
17324,GO:1900028,1.00000000000564,0.648359600186387,0,4,negative regulation of ruffle assembly,BP,
1416,GO:0003360,1.00000000000566,0.705650295652589,0,3,brainstem development,BP,
6014,GO:0019072,1.00000000000567,0.779046206428844,0,2,viral genome packaging,BP,
6015,GO:0019074,1.00000000000567,0.779046206428844,0,2,viral RNA genome packaging,BP,
7963,GO:0032584,1.00000000000568,0.71175063182631,0,3,growth cone membrane,CC,
13528,GO:0060011,1.00000000000568,0.73832816542049,0,3,Sertoli cell proliferation,BP,
483,GO:0001534,1.00000000000569,0.888884551604054,0,1,radial spoke,CC,
484,GO:0001536,1.00000000000569,0.888884551604054,0,1,radial spoke stalk,CC,
19964,GO:2000580,1.00000000000569,0.707699240533264,0,4,regulation of ATP-dependent microtubule motor activity, plus-end-directed,BP,
19965,GO:2000582,1.00000000000569,0.707699240533264,0,4,positive regulation of ATP-dependent microtubule motor activity, plus-end-directed,BP,
2064,GO:0004819,1.00000000000571,0.793058743586938,0,2,glutamine-tRNA ligase activity,MF,
2914,GO:0006425,1.00000000000571,0.793058743586938,0,2,glutaminyl-tRNA aminoacylation,BP,
10294,GO:0043084,1.00000000000579,0.635070777756582,0,4,penile erection,BP,
14656,GO:0070291,1.00000000000579,0.715900192005359,0,3,N-acylethanolamine metabolic process,BP,
7858,GO:0032427,1.0000000000058,0.795062431197647,0,2,GBD domain binding,MF,
4684,GO:0010836,1.0000000000058,0.737572621797625,0,3,negative regulation of protein ADP-ribosylation,BP,
10444,GO:0043316,1.0000000000058,0.802859160806882,0,2,cytotoxic T cell degranulation,BP,
8369,GO:0033278,1.00000000000582,0.623140223102977,0,4,cell proliferation in midbrain,BP,
423,GO:0001129,1.00000000000584,0.699397350322317,0,3,RNA polymerase II transcription factor activity, TBP-class protein binding, involved in preinitiation complex assembly,MF,
424,GO:0001132,1.00000000000584,0.699397350322317,0,3,RNA polymerase II transcription factor activity, TBP-class protein binding,MF,
12118,GO:0048213,1.00000000000585,0.899214519325033,0,1,Golgi vesicle prefusion complex stabilization,BP,
3128,GO:0006710,1.00000000000586,0.903989099431233,0,1,androgen catabolic process,BP,
12965,GO:0051388,1.00000000000586,0.629467832720129,0,4,positive regulation of neurotrophin TRK receptor signaling pathway,BP,
6821,GO:0030289,1.00000000000589,0.667938245053452,0,4,protein phosphatase 4 complex,CC,
14338,GO:0061575,1.00000000000589,0.738029345703306,0,4,cyclin-dependent protein serine/threonine kinase activator activity,MF,
2429,GO:0005610,1.0000000000059,0.676229791397791,0,3,laminin-5 complex,CC,
11921,GO:0046984,1.0000000000059,0.653413929807188,0,4,regulation of hemoglobin biosynthetic process,BP,
14307,GO:0061511,1.00000000000591,0.647549693708001,0,4,centriole elongation,BP,
669,GO:0001880,1.00000000000592,0.782619072297855,0,2,Mullerian duct regression,BP,
9326,GO:0035822,1.00000000000592,0.788115026478407,0,2,gene conversion,BP,
11530,GO:0046078,1.00000000000593,0.674459177771436,0,4,dUMP metabolic process,BP,
17976,GO:1902455,1.00000000000594,0.628373599445544,0,4,negative regulation of stem cell population maintenance,BP,
13216,GO:0051901,1.00000000000594,0.698421735678469,0,4,positive regulation of mitochondrial depolarization,BP,
11298,GO:0045632,1.00000000000596,0.657276996583139,0,4,negative regulation of mechanoreceptor differentiation,BP,
20144,GO:2000981,1.00000000000596,0.657276996583139,0,4,negative regulation of inner ear receptor cell differentiation,BP,
10840,GO:0044352,1.00000000000596,0.627376842399522,0,4,pinosome,CC,
10841,GO:0044354,1.00000000000596,0.627376842399522,0,4,macropinosome,CC,
5996,GO:0019008,1.00000000000598,0.808992753491056,0,2,molybdopterin synthase complex,CC,
14303,GO:0061502,1.00000000000598,0.612076078466755,0,4,early endosome to recycling endosome transport,BP,
19244,GO:1905449,1.00000000000598,0.795089692563939,0,2,regulation of Fc-gamma receptor signaling pathway involved in phagocytosis,BP,
19245,GO:1905451,1.00000000000598,0.795089692563939,0,2,positive regulation of Fc-gamma receptor signaling pathway involved in phagocytosis,BP,
4842,GO:0014052,1.000000000006,0.687904543764237,0,3,regulation of gamma-aminobutyric acid secretion,BP,
13947,GO:0060676,1.00000000000602,0.676256531802828,0,4,ureteric bud formation,BP,
15634,GO:0072172,1.00000000000602,0.676256531802828,0,4,mesonephric tubule formation,BP,
6510,GO:0021892,1.00000000000604,0.753798745077867,0,3,cerebral cortex GABAergic interneuron differentiation,BP,
16490,GO:0097212,1.00000000000606,0.81344203790837,0,2,lysosomal membrane organization,BP,
14617,GO:0070212,1.00000000000607,0.62282945628696,0,4,protein poly-ADP-ribosylation,BP,
15301,GO:0071540,1.00000000000609,0.879898959801064,0,1,eukaryotic translation initiation factor 3 complex, eIF3e,CC,
16803,GO:0098706,1.00000000000609,0.615180808698191,0,4,ferric iron import across plasma membrane,BP,
17599,GO:1901317,1.0000000000061,0.700980162113902,0,4,regulation of flagellated sperm motility,BP,
19507,GO:1990423,1.00000000000612,0.707245416634207,0,3,RZZ complex,CC,
17782,GO:1901897,1.00000000000616,0.690520865507214,0,3,regulation of relaxation of cardiac muscle,BP,
301,GO:0000811,1.00000000000617,0.734004228621962,0,3,GINS complex,CC,
848,GO:0002176,1.00000000000618,0.785295458681249,0,3,male germ cell proliferation,BP,
9462,GO:0036093,1.00000000000618,0.785295458681249,0,3,germ cell proliferation,BP,
2426,GO:0005606,1.00000000000619,0.675232828469099,0,3,laminin-1 complex,CC,
803,GO:0002074,1.00000000000621,0.711406660990392,0,3,extraocular skeletal muscle development,BP,
6785,GO:0030229,1.00000000000622,0.693116113428068,0,3,very-low-density lipoprotein particle receptor activity,MF,
13965,GO:0060699,1.00000000000622,0.654831292690355,0,4,regulation of endoribonuclease activity,BP,
10698,GO:0044020,1.00000000000623,0.667398640937255,0,4,histone methyltransferase activity (H4-R3 specific),MF,
592,GO:0001757,1.00000000000626,0.787209886989924,0,2,somite specification,BP,
13761,GO:0060369,1.00000000000626,0.642163734215686,0,4,positive regulation of Fc receptor mediated stimulatory signaling pathway,BP,
6402,GO:0021636,1.00000000000629,0.620829010363239,0,4,trigeminal nerve morphogenesis,BP,
6403,GO:0021637,1.00000000000629,0.620829010363239,0,4,trigeminal nerve structural organization,BP,
1830,GO:0004487,1.00000000000632,0.724432311075983,0,3,methylenetetrahydrofolate dehydrogenase (NAD+) activity,MF,
2251,GO:0005166,1.00000000000632,0.931905747661318,0,1,neurotrophin p75 receptor binding,MF,
3499,GO:0007402,1.00000000000632,0.931905747661318,0,1,ganglion mother cell fate determination,BP,
3611,GO:0008052,1.00000000000632,0.931905747661318,0,1,sensory organ boundary specification,BP,
4406,GO:0010160,1.00000000000632,0.931905747661318,0,1,formation of animal organ boundary,BP,
12403,GO:0048867,1.00000000000632,0.931905747661318,0,1,stem cell fate determination,BP,
14209,GO:0061193,1.00000000000632,0.931905747661318,0,1,taste bud development,BP,
16977,GO:0099082,1.00000000000632,0.931905747661318,0,1,retrograde trans-synaptic signaling by neuropeptide,BP,
16978,GO:0099083,1.00000000000632,0.931905747661318,0,1,retrograde trans-synaptic signaling by neuropeptide, modulating synaptic transmission,BP,
17035,GO:0099538,1.00000000000632,0.931905747661318,0,1,synaptic signaling via neuropeptide,BP,
17036,GO:0099540,1.00000000000632,0.931905747661318,0,1,trans-synaptic signaling by neuropeptide,BP,
17044,GO:0099551,1.00000000000632,0.931905747661318,0,1,trans-synaptic signaling by neuropeptide, modulating synaptic transmission,BP,
14991,GO:0070942,1.00000000000633,0.668536017911059,0,4,neutrophil mediated cytotoxicity,BP,
9588,GO:0036457,1.00000000000636,0.591957779051902,0,4,keratohyalin granule,CC,
14898,GO:0070772,1.00000000000637,0.896979310460089,0,1,PAS complex,CC,
2265,GO:0005184,1.00000000000641,0.786197964567999,0,3,neuropeptide hormone activity,MF,
14153,GO:0061073,1.00000000000641,0.791337962211173,0,2,ciliary body morphogenesis,BP,
10921,GO:0044571,1.00000000000642,0.719053222246859,0,4,[2Fe-2S] cluster assembly,BP,
13277,GO:0052031,1.00000000000643,0.723778954831479,0,3,modulation by symbiont of host defense response,BP,
13311,GO:0052255,1.00000000000643,0.723778954831479,0,3,modulation by organism of defense response of other organism involved in symbiotic interaction,BP,
13343,GO:0052552,1.00000000000643,0.723778954831479,0,3,modulation by organism of immune response of other organism involved in symbiotic interaction,BP,
13344,GO:0052553,1.00000000000643,0.723778954831479,0,3,modulation by symbiont of host immune response,BP,
15937,GO:0075528,1.00000000000643,0.723778954831479,0,3,modulation by virus of host immune response,BP,
3855,GO:0008475,1.00000000000643,0.714228459857945,0,3,procollagen-lysine 5-dioxygenase activity,MF,
11895,GO:0046946,1.00000000000643,0.714228459857945,0,3,hydroxylysine metabolic process,BP,
11896,GO:0046947,1.00000000000643,0.714228459857945,0,3,hydroxylysine biosynthetic process,BP,
5836,GO:0017126,1.00000000000644,0.879884984840783,0,1,nucleologenesis,BP,
4221,GO:0009397,1.00000000000644,0.650363838129145,0,4,folic acid-containing compound catabolic process,BP,
10054,GO:0042560,1.00000000000644,0.650363838129145,0,4,pteridine-containing compound catabolic process,BP,
2173,GO:0005010,1.00000000000645,0.670974296057978,0,3,insulin-like growth factor-activated receptor activity,MF,
17842,GO:1902093,1.00000000000645,0.779881049987537,0,3,positive regulation of flagellated sperm motility,BP,
8488,GO:0033677,1.00000000000645,0.713875266581709,0,3,DNA/RNA helicase activity,MF,
12957,GO:0051379,1.00000000000646,0.81276672253311,0,2,epinephrine binding,MF,
3027,GO:0006574,1.00000000000647,0.662320312637538,0,4,valine catabolic process,BP,
5873,GO:0017198,1.0000000000065,0.937253818157709,0,1,N-terminal peptidyl-serine acetylation,BP,
5874,GO:0018002,1.0000000000065,0.937253818157709,0,1,N-terminal peptidyl-glutamic acid acetylation,BP,
7110,GO:0030920,1.0000000000065,0.937253818157709,0,1,peptidyl-serine acetylation,BP,
14454,GO:0061850,1.0000000000065,0.937253818157709,0,1,growth cone leading edge,CC,
15526,GO:0071960,1.0000000000065,0.937253818157709,0,1,maintenance of mitotic sister chromatid cohesion, centromeric,BP,
19457,GO:1990190,1.0000000000065,0.937253818157709,0,1,peptide-glutamate-N-acetyltransferase activity,MF,
20048,GO:2000718,1.0000000000065,0.937253818157709,0,1,regulation of maintenance of mitotic sister chromatid cohesion, centromeric,BP,
20049,GO:2000719,1.0000000000065,0.937253818157709,0,1,negative regulation of maintenance of mitotic sister chromatid cohesion, centromeric,BP,
9296,GO:0035754,1.0000000000065,0.630498254178624,0,4,B cell chemotaxis,BP,
7184,GO:0031081,1.00000000000651,0.794952852997127,0,2,nuclear pore distribution,BP,
13102,GO:0051664,1.00000000000651,0.794952852997127,0,2,nuclear pore localization,BP,
20040,GO:2000698,1.00000000000652,0.673005466250237,0,4,positive regulation of epithelial cell differentiation involved in kidney development,BP,
6036,GO:0019135,1.00000000000653,0.903835169125293,0,1,deoxyhypusine monooxygenase activity,MF,
3003,GO:0006549,1.00000000000653,0.636841825535202,0,4,isoleucine metabolic process,BP,
18952,GO:1904753,1.00000000000656,0.723438742103067,0,3,negative regulation of vascular associated smooth muscle cell migration,BP,
1984,GO:0004706,1.00000000000656,0.700242449510905,0,3,JUN kinase kinase kinase activity,MF,
17823,GO:1902023,1.00000000000658,0.634510225420249,0,4,L-arginine transport,BP,
16567,GO:0097396,1.00000000000659,0.643862329882855,0,4,response to interleukin-17,BP,
16568,GO:0097398,1.00000000000659,0.643862329882855,0,4,cellular response to interleukin-17,BP,
16569,GO:0097400,1.00000000000659,0.643862329882855,0,4,interleukin-17-mediated signaling pathway,BP,
20015,GO:2000660,1.0000000000066,0.655348953843901,0,4,negative regulation of interleukin-1-mediated signaling pathway,BP,
4989,GO:0015125,1.00000000000661,0.656166511239989,0,4,bile acid transmembrane transporter activity,MF,
4893,GO:0014821,1.00000000000662,0.678337278544448,0,4,phasic smooth muscle contraction,BP,
1315,GO:0003165,1.00000000000665,0.879649818779586,0,1,Purkinje myocyte development,BP,
9887,GO:0042182,1.00000000000666,0.675300836984012,0,4,ketone catabolic process,BP,
13765,GO:0060373,1.00000000000669,0.639831863667745,0,4,regulation of ventricular cardiac muscle cell membrane depolarization,BP,
14099,GO:0060979,1.00000000000669,0.675918675058169,0,3,vasculogenesis involved in coronary vascular morphogenesis,BP,
8084,GO:0032777,1.00000000000669,0.653753052487861,0,4,Piccolo NuA4 histone acetyltransferase complex,CC,
13950,GO:0060681,1.00000000000669,0.707181803345073,0,3,branch elongation involved in ureteric bud branching,BP,
9216,GO:0035614,1.0000000000067,0.75235595600266,0,3,snRNA stem-loop binding,MF,
18003,GO:1902527,1.00000000000673,0.698149614171077,0,4,positive regulation of protein monoubiquitination,BP,
11953,GO:0047192,1.00000000000673,0.70482121816769,0,3,1-alkylglycerophosphocholine O-acetyltransferase activity,MF,
2160,GO:0004993,1.00000000000676,0.745580512394463,0,3,G-protein coupled serotonin receptor activity,MF,
3422,GO:0007210,1.00000000000676,0.745580512394463,0,3,serotonin receptor signaling pathway,BP,
10348,GO:0043176,1.00000000000676,0.745580512394463,0,3,amine binding,MF,
12956,GO:0051378,1.00000000000676,0.745580512394463,0,3,serotonin binding,MF,
16794,GO:0098664,1.00000000000676,0.745580512394463,0,3,G-protein coupled serotonin receptor signaling pathway,BP,
17057,GO:0099589,1.00000000000676,0.745580512394463,0,3,serotonin receptor activity,MF,
8856,GO:0034667,1.00000000000677,0.782668356152384,0,2,integrin alpha3-beta1 complex,CC,
19080,GO:1905031,1.00000000000678,0.684132001311401,0,3,regulation of membrane repolarization during cardiac muscle cell action potential,BP,
9362,GO:0035898,1.0000000000068,0.71339557889892,0,3,parathyroid hormone secretion,BP,
11296,GO:0045630,1.00000000000683,0.671932888975649,0,4,positive regulation of T-helper 2 cell differentiation,BP,
15006,GO:0070966,1.00000000000683,0.699295686158709,0,3,nuclear-transcribed mRNA catabolic process, no-go decay,BP,
19422,GO:1990075,1.00000000000685,0.708714156619159,0,3,periciliary membrane compartment,CC,
8947,GO:0035022,1.00000000000692,0.645511008156586,0,4,positive regulation of Rac protein signal transduction,BP,
11195,GO:0045341,1.00000000000692,0.629360209924071,0,4,MHC class I biosynthetic process,BP,
11197,GO:0045343,1.00000000000692,0.629360209924071,0,4,regulation of MHC class I biosynthetic process,BP,
11198,GO:0045345,1.00000000000692,0.629360209924071,0,4,positive regulation of MHC class I biosynthetic process,BP,
18453,GO:1903575,1.00000000000694,0.816066473026871,0,2,cornified envelope assembly,BP,
8671,GO:0034274,1.00000000000694,0.69668537770861,0,3,Atg12-Atg5-Atg16 complex,CC,
15599,GO:0072108,1.00000000000696,0.746698084075147,0,3,positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,
18627,GO:1903961,1.00000000000697,0.71654167165007,0,3,positive regulation of anion transmembrane transport,BP,
19906,GO:2000434,1.00000000000698,0.885626632412263,0,2,regulation of protein neddylation,BP,
19907,GO:2000435,1.00000000000698,0.885626632412263,0,2,negative regulation of protein neddylation,BP,
18919,GO:1904694,1.00000000000701,0.691997258872634,0,3,negative regulation of vascular smooth muscle contraction,BP,
10070,GO:0042584,1.00000000000703,0.629100059532487,0,4,chromaffin granule membrane,CC,
11103,GO:0045142,1.00000000000704,0.781853279996574,0,2,triplex DNA binding,MF,
16004,GO:0086045,1.00000000000706,0.783080729072059,0,2,membrane depolarization during AV node cell action potential,BP,
962,GO:0002386,1.00000000000707,0.798315026262562,0,2,immune response in mucosal-associated lymphoid tissue,BP,
968,GO:0002415,1.00000000000707,0.798315026262562,0,2,immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor,BP,
3844,GO:0008456,1.00000000000708,0.889384619205062,0,1,alpha-N-acetylgalactosaminidase activity,MF,
1064,GO:0002605,1.00000000000708,0.879572670256848,0,1,negative regulation of dendritic cell antigen processing and presentation,BP,
4629,GO:0010754,1.00000000000708,0.879572670256848,0,1,negative regulation of cGMP-mediated signaling,BP,
16469,GO:0097180,1.0000000000071,0.855121585698395,0,2,serine protease inhibitor complex,CC,
11487,GO:0045988,1.00000000000712,0.7136378721969,0,3,negative regulation of striated muscle contraction,BP,
13513,GO:0055118,1.00000000000712,0.7136378721969,0,3,negative regulation of cardiac muscle contraction,BP,
9521,GO:0036265,1.00000000000713,0.699843089897019,0,4,RNA (guanine-N7)-methylation,BP,
14844,GO:0070640,1.00000000000713,0.719885783305288,0,3,vitamin D3 metabolic process,BP,
18975,GO:1904799,1.00000000000713,0.886674417260018,0,1,regulation of neuron remodeling,BP,
18976,GO:1904800,1.00000000000713,0.886674417260018,0,1,negative regulation of neuron remodeling,BP,
19745,GO:2000173,1.00000000000713,0.886674417260018,0,1,negative regulation of branching morphogenesis of a nerve,BP,
13928,GO:0060631,1.00000000000714,0.716553776205923,0,3,regulation of meiosis I,BP,
19,GO:0000035,1.00000000000715,0.90169860316943,0,2,acyl binding,MF,
20,GO:0000036,1.00000000000715,0.90169860316943,0,2,acyl carrier activity,MF,
4171,GO:0009245,1.00000000000715,0.90169860316943,0,2,lipid A biosynthetic process,BP,
10937,GO:0044620,1.00000000000715,0.90169860316943,0,2,ACP phosphopantetheine attachment site binding,MF,
11686,GO:0046493,1.00000000000715,0.90169860316943,0,2,lipid A metabolic process,BP,
12849,GO:0051192,1.00000000000715,0.90169860316943,0,2,prosthetic group binding,MF,
17582,GO:1901269,1.00000000000715,0.90169860316943,0,2,lipooligosaccharide metabolic process,BP,
17583,GO:1901271,1.00000000000715,0.90169860316943,0,2,lipooligosaccharide biosynthetic process,BP,
13708,GO:0060298,1.00000000000717,0.71004005871427,0,3,positive regulation of sarcomere organization,BP,
1948,GO:0004654,1.0000000000072,0.881760800961997,0,1,polyribonucleotide nucleotidyltransferase activity,MF,
16328,GO:0090616,1.0000000000072,0.881760800961997,0,1,mitochondrial mRNA 3'-end processing,BP,
16492,GO:0097222,1.0000000000072,0.881760800961997,0,1,mitochondrial mRNA polyadenylation,BP,
4390,GO:0010046,1.0000000000072,0.65742406802136,0,4,response to mycotoxin,BP,
18349,GO:1903371,1.00000000000721,0.611581070363581,0,4,regulation of endoplasmic reticulum tubular network organization,BP,
9242,GO:0035658,1.00000000000721,0.725928318240411,0,3,Mon1-Ccz1 complex,CC,
17898,GO:1902232,1.00000000000721,0.816084400459388,0,2,regulation of positive thymic T cell selection,BP,
1052,GO:0002580,1.00000000000723,0.754959372673455,0,3,regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,
9135,GO:0035494,1.00000000000727,0.721982282362074,0,3,SNARE complex disassembly,BP,
16187,GO:0090241,1.00000000000727,0.659351175948804,0,4,negative regulation of histone H4 acetylation,BP,
1681,GO:0004149,1.00000000000727,0.899111955040621,0,1,dihydrolipoyllysine-residue succinyltransferase activity,MF,
5652,GO:0016751,1.00000000000727,0.899111955040621,0,1,S-succinyltransferase activity,MF,
1091,GO:0002679,1.00000000000732,0.744473289257434,0,3,respiratory burst involved in defense response,BP,
1294,GO:0003129,1.00000000000732,0.734678943351295,0,3,heart induction,BP,
19124,GO:1905150,1.00000000000737,0.776294878259706,0,2,regulation of voltage-gated sodium channel activity,BP,
1789,GO:0004420,1.00000000000738,0.882199845719929,0,1,hydroxymethylglutaryl-CoA reductase (NADPH) activity,MF,
9922,GO:0042282,1.00000000000738,0.882199845719929,0,1,hydroxymethylglutaryl-CoA reductase activity,MF,
16372,GO:0097010,1.00000000000738,0.701807127118377,0,3,eukaryotic translation initiation factor 4F complex assembly,BP,
18041,GO:1902618,1.0000000000074,0.879476293912636,0,1,cellular response to fluoride,BP,
17828,GO:1902037,1.00000000000741,0.727931341451224,0,3,negative regulation of hematopoietic stem cell differentiation,BP,
4610,GO:0010730,1.00000000000742,0.701207975415584,0,3,negative regulation of hydrogen peroxide biosynthetic process,BP,
19569,GO:1990698,1.00000000000744,0.802755009367867,0,2,palmitoleoyltransferase activity,MF,
2565,GO:0005850,1.00000000000744,0.630819110624278,0,4,eukaryotic translation initiation factor 2 complex,CC,
15362,GO:0071630,1.00000000000744,0.69563643986395,0,3,nuclear protein quality control by the ubiquitin-proteasome system,BP,
16736,GO:0098536,1.00000000000746,0.693610577809255,0,3,deuterosome,CC,
12437,GO:0050220,1.00000000000747,0.696242738616925,0,4,prostaglandin-E synthase activity,MF,
15775,GO:0072429,1.00000000000747,0.72908052257118,0,3,response to intra-S DNA damage checkpoint signaling,BP,
3712,GO:0008228,1.00000000000747,0.772524634950769,0,2,opsonization,BP,
13056,GO:0051584,1.00000000000749,0.698026924263738,0,4,regulation of dopamine uptake involved in synaptic transmission,BP,
13238,GO:0051940,1.00000000000749,0.698026924263738,0,4,regulation of catecholamine uptake involved in synaptic transmission,BP,
9441,GO:0036042,1.00000000000749,0.708293211313408,0,4,long-chain fatty acyl-CoA binding,MF,
1904,GO:0004594,1.00000000000749,0.655776374399831,0,4,pantothenate kinase activity,MF,
13763,GO:0060371,1.0000000000075,0.707880778803071,0,3,regulation of atrial cardiac muscle cell membrane depolarization,BP,
1418,GO:0003365,1.00000000000753,0.677745841956713,0,3,establishment of cell polarity involved in ameboidal cell migration,BP,
12811,GO:0051138,1.00000000000754,0.688037100701096,0,3,positive regulation of NK T cell differentiation,BP,
9089,GO:0035370,1.00000000000754,0.81092520637563,0,2,UBC13-UEV1A complex,CC,
9149,GO:0035514,1.00000000000754,0.751302625120985,0,3,DNA demethylase activity,MF,
17822,GO:1902022,1.00000000000756,0.714698502632477,0,3,L-lysine transport,BP,
18366,GO:1903401,1.00000000000756,0.714698502632477,0,3,L-lysine transmembrane transport,BP,
9351,GO:0035877,1.00000000000756,0.655392333682582,0,4,death effector domain binding,MF,
11193,GO:0045338,1.00000000000756,0.660436280372018,0,4,farnesyl diphosphate metabolic process,BP,
10808,GO:0044313,1.00000000000757,0.685855216768723,0,3,protein K6-linked deubiquitination,BP,
13649,GO:0060197,1.00000000000757,0.798195788183183,0,2,cloacal septation,BP,
15532,GO:0071987,1.00000000000758,0.626466402657045,0,4,WD40-repeat domain binding,MF,
7620,GO:0032027,1.00000000000765,0.707759235922718,0,3,myosin light chain binding,MF,
1459,GO:0003708,1.00000000000766,0.636130052245061,0,4,retinoic acid receptor activity,MF,
16963,GO:0099053,1.00000000000766,0.713899191022695,0,3,activating signal cointegrator 1 complex,CC,
10157,GO:0042758,1.00000000000767,0.650940033993641,0,4,long-chain fatty acid catabolic process,BP,
12415,GO:0048936,1.00000000000769,0.7228431208463,0,3,peripheral nervous system neuron axonogenesis,BP,
7354,GO:0031404,1.00000000000771,0.728577623572477,0,3,chloride ion binding,MF,
2190,GO:0005052,1.00000000000771,0.798693585294973,0,2,peroxisome matrix targeting signal-1 binding,MF,
11975,GO:0047349,1.00000000000771,0.879780149776033,0,1,D-ribitol-5-phosphate cytidylyltransferase activity,MF,
15732,GO:0072344,1.00000000000771,0.657863601119727,0,4,rescue of stalled ribosome,BP,
1680,GO:0004148,1.00000000000772,0.891203188347081,0,1,dihydrolipoyl dehydrogenase activity,MF,
10336,GO:0043159,1.00000000000772,0.891203188347081,0,1,acrosomal matrix,CC,
10566,GO:0043544,1.00000000000772,0.891203188347081,0,1,lipoamide binding,MF,
12766,GO:0051068,1.00000000000772,0.891203188347081,0,1,dihydrolipoamide metabolic process,BP,
1942,GO:0004647,1.00000000000772,0.813773906420682,0,2,phosphoserine phosphatase activity,MF,
10636,GO:0043686,1.00000000000775,0.748703475655836,0,3,co-translational protein modification,BP,
14430,GO:0061772,1.00000000000776,0.893375596240525,0,1,drug transport across blood-nerve barrier,BP,
18434,GO:1903544,1.00000000000776,0.893375596240525,0,1,response to butyrate,BP,
18435,GO:1903545,1.00000000000776,0.893375596240525,0,1,cellular response to butyrate,BP,
16204,GO:0090271,1.00000000000777,0.77253410312767,0,2,positive regulation of fibroblast growth factor production,BP,
5919,GO:0018197,1.00000000000778,0.69349243910987,0,3,peptidyl-aspartic acid modification,BP,
14911,GO:0070815,1.00000000000778,0.636170552832752,0,4,peptidyl-lysine 5-dioxygenase activity,MF,
19835,GO:2000328,1.00000000000779,0.752611576801421,0,3,regulation of T-helper 17 cell lineage commitment,BP,
17677,GO:1901585,1.00000000000779,0.899277902478715,0,1,regulation of acid-sensing ion channel activity,BP,
2089,GO:0004855,1.00000000000781,0.879604104964672,0,1,xanthine oxidase activity,MF,
5639,GO:0016727,1.00000000000781,0.879604104964672,0,1,oxidoreductase activity, acting on CH or CH2 groups, oxygen as acceptor,MF,
20234,GO:2001213,1.00000000000781,0.879604104964672,0,1,negative regulation of vasculogenesis,BP,
13672,GO:0060244,1.00000000000783,0.726579458929122,0,3,negative regulation of cell proliferation involved in contact inhibition,BP,
16277,GO:0090402,1.00000000000784,0.811831840379675,0,2,oncogene-induced cell senescence,BP,
10087,GO:0042610,1.00000000000784,0.901930731059195,0,1,CD8 receptor binding,MF,
19234,GO:1905429,1.00000000000784,0.901930731059195,0,1,response to glycine,BP,
19235,GO:1905430,1.00000000000784,0.901930731059195,0,1,cellular response to glycine,BP,
8604,GO:0034127,1.00000000000785,0.640684187066931,0,4,regulation of MyD88-independent toll-like receptor signaling pathway,BP,
18531,GO:1903764,1.00000000000786,0.880364670227758,0,1,regulation of potassium ion export across plasma membrane,BP,
1834,GO:0004491,1.0000000000079,0.901286723718111,0,1,methylmalonate-semialdehyde dehydrogenase (acylating) activity,MF,
4734,GO:0010904,1.0000000000079,0.901286723718111,0,1,regulation of UDP-glucose catabolic process,BP,
4735,GO:0010905,1.0000000000079,0.901286723718111,0,1,negative regulation of UDP-glucose catabolic process,BP,
5974,GO:0018478,1.0000000000079,0.901286723718111,0,1,malonate-semialdehyde dehydrogenase (acetylating) activity,MF,
18727,GO:1904226,1.0000000000079,0.901286723718111,0,1,regulation of glycogen synthase activity, transferring glucose-1-phosphate,BP,
18728,GO:1904227,1.0000000000079,0.901286723718111,0,1,negative regulation of glycogen synthase activity, transferring glucose-1-phosphate,BP,
836,GO:0002143,1.0000000000079,0.66488945163214,0,4,tRNA wobble position uridine thiolation,BP,
8061,GO:0032741,1.00000000000792,0.78785790833201,0,2,positive regulation of interleukin-18 production,BP,
744,GO:0001976,1.00000000000793,0.643196614496988,0,4,neurological system process involved in regulation of systemic arterial blood pressure,BP,
4123,GO:0009184,1.00000000000793,0.91155734674085,0,1,purine deoxyribonucleoside diphosphate catabolic process,BP,
4131,GO:0009192,1.00000000000793,0.91155734674085,0,1,deoxyribonucleoside diphosphate catabolic process,BP,
10948,GO:0044716,1.00000000000793,0.91155734674085,0,1,8-oxo-GDP phosphatase activity,MF,
10949,GO:0044717,1.00000000000793,0.91155734674085,0,1,8-hydroxy-dADP phosphatase activity,MF,
11516,GO:0046057,1.00000000000793,0.91155734674085,0,1,dADP catabolic process,BP,
11522,GO:0046067,1.00000000000793,0.91155734674085,0,1,dGDP catabolic process,BP,
11802,GO:0046712,1.00000000000793,0.91155734674085,0,1,GDP catabolic process,BP,
18179,GO:1902988,1.00000000000795,0.689466350039189,0,3,neurofibrillary tangle assembly,BP,
6805,GO:0030263,1.00000000000796,0.625198407340616,0,4,apoptotic chromosome condensation,BP,
8219,GO:0032991,1.00000000000796,0,286,3843,protein-containing complex,CC,ITGB6;DDB2;APOE;GPSM1;HSPA2;FBXW4;EGFR;ESPN;GIGYF1;CIRBP;PKD2;CAPRIN2;XPC;APOBEC3C;RBM3;ASH2L;OBSL1;KIF26B;EPS8L2;EPHB2;DCAF16;PIK3R1;RBCK1;COL22A1;CUL9;EVC;POU3F1;WNT3;DHTKD1;UNK;MVB12B;KCNAB2;ZFPM1;CUL7;VAMP3;C1QTNF6;STAT1;IMPACT;MYL9;WDR63;ITGB5;COL10A1;GJD3;NOS1;PRKACB;CRTAP;NFATC4;BTBD2;SCARA3;FERMT1;H1F0;AP5Z1;CNTRL;PIK3C2G;PLXNB1;VPS11;COL7A1;KCNC4;ITPR3;MDM2;MLH3;PPP2R2C;GPRC5C;HLA-B;MYH11;NDUFA4L2;ACTR1B;TNXB;NEO1;SPSB3;POLR2J2;NUDCD3;KIF26A;AP1G2;HPS4;BLOC1S4;SPTB;DNAH1;TUBGCP5;CLTCL1;FLOT1;DHX32;TCEA2;SOX12;SLX1A;SLX1B;GJC2;FBXO44;C5;SNTA1;PHF2;WWTR1;ITGA2;ULK1;GLI3;THRAP3;SMARCA1;AKAP7;VAMP2;LTBP1;ITGA6;KCNJ5;SESN3;JARID2;NUPR1;INSR;GSN;CHD3;CDK14;TTN;SCNN1A;PLXNB3;SUN1;POLD4;PMS2P3;SCN4B;SEPT6;VPS39;RTF1;BLOC1S3;RICTOR;H2AFJ;TCIRG1;PDK1;SQSTM1;SHARPIN;METTL23;ARHGAP33;H1FX;NSMCE4A;CENPC;BBS2;TCF4;ATP6V0A2;COL6A1;PEX11B;RCOR2;WRN;SEPT5;DNM1;MCM9;ZYG11B;KLHL24;CDK5R1;ATRX;REC8;POLR2J3;HOOK2;SESN1;SHANK3;HFE;CYBA;AGO4;ERCC6;RRM2B;CLIP2;FBXO2;WASH3P;IFT140;GABBR1;XRN1;MLXIPL;FBXW7;KCNMA1;ING4;ATXN1;LMO2;MXI1;CHMP1B;THRA;APC2;METTL21A;MX2;IKZF4;DCAF10;OGDHL;NLRP1;GNG2;FBXW5;CAPG;LRP1;KLHDC8B;HLA-A;TSNARE1;PLA2G7;SYNPO2;C12ORF66;CENPH;KCNG1;MYO3B;APPL2;SALL2;BBS1;JPH2;SDHA;RET;DAB2IP;TEAD2;FBXO4;OLFM2;PIK3C3;ZNF276;FGFR4;ERCC5;BBS5;EXOC2;PIK3R2;SCN2A;ABTB1;KLHL3;MYO9A;VDR;CACNB3;TNRC18;VIPR1;PLXND1;NDUFV3;PPP1R2;PHF1;TMEM231;TFDP2;SNX1;GOLGA7B;ACVR1B;SHROOM4;DLG4;CCDC113;TNNI2;PPP2R3B;IGFBP6;DYDC1;DQX1;TCF7;SHANK2;ZFP36L1;KAT2B;TEP1;DMXL2;CEP250;ANO1;ERN1;IVNS1ABP;RAD50;TRERF1;ZSWIM8;CBR4;DCAF8;MYH16;TAS1R3;NELFCD;PHC2;KIF7;CPT1C;KLHL29;CHD6;TRAF5;RANBP9;CACNB1;HDAC11;GJB5;COL13A1;ERBB2;ABCA2;AKAP6;ATG14;MPP7;RORA;PPARG;PRKACA;LDLRAP1;NPAP1;SYNE2;PLTP;SUCLG2;LAMB2;AIP;COG1;KCNS3;PRMT3;MSH5;MAP1A;PTBP2;NPNT;EML2;CTNNBIP1;GCLC
6540,GO:0021957,1.00000000000797,0.606195998766911,0,4,corticospinal tract morphogenesis,BP,
13168,GO:0051795,1.00000000000798,0.747730215520981,0,3,positive regulation of timing of catagen,BP,
6297,GO:0019918,1.00000000000802,0.655148905070521,0,4,peptidyl-arginine methylation, to symmetrical-dimethyl arginine,BP,
9019,GO:0035243,1.00000000000802,0.655148905070521,0,4,protein-arginine omega-N symmetric methyltransferase activity,MF,
17360,GO:1900107,1.00000000000803,0.791301497465055,0,2,regulation of nodal signaling pathway,BP,
17387,GO:1900145,1.00000000000803,0.791301497465055,0,2,regulation of nodal signaling pathway involved in determination of left/right asymmetry,BP,
17402,GO:1900175,1.00000000000803,0.791301497465055,0,2,regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,BP,
8636,GO:0034189,1.00000000000804,0.793354596570235,0,2,very-low-density lipoprotein particle binding,MF,
5570,GO:0016590,1.00000000000804,0.879466087617183,0,1,ACF complex,CC,
16540,GO:0097343,1.00000000000804,0.691915256235064,0,3,ripoptosome assembly,BP,
17510,GO:1901026,1.00000000000804,0.691915256235064,0,3,ripoptosome assembly involved in necroptotic process,BP,
1051,GO:0002579,1.00000000000804,0.669681221175216,0,4,positive regulation of antigen processing and presentation,BP,
11769,GO:0046645,1.00000000000807,0.683660177057914,0,3,positive regulation of gamma-delta T cell activation,BP,
4486,GO:0010511,1.00000000000807,0.667121891277342,0,4,regulation of phosphatidylinositol biosynthetic process,BP,
18672,GO:1904047,1.00000000000809,0.729298082331777,0,3,S-adenosyl-L-methionine binding,MF,
19453,GO:1990180,1.00000000000812,0.756324918948879,0,3,mitochondrial tRNA 3'-end processing,BP,
20030,GO:2000676,1.00000000000814,0.649213549129562,0,4,positive regulation of type B pancreatic cell apoptotic process,BP,
9213,GO:0035611,1.00000000000816,0.89916393041043,0,1,protein branching point deglutamylation,BP,
19717,GO:2000110,1.00000000000817,0.734214117680424,0,3,negative regulation of macrophage apoptotic process,BP,
2348,GO:0005412,1.00000000000817,0.79395224830152,0,2,glucose:sodium symporter activity,MF,
15242,GO:0071438,1.00000000000818,0.643373306973634,0,4,invadopodium membrane,CC,
7532,GO:0031802,1.00000000000823,0.712390168888871,0,3,type 5 metabotropic glutamate receptor binding,MF,
5095,GO:0015373,1.00000000000823,0.783166977144918,0,2,anion:sodium symporter activity,MF,
13544,GO:0060029,1.00000000000823,0.624253586946199,0,4,convergent extension involved in organogenesis,BP,
1366,GO:0003253,1.00000000000824,0.636008473806552,0,4,cardiac neural crest cell migration involved in outflow tract morphogenesis,BP,
15034,GO:0071008,1.00000000000828,0.669307844231606,0,4,U2-type post-mRNA release spliceosomal complex,CC,
14012,GO:0060763,1.0000000000083,0.791693988373744,0,2,mammary duct terminal end bud growth,BP,
16688,GO:0097692,1.00000000000831,0.879288396307157,0,1,histone H3-K4 monomethylation,BP,
17780,GO:1901895,1.00000000000831,0.879288396307157,0,1,negative regulation of calcium-transporting ATPase activity,BP,
15750,GO:0072367,1.00000000000831,0.608625690445954,0,4,regulation of lipid transport by regulation of transcription from RNA polymerase II promoter,BP,
16710,GO:0097742,1.00000000000834,0.68787863836012,0,3,de novo centriole assembly,BP,
16735,GO:0098535,1.00000000000834,0.68787863836012,0,3,de novo centriole assembly involved in multi-ciliated epithelial cell differentiation,BP,
15223,GO:0071403,1.00000000000835,0.80066079384526,0,2,cellular response to high density lipoprotein particle stimulus,BP,
8760,GO:0034448,1.00000000000838,0.677148103305668,0,4,EGO complex,CC,
2135,GO:0004947,1.0000000000084,0.813107402188905,0,2,bradykinin receptor activity,MF,
2300,GO:0005280,1.0000000000084,0.706821873454026,0,3,amino acid:proton symporter activity,MF,
16177,GO:0090230,1.00000000000842,0.625310847484549,0,4,regulation of centromere complex assembly,BP,
1717,GO:0004311,1.00000000000848,0.728224458209879,0,3,farnesyltranstransferase activity,MF,
10305,GO:0043103,1.00000000000849,0.750148190036439,0,3,hypoxanthine salvage,BP,
15335,GO:0071586,1.00000000000849,0.818425910444324,0,2,CAAX-box protein processing,BP,
15953,GO:0080120,1.00000000000849,0.818425910444324,0,2,CAAX-box protein maturation,BP,
14730,GO:0070426,1.00000000000851,0.810750962445559,0,2,positive regulation of nucleotide-binding oligomerization domain containing signaling pathway,BP,
14737,GO:0070434,1.00000000000851,0.810750962445559,0,2,positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway,BP,
10980,GO:0044793,1.00000000000851,0.626597256201291,0,4,negative regulation by host of viral process,BP,
10995,GO:0044828,1.00000000000851,0.626597256201291,0,4,negative regulation by host of viral genome replication,BP,
11211,GO:0045358,1.00000000000851,0.829548077853987,0,2,negative regulation of interferon-beta biosynthetic process,BP,
1254,GO:0003010,1.00000000000854,0.818330075865325,0,2,voluntary skeletal muscle contraction,BP,
4866,GO:0014721,1.00000000000854,0.818330075865325,0,2,twitch skeletal muscle contraction,BP,
1299,GO:0003139,1.00000000000856,0.665651626616522,0,4,secondary heart field specification,BP,
17429,GO:1900227,1.00000000000858,0.620382876309004,0,4,positive regulation of NLRP3 inflammasome complex assembly,BP,
12637,GO:0050861,1.00000000000862,0.635537469991712,0,4,positive regulation of B cell receptor signaling pathway,BP,
8424,GO:0033553,1.00000000000865,0.635127619204331,0,4,rDNA heterochromatin,CC,
14904,GO:0070778,1.00000000000865,0.635798098677934,0,4,L-aspartate transmembrane transport,BP,
3824,GO:0008426,1.00000000000869,0.765046502397517,0,3,protein kinase C inhibitor activity,MF,
2896,GO:0006404,1.00000000000869,0.736315773031597,0,3,RNA import into nucleus,BP,
2206,GO:0005093,1.0000000000087,0.810970015229379,0,2,Rab GDP-dissociation inhibitor activity,MF,
6517,GO:0021902,1.00000000000871,0.772393551049559,0,2,commitment of neuronal cell to specific neuron type in forebrain,BP,
6222,GO:0019776,1.00000000000871,0.72777914375854,0,3,Atg8 ligase activity,MF,
2575,GO:0005863,1.00000000000872,0.889567654049938,0,1,striated muscle myosin thick filament,CC,
3310,GO:0007014,1.00000000000872,0.889567654049938,0,1,actin ubiquitination,BP,
9568,GO:0036392,1.00000000000872,0.889567654049938,0,1,chemokine (C-C motif) ligand 20 production,BP,
18580,GO:1903881,1.00000000000872,0.889567654049938,0,1,regulation of interleukin-17-mediated signaling pathway,BP,
18581,GO:1903883,1.00000000000872,0.889567654049938,0,1,positive regulation of interleukin-17-mediated signaling pathway,BP,
18582,GO:1903884,1.00000000000872,0.889567654049938,0,1,regulation of chemokine (C-C motif) ligand 20 production,BP,
18583,GO:1903886,1.00000000000872,0.889567654049938,0,1,positive regulation of chemokine (C-C motif) ligand 20 production,BP,
19420,GO:1990072,1.00000000000873,0.847972315328449,0,2,TRAPPIII protein complex,CC,
9969,GO:0042374,1.00000000000878,0.926686397116891,0,1,phylloquinone metabolic process,BP,
9970,GO:0042376,1.00000000000878,0.926686397116891,0,1,phylloquinone catabolic process,BP,
17711,GO:1901662,1.00000000000878,0.926686397116891,0,1,quinone catabolic process,BP,
14142,GO:0061046,1.00000000000881,0.646385419642946,0,4,regulation of branching involved in lung morphogenesis,BP,
5315,GO:0016035,1.00000000000882,0.807248715207822,0,2,zeta DNA polymerase complex,CC,
18077,GO:1902731,1.00000000000883,0.764357625081243,0,2,negative regulation of chondrocyte proliferation,BP,
10920,GO:0044565,1.00000000000885,0.820557842213157,0,2,dendritic cell proliferation,BP,
6152,GO:0019474,1.00000000000886,0.71256849996576,0,3,L-lysine catabolic process to acetyl-CoA,BP,
6153,GO:0019477,1.00000000000886,0.71256849996576,0,3,L-lysine catabolic process,BP,
8416,GO:0033512,1.00000000000886,0.71256849996576,0,3,L-lysine catabolic process to acetyl-CoA via saccharopine,BP,
11652,GO:0046440,1.00000000000886,0.71256849996576,0,3,L-lysine metabolic process,BP,
9412,GO:0035990,1.00000000000887,0.905409991830084,0,1,tendon cell differentiation,BP,
9413,GO:0035992,1.00000000000887,0.905409991830084,0,1,tendon formation,BP,
12194,GO:0048389,1.00000000000887,0.905409991830084,0,1,intermediate mesoderm development,BP,
12195,GO:0048390,1.00000000000887,0.905409991830084,0,1,intermediate mesoderm morphogenesis,BP,
12196,GO:0048391,1.00000000000887,0.905409991830084,0,1,intermediate mesoderm formation,BP,
12197,GO:0048392,1.00000000000887,0.905409991830084,0,1,intermediate mesodermal cell differentiation,BP,
13460,GO:0055018,1.00000000000887,0.905409991830084,0,1,regulation of cardiac muscle fiber development,BP,
13461,GO:0055020,1.00000000000887,0.905409991830084,0,1,positive regulation of cardiac muscle fiber development,BP,
13856,GO:0060503,1.00000000000887,0.905409991830084,0,1,bud dilation involved in lung branching,BP,
14190,GO:0061149,1.00000000000887,0.905409991830084,0,1,BMP signaling pathway involved in ureter morphogenesis,BP,
14191,GO:0061150,1.00000000000887,0.905409991830084,0,1,renal system segmentation,BP,
14192,GO:0061151,1.00000000000887,0.905409991830084,0,1,BMP signaling pathway involved in renal system segmentation,BP,
14196,GO:0061155,1.00000000000887,0.905409991830084,0,1,pulmonary artery endothelial tube morphogenesis,BP,
14218,GO:0061216,1.00000000000887,0.905409991830084,0,1,regulation of transcription from RNA polymerase II promoter involved in mesonephros development,BP,
14221,GO:0061227,1.00000000000887,0.905409991830084,0,1,pattern specification involved in mesonephros development,BP,
15492,GO:0071893,1.00000000000887,0.905409991830084,0,1,BMP signaling pathway involved in nephric duct formation,BP,
15588,GO:0072096,1.00000000000887,0.905409991830084,0,1,negative regulation of branch elongation involved in ureteric bud branching,BP,
15589,GO:0072097,1.00000000000887,0.905409991830084,0,1,negative regulation of branch elongation involved in ureteric bud branching by BMP signaling pathway,BP,
15590,GO:0072098,1.00000000000887,0.905409991830084,0,1,anterior/posterior pattern specification involved in kidney development,BP,
15591,GO:0072099,1.00000000000887,0.905409991830084,0,1,anterior/posterior pattern specification involved in ureteric bud development,BP,
15592,GO:0072100,1.00000000000887,0.905409991830084,0,1,specification of ureteric bud anterior/posterior symmetry,BP,
15593,GO:0072101,1.00000000000887,0.905409991830084,0,1,specification of ureteric bud anterior/posterior symmetry by BMP signaling pathway,BP,
15649,GO:0072192,1.00000000000887,0.905409991830084,0,1,ureter epithelial cell differentiation,BP,
15653,GO:0072198,1.00000000000887,0.905409991830084,0,1,mesenchymal cell proliferation involved in ureter development,BP,
15654,GO:0072199,1.00000000000887,0.905409991830084,0,1,regulation of mesenchymal cell proliferation involved in ureter development,BP,
15655,GO:0072200,1.00000000000887,0.905409991830084,0,1,negative regulation of mesenchymal cell proliferation involved in ureter development,BP,
17795,GO:1901964,1.00000000000887,0.905409991830084,0,1,positive regulation of cell proliferation involved in outflow tract morphogenesis,BP,
19664,GO:2000004,1.00000000000887,0.905409991830084,0,1,regulation of metanephric S-shaped body morphogenesis,BP,
19665,GO:2000005,1.00000000000887,0.905409991830084,0,1,negative regulation of metanephric S-shaped body morphogenesis,BP,
19666,GO:2000006,1.00000000000887,0.905409991830084,0,1,regulation of metanephric comma-shaped body morphogenesis,BP,
19667,GO:2000007,1.00000000000887,0.905409991830084,0,1,negative regulation of metanephric comma-shaped body morphogenesis,BP,
12741,GO:0051030,1.00000000000888,0.687941844017751,0,4,snRNA transport,BP,
11548,GO:0046110,1.0000000000089,0.705551842470981,0,3,xanthine metabolic process,BP,
5552,GO:0016561,1.0000000000089,0.80595663927579,0,2,protein import into peroxisome matrix, translocation,BP,
1726,GO:0004322,1.00000000000895,0.712096714990627,0,3,ferroxidase activity,MF,
5636,GO:0016724,1.00000000000895,0.712096714990627,0,3,oxidoreductase activity, oxidizing metal ions, oxygen as acceptor,MF,
12025,GO:0047800,1.00000000000895,0.889510759597537,0,1,cysteamine dioxygenase activity,MF,
19862,GO:2000370,1.00000000000896,0.614273634687603,0,4,positive regulation of clathrin-dependent endocytosis,BP,
14675,GO:0070318,1.00000000000901,0.650235121606931,0,4,positive regulation of G0 to G1 transition,BP,
17305,GO:0150018,1.00000000000902,0.697779801596473,0,3,basal dendrite development,BP,
17306,GO:0150019,1.00000000000902,0.697779801596473,0,3,basal dendrite morphogenesis,BP,
17307,GO:0150020,1.00000000000902,0.697779801596473,0,3,basal dendrite arborization,BP,
9218,GO:0035616,1.00000000000904,0.695156437185324,0,3,histone H2B conserved C-terminal lysine deubiquitination,BP,
19117,GO:1905123,1.00000000000905,0.780807983081486,0,2,regulation of glucosylceramidase activity,BP,
6563,GO:0022028,1.00000000000908,0.603434275120188,0,4,tangential migration from the subventricular zone to the olfactory bulb,BP,
20140,GO:2000977,1.00000000000909,0.753189849679243,0,3,regulation of forebrain neuron differentiation,BP,
14411,GO:0061739,1.00000000000913,0.706375416778449,0,3,protein lipidation involved in autophagosome assembly,BP,
6169,GO:0019534,1.00000000000916,0.614410690308627,0,4,toxin transmembrane transporter activity,MF,
18235,GO:1903094,1.0000000000092,0.859308269950301,0,2,negative regulation of protein K48-linked deubiquitination,BP,
19739,GO:2000157,1.0000000000092,0.859308269950301,0,2,negative regulation of ubiquitin-specific protease activity,BP,
19978,GO:2000609,1.00000000000923,0.719976342750745,0,3,regulation of thyroid hormone generation,BP,
3832,GO:0008440,1.00000000000925,0.628886261316847,0,4,inositol-1,4,5-trisphosphate 3-kinase activity,MF,
1243,GO:0002945,1.00000000000927,0.791677523049993,0,2,cyclin K-CDK13 complex,CC,
1434,GO:0003415,1.00000000000928,0.622121545995981,0,4,chondrocyte hypertrophy,BP,
14032,GO:0060825,1.00000000000928,0.820497150667789,0,2,fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
19822,GO:2000313,1.00000000000928,0.820497150667789,0,2,regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
1264,GO:0003032,1.00000000000928,0.807422048895456,0,2,detection of oxygen,BP,
8199,GO:0032962,1.00000000000928,0.712033435092372,0,3,positive regulation of inositol trisphosphate biosynthetic process,BP,
3364,GO:0007113,1.0000000000093,0.757428399752253,0,3,endomitotic cell cycle,BP,
1793,GO:0004427,1.00000000000935,0.758924980661684,0,3,inorganic diphosphatase activity,MF,
786,GO:0002051,1.00000000000936,0.609398374604711,0,4,osteoblast fate commitment,BP,
2683,GO:0006046,1.00000000000937,0.736158511151958,0,3,N-acetylglucosamine catabolic process,BP,
3764,GO:0008310,1.0000000000094,0.662339754501553,0,4,single-stranded DNA 3'-5' exodeoxyribonuclease activity,MF,
3987,GO:0008859,1.0000000000094,0.933780695831665,0,1,exoribonuclease II activity,MF,
12953,GO:0051365,1.00000000000941,0.894616874225673,0,1,cellular response to potassium ion starvation,BP,
5111,GO:0015432,1.00000000000941,0.891804724248232,0,1,bile acid-exporting ATPase activity,MF,
8371,GO:0033283,1.00000000000941,0.891804724248232,0,1,organic acid-transporting ATPase activity,MF,
8372,GO:0033284,1.00000000000941,0.891804724248232,0,1,carboxylic acid-transporting ATPase activity,MF,
8373,GO:0033285,1.00000000000941,0.891804724248232,0,1,monocarboxylic acid-transporting ATPase activity,MF,
8338,GO:0033206,1.00000000000943,0.628660464879985,0,4,meiotic cytokinesis,BP,
14951,GO:0070877,1.00000000000949,0.793297552826527,0,2,microprocessor complex,CC,
18236,GO:1903095,1.00000000000949,0.793297552826527,0,2,ribonuclease III complex,CC,
8778,GO:0034473,1.0000000000095,0.769047499122495,0,3,U1 snRNA 3'-end processing,BP,
8781,GO:0034476,1.0000000000095,0.769047499122495,0,3,U5 snRNA 3'-end processing,BP,
7680,GO:0032138,1.0000000000095,0.627725066131914,0,4,single base insertion or deletion binding,MF,
12788,GO:0051102,1.00000000000954,0.885652817130071,0,1,DNA ligation involved in DNA recombination,BP,
7909,GO:0032490,1.00000000000955,0.624021573651724,0,4,detection of molecule of bacterial origin,BP,
9245,GO:0035663,1.00000000000955,0.796314534302918,0,2,Toll-like receptor 2 binding,MF,
2177,GO:0005025,1.00000000000958,0.694788964181754,0,3,transforming growth factor beta receptor activity, type I,MF,
1360,GO:0003245,1.00000000000958,0.815357230072357,0,2,cardiac muscle tissue growth involved in heart morphogenesis,BP,
2281,GO:0005234,1.00000000000959,0.772597870434451,0,2,extracellularly glutamate-gated ion channel activity,MF,
10754,GO:0044214,1.0000000000096,0.692698100984466,0,3,spanning component of plasma membrane,CC,
12662,GO:0050893,1.0000000000096,0.73147275626813,0,3,sensory processing,BP,
7758,GO:0032286,1.0000000000096,0.710961983574178,0,3,central nervous system myelin maintenance,BP,
337,GO:0000938,1.00000000000961,0.629054951015496,0,4,GARP complex,CC,
17533,GO:1901097,1.00000000000961,0.635759447381588,0,4,negative regulation of autophagosome maturation,BP,
4473,GO:0010481,1.00000000000965,0.727772302338361,0,3,epidermal cell division,BP,
4474,GO:0010482,1.00000000000965,0.727772302338361,0,3,regulation of epidermal cell division,BP,
17453,GO:1900368,1.00000000000966,0.752596006292014,0,3,regulation of RNA interference,BP,
12559,GO:0050733,1.00000000000966,0.642025346256538,0,4,RS domain binding,MF,
3763,GO:0008309,1.00000000000968,0.664942502247144,0,4,double-stranded DNA exodeoxyribonuclease activity,MF,
8961,GO:0035061,1.00000000000971,0.611426321277027,0,4,interchromatin granule,CC,
5146,GO:0015680,1.00000000000971,0.784380352320931,0,3,intracellular copper ion transport,BP,
2021,GO:0004753,1.00000000000974,0.879526067144994,0,1,saccharopine dehydrogenase activity,MF,
11942,GO:0047130,1.00000000000974,0.879526067144994,0,1,saccharopine dehydrogenase (NADP+, L-lysine-forming) activity,MF,
11943,GO:0047131,1.00000000000974,0.879526067144994,0,1,saccharopine dehydrogenase (NAD+, L-glutamate-forming) activity,MF,
17428,GO:1900226,1.00000000000985,0.63675038944924,0,4,negative regulation of NLRP3 inflammasome complex assembly,BP,
11202,GO:0045349,1.00000000000985,0.655350511109192,0,4,interferon-alpha biosynthetic process,BP,
11207,GO:0045354,1.00000000000985,0.655350511109192,0,4,regulation of interferon-alpha biosynthetic process,BP,
16019,GO:0086070,1.0000000000099,0.690371801014511,0,3,SA node cell to atrial cardiac muscle cell communication,BP,
10749,GO:0044209,1.00000000000993,0.852446062955515,0,2,AMP salvage,BP,
16202,GO:0090269,1.00000000000993,0.679549937387399,0,3,fibroblast growth factor production,BP,
16203,GO:0090270,1.00000000000993,0.679549937387399,0,3,regulation of fibroblast growth factor production,BP,
19274,GO:1905550,1.00000000000993,0.829055551431109,0,2,regulation of protein localization to endoplasmic reticulum,BP,
19275,GO:1905552,1.00000000000993,0.829055551431109,0,2,positive regulation of protein localization to endoplasmic reticulum,BP,
18906,GO:1904672,1.00000000000994,0.693213054752534,0,3,regulation of somatic stem cell population maintenance,BP,
17096,GO:0102005,1.00000000000994,0.911819840252961,0,1,2-octaprenyl-6-methoxy-1,4-benzoquinone methylase activity,MF,
17494,GO:1900748,1.00000000000996,0.680323010579281,0,3,positive regulation of vascular endothelial growth factor signaling pathway,BP,
12277,GO:0048630,1.00000000000997,0.702991309938356,0,3,skeletal muscle tissue growth,BP,
12278,GO:0048631,1.00000000000997,0.702991309938356,0,3,regulation of skeletal muscle tissue growth,BP,
12279,GO:0048633,1.00000000000997,0.702991309938356,0,3,positive regulation of skeletal muscle tissue growth,BP,
13538,GO:0060023,1.00000000000997,0.627758805726982,0,4,soft palate development,BP,
1558,GO:0003960,1.00000000000997,0.746776804196325,0,3,NADPH:quinone reductase activity,MF,
10809,GO:0044314,1.00000000000999,0.706725727468537,0,4,protein K27-linked ubiquitination,BP,
6012,GO:0019065,1.00000000001002,0.710303598928849,0,3,receptor-mediated endocytosis of virus by host cell,BP,
15932,GO:0075509,1.00000000001002,0.710303598928849,0,3,endocytosis involved in viral entry into host cell,BP,
2224,GO:0005128,1.00000000001004,0.895191123237626,0,1,erythropoietin receptor binding,MF,
2230,GO:0005135,1.00000000001004,0.895191123237626,0,1,interleukin-3 receptor binding,MF,
13255,GO:0051964,1.00000000001005,0.609975732137747,0,4,negative regulation of synapse assembly,BP,
5114,GO:0015440,1.00000000001009,0.633311694423697,0,4,peptide-transporting ATPase activity,MF,
8344,GO:0033220,1.00000000001009,0.633311694423697,0,4,amide-transporting ATPase activity,MF,
11767,GO:0046642,1.00000000001009,0.705602287435181,0,3,negative regulation of alpha-beta T cell proliferation,BP,
8409,GO:0033489,1.00000000001012,0.660919869519866,0,4,cholesterol biosynthetic process via desmosterol,BP,
8410,GO:0033490,1.00000000001012,0.660919869519866,0,4,cholesterol biosynthetic process via lathosterol,BP,
7179,GO:0031074,1.00000000001016,0.721325579698794,0,3,nucleocytoplasmic transport complex,CC,
2337,GO:0005367,1.00000000001016,0.870263776430015,0,1,myo-inositol:sodium symporter activity,MF,
8165,GO:0032911,1.00000000001017,0.701094963260732,0,3,negative regulation of transforming growth factor beta1 production,BP,
12687,GO:0050925,1.00000000001017,0.772355633730732,0,2,negative regulation of negative chemotaxis,BP,
587,GO:0001743,1.00000000001018,0.704662521445031,0,3,optic placode formation,BP,
19215,GO:1905383,1.0000000000102,0.763241596236605,0,3,protein localization to presynapse,BP,
9912,GO:0042270,1.00000000001022,0.727913906403633,0,3,protection from natural killer cell mediated cytotoxicity,BP,
18755,GO:1904288,1.00000000001023,0.625130470641828,0,4,BAT3 complex binding,MF,
328,GO:0000917,1.00000000001025,0.904355825947043,0,1,division septum assembly,BP,
16304,GO:0090529,1.00000000001025,0.904355825947043,0,1,cell septum assembly,BP,
2635,GO:0005968,1.00000000001027,0.639463971329173,0,4,Rab-protein geranylgeranyltransferase complex,CC,
5695,GO:0016822,1.00000000001027,0.828908347351003,0,2,hydrolase activity, acting on acid carbon-carbon bonds,MF,
5696,GO:0016823,1.00000000001027,0.828908347351003,0,2,hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances,MF,
9171,GO:0035553,1.00000000001028,0.718215164012708,0,3,oxidative single-stranded RNA demethylation,BP,
14413,GO:0061741,1.0000000000103,0.811263129750529,0,2,chaperone-mediated protein transport involved in chaperone-mediated autophagy,BP,
18463,GO:1903593,1.00000000001031,0.765735926406553,0,3,regulation of histamine secretion by mast cell,BP,
18464,GO:1903595,1.00000000001031,0.765735926406553,0,3,positive regulation of histamine secretion by mast cell,BP,
13858,GO:0060510,1.00000000001033,0.808870490934291,0,2,Type II pneumocyte differentiation,BP,
8307,GO:0033152,1.00000000001041,0.622460891524216,0,4,immunoglobulin V(D)J recombination,BP,
14787,GO:0070537,1.00000000001042,0.726677189509501,0,3,histone H2A K63-linked deubiquitination,BP,
16112,GO:0090135,1.00000000001043,0.716366223761448,0,3,actin filament branching,BP,
10933,GO:0044611,1.00000000001044,0.683283249172699,0,3,nuclear pore inner ring,CC,
4520,GO:0010585,1.00000000001046,0.903331732006424,0,1,glutamine secretion,BP,
18553,GO:1903803,1.00000000001046,0.903331732006424,0,1,L-glutamine import across plasma membrane,BP,
2458,GO:0005672,1.00000000001049,0.688484737545025,0,4,transcription factor TFIIA complex,CC,
6392,GO:0021603,1.00000000001049,0.633680471183421,0,4,cranial nerve formation,BP,
9411,GO:0035989,1.00000000001051,0.697194836798461,0,3,tendon development,BP,
11948,GO:0047166,1.00000000001052,0.903462651662396,0,1,1-alkenylglycerophosphoethanolamine O-acyltransferase activity,MF,
1820,GO:0004475,1.00000000001057,0.909219618659775,0,1,mannose-1-phosphate guanylyltransferase activity,MF,
3998,GO:0008905,1.00000000001057,0.909219618659775,0,1,mannose-phosphate guanylyltransferase activity,MF,
11185,GO:0045323,1.00000000001067,0.720403665940284,0,3,interleukin-1 receptor complex,CC,
15920,GO:0072750,1.00000000001068,0.919418085557881,0,1,cellular response to leptomycin B,BP,
17612,GO:1901344,1.00000000001068,0.919418085557881,0,1,response to leptomycin B,BP,
17733,GO:1901707,1.00000000001068,0.919418085557881,0,1,leptomycin B binding,MF,
17366,GO:1900114,1.0000000000107,0.776394336903091,0,2,positive regulation of histone H3-K9 trimethylation,BP,
12242,GO:0048539,1.00000000001071,0.636997416669112,0,4,bone marrow development,BP,
8637,GO:0034190,1.00000000001072,0.634529231873554,0,4,apolipoprotein receptor binding,MF,
14827,GO:0070602,1.00000000001074,0.743930901369278,0,3,regulation of centromeric sister chromatid cohesion,BP,
5581,GO:0016602,1.00000000001074,0.655698296783589,0,4,CCAAT-binding factor complex,CC,
341,GO:0000942,1.00000000001076,0.653517806039022,0,4,condensed nuclear chromosome outer kinetochore,CC,
14243,GO:0061325,1.00000000001077,0.728744376840663,0,3,cell proliferation involved in outflow tract morphogenesis,BP,
19376,GO:1905907,1.00000000001078,0.676900910348042,0,4,negative regulation of amyloid fibril formation,BP,
16399,GO:0097057,1.00000000001079,0.841058212338191,0,2,TRAF2-GSTP1 complex,CC,
13100,GO:0051660,1.00000000001082,0.616356310560835,0,4,establishment of centrosome localization,BP,
15917,GO:0072740,1.00000000001082,0.903737446022174,0,1,cellular response to anisomycin,BP,
17440,GO:1900259,1.00000000001082,0.903737446022174,0,1,regulation of RNA-directed 5'-3' RNA polymerase activity,BP,
17441,GO:1900260,1.00000000001082,0.903737446022174,0,1,negative regulation of RNA-directed 5'-3' RNA polymerase activity,BP,
7337,GO:0031372,1.00000000001085,0.820573862281349,0,2,UBC13-MMS2 complex,CC,
7271,GO:0031262,1.00000000001086,0.709064895771753,0,4,Ndc80 complex,CC,
16273,GO:0090394,1.00000000001089,0.626066968146419,0,4,negative regulation of excitatory postsynaptic potential,BP,
6099,GO:0019322,1.0000000000109,0.675510119268872,0,4,pentose biosynthetic process,BP,
3415,GO:0007198,1.00000000001091,0.827433315943592,0,2,adenylate cyclase-inhibiting serotonin receptor signaling pathway,BP,
373,GO:0000995,1.00000000001093,0.612605398454816,0,4,transcription factor activity, core RNA polymerase III binding,MF,
16586,GO:0097442,1.00000000001095,0.879647666525186,0,1,CA3 pyramidal cell dendrite,CC,
8111,GO:0032807,1.00000000001095,0.647990671902642,0,4,DNA ligase IV complex,CC,
18439,GO:1903553,1.00000000001095,0.639056895468424,0,4,positive regulation of extracellular exosome assembly,BP,
15843,GO:0072586,1.00000000001096,0.882237785715,0,1,DNA topoisomerase (ATP-hydrolyzing) regulator activity,MF,
15844,GO:0072587,1.00000000001096,0.882237785715,0,1,DNA topoisomerase (ATP-hydrolyzing) activator activity,MF,
11980,GO:0047391,1.00000000001098,0.811868175477578,0,2,alkylglycerophosphoethanolamine phosphodiesterase activity,MF,
8946,GO:0035021,1.00000000001099,0.618456925763587,0,4,negative regulation of Rac protein signal transduction,BP,
168,GO:0000350,1.00000000001102,0.740487478914206,0,3,generation of catalytic spliceosome for second transesterification step,BP,
15693,GO:0072268,1.00000000001102,0.733141669237614,0,3,pattern specification involved in metanephros development,BP,
6477,GO:0021825,1.00000000001105,0.612340373603104,0,4,substrate-dependent cerebral cortex tangential migration,BP,
4904,GO:0014839,1.00000000001106,0.827530287626817,0,2,myoblast migration involved in skeletal muscle regeneration,BP,
1930,GO:0004631,1.00000000001106,0.918927121661394,0,1,phosphomevalonate kinase activity,MF,
8509,GO:0033745,1.00000000001107,0.718784706080842,0,3,L-methionine-(R)-S-oxide reductase activity,MF,
18538,GO:1903778,1.00000000001114,0.791396471993295,0,2,protein localization to vacuolar membrane,BP,
20009,GO:2000653,1.00000000001116,0.705729624182097,0,3,regulation of genetic imprinting,BP,
1313,GO:0003163,1.00000000001116,0.775171833440466,0,2,sinoatrial node development,BP,
14071,GO:0060921,1.00000000001116,0.775171833440466,0,2,sinoatrial node cell differentiation,BP,
14076,GO:0060931,1.00000000001116,0.775171833440466,0,2,sinoatrial node cell development,BP,
18350,GO:1903373,1.00000000001118,0.696725836534329,0,3,positive regulation of endoplasmic reticulum tubular network organization,BP,
4608,GO:0010728,1.00000000001119,0.632704111696618,0,4,regulation of hydrogen peroxide biosynthetic process,BP,
3208,GO:0006848,1.00000000001126,0.720500083452309,0,3,pyruvate transport,BP,
12620,GO:0050833,1.00000000001126,0.720500083452309,0,3,pyruvate transmembrane transporter activity,MF,
17636,GO:1901475,1.00000000001126,0.720500083452309,0,3,pyruvate transmembrane transport,BP,
3920,GO:0008594,1.00000000001128,0.784580044118042,0,2,photoreceptor cell morphogenesis,BP,
9475,GO:0036122,1.00000000001128,0.702932197584485,0,3,BMP binding,MF,
8768,GO:0034457,1.00000000001136,0.770791134888319,0,3,Mpp10 complex,CC,
9271,GO:0035720,1.00000000001137,0.707501023706408,0,3,intraciliary anterograde transport,BP,
4769,GO:0010957,1.00000000001139,0.718729132872232,0,3,negative regulation of vitamin D biosynthetic process,BP,
11567,GO:0046137,1.00000000001139,0.718729132872232,0,3,negative regulation of vitamin metabolic process,BP,
4925,GO:0014878,1.00000000001139,0.879893728341941,0,1,response to electrical stimulus involved in regulation of muscle adaptation,BP,
18944,GO:1904744,1.0000000000114,0.838289214428783,0,2,positive regulation of telomeric DNA binding,BP,
8451,GO:0033600,1.00000000001141,0.627250412285509,0,4,negative regulation of mammary gland epithelial cell proliferation,BP,
6612,GO:0022840,1.00000000001142,0.660831432469856,0,4,leak channel activity,MF,
6614,GO:0022842,1.00000000001142,0.660831432469856,0,4,narrow pore channel activity,MF,
3383,GO:0007161,1.00000000001142,0.603785081152092,0,4,calcium-independent cell-matrix adhesion,BP,
142,GO:0000294,1.00000000001144,0.791672193475595,0,2,nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay,BP,
17713,GO:1901664,1.00000000001148,0.728385353685438,0,3,regulation of NAD+ ADP-ribosyltransferase activity,BP,
17714,GO:1901666,1.00000000001148,0.728385353685438,0,3,positive regulation of NAD+ ADP-ribosyltransferase activity,BP,
4732,GO:0010899,1.00000000001148,0.760865904715714,0,3,regulation of phosphatidylcholine catabolic process,BP,
13165,GO:0051792,1.0000000000115,0.662198561630187,0,4,medium-chain fatty acid biosynthetic process,BP,
6961,GO:0030622,1.0000000000115,0.712696763032672,0,3,U4atac snRNA binding,MF,
16468,GO:0097179,1.00000000001153,0.750698854512776,0,4,protease inhibitor complex,CC,
18683,GO:1904090,1.00000000001153,0.750698854512776,0,4,peptidase inhibitor complex,CC,
13113,GO:0051694,1.00000000001154,0.789530008448227,0,2,pointed-end actin filament capping,BP,
14238,GO:0061316,1.00000000001154,0.728152403031531,0,3,canonical Wnt signaling pathway involved in heart development,BP,
8381,GO:0033306,1.00000000001155,0.803526908242412,0,2,phytol metabolic process,BP,
18260,GO:1903173,1.00000000001155,0.803526908242412,0,2,fatty alcohol metabolic process,BP,
6093,GO:0019303,1.00000000001158,0.851246611634902,0,2,D-ribose catabolic process,BP,
16720,GO:0098502,1.0000000000116,0.760913680853413,0,3,DNA dephosphorylation,BP,
7066,GO:0030862,1.00000000001166,0.879712446877271,0,1,positive regulation of polarized epithelial cell differentiation,BP,
9734,GO:0039007,1.00000000001166,0.879712446877271,0,1,pronephric nephron morphogenesis,BP,
9735,GO:0039008,1.00000000001166,0.879712446877271,0,1,pronephric nephron tubule morphogenesis,BP,
9738,GO:0039020,1.00000000001166,0.879712446877271,0,1,pronephric nephron tubule development,BP,
9739,GO:0039022,1.00000000001166,0.879712446877271,0,1,pronephric duct development,BP,
9740,GO:0039023,1.00000000001166,0.879712446877271,0,1,pronephric duct morphogenesis,BP,
14558,GO:0070121,1.00000000001166,0.879712446877271,0,1,Kupffer's vesicle development,BP,
15604,GO:0072114,1.00000000001166,0.879712446877271,0,1,pronephros morphogenesis,BP,
849,GO:0002177,1.00000000001169,0.752400059107527,0,3,manchette,CC,
17654,GO:1901537,1.0000000000117,0.670832001566684,0,3,positive regulation of DNA demethylation,BP,
9145,GO:0035509,1.0000000000117,0.685342152947702,0,3,negative regulation of myosin-light-chain-phosphatase activity,BP,
18336,GO:1903347,1.0000000000117,0.685342152947702,0,3,negative regulation of bicellular tight junction assembly,BP,
18374,GO:1903422,1.00000000001177,0.688685001321054,0,3,negative regulation of synaptic vesicle recycling,BP,
15859,GO:0072610,1.00000000001179,0.641029137643448,0,4,interleukin-12 secretion,BP,
20215,GO:2001182,1.00000000001179,0.641029137643448,0,4,regulation of interleukin-12 secretion,BP,
13114,GO:0051697,1.0000000000119,0.662741522873808,0,4,protein delipidation,BP,
2984,GO:0006528,1.00000000001193,0.745990902364972,0,3,asparagine metabolic process,BP,
14147,GO:0061052,1.00000000001193,0.645051454440527,0,4,negative regulation of cell growth involved in cardiac muscle cell development,BP,
14777,GO:0070522,1.00000000001194,0.637230670231593,0,4,ERCC4-ERCC1 complex,CC,
12368,GO:0048793,1.00000000001198,0.610105300587698,0,4,pronephros development,BP,
9227,GO:0035630,1.00000000001199,0.78987620625639,0,2,bone mineralization involved in bone maturation,BP,
2304,GO:0005290,1.00000000001209,0.809053515575949,0,2,L-histidine transmembrane transporter activity,MF,
6235,GO:0019797,1.00000000001209,0.726187109920058,0,3,procollagen-proline 3-dioxygenase activity,MF,
13434,GO:0052905,1.00000000001209,0.726187109920058,0,3,tRNA (guanine(9)-N(1))-methyltransferase activity,MF,
4874,GO:0014738,1.00000000001213,0.726752025650428,0,3,regulation of muscle hyperplasia,BP,
19531,GO:1990511,1.00000000001214,0.630862988711814,0,4,piRNA biosynthetic process,BP,
14461,GO:0061888,1.00000000001217,0.720532917927725,0,3,regulation of astrocyte activation,BP,
9240,GO:0035651,1.00000000001217,0.746781841906693,0,3,AP-3 adaptor complex binding,MF,
14968,GO:0070901,1.00000000001218,0.668113001724384,0,4,mitochondrial tRNA methylation,BP,
8689,GO:0034334,1.00000000001225,0.62258065476848,0,4,adherens junction maintenance,BP,
14989,GO:0070939,1.00000000001227,0.708997428083613,0,3,Dsl1/NZR complex,CC,
12918,GO:0051295,1.00000000001231,0.691670922073656,0,3,establishment of meiotic spindle localization,BP,
15010,GO:0070973,1.00000000001232,0.617018093762044,0,4,protein localization to endoplasmic reticulum exit site,BP,
5948,GO:0018307,1.00000000001233,0.841790943775226,0,2,enzyme active site formation,BP,
13867,GO:0060528,1.00000000001234,0.693434078217972,0,3,secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development,BP,
8484,GO:0033668,1.00000000001241,0.664572666131418,0,4,negative regulation by symbiont of host apoptotic process,BP,
13280,GO:0052041,1.00000000001241,0.664572666131418,0,4,negative regulation by symbiont of host programmed cell death,BP,
13334,GO:0052490,1.00000000001241,0.664572666131418,0,4,negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction,BP,
15466,GO:0071847,1.00000000001245,0.79120373843413,0,2,TNFSF11-mediated signaling pathway,BP,
2527,GO:0005784,1.00000000001251,0.745221054806611,0,4,Sec61 translocon complex,CC,
15126,GO:0071256,1.00000000001251,0.745221054806611,0,4,translocon complex,CC,
12783,GO:0051097,1.00000000001251,0.72278165286879,0,3,negative regulation of helicase activity,BP,
6311,GO:0019960,1.00000000001252,0.6868733989077,0,3,C-X3-C chemokine binding,MF,
9855,GO:0042126,1.00000000001252,0.655170209220879,0,4,nitrate metabolic process,BP,
971,GO:0002420,1.00000000001255,0.636540078328931,0,4,natural killer cell mediated cytotoxicity directed against tumor cell target,BP,
972,GO:0002423,1.00000000001255,0.636540078328931,0,4,natural killer cell mediated immune response to tumor cell,BP,
1195,GO:0002855,1.00000000001255,0.636540078328931,0,4,regulation of natural killer cell mediated immune response to tumor cell,BP,
1198,GO:0002858,1.00000000001255,0.636540078328931,0,4,regulation of natural killer cell mediated cytotoxicity directed against tumor cell target,BP,
19932,GO:2000508,1.00000000001262,0.672340400135575,0,4,regulation of dendritic cell chemotaxis,BP,
19933,GO:2000510,1.00000000001262,0.672340400135575,0,4,positive regulation of dendritic cell chemotaxis,BP,
16549,GO:0097360,1.00000000001267,0.79125546365525,0,2,chorionic trophoblast cell proliferation,BP,
17625,GO:1901382,1.00000000001267,0.79125546365525,0,2,regulation of chorionic trophoblast cell proliferation,BP,
12139,GO:0048263,1.00000000001267,0.677716054729645,0,4,determination of dorsal identity,BP,
14910,GO:0070814,1.00000000001272,0.653652907343313,0,4,hydrogen sulfide biosynthetic process,BP,
7677,GO:0032133,1.00000000001272,0.672970827274498,0,4,chromosome passenger complex,CC,
14818,GO:0070579,1.00000000001275,0.600690037794986,0,4,methylcytosine dioxygenase activity,MF,
16749,GO:0098574,1.0000000000128,0.648870547802439,0,4,cytoplasmic side of lysosomal membrane,CC,
10681,GO:0043974,1.00000000001281,0.70082553553014,0,3,histone H3-K27 acetylation,BP,
17718,GO:1901674,1.00000000001281,0.70082553553014,0,3,regulation of histone H3-K27 acetylation,BP,
15139,GO:0071279,1.00000000001288,0.653930895264645,0,4,cellular response to cobalt ion,BP,
20224,GO:2001198,1.00000000001298,0.745565712204444,0,3,regulation of dendritic cell differentiation,BP,
10039,GO:0042535,1.00000000001299,0.647673442149775,0,4,positive regulation of tumor necrosis factor biosynthetic process,BP,
4385,GO:0010040,1.00000000001302,0.67293875305674,0,4,response to iron(II) ion,BP,
7505,GO:0031698,1.00000000001303,0.62906591126522,0,4,beta-2 adrenergic receptor binding,MF,
11200,GO:0045347,1.00000000001304,0.712069508417216,0,3,negative regulation of MHC class II biosynthetic process,BP,
1976,GO:0004694,1.00000000001312,0.615708827390422,0,4,eukaryotic translation initiation factor 2alpha kinase activity,MF,
4557,GO:0010641,1.00000000001313,0.618140954213424,0,4,positive regulation of platelet-derived growth factor receptor signaling pathway,BP,
6824,GO:0030292,1.00000000001316,0.716678471378749,0,3,protein tyrosine kinase inhibitor activity,MF,
4469,GO:0010467,1.00000000001317,0,333,4265,gene expression,BP,TNFAIP3;HES2;SERPINE2;ZSCAN18;TSC22D1;SIK1;TP53INP1;PTHLH;SREBF1;ACTA2;APOE;MN1;LMF1;EGFR;CIRBP;PKD2;CAPRIN2;MNT;RBM3;ASH2L;TRIM22;SRSF5;SFRP1;PERM1;SEC14L2;EPHB2;DGKQ;PIK3R1;RBCK1;KDM3A;TSC22D3;POU3F1;WNT3;UNK;HR;HTRA1;TFCP2L1;RGMA;ZFPM1;HOXC5;ZNF362;CITED4;IRF2BPL;MC1R;ZNF266;STAT1;IMPACT;CAMK2N1;CRY2;THAP8;NOS1;PRKACB;ZNF704;HOXA3;CRY1;ZNF699;MAML3;ZFP41;SCMH1;KLF13;MAGEF1;NFATC4;ZNF783;RNF187;FERMT1;CYP26B1;HSF4;ZNF251;EAPP;MDM2;CRTC1;NDN;ZNF662;TYSND1;NEO1;ZNF414;TCF25;PCBP4;CTSV;POLR2J2;MLLT6;RGS2;F2R;PDCD4;ZNF160;SWT1;ZFP36L2;TRPV4;GLI2;ANK3;KLF7;RNF165;DHX32;ADAMTS13;LAMP3;TCEA2;ZNF76;SOX12;PIDD1;ZNF747;GJC2;ZCCHC11;RHBDF1;PER2;C5;ZNF658;PHF2;ABHD14B;TCEAL1;WWTR1;ITGA2;GLI3;SPPL2B;PCSK1;THRAP3;ZNF558;IRX4;SMARCA1;BHLHE40;ZNF655;NAIP;ZNF333;MAP2K5;ITGA6;ZNF318;LZTS1;TCFL5;TRAK1;JARID2;NUPR1;INSR;CCDC85B;HSF2BP;GSN;CHD3;TTN;ZNF18;AHNAK2;MXD4;ZNF287;NSUN5P2;PMS2P3;ZNF446;ZNF581;RTF1;MDK;IRF9;RICTOR;H2AFJ;BMP6;NLRX1;MAP2K2;GLI4;SQSTM1;FZD7;ETV5;DLX3;HEXB;KDM4C;METTL23;ZNF608;GDF15;BBS2;TXNIP;TCF4;PLAG1;RCOR2;IFI27;LPIN3;CDK5R1;ATRX;POLR2J3;MAPK10;HFE;ADIRF;HMG20B;TRIM38;AGO4;ERCC6;SLIT3;EDA2R;SPRY2;MEF2D;CREBRF;XRN1;MLXIPL;TARBP1;FBXW7;ING4;CDK5RAP3;ZNF862;ATXN1;LMO2;NFIX;PAK6;CARF;MXI1;THRA;ADARB1;RAI1;ELF1;IKZF4;ACACB;ZBTB34;ZNF627;MIF4GD;DBP;NAB2;EPM2AIP1;PEG3;RGS12;RFX2;ZNF554;SALL2;ZNF107;ZNF532;ZBTB20;PDE2A;ZNF334;MAF;STK16;RET;ZMYND8;PRX;DAB2IP;CASZ1;RWDD3;CALCOCO1;TEAD2;MYSM1;FBXO4;TSHZ2;PIK3C3;ZNF276;IFI16;DALRD3;FGFR4;PIK3R2;TEF;ZNF25;ABTB1;RPS6KA5;APBB3;ZNF630;BTG1;ZNF687;VDR;MAMSTR;TNRC18;TNRC6C;ZFP28;PLXND1;ZMYM3;SIX5;HLTF;PCSK6;ZNF789;ZNF563;ZNF517;STAT2;WWC3;PHF1;ZNF292;TFDP2;NRARP;ACVR1B;ZNF737;TNNI2;ZNF701;NAT14;TCEAL4;ZNF91;DYDC1;GTF2IRD2;DQX1;TCF7;ZFP36L1;GLMP;IL11;KAT2B;TEP1;ERN1;RNF141;IVNS1ABP;ZNF439;ANGEL2;TRERF1;SCG5;APBB2;STAT6;PCSK1N;SOX13;PRDX5;NELFCD;KLF8;CHD6;TRAF5;GOLGB1;HDAC11;ERBB2;SPOCD1;ABCA2;KMT5C;ATG14;RORA;PPARG;PRKACA;CXXC5;ZNF572;ZNF658B;SERPING1;PARN;ZNF529;UFL1;RIPK3;KLF9;AIP;SCAND1;LONP2;PRMT3;HARS2;ZFP90;PER3;ZFP30;FOXP2;PTBP2;ZC3H6;HIVEP1;SMURF1;NPNT;CTNNBIP1;GCLC;ECM1
6970,GO:0030643,1.0000000000132,0.611357411591923,0,4,cellular phosphate ion homeostasis,BP,
15784,GO:0072501,1.0000000000132,0.611357411591923,0,4,cellular divalent inorganic anion homeostasis,BP,
15785,GO:0072502,1.0000000000132,0.611357411591923,0,4,cellular trivalent inorganic anion homeostasis,BP,
10245,GO:0042997,1.00000000001323,0.714693868485638,0,3,negative regulation of Golgi to plasma membrane protein transport,BP,
7941,GO:0032545,1.00000000001324,0.733434880857113,0,3,CURI complex,CC,
8767,GO:0034456,1.00000000001324,0.733434880857113,0,3,UTP-C complex,CC,
16315,GO:0090560,1.00000000001325,0.901432445876381,0,1,2-(3-amino-3-carboxypropyl)histidine synthase activity,MF,
5960,GO:0018352,1.00000000001325,0.816076636347637,0,2,protein-pyridoxal-5-phosphate linkage,BP,
15387,GO:0071672,1.00000000001326,0.742639117649814,0,3,negative regulation of smooth muscle cell chemotaxis,BP,
17887,GO:1902219,1.00000000001333,0.620219535103978,0,4,negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress,BP,
14295,GO:0061470,1.00000000001333,0.625207249155251,0,4,T follicular helper cell differentiation,BP,
3882,GO:0008517,1.00000000001335,0.631990579339803,0,4,folic acid transmembrane transporter activity,MF,
9625,GO:0036505,1.00000000001335,0.898394068558743,0,1,prosaposin receptor activity,MF,
2886,GO:0006391,1.00000000001338,0.726407441324447,0,3,transcription initiation from mitochondrial promoter,BP,
5793,GO:0017040,1.0000000000134,0.679520043431151,0,4,N-acylsphingosine amidohydrolase activity,MF,
14476,GO:0061945,1.00000000001343,0.716840923822163,0,3,regulation of protein K48-linked ubiquitination,BP,
1897,GO:0004583,1.00000000001346,0.635108918262176,0,4,dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity,MF,
10856,GO:0044393,1.00000000001348,0.716221781181263,0,3,microspike,CC,
9657,GO:0038027,1.00000000001353,0.608966135995495,0,4,apolipoprotein A-I-mediated signaling pathway,BP,
10726,GO:0044107,1.00000000001354,0.66525845337599,0,4,cellular alcohol metabolic process,BP,
10727,GO:0044108,1.00000000001354,0.66525845337599,0,4,cellular alcohol biosynthetic process,BP,
14765,GO:0070492,1.0000000000136,0.684379312994255,0,4,oligosaccharide binding,MF,
15453,GO:0071818,1.00000000001361,0.730198373860007,0,3,BAT3 complex,CC,
15755,GO:0072379,1.00000000001361,0.730198373860007,0,3,ER membrane insertion complex,CC,
10585,GO:0043569,1.00000000001361,0.704882826686564,0,3,negative regulation of insulin-like growth factor receptor signaling pathway,BP,
19987,GO:2000622,1.00000000001363,0.622263537449256,0,4,regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,BP,
19988,GO:2000623,1.00000000001363,0.622263537449256,0,4,negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,BP,
6957,GO:0030618,1.00000000001364,0.605976535521865,0,4,transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity,MF,
18837,GO:1904491,1.00000000001365,0.670174544393706,0,4,protein localization to ciliary transition zone,BP,
4725,GO:0010890,1.00000000001375,0.760976195700065,0,3,positive regulation of sequestering of triglyceride,BP,
2352,GO:0005432,1.00000000001376,0.712165714518029,0,3,calcium:sodium antiporter activity,MF,
7705,GO:0032202,1.0000000000138,0.651584323330976,0,4,telomere assembly,BP,
18801,GO:1904396,1.00000000001381,0.677597737418842,0,3,regulation of neuromuscular junction development,BP,
2667,GO:0006015,1.00000000001387,0.72984755487783,0,3,5-phosphoribose 1-diphosphate biosynthetic process,BP,
11638,GO:0046391,1.00000000001387,0.72984755487783,0,3,5-phosphoribose 1-diphosphate metabolic process,BP,
6613,GO:0022841,1.0000000000139,0.734625219588605,0,3,potassium ion leak channel activity,MF,
9798,GO:0040038,1.00000000001395,0.78775711844375,0,2,polar body extrusion after meiotic divisions,BP,
14849,GO:0070649,1.00000000001395,0.78775711844375,0,2,formin-nucleated actin cable assembly,BP,
17205,GO:0110009,1.00000000001395,0.78775711844375,0,2,formin-nucleated actin cable organization,BP,
2997,GO:0006543,1.00000000001402,0.7067633153801,0,3,glutamine catabolic process,BP,
697,GO:0001918,1.00000000001404,0.899458676259401,0,1,farnesylated protein binding,MF,
2883,GO:0006386,1.00000000001407,0.941964687479332,0,1,termination of RNA polymerase III transcription,BP,
12275,GO:0048625,1.00000000001413,0.632718551902199,0,4,myoblast fate commitment,BP,
8842,GO:0034648,1.00000000001413,0.610331409667661,0,4,histone demethylase activity (H3-dimethyl-K4 specific),MF,
16893,GO:0098881,1.00000000001415,0.713706128810634,0,3,exocytic insertion of neurotransmitter receptor to plasma membrane,BP,
16936,GO:0098967,1.00000000001415,0.713706128810634,0,3,exocytic insertion of neurotransmitter receptor to postsynaptic membrane,BP,
12267,GO:0048597,1.00000000001416,0.779374225799114,0,3,post-embryonic camera-type eye morphogenesis,BP,
16392,GO:0097048,1.00000000001416,0.625649496910529,0,4,dendritic cell apoptotic process,BP,
20023,GO:2000668,1.00000000001416,0.625649496910529,0,4,regulation of dendritic cell apoptotic process,BP,
15050,GO:0071034,1.00000000001421,0.658388690885587,0,4,CUT catabolic process,BP,
15054,GO:0071043,1.00000000001421,0.658388690885587,0,4,CUT metabolic process,BP,
2232,GO:0005137,1.00000000001425,0.901376915146527,0,1,interleukin-5 receptor binding,MF,
2597,GO:0005895,1.00000000001425,0.901376915146527,0,1,interleukin-5 receptor complex,CC,
11928,GO:0047016,1.00000000001426,0.901277079948202,0,1,cholest-5-ene-3-beta,7-alpha-diol 3-beta-dehydrogenase activity,MF,
5435,GO:0016300,1.00000000001426,0.713438205169382,0,3,tRNA (uracil) methyltransferase activity,MF,
4313,GO:0009794,1.00000000001431,0.651698152787878,0,4,regulation of mitotic cell cycle, embryonic,BP,
11233,GO:0045448,1.00000000001431,0.651698152787878,0,4,mitotic cell cycle, embryonic,BP,
18930,GO:1904715,1.00000000001433,0.729528232958739,0,3,negative regulation of chaperone-mediated autophagy,BP,
14660,GO:0070295,1.00000000001435,0.729852579155894,0,3,renal water absorption,BP,
6877,GO:0030388,1.00000000001442,0.666416647089406,0,4,fructose 1,6-bisphosphate metabolic process,BP,
14070,GO:0060920,1.00000000001443,0.681837657009073,0,3,cardiac pacemaker cell differentiation,BP,
14074,GO:0060926,1.00000000001443,0.681837657009073,0,3,cardiac pacemaker cell development,BP,
12131,GO:0048254,1.00000000001453,0.675501420715528,0,4,snoRNA localization,BP,
14440,GO:0061819,1.00000000001464,0.708961588677549,0,3,telomeric DNA-containing double minutes formation,BP,
19331,GO:1905764,1.00000000001464,0.708961588677549,0,3,regulation of protection from non-homologous end joining at telomere,BP,
19332,GO:1905765,1.00000000001464,0.708961588677549,0,3,negative regulation of protection from non-homologous end joining at telomere,BP,
19552,GO:1990599,1.00000000001464,0.708961588677549,0,3,3' overhang single-stranded DNA endodeoxyribonuclease activity,MF,
18033,GO:1902603,1.00000000001464,0.729239989937284,0,3,carnitine transmembrane transport,BP,
19758,GO:2000196,1.00000000001466,0.810888847543444,0,2,positive regulation of female gonad development,BP,
19874,GO:2000386,1.00000000001466,0.810888847543444,0,2,positive regulation of ovarian follicle development,BP,
18160,GO:1902951,1.0000000000147,0.811479586191379,0,2,negative regulation of dendritic spine maintenance,BP,
19314,GO:1905664,1.0000000000147,0.811479586191379,0,2,regulation of calcium ion import across plasma membrane,BP,
11401,GO:0045829,1.00000000001487,0.716472119927965,0,3,negative regulation of isotype switching,BP,
5971,GO:0018444,1.00000000001488,0.702893519833659,0,3,translation release factor complex,CC,
6436,GO:0021747,1.000000000015,0.688963341624222,0,3,cochlear nucleus development,BP,
18912,GO:1904684,1.00000000001502,0.601477869293447,0,4,negative regulation of metalloendopeptidase activity,BP,
2889,GO:0006397,1.00000000001517,0,9,439,mRNA processing,BP,SRSF5;DHX32;THRAP3;ADARB1;DQX1;ZFP36L1;ERN1;PRKACA;PTBP2
5290,GO:0015960,1.00000000001518,0.721642029167959,0,3,diadenosine polyphosphate biosynthetic process,BP,
5292,GO:0015965,1.00000000001518,0.721642029167959,0,3,diadenosine tetraphosphate metabolic process,BP,
5293,GO:0015966,1.00000000001518,0.721642029167959,0,3,diadenosine tetraphosphate biosynthetic process,BP,
5411,GO:0016259,1.00000000001521,0.644615188791647,0,4,selenocysteine metabolic process,BP,
5031,GO:0015204,1.00000000001523,0.71856243614668,0,3,urea transmembrane transporter activity,MF,
5226,GO:0015840,1.00000000001523,0.71856243614668,0,3,urea transport,BP,
13615,GO:0060136,1.00000000001524,0.631142127253093,0,4,embryonic process involved in female pregnancy,BP,
7767,GO:0032299,1.00000000001526,0.757201635897422,0,3,ribonuclease H2 complex,CC,
2070,GO:0004825,1.00000000001529,0.807431323392917,0,2,methionine-tRNA ligase activity,MF,
2920,GO:0006431,1.00000000001529,0.807431323392917,0,2,methionyl-tRNA aminoacylation,BP,
9017,GO:0035241,1.00000000001534,0.728532309910358,0,3,protein-arginine omega-N monomethyltransferase activity,MF,
3350,GO:0007079,1.00000000001535,0.695541886512934,0,3,mitotic chromosome movement towards spindle pole,BP,
18243,GO:1903121,1.00000000001537,0.652704550688183,0,4,regulation of TRAIL-activated apoptotic signaling pathway,BP,
19515,GO:1990441,1.00000000001545,0.653337791886069,0,4,negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress,BP,
19587,GO:1990745,1.0000000000155,0.637973760025506,0,4,EARP complex,CC,
15574,GO:0072076,1.00000000001561,0.699369509500515,0,3,nephrogenic mesenchyme development,BP,
9658,GO:0038028,1.00000000001566,0.632061163203477,0,4,insulin receptor signaling pathway via phosphatidylinositol 3-kinase,BP,
3102,GO:0006680,1.00000000001568,0.721502206568605,0,3,glucosylceramide catabolic process,BP,
19411,GO:1990037,1.00000000001569,0.737885256844421,0,3,Lewy body core,CC,
8690,GO:0034338,1.0000000000158,0.71045343692111,0,3,short-chain carboxylesterase activity,MF,
9488,GO:0036146,1.00000000001587,0.729478670007054,0,3,cellular response to mycotoxin,BP,
10171,GO:0042776,1.0000000000159,0.744178922738174,0,4,mitochondrial ATP synthesis coupled proton transport,BP,
1533,GO:0003920,1.00000000001594,0.903894809323035,0,1,GMP reductase activity,MF,
5287,GO:0015950,1.00000000001594,0.903894809323035,0,1,purine nucleotide interconversion,BP,
5288,GO:0015951,1.00000000001594,0.903894809323035,0,1,purine ribonucleotide interconversion,BP,
5609,GO:0016657,1.00000000001594,0.903894809323035,0,1,oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor,MF,
18016,GO:1902560,1.00000000001594,0.903894809323035,0,1,GMP reductase complex,CC,
2018,GO:0004749,1.00000000001594,0.660494989477907,0,4,ribose phosphate diphosphokinase activity,MF,
5665,GO:0016778,1.00000000001594,0.660494989477907,0,4,diphosphotransferase activity,MF,
20189,GO:2001136,1.00000000001608,0.89422550296314,0,1,negative regulation of endocytic recycling,BP,
1777,GO:0004392,1.0000000000161,0.825214631029874,0,2,heme oxygenase (decyclizing) activity,MF,
3174,GO:0006788,1.0000000000161,0.825214631029874,0,2,heme oxidation,BP,
4002,GO:0008948,1.0000000000162,0.644723251071689,0,4,oxaloacetate decarboxylase activity,MF,
20272,GO:2001274,1.00000000001647,0.79197425278617,0,2,negative regulation of glucose import in response to insulin stimulus,BP,
1593,GO:0004013,1.00000000001654,0.70248279549831,0,3,adenosylhomocysteinase activity,MF,
5683,GO:0016802,1.00000000001654,0.70248279549831,0,3,trialkylsulfonium hydrolase activity,MF,
8454,GO:0033603,1.00000000001663,0.75065483640268,0,3,positive regulation of dopamine secretion,BP,
6004,GO:0019049,1.00000000001665,0.627609650883038,0,4,evasion or tolerance of host defenses by virus,BP,
10862,GO:0044413,1.00000000001665,0.627609650883038,0,4,avoidance of host defenses,BP,
10864,GO:0044415,1.00000000001665,0.627609650883038,0,4,evasion or tolerance of host defenses,BP,
13183,GO:0051832,1.00000000001665,0.627609650883038,0,4,avoidance of defenses of other organism involved in symbiotic interaction,BP,
13185,GO:0051834,1.00000000001665,0.627609650883038,0,4,evasion or tolerance of defenses of other organism involved in symbiotic interaction,BP,
20214,GO:2001181,1.00000000001678,0.769424059175814,0,3,positive regulation of interleukin-10 secretion,BP,
19825,GO:2000317,1.00000000001679,0.716738054982269,0,3,negative regulation of T-helper 17 type immune response,BP,
19828,GO:2000320,1.00000000001679,0.716738054982269,0,3,negative regulation of T-helper 17 cell differentiation,BP,
19045,GO:1904947,1.00000000001687,0.897779428017854,0,1,folic acid import into mitochondrion,BP,
4937,GO:0014900,1.0000000000169,0.661821505333034,0,4,muscle hyperplasia,BP,
16614,GO:0097494,1.00000000001696,0.640537098994151,0,4,regulation of vesicle size,BP,
9244,GO:0035662,1.00000000001697,0.832954551057325,0,3,Toll-like receptor 4 binding,MF,
3932,GO:0008616,1.0000000000171,0.760918728887729,0,3,queuosine biosynthetic process,BP,
11552,GO:0046116,1.0000000000171,0.760918728887729,0,3,queuosine metabolic process,BP,
2149,GO:0004969,1.00000000001711,0.793421771259752,0,2,histamine receptor activity,MF,
13080,GO:0051615,1.0000000000173,0.879667834656831,0,1,histamine uptake,BP,
18380,GO:1903430,1.00000000001745,0.67562593243042,0,4,negative regulation of cell maturation,BP,
14443,GO:0061825,1.00000000001748,0.886985091677207,0,1,podosome core,CC,
16524,GO:0097298,1.00000000001748,0.886985091677207,0,1,regulation of nucleus size,BP,
19922,GO:2000481,1.00000000001776,0.616850848030843,0,4,positive regulation of cAMP-dependent protein kinase activity,BP,
1814,GO:0004466,1.00000000001791,0.667988551320681,0,4,long-chain-acyl-CoA dehydrogenase activity,MF,
5822,GO:0017099,1.00000000001791,0.667988551320681,0,4,very-long-chain-acyl-CoA dehydrogenase activity,MF,
5631,GO:0016715,1.00000000001811,0.798293439903524,0,2,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen,MF,
15594,GO:0072102,1.00000000001813,0.699287429061078,0,3,glomerulus morphogenesis,BP,
10512,GO:0043461,1.00000000001821,0.659441464831019,0,4,proton-transporting ATP synthase complex assembly,BP,
8854,GO:0034665,1.00000000001829,0.783056667462367,0,2,integrin alpha1-beta1 complex,CC,
10371,GO:0043208,1.00000000001831,0.65185067529391,0,4,glycosphingolipid binding,MF,
1862,GO:0004528,1.00000000001837,0.650116980795763,0,4,phosphodiesterase I activity,MF,
6889,GO:0030430,1.00000000001851,0.640555609366561,0,4,host cell cytoplasm,CC,
8483,GO:0033655,1.00000000001851,0.640555609366561,0,4,host cell cytoplasm part,CC,
7934,GO:0032532,1.00000000001863,0.724588290799874,0,3,regulation of microvillus length,BP,
7102,GO:0030906,1.00000000001865,0.664842723689421,0,4,retromer, cargo-selective complex,CC,
14230,GO:0061303,1.00000000001894,0.702470613320377,0,3,cornea development in camera-type eye,BP,
16233,GO:0090309,1.00000000001897,0.615655646279667,0,4,positive regulation of methylation-dependent chromatin silencing,BP,
7406,GO:0031501,1.00000000001918,0.733113078527079,0,4,mannosyltransferase complex,CC,
6011,GO:0019064,1.00000000001923,0.730958406257642,0,3,fusion of virus membrane with host plasma membrane,BP,
9767,GO:0039663,1.00000000001923,0.730958406257642,0,3,membrane fusion involved in viral entry into host cell,BP,
10985,GO:0044800,1.00000000001923,0.730958406257642,0,3,multi-organism membrane fusion,BP,
14160,GO:0061083,1.00000000001925,0.641370709938137,0,4,regulation of protein refolding,BP,
14161,GO:0061084,1.00000000001925,0.641370709938137,0,4,negative regulation of protein refolding,BP,
18224,GO:1903059,1.00000000001942,0.637742460896783,0,4,regulation of protein lipidation,BP,
18225,GO:1903061,1.00000000001942,0.637742460896783,0,4,positive regulation of protein lipidation,BP,
101,GO:0000213,1.00000000001952,0.662375807202606,0,4,tRNA-intron endonuclease activity,MF,
7947,GO:0032554,1.00000000001971,0.681308635990188,0,4,purine deoxyribonucleotide binding,MF,
19888,GO:2000405,1.00000000001977,0.879754927627483,0,1,negative regulation of T cell migration,BP,
3015,GO:0006561,1.00000000001993,0.660656942910512,0,4,proline biosynthetic process,BP,
13517,GO:0055129,1.00000000001993,0.660656942910512,0,4,L-proline biosynthetic process,BP,
15472,GO:0071865,1.00000000002002,0.660554043343135,0,4,regulation of apoptotic process in bone marrow,BP,
15473,GO:0071866,1.00000000002002,0.660554043343135,0,4,negative regulation of apoptotic process in bone marrow,BP,
8508,GO:0033743,1.00000000002015,0.659515171487365,0,4,peptide-methionine (R)-S-oxide reductase activity,MF,
4499,GO:0010533,1.00000000002017,0.79036156467965,0,3,regulation of activation of Janus kinase activity,BP,
18393,GO:1903445,1.00000000002018,0.753827485526458,0,3,protein transport from ciliary membrane to plasma membrane,BP,
221,GO:0000461,1.00000000002098,0.893502637216209,0,2,endonucleolytic cleavage to generate mature 3'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
6884,GO:0030423,1.00000000002098,0.637441664534443,0,4,targeting of mRNA for destruction involved in RNA interference,BP,
14412,GO:0061740,1.00000000002127,0.718308796790272,0,3,protein targeting to lysosome involved in chaperone-mediated autophagy,BP,
4729,GO:0010896,1.00000000002132,0.714894838620434,0,3,regulation of triglyceride catabolic process,BP,
13895,GO:0060574,1.00000000002135,0.66675822045512,0,4,intestinal epithelial cell maturation,BP,
12517,GO:0050682,1.00000000002247,0.786404952811646,0,2,AF-2 domain binding,MF,
10510,GO:0043456,1.00000000002294,0.667958948344386,0,4,regulation of pentose-phosphate shunt,BP,
3012,GO:0006558,1.00000000002338,0.708798324542901,0,4,L-phenylalanine metabolic process,BP,
3013,GO:0006559,1.00000000002338,0.708798324542901,0,4,L-phenylalanine catabolic process,BP,
17889,GO:1902221,1.00000000002338,0.708798324542901,0,4,erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process,BP,
17890,GO:1902222,1.00000000002338,0.708798324542901,0,4,erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process,BP,
6586,GO:0022605,1.00000000002365,0.662070739009939,0,4,mammalian oogenesis stage,BP,
1859,GO:0004525,1.00000000002369,0.627776000532218,0,4,ribonuclease III activity,MF,
7765,GO:0032296,1.00000000002369,0.627776000532218,0,4,double-stranded RNA-specific ribonuclease activity,MF,
6043,GO:0019166,1.00000000002394,0.740607583585797,0,3,trans-2-enoyl-CoA reductase (NADPH) activity,MF,
7360,GO:0031415,1.00000000002402,0.664792359327952,0,4,NatA complex,CC,
3897,GO:0008537,1.00000000002471,0.78118388150193,0,3,proteasome activator complex,CC,
11971,GO:0047323,1.00000000002656,0.90157085492949,0,1,[3-methyl-2-oxobutanoate dehydrogenase (acetyl-transferring)] kinase activity,MF,
13324,GO:0052381,1.00000000002656,0.90157085492949,0,1,tRNA dimethylallyltransferase activity,MF,
10381,GO:0043227,1.00000000002732,0,848,9228,membrane-bounded organelle,CC,TNFAIP3;TGFBI;POSTN;ITGB6;HES2;SERPINE2;ZSCAN18;ULK2;GPNMB;TSC22D1;SIK1;SLFN5;SUGCT;EPM2A;MUC19;NPEPL1;DDB2;TP53INP1;MAP6;IFI6;PTHLH;SREBF1;AMACR;PYGB;MXRA5;ACTA2;APOE;GPSM1;CES2;NT5E;GAMT;OAS2;ADAM19;LMF1;HSPA2;EGFR;TRIM65;HERC3;PTPRS;CIRBP;FAM20C;PKD2;CAPRIN2;MNT;XPC;APOBEC3C;SYT8;CXCR1;CPT2;RBM3;SYN1;ASH2L;TRIM22;ALDH1A3;SRSF5;LRIG3;CTSO;SFRP1;OBSL1;PERM1;SEC14L2;PCDH1;EPS8L2;EPHB2;RALGDS;GPX3;MAP3K14;GLUD1;BPHL;DCAF16;DGKQ;TMEM129;PIK3R1;ADAMTS7;BRSK1;TXNRD3;MARVELD1;KDM3A;CXCL14;COL22A1;TSC22D3;EYS;EVC;POU3F1;SULF2;WNT3;H6PD;DHTKD1;CAMKK1;UBXN4;VAV3;ST6GALNAC2;HR;CSPG4;ISG15;MVB12B;CYBRD1;HTRA1;SPATA18;TFCP2L1;TENM4;RGMA;KCNAB2;ZFPM1;HOXC5;ZDHHC1;ZNF362;CUL7;VAMP3;CITED4;SNN;IRF2BPL;NAPRT;REEP2;PRICKLE2;ASAP3;ZNF266;SRD5A3;OR2A4;STAT1;CRY2;KRT15;HS1BP3;LGALS7B;MARCKSL1;NSG1;UROS;KDSR;ITGB5;COL10A1;RAB43;RAB40B;NOS1;PRKACB;ZNF704;HOXA3;B4GALNT4;CRY1;ZNF699;MAML3;ZFP41;SCMH1;KLF13;CRTAP;SDC3;BCAM;MAGEF1;PLEKHG5;NFATC4;ZNF783;HMGCL;D2HGDH;SCARA3;FKBP5;RNF187;H1F0;CYP26B1;GAA;AP5Z1;CMPK2;HSF4;ZNF251;MICALL1;LIG1;CDK18;VPS11;SPEG;NDRG1;COL7A1;ITPR3;EAPP;NAGLU;CYHR1;MDM2;CRTC1;LZTS2;PLCD1;NDN;MLH3;DDX59;ST6GALNAC6;ZNF662;TYSND1;LTBP4;PIK3IP1;OBSCN;IDUA;GOLGA8A;GPRC5C;HLA-B;TNFSF10;PRODH;HGSNAT;MYH11;SYTL1;FKBP9;NDUFA4L2;CALML3;ACTR1B;TNXB;RHOBTB2;UGT1A3;CERS4;CYP3A5;NEO1;RAPGEF3;PHACTR3;ZNF414;TCF25;ENDOD1;FAM210B;CTSV;POLH;BLVRB;POLR2J2;OAS1;FLRT3;TRIM66;GAL3ST4;CRAT;B4GALT6;MLLT6;AP1G2;RGL4;RGS2;ACAP3;F2R;MLYCD;PPL;C2CD4C;HPS4;PHYH;MT1X;PDCD4;SPTB;SERPINB5;NOL4L;ZNF160;CAPN7;SWT1;SLC27A3;ARSI;NEK9;RTN4RL1;ZFP36L2;CLTCL1;TRPV4;TMC6;FLOT1;GLI2;AGAP4;TOM1L2;ANK3;KLF7;RNF165;DHX32;ADAMTS13;LAMP3;TCEA2;RALGAPA1;MAPK8IP3;GOLGA8B;ZNF76;SOX12;PIDD1;AVL9;SLX1A;SLX1B;G6PC3;ATG16L2;SPG11;ZCCHC11;RHBDF1;SULT1E1;PER2;CLCN6;PTGS1;DIRC2;HEXA;FNDC4;C5;ZNF658;ARSD;WIPF1;PSKH1;MINK1;PHF2;ABHD14B;GSTM2;TCEAL1;AMIGO2;WWTR1;MBOAT2;ASAP2;LHFPL2;ITGA2;FAM110C;ULK1;GLI3;SPPL2B;PCSK1;THRAP3;ZNF558;IRX4;SMARCA1;AKAP7;BHLHE40;DGCR6L;VAMP2;ZNF655;NAIP;LTBP1;ZNF333;NEK8;MAP2K5;GAS8;BOC;LTBP3;CES3;BSN;SESN3;ZNF318;IGFBP4;TCFL5;TRAK1;JARID2;NUPR1;GPC2;NISCH;INSR;TST;CCDC85B;CELSR1;GSN;ALDH4A1;CEP68;HEBP1;CHD3;CDK14;ST3GAL5;BAIAP2;TTN;CBLC;SCNN1A;DDT;ZNF18;SUN1;AHNAK2;PLEKHH2;TRIOBP;MXD4;POLD4;DNAJC30;CTSF;ZNF287;CD109;CYP2D7;NSUN5P2;PNMA1;PGLS;PMS2P3;ETAA1;RMI2;ZNF446;SEPT6;RAB11FIP4;VPS39;ZNF581;MGST2;TP53AIP1;ENDOG;SLC27A1;PGAP1;TM7SF3;NRSN2;RTF1;BLOC1S3;CASP14;IRF9;TMEM9;H2AFJ;BMP6;F8A1;NLRX1;B4GALT2;PEX10;SLC2A3;TCIRG1;S100A4;MICALL2;MAP2K2;PDK1;VEGFB;ALDH7A1;GLI4;SQSTM1;CABYR;PTK6;TMEM8B;FZD7;ETV5;AKR7A2;LOXL1;FNBP4;FAM213A;FAT2;DLX3;TMEM117;HEXB;KDM4C;HYAL1;METTL23;CLCA2;H1FX;UBOX5;NSMCE4A;ARRDC1;KIAA0319L;B3GNT9;WHAMMP3;CENPC;PLA2G6;CST3;PDIK1L;MMRN2;GDF15;PEX7;BBS2;TXNIP;THSD4;TCF4;ATP6V0A2;KLHDC2;COL6A1;PEX11B;PLAG1;IDH2;CERCAM;RCOR2;WRN;PODXL;SEPT5;IFI27;MALL;OXLD1;DNM1;MCM9;MACROD1;IQCB1;PLD3;TREX1;LPIN3;ZDHHC12;ABHD14A;MCTP1;CDK5R1;ATRX;REC8;ARHGAP27;AGAP6;NET1;PIGZ;CA2;POLR2J3;HOOK2;SESN1;MAPK10;NKTR;SHANK3;HFE;ADIRF;HMG20B;CYBA;NID1;AGO4;ERCC6;HADH;RRM2B;SLIT3;KRT14;HLCS;SPRY2;FBXO2;WASH3P;MEF2D;CREBRF;XRN1;AGAP7P;RAB11FIP3;TIGD5;MLXIPL;CTSB;KLK5;TARBP1;FBXW7;KCNMA1;ANKRD28;ING4;NUDT6;CDK5RAP3;ZNF862;ATXN1;LMO2;CCDC92;NFIX;PAK6;CARF;PGM1;MXI1;PFKFB2;RNF170;CHMP1B;THRA;HSD11B1L;APC2;METTL21A;ACADS;ARAP1;ASTN2;GOLGA8N;ADARB1;RAI1;ELF1;MX2;IKZF4;DCAF10;RPH3AL;SLC2A1;ACACB;OGDHL;NLRP1;C1RL;FRAT1;ZBTB34;REEP4;ZNF627;TK2;GPR155;LACTB2;BEX2;GLUL;TBC1D17;MIF4GD;DBP;NDST2;NAB2;EPM2AIP1;GNG2;PRR7;CAPG;TSPYL4;LRP1;HLA-A;PEG3;NPHP4;RGS12;CCDC136;ATE1;ACP5;MPG;SYNPO2;RNPEP;C12ORF66;CENPH;RFX2;DLK2;ZNF554;BRINP1;SLC48A1;BDH1;PPCS;APPL2;HEXDC;SALL2;PMEL;ZNF107;ZNF532;BBS1;JPH2;ZBTB20;PDE2A;ZNF334;SDHA;MAF;STK16;LTB4R2;RET;ZMYND8;PRX;DAB2IP;CASZ1;RWDD3;ACOX3;CALCOCO1;SLC37A2;TEAD2;MYSM1;DDHD2;SHROOM2;RNF213;OLFM2;TSHZ2;PIK3C3;ZNF276;IFI16;SYT7;FGFR4;ERCC5;BBS5;PIK3R2;RETSAT;TEF;ZNF25;SETD4;OSBPL5;AREG;ABTB1;TMEM203;DEF6;SNCB;ETFB;RPS6KA5;APBB3;ZNF630;BTG1;BST2;ZNF687;VDR;LETMD1;SNX21;MAMSTR;PHF7;TNRC18;ZFP28;DPY19L2P2;ZMYM3;SIX5;HLTF;MARCH8;EHBP1;PCSK6;ZNF789;MPPE1;ZNF563;ZNF517;TBC1D16;STK19;NDUFV3;LPAR6;DMTN;STAT2;SGSM2;ARFGEF2;LMTK3;PHF1;ZNF292;SLC36A4;TMEM231;TFDP2;SNX1;GOLGA7B;OSBPL1A;ACVR1B;TMX4;ZNF737;TACC1;CADM4;KDELC2;PRIMPOL;NECAB3;CCDC88B;DLG4;CCDC113;TNNI2;PPP2R3B;ESYT2;TSSK1B;IQSEC1;ZNF701;NAT14;PANO1;PALB2;MPI;SNX29;IGFBP6;TCEAL4;ZNF91;NBEAL2;CD68;GALE;PTMS;WEE1;DYDC1;R3HDM4;TMEM143;GTF2IRD2;GOLGA6L4;SLC35G2;DQX1;AMT;TCF7;SHANK2;RSAD2;TNFRSF25;NEMP2;ZFP36L1;XYLT1;LMNA;MXRA8;CLSTN3;GLMP;TOP3B;ACSL1;KAT2B;TEP1;APOLD1;DMXL2;CEP250;ANO1;CAPS;MBLAC2;METTL7A;ERN1;IVNS1ABP;ALOX15B;RAD50;ZNF439;TKFC;LAPTM4A;ANGEL2;ZMAT3;PNPO;MAN1B1;DHRS4;PEX1;ECI1;S100A6;TRERF1;FAAH;SCYL3;EFEMP2;SCG5;APBB2;CBR4;TTC19;SGSH;GAREM2;PBLD;DCAF8;CCDC90B;RAPGEF5;CERS5;STAT6;PCSK1N;SOX13;PRDX5;PHPT1;NELFCD;PHC2;SMPDL3B;TUB;GLB1;GOLGA1;CPT1C;KLF8;GSTM3;CHD6;NAP1L5;GOLGB1;ACSS2;DPP7;CD9;PLIN4;RANBP9;HDAC11;CTSD;COL13A1;ERBB2;SYNGR1;PLCB3;NUDT10;UVSSA;ZDHHC24;ARHGAP23;PPM1M;ABCA2;KMT5C;AKAP6;SLC2A11;TH;ATG14;MPP7;RORA;SSH3;PPARG;PRKACA;LDLRAP1;CXXC5;NPAP1;C6ORF120;POLM;FMNL3;ACOT2;GCNT4;ZNF572;SYNE2;ACKR3;ZNF658B;SERPING1;SUCLG2;UCKL1;PARN;DDX12P;ZNF529;UFL1;LAMB2;IP6K2;RIPK3;NFASC;KLF9;PI4K2B;AIP;COG1;KCNS3;SCAND1;LONP2;SNX33;HARS2;CIT;ZFP90;EHHADH;MSH5;CLCN7;CCDC3;PER3;ZFP30;FOXP2;PTBP2;ZC3H6;HIVEP1;SMURF1;NPNT;CTNNBIP1;PEMT;ABCA11P;OCIAD2;SERINC3;ECM1
376,GO:0001007,1.00000000003239,0.6155784829889,0,4,transcription factor activity, RNA polymerase III transcription factor binding,MF,
